ID   SGTA_HUMAN              Reviewed;         313 AA.
AC   O43765; D6W610; Q6FIA9; Q9BTZ9;
DT   30-MAY-2000, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-1998, sequence version 1.
DT   23-MAY-2018, entry version 180.
DE   RecName: Full=Small glutamine-rich tetratricopeptide repeat-containing protein alpha;
DE   AltName: Full=Alpha-SGT;
DE   AltName: Full=Vpu-binding protein;
DE            Short=UBP;
GN   Name=SGTA; Synonyms=SGT, SGT1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=9740675; DOI=10.1006/geno.1998.5385;
RA   Kordes E., Savelyeva L., Schwab M., Rommelaere J., Jauniaux J.-C.,
RA   Cziepluch C.;
RT   "Isolation and characterization of human SGT and identification of
RT   homologues in Saccharomyces cerevisiae and Caenorhabditis elegans.";
RL   Genomics 52:90-94(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=10567422; DOI=10.1074/jbc.274.48.34425;
RA   Liu F.H., Wu S.J., Hu S.M., Hsiao C.D., Wang C.;
RT   "Specific interaction of the 70-kDa heat shock cognate protein with
RT   the tetratricopeptide repeats.";
RL   J. Biol. Chem. 274:34425-34432(1999).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND INTERACTION WITH HIV-1V PU AND GAG
RP   (MICROBIAL INFECTION).
RX   PubMed=9573291;
RA   Callahan M.A., Handley M.A., Lee Y.H., Talbot K.J., Harper J.W.,
RA   Panganiban A.T.;
RT   "Functional interaction of human immunodeficiency virus type 1 Vpu and
RT   Gag with a novel member of the tetratricopeptide repeat protein
RT   family.";
RL   J. Virol. 72:5189-5197(1998).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RA   Tobaben S., Stahl B.;
RL   Submitted (APR-2001) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Uterus;
RX   PubMed=11230166; DOI=10.1101/gr.GR1547R;
RA   Wiemann S., Weil B., Wellenreuther R., Gassenhuber J., Glassl S.,
RA   Ansorge W., Boecher M., Bloecker H., Bauersachs S., Blum H.,
RA   Lauber J., Duesterhoeft A., Beyer A., Koehrer K., Strack N.,
RA   Mewes H.-W., Ottenwaelder B., Obermaier B., Tampe J., Heubner D.,
RA   Wambutt R., Korn B., Klein M., Poustka A.;
RT   "Towards a catalog of human genes and proteins: sequencing and
RT   analysis of 500 novel complete protein coding human cDNAs.";
RL   Genome Res. 11:422-435(2001).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Halleck A., Ebert L., Mkoundinya M., Schick M., Eisenstein S.,
RA   Neubert P., Kstrang K., Schatten R., Shen B., Henze S., Mar W.,
RA   Korn B., Zuo D., Hu Y., LaBaer J.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057824; DOI=10.1038/nature02399;
RA   Grimwood J., Gordon L.A., Olsen A.S., Terry A., Schmutz J.,
RA   Lamerdin J.E., Hellsten U., Goodstein D., Couronne O., Tran-Gyamfi M.,
RA   Aerts A., Altherr M., Ashworth L., Bajorek E., Black S., Branscomb E.,
RA   Caenepeel S., Carrano A.V., Caoile C., Chan Y.M., Christensen M.,
RA   Cleland C.A., Copeland A., Dalin E., Dehal P., Denys M., Detter J.C.,
RA   Escobar J., Flowers D., Fotopulos D., Garcia C., Georgescu A.M.,
RA   Glavina T., Gomez M., Gonzales E., Groza M., Hammon N., Hawkins T.,
RA   Haydu L., Ho I., Huang W., Israni S., Jett J., Kadner K., Kimball H.,
RA   Kobayashi A., Larionov V., Leem S.-H., Lopez F., Lou Y., Lowry S.,
RA   Malfatti S., Martinez D., McCready P.M., Medina C., Morgan J.,
RA   Nelson K., Nolan M., Ovcharenko I., Pitluck S., Pollard M.,
RA   Popkie A.P., Predki P., Quan G., Ramirez L., Rash S., Retterer J.,
RA   Rodriguez A., Rogers S., Salamov A., Salazar A., She X., Smith D.,
RA   Slezak T., Solovyev V., Thayer N., Tice H., Tsai M., Ustaszewska A.,
RA   Vo N., Wagner M., Wheeler J., Wu K., Xie G., Yang J., Dubchak I.,
RA   Furey T.S., DeJong P., Dickson M., Gordon D., Eichler E.E.,
RA   Pennacchio L.A., Richardson P., Stubbs L., Rokhsar D.S., Myers R.M.,
RA   Rubin E.M., Lucas S.M.;
RT   "The DNA sequence and biology of human chromosome 19.";
RL   Nature 428:529-535(2004).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Lung, Muscle, and Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [10]
RP   PROTEIN SEQUENCE OF 138-160; 165-174 AND 185-196.
RC   TISSUE=Fetal brain cortex;
RA   Lubec G., Chen W.-Q., Sun Y.;
RL   Submitted (DEC-2008) to UniProtKB.
RN   [11]
RP   SUBUNIT, AND INTERACTION WITH HSP90AA1 AND SLC2A1.
RX   PubMed=15708368; DOI=10.1016/j.abb.2004.12.020;
RA   Liou S.T., Wang C.;
RT   "Small glutamine-rich tetratricopeptide repeat-containing protein is
RT   composed of three structural units with distinct functions.";
RL   Arch. Biochem. Biophys. 435:253-263(2005).
RN   [12]
RP   INTERACTION WITH HSP90AB1, AND SUBCELLULAR LOCATION.
RX   PubMed=16580629; DOI=10.1016/j.bbrc.2006.03.090;
RA   Yin H., Wang H., Zong H., Chen X., Wang Y., Yun X., Wu Y., Wang J.,
RA   Gu J.;
RT   "SGT, a Hsp90beta binding partner, is accumulated in the nucleus
RT   during cell apoptosis.";
RL   Biochem. Biophys. Res. Commun. 343:1153-1158(2006).
RN   [13]
RP   INTERACTION WITH SARS-COV ACCESSORY PROTEIN 7A (MICROBIAL INFECTION).
RX   PubMed=16580632; DOI=10.1016/j.bbrc.2006.03.091;
RA   Fielding B.C., Gunalan V., Tan T.H.P., Chou C.-F., Shen S., Khan S.,
RA   Lim S.G., Hong W., Tan Y.-J.;
RT   "Severe acute respiratory syndrome coronavirus protein 7a interacts
RT   with hSGT.";
RL   Biochem. Biophys. Res. Commun. 343:1201-1208(2006).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-305, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=16964243; DOI=10.1038/nbt1240;
RA   Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
RT   "A probability-based approach for high-throughput protein
RT   phosphorylation analysis and site localization.";
RL   Nat. Biotechnol. 24:1285-1292(2006).
RN   [15]
RP   INTERACTION WITH DNAJC5 AND DNAJC5B.
RX   PubMed=17034881; DOI=10.1016/j.bbamcr.2006.08.054;
RA   Boal F., Le Pevelen S., Cziepluch C., Scotti P., Lang J.;
RT   "Cysteine-string protein isoform beta (Cspbeta) is targeted to the
RT   trans-Golgi network as a non-palmitoylated CSP in clonal beta-cells.";
RL   Biochim. Biophys. Acta 1773:109-119(2007).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-77; THR-81; SER-301;
RP   THR-303 AND SER-305, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE
RP   SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-77; THR-81 AND SER-305,
RP   AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [18]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-137, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [19]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-303, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [20]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [21]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-301 AND SER-305, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [22]
RP   FUNCTION, AND INTERACTION WITH BAG6.
RX   PubMed=23129660; DOI=10.1073/pnas.1209997109;
RA   Leznicki P., High S.;
RT   "SGTA antagonizes BAG6-mediated protein triage.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:19214-19219(2012).
RN   [23]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-77; THR-81 AND SER-301,
RP   AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [24]
RP   FUNCTION, AND INTERACTION WITH BAG6.
RX   PubMed=25179605; DOI=10.1242/jcs.155648;
RA   Wunderley L., Leznicki P., Payapilly A., High S.;
RT   "SGTA regulates the cytosolic quality control of hydrophobic
RT   substrates.";
RL   J. Cell Sci. 127:4728-4739(2014).
RN   [25]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-81; THR-303 AND SER-305,
RP   AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [26]
RP   FUNCTION (MICROBIAL INFECTION), IDENTIFICATION IN A COMPLEX WITH
RP   DNAJB12 AND DNAJB14, AND INTERACTION WITH HSPA8.
RX   PubMed=24675744; DOI=10.1371/journal.ppat.1004007;
RA   Walczak C.P., Ravindran M.S., Inoue T., Tsai B.;
RT   "A cytosolic chaperone complexes with dynamic membrane J-proteins and
RT   mobilizes a nonenveloped virus out of the endoplasmic reticulum.";
RL   PLoS Pathog. 10:E1004007-E1004007(2014).
RN   [27]
RP   FUNCTION, AND INTERACTION WITH BAG6.
RX   PubMed=27193484; DOI=10.1038/srep26433;
RA   Krysztofinska E.M., Martinez-Lumbreras S., Thapaliya A., Evans N.J.,
RA   High S., Isaacson R.L.;
RT   "Structural and functional insights into the E3 ligase, RNF126.";
RL   Sci. Rep. 6:26433-26433(2016).
RN   [28]
RP   FUNCTION.
RX   PubMed=28104892; DOI=10.1126/science.aah6130;
RA   Shao S., Rodrigo-Brenni M.C., Kivlen M.H., Hegde R.S.;
RT   "Mechanistic basis for a molecular triage reaction.";
RL   Science 355:298-302(2017).
RN   [29]
RP   X-RAY CRYSTALLOGRAPHY (2.4 ANGSTROMS) OF 84-210, SUBUNIT (MICROBIAL
RP   INFECTION), AND FUNCTION.
RX   PubMed=18759457; DOI=10.1021/bi800758a;
RA   Dutta S., Tan Y.J.;
RT   "Structural and functional characterization of human SGT and its
RT   interaction with Vpu of the human immunodeficiency virus type 1.";
RL   Biochemistry 47:10123-10131(2008).
CC   -!- FUNCTION: Co-chaperone that binds misfolded and hydrophobic
CC       patches-containing client proteins in the cytosol. Mediates their
CC       targeting to the endoplasmic reticulum but also regulates their
CC       sorting to the proteasome when targeting fails (PubMed:28104892).
CC       Functions in tail-anchored/type II transmembrane proteins membrane
CC       insertion constituting with ASNA1 and the BAG6 complex a targeting
CC       module (PubMed:28104892). Probably functions upstream of the BAG6
CC       complex and ASNA1, binding more rapidly the transmembrane domain
CC       of newly synthesized proteins (PubMed:28104892). It is also
CC       involved in the regulation of the endoplasmic reticulum-associated
CC       misfolded protein catabolic process via its interaction with BAG6:
CC       collaborates with the BAG6 complex to maintain hydrophobic
CC       substrates in non-ubiquitinated states (PubMed:23129660,
CC       PubMed:25179605). Competes with RNF126 for interaction with BAG6,
CC       preventing the ubiquitination of client proteins associated with
CC       the BAG6 complex (PubMed:27193484). Binds directly to HSC70 and
CC       HSP70 and regulates their ATPase activity (PubMed:18759457).
CC       {ECO:0000269|PubMed:18759457, ECO:0000269|PubMed:23129660,
CC       ECO:0000269|PubMed:25179605, ECO:0000269|PubMed:27193484,
CC       ECO:0000269|PubMed:28104892}.
CC   -!- FUNCTION: (Microbial infection) In case of infection by
CC       polyomavirus, involved in the virus endoplasmic reticulum membrane
CC       penetration and infection via interaction with DNAJB12, DNAJB14
CC       and HSPA8/Hsc70 (PubMed:24675744). {ECO:0000269|PubMed:24675744}.
CC   -!- SUBUNIT: Homodimer (PubMed:15708368). Homooligomer (By
CC       similarity). Interacts with DNAJC5 and DNAJC5B. Interacts (via TPR
CC       repeats) with HSP90AA1 (PubMed:15708368). Interacts (via Gln-rich
CC       region) with SLC2A1 (PubMed:15708368). Interacts with HSP90AB1
CC       (PubMed:16580629). Interacts (via TPR repeats) with HSPA8/Hsc70;
CC       the interaction is direct (PubMed:24675744). Interacts with BAG6
CC       (via ubiquitin-like domain); interaction prevents interaction
CC       between BAG6 and RNF126 (PubMed:23129660, PubMed:25179605,
CC       PubMed:27193484). Forms a multiprotein complex, at least composed
CC       of DNAJB12, DNAJB14, HSPA8/Hsc70 and SGTA; interaction with
CC       DNAJB14 and HSPA8/Hsc70 is direct (PubMed:24675744).
CC       {ECO:0000250|UniProtKB:O70593, ECO:0000269|PubMed:15708368,
CC       ECO:0000269|PubMed:16580629, ECO:0000269|PubMed:17034881,
CC       ECO:0000269|PubMed:18759457, ECO:0000269|PubMed:23129660,
CC       ECO:0000269|PubMed:24675744, ECO:0000269|PubMed:25179605,
CC       ECO:0000269|PubMed:27193484}.
CC   -!- SUBUNIT: (Microbial infection) Interacts with Vpu and Gag from
CC       HIV-1. {ECO:0000269|PubMed:18759457, ECO:0000269|PubMed:9573291}.
CC   -!- SUBUNIT: (Microbial infection) Interacts with SARS-CoV accessory
CC       protein 7a. {ECO:0000269|PubMed:16580632}.
CC   -!- INTERACTION:
CC       A8K660:ADIPOQ; NbExp=3; IntAct=EBI-347996, EBI-10174479;
CC       Q15848:ADIPOQ; NbExp=5; IntAct=EBI-347996, EBI-10827839;
CC       Q8TD06:AGR3; NbExp=5; IntAct=EBI-347996, EBI-3925742;
CC       O95816:BAG2; NbExp=2; IntAct=EBI-347996, EBI-355275;
CC       P46379:BAG6; NbExp=5; IntAct=EBI-347996, EBI-347552;
CC       P35070:BTC; NbExp=5; IntAct=EBI-347996, EBI-6590057;
CC       Q9BXJ1:C1QTNF1; NbExp=4; IntAct=EBI-347996, EBI-750200;
CC       Q9BXI9:C1QTNF6; NbExp=3; IntAct=EBI-347996, EBI-10301084;
CC       Q8N6L0:CCDC155; NbExp=9; IntAct=EBI-347996, EBI-749265;
CC       P40259:CD79B; NbExp=6; IntAct=EBI-347996, EBI-2873732;
CC       Q8TCZ2:CD99L2; NbExp=5; IntAct=EBI-347996, EBI-2824782;
CC       P55291:CDH15; NbExp=5; IntAct=EBI-347996, EBI-10215061;
CC       A0A0S2Z3K0:COL1A2; NbExp=3; IntAct=EBI-347996, EBI-16431143;
CC       P08123:COL1A2; NbExp=8; IntAct=EBI-347996, EBI-983038;
CC       Q4VAQ0:COL8A2; NbExp=3; IntAct=EBI-347996, EBI-10241815;
CC       P09603:CSF1; NbExp=5; IntAct=EBI-347996, EBI-2872294;
CC       P01037:CST1; NbExp=3; IntAct=EBI-347996, EBI-1056240;
CC       P78358:CTAG1B; NbExp=4; IntAct=EBI-347996, EBI-1188472;
CC       P07711:CTSL; NbExp=3; IntAct=EBI-347996, EBI-1220160;
CC       A0A0S2Z3V1:EFEMP1; NbExp=3; IntAct=EBI-347996, EBI-16434097;
CC       Q12805:EFEMP1; NbExp=12; IntAct=EBI-347996, EBI-536772;
CC       O95967:EFEMP2; NbExp=6; IntAct=EBI-347996, EBI-743414;
CC       Q96DN0:ERP27; NbExp=5; IntAct=EBI-347996, EBI-953772;
CC       Q9NVM1:EVA1B; NbExp=5; IntAct=EBI-347996, EBI-10314666;
CC       Q9Y624:F11R; NbExp=9; IntAct=EBI-347996, EBI-742600;
CC       Q96RJ6:FERD3L; NbExp=3; IntAct=EBI-347996, EBI-10183007;
CC       Q9Y680:FKBP7; NbExp=3; IntAct=EBI-347996, EBI-3918971;
CC       P58549:FXYD7; NbExp=7; IntAct=EBI-347996, EBI-10216171;
CC       P22466:GAL; NbExp=3; IntAct=EBI-347996, EBI-6624768;
CC       P09681:GIP; NbExp=7; IntAct=EBI-347996, EBI-8588553;
CC       Q14440:GPErik; NbExp=3; IntAct=EBI-347996, EBI-10232920;
CC       Q96SL4:GPX7; NbExp=5; IntAct=EBI-347996, EBI-749411;
CC       P28799:GRN; NbExp=6; IntAct=EBI-347996, EBI-747754;
CC       Q02747:GUCA2A; NbExp=4; IntAct=EBI-347996, EBI-12244272;
CC       A0A0C4DFT7:GYPA; NbExp=3; IntAct=EBI-347996, EBI-12044847;
CC       B8Q183:GYPA; NbExp=4; IntAct=EBI-347996, EBI-10176190;
CC       P48723:HSPA13; NbExp=5; IntAct=EBI-347996, EBI-750892;
CC       P46695:IER3; NbExp=4; IntAct=EBI-347996, EBI-1748945;
CC       Q6PIQ7:IGL@; NbExp=3; IntAct=EBI-347996, EBI-6677651;
CC       Q8N355:IGL@; NbExp=4; IntAct=EBI-347996, EBI-748681;
CC       Q14653:IRF3; NbExp=3; IntAct=EBI-347996, EBI-2650369;
CC       Q13568:IRF5; NbExp=3; IntAct=EBI-347996, EBI-3931258;
CC       Q6GPH6:ITPRIPL1; NbExp=3; IntAct=EBI-347996, EBI-953819;
CC       P02538:KRT6A; NbExp=3; IntAct=EBI-347996, EBI-702198;
CC       Q86UP2:KTN1; NbExp=3; IntAct=EBI-347996, EBI-359761;
CC       Q6ISS4:LAIR2; NbExp=5; IntAct=EBI-347996, EBI-10250491;
CC       O43561:LAT; NbExp=3; IntAct=EBI-347996, EBI-1222766;
CC       P80188:LCN2; NbExp=4; IntAct=EBI-347996, EBI-11911016;
CC       P08118:MSMB; NbExp=3; IntAct=EBI-347996, EBI-10195681;
CC       Q969H8:MYDGF; NbExp=5; IntAct=EBI-347996, EBI-718622;
CC       Q8IW45:NAXD; NbExp=6; IntAct=EBI-347996, EBI-8650724;
CC       Q13232:NME3; NbExp=8; IntAct=EBI-347996, EBI-713684;
CC       C3PTT6:PAUF; NbExp=3; IntAct=EBI-347996, EBI-3505892;
CC       Q96AQ6:PBXIP1; NbExp=3; IntAct=EBI-347996, EBI-740845;
CC       Q9UN74:PCDHA4; NbExp=3; IntAct=EBI-347996, EBI-712273;
CC       P23284:PPIB; NbExp=5; IntAct=EBI-347996, EBI-359252;
CC       P45877:PPIC; NbExp=5; IntAct=EBI-347996, EBI-953909;
CC       Q96NZ9:PRAP1; NbExp=5; IntAct=EBI-347996, EBI-2116102;
CC       Q9UL19:RARRES3; NbExp=3; IntAct=EBI-347996, EBI-10323452;
CC       Q96K19-5:RNF170; NbExp=4; IntAct=EBI-347996, EBI-12055631;
CC       P04843:RPN1; NbExp=5; IntAct=EBI-347996, EBI-355963;
CC       P31431:SDC4; NbExp=5; IntAct=EBI-347996, EBI-3913237;
CC       P05121:SERPINE1; NbExp=5; IntAct=EBI-347996, EBI-953978;
CC       Q16586:SGCA; NbExp=12; IntAct=EBI-347996, EBI-5663553;
CC       Q16586-2:SGCA; NbExp=4; IntAct=EBI-347996, EBI-16434133;
CC       P03973:SLPI; NbExp=3; IntAct=EBI-347996, EBI-355293;
CC       Q0VAQ4:SMAGP; NbExp=3; IntAct=EBI-347996, EBI-10226799;
CC       Q71RC9:SMIM5; NbExp=4; IntAct=EBI-347996, EBI-12334905;
CC       P08294:SOD3; NbExp=3; IntAct=EBI-347996, EBI-10195782;
CC       P10451:SPP1; NbExp=8; IntAct=EBI-347996, EBI-723648;
CC       Q8TCT8:SPPL2A; NbExp=6; IntAct=EBI-347996, EBI-750784;
CC       P10124:SRGN; NbExp=8; IntAct=EBI-347996, EBI-744915;
CC       Q9BT88:SYT11; NbExp=6; IntAct=EBI-347996, EBI-751770;
CC       Q9H2B2:SYT4; NbExp=6; IntAct=EBI-347996, EBI-751132;
CC       Q07654:TFF3; NbExp=3; IntAct=EBI-347996, EBI-10224676;
CC       P02786:TFRC; NbExp=5; IntAct=EBI-347996, EBI-355727;
CC       P01135:TGFA; NbExp=3; IntAct=EBI-347996, EBI-1034374;
CC       Q8WUU8:TMEM174; NbExp=5; IntAct=EBI-347996, EBI-10276729;
CC       Q5JXX7:TMEM31; NbExp=3; IntAct=EBI-347996, EBI-10244617;
CC       Q71RG4:TMUB2; NbExp=3; IntAct=EBI-347996, EBI-2820477;
CC       O14836:TNFRSF13B; NbExp=3; IntAct=EBI-347996, EBI-519160;
CC       O14836-2:TNFRSF13B; NbExp=5; IntAct=EBI-347996, EBI-12023110;
CC       Q5BVD1:TTMP; NbExp=5; IntAct=EBI-347996, EBI-10243654;
CC       Q9GZX9:TWSG1; NbExp=3; IntAct=EBI-347996, EBI-10304067;
CC       O95881:TXNDC12; NbExp=3; IntAct=EBI-347996, EBI-2564581;
CC       P11441:UBL4A; NbExp=4; IntAct=EBI-347996, EBI-356983;
CC       O75631:UPK3A; NbExp=3; IntAct=EBI-347996, EBI-10188907;
CC       P01282:VIP; NbExp=3; IntAct=EBI-347996, EBI-751454;
CC       Q9NX94:WBP1L; NbExp=3; IntAct=EBI-347996, EBI-10316321;
CC       O60844:ZG16; NbExp=8; IntAct=EBI-347996, EBI-746479;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:16580629}.
CC       Nucleus {ECO:0000269|PubMed:16580629}. Note=Co-localizes with
CC       HSP90AB1 in the cytoplasm. Increased nuclear accumulation seen
CC       during cell apoptosis. {ECO:0000269|PubMed:16580629}.
CC   -!- TISSUE SPECIFICITY: Ubiquitous.
CC   -!- DOMAIN: The second tetratricopeptide repeat (TPR 2) mediates the
CC       interaction with SARS-CoV accessory protein 7a.
CC   -!- SIMILARITY: Belongs to the SGT family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AJ223828; CAA11565.1; -; mRNA.
DR   EMBL; AJ133129; CAB39725.1; -; mRNA.
DR   EMBL; AF408399; AAL01051.1; -; mRNA.
DR   EMBL; AF368279; AAP29457.1; -; mRNA.
DR   EMBL; AL050156; CAB43297.2; -; mRNA.
DR   EMBL; CR533517; CAG38548.1; -; mRNA.
DR   EMBL; CR542282; CAG47077.1; -; mRNA.
DR   EMBL; AC006538; AAD13117.1; -; Genomic_DNA.
DR   EMBL; CH471139; EAW69366.1; -; Genomic_DNA.
DR   EMBL; CH471139; EAW69367.1; -; Genomic_DNA.
DR   EMBL; CH471139; EAW69368.1; -; Genomic_DNA.
DR   EMBL; BC000390; AAH00390.1; -; mRNA.
DR   EMBL; BC002989; AAH02989.2; -; mRNA.
DR   EMBL; BC005165; AAH05165.1; -; mRNA.
DR   EMBL; BC008885; AAH08885.1; -; mRNA.
DR   CCDS; CCDS12094.1; -.
DR   RefSeq; NP_003012.1; NM_003021.3.
DR   RefSeq; XP_011526480.1; XM_011528178.2.
DR   UniGene; Hs.203910; -.
DR   PDB; 2VYI; X-ray; 2.40 A; A/B=84-210.
DR   PDB; 4CPG; NMR; -; A/B=1-69.
DR   PDB; 4GOD; X-ray; 1.40 A; A/B=4-54.
DR   PDB; 4GOE; X-ray; 1.45 A; A/B=4-54.
DR   PDB; 4GOF; X-ray; 1.35 A; A/B=4-54.
DR   PDBsum; 2VYI; -.
DR   PDBsum; 4CPG; -.
DR   PDBsum; 4GOD; -.
DR   PDBsum; 4GOE; -.
DR   PDBsum; 4GOF; -.
DR   ProteinModelPortal; O43765; -.
DR   SMR; O43765; -.
DR   BioGrid; 112347; 141.
DR   IntAct; O43765; 188.
DR   MINT; O43765; -.
DR   STRING; 9606.ENSP00000221566; -.
DR   iPTMnet; O43765; -.
DR   PhosphoSitePlus; O43765; -.
DR   BioMuta; SGTA; -.
DR   EPD; O43765; -.
DR   MaxQB; O43765; -.
DR   PaxDb; O43765; -.
DR   PeptideAtlas; O43765; -.
DR   PRIDE; O43765; -.
DR   TopDownProteomics; O43765; -.
DR   DNASU; 6449; -.
DR   Ensembl; ENST00000221566; ENSP00000221566; ENSG00000104969.
DR   GeneID; 6449; -.
DR   KEGG; hsa:6449; -.
DR   UCSC; uc002lwi.2; human.
DR   CTD; 6449; -.
DR   DisGeNET; 6449; -.
DR   EuPathDB; HostDB:ENSG00000104969.9; -.
DR   GeneCards; SGTA; -.
DR   HGNC; HGNC:10819; SGTA.
DR   HPA; HPA056309; -.
DR   MIM; 603419; gene.
DR   neXtProt; NX_O43765; -.
DR   OpenTargets; ENSG00000104969; -.
DR   PharmGKB; PA35727; -.
DR   eggNOG; KOG0553; Eukaryota.
DR   eggNOG; COG0457; LUCA.
DR   GeneTree; ENSGT00730000110724; -.
DR   HOGENOM; HOG000208193; -.
DR   HOVERGEN; HBG000885; -.
DR   InParanoid; O43765; -.
DR   KO; K16365; -.
DR   OMA; EAVVYYK; -.
DR   OrthoDB; EOG091G0C0Q; -.
DR   PhylomeDB; O43765; -.
DR   TreeFam; TF313092; -.
DR   ChiTaRS; SGTA; human.
DR   EvolutionaryTrace; O43765; -.
DR   GeneWiki; SGTA; -.
DR   GenomeRNAi; 6449; -.
DR   PRO; PR:O43765; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   Bgee; ENSG00000104969; -.
DR   CleanEx; HS_SGTA; -.
DR   ExpressionAtlas; O43765; baseline and differential.
DR   Genevisible; O43765; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0016020; C:membrane; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:1904288; F:BAT3 complex binding; IPI:ParkinsonsUK-UCL.
DR   GO; GO:0043621; F:protein self-association; IDA:UniProtKB.
DR   GO; GO:1903070; P:negative regulation of ER-associated ubiquitin-dependent protein catabolic process; IDA:UniProtKB.
DR   GO; GO:2000059; P:negative regulation of ubiquitin-dependent protein catabolic process; IDA:UniProtKB.
DR   GO; GO:1903071; P:positive regulation of ER-associated ubiquitin-dependent protein catabolic process; IMP:ParkinsonsUK-UCL.
DR   GO; GO:0030433; P:ubiquitin-dependent ERAD pathway; IDA:UniProtKB.
DR   GO; GO:0016032; P:viral process; IEA:UniProtKB-KW.
DR   Gene3D; 1.25.40.10; -; 1.
DR   InterPro; IPR032374; SGTA_dimer.
DR   InterPro; IPR013026; TPR-contain_dom.
DR   InterPro; IPR011990; TPR-like_helical_dom_sf.
DR   InterPro; IPR001440; TPR_1.
DR   InterPro; IPR019734; TPR_repeat.
DR   Pfam; PF16546; SGTA_dimer; 1.
DR   Pfam; PF00515; TPR_1; 2.
DR   Pfam; PF13181; TPR_8; 1.
DR   SMART; SM00028; TPR; 3.
DR   SUPFAM; SSF48452; SSF48452; 1.
DR   PROSITE; PS50005; TPR; 3.
DR   PROSITE; PS50293; TPR_REGION; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Chaperone; Complete proteome; Cytoplasm;
KW   Direct protein sequencing; Host-virus interaction; Nucleus;
KW   Phosphoprotein; Reference proteome; Repeat; TPR repeat.
FT   CHAIN         1    313       Small glutamine-rich tetratricopeptide
FT                                repeat-containing protein alpha.
FT                                /FTId=PRO_0000106365.
FT   REPEAT       91    124       TPR 1.
FT   REPEAT      125    158       TPR 2.
FT   REPEAT      159    192       TPR 3.
FT   COMPBIAS    275    287       Gln-rich.
FT   MOD_RES      77     77       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES      81     81       Phosphothreonine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES      84     84       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:O70593}.
FT   MOD_RES     137    137       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     301    301       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     303    303       Phosphothreonine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     305    305       Phosphoserine.
FT                                {ECO:0000244|PubMed:16964243,
FT                                ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:24275569}.
FT   HELIX         5     21       {ECO:0000244|PDB:4GOF}.
FT   HELIX        26     43       {ECO:0000244|PDB:4GOF}.
FT   HELIX        48     51       {ECO:0000244|PDB:4CPG}.
FT   HELIX        58     65       {ECO:0000244|PDB:4CPG}.
FT   HELIX        87    103       {ECO:0000244|PDB:2VYI}.
FT   HELIX       107    120       {ECO:0000244|PDB:2VYI}.
FT   HELIX       125    137       {ECO:0000244|PDB:2VYI}.
FT   HELIX       141    154       {ECO:0000244|PDB:2VYI}.
FT   HELIX       159    171       {ECO:0000244|PDB:2VYI}.
FT   HELIX       175    188       {ECO:0000244|PDB:2VYI}.
FT   HELIX       193    206       {ECO:0000244|PDB:2VYI}.
SQ   SEQUENCE   313 AA;  34063 MW;  80B3C71B41F3CB55 CRC64;
     MDNKKRLAYA IIQFLHDQLR HGGLSSDAQE SLEVAIQCLE TAFGVTVEDS DLALPQTLPE
     IFEAAATGKE MPQDLRSPAR TPPSEEDSAE AERLKTEGNE QMKVENFEAA VHFYGKAIEL
     NPANAVYFCN RAAAYSKLGN YAGAVQDCER AICIDPAYSK AYGRMGLALS SLNKHVEAVA
     YYKKALELDP DNETYKSNLK IAELKLREAP SPTGGVGSFD IAGLLNNPGF MSMASNLMNN
     PQIQQLMSGM ISGGNNPLGT PGTSPSQNDL ASLIQAGQQF AQQMQQQNPE LIEQLRSQIR
     SRTPSASNDD QQE
//
ID   A0A024RDE2_HUMAN        Unreviewed;       314 AA.
AC   A0A024RDE2;
DT   09-JUL-2014, integrated into UniProtKB/TrEMBL.
DT   09-JUL-2014, sequence version 1.
DT   23-MAY-2018, entry version 39.
DE   SubName: Full=Secreted phosphoprotein 1 (Osteopontin, bone sialoprotein I, early T-lymphocyte activation 1), isoform CRA_b {ECO:0000313|EMBL:EAX06007.1};
GN   Name=SPP1 {ECO:0000313|EMBL:EAX06007.1};
GN   ORFNames=hCG_38538 {ECO:0000313|EMBL:EAX06007.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:EAX06007.1};
RN   [1] {ECO:0000313|EMBL:EAX06007.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAX06007.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; CH471057; EAX06007.1; -; Genomic_DNA.
DR   EMBL; CH471057; EAX06008.1; -; Genomic_DNA.
DR   RefSeq; NP_001035147.1; NM_001040058.1.
DR   UniGene; Hs.313; -.
DR   PRIDE; A0A024RDE2; -.
DR   GeneID; 6696; -.
DR   KEGG; hsa:6696; -.
DR   CTD; 6696; -.
DR   EuPathDB; HostDB:ENSG00000118785.13; -.
DR   eggNOG; ENOG410IVP1; Eukaryota.
DR   eggNOG; ENOG41116B5; LUCA.
DR   KO; K06250; -.
DR   OMA; VICFCLL; -.
DR   OrthoDB; EOG091G0KVC; -.
DR   ChiTaRS; SPP1; human.
DR   GenomeRNAi; 6696; -.
DR   Bgee; ENSG00000118785; -.
DR   ExpressionAtlas; A0A024RDE2; baseline and differential.
DR   GO; GO:0042995; C:cell projection; IEA:Ensembl.
DR   GO; GO:0005615; C:extracellular space; IEA:Ensembl.
DR   GO; GO:0005794; C:Golgi apparatus; IDA:HPA.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IEA:Ensembl.
DR   GO; GO:0031982; C:vesicle; IEA:Ensembl.
DR   GO; GO:0007155; P:cell adhesion; IEA:Ensembl.
DR   GO; GO:0006954; P:inflammatory response; IEA:Ensembl.
DR   GO; GO:0048685; P:negative regulation of collateral sprouting of intact axon in response to injury; IEA:Ensembl.
DR   GO; GO:0001649; P:osteoblast differentiation; IEA:Ensembl.
DR   GO; GO:0045780; P:positive regulation of bone resorption; IEA:Ensembl.
DR   GO; GO:0048545; P:response to steroid hormone; IEA:Ensembl.
DR   InterPro; IPR002038; Osteopontin.
DR   InterPro; IPR019841; Osteopontin_CS.
DR   PANTHER; PTHR10607; PTHR10607; 1.
DR   Pfam; PF00865; Osteopontin; 1.
DR   PRINTS; PR00216; OSTEOPONTIN.
DR   SMART; SM00017; OSTEO; 1.
DR   PROSITE; PS00884; OSTEOPONTIN; 1.
PE   4: Predicted;
KW   Signal {ECO:0000256|SAM:SignalP}.
FT   SIGNAL        1     16       {ECO:0000256|SAM:SignalP}.
FT   CHAIN        17    314       {ECO:0000256|SAM:SignalP}.
FT                                /FTId=PRO_5014214297.
SQ   SEQUENCE   314 AA;  35423 MW;  4996429EC4752B86 CRC64;
     MRIAVICFCL LGITCAIPVK QADSGSSEEK QLYNKYPDAV ATWLNPDPSQ KQNLLAPQNA
     VSSEETNDFK QETLPSKSNE SHDHMDDMDD EDDDDHVDSQ DSIDSNDSDD VDDTDDSHQS
     DESHHSDESD ELVTDFPTDL PATEVFTPVV PTVDTYDGRG DSVVYGLRSK SKKFRRPDIQ
     YPDATDEDIT SHMESEELNG AYKAIPVAQD LNAPSDWDSR GKDSYETSQL DDQSAETHSH
     KQSRLYKRKA NDESNEHSDV IDSQELSKVS REFHSHEFHS HEDMLVVDPK SKEEDKHLKF
     RISHELDSAS SEVN
//
ID   A0A024RDE6_HUMAN        Unreviewed;       300 AA.
AC   A0A024RDE6;
DT   09-JUL-2014, integrated into UniProtKB/TrEMBL.
DT   09-JUL-2014, sequence version 1.
DT   28-FEB-2018, entry version 22.
DE   SubName: Full=Secreted phosphoprotein 1 (Osteopontin, bone sialoprotein I, early T-lymphocyte activation 1), isoform CRA_c {ECO:0000313|EMBL:EAX06009.1};
GN   Name=SPP1 {ECO:0000313|EMBL:EAX06009.1};
GN   ORFNames=hCG_38538 {ECO:0000313|EMBL:EAX06009.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:EAX06009.1};
RN   [1] {ECO:0000313|EMBL:EAX06009.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAX06009.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; CH471057; EAX06009.1; -; Genomic_DNA.
DR   RefSeq; NP_000573.1; NM_000582.2.
DR   UniGene; Hs.313; -.
DR   ProteinModelPortal; A0A024RDE6; -.
DR   PRIDE; A0A024RDE6; -.
DR   GeneID; 6696; -.
DR   CTD; 6696; -.
DR   EuPathDB; HostDB:ENSG00000118785.13; -.
DR   eggNOG; ENOG410IVP1; Eukaryota.
DR   eggNOG; ENOG41116B5; LUCA.
DR   ChiTaRS; SPP1; human.
DR   GenomeRNAi; 6696; -.
DR   Bgee; ENSG00000118785; -.
DR   ExpressionAtlas; A0A024RDE6; baseline and differential.
DR   GO; GO:0005794; C:Golgi apparatus; IDA:HPA.
DR   GO; GO:0007155; P:cell adhesion; IEA:InterPro.
DR   GO; GO:0001503; P:ossification; IEA:InterPro.
DR   InterPro; IPR002038; Osteopontin.
DR   InterPro; IPR019841; Osteopontin_CS.
DR   PANTHER; PTHR10607; PTHR10607; 1.
DR   Pfam; PF00865; Osteopontin; 1.
DR   PRINTS; PR00216; OSTEOPONTIN.
DR   SMART; SM00017; OSTEO; 1.
DR   PROSITE; PS00884; OSTEOPONTIN; 1.
PE   4: Predicted;
KW   Signal {ECO:0000256|SAM:SignalP}.
FT   SIGNAL        1     16       {ECO:0000256|SAM:SignalP}.
FT   CHAIN        17    300       {ECO:0000256|SAM:SignalP}.
FT                                /FTId=PRO_5001536677.
SQ   SEQUENCE   300 AA;  33843 MW;  B844D7EBDD096CBF CRC64;
     MRIAVICFCL LGITCAIPVK QADSGSSEEK QLYNKYPDAV ATWLNPDPSQ KQNLLAPQTL
     PSKSNESHDH MDDMDDEDDD DHVDSQDSID SNDSDDVDDT DDSHQSDESH HSDESDELVT
     DFPTDLPATE VFTPVVPTVD TYDGRGDSVV YGLRSKSKKF RRPDIQYPDA TDEDITSHME
     SEELNGAYKA IPVAQDLNAP SDWDSRGKDS YETSQLDDQS AETHSHKQSR LYKRKANDES
     NEHSDVIDSQ ELSKVSREFH SHEFHSHEDM LVVDPKSKEE DKHLKFRISH ELDSASSEVN
//
ID   A0A024RDJ0_HUMAN        Unreviewed;       287 AA.
AC   A0A024RDJ0;
DT   09-JUL-2014, integrated into UniProtKB/TrEMBL.
DT   09-JUL-2014, sequence version 1.
DT   23-MAY-2018, entry version 19.
DE   SubName: Full=Secreted phosphoprotein 1 (Osteopontin, bone sialoprotein I, early T-lymphocyte activation 1), isoform CRA_a {ECO:0000313|EMBL:EAX06010.1};
GN   Name=SPP1 {ECO:0000313|EMBL:EAX06010.1};
GN   ORFNames=hCG_38538 {ECO:0000313|EMBL:EAX06010.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:EAX06010.1};
RN   [1] {ECO:0000313|EMBL:EAX06010.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAX06010.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; CH471057; EAX06010.1; -; Genomic_DNA.
DR   RefSeq; NP_001035149.1; NM_001040060.1.
DR   UniGene; Hs.313; -.
DR   ProteinModelPortal; A0A024RDJ0; -.
DR   PRIDE; A0A024RDJ0; -.
DR   GeneID; 6696; -.
DR   CTD; 6696; -.
DR   EuPathDB; HostDB:ENSG00000118785.13; -.
DR   ChiTaRS; SPP1; human.
DR   GenomeRNAi; 6696; -.
DR   Bgee; ENSG00000118785; -.
DR   ExpressionAtlas; A0A024RDJ0; baseline and differential.
DR   GO; GO:0005794; C:Golgi apparatus; IDA:HPA.
DR   GO; GO:0007155; P:cell adhesion; IEA:InterPro.
DR   GO; GO:0001503; P:ossification; IEA:InterPro.
DR   InterPro; IPR002038; Osteopontin.
DR   InterPro; IPR019841; Osteopontin_CS.
DR   PANTHER; PTHR10607; PTHR10607; 1.
DR   Pfam; PF00865; Osteopontin; 1.
DR   PRINTS; PR00216; OSTEOPONTIN.
DR   SMART; SM00017; OSTEO; 1.
DR   PROSITE; PS00884; OSTEOPONTIN; 1.
PE   4: Predicted;
KW   Signal {ECO:0000256|SAM:SignalP}.
FT   SIGNAL        1     16       {ECO:0000256|SAM:SignalP}.
FT   CHAIN        17    287       {ECO:0000256|SAM:SignalP}.
FT                                /FTId=PRO_5001536765.
SQ   SEQUENCE   287 AA;  32355 MW;  AF604D4E223BA02F CRC64;
     MRIAVICFCL LGITCAIPVK QADSGSSEEK QNAVSSEETN DFKQETLPSK SNESHDHMDD
     MDDEDDDDHV DSQDSIDSND SDDVDDTDDS HQSDESHHSD ESDELVTDFP TDLPATEVFT
     PVVPTVDTYD GRGDSVVYGL RSKSKKFRRP DIQYPDATDE DITSHMESEE LNGAYKAIPV
     AQDLNAPSDW DSRGKDSYET SQLDDQSAET HSHKQSRLYK RKANDESNEH SDVIDSQELS
     KVSREFHSHE FHSHEDMLVV DPKSKEEDKH LKFRISHELD SASSEVN
//
ID   B7Z351_HUMAN            Unreviewed;       327 AA.
AC   B7Z351;
DT   03-MAR-2009, integrated into UniProtKB/TrEMBL.
DT   03-MAR-2009, sequence version 1.
DT   23-MAY-2018, entry version 35.
DE   SubName: Full=Secreted phosphoprotein 1 variant 6 {ECO:0000313|EMBL:ALE30613.1};
DE   SubName: Full=cDNA FLJ54682, highly similar to Osteopontin {ECO:0000313|EMBL:BAH12087.1};
GN   Name=SPP1 {ECO:0000313|EMBL:ALE30613.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAH12087.1};
RN   [1] {ECO:0000313|EMBL:BAH12087.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Hippocampus {ECO:0000313|EMBL:BAH12087.1};
RA   Wakamatsu A., Yamamoto J., Kimura K., Ishii S., Watanabe K.,
RA   Sugiyama A., Murakawa K., Kaida T., Tsuchiya K., Fukuzumi Y.,
RA   Kumagai A., Oishi Y., Yamamoto S., Ono Y., Komori Y., Yamazaki M.,
RA   Kisu Y., Nishikawa T., Sugano S., Nomura N., Isogai T.;
RT   "NEDO human cDNA sequencing project focused on splicing variants.";
RL   Submitted (OCT-2007) to the EMBL/GenBank/DDBJ databases.
RN   [2] {ECO:0000313|EMBL:ALE30613.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mehravar M., Poursani E.M.;
RT   "Identification of new alternative polyadenylation variant of SPP1
RT   gene in U87-MG cell line.";
RL   Submitted (APR-2015) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; KR062183; ALE30613.1; -; mRNA.
DR   EMBL; AK295491; BAH12087.1; -; mRNA.
DR   RefSeq; NP_001238759.1; NM_001251830.1.
DR   RefSeq; XP_016864053.1; XM_017008564.1.
DR   UniGene; Hs.313; -.
DR   MaxQB; B7Z351; -.
DR   PeptideAtlas; B7Z351; -.
DR   PRIDE; B7Z351; -.
DR   GeneID; 6696; -.
DR   CTD; 6696; -.
DR   HOGENOM; HOG000059656; -.
DR   HOVERGEN; HBG001731; -.
DR   ChiTaRS; SPP1; human.
DR   GenomeRNAi; 6696; -.
DR   Genevisible; B7Z351; HS.
DR   GO; GO:0007155; P:cell adhesion; IEA:InterPro.
DR   GO; GO:0001503; P:ossification; IEA:InterPro.
DR   InterPro; IPR002038; Osteopontin.
DR   PANTHER; PTHR10607; PTHR10607; 1.
DR   Pfam; PF00865; Osteopontin; 1.
DR   PRINTS; PR00216; OSTEOPONTIN.
DR   SMART; SM00017; OSTEO; 1.
PE   2: Evidence at transcript level;
SQ   SEQUENCE   327 AA;  37245 MW;  D90C8AB78360F1B9 CRC64;
     MGIVPRSLDK KAHRVQFQLN RIKAKIELPW GSLQLDCLMK TLKELYNKYP DAVATWLNPD
     PSQKQNLLAP QNAVSSEETN DFKQETLPSK SNESHDHMDD MDDEDDDDHV DSQDSIDSND
     SDDVDDTDDS HQSDESHHSD ESDELVTDFP TDLPATEVFT PVVPTVDTYD GRGDSVVYGL
     RSKSKKFRRP DIQYPDATDE DITSHMESEE LNGAYKAIPV AQDLNAPSDW DSRGKDSYET
     SQLDDQSAET HSHKQSRLYK RKANDESNEH SDVIDSQELS KVSREFHSHE FHSHEDMLVV
     DPKSKEEDKH LKFRISHELD SASSEVN
//
ID   OSTP_HUMAN              Reviewed;         314 AA.
AC   P10451; B2RDA1; Q15681; Q15682; Q15683; Q4W597; Q567T5; Q8NBK2;
AC   Q96IZ1;
DT   01-JUL-1989, integrated into UniProtKB/Swiss-Prot.
DT   01-JUL-1989, sequence version 1.
DT   23-MAY-2018, entry version 202.
DE   RecName: Full=Osteopontin;
DE   AltName: Full=Bone sialoprotein 1;
DE   AltName: Full=Nephropontin;
DE   AltName: Full=Secreted phosphoprotein 1;
DE            Short=SPP-1;
DE   AltName: Full=Urinary stone protein;
DE   AltName: Full=Uropontin;
DE   Flags: Precursor;
GN   Name=SPP1; Synonyms=BNSP, OPN; ORFNames=PSEC0156;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM A).
RX   PubMed=2726470; DOI=10.1093/nar/17.8.3306;
RA   Kiefer M.C., Bauer D.M., Barr P.J.;
RT   "The cDNA and derived amino acid sequence for human osteopontin.";
RL   Nucleic Acids Res. 17:3306-3306(1989).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM B).
RX   PubMed=1974876; DOI=10.1016/0888-7543(90)90191-V;
RA   Young M.F., Kerr J.M., Termine J.D., Wewer U.M., Wang M.G.,
RA   McBride O.W., Fisher L.W.;
RT   "cDNA cloning, mRNA distribution and heterogeneity, chromosomal
RT   location, and RFLP analysis of human osteopontin (OPN).";
RL   Genomics 7:491-502(1990).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM A).
RX   PubMed=1729712; DOI=10.1073/pnas.89.1.426;
RA   Shiraga H., Min W., VanDusen W.J., Clayman M.D., Miner D.,
RA   Terrell C.H., Sherbotie J.R., Foreman J.W., Przysiecki C.,
RA   Neilson E.G., Hoyer J.R.;
RT   "Inhibition of calcium oxalate crystal growth in vitro by uropontin:
RT   another member of the aspartic acid-rich protein superfamily.";
RL   Proc. Natl. Acad. Sci. U.S.A. 89:426-430(1992).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM A).
RX   PubMed=7665163; DOI=10.1006/geno.1995.1018;
RA   Crosby A.H., Edwards S.J., Murray J.C., Dixon M.J.;
RT   "Genomic organization of the human osteopontin gene: exclusion of the
RT   locus from a causative role in the pathogenesis of dentinogenesis
RT   imperfecta type II.";
RL   Genomics 27:155-160(1995).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM A).
RC   TISSUE=Liver;
RX   PubMed=7945249; DOI=10.1042/bj3030255;
RA   Hijiya N., Setoguchi M., Matsuura K., Higuchi Y., Akizuki S.,
RA   Yamamoto S.;
RT   "Cloning and characterization of the human osteopontin gene and its
RT   promoter.";
RL   Biochem. J. 303:255-262(1994).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS A; B AND C).
RX   PubMed=7837791;
RA   Saitoh Y., Kuratsu J., Takeshima H., Yamamoto S., Ushio Y.;
RT   "Expression of osteopontin in human glioma. Its correlation with the
RT   malignancy.";
RL   Lab. Invest. 72:55-63(1995).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM B).
RC   TISSUE=Brain;
RA   Yu W., Sarginson J., Gibbs R.A.;
RL   Submitted (MAR-1998) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM C).
RA   Sivakumar S., Niranjali Devaraj S.;
RT   "Osteopontin splice variants in Indian breast cancer patients as
RT   biomarker.";
RL   Submitted (FEB-2011) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS A; C AND 5).
RC   TISSUE=Kidney, and Subthalamic nucleus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM D).
RC   TISSUE=Placenta;
RX   PubMed=16303743; DOI=10.1093/dnares/12.2.117;
RA   Otsuki T., Ota T., Nishikawa T., Hayashi K., Suzuki Y., Yamamoto J.,
RA   Wakamatsu A., Kimura K., Sakamoto K., Hatano N., Kawai Y., Ishii S.,
RA   Saito K., Kojima S., Sugiyama T., Ono T., Okano K., Yoshikawa Y.,
RA   Aotsuka S., Sasaki N., Hattori A., Okumura K., Nagai K., Sugano S.,
RA   Isogai T.;
RT   "Signal sequence and keyword trap in silico for selection of full-
RT   length human cDNAs encoding secretion or membrane proteins from oligo-
RT   capped cDNA libraries.";
RL   DNA Res. 12:117-126(2005).
RN   [11]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM A).
RA   Yu Z., Zheng Z., Tang T., Fu Y.;
RT   "A computer system platform used to predict novel genes.";
RL   Submitted (JUL-2006) to the EMBL/GenBank/DDBJ databases.
RN   [12]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [13]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [14]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS A; B AND C).
RC   TISSUE=Brain, and Kidney;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [15]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 67-278.
RC   TISSUE=Kidney;
RX   PubMed=1575754; DOI=10.1016/0006-291X(92)90669-C;
RA   Kohri K., Suzuki Y., Yoshida K., Yamamoto K., Amasaki N., Yamate T.,
RA   Umekawa T., Iguchi M., Sinohara H., Kurita T.;
RT   "Molecular cloning and sequencing of cDNA encoding urinary stone
RT   protein, which is identical to osteopontin.";
RL   Biochem. Biophys. Res. Commun. 184:859-864(1992).
RN   [16]
RP   PROTEIN SEQUENCE OF 17-23 AND 169-182.
RC   TISSUE=Milk;
RX   PubMed=2736258; DOI=10.1016/0167-4838(89)90092-7;
RA   Senger D.R., Perruzzi C.A., Papadopoulos A., Tenen D.G.;
RT   "Purification of a human milk protein closely similar to tumor-
RT   secreted phosphoproteins and osteopontin.";
RL   Biochim. Biophys. Acta 996:43-48(1989).
RN   [17]
RP   PHOSPHORYLATION AT SER-24; SER-26; SER-27; SER-62; SER-63; THR-66;
RP   SER-76; SER-81; SER-99; SER-102; SER-108; SER-117; SER-120; SER-123;
RP   SER-129; THR-185; SER-191; SER-195; SER-215; SER-219; SER-224;
RP   SER-228; SER-234; SER-254; SER-263; SER-267; SER-275; SER-280;
RP   SER-303; SER-308; SER-310; SER-105 AND SER-126, AND GLYCOSYLATION AT
RP   ASN-79; ASN-106; THR-134; THR-138; THR-143; THR-147 AND THR-152.
RC   TISSUE=Milk;
RX   PubMed=15869464; DOI=10.1042/BJ20050341;
RA   Christensen B., Nielsen M.S., Haselmann K.F., Petersen T.E.,
RA   Sorensen E.S.;
RT   "Post-translationally modified residues of native human osteopontin
RT   are located in clusters: identification of 36 phosphorylation and five
RT   O-glycosylation sites and their biological implications.";
RL   Biochem. J. 390:285-292(2005).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-81, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Pituitary;
RX   PubMed=16807684; DOI=10.1007/s11102-006-8916-x;
RA   Beranova-Giorgianni S., Zhao Y., Desiderio D.M., Giorgianni F.;
RT   "Phosphoproteomic analysis of the human pituitary.";
RL   Pituitary 9:109-120(2006).
RN   [19]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-219; SER-224; SER-234
RP   AND SER-254, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [20]
RP   PHOSPHORYLATION BY FAM20C.
RX   PubMed=22582013; DOI=10.1126/science.1217817;
RA   Tagliabracci V.S., Engel J.L., Wen J., Wiley S.E., Worby C.A.,
RA   Kinch L.N., Xiao J., Grishin N.V., Dixon J.E.;
RT   "Secreted kinase phosphorylates extracellular proteins that regulate
RT   biomineralization.";
RL   Science 336:1150-1153(2012).
RN   [21]
RP   GLYCOSYLATION, AND IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=23234360; DOI=10.1021/pr300963h;
RA   Halim A., Ruetschi U., Larson G., Nilsson J.;
RT   "LC-MS/MS characterization of O-glycosylation sites and glycan
RT   structures of human cerebrospinal fluid glycoproteins.";
RL   J. Proteome Res. 12:573-584(2013).
RN   [22]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [23]
RP   PHOSPHORYLATION AT SER-26; SER-27; SER-62; SER-63; THR-190; SER-191;
RP   SER-195; SER-215; SER-219; SER-224; TYR-225; SER-228; SER-234;
RP   THR-237; SER-239; SER-243; SER-254; SER-258; SER-263; SER-267;
RP   SER-270; SER-275; SER-280; SER-291; SER-303; SER-308; SER-310 AND
RP   SER-311.
RX   PubMed=26091039; DOI=10.1016/j.cell.2015.05.028;
RA   Tagliabracci V.S., Wiley S.E., Guo X., Kinch L.N., Durrant E., Wen J.,
RA   Xiao J., Cui J., Nguyen K.B., Engel J.L., Coon J.J., Grishin N.,
RA   Pinna L.A., Pagliarini D.J., Dixon J.E.;
RT   "A single kinase generates the majority of the secreted
RT   phosphoproteome.";
RL   Cell 161:1619-1632(2015).
CC   -!- FUNCTION: Binds tightly to hydroxyapatite. Appears to form an
CC       integral part of the mineralized matrix. Probably important to
CC       cell-matrix interaction.
CC   -!- FUNCTION: Acts as a cytokine involved in enhancing production of
CC       interferon-gamma and interleukin-12 and reducing production of
CC       interleukin-10 and is essential in the pathway that leads to type
CC       I immunity. {ECO:0000250}.
CC   -!- SUBUNIT: Ligand for integrin alpha-V/beta-3.
CC   -!- INTERACTION:
CC       P16070:CD44; NbExp=4; IntAct=EBI-723648, EBI-490245;
CC       Q8IXL6:FAM20C; NbExp=3; IntAct=EBI-723648, EBI-7147442;
CC       P50222:MEOX2; NbExp=3; IntAct=EBI-723648, EBI-748397;
CC       O43765:SGTA; NbExp=8; IntAct=EBI-723648, EBI-347996;
CC       Q96EQ0:SGTB; NbExp=4; IntAct=EBI-723648, EBI-744081;
CC   -!- SUBCELLULAR LOCATION: Secreted.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=5;
CC       Name=A; Synonyms=OPN-a, OP1B;
CC         IsoId=P10451-1; Sequence=Displayed;
CC       Name=B; Synonyms=OPN-b, OP1A;
CC         IsoId=P10451-2; Sequence=VSP_003778;
CC       Name=C; Synonyms=OPN-c;
CC         IsoId=P10451-3; Sequence=VSP_003777;
CC       Name=D;
CC         IsoId=P10451-4; Sequence=VSP_011639;
CC       Name=5;
CC         IsoId=P10451-5; Sequence=VSP_043695;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Bone. Found in plasma.
CC   -!- PTM: Extensively phosphorylated by FAM20C in the extracellular
CC       medium at multiple sites within the S-x-E/pS motif.
CC       {ECO:0000269|PubMed:15869464, ECO:0000269|PubMed:22582013,
CC       ECO:0000269|PubMed:26091039}.
CC   -!- PTM: N- and O-glycosylated. Isoform 5 is GalNAc O-glycosylated at
CC       Thr-59 or Ser-62. {ECO:0000269|PubMed:15869464,
CC       ECO:0000269|PubMed:23234360}.
CC   -!- SIMILARITY: Belongs to the osteopontin family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/SPP1ID42379ch4q22.html";
CC   -!- WEB RESOURCE: Name=Wikipedia; Note=Osteopontin entry;
CC       URL="https://en.wikipedia.org/wiki/Osteopontin";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X13694; CAA31984.1; -; mRNA.
DR   EMBL; J04765; AAA59974.1; -; mRNA.
DR   EMBL; M83248; AAA17675.1; -; mRNA.
DR   EMBL; U20758; AAA86886.1; -; Genomic_DNA.
DR   EMBL; D14813; BAA03554.1; -; Genomic_DNA.
DR   EMBL; D28759; BAA05949.1; -; mRNA.
DR   EMBL; D28760; BAA05950.1; -; mRNA.
DR   EMBL; D28761; BAA05951.1; -; mRNA.
DR   EMBL; AF052124; AAC28619.1; -; mRNA.
DR   EMBL; AK290104; BAF82793.1; -; mRNA.
DR   EMBL; JF412667; AEA49031.1; -; mRNA.
DR   EMBL; AK075463; BAC11635.1; -; mRNA.
DR   EMBL; AK290090; BAF82779.1; -; mRNA.
DR   EMBL; AK296035; BAG58801.1; -; mRNA.
DR   EMBL; AK315461; BAG37848.1; -; mRNA.
DR   EMBL; DQ839491; ABI63352.1; -; mRNA.
DR   EMBL; DQ846871; ABI63358.1; -; mRNA.
DR   EMBL; AC131944; AAY41035.1; -; Genomic_DNA.
DR   EMBL; CH471057; EAX06004.1; -; Genomic_DNA.
DR   EMBL; CH471057; EAX06005.1; -; Genomic_DNA.
DR   EMBL; CH471057; EAX06006.1; -; Genomic_DNA.
DR   EMBL; BC007016; AAH07016.1; -; mRNA.
DR   EMBL; BC017387; AAH17387.1; -; mRNA.
DR   EMBL; BC022844; AAH22844.1; -; mRNA.
DR   EMBL; BC093033; AAH93033.1; -; mRNA.
DR   CCDS; CCDS34027.1; -. [P10451-3]
DR   CCDS; CCDS3626.1; -. [P10451-5]
DR   CCDS; CCDS43250.1; -. [P10451-1]
DR   PIR; S50028; S09575.
DR   RefSeq; NP_000573.1; NM_000582.2. [P10451-5]
DR   RefSeq; NP_001035147.1; NM_001040058.1. [P10451-1]
DR   RefSeq; NP_001035149.1; NM_001040060.1. [P10451-3]
DR   RefSeq; NP_001238758.1; NM_001251829.1.
DR   RefSeq; NP_001238759.1; NM_001251830.1.
DR   UniGene; Hs.313; -.
DR   PDB; 3CXD; X-ray; 2.80 A; P=40-51.
DR   PDB; 3DSF; X-ray; 2.80 A; P=40-51.
DR   PDBsum; 3CXD; -.
DR   PDBsum; 3DSF; -.
DR   DisProt; DP00214; -.
DR   BioGrid; 112574; 81.
DR   CORUM; P10451; -.
DR   DIP; DIP-49933N; -.
DR   ELM; P10451; -.
DR   IntAct; P10451; 16.
DR   STRING; 9606.ENSP00000378517; -.
DR   ChEMBL; CHEMBL1741309; -.
DR   GlyConnect; 474; -.
DR   iPTMnet; P10451; -.
DR   PhosphoSitePlus; P10451; -.
DR   UniCarbKB; P10451; -.
DR   BioMuta; SPP1; -.
DR   DMDM; 129260; -.
DR   PaxDb; P10451; -.
DR   PeptideAtlas; P10451; -.
DR   PRIDE; P10451; -.
DR   DNASU; 6696; -.
DR   Ensembl; ENST00000237623; ENSP00000237623; ENSG00000118785. [P10451-5]
DR   Ensembl; ENST00000360804; ENSP00000354042; ENSG00000118785. [P10451-3]
DR   Ensembl; ENST00000395080; ENSP00000378517; ENSG00000118785. [P10451-1]
DR   Ensembl; ENST00000614857; ENSP00000477824; ENSG00000118785. [P10451-4]
DR   GeneID; 6696; -.
DR   KEGG; hsa:6696; -.
DR   UCSC; uc003hra.4; human. [P10451-1]
DR   CTD; 6696; -.
DR   DisGeNET; 6696; -.
DR   EuPathDB; HostDB:ENSG00000118785.13; -.
DR   GeneCards; SPP1; -.
DR   H-InvDB; HIX0004361; -.
DR   HGNC; HGNC:11255; SPP1.
DR   HPA; CAB002212; -.
DR   HPA; HPA027540; -.
DR   HPA; HPA027541; -.
DR   MalaCards; SPP1; -.
DR   MIM; 166490; gene.
DR   neXtProt; NX_P10451; -.
DR   OpenTargets; ENSG00000118785; -.
DR   Orphanet; 93552; Pediatric systemic lupus erythematosus.
DR   Orphanet; 536; Systemic lupus erythematosus.
DR   PharmGKB; PA36085; -.
DR   eggNOG; ENOG410IVP1; Eukaryota.
DR   eggNOG; ENOG41116B5; LUCA.
DR   GeneTree; ENSGT00390000002509; -.
DR   HOGENOM; HOG000059656; -.
DR   HOVERGEN; HBG001731; -.
DR   InParanoid; P10451; -.
DR   KO; K06250; -.
DR   OMA; VICFCLL; -.
DR   OrthoDB; EOG091G0KVC; -.
DR   PhylomeDB; P10451; -.
DR   TreeFam; TF350201; -.
DR   Reactome; R-HSA-1474228; Degradation of the extracellular matrix.
DR   Reactome; R-HSA-186797; Signaling by PDGF.
DR   Reactome; R-HSA-216083; Integrin cell surface interactions.
DR   Reactome; R-HSA-381426; Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs).
DR   Reactome; R-HSA-8949275; RUNX3 Regulates Immune Response and Cell Migration.
DR   Reactome; R-HSA-8957275; Post-translational protein phosphorylation.
DR   SIGNOR; P10451; -.
DR   ChiTaRS; SPP1; human.
DR   EvolutionaryTrace; P10451; -.
DR   GeneWiki; Osteopontin; -.
DR   GenomeRNAi; 6696; -.
DR   PMAP-CutDB; P10451; -.
DR   PRO; PR:P10451; -.
DR   Proteomes; UP000005640; Chromosome 4.
DR   Bgee; ENSG00000118785; -.
DR   CleanEx; HS_SPP1; -.
DR   ExpressionAtlas; P10451; baseline and differential.
DR   Genevisible; P10451; HS.
DR   GO; GO:0042995; C:cell projection; IEA:Ensembl.
DR   GO; GO:0005788; C:endoplasmic reticulum lumen; TAS:Reactome.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0005576; C:extracellular region; TAS:Reactome.
DR   GO; GO:0005615; C:extracellular space; IDA:BHF-UCL.
DR   GO; GO:0005794; C:Golgi apparatus; IDA:HPA.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IEA:Ensembl.
DR   GO; GO:0005125; F:cytokine activity; IEA:UniProtKB-KW.
DR   GO; GO:0050840; F:extracellular matrix binding; IBA:GO_Central.
DR   GO; GO:0006710; P:androgen catabolic process; IDA:CAFA.
DR   GO; GO:0031214; P:biomineral tissue development; IEA:UniProtKB-KW.
DR   GO; GO:0007155; P:cell adhesion; IBA:GO_Central.
DR   GO; GO:0044267; P:cellular protein metabolic process; TAS:Reactome.
DR   GO; GO:0071394; P:cellular response to testosterone stimulus; IDA:CAFA.
DR   GO; GO:0046697; P:decidualization; TAS:BHF-UCL.
DR   GO; GO:0007566; P:embryo implantation; TAS:BHF-UCL.
DR   GO; GO:0030198; P:extracellular matrix organization; TAS:Reactome.
DR   GO; GO:0006954; P:inflammatory response; IEA:Ensembl.
DR   GO; GO:0048685; P:negative regulation of collateral sprouting of intact axon in response to injury; IEA:Ensembl.
DR   GO; GO:0001649; P:osteoblast differentiation; IBA:GO_Central.
DR   GO; GO:0045780; P:positive regulation of bone resorption; IBA:GO_Central.
DR   GO; GO:2000866; P:positive regulation of estradiol secretion; IDA:CAFA.
DR   GO; GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:CAFA.
DR   GO; GO:0043687; P:post-translational protein modification; TAS:Reactome.
DR   GO; GO:0048545; P:response to steroid hormone; IEA:Ensembl.
DR   GO; GO:0033280; P:response to vitamin D; IDA:BHF-UCL.
DR   InterPro; IPR002038; Osteopontin.
DR   InterPro; IPR019841; Osteopontin_CS.
DR   PANTHER; PTHR10607; PTHR10607; 1.
DR   Pfam; PF00865; Osteopontin; 1.
DR   PRINTS; PR00216; OSTEOPONTIN.
DR   SMART; SM00017; OSTEO; 1.
DR   PROSITE; PS00884; OSTEOPONTIN; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Biomineralization; Cell adhesion;
KW   Complete proteome; Cytokine; Direct protein sequencing; Glycoprotein;
KW   Phosphoprotein; Polymorphism; Reference proteome; Secreted;
KW   Sialic acid; Signal.
FT   SIGNAL        1     16       {ECO:0000255}.
FT   CHAIN        17    314       Osteopontin.
FT                                /FTId=PRO_0000020321.
FT   MOTIF       159    161       Cell attachment site.
FT   MOD_RES      24     24       Phosphoserine.
FT                                {ECO:0000269|PubMed:15869464}.
FT   MOD_RES      26     26       Phosphoserine; by FAM20C.
FT                                {ECO:0000269|PubMed:15869464,
FT                                ECO:0000269|PubMed:26091039}.
FT   MOD_RES      27     27       Phosphoserine; by FAM20C.
FT                                {ECO:0000269|PubMed:15869464,
FT                                ECO:0000269|PubMed:26091039}.
FT   MOD_RES      62     62       Phosphoserine; by FAM20C.
FT                                {ECO:0000269|PubMed:15869464,
FT                                ECO:0000269|PubMed:26091039}.
FT   MOD_RES      63     63       Phosphoserine; by FAM20C.
FT                                {ECO:0000269|PubMed:15869464,
FT                                ECO:0000269|PubMed:26091039}.
FT   MOD_RES      66     66       Phosphothreonine.
FT                                {ECO:0000269|PubMed:15869464}.
FT   MOD_RES      76     76       Phosphoserine.
FT                                {ECO:0000269|PubMed:15869464}.
FT   MOD_RES      78     78       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P31096}.
FT   MOD_RES      81     81       Phosphoserine.
FT                                {ECO:0000244|PubMed:16807684,
FT                                ECO:0000269|PubMed:15869464}.
FT   MOD_RES      99     99       Phosphoserine.
FT                                {ECO:0000269|PubMed:15869464}.
FT   MOD_RES     102    102       Phosphoserine.
FT                                {ECO:0000269|PubMed:15869464}.
FT   MOD_RES     105    105       Phosphoserine.
FT                                {ECO:0000269|PubMed:15869464}.
FT   MOD_RES     108    108       Phosphoserine.
FT                                {ECO:0000269|PubMed:15869464}.
FT   MOD_RES     117    117       Phosphoserine.
FT                                {ECO:0000269|PubMed:15869464}.
FT   MOD_RES     120    120       Phosphoserine.
FT                                {ECO:0000269|PubMed:15869464}.
FT   MOD_RES     123    123       Phosphoserine.
FT                                {ECO:0000269|PubMed:15869464}.
FT   MOD_RES     126    126       Phosphoserine.
FT                                {ECO:0000269|PubMed:15869464}.
FT   MOD_RES     129    129       Phosphoserine.
FT                                {ECO:0000269|PubMed:15869464}.
FT   MOD_RES     185    185       Phosphothreonine.
FT                                {ECO:0000269|PubMed:15869464}.
FT   MOD_RES     190    190       Phosphothreonine; by FAM20C.
FT                                {ECO:0000269|PubMed:26091039}.
FT   MOD_RES     191    191       Phosphoserine; by FAM20C.
FT                                {ECO:0000269|PubMed:15869464,
FT                                ECO:0000269|PubMed:26091039}.
FT   MOD_RES     195    195       Phosphoserine; by FAM20C.
FT                                {ECO:0000269|PubMed:15869464,
FT                                ECO:0000269|PubMed:26091039}.
FT   MOD_RES     215    215       Phosphoserine; by FAM20C.
FT                                {ECO:0000269|PubMed:15869464,
FT                                ECO:0000269|PubMed:26091039}.
FT   MOD_RES     219    219       Phosphoserine; by FAM20C.
FT                                {ECO:0000244|PubMed:21406692,
FT                                ECO:0000269|PubMed:15869464,
FT                                ECO:0000269|PubMed:26091039}.
FT   MOD_RES     224    224       Phosphoserine; by FAM20C.
FT                                {ECO:0000244|PubMed:21406692,
FT                                ECO:0000269|PubMed:15869464,
FT                                ECO:0000269|PubMed:26091039}.
FT   MOD_RES     225    225       Phosphotyrosine.
FT                                {ECO:0000269|PubMed:26091039}.
FT   MOD_RES     228    228       Phosphoserine; by FAM20C.
FT                                {ECO:0000269|PubMed:15869464,
FT                                ECO:0000269|PubMed:26091039}.
FT   MOD_RES     234    234       Phosphoserine; by FAM20C.
FT                                {ECO:0000244|PubMed:21406692,
FT                                ECO:0000269|PubMed:15869464,
FT                                ECO:0000269|PubMed:26091039}.
FT   MOD_RES     237    237       Phosphothreonine; by FAM20C.
FT                                {ECO:0000269|PubMed:26091039}.
FT   MOD_RES     239    239       Phosphoserine; by FAM20C.
FT                                {ECO:0000269|PubMed:26091039}.
FT   MOD_RES     243    243       Phosphoserine; by FAM20C.
FT                                {ECO:0000269|PubMed:26091039}.
FT   MOD_RES     254    254       Phosphoserine; by FAM20C.
FT                                {ECO:0000244|PubMed:21406692,
FT                                ECO:0000269|PubMed:15869464,
FT                                ECO:0000269|PubMed:26091039}.
FT   MOD_RES     258    258       Phosphoserine; by FAM20C.
FT                                {ECO:0000269|PubMed:26091039}.
FT   MOD_RES     263    263       Phosphoserine; by FAM20C.
FT                                {ECO:0000269|PubMed:15869464,
FT                                ECO:0000269|PubMed:26091039}.
FT   MOD_RES     267    267       Phosphoserine; by FAM20C.
FT                                {ECO:0000269|PubMed:15869464,
FT                                ECO:0000269|PubMed:26091039}.
FT   MOD_RES     270    270       Phosphoserine; by FAM20C.
FT                                {ECO:0000269|PubMed:26091039}.
FT   MOD_RES     275    275       Phosphoserine; by FAM20C.
FT                                {ECO:0000269|PubMed:15869464,
FT                                ECO:0000269|PubMed:26091039}.
FT   MOD_RES     280    280       Phosphoserine; by FAM20C.
FT                                {ECO:0000269|PubMed:15869464,
FT                                ECO:0000269|PubMed:26091039}.
FT   MOD_RES     291    291       Phosphoserine; by FAM20C.
FT                                {ECO:0000269|PubMed:26091039}.
FT   MOD_RES     303    303       Phosphoserine; by FAM20C.
FT                                {ECO:0000269|PubMed:15869464,
FT                                ECO:0000269|PubMed:26091039}.
FT   MOD_RES     308    308       Phosphoserine; by FAM20C.
FT                                {ECO:0000269|PubMed:15869464,
FT                                ECO:0000269|PubMed:26091039}.
FT   MOD_RES     310    310       Phosphoserine; by FAM20C.
FT                                {ECO:0000269|PubMed:15869464,
FT                                ECO:0000269|PubMed:26091039}.
FT   MOD_RES     311    311       Phosphoserine; by FAM20C.
FT                                {ECO:0000269|PubMed:26091039}.
FT   CARBOHYD     79     79       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:15869464}.
FT   CARBOHYD    106    106       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:15869464}.
FT   CARBOHYD    134    134       O-linked (GalNAc...) threonine.
FT                                {ECO:0000269|PubMed:15869464}.
FT   CARBOHYD    138    138       O-linked (GalNAc...) threonine.
FT                                {ECO:0000269|PubMed:15869464}.
FT   CARBOHYD    143    143       O-linked (GalNAc...) threonine.
FT                                {ECO:0000269|PubMed:15869464}.
FT   CARBOHYD    147    147       O-linked (GalNAc...) threonine.
FT                                {ECO:0000269|PubMed:15869464}.
FT   CARBOHYD    152    152       O-linked (GalNAc...) threonine.
FT                                {ECO:0000269|PubMed:15869464}.
FT   VAR_SEQ      31     57       Missing (in isoform C).
FT                                {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:7837791,
FT                                ECO:0000303|Ref.8}.
FT                                /FTId=VSP_003777.
FT   VAR_SEQ      58     71       Missing (in isoform B).
FT                                {ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:1974876,
FT                                ECO:0000303|PubMed:7837791,
FT                                ECO:0000303|Ref.7}.
FT                                /FTId=VSP_003778.
FT   VAR_SEQ      59     72       Missing (in isoform 5).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_043695.
FT   VAR_SEQ      95    116       Missing (in isoform D).
FT                                {ECO:0000303|PubMed:16303743}.
FT                                /FTId=VSP_011639.
FT   VARIANT     224    224       S -> N (in dbSNP:rs7435825).
FT                                /FTId=VAR_050432.
FT   VARIANT     301    301       R -> H (in dbSNP:rs4660).
FT                                /FTId=VAR_014717.
FT   CONFLICT    188    188       D -> H (in Ref. 6; BAA05949/BAA05950/
FT                                BAA05951). {ECO:0000305}.
FT   CONFLICT    237    237       T -> A (in Ref. 6; BAA05949/BAA05950/
FT                                BAA05951). {ECO:0000305}.
FT   CONFLICT    275    278       SHEF -> GNSL (in Ref. 2). {ECO:0000305}.
FT   STRAND       44     47       {ECO:0000244|PDB:3CXD}.
SQ   SEQUENCE   314 AA;  35423 MW;  4996429EC4752B86 CRC64;
     MRIAVICFCL LGITCAIPVK QADSGSSEEK QLYNKYPDAV ATWLNPDPSQ KQNLLAPQNA
     VSSEETNDFK QETLPSKSNE SHDHMDDMDD EDDDDHVDSQ DSIDSNDSDD VDDTDDSHQS
     DESHHSDESD ELVTDFPTDL PATEVFTPVV PTVDTYDGRG DSVVYGLRSK SKKFRRPDIQ
     YPDATDEDIT SHMESEELNG AYKAIPVAQD LNAPSDWDSR GKDSYETSQL DDQSAETHSH
     KQSRLYKRKA NDESNEHSDV IDSQELSKVS REFHSHEFHS HEDMLVVDPK SKEEDKHLKF
     RISHELDSAS SEVN
//
ID   Q3LGB0_HUMAN            Unreviewed;       273 AA.
AC   Q3LGB0;
DT   08-NOV-2005, integrated into UniProtKB/TrEMBL.
DT   08-NOV-2005, sequence version 1.
DT   25-OCT-2017, entry version 62.
DE   SubName: Full=Osteopontin {ECO:0000313|EMBL:BAE45628.1};
DE   Flags: Fragment;
GN   Name=opn {ECO:0000313|EMBL:BAE45628.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAE45628.1};
RN   [1] {ECO:0000313|EMBL:BAE45628.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Saitoh Y.;
RT   "A splicing variant of osteopontin in human glioma.";
RL   Submitted (MAR-2005) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB209987; BAE45628.1; -; mRNA.
DR   RefSeq; NP_001238758.1; NM_001251829.1.
DR   UniGene; Hs.313; -.
DR   ProteinModelPortal; Q3LGB0; -.
DR   MaxQB; Q3LGB0; -.
DR   PeptideAtlas; Q3LGB0; -.
DR   PRIDE; Q3LGB0; -.
DR   GeneID; 6696; -.
DR   CTD; 6696; -.
DR   HOVERGEN; HBG001731; -.
DR   ChiTaRS; SPP1; human.
DR   GenomeRNAi; 6696; -.
DR   Genevisible; Q3LGB0; HS.
DR   GO; GO:0007155; P:cell adhesion; IEA:InterPro.
DR   GO; GO:0001503; P:ossification; IEA:InterPro.
DR   InterPro; IPR002038; Osteopontin.
DR   InterPro; IPR019841; Osteopontin_CS.
DR   PANTHER; PTHR10607; PTHR10607; 2.
DR   Pfam; PF00865; Osteopontin; 1.
DR   PRINTS; PR00216; OSTEOPONTIN.
DR   SMART; SM00017; OSTEO; 1.
DR   PROSITE; PS00884; OSTEOPONTIN; 1.
PE   2: Evidence at transcript level;
KW   Signal {ECO:0000256|SAM:SignalP}.
FT   SIGNAL        1     16       {ECO:0000256|SAM:SignalP}.
FT   CHAIN        17    273       {ECO:0000256|SAM:SignalP}.
FT                                /FTId=PRO_5004227920.
FT   NON_TER     273    273       {ECO:0000313|EMBL:BAE45628.1}.
SQ   SEQUENCE   273 AA;  30776 MW;  60731AB3E45328A2 CRC64;
     MRIAVICFCL LGITCAIPVK QADSGSSEEK QTLPSKSNES HDHMDDMDDE DDDDHVDSQD
     SIDSNDSDDV DDTDDSHQSD ESHHSDESDE LVTDFPTDLP ATEVFTPVVP TVDTYDGRGD
     SVVYGLRSKS KKFRRPDIQY PDATDEDITS HMESEELNGA YKAIPVAQDL NAPSDWDSRG
     KDSYETSQLD DQSAETHSHK QSRLYKRKAN DESNEHSDVI DSQELSKVSR EFHSHEFHSH
     EDMLVVDPKS KEEDKHLKFR ISHELDSASS EVN
//
ID   Q6FIB4_HUMAN            Unreviewed;       299 AA.
AC   Q6FIB4;
DT   10-MAY-2005, integrated into UniProtKB/TrEMBL.
DT   10-MAY-2005, sequence version 1.
DT   23-MAY-2018, entry version 139.
DE   SubName: Full=F11 receptor {ECO:0000313|EMBL:AAV38906.1};
DE   SubName: Full=F11 receptor protein {ECO:0000313|EMBL:AAG28379.1};
DE   SubName: Full=F11 receptor, isoform CRA_c {ECO:0000313|EMBL:EAW52680.1};
DE   SubName: Full=F11R protein {ECO:0000313|EMBL:CAG38543.1};
DE   SubName: Full=JAM1 {ECO:0000313|EMBL:AAO84556.1};
DE   SubName: Full=cDNA FLJ90671 fis, clone PLACE1005544, highly similar to Junctional adhesion molecule 1 {ECO:0000313|EMBL:BAC11436.1};
GN   Name=F11R {ECO:0000313|EMBL:CAG38543.1};
GN   ORFNames=hCG_20857 {ECO:0000313|EMBL:EAW52680.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:CAG38543.1};
RN   [1] {ECO:0000313|EMBL:AAG28379.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=11087121; DOI=10.1080/15216540050176593;
RA   Gupta S.K., Pillarisetti K., Ohlstein E.H.;
RT   "Platelet agonist F11 receptor is a member of the immunoglobulin
RT   superfamily and identical with junctional adhesion molecule (JAM):
RT   regulation of expression in human endothelial cells and macrophages.";
RL   IUBMB Life 50:51-56(2000).
RN   [2] {ECO:0000313|EMBL:EAW52680.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [3] {ECO:0000313|EMBL:AAO84556.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=12817473; DOI=10.1515/BC.2003.085;
RA   Wenzel K., Felix S.B., Flachmeier C., Heere P., Schulze W.,
RA   Grunewald I., Pankow H., Hewelt A., Scherneck S., Bauer D.,
RA   Hoehe M.R.;
RT   "Identification and characterization of KAT, a novel gene
RT   preferentially expressed in several human cancer cell lines.";
RL   Biol. Chem. 384:763-775(2003).
RN   [4] {ECO:0000313|EMBL:CAG38543.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [5] {ECO:0000313|EMBL:AAV38906.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) System Donor
RT   vector.";
RL   Submitted (OCT-2004) to the EMBL/GenBank/DDBJ databases.
RN   [6] {ECO:0000313|EMBL:BAC11436.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Placenta {ECO:0000313|EMBL:BAC11436.1};
RX   PubMed=16303743; DOI=10.1093/dnares/12.2.117;
RA   Otsuki T., Ota T., Nishikawa T., Hayashi K., Suzuki Y., Yamamoto J.,
RA   Wakamatsu A., Kimura K., Sakamoto K., Hatano N., Kawai Y., Ishii S.,
RA   Saito K., Kojima S., Sugiyama T., Ono T., Okano K., Yoshikawa Y.,
RA   Aotsuka S., Sasaki N., Hattori A., Okumura K., Nagai K., Sugano S.,
RA   Isogai T.;
RT   "Signal sequence and keyword trap in silico for selection of full-
RT   length human cDNAs encoding secretion or membrane proteins from oligo-
RT   capped cDNA libraries.";
RL   DNA Res. 12:117-126(2005).
RN   [7] {ECO:0000313|EMBL:EAW52680.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF191495; AAG28379.1; -; mRNA.
DR   EMBL; AF490407; AAO84556.1; -; Genomic_DNA.
DR   EMBL; BT020103; AAV38906.1; -; mRNA.
DR   EMBL; AK075152; BAC11436.1; -; mRNA.
DR   EMBL; CR533512; CAG38543.1; -; mRNA.
DR   EMBL; CH471121; EAW52680.1; -; Genomic_DNA.
DR   RefSeq; NP_058642.1; NM_016946.5.
DR   UniGene; Hs.517293; -.
DR   DNASU; 50848; -.
DR   GeneID; 50848; -.
DR   KEGG; hsa:50848; -.
DR   CTD; 50848; -.
DR   EuPathDB; HostDB:ENSG00000158769.17; -.
DR   PharmGKB; PA29991; -.
DR   eggNOG; ENOG410IWUE; Eukaryota.
DR   eggNOG; ENOG410YHHV; LUCA.
DR   HOVERGEN; HBG000518; -.
DR   KO; K06089; -.
DR   OMA; NRAFSNS; -.
DR   OrthoDB; EOG091G05PI; -.
DR   ChiTaRS; F11R; human.
DR   GenomeRNAi; 50848; -.
DR   Bgee; ENSG00000158769; -.
DR   GO; GO:0005923; C:bicellular tight junction; IEA:Ensembl.
DR   GO; GO:0031410; C:cytoplasmic vesicle; IEA:Ensembl.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0036057; C:slit diaphragm; IEA:Ensembl.
DR   GO; GO:0007155; P:cell adhesion; IEA:Ensembl.
DR   GO; GO:0030855; P:epithelial cell differentiation; IEA:Ensembl.
DR   GO; GO:0050892; P:intestinal absorption; IEA:Ensembl.
DR   GO; GO:0045777; P:positive regulation of blood pressure; IEA:Ensembl.
DR   GO; GO:0001817; P:regulation of cytokine production; IEA:Ensembl.
DR   GO; GO:0090559; P:regulation of membrane permeability; IEA:Ensembl.
DR   GO; GO:0009314; P:response to radiation; IEA:Ensembl.
DR   Gene3D; 2.60.40.10; -; 2.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR036179; Ig-like_dom_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR003599; Ig_sub.
DR   InterPro; IPR003598; Ig_sub2.
DR   InterPro; IPR013106; Ig_V-set.
DR   Pfam; PF07686; V-set; 1.
DR   SMART; SM00409; IG; 2.
DR   SMART; SM00408; IGc2; 2.
DR   SMART; SM00406; IGv; 1.
DR   SUPFAM; SSF48726; SSF48726; 2.
DR   PROSITE; PS50835; IG_LIKE; 2.
PE   2: Evidence at transcript level;
KW   Membrane {ECO:0000256|SAM:Phobius};
KW   Receptor {ECO:0000313|EMBL:AAG28379.1};
KW   Signal {ECO:0000256|SAM:SignalP};
KW   Transmembrane {ECO:0000256|SAM:Phobius};
KW   Transmembrane helix {ECO:0000256|SAM:Phobius}.
FT   SIGNAL        1     27       {ECO:0000256|SAM:SignalP}.
FT   CHAIN        28    299       {ECO:0000256|SAM:SignalP}.
FT                                /FTId=PRO_5014587299.
FT   TRANSMEM    236    261       Helical. {ECO:0000256|SAM:Phobius}.
FT   DOMAIN       27    125       Ig-like. {ECO:0000259|PROSITE:PS50835}.
FT   DOMAIN      135    228       Ig-like. {ECO:0000259|PROSITE:PS50835}.
SQ   SEQUENCE   299 AA;  32583 MW;  D95DE2FEA23D2851 CRC64;
     MGTKAQVERK LLCLFILAIL LCSLALGSVT VHSSEPEVRI PENNPVKLSC AYSGFSSPRV
     EWKFDQGDTT RLVCYNNKIT ASYEDRVTFL PTGITFKSVT REDTGTYTCM VSEEGGNSYG
     EVKVKLIVLV PPSKPTVNIP SSATIGNRAV LTCSEQDGSP PSEYTWFKDG IVMPTNPKST
     RAFSNSSYVL NPTTGELVFD PLSASDTGEY SCEARNGYGT PMTSNAVRME AVERNVGVIV
     AAVLVTLILL GILVFGIWFA YSRGHFDRTK KGTSSKKVIY SQPSARSEGE FKQTSSFLV
//
ID   JAM1_HUMAN              Reviewed;         299 AA.
AC   Q9Y624; B7Z941;
DT   01-DEC-2000, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1999, sequence version 1.
DT   23-MAY-2018, entry version 184.
DE   RecName: Full=Junctional adhesion molecule A;
DE            Short=JAM-A;
DE   AltName: Full=Junctional adhesion molecule 1;
DE            Short=JAM-1;
DE   AltName: Full=Platelet F11 receptor;
DE   AltName: Full=Platelet adhesion molecule 1;
DE            Short=PAM-1;
DE   AltName: CD_antigen=CD321;
DE   Flags: Precursor;
GN   Name=F11R; Synonyms=JAM1, JCAM; ORFNames=UNQ264/PRO301;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=10395639;
RA   Ozaki H., Ishii K., Horiuchi H., Arai H., Kawamoto T., Okawa K.,
RA   Iwamatsu A., Kita T.;
RT   "Combined treatment of TNF-alpha and IFN-gamma causes redistribution
RT   of junctional adhesion molecule in human endothelial cells.";
RL   J. Immunol. 163:553-557(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND FUNCTION.
RX   PubMed=10753840;
RA   Sobocka M.B., Sobocki T., Banerjee P., Weiss C., Rushbrook J.I.,
RA   Norin A.J., Hartwig J., Salifu M.O., Markell M.S., Babinska A.,
RA   Ehrlich Y.H., Kornecki E.;
RT   "Cloning of the human platelet F11 receptor: a cell adhesion molecule
RT   member of the immunoglobulin superfamily involved in platelet
RT   aggregation.";
RL   Blood 95:2600-2609(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND SUBCELLULAR LOCATION.
RX   PubMed=11171323;
RA   Naik U.P., Naik M.U., Eckfeld K., Martin-DeLeon P., Spychala J.;
RT   "Characterization and chromosomal localization of JAM-1, a platelet
RT   receptor for a stimulatory monoclonal antibody.";
RL   J. Cell Sci. 114:539-547(2001).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=11230166; DOI=10.1101/gr.GR1547R;
RA   Wiemann S., Weil B., Wellenreuther R., Gassenhuber J., Glassl S.,
RA   Ansorge W., Boecher M., Bloecker H., Bauersachs S., Blum H.,
RA   Lauber J., Duesterhoeft A., Beyer A., Koehrer K., Strack N.,
RA   Mewes H.-W., Ottenwaelder B., Obermaier B., Tampe J., Heubner D.,
RA   Wambutt R., Korn B., Klein M., Poustka A.;
RT   "Towards a catalog of human genes and proteins: sequencing and
RT   analysis of 500 novel complete protein coding human cDNAs.";
RL   Genome Res. 11:422-435(2001).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RX   PubMed=12975309; DOI=10.1101/gr.1293003;
RA   Clark H.F., Gurney A.L., Abaya E., Baker K., Baldwin D.T., Brush J.,
RA   Chen J., Chow B., Chui C., Crowley C., Currell B., Deuel B., Dowd P.,
RA   Eaton D., Foster J.S., Grimaldi C., Gu Q., Hass P.E., Heldens S.,
RA   Huang A., Kim H.S., Klimowski L., Jin Y., Johnson S., Lee J.,
RA   Lewis L., Liao D., Mark M.R., Robbie E., Sanchez C., Schoenfeld J.,
RA   Seshagiri S., Simmons L., Singh J., Smith V., Stinson J., Vagts A.,
RA   Vandlen R.L., Watanabe C., Wieand D., Woods K., Xie M.-H.,
RA   Yansura D.G., Yi S., Yu G., Yuan J., Zhang M., Zhang Z., Goddard A.D.,
RA   Wood W.I., Godowski P.J., Gray A.M.;
RT   "The secreted protein discovery initiative (SPDI), a large-scale
RT   effort to identify novel human secreted and transmembrane proteins: a
RT   bioinformatics assessment.";
RL   Genome Res. 13:2265-2270(2003).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Trachea;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Ovary;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   PROTEIN SEQUENCE OF 28-103 AND 123-130, AND GLYCOSYLATION.
RX   PubMed=7646439; DOI=10.1042/bj3100155;
RA   Naik U.P., Ehrlich Y.H., Kornecki E.;
RT   "Mechanisms of platelet activation by a stimulatory antibody: cross-
RT   linking of a novel platelet receptor for monoclonal antibody F11 with
RT   the Fc gamma RII receptor.";
RL   Biochem. J. 310:155-162(1995).
RN   [10]
RP   PROTEIN SEQUENCE OF 28-42.
RX   PubMed=15340161; DOI=10.1110/ps.04682504;
RA   Zhang Z., Henzel W.J.;
RT   "Signal peptide prediction based on analysis of experimentally
RT   verified cleavage sites.";
RL   Protein Sci. 13:2819-2824(2004).
RN   [11]
RP   PROTEIN SEQUENCE OF 28-39.
RC   TISSUE=Platelet;
RX   PubMed=12665801; DOI=10.1038/nbt810;
RA   Gevaert K., Goethals M., Martens L., Van Damme J., Staes A.,
RA   Thomas G.R., Vandekerckhove J.;
RT   "Exploring proteomes and analyzing protein processing by mass
RT   spectrometric identification of sorted N-terminal peptides.";
RL   Nat. Biotechnol. 21:566-569(2003).
RN   [12]
RP   FUNCTION, AND INTERACTION WITH MPDZ.
RX   PubMed=11489913; DOI=10.1083/jcb.200103047;
RA   Itoh M., Sasaki H., Furuse M., Ozaki H., Kita T., Tsukita S.;
RT   "Junctional adhesion molecule (JAM) binds to PAR-3: a possible
RT   mechanism for the recruitment of PAR-3 to tight junctions.";
RL   J. Cell Biol. 154:491-497(2001).
RN   [13]
RP   FUNCTION (MICROBIAL INFECTION), AND INTERACTION WITH MAMMALIAN
RP   REOVIRUS SIGMA-1 PROTEIN.
RX   PubMed=11239401; DOI=10.1016/S0092-8674(01)00231-8;
RA   Barton E.S., Forrest J.C., Connolly J.L., Chappell J.D., Liu Y.,
RA   Schnell F.J., Nusrat A., Parkos C.A., Dermody T.S.;
RT   "Junction adhesion molecule is a receptor for reovirus.";
RL   Cell 104:441-451(2001).
RN   [14]
RP   FUNCTION, SUBCELLULAR LOCATION, TISSUE SPECIFICITY, AND DOMAIN.
RX   PubMed=11812992; DOI=10.1038/ni755;
RA   Ostermann G., Weber K.S., Zernecke A., Schroeder A., Weber C.;
RT   "JAM-1 is a ligand of the beta(2) integrin LFA-1 involved in
RT   transendothelial migration of leukocytes.";
RL   Nat. Immunol. 3:151-158(2002).
RN   [15]
RP   REVIEW, AND NOMENCLATURE.
RX   PubMed=12810109; DOI=10.1016/S1471-4906(03)00117-0;
RA   Muller W.A.;
RT   "Leukocyte-endothelial-cell interactions in leukocyte transmigration
RT   and the inflammatory response.";
RL   Trends Immunol. 24:327-334(2003).
RN   [16]
RP   INTERACTION WITH ITGAL.
RX   PubMed=15528364; DOI=10.4049/jimmunol.173.10.6259;
RA   Fraemohs L., Koenen R.R., Ostermann G., Heinemann B., Weber C.;
RT   "The functional interaction of the beta 2 integrin lymphocyte
RT   function-associated antigen-1 with junctional adhesion molecule-A is
RT   mediated by the I domain.";
RL   J. Immunol. 173:6259-6264(2004).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-284, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Platelet;
RX   PubMed=18088087; DOI=10.1021/pr0704130;
RA   Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J.,
RA   Schuetz C., Walter U., Gambaryan S., Sickmann A.;
RT   "Phosphoproteome of resting human platelets.";
RL   J. Proteome Res. 7:526-534(2008).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-281; SER-284 AND
RP   SER-287, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [19]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-185 AND ASN-191.
RC   TISSUE=Liver;
RX   PubMed=19159218; DOI=10.1021/pr8008012;
RA   Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.;
RT   "Glycoproteomics analysis of human liver tissue by combination of
RT   multiple enzyme digestion and hydrazide chemistry.";
RL   J. Proteome Res. 8:651-661(2009).
RN   [20]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-284, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [21]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [22]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-284, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [23]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-284 AND SER-287, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [24]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-284, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [25]
RP   CLEAVAGE OF SIGNAL PEPTIDE [LARGE SCALE ANALYSIS] AFTER GLY-27, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [26]
RP   FUNCTION (MICROBIAL INFECTION), AND INTERACTION WITH HUMAN ROTAVIRUS
RP   STRAIN WA VP4 PROTEIN.
RX   PubMed=25481868; DOI=10.1016/j.virol.2014.11.016;
RA   Torres-Flores J.M., Silva-Ayala D., Espinoza M.A., Lopez S.,
RA   Arias C.F.;
RT   "The tight junction protein JAM-A functions as coreceptor for
RT   rotavirus entry into MA104 cells.";
RL   Virology 475:172-178(2015).
RN   [27]
RP   X-RAY CRYSTALLOGRAPHY (2.90 ANGSTROMS) OF 27-233, AND DISULFIDE BONDS.
RX   PubMed=12697893; DOI=10.1073/pnas.0937718100;
RA   Prota A.E., Campbell J.A., Schelling P., Forrest J.C., Watson M.J.,
RA   Peters T.R., Aurrand-Lions M.A., Imhof B.A., Dermody T.S., Stehle T.;
RT   "Crystal structure of human junctional adhesion molecule 1:
RT   implications for reovirus binding.";
RL   Proc. Natl. Acad. Sci. U.S.A. 100:5366-5371(2003).
CC   -!- FUNCTION: Seems to play a role in epithelial tight junction
CC       formation. Appears early in primordial forms of cell junctions and
CC       recruits PARD3 (PubMed:11489913). The association of the PARD6-
CC       PARD3 complex may prevent the interaction of PARD3 with JAM1,
CC       thereby preventing tight junction assembly (By similarity). Plays
CC       a role in regulating monocyte transmigration involved in integrity
CC       of epithelial barrier (By similarity). Ligand for integrin alpha-
CC       L/beta-2 involved in memory T-cell and neutrophil transmigration
CC       (PubMed:11812992). Involved in platelet activation
CC       (PubMed:10753840). {ECO:0000250|UniProtKB:O88792,
CC       ECO:0000269|PubMed:10753840, ECO:0000269|PubMed:11489913,
CC       ECO:0000269|PubMed:11812992}.
CC   -!- FUNCTION: (Microbial infection) Acts as a receptor for Mammalian
CC       reovirus sigma-1. {ECO:0000269|PubMed:11239401}.
CC   -!- FUNCTION: (Microbial infection) Acts as a receptor for Human
CC       Rotavirus strain Wa. {ECO:0000269|PubMed:25481868}.
CC   -!- SUBUNIT: Interacts with the ninth PDZ domain of MPDZ
CC       (PubMed:11489913). Interacts with the first PDZ domain of PARD3
CC       (PubMed:11489913). The association between PARD3 and PARD6B
CC       probably disrupts this interaction (By similarity). Interacts with
CC       ITGAL (via I-domain) (PubMed:15528364).
CC       {ECO:0000250|UniProtKB:O88792, ECO:0000269|PubMed:11489913,
CC       ECO:0000269|PubMed:15528364}.
CC   -!- SUBUNIT: (Microbial infection) Interacts with Mammalian reovirus
CC       sigma-1 capsid protein. {ECO:0000269|PubMed:11239401}.
CC   -!- SUBUNIT: (Microbial infection) Interacts with Human Rotavirus
CC       strain Wa vp4 capsid protein. {ECO:0000269|PubMed:25481868}.
CC   -!- INTERACTION:
CC       Q8TEW0:PARD3; NbExp=2; IntAct=EBI-742600, EBI-81968;
CC       Q05513:PRKCZ; NbExp=2; IntAct=EBI-742600, EBI-295351;
CC       O43765:SGTA; NbExp=9; IntAct=EBI-742600, EBI-347996;
CC   -!- SUBCELLULAR LOCATION: Cell junction, tight junction
CC       {ECO:0000269|PubMed:11171323}. Cell membrane
CC       {ECO:0000269|PubMed:11171323}; Single-pass type I membrane protein
CC       {ECO:0000269|PubMed:11171323}. Note=Localized at tight junctions
CC       of both epithelial and endothelial cells.
CC       {ECO:0000269|PubMed:11171323}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9Y624-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9Y624-2; Sequence=VSP_056218;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Expressed in endothelium, epithelium and
CC       leukocytes (at protein level). {ECO:0000269|PubMed:11812992}.
CC   -!- DOMAIN: The Ig-like V-type 2 domain is necessary and sufficient
CC       for interaction with integrin alpha-L/beta-2.
CC       {ECO:0000269|PubMed:11812992}.
CC   -!- PTM: N-glycosylated. {ECO:0000269|PubMed:19159218,
CC       ECO:0000269|PubMed:7646439}.
CC   -!- SIMILARITY: Belongs to the immunoglobulin superfamily.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF111713; AAD42050.1; -; mRNA.
DR   EMBL; AF207907; AAF22829.1; -; mRNA.
DR   EMBL; AF172398; AAD48877.1; -; mRNA.
DR   EMBL; AL136649; CAB66584.1; -; mRNA.
DR   EMBL; AY358896; AAQ89255.1; -; mRNA.
DR   EMBL; AK304412; BAH14177.1; -; mRNA.
DR   EMBL; AL591806; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC001533; AAH01533.1; -; mRNA.
DR   CCDS; CCDS1213.1; -. [Q9Y624-1]
DR   PIR; A59406; S56749.
DR   RefSeq; NP_001335020.1; NM_001348091.1. [Q9Y624-2]
DR   RefSeq; NP_058642.1; NM_016946.5. [Q9Y624-1]
DR   UniGene; Hs.517293; -.
DR   PDB; 1NBQ; X-ray; 2.90 A; A/B=27-233.
DR   PDB; 3EOY; X-ray; 3.40 A; G/H/I/J/K/L=28-129.
DR   PDB; 3TSZ; X-ray; 2.50 A; B=288-299.
DR   PDB; 4ODB; X-ray; 3.20 A; D/E/F=28-129.
DR   PDBsum; 1NBQ; -.
DR   PDBsum; 3EOY; -.
DR   PDBsum; 3TSZ; -.
DR   PDBsum; 4ODB; -.
DR   ProteinModelPortal; Q9Y624; -.
DR   SMR; Q9Y624; -.
DR   BioGrid; 119153; 16.
DR   CORUM; Q9Y624; -.
DR   IntAct; Q9Y624; 7.
DR   MINT; Q9Y624; -.
DR   STRING; 9606.ENSP00000289779; -.
DR   iPTMnet; Q9Y624; -.
DR   PhosphoSitePlus; Q9Y624; -.
DR   SwissPalm; Q9Y624; -.
DR   BioMuta; F11R; -.
DR   DMDM; 10720061; -.
DR   EPD; Q9Y624; -.
DR   PaxDb; Q9Y624; -.
DR   PeptideAtlas; Q9Y624; -.
DR   PRIDE; Q9Y624; -.
DR   DNASU; 50848; -.
DR   Ensembl; ENST00000368026; ENSP00000357005; ENSG00000158769. [Q9Y624-1]
DR   Ensembl; ENST00000537746; ENSP00000440812; ENSG00000158769. [Q9Y624-2]
DR   GeneID; 50848; -.
DR   KEGG; hsa:50848; -.
DR   UCSC; uc009wtt.4; human. [Q9Y624-1]
DR   CTD; 50848; -.
DR   DisGeNET; 50848; -.
DR   EuPathDB; HostDB:ENSG00000158769.17; -.
DR   GeneCards; F11R; -.
DR   HGNC; HGNC:14685; F11R.
DR   HPA; CAB004671; -.
DR   HPA; HPA043616; -.
DR   HPA; HPA061700; -.
DR   MIM; 605721; gene.
DR   neXtProt; NX_Q9Y624; -.
DR   OpenTargets; ENSG00000158769; -.
DR   PharmGKB; PA29991; -.
DR   eggNOG; ENOG410IWUE; Eukaryota.
DR   eggNOG; ENOG410YHHV; LUCA.
DR   GeneTree; ENSGT00730000110678; -.
DR   HOVERGEN; HBG000518; -.
DR   InParanoid; Q9Y624; -.
DR   KO; K06089; -.
DR   OMA; NRAFSNS; -.
DR   OrthoDB; EOG091G05PI; -.
DR   PhylomeDB; Q9Y624; -.
DR   TreeFam; TF343984; -.
DR   Reactome; R-HSA-202733; Cell surface interactions at the vascular wall.
DR   Reactome; R-HSA-216083; Integrin cell surface interactions.
DR   Reactome; R-HSA-2173791; TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition).
DR   Reactome; R-HSA-420029; Tight junction interactions.
DR   SIGNOR; Q9Y624; -.
DR   ChiTaRS; F11R; human.
DR   EvolutionaryTrace; Q9Y624; -.
DR   GeneWiki; F11_receptor; -.
DR   GenomeRNAi; 50848; -.
DR   PRO; PR:Q9Y624; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000158769; -.
DR   CleanEx; HS_F11R; -.
DR   ExpressionAtlas; Q9Y624; baseline and differential.
DR   Genevisible; Q9Y624; HS.
DR   GO; GO:0005923; C:bicellular tight junction; IDA:UniProtKB.
DR   GO; GO:0030054; C:cell junction; TAS:Reactome.
DR   GO; GO:0005911; C:cell-cell junction; TAS:ProtInc.
DR   GO; GO:0031410; C:cytoplasmic vesicle; IEA:Ensembl.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005886; C:plasma membrane; IDA:LIFEdb.
DR   GO; GO:0036057; C:slit diaphragm; IEA:Ensembl.
DR   GO; GO:0045296; F:cadherin binding; HDA:BHF-UCL.
DR   GO; GO:0030165; F:PDZ domain binding; IPI:UniProtKB.
DR   GO; GO:0001618; F:virus receptor activity; IEA:UniProtKB-KW.
DR   GO; GO:0031032; P:actomyosin structure organization; IMP:UniProtKB.
DR   GO; GO:0070830; P:bicellular tight junction assembly; TAS:Reactome.
DR   GO; GO:0007155; P:cell adhesion; IEA:Ensembl.
DR   GO; GO:0090557; P:establishment of endothelial intestinal barrier; IMP:UniProtKB.
DR   GO; GO:0030198; P:extracellular matrix organization; TAS:Reactome.
DR   GO; GO:0006954; P:inflammatory response; TAS:ProtInc.
DR   GO; GO:0050892; P:intestinal absorption; IMP:UniProtKB.
DR   GO; GO:0050900; P:leukocyte migration; TAS:Reactome.
DR   GO; GO:0034260; P:negative regulation of GTPase activity; IMP:UniProtKB.
DR   GO; GO:0045777; P:positive regulation of blood pressure; IEA:Ensembl.
DR   GO; GO:0043547; P:positive regulation of GTPase activity; IMP:UniProtKB.
DR   GO; GO:0072659; P:protein localization to plasma membrane; IMP:UniProtKB.
DR   GO; GO:2000249; P:regulation of actin cytoskeleton reorganization; IMP:UniProtKB.
DR   GO; GO:0001817; P:regulation of cytokine production; IEA:Ensembl.
DR   GO; GO:0090559; P:regulation of membrane permeability; IMP:UniProtKB.
DR   GO; GO:0009314; P:response to radiation; IEA:Ensembl.
DR   GO; GO:0007179; P:transforming growth factor beta receptor signaling pathway; TAS:Reactome.
DR   Gene3D; 2.60.40.10; -; 2.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR036179; Ig-like_dom_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR003599; Ig_sub.
DR   InterPro; IPR003598; Ig_sub2.
DR   InterPro; IPR013106; Ig_V-set.
DR   Pfam; PF07686; V-set; 1.
DR   SMART; SM00409; IG; 2.
DR   SMART; SM00408; IGc2; 2.
DR   SMART; SM00406; IGv; 1.
DR   SUPFAM; SSF48726; SSF48726; 2.
DR   PROSITE; PS50835; IG_LIKE; 2.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Cell junction; Cell membrane;
KW   Complete proteome; Direct protein sequencing; Disulfide bond;
KW   Glycoprotein; Host cell receptor for virus entry;
KW   Host-virus interaction; Immunoglobulin domain; Membrane;
KW   Phosphoprotein; Receptor; Reference proteome; Repeat; Signal;
KW   Tight junction; Transmembrane; Transmembrane helix.
FT   SIGNAL        1     27       {ECO:0000244|PubMed:25944712,
FT                                ECO:0000269|PubMed:12665801,
FT                                ECO:0000269|PubMed:15340161,
FT                                ECO:0000269|PubMed:7646439}.
FT   CHAIN        28    299       Junctional adhesion molecule A.
FT                                /FTId=PRO_0000015066.
FT   TOPO_DOM     28    238       Extracellular. {ECO:0000255}.
FT   TRANSMEM    239    259       Helical. {ECO:0000255}.
FT   TOPO_DOM    260    299       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN       28    125       Ig-like V-type 1.
FT   DOMAIN      135    228       Ig-like V-type 2.
FT   MOD_RES     281    281       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   MOD_RES     284    284       Phosphoserine.
FT                                {ECO:0000244|PubMed:18088087,
FT                                ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     287    287       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:23186163}.
FT   CARBOHYD    185    185       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:19159218}.
FT   CARBOHYD    191    191       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:19159218}.
FT   DISULFID     50    109       {ECO:0000269|PubMed:12697893}.
FT   DISULFID    153    212       {ECO:0000269|PubMed:12697893}.
FT   VAR_SEQ      81    129       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_056218.
FT   STRAND       30     32       {ECO:0000244|PDB:1NBQ}.
FT   STRAND       36     41       {ECO:0000244|PDB:4ODB}.
FT   STRAND       47     49       {ECO:0000244|PDB:1NBQ}.
FT   STRAND       51     54       {ECO:0000244|PDB:1NBQ}.
FT   STRAND       56     66       {ECO:0000244|PDB:1NBQ}.
FT   STRAND       69     75       {ECO:0000244|PDB:1NBQ}.
FT   STRAND       76     79       {ECO:0000244|PDB:3EOY}.
FT   TURN         81     86       {ECO:0000244|PDB:1NBQ}.
FT   STRAND       88     90       {ECO:0000244|PDB:1NBQ}.
FT   STRAND       93     95       {ECO:0000244|PDB:1NBQ}.
FT   HELIX       101    103       {ECO:0000244|PDB:4ODB}.
FT   STRAND      105    113       {ECO:0000244|PDB:1NBQ}.
FT   STRAND      123    125       {ECO:0000244|PDB:1NBQ}.
FT   STRAND      128    130       {ECO:0000244|PDB:1NBQ}.
FT   STRAND      140    144       {ECO:0000244|PDB:1NBQ}.
FT   STRAND      149    151       {ECO:0000244|PDB:1NBQ}.
FT   STRAND      163    168       {ECO:0000244|PDB:1NBQ}.
FT   STRAND      177    182       {ECO:0000244|PDB:1NBQ}.
FT   TURN        192    194       {ECO:0000244|PDB:1NBQ}.
FT   STRAND      197    201       {ECO:0000244|PDB:1NBQ}.
FT   HELIX       204    206       {ECO:0000244|PDB:1NBQ}.
FT   STRAND      210    215       {ECO:0000244|PDB:1NBQ}.
FT   STRAND      217    219       {ECO:0000244|PDB:1NBQ}.
FT   STRAND      230    232       {ECO:0000244|PDB:1NBQ}.
SQ   SEQUENCE   299 AA;  32583 MW;  D95DE2FEA23D2851 CRC64;
     MGTKAQVERK LLCLFILAIL LCSLALGSVT VHSSEPEVRI PENNPVKLSC AYSGFSSPRV
     EWKFDQGDTT RLVCYNNKIT ASYEDRVTFL PTGITFKSVT REDTGTYTCM VSEEGGNSYG
     EVKVKLIVLV PPSKPTVNIP SSATIGNRAV LTCSEQDGSP PSEYTWFKDG IVMPTNPKST
     RAFSNSSYVL NPTTGELVFD PLSASDTGEY SCEARNGYGT PMTSNAVRME AVERNVGVIV
     AAVLVTLILL GILVFGIWFA YSRGHFDRTK KGTSSKKVIY SQPSARSEGE FKQTSSFLV
//
ID   SRGN_HUMAN              Reviewed;         158 AA.
AC   P10124; B2R4L7; Q5VW06;
DT   01-JUL-1989, integrated into UniProtKB/Swiss-Prot.
DT   24-NOV-2009, sequence version 3.
DT   28-FEB-2018, entry version 166.
DE   RecName: Full=Serglycin;
DE   AltName: Full=Hematopoietic proteoglycan core protein;
DE   AltName: Full=Platelet proteoglycan core protein;
DE            Short=P.PG;
DE   AltName: Full=Secretory granule proteoglycan core protein;
DE   Flags: Precursor;
GN   Name=SRGN; Synonyms=PRG, PRG1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT GLN-31.
RX   PubMed=2835370;
RA   Stevens R.L., Avraham S., Gartner M.C., Bruns G.A.P., Austen K.F.,
RA   Weis J.H.;
RT   "Isolation and characterization of a cDNA that encodes the peptide
RT   core of the secretory granule proteoglycan of human promyelocytic
RT   leukemia HL-60 cells.";
RL   J. Biol. Chem. 263:7287-7291(1988).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT GLN-31.
RX   PubMed=2798108; DOI=10.1093/nar/17.18.7523;
RA   Stellrecht C.M., Saunders G.F.;
RT   "Nucleotide sequence of a cDNA encoding a hemopoietic proteoglycan
RT   core protein.";
RL   Nucleic Acids Res. 17:7523-7523(1989).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT GLN-31.
RX   PubMed=2180935;
RA   Nicodemus C.F., Avraham S., Austen K.F., Purdy S., Jablonski J.,
RA   Stevens R.L.;
RT   "Characterization of the human gene that encodes the peptide core of
RT   secretory granule proteoglycans in promyelocytic leukemia HL-60 cells
RT   and analysis of the translated product.";
RL   J. Biol. Chem. 265:5889-5896(1990).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=1377686;
RA   Humphries D.E., Nicodemus C.F., Schiller V., Stevens R.L.;
RT   "The human serglycin gene. Nucleotide sequence and methylation pattern
RT   in human promyelocytic leukemia HL-60 cells and T-lymphoblast Molt-4
RT   cells.";
RL   J. Biol. Chem. 267:13558-13563(1992).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT GLN-31.
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164054; DOI=10.1038/nature02462;
RA   Deloukas P., Earthrowl M.E., Grafham D.V., Rubenfield M., French L.,
RA   Steward C.A., Sims S.K., Jones M.C., Searle S., Scott C., Howe K.,
RA   Hunt S.E., Andrews T.D., Gilbert J.G.R., Swarbreck D., Ashurst J.L.,
RA   Taylor A., Battles J., Bird C.P., Ainscough R., Almeida J.P.,
RA   Ashwell R.I.S., Ambrose K.D., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Bates K., Beasley H., Bray-Allen S., Brown A.J.,
RA   Brown J.Y., Burford D.C., Burrill W., Burton J., Cahill P., Camire D.,
RA   Carter N.P., Chapman J.C., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Corby N., Coulson A., Dhami P., Dutta I., Dunn M., Faulkner L.,
RA   Frankish A., Frankland J.A., Garner P., Garnett J., Gribble S.,
RA   Griffiths C., Grocock R., Gustafson E., Hammond S., Harley J.L.,
RA   Hart E., Heath P.D., Ho T.P., Hopkins B., Horne J., Howden P.J.,
RA   Huckle E., Hynds C., Johnson C., Johnson D., Kana A., Kay M.,
RA   Kimberley A.M., Kershaw J.K., Kokkinaki M., Laird G.K., Lawlor S.,
RA   Lee H.M., Leongamornlert D.A., Laird G., Lloyd C., Lloyd D.M.,
RA   Loveland J., Lovell J., McLaren S., McLay K.E., McMurray A.,
RA   Mashreghi-Mohammadi M., Matthews L., Milne S., Nickerson T.,
RA   Nguyen M., Overton-Larty E., Palmer S.A., Pearce A.V., Peck A.I.,
RA   Pelan S., Phillimore B., Porter K., Rice C.M., Rogosin A., Ross M.T.,
RA   Sarafidou T., Sehra H.K., Shownkeen R., Skuce C.D., Smith M.,
RA   Standring L., Sycamore N., Tester J., Thorpe A., Torcasso W.,
RA   Tracey A., Tromans A., Tsolas J., Wall M., Walsh J., Wang H.,
RA   Weinstock K., West A.P., Willey D.L., Whitehead S.L., Wilming L.,
RA   Wray P.W., Young L., Chen Y., Lovering R.C., Moschonas N.K.,
RA   Siebert R., Fechtel K., Bentley D., Durbin R.M., Hubbard T.,
RA   Doucette-Stamm L., Beck S., Smith D.R., Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 10.";
RL   Nature 429:375-381(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND VARIANT GLN-31.
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT GLN-31.
RC   TISSUE=Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   PROTEIN SEQUENCE OF 28-158, NUCLEOTIDE SEQUENCE [MRNA] OF 34-158, AND
RP   GLYCOSYLATION AT SER-94 AND SER-96.
RX   PubMed=3402609; DOI=10.1016/0014-5793(88)80298-9;
RA   Alliel P.M., Perin J.-P., Maillet P., Bonnet F., Rosa J.-P.,
RA   Jolles P.;
RT   "Complete amino acid sequence of a human platelet proteoglycan.";
RL   FEBS Lett. 236:123-126(1988).
RN   [10]
RP   PROTEIN SEQUENCE OF 28-93.
RX   PubMed=3214420; DOI=10.1042/bj2551007;
RA   Perin J.-P., Bonnet F., Maillet P., Jolles P.;
RT   "Characterization and N-terminal sequence of human platelet
RT   proteoglycan.";
RL   Biochem. J. 255:1007-1013(1988).
RN   [11]
RP   SUBCELLULAR LOCATION.
RX   PubMed=11154222; DOI=10.1182/blood.V97.2.449;
RA   Schick B.P., Gradowski J.F., San Antonio J.D.;
RT   "Synthesis, secretion, and subcellular localization of serglycin
RT   proteoglycan in human endothelial cells.";
RL   Blood 97:449-458(2001).
RN   [12]
RP   FUNCTION, AND INTERACTION WITH GZMB.
RX   PubMed=11911826; DOI=10.1016/S1074-7613(02)00286-8;
RA   Metkar S.S., Wang B., Aguilar-Santelises M., Raja S.M.,
RA   Uhlin-Hansen L., Podack E., Trapani J.A., Froelich C.J.;
RT   "Cytotoxic cell granule-mediated apoptosis: perforin delivers granzyme
RT   B-serglycin complexes into target cells without plasma membrane pore
RT   formation.";
RL   Immunity 16:417-428(2002).
RN   [13]
RP   INTERACTION WITH GZMB.
RX   PubMed=12388539; DOI=10.1074/jbc.M209607200;
RA   Raja S.M., Wang B., Dantuluri M., Desai U.R., Demeler B., Spiegel K.,
RA   Metkar S.S., Froelich C.J.;
RT   "Cytotoxic cell granule-mediated apoptosis. Characterization of the
RT   macromolecular complex of granzyme B with serglycin.";
RL   J. Biol. Chem. 277:49523-49530(2002).
RN   [14]
RP   SUBCELLULAR LOCATION.
RX   PubMed=15136585; DOI=10.1189/jlb.1003502;
RA   Niemann C.U., Cowland J.B., Klausen P., Askaa J., Calafat J.,
RA   Borregaard N.;
RT   "Localization of serglycin in human neutrophil granulocytes and their
RT   precursors.";
RL   J. Leukoc. Biol. 76:406-415(2004).
RN   [15]
RP   FUNCTION.
RX   PubMed=16420477; DOI=10.1111/j.1742-4658.2005.05085.x;
RA   Zernichow L., Dalen K.T., Prydz K., Winberg J.-O., Kolset S.O.;
RT   "Secretion of proteases in serglycin transfected Madin-Darby canine
RT   kidney cells.";
RL   FEBS J. 273:536-547(2006).
RN   [16]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=16870619; DOI=10.1074/jbc.M601061200;
RA   Theocharis A.D., Seidel C., Borset M., Dobra K., Baykov V.,
RA   Labropoulou V., Kanakis I., Dalas E., Karamanos N.K., Sundan A.,
RA   Hjerpe A.;
RT   "Serglycin constitutively secreted by myeloma plasma cells is a potent
RT   inhibitor of bone mineralization in vitro.";
RL   J. Biol. Chem. 281:35116-35128(2006).
CC   -!- FUNCTION: Plays a role in formation of mast cell secretory
CC       granules and mediates storage of various compounds in secretory
CC       vesicles. Required for storage of some proteases in both
CC       connective tissue and mucosal mast cells and for storage of
CC       granzyme B in T-lymphocytes. Plays a role in localizing neutrophil
CC       elastase in azurophil granules of neutrophils. Mediates processing
CC       of MMP2. Plays a role in cytotoxic cell granule-mediated apoptosis
CC       by forming a complex with granzyme B which is delivered to cells
CC       by perforin to induce apoptosis. Regulates the secretion of TNF-
CC       alpha and may also regulate protease secretion. Inhibits bone
CC       mineralization. {ECO:0000269|PubMed:11911826,
CC       ECO:0000269|PubMed:16420477, ECO:0000269|PubMed:16870619}.
CC   -!- SUBUNIT: Binds to activated CD44 and to GZMB.
CC   -!- INTERACTION:
CC       P10144:GZMB; NbExp=2; IntAct=EBI-744915, EBI-2505785;
CC       O43765:SGTA; NbExp=8; IntAct=EBI-744915, EBI-347996;
CC       Q9UMX0:UBQLN1; NbExp=5; IntAct=EBI-744915, EBI-741480;
CC       Q9UMX0-2:UBQLN1; NbExp=3; IntAct=EBI-744915, EBI-10173939;
CC   -!- SUBCELLULAR LOCATION: Cytoplasmic granule
CC       {ECO:0000269|PubMed:11154222}. Secreted, extracellular space
CC       {ECO:0000269|PubMed:11154222, ECO:0000269|PubMed:16870619}. Golgi
CC       apparatus {ECO:0000269|PubMed:11154222,
CC       ECO:0000269|PubMed:15136585}. Note=Found in mast cell granules and
CC       in cytoplasmic granules of cytolytic T lymphocytes from where it
CC       is secreted upon cell activation (By similarity). Secreted
CC       constitutively by endothelial cells and macrophages
CC       (PubMed:11154222). Located to Golgi apparatus during neutrophil
CC       differentiation (PubMed:15136585). {ECO:0000250|UniProtKB:P13609,
CC       ECO:0000269|PubMed:11154222, ECO:0000269|PubMed:15136585}.
CC   -!- INDUCTION: By Epstein-Barr virus (EBV).
CC   -!- PTM: O-glycosylated; contains chondroitin sulfate and heparan
CC       sulfate. {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the serglycin family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; J03223; AAA60179.1; -; mRNA.
DR   EMBL; X17042; CAA34900.1; -; mRNA.
DR   EMBL; M33651; AAA60322.1; -; Genomic_DNA.
DR   EMBL; M33649; AAA60322.1; JOINED; Genomic_DNA.
DR   EMBL; M33650; AAA60322.1; JOINED; Genomic_DNA.
DR   EMBL; M90058; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AK311873; BAG34814.1; -; mRNA.
DR   EMBL; AL442635; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471083; EAW54309.1; -; Genomic_DNA.
DR   EMBL; BC015516; AAH15516.1; -; mRNA.
DR   EMBL; X12765; CAA31255.1; -; mRNA.
DR   CCDS; CCDS7285.1; -.
DR   PIR; A35183; A28058.
DR   RefSeq; NP_001307982.1; NM_001321053.1.
DR   RefSeq; NP_001307983.1; NM_001321054.1.
DR   RefSeq; NP_002718.2; NM_002727.3.
DR   RefSeq; XP_016871881.1; XM_017016392.1.
DR   UniGene; Hs.1908; -.
DR   ProteinModelPortal; P10124; -.
DR   BioGrid; 111543; 10.
DR   IntAct; P10124; 21.
DR   MINT; P10124; -.
DR   STRING; 9606.ENSP00000242465; -.
DR   iPTMnet; P10124; -.
DR   BioMuta; SRGN; -.
DR   DMDM; 269849659; -.
DR   EPD; P10124; -.
DR   MaxQB; P10124; -.
DR   PaxDb; P10124; -.
DR   PeptideAtlas; P10124; -.
DR   PRIDE; P10124; -.
DR   DNASU; 5552; -.
DR   Ensembl; ENST00000242465; ENSP00000242465; ENSG00000122862.
DR   GeneID; 5552; -.
DR   KEGG; hsa:5552; -.
DR   UCSC; uc001joz.4; human.
DR   CTD; 5552; -.
DR   DisGeNET; 5552; -.
DR   EuPathDB; HostDB:ENSG00000122862.4; -.
DR   GeneCards; SRGN; -.
DR   HGNC; HGNC:9361; SRGN.
DR   HPA; HPA000759; -.
DR   MIM; 177040; gene.
DR   neXtProt; NX_P10124; -.
DR   OpenTargets; ENSG00000122862; -.
DR   PharmGKB; PA33733; -.
DR   eggNOG; ENOG410J42T; Eukaryota.
DR   eggNOG; ENOG4111DTK; LUCA.
DR   GeneTree; ENSGT00390000000885; -.
DR   HOGENOM; HOG000154415; -.
DR   HOVERGEN; HBG008180; -.
DR   InParanoid; P10124; -.
DR   KO; K06849; -.
DR   OMA; QWVRCNP; -.
DR   OrthoDB; EOG091G19FW; -.
DR   PhylomeDB; P10124; -.
DR   TreeFam; TF336310; -.
DR   Reactome; R-HSA-114608; Platelet degranulation.
DR   ChiTaRS; SRGN; human.
DR   GeneWiki; SRGN; -.
DR   GenomeRNAi; 5552; -.
DR   PRO; PR:P10124; -.
DR   Proteomes; UP000005640; Chromosome 10.
DR   Bgee; ENSG00000122862; -.
DR   CleanEx; HS_SRGN; -.
DR   Genevisible; P10124; HS.
DR   GO; GO:0005576; C:extracellular region; TAS:Reactome.
DR   GO; GO:0005615; C:extracellular space; IDA:UniProtKB.
DR   GO; GO:0005794; C:Golgi apparatus; IDA:UniProtKB.
DR   GO; GO:0042629; C:mast cell granule; ISS:UniProtKB.
DR   GO; GO:0031093; C:platelet alpha granule lumen; TAS:Reactome.
DR   GO; GO:0031214; P:biomineral tissue development; IEA:UniProtKB-KW.
DR   GO; GO:0008626; P:granzyme-mediated apoptotic signaling pathway; IDA:UniProtKB.
DR   GO; GO:0033382; P:maintenance of granzyme B location in T cell secretory granule; ISS:UniProtKB.
DR   GO; GO:0033373; P:maintenance of protease location in mast cell secretory granule; ISS:UniProtKB.
DR   GO; GO:0033364; P:mast cell secretory granule organization; ISS:UniProtKB.
DR   GO; GO:0030502; P:negative regulation of bone mineralization; IDA:UniProtKB.
DR   GO; GO:0050710; P:negative regulation of cytokine secretion; ISS:UniProtKB.
DR   GO; GO:0002576; P:platelet degranulation; TAS:Reactome.
DR   GO; GO:0033368; P:protease localization to mast cell secretory granule; IBA:GO_Central.
DR   GO; GO:0016485; P:protein processing; ISS:UniProtKB.
DR   GO; GO:0033371; P:T cell secretory granule organization; ISS:UniProtKB.
DR   InterPro; IPR007455; Serglycin.
DR   Pfam; PF04360; Serglycin; 1.
PE   1: Evidence at protein level;
KW   Apoptosis; Biomineralization; Complete proteome;
KW   Direct protein sequencing; Disulfide bond; Glycoprotein;
KW   Golgi apparatus; Polymorphism; Proteoglycan; Reference proteome;
KW   Repeat; Secreted; Signal.
FT   SIGNAL        1     27       {ECO:0000269|PubMed:3214420,
FT                                ECO:0000269|PubMed:3402609}.
FT   CHAIN        28    158       Serglycin.
FT                                /FTId=PRO_0000026679.
FT   REPEAT       94     95       1.
FT   REPEAT       96     97       2.
FT   REPEAT       98     99       3.
FT   REPEAT      100    101       4.
FT   REPEAT      102    103       5.
FT   REPEAT      104    105       6.
FT   REPEAT      106    107       7.
FT   REPEAT      108    109       8.
FT   REPEAT      110    111       9.
FT   REGION       94    111       9 X 2 AA tandem repeats of [SF]-G.
FT   CARBOHYD     94     94       O-linked (Xyl...) (glycosaminoglycan)
FT                                serine. {ECO:0000269|PubMed:3402609}.
FT   CARBOHYD     96     96       O-linked (Xyl...) (glycosaminoglycan)
FT                                serine. {ECO:0000269|PubMed:3402609}.
FT   CARBOHYD    100    100       O-linked (Xyl...) (glycosaminoglycan)
FT                                serine. {ECO:0000255}.
FT   CARBOHYD    102    102       O-linked (Xyl...) (glycosaminoglycan)
FT                                serine. {ECO:0000255}.
FT   CARBOHYD    104    104       O-linked (Xyl...) (glycosaminoglycan)
FT                                serine. {ECO:0000255}.
FT   CARBOHYD    106    106       O-linked (Xyl...) (glycosaminoglycan)
FT                                serine. {ECO:0000255}.
FT   CARBOHYD    108    108       O-linked (Xyl...) (glycosaminoglycan)
FT                                serine. {ECO:0000255}.
FT   CARBOHYD    110    110       O-linked (Xyl...) (glycosaminoglycan)
FT                                serine. {ECO:0000255}.
FT   DISULFID     40     49       {ECO:0000255}.
FT   VARIANT      31     31       R -> Q (in dbSNP:rs2229498).
FT                                {ECO:0000269|PubMed:14702039,
FT                                ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|PubMed:2180935,
FT                                ECO:0000269|PubMed:2798108,
FT                                ECO:0000269|PubMed:2835370,
FT                                ECO:0000269|Ref.7}.
FT                                /FTId=VAR_032761.
FT   CONFLICT    139    139       N -> S (in Ref. 9; CAA31255).
FT                                {ECO:0000305}.
SQ   SEQUENCE   158 AA;  17652 MW;  BD7767F39FFBC477 CRC64;
     MMQKLLKCSR LVLALALILV LESSVQGYPT RRARYQWVRC NPDSNSANCL EEKGPMFELL
     PGESNKIPRL RTDLFPKTRI QDLNRIFPLS EDYSGSGFGS GSGSGSGSGS GFLTEMEQDY
     QLVDESDAFH DNLRSLDRNL PSDSQDLGQH GLEEDFML
//
ID   A0A024R5G1_HUMAN        Unreviewed;       443 AA.
AC   A0A024R5G1;
DT   09-JUL-2014, integrated into UniProtKB/TrEMBL.
DT   09-JUL-2014, sequence version 1.
DT   23-MAY-2018, entry version 44.
DE   SubName: Full=EGF-containing fibulin-like extracellular matrix protein 2, isoform CRA_a {ECO:0000313|EMBL:EAW74459.1};
GN   Name=EFEMP2 {ECO:0000313|EMBL:EAW74459.1};
GN   ORFNames=hCG_2019682 {ECO:0000313|EMBL:EAW74459.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:EAW74459.1};
RN   [1] {ECO:0000313|EMBL:EAW74459.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAW74459.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
CC   -!- CAUTION: Lacks conserved residue(s) required for the propagation
CC       of feature annotation. {ECO:0000256|PROSITE-ProRule:PRU00076}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; CH471076; EAW74455.1; -; Genomic_DNA.
DR   EMBL; CH471076; EAW74456.1; -; Genomic_DNA.
DR   EMBL; CH471076; EAW74457.1; -; Genomic_DNA.
DR   EMBL; CH471076; EAW74458.1; -; Genomic_DNA.
DR   EMBL; CH471076; EAW74459.1; -; Genomic_DNA.
DR   EMBL; CH471076; EAW74461.1; -; Genomic_DNA.
DR   EMBL; CH471076; EAW74462.1; -; Genomic_DNA.
DR   RefSeq; NP_058634.4; NM_016938.4.
DR   UniGene; Hs.731454; -.
DR   SMR; A0A024R5G1; -.
DR   PRIDE; A0A024R5G1; -.
DR   GeneID; 30008; -.
DR   KEGG; hsa:30008; -.
DR   CTD; 30008; -.
DR   EuPathDB; HostDB:ENSG00000172638.12; -.
DR   eggNOG; ENOG410IR6U; Eukaryota.
DR   eggNOG; ENOG410ZNNG; LUCA.
DR   KO; K19866; -.
DR   OMA; QECHNLP; -.
DR   OrthoDB; EOG091G04QP; -.
DR   GenomeRNAi; 30008; -.
DR   Bgee; ENSG00000172638; -.
DR   ExpressionAtlas; A0A024R5G1; baseline and differential.
DR   GO; GO:0005615; C:extracellular space; IEA:InterPro.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   GO; GO:0048251; P:elastic fiber assembly; IEA:InterPro.
DR   InterPro; IPR026823; cEGF.
DR   InterPro; IPR026824; Efemp2.
DR   InterPro; IPR001881; EGF-like_Ca-bd_dom.
DR   InterPro; IPR013032; EGF-like_CS.
DR   InterPro; IPR000742; EGF-like_dom.
DR   InterPro; IPR000152; EGF-type_Asp/Asn_hydroxyl_site.
DR   InterPro; IPR018097; EGF_Ca-bd_CS.
DR   InterPro; IPR037287; Fibulin_3/4/5.
DR   InterPro; IPR009030; Growth_fac_rcpt_cys_sf.
DR   PANTHER; PTHR44074; PTHR44074; 1.
DR   PANTHER; PTHR44074:SF3; PTHR44074:SF3; 1.
DR   Pfam; PF12662; cEGF; 2.
DR   Pfam; PF07645; EGF_CA; 3.
DR   SMART; SM00181; EGF; 5.
DR   SMART; SM00179; EGF_CA; 6.
DR   SUPFAM; SSF57184; SSF57184; 2.
DR   PROSITE; PS00010; ASX_HYDROXYL; 4.
DR   PROSITE; PS01186; EGF_2; 3.
DR   PROSITE; PS50026; EGF_3; 4.
DR   PROSITE; PS01187; EGF_CA; 2.
PE   4: Predicted;
KW   Calcium {ECO:0000256|SAAS:SAAS00909960};
KW   Disulfide bond {ECO:0000256|PROSITE-ProRule:PRU00076,
KW   ECO:0000256|SAAS:SAAS00601599};
KW   EGF-like domain {ECO:0000256|PROSITE-ProRule:PRU00076,
KW   ECO:0000256|SAAS:SAAS00032677};
KW   Repeat {ECO:0000256|SAAS:SAAS00594563};
KW   Signal {ECO:0000256|SAM:SignalP}.
FT   SIGNAL        1     27       {ECO:0000256|SAM:SignalP}.
FT   CHAIN        28    443       {ECO:0000256|SAM:SignalP}.
FT                                /FTId=PRO_5014214242.
FT   DOMAIN      123    163       EGF-like. {ECO:0000259|PROSITE:PS50026}.
FT   DOMAIN      164    202       EGF-like. {ECO:0000259|PROSITE:PS50026}.
FT   DOMAIN      203    238       EGF-like. {ECO:0000259|PROSITE:PS50026}.
FT   DOMAIN      243    282       EGF-like. {ECO:0000259|PROSITE:PS50026}.
FT   DISULFID    207    217       {ECO:0000256|PROSITE-ProRule:PRU00076}.
SQ   SEQUENCE   443 AA;  49405 MW;  9315CFBBAA0FD3A7 CRC64;
     MLPCASCLPG SLLLWALLLL LLGSASPQDS EEPDSYTECT DGYEWDPDSQ HCRDVNECLT
     IPEACKGEMK CINHYGGYLC LPRSAAVIND LHGEGPPPPV PPAQHPNPCP PGYEPDDQDS
     CVDVDECAQA LHDCRPSQDC HNLPGSYQCT CPDGYRKIGP ECVDIDECRY RYCQHRCVNL
     PGSFRCQCEP GFQLGPNNRS CVDVNECDMG APCEQRCFNS YGTFLCRCHQ GYELHRDGFS
     CSDIDECSYS SYLCQYRCIN EPGRFSCHCP QGYQLLATRL CQDIDECESG AHQCSEAQTC
     VNFHGGYRCV DTNRCVEPYI QVSENRCLCP ASNPLCREQP SSIVHRYMTI TSERSVPADV
     FQIQATSVYP GAYNAFQIRA GNSQGDFYIR QINNVSAMLV LARPVTGPRE YVLDLEMVTM
     NSLMSYRASS VLRLTVFVGA YTF
//
ID   FBLN4_HUMAN             Reviewed;         443 AA.
AC   O95967; A8K7R4; B3KM31; B3KQT1; O75967;
DT   01-DEC-2000, integrated into UniProtKB/Swiss-Prot.
DT   20-MAR-2007, sequence version 3.
DT   23-MAY-2018, entry version 187.
DE   RecName: Full=EGF-containing fibulin-like extracellular matrix protein 2;
DE   AltName: Full=Fibulin-4;
DE            Short=FIBL-4;
DE   AltName: Full=Protein UPH1;
DE   Flags: Precursor;
GN   Name=EFEMP2; Synonyms=FBLN4; ORFNames=UNQ200/PRO226;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT VAL-259.
RC   TISSUE=Melanoma;
RX   PubMed=10601734; DOI=10.1016/S0945-053X(99)00038-4;
RA   Giltay R., Timpl R., Kostka G.;
RT   "Sequence, recombinant expression and tissue localization of two novel
RT   extracellular matrix proteins, fibulin-3 and fibulin-4.";
RL   Matrix Biol. 18:469-480(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT VAL-259.
RA   Zemel R., Shaul Y.;
RL   Submitted (SEP-1998) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT VAL-259.
RX   PubMed=10982184; DOI=10.1007/s004390051011;
RA   Katsanis N., Venable S., Smith J.R., Lupski J.R.;
RT   "Isolation of a paralog of the Doyne honeycomb retinal dystrophy gene
RT   from the multiple retinopathy critical region on 11q13.";
RL   Hum. Genet. 106:66-72(2000).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT VAL-259.
RC   TISSUE=Embryo, and Synovium;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT VAL-259.
RX   PubMed=12975309; DOI=10.1101/gr.1293003;
RA   Clark H.F., Gurney A.L., Abaya E., Baker K., Baldwin D.T., Brush J.,
RA   Chen J., Chow B., Chui C., Crowley C., Currell B., Deuel B., Dowd P.,
RA   Eaton D., Foster J.S., Grimaldi C., Gu Q., Hass P.E., Heldens S.,
RA   Huang A., Kim H.S., Klimowski L., Jin Y., Johnson S., Lee J.,
RA   Lewis L., Liao D., Mark M.R., Robbie E., Sanchez C., Schoenfeld J.,
RA   Seshagiri S., Simmons L., Singh J., Smith V., Stinson J., Vagts A.,
RA   Vandlen R.L., Watanabe C., Wieand D., Woods K., Xie M.-H.,
RA   Yansura D.G., Yi S., Yu G., Yuan J., Zhang M., Zhang Z., Goddard A.D.,
RA   Wood W.I., Godowski P.J., Gray A.M.;
RT   "The secreted protein discovery initiative (SPDI), a large-scale
RT   effort to identify novel human secreted and transmembrane proteins: a
RT   bioinformatics assessment.";
RL   Genome Res. 13:2265-2270(2003).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT VAL-259.
RC   TISSUE=Placenta;
RX   PubMed=16303743; DOI=10.1093/dnares/12.2.117;
RA   Otsuki T., Ota T., Nishikawa T., Hayashi K., Suzuki Y., Yamamoto J.,
RA   Wakamatsu A., Kimura K., Sakamoto K., Hatano N., Kawai Y., Ishii S.,
RA   Saito K., Kojima S., Sugiyama T., Ono T., Okano K., Yoshikawa Y.,
RA   Aotsuka S., Sasaki N., Hattori A., Okumura K., Nagai K., Sugano S.,
RA   Isogai T.;
RT   "Signal sequence and keyword trap in silico for selection of full-
RT   length human cDNAs encoding secretion or membrane proteins from oligo-
RT   capped cDNA libraries.";
RL   DNA Res. 12:117-126(2005).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16554811; DOI=10.1038/nature04632;
RA   Taylor T.D., Noguchi H., Totoki Y., Toyoda A., Kuroki Y., Dewar K.,
RA   Lloyd C., Itoh T., Takeda T., Kim D.-W., She X., Barlow K.F.,
RA   Bloom T., Bruford E., Chang J.L., Cuomo C.A., Eichler E.,
RA   FitzGerald M.G., Jaffe D.B., LaButti K., Nicol R., Park H.-S.,
RA   Seaman C., Sougnez C., Yang X., Zimmer A.R., Zody M.C., Birren B.W.,
RA   Nusbaum C., Fujiyama A., Hattori M., Rogers J., Lander E.S.,
RA   Sakaki Y.;
RT   "Human chromosome 11 DNA sequence and analysis including novel gene
RT   identification.";
RL   Nature 440:497-500(2006).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT VAL-259.
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   INTERACTION WITH FBN1.
RX   PubMed=17255108; DOI=10.1074/jbc.M608204200;
RA   El-Hallous E., Sasaki T., Hubmacher D., Getie M., Tiedemann K.,
RA   Brinckmann J., Baetge B., Davis E.C., Reinhardt D.P.;
RT   "Fibrillin-1 interactions with fibulins depend on the first hybrid
RT   domain and provide an adaptor function to tropoelastin.";
RL   J. Biol. Chem. 282:8935-8946(2007).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [11]
RP   STRUCTURE BY NMR OF 54-123, AND DISULFIDE BONDS.
RG   Northeast structural genomics consortium (NESG);
RT   "Solution NMR structure of the EGF-like 1 domain of human fibulin-4.";
RL   Submitted (JUL-2009) to the PDB data bank.
RN   [12]
RP   VARIANT ARCL1B LYS-57.
RX   PubMed=16685658; DOI=10.1086/504304;
RA   Hucthagowder V., Sausgruber N., Kim K.H., Angle B., Marmorstein L.Y.,
RA   Urban Z.;
RT   "Fibulin-4: a novel gene for an autosomal recessive cutis laxa
RT   syndrome.";
RL   Am. J. Hum. Genet. 78:1075-1080(2006).
RN   [13]
RP   VARIANT ARCL1B CYS-279.
RX   PubMed=17937443; DOI=10.1002/ajmg.a.31980;
RA   Dasouki M., Markova D., Garola R., Sasaki T., Charbonneau N.L.,
RA   Sakai L.Y., Chu M.L.;
RT   "Compound heterozygous mutations in fibulin-4 causing neonatal lethal
RT   pulmonary artery occlusion, aortic aneurysm, arachnodactyly, and mild
RT   cutis laxa.";
RL   Am. J. Med. Genet. A 143:2635-2641(2007).
RN   [14]
RP   VARIANT ARCL1B TYR-267.
RX   PubMed=19664000; DOI=10.1111/j.1399-0004.2009.01204.x;
RA   Hoyer J., Kraus C., Hammersen G., Geppert J.P., Rauch A.;
RT   "Lethal cutis laxa with contractural arachnodactyly, overgrowth and
RT   soft tissue bleeding due to a novel homozygous fibulin-4 gene
RT   mutation.";
RL   Clin. Genet. 76:276-281(2009).
CC   -!- SUBUNIT: Interacts with FBN1 (via N-terminal domain)
CC       (PubMed:17255108). {ECO:0000269|PubMed:17255108}.
CC   -!- INTERACTION:
CC       Q9Y4X0:AMMECR1; NbExp=3; IntAct=EBI-743414, EBI-8583355;
CC       P54259:ATN1; NbExp=3; IntAct=EBI-743414, EBI-945980;
CC       Q7Z6I8:C5orf24; NbExp=3; IntAct=EBI-743414, EBI-9995695;
CC       Q02930-3:CREB5; NbExp=7; IntAct=EBI-743414, EBI-10192698;
CC       P15502:ELN; NbExp=5; IntAct=EBI-743414, EBI-1222108;
CC       Q5TZK3:FAM74A6; NbExp=5; IntAct=EBI-743414, EBI-10247271;
CC       Q9UBX5:FBLN5; NbExp=3; IntAct=EBI-743414, EBI-947897;
CC       P35555:FBN1; NbExp=3; IntAct=EBI-743414, EBI-2505934;
CC       P56524:HDAC4; NbExp=3; IntAct=EBI-743414, EBI-308629;
CC       Q96JK4-2:HHIPL1; NbExp=4; IntAct=EBI-743414, EBI-12083878;
CC       P09022:Hoxa1 (xeno); NbExp=3; IntAct=EBI-743414, EBI-3957603;
CC       Q8IUU6:IL16; NbExp=3; IntAct=EBI-743414, EBI-746574;
CC       Q5TA81:LCE2C; NbExp=4; IntAct=EBI-743414, EBI-11973993;
CC       Q5TA82:LCE2D; NbExp=3; IntAct=EBI-743414, EBI-10246750;
CC       Q5T5A8:LCE3C; NbExp=3; IntAct=EBI-743414, EBI-10245291;
CC       P28300:LOX; NbExp=7; IntAct=EBI-743414, EBI-3893481;
CC       P50222:MEOX2; NbExp=3; IntAct=EBI-743414, EBI-748397;
CC       Q7Z417:NUFIP2; NbExp=5; IntAct=EBI-743414, EBI-1210753;
CC       O75360:PROP1; NbExp=4; IntAct=EBI-743414, EBI-9027467;
CC       Q8WWY3:PRPF31; NbExp=5; IntAct=EBI-743414, EBI-1567797;
CC       P43115-12:PTGER3; NbExp=3; IntAct=EBI-743414, EBI-10234038;
CC       Q93062:RBPMS; NbExp=3; IntAct=EBI-743414, EBI-740322;
CC       Q9BQY4:RHOXF2; NbExp=2; IntAct=EBI-743414, EBI-372094;
CC       Q8WVD3:RNF138; NbExp=4; IntAct=EBI-743414, EBI-749039;
CC       O43765:SGTA; NbExp=6; IntAct=EBI-743414, EBI-347996;
CC       Q96EQ0:SGTB; NbExp=6; IntAct=EBI-743414, EBI-744081;
CC       O75716:STK16; NbExp=5; IntAct=EBI-743414, EBI-749295;
CC       Q9UMX0:UBQLN1; NbExp=4; IntAct=EBI-743414, EBI-741480;
CC       Q9UMX0-2:UBQLN1; NbExp=3; IntAct=EBI-743414, EBI-10173939;
CC   -!- SUBCELLULAR LOCATION: Secreted.
CC   -!- DISEASE: Cutis laxa, autosomal recessive, 1B (ARCL1B)
CC       [MIM:614437]: A connective tissue disorder characterized by loose,
CC       hyperextensible skin with decreased resilience and elasticity
CC       leading to a premature aged appearance. Face, hands, feet, joints,
CC       and torso may be differentially affected. The clinical spectrum of
CC       autosomal recessive cutis laxa is highly heterogeneous with
CC       respect to organ involvement and severity. ARCL1B features include
CC       emphysema, lethal pulmonary artery occlusion, aortic aneurysm,
CC       cardiopulmonary insufficiency, birth fractures, arachnodactyly,
CC       and fragility of blood vessels. {ECO:0000269|PubMed:16685658,
CC       ECO:0000269|PubMed:17937443, ECO:0000269|PubMed:19664000}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- SIMILARITY: Belongs to the fibulin family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AJ132819; CAA10791.2; -; mRNA.
DR   EMBL; AF093119; AAC62108.1; -; mRNA.
DR   EMBL; AF109121; AAF65188.1; -; mRNA.
DR   EMBL; AK000980; BAG50843.1; -; mRNA.
DR   EMBL; AK292079; BAF84768.1; -; mRNA.
DR   EMBL; AY358899; AAQ89258.1; -; mRNA.
DR   EMBL; AK075453; BAG52143.1; -; mRNA.
DR   EMBL; AP001201; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC010456; AAH10456.1; -; mRNA.
DR   CCDS; CCDS8116.1; -.
DR   RefSeq; NP_058634.4; NM_016938.4.
DR   UniGene; Hs.731454; -.
DR   PDB; 2KL7; NMR; -; A=54-123.
DR   PDBsum; 2KL7; -.
DR   ProteinModelPortal; O95967; -.
DR   SMR; O95967; -.
DR   BioGrid; 119026; 51.
DR   DIP; DIP-34518N; -.
DR   IntAct; O95967; 132.
DR   MINT; O95967; -.
DR   STRING; 9606.ENSP00000309953; -.
DR   iPTMnet; O95967; -.
DR   PhosphoSitePlus; O95967; -.
DR   BioMuta; EFEMP2; -.
DR   PaxDb; O95967; -.
DR   PeptideAtlas; O95967; -.
DR   PRIDE; O95967; -.
DR   DNASU; 30008; -.
DR   Ensembl; ENST00000307998; ENSP00000309953; ENSG00000172638.
DR   Ensembl; ENST00000531972; ENSP00000435295; ENSG00000172638.
DR   GeneID; 30008; -.
DR   KEGG; hsa:30008; -.
DR   UCSC; uc001ofy.5; human.
DR   CTD; 30008; -.
DR   DisGeNET; 30008; -.
DR   EuPathDB; HostDB:ENSG00000172638.12; -.
DR   GeneCards; EFEMP2; -.
DR   GeneReviews; EFEMP2; -.
DR   HGNC; HGNC:3219; EFEMP2.
DR   HPA; HPA023270; -.
DR   MalaCards; EFEMP2; -.
DR   MIM; 604633; gene.
DR   MIM; 614437; phenotype.
DR   neXtProt; NX_O95967; -.
DR   OpenTargets; ENSG00000172638; -.
DR   Orphanet; 90349; Autosomal recessive cutis laxa type 1.
DR   Orphanet; 314718; Lethal arteriopathy syndrome due to fibulin-4 deficiency.
DR   PharmGKB; PA27653; -.
DR   eggNOG; ENOG410IR6U; Eukaryota.
DR   eggNOG; ENOG410ZNNG; LUCA.
DR   GeneTree; ENSGT00760000118806; -.
DR   HOGENOM; HOG000234337; -.
DR   HOVERGEN; HBG051560; -.
DR   InParanoid; O95967; -.
DR   KO; K19866; -.
DR   OMA; QECHNLP; -.
DR   OrthoDB; EOG091G04QP; -.
DR   PhylomeDB; O95967; -.
DR   TreeFam; TF317514; -.
DR   Reactome; R-HSA-2129379; Molecules associated with elastic fibres.
DR   SIGNOR; O95967; -.
DR   EvolutionaryTrace; O95967; -.
DR   GeneWiki; EFEMP2; -.
DR   GenomeRNAi; 30008; -.
DR   PRO; PR:O95967; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   Bgee; ENSG00000172638; -.
DR   CleanEx; HS_EFEMP2; -.
DR   ExpressionAtlas; O95967; baseline and differential.
DR   Genevisible; O95967; HS.
DR   GO; GO:0005604; C:basement membrane; TAS:ProtInc.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0005576; C:extracellular region; TAS:Reactome.
DR   GO; GO:1903561; C:extracellular vesicle; HDA:UniProtKB.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   GO; GO:0005201; F:extracellular matrix structural constituent; TAS:ProtInc.
DR   GO; GO:0048251; P:elastic fiber assembly; IEA:InterPro.
DR   InterPro; IPR026823; cEGF.
DR   InterPro; IPR026824; Efemp2.
DR   InterPro; IPR001881; EGF-like_Ca-bd_dom.
DR   InterPro; IPR013032; EGF-like_CS.
DR   InterPro; IPR000742; EGF-like_dom.
DR   InterPro; IPR000152; EGF-type_Asp/Asn_hydroxyl_site.
DR   InterPro; IPR018097; EGF_Ca-bd_CS.
DR   InterPro; IPR037287; Fibulin_3/4/5.
DR   InterPro; IPR009030; Growth_fac_rcpt_cys_sf.
DR   PANTHER; PTHR44074; PTHR44074; 1.
DR   PANTHER; PTHR44074:SF3; PTHR44074:SF3; 1.
DR   Pfam; PF12662; cEGF; 2.
DR   Pfam; PF07645; EGF_CA; 3.
DR   SMART; SM00181; EGF; 5.
DR   SMART; SM00179; EGF_CA; 6.
DR   SUPFAM; SSF57184; SSF57184; 2.
DR   PROSITE; PS00010; ASX_HYDROXYL; 4.
DR   PROSITE; PS01186; EGF_2; 4.
DR   PROSITE; PS50026; EGF_3; 4.
DR   PROSITE; PS01187; EGF_CA; 6.
PE   1: Evidence at protein level;
KW   3D-structure; Calcium; Complete proteome; Disease mutation;
KW   Disulfide bond; EGF-like domain; Glycoprotein; Polymorphism;
KW   Reference proteome; Repeat; Secreted; Signal.
FT   SIGNAL        1     25       {ECO:0000255}.
FT   CHAIN        26    443       EGF-containing fibulin-like extracellular
FT                                matrix protein 2.
FT                                /FTId=PRO_0000007575.
FT   DOMAIN       36     81       EGF-like 1; atypical.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DOMAIN      123    163       EGF-like 2; calcium-binding.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DOMAIN      164    202       EGF-like 3; calcium-binding.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DOMAIN      203    242       EGF-like 4; calcium-binding.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DOMAIN      243    282       EGF-like 5; calcium-binding.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DOMAIN      283    328       EGF-like 6; calcium-binding.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   CARBOHYD    198    198       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    394    394       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID     58    121       {ECO:0000255|PROSITE-ProRule:PRU00076,
FT                                ECO:0000269|Ref.11}.
FT   DISULFID     65     80       {ECO:0000255|PROSITE-ProRule:PRU00076,
FT                                ECO:0000269|Ref.11}.
FT   DISULFID     71    109       {ECO:0000255|PROSITE-ProRule:PRU00076,
FT                                ECO:0000269|Ref.11}.
FT   DISULFID    127    140       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID    134    149       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID    151    162       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID    168    177       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID    173    186       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID    188    201       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID    207    217       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID    213    226       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID    228    241       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID    247    258       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID    254    267       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID    269    281       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID    287    300       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID    294    309       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID    315    327       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   VARIANT      57     57       E -> K (in ARCL1B; dbSNP:rs119489101).
FT                                {ECO:0000269|PubMed:16685658}.
FT                                /FTId=VAR_027019.
FT   VARIANT     259    259       I -> V (in dbSNP:rs601314).
FT                                {ECO:0000269|PubMed:10601734,
FT                                ECO:0000269|PubMed:10982184,
FT                                ECO:0000269|PubMed:12975309,
FT                                ECO:0000269|PubMed:14702039,
FT                                ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|PubMed:16303743,
FT                                ECO:0000269|Ref.2}.
FT                                /FTId=VAR_027020.
FT   VARIANT     267    267       C -> Y (in ARCL1B; dbSNP:rs193302866).
FT                                {ECO:0000269|PubMed:19664000}.
FT                                /FTId=VAR_067069.
FT   VARIANT     279    279       R -> C (in ARCL1B; dbSNP:rs119489102).
FT                                {ECO:0000269|PubMed:17937443}.
FT                                /FTId=VAR_067070.
FT   CONFLICT      5      5       A -> T (in Ref. 1; CAA10791).
FT                                {ECO:0000305}.
FT   CONFLICT     44     51       EWDPDSQH -> TQTAN (in Ref. 2; AAC62108).
FT                                {ECO:0000305}.
FT   CONFLICT     46     46       D -> G (in Ref. 4; BAF84768).
FT                                {ECO:0000305}.
FT   CONFLICT     96     96       P -> L (in Ref. 4; BAG50843).
FT                                {ECO:0000305}.
FT   CONFLICT    103    111       AQHPNPCPP -> VNTQPLPT (in Ref. 2;
FT                                AAC62108). {ECO:0000305}.
FT   CONFLICT    294    294       C -> W (in Ref. 2; AAC62108).
FT                                {ECO:0000305}.
FT   CONFLICT    354    356       RSV -> AER (in Ref. 2; AAC62108).
FT                                {ECO:0000305}.
FT   CONFLICT    355    355       S -> R (in Ref. 3; AAF65188).
FT                                {ECO:0000305}.
FT   STRAND       68     73       {ECO:0000244|PDB:2KL7}.
FT   STRAND       78     82       {ECO:0000244|PDB:2KL7}.
FT   STRAND      113    116       {ECO:0000244|PDB:2KL7}.
SQ   SEQUENCE   443 AA;  49405 MW;  9315CFBBAA0FD3A7 CRC64;
     MLPCASCLPG SLLLWALLLL LLGSASPQDS EEPDSYTECT DGYEWDPDSQ HCRDVNECLT
     IPEACKGEMK CINHYGGYLC LPRSAAVIND LHGEGPPPPV PPAQHPNPCP PGYEPDDQDS
     CVDVDECAQA LHDCRPSQDC HNLPGSYQCT CPDGYRKIGP ECVDIDECRY RYCQHRCVNL
     PGSFRCQCEP GFQLGPNNRS CVDVNECDMG APCEQRCFNS YGTFLCRCHQ GYELHRDGFS
     CSDIDECSYS SYLCQYRCIN EPGRFSCHCP QGYQLLATRL CQDIDECESG AHQCSEAQTC
     VNFHGGYRCV DTNRCVEPYI QVSENRCLCP ASNPLCREQP SSIVHRYMTI TSERSVPADV
     FQIQATSVYP GAYNAFQIRA GNSQGDFYIR QINNVSAMLV LARPVTGPRE YVLDLEMVTM
     NSLMSYRASS VLRLTVFVGA YTF
//
ID   Q9H3D5_HUMAN            Unreviewed;       443 AA.
AC   Q9H3D5;
DT   01-MAR-2001, integrated into UniProtKB/TrEMBL.
DT   01-MAR-2001, sequence version 1.
DT   31-JAN-2018, entry version 122.
DE   SubName: Full=Fibulin-like extracellular matrix protein {ECO:0000313|EMBL:AAG45245.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:AAG45245.1};
RN   [1] {ECO:0000313|EMBL:AAG45245.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Seibold S., Marx M.;
RT   "Cloning of a new fibulin-like gene.";
RL   Submitted (JAN-1999) to the EMBL/GenBank/DDBJ databases.
CC   -!- CAUTION: Lacks conserved residue(s) required for the propagation
CC       of feature annotation. {ECO:0000256|PROSITE-ProRule:PRU00076}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF124486; AAG45245.1; -; mRNA.
DR   RefSeq; NP_058634.4; NM_016938.4.
DR   UniGene; Hs.731454; -.
DR   ProteinModelPortal; Q9H3D5; -.
DR   PeptideAtlas; Q9H3D5; -.
DR   PRIDE; Q9H3D5; -.
DR   DNASU; 30008; -.
DR   GeneID; 30008; -.
DR   KEGG; hsa:30008; -.
DR   CTD; 30008; -.
DR   eggNOG; ENOG410IR6U; Eukaryota.
DR   eggNOG; ENOG410ZNNG; LUCA.
DR   HOVERGEN; HBG051560; -.
DR   KO; K19866; -.
DR   GenomeRNAi; 30008; -.
DR   Genevisible; Q9H3D5; HS.
DR   GO; GO:0005615; C:extracellular space; IEA:InterPro.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   GO; GO:0048251; P:elastic fiber assembly; IEA:InterPro.
DR   InterPro; IPR026823; cEGF.
DR   InterPro; IPR026824; Efemp2.
DR   InterPro; IPR001881; EGF-like_Ca-bd_dom.
DR   InterPro; IPR013032; EGF-like_CS.
DR   InterPro; IPR000742; EGF-like_dom.
DR   InterPro; IPR000152; EGF-type_Asp/Asn_hydroxyl_site.
DR   InterPro; IPR018097; EGF_Ca-bd_CS.
DR   InterPro; IPR037287; Fibulin_3/4/5.
DR   InterPro; IPR009030; Growth_fac_rcpt_cys_sf.
DR   PANTHER; PTHR44074; PTHR44074; 1.
DR   PANTHER; PTHR44074:SF3; PTHR44074:SF3; 1.
DR   Pfam; PF12662; cEGF; 2.
DR   Pfam; PF07645; EGF_CA; 3.
DR   SMART; SM00181; EGF; 5.
DR   SMART; SM00179; EGF_CA; 6.
DR   SUPFAM; SSF57184; SSF57184; 2.
DR   PROSITE; PS00010; ASX_HYDROXYL; 4.
DR   PROSITE; PS01186; EGF_2; 3.
DR   PROSITE; PS50026; EGF_3; 4.
DR   PROSITE; PS01187; EGF_CA; 2.
PE   2: Evidence at transcript level;
KW   Calcium {ECO:0000256|SAAS:SAAS00909960};
KW   Disulfide bond {ECO:0000256|PROSITE-ProRule:PRU00076,
KW   ECO:0000256|SAAS:SAAS00601599};
KW   EGF-like domain {ECO:0000256|PROSITE-ProRule:PRU00076,
KW   ECO:0000256|SAAS:SAAS00032677};
KW   Repeat {ECO:0000256|SAAS:SAAS00594563};
KW   Signal {ECO:0000256|SAM:SignalP}.
FT   SIGNAL        1     27       {ECO:0000256|SAM:SignalP}.
FT   CHAIN        28    443       {ECO:0000256|SAM:SignalP}.
FT                                /FTId=PRO_5004327935.
FT   DOMAIN      123    163       EGF-like. {ECO:0000259|PROSITE:PS50026}.
FT   DOMAIN      164    202       EGF-like. {ECO:0000259|PROSITE:PS50026}.
FT   DOMAIN      203    238       EGF-like. {ECO:0000259|PROSITE:PS50026}.
FT   DOMAIN      243    282       EGF-like. {ECO:0000259|PROSITE:PS50026}.
FT   DISULFID    207    217       {ECO:0000256|PROSITE-ProRule:PRU00076}.
SQ   SEQUENCE   443 AA;  49536 MW;  D91784BF36A8A060 CRC64;
     MLPCASCLPG SLLLWALLLL LLGSASPQDS EEPDSYTECT DGYEWDPDSQ HCRDVNECLT
     IPEACKGEMK CINHYGGYLC LPRSAAVIND LHGEGPPPPV PPAQHPNPCP PGYEPDDQDS
     CVDVDECAQA LHDRRPSQDC HNLSGSYQCT CPDGYRKIGP ECVDIDECRY RYCQHRCVNL
     PGSFRCQCEP GFQLGPNNRS CVDVNECDMG APCEQRCFNS YGTFLCRCHQ GYELHRDGFS
     CSDIDECSYS SYLCQYRCVN EPGRFSCHCP QGYQLLATRL CQDIDECESG AHQCSEAQTC
     VNFHGGYRCV DTNRCVEPYI QVSENRCLCP ASNPLCREQP SSIVHRYMTI TSERMRPADV
     FQIQATSVYP GAYNAFQIRA GNSQGDFYIR QINNVSAMLV LARPVTGPRE YVLDLEMVTM
     NSLMSYRASS VLRLTVFVGA YTF
//
ID   NDK3_HUMAN              Reviewed;         169 AA.
AC   Q13232; Q9BWH4;
DT   15-DEC-1998, integrated into UniProtKB/Swiss-Prot.
DT   27-MAY-2002, sequence version 2.
DT   23-MAY-2018, entry version 166.
DE   RecName: Full=Nucleoside diphosphate kinase 3;
DE            Short=NDK 3;
DE            Short=NDP kinase 3;
DE            EC=2.7.4.6;
DE   AltName: Full=DR-nm23;
DE   AltName: Full=Nucleoside diphosphate kinase C;
DE            Short=NDPKC;
DE   AltName: Full=nm23-H3;
GN   Name=NME3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=7638209; DOI=10.1073/pnas.92.16.7435;
RA   Venturelli D., Martinez R., Melotti P., Casella I., Peschle C.,
RA   Cucco C., Spampinato G., Darzynkiewicz Z., Calabretta B.;
RT   "Overexpression of DR-nm23, a protein encoded by a member of the nm23
RT   gene family, inhibits granulocyte differentiation and induces
RT   apoptosis in 32Dc13 myeloid cells.";
RL   Proc. Natl. Acad. Sci. U.S.A. 92:7435-7439(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11157797; DOI=10.1093/hmg/10.4.339;
RA   Daniels R.J., Peden J.F., Lloyd C., Horsley S.W., Clark K.,
RA   Tufarelli C., Kearney L., Buckle V.J., Doggett N.A., Flint J.,
RA   Higgs D.R.;
RT   "Sequence, structure and pathology of the fully annotated terminal 2
RT   Mb of the short arm of human chromosome 16.";
RL   Hum. Mol. Genet. 10:339-352(2001).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Eye;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
CC   -!- FUNCTION: Major role in the synthesis of nucleoside triphosphates
CC       other than ATP. The ATP gamma phosphate is transferred to the NDP
CC       beta phosphate via a ping-pong mechanism, using a phosphorylated
CC       active-site intermediate. Probably has a role in normal
CC       hematopoiesis by inhibition of granulocyte differentiation and
CC       induction of apoptosis.
CC   -!- CATALYTIC ACTIVITY: ATP + nucleoside diphosphate = ADP +
CC       nucleoside triphosphate.
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420; Evidence={ECO:0000250};
CC   -!- INTERACTION:
CC       Q6ICB0:DESI1; NbExp=6; IntAct=EBI-713684, EBI-2806959;
CC       P15531:NME1; NbExp=4; IntAct=EBI-713684, EBI-741141;
CC       O43765:SGTA; NbExp=8; IntAct=EBI-713684, EBI-347996;
CC       Q9UMX0:UBQLN1; NbExp=7; IntAct=EBI-713684, EBI-741480;
CC       Q9UMX0-2:UBQLN1; NbExp=3; IntAct=EBI-713684, EBI-10173939;
CC   -!- DEVELOPMENTAL STAGE: Preferentially expressed at early stages of
CC       myeloid differentiation of highly purified CD34+ cells.
CC   -!- SIMILARITY: Belongs to the NDK family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U29656; AAA85097.1; -; mRNA.
DR   EMBL; AE006639; AAK61291.1; -; Genomic_DNA.
DR   EMBL; BC000250; AAH00250.1; -; mRNA.
DR   CCDS; CCDS10443.1; -.
DR   PIR; I39074; I39074.
DR   RefSeq; NP_002504.2; NM_002513.2.
DR   UniGene; Hs.514065; -.
DR   PDB; 1ZS6; X-ray; 2.30 A; A/B/D=1-169.
DR   PDBsum; 1ZS6; -.
DR   ProteinModelPortal; Q13232; -.
DR   SMR; Q13232; -.
DR   BioGrid; 110896; 27.
DR   DIP; DIP-49960N; -.
DR   IntAct; Q13232; 23.
DR   MINT; Q13232; -.
DR   STRING; 9606.ENSP00000219302; -.
DR   iPTMnet; Q13232; -.
DR   PhosphoSitePlus; Q13232; -.
DR   BioMuta; NME3; -.
DR   DMDM; 21264477; -.
DR   EPD; Q13232; -.
DR   MaxQB; Q13232; -.
DR   PaxDb; Q13232; -.
DR   PeptideAtlas; Q13232; -.
DR   PRIDE; Q13232; -.
DR   DNASU; 4832; -.
DR   Ensembl; ENST00000219302; ENSP00000219302; ENSG00000103024.
DR   GeneID; 4832; -.
DR   KEGG; hsa:4832; -.
DR   UCSC; uc002cmm.4; human.
DR   CTD; 4832; -.
DR   DisGeNET; 4832; -.
DR   EuPathDB; HostDB:ENSG00000103024.7; -.
DR   GeneCards; NME3; -.
DR   HGNC; HGNC:7851; NME3.
DR   HPA; HPA041113; -.
DR   HPA; HPA052733; -.
DR   MIM; 601817; gene.
DR   neXtProt; NX_Q13232; -.
DR   OpenTargets; ENSG00000103024; -.
DR   PharmGKB; PA31656; -.
DR   eggNOG; KOG0888; Eukaryota.
DR   eggNOG; COG0105; LUCA.
DR   GeneTree; ENSGT00760000119146; -.
DR   HOGENOM; HOG000224564; -.
DR   HOVERGEN; HBG000423; -.
DR   InParanoid; Q13232; -.
DR   KO; K00940; -.
DR   OMA; RLVKYMG; -.
DR   OrthoDB; EOG091G0PLD; -.
DR   PhylomeDB; Q13232; -.
DR   TreeFam; TF106373; -.
DR   Reactome; R-HSA-499943; Interconversion of nucleotide di- and triphosphates.
DR   ChiTaRS; NME3; human.
DR   EvolutionaryTrace; Q13232; -.
DR   GeneWiki; NME3; -.
DR   GenomeRNAi; 4832; -.
DR   PRO; PR:Q13232; -.
DR   Proteomes; UP000005640; Chromosome 16.
DR   Bgee; ENSG00000103024; -.
DR   CleanEx; HS_NME3; -.
DR   ExpressionAtlas; Q13232; baseline and differential.
DR   Genevisible; Q13232; HS.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0005622; C:intracellular; IBA:GO_Central.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0004550; F:nucleoside diphosphate kinase activity; IBA:GO_Central.
DR   GO; GO:0006915; P:apoptotic process; TAS:ProtInc.
DR   GO; GO:0006241; P:CTP biosynthetic process; IEA:InterPro.
DR   GO; GO:0006183; P:GTP biosynthetic process; IEA:InterPro.
DR   GO; GO:0015949; P:nucleobase-containing small molecule interconversion; TAS:Reactome.
DR   GO; GO:0042981; P:regulation of apoptotic process; IBA:GO_Central.
DR   GO; GO:0006228; P:UTP biosynthetic process; IEA:InterPro.
DR   Gene3D; 3.30.70.141; -; 1.
DR   HAMAP; MF_00451; NDP_kinase; 1.
DR   InterPro; IPR034907; NDK-like_dom.
DR   InterPro; IPR036850; NDK-like_dom_sf.
DR   InterPro; IPR001564; Nucleoside_diP_kinase.
DR   InterPro; IPR023005; Nucleoside_diP_kinase_AS.
DR   Pfam; PF00334; NDK; 1.
DR   PRINTS; PR01243; NUCDPKINASE.
DR   SMART; SM00562; NDK; 1.
DR   SUPFAM; SSF54919; SSF54919; 1.
DR   PROSITE; PS00469; NDP_KINASES; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Apoptosis; ATP-binding; Complete proteome; Kinase;
KW   Magnesium; Metal-binding; Nucleotide metabolism; Nucleotide-binding;
KW   Reference proteome; Transferase.
FT   CHAIN         1    169       Nucleoside diphosphate kinase 3.
FT                                /FTId=PRO_0000137123.
FT   ACT_SITE    135    135       Pros-phosphohistidine intermediate.
FT                                {ECO:0000250}.
FT   BINDING      29     29       ATP. {ECO:0000250}.
FT   BINDING      77     77       ATP. {ECO:0000250}.
FT   BINDING     105    105       ATP. {ECO:0000250}.
FT   BINDING     111    111       ATP. {ECO:0000250}.
FT   BINDING     122    122       ATP. {ECO:0000250}.
FT   BINDING     132    132       ATP. {ECO:0000250}.
FT   CONFLICT     60     60       A -> S (in Ref. 1; AAA85097).
FT                                {ECO:0000305}.
FT   CONFLICT    131    131       Missing (in Ref. 1; AAA85097).
FT                                {ECO:0000305}.
FT   HELIX        19     21       {ECO:0000244|PDB:1ZS6}.
FT   STRAND       23     28       {ECO:0000244|PDB:1ZS6}.
FT   HELIX        30     34       {ECO:0000244|PDB:1ZS6}.
FT   HELIX        38     48       {ECO:0000244|PDB:1ZS6}.
FT   STRAND       51     58       {ECO:0000244|PDB:1ZS6}.
FT   HELIX        62     68       {ECO:0000244|PDB:1ZS6}.
FT   HELIX        70     72       {ECO:0000244|PDB:1ZS6}.
FT   HELIX        78     85       {ECO:0000244|PDB:1ZS6}.
FT   STRAND       90     97       {ECO:0000244|PDB:1ZS6}.
FT   HELIX       100    108       {ECO:0000244|PDB:1ZS6}.
FT   HELIX       113    115       {ECO:0000244|PDB:1ZS6}.
FT   HELIX       121    125       {ECO:0000244|PDB:1ZS6}.
FT   HELIX       129    131       {ECO:0000244|PDB:1ZS6}.
FT   STRAND      133    136       {ECO:0000244|PDB:1ZS6}.
FT   HELIX       140    150       {ECO:0000244|PDB:1ZS6}.
FT   HELIX       153    155       {ECO:0000244|PDB:1ZS6}.
FT   HELIX       164    167       {ECO:0000244|PDB:1ZS6}.
SQ   SEQUENCE   169 AA;  19015 MW;  CCA41A122A37202D CRC64;
     MICLVLTIFA NLFPAACTGA HERTFLAVKP DGVQRRLVGE IVRRFERKGF KLVALKLVQA
     SEELLREHYA ELRERPFYGR LVKYMASGPV VAMVWQGLDV VRTSRALIGA TNPADAPPGT
     IRGDFCIEVG KNLIHGSDSV ESARREIALW FRADELLCWE DSAGHWLYE
//
ID   GPX7_HUMAN              Reviewed;         187 AA.
AC   Q96SL4; O95337; Q5T501;
DT   04-AUG-2003, integrated into UniProtKB/Swiss-Prot.
DT   01-DEC-2001, sequence version 1.
DT   28-FEB-2018, entry version 149.
DE   RecName: Full=Glutathione peroxidase 7;
DE            Short=GPx-7;
DE            Short=GSHPx-7;
DE            EC=1.11.1.9;
DE   AltName: Full=CL683;
DE   Flags: Precursor;
GN   Name=GPX7; Synonyms=GPX6; ORFNames=UNQ469/PRO828;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Fetal brain;
RA   Gu S., Lin S., Ying K., Xie Y., Mao Y.;
RT   "Cloning and characterizing a novel human glutathione peroxidase-
RT   GPX6.";
RL   Submitted (NOV-2000) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=12975309; DOI=10.1101/gr.1293003;
RA   Clark H.F., Gurney A.L., Abaya E., Baker K., Baldwin D.T., Brush J.,
RA   Chen J., Chow B., Chui C., Crowley C., Currell B., Deuel B., Dowd P.,
RA   Eaton D., Foster J.S., Grimaldi C., Gu Q., Hass P.E., Heldens S.,
RA   Huang A., Kim H.S., Klimowski L., Jin Y., Johnson S., Lee J.,
RA   Lewis L., Liao D., Mark M.R., Robbie E., Sanchez C., Schoenfeld J.,
RA   Seshagiri S., Simmons L., Singh J., Smith V., Stinson J., Vagts A.,
RA   Vandlen R.L., Watanabe C., Wieand D., Woods K., Xie M.-H.,
RA   Yansura D.G., Yi S., Yu G., Yuan J., Zhang M., Zhang Z., Goddard A.D.,
RA   Wood W.I., Godowski P.J., Gray A.M.;
RT   "The secreted protein discovery initiative (SPDI), a large-scale
RT   effort to identify novel human secreted and transmembrane proteins: a
RT   bioinformatics assessment.";
RL   Genome Res. 13:2265-2270(2003).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RG   NIEHS SNPs program;
RL   Submitted (JUN-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Blood;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 75-187.
RA   Barrow I.K.-P., Boguski M.S., Touchman J.W., Spencer F.;
RT   "Full-insert sequence of mapped XREF EST.";
RL   Submitted (AUG-1998) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   FUNCTION, TISSUE SPECIFICITY, AND INVOLVEMENT IN BE.
RX   PubMed=22157330; DOI=10.1136/gutjnl-2011-301078;
RA   Peng D., Belkhiri A., Hu T., Chaturvedi R., Asim M., Wilson K.T.,
RA   Zaika A., El-Rifai W.;
RT   "Glutathione peroxidase 7 protects against oxidative DNA damage in
RT   oesophageal cells.";
RL   Gut 61:1250-1260(2012).
RN   [9]
RP   X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) OF 20-177.
RG   Structural genomics consortium (SGC);
RT   "Crystal structure of human glutathione peroxidase 7.";
RL   Submitted (MAR-2007) to the PDB data bank.
CC   -!- FUNCTION: It protects esophageal epithelia from hydrogen peroxide-
CC       induced oxidative stress. It suppresses acidic bile acid-induced
CC       reactive oxigen species (ROS) and protects against oxidative DNA
CC       damage and double-strand breaks. {ECO:0000269|PubMed:22157330}.
CC   -!- CATALYTIC ACTIVITY: 2 glutathione + H(2)O(2) = glutathione
CC       disulfide + 2 H(2)O.
CC   -!- INTERACTION:
CC       O43681:ASNA1; NbExp=5; IntAct=EBI-749411, EBI-2515857;
CC       Q8NHQ1:CEP70; NbExp=3; IntAct=EBI-749411, EBI-739624;
CC       O43765:SGTA; NbExp=5; IntAct=EBI-749411, EBI-347996;
CC       Q96EQ0:SGTB; NbExp=4; IntAct=EBI-749411, EBI-744081;
CC       Q9UHD9:UBQLN2; NbExp=4; IntAct=EBI-749411, EBI-947187;
CC   -!- SUBCELLULAR LOCATION: Secreted {ECO:0000305}.
CC   -!- TISSUE SPECIFICITY: Expressed in esophageal epithelial cells;
CC       expression is up-regulated after exposure to acidic bile acids.
CC       {ECO:0000269|PubMed:22157330}.
CC   -!- DISEASE: Barrett esophagus (BE) [MIM:614266]: A condition
CC       characterized by a metaplastic change in which normal esophageal
CC       squamous epithelium is replaced by a columnar and intestinal-type
CC       epithelium. Patients with Barrett esophagus have an increased risk
CC       of esophageal adenocarcinoma. The main cause of Barrett esophagus
CC       is gastroesophageal reflux. The retrograde movement of acid and
CC       bile salts from the stomach into the esophagus causes prolonged
CC       injury to the esophageal epithelium and induces chronic
CC       esophagitis, which in turn is believed to trigger the pathologic
CC       changes. {ECO:0000269|PubMed:22157330}. Note=The disease is caused
CC       by mutations affecting the gene represented in this entry. The
CC       pathologic mechanisms leading to Barrett esophagus involve GPX7
CC       dysfunction that results in higher levels of hydrogen peroxide and
CC       ROS-induced oxidative stress and DNA damage in esophageal cells.
CC   -!- SIMILARITY: Belongs to the glutathione peroxidase family.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAC72961.1; Type=Erroneous translation; Note=Wrong choice of frame.; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=NIEHS-SNPs;
CC       URL="http://egp.gs.washington.edu/data/gpx7/";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF320068; AAN76501.1; -; mRNA.
DR   EMBL; AY358402; AAQ88768.1; -; mRNA.
DR   EMBL; AK027683; BAB55294.1; -; mRNA.
DR   EMBL; DQ096732; AAY88741.1; -; Genomic_DNA.
DR   EMBL; AL356976; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC032788; AAH32788.1; -; mRNA.
DR   EMBL; AF091092; AAC72961.1; ALT_SEQ; mRNA.
DR   CCDS; CCDS569.1; -.
DR   RefSeq; NP_056511.2; NM_015696.4.
DR   UniGene; Hs.43728; -.
DR   PDB; 2P31; X-ray; 2.00 A; A/B=20-177.
DR   PDBsum; 2P31; -.
DR   ProteinModelPortal; Q96SL4; -.
DR   SMR; Q96SL4; -.
DR   BioGrid; 109139; 45.
DR   IntAct; Q96SL4; 11.
DR   STRING; 9606.ENSP00000354677; -.
DR   DrugBank; DB00143; Glutathione.
DR   PeroxiBase; 3606; HsGPx07.
DR   iPTMnet; Q96SL4; -.
DR   PhosphoSitePlus; Q96SL4; -.
DR   BioMuta; GPX7; -.
DR   DMDM; 33516901; -.
DR   EPD; Q96SL4; -.
DR   MaxQB; Q96SL4; -.
DR   PaxDb; Q96SL4; -.
DR   PeptideAtlas; Q96SL4; -.
DR   PRIDE; Q96SL4; -.
DR   DNASU; 2882; -.
DR   Ensembl; ENST00000361314; ENSP00000354677; ENSG00000116157.
DR   GeneID; 2882; -.
DR   KEGG; hsa:2882; -.
DR   UCSC; uc001cue.4; human.
DR   CTD; 2882; -.
DR   DisGeNET; 2882; -.
DR   EuPathDB; HostDB:ENSG00000116157.5; -.
DR   GeneCards; GPX7; -.
DR   HGNC; HGNC:4559; GPX7.
DR   HPA; HPA025829; -.
DR   MIM; 614266; phenotype.
DR   MIM; 615784; gene.
DR   neXtProt; NX_Q96SL4; -.
DR   OpenTargets; ENSG00000116157; -.
DR   PharmGKB; PA28955; -.
DR   eggNOG; KOG1651; Eukaryota.
DR   eggNOG; COG0386; LUCA.
DR   GeneTree; ENSGT00760000119230; -.
DR   HOGENOM; HOG000277054; -.
DR   HOVERGEN; HBG004333; -.
DR   InParanoid; Q96SL4; -.
DR   KO; K00432; -.
DR   OMA; IAQTCHI; -.
DR   OrthoDB; EOG091G0OJG; -.
DR   PhylomeDB; Q96SL4; -.
DR   TreeFam; TF331942; -.
DR   BRENDA; 1.11.1.9; 2681.
DR   Reactome; R-HSA-3299685; Detoxification of Reactive Oxygen Species.
DR   ChiTaRS; GPX7; human.
DR   EvolutionaryTrace; Q96SL4; -.
DR   GeneWiki; GPX7; -.
DR   GenomeRNAi; 2882; -.
DR   PRO; PR:Q96SL4; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000116157; -.
DR   CleanEx; HS_GPX6; -.
DR   CleanEx; HS_GPX7; -.
DR   Genevisible; Q96SL4; HS.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:UniProtKB.
DR   GO; GO:0005788; C:endoplasmic reticulum lumen; TAS:Reactome.
DR   GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR   GO; GO:0004096; F:catalase activity; IDA:CACAO.
DR   GO; GO:0004602; F:glutathione peroxidase activity; IEA:UniProtKB-EC.
DR   GO; GO:0004601; F:peroxidase activity; EXP:Reactome.
DR   GO; GO:0034599; P:cellular response to oxidative stress; TAS:Reactome.
DR   CDD; cd00340; GSH_Peroxidase; 1.
DR   InterPro; IPR013376; Glut_perox_Gpx7.
DR   InterPro; IPR000889; Glutathione_peroxidase.
DR   InterPro; IPR029759; GPX_AS.
DR   InterPro; IPR029760; GPX_CS.
DR   InterPro; IPR036249; Thioredoxin-like_sf.
DR   PANTHER; PTHR11592; PTHR11592; 1.
DR   Pfam; PF00255; GSHPx; 1.
DR   PIRSF; PIRSF000303; Glutathion_perox; 1.
DR   PRINTS; PR01011; GLUTPROXDASE.
DR   SUPFAM; SSF52833; SSF52833; 1.
DR   TIGRFAMs; TIGR02540; gpx7; 1.
DR   PROSITE; PS00460; GLUTATHIONE_PEROXID_1; 1.
DR   PROSITE; PS00763; GLUTATHIONE_PEROXID_2; 1.
DR   PROSITE; PS51355; GLUTATHIONE_PEROXID_3; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Complete proteome; Oxidoreductase; Peroxidase;
KW   Reference proteome; Secreted; Signal.
FT   SIGNAL        1     19       {ECO:0000255}.
FT   CHAIN        20    187       Glutathione peroxidase 7.
FT                                /FTId=PRO_0000013084.
FT   ACT_SITE     57     57       {ECO:0000250}.
FT   CONFLICT     75     77       GPH -> HED (in Ref. 7). {ECO:0000305}.
FT   HELIX        25     27       {ECO:0000244|PDB:2P31}.
FT   STRAND       29     32       {ECO:0000244|PDB:2P31}.
FT   STRAND       37     39       {ECO:0000244|PDB:2P31}.
FT   HELIX        40     43       {ECO:0000244|PDB:2P31}.
FT   STRAND       46     53       {ECO:0000244|PDB:2P31}.
FT   STRAND       55     57       {ECO:0000244|PDB:2P31}.
FT   HELIX        60     74       {ECO:0000244|PDB:2P31}.
FT   HELIX        75     77       {ECO:0000244|PDB:2P31}.
FT   STRAND       79     85       {ECO:0000244|PDB:2P31}.
FT   HELIX        97    108       {ECO:0000244|PDB:2P31}.
FT   HELIX       127    136       {ECO:0000244|PDB:2P31}.
FT   STRAND      146    149       {ECO:0000244|PDB:2P31}.
FT   STRAND      155    159       {ECO:0000244|PDB:2P31}.
FT   HELIX       165    173       {ECO:0000244|PDB:2P31}.
SQ   SEQUENCE   187 AA;  20996 MW;  0ACB80AC2522EFCD CRC64;
     MVAATVAAAW LLLWAAACAQ QEQDFYDFKA VNIRGKLVSL EKYRGSVSLV VNVASECGFT
     DQHYRALQQL QRDLGPHHFN VLAFPCNQFG QQEPDSNKEI ESFARRTYSV SFPMFSKIAV
     TGTGAHPAFK YLAQTSGKEP TWNFWKYLVA PDGKVVGAWD PTVSVEEVRP QITALVRKLI
     LLKREDL
//
ID   A0A0C4DFP7_HUMAN        Unreviewed;       199 AA.
AC   A0A0C4DFP7;
DT   01-APR-2015, integrated into UniProtKB/TrEMBL.
DT   01-APR-2015, sequence version 1.
DT   23-MAY-2018, entry version 29.
DE   SubName: Full=Complement C1q tumor necrosis factor-related protein 1 {ECO:0000313|Ensembl:ENSP00000311265};
GN   Name=C1QTNF1 {ECO:0000313|Ensembl:ENSP00000311265};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000311265, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Ensembl:ENSP00000311265, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16625196; DOI=10.1038/nature04689;
RA   Zody M.C., Garber M., Adams D.J., Sharpe T., Harrow J., Lupski J.R.,
RA   Nicholson C., Searle S.M., Wilming L., Young S.K., Abouelleil A.,
RA   Allen N.R., Bi W., Bloom T., Borowsky M.L., Bugalter B.E., Butler J.,
RA   Chang J.L., Chen C.K., Cook A., Corum B., Cuomo C.A., de Jong P.J.,
RA   DeCaprio D., Dewar K., FitzGerald M., Gilbert J., Gibson R.,
RA   Gnerre S., Goldstein S., Grafham D.V., Grocock R., Hafez N.,
RA   Hagopian D.S., Hart E., Norman C.H., Humphray S., Jaffe D.B.,
RA   Jones M., Kamal M., Khodiyar V.K., LaButti K., Laird G., Lehoczky J.,
RA   Liu X., Lokyitsang T., Loveland J., Lui A., Macdonald P., Major J.E.,
RA   Matthews L., Mauceli E., McCarroll S.A., Mihalev A.H., Mudge J.,
RA   Nguyen C., Nicol R., O'Leary S.B., Osoegawa K., Schwartz D.C.,
RA   Shaw-Smith C., Stankiewicz P., Steward C., Swarbreck D.,
RA   Venkataraman V., Whittaker C.A., Yang X., Zimmer A.R., Bradley A.,
RA   Hubbard T., Birren B.W., Rogers J., Lander E.S., Nusbaum C.;
RT   "DNA sequence of human chromosome 17 and analysis of rearrangement in
RT   the human lineage.";
RL   Nature 440:1045-1049(2006).
RN   [2] {ECO:0000313|Ensembl:ENSP00000311265}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (FEB-2015) to UniProtKB.
CC   -!- SUBCELLULAR LOCATION: Secreted {ECO:0000256|SAAS:SAAS00562217}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AC073624; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; KF456330; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; KF456331; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   RefSeq; NP_940996.1; NM_198594.3.
DR   RefSeq; XP_016879615.1; XM_017024126.1.
DR   UniGene; Hs.201398; -.
DR   UniGene; Hs.741602; -.
DR   SMR; A0A0C4DFP7; -.
DR   PeptideAtlas; A0A0C4DFP7; -.
DR   PRIDE; A0A0C4DFP7; -.
DR   Ensembl; ENST00000311661; ENSP00000311265; ENSG00000173918.
DR   Ensembl; ENST00000578229; ENSP00000463337; ENSG00000173918.
DR   GeneID; 114897; -.
DR   CTD; 114897; -.
DR   EuPathDB; HostDB:ENSG00000173918.14; -.
DR   HGNC; HGNC:14324; C1QTNF1.
DR   OpenTargets; ENSG00000173918; -.
DR   eggNOG; ENOG410IKX5; Eukaryota.
DR   eggNOG; ENOG410XQIM; LUCA.
DR   GeneTree; ENSGT00900000140911; -.
DR   ChiTaRS; C1QTNF1; human.
DR   GenomeRNAi; 114897; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   Bgee; ENSG00000173918; -.
DR   ExpressionAtlas; A0A0C4DFP7; baseline and differential.
DR   GO; GO:0005581; C:collagen trimer; IEA:UniProtKB-KW.
DR   GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR   Gene3D; 2.60.120.40; -; 1.
DR   InterPro; IPR001073; C1q_dom.
DR   InterPro; IPR008160; Collagen.
DR   InterPro; IPR008983; Tumour_necrosis_fac-like_dom.
DR   Pfam; PF00386; C1q; 1.
DR   Pfam; PF01391; Collagen; 1.
DR   PRINTS; PR00007; COMPLEMNTC1Q.
DR   SMART; SM00110; C1Q; 1.
DR   SUPFAM; SSF49842; SSF49842; 1.
DR   PROSITE; PS50871; C1Q; 1.
PE   1: Evidence at protein level;
KW   Collagen {ECO:0000256|SAAS:SAAS00562261};
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   Proteomics identification {ECO:0000213|MaxQB:A0A0C4DFP7,
KW   ECO:0000213|PeptideAtlas:A0A0C4DFP7};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640};
KW   Secreted {ECO:0000256|SAAS:SAAS00562230}.
FT   DOMAIN       59    199       C1q. {ECO:0000259|PROSITE:PS50871}.
SQ   SEQUENCE   199 AA;  22742 MW;  453C78D9090E0428 CRC64;
     MYPATAVPQI NITILKGEKG DRGDRGLQGK YGKTGSAGAR GHTGPKGQKG SMGAPGERCK
     SHYAAFSVGR KKPMHSNHYY QTVIFDTEFV NLYDHFNMFT GKFYCYVPGL YFFSLNVHTW
     NQKETYLHIM KNEEEVVILF AQVGDRSIMQ SQSLMLELRE QDQVWVRLYK GERENAIFSE
     ELDTYITFSG YLVKHATEP
//
ID   C1QT1_HUMAN             Reviewed;         281 AA.
AC   Q9BXJ1; Q6ZMH6; Q96NF2; Q9GZR4;
DT   16-APR-2002, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-2001, sequence version 1.
DT   23-MAY-2018, entry version 149.
DE   RecName: Full=Complement C1q tumor necrosis factor-related protein 1;
DE   AltName: Full=G protein-coupled receptor-interacting protein;
DE            Short=GIP;
DE   Flags: Precursor;
GN   Name=C1QTNF1; Synonyms=CTRP1; ORFNames=UNQ310/PRO353;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANT GLN-241.
RA   Innamorati G., Le Gouill C., Whang I., Birnbaumer M.;
RT   "GIP, a putative GPCR interacting protein.";
RL   Submitted (FEB-2000) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RA   Sheppard P.O.;
RT   "Homo sapiens complement-c1q tumor necrosis factor-related protein.";
RL   Submitted (DEC-2000) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RX   PubMed=12975309; DOI=10.1101/gr.1293003;
RA   Clark H.F., Gurney A.L., Abaya E., Baker K., Baldwin D.T., Brush J.,
RA   Chen J., Chow B., Chui C., Crowley C., Currell B., Deuel B., Dowd P.,
RA   Eaton D., Foster J.S., Grimaldi C., Gu Q., Hass P.E., Heldens S.,
RA   Huang A., Kim H.S., Klimowski L., Jin Y., Johnson S., Lee J.,
RA   Lewis L., Liao D., Mark M.R., Robbie E., Sanchez C., Schoenfeld J.,
RA   Seshagiri S., Simmons L., Singh J., Smith V., Stinson J., Vagts A.,
RA   Vandlen R.L., Watanabe C., Wieand D., Woods K., Xie M.-H.,
RA   Yansura D.G., Yi S., Yu G., Yuan J., Zhang M., Zhang Z., Goddard A.D.,
RA   Wood W.I., Godowski P.J., Gray A.M.;
RT   "The secreted protein discovery initiative (SPDI), a large-scale
RT   effort to identify novel human secreted and transmembrane proteins: a
RT   bioinformatics assessment.";
RL   Genome Res. 13:2265-2270(2003).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2), AND NUCLEOTIDE
RP   SEQUENCE [LARGE SCALE MRNA] OF 83-281 (ISOFORM 1).
RC   TISSUE=Colon;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16625196; DOI=10.1038/nature04689;
RA   Zody M.C., Garber M., Adams D.J., Sharpe T., Harrow J., Lupski J.R.,
RA   Nicholson C., Searle S.M., Wilming L., Young S.K., Abouelleil A.,
RA   Allen N.R., Bi W., Bloom T., Borowsky M.L., Bugalter B.E., Butler J.,
RA   Chang J.L., Chen C.-K., Cook A., Corum B., Cuomo C.A., de Jong P.J.,
RA   DeCaprio D., Dewar K., FitzGerald M., Gilbert J., Gibson R.,
RA   Gnerre S., Goldstein S., Grafham D.V., Grocock R., Hafez N.,
RA   Hagopian D.S., Hart E., Norman C.H., Humphray S., Jaffe D.B.,
RA   Jones M., Kamal M., Khodiyar V.K., LaButti K., Laird G., Lehoczky J.,
RA   Liu X., Lokyitsang T., Loveland J., Lui A., Macdonald P., Major J.E.,
RA   Matthews L., Mauceli E., McCarroll S.A., Mihalev A.H., Mudge J.,
RA   Nguyen C., Nicol R., O'Leary S.B., Osoegawa K., Schwartz D.C.,
RA   Shaw-Smith C., Stankiewicz P., Steward C., Swarbreck D.,
RA   Venkataraman V., Whittaker C.A., Yang X., Zimmer A.R., Bradley A.,
RA   Hubbard T., Birren B.W., Rogers J., Lander E.S., Nusbaum C.;
RT   "DNA sequence of human chromosome 17 and analysis of rearrangement in
RT   the human lineage.";
RL   Nature 440:1045-1049(2006).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -!- INTERACTION:
CC       Q8TBB1:LNX1; NbExp=3; IntAct=EBI-750200, EBI-739832;
CC       Q8WWY3:PRPF31; NbExp=5; IntAct=EBI-11536642, EBI-1567797;
CC       O43765:SGTA; NbExp=4; IntAct=EBI-750200, EBI-347996;
CC   -!- SUBCELLULAR LOCATION: Secreted {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9BXJ1-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9BXJ1-2; Sequence=VSP_055570;
CC         Note=No experimental confirmation available.;
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAG44303.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC       Sequence=CAC20425.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AJ272138; CAC20425.1; ALT_INIT; mRNA.
DR   EMBL; AF232905; AAG44303.1; ALT_INIT; mRNA.
DR   EMBL; AF329840; AAK17964.1; -; mRNA.
DR   EMBL; AY358424; AAQ88790.1; -; mRNA.
DR   EMBL; AK055541; BAB70947.1; -; mRNA.
DR   EMBL; AK075175; BAC11451.1; -; mRNA.
DR   EMBL; AK172767; BAD18750.1; -; mRNA.
DR   EMBL; AC073624; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC021553; AAH21553.1; -; mRNA.
DR   CCDS; CCDS11761.1; -. [Q9BXJ1-1]
DR   RefSeq; NP_112230.1; NM_030968.4. [Q9BXJ1-1]
DR   RefSeq; NP_699203.1; NM_153372.2. [Q9BXJ1-1]
DR   RefSeq; NP_940995.1; NM_198593.4. [Q9BXJ1-1]
DR   RefSeq; NP_940996.1; NM_198594.3.
DR   RefSeq; XP_006721729.1; XM_006721666.1. [Q9BXJ1-2]
DR   RefSeq; XP_016879615.1; XM_017024126.1.
DR   UniGene; Hs.201398; -.
DR   UniGene; Hs.741602; -.
DR   ProteinModelPortal; Q9BXJ1; -.
DR   BioGrid; 125388; 7.
DR   IntAct; Q9BXJ1; 6.
DR   STRING; 9606.ENSP00000340864; -.
DR   iPTMnet; Q9BXJ1; -.
DR   PhosphoSitePlus; Q9BXJ1; -.
DR   BioMuta; C1QTNF1; -.
DR   DMDM; 20177862; -.
DR   PaxDb; Q9BXJ1; -.
DR   PeptideAtlas; Q9BXJ1; -.
DR   PRIDE; Q9BXJ1; -.
DR   DNASU; 114897; -.
DR   Ensembl; ENST00000339142; ENSP00000340864; ENSG00000173918. [Q9BXJ1-1]
DR   Ensembl; ENST00000354124; ENSP00000343230; ENSG00000173918. [Q9BXJ1-1]
DR   Ensembl; ENST00000392445; ENSP00000376240; ENSG00000173918. [Q9BXJ1-1]
DR   Ensembl; ENST00000579760; ENSP00000463922; ENSG00000173918. [Q9BXJ1-1]
DR   Ensembl; ENST00000580454; ENSP00000462990; ENSG00000173918. [Q9BXJ1-1]
DR   Ensembl; ENST00000580474; ENSP00000463108; ENSG00000173918. [Q9BXJ1-1]
DR   Ensembl; ENST00000581774; ENSP00000462481; ENSG00000173918. [Q9BXJ1-1]
DR   Ensembl; ENST00000583904; ENSP00000463008; ENSG00000173918. [Q9BXJ1-1]
DR   GeneID; 114897; -.
DR   KEGG; hsa:114897; -.
DR   UCSC; uc002jwp.5; human. [Q9BXJ1-1]
DR   CTD; 114897; -.
DR   DisGeNET; 114897; -.
DR   EuPathDB; HostDB:ENSG00000173918.14; -.
DR   GeneCards; C1QTNF1; -.
DR   HGNC; HGNC:14324; C1QTNF1.
DR   HPA; CAB025429; -.
DR   HPA; HPA051101; -.
DR   MIM; 610365; gene.
DR   neXtProt; NX_Q9BXJ1; -.
DR   OpenTargets; ENSG00000173918; -.
DR   PharmGKB; PA25628; -.
DR   eggNOG; ENOG410IKX5; Eukaryota.
DR   eggNOG; ENOG410XQIM; LUCA.
DR   GeneTree; ENSGT00900000140911; -.
DR   HOGENOM; HOG000101544; -.
DR   HOVERGEN; HBG108220; -.
DR   InParanoid; Q9BXJ1; -.
DR   OMA; RCCDPGT; -.
DR   OrthoDB; EOG091G0LRA; -.
DR   PhylomeDB; Q9BXJ1; -.
DR   TreeFam; TF329591; -.
DR   ChiTaRS; C1QTNF1; human.
DR   GeneWiki; C1QTNF1; -.
DR   GenomeRNAi; 114897; -.
DR   PRO; PR:Q9BXJ1; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   Bgee; ENSG00000173918; -.
DR   CleanEx; HS_C1QTNF1; -.
DR   ExpressionAtlas; Q9BXJ1; baseline and differential.
DR   Genevisible; Q9BXJ1; HS.
DR   GO; GO:0005581; C:collagen trimer; IEA:UniProtKB-KW.
DR   GO; GO:0005615; C:extracellular space; IDA:UniProtKB.
DR   GO; GO:0005887; C:integral component of plasma membrane; IDA:UniProtKB.
DR   GO; GO:0005518; F:collagen binding; IDA:UniProtKB.
DR   GO; GO:0010544; P:negative regulation of platelet activation; IDA:UniProtKB.
DR   GO; GO:0090331; P:negative regulation of platelet aggregation; IDA:UniProtKB.
DR   GO; GO:2000860; P:positive regulation of aldosterone secretion; IDA:UniProtKB.
DR   GO; GO:0007204; P:positive regulation of cytosolic calcium ion concentration; IDA:UniProtKB.
DR   GO; GO:0010628; P:positive regulation of gene expression; IDA:UniProtKB.
DR   GO; GO:0043410; P:positive regulation of MAPK cascade; IEA:Ensembl.
DR   GO; GO:0051897; P:positive regulation of protein kinase B signaling; IEA:Ensembl.
DR   GO; GO:0070208; P:protein heterotrimerization; IEA:Ensembl.
DR   GO; GO:0051260; P:protein homooligomerization; IEA:Ensembl.
DR   GO; GO:0010906; P:regulation of glucose metabolic process; IEA:Ensembl.
DR   Gene3D; 2.60.120.40; -; 1.
DR   InterPro; IPR001073; C1q_dom.
DR   InterPro; IPR008160; Collagen.
DR   InterPro; IPR008983; Tumour_necrosis_fac-like_dom.
DR   Pfam; PF00386; C1q; 1.
DR   Pfam; PF01391; Collagen; 1.
DR   PRINTS; PR00007; COMPLEMNTC1Q.
DR   SMART; SM00110; C1Q; 1.
DR   SUPFAM; SSF49842; SSF49842; 1.
DR   PROSITE; PS50871; C1Q; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Collagen; Complete proteome; Glycoprotein;
KW   Polymorphism; Reference proteome; Secreted; Signal.
FT   SIGNAL        1     25       {ECO:0000255}.
FT   CHAIN        26    281       Complement C1q tumor necrosis factor-
FT                                related protein 1.
FT                                /FTId=PRO_0000003529.
FT   DOMAIN       99    140       Collagen-like.
FT   DOMAIN      141    281       C1q. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00368}.
FT   CARBOHYD     93     93       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   VAR_SEQ       1      1       M -> MMSATGPGRKM (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_055570.
FT   VARIANT     241    241       R -> Q (in dbSNP:rs35035542).
FT                                {ECO:0000269|Ref.1}.
FT                                /FTId=VAR_068885.
FT   CONFLICT     22     22       L -> P (in Ref. 1; CAC20425/AAG44303).
FT                                {ECO:0000305}.
SQ   SEQUENCE   281 AA;  31743 MW;  49E248CB88ACFB7C CRC64;
     MGSRGQGLLL AYCLLLAFAS GLVLSRVPHV QGEQQEWEGT EELPSPPDHA ERAEEQHEKY
     RPSQDQGLPA SRCLRCCDPG TSMYPATAVP QINITILKGE KGDRGDRGLQ GKYGKTGSAG
     ARGHTGPKGQ KGSMGAPGER CKSHYAAFSV GRKKPMHSNH YYQTVIFDTE FVNLYDHFNM
     FTGKFYCYVP GLYFFSLNVH TWNQKETYLH IMKNEEEVVI LFAQVGDRSI MQSQSLMLEL
     REQDQVWVRL YKGERENAIF SEELDTYITF SGYLVKHATE P
//
ID   SPP2A_HUMAN             Reviewed;         520 AA.
AC   Q8TCT8; B2RDS0; Q8TAW1; Q96SZ8;
DT   08-NOV-2002, integrated into UniProtKB/Swiss-Prot.
DT   08-NOV-2002, sequence version 2.
DT   28-FEB-2018, entry version 136.
DE   RecName: Full=Signal peptide peptidase-like 2A {ECO:0000303|PubMed:15385547, ECO:0000312|HGNC:HGNC:30227};
DE            Short=SPP-like 2A {ECO:0000303|PubMed:15385547};
DE            Short=SPPL2a {ECO:0000303|PubMed:15385547};
DE            EC=3.4.23.-;
DE   AltName: Full=Intramembrane protease 3 {ECO:0000303|PubMed:12139484};
DE            Short=IMP-3 {ECO:0000303|PubMed:12139484};
DE   AltName: Full=Presenilin-like protein 2;
DE   Flags: Precursor;
GN   Name=SPPL2A {ECO:0000303|PubMed:15385547,
GN   ECO:0000312|HGNC:HGNC:30227};
GN   Synonyms=IMP3 {ECO:0000303|PubMed:12139484}, PSL2; ORFNames=PSEC0147;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RA   Irmler M., Tomiuk S., Korner M.R., Hofmann K., Conradt M.;
RT   "Characterization of a new protein family with homology to
RT   presenilins.";
RL   Submitted (SEP-2001) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Blood;
RX   PubMed=12139484; DOI=10.1023/A:1016365227942;
RA   Grigorenko A.P., Moliaka Y.K., Korovaitseva G.I., Rogaev E.I.;
RT   "Novel class of polytopic proteins with domains associated with
RT   putative protease activity.";
RL   Biochemistry (Mosc.) 67:826-834(2002).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Synovium, and Teratocarcinoma;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Placenta;
RX   PubMed=16303743; DOI=10.1093/dnares/12.2.117;
RA   Otsuki T., Ota T., Nishikawa T., Hayashi K., Suzuki Y., Yamamoto J.,
RA   Wakamatsu A., Kimura K., Sakamoto K., Hatano N., Kawai Y., Ishii S.,
RA   Saito K., Kojima S., Sugiyama T., Ono T., Okano K., Yoshikawa Y.,
RA   Aotsuka S., Sasaki N., Hattori A., Okumura K., Nagai K., Sugano S.,
RA   Isogai T.;
RT   "Signal sequence and keyword trap in silico for selection of full-
RT   length human cDNAs encoding secretion or membrane proteins from oligo-
RT   capped cDNA libraries.";
RL   DNA Res. 12:117-126(2005).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Pancreas;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 91-520.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=12077416; DOI=10.1126/science.1070925;
RA   Weihofen A., Binns K., Lemberg M.K., Ashman K., Martoglio B.;
RT   "Identification of signal peptide peptidase, a presenilin-type
RT   aspartic protease.";
RL   Science 296:2215-2218(2002).
RN   [8]
RP   GLYCOSYLATION, TOPOLOGY, SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=15385547; DOI=10.1074/jbc.M407898200;
RA   Friedmann E., Lemberg M.K., Weihofen A., Dev K.K., Dengler U.,
RA   Rovelli G., Martoglio B.;
RT   "Consensus analysis of signal peptide peptidase and homologous human
RT   aspartic proteases reveals opposite topology of catalytic domains
RT   compared with presenilins.";
RL   J. Biol. Chem. 279:50790-50798(2004).
RN   [9]
RP   FUNCTION IN CLEAVAGE OF TNF, SUBCELLULAR LOCATION, AND MUTAGENESIS OF
RP   ASP-412.
RX   PubMed=16829952; DOI=10.1038/ncb1440;
RA   Friedmann E., Hauben E., Maylandt K., Schleeger S., Vreugde S.,
RA   Lichtenthaler S.F., Kuhn P.H., Stauffer D., Rovelli G., Martoglio B.;
RT   "SPPL2a and SPPL2b promote intramembrane proteolysis of TNFalpha in
RT   activated dendritic cells to trigger IL-12 production.";
RL   Nat. Cell Biol. 8:843-848(2006).
RN   [10]
RP   FUNCTION IN CLEAVAGE OF TNF.
RX   PubMed=16829951; DOI=10.1038/ncb1450;
RA   Fluhrer R., Grammer G., Israel L., Condron M.M., Haffner C.,
RA   Friedmann E., Bohland C., Imhof A., Martoglio B., Teplow D.B.,
RA   Haass C.;
RT   "A gamma-secretase-like intramembrane cleavage of TNFalpha by the GxGD
RT   aspartyl protease SPPL2b.";
RL   Nat. Cell Biol. 8:894-896(2006).
RN   [11]
RP   FUNCTION IN CLEAVAGE OF FASLG, AND MUTAGENESIS OF ASP-412.
RX   PubMed=17557115; DOI=10.1038/sj.cdd.4402175;
RA   Kirkin V., Cahuzac N., Guardiola-Serrano F., Huault S., Luckerath K.,
RA   Friedmann E., Novac N., Wels W.S., Martoglio B., Hueber A.O.,
RA   Zornig M.;
RT   "The Fas ligand intracellular domain is released by ADAM10 and SPPL2a
RT   cleavage in T-cells.";
RL   Cell Death Differ. 14:1678-1687(2007).
RN   [12]
RP   FUNCTION IN CLEAVAGE OF ITM2B, INTERACTION WITH ITM2B, AND MUTAGENESIS
RP   OF ASP-412.
RX   PubMed=17965014; DOI=10.1074/jbc.M706661200;
RA   Martin L., Fluhrer R., Reiss K., Kremmer E., Saftig P., Haass C.;
RT   "Regulated intramembrane proteolysis of Bri2 (Itm2b) by ADAM10 and
RT   SPPL2a/SPPL2b.";
RL   J. Biol. Chem. 283:1644-1652(2008).
RN   [13]
RP   GLYCOSYLATION AT ASN-155.
RX   PubMed=19139490; DOI=10.1074/mcp.M800504-MCP200;
RA   Jia W., Lu Z., Fu Y., Wang H.P., Wang L.H., Chi H., Yuan Z.F.,
RA   Zheng Z.B., Song L.N., Han H.H., Liang Y.M., Wang J.L., Cai Y.,
RA   Zhang Y.K., Deng Y.L., Ying W.T., He S.M., Qian X.H.;
RT   "A strategy for precise and large scale identification of core
RT   fucosylated glycoproteins.";
RL   Mol. Cell. Proteomics 8:913-923(2009).
RN   [14]
RP   FUNCTION, AND MUTAGENESIS OF ASP-412.
RX   PubMed=23132852; DOI=10.1074/jbc.M112.371369;
RA   Voss M., Fukumori A., Kuhn P.H., Kunzel U., Klier B., Grammer G.,
RA   Haug-Kroper M., Kremmer E., Lichtenthaler S.F., Steiner H.,
RA   Schroder B., Haass C., Fluhrer R.;
RT   "Foamy virus envelope protein is a substrate for signal peptide
RT   peptidase-like 3 (SPPL3).";
RL   J. Biol. Chem. 287:43401-43409(2012).
CC   -!- FUNCTION: Intramembrane-cleaving aspartic protease (I-CLiP) that
CC       cleaves type II membrane signal peptides in the hydrophobic plane
CC       of the membrane. Functions in FASLG, ITM2B and TNF processing
CC       (PubMed:16829952, PubMed:16829951, PubMed:17557115,
CC       PubMed:17965014). Catalyzes the intramembrane cleavage of the
CC       anchored fragment of shed TNF-alpha (TNF), which promotes the
CC       release of the intracellular domain (ICD) for signaling to the
CC       nucleus (PubMed:16829952). Also responsible for the intramembrane
CC       cleavage of Fas antigen ligand FASLG, which promotes the release
CC       of the intracellular FasL domain (FasL ICD) (PubMed:17557115). May
CC       play a role in the regulation of innate and adaptive immunity
CC       (PubMed:16829952). Catalyzes the intramembrane cleavage of the
CC       simian foamy virus envelope glycoprotein gp130 independently of
CC       prior ectodomain shedding by furin or furin-like proprotein
CC       convertase (PC)-mediated cleavage proteolysis (PubMed:23132852).
CC       {ECO:0000269|PubMed:16829951, ECO:0000269|PubMed:16829952,
CC       ECO:0000269|PubMed:17557115, ECO:0000269|PubMed:17965014,
CC       ECO:0000269|PubMed:23132852}.
CC   -!- SUBUNIT: Interacts with ITM2B (PubMed:17965014).
CC       {ECO:0000269|PubMed:17965014}.
CC   -!- INTERACTION:
CC       O43765:SGTA; NbExp=6; IntAct=EBI-750784, EBI-347996;
CC   -!- SUBCELLULAR LOCATION: Late endosome membrane
CC       {ECO:0000269|PubMed:16829952}; Multi-pass membrane protein
CC       {ECO:0000305}. Lysosome membrane {ECO:0000250|UniProtKB:Q9JJF9};
CC       Multi-pass membrane protein {ECO:0000250|UniProtKB:Q9JJF9}.
CC       Membrane {ECO:0000269|PubMed:15385547}; Multi-pass membrane
CC       protein {ECO:0000305}; Lumenal side {ECO:0000269|PubMed:15385547}.
CC       Note=Colocalizes with palmitoylated and myristoylated proteins at
CC       the plasma membrane.
CC   -!- TISSUE SPECIFICITY: Ubiquitous. {ECO:0000269|PubMed:15385547}.
CC   -!- DOMAIN: The PAL motif is required for normal active site
CC       conformation. The catalytic domains embedded in the membrane are
CC       in the opposite orientation to that of the presenilin protein
CC       family; therefore, it is predicted to cleave type II-oriented
CC       substrate peptides like the prototypic protease SPP. The C-
CC       terminal tail is necessary for lysosomal transport.
CC       {ECO:0000250|UniProtKB:P49768, ECO:0000250|UniProtKB:Q9JJF9}.
CC   -!- PTM: Glycosylated. {ECO:0000269|PubMed:15385547,
CC       ECO:0000269|PubMed:19139490}.
CC   -!- SIMILARITY: Belongs to the peptidase A22B family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAB55117.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=CAD13133.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AJ345028; CAC87789.1; -; mRNA.
DR   EMBL; AY169314; AAO12539.1; -; mRNA.
DR   EMBL; AK027446; BAB55117.1; ALT_INIT; mRNA.
DR   EMBL; AK315651; BAG38017.1; -; mRNA.
DR   EMBL; AK075454; BAC11630.1; -; mRNA.
DR   EMBL; CH471082; EAW77410.1; -; Genomic_DNA.
DR   EMBL; BC025740; AAH25740.1; -; mRNA.
DR   EMBL; AJ420896; CAD13133.1; ALT_INIT; mRNA.
DR   CCDS; CCDS10138.1; -.
DR   RefSeq; NP_116191.2; NM_032802.3.
DR   UniGene; Hs.401537; -.
DR   ProteinModelPortal; Q8TCT8; -.
DR   BioGrid; 124328; 3.
DR   IntAct; Q8TCT8; 4.
DR   MINT; Q8TCT8; -.
DR   STRING; 9606.ENSP00000261854; -.
DR   MEROPS; A22.007; -.
DR   TCDB; 1.A.54.3.2; the presenilin er ca(2+) leak channel (presenilin) family.
DR   iPTMnet; Q8TCT8; -.
DR   PhosphoSitePlus; Q8TCT8; -.
DR   SwissPalm; Q8TCT8; -.
DR   BioMuta; SPPL2A; -.
DR   DMDM; 25008981; -.
DR   EPD; Q8TCT8; -.
DR   MaxQB; Q8TCT8; -.
DR   PaxDb; Q8TCT8; -.
DR   PeptideAtlas; Q8TCT8; -.
DR   PRIDE; Q8TCT8; -.
DR   DNASU; 84888; -.
DR   Ensembl; ENST00000261854; ENSP00000261854; ENSG00000138600.
DR   GeneID; 84888; -.
DR   KEGG; hsa:84888; -.
DR   UCSC; uc001zyv.4; human.
DR   CTD; 84888; -.
DR   DisGeNET; 84888; -.
DR   EuPathDB; HostDB:ENSG00000138600.9; -.
DR   GeneCards; SPPL2A; -.
DR   HGNC; HGNC:30227; SPPL2A.
DR   HPA; HPA036062; -.
DR   HPA; HPA067304; -.
DR   MIM; 608238; gene.
DR   neXtProt; NX_Q8TCT8; -.
DR   OpenTargets; ENSG00000138600; -.
DR   eggNOG; KOG2442; Eukaryota.
DR   eggNOG; ENOG410ZP52; LUCA.
DR   GeneTree; ENSGT00530000062920; -.
DR   HOGENOM; HOG000231496; -.
DR   HOVERGEN; HBG024193; -.
DR   InParanoid; Q8TCT8; -.
DR   KO; K09596; -.
DR   OMA; KKFWKGS; -.
DR   OrthoDB; EOG091G05NG; -.
DR   PhylomeDB; Q8TCT8; -.
DR   TreeFam; TF319186; -.
DR   Reactome; R-HSA-5357905; Regulation of TNFR1 signaling.
DR   GeneWiki; SPPL2A; -.
DR   GenomeRNAi; 84888; -.
DR   PRO; PR:Q8TCT8; -.
DR   Proteomes; UP000005640; Chromosome 15.
DR   Bgee; ENSG00000138600; -.
DR   ExpressionAtlas; Q8TCT8; baseline and differential.
DR   Genevisible; Q8TCT8; HS.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0030660; C:Golgi-associated vesicle membrane; IDA:UniProtKB.
DR   GO; GO:0071458; C:integral component of cytoplasmic side of endoplasmic reticulum membrane; IDA:UniProtKB.
DR   GO; GO:0071556; C:integral component of lumenal side of endoplasmic reticulum membrane; IDA:UniProtKB.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; IDA:HPA.
DR   GO; GO:0005770; C:late endosome; IDA:UniProtKB.
DR   GO; GO:0031902; C:late endosome membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005765; C:lysosomal membrane; HDA:UniProtKB.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IDA:HPA.
DR   GO; GO:0042500; F:aspartic endopeptidase activity, intramembrane cleaving; IDA:UniProtKB.
DR   GO; GO:0042803; F:protein homodimerization activity; IDA:UniProtKB.
DR   GO; GO:0006509; P:membrane protein ectodomain proteolysis; IDA:UniProtKB.
DR   GO; GO:0031293; P:membrane protein intracellular domain proteolysis; IDA:UniProtKB.
DR   GO; GO:0033619; P:membrane protein proteolysis; IDA:UniProtKB.
DR   GO; GO:0050776; P:regulation of immune response; IMP:UniProtKB.
DR   GO; GO:0010803; P:regulation of tumor necrosis factor-mediated signaling pathway; TAS:Reactome.
DR   InterPro; IPR003137; PA_domain.
DR   InterPro; IPR007369; Peptidase_A22B_SPP.
DR   InterPro; IPR006639; Preselin/SPP.
DR   InterPro; IPR033151; SPPL2a.
DR   PANTHER; PTHR12174; PTHR12174; 1.
DR   PANTHER; PTHR12174:SF34; PTHR12174:SF34; 1.
DR   Pfam; PF02225; PA; 1.
DR   Pfam; PF04258; Peptidase_A22B; 1.
DR   SMART; SM00730; PSN; 1.
PE   1: Evidence at protein level;
KW   Complete proteome; Endosome; Glycoprotein; Hydrolase; Lysosome;
KW   Membrane; Polymorphism; Protease; Reference proteome; Signal;
KW   Transmembrane; Transmembrane helix.
FT   SIGNAL        1     25       {ECO:0000269|PubMed:15385547}.
FT   CHAIN        26    520       Signal peptide peptidase-like 2A.
FT                                /FTId=PRO_0000073910.
FT   TOPO_DOM     26    172       Lumenal. {ECO:0000269|PubMed:15385547}.
FT   TRANSMEM    173    193       Helical. {ECO:0000255}.
FT   TOPO_DOM    194    220       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    221    241       Helical. {ECO:0000255}.
FT   TOPO_DOM    242    247       Lumenal. {ECO:0000255}.
FT   TRANSMEM    248    268       Helical. {ECO:0000255}.
FT   TOPO_DOM    269    285       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    286    306       Helical. {ECO:0000255}.
FT   TOPO_DOM    307    311       Lumenal. {ECO:0000255}.
FT   TRANSMEM    312    332       Helical. {ECO:0000255}.
FT   TOPO_DOM    333    340       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    341    361       Helical. {ECO:0000255}.
FT   TOPO_DOM    362    399       Lumenal. {ECO:0000269|PubMed:15385547}.
FT   TRANSMEM    400    420       Helical. {ECO:0000255}.
FT   TOPO_DOM    421    437       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    438    458       Helical. {ECO:0000255}.
FT   TOPO_DOM    459    460       Lumenal. {ECO:0000255}.
FT   TRANSMEM    461    481       Helical. {ECO:0000255}.
FT   TOPO_DOM    482    520       Cytoplasmic.
FT                                {ECO:0000269|PubMed:15385547}.
FT   DOMAIN       63    151       PA.
FT   MOTIF       463    465       PAL.
FT   MOTIF       495    498       YXXo lysosomal targeting motif.
FT   ACT_SITE    351    351       {ECO:0000250|UniProtKB:P49810}.
FT   ACT_SITE    412    412       {ECO:0000250|UniProtKB:P49810}.
FT   CARBOHYD     58     58       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD     66     66       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD     74     74       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    116    116       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    126    126       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    149    149       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    155    155       N-linked (GlcNAc...) (complex)
FT                                asparagine.
FT                                {ECO:0000269|PubMed:19139490}.
FT   VARIANT      90     90       V -> I (in dbSNP:rs8034443).
FT                                /FTId=VAR_051790.
FT   MUTAGEN     412    412       D->A: Loss of intramembrane-cleaving
FT                                activity toward FASLG, ITM2B, TNF and the
FT                                simian foamy virus envelope glycoprotein
FT                                gp130. {ECO:0000269|PubMed:16829952,
FT                                ECO:0000269|PubMed:17557115,
FT                                ECO:0000269|PubMed:17965014,
FT                                ECO:0000269|PubMed:23132852}.
FT   CONFLICT    126    126       N -> D (in Ref. 3; BAB55117).
FT                                {ECO:0000305}.
FT   CONFLICT    271    271       I -> T (in Ref. 4; BAC11630).
FT                                {ECO:0000305}.
FT   CONFLICT    406    406       S -> L (in Ref. 4; BAC11630).
FT                                {ECO:0000305}.
FT   CONFLICT    446    446       I -> F (in Ref. 4; BAC11630).
FT                                {ECO:0000305}.
FT   CONFLICT    511    511       V -> E (in Ref. 3; BAB55117).
FT                                {ECO:0000305}.
SQ   SEQUENCE   520 AA;  58143 MW;  A7A933A6504507DC CRC64;
     MGPQRRLSPA GAALLWGFLL QLTAAQEAIL HASGNGTTKD YCMLYNPYWT ALPSTLENAT
     SISLMNLTST PLCNLSDIPP VGIKSKAVVV PWGSCHFLEK ARIAQKGGAE AMLVVNNSVL
     FPPSGNRSEF PDVKILIAFI SYKDFRDMNQ TLGDNITVKM YSPSWPNFDY TMVVIFVIAV
     FTVALGGYWS GLVELENLKA VTTEDREMRK KKEEYLTFSP LTVVIFVVIC CVMMVLLYFF
     YKWLVYVMIA IFCIASAMSL YNCLAALIHK IPYGQCTIAC RGKNMEVRLI FLSGLCIAVA
     VVWAVFRNED RWAWILQDIL GIAFCLNLIK TLKLPNFKSC VILLGLLLLY DVFFVFITPF
     ITKNGESIMV ELAAGPFGNN EKLPVVIRVP KLIYFSVMSV CLMPVSILGF GDIIVPGLLI
     AYCRRFDVQT GSSYIYYVSS TVAYAIGMIL TFVVLVLMKK GQPALLYLVP CTLITASVVA
     WRRKEMKKFW KGNSYQMMDH LDCATNEENP VISGEQIVQQ
//
ID   SYT4_HUMAN              Reviewed;         425 AA.
AC   Q9H2B2; B4DEU3; Q9P2K4;
DT   18-OCT-2001, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2001, sequence version 1.
DT   23-MAY-2018, entry version 154.
DE   RecName: Full=Synaptotagmin-4;
DE   AltName: Full=Synaptotagmin IV;
DE            Short=SytIV;
GN   Name=SYT4; Synonyms=KIAA1342;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=10938284; DOI=10.1074/jbc.M005801200;
RA   Ferguson G.D., Chen X.-N., Korenberg J.R., Herschman H.R.;
RT   "The human synaptotagmin IV gene defines an evolutionary break point
RT   between syntenic mouse and human chromosome regions but retains ligand
RT   inducibility and tissue specificity.";
RL   J. Biol. Chem. 275:36920-36926(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=10718198; DOI=10.1093/dnares/7.1.65;
RA   Nagase T., Kikuno R., Ishikawa K., Hirosawa M., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. XVI.
RT   The complete sequences of 150 new cDNA clones from brain which code
RT   for large proteins in vitro.";
RL   DNA Res. 7:65-73(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Cerebellum;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16177791; DOI=10.1038/nature03983;
RA   Nusbaum C., Zody M.C., Borowsky M.L., Kamal M., Kodira C.D.,
RA   Taylor T.D., Whittaker C.A., Chang J.L., Cuomo C.A., Dewar K.,
RA   FitzGerald M.G., Yang X., Abouelleil A., Allen N.R., Anderson S.,
RA   Bloom T., Bugalter B., Butler J., Cook A., DeCaprio D., Engels R.,
RA   Garber M., Gnirke A., Hafez N., Hall J.L., Norman C.H., Itoh T.,
RA   Jaffe D.B., Kuroki Y., Lehoczky J., Lui A., Macdonald P., Mauceli E.,
RA   Mikkelsen T.S., Naylor J.W., Nicol R., Nguyen C., Noguchi H.,
RA   O'Leary S.B., Piqani B., Smith C.L., Talamas J.A., Topham K.,
RA   Totoki Y., Toyoda A., Wain H.M., Young S.K., Zeng Q., Zimmer A.R.,
RA   Fujiyama A., Hattori M., Birren B.W., Sakaki Y., Lander E.S.;
RT   "DNA sequence and analysis of human chromosome 18.";
RL   Nature 437:551-555(2005).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   FUNCTION, AND TISSUE SPECIFICITY.
RX   PubMed=23999003; DOI=10.1016/j.jdermsci.2013.07.010;
RA   Yoo J.C., Lim T.Y., Park J.S., Hah Y.S., Park N., Hong S.G.,
RA   Park J.Y., Yoon T.J.;
RT   "SYT14L, especially its C2 domain, is involved in regulating
RT   melanocyte differentiation.";
RL   J. Dermatol. Sci. 72:246-251(2013).
RN   [7]
RP   STRUCTURE BY NMR OF 154-278.
RG   RIKEN structural genomics initiative (RSGI);
RT   "Solution structure of the first C2 domain of synaptotagmin IV from
RT   human fetal brain (KIAA1342).";
RL   Submitted (DEC-2003) to the PDB data bank.
CC   -!- FUNCTION: May be involved in Ca(2+)-dependent exocytosis of
CC       secretory vesicles through Ca(2+) and phospholipid binding to the
CC       C2 domain or may serve as Ca(2+) sensors in the process of
CC       vesicular trafficking and exocytosis (By similarity). Plays a role
CC       in dendrite formation by melanocytes (PubMed:23999003).
CC       {ECO:0000250|UniProtKB:P50232, ECO:0000269|PubMed:23999003}.
CC   -!- COFACTOR:
CC       Name=Ca(2+); Xref=ChEBI:CHEBI:29108; Evidence={ECO:0000250};
CC       Note=Binds 3 Ca(2+) ions per subunit. The ions are bound to the C2
CC       domains. {ECO:0000250};
CC   -!- INTERACTION:
CC       Q14596:NBR1; NbExp=3; IntAct=EBI-751132, EBI-742698;
CC       O43765:SGTA; NbExp=6; IntAct=EBI-751132, EBI-347996;
CC   -!- SUBCELLULAR LOCATION: Cytoplasmic vesicle, secretory vesicle,
CC       synaptic vesicle membrane; Single-pass membrane protein.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9H2B2-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9H2B2-2; Sequence=VSP_056643;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Expressed in melanocytes (PubMed:23999003).
CC       Expressed in brain. Within brain, expression is highest in
CC       hippocampus, with substantial levels also detected in amygdala and
CC       thalamus (PubMed:23999003). {ECO:0000269|PubMed:23999003}.
CC   -!- SIMILARITY: Belongs to the synaptotagmin family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAA92580.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF299075; AAG37229.1; -; mRNA.
DR   EMBL; AB037763; BAA92580.1; ALT_INIT; mRNA.
DR   EMBL; AK293791; BAG57204.1; -; mRNA.
DR   EMBL; AC091039; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC036538; AAH36538.1; -; mRNA.
DR   CCDS; CCDS11922.1; -. [Q9H2B2-1]
DR   RefSeq; NP_065834.1; NM_020783.3. [Q9H2B2-1]
DR   UniGene; Hs.8059; -.
DR   PDB; 1UGK; NMR; -; A=154-278.
DR   PDBsum; 1UGK; -.
DR   ProteinModelPortal; Q9H2B2; -.
DR   SMR; Q9H2B2; -.
DR   BioGrid; 112724; 4.
DR   ELM; Q9H2B2; -.
DR   IntAct; Q9H2B2; 3.
DR   STRING; 9606.ENSP00000255224; -.
DR   iPTMnet; Q9H2B2; -.
DR   PhosphoSitePlus; Q9H2B2; -.
DR   BioMuta; SYT4; -.
DR   DMDM; 18202937; -.
DR   PaxDb; Q9H2B2; -.
DR   PeptideAtlas; Q9H2B2; -.
DR   PRIDE; Q9H2B2; -.
DR   DNASU; 6860; -.
DR   Ensembl; ENST00000255224; ENSP00000255224; ENSG00000132872. [Q9H2B2-1]
DR   Ensembl; ENST00000590752; ENSP00000466930; ENSG00000132872. [Q9H2B2-2]
DR   GeneID; 6860; -.
DR   KEGG; hsa:6860; -.
DR   UCSC; uc002law.4; human. [Q9H2B2-1]
DR   CTD; 6860; -.
DR   DisGeNET; 6860; -.
DR   EuPathDB; HostDB:ENSG00000132872.11; -.
DR   GeneCards; SYT4; -.
DR   HGNC; HGNC:11512; SYT4.
DR   HPA; HPA010574; -.
DR   MIM; 600103; gene.
DR   neXtProt; NX_Q9H2B2; -.
DR   OpenTargets; ENSG00000132872; -.
DR   PharmGKB; PA36293; -.
DR   eggNOG; KOG1028; Eukaryota.
DR   eggNOG; ENOG410XRME; LUCA.
DR   GeneTree; ENSGT00760000118973; -.
DR   HOGENOM; HOG000232126; -.
DR   HOVERGEN; HBG005010; -.
DR   InParanoid; Q9H2B2; -.
DR   KO; K19904; -.
DR   OMA; QIAKWHM; -.
DR   OrthoDB; EOG091G09ZN; -.
DR   PhylomeDB; Q9H2B2; -.
DR   TreeFam; TF315600; -.
DR   ChiTaRS; SYT4; human.
DR   EvolutionaryTrace; Q9H2B2; -.
DR   GeneWiki; SYT4; -.
DR   GenomeRNAi; 6860; -.
DR   PRO; PR:Q9H2B2; -.
DR   Proteomes; UP000005640; Chromosome 18.
DR   Bgee; ENSG00000132872; -.
DR   CleanEx; HS_SYT4; -.
DR   ExpressionAtlas; Q9H2B2; baseline and differential.
DR   Genevisible; Q9H2B2; HS.
DR   GO; GO:0097449; C:astrocyte projection; IEA:Ensembl.
DR   GO; GO:0030424; C:axon; IEA:Ensembl.
DR   GO; GO:0030054; C:cell junction; IEA:UniProtKB-KW.
DR   GO; GO:0030425; C:dendrite; IEA:Ensembl.
DR   GO; GO:0032127; C:dense core granule membrane; NAS:ParkinsonsUK-UCL.
DR   GO; GO:0030173; C:integral component of Golgi membrane; NAS:ParkinsonsUK-UCL.
DR   GO; GO:0030285; C:integral component of synaptic vesicle membrane; NAS:ParkinsonsUK-UCL.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; IDA:HPA.
DR   GO; GO:1990742; C:microvesicle; IEA:Ensembl.
DR   GO; GO:0044306; C:neuron projection terminus; IEA:Ensembl.
DR   GO; GO:0043025; C:neuronal cell body; IEA:Ensembl.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IEA:Ensembl.
DR   GO; GO:0005886; C:plasma membrane; IDA:HPA.
DR   GO; GO:0005544; F:calcium-dependent phospholipid binding; IEA:Ensembl.
DR   GO; GO:0030276; F:clathrin binding; IBA:GO_Central.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0001786; F:phosphatidylserine binding; IEA:Ensembl.
DR   GO; GO:0046982; F:protein heterodimerization activity; IEA:Ensembl.
DR   GO; GO:0042803; F:protein homodimerization activity; IEA:Ensembl.
DR   GO; GO:0019905; F:syntaxin binding; IBA:GO_Central.
DR   GO; GO:0017075; F:syntaxin-1 binding; IEA:Ensembl.
DR   GO; GO:0030348; F:syntaxin-3 binding; IEA:Ensembl.
DR   GO; GO:0007420; P:brain development; IEA:Ensembl.
DR   GO; GO:0048791; P:calcium ion-regulated exocytosis of neurotransmitter; IBA:GO_Central.
DR   GO; GO:0007613; P:memory; IEA:Ensembl.
DR   GO; GO:0045955; P:negative regulation of calcium ion-dependent exocytosis; NAS:ParkinsonsUK-UCL.
DR   GO; GO:0033604; P:negative regulation of catecholamine secretion; IGI:ParkinsonsUK-UCL.
DR   GO; GO:1905414; P:negative regulation of dense core granule exocytosis; IEA:Ensembl.
DR   GO; GO:0050709; P:negative regulation of protein secretion; IEA:Ensembl.
DR   GO; GO:1905433; P:negative regulation of retrograde trans-synaptic signaling by neuropeptide; IEA:Ensembl.
DR   GO; GO:0048174; P:negative regulation of short-term neuronal synaptic plasticity; IEA:Ensembl.
DR   GO; GO:2000301; P:negative regulation of synaptic vesicle exocytosis; IEA:Ensembl.
DR   GO; GO:0031339; P:negative regulation of vesicle fusion; IEA:Ensembl.
DR   GO; GO:0045956; P:positive regulation of calcium ion-dependent exocytosis; NAS:ParkinsonsUK-UCL.
DR   GO; GO:1903861; P:positive regulation of dendrite extension; IDA:UniProtKB.
DR   GO; GO:1905415; P:positive regulation of dense core granule exocytosis; IEA:Ensembl.
DR   GO; GO:0014049; P:positive regulation of glutamate secretion; IEA:Ensembl.
DR   GO; GO:0014059; P:regulation of dopamine secretion; IEA:Ensembl.
DR   GO; GO:0030100; P:regulation of endocytosis; IEA:Ensembl.
DR   GO; GO:0061792; P:secretory granule maturation; IEA:Ensembl.
DR   GO; GO:0006906; P:vesicle fusion; IBA:GO_Central.
DR   GO; GO:0061782; P:vesicle fusion with vesicle; IEA:Ensembl.
DR   Gene3D; 2.60.40.150; -; 2.
DR   InterPro; IPR000008; C2_dom.
DR   InterPro; IPR035892; C2_domain_sf.
DR   InterPro; IPR001565; Synaptotagmin.
DR   InterPro; IPR028683; SYT4.
DR   PANTHER; PTHR10024:SF114; PTHR10024:SF114; 1.
DR   Pfam; PF00168; C2; 2.
DR   PRINTS; PR00399; SYNAPTOTAGMN.
DR   SMART; SM00239; C2; 2.
DR   PROSITE; PS50004; C2; 2.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Calcium; Cell junction;
KW   Complete proteome; Cytoplasmic vesicle; Differentiation; Membrane;
KW   Metal-binding; Phosphoprotein; Polymorphism; Reference proteome;
KW   Repeat; Synapse; Transmembrane; Transmembrane helix.
FT   CHAIN         1    425       Synaptotagmin-4.
FT                                /FTId=PRO_0000183948.
FT   TOPO_DOM      1     16       Vesicular. {ECO:0000255}.
FT   TRANSMEM     17     37       Helical. {ECO:0000255}.
FT   TOPO_DOM     38    425       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN      155    258       C2 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00041}.
FT   DOMAIN      289    392       C2 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00041}.
FT   REGION      147    297       Phospholipid binding. {ECO:0000305}.
FT   METAL       184    184       Calcium 1. {ECO:0000250}.
FT   METAL       184    184       Calcium 2. {ECO:0000250}.
FT   METAL       191    191       Calcium 1. {ECO:0000250}.
FT   METAL       245    245       Calcium 1; via carbonyl oxygen.
FT                                {ECO:0000250}.
FT   METAL       246    246       Calcium 1. {ECO:0000250}.
FT   METAL       246    246       Calcium 2. {ECO:0000250}.
FT   METAL       246    246       Calcium 3. {ECO:0000250}.
FT   METAL       249    249       Calcium 3. {ECO:0000250}.
FT   METAL       252    252       Calcium 2. {ECO:0000250}.
FT   METAL       252    252       Calcium 3. {ECO:0000250}.
FT   MOD_RES     135    135       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P40749}.
FT   VAR_SEQ      12     29       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_056643.
FT   VARIANT     142    142       S -> N (in dbSNP:rs16977447).
FT                                /FTId=VAR_052239.
FT   STRAND      156    164       {ECO:0000244|PDB:1UGK}.
FT   HELIX       165    167       {ECO:0000244|PDB:1UGK}.
FT   STRAND      169    179       {ECO:0000244|PDB:1UGK}.
FT   TURN        185    188       {ECO:0000244|PDB:1UGK}.
FT   STRAND      191    199       {ECO:0000244|PDB:1UGK}.
FT   TURN        200    202       {ECO:0000244|PDB:1UGK}.
FT   STRAND      204    207       {ECO:0000244|PDB:1UGK}.
FT   STRAND      218    226       {ECO:0000244|PDB:1UGK}.
FT   HELIX       233    235       {ECO:0000244|PDB:1UGK}.
FT   STRAND      237    245       {ECO:0000244|PDB:1UGK}.
FT   STRAND      255    260       {ECO:0000244|PDB:1UGK}.
FT   STRAND      271    276       {ECO:0000244|PDB:1UGK}.
SQ   SEQUENCE   425 AA;  47958 MW;  DA3D4CB175CB528D CRC64;
     MAPITTSREE FDEIPTVVGI FSAFGLVFTV SLFAWICCQR KSSKSNKTPP YKFVHVLKGV
     DIYPENLNSK KKFGADDKNE VKNKPAVPKN SLHLDLEKRD LNGNFPKTNL KPGSPSDLEN
     ATPKLFLEGE KESVSPESLK SSTSLTSEEK QEKLGTLFFS LEYNFERKAF VVNIKEARGL
     PAMDEQSMTS DPYIKMTILP EKKHKVKTRV LRKTLDPAFD ETFTFYGIPY TQIQELALHF
     TILSFDRFSR DDIIGEVLIP LSGIELSEGK MLMNREIIKR NVRKSSGRGE LLISLCYQST
     TNTLTVVVLK ARHLPKSDVS GLSDPYVKVN LYHAKKRISK KKTHVKKCTP NAVFNELFVF
     DIPCEGLEDI SVEFLVLDSE RGSRNEVIGQ LVLGAAAEGT GGEHWKEICD YPRRQIAKWH
     VLCDG
//
ID   A0A0S2Z3V1_HUMAN        Unreviewed;       413 AA.
AC   A0A0S2Z3V1;
DT   17-FEB-2016, integrated into UniProtKB/TrEMBL.
DT   17-FEB-2016, sequence version 1.
DT   23-MAY-2018, entry version 21.
DE   SubName: Full=EGF containing fibulin-like extracellular matrix protein 1 isoform 2 {ECO:0000313|EMBL:ALQ33517.1};
DE   SubName: Full=HCG16977, isoform CRA_b {ECO:0000313|EMBL:EAX00083.1};
DE   Flags: Fragment;
GN   Name=EFEMP1 {ECO:0000313|EMBL:ALQ33517.1};
GN   ORFNames=hCG_16977 {ECO:0000313|EMBL:EAX00083.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:ALQ33517.1};
RN   [1] {ECO:0000313|EMBL:EAX00083.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAX00083.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3] {ECO:0000313|EMBL:ALQ33517.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=26871637; DOI=10.1016/j.cell.2016.01.029;
RA   Yang X., Coulombe-Huntington J., Kang S., Sheynkman G.M., Hao T.,
RA   Richardson A., Sun S., Yang F., Shen Y.A., Murray R., Spirohn K.,
RA   Begg B.E., Duran-Frigola M., MacWilliams A., Pevzner S.J., Zhong Q.,
RA   Trigg S.A., Tam S., Ghamsari L., Sahni N., Yi S., Rodriguez M.D.,
RA   Balcha D., Tan G., Costanzo M., Andrews B., Boone C., Zhou X.J.,
RA   Salehi-Ashtiani K., Charloteaux B., Chen A., Calderwood M.A., Aloy P.,
RA   Roth F.P., Hill D.E., Iakoucheva L.M., Xia Y., Vidal M.;
RT   "Widespread Expansion of Protein Interaction Capabilities by
RT   Alternative Splicing.";
RL   Cell 164:805-817(2016).
CC   -!- INTERACTION:
CC       Q6FHY5:MEOX2; NbExp=3; IntAct=EBI-16434097, EBI-16439278;
CC       O43765:SGTA; NbExp=3; IntAct=EBI-16434097, EBI-347996;
CC       Q12933:TRAF2; NbExp=3; IntAct=EBI-16434097, EBI-355744;
CC   -!- CAUTION: Lacks conserved residue(s) required for the propagation
CC       of feature annotation. {ECO:0000256|PROSITE-ProRule:PRU00076}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; KU178059; ALQ33517.1; -; mRNA.
DR   EMBL; CH471053; EAX00083.1; -; Genomic_DNA.
DR   RefSeq; XP_016859075.1; XM_017003586.1.
DR   UniGene; Hs.732348; -.
DR   UniGene; Hs.76224; -.
DR   IntAct; A0A0S2Z3V1; 3.
DR   PeptideAtlas; A0A0S2Z3V1; -.
DR   GeneID; 2202; -.
DR   CTD; 2202; -.
DR   ChiTaRS; EFEMP1; human.
DR   GO; GO:0031012; C:extracellular matrix; IEA:InterPro.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   GO; GO:0005006; F:epidermal growth factor-activated receptor activity; IEA:InterPro.
DR   InterPro; IPR032973; EFEMP1.
DR   InterPro; IPR001881; EGF-like_Ca-bd_dom.
DR   InterPro; IPR013032; EGF-like_CS.
DR   InterPro; IPR000742; EGF-like_dom.
DR   InterPro; IPR000152; EGF-type_Asp/Asn_hydroxyl_site.
DR   InterPro; IPR018097; EGF_Ca-bd_CS.
DR   InterPro; IPR037287; Fibulin_3/4/5.
DR   InterPro; IPR009030; Growth_fac_rcpt_cys_sf.
DR   PANTHER; PTHR44074; PTHR44074; 2.
DR   PANTHER; PTHR44074:SF2; PTHR44074:SF2; 2.
DR   Pfam; PF07645; EGF_CA; 4.
DR   SMART; SM00181; EGF; 3.
DR   SMART; SM00179; EGF_CA; 4.
DR   SUPFAM; SSF57184; SSF57184; 2.
DR   PROSITE; PS00010; ASX_HYDROXYL; 2.
DR   PROSITE; PS01186; EGF_2; 2.
DR   PROSITE; PS50026; EGF_3; 2.
DR   PROSITE; PS01187; EGF_CA; 2.
PE   1: Evidence at protein level;
KW   Disulfide bond {ECO:0000256|SAAS:SAAS00601599};
KW   EGF-like domain {ECO:0000256|PROSITE-ProRule:PRU00076,
KW   ECO:0000256|SAAS:SAAS00602928};
KW   Repeat {ECO:0000256|SAAS:SAAS00594563};
KW   Signal {ECO:0000256|SAM:SignalP}.
FT   SIGNAL        1     17       {ECO:0000256|SAM:SignalP}.
FT   CHAIN        18    413       {ECO:0000256|SAM:SignalP}.
FT                                /FTId=PRO_5014035617.
FT   DOMAIN      173    213       EGF-like. {ECO:0000259|PROSITE:PS50026}.
FT   DOMAIN      214    253       EGF-like. {ECO:0000259|PROSITE:PS50026}.
FT   NON_TER     413    413       {ECO:0000313|EMBL:ALQ33517.1}.
SQ   SEQUENCE   413 AA;  45723 MW;  7A105B1E64DFEF2C CRC64;
     MLKALFLTML TLALVKSQDT EETITYTQCT DGYEWDPVRQ QCKDIDECDI VPDACKGGMK
     CVNHYGGYLC LPKTAQIIVN NEQPQQETQP AEGTSGATTG VVAASSMATS GVLPGGGFVA
     SAAAVAGPEM QTGRNNFVIR RNPADPQRIP SNPSHRIQCA AGYEQSEHNV CQDIDECTAG
     THNCRADQVC INLRGSFACQ CPPGYQKRGE QCVDIDECRT SSYLCQYQCV NEPGKFSCMC
     PQGYQVVRSR TCQDINECET TNECREDEMC WNYHGGFRCY PRNPCQDPYI LTPENRCVCP
     VSNAMCRELP QSIVYKYMSI RSDRSVPSDI FQIQATTIYA NTINTFRIKS GNENGEFYLR
     QTSPVSAMLV LVKSLSGPRE HIVDLEMLTV SSIGTFRTSS VLRLTIIVGP FSF
//
ID   A0A0S2Z4F1_HUMAN        Unreviewed;       493 AA.
AC   A0A0S2Z4F1;
DT   17-FEB-2016, integrated into UniProtKB/TrEMBL.
DT   17-FEB-2016, sequence version 1.
DT   23-MAY-2018, entry version 18.
DE   SubName: Full=EGF containing fibulin-like extracellular matrix protein 1 isoform 1 {ECO:0000313|EMBL:ALQ33516.1};
DE   Flags: Fragment;
GN   Name=EFEMP1 {ECO:0000313|EMBL:ALQ33516.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:ALQ33516.1};
RN   [1] {ECO:0000313|EMBL:ALQ33516.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=26871637; DOI=10.1016/j.cell.2016.01.029;
RA   Yang X., Coulombe-Huntington J., Kang S., Sheynkman G.M., Hao T.,
RA   Richardson A., Sun S., Yang F., Shen Y.A., Murray R., Spirohn K.,
RA   Begg B.E., Duran-Frigola M., MacWilliams A., Pevzner S.J., Zhong Q.,
RA   Trigg S.A., Tam S., Ghamsari L., Sahni N., Yi S., Rodriguez M.D.,
RA   Balcha D., Tan G., Costanzo M., Andrews B., Boone C., Zhou X.J.,
RA   Salehi-Ashtiani K., Charloteaux B., Chen A., Calderwood M.A., Aloy P.,
RA   Roth F.P., Hill D.E., Iakoucheva L.M., Xia Y., Vidal M.;
RT   "Widespread Expansion of Protein Interaction Capabilities by
RT   Alternative Splicing.";
RL   Cell 164:805-817(2016).
CC   -!- CAUTION: Lacks conserved residue(s) required for the propagation
CC       of feature annotation. {ECO:0000256|PROSITE-ProRule:PRU00076}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; KU178058; ALQ33516.1; -; mRNA.
DR   RefSeq; NP_001034437.1; NM_001039348.2.
DR   RefSeq; NP_001034438.1; NM_001039349.2.
DR   UniGene; Hs.732348; -.
DR   UniGene; Hs.76224; -.
DR   ProteinModelPortal; A0A0S2Z4F1; -.
DR   SMR; A0A0S2Z4F1; -.
DR   PRIDE; A0A0S2Z4F1; -.
DR   GeneID; 2202; -.
DR   KEGG; hsa:2202; -.
DR   CTD; 2202; -.
DR   KO; K18262; -.
DR   OMA; PCQDPYV; -.
DR   PhylomeDB; A0A0S2Z4F1; -.
DR   ChiTaRS; EFEMP1; human.
DR   ExpressionAtlas; A0A0S2Z4F1; baseline and differential.
DR   GO; GO:0031012; C:extracellular matrix; IEA:InterPro.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   GO; GO:0005006; F:epidermal growth factor-activated receptor activity; IEA:InterPro.
DR   InterPro; IPR026823; cEGF.
DR   InterPro; IPR032973; EFEMP1.
DR   InterPro; IPR001881; EGF-like_Ca-bd_dom.
DR   InterPro; IPR013032; EGF-like_CS.
DR   InterPro; IPR000742; EGF-like_dom.
DR   InterPro; IPR000152; EGF-type_Asp/Asn_hydroxyl_site.
DR   InterPro; IPR018097; EGF_Ca-bd_CS.
DR   InterPro; IPR037287; Fibulin_3/4/5.
DR   InterPro; IPR009030; Growth_fac_rcpt_cys_sf.
DR   PANTHER; PTHR44074; PTHR44074; 1.
DR   PANTHER; PTHR44074:SF2; PTHR44074:SF2; 1.
DR   Pfam; PF12662; cEGF; 2.
DR   Pfam; PF07645; EGF_CA; 3.
DR   SMART; SM00181; EGF; 5.
DR   SMART; SM00179; EGF_CA; 6.
DR   SUPFAM; SSF57184; SSF57184; 1.
DR   PROSITE; PS00010; ASX_HYDROXYL; 4.
DR   PROSITE; PS01186; EGF_2; 4.
DR   PROSITE; PS50026; EGF_3; 4.
DR   PROSITE; PS01187; EGF_CA; 2.
PE   2: Evidence at transcript level;
KW   Disulfide bond {ECO:0000256|PROSITE-ProRule:PRU00076,
KW   ECO:0000256|SAAS:SAAS00601599};
KW   EGF-like domain {ECO:0000256|PROSITE-ProRule:PRU00076,
KW   ECO:0000256|SAAS:SAAS00602928};
KW   Repeat {ECO:0000256|SAAS:SAAS00594563};
KW   Signal {ECO:0000256|SAM:SignalP}.
FT   SIGNAL        1     17       {ECO:0000256|SAM:SignalP}.
FT   CHAIN        18    493       {ECO:0000256|SAM:SignalP}.
FT                                /FTId=PRO_5006608236.
FT   DOMAIN      173    213       EGF-like. {ECO:0000259|PROSITE:PS50026}.
FT   DOMAIN      214    253       EGF-like. {ECO:0000259|PROSITE:PS50026}.
FT   DOMAIN      254    293       EGF-like. {ECO:0000259|PROSITE:PS50026}.
FT   DOMAIN      294    333       EGF-like. {ECO:0000259|PROSITE:PS50026}.
FT   DISULFID    218    228       {ECO:0000256|PROSITE-ProRule:PRU00076}.
FT   DISULFID    258    268       {ECO:0000256|PROSITE-ProRule:PRU00076}.
FT   NON_TER     493    493       {ECO:0000313|EMBL:ALQ33516.1}.
SQ   SEQUENCE   493 AA;  54641 MW;  128CA5ED140DF414 CRC64;
     MLKALFLTML TLALVKSQDT EETITYTQCT DGYEWDPVRQ QCKDIDECDI VPDACKGGMK
     CVNHYGGYLC LPKTAQIIVN NEQPQQETQP AEGTSGATTG VVAASSMATS GVLPGGGFVA
     SAAAVAGPEM QTGRNNFVIR RNPADPQRIP SNPSHRIQCA AGYEQSEHNV CQDIDECTAG
     THNCRADQVC INLRGSFACQ CPPGYQKRGE QCVDIDECTI PPYCHQRCVN TPGSFYCQCS
     PGFQLAANNY TCVDINECDA SNQCAQQCYN ILGSFICQCN QGYELSSDRL NCEDIDECRT
     SSYLCQYQCV NEPGKFSCMC PQGYQVVRSR TCQDINECET TNECREDEMC WNYHGGFRCY
     PRNPCQDPYI LTPENRCVCP VSNAMCRELP QSIVYKYMSI RSDRSVPSDI FQIQATTIYA
     NTINTFRIKS GNENGEFYLR QTSPVSAMLV LVKSLSGPRE HIVDLEMLTV SSIGTFRTSS
     VLRLTIIVGP FSF
//
ID   B2R6M6_HUMAN            Unreviewed;       493 AA.
AC   B2R6M6;
DT   01-JUL-2008, integrated into UniProtKB/TrEMBL.
DT   01-JUL-2008, sequence version 1.
DT   31-JAN-2018, entry version 70.
DE   SubName: Full=cDNA, FLJ93024, highly similar to Homo sapiens EGF-containing fibulin-like extracellular matrix protein 1 (EFEMP1), transcript variant 1, mRNA {ECO:0000313|EMBL:BAG35523.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAG35523.1};
RN   [1] {ECO:0000313|EMBL:BAG35523.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Wakamatsu A., Yamamoto J., Kimura K., Kaida T., Tsuchiya K., Iida Y.,
RA   Takayama Y., Murakawa K., Kanehori K., Andoh T., Kagawa N., Sato R.,
RA   Kawamura Y., Tanaka S., Kisu Y., Sugano S., Goshima N., Nomura N.,
RA   Isogai T.;
RT   "NEDO functional analysis of protein and research application
RT   project.";
RL   Submitted (JAN-2008) to the EMBL/GenBank/DDBJ databases.
CC   -!- CAUTION: Lacks conserved residue(s) required for the propagation
CC       of feature annotation. {ECO:0000256|PROSITE-ProRule:PRU00076}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK312639; BAG35523.1; -; mRNA.
DR   RefSeq; NP_001034437.1; NM_001039348.2.
DR   UniGene; Hs.732348; -.
DR   UniGene; Hs.76224; -.
DR   PeptideAtlas; B2R6M6; -.
DR   PRIDE; B2R6M6; -.
DR   DNASU; 2202; -.
DR   GeneID; 2202; -.
DR   KEGG; hsa:2202; -.
DR   CTD; 2202; -.
DR   eggNOG; ENOG410IR77; Eukaryota.
DR   eggNOG; ENOG410YCRW; LUCA.
DR   HOVERGEN; HBG051560; -.
DR   KO; K18262; -.
DR   GenomeRNAi; 2202; -.
DR   Genevisible; B2R6M6; HS.
DR   GO; GO:0031012; C:extracellular matrix; IEA:InterPro.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   GO; GO:0005006; F:epidermal growth factor-activated receptor activity; IEA:InterPro.
DR   InterPro; IPR026823; cEGF.
DR   InterPro; IPR032973; EFEMP1.
DR   InterPro; IPR001881; EGF-like_Ca-bd_dom.
DR   InterPro; IPR013032; EGF-like_CS.
DR   InterPro; IPR000742; EGF-like_dom.
DR   InterPro; IPR000152; EGF-type_Asp/Asn_hydroxyl_site.
DR   InterPro; IPR018097; EGF_Ca-bd_CS.
DR   InterPro; IPR037287; Fibulin_3/4/5.
DR   InterPro; IPR009030; Growth_fac_rcpt_cys_sf.
DR   PANTHER; PTHR44074; PTHR44074; 1.
DR   PANTHER; PTHR44074:SF2; PTHR44074:SF2; 1.
DR   Pfam; PF12662; cEGF; 2.
DR   Pfam; PF07645; EGF_CA; 3.
DR   SMART; SM00181; EGF; 5.
DR   SMART; SM00179; EGF_CA; 6.
DR   SUPFAM; SSF57184; SSF57184; 1.
DR   PROSITE; PS00010; ASX_HYDROXYL; 4.
DR   PROSITE; PS01186; EGF_2; 4.
DR   PROSITE; PS50026; EGF_3; 4.
DR   PROSITE; PS01187; EGF_CA; 2.
PE   2: Evidence at transcript level;
KW   Calcium {ECO:0000256|SAAS:SAAS00909960};
KW   Disulfide bond {ECO:0000256|PROSITE-ProRule:PRU00076,
KW   ECO:0000256|SAAS:SAAS00601599};
KW   EGF-like domain {ECO:0000256|PROSITE-ProRule:PRU00076,
KW   ECO:0000256|SAAS:SAAS00032677};
KW   Repeat {ECO:0000256|SAAS:SAAS00594563};
KW   Signal {ECO:0000256|SAM:SignalP}.
FT   SIGNAL        1     17       {ECO:0000256|SAM:SignalP}.
FT   CHAIN        18    493       {ECO:0000256|SAM:SignalP}.
FT                                /FTId=PRO_5002781797.
FT   DOMAIN      173    213       EGF-like. {ECO:0000259|PROSITE:PS50026}.
FT   DOMAIN      214    253       EGF-like. {ECO:0000259|PROSITE:PS50026}.
FT   DOMAIN      254    293       EGF-like. {ECO:0000259|PROSITE:PS50026}.
FT   DOMAIN      294    333       EGF-like. {ECO:0000259|PROSITE:PS50026}.
FT   DISULFID    218    228       {ECO:0000256|PROSITE-ProRule:PRU00076}.
FT   DISULFID    258    268       {ECO:0000256|PROSITE-ProRule:PRU00076}.
SQ   SEQUENCE   493 AA;  54627 MW;  FE5CA5F5AFAEECAF CRC64;
     MLKALFLTML TLALVKSQDT EETITYTQCT DGYEWDPVRQ QCKDIDECDI VPDACKGGMK
     CVNHYGGYLC LPKTAQIIVN NEQPQQETQP AEGTSGATTG VVAASSMATS GVLPGGGFVA
     SAAAVAGPEM QTGRNNFVIR RNPADPQRIP SNPSHRIQCA AGYEQSEHNV CQDIDECTAG
     THNCRADQVC INLRGSFACQ CPPGYQKRGE QCVDIDECTI PPYCHQRCVN TPGSFYCQCS
     PGFQLAANNY TCVDINECDA SNQCAQQCYN ILGSFICQCN QGYELSSDRL NCEDIDECRT
     SSYLCQYQCV NEPGKFSCMC PQGYQVVRSR TCQDINECET TNECREDEMC WNYHGGFRCY
     PRNPCQDPYI LTPENRCVCP VSNAMCRELP QSIVYKYMSI RSDRSVPSDI FQIQATTVYA
     NTINTFRIKS GNENGEFYLR QTSPVSAMLV LVKSLSGPRE HIVDLEMLTV SSIGTFRTSS
     VLRLTIIVGP FSF
//
ID   FBLN3_HUMAN             Reviewed;         493 AA.
AC   Q12805; A8K3I4; B4DW75; D6W5D2; Q541U7;
DT   01-DEC-2000, integrated into UniProtKB/Swiss-Prot.
DT   01-DEC-2000, sequence version 2.
DT   23-MAY-2018, entry version 186.
DE   RecName: Full=EGF-containing fibulin-like extracellular matrix protein 1;
DE   AltName: Full=Extracellular protein S1-5;
DE   AltName: Full=Fibrillin-like protein;
DE   AltName: Full=Fibulin-3;
DE            Short=FIBL-3;
DE   Flags: Precursor;
GN   Name=EFEMP1; Synonyms=FBLN3, FBNL;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND POSSIBLE ALTERNATIVE SPLICING.
RC   TISSUE=Skin;
RX   PubMed=7799918; DOI=10.1128/MCB.15.1.120;
RA   Lecka-Czernik B., Lumpkin C.K. Jr., Goldstein S.;
RT   "An overexpressed gene transcript in senescent and quiescent human
RT   fibroblasts encoding a novel protein in the epidermal growth factor-
RT   like repeat family stimulates DNA synthesis.";
RL   Mol. Cell. Biol. 15:120-128(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=8812496; DOI=10.1006/geno.1996.0402;
RA   Ikegawa S., Toda T., Okui K., Nakamura Y.;
RT   "Structure and chromosomal assignment of the human S1-5 gene (FBNL)
RT   that is highly homologous to fibrillin.";
RL   Genomics 35:590-592(1996).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=10601734; DOI=10.1016/S0945-053X(99)00038-4;
RA   Giltay R., Timpl R., Kostka G.;
RT   "Sequence, recombinant expression and tissue localization of two novel
RT   extracellular matrix proteins, fibulin-3 and fibulin-4.";
RL   Matrix Biol. 18:469-480(1999).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=11262647; DOI=10.1076/opge.22.1.27.2239;
RA   Sauer C.G., White K., Kellner U., Rudolph G., Jurklies B.,
RA   Pauleikhoff D., Weber B.H.;
RT   "EFEMP1 is not associated with sporadic early onset drusen.";
RL   Ophthalmic Genet. 22:27-34(2001).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 5).
RC   TISSUE=Synovium;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   TISSUE SPECIFICITY, AND CHARACTERIZATION OF VARIANT DHRD TRP-345.
RX   PubMed=12242346; DOI=10.1073/pnas.202491599;
RA   Marmorstein L.Y., Munier F.L., Arsenijevic Y., Schorderet D.F.,
RA   McLaughlin P.J., Chung D., Traboulsi E., Marmorstein A.D.;
RT   "Aberrant accumulation of EFEMP1 underlies drusen formation in
RT   Malattia Leventinese and age-related macular degeneration.";
RL   Proc. Natl. Acad. Sci. U.S.A. 99:13067-13072(2002).
RN   [10]
RP   INTERACTION WITH TIMP3.
RX   PubMed=15123717; DOI=10.1074/jbc.M403026200;
RA   Klenotic P.A., Munier F.L., Marmorstein L.Y., Anand-Apte B.;
RT   "Tissue inhibitor of metalloproteinases-3 (TIMP-3) is a binding
RT   partner of epithelial growth factor-containing fibulin-like
RT   extracellular matrix protein 1 (EFEMP1). Implications for macular
RT   degenerations.";
RL   J. Biol. Chem. 279:30469-30473(2004).
RN   [11]
RP   FUNCTION IN EGFR ACTIVATION.
RX   PubMed=19804359; DOI=10.1515/BC.2009.140;
RA   Camaj P., Seeliger H., Ischenko I., Krebs S., Blum H., De Toni E.N.,
RA   Faktorova D., Jauch K.W., Bruns C.J.;
RT   "EFEMP1 binds the EGF receptor and activates MAPK and Akt pathways in
RT   pancreatic carcinoma cells.";
RL   Biol. Chem. 390:1293-1302(2009).
RN   [12]
RP   INTERACTION WITH ECM1.
RX   PubMed=19275936; DOI=10.1016/j.matbio.2009.02.003;
RA   Sercu S., Lambeir A.M., Steenackers E., El Ghalbzouri A.,
RA   Geentjens K., Sasaki T., Oyama N., Merregaert J.;
RT   "ECM1 interacts with fibulin-3 and the beta 3 chain of laminin 332
RT   through its serum albumin subdomain-like 2 domain.";
RL   Matrix Biol. 28:160-169(2009).
RN   [13]
RP   FUNCTION.
RX   PubMed=19887559; DOI=10.1158/1541-7786.MCR-09-0207;
RA   Hu B., Thirtamara-Rajamani K.K., Sim H., Viapiano M.S.;
RT   "Fibulin-3 is uniquely upregulated in malignant gliomas and promotes
RT   tumor cell motility and invasion.";
RL   Mol. Cancer Res. 7:1756-1770(2009).
RN   [14]
RP   FUNCTION, SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=20005202; DOI=10.1016/j.bbrc.2009.12.034;
RA   Wakabayashi T., Matsumine A., Nakazora S., Hasegawa M., Iino T.,
RA   Ota H., Sonoda H., Sudo A., Uchida A.;
RT   "Fibulin-3 negatively regulates chondrocyte differentiation.";
RL   Biochem. Biophys. Res. Commun. 391:1116-1121(2010).
RN   [15]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22905912; DOI=10.1021/pr300539b;
RA   Rosenow A., Noben J.P., Jocken J., Kallendrusch S.,
RA   Fischer-Posovszky P., Mariman E.C., Renes J.;
RT   "Resveratrol-induced changes of the human adipocyte secretion
RT   profile.";
RL   J. Proteome Res. 11:4733-4743(2012).
RN   [16]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [17]
RP   VARIANT DHRD TRP-345, AND VARIANT PHE-220.
RX   PubMed=10369267; DOI=10.1038/9722;
RA   Stone E.M., Lotery A.J., Munier F.L., Heon E., Piguet B., Guymer R.H.,
RA   Vandenburgh K., Cousin P., Nishimura D., Swiderski R.E., Silvestri G.,
RA   Mackey D.A., Hagerman G.S., Bird A.C., Sheffield V.C.,
RA   Schorderet D.F.;
RT   "A single EFEMP1 mutation associated with both malattia Leventinese
RT   and Doyne honeycomb retinal dystrophy.";
RL   Nat. Genet. 22:199-202(1999).
RN   [18]
RP   VARIANT DHRD TRP-345.
RX   PubMed=11384588; DOI=10.1016/S0002-9394(00)00926-0;
RA   Matsumoto M., Traboulsi E.I.;
RT   "Dominant radial drusen and Arg345Trp EFEMP1 mutation.";
RL   Am. J. Ophthalmol. 131:810-812(2001).
RN   [19]
RP   CHARACTERIZATION OF VARIANT DHRD TRP-345.
RX   PubMed=17666404; DOI=10.1093/hmg/ddm198;
RA   Fu L., Garland D., Yang Z., Shukla D., Rajendran A., Pearson E.,
RA   Stone E.M., Zhang K., Pierce E.A.;
RT   "The R345W mutation in EFEMP1 is pathogenic and causes AMD-like
RT   deposits in mice.";
RL   Hum. Mol. Genet. 16:2411-2422(2007).
CC   -!- FUNCTION: Binds EGFR, the EGF receptor, inducing EGFR
CC       autophosphorylation and the activation of downstream signaling
CC       pathways. May play a role in cell adhesion and migration. May
CC       function as a negative regulator of chondrocyte differentiation.
CC       In the olfactory epithelium, it may regulate glial cell migration,
CC       differentiation and the ability of glial cells to support neuronal
CC       neurite outgrowth. {ECO:0000269|PubMed:19804359,
CC       ECO:0000269|PubMed:19887559, ECO:0000269|PubMed:20005202}.
CC   -!- SUBUNIT: Interacts with ECM1. Interacts with TIMP3.
CC       {ECO:0000269|PubMed:15123717, ECO:0000269|PubMed:19275936}.
CC   -!- INTERACTION:
CC       Q9WMX2:- (xeno); NbExp=2; IntAct=EBI-536772, EBI-6863748;
CC       P10398:ARAF; NbExp=3; IntAct=EBI-536772, EBI-365961;
CC       P54259:ATN1; NbExp=3; IntAct=EBI-536772, EBI-945980;
CC       P46379:BAG6; NbExp=3; IntAct=EBI-536772, EBI-347552;
CC       P53673:CRYBA4; NbExp=3; IntAct=EBI-536772, EBI-7519711;
CC       P50222:MEOX2; NbExp=5; IntAct=EBI-536772, EBI-748397;
CC       Q6FHY5:MEOX2; NbExp=3; IntAct=EBI-536772, EBI-16439278;
CC       Q9NPQ8-4:RIC8A; NbExp=3; IntAct=EBI-536772, EBI-9091816;
CC       O43765:SGTA; NbExp=12; IntAct=EBI-536772, EBI-347996;
CC       Q12933:TRAF2; NbExp=11; IntAct=EBI-536772, EBI-355744;
CC       Q86UY0:TXNDC5; NbExp=3; IntAct=EBI-536772, EBI-2825190;
CC       Q9UHD9:UBQLN2; NbExp=4; IntAct=EBI-536772, EBI-947187;
CC   -!- SUBCELLULAR LOCATION: Secreted, extracellular space {ECO:0000250}.
CC       Secreted, extracellular space, extracellular matrix {ECO:0000250}.
CC       Note=Localizes to the lamina propria underneath the olfactory
CC       epithelium. {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=5;
CC         Comment=Experimental confirmation may be lacking for some
CC         isoforms.;
CC       Name=1;
CC         IsoId=Q12805-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q12805-2; Sequence=VSP_001392;
CC       Name=3;
CC         IsoId=Q12805-3; Sequence=VSP_001393;
CC       Name=4;
CC         IsoId=Q12805-4; Sequence=VSP_001394;
CC       Name=5;
CC         IsoId=Q12805-5; Sequence=VSP_054372, VSP_054373;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: In the eye, associated with photoreceptor
CC       outer and inner segment regions, the nerve fiber layer, outer
CC       nuclear layer and inner and outer plexiform layers of the retina.
CC       {ECO:0000269|PubMed:12242346, ECO:0000269|PubMed:20005202}.
CC   -!- DISEASE: Doyne honeycomb retinal dystrophy (DHRD) [MIM:126600]:
CC       Autosomal dominant disease characterized by yellow-white deposits
CC       known as drusen that accumulate beneath the retinal pigment
CC       epithelium. {ECO:0000269|PubMed:10369267,
CC       ECO:0000269|PubMed:11384588, ECO:0000269|PubMed:12242346,
CC       ECO:0000269|PubMed:17666404}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- MISCELLANEOUS: Up-regulated in malignant gliomas. May increase
CC       glioma cell adhesiveness and invasive properties.
CC   -!- SIMILARITY: Belongs to the fibulin family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Mutations of the EFEMP1 gene; Note=Retina
CC       International's Scientific Newsletter;
CC       URL="http://www.retina-international.org/files/sci-news/efempmut.htm";
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/EFEMP1ID49818ch2p16.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U03877; AAA65590.1; -; mRNA.
DR   EMBL; AY004330; AAK11491.1; -; Genomic_DNA.
DR   EMBL; AY004321; AAK11491.1; JOINED; Genomic_DNA.
DR   EMBL; AY004322; AAK11491.1; JOINED; Genomic_DNA.
DR   EMBL; AY004325; AAK11491.1; JOINED; Genomic_DNA.
DR   EMBL; AY004324; AAK11491.1; JOINED; Genomic_DNA.
DR   EMBL; AY004323; AAK11491.1; JOINED; Genomic_DNA.
DR   EMBL; AY004326; AAK11491.1; JOINED; Genomic_DNA.
DR   EMBL; AY004328; AAK11491.1; JOINED; Genomic_DNA.
DR   EMBL; AY004329; AAK11491.1; JOINED; Genomic_DNA.
DR   EMBL; AY004327; AAK11491.1; JOINED; Genomic_DNA.
DR   EMBL; AK290599; BAF83288.1; -; mRNA.
DR   EMBL; AK301402; BAG62937.1; -; mRNA.
DR   EMBL; AC010895; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC096549; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471053; EAX00080.1; -; Genomic_DNA.
DR   EMBL; CH471053; EAX00081.1; -; Genomic_DNA.
DR   EMBL; CH471053; EAX00082.1; -; Genomic_DNA.
DR   EMBL; BC014410; AAH14410.1; -; mRNA.
DR   EMBL; BC098561; AAH98561.1; -; mRNA.
DR   CCDS; CCDS1857.1; -. [Q12805-1]
DR   PIR; I38449; I38449.
DR   RefSeq; NP_001034437.1; NM_001039348.2. [Q12805-1]
DR   RefSeq; NP_001034438.1; NM_001039349.2. [Q12805-1]
DR   UniGene; Hs.732348; -.
DR   UniGene; Hs.76224; -.
DR   ProteinModelPortal; Q12805; -.
DR   SMR; Q12805; -.
DR   BioGrid; 108496; 57.
DR   IntAct; Q12805; 44.
DR   MINT; Q12805; -.
DR   STRING; 9606.ENSP00000347596; -.
DR   iPTMnet; Q12805; -.
DR   PhosphoSitePlus; Q12805; -.
DR   SwissPalm; Q12805; -.
DR   BioMuta; EFEMP1; -.
DR   DMDM; 9973182; -.
DR   MaxQB; Q12805; -.
DR   PaxDb; Q12805; -.
DR   PeptideAtlas; Q12805; -.
DR   PRIDE; Q12805; -.
DR   DNASU; 2202; -.
DR   Ensembl; ENST00000355426; ENSP00000347596; ENSG00000115380. [Q12805-1]
DR   Ensembl; ENST00000394555; ENSP00000378058; ENSG00000115380. [Q12805-1]
DR   GeneID; 2202; -.
DR   KEGG; hsa:2202; -.
DR   UCSC; uc002rzi.4; human. [Q12805-1]
DR   CTD; 2202; -.
DR   DisGeNET; 2202; -.
DR   EuPathDB; HostDB:ENSG00000115380.19; -.
DR   GeneCards; EFEMP1; -.
DR   HGNC; HGNC:3218; EFEMP1.
DR   HPA; CAB016368; -.
DR   HPA; HPA049806; -.
DR   HPA; HPA070841; -.
DR   HPA; HPA071588; -.
DR   MalaCards; EFEMP1; -.
DR   MIM; 126600; phenotype.
DR   MIM; 601548; gene.
DR   neXtProt; NX_Q12805; -.
DR   OpenTargets; ENSG00000115380; -.
DR   Orphanet; 75376; Familial drusen.
DR   PharmGKB; PA27652; -.
DR   eggNOG; ENOG410IR77; Eukaryota.
DR   eggNOG; ENOG410YCRW; LUCA.
DR   GeneTree; ENSGT00760000118806; -.
DR   HOGENOM; HOG000234337; -.
DR   HOVERGEN; HBG051560; -.
DR   InParanoid; Q12805; -.
DR   KO; K18262; -.
DR   OMA; PCQDPYV; -.
DR   OrthoDB; EOG091G04QP; -.
DR   PhylomeDB; Q12805; -.
DR   TreeFam; TF317514; -.
DR   Reactome; R-HSA-2129379; Molecules associated with elastic fibres.
DR   ChiTaRS; EFEMP1; human.
DR   GeneWiki; EFEMP1; -.
DR   GenomeRNAi; 2202; -.
DR   PRO; PR:Q12805; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   Bgee; ENSG00000115380; -.
DR   CleanEx; HS_EFEMP1; -.
DR   ExpressionAtlas; Q12805; baseline and differential.
DR   Genevisible; Q12805; HS.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0005576; C:extracellular region; HDA:BHF-UCL.
DR   GO; GO:0005615; C:extracellular space; IDA:UniProtKB.
DR   GO; GO:0005578; C:proteinaceous extracellular matrix; TAS:ProtInc.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   GO; GO:0005154; F:epidermal growth factor receptor binding; IDA:UniProtKB.
DR   GO; GO:0005006; F:epidermal growth factor-activated receptor activity; IDA:UniProtKB.
DR   GO; GO:0008083; F:growth factor activity; IEA:UniProtKB-KW.
DR   GO; GO:0043010; P:camera-type eye development; IEP:UniProtKB.
DR   GO; GO:0048048; P:embryonic eye morphogenesis; IEP:UniProtKB.
DR   GO; GO:0007173; P:epidermal growth factor receptor signaling pathway; IDA:UniProtKB.
DR   GO; GO:0032331; P:negative regulation of chondrocyte differentiation; IDA:UniProtKB.
DR   GO; GO:0018108; P:peptidyl-tyrosine phosphorylation; IDA:UniProtKB.
DR   GO; GO:0048050; P:post-embryonic eye morphogenesis; IEP:UniProtKB.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; IDA:UniProtKB.
DR   GO; GO:0007601; P:visual perception; TAS:ProtInc.
DR   InterPro; IPR026823; cEGF.
DR   InterPro; IPR032973; EFEMP1.
DR   InterPro; IPR001881; EGF-like_Ca-bd_dom.
DR   InterPro; IPR013032; EGF-like_CS.
DR   InterPro; IPR000742; EGF-like_dom.
DR   InterPro; IPR000152; EGF-type_Asp/Asn_hydroxyl_site.
DR   InterPro; IPR018097; EGF_Ca-bd_CS.
DR   InterPro; IPR037287; Fibulin_3/4/5.
DR   InterPro; IPR009030; Growth_fac_rcpt_cys_sf.
DR   PANTHER; PTHR44074; PTHR44074; 1.
DR   PANTHER; PTHR44074:SF2; PTHR44074:SF2; 1.
DR   Pfam; PF12662; cEGF; 2.
DR   Pfam; PF07645; EGF_CA; 3.
DR   SMART; SM00181; EGF; 5.
DR   SMART; SM00179; EGF_CA; 6.
DR   SUPFAM; SSF57184; SSF57184; 1.
DR   PROSITE; PS00010; ASX_HYDROXYL; 4.
DR   PROSITE; PS01186; EGF_2; 4.
DR   PROSITE; PS50026; EGF_3; 4.
DR   PROSITE; PS01187; EGF_CA; 6.
PE   1: Evidence at protein level;
KW   Alternative splicing; Calcium; Complete proteome; Disease mutation;
KW   Disulfide bond; EGF-like domain; Extracellular matrix; Glycoprotein;
KW   Growth factor; Polymorphism; Reference proteome; Repeat; Secreted;
KW   Signal.
FT   SIGNAL        1     17       {ECO:0000255}.
FT   CHAIN        18    493       EGF-containing fibulin-like extracellular
FT                                matrix protein 1.
FT                                /FTId=PRO_0000007570.
FT   DOMAIN       26     71       EGF-like 1; atypical.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DOMAIN      173    213       EGF-like 2; calcium-binding.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DOMAIN      214    253       EGF-like 3; calcium-binding.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DOMAIN      254    293       EGF-like 4; calcium-binding.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DOMAIN      294    333       EGF-like 5; calcium-binding.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DOMAIN      334    378       EGF-like 6; calcium-binding.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   REGION      259    493       Mediates interaction with TIMP3.
FT                                {ECO:0000269|PubMed:15123717}.
FT   CARBOHYD    249    249       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID    177    190       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID    184    199       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID    201    212       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID    218    228       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID    224    237       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID    239    252       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID    258    268       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID    264    277       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID    279    292       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID    298    309       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID    305    318       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID    320    332       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID    338    350       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID    344    359       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID    365    377       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   VAR_SEQ       1     58       Missing (in isoform 5).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_054372.
FT   VAR_SEQ       1      8       Missing (in isoform 2). {ECO:0000305}.
FT                                /FTId=VSP_001392.
FT   VAR_SEQ      58     58       Missing (in isoform 3). {ECO:0000305}.
FT                                /FTId=VSP_001393.
FT   VAR_SEQ     106    106       Missing (in isoform 4). {ECO:0000305}.
FT                                /FTId=VSP_001394.
FT   VAR_SEQ     214    293       Missing (in isoform 5).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_054373.
FT   VARIANT     220    220       I -> F (in dbSNP:rs748965004).
FT                                {ECO:0000269|PubMed:10369267}.
FT                                /FTId=VAR_009512.
FT   VARIANT     345    345       R -> W (in DHRD; misfolded, accumulates
FT                                in cells due to inefficient secretion;
FT                                induces the formation of deposits between
FT                                Bruch's membrane and the retinal pigment
FT                                epithelium where it accumulates;
FT                                dbSNP:rs121434491).
FT                                {ECO:0000269|PubMed:10369267,
FT                                ECO:0000269|PubMed:11384588,
FT                                ECO:0000269|PubMed:12242346,
FT                                ECO:0000269|PubMed:17666404}.
FT                                /FTId=VAR_009513.
SQ   SEQUENCE   493 AA;  54641 MW;  128CA5ED140DF414 CRC64;
     MLKALFLTML TLALVKSQDT EETITYTQCT DGYEWDPVRQ QCKDIDECDI VPDACKGGMK
     CVNHYGGYLC LPKTAQIIVN NEQPQQETQP AEGTSGATTG VVAASSMATS GVLPGGGFVA
     SAAAVAGPEM QTGRNNFVIR RNPADPQRIP SNPSHRIQCA AGYEQSEHNV CQDIDECTAG
     THNCRADQVC INLRGSFACQ CPPGYQKRGE QCVDIDECTI PPYCHQRCVN TPGSFYCQCS
     PGFQLAANNY TCVDINECDA SNQCAQQCYN ILGSFICQCN QGYELSSDRL NCEDIDECRT
     SSYLCQYQCV NEPGKFSCMC PQGYQVVRSR TCQDINECET TNECREDEMC WNYHGGFRCY
     PRNPCQDPYI LTPENRCVCP VSNAMCRELP QSIVYKYMSI RSDRSVPSDI FQIQATTIYA
     NTINTFRIKS GNENGEFYLR QTSPVSAMLV LVKSLSGPRE HIVDLEMLTV SSIGTFRTSS
     VLRLTIIVGP FSF
//
ID   A0A087X0H5_HUMAN        Unreviewed;       645 AA.
AC   A0A087X0H5;
DT   29-OCT-2014, integrated into UniProtKB/TrEMBL.
DT   29-OCT-2014, sequence version 1.
DT   23-MAY-2018, entry version 29.
DE   SubName: Full=Growth hormone receptor {ECO:0000313|Ensembl:ENSP00000483403};
GN   Name=GHR {ECO:0000313|Ensembl:ENSP00000483403};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000483403, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Ensembl:ENSP00000483403, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15372022; DOI=10.1038/nature02919;
RA   Schmutz J., Martin J., Terry A., Couronne O., Grimwood J., Lowry S.,
RA   Gordon L.A., Scott D., Xie G., Huang W., Hellsten U., Tran-Gyamfi M.,
RA   She X., Prabhakar S., Aerts A., Altherr M., Bajorek E., Black S.,
RA   Branscomb E., Caoile C., Challacombe J.F., Chan Y.M., Denys M.,
RA   Detter J.C., Escobar J., Flowers D., Fotopulos D., Glavina T.,
RA   Gomez M., Gonzales E., Goodstein D., Grigoriev I., Groza M.,
RA   Hammon N., Hawkins T., Haydu L., Israni S., Jett J., Kadner K.,
RA   Kimball H., Kobayashi A., Lopez F., Lou Y., Martinez D., Medina C.,
RA   Morgan J., Nandkeshwar R., Noonan J.P., Pitluck S., Pollard M.,
RA   Predki P., Priest J., Ramirez L., Retterer J., Rodriguez A.,
RA   Rogers S., Salamov A., Salazar A., Thayer N., Tice H., Tsai M.,
RA   Ustaszewska A., Vo N., Wheeler J., Wu K., Yang J., Dickson M.,
RA   Cheng J.-F., Eichler E.E., Olsen A., Pennacchio L.A., Rokhsar D.S.,
RA   Richardson P., Lucas S.M., Myers R.M., Rubin E.M.;
RT   "The DNA sequence and comparative analysis of human chromosome 5.";
RL   Nature 431:268-274(2004).
RN   [2] {ECO:0000213|PubMed:24275569}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [3] {ECO:0000313|Ensembl:ENSP00000483403}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (SEP-2014) to UniProtKB.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AC093225; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC113368; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC114941; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC116343; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; KC876969; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; KF457892; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   RefSeq; NP_001229328.1; NM_001242399.2.
DR   UniGene; Hs.125180; -.
DR   UniGene; Hs.684632; -.
DR   UniGene; Hs.688223; -.
DR   ProteinModelPortal; A0A087X0H5; -.
DR   SMR; A0A087X0H5; -.
DR   PRIDE; A0A087X0H5; -.
DR   Ensembl; ENST00000620156; ENSP00000483403; ENSG00000112964.
DR   GeneID; 2690; -.
DR   UCSC; uc021xxv.1; human.
DR   CTD; 2690; -.
DR   EuPathDB; HostDB:ENSG00000112964.13; -.
DR   HGNC; HGNC:4263; GHR.
DR   OpenTargets; ENSG00000112964; -.
DR   eggNOG; ENOG410IFQI; Eukaryota.
DR   eggNOG; ENOG410XTHJ; LUCA.
DR   GeneTree; ENSGT00530000063112; -.
DR   OMA; IDFYAQV; -.
DR   OrthoDB; EOG091G03CN; -.
DR   ChiTaRS; GHR; human.
DR   GenomeRNAi; 2690; -.
DR   Proteomes; UP000005640; Chromosome 5.
DR   Bgee; ENSG00000112964; -.
DR   ExpressionAtlas; A0A087X0H5; baseline and differential.
DR   GO; GO:0036464; C:cytoplasmic ribonucleoprotein granule; IDA:HPA.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005615; C:extracellular space; IEA:Ensembl.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005739; C:mitochondrion; IEA:Ensembl.
DR   GO; GO:0043025; C:neuronal cell body; IEA:Ensembl.
DR   GO; GO:0005634; C:nucleus; IEA:Ensembl.
DR   GO; GO:0005886; C:plasma membrane; IDA:HPA.
DR   GO; GO:0004903; F:growth hormone receptor activity; IEA:Ensembl.
DR   GO; GO:0019901; F:protein kinase binding; IEA:Ensembl.
DR   GO; GO:0019903; F:protein phosphatase binding; IEA:Ensembl.
DR   GO; GO:0042169; F:SH2 domain binding; IEA:Ensembl.
DR   GO; GO:0042976; P:activation of Janus kinase activity; IEA:Ensembl.
DR   GO; GO:0000187; P:activation of MAPK activity; IEA:Ensembl.
DR   GO; GO:0060351; P:cartilage development involved in endochondral bone morphogenesis; IEA:Ensembl.
DR   GO; GO:0032869; P:cellular response to insulin stimulus; IEA:Ensembl.
DR   GO; GO:0060396; P:growth hormone receptor signaling pathway; IEA:Ensembl.
DR   GO; GO:0009755; P:hormone-mediated signaling pathway; IEA:Ensembl.
DR   GO; GO:0007259; P:JAK-STAT cascade; IEA:Ensembl.
DR   GO; GO:1901215; P:negative regulation of neuron death; IEA:Ensembl.
DR   GO; GO:0045597; P:positive regulation of cell differentiation; IEA:Ensembl.
DR   GO; GO:0032094; P:response to food; IEA:Ensembl.
DR   GO; GO:0051384; P:response to glucocorticoid; IEA:Ensembl.
DR   GO; GO:0070555; P:response to interleukin-1; IEA:Ensembl.
DR   GO; GO:0043278; P:response to morphine; IEA:Ensembl.
DR   CDD; cd00063; FN3; 1.
DR   Gene3D; 2.60.40.10; -; 2.
DR   InterPro; IPR003961; FN3_dom.
DR   InterPro; IPR036116; FN3_sf.
DR   InterPro; IPR025871; GHBP.
DR   InterPro; IPR015152; Growth/epo_recpt_lig-bind.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR003528; Long_hematopoietin_rcpt_CS.
DR   Pfam; PF09067; EpoR_lig-bind; 1.
DR   Pfam; PF00041; fn3; 1.
DR   Pfam; PF12772; GHBP; 1.
DR   SUPFAM; SSF49265; SSF49265; 2.
DR   PROSITE; PS50853; FN3; 1.
DR   PROSITE; PS01352; HEMATOPO_REC_L_F1; 1.
PE   1: Evidence at protein level;
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   Membrane {ECO:0000256|SAM:Phobius};
KW   Proteomics identification {ECO:0000213|PeptideAtlas:A0A087X0H5};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640};
KW   Signal {ECO:0000256|SAM:SignalP};
KW   Transmembrane {ECO:0000256|SAM:Phobius};
KW   Transmembrane helix {ECO:0000256|SAM:Phobius}.
FT   SIGNAL        1     25       {ECO:0000256|SAM:SignalP}.
FT   CHAIN        26    645       {ECO:0000256|SAM:SignalP}.
FT                                /FTId=PRO_5001832168.
FT   TRANSMEM    271    294       Helical. {ECO:0000256|SAM:Phobius}.
FT   DOMAIN      158    261       Fibronectin type-III.
FT                                {ECO:0000259|PROSITE:PS50853}.
SQ   SEQUENCE   645 AA;  72243 MW;  D757356B10C5D250 CRC64;
     MNWGPTGMDL WQLLLTLALA GSSDAFSGSE ATAAILSRAP WSLQSVNPGL KTNSSKEPKF
     TKCRSPERET FSCHWTDEVH HGTKNLGPIQ LFYTRRNTQE WTQEWKECPD YVSAGENSCY
     FNSSFTSIWI PYCIKLTSNG GTVDEKCFSV DEIVQPDPPI ALNWTLLNVS LTGIHADIQV
     RWEAPRNADI QKGWMVLEYE LQYKEVNETK WKMMDPILTT SVPVYSLKVD KEYEVRVRSK
     QRNSGNYGEF SEVLYVTLPQ MSQFTCEEDF YFPWLLIIIF GIFGLTVMLF VFLFSKQQRI
     KMLILPPVPV PKIKGIDPDL LKEGKLEEVN TILAIHDSYK PEFHSDDSWV EFIELDIDEP
     DEKTEESDTD RLLSSDHEKS HSNLGVKDGD SGRTSCCEPD ILETDFNAND IHEGTSEVAQ
     PQRLKGEADL LCLDQKNQNN SPYHDACPAT QQPSVIQAEK NKPQPLPTEG AESTHQAAHI
     QLSNPSSLSN IDFYAQVSDI TPAGSVVLSP GQKNKAGMSQ CDMHPEMVSL CQENFLMDNA
     YFCEADAKKC IPVAPHIKVE SHIQPSLNQE DIYITTESLT TAAGRPGTGE HVPGSEMPVP
     DYTSIHIVQS PQGLILNATA LPLPDKEFLS SCGYVSTDQL NKIMP
//
ID   A0A087X162_HUMAN        Unreviewed;       295 AA.
AC   A0A087X162;
DT   29-OCT-2014, integrated into UniProtKB/TrEMBL.
DT   29-OCT-2014, sequence version 1.
DT   23-MAY-2018, entry version 27.
DE   SubName: Full=Growth hormone receptor {ECO:0000313|Ensembl:ENSP00000483926};
GN   Name=GHR {ECO:0000313|Ensembl:ENSP00000483926};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000483926, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Ensembl:ENSP00000483926, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15372022; DOI=10.1038/nature02919;
RA   Schmutz J., Martin J., Terry A., Couronne O., Grimwood J., Lowry S.,
RA   Gordon L.A., Scott D., Xie G., Huang W., Hellsten U., Tran-Gyamfi M.,
RA   She X., Prabhakar S., Aerts A., Altherr M., Bajorek E., Black S.,
RA   Branscomb E., Caoile C., Challacombe J.F., Chan Y.M., Denys M.,
RA   Detter J.C., Escobar J., Flowers D., Fotopulos D., Glavina T.,
RA   Gomez M., Gonzales E., Goodstein D., Grigoriev I., Groza M.,
RA   Hammon N., Hawkins T., Haydu L., Israni S., Jett J., Kadner K.,
RA   Kimball H., Kobayashi A., Lopez F., Lou Y., Martinez D., Medina C.,
RA   Morgan J., Nandkeshwar R., Noonan J.P., Pitluck S., Pollard M.,
RA   Predki P., Priest J., Ramirez L., Retterer J., Rodriguez A.,
RA   Rogers S., Salamov A., Salazar A., Thayer N., Tice H., Tsai M.,
RA   Ustaszewska A., Vo N., Wheeler J., Wu K., Yang J., Dickson M.,
RA   Cheng J.-F., Eichler E.E., Olsen A., Pennacchio L.A., Rokhsar D.S.,
RA   Richardson P., Lucas S.M., Myers R.M., Rubin E.M.;
RT   "The DNA sequence and comparative analysis of human chromosome 5.";
RL   Nature 431:268-274(2004).
RN   [2] {ECO:0000313|Ensembl:ENSP00000483926}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (SEP-2014) to UniProtKB.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AC093225; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC113368; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC114941; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC116343; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; KC876969; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; KF457892; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   RefSeq; NP_001229391.1; NM_001242462.1.
DR   UniGene; Hs.125180; -.
DR   UniGene; Hs.684632; -.
DR   UniGene; Hs.688223; -.
DR   ProteinModelPortal; A0A087X162; -.
DR   SMR; A0A087X162; -.
DR   PeptideAtlas; A0A087X162; -.
DR   PRIDE; A0A087X162; -.
DR   Ensembl; ENST00000622294; ENSP00000483926; ENSG00000112964.
DR   GeneID; 2690; -.
DR   UCSC; uc021xyc.1; human.
DR   CTD; 2690; -.
DR   EuPathDB; HostDB:ENSG00000112964.13; -.
DR   HGNC; HGNC:4263; GHR.
DR   OpenTargets; ENSG00000112964; -.
DR   eggNOG; ENOG410IFQI; Eukaryota.
DR   eggNOG; ENOG410XTHJ; LUCA.
DR   GeneTree; ENSGT00530000063112; -.
DR   ChiTaRS; GHR; human.
DR   GenomeRNAi; 2690; -.
DR   Proteomes; UP000005640; Chromosome 5.
DR   Bgee; ENSG00000112964; -.
DR   ExpressionAtlas; A0A087X162; baseline and differential.
DR   GO; GO:0036464; C:cytoplasmic ribonucleoprotein granule; IDA:HPA.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005886; C:plasma membrane; IDA:HPA.
DR   GO; GO:0004896; F:cytokine receptor activity; IEA:InterPro.
DR   CDD; cd00063; FN3; 1.
DR   Gene3D; 2.60.40.10; -; 2.
DR   InterPro; IPR003961; FN3_dom.
DR   InterPro; IPR036116; FN3_sf.
DR   InterPro; IPR015152; Growth/epo_recpt_lig-bind.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR003528; Long_hematopoietin_rcpt_CS.
DR   Pfam; PF09067; EpoR_lig-bind; 1.
DR   Pfam; PF00041; fn3; 1.
DR   SUPFAM; SSF49265; SSF49265; 2.
DR   PROSITE; PS50853; FN3; 1.
DR   PROSITE; PS01352; HEMATOPO_REC_L_F1; 1.
PE   1: Evidence at protein level;
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   Membrane {ECO:0000256|SAM:Phobius};
KW   Proteomics identification {ECO:0000213|PeptideAtlas:A0A087X162};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640};
KW   Signal {ECO:0000256|SAM:SignalP};
KW   Transmembrane {ECO:0000256|SAM:Phobius};
KW   Transmembrane helix {ECO:0000256|SAM:Phobius}.
FT   SIGNAL        1     18       {ECO:0000256|SAM:SignalP}.
FT   CHAIN        19    295       {ECO:0000256|SAM:SignalP}.
FT                                /FTId=PRO_5001832170.
FT   TRANSMEM    264    287       Helical. {ECO:0000256|SAM:Phobius}.
FT   DOMAIN      151    254       Fibronectin type-III.
FT                                {ECO:0000259|PROSITE:PS50853}.
SQ   SEQUENCE   295 AA;  34045 MW;  98B1DD31AAC8F6FD CRC64;
     MDLWQLLLTL ALAGSSDAFS GSEATAAILS RAPWSLQSVN PGLKTNSSKE PKFTKCRSPE
     RETFSCHWTD EVHHGTKNLG PIQLFYTRRN TQEWTQEWKE CPDYVSAGEN SCYFNSSFTS
     IWIPYCIKLT SNGGTVDEKC FSVDEIVQPD PPIALNWTLL NVSLTGIHAD IQVRWEAPRN
     ADIQKGWMVL EYELQYKEVN ETKWKMMDPI LTTSVPVYSL KVDKEYEVRV RSKQRNSGNY
     GEFSEVLYVT LPQMSQFTCE EDFYFPWLLI IIFGIFGLTV MLFVFLFSKQ QRKEN
//
ID   GHR_HUMAN               Reviewed;         638 AA.
AC   P10912; Q9HCX2;
DT   01-JUL-1989, integrated into UniProtKB/Swiss-Prot.
DT   01-JUL-1989, sequence version 1.
DT   23-MAY-2018, entry version 210.
DE   RecName: Full=Growth hormone receptor;
DE            Short=GH receptor;
DE   AltName: Full=Somatotropin receptor;
DE   Contains:
DE     RecName: Full=Growth hormone-binding protein;
DE              Short=GH-binding protein;
DE              Short=GHBP;
DE     AltName: Full=Serum-binding protein;
DE   Flags: Precursor;
GN   Name=GHR;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND PARTIAL PROTEIN SEQUENCE.
RC   TISSUE=Liver;
RX   PubMed=2825030; DOI=10.1038/330537a0;
RA   Leung D.W., Spencer S.A., Cachianes G., Hammonds R.G., Collins C.,
RA   Henzel W.J., Barnard R., Waters M.J., Wood W.I.;
RT   "Growth hormone receptor and serum binding protein: purification,
RT   cloning and expression.";
RL   Nature 330:537-543(1987).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM 1), AND VARIANT LEU-544.
RX   PubMed=2813379; DOI=10.1073/pnas.86.20.8083;
RA   Godowski P.J., Leung D.W., Meacham L.R., Galgani J.P., Hellmiss R.,
RA   Keret R., Rotwein P.S., Parks J.S., Laron Z., Wood W.I.;
RT   "Characterization of the human growth hormone receptor gene and
RT   demonstration of a partial gene deletion in two patients with Laron-
RT   type dwarfism.";
RL   Proc. Natl. Acad. Sci. U.S.A. 86:8083-8087(1989).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 4).
RC   TISSUE=Placenta;
RX   PubMed=1569971; DOI=10.1210/mend.6.2.1569971;
RA   Urbanek M., MacLeod J.N., Cooke N.E., Liebhaber S.A.;
RT   "Expression of a human growth hormone (hGH) receptor isoform is
RT   predicted by tissue-specific alternative splicing of exon 3 of the hGH
RT   receptor gene transcript.";
RL   Mol. Endocrinol. 6:279-287(1992).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RC   TISSUE=Liver;
RX   PubMed=8855247; DOI=10.1073/pnas.93.20.10723;
RA   Dastot F., Sobrier M.-L., Duquesnoy P., Duriez B., Goossens M.,
RA   Amselem S.;
RT   "Alternatively spliced forms in the cytoplasmic domain of the human
RT   growth hormone (GH) receptor regulate its ability to generate a
RT   soluble GH-binding protein.";
RL   Proc. Natl. Acad. Sci. U.S.A. 93:10723-10728(1996).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RX   PubMed=9360546; DOI=10.1210/jcem.82.11.4358;
RA   Amit T., Bergman T., Dastot F., Youdim M.B.H., Amselem S.,
RA   Hochberg Z.;
RT   "A membrane-fixed, truncated isoform of the human growth hormone
RT   receptor.";
RL   J. Clin. Endocrinol. Metab. 82:3813-3817(1997).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1; 2 AND 3).
RC   TISSUE=Liver;
RX   PubMed=9058373; DOI=10.1210/mend.11.3.9901;
RA   Ross R.J., Esposito N., Shen X.Y., Von Laue S., Chew S.L.,
RA   Dobson P.R., Postel-Vinay M.-C., Finidori J.;
RT   "A short isoform of the human growth hormone receptor functions as a
RT   dominant negative inhibitor of the full-length receptor and generates
RT   large amounts of binding protein.";
RL   Mol. Endocrinol. 11:265-273(1997).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 263-336.
RA   Orlovsky I.V., Borovikova I.E., Rubtsov P.M.;
RT   "Comparing of nucleotide sequences of alternatively spliced region of
RT   mammalian growth hormone receptor genes.";
RL   Submitted (JUL-2000) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   CHARACTERIZATION (ISOFORM 4).
RX   PubMed=8360189;
RA   Urbanek M., Russell J.E., Cooke N.E., Liebhaber S.A.;
RT   "Functional characterization of the alternatively spliced, placental
RT   human growth hormone receptor.";
RL   J. Biol. Chem. 268:19025-19032(1993).
RN   [9]
RP   MOLECULAR MECHANISM OF PRODUCTION (ISOFORM 4).
RX   PubMed=10764769; DOI=10.1074/jbc.M001615200;
RA   Pantel J., Machinis K., Sobrier M.-L., Duquesnoy P., Goossens M.,
RA   Amselem S.;
RT   "Species-specific alternative splice mimicry at the growth hormone
RT   receptor locus revealed by the lineage of retroelements during primate
RT   evolution.";
RL   J. Biol. Chem. 275:18664-18669(2000).
RN   [10]
RP   DISULFIDE BONDS.
RX   PubMed=2406245;
RA   Fuh G., Mulkerrin M.G., Bass S., McFarland N., Brochier M.,
RA   Bourrel J.H., Light D.R., Wells J.A.;
RT   "The human growth hormone receptor. Secretion from Escherichia coli
RT   and disulfide bonding pattern of the extracellular binding domain.";
RL   J. Biol. Chem. 265:3111-3115(1990).
RN   [11]
RP   SITE CRITICAL TO PROTEOLYSIS, AND MUTAGENESIS OF GLU-260; GLU-261 AND
RP   ASP-262.
RX   PubMed=11785980; DOI=10.1006/bbrc.2001.6261;
RA   Conte F., Salles J.P., Raynal P., Fernandez L., Molinas C., Tauber M.,
RA   Bieth E.;
RT   "Identification of a region critical for proteolysis of the human
RT   growth hormone receptor.";
RL   Biochem. Biophys. Res. Commun. 290:851-857(2002).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-341, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [13]
RP   X-RAY CRYSTALLOGRAPHY (2.8 ANGSTROMS) OF 19-254 IN COMPLEX WITH GROWTH
RP   HORMONE.
RX   PubMed=1549776; DOI=10.1126/science.1549776;
RA   de Vos A.M., Ultsch M., Kossiakoff A.A.;
RT   "Human growth hormone and extracellular domain of its receptor:
RT   crystal structure of the complex.";
RL   Science 255:306-312(1992).
RN   [14]
RP   X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS) OF 19-256 IN COMPLEX WITH GROWTH
RP   HORMONE.
RX   PubMed=8943276; DOI=10.1074/jbc.271.50.32197;
RA   Sundstroem M., Lundqvist T., Roedin J., Giebel L.B., Milligan D.,
RA   Norstedt G.;
RT   "Crystal structure of an antagonist mutant of human growth hormone,
RT   G120R, in complex with its receptor at 2.9-A resolution.";
RL   J. Biol. Chem. 271:32197-32203(1996).
RN   [15]
RP   VARIANT LARS SER-114.
RX   PubMed=2779634; DOI=10.1056/NEJM198910123211501;
RA   Amselem S., Duquesnoy P., Attree O., Novelli G., Bousnina S.,
RA   Postel-Vinay M.-C., Goossens M.;
RT   "Laron dwarfism and mutations of the growth hormone-receptor gene.";
RL   N. Engl. J. Med. 321:989-995(1989).
RN   [16]
RP   VARIANT PHE-440.
RX   PubMed=8421103; DOI=10.1210/jcem.76.1.8421103;
RA   Kou K., Lajara R., Rotwein P.;
RT   "Amino acid substitutions in the intracellular part of the growth
RT   hormone receptor in a patient with the Laron syndrome.";
RL   J. Clin. Endocrinol. Metab. 76:54-59(1993).
RN   [17]
RP   VARIANTS LARS LYS-89; GLN-149; ASP-162; CYS-179 AND GLY-229.
RX   PubMed=8504296; DOI=10.1093/hmg/2.4.355;
RA   Amselem S., Duquesnoy P., Duriez B., Dastot F., Sobrier M.-L.,
RA   Valleix S., Goossens M.;
RT   "Spectrum of growth hormone receptor mutations and associated
RT   haplotypes in Laron syndrome.";
RL   Hum. Mol. Genet. 2:355-359(1993).
RN   [18]
RP   CHARACTERIZATION OF VARIANT LARS SER-114.
RX   PubMed=8450064; DOI=10.1172/JCI116304;
RA   Edery M., Rozakis-Adcock M., Goujon L., Finidori J., Levi-Meyrueis C.,
RA   Paly J., Djiane J., Postel-Vinay M.-C., Kelly P.A.;
RT   "Lack of hormone binding in COS-7 cells expressing a mutated growth
RT   hormone receptor found in Laron dwarfism.";
RL   J. Clin. Invest. 91:838-844(1993).
RN   [19]
RP   VARIANT LARS HIS-170.
RX   PubMed=8137822;
RA   Duquesnoy P., Sobrier M.-L., Duriez B., Dastot F., Buchanan C.R.,
RA   Savage M.O., Preece M.A., Craescu C.T., Blouquit Y., Goossens M.,
RA   Amselem S.;
RT   "A single amino acid substitution in the exoplasmic domain of the
RT   human growth hormone (GH) receptor confers familial GH resistance
RT   (Laron syndrome) with positive GH-binding activity by abolishing
RT   receptor homodimerization.";
RL   EMBO J. 13:1386-1395(1994).
RN   [20]
RP   VARIANTS GHIP LYS-62 AND CYS-179, AND VARIANTS HIS-229 AND ASP-242.
RX   PubMed=7565946; DOI=10.1056/NEJM199510263331701;
RA   Goddard A.D., Covello R., Luoh S.-M., Clackson T., Attie K.M.,
RA   Gesundheit N., Rundle A.C., Wells J.A., Carlsson L.M.S.;
RT   "Mutations of the growth hormone receptor in children with idiopathic
RT   short stature.";
RL   N. Engl. J. Med. 333:1093-1098(1995).
RN   [21]
RP   VARIANTS LARS SER-56; LEU-58 AND ARG-68.
RX   PubMed=9024232; DOI=10.1210/jcem.82.2.3725;
RA   Sobrier M.-L., Dastot F., Duquesnoy P., Kandemir N., Yordam N.,
RA   Goossens M., Amselem S.;
RT   "Nine novel growth hormone receptor gene mutations in patients with
RT   Laron syndrome.";
RL   J. Clin. Endocrinol. Metab. 82:435-437(1997).
RN   [22]
RP   VARIANT LARS GLN-149, AND CHARACTERIZATION OF VARIANT LARS GLN-149.
RX   PubMed=9661642; DOI=10.1210/jcem.83.7.4954;
RA   Walker J.L., Crock P.A., Behncken S.N., Rowlinson S.W.,
RA   Nicholson L.M., Boulton T.J.C., Waters M.J.;
RT   "A novel mutation affecting the interdomain link region of the growth
RT   hormone receptor in a Vietnamese girl, and response to long-term
RT   treatment with recombinant human insulin-like growth factor-I and
RT   luteinizing hormone-releasing hormone analogue.";
RL   J. Clin. Endocrinol. Metab. 83:2554-2561(1998).
RN   [23]
RP   VARIANT ILE-162.
RX   PubMed=9814495; DOI=10.1210/jcem.83.11.5238;
RA   Sanchez J.E., Perera E., Baumbach L., Cleveland W.W.;
RT   "Growth hormone receptor mutations in children with idiopathic short
RT   stature.";
RL   J. Clin. Endocrinol. Metab. 83:4079-4083(1998).
RN   [24]
RP   VARIANTS LARS HIS-170; THR-171; PRO-172 AND GLY-173, AND
RP   CHARACTERIZATION OF VARIANTS LARS THR-171; PRO-172 AND GLY-173.
RX   PubMed=9851797; DOI=10.1210/jcem.83.12.5357;
RA   Wojcik J., Berg M.A., Esposito N., Geffner M.E., Sakati N.,
RA   Reiter E.O., Dower S., Francke U., Postel-Vinay M.-C., Finidori J.;
RT   "Four contiguous amino acid substitutions, identified in patients with
RT   Laron syndrome, differently affect the binding affinity and
RT   intracellular trafficking of the growth hormone receptor.";
RL   J. Clin. Endocrinol. Metab. 83:4481-4489(1998).
RN   [25]
RP   VARIANTS HIS-179; HIS-229; PHE-440; THR-495; LEU-544 AND THR-579.
RX   PubMed=10391209; DOI=10.1038/10290;
RA   Cargill M., Altshuler D., Ireland J., Sklar P., Ardlie K., Patil N.,
RA   Shaw N., Lane C.R., Lim E.P., Kalyanaraman N., Nemesh J., Ziaugra L.,
RA   Friedland L., Rolfe A., Warrington J., Lipshutz R., Daley G.Q.,
RA   Lander E.S.;
RT   "Characterization of single-nucleotide polymorphisms in coding regions
RT   of human genes.";
RL   Nat. Genet. 22:231-238(1999).
RN   [26]
RP   ERRATUM.
RA   Cargill M., Altshuler D., Ireland J., Sklar P., Ardlie K., Patil N.,
RA   Shaw N., Lane C.R., Lim E.P., Kalyanaraman N., Nemesh J., Ziaugra L.,
RA   Friedland L., Rolfe A., Warrington J., Lipshutz R., Daley G.Q.,
RA   Lander E.S.;
RL   Nat. Genet. 23:373-373(1999).
RN   [27]
RP   VARIANTS LARS CYS-226 AND ASN-262.
RX   PubMed=10870033; DOI=10.1530/eje.0.1430071;
RA   Enberg B., Luthman H., Segnestam K., Ritzen E.M., Sundstroem M.,
RA   Norstedt G.;
RT   "Characterisation of novel missense mutations in the GH receptor gene
RT   causing severe growth retardation.";
RL   Eur. J. Endocrinol. 143:71-76(2000).
RN   [28]
RP   VARIANT LEU-544.
RX   PubMed=12910492; DOI=10.1002/ajmg.a.20172;
RA   Takada D., Ezura Y., Ono S., Iino Y., Katayama Y., Xin Y., Wu L.L.,
RA   Larringa-Shum S., Stephenson S.H., Hunt S.C., Hopkins P.N., Emi M.;
RT   "Growth hormone receptor variant (L526I) modifies plasma HDL
RT   cholesterol phenotype in familial hypercholesterolemia: intra-familial
RT   association study in an eight-generation hyperlipidemic kindred.";
RL   Am. J. Med. Genet. A 121:136-140(2003).
RN   [29]
RP   VARIANT LARS ILE-244.
RX   PubMed=14678285; DOI=10.1111/j.1365-2265.2004.01930.x;
RA   Jorge A.A.L., Souza S.C.A.L., Arnhold I.J.P., Mendonca B.B.;
RT   "The first homozygous mutation (S226I) in the highly-conserved WSXWS-
RT   like motif of the GH receptor causing Laron syndrome: suppression of
RT   GH secretion by GnRH analogue therapy not restored by
RT   dihydrotestosterone administration.";
RL   Clin. Endocrinol. (Oxf.) 60:36-40(2004).
CC   -!- FUNCTION: Receptor for pituitary gland growth hormone involved in
CC       regulating postnatal body growth. On ligand binding, couples to
CC       the JAK2/STAT5 pathway (By similarity). {ECO:0000250}.
CC   -!- FUNCTION: The soluble form (GHBP) acts as a reservoir of growth
CC       hormone in plasma and may be a modulator/inhibitor of GH
CC       signaling.
CC   -!- FUNCTION: Isoform 2 up-regulates the production of GHBP and acts
CC       as a negative inhibitor of GH signaling.
CC   -!- SUBUNIT: On growth hormone (GH) binding, forms homodimers and
CC       binds JAK2 via a box 1-containing domain. Binding to SOCS3
CC       inhibits JAK2 activation, binding to CIS and SOCS2 inhibits STAT5
CC       activation. Interacts with ADAM17. {ECO:0000250}.
CC   -!- INTERACTION:
CC       Self; NbExp=4; IntAct=EBI-286316, EBI-286316;
CC       Q16829:DUSP7; NbExp=2; IntAct=EBI-286316, EBI-1265847;
CC       P01241:GH1; NbExp=3; IntAct=EBI-286316, EBI-1026046;
CC       P16333:NCK1; NbExp=3; IntAct=EBI-286316, EBI-389883;
CC       Q9JLI4:Ncoa6 (xeno); NbExp=2; IntAct=EBI-286316, EBI-286271;
CC       P18031:PTPN1; NbExp=5; IntAct=EBI-286316, EBI-968788;
CC       P17706:PTPN2; NbExp=8; IntAct=EBI-286316, EBI-984930;
CC       P26045:PTPN3; NbExp=4; IntAct=EBI-286316, EBI-1047946;
CC       P43378:PTPN9; NbExp=2; IntAct=EBI-286316, EBI-742898;
CC       P23467:PTPRB; NbExp=3; IntAct=EBI-286316, EBI-1265766;
CC       Q9HD43:PTPRH; NbExp=4; IntAct=EBI-286316, EBI-1267176;
CC       Q12913:PTPRJ; NbExp=2; IntAct=EBI-286316, EBI-2264500;
CC   -!- SUBCELLULAR LOCATION: Cell membrane; Single-pass type I membrane
CC       protein. Note=On growth hormone binding, GHR is ubiquitinated,
CC       internalized, down-regulated and transported into a degradative or
CC       non-degradative pathway. {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Isoform 2: Cell membrane; Single-pass type I
CC       membrane protein. Note=Remains fixed to the cell membrane and is
CC       not internalized.
CC   -!- SUBCELLULAR LOCATION: Growth hormone-binding protein: Secreted.
CC       Note=Complexed to a substantial fraction of circulating GH.
CC       {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1; Synonyms=GHRfl;
CC         IsoId=P10912-1; Sequence=Displayed;
CC       Name=2; Synonyms=GHRtr, GHR1-279;
CC         IsoId=P10912-2; Sequence=VSP_010227, VSP_010228;
CC       Name=3; Synonyms=GHR1-277;
CC         IsoId=P10912-3; Sequence=VSP_010229, VSP_010230;
CC       Name=4; Synonyms=GHRd3;
CC         IsoId=P10912-4; Sequence=VSP_010225, VSP_010226;
CC         Note=Arises by species-specific retrovirus-mediated alternative
CC         splice mimicry.;
CC   -!- TISSUE SPECIFICITY: Expressed in various tissues with high
CC       expression in liver and skeletal muscle. Isoform 4 is
CC       predominantly expressed in kidney, bladder, adrenal gland and
CC       brain stem. Isoform 1 expression in placenta is predominant in
CC       chorion and decidua. Isoform 4 is highly expressed in placental
CC       villi. Isoform 2 is expressed in lung, stomach and muscle. Low
CC       levels in liver.
CC   -!- DOMAIN: The WSXWS motif appears to be necessary for proper protein
CC       folding and thereby efficient intracellular transport and cell-
CC       surface receptor binding.
CC   -!- DOMAIN: The box 1 motif is required for JAK interaction and/or
CC       activation.
CC   -!- DOMAIN: The extracellular domain is the ligand-binding domain
CC       representing the growth hormone-binding protein (GHBP).
CC   -!- DOMAIN: The ubiquitination-dependent endocytosis motif (UbE) is
CC       required for recruitment of the ubiquitin conjugation system on to
CC       the receptor and for its internalization.
CC   -!- PTM: The soluble form (GHBP) is produced by phorbol ester-promoted
CC       proteolytic cleavage at the cell surface (shedding) by
CC       ADAM17/TACE. Shedding is inhibited by growth hormone (GH) binding
CC       to the receptor probably due to a conformational change in GHR
CC       rendering the receptor inaccessible to ADAM17 (By similarity).
CC       {ECO:0000250}.
CC   -!- PTM: On GH binding, phosphorylated on tyrosine residues in the
CC       cytoplasmic domain by JAK2. {ECO:0000250}.
CC   -!- PTM: On ligand binding, ubiquitinated on lysine residues in the
CC       cytoplasmic domain. This ubiquitination is not sufficient for GHR
CC       internalization (By similarity). {ECO:0000250}.
CC   -!- POLYMORPHISM: Genetic variation in GHR may act as phenotype
CC       modifier in familial hypercholesterolemia [MIM:143890] patients
CC       carrying a mutation in the LDLR gene.
CC   -!- DISEASE: Laron syndrome (LARS) [MIM:262500]: A severe form of
CC       growth hormone insensitivity characterized by growth impairment,
CC       short stature, dysfunctional growth hormone receptor, and failure
CC       to generate insulin-like growth factor I in response to growth
CC       hormone. {ECO:0000269|PubMed:10870033,
CC       ECO:0000269|PubMed:14678285, ECO:0000269|PubMed:2779634,
CC       ECO:0000269|PubMed:8137822, ECO:0000269|PubMed:8450064,
CC       ECO:0000269|PubMed:8504296, ECO:0000269|PubMed:9024232,
CC       ECO:0000269|PubMed:9661642, ECO:0000269|PubMed:9851797}. Note=The
CC       disease is caused by mutations affecting the gene represented in
CC       this entry.
CC   -!- DISEASE: Growth hormone insensitivity, partial (GHIP)
CC       [MIM:604271]: A disease characterized by partial resistance to
CC       growth hormone resulting in short stature. Short stature is
CC       defined by a standing height more than 2 standard deviations below
CC       the mean (or below the 2.5 percentile) for sex and chronological
CC       age, compared with a well-nourished, healthy, genetically relevant
CC       population. {ECO:0000269|PubMed:7565946}. Note=The disease is
CC       caused by mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the type I cytokine receptor family. Type 1
CC       subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X06562; CAA29808.1; -; mRNA.
DR   EMBL; M28466; AAA52555.1; -; Genomic_DNA.
DR   EMBL; M28458; AAA52555.1; JOINED; Genomic_DNA.
DR   EMBL; M28459; AAA52555.1; JOINED; Genomic_DNA.
DR   EMBL; M28460; AAA52555.1; JOINED; Genomic_DNA.
DR   EMBL; M28461; AAA52555.1; JOINED; Genomic_DNA.
DR   EMBL; M28462; AAA52555.1; JOINED; Genomic_DNA.
DR   EMBL; M28463; AAA52555.1; JOINED; Genomic_DNA.
DR   EMBL; M28464; AAA52555.1; JOINED; Genomic_DNA.
DR   EMBL; M28465; AAA52555.1; JOINED; Genomic_DNA.
DR   EMBL; AJ278681; CAC06613.1; -; Genomic_DNA.
DR   CCDS; CCDS3940.1; -. [P10912-1]
DR   CCDS; CCDS56364.1; -. [P10912-4]
DR   PIR; A33991; A33991.
DR   RefSeq; NP_000154.1; NM_000163.4. [P10912-1]
DR   RefSeq; NP_001229328.1; NM_001242399.2.
DR   RefSeq; NP_001229329.1; NM_001242400.2. [P10912-1]
DR   RefSeq; NP_001229330.1; NM_001242401.3. [P10912-1]
DR   RefSeq; NP_001229331.1; NM_001242402.2. [P10912-1]
DR   RefSeq; NP_001229332.1; NM_001242403.2. [P10912-1]
DR   RefSeq; NP_001229333.1; NM_001242404.2. [P10912-1]
DR   RefSeq; NP_001229334.1; NM_001242405.2. [P10912-1]
DR   RefSeq; NP_001229335.1; NM_001242406.2. [P10912-1]
DR   RefSeq; NP_001229389.1; NM_001242460.1. [P10912-4]
DR   RefSeq; NP_001229391.1; NM_001242462.1.
DR   UniGene; Hs.125180; -.
DR   UniGene; Hs.684632; -.
DR   UniGene; Hs.688223; -.
DR   PDB; 1A22; X-ray; 2.60 A; B=19-256.
DR   PDB; 1AXI; X-ray; 2.10 A; B=19-254.
DR   PDB; 1HWG; X-ray; 2.50 A; B/C=19-255.
DR   PDB; 1HWH; X-ray; 2.90 A; B=19-255.
DR   PDB; 1KF9; X-ray; 2.60 A; B/C/E/F=19-256.
DR   PDB; 2AEW; X-ray; 2.70 A; A/B=47-251.
DR   PDB; 3HHR; X-ray; 2.80 A; B/C=50-254.
DR   PDB; 5OEK; NMR; -; A/B=254-294.
DR   PDB; 5OHD; NMR; -; A/B=254-294.
DR   PDBsum; 1A22; -.
DR   PDBsum; 1AXI; -.
DR   PDBsum; 1HWG; -.
DR   PDBsum; 1HWH; -.
DR   PDBsum; 1KF9; -.
DR   PDBsum; 2AEW; -.
DR   PDBsum; 3HHR; -.
DR   PDBsum; 5OEK; -.
DR   PDBsum; 5OHD; -.
DR   DisProt; DP00033; -.
DR   ProteinModelPortal; P10912; -.
DR   SMR; P10912; -.
DR   BioGrid; 108957; 42.
DR   DIP; DIP-630N; -.
DR   ELM; P10912; -.
DR   IntAct; P10912; 22.
DR   STRING; 9606.ENSP00000230882; -.
DR   ChEMBL; CHEMBL1976; -.
DR   DrugBank; DB00082; Pegvisomant.
DR   DrugBank; DB00052; Somatropin recombinant.
DR   iPTMnet; P10912; -.
DR   PhosphoSitePlus; P10912; -.
DR   BioMuta; GHR; -.
DR   DMDM; 121180; -.
DR   EPD; P10912; -.
DR   PaxDb; P10912; -.
DR   PeptideAtlas; P10912; -.
DR   PRIDE; P10912; -.
DR   Ensembl; ENST00000230882; ENSP00000230882; ENSG00000112964. [P10912-1]
DR   Ensembl; ENST00000357703; ENSP00000350335; ENSG00000112964. [P10912-4]
DR   Ensembl; ENST00000537449; ENSP00000442206; ENSG00000112964. [P10912-1]
DR   Ensembl; ENST00000612382; ENSP00000478332; ENSG00000112964. [P10912-1]
DR   Ensembl; ENST00000612626; ENSP00000479846; ENSG00000112964. [P10912-1]
DR   Ensembl; ENST00000615111; ENSP00000478291; ENSG00000112964. [P10912-1]
DR   Ensembl; ENST00000618088; ENSP00000482373; ENSG00000112964. [P10912-1]
DR   GeneID; 2690; -.
DR   KEGG; hsa:2690; -.
DR   UCSC; uc003jmt.4; human. [P10912-1]
DR   CTD; 2690; -.
DR   DisGeNET; 2690; -.
DR   EuPathDB; HostDB:ENSG00000112964.13; -.
DR   GeneCards; GHR; -.
DR   HGNC; HGNC:4263; GHR.
DR   HPA; HPA045339; -.
DR   HPA; HPA057705; -.
DR   MalaCards; GHR; -.
DR   MIM; 143890; phenotype.
DR   MIM; 262500; phenotype.
DR   MIM; 600946; gene.
DR   MIM; 604271; phenotype.
DR   neXtProt; NX_P10912; -.
DR   OpenTargets; ENSG00000112964; -.
DR   Orphanet; 633; Laron syndrome.
DR   Orphanet; 314802; Short stature due to partial GHR deficiency.
DR   PharmGKB; PA28674; -.
DR   eggNOG; ENOG410IFQI; Eukaryota.
DR   eggNOG; ENOG410XTHJ; LUCA.
DR   GeneTree; ENSGT00530000063112; -.
DR   HOGENOM; HOG000015773; -.
DR   HOVERGEN; HBG005836; -.
DR   InParanoid; P10912; -.
DR   KO; K05080; -.
DR   PhylomeDB; P10912; -.
DR   TreeFam; TF330851; -.
DR   Reactome; R-HSA-1170546; Prolactin receptor signaling.
DR   Reactome; R-HSA-982772; Growth hormone receptor signaling.
DR   SignaLink; P10912; -.
DR   SIGNOR; P10912; -.
DR   ChiTaRS; GHR; human.
DR   EvolutionaryTrace; P10912; -.
DR   GeneWiki; Growth_hormone_receptor; -.
DR   GenomeRNAi; 2690; -.
DR   PMAP-CutDB; P10912; -.
DR   PRO; PR:P10912; -.
DR   Proteomes; UP000005640; Chromosome 5.
DR   Bgee; ENSG00000112964; -.
DR   CleanEx; HS_GHR; -.
DR   ExpressionAtlas; P10912; baseline and differential.
DR   Genevisible; P10912; HS.
DR   GO; GO:0009986; C:cell surface; IDA:BHF-UCL.
DR   GO; GO:0036464; C:cytoplasmic ribonucleoprotein granule; IDA:HPA.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005576; C:extracellular region; TAS:Reactome.
DR   GO; GO:0005615; C:extracellular space; IDA:BHF-UCL.
DR   GO; GO:0070195; C:growth hormone receptor complex; IDA:CAFA.
DR   GO; GO:0016021; C:integral component of membrane; IDA:BHF-UCL.
DR   GO; GO:0005887; C:integral component of plasma membrane; IDA:BHF-UCL.
DR   GO; GO:0005886; C:plasma membrane; IDA:HPA.
DR   GO; GO:0043235; C:receptor complex; IDA:BHF-UCL.
DR   GO; GO:0004896; F:cytokine receptor activity; IEA:InterPro.
DR   GO; GO:0019838; F:growth factor binding; IPI:BHF-UCL.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0017046; F:peptide hormone binding; IPI:BHF-UCL.
DR   GO; GO:0070064; F:proline-rich region binding; ISS:BHF-UCL.
DR   GO; GO:0042803; F:protein homodimerization activity; IDA:BHF-UCL.
DR   GO; GO:0019901; F:protein kinase binding; ISS:BHF-UCL.
DR   GO; GO:0006103; P:2-oxoglutarate metabolic process; ISS:BHF-UCL.
DR   GO; GO:0042976; P:activation of Janus kinase activity; ISS:BHF-UCL.
DR   GO; GO:0000187; P:activation of MAPK activity; ISS:BHF-UCL.
DR   GO; GO:0000255; P:allantoin metabolic process; ISS:BHF-UCL.
DR   GO; GO:0032870; P:cellular response to hormone stimulus; IMP:BHF-UCL.
DR   GO; GO:0006101; P:citrate metabolic process; ISS:BHF-UCL.
DR   GO; GO:0006600; P:creatine metabolic process; ISS:BHF-UCL.
DR   GO; GO:0046449; P:creatinine metabolic process; ISS:BHF-UCL.
DR   GO; GO:0006897; P:endocytosis; IEA:UniProtKB-KW.
DR   GO; GO:0006631; P:fatty acid metabolic process; ISS:BHF-UCL.
DR   GO; GO:0060396; P:growth hormone receptor signaling pathway; IMP:BHF-UCL.
DR   GO; GO:0042445; P:hormone metabolic process; IMP:BHF-UCL.
DR   GO; GO:0048009; P:insulin-like growth factor receptor signaling pathway; IMP:BHF-UCL.
DR   GO; GO:0006549; P:isoleucine metabolic process; ISS:BHF-UCL.
DR   GO; GO:0007259; P:JAK-STAT cascade; ISS:BHF-UCL.
DR   GO; GO:0060397; P:JAK-STAT cascade involved in growth hormone signaling pathway; TAS:Reactome.
DR   GO; GO:0006107; P:oxaloacetate metabolic process; ISS:BHF-UCL.
DR   GO; GO:0040018; P:positive regulation of multicellular organism growth; IMP:BHF-UCL.
DR   GO; GO:0050731; P:positive regulation of peptidyl-tyrosine phosphorylation; ISS:BHF-UCL.
DR   GO; GO:0042531; P:positive regulation of tyrosine phosphorylation of STAT protein; ISS:BHF-UCL.
DR   GO; GO:0031623; P:receptor internalization; IDA:BHF-UCL.
DR   GO; GO:0040014; P:regulation of multicellular organism growth; ISS:BHF-UCL.
DR   GO; GO:0046898; P:response to cycloheximide; IDA:BHF-UCL.
DR   GO; GO:0032355; P:response to estradiol; IDA:BHF-UCL.
DR   GO; GO:0006105; P:succinate metabolic process; ISS:BHF-UCL.
DR   GO; GO:0019530; P:taurine metabolic process; ISS:BHF-UCL.
DR   GO; GO:0006573; P:valine metabolic process; ISS:BHF-UCL.
DR   CDD; cd00063; FN3; 1.
DR   Gene3D; 2.60.40.10; -; 2.
DR   InterPro; IPR003961; FN3_dom.
DR   InterPro; IPR036116; FN3_sf.
DR   InterPro; IPR025871; GHBP.
DR   InterPro; IPR015152; Growth/epo_recpt_lig-bind.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR003528; Long_hematopoietin_rcpt_CS.
DR   Pfam; PF09067; EpoR_lig-bind; 1.
DR   Pfam; PF00041; fn3; 1.
DR   Pfam; PF12772; GHBP; 1.
DR   SUPFAM; SSF49265; SSF49265; 2.
DR   PROSITE; PS50853; FN3; 1.
DR   PROSITE; PS01352; HEMATOPO_REC_L_F1; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Cell membrane; Complete proteome;
KW   Direct protein sequencing; Disease mutation; Disulfide bond; Dwarfism;
KW   Endocytosis; Glycoprotein; Membrane; Phosphoprotein; Polymorphism;
KW   Receptor; Reference proteome; Secreted; Signal; Transmembrane;
KW   Transmembrane helix; Ubl conjugation.
FT   SIGNAL        1     18       {ECO:0000255}.
FT   CHAIN        19    638       Growth hormone receptor.
FT                                /FTId=PRO_0000010957.
FT   CHAIN        19    256       Growth hormone-binding protein.
FT                                {ECO:0000250}.
FT                                /FTId=PRO_0000010958.
FT   TOPO_DOM     19    264       Extracellular. {ECO:0000255}.
FT   TRANSMEM    265    288       Helical. {ECO:0000255}.
FT   TOPO_DOM    289    638       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN      151    254       Fibronectin type-III.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00316}.
FT   REGION      260    262       Required for ADAM17-mediated proteolysis.
FT                                {ECO:0000250}.
FT   MOTIF       240    244       WSXWS motif.
FT   MOTIF       297    305       Box 1 motif.
FT   MOTIF       340    349       UbE motif.
FT   SITE        345    345       Required for endocytosis and down-
FT                                regulation. {ECO:0000250}.
FT   MOD_RES     341    341       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   CARBOHYD     46     46       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    115    115       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    156    156       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    161    161       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    200    200       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID     56     66       {ECO:0000269|PubMed:2406245}.
FT   DISULFID    101    112       {ECO:0000269|PubMed:2406245}.
FT   DISULFID    126    140       {ECO:0000269|PubMed:2406245}.
FT   VAR_SEQ      24     24       A -> D (in isoform 4).
FT                                {ECO:0000303|PubMed:1569971}.
FT                                /FTId=VSP_010225.
FT   VAR_SEQ      25     46       Missing (in isoform 4).
FT                                {ECO:0000303|PubMed:1569971}.
FT                                /FTId=VSP_010226.
FT   VAR_SEQ     292    297       RIKMLI -> SSSSKD (in isoform 2).
FT                                {ECO:0000303|PubMed:8855247,
FT                                ECO:0000303|PubMed:9058373,
FT                                ECO:0000303|PubMed:9360546}.
FT                                /FTId=VSP_010227.
FT   VAR_SEQ     292    294       RIK -> KEN (in isoform 3).
FT                                {ECO:0000303|PubMed:9058373}.
FT                                /FTId=VSP_010229.
FT   VAR_SEQ     295    638       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:9058373}.
FT                                /FTId=VSP_010230.
FT   VAR_SEQ     298    638       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:8855247,
FT                                ECO:0000303|PubMed:9058373,
FT                                ECO:0000303|PubMed:9360546}.
FT                                /FTId=VSP_010228.
FT   VARIANT      56     56       C -> S (in LARS).
FT                                {ECO:0000269|PubMed:9024232}.
FT                                /FTId=VAR_018426.
FT   VARIANT      58     58       S -> L (in LARS).
FT                                {ECO:0000269|PubMed:9024232}.
FT                                /FTId=VAR_018427.
FT   VARIANT      62     62       E -> K (in GHIP; dbSNP:rs121909361).
FT                                {ECO:0000269|PubMed:7565946}.
FT                                /FTId=VAR_002708.
FT   VARIANT      68     68       W -> R (in LARS).
FT                                {ECO:0000269|PubMed:9024232}.
FT                                /FTId=VAR_018428.
FT   VARIANT      89     89       R -> K (in LARS).
FT                                {ECO:0000269|PubMed:8504296}.
FT                                /FTId=VAR_002709.
FT   VARIANT     114    114       F -> S (in LARS; loss of ability to bind
FT                                ligand; dbSNP:rs121909357).
FT                                {ECO:0000269|PubMed:2779634,
FT                                ECO:0000269|PubMed:8450064}.
FT                                /FTId=VAR_002710.
FT   VARIANT     143    143       V -> A (in LARS).
FT                                /FTId=VAR_002711.
FT   VARIANT     149    149       P -> Q (in LARS; disrupts GH binding;
FT                                dbSNP:rs121909365).
FT                                {ECO:0000269|PubMed:8504296,
FT                                ECO:0000269|PubMed:9661642}.
FT                                /FTId=VAR_018429.
FT   VARIANT     162    162       V -> D (in LARS).
FT                                {ECO:0000269|PubMed:8504296}.
FT                                /FTId=VAR_002712.
FT   VARIANT     162    162       V -> F (in dbSNP:rs6413484).
FT                                /FTId=VAR_020002.
FT   VARIANT     162    162       V -> I (found in a patient with
FT                                idiopathic short stature; unknown
FT                                pathological significance;
FT                                dbSNP:rs6413484).
FT                                {ECO:0000269|PubMed:9814495}.
FT                                /FTId=VAR_018430.
FT   VARIANT     170    170       D -> H (in LARS; abolishes receptor
FT                                homodimerization; dbSNP:rs121909366).
FT                                {ECO:0000269|PubMed:8137822,
FT                                ECO:0000269|PubMed:9851797}.
FT                                /FTId=VAR_002713.
FT   VARIANT     171    171       I -> T (in LARS; almost completely
FT                                abolishes GH-binding at cell surface: 53%
FT                                binding to membrane fractions;
FT                                dbSNP:rs121909367).
FT                                {ECO:0000269|PubMed:9851797}.
FT                                /FTId=VAR_018431.
FT   VARIANT     172    172       Q -> P (in LARS; almost completely
FT                                abolishes GH-binding at cell surface and
FT                                in membrane fractions;
FT                                dbSNP:rs121909368).
FT                                {ECO:0000269|PubMed:9851797}.
FT                                /FTId=VAR_018432.
FT   VARIANT     173    173       V -> G (in LARS; almost completely
FT                                abolishes GH-binding at cell surface: 26%
FT                                binding to membrane fractions;
FT                                dbSNP:rs121909369).
FT                                {ECO:0000269|PubMed:9851797}.
FT                                /FTId=VAR_018433.
FT   VARIANT     179    179       R -> C (in LARS and GHIP;
FT                                dbSNP:rs121909362).
FT                                {ECO:0000269|PubMed:7565946,
FT                                ECO:0000269|PubMed:8504296}.
FT                                /FTId=VAR_002714.
FT   VARIANT     179    179       R -> H (in dbSNP:rs6181).
FT                                {ECO:0000269|PubMed:10391209}.
FT                                /FTId=VAR_013937.
FT   VARIANT     226    226       Y -> C (in LARS).
FT                                {ECO:0000269|PubMed:10870033}.
FT                                /FTId=VAR_018434.
FT   VARIANT     229    229       R -> G (in LARS).
FT                                {ECO:0000269|PubMed:8504296}.
FT                                /FTId=VAR_002715.
FT   VARIANT     229    229       R -> H (found in a patient with
FT                                idiopathic short stature; unknown
FT                                pathological significance; dbSNP:rs6177).
FT                                {ECO:0000269|PubMed:10391209,
FT                                ECO:0000269|PubMed:7565946}.
FT                                /FTId=VAR_013938.
FT   VARIANT     242    242       E -> D (found in a patient with
FT                                idiopathic short stature; unknown
FT                                pathological significance;
FT                                dbSNP:rs45588036).
FT                                {ECO:0000269|PubMed:7565946}.
FT                                /FTId=VAR_002716.
FT   VARIANT     244    244       S -> I (in LARS).
FT                                {ECO:0000269|PubMed:14678285}.
FT                                /FTId=VAR_018435.
FT   VARIANT     262    262       D -> N (in LARS).
FT                                {ECO:0000269|PubMed:10870033}.
FT                                /FTId=VAR_018436.
FT   VARIANT     440    440       C -> F (in dbSNP:rs6182).
FT                                {ECO:0000269|PubMed:10391209,
FT                                ECO:0000269|PubMed:8421103}.
FT                                /FTId=VAR_013939.
FT   VARIANT     465    465       E -> K (in dbSNP:rs34283856).
FT                                /FTId=VAR_032704.
FT   VARIANT     495    495       P -> T (in dbSNP:rs6183).
FT                                {ECO:0000269|PubMed:10391209}.
FT                                /FTId=VAR_013940.
FT   VARIANT     544    544       I -> L (polymorphism with a modifier
FT                                effect on plasma HDL cholesterol levels
FT                                in familial hypercholesterolemia
FT                                patients; dbSNP:rs6180).
FT                                {ECO:0000269|PubMed:10391209,
FT                                ECO:0000269|PubMed:12910492,
FT                                ECO:0000269|PubMed:2813379}.
FT                                /FTId=VAR_013941.
FT   VARIANT     579    579       P -> T (in dbSNP:rs6184).
FT                                {ECO:0000269|PubMed:10391209}.
FT                                /FTId=VAR_013942.
FT   MUTAGEN     260    260       E->A: No change in shedding activity: No
FT                                change in hormone binding.
FT                                {ECO:0000269|PubMed:11785980}.
FT   MUTAGEN     261    261       E->A: No change in shedding activity: No
FT                                change in hormone binding.
FT                                {ECO:0000269|PubMed:11785980}.
FT   MUTAGEN     262    262       D->A: No change in shedding activity: No
FT                                change in hormone binding.
FT                                {ECO:0000269|PubMed:11785980}.
FT   STRAND       53     62       {ECO:0000244|PDB:1AXI}.
FT   STRAND       64     68       {ECO:0000244|PDB:1AXI}.
FT   STRAND       83     88       {ECO:0000244|PDB:1AXI}.
FT   TURN         93     96       {ECO:0000244|PDB:1HWG}.
FT   TURN        104    107       {ECO:0000244|PDB:3HHR}.
FT   STRAND      111    114       {ECO:0000244|PDB:1AXI}.
FT   HELIX       116    118       {ECO:0000244|PDB:1AXI}.
FT   STRAND      121    131       {ECO:0000244|PDB:1AXI}.
FT   STRAND      134    142       {ECO:0000244|PDB:1AXI}.
FT   HELIX       143    146       {ECO:0000244|PDB:1AXI}.
FT   STRAND      153    159       {ECO:0000244|PDB:1AXI}.
FT   STRAND      167    176       {ECO:0000244|PDB:1AXI}.
FT   TURN        183    186       {ECO:0000244|PDB:1AXI}.
FT   STRAND      190    198       {ECO:0000244|PDB:1AXI}.
FT   STRAND      210    221       {ECO:0000244|PDB:1AXI}.
FT   STRAND      226    234       {ECO:0000244|PDB:1AXI}.
FT   STRAND      240    243       {ECO:0000244|PDB:2AEW}.
FT   STRAND      247    249       {ECO:0000244|PDB:1AXI}.
SQ   SEQUENCE   638 AA;  71500 MW;  EAF77EADE4787822 CRC64;
     MDLWQLLLTL ALAGSSDAFS GSEATAAILS RAPWSLQSVN PGLKTNSSKE PKFTKCRSPE
     RETFSCHWTD EVHHGTKNLG PIQLFYTRRN TQEWTQEWKE CPDYVSAGEN SCYFNSSFTS
     IWIPYCIKLT SNGGTVDEKC FSVDEIVQPD PPIALNWTLL NVSLTGIHAD IQVRWEAPRN
     ADIQKGWMVL EYELQYKEVN ETKWKMMDPI LTTSVPVYSL KVDKEYEVRV RSKQRNSGNY
     GEFSEVLYVT LPQMSQFTCE EDFYFPWLLI IIFGIFGLTV MLFVFLFSKQ QRIKMLILPP
     VPVPKIKGID PDLLKEGKLE EVNTILAIHD SYKPEFHSDD SWVEFIELDI DEPDEKTEES
     DTDRLLSSDH EKSHSNLGVK DGDSGRTSCC EPDILETDFN ANDIHEGTSE VAQPQRLKGE
     ADLLCLDQKN QNNSPYHDAC PATQQPSVIQ AEKNKPQPLP TEGAESTHQA AHIQLSNPSS
     LSNIDFYAQV SDITPAGSVV LSPGQKNKAG MSQCDMHPEM VSLCQENFLM DNAYFCEADA
     KKCIPVAPHI KVESHIQPSL NQEDIYITTE SLTTAAGRPG TGEHVPGSEM PVPDYTSIHI
     VQSPQGLILN ATALPLPDKE FLSSCGYVST DQLNKIMP
//
ID   PROF2_HUMAN             Reviewed;         140 AA.
AC   P35080; B2R4C8; D3DNI4; Q4VBQ4; Q8WVF9; Q9HBK2;
DT   01-FEB-1994, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 3.
DT   23-MAY-2018, entry version 184.
DE   RecName: Full=Profilin-2;
DE   AltName: Full=Profilin II;
GN   Name=PFN2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM IIB).
RC   TISSUE=Epithelium;
RX   PubMed=8365484; DOI=10.1016/0014-5793(93)80262-S;
RA   Honore B., Madsen P.S., Andersen A.H., Leffers H.;
RT   "Cloning and expression of a novel human profilin variant, profilin
RT   II.";
RL   FEBS Lett. 330:151-155(1993).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM IIA).
RC   TISSUE=Brain;
RX   PubMed=11027290; DOI=10.1128/MCB.20.21.8209-8219.2000;
RA   Lambrechts A., Braun A., Jonckheere V., Aszodi A., Lanier L.M.,
RA   Robbens J., Van Colen I., Vandekerckhove J., Faessler R., Ampe C.;
RT   "Profilin II is alternatively spliced, resulting in profilin isoforms
RT   that are differentially expressed and have distinct biochemical
RT   properties.";
RL   Mol. Cell. Biol. 20:8209-8219(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS IIA AND IIB).
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS IIA AND IIB).
RC   TISSUE=Brain, Lung, and Spinal cord;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   PROTEIN SEQUENCE OF 30-69; 76-89; 92-105 AND 109-116, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Fetal brain cortex;
RA   Lubec G., Chen W.-Q., Sun Y.;
RL   Submitted (DEC-2008) to UniProtKB.
RN   [7]
RP   INTERACTION WITH ACTIN.
RX   PubMed=7758455; DOI=10.1111/j.1432-1033.1995.tb20506.x;
RA   Gieselmann R., Kwiatkowski D.J., Janmey P.A., Witke W.;
RT   "Distinct biochemical characteristics of the two human profilin
RT   isoforms.";
RL   Eur. J. Biochem. 229:621-628(1995).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [9]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22223895; DOI=10.1074/mcp.M111.015131;
RA   Bienvenut W.V., Sumpton D., Martinez A., Lilla S., Espagne C.,
RA   Meinnel T., Giglione C.;
RT   "Comparative large-scale characterisation of plant vs. mammal proteins
RT   reveals similar and idiosyncratic N-alpha acetylation features.";
RL   Mol. Cell. Proteomics 11:M111.015131-M111.015131(2012).
RN   [10]
RP   X-RAY CRYSTALLOGRAPHY (2.2 ANGSTROMS).
RX   PubMed=10600384; DOI=10.1006/jmbi.1999.3318;
RA   Nodelman I.M., Bowman G.D., Lindberg U., Schutt C.E.;
RT   "X-ray structure determination of human profilin II: a comparative
RT   structural analysis of human profilins.";
RL   J. Mol. Biol. 294:1271-1285(1999).
CC   -!- FUNCTION: Binds to actin and affects the structure of the
CC       cytoskeleton. At high concentrations, profilin prevents the
CC       polymerization of actin, whereas it enhances it at low
CC       concentrations. By binding to PIP2, it inhibits the formation of
CC       IP3 and DG.
CC   -!- SUBUNIT: Occurs in many kinds of cells as a complex with monomeric
CC       actin in a 1:1 ratio (PubMed:7758455). Interacts with PFN2 (By
CC       similarity). {ECO:0000250|UniProtKB:Q9JJV2,
CC       ECO:0000269|PubMed:7758455}.
CC   -!- INTERACTION:
CC       Q14789:GOLGB1; NbExp=2; IntAct=EBI-473138, EBI-709973;
CC       P42858:HTT; NbExp=4; IntAct=EBI-473138, EBI-466029;
CC       O08816:Wasl (xeno); NbExp=3; IntAct=EBI-473138, EBI-6142604;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=IIa;
CC         IsoId=P35080-1; Sequence=Displayed;
CC       Name=IIb;
CC         IsoId=P35080-2; Sequence=VSP_005217;
CC   -!- TISSUE SPECIFICITY: Highly expressed in brain, skeletal muscle and
CC       kidney and less strongly in heart, placenta, lung and liver.
CC   -!- SIMILARITY: Belongs to the profilin family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; L10678; AAA03022.1; -; mRNA.
DR   EMBL; AF228738; AAG24949.1; -; mRNA.
DR   EMBL; AK311780; BAG34723.1; -; mRNA.
DR   EMBL; AK311782; BAG34725.1; -; mRNA.
DR   EMBL; CH471052; EAW78850.1; -; Genomic_DNA.
DR   EMBL; BC002964; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; CH471052; EAW78852.1; -; Genomic_DNA.
DR   EMBL; BC018049; AAH18049.1; -; mRNA.
DR   EMBL; BC043646; AAH43646.1; -; mRNA.
DR   EMBL; BC095444; AAH95444.1; -; mRNA.
DR   CCDS; CCDS3148.1; -. [P35080-1]
DR   CCDS; CCDS46934.1; -. [P35080-2]
DR   PIR; S36804; S36804.
DR   RefSeq; NP_002619.1; NM_002628.4. [P35080-2]
DR   RefSeq; NP_444252.1; NM_053024.3. [P35080-1]
DR   UniGene; Hs.91747; -.
DR   PDB; 1D1J; X-ray; 2.20 A; A/B/C/D=2-138.
DR   PDBsum; 1D1J; -.
DR   ProteinModelPortal; P35080; -.
DR   SMR; P35080; -.
DR   BioGrid; 111238; 51.
DR   CORUM; P35080; -.
DR   IntAct; P35080; 34.
DR   MINT; P35080; -.
DR   STRING; 9606.ENSP00000239940; -.
DR   DrugBank; DB02580; 1-(2-Methoxy-Ethoxy)-2-{2-[2-(2-Methoxy-Ethoxy]-Ethoxy}-Ethane.
DR   DrugBank; DB02078; 1-Methoxy-2-[2-(2-Methoxy-Ethoxy]-Ethane.
DR   iPTMnet; P35080; -.
DR   PhosphoSitePlus; P35080; -.
DR   BioMuta; PFN2; -.
DR   DMDM; 20178322; -.
DR   REPRODUCTION-2DPAGE; P35080; -.
DR   EPD; P35080; -.
DR   MaxQB; P35080; -.
DR   PaxDb; P35080; -.
DR   PeptideAtlas; P35080; -.
DR   PRIDE; P35080; -.
DR   DNASU; 5217; -.
DR   Ensembl; ENST00000239940; ENSP00000239940; ENSG00000070087. [P35080-1]
DR   Ensembl; ENST00000452853; ENSP00000410464; ENSG00000070087. [P35080-2]
DR   GeneID; 5217; -.
DR   KEGG; hsa:5217; -.
DR   UCSC; uc003ext.3; human. [P35080-1]
DR   CTD; 5217; -.
DR   DisGeNET; 5217; -.
DR   EuPathDB; HostDB:ENSG00000070087.13; -.
DR   GeneCards; PFN2; -.
DR   HGNC; HGNC:8882; PFN2.
DR   HPA; CAB037073; -.
DR   HPA; HPA035611; -.
DR   MIM; 176590; gene.
DR   neXtProt; NX_P35080; -.
DR   OpenTargets; ENSG00000070087; -.
DR   PharmGKB; PA33220; -.
DR   eggNOG; KOG1755; Eukaryota.
DR   eggNOG; ENOG41126PD; LUCA.
DR   GeneTree; ENSGT00390000010143; -.
DR   HOGENOM; HOG000171592; -.
DR   HOVERGEN; HBG053683; -.
DR   InParanoid; P35080; -.
DR   KO; K05759; -.
DR   OMA; FFHMCSV; -.
DR   PhylomeDB; P35080; -.
DR   TreeFam; TF331744; -.
DR   Reactome; R-HSA-376176; Signaling by ROBO receptors.
DR   Reactome; R-HSA-5663220; RHO GTPases Activate Formins.
DR   ChiTaRS; PFN2; human.
DR   EvolutionaryTrace; P35080; -.
DR   GeneWiki; PFN2; -.
DR   GenomeRNAi; 5217; -.
DR   PRO; PR:P35080; -.
DR   Proteomes; UP000005640; Chromosome 3.
DR   Bgee; ENSG00000070087; -.
DR   CleanEx; HS_PFN2; -.
DR   ExpressionAtlas; P35080; baseline and differential.
DR   Genevisible; P35080; HS.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0005856; C:cytoskeleton; IEA:UniProtKB-SubCell.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0043195; C:terminal bouton; IEA:Ensembl.
DR   GO; GO:0003785; F:actin monomer binding; IPI:UniProtKB.
DR   GO; GO:0016887; F:ATPase activity; IDA:GO_Central.
DR   GO; GO:0005546; F:phosphatidylinositol-4,5-bisphosphate binding; IDA:UniProtKB.
DR   GO; GO:0030036; P:actin cytoskeleton organization; IEA:InterPro.
DR   GO; GO:0030837; P:negative regulation of actin filament polymerization; IDA:UniProtKB.
DR   GO; GO:0010633; P:negative regulation of epithelial cell migration; IMP:UniProtKB.
DR   GO; GO:1900028; P:negative regulation of ruffle assembly; IMP:UniProtKB.
DR   GO; GO:0032233; P:positive regulation of actin filament bundle assembly; IMP:UniProtKB.
DR   GO; GO:0030838; P:positive regulation of actin filament polymerization; IGI:UniProtKB.
DR   GO; GO:0032781; P:positive regulation of ATPase activity; IDA:UniProtKB.
DR   GO; GO:0033138; P:positive regulation of peptidyl-serine phosphorylation; IMP:UniProtKB.
DR   GO; GO:0051496; P:positive regulation of stress fiber assembly; IMP:UniProtKB.
DR   GO; GO:0050821; P:protein stabilization; IDA:UniProtKB.
DR   GO; GO:2000300; P:regulation of synaptic vesicle exocytosis; IEA:Ensembl.
DR   CDD; cd00148; PROF; 1.
DR   InterPro; IPR005455; PFN.
DR   InterPro; IPR029891; PFN2.
DR   InterPro; IPR036140; PFN_sf.
DR   InterPro; IPR005454; Profilin1/2/3_vertebrate.
DR   InterPro; IPR027310; Profilin_CS.
DR   PANTHER; PTHR13936:SF15; PTHR13936:SF15; 1.
DR   Pfam; PF00235; Profilin; 1.
DR   PRINTS; PR00392; PROFILIN.
DR   PRINTS; PR01639; PROFILINMAML.
DR   SMART; SM00392; PROF; 1.
DR   SUPFAM; SSF55770; SSF55770; 1.
DR   PROSITE; PS00414; PROFILIN; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Actin-binding; Alternative splicing;
KW   Complete proteome; Cytoplasm; Cytoskeleton; Direct protein sequencing;
KW   Reference proteome.
FT   INIT_MET      1      1       Removed. {ECO:0000244|PubMed:22223895}.
FT   CHAIN         2    140       Profilin-2.
FT                                /FTId=PRO_0000199575.
FT   MOD_RES       2      2       N-acetylalanine.
FT                                {ECO:0000244|PubMed:22223895}.
FT   VAR_SEQ     109    140       VLVFVMGKEGVHGGGLNKKAYSMAKYLRDSGF -> ALVIV
FT                                MGKEGVHGGTLNKKAYELALYLRRSDV (in isoform
FT                                IIb). {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:8365484}.
FT                                /FTId=VSP_005217.
FT   CONFLICT     65     65       T -> A (in Ref. 5; AAH18049).
FT                                {ECO:0000305}.
FT   HELIX         5     11       {ECO:0000244|PDB:1D1J}.
FT   STRAND       17     24       {ECO:0000244|PDB:1D1J}.
FT   STRAND       26     28       {ECO:0000244|PDB:1D1J}.
FT   STRAND       30     34       {ECO:0000244|PDB:1D1J}.
FT   HELIX        40     42       {ECO:0000244|PDB:1D1J}.
FT   HELIX        45     52       {ECO:0000244|PDB:1D1J}.
FT   HELIX        58     62       {ECO:0000244|PDB:1D1J}.
FT   STRAND       64     66       {ECO:0000244|PDB:1D1J}.
FT   STRAND       69     80       {ECO:0000244|PDB:1D1J}.
FT   STRAND       85     90       {ECO:0000244|PDB:1D1J}.
FT   STRAND       93     95       {ECO:0000244|PDB:1D1J}.
FT   STRAND      100    105       {ECO:0000244|PDB:1D1J}.
FT   STRAND      107    115       {ECO:0000244|PDB:1D1J}.
FT   HELIX       121    137       {ECO:0000244|PDB:1D1J}.
SQ   SEQUENCE   140 AA;  15046 MW;  F43884E1427C9A99 CRC64;
     MAGWQSYVDN LMCDGCCQEA AIVGYCDAKY VWAATAGGVF QSITPIEIDM IVGKDREGFF
     TNGLTLGAKK CSVIRDSLYV DGDCTMDIRT KSQGGEPTYN VAVGRAGRVL VFVMGKEGVH
     GGGLNKKAYS MAKYLRDSGF
//
ID   A0A024R778_HUMAN        Unreviewed;       168 AA.
AC   A0A024R778;
DT   09-JUL-2014, integrated into UniProtKB/TrEMBL.
DT   09-JUL-2014, sequence version 1.
DT   23-MAY-2018, entry version 30.
DE   SubName: Full=Pleiotrophin (Heparin binding growth factor 8, neurite growth-promoting factor 1), isoform CRA_a {ECO:0000313|EMBL:EAW83872.1};
GN   Name=PTN {ECO:0000313|EMBL:EAW83872.1};
GN   ORFNames=hCG_18946 {ECO:0000313|EMBL:EAW83872.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:EAW83872.1};
RN   [1] {ECO:0000313|EMBL:EAW83872.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAW83872.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; CH471070; EAW83872.1; -; Genomic_DNA.
DR   RefSeq; NP_001308315.1; NM_001321386.2.
DR   RefSeq; NP_002816.1; NM_002825.6.
DR   UniGene; Hs.371249; -.
DR   ProteinModelPortal; A0A024R778; -.
DR   SMR; A0A024R778; -.
DR   GeneID; 5764; -.
DR   KEGG; hsa:5764; -.
DR   CTD; 5764; -.
DR   EuPathDB; HostDB:ENSG00000105894.11; -.
DR   eggNOG; ENOG410IWNA; Eukaryota.
DR   eggNOG; ENOG4111ZWP; LUCA.
DR   KO; K16642; -.
DR   OMA; GEDICNS; -.
DR   OrthoDB; EOG091G0VCN; -.
DR   PhylomeDB; A0A024R778; -.
DR   ChiTaRS; PTN; human.
DR   GenomeRNAi; 5764; -.
DR   Bgee; ENSG00000105894; -.
DR   ExpressionAtlas; A0A024R778; baseline and differential.
DR   GO; GO:0005604; C:basement membrane; IEA:Ensembl.
DR   GO; GO:0009986; C:cell surface; IEA:Ensembl.
DR   GO; GO:0016020; C:membrane; IEA:Ensembl.
DR   GO; GO:0031594; C:neuromuscular junction; IEA:Ensembl.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IEA:Ensembl.
DR   GO; GO:0008083; F:growth factor activity; IEA:Ensembl.
DR   GO; GO:1904399; F:heparan sulfate binding; IEA:Ensembl.
DR   GO; GO:0008201; F:heparin binding; IEA:Ensembl.
DR   GO; GO:0030282; P:bone mineralization; IEA:Ensembl.
DR   GO; GO:0071456; P:cellular response to hypoxia; IEA:Ensembl.
DR   GO; GO:0036120; P:cellular response to platelet-derived growth factor stimulus; IEA:Ensembl.
DR   GO; GO:0034644; P:cellular response to UV; IEA:Ensembl.
DR   GO; GO:0071305; P:cellular response to vitamin D; IEA:Ensembl.
DR   GO; GO:0021549; P:cerebellum development; IEA:Ensembl.
DR   GO; GO:0045446; P:endothelial cell differentiation; IEA:Ensembl.
DR   GO; GO:0044849; P:estrous cycle; IEA:Ensembl.
DR   GO; GO:0007507; P:heart development; IEA:Ensembl.
DR   GO; GO:0007612; P:learning; IEA:Ensembl.
DR   GO; GO:0001889; P:liver development; IEA:Ensembl.
DR   GO; GO:0060291; P:long-term synaptic potentiation; IEA:Ensembl.
DR   GO; GO:0030324; P:lung development; IEA:Ensembl.
DR   GO; GO:0016525; P:negative regulation of angiogenesis; IEA:Ensembl.
DR   GO; GO:0030336; P:negative regulation of cell migration; IEA:Ensembl.
DR   GO; GO:0050680; P:negative regulation of epithelial cell proliferation; IEA:Ensembl.
DR   GO; GO:0060253; P:negative regulation of glial cell proliferation; IEA:Ensembl.
DR   GO; GO:0045837; P:negative regulation of membrane potential; IEA:Ensembl.
DR   GO; GO:0072201; P:negative regulation of mesenchymal cell proliferation; IEA:Ensembl.
DR   GO; GO:1904397; P:negative regulation of neuromuscular junction development; IEA:Ensembl.
DR   GO; GO:0043065; P:positive regulation of apoptotic process; IEA:Ensembl.
DR   GO; GO:0010811; P:positive regulation of cell-substrate adhesion; IEA:Ensembl.
DR   GO; GO:2000347; P:positive regulation of hepatocyte proliferation; IEA:Ensembl.
DR   GO; GO:0010976; P:positive regulation of neuron projection development; IEA:Ensembl.
DR   GO; GO:1904395; P:positive regulation of skeletal muscle acetylcholine-gated channel clustering; IEA:Ensembl.
DR   GO; GO:0008360; P:regulation of cell shape; IEA:Ensembl.
DR   GO; GO:0014823; P:response to activity; IEA:Ensembl.
DR   GO; GO:1904391; P:response to ciliary neurotrophic factor; IEA:Ensembl.
DR   GO; GO:0032355; P:response to estradiol; IEA:Ensembl.
DR   GO; GO:1904373; P:response to kainic acid; IEA:Ensembl.
DR   GO; GO:1990089; P:response to nerve growth factor; IEA:Ensembl.
DR   GO; GO:0032570; P:response to progesterone; IEA:Ensembl.
DR   GO; GO:0060221; P:retinal rod cell differentiation; IEA:Ensembl.
DR   GO; GO:1904389; P:rod bipolar cell differentiation; IEA:Ensembl.
DR   GO; GO:0021510; P:spinal cord development; IEA:Ensembl.
DR   GO; GO:0021794; P:thalamus development; IEA:Ensembl.
DR   Gene3D; 2.20.60.10; -; 1.
DR   Gene3D; 2.30.90.10; -; 1.
DR   InterPro; IPR000762; Midkine_heparin-bd_GF.
DR   InterPro; IPR020090; PTN/MK_C_dom.
DR   InterPro; IPR038130; PTN/MK_C_dom_sf.
DR   InterPro; IPR020091; PTN/MK_diS_sf.
DR   InterPro; IPR020089; PTN/MK_N_dom.
DR   InterPro; IPR037122; PTN/MK_N_dom_sf.
DR   InterPro; IPR020092; PTN_MK_heparin-bd_GF_CS.
DR   PANTHER; PTHR13850; PTHR13850; 1.
DR   Pfam; PF01091; PTN_MK_C; 1.
DR   Pfam; PF05196; PTN_MK_N; 1.
DR   PRINTS; PR00269; PTNMIDKINE.
DR   ProDom; PD005592; PTN_MK_hepar_bd; 1.
DR   SMART; SM00193; PTN; 1.
DR   SUPFAM; SSF57288; SSF57288; 2.
DR   PROSITE; PS00619; PTN_MK_1; 1.
DR   PROSITE; PS00620; PTN_MK_2; 1.
PE   4: Predicted;
KW   Signal {ECO:0000256|SAM:SignalP}.
FT   SIGNAL        1     32       {ECO:0000256|SAM:SignalP}.
FT   CHAIN        33    168       {ECO:0000256|SAM:SignalP}.
FT                                /FTId=PRO_5001533626.
FT   DOMAIN       34     95       PTN_MK_N. {ECO:0000259|Pfam:PF05196}.
FT   DOMAIN       96    158       PTN_MK_C. {ECO:0000259|Pfam:PF01091}.
SQ   SEQUENCE   168 AA;  18942 MW;  0359C08B6497B579 CRC64;
     MQAQQYQQQR RKFAAAFLAF IFILAAVDTA EAGKKEKPEK KVKKSDCGEW QWSVCVPTSG
     DCGLGTREGT RTGAECKQTM KTQRCKIPCN WKKQFGAECK YQFQAWGECD LNTALKTRTG
     SLKRALHNAE CQKTVTISKP CGKLTKPKPQ AESKKKKKEG KKQEKMLD
//
ID   PTN_HUMAN               Reviewed;         168 AA.
AC   P21246; Q5U0B0; Q6ICQ5; Q9UCC6;
DT   01-MAY-1991, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-1991, sequence version 1.
DT   23-MAY-2018, entry version 171.
DE   RecName: Full=Pleiotrophin;
DE            Short=PTN;
DE   AltName: Full=Heparin-binding brain mitogen;
DE            Short=HBBM;
DE   AltName: Full=Heparin-binding growth factor 8;
DE            Short=HBGF-8;
DE   AltName: Full=Heparin-binding growth-associated molecule;
DE            Short=HB-GAM;
DE   AltName: Full=Heparin-binding neurite outgrowth-promoting factor 1;
DE            Short=HBNF-1;
DE   AltName: Full=Osteoblast-specific factor 1;
DE            Short=OSF-1;
DE   Flags: Precursor;
GN   Name=PTN; Synonyms=HBNF1, NEGF1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=1701634; DOI=10.1016/S0006-291X(05)81048-4;
RA   Tezuka K.I., Takeshita S., Hakeda Y., Kumegawa M., Kikuno R.,
RA   Hashimoto-Gotoh T.;
RT   "Isolation of mouse and human cDNA clones encoding a protein expressed
RT   specifically in osteoblasts and brain tissues.";
RL   Biochem. Biophys. Res. Commun. 173:246-251(1990).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Placenta;
RX   PubMed=2270483; DOI=10.1126/science.2270483;
RA   Li Y.-S., Milner P.G., Chauhan A.K., Watson M.A., Hoffman R.M.,
RA   Kodner C.M., Milbrandt J., Deuel T.F.;
RT   "Cloning and expression of a developmentally regulated protein that
RT   induces mitogenic and neurite outgrowth activity.";
RL   Science 250:1690-1694(1990).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, AND INDUCTION.
RX   PubMed=1768439; DOI=10.3109/08977199109000275;
RA   Kretschmer P.J., Fairhurst J.L., Decker M.M., Chan C.P., Gluzman Y.,
RA   Boehlen P., Kovesdi I.;
RT   "Cloning, characterization and developmental regulation of two members
RT   of a novel human gene family of neurite outgrowth-promoting
RT   proteins.";
RL   Growth Factors 5:99-114(1991).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=1457401; DOI=10.1021/bi00163a009;
RA   Milner P.G., Shah D., Veile R., Donis-Keller H., Kumar B.V.;
RT   "Cloning, nucleotide sequence, and chromosome localization of the
RT   human pleiotrophin gene.";
RL   Biochemistry 31:12023-12028(1992).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=8484754; DOI=10.1006/bbrc.1993.1432;
RA   Kretschmer P.J., Fairhurst J.L., Hulmes J.D., Popjes M.L., Boehlen P.,
RA   Kovesdi I.;
RT   "Genomic organization of the human HBNF gene and characterization of
RT   an HBNF variant protein as a splice mutant.";
RL   Biochem. Biophys. Res. Commun. 192:420-429(1993).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=9299545; DOI=10.1006/bbrc.1997.7188;
RA   Masuda H., Tsujimura A., Yoshioka M., Arai Y., Kuboki Y., Mukai T.,
RA   Nakamura T., Tsuji H., Nakagawa M., Hashimoto-Gotoh T.;
RT   "Bone mass loss due to estrogen deficiency is compensated in
RT   transgenic mice overexpressing human osteoblast stimulating factor-
RT   1.";
RL   Biochem. Biophys. Res. Commun. 238:528-533(1997).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain, and Cerebellum;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (OCT-2004) to the EMBL/GenBank/DDBJ databases.
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12690205; DOI=10.1126/science.1083423;
RA   Scherer S.W., Cheung J., MacDonald J.R., Osborne L.R., Nakabayashi K.,
RA   Herbrick J.-A., Carson A.R., Parker-Katiraee L., Skaug J., Khaja R.,
RA   Zhang J., Hudek A.K., Li M., Haddad M., Duggan G.E., Fernandez B.A.,
RA   Kanematsu E., Gentles S., Christopoulos C.C., Choufani S.,
RA   Kwasnicka D., Zheng X.H., Lai Z., Nusskern D.R., Zhang Q., Gu Z.,
RA   Lu F., Zeesman S., Nowaczyk M.J., Teshima I., Chitayat D., Shuman C.,
RA   Weksberg R., Zackai E.H., Grebe T.A., Cox S.R., Kirkpatrick S.J.,
RA   Rahman N., Friedman J.M., Heng H.H.Q., Pelicci P.G., Lo-Coco F.,
RA   Belloni E., Shaffer L.G., Pober B., Morton C.C., Gusella J.F.,
RA   Bruns G.A.P., Korf B.R., Quade B.J., Ligon A.H., Ferguson H.,
RA   Higgins A.W., Leach N.T., Herrick S.R., Lemyre E., Farra C.G.,
RA   Kim H.-G., Summers A.M., Gripp K.W., Roberts W., Szatmari P.,
RA   Winsor E.J.T., Grzeschik K.-H., Teebi A., Minassian B.A., Kere J.,
RA   Armengol L., Pujana M.A., Estivill X., Wilson M.D., Koop B.F.,
RA   Tosi S., Moore G.E., Boright A.P., Zlotorynski E., Kerem B.,
RA   Kroisel P.M., Petek E., Oscier D.G., Mould S.J., Doehner H.,
RA   Doehner K., Rommens J.M., Vincent J.B., Venter J.C., Li P.W.,
RA   Mural R.J., Adams M.D., Tsui L.-C.;
RT   "Human chromosome 7: DNA sequence and biology.";
RL   Science 300:767-772(2003).
RN   [11]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [12]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Prostate;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [13]
RP   PROTEIN SEQUENCE OF 33-58.
RC   TISSUE=Brain;
RX   PubMed=2388713; DOI=10.1007/BF00969930;
RA   Huber D., Gautschi-Sova P., Bohlen P.;
RT   "Amino-terminal sequences of a novel heparin-binding protein from
RT   human, bovine, rat, and chick brain: high interspecies homology.";
RL   Neurochem. Res. 15:435-439(1990).
RN   [14]
RP   PROTEIN SEQUENCE OF 33-52, SUBCELLULAR LOCATION, HEPARIN-BINDING, AND
RP   FUNCTION.
RX   PubMed=1733956;
RA   Wellsein A., Fang W., Khatri A., Lu Y., Swain S.S., Dickson R.B.,
RA   Sasse J., Riegel A.T., Lippman M.E.;
RT   "A heparin-binding growth factor secreted from breast cancer cells
RT   homologous to a developmentally regulated cytokine.";
RL   J. Biol. Chem. 267:2582-2587(1992).
RN   [15]
RP   PROTEIN SEQUENCE OF 33-49, INDUCTION, AND SUBCELLULAR LOCATION.
RC   TISSUE=Plasma;
RX   PubMed=8241100;
RA   Novotny W.F., Maffi T., Mehta R.L., Milner P.G.;
RT   "Identification of novel heparin-releasable proteins, as well as the
RT   cytokines midkine and pleiotrophin, in human postheparin plasma.";
RL   Arterioscler. Thromb. 13:1798-1805(1993).
RN   [16]
RP   DISULFIDE BONDS.
RX   PubMed=8484780; DOI=10.1006/bbrc.1993.1476;
RA   Hulmes J.D., Seddon A.P., Decker M.M., Bohlen P.;
RT   "Comparison of the disulfide bond arrangements of human recombinant
RT   and bovine brain heparin binding neurite-promoting factors.";
RL   Biochem. Biophys. Res. Commun. 192:738-746(1993).
RN   [17]
RP   INTERACTION WITH ALK, AND FUNCTION.
RX   PubMed=11278720; DOI=10.1074/jbc.M010660200;
RA   Stoica G.E., Kuo A., Aigner A., Sunitha I., Souttou B., Malerczyk C.,
RA   Caughey D.J., Wen D., Karavanov A., Riegel A.T., Wellstein A.;
RT   "Identification of anaplastic lymphoma kinase as a receptor for the
RT   growth factor pleiotrophin.";
RL   J. Biol. Chem. 276:16772-16779(2001).
RN   [18]
RP   FUNCTION, AND INTERACTION WITH PTPRZ1.
RX   PubMed=16814777; DOI=10.1016/j.febslet.2006.06.041;
RA   Fukada M., Fujikawa A., Chow J.P., Ikematsu S., Sakuma S., Noda M.;
RT   "Protein tyrosine phosphatase receptor type Z is inactivated by
RT   ligand-induced oligomerization.";
RL   FEBS Lett. 580:4051-4056(2006).
RN   [19]
RP   INTERACTION WITH NEK6, AND PHOSPHORYLATION BY NEK6.
RX   PubMed=20873783; DOI=10.1021/pr100562w;
RA   Vaz Meirelles G., Ferreira Lanza D.C., da Silva J.C.,
RA   Santana Bernachi J., Paes Leme A.F., Kobarg J.;
RT   "Characterization of hNek6 interactome reveals an important role for
RT   its short N-terminal domain and colocalization with proteins at the
RT   centrosome.";
RL   J. Proteome Res. 9:6298-6316(2010).
RN   [20] {ECO:0000244|PDB:2N6F}
RP   STRUCTURE BY NMR OF 33-168, FUNCTION, SUBUNIT, AND DISULFIDE BONDS.
RX   PubMed=26896299; DOI=10.1111/febs.13686;
RA   Ryan E., Shen D., Wang X.;
RT   "Structural studies reveal an important role for the pleiotrophin C-
RT   terminus in mediating interactions with chondroitin sulfate.";
RL   FEBS J. 283:1488-1503(2016).
CC   -!- FUNCTION: Secreted growth factor that induces neurite outgrowth
CC       and which is mitogenic for fibroblasts, epithelial, and
CC       endothelial cells (PubMed:1768439, PubMed:1733956). Binds
CC       anaplastic lymphoma kinase (ALK) which induces MAPK pathway
CC       activation, an important step in the anti-apoptotic signaling of
CC       PTN and regulation of cell proliferation (PubMed:11278720). Binds
CC       to cell-surface target proteins via their chondroitin sulfate
CC       groups (PubMed:26896299). Down-regulates PTPRZ1 activity
CC       (PubMed:16814777). {ECO:0000269|PubMed:11278720,
CC       ECO:0000269|PubMed:16814777, ECO:0000269|PubMed:1768439,
CC       ECO:0000269|PubMed:26896299}.
CC   -!- SUBUNIT: Interacts with ALK and NEK6 (PubMed:11278720,
CC       PubMed:20873783). Interacts with PTPRZ1 (probably via chondroitin
CC       sulfate groups) (PubMed:16814777, PubMed:26896299).
CC       {ECO:0000269|PubMed:11278720, ECO:0000269|PubMed:16814777,
CC       ECO:0000269|PubMed:20873783, ECO:0000305|PubMed:26896299}.
CC   -!- SUBCELLULAR LOCATION: Secreted {ECO:0000269|PubMed:1733956,
CC       ECO:0000269|PubMed:8241100}.
CC   -!- TISSUE SPECIFICITY: Osteoblast and brain.
CC   -!- INDUCTION: By heparin and retinoic acid.
CC       {ECO:0000269|PubMed:1768439, ECO:0000269|PubMed:8241100}.
CC   -!- PTM: Phosphorylated by NEK6. {ECO:0000269|PubMed:20873783}.
CC   -!- SIMILARITY: Belongs to the pleiotrophin family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Wikipedia; Note=Pleiotrophin entry;
CC       URL="https://en.wikipedia.org/wiki/Pleiotrophin";
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/PTNID41904ch7q33.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; D90226; BAA14261.1; -; mRNA.
DR   EMBL; X52946; CAA37121.1; -; mRNA.
DR   EMBL; M57399; AAA35961.1; -; mRNA.
DR   EMBL; S50409; AAB24425.1; -; Genomic_DNA.
DR   EMBL; S50405; AAB24425.1; JOINED; Genomic_DNA.
DR   EMBL; S50408; AAB24425.1; JOINED; Genomic_DNA.
DR   EMBL; S50394; AAB24425.1; JOINED; Genomic_DNA.
DR   EMBL; S60110; AAB26456.1; -; Genomic_DNA.
DR   EMBL; S59641; AAB26456.1; JOINED; Genomic_DNA.
DR   EMBL; S60111; AAB26456.1; JOINED; Genomic_DNA.
DR   EMBL; S60736; AAB26456.1; JOINED; Genomic_DNA.
DR   EMBL; AB004306; BAA22944.1; -; Genomic_DNA.
DR   EMBL; AK290488; BAF83177.1; -; mRNA.
DR   EMBL; AK313424; BAG36216.1; -; mRNA.
DR   EMBL; CR450338; CAG29334.1; -; mRNA.
DR   EMBL; BT019692; AAV38498.1; -; mRNA.
DR   EMBL; CH236950; EAL24052.1; -; Genomic_DNA.
DR   EMBL; CH471070; EAW83869.1; -; Genomic_DNA.
DR   EMBL; BC005916; AAH05916.1; -; mRNA.
DR   CCDS; CCDS5844.1; -.
DR   PIR; JN0474; C37780.
DR   RefSeq; NP_001308315.1; NM_001321386.2.
DR   RefSeq; NP_001308316.1; NM_001321387.2.
DR   RefSeq; NP_002816.1; NM_002825.6.
DR   UniGene; Hs.371249; -.
DR   PDB; 2N6F; NMR; -; A=33-168.
DR   PDBsum; 2N6F; -.
DR   DisProt; DP00887; -.
DR   ProteinModelPortal; P21246; -.
DR   SMR; P21246; -.
DR   BioGrid; 111731; 94.
DR   DIP; DIP-5953N; -.
DR   IntAct; P21246; 91.
DR   MINT; P21246; -.
DR   STRING; 9606.ENSP00000341170; -.
DR   iPTMnet; P21246; -.
DR   PhosphoSitePlus; P21246; -.
DR   BioMuta; PTN; -.
DR   DMDM; 131553; -.
DR   PaxDb; P21246; -.
DR   PeptideAtlas; P21246; -.
DR   PRIDE; P21246; -.
DR   DNASU; 5764; -.
DR   Ensembl; ENST00000348225; ENSP00000341170; ENSG00000105894.
DR   GeneID; 5764; -.
DR   KEGG; hsa:5764; -.
DR   UCSC; uc003vtq.4; human.
DR   CTD; 5764; -.
DR   DisGeNET; 5764; -.
DR   EuPathDB; HostDB:ENSG00000105894.11; -.
DR   GeneCards; PTN; -.
DR   HGNC; HGNC:9630; PTN.
DR   HPA; CAB017685; -.
DR   MIM; 162095; gene.
DR   neXtProt; NX_P21246; -.
DR   OpenTargets; ENSG00000105894; -.
DR   PharmGKB; PA33974; -.
DR   eggNOG; ENOG410IWNA; Eukaryota.
DR   eggNOG; ENOG4111ZWP; LUCA.
DR   GeneTree; ENSGT00390000007640; -.
DR   HOGENOM; HOG000231473; -.
DR   HOVERGEN; HBG008317; -.
DR   InParanoid; P21246; -.
DR   KO; K16642; -.
DR   OMA; GEDICNS; -.
DR   OrthoDB; EOG091G0VCN; -.
DR   PhylomeDB; P21246; -.
DR   TreeFam; TF332376; -.
DR   SignaLink; P21246; -.
DR   SIGNOR; P21246; -.
DR   ChiTaRS; PTN; human.
DR   GeneWiki; Pleiotrophin; -.
DR   GenomeRNAi; 5764; -.
DR   PMAP-CutDB; P21246; -.
DR   PRO; PR:P21246; -.
DR   Proteomes; UP000005640; Chromosome 7.
DR   Bgee; ENSG00000105894; -.
DR   CleanEx; HS_PTN; -.
DR   ExpressionAtlas; P21246; baseline and differential.
DR   Genevisible; P21246; HS.
DR   GO; GO:0005604; C:basement membrane; IEA:Ensembl.
DR   GO; GO:0009986; C:cell surface; IEA:Ensembl.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:LIFEdb.
DR   GO; GO:0005615; C:extracellular space; IDA:UniProtKB.
DR   GO; GO:0016020; C:membrane; IEA:Ensembl.
DR   GO; GO:0031594; C:neuromuscular junction; IEA:Ensembl.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IEA:Ensembl.
DR   GO; GO:0032991; C:protein-containing complex; IDA:UniProtKB.
DR   GO; GO:0035374; F:chondroitin sulfate binding; IDA:UniProtKB.
DR   GO; GO:0008083; F:growth factor activity; IDA:UniProtKB.
DR   GO; GO:1904399; F:heparan sulfate binding; IEA:Ensembl.
DR   GO; GO:0008201; F:heparin binding; IDA:UniProtKB.
DR   GO; GO:0019901; F:protein kinase binding; IPI:UniProtKB.
DR   GO; GO:0004864; F:protein phosphatase inhibitor activity; TAS:ProtInc.
DR   GO; GO:0030282; P:bone mineralization; IEA:Ensembl.
DR   GO; GO:0071456; P:cellular response to hypoxia; IEA:Ensembl.
DR   GO; GO:0036120; P:cellular response to platelet-derived growth factor stimulus; IEA:Ensembl.
DR   GO; GO:0034644; P:cellular response to UV; IEA:Ensembl.
DR   GO; GO:0071305; P:cellular response to vitamin D; IEA:Ensembl.
DR   GO; GO:0021549; P:cerebellum development; IEA:Ensembl.
DR   GO; GO:0045446; P:endothelial cell differentiation; IEA:Ensembl.
DR   GO; GO:0044849; P:estrous cycle; IEA:Ensembl.
DR   GO; GO:0007507; P:heart development; IEA:Ensembl.
DR   GO; GO:0007612; P:learning; IEA:Ensembl.
DR   GO; GO:0001889; P:liver development; IEA:Ensembl.
DR   GO; GO:0060291; P:long-term synaptic potentiation; IEA:Ensembl.
DR   GO; GO:0030324; P:lung development; IEA:Ensembl.
DR   GO; GO:0016525; P:negative regulation of angiogenesis; IEA:Ensembl.
DR   GO; GO:0030336; P:negative regulation of cell migration; IEA:Ensembl.
DR   GO; GO:0050680; P:negative regulation of epithelial cell proliferation; IEA:Ensembl.
DR   GO; GO:0060253; P:negative regulation of glial cell proliferation; IEA:Ensembl.
DR   GO; GO:0045837; P:negative regulation of membrane potential; IEA:Ensembl.
DR   GO; GO:0072201; P:negative regulation of mesenchymal cell proliferation; IEA:Ensembl.
DR   GO; GO:1904397; P:negative regulation of neuromuscular junction development; IEA:Ensembl.
DR   GO; GO:0007399; P:nervous system development; TAS:ProtInc.
DR   GO; GO:0043065; P:positive regulation of apoptotic process; IEA:Ensembl.
DR   GO; GO:0051781; P:positive regulation of cell division; IEA:UniProtKB-KW.
DR   GO; GO:0008284; P:positive regulation of cell proliferation; IDA:UniProtKB.
DR   GO; GO:0010811; P:positive regulation of cell-substrate adhesion; IEA:Ensembl.
DR   GO; GO:2000347; P:positive regulation of hepatocyte proliferation; IEA:Ensembl.
DR   GO; GO:0010976; P:positive regulation of neuron projection development; IEA:Ensembl.
DR   GO; GO:1904395; P:positive regulation of skeletal muscle acetylcholine-gated channel clustering; IEA:Ensembl.
DR   GO; GO:0008360; P:regulation of cell shape; IEA:Ensembl.
DR   GO; GO:0014823; P:response to activity; IEA:Ensembl.
DR   GO; GO:1904391; P:response to ciliary neurotrophic factor; IEA:Ensembl.
DR   GO; GO:0032355; P:response to estradiol; IEA:Ensembl.
DR   GO; GO:1904373; P:response to kainic acid; IEA:Ensembl.
DR   GO; GO:1990089; P:response to nerve growth factor; IEA:Ensembl.
DR   GO; GO:0032570; P:response to progesterone; IEA:Ensembl.
DR   GO; GO:0060221; P:retinal rod cell differentiation; IEA:Ensembl.
DR   GO; GO:1904389; P:rod bipolar cell differentiation; IEA:Ensembl.
DR   GO; GO:0021510; P:spinal cord development; IEA:Ensembl.
DR   GO; GO:0021794; P:thalamus development; IEA:Ensembl.
DR   GO; GO:0007185; P:transmembrane receptor protein tyrosine phosphatase signaling pathway; TAS:ProtInc.
DR   Gene3D; 2.20.60.10; -; 1.
DR   Gene3D; 2.30.90.10; -; 1.
DR   InterPro; IPR000762; Midkine_heparin-bd_GF.
DR   InterPro; IPR020090; PTN/MK_C_dom.
DR   InterPro; IPR038130; PTN/MK_C_dom_sf.
DR   InterPro; IPR020091; PTN/MK_diS_sf.
DR   InterPro; IPR020089; PTN/MK_N_dom.
DR   InterPro; IPR037122; PTN/MK_N_dom_sf.
DR   InterPro; IPR020092; PTN_MK_heparin-bd_GF_CS.
DR   PANTHER; PTHR13850; PTHR13850; 1.
DR   Pfam; PF01091; PTN_MK_C; 1.
DR   Pfam; PF05196; PTN_MK_N; 1.
DR   PRINTS; PR00269; PTNMIDKINE.
DR   ProDom; PD005592; PTN_MK_hepar_bd; 1.
DR   SMART; SM00193; PTN; 1.
DR   SUPFAM; SSF57288; SSF57288; 2.
DR   PROSITE; PS00619; PTN_MK_1; 1.
DR   PROSITE; PS00620; PTN_MK_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Complete proteome; Direct protein sequencing;
KW   Disulfide bond; Growth factor; Heparin-binding; Mitogen;
KW   Reference proteome; Secreted; Signal.
FT   SIGNAL        1     32       {ECO:0000269|PubMed:1733956,
FT                                ECO:0000269|PubMed:2388713,
FT                                ECO:0000269|PubMed:8241100}.
FT   CHAIN        33    168       Pleiotrophin.
FT                                /FTId=PRO_0000024659.
FT   REGION       92     99       Chondroitin sulfate binding.
FT                                {ECO:0000269|PubMed:26896299}.
FT   REGION      123    131       Chondroitin sulfate binding.
FT                                {ECO:0000269|PubMed:26896299}.
FT   REGION      147    168       Chondroitin sulfate A binding.
FT                                {ECO:0000269|PubMed:26896299}.
FT   DISULFID     47     76       {ECO:0000244|PDB:2N6F,
FT                                ECO:0000269|PubMed:26896299,
FT                                ECO:0000269|PubMed:8484780}.
FT   DISULFID     55     85       {ECO:0000244|PDB:2N6F,
FT                                ECO:0000269|PubMed:26896299,
FT                                ECO:0000269|PubMed:8484780}.
FT   DISULFID     62     89       {ECO:0000244|PDB:2N6F,
FT                                ECO:0000269|PubMed:26896299,
FT                                ECO:0000269|PubMed:8484780}.
FT   DISULFID     99    131       {ECO:0000244|PDB:2N6F,
FT                                ECO:0000269|PubMed:26896299,
FT                                ECO:0000269|PubMed:8484780}.
FT   DISULFID    109    141       {ECO:0000244|PDB:2N6F,
FT                                ECO:0000269|PubMed:26896299,
FT                                ECO:0000269|PubMed:8484780}.
FT   CONFLICT     42     42       V -> K (in Ref. 14; AA sequence).
FT                                {ECO:0000305}.
FT   CONFLICT     47     47       C -> D (in Ref. 14; AA sequence).
FT                                {ECO:0000305}.
FT   CONFLICT     75     75       E -> G (in Ref. 9; AAV38498).
FT                                {ECO:0000305}.
FT   STRAND       48     52       {ECO:0000244|PDB:2N6F}.
FT   STRAND       60     62       {ECO:0000244|PDB:2N6F}.
FT   STRAND       66     72       {ECO:0000244|PDB:2N6F}.
FT   STRAND       78     84       {ECO:0000244|PDB:2N6F}.
FT   STRAND       97    104       {ECO:0000244|PDB:2N6F}.
FT   TURN        111    114       {ECO:0000244|PDB:2N6F}.
FT   STRAND      115    124       {ECO:0000244|PDB:2N6F}.
FT   STRAND      133    142       {ECO:0000244|PDB:2N6F}.
FT   TURN        163    166       {ECO:0000244|PDB:2N6F}.
SQ   SEQUENCE   168 AA;  18942 MW;  0359C08B6497B579 CRC64;
     MQAQQYQQQR RKFAAAFLAF IFILAAVDTA EAGKKEKPEK KVKKSDCGEW QWSVCVPTSG
     DCGLGTREGT RTGAECKQTM KTQRCKIPCN WKKQFGAECK YQFQAWGECD LNTALKTRTG
     SLKRALHNAE CQKTVTISKP CGKLTKPKPQ AESKKKKKEG KKQEKMLD
//
ID   HSP74_HUMAN             Reviewed;         840 AA.
AC   P34932; O95756; Q2TAL4; Q9BUK9;
DT   01-FEB-1994, integrated into UniProtKB/Swiss-Prot.
DT   23-SEP-2008, sequence version 4.
DT   23-MAY-2018, entry version 183.
DE   RecName: Full=Heat shock 70 kDa protein 4;
DE   AltName: Full=HSP70RY;
DE   AltName: Full=Heat shock 70-related protein APG-2;
GN   Name=HSPA4; Synonyms=APG2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RA   Nonoguchi K., Fujita J.;
RT   "Cloning and characterization of human apg-1 and apg-2, members of the
RT   hsp110 family, cDNAs and chromosomal assignment of the genes.";
RL   Submitted (FEB-1999) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15372022; DOI=10.1038/nature02919;
RA   Schmutz J., Martin J., Terry A., Couronne O., Grimwood J., Lowry S.,
RA   Gordon L.A., Scott D., Xie G., Huang W., Hellsten U., Tran-Gyamfi M.,
RA   She X., Prabhakar S., Aerts A., Altherr M., Bajorek E., Black S.,
RA   Branscomb E., Caoile C., Challacombe J.F., Chan Y.M., Denys M.,
RA   Detter J.C., Escobar J., Flowers D., Fotopulos D., Glavina T.,
RA   Gomez M., Gonzales E., Goodstein D., Grigoriev I., Groza M.,
RA   Hammon N., Hawkins T., Haydu L., Israni S., Jett J., Kadner K.,
RA   Kimball H., Kobayashi A., Lopez F., Lou Y., Martinez D., Medina C.,
RA   Morgan J., Nandkeshwar R., Noonan J.P., Pitluck S., Pollard M.,
RA   Predki P., Priest J., Ramirez L., Retterer J., Rodriguez A.,
RA   Rogers S., Salamov A., Salazar A., Thayer N., Tice H., Tsai M.,
RA   Ustaszewska A., Vo N., Wheeler J., Wu K., Yang J., Dickson M.,
RA   Cheng J.-F., Eichler E.E., Olsen A., Pennacchio L.A., Rokhsar D.S.,
RA   Richardson P., Lucas S.M., Myers R.M., Rubin E.M.;
RT   "The DNA sequence and comparative analysis of human chromosome 5.";
RL   Nature 431:268-274(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Brain, Placenta, and Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-749 (ISOFORM 1).
RC   TISSUE=Lymphocyte;
RX   PubMed=8335910;
RA   Fathallah D.M., Cherif D., Dellagi K., Arnaout M.A.;
RT   "Molecular cloning of a novel human hsp70 from a B cell line and its
RT   assignment to chromosome 5.";
RL   J. Immunol. 151:810-813(1993).
RN   [6]
RP   PROTEIN SEQUENCE OF 20-33; 111-124; 170-185; 222-234; 333-346; 361-374
RP   AND 391-422, AND IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Brain, Cajal-Retzius cell, and Fetal brain cortex;
RA   Lubec G., Afjehi-Sadat L., Chen W.-Q., Sun Y.;
RL   Submitted (DEC-2008) to UniProtKB.
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-89 AND TYR-336, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=15592455; DOI=10.1038/nbt1046;
RA   Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H.,
RA   Zha X.-M., Polakiewicz R.D., Comb M.J.;
RT   "Immunoaffinity profiling of tyrosine phosphorylation in cancer
RT   cells.";
RL   Nat. Biotechnol. 23:94-101(2005).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Embryonic kidney;
RX   PubMed=17525332; DOI=10.1126/science.1140321;
RA   Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,
RA   Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,
RA   Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.;
RT   "ATM and ATR substrate analysis reveals extensive protein networks
RT   responsive to DNA damage.";
RL   Science 316:1160-1166(2007).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-538, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-76 AND TYR-336, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [11]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-430 AND LYS-679, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-76 AND SER-546, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-76; SER-393; THR-538;
RP   SER-647 AND SER-756, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE
RP   SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [15]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [16]
RP   METHYLATION [LARGE SCALE ANALYSIS] AT LYS-773, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Colon carcinoma;
RX   PubMed=24129315; DOI=10.1074/mcp.O113.027870;
RA   Guo A., Gu H., Zhou J., Mulhern D., Wang Y., Lee K.A., Yang V.,
RA   Aguiar M., Kornhauser J., Jia X., Ren J., Beausoleil S.A., Silva J.C.,
RA   Vemulapalli V., Bedford M.T., Comb M.J.;
RT   "Immunoaffinity enrichment and mass spectrometry analysis of protein
RT   methylation.";
RL   Mol. Cell. Proteomics 13:372-387(2014).
CC   -!- SUBUNIT: Interacts with TJP1/ZO-1. {ECO:0000250}.
CC   -!- INTERACTION:
CC       Q6RW13:AGTRAP; NbExp=3; IntAct=EBI-356933, EBI-741181;
CC       Q92624:APPBP2; NbExp=5; IntAct=EBI-356933, EBI-743771;
CC       P11142:HSPA8; NbExp=5; IntAct=EBI-356933, EBI-351896;
CC       P78424:POU6F2; NbExp=4; IntAct=EBI-356933, EBI-12029004;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P34932-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P34932-2; Sequence=VSP_056885;
CC   -!- SIMILARITY: Belongs to the heat shock protein 70 family.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAA02807.1; Type=Frameshift; Positions=567, 586, 697, 715, 722; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB023420; BAA75062.1; -; mRNA.
DR   EMBL; BT007375; AAP36039.1; -; mRNA.
DR   EMBL; AC113410; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC002526; AAH02526.1; -; mRNA.
DR   EMBL; BC110861; AAI10862.1; -; mRNA.
DR   EMBL; BC126122; AAI26123.1; -; mRNA.
DR   EMBL; BC126124; AAI26125.1; -; mRNA.
DR   EMBL; L12723; AAA02807.1; ALT_FRAME; mRNA.
DR   CCDS; CCDS4166.1; -. [P34932-1]
DR   PIR; I56208; I56208.
DR   RefSeq; NP_002145.3; NM_002154.3. [P34932-1]
DR   UniGene; Hs.90093; -.
DR   ProteinModelPortal; P34932; -.
DR   SMR; P34932; -.
DR   BioGrid; 109540; 357.
DR   CORUM; P34932; -.
DR   DIP; DIP-460N; -.
DR   IntAct; P34932; 45.
DR   MINT; P34932; -.
DR   STRING; 9606.ENSP00000302961; -.
DR   iPTMnet; P34932; -.
DR   PhosphoSitePlus; P34932; -.
DR   SwissPalm; P34932; -.
DR   BioMuta; HSPA4; -.
DR   DMDM; 206729934; -.
DR   DOSAC-COBS-2DPAGE; P34932; -.
DR   REPRODUCTION-2DPAGE; IPI00002966; -.
DR   REPRODUCTION-2DPAGE; P34932; -.
DR   EPD; P34932; -.
DR   MaxQB; P34932; -.
DR   PaxDb; P34932; -.
DR   PeptideAtlas; P34932; -.
DR   PRIDE; P34932; -.
DR   DNASU; 3308; -.
DR   Ensembl; ENST00000304858; ENSP00000302961; ENSG00000170606. [P34932-1]
DR   GeneID; 3308; -.
DR   KEGG; hsa:3308; -.
DR   UCSC; uc003kyj.4; human. [P34932-1]
DR   CTD; 3308; -.
DR   DisGeNET; 3308; -.
DR   EuPathDB; HostDB:ENSG00000170606.13; -.
DR   GeneCards; HSPA4; -.
DR   HGNC; HGNC:5237; HSPA4.
DR   HPA; CAB025529; -.
DR   HPA; HPA010023; -.
DR   MIM; 601113; gene.
DR   neXtProt; NX_P34932; -.
DR   OpenTargets; ENSG00000170606; -.
DR   PharmGKB; PA29503; -.
DR   eggNOG; KOG0103; Eukaryota.
DR   eggNOG; COG0443; LUCA.
DR   GeneTree; ENSGT00390000016919; -.
DR   HOGENOM; HOG000228138; -.
DR   HOVERGEN; HBG047955; -.
DR   InParanoid; P34932; -.
DR   KO; K09489; -.
DR   OMA; KMDQPPQ; -.
DR   OrthoDB; EOG091G04Y6; -.
DR   PhylomeDB; P34932; -.
DR   TreeFam; TF105043; -.
DR   Reactome; R-HSA-3371453; Regulation of HSF1-mediated heat shock response.
DR   ChiTaRS; HSPA4; human.
DR   GeneWiki; HSPA4; -.
DR   GenomeRNAi; 3308; -.
DR   PRO; PR:P34932; -.
DR   Proteomes; UP000005640; Chromosome 5.
DR   Bgee; ENSG00000170606; -.
DR   CleanEx; HS_HSPA4; -.
DR   ExpressionAtlas; P34932; baseline and differential.
DR   Genevisible; P34932; HS.
DR   GO; GO:0005829; C:cytosol; IDA:UniProtKB.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; NAS:UniProtKB.
DR   GO; GO:0051131; P:chaperone-mediated protein complex assembly; IDA:BHF-UCL.
DR   GO; GO:0045040; P:protein import into mitochondrial outer membrane; IDA:BHF-UCL.
DR   GO; GO:0006986; P:response to unfolded protein; NAS:UniProtKB.
DR   Gene3D; 1.20.1270.10; -; 1.
DR   Gene3D; 2.60.34.10; -; 1.
DR   InterPro; IPR018181; Heat_shock_70_CS.
DR   InterPro; IPR029048; HSP70_C_sf.
DR   InterPro; IPR029047; HSP70_peptide-bd_sf.
DR   InterPro; IPR013126; Hsp_70_fam.
DR   PANTHER; PTHR19375; PTHR19375; 1.
DR   Pfam; PF00012; HSP70; 1.
DR   PRINTS; PR00301; HEATSHOCK70.
DR   SUPFAM; SSF100920; SSF100920; 2.
DR   SUPFAM; SSF100934; SSF100934; 2.
DR   PROSITE; PS00329; HSP70_2; 1.
DR   PROSITE; PS01036; HSP70_3; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Alternative splicing; ATP-binding; Complete proteome;
KW   Cytoplasm; Direct protein sequencing; Methylation; Nucleotide-binding;
KW   Phosphoprotein; Reference proteome; Stress response.
FT   CHAIN         1    840       Heat shock 70 kDa protein 4.
FT                                /FTId=PRO_0000078262.
FT   MOD_RES      53     53       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:Q61316}.
FT   MOD_RES      76     76       Phosphoserine.
FT                                {ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES      89     89       Phosphotyrosine.
FT                                {ECO:0000244|PubMed:15592455}.
FT   MOD_RES     336    336       Phosphotyrosine.
FT                                {ECO:0000244|PubMed:15592455,
FT                                ECO:0000244|PubMed:19690332}.
FT   MOD_RES     393    393       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     415    415       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q61316}.
FT   MOD_RES     430    430       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     538    538       Phosphothreonine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     546    546       Phosphoserine.
FT                                {ECO:0000244|PubMed:21406692}.
FT   MOD_RES     647    647       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     660    660       Phosphotyrosine.
FT                                {ECO:0000250|UniProtKB:Q61316}.
FT   MOD_RES     679    679       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     756    756       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     773    773       N6-methyllysine.
FT                                {ECO:0000244|PubMed:24129315}.
FT   VAR_SEQ     109    800       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|Ref.2}.
FT                                /FTId=VSP_056885.
FT   CONFLICT     94     94       L -> W (in Ref. 5; AAA02807).
FT                                {ECO:0000305}.
FT   CONFLICT    190    190       A -> R (in Ref. 5; AAA02807).
FT                                {ECO:0000305}.
FT   CONFLICT    583    586       NQLL -> ESAI (in Ref. 5; AAA02807).
FT                                {ECO:0000305}.
FT   CONFLICT    622    622       E -> R (in Ref. 1; BAA75062).
FT                                {ECO:0000305}.
FT   CONFLICT    644    644       D -> G (in Ref. 1; BAA75062).
FT                                {ECO:0000305}.
FT   CONFLICT    746    749       NNKL -> EVTP (in Ref. 5; AAA02807).
FT                                {ECO:0000305}.
SQ   SEQUENCE   840 AA;  94331 MW;  8B690A52A0729C2A CRC64;
     MSVVGIDLGF QSCYVAVARA GGIETIANEY SDRCTPACIS FGPKNRSIGA AAKSQVISNA
     KNTVQGFKRF HGRAFSDPFV EAEKSNLAYD IVQLPTGLTG IKVTYMEEER NFTTEQVTAM
     LLSKLKETAE SVLKKPVVDC VVSVPCFYTD AERRSVMDAT QIAGLNCLRL MNETTAVALA
     YGIYKQDLPA LEEKPRNVVF VDMGHSAYQV SVCAFNRGKL KVLATAFDTT LGGRKFDEVL
     VNHFCEEFGK KYKLDIKSKI RALLRLSQEC EKLKKLMSAN ASDLPLSIEC FMNDVDVSGT
     MNRGKFLEMC NDLLARVEPP LRSVLEQTKL KKEDIYAVEI VGGATRIPAV KEKISKFFGK
     ELSTTLNADE AVTRGCALQC AILSPAFKVR EFSITDVVPY PISLRWNSPA EEGSSDCEVF
     SKNHAAPFSK VLTFYRKEPF TLEAYYSSPQ DLPYPDPAIA QFSVQKVTPQ SDGSSSKVKV
     KVRVNVHGIF SVSSASLVEV HKSEENEEPM ETDQNAKEEE KMQVDQEEPH VEEQQQQTPA
     ENKAESEEME TSQAGSKDKK MDQPPQAKKA KVKTSTVDLP IENQLLWQID REMLNLYIEN
     EGKMIMQDKL EKERNDAKNA VEEYVYEMRD KLSGEYEKFV SEDDRNSFTL KLEDTENWLY
     EDGEDQPKQV YVDKLAELKN LGQPIKIRFQ ESEERPKLFE ELGKQIQQYM KIISSFKNKE
     DQYDHLDAAD MTKVEKSTNE AMEWMNNKLN LQNKQSLTMD PVVKSKEIEA KIKELTSTCS
     PIISKPKPKV EPPKEEQKNA EQNGPVDGQG DNPGPQAAEQ GTDTAVPSDS DKKLPEMDID
//
ID   K9JA46_HUMAN            Unreviewed;       732 AA.
AC   K9JA46;
DT   06-MAR-2013, integrated into UniProtKB/TrEMBL.
DT   06-MAR-2013, sequence version 1.
DT   23-MAY-2018, entry version 51.
DE   SubName: Full=Epididymis luminal secretory protein 52 {ECO:0000313|EMBL:ADD71695.1};
DE   SubName: Full=Epididymis secretory sperm binding protein Li 65p {ECO:0000313|EMBL:ACV87205.1};
DE   SubName: Full=Heat shock protein 90kDa alpha (Cytosolic), class A member 1, isoform CRA_a {ECO:0000313|EMBL:EAW81766.1};
GN   Name=EL52 {ECO:0000313|EMBL:ADD71695.1};
GN   Synonyms=HEL-S-65p {ECO:0000313|EMBL:ACV87205.1},
GN   HSP90AA1 {ECO:0000313|EMBL:EAW81766.1};
GN   ORFNames=hCG_1814169 {ECO:0000313|EMBL:EAW81766.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:ADD71695.1};
RN   [1] {ECO:0000313|EMBL:EAW81766.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAW81766.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3] {ECO:0000313|EMBL:ADD71695.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Li J.Y.;
RT   "Human epididymis cDNA library.";
RL   Submitted (MAY-2009) to the EMBL/GenBank/DDBJ databases.
RN   [4] {ECO:0000313|EMBL:ACV87205.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Sahoo P.;
RL   Submitted (AUG-2009) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; GQ472230; ACV87205.1; -; mRNA.
DR   EMBL; GQ149083; ADD71695.1; -; mRNA.
DR   EMBL; CH471061; EAW81766.1; -; Genomic_DNA.
DR   RefSeq; NP_005339.3; NM_005348.3.
DR   UniGene; Hs.525600; -.
DR   SMR; K9JA46; -.
DR   IntAct; K9JA46; 14.
DR   PRIDE; K9JA46; -.
DR   GeneID; 3320; -.
DR   KEGG; hsa:3320; -.
DR   CTD; 3320; -.
DR   EuPathDB; HostDB:ENSG00000080824.18; -.
DR   eggNOG; KOG0019; Eukaryota.
DR   eggNOG; KOG0020; Eukaryota.
DR   eggNOG; COG0326; LUCA.
DR   KO; K04079; -.
DR   ChiTaRS; HSP90AA1; human.
DR   GenomeRNAi; 3320; -.
DR   Bgee; ENSG00000080824; -.
DR   ExpressionAtlas; K9JA46; baseline and differential.
DR   GO; GO:0005737; C:cytoplasm; ISS:AgBase.
DR   GO; GO:0005634; C:nucleus; ISS:AgBase.
DR   GO; GO:0005524; F:ATP binding; IEA:InterPro.
DR   GO; GO:0051082; F:unfolded protein binding; IEA:InterPro.
DR   GO; GO:0006457; P:protein folding; IEA:InterPro.
DR   GO; GO:0046677; P:response to antibiotic; ISS:AgBase.
DR   GO; GO:0009409; P:response to cold; ISS:AgBase.
DR   GO; GO:0009408; P:response to heat; ISS:AgBase.
DR   CDD; cd00075; HATPase_c; 1.
DR   Gene3D; 1.20.120.790; -; 1.
DR   Gene3D; 3.30.565.10; -; 1.
DR   HAMAP; MF_00505; HSP90; 1.
DR   InterPro; IPR003594; HATPase_C.
DR   InterPro; IPR036890; HATPase_C_sf.
DR   InterPro; IPR019805; Heat_shock_protein_90_CS.
DR   InterPro; IPR037196; HSP90_C.
DR   InterPro; IPR001404; Hsp90_fam.
DR   InterPro; IPR020575; Hsp90_N.
DR   InterPro; IPR020568; Ribosomal_S5_D2-typ_fold.
DR   PANTHER; PTHR11528; PTHR11528; 1.
DR   Pfam; PF02518; HATPase_c; 1.
DR   Pfam; PF00183; HSP90; 1.
DR   PIRSF; PIRSF002583; Hsp90; 1.
DR   PRINTS; PR00775; HEATSHOCK90.
DR   SMART; SM00387; HATPase_c; 1.
DR   SUPFAM; SSF110942; SSF110942; 1.
DR   SUPFAM; SSF54211; SSF54211; 1.
DR   SUPFAM; SSF55874; SSF55874; 1.
DR   PROSITE; PS00298; HSP90; 1.
PE   2: Evidence at transcript level;
KW   Coiled coil {ECO:0000256|SAM:Coils};
KW   Stress response {ECO:0000313|EMBL:EAW81766.1}.
FT   DOMAIN       40    194       HATPase_c. {ECO:0000259|SMART:SM00387}.
FT   COILED      228    255       {ECO:0000256|SAM:Coils}.
FT   COILED      263    283       {ECO:0000256|SAM:Coils}.
FT   COILED      551    571       {ECO:0000256|SAM:Coils}.
SQ   SEQUENCE   732 AA;  84660 MW;  969F65FCC0BC86FD CRC64;
     MPEETQTQDQ PMEEEEVETF AFQAEIAQLM SLIINTFYSN KEIFLRELIS NSSDALDKIR
     YESLTDPSKL DSGKELHINL IPNKQDRTLT IVDTGIGMTK ADLINNLGTI AKSGTKAFME
     ALQAGADISM IGQFGVGFYS AYLVAEKVTV ITKHNDDEQY AWESSAGGSF TVRTDTGEPM
     GRGTKVILHL KEDQTEYLEE RRIKEIVKKH SQFIGYPITL FVEKERDKEV SDDEAEEKED
     KEEEKEKEEK ESEDKPEIED VGSDEEEEKK DGDKKKKKKI KEKYIDQEEL NKTKPIWTRN
     PDDITNEEYG EFYKSLTNDW EDHLAVKHFS VEGQLEFRAL LFVPRRAPFD LFENRKKKNN
     IKLYVRRVFI MDNCEELIPE YLNFIRGVVD SEDLPLNISR EMLQQSKILK VIRKNLVKKC
     LELFTELAED KENYKKFYEQ FSKNIKLGIH EDSQNRKKLS ELLRYYTSAS GDEMVSLKDY
     CTRMKENQKH IYYITGETKD QVANSAFVER LRKHGLEVIY MIEPIDEYCV QQLKEFEGKT
     LVSVTKEGLE LPEDEEEKKK QEEKKTKFEN LCKIMKDILE KKVEKVVVSN RLVTSPCCIV
     TSTYGWTANM ERIMKAQALR DNSTMGYMAA KKHLEINPDH SIIETLRQKA EADKNDKSVK
     DLVILLYETA LLSSGFSLED PQTHANRIYR MIKLGLGIDE DDPTADDTSA AVTEEMPPLE
     GDDDTSRMEE VD
//
ID   HS90A_HUMAN             Reviewed;         732 AA.
AC   P07900; A8K500; B3KPJ9; Q2PP14; Q5CAQ6; Q5CAQ7; Q9BVQ5;
DT   01-AUG-1988, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 5.
DT   23-MAY-2018, entry version 236.
DE   RecName: Full=Heat shock protein HSP 90-alpha;
DE   AltName: Full=Heat shock 86 kDa;
DE            Short=HSP 86;
DE            Short=HSP86;
DE   AltName: Full=Lipopolysaccharide-associated protein 2;
DE            Short=LAP-2;
DE            Short=LPS-associated protein 2;
DE   AltName: Full=Renal carcinoma antigen NY-REN-38;
GN   Name=HSP90AA1; Synonyms=HSP90A, HSPC1, HSPCA;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Peripheral blood lymphocyte;
RX   PubMed=2780322; DOI=10.1093/nar/17.17.7108;
RA   Soeda E., Yokoyama K., Yamazaki M., Akaogi K., Miwa T., Imai T.;
RT   "Nucleotide sequence of a full-length cDNA for 90 kDa heat-shock
RT   protein from human peripheral blood lymphocytes.";
RL   Nucleic Acids Res. 17:7108-7108(1989).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=1368637; DOI=10.1271/bbb1961.54.3163;
RA   Yamazaki M., Tashiro H., Yokoyama K., Soeda E.;
RT   "Molecular cloning of cDNA encoding a human heat-shock protein whose
RT   expression is induced by adenovirus type 12 E1A in HeLa cells.";
RL   Agric. Biol. Chem. 54:3163-3170(1990).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   TISSUE=Placenta;
RX   PubMed=2527334; DOI=10.1128/MCB.9.6.2615;
RA   Hickey E., Brandon S.E., Smale G., Lloyd D., Weber L.A.;
RT   "Sequence and regulation of a gene encoding a human 89-kilodalton heat
RT   shock protein.";
RL   Mol. Cell. Biol. 9:2615-2626(1989).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2), AND NOMENCLATURE.
RX   PubMed=16269234; DOI=10.1016/j.ygeno.2005.08.012;
RA   Chen B., Piel W.H., Gui L., Bruford E., Monteiro A.;
RT   "The HSP90 family of genes in the human genome: insights into their
RT   divergence and evolution.";
RL   Genomics 86:627-637(2005).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RG   NHLBI resequencing and genotyping service (RS&G);
RL   Submitted (DEC-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Placenta, and Teratocarcinoma;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12508121; DOI=10.1038/nature01348;
RA   Heilig R., Eckenberg R., Petit J.-L., Fonknechten N., Da Silva C.,
RA   Cattolico L., Levy M., Barbe V., De Berardinis V., Ureta-Vidal A.,
RA   Pelletier E., Vico V., Anthouard V., Rowen L., Madan A., Qin S.,
RA   Sun H., Du H., Pepin K., Artiguenave F., Robert C., Cruaud C.,
RA   Bruels T., Jaillon O., Friedlander L., Samson G., Brottier P.,
RA   Cure S., Segurens B., Aniere F., Samain S., Crespeau H., Abbasi N.,
RA   Aiach N., Boscus D., Dickhoff R., Dors M., Dubois I., Friedman C.,
RA   Gouyvenoux M., James R., Madan A., Mairey-Estrada B., Mangenot S.,
RA   Martins N., Menard M., Oztas S., Ratcliffe A., Shaffer T., Trask B.,
RA   Vacherie B., Bellemere C., Belser C., Besnard-Gonnet M.,
RA   Bartol-Mavel D., Boutard M., Briez-Silla S., Combette S.,
RA   Dufosse-Laurent V., Ferron C., Lechaplais C., Louesse C., Muselet D.,
RA   Magdelenat G., Pateau E., Petit E., Sirvain-Trukniewicz P., Trybou A.,
RA   Vega-Czarny N., Bataille E., Bluet E., Bordelais I., Dubois M.,
RA   Dumont C., Guerin T., Haffray S., Hammadi R., Muanga J., Pellouin V.,
RA   Robert D., Wunderle E., Gauguet G., Roy A., Sainte-Marthe L.,
RA   Verdier J., Verdier-Discala C., Hillier L.W., Fulton L., McPherson J.,
RA   Matsuda F., Wilson R., Scarpelli C., Gyapay G., Wincker P., Saurin W.,
RA   Quetier F., Waterston R., Hood L., Weissenbach J.;
RT   "The DNA sequence and analysis of human chromosome 14.";
RL   Nature 421:601-607(2003).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-312.
RX   PubMed=2469626; DOI=10.1016/0378-1119(88)90182-5;
RA   Hoffmann T., Hovemann B.;
RT   "Heat-shock proteins, Hsp84 and Hsp86, of mice and men: two related
RT   genes encode formerly identified tumour-specific transplantation
RT   antigens.";
RL   Gene 74:491-501(1988).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-312.
RX   PubMed=2591742; DOI=10.1016/0378-1119(89)90408-3;
RA   Walter T., Drabent B., Krebs H., Tomalak M., Heiss S., Benecke B.J.J.;
RT   "Cloning and analysis of a human 86-kDa heat-shock-protein-encoding
RT   gene.";
RL   Gene 83:105-115(1989).
RN   [11]
RP   PROTEIN SEQUENCE OF 101-112; 210-224; 300-314; 328-338; 346-355;
RP   387-400; 465-478 AND 633-647, AND IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Brain, Cajal-Retzius cell, and Fetal brain cortex;
RA   Lubec G., Vishwanath V., Chen W.-Q., Sun Y.;
RL   Submitted (DEC-2008) to UniProtKB.
RN   [12]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 185-732.
RC   TISSUE=Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [13]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 539-732.
RC   TISSUE=Heart;
RA   Tanaka M., Tanaka T., Mitsui Y., Yamamoto M., Wood J.N.;
RT   "The analysis of the genes reactive to monoclonal antibody, CE5.";
RL   Submitted (SEP-1996) to the EMBL/GenBank/DDBJ databases.
RN   [14]
RP   PROTEIN SEQUENCE OF 2-21, AND PHOSPHORYLATION AT SER-231 AND SER-263.
RX   PubMed=2492519;
RA   Lees-Miller S.P., Anderson C.W.;
RT   "Two human 90-kDa heat shock proteins are phosphorylated in vivo at
RT   conserved serines that are phosphorylated in vitro by casein kinase
RT   II.";
RL   J. Biol. Chem. 264:2431-2437(1989).
RN   [15]
RP   PROTEIN SEQUENCE OF 154-163 AND 186-191, AND INTERACTION WITH KSR1.
RX   PubMed=10409742; DOI=10.1128/MCB.19.8.5523;
RA   Stewart S., Sundaram M., Zhang Y., Lee J., Han M., Guan K.L.;
RT   "Kinase suppressor of Ras forms a multiprotein signaling complex and
RT   modulates MEK localization.";
RL   Mol. Cell. Biol. 19:5523-5534(1999).
RN   [16]
RP   PROTEIN SEQUENCE OF 592-612, FUNCTION, CATALYTIC ACTIVITY, MUTAGENESIS
RP   OF CYS-598, AND S-NITROSYLATION AT CYS-598.
RX   PubMed=15937123; DOI=10.1073/pnas.0407294102;
RA   Martinez-Ruiz A., Villanueva L., Gonzalez de Orduna C.,
RA   Lopez-Ferrer D., Higueras M.A., Tarin C., Rodriguez-Crespo I.,
RA   Vazquez J., Lamas S.;
RT   "S-nitrosylation of Hsp90 promotes the inhibition of its ATPase and
RT   endothelial nitric oxide synthase regulatory activities.";
RL   Proc. Natl. Acad. Sci. U.S.A. 102:8525-8530(2005).
RN   [17]
RP   PHOSPHORYLATION AT THR-5 AND THR-7.
RX   PubMed=2507541;
RA   Lees-Miller S.P., Anderson C.W.;
RT   "The human double-stranded DNA-activated protein kinase phosphorylates
RT   the 90-kDa heat-shock protein, hsp90 alpha at two NH2-terminal
RT   threonine residues.";
RL   J. Biol. Chem. 264:17275-17280(1989).
RN   [18]
RP   HOMODIMERIZATION.
RX   PubMed=8289821; DOI=10.1128/MCB.14.2.1459;
RA   Minami Y., Kimura Y., Kawasaki H., Suzuki K., Yahara I.;
RT   "The carboxy-terminal region of mammalian HSP90 is required for its
RT   dimerization and function in vivo.";
RL   Mol. Cell. Biol. 14:1459-1464(1994).
RN   [19]
RP   SUBUNIT.
RX   PubMed=7588731; DOI=10.1111/j.1432-1033.1995.001_1.x;
RA   Nemoto T., Ohara-Nemoto Y., Ota M., Takagi T., Yokoyama K.;
RT   "Mechanism of dimer formation of the 90-kDa heat-shock protein.";
RL   Eur. J. Biochem. 233:1-8(1995).
RN   [20]
RP   IDENTIFICATION IN A COMPLEX WITH NR3C1 AND FKBP4; PPID; PPP5C OR
RP   STIP1.
RX   PubMed=9195923; DOI=10.1074/jbc.272.26.16224;
RA   Silverstein A.M., Galigniana M.D., Chen M.S., Owens-Grillo J.K.,
RA   Chinkers M., Pratt W.B.;
RT   "Protein phosphatase 5 is a major component of glucocorticoid
RT   receptor.hsp90 complexes with properties of an FK506-binding
RT   immunophilin.";
RL   J. Biol. Chem. 272:16224-16230(1997).
RN   [21]
RP   INTERACTION WITH TOM34.
RX   PubMed=9660753; DOI=10.1074/jbc.273.29.18007;
RA   Young J.C., Obermann W.M., Hartl F.U.;
RT   "Specific binding of tetratricopeptide repeat proteins to the C-
RT   terminal 12-kDa domain of hsp90.";
RL   J. Biol. Chem. 273:18007-18010(1998).
RN   [22]
RP   IDENTIFICATION AS A RENAL CANCER ANTIGEN.
RC   TISSUE=Renal cell carcinoma;
RX   PubMed=10508479;
RX   DOI=10.1002/(SICI)1097-0215(19991112)83:4<456::AID-IJC4>3.0.CO;2-5;
RA   Scanlan M.J., Gordan J.D., Williamson B., Stockert E., Bander N.H.,
RA   Jongeneel C.V., Gure A.O., Jaeger D., Jaeger E., Knuth A., Chen Y.-T.,
RA   Old L.J.;
RT   "Antigens recognized by autologous antibody in patients with renal-
RT   cell carcinoma.";
RL   Int. J. Cancer 83:456-464(1999).
RN   [23]
RP   INTERACTION WITH TERT, AND FUNCTION AS A CO-CHAPERONE IN TELOMERASE
RP   HOLOENZYME ASSEMBLY.
RX   PubMed=11274138; DOI=10.1074/jbc.C100055200;
RA   Forsythe H.L., Jarvis J.L., Turner J.W., Elmore L.W., Holt S.E.;
RT   "Stable association of hsp90 and p23, but Not hsp70, with active human
RT   telomerase.";
RL   J. Biol. Chem. 276:15571-15574(2001).
RN   [24]
RP   INTERACTION WITH HSF1.
RX   PubMed=11583998; DOI=10.1074/jbc.M105931200;
RA   Guo Y., Guettouche T., Fenna M., Boellmann F., Pratt W.B., Toft D.O.,
RA   Smith D.F., Voellmy R.;
RT   "Evidence for a mechanism of repression of heat shock factor 1
RT   transcriptional activity by a multichaperone complex.";
RL   J. Biol. Chem. 276:45791-45799(2001).
RN   [25]
RP   FUNCTION, IDENTIFICATION AS LPS RECEPTOR, INTERACTION WITH CXCR4; GDF5
RP   AND HSPA8, SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=11276205; DOI=10.1038/86342;
RA   Triantafilou K., Triantafilou M., Dedrick R.L.;
RT   "A CD14-independent LPS receptor cluster.";
RL   Nat. Immunol. 2:338-345(2001).
RN   [26]
RP   INTERACTION WITH DNAJC7.
RX   PubMed=12853476; DOI=10.1093/emboj/cdg362;
RA   Brychzy A., Rein T., Winklhofer K.F., Hartl F.U., Young J.C.,
RA   Obermann W.M.;
RT   "Cofactor Tpr2 combines two TPR domains and a J domain to regulate the
RT   Hsp70/Hsp90 chaperone system.";
RL   EMBO J. 22:3613-3623(2003).
RN   [27]
RP   INTERACTION WITH AHSA1.
RX   PubMed=12604615; DOI=10.1074/jbc.M212761200;
RA   Lotz G.P., Lin H., Harst A., Obermann W.M.J.;
RT   "Aha1 binds to the middle domain of Hsp90, contributes to client
RT   protein activation, and stimulates the ATPase activity of the
RT   molecular chaperone.";
RL   J. Biol. Chem. 278:17228-17235(2003).
RN   [28]
RP   INTERACTION WITH SMYD3.
RX   PubMed=15235609; DOI=10.1038/ncb1151;
RA   Hamamoto R., Furukawa Y., Morita M., Iimura Y., Silva F.P., Li M.,
RA   Yagyu R., Nakamura Y.;
RT   "SMYD3 encodes a histone methyltransferase involved in the
RT   proliferation of cancer cells.";
RL   Nat. Cell Biol. 6:731-740(2004).
RN   [29]
RP   INTERACTION WITH SGTA AND TTC1.
RX   PubMed=15708368; DOI=10.1016/j.abb.2004.12.020;
RA   Liou S.T., Wang C.;
RT   "Small glutamine-rich tetratricopeptide repeat-containing protein is
RT   composed of three structural units with distinct functions.";
RL   Arch. Biochem. Biophys. 435:253-263(2005).
RN   [30]
RP   INTERACTION WITH PPP5C, AND IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=15383005; DOI=10.1042/BJ20040690;
RA   Zeke T., Morrice N., Vazquez-Martin C., Cohen P.T.;
RT   "Human protein phosphatase 5 dissociates from heat-shock proteins and
RT   is proteolytically activated in response to arachidonic acid and the
RT   microtubule-depolymerizing drug nocodazole.";
RL   Biochem. J. 385:45-56(2005).
RN   [31]
RP   FUNCTION, AND INTERACTION WITH PPP5C.
RX   PubMed=15577939; DOI=10.1038/sj.emboj.7600496;
RA   Yang J., Roe S.M., Cliff M.J., Williams M.A., Ladbury J.E.,
RA   Cohen P.T., Barford D.;
RT   "Molecular basis for TPR domain-mediated regulation of protein
RT   phosphatase 5.";
RL   EMBO J. 24:1-10(2005).
RN   [32]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-231 AND SER-263, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [33]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-263, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Pituitary;
RX   PubMed=16807684; DOI=10.1007/s11102-006-8916-x;
RA   Beranova-Giorgianni S., Zhao Y., Desiderio D.M., Giorgianni F.;
RT   "Phosphoproteomic analysis of the human pituitary.";
RL   Pituitary 9:109-120(2006).
RN   [34]
RP   INTERACTION WITH PPP5C.
RX   PubMed=16531226; DOI=10.1016/j.str.2005.12.009;
RA   Cliff M.J., Harris R., Barford D., Ladbury J.E., Williams M.A.;
RT   "Conformational diversity in the TPR domain-mediated interaction of
RT   protein phosphatase 5 with Hsp90.";
RL   Structure 14:415-426(2006).
RN   [35]
RP   SUBUNIT, ENZYME REGULATION, AND BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=18400751; DOI=10.1074/jbc.M800540200;
RA   Richter K., Soroka J., Skalniak L., Leskovar A., Hessling M.,
RA   Reinstein J., Buchner J.;
RT   "Conserved conformational changes in the ATPase cycle of human
RT   Hsp90.";
RL   J. Biol. Chem. 283:17757-17765(2008).
RN   [36]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-263, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=T-cell;
RX   PubMed=19367720; DOI=10.1021/pr800500r;
RA   Carrascal M., Ovelleiro D., Casas V., Gay M., Abian J.;
RT   "Phosphorylation analysis of primary human T lymphocytes using
RT   sequential IMAC and titanium oxide enrichment.";
RL   J. Proteome Res. 7:5167-5176(2008).
RN   [37]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-252 AND SER-263, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Platelet;
RX   PubMed=18088087; DOI=10.1021/pr0704130;
RA   Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J.,
RA   Schuetz C., Walter U., Gambaryan S., Sickmann A.;
RT   "Phosphoproteome of resting human platelets.";
RL   J. Proteome Res. 7:526-534(2008).
RN   [38]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-263, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [39]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-263, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [40]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-231 AND SER-263, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=18318008; DOI=10.1002/pmic.200700884;
RA   Han G., Ye M., Zhou H., Jiang X., Feng S., Jiang X., Tian R., Wan D.,
RA   Zou H., Gu J.;
RT   "Large-scale phosphoproteome analysis of human liver tissue by
RT   enrichment and fractionation of phosphopeptides with strong anion
RT   exchange chromatography.";
RL   Proteomics 8:1346-1361(2008).
RN   [41]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [42]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [43]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-443; LYS-458; LYS-489 AND
RP   LYS-585, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [44]
RP   INTERACTION WITH CHORDC1.
RX   PubMed=19875381; DOI=10.1074/mcp.M900261-MCP200;
RA   Gano J.J., Simon J.A.;
RT   "A proteomic investigation of ligand-dependent HSP90 complexes reveals
RT   CHORDC1 as a novel ADP-dependent HSP90-interacting protein.";
RL   Mol. Cell. Proteomics 9:255-270(2010).
RN   [45]
RP   ISGYLATION.
RX   PubMed=16139798; DOI=10.1016/j.bbrc.2005.08.132;
RA   Giannakopoulos N.V., Luo J.K., Papov V., Zou W., Lenschow D.J.,
RA   Jacobs B.S., Borden E.C., Li J., Virgin H.W., Zhang D.E.;
RT   "Proteomic identification of proteins conjugated to ISG15 in mouse and
RT   human cells.";
RL   Biochem. Biophys. Res. Commun. 336:496-506(2005).
RN   [46]
RP   SUBCELLULAR LOCATION [LARGE SCALE ANALYSIS].
RC   TISSUE=Melanoma;
RX   PubMed=17081065; DOI=10.1021/pr060363j;
RA   Chi A., Valencia J.C., Hu Z.-Z., Watabe H., Yamaguchi H.,
RA   Mangini N.J., Huang H., Canfield V.A., Cheng K.C., Yang F., Abe R.,
RA   Yamagishi S., Shabanowitz J., Hearing V.J., Wu C., Appella E.,
RA   Hunt D.F.;
RT   "Proteomic and bioinformatic characterization of the biogenesis and
RT   function of melanosomes.";
RL   J. Proteome Res. 5:3135-3144(2006).
RN   [47]
RP   INTERACTION WITH FNIP1, AND IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=17028174; DOI=10.1073/pnas.0603781103;
RA   Baba M., Hong S.-B., Sharma N., Warren M.B., Nickerson M.L.,
RA   Iwamatsu A., Esposito D., Gillette W.K., Hopkins R.F. III,
RA   Hartley J.L., Furihata M., Oishi S., Zhen W., Burke T.R. Jr.,
RA   Linehan W.M., Schmidt L.S., Zbar B.;
RT   "Folliculin encoded by the BHD gene interacts with a binding protein,
RT   FNIP1, and AMPK, and is involved in AMPK and mTOR signaling.";
RL   Proc. Natl. Acad. Sci. U.S.A. 103:15552-15557(2006).
RN   [48]
RP   MUTAGENESIS OF GLY-97.
RX   PubMed=18256191; DOI=10.1242/dev.018150;
RA   Hawkins T.A., Haramis A.P., Etard C., Prodromou C., Vaughan C.K.,
RA   Ashworth R., Ray S., Behra M., Holder N., Talbot W.S., Pearl L.H.,
RA   Strahle U., Wilson S.W.;
RT   "The ATPase-dependent chaperoning activity of Hsp90a regulates thick
RT   filament formation and integration during skeletal muscle
RT   myofibrillogenesis.";
RL   Development 135:1147-1156(2008).
RN   [49]
RP   MUTAGENESIS OF CYS-598.
RX   PubMed=19696785; DOI=10.1038/embor.2009.153;
RA   Retzlaff M., Stahl M., Eberl H.C., Lagleder S., Beck J., Kessler H.,
RA   Buchner J.;
RT   "Hsp90 is regulated by a switch point in the C-terminal domain.";
RL   EMBO Rep. 10:1147-1153(2009).
RN   [50]
RP   INTERACTION WITH HSP90AB1.
RX   PubMed=20353823; DOI=10.1016/j.cellsig.2010.03.012;
RA   Cheng M.B., Zhang Y., Zhong X., Sutter B., Cao C.Y., Chen X.S.,
RA   Cheng X.K., Zhang Y., Xiao L., Shen Y.F.;
RT   "Stat1 mediates an auto-regulation of hsp90beta gene in heat shock
RT   response.";
RL   Cell. Signal. 22:1206-1213(2010).
RN   [51]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [52]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [53]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-252, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [54]
RP   INTERACTION WITH CDC37.
RX   PubMed=23569206; DOI=10.1074/jbc.M112.439257;
RA   Eckl J.M., Rutz D.A., Haslbeck V., Zierer B.K., Reinstein J.,
RA   Richter K.;
RT   "Cdc37 (cell division cycle 37) restricts Hsp90 (heat shock protein
RT   90) motility by interaction with N-terminal and middle domain binding
RT   sites.";
RL   J. Biol. Chem. 288:16032-16042(2013).
RN   [55]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-231; SER-252; SER-263;
RP   SER-476 AND SER-641, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE
RP   SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [56]
RP   FUNCTION, AND INTERACTION WITH STUB1 AND SMAD3.
RX   PubMed=24613385; DOI=10.1016/j.bbrc.2014.02.124;
RA   Shang Y., Xu X., Duan X., Guo J., Wang Y., Ren F., He D., Chang Z.;
RT   "Hsp70 and Hsp90 oppositely regulate TGF-beta signaling through
RT   CHIP/Stub1.";
RL   Biochem. Biophys. Res. Commun. 446:387-392(2014).
RN   [57]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-231, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [58]
RP   INTERACTION WITH NWD1.
RX   PubMed=24681825;
RA   Correa R.G., Krajewska M., Ware C.F., Gerlic M., Reed J.C.;
RT   "The NLR-related protein NWD1 is associated with prostate cancer and
RT   modulates androgen receptor signaling.";
RL   Oncotarget 5:1666-1682(2014).
RN   [59]
RP   REVIEW.
RX   PubMed=25973397; DOI=10.3389/fonc.2015.00100;
RA   Khurana N., Bhattacharyya S.;
RT   "Hsp90, the concertmaster: tuning transcription.";
RL   Front. Oncol. 5:100-100(2015).
RN   [60]
RP   INTERACTION WITH SMYD3.
RX   PubMed=25738358; DOI=10.18632/oncotarget.2970;
RA   Brown M.A., Foreman K., Harriss J., Das C., Zhu L., Edwards M.,
RA   Shaaban S., Tucker H.;
RT   "C-terminal domain of SMYD3 serves as a unique HSP90-regulated motif
RT   in oncogenesis.";
RL   Oncotarget 6:4005-4019(2015).
RN   [61]
RP   INTERACTION WITH HSF1; HIF1A; ERBB2; MET; KEAP1 AND RHOBTB2, AND
RP   MUTAGENESIS OF GLU-47 AND ASP-93.
RX   PubMed=26517842; DOI=10.1371/journal.pone.0141786;
RA   Prince T.L., Kijima T., Tatokoro M., Lee S., Tsutsumi S., Yim K.,
RA   Rivas C., Alarcon S., Schwartz H., Khamit-Kush K., Scroggins B.T.,
RA   Beebe K., Trepel J.B., Neckers L.;
RT   "Client proteins and small molecule inhibitors display distinct
RT   binding preferences for constitutive and stress-induced HSP90 isoforms
RT   and their conformationally restricted mutants.";
RL   PLoS ONE 10:E0141786-E0141786(2015).
RN   [62]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [63]
RP   REVIEW.
RX   PubMed=27295069; DOI=10.1016/j.biochi.2016.05.018;
RA   Verma S., Goyal S., Jamal S., Singh A., Grover A.;
RT   "Hsp90: Friends, clients and natural foes.";
RL   Biochimie 127:227-240(2016).
RN   [64]
RP   REVIEW.
RX   PubMed=26991466; DOI=10.1002/bip.22835;
RA   Pearl L.H.;
RT   "Review: The HSP90 molecular chaperone-an enigmatic ATPase.";
RL   Biopolymers 105:594-607(2016).
RN   [65]
RP   FUNCTION, AND INTERACTION WITH FLCN; AHSA1; HSP70; CDC37; FNIP1;
RP   FNIP2; STUB1; STIP1; PTGES3 AND PPP5C.
RX   PubMed=27353360; DOI=10.1038/ncomms12037;
RA   Woodford M.R., Dunn D.M., Blanden A.R., Capriotti D., Loiselle D.,
RA   Prodromou C., Panaretou B., Hughes P.F., Smith A., Ackerman W.,
RA   Haystead T.A., Loh S.N., Bourboulia D., Schmidt L.S.,
RA   Marston Linehan W., Bratslavsky G., Mollapour M.;
RT   "The FNIP co-chaperones decelerate the Hsp90 chaperone cycle and
RT   enhance drug binding.";
RL   Nat. Commun. 7:12037-12037(2016).
RN   [66]
RP   INTERACTION WITH HSF1.
RX   PubMed=26754925; DOI=10.1038/srep19174;
RA   Asano Y., Kawase T., Okabe A., Tsutsumi S., Ichikawa H., Tatebe S.,
RA   Kitabayashi I., Tashiro F., Namiki H., Kondo T., Semba K.,
RA   Aburatani H., Taya Y., Nakagama H., Ohki R.;
RT   "IER5 generates a novel hypo-phosphorylated active form of HSF1 and
RT   contributes to tumorigenesis.";
RL   Sci. Rep. 6:19174-19174(2016).
RN   [67]
RP   FUNCTION, ENZYME REGULATION, IDENTIFICATION IN A COMPLEX WITH TSC1 AND
RP   TSC2, INTERACTION WITH TSC1 AND AHSA1, SUBUNIT, AND MUTAGENESIS OF
RP   GLU-47; ASP-93; TYR-313 AND 728-MET--ASP-732.
RX   PubMed=29127155; DOI=10.15252/embj.201796700;
RA   Woodford M.R., Sager R.A., Marris E., Dunn D.M., Blanden A.R.,
RA   Murphy R.L., Rensing N., Shapiro O., Panaretou B., Prodromou C.,
RA   Loh S.N., Gutmann D.H., Bourboulia D., Bratslavsky G., Wong M.,
RA   Mollapour M.;
RT   "Tumor suppressor Tsc1 is a new Hsp90 co-chaperone that facilitates
RT   folding of kinase and non-kinase clients.";
RL   EMBO J. 36:3650-3665(2017).
RN   [68]
RP   X-RAY CRYSTALLOGRAPHY (1.9 ANGSTROMS) OF 11-223 IN COMPLEX WITH
RP   GELDANAMYCIN.
RX   PubMed=9108479; DOI=10.1016/S0092-8674(00)80203-2;
RA   Stebbins C.E., Russo A.A., Schneider C., Rosen N., Hartl F.U.,
RA   Pavletich N.P.;
RT   "Crystal structure of an Hsp90-geldanamycin complex: targeting of a
RT   protein chaperone by an antitumor agent.";
RL   Cell 89:239-250(1997).
RN   [69]
RP   X-RAY CRYSTALLOGRAPHY (1.5 ANGSTROMS) OF 11-223 IN COMPLEX WITH ADP,
RP   CATALYTIC ACTIVITY, AND INTERACTION WITH PTGES3.
RX   PubMed=9817749; DOI=10.1083/jcb.143.4.901;
RA   Obermann W.M., Sondermann H., Russo A.A., Pavletich N.P., Hartl F.U.;
RT   "In vivo function of Hsp90 is dependent on ATP binding and ATP
RT   hydrolysis.";
RL   J. Cell Biol. 143:901-910(1998).
RN   [70]
RP   X-RAY CRYSTALLOGRAPHY (3.30 ANGSTROMS) OF 724-732 IN COMPLEX WITH
RP   STUB1, INTERACTION WITH STUB1 AND UBE2N, AND MOTIF TPR REPEAT-BINDING.
RX   PubMed=16307917; DOI=10.1016/j.molcel.2005.09.023;
RA   Zhang M., Windheim M., Roe S.M., Peggie M., Cohen P., Prodromou C.,
RA   Pearl L.H.;
RT   "Chaperoned ubiquitylation -- crystal structures of the CHIP U box E3
RT   ubiquitin ligase and a CHIP-Ubc13-Uev1a complex.";
RL   Mol. Cell 20:525-538(2005).
CC   -!- FUNCTION: Molecular chaperone that promotes the maturation,
CC       structural maintenance and proper regulation of specific target
CC       proteins involved for instance in cell cycle control and signal
CC       transduction. Undergoes a functional cycle that is linked to its
CC       ATPase activity which is essential for its chaperone activity.
CC       This cycle probably induces conformational changes in the client
CC       proteins, thereby causing their activation. Interacts dynamically
CC       with various co-chaperones that modulate its substrate
CC       recognition, ATPase cycle and chaperone function (PubMed:11274138,
CC       PubMed:15577939, PubMed:15937123, PubMed:27353360,
CC       PubMed:29127155). Engages with a range of client protein classes
CC       via its interaction with various co-chaperone proteins or
CC       complexes, that act as adapters, simultaneously able to interact
CC       with the specific client and the central chaperone itself
CC       (PubMed:29127155). Recruitment of ATP and co-chaperone followed by
CC       client protein forms a functional chaperone. After the completion
CC       of the chaperoning process, properly folded client protein and co-
CC       chaperone leave HSP90 in an ADP-bound partially open conformation
CC       and finally, ADP is released from HSP90 which acquires an open
CC       conformation for the next cycle (PubMed:27295069,
CC       PubMed:26991466). Apart from its chaperone activity, it also plays
CC       a role in the regulation of the transcription machinery. HSP90 and
CC       its co-chaperones modulate transcription at least at three
CC       different levels (PubMed:25973397). In the first place, they alter
CC       the steady-state levels of certain transcription factors in
CC       response to various physiological cues(PubMed:25973397). Second,
CC       they modulate the activity of certain epigenetic modifiers, such
CC       as histone deacetylases or DNA methyl transferases, and thereby
CC       respond to the change in the environment (PubMed:25973397). Third,
CC       they participate in the eviction of histones from the promoter
CC       region of certain genes and thereby turn on gene expression
CC       (PubMed:25973397). Binds bacterial lipopolysaccharide (LPS) and
CC       mediates LPS-induced inflammatory response, including TNF
CC       secretion by monocytes (PubMed:11276205). Antagonizes STUB1-
CC       mediated inhibition of TGF-beta signaling via inhibition of STUB1-
CC       mediated SMAD3 ubiquitination and degradation (PubMed:24613385).
CC       {ECO:0000269|PubMed:11274138, ECO:0000269|PubMed:11276205,
CC       ECO:0000269|PubMed:15577939, ECO:0000269|PubMed:15937123,
CC       ECO:0000269|PubMed:24613385, ECO:0000269|PubMed:27353360,
CC       ECO:0000269|PubMed:29127155, ECO:0000303|PubMed:25973397,
CC       ECO:0000303|PubMed:26991466, ECO:0000303|PubMed:27295069}.
CC   -!- ENZYME REGULATION: In the resting state, through the dimerization
CC       of its C-terminal domain, HSP90 forms a homodimer which is defined
CC       as the open conformation (PubMed:18400751). Upon ATP-binding, the
CC       N-terminal domain undergoes significant conformational changes and
CC       comes in contact to form an active closed conformation
CC       (PubMed:18400751). After HSP90 finishes its chaperoning tasks of
CC       assisting the proper folding, stabilization and activation of
CC       client proteins under the active state, ATP molecule is hydrolyzed
CC       to ADP which then dissociates from HSP90 and directs the protein
CC       back to the resting state (PubMed:18400751). Co-chaperone TSC1
CC       promotes ATP binding and inhibits HSP90AA1 ATPase activity
CC       (PubMed:29127155). Binding to phosphorylated AHSA1 promotes
CC       HSP90AA1 ATPase activity (PubMed:29127155). Inhibited by
CC       Ganetespib (STA-9090) and SNX-2112 (PubMed:29127155).
CC       {ECO:0000269|PubMed:18400751, ECO:0000269|PubMed:29127155}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=300 uM for ATP {ECO:0000269|PubMed:18400751};
CC   -!- SUBUNIT: Homodimer (PubMed:7588731, PubMed:8289821,
CC       PubMed:18400751, PubMed:29127155). Identified in NR3C1/GCR steroid
CC       receptor-chaperone complexes formed at least by NR3C1, HSP90AA1
CC       and a variety of proteins containing TPR repeats such as FKBP4,
CC       FKBP5, PPID, PPP5C or STIP1 (PubMed:15383005, PubMed:9195923).
CC       Forms a complex containing HSP90AA1, TSC1 and TSC2; TSC1 is
CC       required to recruit TCS2 to the complex (PubMed:29127155). The
CC       closed form interacts (via the middle domain and TPR repeat-
CC       binding motif) with co-chaperone TSC1 (via C-terminus)
CC       (PubMed:29127155). Interacts with TOM34 (PubMed:9660753).
CC       Interacts with TERT; the interaction, together with PTGES3, is
CC       required for correct assembly and stabilization of the TERT
CC       holoenzyme complex (PubMed:11274138, PubMed:9817749). Interacts
CC       with CHORDC1 and DNAJC7 (PubMed:12853476, PubMed:19875381).
CC       Interacts with STUB1 and UBE2N; may couple the chaperone and
CC       ubiquitination systems (PubMed:16307917, PubMed:27353360).
CC       Interacts (via TPR repeat-binding motif) with PPP5C (via TPR
CC       repeats); the interaction is direct and activates PPP5C
CC       phosphatase activity (PubMed:15383005, PubMed:15577939,
CC       PubMed:16531226, PubMed:27353360). Following LPS binding, may form
CC       a complex with CXCR4, GDF5 and HSPA8 (PubMed:11276205). Interacts
CC       with KSR1 (PubMed:10409742). Interacts with co-chaperone CDC37
CC       (via C-terminus); the interaction inhibits HSP90AA1 ATPase
CC       activity (PubMed:23569206, PubMed:27353360). May interact with
CC       NWD1 (PubMed:24681825). Interacts with FNIP1 and FNIP2; the
CC       interaction inhibits HSP90AA1 ATPase activity (PubMed:17028174,
CC       PubMed:27353360). Interacts with co-chaperone AHSA1
CC       (phosphorylated on 'Tyr-223'); the interaction activates HSP90AA1
CC       ATPase activity and results in the dissociation of TSC1 from
CC       HSP90AA1 (PubMed:12604615, PubMed:27353360, PubMed:29127155).
CC       Interacts with FLCN in the presence of FNIP1 (PubMed:27353360).
CC       Interacts with HSP70, STIP1 and PTGES3 (PubMed:27353360).
CC       Interacts with SMYD3; this interaction enhances SMYD3 histone-
CC       lysine N-methyltransferase (PubMed:15235609, PubMed:25738358).
CC       Interacts with SGTA (via TPR repeats) (PubMed:15708368). Interacts
CC       with TTC1 (via TPR repeats) (PubMed:15708368). Interacts with HSF1
CC       in an ATP-dependent manner (PubMed:11583998. PubMed:26517842).
CC       Interacts with MET; the interaction suppresses MET kinase activity
CC       (PubMed:26517842). Interacts with ERBB2 in an ATP-dependent
CC       manner; the interaction suppresses ERBB2 kinase activity
CC       (PubMed:26517842). Interacts with HIF1A, KEAP1 and RHOBTB2
CC       (PubMed:26517842). Interacts with HSF1; this interaction is
CC       decreased in a IER5-dependent manner, promoting HSF1 accumulation
CC       in the nucleus, homotrimerization and DNA-binding activities
CC       (PubMed:26754925). Interacts with STUB1 and SMAD3
CC       (PubMed:24613385). Interacts with HSP90AB1; interaction is
CC       constitutive (PubMed:20353823). Interacts with HECTD1 (via N-
CC       terminus) (By similarity). {ECO:0000250|UniProtKB:P07901,
CC       ECO:0000269|PubMed:10409742, ECO:0000269|PubMed:11274138,
CC       ECO:0000269|PubMed:11276205, ECO:0000269|PubMed:11583998,
CC       ECO:0000269|PubMed:12604615, ECO:0000269|PubMed:12853476,
CC       ECO:0000269|PubMed:15235609, ECO:0000269|PubMed:15383005,
CC       ECO:0000269|PubMed:15577939, ECO:0000269|PubMed:15708368,
CC       ECO:0000269|PubMed:16307917, ECO:0000269|PubMed:16531226,
CC       ECO:0000269|PubMed:17028174, ECO:0000269|PubMed:18400751,
CC       ECO:0000269|PubMed:19875381, ECO:0000269|PubMed:20353823,
CC       ECO:0000269|PubMed:23569206, ECO:0000269|PubMed:24613385,
CC       ECO:0000269|PubMed:24681825, ECO:0000269|PubMed:25738358,
CC       ECO:0000269|PubMed:26517842, ECO:0000269|PubMed:26754925,
CC       ECO:0000269|PubMed:27353360, ECO:0000269|PubMed:29127155,
CC       ECO:0000269|PubMed:7588731, ECO:0000269|PubMed:8289821,
CC       ECO:0000269|PubMed:9195923, ECO:0000269|PubMed:9660753,
CC       ECO:0000269|PubMed:9817749}.
CC   -!- INTERACTION:
CC       Self; NbExp=6; IntAct=EBI-296047, EBI-296047;
CC       O95433:AHSA1; NbExp=4; IntAct=EBI-296047, EBI-448610;
CC       Q8IWD4:CCDC117; NbExp=5; IntAct=EBI-296047, EBI-3387963;
CC       Q16543:CDC37; NbExp=14; IntAct=EBI-296047, EBI-295634;
CC       Q7L3B6:CDC37L1; NbExp=2; IntAct=EBI-296047, EBI-2841876;
CC       P50750:CDK9; NbExp=2; IntAct=EBI-296047, EBI-1383449;
CC       Q96G23:CERS2; NbExp=2; IntAct=EBI-296047, EBI-1057080;
CC       Q9UHD1:CHORDC1; NbExp=8; IntAct=EBI-296047, EBI-2550959;
CC       O15111:CHUK; NbExp=3; IntAct=EBI-296047, EBI-81249;
CC       P00533:EGFR; NbExp=5; IntAct=EBI-296047, EBI-297353;
CC       P04626:ERBB2; NbExp=5; IntAct=EBI-296047, EBI-641062;
CC       Q02790:FKBP4; NbExp=8; IntAct=EBI-296047, EBI-1047444;
CC       Q14318:FKBP8; NbExp=7; IntAct=EBI-296047, EBI-724839;
CC       Q6PK50:HSP90AB1; NbExp=2; IntAct=EBI-296047, EBI-9356629;
CC       Q9Y6K9:IKBKG; NbExp=3; IntAct=EBI-296047, EBI-81279;
CC       Q9UHH9:IP6K2; NbExp=2; IntAct=EBI-296047, EBI-747509;
CC       P05412:JUN; NbExp=4; IntAct=EBI-296047, EBI-852823;
CC       Q6VAB6:KSR2; NbExp=5; IntAct=EBI-296047, EBI-6424389;
CC       O43318-2:MAP3K7; NbExp=5; IntAct=EBI-296047, EBI-358700;
CC       P04150:NR3C1; NbExp=7; IntAct=EBI-296047, EBI-493507;
CC       Q8WVJ2:NUDCD2; NbExp=4; IntAct=EBI-296047, EBI-1052153;
CC       P43034:PAFAH1B1; NbExp=5; IntAct=EBI-296047, EBI-720620;
CC       P26882:PPID (xeno); NbExp=4; IntAct=EBI-296047, EBI-6477155;
CC       P53041:PPP5C; NbExp=11; IntAct=EBI-296047, EBI-716663;
CC       Q15185:PTGES3; NbExp=6; IntAct=EBI-296047, EBI-1049387;
CC       Q9H6T3:RPAP3; NbExp=6; IntAct=EBI-296047, EBI-356928;
CC       P61247:RPS3A; NbExp=3; IntAct=EBI-296047, EBI-352378;
CC       P35467:S100a1 (xeno); NbExp=4; IntAct=EBI-296047, EBI-6477109;
CC       Q15831:STK11; NbExp=2; IntAct=EBI-296047, EBI-306838;
CC       Q9UNE7:STUB1; NbExp=9; IntAct=EBI-296047, EBI-357085;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:P07901}.
CC       Cytoplasm {ECO:0000250|UniProtKB:P07901}. Melanosome
CC       {ECO:0000269|PubMed:17081065}. Cell membrane
CC       {ECO:0000269|PubMed:11276205}. Note=Identified by mass
CC       spectrometry in melanosome fractions from stage I to stage IV.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1; Synonyms=HSP90AA1-1, HSP90-alpha 2;
CC         IsoId=P07900-1; Sequence=Displayed;
CC       Name=2; Synonyms=HSP90AA1-2;
CC         IsoId=P07900-2; Sequence=VSP_026604;
CC         Note=Variant in position: 71:M->L (in dbSNP:rs8005905).;
CC   -!- DOMAIN: The TPR repeat-binding motif mediates interaction with TPR
CC       repeat-containing proteins like the co-chaperone STUB1.
CC       {ECO:0000269|PubMed:16307917}.
CC   -!- PTM: ISGylated. {ECO:0000269|PubMed:16139798}.
CC   -!- PTM: S-nitrosylated; negatively regulates the ATPase activity and
CC       the activation of eNOS by HSP90AA1. {ECO:0000269|PubMed:15937123}.
CC   -!- PTM: Ubiquitinated via 'Lys-63'-linked polyubiquitination by
CC       HECTD1. Ubiquitination promotes translocation into the cytoplasm
CC       away from the membrane and secretory pathways.
CC       {ECO:0000250|UniProtKB:P07901}.
CC   -!- SIMILARITY: Belongs to the heat shock protein 90 family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X15183; CAA33259.1; -; mRNA.
DR   EMBL; M27024; AAA63194.1; -; Genomic_DNA.
DR   EMBL; AJ890082; CAI64495.1; -; mRNA.
DR   EMBL; AJ890083; CAI64496.1; -; mRNA.
DR   EMBL; DQ314871; ABC40730.1; -; Genomic_DNA.
DR   EMBL; AK056446; BAG51711.1; -; mRNA.
DR   EMBL; AK291115; BAF83804.1; -; mRNA.
DR   EMBL; AK291607; BAF84296.1; -; mRNA.
DR   EMBL; AL133223; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471061; EAW81765.1; -; Genomic_DNA.
DR   EMBL; X07270; CAA30255.1; -; mRNA.
DR   EMBL; M30626; AAA36023.1; -; Genomic_DNA.
DR   EMBL; BC000987; AAH00987.1; -; mRNA.
DR   EMBL; BC121062; AAI21063.1; -; mRNA.
DR   EMBL; D87666; BAA13430.1; -; mRNA.
DR   EMBL; D87666; BAA13431.1; -; mRNA.
DR   CCDS; CCDS32160.1; -. [P07900-2]
DR   CCDS; CCDS9967.1; -. [P07900-1]
DR   PIR; A32319; HHHU86.
DR   RefSeq; NP_001017963.2; NM_001017963.2. [P07900-2]
DR   RefSeq; NP_005339.3; NM_005348.3. [P07900-1]
DR   UniGene; Hs.525600; -.
DR   PDB; 1BYQ; X-ray; 1.50 A; A=9-236.
DR   PDB; 1OSF; X-ray; 1.75 A; A=9-223.
DR   PDB; 1UY6; X-ray; 1.90 A; A=2-236.
DR   PDB; 1UY7; X-ray; 1.90 A; A=2-236.
DR   PDB; 1UY8; X-ray; 1.98 A; A=2-236.
DR   PDB; 1UY9; X-ray; 2.00 A; A=2-236.
DR   PDB; 1UYC; X-ray; 2.00 A; A=2-236.
DR   PDB; 1UYD; X-ray; 2.20 A; A=2-236.
DR   PDB; 1UYE; X-ray; 2.00 A; A=2-236.
DR   PDB; 1UYF; X-ray; 2.00 A; A=2-236.
DR   PDB; 1UYG; X-ray; 2.00 A; A=2-236.
DR   PDB; 1UYH; X-ray; 2.20 A; A=2-236.
DR   PDB; 1UYI; X-ray; 2.20 A; A=2-236.
DR   PDB; 1UYK; X-ray; 2.20 A; A=2-236.
DR   PDB; 1UYL; X-ray; 1.40 A; A=2-236.
DR   PDB; 1YC1; X-ray; 1.70 A; A=9-236.
DR   PDB; 1YC3; X-ray; 2.12 A; A=9-236.
DR   PDB; 1YC4; X-ray; 1.81 A; A=9-236.
DR   PDB; 1YER; X-ray; 1.65 A; A=9-236.
DR   PDB; 1YES; X-ray; 2.20 A; A=9-236.
DR   PDB; 1YET; X-ray; 1.90 A; A=9-236.
DR   PDB; 2BSM; X-ray; 2.05 A; A=2-236.
DR   PDB; 2BT0; X-ray; 1.90 A; A/B=2-236.
DR   PDB; 2BUG; NMR; -; B=728-732.
DR   PDB; 2BYH; X-ray; 1.90 A; A=11-236.
DR   PDB; 2BYI; X-ray; 1.60 A; A=11-236.
DR   PDB; 2BZ5; X-ray; 1.90 A; A/B=2-236.
DR   PDB; 2C2L; X-ray; 3.30 A; E/F/G/H=724-732.
DR   PDB; 2CCS; X-ray; 1.79 A; A=1-236.
DR   PDB; 2CCT; X-ray; 2.30 A; A=1-236.
DR   PDB; 2CCU; X-ray; 2.70 A; A=1-236.
DR   PDB; 2FWY; X-ray; 2.10 A; A=1-236.
DR   PDB; 2FWZ; X-ray; 2.10 A; A=1-236.
DR   PDB; 2H55; X-ray; 2.00 A; A=1-236.
DR   PDB; 2JJC; X-ray; 1.95 A; A=9-223.
DR   PDB; 2K5B; NMR; -; A=14-223.
DR   PDB; 2QF6; X-ray; 3.10 A; A/B/C/D=17-223.
DR   PDB; 2QFO; X-ray; 1.68 A; A/B=17-223.
DR   PDB; 2QG0; X-ray; 1.85 A; A/B=17-223.
DR   PDB; 2QG2; X-ray; 1.80 A; A=17-223.
DR   PDB; 2UWD; X-ray; 1.90 A; A=2-236.
DR   PDB; 2VCI; X-ray; 2.00 A; A=1-236.
DR   PDB; 2VCJ; X-ray; 2.50 A; A=1-236.
DR   PDB; 2WI1; X-ray; 2.30 A; A=1-236.
DR   PDB; 2WI2; X-ray; 2.09 A; A/B=1-236.
DR   PDB; 2WI3; X-ray; 1.90 A; A=1-236.
DR   PDB; 2WI4; X-ray; 2.40 A; A=1-236.
DR   PDB; 2WI5; X-ray; 2.10 A; A=1-236.
DR   PDB; 2WI6; X-ray; 2.18 A; A=1-236.
DR   PDB; 2WI7; X-ray; 2.50 A; A=1-236.
DR   PDB; 2XAB; X-ray; 1.90 A; A/B=9-236.
DR   PDB; 2XDK; X-ray; 1.97 A; A=9-236.
DR   PDB; 2XDL; X-ray; 1.98 A; A=9-236.
DR   PDB; 2XDS; X-ray; 1.97 A; A=9-236.
DR   PDB; 2XDU; X-ray; 1.74 A; A=14-224.
DR   PDB; 2XDX; X-ray; 2.42 A; A=9-236.
DR   PDB; 2XHR; X-ray; 2.20 A; A=9-236.
DR   PDB; 2XHT; X-ray; 2.27 A; A=9-236.
DR   PDB; 2XHX; X-ray; 2.80 A; A=9-236.
DR   PDB; 2XJG; X-ray; 2.25 A; A=9-236.
DR   PDB; 2XJJ; X-ray; 1.90 A; A/B=9-236.
DR   PDB; 2XJX; X-ray; 1.66 A; A=9-236.
DR   PDB; 2XK2; X-ray; 1.95 A; A=9-236.
DR   PDB; 2YE2; X-ray; 1.90 A; A=9-236.
DR   PDB; 2YE3; X-ray; 1.95 A; A=9-236.
DR   PDB; 2YE4; X-ray; 2.30 A; A=9-236.
DR   PDB; 2YE5; X-ray; 1.73 A; A=9-236.
DR   PDB; 2YE6; X-ray; 2.56 A; A=9-236.
DR   PDB; 2YE7; X-ray; 2.20 A; A=9-236.
DR   PDB; 2YE8; X-ray; 2.30 A; A=9-236.
DR   PDB; 2YE9; X-ray; 2.20 A; A=9-236.
DR   PDB; 2YEA; X-ray; 1.73 A; A=9-236.
DR   PDB; 2YEB; X-ray; 2.40 A; A=9-236.
DR   PDB; 2YEC; X-ray; 2.10 A; A=9-236.
DR   PDB; 2YED; X-ray; 2.10 A; A=9-236.
DR   PDB; 2YEE; X-ray; 2.30 A; A=9-236.
DR   PDB; 2YEF; X-ray; 1.55 A; A=9-236.
DR   PDB; 2YEG; X-ray; 2.50 A; A/B=9-236.
DR   PDB; 2YEH; X-ray; 2.10 A; A=9-236.
DR   PDB; 2YEI; X-ray; 2.20 A; A=9-236.
DR   PDB; 2YEJ; X-ray; 2.20 A; A=9-236.
DR   PDB; 2YI0; X-ray; 1.60 A; A=1-229.
DR   PDB; 2YI5; X-ray; 2.50 A; A=1-229.
DR   PDB; 2YI6; X-ray; 1.80 A; A=1-229.
DR   PDB; 2YI7; X-ray; 1.40 A; A=1-229.
DR   PDB; 2YJW; X-ray; 1.61 A; A=18-223.
DR   PDB; 2YJX; X-ray; 1.83 A; A=18-223.
DR   PDB; 2YK2; X-ray; 1.74 A; A=18-223.
DR   PDB; 2YK9; X-ray; 1.32 A; A=18-223.
DR   PDB; 2YKB; X-ray; 1.93 A; A=18-223.
DR   PDB; 2YKC; X-ray; 1.67 A; A=18-223.
DR   PDB; 2YKE; X-ray; 1.43 A; A=18-223.
DR   PDB; 2YKI; X-ray; 1.67 A; A=18-223.
DR   PDB; 2YKJ; X-ray; 1.46 A; A=18-223.
DR   PDB; 3B24; X-ray; 1.70 A; A/B=9-236.
DR   PDB; 3B25; X-ray; 1.75 A; A=9-236.
DR   PDB; 3B26; X-ray; 2.10 A; A/B=9-236.
DR   PDB; 3B27; X-ray; 1.50 A; A=9-236.
DR   PDB; 3B28; X-ray; 1.35 A; A/B=9-236.
DR   PDB; 3BM9; X-ray; 1.60 A; A=14-236.
DR   PDB; 3BMY; X-ray; 1.60 A; A=14-236.
DR   PDB; 3D0B; X-ray; 1.74 A; A=1-232.
DR   PDB; 3EKO; X-ray; 1.55 A; A/B=9-225.
DR   PDB; 3EKR; X-ray; 2.00 A; A/B=9-225.
DR   PDB; 3FT5; X-ray; 1.90 A; A=9-236.
DR   PDB; 3FT8; X-ray; 2.00 A; A=9-236.
DR   PDB; 3HEK; X-ray; 1.95 A; A/B=9-225.
DR   PDB; 3HHU; X-ray; 1.59 A; A/B=1-224.
DR   PDB; 3HYY; X-ray; 1.90 A; A=9-236.
DR   PDB; 3HYZ; X-ray; 2.30 A; A/B=9-236.
DR   PDB; 3HZ1; X-ray; 2.30 A; A=9-236.
DR   PDB; 3HZ5; X-ray; 1.90 A; A=9-236.
DR   PDB; 3INW; X-ray; 1.95 A; A=10-236.
DR   PDB; 3INX; X-ray; 1.75 A; A=10-236.
DR   PDB; 3K97; X-ray; 1.95 A; A=9-236.
DR   PDB; 3K98; X-ray; 2.40 A; A/B=9-225.
DR   PDB; 3K99; X-ray; 2.10 A; A/B/C/D=9-225.
DR   PDB; 3MNR; X-ray; 1.90 A; P=1-232.
DR   PDB; 3O0I; X-ray; 1.47 A; A=1-236.
DR   PDB; 3OW6; X-ray; 1.80 A; A=17-223.
DR   PDB; 3OWB; X-ray; 2.05 A; A=17-223.
DR   PDB; 3OWD; X-ray; 1.63 A; A=17-223.
DR   PDB; 3Q6M; X-ray; 3.00 A; A/B/C=293-732.
DR   PDB; 3Q6N; X-ray; 3.05 A; A/B/C/D/E/F=293-732.
DR   PDB; 3QDD; X-ray; 1.79 A; A=1-236.
DR   PDB; 3QTF; X-ray; 1.57 A; A=14-236.
DR   PDB; 3R4M; X-ray; 1.70 A; A=9-236.
DR   PDB; 3R4N; X-ray; 2.00 A; A/B=9-225.
DR   PDB; 3R4O; X-ray; 2.65 A; A/B=9-225.
DR   PDB; 3R4P; X-ray; 1.70 A; A/B=9-225.
DR   PDB; 3R91; X-ray; 1.58 A; A=14-236.
DR   PDB; 3R92; X-ray; 1.58 A; A=14-236.
DR   PDB; 3RKZ; X-ray; 1.57 A; A=14-236.
DR   PDB; 3RLP; X-ray; 1.70 A; A/B=9-225.
DR   PDB; 3RLQ; X-ray; 1.90 A; A/B=9-225.
DR   PDB; 3RLR; X-ray; 1.70 A; A/B=9-225.
DR   PDB; 3T0H; X-ray; 1.20 A; A=9-236.
DR   PDB; 3T0Z; X-ray; 2.19 A; A=9-236.
DR   PDB; 3T10; X-ray; 1.24 A; A=9-236.
DR   PDB; 3T1K; X-ray; 1.50 A; A/B=9-236.
DR   PDB; 3T2S; X-ray; 1.50 A; A/B=9-236.
DR   PDB; 3TUH; X-ray; 1.80 A; A/B=16-224.
DR   PDB; 3VHA; X-ray; 1.39 A; A=9-236.
DR   PDB; 3VHC; X-ray; 1.41 A; A=9-236.
DR   PDB; 3VHD; X-ray; 1.52 A; A/B=9-236.
DR   PDB; 3WHA; X-ray; 1.30 A; A/B=9-236.
DR   PDB; 3WQ9; X-ray; 1.80 A; A=1-236.
DR   PDB; 4AIF; X-ray; 2.01 A; D/E=726-732.
DR   PDB; 4AWO; X-ray; 1.70 A; A/B=9-236.
DR   PDB; 4AWP; X-ray; 1.82 A; A/B=9-236.
DR   PDB; 4AWQ; X-ray; 1.60 A; A/B=9-236.
DR   PDB; 4B7P; X-ray; 1.70 A; A=9-236.
DR   PDB; 4BQG; X-ray; 1.90 A; A=9-236.
DR   PDB; 4BQJ; X-ray; 2.00 A; A=9-236.
DR   PDB; 4CGQ; X-ray; 2.00 A; Q=726-732.
DR   PDB; 4CGU; X-ray; 2.11 A; C=726-732.
DR   PDB; 4CGV; X-ray; 2.54 A; E/F=726-732.
DR   PDB; 4CGW; X-ray; 3.00 A; C/D=726-732.
DR   PDB; 4CWF; X-ray; 2.00 A; A=9-236.
DR   PDB; 4CWN; X-ray; 1.80 A; A=9-236.
DR   PDB; 4CWO; X-ray; 2.31 A; A=9-236.
DR   PDB; 4CWP; X-ray; 1.95 A; A=9-236.
DR   PDB; 4CWQ; X-ray; 2.00 A; A=9-236.
DR   PDB; 4CWR; X-ray; 2.00 A; A=9-236.
DR   PDB; 4CWS; X-ray; 2.30 A; A=9-236.
DR   PDB; 4CWT; X-ray; 1.90 A; A=9-236.
DR   PDB; 4EEH; X-ray; 1.60 A; A=9-236.
DR   PDB; 4EFT; X-ray; 2.12 A; A=9-236.
DR   PDB; 4EFU; X-ray; 2.00 A; A=9-236.
DR   PDB; 4EGH; X-ray; 1.60 A; A=9-236.
DR   PDB; 4EGI; X-ray; 1.79 A; A=9-236.
DR   PDB; 4EGK; X-ray; 1.69 A; A=9-236.
DR   PDB; 4FCP; X-ray; 2.00 A; A/B=1-236.
DR   PDB; 4FCQ; X-ray; 2.15 A; A=1-236.
DR   PDB; 4FCR; X-ray; 1.70 A; A=1-236.
DR   PDB; 4HY6; X-ray; 1.65 A; A=9-236.
DR   PDB; 4JQL; X-ray; 1.72 A; A=9-236.
DR   PDB; 4L8Z; X-ray; 1.70 A; A=9-236.
DR   PDB; 4L90; X-ray; 2.00 A; A=9-236.
DR   PDB; 4L91; X-ray; 1.75 A; A=9-236.
DR   PDB; 4L93; X-ray; 1.84 A; A/B=9-236.
DR   PDB; 4L94; X-ray; 1.65 A; A=9-236.
DR   PDB; 4LWE; X-ray; 1.50 A; A=17-224.
DR   PDB; 4LWF; X-ray; 1.75 A; A=17-224.
DR   PDB; 4LWG; X-ray; 1.60 A; A=17-224.
DR   PDB; 4LWH; X-ray; 1.70 A; A=16-224.
DR   PDB; 4LWI; X-ray; 1.70 A; A=17-224.
DR   PDB; 4NH7; X-ray; 2.00 A; A/B=9-236.
DR   PDB; 4NH8; X-ray; 1.65 A; A=9-236.
DR   PDB; 4O04; X-ray; 1.82 A; A=9-236.
DR   PDB; 4O05; X-ray; 1.79 A; A=9-236.
DR   PDB; 4O07; X-ray; 1.86 A; A=9-236.
DR   PDB; 4O09; X-ray; 1.96 A; A=9-236.
DR   PDB; 4O0B; X-ray; 1.93 A; A=9-236.
DR   PDB; 4R3M; X-ray; 1.80 A; A=16-224.
DR   PDB; 4U93; X-ray; 1.55 A; A=1-236.
DR   PDB; 4W7T; X-ray; 1.80 A; A=1-236.
DR   PDB; 4XIP; X-ray; 1.70 A; A=9-236.
DR   PDB; 4XIQ; X-ray; 1.84 A; A=9-236.
DR   PDB; 4XIR; X-ray; 1.70 A; A=9-236.
DR   PDB; 4XIT; X-ray; 1.86 A; A=9-236.
DR   PDB; 4YKQ; X-ray; 1.91 A; A=2-236.
DR   PDB; 4YKR; X-ray; 1.61 A; A=2-236.
DR   PDB; 4YKT; X-ray; 1.85 A; A=2-236.
DR   PDB; 4YKU; X-ray; 1.70 A; A=2-236.
DR   PDB; 4YKW; X-ray; 1.85 A; A/B=2-236.
DR   PDB; 4YKX; X-ray; 1.80 A; A=2-236.
DR   PDB; 4YKY; X-ray; 1.78 A; A=2-236.
DR   PDB; 4YKZ; X-ray; 1.85 A; A=2-236.
DR   PDB; 5CF0; X-ray; 1.80 A; A=9-236.
DR   PDB; 5FNC; X-ray; 2.20 A; A=1-236.
DR   PDB; 5FND; X-ray; 2.00 A; A=1-236.
DR   PDB; 5FNF; X-ray; 2.10 A; A=1-236.
DR   PDB; 5GGZ; X-ray; 2.02 A; A/B/C/D=16-225.
DR   PDB; 5J20; X-ray; 1.76 A; A=17-223.
DR   PDB; 5J27; X-ray; 1.70 A; A=16-224.
DR   PDB; 5J2V; X-ray; 1.59 A; A=17-223.
DR   PDB; 5J2X; X-ray; 1.22 A; A=17-224.
DR   PDB; 5J64; X-ray; 1.38 A; A=9-236.
DR   PDB; 5J6L; X-ray; 1.75 A; A=9-236.
DR   PDB; 5J6M; X-ray; 1.64 A; A=9-234.
DR   PDB; 5J6N; X-ray; 1.90 A; A=9-234.
DR   PDB; 5J80; X-ray; 1.17 A; A=9-233.
DR   PDB; 5J82; X-ray; 2.17 A; A=9-233.
DR   PDB; 5J86; X-ray; 1.87 A; A=9-233.
DR   PDB; 5J8M; X-ray; 1.90 A; A/B=9-233.
DR   PDB; 5J8U; X-ray; 1.75 A; A/B=9-233.
DR   PDB; 5J9X; X-ray; 1.80 A; A=9-233.
DR   PDB; 5LNY; X-ray; 1.88 A; A=9-236.
DR   PDB; 5LNZ; X-ray; 1.54 A; A=9-236.
DR   PDB; 5LO0; X-ray; 2.30 A; A=9-236.
DR   PDB; 5LO1; X-ray; 2.70 A; A=9-236.
DR   PDB; 5LO5; X-ray; 1.44 A; A=9-236.
DR   PDB; 5LO6; X-ray; 2.40 A; A=9-236.
DR   PDB; 5LQ9; X-ray; 1.90 A; A=17-223.
DR   PDB; 5LR1; X-ray; 1.44 A; A=18-223.
DR   PDB; 5LR7; X-ray; 1.86 A; A=18-223.
DR   PDB; 5LRL; X-ray; 1.33 A; A=18-223.
DR   PDB; 5LRZ; X-ray; 2.00 A; A=18-223.
DR   PDB; 5LS1; X-ray; 1.85 A; A=17-223.
DR   PDB; 5M4E; X-ray; 1.90 A; A=9-236.
DR   PDB; 5M4H; X-ray; 2.00 A; A=9-236.
DR   PDB; 5T21; X-ray; 2.10 A; A=18-223.
DR   PDBsum; 1BYQ; -.
DR   PDBsum; 1OSF; -.
DR   PDBsum; 1UY6; -.
DR   PDBsum; 1UY7; -.
DR   PDBsum; 1UY8; -.
DR   PDBsum; 1UY9; -.
DR   PDBsum; 1UYC; -.
DR   PDBsum; 1UYD; -.
DR   PDBsum; 1UYE; -.
DR   PDBsum; 1UYF; -.
DR   PDBsum; 1UYG; -.
DR   PDBsum; 1UYH; -.
DR   PDBsum; 1UYI; -.
DR   PDBsum; 1UYK; -.
DR   PDBsum; 1UYL; -.
DR   PDBsum; 1YC1; -.
DR   PDBsum; 1YC3; -.
DR   PDBsum; 1YC4; -.
DR   PDBsum; 1YER; -.
DR   PDBsum; 1YES; -.
DR   PDBsum; 1YET; -.
DR   PDBsum; 2BSM; -.
DR   PDBsum; 2BT0; -.
DR   PDBsum; 2BUG; -.
DR   PDBsum; 2BYH; -.
DR   PDBsum; 2BYI; -.
DR   PDBsum; 2BZ5; -.
DR   PDBsum; 2C2L; -.
DR   PDBsum; 2CCS; -.
DR   PDBsum; 2CCT; -.
DR   PDBsum; 2CCU; -.
DR   PDBsum; 2FWY; -.
DR   PDBsum; 2FWZ; -.
DR   PDBsum; 2H55; -.
DR   PDBsum; 2JJC; -.
DR   PDBsum; 2K5B; -.
DR   PDBsum; 2QF6; -.
DR   PDBsum; 2QFO; -.
DR   PDBsum; 2QG0; -.
DR   PDBsum; 2QG2; -.
DR   PDBsum; 2UWD; -.
DR   PDBsum; 2VCI; -.
DR   PDBsum; 2VCJ; -.
DR   PDBsum; 2WI1; -.
DR   PDBsum; 2WI2; -.
DR   PDBsum; 2WI3; -.
DR   PDBsum; 2WI4; -.
DR   PDBsum; 2WI5; -.
DR   PDBsum; 2WI6; -.
DR   PDBsum; 2WI7; -.
DR   PDBsum; 2XAB; -.
DR   PDBsum; 2XDK; -.
DR   PDBsum; 2XDL; -.
DR   PDBsum; 2XDS; -.
DR   PDBsum; 2XDU; -.
DR   PDBsum; 2XDX; -.
DR   PDBsum; 2XHR; -.
DR   PDBsum; 2XHT; -.
DR   PDBsum; 2XHX; -.
DR   PDBsum; 2XJG; -.
DR   PDBsum; 2XJJ; -.
DR   PDBsum; 2XJX; -.
DR   PDBsum; 2XK2; -.
DR   PDBsum; 2YE2; -.
DR   PDBsum; 2YE3; -.
DR   PDBsum; 2YE4; -.
DR   PDBsum; 2YE5; -.
DR   PDBsum; 2YE6; -.
DR   PDBsum; 2YE7; -.
DR   PDBsum; 2YE8; -.
DR   PDBsum; 2YE9; -.
DR   PDBsum; 2YEA; -.
DR   PDBsum; 2YEB; -.
DR   PDBsum; 2YEC; -.
DR   PDBsum; 2YED; -.
DR   PDBsum; 2YEE; -.
DR   PDBsum; 2YEF; -.
DR   PDBsum; 2YEG; -.
DR   PDBsum; 2YEH; -.
DR   PDBsum; 2YEI; -.
DR   PDBsum; 2YEJ; -.
DR   PDBsum; 2YI0; -.
DR   PDBsum; 2YI5; -.
DR   PDBsum; 2YI6; -.
DR   PDBsum; 2YI7; -.
DR   PDBsum; 2YJW; -.
DR   PDBsum; 2YJX; -.
DR   PDBsum; 2YK2; -.
DR   PDBsum; 2YK9; -.
DR   PDBsum; 2YKB; -.
DR   PDBsum; 2YKC; -.
DR   PDBsum; 2YKE; -.
DR   PDBsum; 2YKI; -.
DR   PDBsum; 2YKJ; -.
DR   PDBsum; 3B24; -.
DR   PDBsum; 3B25; -.
DR   PDBsum; 3B26; -.
DR   PDBsum; 3B27; -.
DR   PDBsum; 3B28; -.
DR   PDBsum; 3BM9; -.
DR   PDBsum; 3BMY; -.
DR   PDBsum; 3D0B; -.
DR   PDBsum; 3EKO; -.
DR   PDBsum; 3EKR; -.
DR   PDBsum; 3FT5; -.
DR   PDBsum; 3FT8; -.
DR   PDBsum; 3HEK; -.
DR   PDBsum; 3HHU; -.
DR   PDBsum; 3HYY; -.
DR   PDBsum; 3HYZ; -.
DR   PDBsum; 3HZ1; -.
DR   PDBsum; 3HZ5; -.
DR   PDBsum; 3INW; -.
DR   PDBsum; 3INX; -.
DR   PDBsum; 3K97; -.
DR   PDBsum; 3K98; -.
DR   PDBsum; 3K99; -.
DR   PDBsum; 3MNR; -.
DR   PDBsum; 3O0I; -.
DR   PDBsum; 3OW6; -.
DR   PDBsum; 3OWB; -.
DR   PDBsum; 3OWD; -.
DR   PDBsum; 3Q6M; -.
DR   PDBsum; 3Q6N; -.
DR   PDBsum; 3QDD; -.
DR   PDBsum; 3QTF; -.
DR   PDBsum; 3R4M; -.
DR   PDBsum; 3R4N; -.
DR   PDBsum; 3R4O; -.
DR   PDBsum; 3R4P; -.
DR   PDBsum; 3R91; -.
DR   PDBsum; 3R92; -.
DR   PDBsum; 3RKZ; -.
DR   PDBsum; 3RLP; -.
DR   PDBsum; 3RLQ; -.
DR   PDBsum; 3RLR; -.
DR   PDBsum; 3T0H; -.
DR   PDBsum; 3T0Z; -.
DR   PDBsum; 3T10; -.
DR   PDBsum; 3T1K; -.
DR   PDBsum; 3T2S; -.
DR   PDBsum; 3TUH; -.
DR   PDBsum; 3VHA; -.
DR   PDBsum; 3VHC; -.
DR   PDBsum; 3VHD; -.
DR   PDBsum; 3WHA; -.
DR   PDBsum; 3WQ9; -.
DR   PDBsum; 4AIF; -.
DR   PDBsum; 4AWO; -.
DR   PDBsum; 4AWP; -.
DR   PDBsum; 4AWQ; -.
DR   PDBsum; 4B7P; -.
DR   PDBsum; 4BQG; -.
DR   PDBsum; 4BQJ; -.
DR   PDBsum; 4CGQ; -.
DR   PDBsum; 4CGU; -.
DR   PDBsum; 4CGV; -.
DR   PDBsum; 4CGW; -.
DR   PDBsum; 4CWF; -.
DR   PDBsum; 4CWN; -.
DR   PDBsum; 4CWO; -.
DR   PDBsum; 4CWP; -.
DR   PDBsum; 4CWQ; -.
DR   PDBsum; 4CWR; -.
DR   PDBsum; 4CWS; -.
DR   PDBsum; 4CWT; -.
DR   PDBsum; 4EEH; -.
DR   PDBsum; 4EFT; -.
DR   PDBsum; 4EFU; -.
DR   PDBsum; 4EGH; -.
DR   PDBsum; 4EGI; -.
DR   PDBsum; 4EGK; -.
DR   PDBsum; 4FCP; -.
DR   PDBsum; 4FCQ; -.
DR   PDBsum; 4FCR; -.
DR   PDBsum; 4HY6; -.
DR   PDBsum; 4JQL; -.
DR   PDBsum; 4L8Z; -.
DR   PDBsum; 4L90; -.
DR   PDBsum; 4L91; -.
DR   PDBsum; 4L93; -.
DR   PDBsum; 4L94; -.
DR   PDBsum; 4LWE; -.
DR   PDBsum; 4LWF; -.
DR   PDBsum; 4LWG; -.
DR   PDBsum; 4LWH; -.
DR   PDBsum; 4LWI; -.
DR   PDBsum; 4NH7; -.
DR   PDBsum; 4NH8; -.
DR   PDBsum; 4O04; -.
DR   PDBsum; 4O05; -.
DR   PDBsum; 4O07; -.
DR   PDBsum; 4O09; -.
DR   PDBsum; 4O0B; -.
DR   PDBsum; 4R3M; -.
DR   PDBsum; 4U93; -.
DR   PDBsum; 4W7T; -.
DR   PDBsum; 4XIP; -.
DR   PDBsum; 4XIQ; -.
DR   PDBsum; 4XIR; -.
DR   PDBsum; 4XIT; -.
DR   PDBsum; 4YKQ; -.
DR   PDBsum; 4YKR; -.
DR   PDBsum; 4YKT; -.
DR   PDBsum; 4YKU; -.
DR   PDBsum; 4YKW; -.
DR   PDBsum; 4YKX; -.
DR   PDBsum; 4YKY; -.
DR   PDBsum; 4YKZ; -.
DR   PDBsum; 5CF0; -.
DR   PDBsum; 5FNC; -.
DR   PDBsum; 5FND; -.
DR   PDBsum; 5FNF; -.
DR   PDBsum; 5GGZ; -.
DR   PDBsum; 5J20; -.
DR   PDBsum; 5J27; -.
DR   PDBsum; 5J2V; -.
DR   PDBsum; 5J2X; -.
DR   PDBsum; 5J64; -.
DR   PDBsum; 5J6L; -.
DR   PDBsum; 5J6M; -.
DR   PDBsum; 5J6N; -.
DR   PDBsum; 5J80; -.
DR   PDBsum; 5J82; -.
DR   PDBsum; 5J86; -.
DR   PDBsum; 5J8M; -.
DR   PDBsum; 5J8U; -.
DR   PDBsum; 5J9X; -.
DR   PDBsum; 5LNY; -.
DR   PDBsum; 5LNZ; -.
DR   PDBsum; 5LO0; -.
DR   PDBsum; 5LO1; -.
DR   PDBsum; 5LO5; -.
DR   PDBsum; 5LO6; -.
DR   PDBsum; 5LQ9; -.
DR   PDBsum; 5LR1; -.
DR   PDBsum; 5LR7; -.
DR   PDBsum; 5LRL; -.
DR   PDBsum; 5LRZ; -.
DR   PDBsum; 5LS1; -.
DR   PDBsum; 5M4E; -.
DR   PDBsum; 5M4H; -.
DR   PDBsum; 5T21; -.
DR   ProteinModelPortal; P07900; -.
DR   SMR; P07900; -.
DR   BioGrid; 109552; 825.
DR   CORUM; P07900; -.
DR   DIP; DIP-27595N; -.
DR   IntAct; P07900; 241.
DR   MINT; P07900; -.
DR   STRING; 9606.ENSP00000335153; -.
DR   BindingDB; P07900; -.
DR   ChEMBL; CHEMBL3880; -.
DR   DrugBank; DB07317; (3E)-3-[(phenylamino)methylidene]dihydrofuran-2(3H)-one.
DR   DrugBank; DB03080; 17-Dmag.
DR   DrugBank; DB08786; 4-(2-methoxyethoxy)-6-methylpyrimidin-2-amine.
DR   DrugBank; DB03809; 9-Butyl-8-(3-Methoxybenzyl)-9h-Purin-6-Amine.
DR   DrugBank; DB03899; 9-Butyl-8-(4-Methoxybenzyl)-9h-Purin-6-Amine.
DR   DrugBank; DB05134; CNF1010.
DR   DrugBank; DB02424; Geldanamycin.
DR   DrugBank; DB07325; N-[(2-AMINO-6-METHYLPYRIMIDIN-4-YL)METHYL]-3-{[(E)-(2-OXODIHYDROFURAN-3(2H)-YLIDENE)METHYL]AMINO}BENZENESULFONAMIDE.
DR   DrugBank; DB00716; Nedocromil.
DR   DrugBank; DB00615; Rifabutin.
DR   DrugBank; DB06070; SNX-5422.
DR   GuidetoPHARMACOLOGY; 2905; -.
DR   CarbonylDB; P07900; -.
DR   iPTMnet; P07900; -.
DR   PhosphoSitePlus; P07900; -.
DR   SwissPalm; P07900; -.
DR   BioMuta; HSP90AA1; -.
DR   DMDM; 92090606; -.
DR   OGP; P07900; -.
DR   REPRODUCTION-2DPAGE; IPI00784295; -.
DR   EPD; P07900; -.
DR   MaxQB; P07900; -.
DR   PaxDb; P07900; -.
DR   PeptideAtlas; P07900; -.
DR   PRIDE; P07900; -.
DR   TopDownProteomics; P07900-1; -. [P07900-1]
DR   Ensembl; ENST00000216281; ENSP00000216281; ENSG00000080824. [P07900-1]
DR   Ensembl; ENST00000334701; ENSP00000335153; ENSG00000080824. [P07900-2]
DR   GeneID; 3320; -.
DR   KEGG; hsa:3320; -.
DR   UCSC; uc001yku.5; human. [P07900-1]
DR   CTD; 3320; -.
DR   DisGeNET; 3320; -.
DR   EuPathDB; HostDB:ENSG00000080824.18; -.
DR   GeneCards; HSP90AA1; -.
DR   HGNC; HGNC:5253; HSP90AA1.
DR   HPA; CAB002058; -.
DR   MIM; 140571; gene.
DR   neXtProt; NX_P07900; -.
DR   OpenTargets; ENSG00000080824; -.
DR   PharmGKB; PA29519; -.
DR   eggNOG; KOG0019; Eukaryota.
DR   eggNOG; KOG0020; Eukaryota.
DR   eggNOG; COG0326; LUCA.
DR   GeneTree; ENSGT00910000144050; -.
DR   HOVERGEN; HBG007374; -.
DR   InParanoid; P07900; -.
DR   KO; K04079; -.
DR   OMA; VKRHSEF; -.
DR   OrthoDB; EOG091G0270; -.
DR   PhylomeDB; P07900; -.
DR   TreeFam; TF300686; -.
DR   Reactome; R-HSA-1227986; Signaling by ERBB2.
DR   Reactome; R-HSA-1236382; Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants.
DR   Reactome; R-HSA-1474151; Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation.
DR   Reactome; R-HSA-192905; vRNP Assembly.
DR   Reactome; R-HSA-2029482; Regulation of actin dynamics for phagocytic cup formation.
DR   Reactome; R-HSA-203615; eNOS activation.
DR   Reactome; R-HSA-2565942; Regulation of PLK1 Activity at G2/M Transition.
DR   Reactome; R-HSA-3000484; Scavenging by Class F Receptors.
DR   Reactome; R-HSA-3371497; HSP90 chaperone cycle for steroid hormone receptors (SHR).
DR   Reactome; R-HSA-3371511; HSF1 activation.
DR   Reactome; R-HSA-3371568; Attenuation phase.
DR   Reactome; R-HSA-3371571; HSF1-dependent transactivation.
DR   Reactome; R-HSA-380259; Loss of Nlp from mitotic centrosomes.
DR   Reactome; R-HSA-380270; Recruitment of mitotic centrosome proteins and complexes.
DR   Reactome; R-HSA-380284; Loss of proteins required for interphase microtubule organization from the centrosome.
DR   Reactome; R-HSA-380320; Recruitment of NuMA to mitotic centrosomes.
DR   Reactome; R-HSA-399954; Sema3A PAK dependent Axon repulsion.
DR   Reactome; R-HSA-4420097; VEGFA-VEGFR2 Pathway.
DR   Reactome; R-HSA-5218920; VEGFR2 mediated vascular permeability.
DR   Reactome; R-HSA-5336415; Uptake and function of diphtheria toxin.
DR   Reactome; R-HSA-5601884; PIWI-interacting RNA (piRNA) biogenesis.
DR   Reactome; R-HSA-5620912; Anchoring of the basal body to the plasma membrane.
DR   Reactome; R-HSA-5637810; Constitutive Signaling by EGFRvIII.
DR   Reactome; R-HSA-6785807; Interleukin-4 and 13 signaling.
DR   Reactome; R-HSA-6798695; Neutrophil degranulation.
DR   Reactome; R-HSA-8852276; The role of GTSE1 in G2/M progression after G2 checkpoint.
DR   Reactome; R-HSA-8854518; AURKA Activation by TPX2.
DR   Reactome; R-HSA-8863795; Downregulation of ERBB2 signaling.
DR   Reactome; R-HSA-8939211; ESR-mediated signaling.
DR   Reactome; R-HSA-9018519; Estrogen-dependent gene expression.
DR   SIGNOR; P07900; -.
DR   ChiTaRS; HSP90AA1; human.
DR   EvolutionaryTrace; P07900; -.
DR   GenomeRNAi; 3320; -.
DR   PMAP-CutDB; P07900; -.
DR   PRO; PR:P07900; -.
DR   Proteomes; UP000005640; Chromosome 14.
DR   Bgee; ENSG00000080824; -.
DR   CleanEx; HS_HSP90AA1; -.
DR   ExpressionAtlas; P07900; baseline and differential.
DR   Genevisible; P07900; HS.
DR   GO; GO:0044295; C:axonal growth cone; ISS:ARUK-UCL.
DR   GO; GO:0005737; C:cytoplasm; IDA:CAFA.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0044294; C:dendritic growth cone; ISS:ARUK-UCL.
DR   GO; GO:0071682; C:endocytic vesicle lumen; TAS:Reactome.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0005576; C:extracellular region; TAS:Reactome.
DR   GO; GO:1904813; C:ficolin-1-rich granule lumen; TAS:Reactome.
DR   GO; GO:0043202; C:lysosomal lumen; TAS:ParkinsonsUK-UCL.
DR   GO; GO:0042470; C:melanosome; IEA:UniProtKB-SubCell.
DR   GO; GO:0016020; C:membrane; HDA:UniProtKB.
DR   GO; GO:0043209; C:myelin sheath; IEA:Ensembl.
DR   GO; GO:0043025; C:neuronal cell body; ISS:ARUK-UCL.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0005634; C:nucleus; HDA:UniProtKB.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; ISS:ARUK-UCL.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0032991; C:protein-containing complex; IDA:UniProtKB.
DR   GO; GO:0032587; C:ruffle membrane; IEA:Ensembl.
DR   GO; GO:0034774; C:secretory granule lumen; TAS:Reactome.
DR   GO; GO:0005524; F:ATP binding; IDA:UniProtKB.
DR   GO; GO:0016887; F:ATPase activity; IDA:UniProtKB.
DR   GO; GO:0042623; F:ATPase activity, coupled; TAS:Reactome.
DR   GO; GO:0097718; F:disordered domain specific binding; IPI:CAFA.
DR   GO; GO:0070182; F:DNA polymerase binding; IPI:BHF-UCL.
DR   GO; GO:0051020; F:GTPase binding; IPI:UniProtKB.
DR   GO; GO:0042826; F:histone deacetylase binding; IPI:BHF-UCL.
DR   GO; GO:0042802; F:identical protein binding; IDA:UniProtKB.
DR   GO; GO:0023026; F:MHC class II protein complex binding; HDA:UniProtKB.
DR   GO; GO:0030235; F:nitric-oxide synthase regulator activity; IDA:UniProtKB.
DR   GO; GO:0000166; F:nucleotide binding; TAS:UniProtKB.
DR   GO; GO:0042803; F:protein homodimerization activity; IDA:UniProtKB.
DR   GO; GO:0004713; F:protein tyrosine kinase activity; EXP:Reactome.
DR   GO; GO:1990782; F:protein tyrosine kinase binding; IPI:UniProtKB.
DR   GO; GO:0003723; F:RNA binding; HDA:UniProtKB.
DR   GO; GO:0097110; F:scaffold protein binding; IPI:UniProtKB.
DR   GO; GO:0048156; F:tau protein binding; IPI:ARUK-UCL.
DR   GO; GO:0030911; F:TPR domain binding; IDA:UniProtKB.
DR   GO; GO:0031625; F:ubiquitin protein ligase binding; IPI:ARUK-UCL.
DR   GO; GO:0051082; F:unfolded protein binding; IEA:InterPro.
DR   GO; GO:0048675; P:axon extension; ISS:ARUK-UCL.
DR   GO; GO:0021955; P:central nervous system neuron axonogenesis; ISS:ARUK-UCL.
DR   GO; GO:0061684; P:chaperone-mediated autophagy; TAS:ParkinsonsUK-UCL.
DR   GO; GO:0051131; P:chaperone-mediated protein complex assembly; IDA:BHF-UCL.
DR   GO; GO:0097711; P:ciliary basal body-plasma membrane docking; TAS:Reactome.
DR   GO; GO:0051186; P:cofactor metabolic process; TAS:Reactome.
DR   GO; GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome.
DR   GO; GO:0038128; P:ERBB2 signaling pathway; TAS:Reactome.
DR   GO; GO:0030010; P:establishment of cell polarity; ISS:ARUK-UCL.
DR   GO; GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome.
DR   GO; GO:0000086; P:G2/M transition of mitotic cell cycle; TAS:Reactome.
DR   GO; GO:0006839; P:mitochondrial transport; TAS:UniProtKB.
DR   GO; GO:0043312; P:neutrophil degranulation; TAS:Reactome.
DR   GO; GO:1903364; P:positive regulation of cellular protein catabolic process; IGI:ARUK-UCL.
DR   GO; GO:0045429; P:positive regulation of nitric oxide biosynthetic process; ISS:UniProtKB.
DR   GO; GO:0033138; P:positive regulation of peptidyl-serine phosphorylation; ISS:ARUK-UCL.
DR   GO; GO:0051897; P:positive regulation of protein kinase B signaling; ISS:ARUK-UCL.
DR   GO; GO:0001934; P:positive regulation of protein phosphorylation; IDA:ARUK-UCL.
DR   GO; GO:0032273; P:positive regulation of protein polymerization; IDA:ARUK-UCL.
DR   GO; GO:1902949; P:positive regulation of tau-protein kinase activity; IDA:ARUK-UCL.
DR   GO; GO:0051973; P:positive regulation of telomerase activity; IDA:BHF-UCL.
DR   GO; GO:0045040; P:protein import into mitochondrial outer membrane; IDA:BHF-UCL.
DR   GO; GO:0042026; P:protein refolding; TAS:UniProtKB.
DR   GO; GO:0050821; P:protein stabilization; IMP:UniProtKB.
DR   GO; GO:0043335; P:protein unfolding; NAS:ParkinsonsUK-UCL.
DR   GO; GO:0006898; P:receptor-mediated endocytosis; TAS:Reactome.
DR   GO; GO:1903827; P:regulation of cellular protein localization; ISS:ARUK-UCL.
DR   GO; GO:1900034; P:regulation of cellular response to heat; TAS:Reactome.
DR   GO; GO:0010389; P:regulation of G2/M transition of mitotic cell cycle; TAS:Reactome.
DR   GO; GO:0050999; P:regulation of nitric-oxide synthase activity; TAS:Reactome.
DR   GO; GO:0043254; P:regulation of protein complex assembly; NAS:ParkinsonsUK-UCL.
DR   GO; GO:0031396; P:regulation of protein ubiquitination; IDA:BHF-UCL.
DR   GO; GO:0046677; P:response to antibiotic; ISS:AgBase.
DR   GO; GO:0009409; P:response to cold; ISS:AgBase.
DR   GO; GO:0009408; P:response to heat; ISS:AgBase.
DR   GO; GO:0006986; P:response to unfolded protein; NAS:UniProtKB.
DR   GO; GO:0007165; P:signal transduction; NAS:UniProtKB.
DR   GO; GO:1905323; P:telomerase holoenzyme complex assembly; IDA:BHF-UCL.
DR   GO; GO:0007004; P:telomere maintenance via telomerase; IDA:BHF-UCL.
DR   GO; GO:0048010; P:vascular endothelial growth factor receptor signaling pathway; TAS:Reactome.
DR   CDD; cd00075; HATPase_c; 1.
DR   Gene3D; 1.20.120.790; -; 1.
DR   Gene3D; 3.30.565.10; -; 1.
DR   HAMAP; MF_00505; HSP90; 1.
DR   InterPro; IPR003594; HATPase_C.
DR   InterPro; IPR036890; HATPase_C_sf.
DR   InterPro; IPR019805; Heat_shock_protein_90_CS.
DR   InterPro; IPR037196; HSP90_C.
DR   InterPro; IPR001404; Hsp90_fam.
DR   InterPro; IPR020575; Hsp90_N.
DR   InterPro; IPR020568; Ribosomal_S5_D2-typ_fold.
DR   PANTHER; PTHR11528; PTHR11528; 1.
DR   Pfam; PF02518; HATPase_c; 1.
DR   Pfam; PF00183; HSP90; 1.
DR   PIRSF; PIRSF002583; Hsp90; 1.
DR   PRINTS; PR00775; HEATSHOCK90.
DR   SMART; SM00387; HATPase_c; 1.
DR   SUPFAM; SSF110942; SSF110942; 1.
DR   SUPFAM; SSF54211; SSF54211; 1.
DR   SUPFAM; SSF55874; SSF55874; 1.
DR   PROSITE; PS00298; HSP90; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; ATP-binding;
KW   Cell membrane; Chaperone; Complete proteome; Cytoplasm;
KW   Direct protein sequencing; Membrane; Nucleotide-binding; Nucleus;
KW   Phosphoprotein; Reference proteome; S-nitrosylation; Stress response;
KW   Ubl conjugation.
FT   INIT_MET      1      1       Removed. {ECO:0000269|PubMed:2492519}.
FT   CHAIN         2    732       Heat shock protein HSP 90-alpha.
FT                                /FTId=PRO_0000062911.
FT   REGION      284    732       Interaction with FLCN and FNIP1.
FT                                {ECO:0000269|PubMed:27353360}.
FT   REGION      284    620       Interaction with FNIP2 and TSC1.
FT                                {ECO:0000269|PubMed:27353360,
FT                                ECO:0000269|PubMed:29127155}.
FT   REGION      682    732       Required for homodimerization.
FT                                {ECO:0000269|PubMed:8289821}.
FT   REGION      728    732       Essential for interaction with SMYD3,
FT                                TSC1 and STIP1/HOP.
FT                                {ECO:0000269|PubMed:25738358,
FT                                ECO:0000269|PubMed:29127155}.
FT   REGION      729    732       Essential for interaction with SGTA and
FT                                TTC1. {ECO:0000269|PubMed:15708368}.
FT   MOTIF       723    732       TPR repeat-binding.
FT                                {ECO:0000269|PubMed:16307917}.
FT   BINDING      51     51       ATP.
FT   BINDING      93     93       ATP.
FT   BINDING     112    112       ATP. {ECO:0000250}.
FT   BINDING     138    138       ATP; via amide nitrogen.
FT   BINDING     400    400       ATP. {ECO:0000250}.
FT   MOD_RES       5      5       Phosphothreonine; by PRKDC.
FT                                {ECO:0000269|PubMed:2507541}.
FT   MOD_RES       7      7       Phosphothreonine; by PRKDC.
FT                                {ECO:0000269|PubMed:2507541}.
FT   MOD_RES      58     58       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:P07901}.
FT   MOD_RES      84     84       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:P07901}.
FT   MOD_RES     231    231       Phosphoserine.
FT                                {ECO:0000244|PubMed:17081983,
FT                                ECO:0000244|PubMed:18318008,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569,
FT                                ECO:0000269|PubMed:2492519}.
FT   MOD_RES     252    252       Phosphoserine.
FT                                {ECO:0000244|PubMed:18088087,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     263    263       Phosphoserine.
FT                                {ECO:0000244|PubMed:16807684,
FT                                ECO:0000244|PubMed:17081983,
FT                                ECO:0000244|PubMed:18088087,
FT                                ECO:0000244|PubMed:18318008,
FT                                ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:18691976,
FT                                ECO:0000244|PubMed:19367720,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000269|PubMed:2492519}.
FT   MOD_RES     313    313       Phosphotyrosine.
FT                                {ECO:0000250|UniProtKB:P07901}.
FT   MOD_RES     443    443       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     453    453       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P82995}.
FT   MOD_RES     458    458       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     476    476       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     489    489       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     492    492       Phosphotyrosine.
FT                                {ECO:0000250|UniProtKB:P07901}.
FT   MOD_RES     585    585       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     598    598       S-nitrosocysteine.
FT                                {ECO:0000269|PubMed:15937123}.
FT   MOD_RES     641    641       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   VAR_SEQ       1      1       M -> MPPCSGGDGSTPPGPSLRDRDCPAQSAEYPRDRLDP
FT                                RPGSPSEASSPPFLRSRAPVNWYQEKAQVFLWHLMVSGSTT
FT                                LLCLWKQPFHVSAFPVTASLAFRQSQGAGQHLYKDLQPFIL
FT                                LRLLM (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:16269234}.
FT                                /FTId=VSP_026604.
FT   MUTAGEN      47     47       E->A: Strong ATP-binding. Strong
FT                                interaction with HSF1, HIF1A, ERBB2, MET,
FT                                KEAP1 and RHOBTB2. No effect on
FT                                interaction with TSC1.
FT                                {ECO:0000269|PubMed:26517842,
FT                                ECO:0000269|PubMed:29127155}.
FT   MUTAGEN      93     93       D->A: Impaired ATP-binding. Strong
FT                                interaction with HIF1A, MET, KEAP1 and
FT                                RHOBTB2. Loss of interaction with HSF1
FT                                and ERBB2. Los of interaction with TSC1.
FT                                {ECO:0000269|PubMed:26517842,
FT                                ECO:0000269|PubMed:29127155}.
FT   MUTAGEN      97     97       G->D: Abolishes ATPase activity.
FT                                {ECO:0000269|PubMed:18256191}.
FT   MUTAGEN     313    313       Y->E: Loss of interaction with TSC1 and
FT                                increases interacrion with AHSA1.
FT                                {ECO:0000269|PubMed:29127155}.
FT   MUTAGEN     313    313       Y->F: No deffect on the interaction with
FT                                TSC1. {ECO:0000269|PubMed:29127155}.
FT   MUTAGEN     598    598       C->A,N,D: Reduces ATPase activity and
FT                                client protein activation.
FT                                {ECO:0000269|PubMed:15937123,
FT                                ECO:0000269|PubMed:19696785}.
FT   MUTAGEN     598    598       C->S: Loss of S-nitrosylation.
FT                                {ECO:0000269|PubMed:15937123,
FT                                ECO:0000269|PubMed:19696785}.
FT   MUTAGEN     728    732       Missing: Loss of interaction with TSC1.
FT                                {ECO:0000269|PubMed:29127155}.
FT   CONFLICT     63     63       S -> T (in Ref. 1; CAA33259).
FT                                {ECO:0000305}.
FT   CONFLICT     74     74       K -> R (in Ref. 4; CAI64495 and 6;
FT                                BAG51711). {ECO:0000305}.
FT   CONFLICT     86     86       D -> G (in Ref. 4; CAI64495 and 6;
FT                                BAG51711). {ECO:0000305}.
FT   CONFLICT    162    162       W -> D (in Ref. 15; AA sequence).
FT                                {ECO:0000305}.
FT   STRAND       18     21       {ECO:0000244|PDB:5J80}.
FT   HELIX        24     35       {ECO:0000244|PDB:5J80}.
FT   HELIX        43     65       {ECO:0000244|PDB:5J80}.
FT   HELIX        67     70       {ECO:0000244|PDB:5J80}.
FT   STRAND       78     83       {ECO:0000244|PDB:5J80}.
FT   TURN         84     87       {ECO:0000244|PDB:5J80}.
FT   STRAND       88     93       {ECO:0000244|PDB:5J80}.
FT   HELIX       100    104       {ECO:0000244|PDB:5J80}.
FT   TURN        105    108       {ECO:0000244|PDB:5J80}.
FT   HELIX       111    123       {ECO:0000244|PDB:5J80}.
FT   HELIX       128    134       {ECO:0000244|PDB:5J80}.
FT   HELIX       137    143       {ECO:0000244|PDB:5J80}.
FT   STRAND      145    153       {ECO:0000244|PDB:5J80}.
FT   STRAND      155    157       {ECO:0000244|PDB:2WI6}.
FT   STRAND      160    164       {ECO:0000244|PDB:5J80}.
FT   STRAND      169    174       {ECO:0000244|PDB:5J80}.
FT   STRAND      181    190       {ECO:0000244|PDB:5J80}.
FT   HELIX       192    198       {ECO:0000244|PDB:5J80}.
FT   HELIX       200    210       {ECO:0000244|PDB:5J80}.
FT   STRAND      212    216       {ECO:0000244|PDB:3VHC}.
FT   STRAND      218    220       {ECO:0000244|PDB:5J80}.
FT   TURN        221    224       {ECO:0000244|PDB:3T1K}.
FT   STRAND      225    227       {ECO:0000244|PDB:3T1K}.
FT   HELIX       228    230       {ECO:0000244|PDB:2XJX}.
FT   HELIX       296    298       {ECO:0000244|PDB:3Q6M}.
FT   HELIX       306    317       {ECO:0000244|PDB:3Q6M}.
FT   STRAND      324    331       {ECO:0000244|PDB:3Q6M}.
FT   STRAND      333    335       {ECO:0000244|PDB:3Q6M}.
FT   STRAND      337    343       {ECO:0000244|PDB:3Q6M}.
FT   STRAND      361    365       {ECO:0000244|PDB:3Q6M}.
FT   STRAND      368    372       {ECO:0000244|PDB:3Q6M}.
FT   HELIX       380    382       {ECO:0000244|PDB:3Q6M}.
FT   STRAND      386    392       {ECO:0000244|PDB:3Q6M}.
FT   HELIX       408    427       {ECO:0000244|PDB:3Q6M}.
FT   HELIX       431    451       {ECO:0000244|PDB:3Q6M}.
FT   HELIX       453    455       {ECO:0000244|PDB:3Q6M}.
FT   HELIX       456    460       {ECO:0000244|PDB:3Q6M}.
FT   STRAND      464    467       {ECO:0000244|PDB:3Q6M}.
FT   TURN        468    472       {ECO:0000244|PDB:3Q6M}.
FT   HELIX       477    482       {ECO:0000244|PDB:3Q6M}.
FT   STRAND      490    495       {ECO:0000244|PDB:3Q6M}.
FT   HELIX       499    503       {ECO:0000244|PDB:3Q6M}.
FT   HELIX       506    508       {ECO:0000244|PDB:3Q6M}.
FT   HELIX       509    514       {ECO:0000244|PDB:3Q6M}.
FT   STRAND      518    521       {ECO:0000244|PDB:3Q6M}.
FT   HELIX       525    529       {ECO:0000244|PDB:3Q6M}.
FT   TURN        530    532       {ECO:0000244|PDB:3Q6M}.
FT   STRAND      539    543       {ECO:0000244|PDB:3Q6M}.
FT   HELIX       555    567       {ECO:0000244|PDB:3Q6M}.
FT   HELIX       569    578       {ECO:0000244|PDB:3Q6M}.
FT   HELIX       580    582       {ECO:0000244|PDB:3Q6M}.
FT   STRAND      584    588       {ECO:0000244|PDB:3Q6M}.
FT   STRAND      593    601       {ECO:0000244|PDB:3Q6M}.
FT   STRAND      603    605       {ECO:0000244|PDB:3Q6M}.
FT   HELIX       608    613       {ECO:0000244|PDB:3Q6M}.
FT   STRAND      632    636       {ECO:0000244|PDB:3Q6M}.
FT   HELIX       641    652       {ECO:0000244|PDB:3Q6M}.
FT   HELIX       657    673       {ECO:0000244|PDB:3Q6M}.
FT   HELIX       681    694       {ECO:0000244|PDB:3Q6M}.
FT   STRAND      728    730       {ECO:0000244|PDB:4CGW}.
SQ   SEQUENCE   732 AA;  84660 MW;  969F65FCC0BC86FD CRC64;
     MPEETQTQDQ PMEEEEVETF AFQAEIAQLM SLIINTFYSN KEIFLRELIS NSSDALDKIR
     YESLTDPSKL DSGKELHINL IPNKQDRTLT IVDTGIGMTK ADLINNLGTI AKSGTKAFME
     ALQAGADISM IGQFGVGFYS AYLVAEKVTV ITKHNDDEQY AWESSAGGSF TVRTDTGEPM
     GRGTKVILHL KEDQTEYLEE RRIKEIVKKH SQFIGYPITL FVEKERDKEV SDDEAEEKED
     KEEEKEKEEK ESEDKPEIED VGSDEEEEKK DGDKKKKKKI KEKYIDQEEL NKTKPIWTRN
     PDDITNEEYG EFYKSLTNDW EDHLAVKHFS VEGQLEFRAL LFVPRRAPFD LFENRKKKNN
     IKLYVRRVFI MDNCEELIPE YLNFIRGVVD SEDLPLNISR EMLQQSKILK VIRKNLVKKC
     LELFTELAED KENYKKFYEQ FSKNIKLGIH EDSQNRKKLS ELLRYYTSAS GDEMVSLKDY
     CTRMKENQKH IYYITGETKD QVANSAFVER LRKHGLEVIY MIEPIDEYCV QQLKEFEGKT
     LVSVTKEGLE LPEDEEEKKK QEEKKTKFEN LCKIMKDILE KKVEKVVVSN RLVTSPCCIV
     TSTYGWTANM ERIMKAQALR DNSTMGYMAA KKHLEINPDH SIIETLRQKA EADKNDKSVK
     DLVILLYETA LLSSGFSLED PQTHANRIYR MIKLGLGIDE DDPTADDTSA AVTEEMPPLE
     GDDDTSRMEE VD
//
ID   Q86SX1_HUMAN            Unreviewed;       262 AA.
AC   Q86SX1;
DT   01-JUN-2003, integrated into UniProtKB/TrEMBL.
DT   01-JUN-2003, sequence version 1.
DT   31-JAN-2018, entry version 93.
DE   SubName: Full=Full-length cDNA 5-PRIME end of clone CS0DN005YI08 of Adult brain of Homo sapiens (human) {ECO:0000313|EMBL:CAD66568.1};
DE   Flags: Fragment;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:CAD66568.1};
RN   [1] {ECO:0000313|EMBL:CAD66568.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Adult brain {ECO:0000313|EMBL:CAD66568.1};
RA   Li W.B., Gruber C., Jessee J., Polayes D.;
RT   "Full-length cDNA libraries and normalization.";
RL   Submitted (FEB-2003) to the EMBL/GenBank/DDBJ databases.
RN   [2] {ECO:0000313|EMBL:CAD66568.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Adult brain {ECO:0000313|EMBL:CAD66568.1};
RA   Genoscope;
RL   Submitted (FEB-2003) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; BX248761; CAD66568.1; -; mRNA.
DR   RefSeq; NP_001017963.2; NM_001017963.2.
DR   UniGene; Hs.525600; -.
DR   ProteinModelPortal; Q86SX1; -.
DR   IntAct; Q86SX1; 14.
DR   PeptideAtlas; Q86SX1; -.
DR   PRIDE; Q86SX1; -.
DR   GeneID; 3320; -.
DR   CTD; 3320; -.
DR   PharmGKB; PA29519; -.
DR   eggNOG; KOG0019; Eukaryota.
DR   eggNOG; KOG0020; Eukaryota.
DR   eggNOG; COG0326; LUCA.
DR   GenomeRNAi; 3320; -.
DR   Genevisible; Q86SX1; HS.
DR   GO; GO:0005524; F:ATP binding; IEA:InterPro.
DR   GO; GO:0051082; F:unfolded protein binding; IEA:InterPro.
DR   GO; GO:0006457; P:protein folding; IEA:InterPro.
DR   GO; GO:0006950; P:response to stress; IEA:InterPro.
DR   CDD; cd00075; HATPase_c; 1.
DR   Gene3D; 3.30.565.10; -; 1.
DR   InterPro; IPR003594; HATPase_C.
DR   InterPro; IPR036890; HATPase_C_sf.
DR   InterPro; IPR019805; Heat_shock_protein_90_CS.
DR   InterPro; IPR001404; Hsp90_fam.
DR   InterPro; IPR020575; Hsp90_N.
DR   PANTHER; PTHR11528; PTHR11528; 1.
DR   Pfam; PF02518; HATPase_c; 1.
DR   PRINTS; PR00775; HEATSHOCK90.
DR   SUPFAM; SSF55874; SSF55874; 1.
DR   PROSITE; PS00298; HSP90; 1.
PE   2: Evidence at transcript level;
FT   DOMAIN      162    260       HATPase_c. {ECO:0000259|Pfam:PF02518}.
FT   NON_TER     262    262       {ECO:0000313|EMBL:CAD66568.1}.
SQ   SEQUENCE   262 AA;  29031 MW;  886BBF5DEE3BFF29 CRC64;
     MPPCSGGDGS TPPGPSLRDR DCPAQSAEYP RDRLDPRPGS PSEASSPPFL RSRAPVNWYQ
     EKAQVFLWHL MVSGSTTLLC LWKQPFHVSA FPVTASLAFR QSQGAGQHLY KDLQPFILLR
     LLMPEETQTQ DQPMEEEEVE TFAFQAEIAQ LMSLIINTFY SNKEIFLREL ISNSSDALDK
     IRYESLTDPS KLDSGKELHI NLIPNKQDRT LTIVDTGIGM TKADLINNLG TIAKSGTKAF
     MEALQAGADI SMIGQFGVGF YS
//
ID   UBL4A_HUMAN             Reviewed;         157 AA.
AC   P11441; Q5HY80;
DT   01-OCT-1989, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-1989, sequence version 1.
DT   23-MAY-2018, entry version 169.
DE   RecName: Full=Ubiquitin-like protein 4A;
DE   AltName: Full=Ubiquitin-like protein GDX;
GN   Name=UBL4A; Synonyms=DXS254E, GDX, UBL4;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=2829204; DOI=10.1073/pnas.85.3.851;
RA   Toniolo D., Persico M., Alcalay M.;
RT   "A 'housekeeping' gene on the X chromosome encodes a protein similar
RT   to ubiquitin.";
RL   Proc. Natl. Acad. Sci. U.S.A. 85:851-855(1988).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=8733135; DOI=10.1093/hmg/5.5.659;
RA   Chen E.Y., Zollo M., Mazzarella R.A., Ciccodicola A., Chen C.-N.,
RA   Zuo L., Heiner C., Burough F.W., Ripetto M., Schlessinger D.,
RA   D'Urso M.;
RT   "Long-range sequence analysis in Xq28: thirteen known and six
RT   candidate genes in 219.4 kb of high GC DNA between the RCP/GCP and
RT   G6PD loci.";
RL   Hum. Mol. Genet. 5:659-668(1996).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15772651; DOI=10.1038/nature03440;
RA   Ross M.T., Grafham D.V., Coffey A.J., Scherer S., McLay K., Muzny D.,
RA   Platzer M., Howell G.R., Burrows C., Bird C.P., Frankish A.,
RA   Lovell F.L., Howe K.L., Ashurst J.L., Fulton R.S., Sudbrak R., Wen G.,
RA   Jones M.C., Hurles M.E., Andrews T.D., Scott C.E., Searle S.,
RA   Ramser J., Whittaker A., Deadman R., Carter N.P., Hunt S.E., Chen R.,
RA   Cree A., Gunaratne P., Havlak P., Hodgson A., Metzker M.L.,
RA   Richards S., Scott G., Steffen D., Sodergren E., Wheeler D.A.,
RA   Worley K.C., Ainscough R., Ambrose K.D., Ansari-Lari M.A., Aradhya S.,
RA   Ashwell R.I., Babbage A.K., Bagguley C.L., Ballabio A., Banerjee R.,
RA   Barker G.E., Barlow K.F., Barrett I.P., Bates K.N., Beare D.M.,
RA   Beasley H., Beasley O., Beck A., Bethel G., Blechschmidt K., Brady N.,
RA   Bray-Allen S., Bridgeman A.M., Brown A.J., Brown M.J., Bonnin D.,
RA   Bruford E.A., Buhay C., Burch P., Burford D., Burgess J., Burrill W.,
RA   Burton J., Bye J.M., Carder C., Carrel L., Chako J., Chapman J.C.,
RA   Chavez D., Chen E., Chen G., Chen Y., Chen Z., Chinault C.,
RA   Ciccodicola A., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Clerc-Blankenburg K., Clifford K., Cobley V., Cole C.G., Conquer J.S.,
RA   Corby N., Connor R.E., David R., Davies J., Davis C., Davis J.,
RA   Delgado O., Deshazo D., Dhami P., Ding Y., Dinh H., Dodsworth S.,
RA   Draper H., Dugan-Rocha S., Dunham A., Dunn M., Durbin K.J., Dutta I.,
RA   Eades T., Ellwood M., Emery-Cohen A., Errington H., Evans K.L.,
RA   Faulkner L., Francis F., Frankland J., Fraser A.E., Galgoczy P.,
RA   Gilbert J., Gill R., Gloeckner G., Gregory S.G., Gribble S.,
RA   Griffiths C., Grocock R., Gu Y., Gwilliam R., Hamilton C., Hart E.A.,
RA   Hawes A., Heath P.D., Heitmann K., Hennig S., Hernandez J.,
RA   Hinzmann B., Ho S., Hoffs M., Howden P.J., Huckle E.J., Hume J.,
RA   Hunt P.J., Hunt A.R., Isherwood J., Jacob L., Johnson D., Jones S.,
RA   de Jong P.J., Joseph S.S., Keenan S., Kelly S., Kershaw J.K., Khan Z.,
RA   Kioschis P., Klages S., Knights A.J., Kosiura A., Kovar-Smith C.,
RA   Laird G.K., Langford C., Lawlor S., Leversha M., Lewis L., Liu W.,
RA   Lloyd C., Lloyd D.M., Loulseged H., Loveland J.E., Lovell J.D.,
RA   Lozado R., Lu J., Lyne R., Ma J., Maheshwari M., Matthews L.H.,
RA   McDowall J., McLaren S., McMurray A., Meidl P., Meitinger T.,
RA   Milne S., Miner G., Mistry S.L., Morgan M., Morris S., Mueller I.,
RA   Mullikin J.C., Nguyen N., Nordsiek G., Nyakatura G., O'dell C.N.,
RA   Okwuonu G., Palmer S., Pandian R., Parker D., Parrish J.,
RA   Pasternak S., Patel D., Pearce A.V., Pearson D.M., Pelan S.E.,
RA   Perez L., Porter K.M., Ramsey Y., Reichwald K., Rhodes S.,
RA   Ridler K.A., Schlessinger D., Schueler M.G., Sehra H.K.,
RA   Shaw-Smith C., Shen H., Sheridan E.M., Shownkeen R., Skuce C.D.,
RA   Smith M.L., Sotheran E.C., Steingruber H.E., Steward C.A., Storey R.,
RA   Swann R.M., Swarbreck D., Tabor P.E., Taudien S., Taylor T.,
RA   Teague B., Thomas K., Thorpe A., Timms K., Tracey A., Trevanion S.,
RA   Tromans A.C., d'Urso M., Verduzco D., Villasana D., Waldron L.,
RA   Wall M., Wang Q., Warren J., Warry G.L., Wei X., West A.,
RA   Whitehead S.L., Whiteley M.N., Wilkinson J.E., Willey D.L.,
RA   Williams G., Williams L., Williamson A., Williamson H., Wilming L.,
RA   Woodmansey R.L., Wray P.W., Yen J., Zhang J., Zhou J., Zoghbi H.,
RA   Zorilla S., Buck D., Reinhardt R., Poustka A., Rosenthal A.,
RA   Lehrach H., Meindl A., Minx P.J., Hillier L.W., Willard H.F.,
RA   Wilson R.K., Waterston R.H., Rice C.M., Vaudin M., Coulson A.,
RA   Nelson D.L., Weinstock G., Sulston J.E., Durbin R.M., Hubbard T.,
RA   Gibbs R.A., Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence of the human X chromosome.";
RL   Nature 434:325-337(2005).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain, and Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-90, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-90, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [8]
RP   FUNCTION, SUBCELLULAR LOCATION, IDENTIFICATION BY MASS SPECTROMETRY,
RP   AND IDENTIFICATION IN THE BAG6/BAT3 COMPLEX.
RX   PubMed=20676083; DOI=10.1038/nature09296;
RA   Mariappan M., Li X., Stefanovic S., Sharma A., Mateja A., Keenan R.J.,
RA   Hegde R.S.;
RT   "A ribosome-associating factor chaperones tail-anchored membrane
RT   proteins.";
RL   Nature 466:1120-1124(2010).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-90, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [11]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=21636303; DOI=10.1016/j.molcel.2011.05.010;
RA   Wang Q., Liu Y., Soetandyo N., Baek K., Hegde R., Ye Y.;
RT   "A ubiquitin ligase-associated chaperone holdase maintains
RT   polypeptides in soluble states for proteasome degradation.";
RL   Mol. Cell 42:758-770(2011).
RN   [12]
RP   FUNCTION.
RX   PubMed=21743475; DOI=10.1038/nature10181;
RA   Hessa T., Sharma A., Mariappan M., Eshleman H.D., Gutierrez E.,
RA   Hegde R.S.;
RT   "Protein targeting and degradation are coupled for elimination of
RT   mislocalized proteins.";
RL   Nature 475:394-397(2011).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-90, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [15]
RP   INTERACTION WITH USP13, UBIQUITINATION AT LYS-48 BY AMFR,
RP   DEUBIQUITINATION BY USP13, AND MUTAGENESIS OF LYS-48.
RX   PubMed=24424410; DOI=10.7554/eLife.01369;
RA   Liu Y., Soetandyo N., Lee J.G., Liu L., Xu Y., Clemons W.M. Jr.,
RA   Ye Y.;
RT   "USP13 antagonizes gp78 to maintain functionality of a chaperone in
RT   ER-associated degradation.";
RL   Elife 3:E01369-E01369(2014).
RN   [16]
RP   FUNCTION.
RX   PubMed=28104892; DOI=10.1126/science.aah6130;
RA   Shao S., Rodrigo-Brenni M.C., Kivlen M.H., Hegde R.S.;
RT   "Mechanistic basis for a molecular triage reaction.";
RL   Science 355:298-302(2017).
RN   [17]
RP   STRUCTURE BY NMR OF 1-74.
RG   RIKEN structural genomics initiative (RSGI);
RT   "Solution structure of the N-terminal ubiquitin-like domain in human
RT   ubiquitin-like protein 4A (GDX).";
RL   Submitted (MAR-2007) to the PDB data bank.
CC   -!- FUNCTION: As part of a cytosolic protein quality control complex,
CC       the BAG6/BAT3 complex, maintains misfolded and hydrophobic
CC       patches-containing proteins in a soluble state and participates to
CC       their proper delivery to the endoplasmic reticulum or
CC       alternatively can promote their sorting to the proteasome where
CC       they undergo degradation (PubMed:20676083, PubMed:21636303,
CC       PubMed:21743475, PubMed:28104892). The BAG6/BAT3 complex is
CC       involved in the post-translational delivery of tail-anchored/type
CC       II transmembrane proteins to the endoplasmic reticulum membrane.
CC       Recruited to ribosomes, it interacts with the transmembrane region
CC       of newly synthesized tail-anchored proteins and together with SGTA
CC       and ASNA1 mediates their delivery to the endoplasmic reticulum
CC       (PubMed:20676083, PubMed:28104892). Client proteins that cannot be
CC       properly delivered to the endoplasmic reticulum are ubiquitinated
CC       and sorted to the proteasome (PubMed:28104892). Similarly, the
CC       BAG6/BAT3 complex also functions as a sorting platform for
CC       proteins of the secretory pathway that are mislocalized to the
CC       cytosol either delivering them to the proteasome for degradation
CC       or to the endoplasmic reticulum (PubMed:21743475). The BAG6/BAT3
CC       complex also plays a role in the endoplasmic reticulum-associated
CC       degradation (ERAD), a quality control mechanism that eliminates
CC       unwanted proteins of the endoplasmic reticulum through their
CC       retrotranslocation to the cytosol and their targeting to the
CC       proteasome. It maintains these retrotranslocated proteins in an
CC       unfolded yet soluble state condition in the cytosol to ensure
CC       their proper delivery to the proteasome (PubMed:21636303).
CC       {ECO:0000269|PubMed:20676083, ECO:0000269|PubMed:21636303,
CC       ECO:0000269|PubMed:21743475, ECO:0000269|PubMed:28104892}.
CC   -!- SUBUNIT: Component of the BAG6/BAT3 complex, at least composed of
CC       BAG6, UBL4A and GET4/TRC35 (PubMed:20676083). Interacts with
CC       USP13; may be indirect via BAG6 (PubMed:24424410).
CC       {ECO:0000269|PubMed:20676083, ECO:0000269|PubMed:24424410}.
CC   -!- INTERACTION:
CC       Q96GN5:CDCA7L; NbExp=3; IntAct=EBI-356983, EBI-5278764;
CC       P50222:MEOX2; NbExp=3; IntAct=EBI-356983, EBI-748397;
CC       O43765:SGTA; NbExp=4; IntAct=EBI-356983, EBI-347996;
CC       Q96EQ0:SGTB; NbExp=5; IntAct=EBI-356983, EBI-744081;
CC       Q9BUZ4:TRAF4; NbExp=7; IntAct=EBI-356983, EBI-3650647;
CC       P12504:vif (xeno); NbExp=2; IntAct=EBI-356983, EBI-779991;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytosol
CC       {ECO:0000269|PubMed:20676083, ECO:0000269|PubMed:21636303}.
CC       Nucleus {ECO:0000269|PubMed:21636303}.
CC   -!- PTM: Polyubiquitinated. Ubiquitination by AMFR and
CC       deubiquitination by USP13 may regulate the interaction between the
CC       BAG6/BAT3 complex and SGTA and therefore may regulate client
CC       proteins fate. {ECO:0000269|PubMed:24424410}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; J03589; AAA36790.1; -; Genomic_DNA.
DR   EMBL; L44140; AAA92650.1; -; Genomic_DNA.
DR   EMBL; BX664739; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471172; EAW72700.1; -; Genomic_DNA.
DR   EMBL; BC043346; AAH43346.1; -; mRNA.
DR   EMBL; BC053589; AAH53589.1; -; mRNA.
DR   CCDS; CCDS14754.1; -.
DR   PIR; A31084; A31084.
DR   RefSeq; NP_055050.1; NM_014235.4.
DR   UniGene; Hs.76480; -.
DR   PDB; 2DZI; NMR; -; A=1-74.
DR   PDB; 4WWR; X-ray; 2.00 A; B/D/F/H=93-139.
DR   PDB; 4X86; X-ray; 1.85 A; A=95-147.
DR   PDBsum; 2DZI; -.
DR   PDBsum; 4WWR; -.
DR   PDBsum; 4X86; -.
DR   ProteinModelPortal; P11441; -.
DR   SMR; P11441; -.
DR   BioGrid; 113885; 308.
DR   IntAct; P11441; 50.
DR   MINT; P11441; -.
DR   STRING; 9606.ENSP00000358674; -.
DR   iPTMnet; P11441; -.
DR   PhosphoSitePlus; P11441; -.
DR   DMDM; 136662; -.
DR   EPD; P11441; -.
DR   MaxQB; P11441; -.
DR   PaxDb; P11441; -.
DR   PeptideAtlas; P11441; -.
DR   PRIDE; P11441; -.
DR   DNASU; 8266; -.
DR   Ensembl; ENST00000369660; ENSP00000358674; ENSG00000102178.
DR   GeneID; 8266; -.
DR   KEGG; hsa:8266; -.
DR   UCSC; uc004flo.4; human.
DR   CTD; 8266; -.
DR   DisGeNET; 8266; -.
DR   EuPathDB; HostDB:ENSG00000102178.12; -.
DR   GeneCards; UBL4A; -.
DR   HGNC; HGNC:12505; UBL4A.
DR   HPA; HPA003617; -.
DR   MIM; 312070; gene.
DR   neXtProt; NX_P11441; -.
DR   OpenTargets; ENSG00000102178; -.
DR   PharmGKB; PA37152; -.
DR   eggNOG; KOG0001; Eukaryota.
DR   eggNOG; COG5272; LUCA.
DR   GeneTree; ENSGT00730000111022; -.
DR   HOGENOM; HOG000006827; -.
DR   HOVERGEN; HBG072205; -.
DR   InParanoid; P11441; -.
DR   OMA; YPGIKDG; -.
DR   PhylomeDB; P11441; -.
DR   TreeFam; TF354228; -.
DR   EvolutionaryTrace; P11441; -.
DR   GeneWiki; UBL4A; -.
DR   GenomeRNAi; 8266; -.
DR   PRO; PR:P11441; -.
DR   Proteomes; UP000005640; Chromosome X.
DR   Bgee; ENSG00000102178; -.
DR   CleanEx; HS_UBL4A; -.
DR   ExpressionAtlas; P11441; baseline and differential.
DR   Genevisible; P11441; HS.
DR   GO; GO:0071818; C:BAT3 complex; IDA:UniProtKB.
DR   GO; GO:0005737; C:cytoplasm; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0005829; C:cytosol; IDA:UniProtKB.
DR   GO; GO:0016020; C:membrane; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0051087; F:chaperone binding; IPI:BHF-UCL.
DR   GO; GO:0019787; F:ubiquitin-like protein transferase activity; TAS:ProtInc.
DR   GO; GO:0006464; P:cellular protein modification process; TAS:ProtInc.
DR   GO; GO:0071816; P:tail-anchored membrane protein insertion into ER membrane; IMP:UniProtKB.
DR   InterPro; IPR019956; Ubiquitin.
DR   InterPro; IPR029071; Ubiquitin-like_domsf.
DR   InterPro; IPR019954; Ubiquitin_CS.
DR   InterPro; IPR000626; Ubiquitin_dom.
DR   Pfam; PF00240; ubiquitin; 1.
DR   PRINTS; PR00348; UBIQUITIN.
DR   SMART; SM00213; UBQ; 1.
DR   SUPFAM; SSF54236; SSF54236; 1.
DR   PROSITE; PS00299; UBIQUITIN_1; 1.
DR   PROSITE; PS50053; UBIQUITIN_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Complete proteome; Cytoplasm; Isopeptide bond; Nucleus;
KW   Phosphoprotein; Reference proteome; Transport; Ubl conjugation.
FT   CHAIN         1    157       Ubiquitin-like protein 4A.
FT                                /FTId=PRO_0000114864.
FT   DOMAIN        1     76       Ubiquitin-like. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00214}.
FT   MOD_RES      90     90       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163}.
FT   CROSSLNK     48     48       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in ubiquitin).
FT                                {ECO:0000269|PubMed:24424410}.
FT   MUTAGEN      48     48       K->R: Loss of polyubiquitination by AMFR.
FT                                {ECO:0000269|PubMed:24424410}.
FT   STRAND        1      7       {ECO:0000244|PDB:2DZI}.
FT   STRAND       12     17       {ECO:0000244|PDB:2DZI}.
FT   HELIX        23     33       {ECO:0000244|PDB:2DZI}.
FT   TURN         38     40       {ECO:0000244|PDB:2DZI}.
FT   STRAND       42     45       {ECO:0000244|PDB:2DZI}.
FT   HELIX        56     59       {ECO:0000244|PDB:2DZI}.
FT   STRAND       63     65       {ECO:0000244|PDB:2DZI}.
FT   STRAND       68     70       {ECO:0000244|PDB:2DZI}.
FT   HELIX        95    106       {ECO:0000244|PDB:4X86}.
FT   HELIX       109    129       {ECO:0000244|PDB:4X86}.
FT   HELIX       132    142       {ECO:0000244|PDB:4X86}.
SQ   SEQUENCE   157 AA;  17777 MW;  9D6EE2D20D2C4C60 CRC64;
     MQLTVKALQG RECSLQVPED ELVSTLKQLV SEKLNVPVRQ QRLLFKGKAL ADGKRLSDYS
     IGPNSKLNLV VKPLEKVLLE EGEAQRLADS PPPQVWQLIS KVLARHFSAA DASRVLEQLQ
     RDYERSLSRL TLDDIERLAS RFLHPEVTET MEKGFSK
//
ID   A0A024R1F5_HUMAN        Unreviewed;       192 AA.
AC   A0A024R1F5;
DT   09-JUL-2014, integrated into UniProtKB/TrEMBL.
DT   09-JUL-2014, sequence version 1.
DT   28-FEB-2018, entry version 23.
DE   SubName: Full=Ring finger protein 185, isoform CRA_e {ECO:0000313|EMBL:EAW59951.1};
GN   Name=RNF185 {ECO:0000313|EMBL:EAW59951.1};
GN   ORFNames=hCG_2010785 {ECO:0000313|EMBL:EAW59951.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:EAW59951.1};
RN   [1] {ECO:0000313|EMBL:EAW59951.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAW59951.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; CH471095; EAW59951.1; -; Genomic_DNA.
DR   RefSeq; NP_689480.2; NM_152267.3.
DR   UniGene; Hs.517553; -.
DR   ProteinModelPortal; A0A024R1F5; -.
DR   SMR; A0A024R1F5; -.
DR   GeneID; 91445; -.
DR   KEGG; hsa:91445; -.
DR   CTD; 91445; -.
DR   EuPathDB; HostDB:ENSG00000138942.15; -.
DR   eggNOG; KOG0823; Eukaryota.
DR   eggNOG; ENOG4111IHV; LUCA.
DR   KO; K10666; -.
DR   OMA; DGGFHMS; -.
DR   OrthoDB; EOG091G0W2I; -.
DR   PhylomeDB; A0A024R1F5; -.
DR   ChiTaRS; RNF185; human.
DR   GenomeRNAi; 91445; -.
DR   Bgee; ENSG00000138942; -.
DR   ExpressionAtlas; A0A024R1F5; baseline and differential.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   Gene3D; 3.30.40.10; -; 1.
DR   InterPro; IPR001841; Znf_RING.
DR   InterPro; IPR013083; Znf_RING/FYVE/PHD.
DR   InterPro; IPR017907; Znf_RING_CS.
DR   SMART; SM00184; RING; 1.
DR   PROSITE; PS00518; ZF_RING_1; 1.
DR   PROSITE; PS50089; ZF_RING_2; 1.
PE   4: Predicted;
KW   Membrane {ECO:0000256|SAM:Phobius};
KW   Metal-binding {ECO:0000256|PROSITE-ProRule:PRU00175};
KW   Transmembrane {ECO:0000256|SAM:Phobius};
KW   Transmembrane helix {ECO:0000256|SAM:Phobius};
KW   Zinc {ECO:0000256|PROSITE-ProRule:PRU00175};
KW   Zinc-finger {ECO:0000256|PROSITE-ProRule:PRU00175}.
FT   TRANSMEM    133    153       Helical. {ECO:0000256|SAM:Phobius}.
FT   TRANSMEM    173    191       Helical. {ECO:0000256|SAM:Phobius}.
FT   DOMAIN       39     80       RING-type. {ECO:0000259|PROSITE:PS50089}.
SQ   SEQUENCE   192 AA;  20459 MW;  F24B49EA566740B3 CRC64;
     MASKGPSASA SPENSSAGGP SGSSNGAGES GGQDSTFECN ICLDTAKDAV ISLCGHLFCW
     PCLHQWLETR PNRQVCPVCK AGISRDKVIP LYGRGSTGQQ DPREKTPPRP QGQRPEPENR
     GGFQGFGFGD GGFQMSFGIG AFPFGIFATA FNINDGRPPP AVPGTPQYVD EQFLSRLFLF
     VALVIMFWLL IA
//
ID   A0A024R1H4_HUMAN        Unreviewed;       136 AA.
AC   A0A024R1H4;
DT   09-JUL-2014, integrated into UniProtKB/TrEMBL.
DT   09-JUL-2014, sequence version 1.
DT   28-FEB-2018, entry version 22.
DE   SubName: Full=Ring finger protein 185, isoform CRA_g {ECO:0000313|EMBL:EAW59950.1};
GN   Name=RNF185 {ECO:0000313|EMBL:EAW59950.1};
GN   ORFNames=hCG_2010785 {ECO:0000313|EMBL:EAW59950.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:EAW59950.1};
RN   [1] {ECO:0000313|EMBL:EAW59950.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAW59950.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; CH471095; EAW59950.1; -; Genomic_DNA.
DR   RefSeq; NP_001129297.1; NM_001135825.1.
DR   UniGene; Hs.517553; -.
DR   ProteinModelPortal; A0A024R1H4; -.
DR   GeneID; 91445; -.
DR   CTD; 91445; -.
DR   EuPathDB; HostDB:ENSG00000138942.15; -.
DR   ChiTaRS; RNF185; human.
DR   GenomeRNAi; 91445; -.
DR   Bgee; ENSG00000138942; -.
DR   ExpressionAtlas; A0A024R1H4; baseline and differential.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   Gene3D; 3.30.40.10; -; 1.
DR   InterPro; IPR018957; Znf_C3HC4_RING-type.
DR   InterPro; IPR001841; Znf_RING.
DR   InterPro; IPR013083; Znf_RING/FYVE/PHD.
DR   InterPro; IPR017907; Znf_RING_CS.
DR   Pfam; PF00097; zf-C3HC4; 1.
DR   PROSITE; PS00518; ZF_RING_1; 1.
DR   PROSITE; PS50089; ZF_RING_2; 1.
PE   4: Predicted;
KW   Membrane {ECO:0000256|SAM:Phobius};
KW   Metal-binding {ECO:0000256|PROSITE-ProRule:PRU00175,
KW   ECO:0000256|SAAS:SAAS00988536};
KW   Transmembrane {ECO:0000256|SAM:Phobius};
KW   Transmembrane helix {ECO:0000256|SAM:Phobius};
KW   Zinc {ECO:0000256|PROSITE-ProRule:PRU00175,
KW   ECO:0000256|SAAS:SAAS00988536};
KW   Zinc-finger {ECO:0000256|PROSITE-ProRule:PRU00175,
KW   ECO:0000256|SAAS:SAAS00988536}.
FT   TRANSMEM     77     97       Helical. {ECO:0000256|SAM:Phobius}.
FT   TRANSMEM    117    135       Helical. {ECO:0000256|SAM:Phobius}.
FT   DOMAIN       39     63       RING-type. {ECO:0000259|PROSITE:PS50089}.
SQ   SEQUENCE   136 AA;  14139 MW;  00AAB3A853E80773 CRC64;
     MASKGPSASA SPENSSAGGP SGSSNGAGES GGQDSTFECN ICLDTAKDAV ISLCGHLFCW
     PCLHQGFQGF GFGDGGFQMS FGIGAFPFGI FATAFNINDG RPPPAVPGTP QYVDEQFLSR
     LFLFVALVIM FWLLIA
//
ID   RN185_HUMAN             Reviewed;         192 AA.
AC   Q96GF1; A8K5C1; A9X3T8; Q8N900;
DT   25-JUL-2006, integrated into UniProtKB/Swiss-Prot.
DT   01-DEC-2001, sequence version 1.
DT   23-MAY-2018, entry version 133.
DE   RecName: Full=E3 ubiquitin-protein ligase RNF185;
DE            EC=2.3.2.27 {ECO:0000269|PubMed:21931693, ECO:0000269|PubMed:27485036};
DE   AltName: Full=RING finger protein 185;
DE   AltName: Full=RING-type E3 ubiquitin transferase RNF185 {ECO:0000305};
GN   Name=RNF185;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Pancreas, and Testis;
RA   Martinez Gamboa L., Stuhlmueller B., Burmester G.R.;
RT   "Multiple splice variants of the gene coding for ring finger protein
RT   RNF185.";
RL   Submitted (NOV-2005) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RX   PubMed=15461802; DOI=10.1186/gb-2004-5-10-r84;
RA   Collins J.E., Wright C.L., Edwards C.A., Davis M.P., Grinham J.A.,
RA   Cole C.G., Goward M.E., Aguado B., Mallya M., Mokrab Y., Huckle E.J.,
RA   Beare D.M., Dunham I.;
RT   "A genome annotation-driven approach to cloning the human ORFeome.";
RL   Genome Biol. 5:R84.1-R84.11(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=10591208; DOI=10.1038/990031;
RA   Dunham I., Hunt A.R., Collins J.E., Bruskiewich R., Beare D.M.,
RA   Clamp M., Smink L.J., Ainscough R., Almeida J.P., Babbage A.K.,
RA   Bagguley C., Bailey J., Barlow K.F., Bates K.N., Beasley O.P.,
RA   Bird C.P., Blakey S.E., Bridgeman A.M., Buck D., Burgess J.,
RA   Burrill W.D., Burton J., Carder C., Carter N.P., Chen Y., Clark G.,
RA   Clegg S.M., Cobley V.E., Cole C.G., Collier R.E., Connor R.,
RA   Conroy D., Corby N.R., Coville G.J., Cox A.V., Davis J., Dawson E.,
RA   Dhami P.D., Dockree C., Dodsworth S.J., Durbin R.M., Ellington A.G.,
RA   Evans K.L., Fey J.M., Fleming K., French L., Garner A.A.,
RA   Gilbert J.G.R., Goward M.E., Grafham D.V., Griffiths M.N.D., Hall C.,
RA   Hall R.E., Hall-Tamlyn G., Heathcott R.W., Ho S., Holmes S.,
RA   Hunt S.E., Jones M.C., Kershaw J., Kimberley A.M., King A.,
RA   Laird G.K., Langford C.F., Leversha M.A., Lloyd C., Lloyd D.M.,
RA   Martyn I.D., Mashreghi-Mohammadi M., Matthews L.H., Mccann O.T.,
RA   Mcclay J., Mclaren S., McMurray A.A., Milne S.A., Mortimore B.J.,
RA   Odell C.N., Pavitt R., Pearce A.V., Pearson D., Phillimore B.J.C.T.,
RA   Phillips S.H., Plumb R.W., Ramsay H., Ramsey Y., Rogers L., Ross M.T.,
RA   Scott C.E., Sehra H.K., Skuce C.D., Smalley S., Smith M.L.,
RA   Soderlund C., Spragon L., Steward C.A., Sulston J.E., Swann R.M.,
RA   Vaudin M., Wall M., Wallis J.M., Whiteley M.N., Willey D.L.,
RA   Williams L., Williams S.A., Williamson H., Wilmer T.E., Wilming L.,
RA   Wright C.L., Hubbard T., Bentley D.R., Beck S., Rogers J., Shimizu N.,
RA   Minoshima S., Kawasaki K., Sasaki T., Asakawa S., Kudoh J.,
RA   Shintani A., Shibuya K., Yoshizaki Y., Aoki N., Mitsuyama S.,
RA   Roe B.A., Chen F., Chu L., Crabtree J., Deschamps S., Do A., Do T.,
RA   Dorman A., Fang F., Fu Y., Hu P., Hua A., Kenton S., Lai H., Lao H.I.,
RA   Lewis J., Lewis S., Lin S.-P., Loh P., Malaj E., Nguyen T., Pan H.,
RA   Phan S., Qi S., Qian Y., Ray L., Ren Q., Shaull S., Sloan D., Song L.,
RA   Wang Q., Wang Y., Wang Z., White J., Willingham D., Wu H., Yao Z.,
RA   Zhan M., Zhang G., Chissoe S., Murray J., Miller N., Minx P.,
RA   Fulton R., Johnson D., Bemis G., Bentley D., Bradshaw H., Bourne S.,
RA   Cordes M., Du Z., Fulton L., Goela D., Graves T., Hawkins J.,
RA   Hinds K., Kemp K., Latreille P., Layman D., Ozersky P., Rohlfing T.,
RA   Scheet P., Walker C., Wamsley A., Wohldmann P., Pepin K., Nelson J.,
RA   Korf I., Bedell J.A., Hillier L.W., Mardis E., Waterston R.,
RA   Wilson R., Emanuel B.S., Shaikh T., Kurahashi H., Saitta S.,
RA   Budarf M.L., McDermid H.E., Johnson A., Wong A.C.C., Morrow B.E.,
RA   Edelmann L., Kim U.J., Shizuya H., Simon M.I., Dumanski J.P.,
RA   Peyrard M., Kedra D., Seroussi E., Fransson I., Tapia I., Bruder C.E.,
RA   O'Brien K.P., Wilkinson P., Bodenteich A., Hartman K., Hu X.,
RA   Khan A.S., Lane L., Tilahun Y., Wright H.;
RT   "The DNA sequence of human chromosome 22.";
RL   Nature 402:489-495(1999).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Colon, Lung, Muscle, and Pancreas;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   FUNCTION, CATALYTIC ACTIVITY, SUBCELLULAR LOCATION, TOPOLOGY, AND
RP   INTERACTION WITH ATG5 AND BNIP1.
RX   PubMed=21931693; DOI=10.1371/journal.pone.0024367;
RA   Tang F., Wang B., Li N., Wu Y., Jia J., Suo T., Chen Q., Liu Y.J.,
RA   Tang J.;
RT   "RNF185, a novel mitochondrial ubiquitin E3 ligase, regulates
RT   autophagy through interaction with BNIP1.";
RL   PLoS ONE 6:E24367-E24367(2011).
RN   [8]
RP   FUNCTION, INDUCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=24019521; DOI=10.1074/jbc.M113.470500;
RA   El Khouri E., Le Pavec G., Toledano M.B., Delaunay-Moisan A.;
RT   "RNF185 is a novel E3 ligase of endoplasmic reticulum-associated
RT   degradation (ERAD) that targets cystic fibrosis transmembrane
RT   conductance regulator (CFTR).";
RL   J. Biol. Chem. 288:31177-31191(2013).
RN   [9]
RP   FUNCTION, CATALYTIC ACTIVITY, SUBCELLULAR LOCATION, TISSUE
RP   SPECIFICITY, INDUCTION, DOMAIN, AND MUTAGENESIS OF CYS-39.
RX   PubMed=27485036; DOI=10.1038/srep30955;
RA   Kaneko M., Iwase I., Yamasaki Y., Takai T., Wu Y., Kanemoto S.,
RA   Matsuhisa K., Asada R., Okuma Y., Watanabe T., Imaizumi K., Nomura Y.;
RT   "Genome-wide identification and gene expression profiling of ubiquitin
RT   ligases for endoplasmic reticulum protein degradation.";
RL   Sci. Rep. 6:30955-30955(2016).
CC   -!- FUNCTION: E3 ubiquitin-protein ligase that regulates selective
CC       mitochondrial autophagy by mediating 'Lys-63'-linked
CC       polyubiquitination of BNIP1 (PubMed:21931693). Acts in the
CC       endoplasmic reticulum (ER)-associated degradation (ERAD) pathway,
CC       which targets misfolded proteins that accumulate in the
CC       endoplasmic reticulum (ER) for ubiquitination and subsequent
CC       proteasome-mediated degradation (PubMed:27485036). Protects cells
CC       from ER stress-induced apoptosis (PubMed:27485036). Responsible
CC       for the cotranslational ubiquitination and degradation of CFTR in
CC       the ERAD pathway (PubMed:24019521). Preferentially associates with
CC       the E2 enzymes UBE2J1 and UBE2J2 (PubMed:24019521).
CC       {ECO:0000269|PubMed:21931693, ECO:0000269|PubMed:24019521,
CC       ECO:0000269|PubMed:27485036}.
CC   -!- CATALYTIC ACTIVITY: S-ubiquitinyl-[E2 ubiquitin-conjugating
CC       enzyme]-L-cysteine + [acceptor protein]-L-lysine = [E2 ubiquitin-
CC       conjugating enzyme]-L-cysteine + N(6)-ubiquitinyl-[acceptor
CC       protein]-L-lysine. {ECO:0000269|PubMed:21931693,
CC       ECO:0000269|PubMed:27485036}.
CC   -!- PATHWAY: Protein modification; protein ubiquitination.
CC   -!- SUBUNIT: Interacts with ATG5 and BNIP1.
CC       {ECO:0000269|PubMed:21931693}.
CC   -!- INTERACTION:
CC       O75915:ARL6IP5; NbExp=3; IntAct=EBI-2340249, EBI-2860752;
CC       Q96DZ9:CMTM5; NbExp=3; IntAct=EBI-2340249, EBI-2548702;
CC       Q8NBI2:CYB561A3; NbExp=4; IntAct=EBI-2340249, EBI-10269179;
CC       Q99942:RNF5; NbExp=3; IntAct=EBI-2340249, EBI-348482;
CC       P51668:UBE2D1; NbExp=3; IntAct=EBI-2340249, EBI-743540;
CC       P62837:UBE2D2; NbExp=3; IntAct=EBI-2340249, EBI-347677;
CC       Q9Y2X8:UBE2D4; NbExp=3; IntAct=EBI-2340249, EBI-745527;
CC       Q96LR5:UBE2E2; NbExp=3; IntAct=EBI-2340249, EBI-2129763;
CC       Q969T4:UBE2E3; NbExp=6; IntAct=EBI-2340249, EBI-348496;
CC       Q9BWQ6:YIPF2; NbExp=5; IntAct=EBI-2340249, EBI-751204;
CC       Q9BSR8:YIPF4; NbExp=3; IntAct=EBI-2340249, EBI-751253;
CC   -!- SUBCELLULAR LOCATION: Mitochondrion outer membrane
CC       {ECO:0000269|PubMed:21931693}; Multi-pass membrane protein
CC       {ECO:0000305}. Endoplasmic reticulum membrane
CC       {ECO:0000269|PubMed:24019521, ECO:0000269|PubMed:27485036}; Multi-
CC       pass membrane protein {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q96GF1-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q96GF1-2; Sequence=VSP_020004;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Ubiquitously expressed.
CC       {ECO:0000269|PubMed:27485036}.
CC   -!- INDUCTION: Up-regulated by unfolded protein response (UPR) and
CC       endoplasmic reticulum (ER) stress triggered by thapsigargin or
CC       tunicamycin. {ECO:0000269|PubMed:24019521,
CC       ECO:0000269|PubMed:27485036}.
CC   -!- DOMAIN: The RING-type zinc finger domain is responsible for E3
CC       ubiquitin ligase activity. {ECO:0000269|PubMed:27485036}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; DQ296559; ABB97506.1; -; mRNA.
DR   EMBL; DQ296561; ABB97508.1; -; mRNA.
DR   EMBL; DQ296562; ABB97509.1; -; mRNA.
DR   EMBL; DQ296565; ABB97512.1; -; mRNA.
DR   EMBL; CR456349; CAG30235.1; -; mRNA.
DR   EMBL; AK095947; BAC04659.1; -; mRNA.
DR   EMBL; AK291236; BAF83925.1; -; mRNA.
DR   EMBL; AC002073; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC005005; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471095; EAW59947.1; -; Genomic_DNA.
DR   EMBL; CH471095; EAW59949.1; -; Genomic_DNA.
DR   EMBL; BC009504; AAH09504.1; -; mRNA.
DR   EMBL; BC026040; AAH26040.1; -; mRNA.
DR   EMBL; BC033166; AAH33166.1; -; mRNA.
DR   EMBL; BC012817; AAH12817.1; -; mRNA.
DR   EMBL; BC035684; AAH35684.1; -; mRNA.
DR   CCDS; CCDS13890.1; -. [Q96GF1-1]
DR   CCDS; CCDS46689.1; -. [Q96GF1-2]
DR   RefSeq; NP_001129297.1; NM_001135825.1. [Q96GF1-2]
DR   RefSeq; NP_689480.2; NM_152267.3. [Q96GF1-1]
DR   UniGene; Hs.517553; -.
DR   ProteinModelPortal; Q96GF1; -.
DR   SMR; Q96GF1; -.
DR   BioGrid; 124834; 70.
DR   IntAct; Q96GF1; 31.
DR   STRING; 9606.ENSP00000320508; -.
DR   iPTMnet; Q96GF1; -.
DR   PhosphoSitePlus; Q96GF1; -.
DR   BioMuta; RNF185; -.
DR   DMDM; 74751883; -.
DR   EPD; Q96GF1; -.
DR   MaxQB; Q96GF1; -.
DR   PaxDb; Q96GF1; -.
DR   PeptideAtlas; Q96GF1; -.
DR   PRIDE; Q96GF1; -.
DR   TopDownProteomics; Q96GF1-1; -. [Q96GF1-1]
DR   TopDownProteomics; Q96GF1-2; -. [Q96GF1-2]
DR   DNASU; 91445; -.
DR   Ensembl; ENST00000266252; ENSP00000266252; ENSG00000138942. [Q96GF1-2]
DR   Ensembl; ENST00000326132; ENSP00000320508; ENSG00000138942. [Q96GF1-1]
DR   Ensembl; ENST00000518626; ENSP00000427755; ENSG00000138942. [Q96GF1-1]
DR   GeneID; 91445; -.
DR   KEGG; hsa:91445; -.
DR   UCSC; uc003akb.4; human. [Q96GF1-1]
DR   CTD; 91445; -.
DR   EuPathDB; HostDB:ENSG00000138942.15; -.
DR   GeneCards; RNF185; -.
DR   HGNC; HGNC:26783; RNF185.
DR   neXtProt; NX_Q96GF1; -.
DR   OpenTargets; ENSG00000138942; -.
DR   PharmGKB; PA142671056; -.
DR   eggNOG; KOG0823; Eukaryota.
DR   eggNOG; ENOG4111IHV; LUCA.
DR   GeneTree; ENSGT00760000119075; -.
DR   HOGENOM; HOG000238304; -.
DR   HOVERGEN; HBG054495; -.
DR   InParanoid; Q96GF1; -.
DR   KO; K10666; -.
DR   OMA; DGGFHMS; -.
DR   OrthoDB; EOG091G0W2I; -.
DR   PhylomeDB; Q96GF1; -.
DR   TreeFam; TF317334; -.
DR   Reactome; R-HSA-382556; ABC-family proteins mediated transport.
DR   Reactome; R-HSA-5678895; Defective CFTR causes cystic fibrosis.
DR   Reactome; R-HSA-901032; ER Quality Control Compartment (ERQC).
DR   UniPathway; UPA00143; -.
DR   ChiTaRS; RNF185; human.
DR   GenomeRNAi; 91445; -.
DR   PRO; PR:Q96GF1; -.
DR   Proteomes; UP000005640; Chromosome 22.
DR   Bgee; ENSG00000138942; -.
DR   CleanEx; HS_RNF185; -.
DR   ExpressionAtlas; Q96GF1; baseline and differential.
DR   Genevisible; Q96GF1; HS.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0044322; C:endoplasmic reticulum quality control compartment; IEA:GOC.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005741; C:mitochondrial outer membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0061630; F:ubiquitin protein ligase activity; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0044390; F:ubiquitin-like protein conjugating enzyme binding; IPI:ParkinsonsUK-UCL.
DR   GO; GO:0006914; P:autophagy; IEA:UniProtKB-KW.
DR   GO; GO:1904380; P:endoplasmic reticulum mannose trimming; TAS:Reactome.
DR   GO; GO:0071712; P:ER-associated misfolded protein catabolic process; IBA:GO_Central.
DR   GO; GO:0036503; P:ERAD pathway; IGI:ParkinsonsUK-UCL.
DR   GO; GO:0051865; P:protein autoubiquitination; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0055085; P:transmembrane transport; TAS:Reactome.
DR   GO; GO:0030433; P:ubiquitin-dependent ERAD pathway; IMP:ParkinsonsUK-UCL.
DR   Gene3D; 3.30.40.10; -; 1.
DR   InterPro; IPR001841; Znf_RING.
DR   InterPro; IPR013083; Znf_RING/FYVE/PHD.
DR   InterPro; IPR017907; Znf_RING_CS.
DR   SMART; SM00184; RING; 1.
DR   PROSITE; PS00518; ZF_RING_1; 1.
DR   PROSITE; PS50089; ZF_RING_2; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Autophagy; Complete proteome;
KW   Endoplasmic reticulum; Membrane; Metal-binding; Mitochondrion;
KW   Mitochondrion outer membrane; Reference proteome; Transferase;
KW   Transmembrane; Transmembrane helix; Ubl conjugation pathway; Zinc;
KW   Zinc-finger.
FT   CHAIN         1    192       E3 ubiquitin-protein ligase RNF185.
FT                                /FTId=PRO_0000247520.
FT   TOPO_DOM      1    130       Cytoplasmic.
FT                                {ECO:0000269|PubMed:21931693}.
FT   TRANSMEM    131    151       Helical. {ECO:0000255}.
FT   TOPO_DOM    152    171       Mitochondrial intermembrane.
FT                                {ECO:0000269|PubMed:21931693}.
FT   TRANSMEM    172    192       Helical. {ECO:0000255}.
FT   ZN_FING      39     80       RING-type. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00175}.
FT   REGION       29     80       Required for ubiquitin ligase activity
FT                                and protection against ER stress-induced
FT                                cell death.
FT                                {ECO:0000269|PubMed:27485036}.
FT   VAR_SEQ      66    121       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|Ref.1}.
FT                                /FTId=VSP_020004.
FT   MUTAGEN      39     39       C->S: Decreased ubiquitin ligase
FT                                activity. {ECO:0000269|PubMed:27485036}.
SQ   SEQUENCE   192 AA;  20459 MW;  F24B49EA566740B3 CRC64;
     MASKGPSASA SPENSSAGGP SGSSNGAGES GGQDSTFECN ICLDTAKDAV ISLCGHLFCW
     PCLHQWLETR PNRQVCPVCK AGISRDKVIP LYGRGSTGQQ DPREKTPPRP QGQRPEPENR
     GGFQGFGFGD GGFQMSFGIG AFPFGIFATA FNINDGRPPP AVPGTPQYVD EQFLSRLFLF
     VALVIMFWLL IA
//
ID   UBC_HUMAN               Reviewed;         685 AA.
AC   P0CG48; P02248; P02249; P02250; P62988; Q29120; Q6LBL4; Q6LDU5;
AC   Q8WYN8; Q91887; Q91888; Q9BWD6; Q9BX98; Q9UEF2; Q9UEG1; Q9UEK8;
AC   Q9UPK7;
DT   10-AUG-2010, integrated into UniProtKB/Swiss-Prot.
DT   13-JUN-2012, sequence version 3.
DT   23-MAY-2018, entry version 90.
DE   RecName: Full=Polyubiquitin-C;
DE   Contains:
DE     RecName: Full=Ubiquitin;
DE   Flags: Precursor;
GN   Name=UBC;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=2988935;
RA   Wiborg O., Pedersen M.S., Wind A., Berglund L.E., Marcker K.A.,
RA   Vuust J.;
RT   "The human ubiquitin multigene family: some genes contain multiple
RT   directly repeated ubiquitin coding sequences.";
RL   EMBO J. 4:755-759(1985).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=9644242; DOI=10.1093/oxfordjournals.jbchem.a022093;
RA   Kim N.S., Yamaguchi T., Sekine S., Saeki M., Iwamuro S., Kato S.;
RT   "Cloning of human polyubiquitin cDNAs and a ubiquitin-binding assay
RT   involving its in vitro translation product.";
RL   J. Biochem. 124:35-39(1998).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=14745543; DOI=10.1007/s00239-003-2532-4;
RA   Tachikui H., Saitou N., Nakajima T., Hayasaka I., Ishida T., Inoue I.;
RT   "Lineage-specific homogenization of the polyubiquitin gene among human
RT   and great apes.";
RL   J. Mol. Evol. 57:737-744(2003).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16541075; DOI=10.1038/nature04569;
RA   Scherer S.E., Muzny D.M., Buhay C.J., Chen R., Cree A., Ding Y.,
RA   Dugan-Rocha S., Gill R., Gunaratne P., Harris R.A., Hawes A.C.,
RA   Hernandez J., Hodgson A.V., Hume J., Jackson A., Khan Z.M.,
RA   Kovar-Smith C., Lewis L.R., Lozado R.J., Metzker M.L.,
RA   Milosavljevic A., Miner G.R., Montgomery K.T., Morgan M.B.,
RA   Nazareth L.V., Scott G., Sodergren E., Song X.-Z., Steffen D.,
RA   Lovering R.C., Wheeler D.A., Worley K.C., Yuan Y., Zhang Z.,
RA   Adams C.Q., Ansari-Lari M.A., Ayele M., Brown M.J., Chen G., Chen Z.,
RA   Clerc-Blankenburg K.P., Davis C., Delgado O., Dinh H.H., Draper H.,
RA   Gonzalez-Garay M.L., Havlak P., Jackson L.R., Jacob L.S., Kelly S.H.,
RA   Li L., Li Z., Liu J., Liu W., Lu J., Maheshwari M., Nguyen B.-V.,
RA   Okwuonu G.O., Pasternak S., Perez L.M., Plopper F.J.H., Santibanez J.,
RA   Shen H., Tabor P.E., Verduzco D., Waldron L., Wang Q., Williams G.A.,
RA   Zhang J., Zhou J., Allen C.C., Amin A.G., Anyalebechi V., Bailey M.,
RA   Barbaria J.A., Bimage K.E., Bryant N.P., Burch P.E., Burkett C.E.,
RA   Burrell K.L., Calderon E., Cardenas V., Carter K., Casias K.,
RA   Cavazos I., Cavazos S.R., Ceasar H., Chacko J., Chan S.N., Chavez D.,
RA   Christopoulos C., Chu J., Cockrell R., Cox C.D., Dang M.,
RA   Dathorne S.R., David R., Davis C.M., Davy-Carroll L., Deshazo D.R.,
RA   Donlin J.E., D'Souza L., Eaves K.A., Egan A., Emery-Cohen A.J.,
RA   Escotto M., Flagg N., Forbes L.D., Gabisi A.M., Garza M., Hamilton C.,
RA   Henderson N., Hernandez O., Hines S., Hogues M.E., Huang M.,
RA   Idlebird D.G., Johnson R., Jolivet A., Jones S., Kagan R., King L.M.,
RA   Leal B., Lebow H., Lee S., LeVan J.M., Lewis L.C., London P.,
RA   Lorensuhewa L.M., Loulseged H., Lovett D.A., Lucier A., Lucier R.L.,
RA   Ma J., Madu R.C., Mapua P., Martindale A.D., Martinez E., Massey E.,
RA   Mawhiney S., Meador M.G., Mendez S., Mercado C., Mercado I.C.,
RA   Merritt C.E., Miner Z.L., Minja E., Mitchell T., Mohabbat F.,
RA   Mohabbat K., Montgomery B., Moore N., Morris S., Munidasa M.,
RA   Ngo R.N., Nguyen N.B., Nickerson E., Nwaokelemeh O.O., Nwokenkwo S.,
RA   Obregon M., Oguh M., Oragunye N., Oviedo R.J., Parish B.J.,
RA   Parker D.N., Parrish J., Parks K.L., Paul H.A., Payton B.A., Perez A.,
RA   Perrin W., Pickens A., Primus E.L., Pu L.-L., Puazo M., Quiles M.M.,
RA   Quiroz J.B., Rabata D., Reeves K., Ruiz S.J., Shao H., Sisson I.,
RA   Sonaike T., Sorelle R.P., Sutton A.E., Svatek A.F., Svetz L.A.,
RA   Tamerisa K.S., Taylor T.R., Teague B., Thomas N., Thorn R.D.,
RA   Trejos Z.Y., Trevino B.K., Ukegbu O.N., Urban J.B., Vasquez L.I.,
RA   Vera V.A., Villasana D.M., Wang L., Ward-Moore S., Warren J.T.,
RA   Wei X., White F., Williamson A.L., Wleczyk R., Wooden H.S.,
RA   Wooden S.H., Yen J., Yoon L., Yoon V., Zorrilla S.E., Nelson D.,
RA   Kucherlapati R., Weinstock G., Gibbs R.A.;
RT   "The finished DNA sequence of human chromosome 12.";
RL   Nature 440:346-351(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain, Liver, Lung, and Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-611.
RX   PubMed=8917096; DOI=10.1016/0378-1119(96)00145-X;
RA   Nenoi M., Mita K., Ichimura S., Cartwright I.L., Takahashi E.,
RA   Yamauchi M., Tsuji H.;
RT   "Heterogeneous structure of the polyubiquitin gene UbC of HeLa S3
RT   cells.";
RL   Gene 175:179-185(1996).
RN   [7]
RP   PROTEIN SEQUENCE OF 1-74.
RX   PubMed=1128706; DOI=10.1038/255423a0;
RA   Schlesinger D.H., Goldstein G.;
RT   "Molecular conservation of 74 amino acid sequence of ubiquitin between
RT   cattle and man.";
RL   Nature 255:423-424(1975).
RN   [8]
RP   PROTEIN SEQUENCE OF 1-27; 30-42 AND 55-72, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RC   TISSUE=Fetal brain cortex;
RA   Lubec G., Chen W.-Q., Sun Y.;
RL   Submitted (DEC-2008) to UniProtKB.
RN   [9]
RP   PROTEIN SEQUENCE OF 1-27 AND 43-54, UBIQUITINATION AT LYS-6; LYS-11
RP   AND LYS-48, AND IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=16443603; DOI=10.1074/jbc.M512786200;
RA   Cripps D., Thomas S.N., Jeng Y., Yang F., Davies P., Yang A.J.;
RT   "Alzheimer disease-specific conformation of hyperphosphorylated paired
RT   helical filament-tau is polyubiquitinated through Lys-48, Lys-11, and
RT   Lys-6 ubiquitin conjugation.";
RL   J. Biol. Chem. 281:10825-10838(2006).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 77-685.
RX   PubMed=9504932;
RA   Nenoi M., Mita K., Ichimura S., Kawano A.;
RT   "Higher frequency of concerted evolutionary events in rodents than in
RT   man at the polyubiquitin gene VNTR locus.";
RL   Genetics 148:867-876(1998).
RN   [11]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 417-685.
RX   PubMed=2820408; DOI=10.1016/0006-291X(87)90970-3;
RA   Einspanier R., Sharma H.S., Scheit K.H.;
RT   "Cloning and sequence analysis of a cDNA encoding poly-ubiquitin in
RT   human ovarian granulosa cells.";
RL   Biochem. Biophys. Res. Commun. 147:581-587(1987).
RN   [12]
RP   FUNCTION, UBIQUITINATION AT LYS-11; LYS-29; LYS-48 AND LYS-63, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=16543144; DOI=10.1016/j.molcel.2006.02.018;
RA   Huang F., Kirkpatrick D., Jiang X., Gygi S.P., Sorkin A.;
RT   "Differential regulation of EGF receptor internalization and
RT   degradation by multiubiquitination within the kinase domain.";
RL   Mol. Cell 21:737-748(2006).
RN   [13]
RP   UBIQUITINATION AT LYS-27.
RX   PubMed=15466860; DOI=10.1074/jbc.M402916200;
RA   Okumura F., Hatakeyama S., Matsumoto M., Kamura T., Nakayama K.;
RT   "Functional regulation of FEZ1 by the U-box-type ubiquitin ligase E4B
RT   contributes to neuritogenesis.";
RL   J. Biol. Chem. 279:53533-53543(2004).
RN   [14]
RP   UBIQUITINATION AT LYS-63, AND MUTAGENESIS OF LYS-48 AND LYS-63.
RX   PubMed=18719106; DOI=10.1073/pnas.0805685105;
RA   Motegi A., Liaw H.-J., Lee K.-Y., Roest H.P., Maas A., Wu X.,
RA   Moinova H., Markowitz S.D., Ding H., Hoeijmakers J.H.J., Myung K.;
RT   "Polyubiquitination of proliferating cell nuclear antigen by HLTF and
RT   SHPRH prevents genomic instability from stalled replication forks.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:12411-12416(2008).
RN   [15]
RP   REVIEW, AND FUNCTION.
RX   PubMed=19754430; DOI=10.1042/BST0370937;
RA   Komander D.;
RT   "The emerging complexity of protein ubiquitination.";
RL   Biochem. Soc. Trans. 37:937-953(2009).
RN   [16]
RP   PHOSPHORYLATION AT SER-65, AND MUTAGENESIS OF SER-65.
RX   PubMed=24660806; DOI=10.1042/BJ20140334;
RA   Kazlauskaite A., Kondapalli C., Gourlay R., Campbell D.G.,
RA   Ritorto M.S., Hofmann K., Alessi D.R., Knebel A., Trost M.,
RA   Muqit M.M.;
RT   "Parkin is activated by PINK1-dependent phosphorylation of ubiquitin
RT   at Ser65.";
RL   Biochem. J. 460:127-139(2014).
RN   [17]
RP   PHOSPHORYLATION AT SER-65, AND MUTAGENESIS OF SER-65.
RX   PubMed=24751536; DOI=10.1083/jcb.201402104;
RA   Kane L.A., Lazarou M., Fogel A.I., Li Y., Yamano K., Sarraf S.A.,
RA   Banerjee S., Youle R.J.;
RT   "PINK1 phosphorylates ubiquitin to activate Parkin E3 ubiquitin ligase
RT   activity.";
RL   J. Cell Biol. 205:143-153(2014).
RN   [18]
RP   PHOSPHORYLATION AT SER-65, AND MUTAGENESIS OF SER-65.
RX   PubMed=24784582; DOI=10.1038/nature13392;
RA   Koyano F., Okatsu K., Kosako H., Tamura Y., Go E., Kimura M.,
RA   Kimura Y., Tsuchiya H., Yoshihara H., Hirokawa T., Endo T., Fon E.A.,
RA   Trempe J.F., Saeki Y., Tanaka K., Matsuda N.;
RT   "Ubiquitin is phosphorylated by PINK1 to activate parkin.";
RL   Nature 510:162-166(2014).
RN   [19]
RP   ADP-RIBOSYLATION, AND MUTAGENESIS OF HIS-68; ARG-72; ARG-74 AND
RP   GLY-76.
RX   PubMed=28525742; DOI=10.1016/j.molcel.2017.04.028;
RA   Yang C.S., Jividen K., Spencer A., Dworak N., Ni L., Oostdyk L.T.,
RA   Chatterjee M., Kusmider B., Reon B., Parlak M., Gorbunova V.,
RA   Abbas T., Jeffery E., Sherman N.E., Paschal B.M.;
RT   "Ubiquitin Modification by the E3 Ligase/ADP-Ribosyltransferase
RT   Dtx3L/Parp9.";
RL   Mol. Cell 66:503-516(2017).
RN   [20]
RP   X-RAY CRYSTALLOGRAPHY (1.8 ANGSTROMS).
RX   PubMed=3041007; DOI=10.1016/0022-2836(87)90679-6;
RA   Vijay-Kumar S., Bugg C.E., Cook W.J.;
RT   "Structure of ubiquitin refined at 1.8-A resolution.";
RL   J. Mol. Biol. 194:531-544(1987).
RN   [21]
RP   X-RAY CRYSTALLOGRAPHY (1.8 ANGSTROMS).
RX   PubMed=8166633; DOI=10.1042/bj2990151;
RA   Ramage R., Green J., Muir T.W., Ogunjobi O.M., Love S., Shaw K.;
RT   "Synthetic, structural and biological studies of the ubiquitin system:
RT   the total chemical synthesis of ubiquitin.";
RL   Biochem. J. 299:151-158(1994).
RN   [22]
RP   X-RAY CRYSTALLOGRAPHY (1.8 ANGSTROMS).
RX   PubMed=8107144; DOI=10.1006/jmbi.1994.1169;
RA   Cook W.J., Jeffrey L.C., Kasperek E., Pickart C.M.;
RT   "Structure of tetraubiquitin shows how multiubiquitin chains can be
RT   formed.";
RL   J. Mol. Biol. 236:601-609(1994).
RN   [23]
RP   X-RAY CRYSTALLOGRAPHY (2.7 ANGSTROMS).
RX   PubMed=11173499; DOI=10.1107/S090744490001800X;
RA   Phillips C.L., Thrower J., Pickart C.M., Hill C.P.;
RT   "Structure of a new crystal form of tetraubiquitin.";
RL   Acta Crystallogr. D 57:341-344(2001).
RN   [24]
RP   X-RAY CRYSTALLOGRAPHY (2.3 ANGSTROMS) OF 1-75 IN COMPLEX WITH USP7.
RX   PubMed=12507430; DOI=10.1016/S0092-8674(02)01199-6;
RA   Hu M., Li P., Li M., Li W., Yao T., Wu J.-W., Gu W., Cohen R.E.,
RA   Shi Y.;
RT   "Crystal structure of a UBP-family deubiquitinating enzyme in
RT   isolation and in complex with ubiquitin aldehyde.";
RL   Cell 111:1041-1054(2002).
RN   [25]
RP   X-RAY CRYSTALLOGRAPHY (2.59 ANGSTROMS) OF 1-75 IN COMPLEX WITH USP21.
RX   PubMed=21399617; DOI=10.1038/embor.2011.17;
RA   Ye Y., Akutsu M., Reyes-Turcu F., Enchev R.I., Wilkinson K.D.,
RA   Komander D.;
RT   "Polyubiquitin binding and cross-reactivity in the USP domain
RT   deubiquitinase USP21.";
RL   EMBO Rep. 12:350-357(2011).
RN   [26]
RP   X-RAY CRYSTALLOGRAPHY (2.2 ANGSTROMS) OF 1-76.
RX   PubMed=20622874; DOI=10.1038/nsmb.1873;
RA   Bremm A., Freund S.M., Komander D.;
RT   "Lys11-linked ubiquitin chains adopt compact conformations and are
RT   preferentially hydrolyzed by the deubiquitinase Cezanne.";
RL   Nat. Struct. Mol. Biol. 17:939-947(2010).
RN   [27]
RP   X-RAY CRYSTALLOGRAPHY (3.03 ANGSTROMS) OF 1-76 IN COMPLEX WITH YOD1.
RX   PubMed=23827681; DOI=10.1016/j.cell.2013.05.046;
RA   Mevissen T.E., Hospenthal M.K., Geurink P.P., Elliott P.R., Akutsu M.,
RA   Arnaudo N., Ekkebus R., Kulathu Y., Wauer T., El Oualid F.,
RA   Freund S.M., Ovaa H., Komander D.;
RT   "OTU deubiquitinases reveal mechanisms of linkage specificity and
RT   enable ubiquitin chain restriction analysis.";
RL   Cell 154:169-184(2013).
RN   [28]
RP   X-RAY CRYSTALLOGRAPHY (1.90 ANGSTROMS) OF 153-228 PHOSPHORYLATED AT
RP   SER-65, AND PHOSPHORYLATION AT SER-65.
RX   PubMed=25527291; DOI=10.15252/embj.201489847;
RA   Wauer T., Swatek K.N., Wagstaff J.L., Gladkova C., Pruneda J.N.,
RA   Michel M.A., Gersch M., Johnson C.M., Freund S.M., Komander D.;
RT   "Ubiquitin Ser65 phosphorylation affects ubiquitin structure, chain
RT   assembly and hydrolysis.";
RL   EMBO J. 34:307-325(2015).
CC   -!- FUNCTION: Ubiquitin: Exists either covalently attached to another
CC       protein, or free (unanchored). When covalently bound, it is
CC       conjugated to target proteins via an isopeptide bond either as a
CC       monomer (monoubiquitin), a polymer linked via different Lys
CC       residues of the ubiquitin (polyubiquitin chains) or a linear
CC       polymer linked via the initiator Met of the ubiquitin (linear
CC       polyubiquitin chains). Polyubiquitin chains, when attached to a
CC       target protein, have different functions depending on the Lys
CC       residue of the ubiquitin that is linked: Lys-6-linked may be
CC       involved in DNA repair; Lys-11-linked is involved in ERAD
CC       (endoplasmic reticulum-associated degradation) and in cell-cycle
CC       regulation; Lys-29-linked is involved in lysosomal degradation;
CC       Lys-33-linked is involved in kinase modification; Lys-48-linked is
CC       involved in protein degradation via the proteasome; Lys-63-linked
CC       is involved in endocytosis, DNA-damage responses as well as in
CC       signaling processes leading to activation of the transcription
CC       factor NF-kappa-B. Linear polymer chains formed via attachment by
CC       the initiator Met lead to cell signaling. Ubiquitin is usually
CC       conjugated to Lys residues of target proteins, however, in rare
CC       cases, conjugation to Cys or Ser residues has been observed. When
CC       polyubiquitin is free (unanchored-polyubiquitin), it also has
CC       distinct roles, such as in activation of protein kinases, and in
CC       signaling. {ECO:0000269|PubMed:16543144,
CC       ECO:0000269|PubMed:19754430}.
CC   -!- INTERACTION:
CC       Q9UNQ0:ABCG2; NbExp=2; IntAct=EBI-3390054, EBI-1569435;
CC       Q16186:ADRM1; NbExp=10; IntAct=EBI-3390054, EBI-954387;
CC       Q9ULH1:ASAP1; NbExp=2; IntAct=EBI-3390054, EBI-346622;
CC       O43150:ASAP2; NbExp=2; IntAct=EBI-3390054, EBI-310968;
CC       P54252-1:ATXN3; NbExp=2; IntAct=EBI-3390054, EBI-946068;
CC       Q9HB09-1:BCL2L12; NbExp=3; IntAct=EBI-3390054, EBI-6968951;
CC       P35226:BMI1; NbExp=2; IntAct=EBI-3390054, EBI-2341576;
CC       O60566:BUB1B; NbExp=3; IntAct=EBI-3390054, EBI-1001438;
CC       P06493:CDK1; NbExp=6; IntAct=EBI-3390054, EBI-444308;
CC       Q99062:CSF3R; NbExp=2; IntAct=EBI-3390054, EBI-7331284;
CC       Q9UER7:DAXX; NbExp=2; IntAct=EBI-3390054, EBI-77321;
CC       Q15038:DAZAP2; NbExp=4; IntAct=EBI-3390054, EBI-724310;
CC       P40087:DDI1 (xeno); NbExp=2; IntAct=EBI-3390054, EBI-5717;
CC       O43583:DENR; NbExp=3; IntAct=EBI-3390054, EBI-716083;
CC       Q6ICB0:DESI1; NbExp=4; IntAct=EBI-3390054, EBI-2806959;
CC       P48510:DSK2 (xeno); NbExp=2; IntAct=EBI-3390054, EBI-6174;
CC       Q86Y01:DTX1; NbExp=2; IntAct=EBI-3390054, EBI-1755174;
CC       Q15717:ELAVL1; NbExp=4; IntAct=EBI-3390054, EBI-374260;
CC       Q92567-2:FAM168A; NbExp=4; IntAct=EBI-3390054, EBI-11978259;
CC       Q61088:Fzd4 (xeno); NbExp=3; IntAct=EBI-3390054, EBI-7987880;
CC       P25098:GRK2; NbExp=3; IntAct=EBI-3390054, EBI-3904795;
CC       Q9Y6K9:IKBKG; NbExp=4; IntAct=EBI-3390054, EBI-81279;
CC       O88522:Ikbkg (xeno); NbExp=3; IntAct=EBI-3390054, EBI-998011;
CC       Q13887:KLF5; NbExp=2; IntAct=EBI-3390054, EBI-2696013;
CC       P06239:LCK; NbExp=2; IntAct=EBI-3390054, EBI-1348;
CC       P48357-3:LEPR; NbExp=2; IntAct=EBI-3390054, EBI-7886448;
CC       Q9UDY8:MALT1; NbExp=4; IntAct=EBI-3390054, EBI-1047372;
CC       Q9Y6R4:MAP3K4; NbExp=2; IntAct=EBI-3390054, EBI-448104;
CC       O43318:MAP3K7; NbExp=4; IntAct=EBI-3390054, EBI-358684;
CC       Q9NX47:MARCH5; NbExp=2; IntAct=EBI-3390054, EBI-2341610;
CC       Q00987:MDM2; NbExp=6; IntAct=EBI-3390054, EBI-389668;
CC       P01106:MYC; NbExp=5; IntAct=EBI-3390054, EBI-447544;
CC       O43639:NCK2; NbExp=2; IntAct=EBI-3390054, EBI-713635;
CC       Q14934:NFATC4; NbExp=3; IntAct=EBI-3390054, EBI-3905796;
CC       P25963:NFKBIA; NbExp=3; IntAct=EBI-3390054, EBI-307386;
CC       P09874:PARP1; NbExp=2; IntAct=EBI-3390054, EBI-355676;
CC       P35227:PCGF2; NbExp=2; IntAct=EBI-3390054, EBI-2129767;
CC       Q9Y253:POLH; NbExp=4; IntAct=EBI-3390054, EBI-2827270;
CC       Q9UNA4:POLI; NbExp=4; IntAct=EBI-3390054, EBI-741774;
CC       P17252:PRKCA; NbExp=2; IntAct=EBI-3390054, EBI-1383528;
CC       P55036:PSMD4; NbExp=8; IntAct=EBI-3390054, EBI-359318;
CC       P32628:RAD23 (xeno); NbExp=4; IntAct=EBI-3390054, EBI-14668;
CC       P54727:RAD23B; NbExp=6; IntAct=EBI-3390054, EBI-954531;
CC       Q84L31:RAD23C (xeno); NbExp=2; IntAct=EBI-3390054, EBI-4437395;
CC       Q62921:Rbck1 (xeno); NbExp=2; IntAct=EBI-3390054, EBI-7266339;
CC       Q96NR8:RDH12; NbExp=2; IntAct=EBI-3390054, EBI-3916363;
CC       Q04206:RELA; NbExp=6; IntAct=EBI-3390054, EBI-73886;
CC       P04325:rev (xeno); NbExp=2; IntAct=EBI-3390054, EBI-7061954;
CC       P55034:RPN10 (xeno); NbExp=2; IntAct=EBI-3390054, EBI-2620423;
CC       O48726:RPN13 (xeno); NbExp=9; IntAct=EBI-3390054, EBI-7710745;
CC       Q8N488:RYBP; NbExp=3; IntAct=EBI-3390054, EBI-752324;
CC       Q9H4L4:SENP3; NbExp=2; IntAct=EBI-3390054, EBI-2880236;
CC       Q96B97:SH3KBP1; NbExp=6; IntAct=EBI-3390054, EBI-346595;
CC       Q9Y5X1:SNX9; NbExp=2; IntAct=EBI-3390054, EBI-77848;
CC       Q13501:SQSTM1; NbExp=3; IntAct=EBI-3390054, EBI-307104;
CC       Q92783:STAM; NbExp=2; IntAct=EBI-3390054, EBI-752333;
CC       Q86VP1:TAX1BP1; NbExp=7; IntAct=EBI-3390054, EBI-529518;
CC       P04637:TP53; NbExp=15; IntAct=EBI-3390054, EBI-366083;
CC       Q9Y4K3:TRAF6; NbExp=3; IntAct=EBI-3390054, EBI-359276;
CC       Q9EPK8:Trpv4 (xeno); NbExp=3; IntAct=EBI-3390054, EBI-7091763;
CC       Q9UMX0:UBQLN1; NbExp=3; IntAct=EBI-3390054, EBI-741480;
CC       P98170:XIAP; NbExp=3; IntAct=EBI-3390054, EBI-517127;
CC       O76080:ZFAND5; NbExp=3; IntAct=EBI-3390054, EBI-8028844;
CC       Q9UGI0:ZRANB1; NbExp=2; IntAct=EBI-3390054, EBI-527853;
CC   -!- SUBCELLULAR LOCATION: Ubiquitin: Cytoplasm {ECO:0000250}. Nucleus
CC       {ECO:0000250}.
CC   -!- PTM: Ubiquitin: Phosphorylated at Ser-65 by PINK1 during
CC       mitophagy. Phosphorylated ubiquitin specifically binds and
CC       activates parkin (PRKN), triggering mitophagy (PubMed:24660806,
CC       PubMed:24751536, PubMed:24784582, PubMed:25527291).
CC       Phosphorylation does not affect E1-mediated E2 charging of
CC       ubiquitin but affects discharging of E2 enzymes to form
CC       polyubiquitin chains. It also affects deubiquitination by
CC       deubiquitinase enzymes such as USP30 (PubMed:25527291).
CC       {ECO:0000269|PubMed:24660806, ECO:0000269|PubMed:24751536,
CC       ECO:0000269|PubMed:24784582, ECO:0000269|PubMed:25527291}.
CC   -!- PTM: Ubiquitin: Mono-ADP-riblosylated at the C-terminus by PARP9,
CC       a component of the PPAR9-DTX3L complex. ADP-ribosylation requires
CC       processing by E1 and E2 enzymes and prevents ubiquitin conjugation
CC       to substrates such as histones. {ECO:0000269|PubMed:28525742}.
CC   -!- MISCELLANEOUS: Ubiquitin is encoded by 4 different genes. UBA52
CC       and RPS27A genes code for a single copy of ubiquitin fused to the
CC       ribosomal proteins L40 and S27a, respectively. UBB and UBC genes
CC       code for a polyubiquitin precursor with exact head to tail
CC       repeats, the number of repeats differ between species and strains.
CC   -!- MISCELLANEOUS: For the sake of clarity sequence features are
CC       annotated only for the first chain, and are not repeated for each
CC       of the following chains.
CC   -!- SIMILARITY: Belongs to the ubiquitin family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M26880; AAA36789.1; -; mRNA.
DR   EMBL; AB009010; BAA23632.1; -; mRNA.
DR   EMBL; AB089613; BAC56951.1; -; Genomic_DNA.
DR   EMBL; AC126309; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC039193; AAH39193.1; -; mRNA.
DR   EMBL; D63791; BAA09860.1; -; Genomic_DNA.
DR   EMBL; AB003730; BAA23486.1; -; Genomic_DNA.
DR   EMBL; M17597; AAA36787.1; -; mRNA.
DR   CCDS; CCDS9260.1; -.
DR   PIR; A02574; UQHU.
DR   PIR; A22005; UQHUC.
DR   PIR; A29526; A29526.
DR   RefSeq; NP_066289.3; NM_021009.6.
DR   UniGene; Hs.520348; -.
DR   UniGene; Hs.707528; -.
DR   UniGene; Hs.731841; -.
DR   PDB; 1C3T; NMR; -; A=1-76.
DR   PDB; 1CMX; X-ray; 2.25 A; B/D=1-76.
DR   PDB; 1D3Z; NMR; -; A=1-76.
DR   PDB; 1F9J; X-ray; 2.70 A; A/B=1-76.
DR   PDB; 1FXT; NMR; -; B=1-76.
DR   PDB; 1G6J; NMR; -; A=1-76.
DR   PDB; 1GJZ; NMR; -; A/B=1-51.
DR   PDB; 1NBF; X-ray; 2.30 A; C/D=1-76.
DR   PDB; 1OGW; X-ray; 1.32 A; A=1-76.
DR   PDB; 1Q5W; NMR; -; B=1-76.
DR   PDB; 1S1Q; X-ray; 2.00 A; B/D=1-76.
DR   PDB; 1SIF; X-ray; 2.18 A; A=6-76.
DR   PDB; 1TBE; X-ray; 2.40 A; A/B=1-76.
DR   PDB; 1UBI; X-ray; 1.80 A; A=1-76.
DR   PDB; 1UBQ; X-ray; 1.80 A; A=1-76.
DR   PDB; 1UD7; NMR; -; A=1-76.
DR   PDB; 1XD3; X-ray; 1.45 A; B/D=1-75.
DR   PDB; 1XQQ; NMR; -; A=1-76.
DR   PDB; 1YX5; NMR; -; B=1-76.
DR   PDB; 1YX6; NMR; -; B=1-76.
DR   PDB; 1ZGU; NMR; -; B=1-76.
DR   PDB; 1ZO6; Model; -; B/C=1-76.
DR   PDB; 2AYO; X-ray; 3.50 A; B=1-76.
DR   PDB; 2BGF; NMR; -; A/B=1-76.
DR   PDB; 2DEN; NMR; -; B=1-76.
DR   PDB; 2FUH; NMR; -; B=1-76.
DR   PDB; 2G45; X-ray; 1.99 A; B/E=1-76.
DR   PDB; 2GBJ; X-ray; 1.35 A; A/B=1-76.
DR   PDB; 2GBK; X-ray; 1.99 A; A/B/C/D=10-76.
DR   PDB; 2GBM; X-ray; 1.55 A; A/B/C/D=1-76.
DR   PDB; 2GBN; X-ray; 1.60 A; A=1-76.
DR   PDB; 2GBR; X-ray; 2.00 A; A/B/C=1-76.
DR   PDB; 2GMI; X-ray; 2.50 A; C=1-76.
DR   PDB; 2HTH; X-ray; 2.70 A; A=1-76.
DR   PDB; 2IBI; X-ray; 2.20 A; B=1-75.
DR   PDB; 2J7Q; X-ray; 1.80 A; B/D=1-75.
DR   PDB; 2JF5; X-ray; 1.95 A; A/B=1-76.
DR   PDB; 2JRI; NMR; -; B/C=1-76.
DR   PDB; 2JY6; NMR; -; A=1-76.
DR   PDB; 2JZZ; NMR; -; A=1-76.
DR   PDB; 2K25; NMR; -; A=1-75.
DR   PDB; 2K6D; NMR; -; B=1-75.
DR   PDB; 2K8B; NMR; -; A=1-76.
DR   PDB; 2K8C; NMR; -; A=1-76.
DR   PDB; 2KDF; NMR; -; B/C=1-76.
DR   PDB; 2KHW; NMR; -; B=1-76.
DR   PDB; 2KJH; NMR; -; B=1-75.
DR   PDB; 2KLG; NMR; -; A=1-76.
DR   PDB; 2KN5; NMR; -; A=1-76.
DR   PDB; 2KX0; NMR; -; A=74-151.
DR   PDB; 2L3Z; NMR; -; A=1-76.
DR   PDB; 2LD9; NMR; -; A=76-152.
DR   PDB; 2LVO; NMR; -; A=1-76.
DR   PDB; 2LVP; NMR; -; A/B=1-76.
DR   PDB; 2LVQ; NMR; -; A/B=1-76.
DR   PDB; 2LZ6; NMR; -; A=609-684.
DR   PDB; 2MBO; NMR; -; A/B=609-684.
DR   PDB; 2MBQ; NMR; -; A/B=609-684.
DR   PDB; 2MCN; NMR; -; B=609-684.
DR   PDB; 2MI8; NMR; -; A=609-684.
DR   PDB; 2MJ5; NMR; -; A=609-684.
DR   PDB; 2MOR; NMR; -; A=609-684.
DR   PDB; 2MRE; NMR; -; A=609-684.
DR   PDB; 2MWS; NMR; -; A=609-684.
DR   PDB; 2N2K; NMR; -; A=609-684, B=609-679.
DR   PDB; 2NR2; NMR; -; A=1-76.
DR   PDB; 2O6V; X-ray; 2.20 A; A/B/C/D/E/F/G/H=1-76.
DR   PDB; 2OJR; X-ray; 2.60 A; A=1-76.
DR   PDB; 2PE9; NMR; -; A/B=1-76.
DR   PDB; 2PEA; NMR; -; A/B=1-76.
DR   PDB; 2RR9; NMR; -; A/B=1-76.
DR   PDB; 2RU6; NMR; -; A=609-684.
DR   PDB; 2W9N; X-ray; 2.25 A; A=1-152.
DR   PDB; 2WDT; X-ray; 2.30 A; B/D=1-75.
DR   PDB; 2XEW; X-ray; 2.20 A; A/B/C/D/E/F/G/H/I/J/K/L=1-76.
DR   PDB; 2Y5B; X-ray; 2.70 A; B/F=1-152.
DR   PDB; 2Z59; NMR; -; B=1-76.
DR   PDB; 2ZCB; X-ray; 1.60 A; A/B/C=1-76.
DR   PDB; 2ZVN; X-ray; 3.00 A; A/C/E/G=1-152.
DR   PDB; 2ZVO; X-ray; 2.90 A; A/G=1-152.
DR   PDB; 3A33; X-ray; 2.20 A; B=1-76.
DR   PDB; 3ALB; X-ray; 1.85 A; A/B/C/D=1-76.
DR   PDB; 3AUL; X-ray; 2.39 A; A/B=1-76.
DR   PDB; 3B08; X-ray; 1.70 A; A/D/G/J=1-152.
DR   PDB; 3B0A; X-ray; 1.90 A; A/D=1-152.
DR   PDB; 3BY4; X-ray; 1.55 A; B=1-75.
DR   PDB; 3C0R; X-ray; 2.31 A; B/D=1-75.
DR   PDB; 3DVG; X-ray; 2.60 A; X/Y=1-76.
DR   PDB; 3DVN; X-ray; 2.70 A; U/V/X/Y=1-76.
DR   PDB; 3EEC; X-ray; 3.00 A; A/B=1-76.
DR   PDB; 3EFU; X-ray; 1.84 A; A=1-76.
DR   PDB; 3EHV; X-ray; 1.81 A; A/B/C=1-76.
DR   PDB; 3H7P; X-ray; 1.90 A; A/B=1-76.
DR   PDB; 3H7S; X-ray; 2.30 A; A/B=1-76.
DR   PDB; 3HM3; X-ray; 1.96 A; A/B/C/D=1-76.
DR   PDB; 3I3T; X-ray; 2.59 A; B/D/F/H=1-75.
DR   PDB; 3IFW; X-ray; 2.40 A; B=1-75.
DR   PDB; 3IHP; X-ray; 2.80 A; C/D=1-75.
DR   PDB; 3JSV; X-ray; 2.70 A; A/B=1-76.
DR   PDB; 3JVZ; X-ray; 3.30 A; X/Y=1-76.
DR   PDB; 3JW0; X-ray; 3.10 A; X/Y=1-76.
DR   PDB; 3K9O; X-ray; 1.80 A; B=76-151.
DR   PDB; 3K9P; X-ray; 2.80 A; B=1-76.
DR   PDB; 3KVF; X-ray; 2.80 A; B=1-75.
DR   PDB; 3KW5; X-ray; 2.83 A; B=1-75.
DR   PDB; 3LDZ; X-ray; 2.60 A; E/F/G=1-73.
DR   PDB; 3MHS; X-ray; 1.89 A; D=1-76.
DR   PDB; 3MTN; X-ray; 2.70 A; B/D=1-76.
DR   PDB; 3N30; X-ray; 3.00 A; A/B=1-76.
DR   PDB; 3N32; X-ray; 1.80 A; A=1-76.
DR   PDB; 3N3K; X-ray; 2.60 A; B=5-76.
DR   PDB; 3NS8; X-ray; 1.71 A; A/B=1-76.
DR   PDB; 3O65; X-ray; 2.70 A; B/D/F/H=1-75.
DR   PDB; 3OFI; X-ray; 2.35 A; C/D=1-76.
DR   PDB; 3OJ3; X-ray; 2.50 A; A/B/C/D/E/F/G/H=1-76.
DR   PDB; 3OJ4; X-ray; 3.40 A; B/E=1-76.
DR   PDB; 3ONS; X-ray; 1.80 A; A=1-72.
DR   PDB; 3PRM; X-ray; 2.30 A; B/D=1-75.
DR   PDB; 3PT2; X-ray; 2.50 A; B=1-75.
DR   PDB; 3PTF; X-ray; 2.70 A; C/D=1-76.
DR   PDB; 3Q3F; X-ray; 2.17 A; A=2-76.
DR   PDB; 3RUL; X-ray; 2.50 A; A/B/C/D=1-75.
DR   PDB; 3TMP; X-ray; 1.91 A; B/D/F/H=1-76.
DR   PDB; 3U30; X-ray; 2.43 A; A/D=1-152.
DR   PDB; 3UGB; X-ray; 2.35 A; B=1-76.
DR   PDB; 3V6C; X-ray; 1.70 A; B=74-150.
DR   PDB; 3V6E; X-ray; 2.10 A; B=74-150.
DR   PDB; 3VFK; X-ray; 2.80 A; A=1-75.
DR   PDB; 3VUW; X-ray; 1.95 A; A/B/C=1-76.
DR   PDB; 3VUX; X-ray; 1.70 A; A/B/C=1-76.
DR   PDB; 3VUY; X-ray; 1.98 A; A/B/C=1-76.
DR   PDB; 3WXE; X-ray; 2.50 A; B=533-680.
DR   PDB; 3WXF; X-ray; 2.30 A; B/D=533-680.
DR   PDB; 3ZLZ; X-ray; 2.90 A; A/B=1-76.
DR   PDB; 3ZNH; X-ray; 2.30 A; B=1-75.
DR   PDB; 3ZNI; X-ray; 2.21 A; D/H/L/P=1-76.
DR   PDB; 3ZNZ; X-ray; 1.90 A; B=1-152.
DR   PDB; 4AP4; X-ray; 2.21 A; C/F=608-684.
DR   PDB; 4AUQ; X-ray; 2.18 A; C/F=1-76.
DR   PDB; 4BOS; X-ray; 2.35 A; C/E=609-684, F=612-625.
DR   PDB; 4BOZ; X-ray; 3.03 A; B/C/E=1-76.
DR   PDB; 4BVU; X-ray; 2.70 A; C=609-684.
DR   PDB; 4DDG; X-ray; 3.30 A; D/E/F/G/H/I/M/N/O/P/Q/R=1-76.
DR   PDB; 4DDI; X-ray; 3.80 A; G/H/I/J/K/L=1-76.
DR   PDB; 4DHJ; X-ray; 2.35 A; B/F/J/M=1-76, D/H=1-75.
DR   PDB; 4DHZ; X-ray; 3.11 A; B=1-76, E=1-75.
DR   PDB; 4FJV; X-ray; 2.05 A; B/D=1-76.
DR   PDB; 4HK2; X-ray; 1.40 A; A/B/C/D=1-76.
DR   PDB; 4HXD; X-ray; 2.85 A; A/C=1-75.
DR   PDB; 4I6L; X-ray; 2.49 A; B=77-150.
DR   PDB; 4I6N; X-ray; 1.70 A; B/D=1-75.
DR   PDB; 4IG7; X-ray; 2.00 A; B=1-75.
DR   PDB; 4IUM; X-ray; 1.45 A; B=1-75.
DR   PDB; 4JQW; X-ray; 2.90 A; C=609-684.
DR   PDB; 4K1R; X-ray; 1.63 A; B/D=607-684.
DR   PDB; 4K7S; X-ray; 1.76 A; A/B/C=1-76.
DR   PDB; 4K7U; X-ray; 1.76 A; A/B/C=1-76.
DR   PDB; 4K7W; X-ray; 1.76 A; A/B/C=1-76.
DR   PDB; 4KSK; X-ray; 2.40 A; C/D=76-152.
DR   PDB; 4KSL; X-ray; 2.83 A; C/D/F/H/J/L/N/P/R/T/V/X=76-228.
DR   PDB; 4LCD; X-ray; 3.10 A; E/F=609-683.
DR   PDB; 4LDT; X-ray; 1.90 A; B/D=609-684.
DR   PDB; 4MDK; X-ray; 2.61 A; E/F/G/H=608-684.
DR   PDB; 4MM3; X-ray; 2.75 A; A=609-684.
DR   PDB; 4MSM; X-ray; 1.74 A; B/D=609-684.
DR   PDB; 4MSQ; X-ray; 1.95 A; B/D=609-684.
DR   PDB; 4NQK; X-ray; 3.70 A; E/F/G/H/I/J=608-684.
DR   PDB; 4UN2; X-ray; 1.51 A; A=609-684.
DR   PDB; 4V3K; X-ray; 2.04 A; B/E=609-684.
DR   PDB; 4V3L; X-ray; 1.53 A; B/D=609-684.
DR   PDB; 4WZP; X-ray; 1.90 A; A/B/C/D/E/F/G/H=153-228.
DR   PDB; 4XOK; X-ray; 2.20 A; A/B/C=1-76.
DR   PDB; 4XOL; X-ray; 2.91 A; A/B=1-76.
DR   PDB; 4ZQS; X-ray; 1.80 A; A/B=533-684.
DR   PDB; 5A5B; EM; 9.50 A; 9=609-684.
DR   PDB; 5AF4; X-ray; 1.85 A; A/B/C/D/E/F/G/H=1-76.
DR   PDB; 5AF5; X-ray; 1.68 A; A=1-73.
DR   PDB; 5AF6; X-ray; 3.40 A; A/B/C/D/E=1-76.
DR   PDB; 5AIT; X-ray; 3.40 A; C/F=609-684.
DR   PDB; 5AIU; X-ray; 2.21 A; C/F=609-684.
DR   PDB; 5B83; X-ray; 2.69 A; A/D=1-304.
DR   PDB; 5C7J; X-ray; 3.00 A; C/D=1-74.
DR   PDB; 5C7M; X-ray; 3.03 A; B/C=1-75.
DR   PDB; 5E6J; X-ray; 2.85 A; B/E=609-683.
DR   PDB; 5H07; X-ray; 2.59 A; A=1-228.
DR   PDB; 5NL4; X-ray; 1.32 A; A/B/C=1-76.
DR   PDB; 5NLF; X-ray; 1.50 A; A/B/C=1-76.
DR   PDB; 5NLI; X-ray; 1.53 A; A/B/C=1-76.
DR   PDB; 5NMC; X-ray; 1.70 A; A/B/C=1-76.
DR   PDB; 5OE7; X-ray; 2.95 A; B=1-146.
DR   PDB; 5OHV; X-ray; 2.80 A; A/C=1-76.
DR   PDB; 5OXH; X-ray; 1.60 A; A=1-76.
DR   PDB; 5OXI; X-ray; 1.63 A; A/B=1-76.
DR   PDB; 5UDH; X-ray; 3.24 A; E=1-76.
DR   PDB; 5WQ4; X-ray; 3.00 A; A/B=1-152.
DR   PDB; 6EQI; X-ray; 3.10 A; A=1-76.
DR   PDBsum; 1C3T; -.
DR   PDBsum; 1CMX; -.
DR   PDBsum; 1D3Z; -.
DR   PDBsum; 1F9J; -.
DR   PDBsum; 1FXT; -.
DR   PDBsum; 1G6J; -.
DR   PDBsum; 1GJZ; -.
DR   PDBsum; 1NBF; -.
DR   PDBsum; 1OGW; -.
DR   PDBsum; 1Q5W; -.
DR   PDBsum; 1S1Q; -.
DR   PDBsum; 1SIF; -.
DR   PDBsum; 1TBE; -.
DR   PDBsum; 1UBI; -.
DR   PDBsum; 1UBQ; -.
DR   PDBsum; 1UD7; -.
DR   PDBsum; 1XD3; -.
DR   PDBsum; 1XQQ; -.
DR   PDBsum; 1YX5; -.
DR   PDBsum; 1YX6; -.
DR   PDBsum; 1ZGU; -.
DR   PDBsum; 1ZO6; -.
DR   PDBsum; 2AYO; -.
DR   PDBsum; 2BGF; -.
DR   PDBsum; 2DEN; -.
DR   PDBsum; 2FUH; -.
DR   PDBsum; 2G45; -.
DR   PDBsum; 2GBJ; -.
DR   PDBsum; 2GBK; -.
DR   PDBsum; 2GBM; -.
DR   PDBsum; 2GBN; -.
DR   PDBsum; 2GBR; -.
DR   PDBsum; 2GMI; -.
DR   PDBsum; 2HTH; -.
DR   PDBsum; 2IBI; -.
DR   PDBsum; 2J7Q; -.
DR   PDBsum; 2JF5; -.
DR   PDBsum; 2JRI; -.
DR   PDBsum; 2JY6; -.
DR   PDBsum; 2JZZ; -.
DR   PDBsum; 2K25; -.
DR   PDBsum; 2K6D; -.
DR   PDBsum; 2K8B; -.
DR   PDBsum; 2K8C; -.
DR   PDBsum; 2KDF; -.
DR   PDBsum; 2KHW; -.
DR   PDBsum; 2KJH; -.
DR   PDBsum; 2KLG; -.
DR   PDBsum; 2KN5; -.
DR   PDBsum; 2KX0; -.
DR   PDBsum; 2L3Z; -.
DR   PDBsum; 2LD9; -.
DR   PDBsum; 2LVO; -.
DR   PDBsum; 2LVP; -.
DR   PDBsum; 2LVQ; -.
DR   PDBsum; 2LZ6; -.
DR   PDBsum; 2MBO; -.
DR   PDBsum; 2MBQ; -.
DR   PDBsum; 2MCN; -.
DR   PDBsum; 2MI8; -.
DR   PDBsum; 2MJ5; -.
DR   PDBsum; 2MOR; -.
DR   PDBsum; 2MRE; -.
DR   PDBsum; 2MWS; -.
DR   PDBsum; 2N2K; -.
DR   PDBsum; 2NR2; -.
DR   PDBsum; 2O6V; -.
DR   PDBsum; 2OJR; -.
DR   PDBsum; 2PE9; -.
DR   PDBsum; 2PEA; -.
DR   PDBsum; 2RR9; -.
DR   PDBsum; 2RU6; -.
DR   PDBsum; 2W9N; -.
DR   PDBsum; 2WDT; -.
DR   PDBsum; 2XEW; -.
DR   PDBsum; 2Y5B; -.
DR   PDBsum; 2Z59; -.
DR   PDBsum; 2ZCB; -.
DR   PDBsum; 2ZVN; -.
DR   PDBsum; 2ZVO; -.
DR   PDBsum; 3A33; -.
DR   PDBsum; 3ALB; -.
DR   PDBsum; 3AUL; -.
DR   PDBsum; 3B08; -.
DR   PDBsum; 3B0A; -.
DR   PDBsum; 3BY4; -.
DR   PDBsum; 3C0R; -.
DR   PDBsum; 3DVG; -.
DR   PDBsum; 3DVN; -.
DR   PDBsum; 3EEC; -.
DR   PDBsum; 3EFU; -.
DR   PDBsum; 3EHV; -.
DR   PDBsum; 3H7P; -.
DR   PDBsum; 3H7S; -.
DR   PDBsum; 3HM3; -.
DR   PDBsum; 3I3T; -.
DR   PDBsum; 3IFW; -.
DR   PDBsum; 3IHP; -.
DR   PDBsum; 3JSV; -.
DR   PDBsum; 3JVZ; -.
DR   PDBsum; 3JW0; -.
DR   PDBsum; 3K9O; -.
DR   PDBsum; 3K9P; -.
DR   PDBsum; 3KVF; -.
DR   PDBsum; 3KW5; -.
DR   PDBsum; 3LDZ; -.
DR   PDBsum; 3MHS; -.
DR   PDBsum; 3MTN; -.
DR   PDBsum; 3N30; -.
DR   PDBsum; 3N32; -.
DR   PDBsum; 3N3K; -.
DR   PDBsum; 3NS8; -.
DR   PDBsum; 3O65; -.
DR   PDBsum; 3OFI; -.
DR   PDBsum; 3OJ3; -.
DR   PDBsum; 3OJ4; -.
DR   PDBsum; 3ONS; -.
DR   PDBsum; 3PRM; -.
DR   PDBsum; 3PT2; -.
DR   PDBsum; 3PTF; -.
DR   PDBsum; 3Q3F; -.
DR   PDBsum; 3RUL; -.
DR   PDBsum; 3TMP; -.
DR   PDBsum; 3U30; -.
DR   PDBsum; 3UGB; -.
DR   PDBsum; 3V6C; -.
DR   PDBsum; 3V6E; -.
DR   PDBsum; 3VFK; -.
DR   PDBsum; 3VUW; -.
DR   PDBsum; 3VUX; -.
DR   PDBsum; 3VUY; -.
DR   PDBsum; 3WXE; -.
DR   PDBsum; 3WXF; -.
DR   PDBsum; 3ZLZ; -.
DR   PDBsum; 3ZNH; -.
DR   PDBsum; 3ZNI; -.
DR   PDBsum; 3ZNZ; -.
DR   PDBsum; 4AP4; -.
DR   PDBsum; 4AUQ; -.
DR   PDBsum; 4BOS; -.
DR   PDBsum; 4BOZ; -.
DR   PDBsum; 4BVU; -.
DR   PDBsum; 4DDG; -.
DR   PDBsum; 4DDI; -.
DR   PDBsum; 4DHJ; -.
DR   PDBsum; 4DHZ; -.
DR   PDBsum; 4FJV; -.
DR   PDBsum; 4HK2; -.
DR   PDBsum; 4HXD; -.
DR   PDBsum; 4I6L; -.
DR   PDBsum; 4I6N; -.
DR   PDBsum; 4IG7; -.
DR   PDBsum; 4IUM; -.
DR   PDBsum; 4JQW; -.
DR   PDBsum; 4K1R; -.
DR   PDBsum; 4K7S; -.
DR   PDBsum; 4K7U; -.
DR   PDBsum; 4K7W; -.
DR   PDBsum; 4KSK; -.
DR   PDBsum; 4KSL; -.
DR   PDBsum; 4LCD; -.
DR   PDBsum; 4LDT; -.
DR   PDBsum; 4MDK; -.
DR   PDBsum; 4MM3; -.
DR   PDBsum; 4MSM; -.
DR   PDBsum; 4MSQ; -.
DR   PDBsum; 4NQK; -.
DR   PDBsum; 4UN2; -.
DR   PDBsum; 4V3K; -.
DR   PDBsum; 4V3L; -.
DR   PDBsum; 4WZP; -.
DR   PDBsum; 4XOK; -.
DR   PDBsum; 4XOL; -.
DR   PDBsum; 4ZQS; -.
DR   PDBsum; 5A5B; -.
DR   PDBsum; 5AF4; -.
DR   PDBsum; 5AF5; -.
DR   PDBsum; 5AF6; -.
DR   PDBsum; 5AIT; -.
DR   PDBsum; 5AIU; -.
DR   PDBsum; 5B83; -.
DR   PDBsum; 5C7J; -.
DR   PDBsum; 5C7M; -.
DR   PDBsum; 5E6J; -.
DR   PDBsum; 5H07; -.
DR   PDBsum; 5NL4; -.
DR   PDBsum; 5NLF; -.
DR   PDBsum; 5NLI; -.
DR   PDBsum; 5NMC; -.
DR   PDBsum; 5OE7; -.
DR   PDBsum; 5OHV; -.
DR   PDBsum; 5OXH; -.
DR   PDBsum; 5OXI; -.
DR   PDBsum; 5UDH; -.
DR   PDBsum; 5WQ4; -.
DR   PDBsum; 6EQI; -.
DR   ProteinModelPortal; P0CG48; -.
DR   SMR; P0CG48; -.
DR   BioGrid; 113164; 1580.
DR   IntAct; P0CG48; 183.
DR   MINT; P0CG48; -.
DR   STRING; 9606.ENSP00000344818; -.
DR   DrugBank; DB04464; N-Formylmethionine.
DR   iPTMnet; P0CG48; -.
DR   PhosphoSitePlus; P0CG48; -.
DR   SwissPalm; P0CG48; -.
DR   DMDM; 391358178; -.
DR   EPD; P0CG48; -.
DR   MaxQB; P0CG48; -.
DR   PaxDb; P0CG48; -.
DR   PeptideAtlas; P0CG48; -.
DR   PRIDE; P0CG48; -.
DR   TopDownProteomics; P0CG48; -.
DR   Ensembl; ENST00000339647; ENSP00000344818; ENSG00000150991.
DR   Ensembl; ENST00000536769; ENSP00000441543; ENSG00000150991.
DR   GeneID; 7316; -.
DR   KEGG; hsa:7316; -.
DR   UCSC; uc001ugs.5; human.
DR   CTD; 7316; -.
DR   DisGeNET; 7316; -.
DR   EuPathDB; HostDB:ENSG00000150991.14; -.
DR   GeneCards; UBC; -.
DR   HGNC; HGNC:12468; UBC.
DR   HPA; CAB000362; -.
DR   HPA; CAB005419; -.
DR   HPA; HPA041344; -.
DR   HPA; HPA049132; -.
DR   MIM; 191340; gene.
DR   neXtProt; NX_P0CG48; -.
DR   OpenTargets; ENSG00000150991; -.
DR   eggNOG; KOG0001; Eukaryota.
DR   eggNOG; COG5272; LUCA.
DR   GeneTree; ENSGT00810000125435; -.
DR   InParanoid; P0CG48; -.
DR   KO; K08770; -.
DR   OMA; HINTATF; -.
DR   OrthoDB; EOG091G178I; -.
DR   TreeFam; TF354256; -.
DR   Reactome; R-HSA-110312; Translesion synthesis by REV1.
DR   Reactome; R-HSA-110314; Recognition of DNA damage by PCNA-containing replication complex.
DR   Reactome; R-HSA-110320; Translesion Synthesis by POLH.
DR   Reactome; R-HSA-1169091; Activation of NF-kappaB in B cells.
DR   Reactome; R-HSA-1169408; ISG15 antiviral mechanism.
DR   Reactome; R-HSA-1234176; Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha.
DR   Reactome; R-HSA-1236382; Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants.
DR   Reactome; R-HSA-1236974; ER-Phagosome pathway.
DR   Reactome; R-HSA-1253288; Downregulation of ERBB4 signaling.
DR   Reactome; R-HSA-1295596; Spry regulation of FGF signaling.
DR   Reactome; R-HSA-1358803; Downregulation of ERBB2:ERBB3 signaling.
DR   Reactome; R-HSA-162588; Budding and maturation of HIV virion.
DR   Reactome; R-HSA-168638; NOD1/2 Signaling Pathway.
DR   Reactome; R-HSA-168927; TICAM1, RIP1-mediated IKK complex recruitment.
DR   Reactome; R-HSA-168928; DDX58/IFIH1-mediated induction of interferon-alpha/beta.
DR   Reactome; R-HSA-174048; APC/C:Cdc20 mediated degradation of Cyclin B.
DR   Reactome; R-HSA-174084; Autodegradation of Cdh1 by Cdh1:APC/C.
DR   Reactome; R-HSA-174113; SCF-beta-TrCP mediated degradation of Emi1.
DR   Reactome; R-HSA-174154; APC/C:Cdc20 mediated degradation of Securin.
DR   Reactome; R-HSA-174178; APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1.
DR   Reactome; R-HSA-174184; Cdc20:Phospho-APC/C mediated degradation of Cyclin A.
DR   Reactome; R-HSA-174490; Membrane binding and targetting of GAG proteins.
DR   Reactome; R-HSA-175474; Assembly Of The HIV Virion.
DR   Reactome; R-HSA-179409; APC-Cdc20 mediated degradation of Nek2A.
DR   Reactome; R-HSA-180534; Vpu mediated degradation of CD4.
DR   Reactome; R-HSA-180585; Vif-mediated degradation of APOBEC3G.
DR   Reactome; R-HSA-182971; EGFR downregulation.
DR   Reactome; R-HSA-187577; SCF(Skp2)-mediated degradation of p27/p21.
DR   Reactome; R-HSA-195253; Degradation of beta-catenin by the destruction complex.
DR   Reactome; R-HSA-201681; TCF dependent signaling in response to WNT.
DR   Reactome; R-HSA-202424; Downstream TCR signaling.
DR   Reactome; R-HSA-205043; NRIF signals cell death from the nucleus.
DR   Reactome; R-HSA-209543; p75NTR recruits signalling complexes.
DR   Reactome; R-HSA-209560; NF-kB is activated and signals survival.
DR   Reactome; R-HSA-211733; Regulation of activated PAK-2p34 by proteasome mediated degradation.
DR   Reactome; R-HSA-2122947; NOTCH1 Intracellular Domain Regulates Transcription.
DR   Reactome; R-HSA-2122948; Activated NOTCH1 Transmits Signal to the Nucleus.
DR   Reactome; R-HSA-2173788; Downregulation of TGF-beta receptor signaling.
DR   Reactome; R-HSA-2173791; TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition).
DR   Reactome; R-HSA-2173795; Downregulation of SMAD2/3:SMAD4 transcriptional activity.
DR   Reactome; R-HSA-2173796; SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription.
DR   Reactome; R-HSA-2467813; Separation of Sister Chromatids.
DR   Reactome; R-HSA-2559580; Oxidative Stress Induced Senescence.
DR   Reactome; R-HSA-2559582; Senescence-Associated Secretory Phenotype (SASP).
DR   Reactome; R-HSA-2559585; Oncogene Induced Senescence.
DR   Reactome; R-HSA-2565942; Regulation of PLK1 Activity at G2/M Transition.
DR   Reactome; R-HSA-2644606; Constitutive Signaling by NOTCH1 PEST Domain Mutants.
DR   Reactome; R-HSA-2672351; Stimuli-sensing channels.
DR   Reactome; R-HSA-2691232; Constitutive Signaling by NOTCH1 HD Domain Mutants.
DR   Reactome; R-HSA-2871837; FCERI mediated NF-kB activation.
DR   Reactome; R-HSA-2894862; Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants.
DR   Reactome; R-HSA-2979096; NOTCH2 Activation and Transmission of Signal to the Nucleus.
DR   Reactome; R-HSA-3134975; Regulation of innate immune responses to cytosolic DNA.
DR   Reactome; R-HSA-3322077; Glycogen synthesis.
DR   Reactome; R-HSA-349425; Autodegradation of the E3 ubiquitin ligase COP1.
DR   Reactome; R-HSA-3769402; Deactivation of the beta-catenin transactivating complex.
DR   Reactome; R-HSA-3785653; Myoclonic epilepsy of Lafora.
DR   Reactome; R-HSA-382556; ABC-family proteins mediated transport.
DR   Reactome; R-HSA-400253; Circadian Clock.
DR   Reactome; R-HSA-445989; TAK1 activates NFkB by phosphorylation and activation of IKKs complex.
DR   Reactome; R-HSA-450302; activated TAK1 mediates p38 MAPK activation.
DR   Reactome; R-HSA-450321; JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1.
DR   Reactome; R-HSA-450408; AUF1 (hnRNP D0) binds and destabilizes mRNA.
DR   Reactome; R-HSA-4608870; Asymmetric localization of PCP proteins.
DR   Reactome; R-HSA-4641257; Degradation of AXIN.
DR   Reactome; R-HSA-4641258; Degradation of DVL.
DR   Reactome; R-HSA-4641263; Regulation of FZD by ubiquitination.
DR   Reactome; R-HSA-5205685; Pink/Parkin Mediated Mitophagy.
DR   Reactome; R-HSA-532668; N-glycan trimming in the ER and Calnexin/Calreticulin cycle.
DR   Reactome; R-HSA-5357905; Regulation of TNFR1 signaling.
DR   Reactome; R-HSA-5357956; TNFR1-induced NFkappaB signaling pathway.
DR   Reactome; R-HSA-5358346; Hedgehog ligand biogenesis.
DR   Reactome; R-HSA-5362768; Hh mutants that don't undergo autocatalytic processing are degraded by ERAD.
DR   Reactome; R-HSA-5607761; Dectin-1 mediated noncanonical NF-kB signaling.
DR   Reactome; R-HSA-5607764; CLEC7A (Dectin-1) signaling.
DR   Reactome; R-HSA-5610780; Degradation of GLI1 by the proteasome.
DR   Reactome; R-HSA-5610783; Degradation of GLI2 by the proteasome.
DR   Reactome; R-HSA-5610785; GLI3 is processed to GLI3R by the proteasome.
DR   Reactome; R-HSA-5632684; Hedgehog 'on' state.
DR   Reactome; R-HSA-5654726; Negative regulation of FGFR1 signaling.
DR   Reactome; R-HSA-5654727; Negative regulation of FGFR2 signaling.
DR   Reactome; R-HSA-5654732; Negative regulation of FGFR3 signaling.
DR   Reactome; R-HSA-5654733; Negative regulation of FGFR4 signaling.
DR   Reactome; R-HSA-5655862; Translesion synthesis by POLK.
DR   Reactome; R-HSA-5656121; Translesion synthesis by POLI.
DR   Reactome; R-HSA-5656169; Termination of translesion DNA synthesis.
DR   Reactome; R-HSA-5658442; Regulation of RAS by GAPs.
DR   Reactome; R-HSA-5668541; TNFR2 non-canonical NF-kB pathway.
DR   Reactome; R-HSA-5675221; Negative regulation of MAPK pathway.
DR   Reactome; R-HSA-5675482; Regulation of necroptotic cell death.
DR   Reactome; R-HSA-5676590; NIK-->noncanonical NF-kB signaling.
DR   Reactome; R-HSA-5678895; Defective CFTR causes cystic fibrosis.
DR   Reactome; R-HSA-5684264; MAP3K8 (TPL2)-dependent MAPK1/3 activation.
DR   Reactome; R-HSA-5685942; HDR through Homologous Recombination (HRR).
DR   Reactome; R-HSA-5687128; MAPK6/MAPK4 signaling.
DR   Reactome; R-HSA-5689603; UCH proteinases.
DR   Reactome; R-HSA-5689877; Josephin domain DUBs.
DR   Reactome; R-HSA-5689880; Ub-specific processing proteases.
DR   Reactome; R-HSA-5689896; Ovarian tumor domain proteases.
DR   Reactome; R-HSA-5689901; Metalloprotease DUBs.
DR   Reactome; R-HSA-5693565; Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks.
DR   Reactome; R-HSA-5693607; Processing of DNA double-strand break ends.
DR   Reactome; R-HSA-5696394; DNA Damage Recognition in GG-NER.
DR   Reactome; R-HSA-5696395; Formation of Incision Complex in GG-NER.
DR   Reactome; R-HSA-5696397; Gap-filling DNA repair synthesis and ligation in GG-NER.
DR   Reactome; R-HSA-5696400; Dual Incision in GG-NER.
DR   Reactome; R-HSA-6781823; Formation of TC-NER Pre-Incision Complex.
DR   Reactome; R-HSA-6781827; Transcription-Coupled Nucleotide Excision Repair (TC-NER).
DR   Reactome; R-HSA-6782135; Dual incision in TC-NER.
DR   Reactome; R-HSA-6782210; Gap-filling DNA repair synthesis and ligation in TC-NER.
DR   Reactome; R-HSA-6783310; Fanconi Anemia Pathway.
DR   Reactome; R-HSA-6804756; Regulation of TP53 Activity through Phosphorylation.
DR   Reactome; R-HSA-6804757; Regulation of TP53 Degradation.
DR   Reactome; R-HSA-6804760; Regulation of TP53 Activity through Methylation.
DR   Reactome; R-HSA-6807004; Negative regulation of MET activity.
DR   Reactome; R-HSA-68827; CDT1 association with the CDC6:ORC:origin complex.
DR   Reactome; R-HSA-68949; Orc1 removal from chromatin.
DR   Reactome; R-HSA-69017; CDK-mediated phosphorylation and removal of Cdc6.
DR   Reactome; R-HSA-69229; Ubiquitin-dependent degradation of Cyclin D1.
DR   Reactome; R-HSA-69231; Cyclin D associated events in G1.
DR   Reactome; R-HSA-69481; G2/M Checkpoints.
DR   Reactome; R-HSA-69541; Stabilization of p53.
DR   Reactome; R-HSA-69601; Ubiquitin Mediated Degradation of Phosphorylated Cdc25A.
DR   Reactome; R-HSA-8849469; PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1.
DR   Reactome; R-HSA-8852276; The role of GTSE1 in G2/M progression after G2 checkpoint.
DR   Reactome; R-HSA-8854050; FBXL7 down-regulates AURKA during mitotic entry and in early mitosis.
DR   Reactome; R-HSA-8856825; Cargo recognition for clathrin-mediated endocytosis.
DR   Reactome; R-HSA-8856828; Clathrin-mediated endocytosis.
DR   Reactome; R-HSA-8863795; Downregulation of ERBB2 signaling.
DR   Reactome; R-HSA-8866652; Synthesis of active ubiquitin: roles of E1 and E2 enzymes.
DR   Reactome; R-HSA-8866654; E3 ubiquitin ligases ubiquitinate target proteins.
DR   Reactome; R-HSA-8875360; InlB-mediated entry of Listeria monocytogenes into host cell.
DR   Reactome; R-HSA-8876493; InlA-mediated entry of Listeria monocytogenes into host cells.
DR   Reactome; R-HSA-8939236; RUNX1 regulates transcription of genes involved in differentiation of HSCs.
DR   Reactome; R-HSA-8939902; Regulation of RUNX2 expression and activity.
DR   Reactome; R-HSA-8941858; Regulation of RUNX3 expression and activity.
DR   Reactome; R-HSA-8948747; Regulation of PTEN localization.
DR   Reactome; R-HSA-8948751; Regulation of PTEN stability and activity.
DR   Reactome; R-HSA-8951664; Neddylation.
DR   Reactome; R-HSA-901032; ER Quality Control Compartment (ERQC).
DR   Reactome; R-HSA-9010553; Regulation of expression of SLITs and ROBOs.
DR   Reactome; R-HSA-9013507; NOTCH3 Activation and Transmission of Signal to the Nucleus.
DR   Reactome; R-HSA-9013973; TICAM1-dependent activation of IRF3/IRF7.
DR   Reactome; R-HSA-9014325; TICAM1,TRAF6-dependent induction of TAK1 complex.
DR   Reactome; R-HSA-9020702; Interleukin-1 signaling.
DR   Reactome; R-HSA-9033241; Peroxisomal protein import.
DR   Reactome; R-HSA-912631; Regulation of signaling by CBL.
DR   Reactome; R-HSA-917729; Endosomal Sorting Complex Required For Transport (ESCRT).
DR   Reactome; R-HSA-917937; Iron uptake and transport.
DR   Reactome; R-HSA-936440; Negative regulators of DDX58/IFIH1 signaling.
DR   Reactome; R-HSA-936964; Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon.
DR   Reactome; R-HSA-937039; IRAK1 recruits IKK complex.
DR   Reactome; R-HSA-937041; IKK complex recruitment mediated by RIP1.
DR   Reactome; R-HSA-937042; IRAK2 mediated activation of TAK1 complex.
DR   Reactome; R-HSA-937072; TRAF6-mediated induction of TAK1 complex within TLR4 complex.
DR   Reactome; R-HSA-975110; TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling.
DR   Reactome; R-HSA-975144; IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation.
DR   Reactome; R-HSA-975163; IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation.
DR   Reactome; R-HSA-977225; Amyloid fiber formation.
DR   Reactome; R-HSA-983168; Antigen processing: Ubiquitination & Proteasome degradation.
DR   SIGNOR; P0CG48; -.
DR   ChiTaRS; UBC; human.
DR   EvolutionaryTrace; P0CG48; -.
DR   GeneWiki; Ubiquitin_C; -.
DR   GenomeRNAi; 7316; -.
DR   PRO; PR:P0CG48; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   Bgee; ENSG00000150991; -.
DR   ExpressionAtlas; P0CG48; baseline and differential.
DR   Genevisible; P0CG48; HS.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0030666; C:endocytic vesicle membrane; TAS:Reactome.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0010008; C:endosome membrane; TAS:Reactome.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0005615; C:extracellular space; HDA:UniProtKB.
DR   GO; GO:0043657; C:host cell; IEA:GOC.
DR   GO; GO:0005741; C:mitochondrial outer membrane; TAS:Reactome.
DR   GO; GO:0043209; C:myelin sheath; IEA:Ensembl.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0005634; C:nucleus; HDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0031982; C:vesicle; HDA:UniProtKB.
DR   GO; GO:0002020; F:protease binding; IPI:UniProtKB.
DR   GO; GO:0003723; F:RNA binding; HDA:UniProtKB.
DR   GO; GO:0000187; P:activation of MAPK activity; TAS:Reactome.
DR   GO; GO:0031145; P:anaphase-promoting complex-dependent catabolic process; TAS:Reactome.
DR   GO; GO:0044267; P:cellular protein metabolic process; TAS:Reactome.
DR   GO; GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome.
DR   GO; GO:0042769; P:DNA damage response, detection of DNA damage; TAS:Reactome.
DR   GO; GO:0016197; P:endosomal transport; TAS:Reactome.
DR   GO; GO:0070987; P:error-free translesion synthesis; TAS:Reactome.
DR   GO; GO:0042276; P:error-prone translesion synthesis; TAS:Reactome.
DR   GO; GO:0070911; P:global genome nucleotide-excision repair; TAS:Reactome.
DR   GO; GO:0007249; P:I-kappaB kinase/NF-kappaB signaling; TAS:Reactome.
DR   GO; GO:0070498; P:interleukin-1-mediated signaling pathway; TAS:Reactome.
DR   GO; GO:0036297; P:interstrand cross-link repair; TAS:Reactome.
DR   GO; GO:0075733; P:intracellular transport of virus; TAS:Reactome.
DR   GO; GO:0007254; P:JNK cascade; TAS:Reactome.
DR   GO; GO:0061024; P:membrane organization; TAS:Reactome.
DR   GO; GO:0002755; P:MyD88-dependent toll-like receptor signaling pathway; TAS:Reactome.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; TAS:Reactome.
DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; TAS:Reactome.
DR   GO; GO:0030512; P:negative regulation of transforming growth factor beta receptor signaling pathway; TAS:Reactome.
DR   GO; GO:0070423; P:nucleotide-binding oligomerization domain containing signaling pathway; TAS:Reactome.
DR   GO; GO:0000715; P:nucleotide-excision repair, DNA damage recognition; TAS:Reactome.
DR   GO; GO:0006297; P:nucleotide-excision repair, DNA gap filling; TAS:Reactome.
DR   GO; GO:0033683; P:nucleotide-excision repair, DNA incision; TAS:Reactome.
DR   GO; GO:0006296; P:nucleotide-excision repair, DNA incision, 5'-to lesion; TAS:Reactome.
DR   GO; GO:0006294; P:nucleotide-excision repair, preincision complex assembly; TAS:Reactome.
DR   GO; GO:0043065; P:positive regulation of apoptotic process; TAS:Reactome.
DR   GO; GO:0051092; P:positive regulation of NF-kappaB transcription factor activity; TAS:Reactome.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; TAS:Reactome.
DR   GO; GO:0016579; P:protein deubiquitination; TAS:Reactome.
DR   GO; GO:0000209; P:protein polyubiquitination; TAS:Reactome.
DR   GO; GO:0006625; P:protein targeting to peroxisome; TAS:Reactome.
DR   GO; GO:0016567; P:protein ubiquitination; TAS:Reactome.
DR   GO; GO:0043488; P:regulation of mRNA stability; TAS:Reactome.
DR   GO; GO:0061418; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; TAS:Reactome.
DR   GO; GO:0051403; P:stress-activated MAPK cascade; TAS:Reactome.
DR   GO; GO:0006283; P:transcription-coupled nucleotide-excision repair; TAS:Reactome.
DR   GO; GO:0007179; P:transforming growth factor beta receptor signaling pathway; TAS:Reactome.
DR   GO; GO:0019985; P:translesion synthesis; TAS:Reactome.
DR   GO; GO:0055085; P:transmembrane transport; TAS:Reactome.
DR   GO; GO:0035666; P:TRIF-dependent toll-like receptor signaling pathway; TAS:Reactome.
DR   GO; GO:0019058; P:viral life cycle; TAS:Reactome.
DR   GO; GO:0019068; P:virion assembly; TAS:Reactome.
DR   GO; GO:0016055; P:Wnt signaling pathway; TAS:Reactome.
DR   InterPro; IPR019956; Ubiquitin.
DR   InterPro; IPR029071; Ubiquitin-like_domsf.
DR   InterPro; IPR019954; Ubiquitin_CS.
DR   InterPro; IPR000626; Ubiquitin_dom.
DR   Pfam; PF00240; ubiquitin; 9.
DR   PRINTS; PR00348; UBIQUITIN.
DR   SMART; SM00213; UBQ; 9.
DR   SUPFAM; SSF54236; SSF54236; 9.
DR   PROSITE; PS00299; UBIQUITIN_1; 9.
DR   PROSITE; PS50053; UBIQUITIN_2; 9.
PE   1: Evidence at protein level;
KW   3D-structure; ADP-ribosylation; Complete proteome; Cytoplasm;
KW   Direct protein sequencing; Isopeptide bond; Nucleus; Phosphoprotein;
KW   Reference proteome; Repeat; Ubl conjugation.
FT   CHAIN         1     76       Ubiquitin.
FT                                /FTId=PRO_0000396178.
FT   CHAIN        77    152       Ubiquitin.
FT                                /FTId=PRO_0000396179.
FT   CHAIN       153    228       Ubiquitin.
FT                                /FTId=PRO_0000396180.
FT   CHAIN       229    304       Ubiquitin.
FT                                /FTId=PRO_0000396181.
FT   CHAIN       305    380       Ubiquitin.
FT                                /FTId=PRO_0000396182.
FT   CHAIN       381    456       Ubiquitin.
FT                                /FTId=PRO_0000396183.
FT   CHAIN       457    532       Ubiquitin.
FT                                /FTId=PRO_0000396184.
FT   CHAIN       533    608       Ubiquitin.
FT                                /FTId=PRO_0000396185.
FT   CHAIN       609    684       Ubiquitin.
FT                                /FTId=PRO_0000396186.
FT   PROPEP      685    685
FT                                /FTId=PRO_0000396187.
FT   DOMAIN        1     76       Ubiquitin-like 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00214}.
FT   DOMAIN       77    152       Ubiquitin-like 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00214}.
FT   DOMAIN      153    228       Ubiquitin-like 3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00214}.
FT   DOMAIN      229    304       Ubiquitin-like 4. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00214}.
FT   DOMAIN      305    380       Ubiquitin-like 5. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00214}.
FT   DOMAIN      381    456       Ubiquitin-like 6. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00214}.
FT   DOMAIN      457    532       Ubiquitin-like 7. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00214}.
FT   DOMAIN      533    608       Ubiquitin-like 8. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00214}.
FT   DOMAIN      609    684       Ubiquitin-like 9. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00214}.
FT   BINDING      54     54       Activating enzyme.
FT   BINDING      72     72       Activating enzyme.
FT   SITE         68     68       Essential for function.
FT   MOD_RES      65     65       Phosphoserine; by PINK1.
FT                                {ECO:0000269|PubMed:24660806,
FT                                ECO:0000269|PubMed:24751536,
FT                                ECO:0000269|PubMed:24784582,
FT                                ECO:0000269|PubMed:25527291}.
FT   CROSSLNK      6      6       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in ubiquitin).
FT                                {ECO:0000269|PubMed:16443603}.
FT   CROSSLNK     11     11       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in ubiquitin).
FT                                {ECO:0000269|PubMed:16443603,
FT                                ECO:0000269|PubMed:16543144}.
FT   CROSSLNK     27     27       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in ubiquitin).
FT                                {ECO:0000305|PubMed:15466860}.
FT   CROSSLNK     29     29       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in ubiquitin).
FT                                {ECO:0000269|PubMed:16543144}.
FT   CROSSLNK     48     48       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in ubiquitin).
FT                                {ECO:0000269|PubMed:16443603,
FT                                ECO:0000269|PubMed:16543144}.
FT   CROSSLNK     63     63       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in ubiquitin).
FT                                {ECO:0000269|PubMed:16543144,
FT                                ECO:0000269|PubMed:18719106}.
FT   CROSSLNK     76     76       Glycyl lysine isopeptide (Gly-Lys)
FT                                (interchain with K-? in acceptor
FT                                proteins).
FT   MUTAGEN      48     48       K->R: No effect on HLTF-mediated
FT                                polyubiquitination of PCNA.
FT                                {ECO:0000269|PubMed:18719106}.
FT   MUTAGEN      63     63       K->R: Abolishes HLTF-mediated
FT                                polyubiquitination of PCNA.
FT                                {ECO:0000269|PubMed:18719106}.
FT   MUTAGEN      65     65       S->A: Prevents phosphorylation in case of
FT                                mitophagy. {ECO:0000269|PubMed:24660806,
FT                                ECO:0000269|PubMed:24751536,
FT                                ECO:0000269|PubMed:24784582}.
FT   MUTAGEN      65     65       S->D: Phosphomimetic mutant that binds
FT                                and activates PRKN.
FT                                {ECO:0000269|PubMed:24751536}.
FT   MUTAGEN      68     68       H->G: Loss of DTX3L-mediated
FT                                polyubiquitination of histone H3 and H4.
FT                                {ECO:0000269|PubMed:28525742}.
FT   MUTAGEN      72     72       R->G: No effect on ADP-ribosylation.
FT                                {ECO:0000269|PubMed:28525742}.
FT   MUTAGEN      72     72       R->K: No effect on ADP-ribosylation, when
FT                                associated with K-74.
FT                                {ECO:0000269|PubMed:28525742}.
FT   MUTAGEN      74     74       R->G: No effect on ADP-ribosylation.
FT                                {ECO:0000269|PubMed:28525742}.
FT   MUTAGEN      74     74       R->K: No effect on ADP-ribosylation, when
FT                                associated with K-72.
FT                                {ECO:0000269|PubMed:28525742}.
FT   MUTAGEN      76     76       G->A: Loss of ADP-ribosylation.
FT                                {ECO:0000269|PubMed:28525742}.
FT   CONFLICT    190    190       P -> S (in Ref. 4; AC126309).
FT                                {ECO:0000305}.
FT   CONFLICT    397    397       V -> G (in Ref. 6; BAA09860).
FT                                {ECO:0000305}.
FT   STRAND      383    386       {ECO:0000244|PDB:5B83}.
FT   STRAND      392    395       {ECO:0000244|PDB:5B83}.
FT   HELIX       403    411       {ECO:0000244|PDB:5B83}.
FT   HELIX       418    420       {ECO:0000244|PDB:5B83}.
FT   STRAND      421    425       {ECO:0000244|PDB:5B83}.
FT   STRAND      428    430       {ECO:0000244|PDB:5B83}.
FT   HELIX       436    438       {ECO:0000244|PDB:5B83}.
FT   STRAND      446    451       {ECO:0000244|PDB:5B83}.
FT   STRAND      458    463       {ECO:0000244|PDB:5H07}.
FT   STRAND      468    472       {ECO:0000244|PDB:5H07}.
FT   HELIX       479    490       {ECO:0000244|PDB:5H07}.
FT   HELIX       494    496       {ECO:0000244|PDB:5H07}.
FT   STRAND      497    501       {ECO:0000244|PDB:5H07}.
FT   HELIX       513    515       {ECO:0000244|PDB:5H07}.
FT   STRAND      522    527       {ECO:0000244|PDB:5H07}.
FT   STRAND      534    539       {ECO:0000244|PDB:3B08}.
FT   STRAND      540    542       {ECO:0000244|PDB:2W9N}.
FT   STRAND      544    548       {ECO:0000244|PDB:3B08}.
FT   HELIX       555    566       {ECO:0000244|PDB:3B08}.
FT   HELIX       570    572       {ECO:0000244|PDB:3B08}.
FT   STRAND      573    577       {ECO:0000244|PDB:3B08}.
FT   STRAND      579    581       {ECO:0000244|PDB:3N3K}.
FT   STRAND      586    588       {ECO:0000244|PDB:3WXE}.
FT   HELIX       589    591       {ECO:0000244|PDB:3B08}.
FT   STRAND      598    603       {ECO:0000244|PDB:3B08}.
FT   STRAND      610    615       {ECO:0000244|PDB:1OGW}.
FT   STRAND      616    618       {ECO:0000244|PDB:4K1R}.
FT   STRAND      620    624       {ECO:0000244|PDB:1OGW}.
FT   STRAND      627    630       {ECO:0000244|PDB:1G6J}.
FT   HELIX       631    642       {ECO:0000244|PDB:1OGW}.
FT   HELIX       646    648       {ECO:0000244|PDB:1OGW}.
FT   STRAND      649    653       {ECO:0000244|PDB:1OGW}.
FT   STRAND      654    657       {ECO:0000244|PDB:4BVU}.
FT   STRAND      660    663       {ECO:0000244|PDB:3JSV}.
FT   HELIX       664    667       {ECO:0000244|PDB:1OGW}.
FT   TURN        668    670       {ECO:0000244|PDB:5OXH}.
FT   STRAND      671    673       {ECO:0000244|PDB:6EQI}.
FT   STRAND      674    679       {ECO:0000244|PDB:1OGW}.
SQ   SEQUENCE   685 AA;  77039 MW;  B6E7BC06FEE77196 CRC64;
     MQIFVKTLTG KTITLEVEPS DTIENVKAKI QDKEGIPPDQ QRLIFAGKQL EDGRTLSDYN
     IQKESTLHLV LRLRGGMQIF VKTLTGKTIT LEVEPSDTIE NVKAKIQDKE GIPPDQQRLI
     FAGKQLEDGR TLSDYNIQKE STLHLVLRLR GGMQIFVKTL TGKTITLEVE PSDTIENVKA
     KIQDKEGIPP DQQRLIFAGK QLEDGRTLSD YNIQKESTLH LVLRLRGGMQ IFVKTLTGKT
     ITLEVEPSDT IENVKAKIQD KEGIPPDQQR LIFAGKQLED GRTLSDYNIQ KESTLHLVLR
     LRGGMQIFVK TLTGKTITLE VEPSDTIENV KAKIQDKEGI PPDQQRLIFA GKQLEDGRTL
     SDYNIQKEST LHLVLRLRGG MQIFVKTLTG KTITLEVEPS DTIENVKAKI QDKEGIPPDQ
     QRLIFAGKQL EDGRTLSDYN IQKESTLHLV LRLRGGMQIF VKTLTGKTIT LEVEPSDTIE
     NVKAKIQDKE GIPPDQQRLI FAGKQLEDGR TLSDYNIQKE STLHLVLRLR GGMQIFVKTL
     TGKTITLEVE PSDTIENVKA KIQDKEGIPP DQQRLIFAGK QLEDGRTLSD YNIQKESTLH
     LVLRLRGGMQ IFVKTLTGKT ITLEVEPSDT IENVKAKIQD KEGIPPDQQR LIFAGKQLED
     GRTLSDYNIQ KESTLHLVLR LRGGV
//
ID   PPR3C_HUMAN             Reviewed;         317 AA.
AC   Q9UQK1; B2R7X0; O95686;
DT   01-MAY-2007, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-2007, sequence version 2.
DT   28-MAR-2018, entry version 117.
DE   RecName: Full=Protein phosphatase 1 regulatory subunit 3C;
DE   AltName: Full=Protein phosphatase 1 regulatory subunit 5;
DE            Short=PP1 subunit R5;
DE   AltName: Full=Protein targeting to glycogen;
DE            Short=PTG;
GN   Name=PPP1R3C {ECO:0000312|HGNC:HGNC:9293};
GN   Synonyms=PPP1R5 {ECO:0000312|EMBL:CAA77082.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1] {ECO:0000305, ECO:0000312|EMBL:CAA77082.1}
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, AND INTERACTION WITH PPP1CC.
RC   TISSUE=Gall bladder {ECO:0000269|PubMed:8985175};
RX   PubMed=8985175; DOI=10.1016/S0014-5793(96)01357-9;
RA   Doherty M.J., Young P.R., Cohen P.T.W.;
RT   "Amino acid sequence of a novel protein phosphatase 1 binding protein
RT   (R5) which is related to the liver- and muscle-specific glycogen
RT   binding subunits of protein phosphatase 1.";
RL   FEBS Lett. 399:339-343(1996).
RN   [2] {ECO:0000312|EMBL:AAD33215.1}
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=10222257; DOI=10.1006/bbrc.1999.0614;
RA   Permana P.A., Luczy-Bachman G., Bogardus C.;
RT   "Protein targeting to glycogen/PPP1R5: screening of coding and
RT   flanking genomic regions for polymorphisms and association analysis
RT   with insulin action in Pima Indians.";
RL   Biochem. Biophys. Res. Commun. 258:184-186(1999).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Retina;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [5] {ECO:0000312|EMBL:CAH69995.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164054; DOI=10.1038/nature02462;
RA   Deloukas P., Earthrowl M.E., Grafham D.V., Rubenfield M., French L.,
RA   Steward C.A., Sims S.K., Jones M.C., Searle S., Scott C., Howe K.,
RA   Hunt S.E., Andrews T.D., Gilbert J.G.R., Swarbreck D., Ashurst J.L.,
RA   Taylor A., Battles J., Bird C.P., Ainscough R., Almeida J.P.,
RA   Ashwell R.I.S., Ambrose K.D., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Bates K., Beasley H., Bray-Allen S., Brown A.J.,
RA   Brown J.Y., Burford D.C., Burrill W., Burton J., Cahill P., Camire D.,
RA   Carter N.P., Chapman J.C., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Corby N., Coulson A., Dhami P., Dutta I., Dunn M., Faulkner L.,
RA   Frankish A., Frankland J.A., Garner P., Garnett J., Gribble S.,
RA   Griffiths C., Grocock R., Gustafson E., Hammond S., Harley J.L.,
RA   Hart E., Heath P.D., Ho T.P., Hopkins B., Horne J., Howden P.J.,
RA   Huckle E., Hynds C., Johnson C., Johnson D., Kana A., Kay M.,
RA   Kimberley A.M., Kershaw J.K., Kokkinaki M., Laird G.K., Lawlor S.,
RA   Lee H.M., Leongamornlert D.A., Laird G., Lloyd C., Lloyd D.M.,
RA   Loveland J., Lovell J., McLaren S., McLay K.E., McMurray A.,
RA   Mashreghi-Mohammadi M., Matthews L., Milne S., Nickerson T.,
RA   Nguyen M., Overton-Larty E., Palmer S.A., Pearce A.V., Peck A.I.,
RA   Pelan S., Phillimore B., Porter K., Rice C.M., Rogosin A., Ross M.T.,
RA   Sarafidou T., Sehra H.K., Shownkeen R., Skuce C.D., Smith M.,
RA   Standring L., Sycamore N., Tester J., Thorpe A., Torcasso W.,
RA   Tracey A., Tromans A., Tsolas J., Wall M., Walsh J., Wang H.,
RA   Weinstock K., West A.P., Willey D.L., Whitehead S.L., Wilming L.,
RA   Wray P.W., Young L., Chen Y., Lovering R.C., Moschonas N.K.,
RA   Siebert R., Fechtel K., Bentley D., Durbin R.M., Hubbard T.,
RA   Doucette-Stamm L., Beck S., Smith D.R., Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 10.";
RL   Nature 429:375-381(2004).
RN   [6] {ECO:0000312|EMBL:CAD97641.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7] {ECO:0000312|EMBL:AAH12625.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Skeletal muscle {ECO:0000312|EMBL:AAH12625.1};
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8] {ECO:0000305}
RP   INTERACTION WITH EPM2A, AND MUTAGENESIS OF VAL-85; PHE-87; ASP-247 AND
RP   ASP-250.
RX   PubMed=14532330; DOI=10.1093/hmg/ddg340;
RA   Fernandez-Sanchez M.E., Criado-Garcia O., Heath K.E.,
RA   Garcia-Fojeda B., Medrano-Fernandez I., Gomez-Garre P., Sanz P.,
RA   Serratosa J.M., Rodriguez de Cordoba S.;
RT   "Laforin, the dual-phosphatase responsible for Lafora disease,
RT   interacts with R5 (PTG), a regulatory subunit of protein phosphatase-1
RT   that enhances glycogen accumulation.";
RL   Hum. Mol. Genet. 12:3161-3171(2003).
RN   [9]
RP   UBIQUITINATION, AND INTERACTION WITH EPM2A.
RX   PubMed=18070875; DOI=10.1074/jbc.M708712200;
RA   Worby C.A., Gentry M.S., Dixon J.E.;
RT   "Malin decreases glycogen accumulation by promoting the degradation of
RT   protein targeting to glycogen (PTG).";
RL   J. Biol. Chem. 283:4069-4076(2008).
RN   [10]
RP   VARIANT SER-249.
RX   PubMed=21738631; DOI=10.1371/journal.pone.0021294;
RA   Guerrero R., Vernia S., Sanz R., Abreu-Rodriguez I., Almaraz C.,
RA   Garcia-Hoyos M., Michelucci R., Tassinari C.A., Riguzzi P., Nobile C.,
RA   Sanz P., Serratosa J.M., Gomez-Garre P.;
RT   "A PTG variant contributes to a milder phenotype in Lafora disease.";
RL   PLoS ONE 6:E21294-E21294(2011).
CC   -!- FUNCTION: Acts as a glycogen-targeting subunit for PP1 and
CC       regulates its activity. Activates glycogen synthase, reduces
CC       glycogen phosphorylase activity and limits glycogen breakdown.
CC       Dramatically increases basal and insulin-stimulated glycogen
CC       synthesis upon overexpression in a variety of cell types.
CC       {ECO:0000250|UniProtKB:Q7TMB3, ECO:0000269|PubMed:8985175}.
CC   -!- SUBUNIT: Interacts with PPP1CC catalytic subunit of PP1 and
CC       associates with glycogen. Forms complexes with glycogen
CC       phosphorylase, glycogen synthase and phosphorylase kinase which is
CC       necessary for its regulation of PP1 activity. Also interacts with
CC       EPM2A/laforin. {ECO:0000250|UniProtKB:Q7TMB3,
CC       ECO:0000269|PubMed:14532330, ECO:0000269|PubMed:18070875,
CC       ECO:0000269|PubMed:8985175}.
CC   -!- INTERACTION:
CC       O95278:EPM2A; NbExp=5; IntAct=EBI-2506727, EBI-2506661;
CC       P62140:PPP1CB; NbExp=6; IntAct=EBI-2506727, EBI-352350;
CC   -!- DOMAIN: The N-terminal region is required for binding to PP1, the
CC       central region is required for binding to glycogen and the C-
CC       terminal region is required for binding to glycogen phosphorylase,
CC       glycogen synthase and phosphorylase kinase.
CC       {ECO:0000250|UniProtKB:Q7TMB3}.
CC   -!- PTM: Ubiquitinated by NHLRC1/malin in a EPM2A/laforin-dependent
CC       manner. {ECO:0000269|PubMed:18070875}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAD33215.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; Y18207; CAA77082.1; -; mRNA.
DR   EMBL; AF110824; AAD33215.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; AK313149; BAG35967.1; -; mRNA.
DR   EMBL; BX537399; CAD97641.1; -; mRNA.
DR   EMBL; AL359986; CAH69995.1; -; Genomic_DNA.
DR   EMBL; CH471066; EAW50107.1; -; Genomic_DNA.
DR   EMBL; BC012625; AAH12625.1; -; mRNA.
DR   CCDS; CCDS7416.1; -.
DR   RefSeq; NP_005389.1; NM_005398.6.
DR   UniGene; Hs.303090; -.
DR   UniGene; Hs.744999; -.
DR   ProteinModelPortal; Q9UQK1; -.
DR   SMR; Q9UQK1; -.
DR   BioGrid; 111500; 20.
DR   IntAct; Q9UQK1; 17.
DR   MINT; Q9UQK1; -.
DR   STRING; 9606.ENSP00000238994; -.
DR   CAZy; CBM21; Carbohydrate-Binding Module Family 21.
DR   iPTMnet; Q9UQK1; -.
DR   PhosphoSitePlus; Q9UQK1; -.
DR   BioMuta; PPP1R3C; -.
DR   DMDM; 146325084; -.
DR   PaxDb; Q9UQK1; -.
DR   PeptideAtlas; Q9UQK1; -.
DR   PRIDE; Q9UQK1; -.
DR   DNASU; 5507; -.
DR   Ensembl; ENST00000238994; ENSP00000238994; ENSG00000119938.
DR   GeneID; 5507; -.
DR   KEGG; hsa:5507; -.
DR   UCSC; uc001kho.4; human.
DR   CTD; 5507; -.
DR   DisGeNET; 5507; -.
DR   EuPathDB; HostDB:ENSG00000119938.8; -.
DR   GeneCards; PPP1R3C; -.
DR   HGNC; HGNC:9293; PPP1R3C.
DR   HPA; HPA027041; -.
DR   MIM; 602999; gene.
DR   neXtProt; NX_Q9UQK1; -.
DR   OpenTargets; ENSG00000119938; -.
DR   PharmGKB; PA33653; -.
DR   eggNOG; KOG3986; Eukaryota.
DR   eggNOG; ENOG4111FT1; LUCA.
DR   GeneTree; ENSGT00530000062978; -.
DR   HOGENOM; HOG000026799; -.
DR   HOVERGEN; HBG052744; -.
DR   InParanoid; Q9UQK1; -.
DR   KO; K07189; -.
DR   OMA; FDTWKTY; -.
DR   OrthoDB; EOG091G0GB5; -.
DR   PhylomeDB; Q9UQK1; -.
DR   TreeFam; TF105537; -.
DR   Reactome; R-HSA-3322077; Glycogen synthesis.
DR   Reactome; R-HSA-3785653; Myoclonic epilepsy of Lafora.
DR   ChiTaRS; PPP1R3C; human.
DR   GeneWiki; PPP1R3C; -.
DR   GenomeRNAi; 5507; -.
DR   PRO; PR:Q9UQK1; -.
DR   Proteomes; UP000005640; Chromosome 10.
DR   Bgee; ENSG00000119938; -.
DR   CleanEx; HS_PPP1R3C; -.
DR   Genevisible; Q9UQK1; HS.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0019903; F:protein phosphatase binding; ISS:UniProtKB.
DR   GO; GO:0019888; F:protein phosphatase regulator activity; IEA:InterPro.
DR   GO; GO:0004722; F:protein serine/threonine phosphatase activity; TAS:ProtInc.
DR   GO; GO:0005978; P:glycogen biosynthetic process; ISS:UniProtKB.
DR   GO; GO:0005977; P:glycogen metabolic process; ISS:UniProtKB.
DR   Gene3D; 2.60.40.2440; -; 1.
DR   InterPro; IPR005036; CBM21_dom.
DR   InterPro; IPR038175; CBM21_dom_sf.
DR   InterPro; IPR017434; Pase-1_reg-su_3B/C/D_met.
DR   InterPro; IPR030683; PP1_3C.
DR   PANTHER; PTHR12307:SF15; PTHR12307:SF15; 1.
DR   Pfam; PF03370; CBM_21; 1.
DR   PIRSF; PIRSF038207; PP1_GT_animal; 1.
DR   PIRSF; PIRSF500813; PP1_PTG; 1.
DR   PROSITE; PS51159; CBM21; 1.
PE   1: Evidence at protein level;
KW   Carbohydrate metabolism; Complete proteome; Glycogen metabolism;
KW   Polymorphism; Reference proteome; Ubl conjugation.
FT   CHAIN         1    317       Protein phosphatase 1 regulatory subunit
FT                                3C.
FT                                /FTId=PRO_0000285927.
FT   DOMAIN      149    257       CBM21. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00491}.
FT   REGION      141    263       Interaction with EPM2A.
FT                                {ECO:0000269|PubMed:14532330}.
FT   MOTIF        84     87       PP1-binding motif.
FT   VARIANT     109    109       A -> S (in dbSNP:rs7089948).
FT                                /FTId=VAR_059775.
FT   VARIANT     249    249       N -> S (found in a patient with
FT                                progressive myoclonic epilepsy type 2
FT                                also carrying two mutations in EPM2B;
FT                                dbSNP:rs373998228).
FT                                {ECO:0000269|PubMed:21738631}.
FT                                /FTId=VAR_067339.
FT   MUTAGEN      85     85       V->A: No effect on interaction with
FT                                EPM2A; when associated with A-87.
FT                                {ECO:0000269|PubMed:14532330}.
FT   MUTAGEN      87     87       F->A: No effect on interaction with
FT                                EPM2A; when associated with A-85.
FT                                {ECO:0000269|PubMed:14532330}.
FT   MUTAGEN     247    247       D->A: No interaction with EPM2A; when
FT                                associated with A-250.
FT                                {ECO:0000269|PubMed:14532330}.
FT   MUTAGEN     250    250       D->A: No interaction with EPM2A; when
FT                                associated with A-247.
FT                                {ECO:0000269|PubMed:14532330}.
SQ   SEQUENCE   317 AA;  36445 MW;  FBFD6DE015F9AB2D CRC64;
     MSCTRMIQVL DPRPLTSSVM PVDVAMRLCL AHSPPVKSFL GPYDEFQRRH FVNKLKPLKS
     CLNIKHKAKS QNDWKCSHNQ AKKRVVFADS KGLSLTAIHV FSDLPEEPAW DLQFDLLDLN
     DISSALKHHE EKNLILDFPQ PSTDYLSFRS HFQKNFVCLE NCSLQERTVT GTVKVKNVSF
     EKKVQIRITF DSWKNYTDVD CVYMKNVYGG TDSDTFSFAI DLPPVIPTEQ KIEFCISYHA
     NGQVFWDNND GQNYRIVHVQ WKPDGVQTQM APQDCAFHQT SPKTELESTI FGSPRLASGL
     FPEWQSWGRM ENLASYR
//
ID   HSP7C_HUMAN             Reviewed;         646 AA.
AC   P11142; Q9H3R6;
DT   01-JUL-1989, integrated into UniProtKB/Swiss-Prot.
DT   01-JUL-1989, sequence version 1.
DT   23-MAY-2018, entry version 222.
DE   RecName: Full=Heat shock cognate 71 kDa protein;
DE   AltName: Full=Heat shock 70 kDa protein 8;
DE   AltName: Full=Lipopolysaccharide-associated protein 1;
DE            Short=LAP-1;
DE            Short=LPS-associated protein 1;
GN   Name=HSPA8; Synonyms=HSC70, HSP73, HSPA10;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM 1).
RX   PubMed=3037489; DOI=10.1093/nar/15.13.5181;
RA   Dworniczak B.P., Mirault M.-E.;
RT   "Structure and expression of a human gene coding for a 71 kd heat
RT   shock 'cognate' protein.";
RL   Nucleic Acids Res. 15:5181-5197(1987).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RX   PubMed=11093761;
RA   Tsukahara F., Yoshioka T., Muraki T.;
RT   "Molecular and functional characterization of HSC54, a novel variant
RT   of human heat shock cognate protein 70.";
RL   Mol. Pharmacol. 58:1257-1263(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RA   Niswonger M.L., Berk L.R., Srivastava P.K.;
RT   "Complete coding sequence of human HSC70.";
RL   Submitted (FEB-2001) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Placenta, and Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   PROTEIN SEQUENCE OF 2-49; 57-71; 77-102; 103-155; 160-188; 221-247;
RP   273-311; 326-342; 349-416; 424-447; 452-493; 510-517; 540-550; 570-597
RP   AND 602-646, CLEAVAGE OF INITIATOR METHIONINE, ACETYLATION AT SER-2,
RP   AND IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Embryonic kidney;
RA   Bienvenut W.V., Waridel P., Quadroni M.;
RL   Submitted (MAR-2009) to UniProtKB.
RN   [6]
RP   PROTEIN SEQUENCE OF 2-49; 57-72; 78-88; 113-188; 221-247; 300-319;
RP   326-342; 349-357; 362-384; 424-447; 452-469; 510-517; 540-550 AND
RP   584-609, CLEAVAGE OF INITIATOR METHIONINE, ACETYLATION AT SER-2, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Colon carcinoma, and Ovarian carcinoma;
RA   Bienvenut W.V., Lilla S., von Kriegsheim A., Lempens A., Kolch W.,
RA   Bilsland A.E., Keith W.N.;
RL   Submitted (JAN-2010) to UniProtKB.
RN   [7]
RP   PROTEIN SEQUENCE OF 4-49; 57-71; 77-88; 113-126; 129-155; 160-187;
RP   221-246; 300-311; 329-342; 362-384; 424-447; 540-550 AND 574-583, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Brain, Cajal-Retzius cell, and Fetal brain cortex;
RA   Lubec G., Vishwanath V., Chen W.-Q., Sun Y.;
RL   Submitted (DEC-2008) to UniProtKB.
RN   [8]
RP   PROTEIN SEQUENCE OF 50-55; 103-107 AND 580-596.
RX   PubMed=1286667; DOI=10.1002/elps.11501301199;
RA   Rasmussen H.H., van Damme J., Puype M., Gesser B., Celis J.E.,
RA   Vandekerckhove J.;
RT   "Microsequences of 145 proteins recorded in the two-dimensional gel
RT   protein database of normal human epidermal keratinocytes.";
RL   Electrophoresis 13:960-969(1992).
RN   [9]
RP   PROTEIN SEQUENCE OF 77-86; 221-236 AND 302-311.
RX   PubMed=8713105; DOI=10.1006/bbrc.1996.1082;
RA   Egerton M., Moritz R.L., Druker B., Kelso A., Simpson R.J.;
RT   "Identification of the 70kD heat shock cognate protein (Hsc70) and
RT   alpha-actinin-1 as novel phosphotyrosine-containing proteins in T
RT   lymphocytes.";
RL   Biochem. Biophys. Res. Commun. 224:666-674(1996).
RN   [10]
RP   PROTEIN SEQUENCE OF 551-567, METHYLATION AT LYS-561, MUTAGENESIS OF
RP   LYS-561, AND IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=23349634; DOI=10.1371/journal.pgen.1003210;
RA   Cloutier P., Lavallee-Adam M., Faubert D., Blanchette M., Coulombe B.;
RT   "A newly uncovered group of distantly related lysine
RT   methyltransferases preferentially interact with molecular chaperones
RT   to regulate their activity.";
RL   PLoS Genet. 9:E1003210-E1003210(2013).
RN   [11]
RP   SUBCELLULAR LOCATION.
RX   PubMed=1586970;
RA   Hattori H., Liu Y.-C., Tohnai I., Ueda M., Kaneda T., Kobayashi T.,
RA   Tanabe K., Ohtsuka K.;
RT   "Intracellular localization and partial amino acid sequence of a
RT   stress-inducible 40-kDa protein in HeLa cells.";
RL   Cell Struct. Funct. 17:77-86(1992).
RN   [12]
RP   INTERACTION WITH BAG1, AND DOMAIN.
RX   PubMed=9305631; DOI=10.1093/emboj/16.16.4887;
RA   Takayama S., Bimston D.N., Matsuzawa S.-I., Freeman B.C.,
RA   Aime-Sempe C., Xie Z., Morimoto R.I., Reed J.C.;
RT   "BAG-1 modulates the chaperone activity of Hsp70/Hsc70.";
RL   EMBO J. 16:4887-4896(1997).
RN   [13]
RP   INTERACTION WITH BAG1.
RX   PubMed=9679980;
RA   Takayama S., Krajewski S., Krajewska M., Kitada S., Zapata J.M.,
RA   Kochel K., Knee D., Scudiero D., Tudor G., Miller G.J., Miyashita T.,
RA   Yamada M., Reed J.C.;
RT   "Expression and location of Hsp70/Hsc-binding anti-apoptotic protein
RT   BAG-1 and its variants in normal tissues and tumor cell lines.";
RL   Cancer Res. 58:3116-3131(1998).
RN   [14]
RP   INTERACTION WITH HSF1.
RX   PubMed=9499401; DOI=10.1101/gad.12.5.654;
RA   Shi Y., Mosser D.D., Morimoto R.I.;
RT   "Molecular chaperones as HSF1-specific transcriptional repressors.";
RL   Genes Dev. 12:654-666(1998).
RN   [15]
RP   INTERACTION WITH SV40 VP1.
RX   PubMed=11147964; DOI=10.1379/1466-1268(2000)005<0132:HIWSVP>2.0.CO;2;
RA   Sainis L., Angelidis C., Pagoulatos G.N., Lazaridis L.;
RT   "HSC70 interactions with SV40 viral proteins differ between permissive
RT   and nonpermissive mammalian cells.";
RL   Cell Stress Chaperones 5:132-138(2000).
RN   [16]
RP   FUNCTION, AND INTERACTION WITH CITED1.
RX   PubMed=10722728; DOI=10.1074/jbc.275.12.8825;
RA   Yahata T., de Caestecker M.P., Lechleider R.J., Andriole S.,
RA   Roberts A.B., Isselbacher K.J., Shioda T.;
RT   "The MSG1 non-DNA-binding transactivator binds to the p300/CBP
RT   coactivators, enhancing their functional link to the Smad
RT   transcription factors.";
RL   J. Biol. Chem. 275:8825-8834(2000).
RN   [17]
RP   FUNCTION, IDENTIFICATION AS LPS RECEPTOR, INTERACTION WITH CXCR4; GDF5
RP   AND HSP90AA1, SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=11276205; DOI=10.1038/86342;
RA   Triantafilou K., Triantafilou M., Dedrick R.L.;
RT   "A CD14-independent LPS receptor cluster.";
RL   Nat. Immunol. 2:338-345(2001).
RN   [18]
RP   INTERACTION WITH PACRG.
RX   PubMed=14532270; DOI=10.1074/jbc.M309655200;
RA   Imai Y., Soda M., Murakami T., Shoji M., Abe K., Takahashi R.;
RT   "A product of the human gene adjacent to parkin is a component of Lewy
RT   bodies and suppresses Pael receptor-induced cell death.";
RL   J. Biol. Chem. 278:51901-51910(2003).
RN   [19]
RP   INTERACTION WITH TTC1.
RX   PubMed=15708368; DOI=10.1016/j.abb.2004.12.020;
RA   Liou S.T., Wang C.;
RT   "Small glutamine-rich tetratricopeptide repeat-containing protein is
RT   composed of three structural units with distinct functions.";
RL   Arch. Biochem. Biophys. 435:253-263(2005).
RN   [20]
RP   ISGYLATION.
RX   PubMed=16139798; DOI=10.1016/j.bbrc.2005.08.132;
RA   Giannakopoulos N.V., Luo J.K., Papov V., Zou W., Lenschow D.J.,
RA   Jacobs B.S., Borden E.C., Li J., Virgin H.W., Zhang D.E.;
RT   "Proteomic identification of proteins conjugated to ISG15 in mouse and
RT   human cells.";
RL   Biochem. Biophys. Res. Commun. 336:496-506(2005).
RN   [21]
RP   INTERACTION WITH TSC2, AND IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=15963462; DOI=10.1016/j.bbrc.2005.05.175;
RA   Nellist M., Burgers P.C., van den Ouweland A.M.W., Halley D.J.J.,
RA   Luider T.M.;
RT   "Phosphorylation and binding partner analysis of the TSC1-TSC2
RT   complex.";
RL   Biochem. Biophys. Res. Commun. 333:818-826(2005).
RN   [22]
RP   INTERACTION WITH DNAJB2.
RX   PubMed=15936278; DOI=10.1016/j.cub.2005.04.058;
RA   Westhoff B., Chapple J.P., van der Spuy J., Hoehfeld J.,
RA   Cheetham M.E.;
RT   "HSJ1 is a neuronal shuttling factor for the sorting of chaperone
RT   clients to the proteasome.";
RL   Curr. Biol. 15:1058-1064(2005).
RN   [23]
RP   SUBCELLULAR LOCATION [LARGE SCALE ANALYSIS].
RC   TISSUE=Melanoma;
RX   PubMed=17081065; DOI=10.1021/pr060363j;
RA   Chi A., Valencia J.C., Hu Z.-Z., Watabe H., Yamaguchi H.,
RA   Mangini N.J., Huang H., Canfield V.A., Cheng K.C., Yang F., Abe R.,
RA   Yamagishi S., Shabanowitz J., Hearing V.J., Wu C., Appella E.,
RA   Hunt D.F.;
RT   "Proteomic and bioinformatic characterization of the biogenesis and
RT   function of melanosomes.";
RL   J. Proteome Res. 5:3135-3144(2006).
RN   [24]
RP   INTERACTION WITH HERC5, AND ISGYLATION.
RX   PubMed=16815975; DOI=10.1073/pnas.0600397103;
RA   Wong J.J., Pung Y.F., Sze N.S., Chin K.C.;
RT   "HERC5 is an IFN-induced HECT-type E3 protein ligase that mediates
RT   type I IFN-induced ISGylation of protein targets.";
RL   Proc. Natl. Acad. Sci. U.S.A. 103:10735-10740(2006).
RN   [25]
RP   INTERACTION WITH DNAJC9.
RX   PubMed=17182002; DOI=10.1016/j.bbrc.2006.12.013;
RA   Han C., Chen T., Li N., Yang M., Wan T., Cao X.;
RT   "HDJC9, a novel human type C DnaJ/HSP40 member interacts with and
RT   cochaperones HSP70 through the J domain.";
RL   Biochem. Biophys. Res. Commun. 353:280-285(2007).
RN   [26]
RP   IDENTIFICATION IN A MRNP GRANULE COMPLEX, IDENTIFICATION BY MASS
RP   SPECTROMETRY, AND SUBCELLULAR LOCATION.
RX   PubMed=17289661; DOI=10.1074/mcp.M600346-MCP200;
RA   Joeson L., Vikesaa J., Krogh A., Nielsen L.K., Hansen T., Borup R.,
RA   Johnsen A.H., Christiansen J., Nielsen F.C.;
RT   "Molecular composition of IMP1 ribonucleoprotein granules.";
RL   Mol. Cell. Proteomics 6:798-811(2007).
RN   [27]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-153, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Embryonic kidney;
RX   PubMed=17525332; DOI=10.1126/science.1140321;
RA   Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,
RA   Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,
RA   Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.;
RT   "ATM and ATR substrate analysis reveals extensive protein networks
RT   responsive to DNA damage.";
RL   Science 316:1160-1166(2007).
RN   [28]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [29]
RP   IDENTIFICATION IN A COMPLEX WITH HCFC1; MKI67; EMSY; MATR3; ZNF335;
RP   TUBB2A; CCAR2; ASCL2; RBBP5 AND WDR5.
RX   PubMed=19131338; DOI=10.1074/jbc.M805872200;
RA   Garapaty S., Xu C.F., Trojer P., Mahajan M.A., Neubert T.A.,
RA   Samuels H.H.;
RT   "Identification and characterization of a novel nuclear protein
RT   complex involved in nuclear hormone receptor-mediated gene
RT   regulation.";
RL   J. Biol. Chem. 284:7542-7552(2009).
RN   [30]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [31]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-246; LYS-319; LYS-589;
RP   LYS-597 AND LYS-601, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE
RP   SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [32]
RP   INTERACTION WITH DNAJB12.
RX   PubMed=21150129; DOI=10.1247/csf.10023;
RA   Yamamoto Y.H., Kimura T., Momohara S., Takeuchi M., Tani T.,
RA   Kimata Y., Kadokura H., Kohno K.;
RT   "A novel ER J-protein DNAJB12 accelerates ER-associated degradation of
RT   membrane proteins including CFTR.";
RL   Cell Struct. Funct. 35:107-116(2010).
RN   [33]
RP   INTERACTION WITH TRIM5.
RX   PubMed=20053985; DOI=10.1074/jbc.M109.040618;
RA   Hwang C.Y., Holl J., Rajan D., Lee Y., Kim S., Um M., Kwon K.S.,
RA   Song B.;
RT   "Hsp70 interacts with the retroviral restriction factor TRIM5alpha and
RT   assists the folding of TRIM5alpha.";
RL   J. Biol. Chem. 285:7827-7837(2010).
RN   [34]
RP   IDENTIFICATION AS A COMPONENT OF THE PRP19-CDC5L COMPLEX, AND
RP   SUBCELLULAR LOCATION.
RX   PubMed=20176811; DOI=10.1128/MCB.01505-09;
RA   Grote M., Wolf E., Will C.L., Lemm I., Agafonov D.E., Schomburg A.,
RA   Fischle W., Urlaub H., Luhrmann R.;
RT   "Molecular architecture of the human Prp19/CDC5L complex.";
RL   Mol. Cell. Biol. 30:2105-2119(2010).
RN   [35]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-362, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [36]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [37]
RP   INTERACTION WITH DNAJB12.
RX   PubMed=21148293; DOI=10.1091/mbc.E10-09-0760;
RA   Grove D.E., Fan C.Y., Ren H.Y., Cyr D.M.;
RT   "The endoplasmic reticulum-associated Hsp40 DNAJB12 and Hsc70
RT   cooperate to facilitate RMA1 E3-dependent degradation of nascent
RT   CFTRDeltaF508.";
RL   Mol. Biol. Cell 22:301-314(2011).
RN   [38]
RP   INTERACTION WITH DNAJB14.
RX   PubMed=23018488; DOI=10.1247/csf.12017;
RA   Sopha P., Kadokura H., Yamamoto Y.H., Takeuchi M., Saito M., Tsuru A.,
RA   Kohno K.;
RT   "A novel mammalian ER-located J-protein, DNAJB14, can accelerate ERAD
RT   of misfolded membrane proteins.";
RL   Cell Struct. Funct. 37:177-187(2012).
RN   [39]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [40]
RP   REVIEW.
RX   PubMed=24121476; DOI=10.4161/auto.26448;
RA   Stricher F., Macri C., Ruff M., Muller S.;
RT   "HSPA8/HSC70 chaperone protein: structure, function, and chemical
RT   targeting.";
RL   Autophagy 9:1937-1954(2013).
RN   [41]
RP   SUBUNIT, AND INTERACTION WITH STUB1.
RX   PubMed=23865999; DOI=10.1021/bi4009209;
RA   Smith M.C., Scaglione K.M., Assimon V.A., Patury S., Thompson A.D.,
RA   Dickey C.A., Southworth D.R., Paulson H.L., Gestwicki J.E.,
RA   Zuiderweg E.R.;
RT   "The E3 ubiquitin ligase CHIP and the molecular chaperone Hsc70 form a
RT   dynamic, tethered complex.";
RL   Biochemistry 52:5354-5364(2013).
RN   [42]
RP   INTERACTION WITH FOXP3.
RX   PubMed=23973223; DOI=10.1016/j.immuni.2013.08.006;
RA   Chen Z., Barbi J., Bu S., Yang H.Y., Li Z., Gao Y., Jinasena D.,
RA   Fu J., Lin F., Chen C., Zhang J., Yu N., Li X., Shan Z., Nie J.,
RA   Gao Z., Tian H., Li Y., Yao Z., Zheng Y., Park B.V., Pan Z., Zhang J.,
RA   Dang E., Li Z., Wang H., Luo W., Li L., Semenza G.L., Zheng S.G.,
RA   Loser K., Tsun A., Greene M.I., Pardoll D.M., Pan F., Li B.;
RT   "The ubiquitin ligase Stub1 negatively modulates regulatory T cell
RT   suppressive activity by promoting degradation of the transcription
RT   factor Foxp3.";
RL   Immunity 39:272-285(2013).
RN   [43]
RP   METHYLATION AT LYS-561, MUTAGENESIS OF LYS-561, AND INTERACTION WITH
RP   METTL21A.
RX   PubMed=23921388; DOI=10.1074/jbc.M113.483248;
RA   Jakobsson M.E., Moen A., Bousset L., Egge-Jacobsen W., Kernstock S.,
RA   Melki R., Falnes P.O.;
RT   "Identification and characterization of a novel human
RT   methyltransferase modulating Hsp70 function through lysine
RT   methylation.";
RL   J. Biol. Chem. 288:27752-27763(2013).
RN   [44]
RP   FUNCTION IN ERAD, AND INTERACTION WITH STUB1.
RX   PubMed=23990462; DOI=10.1074/jbc.M113.479345;
RA   Matsumura Y., Sakai J., Skach W.R.;
RT   "Endoplasmic reticulum protein quality control is determined by
RT   cooperative interactions between Hsp/c70 protein and the CHIP E3
RT   ligase.";
RL   J. Biol. Chem. 288:31069-31079(2013).
RN   [45]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-329 AND SER-541, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [46]
RP   INTERACTION WITH PRKN.
RX   PubMed=24270810; DOI=10.1038/nature12748;
RA   Hasson S.A., Kane L.A., Yamano K., Huang C.H., Sliter D.A.,
RA   Buehler E., Wang C., Heman-Ackah S.M., Hessa T., Guha R., Martin S.E.,
RA   Youle R.J.;
RT   "High-content genome-wide RNAi screens identify regulators of parkin
RT   upstream of mitophagy.";
RL   Nature 504:291-295(2013).
RN   [47]
RP   INTERACTION WITH DNAJC12.
RX   PubMed=24122553; DOI=10.1007/s12192-013-0471-6;
RA   Choi J., Djebbar S., Fournier A., Labrie C.;
RT   "The co-chaperone DNAJC12 binds to Hsc70 and is upregulated by
RT   endoplasmic reticulum stress.";
RL   Cell Stress Chaperones 19:439-446(2014).
RN   [48]
RP   INTERACTION WITH MLLT11.
RX   PubMed=24880125; DOI=10.1016/j.yexcr.2014.05.013;
RA   Li P., Ji M., Lu F., Zhang J., Li H., Cui T., Li Wang X., Tang D.,
RA   Ji C.;
RT   "Degradation of AF1Q by chaperone-mediated autophagy.";
RL   Exp. Cell Res. 327:48-56(2014).
RN   [49]
RP   FUNCTION, AND INTERACTION WITH BAG1; BAG2; BAG3 AND HSPH1.
RX   PubMed=24318877; DOI=10.1074/jbc.M113.521997;
RA   Rauch J.N., Gestwicki J.E.;
RT   "Binding of human nucleotide exchange factors to heat shock protein 70
RT   (Hsp70) generates functionally distinct complexes in vitro.";
RL   J. Biol. Chem. 289:1402-1414(2014).
RN   [50]
RP   INTERACTION WITH RNF207.
RX   PubMed=25281747; DOI=10.1074/jbc.M114.592295;
RA   Roder K., Werdich A.A., Li W., Liu M., Kim T.Y., Organ-Darling L.E.,
RA   Moshal K.S., Hwang J.M., Lu Y., Choi B.R., MacRae C.A., Koren G.;
RT   "RING finger protein RNF207, a novel regulator of cardiac
RT   excitation.";
RL   J. Biol. Chem. 289:33730-33740(2014).
RN   [51]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [52]
RP   METHYLATION [LARGE SCALE ANALYSIS] AT ARG-469 AND LYS-561, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Colon carcinoma;
RX   PubMed=24129315; DOI=10.1074/mcp.O113.027870;
RA   Guo A., Gu H., Zhou J., Mulhern D., Wang Y., Lee K.A., Yang V.,
RA   Aguiar M., Kornhauser J., Jia X., Ren J., Beausoleil S.A., Silva J.C.,
RA   Vemulapalli V., Bedford M.T., Comb M.J.;
RT   "Immunoaffinity enrichment and mass spectrometry analysis of protein
RT   methylation.";
RL   Mol. Cell. Proteomics 13:372-387(2014).
RN   [53]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-512, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25218447; DOI=10.1038/nsmb.2890;
RA   Hendriks I.A., D'Souza R.C., Yang B., Verlaan-de Vries M., Mann M.,
RA   Vertegaal A.C.;
RT   "Uncovering global SUMOylation signaling networks in a site-specific
RT   manner.";
RL   Nat. Struct. Mol. Biol. 21:927-936(2014).
RN   [54]
RP   INTERACTION WITH DNAJB12 AND DNAJB14.
RX   PubMed=24732912; DOI=10.1371/journal.pone.0094322;
RA   Goodwin E.C., Motamedi N., Lipovsky A., Fernandez-Busnadiego R.,
RA   DiMaio D.;
RT   "Expression of DNAJB12 or DNAJB14 causes coordinate invasion of the
RT   nucleus by membranes associated with a novel nuclear pore structure.";
RL   PLoS ONE 9:E94322-E94322(2014).
RN   [55]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-512, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25114211; DOI=10.1073/pnas.1413825111;
RA   Impens F., Radoshevich L., Cossart P., Ribet D.;
RT   "Mapping of SUMO sites and analysis of SUMOylation changes induced by
RT   external stimuli.";
RL   Proc. Natl. Acad. Sci. U.S.A. 111:12432-12437(2014).
RN   [56]
RP   INTERACTION WITH HSPA8.
RX   PubMed=25760597; DOI=10.1107/S1399004714026881;
RA   Song J., Kose S., Watanabe A., Son S.Y., Choi S., Hong H.,
RA   Yamashita E., Park I.Y., Imamoto N., Lee S.J.;
RT   "Structural and functional analysis of Hikeshi, a new nuclear
RT   transport receptor of Hsp70s.";
RL   Acta Crystallogr. D 71:473-483(2015).
RN   [57]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [58]
RP   INTERACTION WITH DNAJC21.
RX   PubMed=27346687; DOI=10.1016/j.ajhg.2016.05.002;
RA   Tummala H., Walne A.J., Williams M., Bockett N., Collopy L.,
RA   Cardoso S., Ellison A., Wynn R., Leblanc T., Fitzgibbon J.,
RA   Kelsell D.P., van Heel D.A., Payne E., Plagnol V., Dokal I.,
RA   Vulliamy T.;
RT   "DNAJC21 mutations link a cancer-prone bone marrow failure syndrome to
RT   corruption in 60S ribosome subunit maturation.";
RL   Am. J. Hum. Genet. 99:115-124(2016).
RN   [59]
RP   REVIEW.
RX   PubMed=26865365; DOI=10.1007/s12192-016-0676-6;
RA   Radons J.;
RT   "The human HSP70 family of chaperones: where do we stand?";
RL   Cell Stress Chaperones 21:379-404(2016).
RN   [60]
RP   FUNCTION, INTERACTION WITH BAG1 AND BAG3, REGION NBD, AND REGION SBD.
RX   PubMed=27474739; DOI=10.1074/jbc.M116.742502;
RA   Rauch J.N., Zuiderweg E.R., Gestwicki J.E.;
RT   "Non-canonical interactions between heat shock cognate protein 70
RT   (Hsc70) and Bcl2-associated anthanogene (BAG) co-chaperones are
RT   important for client release.";
RL   J. Biol. Chem. 291:19848-19857(2016).
RN   [61]
RP   INTERACTION WITH HOPX; STUB1; HSP40 AND HSP90.
RX   PubMed=27708256; DOI=10.1038/ncomms12882;
RA   Seo J.H., Park J.H., Lee E.J., Vo T.T., Choi H., Kim J.Y., Jang J.K.,
RA   Wee H.J., Lee H.S., Jang S.H., Park Z.Y., Jeong J., Lee K.J.,
RA   Seok S.H., Park J.Y., Lee B.J., Lee M.N., Oh G.T., Kim K.W.;
RT   "ARD1-mediated Hsp70 acetylation balances stress-induced protein
RT   refolding and degradation.";
RL   Nat. Commun. 7:12882-12882(2016).
RN   [62]
RP   INTERACTION WITH DNAJB12 AND DNAJB14.
RX   PubMed=27916661; DOI=10.1016/j.molcel.2016.10.027;
RA   Li K., Jiang Q., Bai X., Yang Y.F., Ruan M.Y., Cai S.Q.;
RT   "Tetrameric assembly of K(+) channels requires ER-located chaperone
RT   proteins.";
RL   Mol. Cell 65:52-65(2017).
RN   [63]
RP   X-RAY CRYSTALLOGRAPHY (2.05 ANGSTROMS) OF 1-634.
RX   PubMed=19586912; DOI=10.1074/jbc.M109.033894;
RA   Kajander T., Sachs J.N., Goldman A., Regan L.;
RT   "Electrostatic interactions of Hsp-organizing protein
RT   tetratricopeptide domains with Hsp70 and Hsp90: computational analysis
RT   and protein engineering.";
RL   J. Biol. Chem. 284:25364-25374(2009).
RN   [64]
RP   X-RAY CRYSTALLOGRAPHY (2.00 ANGSTROMS) OF 4-381 IN COMPLEXES WITH ATP
RP   AND ATP ANALOGS.
RX   PubMed=19256508; DOI=10.1021/jm801627a;
RA   Williamson D.S., Borgognoni J., Clay A., Daniels Z., Dokurno P.,
RA   Drysdale M.J., Foloppe N., Francis G.L., Graham C.J., Howes R.,
RA   Macias A.T., Murray J.B., Parsons R., Shaw T., Surgenor A.E.,
RA   Terry L., Wang Y., Wood M., Massey A.J.;
RT   "Novel adenosine-derived inhibitors of 70 kDa heat shock protein,
RT   discovered through structure-based design.";
RL   J. Med. Chem. 52:1510-1513(2009).
RN   [65]
RP   X-RAY CRYSTALLOGRAPHY (1.90 ANGSTROMS) OF 4-381 IN COMPLEXES WITH ATP
RP   ANALOGS.
RX   PubMed=21526763; DOI=10.1021/jm101625x;
RA   Macias A.T., Williamson D.S., Allen N., Borgognoni J., Clay A.,
RA   Daniels Z., Dokurno P., Drysdale M.J., Francis G.L., Graham C.J.,
RA   Howes R., Matassova N., Murray J.B., Parsons R., Shaw T.,
RA   Surgenor A.E., Terry L., Wang Y., Wood M., Massey A.J.;
RT   "Adenosine-derived inhibitors of 78 kDa glucose regulated protein
RT   (Grp78) ATPase: insights into isoform selectivity.";
RL   J. Med. Chem. 54:4034-4041(2011).
CC   -!- FUNCTION: Molecular chaperone implicated in a wide variety of
CC       cellular processes, including protection of the proteome from
CC       stress, folding and transport of newly synthesized polypeptides,
CC       activation of proteolysis of misfolded proteins and the formation
CC       and dissociation of protein complexes. Plays a pivotal role in the
CC       protein quality control system, ensuring the correct folding of
CC       proteins, the re-folding of misfolded proteins and controlling the
CC       targeting of proteins for subsequent degradation (PubMed:21150129,
CC       PubMed:21148293, PubMed:24732912, PubMed:27916661,
CC       PubMed:23018488). This is achieved through cycles of ATP binding,
CC       ATP hydrolysis and ADP release, mediated by co-chaperones
CC       (PubMed:21150129, PubMed:21148293, PubMed:24732912,
CC       PubMed:27916661, PubMed:23018488). The co-chaperones have been
CC       shown to not only regulate different steps of the ATPase cycle of
CC       HSP70, but they also have an individual specificity such that one
CC       co-chaperone may promote folding of a substrate while another may
CC       promote degradation (PubMed:21150129, PubMed:21148293,
CC       PubMed:24732912, PubMed:27916661, PubMed:23018488). The affinity
CC       of HSP70 for polypeptides is regulated by its nucleotide bound
CC       state. In the ATP-bound form, it has a low affinity for substrate
CC       proteins. However, upon hydrolysis of the ATP to ADP, it undergoes
CC       a conformational change that increases its affinity for substrate
CC       proteins. HSP70 goes through repeated cycles of ATP hydrolysis and
CC       nucleotide exchange, which permits cycles of substrate binding and
CC       release. The HSP70-associated co-chaperones are of three types: J-
CC       domain co-chaperones HSP40s (stimulate ATPase hydrolysis by
CC       HSP70), the nucleotide exchange factors (NEF) such as BAG1/2/3
CC       (facilitate conversion of HSP70 from the ADP-bound to the ATP-
CC       bound state thereby promoting substrate release), and the TPR
CC       domain chaperones such as HOPX and STUB1 (PubMed:24318877,
CC       PubMed:27474739, PubMed:24121476, PubMed:26865365). Acts as a
CC       repressor of transcriptional activation. Inhibits the
CC       transcriptional coactivator activity of CITED1 on Smad-mediated
CC       transcription. Component of the PRP19-CDC5L complex that forms an
CC       integral part of the spliceosome and is required for activating
CC       pre-mRNA splicing. May have a scaffolding role in the spliceosome
CC       assembly as it contacts all other components of the core complex.
CC       Binds bacterial lipopolysaccharide (LPS) and mediates LPS-induced
CC       inflammatory response, including TNF secretion by monocytes
CC       (PubMed:10722728, PubMed:11276205). Participates in the ER-
CC       associated degradation (ERAD) quality control pathway in
CC       conjunction with J domain-containing co-chaperones and the E3
CC       ligase STUB1 (PubMed:23990462). {ECO:0000269|PubMed:10722728,
CC       ECO:0000269|PubMed:11276205, ECO:0000269|PubMed:21148293,
CC       ECO:0000269|PubMed:21150129, ECO:0000269|PubMed:23018488,
CC       ECO:0000269|PubMed:23990462, ECO:0000269|PubMed:24318877,
CC       ECO:0000269|PubMed:24732912, ECO:0000269|PubMed:27474739,
CC       ECO:0000269|PubMed:27916661, ECO:0000303|PubMed:24121476,
CC       ECO:0000303|PubMed:26865365}.
CC   -!- SUBUNIT: Identified in a IGF2BP1-dependent mRNP granule complex
CC       containing untranslated mRNAs. Interacts with PACRG. Interacts
CC       with HSPH1/HSP105. Interacts with IRAK1BP1 and BAG1. Interacts
CC       with DNAJC7. Interacts with DNAJB12 (via J domain)
CC       (PubMed:21150129, PubMed:21148293, PubMed:24732912,
CC       PubMed:27916661). Interacts with DNAJB14 (via J domain)
CC       (PubMed:23018488, PubMed:24732912, PubMed:27916661). Interacts
CC       (via C-terminus) with the E3 ligase CHIP forming a 210 kDa complex
CC       of one CHIP and two HSPA8 molecules. Interacts with CITED1 (via N-
CC       terminus); the interaction suppresses the association of CITED1 to
CC       p300/CBP and Smad-mediated transcription transactivation.
CC       Component of the PRP19-CDC5L splicing complex composed of a core
CC       complex comprising a homotetramer of PRPF19, CDC5L, PLRG1 and
CC       BCAS2, and at least three less stably associated proteins CTNNBL1,
CC       CWC15 and HSPA8. Interacts with SV40 VP1. Interacts with TRIM5.
CC       Part of a complex composed at least of ASCL2, EMSY, HCFC1, HSPA8,
CC       CCAR2, MATR3, MKI67, RBBP5, TUBB2A, WDR5 and ZNF335; this complex
CC       may have a histone H3-specific methyltransferase activity.
CC       Interacts with METTL21A. Following LPS binding, may form a complex
CC       with CXCR4, GDF5 and HSP90AA1. Interacts with PRKN. Interacts with
CC       FOXP3. Interacts with DNAJC9 (via J domain) (PubMed:17182002).
CC       Interacts with MLLT11 (PubMed:24880125). Interacts with RNF207
CC       (PubMed:25281747). Interacts with DNAJC21 (PubMed:27346687).
CC       Interacts with DNAJB2 (PubMed:15936278). Interacts with TTC1 (via
CC       TPR repeats) (PubMed:15708368). Interacts with SGTA (via TPR
CC       repeats) (By similarity). Interacts with HSF1 (via transactivation
CC       domain) (PubMed:9499401). Interacts with HOPX, HSP40 and HSP90
CC       (PubMed:27708256). Interacts with STUB1 (PubMed:27708256).
CC       Interacts with BAG2 (PubMed:24318877). Interacts with BAG3
CC       (PubMed:27474739, PubMed:24318877). Interacts with DNAJC12
CC       (PubMed:24122553). Interacts with HSPC138 (PubMed:25760597).
CC       {ECO:0000250|UniProtKB:P63018, ECO:0000269|PubMed:10722728,
CC       ECO:0000269|PubMed:11147964, ECO:0000269|PubMed:11276205,
CC       ECO:0000269|PubMed:14532270, ECO:0000269|PubMed:15708368,
CC       ECO:0000269|PubMed:15936278, ECO:0000269|PubMed:15963462,
CC       ECO:0000269|PubMed:16815975, ECO:0000269|PubMed:17182002,
CC       ECO:0000269|PubMed:17289661, ECO:0000269|PubMed:19131338,
CC       ECO:0000269|PubMed:20053985, ECO:0000269|PubMed:21148293,
CC       ECO:0000269|PubMed:21150129, ECO:0000269|PubMed:23018488,
CC       ECO:0000269|PubMed:23865999, ECO:0000269|PubMed:23921388,
CC       ECO:0000269|PubMed:23973223, ECO:0000269|PubMed:23990462,
CC       ECO:0000269|PubMed:24122553, ECO:0000269|PubMed:24270810,
CC       ECO:0000269|PubMed:24318877, ECO:0000269|PubMed:24732912,
CC       ECO:0000269|PubMed:24880125, ECO:0000269|PubMed:25281747,
CC       ECO:0000269|PubMed:25760597, ECO:0000269|PubMed:27346687,
CC       ECO:0000269|PubMed:27474739, ECO:0000269|PubMed:27708256,
CC       ECO:0000269|PubMed:27916661, ECO:0000269|PubMed:9305631,
CC       ECO:0000269|PubMed:9499401, ECO:0000269|PubMed:9679980}.
CC   -!- INTERACTION:
CC       Q99IB8:- (xeno); NbExp=3; IntAct=EBI-351896, EBI-6927928;
CC       P60709:ACTB; NbExp=2; IntAct=EBI-351896, EBI-353944;
CC       Q9GZX7:AICDA; NbExp=2; IntAct=EBI-351896, EBI-3834328;
CC       P49407:ARRB1; NbExp=4; IntAct=EBI-351896, EBI-743313;
CC       P32121:ARRB2; NbExp=4; IntAct=EBI-351896, EBI-714559;
CC       Q9NQ11:ATP13A2; NbExp=2; IntAct=EBI-351896, EBI-6308763;
CC       Q99933:BAG1; NbExp=13; IntAct=EBI-351896, EBI-1030678;
CC       O95816:BAG2; NbExp=7; IntAct=EBI-351896, EBI-355275;
CC       O95429:BAG4; NbExp=3; IntAct=EBI-351896, EBI-2949658;
CC       Q8AZK7:EBNA-LP (xeno); NbExp=3; IntAct=EBI-351896, EBI-1185167;
CC       P00533:EGFR; NbExp=5; IntAct=EBI-351896, EBI-297353;
CC       O14976:GAK; NbExp=6; IntAct=EBI-351896, EBI-714707;
CC       P34932:HSPA4; NbExp=5; IntAct=EBI-351896, EBI-356933;
CC       Q9NZL4:HSPBP1; NbExp=11; IntAct=EBI-351896, EBI-356763;
CC       P05412:JUN; NbExp=3; IntAct=EBI-351896, EBI-852823;
CC       P00338:LDHA; NbExp=4; IntAct=EBI-351896, EBI-372327;
CC       Q5S007:LRRK2; NbExp=5; IntAct=EBI-351896, EBI-5323863;
CC       P03485:M (xeno); NbExp=4; IntAct=EBI-351896, EBI-2547543;
CC       P14598:NCF1; NbExp=2; IntAct=EBI-351896, EBI-395044;
CC       Q9UNE7:STUB1; NbExp=8; IntAct=EBI-351896, EBI-357085;
CC       Q9UNE7-1:STUB1; NbExp=4; IntAct=EBI-351908, EBI-15687717;
CC       P61764:STXBP1; NbExp=2; IntAct=EBI-351896, EBI-960169;
CC       O00635:TRIM38; NbExp=5; IntAct=EBI-351896, EBI-2130415;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm. Melanosome. Nucleus, nucleolus.
CC       Cell membrane. Note=Localized in cytoplasmic mRNP granules
CC       containing untranslated mRNAs. Translocates rapidly from the
CC       cytoplasm to the nuclei, and especially to the nucleoli, upon heat
CC       shock.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P11142-1; Sequence=Displayed;
CC       Name=2; Synonyms=HSC54;
CC         IsoId=P11142-2; Sequence=VSP_002427;
CC   -!- TISSUE SPECIFICITY: Ubiquitous. {ECO:0000269|PubMed:11276205}.
CC   -!- INDUCTION: Constitutively synthesized.
CC   -!- DOMAIN: The N-terminal nucleotide binding domain (NBD) (also known
CC       as the ATPase domain) is responsible for binding and hydrolyzing
CC       ATP. The C-terminal substrate-binding domain (SBD) (also known as
CC       peptide-binding domain) binds to the client/substrate proteins.
CC       The two domains are allosterically coupled so that, when ATP is
CC       bound to the NBD, the SBD binds relatively weakly to clients. When
CC       ADP is bound in the NBD, a conformational change enhances the
CC       affinity of the SBD for client proteins.
CC       {ECO:0000269|PubMed:9305631}.
CC   -!- PTM: Acetylated. {ECO:0000269|Ref.5, ECO:0000269|Ref.6}.
CC   -!- PTM: ISGylated. {ECO:0000269|PubMed:16139798,
CC       ECO:0000269|PubMed:16815975}.
CC   -!- PTM: Trimethylation at Lys-561 reduces fibrillar SNCA binding.
CC   -!- SIMILARITY: Belongs to the heat shock protein 70 family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; Y00371; CAA68445.1; -; Genomic_DNA.
DR   EMBL; AB034951; BAB18615.1; -; mRNA.
DR   EMBL; AF352832; AAK17898.1; -; mRNA.
DR   EMBL; BC016179; AAH16179.1; -; mRNA.
DR   EMBL; BC016660; AAH16660.1; -; mRNA.
DR   EMBL; BC019816; AAH19816.1; -; mRNA.
DR   CCDS; CCDS44754.1; -. [P11142-2]
DR   CCDS; CCDS8440.1; -. [P11142-1]
DR   PIR; A27077; A27077.
DR   RefSeq; NP_006588.1; NM_006597.5. [P11142-1]
DR   RefSeq; NP_694881.1; NM_153201.3. [P11142-2]
DR   RefSeq; XP_011541100.1; XM_011542798.1. [P11142-1]
DR   UniGene; Hs.180414; -.
DR   PDB; 3AGY; X-ray; 1.85 A; C/D/F=639-646.
DR   PDB; 3AGZ; X-ray; 2.51 A; C/D/E/F=639-646.
DR   PDB; 3ESK; X-ray; 2.05 A; B=635-646.
DR   PDB; 3FZF; X-ray; 2.20 A; A=4-381.
DR   PDB; 3FZH; X-ray; 2.00 A; A=4-381.
DR   PDB; 3FZK; X-ray; 2.10 A; A=4-381.
DR   PDB; 3FZL; X-ray; 2.20 A; A=4-381.
DR   PDB; 3FZM; X-ray; 2.30 A; A=4-381.
DR   PDB; 3LDQ; X-ray; 1.90 A; A=4-381.
DR   PDB; 3M3Z; X-ray; 2.10 A; A=4-381.
DR   PDB; 4H5N; X-ray; 1.86 A; A/B=2-384.
DR   PDB; 4H5R; X-ray; 1.64 A; A/B=2-384.
DR   PDB; 4H5T; X-ray; 1.90 A; A=2-384.
DR   PDB; 4H5V; X-ray; 1.75 A; A=2-384.
DR   PDB; 4H5W; X-ray; 1.94 A; A/B=2-384.
DR   PDB; 4HWI; X-ray; 2.27 A; A=5-381.
DR   PDB; 4KBQ; X-ray; 2.91 A; C/D=541-646.
DR   PDB; 5AQF; X-ray; 1.88 A; A/C=1-381.
DR   PDB; 5AQG; X-ray; 2.24 A; A/C/E=1-381.
DR   PDB; 5AQH; X-ray; 2.00 A; A=1-381.
DR   PDB; 5AQI; X-ray; 1.98 A; A/C=1-381.
DR   PDB; 5AQJ; X-ray; 1.96 A; A/C/E=1-381.
DR   PDB; 5AQK; X-ray; 2.09 A; A=1-381.
DR   PDB; 5AQL; X-ray; 1.69 A; A/C=1-381.
DR   PDB; 5AQM; X-ray; 1.63 A; A/C=1-381.
DR   PDB; 5AQN; X-ray; 2.45 A; A/C/E=1-381.
DR   PDB; 5AQO; X-ray; 2.12 A; A/C/E=1-381.
DR   PDB; 5AQP; X-ray; 2.08 A; A/C/E=1-381.
DR   PDB; 5AQQ; X-ray; 2.72 A; A/C/E=1-381.
DR   PDB; 5AQR; X-ray; 1.91 A; A/C/E=1-381.
DR   PDB; 5AQS; X-ray; 2.00 A; A/C=1-381.
DR   PDB; 5AQT; X-ray; 1.90 A; A=1-381.
DR   PDB; 5AQU; X-ray; 1.92 A; A=1-381.
DR   PDB; 5AQV; X-ray; 1.75 A; A=1-381.
DR   PDB; 6B1I; X-ray; 2.30 A; A/B=5-381.
DR   PDB; 6B1M; X-ray; 1.90 A; A/B=5-381.
DR   PDB; 6B1N; X-ray; 1.80 A; A/B=5-381.
DR   PDBsum; 3AGY; -.
DR   PDBsum; 3AGZ; -.
DR   PDBsum; 3ESK; -.
DR   PDBsum; 3FZF; -.
DR   PDBsum; 3FZH; -.
DR   PDBsum; 3FZK; -.
DR   PDBsum; 3FZL; -.
DR   PDBsum; 3FZM; -.
DR   PDBsum; 3LDQ; -.
DR   PDBsum; 3M3Z; -.
DR   PDBsum; 4H5N; -.
DR   PDBsum; 4H5R; -.
DR   PDBsum; 4H5T; -.
DR   PDBsum; 4H5V; -.
DR   PDBsum; 4H5W; -.
DR   PDBsum; 4HWI; -.
DR   PDBsum; 4KBQ; -.
DR   PDBsum; 5AQF; -.
DR   PDBsum; 5AQG; -.
DR   PDBsum; 5AQH; -.
DR   PDBsum; 5AQI; -.
DR   PDBsum; 5AQJ; -.
DR   PDBsum; 5AQK; -.
DR   PDBsum; 5AQL; -.
DR   PDBsum; 5AQM; -.
DR   PDBsum; 5AQN; -.
DR   PDBsum; 5AQO; -.
DR   PDBsum; 5AQP; -.
DR   PDBsum; 5AQQ; -.
DR   PDBsum; 5AQR; -.
DR   PDBsum; 5AQS; -.
DR   PDBsum; 5AQT; -.
DR   PDBsum; 5AQU; -.
DR   PDBsum; 5AQV; -.
DR   PDBsum; 6B1I; -.
DR   PDBsum; 6B1M; -.
DR   PDBsum; 6B1N; -.
DR   ProteinModelPortal; P11142; -.
DR   SMR; P11142; -.
DR   BioGrid; 109544; 573.
DR   CORUM; P11142; -.
DR   DIP; DIP-32874N; -.
DR   IntAct; P11142; 216.
DR   MINT; P11142; -.
DR   STRING; 9606.ENSP00000227378; -.
DR   BindingDB; P11142; -.
DR   ChEMBL; CHEMBL1275223; -.
DR   iPTMnet; P11142; -.
DR   PhosphoSitePlus; P11142; -.
DR   SwissPalm; P11142; -.
DR   DMDM; 123648; -.
DR   DOSAC-COBS-2DPAGE; P11142; -.
DR   OGP; P11142; -.
DR   REPRODUCTION-2DPAGE; IPI00003865; -.
DR   SWISS-2DPAGE; P11142; -.
DR   UCD-2DPAGE; P11142; -.
DR   EPD; P11142; -.
DR   PaxDb; P11142; -.
DR   PeptideAtlas; P11142; -.
DR   PRIDE; P11142; -.
DR   TopDownProteomics; P11142-1; -. [P11142-1]
DR   TopDownProteomics; P11142-2; -. [P11142-2]
DR   DNASU; 3312; -.
DR   Ensembl; ENST00000227378; ENSP00000227378; ENSG00000109971. [P11142-1]
DR   Ensembl; ENST00000453788; ENSP00000404372; ENSG00000109971. [P11142-2]
DR   Ensembl; ENST00000532636; ENSP00000437125; ENSG00000109971. [P11142-1]
DR   Ensembl; ENST00000534624; ENSP00000432083; ENSG00000109971. [P11142-1]
DR   GeneID; 3312; -.
DR   KEGG; hsa:3312; -.
DR   UCSC; uc001pyp.5; human. [P11142-1]
DR   CTD; 3312; -.
DR   DisGeNET; 3312; -.
DR   EuPathDB; HostDB:ENSG00000109971.13; -.
DR   GeneCards; HSPA8; -.
DR   H-InvDB; HIX0033867; -.
DR   HGNC; HGNC:5241; HSPA8.
DR   HPA; CAB002056; -.
DR   HPA; HPA052504; -.
DR   MIM; 600816; gene.
DR   neXtProt; NX_P11142; -.
DR   OpenTargets; ENSG00000109971; -.
DR   PharmGKB; PA29507; -.
DR   eggNOG; KOG0101; Eukaryota.
DR   eggNOG; COG0443; LUCA.
DR   GeneTree; ENSGT00910000144045; -.
DR   HOGENOM; HOG000228135; -.
DR   HOVERGEN; HBG051845; -.
DR   InParanoid; P11142; -.
DR   KO; K03283; -.
DR   OMA; AYTKNQD; -.
DR   OrthoDB; EOG091G03SF; -.
DR   PhylomeDB; P11142; -.
DR   TreeFam; TF105042; -.
DR   BRENDA; 3.6.3.51; 2681.
DR   Reactome; R-HSA-3371453; Regulation of HSF1-mediated heat shock response.
DR   Reactome; R-HSA-3371497; HSP90 chaperone cycle for steroid hormone receptors (SHR).
DR   Reactome; R-HSA-3371568; Attenuation phase.
DR   Reactome; R-HSA-3371571; HSF1-dependent transactivation.
DR   Reactome; R-HSA-432720; Lysosome Vesicle Biogenesis.
DR   Reactome; R-HSA-432722; Golgi Associated Vesicle Biogenesis.
DR   Reactome; R-HSA-447041; CHL1 interactions.
DR   Reactome; R-HSA-450408; AUF1 (hnRNP D0) binds and destabilizes mRNA.
DR   Reactome; R-HSA-6785807; Interleukin-4 and 13 signaling.
DR   Reactome; R-HSA-6798695; Neutrophil degranulation.
DR   Reactome; R-HSA-72163; mRNA Splicing - Major Pathway.
DR   Reactome; R-HSA-8856828; Clathrin-mediated endocytosis.
DR   Reactome; R-HSA-8876725; Protein methylation.
DR   Reactome; R-HSA-888590; GABA synthesis, release, reuptake and degradation.
DR   SIGNOR; P11142; -.
DR   ChiTaRS; HSPA8; human.
DR   EvolutionaryTrace; P11142; -.
DR   GeneWiki; HSPA8; -.
DR   GenomeRNAi; 3312; -.
DR   PMAP-CutDB; P11142; -.
DR   PRO; PR:P11142; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   Bgee; ENSG00000109971; -.
DR   CleanEx; HS_HSPA8; -.
DR   ExpressionAtlas; P11142; baseline and differential.
DR   Genevisible; P11142; HS.
DR   GO; GO:0072562; C:blood microparticle; HDA:UniProtKB.
DR   GO; GO:0101031; C:chaperone complex; IPI:ARUK-UCL.
DR   GO; GO:0061202; C:clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane; TAS:Reactome.
DR   GO; GO:0005829; C:cytosol; IDA:UniProtKB.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005576; C:extracellular region; TAS:Reactome.
DR   GO; GO:0005615; C:extracellular space; HDA:UniProtKB.
DR   GO; GO:1904813; C:ficolin-1-rich granule lumen; TAS:Reactome.
DR   GO; GO:0005925; C:focal adhesion; HDA:UniProtKB.
DR   GO; GO:0005622; C:intracellular; TAS:ParkinsonsUK-UCL.
DR   GO; GO:0005770; C:late endosome; IEA:Ensembl.
DR   GO; GO:0098575; C:lumenal side of lysosomal membrane; TAS:ParkinsonsUK-UCL.
DR   GO; GO:0043202; C:lysosomal lumen; TAS:ParkinsonsUK-UCL.
DR   GO; GO:0005765; C:lysosomal membrane; ISS:ParkinsonsUK-UCL.
DR   GO; GO:0042470; C:melanosome; IEA:UniProtKB-SubCell.
DR   GO; GO:0016020; C:membrane; HDA:UniProtKB.
DR   GO; GO:0043209; C:myelin sheath; IEA:Ensembl.
DR   GO; GO:0005730; C:nucleolus; IEA:UniProtKB-SubCell.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0000974; C:Prp19 complex; IDA:UniProtKB.
DR   GO; GO:1990904; C:ribonucleoprotein complex; IDA:UniProtKB.
DR   GO; GO:0034774; C:secretory granule lumen; TAS:Reactome.
DR   GO; GO:0005681; C:spliceosomal complex; IEA:UniProtKB-KW.
DR   GO; GO:0005524; F:ATP binding; IDA:BHF-UCL.
DR   GO; GO:0016887; F:ATPase activity; IDA:BHF-UCL.
DR   GO; GO:0042623; F:ATPase activity, coupled; TAS:Reactome.
DR   GO; GO:0055131; F:C3HC4-type RING finger domain binding; IPI:BHF-UCL.
DR   GO; GO:0045296; F:cadherin binding; HDA:BHF-UCL.
DR   GO; GO:0051087; F:chaperone binding; IPI:ARUK-UCL.
DR   GO; GO:0019899; F:enzyme binding; IPI:BHF-UCL.
DR   GO; GO:0001664; F:G-protein coupled receptor binding; IPI:ParkinsonsUK-UCL.
DR   GO; GO:0031072; F:heat shock protein binding; IPI:UniProtKB.
DR   GO; GO:0023026; F:MHC class II protein complex binding; HDA:UniProtKB.
DR   GO; GO:0001786; F:phosphatidylserine binding; IEA:Ensembl.
DR   GO; GO:0030674; F:protein binding, bridging; IPI:ARUK-UCL.
DR   GO; GO:0003723; F:RNA binding; HDA:UniProtKB.
DR   GO; GO:0031625; F:ubiquitin protein ligase binding; IPI:ParkinsonsUK-UCL.
DR   GO; GO:0051082; F:unfolded protein binding; IDA:UniProtKB.
DR   GO; GO:0046034; P:ATP metabolic process; IDA:BHF-UCL.
DR   GO; GO:0009267; P:cellular response to starvation; TAS:ParkinsonsUK-UCL.
DR   GO; GO:0051085; P:chaperone cofactor-dependent protein refolding; IEA:Ensembl.
DR   GO; GO:0061684; P:chaperone-mediated autophagy; ISS:ParkinsonsUK-UCL.
DR   GO; GO:1904764; P:chaperone-mediated autophagy translocation complex disassembly; ISS:ParkinsonsUK-UCL.
DR   GO; GO:0061741; P:chaperone-mediated protein transport involved in chaperone-mediated autophagy; NAS:ParkinsonsUK-UCL.
DR   GO; GO:0072318; P:clathrin coat disassembly; IEA:Ensembl.
DR   GO; GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome.
DR   GO; GO:0061738; P:late endosomal microautophagy; IEA:Ensembl.
DR   GO; GO:0061024; P:membrane organization; TAS:Reactome.
DR   GO; GO:0000398; P:mRNA splicing, via spliceosome; TAS:Reactome.
DR   GO; GO:1902904; P:negative regulation of supramolecular fiber organization; IDA:BHF-UCL.
DR   GO; GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB.
DR   GO; GO:0043312; P:neutrophil degranulation; TAS:Reactome.
DR   GO; GO:0044829; P:positive regulation by host of viral genome replication; IEA:Ensembl.
DR   GO; GO:0048026; P:positive regulation of mRNA splicing, via spliceosome; IEA:Ensembl.
DR   GO; GO:0006457; P:protein folding; NAS:UniProtKB.
DR   GO; GO:0042026; P:protein refolding; IDA:UniProtKB.
DR   GO; GO:0061740; P:protein targeting to lysosome involved in chaperone-mediated autophagy; IMP:ParkinsonsUK-UCL.
DR   GO; GO:0051726; P:regulation of cell cycle; IEA:Ensembl.
DR   GO; GO:1900034; P:regulation of cellular response to heat; TAS:Reactome.
DR   GO; GO:0043488; P:regulation of mRNA stability; TAS:Reactome.
DR   GO; GO:0043254; P:regulation of protein complex assembly; TAS:ParkinsonsUK-UCL.
DR   GO; GO:0061635; P:regulation of protein complex stability; ISS:ParkinsonsUK-UCL.
DR   GO; GO:1904589; P:regulation of protein import; TAS:ParkinsonsUK-UCL.
DR   GO; GO:0031647; P:regulation of protein stability; IMP:ParkinsonsUK-UCL.
DR   GO; GO:0006986; P:response to unfolded protein; NAS:UniProtKB.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   GO; GO:0016032; P:viral process; IEA:UniProtKB-KW.
DR   Gene3D; 1.20.1270.10; -; 1.
DR   Gene3D; 2.60.34.10; -; 1.
DR   InterPro; IPR018181; Heat_shock_70_CS.
DR   InterPro; IPR029048; HSP70_C_sf.
DR   InterPro; IPR029047; HSP70_peptide-bd_sf.
DR   InterPro; IPR013126; Hsp_70_fam.
DR   PANTHER; PTHR19375; PTHR19375; 1.
DR   Pfam; PF00012; HSP70; 1.
DR   PRINTS; PR00301; HEATSHOCK70.
DR   SUPFAM; SSF100920; SSF100920; 1.
DR   SUPFAM; SSF100934; SSF100934; 1.
DR   PROSITE; PS00297; HSP70_1; 1.
DR   PROSITE; PS00329; HSP70_2; 1.
DR   PROSITE; PS01036; HSP70_3; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; ATP-binding;
KW   Cell membrane; Chaperone; Complete proteome; Cytoplasm;
KW   Direct protein sequencing; Host-virus interaction; Isopeptide bond;
KW   Membrane; Methylation; mRNA processing; mRNA splicing;
KW   Nucleotide-binding; Nucleus; Phosphoprotein; Polymorphism;
KW   Reference proteome; Repressor; Spliceosome; Stress response;
KW   Transcription; Transcription regulation; Ubl conjugation.
FT   INIT_MET      1      1       Removed. {ECO:0000244|PubMed:19413330,
FT                                ECO:0000269|Ref.5, ECO:0000269|Ref.6}.
FT   CHAIN         2    646       Heat shock cognate 71 kDa protein.
FT                                /FTId=PRO_0000078270.
FT   NP_BIND      12     15       ATP.
FT   NP_BIND     202    204       ATP.
FT   NP_BIND     268    275       ATP.
FT   NP_BIND     339    342       ATP.
FT   REGION        2    386       Nucleotide-binding domain (NBD).
FT                                {ECO:0000305|PubMed:27474739}.
FT   REGION      186    377       Interaction with BAG1.
FT   REGION      394    509       Substrate-binding domain (SBD).
FT                                {ECO:0000305|PubMed:27474739}.
FT   BINDING      71     71       ATP.
FT   MOD_RES       2      2       N-acetylserine.
FT                                {ECO:0000244|PubMed:19413330,
FT                                ECO:0000269|Ref.5, ECO:0000269|Ref.6}.
FT   MOD_RES     108    108       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:P63017}.
FT   MOD_RES     153    153       Phosphoserine.
FT                                {ECO:0000244|PubMed:17525332}.
FT   MOD_RES     246    246       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     319    319       N6-acetyllysine; alternate.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     319    319       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P63017}.
FT   MOD_RES     328    328       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:P63017}.
FT   MOD_RES     329    329       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     362    362       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231}.
FT   MOD_RES     469    469       Omega-N-methylarginine.
FT                                {ECO:0000244|PubMed:24129315}.
FT   MOD_RES     512    512       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P63017}.
FT   MOD_RES     512    512       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P63017}.
FT   MOD_RES     524    524       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:P63017}.
FT   MOD_RES     541    541       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     561    561       N6,N6,N6-trimethyllysine; by METTL21A;
FT                                alternate. {ECO:0000269|PubMed:23349634,
FT                                ECO:0000269|PubMed:23921388}.
FT   MOD_RES     561    561       N6,N6-dimethyllysine; alternate.
FT                                {ECO:0000244|PubMed:24129315}.
FT   MOD_RES     589    589       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     597    597       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     601    601       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   CROSSLNK    512    512       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO1);
FT                                alternate. {ECO:0000244|PubMed:25114211}.
FT   CROSSLNK    512    512       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2);
FT                                alternate. {ECO:0000244|PubMed:25218447}.
FT   VAR_SEQ     464    616       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:11093761}.
FT                                /FTId=VSP_002427.
FT   VARIANT      32     32       D -> Y (in dbSNP:rs11551602).
FT                                /FTId=VAR_049619.
FT   VARIANT     459    459       F -> L (in dbSNP:rs11551598).
FT                                /FTId=VAR_049620.
FT   MUTAGEN     561    561       K->R: Complete loss of in vitro
FT                                methylation by METTL21A.
FT                                {ECO:0000269|PubMed:23349634,
FT                                ECO:0000269|PubMed:23921388}.
FT   STRAND        7     10       {ECO:0000244|PDB:5AQM}.
FT   STRAND       13     22       {ECO:0000244|PDB:5AQM}.
FT   STRAND       25     28       {ECO:0000244|PDB:5AQM}.
FT   STRAND       36     39       {ECO:0000244|PDB:5AQM}.
FT   STRAND       42     44       {ECO:0000244|PDB:5AQM}.
FT   STRAND       49     51       {ECO:0000244|PDB:5AQM}.
FT   HELIX        53     57       {ECO:0000244|PDB:5AQM}.
FT   TURN         58     61       {ECO:0000244|PDB:5AQM}.
FT   HELIX        63     65       {ECO:0000244|PDB:5AQM}.
FT   HELIX        70     72       {ECO:0000244|PDB:5AQM}.
FT   TURN         73     75       {ECO:0000244|PDB:5AQM}.
FT   HELIX        81     87       {ECO:0000244|PDB:5AQM}.
FT   STRAND       91     97       {ECO:0000244|PDB:5AQM}.
FT   STRAND      100    107       {ECO:0000244|PDB:5AQM}.
FT   STRAND      110    114       {ECO:0000244|PDB:5AQM}.
FT   HELIX       116    135       {ECO:0000244|PDB:5AQM}.
FT   STRAND      136    138       {ECO:0000244|PDB:5AQF}.
FT   STRAND      141    146       {ECO:0000244|PDB:5AQM}.
FT   HELIX       152    164       {ECO:0000244|PDB:5AQM}.
FT   STRAND      168    174       {ECO:0000244|PDB:5AQM}.
FT   HELIX       175    182       {ECO:0000244|PDB:5AQM}.
FT   HELIX       185    187       {ECO:0000244|PDB:5AQM}.
FT   STRAND      188    191       {ECO:0000244|PDB:5AQL}.
FT   STRAND      193    201       {ECO:0000244|PDB:5AQM}.
FT   STRAND      204    213       {ECO:0000244|PDB:5AQM}.
FT   STRAND      216    225       {ECO:0000244|PDB:5AQM}.
FT   HELIX       230    249       {ECO:0000244|PDB:5AQM}.
FT   HELIX       253    255       {ECO:0000244|PDB:3LDQ}.
FT   HELIX       257    276       {ECO:0000244|PDB:5AQM}.
FT   STRAND      278    288       {ECO:0000244|PDB:5AQM}.
FT   STRAND      291    298       {ECO:0000244|PDB:5AQM}.
FT   HELIX       299    305       {ECO:0000244|PDB:5AQM}.
FT   HELIX       307    312       {ECO:0000244|PDB:5AQM}.
FT   HELIX       314    324       {ECO:0000244|PDB:5AQM}.
FT   HELIX       328    330       {ECO:0000244|PDB:5AQM}.
FT   STRAND      333    338       {ECO:0000244|PDB:5AQM}.
FT   HELIX       339    342       {ECO:0000244|PDB:5AQM}.
FT   HELIX       344    353       {ECO:0000244|PDB:5AQM}.
FT   TURN        354    356       {ECO:0000244|PDB:5AQM}.
FT   STRAND      357    360       {ECO:0000244|PDB:3FZF}.
FT   TURN        365    367       {ECO:0000244|PDB:5AQM}.
FT   HELIX       368    380       {ECO:0000244|PDB:5AQM}.
FT   HELIX       541    556       {ECO:0000244|PDB:4KBQ}.
FT   HELIX       564    582       {ECO:0000244|PDB:4KBQ}.
FT   HELIX       594    612       {ECO:0000244|PDB:4KBQ}.
FT   HELIX       613    616       {ECO:0000244|PDB:4KBQ}.
FT   STRAND      641    644       {ECO:0000244|PDB:3AGY}.
SQ   SEQUENCE   646 AA;  70898 MW;  9AA27B210730670C CRC64;
     MSKGPAVGID LGTTYSCVGV FQHGKVEIIA NDQGNRTTPS YVAFTDTERL IGDAAKNQVA
     MNPTNTVFDA KRLIGRRFDD AVVQSDMKHW PFMVVNDAGR PKVQVEYKGE TKSFYPEEVS
     SMVLTKMKEI AEAYLGKTVT NAVVTVPAYF NDSQRQATKD AGTIAGLNVL RIINEPTAAA
     IAYGLDKKVG AERNVLIFDL GGGTFDVSIL TIEDGIFEVK STAGDTHLGG EDFDNRMVNH
     FIAEFKRKHK KDISENKRAV RRLRTACERA KRTLSSSTQA SIEIDSLYEG IDFYTSITRA
     RFEELNADLF RGTLDPVEKA LRDAKLDKSQ IHDIVLVGGS TRIPKIQKLL QDFFNGKELN
     KSINPDEAVA YGAAVQAAIL SGDKSENVQD LLLLDVTPLS LGIETAGGVM TVLIKRNTTI
     PTKQTQTFTT YSDNQPGVLI QVYEGERAMT KDNNLLGKFE LTGIPPAPRG VPQIEVTFDI
     DANGILNVSA VDKSTGKENK ITITNDKGRL SKEDIERMVQ EAEKYKAEDE KQRDKVSSKN
     SLESYAFNMK ATVEDEKLQG KINDEDKQKI LDKCNEIINW LDKNQTAEKE EFEHQQKELE
     KVCNPIITKL YQSAGGMPGG MPGGFPGGGA PPSGGASSGP TIEEVD
//
ID   Q53HF2_HUMAN            Unreviewed;       493 AA.
AC   Q53HF2;
DT   24-MAY-2005, integrated into UniProtKB/TrEMBL.
DT   24-MAY-2005, sequence version 1.
DT   28-FEB-2018, entry version 82.
DE   SubName: Full=Heat shock 70kDa protein 8 isoform 2 variant {ECO:0000313|EMBL:BAD96348.1};
DE   Flags: Fragment;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAD96348.1};
RN   [1] {ECO:0000313|EMBL:BAD96348.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Cerebellum {ECO:0000313|EMBL:BAD96348.1};
RX   PubMed=8125298; DOI=10.1016/0378-1119(94)90802-8;
RA   Maruyama K., Sugano S.;
RT   "Oligo-capping: a simple method to replace the cap structure of
RT   eukaryotic mRNAs with oligoribonucleotides.";
RL   Gene 138:171-174(1994).
RN   [2] {ECO:0000313|EMBL:BAD96348.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Cerebellum {ECO:0000313|EMBL:BAD96348.1};
RX   PubMed=9373149; DOI=10.1016/S0378-1119(97)00411-3;
RA   Suzuki Y., Yoshitomo K., Maruyama K., Suyama A., Sugano S.;
RT   "Construction and characterization of a full length-enriched and a 5'-
RT   end-enriched cDNA library.";
RL   Gene 200:149-156(1997).
RN   [3] {ECO:0000313|EMBL:BAD96348.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Cerebellum {ECO:0000313|EMBL:BAD96348.1};
RA   Suzuki Y., Sugano S., Totoki Y., Toyoda A., Takeda T., Sakaki Y.,
RA   Tanaka A., Yokoyama S.;
RL   Submitted (APR-2005) to the EMBL/GenBank/DDBJ databases.
CC   -!- INTERACTION:
CC       Q13387:MAPK8IP2; NbExp=2; IntAct=EBI-877761, EBI-722813;
CC       O14796:SH2D1B; NbExp=3; IntAct=EBI-877761, EBI-3923013;
CC   -!- SIMILARITY: Belongs to the heat shock protein 70 family.
CC       {ECO:0000256|RuleBase:RU003322}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK222628; BAD96348.1; -; mRNA.
DR   RefSeq; NP_006588.1; NM_006597.5.
DR   RefSeq; NP_694881.1; NM_153201.3.
DR   UniGene; Hs.180414; -.
DR   IntAct; Q53HF2; 2.
DR   PeptideAtlas; Q53HF2; -.
DR   PRIDE; Q53HF2; -.
DR   DNASU; 3312; -.
DR   GeneID; 3312; -.
DR   KEGG; hsa:3312; -.
DR   CTD; 3312; -.
DR   eggNOG; KOG0101; Eukaryota.
DR   eggNOG; COG0443; LUCA.
DR   HOGENOM; HOG000228135; -.
DR   HOVERGEN; HBG051845; -.
DR   KO; K03283; -.
DR   GenomeRNAi; 3312; -.
DR   Genevisible; Q53HF2; HS.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   Gene3D; 2.60.34.10; -; 1.
DR   InterPro; IPR018181; Heat_shock_70_CS.
DR   InterPro; IPR029047; HSP70_peptide-bd_sf.
DR   InterPro; IPR013126; Hsp_70_fam.
DR   PANTHER; PTHR19375; PTHR19375; 2.
DR   Pfam; PF00012; HSP70; 1.
DR   PRINTS; PR00301; HEATSHOCK70.
DR   SUPFAM; SSF100920; SSF100920; 1.
DR   PROSITE; PS00297; HSP70_1; 1.
DR   PROSITE; PS00329; HSP70_2; 1.
DR   PROSITE; PS01036; HSP70_3; 1.
PE   1: Evidence at protein level;
KW   ATP-binding {ECO:0000256|RuleBase:RU003322};
KW   Nucleotide-binding {ECO:0000256|RuleBase:RU003322};
KW   Stress response {ECO:0000313|EMBL:BAD96348.1}.
FT   NON_TER       1      1       {ECO:0000313|EMBL:BAD96348.1}.
SQ   SEQUENCE   493 AA;  53500 MW;  518CE1F703509AFA CRC64;
     MSKGPAVGID LGTTYSCVGV FQHGKVEIIA NDQGNRTTPS YVAFTDTERL IGDAAKNQVA
     MNPTNTVFDA KRLIGRRFDD AVVQSDMKHW PFMVVNDAGR PKVQVEYKGE TKSFYPEEVS
     SMVLTKMKEI AEAYLGKTVT NAVVTVPAYF NDSQRQATKD AGTIAGLNVL RIINEPTAAA
     IAYGLDKKVG AERNVLIFDL GGGTFDVSIL TIEDGIFEVK STAGDTHLGG EDFDNRMVNH
     FIAEFKRKHK KDISENKRAV RRLRTACERA KRTLSSSTQA SIEIDSLYEG IDFYTSITRA
     RFEELNADLF RGTLDPVEKA LRDAKLDKSQ IHDIVLVGGS TRIPKIQKLL QDFFNGKELN
     KSINPDEAVA YGAAVQAAIL SGDKSENVQD LLLLDVTPLS LGIETAGGVT TVLIKRNTTI
     PIKQTQTFTT YSDNQPGVLI QVYEGERAMT KDNNLLGKFE LTGMPGGMPG GFPGGGAPPS
     GGASSGPTIE EVD
//
ID   V9HW22_HUMAN            Unreviewed;       646 AA.
AC   V9HW22;
DT   19-MAR-2014, integrated into UniProtKB/TrEMBL.
DT   19-MAR-2014, sequence version 1.
DT   23-MAY-2018, entry version 46.
DE   SubName: Full=Epididymis luminal protein 33 {ECO:0000313|EMBL:ACF94502.1};
DE   SubName: Full=Epididymis secretory sperm binding protein Li 72p {ECO:0000313|EMBL:ACI45986.1};
DE   SubName: Full=Heat shock 70kDa protein 8, isoform CRA_a {ECO:0000313|EMBL:EAW67539.1};
GN   Name=HEL-S-72p {ECO:0000313|EMBL:ACI45986.1};
GN   Synonyms=HEL-33 {ECO:0000313|EMBL:ACF94502.1},
GN   HSPA8 {ECO:0000313|EMBL:EAW67539.1};
GN   ORFNames=hCG_2032950 {ECO:0000313|EMBL:EAW67539.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:ACI45986.1};
RN   [1] {ECO:0000313|EMBL:EAW67539.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAW67539.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3] {ECO:0000313|EMBL:ACF94502.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Li J.Y., Wang H.Y., Liu F.J., Liu J.;
RL   Submitted (APR-2008) to the EMBL/GenBank/DDBJ databases.
RN   [4] {ECO:0000313|EMBL:ACI45986.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Li J.Y., Wang H.Y., Liu J., Liu F.J.;
RL   Submitted (SEP-2008) to the EMBL/GenBank/DDBJ databases.
CC   -!- SIMILARITY: Belongs to the heat shock protein 70 family.
CC       {ECO:0000256|RuleBase:RU003322}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; EU668349; ACF94502.1; -; mRNA.
DR   EMBL; FJ224294; ACI45986.1; -; mRNA.
DR   EMBL; CH471065; EAW67539.1; -; Genomic_DNA.
DR   EMBL; CH471065; EAW67540.1; -; Genomic_DNA.
DR   RefSeq; NP_006588.1; NM_006597.5.
DR   RefSeq; XP_011541100.1; XM_011542798.1.
DR   UniGene; Hs.180414; -.
DR   SMR; V9HW22; -.
DR   MaxQB; V9HW22; -.
DR   PRIDE; V9HW22; -.
DR   GeneID; 3312; -.
DR   KEGG; hsa:3312; -.
DR   UCSC; uc001pyo.5; human.
DR   CTD; 3312; -.
DR   EuPathDB; HostDB:ENSG00000109971.13; -.
DR   eggNOG; KOG0101; Eukaryota.
DR   eggNOG; COG0443; LUCA.
DR   KO; K03283; -.
DR   OMA; AYTKNQD; -.
DR   OrthoDB; EOG091G03SF; -.
DR   ChiTaRS; HSPA8; human.
DR   GenomeRNAi; 3312; -.
DR   Bgee; ENSG00000109971; -.
DR   ExpressionAtlas; V9HW22; baseline and differential.
DR   GO; GO:0005829; C:cytosol; IEA:Ensembl.
DR   GO; GO:0070062; C:extracellular exosome; IEA:Ensembl.
DR   GO; GO:0005770; C:late endosome; IEA:Ensembl.
DR   GO; GO:0043209; C:myelin sheath; IEA:Ensembl.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0042623; F:ATPase activity, coupled; IEA:Ensembl.
DR   GO; GO:0001786; F:phosphatidylserine binding; IEA:Ensembl.
DR   GO; GO:0051082; F:unfolded protein binding; IEA:Ensembl.
DR   GO; GO:0051085; P:chaperone cofactor-dependent protein refolding; IEA:Ensembl.
DR   GO; GO:0072318; P:clathrin coat disassembly; IEA:Ensembl.
DR   GO; GO:0061738; P:late endosomal microautophagy; IEA:Ensembl.
DR   GO; GO:0044829; P:positive regulation by host of viral genome replication; IEA:Ensembl.
DR   GO; GO:0048026; P:positive regulation of mRNA splicing, via spliceosome; IEA:Ensembl.
DR   GO; GO:0051726; P:regulation of cell cycle; IEA:Ensembl.
DR   Gene3D; 1.20.1270.10; -; 1.
DR   Gene3D; 2.60.34.10; -; 1.
DR   InterPro; IPR018181; Heat_shock_70_CS.
DR   InterPro; IPR029048; HSP70_C_sf.
DR   InterPro; IPR029047; HSP70_peptide-bd_sf.
DR   InterPro; IPR013126; Hsp_70_fam.
DR   PANTHER; PTHR19375; PTHR19375; 1.
DR   Pfam; PF00012; HSP70; 1.
DR   PRINTS; PR00301; HEATSHOCK70.
DR   SUPFAM; SSF100920; SSF100920; 1.
DR   SUPFAM; SSF100934; SSF100934; 1.
DR   PROSITE; PS00297; HSP70_1; 1.
DR   PROSITE; PS00329; HSP70_2; 1.
DR   PROSITE; PS01036; HSP70_3; 1.
PE   2: Evidence at transcript level;
KW   ATP-binding {ECO:0000256|RuleBase:RU003322};
KW   Coiled coil {ECO:0000256|SAM:Coils};
KW   Nucleotide-binding {ECO:0000256|RuleBase:RU003322};
KW   Stress response {ECO:0000313|EMBL:EAW67539.1}.
FT   COILED      512    535       {ECO:0000256|SAM:Coils}.
SQ   SEQUENCE   646 AA;  70898 MW;  9AA27B210730670C CRC64;
     MSKGPAVGID LGTTYSCVGV FQHGKVEIIA NDQGNRTTPS YVAFTDTERL IGDAAKNQVA
     MNPTNTVFDA KRLIGRRFDD AVVQSDMKHW PFMVVNDAGR PKVQVEYKGE TKSFYPEEVS
     SMVLTKMKEI AEAYLGKTVT NAVVTVPAYF NDSQRQATKD AGTIAGLNVL RIINEPTAAA
     IAYGLDKKVG AERNVLIFDL GGGTFDVSIL TIEDGIFEVK STAGDTHLGG EDFDNRMVNH
     FIAEFKRKHK KDISENKRAV RRLRTACERA KRTLSSSTQA SIEIDSLYEG IDFYTSITRA
     RFEELNADLF RGTLDPVEKA LRDAKLDKSQ IHDIVLVGGS TRIPKIQKLL QDFFNGKELN
     KSINPDEAVA YGAAVQAAIL SGDKSENVQD LLLLDVTPLS LGIETAGGVM TVLIKRNTTI
     PTKQTQTFTT YSDNQPGVLI QVYEGERAMT KDNNLLGKFE LTGIPPAPRG VPQIEVTFDI
     DANGILNVSA VDKSTGKENK ITITNDKGRL SKEDIERMVQ EAEKYKAEDE KQRDKVSSKN
     SLESYAFNMK ATVEDEKLQG KINDEDKQKI LDKCNEIINW LDKNQTAEKE EFEHQQKELE
     KVCNPIITKL YQSAGGMPGG MPGGFPGGGA PPSGGASSGP TIEEVD
//
ID   A0A1U9X7A6_HUMAN        Unreviewed;      1126 AA.
AC   A0A1U9X7A6;
DT   07-JUN-2017, integrated into UniProtKB/TrEMBL.
DT   07-JUN-2017, sequence version 1.
DT   23-MAY-2018, entry version 10.
DE   SubName: Full=BAG6 {ECO:0000313|EMBL:AQY76674.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:AQY76674.1};
RN   [1] {ECO:0000313|EMBL:AQY76674.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Norman P.J., Norberg S.J., Nemat-Gorgani N., Ronaghi M., Parham P.;
RT   "CDS alleles of MHC region genes derived from homozygous
RT   individuals.";
RL   Submitted (MAR-2017) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; KY500163; AQY76667.1; -; Genomic_DNA.
DR   EMBL; KY500166; AQY76670.1; -; Genomic_DNA.
DR   EMBL; KY500168; AQY76672.1; -; Genomic_DNA.
DR   EMBL; KY500170; AQY76674.1; -; Genomic_DNA.
DR   RefSeq; NP_001092004.1; NM_001098534.1.
DR   RefSeq; NP_542433.1; NM_080702.2.
DR   RefSeq; NP_542434.1; NM_080703.2.
DR   UniGene; Hs.440900; -.
DR   SMR; A0A1U9X7A6; -.
DR   GeneID; 7917; -.
DR   CTD; 7917; -.
DR   ExpressionAtlas; A0A1U9X7A6; baseline and differential.
DR   InterPro; IPR021925; BAG6.
DR   InterPro; IPR029071; Ubiquitin-like_domsf.
DR   InterPro; IPR019954; Ubiquitin_CS.
DR   InterPro; IPR000626; Ubiquitin_dom.
DR   Pfam; PF12057; DUF3538; 1.
DR   Pfam; PF00240; ubiquitin; 1.
DR   SMART; SM00213; UBQ; 1.
DR   SUPFAM; SSF54236; SSF54236; 1.
DR   PROSITE; PS00299; UBIQUITIN_1; 1.
DR   PROSITE; PS50053; UBIQUITIN_2; 1.
PE   4: Predicted;
FT   DOMAIN       17     77       Ubiquitin-like.
FT                                {ECO:0000259|PROSITE:PS50053}.
SQ   SEQUENCE   1126 AA;  118693 MW;  8A67290BC8176ABA CRC64;
     MEPNDSTSTA VEEPDSLEVL VKTLDSQTRT FIVGAQMNVK EFKEHIAASV SIPSEKQRLI
     YQGRVLQDDK KLQEYNVGGK VIHLVERAPP QTHLPSGASS GTGSASATHG GGSPPGTRGP
     GASVHDRNAN SYVMVGTFNL PSDGSAVDVH INMEQAPIQS EPRVRLVMAQ HMIRDIQTLL
     SRMECRGGPQ PQHSQPPPQP PAVTPEPVAL SSQTSEPVES EAPPREPMEA EEVEERAPAQ
     NPELTPGPAP AGPTPAPETN APNHPSPAEY VEVLQELQRL ESRLQPFLQR YYEVLGAAAT
     TDYNNNHEGR EEDQRLINLV GESLRLLGNT FVALSDLRCN LACTPPRHLH VVRPMSHYTT
     PMVLQQAAIP IQINVGTTVT MTGNGTRPPP TPNAEAPPPG PGQASSVAPS STNVESSAEG
     APPPGPAPPP ATSHPRVIRI SHQSVEPVVM MHMNIQDSGT QPGGVPSAPT GPLGPPGHGQ
     TLGQQVPGFP TAPTRVVIAR PTPPQARPSH PGGPPVSGTL QGAGLGTNAS LAQMVSGLVG
     QLLMQPVLVA QGTPGMAPPP APATASASAG TTNTATTAGP APGGPAQPPP TPQPSMADLQ
     FSQLLGNLLG PAGPGAGGSG VASPTITVAM PGVPAFLQGM TDFLQATQTA PPPPPPPPPP
     PPAPEQQTMP PPGSPSGGAG SPGGLGLESL SPEFFTSVVQ GVLSSLLGSL GARAGSSESI
     AAFIQRLSGS SNIFEPGADG ALGFFGALLS LLCQNFSMVD VVMLLHGHFQ PLQRLQPQLR
     SFFHQHYLGG QEPTPSNIRM ATHTLITGLE EYVRESFSLV QVQPGVDIIR TNLEFLQEQF
     NSIAAHVLHC TDSGFGARLL ELCNQGLFEC LALNLHCLGG QQMELAAVIN GRIRRMSRGV
     NPSLVSWLTT MMGLRLQVVL EHMPVGPDAI LRYVRRVGDP PQPLPEEPME VQGAERASPE
     PQRENASPAP GTTAEEAMSR GPPPAPEGGS RDEQDGASAE TEPWAAAVPP EWVPIIQQDI
     QSQRKVKPQP PLSDAYLSGM PAKRRKTMQG EGPQLLLSEA VSRAAKAAGA RPLTSPESLS
     RDLEAPEVQE SYRQQLRSDI QKRLQEDPNY SPQRFPNAQR AFADDP
//
ID   BAG6_HUMAN              Reviewed;        1132 AA.
AC   P46379; A2ADJ7; A3KQ42; A3KQ44; A6NGY6; A6PWF7; B0UX84; B4DZ12;
AC   B4E3V4; E7EMZ4; F8VXY4; O95874; Q5HYL9; Q5SQ35; Q5SQ36; Q5SQ37;
AC   Q5SQ41; Q5SRP8; Q5SRP9; Q5STC1; Q5STX1; Q5STX3; Q96SA6; Q9BCN4;
DT   01-NOV-1995, integrated into UniProtKB/Swiss-Prot.
DT   27-SEP-2005, sequence version 2.
DT   23-MAY-2018, entry version 175.
DE   RecName: Full=Large proline-rich protein BAG6 {ECO:0000305};
DE   AltName: Full=BAG family molecular chaperone regulator 6;
DE   AltName: Full=BCL2-associated athanogene 6 {ECO:0000312|HGNC:HGNC:13919};
DE            Short=BAG-6;
DE   AltName: Full=HLA-B-associated transcript 3 {ECO:0000303|PubMed:2156268};
DE   AltName: Full=Protein G3;
DE   AltName: Full=Protein Scythe {ECO:0000303|PubMed:17403783};
GN   Name=BAG6 {ECO:0000312|HGNC:HGNC:13919};
GN   Synonyms=BAT3 {ECO:0000303|PubMed:2156268}, G3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORM 1), VARIANT PRO-625,
RP   AND REPEAT.
RC   TISSUE=T-cell;
RX   PubMed=2156268; DOI=10.1073/pnas.87.6.2374;
RA   Banerji J., Sands J., Strominger J.L., Spies T.;
RT   "A gene pair from the human major histocompatibility complex encodes
RT   large proline-rich proteins with multiple repeated motifs and a single
RT   ubiquitin-like domain.";
RL   Proc. Natl. Acad. Sci. U.S.A. 87:2374-2378(1990).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Endometrium;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 4 AND 5), AND VARIANT
RP   PRO-625.
RC   TISSUE=Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=14656967; DOI=10.1101/gr.1736803;
RA   Xie T., Rowen L., Aguado B., Ahearn M.E., Madan A., Qin S.,
RA   Campbell R.D., Hood L.;
RT   "Analysis of the gene-dense major histocompatibility complex class III
RT   region and its comparison to mouse.";
RL   Genome Res. 13:2621-2636(2003).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND VARIANT PRO-625.
RA   Hirakawa M., Yamaguchi H., Imai K., Shimada J., Shiina S., Tamiya G.,
RA   Oka A., Inoko H.;
RT   "Homo sapiens 2,229,817bp genomic DNA of 6p21.3 HLA class I region.";
RL   Submitted (DEC-2004) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND VARIANT PRO-625.
RX   PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E.,
RA   Gilbert J.G.R., Clamp M.E., Bethel G., Milne S., Ainscough R.,
RA   Almeida J.P., Ambrose K.D., Andrews T.D., Ashwell R.I.S.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Banerjee R., Barker D.J.,
RA   Barlow K.F., Bates K., Beare D.M., Beasley H., Beasley O., Bird C.P.,
RA   Blakey S.E., Bray-Allen S., Brook J., Brown A.J., Brown J.Y.,
RA   Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E.,
RA   Ellington A.E., Evans K.A., Faulkner L., Francis M.D., Frankish A.,
RA   Frankland J., French L., Garner P., Garnett J., Ghori M.J.,
RA   Gilby L.M., Gillson C.J., Glithero R.J., Grafham D.V., Grant M.,
RA   Gribble S., Griffiths C., Griffiths M.N.D., Hall R., Halls K.S.,
RA   Hammond S., Harley J.L., Hart E.A., Heath P.D., Heathcott R.,
RA   Holmes S.J., Howden P.J., Howe K.L., Howell G.R., Huckle E.,
RA   Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M., Joy A.A.,
RA   Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R., Lloyd D.M.,
RA   Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K.,
RA   McMurray A., Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T.,
RA   Novik K.L., Oliver K., Overton-Larty E.K., Parker A., Patel R.,
RA   Pearce A.V., Peck A.I., Phillimore B.J.C.T., Phillips S., Plumb R.W.,
RA   Porter K.M., Ramsey Y., Ranby S.A., Rice C.M., Ross M.T., Searle S.M.,
RA   Sehra H.K., Sheridan E., Skuce C.D., Smith S., Smith M., Spraggon L.,
RA   Squares S.L., Steward C.A., Sycamore N., Tamlyn-Hall G., Tester J.,
RA   Theaker A.J., Thomas D.W., Thorpe A., Tracey A., Tromans A., Tubby B.,
RA   Wall M., Wallis J.M., West A.P., White S.S., Whitehead S.L.,
RA   Whittaker H., Wild A., Willey D.J., Wilmer T.E., Wood J.M., Wray P.W.,
RA   Wyatt J.C., Young L., Younger R.M., Bentley D.R., Coulson A.,
RA   Durbin R.M., Hubbard T., Sulston J.E., Dunham I., Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND VARIANT PRO-625.
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Kidney;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   FUNCTION, SUBCELLULAR LOCATION, INTERACTION WITH RICIN A CHAIN,
RP   MUTAGENESIS OF ASP-1001, AND CLEAVAGE BY CASP3.
RX   PubMed=14960581; DOI=10.1074/jbc.M307049200;
RA   Wu Y.-H., Shih S.-F., Lin J.-Y.;
RT   "Ricin triggers apoptotic morphological changes through caspase-3
RT   cleavage of BAT3.";
RL   J. Biol. Chem. 279:19264-19275(2004).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1117, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=16964243; DOI=10.1038/nbt1240;
RA   Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
RT   "A probability-based approach for high-throughput protein
RT   phosphorylation analysis and site localization.";
RL   Nat. Biotechnol. 24:1285-1292(2006).
RN   [12]
RP   FUNCTION, SUBCELLULAR LOCATION, AND INTERACTION WITH EP300.
RX   PubMed=17403783; DOI=10.1101/gad.1534107;
RA   Sasaki T., Gan E.C., Wakeham A., Kornbluth S., Mak T.W., Okada H.;
RT   "HLA-B-associated transcript 3 (Bat3)/Scythe is essential for p300-
RT   mediated acetylation of p53.";
RL   Genes Dev. 21:848-861(2007).
RN   [13]
RP   FUNCTION IN NK CELL ACTIVATION, AND SUBCELLULAR LOCATION.
RX   PubMed=18055229; DOI=10.1016/j.immuni.2007.10.010;
RA   Pogge von Strandmann E., Simhadri V.R., von Tresckow B., Sasse S.,
RA   Reiners K.S., Hansen H.P., Rothe A., Boll B., Simhadri V.L.,
RA   Borchmann P., McKinnon P.J., Hallek M., Engert A.;
RT   "Human leukocyte antigen-B-associated transcript 3 is released from
RT   tumor cells and engages the NKp30 receptor on natural killer cells.";
RL   Immunity 27:965-974(2007).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-113, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17924679; DOI=10.1021/pr070152u;
RA   Yu L.R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D.;
RT   "Improved titanium dioxide enrichment of phosphopeptides from HeLa
RT   cells and high confident phosphopeptide identification by cross-
RT   validation of MS/MS and MS/MS/MS spectra.";
RL   J. Proteome Res. 6:4150-4162(2007).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-973, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Platelet;
RX   PubMed=18088087; DOI=10.1021/pr0704130;
RA   Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J.,
RA   Schuetz C., Walter U., Gambaryan S., Sickmann A.;
RT   "Phosphoproteome of resting human platelets.";
RL   J. Proteome Res. 7:526-534(2008).
RN   [16]
RP   FUNCTION, AND INTERACTION WITH CTCFL.
RX   PubMed=18765639; DOI=10.1128/MCB.00568-08;
RA   Nguyen P., Bar-Sela G., Sun L., Bisht K.S., Cui H., Kohn E.,
RA   Feinberg A.P., Gius D.;
RT   "BAT3 and SET1A form a complex with CTCFL/BORIS to modulate H3K4
RT   histone dimethylation and gene expression.";
RL   Mol. Cell. Biol. 28:6720-6729(2008).
RN   [17]
RP   FUNCTION IN NK CELL ACTIVATION, SUBCELLULAR LOCATION, AND TISSUE
RP   SPECIFICITY.
RX   PubMed=18852879; DOI=10.1371/journal.pone.0003377;
RA   Simhadri V.R., Reiners K.S., Hansen H.P., Topolar D., Simhadri V.L.,
RA   Nohroudi K., Kufer T.A., Engert A., Pogge von Strandmann E.;
RT   "Dendritic cells release HLA-B-associated transcript-3 positive
RT   exosomes to regulate natural killer function.";
RL   PLoS ONE 3:E3377-E3377(2008).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-113; SER-973; SER-1081
RP   AND SER-1117, PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-832
RP   (ISOFORM 4), AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [19]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [20]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-964 AND SER-973, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [21]
RP   UBIQUITINATION IN CASE OF INFECTION BY L.PNEUMOPHILA (MICROBIAL
RP   INFECTION), AND INTERACTION WITH LPG2160 AND LEGU1 (MICROBIAL
RP   INFECTION).
RX   PubMed=20547746; DOI=10.1128/IAI.00344-10;
RA   Ensminger A.W., Isberg R.R.;
RT   "E3 ubiquitin ligase activity and targeting of BAT3 by multiple
RT   Legionella pneumophila translocated substrates.";
RL   Infect. Immun. 78:3905-3919(2010).
RN   [22]
RP   FUNCTION.
RX   PubMed=20516149; DOI=10.1242/jcs.066738;
RA   Leznicki P., Clancy A., Schwappach B., High S.;
RT   "Bat3 promotes the membrane integration of tail-anchored proteins.";
RL   J. Cell Sci. 123:2170-2178(2010).
RN   [23]
RP   FUNCTION, SUBCELLULAR LOCATION, RIBOSOME-BINDING, IDENTIFICATION BY
RP   MASS SPECTROMETRY, AND IDENTIFICATION IN THE BAG6/BAT3 COMPLEX.
RX   PubMed=20676083; DOI=10.1038/nature09296;
RA   Mariappan M., Li X., Stefanovic S., Sharma A., Mateja A., Keenan R.J.,
RA   Hegde R.S.;
RT   "A ribosome-associating factor chaperones tail-anchored membrane
RT   proteins.";
RL   Nature 466:1120-1124(2010).
RN   [24]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-350; SER-964; SER-973
RP   AND SER-1117, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [25]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [26]
RP   FUNCTION, INTERACTION WITH AMFR; SYVN1 AND VCP, AND SUBCELLULAR
RP   LOCATION.
RX   PubMed=21636303; DOI=10.1016/j.molcel.2011.05.010;
RA   Wang Q., Liu Y., Soetandyo N., Baek K., Hegde R., Ye Y.;
RT   "A ubiquitin ligase-associated chaperone holdase maintains
RT   polypeptides in soluble states for proteasome degradation.";
RL   Mol. Cell 42:758-770(2011).
RN   [27]
RP   FUNCTION, AND DOMAIN.
RX   PubMed=21743475; DOI=10.1038/nature10181;
RA   Hessa T., Sharma A., Mariappan M., Eshleman H.D., Gutierrez E.,
RA   Hegde R.S.;
RT   "Protein targeting and degradation are coupled for elimination of
RT   mislocalized proteins.";
RL   Nature 475:394-397(2011).
RN   [28]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-964 AND SER-973, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [29]
RP   FUNCTION, AND INTERACTION WITH SGTA.
RX   PubMed=23129660; DOI=10.1073/pnas.1209997109;
RA   Leznicki P., High S.;
RT   "SGTA antagonizes BAG6-mediated protein triage.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:19214-19219(2012).
RN   [30]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-113; SER-964; SER-973;
RP   THR-1053; SER-1081 AND SER-1117, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [31]
RP   INTERACTION WITH ZFAND2B.
RX   PubMed=24160817; DOI=10.1042/BJ20130710;
RA   Glinka T., Alter J., Braunstein I., Tzach L., Wei Sheng C.,
RA   Geifman S., Edelmann M.J., Kessler B.M., Stanhill A.;
RT   "Signal-peptide-mediated translocation is regulated by a p97-AIRAPL
RT   complex.";
RL   Biochem. J. 457:253-261(2014).
RN   [32]
RP   INTERACTION WITH SGTA AND USP13.
RX   PubMed=24424410; DOI=10.7554/eLife.01369;
RA   Liu Y., Soetandyo N., Lee J.G., Liu L., Xu Y., Clemons W.M. Jr.,
RA   Ye Y.;
RT   "USP13 antagonizes gp78 to maintain functionality of a chaperone in
RT   ER-associated degradation.";
RL   Elife 3:E01369-E01369(2014).
RN   [33]
RP   FUNCTION, AND INTERACTION WITH SGTA.
RX   PubMed=25179605; DOI=10.1242/jcs.155648;
RA   Wunderley L., Leznicki P., Payapilly A., High S.;
RT   "SGTA regulates the cytosolic quality control of hydrophobic
RT   substrates.";
RL   J. Cell Sci. 127:4728-4739(2014).
RN   [34]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-96 AND THR-117, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [35]
RP   FUNCTION, INTERACTION WITH RNF126, AND DOMAIN.
RX   PubMed=24981174; DOI=10.1016/j.molcel.2014.05.025;
RA   Rodrigo-Brenni M.C., Gutierrez E., Hegde R.S.;
RT   "Cytosolic quality control of mislocalized proteins requires RNF126
RT   recruitment to Bag6.";
RL   Mol. Cell 55:227-237(2014).
RN   [36]
RP   FUNCTION.
RX   PubMed=26565908; DOI=10.1016/j.celrep.2015.09.047;
RA   Kadowaki H., Nagai A., Maruyama T., Takami Y., Satrimafitrah P.,
RA   Kato H., Honda A., Hatta T., Natsume T., Sato T., Kai H., Ichijo H.,
RA   Nishitoh H.;
RT   "Pre-emptive quality control protects the ER from protein overload via
RT   the proximity of ERAD components and SRP.";
RL   Cell Rep. 13:944-956(2015).
RN   [37]
RP   INTERACTION WITH ZFAND2B.
RX   PubMed=26337389; DOI=10.1091/mbc.E15-02-0085;
RA   Braunstein I., Zach L., Allan S., Kalies K.U., Stanhill A.;
RT   "Proteasomal degradation of preemptive quality control (pQC)
RT   substrates is mediated by an AIRAPL-p97 complex.";
RL   Mol. Biol. Cell 26:3719-3727(2015).
RN   [38]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [39]
RP   FUNCTION.
RX   PubMed=26692333; DOI=10.1038/nm.4013;
RA   Osorio F.G., Soria-Valles C., Santiago-Fernandez O., Bernal T.,
RA   Mittelbrunn M., Colado E., Rodriguez F., Bonzon-Kulichenko E.,
RA   Vazquez J., Porta-de-la-Riva M., Ceron J., Fueyo A., Li J.,
RA   Green A.R., Freije J.M., Lopez-Otin C.;
RT   "Loss of the proteostasis factor AIRAPL causes myeloid transformation
RT   by deregulating IGF-1 signaling.";
RL   Nat. Med. 22:91-96(2016).
RN   [40]
RP   FUNCTION, DOMAIN, AND REGION.
RX   PubMed=28104892; DOI=10.1126/science.aah6130;
RA   Shao S., Rodrigo-Brenni M.C., Kivlen M.H., Hegde R.S.;
RT   "Mechanistic basis for a molecular triage reaction.";
RL   Science 355:298-302(2017).
RN   [41]
RP   STRUCTURE BY NMR OF 17-89.
RG   RIKEN structural genomics initiative (RSGI);
RT   "Solution structure of the N-terminal ubiquitin-like domain in the
RT   human BAT3 protein.";
RL   Submitted (JUL-2005) to the PDB data bank.
RN   [42]
RP   STRUCTURE BY NMR OF 17-101 IN COMPLEX WITH RNF126, FUNCTION,
RP   INTERACTION WITH RNF126 AND SGTA, AND DOMAIN.
RX   PubMed=27193484; DOI=10.1038/srep26433;
RA   Krysztofinska E.M., Martinez-Lumbreras S., Thapaliya A., Evans N.J.,
RA   High S., Isaacson R.L.;
RT   "Structural and functional insights into the E3 ligase, RNF126.";
RL   Sci. Rep. 6:26433-26433(2016).
CC   -!- FUNCTION: ATP-independent molecular chaperone preventing the
CC       aggregation of misfolded and hydrophobic patches-containing
CC       proteins (PubMed:21636303). Functions as part of a cytosolic
CC       protein quality control complex, the BAG6/BAT3 complex, which
CC       maintains these client proteins in a soluble state and
CC       participates to their proper delivery to the endoplasmic reticulum
CC       or alternatively can promote their sorting to the proteasome where
CC       they undergo degradation (PubMed:20516149, PubMed:21636303,
CC       PubMed:21743475, PubMed:28104892). The BAG6/BAT3 complex is
CC       involved in the post-translational delivery of tail-anchored/type
CC       II transmembrane proteins to the endoplasmic reticulum membrane.
CC       Recruited to ribosomes, it interacts with the transmembrane region
CC       of newly synthesized tail-anchored proteins and together with SGTA
CC       and ASNA1 mediates their delivery to the endoplasmic reticulum
CC       (PubMed:20516149, PubMed:20676083, PubMed:28104892). Client
CC       proteins that cannot be properly delivered to the endoplasmic
CC       reticulum are ubiquitinated by RNF126, an E3 ubiquitin-protein
CC       ligase associated with BAG6 and are sorted to the proteasome
CC       (PubMed:24981174, PubMed:28104892, PubMed:27193484). SGTA which
CC       prevents the recruitment of RNF126 to BAG6 may negatively regulate
CC       the ubiquitination and the proteasomal degradation of client
CC       proteins (PubMed:23129660, PubMed:25179605, PubMed:27193484).
CC       Similarly, the BAG6/BAT3 complex also functions as a sorting
CC       platform for proteins of the secretory pathway that are
CC       mislocalized to the cytosol either delivering them to the
CC       proteasome for degradation or to the endoplasmic reticulum
CC       (PubMed:21743475). The BAG6/BAT3 complex also plays a role in the
CC       endoplasmic reticulum-associated degradation (ERAD), a quality
CC       control mechanism that eliminates unwanted proteins of the
CC       endoplasmic reticulum through their retrotranslocation to the
CC       cytosol and their targeting to the proteasome. It maintains these
CC       retrotranslocated proteins in an unfolded yet soluble state
CC       condition in the cytosol to ensure their proper delivery to the
CC       proteasome (PubMed:21636303). BAG6 is also required for selective
CC       ubiquitin-mediated degradation of defective nascent chain
CC       polypeptides by the proteasome. In this context, it may
CC       participate to the production of antigenic peptides and play a
CC       role in antigen presentation in immune response (By similarity).
CC       BAG6 is also involved in endoplasmic reticulum stress-induced pre-
CC       emptive quality control, a mechanism that selectively attenuates
CC       the translocation of newly synthesized proteins into the
CC       endoplasmic reticulum and reroutes them to the cytosol for
CC       proteasomal degradation. BAG6 may ensure the proper degradation of
CC       these proteins and thereby protects the endoplasmic reticulum from
CC       protein overload upon stress (PubMed:26565908). By inhibiting the
CC       polyubiquitination and subsequent proteasomal degradation of HSPA2
CC       it may also play a role in the assembly of the synaptonemal
CC       complex during spermatogenesis (By similarity). Also positively
CC       regulates apoptosis by interacting with and stabilizing the
CC       proapoptotic factor AIFM1 (By similarity). By controlling the
CC       steady-state expression of the IGF1R receptor, indirectly
CC       regulates the insulin-like growth factor receptor signaling
CC       pathway (PubMed:26692333). {ECO:0000250|UniProtKB:Q9Z1R2,
CC       ECO:0000269|PubMed:20516149, ECO:0000269|PubMed:20676083,
CC       ECO:0000269|PubMed:21636303, ECO:0000269|PubMed:21743475,
CC       ECO:0000269|PubMed:23129660, ECO:0000269|PubMed:24981174,
CC       ECO:0000269|PubMed:25179605, ECO:0000269|PubMed:26565908,
CC       ECO:0000269|PubMed:26692333, ECO:0000269|PubMed:27193484,
CC       ECO:0000269|PubMed:28104892}.
CC   -!- FUNCTION: Involved in DNA damage-induced apoptosis: following DNA
CC       damage, accumulates in the nucleus and forms a complex with
CC       p300/EP300, enhancing p300/EP300-mediated p53/TP53 acetylation
CC       leading to increase p53/TP53 transcriptional activity
CC       (PubMed:17403783). When nuclear, may also act as a component of
CC       some chromatin regulator complex that regulates histone 3 'Lys-4'
CC       dimethylation (H3K4me2) (PubMed:18765639).
CC       {ECO:0000269|PubMed:17403783, ECO:0000269|PubMed:18765639}.
CC   -!- FUNCTION: Released extracellularly via exosomes, it is a ligand of
CC       the natural killer/NK cells receptor NCR3 and stimulates NK cells
CC       cytotoxicity. It may thereby trigger NK cells cytotoxicity against
CC       neighboring tumor cells and immature myeloid dendritic cells (DC).
CC       {ECO:0000269|PubMed:18055229, ECO:0000269|PubMed:18852879}.
CC   -!- FUNCTION: Mediates ricin-induced apoptosis.
CC       {ECO:0000269|PubMed:14960581}.
CC   -!- SUBUNIT: Component of the BAG6/BAT3 complex, also named BAT3
CC       complex, at least composed of BAG6, UBL4A and GET4/TRC35
CC       (PubMed:20676083). Interacts with GET4; the interaction is direct
CC       and localizes BAG6 in the cytosol (PubMed:21636303). Interacts
CC       with AIFM1 (By similarity). Interacts with HSPA2 (By similarity).
CC       Interacts with CTCFL (PubMed:18765639). Interacts with p300/EP300
CC       (PubMed:17403783). Interacts (via ubiquitin-like domain) with
CC       RNF126; required for BAG6-dependent ubiquitination of proteins
CC       mislocalized to the cytosol (PubMed:24981174, PubMed:27193484).
CC       Interacts (via ubiquitin-like domain) with SGTA; SGTA competes
CC       with RNF126 by binding the same region of BAG6, thereby promoting
CC       deubiquitination of BAG6-target proteins and rescuing them from
CC       degradation (PubMed:23129660, PubMed:24424410, PubMed:25179605,
CC       PubMed:27193484). Interacts with ricin A chain (PubMed:14960581).
CC       Interacts with VCP and AMFR; both form the VCP/p97-AMFR/gp78
CC       complex (PubMed:21636303). Interacts with SYVN1 (PubMed:21636303).
CC       Interacts with USP13; the interaction is direct and may mediate
CC       UBL4A deubiquitination (PubMed:24424410). Interacts with ZFAND2B
CC       (PubMed:24160817, PubMed:26337389). {ECO:0000250|UniProtKB:Q9Z1R2,
CC       ECO:0000269|PubMed:14960581, ECO:0000269|PubMed:17403783,
CC       ECO:0000269|PubMed:18765639, ECO:0000269|PubMed:20676083,
CC       ECO:0000269|PubMed:21636303, ECO:0000269|PubMed:23129660,
CC       ECO:0000269|PubMed:24160817, ECO:0000269|PubMed:24424410,
CC       ECO:0000269|PubMed:24981174, ECO:0000269|PubMed:25179605,
CC       ECO:0000269|PubMed:26337389, ECO:0000269|PubMed:27193484}.
CC   -!- SUBUNIT: (Microbial infection) Interacts with L. pneumophila
CC       Lpg2160 and LegU1 proteins. {ECO:0000269|PubMed:20547746}.
CC   -!- INTERACTION:
CC       Q12805:EFEMP1; NbExp=3; IntAct=EBI-347552, EBI-536772;
CC       Q8IZU0:FAM9B; NbExp=3; IntAct=EBI-347552, EBI-10175124;
CC       Q53G59:KLHL12; NbExp=4; IntAct=EBI-347552, EBI-740929;
CC       Q7Z434:MAVS; NbExp=2; IntAct=EBI-347552, EBI-995373;
CC       O14931:NCR3; NbExp=6; IntAct=EBI-347552, EBI-14989262;
CC       O14931-1:NCR3; NbExp=5; IntAct=EBI-9640181, EBI-15013584;
CC       Q9BV68:RNF126; NbExp=4; IntAct=EBI-347552, EBI-357322;
CC       O43765:SGTA; NbExp=5; IntAct=EBI-347552, EBI-347996;
CC       Q12800:TFCP2; NbExp=3; IntAct=EBI-347552, EBI-717422;
CC       Q9UHD9:UBQLN2; NbExp=4; IntAct=EBI-10988864, EBI-947187;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytosol
CC       {ECO:0000269|PubMed:17403783, ECO:0000269|PubMed:20676083,
CC       ECO:0000269|PubMed:21636303}. Nucleus
CC       {ECO:0000269|PubMed:14960581, ECO:0000269|PubMed:17403783,
CC       ECO:0000269|PubMed:21636303}. Secreted, exosome
CC       {ECO:0000269|PubMed:18055229, ECO:0000269|PubMed:18852879}.
CC       Note=Normally localized in cytosol and nucleus, it can also be
CC       released extracellularly, in exosomes, by tumor and myeloid
CC       dendritic cells. {ECO:0000269|PubMed:18055229,
CC       ECO:0000269|PubMed:18852879}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=5;
CC       Name=1;
CC         IsoId=P46379-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P46379-2; Sequence=VSP_015695;
CC       Name=3;
CC         IsoId=P46379-3; Sequence=VSP_015695, VSP_030519;
CC         Note=No experimental confirmation available.;
CC       Name=4;
CC         IsoId=P46379-4; Sequence=VSP_015695, VSP_045910, VSP_045911,
CC                                  VSP_045912, VSP_045913;
CC         Note=No experimental confirmation available. Contains a
CC         phosphoserine at position 832.;
CC       Name=5;
CC         IsoId=P46379-5; Sequence=VSP_015695, VSP_045913;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Expressed by immature dendritic cells (at
CC       protein level). {ECO:0000269|PubMed:18852879}.
CC   -!- DOMAIN: The ubiquitin-like domain mediates interaction with the E3
CC       ubiquitin-protein ligase RNF126 which is responsible for the BAG6-
CC       dependent ubiquitination of client proteins (PubMed:21743475,
CC       PubMed:24981174, PubMed:28104892, PubMed:27193484). SGTA also
CC       binds this domain and competes with RNF126 to antagonize client
CC       protein ubiquitination and degradation (PubMed:28104892). The
CC       ubiquitin-like domain also mediates the interaction with USP13
CC       (PubMed:24424410). {ECO:0000269|PubMed:21743475,
CC       ECO:0000269|PubMed:24424410, ECO:0000269|PubMed:24981174,
CC       ECO:0000269|PubMed:27193484, ECO:0000269|PubMed:28104892}.
CC   -!- PTM: Ricin can induce a cleavage by the caspase CASP3. The
CC       released C-terminal peptide induces apoptosis.
CC       {ECO:0000269|PubMed:14960581}.
CC   -!- PTM: (Microbial infection) In case of infection by L.pneumophila,
CC       ubiquitinated by the SCF(LegU1) complex.
CC       {ECO:0000269|PubMed:20547746}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAD18085.1; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC       Sequence=BAB63390.1; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC       Sequence=CAI18318.2; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M33519; AAA35587.1; -; mRNA.
DR   EMBL; M33521; AAA35588.1; -; Genomic_DNA.
DR   EMBL; M33520; AAA35588.1; JOINED; Genomic_DNA.
DR   EMBL; BX647244; CAI46045.1; -; mRNA.
DR   EMBL; AK302695; BAG63924.1; -; mRNA.
DR   EMBL; AK304879; BAG65616.1; -; mRNA.
DR   EMBL; AF129756; AAD18085.1; ALT_INIT; Genomic_DNA.
DR   EMBL; BA000025; BAB63390.1; ALT_INIT; Genomic_DNA.
DR   EMBL; AL662801; CAI18314.1; -; Genomic_DNA.
DR   EMBL; AL662801; CAI18315.1; -; Genomic_DNA.
DR   EMBL; AL662801; CAI18316.2; -; Genomic_DNA.
DR   EMBL; AL662801; CAI18318.2; ALT_SEQ; Genomic_DNA.
DR   EMBL; AL662847; CAI17658.1; -; Genomic_DNA.
DR   EMBL; AL670886; CAI17658.1; JOINED; Genomic_DNA.
DR   EMBL; AL662847; CAI17659.1; -; Genomic_DNA.
DR   EMBL; AL670886; CAI17659.1; JOINED; Genomic_DNA.
DR   EMBL; AL670886; CAI17784.1; -; Genomic_DNA.
DR   EMBL; AL662847; CAI17784.1; JOINED; Genomic_DNA.
DR   EMBL; AL670886; CAI17785.1; -; Genomic_DNA.
DR   EMBL; AL662847; CAI17785.1; JOINED; Genomic_DNA.
DR   EMBL; AL670886; CAI17786.1; -; Genomic_DNA.
DR   EMBL; AL662847; CAI17786.1; JOINED; Genomic_DNA.
DR   EMBL; AL805934; CAI18501.1; -; Genomic_DNA.
DR   EMBL; AL805934; CAI18504.1; -; Genomic_DNA.
DR   EMBL; AL805934; CAI18508.2; -; Genomic_DNA.
DR   EMBL; AL805934; CAI18509.1; -; Genomic_DNA.
DR   EMBL; AL670886; CAM25014.1; -; Genomic_DNA.
DR   EMBL; AL662847; CAM25014.1; JOINED; Genomic_DNA.
DR   EMBL; BX511262; CAM45799.1; -; Genomic_DNA.
DR   EMBL; BX511262; CAM45800.1; -; Genomic_DNA.
DR   EMBL; BX511262; CAM45801.1; -; Genomic_DNA.
DR   EMBL; AL662847; CAO72072.1; -; Genomic_DNA.
DR   EMBL; AL670886; CAO72072.1; JOINED; Genomic_DNA.
DR   EMBL; CR753842; CAQ06558.1; -; Genomic_DNA.
DR   EMBL; CR753892; CAQ06558.1; JOINED; Genomic_DNA.
DR   EMBL; CR753892; CAQ06931.1; -; Genomic_DNA.
DR   EMBL; CR753842; CAQ06931.1; JOINED; Genomic_DNA.
DR   EMBL; CR354443; CAQ06977.1; -; Genomic_DNA.
DR   EMBL; CR759761; CAQ10854.1; -; Genomic_DNA.
DR   EMBL; CH471081; EAX03455.1; -; Genomic_DNA.
DR   EMBL; BC003133; AAH03133.1; -; mRNA.
DR   CCDS; CCDS4709.1; -. [P46379-2]
DR   CCDS; CCDS47403.1; -. [P46379-1]
DR   CCDS; CCDS56414.1; -. [P46379-4]
DR   CCDS; CCDS56415.1; -. [P46379-5]
DR   PIR; A35098; A35098.
DR   RefSeq; NP_001092004.1; NM_001098534.1. [P46379-2]
DR   RefSeq; NP_001186626.1; NM_001199697.1. [P46379-4]
DR   RefSeq; NP_001186627.1; NM_001199698.1. [P46379-5]
DR   RefSeq; NP_004630.3; NM_004639.3. [P46379-1]
DR   RefSeq; NP_542433.1; NM_080702.2. [P46379-2]
DR   RefSeq; NP_542434.1; NM_080703.2. [P46379-2]
DR   RefSeq; XP_016866776.1; XM_017011287.1. [P46379-3]
DR   UniGene; Hs.440900; -.
DR   PDB; 1WX9; NMR; -; A=17-89.
DR   PDB; 2N9P; NMR; -; C=17-101.
DR   PDB; 4DWF; X-ray; 1.80 A; A/B=13-101.
DR   PDB; 4EEW; X-ray; 1.30 A; A/B=1-87.
DR   PDB; 4WWR; X-ray; 2.00 A; A/C/E/G=1060-1111.
DR   PDB; 4X86; X-ray; 1.85 A; B=1048-1123.
DR   PDB; 6AU8; X-ray; 1.80 A; C=1008-1050.
DR   PDBsum; 1WX9; -.
DR   PDBsum; 2N9P; -.
DR   PDBsum; 4DWF; -.
DR   PDBsum; 4EEW; -.
DR   PDBsum; 4WWR; -.
DR   PDBsum; 4X86; -.
DR   PDBsum; 6AU8; -.
DR   ProteinModelPortal; P46379; -.
DR   SMR; P46379; -.
DR   BioGrid; 113647; 294.
DR   CORUM; P46379; -.
DR   DIP; DIP-31191N; -.
DR   IntAct; P46379; 260.
DR   MINT; P46379; -.
DR   STRING; 9606.ENSP00000365131; -.
DR   iPTMnet; P46379; -.
DR   PhosphoSitePlus; P46379; -.
DR   SwissPalm; P46379; -.
DR   BioMuta; BAG6; -.
DR   DMDM; 76800648; -.
DR   EPD; P46379; -.
DR   MaxQB; P46379; -.
DR   PaxDb; P46379; -.
DR   PeptideAtlas; P46379; -.
DR   PRIDE; P46379; -.
DR   Ensembl; ENST00000211379; ENSP00000211379; ENSG00000204463. [P46379-2]
DR   Ensembl; ENST00000361076; ENSP00000354368; ENSG00000096155. [P46379-1]
DR   Ensembl; ENST00000362049; ENSP00000354875; ENSG00000204463. [P46379-5]
DR   Ensembl; ENST00000375964; ENSP00000365131; ENSG00000204463. [P46379-1]
DR   Ensembl; ENST00000375976; ENSP00000365143; ENSG00000204463. [P46379-2]
DR   Ensembl; ENST00000383446; ENSP00000372938; ENSG00000096155. [P46379-2]
DR   Ensembl; ENST00000383448; ENSP00000372940; ENSG00000096155. [P46379-2]
DR   Ensembl; ENST00000417144; ENSP00000412110; ENSG00000229524. [P46379-2]
DR   Ensembl; ENST00000419847; ENSP00000389121; ENSG00000233348. [P46379-2]
DR   Ensembl; ENST00000439687; ENSP00000402856; ENSG00000204463. [P46379-4]
DR   Ensembl; ENST00000442479; ENSP00000413698; ENSG00000229524. [P46379-2]
DR   Ensembl; ENST00000443182; ENSP00000410156; ENSG00000233348. [P46379-2]
DR   Ensembl; ENST00000449450; ENSP00000397894; ENSG00000229524. [P46379-1]
DR   Ensembl; ENST00000451932; ENSP00000390966; ENSG00000233348. [P46379-1]
DR   Ensembl; ENST00000551350; ENSP00000447546; ENSG00000229524. [P46379-5]
DR   Ensembl; ENST00000552116; ENSP00000447946; ENSG00000233348. [P46379-5]
DR   Ensembl; ENST00000552605; ENSP00000446525; ENSG00000096155. [P46379-5]
DR   Ensembl; ENST00000613474; ENSP00000478966; ENSG00000227761. [P46379-4]
DR   Ensembl; ENST00000615143; ENSP00000482413; ENSG00000229524. [P46379-4]
DR   Ensembl; ENST00000615224; ENSP00000477951; ENSG00000228760. [P46379-4]
DR   Ensembl; ENST00000615725; ENSP00000479238; ENSG00000233348. [P46379-4]
DR   Ensembl; ENST00000617635; ENSP00000484238; ENSG00000096155. [P46379-4]
DR   Ensembl; ENST00000621056; ENSP00000477867; ENSG00000234651. [P46379-4]
DR   GeneID; 7917; -.
DR   KEGG; hsa:7917; -.
DR   UCSC; uc003nvf.4; human. [P46379-1]
DR   CTD; 7917; -.
DR   DisGeNET; 7917; -.
DR   EuPathDB; HostDB:ENSG00000204463.12; -.
DR   GeneCards; BAG6; -.
DR   H-InvDB; HIX0165051; -.
DR   H-InvDB; HIX0166179; -.
DR   H-InvDB; HIX0166289; -.
DR   H-InvDB; HIX0166578; -.
DR   H-InvDB; HIX0166832; -.
DR   H-InvDB; HIX0167081; -.
DR   H-InvDB; HIX0167222; -.
DR   H-InvDB; HIX0167321; -.
DR   H-InvDB; HIX0167461; -.
DR   H-InvDB; HIX0167568; -.
DR   HGNC; HGNC:13919; BAG6.
DR   HPA; CAB020704; -.
DR   HPA; HPA045116; -.
DR   HPA; HPA053291; -.
DR   MIM; 142590; gene.
DR   neXtProt; NX_P46379; -.
DR   OpenTargets; ENSG00000204463; -.
DR   PharmGKB; PA25264; -.
DR   eggNOG; KOG4248; Eukaryota.
DR   eggNOG; ENOG410XS9P; LUCA.
DR   GeneTree; ENSGT00390000016199; -.
DR   HOVERGEN; HBG002193; -.
DR   InParanoid; P46379; -.
DR   OMA; PMVAPNA; -.
DR   OrthoDB; EOG091G0XSR; -.
DR   PhylomeDB; P46379; -.
DR   TreeFam; TF328437; -.
DR   ChiTaRS; BAG6; human.
DR   EvolutionaryTrace; P46379; -.
DR   GeneWiki; HLA-B_associated_transcript_3; -.
DR   GenomeRNAi; 7917; -.
DR   PMAP-CutDB; B0UX84; -.
DR   PRO; PR:P46379; -.
DR   Proteomes; UP000005640; Chromosome 6.
DR   Bgee; ENSG00000204463; -.
DR   ExpressionAtlas; P46379; baseline and differential.
DR   Genevisible; P46379; HS.
DR   GO; GO:0071818; C:BAT3 complex; IDA:UniProtKB.
DR   GO; GO:0005737; C:cytoplasm; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0005829; C:cytosol; IDA:UniProtKB.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; IDA:HPA.
DR   GO; GO:0016020; C:membrane; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0030544; F:Hsp70 protein binding; IEA:Ensembl.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0051787; F:misfolded protein binding; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0031593; F:polyubiquitin modification-dependent protein binding; ISS:UniProtKB.
DR   GO; GO:0070628; F:proteasome binding; ISS:UniProtKB.
DR   GO; GO:0043022; F:ribosome binding; IDA:UniProtKB.
DR   GO; GO:0005102; F:signaling receptor binding; IPI:UniProtKB.
DR   GO; GO:0031625; F:ubiquitin protein ligase binding; IPI:UniProtKB.
DR   GO; GO:1990381; F:ubiquitin-specific protease binding; IPI:ParkinsonsUK-UCL.
DR   GO; GO:0006915; P:apoptotic process; IDA:UniProtKB.
DR   GO; GO:0007420; P:brain development; ISS:UniProtKB.
DR   GO; GO:0030154; P:cell differentiation; IEA:UniProtKB-KW.
DR   GO; GO:0006325; P:chromatin organization; IEA:UniProtKB-KW.
DR   GO; GO:0009790; P:embryo development; ISS:UniProtKB.
DR   GO; GO:0061857; P:endoplasmic reticulum stress-induced pre-emptive quality control; IMP:UniProtKB.
DR   GO; GO:0071712; P:ER-associated misfolded protein catabolic process; IDA:UniProtKB.
DR   GO; GO:0002429; P:immune response-activating cell surface receptor signaling pathway; IDA:UniProtKB.
DR   GO; GO:0018393; P:internal peptidyl-lysine acetylation; IDA:UniProtKB.
DR   GO; GO:0042771; P:intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; IMP:UniProtKB.
DR   GO; GO:0070059; P:intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress; ISS:UniProtKB.
DR   GO; GO:0001822; P:kidney development; ISS:UniProtKB.
DR   GO; GO:0030324; P:lung development; ISS:UniProtKB.
DR   GO; GO:1904378; P:maintenance of unfolded protein involved in ERAD pathway; IMP:ParkinsonsUK-UCL.
DR   GO; GO:0030101; P:natural killer cell activation; IDA:UniProtKB.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; IEA:Ensembl.
DR   GO; GO:0032435; P:negative regulation of proteasomal ubiquitin-dependent protein catabolic process; ISS:UniProtKB.
DR   GO; GO:0045861; P:negative regulation of proteolysis; ISS:UniProtKB.
DR   GO; GO:1904294; P:positive regulation of ERAD pathway; IMP:ParkinsonsUK-UCL.
DR   GO; GO:0010498; P:proteasomal protein catabolic process; IMP:UniProtKB.
DR   GO; GO:1904379; P:protein localization to cytosolic proteasome complex involved in ERAD pathway; NAS:ParkinsonsUK-UCL.
DR   GO; GO:0050821; P:protein stabilization; ISS:UniProtKB.
DR   GO; GO:0042127; P:regulation of cell proliferation; IEA:Ensembl.
DR   GO; GO:0007283; P:spermatogenesis; ISS:UniProtKB.
DR   GO; GO:0007130; P:synaptonemal complex assembly; ISS:UniProtKB.
DR   GO; GO:0071816; P:tail-anchored membrane protein insertion into ER membrane; IDA:UniProtKB.
DR   GO; GO:0030433; P:ubiquitin-dependent ERAD pathway; IDA:UniProtKB.
DR   GO; GO:0006511; P:ubiquitin-dependent protein catabolic process; ISS:UniProtKB.
DR   InterPro; IPR021925; BAG6.
DR   InterPro; IPR029071; Ubiquitin-like_domsf.
DR   InterPro; IPR019954; Ubiquitin_CS.
DR   InterPro; IPR000626; Ubiquitin_dom.
DR   Pfam; PF12057; DUF3538; 1.
DR   Pfam; PF00240; ubiquitin; 1.
DR   SMART; SM00213; UBQ; 1.
DR   SUPFAM; SSF54236; SSF54236; 1.
DR   PROSITE; PS00299; UBIQUITIN_1; 1.
DR   PROSITE; PS50053; UBIQUITIN_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Apoptosis; Chaperone;
KW   Chromatin regulator; Complete proteome; Cytoplasm; Differentiation;
KW   Immunity; Nucleus; Phosphoprotein; Polymorphism; Reference proteome;
KW   Repeat; Secreted; Spermatogenesis; Transport; Ubl conjugation.
FT   CHAIN         1   1132       Large proline-rich protein BAG6.
FT                                /FTId=PRO_0000114897.
FT   DOMAIN       17     92       Ubiquitin-like. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00214}.
FT   REPEAT      242    270       1. {ECO:0000303|PubMed:2156268}.
FT   REPEAT      415    443       2. {ECO:0000303|PubMed:2156268}.
FT   REPEAT      574    602       3. {ECO:0000303|PubMed:2156268}.
FT   REPEAT      608    636       4. {ECO:0000303|PubMed:2156268}.
FT   REGION      242    636       4 X 29 AA approximate repeats.
FT                                {ECO:0000303|PubMed:2156268}.
FT   REGION     1022   1132       Mediates interaction with UBL4A and GET4
FT                                and is sufficient for the delivery of
FT                                client proteins to the endoplasmic
FT                                reticulum. {ECO:0000269|PubMed:28104892}.
FT   COMPBIAS    195    273       Pro-rich. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00015}.
FT   COMPBIAS    394    681       Pro-rich. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00015}.
FT   SITE       1001   1002       Cleavage; by CASP3.
FT                                {ECO:0000269|PubMed:14960581}.
FT   MOD_RES       1      1       N-acetylmethionine.
FT                                {ECO:0000244|PubMed:19413330}.
FT   MOD_RES      96     96       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     113    113       Phosphoserine.
FT                                {ECO:0000244|PubMed:17924679,
FT                                ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     117    117       Phosphothreonine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     350    350       Phosphothreonine.
FT                                {ECO:0000244|PubMed:20068231}.
FT   MOD_RES     964    964       Phosphoserine.
FT                                {ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     973    973       Phosphoserine.
FT                                {ECO:0000244|PubMed:18088087,
FT                                ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES    1053   1053       Phosphothreonine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES    1081   1081       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES    1117   1117       Phosphoserine.
FT                                {ECO:0000244|PubMed:16964243,
FT                                ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163}.
FT   VAR_SEQ     185    190       Missing (in isoform 2, isoform 3, isoform
FT                                4 and isoform 5).
FT                                {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:17974005}.
FT                                /FTId=VSP_015695.
FT   VAR_SEQ     489    489       G -> GSTLIQLPSLPPEFMHAVAHQITHQAMVAAVASAAA
FT                                G (in isoform 3). {ECO:0000305}.
FT                                /FTId=VSP_030519.
FT   VAR_SEQ     527    527       Missing (in isoform 4).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_045910.
FT   VAR_SEQ     561    685       Missing (in isoform 4).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_045911.
FT   VAR_SEQ     969   1016       Missing (in isoform 4).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_045912.
FT   VAR_SEQ    1053   1101       Missing (in isoform 4 and isoform 5).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_045913.
FT   VARIANT     625    625       S -> P (in dbSNP:rs1052486).
FT                                {ECO:0000269|PubMed:14574404,
FT                                ECO:0000269|PubMed:14702039,
FT                                ECO:0000269|PubMed:2156268,
FT                                ECO:0000269|Ref.5, ECO:0000269|Ref.7}.
FT                                /FTId=VAR_023531.
FT   VARIANT     728    728       A -> V (in dbSNP:rs11548856).
FT                                /FTId=VAR_037150.
FT   MUTAGEN    1001   1001       D->A: Abolishes cleavage by the caspase
FT                                CASP3. {ECO:0000269|PubMed:14960581}.
FT   CONFLICT     43     43       K -> R (in Ref. 3; BAG65616).
FT                                {ECO:0000305}.
FT   CONFLICT     47     47       A -> R (in Ref. 1; AAA35587).
FT                                {ECO:0000305}.
FT   CONFLICT    150    150       H -> D (in Ref. 3; BAG65616).
FT                                {ECO:0000305}.
FT   CONFLICT    511    511       Q -> R (in Ref. 3; BAG65616).
FT                                {ECO:0000305}.
FT   CONFLICT    561    561       G -> D (in Ref. 3; BAG65616).
FT                                {ECO:0000305}.
FT   CONFLICT    617    617       P -> L (in Ref. 3; BAG65616).
FT                                {ECO:0000305}.
FT   CONFLICT    679    679       G -> R (in Ref. 3; BAG65616).
FT                                {ECO:0000305}.
FT   CONFLICT    839    839       L -> R (in Ref. 3; BAG63924).
FT                                {ECO:0000305}.
FT   CONFLICT    842    842       L -> P (in Ref. 3; BAG63924).
FT                                {ECO:0000305}.
FT   CONFLICT    853    853       V -> M (in Ref. 2; CAI46045).
FT                                {ECO:0000305}.
FT   CONFLICT    854    854       L -> Q (in Ref. 3; BAG65616).
FT                                {ECO:0000305}.
FT   CONFLICT    927    927       E -> D (in Ref. 3; BAG65616).
FT                                {ECO:0000305}.
FT   STRAND       16     23       {ECO:0000244|PDB:4EEW}.
FT   STRAND       28     34       {ECO:0000244|PDB:4EEW}.
FT   STRAND       35     37       {ECO:0000244|PDB:2N9P}.
FT   HELIX        39     50       {ECO:0000244|PDB:4EEW}.
FT   HELIX        54     56       {ECO:0000244|PDB:4EEW}.
FT   STRAND       57     61       {ECO:0000244|PDB:4EEW}.
FT   STRAND       64     66       {ECO:0000244|PDB:2N9P}.
FT   STRAND       68     71       {ECO:0000244|PDB:1WX9}.
FT   HELIX        72     75       {ECO:0000244|PDB:4EEW}.
FT   STRAND       80     86       {ECO:0000244|PDB:4EEW}.
FT   TURN         91     93       {ECO:0000244|PDB:2N9P}.
FT   HELIX      1009   1013       {ECO:0000244|PDB:6AU8}.
FT   HELIX      1016   1018       {ECO:0000244|PDB:6AU8}.
FT   HELIX      1019   1028       {ECO:0000244|PDB:6AU8}.
FT   HELIX      1040   1043       {ECO:0000244|PDB:6AU8}.
FT   HELIX      1063   1074       {ECO:0000244|PDB:4X86}.
FT   HELIX      1082   1089       {ECO:0000244|PDB:4X86}.
FT   HELIX      1092   1110       {ECO:0000244|PDB:4X86}.
SQ   SEQUENCE   1132 AA;  119409 MW;  625B5F86321367ED CRC64;
     MEPNDSTSTA VEEPDSLEVL VKTLDSQTRT FIVGAQMNVK EFKEHIAASV SIPSEKQRLI
     YQGRVLQDDK KLQEYNVGGK VIHLVERAPP QTHLPSGASS GTGSASATHG GGSPPGTRGP
     GASVHDRNAN SYVMVGTFNL PSDGSAVDVH INMEQAPIQS EPRVRLVMAQ HMIRDIQTLL
     SRMETLPYLQ CRGGPQPQHS QPPPQPPAVT PEPVALSSQT SEPVESEAPP REPMEAEEVE
     ERAPAQNPEL TPGPAPAGPT PAPETNAPNH PSPAEYVEVL QELQRLESRL QPFLQRYYEV
     LGAAATTDYN NNHEGREEDQ RLINLVGESL RLLGNTFVAL SDLRCNLACT PPRHLHVVRP
     MSHYTTPMVL QQAAIPIQIN VGTTVTMTGN GTRPPPTPNA EAPPPGPGQA SSVAPSSTNV
     ESSAEGAPPP GPAPPPATSH PRVIRISHQS VEPVVMMHMN IQDSGTQPGG VPSAPTGPLG
     PPGHGQTLGQ QVPGFPTAPT RVVIARPTPP QARPSHPGGP PVSGTLQGAG LGTNASLAQM
     VSGLVGQLLM QPVLVAQGTP GMAPPPAPAT ASASAGTTNT ATTAGPAPGG PAQPPPTPQP
     SMADLQFSQL LGNLLGPAGP GAGGSGVASP TITVAMPGVP AFLQGMTDFL QATQTAPPPP
     PPPPPPPPAP EQQTMPPPGS PSGGAGSPGG LGLESLSPEF FTSVVQGVLS SLLGSLGARA
     GSSESIAAFI QRLSGSSNIF EPGADGALGF FGALLSLLCQ NFSMVDVVML LHGHFQPLQR
     LQPQLRSFFH QHYLGGQEPT PSNIRMATHT LITGLEEYVR ESFSLVQVQP GVDIIRTNLE
     FLQEQFNSIA AHVLHCTDSG FGARLLELCN QGLFECLALN LHCLGGQQME LAAVINGRIR
     RMSRGVNPSL VSWLTTMMGL RLQVVLEHMP VGPDAILRYV RRVGDPPQPL PEEPMEVQGA
     ERASPEPQRE NASPAPGTTA EEAMSRGPPP APEGGSRDEQ DGASAETEPW AAAVPPEWVP
     IIQQDIQSQR KVKPQPPLSD AYLSGMPAKR RKTMQGEGPQ LLLSEAVSRA AKAAGARPLT
     SPESLSRDLE APEVQESYRQ QLRSDIQKRL QEDPNYSPQR FPNAQRAFAD DP
//
ID   A0A024QZC1_HUMAN        Unreviewed;       341 AA.
AC   A0A024QZC1;
DT   09-JUL-2014, integrated into UniProtKB/TrEMBL.
DT   09-JUL-2014, sequence version 1.
DT   23-MAY-2018, entry version 35.
DE   SubName: Full=CD2 antigen (Cytoplasmic tail) binding protein 2, isoform CRA_a {ECO:0000313|EMBL:EAW52261.1};
DE   SubName: Full=CD2 binding protein 2 isoform 1 {ECO:0000313|EMBL:ALQ33976.1};
GN   Name=CD2BP2 {ECO:0000313|EMBL:EAW52261.1};
GN   ORFNames=hCG_96444 {ECO:0000313|EMBL:EAW52261.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:EAW52261.1};
RN   [1] {ECO:0000313|EMBL:EAW52261.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAW52261.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3] {ECO:0000313|EMBL:ALQ33976.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=26871637; DOI=10.1016/j.cell.2016.01.029;
RA   Yang X., Coulombe-Huntington J., Kang S., Sheynkman G.M., Hao T.,
RA   Richardson A., Sun S., Yang F., Shen Y.A., Murray R., Spirohn K.,
RA   Begg B.E., Duran-Frigola M., MacWilliams A., Pevzner S.J., Zhong Q.,
RA   Trigg S.A., Tam S., Ghamsari L., Sahni N., Yi S., Rodriguez M.D.,
RA   Balcha D., Tan G., Costanzo M., Andrews B., Boone C., Zhou X.J.,
RA   Salehi-Ashtiani K., Charloteaux B., Chen A., Calderwood M.A., Aloy P.,
RA   Roth F.P., Hill D.E., Iakoucheva L.M., Xia Y., Vidal M.;
RT   "Widespread Expansion of Protein Interaction Capabilities by
RT   Alternative Splicing.";
RL   Cell 164:805-817(2016).
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; KU178518; ALQ33976.1; -; mRNA.
DR   EMBL; CH471192; EAW52261.1; -; Genomic_DNA.
DR   RefSeq; NP_001230575.1; NM_001243646.1.
DR   RefSeq; NP_006101.1; NM_006110.2.
DR   UniGene; Hs.202677; -.
DR   SMR; A0A024QZC1; -.
DR   PRIDE; A0A024QZC1; -.
DR   GeneID; 10421; -.
DR   KEGG; hsa:10421; -.
DR   CTD; 10421; -.
DR   EuPathDB; HostDB:ENSG00000169217.8; -.
DR   eggNOG; KOG2950; Eukaryota.
DR   eggNOG; ENOG4111KF5; LUCA.
DR   KO; K13099; -.
DR   OMA; TGNMDIY; -.
DR   OrthoDB; EOG091G0MVR; -.
DR   ChiTaRS; CD2BP2; human.
DR   GenomeRNAi; 10421; -.
DR   Bgee; ENSG00000169217; -.
DR   ExpressionAtlas; A0A024QZC1; baseline and differential.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0001650; C:fibrillar center; IDA:HPA.
DR   GO; GO:0016607; C:nuclear speck; IDA:HPA.
DR   CDD; cd00072; GYF; 1.
DR   Gene3D; 3.30.1490.40; -; 1.
DR   InterPro; IPR003169; GYF.
DR   InterPro; IPR035445; GYF-like_dom_sf.
DR   Pfam; PF02213; GYF; 1.
DR   SMART; SM00444; GYF; 1.
DR   SUPFAM; SSF55277; SSF55277; 1.
DR   PROSITE; PS50829; GYF; 1.
PE   2: Evidence at transcript level;
FT   DOMAIN      280    338       GYF. {ECO:0000259|PROSITE:PS50829}.
FT   NON_TER     341    341       {ECO:0000313|EMBL:ALQ33976.1}.
SQ   SEQUENCE   341 AA;  37646 MW;  8E9A7EE0C40474D5 CRC64;
     MPKRKVTFQG VGDEEDEDEI IVPKKKLVDP VAGSGGPGSR FKGKHSLDSD EEEDDDDGGS
     SKYDILASED VEGQEAATLP SEGGVRITPF NLQEEMEEGH FDADGNYFLN RDAQIRDSWL
     DNIDWVKIRE RPPGQRQASD SEEEDSLGQT SMSAQALLEG LLELLLPRET VAGALRRLGA
     RGGGKGRKGP GQPSSPQRLD RLSGLADQMV ARGNLGVYQE TRERLAMRLK GLGCQTLGPH
     NPTPPPSLDM FAEELAEEEL ETPTPTQRGE AESRGDGLVD VMWEYKWENT GDAELYGPFT
     SAQMQTWVSE GYFPDGVYCR KLDPPGGQFY NSKRIDFDLY T
//
ID   CD2B2_HUMAN             Reviewed;         341 AA.
AC   O95400; B2RDX2; Q9ULP2;
DT   30-MAY-2003, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-1999, sequence version 1.
DT   23-MAY-2018, entry version 158.
DE   RecName: Full=CD2 antigen cytoplasmic tail-binding protein 2;
DE            Short=CD2 cytoplasmic domain-binding protein 2;
DE            Short=CD2 tail-binding protein 2;
DE   AltName: Full=U5 snRNP 52K protein;
DE            Short=U5-52K;
GN   Name=CD2BP2; Synonyms=KIAA1178;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND INTERACTION WITH CD2.
RX   PubMed=9843987; DOI=10.1073/pnas.95.25.14897;
RA   Nishizawa K., Freund C., Li J., Wagner G., Reinherz E.L.;
RT   "Identification of a proline-binding motif regulating CD2-triggered T
RT   lymphocyte activation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 95:14897-14902(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 218-341.
RC   TISSUE=Brain;
RX   PubMed=10574461; DOI=10.1093/dnares/6.5.329;
RA   Hirosawa M., Nagase T., Ishikawa K., Kikuno R., Nomura N., Ohara O.;
RT   "Characterization of cDNA clones selected by the GeneMark analysis
RT   from size-fractionated cDNA libraries from human brain.";
RL   DNA Res. 6:329-336(1999).
RN   [6]
RP   FUNCTION, SUBUNIT, INTERACTION WITH PRPF6 AND TXNL4A, AND SUBCELLULAR
RP   LOCATION.
RX   PubMed=15840814; DOI=10.1261/rna.2300805;
RA   Laggerbauer B., Liu S., Makarov E., Vornlocher H.P., Makarova O.,
RA   Ingelfinger D., Achsel T., Luhrmann R.;
RT   "The human U5 snRNP 52K protein (CD2BP2) interacts with U5-102K
RT   (hPrp6), a U4/U6.U5 tri-snRNP bridging protein, but dissociates upon
RT   tri-snRNP formation.";
RL   RNA 11:598-608(2005).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-49, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [8]
RP   SUBUNIT.
RX   PubMed=16723661; DOI=10.1261/rna.55406;
RA   Liu S., Rauhut R., Vornlocher H.-P., Luehrmann R.;
RT   "The network of protein-protein interactions within the human U4/U6.U5
RT   tri-snRNP.";
RL   RNA 12:1418-1430(2006).
RN   [9]
RP   SUBCELLULAR LOCATION.
RX   PubMed=17906334; DOI=10.1093/intimm/dxm100;
RA   Heinze M., Kofler M., Freund C.;
RT   "Investigating the functional role of CD2BP2 in T cells.";
RL   Int. Immunol. 19:1313-1318(2007).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-49, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Embryonic kidney;
RX   PubMed=17693683; DOI=10.1074/mcp.M700120-MCP200;
RA   Tang L.-Y., Deng N., Wang L.-S., Dai J., Wang Z.-L., Jiang X.-S.,
RA   Li S.-J., Li L., Sheng Q.-H., Wu D.-Q., Li L., Zeng R.;
RT   "Quantitative phosphoproteome profiling of Wnt3a-mediated signaling
RT   network: indicating the involvement of ribonucleoside-diphosphate
RT   reductase M2 subunit phosphorylation at residue serine 20 in canonical
RT   Wnt signal transduction.";
RL   Mol. Cell. Proteomics 6:1952-1967(2007).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-49, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=T-cell;
RX   PubMed=19367720; DOI=10.1021/pr800500r;
RA   Carrascal M., Ovelleiro D., Casas V., Gay M., Abian J.;
RT   "Phosphorylation analysis of primary human T lymphocytes using
RT   sequential IMAC and titanium oxide enrichment.";
RL   J. Proteome Res. 7:5167-5176(2008).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-49, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=18318008; DOI=10.1002/pmic.200700884;
RA   Han G., Ye M., Zhou H., Jiang X., Feng S., Jiang X., Tian R., Wan D.,
RA   Zou H., Gu J.;
RT   "Large-scale phosphoproteome analysis of human liver tissue by
RT   enrichment and fractionation of phosphopeptides with strong anion
RT   exchange chromatography.";
RL   Proteomics 8:1346-1361(2008).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-49; SER-118; SER-194 AND
RP   SER-195, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [15]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-49, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-49 AND SER-195, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-46 AND SER-49, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [19]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-26, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-
RT   modification with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
RN   [20]
RP   STRUCTURE BY NMR OF 280-341.
RX   PubMed=10404223; DOI=10.1038/10712;
RA   Freund C., Dotsch V., Nishizawa K., Reinherz E.L., Wagner G.;
RT   "The GYF domain is a novel structural fold that is involved in
RT   lymphoid signaling through proline-rich sequences.";
RL   Nat. Struct. Biol. 6:656-660(1999).
RN   [21]
RP   STRUCTURE BY NMR OF 280-341, INTERACTION WITH CD2 PEPTIDE, AND
RP   SUBCELLULAR LOCATION.
RX   PubMed=12426371; DOI=10.1093/emboj/cdf602;
RA   Freund C., Kuhne R., Yang H., Park S., Reinherz E.L., Wagner G.;
RT   "Dynamic interaction of CD2 with the GYF and the SH3 domain of
RT   compartmentalized effector molecules.";
RL   EMBO J. 21:5985-5995(2002).
RN   [22]
RP   X-RAY CRYSTALLOGRAPHY (2.35 ANGSTROMS) OF 256-341 IN COMPLEX WITH
RP   TXNL4A, AND INTERACTION WITH TXNL4A.
RX   PubMed=17467737; DOI=10.1016/j.jmb.2007.03.077;
RA   Nielsen T.K., Liu S., Luhrmann R., Ficner R.;
RT   "Structural basis for the bifunctionality of the U5 snRNP 52K protein
RT   (CD2BP2).";
RL   J. Mol. Biol. 369:902-908(2007).
RN   [23]
RP   X-RAY CRYSTALLOGRAPHY (2.50 ANGSTROMS) OF 280-341 IN COMPLEX WITH
RP   PQBP1 AND TXNL4A, AND SUBUNIT.
RX   PubMed=24781215; DOI=10.1038/ncomms4822;
RA   Mizuguchi M., Obita T., Serita T., Kojima R., Nabeshima Y.,
RA   Okazawa H.;
RT   "Mutations in the PQBP1 gene prevent its interaction with the
RT   spliceosomal protein U5-15 kD.";
RL   Nat. Commun. 5:3822-3822(2014).
CC   -!- FUNCTION: Involved in pre-mRNA splicing as component of the U5
CC       snRNP complex that is involved in spliceosome assembly.
CC       {ECO:0000269|PubMed:15840814}.
CC   -!- SUBUNIT: Component of the U5 snRNP complex composed of the U5
CC       snRNA and at least PRPF6, PRPF8, SNRNP200, EFTUD2, SNRNP40, DDX23,
CC       TXNL4A and CD2BP2. Interacts directly with TXNL4A and PRPF6.
CC       Interacts (via GYF domain) with CD2 (via Pro-rich sequence in the
CC       cytoplasmic domain). Interacts with PQBP1.
CC       {ECO:0000269|PubMed:12426371, ECO:0000269|PubMed:15840814,
CC       ECO:0000269|PubMed:16723661, ECO:0000269|PubMed:17467737,
CC       ECO:0000269|PubMed:24781215, ECO:0000269|PubMed:9843987}.
CC   -!- INTERACTION:
CC       P06729:CD2; NbExp=3; IntAct=EBI-768015, EBI-3912464;
CC       P62136:PPP1CA; NbExp=2; IntAct=EBI-768015, EBI-357253;
CC       P36873:PPP1CC; NbExp=3; IntAct=EBI-768015, EBI-356283;
CC       O94906:PRPF6; NbExp=5; IntAct=EBI-768015, EBI-536755;
CC       P14678-2:SNRPB; NbExp=5; IntAct=EBI-768015, EBI-372475;
CC       P83876:TXNL4A; NbExp=2; IntAct=EBI-768015, EBI-746539;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm. Nucleus. Note=Predominantly
CC       nuclear.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF104222; AAC84141.1; -; mRNA.
DR   EMBL; AK315708; BAG38069.1; -; mRNA.
DR   EMBL; CH471192; EAW52260.1; -; Genomic_DNA.
DR   EMBL; BC000495; AAH00495.1; -; mRNA.
DR   EMBL; BC001947; AAH01947.1; -; mRNA.
DR   EMBL; AB033004; BAA86492.1; -; mRNA.
DR   CCDS; CCDS10675.1; -.
DR   RefSeq; NP_001230575.1; NM_001243646.1.
DR   RefSeq; NP_006101.1; NM_006110.2.
DR   UniGene; Hs.202677; -.
DR   PDB; 1GYF; NMR; -; A=280-341.
DR   PDB; 1L2Z; NMR; -; A=280-341.
DR   PDB; 1SYX; X-ray; 2.34 A; B/D/F=262-341.
DR   PDB; 4BWS; X-ray; 2.50 A; C/F=280-341.
DR   PDBsum; 1GYF; -.
DR   PDBsum; 1L2Z; -.
DR   PDBsum; 1SYX; -.
DR   PDBsum; 4BWS; -.
DR   ProteinModelPortal; O95400; -.
DR   SMR; O95400; -.
DR   BioGrid; 115690; 143.
DR   CORUM; O95400; -.
DR   ELM; O95400; -.
DR   IntAct; O95400; 26.
DR   MINT; O95400; -.
DR   STRING; 9606.ENSP00000304903; -.
DR   iPTMnet; O95400; -.
DR   PhosphoSitePlus; O95400; -.
DR   BioMuta; CD2BP2; -.
DR   EPD; O95400; -.
DR   MaxQB; O95400; -.
DR   PaxDb; O95400; -.
DR   PeptideAtlas; O95400; -.
DR   PRIDE; O95400; -.
DR   DNASU; 10421; -.
DR   Ensembl; ENST00000305596; ENSP00000304903; ENSG00000169217.
DR   Ensembl; ENST00000569466; ENSP00000456935; ENSG00000169217.
DR   GeneID; 10421; -.
DR   KEGG; hsa:10421; -.
DR   UCSC; uc002dxr.4; human.
DR   CTD; 10421; -.
DR   DisGeNET; 10421; -.
DR   EuPathDB; HostDB:ENSG00000169217.8; -.
DR   GeneCards; CD2BP2; -.
DR   HGNC; HGNC:1656; CD2BP2.
DR   HPA; HPA041508; -.
DR   HPA; HPA061309; -.
DR   MIM; 604470; gene.
DR   neXtProt; NX_O95400; -.
DR   OpenTargets; ENSG00000169217; -.
DR   PharmGKB; PA26209; -.
DR   eggNOG; KOG2950; Eukaryota.
DR   eggNOG; ENOG4111KF5; LUCA.
DR   GeneTree; ENSGT00390000012483; -.
DR   HOGENOM; HOG000007061; -.
DR   HOVERGEN; HBG056920; -.
DR   InParanoid; O95400; -.
DR   KO; K13099; -.
DR   OMA; TGNMDIY; -.
DR   OrthoDB; EOG091G0MVR; -.
DR   PhylomeDB; O95400; -.
DR   TreeFam; TF313042; -.
DR   Reactome; R-HSA-72163; mRNA Splicing - Major Pathway.
DR   ChiTaRS; CD2BP2; human.
DR   EvolutionaryTrace; O95400; -.
DR   GeneWiki; CD2BP2; -.
DR   GenomeRNAi; 10421; -.
DR   PRO; PR:O95400; -.
DR   Proteomes; UP000005640; Chromosome 16.
DR   Bgee; ENSG00000169217; -.
DR   CleanEx; HS_CD2BP2; -.
DR   ExpressionAtlas; O95400; baseline and differential.
DR   Genevisible; O95400; HS.
DR   GO; GO:0005737; C:cytoplasm; TAS:ProtInc.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0001650; C:fibrillar center; IDA:HPA.
DR   GO; GO:0016607; C:nuclear speck; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:BHF-UCL.
DR   GO; GO:0005634; C:nucleus; IDA:BHF-UCL.
DR   GO; GO:0005682; C:U5 snRNP; IDA:BHF-UCL.
DR   GO; GO:0043021; F:ribonucleoprotein complex binding; IDA:BHF-UCL.
DR   GO; GO:0000398; P:mRNA splicing, via spliceosome; TAS:Reactome.
DR   GO; GO:0010923; P:negative regulation of phosphatase activity; IDA:UniProtKB.
DR   GO; GO:0000244; P:spliceosomal tri-snRNP complex assembly; NAS:BHF-UCL.
DR   CDD; cd00072; GYF; 1.
DR   Gene3D; 3.30.1490.40; -; 1.
DR   InterPro; IPR003169; GYF.
DR   InterPro; IPR035445; GYF-like_dom_sf.
DR   Pfam; PF02213; GYF; 1.
DR   SMART; SM00444; GYF; 1.
DR   SUPFAM; SSF55277; SSF55277; 1.
DR   PROSITE; PS50829; GYF; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Complete proteome; Cytoplasm;
KW   Isopeptide bond; mRNA processing; mRNA splicing; Nucleus;
KW   Phosphoprotein; Polymorphism; Reference proteome; Ubl conjugation.
FT   CHAIN         1    341       CD2 antigen cytoplasmic tail-binding
FT                                protein 2.
FT                                /FTId=PRO_0000089437.
FT   DOMAIN      280    338       GYF. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00101}.
FT   MOD_RES      44     44       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:Q9CWK3}.
FT   MOD_RES      46     46       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES      49     49       Phosphoserine.
FT                                {ECO:0000244|PubMed:17081983,
FT                                ECO:0000244|PubMed:17693683,
FT                                ECO:0000244|PubMed:18318008,
FT                                ECO:0000244|PubMed:19367720,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     118    118       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231}.
FT   MOD_RES     194    194       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231}.
FT   MOD_RES     195    195       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163}.
FT   CROSSLNK     26     26       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   VARIANT     231    231       G -> D (in dbSNP:rs13330462).
FT                                /FTId=VAR_050772.
FT   VARIANT     262    262       T -> I (in dbSNP:rs34391305).
FT                                /FTId=VAR_050773.
FT   STRAND      282    293       {ECO:0000244|PDB:1SYX}.
FT   STRAND      296    300       {ECO:0000244|PDB:1SYX}.
FT   HELIX       301    309       {ECO:0000244|PDB:1SYX}.
FT   STRAND      318    324       {ECO:0000244|PDB:1SYX}.
FT   HELIX       332    334       {ECO:0000244|PDB:1SYX}.
FT   HELIX       337    340       {ECO:0000244|PDB:1SYX}.
SQ   SEQUENCE   341 AA;  37646 MW;  8E9A7EE0C40474D5 CRC64;
     MPKRKVTFQG VGDEEDEDEI IVPKKKLVDP VAGSGGPGSR FKGKHSLDSD EEEDDDDGGS
     SKYDILASED VEGQEAATLP SEGGVRITPF NLQEEMEEGH FDADGNYFLN RDAQIRDSWL
     DNIDWVKIRE RPPGQRQASD SEEEDSLGQT SMSAQALLEG LLELLLPRET VAGALRRLGA
     RGGGKGRKGP GQPSSPQRLD RLSGLADQMV ARGNLGVYQE TRERLAMRLK GLGCQTLGPH
     NPTPPPSLDM FAEELAEEEL ETPTPTQRGE AESRGDGLVD VMWEYKWENT GDAELYGPFT
     SAQMQTWVSE GYFPDGVYCR KLDPPGGQFY NSKRIDFDLY T
//
ID   A0A024R0A8_HUMAN        Unreviewed;       530 AA.
AC   A0A024R0A8;
DT   09-JUL-2014, integrated into UniProtKB/TrEMBL.
DT   09-JUL-2014, sequence version 1.
DT   23-MAY-2018, entry version 41.
DE   RecName: Full=Adenosylhomocysteinase {ECO:0000256|RuleBase:RU000548};
DE            EC=3.3.1.1 {ECO:0000256|RuleBase:RU000548};
GN   Name=AHCYL1 {ECO:0000313|EMBL:EAW56427.1};
GN   ORFNames=hCG_38162 {ECO:0000313|EMBL:EAW56427.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:EAW56427.1};
RN   [1] {ECO:0000313|EMBL:EAW56427.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAW56427.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
CC   -!- CATALYTIC ACTIVITY: S-adenosyl-L-homocysteine + H(2)O = L-
CC       homocysteine + adenosine. {ECO:0000256|RuleBase:RU000548}.
CC   -!- COFACTOR:
CC       Name=NAD(+); Xref=ChEBI:CHEBI:57540;
CC         Evidence={ECO:0000256|RuleBase:RU000548};
CC       Note=Binds 1 NAD(+) per subunit. {ECO:0000256|RuleBase:RU000548};
CC   -!- PATHWAY: Amino-acid biosynthesis; L-homocysteine biosynthesis; L-
CC       homocysteine from S-adenosyl-L-homocysteine: step 1/1.
CC       {ECO:0000256|RuleBase:RU000548}.
CC   -!- SIMILARITY: Belongs to the adenosylhomocysteinase family.
CC       {ECO:0000256|RuleBase:RU004166}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; CH471122; EAW56425.1; -; Genomic_DNA.
DR   EMBL; CH471122; EAW56427.1; -; Genomic_DNA.
DR   RefSeq; NP_006612.2; NM_006621.5.
DR   UniGene; Hs.743973; -.
DR   SMR; A0A024R0A8; -.
DR   PRIDE; A0A024R0A8; -.
DR   GeneID; 10768; -.
DR   KEGG; hsa:10768; -.
DR   CTD; 10768; -.
DR   EuPathDB; HostDB:ENSG00000168710.17; -.
DR   eggNOG; KOG1370; Eukaryota.
DR   eggNOG; COG0499; LUCA.
DR   KO; K01251; -.
DR   OMA; HKPVKKQ; -.
DR   OrthoDB; EOG091G06EB; -.
DR   UniPathway; UPA00314; UER00076.
DR   ChiTaRS; AHCYL1; human.
DR   GenomeRNAi; 10768; -.
DR   Bgee; ENSG00000168710; -.
DR   ExpressionAtlas; A0A024R0A8; baseline and differential.
DR   GO; GO:0016324; C:apical plasma membrane; IEA:Ensembl.
DR   GO; GO:0005829; C:cytosol; IEA:Ensembl.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; IEA:Ensembl.
DR   GO; GO:0004013; F:adenosylhomocysteinase activity; IEA:UniProtKB-EC.
DR   GO; GO:0042045; P:epithelial fluid transport; IEA:Ensembl.
DR   GO; GO:0006378; P:mRNA polyadenylation; IEA:Ensembl.
DR   GO; GO:0006730; P:one-carbon metabolic process; IEA:UniProtKB-KW.
DR   GO; GO:0010765; P:positive regulation of sodium ion transport; IEA:Ensembl.
DR   GO; GO:0006611; P:protein export from nucleus; IEA:Ensembl.
DR   GO; GO:0044070; P:regulation of anion transport; IEA:Ensembl.
DR   GO; GO:0032412; P:regulation of ion transmembrane transporter activity; IEA:Ensembl.
DR   GO; GO:0031440; P:regulation of mRNA 3'-end processing; IEA:Ensembl.
DR   CDD; cd00401; SAHH; 1.
DR   InterPro; IPR000043; Adenosylhomocysteinase-like.
DR   InterPro; IPR015878; Ado_hCys_hydrolase_NAD-bd.
DR   InterPro; IPR036291; NAD(P)-bd_dom_sf.
DR   InterPro; IPR020082; S-Ado-L-homoCys_hydrolase_CS.
DR   PANTHER; PTHR23420; PTHR23420; 1.
DR   Pfam; PF05221; AdoHcyase; 1.
DR   Pfam; PF00670; AdoHcyase_NAD; 1.
DR   PIRSF; PIRSF001109; Ad_hcy_hydrolase; 1.
DR   SMART; SM00996; AdoHcyase; 1.
DR   SMART; SM00997; AdoHcyase_NAD; 1.
DR   SUPFAM; SSF51735; SSF51735; 1.
DR   TIGRFAMs; TIGR00936; ahcY; 1.
DR   PROSITE; PS00738; ADOHCYASE_1; 1.
DR   PROSITE; PS00739; ADOHCYASE_2; 1.
PE   3: Inferred from homology;
KW   Coiled coil {ECO:0000256|SAM:Coils};
KW   Hydrolase {ECO:0000256|RuleBase:RU000548,
KW   ECO:0000313|EMBL:EAW56427.1}; NAD {ECO:0000256|RuleBase:RU000548};
KW   One-carbon metabolism {ECO:0000256|RuleBase:RU000548}.
FT   DOMAIN      289    450       AdoHcyase_NAD.
FT                                {ECO:0000259|SMART:SM00997}.
FT   COILED      120    140       {ECO:0000256|SAM:Coils}.
FT   BINDING     155    155       Substrate.
FT                                {ECO:0000256|PIRSR:PIRSR001109-1}.
FT   BINDING     229    229       Substrate.
FT                                {ECO:0000256|PIRSR:PIRSR001109-1}.
FT   BINDING     254    254       Substrate.
FT                                {ECO:0000256|PIRSR:PIRSR001109-1}.
FT   BINDING     284    284       Substrate.
FT                                {ECO:0000256|PIRSR:PIRSR001109-1}.
FT   BINDING     288    288       Substrate.
FT                                {ECO:0000256|PIRSR:PIRSR001109-1}.
SQ   SEQUENCE   530 AA;  58951 MW;  974D23361A245D04 CRC64;
     MSMPDAMPLP GVGEELKQAK EIEDAEKYSF MATVTKAPKK QIQFADDMQE FTKFPTKTGR
     RSLSRSISQS STDSYSSAAS YTDSSDDEVS PREKQQTNSK GSSNFCVKNI KQAEFGRREI
     EIAEQDMSAL ISLRKRAQGE KPLAGAKIVG CTHITAQTAV LIETLCALGA QCRWSACNIY
     STQNEVAAAL AEAGVAVFAW KGESEDDFWW CIDRCVNMDG WQANMILDDG GDLTHWVYKK
     YPNVFKKIRG IVEESVTGVH RLYQLSKAGK LCVPAMNVND SVTKQKFDNL YCCRESILDG
     LKRTTDVMFG GKQVVVCGYG EVGKGCCAAL KALGAIVYIT EIDPICALQA CMDGFRVVKL
     NEVIRQVDVV ITCTGNKNVV TREHLDRMKN SCIVCNMGHS NTEIDVTSLR TPELTWERVR
     SQVDHVIWPD GKRVVLLAEG RLLNLSCSTV PTFVLSITAT TQALALIELY NAPEGRYKQD
     VYLLPKKMDE YVASLHLPSF DAHLTELTDD QAKYLGLNKN GPFKPNYYRY
//
ID   SAHH2_HUMAN             Reviewed;         530 AA.
AC   O43865; B4E168; Q2TAJ6; Q502W8; Q5VSM0; Q6P171; Q96PK4; Q9UG84;
DT   15-DEC-1998, integrated into UniProtKB/Swiss-Prot.
DT   04-APR-2006, sequence version 2.
DT   23-MAY-2018, entry version 174.
DE   RecName: Full=S-adenosylhomocysteine hydrolase-like protein 1 {ECO:0000312|HGNC:HGNC:344};
DE   AltName: Full=DC-expressed AHCY-like molecule;
DE   AltName: Full=IP(3)Rs binding protein released with IP(3);
DE            Short=IRBIT;
DE   AltName: Full=Putative adenosylhomocysteinase 2;
DE   AltName: Full=S-adenosyl-L-homocysteine hydrolase 2;
DE            Short=AdoHcyase 2;
GN   Name=AHCYL1 {ECO:0000312|HGNC:HGNC:344};
GN   Synonyms=DCAL, IRBIT, XPVKONA {ECO:0000312|HGNC:HGNC:344};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), TISSUE SPECIFICITY, AND
RP   DEVELOPMENTAL STAGE.
RX   PubMed=11904675; DOI=10.1007/s00251-001-0402-z;
RA   Dekker J.W., Budhia S., Angel N.Z., Cooper B.J., Clark G.J.,
RA   Hart D.N., Kato M.;
RT   "Identification of an S-adenosylhomocysteine hydrolase-like transcript
RT   induced during dendritic cell differentiation.";
RL   Immunogenetics 53:993-1001(2002).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Kidney, and Thalamus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Brain;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND NUCLEOTIDE
RP   SEQUENCE [LARGE SCALE MRNA] OF 48-251 (ISOFORM 2).
RC   TISSUE=Brain, Colon, Eye, Placenta, PNS, and Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 16-530 (ISOFORM 1).
RC   TISSUE=Skin;
RA   Volpe J.P.G., McDowell M., Jostes R.F., Afzal V., Sadinski W.,
RA   Trask B.J., Legerski R., Cleaver J.E.;
RT   "Complementation of chromosomal instability in the xeroderma
RT   pigmentosum variant by a gene on human chromosome 1 with homology to
RT   S-adenosyl homocysteine hydrolase.";
RL   Submitted (DEC-1996) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 48-164 (ISOFORM 2).
RC   TISSUE=Chondrocyte;
RX   PubMed=12878157; DOI=10.1016/S0014-4827(03)00130-7;
RA   Imabayashi H., Mori T., Gojo S., Kiyono T., Sugiyama T., Irie R.,
RA   Isogai T., Hata J., Toyama Y., Umezawa A.;
RT   "Redifferentiation of dedifferentiated chondrocytes and chondrogenesis
RT   of human bone marrow stromal cells via chondrosphere formation with
RT   expression profiling by large-scale cDNA analysis.";
RL   Exp. Cell Res. 288:35-50(2003).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 48-105 (ISOFORM 2).
RC   TISSUE=Testis;
RX   PubMed=7782076; DOI=10.1016/0888-7543(95)80096-5;
RA   Pawlak A., Toussaint C., Levy I., Bulle F., Poyard M., Barouki R.,
RA   Guellaen G.;
RT   "Characterization of a large population of mRNAs from human testis.";
RL   Genomics 26:151-158(1995).
RN   [10]
RP   IDENTIFICATION (ISOFORM 2).
RX   PubMed=16754674; DOI=10.1074/jbc.M602520200;
RA   Cooper B.J., Key B., Carter A., Angel N.Z., Hart D.N.J., Kato M.;
RT   "Suppression and overexpression of adenosylhomocysteine hydrolase-like
RT   protein 1 (AHCYL1) influences zebrafish embryo development: a possible
RT   role for AHCYL1 in inositol phospholipid signaling.";
RL   J. Biol. Chem. 281:22471-22484(2006).
RN   [11]
RP   FUNCTION, SUBUNIT, INTERACTION WITH ITPR1, PHOSPHORYLATION AT SER-68
RP   AND SER-71, AND MUTAGENESIS OF SER-64; SER-66; SER-68; SER-70; SER-71;
RP   THR-72; SER-74; SER-76; SER-77; SER-80; THR-82; SER-84; SER-85; SER-90
RP   AND THR-97.
RX   PubMed=16793548; DOI=10.1016/j.molcel.2006.05.017;
RA   Ando H., Mizutani A., Kiefer H., Tsuzurugi D., Michikawa T.,
RA   Mikoshiba K.;
RT   "IRBIT suppresses IP3 receptor activity by competing with IP3 for the
RT   common binding site on the IP3 receptor.";
RL   Mol. Cell 22:795-806(2006).
RN   [12]
RP   FUNCTION, INTERACTION WITH SLC4A4, AND MUTAGENESIS OF THR-52; THR-58;
RP   SER-62; SER-64; SER-66; SER-68; SER-70; SER-71; THR-72; SER-74;
RP   SER-76; SER-77; SER-80; THR-82; SER-84; SER-85; SER-90 AND THR-97.
RX   PubMed=16769890; DOI=10.1073/pnas.0602250103;
RA   Shirakabe K., Priori G., Yamada H., Ando H., Horita S., Fujita T.,
RA   Fujimoto I., Mizutani A., Seki G., Mikoshiba K.;
RT   "IRBIT, an inositol 1,4,5-trisphosphate receptor-binding protein,
RT   specifically binds to and activates pancreas-type Na+/HCO3-
RT   cotransporter 1 (pNBC1).";
RL   Proc. Natl. Acad. Sci. U.S.A. 103:9542-9547(2006).
RN   [13]
RP   FUNCTION, AND INTERACTION WITH SLC9A3.
RX   PubMed=18829453; DOI=10.1074/jbc.M805534200;
RA   He P., Zhang H., Yun C.C.;
RT   "IRBIT, inositol 1,4,5-triphosphate (IP3) receptor-binding protein
RT   released with IP3, binds Na+/H+ exchanger NHE3 and activates NHE3
RT   activity in response to calcium.";
RL   J. Biol. Chem. 283:33544-33553(2008).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-391, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [15]
RP   FUNCTION, INTERACTION WITH FIP1L1 AND PAPOLA, RNA-BINDING, AND
RP   MUTAGENESIS OF SER-62; SER-64; SER-66; SER-68; SER-70; SER-71; THR-72;
RP   SER-74; SER-76; SER-77; SER-80; THR-82; SER-84; SER-85; SER-90 AND
RP   THR-97.
RX   PubMed=19224921; DOI=10.1074/jbc.M807136200;
RA   Kiefer H., Mizutani A., Iemura S., Natsume T., Ando H., Kuroda Y.,
RA   Mikoshiba K.;
RT   "Inositol 1,4,5-triphosphate receptor-binding protein released with
RT   inositol 1,4,5-triphosphate (IRBIT) associates with components of the
RT   mRNA 3' processing machinery in a phosphorylation-dependent manner and
RT   inhibits polyadenylation.";
RL   J. Biol. Chem. 284:10694-10705(2009).
RN   [16]
RP   INTERACTION WITH AHCYL2 AND ITPR1, AND PHOSPHORYLATION AT SER-68;
RP   SER-71; SER-74 AND SER-77.
RX   PubMed=19220705; DOI=10.1111/j.1471-4159.2009.05979.x;
RA   Ando H., Mizutani A., Mikoshiba K.;
RT   "An IRBIT homologue lacks binding activity to inositol 1,4,5-
RT   trisphosphate receptor due to the unique N-terminal appendage.";
RL   J. Neurochem. 109:539-550(2009).
RN   [17]
RP   FUNCTION, INTERACTION WITH SLC9A3, AND MUTAGENESIS OF SER-68; SER-71
RP   AND SER-74.
RX   PubMed=20584908; DOI=10.1074/jbc.M110.133066;
RA   He P., Klein J., Yun C.C.;
RT   "Activation of Na+/H+ exchanger NHE3 by angiotensin II is mediated by
RT   inositol 1,4,5-triphosphate (IP3) receptor-binding protein released
RT   with IP3 (IRBIT) and Ca2+/calmodulin-dependent protein kinase II.";
RL   J. Biol. Chem. 285:27869-27878(2010).
RN   [18]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [19]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2, PHOSPHORYLATION [LARGE
RP   SCALE ANALYSIS] AT SER-2, CLEAVAGE OF INITIATOR METHIONINE [LARGE
RP   SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [20]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1 (ISOFORM 2), AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [21]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-2, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [22]
RP   X-RAY CRYSTALLOGRAPHY (2.64 ANGSTROMS) OF 89-530 OF MUTANT ALA-508 IN
RP   COMPLEX WITH NAD, COFACTOR, FUNCTION, INTERACTION WITH RRM1,
RP   MISCELLANEOUS, PEST REGION, AND PHOSPHORYLATION.
RX   PubMed=25237103; DOI=10.1126/science.1251550;
RA   Arnaoutov A., Dasso M.;
RT   "Enzyme regulation. IRBIT is a novel regulator of ribonucleotide
RT   reductase in higher eukaryotes.";
RL   Science 345:1512-1515(2014).
CC   -!- FUNCTION: Multifaceted cellular regulator which coordinates
CC       several essential cellular functions including regulation of
CC       epithelial HCO3(-) and fluid secretion, mRNA processing and DNA
CC       replication. Regulates ITPR1 sensitivity to inositol 1,4,5-
CC       trisphosphate competing for the common binding site and acting as
CC       endogenous 'pseudoligand' whose inhibitory activity can be
CC       modulated by its phosphorylation status. In the pancreatic and
CC       salivary ducts, at resting state, attenuates inositol 1,4,5-
CC       trisphosphate-induced calcium release by interacting with ITPR1
CC       (PubMed:16793548). When extracellular stimuli induce ITPR1
CC       phosphorylation or inositol 1,4,5-trisphosphate production,
CC       dissociates of ITPR1 to interact with CFTR and SLC26A6 mediating
CC       their synergistic activation by calcium and cAMP that stimulates
CC       the epithelial secretion of electrolytes and fluid (By
CC       similarity). Also activates basolateral SLC4A4 isoform 1 to
CC       coordinate fluid and HCO3(-) secretion (PubMed:16769890). Inhibits
CC       the effect of STK39 on SLC4A4 and CFTR by recruiting PP1
CC       phosphatase which activates SLC4A4, SLC26A6 and CFTR through
CC       dephosphorylation (By similarity). Mediates the induction of
CC       SLC9A3 surface expression produced by Angiotensin-2
CC       (PubMed:20584908). Depending on the cell type, activates SLC9A3 in
CC       response to calcium or reverses SLC9A3R2-dependent calcium
CC       inhibition (PubMed:18829453). May modulate the polyadenylation
CC       state of specific mRNAs, both by controlling the subcellular
CC       location of FIP1L1 and by inhibiting PAPOLA activity, in response
CC       to a stimulus that alters its phosphorylation state
CC       (PubMed:19224921). Acts as a (dATP)-dependent inhibitor of
CC       ribonucleotide reductase large subunit RRM1, controlling the
CC       endogenous dNTP pool and ensuring normal cell cycle progression
CC       (PubMed:25237103). In vitro does not exhibit any S-adenosyl-L-
CC       homocysteine hydrolase activity (By similarity).
CC       {ECO:0000250|UniProtKB:B5DFN2, ECO:0000250|UniProtKB:Q80SW1,
CC       ECO:0000269|PubMed:16769890, ECO:0000269|PubMed:16793548,
CC       ECO:0000269|PubMed:18829453, ECO:0000269|PubMed:19224921,
CC       ECO:0000269|PubMed:20584908, ECO:0000269|PubMed:25237103}.
CC   -!- COFACTOR:
CC       Name=NAD(+); Xref=ChEBI:CHEBI:57540;
CC         Evidence={ECO:0000269|PubMed:25237103};
CC       Note=Binds 1 NAD(+) per subunit. {ECO:0000269|PubMed:25237103};
CC   -!- SUBUNIT: Forms multimers (PubMed:16793548). Forms heteromultimers
CC       with AHCYL2 (via the C-terminal region) (PubMed:19220705).
CC       Interacts (when phosphorylated) with ITPR1 (when not
CC       phosphorylated); the interaction suppresses inositol 1,4,5-
CC       trisphosphate binding to ITPR1 (PubMed:16793548). Interacts with
CC       CFTR and SLC26A6; the interactions take place once AHCYL1 is
CC       released from ITPR1 and increase CFTR and SLC26A6 activities (By
CC       similarity). Interacts with RRM1; in a phosphorylation- and
CC       (dATP)-dependent manner. Interacts (via PEST domain when
CC       phosphorylated) with SLC4A4 isoform 1 but not isoform 2; the
CC       interaction increases SLC4A4 isoform 1 activity (PubMed:16769890).
CC       Interacts (when phosphorylated) with SLC9A3; the interaction is
CC       required for SLC9A3 apical location and activity (PubMed:18829453,
CC       PubMed:20584908). Interacts (when phosphorylated) with FIP1L1; the
CC       interaction is direct and associates AHCYL1 with the CPSF complex
CC       and RNA (PubMed:19224921). Interacts with PAPOLA
CC       (PubMed:19224921). {ECO:0000250|UniProtKB:B5DFN2,
CC       ECO:0000250|UniProtKB:Q80SW1, ECO:0000269|PubMed:16769890,
CC       ECO:0000269|PubMed:16793548, ECO:0000269|PubMed:18829453,
CC       ECO:0000269|PubMed:19220705, ECO:0000269|PubMed:19224921,
CC       ECO:0000269|PubMed:20584908, ECO:0000269|PubMed:25237103}.
CC   -!- INTERACTION:
CC       Self; NbExp=4; IntAct=EBI-2371423, EBI-2371423;
CC       P55957:BID; NbExp=3; IntAct=EBI-2371423, EBI-519672;
CC       P55957-2:BID; NbExp=3; IntAct=EBI-2371423, EBI-10215147;
CC       P42773:CDKN2C; NbExp=8; IntAct=EBI-2371423, EBI-711290;
CC       Q9UI36-2:DACH1; NbExp=9; IntAct=EBI-2371423, EBI-10186082;
CC       P55040:GEM; NbExp=7; IntAct=EBI-2371423, EBI-744104;
CC       P50222:MEOX2; NbExp=3; IntAct=EBI-2371423, EBI-748397;
CC       O60437:PPL; NbExp=3; IntAct=EBI-2371423, EBI-368321;
CC       O00233:PSMD9; NbExp=3; IntAct=EBI-2371423, EBI-750973;
CC       A0A0S2Z4G9:RNF6; NbExp=3; IntAct=EBI-2371423, EBI-16428950;
CC       Q9UHI7:SLC23A1; NbExp=3; IntAct=EBI-2371423, EBI-1759386;
CC       O94993:SOX30; NbExp=3; IntAct=EBI-2371423, EBI-742973;
CC       P04608:tat (xeno); NbExp=5; IntAct=EBI-2371423, EBI-6164389;
CC       P49910:ZNF165; NbExp=4; IntAct=EBI-2371423, EBI-741694;
CC       Q53Z40:ZNF165; NbExp=5; IntAct=EBI-2371423, EBI-10186058;
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum
CC       {ECO:0000250|UniProtKB:Q80SW1}. Cytoplasm, cytosol
CC       {ECO:0000250|UniProtKB:Q80SW1}. Microsome
CC       {ECO:0000250|UniProtKB:Q80SW1}. Apical cell membrane
CC       {ECO:0000250|UniProtKB:B5DFN2}. Note=Associates with membranes
CC       when phosphorylated, probably through interaction with ITPR1.
CC       {ECO:0000250|UniProtKB:Q80SW1}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=O43865-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=O43865-2; Sequence=VSP_021751;
CC         Note=Derived from EST data. Contains a N-acetylmethionine at
CC         position 1. {ECO:0000244|PubMed:22814378};
CC   -!- TISSUE SPECIFICITY: Expressed in dendritic cells.
CC       {ECO:0000269|PubMed:11904675}.
CC   -!- DEVELOPMENTAL STAGE: Expression increases markedly during
CC       activation of blood and skin DC (Langerhans cells), but is
CC       diminished in terminally differentiated tonsil DC.
CC       {ECO:0000269|PubMed:11904675}.
CC   -!- DOMAIN: The PEST region is essential for the interaction with
CC       ITPR1, and, when phosphorylated, is also the RRM1-binding region.
CC       The PDZ-binding region is required for maximal interaction with
CC       ITPR1 and is also responsible for the IP3-insensitive interaction
CC       with ITPR1 (By similarity). {ECO:0000250|UniProtKB:Q80SW1,
CC       ECO:0000269|PubMed:25237103}.
CC   -!- PTM: Phosphorylated at Ser/Thr residues between Ser-68 and Thr-72
CC       in the PEST region: required for interaction with dATP-bound RRM1
CC       and ITPR1. Phosphorylation at Ser-68 by PRKD1 and CAMK4 is
CC       required for further phosphorylations by CSNK1A1
CC       (PubMed:16793548). Phosphorylation is induced by oxidative stress
CC       (PubMed:19224921). Probably phosphorylated by CAMK2A;
CC       phosphorylation at Ser-68 may be required for interaction with
CC       SLC9A3 (PubMed:20584908). {ECO:0000269|PubMed:16793548,
CC       ECO:0000269|PubMed:19224921, ECO:0000269|PubMed:25237103,
CC       ECO:0000305|PubMed:20584908}.
CC   -!- MISCELLANEOUS: Ablation of expression in HeLa cells causes
CC       imbalanced dNTP pools and altered cell cycle progression.
CC       {ECO:0000269|PubMed:25237103}.
CC   -!- SIMILARITY: Belongs to the adenosylhomocysteinase family.
CC       {ECO:0000305}.
CC   -!- CAUTION: In spite of its similarity with AHCY, which catalyzes the
CC       reversible hydrolysis of S-adenosyl-L-homocysteine to adenosine
CC       and homocysteine, recombinant AHCYL1 expressed in bacteria shows
CC       no hydrolysase activity, nor does it affect the enzyme activity of
CC       AHCY. {ECO:0000250|UniProtKB:Q80SW1}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAC01960.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=BI460083; Type=Frameshift; Positions=Several; Evidence={ECO:0000305};
CC       Sequence=CAB43223.2; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF315687; AAL26869.1; -; mRNA.
DR   EMBL; AL036027; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; AK303690; BAG64680.1; -; mRNA.
DR   EMBL; AK316110; BAH14481.1; -; mRNA.
DR   EMBL; AL049954; CAB43223.2; ALT_INIT; mRNA.
DR   EMBL; AL772411; CAH70965.1; -; Genomic_DNA.
DR   EMBL; AL772411; CAH70966.1; -; Genomic_DNA.
DR   EMBL; CH471122; EAW56426.1; -; Genomic_DNA.
DR   EMBL; BC007576; AAH07576.3; -; mRNA.
DR   EMBL; BC010681; AAH10681.3; -; mRNA.
DR   EMBL; BC016942; AAH16942.3; -; mRNA.
DR   EMBL; BC065254; AAH65254.2; -; mRNA.
DR   EMBL; BC095476; AAH95476.2; -; mRNA.
DR   EMBL; BC110896; AAI10897.2; -; mRNA.
DR   EMBL; BI460083; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; U82761; AAC01960.1; ALT_INIT; mRNA.
DR   EMBL; AU279527; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; T19009; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; BK005418; DAA05763.1; -; mRNA.
DR   EMBL; BK005417; DAA05762.1; -; mRNA.
DR   CCDS; CCDS55620.1; -. [O43865-2]
DR   CCDS; CCDS818.1; -. [O43865-1]
DR   PIR; T08681; T08681.
DR   RefSeq; NP_001229602.1; NM_001242673.1. [O43865-2]
DR   RefSeq; NP_001229603.1; NM_001242674.1. [O43865-2]
DR   RefSeq; NP_001229604.1; NM_001242675.1. [O43865-2]
DR   RefSeq; NP_001229605.1; NM_001242676.1. [O43865-2]
DR   RefSeq; NP_006612.2; NM_006621.5. [O43865-1]
DR   UniGene; Hs.743973; -.
DR   PDB; 3MTG; X-ray; 2.64 A; A/B=89-530.
DR   PDBsum; 3MTG; -.
DR   ProteinModelPortal; O43865; -.
DR   SMR; O43865; -.
DR   BioGrid; 115987; 192.
DR   IntAct; O43865; 34.
DR   MINT; O43865; -.
DR   STRING; 9606.ENSP00000358814; -.
DR   BindingDB; O43865; -.
DR   ChEMBL; CHEMBL3751646; -.
DR   iPTMnet; O43865; -.
DR   PhosphoSitePlus; O43865; -.
DR   BioMuta; AHCYL1; -.
DR   EPD; O43865; -.
DR   MaxQB; O43865; -.
DR   PaxDb; O43865; -.
DR   PeptideAtlas; O43865; -.
DR   PRIDE; O43865; -.
DR   DNASU; 10768; -.
DR   Ensembl; ENST00000359172; ENSP00000352092; ENSG00000168710. [O43865-2]
DR   Ensembl; ENST00000369799; ENSP00000358814; ENSG00000168710. [O43865-1]
DR   Ensembl; ENST00000393614; ENSP00000377238; ENSG00000168710. [O43865-2]
DR   GeneID; 10768; -.
DR   KEGG; hsa:10768; -.
DR   UCSC; uc001dyx.4; human. [O43865-1]
DR   CTD; 10768; -.
DR   DisGeNET; 10768; -.
DR   EuPathDB; HostDB:ENSG00000168710.17; -.
DR   GeneCards; AHCYL1; -.
DR   HGNC; HGNC:344; AHCYL1.
DR   HPA; HPA042589; -.
DR   MIM; 607826; gene.
DR   neXtProt; NX_O43865; -.
DR   OpenTargets; ENSG00000168710; -.
DR   PharmGKB; PA24637; -.
DR   eggNOG; KOG1370; Eukaryota.
DR   eggNOG; COG0499; LUCA.
DR   GeneTree; ENSGT00390000003626; -.
DR   HOGENOM; HOG000227986; -.
DR   HOVERGEN; HBG005041; -.
DR   InParanoid; O43865; -.
DR   KO; K01251; -.
DR   OMA; HKPVKKQ; -.
DR   OrthoDB; EOG091G06EB; -.
DR   PhylomeDB; O43865; -.
DR   TreeFam; TF300415; -.
DR   Reactome; R-HSA-112043; PLC beta mediated events.
DR   Reactome; R-HSA-1489509; DAG and IP3 signaling.
DR   Reactome; R-HSA-2029485; Role of phospholipids in phagocytosis.
DR   Reactome; R-HSA-2871809; FCERI mediated Ca+2 mobilization.
DR   Reactome; R-HSA-422356; Regulation of insulin secretion.
DR   Reactome; R-HSA-5218921; VEGFR2 mediated cell proliferation.
DR   Reactome; R-HSA-5578775; Ion homeostasis.
DR   Reactome; R-HSA-5607763; CLEC7A (Dectin-1) induces NFAT activation.
DR   Reactome; R-HSA-983695; Antigen activates B Cell Receptor (BCR) leading to generation of second messengers.
DR   SIGNOR; O43865; -.
DR   ChiTaRS; AHCYL1; human.
DR   EvolutionaryTrace; O43865; -.
DR   GeneWiki; AHCYL1; -.
DR   GenomeRNAi; 10768; -.
DR   PMAP-CutDB; O43865; -.
DR   PRO; PR:O43865; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000168710; -.
DR   CleanEx; HS_AHCYL1; -.
DR   ExpressionAtlas; O43865; baseline and differential.
DR   Genevisible; O43865; HS.
DR   GO; GO:0016324; C:apical plasma membrane; ISS:UniProtKB.
DR   GO; GO:0005737; C:cytoplasm; ISS:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IBA:GO_Central.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0003723; F:RNA binding; IEA:UniProtKB-KW.
DR   GO; GO:0038166; P:angiotensin-activated signaling pathway; IDA:UniProtKB.
DR   GO; GO:0042045; P:epithelial fluid transport; IEA:Ensembl.
DR   GO; GO:0006378; P:mRNA polyadenylation; IDA:UniProtKB.
DR   GO; GO:0006730; P:one-carbon metabolic process; IEA:UniProtKB-KW.
DR   GO; GO:0010765; P:positive regulation of sodium ion transport; IMP:UniProtKB.
DR   GO; GO:0006611; P:protein export from nucleus; IEA:Ensembl.
DR   GO; GO:0044070; P:regulation of anion transport; IEA:Ensembl.
DR   GO; GO:1903779; P:regulation of cardiac conduction; TAS:Reactome.
DR   GO; GO:0032412; P:regulation of ion transmembrane transporter activity; IMP:UniProtKB.
DR   GO; GO:0031440; P:regulation of mRNA 3'-end processing; IDA:UniProtKB.
DR   GO; GO:0051592; P:response to calcium ion; IDA:UniProtKB.
DR   GO; GO:0033353; P:S-adenosylmethionine cycle; IBA:GO_Central.
DR   CDD; cd00401; SAHH; 1.
DR   InterPro; IPR000043; Adenosylhomocysteinase-like.
DR   InterPro; IPR015878; Ado_hCys_hydrolase_NAD-bd.
DR   InterPro; IPR036291; NAD(P)-bd_dom_sf.
DR   InterPro; IPR020082; S-Ado-L-homoCys_hydrolase_CS.
DR   PANTHER; PTHR23420; PTHR23420; 1.
DR   Pfam; PF05221; AdoHcyase; 1.
DR   Pfam; PF00670; AdoHcyase_NAD; 1.
DR   PIRSF; PIRSF001109; Ad_hcy_hydrolase; 1.
DR   SMART; SM00996; AdoHcyase; 1.
DR   SMART; SM00997; AdoHcyase_NAD; 1.
DR   SUPFAM; SSF51735; SSF51735; 1.
DR   TIGRFAMs; TIGR00936; ahcY; 1.
DR   PROSITE; PS00738; ADOHCYASE_1; 1.
DR   PROSITE; PS00739; ADOHCYASE_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Cell membrane;
KW   Complete proteome; Cytoplasm; Endoplasmic reticulum; Membrane;
KW   Microsome; NAD; One-carbon metabolism; Phosphoprotein;
KW   Reference proteome; RNA-binding.
FT   INIT_MET      1      1       Removed. {ECO:0000244|PubMed:21406692}.
FT   CHAIN         2    530       S-adenosylhomocysteine hydrolase-like
FT                                protein 1.
FT                                /FTId=PRO_0000116908.
FT   NP_BIND     318    322       NAD. {ECO:0000269|PubMed:25237103}.
FT   NP_BIND     397    399       NAD. {ECO:0000269|PubMed:25237103}.
FT   REGION       65     92       PEST. {ECO:0000269|PubMed:25237103}.
FT   REGION      281    448       NAD binding. {ECO:0000250}.
FT   REGION      520    530       PDZ-binding. {ECO:0000250}.
FT   BINDING     155    155       Substrate. {ECO:0000250}.
FT   BINDING     229    229       Substrate. {ECO:0000250}.
FT   BINDING     254    254       Substrate. {ECO:0000250}.
FT   BINDING     284    284       Substrate. {ECO:0000250}.
FT   BINDING     288    288       Substrate. {ECO:0000250}.
FT   BINDING     341    341       NAD. {ECO:0000269|PubMed:25237103}.
FT   BINDING     376    376       NAD. {ECO:0000269|PubMed:25237103}.
FT   MOD_RES       2      2       N-acetylserine.
FT                                {ECO:0000244|PubMed:21406692}.
FT   MOD_RES       2      2       Phosphoserine.
FT                                {ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES      40     40       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:Q80SW1}.
FT   MOD_RES      68     68       Phosphoserine.
FT                                {ECO:0000305|PubMed:16793548,
FT                                ECO:0000305|PubMed:19220705}.
FT   MOD_RES      71     71       Phosphoserine.
FT                                {ECO:0000305|PubMed:16793548,
FT                                ECO:0000305|PubMed:19220705}.
FT   MOD_RES      74     74       Phosphoserine.
FT                                {ECO:0000305|PubMed:19220705}.
FT   MOD_RES      77     77       Phosphoserine.
FT                                {ECO:0000305|PubMed:19220705}.
FT   MOD_RES      84     84       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q80SW1}.
FT   MOD_RES     391    391       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   VAR_SEQ       1     47       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:12878157,
FT                                ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:17974005,
FT                                ECO:0000303|PubMed:7782076}.
FT                                /FTId=VSP_021751.
FT   MUTAGEN      52     52       T->A: No effect on interaction with
FT                                SLC4A4. {ECO:0000269|PubMed:16769890}.
FT   MUTAGEN      58     58       T->A: No effect on interaction with
FT                                SLC4A4. {ECO:0000269|PubMed:16769890}.
FT   MUTAGEN      62     62       S->A: No effect on interaction with
FT                                SLC4A4. No effect on interaction with
FT                                FIP1L1. {ECO:0000269|PubMed:16769890,
FT                                ECO:0000269|PubMed:19224921}.
FT   MUTAGEN      64     64       S->A: No effect on interaction with
FT                                ITPR1. No effect on phosphorylation. No
FT                                effect on interaction with SLC4A4. No
FT                                effect on interaction with FIP1L1.
FT                                {ECO:0000269|PubMed:16769890,
FT                                ECO:0000269|PubMed:16793548,
FT                                ECO:0000269|PubMed:19224921}.
FT   MUTAGEN      66     66       S->A: Slightly decreases interaction with
FT                                ITPR1. Slightly decreases
FT                                phosphorylation. No effect on interaction
FT                                with SLC4A4. Abolishes interaction with
FT                                FIP1L1. {ECO:0000269|PubMed:16769890,
FT                                ECO:0000269|PubMed:16793548,
FT                                ECO:0000269|PubMed:19224921}.
FT   MUTAGEN      68     68       S->A: Abolishes interaction with ITPR1.
FT                                Highly decreases phosphorylation. No
FT                                effect on formation of multimers.
FT                                Abolishes interaction with SLC4A4.
FT                                Abolishes interaction with FIP1L1. Highly
FT                                decreases interaction with SLC9A3. Highly
FT                                decreases interaction with SLC9A3; when
FT                                associated whith A-71 and A-74.
FT                                {ECO:0000269|PubMed:16769890,
FT                                ECO:0000269|PubMed:16793548,
FT                                ECO:0000269|PubMed:19224921,
FT                                ECO:0000269|PubMed:20584908}.
FT   MUTAGEN      70     70       S->A: Highly decreases interaction with
FT                                ITPR1. No effect on phosphorylation. No
FT                                effect on interaction with SLC4A4.
FT                                Abolishes interaction with FIP1L1.
FT                                {ECO:0000269|PubMed:16769890,
FT                                ECO:0000269|PubMed:16793548,
FT                                ECO:0000269|PubMed:19224921}.
FT   MUTAGEN      71     71       S->A: Abolishes interaction with ITPR1.
FT                                Highly decreases phosphorylation.
FT                                Abolishes interaction with SLC4A4.
FT                                Abolishes interaction with FIP1L1. Highly
FT                                decreases interaction with SLC9A3; when
FT                                associated whith A-68 and A-74.
FT                                {ECO:0000269|PubMed:16769890,
FT                                ECO:0000269|PubMed:16793548,
FT                                ECO:0000269|PubMed:19224921,
FT                                ECO:0000269|PubMed:20584908}.
FT   MUTAGEN      72     72       T->A: Highly decreases interaction with
FT                                ITPR1. Slightly increases
FT                                phosphorylation. No effect on interaction
FT                                with SLC4A4. Highly decreases interaction
FT                                with FIP1L1.
FT                                {ECO:0000269|PubMed:16769890,
FT                                ECO:0000269|PubMed:16793548,
FT                                ECO:0000269|PubMed:19224921}.
FT   MUTAGEN      74     74       S->G: Abolishes interaction with ITPR1.
FT                                Slightly decreases phosphorylation.
FT                                Strongly decreases interaction with
FT                                SLC4A4. Abolishes interaction with
FT                                FIP1L1. Highly decreases interaction with
FT                                SLC9A3; when associated whith A-68 and A-
FT                                71. {ECO:0000269|PubMed:16769890,
FT                                ECO:0000269|PubMed:16793548,
FT                                ECO:0000269|PubMed:19224921,
FT                                ECO:0000269|PubMed:20584908}.
FT   MUTAGEN      76     76       S->G: No effect on interaction with
FT                                ITPR1. No effect on phosphorylation. No
FT                                effect on interaction with SLC4A4. No
FT                                effect on interaction with FIP1L1.
FT                                {ECO:0000269|PubMed:16769890,
FT                                ECO:0000269|PubMed:16793548,
FT                                ECO:0000269|PubMed:19224921}.
FT   MUTAGEN      77     77       S->A: Highly decreases interaction with
FT                                ITPR1. Slightly decreases
FT                                phosphorylation. Strongly decreases
FT                                interaction with SLC4A4. Abolishes
FT                                interaction with FIP1L1.
FT                                {ECO:0000269|PubMed:16769890,
FT                                ECO:0000269|PubMed:16793548,
FT                                ECO:0000269|PubMed:19224921}.
FT   MUTAGEN      80     80       S->A: No effect on interaction with
FT                                SLC4A4. Highly decreases interaction with
FT                                FIP1L1. {ECO:0000269|PubMed:16769890,
FT                                ECO:0000269|PubMed:16793548,
FT                                ECO:0000269|PubMed:19224921}.
FT   MUTAGEN      82     82       T->A: No effect on interaction with
FT                                ITPR1. No effect on phosphorylation. No
FT                                effect on interaction with SLC4A4.
FT                                Decreases interaction with FIP1L1.
FT                                {ECO:0000269|PubMed:16769890,
FT                                ECO:0000269|PubMed:16793548,
FT                                ECO:0000269|PubMed:19224921}.
FT   MUTAGEN      84     84       S->A: Slightly decreases interaction with
FT                                ITPR1. No effect on phosphorylation. No
FT                                effect on interaction with SLC4A4.
FT                                Decreases interaction with FIP1L1.
FT                                {ECO:0000269|PubMed:16769890,
FT                                ECO:0000269|PubMed:16793548,
FT                                ECO:0000269|PubMed:19224921}.
FT   MUTAGEN      85     85       S->A: Slightly decreases interaction with
FT                                ITPR1. No effect on phosphorylation. No
FT                                effect on interaction with SLC4A4.
FT                                Decreases interaction with FIP1L1.
FT                                {ECO:0000269|PubMed:16769890,
FT                                ECO:0000269|PubMed:16793548,
FT                                ECO:0000269|PubMed:19224921}.
FT   MUTAGEN      90     90       S->A: No effect on interaction with
FT                                ITPR1. No effect on phosphorylation. No
FT                                effect on interaction with SLC4A4. No
FT                                effect on interaction with FIP1L1.
FT                                {ECO:0000269|PubMed:16769890,
FT                                ECO:0000269|PubMed:16793548,
FT                                ECO:0000269|PubMed:19224921}.
FT   MUTAGEN      97     97       T->A: No effect on interaction with
FT                                ITPR1. No effect on interaction with
FT                                SLC4A4. No effect on interaction with
FT                                FIP1L1. {ECO:0000269|PubMed:16769890,
FT                                ECO:0000269|PubMed:16793548,
FT                                ECO:0000269|PubMed:19224921}.
FT   CONFLICT     94     94       K -> M (in Ref. 9; T19009).
FT                                {ECO:0000305}.
FT   CONFLICT     99     99       S -> F (in Ref. 9; T19009).
FT                                {ECO:0000305}.
FT   HELIX       113    124       {ECO:0000244|PDB:3MTG}.
FT   HELIX       128    137       {ECO:0000244|PDB:3MTG}.
FT   TURN        142    145       {ECO:0000244|PDB:3MTG}.
FT   STRAND      147    152       {ECO:0000244|PDB:3MTG}.
FT   HELIX       156    167       {ECO:0000244|PDB:3MTG}.
FT   STRAND      171    175       {ECO:0000244|PDB:3MTG}.
FT   STRAND      177    180       {ECO:0000244|PDB:3MTG}.
FT   HELIX       184    193       {ECO:0000244|PDB:3MTG}.
FT   STRAND      196    198       {ECO:0000244|PDB:3MTG}.
FT   HELIX       205    216       {ECO:0000244|PDB:3MTG}.
FT   STRAND      224    231       {ECO:0000244|PDB:3MTG}.
FT   HELIX       232    240       {ECO:0000244|PDB:3MTG}.
FT   HELIX       242    245       {ECO:0000244|PDB:3MTG}.
FT   STRAND      249    253       {ECO:0000244|PDB:3MTG}.
FT   HELIX       256    265       {ECO:0000244|PDB:3MTG}.
FT   TURN        266    269       {ECO:0000244|PDB:3MTG}.
FT   STRAND      275    277       {ECO:0000244|PDB:3MTG}.
FT   HELIX       282    293       {ECO:0000244|PDB:3MTG}.
FT   HELIX       299    305       {ECO:0000244|PDB:3MTG}.
FT   STRAND      313    317       {ECO:0000244|PDB:3MTG}.
FT   HELIX       321    333       {ECO:0000244|PDB:3MTG}.
FT   STRAND      336    340       {ECO:0000244|PDB:3MTG}.
FT   HELIX       344    352       {ECO:0000244|PDB:3MTG}.
FT   HELIX       360    362       {ECO:0000244|PDB:3MTG}.
FT   TURN        363    366       {ECO:0000244|PDB:3MTG}.
FT   STRAND      368    372       {ECO:0000244|PDB:3MTG}.
FT   HELIX       382    387       {ECO:0000244|PDB:3MTG}.
FT   STRAND      392    396       {ECO:0000244|PDB:3MTG}.
FT   TURN        400    403       {ECO:0000244|PDB:3MTG}.
FT   HELIX       406    409       {ECO:0000244|PDB:3MTG}.
FT   STRAND      415    420       {ECO:0000244|PDB:3MTG}.
FT   STRAND      423    427       {ECO:0000244|PDB:3MTG}.
FT   STRAND      433    437       {ECO:0000244|PDB:3MTG}.
FT   HELIX       438    440       {ECO:0000244|PDB:3MTG}.
FT   HELIX       444    446       {ECO:0000244|PDB:3MTG}.
FT   HELIX       452    471       {ECO:0000244|PDB:3MTG}.
FT   STRAND      479    482       {ECO:0000244|PDB:3MTG}.
FT   HELIX       486    496       {ECO:0000244|PDB:3MTG}.
FT   HELIX       497    500       {ECO:0000244|PDB:3MTG}.
FT   HELIX       509    514       {ECO:0000244|PDB:3MTG}.
FT   STRAND      519    521       {ECO:0000244|PDB:3MTG}.
SQ   SEQUENCE   530 AA;  58951 MW;  974D23361A245D04 CRC64;
     MSMPDAMPLP GVGEELKQAK EIEDAEKYSF MATVTKAPKK QIQFADDMQE FTKFPTKTGR
     RSLSRSISQS STDSYSSAAS YTDSSDDEVS PREKQQTNSK GSSNFCVKNI KQAEFGRREI
     EIAEQDMSAL ISLRKRAQGE KPLAGAKIVG CTHITAQTAV LIETLCALGA QCRWSACNIY
     STQNEVAAAL AEAGVAVFAW KGESEDDFWW CIDRCVNMDG WQANMILDDG GDLTHWVYKK
     YPNVFKKIRG IVEESVTGVH RLYQLSKAGK LCVPAMNVND SVTKQKFDNL YCCRESILDG
     LKRTTDVMFG GKQVVVCGYG EVGKGCCAAL KALGAIVYIT EIDPICALQA CMDGFRVVKL
     NEVIRQVDVV ITCTGNKNVV TREHLDRMKN SCIVCNMGHS NTEIDVTSLR TPELTWERVR
     SQVDHVIWPD GKRVVLLAEG RLLNLSCSTV PTFVLSITAT TQALALIELY NAPEGRYKQD
     VYLLPKKMDE YVASLHLPSF DAHLTELTDD QAKYLGLNKN GPFKPNYYRY
//
ID   LSM4_HUMAN              Reviewed;         139 AA.
AC   Q9Y4Z0;
DT   01-DEC-2000, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1999, sequence version 1.
DT   23-MAY-2018, entry version 162.
DE   RecName: Full=U6 snRNA-associated Sm-like protein LSm4;
DE   AltName: Full=Glycine-rich protein;
DE            Short=GRP;
GN   Name=LSM4;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Liver;
RX   PubMed=10369684; DOI=10.1093/emboj/18.12.3451;
RA   Salgado-Garrido J., Bragado-Nilsson E., Kandels-Lewis S., Seraphin B.;
RT   "Sm and Sm-like proteins assemble in two related complexes of deep
RT   evolutionary origin.";
RL   EMBO J. 18:3451-3462(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND PARTIAL PROTEIN SEQUENCE.
RX   PubMed=10523320; DOI=10.1093/emboj/18.20.5789;
RA   Achsel T., Brahms H., Kastner B., Bachi A., Wilm M., Luehrmann R.;
RT   "A doughnut-shaped heteromer of human Sm-like proteins binds to the
RT   3'-end of U6 snRNA, thereby facilitating U4/U6 duplex formation in
RT   vitro.";
RL   EMBO J. 18:5789-5802(1999).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Hypothalamus;
RX   PubMed=10931946; DOI=10.1073/pnas.160270997;
RA   Hu R.-M., Han Z.-G., Song H.-D., Peng Y.-D., Huang Q.-H., Ren S.-X.,
RA   Gu Y.-J., Huang C.-H., Li Y.-B., Jiang C.-L., Fu G., Zhang Q.-H.,
RA   Gu B.-W., Dai M., Mao Y.-F., Gao G.-F., Rong R., Ye M., Zhou J.,
RA   Xu S.-H., Gu J., Shi J.-X., Jin W.-R., Zhang C.-K., Wu T.-M.,
RA   Huang G.-Y., Chen Z., Chen M.-D., Chen J.-L.;
RT   "Gene expression profiling in the human hypothalamus-pituitary-adrenal
RT   axis and full-length cDNA cloning.";
RL   Proc. Natl. Acad. Sci. U.S.A. 97:9543-9548(2000).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RA   Chan E.K.L.;
RL   Submitted (APR-2000) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   PROTEIN SEQUENCE OF 1-20, ACETYLATION AT MET-1, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY.
RC   TISSUE=Mammary carcinoma;
RA   Bienvenut W.V., Matallanas D., Cooper W.N., Kolch W.;
RL   Submitted (JUL-2007) to UniProtKB.
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [10]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-80, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-
RT   modification with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
CC   -!- FUNCTION: Binds specifically to the 3'-terminal U-tract of U6
CC       snRNA.
CC   -!- SUBUNIT: LSm subunits form a heteromer with a doughnut shape.
CC   -!- INTERACTION:
CC       Q13137:CALCOCO2; NbExp=6; IntAct=EBI-372521, EBI-739580;
CC       Q13422:IKZF1; NbExp=3; IntAct=EBI-372521, EBI-745305;
CC       Q96JM7:L3MBTL3; NbExp=3; IntAct=EBI-372521, EBI-2686809;
CC       O15116:LSM1; NbExp=4; IntAct=EBI-372521, EBI-347619;
CC       Q9UK45:LSM7; NbExp=8; IntAct=EBI-372521, EBI-348372;
CC       O95777:LSM8; NbExp=4; IntAct=EBI-372521, EBI-347779;
CC       O43586:PSTPIP1; NbExp=7; IntAct=EBI-372521, EBI-1050964;
CC       Q96DT7:ZBTB10; NbExp=3; IntAct=EBI-372521, EBI-10235384;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the snRNP Sm proteins family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AJ238096; CAB45867.1; -; mRNA.
DR   EMBL; AF182290; AAD56228.1; -; mRNA.
DR   EMBL; AF117235; AAF17216.1; -; mRNA.
DR   EMBL; AF251218; AAF90055.1; -; mRNA.
DR   EMBL; BC000387; AAH00387.1; -; mRNA.
DR   EMBL; BC003652; AAH03652.1; -; mRNA.
DR   EMBL; BC022198; AAH22198.1; -; mRNA.
DR   EMBL; BC023665; AAH23665.1; -; mRNA.
DR   CCDS; CCDS12374.1; -.
DR   RefSeq; NP_036453.1; NM_012321.4.
DR   UniGene; Hs.515255; -.
DR   PDB; 3JCR; EM; 7.00 A; 4=1-139.
DR   PDB; 5O9Z; EM; 4.50 A; q=1-139.
DR   PDBsum; 3JCR; -.
DR   PDBsum; 5O9Z; -.
DR   ProteinModelPortal; Q9Y4Z0; -.
DR   SMR; Q9Y4Z0; -.
DR   BioGrid; 117336; 65.
DR   CORUM; Q9Y4Z0; -.
DR   DIP; DIP-31209N; -.
DR   IntAct; Q9Y4Z0; 26.
DR   MINT; Q9Y4Z0; -.
DR   STRING; 9606.ENSP00000469468; -.
DR   iPTMnet; Q9Y4Z0; -.
DR   PhosphoSitePlus; Q9Y4Z0; -.
DR   SwissPalm; Q9Y4Z0; -.
DR   BioMuta; LSM4; -.
DR   DMDM; 10720082; -.
DR   EPD; Q9Y4Z0; -.
DR   MaxQB; Q9Y4Z0; -.
DR   PaxDb; Q9Y4Z0; -.
DR   PeptideAtlas; Q9Y4Z0; -.
DR   PRIDE; Q9Y4Z0; -.
DR   DNASU; 25804; -.
DR   Ensembl; ENST00000593829; ENSP00000469468; ENSG00000130520.
DR   GeneID; 25804; -.
DR   KEGG; hsa:25804; -.
DR   UCSC; uc002niq.4; human.
DR   CTD; 25804; -.
DR   DisGeNET; 25804; -.
DR   EuPathDB; HostDB:ENSG00000130520.10; -.
DR   GeneCards; LSM4; -.
DR   HGNC; HGNC:17259; LSM4.
DR   HPA; HPA040932; -.
DR   MIM; 607284; gene.
DR   neXtProt; NX_Q9Y4Z0; -.
DR   OpenTargets; ENSG00000130520; -.
DR   PharmGKB; PA134906569; -.
DR   eggNOG; KOG3293; Eukaryota.
DR   eggNOG; ENOG4111TZU; LUCA.
DR   GeneTree; ENSGT00610000086173; -.
DR   HOGENOM; HOG000182713; -.
DR   HOVERGEN; HBG000486; -.
DR   InParanoid; Q9Y4Z0; -.
DR   KO; K12623; -.
DR   OMA; DRFWKLK; -.
DR   PhylomeDB; Q9Y4Z0; -.
DR   TreeFam; TF315027; -.
DR   Reactome; R-HSA-430039; mRNA decay by 5' to 3' exoribonuclease.
DR   Reactome; R-HSA-72163; mRNA Splicing - Major Pathway.
DR   ChiTaRS; LSM4; human.
DR   GeneWiki; LSM4; -.
DR   GenomeRNAi; 25804; -.
DR   PRO; PR:Q9Y4Z0; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   Bgee; ENSG00000130520; -.
DR   CleanEx; HS_LSM4; -.
DR   ExpressionAtlas; Q9Y4Z0; baseline and differential.
DR   Genevisible; Q9Y4Z0; HS.
DR   GO; GO:0005829; C:cytosol; IDA:CAFA.
DR   GO; GO:0016020; C:membrane; IDA:CAFA.
DR   GO; GO:0043005; C:neuron projection; IEA:Ensembl.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0000932; C:P-body; IBA:GO_Central.
DR   GO; GO:0032991; C:protein-containing complex; IDA:CAFA.
DR   GO; GO:0005681; C:spliceosomal complex; IEA:UniProtKB-KW.
DR   GO; GO:0097526; C:spliceosomal tri-snRNP complex; IBA:GO_Central.
DR   GO; GO:0005688; C:U6 snRNP; TAS:ProtInc.
DR   GO; GO:0042731; F:PH domain binding; IDA:CAFA.
DR   GO; GO:0003723; F:RNA binding; HDA:UniProtKB.
DR   GO; GO:0017070; F:U6 snRNA binding; IBA:GO_Central.
DR   GO; GO:0033962; P:cytoplasmic mRNA processing body assembly; IBA:GO_Central.
DR   GO; GO:0043928; P:exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay; TAS:Reactome.
DR   GO; GO:0000398; P:mRNA splicing, via spliceosome; TAS:Reactome.
DR   GO; GO:0000956; P:nuclear-transcribed mRNA catabolic process; IBA:GO_Central.
DR   GO; GO:0008380; P:RNA splicing; TAS:ProtInc.
DR   GO; GO:0000245; P:spliceosomal complex assembly; IBA:GO_Central.
DR   GO; GO:0000387; P:spliceosomal snRNP assembly; IBA:GO_Central.
DR   CDD; cd01723; LSm4; 1.
DR   InterPro; IPR034101; Lsm4.
DR   InterPro; IPR027141; LSm4/Sm_D1/D3.
DR   InterPro; IPR001163; LSM_dom_euk/arc.
DR   InterPro; IPR010920; LSM_dom_sf.
DR   PANTHER; PTHR23338; PTHR23338; 1.
DR   Pfam; PF01423; LSM; 1.
DR   SMART; SM00651; Sm; 1.
DR   SUPFAM; SSF50182; SSF50182; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Complete proteome;
KW   Direct protein sequencing; Isopeptide bond; mRNA processing;
KW   mRNA splicing; Nucleus; Reference proteome; Ribonucleoprotein;
KW   RNA-binding; Spliceosome; Ubl conjugation.
FT   CHAIN         1    139       U6 snRNA-associated Sm-like protein LSm4.
FT                                /FTId=PRO_0000125564.
FT   MOD_RES       1      1       N-acetylmethionine. {ECO:0000269|Ref.6}.
FT   CROSSLNK     80     80       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
SQ   SEQUENCE   139 AA;  15350 MW;  BCEFB20247335A1B CRC64;
     MLPLSLLKTA QNHPMLVELK NGETYNGHLV SCDNWMNINL REVICTSRDG DKFWRMPECY
     IRGSTIKYLR IPDEIIDMVK EEVVAKGRGR GGLQQQKQQK GRGMGGAGRG VFGGRGRGGI
     PGTGRGQPEK KPGRQAGKQ
//
ID   U3KQK1_HUMAN            Unreviewed;       125 AA.
AC   U3KQK1;
DT   13-NOV-2013, integrated into UniProtKB/TrEMBL.
DT   13-NOV-2013, sequence version 1.
DT   23-MAY-2018, entry version 36.
DE   SubName: Full=U6 snRNA-associated Sm-like protein LSm4 {ECO:0000313|Ensembl:ENSP00000475950};
GN   Name=LSM4 {ECO:0000313|Ensembl:ENSP00000475950};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000475950, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Ensembl:ENSP00000475950, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057824; DOI=10.1038/nature02399;
RA   Grimwood J., Gordon L.A., Olsen A.S., Terry A., Schmutz J.,
RA   Lamerdin J.E., Hellsten U., Goodstein D., Couronne O., Tran-Gyamfi M.,
RA   Aerts A., Altherr M., Ashworth L., Bajorek E., Black S., Branscomb E.,
RA   Caenepeel S., Carrano A.V., Caoile C., Chan Y.M., Christensen M.,
RA   Cleland C.A., Copeland A., Dalin E., Dehal P., Denys M., Detter J.C.,
RA   Escobar J., Flowers D., Fotopulos D., Garcia C., Georgescu A.M.,
RA   Glavina T., Gomez M., Gonzales E., Groza M., Hammon N., Hawkins T.,
RA   Haydu L., Ho I., Huang W., Israni S., Jett J., Kadner K., Kimball H.,
RA   Kobayashi A., Larionov V., Leem S.-H., Lopez F., Lou Y., Lowry S.,
RA   Malfatti S., Martinez D., McCready P.M., Medina C., Morgan J.,
RA   Nelson K., Nolan M., Ovcharenko I., Pitluck S., Pollard M.,
RA   Popkie A.P., Predki P., Quan G., Ramirez L., Rash S., Retterer J.,
RA   Rodriguez A., Rogers S., Salamov A., Salazar A., She X., Smith D.,
RA   Slezak T., Solovyev V., Thayer N., Tice H., Tsai M., Ustaszewska A.,
RA   Vo N., Wagner M., Wheeler J., Wu K., Xie G., Yang J., Dubchak I.,
RA   Furey T.S., DeJong P., Dickson M., Gordon D., Eichler E.E.,
RA   Pennacchio L.A., Richardson P., Stubbs L., Rokhsar D.S., Myers R.M.,
RA   Rubin E.M., Lucas S.M.;
RT   "The DNA sequence and biology of human chromosome 19.";
RL   Nature 428:529-535(2004).
RN   [2] {ECO:0000213|PubMed:21269460}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Burckstummer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [3] {ECO:0000313|Ensembl:ENSP00000475950}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (SEP-2013) to UniProtKB.
RN   [4] {ECO:0000213|PubMed:24275569}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [5] {ECO:0000213|PubMed:25944712}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [6] {ECO:0000213|PubMed:28112733}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=28112733;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-
RT   modification with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AC008397; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   RefSeq; NP_001239058.1; NM_001252129.1.
DR   UniGene; Hs.515255; -.
DR   ProteinModelPortal; U3KQK1; -.
DR   MaxQB; U3KQK1; -.
DR   PeptideAtlas; U3KQK1; -.
DR   Ensembl; ENST00000252816; ENSP00000475950; ENSG00000130520.
DR   GeneID; 25804; -.
DR   UCSC; uc021uqn.2; human.
DR   CTD; 25804; -.
DR   EuPathDB; HostDB:ENSG00000130520.10; -.
DR   HGNC; HGNC:17259; LSM4.
DR   OpenTargets; ENSG00000130520; -.
DR   eggNOG; KOG3293; Eukaryota.
DR   eggNOG; ENOG4111TZU; LUCA.
DR   GeneTree; ENSGT00610000086173; -.
DR   ChiTaRS; LSM4; human.
DR   GenomeRNAi; 25804; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   Bgee; ENSG00000130520; -.
DR   ExpressionAtlas; U3KQK1; baseline and differential.
DR   GO; GO:0000398; P:mRNA splicing, via spliceosome; IEA:InterPro.
DR   GO; GO:0000956; P:nuclear-transcribed mRNA catabolic process; IEA:InterPro.
DR   CDD; cd01723; LSm4; 1.
DR   InterPro; IPR034101; Lsm4.
DR   InterPro; IPR027141; LSm4/Sm_D1/D3.
DR   InterPro; IPR001163; LSM_dom_euk/arc.
DR   InterPro; IPR010920; LSM_dom_sf.
DR   PANTHER; PTHR23338; PTHR23338; 1.
DR   Pfam; PF01423; LSM; 1.
DR   SMART; SM00651; Sm; 1.
DR   SUPFAM; SSF50182; SSF50182; 1.
PE   1: Evidence at protein level;
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   Proteomics identification {ECO:0000213|EPD:U3KQK1,
KW   ECO:0000213|MaxQB:U3KQK1, ECO:0000213|PeptideAtlas:U3KQK1};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640};
KW   Ribonucleoprotein {ECO:0000256|SAAS:SAAS00688091}.
FT   DOMAIN        1     57       Sm. {ECO:0000259|SMART:SM00651}.
SQ   SEQUENCE   125 AA;  13805 MW;  7AE5A7F300EE2463 CRC64;
     MLVELKNGET YNGHLVSCDN WMNINLREVI CTSRDGDKFW RMPECYIRGS TIKYLRIPDE
     IIDMVKEEVV AKGRGRGGLQ QQKQQKGRGM GGAGRGVFGG RGRGGIPGTG RGQPEKKPGR
     QAGKQ
//
ID   KPB1_HUMAN              Reviewed;        1223 AA.
AC   P46020; B7ZL05; B7ZL07; Q2M3D7;
DT   01-NOV-1995, integrated into UniProtKB/Swiss-Prot.
DT   11-JUL-2006, sequence version 2.
DT   23-MAY-2018, entry version 167.
DE   RecName: Full=Phosphorylase b kinase regulatory subunit alpha, skeletal muscle isoform;
DE            Short=Phosphorylase kinase alpha M subunit;
GN   Name=PHKA1; Synonyms=PHKA;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Muscle;
RX   PubMed=8226841;
RA   Wuellrich A., Hamacher C., Schneider A., Kilimann M.W.;
RT   "The multiphosphorylation domain of the phosphorylase kinase alpha M
RT   and alpha L subunits is a hotspot of differential mRNA processing and
RT   of molecular evolution.";
RL   J. Biol. Chem. 268:23208-23214(1993).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15772651; DOI=10.1038/nature03440;
RA   Ross M.T., Grafham D.V., Coffey A.J., Scherer S., McLay K., Muzny D.,
RA   Platzer M., Howell G.R., Burrows C., Bird C.P., Frankish A.,
RA   Lovell F.L., Howe K.L., Ashurst J.L., Fulton R.S., Sudbrak R., Wen G.,
RA   Jones M.C., Hurles M.E., Andrews T.D., Scott C.E., Searle S.,
RA   Ramser J., Whittaker A., Deadman R., Carter N.P., Hunt S.E., Chen R.,
RA   Cree A., Gunaratne P., Havlak P., Hodgson A., Metzker M.L.,
RA   Richards S., Scott G., Steffen D., Sodergren E., Wheeler D.A.,
RA   Worley K.C., Ainscough R., Ambrose K.D., Ansari-Lari M.A., Aradhya S.,
RA   Ashwell R.I., Babbage A.K., Bagguley C.L., Ballabio A., Banerjee R.,
RA   Barker G.E., Barlow K.F., Barrett I.P., Bates K.N., Beare D.M.,
RA   Beasley H., Beasley O., Beck A., Bethel G., Blechschmidt K., Brady N.,
RA   Bray-Allen S., Bridgeman A.M., Brown A.J., Brown M.J., Bonnin D.,
RA   Bruford E.A., Buhay C., Burch P., Burford D., Burgess J., Burrill W.,
RA   Burton J., Bye J.M., Carder C., Carrel L., Chako J., Chapman J.C.,
RA   Chavez D., Chen E., Chen G., Chen Y., Chen Z., Chinault C.,
RA   Ciccodicola A., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Clerc-Blankenburg K., Clifford K., Cobley V., Cole C.G., Conquer J.S.,
RA   Corby N., Connor R.E., David R., Davies J., Davis C., Davis J.,
RA   Delgado O., Deshazo D., Dhami P., Ding Y., Dinh H., Dodsworth S.,
RA   Draper H., Dugan-Rocha S., Dunham A., Dunn M., Durbin K.J., Dutta I.,
RA   Eades T., Ellwood M., Emery-Cohen A., Errington H., Evans K.L.,
RA   Faulkner L., Francis F., Frankland J., Fraser A.E., Galgoczy P.,
RA   Gilbert J., Gill R., Gloeckner G., Gregory S.G., Gribble S.,
RA   Griffiths C., Grocock R., Gu Y., Gwilliam R., Hamilton C., Hart E.A.,
RA   Hawes A., Heath P.D., Heitmann K., Hennig S., Hernandez J.,
RA   Hinzmann B., Ho S., Hoffs M., Howden P.J., Huckle E.J., Hume J.,
RA   Hunt P.J., Hunt A.R., Isherwood J., Jacob L., Johnson D., Jones S.,
RA   de Jong P.J., Joseph S.S., Keenan S., Kelly S., Kershaw J.K., Khan Z.,
RA   Kioschis P., Klages S., Knights A.J., Kosiura A., Kovar-Smith C.,
RA   Laird G.K., Langford C., Lawlor S., Leversha M., Lewis L., Liu W.,
RA   Lloyd C., Lloyd D.M., Loulseged H., Loveland J.E., Lovell J.D.,
RA   Lozado R., Lu J., Lyne R., Ma J., Maheshwari M., Matthews L.H.,
RA   McDowall J., McLaren S., McMurray A., Meidl P., Meitinger T.,
RA   Milne S., Miner G., Mistry S.L., Morgan M., Morris S., Mueller I.,
RA   Mullikin J.C., Nguyen N., Nordsiek G., Nyakatura G., O'dell C.N.,
RA   Okwuonu G., Palmer S., Pandian R., Parker D., Parrish J.,
RA   Pasternak S., Patel D., Pearce A.V., Pearson D.M., Pelan S.E.,
RA   Perez L., Porter K.M., Ramsey Y., Reichwald K., Rhodes S.,
RA   Ridler K.A., Schlessinger D., Schueler M.G., Sehra H.K.,
RA   Shaw-Smith C., Shen H., Sheridan E.M., Shownkeen R., Skuce C.D.,
RA   Smith M.L., Sotheran E.C., Steingruber H.E., Steward C.A., Storey R.,
RA   Swann R.M., Swarbreck D., Tabor P.E., Taudien S., Taylor T.,
RA   Teague B., Thomas K., Thorpe A., Timms K., Tracey A., Trevanion S.,
RA   Tromans A.C., d'Urso M., Verduzco D., Villasana D., Waldron L.,
RA   Wall M., Wang Q., Warren J., Warry G.L., Wei X., West A.,
RA   Whitehead S.L., Whiteley M.N., Wilkinson J.E., Willey D.L.,
RA   Williams G., Williams L., Williamson A., Williamson H., Wilming L.,
RA   Woodmansey R.L., Wray P.W., Yen J., Zhang J., Zhou J., Zoghbi H.,
RA   Zorilla S., Buck D., Reinhardt R., Poustka A., Rosenthal A.,
RA   Lehrach H., Meindl A., Minx P.J., Hillier L.W., Willard H.F.,
RA   Wilson R.K., Waterston R.H., Rice C.M., Vaudin M., Coulson A.,
RA   Nelson D.L., Weinstock G., Sulston J.E., Durbin R.M., Hubbard T.,
RA   Gibbs R.A., Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence of the human X chromosome.";
RL   Nature 434:325-337(2005).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 2 AND 3).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-735, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [5]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-972 AND SER-985, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-758; SER-972 AND
RP   SER-985, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-729; SER-972; SER-981
RP   AND SER-985, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [9]
RP   VARIANT GSD9D VAL-299.
RX   PubMed=12825073; DOI=10.1038/sj.ejhg.5200996;
RA   Burwinkel B., Hu B., Schroers A., Clemens P.R., Moses S.W., Shin Y.S.,
RA   Pongratz D., Vorgerd M., Kilimann M.W.;
RT   "Muscle glycogenosis with low phosphorylase kinase activity: mutations
RT   in PHKA1, PHKG1 or six other candidate genes explain only a minority
RT   of cases.";
RL   Eur. J. Hum. Genet. 11:516-526(2003).
CC   -!- FUNCTION: Phosphorylase b kinase catalyzes the phosphorylation of
CC       serine in certain substrates, including troponin I. The alpha
CC       chain may bind calmodulin.
CC   -!- ENZYME REGULATION: By phosphorylation of various serine residues.
CC       Allosteric regulation by calcium.
CC   -!- PATHWAY: Glycan biosynthesis; glycogen metabolism.
CC   -!- SUBUNIT: Hexadecamer of 4 heterotetramers, each composed of alpha,
CC       beta, gamma, and delta subunits. Alpha (PHKA1 or PHKA2) and beta
CC       (PHKB) are regulatory subunits, gamma (PHKG1 or PHKG2) is the
CC       catalytic subunit, and delta is calmodulin.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000305}; Lipid-anchor
CC       {ECO:0000305}; Cytoplasmic side {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1; Synonyms=AC;
CC         IsoId=P46020-1; Sequence=Displayed;
CC       Name=2; Synonyms=C;
CC         IsoId=P46020-2; Sequence=VSP_004697;
CC       Name=3;
CC         IsoId=P46020-3; Sequence=VSP_042517, VSP_042518;
CC   -!- TISSUE SPECIFICITY: Muscle specific. Isoform 1 is predominant in
CC       vastus lateralis muscle. Isoform 2 predominates slightly in heart,
CC       and it predominates clearly in the other tissues tested.
CC   -!- PTM: Although the final Cys may be farnesylated, the terminal
CC       tripeptide is probably not removed, and the C-terminus is not
CC       methylated. {ECO:0000250|UniProtKB:P18688}.
CC   -!- DISEASE: Glycogen storage disease 9D (GSD9D) [MIM:300559]: A
CC       metabolic disorder characterized by slowly progressive,
CC       predominantly distal muscle weakness and atrophy. Clinical
CC       features include exercise intolerance with early fatigability,
CC       pain, cramps and occasionally myoglobinuria.
CC       {ECO:0000269|PubMed:12825073}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the phosphorylase b kinase regulatory chain
CC       family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X73874; CAA52083.1; -; mRNA.
DR   EMBL; BX295541; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BX295542; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC104944; AAI04945.1; -; mRNA.
DR   EMBL; BC143499; AAI43500.1; -; mRNA.
DR   EMBL; BC143501; AAI43502.1; -; mRNA.
DR   CCDS; CCDS14421.1; -. [P46020-1]
DR   CCDS; CCDS48137.1; -. [P46020-2]
DR   CCDS; CCDS55453.1; -. [P46020-3]
DR   PIR; I38111; I38111.
DR   RefSeq; NP_001116142.1; NM_001122670.1. [P46020-2]
DR   RefSeq; NP_001165907.1; NM_001172436.1. [P46020-3]
DR   RefSeq; NP_002628.2; NM_002637.3. [P46020-1]
DR   UniGene; Hs.201379; -.
DR   ProteinModelPortal; P46020; -.
DR   BioGrid; 111273; 15.
DR   CORUM; P46020; -.
DR   IntAct; P46020; 5.
DR   STRING; 9606.ENSP00000362643; -.
DR   ChEMBL; CHEMBL2111324; -.
DR   iPTMnet; P46020; -.
DR   PhosphoSitePlus; P46020; -.
DR   BioMuta; PHKA1; -.
DR   DMDM; 110282976; -.
DR   EPD; P46020; -.
DR   MaxQB; P46020; -.
DR   PaxDb; P46020; -.
DR   PeptideAtlas; P46020; -.
DR   PRIDE; P46020; -.
DR   TopDownProteomics; P46020-2; -. [P46020-2]
DR   DNASU; 5255; -.
DR   Ensembl; ENST00000339490; ENSP00000342469; ENSG00000067177. [P46020-2]
DR   Ensembl; ENST00000373542; ENSP00000362643; ENSG00000067177. [P46020-1]
DR   Ensembl; ENST00000541944; ENSP00000441251; ENSG00000067177. [P46020-3]
DR   GeneID; 5255; -.
DR   KEGG; hsa:5255; -.
DR   UCSC; uc004eax.5; human. [P46020-1]
DR   CTD; 5255; -.
DR   DisGeNET; 5255; -.
DR   EuPathDB; HostDB:ENSG00000067177.14; -.
DR   GeneCards; PHKA1; -.
DR   GeneReviews; PHKA1; -.
DR   HGNC; HGNC:8925; PHKA1.
DR   HPA; HPA001081; -.
DR   MalaCards; PHKA1; -.
DR   MIM; 300559; phenotype.
DR   MIM; 311870; gene.
DR   neXtProt; NX_P46020; -.
DR   OpenTargets; ENSG00000067177; -.
DR   Orphanet; 715; Glycogen storage disease due to muscle phosphorylase kinase deficiency.
DR   PharmGKB; PA33266; -.
DR   eggNOG; KOG3635; Eukaryota.
DR   eggNOG; ENOG410XPJZ; LUCA.
DR   GeneTree; ENSGT00520000055553; -.
DR   HOGENOM; HOG000231478; -.
DR   HOVERGEN; HBG000273; -.
DR   InParanoid; P46020; -.
DR   KO; K07190; -.
DR   PhylomeDB; P46020; -.
DR   TreeFam; TF313970; -.
DR   BioCyc; MetaCyc:HS00901-MONOMER; -.
DR   BRENDA; 2.7.11.19; 2681.
DR   Reactome; R-HSA-70221; Glycogen breakdown (glycogenolysis).
DR   SIGNOR; P46020; -.
DR   UniPathway; UPA00163; -.
DR   ChiTaRS; PHKA1; human.
DR   GeneWiki; Phosphorylase_kinase,_alpha_1; -.
DR   GenomeRNAi; 5255; -.
DR   PRO; PR:P46020; -.
DR   Proteomes; UP000005640; Chromosome X.
DR   Bgee; ENSG00000067177; -.
DR   CleanEx; HS_PHKA1; -.
DR   ExpressionAtlas; P46020; baseline and differential.
DR   Genevisible; P46020; HS.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0005964; C:phosphorylase kinase complex; IBA:GO_Central.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005516; F:calmodulin binding; IEA:UniProtKB-KW.
DR   GO; GO:0004689; F:phosphorylase kinase activity; TAS:ProtInc.
DR   GO; GO:0006091; P:generation of precursor metabolites and energy; TAS:ProtInc.
DR   GO; GO:0005977; P:glycogen metabolic process; TAS:ProtInc.
DR   Gene3D; 1.50.10.10; -; 1.
DR   InterPro; IPR008928; 6-hairpin_glycosidase_sf.
DR   InterPro; IPR012341; 6hp_glycosidase-like_sf.
DR   InterPro; IPR011613; Glyco_hydro_15/PHK.
DR   InterPro; IPR008734; PHK_A/B_su.
DR   PANTHER; PTHR10749; PTHR10749; 1.
DR   Pfam; PF00723; Glyco_hydro_15; 1.
DR   SUPFAM; SSF48208; SSF48208; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Calmodulin-binding; Carbohydrate metabolism;
KW   Cell membrane; Complete proteome; Disease mutation;
KW   Glycogen metabolism; Glycogen storage disease; Lipoprotein; Membrane;
KW   Muscle protein; Phosphoprotein; Prenylation; Reference proteome.
FT   CHAIN         1   1223       Phosphorylase b kinase regulatory subunit
FT                                alpha, skeletal muscle isoform.
FT                                /FTId=PRO_0000057726.
FT   REGION      810    840       Calmodulin-binding. {ECO:0000255}.
FT   REGION     1046   1086       Calmodulin-binding. {ECO:0000255}.
FT   MOD_RES     629    629       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q64649}.
FT   MOD_RES     729    729       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     735    735       Phosphoserine.
FT                                {ECO:0000244|PubMed:18691976}.
FT   MOD_RES     758    758       Phosphoserine.
FT                                {ECO:0000244|PubMed:19690332}.
FT   MOD_RES     972    972       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     981    981       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     985    985       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES    1007   1007       Phosphoserine; by autocatalysis.
FT                                {ECO:0000250|UniProtKB:P18688}.
FT   MOD_RES    1018   1018       Phosphoserine; by PKA.
FT                                {ECO:0000250|UniProtKB:P18688}.
FT   MOD_RES    1020   1020       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P18688}.
FT   MOD_RES    1023   1023       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P18688}.
FT   MOD_RES    1113   1113       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q64649}.
FT   LIPID      1220   1220       S-farnesyl cysteine.
FT                                {ECO:0000250|UniProtKB:P18688}.
FT   VAR_SEQ     654    713       ARCGDEVARYLDHLLAHTAPHPKLAPTSQKGGLDRFQAAVQ
FT                                TTCDLMSLVTKAKELHVQN -> D (in isoform 3).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_042517.
FT   VAR_SEQ    1011   1023       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_042518.
FT   VAR_SEQ    1012   1024       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:8226841}.
FT                                /FTId=VSP_004697.
FT   VARIANT     299    299       D -> V (in GSD9D; dbSNP:rs137852547).
FT                                {ECO:0000269|PubMed:12825073}.
FT                                /FTId=VAR_020856.
FT   CONFLICT    568    568       H -> Y (in Ref. 1; CAA52083).
FT                                {ECO:0000305}.
SQ   SEQUENCE   1223 AA;  137312 MW;  48511719C0BFE40F CRC64;
     MRSRSNSGVR LDGYARLVQQ TILCHQNPVT GLLPASYDQK DAWVRDNVYS ILAVWGLGLA
     YRKNADRDED KAKAYELEQS VVKLMRGLLH CMIRQVDKVE SFKYSQSTKD SLHAKYNTKT
     CATVVGDDQW GHLQLDATSV YLLFLAQMTA SGLHIIHSLD EVNFIQNLVF YIEAAYKTAD
     FGIWERGDKT NQGISELNAS SVGMAKAALE ALDELDLFGV KGGPQSVIHV LADEVQHCQS
     ILNSLLPRAS TSKEVDASLL SVVSFPAFAV EDSQLVELTK QEIITKLQGR YGCCRFLRDG
     YKTPKEDPNR LYYEPAELKL FENIECEWPL FWTYFILDGV FSGNAEQVQE YKEALEAVLI
     KGKNGVPLLP ELYSVPPDRV DEEYQNPHTV DRVPMGKLPH MWGQSLYILG SLMAEGFLAP
     GEIDPLNRRF STVPKPDVVV QVSILAETEE IKTILKDKGI YVETIAEVYP IRVQPARILS
     HIYSSLGCNN RMKLSGRPYR HMGVLGTSKL YDIRKTIFTF TPQFIDQQQF YLALDNKMIV
     EMLRTDLSYL CSRWRMTGQP TITFPISHSM LDEDGTSLNS SILAALRKMQ DGYFGGARVQ
     TGKLSEFLTT SCCTHLSFMD PGPEGKLYSE DYDDNYDYLE SGNWMNDYDS TSHARCGDEV
     ARYLDHLLAH TAPHPKLAPT SQKGGLDRFQ AAVQTTCDLM SLVTKAKELH VQNVHMYLPT
     KLFQASRPSF NLLDSPHPRQ ENQVPSVRVE IHLPRDQSGE VDFKALVLQL KETSSLQEQA
     DILYMLYTMK GPDWNTELYN ERSATVRELL TELYGKVGEI RHWGLIRYIS GILRKKVEAL
     DEACTDLLSH QKHLTVGLPP EPREKTISAP LPYEALTQLI DEASEGDMSI SILTQEIMVY
     LAMYMRTQPG LFAEMFRLRI GLIIQVMATE LAHSLRCSAE EATEGLMNLS PSAMKNLLHH
     ILSGKEFGVE RSVRPTDSNV SPAISIHEIG AVGATKTERT GIMQLKSEIK QVEFRRLSIS
     AESQSPGTSM TPSSGSFPSA YDQQSSKDSR QGQWQRRRRL DGALNRVPVG FYQKVWKVLQ
     KCHGLSVEGF VLPSSTTREM TPGEIKFSVH VESVLNRVPQ PEYRQLLVEA ILVLTMLADI
     EIHSIGSIIA VEKIVHIAND LFLQEQKTLG ADDTMLAKDP ASGICTLLYD SAPSGRFGTM
     TYLSKAAATY VQEFLPHSIC AMQ
//
ID   CPLX1_HUMAN             Reviewed;         134 AA.
AC   O14810; A6NI80; B2R4R5; D3DVN3; F1T0G1;
DT   15-JUL-1999, integrated into UniProtKB/Swiss-Prot.
DT   01-JAN-1998, sequence version 1.
DT   23-MAY-2018, entry version 130.
DE   RecName: Full=Complexin-1;
DE   AltName: Full=Complexin I;
DE            Short=CPX I;
DE   AltName: Full=Synaphin-2;
GN   Name=CPLX1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Brain;
RX   PubMed=7553862; DOI=10.1016/0092-8674(95)90239-2;
RA   McMahon H.T., Missler M., Li C., Suedhof T.C.;
RT   "Complexins: cytosolic proteins that regulate SNAP receptor
RT   function.";
RL   Cell 83:111-119(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Fetal brain;
RX   PubMed=24722188; DOI=10.1038/ncomms4650;
RA   Corominas R., Yang X., Lin G.N., Kang S., Shen Y., Ghamsari L.,
RA   Broly M., Rodriguez M., Tam S., Wanamaker S.A., Fan C., Yi S.,
RA   Tasan M., Lemmens I., Kuang X., Zhao N., Malhotra D., Michaelson J.J.,
RA   Vacic V., Calderwood M.A., Roth F.P., Tavernier J., Horvath S.,
RA   Salehi-Ashtiani K., Korkin D., Sebat J., Hill D.E., Hao T., Vidal M.,
RA   Iakoucheva L.M.;
RT   "Protein interaction network of alternatively spliced isoforms from
RT   brain links genetic risk factors for autism.";
RL   Nat. Commun. 5:3650-3650(2014).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (OCT-2004) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=21697133; DOI=10.1167/iovs.11-7479;
RA   Oshikawa M., Tsutsui C., Ikegami T., Fuchida Y., Matsubara M.,
RA   Toyama S., Usami R., Ohtoko K., Kato S.;
RT   "Full-length transcriptome analysis of human retina-derived cell lines
RT   ARPE-19 and Y79 using the vector-capping method.";
RL   Invest. Ophthalmol. Vis. Sci. 52:6662-6670(2011).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Cerebellum;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Eye;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   TISSUE SPECIFICITY.
RX   PubMed=9853440; DOI=10.1016/S0140-6736(98)03341-8;
RA   Harrison P.J., Eastwood S.L.;
RT   "Preferential involvement of excitatory neurons in medial temporal
RT   lobe in schizophrenia.";
RL   Lancet 352:1669-1673(1998).
RN   [10]
RP   TISSUE SPECIFICITY.
RX   PubMed=11483314; DOI=10.1016/S0306-4522(01)00141-5;
RA   Eastwood S.L., Cotter D., Harrison P.J.;
RT   "Cerebellar synaptic protein expression in schizophrenia.";
RL   Neuroscience 105:219-229(2001).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY, AND TISSUE SPECIFICITY.
RX   PubMed=15526345; DOI=10.1002/pmic.200400848;
RA   Basso M., Giraudo S., Corpillo D., Bergamasco B., Lopiano L.,
RA   Fasano M.;
RT   "Proteome analysis of human substantia nigra in Parkinson's disease.";
RL   Proteomics 4:3943-3952(2004).
RN   [12]
RP   X-RAY CRYSTALLOGRAPHY (3.5 ANGSTROMS) OF 28-83 ALONE AND IN COMPLEX
RP   WITH SNAP25; VAMP2 AND RAT STX1A, SUBUNIT, AND FUNCTION.
RX   PubMed=21785414; DOI=10.1038/nsmb.2101;
RA   Kummel D., Krishnakumar S.S., Radoff D.T., Li F., Giraudo C.G.,
RA   Pincet F., Rothman J.E., Reinisch K.M.;
RT   "Complexin cross-links prefusion SNAREs into a zigzag array.";
RL   Nat. Struct. Mol. Biol. 18:927-933(2011).
CC   -!- FUNCTION: Positively regulates a late step in exocytosis of
CC       various cytoplasmic vesicles, such as synaptic vesicles and other
CC       secretory vesicles (PubMed:21785414). Organizes the SNAREs into a
CC       cross-linked zigzag topology that, when interposed between the
CC       vesicle and plasma membranes, is incompatible with fusion, thereby
CC       preventing SNAREs from releasing neurotransmitters until an action
CC       potential arrives at the synapse (PubMed:21785414). Also involved
CC       in glucose-induced secretion of insulin by pancreatic beta-cells.
CC       Essential for motor behavior. {ECO:0000250|UniProtKB:P63040,
CC       ECO:0000269|PubMed:21785414}.
CC   -!- SUBUNIT: Binds to the SNARE core complex containing SNAP25, VAMP2
CC       and STX1A. {ECO:0000269|PubMed:21785414}.
CC   -!- INTERACTION:
CC       P60880-2:SNAP25; NbExp=6; IntAct=EBI-2691813, EBI-12177361;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytosol
CC       {ECO:0000250|UniProtKB:P63040}. Note=Enriched at synaptic-
CC       releasing sites in mature neurons. {ECO:0000250|UniProtKB:P63040}.
CC   -!- TISSUE SPECIFICITY: Nervous system. In hippocampus and cerebellum,
CC       expressed mainly by inhibitory neurons. Overexpressed in
CC       substantia nigra from patients with Parkinson disease.
CC       {ECO:0000269|PubMed:11483314, ECO:0000269|PubMed:15526345,
CC       ECO:0000269|PubMed:9853440}.
CC   -!- SIMILARITY: Belongs to the complexin/synaphin family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF022383; AAB72108.1; -; mRNA.
DR   EMBL; KJ534815; AHW56455.1; -; mRNA.
DR   EMBL; BT007029; AAP35676.1; -; mRNA.
DR   EMBL; AB593095; BAJ84035.1; -; mRNA.
DR   EMBL; AK311921; BAG34862.1; -; mRNA.
DR   EMBL; AC139887; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471131; EAW82648.1; -; Genomic_DNA.
DR   EMBL; CH471131; EAW82649.1; -; Genomic_DNA.
DR   EMBL; BC002471; AAH02471.1; -; mRNA.
DR   CCDS; CCDS46995.1; -.
DR   RefSeq; NP_006642.1; NM_006651.3.
DR   UniGene; Hs.478930; -.
DR   PDB; 3RK3; X-ray; 3.50 A; E=26-83.
DR   PDB; 3RL0; X-ray; 3.80 A; g/h/i/j/k/l/m/n=26-83.
DR   PDBsum; 3RK3; -.
DR   PDBsum; 3RL0; -.
DR   ProteinModelPortal; O14810; -.
DR   SMR; O14810; -.
DR   BioGrid; 116028; 37.
DR   CORUM; O14810; -.
DR   DIP; DIP-56109N; -.
DR   IntAct; O14810; 5.
DR   STRING; 9606.ENSP00000305613; -.
DR   iPTMnet; O14810; -.
DR   PhosphoSitePlus; O14810; -.
DR   BioMuta; CPLX1; -.
DR   MaxQB; O14810; -.
DR   PaxDb; O14810; -.
DR   PeptideAtlas; O14810; -.
DR   PRIDE; O14810; -.
DR   DNASU; 10815; -.
DR   Ensembl; ENST00000304062; ENSP00000305613; ENSG00000168993.
DR   GeneID; 10815; -.
DR   KEGG; hsa:10815; -.
DR   UCSC; uc003gbi.4; human.
DR   CTD; 10815; -.
DR   DisGeNET; 10815; -.
DR   EuPathDB; HostDB:ENSG00000168993.14; -.
DR   GeneCards; CPLX1; -.
DR   HGNC; HGNC:2309; CPLX1.
DR   HPA; HPA071191; -.
DR   MalaCards; CPLX1; -.
DR   MIM; 605032; gene.
DR   neXtProt; NX_O14810; -.
DR   OpenTargets; ENSG00000168993; -.
DR   PharmGKB; PA26826; -.
DR   eggNOG; ENOG410IWGS; Eukaryota.
DR   eggNOG; ENOG4111MX0; LUCA.
DR   GeneTree; ENSGT00490000043416; -.
DR   HOGENOM; HOG000017716; -.
DR   HOVERGEN; HBG062792; -.
DR   InParanoid; O14810; -.
DR   KO; K15294; -.
DR   OMA; TVMKFIP; -.
DR   OrthoDB; EOG091G0WGX; -.
DR   PhylomeDB; O14810; -.
DR   TreeFam; TF315172; -.
DR   Reactome; R-HSA-181429; Serotonin Neurotransmitter Release Cycle.
DR   Reactome; R-HSA-181430; Norepinephrine Neurotransmitter Release Cycle.
DR   Reactome; R-HSA-210500; Glutamate Neurotransmitter Release Cycle.
DR   Reactome; R-HSA-212676; Dopamine Neurotransmitter Release Cycle.
DR   Reactome; R-HSA-264642; Acetylcholine Neurotransmitter Release Cycle.
DR   Reactome; R-HSA-888590; GABA synthesis, release, reuptake and degradation.
DR   ChiTaRS; CPLX1; human.
DR   GeneWiki; CPLX1; -.
DR   GenomeRNAi; 10815; -.
DR   PRO; PR:O14810; -.
DR   Proteomes; UP000005640; Chromosome 4.
DR   Bgee; ENSG00000168993; -.
DR   CleanEx; HS_CPLX1; -.
DR   ExpressionAtlas; O14810; baseline and differential.
DR   Genevisible; O14810; HS.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0030425; C:dendrite; IEA:Ensembl.
DR   GO; GO:0043025; C:neuronal cell body; IEA:Ensembl.
DR   GO; GO:0098793; C:presynapse; IEA:GOC.
DR   GO; GO:0070032; C:synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex; IEA:Ensembl.
DR   GO; GO:0070554; C:synaptobrevin 2-SNAP-25-syntaxin-3-complexin complex; TAS:ParkinsonsUK-UCL.
DR   GO; GO:0005326; F:neurotransmitter transporter activity; IEA:Ensembl.
DR   GO; GO:0017075; F:syntaxin-1 binding; IEA:Ensembl.
DR   GO; GO:0007268; P:chemical synaptic transmission; TAS:ProtInc.
DR   GO; GO:0006887; P:exocytosis; TAS:ProtInc.
DR   GO; GO:0030073; P:insulin secretion; IEA:Ensembl.
DR   GO; GO:0017157; P:regulation of exocytosis; TAS:ParkinsonsUK-UCL.
DR   GO; GO:0016079; P:synaptic vesicle exocytosis; IEA:Ensembl.
DR   InterPro; IPR008849; Synaphin.
DR   PANTHER; PTHR16705; PTHR16705; 1.
DR   Pfam; PF05835; Synaphin; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Coiled coil; Complete proteome; Cytoplasm; Exocytosis;
KW   Neurotransmitter transport; Reference proteome; Transport.
FT   CHAIN         1    134       Complexin-1.
FT                                /FTId=PRO_0000144870.
FT   REGION       48     70       Interaction with the SNARE complex.
FT                                {ECO:0000250}.
FT   COILED       29     69       {ECO:0000255}.
FT   HELIX        29     70       {ECO:0000244|PDB:3RK3}.
SQ   SEQUENCE   134 AA;  15030 MW;  A7A52F17F10D28A4 CRC64;
     MEFVMKQALG GATKDMGKML GGDEEKDPDA AKKEEERQEA LRQAEEERKA KYAKMEAERE
     AVRQGIRDKY GIKKKEEREA EAQAAMEANS EGSLTRPKKA IPPGCGDEVE EEDESILDTV
     IKYLPGPLQD MLKK
//
ID   A0A024R5Q7_HUMAN        Unreviewed;       456 AA.
AC   A0A024R5Q7;
DT   09-JUL-2014, integrated into UniProtKB/TrEMBL.
DT   09-JUL-2014, sequence version 1.
DT   28-MAR-2018, entry version 32.
DE   RecName: Full=Adenylosuccinate synthetase isozyme 2 {ECO:0000256|HAMAP-Rule:MF_03127};
DE            Short=AMPSase 2 {ECO:0000256|HAMAP-Rule:MF_03127};
DE            Short=AdSS 2 {ECO:0000256|HAMAP-Rule:MF_03127};
DE            EC=6.3.4.4 {ECO:0000256|HAMAP-Rule:MF_03127};
DE   AltName: Full=Adenylosuccinate synthetase, acidic isozyme {ECO:0000256|HAMAP-Rule:MF_03127};
DE   AltName: Full=Adenylosuccinate synthetase, liver isozyme {ECO:0000256|HAMAP-Rule:MF_03127};
DE            Short=L-type adenylosuccinate synthetase {ECO:0000256|HAMAP-Rule:MF_03127};
DE   AltName: Full=IMP--aspartate ligase 2 {ECO:0000256|HAMAP-Rule:MF_03127};
GN   Name=ADSS {ECO:0000256|HAMAP-Rule:MF_03127,
GN   ECO:0000313|EMBL:EAW77103.1};
GN   Synonyms=ADSS2 {ECO:0000256|HAMAP-Rule:MF_03127};
GN   ORFNames=hCG_15389 {ECO:0000313|EMBL:EAW77103.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:EAW77103.1};
RN   [1] {ECO:0000313|EMBL:EAW77103.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAW77103.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
CC   -!- FUNCTION: Plays an important role in the de novo pathway and in
CC       the salvage pathway of purine nucleotide biosynthesis. Catalyzes
CC       the first commited step in the biosynthesis of AMP from IMP.
CC       {ECO:0000256|HAMAP-Rule:MF_03127}.
CC   -!- FUNCTION: Plays an important role in the de novo pathway of purine
CC       nucleotide biosynthesis. {ECO:0000256|RuleBase:RU000520}.
CC   -!- CATALYTIC ACTIVITY: GTP + IMP + L-aspartate = GDP + phosphate +
CC       N(6)-(1,2-dicarboxyethyl)-AMP. {ECO:0000256|HAMAP-Rule:MF_03127,
CC       ECO:0000256|RuleBase:RU000520}.
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC         Evidence={ECO:0000256|HAMAP-Rule:MF_03127};
CC       Note=Binds 1 Mg(2+) ion per subunit. {ECO:0000256|HAMAP-
CC       Rule:MF_03127};
CC   -!- PATHWAY: Purine metabolism; AMP biosynthesis via de novo pathway;
CC       AMP from IMP: step 1/2. {ECO:0000256|HAMAP-Rule:MF_03127,
CC       ECO:0000256|RuleBase:RU000520}.
CC   -!- SUBUNIT: Homodimer. {ECO:0000256|HAMAP-Rule:MF_03127}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000256|HAMAP-Rule:MF_03127}.
CC   -!- SIMILARITY: Belongs to the adenylosuccinate synthetase family.
CC       {ECO:0000256|HAMAP-Rule:MF_03127, ECO:0000256|RuleBase:RU000520}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; CH471148; EAW77103.1; -; Genomic_DNA.
DR   RefSeq; NP_001117.2; NM_001126.3.
DR   UniGene; Hs.498313; -.
DR   ProteinModelPortal; A0A024R5Q7; -.
DR   SMR; A0A024R5Q7; -.
DR   PRIDE; A0A024R5Q7; -.
DR   GeneID; 159; -.
DR   KEGG; hsa:159; -.
DR   CTD; 159; -.
DR   EuPathDB; HostDB:ENSG00000035687.9; -.
DR   eggNOG; KOG1355; Eukaryota.
DR   eggNOG; COG0104; LUCA.
DR   KO; K01939; -.
DR   OMA; GIAPFYS; -.
DR   OrthoDB; EOG091G1BIK; -.
DR   PhylomeDB; A0A024R5Q7; -.
DR   UniPathway; UPA00075; UER00335.
DR   ChiTaRS; ADSS; human.
DR   GenomeRNAi; 159; -.
DR   Bgee; ENSG00000035687; -.
DR   ExpressionAtlas; A0A024R5Q7; baseline and differential.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005886; C:plasma membrane; IDA:HPA.
DR   GO; GO:0004019; F:adenylosuccinate synthase activity; IEA:UniProtKB-UniRule.
DR   GO; GO:0005525; F:GTP binding; IEA:UniProtKB-UniRule.
DR   GO; GO:0000287; F:magnesium ion binding; IEA:UniProtKB-UniRule.
DR   GO; GO:0044208; P:'de novo' AMP biosynthetic process; IEA:UniProtKB-UniPathway.
DR   GO; GO:0006531; P:aspartate metabolic process; IEA:Ensembl.
DR   GO; GO:0071257; P:cellular response to electrical stimulus; IEA:Ensembl.
DR   GO; GO:0046040; P:IMP metabolic process; IEA:Ensembl.
DR   GO; GO:0060359; P:response to ammonium ion; IEA:Ensembl.
DR   GO; GO:0014074; P:response to purine-containing compound; IEA:Ensembl.
DR   CDD; cd03108; AdSS; 1.
DR   HAMAP; MF_00011; Adenylosucc_synth; 1.
DR   HAMAP; MF_03127; Adenylosucc_synth_vert_acid; 1.
DR   InterPro; IPR018220; Adenylosuccin_syn_GTP-bd.
DR   InterPro; IPR033128; Adenylosuccin_syn_Lys_AS.
DR   InterPro; IPR001114; Adenylosuccinate_synthetase.
DR   InterPro; IPR027529; AdSS_2_vert.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   PANTHER; PTHR11846; PTHR11846; 1.
DR   Pfam; PF00709; Adenylsucc_synt; 1.
DR   SMART; SM00788; Adenylsucc_synt; 1.
DR   SUPFAM; SSF52540; SSF52540; 1.
DR   TIGRFAMs; TIGR00184; purA; 1.
DR   PROSITE; PS01266; ADENYLOSUCCIN_SYN_1; 1.
DR   PROSITE; PS00513; ADENYLOSUCCIN_SYN_2; 1.
PE   3: Inferred from homology;
KW   Cytoplasm {ECO:0000256|HAMAP-Rule:MF_03127};
KW   GTP-binding {ECO:0000256|HAMAP-Rule:MF_03127,
KW   ECO:0000256|RuleBase:RU000520};
KW   Ligase {ECO:0000256|HAMAP-Rule:MF_03127,
KW   ECO:0000256|RuleBase:RU000520};
KW   Magnesium {ECO:0000256|HAMAP-Rule:MF_03127,
KW   ECO:0000256|RuleBase:RU000520};
KW   Metal-binding {ECO:0000256|HAMAP-Rule:MF_03127,
KW   ECO:0000256|RuleBase:RU000520};
KW   Nucleotide-binding {ECO:0000256|HAMAP-Rule:MF_03127,
KW   ECO:0000256|RuleBase:RU000520};
KW   Purine biosynthesis {ECO:0000256|HAMAP-Rule:MF_03127,
KW   ECO:0000256|RuleBase:RU000520}.
FT   NP_BIND      39     45       GTP. {ECO:0000256|HAMAP-Rule:MF_03127}.
FT   NP_BIND      67     69       GTP. {ECO:0000256|HAMAP-Rule:MF_03127}.
FT   NP_BIND     362    364       GTP. {ECO:0000256|HAMAP-Rule:MF_03127}.
FT   NP_BIND     444    447       GTP. {ECO:0000256|HAMAP-Rule:MF_03127}.
FT   REGION       40     43       IMP binding. {ECO:0000256|HAMAP-
FT                                Rule:MF_03127}.
FT   REGION       65     68       IMP binding. {ECO:0000256|HAMAP-
FT                                Rule:MF_03127}.
FT   REGION      330    336       Substrate binding. {ECO:0000256|HAMAP-
FT                                Rule:MF_03127}.
FT   ACT_SITE     40     40       Proton acceptor. {ECO:0000256|HAMAP-
FT                                Rule:MF_03127}.
FT   ACT_SITE     68     68       Proton donor. {ECO:0000256|HAMAP-
FT                                Rule:MF_03127}.
FT   ACT_SITE    173    173       {ECO:0000256|PROSITE-ProRule:PRU10134}.
FT   METAL        40     40       Magnesium. {ECO:0000256|HAMAP-
FT                                Rule:MF_03127}.
FT   METAL        67     67       Magnesium; via carbonyl oxygen.
FT                                {ECO:0000256|HAMAP-Rule:MF_03127}.
FT   BINDING      40     40       Substrate. {ECO:0000256|HAMAP-
FT                                Rule:MF_03127}.
FT   BINDING     162    162       IMP. {ECO:0000256|HAMAP-Rule:MF_03127}.
FT   BINDING     176    176       IMP; shared with dimeric partner.
FT                                {ECO:0000256|HAMAP-Rule:MF_03127}.
FT   BINDING     255    255       IMP. {ECO:0000256|HAMAP-Rule:MF_03127}.
FT   BINDING     270    270       IMP. {ECO:0000256|HAMAP-Rule:MF_03127}.
FT   BINDING     334    334       IMP. {ECO:0000256|HAMAP-Rule:MF_03127}.
FT   BINDING     336    336       GTP. {ECO:0000256|HAMAP-Rule:MF_03127}.
SQ   SEQUENCE   456 AA;  50097 MW;  23B7AAC58A238783 CRC64;
     MAFAETYPAA SSLPNGDCGR PRARPGGNRV TVVLGAQWGD EGKGKVVDLL AQDADIVCRC
     QGGNNAGHTV VVDSVEYDFH LLPSGIINPN VTAFIGNGVV IHLPGLFEEA EKNVQKGKGL
     EGWEKRLIIS DRAHIVFDFH QAADGIQEQQ RQEQAGKNLG TTKKGIGPVY SSKAARSGLR
     MCDLVSDFDG FSERFKVLAN QYKSIYPTLE IDIEGELQKL KGYMEKIKPM VRDGVYFLYE
     ALHGPPKKIL VEGANAALLD IDFGTYPFVT SSNCTVGGVC TGLGMPPQNV GEVYGVVKAY
     TTRVGIGAFP TEQDNEIGEL LQTRGREFGV TTGRKRRCGW LDLVLLKYAH MINGFTALAL
     TKLDILDMFT EIKVGVAYKL DGEIIPHIPA NQEVLNKVEV QYKTLPGWNT DISNARAFKE
     LPVNAQNYVR FIEDELQIPV KWIGVGKSRE SMIQLF
//
ID   PURA2_HUMAN             Reviewed;         456 AA.
AC   P30520; B1AQM5; Q96EG7;
DT   01-APR-1993, integrated into UniProtKB/Swiss-Prot.
DT   27-MAY-2002, sequence version 3.
DT   23-MAY-2018, entry version 183.
DE   RecName: Full=Adenylosuccinate synthetase isozyme 2 {ECO:0000255|HAMAP-Rule:MF_03127};
DE            Short=AMPSase 2 {ECO:0000255|HAMAP-Rule:MF_03127};
DE            Short=AdSS 2 {ECO:0000255|HAMAP-Rule:MF_03127};
DE            EC=6.3.4.4 {ECO:0000255|HAMAP-Rule:MF_03127};
DE   AltName: Full=Adenylosuccinate synthetase, acidic isozyme {ECO:0000255|HAMAP-Rule:MF_03127};
DE   AltName: Full=Adenylosuccinate synthetase, liver isozyme {ECO:0000255|HAMAP-Rule:MF_03127};
DE            Short=L-type adenylosuccinate synthetase {ECO:0000255|HAMAP-Rule:MF_03127};
DE   AltName: Full=IMP--aspartate ligase 2 {ECO:0000255|HAMAP-Rule:MF_03127};
GN   Name=ADSS {ECO:0000255|HAMAP-Rule:MF_03127};
GN   Synonyms=ADSS2 {ECO:0000255|HAMAP-Rule:MF_03127};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   TISSUE=Liver;
RX   PubMed=1592113; DOI=10.1016/0014-5793(92)80465-S;
RA   Powell S.M., Zalkin H., Dixon J.E.;
RT   "Cloning and characterization of the cDNA encoding human
RT   adenylosuccinate synthetase.";
RL   FEBS Lett. 303:4-10(1992).
RN   [2]
RP   SEQUENCE REVISION.
RA   Stone R.L.;
RL   Submitted (NOV-1993) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Eye;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [8]
RP   X-RAY CRYSTALLOGRAPHY (1.9 ANGSTROMS) OF 21-456 IN COMPLEX WITH GDP.
RG   Structural genomics consortium (SGC);
RT   "Human adenylosuccinate synthetase isozyme 2 in complex with GDP.";
RL   Submitted (FEB-2009) to the PDB data bank.
CC   -!- FUNCTION: Plays an important role in the de novo pathway and in
CC       the salvage pathway of purine nucleotide biosynthesis. Catalyzes
CC       the first committed step in the biosynthesis of AMP from IMP.
CC   -!- CATALYTIC ACTIVITY: GTP + IMP + L-aspartate = GDP + phosphate +
CC       N(6)-(1,2-dicarboxyethyl)-AMP. {ECO:0000255|HAMAP-Rule:MF_03127}.
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC         Evidence={ECO:0000255|HAMAP-Rule:MF_03127};
CC       Note=Binds 1 Mg(2+) ion per subunit. {ECO:0000255|HAMAP-
CC       Rule:MF_03127};
CC   -!- PATHWAY: Purine metabolism; AMP biosynthesis via de novo pathway;
CC       AMP from IMP: step 1/2. {ECO:0000255|HAMAP-Rule:MF_03127}.
CC   -!- SUBUNIT: Homodimer. {ECO:0000255|HAMAP-Rule:MF_03127}.
CC   -!- INTERACTION:
CC       Q8NB12:SMYD1; NbExp=2; IntAct=EBI-1042898, EBI-8463848;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm. Note=Partially associated with
CC       particulate fractions.
CC   -!- SIMILARITY: Belongs to the adenylosuccinate synthetase family.
CC       {ECO:0000255|HAMAP-Rule:MF_03127}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X66503; CAA47123.1; -; Genomic_DNA.
DR   EMBL; AL591594; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL645465; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471148; EAW77102.1; -; Genomic_DNA.
DR   EMBL; BC012356; AAH12356.1; -; mRNA.
DR   CCDS; CCDS1624.1; -.
DR   PIR; S21166; S21166.
DR   RefSeq; NP_001117.2; NM_001126.3.
DR   UniGene; Hs.498313; -.
DR   PDB; 2V40; X-ray; 1.90 A; A=21-456.
DR   PDBsum; 2V40; -.
DR   ProteinModelPortal; P30520; -.
DR   SMR; P30520; -.
DR   BioGrid; 106668; 45.
DR   IntAct; P30520; 7.
DR   MINT; P30520; -.
DR   STRING; 9606.ENSP00000355493; -.
DR   BindingDB; P30520; -.
DR   ChEMBL; CHEMBL4875; -.
DR   DrugBank; DB00128; L-Aspartic Acid.
DR   iPTMnet; P30520; -.
DR   PhosphoSitePlus; P30520; -.
DR   SwissPalm; P30520; -.
DR   BioMuta; ADSS; -.
DR   DMDM; 21264498; -.
DR   EPD; P30520; -.
DR   MaxQB; P30520; -.
DR   PaxDb; P30520; -.
DR   PeptideAtlas; P30520; -.
DR   PRIDE; P30520; -.
DR   DNASU; 159; -.
DR   Ensembl; ENST00000366535; ENSP00000355493; ENSG00000035687.
DR   GeneID; 159; -.
DR   KEGG; hsa:159; -.
DR   UCSC; uc001iaj.4; human.
DR   CTD; 159; -.
DR   DisGeNET; 159; -.
DR   EuPathDB; HostDB:ENSG00000035687.9; -.
DR   GeneCards; ADSS; -.
DR   HGNC; HGNC:292; ADSS.
DR   HPA; HPA024400; -.
DR   MIM; 103060; gene.
DR   neXtProt; NX_P30520; -.
DR   OpenTargets; ENSG00000035687; -.
DR   PharmGKB; PA24601; -.
DR   eggNOG; KOG1355; Eukaryota.
DR   eggNOG; COG0104; LUCA.
DR   GeneTree; ENSGT00390000015553; -.
DR   HOGENOM; HOG000260959; -.
DR   HOVERGEN; HBG053768; -.
DR   InParanoid; P30520; -.
DR   KO; K01939; -.
DR   OMA; GIAPFYS; -.
DR   OrthoDB; EOG091G1BIK; -.
DR   PhylomeDB; P30520; -.
DR   TreeFam; TF300486; -.
DR   Reactome; R-HSA-73817; Purine ribonucleoside monophosphate biosynthesis.
DR   UniPathway; UPA00075; UER00335.
DR   ChiTaRS; ADSS; human.
DR   EvolutionaryTrace; P30520; -.
DR   GenomeRNAi; 159; -.
DR   PRO; PR:P30520; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000035687; -.
DR   CleanEx; HS_ADSS; -.
DR   ExpressionAtlas; P30520; baseline and differential.
DR   Genevisible; P30520; HS.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IDA:HPA.
DR   GO; GO:0004019; F:adenylosuccinate synthase activity; IDA:UniProtKB.
DR   GO; GO:0005525; F:GTP binding; NAS:UniProtKB.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0042301; F:phosphate ion binding; NAS:UniProtKB.
DR   GO; GO:0044208; P:'de novo' AMP biosynthetic process; IBA:GO_Central.
DR   GO; GO:0006167; P:AMP biosynthetic process; IDA:UniProtKB.
DR   GO; GO:0006531; P:aspartate metabolic process; IEA:Ensembl.
DR   GO; GO:0071257; P:cellular response to electrical stimulus; IEA:Ensembl.
DR   GO; GO:0002376; P:immune system process; NAS:UniProtKB.
DR   GO; GO:0046040; P:IMP metabolic process; IBA:GO_Central.
DR   GO; GO:0009168; P:purine ribonucleoside monophosphate biosynthetic process; TAS:Reactome.
DR   GO; GO:0060359; P:response to ammonium ion; IEA:Ensembl.
DR   GO; GO:0014074; P:response to purine-containing compound; IEA:Ensembl.
DR   CDD; cd03108; AdSS; 1.
DR   HAMAP; MF_00011; Adenylosucc_synth; 1.
DR   HAMAP; MF_03127; Adenylosucc_synth_vert_acid; 1.
DR   InterPro; IPR018220; Adenylosuccin_syn_GTP-bd.
DR   InterPro; IPR033128; Adenylosuccin_syn_Lys_AS.
DR   InterPro; IPR001114; Adenylosuccinate_synthetase.
DR   InterPro; IPR027529; AdSS_2_vert.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   PANTHER; PTHR11846; PTHR11846; 1.
DR   Pfam; PF00709; Adenylsucc_synt; 1.
DR   SMART; SM00788; Adenylsucc_synt; 1.
DR   SUPFAM; SSF52540; SSF52540; 1.
DR   TIGRFAMs; TIGR00184; purA; 1.
DR   PROSITE; PS01266; ADENYLOSUCCIN_SYN_1; 1.
DR   PROSITE; PS00513; ADENYLOSUCCIN_SYN_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Complete proteome; Cytoplasm; GTP-binding; Ligase;
KW   Magnesium; Metal-binding; Nucleotide-binding; Polymorphism;
KW   Purine biosynthesis; Reference proteome.
FT   CHAIN         1    456       Adenylosuccinate synthetase isozyme 2.
FT                                /FTId=PRO_0000095130.
FT   NP_BIND      39     45       GTP.
FT   NP_BIND      67     69       GTP.
FT   NP_BIND     362    364       GTP.
FT   NP_BIND     444    447       GTP.
FT   REGION       40     43       IMP binding. {ECO:0000255|HAMAP-
FT                                Rule:MF_03127}.
FT   REGION       65     68       IMP binding. {ECO:0000255|HAMAP-
FT                                Rule:MF_03127}.
FT   REGION      330    336       Substrate binding. {ECO:0000255|HAMAP-
FT                                Rule:MF_03127}.
FT   ACT_SITE     40     40       Proton acceptor. {ECO:0000255|HAMAP-
FT                                Rule:MF_03127}.
FT   ACT_SITE     68     68       Proton donor. {ECO:0000255|HAMAP-
FT                                Rule:MF_03127}.
FT   METAL        40     40       Magnesium. {ECO:0000255|HAMAP-
FT                                Rule:MF_03127}.
FT   METAL        67     67       Magnesium; via carbonyl oxygen.
FT                                {ECO:0000255|HAMAP-Rule:MF_03127}.
FT   BINDING      40     40       Substrate. {ECO:0000255|HAMAP-
FT                                Rule:MF_03127}.
FT   BINDING     162    162       IMP. {ECO:0000255|HAMAP-Rule:MF_03127}.
FT   BINDING     176    176       IMP; shared with dimeric partner.
FT                                {ECO:0000255|HAMAP-Rule:MF_03127}.
FT   BINDING     255    255       IMP. {ECO:0000255|HAMAP-Rule:MF_03127}.
FT   BINDING     270    270       IMP. {ECO:0000255|HAMAP-Rule:MF_03127}.
FT   BINDING     334    334       IMP. {ECO:0000255|HAMAP-Rule:MF_03127}.
FT   BINDING     336    336       GTP. {ECO:0000255|HAMAP-Rule:MF_03127}.
FT   VARIANT     179    179       L -> F (in dbSNP:rs12134870).
FT                                /FTId=VAR_051881.
FT   CONFLICT     24     25       RP -> A (in Ref. 1; CAA47123).
FT                                {ECO:0000305}.
FT   STRAND       30     39       {ECO:0000244|PDB:2V40}.
FT   HELIX        43     51       {ECO:0000244|PDB:2V40}.
FT   STRAND       55     59       {ECO:0000244|PDB:2V40}.
FT   STRAND       68     72       {ECO:0000244|PDB:2V40}.
FT   STRAND       75     82       {ECO:0000244|PDB:2V40}.
FT   HELIX        84     87       {ECO:0000244|PDB:2V40}.
FT   STRAND       92     95       {ECO:0000244|PDB:2V40}.
FT   STRAND       99    102       {ECO:0000244|PDB:2V40}.
FT   HELIX       103    116       {ECO:0000244|PDB:2V40}.
FT   HELIX       118    120       {ECO:0000244|PDB:2V40}.
FT   HELIX       123    125       {ECO:0000244|PDB:2V40}.
FT   STRAND      126    130       {ECO:0000244|PDB:2V40}.
FT   STRAND      134    136       {ECO:0000244|PDB:2V40}.
FT   HELIX       138    149       {ECO:0000244|PDB:2V40}.
FT   HELIX       166    174       {ECO:0000244|PDB:2V40}.
FT   HELIX       181    184       {ECO:0000244|PDB:2V40}.
FT   HELIX       188    205       {ECO:0000244|PDB:2V40}.
FT   HELIX       213    227       {ECO:0000244|PDB:2V40}.
FT   HELIX       228    230       {ECO:0000244|PDB:2V40}.
FT   HELIX       234    243       {ECO:0000244|PDB:2V40}.
FT   STRAND      249    252       {ECO:0000244|PDB:2V40}.
FT   HELIX       257    259       {ECO:0000244|PDB:2V40}.
FT   TURN        261    263       {ECO:0000244|PDB:2V40}.
FT   HELIX       277    283       {ECO:0000244|PDB:2V40}.
FT   HELIX       287    289       {ECO:0000244|PDB:2V40}.
FT   STRAND      290    307       {ECO:0000244|PDB:2V40}.
FT   HELIX       316    324       {ECO:0000244|PDB:2V40}.
FT   TURN        330    332       {ECO:0000244|PDB:2V40}.
FT   STRAND      337    339       {ECO:0000244|PDB:2V40}.
FT   HELIX       343    353       {ECO:0000244|PDB:2V40}.
FT   STRAND      356    361       {ECO:0000244|PDB:2V40}.
FT   HELIX       363    368       {ECO:0000244|PDB:2V40}.
FT   STRAND      370    380       {ECO:0000244|PDB:2V40}.
FT   STRAND      383    387       {ECO:0000244|PDB:2V40}.
FT   HELIX       392    395       {ECO:0000244|PDB:2V40}.
FT   STRAND      399    406       {ECO:0000244|PDB:2V40}.
FT   HELIX       418    420       {ECO:0000244|PDB:2V40}.
FT   HELIX       423    436       {ECO:0000244|PDB:2V40}.
FT   STRAND      440    444       {ECO:0000244|PDB:2V40}.
FT   STRAND      446    448       {ECO:0000244|PDB:2V40}.
FT   STRAND      451    454       {ECO:0000244|PDB:2V40}.
SQ   SEQUENCE   456 AA;  50097 MW;  23B7AAC58A238783 CRC64;
     MAFAETYPAA SSLPNGDCGR PRARPGGNRV TVVLGAQWGD EGKGKVVDLL AQDADIVCRC
     QGGNNAGHTV VVDSVEYDFH LLPSGIINPN VTAFIGNGVV IHLPGLFEEA EKNVQKGKGL
     EGWEKRLIIS DRAHIVFDFH QAADGIQEQQ RQEQAGKNLG TTKKGIGPVY SSKAARSGLR
     MCDLVSDFDG FSERFKVLAN QYKSIYPTLE IDIEGELQKL KGYMEKIKPM VRDGVYFLYE
     ALHGPPKKIL VEGANAALLD IDFGTYPFVT SSNCTVGGVC TGLGMPPQNV GEVYGVVKAY
     TTRVGIGAFP TEQDNEIGEL LQTRGREFGV TTGRKRRCGW LDLVLLKYAH MINGFTALAL
     TKLDILDMFT EIKVGVAYKL DGEIIPHIPA NQEVLNKVEV QYKTLPGWNT DISNARAFKE
     LPVNAQNYVR FIEDELQIPV KWIGVGKSRE SMIQLF
//
ID   SMC5_HUMAN              Reviewed;        1101 AA.
AC   Q8IY18; A6NM81; O60335; Q05D92; Q5VZ60; Q96SB9;
DT   09-JAN-2007, integrated into UniProtKB/Swiss-Prot.
DT   09-JAN-2007, sequence version 2.
DT   23-MAY-2018, entry version 125.
DE   RecName: Full=Structural maintenance of chromosomes protein 5;
DE            Short=SMC protein 5;
DE            Short=SMC-5;
DE            Short=hSMC5;
GN   Name=SMC5; Synonyms=KIAA0594, SMC5L1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], INTERACTION WITH SMC6, SUBCELLULAR
RP   LOCATION, TISSUE SPECIFICITY, AND VARIANTS ILE-306 AND ARG-308.
RX   PubMed=11408570; DOI=10.1091/mbc.12.6.1583;
RA   Taylor E.M., Moghraby J.S., Lees J.H., Smit B., Moens P.B.,
RA   Lehmann A.R.;
RT   "Characterization of a novel human SMC heterodimer homologous to the
RT   Schizosaccharomyces pombe Rad18/Spr18 complex.";
RL   Mol. Biol. Cell 12:1583-1594(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT ILE-306.
RC   TISSUE=Brain;
RX   PubMed=9628581; DOI=10.1093/dnares/5.1.31;
RA   Nagase T., Ishikawa K., Miyajima N., Tanaka A., Kotani H., Nomura N.,
RA   Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. IX.
RT   The complete sequences of 100 new cDNA clones from brain which can
RT   code for large proteins in vitro.";
RL   DNA Res. 5:31-39(1998).
RN   [3]
RP   SEQUENCE REVISION.
RX   PubMed=12168954; DOI=10.1093/dnares/9.3.99;
RA   Nakajima D., Okazaki N., Yamakawa H., Kikuno R., Ohara O., Nagase T.;
RT   "Construction of expression-ready cDNA clones for KIAA genes: manual
RT   curation of 330 KIAA cDNA clones.";
RL   DNA Res. 9:99-106(2002).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164053; DOI=10.1038/nature02465;
RA   Humphray S.J., Oliver K., Hunt A.R., Plumb R.W., Loveland J.E.,
RA   Howe K.L., Andrews T.D., Searle S., Hunt S.E., Scott C.E., Jones M.C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Ashwell R.I.S.,
RA   Babbage A.K., Babbage S., Bagguley C.L., Bailey J., Banerjee R.,
RA   Barker D.J., Barlow K.F., Bates K., Beasley H., Beasley O., Bird C.P.,
RA   Bray-Allen S., Brown A.J., Brown J.Y., Burford D., Burrill W.,
RA   Burton J., Carder C., Carter N.P., Chapman J.C., Chen Y., Clarke G.,
RA   Clark S.Y., Clee C.M., Clegg S., Collier R.E., Corby N., Crosier M.,
RA   Cummings A.T., Davies J., Dhami P., Dunn M., Dutta I., Dyer L.W.,
RA   Earthrowl M.E., Faulkner L., Fleming C.J., Frankish A.,
RA   Frankland J.A., French L., Fricker D.G., Garner P., Garnett J.,
RA   Ghori J., Gilbert J.G.R., Glison C., Grafham D.V., Gribble S.,
RA   Griffiths C., Griffiths-Jones S., Grocock R., Guy J., Hall R.E.,
RA   Hammond S., Harley J.L., Harrison E.S.I., Hart E.A., Heath P.D.,
RA   Henderson C.D., Hopkins B.L., Howard P.J., Howden P.J., Huckle E.,
RA   Johnson C., Johnson D., Joy A.A., Kay M., Keenan S., Kershaw J.K.,
RA   Kimberley A.M., King A., Knights A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C., Lloyd D.M.,
RA   Lovell J., Martin S., Mashreghi-Mohammadi M., Matthews L., McLaren S.,
RA   McLay K.E., McMurray A., Milne S., Nickerson T., Nisbett J.,
RA   Nordsiek G., Pearce A.V., Peck A.I., Porter K.M., Pandian R.,
RA   Pelan S., Phillimore B., Povey S., Ramsey Y., Rand V., Scharfe M.,
RA   Sehra H.K., Shownkeen R., Sims S.K., Skuce C.D., Smith M.,
RA   Steward C.A., Swarbreck D., Sycamore N., Tester J., Thorpe A.,
RA   Tracey A., Tromans A., Thomas D.W., Wall M., Wallis J.M., West A.P.,
RA   Whitehead S.L., Willey D.L., Williams S.A., Wilming L., Wray P.W.,
RA   Young L., Ashurst J.L., Coulson A., Blocker H., Durbin R.M.,
RA   Sulston J.E., Hubbard T., Jackson M.J., Bentley D.R., Beck S.,
RA   Rogers J., Dunham I.;
RT   "DNA sequence and analysis of human chromosome 9.";
RL   Nature 429:369-374(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANTS ILE-306 AND
RP   ARG-308.
RC   TISSUE=Mammary gland, and Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   INTERACTION WITH NSMCE2.
RX   PubMed=16055714; DOI=10.1128/MCB.25.16.7021-7032.2005;
RA   Potts P.R., Yu H.;
RT   "Human MMS21/NSE2 is a SUMO ligase required for DNA repair.";
RL   Mol. Cell. Biol. 25:7021-7032(2005).
RN   [7]
RP   FUNCTION.
RX   PubMed=16810316; DOI=10.1038/sj.emboj.7601218;
RA   Potts P.R., Porteus M.H., Yu H.;
RT   "Human SMC5/6 complex promotes sister chromatid homologous
RT   recombination by recruiting the SMC1/3 cohesin complex to double-
RT   strand breaks.";
RL   EMBO J. 25:3377-3388(2006).
RN   [8]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=17589526; DOI=10.1038/nsmb1259;
RA   Potts P.R., Yu H.;
RT   "The SMC5/6 complex maintains telomere length in ALT cancer cells
RT   through SUMOylation of telomere-binding proteins.";
RL   Nat. Struct. Mol. Biol. 14:581-590(2007).
RN   [9]
RP   SUMOYLATION, UBIQUITINATION, AND IDENTIFICATION IN THE SMC5-SMC6
RP   COMPLEX.
RX   PubMed=18086888; DOI=10.1128/MCB.00767-07;
RA   Taylor E.M., Copsey A.C., Hudson J.J., Vidot S., Lehmann A.R.;
RT   "Identification of the proteins, including MAGEG1, that make up the
RT   human SMC5-6 protein complex.";
RL   Mol. Cell. Biol. 28:1197-1206(2008).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-35, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [11]
RP   FUNCTION.
RX   PubMed=19502785; DOI=10.4161/cc.8.14.8979;
RA   Behlke-Steinert S., Touat-Todeschini L., Skoufias D.A., Margolis R.L.;
RT   "SMC5 and MMS21 are required for chromosome cohesion and mitotic
RT   progression.";
RL   Cell Cycle 8:2211-2218(2009).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-35, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-25 AND SER-35, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-35, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [16]
RP   INTERACTION WITH RAD18 AND SLF2, SUBCELLULAR LOCATION, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=25931565; DOI=10.1126/science.1253671;
RA   Raeschle M., Smeenk G., Hansen R.K., Temu T., Oka Y., Hein M.Y.,
RA   Nagaraj N., Long D.T., Walter J.C., Hofmann K., Storchova Z., Cox J.,
RA   Bekker-Jensen S., Mailand N., Mann M.;
RT   "DNA repair. Proteomics reveals dynamic assembly of repair complexes
RT   during bypass of DNA cross-links.";
RL   Science 348:1253671-1253671(2015).
RN   [17]
RP   FUNCTION, DEGRADATION (MICROBIAL INFECTION), AND SUBUNIT (MICROBIAL
RP   INFECTION).
RX   PubMed=26983541; DOI=10.1038/nature17170;
RA   Decorsiere A., Mueller H., van Breugel P.C., Abdul F., Gerossier L.,
RA   Beran R.K., Livingston C.M., Niu C., Fletcher S.P., Hantz O.,
RA   Strubin M.;
RT   "Hepatitis B virus X protein identifies the Smc5/6 complex as a host
RT   restriction factor.";
RL   Nature 531:386-389(2016).
CC   -!- FUNCTION: Core component of the SMC5-SMC6 complex, a complex
CC       involved in repair of DNA double-strand breaks by homologous
CC       recombination. The complex may promote sister chromatid homologous
CC       recombination by recruiting the SMC1-SMC3 cohesin complex to
CC       double-strand breaks. The complex is required for telomere
CC       maintenance via recombination in ALT (alternative lengthening of
CC       telomeres) cell lines and mediates sumoylation of shelterin
CC       complex (telosome) components which is proposed to lead to
CC       shelterin complex disassembly in ALT-associated PML bodies (APBs).
CC       Required for recruitment of telomeres to PML nuclear bodies.
CC       Required for sister chromatid cohesion during prometaphase and
CC       mitotic progression; the function seems to be independent of SMC6.
CC       SMC5-SMC6 complex may prevent transcription of episomal DNA, such
CC       as circular viral DNA genome (PubMed:26983541).
CC       {ECO:0000269|PubMed:16810316, ECO:0000269|PubMed:17589526,
CC       ECO:0000269|PubMed:19502785, ECO:0000269|PubMed:26983541}.
CC   -!- SUBUNIT: Forms a heterodimer with SMC6 (PubMed:11408570).
CC       Component of the SMC5-SMC6 complex which consists at least of
CC       SMC5, SMC6, NSMCE2, NSMCE1, NSMCE4A or EID3 and NSMCE3
CC       (PubMed:18086888). Interacts with NSMCE2 (PubMed:16055714).
CC       Interacts with SLF2; this interaction induces an association of
CC       the SLF1-SLF2 complex with the SMC5-SMC6 complex
CC       (PubMed:25931565). Interacts with RAD18; this interaction is
CC       increased in a SLF1 or SLF2-dependent manner (PubMed:25931565).
CC       {ECO:0000269|PubMed:11408570, ECO:0000269|PubMed:16055714,
CC       ECO:0000269|PubMed:18086888, ECO:0000269|PubMed:25931565}.
CC   -!- SUBUNIT: (Microbial infection) SMC5-SMC6 complex interacts with
CC       Hepatitis B X protein. {ECO:0000269|PubMed:26983541}.
CC   -!- INTERACTION:
CC       Q96SB8:SMC6; NbExp=4; IntAct=EBI-605405, EBI-605415;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:11408570,
CC       ECO:0000269|PubMed:25931565}. Chromosome
CC       {ECO:0000250|UniProtKB:Q8CG46}. Nucleus, PML body
CC       {ECO:0000269|PubMed:17589526}. Chromosome, telomere
CC       {ECO:0000269|PubMed:17589526}. Note=Associates with chromatin
CC       (PubMed:25931565). Colocalizes with SMC6 on the X-Y chromosome
CC       pair within the sex vesicle during late pachytene/diplotene (By
CC       similarity). Localizes to PML nuclear bodies in ALT cell lines
CC       (PubMed:17589526). Accumulates with RAD18 and the SLF1-SLF2
CC       complex at replication-coupled DNA interstrand repair and DNA
CC       double-strand breaks (DSBs) sites on chromatin in a ubiquitin-
CC       dependent manner (PubMed:25931565). {ECO:0000250|UniProtKB:Q8CG46,
CC       ECO:0000269|PubMed:25931565}.
CC   -!- TISSUE SPECIFICITY: Widely expressed (PubMed:11408570). Strongly
CC       expressed in testis (PubMed:11408570).
CC       {ECO:0000269|PubMed:11408570}.
CC   -!- DOMAIN: The flexible hinge domain, which separates the large
CC       intramolecular coiled coil regions, allows the heterotypic
CC       interaction with the corresponding domain of SMC6, forming a V-
CC       shaped heterodimer. {ECO:0000250}.
CC   -!- PTM: Sumoylated. {ECO:0000269|PubMed:18086888}.
CC   -!- PTM: Ubiquitinated. {ECO:0000269|PubMed:18086888}.
CC   -!- PTM: (Microbial infection) SMC5-SMC6 complex is degraded by the
CC       activity of Hepatitis B X protein. {ECO:0000269|PubMed:26983541}.
CC   -!- SIMILARITY: Belongs to the SMC family. SMC5 subfamily.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH17666.1; Type=Miscellaneous discrepancy; Note=Contaminating sequence. Potential poly-A sequence.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AJ310550; CAC39247.1; -; mRNA.
DR   EMBL; AB011166; BAA25520.2; -; mRNA.
DR   EMBL; AL162390; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC017666; AAH17666.1; ALT_SEQ; mRNA.
DR   EMBL; BC038225; AAH38225.1; -; mRNA.
DR   CCDS; CCDS6632.1; -.
DR   RefSeq; NP_055925.2; NM_015110.3.
DR   UniGene; Hs.534189; -.
DR   UniGene; Hs.601181; -.
DR   ProteinModelPortal; Q8IY18; -.
DR   SMR; Q8IY18; -.
DR   BioGrid; 116754; 18.
DR   IntAct; Q8IY18; 10.
DR   MINT; Q8IY18; -.
DR   STRING; 9606.ENSP00000354957; -.
DR   iPTMnet; Q8IY18; -.
DR   PhosphoSitePlus; Q8IY18; -.
DR   BioMuta; SMC5; -.
DR   DMDM; 122070387; -.
DR   EPD; Q8IY18; -.
DR   MaxQB; Q8IY18; -.
DR   PaxDb; Q8IY18; -.
DR   PeptideAtlas; Q8IY18; -.
DR   PRIDE; Q8IY18; -.
DR   DNASU; 23137; -.
DR   Ensembl; ENST00000361138; ENSP00000354957; ENSG00000198887.
DR   GeneID; 23137; -.
DR   KEGG; hsa:23137; -.
DR   UCSC; uc004ahr.3; human.
DR   CTD; 23137; -.
DR   DisGeNET; 23137; -.
DR   EuPathDB; HostDB:ENSG00000198887.8; -.
DR   GeneCards; SMC5; -.
DR   H-InvDB; HIX0201342; -.
DR   HGNC; HGNC:20465; SMC5.
DR   HPA; HPA054900; -.
DR   MIM; 609386; gene.
DR   neXtProt; NX_Q8IY18; -.
DR   OpenTargets; ENSG00000198887; -.
DR   PharmGKB; PA134993662; -.
DR   eggNOG; KOG0979; Eukaryota.
DR   eggNOG; COG1196; LUCA.
DR   GeneTree; ENSGT00550000074963; -.
DR   HOGENOM; HOG000154342; -.
DR   HOVERGEN; HBG093963; -.
DR   InParanoid; Q8IY18; -.
DR   OMA; MVEIELF; -.
DR   OrthoDB; EOG091G0A1Y; -.
DR   PhylomeDB; Q8IY18; -.
DR   TreeFam; TF105708; -.
DR   Reactome; R-HSA-3108214; SUMOylation of DNA damage response and repair proteins.
DR   ChiTaRS; SMC5; human.
DR   GeneWiki; SMC5; -.
DR   GenomeRNAi; 23137; -.
DR   PRO; PR:Q8IY18; -.
DR   Proteomes; UP000005640; Chromosome 9.
DR   Bgee; ENSG00000198887; -.
DR   CleanEx; HS_SMC5; -.
DR   Genevisible; Q8IY18; HS.
DR   GO; GO:0030054; C:cell junction; IDA:HPA.
DR   GO; GO:0000781; C:chromosome, telomeric region; IDA:UniProtKB.
DR   GO; GO:0035061; C:interchromatin granule; IDA:UniProtKB.
DR   GO; GO:0016607; C:nuclear speck; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0016605; C:PML body; IDA:UniProtKB.
DR   GO; GO:0000803; C:sex chromosome; ISS:UniProtKB.
DR   GO; GO:0035861; C:site of double-strand break; IDA:UniProtKB.
DR   GO; GO:0030915; C:Smc5-Smc6 complex; IDA:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0051301; P:cell division; IEA:UniProtKB-KW.
DR   GO; GO:0006974; P:cellular response to DNA damage stimulus; IDA:UniProtKB.
DR   GO; GO:0090398; P:cellular senescence; IMP:UniProtKB.
DR   GO; GO:0000724; P:double-strand break repair via homologous recombination; IMP:UniProtKB.
DR   GO; GO:0051984; P:positive regulation of chromosome segregation; IMP:UniProtKB.
DR   GO; GO:0034184; P:positive regulation of maintenance of mitotic sister chromatid cohesion; IMP:UniProtKB.
DR   GO; GO:0007062; P:sister chromatid cohesion; IEA:InterPro.
DR   GO; GO:0000722; P:telomere maintenance via recombination; IMP:UniProtKB.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   InterPro; IPR003395; RecF/RecN/SMC_N.
DR   InterPro; IPR027131; SMC5.
DR   PANTHER; PTHR19306:SF1; PTHR19306:SF1; 1.
DR   Pfam; PF02463; SMC_N; 1.
DR   SUPFAM; SSF52540; SSF52540; 2.
PE   1: Evidence at protein level;
KW   ATP-binding; Cell cycle; Cell division; Chromosome; Coiled coil;
KW   Complete proteome; DNA damage; DNA recombination; DNA repair; Mitosis;
KW   Nucleotide-binding; Nucleus; Phosphoprotein; Polymorphism;
KW   Reference proteome; Telomere; Ubl conjugation.
FT   CHAIN         1   1101       Structural maintenance of chromosomes
FT                                protein 5.
FT                                /FTId=PRO_0000270951.
FT   NP_BIND      80     87       ATP. {ECO:0000255}.
FT   REGION      446    646       Flexible hinge.
FT   COILED      207    445       {ECO:0000255}.
FT   COILED      647    828       {ECO:0000255}.
FT   COILED      888    927       {ECO:0000255}.
FT   COMPBIAS    991   1026       Ala/Asp-rich (DA-box).
FT   MOD_RES      25     25       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES      35     35       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   VARIANT     306    306       V -> I (in dbSNP:rs1180116).
FT                                {ECO:0000269|PubMed:11408570,
FT                                ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|PubMed:9628581}.
FT                                /FTId=VAR_029824.
FT   VARIANT     308    308       C -> R (in dbSNP:rs1180117).
FT                                {ECO:0000269|PubMed:11408570,
FT                                ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_029825.
FT   VARIANT     682    682       H -> R (in dbSNP:rs11142365).
FT                                /FTId=VAR_061869.
SQ   SEQUENCE   1101 AA;  128806 MW;  54393D50688A914A CRC64;
     MATPSKKTST PSPQPSKRAL PRDPSSEVPS KRKNSAPQLP LLQSSGPFVE GSIVRISMEN
     FLTYDICEVS PGPHLNMIVG ANGTGKSSIV CAICLGLAGK PAFMGRADKV GFFVKRGCSR
     GMVEIELFRA SGNLVITREI DVAKNQSFWF INKKSTTQKI VEEKVAALNI QVGNLCQFLP
     QDKVGEFAKL SKIELLEATE KSIGPPEMHK YHCELKNLRE KEKQLETSCK EKTEYLQKMV
     QRNERYKQDV ERFYERKRHL DLIEMLEAKR PWVEYENVRQ EYEEVKLVRD RVKEEVRKLK
     EGQIPVTCRI EEMENERHNL EARIKEKATD IKEASQKCKQ KQDVIERKDK HIEELQQALI
     VKQNEELDRQ RRIGNTRKMI EDLQNELKTT ENCENLQPQI DAITNDLRRI QDEKALCEGE
     IIDKRRERET LEKEKKSVDD HIVRFDNLMN QKEDKLRQRF RDTYDAVLWL RNNRDKFKQR
     VCEPIMLTIN MKDNKNAKYI ENHIPSNDLR AFVFESQEDM EVFLKEVRDN KKLRVNAVIA
     PKSSYADKAP SRSLNELKQY GFFSYLRELF DAPDPVMSYL CCQYHIHEVP VGTEKTRERI
     ERVIQETRLK QIYTAEEKYV VKTSFYSNKV ISSNTSLKVA QFLTVTVDLE QRRHLEEQLK
     EIHRKLQAVD SGLIALRETS KHLEHKDNEL RQKKKELLER KTKKRQLEQK ISSKLGSLKL
     MEQDTCNLEE EERKASTKIK EINVQKAKLV TELTNLIKIC TSLHIQKVDL ILQNTTVISE
     KNKLESDYMA ASSQLRLTEQ HFIELDENRQ RLLQKCKELM KRARQVCNLG AEQTLPQEYQ
     TQVPTIPNGH NSSLPMVFQD LPNTLDEIDA LLTEERSRAS CFTGLNPTIV QEYTKREEEI
     EQLTEELKGK KVELDQYREN ISQVKERWLN PLKELVEKIN EKFSNFFSSM QCAGEVDLHT
     ENEEDYDKYG IRIRVKFRSS TQLHELTPHH QSGGERSVST MLYLMALQEL NRCPFRVVDE
     INQGMDPINE RRVFEMVVNT ACKENTSQYF FITPKLLQNL PYSEKMTVLF VYNGPHMLEP
     NTWNLKAFQR RRRRITFTQP S
//
ID   DEST_HUMAN              Reviewed;         165 AA.
AC   P60981; B2R6N2; B4DYA6; P18282; Q5W166; Q6IAW2;
DT   26-APR-2004, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 3.
DT   23-MAY-2018, entry version 143.
DE   RecName: Full=Destrin;
DE   AltName: Full=Actin-depolymerizing factor;
DE            Short=ADF;
GN   Name=DSTN; Synonyms=ACTDP, DSN;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=8399167; DOI=10.1021/bi00089a014;
RA   Hawkins M., Pope B., Maciver S.K., Weeds A.G.;
RT   "Human actin depolymerizing factor mediates a pH-sensitive destruction
RT   of actin filaments.";
RL   Biochemistry 32:9985-9993(1993).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11780052; DOI=10.1038/414865a;
RA   Deloukas P., Matthews L.H., Ashurst J.L., Burton J., Gilbert J.G.R.,
RA   Jones M., Stavrides G., Almeida J.P., Babbage A.K., Bagguley C.L.,
RA   Bailey J., Barlow K.F., Bates K.N., Beard L.M., Beare D.M.,
RA   Beasley O.P., Bird C.P., Blakey S.E., Bridgeman A.M., Brown A.J.,
RA   Buck D., Burrill W.D., Butler A.P., Carder C., Carter N.P.,
RA   Chapman J.C., Clamp M., Clark G., Clark L.N., Clark S.Y., Clee C.M.,
RA   Clegg S., Cobley V.E., Collier R.E., Connor R.E., Corby N.R.,
RA   Coulson A., Coville G.J., Deadman R., Dhami P.D., Dunn M.,
RA   Ellington A.G., Frankland J.A., Fraser A., French L., Garner P.,
RA   Grafham D.V., Griffiths C., Griffiths M.N.D., Gwilliam R., Hall R.E.,
RA   Hammond S., Harley J.L., Heath P.D., Ho S., Holden J.L., Howden P.J.,
RA   Huckle E., Hunt A.R., Hunt S.E., Jekosch K., Johnson C.M., Johnson D.,
RA   Kay M.P., Kimberley A.M., King A., Knights A., Laird G.K., Lawlor S.,
RA   Lehvaeslaiho M.H., Leversha M.A., Lloyd C., Lloyd D.M., Lovell J.D.,
RA   Marsh V.L., Martin S.L., McConnachie L.J., McLay K., McMurray A.A.,
RA   Milne S.A., Mistry D., Moore M.J.F., Mullikin J.C., Nickerson T.,
RA   Oliver K., Parker A., Patel R., Pearce T.A.V., Peck A.I.,
RA   Phillimore B.J.C.T., Prathalingam S.R., Plumb R.W., Ramsay H.,
RA   Rice C.M., Ross M.T., Scott C.E., Sehra H.K., Shownkeen R., Sims S.,
RA   Skuce C.D., Smith M.L., Soderlund C., Steward C.A., Sulston J.E.,
RA   Swann R.M., Sycamore N., Taylor R., Tee L., Thomas D.W., Thorpe A.,
RA   Tracey A., Tromans A.C., Vaudin M., Wall M., Wallis J.M.,
RA   Whitehead S.L., Whittaker P., Willey D.L., Williams L., Williams S.A.,
RA   Wilming L., Wray P.W., Hubbard T., Durbin R.M., Bentley D.R., Beck S.,
RA   Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 20.";
RL   Nature 414:865-871(2001).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   PROTEIN SEQUENCE OF 2-13, AND ACETYLATION AT ALA-2.
RC   TISSUE=Platelet;
RX   PubMed=12665801; DOI=10.1038/nbt810;
RA   Gevaert K., Goethals M., Martens L., Van Damme J., Staes A.,
RA   Thomas G.R., Vandekerckhove J.;
RT   "Exploring proteomes and analyzing protein processing by mass
RT   spectrometric identification of sorted N-terminal peptides.";
RL   Nat. Biotechnol. 21:566-569(2003).
RN   [8]
RP   PROTEIN SEQUENCE OF 54-69, AND IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Brain, and Cajal-Retzius cell;
RA   Lubec G., Vishwanath V.;
RL   Submitted (MAR-2007) to UniProtKB.
RN   [9]
RP   FUNCTION.
RX   PubMed=11812157; DOI=10.1006/jmbi.2001.5280;
RA   Yeoh S., Pope B., Mannherz H.G., Weeds A.;
RT   "Determining the differences in actin binding by human ADF and
RT   cofilin.";
RL   J. Mol. Biol. 315:911-925(2002).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-3, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [11]
RP   ISGYLATION.
RX   PubMed=16815975; DOI=10.1073/pnas.0600397103;
RA   Wong J.J., Pung Y.F., Sze N.S., Chin K.C.;
RT   "HERC5 is an IFN-induced HECT-type E3 protein ligase that mediates
RT   type I IFN-induced ISGylation of protein targets.";
RL   Proc. Natl. Acad. Sci. U.S.A. 103:10735-10740(2006).
RN   [12]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [13]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, PHOSPHORYLATION [LARGE
RP   SCALE ANALYSIS] AT SER-3, CLEAVAGE OF INITIATOR METHIONINE [LARGE
RP   SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [14]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-19, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [15]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, PHOSPHORYLATION [LARGE
RP   SCALE ANALYSIS] AT SER-3, CLEAVAGE OF INITIATOR METHIONINE [LARGE
RP   SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [16]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [17]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, PHOSPHORYLATION [LARGE
RP   SCALE ANALYSIS] AT SER-3, CLEAVAGE OF INITIATOR METHIONINE [LARGE
RP   SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [18]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22223895; DOI=10.1074/mcp.M111.015131;
RA   Bienvenut W.V., Sumpton D., Martinez A., Lilla S., Espagne C.,
RA   Meinnel T., Giglione C.;
RT   "Comparative large-scale characterisation of plant vs. mammal proteins
RT   reveals similar and idiosyncratic N-alpha acetylation features.";
RL   Mol. Cell. Proteomics 11:M111.015131-M111.015131(2012).
RN   [19]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [20]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-3, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [21]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [22]
RP   VARIANT [LARGE SCALE ANALYSIS] GLU-139.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S.,
RA   Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J.,
RA   Dawson D., Willson J.K.V., Gazdar A.F., Hartigan J., Wu L., Liu C.,
RA   Parmigiani G., Park B.H., Bachman K.E., Papadopoulos N.,
RA   Vogelstein B., Kinzler K.W., Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal
RT   cancers.";
RL   Science 314:268-274(2006).
CC   -!- FUNCTION: Actin-depolymerizing protein. Severs actin filaments (F-
CC       actin) and binds to actin monomers (G-actin). Acts in a pH-
CC       independent manner. {ECO:0000269|PubMed:11812157}.
CC   -!- INTERACTION:
CC       P60709:ACTB; NbExp=6; IntAct=EBI-745191, EBI-353944;
CC       P63261:ACTG1; NbExp=7; IntAct=EBI-745191, EBI-351292;
CC       Q549N0:CFL2; NbExp=3; IntAct=EBI-745191, EBI-10201319;
CC       Q1KLZ0:PS1TP5BP1; NbExp=3; IntAct=EBI-745191, EBI-9978131;
CC       Q86VP1:TAX1BP1; NbExp=5; IntAct=EBI-745191, EBI-529518;
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P60981-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P60981-2; Sequence=VSP_043069;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Widely distributed in various tissues.
CC   -!- PTM: ISGylated. {ECO:0000305|PubMed:16815975}.
CC   -!- SIMILARITY: Belongs to the actin-binding proteins ADF family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; S65738; AAB28361.1; -; mRNA.
DR   EMBL; CR457042; CAG33323.1; -; mRNA.
DR   EMBL; AK302338; BAG63668.1; -; mRNA.
DR   EMBL; AK312645; BAG35529.1; -; mRNA.
DR   EMBL; AL132765; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471133; EAX10274.1; -; Genomic_DNA.
DR   EMBL; CH471133; EAX10275.1; -; Genomic_DNA.
DR   EMBL; CH471133; EAX10276.1; -; Genomic_DNA.
DR   EMBL; BC009477; AAH09477.1; -; mRNA.
DR   CCDS; CCDS13127.1; -. [P60981-1]
DR   CCDS; CCDS46580.1; -. [P60981-2]
DR   PIR; A54184; A54184.
DR   RefSeq; NP_001011546.1; NM_001011546.1. [P60981-2]
DR   RefSeq; NP_006861.1; NM_006870.3. [P60981-1]
DR   RefSeq; XP_011527444.1; XM_011529142.1. [P60981-1]
DR   RefSeq; XP_011527445.1; XM_011529143.1. [P60981-1]
DR   RefSeq; XP_011527446.1; XM_011529144.1. [P60981-2]
DR   UniGene; Hs.304192; -.
DR   UniGene; Hs.705996; -.
DR   ProteinModelPortal; P60981; -.
DR   SMR; P60981; -.
DR   BioGrid; 116223; 96.
DR   IntAct; P60981; 17.
DR   MINT; P60981; -.
DR   STRING; 9606.ENSP00000246069; -.
DR   DrugBank; DB04147; Lauryl Dimethylamine-N-Oxide.
DR   iPTMnet; P60981; -.
DR   PhosphoSitePlus; P60981; -.
DR   SwissPalm; P60981; -.
DR   BioMuta; DSTN; -.
DR   DMDM; 46577586; -.
DR   OGP; P18282; -.
DR   REPRODUCTION-2DPAGE; IPI00473014; -.
DR   UCD-2DPAGE; P60981; -.
DR   EPD; P60981; -.
DR   PaxDb; P60981; -.
DR   PeptideAtlas; P60981; -.
DR   PRIDE; P60981; -.
DR   DNASU; 11034; -.
DR   Ensembl; ENST00000246069; ENSP00000246069; ENSG00000125868. [P60981-1]
DR   Ensembl; ENST00000474024; ENSP00000476975; ENSG00000125868. [P60981-2]
DR   GeneID; 11034; -.
DR   KEGG; hsa:11034; -.
DR   UCSC; uc002wpq.4; human. [P60981-1]
DR   CTD; 11034; -.
DR   DisGeNET; 11034; -.
DR   EuPathDB; HostDB:ENSG00000125868.15; -.
DR   GeneCards; DSTN; -.
DR   HGNC; HGNC:15750; DSTN.
DR   HPA; CAB037094; -.
DR   MIM; 609114; gene.
DR   neXtProt; NX_P60981; -.
DR   OpenTargets; ENSG00000125868; -.
DR   PharmGKB; PA27509; -.
DR   eggNOG; KOG1735; Eukaryota.
DR   eggNOG; ENOG41122P5; LUCA.
DR   GeneTree; ENSGT00440000033289; -.
DR   HOGENOM; HOG000039697; -.
DR   HOVERGEN; HBG000381; -.
DR   InParanoid; P60981; -.
DR   KO; K10363; -.
DR   OMA; QMLPEKD; -.
DR   OrthoDB; EOG091G0PWC; -.
DR   PhylomeDB; P60981; -.
DR   TreeFam; TF328601; -.
DR   SIGNOR; P60981; -.
DR   ChiTaRS; DSTN; human.
DR   GenomeRNAi; 11034; -.
DR   PRO; PR:P60981; -.
DR   Proteomes; UP000005640; Chromosome 20.
DR   Bgee; ENSG00000125868; -.
DR   CleanEx; HS_DSTN; -.
DR   ExpressionAtlas; P60981; baseline and differential.
DR   Genevisible; P60981; HS.
DR   GO; GO:0015629; C:actin cytoskeleton; TAS:ProtInc.
DR   GO; GO:0030864; C:cortical actin cytoskeleton; IEA:Ensembl.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0051015; F:actin filament binding; IDA:UniProtKB.
DR   GO; GO:0030042; P:actin filament depolymerization; IDA:UniProtKB.
DR   GO; GO:0030043; P:actin filament fragmentation; IEA:Ensembl.
DR   GO; GO:0051014; P:actin filament severing; TAS:ProtInc.
DR   GO; GO:0008154; P:actin polymerization or depolymerization; TAS:ProtInc.
DR   GO; GO:0030836; P:positive regulation of actin filament depolymerization; IEA:Ensembl.
DR   CDD; cd11286; ADF_cofilin_like; 1.
DR   Gene3D; 3.40.20.10; -; 1.
DR   InterPro; IPR002108; ADF-H.
DR   InterPro; IPR029006; ADF-H/Gelsolin-like_dom_sf.
DR   InterPro; IPR017904; ADF/Cofilin.
DR   InterPro; IPR029924; Dstn.
DR   PANTHER; PTHR11913; PTHR11913; 1.
DR   PANTHER; PTHR11913:SF18; PTHR11913:SF18; 1.
DR   Pfam; PF00241; Cofilin_ADF; 1.
DR   PRINTS; PR00006; COFILIN.
DR   SMART; SM00102; ADF; 1.
DR   PROSITE; PS51263; ADF_H; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Actin-binding; Alternative splicing; Complete proteome;
KW   Direct protein sequencing; Phosphoprotein; Polymorphism;
KW   Reference proteome; Ubl conjugation.
FT   INIT_MET      1      1       Removed. {ECO:0000244|PubMed:19369195,
FT                                ECO:0000244|PubMed:19413330,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:22223895,
FT                                ECO:0000244|PubMed:22814378,
FT                                ECO:0000244|PubMed:25944712,
FT                                ECO:0000269|PubMed:12665801}.
FT   CHAIN         2    165       Destrin.
FT                                /FTId=PRO_0000214918.
FT   DOMAIN        4    153       ADF-H. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00599}.
FT   MOTIF        30     34       Nuclear localization signal.
FT                                {ECO:0000255}.
FT   MOD_RES       2      2       N-acetylalanine.
FT                                {ECO:0000244|PubMed:19369195,
FT                                ECO:0000244|PubMed:19413330,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:22223895,
FT                                ECO:0000244|PubMed:22814378,
FT                                ECO:0000244|PubMed:25944712,
FT                                ECO:0000269|PubMed:12665801}.
FT   MOD_RES       3      3       Phosphoserine.
FT                                {ECO:0000244|PubMed:17081983,
FT                                ECO:0000244|PubMed:19369195,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES      19     19       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   VAR_SEQ       1     17       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_043069.
FT   VARIANT     139    139       G -> E (in a colorectal cancer sample;
FT                                somatic mutation).
FT                                {ECO:0000269|PubMed:16959974}.
FT                                /FTId=VAR_036459.
SQ   SEQUENCE   165 AA;  18506 MW;  8868A3167924100E CRC64;
     MASGVQVADE VCRIFYDMKV RKCSTPEEIK KRKKAVIFCL SADKKCIIVE EGKEILVGDV
     GVTITDPFKH FVGMLPEKDC RYALYDASFE TKESRKEELM FFLWAPELAP LKSKMIYASS
     KDAIKKKFQG IKHECQANGP EDLNRACIAE KLGGSLIVAF EGCPV
//
ID   V9HWA6_HUMAN            Unreviewed;       165 AA.
AC   V9HWA6;
DT   19-MAR-2014, integrated into UniProtKB/TrEMBL.
DT   19-MAR-2014, sequence version 1.
DT   23-MAY-2018, entry version 34.
DE   SubName: Full=Epididymis luminal protein 32 {ECO:0000313|EMBL:ACJ13660.1};
GN   Name=HEL32 {ECO:0000313|EMBL:ACJ13660.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:ACJ13660.1};
RN   [1] {ECO:0000313|EMBL:ACJ13660.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Li J.Y., Wang H.Y., Liu F.J., Liu J.;
RL   Submitted (JUN-2008) to the EMBL/GenBank/DDBJ databases.
CC   -!- SIMILARITY: Belongs to the actin-binding proteins ADF family.
CC       {ECO:0000256|SAAS:SAAS00548240}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; EU794606; ACJ13660.1; -; mRNA.
DR   RefSeq; NP_006861.1; NM_006870.3.
DR   RefSeq; XP_011527444.1; XM_011529142.1.
DR   RefSeq; XP_011527445.1; XM_011529143.1.
DR   UniGene; Hs.304192; -.
DR   UniGene; Hs.705996; -.
DR   ProteinModelPortal; V9HWA6; -.
DR   SMR; V9HWA6; -.
DR   MaxQB; V9HWA6; -.
DR   PRIDE; V9HWA6; -.
DR   GeneID; 11034; -.
DR   KEGG; hsa:11034; -.
DR   UCSC; uc002wpr.4; human.
DR   CTD; 11034; -.
DR   EuPathDB; HostDB:ENSG00000125868.15; -.
DR   eggNOG; KOG1735; Eukaryota.
DR   eggNOG; ENOG41122P5; LUCA.
DR   KO; K10363; -.
DR   OMA; QMLPEKD; -.
DR   OrthoDB; EOG091G0PWC; -.
DR   PhylomeDB; V9HWA6; -.
DR   ChiTaRS; DSTN; human.
DR   GenomeRNAi; 11034; -.
DR   Bgee; ENSG00000125868; -.
DR   ExpressionAtlas; V9HWA6; baseline and differential.
DR   GO; GO:0030864; C:cortical actin cytoskeleton; IEA:Ensembl.
DR   GO; GO:0051015; F:actin filament binding; IEA:Ensembl.
DR   GO; GO:0030043; P:actin filament fragmentation; IEA:Ensembl.
DR   GO; GO:0051014; P:actin filament severing; IEA:InterPro.
DR   GO; GO:0030836; P:positive regulation of actin filament depolymerization; IEA:Ensembl.
DR   CDD; cd11286; ADF_cofilin_like; 1.
DR   Gene3D; 3.40.20.10; -; 1.
DR   InterPro; IPR002108; ADF-H.
DR   InterPro; IPR029006; ADF-H/Gelsolin-like_dom_sf.
DR   InterPro; IPR017904; ADF/Cofilin.
DR   InterPro; IPR029924; Dstn.
DR   PANTHER; PTHR11913; PTHR11913; 1.
DR   PANTHER; PTHR11913:SF18; PTHR11913:SF18; 1.
DR   Pfam; PF00241; Cofilin_ADF; 1.
DR   PRINTS; PR00006; COFILIN.
DR   SMART; SM00102; ADF; 1.
DR   PROSITE; PS51263; ADF_H; 1.
PE   2: Evidence at transcript level;
KW   Actin-binding {ECO:0000256|SAAS:SAAS00501205}.
FT   DOMAIN        4    153       ADF-H. {ECO:0000259|PROSITE:PS51263}.
SQ   SEQUENCE   165 AA;  18506 MW;  8868A3167924100E CRC64;
     MASGVQVADE VCRIFYDMKV RKCSTPEEIK KRKKAVIFCL SADKKCIIVE EGKEILVGDV
     GVTITDPFKH FVGMLPEKDC RYALYDASFE TKESRKEELM FFLWAPELAP LKSKMIYASS
     KDAIKKKFQG IKHECQANGP EDLNRACIAE KLGGSLIVAF EGCPV
//
ID   A8K9T9_HUMAN            Unreviewed;      1338 AA.
AC   A8K9T9;
DT   04-DEC-2007, integrated into UniProtKB/TrEMBL.
DT   04-DEC-2007, sequence version 1.
DT   23-MAY-2018, entry version 55.
DE   SubName: Full=cDNA FLJ75059, highly similar to Homo sapiens phosphoribosylformylglycinamidine synthase (FGAR amidotransferase) (PFAS), mRNA {ECO:0000313|EMBL:BAF85493.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAF85493.1};
RN   [1] {ECO:0000313|EMBL:BAF85493.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Trachea {ECO:0000313|EMBL:BAF85493.1};
RA   Wakamatsu A., Yamamoto J., Kimura K., Ishii S., Watanabe K.,
RA   Sugiyama A., Murakawa K., Kaida T., Tsuchiya K., Fukuzumi Y.,
RA   Kumagai A., Oishi Y., Yamamoto S., Ono Y., Komori Y., Yamazaki M.,
RA   Kisu Y., Nishikawa T., Sugano S., Nomura N., Isogai T.;
RT   "NEDO human cDNA sequencing project.";
RL   Submitted (OCT-2007) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK292804; BAF85493.1; -; mRNA.
DR   RefSeq; NP_036525.1; NM_012393.2.
DR   UniGene; Hs.573976; -.
DR   ProteinModelPortal; A8K9T9; -.
DR   PeptideAtlas; A8K9T9; -.
DR   PRIDE; A8K9T9; -.
DR   GeneID; 5198; -.
DR   KEGG; hsa:5198; -.
DR   CTD; 5198; -.
DR   PharmGKB; PA33205; -.
DR   eggNOG; KOG1907; Eukaryota.
DR   eggNOG; COG0046; LUCA.
DR   eggNOG; COG0047; LUCA.
DR   HOVERGEN; HBG108309; -.
DR   KO; K01952; -.
DR   GenomeRNAi; 5198; -.
DR   Genevisible; A8K9T9; HS.
DR   GO; GO:0004642; F:phosphoribosylformylglycinamidine synthase activity; IEA:InterPro.
DR   GO; GO:0016740; F:transferase activity; IEA:UniProtKB-KW.
DR   GO; GO:0006189; P:'de novo' IMP biosynthetic process; IEA:InterPro.
DR   Gene3D; 3.30.1330.10; -; 2.
DR   Gene3D; 3.40.50.880; -; 1.
DR   Gene3D; 3.90.650.10; -; 2.
DR   HAMAP; MF_00419; PurL_1; 1.
DR   InterPro; IPR029062; Class_I_gatase-like.
DR   InterPro; IPR017926; GATASE.
DR   InterPro; IPR010073; PRibForGlyAmidine_synth.
DR   InterPro; IPR010918; PurM-like_C_dom.
DR   InterPro; IPR036676; PurM-like_C_sf.
DR   InterPro; IPR036921; PurM-like_N_sf.
DR   InterPro; IPR036604; PurS-like_sf.
DR   Pfam; PF02769; AIRS_C; 2.
DR   SUPFAM; SSF52317; SSF52317; 1.
DR   SUPFAM; SSF55326; SSF55326; 2.
DR   SUPFAM; SSF56042; SSF56042; 2.
DR   SUPFAM; SSF82697; SSF82697; 1.
DR   TIGRFAMs; TIGR01735; FGAM_synt; 1.
DR   PROSITE; PS51273; GATASE_TYPE_1; 1.
PE   2: Evidence at transcript level;
KW   Glutamine amidotransferase {ECO:0000256|PROSITE-ProRule:PRU00605};
KW   Transferase {ECO:0000313|EMBL:BAF85493.1}.
FT   DOMAIN     1064   1336       Glutamine amidotransferase type-1.
FT                                {ECO:0000259|PROSITE:PS51273}.
FT   ACT_SITE   1158   1158       Nucleophile. {ECO:0000256|PROSITE-
FT                                ProRule:PRU00605}.
FT   ACT_SITE   1297   1297       {ECO:0000256|PROSITE-ProRule:PRU00605}.
FT   ACT_SITE   1299   1299       {ECO:0000256|PROSITE-ProRule:PRU00605}.
SQ   SEQUENCE   1338 AA;  144643 MW;  9EC9A465396B59AA CRC64;
     MSPVLHFYVR PSGHEGAAPG HTRRKLQGKL PELQGVETEL CYNVNWTAEA LPSAEETKKL
     MWLFGCPLLL DDVARESWLL PGSNDLLLEV GPRLNFSTPT STNIVSVCRA TGLGPVDRVE
     TTRRYRLSFA HPPSAEVEAI ALATLHDRMT EQHFPHPIQS FSPESMPEPL NGPINILGEG
     RLALEKANQE LGLALDSWDL DFYTKRFQEL QRNPSTVEAF DLAQSNSEHS RHWFFKGQLH
     VDGQKLVHSL FESIMSTQES SNPNNVLKFC DNSSAIQGKE VRFLRPEDPT RPSRFQQQQG
     LRHVVFTAET HNFPTGVCPF SGATTGTGGR IRDVQCTGRG AHVVAGTAGY CFGNLHIPGY
     NLPWEDPSFQ YPGNFARPLE VAIEASNGAS DYGNKFGEPV LAGFARSLGL QLPDGQRREW
     IKPIMFSGGI GSMEADHISK EAPEPGMEVV KVGGPVYRIG VGGGAASSVQ VQGDNTSDLD
     FGAVQRGDPE MEQKMNRVIR ACVEAPKGNP ICSLHDQGAG GNGNVLKELS DPAGAIIYTS
     RFQLGDPTLN ALEIWGAEYQ ESNALLLRSP NRDFLTHVSA RERCPACFVG TITGDRRIVL
     VDDRECPVRR NGQGDAPPTP LPTPVDLELG WVLGKMPRKE FFLQRKPPML QPLALPPGLS
     VHQALERVLR LPAVASKRYL TNKVDRSVGG LVAQQQCVGP LQTPLADVAV VALSHEELIG
     AATALGEQPV KSLLDPKVAA RLAVAEALTN LVFALVTDLR DVKCSGNWMW AAKLPGEGAA
     LADACEAMVA VMAALGVAVD GGKDSLSMAA RVGTETVRAP GSLVISAYAV CPDITATVTP
     DLKHPEGRGH LLYVALSPGQ HRLGGTALAQ CFSQLGEHPP DLDLPENLVR AFSITQGLLK
     DRLLCSGHDV SDGGLVTCLL EMAFAGNCGL QVDVPVPRVD VLSVLFAEEP GLVLEVQEPD
     LAQVLKRYRD AGLHCLELGH TGEAGPHAMV RVSVNGAVVL EEPVGELRAL WEETSFQLDR
     LQAEPRCVAE EERGLRERMG PSYCLPPTFP KASVPREPGG PSPRVAILRE EGSNGDREMA
     DAFHLAGFEV WDVTMQDLCS GAIGLDTFRG VAFVGGFSYA DVLGSAKGWA AAVTFHPRAG
     AELRRFRKRP DTFSLGVCNG CQLLALLGWV GGDPNEDAAE MGPDSQPARP GLLLHHNLSG
     RYESRWASVR VGPGPALMLR GMEGAVLPVW SAHGEGYVAF SSPELQAQIE ARGLAPLHWA
     DDDGNPTEQY PLNPNGSPGG VAGICSCDGR HLAVMPHPER AVRPWQWAWR PPPFDTLTTS
     PWLQLFINAR NWTLEGSC
//
ID   PUR4_HUMAN              Reviewed;        1338 AA.
AC   O15067; A6H8V8;
DT   11-JAN-2001, integrated into UniProtKB/Swiss-Prot.
DT   11-JAN-2011, sequence version 4.
DT   23-MAY-2018, entry version 175.
DE   RecName: Full=Phosphoribosylformylglycinamidine synthase;
DE            Short=FGAM synthase;
DE            Short=FGAMS;
DE            EC=6.3.5.3;
DE   AltName: Full=Formylglycinamide ribonucleotide amidotransferase;
DE            Short=FGAR amidotransferase;
DE            Short=FGAR-AT;
DE   AltName: Full=Formylglycinamide ribotide amidotransferase;
GN   Name=PFAS; Synonyms=KIAA0361;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANTS SER-19; LEU-367 AND PRO-621.
RX   PubMed=10548741; DOI=10.1016/S0378-1119(99)00378-9;
RA   Patterson D., Bleskan J., Gardiner K., Bowersox J.;
RT   "Human phosphoribosylformylglycinamide amidotransferase (FGARAT):
RT   regional mapping, complete coding sequence, isolation of a functional
RT   genomic clone, and DNA sequence analysis.";
RL   Gene 239:381-391(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANTS SER-19; LEU-367
RP   AND PRO-621.
RC   TISSUE=Brain;
RX   PubMed=9205841; DOI=10.1093/dnares/4.2.141;
RA   Nagase T., Ishikawa K., Nakajima D., Ohira M., Seki N., Miyajima N.,
RA   Tanaka A., Kotani H., Nomura N., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. VII.
RT   The complete sequences of 100 new cDNA clones from brain which can
RT   code for large proteins in vitro.";
RL   DNA Res. 4:141-150(1997).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16625196; DOI=10.1038/nature04689;
RA   Zody M.C., Garber M., Adams D.J., Sharpe T., Harrow J., Lupski J.R.,
RA   Nicholson C., Searle S.M., Wilming L., Young S.K., Abouelleil A.,
RA   Allen N.R., Bi W., Bloom T., Borowsky M.L., Bugalter B.E., Butler J.,
RA   Chang J.L., Chen C.-K., Cook A., Corum B., Cuomo C.A., de Jong P.J.,
RA   DeCaprio D., Dewar K., FitzGerald M., Gilbert J., Gibson R.,
RA   Gnerre S., Goldstein S., Grafham D.V., Grocock R., Hafez N.,
RA   Hagopian D.S., Hart E., Norman C.H., Humphray S., Jaffe D.B.,
RA   Jones M., Kamal M., Khodiyar V.K., LaButti K., Laird G., Lehoczky J.,
RA   Liu X., Lokyitsang T., Loveland J., Lui A., Macdonald P., Major J.E.,
RA   Matthews L., Mauceli E., McCarroll S.A., Mihalev A.H., Mudge J.,
RA   Nguyen C., Nicol R., O'Leary S.B., Osoegawa K., Schwartz D.C.,
RA   Shaw-Smith C., Stankiewicz P., Steward C., Swarbreck D.,
RA   Venkataraman V., Whittaker C.A., Yang X., Zimmer A.R., Bradley A.,
RA   Hubbard T., Birren B.W., Rogers J., Lander E.S., Nusbaum C.;
RT   "DNA sequence of human chromosome 17 and analysis of rearrangement in
RT   the human lineage.";
RL   Nature 440:1045-1049(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANTS SER-19; LEU-367
RP   AND PRO-621.
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-569, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-619 AND THR-623, VARIANT
RP   [LARGE SCALE ANALYSIS] PRO-621, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-569 AND THR-619, VARIANT
RP   [LARGE SCALE ANALYSIS] PRO-621, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-569, VARIANT [LARGE
RP   SCALE ANALYSIS] PRO-621, AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-215 AND SER-569, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [12]
RP   VARIANT [LARGE SCALE ANALYSIS] PRO-621, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
CC   -!- FUNCTION: Phosphoribosylformylglycinamidine synthase involved in
CC       the purines biosynthetic pathway. Catalyzes the ATP-dependent
CC       conversion of formylglycinamide ribonucleotide (FGAR) and
CC       glutamine to yield formylglycinamidine ribonucleotide (FGAM) and
CC       glutamate (By similarity). {ECO:0000250}.
CC   -!- CATALYTIC ACTIVITY: ATP + N(2)-formyl-N(1)-(5-phospho-D-
CC       ribosyl)glycinamide + L-glutamine + H(2)O = ADP + phosphate + 2-
CC       (formamido)-N(1)-(5-phospho-D-ribosyl)acetamidine + L-glutamate.
CC   -!- PATHWAY: Purine metabolism; IMP biosynthesis via de novo pathway;
CC       5-amino-1-(5-phospho-D-ribosyl)imidazole from N(2)-formyl-N(1)-(5-
CC       phospho-D-ribosyl)glycinamide: step 1/2.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}.
CC   -!- SIMILARITY: In the N-terminal section; belongs to the FGAMS
CC       family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAA20816.1; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB002359; BAA20816.1; ALT_INIT; mRNA.
DR   EMBL; AC135178; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC146768; AAI46769.1; -; mRNA.
DR   EMBL; BC167158; AAI67158.1; -; mRNA.
DR   CCDS; CCDS11136.1; -.
DR   RefSeq; NP_036525.1; NM_012393.2.
DR   UniGene; Hs.573976; -.
DR   ProteinModelPortal; O15067; -.
DR   SMR; O15067; -.
DR   BioGrid; 111221; 73.
DR   IntAct; O15067; 11.
DR   STRING; 9606.ENSP00000313490; -.
DR   DrugBank; DB00142; L-Glutamic Acid.
DR   DrugBank; DB00130; L-Glutamine.
DR   MEROPS; C56.972; -.
DR   iPTMnet; O15067; -.
DR   PhosphoSitePlus; O15067; -.
DR   BioMuta; PFAS; -.
DR   EPD; O15067; -.
DR   MaxQB; O15067; -.
DR   PaxDb; O15067; -.
DR   PeptideAtlas; O15067; -.
DR   PRIDE; O15067; -.
DR   Ensembl; ENST00000314666; ENSP00000313490; ENSG00000178921.
DR   GeneID; 5198; -.
DR   KEGG; hsa:5198; -.
DR   UCSC; uc002gkr.4; human.
DR   CTD; 5198; -.
DR   DisGeNET; 5198; -.
DR   EuPathDB; HostDB:ENSG00000178921.13; -.
DR   GeneCards; PFAS; -.
DR   H-InvDB; HIX0019361; -.
DR   HGNC; HGNC:8863; PFAS.
DR   HPA; HPA022140; -.
DR   HPA; HPA022886; -.
DR   MIM; 602133; gene.
DR   neXtProt; NX_O15067; -.
DR   OpenTargets; ENSG00000178921; -.
DR   eggNOG; KOG1907; Eukaryota.
DR   eggNOG; COG0046; LUCA.
DR   eggNOG; COG0047; LUCA.
DR   GeneTree; ENSGT00390000007600; -.
DR   HOGENOM; HOG000261358; -.
DR   HOVERGEN; HBG108309; -.
DR   InParanoid; O15067; -.
DR   KO; K01952; -.
DR   OMA; SLSANWM; -.
DR   OrthoDB; EOG091G00SI; -.
DR   PhylomeDB; O15067; -.
DR   TreeFam; TF106371; -.
DR   BioCyc; MetaCyc:HS11329-MONOMER; -.
DR   Reactome; R-HSA-73817; Purine ribonucleoside monophosphate biosynthesis.
DR   UniPathway; UPA00074; UER00128.
DR   ChiTaRS; PFAS; human.
DR   GenomeRNAi; 5198; -.
DR   PRO; PR:O15067; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   Bgee; ENSG00000178921; -.
DR   CleanEx; HS_PFAS; -.
DR   ExpressionAtlas; O15067; baseline and differential.
DR   Genevisible; O15067; HS.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0004642; F:phosphoribosylformylglycinamidine synthase activity; IDA:UniProtKB.
DR   GO; GO:0006189; P:'de novo' IMP biosynthetic process; NAS:UniProtKB.
DR   GO; GO:0097065; P:anterior head development; IEA:Ensembl.
DR   GO; GO:0006541; P:glutamine metabolic process; IEA:UniProtKB-KW.
DR   GO; GO:0009168; P:purine ribonucleoside monophosphate biosynthetic process; TAS:Reactome.
DR   GO; GO:0042493; P:response to drug; IEA:Ensembl.
DR   Gene3D; 3.30.1330.10; -; 2.
DR   Gene3D; 3.40.50.880; -; 1.
DR   Gene3D; 3.90.650.10; -; 2.
DR   HAMAP; MF_00419; PurL_1; 1.
DR   InterPro; IPR029062; Class_I_gatase-like.
DR   InterPro; IPR017926; GATASE.
DR   InterPro; IPR010073; PRibForGlyAmidine_synth.
DR   InterPro; IPR010918; PurM-like_C_dom.
DR   InterPro; IPR036676; PurM-like_C_sf.
DR   InterPro; IPR036921; PurM-like_N_sf.
DR   InterPro; IPR036604; PurS-like_sf.
DR   Pfam; PF02769; AIRS_C; 2.
DR   SUPFAM; SSF52317; SSF52317; 1.
DR   SUPFAM; SSF55326; SSF55326; 2.
DR   SUPFAM; SSF56042; SSF56042; 2.
DR   SUPFAM; SSF82697; SSF82697; 1.
DR   TIGRFAMs; TIGR01735; FGAM_synt; 1.
DR   PROSITE; PS51273; GATASE_TYPE_1; 1.
PE   1: Evidence at protein level;
KW   ATP-binding; Complete proteome; Cytoplasm; Glutamine amidotransferase;
KW   Ligase; Magnesium; Metal-binding; Nucleotide-binding; Phosphoprotein;
KW   Polymorphism; Purine biosynthesis; Reference proteome.
FT   CHAIN         1   1338       Phosphoribosylformylglycinamidine
FT                                synthase.
FT                                /FTId=PRO_0000100401.
FT   DOMAIN     1064   1302       Glutamine amidotransferase type-1.
FT   NP_BIND     322    333       ATP. {ECO:0000255}.
FT   NP_BIND     402    404       ATP. {ECO:0000250}.
FT   ACT_SITE   1158   1158       Nucleophile. {ECO:0000250}.
FT   ACT_SITE   1297   1297       {ECO:0000250}.
FT   ACT_SITE   1299   1299       {ECO:0000250}.
FT   METAL       707    707       Magnesium. {ECO:0000250}.
FT   METAL       746    746       Magnesium. {ECO:0000250}.
FT   METAL       750    750       Magnesium. {ECO:0000250}.
FT   METAL       909    909       Magnesium. {ECO:0000250}.
FT   BINDING     706    706       ATP; via carbonyl oxygen. {ECO:0000250}.
FT   BINDING     911    911       ATP. {ECO:0000250}.
FT   MOD_RES     215    215       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     569    569       Phosphoserine.
FT                                {ECO:0000244|PubMed:17081983,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     619    619       Phosphothreonine.
FT                                {ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:20068231}.
FT   MOD_RES     623    623       Phosphothreonine.
FT                                {ECO:0000244|PubMed:19690332}.
FT   VARIANT      19     19       P -> S (in dbSNP:rs9891699).
FT                                {ECO:0000269|PubMed:10548741,
FT                                ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|PubMed:9205841}.
FT                                /FTId=VAR_055008.
FT   VARIANT     367    367       P -> L (in dbSNP:rs4791641).
FT                                {ECO:0000269|PubMed:10548741,
FT                                ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|PubMed:9205841}.
FT                                /FTId=VAR_055009.
FT   VARIANT     481    481       F -> Y (in dbSNP:rs35217368).
FT                                /FTId=VAR_055010.
FT   VARIANT     621    621       L -> P (in dbSNP:rs11078738).
FT                                {ECO:0000244|PubMed:19413330,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000269|PubMed:10548741,
FT                                ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|PubMed:9205841}.
FT                                /FTId=VAR_055011.
FT   CONFLICT   1326   1326       F -> S (in Ref. 1, 2; BAA20816 and 4;
FT                                AAI46769/AAI67158). {ECO:0000305}.
SQ   SEQUENCE   1338 AA;  144734 MW;  273405025B701DAF CRC64;
     MSPVLHFYVR PSGHEGAAPG HTRRKLQGKL PELQGVETEL CYNVNWTAEA LPSAEETKKL
     MWLFGCPLLL DDVARESWLL PGSNDLLLEV GPRLNFSTPT STNIVSVCRA TGLGPVDRVE
     TTRRYRLSFA HPPSAEVEAI ALATLHDRMT EQHFPHPIQS FSPESMPEPL NGPINILGEG
     RLALEKANQE LGLALDSWDL DFYTKRFQEL QRNPSTVEAF DLAQSNSEHS RHWFFKGQLH
     VDGQKLVHSL FESIMSTQES SNPNNVLKFC DNSSAIQGKE VRFLRPEDPT RPSRFQQQQG
     LRHVVFTAET HNFPTGVCPF SGATTGTGGR IRDVQCTGRG AHVVAGTAGY CFGNLHIPGY
     NLPWEDPSFQ YPGNFARPLE VAIEASNGAS DYGNKFGEPV LAGFARSLGL QLPDGQRREW
     IKPIMFSGGI GSMEADHISK EAPEPGMEVV KVGGPVYRIG VGGGAASSVQ VQGDNTSDLD
     FGAVQRGDPE MEQKMNRVIR ACVEAPKGNP ICSLHDQGAG GNGNVLKELS DPAGAIIYTS
     RFQLGDPTLN ALEIWGAEYQ ESNALLLRSP NRDFLTHVSA RERCPACFVG TITGDRRIVL
     VDDRECPVRR NGQGDAPPTP LPTPVDLELE WVLGKMPRKE FFLQRKPPML QPLALPPGLS
     VHQALERVLR LPAVASKRYL TNKVDRSVGG LVAQQQCVGP LQTPLADVAV VALSHEELIG
     AATALGEQPV KSLLDPKVAA RLAVAEALTN LVFALVTDLR DVKCSGNWMW AAKLPGEGAA
     LADACEAMVA VMAALGVAVD GGKDSLSMAA RVGTETVRAP GSLVISAYAV CPDITATVTP
     DLKHPEGRGH LLYVALSPGQ HRLGGTALAQ CFSQLGEHPP DLDLPENLVR AFSITQGLLK
     DRLLCSGHDV SDGGLVTCLL EMAFAGNCGL QVDVPVPRVD VLSVLFAEEP GLVLEVQEPD
     LAQVLKRYRD AGLHCLELGH TGEAGPHAMV RVSVNGAVVL EEPVGELRAL WEETSFQLDR
     LQAEPRCVAE EERGLRERMG PSYCLPPTFP KASVPREPGG PSPRVAILRE EGSNGDREMA
     DAFHLAGFEV WDVTMQDLCS GAIGLDTFRG VAFVGGFSYA DVLGSAKGWA AAVTFHPRAG
     AELRRFRKRP DTFSLGVCNG CQLLALLGWV GGDPNEDAAE MGPDSQPARP GLLLRHNLSG
     RYESRWASVR VGPGPALMLR GMEGAVLPVW SAHGEGYVAF SSPELQAQIE ARGLAPLHWA
     DDDGNPTEQY PLNPNGSPGG VAGICSCDGR HLAVMPHPER AVRPWQWAWR PPPFDTLTTS
     PWLQLFINAR NWTLEGSC
//
ID   Q6P4B4_HUMAN            Unreviewed;       748 AA.
AC   Q6P4B4;
DT   05-JUL-2004, integrated into UniProtKB/TrEMBL.
DT   05-JUL-2004, sequence version 1.
DT   23-MAY-2018, entry version 70.
DE   SubName: Full=PFAS protein {ECO:0000313|EMBL:AAH63538.1};
DE   Flags: Fragment;
GN   Name=PFAS {ECO:0000313|EMBL:AAH63538.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:AAH63538.1};
RN   [1] {ECO:0000313|EMBL:AAH63538.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Liver {ECO:0000313|EMBL:AAH63538.1};
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RA   Gerhard D.S., Wagner L., Feingold E.A., Shenmen C.M., Grouse L.H.,
RA   Schuler G., Klein S.L., Old S., Rasooly R., Good P., Guyer M.,
RA   Peck A.M., Derge J.G., Lipman D., Collins F.S., Jang W., Sherry S.,
RA   Feolo M., Misquitta L., Lee E., Rotmistrovsky K., Greenhut S.F.,
RA   Schaefer C.F., Buetow K., Bonner T.I., Haussler D., Kent J.,
RA   Kiekhaus M., Furey T., Brent M., Prange C., Schreiber K., Shapiro N.,
RA   Bhat N.K., Hopkins R.F., Hsie F., Driscoll T., Soares M.B.,
RA   Casavant T.L., Scheetz T.E., Brown-stein M.J., Usdin T.B.,
RA   Toshiyuki S., Carninci P., Piao Y., Dudekula D.B., Ko M.S.,
RA   Kawakami K., Suzuki Y., Sugano S., Gruber C.E., Smith M.R.,
RA   Simmons B., Moore T., Waterman R., Johnson S.L., Ruan Y., Wei C.L.,
RA   Mathavan S., Gunaratne P.H., Wu J., Garcia A.M., Hulyk S.W., Fuh E.,
RA   Yuan Y., Sneed A., Kowis C., Hodgson A., Muzny D.M., McPherson J.,
RA   Gibbs R.A., Fahey J., Helton E., Ketteman M., Madan A., Rodrigues S.,
RA   Sanchez A., Whiting M., Madari A., Young A.C., Wetherby K.D.,
RA   Granite S.J., Kwong P.N., Brinkley C.P., Pearson R.L., Bouffard G.G.,
RA   Blakesly R.W., Green E.D., Dickson M.C., Rodriguez A.C., Grimwood J.,
RA   Schmutz J., Myers R.M., Butterfield Y.S., Griffith M., Griffith O.L.,
RA   Krzywinski M.I., Liao N., Morin R., Morrin R., Palmquist D.,
RA   Petrescu A.S., Skalska U., Smailus D.E., Stott J.M., Schnerch A.,
RA   Schein J.E., Jones S.J., Holt R.A., Baross A., Marra M.A., Clifton S.,
RA   Makowski K.A., Bosak S., Malek J.;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; BC063538; AAH63538.1; -; mRNA.
DR   RefSeq; NP_036525.1; NM_012393.2.
DR   UniGene; Hs.573976; -.
DR   ProteinModelPortal; Q6P4B4; -.
DR   PeptideAtlas; Q6P4B4; -.
DR   PRIDE; Q6P4B4; -.
DR   GeneID; 5198; -.
DR   KEGG; hsa:5198; -.
DR   CTD; 5198; -.
DR   PharmGKB; PA33205; -.
DR   eggNOG; KOG1907; Eukaryota.
DR   eggNOG; COG0046; LUCA.
DR   eggNOG; COG0047; LUCA.
DR   HOVERGEN; HBG108309; -.
DR   KO; K01952; -.
DR   ChiTaRS; PFAS; human.
DR   GenomeRNAi; 5198; -.
DR   Genevisible; Q6P4B4; HS.
DR   GO; GO:0004642; F:phosphoribosylformylglycinamidine synthase activity; IEA:InterPro.
DR   GO; GO:0006189; P:'de novo' IMP biosynthetic process; IEA:InterPro.
DR   Gene3D; 3.30.1330.10; -; 1.
DR   Gene3D; 3.40.50.880; -; 1.
DR   Gene3D; 3.90.650.10; -; 1.
DR   InterPro; IPR029062; Class_I_gatase-like.
DR   InterPro; IPR017926; GATASE.
DR   InterPro; IPR010073; PRibForGlyAmidine_synth.
DR   InterPro; IPR010918; PurM-like_C_dom.
DR   InterPro; IPR036676; PurM-like_C_sf.
DR   InterPro; IPR036921; PurM-like_N_sf.
DR   Pfam; PF02769; AIRS_C; 1.
DR   SUPFAM; SSF52317; SSF52317; 1.
DR   SUPFAM; SSF55326; SSF55326; 1.
DR   SUPFAM; SSF56042; SSF56042; 1.
DR   TIGRFAMs; TIGR01735; FGAM_synt; 1.
DR   PROSITE; PS51273; GATASE_TYPE_1; 1.
PE   2: Evidence at transcript level;
KW   Glutamine amidotransferase {ECO:0000256|PROSITE-ProRule:PRU00605}.
FT   DOMAIN      474    746       Glutamine amidotransferase type-1.
FT                                {ECO:0000259|PROSITE:PS51273}.
FT   ACT_SITE    568    568       Nucleophile. {ECO:0000256|PROSITE-
FT                                ProRule:PRU00605}.
FT   ACT_SITE    707    707       {ECO:0000256|PROSITE-ProRule:PRU00605}.
FT   ACT_SITE    709    709       {ECO:0000256|PROSITE-ProRule:PRU00605}.
FT   NON_TER       1      1       {ECO:0000313|EMBL:AAH63538.1}.
SQ   SEQUENCE   748 AA;  80186 MW;  017E6CAC4CDE9CFE CRC64;
     TITGDRRIVL VDDRECPVRR NGQGDAPPTP LPTPVDLELE WVLGKMPRKE FFLQRKPPML
     QPLALPPGLS VHQALERVLR LPAVASKRYL TNKVDRSVGG LVAQQQCVGP LQTPLADVAV
     VALSHEELIG AATALGEQPV KSLLDPKVAA RLAVAEALTN LVFALVTDLR DVKCSGNWMW
     AAKLPGEGAA LADACEAMVA VMAALGVAVD GGKDSLSMAA RVGTETVRAP GSLVISAYAV
     CPDITATVTP DLKHPEGRGH LLYVALSPGQ HRLGGTALAQ CFSQLGEHPP DLDLPENLVR
     AFSITQGLLK DRLLCSGHDV SDGGLVTCLL EMAFAGNCGL QVDVPVPRVD VLSVLFAEEP
     GLVLEVQEPD LAQVLKRYRD AGLHCLELGH TGEAGPHAMV RVSVNGAVVL EEPVGELRAL
     WEETSFQLDR LQAEPRCVAE EERGLRERMG PSYCLPPTFP KASVPREPGG PSPRVAILRE
     EGSNGDREMA DAFHLAGFEV WDVTMQDLCS GAIGLDTFRG VAFVGGFSYA DVLGSAKGWA
     AAVTFHPRAG AELRRFRKRP DTFSLGVCNG CQLLALLGWV GGDPNEDAAE MGPDSQPARP
     GLLLRHNLSG RYESRWASVR VGPGPALMLR GMEGAVLPVW SAHGEGYVAF SSPELQAQIE
     ARGLAPLHWA DDDGNPTEQY PLNPNGSPGG VAGICSCDGR HLAVMPHPER AVRPWQWAWR
     PPPFDTLTTS PWLQLFINAR NWTLEGSC
//
ID   SC23A_HUMAN             Reviewed;         765 AA.
AC   Q15436; B2R5P4; B3KXI2; Q8NE16;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   06-MAR-2007, sequence version 2.
DT   23-MAY-2018, entry version 175.
DE   RecName: Full=Protein transport protein Sec23A {ECO:0000305};
DE            Short=hSec23A {ECO:0000303|PubMed:8898360};
DE   AltName: Full=SEC23-related protein A;
GN   Name=SEC23A {ECO:0000312|HGNC:HGNC:10701};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), VARIANT VAL-211, FUNCTION,
RP   SUBCELLULAR LOCATION, TOPOLOGY, AND TISSUE SPECIFICITY.
RC   TISSUE=B-cell;
RX   PubMed=8898360; DOI=10.1091/mbc.7.10.1535;
RA   Paccaud J.-P., Reith W., Carpentier J.-L., Ravazzola M., Amherdt M.,
RA   Schekman R., Orci L.;
RT   "Cloning and functional characterization of mammalian homologues of
RT   the COPII component Sec23.";
RL   Mol. Biol. Cell 7:1535-1546(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2), AND VARIANT
RP   VAL-211.
RC   TISSUE=Hippocampus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12508121; DOI=10.1038/nature01348;
RA   Heilig R., Eckenberg R., Petit J.-L., Fonknechten N., Da Silva C.,
RA   Cattolico L., Levy M., Barbe V., De Berardinis V., Ureta-Vidal A.,
RA   Pelletier E., Vico V., Anthouard V., Rowen L., Madan A., Qin S.,
RA   Sun H., Du H., Pepin K., Artiguenave F., Robert C., Cruaud C.,
RA   Bruels T., Jaillon O., Friedlander L., Samson G., Brottier P.,
RA   Cure S., Segurens B., Aniere F., Samain S., Crespeau H., Abbasi N.,
RA   Aiach N., Boscus D., Dickhoff R., Dors M., Dubois I., Friedman C.,
RA   Gouyvenoux M., James R., Madan A., Mairey-Estrada B., Mangenot S.,
RA   Martins N., Menard M., Oztas S., Ratcliffe A., Shaffer T., Trask B.,
RA   Vacherie B., Bellemere C., Belser C., Besnard-Gonnet M.,
RA   Bartol-Mavel D., Boutard M., Briez-Silla S., Combette S.,
RA   Dufosse-Laurent V., Ferron C., Lechaplais C., Louesse C., Muselet D.,
RA   Magdelenat G., Pateau E., Petit E., Sirvain-Trukniewicz P., Trybou A.,
RA   Vega-Czarny N., Bataille E., Bluet E., Bordelais I., Dubois M.,
RA   Dumont C., Guerin T., Haffray S., Hammadi R., Muanga J., Pellouin V.,
RA   Robert D., Wunderle E., Gauguet G., Roy A., Sainte-Marthe L.,
RA   Verdier J., Verdier-Discala C., Hillier L.W., Fulton L., McPherson J.,
RA   Matsuda F., Wilson R., Scarpelli C., Gyapay G., Wincker P., Saurin W.,
RA   Quetier F., Waterston R., Hood L., Weissenbach J.;
RT   "The DNA sequence and analysis of human chromosome 14.";
RL   Nature 421:601-607(2003).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT
RP   VAL-211.
RC   TISSUE=Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   INTERACTION WITH SEC16A.
RC   TISSUE=Liver;
RX   PubMed=17192411; DOI=10.1091/mbc.E06-08-0707;
RA   Bhattacharyya D., Glick B.S.;
RT   "Two mammalian Sec16 homologues have nonredundant functions in
RT   endoplasmic reticulum (ER) export and transitional ER organization.";
RL   Mol. Biol. Cell 18:839-849(2007).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-308, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [8]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT THR-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22223895; DOI=10.1074/mcp.M111.015131;
RA   Bienvenut W.V., Sumpton D., Martinez A., Lilla S., Espagne C.,
RA   Meinnel T., Giglione C.;
RT   "Comparative large-scale characterisation of plant vs. mammal proteins
RT   reveals similar and idiosyncratic N-alpha acetylation features.";
RL   Mol. Cell. Proteomics 11:M111.015131-M111.015131(2012).
RN   [9]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT THR-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [12] {ECO:0000244|PDB:2YRC, ECO:0000244|PDB:2YRD}
RP   STRUCTURE BY NMR OF 57-108 IN COMPLEX WITH ZINC.
RG   RIKEN structural genomics initiative (RSGI);
RT   "Solution structure of the ZF-SEC23_SEC24 from human SEC23A.";
RL   Submitted (OCT-2007) to the PDB data bank.
RN   [13] {ECO:0000244|PDB:2NUP, ECO:0000244|PDB:2NUT}
RP   X-RAY CRYSTALLOGRAPHY (2.30 ANGSTROMS) IN COMPLEX WITH SEC22B; SEC24A
RP   AND ZINC, FUNCTION, SUBUNIT, AND INTERACTION WITH SEC22B.
RX   PubMed=17499046; DOI=10.1016/j.molcel.2007.03.017;
RA   Mancias J.D., Goldberg J.;
RT   "The transport signal on Sec22 for packaging into COPII-coated
RT   vesicles is a conformational epitope.";
RL   Mol. Cell 26:403-414(2007).
RN   [14] {ECO:0000244|PDB:3EFO, ECO:0000244|PDB:3EG9, ECO:0000244|PDB:3EGD, ECO:0000244|PDB:3EGX}
RP   X-RAY CRYSTALLOGRAPHY (2.70 ANGSTROMS) OF 1-764 IN COMPLEX WITH CARGO
RP   PEPTIDES; SEC22B; SEC24A; SEC24D AND ZINC, AND FUNCTION.
RX   PubMed=18843296; DOI=10.1038/emboj.2008.208;
RA   Mancias J.D., Goldberg J.;
RT   "Structural basis of cargo membrane protein discrimination by the
RT   human COPII coat machinery.";
RL   EMBO J. 27:2918-2928(2008).
RN   [15] {ECO:0000244|PDB:5KYN, ECO:0000244|PDB:5KYU, ECO:0000244|PDB:5KYW, ECO:0000244|PDB:5KYX, ECO:0000244|PDB:5KYY}
RP   X-RAY CRYSTALLOGRAPHY (2.55 ANGSTROMS) IN COMPLEX WITH MIA3 PEPTIDE;
RP   SEC24D AND ZINC, FUNCTION, INTERACTION WITH CTAGE5; MIA3 AND SEC31A,
RP   MUTAGENESIS OF PHE-628; TYR-672; TYR-678 AND PHE-681, AND DOMAIN.
RX   PubMed=27551091; DOI=10.1073/pnas.1605916113;
RA   Ma W., Goldberg J.;
RT   "TANGO1/cTAGE5 receptor as a polyvalent template for assembly of large
RT   COPII coats.";
RL   Proc. Natl. Acad. Sci. U.S.A. 113:10061-10066(2016).
RN   [16]
RP   VARIANT CLSD LEU-382, CHARACTERIZATION OF VARIANT CLSD LEU-382, AND
RP   FUNCTION.
RX   PubMed=16980979; DOI=10.1038/ng1876;
RA   Boyadjiev S.A., Fromme J.C., Ben J., Chong S.S., Nauta C., Hur D.J.,
RA   Zhang G., Hamamoto S., Schekman R., Ravazzola M., Orci L., Eyaid W.;
RT   "Cranio-lenticulo-sutural dysplasia is caused by a SEC23A mutation
RT   leading to abnormal endoplasmic-reticulum-to-Golgi trafficking.";
RL   Nat. Genet. 38:1192-1197(2006).
CC   -!- FUNCTION: Component of the coat protein complex II (COPII) which
CC       promotes the formation of transport vesicles from the endoplasmic
CC       reticulum (ER). The coat has two main functions, the physical
CC       deformation of the endoplasmic reticulum membrane into vesicles
CC       and the selection of cargo molecules for their transport to the
CC       Golgi complex. {ECO:0000269|PubMed:16980979,
CC       ECO:0000269|PubMed:17499046, ECO:0000269|PubMed:18843296,
CC       ECO:0000269|PubMed:27551091, ECO:0000269|PubMed:8898360}.
CC   -!- SUBUNIT: COPII is composed of at least five proteins: the Sec23/24
CC       complex, the Sec13/31 complex and Sar1 (PubMed:17499046).
CC       Interacts with SEC23IP. Interacts with HTR4 (By similarity).
CC       Interacts with SEC16A (PubMed:17192411). Interacts with SLC6A4 (By
CC       similarity). Interacts (as part of the Sec23/24 complex) with
CC       SEC22B; recruits SEC22B into COPII-coated vesicles and allows the
CC       transport of this cargo from the endoplasmic reticulum to the
CC       Golgi (PubMed:17499046). Interacts (via Gelsolin-like repeat) with
CC       CTAGE5 and MIA3; specifically involved in the transport of large
CC       cargos like the collagen COL7A1 (PubMed:27551091).
CC       {ECO:0000250|UniProtKB:Q01405, ECO:0000269|PubMed:17192411,
CC       ECO:0000269|PubMed:17499046, ECO:0000269|PubMed:27551091}.
CC   -!- INTERACTION:
CC       Q00536:CDK16; NbExp=3; IntAct=EBI-81088, EBI-726261;
CC       P50570:DNM2; NbExp=4; IntAct=EBI-81088, EBI-346547;
CC       P53992:SEC24C; NbExp=5; IntAct=EBI-81088, EBI-81134;
CC   -!- SUBCELLULAR LOCATION: Cytoplasmic vesicle, COPII-coated vesicle
CC       membrane {ECO:0000305|PubMed:8898360}; Peripheral membrane protein
CC       {ECO:0000269|PubMed:8898360}; Cytoplasmic side
CC       {ECO:0000269|PubMed:8898360}. Endoplasmic reticulum membrane
CC       {ECO:0000269|PubMed:8898360}; Peripheral membrane protein
CC       {ECO:0000269|PubMed:8898360}; Cytoplasmic side
CC       {ECO:0000269|PubMed:8898360}. Cytoplasm, cytosol
CC       {ECO:0000269|PubMed:8898360}. Note=Enriched at endoplasmic
CC       reticulum exit sites. {ECO:0000269|PubMed:8898360}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q15436-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q15436-2; Sequence=VSP_056230;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Ubiquitously expressed.
CC       {ECO:0000269|PubMed:8898360}.
CC   -!- DOMAIN: The Gelsolin-like repeat mediates interaction with
CC       proteins containing PPP motifs that include CTAGE5, MIA3 but also
CC       SEC31A. These interactions are probably competitive.
CC       {ECO:0000269|PubMed:27551091}.
CC   -!- DISEASE: Craniolenticulosutural dysplasia (CLSD) [MIM:607812]:
CC       Autosomal recessive syndrome characterized by late-closing
CC       fontanels, sutural cataracts, facial dysmorphisms and skeletal
CC       defects. {ECO:0000269|PubMed:16980979}. Note=The disease is caused
CC       by mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the SEC23/SEC24 family. SEC23 subfamily.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X97064; CAA65774.1; -; mRNA.
DR   EMBL; AK127355; BAG54494.1; -; mRNA.
DR   EMBL; AK312259; BAG35191.1; -; mRNA.
DR   EMBL; AL109628; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC036649; AAH36649.1; -; mRNA.
DR   CCDS; CCDS9668.1; -. [Q15436-1]
DR   PIR; T09574; T09574.
DR   RefSeq; NP_006355.2; NM_006364.3. [Q15436-1]
DR   UniGene; Hs.272927; -.
DR   PDB; 2NUP; X-ray; 2.80 A; A=1-765.
DR   PDB; 2NUT; X-ray; 2.30 A; A=1-765.
DR   PDB; 2YRC; NMR; -; A=57-108.
DR   PDB; 2YRD; NMR; -; A=57-108.
DR   PDB; 3EFO; X-ray; 2.70 A; A=1-765.
DR   PDB; 3EG9; X-ray; 3.00 A; A=1-764.
DR   PDB; 3EGD; X-ray; 2.70 A; A=1-764.
DR   PDB; 3EGX; X-ray; 3.30 A; A=1-764.
DR   PDB; 5KYN; X-ray; 2.55 A; A/B=1-765.
DR   PDB; 5KYU; X-ray; 3.51 A; A=1-765.
DR   PDB; 5KYW; X-ray; 3.20 A; A=1-765.
DR   PDB; 5KYX; X-ray; 3.52 A; A=1-765.
DR   PDB; 5KYY; X-ray; 3.40 A; A=1-765.
DR   PDB; 5VNE; X-ray; 2.70 A; A=1-764.
DR   PDB; 5VNF; X-ray; 2.41 A; A=1-764.
DR   PDB; 5VNG; X-ray; 2.60 A; A=1-764.
DR   PDB; 5VNH; X-ray; 2.60 A; A=1-764.
DR   PDB; 5VNI; X-ray; 2.79 A; A=1-764.
DR   PDB; 5VNJ; X-ray; 2.81 A; A=1-764.
DR   PDB; 5VNK; X-ray; 2.55 A; A=1-764.
DR   PDB; 5VNL; X-ray; 2.39 A; A=1-764.
DR   PDB; 5VNM; X-ray; 2.77 A; A=1-764.
DR   PDB; 5VNN; X-ray; 2.50 A; A=1-764.
DR   PDB; 5VNO; X-ray; 2.90 A; A=1-764.
DR   PDBsum; 2NUP; -.
DR   PDBsum; 2NUT; -.
DR   PDBsum; 2YRC; -.
DR   PDBsum; 2YRD; -.
DR   PDBsum; 3EFO; -.
DR   PDBsum; 3EG9; -.
DR   PDBsum; 3EGD; -.
DR   PDBsum; 3EGX; -.
DR   PDBsum; 5KYN; -.
DR   PDBsum; 5KYU; -.
DR   PDBsum; 5KYW; -.
DR   PDBsum; 5KYX; -.
DR   PDBsum; 5KYY; -.
DR   PDBsum; 5VNE; -.
DR   PDBsum; 5VNF; -.
DR   PDBsum; 5VNG; -.
DR   PDBsum; 5VNH; -.
DR   PDBsum; 5VNI; -.
DR   PDBsum; 5VNJ; -.
DR   PDBsum; 5VNK; -.
DR   PDBsum; 5VNL; -.
DR   PDBsum; 5VNM; -.
DR   PDBsum; 5VNN; -.
DR   PDBsum; 5VNO; -.
DR   ProteinModelPortal; Q15436; -.
DR   SMR; Q15436; -.
DR   BioGrid; 115747; 87.
DR   IntAct; Q15436; 57.
DR   MINT; Q15436; -.
DR   STRING; 9606.ENSP00000306881; -.
DR   iPTMnet; Q15436; -.
DR   PhosphoSitePlus; Q15436; -.
DR   SwissPalm; Q15436; -.
DR   BioMuta; SEC23A; -.
DR   DMDM; 143811354; -.
DR   EPD; Q15436; -.
DR   MaxQB; Q15436; -.
DR   PaxDb; Q15436; -.
DR   PeptideAtlas; Q15436; -.
DR   PRIDE; Q15436; -.
DR   DNASU; 10484; -.
DR   Ensembl; ENST00000307712; ENSP00000306881; ENSG00000100934. [Q15436-1]
DR   Ensembl; ENST00000537403; ENSP00000444193; ENSG00000100934. [Q15436-2]
DR   GeneID; 10484; -.
DR   KEGG; hsa:10484; -.
DR   UCSC; uc001wup.2; human. [Q15436-1]
DR   CTD; 10484; -.
DR   DisGeNET; 10484; -.
DR   EuPathDB; HostDB:ENSG00000100934.14; -.
DR   GeneCards; SEC23A; -.
DR   H-InvDB; HIX0011611; -.
DR   HGNC; HGNC:10701; SEC23A.
DR   HPA; HPA043806; -.
DR   HPA; HPA069974; -.
DR   MalaCards; SEC23A; -.
DR   MIM; 607812; phenotype.
DR   MIM; 610511; gene.
DR   neXtProt; NX_Q15436; -.
DR   OpenTargets; ENSG00000100934; -.
DR   Orphanet; 50814; Craniolenticulosutural dysplasia.
DR   PharmGKB; PA35624; -.
DR   eggNOG; KOG1986; Eukaryota.
DR   eggNOG; COG5047; LUCA.
DR   GeneTree; ENSGT00390000006916; -.
DR   HOGENOM; HOG000231690; -.
DR   HOVERGEN; HBG055039; -.
DR   InParanoid; Q15436; -.
DR   KO; K14006; -.
DR   OMA; QVHEIGY; -.
DR   OrthoDB; EOG091G063R; -.
DR   PhylomeDB; Q15436; -.
DR   TreeFam; TF300693; -.
DR   Reactome; R-HSA-1655829; Regulation of cholesterol biosynthesis by SREBP (SREBF).
DR   Reactome; R-HSA-204005; COPII-mediated vesicle transport.
DR   Reactome; R-HSA-2132295; MHC class II antigen presentation.
DR   Reactome; R-HSA-5694530; Cargo concentration in the ER.
DR   Reactome; R-HSA-983170; Antigen Presentation: Folding, assembly and peptide loading of class I MHC.
DR   ChiTaRS; SEC23A; human.
DR   EvolutionaryTrace; Q15436; -.
DR   GeneWiki; SEC23A; -.
DR   GenomeRNAi; 10484; -.
DR   PRO; PR:Q15436; -.
DR   Proteomes; UP000005640; Chromosome 14.
DR   Bgee; ENSG00000100934; -.
DR   CleanEx; HS_SEC23A; -.
DR   ExpressionAtlas; Q15436; baseline and differential.
DR   Genevisible; Q15436; HS.
DR   GO; GO:0030127; C:COPII vesicle coat; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IDA:UniProtKB.
DR   GO; GO:0070971; C:endoplasmic reticulum exit site; IDA:UniProtKB.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0012507; C:ER to Golgi transport vesicle membrane; IGI:UniProtKB.
DR   GO; GO:0019898; C:extrinsic component of membrane; IDA:UniProtKB.
DR   GO; GO:0000139; C:Golgi membrane; IEA:Ensembl.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IEA:Ensembl.
DR   GO; GO:0008270; F:zinc ion binding; IDA:UniProtKB.
DR   GO; GO:0019886; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; TAS:Reactome.
DR   GO; GO:0002474; P:antigen processing and presentation of peptide antigen via MHC class I; TAS:Reactome.
DR   GO; GO:0090110; P:cargo loading into COPII-coated vesicle; IDA:UniProtKB.
DR   GO; GO:0048208; P:COPII vesicle coating; TAS:Reactome.
DR   GO; GO:0006888; P:ER to Golgi vesicle-mediated transport; TAS:Reactome.
DR   GO; GO:0006886; P:intracellular protein transport; IEA:InterPro.
DR   CDD; cd11287; Sec23_C; 1.
DR   Gene3D; 3.40.20.10; -; 1.
DR   Gene3D; 3.40.50.410; -; 1.
DR   InterPro; IPR029006; ADF-H/Gelsolin-like_dom_sf.
DR   InterPro; IPR007123; Gelsolin-like_dom.
DR   InterPro; IPR036180; Gelsolin-like_dom_sf.
DR   InterPro; IPR037364; Sec23.
DR   InterPro; IPR006900; Sec23/24_helical_dom.
DR   InterPro; IPR036175; Sec23/24_helical_dom_sf.
DR   InterPro; IPR006896; Sec23/24_trunk_dom.
DR   InterPro; IPR012990; Sec23_24_beta_S.
DR   InterPro; IPR037550; Sec23_C.
DR   InterPro; IPR036465; vWFA_dom_sf.
DR   InterPro; IPR006895; Znf_Sec23_Sec24.
DR   InterPro; IPR036174; Znf_Sec23_Sec24_sf.
DR   PANTHER; PTHR11141; PTHR11141; 1.
DR   Pfam; PF00626; Gelsolin; 1.
DR   Pfam; PF08033; Sec23_BS; 1.
DR   Pfam; PF04815; Sec23_helical; 1.
DR   Pfam; PF04811; Sec23_trunk; 1.
DR   Pfam; PF04810; zf-Sec23_Sec24; 1.
DR   SUPFAM; SSF53300; SSF53300; 1.
DR   SUPFAM; SSF81811; SSF81811; 1.
DR   SUPFAM; SSF82754; SSF82754; 1.
DR   SUPFAM; SSF82919; SSF82919; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Complete proteome;
KW   Cytoplasm; Cytoplasmic vesicle; Disease mutation;
KW   Endoplasmic reticulum; ER-Golgi transport; Membrane; Metal-binding;
KW   Phosphoprotein; Polymorphism; Protein transport; Reference proteome;
KW   Transport.
FT   INIT_MET      1      1       Removed. {ECO:0000244|PubMed:22223895,
FT                                ECO:0000244|PubMed:22814378}.
FT   CHAIN         2    765       Protein transport protein Sec23A.
FT                                /FTId=PRO_0000205146.
FT   REPEAT      632    718       Gelsolin-like. {ECO:0000255}.
FT   METAL        61     61       Zinc. {ECO:0000244|PDB:2NUP,
FT                                ECO:0000244|PDB:2YRD,
FT                                ECO:0000244|PDB:3EFO,
FT                                ECO:0000244|PDB:3EG9,
FT                                ECO:0000244|PDB:3EGD,
FT                                ECO:0000244|PDB:5KYN,
FT                                ECO:0000244|PDB:5KYU,
FT                                ECO:0000244|PDB:5KYX}.
FT   METAL        66     66       Zinc. {ECO:0000244|PDB:2NUP,
FT                                ECO:0000244|PDB:2YRD,
FT                                ECO:0000244|PDB:3EFO,
FT                                ECO:0000244|PDB:3EG9,
FT                                ECO:0000244|PDB:3EGD,
FT                                ECO:0000244|PDB:5KYN,
FT                                ECO:0000244|PDB:5KYU,
FT                                ECO:0000244|PDB:5KYX}.
FT   METAL        85     85       Zinc. {ECO:0000244|PDB:2NUP,
FT                                ECO:0000244|PDB:2YRD,
FT                                ECO:0000244|PDB:3EFO,
FT                                ECO:0000244|PDB:3EG9,
FT                                ECO:0000244|PDB:3EGD,
FT                                ECO:0000244|PDB:5KYN,
FT                                ECO:0000244|PDB:5KYU,
FT                                ECO:0000244|PDB:5KYX}.
FT   METAL        88     88       Zinc. {ECO:0000244|PDB:2NUP,
FT                                ECO:0000244|PDB:2YRD,
FT                                ECO:0000244|PDB:3EFO,
FT                                ECO:0000244|PDB:3EG9,
FT                                ECO:0000244|PDB:3EGD,
FT                                ECO:0000244|PDB:5KYN,
FT                                ECO:0000244|PDB:5KYU,
FT                                ECO:0000244|PDB:5KYX}.
FT   MOD_RES       2      2       N-acetylthreonine.
FT                                {ECO:0000244|PubMed:22223895,
FT                                ECO:0000244|PubMed:22814378}.
FT   MOD_RES     308    308       Phosphothreonine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   VAR_SEQ       1    202       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_056230.
FT   VARIANT     211    211       L -> V (in dbSNP:rs8018720).
FT                                {ECO:0000269|PubMed:14702039,
FT                                ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|PubMed:8898360}.
FT                                /FTId=VAR_031029.
FT   VARIANT     382    382       F -> L (in CLSD; loss of COPII vesicle
FT                                coating; results in absence of
FT                                incorporation of cargo proteins into
FT                                vesicles; dbSNP:rs118204000).
FT                                {ECO:0000269|PubMed:16980979}.
FT                                /FTId=VAR_031030.
FT   MUTAGEN     628    628       F->A: Decreased interaction with MIA3;
FT                                when associated with A-681.
FT                                {ECO:0000269|PubMed:27551091}.
FT   MUTAGEN     672    672       Y->K: Decreased interaction with MIA3;
FT                                when associated with A-678.
FT                                {ECO:0000269|PubMed:27551091}.
FT   MUTAGEN     678    678       Y->A: Decreased interaction with MIA3;
FT                                when associated with K-672.
FT                                {ECO:0000269|PubMed:27551091}.
FT   MUTAGEN     681    681       F->A: Decreased interaction with MIA3;
FT                                when associated with A-628.
FT                                {ECO:0000269|PubMed:27551091}.
FT   CONFLICT    623    623       L -> M (in Ref. 4; AAH36649).
FT                                {ECO:0000305}.
FT   HELIX         4     15       {ECO:0000244|PDB:2NUT}.
FT   STRAND       16     24       {ECO:0000244|PDB:2NUT}.
FT   HELIX        28     31       {ECO:0000244|PDB:2NUT}.
FT   STRAND       34     36       {ECO:0000244|PDB:5KYN}.
FT   STRAND       39     42       {ECO:0000244|PDB:2NUT}.
FT   STRAND       49     51       {ECO:0000244|PDB:5KYY}.
FT   TURN         64     66       {ECO:0000244|PDB:5VNL}.
FT   STRAND       74     77       {ECO:0000244|PDB:2NUT}.
FT   TURN         78     81       {ECO:0000244|PDB:2NUT}.
FT   STRAND       82     84       {ECO:0000244|PDB:2NUT}.
FT   STRAND       86     88       {ECO:0000244|PDB:2NUT}.
FT   STRAND       91     93       {ECO:0000244|PDB:2NUT}.
FT   HELIX        96     98       {ECO:0000244|PDB:2NUT}.
FT   STRAND      103    105       {ECO:0000244|PDB:5VNL}.
FT   HELIX       108    110       {ECO:0000244|PDB:2NUT}.
FT   HELIX       112    114       {ECO:0000244|PDB:2NUT}.
FT   STRAND      115    121       {ECO:0000244|PDB:2NUT}.
FT   STRAND      130    136       {ECO:0000244|PDB:2NUT}.
FT   HELIX       141    155       {ECO:0000244|PDB:2NUT}.
FT   STRAND      163    179       {ECO:0000244|PDB:2NUT}.
FT   TURN        181    183       {ECO:0000244|PDB:5VNL}.
FT   STRAND      185    190       {ECO:0000244|PDB:2NUT}.
FT   HELIX       198    204       {ECO:0000244|PDB:2NUT}.
FT   STRAND      228    232       {ECO:0000244|PDB:2NUT}.
FT   HELIX       233    246       {ECO:0000244|PDB:2NUT}.
FT   HELIX       264    278       {ECO:0000244|PDB:2NUT}.
FT   STRAND      285    292       {ECO:0000244|PDB:2NUT}.
FT   STRAND      296    299       {ECO:0000244|PDB:2NUT}.
FT   HELIX       313    317       {ECO:0000244|PDB:2NUT}.
FT   HELIX       324    341       {ECO:0000244|PDB:2NUT}.
FT   STRAND      344    350       {ECO:0000244|PDB:2NUT}.
FT   HELIX       357    360       {ECO:0000244|PDB:2NUT}.
FT   HELIX       362    366       {ECO:0000244|PDB:2NUT}.
FT   STRAND      371    375       {ECO:0000244|PDB:2NUT}.
FT   STRAND      377    379       {ECO:0000244|PDB:2NUT}.
FT   HELIX       380    388       {ECO:0000244|PDB:2NUT}.
FT   STRAND      401    410       {ECO:0000244|PDB:2NUT}.
FT   STRAND      414    422       {ECO:0000244|PDB:2NUT}.
FT   STRAND      431    433       {ECO:0000244|PDB:3EG9}.
FT   STRAND      439    442       {ECO:0000244|PDB:5VNL}.
FT   STRAND      444    451       {ECO:0000244|PDB:2NUT}.
FT   STRAND      457    463       {ECO:0000244|PDB:2NUT}.
FT   STRAND      467    469       {ECO:0000244|PDB:3EG9}.
FT   STRAND      477    487       {ECO:0000244|PDB:2NUT}.
FT   STRAND      488    490       {ECO:0000244|PDB:2NUP}.
FT   STRAND      492    501       {ECO:0000244|PDB:2NUT}.
FT   HELIX       506    508       {ECO:0000244|PDB:2NUT}.
FT   HELIX       509    515       {ECO:0000244|PDB:2NUT}.
FT   HELIX       519    534       {ECO:0000244|PDB:2NUT}.
FT   HELIX       542    557       {ECO:0000244|PDB:2NUT}.
FT   STRAND      558    561       {ECO:0000244|PDB:3EGD}.
FT   HELIX       565    567       {ECO:0000244|PDB:2NUT}.
FT   TURN        572    576       {ECO:0000244|PDB:2NUT}.
FT   HELIX       577    586       {ECO:0000244|PDB:2NUT}.
FT   TURN        588    590       {ECO:0000244|PDB:2NUT}.
FT   HELIX       592    594       {ECO:0000244|PDB:3EFO}.
FT   HELIX       597    607       {ECO:0000244|PDB:2NUT}.
FT   HELIX       612    619       {ECO:0000244|PDB:2NUT}.
FT   STRAND      622    626       {ECO:0000244|PDB:2NUT}.
FT   STRAND      628    631       {ECO:0000244|PDB:2NUT}.
FT   STRAND      633    635       {ECO:0000244|PDB:5VNF}.
FT   HELIX       639    641       {ECO:0000244|PDB:2NUT}.
FT   STRAND      647    651       {ECO:0000244|PDB:2NUT}.
FT   STRAND      653    660       {ECO:0000244|PDB:2NUT}.
FT   HELIX       662    670       {ECO:0000244|PDB:2NUT}.
FT   TURN        671    674       {ECO:0000244|PDB:2NUT}.
FT   HELIX       676    678       {ECO:0000244|PDB:2NUT}.
FT   HELIX       679    698       {ECO:0000244|PDB:2NUT}.
FT   STRAND      699    701       {ECO:0000244|PDB:2NUT}.
FT   STRAND      704    709       {ECO:0000244|PDB:2NUT}.
FT   HELIX       713    715       {ECO:0000244|PDB:5VNL}.
FT   HELIX       716    721       {ECO:0000244|PDB:2NUT}.
FT   HELIX       749    760       {ECO:0000244|PDB:2NUT}.
SQ   SEQUENCE   765 AA;  86161 MW;  128DF9964B253313 CRC64;
     MTTYLEFIQQ NEERDGVRFS WNVWPSSRLE ATRMVVPVAA LFTPLKERPD LPPIQYEPVL
     CSRTTCRAVL NPLCQVDYRA KLWACNFCYQ RNQFPPSYAG ISELNQPAEL LPQFSSIEYV
     VLRGPQMPLI FLYVVDTCME DEDLQALKES MQMSLSLLPP TALVGLITFG RMVQVHELGC
     EGISKSYVFR GTKDLSAKQL QEMLGLSKVP LTQATRGPQV QQPPPSNRFL QPVQKIDMNL
     TDLLGELQRD PWPVPQGKRP LRSSGVALSI AVGLLECTFP NTGARIMMFI GGPATQGPGM
     VVGDELKTPI RSWHDIDKDN AKYVKKGTKH FEALANRAAT TGHVIDIYAC ALDQTGLLEM
     KCCPNLTGGY MVMGDSFNTS LFKQTFQRVF TKDMHGQFKM GFGGTLEIKT SREIKISGAI
     GPCVSLNSKG PCVSENEIGT GGTCQWKICG LSPTTTLAIY FEVVNQHNAP IPQGGRGAIQ
     FVTQYQHSSG QRRIRVTTIA RNWADAQTQI QNIAASFDQE AAAILMARLA IYRAETEEGP
     DVLRWLDRQL IRLCQKFGEY HKDDPSSFRF SETFSLYPQF MFHLRRSSFL QVFNNSPDES
     SYYRHHFMRQ DLTQSLIMIQ PILYAYSFSG PPEPVLLDSS SILADRILLM DTFFQILIYH
     GETIAQWRKS GYQDMPEYEN FRHLLQAPVD DAQEILHSRF PMPRYIDTEH GGSQARFLLS
     KVNPSQTHNN MYAWGQESGA PILTDDVSLQ VFMDHLKKLA VSSAA
//
ID   KYNU_HUMAN              Reviewed;         465 AA.
AC   Q16719; B2RCZ5; D3DP79; Q6I9T2; Q9BVW3;
DT   15-DEC-1998, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   25-APR-2018, entry version 165.
DE   RecName: Full=Kynureninase {ECO:0000255|HAMAP-Rule:MF_03017};
DE            EC=3.7.1.3 {ECO:0000255|HAMAP-Rule:MF_03017, ECO:0000269|PubMed:11985583, ECO:0000269|PubMed:17300176, ECO:0000269|PubMed:8706755, ECO:0000269|PubMed:9180257};
DE   AltName: Full=L-kynurenine hydrolase {ECO:0000255|HAMAP-Rule:MF_03017};
GN   Name=KYNU {ECO:0000255|HAMAP-Rule:MF_03017,
GN   ECO:0000312|HGNC:HGNC:6469};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, SUBCELLULAR
RP   LOCATION, TISSUE SPECIFICITY, CATALYTIC ACTIVITY, ENZYME REGULATION,
RP   AND BIOPHYSICOCHEMICAL PROPERTIES.
RC   TISSUE=Hepatoma;
RX   PubMed=8706755; DOI=10.1111/j.1432-1033.1996.0460u.x;
RA   Alberati-Giani D., Buchli R., Malherbe P., Broger C., Lang G.,
RA   Koehler C., Lahm H.-W., Cesura A.M.;
RT   "Isolation and expression of a cDNA clone encoding human
RT   kynureninase.";
RL   Eur. J. Biochem. 239:460-468(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, TISSUE SPECIFICITY,
RP   CATALYTIC ACTIVITY, ENZYME REGULATION, AND BIOPHYSICOCHEMICAL
RP   PROPERTIES.
RC   TISSUE=Liver;
RX   PubMed=9180257; DOI=10.1016/S0014-5793(97)00374-8;
RA   Toma S., Nakamura M., Tone S., Okuno E., Kido R., Breton J.,
RA   Avanzi N., Cozzi L., Speciale C., Mostardini M., Gatti S., Benatti L.;
RT   "Cloning and recombinant expression of rat and human kynureninase.";
RL   FEBS Lett. 408:5-10(1997).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT
RP   GLU-412.
RC   TISSUE=Synovium;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Cervix;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   MASS SPECTROMETRY, FUNCTION, CATALYTIC ACTIVITY, AND
RP   BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=11985583; DOI=10.1046/j.1432-1033.2002.02854.x;
RA   Walsh H.A., Botting N.P.;
RT   "Purification and biochemical characterization of some of the
RT   properties of recombinant human kynureninase.";
RL   Eur. J. Biochem. 269:2069-2074(2002).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [10]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [12]
RP   X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) IN COMPLEX WITH PYRIDOXAL
RP   PHOSPHATE, HOMODIMERIZATION, COFACTOR, FUNCTION, CATALYTIC ACTIVITY,
RP   AND BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=17300176; DOI=10.1021/bi0616697;
RA   Lima S., Khristoforov R., Momany C., Phillips R.S.;
RT   "Crystal structure of Homo sapiens kynureninase.";
RL   Biochemistry 46:2735-2744(2007).
RN   [13]
RP   INVOLVEMENT IN HYXKY, AND VARIANT HYXKY ALA-198.
RX   PubMed=17334708; DOI=10.1007/s10545-007-0396-2;
RA   Christensen M., Duno M., Lund A.M., Skovby F., Christensen E.;
RT   "Xanthurenic aciduria due to a mutation in KYNU encoding
RT   kynureninase.";
RL   J. Inherit. Metab. Dis. 30:248-255(2007).
RN   [14]
RP   INVOLVEMENT IN VCRL2, VARIANT VCRL2 156-TYR--ASN-465 DEL, FUNCTION,
RP   CATALYTIC ACTIVITY, PATHWAY, CHARACTERIZATION OF VARIANT VCRL2
RP   156-TYR--ASN-465 DEL, AND CHARACTERIZATION OF VARIANT HYXKY ALA-198.
RX   PubMed=28792876; DOI=10.1056/NEJMoa1616361;
RA   Shi H., Enriquez A., Rapadas M., Martin E.M.M.A., Wang R., Moreau J.,
RA   Lim C.K., Szot J.O., Ip E., Hughes J.N., Sugimoto K., Humphreys D.T.,
RA   McInerney-Leo A.M., Leo P.J., Maghzal G.J., Halliday J., Smith J.,
RA   Colley A., Mark P.R., Collins F., Sillence D.O., Winlaw D.S.,
RA   Ho J.W.K., Guillemin G.J., Brown M.A., Kikuchi K., Thomas P.Q.,
RA   Stocker R., Giannoulatou E., Chapman G., Duncan E.L., Sparrow D.B.,
RA   Dunwoodie S.L.;
RT   "NAD deficiency, congenital malformations, and niacin
RT   supplementation.";
RL   N. Engl. J. Med. 377:544-552(2017).
CC   -!- FUNCTION: Catalyzes the cleavage of L-kynurenine (L-Kyn) and L-3-
CC       hydroxykynurenine (L-3OHKyn) into anthranilic acid (AA) and 3-
CC       hydroxyanthranilic acid (3-OHAA), respectively. Has a preference
CC       for the L-3-hydroxy form. Also has cysteine-conjugate-beta-lyase
CC       activity. {ECO:0000269|PubMed:11985583,
CC       ECO:0000269|PubMed:17300176, ECO:0000269|PubMed:28792876,
CC       ECO:0000269|PubMed:8706755, ECO:0000269|PubMed:9180257}.
CC   -!- CATALYTIC ACTIVITY: L-kynurenine + H(2)O = anthranilate + L-
CC       alanine. {ECO:0000255|HAMAP-Rule:MF_03017,
CC       ECO:0000269|PubMed:11985583, ECO:0000269|PubMed:17300176,
CC       ECO:0000269|PubMed:8706755, ECO:0000269|PubMed:9180257}.
CC   -!- CATALYTIC ACTIVITY: L-3-hydroxykynurenine + H(2)O = 3-
CC       hydroxyanthranilate + L-alanine. {ECO:0000255|HAMAP-Rule:MF_03017,
CC       ECO:0000269|PubMed:11985583, ECO:0000269|PubMed:17300176,
CC       ECO:0000269|PubMed:28792876, ECO:0000269|PubMed:8706755,
CC       ECO:0000269|PubMed:9180257}.
CC   -!- COFACTOR:
CC       Name=pyridoxal 5'-phosphate; Xref=ChEBI:CHEBI:597326;
CC         Evidence={ECO:0000269|PubMed:17300176};
CC   -!- ENZYME REGULATION: Inhibited by o-methoxybenzoylalanine (OMBA).
CC       {ECO:0000269|PubMed:8706755, ECO:0000269|PubMed:9180257}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=493 uM for L-kynurenine (at pH 7.0)
CC         {ECO:0000269|PubMed:11985583, ECO:0000269|PubMed:17300176,
CC         ECO:0000269|PubMed:8706755, ECO:0000269|PubMed:9180257};
CC         KM=28.3 uM for DL-3-hydroxykynurenine (at pH 7.0)
CC         {ECO:0000269|PubMed:11985583, ECO:0000269|PubMed:17300176,
CC         ECO:0000269|PubMed:8706755, ECO:0000269|PubMed:9180257};
CC         KM=3.0 uM for DL-3-hydroxykynurenine (at pH 7.9)
CC         {ECO:0000269|PubMed:11985583, ECO:0000269|PubMed:17300176,
CC         ECO:0000269|PubMed:8706755, ECO:0000269|PubMed:9180257};
CC       pH dependence:
CC         Optimum pH is 8.25 with DL-3-hydroxykynurenine as substrate.
CC         {ECO:0000269|PubMed:11985583, ECO:0000269|PubMed:17300176,
CC         ECO:0000269|PubMed:8706755, ECO:0000269|PubMed:9180257};
CC   -!- PATHWAY: Amino-acid degradation; L-kynurenine degradation; L-
CC       alanine and anthranilate from L-kynurenine: step 1/1.
CC       {ECO:0000255|HAMAP-Rule:MF_03017}.
CC   -!- PATHWAY: Cofactor biosynthesis; NAD(+) biosynthesis; quinolinate
CC       from L-kynurenine: step 2/3. {ECO:0000255|HAMAP-Rule:MF_03017,
CC       ECO:0000269|PubMed:28792876}.
CC   -!- SUBUNIT: Homodimer. {ECO:0000255|HAMAP-Rule:MF_03017,
CC       ECO:0000269|PubMed:17300176}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytosol {ECO:0000255|HAMAP-
CC       Rule:MF_03017, ECO:0000269|PubMed:8706755}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q16719-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q16719-2; Sequence=VSP_042739, VSP_042740;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Expressed in all tissues tested (heart, brain
CC       placenta, lung, liver, skeletal muscle, kidney and pancreas).
CC       Highest levels found in placenta, liver and lung. Expressed in all
CC       brain regions. {ECO:0000269|PubMed:8706755,
CC       ECO:0000269|PubMed:9180257}.
CC   -!- INDUCTION: Increased levels in several cerebral and systemic
CC       inflammatory conditions.
CC   -!- MASS SPECTROMETRY: Mass=52400; Method=MALDI; Range=1-465; Note=The
CC       reported mass is given to only three significant figures.;
CC       Evidence={ECO:0000269|PubMed:11985583};
CC   -!- DISEASE: Hydroxykynureninuria (HYXKY) [MIM:236800]: An inborn
CC       error of amino acid metabolism characterized by massive urinary
CC       excretion of large amounts of kynurenine, 3-hydroxykynurenine and
CC       xanthurenic acid. Affected individuals manifest renal tubular
CC       dysfunction, metabolic acidosis, psychomotor retardation, non-
CC       progressive encephalopathy, and muscular hypertonia.
CC       {ECO:0000269|PubMed:17334708, ECO:0000269|PubMed:28792876}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- DISEASE: Vertebral, cardiac, renal, and limb defects syndrome 2
CC       (VCRL2) [MIM:617661]: An autosomal recessive congenital
CC       malformation syndrome characterized by vertebral segmentation
CC       abnormalities, congenital cardiac defects, renal defects, and
CC       distal mild limb defects. {ECO:0000269|PubMed:28792876}. Note=The
CC       disease is caused by mutations affecting the gene represented in
CC       this entry.
CC   -!- SIMILARITY: Belongs to the kynureninase family.
CC       {ECO:0000255|HAMAP-Rule:MF_03017}.
CC   -!- CAUTION: It has been reported that this enzyme possesses no
CC       measurable activity against L-kynurenine and is subject to
CC       inhibition by both L-kynurenine and D-kynurenine at pH 7.9.
CC       {ECO:0000305|PubMed:11985583}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U57721; AAC50650.1; -; mRNA.
DR   EMBL; AK315343; BAG37742.1; -; mRNA.
DR   EMBL; CR457423; CAG33704.1; -; mRNA.
DR   EMBL; AC013437; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC013444; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471058; EAX11599.1; -; Genomic_DNA.
DR   EMBL; CH471058; EAX11600.1; -; Genomic_DNA.
DR   EMBL; CH471058; EAX11601.1; -; Genomic_DNA.
DR   EMBL; BC000879; AAH00879.1; -; mRNA.
DR   CCDS; CCDS2183.1; -. [Q16719-1]
DR   CCDS; CCDS33299.1; -. [Q16719-2]
DR   PIR; G02652; G02652.
DR   RefSeq; NP_001028170.1; NM_001032998.1. [Q16719-2]
DR   RefSeq; NP_001186170.1; NM_001199241.1. [Q16719-1]
DR   RefSeq; NP_003928.1; NM_003937.2. [Q16719-1]
DR   RefSeq; XP_016860706.1; XM_017005217.1. [Q16719-2]
DR   UniGene; Hs.470126; -.
DR   PDB; 2HZP; X-ray; 2.00 A; A=1-465.
DR   PDB; 3E9K; X-ray; 1.70 A; A=1-465.
DR   PDBsum; 2HZP; -.
DR   PDBsum; 3E9K; -.
DR   ProteinModelPortal; Q16719; -.
DR   SMR; Q16719; -.
DR   BioGrid; 114454; 45.
DR   IntAct; Q16719; 6.
DR   STRING; 9606.ENSP00000264170; -.
DR   BindingDB; Q16719; -.
DR   ChEMBL; CHEMBL5100; -.
DR   DrugBank; DB07069; 3-Hydroxyhippuric acid.
DR   DrugBank; DB00160; L-Alanine.
DR   DrugBank; DB00114; Pyridoxal Phosphate.
DR   iPTMnet; Q16719; -.
DR   PhosphoSitePlus; Q16719; -.
DR   BioMuta; KYNU; -.
DR   DMDM; 3913982; -.
DR   EPD; Q16719; -.
DR   MaxQB; Q16719; -.
DR   PaxDb; Q16719; -.
DR   PeptideAtlas; Q16719; -.
DR   PRIDE; Q16719; -.
DR   DNASU; 8942; -.
DR   Ensembl; ENST00000264170; ENSP00000264170; ENSG00000115919. [Q16719-1]
DR   Ensembl; ENST00000375773; ENSP00000364928; ENSG00000115919. [Q16719-2]
DR   Ensembl; ENST00000409512; ENSP00000386731; ENSG00000115919. [Q16719-1]
DR   GeneID; 8942; -.
DR   KEGG; hsa:8942; -.
DR   UCSC; uc002tvk.4; human. [Q16719-1]
DR   CTD; 8942; -.
DR   DisGeNET; 8942; -.
DR   EuPathDB; HostDB:ENSG00000115919.14; -.
DR   GeneCards; KYNU; -.
DR   HGNC; HGNC:6469; KYNU.
DR   HPA; HPA031686; -.
DR   MalaCards; KYNU; -.
DR   MIM; 236800; phenotype.
DR   MIM; 605197; gene.
DR   MIM; 617661; phenotype.
DR   neXtProt; NX_Q16719; -.
DR   OpenTargets; ENSG00000115919; -.
DR   Orphanet; 79155; Encephalopathy due to hydroxykynureninuria.
DR   PharmGKB; PA30258; -.
DR   eggNOG; KOG3846; Eukaryota.
DR   eggNOG; COG3844; LUCA.
DR   GeneTree; ENSGT00390000008033; -.
DR   HOGENOM; HOG000242438; -.
DR   HOVERGEN; HBG001170; -.
DR   InParanoid; Q16719; -.
DR   KO; K01556; -.
DR   OMA; VCSLHAS; -.
DR   OrthoDB; EOG091G077R; -.
DR   PhylomeDB; Q16719; -.
DR   TreeFam; TF300707; -.
DR   BioCyc; MetaCyc:HS03952-MONOMER; -.
DR   BRENDA; 3.7.1.3; 2681.
DR   Reactome; R-HSA-71240; Tryptophan catabolism.
DR   SABIO-RK; Q16719; -.
DR   UniPathway; UPA00253; UER00329.
DR   UniPathway; UPA00334; UER00455.
DR   ChiTaRS; KYNU; human.
DR   EvolutionaryTrace; Q16719; -.
DR   GeneWiki; Kynureninase; -.
DR   GenomeRNAi; 8942; -.
DR   PRO; PR:Q16719; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   Bgee; ENSG00000115919; -.
DR   CleanEx; HS_KYNU; -.
DR   ExpressionAtlas; Q16719; baseline and differential.
DR   Genevisible; Q16719; HS.
DR   GO; GO:0005829; C:cytosol; IDA:UniProtKB.
DR   GO; GO:0005739; C:mitochondrion; IDA:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0061981; F:3-hydroxykynureninase activity; IDA:UniProtKB.
DR   GO; GO:0030429; F:kynureninase activity; IDA:UniProtKB.
DR   GO; GO:0042803; F:protein homodimerization activity; IDA:UniProtKB.
DR   GO; GO:0030170; F:pyridoxal phosphate binding; IEA:Ensembl.
DR   GO; GO:0043420; P:anthranilate metabolic process; IDA:UniProtKB.
DR   GO; GO:0097053; P:L-kynurenine catabolic process; IEA:UniProtKB-UniPathway.
DR   GO; GO:0009435; P:NAD biosynthetic process; IMP:UniProtKB.
DR   GO; GO:0019805; P:quinolinate biosynthetic process; IDA:UniProtKB.
DR   GO; GO:0034341; P:response to interferon-gamma; IDA:UniProtKB.
DR   GO; GO:0034516; P:response to vitamin B6; IMP:UniProtKB.
DR   GO; GO:0006569; P:tryptophan catabolic process; IMP:UniProtKB.
DR   GO; GO:0019442; P:tryptophan catabolic process to acetyl-CoA; IEA:Ensembl.
DR   GO; GO:0019441; P:tryptophan catabolic process to kynurenine; IBA:GO_Central.
DR   Gene3D; 3.40.640.10; -; 1.
DR   Gene3D; 3.90.1150.10; -; 2.
DR   HAMAP; MF_01970; Kynureninase; 1.
DR   InterPro; IPR000192; Aminotrans_V_dom.
DR   InterPro; IPR010111; Kynureninase.
DR   InterPro; IPR015424; PyrdxlP-dep_Trfase.
DR   InterPro; IPR015422; PyrdxlP-dep_Trfase_dom1.
DR   InterPro; IPR015421; PyrdxlP-dep_Trfase_major.
DR   PANTHER; PTHR14084; PTHR14084; 1.
DR   Pfam; PF00266; Aminotran_5; 1.
DR   PIRSF; PIRSF038800; KYNU; 1.
DR   SUPFAM; SSF53383; SSF53383; 1.
DR   TIGRFAMs; TIGR01814; kynureninase; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Complete proteome;
KW   Cytoplasm; Disease mutation; Hydrolase; Polymorphism;
KW   Pyridine nucleotide biosynthesis; Pyridoxal phosphate;
KW   Reference proteome.
FT   CHAIN         1    465       Kynureninase.
FT                                /FTId=PRO_0000218657.
FT   REGION      165    168       Pyridoxal phosphate binding.
FT   BINDING     137    137       Pyridoxal phosphate; via amide nitrogen.
FT                                {ECO:0000255|HAMAP-Rule:MF_03017}.
FT   BINDING     138    138       Pyridoxal phosphate. {ECO:0000255|HAMAP-
FT                                Rule:MF_03017,
FT                                ECO:0000269|PubMed:17300176}.
FT   BINDING     221    221       Pyridoxal phosphate. {ECO:0000255|HAMAP-
FT                                Rule:MF_03017}.
FT   BINDING     250    250       Pyridoxal phosphate. {ECO:0000255|HAMAP-
FT                                Rule:MF_03017,
FT                                ECO:0000269|PubMed:17300176}.
FT   BINDING     253    253       Pyridoxal phosphate. {ECO:0000255|HAMAP-
FT                                Rule:MF_03017,
FT                                ECO:0000269|PubMed:17300176}.
FT   BINDING     275    275       Pyridoxal phosphate. {ECO:0000255|HAMAP-
FT                                Rule:MF_03017,
FT                                ECO:0000269|PubMed:17300176}.
FT   BINDING     305    305       Pyridoxal phosphate. {ECO:0000255|HAMAP-
FT                                Rule:MF_03017,
FT                                ECO:0000269|PubMed:17300176}.
FT   BINDING     333    333       Pyridoxal phosphate. {ECO:0000255|HAMAP-
FT                                Rule:MF_03017,
FT                                ECO:0000269|PubMed:17300176}.
FT   MOD_RES       1      1       N-acetylmethionine.
FT                                {ECO:0000244|PubMed:22814378}.
FT   MOD_RES     276    276       N6-(pyridoxal phosphate)lysine.
FT   VAR_SEQ     302    307       LVGWFG -> RSEFFN (in isoform 2).
FT                                {ECO:0000305}.
FT                                /FTId=VSP_042739.
FT   VAR_SEQ     308    465       Missing (in isoform 2). {ECO:0000305}.
FT                                /FTId=VSP_042740.
FT   VARIANT     156    465       Missing (in VCRL2; strongly reduced 3-
FT                                hydroxykynureninase activity).
FT                                {ECO:0000269|PubMed:28792876}.
FT                                /FTId=VAR_080254.
FT   VARIANT     188    188       R -> Q (in dbSNP:rs2304705).
FT                                /FTId=VAR_049724.
FT   VARIANT     198    198       T -> A (in HYXKY; reduced 3-
FT                                hydroxykynureninase activity;
FT                                dbSNP:rs606231307).
FT                                {ECO:0000269|PubMed:17334708,
FT                                ECO:0000269|PubMed:28792876}.
FT                                /FTId=VAR_054401.
FT   VARIANT     412    412       K -> E (in dbSNP:rs9013).
FT                                {ECO:0000269|PubMed:14702039}.
FT                                /FTId=VAR_022092.
FT   HELIX         9     20       {ECO:0000244|PDB:3E9K}.
FT   HELIX        27     35       {ECO:0000244|PDB:3E9K}.
FT   HELIX        40     45       {ECO:0000244|PDB:3E9K}.
FT   HELIX        51     53       {ECO:0000244|PDB:3E9K}.
FT   HELIX        59     61       {ECO:0000244|PDB:3E9K}.
FT   TURN         73     75       {ECO:0000244|PDB:3E9K}.
FT   HELIX        83     97       {ECO:0000244|PDB:3E9K}.
FT   HELIX        98    102       {ECO:0000244|PDB:3E9K}.
FT   STRAND      104    107       {ECO:0000244|PDB:3E9K}.
FT   HELIX       109    111       {ECO:0000244|PDB:3E9K}.
FT   HELIX       114    117       {ECO:0000244|PDB:3E9K}.
FT   HELIX       118    120       {ECO:0000244|PDB:3E9K}.
FT   HELIX       121    124       {ECO:0000244|PDB:3E9K}.
FT   HELIX       128    130       {ECO:0000244|PDB:3E9K}.
FT   STRAND      131    133       {ECO:0000244|PDB:3E9K}.
FT   HELIX       137    148       {ECO:0000244|PDB:3E9K}.
FT   STRAND      153    155       {ECO:0000244|PDB:3E9K}.
FT   STRAND      157    161       {ECO:0000244|PDB:3E9K}.
FT   HELIX       166    178       {ECO:0000244|PDB:3E9K}.
FT   HELIX       183    186       {ECO:0000244|PDB:3E9K}.
FT   STRAND      187    190       {ECO:0000244|PDB:3E9K}.
FT   HELIX       201    211       {ECO:0000244|PDB:3E9K}.
FT   HELIX       212    214       {ECO:0000244|PDB:3E9K}.
FT   STRAND      215    223       {ECO:0000244|PDB:3E9K}.
FT   TURN        225    227       {ECO:0000244|PDB:3E9K}.
FT   HELIX       233    242       {ECO:0000244|PDB:3E9K}.
FT   STRAND      246    250       {ECO:0000244|PDB:3E9K}.
FT   TURN        252    257       {ECO:0000244|PDB:3E9K}.
FT   HELIX       262    265       {ECO:0000244|PDB:3E9K}.
FT   STRAND      269    272       {ECO:0000244|PDB:3E9K}.
FT   STRAND      274    276       {ECO:0000244|PDB:3E9K}.
FT   STRAND      287    290       {ECO:0000244|PDB:3E9K}.
FT   HELIX       292    294       {ECO:0000244|PDB:3E9K}.
FT   TURN        295    297       {ECO:0000244|PDB:3E9K}.
FT   HELIX       305    307       {ECO:0000244|PDB:3E9K}.
FT   HELIX       310    313       {ECO:0000244|PDB:3E9K}.
FT   HELIX       326    329       {ECO:0000244|PDB:3E9K}.
FT   HELIX       336    352       {ECO:0000244|PDB:3E9K}.
FT   HELIX       354    375       {ECO:0000244|PDB:3E9K}.
FT   STRAND      388    390       {ECO:0000244|PDB:3E9K}.
FT   HELIX       396    398       {ECO:0000244|PDB:3E9K}.
FT   STRAND      403    407       {ECO:0000244|PDB:3E9K}.
FT   HELIX       414    419       {ECO:0000244|PDB:3E9K}.
FT   TURN        420    422       {ECO:0000244|PDB:3E9K}.
FT   STRAND      426    428       {ECO:0000244|PDB:3E9K}.
FT   TURN        429    431       {ECO:0000244|PDB:3E9K}.
FT   STRAND      432    436       {ECO:0000244|PDB:3E9K}.
FT   TURN        439    441       {ECO:0000244|PDB:3E9K}.
FT   HELIX       444    458       {ECO:0000244|PDB:3E9K}.
SQ   SEQUENCE   465 AA;  52352 MW;  BDD136BE18C79EBB CRC64;
     MEPSSLELPA DTVQRIAAEL KCHPTDERVA LHLDEEDKLR HFRECFYIPK IQDLPPVDLS
     LVNKDENAIY FLGNSLGLQP KMVKTYLEEE LDKWAKIAAY GHEVGKRPWI TGDESIVGLM
     KDIVGANEKE IALMNALTVN LHLLMLSFFK PTPKRYKILL EAKAFPSDHY AIESQLQLHG
     LNIEESMRMI KPREGEETLR IEDILEVIEK EGDSIAVILF SGVHFYTGQH FNIPAITKAG
     QAKGCYVGFD LAHAVGNVEL YLHDWGVDFA CWCSYKYLNA GAGGIAGAFI HEKHAHTIKP
     ALVGWFGHEL STRFKMDNKL QLIPGVCGFR ISNPPILLVC SLHASLEIFK QATMKALRKK
     SVLLTGYLEY LIKHNYGKDK AATKKPVVNI ITPSHVEERG CQLTITFSVP NKDVFQELEK
     RGVVCDKRNP NGIRVAPVPL YNSFHDVYKF TNLLTSILDS AETKN
//
ID   MDY2_YEAST              Reviewed;         212 AA.
AC   Q12285; D6W1V6;
DT   16-MAY-2006, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   23-MAY-2018, entry version 138.
DE   RecName: Full=Ubiquitin-like protein MDY2;
DE   AltName: Full=Golgi to ER traffic protein 5;
DE   AltName: Full=Mating-deficient protein 2;
DE   AltName: Full=Translation machinery-associated protein 24;
GN   Name=MDY2; Synonyms=GET5, TMA24; OrderedLocusNames=YOL111C;
OS   Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast).
OC   Eukaryota; Fungi; Dikarya; Ascomycota; Saccharomycotina;
OC   Saccharomycetes; Saccharomycetales; Saccharomycetaceae; Saccharomyces.
OX   NCBI_TaxID=559292;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=ATCC 96604 / S288c / FY1679;
RX   PubMed=7502582; DOI=10.1002/yea.320111108;
RA   Vandenbol M., Durand P., Portetelle D., Hilger F.;
RT   "Sequence analysis of a 44 kb DNA fragment of yeast chromosome XV
RT   including the Ty1-H3 retrotransposon, the suf1(+) frameshift
RT   suppressor gene for tRNA-Gly, the yeast transfer RNA-Thr-1a and a
RT   delta element.";
RL   Yeast 11:1069-1075(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 204508 / S288c;
RX   PubMed=9169874;
RA   Dujon B., Albermann K., Aldea M., Alexandraki D., Ansorge W.,
RA   Arino J., Benes V., Bohn C., Bolotin-Fukuhara M., Bordonne R.,
RA   Boyer J., Camasses A., Casamayor A., Casas C., Cheret G.,
RA   Cziepluch C., Daignan-Fornier B., Dang V.-D., de Haan M., Delius H.,
RA   Durand P., Fairhead C., Feldmann H., Gaillon L., Galisson F.,
RA   Gamo F.-J., Gancedo C., Goffeau A., Goulding S.E., Grivell L.A.,
RA   Habbig B., Hand N.J., Hani J., Hattenhorst U., Hebling U.,
RA   Hernando Y., Herrero E., Heumann K., Hiesel R., Hilger F., Hofmann B.,
RA   Hollenberg C.P., Hughes B., Jauniaux J.-C., Kalogeropoulos A.,
RA   Katsoulou C., Kordes E., Lafuente M.J., Landt O., Louis E.J.,
RA   Maarse A.C., Madania A., Mannhaupt G., Marck C., Martin R.P.,
RA   Mewes H.-W., Michaux G., Paces V., Parle-McDermott A.G., Pearson B.M.,
RA   Perrin A., Pettersson B., Poch O., Pohl T.M., Poirey R.,
RA   Portetelle D., Pujol A., Purnelle B., Ramezani Rad M., Rechmann S.,
RA   Schwager C., Schweizer M., Sor F., Sterky F., Tarassov I.A.,
RA   Teodoru C., Tettelin H., Thierry A., Tobiasch E., Tzermia M.,
RA   Uhlen M., Unseld M., Valens M., Vandenbol M., Vetter I., Vlcek C.,
RA   Voet M., Volckaert G., Voss H., Wambutt R., Wedler H., Wiemann S.,
RA   Winsor B., Wolfe K.H., Zollner A., Zumstein E., Kleine K.;
RT   "The nucleotide sequence of Saccharomyces cerevisiae chromosome XV.";
RL   Nature 387:98-102(1997).
RN   [3]
RP   GENOME REANNOTATION.
RC   STRAIN=ATCC 204508 / S288c;
RX   PubMed=24374639; DOI=10.1534/g3.113.008995;
RA   Engel S.R., Dietrich F.S., Fisk D.G., Binkley G., Balakrishnan R.,
RA   Costanzo M.C., Dwight S.S., Hitz B.C., Karra K., Nash R.S., Weng S.,
RA   Wong E.D., Lloyd P., Skrzypek M.S., Miyasato S.R., Simison M.,
RA   Cherry J.M.;
RT   "The reference genome sequence of Saccharomyces cerevisiae: Then and
RT   now.";
RL   G3 (Bethesda) 4:389-398(2014).
RN   [4]
RP   FUNCTION.
RX   PubMed=10514570;
RX   DOI=10.1002/(SICI)1097-0061(199910)15:14<1529::AID-YEA457>3.0.CO;2-Y;
RA   Iwanejko L., Smith K.N., Loeillet S., Nicolas A., Fabre F.;
RT   "Disruption and functional analysis of six ORFs on chromosome XV:
RT   YOL117w, YOL115w (TRF4), YOL114c, YOL112w (MSB4), YOL111c and
RT   YOL072w.";
RL   Yeast 15:1529-1539(1999).
RN   [5]
RP   SUBCELLULAR LOCATION [LARGE SCALE ANALYSIS].
RX   PubMed=14562095; DOI=10.1038/nature02026;
RA   Huh W.-K., Falvo J.V., Gerke L.C., Carroll A.S., Howson R.W.,
RA   Weissman J.S., O'Shea E.K.;
RT   "Global analysis of protein localization in budding yeast.";
RL   Nature 425:686-691(2003).
RN   [6]
RP   LEVEL OF PROTEIN EXPRESSION [LARGE SCALE ANALYSIS].
RX   PubMed=14562106; DOI=10.1038/nature02046;
RA   Ghaemmaghami S., Huh W.-K., Bower K., Howson R.W., Belle A.,
RA   Dephoure N., O'Shea E.K., Weissman J.S.;
RT   "Global analysis of protein expression in yeast.";
RL   Nature 425:737-741(2003).
RN   [7]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=16390866; DOI=10.1242/jcs.02754;
RA   Hu Z., Potthoff B., Hollenberg C.P., Ramezani-Rad M.;
RT   "Mdy2, a ubiquitin-like (UBL)-domain protein, is required for
RT   efficient mating in Saccharomyces cerevisiae.";
RL   J. Cell Sci. 119:326-338(2006).
RN   [8]
RP   X-RAY CRYSTALLOGRAPHY (1.99 ANGSTROMS) OF 1-59 IN COMPLEX WITH GET4,
RP   AND SUBCELLULAR LOCATION.
RX   PubMed=20106980; DOI=10.1074/jbc.M109.087098;
RA   Chang Y.W., Chuang Y.C., Ho Y.C., Cheng M.Y., Sun Y.J., Hsiao C.D.,
RA   Wang C.;
RT   "Crystal structure of Get4-Get5 complex and its interactions with
RT   Sgt2, Get3, and Ydj1.";
RL   J. Biol. Chem. 285:9962-9970(2010).
CC   -!- FUNCTION: Required for efficient mating. Involved in the
CC       production of alpha-factor, the KAR9 and TUB1 location to the
CC       shmoo tip and nuclear migration into pheromone-induced shmoos.
CC       {ECO:0000269|PubMed:10514570, ECO:0000269|PubMed:16390866}.
CC   -!- SUBUNIT: Interacts with GET4. {ECO:0000269|PubMed:20106980}.
CC   -!- INTERACTION:
CC       Q12154:GET3; NbExp=7; IntAct=EBI-34904, EBI-2989;
CC       Q12125:GET4; NbExp=13; IntAct=EBI-34904, EBI-36940;
CC       Q12118:SGT2; NbExp=9; IntAct=EBI-34904, EBI-31784;
CC       P25491:YDJ1; NbExp=2; IntAct=EBI-34904, EBI-10420;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytosol. Nucleus. Note=Detected
CC       in both cytosol and nucleus but is predominantly cytosolic.
CC   -!- MISCELLANEOUS: Present with 6510 molecules/cell in log phase SD
CC       medium. {ECO:0000269|PubMed:14562106}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; Z48149; CAA88151.1; -; Genomic_DNA.
DR   EMBL; Z74853; CAA99130.1; -; Genomic_DNA.
DR   EMBL; BK006948; DAA10672.1; -; Genomic_DNA.
DR   PIR; S51888; S51888.
DR   RefSeq; NP_014530.1; NM_001183365.1.
DR   PDB; 2LNZ; NMR; -; A/B=152-212.
DR   PDB; 2LXA; NMR; -; A=74-151.
DR   PDB; 2LXC; NMR; -; A=74-151.
DR   PDB; 2WPV; X-ray; 1.99 A; B/D/F/H=1-59.
DR   PDB; 3LKU; X-ray; 2.80 A; B/D/F=3-56.
DR   PDB; 3VEJ; X-ray; 1.23 A; A/B=175-212.
DR   PDB; 3ZDM; X-ray; 1.80 A; C/F=71-151.
DR   PDB; 4A20; X-ray; 1.78 A; A=70-152.
DR   PDB; 4ASW; NMR; -; C=70-152.
DR   PDB; 4GOC; X-ray; 2.40 A; A/B/C=74-148.
DR   PDB; 4PWX; X-ray; 5.40 A; D/F=1-54.
DR   PDB; 5BW8; X-ray; 2.80 A; D=1-54.
DR   PDB; 5BWK; X-ray; 6.00 A; F/H/J/L/R/T/V/X=1-56.
DR   PDBsum; 2LNZ; -.
DR   PDBsum; 2LXA; -.
DR   PDBsum; 2LXC; -.
DR   PDBsum; 2WPV; -.
DR   PDBsum; 3LKU; -.
DR   PDBsum; 3VEJ; -.
DR   PDBsum; 3ZDM; -.
DR   PDBsum; 4A20; -.
DR   PDBsum; 4ASW; -.
DR   PDBsum; 4GOC; -.
DR   PDBsum; 4PWX; -.
DR   PDBsum; 5BW8; -.
DR   PDBsum; 5BWK; -.
DR   ProteinModelPortal; Q12285; -.
DR   SMR; Q12285; -.
DR   BioGrid; 34289; 177.
DR   DIP; DIP-1982N; -.
DR   IntAct; Q12285; 9.
DR   MINT; Q12285; -.
DR   STRING; 4932.YOL111C; -.
DR   TCDB; 3.A.21.1.1; the c-terminal tail-anchored membrane protein biogenesis/ insertion complex (tamp-b) family.
DR   MaxQB; Q12285; -.
DR   PaxDb; Q12285; -.
DR   PRIDE; Q12285; -.
DR   EnsemblFungi; YOL111C; YOL111C; YOL111C.
DR   GeneID; 854038; -.
DR   KEGG; sce:YOL111C; -.
DR   EuPathDB; FungiDB:YOL111C; -.
DR   SGD; S000005471; MDY2.
DR   HOGENOM; HOG000113515; -.
DR   InParanoid; Q12285; -.
DR   OMA; PEHEFVS; -.
DR   OrthoDB; EOG092C4PDD; -.
DR   BioCyc; YEAST:G3O-33508-MONOMER; -.
DR   EvolutionaryTrace; Q12285; -.
DR   PRO; PR:Q12285; -.
DR   Proteomes; UP000002311; Chromosome XV.
DR   GO; GO:0010494; C:cytoplasmic stress granule; IDA:SGD.
DR   GO; GO:0005634; C:nucleus; IDA:SGD.
DR   GO; GO:0072380; C:TRC complex; IDA:SGD.
DR   GO; GO:0000753; P:cell morphogenesis involved in conjugation with cellular fusion; IMP:SGD.
DR   GO; GO:0006620; P:posttranslational protein targeting to endoplasmic reticulum membrane; IDA:SGD.
DR   GO; GO:0045048; P:protein insertion into ER membrane; IGI:SGD.
DR   InterPro; IPR031765; Mdy2_get4-bd.
DR   InterPro; IPR029071; Ubiquitin-like_domsf.
DR   InterPro; IPR000626; Ubiquitin_dom.
DR   Pfam; PF16843; Get5_bdg; 1.
DR   Pfam; PF00240; ubiquitin; 1.
DR   SMART; SM00213; UBQ; 1.
DR   SUPFAM; SSF54236; SSF54236; 1.
DR   PROSITE; PS50053; UBIQUITIN_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Complete proteome; Cytoplasm; Nucleus;
KW   Reference proteome.
FT   CHAIN         1    212       Ubiquitin-like protein MDY2.
FT                                /FTId=PRO_0000235917.
FT   DOMAIN       74    152       Ubiquitin-like. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00214}.
FT   HELIX         4      6       {ECO:0000244|PDB:3LKU}.
FT   HELIX         8     20       {ECO:0000244|PDB:2WPV}.
FT   HELIX        35     37       {ECO:0000244|PDB:2WPV}.
FT   STRAND       74     80       {ECO:0000244|PDB:4A20}.
FT   STRAND       82     84       {ECO:0000244|PDB:4A20}.
FT   STRAND       86     92       {ECO:0000244|PDB:4A20}.
FT   HELIX        98    107       {ECO:0000244|PDB:4A20}.
FT   HELIX       114    116       {ECO:0000244|PDB:4A20}.
FT   STRAND      117    121       {ECO:0000244|PDB:4A20}.
FT   STRAND      124    126       {ECO:0000244|PDB:4A20}.
FT   HELIX       132    134       {ECO:0000244|PDB:4A20}.
FT   STRAND      139    141       {ECO:0000244|PDB:3ZDM}.
FT   STRAND      143    148       {ECO:0000244|PDB:4A20}.
FT   HELIX       179    189       {ECO:0000244|PDB:3VEJ}.
FT   TURN        190    192       {ECO:0000244|PDB:3VEJ}.
FT   HELIX       194    210       {ECO:0000244|PDB:3VEJ}.
SQ   SEQUENCE   212 AA;  23732 MW;  CE6FC4282E0E472C CRC64;
     MSTSASGPEH EFVSKFLTLA TLTEPKLPKS YTKPLKDVTN LGVPLPTLKY KYKQNRAKKL
     KLHQDQQGQD NAAVHLTLKK IQAPKFSIEH DFSPSDTILQ IKQHLISEEK ASHISEIKLL
     LKGKVLHDNL FLSDLKVTPA NSTITVMIKP NPTISKEPEA EKSTNSPAPA PPQELTVPWD
     DIEALLKNNF ENDQAAVRQV MERLQKGWSL AK
//
ID   SC61B_HUMAN             Reviewed;          96 AA.
AC   P60468; P38390; P38391; Q6IBC1;
DT   16-FEB-2004, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 2.
DT   23-MAY-2018, entry version 141.
DE   RecName: Full=Protein transport protein Sec61 subunit beta;
GN   Name=SEC61B;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=8107851; DOI=10.1038/367654a0;
RA   Hartmann E., Sommer T., Prehn S., Goerlich D., Jentsch S.,
RA   Rapoport T.A.;
RT   "Evolutionary conservation of components of the protein translocation
RT   complex.";
RL   Nature 367:654-657(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164053; DOI=10.1038/nature02465;
RA   Humphray S.J., Oliver K., Hunt A.R., Plumb R.W., Loveland J.E.,
RA   Howe K.L., Andrews T.D., Searle S., Hunt S.E., Scott C.E., Jones M.C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Ashwell R.I.S.,
RA   Babbage A.K., Babbage S., Bagguley C.L., Bailey J., Banerjee R.,
RA   Barker D.J., Barlow K.F., Bates K., Beasley H., Beasley O., Bird C.P.,
RA   Bray-Allen S., Brown A.J., Brown J.Y., Burford D., Burrill W.,
RA   Burton J., Carder C., Carter N.P., Chapman J.C., Chen Y., Clarke G.,
RA   Clark S.Y., Clee C.M., Clegg S., Collier R.E., Corby N., Crosier M.,
RA   Cummings A.T., Davies J., Dhami P., Dunn M., Dutta I., Dyer L.W.,
RA   Earthrowl M.E., Faulkner L., Fleming C.J., Frankish A.,
RA   Frankland J.A., French L., Fricker D.G., Garner P., Garnett J.,
RA   Ghori J., Gilbert J.G.R., Glison C., Grafham D.V., Gribble S.,
RA   Griffiths C., Griffiths-Jones S., Grocock R., Guy J., Hall R.E.,
RA   Hammond S., Harley J.L., Harrison E.S.I., Hart E.A., Heath P.D.,
RA   Henderson C.D., Hopkins B.L., Howard P.J., Howden P.J., Huckle E.,
RA   Johnson C., Johnson D., Joy A.A., Kay M., Keenan S., Kershaw J.K.,
RA   Kimberley A.M., King A., Knights A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C., Lloyd D.M.,
RA   Lovell J., Martin S., Mashreghi-Mohammadi M., Matthews L., McLaren S.,
RA   McLay K.E., McMurray A., Milne S., Nickerson T., Nisbett J.,
RA   Nordsiek G., Pearce A.V., Peck A.I., Porter K.M., Pandian R.,
RA   Pelan S., Phillimore B., Povey S., Ramsey Y., Rand V., Scharfe M.,
RA   Sehra H.K., Shownkeen R., Sims S.K., Skuce C.D., Smith M.,
RA   Steward C.A., Swarbreck D., Sycamore N., Tester J., Thorpe A.,
RA   Tracey A., Tromans A., Thomas D.W., Wall M., Wallis J.M., West A.P.,
RA   Whitehead S.L., Willey D.L., Williams S.A., Wilming L., Wray P.W.,
RA   Young L., Ashurst J.L., Coulson A., Blocker H., Durbin R.M.,
RA   Sulston J.E., Hubbard T., Jackson M.J., Bentley D.R., Beck S.,
RA   Rogers J., Dunham I.;
RT   "DNA sequence and analysis of human chromosome 9.";
RL   Nature 429:369-374(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   PROTEIN SEQUENCE OF 2-20, CLEAVAGE OF INITIATOR METHIONINE,
RP   PHOSPHORYLATION AT SER-7, AND IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Embryonic kidney;
RA   Bienvenut W.V., Waridel P., Quadroni M.;
RL   Submitted (MAR-2009) to UniProtKB.
RN   [6]
RP   IDENTIFICATION IN A COMPLEX WITH SEC62 AND SEC63, AND INTERACTION WITH
RP   SEC62.
RX   PubMed=10799540; DOI=10.1074/jbc.275.19.14550;
RA   Meyer H.-A., Grau H., Kraft R., Kostka S., Prehn S., Kalies K.-U.,
RA   Hartmann E.;
RT   "Mammalian Sec61 is associated with Sec62 and Sec63.";
RL   J. Biol. Chem. 275:14550-14557(2000).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-13; SER-14 AND SER-17,
RP   AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-17, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [13]
RP   MUTAGENESIS OF CYS-39, AND PALMITOYLATION AT CYS-39.
RX   PubMed=21044946; DOI=10.1194/jlr.D011106;
RA   Forrester M.T., Hess D.T., Thompson J.W., Hultman R., Moseley M.A.,
RA   Stamler J.S., Casey P.J.;
RT   "Site-specific analysis of protein S-acylation by resin-assisted
RT   capture.";
RL   J. Lipid Res. 52:393-398(2011).
RN   [14]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT PRO-2, PHOSPHORYLATION [LARGE
RP   SCALE ANALYSIS] AT SER-17, CLEAVAGE OF INITIATOR METHIONINE [LARGE
RP   SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [15]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-9; SER-14 AND SER-17,
RP   AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-17, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [18]
RP   CLEAVAGE OF INITIATOR METHIONINE [LARGE SCALE ANALYSIS], AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
CC   -!- FUNCTION: Necessary for protein translocation in the endoplasmic
CC       reticulum.
CC   -!- SUBUNIT: Heterotrimeric complex composed of SEC61-alpha, SEC61-
CC       beta and SEC61-gamma. Part of a complex composed of SEC61, SEC62
CC       and SEC63. Interacts with SEC62. {ECO:0000269|PubMed:10799540}.
CC   -!- INTERACTION:
CC       P51572:BCAP31; NbExp=7; IntAct=EBI-1788819, EBI-77683;
CC       Q12154:GET3 (xeno); NbExp=4; IntAct=EBI-1788819, EBI-2989;
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane; Single-pass
CC       membrane protein.
CC   -!- SIMILARITY: Belongs to the SEC61-beta family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; L25085; AAA19706.1; -; mRNA.
DR   EMBL; CR456883; CAG33164.1; -; mRNA.
DR   EMBL; AL137067; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC001734; AAH01734.1; -; mRNA.
DR   CCDS; CCDS6741.1; -.
DR   PIR; S42410; S42410.
DR   RefSeq; NP_006799.1; NM_006808.2.
DR   UniGene; Hs.191887; -.
DR   ProteinModelPortal; P60468; -.
DR   SMR; P60468; -.
DR   BioGrid; 116152; 50.
DR   CORUM; P60468; -.
DR   DIP; DIP-40997N; -.
DR   IntAct; P60468; 51.
DR   MINT; P60468; -.
DR   STRING; 9606.ENSP00000223641; -.
DR   TCDB; 3.A.5.9.1; the general secretory pathway (sec) family.
DR   iPTMnet; P60468; -.
DR   PhosphoSitePlus; P60468; -.
DR   SwissPalm; P60468; -.
DR   BioMuta; SEC61B; -.
DR   DMDM; 42560366; -.
DR   EPD; P60468; -.
DR   MaxQB; P60468; -.
DR   PaxDb; P60468; -.
DR   PeptideAtlas; P60468; -.
DR   PRIDE; P60468; -.
DR   TopDownProteomics; P60468; -.
DR   Ensembl; ENST00000223641; ENSP00000223641; ENSG00000106803.
DR   GeneID; 10952; -.
DR   KEGG; hsa:10952; -.
DR   UCSC; uc004azh.4; human.
DR   CTD; 10952; -.
DR   EuPathDB; HostDB:ENSG00000106803.9; -.
DR   GeneCards; SEC61B; -.
DR   HGNC; HGNC:16993; SEC61B.
DR   HPA; HPA049407; -.
DR   MIM; 609214; gene.
DR   neXtProt; NX_P60468; -.
DR   OpenTargets; ENSG00000106803; -.
DR   PharmGKB; PA134888963; -.
DR   eggNOG; KOG3457; Eukaryota.
DR   eggNOG; ENOG4111UAR; LUCA.
DR   GeneTree; ENSGT00390000003561; -.
DR   HOGENOM; HOG000211109; -.
DR   HOVERGEN; HBG061281; -.
DR   InParanoid; P60468; -.
DR   KO; K09481; -.
DR   OMA; NSGGMWR; -.
DR   OrthoDB; EOG091G17J4; -.
DR   PhylomeDB; P60468; -.
DR   TreeFam; TF313144; -.
DR   Reactome; R-HSA-1236974; ER-Phagosome pathway.
DR   Reactome; R-HSA-1799339; SRP-dependent cotranslational protein targeting to membrane.
DR   Reactome; R-HSA-381038; XBP1(S) activates chaperone genes.
DR   GeneWiki; SEC61B; -.
DR   GenomeRNAi; 10952; -.
DR   PRO; PR:P60468; -.
DR   Proteomes; UP000005640; Chromosome 9.
DR   Bgee; ENSG00000106803; -.
DR   CleanEx; HS_SEC61B; -.
DR   ExpressionAtlas; P60468; baseline and differential.
DR   Genevisible; P60468; HS.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0031205; C:endoplasmic reticulum Sec complex; ISS:UniProtKB.
DR   GO; GO:0016021; C:integral component of membrane; NAS:UniProtKB.
DR   GO; GO:0016020; C:membrane; IDA:MGI.
DR   GO; GO:0005784; C:Sec61 translocon complex; IEA:InterPro.
DR   GO; GO:0005086; F:ARF guanyl-nucleotide exchange factor activity; IBA:GO_Central.
DR   GO; GO:0048408; F:epidermal growth factor binding; IPI:UniProtKB.
DR   GO; GO:0003723; F:RNA binding; HDA:UniProtKB.
DR   GO; GO:0031204; P:posttranslational protein targeting to membrane, translocation; IBA:GO_Central.
DR   GO; GO:0000060; P:protein import into nucleus, translocation; IMP:UniProtKB.
DR   GO; GO:0030970; P:retrograde protein transport, ER to cytosol; IMP:UniProtKB.
DR   GO; GO:0006616; P:SRP-dependent cotranslational protein targeting to membrane, translocation; IBA:GO_Central.
DR   GO; GO:0030433; P:ubiquitin-dependent ERAD pathway; IDA:UniProtKB.
DR   InterPro; IPR030671; Sec61-beta/Sbh.
DR   InterPro; IPR016482; SecG/Sec61-beta/Sbh.
DR   PANTHER; PTHR13509; PTHR13509; 1.
DR   Pfam; PF03911; Sec61_beta; 1.
DR   PIRSF; PIRSF006398; Sec61_beta_euk; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Complete proteome; Direct protein sequencing;
KW   Endoplasmic reticulum; Lipoprotein; Membrane; Palmitate;
KW   Phosphoprotein; Protein transport; Reference proteome; Translocation;
KW   Transmembrane; Transmembrane helix; Transport.
FT   INIT_MET      1      1       Removed. {ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:25944712,
FT                                ECO:0000269|Ref.5}.
FT   CHAIN         2     96       Protein transport protein Sec61 subunit
FT                                beta.
FT                                /FTId=PRO_0000157254.
FT   TOPO_DOM      2     70       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     71     91       Helical. {ECO:0000255}.
FT   MOD_RES       2      2       N-acetylproline.
FT                                {ECO:0000244|PubMed:21406692}.
FT   MOD_RES       7      7       Phosphoserine. {ECO:0000269|Ref.5}.
FT   MOD_RES       9      9       Phosphothreonine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES      13     13       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   MOD_RES      14     14       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES      17     17       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   LIPID        39     39       S-palmitoyl cysteine.
FT                                {ECO:0000305|PubMed:21044946}.
FT   MUTAGEN      39     39       C->S: Abolishes S-acylation.
FT                                {ECO:0000269|PubMed:21044946}.
SQ   SEQUENCE   96 AA;  9974 MW;  5FAFF4197A62FA49 CRC64;
     MPGPTPSGTN VGSSGRSPSK AVAARAAGST VRQRKNASCG TRSAGRTTSA GTGGMWRFYT
     EDSPGLKVGP VPVLVMSLLF IASVFMLHIW GKYTRS
//
ID   HSP7C_RAT               Reviewed;         646 AA.
AC   P63018; P08109; P12225; Q4FZY7; Q62373; Q62374; Q62375;
DT   01-AUG-1988, integrated into UniProtKB/Swiss-Prot.
DT   01-AUG-1988, sequence version 1.
DT   23-MAY-2018, entry version 140.
DE   RecName: Full=Heat shock cognate 71 kDa protein;
DE   AltName: Full=Heat shock 70 kDa protein 8;
GN   Name=Hspa8; Synonyms=Hsc70, Hsc73;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha;
OC   Muroidea; Muridae; Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=3595567;
RA   Sorger P.K., Pelham H.R.B.;
RT   "Cloning and expression of a gene encoding hsc73, the major hsp70-like
RT   protein in unstressed rat cells.";
RL   EMBO J. 6:993-998(1987).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=3939319; DOI=10.1128/MCB.5.12.3476;
RA   O'Malley K., Mauron A., Barchas J.D., Kedes L.;
RT   "Constitutively expressed rat mRNA encoding a 70-kilodalton heat-
RT   shock-like protein.";
RL   Mol. Cell. Biol. 5:3476-3483(1985).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Heart, and Pituitary;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   PROTEIN SEQUENCE OF 4-36; 57-71; 77-108; 127-155; 160-171; 237-246;
RP   300-319; 349-357; 424-447; 452-458; 518-526; 540-550; 584-597 AND
RP   602-609, AND IDENTIFICATION BY MASS SPECTROMETRY.
RC   STRAIN=Sprague-Dawley; TISSUE=Brain, Hippocampus, and Spinal cord;
RA   Lubec G., Afjehi-Sadat L., Chen W.-Q., Kang S.U., Lubec S.;
RL   Submitted (SEP-2007) to UniProtKB.
RN   [5]
RP   INTERACTION WITH DNAJC7.
RX   PubMed=10567422; DOI=10.1074/jbc.274.48.34425;
RA   Liu F.H., Wu S.J., Hu S.M., Hsiao C.D., Wang C.;
RT   "Specific interaction of the 70-kDa heat shock cognate protein with
RT   the tetratricopeptide repeats.";
RL   J. Biol. Chem. 274:34425-34432(1999).
RN   [6]
RP   INTERACTION WITH SGTA.
RX   PubMed=15708368; DOI=10.1016/j.abb.2004.12.020;
RA   Liou S.T., Wang C.;
RT   "Small glutamine-rich tetratricopeptide repeat-containing protein is
RT   composed of three structural units with distinct functions.";
RL   Arch. Biochem. Biophys. 435:253-263(2005).
RN   [7]
RP   STRUCTURE BY NMR OF 385-543.
RX   PubMed=10373374; DOI=10.1006/jmbi.1999.2776;
RA   Morshauser R.C., Hu W., Wang H., Pang Y., Flynn G.C.,
RA   Zuiderweg E.R.P.;
RT   "High-resolution solution structure of the 18 kDa substrate-binding
RT   domain of the mammalian chaperone protein Hsc70.";
RL   J. Mol. Biol. 289:1387-1403(1999).
CC   -!- FUNCTION: Molecular chaperone implicated in a wide variety of
CC       cellular processes, including protection of the proteome from
CC       stress, folding and transport of newly synthesized polypeptides,
CC       activation of proteolysis of misfolded proteins and the formation
CC       and dissociation of protein complexes. Plays a pivotal role in the
CC       protein quality control system, ensuring the correct folding of
CC       proteins, the re-folding of misfolded proteins and controlling the
CC       targeting of proteins for subsequent degradation. This is achieved
CC       through cycles of ATP binding, ATP hydrolysis and ADP release,
CC       mediated by co-chaperones. The co-chaperones have been shown to
CC       not only regulate different steps of the ATPase cycle of HSP70,
CC       but they also have an individual specificity such that one co-
CC       chaperone may promote folding of a substrate while another may
CC       promote degradation. The affinity of HSP70 for polypeptides is
CC       regulated by its nucleotide bound state. In the ATP-bound form, it
CC       has a low affinity for substrate proteins. However, upon
CC       hydrolysis of the ATP to ADP, it undergoes a conformational change
CC       that increases its affinity for substrate proteins. HSP70 goes
CC       through repeated cycles of ATP hydrolysis and nucleotide exchange,
CC       which permits cycles of substrate binding and release. The HSP70-
CC       associated co-chaperones are of three types: J-domain co-
CC       chaperones HSP40s (stimulate ATPase hydrolysis by HSP70), the
CC       nucleotide exchange factors (NEF) such as BAG1/2/3 (facilitate
CC       conversion of HSP70 from the ADP-bound to the ATP-bound state
CC       thereby promoting substrate release), and the TPR domain
CC       chaperones such as HOPX and STUB1. Acts as a repressor of
CC       transcriptional activation. Inhibits the transcriptional
CC       coactivator activity of CITED1 on Smad-mediated transcription.
CC       Component of the PRP19-CDC5L complex that forms an integral part
CC       of the spliceosome and is required for activating pre-mRNA
CC       splicing. May have a scaffolding role in the spliceosome assembly
CC       as it contacts all other components of the core complex. Binds
CC       bacterial lipopolysaccharide (LPS) and mediates LPS-induced
CC       inflammatory response, including TNF secretion. Participates in
CC       the ER-associated degradation (ERAD) quality control pathway in
CC       conjunction with J domain-containing co-chaperones and the E3
CC       ligase STUB1. {ECO:0000250|UniProtKB:P11142}.
CC   -!- SUBUNIT: Identified in a IGF2BP1-dependent mRNP granule complex
CC       containing untranslated mRNAs. Interacts with PACRG. Interacts
CC       with HSPH1/HSP105. Interacts with IRAK1BP1 and BAG1 (By
CC       similarity). Interacts with DNAJC7 (PubMed:10567422). Interacts
CC       with DNAJB12 (via J domain). Interacts with DNAJB14 (via J
CC       domain). Interacts (via C-terminus) with the E3 ligase STUB1
CC       forming a 210 kDa complex of one STUB1 and two HSPA8 molecules.
CC       Interacts with CITED1 (via N-terminus); the interaction suppresses
CC       the association of CITED1 to p300/CBP and Smad-mediated
CC       transcription transactivation. Component of the PRP19-CDC5L
CC       splicing complex composed of a core complex comprising a
CC       homotetramer of PRPF19, CDC5L, PLRG1 and BCAS2, and at least three
CC       less stably associated proteins CTNNBL1, CWC15 and HSPA8.
CC       Interacts with TRIM5. Part of a complex composed at least of
CC       ASCL2, EMSY, HCFC1, HSPA8, CCAR2, MATR3, MKI67, RBBP5, TUBB2A,
CC       WDR5 and ZNF335; this complex may have a histone H3-specific
CC       methyltransferase activity. Interacts with METTL21A. Following LPS
CC       binding, may form a complex with CXCR4, GDF5 and HSP90AA1.
CC       Interacts with PRKN. Interacts with FOXP3. Interacts with DNAJC9
CC       (via J domain). Interacts with MLLT11. Interacts with RNF207.
CC       Interacts with DNAJC21. Interacts with DNAJB2. Interacts with TTC1
CC       (via TPR repeats) (By similarity). Interacts with SGTA (via TPR
CC       repeats) (PubMed:15708368). Interacts with HSF1 (via
CC       transactivation domain). Interacts with HOPX, STUB1, HSP40, HSP90,
CC       BAG2 and BAG3 (By similarity). Interacts with DNAJC12 (By
CC       similarity). Interacts with HSPC138 (By similarity).
CC       {ECO:0000250|UniProtKB:P11142, ECO:0000269|PubMed:10567422,
CC       ECO:0000269|PubMed:15708368}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}. Melanosome
CC       {ECO:0000250}. Nucleus, nucleolus {ECO:0000250}. Cell membrane
CC       {ECO:0000250}. Note=Localized in cytoplasmic mRNP granules
CC       containing untranslated mRNAs. Translocates rapidly from the
CC       cytoplasm to the nuclei, and especially to the nucleoli, upon heat
CC       shock (By similarity). {ECO:0000250}.
CC   -!- INDUCTION: Constitutively synthesized.
CC   -!- DOMAIN: The N-terminal nucleotide binding domain (NBD) (also known
CC       as the ATPase domain) is responsible for binding and hydrolyzing
CC       ATP. The C-terminal substrate-binding domain (SBD) (also known as
CC       peptide-binding domain) binds to the client/substrate proteins.
CC       The two domains are allosterically coupled so that, when ATP is
CC       bound to the NBD, the SBD binds relatively weakly to clients. When
CC       ADP is bound in the NBD, a conformational change enhances the
CC       affinity of the SBD for client proteins.
CC       {ECO:0000250|UniProtKB:P11142}.
CC   -!- PTM: Acetylated. {ECO:0000250|UniProtKB:P11142}.
CC   -!- PTM: ISGylated. {ECO:0000250|UniProtKB:P11142}.
CC   -!- PTM: Trimethylation at Lys-561 reduces fibrillar SNCA binding.
CC       {ECO:0000250|UniProtKB:P11142}.
CC   -!- SIMILARITY: Belongs to the heat shock protein 70 family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; Y00054; CAA68265.1; -; Genomic_DNA.
DR   EMBL; M11942; AAA41354.1; -; mRNA.
DR   EMBL; BC061547; AAH61547.1; -; mRNA.
DR   EMBL; BC098914; AAH98914.1; -; mRNA.
DR   PIR; S07197; S07197.
DR   RefSeq; NP_077327.1; NM_024351.2.
DR   UniGene; Rn.120392; -.
DR   UniGene; Rn.129299; -.
DR   UniGene; Rn.201298; -.
DR   PDB; 1CKR; NMR; -; A=385-543.
DR   PDB; 1Q2G; Model; -; C=385-543.
DR   PDB; 1UD0; X-ray; 3.45 A; A/B/C/D=542-646.
DR   PDB; 2V7Z; X-ray; 3.50 A; A/B=1-543.
DR   PDB; 7HSC; NMR; -; A=385-543.
DR   PDBsum; 1CKR; -.
DR   PDBsum; 1Q2G; -.
DR   PDBsum; 1UD0; -.
DR   PDBsum; 2V7Z; -.
DR   PDBsum; 7HSC; -.
DR   ProteinModelPortal; P63018; -.
DR   SMR; P63018; -.
DR   BioGrid; 246629; 16.
DR   CORUM; P63018; -.
DR   DIP; DIP-33262N; -.
DR   IntAct; P63018; 12.
DR   MINT; P63018; -.
DR   STRING; 10116.ENSRNOP00000058593; -.
DR   iPTMnet; P63018; -.
DR   PhosphoSitePlus; P63018; -.
DR   SwissPalm; P63018; -.
DR   World-2DPAGE; 0004:P63018; -.
DR   PaxDb; P63018; -.
DR   PRIDE; P63018; -.
DR   GeneID; 24468; -.
DR   KEGG; rno:24468; -.
DR   UCSC; RGD:621725; rat.
DR   CTD; 3312; -.
DR   RGD; 621725; Hspa8.
DR   eggNOG; KOG0101; Eukaryota.
DR   eggNOG; COG0443; LUCA.
DR   HOVERGEN; HBG051845; -.
DR   InParanoid; P63018; -.
DR   KO; K03283; -.
DR   PhylomeDB; P63018; -.
DR   EvolutionaryTrace; P63018; -.
DR   PRO; PR:P63018; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0032279; C:asymmetric synapse; IDA:RGD.
DR   GO; GO:0005776; C:autophagosome; IDA:RGD.
DR   GO; GO:0030424; C:axon; IDA:RGD.
DR   GO; GO:0009986; C:cell surface; IDA:RGD.
DR   GO; GO:0005737; C:cytoplasm; IDA:RGD.
DR   GO; GO:0005829; C:cytosol; IDA:RGD.
DR   GO; GO:0030425; C:dendrite; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0043198; C:dendritic shaft; IDA:RGD.
DR   GO; GO:0043197; C:dendritic spine; IDA:RGD.
DR   GO; GO:0070062; C:extracellular exosome; IDA:RGD.
DR   GO; GO:0005882; C:intermediate filament; IDA:RGD.
DR   GO; GO:1990836; C:lysosomal matrix; IDA:MGI.
DR   GO; GO:0005765; C:lysosomal membrane; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0005764; C:lysosome; IDA:RGD.
DR   GO; GO:0042470; C:melanosome; IEA:UniProtKB-SubCell.
DR   GO; GO:0045121; C:membrane raft; IDA:RGD.
DR   GO; GO:1990124; C:messenger ribonucleoprotein complex; IDA:RGD.
DR   GO; GO:0005874; C:microtubule; IDA:RGD.
DR   GO; GO:0043005; C:neuron projection; IDA:RGD.
DR   GO; GO:0044309; C:neuron spine; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0043025; C:neuronal cell body; IDA:RGD.
DR   GO; GO:0005730; C:nucleolus; IEA:UniProtKB-SubCell.
DR   GO; GO:0005634; C:nucleus; IDA:RGD.
DR   GO; GO:0043204; C:perikaryon; IDA:RGD.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IDA:RGD.
DR   GO; GO:0001917; C:photoreceptor inner segment; IDA:RGD.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0099524; C:postsynaptic cytosol; IDA:SynGO.
DR   GO; GO:0014069; C:postsynaptic density; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0099523; C:presynaptic cytosol; IDA:SynGO.
DR   GO; GO:0032991; C:protein-containing complex; IDA:RGD.
DR   GO; GO:0000974; C:Prp19 complex; ISS:UniProtKB.
DR   GO; GO:1990904; C:ribonucleoprotein complex; ISS:UniProtKB.
DR   GO; GO:0005681; C:spliceosomal complex; IEA:UniProtKB-KW.
DR   GO; GO:0008021; C:synaptic vesicle; IDA:RGD.
DR   GO; GO:0043195; C:terminal bouton; IDA:RGD.
DR   GO; GO:0043531; F:ADP binding; IDA:RGD.
DR   GO; GO:0005524; F:ATP binding; IDA:RGD.
DR   GO; GO:0016887; F:ATPase activity; IDA:MGI.
DR   GO; GO:0042623; F:ATPase activity, coupled; IDA:RGD.
DR   GO; GO:1990833; F:clathrin-uncoating ATPase activity; IDA:RGD.
DR   GO; GO:0042277; F:peptide binding; IDA:RGD.
DR   GO; GO:1904593; F:prostaglandin binding; IPI:RGD.
DR   GO; GO:0003723; F:RNA binding; IDA:RGD.
DR   GO; GO:0051082; F:unfolded protein binding; IMP:RGD.
DR   GO; GO:0007568; P:aging; IEP:RGD.
DR   GO; GO:0008088; P:axo-dendritic transport; IEP:RGD.
DR   GO; GO:0043624; P:cellular protein complex disassembly; IMP:MGI.
DR   GO; GO:0071276; P:cellular response to cadmium ion; IEP:RGD.
DR   GO; GO:0034605; P:cellular response to heat; IEP:RGD.
DR   GO; GO:0021549; P:cerebellum development; IEP:RGD.
DR   GO; GO:0061684; P:chaperone-mediated autophagy; IDA:ParkinsonsUK-UCL.
DR   GO; GO:1904764; P:chaperone-mediated autophagy translocation complex disassembly; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0061077; P:chaperone-mediated protein folding; IDA:RGD.
DR   GO; GO:0061741; P:chaperone-mediated protein transport involved in chaperone-mediated autophagy; IGI:MGI.
DR   GO; GO:0072318; P:clathrin coat disassembly; IDA:RGD.
DR   GO; GO:0044849; P:estrous cycle; IEP:RGD.
DR   GO; GO:0030900; P:forebrain development; IEP:RGD.
DR   GO; GO:0000082; P:G1/S transition of mitotic cell cycle; IEP:RGD.
DR   GO; GO:0001822; P:kidney development; IEP:RGD.
DR   GO; GO:0006397; P:mRNA processing; IEA:UniProtKB-KW.
DR   GO; GO:0010667; P:negative regulation of cardiac muscle cell apoptotic process; IMP:RGD.
DR   GO; GO:1903206; P:negative regulation of hydrogen peroxide-induced cell death; IEP:RGD.
DR   GO; GO:0045892; P:negative regulation of transcription, DNA-templated; ISS:UniProtKB.
DR   GO; GO:0043085; P:positive regulation of catalytic activity; IMP:RGD.
DR   GO; GO:0010628; P:positive regulation of gene expression; IMP:RGD.
DR   GO; GO:0097214; P:positive regulation of lysosomal membrane permeability; IMP:RGD.
DR   GO; GO:0050766; P:positive regulation of phagocytosis; IMP:RGD.
DR   GO; GO:1904592; P:positive regulation of protein refolding; IDA:RGD.
DR   GO; GO:0045862; P:positive regulation of proteolysis; IDA:RGD.
DR   GO; GO:0001916; P:positive regulation of T cell mediated cytotoxicity; IMP:RGD.
DR   GO; GO:0046777; P:protein autophosphorylation; IDA:RGD.
DR   GO; GO:0006606; P:protein import into nucleus; IMP:RGD.
DR   GO; GO:0042026; P:protein refolding; ISS:ParkinsonsUK-UCL.
DR   GO; GO:0044743; P:protein transmembrane import into intracellular organelle; IEP:RGD.
DR   GO; GO:0061635; P:regulation of protein complex stability; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0014823; P:response to activity; IEP:RGD.
DR   GO; GO:0042493; P:response to drug; IEP:RGD.
DR   GO; GO:0032355; P:response to estradiol; IEP:RGD.
DR   GO; GO:0045471; P:response to ethanol; IEP:RGD.
DR   GO; GO:0009408; P:response to heat; IEP:RGD.
DR   GO; GO:0010045; P:response to nickel cation; IEP:RGD.
DR   GO; GO:1990834; P:response to odorant; IEP:RGD.
DR   GO; GO:0032570; P:response to progesterone; IEP:RGD.
DR   GO; GO:0042594; P:response to starvation; IEP:RGD.
DR   GO; GO:0008380; P:RNA splicing; IEA:UniProtKB-KW.
DR   GO; GO:0007608; P:sensory perception of smell; IEP:RGD.
DR   GO; GO:0007519; P:skeletal muscle tissue development; IEP:RGD.
DR   GO; GO:1990832; P:slow axonal transport; IEP:RGD.
DR   GO; GO:0016191; P:synaptic vesicle uncoating; IC:SynGO.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   Gene3D; 1.20.1270.10; -; 1.
DR   Gene3D; 2.60.34.10; -; 1.
DR   InterPro; IPR018181; Heat_shock_70_CS.
DR   InterPro; IPR029048; HSP70_C_sf.
DR   InterPro; IPR029047; HSP70_peptide-bd_sf.
DR   InterPro; IPR013126; Hsp_70_fam.
DR   PANTHER; PTHR19375; PTHR19375; 1.
DR   Pfam; PF00012; HSP70; 1.
DR   PRINTS; PR00301; HEATSHOCK70.
DR   SUPFAM; SSF100920; SSF100920; 1.
DR   SUPFAM; SSF100934; SSF100934; 1.
DR   PROSITE; PS00297; HSP70_1; 1.
DR   PROSITE; PS00329; HSP70_2; 1.
DR   PROSITE; PS01036; HSP70_3; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; ATP-binding; Cell membrane; Chaperone;
KW   Complete proteome; Cytoplasm; Direct protein sequencing;
KW   Isopeptide bond; Membrane; Methylation; mRNA processing;
KW   mRNA splicing; Nucleotide-binding; Nucleus; Phosphoprotein;
KW   Reference proteome; Repressor; Spliceosome; Stress response;
KW   Transcription; Transcription regulation; Ubl conjugation.
FT   INIT_MET      1      1       Removed. {ECO:0000250|UniProtKB:P11142}.
FT   CHAIN         2    646       Heat shock cognate 71 kDa protein.
FT                                /FTId=PRO_0000078273.
FT   NP_BIND      12     15       ATP. {ECO:0000250}.
FT   NP_BIND     202    204       ATP. {ECO:0000250}.
FT   NP_BIND     268    275       ATP. {ECO:0000250}.
FT   NP_BIND     339    342       ATP. {ECO:0000250}.
FT   REGION        2    386       Nucleotide-binding domain (NBD).
FT                                {ECO:0000250|UniProtKB:P11142}.
FT   REGION      186    377       Interaction with BAG1. {ECO:0000250}.
FT   REGION      394    509       Substrate-binding domain (SBD).
FT                                {ECO:0000250|UniProtKB:P11142}.
FT   BINDING      71     71       ATP. {ECO:0000250}.
FT   MOD_RES       2      2       N-acetylserine.
FT                                {ECO:0000250|UniProtKB:P11142}.
FT   MOD_RES     108    108       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:P63017}.
FT   MOD_RES     153    153       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P11142}.
FT   MOD_RES     246    246       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:P11142}.
FT   MOD_RES     319    319       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P11142}.
FT   MOD_RES     319    319       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P63017}.
FT   MOD_RES     328    328       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:P63017}.
FT   MOD_RES     329    329       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P11142}.
FT   MOD_RES     362    362       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P11142}.
FT   MOD_RES     469    469       Omega-N-methylarginine.
FT                                {ECO:0000250|UniProtKB:P11142}.
FT   MOD_RES     512    512       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P63017}.
FT   MOD_RES     512    512       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P63017}.
FT   MOD_RES     524    524       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:P63017}.
FT   MOD_RES     541    541       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P11142}.
FT   MOD_RES     561    561       N6,N6,N6-trimethyllysine; by METTL21A;
FT                                alternate.
FT                                {ECO:0000250|UniProtKB:P11142}.
FT   MOD_RES     561    561       N6,N6-dimethyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P11142}.
FT   MOD_RES     589    589       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:P11142}.
FT   MOD_RES     597    597       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:P11142}.
FT   MOD_RES     601    601       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:P11142}.
FT   CROSSLNK    512    512       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO1);
FT                                alternate.
FT                                {ECO:0000250|UniProtKB:P11142}.
FT   CROSSLNK    512    512       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2);
FT                                alternate.
FT                                {ECO:0000250|UniProtKB:P11142}.
FT   STRAND        6     10       {ECO:0000244|PDB:2V7Z}.
FT   STRAND       13     22       {ECO:0000244|PDB:2V7Z}.
FT   STRAND       25     28       {ECO:0000244|PDB:2V7Z}.
FT   STRAND       32     34       {ECO:0000244|PDB:2V7Z}.
FT   STRAND       41     44       {ECO:0000244|PDB:2V7Z}.
FT   STRAND       49     52       {ECO:0000244|PDB:2V7Z}.
FT   HELIX        53     58       {ECO:0000244|PDB:2V7Z}.
FT   TURN         59     61       {ECO:0000244|PDB:2V7Z}.
FT   STRAND       66     68       {ECO:0000244|PDB:2V7Z}.
FT   TURN         71     75       {ECO:0000244|PDB:2V7Z}.
FT   HELIX        81     86       {ECO:0000244|PDB:2V7Z}.
FT   STRAND       91     97       {ECO:0000244|PDB:2V7Z}.
FT   STRAND      100    105       {ECO:0000244|PDB:2V7Z}.
FT   STRAND      112    114       {ECO:0000244|PDB:2V7Z}.
FT   HELIX       116    135       {ECO:0000244|PDB:2V7Z}.
FT   STRAND      141    146       {ECO:0000244|PDB:2V7Z}.
FT   HELIX       152    165       {ECO:0000244|PDB:2V7Z}.
FT   STRAND      168    174       {ECO:0000244|PDB:2V7Z}.
FT   HELIX       175    182       {ECO:0000244|PDB:2V7Z}.
FT   TURN        183    186       {ECO:0000244|PDB:2V7Z}.
FT   STRAND      193    200       {ECO:0000244|PDB:2V7Z}.
FT   STRAND      205    213       {ECO:0000244|PDB:2V7Z}.
FT   STRAND      216    223       {ECO:0000244|PDB:2V7Z}.
FT   HELIX       230    249       {ECO:0000244|PDB:2V7Z}.
FT   HELIX       257    276       {ECO:0000244|PDB:2V7Z}.
FT   STRAND      278    288       {ECO:0000244|PDB:2V7Z}.
FT   STRAND      291    298       {ECO:0000244|PDB:2V7Z}.
FT   HELIX       299    305       {ECO:0000244|PDB:2V7Z}.
FT   HELIX       307    312       {ECO:0000244|PDB:2V7Z}.
FT   HELIX       314    323       {ECO:0000244|PDB:2V7Z}.
FT   HELIX       328    330       {ECO:0000244|PDB:2V7Z}.
FT   STRAND      332    338       {ECO:0000244|PDB:2V7Z}.
FT   HELIX       339    342       {ECO:0000244|PDB:2V7Z}.
FT   HELIX       344    353       {ECO:0000244|PDB:2V7Z}.
FT   TURN        354    356       {ECO:0000244|PDB:2V7Z}.
FT   TURN        365    367       {ECO:0000244|PDB:2V7Z}.
FT   HELIX       368    380       {ECO:0000244|PDB:2V7Z}.
FT   STRAND      388    391       {ECO:0000244|PDB:1CKR}.
FT   STRAND      396    399       {ECO:0000244|PDB:1CKR}.
FT   STRAND      401    405       {ECO:0000244|PDB:1CKR}.
FT   TURN        406    408       {ECO:0000244|PDB:1CKR}.
FT   STRAND      409    411       {ECO:0000244|PDB:1CKR}.
FT   STRAND      418    429       {ECO:0000244|PDB:1CKR}.
FT   STRAND      431    434       {ECO:0000244|PDB:1CKR}.
FT   STRAND      438    445       {ECO:0000244|PDB:1CKR}.
FT   STRAND      447    450       {ECO:0000244|PDB:1CKR}.
FT   STRAND      452    461       {ECO:0000244|PDB:1CKR}.
FT   STRAND      468    470       {ECO:0000244|PDB:7HSC}.
FT   STRAND      472    481       {ECO:0000244|PDB:1CKR}.
FT   TURN        482    484       {ECO:0000244|PDB:1CKR}.
FT   STRAND      485    492       {ECO:0000244|PDB:1CKR}.
FT   TURN        493    496       {ECO:0000244|PDB:1CKR}.
FT   STRAND      497    503       {ECO:0000244|PDB:1CKR}.
FT   HELIX       511    518       {ECO:0000244|PDB:1CKR}.
FT   TURN        519    521       {ECO:0000244|PDB:1CKR}.
FT   HELIX       522    527       {ECO:0000244|PDB:1CKR}.
FT   TURN        532    534       {ECO:0000244|PDB:1CKR}.
FT   STRAND      537    541       {ECO:0000244|PDB:1CKR}.
FT   HELIX       542    553       {ECO:0000244|PDB:1UD0}.
FT   HELIX       556    558       {ECO:0000244|PDB:1UD0}.
FT   TURN        559    561       {ECO:0000244|PDB:1UD0}.
FT   HELIX       564    595       {ECO:0000244|PDB:1UD0}.
FT   HELIX       597    610       {ECO:0000244|PDB:1UD0}.
SQ   SEQUENCE   646 AA;  70871 MW;  03A27B30E6C076ED CRC64;
     MSKGPAVGID LGTTYSCVGV FQHGKVEIIA NDQGNRTTPS YVAFTDTERL IGDAAKNQVA
     MNPTNTVFDA KRLIGRRFDD AVVQSDMKHW PFMVVNDAGR PKVQVEYKGE TKSFYPEEVS
     SMVLTKMKEI AEAYLGKTVT NAVVTVPAYF NDSQRQATKD AGTIAGLNVL RIINEPTAAA
     IAYGLDKKVG AERNVLIFDL GGGTFDVSIL TIEDGIFEVK STAGDTHLGG EDFDNRMVNH
     FIAEFKRKHK KDISENKRAV RRLRTACERA KRTLSSSTQA SIEIDSLYEG IDFYTSITRA
     RFEELNADLF RGTLDPVEKA LRDAKLDKSQ IHDIVLVGGS TRIPKIQKLL QDFFNGKELN
     KSINPDEAVA YGAAVQAAIL SGDKSENVQD LLLLDVTPLS LGIETAGGVM TVLIKRNTTI
     PTKQTQTFTT YSDNQPGVLI QVYEGERAMT KDNNLLGKFE LTGIPPAPRG VPQIEVTFDI
     DANGILNVSA VDKSTGKENK ITITNDKGRL SKEDIERMVQ EAEKYKAEDE KQRDKVSSKN
     SLESYAFNMK ATVEDEKLQG KINDEDKQKI LDKCNEIISW LDKNQTAEKE EFEHQQKELE
     KVCNPIITKL YQSAGGMPGG MPGGFPGGGA PPSGGASSGP TIEEVD
//
ID   E2GIM5_HUMAN            Unreviewed;       392 AA.
AC   E2GIM5;
DT   30-NOV-2010, integrated into UniProtKB/TrEMBL.
DT   30-NOV-2010, sequence version 1.
DT   23-MAY-2018, entry version 46.
DE   SubName: Full=Interferon regulatory factor 3a {ECO:0000313|EMBL:ADN86147.1};
GN   Name=IRF3 {ECO:0000313|EMBL:ADN86147.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:ADN86147.1};
RN   [1] {ECO:0000313|EMBL:ADN86147.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=21281747; DOI=10.1016/j.bbagrm.2011.01.006;
RA   Li Y., Hu X., Song Y., Lu Z., Ning T., Cai H., Ke Y.;
RT   "Identification of novel alternative splicing variants of interferon
RT   regulatory factor 3.";
RL   Biochim. Biophys. Acta 1809:166-175(2011).
CC   -!- SIMILARITY: Belongs to the IRF family. {ECO:0000256|PROSITE-
CC       ProRule:PRU00840}.
CC   -!- CAUTION: Lacks conserved residue(s) required for the propagation
CC       of feature annotation. {ECO:0000256|PROSITE-ProRule:PRU00840}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; HM357932; ADN86147.1; -; mRNA.
DR   RefSeq; NP_001184052.1; NM_001197123.1.
DR   UniGene; Hs.289052; -.
DR   UniGene; Hs.731922; -.
DR   UniGene; Hs.75254; -.
DR   PeptideAtlas; E2GIM5; -.
DR   DNASU; 3661; -.
DR   GeneID; 3661; -.
DR   CTD; 3661; -.
DR   eggNOG; ENOG410IXD8; Eukaryota.
DR   eggNOG; ENOG410YA4B; LUCA.
DR   SignaLink; E2GIM5; -.
DR   ChiTaRS; IRF3; human.
DR   GenomeRNAi; 3661; -.
DR   Genevisible; E2GIM5; HS.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-UniRule.
DR   GO; GO:0003700; F:DNA binding transcription factor activity; IEA:InterPro.
DR   GO; GO:0044212; F:transcription regulatory region DNA binding; IEA:InterPro.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-UniRule.
DR   Gene3D; 1.10.10.10; -; 1.
DR   Gene3D; 2.60.200.10; -; 1.
DR   InterPro; IPR001346; Interferon_reg_fact_DNA-bd_dom.
DR   InterPro; IPR019471; Interferon_reg_factor-3.
DR   InterPro; IPR017855; SMAD-like_dom_sf.
DR   InterPro; IPR008984; SMAD_FHA_dom_sf.
DR   InterPro; IPR036388; WH-like_DNA-bd_sf.
DR   InterPro; IPR036390; WH_DNA-bd_sf.
DR   PANTHER; PTHR11949; PTHR11949; 1.
DR   Pfam; PF00605; IRF; 1.
DR   Pfam; PF10401; IRF-3; 1.
DR   SMART; SM00348; IRF; 1.
DR   SMART; SM01243; IRF-3; 1.
DR   SUPFAM; SSF46785; SSF46785; 1.
DR   SUPFAM; SSF49879; SSF49879; 1.
DR   PROSITE; PS51507; IRF_2; 1.
PE   2: Evidence at transcript level;
KW   DNA-binding {ECO:0000256|PROSITE-ProRule:PRU00840};
KW   Nucleus {ECO:0000256|PROSITE-ProRule:PRU00840};
KW   Transcription {ECO:0000256|PROSITE-ProRule:PRU00840};
KW   Transcription regulation {ECO:0000256|PROSITE-ProRule:PRU00840}.
FT   DOMAIN        1     76       IRF tryptophan pentad repeat.
FT                                {ECO:0000259|PROSITE:PS51507}.
SQ   SEQUENCE   392 AA;  42970 MW;  9A942E0AE51F388C CRC64;
     MVGRKQGWSC RLTGIKPGKP AWAEATGAYV PGRDKPDLPT WKRNFRSALN RKEGLRLAED
     RSKDPHDPHK IYEFVNSGVG DFSQPDTSPD TNGGGSTSDT QEDILDELLG NMVLAPLPDP
     GPPSLAVAPE PCPQPLRSPS LDNPTPFPNL GPSENPLKRL LVPGEEWEFE VTAFYRGRQV
     FQQTISCPEG LRLVGSEVGD RTLPGWPVTL PDPGMSLTDR GVMSYVRHVP SCLGGGLALW
     RAGQWLWAQR LGHCHTYWAV SEELLPNSGH GPDGEVPKDK EGGVFDLGPF IVDLITFTEG
     SGRSPRYALW FCVGESWPQD QPWTKRLVMV KVVPTCLRAL VEMARVGGAS SLENTVDLHI
     SNSHPLSLTS DQYKAYLQDL VEGMDFQGPG ET
//
ID   E2GIM6_HUMAN            Unreviewed;       154 AA.
AC   E2GIM6;
DT   30-NOV-2010, integrated into UniProtKB/TrEMBL.
DT   30-NOV-2010, sequence version 1.
DT   23-MAY-2018, entry version 38.
DE   SubName: Full=Interferon regulatory factor 3b {ECO:0000313|EMBL:ADN86148.1};
GN   Name=IRF3 {ECO:0000313|EMBL:ADN86148.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:ADN86148.1};
RN   [1] {ECO:0000313|EMBL:ADN86148.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=21281747; DOI=10.1016/j.bbagrm.2011.01.006;
RA   Li Y., Hu X., Song Y., Lu Z., Ning T., Cai H., Ke Y.;
RT   "Identification of novel alternative splicing variants of interferon
RT   regulatory factor 3.";
RL   Biochim. Biophys. Acta 1809:166-175(2011).
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; HM357933; ADN86148.1; -; mRNA.
DR   RefSeq; NP_001184057.1; NM_001197128.1.
DR   UniGene; Hs.289052; -.
DR   UniGene; Hs.731922; -.
DR   UniGene; Hs.75254; -.
DR   PeptideAtlas; E2GIM6; -.
DR   DNASU; 3661; -.
DR   GeneID; 3661; -.
DR   CTD; 3661; -.
DR   eggNOG; ENOG410IXD8; Eukaryota.
DR   eggNOG; ENOG410YA4B; LUCA.
DR   ChiTaRS; IRF3; human.
DR   GenomeRNAi; 3661; -.
DR   Genevisible; E2GIM6; HS.
DR   GO; GO:0003700; F:DNA binding transcription factor activity; IEA:InterPro.
DR   GO; GO:0044212; F:transcription regulatory region DNA binding; IEA:InterPro.
DR   Gene3D; 2.60.200.10; -; 1.
DR   InterPro; IPR001346; Interferon_reg_fact_DNA-bd_dom.
DR   InterPro; IPR019471; Interferon_reg_factor-3.
DR   InterPro; IPR017855; SMAD-like_dom_sf.
DR   InterPro; IPR008984; SMAD_FHA_dom_sf.
DR   PANTHER; PTHR11949; PTHR11949; 2.
DR   Pfam; PF10401; IRF-3; 1.
DR   SMART; SM01243; IRF-3; 1.
DR   SUPFAM; SSF49879; SSF49879; 1.
PE   2: Evidence at transcript level;
FT   DOMAIN        1    107       IRF-3. {ECO:0000259|SMART:SM01243}.
SQ   SEQUENCE   154 AA;  16718 MW;  7E227E0B7A874231 CRC64;
     MVLAPLPDPG PPSLAVAPEP CPQPLRSPSL DNPTPFPNLG PSENPLKRLL VPGEDLITFT
     EGSGRSPRYA LWFCVGESWP QDQPWTKRLV MVKVVPTCLR ALVEMARVGG ASSLENTVDL
     HISNSHPLSL TSDQHKAYLQ DLVEGMDFQG PGET
//
ID   E2GIM7_HUMAN            Unreviewed;       281 AA.
AC   E2GIM7;
DT   30-NOV-2010, integrated into UniProtKB/TrEMBL.
DT   30-NOV-2010, sequence version 1.
DT   28-FEB-2018, entry version 37.
DE   SubName: Full=Interferon regulatory factor 3c {ECO:0000313|EMBL:ADN86149.1};
DE   SubName: Full=Interferon regulatory factor 3f {ECO:0000313|EMBL:ADN86152.1};
GN   Name=IRF3 {ECO:0000313|EMBL:ADN86149.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:ADN86149.1};
RN   [1] {ECO:0000313|EMBL:ADN86149.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=21281747; DOI=10.1016/j.bbagrm.2011.01.006;
RA   Li Y., Hu X., Song Y., Lu Z., Ning T., Cai H., Ke Y.;
RT   "Identification of novel alternative splicing variants of interferon
RT   regulatory factor 3.";
RL   Biochim. Biophys. Acta 1809:166-175(2011).
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; HM357934; ADN86149.1; -; mRNA.
DR   EMBL; HM357937; ADN86152.1; -; mRNA.
DR   RefSeq; NP_001184052.1; NM_001197123.1.
DR   RefSeq; NP_001184054.1; NM_001197125.1.
DR   RefSeq; NP_001184055.1; NM_001197126.1.
DR   UniGene; Hs.289052; -.
DR   UniGene; Hs.731922; -.
DR   UniGene; Hs.75254; -.
DR   PeptideAtlas; E2GIM7; -.
DR   DNASU; 3661; -.
DR   GeneID; 3661; -.
DR   CTD; 3661; -.
DR   eggNOG; ENOG410IXD8; Eukaryota.
DR   eggNOG; ENOG410YA4B; LUCA.
DR   ChiTaRS; IRF3; human.
DR   GenomeRNAi; 3661; -.
DR   GO; GO:0003700; F:DNA binding transcription factor activity; IEA:InterPro.
DR   GO; GO:0044212; F:transcription regulatory region DNA binding; IEA:InterPro.
DR   Gene3D; 2.60.200.10; -; 1.
DR   InterPro; IPR001346; Interferon_reg_fact_DNA-bd_dom.
DR   InterPro; IPR019471; Interferon_reg_factor-3.
DR   InterPro; IPR017855; SMAD-like_dom_sf.
DR   InterPro; IPR008984; SMAD_FHA_dom_sf.
DR   PANTHER; PTHR11949; PTHR11949; 1.
DR   Pfam; PF10401; IRF-3; 1.
DR   SMART; SM01243; IRF-3; 1.
DR   SUPFAM; SSF49879; SSF49879; 1.
PE   2: Evidence at transcript level;
FT   DOMAIN       55    234       IRF-3. {ECO:0000259|SMART:SM01243}.
SQ   SEQUENCE   281 AA;  30793 MW;  B90CD8A841ACF200 CRC64;
     MVLAPLPDPG PPSLAVAPEP CPQPLRSPSL DNPTPFPNLG PSENPLKRLL VPGEEWEFEV
     TAFYRGRQVF QQTISCPEGL RLVGSEVGDR TLPGWPVTLP DPGMSLTDRG VMSYVRHVLS
     CLGGGLALWR AGQWLWAQRL GHCHTYWAVS EELLPNSGHG PDGEVPKDKE GGVFDLGPFI
     VDLITFTEGS GRSPRYALWF CVGESWPQDQ PWTKRLVMVK VVPTCLRALV EMARVGGASS
     LENTVDLHIS NSHPLSLTSD QYKAYLQDLV EGMDFQGPGE T
//
ID   E2GIM8_HUMAN            Unreviewed;       154 AA.
AC   E2GIM8;
DT   30-NOV-2010, integrated into UniProtKB/TrEMBL.
DT   30-NOV-2010, sequence version 1.
DT   23-MAY-2018, entry version 38.
DE   SubName: Full=Interferon regulatory factor 3d {ECO:0000313|EMBL:ADN86150.1};
GN   Name=IRF3 {ECO:0000313|EMBL:ADN86150.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:ADN86150.1};
RN   [1] {ECO:0000313|EMBL:ADN86150.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=21281747; DOI=10.1016/j.bbagrm.2011.01.006;
RA   Li Y., Hu X., Song Y., Lu Z., Ning T., Cai H., Ke Y.;
RT   "Identification of novel alternative splicing variants of interferon
RT   regulatory factor 3.";
RL   Biochim. Biophys. Acta 1809:166-175(2011).
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; HM357935; ADN86150.1; -; mRNA.
DR   RefSeq; NP_001184053.1; NM_001197124.1.
DR   RefSeq; NP_001184056.1; NM_001197127.1.
DR   RefSeq; NP_001184057.1; NM_001197128.1.
DR   UniGene; Hs.289052; -.
DR   UniGene; Hs.731922; -.
DR   UniGene; Hs.75254; -.
DR   PeptideAtlas; E2GIM8; -.
DR   DNASU; 3661; -.
DR   GeneID; 3661; -.
DR   CTD; 3661; -.
DR   eggNOG; ENOG410IXD8; Eukaryota.
DR   eggNOG; ENOG410YA4B; LUCA.
DR   ChiTaRS; IRF3; human.
DR   GenomeRNAi; 3661; -.
DR   Genevisible; E2GIM8; HS.
DR   GO; GO:0003700; F:DNA binding transcription factor activity; IEA:InterPro.
DR   GO; GO:0044212; F:transcription regulatory region DNA binding; IEA:InterPro.
DR   Gene3D; 2.60.200.10; -; 1.
DR   InterPro; IPR001346; Interferon_reg_fact_DNA-bd_dom.
DR   InterPro; IPR019471; Interferon_reg_factor-3.
DR   InterPro; IPR017855; SMAD-like_dom_sf.
DR   InterPro; IPR008984; SMAD_FHA_dom_sf.
DR   PANTHER; PTHR11949; PTHR11949; 2.
DR   Pfam; PF10401; IRF-3; 1.
DR   SMART; SM01243; IRF-3; 1.
DR   SUPFAM; SSF49879; SSF49879; 1.
PE   2: Evidence at transcript level;
FT   DOMAIN        1    107       IRF-3. {ECO:0000259|SMART:SM01243}.
SQ   SEQUENCE   154 AA;  16744 MW;  7E227E1716F74231 CRC64;
     MVLAPLPDPG PPSLAVAPEP CPQPLRSPSL DNPTPFPNLG PSENPLKRLL VPGEDLITFT
     EGSGRSPRYA LWFCVGESWP QDQPWTKRLV MVKVVPTCLR ALVEMARVGG ASSLENTVDL
     HISNSHPLSL TSDQYKAYLQ DLVEGMDFQG PGET
//
ID   E2GIM9_HUMAN            Unreviewed;       300 AA.
AC   E2GIM9;
DT   30-NOV-2010, integrated into UniProtKB/TrEMBL.
DT   30-NOV-2010, sequence version 1.
DT   28-MAR-2018, entry version 45.
DE   SubName: Full=Interferon regulatory factor 3e {ECO:0000313|EMBL:ADN86151.1};
GN   Name=IRF3 {ECO:0000313|EMBL:ADN86151.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:ADN86151.1};
RN   [1] {ECO:0000313|EMBL:ADN86151.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=21281747; DOI=10.1016/j.bbagrm.2011.01.006;
RA   Li Y., Hu X., Song Y., Lu Z., Ning T., Cai H., Ke Y.;
RT   "Identification of novel alternative splicing variants of interferon
RT   regulatory factor 3.";
RL   Biochim. Biophys. Acta 1809:166-175(2011).
CC   -!- SIMILARITY: Belongs to the IRF family. {ECO:0000256|PROSITE-
CC       ProRule:PRU00840}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; HM357936; ADN86151.1; -; mRNA.
DR   RefSeq; NP_001184053.1; NM_001197124.1.
DR   UniGene; Hs.289052; -.
DR   UniGene; Hs.731922; -.
DR   UniGene; Hs.75254; -.
DR   PeptideAtlas; E2GIM9; -.
DR   DNASU; 3661; -.
DR   GeneID; 3661; -.
DR   CTD; 3661; -.
DR   eggNOG; ENOG410IXD8; Eukaryota.
DR   eggNOG; ENOG410YA4B; LUCA.
DR   ChiTaRS; IRF3; human.
DR   GenomeRNAi; 3661; -.
DR   Genevisible; E2GIM9; HS.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-UniRule.
DR   GO; GO:0003700; F:DNA binding transcription factor activity; IEA:InterPro.
DR   GO; GO:0044212; F:transcription regulatory region DNA binding; IEA:InterPro.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-UniRule.
DR   CDD; cd00103; IRF; 1.
DR   Gene3D; 1.10.10.10; -; 1.
DR   Gene3D; 2.60.200.10; -; 1.
DR   InterPro; IPR019817; Interferon_reg_fac_CS.
DR   InterPro; IPR001346; Interferon_reg_fact_DNA-bd_dom.
DR   InterPro; IPR019471; Interferon_reg_factor-3.
DR   InterPro; IPR017855; SMAD-like_dom_sf.
DR   InterPro; IPR008984; SMAD_FHA_dom_sf.
DR   InterPro; IPR036388; WH-like_DNA-bd_sf.
DR   InterPro; IPR036390; WH_DNA-bd_sf.
DR   PANTHER; PTHR11949; PTHR11949; 2.
DR   Pfam; PF00605; IRF; 1.
DR   Pfam; PF10401; IRF-3; 1.
DR   PRINTS; PR00267; INTFRNREGFCT.
DR   SMART; SM00348; IRF; 1.
DR   SMART; SM01243; IRF-3; 1.
DR   SUPFAM; SSF46785; SSF46785; 1.
DR   SUPFAM; SSF49879; SSF49879; 1.
DR   PROSITE; PS00601; IRF_1; 1.
DR   PROSITE; PS51507; IRF_2; 1.
PE   2: Evidence at transcript level;
KW   DNA-binding {ECO:0000256|PROSITE-ProRule:PRU00840};
KW   Nucleus {ECO:0000256|PROSITE-ProRule:PRU00840};
KW   Transcription {ECO:0000256|PROSITE-ProRule:PRU00840};
KW   Transcription regulation {ECO:0000256|PROSITE-ProRule:PRU00840}.
FT   DOMAIN        5    111       IRF tryptophan pentad repeat.
FT                                {ECO:0000259|PROSITE:PS51507}.
FT   DNA_BIND      5    111       IRF tryptophan pentad repeat.
FT                                {ECO:0000256|PROSITE-ProRule:PRU00840}.
SQ   SEQUENCE   300 AA;  33184 MW;  1585BFBBA65C2DCE CRC64;
     MGTPKPRILP WLVSQLDLGQ LEGVAWVNKS RTRFRIPWKH GLRQDAQQED FGIFQAWAEA
     TGAYVPGRDK PDLPTWKRNF RSALNRKEGL RLAEDRSKDP HDPHKIYEFV NSGVGDFSQP
     DTSPDTNGGG STSDTQEDIL DELLGNMVLA PLPDPGPPSL AVAPEPCPQP LRSPSLDNPT
     PFPNLGPSEN PLKRLLVPGE DLITFTEGSG RSPRYALWFC VGESWPQDQP WTKRLVMVKV
     VPTCLRALVE MARVGGASSL ENTVDLHISN SHPLSLTSDQ YKAYLQDLVE GMDFQGPGET
//
ID   M0QYT9_HUMAN            Unreviewed;       281 AA.
AC   M0QYT9;
DT   03-APR-2013, integrated into UniProtKB/TrEMBL.
DT   03-APR-2013, sequence version 1.
DT   23-MAY-2018, entry version 48.
DE   SubName: Full=Interferon regulatory factor 3 {ECO:0000313|Ensembl:ENSP00000470069};
GN   Name=IRF3 {ECO:0000313|Ensembl:ENSP00000470069};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000470069, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Ensembl:ENSP00000470069, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057824; DOI=10.1038/nature02399;
RA   Grimwood J., Gordon L.A., Olsen A.S., Terry A., Schmutz J.,
RA   Lamerdin J.E., Hellsten U., Goodstein D., Couronne O., Tran-Gyamfi M.,
RA   Aerts A., Altherr M., Ashworth L., Bajorek E., Black S., Branscomb E.,
RA   Caenepeel S., Carrano A.V., Caoile C., Chan Y.M., Christensen M.,
RA   Cleland C.A., Copeland A., Dalin E., Dehal P., Denys M., Detter J.C.,
RA   Escobar J., Flowers D., Fotopulos D., Garcia C., Georgescu A.M.,
RA   Glavina T., Gomez M., Gonzales E., Groza M., Hammon N., Hawkins T.,
RA   Haydu L., Ho I., Huang W., Israni S., Jett J., Kadner K., Kimball H.,
RA   Kobayashi A., Larionov V., Leem S.-H., Lopez F., Lou Y., Lowry S.,
RA   Malfatti S., Martinez D., McCready P.M., Medina C., Morgan J.,
RA   Nelson K., Nolan M., Ovcharenko I., Pitluck S., Pollard M.,
RA   Popkie A.P., Predki P., Quan G., Ramirez L., Rash S., Retterer J.,
RA   Rodriguez A., Rogers S., Salamov A., Salazar A., She X., Smith D.,
RA   Slezak T., Solovyev V., Thayer N., Tice H., Tsai M., Ustaszewska A.,
RA   Vo N., Wagner M., Wheeler J., Wu K., Xie G., Yang J., Dubchak I.,
RA   Furey T.S., DeJong P., Dickson M., Gordon D., Eichler E.E.,
RA   Pennacchio L.A., Richardson P., Stubbs L., Rokhsar D.S., Myers R.M.,
RA   Rubin E.M., Lucas S.M.;
RT   "The DNA sequence and biology of human chromosome 19.";
RL   Nature 428:529-535(2004).
RN   [2] {ECO:0000213|PubMed:23186163}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=23186163;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [3] {ECO:0000313|Ensembl:ENSP00000470069}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (FEB-2013) to UniProtKB.
RN   [4] {ECO:0000213|PubMed:24275569}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [5] {ECO:0000313|Ensembl:ENSP00000366339}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (NOV-2014) to UniProtKB.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AC011495; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   RefSeq; NP_001184054.1; NM_001197125.1.
DR   RefSeq; NP_001184055.1; NM_001197126.1.
DR   UniGene; Hs.289052; -.
DR   UniGene; Hs.731922; -.
DR   UniGene; Hs.75254; -.
DR   MaxQB; M0QYT9; -.
DR   PeptideAtlas; M0QYT9; -.
DR   Ensembl; ENST00000377135; ENSP00000366339; ENSG00000126456.
DR   Ensembl; ENST00000593922; ENSP00000472601; ENSG00000126456.
DR   Ensembl; ENST00000598808; ENSP00000472582; ENSG00000126456.
DR   Ensembl; ENST00000599144; ENSP00000470069; ENSG00000126456.
DR   GeneID; 3661; -.
DR   UCSC; uc021uxp.2; human.
DR   CTD; 3661; -.
DR   EuPathDB; HostDB:ENSG00000126456.15; -.
DR   HGNC; HGNC:6118; IRF3.
DR   OpenTargets; ENSG00000126456; -.
DR   eggNOG; ENOG410IXD8; Eukaryota.
DR   eggNOG; ENOG410YA4B; LUCA.
DR   GeneTree; ENSGT00760000119093; -.
DR   ChiTaRS; IRF3; human.
DR   GenomeRNAi; 3661; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   Bgee; ENSG00000126456; -.
DR   ExpressionAtlas; M0QYT9; baseline and differential.
DR   GO; GO:0003700; F:DNA binding transcription factor activity; IEA:InterPro.
DR   GO; GO:0044212; F:transcription regulatory region DNA binding; IEA:InterPro.
DR   Gene3D; 2.60.200.10; -; 1.
DR   InterPro; IPR001346; Interferon_reg_fact_DNA-bd_dom.
DR   InterPro; IPR019471; Interferon_reg_factor-3.
DR   InterPro; IPR017855; SMAD-like_dom_sf.
DR   InterPro; IPR008984; SMAD_FHA_dom_sf.
DR   PANTHER; PTHR11949; PTHR11949; 1.
DR   Pfam; PF10401; IRF-3; 1.
DR   SMART; SM01243; IRF-3; 1.
DR   SUPFAM; SSF49879; SSF49879; 1.
PE   1: Evidence at protein level;
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   Proteomics identification {ECO:0000213|EPD:M0QYT9,
KW   ECO:0000213|MaxQB:M0QYT9, ECO:0000213|PeptideAtlas:M0QYT9};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640}.
FT   DOMAIN       55    234       IRF-3. {ECO:0000259|SMART:SM01243}.
SQ   SEQUENCE   281 AA;  30779 MW;  BD1CD8A841ACF200 CRC64;
     MVLAPLPDPG PPSLAVAPEP CPQPLRSPSL DNPTPFPNLG PSENPLKRLL VPGEEWEFEV
     TAFYRGRQVF QQTISCPEGL RLVGSEVGDR TLPGWPVTLP DPGMSLTDRG VMSYVRHVLS
     CLGGGLALWR AGQWLWAQRL GHCHTYWAVS EELLPNSGHG PDGEVPKDKE GGVFDLGPFI
     VDLITFTEGS GRSPRYALWF CVGESWPQDQ PWTKRLVMVK VVPTCLRALV EMARVGGASS
     LENTVDLHIS NSHPLSLTSD QYKAYLQDLV EGMDFQGPGE S
//
ID   IRF3_HUMAN              Reviewed;         427 AA.
AC   Q14653; A8K7L2; B2RAZ3; Q5FBY1; Q5FBY2; Q5FBY4; Q7Z5G6;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1997, sequence version 1.
DT   23-MAY-2018, entry version 179.
DE   RecName: Full=Interferon regulatory factor 3;
DE            Short=IRF-3;
GN   Name=IRF3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Retina;
RX   PubMed=8524823; DOI=10.1073/pnas.92.25.11657;
RA   Au W.W.-C., Moore P.P.A., Lowther W.W., Juang Y.-T., Pitha P.M.;
RT   "Identification of a member of the interferon regulatory factor family
RT   that binds to the interferon-stimulated response element and activates
RT   expression of interferon-induced genes.";
RL   Proc. Natl. Acad. Sci. U.S.A. 92:11657-11661(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 2; 3 AND 5).
RA   Tabata Y., Sameshima E., Hayashi A., Iida K., Mitsuyama M., Kanai S.,
RA   Furuya T., Saito T.;
RT   "IRF3 mRNA, nirs splice variants.";
RL   Submitted (FEB-2003) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT
RP   THR-427.
RC   TISSUE=Spleen;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057824; DOI=10.1038/nature02399;
RA   Grimwood J., Gordon L.A., Olsen A.S., Terry A., Schmutz J.,
RA   Lamerdin J.E., Hellsten U., Goodstein D., Couronne O., Tran-Gyamfi M.,
RA   Aerts A., Altherr M., Ashworth L., Bajorek E., Black S., Branscomb E.,
RA   Caenepeel S., Carrano A.V., Caoile C., Chan Y.M., Christensen M.,
RA   Cleland C.A., Copeland A., Dalin E., Dehal P., Denys M., Detter J.C.,
RA   Escobar J., Flowers D., Fotopulos D., Garcia C., Georgescu A.M.,
RA   Glavina T., Gomez M., Gonzales E., Groza M., Hammon N., Hawkins T.,
RA   Haydu L., Ho I., Huang W., Israni S., Jett J., Kadner K., Kimball H.,
RA   Kobayashi A., Larionov V., Leem S.-H., Lopez F., Lou Y., Lowry S.,
RA   Malfatti S., Martinez D., McCready P.M., Medina C., Morgan J.,
RA   Nelson K., Nolan M., Ovcharenko I., Pitluck S., Pollard M.,
RA   Popkie A.P., Predki P., Quan G., Ramirez L., Rash S., Retterer J.,
RA   Rodriguez A., Rogers S., Salamov A., Salazar A., She X., Smith D.,
RA   Slezak T., Solovyev V., Thayer N., Tice H., Tsai M., Ustaszewska A.,
RA   Vo N., Wagner M., Wheeler J., Wu K., Xie G., Yang J., Dubchak I.,
RA   Furey T.S., DeJong P., Dickson M., Gordon D., Eichler E.E.,
RA   Pennacchio L.A., Richardson P., Stubbs L., Rokhsar D.S., Myers R.M.,
RA   Rubin E.M., Lucas S.M.;
RT   "The DNA sequence and biology of human chromosome 19.";
RL   Nature 428:529-535(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND VARIANT THR-427.
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 4).
RC   TISSUE=Eye, and Kidney;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 323-413.
RX   PubMed=9803267; DOI=10.1046/j.1469-1809.1998.6230231.x;
RA   Bellingham J., Gregory-Evans K., Gregory-Evans C.Y.;
RT   "Mapping of human interferon regulatory factor 3 (IRF3) to chromosome
RT   19q13.3-13.4 by an intragenic polymorphic marker.";
RL   Ann. Hum. Genet. 62:231-234(1998).
RN   [8]
RP   MUTAGENESIS OF 385-SER-SER-386 AND 396-SER--SER-405.
RX   PubMed=9566918; DOI=10.1128/MCB.18.5.2986;
RA   Lin R., Heylbroeck C., Pitha P.M., Hiscott J.;
RT   "Virus-dependent phosphorylation of the IRF-3 transcription factor
RT   regulates nuclear translocation, transactivation potential, and
RT   proteasome-mediated degradation.";
RL   Mol. Cell. Biol. 18:2986-2996(1998).
RN   [9]
RP   MUTAGENESIS OF SER-385 AND SER-386.
RX   PubMed=10920266; DOI=10.1093/oxfordjournals.jbchem.a022753;
RA   Suhara W., Yoneyama M., Iwamura T., Yoshimura S., Tamura K.,
RA   Namiki H., Aimoto S., Fujita T.;
RT   "Analyses of virus-induced homomeric and heteromeric protein
RT   associations between IRF-3 and coactivator CBP/p300.";
RL   J. Biochem. 128:301-307(2000).
RN   [10]
RP   SUBCELLULAR LOCATION, AND MUTAGENESIS OF 77-LYS-ARG-78; 86-ARG-LYS-87
RP   AND 139-ILE-LEU-140.
RX   PubMed=10805757; DOI=10.1128/MCB.20.11.4159-4168.2000;
RA   Kumar K.P., McBride K.M., Weaver B.K., Dingwall C., Reich N.C.;
RT   "Regulated nuclear-cytoplasmic localization of interferon regulatory
RT   factor 3, a subunit of double-stranded RNA-activated factor 1.";
RL   Mol. Cell. Biol. 20:4159-4168(2000).
RN   [11]
RP   PHOSPHORYLATION.
RX   PubMed=11035028; DOI=10.1074/jbc.M007790200;
RA   Servant M.J., ten Oever B., LePage C., Conti L., Gessani S.,
RA   Julkunen I., Lin R., Hiscott J.;
RT   "Identification of distinct signaling pathways leading to the
RT   phosphorylation of interferon regulatory factor 3.";
RL   J. Biol. Chem. 276:355-363(2001).
RN   [12]
RP   INHIBITION OF PHOSPHORYLATION BY VACCINIA VIRUS PROTEIN E3 (MICROBIAL
RP   INFECTION).
RX   PubMed=11124948; DOI=10.1074/jbc.M008717200;
RA   Smith E.J., Marie I.J., Prakash A., Garcia-Sastre A., Levy D.E.;
RT   "IRF3 and IRF7 phosphorylation in virus-infected cells does not
RT   require double-stranded RNA-dependent protein kinase R or Ikappa B
RT   kinase but is blocked by Vaccinia virus E3L protein.";
RL   J. Biol. Chem. 276:8951-8957(2001).
RN   [13]
RP   INTERACTION WITH HHV-8 PROTEIN VIRF1 (MICROBIAL INFECTION).
RX   PubMed=11314014; DOI=10.1038/sj.onc.1204163;
RA   Lin R., Genin P., Mamane Y., Sgarbanti M., Battistini A.,
RA   Harrington W.J. Jr., Barber G.N., Hiscott J.;
RT   "HHV-8 encoded vIRF-1 represses the interferon antiviral response by
RT   blocking IRF-3 recruitment of the CBP/p300 coactivators.";
RL   Oncogene 20:800-811(2001).
RN   [14]
RP   REVIEW.
RX   PubMed=11846977; DOI=10.1089/107999002753452674;
RA   Yoneyama M., Suhara W., Fujita T.;
RT   "Control of IRF-3 activation by phosphorylation.";
RL   J. Interferon Cytokine Res. 22:73-76(2002).
RN   [15]
RP   INTERACTION WITH TICAM1.
RX   PubMed=12471095; DOI=10.4049/jimmunol.169.12.6668;
RA   Yamamoto M., Sato S., Mori K., Hoshino K., Takeuchi O., Takeda K.,
RA   Akira S.;
RT   "A novel Toll/IL-1 receptor domain-containing adapter that
RT   preferentially activates the IFN-beta promoter in the Toll-like
RT   receptor signaling.";
RL   J. Immunol. 169:6668-6672(2002).
RN   [16]
RP   INTERACTION WITH ROTAVIRUS A NSP1 (MICROBIAL INFECTION).
RX   PubMed=12186937; DOI=10.1128/JVI.76.18.9545-9550.2002;
RA   Graff J.W., Mitzel D.N., Weisend C.M., Flenniken M.L., Hardy M.E.;
RT   "Interferon regulatory factor 3 is a cellular partner of rotavirus
RT   NSP1.";
RL   J. Virol. 76:9545-9550(2002).
RN   [17]
RP   INTERACTION WITH TICAM2.
RX   PubMed=14517278; DOI=10.1084/jem.20031023;
RA   Fitzgerald K.A., Rowe D.C., Barnes B.J., Caffrey D.R., Visintin A.,
RA   Latz E., Monks B., Pitha P.M., Golenbock D.T.;
RT   "LPS-TLR4 signaling to IRF-3/7 and NF-kappaB involves the toll
RT   adapters TRAM and TRIF.";
RL   J. Exp. Med. 198:1043-1055(2003).
RN   [18]
RP   ERRATUM.
RA   Fitzgerald K.A., Rowe D.C., Barnes B.J., Caffrey D.R., Visintin A.,
RA   Latz E., Monks B., Pitha P.M., Golenbock D.T.;
RL   J. Exp. Med. 198:1451-1451(2003).
RN   [19]
RP   PHOSPHORYLATION.
RX   PubMed=12702806; DOI=10.1126/science.1081315;
RA   Sharma S., tenOever B.R., Grandvaux N., Zhou G.-P., Lin R.,
RA   Hiscott J.;
RT   "Triggering the interferon antiviral response through an IKK-related
RT   pathway.";
RL   Science 300:1148-1151(2003).
RN   [20]
RP   INTERACTION WITH TICAM1.
RX   PubMed=14739303; DOI=10.1074/jbc.M311629200;
RA   Han K.J., Su X., Xu L.-G., Bin L.H., Zhang J., Shu H.-B.;
RT   "Mechanisms of the TRIF-induced interferon-stimulated response element
RT   and NF-kappaB activation and apoptosis pathways.";
RL   J. Biol. Chem. 279:15652-15661(2004).
RN   [21]
RP   INTERACTION WITH IKBKE AND TBK1.
RX   PubMed=16281057; DOI=10.1038/sj.emboj.7600863;
RA   Huang J., Liu T., Xu L.-G., Chen D., Zhai Z., Shu H.-B.;
RT   "SIKE is an IKK epsilon/TBK1-associated suppressor of TLR3- and virus-
RT   triggered IRF-3 activation pathways.";
RL   EMBO J. 24:4018-4028(2005).
RN   [22]
RP   INTERACTION WITH MAVS.
RX   PubMed=16153868; DOI=10.1016/j.molcel.2005.08.014;
RA   Xu L.-G., Wang Y.-Y., Han K.-J., Li L.-Y., Zhai Z., Shu H.-B.;
RT   "VISA is an adapter protein required for virus-triggered IFN-beta
RT   Signaling.";
RL   Mol. Cell 19:727-740(2005).
RN   [23]
RP   REVIEW ON FUNCTION.
RX   PubMed=16846591; DOI=10.1016/j.bcp.2006.06.002;
RA   Solis M., Goubau D., Romieu-Mourez R., Genin P., Civas A., Hiscott J.;
RT   "Distinct functions of IRF-3 and IRF-7 in IFN-alpha gene regulation
RT   and control of anti-tumor activity in primary macrophages.";
RL   Biochem. Pharmacol. 72:1469-1476(2006).
RN   [24]
RP   REVIEW ON FUNCTION.
RX   PubMed=16979567; DOI=10.1016/j.immuni.2006.08.009;
RA   Honda K., Takaoka A., Taniguchi T.;
RT   "Type I interferon gene induction by the interferon regulatory factor
RT   family of transcription factors.";
RL   Immunity 25:349-360(2006).
RN   [25]
RP   ERRATUM.
RA   Honda K., Takaoka A., Taniguchi T.;
RL   Immunity 25:849-849(2006).
RN   [26]
RP   UBIQUITINATION, AND INTERACTION WITH RBCK1.
RX   PubMed=18711448; DOI=10.1038/cr.2008.277;
RA   Zhang M., Tian Y., Wang R.P., Gao D., Zhang Y., Diao F.C., Chen D.Y.,
RA   Zhai Z.H., Shu H.B.;
RT   "Negative feedback regulation of cellular antiviral signaling by
RT   RBCK1-mediated degradation of IRF3.";
RL   Cell Res. 18:1096-1104(2008).
RN   [27]
RP   INTERACTION WITH TRIM21, AND POLYUBIQUITINATION.
RX   PubMed=18641315; DOI=10.4049/jimmunol.181.3.1780;
RA   Higgs R., Ni Gabhann J., Ben Larbi N., Breen E.P., Fitzgerald K.A.,
RA   Jefferies C.A.;
RT   "The E3 ubiquitin ligase Ro52 negatively regulates IFN-beta production
RT   post-pathogen recognition by polyubiquitin-mediated degradation of
RT   IRF3.";
RL   J. Immunol. 181:1780-1786(2008).
RN   [28]
RP   PHOSPHORYLATION BY IKBKE AND TBK1.
RX   PubMed=19153231; DOI=10.1128/JVI.01875-08;
RA   Prins K.C., Cardenas W.B., Basler C.F.;
RT   "Ebola virus protein VP35 impairs the function of interferon
RT   regulatory factor-activating kinases IKKepsilon and TBK-1.";
RL   J. Virol. 83:3069-3077(2009).
RN   [29]
RP   INTERACTION WITH RIOK3.
RX   PubMed=19557502; DOI=10.1007/s11010-009-0180-8;
RA   Shan J., Wang P., Zhou J., Wu D., Shi H., Huo K.;
RT   "RIOK3 interacts with caspase-10 and negatively regulates the NF-
RT   kappaB signaling pathway.";
RL   Mol. Cell. Biochem. 332:113-120(2009).
RN   [30]
RP   REVIEW ON FUNCTION.
RX   PubMed=20049431; DOI=10.1007/s00262-009-0804-6;
RA   Savitsky D., Tamura T., Yanai H., Taniguchi T.;
RT   "Regulation of immunity and oncogenesis by the IRF transcription
RT   factor family.";
RL   Cancer Immunol. Immunother. 59:489-510(2010).
RN   [31]
RP   ISGYLATION AT LYS-193; LYS-360 AND LYS-366, MUTAGENESIS OF LYS-193;
RP   LYS-360 AND LYS-366, AND INTERACTION WITH HERC5.
RX   PubMed=20308324; DOI=10.1128/MCB.01466-09;
RA   Shi H.X., Yang K., Liu X., Liu X.Y., Wei B., Shan Y.F., Zhu L.H.,
RA   Wang C.;
RT   "Positive regulation of interferon regulatory factor 3 activation by
RT   Herc5 via ISG15 modification.";
RL   Mol. Cell. Biol. 30:2424-2436(2010).
RN   [32]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [33]
RP   INTERACTION WITH DDX3X AND IKBKE, AND PHOSPHORYLATION AT SER-396.
RX   PubMed=23478265; DOI=10.1128/MCB.01603-12;
RA   Gu L., Fullam A., Brennan R., Schroder M.;
RT   "Human DEAD box helicase 3 couples IkappaB kinase epsilon to
RT   interferon regulatory factor 3 activation.";
RL   Mol. Cell. Biol. 33:2004-2015(2013).
RN   [34]
RP   PHOSPHORYLATION AT THR-3; SER-14; THR-75; SER-97; THR-180; SER-188;
RP   THR-237; THR-244; THR-253; SER-398; THR-404 AND SER-427,
RP   PHOSPHORYLATION AT SER-386 BY TBK1, AND MUTAGENESIS OF SER-386.
RX   PubMed=23746807; DOI=10.1016/j.str.2013.04.025;
RA   Shu C., Sankaran B., Chaton C.T., Herr A.B., Mishra A., Peng J.,
RA   Li P.;
RT   "Structural insights into the functions of TBK1 in innate
RT   antimicrobial immunity.";
RL   Structure 21:1137-1148(2013).
RN   [35]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [36]
RP   HOMODIMERIZATION, AND INTERACTION WITH TRIM21 AND ULK1.
RX   PubMed=26347139; DOI=10.1083/jcb.201503023;
RA   Kimura T., Jain A., Choi S.W., Mandell M.A., Schroder K., Johansen T.,
RA   Deretic V.;
RT   "TRIM-mediated precision autophagy targets cytoplasmic regulators of
RT   innate immunity.";
RL   J. Cell Biol. 210:973-989(2015).
RN   [37]
RP   INVOLVEMENT IN HSE7, VARIANT HSE7 GLN-285, AND CHARACTERIZATION OF
RP   VARIANT HSE7 GLN-285.
RX   PubMed=26216125; DOI=10.1084/jem.20142274;
RA   Andersen L.L., Moerk N., Reinert L.S., Kofod-Olsen E., Narita R.,
RA   Joergensen S.E., Skipper K.A., Hoening K., Gad H.H., Oestergaard L.,
RA   Oerntoft T.F., Hornung V., Paludan S.R., Mikkelsen J.G., Fujita T.,
RA   Christiansen M., Hartmann R., Mogensen T.H.;
RT   "Functional IRF3 deficiency in a patient with herpes simplex
RT   encephalitis.";
RL   J. Exp. Med. 212:1371-1379(2015).
RN   [38]
RP   X-RAY CRYSTALLOGRAPHY (2.3 ANGSTROMS) OF 175-427, AND DISULFIDE BOND.
RX   PubMed=14555995; DOI=10.1038/nsb1001;
RA   Takahasi K., Suzuki N.N., Horiuchi M., Mori M., Suhara W., Okabe Y.,
RA   Fukuhara Y., Terasawa H., Akira S., Fujita T., Inagaki F.;
RT   "X-ray crystal structure of IRF-3 and its functional implications.";
RL   Nat. Struct. Biol. 10:922-927(2003).
RN   [39]
RP   X-RAY CRYSTALLOGRAPHY (2.1 ANGSTROMS) OF 173-427, AND DISULFIDE BOND.
RX   PubMed=14555996; DOI=10.1038/nsb1002;
RA   Qin B.Y., Liu C., Lam S.S., Srinath H., Delston R., Correia J.J.,
RA   Derynck R., Lin K.;
RT   "Crystal structure of IRF-3 reveals mechanism of autoinhibition and
RT   virus-induced phosphoactivation.";
RL   Nat. Struct. Biol. 10:913-921(2003).
RN   [40]
RP   X-RAY CRYSTALLOGRAPHY (3.0 ANGSTROMS) OF 1-112.
RX   PubMed=15510218; DOI=10.1038/sj.emboj.7600453;
RA   Panne D., Maniatis T., Harrison S.C.;
RT   "Crystal structure of ATF-2/c-Jun and IRF-3 bound to the interferon-
RT   beta enhancer.";
RL   EMBO J. 23:4384-4393(2004).
RN   [41]
RP   X-RAY CRYSTALLOGRAPHY (2.4 ANGSTROMS) OF 173-394.
RX   PubMed=16154084; DOI=10.1016/j.str.2005.06.011;
RA   Qin B.Y., Liu C., Srinath H., Lam S.S., Correia J.J., Derynck R.,
RA   Lin K.;
RT   "Crystal structure of IRF-3 in complex with CBP.";
RL   Structure 13:1269-1277(2005).
CC   -!- FUNCTION: Key transcriptional regulator of type I interferon
CC       (IFN)-dependent immune responses which plays a critical role in
CC       the innate immune response against DNA and RNA viruses. Regulates
CC       the transcription of type I IFN genes (IFN-alpha and IFN-beta) and
CC       IFN-stimulated genes (ISG) by binding to an interferon-stimulated
CC       response element (ISRE) in their promoters. Acts as a more potent
CC       activator of the IFN-beta (IFNB) gene than the IFN-alpha (IFNA)
CC       gene and plays a critical role in both the early and late phases
CC       of the IFNA/B gene induction. Found in an inactive form in the
CC       cytoplasm of uninfected cells and following viral infection,
CC       double-stranded RNA (dsRNA), or toll-like receptor (TLR)
CC       signaling, is phosphorylated by IKBKE and TBK1 kinases. This
CC       induces a conformational change, leading to its dimerization and
CC       nuclear localization and association with CREB binding protein
CC       (CREBBP) to form dsRNA-activated factor 1 (DRAF1), a complex which
CC       activates the transcription of the type I IFN and ISG genes. Can
CC       activate distinct gene expression programs in macrophages and can
CC       induce significant apoptosis in primary macrophages.
CC   -!- ENZYME REGULATION: In the absence of viral infection, maintained
CC       as a monomer in an autoinhibited state and phosphorylation
CC       disrupts this autoinhibition leading to the liberation of the DNA-
CC       binding and dimerization activities and its nuclear localization
CC       where it can activate type I IFN and ISG genes.
CC   -!- SUBUNIT: Monomer. Homodimer; phosphorylation-induced. Heterodimer
CC       with IRF7. Interacts with CREBBP. May interact with MAVS.
CC       Interacts with IKBKE and TBK1. Interacts with TICAM1 and TICAM2.
CC       Interacts with RBCK1. Interacts with HERC5. Interacts with DDX3X
CC       (phosphorylated at 'Ser-102'); the interaction allows the
CC       phosphorylation and activation of IRF3 by IKBKE. Interacts with
CC       TRIM21 and ULK1, in the presence of TRIM21; this interaction leads
CC       to IRF3 degradation by autophagy (PubMed:26347139). Interacts with
CC       RIOK3; RIOK3 probybly mediates the interaction of TBK1 with IRF3.
CC       {ECO:0000269|PubMed:12471095, ECO:0000269|PubMed:14517278,
CC       ECO:0000269|PubMed:14739303, ECO:0000269|PubMed:16153868,
CC       ECO:0000269|PubMed:16281057, ECO:0000269|PubMed:18641315,
CC       ECO:0000269|PubMed:18711448, ECO:0000269|PubMed:19557502,
CC       ECO:0000269|PubMed:20308324, ECO:0000269|PubMed:23478265,
CC       ECO:0000269|PubMed:26347139}.
CC   -!- SUBUNIT: (Microbial infection) Interacts with rotavirus A NSP1
CC       (via C-terminus); this interaction leads to the proteasome-
CC       dependent degradation of IRF3 (PubMed:12186937).
CC       {ECO:0000269|PubMed:12186937}.
CC   -!- SUBUNIT: (Microbial infection) Interacts with herpes virus 8/HHV-8
CC       protein VIRF1 (PubMed:11314014). {ECO:0000269|PubMed:11314014}.
CC   -!- INTERACTION:
CC       Self; NbExp=16; IntAct=EBI-2650369, EBI-2650369;
CC       Q92793:CREBBP; NbExp=10; IntAct=EBI-2650369, EBI-81215;
CC       Q9Y3R0:GRIP1; NbExp=2; IntAct=EBI-2650369, EBI-5349621;
CC       Q14164:IKBKE; NbExp=2; IntAct=EBI-2650369, EBI-307369;
CC       Q9Y5Q3:MAFB; NbExp=4; IntAct=EBI-2650369, EBI-3649340;
CC       P06400:RB1; NbExp=2; IntAct=EBI-2650369, EBI-491274;
CC       P28749:RBL1; NbExp=2; IntAct=EBI-2650369, EBI-971402;
CC       O14730:RIOK3; NbExp=6; IntAct=EBI-2650369, EBI-1047061;
CC       O43765:SGTA; NbExp=3; IntAct=EBI-2650369, EBI-347996;
CC       Q9UHD2:TBK1; NbExp=9; IntAct=EBI-2650369, EBI-356402;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:10805757}.
CC       Nucleus {ECO:0000269|PubMed:10805757}. Note=Shuttles between
CC       cytoplasmic and nuclear compartments, with export being the
CC       prevailing effect. When activated, IRF3 interaction with CREBBP
CC       prevents its export to the cytoplasm.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=5;
CC       Name=1;
CC         IsoId=Q14653-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q14653-2; Sequence=VSP_043319;
CC       Name=3;
CC         IsoId=Q14653-3; Sequence=VSP_046911, VSP_043319;
CC       Name=4;
CC         IsoId=Q14653-4; Sequence=VSP_046912;
CC         Note=No experimental confirmation available.;
CC       Name=5;
CC         IsoId=Q14653-5; Sequence=VSP_047690, VSP_047691;
CC   -!- TISSUE SPECIFICITY: Expressed constitutively in a variety of
CC       tissues.
CC   -!- PTM: Constitutively phosphorylated on many Ser/Thr residues. C-
CC       terminal serine/threonine cluster is phosphorylated in response of
CC       induction by IKBKE and TBK1. Phosphorylated at Ser-396 by IKBKE
CC       upon ssRNA viral infection. Ser-385 and Ser-386 may be
CC       specifically phosphorylated in response to induction.
CC       Phosphorylation at Ser-386 by TBK1 results in oligomerization. An
CC       alternate model propose that the five serine/threonine residues
CC       between 396 and 405 are phosphorylated in response to a viral
CC       infection. {ECO:0000269|PubMed:23478265,
CC       ECO:0000269|PubMed:23746807}.
CC   -!- PTM: (Microbial infection) Phosphorylation and subsequent
CC       activation of IRF3 is inhibited by vaccinia virus protein E3.
CC       {ECO:0000269|PubMed:11124948}.
CC   -!- PTM: Ubiquitinated; ubiquitination involves RBCK1 leading to
CC       proteasomal degradation. Polyubiquitinated; ubiquitination
CC       involves TRIM21 leading to proteasomal degradation.
CC       {ECO:0000269|PubMed:18641315, ECO:0000269|PubMed:18711448}.
CC   -!- PTM: ISGylated by HERC5 resulting in sustained IRF3 activation and
CC       in the inhibition of IRF3 ubiquitination by disrupting PIN1
CC       binding. The phosphorylation state of IRF3 does not alter
CC       ISGylation. {ECO:0000269|PubMed:18641315,
CC       ECO:0000269|PubMed:18711448, ECO:0000269|PubMed:20308324}.
CC   -!- DISEASE: Herpes simplex encephalitis 7 (HSE7) [MIM:616532]: A rare
CC       complication of human herpesvirus 1 (HHV-1) infection, occurring
CC       in only a small minority of HHV-1 infected individuals. HSE is
CC       characterized by hemorrhagic necrosis of parts of the temporal and
CC       frontal lobes. Onset is over several days and involves fever,
CC       headache, seizures, stupor, and often coma, frequently with a
CC       fatal outcome. {ECO:0000269|PubMed:26216125}. Note=Disease
CC       susceptibility is associated with variations affecting the gene
CC       represented in this entry.
CC   -!- SIMILARITY: Belongs to the IRF family. {ECO:0000255|PROSITE-
CC       ProRule:PRU00840}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; Z56281; CAA91227.1; -; mRNA.
DR   EMBL; AB102884; BAD89413.1; -; mRNA.
DR   EMBL; AB102886; BAD89415.1; -; mRNA.
DR   EMBL; AB102887; BAD89416.1; -; mRNA.
DR   EMBL; AK292027; BAF84716.1; -; mRNA.
DR   EMBL; AK314421; BAG37040.1; -; mRNA.
DR   EMBL; AC011495; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471177; EAW52510.1; -; Genomic_DNA.
DR   EMBL; BC000660; AAH00660.1; -; mRNA.
DR   EMBL; BC071721; AAH71721.1; -; mRNA.
DR   EMBL; U86636; AAC68818.1; -; Genomic_DNA.
DR   CCDS; CCDS12775.1; -. [Q14653-1]
DR   CCDS; CCDS56099.1; -. [Q14653-2]
DR   CCDS; CCDS59407.1; -. [Q14653-3]
DR   CCDS; CCDS59409.1; -. [Q14653-4]
DR   RefSeq; NP_001184051.1; NM_001197122.1. [Q14653-4]
DR   RefSeq; NP_001184052.1; NM_001197123.1.
DR   RefSeq; NP_001184053.1; NM_001197124.1. [Q14653-2]
DR   RefSeq; NP_001184054.1; NM_001197125.1.
DR   RefSeq; NP_001184055.1; NM_001197126.1.
DR   RefSeq; NP_001184056.1; NM_001197127.1. [Q14653-3]
DR   RefSeq; NP_001184057.1; NM_001197128.1. [Q14653-3]
DR   RefSeq; NP_001562.1; NM_001571.5. [Q14653-1]
DR   RefSeq; XP_006723260.1; XM_006723197.1. [Q14653-4]
DR   RefSeq; XP_006723261.1; XM_006723198.1. [Q14653-4]
DR   RefSeq; XP_016882255.1; XM_017026766.1. [Q14653-1]
DR   RefSeq; XP_016882256.1; XM_017026767.1. [Q14653-1]
DR   UniGene; Hs.289052; -.
DR   UniGene; Hs.731922; -.
DR   UniGene; Hs.75254; -.
DR   PDB; 1J2F; X-ray; 2.30 A; A/B=175-427.
DR   PDB; 1QWT; X-ray; 2.10 A; A/B=173-427.
DR   PDB; 1T2K; X-ray; 3.00 A; A/B=1-112.
DR   PDB; 1ZOQ; X-ray; 2.37 A; A/B=196-386.
DR   PDB; 2O61; X-ray; 2.80 A; A=9-111.
DR   PDB; 2O6G; X-ray; 3.10 A; E/F/G/H=1-123.
DR   PDB; 2PI0; X-ray; 2.31 A; A/B/C/D=1-113.
DR   PDB; 3A77; X-ray; 1.80 A; A/B/C/D=189-427.
DR   PDB; 3QU6; X-ray; 2.30 A; A/B/C=1-113.
DR   PDB; 5JEJ; X-ray; 2.00 A; A/B=189-427.
DR   PDB; 5JEK; X-ray; 2.40 A; A/B=189-427.
DR   PDB; 5JEL; X-ray; 1.60 A; A=189-427.
DR   PDB; 5JEM; X-ray; 2.50 A; A/B/E/G=189-398.
DR   PDB; 5JEO; X-ray; 1.72 A; A=189-427.
DR   PDB; 5JER; X-ray; 2.91 A; A/C/E/G=189-427.
DR   PDBsum; 1J2F; -.
DR   PDBsum; 1QWT; -.
DR   PDBsum; 1T2K; -.
DR   PDBsum; 1ZOQ; -.
DR   PDBsum; 2O61; -.
DR   PDBsum; 2O6G; -.
DR   PDBsum; 2PI0; -.
DR   PDBsum; 3A77; -.
DR   PDBsum; 3QU6; -.
DR   PDBsum; 5JEJ; -.
DR   PDBsum; 5JEK; -.
DR   PDBsum; 5JEL; -.
DR   PDBsum; 5JEM; -.
DR   PDBsum; 5JEO; -.
DR   PDBsum; 5JER; -.
DR   ProteinModelPortal; Q14653; -.
DR   SMR; Q14653; -.
DR   BioGrid; 109869; 84.
DR   CORUM; Q14653; -.
DR   DIP; DIP-41448N; -.
DR   ELM; Q14653; -.
DR   IntAct; Q14653; 48.
DR   MINT; Q14653; -.
DR   STRING; 9606.ENSP00000310127; -.
DR   iPTMnet; Q14653; -.
DR   PhosphoSitePlus; Q14653; -.
DR   BioMuta; IRF3; -.
DR   DMDM; 2497442; -.
DR   EPD; Q14653; -.
DR   MaxQB; Q14653; -.
DR   PaxDb; Q14653; -.
DR   PeptideAtlas; Q14653; -.
DR   PRIDE; Q14653; -.
DR   DNASU; 3661; -.
DR   Ensembl; ENST00000309877; ENSP00000310127; ENSG00000126456. [Q14653-1]
DR   Ensembl; ENST00000377139; ENSP00000366344; ENSG00000126456. [Q14653-1]
DR   Ensembl; ENST00000442265; ENSP00000400378; ENSG00000126456. [Q14653-5]
DR   Ensembl; ENST00000596765; ENSP00000470512; ENSG00000126456. [Q14653-3]
DR   Ensembl; ENST00000597198; ENSP00000469113; ENSG00000126456. [Q14653-1]
DR   Ensembl; ENST00000599223; ENSP00000471358; ENSG00000126456. [Q14653-2]
DR   Ensembl; ENST00000600022; ENSP00000472700; ENSG00000126456. [Q14653-3]
DR   Ensembl; ENST00000601291; ENSP00000471896; ENSG00000126456. [Q14653-4]
DR   GeneID; 3661; -.
DR   KEGG; hsa:3661; -.
DR   UCSC; uc002pot.3; human. [Q14653-1]
DR   CTD; 3661; -.
DR   DisGeNET; 3661; -.
DR   EuPathDB; HostDB:ENSG00000126456.15; -.
DR   GeneCards; IRF3; -.
DR   HGNC; HGNC:6118; IRF3.
DR   HPA; CAB013018; -.
DR   HPA; HPA004895; -.
DR   MalaCards; IRF3; -.
DR   MIM; 603734; gene.
DR   MIM; 616532; phenotype.
DR   neXtProt; NX_Q14653; -.
DR   OpenTargets; ENSG00000126456; -.
DR   PharmGKB; PA29917; -.
DR   eggNOG; ENOG410IXD8; Eukaryota.
DR   eggNOG; ENOG410YA4B; LUCA.
DR   GeneTree; ENSGT00760000119093; -.
DR   HOGENOM; HOG000033705; -.
DR   HOVERGEN; HBG105601; -.
DR   InParanoid; Q14653; -.
DR   KO; K05411; -.
DR   OMA; CHTYWAV; -.
DR   OrthoDB; EOG091G067P; -.
DR   PhylomeDB; Q14653; -.
DR   TreeFam; TF328512; -.
DR   Reactome; R-HSA-1169408; ISG15 antiviral mechanism.
DR   Reactome; R-HSA-1606341; IRF3 mediated activation of type 1 IFN.
DR   Reactome; R-HSA-3134973; LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production.
DR   Reactome; R-HSA-3134975; Regulation of innate immune responses to cytosolic DNA.
DR   Reactome; R-HSA-3270619; IRF3-mediated induction of type I IFN.
DR   Reactome; R-HSA-877300; Interferon gamma signaling.
DR   Reactome; R-HSA-9013973; TICAM1-dependent activation of IRF3/IRF7.
DR   Reactome; R-HSA-909733; Interferon alpha/beta signaling.
DR   Reactome; R-HSA-918233; TRAF3-dependent IRF activation pathway.
DR   Reactome; R-HSA-933541; TRAF6 mediated IRF7 activation.
DR   Reactome; R-HSA-936440; Negative regulators of DDX58/IFIH1 signaling.
DR   Reactome; R-HSA-936964; Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon.
DR   Reactome; R-HSA-983231; Factors involved in megakaryocyte development and platelet production.
DR   SIGNOR; Q14653; -.
DR   ChiTaRS; IRF3; human.
DR   EvolutionaryTrace; Q14653; -.
DR   GeneWiki; IRF3; -.
DR   GenomeRNAi; 3661; -.
DR   PRO; PR:Q14653; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   Bgee; ENSG00000126456; -.
DR   CleanEx; HS_IRF3; -.
DR   ExpressionAtlas; Q14653; baseline and differential.
DR   Genevisible; Q14653; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:BHF-UCL.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0005634; C:nucleus; IDA:BHF-UCL.
DR   GO; GO:0003677; F:DNA binding; NAS:BHF-UCL.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0019904; F:protein domain specific binding; IPI:CAFA.
DR   GO; GO:0042803; F:protein homodimerization activity; IPI:BHF-UCL.
DR   GO; GO:0000978; F:RNA polymerase II proximal promoter sequence-specific DNA binding; IMP:NTNU_SB.
DR   GO; GO:0000981; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; ISA:NTNU_SB.
DR   GO; GO:0043565; F:sequence-specific DNA binding; IDA:NTNU_SB.
DR   GO; GO:0003712; F:transcription cofactor activity; TAS:ProtInc.
DR   GO; GO:0001077; F:transcriptional activator activity, RNA polymerase II proximal promoter sequence-specific DNA binding; IMP:NTNU_SB.
DR   GO; GO:0001228; F:transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific DNA binding; IC:NTNU_SB.
DR   GO; GO:0001078; F:transcriptional repressor activity, RNA polymerase II proximal promoter sequence-specific DNA binding; IEA:Ensembl.
DR   GO; GO:0006915; P:apoptotic process; TAS:UniProtKB.
DR   GO; GO:0006974; P:cellular response to DNA damage stimulus; TAS:UniProtKB.
DR   GO; GO:0071359; P:cellular response to dsRNA; IEA:Ensembl.
DR   GO; GO:0051607; P:defense response to virus; ISS:UniProtKB.
DR   GO; GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome.
DR   GO; GO:0031663; P:lipopolysaccharide-mediated signaling pathway; IEA:Ensembl.
DR   GO; GO:0071888; P:macrophage apoptotic process; TAS:UniProtKB.
DR   GO; GO:0039530; P:MDA-5 signaling pathway; TAS:UniProtKB.
DR   GO; GO:0050689; P:negative regulation of defense response to virus by host; IEA:Ensembl.
DR   GO; GO:0045358; P:negative regulation of interferon-beta biosynthetic process; IEA:Ensembl.
DR   GO; GO:0032480; P:negative regulation of type I interferon production; TAS:Reactome.
DR   GO; GO:0050715; P:positive regulation of cytokine secretion; IEA:Ensembl.
DR   GO; GO:0043123; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; IEA:Ensembl.
DR   GO; GO:0032727; P:positive regulation of interferon-alpha production; ISS:UniProtKB.
DR   GO; GO:0032728; P:positive regulation of interferon-beta production; ISS:UniProtKB.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IDA:NTNU_SB.
DR   GO; GO:0032481; P:positive regulation of type I interferon production; TAS:Reactome.
DR   GO; GO:0060340; P:positive regulation of type I interferon-mediated signaling pathway; IEA:Ensembl.
DR   GO; GO:0097300; P:programmed necrotic cell death; IEA:Ensembl.
DR   GO; GO:0032479; P:regulation of type I interferon production; TAS:Reactome.
DR   GO; GO:0043330; P:response to exogenous dsRNA; IEA:Ensembl.
DR   GO; GO:0006366; P:transcription by RNA polymerase II; TAS:ProtInc.
DR   GO; GO:0035666; P:TRIF-dependent toll-like receptor signaling pathway; TAS:Reactome.
DR   GO; GO:0045351; P:type I interferon biosynthetic process; IEA:Ensembl.
DR   GO; GO:0060337; P:type I interferon signaling pathway; TAS:Reactome.
DR   GO; GO:0016032; P:viral process; IEA:UniProtKB-KW.
DR   CDD; cd00103; IRF; 1.
DR   Gene3D; 1.10.10.10; -; 1.
DR   Gene3D; 2.60.200.10; -; 1.
DR   InterPro; IPR019817; Interferon_reg_fac_CS.
DR   InterPro; IPR001346; Interferon_reg_fact_DNA-bd_dom.
DR   InterPro; IPR019471; Interferon_reg_factor-3.
DR   InterPro; IPR017855; SMAD-like_dom_sf.
DR   InterPro; IPR008984; SMAD_FHA_dom_sf.
DR   InterPro; IPR036388; WH-like_DNA-bd_sf.
DR   InterPro; IPR036390; WH_DNA-bd_sf.
DR   PANTHER; PTHR11949; PTHR11949; 1.
DR   Pfam; PF00605; IRF; 1.
DR   Pfam; PF10401; IRF-3; 1.
DR   PRINTS; PR00267; INTFRNREGFCT.
DR   SMART; SM00348; IRF; 1.
DR   SMART; SM01243; IRF-3; 1.
DR   SUPFAM; SSF46785; SSF46785; 1.
DR   SUPFAM; SSF49879; SSF49879; 1.
DR   PROSITE; PS00601; IRF_1; 1.
DR   PROSITE; PS51507; IRF_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Activator; Alternative splicing; Antiviral defense;
KW   Complete proteome; Cytoplasm; Disease mutation; Disulfide bond;
KW   DNA-binding; Host-virus interaction; Immunity; Innate immunity;
KW   Isopeptide bond; Nucleus; Phosphoprotein; Polymorphism;
KW   Reference proteome; Transcription; Transcription regulation;
KW   Ubl conjugation.
FT   CHAIN         1    427       Interferon regulatory factor 3.
FT                                /FTId=PRO_0000154553.
FT   DNA_BIND      5    111       IRF tryptophan pentad repeat.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00840}.
FT   REGION      200    360       Involved in HERC5 binding.
FT   MOTIF       139    149       Nuclear export signal.
FT   COMPBIAS    151    191       Pro-rich.
FT   MOD_RES       3      3       Phosphothreonine.
FT                                {ECO:0000269|PubMed:23746807}.
FT   MOD_RES      14     14       Phosphoserine.
FT                                {ECO:0000269|PubMed:23746807}.
FT   MOD_RES      75     75       Phosphothreonine.
FT                                {ECO:0000269|PubMed:23746807}.
FT   MOD_RES      97     97       Phosphoserine.
FT                                {ECO:0000269|PubMed:23746807}.
FT   MOD_RES     123    123       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P70671}.
FT   MOD_RES     180    180       Phosphothreonine.
FT                                {ECO:0000269|PubMed:23746807}.
FT   MOD_RES     188    188       Phosphoserine.
FT                                {ECO:0000269|PubMed:23746807}.
FT   MOD_RES     237    237       Phosphothreonine.
FT                                {ECO:0000269|PubMed:23746807}.
FT   MOD_RES     244    244       Phosphothreonine.
FT                                {ECO:0000269|PubMed:23746807}.
FT   MOD_RES     253    253       Phosphothreonine.
FT                                {ECO:0000269|PubMed:23746807}.
FT   MOD_RES     386    386       Phosphoserine; by TBK1.
FT                                {ECO:0000269|PubMed:23746807}.
FT   MOD_RES     396    396       Phosphoserine; by IKKE.
FT                                {ECO:0000269|PubMed:23478265}.
FT   MOD_RES     398    398       Phosphoserine.
FT                                {ECO:0000269|PubMed:23746807}.
FT   MOD_RES     404    404       Phosphothreonine.
FT                                {ECO:0000269|PubMed:23746807}.
FT   MOD_RES     427    427       Phosphoserine.
FT                                {ECO:0000269|PubMed:23746807}.
FT   DISULFID    267    289       {ECO:0000269|PubMed:14555995,
FT                                ECO:0000269|PubMed:14555996}.
FT   CROSSLNK    193    193       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in ISG15).
FT                                {ECO:0000269|PubMed:20308324}.
FT   CROSSLNK    360    360       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in ISG15).
FT                                {ECO:0000269|PubMed:20308324}.
FT   CROSSLNK    366    366       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in ISG15).
FT                                {ECO:0000269|PubMed:20308324}.
FT   VAR_SEQ       1    146       Missing (in isoform 3).
FT                                {ECO:0000303|Ref.2}.
FT                                /FTId=VSP_046911.
FT   VAR_SEQ      56    104       AWAEATGAYVPGRDKPDLPTWKRNFRSALNRKEGLRLAEDR
FT                                SKDPHDPH -> ELGTFPSQTPLRTPMVEAVLLIPRKTFWM
FT                                SYWVTWCWPHSQIRDPQAWL (in isoform 5).
FT                                {ECO:0000303|Ref.2}.
FT                                /FTId=VSP_047690.
FT   VAR_SEQ     105    427       Missing (in isoform 5).
FT                                {ECO:0000303|Ref.2}.
FT                                /FTId=VSP_047691.
FT   VAR_SEQ     201    327       Missing (in isoform 2 and isoform 3).
FT                                {ECO:0000303|Ref.2}.
FT                                /FTId=VSP_043319.
FT   VAR_SEQ     328    427       DLITFTEGSGRSPRYALWFCVGESWPQDQPWTKRLVMVKVV
FT                                PTCLRALVEMARVGGASSLENTVDLHISNSHPLSLTSDQYK
FT                                AYLQDLVEGMDFQGPGES -> GSWAPRSDYLHGRKRTLTT
FT                                LCPLVLCGGVMAPGPAVDQEARDGQGCAHVPQGLGRNGPGR
FT                                GCLLPGEYCGPAHFQQPPTLPHLRPVQGLPAGLGGGHGFPG
FT                                PWGELSPRSSWCASNPPVPHHLNQ (in isoform 4).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_046912.
FT   VARIANT      96     96       R -> Q (in dbSNP:rs968457).
FT                                /FTId=VAR_011901.
FT   VARIANT     107    107       Y -> F (in dbSNP:rs34745118).
FT                                /FTId=VAR_049643.
FT   VARIANT     285    285       R -> Q (in HSE7; loss of viral infection-
FT                                induced phosphorylation at S-386; loss of
FT                                viral infection-induced homodimerization;
FT                                loss of viral infection-induced
FT                                transcription factor activity; unable to
FT                                activate interferon transcription in
FT                                response to viral infection;
FT                                dbSNP:rs750526659).
FT                                {ECO:0000269|PubMed:26216125}.
FT                                /FTId=VAR_075805.
FT   VARIANT     377    377       E -> K (in dbSNP:rs1049486).
FT                                /FTId=VAR_011902.
FT   VARIANT     427    427       S -> T (in dbSNP:rs7251).
FT                                {ECO:0000269|PubMed:14702039,
FT                                ECO:0000269|Ref.5}.
FT                                /FTId=VAR_011903.
FT   MUTAGEN      77     78       KR->NG: Abolishes nuclear localization.
FT                                {ECO:0000269|PubMed:10805757}.
FT   MUTAGEN      86     87       RK->LQ: No effect on subcellular
FT                                localization.
FT                                {ECO:0000269|PubMed:10805757}.
FT   MUTAGEN     139    140       IL->MM: Abolishes nuclear export.
FT                                {ECO:0000269|PubMed:10805757}.
FT   MUTAGEN     193    193       K->R: Highly diminished ISGylation; when
FT                                associated with R-360 and R-366.
FT                                {ECO:0000269|PubMed:20308324}.
FT   MUTAGEN     360    360       K->R: Highly diminished ISGylation; when
FT                                associated with R-193 and R-366.
FT                                {ECO:0000269|PubMed:20308324}.
FT   MUTAGEN     366    366       K->R: Highly diminished ISGylation; when
FT                                associated with R-193 and R-360.
FT                                {ECO:0000269|PubMed:20308324}.
FT   MUTAGEN     385    386       SS->AA: Complete loss of viral infection
FT                                induced phosphorylation.
FT                                {ECO:0000269|PubMed:9566918}.
FT   MUTAGEN     385    385       S->A,D,E: Complete loss of viral
FT                                infection induced phosphorylation.
FT                                {ECO:0000269|PubMed:10920266}.
FT   MUTAGEN     386    386       S->A,D,E: Complete loss of viral
FT                                infection induced phosphorylation.
FT                                {ECO:0000269|PubMed:10920266,
FT                                ECO:0000269|PubMed:23746807}.
FT   MUTAGEN     386    386       S->A: Abolishes dimerization after
FT                                phosphorylation.
FT                                {ECO:0000269|PubMed:10920266,
FT                                ECO:0000269|PubMed:23746807}.
FT   MUTAGEN     396    405       SNSHPLSLTS->ANAHPLALAA: Complete loss of
FT                                viral infection induced phosphorylation.
FT                                {ECO:0000269|PubMed:9566918}.
FT   MUTAGEN     396    405       SNSHPLSLTS->DNDHPLDLDD: Acts as a
FT                                constitutively activated IRF3.
FT                                {ECO:0000269|PubMed:9566918}.
FT   MUTAGEN     396    398       SNS->ANA: Complete loss of viral
FT                                infection induced phosphorylation.
FT   MUTAGEN     402    405       SLTS->ALAA: Complete loss of viral
FT                                infection induced phosphorylation.
FT   CONFLICT    196    196       L -> F (in Ref. 3; BAG37040).
FT                                {ECO:0000305}.
FT   HELIX         8     18       {ECO:0000244|PDB:3QU6}.
FT   STRAND       25     27       {ECO:0000244|PDB:2O61}.
FT   STRAND       28     31       {ECO:0000244|PDB:2PI0}.
FT   STRAND       33     37       {ECO:0000244|PDB:3QU6}.
FT   STRAND       41     45       {ECO:0000244|PDB:2O6G}.
FT   HELIX        49     51       {ECO:0000244|PDB:2PI0}.
FT   HELIX        53     60       {ECO:0000244|PDB:3QU6}.
FT   STRAND       66     69       {ECO:0000244|PDB:2O61}.
FT   HELIX        73     85       {ECO:0000244|PDB:3QU6}.
FT   STRAND       90     96       {ECO:0000244|PDB:3QU6}.
FT   STRAND      100    102       {ECO:0000244|PDB:3QU6}.
FT   STRAND      104    109       {ECO:0000244|PDB:3QU6}.
FT   HELIX       191    196       {ECO:0000244|PDB:5JEL}.
FT   STRAND      204    210       {ECO:0000244|PDB:5JEL}.
FT   STRAND      213    220       {ECO:0000244|PDB:5JEL}.
FT   STRAND      226    229       {ECO:0000244|PDB:5JEL}.
FT   STRAND      238    244       {ECO:0000244|PDB:5JEL}.
FT   HELIX       248    250       {ECO:0000244|PDB:3A77}.
FT   STRAND      252    254       {ECO:0000244|PDB:5JEJ}.
FT   HELIX       255    266       {ECO:0000244|PDB:5JEL}.
FT   TURN        267    270       {ECO:0000244|PDB:1ZOQ}.
FT   STRAND      272    277       {ECO:0000244|PDB:5JEL}.
FT   STRAND      280    285       {ECO:0000244|PDB:5JEL}.
FT   STRAND      287    289       {ECO:0000244|PDB:5JEL}.
FT   STRAND      291    297       {ECO:0000244|PDB:5JEL}.
FT   STRAND      304    306       {ECO:0000244|PDB:5JEO}.
FT   STRAND      308    310       {ECO:0000244|PDB:5JEL}.
FT   STRAND      313    315       {ECO:0000244|PDB:5JEL}.
FT   STRAND      317    321       {ECO:0000244|PDB:5JEL}.
FT   HELIX       322    333       {ECO:0000244|PDB:5JEL}.
FT   STRAND      343    350       {ECO:0000244|PDB:5JEL}.
FT   STRAND      354    356       {ECO:0000244|PDB:1ZOQ}.
FT   HELIX       358    360       {ECO:0000244|PDB:5JEL}.
FT   STRAND      361    369       {ECO:0000244|PDB:5JEL}.
FT   HELIX       370    383       {ECO:0000244|PDB:5JEL}.
FT   STRAND      384    391       {ECO:0000244|PDB:5JEL}.
FT   STRAND      395    397       {ECO:0000244|PDB:5JER}.
FT   STRAND      401    404       {ECO:0000244|PDB:5JEL}.
FT   HELIX       405    417       {ECO:0000244|PDB:5JEL}.
SQ   SEQUENCE   427 AA;  47219 MW;  F536676FA78B0110 CRC64;
     MGTPKPRILP WLVSQLDLGQ LEGVAWVNKS RTRFRIPWKH GLRQDAQQED FGIFQAWAEA
     TGAYVPGRDK PDLPTWKRNF RSALNRKEGL RLAEDRSKDP HDPHKIYEFV NSGVGDFSQP
     DTSPDTNGGG STSDTQEDIL DELLGNMVLA PLPDPGPPSL AVAPEPCPQP LRSPSLDNPT
     PFPNLGPSEN PLKRLLVPGE EWEFEVTAFY RGRQVFQQTI SCPEGLRLVG SEVGDRTLPG
     WPVTLPDPGM SLTDRGVMSY VRHVLSCLGG GLALWRAGQW LWAQRLGHCH TYWAVSEELL
     PNSGHGPDGE VPKDKEGGVF DLGPFIVDLI TFTEGSGRSP RYALWFCVGE SWPQDQPWTK
     RLVMVKVVPT CLRALVEMAR VGGASSLENT VDLHISNSHP LSLTSDQYKA YLQDLVEGMD
     FQGPGES
//
ID   A0A0G2USB5_HUMAN        Unreviewed;       417 AA.
AC   A0A0G2USB5;
DT   16-SEP-2015, integrated into UniProtKB/TrEMBL.
DT   16-SEP-2015, sequence version 1.
DT   28-MAR-2018, entry version 19.
DE   SubName: Full=Interferon regulatory factor 5 {ECO:0000313|EMBL:AKI32238.1};
DE   Flags: Fragment;
GN   Name=IRF5 {ECO:0000313|EMBL:AKI32238.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:AKI32238.1};
RN   [1] {ECO:0000313|EMBL:AKI32238.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Babaian A., Romanish M.T., Gagnier L., Kuo J., Karimi M.M., Steidl C.,
RA   Mager D.L.;
RT   "Onco-exaptation of an Endogenous Retroviral LTR Drives IRF5
RT   Expression in Hodgkin Lymphoma.";
RL   Submitted (FEB-2015) to the EMBL/GenBank/DDBJ databases.
CC   -!- SIMILARITY: Belongs to the IRF family. {ECO:0000256|PROSITE-
CC       ProRule:PRU00840}.
CC   -!- CAUTION: Lacks conserved residue(s) required for the propagation
CC       of feature annotation. {ECO:0000256|PROSITE-ProRule:PRU00840}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; KP843528; AKI32238.1; -; mRNA.
DR   RefSeq; NP_001334857.1; NM_001347928.1.
DR   UniGene; Hs.521181; -.
DR   PeptideAtlas; A0A0G2USB5; -.
DR   GeneID; 3663; -.
DR   CTD; 3663; -.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-UniRule.
DR   GO; GO:0003700; F:DNA binding transcription factor activity; IEA:InterPro.
DR   GO; GO:0044212; F:transcription regulatory region DNA binding; IEA:InterPro.
DR   GO; GO:0019221; P:cytokine-mediated signaling pathway; IEA:InterPro.
DR   GO; GO:0051607; P:defense response to virus; IEA:InterPro.
DR   GO; GO:0006357; P:regulation of transcription by RNA polymerase II; IEA:InterPro.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-UniRule.
DR   CDD; cd00103; IRF; 1.
DR   Gene3D; 1.10.10.10; -; 1.
DR   Gene3D; 2.60.200.10; -; 1.
DR   InterPro; IPR019817; Interferon_reg_fac_CS.
DR   InterPro; IPR001346; Interferon_reg_fact_DNA-bd_dom.
DR   InterPro; IPR019471; Interferon_reg_factor-3.
DR   InterPro; IPR029838; IRF5.
DR   InterPro; IPR017855; SMAD-like_dom_sf.
DR   InterPro; IPR008984; SMAD_FHA_dom_sf.
DR   InterPro; IPR036388; WH-like_DNA-bd_sf.
DR   InterPro; IPR036390; WH_DNA-bd_sf.
DR   PANTHER; PTHR11949; PTHR11949; 1.
DR   PANTHER; PTHR11949:SF10; PTHR11949:SF10; 1.
DR   Pfam; PF00605; IRF; 1.
DR   Pfam; PF10401; IRF-3; 1.
DR   PRINTS; PR00267; INTFRNREGFCT.
DR   SMART; SM00348; IRF; 1.
DR   SMART; SM01243; IRF-3; 1.
DR   SUPFAM; SSF46785; SSF46785; 1.
DR   SUPFAM; SSF49879; SSF49879; 1.
DR   PROSITE; PS00601; IRF_1; 1.
DR   PROSITE; PS51507; IRF_2; 1.
PE   2: Evidence at transcript level;
KW   DNA-binding {ECO:0000256|PROSITE-ProRule:PRU00840};
KW   Nucleus {ECO:0000256|PROSITE-ProRule:PRU00840};
KW   Transcription {ECO:0000256|PROSITE-ProRule:PRU00840};
KW   Transcription regulation {ECO:0000256|PROSITE-ProRule:PRU00840}.
FT   DOMAIN       14    122       IRF tryptophan pentad repeat.
FT                                {ECO:0000259|PROSITE:PS51507}.
FT   NON_TER     417    417       {ECO:0000313|EMBL:AKI32238.1}.
SQ   SEQUENCE   417 AA;  46816 MW;  85B233DF3782AD4E CRC64;
     MNQSIPVAPT PPRRVRLKPW LVAQVNSCQY PGLQWVNGEK KLFCIPWRHA TRHGPSQDGD
     NTIFKAWAKE TGKYTEGVDE ADPAKWKANL RCALNKSRDF RLIYDGPRDM PPQPYKIYEV
     CSNGPAPTDS QPPEDYSFGA GEEEEEEEEL QRMLPSLSLT DAVQSGPHMT PYSLLKEDVK
     WPPTLQPPTL RPPTLQPPTL QPPVVLGPPA PDPSPLAPPP GNPAGFRELL SEVLEPGPLP
     ASLPPAGEQL LPDLLISPHM LPLTDLEIKF QYRGRPPRAL TISNPHGCRL FYSQLEATQE
     QVELFGPISL EQVRFPSPED IPSDKQRFYT NQLLDVLDRG LILQLQGQDL YAIRLCQCKV
     FWSGPCASAH DSCPNPIQRE VKTKLFSLEH FLNELILFQK GQTNTPPPFE IFFCFGE
//
ID   B7Z1M2_HUMAN            Unreviewed;       140 AA.
AC   B7Z1M2;
DT   03-MAR-2009, integrated into UniProtKB/TrEMBL.
DT   03-MAR-2009, sequence version 1.
DT   23-MAY-2018, entry version 56.
DE   SubName: Full=cDNA FLJ53720, highly similar to Interferon regulatory factor 5 {ECO:0000313|EMBL:BAH11558.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAH11558.1};
RN   [1] {ECO:0000313|EMBL:BAH11558.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Cerebellum {ECO:0000313|EMBL:BAH11558.1};
RA   Wakamatsu A., Yamamoto J., Kimura K., Ishii S., Watanabe K.,
RA   Sugiyama A., Murakawa K., Kaida T., Tsuchiya K., Fukuzumi Y.,
RA   Kumagai A., Oishi Y., Yamamoto S., Ono Y., Komori Y., Yamazaki M.,
RA   Kisu Y., Nishikawa T., Sugano S., Nomura N., Isogai T.;
RT   "NEDO human cDNA sequencing project focused on splicing variants.";
RL   Submitted (OCT-2007) to the EMBL/GenBank/DDBJ databases.
CC   -!- SIMILARITY: Belongs to the IRF family. {ECO:0000256|PROSITE-
CC       ProRule:PRU00840}.
CC   -!- CAUTION: Lacks conserved residue(s) required for the propagation
CC       of feature annotation. {ECO:0000256|PROSITE-ProRule:PRU00840}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK293654; BAH11558.1; -; mRNA.
DR   RefSeq; NP_001092099.1; NM_001098629.2.
DR   RefSeq; NP_001092100.1; NM_001098630.2.
DR   RefSeq; NP_001229381.1; NM_001242452.2.
DR   UniGene; Hs.521181; -.
DR   PeptideAtlas; B7Z1M2; -.
DR   PRIDE; B7Z1M2; -.
DR   GeneID; 3663; -.
DR   CTD; 3663; -.
DR   eggNOG; ENOG410IFCV; Eukaryota.
DR   eggNOG; ENOG410XRXT; LUCA.
DR   HOVERGEN; HBG060290; -.
DR   GenomeRNAi; 3663; -.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-UniRule.
DR   GO; GO:0003700; F:DNA binding transcription factor activity; IEA:InterPro.
DR   GO; GO:0044212; F:transcription regulatory region DNA binding; IEA:InterPro.
DR   GO; GO:0019221; P:cytokine-mediated signaling pathway; IEA:InterPro.
DR   GO; GO:0051607; P:defense response to virus; IEA:InterPro.
DR   GO; GO:0006357; P:regulation of transcription by RNA polymerase II; IEA:InterPro.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-UniRule.
DR   CDD; cd00103; IRF; 1.
DR   Gene3D; 1.10.10.10; -; 1.
DR   InterPro; IPR019817; Interferon_reg_fac_CS.
DR   InterPro; IPR001346; Interferon_reg_fact_DNA-bd_dom.
DR   InterPro; IPR029838; IRF5.
DR   InterPro; IPR036388; WH-like_DNA-bd_sf.
DR   InterPro; IPR036390; WH_DNA-bd_sf.
DR   PANTHER; PTHR11949; PTHR11949; 1.
DR   PANTHER; PTHR11949:SF10; PTHR11949:SF10; 1.
DR   Pfam; PF00605; IRF; 1.
DR   PRINTS; PR00267; INTFRNREGFCT.
DR   SMART; SM00348; IRF; 1.
DR   SUPFAM; SSF46785; SSF46785; 1.
DR   PROSITE; PS00601; IRF_1; 1.
DR   PROSITE; PS51507; IRF_2; 1.
PE   2: Evidence at transcript level;
KW   DNA-binding {ECO:0000256|PROSITE-ProRule:PRU00840};
KW   Nucleus {ECO:0000256|PROSITE-ProRule:PRU00840};
KW   Transcription {ECO:0000256|PROSITE-ProRule:PRU00840};
KW   Transcription regulation {ECO:0000256|PROSITE-ProRule:PRU00840}.
FT   DOMAIN       14    122       IRF tryptophan pentad repeat.
FT                                {ECO:0000259|PROSITE:PS51507}.
SQ   SEQUENCE   140 AA;  16367 MW;  A94DEF487C1D40DC CRC64;
     MNQSIPVAPT PPRRVRLKPW LVAQVNSCQY PGLQWVNGEK KLFCIPWRHA TRHGPSQDGD
     NTIFKAWAKE TGKYTEGVDE ADPAKWKANL RCALNKSRDF RLIYDGPRDM PPQPYKIYET
     PSPLRITLLV QERRRKKRKR
//
ID   C9JAU6_HUMAN            Unreviewed;       514 AA.
AC   C9JAU6; A0A024R763;
DT   03-NOV-2009, integrated into UniProtKB/TrEMBL.
DT   07-JUN-2017, sequence version 9.
DT   23-MAY-2018, entry version 73.
DE   SubName: Full=Interferon regulatory factor 5 {ECO:0000313|Ensembl:ENSP00000418037};
DE   SubName: Full=Interferon regulatory factor 5, isoform CRA_a {ECO:0000313|EMBL:EAW83706.1};
GN   Name=IRF5 {ECO:0000313|EMBL:EAW83706.1,
GN   ECO:0000313|Ensembl:ENSP00000418037};
GN   ORFNames=hCG_40517 {ECO:0000313|EMBL:EAW83706.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000418037, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|EMBL:EAW83706.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12853948; DOI=10.1038/nature01782;
RA   Hillier L.W., Fulton R.S., Fulton L.A., Graves T.A., Pepin K.H.,
RA   Wagner-McPherson C., Layman D., Maas J., Jaeger S., Walker R.,
RA   Wylie K., Sekhon M., Becker M.C., O'Laughlin M.D., Schaller M.E.,
RA   Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Cordes M., Du H.,
RA   Sun H., Edwards J., Bradshaw-Cordum H., Ali J., Andrews S., Isak A.,
RA   Vanbrunt A., Nguyen C., Du F., Lamar B., Courtney L., Kalicki J.,
RA   Ozersky P., Bielicki L., Scott K., Holmes A., Harkins R., Harris A.,
RA   Strong C.M., Hou S., Tomlinson C., Dauphin-Kohlberg S.,
RA   Kozlowicz-Reilly A., Leonard S., Rohlfing T., Rock S.M.,
RA   Tin-Wollam A.-M., Abbott A., Minx P., Maupin R., Strowmatt C.,
RA   Latreille P., Miller N., Johnson D., Murray J., Woessner J.P.,
RA   Wendl M.C., Yang S.-P., Schultz B.R., Wallis J.W., Spieth J.,
RA   Bieri T.A., Nelson J.O., Berkowicz N., Wohldmann P.E., Cook L.L.,
RA   Hickenbotham M.T., Eldred J., Williams D., Bedell J.A., Mardis E.R.,
RA   Clifton S.W., Chissoe S.L., Marra M.A., Raymond C., Haugen E.,
RA   Gillett W., Zhou Y., James R., Phelps K., Iadanoto S., Bubb K.,
RA   Simms E., Levy R., Clendenning J., Kaul R., Kent W.J., Furey T.S.,
RA   Baertsch R.A., Brent M.R., Keibler E., Flicek P., Bork P., Suyama M.,
RA   Bailey J.A., Portnoy M.E., Torrents D., Chinwalla A.T., Gish W.R.,
RA   Eddy S.R., McPherson J.D., Olson M.V., Eichler E.E., Green E.D.,
RA   Waterston R.H., Wilson R.K.;
RT   "The DNA sequence of human chromosome 7.";
RL   Nature 424:157-164(2003).
RN   [3] {ECO:0000313|Ensembl:ENSP00000418037}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [4] {ECO:0000313|EMBL:EAW83706.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5] {ECO:0000313|Ensembl:ENSP00000418037}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (JUL-2011) to UniProtKB.
CC   -!- SIMILARITY: Belongs to the IRF family. {ECO:0000256|PROSITE-
CC       ProRule:PRU00840}.
CC   -!- CAUTION: Lacks conserved residue(s) required for the propagation
CC       of feature annotation. {ECO:0000256|PROSITE-ProRule:PRU00840}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AC025594; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; KF459647; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471070; EAW83706.1; -; Genomic_DNA.
DR   RefSeq; NP_001092099.1; NM_001098629.2.
DR   RefSeq; NP_001334857.1; NM_001347928.1.
DR   RefSeq; XP_005250374.1; XM_005250317.3.
DR   RefSeq; XP_006716037.1; XM_006715974.2.
DR   RefSeq; XP_011514460.1; XM_011516158.2.
DR   RefSeq; XP_011514461.1; XM_011516159.2.
DR   RefSeq; XP_011514462.1; XM_011516160.1.
DR   UniGene; Hs.521181; -.
DR   SMR; C9JAU6; -.
DR   PRIDE; C9JAU6; -.
DR   Ensembl; ENST00000489702; ENSP00000418037; ENSG00000128604.
DR   GeneID; 3663; -.
DR   UCSC; uc064hwe.1; human.
DR   CTD; 3663; -.
DR   EuPathDB; HostDB:ENSG00000128604.18; -.
DR   HGNC; HGNC:6120; IRF5.
DR   OpenTargets; ENSG00000128604; -.
DR   eggNOG; ENOG410IFCV; Eukaryota.
DR   eggNOG; ENOG410XRXT; LUCA.
DR   HOGENOM; HOG000203117; -.
DR   OMA; MPPQPYK; -.
DR   OrthoDB; EOG091G067P; -.
DR   GenomeRNAi; 3663; -.
DR   Proteomes; UP000005640; Chromosome 7.
DR   Bgee; ENSG00000128604; -.
DR   ExpressionAtlas; C9JAU6; baseline and differential.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-UniRule.
DR   GO; GO:0003700; F:DNA binding transcription factor activity; IEA:InterPro.
DR   GO; GO:0044212; F:transcription regulatory region DNA binding; IEA:InterPro.
DR   GO; GO:0019221; P:cytokine-mediated signaling pathway; IEA:InterPro.
DR   GO; GO:0051607; P:defense response to virus; IEA:Ensembl.
DR   GO; GO:0006357; P:regulation of transcription by RNA polymerase II; IEA:InterPro.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-UniRule.
DR   CDD; cd00103; IRF; 1.
DR   Gene3D; 1.10.10.10; -; 1.
DR   Gene3D; 2.60.200.10; -; 1.
DR   InterPro; IPR019817; Interferon_reg_fac_CS.
DR   InterPro; IPR001346; Interferon_reg_fact_DNA-bd_dom.
DR   InterPro; IPR019471; Interferon_reg_factor-3.
DR   InterPro; IPR029838; IRF5.
DR   InterPro; IPR017855; SMAD-like_dom_sf.
DR   InterPro; IPR008984; SMAD_FHA_dom_sf.
DR   InterPro; IPR036388; WH-like_DNA-bd_sf.
DR   InterPro; IPR036390; WH_DNA-bd_sf.
DR   PANTHER; PTHR11949; PTHR11949; 1.
DR   PANTHER; PTHR11949:SF10; PTHR11949:SF10; 1.
DR   Pfam; PF00605; IRF; 1.
DR   Pfam; PF10401; IRF-3; 1.
DR   PRINTS; PR00267; INTFRNREGFCT.
DR   SMART; SM00348; IRF; 1.
DR   SMART; SM01243; IRF-3; 1.
DR   SUPFAM; SSF46785; SSF46785; 1.
DR   SUPFAM; SSF49879; SSF49879; 1.
DR   PROSITE; PS00601; IRF_1; 1.
DR   PROSITE; PS51507; IRF_2; 1.
PE   1: Evidence at protein level;
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   DNA-binding {ECO:0000256|PROSITE-ProRule:PRU00840};
KW   Nucleus {ECO:0000256|PROSITE-ProRule:PRU00840};
KW   Proteomics identification {ECO:0000213|MaxQB:C9JAU6,
KW   ECO:0000213|PeptideAtlas:C9JAU6};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640};
KW   Transcription {ECO:0000256|PROSITE-ProRule:PRU00840};
KW   Transcription regulation {ECO:0000256|PROSITE-ProRule:PRU00840}.
FT   DOMAIN       14    122       IRF tryptophan pentad repeat.
FT                                {ECO:0000259|PROSITE:PS51507}.
SQ   SEQUENCE   514 AA;  57770 MW;  D554D121D9E35893 CRC64;
     MNQSIPVAPT PPRRVRLKPW LVAQVNSCQY PGLQWVNGEK KLFCIPWRHA TRHGPSQDGD
     NTIFKAWAKE TGKYTEGVDE ADPAKWKANL RCALNKSRDF RLIYDGPRDM PPQPYKIYEV
     CSNGPAPTDS QPPEDYSFGA GEEEEEEEEL QRMLPSLSLT DAVQSGPHMT PYSLLKEDVK
     WPPTLQPPTL RPPTLQPPTL QPPVVLGPPA PDPSPLAPPP GNPAGFRELL SEVLEPGPLP
     ASLPPAGEQL LPDLLISPHM LPLTDLEIKF QYRGRPPRAL TISNPHGCRL FYSQLEATQE
     QVELFGPISL EQVRFPSPED IPSDKQRFYT NQLLDVLDRG LILQLQGQDL YAIRLCQCKV
     FWSGPCASAH DSCPNPIQRE VKTKLFSLEH FLNELILFQK GQTNTPPPFE IFFCFGEEWP
     DRKPREKKLI TVQVVPVAAR LLLEMFSGEL SWSADSIRLQ ISNPDLKDRM VEQFKELHHI
     WQSQQRLQPV AQAPPGAGLG VGQGPWPMHP AGMQ
//
ID   IRF5_HUMAN              Reviewed;         498 AA.
AC   Q13568; A4D1J8; A8DUA8; A8DUA9; E7EQ16; E7EW54; Q1A7B4; Q64GA9;
AC   Q64GB1; Q64GB2; Q6RCM8; Q9BQF0;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   16-APR-2002, sequence version 2.
DT   23-MAY-2018, entry version 162.
DE   RecName: Full=Interferon regulatory factor 5;
DE            Short=IRF-5;
GN   Name=IRF5;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 4), AND FUNCTION.
RX   PubMed=11303025; DOI=10.1074/jbc.M101216200;
RA   Barnes B.J., Moore P.A., Pitha P.M.;
RT   "Virus-specific activation of a novel interferon regulatory factor,
RT   IRF-5, results in the induction of distinct interferon alpha genes.";
RL   J. Biol. Chem. 276:23382-23390(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 4), AND FUNCTION.
RX   PubMed=15695821; DOI=10.1074/jbc.M412584200;
RA   Schoenemeyer A., Barnes B.J., Mancl M.E., Latz E., Goutagny N.,
RA   Pitha P.M., Fitzgerald K.A., Golenbock D.T.;
RT   "The interferon regulatory factor, IRF5, is a central mediator of
RT   toll-like receptor 7 signaling.";
RL   J. Biol. Chem. 280:17005-17012(2005).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1; 2 AND 5), AND ALTERNATIVE
RP   SPLICING.
RX   PubMed=15805103; DOI=10.1074/jbc.M500543200;
RA   Mancl M.E., Hu G., Sangster-Guity N., Olshalsky S.L., Hoops K.,
RA   Fitzgerald-Bocarsly P., Pitha P.M., Pinder K., Barnes B.J.;
RT   "Two discrete promoters regulate the alternatively spliced human
RT   interferon regulatory factor-5 isoforms. Multiple isoforms with
RT   distinct cell type-specific expression, localization, regulation, and
RT   function.";
RL   J. Biol. Chem. 280:21078-21090(2005).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 4 AND 6).
RX   PubMed=16642019; DOI=10.1038/ng1782;
RA   Graham R.R., Kozyrev S.V., Baechler E.C., Reddy M.V., Plenge R.M.,
RA   Bauer J.W., Ortmann W.A., Koeuth T., Escribano M.F.,
RA   Collaborative Groups T.A., Pons-Estel B., Petri M., Daly M.,
RA   Gregersen P.K., Martin J., Altshuler D., Behrens T.W.,
RA   Alarcon-Riquelme M.E.;
RT   "A common haplotype of interferon regulatory factor 5 (IRF5) regulates
RT   splicing and expression and is associated with increased risk of
RT   systemic lupus erythematosus.";
RL   Nat. Genet. 38:550-555(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3).
RA   Grossman A., Mittrucker H.W., Lantonio L., Mak T.W.;
RL   Submitted (APR-1996) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RA   Livingston R.J., Shaffer T., McFarland I., Nguyen C.P., Stanaway I.B.,
RA   Rajkumar N., Johnson E.J., da Ponte S.H., Willa H., Ahearn M.O.,
RA   Bertucci C., Acklestad J., Carroll A., Swanson J., Gildersleeve H.I.,
RA   Nickerson D.A.;
RL   Submitted (OCT-2006) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12853948; DOI=10.1038/nature01782;
RA   Hillier L.W., Fulton R.S., Fulton L.A., Graves T.A., Pepin K.H.,
RA   Wagner-McPherson C., Layman D., Maas J., Jaeger S., Walker R.,
RA   Wylie K., Sekhon M., Becker M.C., O'Laughlin M.D., Schaller M.E.,
RA   Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Cordes M., Du H.,
RA   Sun H., Edwards J., Bradshaw-Cordum H., Ali J., Andrews S., Isak A.,
RA   Vanbrunt A., Nguyen C., Du F., Lamar B., Courtney L., Kalicki J.,
RA   Ozersky P., Bielicki L., Scott K., Holmes A., Harkins R., Harris A.,
RA   Strong C.M., Hou S., Tomlinson C., Dauphin-Kohlberg S.,
RA   Kozlowicz-Reilly A., Leonard S., Rohlfing T., Rock S.M.,
RA   Tin-Wollam A.-M., Abbott A., Minx P., Maupin R., Strowmatt C.,
RA   Latreille P., Miller N., Johnson D., Murray J., Woessner J.P.,
RA   Wendl M.C., Yang S.-P., Schultz B.R., Wallis J.W., Spieth J.,
RA   Bieri T.A., Nelson J.O., Berkowicz N., Wohldmann P.E., Cook L.L.,
RA   Hickenbotham M.T., Eldred J., Williams D., Bedell J.A., Mardis E.R.,
RA   Clifton S.W., Chissoe S.L., Marra M.A., Raymond C., Haugen E.,
RA   Gillett W., Zhou Y., James R., Phelps K., Iadanoto S., Bubb K.,
RA   Simms E., Levy R., Clendenning J., Kaul R., Kent W.J., Furey T.S.,
RA   Baertsch R.A., Brent M.R., Keibler E., Flicek P., Bork P., Suyama M.,
RA   Bailey J.A., Portnoy M.E., Torrents D., Chinwalla A.T., Gish W.R.,
RA   Eddy S.R., McPherson J.D., Olson M.V., Eichler E.E., Green E.D.,
RA   Waterston R.H., Wilson R.K.;
RT   "The DNA sequence of human chromosome 7.";
RL   Nature 424:157-164(2003).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12690205; DOI=10.1126/science.1083423;
RA   Scherer S.W., Cheung J., MacDonald J.R., Osborne L.R., Nakabayashi K.,
RA   Herbrick J.-A., Carson A.R., Parker-Katiraee L., Skaug J., Khaja R.,
RA   Zhang J., Hudek A.K., Li M., Haddad M., Duggan G.E., Fernandez B.A.,
RA   Kanematsu E., Gentles S., Christopoulos C.C., Choufani S.,
RA   Kwasnicka D., Zheng X.H., Lai Z., Nusskern D.R., Zhang Q., Gu Z.,
RA   Lu F., Zeesman S., Nowaczyk M.J., Teshima I., Chitayat D., Shuman C.,
RA   Weksberg R., Zackai E.H., Grebe T.A., Cox S.R., Kirkpatrick S.J.,
RA   Rahman N., Friedman J.M., Heng H.H.Q., Pelicci P.G., Lo-Coco F.,
RA   Belloni E., Shaffer L.G., Pober B., Morton C.C., Gusella J.F.,
RA   Bruns G.A.P., Korf B.R., Quade B.J., Ligon A.H., Ferguson H.,
RA   Higgins A.W., Leach N.T., Herrick S.R., Lemyre E., Farra C.G.,
RA   Kim H.-G., Summers A.M., Gripp K.W., Roberts W., Szatmari P.,
RA   Winsor E.J.T., Grzeschik K.-H., Teebi A., Minassian B.A., Kere J.,
RA   Armengol L., Pujana M.A., Estivill X., Wilson M.D., Koop B.F.,
RA   Tosi S., Moore G.E., Boright A.P., Zlotorynski E., Kerem B.,
RA   Kroisel P.M., Petek E., Oscier D.G., Mould S.J., Doehner H.,
RA   Doehner K., Rommens J.M., Vincent J.B., Venter J.C., Li P.W.,
RA   Mural R.J., Adams M.D., Tsui L.-C.;
RT   "Human chromosome 7: DNA sequence and biology.";
RL   Science 300:767-772(2003).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Kidney;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [11]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 130-253 (ISOFORMS 2 AND 3).
RA   Kozyrev S.V., Lewen S., Linga-Reddy P.M.V., Alarcon-Riquelme M.E.;
RT   "Structural indel variation in IRF5 is associated with a risk
RT   haplotype and defines the precise IRF5 isoforms expressed in SLE.";
RL   Submitted (SEP-2006) to the EMBL/GenBank/DDBJ databases.
RN   [12]
RP   SUBCELLULAR LOCATION, AND NUCLEAR LOCALIZATION SIGNAL.
RX   PubMed=12138184; DOI=10.1128/MCB.22.16.5721-5740.2002;
RA   Barnes B.J., Kellum M.J., Field A.E., Pitha P.M.;
RT   "Multiple regulatory domains of IRF-5 control activation, cellular
RT   localization, and induction of chemokines that mediate recruitment of
RT   T lymphocytes.";
RL   Mol. Cell. Biol. 22:5721-5740(2002).
RN   [13]
RP   INVOLVEMENT IN SUSCEPTIBILITY TO SLEB10.
RX   PubMed=15657875; DOI=10.1086/428480;
RA   Sigurdsson S., Nordmark G., Goering H.H.H., Lindroos K., Wiman A.-C.,
RA   Sturfelt G., Joensen A., Rantapaeae-Dahlqvist S., Moeller B., Kere J.,
RA   Koskenmies S., Widen E., Eloranta M.-L., Julkunen H.,
RA   Kristjansdottir H., Steinsson K., Alm G., Roennblom L.,
RA   Syvaenen A.-C.;
RT   "Polymorphisms in the tyrosine kinase 2 and interferon regulatory
RT   factor 5 genes are associated with systemic lupus erythematosus.";
RL   Am. J. Hum. Genet. 76:528-537(2005).
RN   [14]
RP   SUBCELLULAR LOCATION, AND NUCLEAR EXPORT SIGNAL.
RX   PubMed=15556946; DOI=10.1074/jbc.M408452200;
RA   Lin R., Yang L., Arguello M., Penafuerte C., Hiscott J.;
RT   "A CRM1-dependent nuclear export pathway is involved in the regulation
RT   of IRF-5 subcellular localization.";
RL   J. Biol. Chem. 280:3088-3095(2005).
RN   [15]
RP   INVOLVEMENT IN SUSCEPTIBILITY TO RHEUMATOID ARTHRITIS.
RX   PubMed=17599733; DOI=10.1002/art.22704;
RA   Sigurdsson S., Padyukov L., Kurreeman F.A., Liljedahl U., Wiman A.C.,
RA   Alfredsson L., Toes R., Ronnelid J., Klareskog L., Huizinga T.W.,
RA   Alm G., Syvanen A.C., Ronnblom L.;
RT   "Association of a haplotype in the promoter region of the interferon
RT   regulatory factor 5 gene with rheumatoid arthritis.";
RL   Arthritis Rheum. 56:2202-2210(2007).
RN   [16]
RP   INVOLVEMENT IN SUSCEPTIBILITY TO IBD14.
RX   PubMed=17881657; DOI=10.1093/hmg/ddm259;
RA   Dideberg V., Kristjansdottir G., Milani L., Libioulle C.,
RA   Sigurdsson S., Louis E., Wiman A.-C., Vermeire S., Rutgeerts P.,
RA   Belaiche J., Franchimont D., Van Gossum A., Bours V., Syvaenen A.-C.;
RT   "An insertion-deletion polymorphism in the interferon regulatory
RT   Factor 5 (IRF5) gene confers risk of inflammatory bowel diseases.";
RL   Hum. Mol. Genet. 16:3008-3016(2007).
RN   [17]
RP   UBIQUITINATION AT LYS-411 AND LYS-412 BY TRAF6.
RX   PubMed=18824541; DOI=10.1128/MCB.00662-08;
RA   Balkhi M.Y., Fitzgerald K.A., Pitha P.M.;
RT   "Functional regulation of MyD88-activated interferon regulatory factor
RT   5 by K63-linked polyubiquitination.";
RL   Mol. Cell. Biol. 28:7296-7308(2008).
RN   [18]
RP   PHOSPHORYLATION AT THR-10; SER-158; SER-293; SER-301; SER-435 AND
RP   SER-446, AND SUBCELLULAR LOCATION.
RX   PubMed=22412986; DOI=10.1371/journal.pone.0033098;
RA   Chang Foreman H.C., Van Scoy S., Cheng T.F., Reich N.C.;
RT   "Activation of interferon regulatory factor 5 by site specific
RT   phosphorylation.";
RL   PLoS ONE 7:E33098-E33098(2012).
RN   [19]
RP   X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) OF 232-477 OF MUTANT ASP-440,
RP   SUBUNIT, AND PHOSPHORYLATION AT SER-435; SER-437; SER-440 AND SER-446.
RX   PubMed=18836453; DOI=10.1038/nsmb.1496;
RA   Chen W., Lam S.S., Srinath H., Jiang Z., Correia J.J., Schiffer C.A.,
RA   Fitzgerald K.A., Lin K., Royer W.E. Jr.;
RT   "Insights into interferon regulatory factor activation from the
RT   crystal structure of dimeric IRF5.";
RL   Nat. Struct. Mol. Biol. 15:1213-1220(2008).
CC   -!- FUNCTION: Transcription factor involved in the induction of
CC       interferons IFNA and INFB and inflammatory cytokines upon virus
CC       infection. Activated by TLR7 or TLR8 signaling.
CC       {ECO:0000269|PubMed:11303025, ECO:0000269|PubMed:15695821}.
CC   -!- SUBUNIT: Homodimer, when phosphorylated.
CC       {ECO:0000269|PubMed:18836453}.
CC   -!- INTERACTION:
CC       Self; NbExp=3; IntAct=EBI-3931258, EBI-3931258;
CC       Q92793:CREBBP; NbExp=3; IntAct=EBI-3931258, EBI-81215;
CC       Q7Z434:MAVS; NbExp=2; IntAct=EBI-3931258, EBI-995373;
CC       Q04206:RELA; NbExp=4; IntAct=EBI-3931258, EBI-73886;
CC       O43765:SGTA; NbExp=3; IntAct=EBI-3931258, EBI-347996;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm. Nucleus. Note=Shuttles between
CC       the nucleus and the cytoplasm.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=6;
CC       Name=1;
CC         IsoId=Q13568-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q13568-2; Sequence=VSP_041375;
CC       Name=3;
CC         IsoId=Q13568-3; Sequence=VSP_043924;
CC       Name=4;
CC         IsoId=Q13568-4; Sequence=VSP_043925;
CC       Name=5;
CC         IsoId=Q13568-5; Sequence=VSP_044822;
CC       Name=6;
CC         IsoId=Q13568-6; Sequence=VSP_053330, VSP_053331;
CC   -!- PTM: Phosphorylation of serine and threonine residues in a C-
CC       terminal autoinhibitory region, stimulates dimerization, transport
CC       into the nucleus, assembly with the coactivator CBP/p300 and
CC       initiation of transcription. {ECO:0000269|PubMed:18836453,
CC       ECO:0000269|PubMed:22412986}.
CC   -!- PTM: 'Lys-63'-linked polyubiquitination by TRAF6 is required for
CC       activation. {ECO:0000269|PubMed:18824541}.
CC   -!- DISEASE: Inflammatory bowel disease 14 (IBD14) [MIM:612245]: A
CC       chronic, relapsing inflammation of the gastrointestinal tract with
CC       a complex etiology. It is subdivided into Crohn disease and
CC       ulcerative colitis phenotypes. Crohn disease may affect any part
CC       of the gastrointestinal tract from the mouth to the anus, but most
CC       frequently it involves the terminal ileum and colon. Bowel
CC       inflammation is transmural and discontinuous; it may contain
CC       granulomas or be associated with intestinal or perianal fistulas.
CC       In contrast, in ulcerative colitis, the inflammation is continuous
CC       and limited to rectal and colonic mucosal layers; fistulas and
CC       granulomas are not observed. Both diseases include extraintestinal
CC       inflammation of the skin, eyes, or joints.
CC       {ECO:0000269|PubMed:17881657}. Note=Disease susceptibility is
CC       associated with variations affecting the gene represented in this
CC       entry.
CC   -!- DISEASE: Systemic lupus erythematosus 10 (SLEB10) [MIM:612251]: A
CC       chronic, relapsing, inflammatory, and often febrile multisystemic
CC       disorder of connective tissue, characterized principally by
CC       involvement of the skin, joints, kidneys and serosal membranes. It
CC       is of unknown etiology, but is thought to represent a failure of
CC       the regulatory mechanisms of the autoimmune system. The disease is
CC       marked by a wide range of system dysfunctions, an elevated
CC       erythrocyte sedimentation rate, and the formation of LE cells in
CC       the blood or bone marrow. {ECO:0000269|PubMed:15657875}.
CC       Note=Disease susceptibility is associated with variations
CC       affecting the gene represented in this entry.
CC   -!- DISEASE: Rheumatoid arthritis (RA) [MIM:180300]: An inflammatory
CC       disease with autoimmune features and a complex genetic component.
CC       It primarily affects the joints and is characterized by
CC       inflammatory changes in the synovial membranes and articular
CC       structures, widespread fibrinoid degeneration of the collagen
CC       fibers in mesenchymal tissues, and by atrophy and rarefaction of
CC       bony structures. {ECO:0000269|PubMed:17599733}. Note=Disease
CC       susceptibility is associated with variations affecting the gene
CC       represented in this entry.
CC   -!- SIMILARITY: Belongs to the IRF family. {ECO:0000255|PROSITE-
CC       ProRule:PRU00840}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AY504947; AAR90326.1; -; mRNA.
DR   EMBL; AY504946; AAR90325.1; -; mRNA.
DR   EMBL; AY693665; AAU12877.1; -; mRNA.
DR   EMBL; AY693666; AAU12878.1; -; mRNA.
DR   EMBL; AY693668; AAU12880.1; -; mRNA.
DR   EMBL; DQ277633; ABB88960.1; -; mRNA.
DR   EMBL; DQ277634; ABB88961.1; -; mRNA.
DR   EMBL; U51127; AAA96056.1; -; mRNA.
DR   EMBL; EF064718; ABK41901.1; -; Genomic_DNA.
DR   EMBL; AC025594; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH236950; EAL24107.1; -; Genomic_DNA.
DR   EMBL; CH236950; EAL24108.1; -; Genomic_DNA.
DR   EMBL; CH471070; EAW83703.1; -; Genomic_DNA.
DR   EMBL; CH471070; EAW83705.1; -; Genomic_DNA.
DR   EMBL; BC004201; AAH04201.1; -; mRNA.
DR   EMBL; BC004139; AAH04139.1; -; mRNA.
DR   EMBL; DQ995495; ABL96293.1; -; Genomic_DNA.
DR   EMBL; DQ995496; ABL96294.1; -; Genomic_DNA.
DR   CCDS; CCDS43645.1; -. [Q13568-2]
DR   CCDS; CCDS56512.1; -. [Q13568-5]
DR   CCDS; CCDS5808.1; -. [Q13568-1]
DR   PIR; G02474; G02474.
DR   RefSeq; NP_001092097.2; NM_001098627.3. [Q13568-1]
DR   RefSeq; NP_001092099.1; NM_001098629.2. [Q13568-2]
DR   RefSeq; NP_001092100.1; NM_001098630.2. [Q13568-1]
DR   RefSeq; NP_001229381.1; NM_001242452.2. [Q13568-5]
DR   RefSeq; NP_001334857.1; NM_001347928.1. [Q13568-2]
DR   RefSeq; NP_116032.1; NM_032643.4. [Q13568-1]
DR   RefSeq; XP_005250374.1; XM_005250317.3. [Q13568-2]
DR   RefSeq; XP_006716037.1; XM_006715974.2. [Q13568-2]
DR   RefSeq; XP_011514460.1; XM_011516158.2. [Q13568-2]
DR   RefSeq; XP_011514461.1; XM_011516159.2. [Q13568-2]
DR   RefSeq; XP_011514462.1; XM_011516160.1. [Q13568-2]
DR   RefSeq; XP_011514463.1; XM_011516161.1. [Q13568-3]
DR   RefSeq; XP_011514464.1; XM_011516162.1. [Q13568-4]
DR   RefSeq; XP_011514465.1; XM_011516163.2. [Q13568-4]
DR   RefSeq; XP_011514466.1; XM_011516164.1. [Q13568-4]
DR   UniGene; Hs.521181; -.
DR   PDB; 3DSH; X-ray; 2.00 A; A=232-477.
DR   PDBsum; 3DSH; -.
DR   ProteinModelPortal; Q13568; -.
DR   SMR; Q13568; -.
DR   BioGrid; 109871; 34.
DR   DIP; DIP-46348N; -.
DR   IntAct; Q13568; 13.
DR   STRING; 9606.ENSP00000349770; -.
DR   iPTMnet; Q13568; -.
DR   PhosphoSitePlus; Q13568; -.
DR   BioMuta; IRF5; -.
DR   DMDM; 20178305; -.
DR   MaxQB; Q13568; -.
DR   PaxDb; Q13568; -.
DR   PeptideAtlas; Q13568; -.
DR   PRIDE; Q13568; -.
DR   DNASU; 3663; -.
DR   Ensembl; ENST00000249375; ENSP00000249375; ENSG00000128604. [Q13568-1]
DR   Ensembl; ENST00000357234; ENSP00000349770; ENSG00000128604. [Q13568-2]
DR   Ensembl; ENST00000402030; ENSP00000385352; ENSG00000128604. [Q13568-1]
DR   Ensembl; ENST00000465603; ENSP00000418534; ENSG00000128604. [Q13568-6]
DR   Ensembl; ENST00000473745; ENSP00000419149; ENSG00000128604. [Q13568-1]
DR   Ensembl; ENST00000477535; ENSP00000419950; ENSG00000128604. [Q13568-5]
DR   Ensembl; ENST00000489702; ENSP00000418037; ENSG00000128604. [Q13568-2]
DR   Ensembl; ENST00000619830; ENSP00000483292; ENSG00000128604. [Q13568-6]
DR   GeneID; 3663; -.
DR   KEGG; hsa:3663; -.
DR   UCSC; uc003vog.4; human. [Q13568-1]
DR   CTD; 3663; -.
DR   DisGeNET; 3663; -.
DR   EuPathDB; HostDB:ENSG00000128604.18; -.
DR   GeneCards; IRF5; -.
DR   HGNC; HGNC:6120; IRF5.
DR   HPA; HPA046700; -.
DR   MalaCards; IRF5; -.
DR   MIM; 180300; phenotype.
DR   MIM; 607218; gene.
DR   MIM; 612245; phenotype.
DR   MIM; 612251; phenotype.
DR   neXtProt; NX_Q13568; -.
DR   OpenTargets; ENSG00000128604; -.
DR   Orphanet; 206; Crohn disease.
DR   Orphanet; 220393; Diffuse cutaneous systemic sclerosis.
DR   Orphanet; 220402; Limited cutaneous systemic sclerosis.
DR   Orphanet; 186; Primary biliary cirrhosis.
DR   Orphanet; 536; Systemic lupus erythematosus.
DR   Orphanet; 771; Ulcerative colitis.
DR   PharmGKB; PA29919; -.
DR   eggNOG; ENOG410IFCV; Eukaryota.
DR   eggNOG; ENOG410XRXT; LUCA.
DR   GeneTree; ENSGT00760000119093; -.
DR   HOGENOM; HOG000037433; -.
DR   HOVERGEN; HBG105715; -.
DR   InParanoid; Q13568; -.
DR   KO; K09446; -.
DR   OMA; MPPQPYK; -.
DR   PhylomeDB; Q13568; -.
DR   TreeFam; TF328512; -.
DR   Reactome; R-HSA-877300; Interferon gamma signaling.
DR   Reactome; R-HSA-909733; Interferon alpha/beta signaling.
DR   SIGNOR; Q13568; -.
DR   EvolutionaryTrace; Q13568; -.
DR   GeneWiki; IRF5; -.
DR   GenomeRNAi; 3663; -.
DR   PRO; PR:Q13568; -.
DR   Proteomes; UP000005640; Chromosome 7.
DR   Bgee; ENSG00000128604; -.
DR   CleanEx; HS_IRF5; -.
DR   ExpressionAtlas; Q13568; baseline and differential.
DR   Genevisible; Q13568; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:BHF-UCL.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0005634; C:nucleus; IDA:BHF-UCL.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0000981; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; ISA:NTNU_SB.
DR   GO; GO:0043565; F:sequence-specific DNA binding; IMP:NTNU_SB.
DR   GO; GO:0044212; F:transcription regulatory region DNA binding; IEA:InterPro.
DR   GO; GO:0001228; F:transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific DNA binding; IC:NTNU_SB.
DR   GO; GO:0051607; P:defense response to virus; IEA:UniProtKB-KW.
DR   GO; GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome.
DR   GO; GO:0043065; P:positive regulation of apoptotic process; IMP:BHF-UCL.
DR   GO; GO:0032727; P:positive regulation of interferon-alpha production; IC:BHF-UCL.
DR   GO; GO:0032728; P:positive regulation of interferon-beta production; IC:BHF-UCL.
DR   GO; GO:0032735; P:positive regulation of interleukin-12 production; IC:BHF-UCL.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IDA:NTNU_SB.
DR   GO; GO:0032495; P:response to muramyl dipeptide; IDA:BHF-UCL.
DR   GO; GO:0032494; P:response to peptidoglycan; IDA:BHF-UCL.
DR   GO; GO:0060337; P:type I interferon signaling pathway; TAS:Reactome.
DR   CDD; cd00103; IRF; 1.
DR   Gene3D; 1.10.10.10; -; 1.
DR   Gene3D; 2.60.200.10; -; 1.
DR   InterPro; IPR019817; Interferon_reg_fac_CS.
DR   InterPro; IPR001346; Interferon_reg_fact_DNA-bd_dom.
DR   InterPro; IPR019471; Interferon_reg_factor-3.
DR   InterPro; IPR029838; IRF5.
DR   InterPro; IPR017855; SMAD-like_dom_sf.
DR   InterPro; IPR008984; SMAD_FHA_dom_sf.
DR   InterPro; IPR036388; WH-like_DNA-bd_sf.
DR   InterPro; IPR036390; WH_DNA-bd_sf.
DR   PANTHER; PTHR11949; PTHR11949; 1.
DR   PANTHER; PTHR11949:SF10; PTHR11949:SF10; 1.
DR   Pfam; PF00605; IRF; 1.
DR   Pfam; PF10401; IRF-3; 1.
DR   PRINTS; PR00267; INTFRNREGFCT.
DR   SMART; SM00348; IRF; 1.
DR   SMART; SM01243; IRF-3; 1.
DR   SUPFAM; SSF46785; SSF46785; 1.
DR   SUPFAM; SSF49879; SSF49879; 1.
DR   PROSITE; PS00601; IRF_1; 1.
DR   PROSITE; PS51507; IRF_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Antiviral defense;
KW   Complete proteome; Cytoplasm; DNA-binding; Immunity; Innate immunity;
KW   Isopeptide bond; Nucleus; Phosphoprotein; Reference proteome;
KW   Systemic lupus erythematosus; Transcription; Transcription regulation;
KW   Ubl conjugation.
FT   CHAIN         1    498       Interferon regulatory factor 5.
FT                                /FTId=PRO_0000154558.
FT   DNA_BIND     14    122       IRF tryptophan pentad repeat.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00840}.
FT   MOTIF        12     18       Nuclear localization signal.
FT                                {ECO:0000269|PubMed:12138184}.
FT   MOTIF       150    160       Nuclear export signal.
FT   COMPBIAS    142    149       Poly-Glu.
FT   MOD_RES      10     10       Phosphothreonine.
FT                                {ECO:0000269|PubMed:22412986}.
FT   MOD_RES     158    158       Phosphoserine; by TBK1.
FT                                {ECO:0000269|PubMed:22412986}.
FT   MOD_RES     293    293       Phosphoserine; by TBK1.
FT                                {ECO:0000269|PubMed:22412986}.
FT   MOD_RES     301    301       Phosphoserine.
FT                                {ECO:0000269|PubMed:22412986}.
FT   MOD_RES     435    435       Phosphoserine.
FT                                {ECO:0000269|PubMed:18836453,
FT                                ECO:0000269|PubMed:22412986}.
FT   MOD_RES     437    437       Phosphoserine.
FT                                {ECO:0000269|PubMed:18836453}.
FT   MOD_RES     440    440       Phosphoserine.
FT                                {ECO:0000269|PubMed:18836453}.
FT   MOD_RES     446    446       Phosphoserine.
FT                                {ECO:0000269|PubMed:18836453,
FT                                ECO:0000269|PubMed:22412986}.
FT   CROSSLNK    411    411       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in ubiquitin).
FT                                {ECO:0000269|PubMed:18824541}.
FT   CROSSLNK    412    412       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in ubiquitin).
FT                                {ECO:0000269|PubMed:18824541}.
FT   VAR_SEQ     120    147       VCSNGPAPTDSQPPEDYSFGAGEEEEEE -> TPSPLRITL
FT                                LVQERRRKKRKSCRGCCQA (in isoform 6).
FT                                {ECO:0000303|PubMed:16642019}.
FT                                /FTId=VSP_053330.
FT   VAR_SEQ     148    498       Missing (in isoform 6).
FT                                {ECO:0000303|PubMed:16642019}.
FT                                /FTId=VSP_053331.
FT   VAR_SEQ     160    160       T -> TDAVQSGPHMTPYSLLK (in isoform 2).
FT                                {ECO:0000303|PubMed:15805103,
FT                                ECO:0000303|Ref.11}.
FT                                /FTId=VSP_041375.
FT   VAR_SEQ     161    247       EDVKWPPTLQPPTLRPPTLQPPTLQPPVVLGPPAPDPSPLA
FT                                PPPGNPAGFRELLSEVLEPGPLPASLPPAGEQLLPDLLISP
FT                                HMLPL -> V (in isoform 5).
FT                                {ECO:0000303|PubMed:15805103}.
FT                                /FTId=VSP_044822.
FT   VAR_SEQ     161    175       EDVKWPPTLQPPTLR -> DAVQSGPHMTPYSLLKEDVKW
FT                                (in isoform 3). {ECO:0000303|Ref.11,
FT                                ECO:0000303|Ref.5}.
FT                                /FTId=VSP_043924.
FT   VAR_SEQ     166    175       Missing (in isoform 4).
FT                                {ECO:0000303|PubMed:11303025,
FT                                ECO:0000303|PubMed:15695821,
FT                                ECO:0000303|PubMed:16642019}.
FT                                /FTId=VSP_043925.
FT   CONFLICT    253    253       K -> KK (in Ref. 3; AAU12880).
FT                                {ECO:0000305}.
FT   HELIX       235    239       {ECO:0000244|PDB:3DSH}.
FT   TURN        242    244       {ECO:0000244|PDB:3DSH}.
FT   STRAND      250    256       {ECO:0000244|PDB:3DSH}.
FT   STRAND      262    266       {ECO:0000244|PDB:3DSH}.
FT   STRAND      272    275       {ECO:0000244|PDB:3DSH}.
FT   HELIX       283    285       {ECO:0000244|PDB:3DSH}.
FT   HELIX       286    289       {ECO:0000244|PDB:3DSH}.
FT   STRAND      294    298       {ECO:0000244|PDB:3DSH}.
FT   HELIX       308    318       {ECO:0000244|PDB:3DSH}.
FT   STRAND      325    330       {ECO:0000244|PDB:3DSH}.
FT   STRAND      333    338       {ECO:0000244|PDB:3DSH}.
FT   STRAND      340    342       {ECO:0000244|PDB:3DSH}.
FT   STRAND      344    348       {ECO:0000244|PDB:3DSH}.
FT   STRAND      367    371       {ECO:0000244|PDB:3DSH}.
FT   HELIX       372    383       {ECO:0000244|PDB:3DSH}.
FT   STRAND      395    401       {ECO:0000244|PDB:3DSH}.
FT   HELIX       409    411       {ECO:0000244|PDB:3DSH}.
FT   STRAND      413    420       {ECO:0000244|PDB:3DSH}.
FT   HELIX       421    431       {ECO:0000244|PDB:3DSH}.
FT   HELIX       450    465       {ECO:0000244|PDB:3DSH}.
SQ   SEQUENCE   498 AA;  56044 MW;  01B2ED95C28384E8 CRC64;
     MNQSIPVAPT PPRRVRLKPW LVAQVNSCQY PGLQWVNGEK KLFCIPWRHA TRHGPSQDGD
     NTIFKAWAKE TGKYTEGVDE ADPAKWKANL RCALNKSRDF RLIYDGPRDM PPQPYKIYEV
     CSNGPAPTDS QPPEDYSFGA GEEEEEEEEL QRMLPSLSLT EDVKWPPTLQ PPTLRPPTLQ
     PPTLQPPVVL GPPAPDPSPL APPPGNPAGF RELLSEVLEP GPLPASLPPA GEQLLPDLLI
     SPHMLPLTDL EIKFQYRGRP PRALTISNPH GCRLFYSQLE ATQEQVELFG PISLEQVRFP
     SPEDIPSDKQ RFYTNQLLDV LDRGLILQLQ GQDLYAIRLC QCKVFWSGPC ASAHDSCPNP
     IQREVKTKLF SLEHFLNELI LFQKGQTNTP PPFEIFFCFG EEWPDRKPRE KKLITVQVVP
     VAARLLLEMF SGELSWSADS IRLQISNPDL KDRMVEQFKE LHHIWQSQQR LQPVAQAPPG
     AGLGVGQGPW PMHPAGMQ
//
ID   A0A024RD80_HUMAN        Unreviewed;       724 AA.
AC   A0A024RD80;
DT   09-JUL-2014, integrated into UniProtKB/TrEMBL.
DT   09-JUL-2014, sequence version 1.
DT   23-MAY-2018, entry version 37.
DE   SubName: Full=Heat shock protein 90kDa alpha (Cytosolic), class B member 1, isoform CRA_a {ECO:0000313|EMBL:EAX04260.1};
GN   Name=HSP90AB1 {ECO:0000313|EMBL:EAX04260.1};
GN   ORFNames=hCG_19001 {ECO:0000313|EMBL:EAX04260.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:EAX04260.1};
RN   [1] {ECO:0000313|EMBL:EAX04260.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAX04260.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; CH471081; EAX04258.1; -; Genomic_DNA.
DR   EMBL; CH471081; EAX04260.1; -; Genomic_DNA.
DR   RefSeq; NP_001258898.1; NM_001271969.1.
DR   RefSeq; NP_001258899.1; NM_001271970.1.
DR   RefSeq; NP_031381.2; NM_007355.3.
DR   UniGene; Hs.509736; -.
DR   SMR; A0A024RD80; -.
DR   PRIDE; A0A024RD80; -.
DR   GeneID; 3326; -.
DR   KEGG; hsa:3326; -.
DR   CTD; 3326; -.
DR   EuPathDB; HostDB:ENSG00000096384.19; -.
DR   eggNOG; KOG0019; Eukaryota.
DR   eggNOG; KOG0020; Eukaryota.
DR   eggNOG; COG0326; LUCA.
DR   KO; K04079; -.
DR   OMA; LRYHSSQ; -.
DR   OrthoDB; EOG091G0270; -.
DR   ChiTaRS; HSP90AB1; human.
DR   GenomeRNAi; 3326; -.
DR   Bgee; ENSG00000096384; -.
DR   ExpressionAtlas; A0A024RD80; baseline and differential.
DR   GO; GO:0016324; C:apical plasma membrane; IEA:Ensembl.
DR   GO; GO:0044295; C:axonal growth cone; IEA:Ensembl.
DR   GO; GO:0016323; C:basolateral plasma membrane; IEA:Ensembl.
DR   GO; GO:0031526; C:brush border membrane; IEA:Ensembl.
DR   GO; GO:0009986; C:cell surface; IEA:Ensembl.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0044294; C:dendritic growth cone; IEA:Ensembl.
DR   GO; GO:0016234; C:inclusion body; IEA:Ensembl.
DR   GO; GO:0005765; C:lysosomal membrane; IEA:Ensembl.
DR   GO; GO:0043025; C:neuronal cell body; IEA:Ensembl.
DR   GO; GO:1990917; C:ooplasm; IEA:Ensembl.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IEA:Ensembl.
DR   GO; GO:1990913; C:sperm head plasma membrane; IEA:Ensembl.
DR   GO; GO:0005524; F:ATP binding; IEA:Ensembl.
DR   GO; GO:0002135; F:CTP binding; IEA:Ensembl.
DR   GO; GO:0032564; F:dATP binding; IEA:Ensembl.
DR   GO; GO:0005525; F:GTP binding; IEA:Ensembl.
DR   GO; GO:0019901; F:protein kinase binding; IEA:Ensembl.
DR   GO; GO:0019887; F:protein kinase regulator activity; IEA:Ensembl.
DR   GO; GO:0017098; F:sulfonylurea receptor binding; IEA:Ensembl.
DR   GO; GO:0048156; F:tau protein binding; IEA:Ensembl.
DR   GO; GO:0051082; F:unfolded protein binding; IEA:InterPro.
DR   GO; GO:0002134; F:UTP binding; IEA:Ensembl.
DR   GO; GO:0048675; P:axon extension; IEA:Ensembl.
DR   GO; GO:0035690; P:cellular response to drug; IEA:Ensembl.
DR   GO; GO:0071353; P:cellular response to interleukin-4; IEA:Ensembl.
DR   GO; GO:0071407; P:cellular response to organic cyclic compound; IEA:Ensembl.
DR   GO; GO:0021955; P:central nervous system neuron axonogenesis; IEA:Ensembl.
DR   GO; GO:0030010; P:establishment of cell polarity; IEA:Ensembl.
DR   GO; GO:1903660; P:negative regulation of complement-dependent cytotoxicity; IEA:Ensembl.
DR   GO; GO:0043524; P:negative regulation of neuron apoptotic process; IEA:Ensembl.
DR   GO; GO:1901799; P:negative regulation of proteasomal protein catabolic process; IEA:Ensembl.
DR   GO; GO:0001890; P:placenta development; IEA:Ensembl.
DR   GO; GO:0045793; P:positive regulation of cell size; IEA:Ensembl.
DR   GO; GO:1904031; P:positive regulation of cyclin-dependent protein kinase activity; IEA:Ensembl.
DR   GO; GO:0033138; P:positive regulation of peptidyl-serine phosphorylation; IEA:Ensembl.
DR   GO; GO:0032092; P:positive regulation of protein binding; IEA:Ensembl.
DR   GO; GO:0033160; P:positive regulation of protein import into nucleus, translocation; IEA:Ensembl.
DR   GO; GO:0051897; P:positive regulation of protein kinase B signaling; IEA:Ensembl.
DR   GO; GO:0071902; P:positive regulation of protein serine/threonine kinase activity; IEA:Ensembl.
DR   GO; GO:0006457; P:protein folding; IEA:InterPro.
DR   GO; GO:0042220; P:response to cocaine; IEA:Ensembl.
DR   GO; GO:0009651; P:response to salt stress; IEA:Ensembl.
DR   CDD; cd00075; HATPase_c; 1.
DR   Gene3D; 1.20.120.790; -; 1.
DR   Gene3D; 3.30.565.10; -; 1.
DR   HAMAP; MF_00505; HSP90; 1.
DR   InterPro; IPR003594; HATPase_C.
DR   InterPro; IPR036890; HATPase_C_sf.
DR   InterPro; IPR019805; Heat_shock_protein_90_CS.
DR   InterPro; IPR037196; HSP90_C.
DR   InterPro; IPR001404; Hsp90_fam.
DR   InterPro; IPR020575; Hsp90_N.
DR   InterPro; IPR020568; Ribosomal_S5_D2-typ_fold.
DR   PANTHER; PTHR11528; PTHR11528; 1.
DR   Pfam; PF02518; HATPase_c; 1.
DR   Pfam; PF00183; HSP90; 1.
DR   PIRSF; PIRSF002583; Hsp90; 1.
DR   PRINTS; PR00775; HEATSHOCK90.
DR   SMART; SM00387; HATPase_c; 1.
DR   SUPFAM; SSF110942; SSF110942; 1.
DR   SUPFAM; SSF54211; SSF54211; 1.
DR   SUPFAM; SSF55874; SSF55874; 1.
DR   PROSITE; PS00298; HSP90; 1.
PE   3: Inferred from homology;
KW   Coiled coil {ECO:0000256|SAM:Coils};
KW   Stress response {ECO:0000313|EMBL:EAX04260.1}.
FT   DOMAIN       35    189       HATPase_c. {ECO:0000259|SMART:SM00387}.
FT   COILED      543    563       {ECO:0000256|SAM:Coils}.
SQ   SEQUENCE   724 AA;  83264 MW;  A93118C214D03810 CRC64;
     MPEEVHHGEE EVETFAFQAE IAQLMSLIIN TFYSNKEIFL RELISNASDA LDKIRYESLT
     DPSKLDSGKE LKIDIIPNPQ ERTLTLVDTG IGMTKADLIN NLGTIAKSGT KAFMEALQAG
     ADISMIGQFG VGFYSAYLVA EKVVVITKHN DDEQYAWESS AGGSFTVRAD HGEPIGRGTK
     VILHLKEDQT EYLEERRVKE VVKKHSQFIG YPITLYLEKE REKEISDDEA EEEKGEKEEE
     DKDDEEKPKI EDVGSDEEDD SGKDKKKKTK KIKEKYIDQE ELNKTKPIWT RNPDDITQEE
     YGEFYKSLTN DWEDHLAVKH FSVEGQLEFR ALLFIPRRAP FDLFENKKKK NNIKLYVRRV
     FIMDSCDELI PEYLNFIRGV VDSEDLPLNI SREMLQQSKI LKVIRKNIVK KCLELFSELA
     EDKENYKKFY EAFSKNLKLG IHEDSTNRRR LSELLRYHTS QSGDEMTSLS EYVSRMKETQ
     KSIYYITGES KEQVANSAFV ERVRKRGFEV VYMTEPIDEY CVQQLKEFDG KSLVSVTKEG
     LELPEDEEEK KKMEESKAKF ENLCKLMKEI LDKKVEKVTI SNRLVSSPCC IVTSTYGWTA
     NMERIMKAQA LRDNSTMGYM MAKKHLEINP DHPIVETLRQ KAEADKNDKA VKDLVVLLFE
     TALLSSGFSL EDPQTHSNRI YRMIKLGLGI DEDEVAAEEP NAAVPDEIPP LEGDEDASRM
     EEVD
//
ID   B4DGL0_HUMAN            Unreviewed;       714 AA.
AC   B4DGL0;
DT   23-SEP-2008, integrated into UniProtKB/TrEMBL.
DT   23-SEP-2008, sequence version 1.
DT   28-MAR-2018, entry version 63.
DE   SubName: Full=cDNA FLJ53619, highly similar to Heat shock protein HSP 90-beta {ECO:0000313|EMBL:BAG57821.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAG57821.1};
RN   [1] {ECO:0000313|EMBL:BAG57821.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Brain {ECO:0000313|EMBL:BAG57821.1};
RA   Wakamatsu A., Yamamoto J., Kimura K., Ishii S., Watanabe K.,
RA   Sugiyama A., Murakawa K., Kaida T., Tsuchiya K., Fukuzumi Y.,
RA   Kumagai A., Oishi Y., Yamamoto S., Ono Y., Komori Y., Yamazaki M.,
RA   Kisu Y., Nishikawa T., Sugano S., Nomura N., Isogai T.;
RT   "NEDO human cDNA sequencing project focused on splicing variants.";
RL   Submitted (OCT-2007) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK294643; BAG57821.1; -; mRNA.
DR   RefSeq; NP_001258901.1; NM_001271972.1.
DR   UniGene; Hs.509736; -.
DR   ProteinModelPortal; B4DGL0; -.
DR   PeptideAtlas; B4DGL0; -.
DR   PRIDE; B4DGL0; -.
DR   GeneID; 3326; -.
DR   CTD; 3326; -.
DR   eggNOG; KOG0019; Eukaryota.
DR   eggNOG; KOG0020; Eukaryota.
DR   eggNOG; COG0326; LUCA.
DR   HOVERGEN; HBG007374; -.
DR   GenomeRNAi; 3326; -.
DR   GO; GO:0005524; F:ATP binding; IEA:InterPro.
DR   GO; GO:0051082; F:unfolded protein binding; IEA:InterPro.
DR   GO; GO:0006457; P:protein folding; IEA:InterPro.
DR   GO; GO:0006950; P:response to stress; IEA:InterPro.
DR   CDD; cd00075; HATPase_c; 1.
DR   Gene3D; 1.20.120.790; -; 1.
DR   Gene3D; 3.30.565.10; -; 1.
DR   HAMAP; MF_00505; HSP90; 1.
DR   InterPro; IPR003594; HATPase_C.
DR   InterPro; IPR036890; HATPase_C_sf.
DR   InterPro; IPR019805; Heat_shock_protein_90_CS.
DR   InterPro; IPR037196; HSP90_C.
DR   InterPro; IPR001404; Hsp90_fam.
DR   InterPro; IPR020575; Hsp90_N.
DR   InterPro; IPR020568; Ribosomal_S5_D2-typ_fold.
DR   PANTHER; PTHR11528; PTHR11528; 1.
DR   Pfam; PF02518; HATPase_c; 1.
DR   Pfam; PF00183; HSP90; 1.
DR   PIRSF; PIRSF002583; Hsp90; 1.
DR   PRINTS; PR00775; HEATSHOCK90.
DR   SMART; SM00387; HATPase_c; 1.
DR   SUPFAM; SSF110942; SSF110942; 1.
DR   SUPFAM; SSF54211; SSF54211; 1.
DR   SUPFAM; SSF55874; SSF55874; 1.
DR   PROSITE; PS00298; HSP90; 1.
PE   2: Evidence at transcript level;
KW   Coiled coil {ECO:0000256|SAM:Coils};
KW   Stress response {ECO:0000313|EMBL:BAG57821.1}.
FT   DOMAIN       35    179       HATPase_c. {ECO:0000259|SMART:SM00387}.
FT   COILED      533    553       {ECO:0000256|SAM:Coils}.
SQ   SEQUENCE   714 AA;  82170 MW;  1C7927E5F1D9509F CRC64;
     MPEEVHHGEE EVETFAFQAE IAQLMSLIIN TFYSNKEIFL RELISNASDA LDKIRCESLT
     DPSKLDSGKE LKIDIIPNPQ ERTLTLVDTG IGMTKADLIN NLGTIAKSGT KAFMEALQAG
     VGFYSAYLVA EKVVVITKHN DDEQYAWESS AGGSFTVRAD HGDPIGRGTK VILHLKEDQT
     EYLEERRVKE VVKKHSQFIG YPITLYLEKE REKEISDDEA EEEKGEKEEE DKDDEEKPKI
     EDVGSDEEDD SGKDKKKKTK KIKEKYIDQE ELNKTKPIWT RNPDDITQEE YGEFYKSLTN
     DWEDHLAVKH FSVEGQLEFR ALLFIPRRAP FDLFENKKKK NNIKLYVRRV FIMDSCDELI
     PEYLNFIRGV VDSEDLPLNI SREMLQQSKI LKVIRKNIVK KCLELFSELA EDKENYKKFY
     EAFSKNLKLG IHEDSTNRRR LSELLRYHTS QSGDEMTSLS EYVSRMKETQ KSIYYITGES
     KEQVANSAFV ERVRKRGFEV VYMTEPIDEY CVQQLKEFDG KSLVSVTKEG LELPEDEEEK
     KKMEESKAKF ENLCKLMKEI LDKKVEKVTI SNRLVSSPCC IVTSTYGWTA NMERIMKAQA
     LRDNSTMGYM MAKKHLEINP DHPIVETLRQ KAEADKNDKA VKDLVVLLFE TALLSSGFSL
     EDPQTHSNRI YRMIKLGLGI DEDEVAAEEP NAAVPDEIPP LEGDEDASRM EEVD
//
ID   HS90B_HUMAN             Reviewed;         724 AA.
AC   P08238; B2R5P0; Q5T9W7; Q9NQW0; Q9NTK6;
DT   01-AUG-1988, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 4.
DT   23-MAY-2018, entry version 231.
DE   RecName: Full=Heat shock protein HSP 90-beta;
DE            Short=HSP 90;
DE   AltName: Full=Heat shock 84 kDa;
DE            Short=HSP 84;
DE            Short=HSP84;
GN   Name=HSP90AB1; Synonyms=HSP90B, HSPC2, HSPCB;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=3301534; DOI=10.1016/0378-1119(87)90012-6;
RA   Rebbe N.F., Ware J., Bertina R.M., Modrich P., Stafford D.W.;
RT   "Nucleotide sequence of a cDNA for a member of the human 90-kDa heat-
RT   shock protein family.";
RL   Gene 53:235-245(1987).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=2768249;
RA   Rebbe N.F., Hickman W.S., Ley T.J., Stafford D.W., Hickman S.;
RT   "Nucleotide sequence and regulation of a human 90-kDa heat shock
RT   protein gene.";
RL   J. Biol. Chem. 264:15006-15011(1989).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=2469626; DOI=10.1016/0378-1119(88)90182-5;
RA   Hoffmann T., Hovemann B.;
RT   "Heat-shock proteins, Hsp84 and Hsp86, of mice and men: two related
RT   genes encode formerly identified tumour-specific transplantation
RT   antigens.";
RL   Gene 74:491-501(1988).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Testis;
RA   Lu L., Huang X.Y., Yin L.L., Xu M., Li J.M., Zhou Z.M., Sha J.H.;
RT   "Cloning a new isoform of heat shock 90kDa in testis.";
RL   Submitted (AUG-2003) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Amygdala;
RX   PubMed=11230166; DOI=10.1101/gr.GR1547R;
RA   Wiemann S., Weil B., Wellenreuther R., Gassenhuber J., Glassl S.,
RA   Ansorge W., Boecher M., Bloecker H., Bauersachs S., Blum H.,
RA   Lauber J., Duesterhoeft A., Beyer A., Koehrer K., Strack N.,
RA   Mewes H.-W., Ottenwaelder B., Obermaier B., Tampe J., Heubner D.,
RA   Wambutt R., Korn B., Klein M., Poustka A.;
RT   "Towards a catalog of human genes and proteins: sequencing and
RT   analysis of 500 novel complete protein coding human cDNAs.";
RL   Genome Res. 11:422-435(2001).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RG   NHLBI resequencing and genotyping service (RS&G);
RL   Submitted (DEC-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E.,
RA   Gilbert J.G.R., Clamp M.E., Bethel G., Milne S., Ainscough R.,
RA   Almeida J.P., Ambrose K.D., Andrews T.D., Ashwell R.I.S.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Banerjee R., Barker D.J.,
RA   Barlow K.F., Bates K., Beare D.M., Beasley H., Beasley O., Bird C.P.,
RA   Blakey S.E., Bray-Allen S., Brook J., Brown A.J., Brown J.Y.,
RA   Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E.,
RA   Ellington A.E., Evans K.A., Faulkner L., Francis M.D., Frankish A.,
RA   Frankland J., French L., Garner P., Garnett J., Ghori M.J.,
RA   Gilby L.M., Gillson C.J., Glithero R.J., Grafham D.V., Grant M.,
RA   Gribble S., Griffiths C., Griffiths M.N.D., Hall R., Halls K.S.,
RA   Hammond S., Harley J.L., Hart E.A., Heath P.D., Heathcott R.,
RA   Holmes S.J., Howden P.J., Howe K.L., Howell G.R., Huckle E.,
RA   Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M., Joy A.A.,
RA   Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R., Lloyd D.M.,
RA   Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K.,
RA   McMurray A., Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T.,
RA   Novik K.L., Oliver K., Overton-Larty E.K., Parker A., Patel R.,
RA   Pearce A.V., Peck A.I., Phillimore B.J.C.T., Phillips S., Plumb R.W.,
RA   Porter K.M., Ramsey Y., Ranby S.A., Rice C.M., Ross M.T., Searle S.M.,
RA   Sehra H.K., Sheridan E., Skuce C.D., Smith S., Smith M., Spraggon L.,
RA   Squares S.L., Steward C.A., Sycamore N., Tamlyn-Hall G., Tester J.,
RA   Theaker A.J., Thomas D.W., Thorpe A., Tracey A., Tromans A., Tubby B.,
RA   Wall M., Wallis J.M., West A.P., White S.S., Whitehead S.L.,
RA   Whittaker H., Wild A., Willey D.J., Wilmer T.E., Wood J.M., Wray P.W.,
RA   Wyatt J.C., Young L., Younger R.M., Bentley D.R., Coulson A.,
RA   Durbin R.M., Hubbard T., Sulston J.E., Dunham I., Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Colon, Lymph, Muscle, Skin, and Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [11]
RP   PROTEIN SEQUENCE OF 2-21, AND PHOSPHORYLATION.
RX   PubMed=2492519;
RA   Lees-Miller S.P., Anderson C.W.;
RT   "Two human 90-kDa heat shock proteins are phosphorylated in vivo at
RT   conserved serines that are phosphorylated in vitro by casein kinase
RT   II.";
RL   J. Biol. Chem. 264:2431-2437(1989).
RN   [12]
RP   PROTEIN SEQUENCE OF 42-107; 149-168; 181-197; 204-221; 250-265;
RP   274-284; 292-348; 360-392; 412-427; 439-448; 450-475; 482-502;
RP   506-526; 539-551; 584-604; 613-639 AND 653-679, PHOSPHORYLATION AT
RP   SER-255, AND IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Embryonic kidney;
RA   Bienvenut W.V., Waridel P., Quadroni M.;
RL   Submitted (MAR-2009) to UniProtKB.
RN   [13]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 50-118.
RX   PubMed=8180474; DOI=10.1007/BF00292342;
RA   Takahashi I., Tanuma R., Hirata M., Hashimoto K.;
RT   "A cosmid clone at the D6S182 locus on human chromosome 6p12 contains
RT   the 90-kDa heat shock protein beta gene (HSP90 beta).";
RL   Mamm. Genome 5:121-122(1994).
RN   [14]
RP   SEQUENCE REVISION.
RA   Takahashi I., Tanuma R., Hirata M., Hashimoto K.;
RL   Submitted (JUL-2011) to the EMBL/GenBank/DDBJ databases.
RN   [15]
RP   PROTEIN SEQUENCE OF 54-64 AND 187-199.
RC   TISSUE=Colon carcinoma;
RX   PubMed=9150948; DOI=10.1002/elps.1150180344;
RA   Ji H., Reid G.E., Moritz R.L., Eddes J.S., Burgess A.W., Simpson R.J.;
RT   "A two-dimensional gel database of human colon carcinoma proteins.";
RL   Electrophoresis 18:605-613(1997).
RN   [16]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 93-724.
RC   TISSUE=Pancreas;
RA   Mason A., O'Connor D., Greenhalf W.;
RT   "Novel sequence for human Hsp90 beta giving a substitution of R55T
RT   (R147 in original sequence) and M85R (M177 in original sequence).";
RL   Submitted (JUN-2000) to the EMBL/GenBank/DDBJ databases.
RN   [17]
RP   HOMODIMERIZATION.
RX   PubMed=7588731; DOI=10.1111/j.1432-1033.1995.001_1.x;
RA   Nemoto T., Ohara-Nemoto Y., Ota M., Takagi T., Yokoyama K.;
RT   "Mechanism of dimer formation of the 90-kDa heat-shock protein.";
RL   Eur. J. Biochem. 233:1-8(1995).
RN   [18]
RP   SUBCELLULAR LOCATION, AND INTERACTION WITH CDK6 AND CDC37.
RX   PubMed=9482106; DOI=10.1038/sj.onc.1201570;
RA   Mahony D., Parry D.A., Lees E.;
RT   "Active cdk6 complexes are predominantly nuclear and represent only a
RT   minority of the cdk6 in T cells.";
RL   Oncogene 16:603-611(1998).
RN   [19]
RP   PHOSPHORYLATION AT SER-226 AND SER-255, MUTAGENESIS OF SER-226 AND
RP   SER-255, AND INTERACTION WITH AHR.
RX   PubMed=15581363; DOI=10.1021/bi048736m;
RA   Ogiso H., Kagi N., Matsumoto E., Nishimoto M., Arai R., Shirouzu M.,
RA   Mimura J., Fujii-Kuriyama Y., Yokoyama S.;
RT   "Phosphorylation analysis of 90 kDa heat shock protein within the
RT   cytosolic arylhydrocarbon receptor complex.";
RL   Biochemistry 43:15510-15519(2004).
RN   [20]
RP   INTERACTION WITH TP53, AND REGION.
RX   PubMed=15358771; DOI=10.1074/jbc.M407687200;
RA   Mueller L., Schaupp A., Walerych D., Wegele H., Buchner J.;
RT   "Hsp90 regulates the activity of wild type p53 under physiological and
RT   elevated temperatures.";
RL   J. Biol. Chem. 279:48846-48854(2004).
RN   [21]
RP   ISGYLATION.
RX   PubMed=16139798; DOI=10.1016/j.bbrc.2005.08.132;
RA   Giannakopoulos N.V., Luo J.K., Papov V., Zou W., Lenschow D.J.,
RA   Jacobs B.S., Borden E.C., Li J., Virgin H.W., Zhang D.E.;
RT   "Proteomic identification of proteins conjugated to ISG15 in mouse and
RT   human cells.";
RL   Biochem. Biophys. Res. Commun. 336:496-506(2005).
RN   [22]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=15592455; DOI=10.1038/nbt1046;
RA   Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H.,
RA   Zha X.-M., Polakiewicz R.D., Comb M.J.;
RT   "Immunoaffinity profiling of tyrosine phosphorylation in cancer
RT   cells.";
RL   Nat. Biotechnol. 23:94-101(2005).
RN   [23]
RP   INTERACTION WITH SGTA, AND SUBCELLULAR LOCATION.
RX   PubMed=16580629; DOI=10.1016/j.bbrc.2006.03.090;
RA   Yin H., Wang H., Zong H., Chen X., Wang Y., Yun X., Wu Y., Wang J.,
RA   Gu J.;
RT   "SGT, a Hsp90beta binding partner, is accumulated in the nucleus
RT   during cell apoptosis.";
RL   Biochem. Biophys. Res. Commun. 343:1153-1158(2006).
RN   [24]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-255, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [25]
RP   SUBCELLULAR LOCATION [LARGE SCALE ANALYSIS].
RC   TISSUE=Melanoma;
RX   PubMed=17081065; DOI=10.1021/pr060363j;
RA   Chi A., Valencia J.C., Hu Z.-Z., Watabe H., Yamaguchi H.,
RA   Mangini N.J., Huang H., Canfield V.A., Cheng K.C., Yang F., Abe R.,
RA   Yamagishi S., Shabanowitz J., Hearing V.J., Wu C., Appella E.,
RA   Hunt D.F.;
RT   "Proteomic and bioinformatic characterization of the biogenesis and
RT   function of melanosomes.";
RL   J. Proteome Res. 5:3135-3144(2006).
RN   [26]
RP   FUNCTION, AND INTERACTION WITH UNC45A.
RX   PubMed=16478993; DOI=10.1128/MCB.26.5.1722-1730.2006;
RA   Chadli A., Graham J.D., Abel M.G., Jackson T.A., Gordon D.F.,
RA   Wood W.M., Felts S.J., Horwitz K.B., Toft D.;
RT   "GCUNC-45 is a novel regulator for the progesterone receptor/hsp90
RT   chaperoning pathway.";
RL   Mol. Cell. Biol. 26:1722-1730(2006).
RN   [27]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-297, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Embryonic kidney;
RX   PubMed=17525332; DOI=10.1126/science.1140321;
RA   Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,
RA   Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,
RA   Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.;
RT   "ATM and ATR substrate analysis reveals extensive protein networks
RT   responsive to DNA damage.";
RL   Science 316:1160-1166(2007).
RN   [28]
RP   UBIQUITINATION.
RX   PubMed=18042044; DOI=10.1042/BJ20071338;
RA   Windheim M., Peggie M., Cohen P.;
RT   "Two different classes of E2 ubiquitin-conjugating enzymes are
RT   required for the mono-ubiquitination of proteins and elongation by
RT   polyubiquitin chains with a specific topology.";
RL   Biochem. J. 409:723-729(2008).
RN   [29]
RP   INTERACTION WITH DNAJC7.
RX   PubMed=18620420; DOI=10.1021/bi800770g;
RA   Moffatt N.S., Bruinsma E., Uhl C., Obermann W.M., Toft D.;
RT   "Role of the cochaperone Tpr2 in Hsp90 chaperoning.";
RL   Biochemistry 47:8203-8213(2008).
RN   [30]
RP   IDENTIFICATION BY MASS SPECTROMETRY, INTERACTION WITH BIRC2,
RP   SUBCELLULAR LOCATION, AND FUNCTION.
RX   PubMed=18239673; DOI=10.1038/cdd.2008.5;
RA   Didelot C., Lanneau D., Brunet M., Bouchot A., Cartier J., Jacquel A.,
RA   Ducoroy P., Cathelin S., Decologne N., Chiosis G., Dubrez-Daloz L.,
RA   Solary E., Garrido C.;
RT   "Interaction of heat-shock protein 90 beta isoform (HSP90 beta) with
RT   cellular inhibitor of apoptosis 1 (c-IAP1) is required for cell
RT   differentiation.";
RL   Cell Death Differ. 15:859-866(2008).
RN   [31]
RP   SUBUNIT, ENZYME REGULATION, AND BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=18400751; DOI=10.1074/jbc.M800540200;
RA   Richter K., Soroka J., Skalniak L., Leskovar A., Hessling M.,
RA   Reinstein J., Buchner J.;
RT   "Conserved conformational changes in the ATPase cycle of human
RT   Hsp90.";
RL   J. Biol. Chem. 283:17757-17765(2008).
RN   [32]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-226, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Platelet;
RX   PubMed=18088087; DOI=10.1021/pr0704130;
RA   Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J.,
RA   Schuetz C., Walter U., Gambaryan S., Sickmann A.;
RT   "Phosphoproteome of resting human platelets.";
RL   J. Proteome Res. 7:526-534(2008).
RN   [33]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-307, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [34]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-226, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=18318008; DOI=10.1002/pmic.200700884;
RA   Han G., Ye M., Zhou H., Jiang X., Feng S., Jiang X., Tian R., Wan D.,
RA   Zou H., Gu J.;
RT   "Large-scale phosphoproteome analysis of human liver tissue by
RT   enrichment and fractionation of phosphopeptides with strong anion
RT   exchange chromatography.";
RL   Proteomics 8:1346-1361(2008).
RN   [35]
RP   FUNCTION, S-NITROSYLATION AT CYS-590, AND MUTAGENESIS OF CYS-590.
RX   PubMed=19696785; DOI=10.1038/embor.2009.153;
RA   Retzlaff M., Stahl M., Eberl H.C., Lagleder S., Beck J., Kessler H.,
RA   Buchner J.;
RT   "Hsp90 is regulated by a switch point in the C-terminal domain.";
RL   EMBO Rep. 10:1147-1153(2009).
RN   [36]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-435 AND LYS-481, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [37]
RP   INTERACTION WITH TGFB1 PROCESSED FORM (LAP), AND SUBCELLULAR LOCATION.
RX   PubMed=20599762; DOI=10.1016/j.bbrc.2010.06.112;
RA   Suzuki S., Kulkarni A.B.;
RT   "Extracellular heat shock protein HSP90beta secreted by MG63
RT   osteosarcoma cells inhibits activation of latent TGF-beta1.";
RL   Biochem. Biophys. Res. Commun. 398:525-531(2010).
RN   [38]
RP   INTERACTION WITH HSP90AA1; JAK2 AND PRKCE, INDUCTION, AND FUNCTION.
RX   PubMed=20353823; DOI=10.1016/j.cellsig.2010.03.012;
RA   Cheng M.B., Zhang Y., Zhong X., Sutter B., Cao C.Y., Chen X.S.,
RA   Cheng X.K., Zhang Y., Xiao L., Shen Y.F.;
RT   "Stat1 mediates an auto-regulation of hsp90beta gene in heat shock
RT   response.";
RL   Cell. Signal. 22:1206-1213(2010).
RN   [39]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-226, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [40]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [41]
RP   MALONYLATION AT LYS-399.
RX   PubMed=21908771; DOI=10.1074/mcp.M111.012658;
RA   Peng C., Lu Z., Xie Z., Cheng Z., Chen Y., Tan M., Luo H., Zhang Y.,
RA   He W., Yang K., Zwaans B.M., Tishkoff D., Ho L., Lombard D., He T.C.,
RA   Dai J., Verdin E., Ye Y., Zhao Y.;
RT   "The first identification of lysine malonylation substrates and its
RT   regulatory enzyme.";
RL   Mol. Cell. Proteomics 10:M111.012658.01-M111.012658.12(2011).
RN   [42]
RP   INTERACTION WITH AHSA1 AND XPO1.
RX   PubMed=22022502; DOI=10.1371/journal.pone.0026044;
RA   Echeverria P.C., Bernthaler A., Dupuis P., Mayer B., Picard D.;
RT   "An interaction network predicted from public data as a discovery
RT   tool: application to the Hsp90 molecular chaperone machine.";
RL   PLoS ONE 6:E26044-E26044(2011).
RN   [43]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-226, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [44]
RP   PHOSPHORYLATION AT SER-718 BY PLK2 AND PLK3.
RX   PubMed=22828320; DOI=10.1016/j.bbapap.2012.07.003;
RA   Salvi M., Trashi E., Cozza G., Franchin C., Arrigoni G., Pinna L.A.;
RT   "Investigation on PLK2 and PLK3 substrate recognition.";
RL   Biochim. Biophys. Acta 1824:1366-1373(2012).
RN   [45]
RP   INTERACTION WITH CDC25A.
RX   PubMed=22843495; DOI=10.1093/hmg/dds303;
RA   Giessrigl B., Krieger S., Rosner M., Huttary N., Saiko P., Alami M.,
RA   Messaoudi S., Peyrat J.F., Maciuk A., Gollinger M., Kopf S.,
RA   Kazlauskas E., Mazal P., Szekeres T., Hengstschlaeger M., Matulis D.,
RA   Jaeger W., Krupitza G.;
RT   "Hsp90 stabilizes Cdc25A and counteracts heat shock-mediated Cdc25A
RT   degradation and cell-cycle attenuation in pancreatic carcinoma
RT   cells.";
RL   Hum. Mol. Genet. 21:4615-4627(2012).
RN   [46]
RP   PROTEIN CLEAVAGE, AND IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=22848402; DOI=10.1371/journal.pone.0040795;
RA   Beck R., Dejeans N., Glorieux C., Creton M., Delaive E., Dieu M.,
RA   Raes M., Leveque P., Gallez B., Depuydt M., Collet J.F.,
RA   Calderon P.B., Verrax J.;
RT   "Hsp90 is cleaved by reactive oxygen species at a highly conserved N-
RT   terminal amino acid motif.";
RL   PLoS ONE 7:E40795-E40795(2012).
RN   [47]
RP   INTERACTION WITH NOS3, MUTAGENESIS OF TYR-301, AND PHOSPHORYLATION AT
RP   TYR-301 BY SRC.
RX   PubMed=23585225; DOI=10.1152/ajplung.00419.2012;
RA   Barabutis N., Handa V., Dimitropoulou C., Rafikov R., Snead C.,
RA   Kumar S., Joshi A., Thangjam G., Fulton D., Black S.M., Patel V.,
RA   Catravas J.D.;
RT   "LPS induces pp60c-src-mediated tyrosine phosphorylation of Hsp90 in
RT   lung vascular endothelial cells and mouse lung.";
RL   Am. J. Physiol. 304:L883-L893(2013).
RN   [48]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-226; SER-255; THR-297;
RP   SER-445 AND THR-479, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE
RP   SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [49]
RP   INTERACTION WITH MAPK7.
RX   PubMed=23428871; DOI=10.1128/MCB.01246-12;
RA   Erazo T., Moreno A., Ruiz-Babot G., Rodriguez-Asiain A., Morrice N.A.,
RA   Espadamala J., Bayascas J.R., Gomez N., Lizcano J.M.;
RT   "Canonical and kinase activity-independent mechanisms for
RT   extracellular signal-regulated kinase 5 (ERK5) nuclear translocation
RT   require dissociation of Hsp90 from the ERK5-Cdc37 complex.";
RL   Mol. Cell. Biol. 33:1671-1686(2013).
RN   [50]
RP   INTERACTION WITH KCNQ4.
RX   PubMed=23431407; DOI=10.1371/journal.pone.0057282;
RA   Gao Y., Yechikov S., Vazquez A.E., Chen D., Nie L.;
RT   "Distinct roles of molecular chaperones HSP90alpha and HSP90beta in
RT   the biogenesis of KCNQ4 channels.";
RL   PLoS ONE 8:E57282-E57282(2013).
RN   [51]
RP   FUNCTION, AND INTERACTION WITH STUB1 AND SMAD3.
RX   PubMed=24613385; DOI=10.1016/j.bbrc.2014.02.124;
RA   Shang Y., Xu X., Duan X., Guo J., Wang Y., Ren F., He D., Chang Z.;
RT   "Hsp70 and Hsp90 oppositely regulate TGF-beta signaling through
RT   CHIP/Stub1.";
RL   Biochem. Biophys. Res. Commun. 446:387-392(2014).
RN   [52]
RP   METHYLATION AT LYS-531 AND LYS-574 BY SMYD2, IDENTIFICATION BY MASS
RP   SPECTROMETRY, MUTAGENESIS OF LYS-531 AND LYS-574, INTERACTION WITH
RP   STIP1 AND CDC37, AND SUBCELLULAR LOCATION.
RX   PubMed=24880080; DOI=10.1016/j.canlet.2014.05.014;
RA   Hamamoto R., Toyokawa G., Nakakido M., Ueda K., Nakamura Y.;
RT   "SMYD2-dependent HSP90 methylation promotes cancer cell proliferation
RT   by regulating the chaperone complex formation.";
RL   Cancer Lett. 351:126-133(2014).
RN   [53]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-669, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [54]
RP   INTERACTION WITH NWD1.
RX   PubMed=24681825;
RA   Correa R.G., Krajewska M., Ware C.F., Gerlic M., Reed J.C.;
RT   "The NLR-related protein NWD1 is associated with prostate cancer and
RT   modulates androgen receptor signaling.";
RL   Oncotarget 5:1666-1682(2014).
RN   [55]
RP   INTERACTION WITH AHSA1; BIRC2 AND CDC37, AND REGION.
RX   PubMed=25486457; DOI=10.1016/j.bbamcr.2014.11.026;
RA   Synoradzki K., Bieganowski P.;
RT   "Middle domain of human Hsp90 isoforms differentially binds Aha1 in
RT   human cells and alters Hsp90 activity in yeast.";
RL   Biochim. Biophys. Acta 1853:445-452(2015).
RN   [56]
RP   REVIEW.
RX   PubMed=25973397; DOI=10.3389/fonc.2015.00100;
RA   Khurana N., Bhattacharyya S.;
RT   "Hsp90, the concertmaster: tuning transcription.";
RL   Front. Oncol. 5:100-100(2015).
RN   [57]
RP   INTERACTION WITH HSF1; HIF1A; ERBB2; MET; KEAP1 AND RHOBTB2, AND
RP   MUTAGENESIS OF GLU-42 AND ASP-88.
RX   PubMed=26517842; DOI=10.1371/journal.pone.0141786;
RA   Prince T.L., Kijima T., Tatokoro M., Lee S., Tsutsumi S., Yim K.,
RA   Rivas C., Alarcon S., Schwartz H., Khamit-Kush K., Scroggins B.T.,
RA   Beebe K., Trepel J.B., Neckers L.;
RT   "Client proteins and small molecule inhibitors display distinct
RT   binding preferences for constitutive and stress-induced HSP90 isoforms
RT   and their conformationally restricted mutants.";
RL   PLoS ONE 10:E0141786-E0141786(2015).
RN   [58]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [59]
RP   REVIEW.
RX   PubMed=27295069; DOI=10.1016/j.biochi.2016.05.018;
RA   Verma S., Goyal S., Jamal S., Singh A., Grover A.;
RT   "Hsp90: Friends, clients and natural foes.";
RL   Biochimie 127:227-240(2016).
RN   [60]
RP   REVIEW.
RX   PubMed=26991466; DOI=10.1002/bip.22835;
RA   Pearl L.H.;
RT   "Review: The HSP90 molecular chaperone-an enigmatic ATPase.";
RL   Biopolymers 105:594-607(2016).
RN   [61]
RP   X-RAY CRYSTALLOGRAPHY (2.45 ANGSTROMS) OF 1-221 IN COMPLEX WITH PURINE
RP   ANALOG.
RX   PubMed=15217611; DOI=10.1016/j.chembiol.2004.03.033;
RA   Wright L., Barril X., Dymock B., Sheridan L., Surgenor A., Beswick M.,
RA   Drysdale M., Collier A., Massey A., Davies N., Fink A., Fromont C.,
RA   Aherne W., Boxall K., Sharp S., Workman P., Hubbard R.E.;
RT   "Structure-activity relationships in purine-based inhibitor binding to
RT   HSP90 isoforms.";
RL   Chem. Biol. 11:775-785(2004).
RN   [62]
RP   X-RAY CRYSTALLOGRAPHY (3.00 ANGSTROMS) OF 720-724 IN COMPLEX WITH
RP   FKBP4.
RX   PubMed=15159550; DOI=10.1073/pnas.0305969101;
RA   Wu B., Li P., Liu Y., Lou Z., Ding Y., Shu C., Ye S., Bartlam M.,
RA   Shen B., Rao Z.;
RT   "3D structure of human FK506-binding protein 52: implications for the
RT   assembly of the glucocorticoid receptor/Hsp90/immunophilin
RT   heterocomplex.";
RL   Proc. Natl. Acad. Sci. U.S.A. 101:8348-8353(2004).
RN   [63]
RP   X-RAY CRYSTALLOGRAPHY (2.28 ANGSTROMS) OF 284-543.
RG   Structural genomics consortium (SGC);
RT   "Crystal structure of the middle domain of human hsp90-beta.";
RL   Submitted (DEC-2010) to the PDB data bank.
CC   -!- FUNCTION: Molecular chaperone that promotes the maturation,
CC       structural maintenance and proper regulation of specific target
CC       proteins involved for instance in cell cycle control and signal
CC       transduction. Undergoes a functional cycle that is linked to its
CC       ATPase activity. This cycle probably induces conformational
CC       changes in the client proteins, thereby causing their activation.
CC       Interacts dynamically with various co-chaperones that modulate its
CC       substrate recognition, ATPase cycle and chaperone function
CC       (PubMed:16478993, PubMed:19696785). Engages with a range of client
CC       protein classes via its interaction with various co-chaperone
CC       proteins or complexes, that act as adapters, simultaneously able
CC       to interact with the specific client and the central chaperone
CC       itself. Recruitment of ATP and co-chaperone followed by client
CC       protein forms a functional chaperone. After the completion of the
CC       chaperoning process, properly folded client protein and co-
CC       chaperone leave HSP90 in an ADP-bound partially open conformation
CC       and finally, ADP is released from HSP90 which acquires an open
CC       conformation for the next cycle (PubMed:27295069,
CC       PubMed:26991466). Apart from its chaperone activity, it also plays
CC       a role in the regulation of the transcription machinery. HSP90 and
CC       its co-chaperones modulate transcription at least at three
CC       different levels. In the first place, they alter the steady-state
CC       levels of certain transcription factors in response to various
CC       physiological cues. Second, they modulate the activity of certain
CC       epigenetic modifiers, such as histone deacetylases or DNA methyl
CC       transferases, and thereby respond to the change in the
CC       environment. Third, they participate in the eviction of histones
CC       from the promoter region of certain genes and thereby turn on gene
CC       expression (PubMed:25973397). Antagonizes STUB1-mediated
CC       inhibition of TGF-beta signaling via inhibition of STUB1-mediated
CC       SMAD3 ubiquitination and degradation (PubMed:24613385). Promotes
CC       cell differentiation by chaperoning BIRC2 and thereby protecting
CC       from auto-ubiquitination and degradation by the proteasomal
CC       machinery (PubMed:18239673). Main chaperone that is involved in
CC       the phosphorylation/activation of the STAT1 by chaperoning both
CC       JAK2 and PRKCE under heat shock and in turn, activates its own
CC       transcription (PubMed:20353823). {ECO:0000269|PubMed:16478993,
CC       ECO:0000269|PubMed:18239673, ECO:0000269|PubMed:19696785,
CC       ECO:0000269|PubMed:20353823, ECO:0000269|PubMed:24613385,
CC       ECO:0000303|PubMed:25973397, ECO:0000303|PubMed:26991466,
CC       ECO:0000303|PubMed:27295069}.
CC   -!- ENZYME REGULATION: In the resting state, through the dimerization
CC       of its C-terminal domain, HSP90 forms a homodimer which is defined
CC       as the open conformation. Upon ATP-binding, the N-terminal domain
CC       undergoes significant conformational changes and comes in contact
CC       to form an active closed conformation. After HSP90 finishes its
CC       chaperoning tasks of assisting the proper folding, stabilization
CC       and activation of client proteins under the active state, ATP
CC       molecule is hydrolyzed to ADP which then dissociates from HSP90
CC       and directs the protein back to the resting state.
CC       {ECO:0000269|PubMed:18400751}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=300 uM for ATP {ECO:0000269|PubMed:18400751};
CC   -!- SUBUNIT: Monomer (PubMed:24880080). Homodimer (PubMed:7588731,
CC       PubMed:18400751). Forms a complex with CDK6 and CDC37
CC       (PubMed:9482106, PubMed:25486457). Interacts with UNC45A; binding
CC       to UNC45A involves 2 UNC45A monomers per HSP90AB1 dimer
CC       (PubMed:16478993). Interacts with CHORDC1 (By similarity).
CC       Interacts with DNAJC7 (PubMed:18620420). Interacts with FKBP4
CC       (PubMed:15159550). May interact with NWD1 (PubMed:24681825).
CC       Interacts with SGTA (PubMed:16580629). Interacts with HSF1 in an
CC       ATP-dependent manner. Interacts with MET; the interaction
CC       suppresses MET kinase activity. Interacts with ERBB2 in an ATP-
CC       dependent manner; the interaction suppresses ERBB2 kinase
CC       activity. Interacts with HIF1A, KEAP1 and RHOBTB2
CC       (PubMed:26517842). Interacts with STUB1 and SMAD3
CC       (PubMed:24613385). Interacts with XPO1 and AHSA1 (PubMed:22022502,
CC       PubMed:25486457). Interacts with BIRC2 (PubMed:25486457).
CC       Interacts with KCNQ4; promotes cell surface expression of KCNQ4
CC       (PubMed:23431407). Interacts with BIRC2; prevents auto-
CC       ubiquitination and degradation of its client protein BIRC2
CC       (PubMed:18239673). Interacts with NOS3 (PubMed:23585225).
CC       Interacts with AHR; interaction is inhibited by HSP90AB1
CC       phosphorylation on Ser-226 and Ser-255 (PubMed:15581363).
CC       Interacts with STIP1 and CDC37; upon SMYD2-dependent methylation
CC       (PubMed:24880080). Interacts with JAK2 and PRKCE; promotes
CC       functional activation in a heat shock-dependent manner
CC       (PubMed:20353823). Interacts with HSP90AA1; interaction is
CC       constitutive (PubMed:20353823). HSP90AB1-CDC37 chaperone complex
CC       interacts with inactive MAPK7 (via N-terminal half) in resting
CC       cells; the interaction is MAP2K5-independent and prevents from
CC       ubiquitination and proteasomal degradation (PubMed:23428871).
CC       Interacts with CDC25A; prevents heat shock-mediated CDC25A
CC       degradation and contributes to cell cycle progression
CC       (PubMed:22843495). Interacts with TP53 (via DNA binding domain);
CC       suppresses TP53 aggregation and prevents from irreversible thermal
CC       inactivation (PubMed:15358771). Interacts with TGFB1 processed
CC       form (LAP); inhibits latent TGFB1 activation (PubMed:20599762).
CC       Interacts with TRIM8; prevents nucleus translocation of
CC       phosphorylated STAT3 and HSP90AB1 (By similarity).
CC       {ECO:0000250|UniProtKB:P11499, ECO:0000269|PubMed:15159550,
CC       ECO:0000269|PubMed:15358771, ECO:0000269|PubMed:15581363,
CC       ECO:0000269|PubMed:16478993, ECO:0000269|PubMed:16580629,
CC       ECO:0000269|PubMed:18239673, ECO:0000269|PubMed:18400751,
CC       ECO:0000269|PubMed:18620420, ECO:0000269|PubMed:20353823,
CC       ECO:0000269|PubMed:20599762, ECO:0000269|PubMed:22022502,
CC       ECO:0000269|PubMed:22843495, ECO:0000269|PubMed:23428871,
CC       ECO:0000269|PubMed:23431407, ECO:0000269|PubMed:23585225,
CC       ECO:0000269|PubMed:24613385, ECO:0000269|PubMed:24681825,
CC       ECO:0000269|PubMed:24880080, ECO:0000269|PubMed:25486457,
CC       ECO:0000269|PubMed:26517842, ECO:0000269|PubMed:7588731,
CC       ECO:0000269|PubMed:9482106}.
CC   -!- INTERACTION:
CC       Self; NbExp=2; IntAct=EBI-352572, EBI-352572;
CC       P36896:ACVR1B; NbExp=2; IntAct=EBI-352572, EBI-1384128;
CC       Q9UL18:AGO1; NbExp=3; IntAct=EBI-352572, EBI-527363;
CC       O95433:AHSA1; NbExp=3; IntAct=EBI-352572, EBI-448610;
CC       O00170:AIP; NbExp=6; IntAct=EBI-352572, EBI-704197;
CC       P31751:AKT2; NbExp=2; IntAct=EBI-352572, EBI-296058;
CC       Q9UM73:ALK; NbExp=2; IntAct=EBI-352572, EBI-357361;
CC       Q16671:AMHR2; NbExp=2; IntAct=EBI-352572, EBI-6423788;
CC       Q01432:AMPD3; NbExp=2; IntAct=EBI-352572, EBI-1223554;
CC       P10398:ARAF; NbExp=6; IntAct=EBI-352572, EBI-365961;
CC       Q96GD4:AURKB; NbExp=3; IntAct=EBI-352572, EBI-624291;
CC       P15056:BRAF; NbExp=2; IntAct=EBI-352572, EBI-365980;
CC       Q06187:BTK; NbExp=2; IntAct=EBI-352572, EBI-624835;
CC       Q13555:CAMK2G; NbExp=2; IntAct=EBI-352572, EBI-1383465;
CC       Q16543:CDC37; NbExp=11; IntAct=EBI-352572, EBI-295634;
CC       Q7L3B6:CDC37L1; NbExp=5; IntAct=EBI-352572, EBI-2841876;
CC       Q15131:CDK10; NbExp=2; IntAct=EBI-352572, EBI-1646959;
CC       O94921:CDK14; NbExp=2; IntAct=EBI-352572, EBI-1043945;
CC       Q96Q40:CDK15; NbExp=2; IntAct=EBI-352572, EBI-1051975;
CC       P11802:CDK4; NbExp=3; IntAct=EBI-352572, EBI-295644;
CC       Q00534:CDK6; NbExp=2; IntAct=EBI-352572, EBI-295663;
CC       P50750:CDK9; NbExp=2; IntAct=EBI-352572, EBI-1383449;
CC       O14757:CHEK1; NbExp=3; IntAct=EBI-352572, EBI-974488;
CC       Q9UHD1:CHORDC1; NbExp=3; IntAct=EBI-352572, EBI-2550959;
CC       P49674:CSNK1E; NbExp=2; IntAct=EBI-352572, EBI-749343;
CC       Q13618:CUL3; NbExp=2; IntAct=EBI-352572, EBI-456129;
CC       Q16832:DDR2; NbExp=2; IntAct=EBI-352572, EBI-1381484;
CC       P00533:EGFR; NbExp=8; IntAct=EBI-352572, EBI-297353;
CC       P29317:EPHA2; NbExp=2; IntAct=EBI-352572, EBI-702104;
CC       P04626:ERBB2; NbExp=3; IntAct=EBI-352572, EBI-641062;
CC       P21860:ERBB3; NbExp=3; IntAct=EBI-352572, EBI-720706;
CC       Q15303:ERBB4; NbExp=2; IntAct=EBI-352572, EBI-80371;
CC       Q96A26:FAM162A; NbExp=3; IntAct=EBI-352572, EBI-6123466;
CC       Q9UKC9:FBXL2; NbExp=2; IntAct=EBI-352572, EBI-724253;
CC       O75426:FBXO24; NbExp=2; IntAct=EBI-352572, EBI-6425658;
CC       Q9UKT8:FBXW2; NbExp=2; IntAct=EBI-352572, EBI-914727;
CC       P22607:FGFR3; NbExp=2; IntAct=EBI-352572, EBI-348399;
CC       P09769:FGR; NbExp=2; IntAct=EBI-352572, EBI-1383732;
CC       Q02790:FKBP4; NbExp=5; IntAct=EBI-352572, EBI-1047444;
CC       Q13451:FKBP5; NbExp=4; IntAct=EBI-352572, EBI-306914;
CC       P21333:FLNA; NbExp=2; IntAct=EBI-352572, EBI-350432;
CC       P35916:FLT4; NbExp=2; IntAct=EBI-352572, EBI-1005467;
CC       P06241:FYN; NbExp=2; IntAct=EBI-352572, EBI-515315;
CC       P49840:GSK3A; NbExp=2; IntAct=EBI-352572, EBI-1044067;
CC       Q8TF76:HASPIN; NbExp=2; IntAct=EBI-352572, EBI-1237328;
CC       Q9UPZ9:ICK; NbExp=2; IntAct=EBI-352572, EBI-6381479;
CC       O14920:IKBKB; NbExp=2; IntAct=EBI-352572, EBI-81266;
CC       Q14164:IKBKE; NbExp=2; IntAct=EBI-352572, EBI-307369;
CC       Q9Y6K9:IKBKG; NbExp=3; IntAct=EBI-352572, EBI-81279;
CC       Q2WGJ6:KLHL38; NbExp=3; IntAct=EBI-352572, EBI-6426443;
CC       P06239:LCK; NbExp=2; IntAct=EBI-352572, EBI-1348;
CC       P53671:LIMK2; NbExp=2; IntAct=EBI-352572, EBI-1384350;
CC       Q99558:MAP3K14; NbExp=2; IntAct=EBI-352572, EBI-358011;
CC       P41279:MAP3K8; NbExp=2; IntAct=EBI-352572, EBI-354900;
CC       P80192:MAP3K9; NbExp=2; IntAct=EBI-352572, EBI-3951604;
CC       P31152:MAPK4; NbExp=2; IntAct=EBI-352572, EBI-3906061;
CC       P10636-8:MAPT; NbExp=4; IntAct=EBI-352572, EBI-366233;
CC       P42679:MATK; NbExp=2; IntAct=EBI-352572, EBI-751664;
CC       O15146:MUSK; NbExp=2; IntAct=EBI-352572, EBI-6423196;
CC       Q8TD19:NEK9; NbExp=2; IntAct=EBI-352572, EBI-1044009;
CC       P19838:NFKB1; NbExp=3; IntAct=EBI-352572, EBI-300010;
CC       O75469:NR1I2; NbExp=2; IntAct=EBI-352572, EBI-3905991;
CC       Q9P215:POGK; NbExp=2; IntAct=EBI-352572, EBI-2555775;
CC       P53041:PPP5C; NbExp=7; IntAct=EBI-352572, EBI-716663;
CC       Q13131:PRKAA1; NbExp=2; IntAct=EBI-352572, EBI-1181405;
CC       P22694:PRKACB; NbExp=2; IntAct=EBI-352572, EBI-2679622;
CC       Q02156:PRKCE; NbExp=2; IntAct=EBI-352572, EBI-706254;
CC       Q05513:PRKCZ; NbExp=2; IntAct=EBI-352572, EBI-295351;
CC       Q15139:PRKD1; NbExp=2; IntAct=EBI-352572, EBI-1181072;
CC       P51817:PRKX; NbExp=2; IntAct=EBI-352572, EBI-4302903;
CC       P11801:PSKH1; NbExp=2; IntAct=EBI-352572, EBI-3922781;
CC       Q15185:PTGES3; NbExp=4; IntAct=EBI-352572, EBI-1049387;
CC       P04049:RAF1; NbExp=3; IntAct=EBI-352572, EBI-365996;
CC       P49758:RGS6; NbExp=2; IntAct=EBI-352572, EBI-6426927;
CC       Q01974:ROR2; NbExp=2; IntAct=EBI-352572, EBI-6422642;
CC       P62913:RPL11; NbExp=2; IntAct=EBI-352572, EBI-354380;
CC       Q15418:RPS6KA1; NbExp=2; IntAct=EBI-352572, EBI-963034;
CC       P31948:STIP1; NbExp=3; IntAct=EBI-352572, EBI-1054052;
CC       Q15831:STK11; NbExp=3; IntAct=EBI-352572, EBI-306838;
CC       Q15208:STK38; NbExp=2; IntAct=EBI-352572, EBI-458376;
CC       Q9UNE7:STUB1; NbExp=5; IntAct=EBI-352572, EBI-357085;
CC       Q9Y2Z0-2:SUGT1; NbExp=2; IntAct=EBI-352572, EBI-10768076;
CC       Q9UHD2:TBK1; NbExp=2; IntAct=EBI-352572, EBI-356402;
CC       Q96S53:TESK2; NbExp=2; IntAct=EBI-352572, EBI-1384110;
CC       Q9BXA6:TSSK6; NbExp=3; IntAct=EBI-352572, EBI-851883;
CC       P29597:TYK2; NbExp=2; IntAct=EBI-352572, EBI-1383454;
CC       Q8IWX7:UNC45B; NbExp=2; IntAct=EBI-352572, EBI-9363363;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:16580629,
CC       ECO:0000269|PubMed:18239673, ECO:0000269|PubMed:24880080,
CC       ECO:0000269|PubMed:9482106}. Melanosome
CC       {ECO:0000269|PubMed:17081065}. Nucleus
CC       {ECO:0000269|PubMed:18239673}. Secreted
CC       {ECO:0000269|PubMed:20599762}. Cell membrane
CC       {ECO:0000269|PubMed:20599762}. Note=Identified by mass
CC       spectrometry in melanosome fractions from stage I to stage IV
CC       (PubMed:17081065). Translocates with BIRC2 from the nucleus to the
CC       cytoplasm during differentiation (PubMed:18239673). Secreted when
CC       associated with TGFB1 processed form (LAP) (PubMed:20599762).
CC       {ECO:0000269|PubMed:17081065, ECO:0000269|PubMed:18239673,
CC       ECO:0000269|PubMed:20599762}.
CC   -!- INDUCTION: By heat shock. {ECO:0000269|PubMed:20353823}.
CC   -!- DOMAIN: The TPR repeat-binding motif mediates interaction with TPR
CC       repeat-containing proteins. {ECO:0000250|UniProtKB:P07900}.
CC   -!- PTM: Ubiquitinated in the presence of STUB1-UBE2D1 complex (in
CC       vitro). {ECO:0000269|PubMed:18042044}.
CC   -!- PTM: ISGylated. {ECO:0000269|PubMed:16139798}.
CC   -!- PTM: S-nitrosylated; negatively regulates the ATPase activity.
CC       {ECO:0000305|PubMed:19696785}.
CC   -!- PTM: Phosphorylation at Tyr-301 by SRC is induced by
CC       lipopolysaccharide (PubMed:23585225). Phosphorylation at Ser-226
CC       and Ser-255 inhibits AHR interaction (PubMed:15581363).
CC       {ECO:0000269|PubMed:15581363, ECO:0000269|PubMed:23585225}.
CC   -!- PTM: Methylated by SMYD2; facilitates dimerization and chaperone
CC       complex formation; promotes cancer cell proliferation.
CC       {ECO:0000269|PubMed:24880080}.
CC   -!- PTM: Cleaved following oxidative stress resulting in HSP90AB1
CC       protein radicals formation; disrupts the chaperoning function and
CC       the degradation of its client proteins.
CC       {ECO:0000269|PubMed:22848402}.
CC   -!- SIMILARITY: Belongs to the heat shock protein 90 family.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAD14062.3; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=CAB66478.1; Type=Frameshift; Positions=709; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M16660; AAA36025.1; -; mRNA.
DR   EMBL; J04988; AAA36026.1; -; Genomic_DNA.
DR   EMBL; AY359878; AAQ63401.1; -; mRNA.
DR   EMBL; AL136543; CAB66478.1; ALT_FRAME; mRNA.
DR   EMBL; AK312255; BAG35187.1; -; mRNA.
DR   EMBL; DQ314872; ABC40731.1; -; Genomic_DNA.
DR   EMBL; AL139392; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471081; EAX04257.1; -; Genomic_DNA.
DR   EMBL; BC004928; AAH04928.1; -; mRNA.
DR   EMBL; BC009206; AAH09206.2; -; mRNA.
DR   EMBL; BC012807; AAH12807.1; -; mRNA.
DR   EMBL; BC014485; AAH14485.1; -; mRNA.
DR   EMBL; BC016753; AAH16753.1; -; mRNA.
DR   EMBL; BC068474; AAH68474.1; -; mRNA.
DR   EMBL; AH007358; AAD14062.3; ALT_INIT; Genomic_DNA.
DR   EMBL; AF275719; AAF82792.1; -; mRNA.
DR   CCDS; CCDS4909.1; -.
DR   PIR; A29461; HHHU84.
DR   PIR; T46243; T46243.
DR   RefSeq; NP_001258898.1; NM_001271969.1.
DR   RefSeq; NP_001258899.1; NM_001271970.1.
DR   RefSeq; NP_001258900.1; NM_001271971.1.
DR   RefSeq; NP_031381.2; NM_007355.3.
DR   UniGene; Hs.509736; -.
DR   PDB; 1QZ2; X-ray; 3.00 A; G/H=720-724.
DR   PDB; 1UYM; X-ray; 2.45 A; A=2-221.
DR   PDB; 2L6J; NMR; -; B=720-724.
DR   PDB; 3FWV; X-ray; 2.20 A; C/D=719-723.
DR   PDB; 3NMQ; X-ray; 2.20 A; A=1-223.
DR   PDB; 3PRY; X-ray; 2.28 A; A/B/C=284-543.
DR   PDB; 3UQ3; X-ray; 2.60 A; B/C=720-724.
DR   PDB; 5FWK; EM; 3.90 A; A/B=1-724.
DR   PDB; 5FWL; EM; 9.00 A; A/B=1-724.
DR   PDB; 5FWM; EM; 8.00 A; A/B=1-724.
DR   PDB; 5FWP; EM; 7.20 A; A/B=1-724.
DR   PDB; 5UC4; X-ray; 2.05 A; A/B/C/D=1-218.
DR   PDB; 5UCH; X-ray; 2.65 A; A/B/C/D=1-218.
DR   PDB; 5UCI; X-ray; 2.70 A; A/B/C/D=1-218.
DR   PDB; 5UCJ; X-ray; 1.69 A; A/B/C/D=1-218.
DR   PDBsum; 1QZ2; -.
DR   PDBsum; 1UYM; -.
DR   PDBsum; 2L6J; -.
DR   PDBsum; 3FWV; -.
DR   PDBsum; 3NMQ; -.
DR   PDBsum; 3PRY; -.
DR   PDBsum; 3UQ3; -.
DR   PDBsum; 5FWK; -.
DR   PDBsum; 5FWL; -.
DR   PDBsum; 5FWM; -.
DR   PDBsum; 5FWP; -.
DR   PDBsum; 5UC4; -.
DR   PDBsum; 5UCH; -.
DR   PDBsum; 5UCI; -.
DR   PDBsum; 5UCJ; -.
DR   ProteinModelPortal; P08238; -.
DR   SMR; P08238; -.
DR   BioGrid; 109558; 344.
DR   CORUM; P08238; -.
DR   DIP; DIP-413N; -.
DR   IntAct; P08238; 531.
DR   MINT; P08238; -.
DR   STRING; 9606.ENSP00000325875; -.
DR   BindingDB; P08238; -.
DR   ChEMBL; CHEMBL4303; -.
DR   DrugBank; DB05134; CNF1010.
DR   DrugBank; DB02424; Geldanamycin.
DR   DrugBank; DB03758; Radicicol.
DR   DrugBank; DB06070; SNX-5422.
DR   GuidetoPHARMACOLOGY; 2907; -.
DR   CarbonylDB; P08238; -.
DR   iPTMnet; P08238; -.
DR   PhosphoSitePlus; P08238; -.
DR   SwissPalm; P08238; -.
DR   DMDM; 17865718; -.
DR   OGP; P08238; -.
DR   EPD; P08238; -.
DR   MaxQB; P08238; -.
DR   PaxDb; P08238; -.
DR   PeptideAtlas; P08238; -.
DR   PRIDE; P08238; -.
DR   TopDownProteomics; P08238; -.
DR   DNASU; 3326; -.
DR   Ensembl; ENST00000353801; ENSP00000325875; ENSG00000096384.
DR   Ensembl; ENST00000371554; ENSP00000360609; ENSG00000096384.
DR   Ensembl; ENST00000371646; ENSP00000360709; ENSG00000096384.
DR   Ensembl; ENST00000620073; ENSP00000481908; ENSG00000096384.
DR   GeneID; 3326; -.
DR   KEGG; hsa:3326; -.
DR   UCSC; uc003oxa.3; human.
DR   CTD; 3326; -.
DR   DisGeNET; 3326; -.
DR   EuPathDB; HostDB:ENSG00000096384.19; -.
DR   GeneCards; HSP90AB1; -.
DR   H-InvDB; HIX0031498; -.
DR   H-InvDB; HIX0057380; -.
DR   HGNC; HGNC:5258; HSP90AB1.
DR   HPA; CAB005230; -.
DR   HPA; HPA055729; -.
DR   MIM; 140572; gene.
DR   neXtProt; NX_P08238; -.
DR   OpenTargets; ENSG00000096384; -.
DR   PharmGKB; PA29524; -.
DR   eggNOG; KOG0019; Eukaryota.
DR   eggNOG; KOG0020; Eukaryota.
DR   eggNOG; COG0326; LUCA.
DR   GeneTree; ENSGT00910000144050; -.
DR   HOGENOM; HOG000031988; -.
DR   HOVERGEN; HBG007374; -.
DR   InParanoid; P08238; -.
DR   KO; K04079; -.
DR   OMA; LRYHSSQ; -.
DR   OrthoDB; EOG091G0270; -.
DR   PhylomeDB; P08238; -.
DR   TreeFam; TF300686; -.
DR   Reactome; R-HSA-2029482; Regulation of actin dynamics for phagocytic cup formation.
DR   Reactome; R-HSA-3371497; HSP90 chaperone cycle for steroid hormone receptors (SHR).
DR   Reactome; R-HSA-3371511; HSF1 activation.
DR   Reactome; R-HSA-3371568; Attenuation phase.
DR   Reactome; R-HSA-3371571; HSF1-dependent transactivation.
DR   Reactome; R-HSA-399954; Sema3A PAK dependent Axon repulsion.
DR   Reactome; R-HSA-5336415; Uptake and function of diphtheria toxin.
DR   Reactome; R-HSA-6798695; Neutrophil degranulation.
DR   Reactome; R-HSA-844456; The NLRP3 inflammasome.
DR   Reactome; R-HSA-8852276; The role of GTSE1 in G2/M progression after G2 checkpoint.
DR   Reactome; R-HSA-8937144; Aryl hydrocarbon receptor signalling.
DR   Reactome; R-HSA-8939211; ESR-mediated signaling.
DR   Reactome; R-HSA-9018519; Estrogen-dependent gene expression.
DR   SIGNOR; P08238; -.
DR   ChiTaRS; HSP90AB1; human.
DR   EvolutionaryTrace; P08238; -.
DR   GeneWiki; HSP90AB1; -.
DR   GenomeRNAi; 3326; -.
DR   PRO; PR:P08238; -.
DR   Proteomes; UP000005640; Chromosome 6.
DR   Bgee; ENSG00000096384; -.
DR   CleanEx; HS_HSP90AB1; -.
DR   ExpressionAtlas; P08238; baseline and differential.
DR   Genevisible; P08238; HS.
DR   GO; GO:0016324; C:apical plasma membrane; IEA:Ensembl.
DR   GO; GO:0034751; C:aryl hydrocarbon receptor complex; IDA:UniProtKB.
DR   GO; GO:0044295; C:axonal growth cone; ISS:ARUK-UCL.
DR   GO; GO:0016323; C:basolateral plasma membrane; IEA:Ensembl.
DR   GO; GO:0031526; C:brush border membrane; IEA:Ensembl.
DR   GO; GO:0009986; C:cell surface; IEA:Ensembl.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0044294; C:dendritic growth cone; ISS:ARUK-UCL.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0005576; C:extracellular region; IDA:UniProtKB.
DR   GO; GO:1904813; C:ficolin-1-rich granule lumen; TAS:Reactome.
DR   GO; GO:0016234; C:inclusion body; IEA:Ensembl.
DR   GO; GO:0005765; C:lysosomal membrane; IEA:Ensembl.
DR   GO; GO:0042470; C:melanosome; IEA:UniProtKB-SubCell.
DR   GO; GO:0016020; C:membrane; HDA:UniProtKB.
DR   GO; GO:0005739; C:mitochondrion; HDA:UniProtKB.
DR   GO; GO:0043025; C:neuronal cell body; ISS:ARUK-UCL.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:1990917; C:ooplasm; IEA:Ensembl.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; ISS:ARUK-UCL.
DR   GO; GO:0032991; C:protein-containing complex; IDA:UniProtKB.
DR   GO; GO:0034774; C:secretory granule lumen; TAS:Reactome.
DR   GO; GO:1990913; C:sperm head plasma membrane; IEA:Ensembl.
DR   GO; GO:0005524; F:ATP binding; IDA:CAFA.
DR   GO; GO:0043008; F:ATP-dependent protein binding; IPI:CAFA.
DR   GO; GO:0042623; F:ATPase activity, coupled; TAS:Reactome.
DR   GO; GO:0045296; F:cadherin binding; HDA:BHF-UCL.
DR   GO; GO:0002135; F:CTP binding; IEA:Ensembl.
DR   GO; GO:0032564; F:dATP binding; IEA:Ensembl.
DR   GO; GO:0097718; F:disordered domain specific binding; IPI:CAFA.
DR   GO; GO:0070182; F:DNA polymerase binding; IPI:BHF-UCL.
DR   GO; GO:0003725; F:double-stranded RNA binding; IDA:MGI.
DR   GO; GO:0005525; F:GTP binding; IEA:Ensembl.
DR   GO; GO:0031072; F:heat shock protein binding; IPI:UniProtKB.
DR   GO; GO:0042826; F:histone deacetylase binding; IPI:BHF-UCL.
DR   GO; GO:1990226; F:histone methyltransferase binding; IPI:UniProtKB.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0019900; F:kinase binding; IPI:UniProtKB.
DR   GO; GO:0023026; F:MHC class II protein complex binding; HDA:UniProtKB.
DR   GO; GO:0030235; F:nitric-oxide synthase regulator activity; ISS:UniProtKB.
DR   GO; GO:0042277; F:peptide binding; IPI:UniProtKB.
DR   GO; GO:0046983; F:protein dimerization activity; IDA:UniProtKB.
DR   GO; GO:0042803; F:protein homodimerization activity; IDA:CAFA.
DR   GO; GO:0019901; F:protein kinase binding; IEA:Ensembl.
DR   GO; GO:0019887; F:protein kinase regulator activity; IEA:Ensembl.
DR   GO; GO:0003723; F:RNA binding; HDA:UniProtKB.
DR   GO; GO:0017098; F:sulfonylurea receptor binding; IEA:Ensembl.
DR   GO; GO:0048156; F:tau protein binding; IEA:Ensembl.
DR   GO; GO:0030911; F:TPR domain binding; ISS:UniProtKB.
DR   GO; GO:0031625; F:ubiquitin protein ligase binding; IPI:ARUK-UCL.
DR   GO; GO:0051082; F:unfolded protein binding; IEA:InterPro.
DR   GO; GO:0002134; F:UTP binding; IEA:Ensembl.
DR   GO; GO:0048675; P:axon extension; ISS:ARUK-UCL.
DR   GO; GO:0035690; P:cellular response to drug; IEA:Ensembl.
DR   GO; GO:0071353; P:cellular response to interleukin-4; IEA:Ensembl.
DR   GO; GO:0071407; P:cellular response to organic cyclic compound; IEA:Ensembl.
DR   GO; GO:0021955; P:central nervous system neuron axonogenesis; ISS:ARUK-UCL.
DR   GO; GO:0051131; P:chaperone-mediated protein complex assembly; IDA:CAFA.
DR   GO; GO:0030010; P:establishment of cell polarity; ISS:ARUK-UCL.
DR   GO; GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome.
DR   GO; GO:0071157; P:negative regulation of cell cycle arrest; IMP:UniProtKB.
DR   GO; GO:1903660; P:negative regulation of complement-dependent cytotoxicity; IEA:Ensembl.
DR   GO; GO:0043524; P:negative regulation of neuron apoptotic process; IEA:Ensembl.
DR   GO; GO:1901799; P:negative regulation of proteasomal protein catabolic process; ISS:ARUK-UCL.
DR   GO; GO:0032435; P:negative regulation of proteasomal ubiquitin-dependent protein catabolic process; IDA:UniProtKB.
DR   GO; GO:0051248; P:negative regulation of protein metabolic process; ISS:ARUK-UCL.
DR   GO; GO:1901389; P:negative regulation of transforming growth factor beta activation; IDA:UniProtKB.
DR   GO; GO:0043312; P:neutrophil degranulation; TAS:Reactome.
DR   GO; GO:0001890; P:placenta development; IEA:Ensembl.
DR   GO; GO:0045597; P:positive regulation of cell differentiation; IMP:UniProtKB.
DR   GO; GO:0045793; P:positive regulation of cell size; IEA:Ensembl.
DR   GO; GO:1904031; P:positive regulation of cyclin-dependent protein kinase activity; ISS:ARUK-UCL.
DR   GO; GO:0045429; P:positive regulation of nitric oxide biosynthetic process; ISS:UniProtKB.
DR   GO; GO:0033138; P:positive regulation of peptidyl-serine phosphorylation; ISS:ARUK-UCL.
DR   GO; GO:0032516; P:positive regulation of phosphoprotein phosphatase activity; IDA:UniProtKB.
DR   GO; GO:0032092; P:positive regulation of protein binding; IEA:Ensembl.
DR   GO; GO:0033160; P:positive regulation of protein import into nucleus, translocation; IEA:Ensembl.
DR   GO; GO:0051897; P:positive regulation of protein kinase B signaling; ISS:ARUK-UCL.
DR   GO; GO:2000010; P:positive regulation of protein localization to cell surface; IDA:UniProtKB.
DR   GO; GO:0071902; P:positive regulation of protein serine/threonine kinase activity; IEA:Ensembl.
DR   GO; GO:1902949; P:positive regulation of tau-protein kinase activity; IC:ARUK-UCL.
DR   GO; GO:0051973; P:positive regulation of telomerase activity; IDA:BHF-UCL.
DR   GO; GO:0030511; P:positive regulation of transforming growth factor beta receptor signaling pathway; IDA:UniProtKB.
DR   GO; GO:0006457; P:protein folding; IEA:InterPro.
DR   GO; GO:0050821; P:protein stabilization; TAS:Reactome.
DR   GO; GO:1903827; P:regulation of cellular protein localization; ISS:ARUK-UCL.
DR   GO; GO:1900034; P:regulation of cellular response to heat; TAS:Reactome.
DR   GO; GO:0060334; P:regulation of interferon-gamma-mediated signaling pathway; IMP:MGI.
DR   GO; GO:0031396; P:regulation of protein ubiquitination; IDA:BHF-UCL.
DR   GO; GO:0060338; P:regulation of type I interferon-mediated signaling pathway; IMP:MGI.
DR   GO; GO:0042220; P:response to cocaine; IEA:Ensembl.
DR   GO; GO:0009651; P:response to salt stress; IEA:Ensembl.
DR   GO; GO:0006986; P:response to unfolded protein; NAS:UniProtKB.
DR   GO; GO:0097435; P:supramolecular fiber organization; IMP:CACAO.
DR   GO; GO:1905323; P:telomerase holoenzyme complex assembly; IDA:BHF-UCL.
DR   GO; GO:0007004; P:telomere maintenance via telomerase; IDA:BHF-UCL.
DR   GO; GO:0019062; P:virion attachment to host cell; IMP:CACAO.
DR   GO; GO:0006805; P:xenobiotic metabolic process; TAS:Reactome.
DR   CDD; cd00075; HATPase_c; 1.
DR   Gene3D; 1.20.120.790; -; 1.
DR   Gene3D; 3.30.565.10; -; 1.
DR   HAMAP; MF_00505; HSP90; 1.
DR   InterPro; IPR003594; HATPase_C.
DR   InterPro; IPR036890; HATPase_C_sf.
DR   InterPro; IPR019805; Heat_shock_protein_90_CS.
DR   InterPro; IPR037196; HSP90_C.
DR   InterPro; IPR001404; Hsp90_fam.
DR   InterPro; IPR020575; Hsp90_N.
DR   InterPro; IPR020568; Ribosomal_S5_D2-typ_fold.
DR   PANTHER; PTHR11528; PTHR11528; 1.
DR   Pfam; PF02518; HATPase_c; 1.
DR   Pfam; PF00183; HSP90; 1.
DR   PIRSF; PIRSF002583; Hsp90; 1.
DR   PRINTS; PR00775; HEATSHOCK90.
DR   SMART; SM00387; HATPase_c; 1.
DR   SUPFAM; SSF110942; SSF110942; 1.
DR   SUPFAM; SSF54211; SSF54211; 1.
DR   SUPFAM; SSF55874; SSF55874; 1.
DR   PROSITE; PS00298; HSP90; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; ATP-binding; Cell membrane; Chaperone;
KW   Complete proteome; Cytoplasm; Direct protein sequencing; Glycoprotein;
KW   Membrane; Methylation; Nucleotide-binding; Nucleus; Phosphoprotein;
KW   Polymorphism; Reference proteome; S-nitrosylation; Secreted;
KW   Stress response; Ubl conjugation.
FT   INIT_MET      1      1       Removed. {ECO:0000269|PubMed:2492519}.
FT   CHAIN         2    724       Heat shock protein HSP 90-beta.
FT                                /FTId=PRO_0000062917.
FT   REGION        2    527       Interaction with TP53.
FT                                {ECO:0000269|PubMed:15358771}.
FT   REGION        2    214       Interaction with BIRC2.
FT                                {ECO:0000269|PubMed:25486457}.
FT   REGION      215    552       Interaction with AHSA1.
FT                                {ECO:0000269|PubMed:25486457}.
FT   MOTIF       720    724       TPR repeat-binding.
FT   BINDING      46     46       ATP. {ECO:0000250}.
FT   BINDING      88     88       ATP.
FT   BINDING     107    107       ATP. {ECO:0000250}.
FT   BINDING     133    133       ATP; via amide nitrogen. {ECO:0000250}.
FT   BINDING     392    392       ATP. {ECO:0000250}.
FT   SITE        126    127       Cleaved under oxidative stress.
FT                                {ECO:0000269|PubMed:22848402}.
FT   MOD_RES     219    219       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:P11499}.
FT   MOD_RES     226    226       Phosphoserine.
FT                                {ECO:0000244|PubMed:18088087,
FT                                ECO:0000244|PubMed:18318008,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     255    255       Phosphoserine.
FT                                {ECO:0000244|PubMed:17081983,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000269|Ref.12}.
FT   MOD_RES     261    261       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P11499}.
FT   MOD_RES     297    297       Phosphothreonine.
FT                                {ECO:0000244|PubMed:17525332,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     301    301       Phosphotyrosine; by SRC.
FT                                {ECO:0000269|PubMed:23585225}.
FT   MOD_RES     305    305       Phosphotyrosine.
FT                                {ECO:0000250|UniProtKB:P11499}.
FT   MOD_RES     307    307       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   MOD_RES     399    399       N6-malonyllysine.
FT                                {ECO:0000269|PubMed:21908771}.
FT   MOD_RES     435    435       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     445    445       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     479    479       Phosphothreonine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     481    481       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     484    484       Phosphotyrosine.
FT                                {ECO:0000250|UniProtKB:P11499}.
FT   MOD_RES     531    531       N6-methylated lysine; alternate.
FT                                {ECO:0000269|PubMed:24880080}.
FT   MOD_RES     531    531       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P11499}.
FT   MOD_RES     574    574       N6-methylated lysine.
FT                                {ECO:0000269|PubMed:24880080}.
FT   MOD_RES     577    577       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:P11499}.
FT   MOD_RES     590    590       S-nitrosocysteine.
FT                                {ECO:0000305|PubMed:19696785}.
FT   MOD_RES     624    624       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:P11499}.
FT   MOD_RES     669    669       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     718    718       Phosphoserine; by PLK2 and PLK3.
FT                                {ECO:0000269|PubMed:22828320}.
FT   CARBOHYD    434    434       O-linked (GlcNAc) serine. {ECO:0000250}.
FT   CARBOHYD    452    452       O-linked (GlcNAc) serine. {ECO:0000250}.
FT   VARIANT     349    349       K -> E (in dbSNP:rs11538975).
FT                                /FTId=VAR_049624.
FT   MUTAGEN      42     42       E->A: Strong ATP-binding. Strong
FT                                interaction with HSF1, HIF1A, ERBB2, MET,
FT                                KEAP1 and RHOBTB2.
FT                                {ECO:0000269|PubMed:26517842}.
FT   MUTAGEN      88     88       D->A: Impaired ATP-binding. Strong
FT                                interaction with HIF1A, MET, KEAP1 and
FT                                RHOBTB2. Loss of interaction with HSF1
FT                                and ERBB2. {ECO:0000269|PubMed:26517842}.
FT   MUTAGEN     226    226       S->A: Increases the binding affinity for
FT                                AHR; when associated with A-255.
FT                                Increases AHR transcription activity;
FT                                when associated with A-255.
FT                                {ECO:0000269|PubMed:15581363}.
FT   MUTAGEN     226    226       S->E: No effect on the interaction with
FT                                AHR; when associated with E-255.
FT                                {ECO:0000269|PubMed:15581363}.
FT   MUTAGEN     255    255       S->A: Increases the binding affinity for
FT                                AHR; when associated with A-226.
FT                                Increases AHR transcription activity;
FT                                when associated with A-226.
FT                                {ECO:0000269|PubMed:15581363}.
FT   MUTAGEN     255    255       S->E: No effect on the interaction with
FT                                AHR; when associated with E-226.
FT                                {ECO:0000269|PubMed:15581363}.
FT   MUTAGEN     301    301       Y->F: Decreases interaction with NOS3 and
FT                                SRC. impairs resists LPS-induced tyrosine
FT                                phosphorylation. Does not block LPS-
FT                                induced pp60src phosphorylation.
FT                                {ECO:0000269|PubMed:23585225}.
FT   MUTAGEN     531    531       K->A: Highly decreases the signal of
FT                                SMYD2-dependent HSP90AB1 methylation;
FT                                when associated with A-574. Diminishes
FT                                dimerized form; when associated with A-
FT                                574. Reduces interaction with STIP1 or
FT                                CDC37; when associated with A-574.
FT                                {ECO:0000269|PubMed:24880080}.
FT   MUTAGEN     574    574       K->A: Decreases the signal of SMYD2-
FT                                dependent HSP90AB1 methylation. Highly
FT                                decreases the signal of SMYD2-dependent
FT                                HSP90AB1 methylation; when associated
FT                                with A-531. Diminishes dimerized form;
FT                                when associated with A-531. Reduces
FT                                interaction with STIP1 or CDC37; when
FT                                associated with A-531.
FT                                {ECO:0000269|PubMed:24880080}.
FT   MUTAGEN     590    590       C->A,N,D: Reduced ATPase activity and
FT                                client protein activation.
FT                                {ECO:0000269|PubMed:19696785}.
FT   CONFLICT    147    147       T -> R (in Ref. 1; AAA36025).
FT                                {ECO:0000305}.
FT   CONFLICT    177    177       R -> M (in Ref. 1; AAA36025).
FT                                {ECO:0000305}.
FT   CONFLICT    403    403       V -> A (in Ref. 5; CAB66478).
FT                                {ECO:0000305}.
FT   STRAND       11     16       {ECO:0000244|PDB:5UCJ}.
FT   HELIX        19     30       {ECO:0000244|PDB:5UCJ}.
FT   TURN         34     37       {ECO:0000244|PDB:5UCH}.
FT   HELIX        38     60       {ECO:0000244|PDB:5UCJ}.
FT   HELIX        62     65       {ECO:0000244|PDB:5UCJ}.
FT   STRAND       73     78       {ECO:0000244|PDB:5UCJ}.
FT   TURN         79     82       {ECO:0000244|PDB:5UCJ}.
FT   STRAND       83     88       {ECO:0000244|PDB:5UCJ}.
FT   HELIX        95    103       {ECO:0000244|PDB:5UCJ}.
FT   TURN        104    106       {ECO:0000244|PDB:5UCJ}.
FT   HELIX       107    118       {ECO:0000244|PDB:5UCJ}.
FT   HELIX       123    129       {ECO:0000244|PDB:5UCJ}.
FT   HELIX       132    138       {ECO:0000244|PDB:5UCJ}.
FT   STRAND      140    148       {ECO:0000244|PDB:5UCJ}.
FT   STRAND      155    159       {ECO:0000244|PDB:5UCJ}.
FT   STRAND      161    169       {ECO:0000244|PDB:5UCJ}.
FT   STRAND      176    185       {ECO:0000244|PDB:5UCJ}.
FT   HELIX       187    193       {ECO:0000244|PDB:5UCJ}.
FT   HELIX       195    205       {ECO:0000244|PDB:5UCJ}.
FT   STRAND      213    215       {ECO:0000244|PDB:5UCJ}.
FT   HELIX       288    290       {ECO:0000244|PDB:3PRY}.
FT   HELIX       293    295       {ECO:0000244|PDB:3PRY}.
FT   HELIX       298    309       {ECO:0000244|PDB:3PRY}.
FT   STRAND      316    323       {ECO:0000244|PDB:3PRY}.
FT   STRAND      325    327       {ECO:0000244|PDB:3PRY}.
FT   STRAND      329    335       {ECO:0000244|PDB:3PRY}.
FT   STRAND      353    357       {ECO:0000244|PDB:3PRY}.
FT   STRAND      360    364       {ECO:0000244|PDB:3PRY}.
FT   HELIX       367    369       {ECO:0000244|PDB:3PRY}.
FT   HELIX       372    374       {ECO:0000244|PDB:3PRY}.
FT   STRAND      378    386       {ECO:0000244|PDB:3PRY}.
FT   HELIX       395    420       {ECO:0000244|PDB:3PRY}.
FT   HELIX       423    443       {ECO:0000244|PDB:3PRY}.
FT   HELIX       445    447       {ECO:0000244|PDB:3PRY}.
FT   HELIX       448    453       {ECO:0000244|PDB:3PRY}.
FT   STRAND      456    459       {ECO:0000244|PDB:3PRY}.
FT   TURN        460    464       {ECO:0000244|PDB:3PRY}.
FT   HELIX       469    474       {ECO:0000244|PDB:3PRY}.
FT   STRAND      482    486       {ECO:0000244|PDB:3PRY}.
FT   HELIX       491    495       {ECO:0000244|PDB:3PRY}.
FT   HELIX       498    504       {ECO:0000244|PDB:3PRY}.
FT   TURN        505    507       {ECO:0000244|PDB:3PRY}.
FT   STRAND      510    512       {ECO:0000244|PDB:3PRY}.
FT   HELIX       518    525       {ECO:0000244|PDB:3PRY}.
FT   STRAND      531    535       {ECO:0000244|PDB:3PRY}.
SQ   SEQUENCE   724 AA;  83264 MW;  A93118C214D03810 CRC64;
     MPEEVHHGEE EVETFAFQAE IAQLMSLIIN TFYSNKEIFL RELISNASDA LDKIRYESLT
     DPSKLDSGKE LKIDIIPNPQ ERTLTLVDTG IGMTKADLIN NLGTIAKSGT KAFMEALQAG
     ADISMIGQFG VGFYSAYLVA EKVVVITKHN DDEQYAWESS AGGSFTVRAD HGEPIGRGTK
     VILHLKEDQT EYLEERRVKE VVKKHSQFIG YPITLYLEKE REKEISDDEA EEEKGEKEEE
     DKDDEEKPKI EDVGSDEEDD SGKDKKKKTK KIKEKYIDQE ELNKTKPIWT RNPDDITQEE
     YGEFYKSLTN DWEDHLAVKH FSVEGQLEFR ALLFIPRRAP FDLFENKKKK NNIKLYVRRV
     FIMDSCDELI PEYLNFIRGV VDSEDLPLNI SREMLQQSKI LKVIRKNIVK KCLELFSELA
     EDKENYKKFY EAFSKNLKLG IHEDSTNRRR LSELLRYHTS QSGDEMTSLS EYVSRMKETQ
     KSIYYITGES KEQVANSAFV ERVRKRGFEV VYMTEPIDEY CVQQLKEFDG KSLVSVTKEG
     LELPEDEEEK KKMEESKAKF ENLCKLMKEI LDKKVEKVTI SNRLVSSPCC IVTSTYGWTA
     NMERIMKAQA LRDNSTMGYM MAKKHLEINP DHPIVETLRQ KAEADKNDKA VKDLVVLLFE
     TALLSSGFSL EDPQTHSNRI YRMIKLGLGI DEDEVAAEEP NAAVPDEIPP LEGDEDASRM
     EEVD
//
ID   Q6PK50_HUMAN            Unreviewed;       351 AA.
AC   Q6PK50;
DT   05-JUL-2004, integrated into UniProtKB/TrEMBL.
DT   05-JUL-2004, sequence version 1.
DT   28-FEB-2018, entry version 81.
DE   SubName: Full=HSP90AB1 protein {ECO:0000313|EMBL:AAH07327.1};
DE   Flags: Fragment;
GN   Name=HSP90AB1 {ECO:0000313|EMBL:AAH07327.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:AAH07327.1};
RN   [1] {ECO:0000313|EMBL:AAH07327.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Pancreas {ECO:0000313|EMBL:AAH07327.1};
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RA   Gerhard D.S., Wagner L., Feingold E.A., Shenmen C.M., Grouse L.H.,
RA   Schuler G., Klein S.L., Old S., Rasooly R., Good P., Guyer M.,
RA   Peck A.M., Derge J.G., Lipman D., Collins F.S., Jang W., Sherry S.,
RA   Feolo M., Misquitta L., Lee E., Rotmistrovsky K., Greenhut S.F.,
RA   Schaefer C.F., Buetow K., Bonner T.I., Haussler D., Kent J.,
RA   Kiekhaus M., Furey T., Brent M., Prange C., Schreiber K., Shapiro N.,
RA   Bhat N.K., Hopkins R.F., Hsie F., Driscoll T., Soares M.B.,
RA   Casavant T.L., Scheetz T.E., Brown-stein M.J., Usdin T.B.,
RA   Toshiyuki S., Carninci P., Piao Y., Dudekula D.B., Ko M.S.,
RA   Kawakami K., Suzuki Y., Sugano S., Gruber C.E., Smith M.R.,
RA   Simmons B., Moore T., Waterman R., Johnson S.L., Ruan Y., Wei C.L.,
RA   Mathavan S., Gunaratne P.H., Wu J., Garcia A.M., Hulyk S.W., Fuh E.,
RA   Yuan Y., Sneed A., Kowis C., Hodgson A., Muzny D.M., McPherson J.,
RA   Gibbs R.A., Fahey J., Helton E., Ketteman M., Madan A., Rodrigues S.,
RA   Sanchez A., Whiting M., Madari A., Young A.C., Wetherby K.D.,
RA   Granite S.J., Kwong P.N., Brinkley C.P., Pearson R.L., Bouffard G.G.,
RA   Blakesly R.W., Green E.D., Dickson M.C., Rodriguez A.C., Grimwood J.,
RA   Schmutz J., Myers R.M., Butterfield Y.S., Griffith M., Griffith O.L.,
RA   Krzywinski M.I., Liao N., Morin R., Morrin R., Palmquist D.,
RA   Petrescu A.S., Skalska U., Smailus D.E., Stott J.M., Schnerch A.,
RA   Schein J.E., Jones S.J., Holt R.A., Baross A., Marra M.A., Clifton S.,
RA   Makowski K.A., Bosak S., Malek J.;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -!- INTERACTION:
CC       Q7L3B6:CDC37L1; NbExp=2; IntAct=EBI-9356629, EBI-2841876;
CC       P00533:EGFR; NbExp=2; IntAct=EBI-9356629, EBI-297353;
CC       P07900:HSP90AA1; NbExp=2; IntAct=EBI-9356629, EBI-296047;
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; BC007327; AAH07327.1; -; mRNA.
DR   RefSeq; NP_001258901.1; NM_001271972.1.
DR   UniGene; Hs.509736; -.
DR   ProteinModelPortal; Q6PK50; -.
DR   IntAct; Q6PK50; 99.
DR   PeptideAtlas; Q6PK50; -.
DR   PRIDE; Q6PK50; -.
DR   GeneID; 3326; -.
DR   CTD; 3326; -.
DR   eggNOG; KOG0019; Eukaryota.
DR   eggNOG; KOG0020; Eukaryota.
DR   eggNOG; COG0326; LUCA.
DR   HOVERGEN; HBG007374; -.
DR   ChiTaRS; HSP90AB1; human.
DR   GenomeRNAi; 3326; -.
DR   GO; GO:0005524; F:ATP binding; IEA:InterPro.
DR   GO; GO:0051082; F:unfolded protein binding; IEA:InterPro.
DR   GO; GO:0006457; P:protein folding; IEA:InterPro.
DR   GO; GO:0006950; P:response to stress; IEA:InterPro.
DR   CDD; cd00075; HATPase_c; 1.
DR   Gene3D; 3.30.565.10; -; 1.
DR   InterPro; IPR003594; HATPase_C.
DR   InterPro; IPR036890; HATPase_C_sf.
DR   InterPro; IPR019805; Heat_shock_protein_90_CS.
DR   InterPro; IPR001404; Hsp90_fam.
DR   InterPro; IPR020575; Hsp90_N.
DR   InterPro; IPR020568; Ribosomal_S5_D2-typ_fold.
DR   PANTHER; PTHR11528; PTHR11528; 1.
DR   Pfam; PF02518; HATPase_c; 1.
DR   Pfam; PF00183; HSP90; 1.
DR   PRINTS; PR00775; HEATSHOCK90.
DR   SMART; SM00387; HATPase_c; 1.
DR   SUPFAM; SSF54211; SSF54211; 1.
DR   SUPFAM; SSF55874; SSF55874; 1.
DR   PROSITE; PS00298; HSP90; 1.
PE   1: Evidence at protein level;
FT   DOMAIN       35    189       HATPase_c. {ECO:0000259|SMART:SM00387}.
FT   NON_TER     351    351       {ECO:0000313|EMBL:AAH07327.1}.
SQ   SEQUENCE   351 AA;  40295 MW;  5CA7AFC5181A33A5 CRC64;
     MPEEVHHGEE EVETFAFQAE IAQLMSLIIN TFYSNKEIFL RELISNASDA LDKIRYESLT
     DPSKLDSGKE LKIDIIPNPQ ERTLTLVDTG IGMTKADLIN NLGTIAKSGT KAFMEALQAG
     ADISMIGQFG VGFYSAYLVA EKVVVITKHN DDEQYAWESS AGGSFTVRAD HGEPIGRGTK
     VILHLKEDQT EYLEERRVKE VVKKHSQFIG YPITLYLEKE REKEISDDEA EEEKGEKEEE
     DKDDEEKPKI EDVGSDEEDD SGKDKKKKTK KIKEKYIDQE ELNKTKPIWT RNPDDITQEE
     YGEFYKSLTN DWEDHLAVKH FSVEGQLEFR ALLFIPRRAP FDLFEKKKKK K
//
ID   A0A024RAG6_HUMAN        Unreviewed;       245 AA.
AC   A0A024RAG6;
DT   09-JUL-2014, integrated into UniProtKB/TrEMBL.
DT   09-JUL-2014, sequence version 1.
DT   23-MAY-2018, entry version 30.
DE   SubName: Full=Complement component 1, q subcomponent, A chain, isoform CRA_a {ECO:0000313|EMBL:EAW95015.1};
GN   Name=C1QA {ECO:0000313|EMBL:EAW95015.1};
GN   ORFNames=hCG_1981379 {ECO:0000313|EMBL:EAW95015.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:EAW95015.1};
RN   [1] {ECO:0000313|EMBL:EAW95015.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAW95015.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
CC   -!- SUBCELLULAR LOCATION: Secreted {ECO:0000256|SAAS:SAAS00562217}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; CH471134; EAW95015.1; -; Genomic_DNA.
DR   RefSeq; NP_001334394.1; NM_001347465.1.
DR   RefSeq; NP_001334395.1; NM_001347466.1.
DR   RefSeq; NP_057075.1; NM_015991.3.
DR   UniGene; Hs.632379; -.
DR   ProteinModelPortal; A0A024RAG6; -.
DR   SMR; A0A024RAG6; -.
DR   PRIDE; A0A024RAG6; -.
DR   GeneID; 712; -.
DR   KEGG; hsa:712; -.
DR   CTD; 712; -.
DR   EuPathDB; HostDB:ENSG00000173372.16; -.
DR   eggNOG; ENOG410IK45; Eukaryota.
DR   eggNOG; ENOG410YJJD; LUCA.
DR   KO; K03986; -.
DR   OMA; YYYFTFQ; -.
DR   OrthoDB; EOG091G0L3Y; -.
DR   PhylomeDB; A0A024RAG6; -.
DR   ChiTaRS; C1QA; human.
DR   GenomeRNAi; 712; -.
DR   Bgee; ENSG00000173372; -.
DR   ExpressionAtlas; A0A024RAG6; baseline and differential.
DR   GO; GO:0005581; C:collagen trimer; IEA:UniProtKB-KW.
DR   GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR   GO; GO:0006958; P:complement activation, classical pathway; IEA:Ensembl.
DR   GO; GO:0010039; P:response to iron ion; IEA:Ensembl.
DR   Gene3D; 2.60.120.40; -; 1.
DR   InterPro; IPR001073; C1q_dom.
DR   InterPro; IPR008160; Collagen.
DR   InterPro; IPR037572; Complement_C1q_A.
DR   InterPro; IPR008983; Tumour_necrosis_fac-like_dom.
DR   PANTHER; PTHR45066; PTHR45066; 1.
DR   Pfam; PF00386; C1q; 1.
DR   Pfam; PF01391; Collagen; 1.
DR   PRINTS; PR00007; COMPLEMNTC1Q.
DR   SMART; SM00110; C1Q; 1.
DR   SUPFAM; SSF49842; SSF49842; 1.
DR   PROSITE; PS50871; C1Q; 1.
PE   4: Predicted;
KW   Collagen {ECO:0000256|SAAS:SAAS00562261};
KW   Secreted {ECO:0000256|SAAS:SAAS00562230};
KW   Signal {ECO:0000256|SAM:SignalP}.
FT   SIGNAL        1     22       {ECO:0000256|SAM:SignalP}.
FT   CHAIN        23    245       {ECO:0000256|SAM:SignalP}.
FT                                /FTId=PRO_5001533707.
FT   DOMAIN      110    245       C1q. {ECO:0000259|PROSITE:PS50871}.
SQ   SEQUENCE   245 AA;  26017 MW;  8FF6B6AE02D49C4C CRC64;
     MEGPRGWLVL CVLAISLASM VTEDLCRAPD GKKGEAGRPG RRGRPGLKGE QGEPGAPGIR
     TGIQGLKGDQ GEPGPSGNPG KVGYPGPSGP LGARGIPGIK GTKGSPGNIK DQPRPAFSAI
     RRNPPMGGNV VIFDTVITNQ EEPYQNHSGR FVCTVPGYYY FTFQVLSQWE ICLSIVSSSR
     GQVRRSLGFC DTTNKGLFQV VSGGMVLQLQ QGDQVWVEKD PKKGHIYQGS EADSVFSGFL
     IFPSA
//
ID   C1QA_HUMAN              Reviewed;         245 AA.
AC   P02745; B2R4X2; Q5T963;
DT   21-JUL-1986, integrated into UniProtKB/Swiss-Prot.
DT   01-JUL-1993, sequence version 2.
DT   23-MAY-2018, entry version 195.
DE   RecName: Full=Complement C1q subcomponent subunit A;
DE   Flags: Precursor;
GN   Name=C1QA;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   TISSUE=Monocyte;
RX   PubMed=1706597; DOI=10.1042/bj2740481;
RA   Sellar G.C., Blake D.J., Reid K.B.M.;
RT   "Characterization and organization of the genes encoding the A-,
RT   B- and C-chains of human complement subcomponent C1q. The complete
RT   derived amino acid sequence of human C1q.";
RL   Biochem. J. 274:481-490(1991).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RA   Wan T., Zhang W., Cao X.;
RL   Submitted (MAR-1999) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT LYS-23.
RG   SeattleSNPs variation discovery resource;
RL   Submitted (OCT-2004) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Spleen;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Spleen;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   PROTEIN SEQUENCE OF 23-130, HYDROXYLATION AT LYS-33; PRO-39; PRO-45;
RP   LYS-48; PRO-54; PRO-57; LYS-67; PRO-73; PRO-79; PRO-85 AND LYS-100,
RP   AND GLYCOSYLATION AT LYS-33; LYS-48; LYS-67 AND LYS-100.
RX   PubMed=486087; DOI=10.1042/bj1790367;
RA   Reid K.B.M.;
RT   "Complete amino acid sequences of the three collagen-like regions
RT   present in subcomponent C1q of the first component of human
RT   complement.";
RL   Biochem. J. 179:367-371(1979).
RN   [9]
RP   PROTEIN SEQUENCE OF 131-245.
RX   PubMed=6981411; DOI=10.1042/bj2030559;
RA   Reid K.B.M., Gagnon J., Frampton J.;
RT   "Completion of the amino acid sequences of the A and B chains of
RT   subcomponent C1q of the first component of human complement.";
RL   Biochem. J. 203:559-569(1982).
RN   [10]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-146.
RC   TISSUE=Plasma;
RX   PubMed=16335952; DOI=10.1021/pr0502065;
RA   Liu T., Qian W.-J., Gritsenko M.A., Camp D.G. II, Monroe M.E.,
RA   Moore R.J., Smith R.D.;
RT   "Human plasma N-glycoproteome analysis by immunoaffinity subtraction,
RT   hydrazide chemistry, and mass spectrometry.";
RL   J. Proteome Res. 4:2070-2080(2005).
RN   [11]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-146.
RC   TISSUE=Liver;
RX   PubMed=19159218; DOI=10.1021/pr8008012;
RA   Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.;
RT   "Glycoproteomics analysis of human liver tissue by combination of
RT   multiple enzyme digestion and hydrazide chemistry.";
RL   J. Proteome Res. 8:651-661(2009).
RN   [12]
RP   X-RAY CRYSTALLOGRAPHY (1.85 ANGSTROMS) OF 112-244.
RX   PubMed=12960167; DOI=10.1074/jbc.M307764200;
RA   Gaboriaud C., Juanhuix J., Gruez A., Lacroix M., Darnault C.,
RA   Pignol D., Verger D., Fontecilla-Camps J.-C., Arlaud G.J.;
RT   "The crystal structure of the globular head of complement protein C1q
RT   provides a basis for its versatile recognition properties.";
RL   J. Biol. Chem. 278:46974-46982(2003).
RN   [13]
RP   REVIEW ON C1Q DEFICIENCY.
RX   PubMed=9777412;
RA   Petry F.;
RT   "Molecular basis of hereditary C1q deficiency.";
RL   Immunobiology 199:286-294(1998).
CC   -!- FUNCTION: C1q associates with the proenzymes C1r and C1s to yield
CC       C1, the first component of the serum complement system. The
CC       collagen-like regions of C1q interact with the Ca(2+)-dependent
CC       C1r(2)C1s(2) proenzyme complex, and efficient activation of C1
CC       takes place on interaction of the globular heads of C1q with the
CC       Fc regions of IgG or IgM antibody present in immune complexes.
CC   -!- SUBUNIT: C1 is a calcium-dependent trimolecular complex of C1q, R
CC       and S in the molar ration of 1:2:2. C1q subcomponent is composed
CC       of nine subunits, six of which are disulfide-linked dimers of the
CC       A and B chains, and three of which are disulfide-linked dimers of
CC       the C chain.
CC   -!- INTERACTION:
CC       P02746:C1QB; NbExp=5; IntAct=EBI-1220209, EBI-2813376;
CC       Q07021:C1QBP; NbExp=5; IntAct=EBI-1220209, EBI-14032968;
CC       Q9UHD9:UBQLN2; NbExp=3; IntAct=EBI-1220209, EBI-947187;
CC   -!- SUBCELLULAR LOCATION: Secreted.
CC   -!- PTM: O-linked glycans are assumed to be the Glc-Gal disaccharides
CC       typically found as secondary modifications of hydroxylated lysines
CC       in collagen-like domains. {ECO:0000269|PubMed:486087}.
CC   -!- DISEASE: Complement component C1q deficiency (C1QD) [MIM:613652]:
CC       A disorder caused by impaired activation of the complement
CC       classical pathway. It generally leads to severe immune complex
CC       disease with features of systemic lupus erythematosus and
CC       glomerulonephritis. Note=The disease is caused by mutations
CC       affecting the gene represented in this entry.
CC   -!- WEB RESOURCE: Name=C1QAbase; Note=C1QA mutation db;
CC       URL="http://structure.bmc.lu.se/idbase/C1QAbase/";
CC   -!- WEB RESOURCE: Name=SeattleSNPs;
CC       URL="http://pga.gs.washington.edu/data/c1qa/";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF135157; AAD32626.1; -; mRNA.
DR   EMBL; AY789471; AAV40828.1; -; Genomic_DNA.
DR   EMBL; AL158086; CAI22892.1; -; Genomic_DNA.
DR   EMBL; AK311980; BAG34919.1; -; mRNA.
DR   EMBL; AL158086; CAI22893.1; -; Genomic_DNA.
DR   EMBL; CH471134; EAW95014.1; -; Genomic_DNA.
DR   EMBL; BC030153; AAH30153.1; -; mRNA.
DR   EMBL; BC071986; AAH71986.1; -; mRNA.
DR   CCDS; CCDS226.1; -.
DR   PIR; S14350; C1HUQA.
DR   RefSeq; NP_001334394.1; NM_001347465.1.
DR   RefSeq; NP_001334395.1; NM_001347466.1.
DR   RefSeq; NP_057075.1; NM_015991.3.
DR   UniGene; Hs.632379; -.
DR   PDB; 1PK6; X-ray; 1.85 A; A=112-244.
DR   PDB; 2JG8; X-ray; 2.05 A; A/D=112-245.
DR   PDB; 2JG9; X-ray; 1.90 A; A/D=112-245.
DR   PDB; 2WNU; X-ray; 2.30 A; A/D=112-245.
DR   PDB; 2WNV; X-ray; 1.25 A; A/D=112-245.
DR   PDB; 5HKJ; X-ray; 1.35 A; A=110-245.
DR   PDB; 5HZF; X-ray; 1.55 A; A=110-245.
DR   PDB; 6FCZ; EM; 10.00 A; A=112-244.
DR   PDBsum; 1PK6; -.
DR   PDBsum; 2JG8; -.
DR   PDBsum; 2JG9; -.
DR   PDBsum; 2WNU; -.
DR   PDBsum; 2WNV; -.
DR   PDBsum; 5HKJ; -.
DR   PDBsum; 5HZF; -.
DR   PDBsum; 6FCZ; -.
DR   ProteinModelPortal; P02745; -.
DR   SMR; P02745; -.
DR   BioGrid; 107173; 19.
DR   CORUM; P02745; -.
DR   IntAct; P02745; 20.
DR   MINT; P02745; -.
DR   STRING; 9606.ENSP00000363773; -.
DR   DrugBank; DB00054; Abciximab.
DR   DrugBank; DB00051; Adalimumab.
DR   DrugBank; DB00092; Alefacept.
DR   DrugBank; DB00087; Alemtuzumab.
DR   DrugBank; DB00074; Basiliximab.
DR   DrugBank; DB00112; Bevacizumab.
DR   DrugBank; DB00002; Cetuximab.
DR   DrugBank; DB00111; Daclizumab.
DR   DrugBank; DB00095; Efalizumab.
DR   DrugBank; DB00005; Etanercept.
DR   DrugBank; DB00056; Gemtuzumab ozogamicin.
DR   DrugBank; DB00078; Ibritumomab tiuxetan.
DR   DrugBank; DB00075; Muromonab.
DR   DrugBank; DB00108; Natalizumab.
DR   DrugBank; DB00110; Palivizumab.
DR   DrugBank; DB00073; Rituximab.
DR   DrugBank; DB00081; Tositumomab.
DR   DrugBank; DB00072; Trastuzumab.
DR   iPTMnet; P02745; -.
DR   BioMuta; C1QA; -.
DR   DMDM; 399138; -.
DR   PaxDb; P02745; -.
DR   PeptideAtlas; P02745; -.
DR   PRIDE; P02745; -.
DR   DNASU; 712; -.
DR   Ensembl; ENST00000374642; ENSP00000363773; ENSG00000173372.
DR   Ensembl; ENST00000402322; ENSP00000385564; ENSG00000173372.
DR   GeneID; 712; -.
DR   KEGG; hsa:712; -.
DR   UCSC; uc001bfy.4; human.
DR   CTD; 712; -.
DR   DisGeNET; 712; -.
DR   EuPathDB; HostDB:ENSG00000173372.16; -.
DR   GeneCards; C1QA; -.
DR   HGNC; HGNC:1241; C1QA.
DR   HPA; CAB009823; -.
DR   HPA; HPA002350; -.
DR   MalaCards; C1QA; -.
DR   MIM; 120550; gene.
DR   MIM; 613652; phenotype.
DR   neXtProt; NX_P02745; -.
DR   OpenTargets; ENSG00000173372; -.
DR   Orphanet; 169147; Immunodeficiency due to an early component of complement deficiency.
DR   PharmGKB; PA25622; -.
DR   eggNOG; ENOG410IK45; Eukaryota.
DR   eggNOG; ENOG410YJJD; LUCA.
DR   GeneTree; ENSGT00900000140911; -.
DR   HOGENOM; HOG000085653; -.
DR   HOVERGEN; HBG108220; -.
DR   InParanoid; P02745; -.
DR   KO; K03986; -.
DR   OMA; YYYFTFQ; -.
DR   OrthoDB; EOG091G0L3Y; -.
DR   PhylomeDB; P02745; -.
DR   TreeFam; TF329591; -.
DR   Reactome; R-HSA-166663; Initial triggering of complement.
DR   Reactome; R-HSA-173623; Classical antibody-mediated complement activation.
DR   Reactome; R-HSA-977606; Regulation of Complement cascade.
DR   ChiTaRS; C1QA; human.
DR   EvolutionaryTrace; P02745; -.
DR   GeneWiki; C1QA; -.
DR   GenomeRNAi; 712; -.
DR   PRO; PR:P02745; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000173372; -.
DR   CleanEx; HS_C1QA; -.
DR   ExpressionAtlas; P02745; baseline and differential.
DR   Genevisible; P02745; HS.
DR   GO; GO:0005581; C:collagen trimer; IEA:UniProtKB-KW.
DR   GO; GO:0005602; C:complement component C1 complex; TAS:ProtInc.
DR   GO; GO:0005576; C:extracellular region; TAS:Reactome.
DR   GO; GO:0004252; F:serine-type endopeptidase activity; TAS:Reactome.
DR   GO; GO:0007267; P:cell-cell signaling; TAS:ProtInc.
DR   GO; GO:0006956; P:complement activation; TAS:Reactome.
DR   GO; GO:0006958; P:complement activation, classical pathway; TAS:Reactome.
DR   GO; GO:0045087; P:innate immune response; IEA:UniProtKB-KW.
DR   GO; GO:0030449; P:regulation of complement activation; TAS:Reactome.
DR   GO; GO:0010039; P:response to iron ion; IEA:Ensembl.
DR   Gene3D; 2.60.120.40; -; 1.
DR   InterPro; IPR001073; C1q_dom.
DR   InterPro; IPR008160; Collagen.
DR   InterPro; IPR037572; Complement_C1q_A.
DR   InterPro; IPR008983; Tumour_necrosis_fac-like_dom.
DR   PANTHER; PTHR45066; PTHR45066; 1.
DR   Pfam; PF00386; C1q; 1.
DR   Pfam; PF01391; Collagen; 1.
DR   PRINTS; PR00007; COMPLEMNTC1Q.
DR   SMART; SM00110; C1Q; 1.
DR   SUPFAM; SSF49842; SSF49842; 1.
DR   PROSITE; PS50871; C1Q; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Collagen; Complement pathway; Complete proteome;
KW   Direct protein sequencing; Disulfide bond; Glycoprotein;
KW   Hydroxylation; Immunity; Innate immunity; Polymorphism;
KW   Reference proteome; Repeat; Secreted; Signal.
FT   SIGNAL        1     22       {ECO:0000269|PubMed:486087}.
FT   CHAIN        23    245       Complement C1q subcomponent subunit A.
FT                                /FTId=PRO_0000003517.
FT   DOMAIN       31    109       Collagen-like.
FT   DOMAIN      110    245       C1q. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00368}.
FT   MOD_RES      33     33       5-hydroxylysine.
FT                                {ECO:0000269|PubMed:486087}.
FT   MOD_RES      39     39       4-hydroxyproline.
FT                                {ECO:0000269|PubMed:486087}.
FT   MOD_RES      45     45       4-hydroxyproline.
FT                                {ECO:0000269|PubMed:486087}.
FT   MOD_RES      48     48       5-hydroxylysine.
FT                                {ECO:0000269|PubMed:486087}.
FT   MOD_RES      54     54       4-hydroxyproline.
FT                                {ECO:0000269|PubMed:486087}.
FT   MOD_RES      57     57       4-hydroxyproline.
FT                                {ECO:0000269|PubMed:486087}.
FT   MOD_RES      67     67       5-hydroxylysine.
FT                                {ECO:0000269|PubMed:486087}.
FT   MOD_RES      73     73       4-hydroxyproline.
FT                                {ECO:0000269|PubMed:486087}.
FT   MOD_RES      79     79       4-hydroxyproline.
FT                                {ECO:0000269|PubMed:486087}.
FT   MOD_RES      85     85       4-hydroxyproline.
FT                                {ECO:0000269|PubMed:486087}.
FT   MOD_RES     100    100       5-hydroxylysine.
FT                                {ECO:0000269|PubMed:486087}.
FT   CARBOHYD     33     33       O-linked (Gal...) hydroxylysine.
FT                                {ECO:0000269|PubMed:486087}.
FT   CARBOHYD     48     48       O-linked (Gal...) hydroxylysine.
FT                                {ECO:0000269|PubMed:486087}.
FT   CARBOHYD     67     67       O-linked (Gal...) hydroxylysine.
FT                                {ECO:0000269|PubMed:486087}.
FT   CARBOHYD    100    100       O-linked (Gal...) hydroxylysine.
FT                                {ECO:0000269|PubMed:486087}.
FT   CARBOHYD    146    146       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:16335952,
FT                                ECO:0000269|PubMed:19159218}.
FT   DISULFID     26     26       Interchain (with C-29 in B chain).
FT   VARIANT      23     23       E -> K (in dbSNP:rs17887074).
FT                                {ECO:0000269|Ref.3}.
FT                                /FTId=VAR_021090.
FT   CONFLICT     97     97       P -> K (in Ref. 8; AA sequence).
FT                                {ECO:0000305}.
FT   CONFLICT    103    103       K -> P (in Ref. 8; AA sequence).
FT                                {ECO:0000305}.
FT   CONFLICT    172    172       C -> N (in Ref. 9; AA sequence).
FT                                {ECO:0000305}.
FT   CONFLICT    178    178       S -> W (in Ref. 9; AA sequence).
FT                                {ECO:0000305}.
FT   CONFLICT    240    243       LIFP -> ILPGF (in Ref. 9; AA sequence).
FT                                {ECO:0000305}.
FT   STRAND      116    120       {ECO:0000244|PDB:2WNV}.
FT   STRAND      128    130       {ECO:0000244|PDB:5HKJ}.
FT   STRAND      135    140       {ECO:0000244|PDB:2WNV}.
FT   TURN        146    148       {ECO:0000244|PDB:2WNV}.
FT   STRAND      150    152       {ECO:0000244|PDB:2JG9}.
FT   STRAND      157    169       {ECO:0000244|PDB:2WNV}.
FT   STRAND      171    179       {ECO:0000244|PDB:2WNV}.
FT   STRAND      182    184       {ECO:0000244|PDB:2WNV}.
FT   STRAND      188    191       {ECO:0000244|PDB:2WNV}.
FT   STRAND      195    197       {ECO:0000244|PDB:2WNV}.
FT   STRAND      199    209       {ECO:0000244|PDB:2WNV}.
FT   STRAND      214    224       {ECO:0000244|PDB:2WNV}.
FT   STRAND      229    232       {ECO:0000244|PDB:2WNV}.
FT   STRAND      235    243       {ECO:0000244|PDB:2WNV}.
SQ   SEQUENCE   245 AA;  26017 MW;  8FF6B6AE02D49C4C CRC64;
     MEGPRGWLVL CVLAISLASM VTEDLCRAPD GKKGEAGRPG RRGRPGLKGE QGEPGAPGIR
     TGIQGLKGDQ GEPGPSGNPG KVGYPGPSGP LGARGIPGIK GTKGSPGNIK DQPRPAFSAI
     RRNPPMGGNV VIFDTVITNQ EEPYQNHSGR FVCTVPGYYY FTFQVLSQWE ICLSIVSSSR
     GQVRRSLGFC DTTNKGLFQV VSGGMVLQLQ QGDQVWVEKD PKKGHIYQGS EADSVFSGFL
     IFPSA
//
ID   A0A024RDA5_HUMAN        Unreviewed;        99 AA.
AC   A0A024RDA5;
DT   09-JUL-2014, integrated into UniProtKB/TrEMBL.
DT   09-JUL-2014, sequence version 1.
DT   23-MAY-2018, entry version 37.
DE   SubName: Full=Interleukin 8, isoform CRA_b {ECO:0000313|EMBL:EAX05689.1};
GN   Name=IL8 {ECO:0000313|EMBL:EAX05689.1};
GN   Synonyms=CXCL8 {ECO:0000256|RuleBase:RU364007};
GN   ORFNames=hCG_16372 {ECO:0000313|EMBL:EAX05689.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:EAX05689.1};
RN   [1] {ECO:0000313|EMBL:EAX05689.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAX05689.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
CC   -!- SUBUNIT: Homodimer. {ECO:0000256|RuleBase:RU364007}.
CC   -!- SUBCELLULAR LOCATION: Secreted {ECO:0000256|RuleBase:RU361149,
CC       ECO:0000256|SAAS:SAAS00709696}.
CC   -!- SIMILARITY: Belongs to the intercrine alpha (chemokine CxC)
CC       family. {ECO:0000256|RuleBase:RU361149,
CC       ECO:0000256|SAAS:SAAS00709702}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; CH471057; EAX05689.1; -; Genomic_DNA.
DR   RefSeq; NP_000575.1; NM_000584.3.
DR   UniGene; Hs.624; -.
DR   ProteinModelPortal; A0A024RDA5; -.
DR   SMR; A0A024RDA5; -.
DR   PRIDE; A0A024RDA5; -.
DR   GeneID; 3576; -.
DR   KEGG; hsa:3576; -.
DR   CTD; 3576; -.
DR   EuPathDB; HostDB:ENSG00000169429.10; -.
DR   eggNOG; ENOG410J24U; Eukaryota.
DR   eggNOG; ENOG410Z1BP; LUCA.
DR   KO; K10030; -.
DR   OMA; PTAPWVQ; -.
DR   OrthoDB; EOG091G13J8; -.
DR   PhylomeDB; A0A024RDA5; -.
DR   ChiTaRS; CXCL8; human.
DR   GenomeRNAi; 3576; -.
DR   Bgee; ENSG00000169429; -.
DR   ExpressionAtlas; A0A024RDA5; baseline and differential.
DR   GO; GO:0005615; C:extracellular space; IEA:UniProtKB-UniRule.
DR   GO; GO:0008009; F:chemokine activity; IEA:InterPro.
DR   GO; GO:0005153; F:interleukin-8 receptor binding; IEA:InterPro.
DR   GO; GO:0006955; P:immune response; IEA:InterPro.
DR   GO; GO:0006954; P:inflammatory response; IEA:UniProtKB-KW.
DR   GO; GO:0042119; P:neutrophil activation; IEA:InterPro.
DR   GO; GO:0030593; P:neutrophil chemotaxis; IEA:InterPro.
DR   CDD; cd00273; Chemokine_CXC; 1.
DR   InterPro; IPR001089; Chemokine_CXC.
DR   InterPro; IPR018048; Chemokine_CXC_CS.
DR   InterPro; IPR001811; Chemokine_IL8-like_dom.
DR   InterPro; IPR033899; CXC_Chemokine_domain.
DR   InterPro; IPR028469; Interleukin-8.
DR   InterPro; IPR036048; Interleukin_8-like_sf.
DR   PANTHER; PTHR10179; PTHR10179; 1.
DR   PANTHER; PTHR10179:SF70; PTHR10179:SF70; 1.
DR   Pfam; PF00048; IL8; 1.
DR   PRINTS; PR00437; SMALLCYTKCXC.
DR   SMART; SM00199; SCY; 1.
DR   SUPFAM; SSF54117; SSF54117; 1.
DR   PROSITE; PS00471; SMALL_CYTOKINES_CXC; 1.
PE   3: Inferred from homology;
KW   Chemotaxis {ECO:0000256|RuleBase:RU361149};
KW   Cytokine {ECO:0000256|RuleBase:RU361149,
KW   ECO:0000256|SAAS:SAAS00709704};
KW   Disulfide bond {ECO:0000256|RuleBase:RU364007,
KW   ECO:0000256|SAAS:SAAS00709709};
KW   Inflammatory response {ECO:0000256|RuleBase:RU364007};
KW   Secreted {ECO:0000256|RuleBase:RU361149,
KW   ECO:0000256|SAAS:SAAS00709711};
KW   Signal {ECO:0000256|RuleBase:RU361149}.
FT   SIGNAL        1     22       {ECO:0000256|RuleBase:RU361149}.
FT   CHAIN        23     99       {ECO:0000256|RuleBase:RU361149}.
FT                                /FTId=PRO_5005101774.
FT   DOMAIN       31     92       SCY. {ECO:0000259|SMART:SM00199}.
SQ   SEQUENCE   99 AA;  11098 MW;  15C649996E89319F CRC64;
     MTSKLAVALL AAFLISAALC EGAVLPRSAK ELRCQCIKTY SKPFHPKFIK ELRVIESGPH
     CANTEIIVKL SDGRELCLDP KENWVQRVVE KFLKRAENS
//
ID   IL8_HUMAN               Reviewed;          99 AA.
AC   P10145; B2R4L8; Q6FGF6; Q6LAE6; Q96RG6; Q9C077; Q9UCE1; Q9UCR8;
AC   Q9UCR9; Q9UCS0;
DT   01-JUL-1989, integrated into UniProtKB/Swiss-Prot.
DT   01-JUL-1989, sequence version 1.
DT   28-MAR-2018, entry version 210.
DE   RecName: Full=Interleukin-8;
DE            Short=IL-8;
DE   AltName: Full=C-X-C motif chemokine 8;
DE   AltName: Full=Chemokine (C-X-C motif) ligand 8;
DE   AltName: Full=Emoctakin;
DE   AltName: Full=Granulocyte chemotactic protein 1;
DE            Short=GCP-1;
DE   AltName: Full=Monocyte-derived neutrophil chemotactic factor;
DE            Short=MDNCF;
DE   AltName: Full=Monocyte-derived neutrophil-activating peptide;
DE            Short=MONAP;
DE   AltName: Full=Neutrophil-activating protein 1;
DE            Short=NAP-1;
DE   AltName: Full=Protein 3-10C;
DE   AltName: Full=T-cell chemotactic factor;
DE   Contains:
DE     RecName: Full=MDNCF-a;
DE     AltName: Full=GCP/IL-8 protein IV;
DE     AltName: Full=IL8/NAP1 form I;
DE   Contains:
DE     RecName: Full=Interleukin-8;
DE     AltName: Full=(Ala-IL-8)77;
DE     AltName: Full=GCP/IL-8 protein II;
DE     AltName: Full=IL-8(1-77);
DE     AltName: Full=IL8/NAP1 form II;
DE     AltName: Full=MDNCF-b;
DE   Contains:
DE     RecName: Full=IL-8(5-77);
DE   Contains:
DE     RecName: Full=IL-8(6-77);
DE     AltName: Full=(Ser-IL-8)72;
DE     AltName: Full=GCP/IL-8 protein I;
DE     AltName: Full=IL8/NAP1 form III;
DE     AltName: Full=Lymphocyte-derived neutrophil-activating factor;
DE              Short=LYNAP;
DE     AltName: Full=MDNCF-c;
DE     AltName: Full=Neutrophil-activating factor;
DE              Short=NAF;
DE   Contains:
DE     RecName: Full=IL-8(7-77);
DE     AltName: Full=GCP/IL-8 protein V;
DE     AltName: Full=IL8/NAP1 form IV;
DE   Contains:
DE     RecName: Full=IL-8(8-77);
DE     AltName: Full=GCP/IL-8 protein VI;
DE     AltName: Full=IL8/NAP1 form V;
DE   Contains:
DE     RecName: Full=IL-8(9-77);
DE     AltName: Full=GCP/IL-8 protein III;
DE     AltName: Full=IL8/NAP1 form VI;
DE   Flags: Precursor;
GN   Name=CXCL8; Synonyms=IL8;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=2953813;
RA   Schmid J., Weissmann C.;
RT   "Induction of mRNA for a serine protease and a beta-thromboglobulin-
RT   like protein in mitogen-stimulated human leukocytes.";
RL   J. Immunol. 139:250-256(1987).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=3260265; DOI=10.1084/jem.167.6.1883;
RA   Matsushima K., Morishita K., Yoshimura T., Lavu S., Kobayashi Y.,
RA   Lew W., Appella E., Kung H., Leonard E.J., Oppenheim J.J.;
RT   "Molecular cloning of a human monocyte-derived neutrophil chemotactic
RT   factor (MDNCF) and the induction of MDNCF mRNA by interleukin 1 and
RT   tumor necrosis factor.";
RL   J. Exp. Med. 167:1883-1893(1988).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=2663993;
RA   Mukaida N., Shiroo M., Matsushima K.;
RT   "Genomic structure of the human monocyte-derived neutrophil
RT   chemotactic factor IL-8.";
RL   J. Immunol. 143:1366-1371(1989).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=2664463; DOI=10.1128/MCB.9.5.1946;
RA   Kowalski J., Denhardt D.T.;
RT   "Regulation of the mRNA for monocyte-derived neutrophil-activating
RT   peptide in differentiating HL60 promyelocytes.";
RL   Mol. Cell. Biol. 9:1946-1957(1989).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   TISSUE=Lung carcinoma;
RX   PubMed=2200751; DOI=10.1016/0165-2478(90)90043-P;
RA   Hotta K., Hayashi K., Ishikawa J., Tagawa M., Hashimoto K., Mizuno S.,
RA   Suzuki K.;
RT   "Coding region structure of interleukin-8 gene of human lung giant
RT   cell carcinoma LU65C cells that produce LUCT/interleukin-8:
RT   homogeneity in interleukin-8 genes.";
RL   Immunol. Lett. 24:165-169(1990).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Neutrophil;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Halleck A., Ebert L., Mkoundinya M., Schick M., Eisenstein S.,
RA   Neubert P., Kstrang K., Schatten R., Shen B., Henze S., Mar W.,
RA   Korn B., Zuo D., Hu Y., LaBaer J.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RG   SeattleSNPs variation discovery resource;
RL   Submitted (JUN-2001) to the EMBL/GenBank/DDBJ databases.
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [11]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [12]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-91.
RC   TISSUE=Peripheral blood leukocyte;
RA   Jang J.S., Kim B.E.;
RL   Submitted (FEB-1998) to the EMBL/GenBank/DDBJ databases.
RN   [13]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-97.
RC   TISSUE=Kidney;
RA   King C.H., Gordon G.S., Konieczkowski M., Sedor J.R.;
RT   "cDNA cloning of human mesangial cell interleukin 8 by polymerase
RT   chain reaction.";
RL   Submitted (FEB-1992) to the EMBL/GenBank/DDBJ databases.
RN   [14]
RP   PROTEIN SEQUENCE OF 21-41, IDENTIFICATION OF MDNCF-A; IL-8(1-77);
RP   IL-8(6-77); IL-8(7-77); IL-8(8-77) AND IL-8(9-77), AND PROTEOLYTIC
RP   PROCESSING OF N-TERMINUS.
RX   PubMed=2523801; DOI=10.1111/j.1432-1033.1989.tb14729.x;
RA   van Damme J., van Beeumen J., Conings R., Decock B., Billiau A.;
RT   "Purification of granulocyte chemotactic peptide/interleukin-8 reveals
RT   N-terminal sequence heterogeneity similar to that of beta-
RT   thromboglobulin.";
RL   Eur. J. Biochem. 181:337-344(1989).
RN   [15]
RP   PROTEIN SEQUENCE OF 21-41, IDENTIFICATION OF MDNCF-A; IL-8(1-77);
RP   IL-8(6-77); IL-8(7-77); IL-8(8-77) AND IL-8(9-77), PROTEOLYTIC
RP   PROCESSING OF N-TERMINUS, AND FUNCTION.
RX   PubMed=2145175; DOI=10.1002/eji.1830200933;
RA   van Damme J., Rampart M., Coning R., Decock B., van Osselaer N.,
RA   Willems J., Billiau A.;
RT   "The neutrophil-activating proteins interleukin 8 and beta-
RT   thromboglobulin: in vitro and in vivo comparison of NH2-terminally
RT   processed forms.";
RL   Eur. J. Immunol. 20:2113-2118(1990).
RN   [16]
RP   PROTEIN SEQUENCE OF 21-32, IDENTIFICATION OF MDNCF-A; IL-8(1-77) AND
RP   IL-8(6-77), AND PROTEOLYTIC PROCESSING OF N-TERMINUS.
RX   PubMed=2648135; DOI=10.1016/0161-5890(89)90024-2;
RA   Yoshimura T., Robinson E.A., Appella E., Matsushima K.,
RA   Showalter S.D., Skeel A., Leonard E.J.;
RT   "Three forms of monocyte-derived neutrophil chemotactic factor (MDNCF)
RT   distinguished by different lengths of the amino-terminal sequence.";
RL   Mol. Immunol. 26:87-93(1989).
RN   [17]
RP   PROTEIN SEQUENCE OF 23-54, AND IDENTIFICATION OF IL-8(1-77).
RX   PubMed=2659722; DOI=10.1084/jem.169.6.1895;
RA   Suzuki K., Miyasaka H., Ota H., Yamakawa Y., Tagawa M., Kuramoto A.,
RA   Mizuno S.;
RT   "Purification and partial primary sequence of a chemotactic protein
RT   for polymorphonuclear leukocytes derived from human lung giant cell
RT   carcinoma LU65C cells.";
RL   J. Exp. Med. 169:1895-1901(1989).
RN   [18]
RP   PROTEIN SEQUENCE OF 23-47.
RC   TISSUE=Skin;
RX   PubMed=1755384;
RA   Schroeder J.-M.;
RT   "Biochemical and biological characterization of NAP-1/IL-8-related
RT   cytokines in lesional psoriatic scale.";
RL   Adv. Exp. Med. Biol. 305:97-107(1991).
RN   [19]
RP   PROTEIN SEQUENCE OF 23-46, AND IDENTIFICATION OF IL-8(1-77).
RX   PubMed=2655583; DOI=10.1042/bj2590585;
RA   Golds E.E., Mason P., Nyirkos P.;
RT   "Inflammatory cytokines induce synthesis and secretion of gro protein
RT   and a neutrophil chemotactic factor but not beta 2-microglobulin in
RT   human synovial cells and fibroblasts.";
RL   Biochem. J. 259:585-588(1989).
RN   [20]
RP   PROTEIN SEQUENCE OF 23-42.
RC   TISSUE=Chronic myeloid leukemia cell;
RX   PubMed=8344717; DOI=10.1016/0165-2478(93)90071-9;
RA   Suzuki K., Yamakawa Y., Matsuo Y., Kamiya T., Minowada J., Mizuno S.;
RT   "Isolation and amino acid sequence of a chemotactic protein,
RT   LECT/interleukin 8, from a human myeloid leukemia cell line, ML-1.";
RL   Immunol. Lett. 36:71-81(1993).
RN   [21]
RP   PROTEIN SEQUENCE OF 28-99, AND IDENTIFICATION OF IL-8(6-77).
RX   PubMed=3279957; DOI=10.1016/S0006-291X(88)80364-4;
RA   Gregory H., Young J., Schroeder J.-M., Mrowietz U., Christophers E.;
RT   "Structure determination of a human lymphocyte derived neutrophil
RT   activating peptide (LYNAP).";
RL   Biochem. Biophys. Res. Commun. 151:883-890(1988).
RN   [22]
RP   PROTEIN SEQUENCE OF 28-69, AND IDENTIFICATION OF IL-8(6-77).
RX   PubMed=3480540; DOI=10.1073/pnas.84.24.9233;
RA   Yoshimura T., Matsushima K., Tanaka S., Robinson E.A., Appella E.,
RA   Oppenheim J.J., Leonard E.J.;
RT   "Purification of a human monocyte-derived neutrophil chemotactic
RT   factor that has peptide sequence similarity to other host defense
RT   cytokines.";
RL   Proc. Natl. Acad. Sci. U.S.A. 84:9233-9237(1987).
RN   [23]
RP   PROTEIN SEQUENCE OF 28-59, AND IDENTIFICATION OF IL-8(6-77).
RX   PubMed=3322281; DOI=10.1016/0006-291X(87)90432-3;
RA   Walz A., Peveri P., Aschauer H., Baggiolini M.;
RT   "Purification and amino acid sequencing of NAF, a novel neutrophil-
RT   activating factor produced by monocytes.";
RL   Biochem. Biophys. Res. Commun. 149:755-761(1987).
RN   [24]
RP   PROTEOLYTIC PROCESSING OF N-TERMINUS BY THROMBIN, AND FUNCTION.
RX   PubMed=2212672;
RA   Hebert C.A., Luscinskas F.W., Kiely J.-M., Luis E.A., Darbonne W.C.,
RA   Bennett G.L., Liu C.C., Obin M.S., Gimbrone M.A. Jr., Baker J.B.;
RT   "Endothelial and leukocyte forms of IL-8. Conversion by thrombin and
RT   interactions with neutrophils.";
RL   J. Immunol. 145:3033-3040(1990).
RN   [25]
RP   SYNTHESIS OF 28-99.
RX   PubMed=2007144; DOI=10.1021/bi00226a021;
RA   Clark-Lewis I., Mose B., Walz A., Baggiolini M., Scott G.J.,
RA   Aebersold R.;
RT   "Chemical synthesis, purification, and characterization of two
RT   inflammatory proteins, neutrophil activating peptide 1 (interleukin-8)
RT   and neutrophil activating peptide.";
RL   Biochemistry 30:3128-3135(1991).
RN   [26]
RP   PROTEOLYTIC PROCESSING OF N-TERMINUS BY MMP9.
RX   PubMed=11023497;
RA   Van den Steen P.E., Proost P., Wuyts A., Van Damme J., Opdenakker G.;
RT   "Neutrophil gelatinase B potentiates interleukin-8 tenfold by
RT   aminoterminal processing, whereas it degrades CTAP-III, PF-4, and GRO-
RT   alpha and leaves RANTES and MCP-2 intact.";
RL   Blood 96:2673-2681(2000).
RN   [27]
RP   IDENTIFICATION OF IL-8(5-77) AND IL-8(6-77), FUNCTION, AND PROTEOLYTIC
RP   PROCESSING OF N-TERMINUS.
RX   PubMed=11978786; DOI=10.1074/jbc.M112275200;
RA   Schutyser E., Struyf S., Proost P., Opdenakker G., Laureys G.,
RA   Verhasselt B., Peperstraete L., Van de Putte I., Saccani A.,
RA   Allavena P., Mantovani A., Van Damme J.;
RT   "Identification of biologically active chemokine isoforms from ascitic
RT   fluid and elevated levels of CCL18/pulmonary and activation-regulated
RT   chemokine in ovarian carcinoma.";
RL   J. Biol. Chem. 277:24584-24593(2002).
RN   [28]
RP   REVIEW.
RX   PubMed=1639201; DOI=10.1016/0014-5793(92)80909-Z;
RA   Baggiolini M., Clark-Lewis I.;
RT   "Interleukin-8, a chemotactic and inflammatory cytokine.";
RL   FEBS Lett. 307:97-101(1992).
RN   [29]
RP   REVIEW.
RX   PubMed=14711052; DOI=10.1016/S0065-2776(03)81001-5;
RA   Struyf S., Proost P., Van Damme J.;
RT   "Regulation of the immune response by the interaction of chemokines
RT   and proteases.";
RL   Adv. Immunol. 81:1-44(2003).
RN   [30]
RP   CITRULLINATION AT ARG-27.
RX   PubMed=18710930; DOI=10.1084/jem.20080305;
RA   Proost P., Loos T., Mortier A., Schutyser E., Gouwy M., Noppen S.,
RA   Dillen C., Ronsse I., Conings R., Struyf S., Opdenakker G.,
RA   Maudgal P.C., Van Damme J.;
RT   "Citrullination of CXCL8 by peptidylarginine deiminase alters receptor
RT   usage, prevents proteolysis, and dampens tissue inflammation.";
RL   J. Exp. Med. 205:2085-2097(2008).
RN   [31]
RP   CITRULLINATION AT ARG-27.
RX   PubMed=19608678; DOI=10.3324/haematol.2009.006973;
RA   Loos T., Opdenakker G., Van Damme J., Proost P.;
RT   "Citrullination of CXCL8 increases this chemokine's ability to
RT   mobilize neutrophils into the blood circulation.";
RL   Haematologica 94:1346-1353(2009).
RN   [32]
RP   INDUCTION.
RX   PubMed=20829347; DOI=10.1074/jbc.M110.136259;
RA   Park S.H., Choi H.J., Yang H., Do K.H., Kim J., Lee D.W., Moon Y.;
RT   "Endoplasmic reticulum stress-activated C/EBP homologous protein
RT   enhances nuclear factor-kappaB signals via repression of peroxisome
RT   proliferator-activated receptor gamma.";
RL   J. Biol. Chem. 285:35330-35339(2010).
RN   [33]
RP   STRUCTURE BY NMR OF 28-99.
RX   PubMed=2681204;
RA   Clore G.M., Appella E., Yamada M., Matsushima K., Gronenborn A.M.;
RT   "Determination of the secondary structure of interleukin-8 by nuclear
RT   magnetic resonance spectroscopy.";
RL   J. Biol. Chem. 264:18907-18911(1989).
RN   [34]
RP   STRUCTURE BY NMR.
RX   PubMed=2184886; DOI=10.1021/bi00459a004;
RA   Clore G.M., Appella E., Yamada M., Matsushima K., Gronenborn A.M.;
RT   "Three-dimensional structure of interleukin 8 in solution.";
RL   Biochemistry 29:1689-1696(1990).
RN   [35]
RP   STRUCTURE BY NMR OF 28-80.
RX   PubMed=8631339; DOI=10.1111/j.1432-1033.1996.00026.x;
RA   Sticht H., Auer M., Schmitt B., Besemer J., Horcher M., Kirsch T.,
RA   Lindley I.J., Rosch P.;
RT   "Structure and activity of a chimeric interleukin-8-melanoma-growth-
RT   stimulatory-activity protein.";
RL   Eur. J. Biochem. 235:26-35(1996).
RN   [36]
RP   STRUCTURE BY NMR OF COMPLEX TO RECEPTOR.
RX   PubMed=10368283; DOI=10.1016/S0969-2126(99)80022-7;
RA   Skelton N.J., Quan C., Reilly D., Lowman H.;
RT   "Structure of a CXC chemokine-receptor fragment in complex with
RT   interleukin-8.";
RL   Structure 7:157-168(1999).
RN   [37]
RP   X-RAY CRYSTALLOGRAPHY (1.6 ANGSTROMS).
RX   PubMed=2182630;
RA   Baldwin E.T., Franklin K.A., Appella E., Yamada M., Matsushima K.,
RA   Wlodawer A., Weber I.T.;
RT   "Crystallization of human interleukin-8. A protein chemotactic for
RT   neutrophils and T-lymphocytes.";
RL   J. Biol. Chem. 265:6851-6853(1990).
RN   [38]
RP   STRUCTURE BY NMR, AND COMPARISON WITH X-RAY STRUCTURE.
RX   PubMed=2005614; DOI=10.1016/0022-2836(91)90518-B;
RA   Clore G.M., Gronenborn A.M.;
RT   "Comparison of the solution nuclear magnetic resonance and crystal
RT   structures of interleukin-8. Possible implications for the mechanism
RT   of receptor binding.";
RL   J. Mol. Biol. 217:611-620(1991).
RN   [39]
RP   X-RAY CRYSTALLOGRAPHY (1.6 ANGSTROMS), AND STRUCTURE BY NMR.
RX   PubMed=1988949; DOI=10.1073/pnas.88.2.502;
RA   Baldwin E.T., Weber I.T., St Charles R., Xuan J.C., Appella E.,
RA   Yamada M., Matsushima K., Edwards B.F., Clore G.M., Gronenborn A.M.;
RT   "Crystal structure of interleukin 8: symbiosis of NMR and
RT   crystallography.";
RL   Proc. Natl. Acad. Sci. U.S.A. 88:502-506(1991).
RN   [40]
RP   X-RAY CRYSTALLOGRAPHY (2.35 ANGSTROMS) OF MUTANT.
RX   PubMed=10707023;
RX   DOI=10.1002/(SICI)1097-0134(20000301)38:4<361::AID-PROT2>3.0.CO;2-0;
RA   Gerber N., Lowman H., Artis D.R., Eigenbrot C.;
RT   "Receptor-binding conformation of the 'ELR' motif of IL-8: X-ray
RT   structure of the L5C/H33C variant at 2.35 A resolution.";
RL   Proteins 38:361-367(2000).
CC   -!- FUNCTION: IL-8 is a chemotactic factor that attracts neutrophils,
CC       basophils, and T-cells, but not monocytes. It is also involved in
CC       neutrophil activation. It is released from several cell types in
CC       response to an inflammatory stimulus. IL-8(6-77) has a 5-10-fold
CC       higher activity on neutrophil activation, IL-8(5-77) has increased
CC       activity on neutrophil activation and IL-8(7-77) has a higher
CC       affinity to receptors CXCR1 and CXCR2 as compared to IL-8(1-77),
CC       respectively. {ECO:0000269|PubMed:11978786,
CC       ECO:0000269|PubMed:2145175, ECO:0000269|PubMed:2212672}.
CC   -!- SUBUNIT: Homodimer.
CC   -!- INTERACTION:
CC       P9WGV3:ahcY (xeno); NbExp=3; IntAct=EBI-3917999, EBI-11740468;
CC       P25025:CXCR2; NbExp=3; IntAct=EBI-3917999, EBI-2835281;
CC       P9WMN3:glmU (xeno); NbExp=3; IntAct=EBI-3917999, EBI-11740532;
CC       Q6MX51:Rv0296c (xeno); NbExp=3; IntAct=EBI-3917999, EBI-11740572;
CC       P98066:TNFAIP6; NbExp=15; IntAct=EBI-3917999, EBI-11700693;
CC   -!- SUBCELLULAR LOCATION: Secreted.
CC   -!- INDUCTION: By ER stress in a DDIT3/CHOP-dependent manner.
CC       {ECO:0000269|PubMed:20829347}.
CC   -!- PTM: Several N-terminal processed forms are produced by
CC       proteolytic cleavage after secretion from at least peripheral
CC       blood monocytes, leukcocytes and endothelial cells. In general,
CC       IL-8(1-77) is referred to as interleukin-8. IL-8(6-77) is the most
CC       promiment form. {ECO:0000269|PubMed:11023497,
CC       ECO:0000269|PubMed:11978786, ECO:0000269|PubMed:2145175,
CC       ECO:0000269|PubMed:2212672, ECO:0000269|PubMed:2523801,
CC       ECO:0000269|PubMed:2648135}.
CC   -!- PTM: Citrullination at Arg-27 prevents proteolysis, and dampens
CC       tissue inflammation, it also enhances leukocytosis, possibly
CC       through impaired chemokine clearance from the blood circulation.
CC       {ECO:0000269|PubMed:18710930, ECO:0000269|PubMed:19608678}.
CC   -!- SIMILARITY: Belongs to the intercrine alpha (chemokine CxC)
CC       family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAK00048.1; Type=Miscellaneous discrepancy; Note=Chimeric cDNA.; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Wikipedia; Note=Interleukin-8 entry;
CC       URL="https://en.wikipedia.org/wiki/Interleukin_8";
CC   -!- WEB RESOURCE: Name=SeattleSNPs;
CC       URL="http://pga.gs.washington.edu/data/il8/";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M17017; AAA35611.1; -; mRNA.
DR   EMBL; Y00787; CAA68742.1; -; mRNA.
DR   EMBL; M28130; AAA59158.1; -; Genomic_DNA.
DR   EMBL; M26383; AAA36323.1; -; mRNA.
DR   EMBL; D14283; BAA03245.1; -; Genomic_DNA.
DR   EMBL; BT007067; AAP35730.1; -; mRNA.
DR   EMBL; AK311874; BAG34815.1; -; mRNA.
DR   EMBL; CR542151; CAG46948.1; -; mRNA.
DR   EMBL; AF385628; AAK60276.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; CH471057; EAX05688.1; -; Genomic_DNA.
DR   EMBL; BC013615; AAH13615.1; -; mRNA.
DR   EMBL; Z11686; CAA77745.1; -; mRNA.
DR   EMBL; AF043337; AAK00048.1; ALT_SEQ; mRNA.
DR   CCDS; CCDS34005.1; -.
DR   PIR; A37034; A37034.
DR   RefSeq; NP_000575.1; NM_000584.3.
DR   UniGene; Hs.624; -.
DR   PDB; 1ICW; X-ray; 2.01 A; A/B=28-99.
DR   PDB; 1IKL; NMR; -; A=28-99.
DR   PDB; 1IKM; NMR; -; A=28-99.
DR   PDB; 1IL8; NMR; -; A/B=28-99.
DR   PDB; 1ILP; NMR; -; A/B=28-99.
DR   PDB; 1ILQ; NMR; -; A/B=28-99.
DR   PDB; 1QE6; X-ray; 2.35 A; A/B/C/D=28-99.
DR   PDB; 1ROD; NMR; -; A/B=28-80.
DR   PDB; 2IL8; NMR; -; A/B=28-99.
DR   PDB; 3IL8; X-ray; 2.00 A; A=28-99.
DR   PDB; 4XDX; X-ray; 0.95 A; A=30-99.
DR   PDB; 5D14; X-ray; 1.00 A; A=30-99.
DR   PDB; 5WDZ; NMR; -; A=28-93.
DR   PDBsum; 1ICW; -.
DR   PDBsum; 1IKL; -.
DR   PDBsum; 1IKM; -.
DR   PDBsum; 1IL8; -.
DR   PDBsum; 1ILP; -.
DR   PDBsum; 1ILQ; -.
DR   PDBsum; 1QE6; -.
DR   PDBsum; 1ROD; -.
DR   PDBsum; 2IL8; -.
DR   PDBsum; 3IL8; -.
DR   PDBsum; 4XDX; -.
DR   PDBsum; 5D14; -.
DR   PDBsum; 5WDZ; -.
DR   ProteinModelPortal; P10145; -.
DR   SMR; P10145; -.
DR   BioGrid; 109790; 13.
DR   DIP; DIP-3778N; -.
DR   IntAct; P10145; 10.
DR   STRING; 9606.ENSP00000306512; -.
DR   BindingDB; P10145; -.
DR   ChEMBL; CHEMBL2157; -.
DR   DrugBank; DB05434; ABT-510.
DR   DrugBank; DB05484; MDX-018.
DR   DrugBank; DB05855; Rivanicline.
DR   BioMuta; IL8; -.
DR   DMDM; 124359; -.
DR   PaxDb; P10145; -.
DR   PeptideAtlas; P10145; -.
DR   PRIDE; P10145; -.
DR   DNASU; 3576; -.
DR   Ensembl; ENST00000307407; ENSP00000306512; ENSG00000169429.
DR   GeneID; 3576; -.
DR   KEGG; hsa:3576; -.
DR   UCSC; uc003hhe.3; human.
DR   CTD; 3576; -.
DR   DisGeNET; 3576; -.
DR   EuPathDB; HostDB:ENSG00000169429.10; -.
DR   GeneCards; CXCL8; -.
DR   HGNC; HGNC:6025; CXCL8.
DR   HPA; HPA057179; -.
DR   MIM; 146930; gene.
DR   neXtProt; NX_P10145; -.
DR   OpenTargets; ENSG00000169429; -.
DR   PharmGKB; PA29841; -.
DR   eggNOG; ENOG410J24U; Eukaryota.
DR   eggNOG; ENOG410Z1BP; LUCA.
DR   GeneTree; ENSGT00530000062901; -.
DR   HOVERGEN; HBG107789; -.
DR   InParanoid; P10145; -.
DR   KO; K10030; -.
DR   OMA; PTAPWVQ; -.
DR   OrthoDB; EOG091G13J8; -.
DR   PhylomeDB; P10145; -.
DR   TreeFam; TF333433; -.
DR   Reactome; R-HSA-2559582; Senescence-Associated Secretory Phenotype (SASP).
DR   Reactome; R-HSA-375276; Peptide ligand-binding receptors.
DR   Reactome; R-HSA-380108; Chemokine receptors bind chemokines.
DR   Reactome; R-HSA-380994; ATF4 activates genes.
DR   Reactome; R-HSA-418594; G alpha (i) signalling events.
DR   Reactome; R-HSA-6783783; Interleukin-10 signaling.
DR   Reactome; R-HSA-6785807; Interleukin-4 and 13 signaling.
DR   SIGNOR; P10145; -.
DR   ChiTaRS; CXCL8; human.
DR   EvolutionaryTrace; P10145; -.
DR   GeneWiki; Interleukin_8; -.
DR   GenomeRNAi; 3576; -.
DR   PMAP-CutDB; P10145; -.
DR   PRO; PR:P10145; -.
DR   Proteomes; UP000005640; Chromosome 4.
DR   Bgee; ENSG00000169429; -.
DR   CleanEx; HS_IL8; -.
DR   ExpressionAtlas; P10145; baseline and differential.
DR   Genevisible; P10145; HS.
DR   GO; GO:0005576; C:extracellular region; TAS:Reactome.
DR   GO; GO:0005615; C:extracellular space; IBA:GO_Central.
DR   GO; GO:0005622; C:intracellular; IEA:GOC.
DR   GO; GO:0008009; F:chemokine activity; IDA:UniProtKB.
DR   GO; GO:0005153; F:interleukin-8 receptor binding; IPI:UniProtKB.
DR   GO; GO:0001525; P:angiogenesis; TAS:UniProtKB.
DR   GO; GO:0061844; P:antimicrobial humoral immune response mediated by antimicrobial peptide; IDA:UniProtKB.
DR   GO; GO:0019722; P:calcium-mediated signaling; TAS:UniProtKB.
DR   GO; GO:0007050; P:cell cycle arrest; IDA:UniProtKB.
DR   GO; GO:0044344; P:cellular response to fibroblast growth factor stimulus; IEP:UniProtKB.
DR   GO; GO:0071347; P:cellular response to interleukin-1; IEP:UniProtKB.
DR   GO; GO:0071222; P:cellular response to lipopolysaccharide; IDA:BHF-UCL.
DR   GO; GO:0071356; P:cellular response to tumor necrosis factor; IEP:UniProtKB.
DR   GO; GO:0070098; P:chemokine-mediated signaling pathway; IBA:GO_Central.
DR   GO; GO:0006935; P:chemotaxis; TAS:UniProtKB.
DR   GO; GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome.
DR   GO; GO:0048566; P:embryonic digestive tract development; IEP:DFLAT.
DR   GO; GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:Reactome.
DR   GO; GO:0006955; P:immune response; IBA:GO_Central.
DR   GO; GO:0050930; P:induction of positive chemotaxis; IGI:UniProtKB.
DR   GO; GO:0006954; P:inflammatory response; TAS:UniProtKB.
DR   GO; GO:0035556; P:intracellular signal transduction; IDA:UniProtKB.
DR   GO; GO:0031640; P:killing of cells of other organism; IDA:UniProtKB.
DR   GO; GO:0008285; P:negative regulation of cell proliferation; TAS:ProtInc.
DR   GO; GO:0045744; P:negative regulation of G-protein coupled receptor protein signaling pathway; IDA:UniProtKB.
DR   GO; GO:0042119; P:neutrophil activation; IDA:UniProtKB.
DR   GO; GO:0030593; P:neutrophil chemotaxis; IDA:UniProtKB.
DR   GO; GO:0036499; P:PERK-mediated unfolded protein response; TAS:Reactome.
DR   GO; GO:0045766; P:positive regulation of angiogenesis; IDA:CACAO.
DR   GO; GO:0090023; P:positive regulation of neutrophil chemotaxis; TAS:BHF-UCL.
DR   GO; GO:0031623; P:receptor internalization; IDA:UniProtKB.
DR   GO; GO:0030155; P:regulation of cell adhesion; IDA:UniProtKB.
DR   GO; GO:2000535; P:regulation of entry of bacterium into host cell; IMP:AgBase.
DR   GO; GO:0045091; P:regulation of single stranded viral RNA replication via double stranded DNA intermediate; IDA:UniProtKB.
DR   GO; GO:0034976; P:response to endoplasmic reticulum stress; IDA:UniProtKB.
DR   GO; GO:0002237; P:response to molecule of bacterial origin; IDA:BHF-UCL.
DR   GO; GO:0007165; P:signal transduction; TAS:ProtInc.
DR   CDD; cd00273; Chemokine_CXC; 1.
DR   InterPro; IPR001089; Chemokine_CXC.
DR   InterPro; IPR018048; Chemokine_CXC_CS.
DR   InterPro; IPR001811; Chemokine_IL8-like_dom.
DR   InterPro; IPR033899; CXC_Chemokine_domain.
DR   InterPro; IPR028469; Interleukin-8.
DR   InterPro; IPR036048; Interleukin_8-like_sf.
DR   PANTHER; PTHR10179; PTHR10179; 1.
DR   PANTHER; PTHR10179:SF70; PTHR10179:SF70; 1.
DR   Pfam; PF00048; IL8; 1.
DR   PRINTS; PR00437; SMALLCYTKCXC.
DR   SMART; SM00199; SCY; 1.
DR   SUPFAM; SSF54117; SSF54117; 1.
DR   PROSITE; PS00471; SMALL_CYTOKINES_CXC; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Chemotaxis; Citrullination; Complete proteome; Cytokine;
KW   Direct protein sequencing; Disulfide bond; Inflammatory response;
KW   Reference proteome; Secreted; Signal.
FT   SIGNAL        1     20       {ECO:0000269|PubMed:2145175,
FT                                ECO:0000269|PubMed:2523801,
FT                                ECO:0000269|PubMed:2648135}.
FT   CHAIN        21     99       MDNCF-a.
FT                                /FTId=PRO_0000005126.
FT   CHAIN        23     99       Interleukin-8.
FT                                /FTId=PRO_0000005127.
FT   CHAIN        27     99       IL-8(5-77).
FT                                /FTId=PRO_0000041948.
FT   CHAIN        28     99       IL-8(6-77).
FT                                /FTId=PRO_0000005128.
FT   CHAIN        29     99       IL-8(7-77).
FT                                /FTId=PRO_0000005129.
FT   CHAIN        30     99       IL-8(8-77).
FT                                /FTId=PRO_0000005130.
FT   CHAIN        31     99       IL-8(9-77).
FT                                /FTId=PRO_0000005131.
FT   SITE         27     28       Cleavage; by thrombin. {ECO:0000305}.
FT   SITE         28     29       Cleavage; by MMP9.
FT   MOD_RES      27     27       Citrulline. {ECO:0000269|PubMed:18710930,
FT                                ECO:0000269|PubMed:19608678}.
FT   DISULFID     34     61
FT   DISULFID     36     77
FT   CONFLICT     53     53       R -> L (in Ref. 17; AA sequence).
FT                                {ECO:0000305}.
FT   STRAND       37     42       {ECO:0000244|PDB:1ROD}.
FT   HELIX        46     48       {ECO:0000244|PDB:4XDX}.
FT   STRAND       49     55       {ECO:0000244|PDB:4XDX}.
FT   STRAND       58     60       {ECO:0000244|PDB:1ICW}.
FT   STRAND       61     63       {ECO:0000244|PDB:4XDX}.
FT   STRAND       65     70       {ECO:0000244|PDB:4XDX}.
FT   TURN         71     73       {ECO:0000244|PDB:1IKL}.
FT   STRAND       75     78       {ECO:0000244|PDB:4XDX}.
FT   HELIX        83     97       {ECO:0000244|PDB:4XDX}.
SQ   SEQUENCE   99 AA;  11098 MW;  15C649996E89319F CRC64;
     MTSKLAVALL AAFLISAALC EGAVLPRSAK ELRCQCIKTY SKPFHPKFIK ELRVIESGPH
     CANTEIIVKL SDGRELCLDP KENWVQRVVE KFLKRAENS
//
ID   A0A096LP69_HUMAN        Unreviewed;       184 AA.
AC   A0A096LP69;
DT   26-NOV-2014, integrated into UniProtKB/TrEMBL.
DT   26-NOV-2014, sequence version 1.
DT   23-MAY-2018, entry version 28.
DE   SubName: Full=CD99 antigen {ECO:0000313|Ensembl:ENSP00000485427};
GN   Name=CD99 {ECO:0000313|Ensembl:ENSP00000485427};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000485427, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Ensembl:ENSP00000485427, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15772651; DOI=10.1038/nature03440;
RA   Ross M.T., Grafham D.V., Coffey A.J., Scherer S., McLay K., Muzny D.,
RA   Platzer M., Howell G.R., Burrows C., Bird C.P., Frankish A.,
RA   Lovell F.L., Howe K.L., Ashurst J.L., Fulton R.S., Sudbrak R., Wen G.,
RA   Jones M.C., Hurles M.E., Andrews T.D., Scott C.E., Searle S.,
RA   Ramser J., Whittaker A., Deadman R., Carter N.P., Hunt S.E., Chen R.,
RA   Cree A., Gunaratne P., Havlak P., Hodgson A., Metzker M.L.,
RA   Richards S., Scott G., Steffen D., Sodergren E., Wheeler D.A.,
RA   Worley K.C., Ainscough R., Ambrose K.D., Ansari-Lari M.A., Aradhya S.,
RA   Ashwell R.I., Babbage A.K., Bagguley C.L., Ballabio A., Banerjee R.,
RA   Barker G.E., Barlow K.F., Barrett I.P., Bates K.N., Beare D.M.,
RA   Beasley H., Beasley O., Beck A., Bethel G., Blechschmidt K., Brady N.,
RA   Bray-Allen S., Bridgeman A.M., Brown A.J., Brown M.J., Bonnin D.,
RA   Bruford E.A., Buhay C., Burch P., Burford D., Burgess J., Burrill W.,
RA   Burton J., Bye J.M., Carder C., Carrel L., Chako J., Chapman J.C.,
RA   Chavez D., Chen E., Chen G., Chen Y., Chen Z., Chinault C.,
RA   Ciccodicola A., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Clerc-Blankenburg K., Clifford K., Cobley V., Cole C.G., Conquer J.S.,
RA   Corby N., Connor R.E., David R., Davies J., Davis C., Davis J.,
RA   Delgado O., Deshazo D., Dhami P., Ding Y., Dinh H., Dodsworth S.,
RA   Draper H., Dugan-Rocha S., Dunham A., Dunn M., Durbin K.J., Dutta I.,
RA   Eades T., Ellwood M., Emery-Cohen A., Errington H., Evans K.L.,
RA   Faulkner L., Francis F., Frankland J., Fraser A.E., Galgoczy P.,
RA   Gilbert J., Gill R., Gloeckner G., Gregory S.G., Gribble S.,
RA   Griffiths C., Grocock R., Gu Y., Gwilliam R., Hamilton C., Hart E.A.,
RA   Hawes A., Heath P.D., Heitmann K., Hennig S., Hernandez J.,
RA   Hinzmann B., Ho S., Hoffs M., Howden P.J., Huckle E.J., Hume J.,
RA   Hunt P.J., Hunt A.R., Isherwood J., Jacob L., Johnson D., Jones S.,
RA   de Jong P.J., Joseph S.S., Keenan S., Kelly S., Kershaw J.K., Khan Z.,
RA   Kioschis P., Klages S., Knights A.J., Kosiura A., Kovar-Smith C.,
RA   Laird G.K., Langford C., Lawlor S., Leversha M., Lewis L., Liu W.,
RA   Lloyd C., Lloyd D.M., Loulseged H., Loveland J.E., Lovell J.D.,
RA   Lozado R., Lu J., Lyne R., Ma J., Maheshwari M., Matthews L.H.,
RA   McDowall J., McLaren S., McMurray A., Meidl P., Meitinger T.,
RA   Milne S., Miner G., Mistry S.L., Morgan M., Morris S., Mueller I.,
RA   Mullikin J.C., Nguyen N., Nordsiek G., Nyakatura G., O'dell C.N.,
RA   Okwuonu G., Palmer S., Pandian R., Parker D., Parrish J.,
RA   Pasternak S., Patel D., Pearce A.V., Pearson D.M., Pelan S.E.,
RA   Perez L., Porter K.M., Ramsey Y., Reichwald K., Rhodes S.,
RA   Ridler K.A., Schlessinger D., Schueler M.G., Sehra H.K.,
RA   Shaw-Smith C., Shen H., Sheridan E.M., Shownkeen R., Skuce C.D.,
RA   Smith M.L., Sotheran E.C., Steingruber H.E., Steward C.A., Storey R.,
RA   Swann R.M., Swarbreck D., Tabor P.E., Taudien S., Taylor T.,
RA   Teague B., Thomas K., Thorpe A., Timms K., Tracey A., Trevanion S.,
RA   Tromans A.C., d'Urso M., Verduzco D., Villasana D., Waldron L.,
RA   Wall M., Wang Q., Warren J., Warry G.L., Wei X., West A.,
RA   Whitehead S.L., Whiteley M.N., Wilkinson J.E., Willey D.L.,
RA   Williams G., Williams L., Williamson A., Williamson H., Wilming L.,
RA   Woodmansey R.L., Wray P.W., Yen J., Zhang J., Zhou J., Zoghbi H.,
RA   Zorilla S., Buck D., Reinhardt R., Poustka A., Rosenthal A.,
RA   Lehrach H., Meindl A., Minx P.J., Hillier L.W., Willard H.F.,
RA   Wilson R.K., Waterston R.H., Rice C.M., Vaudin M., Coulson A.,
RA   Nelson D.L., Weinstock G., Sulston J.E., Durbin R.M., Hubbard T.,
RA   Gibbs R.A., Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence of the human X chromosome.";
RL   Nature 434:325-337(2005).
RN   [2] {ECO:0000213|PubMed:21269460}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Burckstummer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [3] {ECO:0000213|PubMed:23186163}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=23186163;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [4] {ECO:0000213|PubMed:24275569}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [5] {ECO:0000313|Ensembl:ENSP00000485427}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (OCT-2014) to the EMBL/GenBank/DDBJ databases.
RN   [6] {ECO:0000213|PubMed:25944712}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AC006209; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   RefSeq; NP_001308297.1; NM_001321368.1.
DR   UniGene; Hs.653349; -.
DR   PeptideAtlas; A0A096LP69; -.
DR   Ensembl; ENST00000624481; ENSP00000485427; ENSG00000002586.
DR   GeneID; 4267; -.
DR   UCSC; uc064xus.1; human.
DR   CTD; 4267; -.
DR   EuPathDB; HostDB:ENSG00000002586.18; -.
DR   HGNC; HGNC:7082; CD99.
DR   OpenTargets; ENSG00000002586; -.
DR   eggNOG; ENOG410J50K; Eukaryota.
DR   eggNOG; ENOG410YW6Q; LUCA.
DR   GeneTree; ENSGT00730000111585; -.
DR   GenomeRNAi; 4267; -.
DR   Proteomes; UP000005640; Chromosome X.
DR   Bgee; ENSG00000002586; -.
DR   ExpressionAtlas; A0A096LP69; baseline and differential.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   InterPro; IPR022078; CD99L2.
DR   PANTHER; PTHR15076; PTHR15076; 1.
DR   Pfam; PF12301; CD99L2; 1.
PE   1: Evidence at protein level;
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   Membrane {ECO:0000256|SAM:Phobius};
KW   Proteomics identification {ECO:0000213|EPD:A0A096LP69,
KW   ECO:0000213|MaxQB:A0A096LP69, ECO:0000213|PeptideAtlas:A0A096LP69};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640};
KW   Signal {ECO:0000256|SAM:SignalP};
KW   Transmembrane {ECO:0000256|SAM:Phobius};
KW   Transmembrane helix {ECO:0000256|SAM:Phobius}.
FT   SIGNAL        1     20       {ECO:0000256|SAM:SignalP}.
FT   CHAIN        21    184       {ECO:0000256|SAM:SignalP}.
FT                                /FTId=PRO_5001919112.
FT   TRANSMEM    126    148       Helical. {ECO:0000256|SAM:Phobius}.
SQ   SEQUENCE   184 AA;  18777 MW;  4982CCD5E69DAE9B CRC64;
     MARGAALALL LFGLLGVLVA APDGGFDLSD ALPDNENKKP TAIPKKPSAG DDFDLGDAVV
     DGENDDPRPP NPPKPMPNPN PNHPSSSGSF SDADLADGVS GGEGKGGSDG GGSHRKEGEE
     ADAPGVIPGI VGAVVVAVAG AISSFIAYQK KKLCFKENEQ GEVDMESHRN ANAEPAVQRT
     LLEK
//
ID   CD99_HUMAN              Reviewed;         185 AA.
AC   P14209; A6NIW1; O00518; Q6ICV7;
DT   01-JAN-1990, integrated into UniProtKB/Swiss-Prot.
DT   01-JAN-1990, sequence version 1.
DT   28-MAR-2018, entry version 170.
DE   RecName: Full=CD99 antigen;
DE   AltName: Full=12E7;
DE   AltName: Full=E2 antigen;
DE   AltName: Full=Protein MIC2;
DE   AltName: Full=T-cell surface glycoprotein E2;
DE   AltName: CD_antigen=CD99;
DE   Flags: Precursor;
GN   Name=CD99; Synonyms=MIC2, MIC2X, MIC2Y;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM I), AND PROTEIN SEQUENCE OF 23-39.
RC   TISSUE=T-cell;
RX   PubMed=2479542;
RA   Gelin C., Aubrit F., Phalipon A., Raynal B., Cole S., Kaczorek M.,
RA   Bernard A.;
RT   "The E2 antigen, a 32 kd glycoprotein involved in T-cell adhesion
RT   processes, is the MIC2 gene product.";
RL   EMBO J. 8:3253-3259(1989).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM II).
RA   Park S.H., Hahn J.H., Kim M.K., Sohn H.W., Choi E.Y., Kim S.H.;
RT   "An alternative splicing form of CD99 (MIC2).";
RL   Submitted (DEC-1996) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM I).
RA   Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (MAY-2004) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15772651; DOI=10.1038/nature03440;
RA   Ross M.T., Grafham D.V., Coffey A.J., Scherer S., McLay K., Muzny D.,
RA   Platzer M., Howell G.R., Burrows C., Bird C.P., Frankish A.,
RA   Lovell F.L., Howe K.L., Ashurst J.L., Fulton R.S., Sudbrak R., Wen G.,
RA   Jones M.C., Hurles M.E., Andrews T.D., Scott C.E., Searle S.,
RA   Ramser J., Whittaker A., Deadman R., Carter N.P., Hunt S.E., Chen R.,
RA   Cree A., Gunaratne P., Havlak P., Hodgson A., Metzker M.L.,
RA   Richards S., Scott G., Steffen D., Sodergren E., Wheeler D.A.,
RA   Worley K.C., Ainscough R., Ambrose K.D., Ansari-Lari M.A., Aradhya S.,
RA   Ashwell R.I., Babbage A.K., Bagguley C.L., Ballabio A., Banerjee R.,
RA   Barker G.E., Barlow K.F., Barrett I.P., Bates K.N., Beare D.M.,
RA   Beasley H., Beasley O., Beck A., Bethel G., Blechschmidt K., Brady N.,
RA   Bray-Allen S., Bridgeman A.M., Brown A.J., Brown M.J., Bonnin D.,
RA   Bruford E.A., Buhay C., Burch P., Burford D., Burgess J., Burrill W.,
RA   Burton J., Bye J.M., Carder C., Carrel L., Chako J., Chapman J.C.,
RA   Chavez D., Chen E., Chen G., Chen Y., Chen Z., Chinault C.,
RA   Ciccodicola A., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Clerc-Blankenburg K., Clifford K., Cobley V., Cole C.G., Conquer J.S.,
RA   Corby N., Connor R.E., David R., Davies J., Davis C., Davis J.,
RA   Delgado O., Deshazo D., Dhami P., Ding Y., Dinh H., Dodsworth S.,
RA   Draper H., Dugan-Rocha S., Dunham A., Dunn M., Durbin K.J., Dutta I.,
RA   Eades T., Ellwood M., Emery-Cohen A., Errington H., Evans K.L.,
RA   Faulkner L., Francis F., Frankland J., Fraser A.E., Galgoczy P.,
RA   Gilbert J., Gill R., Gloeckner G., Gregory S.G., Gribble S.,
RA   Griffiths C., Grocock R., Gu Y., Gwilliam R., Hamilton C., Hart E.A.,
RA   Hawes A., Heath P.D., Heitmann K., Hennig S., Hernandez J.,
RA   Hinzmann B., Ho S., Hoffs M., Howden P.J., Huckle E.J., Hume J.,
RA   Hunt P.J., Hunt A.R., Isherwood J., Jacob L., Johnson D., Jones S.,
RA   de Jong P.J., Joseph S.S., Keenan S., Kelly S., Kershaw J.K., Khan Z.,
RA   Kioschis P., Klages S., Knights A.J., Kosiura A., Kovar-Smith C.,
RA   Laird G.K., Langford C., Lawlor S., Leversha M., Lewis L., Liu W.,
RA   Lloyd C., Lloyd D.M., Loulseged H., Loveland J.E., Lovell J.D.,
RA   Lozado R., Lu J., Lyne R., Ma J., Maheshwari M., Matthews L.H.,
RA   McDowall J., McLaren S., McMurray A., Meidl P., Meitinger T.,
RA   Milne S., Miner G., Mistry S.L., Morgan M., Morris S., Mueller I.,
RA   Mullikin J.C., Nguyen N., Nordsiek G., Nyakatura G., O'dell C.N.,
RA   Okwuonu G., Palmer S., Pandian R., Parker D., Parrish J.,
RA   Pasternak S., Patel D., Pearce A.V., Pearson D.M., Pelan S.E.,
RA   Perez L., Porter K.M., Ramsey Y., Reichwald K., Rhodes S.,
RA   Ridler K.A., Schlessinger D., Schueler M.G., Sehra H.K.,
RA   Shaw-Smith C., Shen H., Sheridan E.M., Shownkeen R., Skuce C.D.,
RA   Smith M.L., Sotheran E.C., Steingruber H.E., Steward C.A., Storey R.,
RA   Swann R.M., Swarbreck D., Tabor P.E., Taudien S., Taylor T.,
RA   Teague B., Thomas K., Thorpe A., Timms K., Tracey A., Trevanion S.,
RA   Tromans A.C., d'Urso M., Verduzco D., Villasana D., Waldron L.,
RA   Wall M., Wang Q., Warren J., Warry G.L., Wei X., West A.,
RA   Whitehead S.L., Whiteley M.N., Wilkinson J.E., Willey D.L.,
RA   Williams G., Williams L., Williamson A., Williamson H., Wilming L.,
RA   Woodmansey R.L., Wray P.W., Yen J., Zhang J., Zhou J., Zoghbi H.,
RA   Zorilla S., Buck D., Reinhardt R., Poustka A., Rosenthal A.,
RA   Lehrach H., Meindl A., Minx P.J., Hillier L.W., Willard H.F.,
RA   Wilson R.K., Waterston R.H., Rice C.M., Vaudin M., Coulson A.,
RA   Nelson D.L., Weinstock G., Sulston J.E., Durbin R.M., Hubbard T.,
RA   Gibbs R.A., Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence of the human X chromosome.";
RL   Nature 434:325-337(2005).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS I AND 3).
RC   TISSUE=Brain, Kidney, Lung carcinoma, Skin, and Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 10-105.
RX   PubMed=3472717;
RA   Darling S.M., Goodfellow P.J., Pym B., Banting G.S., Pritchard C.,
RA   Goodfellow P.N.;
RT   "Molecular genetics of MIC2: a gene shared by the human X and Y
RT   chromosomes.";
RL   Cold Spring Harb. Symp. Quant. Biol. 51:205-212(1986).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-22.
RX   PubMed=2456574; DOI=10.1073/pnas.85.15.5605;
RA   Goodfellow P.J., Mondello C., Darling S.M., Pym B., Little P.,
RA   Goodfellow P.N.;
RT   "Absence of methylation of a CpG-rich region at the 5' end of the MIC2
RT   gene on the active X, the inactive X, and the Y chromosome.";
RL   Proc. Natl. Acad. Sci. U.S.A. 85:5605-5609(1988).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-168 AND THR-181, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
CC   -!- FUNCTION: Involved in T-cell adhesion processes and in spontaneous
CC       rosette formation with erythrocytes. Plays a role in a late step
CC       of leukocyte extravasation helping leukocytes to overcome the
CC       endothelial basement membrane. Acts at the same site as, but
CC       independently of, PECAM1. Involved in T-cell adhesion processes
CC       (By similarity). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Single-pass type I
CC       membrane protein {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=I;
CC         IsoId=P14209-1; Sequence=Displayed;
CC       Name=II;
CC         IsoId=P14209-2; Sequence=VSP_004324;
CC       Name=3;
CC         IsoId=P14209-3; Sequence=VSP_046315;
CC         Note=No experimental confirmation available.;
CC   -!- PTM: Extensively O-glycosylated.
CC   -!- MISCELLANEOUS: The gene coding for this protein is located in the
CC       pseudoautosomal region 1 (PAR1) of X and Y chromosomes.
CC   -!- SIMILARITY: Belongs to the CD99 family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X16996; CAA34863.1; -; mRNA.
DR   EMBL; U82164; AAB58501.1; -; mRNA.
DR   EMBL; CR450286; CAG29282.1; -; mRNA.
DR   EMBL; AC006209; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471074; EAW98697.1; -; Genomic_DNA.
DR   EMBL; CH471074; EAW98698.1; -; Genomic_DNA.
DR   EMBL; BC002584; AAH02584.1; -; mRNA.
DR   EMBL; BC003147; AAH03147.1; -; mRNA.
DR   EMBL; BC010109; AAH10109.1; -; mRNA.
DR   EMBL; BC021620; AAH21620.1; -; mRNA.
DR   EMBL; BC024310; AAH24310.1; -; mRNA.
DR   EMBL; BQ948496; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; M16279; AAA02999.1; -; mRNA.
DR   EMBL; J03841; AAA59848.1; -; Genomic_DNA.
DR   CCDS; CCDS14119.1; -. [P14209-1]
DR   CCDS; CCDS48071.1; -. [P14209-3]
DR   CCDS; CCDS75947.1; -. [P14209-2]
DR   PIR; S06786; A60592.
DR   RefSeq; NP_001116370.1; NM_001122898.2. [P14209-3]
DR   RefSeq; NP_001308296.1; NM_001321367.1. [P14209-2]
DR   RefSeq; NP_001308297.1; NM_001321368.1.
DR   RefSeq; NP_001308298.1; NM_001321369.1.
DR   RefSeq; NP_002405.1; NM_002414.4. [P14209-1]
DR   UniGene; Hs.653349; -.
DR   ProteinModelPortal; P14209; -.
DR   SMR; P14209; -.
DR   BioGrid; 110420; 15.
DR   IntAct; P14209; 9.
DR   STRING; 9606.ENSP00000370588; -.
DR   iPTMnet; P14209; -.
DR   PhosphoSitePlus; P14209; -.
DR   SwissPalm; P14209; -.
DR   BioMuta; CD99; -.
DR   DMDM; 119049; -.
DR   EPD; P14209; -.
DR   MaxQB; P14209; -.
DR   PaxDb; P14209; -.
DR   PeptideAtlas; P14209; -.
DR   PRIDE; P14209; -.
DR   DNASU; 4267; -.
DR   Ensembl; ENST00000381187; ENSP00000370582; ENSG00000002586. [P14209-3]
DR   Ensembl; ENST00000381192; ENSP00000370588; ENSG00000002586. [P14209-1]
DR   Ensembl; ENST00000611428; ENSP00000479999; ENSG00000002586. [P14209-2]
DR   Ensembl; ENST00000623253; ENSP00000485545; ENSG00000002586. [P14209-2]
DR   GeneID; 4267; -.
DR   KEGG; hsa:4267; -.
DR   UCSC; uc004cqm.4; human. [P14209-1]
DR   CTD; 4267; -.
DR   DisGeNET; 4267; -.
DR   EuPathDB; HostDB:ENSG00000002586.18; -.
DR   GeneCards; CD99; -.
DR   H-InvDB; HIX0177591; -.
DR   HGNC; HGNC:7082; CD99.
DR   HPA; CAB000020; -.
DR   HPA; HPA035304; -.
DR   MIM; 313470; gene.
DR   MIM; 450000; gene.
DR   neXtProt; NX_P14209; -.
DR   OpenTargets; ENSG00000002586; -.
DR   PharmGKB; PA30804; -.
DR   eggNOG; ENOG410J50K; Eukaryota.
DR   eggNOG; ENOG410YW6Q; LUCA.
DR   GeneTree; ENSGT00730000111585; -.
DR   HOGENOM; HOG000233665; -.
DR   HOVERGEN; HBG067989; -.
DR   InParanoid; P14209; -.
DR   KO; K06520; -.
DR   OMA; MESHRNA; -.
DR   PhylomeDB; P14209; -.
DR   TreeFam; TF336273; -.
DR   Reactome; R-HSA-198933; Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell.
DR   Reactome; R-HSA-202733; Cell surface interactions at the vascular wall.
DR   GeneWiki; CD99; -.
DR   GenomeRNAi; 4267; -.
DR   PMAP-CutDB; P14209; -.
DR   PRO; PR:P14209; -.
DR   Proteomes; UP000005640; Chromosome X.
DR   Bgee; ENSG00000002586; -.
DR   CleanEx; HS_CD99; -.
DR   ExpressionAtlas; P14209; baseline and differential.
DR   Genevisible; P14209; HS.
DR   GO; GO:0005737; C:cytoplasm; TAS:ProtInc.
DR   GO; GO:0005925; C:focal adhesion; HDA:UniProtKB.
DR   GO; GO:0005887; C:integral component of plasma membrane; TAS:ProtInc.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0007155; P:cell adhesion; IEA:UniProtKB-KW.
DR   GO; GO:0050776; P:regulation of immune response; TAS:Reactome.
DR   InterPro; IPR022078; CD99L2.
DR   PANTHER; PTHR15076; PTHR15076; 1.
DR   Pfam; PF12301; CD99L2; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cell adhesion; Complete proteome;
KW   Direct protein sequencing; Glycoprotein; Membrane; Phosphoprotein;
KW   Polymorphism; Reference proteome; Signal; Transmembrane;
KW   Transmembrane helix.
FT   SIGNAL        1     22       {ECO:0000269|PubMed:2479542}.
FT   CHAIN        23    185       CD99 antigen.
FT                                /FTId=PRO_0000021726.
FT   TOPO_DOM     23    122       Extracellular. {ECO:0000255}.
FT   TRANSMEM    123    147       Helical. {ECO:0000255}.
FT   TOPO_DOM    148    185       Cytoplasmic. {ECO:0000255}.
FT   MOD_RES     168    168       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     181    181       Phosphothreonine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   VAR_SEQ      34     49       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_046315.
FT   VAR_SEQ     159    185       AEQGEVDMESHRNANAEPAVQRTLLEK -> DG (in
FT                                isoform II). {ECO:0000303|Ref.2}.
FT                                /FTId=VSP_004324.
FT   VARIANT     166    166       M -> V (in dbSNP:rs4793).
FT                                /FTId=VAR_014733.
FT   VARIANT     173    173       N -> I (in dbSNP:rs4717).
FT                                /FTId=VAR_014734.
SQ   SEQUENCE   185 AA;  18848 MW;  C302E09E6B022EAB CRC64;
     MARGAALALL LFGLLGVLVA APDGGFDLSD ALPDNENKKP TAIPKKPSAG DDFDLGDAVV
     DGENDDPRPP NPPKPMPNPN PNHPSSSGSF SDADLADGVS GGEGKGGSDG GGSHRKEGEE
     ADAPGVIPGI VGAVVVAVAG AISSFIAYQK KKLCFKENAE QGEVDMESHR NANAEPAVQR
     TLLEK
//
ID   J9PH39_HUMAN            Unreviewed;       347 AA.
AC   J9PH39;
DT   28-NOV-2012, integrated into UniProtKB/TrEMBL.
DT   28-NOV-2012, sequence version 1.
DT   31-JAN-2018, entry version 36.
DE   SubName: Full=TNFR1-d2 {ECO:0000313|EMBL:AEO89726.1};
GN   Name=TNFRSF1A {ECO:0000313|EMBL:AEO89726.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:AEO89726.1};
RN   [1] {ECO:0000313|EMBL:AEO89726.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Rittore C., Sanchez E., Soler S., Barat-Houari M., Albers M.,
RA   Obici L., mcDermott M.F., Touitou I., Grandemange S.;
RT   "Identification of a new exon 2-skipped TNFR1 transcript: regulation
RT   by three functional polymorphisms of the TNFR-associated periodic
RT   syndrome (TRAPS) gene.";
RL   Ann. Rheum. Dis. 0:0-0(2013).
CC   -!- CAUTION: Lacks conserved residue(s) required for the propagation
CC       of feature annotation. {ECO:0000256|PROSITE-ProRule:PRU00206}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; JN172914; AEO89726.1; -; mRNA.
DR   RefSeq; NP_001333020.1; NM_001346091.1.
DR   UniGene; Hs.279594; -.
DR   UniGene; Hs.713833; -.
DR   SMR; J9PH39; -.
DR   GeneID; 7132; -.
DR   CTD; 7132; -.
DR   eggNOG; ENOG410IXBX; Eukaryota.
DR   eggNOG; ENOG4111YG2; LUCA.
DR   ChiTaRS; TNFRSF1A; human.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005031; F:tumor necrosis factor-activated receptor activity; IEA:InterPro.
DR   GO; GO:0006954; P:inflammatory response; IEA:InterPro.
DR   GO; GO:0006693; P:prostaglandin metabolic process; IEA:InterPro.
DR   CDD; cd08313; Death_TNFR1; 1.
DR   InterPro; IPR011029; DEATH-like_dom_sf.
DR   InterPro; IPR000488; Death_domain.
DR   InterPro; IPR001368; TNFR/NGFR_Cys_rich_reg.
DR   InterPro; IPR020419; TNFR_1A.
DR   InterPro; IPR033994; TNFRSF1A_death.
DR   Pfam; PF00531; Death; 1.
DR   Pfam; PF00020; TNFR_c6; 1.
DR   PRINTS; PR01918; TNFACTORR1A.
DR   SMART; SM00005; DEATH; 1.
DR   SMART; SM00208; TNFR; 2.
DR   SUPFAM; SSF47986; SSF47986; 1.
DR   PROSITE; PS50017; DEATH_DOMAIN; 1.
DR   PROSITE; PS50050; TNFR_NGFR_2; 1.
PE   2: Evidence at transcript level;
KW   Membrane {ECO:0000256|SAM:Phobius};
KW   Transmembrane {ECO:0000256|SAM:Phobius};
KW   Transmembrane helix {ECO:0000256|SAM:Phobius}.
FT   TRANSMEM    104    126       Helical. {ECO:0000256|SAM:Phobius}.
FT   DOMAIN       18     58       TNFR-Cys. {ECO:0000259|PROSITE:PS50050}.
FT   REPEAT       18     58       TNFR-Cys. {ECO:0000256|PROSITE-
FT                                ProRule:PRU00206}.
FT   DOMAIN      248    333       Death. {ECO:0000259|PROSITE:PS50017}.
SQ   SEQUENCE   347 AA;  38651 MW;  8C629DAF8D7BA515 CRC64;
     MGQVEISSCT VDRDTVCGCR KNQYRHYWSE NLFQCFNCSL CLNGTVHLSC QEKQNTVCTC
     HAGFFLRENE CVSCSNCKKS LECTKLCLPQ IENVKGTEDS GTTVLLPLVI FFGLCLLSLL
     FIGLMYRYQR WKSKLYSIVC GKSTPEKEGE LEGTTTKPLA PNPSFSPTPG FTPTLGFSPV
     PSSTFTSSST YTPGDCPNFA APRREVAPPY QGADPILATA LASDPIPNPL QKWEDSAHKP
     QSLDTDDPAT LYAVVENVPP LRWKEFVRRL GLSDHEIDRL ELQNGRCLRE AQYSMLATWR
     RRTPRREATL ELLGRVLRDM DLLGCLEDIE EALCGPAALP PAPSLLR
//
ID   TNR1A_HUMAN             Reviewed;         455 AA.
AC   P19438; A8K4X3; B2RDE4; B3KPQ1; B4DQB7; B4E309; B5M0B5; D3DUR1;
AC   Q9UCA4;
DT   01-FEB-1991, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-1991, sequence version 1.
DT   23-MAY-2018, entry version 226.
DE   RecName: Full=Tumor necrosis factor receptor superfamily member 1A;
DE   AltName: Full=Tumor necrosis factor receptor 1;
DE            Short=TNF-R1;
DE   AltName: Full=Tumor necrosis factor receptor type I;
DE            Short=TNF-RI;
DE            Short=TNFR-I;
DE   AltName: Full=p55;
DE   AltName: Full=p60;
DE   AltName: CD_antigen=CD120a;
DE   Contains:
DE     RecName: Full=Tumor necrosis factor receptor superfamily member 1A, membrane form;
DE   Contains:
DE     RecName: Full=Tumor necrosis factor-binding protein 1;
DE              Short=TBPI;
DE   Flags: Precursor;
GN   Name=TNFRSF1A; Synonyms=TNFAR, TNFR1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND PROTEIN SEQUENCE OF 30-57
RP   AND 252-264.
RX   PubMed=2158862; DOI=10.1016/0092-8674(90)90815-V;
RA   Loetscher H., Pan Y.-C.E., Lahm H.-W., Gentz R., Brockhaus M.,
RA   Tabuchi H., Lesslauer W.;
RT   "Molecular cloning and expression of the human 55 kd tumor necrosis
RT   factor receptor.";
RL   Cell 61:351-359(1990).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Placenta;
RX   PubMed=2158863; DOI=10.1016/0092-8674(90)90816-W;
RA   Schall T.J., Lewis M., Koller K.J., Lee A., Rice G.C., Wong G.H.W.,
RA   Getanaga T., Granger G.A., Lentz R., Raab H., Kohr W.J., Goeddel D.V.;
RT   "Molecular cloning and expression of a receptor for human tumor
RT   necrosis factor.";
RL   Cell 61:361-370(1990).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=1702293; DOI=10.1089/dna.1990.9.705;
RA   Himmler A., Maurer-Fogy I., Kroenke M., Scheurich P., Pfizenmaier K.,
RA   Lantz M., Olsson I., Hauptmann R., Stratowa C., Adolf G.R.;
RT   "Molecular cloning and expression of human and rat tumor necrosis
RT   factor receptor chain (p60) and its soluble derivative, tumor necrosis
RT   factor-binding protein.";
RL   DNA Cell Biol. 9:705-715(1990).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND PROTEIN SEQUENCE OF 41-53;
RP   110-124 AND 199-201 (ISOFORM 1).
RX   PubMed=1698610;
RA   Nophar Y., Kemper O., Brakebusch C., Engelmann H., Zwang R.,
RA   Aderka D., Holtmann H., Wallach D.;
RT   "Soluble forms of tumor necrosis factor receptors (TNF-Rs). The cDNA
RT   for the type I TNF-R, cloned using amino acid sequence data of its
RT   soluble form, encodes both the cell surface and a soluble form of the
RT   receptor.";
RL   EMBO J. 9:3269-3278(1990).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Placenta;
RX   PubMed=2170974; DOI=10.1073/pnas.87.19.7380;
RA   Gray P.W., Barrett K., Chantry D., Turner M., Feldman M.;
RT   "Cloning of human tumor necrosis factor (TNF) receptor cDNA and
RT   expression of recombinant soluble TNF-binding protein.";
RL   Proc. Natl. Acad. Sci. U.S.A. 87:7380-7384(1990).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=1315717; DOI=10.1016/0888-7543(92)90226-I;
RA   Fuchs P., Strehl S., Dworzak M., Himmler A., Ambros P.F.;
RT   "Structure of the human TNF receptor 1 (p60) gene (TNFR1) and
RT   localization to chromosome 12p13.";
RL   Genomics 13:219-224(1992).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS LEU-75 AND GLN-121.
RG   SeattleSNPs variation discovery resource;
RL   Submitted (JUL-2002) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1; 2 AND 3).
RC   TISSUE=Neutrophil, Teratocarcinoma, Tongue, and Uterus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 5).
RX   PubMed=19906316; DOI=10.1186/1471-2164-10-518;
RA   Wang P., Yu P., Gao P., Shi T., Ma D.;
RT   "Discovery of novel human transcript variants by analysis of intronic
RT   single-block EST with polyadenylation site.";
RL   BMC Genomics 10:518-518(2009).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16541075; DOI=10.1038/nature04569;
RA   Scherer S.E., Muzny D.M., Buhay C.J., Chen R., Cree A., Ding Y.,
RA   Dugan-Rocha S., Gill R., Gunaratne P., Harris R.A., Hawes A.C.,
RA   Hernandez J., Hodgson A.V., Hume J., Jackson A., Khan Z.M.,
RA   Kovar-Smith C., Lewis L.R., Lozado R.J., Metzker M.L.,
RA   Milosavljevic A., Miner G.R., Montgomery K.T., Morgan M.B.,
RA   Nazareth L.V., Scott G., Sodergren E., Song X.-Z., Steffen D.,
RA   Lovering R.C., Wheeler D.A., Worley K.C., Yuan Y., Zhang Z.,
RA   Adams C.Q., Ansari-Lari M.A., Ayele M., Brown M.J., Chen G., Chen Z.,
RA   Clerc-Blankenburg K.P., Davis C., Delgado O., Dinh H.H., Draper H.,
RA   Gonzalez-Garay M.L., Havlak P., Jackson L.R., Jacob L.S., Kelly S.H.,
RA   Li L., Li Z., Liu J., Liu W., Lu J., Maheshwari M., Nguyen B.-V.,
RA   Okwuonu G.O., Pasternak S., Perez L.M., Plopper F.J.H., Santibanez J.,
RA   Shen H., Tabor P.E., Verduzco D., Waldron L., Wang Q., Williams G.A.,
RA   Zhang J., Zhou J., Allen C.C., Amin A.G., Anyalebechi V., Bailey M.,
RA   Barbaria J.A., Bimage K.E., Bryant N.P., Burch P.E., Burkett C.E.,
RA   Burrell K.L., Calderon E., Cardenas V., Carter K., Casias K.,
RA   Cavazos I., Cavazos S.R., Ceasar H., Chacko J., Chan S.N., Chavez D.,
RA   Christopoulos C., Chu J., Cockrell R., Cox C.D., Dang M.,
RA   Dathorne S.R., David R., Davis C.M., Davy-Carroll L., Deshazo D.R.,
RA   Donlin J.E., D'Souza L., Eaves K.A., Egan A., Emery-Cohen A.J.,
RA   Escotto M., Flagg N., Forbes L.D., Gabisi A.M., Garza M., Hamilton C.,
RA   Henderson N., Hernandez O., Hines S., Hogues M.E., Huang M.,
RA   Idlebird D.G., Johnson R., Jolivet A., Jones S., Kagan R., King L.M.,
RA   Leal B., Lebow H., Lee S., LeVan J.M., Lewis L.C., London P.,
RA   Lorensuhewa L.M., Loulseged H., Lovett D.A., Lucier A., Lucier R.L.,
RA   Ma J., Madu R.C., Mapua P., Martindale A.D., Martinez E., Massey E.,
RA   Mawhiney S., Meador M.G., Mendez S., Mercado C., Mercado I.C.,
RA   Merritt C.E., Miner Z.L., Minja E., Mitchell T., Mohabbat F.,
RA   Mohabbat K., Montgomery B., Moore N., Morris S., Munidasa M.,
RA   Ngo R.N., Nguyen N.B., Nickerson E., Nwaokelemeh O.O., Nwokenkwo S.,
RA   Obregon M., Oguh M., Oragunye N., Oviedo R.J., Parish B.J.,
RA   Parker D.N., Parrish J., Parks K.L., Paul H.A., Payton B.A., Perez A.,
RA   Perrin W., Pickens A., Primus E.L., Pu L.-L., Puazo M., Quiles M.M.,
RA   Quiroz J.B., Rabata D., Reeves K., Ruiz S.J., Shao H., Sisson I.,
RA   Sonaike T., Sorelle R.P., Sutton A.E., Svatek A.F., Svetz L.A.,
RA   Tamerisa K.S., Taylor T.R., Teague B., Thomas N., Thorn R.D.,
RA   Trejos Z.Y., Trevino B.K., Ukegbu O.N., Urban J.B., Vasquez L.I.,
RA   Vera V.A., Villasana D.M., Wang L., Ward-Moore S., Warren J.T.,
RA   Wei X., White F., Williamson A.L., Wleczyk R., Wooden H.S.,
RA   Wooden S.H., Yen J., Yoon L., Yoon V., Zorrilla S.E., Nelson D.,
RA   Kucherlapati R., Weinstock G., Gibbs R.A.;
RT   "The finished DNA sequence of human chromosome 12.";
RL   Nature 440:346-351(2006).
RN   [11]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [12]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Muscle;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [13]
RP   PROTEIN SEQUENCE OF 41-57 (ISOFORM 1).
RC   TISSUE=Urine;
RX   PubMed=8015639;
RA   Suzuki J., Tomizawa S., Arai H., Seki Y., Maruyama K., Kuroume T.;
RT   "Purification of two types of TNF inhibitors in the urine of the
RT   patient with chronic glomerulonephritis.";
RL   Nephron 66:386-390(1994).
RN   [14]
RP   PROTEIN SEQUENCE OF 41-45 (ISOFORM 1).
RX   PubMed=2153136;
RA   Engelmann H., Novick D., Wallach D.;
RT   "Two tumor necrosis factor-binding proteins purified from human urine.
RT   Evidence for immunological cross-reactivity with cell surface tumor
RT   necrosis factor receptors.";
RL   J. Biol. Chem. 265:1531-1536(1990).
RN   [15]
RP   INTERACTION WITH HCV CORE PROTEIN.
RX   PubMed=9557650;
RA   Zhu N., Khoshnan A., Schneider R., Matsumoto M., Dennert G.,
RA   Ware C.F., Lai M.M.C.;
RT   "Hepatitis C virus core protein binds to the cytoplasmic domain of
RT   tumor necrosis factor (TNF) receptor 1 and enhances TNF-induced
RT   apoptosis.";
RL   J. Virol. 72:3691-3697(1998).
RN   [16]
RP   INTERACTION WITH RIPK1 AND SQSTM1.
RX   PubMed=10356400; DOI=10.1093/emboj/18.11.3044;
RA   Sanz L., Sanchez P., Lallena M.-J., Diaz-Meco M.T., Moscat J.;
RT   "The interaction of p62 with RIP links the atypical PKCs to NF-kappaB
RT   activation.";
RL   EMBO J. 18:3044-3053(1999).
RN   [17]
RP   INTERACTION WITH FEM1B.
RX   PubMed=10542291; DOI=10.1074/jbc.274.45.32461;
RA   Chan S.-L., Tan K.-O., Zhang L., Yee K.S.Y., Ronca F., Chan M.-Y.,
RA   Yu V.C.;
RT   "F1Aalpha, a death receptor-binding protein homologous to the
RT   Caenorhabditis elegans sex-determining protein, FEM-1, is a caspase
RT   substrate that mediates apoptosis.";
RL   J. Biol. Chem. 274:32461-32468(1999).
RN   [18]
RP   INTERACTION WITH GRB2.
RX   PubMed=10359574; DOI=10.1084/jem.189.11.1707;
RA   Hildt E., Oess S.;
RT   "Identification of Grb2 as a novel binding partner of tumor necrosis
RT   factor (TNF) receptor I.";
RL   J. Exp. Med. 189:1707-1714(1999).
RN   [19]
RP   INTERACTION WITH BAG4.
RX   PubMed=9915703; DOI=10.1126/science.283.5401.543;
RA   Jiang Y., Woronicz J.D., Liu W., Goeddel D.V.;
RT   "Prevention of constitutive TNF receptor 1 signaling by silencer of
RT   death domains.";
RL   Science 283:543-546(1999).
RN   [20]
RP   INTERACTION WITH BABAM2.
RX   PubMed=15465831; DOI=10.1074/jbc.M408678200;
RA   Li Q., Ching A.K.-K., Chan B.C.-L., Chow S.K.-Y., Lim P.-L.,
RA   Ho T.C.-Y., Ip W.-K., Wong C.-K., Lam C.W.-K., Lee K.K.-H.,
RA   Chan J.Y.-H., Chui Y.-L.;
RT   "A death receptor-associated anti-apoptotic protein, BRE, inhibits
RT   mitochondrial apoptotic pathway.";
RL   J. Biol. Chem. 279:52106-52116(2004).
RN   [21]
RP   INTERACTION WITH HHV-5 PROTEIN UL138.
RX   PubMed=21976655; DOI=10.1128/JVI.06005-11;
RA   Le V.T., Trilling M., Hengel H.;
RT   "The cytomegaloviral protein pUL138 acts as potentiator of tumor
RT   necrosis factor (TNF) receptor 1 surface density to enhance ULb'-
RT   encoded modulation of TNF-alpha signaling.";
RL   J. Virol. 85:13260-13270(2011).
RN   [22]
RP   INVOLVEMENT IN MS5, SUBCELLULAR LOCATION, AND ALTERNATIVE SPLICING
RP   (ISOFORM 4).
RX   PubMed=22801493; DOI=10.1038/nature11307;
RA   Gregory A.P., Dendrou C.A., Attfield K.E., Haghikia A., Xifara D.K.,
RA   Butter F., Poschmann G., Kaur G., Lambert L., Leach O.A., Promel S.,
RA   Punwani D., Felce J.H., Davis S.J., Gold R., Nielsen F.C.,
RA   Siegel R.M., Mann M., Bell J.I., McVean G., Fugger L.;
RT   "TNF receptor 1 genetic risk mirrors outcome of anti-TNF therapy in
RT   multiple sclerosis.";
RL   Nature 488:508-511(2012).
RN   [23]
RP   INTERACTION WITH MUMPS VIRUS PROTEIN SH.
RX   PubMed=28659487; DOI=10.1128/JVI.01037-17;
RA   Franz S., Rennert P., Woznik M., Gruetzke J., Luedde A.,
RA   Arriero Pais E.M., Finsterbusch T., Geyer H., Mankertz A.,
RA   Friedrich N.;
RT   "Mumps virus SH protein inhibits NF-kappaB activation by interacting
RT   with tumor necrosis factor receptor 1, interleukin-1 receptor 1, and
RT   Toll-like receptor 3 complexes.";
RL   J. Virol. 91:0-0(2017).
RN   [24]
RP   X-RAY CRYSTALLOGRAPHY (2.85 ANGSTROMS) OF 30-211 IN COMPLEX WITH TNFB.
RX   PubMed=8387891; DOI=10.1016/0092-8674(93)90132-A;
RA   Banner D.W., D'Arcy A., Janes W., Gentz R., Schoenfeld H.-J.,
RA   Broger C., Loetscher H., Lesslauer W.;
RT   "Crystal structure of the soluble human 55 kd TNF receptor-human TNF
RT   beta complex: implications for TNF receptor activation.";
RL   Cell 73:431-445(1993).
RN   [25]
RP   X-RAY CRYSTALLOGRAPHY (1.85 ANGSTROMS) OF 41-202.
RX   PubMed=8939750; DOI=10.1016/S0969-2126(96)00134-7;
RA   Naismith J.H., Devine T.Q., Khono H., Sprang S.R.;
RT   "Structures of the extracellular domain of the type I tumor necrosis
RT   factor receptor.";
RL   Structure 4:1251-1262(1996).
RN   [26]
RP   VARIANTS FHF ARG-59; TYR-62; MET-79; PHE-81; ARG-117 AND TYR-117.
RX   PubMed=10199409; DOI=10.1016/S0092-8674(00)80721-7;
RA   McDermott M.F., Aksentijevich I., Galon J., McDermott E.M.,
RA   Ogunkolade B.W., Centola M., Mansfield E., Gadina M., Karenko L.,
RA   Pettersson T., McCarthy J., Frucht D.M., Aringer M., Torosyan Y.,
RA   Teppo A.-M., Wilson M., Karaarslan H.M., Wan Y., Todd I., Wood G.,
RA   Schlimgen R., Kumarajeewa T.R., Cooper S.M., Vella J.P., Amos C.I.,
RA   Mulley J., Quane K.A., Molloy M.G., Rnaki A., Powell R.J.,
RA   Hitman G.A., O'Shea J., Kastner D.L.;
RT   "Germline mutations in the extracellular domains of the 55 kDa TNF
RT   receptor, TNFR1, define a family of dominantly inherited
RT   autoinflammatory syndromes.";
RL   Cell 97:133-144(1999).
RN   [27]
RP   VARIANT FHF SER-59.
RX   PubMed=10902757;
RX   DOI=10.1002/1529-0131(200007)43:7<1535::AID-ANR18>3.0.CO;2-C;
RA   Dode C., Papo T., Fieschi C., Pecheux C., Dion E., Picard F.,
RA   Godeau P., Bienvenu J., Piette J.-C., Delpech M., Grateau G.;
RT   "A novel missense mutation (C30S) in the gene encoding tumor necrosis
RT   factor receptor 1 linked to autosomal-dominant recurrent fever with
RT   localized myositis in a French family.";
RL   Arthritis Rheum. 43:1535-1542(2000).
RN   [28]
RP   VARIANTS FHF GLN-51; SER-59; GLY-62; LEU-75; GLY-115 AND GLN-121.
RX   PubMed=11443543; DOI=10.1086/321976;
RA   Aksentijevich I., Galon J., Soares M., Mansfield E., Hull K.,
RA   Oh H.-H., Goldbach-Mansky R., Dean J., Athreya B., Reginato A.J.,
RA   Henrickson M., Pons-Estel B., O'Shea J.J., Kastner D.L.;
RT   "The tumor-necrosis-factor receptor-associated periodic syndrome: new
RT   mutations in TNFRSF1A, ancestral origins, genotype-phenotype studies,
RT   and evidence for further genetic heterogeneity of periodic fevers.";
RL   Am. J. Hum. Genet. 69:301-314(2001).
RN   [29]
RP   VARIANTS FHF SER-99 AND PRO-121.
RX   PubMed=13130484; DOI=10.1002/art.11215;
RA   Aganna E., Hammond L., Hawkins P.N., Aldea A., McKee S.A.,
RA   Ploos van Amstel H.K., Mischung C., Kusuhara K., Saulsbury F.T.,
RA   Lachmann H.J., Bybee A., McDermott E.M., La Regina M., Arostegui J.I.,
RA   Campistol J.M., Worthington S., High K.P., Molloy M.G., Baker N.,
RA   Bidwell J.L., Castaner J.L., Whiteford M.L., Janssens-Korpola P.L.,
RA   Manna R., Powell R.J., Woo P., Solis P., Minden K., Frenkel J.,
RA   Yague J., Mirakian R.M., Hitman G.A., McDermott M.F.;
RT   "Heterogeneity among patients with tumor necrosis factor receptor-
RT   associated periodic syndrome phenotypes.";
RL   Arthritis Rheum. 48:2632-2644(2003).
RN   [30]
RP   VARIANT FHF SER-99.
RX   PubMed=14610673; DOI=10.1007/s00431-003-1338-0;
RA   Kusuhara K., Nomura A., Nakao F., Hara T.;
RT   "Tumour necrosis factor receptor-associated periodic syndrome with a
RT   novel mutation in the TNFRSF1A gene in a Japanese family.";
RL   Eur. J. Pediatr. 163:30-32(2004).
CC   -!- FUNCTION: Receptor for TNFSF2/TNF-alpha and homotrimeric
CC       TNFSF1/lymphotoxin-alpha. The adapter molecule FADD recruits
CC       caspase-8 to the activated receptor. The resulting death-inducing
CC       signaling complex (DISC) performs caspase-8 proteolytic activation
CC       which initiates the subsequent cascade of caspases (aspartate-
CC       specific cysteine proteases) mediating apoptosis. Contributes to
CC       the induction of non-cytocidal TNF effects including anti-viral
CC       state and activation of the acid sphingomyelinase.
CC   -!- SUBUNIT: Binding of TNF to the extracellular domain leads to
CC       homotrimerization. The aggregated death domains provide a novel
CC       molecular interface that interacts specifically with the death
CC       domain of TRADD. Various TRADD-interacting proteins such as TRAFS,
CC       RIPK1 and possibly FADD, are recruited to the complex by their
CC       association with TRADD. This complex activates at least two
CC       distinct signaling cascades, apoptosis and NF-kappa-B signaling.
CC       Interacts with BAG4, BABAM2, FEM1B, GRB2, SQSTM1 and TRPC4AP.
CC       Interacts directly with NOL3 (via CARD domain); inhibits TNF-
CC       signaling pathway (By similarity). {ECO:0000250|UniProtKB:P25118,
CC       ECO:0000269|PubMed:10356400, ECO:0000269|PubMed:10359574,
CC       ECO:0000269|PubMed:10542291, ECO:0000269|PubMed:15465831,
CC       ECO:0000269|PubMed:8387891, ECO:0000269|PubMed:9915703}.
CC   -!- SUBUNIT: (Microbial infection) Interacts with mumps virus protein
CC       SH; this interaction inhibits downstream NF-kappa-B pathway
CC       activation (PubMed:28659487). Interacts with HCV core protein.
CC       Interacts with human cytomegalovirus/HHV-5 protein UL138
CC       (PubMed:21976655). {ECO:0000269|PubMed:21976655,
CC       ECO:0000269|PubMed:28659487, ECO:0000269|PubMed:9557650}.
CC   -!- INTERACTION:
CC       P28799:GRN; NbExp=4; IntAct=EBI-299451, EBI-747754;
CC       Q969G6:RFK; NbExp=4; IntAct=EBI-299451, EBI-716872;
CC       Q13546:RIPK1; NbExp=6; IntAct=EBI-299451, EBI-358507;
CC       P01375:TNF; NbExp=15; IntAct=EBI-299451, EBI-359977;
CC       Q15628:TRADD; NbExp=13; IntAct=EBI-299451, EBI-359215;
CC       Q12933:TRAF2; NbExp=4; IntAct=EBI-299451, EBI-355744;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:22801493};
CC       Single-pass type I membrane protein {ECO:0000269|PubMed:22801493}.
CC       Golgi apparatus membrane {ECO:0000269|PubMed:22801493}; Single-
CC       pass type I membrane protein {ECO:0000269|PubMed:22801493}.
CC       Secreted {ECO:0000269|PubMed:22801493}. Note=A secreted form is
CC       produced through proteolytic processing.
CC   -!- SUBCELLULAR LOCATION: Isoform 4: Secreted. Note=Lacks a Golgi-
CC       retention motif, is not membrane bound and therefore is secreted.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=5;
CC       Name=1; Synonyms=FL-TNFR1;
CC         IsoId=P19438-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P19438-2; Sequence=VSP_037153;
CC         Note=No experimental confirmation available.;
CC       Name=4; Synonyms=Delta6-TNFR1;
CC         IsoId=P19438-4; Sequence=VSP_044949;
CC         Note=Disease-associated isoform. Isoform 4 splicing pattern is
CC         driven by a variation in the exon 6/intron 6 boundary region
CC         that alters exon 6 splicing. Exon 6 skipping introduces a
CC         frameshift and the translation of a protein lacking the
CC         intracellular, the transmembrane and part of the extracellular
CC         domain.;
CC       Name=3;
CC         IsoId=P19438-3; Sequence=VSP_037154;
CC         Note=No experimental confirmation available.;
CC       Name=5;
CC         IsoId=P19438-5; Sequence=VSP_047613, VSP_047614;
CC         Note=No experimental confirmation available.;
CC   -!- DOMAIN: The domain that induces A-SMASE is probably identical to
CC       the death domain. The N-SMASE activation domain (NSD) is both
CC       necessary and sufficient for activation of N-SMASE.
CC   -!- DOMAIN: Both the cytoplasmic membrane-proximal region and the C-
CC       terminal region containing the death domain are involved in the
CC       interaction with TRPC4AP. {ECO:0000250}.
CC   -!- PTM: The soluble form is produced from the membrane form by
CC       proteolytic processing.
CC   -!- DISEASE: Familial hibernian fever (FHF) [MIM:142680]: A hereditary
CC       periodic fever syndrome characterized by recurrent fever,
CC       abdominal pain, localized tender skin lesions and myalgia.
CC       Reactive amyloidosis is the main complication and occurs in 25% of
CC       cases. {ECO:0000269|PubMed:10199409, ECO:0000269|PubMed:10902757,
CC       ECO:0000269|PubMed:11443543, ECO:0000269|PubMed:13130484,
CC       ECO:0000269|PubMed:14610673}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Multiple sclerosis 5 (MS5) [MIM:614810]: A
CC       multifactorial, inflammatory, demyelinating disease of the central
CC       nervous system. Sclerotic lesions are characterized by
CC       perivascular infiltration of monocytes and lymphocytes and appear
CC       as indurated areas in pathologic specimens (sclerosis in plaques).
CC       The pathological mechanism is regarded as an autoimmune attack of
CC       the myelin sheath, mediated by both cellular and humoral immunity.
CC       Clinical manifestations include visual loss, extra-ocular movement
CC       disorders, paresthesias, loss of sensation, weakness, dysarthria,
CC       spasticity, ataxia and bladder dysfunction. Genetic and
CC       environmental factors influence susceptibility to the disease.
CC       {ECO:0000269|PubMed:22801493}. Note=Disease susceptibility is
CC       associated with variations affecting the gene represented in this
CC       entry. An intronic mutation affecting alternative splicing and
CC       skipping of exon 6 directs increased expression of isoform 4 a
CC       transcript encoding a C-terminally truncated protein which is
CC       secreted and may function as a TNF antagonist.
CC   -!- WEB RESOURCE: Name=INFEVERS; Note=Repertory of FMF and hereditary
CC       autoinflammatory disorders mutations;
CC       URL="http://fmf.igh.cnrs.fr/ISSAID/infevers/search.php?n=2";
CC   -!- WEB RESOURCE: Name=SeattleSNPs;
CC       URL="http://pga.gs.washington.edu/data/tnfrsf1a/";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M58286; AAA36753.1; -; mRNA.
DR   EMBL; M33294; AAA03210.1; -; mRNA.
DR   EMBL; M63121; AAA36754.1; -; mRNA.
DR   EMBL; X55313; CAA39021.1; -; mRNA.
DR   EMBL; M60275; AAA36756.1; -; mRNA.
DR   EMBL; M75866; AAA61201.1; -; Genomic_DNA.
DR   EMBL; M75864; AAA61201.1; JOINED; Genomic_DNA.
DR   EMBL; M75865; AAA61201.1; JOINED; Genomic_DNA.
DR   EMBL; AY131997; AAM77802.1; -; Genomic_DNA.
DR   EMBL; AK056611; BAG51763.1; -; mRNA.
DR   EMBL; AK291088; BAF83777.1; -; mRNA.
DR   EMBL; AK298729; BAG60879.1; -; mRNA.
DR   EMBL; AK304517; BAG65321.1; -; mRNA.
DR   EMBL; AK315509; BAG37891.1; -; mRNA.
DR   EMBL; EU927389; ACH57451.1; -; mRNA.
DR   EMBL; AC006057; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471116; EAW88805.1; -; Genomic_DNA.
DR   EMBL; CH471116; EAW88806.1; -; Genomic_DNA.
DR   EMBL; BC010140; AAH10140.1; -; mRNA.
DR   CCDS; CCDS8542.1; -. [P19438-1]
DR   PIR; A38208; GQHUT1.
DR   RefSeq; NP_001056.1; NM_001065.3. [P19438-1]
DR   RefSeq; NP_001333020.1; NM_001346091.1. [P19438-2]
DR   RefSeq; NP_001333021.1; NM_001346092.1.
DR   UniGene; Hs.279594; -.
DR   UniGene; Hs.713833; -.
DR   PDB; 1EXT; X-ray; 1.85 A; A/B=41-201.
DR   PDB; 1FT4; X-ray; 2.90 A; A/B=41-201.
DR   PDB; 1ICH; NMR; -; A=345-455.
DR   PDB; 1NCF; X-ray; 2.25 A; A/B=41-201.
DR   PDB; 1TNR; X-ray; 2.85 A; R=44-182.
DR   PDBsum; 1EXT; -.
DR   PDBsum; 1FT4; -.
DR   PDBsum; 1ICH; -.
DR   PDBsum; 1NCF; -.
DR   PDBsum; 1TNR; -.
DR   ProteinModelPortal; P19438; -.
DR   SMR; P19438; -.
DR   BioGrid; 112986; 161.
DR   CORUM; P19438; -.
DR   DIP; DIP-407N; -.
DR   IntAct; P19438; 36.
DR   MINT; P19438; -.
DR   STRING; 9606.ENSP00000162749; -.
DR   BindingDB; P19438; -.
DR   ChEMBL; CHEMBL3378; -.
DR   iPTMnet; P19438; -.
DR   PhosphoSitePlus; P19438; -.
DR   BioMuta; TNFRSF1A; -.
DR   DMDM; 135959; -.
DR   MaxQB; P19438; -.
DR   PaxDb; P19438; -.
DR   PeptideAtlas; P19438; -.
DR   PRIDE; P19438; -.
DR   DNASU; 7132; -.
DR   Ensembl; ENST00000162749; ENSP00000162749; ENSG00000067182. [P19438-1]
DR   Ensembl; ENST00000366159; ENSP00000380389; ENSG00000067182. [P19438-5]
DR   GeneID; 7132; -.
DR   KEGG; hsa:7132; -.
DR   UCSC; uc001qnu.4; human. [P19438-1]
DR   CTD; 7132; -.
DR   DisGeNET; 7132; -.
DR   EuPathDB; HostDB:ENSG00000067182.7; -.
DR   GeneCards; TNFRSF1A; -.
DR   HGNC; HGNC:11916; TNFRSF1A.
DR   HPA; CAB010309; -.
DR   HPA; HPA004102; -.
DR   MalaCards; TNFRSF1A; -.
DR   MIM; 142680; phenotype.
DR   MIM; 191190; gene.
DR   MIM; 614810; phenotype.
DR   neXtProt; NX_P19438; -.
DR   OpenTargets; ENSG00000067182; -.
DR   Orphanet; 329967; Intermittent hydrarthrosis.
DR   Orphanet; 802; Multiple sclerosis.
DR   Orphanet; 32960; Tumor necrosis factor receptor 1 associated periodic syndrome.
DR   PharmGKB; PA36609; -.
DR   eggNOG; ENOG410IXBX; Eukaryota.
DR   eggNOG; ENOG4111YG2; LUCA.
DR   GeneTree; ENSGT00530000064001; -.
DR   HOGENOM; HOG000202854; -.
DR   HOVERGEN; HBG058842; -.
DR   InParanoid; P19438; -.
DR   KO; K03158; -.
DR   OMA; GCLEDIE; -.
DR   OrthoDB; EOG091G07LE; -.
DR   PhylomeDB; P19438; -.
DR   TreeFam; TF333916; -.
DR   Reactome; R-HSA-5357786; TNFR1-induced proapoptotic signaling.
DR   Reactome; R-HSA-5357905; Regulation of TNFR1 signaling.
DR   Reactome; R-HSA-5357956; TNFR1-induced NFkappaB signaling pathway.
DR   Reactome; R-HSA-5626978; TNFR1-mediated ceramide production.
DR   Reactome; R-HSA-5669034; TNFs bind their physiological receptors.
DR   Reactome; R-HSA-6783783; Interleukin-10 signaling.
DR   Reactome; R-HSA-75893; TNF signaling.
DR   SIGNOR; P19438; -.
DR   ChiTaRS; TNFRSF1A; human.
DR   EvolutionaryTrace; P19438; -.
DR   GeneWiki; TNFRSF1A; -.
DR   GenomeRNAi; 7132; -.
DR   PMAP-CutDB; P19438; -.
DR   PRO; PR:P19438; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   Bgee; ENSG00000067182; -.
DR   CleanEx; HS_TNFRSF1A; -.
DR   ExpressionAtlas; P19438; baseline and differential.
DR   Genevisible; P19438; HS.
DR   GO; GO:0009986; C:cell surface; IEA:Ensembl.
DR   GO; GO:0005576; C:extracellular region; TAS:Reactome.
DR   GO; GO:0005615; C:extracellular space; IDA:BHF-UCL.
DR   GO; GO:0000139; C:Golgi membrane; IDA:UniProtKB.
DR   GO; GO:0005887; C:integral component of plasma membrane; TAS:ProtInc.
DR   GO; GO:0045121; C:membrane raft; IDA:BHF-UCL.
DR   GO; GO:0005739; C:mitochondrion; IBA:GO_Central.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0043235; C:receptor complex; IDA:MGI.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0043120; F:tumor necrosis factor binding; IBA:GO_Central.
DR   GO; GO:0005031; F:tumor necrosis factor-activated receptor activity; TAS:UniProtKB.
DR   GO; GO:0071260; P:cellular response to mechanical stimulus; IEP:UniProtKB.
DR   GO; GO:0019221; P:cytokine-mediated signaling pathway; ISS:UniProtKB.
DR   GO; GO:0071550; P:death-inducing signaling complex assembly; TAS:Reactome.
DR   GO; GO:0042742; P:defense response to bacterium; IEA:Ensembl.
DR   GO; GO:0008625; P:extrinsic apoptotic signaling pathway via death domain receptors; TAS:BHF-UCL.
DR   GO; GO:0007249; P:I-kappaB kinase/NF-kappaB signaling; TAS:Reactome.
DR   GO; GO:0006955; P:immune response; IBA:GO_Central.
DR   GO; GO:0006954; P:inflammatory response; ISS:UniProtKB.
DR   GO; GO:0008630; P:intrinsic apoptotic signaling pathway in response to DNA damage; IEA:Ensembl.
DR   GO; GO:0050728; P:negative regulation of inflammatory response; IMP:BHF-UCL.
DR   GO; GO:2000304; P:positive regulation of ceramide biosynthetic process; TAS:Reactome.
DR   GO; GO:0043123; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; IEP:UniProtKB.
DR   GO; GO:0050729; P:positive regulation of inflammatory response; ISS:UniProtKB.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IMP:BHF-UCL.
DR   GO; GO:0042531; P:positive regulation of tyrosine phosphorylation of STAT protein; IMP:BHF-UCL.
DR   GO; GO:0006693; P:prostaglandin metabolic process; IEA:InterPro.
DR   GO; GO:0072659; P:protein localization to plasma membrane; IMP:UniProtKB.
DR   GO; GO:0042981; P:regulation of apoptotic process; IBA:GO_Central.
DR   GO; GO:0042127; P:regulation of cell proliferation; IBA:GO_Central.
DR   GO; GO:1903140; P:regulation of establishment of endothelial barrier; IMP:UniProtKB.
DR   GO; GO:0010803; P:regulation of tumor necrosis factor-mediated signaling pathway; TAS:Reactome.
DR   GO; GO:0032496; P:response to lipopolysaccharide; IBA:GO_Central.
DR   GO; GO:0033209; P:tumor necrosis factor-mediated signaling pathway; IMP:UniProtKB.
DR   GO; GO:0016032; P:viral process; IEA:UniProtKB-KW.
DR   CDD; cd08313; Death_TNFR1; 1.
DR   CDD; cd10576; TNFRSF1A; 1.
DR   InterPro; IPR011029; DEATH-like_dom_sf.
DR   InterPro; IPR000488; Death_domain.
DR   InterPro; IPR001368; TNFR/NGFR_Cys_rich_reg.
DR   InterPro; IPR020419; TNFR_1A.
DR   InterPro; IPR033994; TNFRSF1A_death.
DR   InterPro; IPR033993; TNFRSF1A_N.
DR   Pfam; PF00531; Death; 1.
DR   Pfam; PF00020; TNFR_c6; 3.
DR   PRINTS; PR01918; TNFACTORR1A.
DR   SMART; SM00005; DEATH; 1.
DR   SMART; SM00208; TNFR; 4.
DR   SUPFAM; SSF47986; SSF47986; 1.
DR   PROSITE; PS50017; DEATH_DOMAIN; 1.
DR   PROSITE; PS00652; TNFR_NGFR_1; 3.
DR   PROSITE; PS50050; TNFR_NGFR_2; 3.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Amyloidosis; Apoptosis;
KW   Cell membrane; Cleavage on pair of basic residues; Complete proteome;
KW   Direct protein sequencing; Disease mutation; Disulfide bond;
KW   Glycoprotein; Golgi apparatus; Host-virus interaction; Membrane;
KW   Polymorphism; Receptor; Reference proteome; Repeat; Secreted; Signal;
KW   Transmembrane; Transmembrane helix.
FT   SIGNAL        1     29       {ECO:0000269|PubMed:2158862}.
FT   CHAIN        30    455       Tumor necrosis factor receptor
FT                                superfamily member 1A, membrane form.
FT                                /FTId=PRO_0000034543.
FT   CHAIN        41    201       Tumor necrosis factor-binding protein 1.
FT                                /FTId=PRO_0000034544.
FT   TOPO_DOM     30    211       Extracellular. {ECO:0000255}.
FT   TRANSMEM    212    232       Helical. {ECO:0000255}.
FT   TOPO_DOM    233    455       Cytoplasmic. {ECO:0000255}.
FT   REPEAT       43     82       TNFR-Cys 1.
FT   REPEAT       83    125       TNFR-Cys 2.
FT   REPEAT      126    166       TNFR-Cys 3.
FT   REPEAT      167    196       TNFR-Cys 4.
FT   DOMAIN      356    441       Death. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00064}.
FT   REGION      338    348       N-SMase activation domain (NSD).
FT   CARBOHYD     54     54       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    145    145       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    151    151       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID     44     58
FT   DISULFID     59     72
FT   DISULFID     62     81
FT   DISULFID     84     99
FT   DISULFID    102    117
FT   DISULFID    105    125
FT   DISULFID    127    143
FT   DISULFID    146    158
FT   DISULFID    149    166
FT   DISULFID    168    179
FT   DISULFID    182    195
FT   DISULFID    185    191
FT   VAR_SEQ       1    232       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_037154.
FT   VAR_SEQ       1    108       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_037153.
FT   VAR_SEQ     184    455       NCKKSLECTKLCLPQIENVKGTEDSGTTVLLPLVIFFGLCL
FT                                LSLLFIGLMYRYQRWKSKLYSIVCGKSTPEKEGELEGTTTK
FT                                PLAPNPSFSPTPGFTPTLGFSPVPSSTFTSSSTYTPGDCPN
FT                                FAAPRREVAPPYQGADPILATALASDPIPNPLQKWEDSAHK
FT                                PQSLDTDDPATLYAVVENVPPLRWKEFVRRLGLSDHEIDRL
FT                                ELQNGRCLREAQYSMLATWRRRTPRREATLELLGRVLRDMD
FT                                LLGCLEDIEEALCGPAALPPAPSLLR -> KHHSAVAPGHF
FT                                LWSLPFIPPLHWFNVSLPTVEVQALLHCLWEIDT (in
FT                                isoform 4). {ECO:0000305}.
FT                                /FTId=VSP_044949.
FT   VAR_SEQ     184    218       NCKKSLECTKLCLPQIENVKGTEDSGTTVLLPLVI -> KV
FT                                LLCRPGWNAVARSRLTATSASQIQAILLLQPPK (in
FT                                isoform 5).
FT                                {ECO:0000303|PubMed:19906316}.
FT                                /FTId=VSP_047613.
FT   VAR_SEQ     219    455       Missing (in isoform 5).
FT                                {ECO:0000303|PubMed:19906316}.
FT                                /FTId=VSP_047614.
FT   VARIANT      51     51       H -> Q (in FHF; dbSNP:rs104895254).
FT                                {ECO:0000269|PubMed:11443543}.
FT                                /FTId=VAR_019329.
FT   VARIANT      59     59       C -> R (in FHF; dbSNP:rs104895217).
FT                                {ECO:0000269|PubMed:10199409}.
FT                                /FTId=VAR_013410.
FT   VARIANT      59     59       C -> S (in FHF; dbSNP:rs104895223).
FT                                {ECO:0000269|PubMed:10902757,
FT                                ECO:0000269|PubMed:11443543}.
FT                                /FTId=VAR_019302.
FT   VARIANT      62     62       C -> G (in FHF; dbSNP:rs104895225).
FT                                {ECO:0000269|PubMed:11443543}.
FT                                /FTId=VAR_019303.
FT   VARIANT      62     62       C -> Y (in FHF; dbSNP:rs104895218).
FT                                {ECO:0000269|PubMed:10199409}.
FT                                /FTId=VAR_013411.
FT   VARIANT      75     75       P -> L (in FHF; may be a polymorphism;
FT                                dbSNP:rs4149637).
FT                                {ECO:0000269|PubMed:11443543,
FT                                ECO:0000269|Ref.7}.
FT                                /FTId=VAR_019330.
FT   VARIANT      79     79       T -> M (in FHF; dbSNP:rs104895219).
FT                                {ECO:0000269|PubMed:10199409}.
FT                                /FTId=VAR_013412.
FT   VARIANT      81     81       C -> F (in FHF; dbSNP:rs104895220).
FT                                {ECO:0000269|PubMed:10199409}.
FT                                /FTId=VAR_013413.
FT   VARIANT      99     99       C -> S (in FHF; dbSNP:rs104895228).
FT                                {ECO:0000269|PubMed:13130484,
FT                                ECO:0000269|PubMed:14610673}.
FT                                /FTId=VAR_019304.
FT   VARIANT     115    115       S -> G (in FHF).
FT                                {ECO:0000269|PubMed:11443543}.
FT                                /FTId=VAR_019331.
FT   VARIANT     117    117       C -> R (in FHF; dbSNP:rs104895221).
FT                                {ECO:0000269|PubMed:10199409}.
FT                                /FTId=VAR_013414.
FT   VARIANT     117    117       C -> Y (in FHF; dbSNP:rs104895222).
FT                                {ECO:0000269|PubMed:10199409}.
FT                                /FTId=VAR_013415.
FT   VARIANT     121    121       R -> P (in FHF; dbSNP:rs4149584).
FT                                {ECO:0000269|PubMed:13130484}.
FT                                /FTId=VAR_019305.
FT   VARIANT     121    121       R -> Q (in FHF; unknown pathological
FT                                significance; dbSNP:rs4149584).
FT                                {ECO:0000269|PubMed:11443543,
FT                                ECO:0000269|Ref.7}.
FT                                /FTId=VAR_019332.
FT   VARIANT     305    305       P -> T (in dbSNP:rs1804532).
FT                                /FTId=VAR_011813.
FT   CONFLICT     13     13       L -> LILPQ (in Ref. 8; BAG51763).
FT                                {ECO:0000305}.
FT   CONFLICT    255    255       K -> E (in Ref. 8; BAG37891).
FT                                {ECO:0000305}.
FT   CONFLICT    286    286       S -> G (in Ref. 8; BAG51763).
FT                                {ECO:0000305}.
FT   CONFLICT    394    394       R -> L (in Ref. 8; BAF83777).
FT                                {ECO:0000305}.
FT   CONFLICT    412    412       Missing (in Ref. 5; AAA36756).
FT                                {ECO:0000305}.
FT   CONFLICT    443    446       GPAA -> APP (in Ref. 5; AAA36756).
FT                                {ECO:0000305}.
FT   STRAND       48     50       {ECO:0000244|PDB:1EXT}.
FT   STRAND       52     54       {ECO:0000244|PDB:1FT4}.
FT   STRAND       58     60       {ECO:0000244|PDB:1EXT}.
FT   STRAND       66     70       {ECO:0000244|PDB:1EXT}.
FT   STRAND       80     83       {ECO:0000244|PDB:1EXT}.
FT   STRAND       92     94       {ECO:0000244|PDB:1EXT}.
FT   HELIX       107    109       {ECO:0000244|PDB:1EXT}.
FT   STRAND      112    115       {ECO:0000244|PDB:1EXT}.
FT   STRAND      124    126       {ECO:0000244|PDB:1EXT}.
FT   STRAND      131    137       {ECO:0000244|PDB:1EXT}.
FT   STRAND      140    145       {ECO:0000244|PDB:1EXT}.
FT   STRAND      152    156       {ECO:0000244|PDB:1EXT}.
FT   STRAND      160    162       {ECO:0000244|PDB:1TNR}.
FT   STRAND      165    168       {ECO:0000244|PDB:1EXT}.
FT   STRAND      172    175       {ECO:0000244|PDB:1EXT}.
FT   STRAND      178    181       {ECO:0000244|PDB:1EXT}.
FT   HELIX       182    184       {ECO:0000244|PDB:1EXT}.
FT   HELIX       192    195       {ECO:0000244|PDB:1EXT}.
FT   HELIX       357    365       {ECO:0000244|PDB:1ICH}.
FT   HELIX       371    378       {ECO:0000244|PDB:1ICH}.
FT   HELIX       382    391       {ECO:0000244|PDB:1ICH}.
FT   HELIX       396    410       {ECO:0000244|PDB:1ICH}.
FT   HELIX       417    427       {ECO:0000244|PDB:1ICH}.
FT   HELIX       431    441       {ECO:0000244|PDB:1ICH}.
SQ   SEQUENCE   455 AA;  50495 MW;  4CEFBA96D03B8225 CRC64;
     MGLSTVPDLL LPLVLLELLV GIYPSGVIGL VPHLGDREKR DSVCPQGKYI HPQNNSICCT
     KCHKGTYLYN DCPGPGQDTD CRECESGSFT ASENHLRHCL SCSKCRKEMG QVEISSCTVD
     RDTVCGCRKN QYRHYWSENL FQCFNCSLCL NGTVHLSCQE KQNTVCTCHA GFFLRENECV
     SCSNCKKSLE CTKLCLPQIE NVKGTEDSGT TVLLPLVIFF GLCLLSLLFI GLMYRYQRWK
     SKLYSIVCGK STPEKEGELE GTTTKPLAPN PSFSPTPGFT PTLGFSPVPS STFTSSSTYT
     PGDCPNFAAP RREVAPPYQG ADPILATALA SDPIPNPLQK WEDSAHKPQS LDTDDPATLY
     AVVENVPPLR WKEFVRRLGL SDHEIDRLEL QNGRCLREAQ YSMLATWRRR TPRREATLEL
     LGRVLRDMDL LGCLEDIEEA LCGPAALPPA PSLLR
//
ID   PIAS1_HUMAN             Reviewed;         651 AA.
AC   O75925; B2RB67; B3KSY9; C5J4B4; Q147X4; Q99751; Q9UN02;
DT   05-MAR-2002, integrated into UniProtKB/Swiss-Prot.
DT   05-MAR-2002, sequence version 2.
DT   23-MAY-2018, entry version 181.
DE   RecName: Full=E3 SUMO-protein ligase PIAS1;
DE            EC=2.3.2.-;
DE   AltName: Full=DEAD/H box-binding protein 1;
DE   AltName: Full=E3 SUMO-protein transferase PIAS1 {ECO:0000305};
DE   AltName: Full=Gu-binding protein;
DE            Short=GBP;
DE   AltName: Full=Protein inhibitor of activated STAT protein 1;
DE   AltName: Full=RNA helicase II-binding protein;
GN   Name=PIAS1; Synonyms=DDXBP1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND INTERACTION WITH STAT1.
RC   TISSUE=B-cell;
RX   PubMed=9724754; DOI=10.1073/pnas.95.18.10626;
RA   Liu B., Liao J., Rao X., Kushner S.A., Chung C.D., Chang D.D.,
RA   Shuai K.;
RT   "Inhibition of Stat1-mediated gene activation by PIAS1.";
RL   Proc. Natl. Acad. Sci. U.S.A. 95:10626-10631(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=10628744; DOI=10.1210/mend.14.1.0408;
RA   Tan J., Hall S.H., Hamil K.G., Grossman G., Petrusz P., Liao J.,
RA   Shuai K., French F.S.;
RT   "Protein inhibitor of activated STAT-1 (signal transducer and
RT   activator of transcription-1) is a nuclear receptor coregulator
RT   expressed in human testis.";
RL   Mol. Endocrinol. 14:14-26(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3).
RX   PubMed=19906316; DOI=10.1186/1471-2164-10-518;
RA   Wang P., Yu P., Gao P., Shi T., Ma D.;
RT   "Discovery of novel human transcript variants by analysis of intronic
RT   single-block EST with polyadenylation site.";
RL   BMC Genomics 10:518-518(2009).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Amygdala, and Trachea;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16572171; DOI=10.1038/nature04601;
RA   Zody M.C., Garber M., Sharpe T., Young S.K., Rowen L., O'Neill K.,
RA   Whittaker C.A., Kamal M., Chang J.L., Cuomo C.A., Dewar K.,
RA   FitzGerald M.G., Kodira C.D., Madan A., Qin S., Yang X., Abbasi N.,
RA   Abouelleil A., Arachchi H.M., Baradarani L., Birditt B., Bloom S.,
RA   Bloom T., Borowsky M.L., Burke J., Butler J., Cook A., DeArellano K.,
RA   DeCaprio D., Dorris L. III, Dors M., Eichler E.E., Engels R.,
RA   Fahey J., Fleetwood P., Friedman C., Gearin G., Hall J.L., Hensley G.,
RA   Johnson E., Jones C., Kamat A., Kaur A., Locke D.P., Madan A.,
RA   Munson G., Jaffe D.B., Lui A., Macdonald P., Mauceli E., Naylor J.W.,
RA   Nesbitt R., Nicol R., O'Leary S.B., Ratcliffe A., Rounsley S., She X.,
RA   Sneddon K.M.B., Stewart S., Sougnez C., Stone S.M., Topham K.,
RA   Vincent D., Wang S., Zimmer A.R., Birren B.W., Hood L., Lander E.S.,
RA   Nusbaum C.;
RT   "Analysis of the DNA sequence and duplication history of human
RT   chromosome 15.";
RL   Nature 440:671-675(2006).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 7-651 (ISOFORM 1), INTERACTION WITH
RP   DDX21, SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RC   TISSUE=B-cell;
RX   PubMed=9177271; DOI=10.1006/bbrc.1997.6642;
RA   Valdez B.C., Henning D., Perlaky L., Busch R.K., Busch H.;
RT   "Cloning and characterization of Gu/RH-II binding protein.";
RL   Biochem. Biophys. Res. Commun. 234:335-340(1997).
RN   [8]
RP   INTERACTION WITH CSRP2.
RX   PubMed=11672422; DOI=10.1042/0264-6021:3590485;
RA   Weiskirchen R., Moser M., Weiskirchen S., Erdel M., Dahmen S.,
RA   Buettner R., Gressner A.M.;
RT   "LIM-domain protein cysteine- and glycine-rich protein 2 (CRP2) is a
RT   novel marker of hepatic stellate cells and binding partner of the
RT   protein inhibitor of activated STAT1.";
RL   Biochem. J. 359:485-496(2001).
RN   [9]
RP   INTERACTION WITH UBE2I; SUMO1 AND TP53, AND MUTAGENESIS OF CYS-351.
RX   PubMed=11583632; DOI=10.1016/S1097-2765(01)00349-5;
RA   Kahyo T., Nishida T., Yasuda H.;
RT   "Involvement of PIAS1 in the sumoylation of tumor suppressor p53.";
RL   Mol. Cell 8:713-718(2001).
RN   [10]
RP   TISSUE SPECIFICITY.
RX   PubMed=11439351; DOI=10.1038/sj.onc.1204489;
RA   Gross M., Liu B., Tan J.-A., French F.S., Carey M., Shuai K.;
RT   "Distinct effects of PIAS proteins on androgen-mediated gene
RT   activation in prostate cancer cells.";
RL   Oncogene 20:3880-3887(2001).
RN   [11]
RP   INTERACTION WITH AXIN1.
RX   PubMed=12223491; DOI=10.1074/jbc.M208099200;
RA   Rui H.L., Fan E., Zhou H.M., Xu Z., Zhang Y., Lin S.C.;
RT   "SUMO-1 modification of the C-terminal KVEKVD of Axin is required for
RT   JNK activation but has no effect on Wnt signaling.";
RL   J. Biol. Chem. 277:42981-42986(2002).
RN   [12]
RP   SUMOYLATION OF MDM2, AND SUBCELLULAR LOCATION.
RX   PubMed=12393906; DOI=10.1074/jbc.M208319200;
RA   Miyauchi Y., Yogosawa S., Honda R., Nishida T., Yasuda H.;
RT   "Sumoylation of Mdm2 by protein inhibitor of activated STAT (PIAS) and
RT   RanBP2 enzymes.";
RL   J. Biol. Chem. 277:50131-50136(2002).
RN   [13]
RP   INTERACTION WITH SP3 AND UBE2I.
RX   PubMed=12356736; DOI=10.1093/emboj/cdf510;
RA   Sapetschnig A., Rischitor G., Braun H., Doll A., Schergaut M.,
RA   Melchior F., Suske G.;
RT   "Transcription factor Sp3 is silenced through SUMO modification by
RT   PIAS1.";
RL   EMBO J. 21:5206-5215(2002).
RN   [14]
RP   INTERACTION WITH JUN AND TP53, AND SUMOYLATION.
RX   PubMed=11867732; DOI=10.1073/pnas.052559499;
RA   Schmidt D., Mueller S.;
RT   "Members of the PIAS family act as SUMO ligases for c-Jun and p53 and
RT   repress p53 activity.";
RL   Proc. Natl. Acad. Sci. U.S.A. 99:2872-2877(2002).
RN   [15]
RP   INTERACTION WITH SATB2.
RX   PubMed=14701874; DOI=10.1101/gad.1153003;
RA   Dobreva G., Dambacher J., Grosschedl R.;
RT   "SUMO modification of a novel MAR-binding protein, SATB2, modulates
RT   immunoglobulin mu gene expression.";
RL   Genes Dev. 17:3048-3061(2003).
RN   [16]
RP   FUNCTION, AND INTERACTION WITH PTK2/FAK1.
RX   PubMed=14500712; DOI=10.1074/jbc.M308562200;
RA   Kadare G., Toutant M., Formstecher E., Corvol J.C., Carnaud M.,
RA   Boutterin M.C., Girault J.A.;
RT   "PIAS1-mediated sumoylation of focal adhesion kinase activates its
RT   autophosphorylation.";
RL   J. Biol. Chem. 278:47434-47440(2003).
RN   [17]
RP   INTERACTION WITH PLAG1.
RX   PubMed=15208321; DOI=10.1074/jbc.M401753200;
RA   Van Dyck F., Delvaux E.L.D., Van de Ven W.J.M., Chavez M.V.;
RT   "Repression of the transactivating capacity of the oncoprotein PLAG1
RT   by SUMOylation.";
RL   J. Biol. Chem. 279:36121-36131(2004).
RN   [18]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [19]
RP   INTERACTION WITH KLF8.
RX   PubMed=16617055; DOI=10.1074/jbc.M513135200;
RA   Wei H., Wang X., Gan B., Urvalek A.M., Melkoumian Z.K., Guan J.-L.,
RA   Zhao J.;
RT   "Sumoylation delimits KLF8 transcriptional activity associated with
RT   the cell cycle regulation.";
RL   J. Biol. Chem. 281:16664-16671(2006).
RN   [20]
RP   INTERACTION WITH CHUK.
RX   PubMed=17540171; DOI=10.1016/j.cell.2007.03.056;
RA   Liu B., Yang Y., Chernishof V., Loo R.R., Jang H., Tahk S., Yang R.,
RA   Mink S., Shultz D., Bellone C.J., Loo J.A., Shuai K.;
RT   "Proinflammatory stimuli induce IKKalpha-mediated phosphorylation of
RT   PIAS1 to restrict inflammation and immunity.";
RL   Cell 129:903-914(2007).
RN   [21]
RP   INTERACTION WITH DDX5.
RX   PubMed=17369852; DOI=10.1038/sj.onc.1210387;
RA   Jacobs A.M., Nicol S.M., Hislop R.G., Jaffray E.G., Hay R.T.,
RA   Fuller-Pace F.V.;
RT   "SUMO modification of the DEAD box protein p68 modulates its
RT   transcriptional activity and promotes its interaction with HDAC1.";
RL   Oncogene 26:5866-5876(2007).
RN   [22]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-503 AND SER-522, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [23]
RP   FUNCTION, INTERACTION WITH STAT1, METHYLATION AT ARG-303 BY PRMT1,
RP   IDENTIFICATION BY MASS SPECTROMETRY, SUBCELLULAR LOCATION, AND
RP   MUTAGENESIS OF ARG-303.
RX   PubMed=19136629; DOI=10.1101/gad.489409;
RA   Weber S., Maass F., Schuemann M., Krause E., Suske G., Bauer U.M.;
RT   "PRMT1-mediated arginine methylation of PIAS1 regulates STAT1
RT   signaling.";
RL   Genes Dev. 23:118-132(2009).
RN   [24]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-503 AND SER-510, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [25]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-503, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [26]
RP   FUNCTION, AND INTERACTION WITH MTA1.
RX   PubMed=21965678; DOI=10.1074/jbc.M111.267237;
RA   Cong L., Pakala S.B., Ohshiro K., Li D.Q., Kumar R.;
RT   "SUMOylation and SUMO-interacting motif (SIM) of metastasis tumor
RT   antigen 1 (MTA1) synergistically regulate its transcriptional
RT   repressor function.";
RL   J. Biol. Chem. 286:43793-43808(2011).
RN   [27]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [28]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-485; SER-488 AND
RP   SER-503, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [29]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-467; SER-468 AND
RP   SER-503, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [30]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-46 AND LYS-238, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25218447; DOI=10.1038/nsmb.2890;
RA   Hendriks I.A., D'Souza R.C., Yang B., Verlaan-de Vries M., Mann M.,
RA   Vertegaal A.C.;
RT   "Uncovering global SUMOylation signaling networks in a site-specific
RT   manner.";
RL   Nat. Struct. Mol. Biol. 21:927-936(2014).
RN   [31]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-46; LYS-137 AND LYS-238, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25772364; DOI=10.1016/j.celrep.2015.02.033;
RA   Hendriks I.A., Treffers L.W., Verlaan-de Vries M., Olsen J.V.,
RA   Vertegaal A.C.;
RT   "SUMO-2 orchestrates chromatin modifiers in response to DNA damage.";
RL   Cell Rep. 10:1778-1791(2015).
RN   [32]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-46 AND LYS-137, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25755297; DOI=10.1074/mcp.O114.044792;
RA   Xiao Z., Chang J.G., Hendriks I.A., Sigurdsson J.O., Olsen J.V.,
RA   Vertegaal A.C.;
RT   "System-wide analysis of SUMOylation dynamics in response to
RT   replication stress reveals novel small ubiquitin-like modified target
RT   proteins and acceptor lysines relevant for genome stability.";
RL   Mol. Cell. Proteomics 14:1419-1434(2015).
RN   [33]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-40; LYS-46; LYS-137;
RP   LYS-238; LYS-453 AND LYS-493, AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-
RT   modification with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
RN   [34]
RP   STRUCTURE BY NMR OF 1-65, AND INTERACTION WITH TP53 AND DNA-BINDING.
RX   PubMed=15133049; DOI=10.1074/jbc.M403561200;
RA   Okubo S., Hara F., Tsuchida Y., Shimotakahara S., Suzuki S.,
RA   Hatanaka H., Yokoyama S., Tanaka H., Yasuda H., Shindo H.;
RT   "NMR structure of the N-terminal domain of SUMO ligase PIAS1 and its
RT   interaction with tumor suppressor p53 and A/T-rich DNA oligomers.";
RL   J. Biol. Chem. 279:31455-31461(2004).
CC   -!- FUNCTION: Functions as an E3-type small ubiquitin-like modifier
CC       (SUMO) ligase, stabilizing the interaction between UBE2I and the
CC       substrate, and as a SUMO-tethering factor. Plays a crucial role as
CC       a transcriptional coregulation in various cellular pathways,
CC       including the STAT pathway, the p53 pathway and the steroid
CC       hormone signaling pathway. In vitro, binds A/T-rich DNA. The
CC       effects of this transcriptional coregulation, transactivation or
CC       silencing, may vary depending upon the biological context.
CC       Together with PRMT1, may repress STAT1 transcriptional activity,
CC       in the late phase of interferon gamma (IFN-gamma) signaling.
CC       Sumoylates PML (at'Lys-65' and 'Lys-160') and PML-RAR and promotes
CC       their ubiquitin-mediated degradation. PIAS1-mediated sumoylation
CC       of PML promotes its interaction with CSNK2A1/CK2 which in turn
CC       promotes PML phosphorylation and degradation (By similarity).
CC       Enhances the sumoylation of MTA1 and may participate in its
CC       paralog-selective sumoylation. Plays a dynamic role in
CC       adipogenesis by promoting the SUMOylation and degradation of CEBPB
CC       (By similarity). {ECO:0000250|UniProtKB:O88907,
CC       ECO:0000269|PubMed:14500712, ECO:0000269|PubMed:19136629,
CC       ECO:0000269|PubMed:21965678}.
CC   -!- PATHWAY: Protein modification; protein sumoylation.
CC   -!- SUBUNIT: Interacts with NCOA2 and AR. Interacts with NR2C1; the
CC       interaction promotes its sumoylation (By similarity). Interacts
CC       with DDX21, CSRP2, AXIN1, JUN, UBE2I, SUMO1, SATB2, PLAG1, TP53
CC       and STAT1 (dimer), following IFNA1-stimulation. Interacts with SP3
CC       (preferentially when SUMO-modified). Interacts with KLF8; the
CC       interaction results in SUMO ligation and repression of KLF8
CC       transcriptional activity and of its cell cycle progression into
CC       G(1) phase. Interacts with STAT1. Interacts with CHUK/IKKA; this
CC       interaction induces PIAS1 phosphorylation. Interacts with
CC       PTK2/FAK1; the interaction promotes its sumoylation. Interacts
CC       with DDX5. Interacts with PML (By similarity). Interacts with
CC       MTA1. {ECO:0000250, ECO:0000269|PubMed:11583632,
CC       ECO:0000269|PubMed:11672422, ECO:0000269|PubMed:11867732,
CC       ECO:0000269|PubMed:12223491, ECO:0000269|PubMed:12356736,
CC       ECO:0000269|PubMed:14500712, ECO:0000269|PubMed:14701874,
CC       ECO:0000269|PubMed:15133049, ECO:0000269|PubMed:15208321,
CC       ECO:0000269|PubMed:16617055, ECO:0000269|PubMed:17369852,
CC       ECO:0000269|PubMed:17540171, ECO:0000269|PubMed:19136629,
CC       ECO:0000269|PubMed:21965678, ECO:0000269|PubMed:9177271,
CC       ECO:0000269|PubMed:9724754}.
CC   -!- INTERACTION:
CC       P29991:- (xeno); NbExp=3; IntAct=EBI-629434, EBI-8826488;
CC       Q9UKL3:CASP8AP2; NbExp=4; IntAct=EBI-629434, EBI-2339650;
CC       Q9UIS9:MBD1; NbExp=3; IntAct=EBI-629434, EBI-867196;
CC       O75626:PRDM1; NbExp=2; IntAct=EBI-629434, EBI-948789;
CC       P04637:TP53; NbExp=4; IntAct=EBI-629434, EBI-366083;
CC   -!- SUBCELLULAR LOCATION: Nucleus speckle
CC       {ECO:0000269|PubMed:12393906, ECO:0000269|PubMed:19136629,
CC       ECO:0000269|PubMed:9177271}. Nucleus, PML body {ECO:0000250}.
CC       Note=Interaction with CSRP2 may induce a partial redistribution
CC       along the cytoskeleton.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=O75925-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=O75925-2; Sequence=VSP_056219;
CC         Note=No experimental confirmation available.;
CC       Name=3;
CC         IsoId=O75925-3; Sequence=VSP_057195, VSP_057196;
CC   -!- TISSUE SPECIFICITY: Expressed in numerous tissues with highest
CC       level in testis. {ECO:0000269|PubMed:11439351,
CC       ECO:0000269|PubMed:9177271}.
CC   -!- DOMAIN: The LXXLL motif is a transcriptional coregulator
CC       signature.
CC   -!- DOMAIN: The SP-RING-type domain is required for promoting EKLF
CC       sumoylation. {ECO:0000250}.
CC   -!- PTM: Sumoylated. {ECO:0000269|PubMed:11867732,
CC       ECO:0000269|PubMed:12393906}.
CC   -!- PTM: Dimethylated by PRMT1 at Arg-303 in the late phase of
CC       interferon gamma (IFN-gamma) signaling, leading to preferential
CC       interaction with STAT1 and thus resulting in release of STAT1 from
CC       its target gene.
CC   -!- SIMILARITY: Belongs to the PIAS family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF077951; AAC36702.1; -; mRNA.
DR   EMBL; AF167160; AAD49722.1; -; mRNA.
DR   EMBL; FJ997900; ACR77525.1; -; mRNA.
DR   EMBL; AK094641; BAG52901.1; -; mRNA.
DR   EMBL; AK314515; BAG37114.1; -; mRNA.
DR   EMBL; AC107871; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC135628; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC118587; AAI18588.1; -; mRNA.
DR   EMBL; BC121797; AAI21798.1; -; mRNA.
DR   EMBL; U78524; AAB58488.1; -; mRNA.
DR   CCDS; CCDS45290.1; -. [O75925-1]
DR   CCDS; CCDS81902.1; -. [O75925-2]
DR   RefSeq; NP_001307616.1; NM_001320687.1. [O75925-2]
DR   RefSeq; NP_057250.1; NM_016166.2. [O75925-1]
DR   RefSeq; XP_016878177.1; XM_017022688.1. [O75925-2]
DR   UniGene; Hs.162458; -.
DR   UniGene; Hs.694796; -.
DR   PDB; 1V66; NMR; -; A=1-65.
DR   PDBsum; 1V66; -.
DR   ProteinModelPortal; O75925; -.
DR   SMR; O75925; -.
DR   BioGrid; 114124; 104.
DR   DIP; DIP-5970N; -.
DR   ELM; O75925; -.
DR   IntAct; O75925; 51.
DR   MINT; O75925; -.
DR   STRING; 9606.ENSP00000249636; -.
DR   iPTMnet; O75925; -.
DR   PhosphoSitePlus; O75925; -.
DR   BioMuta; PIAS1; -.
DR   EPD; O75925; -.
DR   MaxQB; O75925; -.
DR   PaxDb; O75925; -.
DR   PeptideAtlas; O75925; -.
DR   PRIDE; O75925; -.
DR   Ensembl; ENST00000249636; ENSP00000249636; ENSG00000033800. [O75925-1]
DR   Ensembl; ENST00000545237; ENSP00000438574; ENSG00000033800. [O75925-2]
DR   GeneID; 8554; -.
DR   KEGG; hsa:8554; -.
DR   UCSC; uc002aqz.4; human. [O75925-1]
DR   CTD; 8554; -.
DR   DisGeNET; 8554; -.
DR   EuPathDB; HostDB:ENSG00000033800.13; -.
DR   GeneCards; PIAS1; -.
DR   HGNC; HGNC:2752; PIAS1.
DR   HPA; CAB012304; -.
DR   HPA; HPA005743; -.
DR   MIM; 603566; gene.
DR   neXtProt; NX_O75925; -.
DR   OpenTargets; ENSG00000033800; -.
DR   PharmGKB; PA33285; -.
DR   eggNOG; KOG2169; Eukaryota.
DR   eggNOG; ENOG410XQ2E; LUCA.
DR   GeneTree; ENSGT00550000074410; -.
DR   HOGENOM; HOG000230594; -.
DR   HOVERGEN; HBG053598; -.
DR   InParanoid; O75925; -.
DR   KO; K04706; -.
DR   OMA; GRTYSMA; -.
DR   OrthoDB; EOG091G08G5; -.
DR   PhylomeDB; O75925; -.
DR   TreeFam; TF323787; -.
DR   Reactome; R-HSA-3108214; SUMOylation of DNA damage response and repair proteins.
DR   Reactome; R-HSA-3232118; SUMOylation of transcription factors.
DR   Reactome; R-HSA-4551638; SUMOylation of chromatin organization proteins.
DR   Reactome; R-HSA-5696395; Formation of Incision Complex in GG-NER.
DR   Reactome; R-HSA-877312; Regulation of IFNG signaling.
DR   SignaLink; O75925; -.
DR   SIGNOR; O75925; -.
DR   UniPathway; UPA00886; -.
DR   ChiTaRS; PIAS1; human.
DR   EvolutionaryTrace; O75925; -.
DR   GeneWiki; PIAS1; -.
DR   GenomeRNAi; 8554; -.
DR   PMAP-CutDB; O75925; -.
DR   PRO; PR:O75925; -.
DR   Proteomes; UP000005640; Chromosome 15.
DR   Bgee; ENSG00000033800; -.
DR   CleanEx; HS_PIAS1; -.
DR   ExpressionAtlas; O75925; baseline and differential.
DR   Genevisible; O75925; HS.
DR   GO; GO:0016607; C:nuclear speck; IEA:UniProtKB-SubCell.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0016605; C:PML body; IEA:UniProtKB-SubCell.
DR   GO; GO:0050681; F:androgen receptor binding; NAS:UniProtKB.
DR   GO; GO:0003677; F:DNA binding; IEA:UniProtKB-KW.
DR   GO; GO:0019899; F:enzyme binding; IPI:UniProtKB.
DR   GO; GO:0019904; F:protein domain specific binding; IEA:Ensembl.
DR   GO; GO:0061665; F:SUMO ligase activity; IDA:BHF-UCL.
DR   GO; GO:0019789; F:SUMO transferase activity; EXP:Reactome.
DR   GO; GO:0003713; F:transcription coactivator activity; NAS:UniProtKB.
DR   GO; GO:0003714; F:transcription corepressor activity; TAS:ProtInc.
DR   GO; GO:0031625; F:ubiquitin protein ligase binding; IEA:Ensembl.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:0030521; P:androgen receptor signaling pathway; NAS:UniProtKB.
DR   GO; GO:0045444; P:fat cell differentiation; IEA:Ensembl.
DR   GO; GO:0000082; P:G1/S transition of mitotic cell cycle; IEA:Ensembl.
DR   GO; GO:0007259; P:JAK-STAT cascade; TAS:ProtInc.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; IEA:Ensembl.
DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; IEA:Ensembl.
DR   GO; GO:0032436; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; ISS:UniProtKB.
DR   GO; GO:0033235; P:positive regulation of protein sumoylation; IDA:UniProtKB.
DR   GO; GO:0051152; P:positive regulation of smooth muscle cell differentiation; IEA:Ensembl.
DR   GO; GO:0045893; P:positive regulation of transcription, DNA-templated; NAS:UniProtKB.
DR   GO; GO:0016925; P:protein sumoylation; IDA:BHF-UCL.
DR   GO; GO:0065004; P:protein-DNA complex assembly; IEA:Ensembl.
DR   GO; GO:0042127; P:regulation of cell proliferation; ISS:UniProtKB.
DR   GO; GO:0060334; P:regulation of interferon-gamma-mediated signaling pathway; TAS:Reactome.
DR   GO; GO:0007283; P:spermatogenesis; IEA:Ensembl.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   GO; GO:0008542; P:visual learning; IEA:Ensembl.
DR   Gene3D; 1.10.720.30; -; 1.
DR   Gene3D; 2.60.120.780; -; 1.
DR   Gene3D; 3.30.40.10; -; 1.
DR   InterPro; IPR023321; PINIT.
DR   InterPro; IPR038654; PINIT_sf.
DR   InterPro; IPR003034; SAP_dom.
DR   InterPro; IPR036361; SAP_dom_sf.
DR   InterPro; IPR004181; Znf_MIZ.
DR   InterPro; IPR013083; Znf_RING/FYVE/PHD.
DR   Pfam; PF14324; PINIT; 1.
DR   Pfam; PF02891; zf-MIZ; 1.
DR   SMART; SM00513; SAP; 1.
DR   SUPFAM; SSF68906; SSF68906; 1.
DR   PROSITE; PS51466; PINIT; 1.
DR   PROSITE; PS50800; SAP; 1.
DR   PROSITE; PS51044; ZF_SP_RING; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Complete proteome;
KW   DNA-binding; Isopeptide bond; Metal-binding; Methylation; Nucleus;
KW   Phosphoprotein; Reference proteome; Repeat; Transcription;
KW   Transcription regulation; Transferase; Ubl conjugation;
KW   Ubl conjugation pathway; Zinc; Zinc-finger.
FT   INIT_MET      1      1       Removed. {ECO:0000244|PubMed:22814378}.
FT   CHAIN         2    651       E3 SUMO-protein ligase PIAS1.
FT                                /FTId=PRO_0000218974.
FT   DOMAIN       11     45       SAP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00186}.
FT   DOMAIN      124    288       PINIT. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00799}.
FT   REPEAT      520    523       1.
FT   REPEAT      557    560       2.
FT   REPEAT      598    601       3; approximate.
FT   REPEAT      612    615       4; approximate.
FT   ZN_FING     320    397       SP-RING-type. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00452}.
FT   REGION      462    473       SUMO1-binding. {ECO:0000250}.
FT   REGION      520    615       4 X 4 AA repeats of N-T-S-L.
FT   MOTIF        19     23       LXXLL motif.
FT   MOTIF        56     64       Nuclear localization signal.
FT                                {ECO:0000255}.
FT   MOTIF       368    380       Nuclear localization signal.
FT                                {ECO:0000255}.
FT   COMPBIAS    577    634       Ser-rich.
FT   MOD_RES       2      2       N-acetylalanine.
FT                                {ECO:0000244|PubMed:22814378}.
FT   MOD_RES     303    303       Asymmetric dimethylarginine; by PRMT1.
FT                                {ECO:0000269|PubMed:19136629}.
FT   MOD_RES     467    467       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     468    468       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     483    483       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:O88907}.
FT   MOD_RES     485    485       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     487    487       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:O88907}.
FT   MOD_RES     488    488       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     503    503       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     510    510       Phosphoserine.
FT                                {ECO:0000244|PubMed:19690332}.
FT   MOD_RES     522    522       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   CROSSLNK     40     40       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK     46     46       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:25218447,
FT                                ECO:0000244|PubMed:25755297,
FT                                ECO:0000244|PubMed:25772364,
FT                                ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    137    137       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:25755297,
FT                                ECO:0000244|PubMed:25772364,
FT                                ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    238    238       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:25218447,
FT                                ECO:0000244|PubMed:25772364,
FT                                ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    453    453       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    493    493       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   VAR_SEQ       1      7       MADSAEL -> MFTLQDSYV (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_056219.
FT   VAR_SEQ     312    325       IKEKLTADPDSEIA -> STYDKLISLIQLFC (in
FT                                isoform 3).
FT                                {ECO:0000303|PubMed:19906316}.
FT                                /FTId=VSP_057195.
FT   VAR_SEQ     326    651       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:19906316}.
FT                                /FTId=VSP_057196.
FT   MUTAGEN     303    303       R->K: Partial loss of repression on STAT1
FT                                transcriptional activity.
FT                                {ECO:0000269|PubMed:19136629}.
FT   MUTAGEN     351    351       C->A,S: Loss of UBE2I-binding; almost
FT                                complete loss of promotion of TP53
FT                                sumoylation; no loss of SUMO1- and TP53-
FT                                binding. {ECO:0000269|PubMed:11583632}.
FT   CONFLICT    119    119       E -> K (in Ref. 1; AAC36702).
FT                                {ECO:0000305}.
FT   CONFLICT    266    268       IVV -> MC (in Ref. 1; AAC36702).
FT                                {ECO:0000305}.
FT   CONFLICT    613    613       S -> T (in Ref. 6; AAB58488).
FT                                {ECO:0000305}.
FT   HELIX         6     11       {ECO:0000244|PDB:1V66}.
FT   HELIX        16     24       {ECO:0000244|PDB:1V66}.
FT   HELIX        34     46       {ECO:0000244|PDB:1V66}.
FT   HELIX        51     63       {ECO:0000244|PDB:1V66}.
SQ   SEQUENCE   651 AA;  71836 MW;  AA69338221124119 CRC64;
     MADSAELKQM VMSLRVSELQ VLLGYAGRNK HGRKHELLTK ALHLLKAGCS PAVQMKIKEL
     YRRRFPQKIM TPADLSIPNV HSSPMPATLS PSTIPQLTYD GHPASSPLLP VSLLGPKHEL
     ELPHLTSALH PVHPDIKLQK LPFYDLLDEL IKPTSLASDN SQRFRETCFA FALTPQQVQQ
     ISSSMDISGT KCDFTVQVQL RFCLSETSCP QEDHFPPNLC VKVNTKPCSL PGYLPPTKNG
     VEPKRPSRPI NITSLVRLST TVPNTIVVSW TAEIGRNYSM AVYLVKQLSS TVLLQRLRAK
     GIRNPDHSRA LIKEKLTADP DSEIATTSLR VSLLCPLGKM RLTIPCRALT CSHLQCFDAT
     LYIQMNEKKP TWVCPVCDKK APYEHLIIDG LFMEILKYCT DCDEIQFKED GTWAPMRSKK
     EVQEVSASYN GVDGCLSSTL EHQVASHHQS SNKNKKVEVI DLTIDSSSDE EEEEPSAKRT
     CPSLSPTSPL NNKGILSLPH QASPVSRTPS LPAVDTSYIN TSLIQDYRHP FHMTPMPYDL
     QGLDFFPFLS GDNQHYNTSL LAAAAAAVSD DQDLLHSSRF FPYTSSQMFL DQLSAGGSTS
     LPTTNGSSSG SNSSLVSSNS LRESHSHTVT NRSSTDTASI FGIIPDIISL D
//
ID   Q1XBU8_HUMAN            Unreviewed;       642 AA.
AC   Q1XBU8;
DT   02-MAY-2006, integrated into UniProtKB/TrEMBL.
DT   02-MAY-2006, sequence version 1.
DT   23-MAY-2018, entry version 87.
DE   SubName: Full=Cell proliferation-inducing protein 23 {ECO:0000313|EMBL:AAX18639.1};
DE   SubName: Full=Protein inhibitor of activated STAT, 1, isoform CRA_b {ECO:0000313|EMBL:EAW77805.1};
GN   Name=PIAS1 {ECO:0000313|EMBL:EAW77805.1};
GN   ORFNames=hCG_23811 {ECO:0000313|EMBL:EAW77805.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:AAX18639.1};
RN   [1] {ECO:0000313|EMBL:EAW77805.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:AAX18639.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Kim J.W.;
RT   "Identification of proliferation-inducing gene.";
RL   Submitted (OCT-2004) to the EMBL/GenBank/DDBJ databases.
RN   [3] {ECO:0000313|EMBL:EAW77805.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AY826819; AAX18639.1; -; mRNA.
DR   EMBL; CH471082; EAW77805.1; -; Genomic_DNA.
DR   RefSeq; XP_016878179.1; XM_017022690.1.
DR   RefSeq; XP_016878180.1; XM_017022691.1.
DR   UniGene; Hs.162458; -.
DR   UniGene; Hs.694796; -.
DR   PeptideAtlas; Q1XBU8; -.
DR   PRIDE; Q1XBU8; -.
DR   GeneID; 8554; -.
DR   CTD; 8554; -.
DR   eggNOG; KOG2169; Eukaryota.
DR   eggNOG; ENOG410XQ2E; LUCA.
DR   HOVERGEN; HBG053598; -.
DR   ChiTaRS; PIAS1; human.
DR   GenomeRNAi; 8554; -.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   Gene3D; 1.10.720.30; -; 1.
DR   Gene3D; 2.60.120.780; -; 1.
DR   Gene3D; 3.30.40.10; -; 1.
DR   InterPro; IPR023321; PINIT.
DR   InterPro; IPR038654; PINIT_sf.
DR   InterPro; IPR003034; SAP_dom.
DR   InterPro; IPR036361; SAP_dom_sf.
DR   InterPro; IPR004181; Znf_MIZ.
DR   InterPro; IPR013083; Znf_RING/FYVE/PHD.
DR   Pfam; PF14324; PINIT; 1.
DR   Pfam; PF02891; zf-MIZ; 1.
DR   SMART; SM00513; SAP; 1.
DR   SUPFAM; SSF68906; SSF68906; 1.
DR   PROSITE; PS51466; PINIT; 1.
DR   PROSITE; PS50800; SAP; 1.
DR   PROSITE; PS51044; ZF_SP_RING; 1.
PE   2: Evidence at transcript level;
KW   Metal-binding {ECO:0000256|PROSITE-ProRule:PRU00452};
KW   Zinc {ECO:0000256|PROSITE-ProRule:PRU00452};
KW   Zinc-finger {ECO:0000256|PROSITE-ProRule:PRU00452}.
FT   DOMAIN        2     36       SAP. {ECO:0000259|PROSITE:PS50800}.
FT   DOMAIN      115    279       PINIT. {ECO:0000259|PROSITE:PS51466}.
FT   DOMAIN      311    388       SP-RING-type.
FT                                {ECO:0000259|PROSITE:PS51044}.
FT   ZN_FING     311    388       SP-RING-type. {ECO:0000256|PROSITE-
FT                                ProRule:PRU00452}.
SQ   SEQUENCE   642 AA;  70862 MW;  62B7AA377E03D427 CRC64;
     MVMSLRVSEL QVLLGYAGRN KHGRKHELLT KALHLLKAGC SPAVQMKIKE LYRRRFPQKI
     MTPADLSIPN VHSSPMPATL SPSTIPQLTY DGHPASSPLL PVSLLGPKHE LELPHLTSAL
     HPVHPDIKLQ KLPFYDLLDE LIKPTSLASD NSQRFRETCF AFALTPQQVQ QISSSMDISG
     TKCDFTVQVQ LRFCLSETSC PQEDHFPPNL CVKVNTKPCS LPGYLPPTKN GVEPKRPSRP
     INITSLVRLS TTVPNTIVVS WTAEIGRNYS MAVYLVKQLS STVLLQRLRA KGIRNPDHSR
     ALIKEKLTAD PDSEIATTSL RVSLLCPLGK MRLTIPCRAL TCSHLQCFDA TLYIQMNEKK
     PTWVCPVCDK KAPYEHLIID GLFMEILKYC TDCDEIQFKE DGTWAPMRSK KEVQEVSASY
     NGVDGCLSST LEHQVASHHQ SSNKNKKVEV IDLTIDSSSD EEEEEPSAKR TCPSLSPTSP
     LNNKGILSLP HQASPVSRTP SLPAVDTSYI NTSLIQDYRH PFHMTPMPYD LQGLDFFPFL
     SGDNQHYNTS LLAAAAAAVS DDQDLLHSSR FFPYTSSQMF LDQLSAGGST SLPTTNGSSS
     GSNSSLVSSN SLRESHSHTV TNRSSTDTAS IFGIIPDIIS LD
//
ID   Q59E96_HUMAN            Unreviewed;       369 AA.
AC   Q59E96;
DT   26-APR-2005, integrated into UniProtKB/TrEMBL.
DT   26-APR-2005, sequence version 1.
DT   23-MAY-2018, entry version 90.
DE   SubName: Full=Nuclear RNA export factor 1 variant {ECO:0000313|EMBL:BAD93152.1};
DE   Flags: Fragment;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAD93152.1};
RN   [1] {ECO:0000313|EMBL:BAD93152.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Aorta endothelial cell {ECO:0000313|EMBL:BAD93152.1};
RA   Totoki Y., Toyoda A., Takeda T., Sakaki Y., Tanaka A., Yokoyama S.,
RA   Ohara O., Nagase T., Kikuno R.F.;
RT   "Homo sapiens protein coding cDNA.";
RL   Submitted (MAR-2005) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB209915; BAD93152.1; -; mRNA.
DR   RefSeq; NP_001074960.1; NM_001081491.1.
DR   UniGene; Hs.523739; -.
DR   UniGene; Hs.601546; -.
DR   DNASU; 10482; -.
DR   GeneID; 10482; -.
DR   CTD; 10482; -.
DR   PharmGKB; PA31858; -.
DR   eggNOG; KOG3763; Eukaryota.
DR   eggNOG; ENOG410XR55; LUCA.
DR   HOVERGEN; HBG013199; -.
DR   GenomeRNAi; 10482; -.
DR   Genevisible; Q59E96; HS.
DR   GO; GO:0005737; C:cytoplasm; IEA:InterPro.
DR   GO; GO:0005634; C:nucleus; IEA:InterPro.
DR   GO; GO:0003723; F:RNA binding; IEA:InterPro.
DR   GO; GO:0006406; P:mRNA export from nucleus; IEA:InterPro.
DR   Gene3D; 3.30.70.330; -; 1.
DR   Gene3D; 3.80.10.10; -; 1.
DR   InterPro; IPR001611; Leu-rich_rpt.
DR   InterPro; IPR032675; LRR_dom_sf.
DR   InterPro; IPR012677; Nucleotide-bd_a/b_plait_sf.
DR   InterPro; IPR030217; NXF_fam.
DR   InterPro; IPR035979; RBD_domain_sf.
DR   InterPro; IPR015245; Tap_RNA-bd.
DR   PANTHER; PTHR10662; PTHR10662; 1.
DR   Pfam; PF09162; Tap-RNA_bind; 1.
DR   ProDom; PD043466; Tap_RNA_bd; 1.
DR   SUPFAM; SSF54928; SSF54928; 1.
DR   PROSITE; PS51450; LRR; 3.
PE   2: Evidence at transcript level;
FT   DOMAIN      129    211       Tap-RNA_bind. {ECO:0000259|Pfam:PF09162}.
FT   NON_TER       1      1       {ECO:0000313|EMBL:BAD93152.1}.
SQ   SEQUENCE   369 AA;  41852 MW;  22790CB637B60811 CRC64;
     RPAPEPALDL RCGMADEGKS YSEHDDERVN FPQRKKKGRG PFRWKYGEGN RRSGRGGSGI
     RSSRLEEDDG DVAMSDAQDG PRVRYNPYTT RPNRRGDTWH DRDRIHVTVR RDRAPPERGG
     AGTSQDGTSK NWFKITIPYG RKYDKAWLLS MIQSKCSVPF TPIEFHYENT RAQFFVEDAS
     TASALKAVNY KILDRENRRI SIIINSSAPP HTILNELKPE QVEQLKLIMS KRYDGSQQAL
     DLKGLRSDPD LVAQNIDVVL NRRSCMAATL RIIEENIPEL LSLNLSNNRL YRLDDMSSIV
     QKAPNLKILN LSGNELKSER ELDKIKGLKL EELWLDGNSL CDTFRDQSTY IRSVVACVSP
     PGDLHPLGG
//
ID   NXF1_HUMAN              Reviewed;         619 AA.
AC   Q9UBU9; B4E269; Q99799; Q9UQL2;
DT   27-MAR-2002, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-2000, sequence version 1.
DT   23-MAY-2018, entry version 201.
DE   RecName: Full=Nuclear RNA export factor 1;
DE   AltName: Full=Tip-associated protein;
DE   AltName: Full=Tip-associating protein;
DE   AltName: Full=mRNA export factor TAP;
GN   Name=NXF1; Synonyms=TAP;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND MUTAGENESIS.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=10202158; DOI=10.1093/emboj/18.7.1953;
RA   Braun I.C., Rohrbach E., Schmitt C., Izaurralde E.;
RT   "TAP binds to the constitutive transport element (CTE) through a novel
RT   RNA-binding motif that is sufficient to promote CTE-dependent RNA
RT   export from the nucleus.";
RL   EMBO J. 18:1953-1965(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=10323864; DOI=10.1101/gad.13.9.1126;
RA   Kang Y., Cullen B.R.;
RT   "The human Tap protein is a nuclear mRNA export factor that contains
RT   novel RNA-binding and nucleocytoplasmic transport sequences.";
RL   Genes Dev. 13:1126-1139(1999).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=10454577; DOI=10.1128/MCB.19.9.6306;
RA   Bear J., Tan W., Zolotukhin A.S., Tabernero C., Hudson E.A.,
RA   Felber B.K.;
RT   "Identification of novel import and export signals of human TAP, the
RT   protein that binds to the constitutive transport element of the type D
RT   retrovirus mRNAs.";
RL   Mol. Cell. Biol. 19:6306-6317(1999).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Lung, and Trachea;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16554811; DOI=10.1038/nature04632;
RA   Taylor T.D., Noguchi H., Totoki Y., Toyoda A., Kuroki Y., Dewar K.,
RA   Lloyd C., Itoh T., Takeda T., Kim D.-W., She X., Barlow K.F.,
RA   Bloom T., Bruford E., Chang J.L., Cuomo C.A., Eichler E.,
RA   FitzGerald M.G., Jaffe D.B., LaButti K., Nicol R., Park H.-S.,
RA   Seaman C., Sougnez C., Yang X., Zimmer A.R., Zody M.C., Birren B.W.,
RA   Nusbaum C., Fujiyama A., Hattori M., Rogers J., Lander E.S.,
RA   Sakaki Y.;
RT   "Human chromosome 11 DNA sequence and analysis including novel gene
RT   identification.";
RL   Nature 440:497-500(2006).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain, and Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 61-619, AND INTERACTION WITH SAIMIRIINE
RP   HERPESVIRUS 2 TIP (MICROBIAL INFECTION).
RC   TISSUE=Lymphocyte;
RX   PubMed=9175835; DOI=10.1016/S1074-7613(00)80345-3;
RA   Yoon D.-W., Lee H., Seol W., DeMaria M., Rosenzweig M., Jung J.U.;
RT   "Tap: a novel cellular protein that interacts with tip of herpesvirus
RT   saimiri and induces lymphocyte aggregation.";
RL   Immunity 6:571-582(1997).
RN   [9]
RP   FUNCTION.
RX   PubMed=9660949; DOI=10.1016/S1097-2765(00)80065-9;
RA   Grueter P., Tabernero C., von Kobbe C., Schmitt C., Saavedra C.,
RA   Bachi A., Wilm M., Felber B.K., Izaurralde E.;
RT   "TAP, the human homolog of Mex67p, mediates CTE-dependent RNA export
RT   from the nucleus.";
RL   Mol. Cell 1:649-659(1998).
RN   [10]
RP   INTERACTION WITH NUPL2.
RX   PubMed=10228171; DOI=10.1093/emboj/18.9.2593;
RA   Katahira J., Straesser K., Podtelejnikov A., Mann M., Jung J.U.,
RA   Hurt E.;
RT   "The Mex67p-mediated nuclear mRNA export pathway is conserved from
RT   yeast to human.";
RL   EMBO J. 18:2593-2609(1999).
RN   [11]
RP   FUNCTION, INTERACTION WITH DHX9, AND SUBCELLULAR LOCATION.
RX   PubMed=10924507; DOI=10.1074/jbc.M003933200;
RA   Tang H., Wong-Staal F.;
RT   "Specific interaction between RNA helicase A and Tap, two cellular
RT   proteins that bind to the constitutive transport element of type D
RT   retrovirus.";
RL   J. Biol. Chem. 275:32694-32700(2000).
RN   [12]
RP   CHARACTERIZATION.
RX   PubMed=11259411; DOI=10.1074/jbc.M100400200;
RA   Braun I.C., Herold A., Rode M., Conti E., Izaurralde E.;
RT   "Overexpression of TAP/p15 heterodimers bypasses nuclear retention and
RT   stimulates nuclear mRNA export.";
RL   J. Biol. Chem. 276:20536-20543(2001).
RN   [13]
RP   CHARACTERIZATION.
RX   PubMed=10668806; DOI=10.1017/S1355838200991994;
RA   Bachi A., Braun I.C., Rodrigues J.P., Pante N., Ribbeck K.,
RA   von Kobbe C., Kutay U., Wilm M., Goerlich D., Carmo-Fonseca M.,
RA   Izaurralde E.;
RT   "The C-terminal domain of TAP interacts with the nuclear pore complex
RT   and promotes export of specific CTE-bearing RNA substrates.";
RL   RNA 6:136-158(2000).
RN   [14]
RP   MUTAGENESIS.
RX   PubMed=11256625; DOI=10.1093/embo-reports/kvd009;
RA   Suyama M., Doerks T., Braun I.C., Sattler M., Izaurralde E., Bork P.;
RT   "Prediction of structural domains of TAP reveals details of its
RT   interaction with p15 and nucleoporins.";
RL   EMBO Rep. 1:53-58(2000).
RN   [15]
RP   INTERACTION WITH ALYREF/THOC4 AND THE EXON JUNCTION COMPLEX.
RX   PubMed=11707413; DOI=10.1093/emboj/20.22.6424;
RA   Kataoka N., Diem M.D., Kim V.N., Yong J., Dreyfuss G.;
RT   "Magoh, a human homolog of Drosophila mago nashi protein, is a
RT   component of the splicing-dependent exon-exon junction complex.";
RL   EMBO J. 20:6424-6433(2001).
RN   [16]
RP   IDENTIFICATION IN A MRNP COMPLEX WITH UPF3A AND UPF3B.
RX   PubMed=11546873; DOI=10.1126/science.1062829;
RA   Kim V.N., Kataoka N., Dreyfuss G.;
RT   "Role of the nonsense-mediated decay factor hUpf3 in the splicing-
RT   dependent exon-exon junction complex.";
RL   Science 293:1832-1836(2001).
RN   [17]
RP   IDENTIFICATION IN A POST-SPLICING COMPLEX WITH RBM8A; UPF1; UPF2;
RP   UPF3A; UPF3B AND RNPS1.
RX   PubMed=11546874; DOI=10.1126/science.1062786;
RA   Lykke-Andersen J., Shu M.-D., Steitz J.A.;
RT   "Communication of the position of exon-exon junctions to the mRNA
RT   surveillance machinery by the protein RNPS1.";
RL   Science 293:1836-1839(2001).
RN   [18]
RP   IDENTIFICATION IN A COMPLEX WITH RANBP2; RANGAP1 AND NXT1.
RX   PubMed=14729961;
RA   Forler D., Rabut G., Ciccarelli F.D., Herold A., Koecher T.,
RA   Niggeweg R., Bork P., Ellenberg J., Izaurralde E.;
RT   "RanBP2/Nup358 provides a major binding site for NXF1-p15 dimers at
RT   the nuclear pore complex and functions in nuclear mRNA export.";
RL   Mol. Cell. Biol. 24:1155-1167(2004).
RN   [19]
RP   INTERACTION WITH EIF4A3 AND ALYREF/THOC4.
RX   PubMed=14730019; DOI=10.1261/rna.5230104;
RA   Chan C.C., Dostie J., Diem M.D., Feng W., Mann M., Rappsilber J.,
RA   Dreyfuss G.;
RT   "eIF4A3 is a novel component of the exon junction complex.";
RL   RNA 10:200-209(2004).
RN   [20]
RP   FUNCTION, AND MUTAGENESIS OF ARG-71; ARG-78; ARG-81; ARG-82; ARG-89;
RP   ARG-91; ARG-97; ARG-98; ARG-100 AND ARG-105.
RX   PubMed=18364396; DOI=10.1073/pnas.0709167105;
RA   Hautbergue G.M., Hung M.L., Golovanov A.P., Lian L.Y., Wilson S.A.;
RT   "Mutually exclusive interactions drive handover of mRNA from export
RT   adaptors to TAP.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:5154-5159(2008).
RN   [21]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [22]
RP   INTERACTION WITH FYTTD1.
RX   PubMed=19836239; DOI=10.1016/j.cub.2009.09.041;
RA   Hautbergue G.M., Hung M.L., Walsh M.J., Snijders A.P., Chang C.T.,
RA   Jones R., Ponting C.P., Dickman M.J., Wilson S.A.;
RT   "UIF, a new mRNA export adaptor that works together with REF/ALY,
RT   requires FACT for recruitment to mRNA.";
RL   Curr. Biol. 19:1918-1924(2009).
RN   [23]
RP   FUNCTION, AND INTERACTION WITH ALYREF/THOC4 AND THOC5.
RX   PubMed=19165146; DOI=10.1038/emboj.2009.5;
RA   Katahira J., Inoue H., Hurt E., Yoneda Y.;
RT   "Adaptor Aly and co-adaptor Thoc5 function in the Tap-p15-mediated
RT   nuclear export of HSP70 mRNA.";
RL   EMBO J. 28:556-567(2009).
RN   [24]
RP   INTERACTION WITH CPSF6, AND SUBCELLULAR LOCATION.
RX   PubMed=19864460; DOI=10.1091/mbc.E09-05-0389;
RA   Ruepp M.D., Aringhieri C., Vivarelli S., Cardinale S., Paro S.,
RA   Schuemperli D., Barabino S.M.;
RT   "Mammalian pre-mRNA 3' end processing factor CF I m 68 functions in
RT   mRNA export.";
RL   Mol. Biol. Cell 20:5211-5223(2009).
RN   [25]
RP   INTERACTION WITH FMR1.
RX   PubMed=18936162; DOI=10.1128/MCB.01377-08;
RA   Kim M., Bellini M., Ceman S.;
RT   "Fragile X mental retardation protein FMRP binds mRNAs in the
RT   nucleus.";
RL   Mol. Cell. Biol. 29:214-228(2009).
RN   [26]
RP   SUBCELLULAR LOCATION.
RX   PubMed=19324961; DOI=10.1261/rna.1387009;
RA   Schmidt U., Im K.-B., Benzing C., Janjetovic S., Rippe K., Lichter P.,
RA   Wachsmuth M.;
RT   "Assembly and mobility of exon-exon junction complexes in living
RT   cells.";
RL   RNA 15:862-876(2009).
RN   [27]
RP   INTERACTION WITH HUMAN HERPES VIRUS 1 ICP27 (MICROBIAL INFECTION).
RX   PubMed=19369354; DOI=10.1128/JVI.00375-09;
RA   Johnson L.A., Li L., Sandri-Goldin R.M.;
RT   "The cellular RNA export receptor TAP/NXF1 is required for ICP27-
RT   mediated export of herpes simplex virus 1 RNA, but the TREX complex
RT   adaptor protein Aly/REF appears to be dispensable.";
RL   J. Virol. 83:6335-6346(2009).
RN   [28]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [29]
RP   INTERACTION WITH FRG1.
RX   PubMed=21699900; DOI=10.1016/j.jmb.2011.06.014;
RA   Sun C.Y., van Koningsbruggen S., Long S.W., Straasheijm K.,
RA   Klooster R., Jones T.I., Bellini M., Levesque L., Brieher W.M.,
RA   van der Maarel S.M., Jones P.L.;
RT   "Facioscapulohumeral muscular dystrophy region gene 1 is a dynamic
RT   RNA-associated and actin-bundling protein.";
RL   J. Mol. Biol. 411:397-416(2011).
RN   [30]
RP   ASSOCIATION WITH THE TREX COMPLEX, RNA-BINDING, AND MUTAGENESIS OF
RP   ARG-453 AND 456-LYS--ARG-459.
RX   PubMed=22893130; DOI=10.1038/ncomms2005;
RA   Viphakone N., Hautbergue G.M., Walsh M., Chang C.T., Holland A.,
RA   Folco E.G., Reed R., Wilson S.A.;
RT   "TREX exposes the RNA-binding domain of Nxf1 to enable mRNA export.";
RL   Nat. Commun. 3:1006-1006(2012).
RN   [31]
RP   INTERACTION WITH CHTOP; THOC5 AND ALYREF, AND MUTAGENESIS OF
RP   450-LEU--ARG-453 AND 456-LYS--ARG-459.
RX   PubMed=23299939; DOI=10.1038/emboj.2012.342;
RA   Chang C.T., Hautbergue G.M., Walsh M.J., Viphakone N., van Dijk T.B.,
RA   Philipsen S., Wilson S.A.;
RT   "Chtop is a component of the dynamic TREX mRNA export complex.";
RL   EMBO J. 32:473-486(2013).
RN   [32]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-9, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [33]
RP   SUBCELLULAR LOCATION, AND INTERACTION WITH CHTOP.
RX   PubMed=23826332; DOI=10.1371/journal.pone.0067676;
RA   Teng I.F., Wilson S.A.;
RT   "Mapping interactions between mRNA export factors in living cells.";
RL   PLoS ONE 8:E67676-E67676(2013).
RN   [34]
RP   SUBCELLULAR LOCATION, AND INTERACTION WITH LUZP4.
RX   PubMed=25662211; DOI=10.1093/nar/gkv070;
RA   Viphakone N., Cumberbatch M.G., Livingstone M.J., Heath P.R.,
RA   Dickman M.J., Catto J.W., Wilson S.A.;
RT   "Luzp4 defines a new mRNA export pathway in cancer cells.";
RL   Nucleic Acids Res. 43:2353-2366(2015).
RN   [35]
RP   X-RAY CRYSTALLOGRAPHY (2.9 ANGSTROMS) OF 102-372.
RX   PubMed=11060011; DOI=10.1093/emboj/19.21.5587;
RA   Liker E., Fernandez E., Izaurralde E., Conti E.;
RT   "The structure of the mRNA export factor TAP reveals a cis arrangement
RT   of a non-canonical RNP domain and an LRR domain.";
RL   EMBO J. 19:5587-5598(2000).
RN   [36]
RP   X-RAY CRYSTALLOGRAPHY (1.9 ANGSTROMS) IN COMPLEX WITH NXT1, X-RAY
RP   CRYSTALLOGRAPHY (2.8 ANGSTROMS) IN COMPLEX WITH NXT1-FG-REPEAT,
RP   SUBUNIT, DOMAINS, AND MUTAGENESIS OF LEU-383; LEU-386; ASP-399;
RP   ASP-482; ILE-518; PRO-521 AND TRP-594.
RX   PubMed=11583626; DOI=10.1016/S1097-2765(01)00348-3;
RA   Fribourg S., Braun I.C., Izaurralde E., Conti E.;
RT   "Structural basis for the recognition of a nucleoporin FG repeat by
RT   the NTF2-like domain of the TAP/p15 mRNA nuclear export factor.";
RL   Mol. Cell 8:645-656(2001).
RN   [37]
RP   X-RAY CRYSTALLOGRAPHY (1.0 ANGSTROMS) OF 561-619 IN COMPLEX WITH
RP   RANBP3.
RX   PubMed=12581645; DOI=10.1016/S0022-2836(02)01474-2;
RA   Grant R.P., Neuhaus D., Stewart M.;
RT   "Structural basis for the interaction between the Tap/NXF1 UBA domain
RT   and FG nucleoporins at 1A resolution.";
RL   J. Mol. Biol. 326:849-858(2003).
RN   [38]
RP   STRUCTURE BY NMR OF 551-619, AND MUTAGENESIS OF PHE-617.
RX   PubMed=11875519; DOI=10.1038/nsb773;
RA   Grant R.P., Hurt E., Neuhaus D., Stewart M.;
RT   "Structure of the C-terminal FG-nucleoporin binding domain of
RT   Tap/NXF1.";
RL   Nat. Struct. Biol. 9:247-251(2002).
CC   -!- FUNCTION: Involved in the nuclear export of mRNA species bearing
CC       retroviral constitutive transport elements (CTE) and in the export
CC       of mRNA from the nucleus to the cytoplasm (TAP/NFX1 pathway)
CC       (PubMed:10924507). The NXF1-NXT1 heterodimer is involved in the
CC       export of HSP70 mRNA in conjunction with ALYREF/THOC4 and THOC5
CC       components of the TREX complex. ALYREF/THOC4-bound mRNA is thought
CC       to be transferred to the NXF1-NXT1 heterodimer for export.
CC       {ECO:0000269|PubMed:10924507, ECO:0000269|PubMed:18364396,
CC       ECO:0000269|PubMed:19165146, ECO:0000269|PubMed:9660949}.
CC   -!- SUBUNIT: Heterodimer (via NTF2 domain) with NXT1
CC       (PubMed:11583626). The formation of NXF1-NXT1 heterodimers is
CC       required for the NXF1-mediated nuclear mRNA export
CC       (PubMed:11583626). Forms a complex with RANBP2/NUP358, NXT1 and
CC       RANGAP1 (PubMed:14729961). Associates with the exon junction
CC       complex (EJC) and with the transcription/export (TREX) complex
CC       (PubMed:11707413, PubMed:22893130). Found in a mRNA complex with
CC       UPF3A and UPF3B (PubMed:11546873). Found in a post-splicing
CC       complex with RBM8A, UPF1, UPF2, UPF3A, UPF3B and RNPS1
CC       (PubMed:11546874). Interacts (via N-terminus) with DHX9 (via N-
CC       terminus); this interaction is direct and negatively regulates
CC       NXF1-mediated nuclear export of constitutive transport element
CC       (CTE)-containing cellular mRNAs (PubMed:10924507). Interacts with
CC       ALYREF/THOC4 (PubMed:11707413, PubMed:14730019, PubMed:19165146,
CC       PubMed:23299939). Interacts with FYTTD1/UIF (PubMed:19836239).
CC       Interacts with EIF4A3 (PubMed:14730019). Interacts with NUPL2
CC       (PubMed:10228171). Interacts with THOC5 (PubMed:19165146,
CC       PubMed:23299939). Interacts with CHTOP (PubMed:23299939,
CC       PubMed:23826332). Interacts with FRG1 (via N-terminus)
CC       (PubMed:21699900). Interacts with LUZP4 (PubMed:25662211).
CC       Interacts with FMR1; the interaction occurs in a mRNA-dependent
CC       and polyribosomes-independent manner in the nucleus
CC       (PubMed:18936162). Interacts with CPSF6 (via N-terminus); this
CC       interaction is direct (PubMed:19864460).
CC       {ECO:0000269|PubMed:10228171, ECO:0000269|PubMed:10924507,
CC       ECO:0000269|PubMed:11546873, ECO:0000269|PubMed:11546874,
CC       ECO:0000269|PubMed:11583626, ECO:0000269|PubMed:11707413,
CC       ECO:0000269|PubMed:12581645, ECO:0000269|PubMed:14729961,
CC       ECO:0000269|PubMed:14730019, ECO:0000269|PubMed:18936162,
CC       ECO:0000269|PubMed:19165146, ECO:0000269|PubMed:19369354,
CC       ECO:0000269|PubMed:19836239, ECO:0000269|PubMed:19864460,
CC       ECO:0000269|PubMed:21699900, ECO:0000269|PubMed:22893130,
CC       ECO:0000269|PubMed:23299939, ECO:0000269|PubMed:23826332,
CC       ECO:0000269|PubMed:25662211, ECO:0000269|PubMed:9175835}.
CC   -!- SUBUNIT: (Microbial infection) Interacts with Saimiriine
CC       herpesvirus 2 TIP protein. {ECO:0000269|PubMed:9175835}.
CC   -!- SUBUNIT: (Microbial infection) Interacts with human herpes virus 1
CC       (HHV-1) ICP27 protein; this interaction allows efficient export of
CC       HHV-1 early and late transcripts. {ECO:0000269|PubMed:19369354}.
CC   -!- INTERACTION:
CC       P22575:- (xeno); NbExp=6; IntAct=EBI-398874, EBI-866709;
CC       Q86V81:ALYREF; NbExp=4; IntAct=EBI-398874, EBI-347640;
CC       Q9BYV9:BACH2; NbExp=4; IntAct=EBI-398874, EBI-1642333;
CC       Q9Y3Y2:CHTOP; NbExp=9; IntAct=EBI-398874, EBI-347794;
CC       O00571:DDX3X; NbExp=5; IntAct=EBI-398874, EBI-353779;
CC       Q08211:DHX9; NbExp=8; IntAct=EBI-398874, EBI-352022;
CC       Q92997:DVL3; NbExp=3; IntAct=EBI-398874, EBI-739789;
CC       P14136:GFAP; NbExp=5; IntAct=EBI-398874, EBI-744302;
CC       Q9H079:KATNBL1; NbExp=4; IntAct=EBI-398874, EBI-715394;
CC       Q6A162:KRT40; NbExp=3; IntAct=EBI-398874, EBI-10171697;
CC       O95751:LDOC1; NbExp=3; IntAct=EBI-398874, EBI-740738;
CC       Q9UJV3-2:MID2; NbExp=3; IntAct=EBI-398874, EBI-10172526;
CC       P37198:NUP62; NbExp=8; IntAct=EBI-398874, EBI-347978;
CC       Q9UKK6:NXT1; NbExp=5; IntAct=EBI-398874, EBI-301889;
CC       P31321:PRKAR1B; NbExp=4; IntAct=EBI-398874, EBI-2805516;
CC       Q8IX06:REXO1L1P; NbExp=4; IntAct=EBI-398874, EBI-10262361;
CC       Q07955:SRSF1; NbExp=5; IntAct=EBI-398874, EBI-398920;
CC       P84103:SRSF3; NbExp=4; IntAct=EBI-398874, EBI-372557;
CC       Q16629:SRSF7; NbExp=4; IntAct=EBI-398874, EBI-398885;
CC       Q9Y2W1:THRAP3; NbExp=4; IntAct=EBI-398874, EBI-352039;
CC       Q96CG3:TIFA; NbExp=5; IntAct=EBI-398874, EBI-740711;
CC       Q13625-3:TP53BP2; NbExp=3; IntAct=EBI-398874, EBI-10175039;
CC       Q9UMX0:UBQLN1; NbExp=4; IntAct=EBI-398874, EBI-741480;
CC       P10238:UL54 (xeno); NbExp=4; IntAct=EBI-398874, EBI-6883946;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:10924507,
CC       ECO:0000269|PubMed:19864460, ECO:0000269|PubMed:25662211}.
CC       Nucleus, nucleoplasm {ECO:0000269|PubMed:19324961,
CC       ECO:0000269|PubMed:23826332}. Nucleus speckle
CC       {ECO:0000269|PubMed:19324961, ECO:0000269|PubMed:23826332}.
CC       Cytoplasm {ECO:0000269|PubMed:10924507,
CC       ECO:0000269|PubMed:19324961, ECO:0000269|PubMed:19864460}.
CC       Note=Localized predominantly in the nucleoplasm and at both the
CC       nucleoplasmic and cytoplasmic faces of the nuclear pore complex.
CC       Shuttles between the nucleus and the cytoplasm. Travels to the
CC       cytoplasm as part of the exon junction complex (EJC) bound to
CC       mRNA. The association with the TREX complex seems to occur in
CC       regions surrounding nuclear speckles known as perispeckles
CC       (PubMed:23826332). Nucleus; nuclear rim (PubMed:25662211).
CC       {ECO:0000269|PubMed:23826332, ECO:0000269|PubMed:25662211}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9UBU9-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9UBU9-2; Sequence=VSP_041427, VSP_041428;
CC   -!- TISSUE SPECIFICITY: Expressed ubiquitously.
CC   -!- DOMAIN: The minimal CTE binding domain consists of an RNP-type RNA
CC       binding domain (RBD) and leucine-rich repeats.
CC       {ECO:0000269|PubMed:11583626}.
CC   -!- DOMAIN: The nucleoporin binding domain consists of a NTF2 domain
CC       (also called NTF2-like domain) and a TAP-C domain (also called
CC       UBA-like domain). It has 2 nucleoporin-FG-repeats binding sites
CC       (one in the NTF2 and the other in the TAP-C domain) which
CC       contribute to nucleoporin association and act synergistically to
CC       export cellular mRNAs. {ECO:0000269|PubMed:11583626}.
CC   -!- DOMAIN: The NTF2 domain is functional only in the presence of NXT1
CC       and is essential for the export of mRNA from the nucleus. It
CC       inhibits RNA binding activity through an intramolecular
CC       interaction with the N-terminal RNA binding domain (RBD); the
CC       inhibition is removed by an association with the TREX complex,
CC       specifically involving ALYREF/THOC4 and THOC5.
CC       {ECO:0000269|PubMed:11583626}.
CC   -!- DOMAIN: The TAP-C domain mediates direct interactions with
CC       nucleoporin-FG-repeats and is necessary and sufficient for
CC       localization of NXF1 to the nuclear rim. The conserved loop 594-
CC       NWD-596 of the TAP-C domain has a critical role in the interaction
CC       with nucleoporins. {ECO:0000269|PubMed:11583626}.
CC   -!- DOMAIN: The leucine-rich repeats are essential for the export of
CC       mRNA from the nucleus. {ECO:0000269|PubMed:11583626}.
CC   -!- DOMAIN: The RNA-binding domain is a non-canonical RNP-type domain.
CC       {ECO:0000269|PubMed:11583626}.
CC   -!- SIMILARITY: Belongs to the NXF family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AJ132712; CAA10753.1; -; mRNA.
DR   EMBL; AF112880; AAD39102.1; -; mRNA.
DR   EMBL; AF126246; AAD20016.1; -; mRNA.
DR   EMBL; AK304137; BAG65031.1; -; mRNA.
DR   EMBL; AK027192; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; AP001160; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471076; EAW74105.1; -; Genomic_DNA.
DR   EMBL; BC004904; AAH04904.1; -; mRNA.
DR   EMBL; BC028041; AAH28041.1; -; mRNA.
DR   EMBL; U80073; AAB81111.1; -; mRNA.
DR   CCDS; CCDS44629.1; -. [Q9UBU9-2]
DR   CCDS; CCDS8037.1; -. [Q9UBU9-1]
DR   RefSeq; NP_001074960.1; NM_001081491.1. [Q9UBU9-2]
DR   RefSeq; NP_006353.2; NM_006362.4. [Q9UBU9-1]
DR   UniGene; Hs.523739; -.
DR   UniGene; Hs.601546; -.
DR   PDB; 1FO1; X-ray; 2.90 A; A/B=102-372.
DR   PDB; 1FT8; X-ray; 3.15 A; A/B/C/D/E=102-372.
DR   PDB; 1GO5; NMR; -; A=551-619.
DR   PDB; 1JKG; X-ray; 1.90 A; B=371-619.
DR   PDB; 1JN5; X-ray; 2.80 A; B=371-619.
DR   PDB; 1KOH; X-ray; 3.80 A; A/B/C/D=96-372.
DR   PDB; 1KOO; X-ray; 3.80 A; A/B/C/D=96-372.
DR   PDB; 1OAI; X-ray; 1.00 A; A=561-619.
DR   PDB; 2Z5K; X-ray; 2.60 A; B=53-82.
DR   PDB; 2Z5M; X-ray; 3.00 A; B=53-82.
DR   PDB; 3RW6; X-ray; 2.30 A; A/B=96-362.
DR   PDB; 3RW7; X-ray; 3.00 A; A/B/C/D=96-362.
DR   PDB; 4WYK; X-ray; 3.40 A; A/C=96-555.
DR   PDBsum; 1FO1; -.
DR   PDBsum; 1FT8; -.
DR   PDBsum; 1GO5; -.
DR   PDBsum; 1JKG; -.
DR   PDBsum; 1JN5; -.
DR   PDBsum; 1KOH; -.
DR   PDBsum; 1KOO; -.
DR   PDBsum; 1OAI; -.
DR   PDBsum; 2Z5K; -.
DR   PDBsum; 2Z5M; -.
DR   PDBsum; 3RW6; -.
DR   PDBsum; 3RW7; -.
DR   PDBsum; 4WYK; -.
DR   ProteinModelPortal; Q9UBU9; -.
DR   SMR; Q9UBU9; -.
DR   BioGrid; 115745; 1132.
DR   CORUM; Q9UBU9; -.
DR   DIP; DIP-31789N; -.
DR   IntAct; Q9UBU9; 105.
DR   MINT; Q9UBU9; -.
DR   STRING; 9606.ENSP00000294172; -.
DR   TCDB; 3.A.18.1.1; the nuclear mrna exporter (mrna-e) family.
DR   iPTMnet; Q9UBU9; -.
DR   PhosphoSitePlus; Q9UBU9; -.
DR   BioMuta; NXF1; -.
DR   DMDM; 20139282; -.
DR   EPD; Q9UBU9; -.
DR   PaxDb; Q9UBU9; -.
DR   PeptideAtlas; Q9UBU9; -.
DR   PRIDE; Q9UBU9; -.
DR   DNASU; 10482; -.
DR   Ensembl; ENST00000294172; ENSP00000294172; ENSG00000162231. [Q9UBU9-1]
DR   Ensembl; ENST00000531709; ENSP00000453885; ENSG00000162231. [Q9UBU9-2]
DR   Ensembl; ENST00000532297; ENSP00000436679; ENSG00000162231. [Q9UBU9-1]
DR   GeneID; 10482; -.
DR   KEGG; hsa:10482; -.
DR   UCSC; uc001nvf.1; human. [Q9UBU9-1]
DR   CTD; 10482; -.
DR   DisGeNET; 10482; -.
DR   EuPathDB; HostDB:ENSG00000162231.13; -.
DR   GeneCards; NXF1; -.
DR   HGNC; HGNC:8071; NXF1.
DR   HPA; CAB016327; -.
DR   HPA; HPA061593; -.
DR   MIM; 602647; gene.
DR   neXtProt; NX_Q9UBU9; -.
DR   OpenTargets; ENSG00000162231; -.
DR   PharmGKB; PA31858; -.
DR   eggNOG; KOG3763; Eukaryota.
DR   eggNOG; ENOG410XR55; LUCA.
DR   GeneTree; ENSGT00390000007539; -.
DR   HOGENOM; HOG000236269; -.
DR   HOVERGEN; HBG013199; -.
DR   InParanoid; Q9UBU9; -.
DR   KO; K14284; -.
DR   OMA; SYFGTET; -.
DR   OrthoDB; EOG091G04QA; -.
DR   PhylomeDB; Q9UBU9; -.
DR   TreeFam; TF314566; -.
DR   Reactome; R-HSA-159227; Transport of the SLBP independent Mature mRNA.
DR   Reactome; R-HSA-159230; Transport of the SLBP Dependant Mature mRNA.
DR   Reactome; R-HSA-159231; Transport of Mature mRNA Derived from an Intronless Transcript.
DR   Reactome; R-HSA-159236; Transport of Mature mRNA derived from an Intron-Containing Transcript.
DR   SIGNOR; Q9UBU9; -.
DR   ChiTaRS; NXF1; human.
DR   EvolutionaryTrace; Q9UBU9; -.
DR   GeneWiki; NXF1; -.
DR   GenomeRNAi; 10482; -.
DR   PRO; PR:Q9UBU9; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   Bgee; ENSG00000162231; -.
DR   CleanEx; HS_NXF1; -.
DR   ExpressionAtlas; Q9UBU9; baseline and differential.
DR   Genevisible; Q9UBU9; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0042405; C:nuclear inclusion body; IEA:Ensembl.
DR   GO; GO:0005643; C:nuclear pore; IEA:Ensembl.
DR   GO; GO:0016607; C:nuclear speck; IDA:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0003729; F:mRNA binding; IEA:Ensembl.
DR   GO; GO:0003723; F:RNA binding; HDA:UniProtKB.
DR   GO; GO:0006406; P:mRNA export from nucleus; IDA:UniProtKB.
DR   GO; GO:0016973; P:poly(A)+ mRNA export from nucleus; IBA:GO_Central.
DR   GO; GO:0006405; P:RNA export from nucleus; TAS:Reactome.
DR   GO; GO:0016032; P:viral process; IEA:UniProtKB-KW.
DR   CDD; cd00780; NTF2; 1.
DR   CDD; cd14342; UBA_TAP-C; 1.
DR   Gene3D; 3.30.70.330; -; 1.
DR   Gene3D; 3.80.10.10; -; 1.
DR   InterPro; IPR001611; Leu-rich_rpt.
DR   InterPro; IPR032675; LRR_dom_sf.
DR   InterPro; IPR002075; NTF2.
DR   InterPro; IPR032710; NTF2-like_dom_sf.
DR   InterPro; IPR018222; Nuclear_transport_factor_2_euk.
DR   InterPro; IPR012677; Nucleotide-bd_a/b_plait_sf.
DR   InterPro; IPR030217; NXF_fam.
DR   InterPro; IPR035979; RBD_domain_sf.
DR   InterPro; IPR005637; TAP_C_dom.
DR   InterPro; IPR015245; Tap_RNA-bd.
DR   InterPro; IPR009060; UBA-like_sf.
DR   PANTHER; PTHR10662; PTHR10662; 1.
DR   Pfam; PF02136; NTF2; 1.
DR   Pfam; PF09162; Tap-RNA_bind; 1.
DR   Pfam; PF03943; TAP_C; 1.
DR   ProDom; PD043466; Tap_RNA_bd; 1.
DR   SMART; SM00804; TAP_C; 1.
DR   SUPFAM; SSF46934; SSF46934; 1.
DR   SUPFAM; SSF54427; SSF54427; 1.
DR   SUPFAM; SSF54928; SSF54928; 1.
DR   PROSITE; PS51450; LRR; 3.
DR   PROSITE; PS50177; NTF2_DOMAIN; 1.
DR   PROSITE; PS51281; TAP_C; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Complete proteome;
KW   Cytoplasm; Host-virus interaction; Leucine-rich repeat; Methylation;
KW   mRNA transport; Nitration; Nucleus; Phosphoprotein;
KW   Reference proteome; Repeat; RNA-binding; Transport.
FT   INIT_MET      1      1       Removed. {ECO:0000244|PubMed:19413330}.
FT   CHAIN         2    619       Nuclear RNA export factor 1.
FT                                /FTId=PRO_0000220529.
FT   DOMAIN      119    198       RRM.
FT   REPEAT      266    291       LRR 1.
FT   REPEAT      292    315       LRR 2.
FT   REPEAT      316    343       LRR 3.
FT   REPEAT      344    371       LRR 4.
FT   DOMAIN      386    536       NTF2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00137}.
FT   DOMAIN      565    619       TAP-C. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00611}.
FT   REGION        2    198       Interaction with ALYREF/THOC4 and LUZP4.
FT                                {ECO:0000269|PubMed:25662211}.
FT   REGION        2    118       RNA-binding (RBD).
FT   REGION        2     60       Minor non-specific RNA-binding.
FT   REGION       61    118       Major non-specific RNA-binding.
FT   MOTIF        67    100       Nuclear localization signal.
FT   MOTIF        83    110       Nuclear export signal.
FT   COMPBIAS    551    561       Pro-rich.
FT   MOD_RES       2      2       N-acetylalanine.
FT                                {ECO:0000244|PubMed:19413330}.
FT   MOD_RES       9      9       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES      42     42       Asymmetric dimethylarginine; alternate.
FT                                {ECO:0000250|UniProtKB:Q99JX7}.
FT   MOD_RES      42     42       Omega-N-methylarginine; alternate.
FT                                {ECO:0000250|UniProtKB:Q99JX7}.
FT   MOD_RES     126    126       Nitrated tyrosine.
FT                                {ECO:0000250|UniProtKB:Q99JX7}.
FT   VAR_SEQ     339    356       SAIRERFPKLLRLDGHEL -> RSVVACVSPPGDLHPLGG
FT                                (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_041427.
FT   VAR_SEQ     357    619       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_041428.
FT   MUTAGEN      71     71       R->A: Greatly reduces RNA binding and no
FT                                effect on interaction with ALYREF/THOC4;
FT                                when associated with A-78, A-81, A-82, A-
FT                                89, A-91, A-97, A-98, A-100 and A-105.
FT                                {ECO:0000269|PubMed:18364396}.
FT   MUTAGEN      78     78       R->A: Greatly reduces RNA binding and no
FT                                effect on interaction with ALYREF/THOC4;
FT                                when associated with A-71, A-81, A-82, A-
FT                                89, A-91, A-97, A-98, A-100 and A-105.
FT                                {ECO:0000269|PubMed:18364396}.
FT   MUTAGEN      81     81       R->A: Greatly reduces RNA binding and no
FT                                effect on interaction with ALYREF/THOC4;
FT                                when associated with A-71, A-78, A-82, A-
FT                                89, A-91, A-97, A-98, A-100 and A-105.
FT                                {ECO:0000269|PubMed:18364396}.
FT   MUTAGEN      82     82       R->A: Greatly reduces RNA binding and no
FT                                effect on interaction with ALYREF/THOC4;
FT                                when associated with A-71, A-78, A-81, A-
FT                                89, A-91, A-97, A-98, A-100 and A-105.
FT                                {ECO:0000269|PubMed:18364396}.
FT   MUTAGEN      89     89       R->A: Greatly reduces RNA binding and no
FT                                effect on interaction with ALYREF/THOC4;
FT                                when associated with A-71, A-78, A-81, A-
FT                                82, A-91, A-97, A-98, A-100 and A-105.
FT                                {ECO:0000269|PubMed:18364396}.
FT   MUTAGEN      91     91       R->A: Greatly reduces RNA binding and no
FT                                effect on interaction with ALYREF/THOC4;
FT                                when associated with A-71, A-78, A-81, A-
FT                                82, A-89, A-97, A-98, A-100 and A-105.
FT                                {ECO:0000269|PubMed:18364396}.
FT   MUTAGEN      97     97       R->A: Greatly reduces RNA binding and no
FT                                effect on interaction with ALYREF/THOC4;
FT                                when associated with A-71, A-78, A-81, A-
FT                                82, A-89, A-91, A-98, A-100 and A-105.
FT                                {ECO:0000269|PubMed:18364396}.
FT   MUTAGEN      98     98       R->A: Greatly reduces RNA binding and no
FT                                effect on interaction with ALYREF/THOC4;
FT                                when associated with A-71, A-78, A-81, A-
FT                                82, A-89, A-91, A-97, A-100 and A-105.
FT                                {ECO:0000269|PubMed:18364396}.
FT   MUTAGEN     100    100       R->A: Greatly reduces RNA binding and no
FT                                effect on interaction with ALYREF/THOC4;
FT                                when associated with A-71, A-78, A-81, A-
FT                                82, A-89, A-91, A-97, A-98 and A-105.
FT                                {ECO:0000269|PubMed:18364396}.
FT   MUTAGEN     105    105       R->A: Greatly reduces RNA binding and no
FT                                effect on interaction with ALYREF/THOC4;
FT                                when associated with A-71, A-78, A-81, A-
FT                                82, A-89, A-91, A-97, A-98 and A-100.
FT                                {ECO:0000269|PubMed:18364396}.
FT   MUTAGEN     306    308       ERE->AAA: Decreases the export of mRNAs
FT                                from the nucleus.
FT   MUTAGEN     383    383       L->R: Diminishes nuclear rim staining and
FT                                80% reduction in mRNA export activity;
FT                                when associated with R-386. Complete loss
FT                                of nuclear rim staining and mRNA export
FT                                activity; when associated with R-386 and
FT                                A-594. {ECO:0000269|PubMed:11583626}.
FT   MUTAGEN     386    386       L->R: Diminishes nuclear rim staining and
FT                                80% reduction in mRNA export activity;
FT                                when associated with R-383. Complete loss
FT                                of nuclear rim staining and mRNA export
FT                                activity; when associated with R-383 and
FT                                A-594. {ECO:0000269|PubMed:11583626}.
FT   MUTAGEN     399    399       D->A: 60% reduction in mRNA export
FT                                activity. {ECO:0000269|PubMed:11583626}.
FT   MUTAGEN     450    453       LRFR->AAAA: Abolishes interaction with
FT                                THOC5 and CHTOP.
FT                                {ECO:0000269|PubMed:23299939}.
FT   MUTAGEN     453    453       R->A: Impairs intramolecular interaction
FT                                between RBD and NTF2.
FT                                {ECO:0000269|PubMed:22893130}.
FT   MUTAGEN     456    459       KHTR->AAAA: Abolishes interaction with
FT                                THOC5 and CHTOP, no effect on interaction
FT                                with NXT1; enhances intramolecular
FT                                interaction between RBD and NTF2, reduces
FT                                RNA binding and mRNA export.
FT                                {ECO:0000269|PubMed:22893130,
FT                                ECO:0000269|PubMed:23299939}.
FT   MUTAGEN     456    456       K->D: Impairs intramolecular interaction
FT                                between RBD and NTF2; when associated
FT                                with D-459.
FT   MUTAGEN     459    459       R->D: Impairs intramolecular interaction
FT                                between RBD and NTF2; when associated
FT                                with D-456.
FT   MUTAGEN     482    482       D->R: 90% reduction in mRNA export
FT                                activity. {ECO:0000269|PubMed:11583626}.
FT   MUTAGEN     518    518       I->R: 98% reduction in mRNA export
FT                                activity. {ECO:0000269|PubMed:11583626}.
FT   MUTAGEN     521    521       P->Q: 35% reduction in mRNA export
FT                                activity. {ECO:0000269|PubMed:11583626}.
FT   MUTAGEN     594    594       W->A: Suppresses FG-nucleoporin binding.
FT                                Diminishes nuclear rim staining and 88%
FT                                reduction in mRNA export activity.
FT                                Complete loss of nuclear rim staining and
FT                                mRNA export activity; when associated
FT                                with R-383 and R-386.
FT                                {ECO:0000269|PubMed:11583626}.
FT   MUTAGEN     595    595       D->R: Suppresses FG-nucleoporin binding.
FT   MUTAGEN     617    617       F->A: Suppresses FG-nucleoporin binding.
FT                                {ECO:0000269|PubMed:11875519}.
FT   CONFLICT    119    119       W -> C (in Ref. 8; AAB81111).
FT                                {ECO:0000305}.
FT   CONFLICT    256    256       T -> N (in Ref. 3; AAD20016).
FT                                {ECO:0000305}.
FT   STRAND      120    124       {ECO:0000244|PDB:3RW6}.
FT   HELIX       127    129       {ECO:0000244|PDB:3RW6}.
FT   HELIX       132    141       {ECO:0000244|PDB:3RW6}.
FT   STRAND      143    145       {ECO:0000244|PDB:3RW7}.
FT   STRAND      150    155       {ECO:0000244|PDB:3RW6}.
FT   STRAND      158    164       {ECO:0000244|PDB:3RW6}.
FT   HELIX       166    174       {ECO:0000244|PDB:3RW6}.
FT   TURN        176    178       {ECO:0000244|PDB:1FO1}.
FT   STRAND      190    193       {ECO:0000244|PDB:3RW6}.
FT   HELIX       198    201       {ECO:0000244|PDB:3RW6}.
FT   HELIX       206    218       {ECO:0000244|PDB:3RW6}.
FT   TURN        222    225       {ECO:0000244|PDB:3RW6}.
FT   STRAND      226    228       {ECO:0000244|PDB:3RW6}.
FT   HELIX       232    234       {ECO:0000244|PDB:3RW6}.
FT   HELIX       236    240       {ECO:0000244|PDB:3RW6}.
FT   HELIX       250    263       {ECO:0000244|PDB:3RW6}.
FT   STRAND      269    271       {ECO:0000244|PDB:3RW6}.
FT   HELIX       281    285       {ECO:0000244|PDB:3RW6}.
FT   HELIX       286    289       {ECO:0000244|PDB:3RW6}.
FT   STRAND      295    297       {ECO:0000244|PDB:3RW6}.
FT   HELIX       306    312       {ECO:0000244|PDB:3RW6}.
FT   STRAND      318    321       {ECO:0000244|PDB:3RW6}.
FT   HELIX       328    330       {ECO:0000244|PDB:3RW6}.
FT   HELIX       334    344       {ECO:0000244|PDB:3RW6}.
FT   STRAND      350    353       {ECO:0000244|PDB:3RW6}.
FT   HELIX       381    398       {ECO:0000244|PDB:1JKG}.
FT   HELIX       403    408       {ECO:0000244|PDB:1JKG}.
FT   STRAND      410    419       {ECO:0000244|PDB:1JKG}.
FT   HELIX       433    436       {ECO:0000244|PDB:1JKG}.
FT   TURN        442    444       {ECO:0000244|PDB:1JKG}.
FT   HELIX       448    454       {ECO:0000244|PDB:1JKG}.
FT   STRAND      455    458       {ECO:0000244|PDB:1JKG}.
FT   HELIX       459    466       {ECO:0000244|PDB:1JKG}.
FT   STRAND      472    474       {ECO:0000244|PDB:1JKG}.
FT   HELIX       476    478       {ECO:0000244|PDB:1JKG}.
FT   STRAND      480    486       {ECO:0000244|PDB:1JKG}.
FT   STRAND      491    501       {ECO:0000244|PDB:1JKG}.
FT   TURN        505    508       {ECO:0000244|PDB:1JKG}.
FT   STRAND      510    521       {ECO:0000244|PDB:1JKG}.
FT   STRAND      525    538       {ECO:0000244|PDB:1JKG}.
FT   HELIX       541    548       {ECO:0000244|PDB:1JKG}.
FT   STRAND      553    557       {ECO:0000244|PDB:1GO5}.
FT   HELIX       565    578       {ECO:0000244|PDB:1OAI}.
FT   HELIX       582    591       {ECO:0000244|PDB:1OAI}.
FT   TURN        592    594       {ECO:0000244|PDB:1OAI}.
FT   HELIX       596    608       {ECO:0000244|PDB:1OAI}.
FT   HELIX       614    617       {ECO:0000244|PDB:1OAI}.
SQ   SEQUENCE   619 AA;  70182 MW;  338872AADA789FBF CRC64;
     MADEGKSYSE HDDERVNFPQ RKKKGRGPFR WKYGEGNRRS GRGGSGIRSS RLEEDDGDVA
     MSDAQDGPRV RYNPYTTRPN RRGDTWHDRD RIHVTVRRDR APPERGGAGT SQDGTSKNWF
     KITIPYGRKY DKAWLLSMIQ SKCSVPFTPI EFHYENTRAQ FFVEDASTAS ALKAVNYKIL
     DRENRRISII INSSAPPHTI LNELKPEQVE QLKLIMSKRY DGSQQALDLK GLRSDPDLVA
     QNIDVVLNRR SCMAATLRII EENIPELLSL NLSNNRLYRL DDMSSIVQKA PNLKILNLSG
     NELKSERELD KIKGLKLEEL WLDGNSLCDT FRDQSTYISA IRERFPKLLR LDGHELPPPI
     AFDVEAPTTL PPCKGSYFGT ENLKSLVLHF LQQYYAIYDS GDRQGLLDAY HDGACCSLSI
     PFIPQNPARS SLAEYFKDSR NVKKLKDPTL RFRLLKHTRL NVVAFLNELP KTQHDVNSFV
     VDISAQTSTL LCFSVNGVFK EVDGKSRDSL RAFTRTFIAV PASNSGLCIV NDELFVRNAS
     SEEIQRAFAM PAPTPSSSPV PTLSPEQQEM LQAFSTQSGM NLEWSQKCLQ DNNWDYTRSA
     QAFTHLKAKG EIPEVAFMK
//
ID   GBRL2_HUMAN             Reviewed;         117 AA.
AC   P60520; O08765; Q6FG91; Q9DCP8; Q9UQF7;
DT   01-MAR-2004, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2004, sequence version 1.
DT   23-MAY-2018, entry version 142.
DE   RecName: Full=Gamma-aminobutyric acid receptor-associated protein-like 2;
DE   AltName: Full=GABA(A) receptor-associated protein-like 2;
DE   AltName: Full=Ganglioside expression factor 2;
DE            Short=GEF-2;
DE   AltName: Full=General protein transport factor p16;
DE   AltName: Full=Golgi-associated ATPase enhancer of 16 kDa;
DE            Short=GATE-16;
DE   AltName: Full=MAP1 light chain 3-related protein;
DE   Flags: Precursor;
GN   Name=GABARAPL2; Synonyms=FLC3A, GEF2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], TISSUE SPECIFICITY, AND INTERACTION WITH
RP   ULK1.
RC   TISSUE=Frontal cortex;
RX   PubMed=11146101; DOI=10.1016/S0169-328X(00)00218-7;
RA   Okazaki N., Yan J., Yuasa S., Ueno T., Kominami E., Masuho Y.,
RA   Koga H., Muramatsu M.-A.;
RT   "Interaction of the Unc-51-like kinase and microtubule-associated
RT   protein light chain 3 related proteins in the brain: possible role of
RT   vesicular transport in axonal elongation.";
RL   Brain Res. Mol. Brain Res. 85:1-12(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND TISSUE SPECIFICITY.
RX   PubMed=11414770; DOI=10.1006/geno.2001.6555;
RA   Xin Y., Yu L., Chen Z., Zheng L., Fu Q., Jiang J., Zhang P., Gong R.,
RA   Zhao S.;
RT   "Cloning, expression patterns, and chromosome localization of three
RT   human and two mouse homologues of GABA(A) receptor-associated
RT   protein.";
RL   Genomics 74:408-413(2001).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RA   Storch S., Braulke T.;
RL   Submitted (AUG-1998) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Pituitary;
RA   Song H., Peng Y., Yu Y., Fu G., Mao M., Zhang Q., Zhu H., Li G.,
RA   Luo M., Chen J., Hu R.;
RT   "Human GEF2 homolog gene.";
RL   Submitted (JUL-1998) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Halleck A., Ebert L., Mkoundinya M., Schick M., Eisenstein S.,
RA   Neubert P., Kstrang K., Schatten R., Shen B., Henze S., Mar W.,
RA   Korn B., Zuo D., Hu Y., LaBaer J.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain, and Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   INTERACTION WITH ATG7.
RX   PubMed=11096062; DOI=10.1074/jbc.C000752200;
RA   Tanida I., Tanida-Miyake E., Ueno T., Kominami E.;
RT   "The human homolog of Saccharomyces cerevisiae Apg7p is a Protein-
RT   activating enzyme for multiple substrates including human Apg12p,
RT   GATE-16, GABARAP, and MAP-LC3.";
RL   J. Biol. Chem. 276:1701-1706(2001).
RN   [10]
RP   INTERACTION WITH ATG3.
RX   PubMed=11825910; DOI=10.1074/jbc.M200385200;
RA   Tanida I., Tanida-Miyake E., Komatsu M., Ueno T., Kominami E.;
RT   "Human Apg3p/Aut1p homologue is an authentic E2 enzyme for multiple
RT   substrates, GATE-16, GABARAP, and MAP-LC3, and facilitates the
RT   conjugation of hApg12p to hApg5p.";
RL   J. Biol. Chem. 277:13739-13744(2002).
RN   [11]
RP   LIPIDATION AT GLY-116, INTERACTION WITH ATG3 AND ATG7, AND SUBCELLULAR
RP   LOCATION.
RX   PubMed=12507496; DOI=10.1016/S0006-291X(02)02907-8;
RA   Tanida I., Komatsu M., Ueno T., Kominami E.;
RT   "GATE-16 and GABARAP are authentic modifiers mediated by Apg7 and
RT   Apg3.";
RL   Biochem. Biophys. Res. Commun. 300:637-644(2003).
RN   [12]
RP   CLEAVAGE, SUBCELLULAR LOCATION, AND MUTAGENESIS OF GLY-116.
RX   PubMed=15169837; DOI=10.1242/jcs.01131;
RA   Kabeya Y., Mizushima N., Yamamoto A., Oshitani-Okamoto S., Ohsumi Y.,
RA   Yoshimori T.;
RT   "LC3, GABARAP and GATE16 localize to autophagosomal membrane depending
RT   on form-II formation.";
RL   J. Cell Sci. 117:2805-2812(2004).
RN   [13]
RP   INTERACTION WITH SQSTM1, AND SUBCELLULAR LOCATION.
RX   PubMed=17580304; DOI=10.1074/jbc.M702824200;
RA   Pankiv S., Clausen T.H., Lamark T., Brech A., Bruun J.A., Outzen H.,
RA   Overvatn A., Bjorkoy G., Johansen T.;
RT   "p62/SQSTM1 binds directly to Atg8/LC3 to facilitate degradation of
RT   ubiquitinated protein aggregates by autophagy.";
RL   J. Biol. Chem. 282:24131-24145(2007).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-39, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Embryonic kidney;
RX   PubMed=17525332; DOI=10.1126/science.1140321;
RA   Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,
RA   Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,
RA   Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.;
RT   "ATM and ATR substrate analysis reveals extensive protein networks
RT   responsive to DNA damage.";
RL   Science 316:1160-1166(2007).
RN   [15]
RP   SUBCELLULAR LOCATION, AND INTERACTION WITH TP53INP2.
RX   PubMed=19056683; DOI=10.1091/mbc.E08-07-0671;
RA   Nowak J., Archange C., Tardivel-Lacombe J., Pontarotti P.,
RA   Pebusque M.J., Vaccaro M.I., Velasco G., Dagorn J.C., Iovanna J.L.;
RT   "The TP53INP2 protein is required for autophagy in mammalian cells.";
RL   Mol. Biol. Cell 20:870-881(2009).
RN   [16]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-24, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [17]
RP   FUNCTION.
RX   PubMed=20418806; DOI=10.1038/emboj.2010.74;
RA   Weidberg H., Shvets E., Shpilka T., Shimron F., Shinder V., Elazar Z.;
RT   "LC3 and GATE-16/GABARAP subfamilies are both essential yet act
RT   differently in autophagosome biogenesis.";
RL   EMBO J. 29:1792-1802(2010).
RN   [18]
RP   INTERACTION WITH TECPR2.
RX   PubMed=20562859; DOI=10.1038/nature09204;
RA   Behrends C., Sowa M.E., Gygi S.P., Harper J.W.;
RT   "Network organization of the human autophagy system.";
RL   Nature 466:68-76(2010).
RN   [19]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [20]
RP   INTERACTION WITH TBC1D25.
RX   PubMed=21383079; DOI=10.1083/jcb.201008107;
RA   Itoh T., Kanno E., Uemura T., Waguri S., Fukuda M.;
RT   "OATL1, a novel autophagosome-resident Rab33B-GAP, regulates
RT   autophagosomal maturation.";
RL   J. Cell Biol. 192:839-853(2011).
RN   [21]
RP   INTERACTION WITH TP53INP1.
RX   PubMed=22421968; DOI=10.1038/cdd.2012.30;
RA   Seillier M., Peuget S., Gayet O., Gauthier C., N'guessan P., Monte M.,
RA   Carrier A., Iovanna J.L., Dusetti N.J.;
RT   "TP53INP1, a tumor suppressor, interacts with LC3 and ATG8-family
RT   proteins through the LC3-interacting region (LIR) and promotes
RT   autophagy-dependent cell death.";
RL   Cell Death Differ. 19:1525-1535(2012).
RN   [22]
RP   INTERACTION WITH ATG13 AND ULK1.
RX   PubMed=23043107; DOI=10.1074/jbc.M112.378109;
RA   Alemu E.A., Lamark T., Torgersen K.M., Birgisdottir A.B., Larsen K.B.,
RA   Jain A., Olsvik H., Overvatn A., Kirkin V., Johansen T.;
RT   "ATG8 family proteins act as scaffolds for assembly of the ULK
RT   complex: sequence requirements for LC3-interacting region (LIR)
RT   motifs.";
RL   J. Biol. Chem. 287:39275-39290(2012).
RN   [23]
RP   INTERACTION WITH TBC1D5.
RX   PubMed=22354992; DOI=10.1128/MCB.06717-11;
RA   Popovic D., Akutsu M., Novak I., Harper J.W., Behrends C., Dikic I.;
RT   "Rab GTPase-activating proteins in autophagy: regulation of endocytic
RT   and autophagy pathways by direct binding to human ATG8 modifiers.";
RL   Mol. Cell. Biol. 32:1733-1744(2012).
RN   [24]
RP   IDENTIFICATION BY MASS SPECTROMETRY, AND SUBCELLULAR LOCATION.
RX   PubMed=22311637; DOI=10.1074/mcp.M111.014035;
RA   Dengjel J., Hoyer-Hansen M., Nielsen M.O., Eisenberg T., Harder L.M.,
RA   Schandorff S., Farkas T., Kirkegaard T., Becker A.C., Schroeder S.,
RA   Vanselow K., Lundberg E., Nielsen M.M., Kristensen A.R., Akimov V.,
RA   Bunkenborg J., Madeo F., Jaattela M., Andersen J.S.;
RT   "Identification of autophagosome-associated proteins and regulators by
RT   quantitative proteomic analysis and genetic screens.";
RL   Mol. Cell. Proteomics 11:M111.014035.1-M111.014035.17(2012).
RN   [25]
RP   INTERACTION WITH TP53INP1 AND TP53INP2.
RX   PubMed=22470510; DOI=10.1371/journal.pone.0034034;
RA   Sancho A., Duran J., Garcia-Espana A., Mauvezin C., Alemu E.A.,
RA   Lamark T., Macias M.J., Desalle R., Royo M., Sala D., Chicote J.U.,
RA   Palacin M., Johansen T., Zorzano A.;
RT   "DOR/Tp53inp2 and Tp53inp1 constitute a metazoan gene family encoding
RT   dual regulators of autophagy and transcription.";
RL   PLoS ONE 7:E34034-E34034(2012).
RN   [26]
RP   INTERACTION WITH BNIP3, AND FUNCTION.
RX   PubMed=23209295; DOI=10.1074/jbc.M112.399345;
RA   Zhu Y., Massen S., Terenzio M., Lang V., Chen-Lindner S., Eils R.,
RA   Novak I., Dikic I., Hamacher-Brady A., Brady N.R.;
RT   "Modulation of serines 17 and 24 in the LC3-interacting region of
RT   Bnip3 determines pro-survival mitophagy versus apoptosis.";
RL   J. Biol. Chem. 288:1099-1113(2013).
RN   [27]
RP   INTERACTION WITH PCM1.
RX   PubMed=24089205; DOI=10.1038/nature12606;
RA   Tang Z., Lin M.G., Stowe T.R., Chen S., Zhu M., Stearns T., Franco B.,
RA   Zhong Q.;
RT   "Autophagy promotes primary ciliogenesis by removing OFD1 from
RT   centriolar satellites.";
RL   Nature 502:254-257(2013).
RN   [28]
RP   INTERACTION WITH TRIM5.
RX   PubMed=25127057; DOI=10.1016/j.devcel.2014.06.013;
RA   Mandell M.A., Jain A., Arko-Mensah J., Chauhan S., Kimura T.,
RA   Dinkins C., Silvestri G., Munch J., Kirchhoff F., Simonsen A., Wei Y.,
RA   Levine B., Johansen T., Deretic V.;
RT   "TRIM proteins regulate autophagy and can target autophagic substrates
RT   by direct recognition.";
RL   Dev. Cell 30:394-409(2014).
RN   [29]
RP   INTERACTION WITH WDFY3.
RX   PubMed=24668264; DOI=10.1002/embr.201338003;
RA   Lystad A.H., Ichimura Y., Takagi K., Yang Y., Pankiv S., Kanegae Y.,
RA   Kageyama S., Suzuki M., Saito I., Mizushima T., Komatsu M.,
RA   Simonsen A.;
RT   "Structural determinants in GABARAP required for the selective binding
RT   and recruitment of ALFY to LC3B-positive structures.";
RL   EMBO Rep. 15:557-565(2014).
RN   [30]
RP   INTERACTION WITH MEFV AND TRIM21.
RX   PubMed=26347139; DOI=10.1083/jcb.201503023;
RA   Kimura T., Jain A., Choi S.W., Mandell M.A., Schroder K., Johansen T.,
RA   Deretic V.;
RT   "TRIM-mediated precision autophagy targets cytoplasmic regulators of
RT   innate immunity.";
RL   J. Cell Biol. 210:973-989(2015).
CC   -!- FUNCTION: Ubiquitin-like modifier involved in intra-Golgi traffic.
CC       Modulates intra-Golgi transport through coupling between NSF
CC       activity and SNAREs activation. It first stimulates the ATPase
CC       activity of NSF which in turn stimulates the association with
CC       GOSR1 (By similarity). Involved in autophagy. Plays a role in
CC       mitophagy which contributes to regulate mitochondrial quantity and
CC       quality by eliminating the mitochondria to a basal level to
CC       fulfill cellular energy requirements and preventing excess ROS
CC       production. Whereas LC3s are involved in elongation of the
CC       phagophore membrane, the GABARAP/GATE-16 subfamily is essential
CC       for a later stage in autophagosome maturation. {ECO:0000250,
CC       ECO:0000269|PubMed:20418806, ECO:0000269|PubMed:23209295}.
CC   -!- SUBUNIT: Monomer. Interacts with GABRG2, NSF, GOSR1 and beta-
CC       tubulin (By similarity). Interacts with ATG3, ATG7, ATG13 and
CC       ULK1. Interacts with TP53INP1 and TP53INP2. Interacts with
CC       TBC1D25. Directly interacts with SQSTM1 and BNIP3. Interacts with
CC       TECPR2 and PCM1. Interacts with TBC1D5 (PubMed:22354992).
CC       Interacts with TRIM5 (PubMed:25127057). Interacts with MEFV and
CC       TRIM21 (PubMed:26347139). Interacts with WDFY3 (PubMed:24668264).
CC       {ECO:0000250, ECO:0000269|PubMed:11096062,
CC       ECO:0000269|PubMed:11146101, ECO:0000269|PubMed:11825910,
CC       ECO:0000269|PubMed:12507496, ECO:0000269|PubMed:17580304,
CC       ECO:0000269|PubMed:19056683, ECO:0000269|PubMed:20562859,
CC       ECO:0000269|PubMed:21383079, ECO:0000269|PubMed:22354992,
CC       ECO:0000269|PubMed:22421968, ECO:0000269|PubMed:22470510,
CC       ECO:0000269|PubMed:23043107, ECO:0000269|PubMed:23209295,
CC       ECO:0000269|PubMed:24089205, ECO:0000269|PubMed:24668264,
CC       ECO:0000269|PubMed:25127057, ECO:0000269|PubMed:26347139}.
CC   -!- INTERACTION:
CC       Q6RW13:AGTRAP; NbExp=3; IntAct=EBI-720116, EBI-741181;
CC       Q8IVF2-2:AHNAK2; NbExp=3; IntAct=EBI-720116, EBI-10217765;
CC       Q9P2R3:ANKFY1; NbExp=2; IntAct=EBI-720116, EBI-2513908;
CC       Q8N6T3:ARFGAP1; NbExp=3; IntAct=EBI-720116, EBI-716933;
CC       Q8N6T3-2:ARFGAP1; NbExp=4; IntAct=EBI-720116, EBI-6288865;
CC       O75143:ATG13; NbExp=3; IntAct=EBI-720116, EBI-2798775;
CC       Q676U5:ATG16L1; NbExp=2; IntAct=EBI-720116, EBI-535909;
CC       Q2TAZ0:ATG2A; NbExp=2; IntAct=EBI-720116, EBI-2514077;
CC       Q9NT62:ATG3; NbExp=5; IntAct=EBI-720116, EBI-988094;
CC       Q9Y4P1:ATG4B; NbExp=9; IntAct=EBI-720116, EBI-712014;
CC       O95352:ATG7; NbExp=7; IntAct=EBI-720116, EBI-987834;
CC       Q9BXK5:BCL2L13; NbExp=4; IntAct=EBI-720116, EBI-747430;
CC       O60238:BNIP3L; NbExp=4; IntAct=EBI-720116, EBI-849893;
CC       Q9Z2F7:Bnip3l (xeno); NbExp=2; IntAct=EBI-720116, EBI-1774669;
CC       Q2T9L4:C15orf59; NbExp=4; IntAct=EBI-720116, EBI-4311436;
CC       Q9P1Z2:CALCOCO1; NbExp=3; IntAct=EBI-720116, EBI-749920;
CC       Q13137:CALCOCO2; NbExp=6; IntAct=EBI-720116, EBI-739580;
CC       Q8N6L0:CCDC155; NbExp=3; IntAct=EBI-720116, EBI-749265;
CC       Q8WXU2:DNAAF4; NbExp=2; IntAct=EBI-720116, EBI-2946907;
CC       P00533:EGFR; NbExp=2; IntAct=EBI-720116, EBI-297353;
CC       Q8IVP5:FUNDC1; NbExp=3; IntAct=EBI-720116, EBI-3059266;
CC       Q9BQS8:FYCO1; NbExp=2; IntAct=EBI-720116, EBI-2869338;
CC       P40939:HADHA; NbExp=4; IntAct=EBI-720116, EBI-356720;
CC       O00410:IPO5; NbExp=5; IntAct=EBI-720116, EBI-356424;
CC       Q86V97:KBTBD6; NbExp=2; IntAct=EBI-720116, EBI-2514778;
CC       Q8WVZ9:KBTBD7; NbExp=3; IntAct=EBI-720116, EBI-473695;
CC       Q8N8K9:KIAA1958; NbExp=5; IntAct=EBI-720116, EBI-10181113;
CC       P60409:KRTAP10-7; NbExp=3; IntAct=EBI-720116, EBI-10172290;
CC       P60411:KRTAP10-9; NbExp=3; IntAct=EBI-720116, EBI-10172052;
CC       Q9UH92:MLX; NbExp=4; IntAct=EBI-720116, EBI-741109;
CC       Q9UH92-3:MLX; NbExp=4; IntAct=EBI-720116, EBI-8852072;
CC       Q14596:NBR1; NbExp=11; IntAct=EBI-720116, EBI-742698;
CC       P46934:NEDD4; NbExp=6; IntAct=EBI-720116, EBI-726944;
CC       Q8TD19:NEK9; NbExp=7; IntAct=EBI-720116, EBI-1044009;
CC       O75323:NIPSNAP2; NbExp=6; IntAct=EBI-720116, EBI-307133;
CC       Q15154:PCM1; NbExp=2; IntAct=EBI-720116, EBI-741421;
CC       Q9NS23:RASSF1; NbExp=2; IntAct=EBI-720116, EBI-367363;
CC       Q8WWW0:RASSF5; NbExp=2; IntAct=EBI-720116, EBI-367390;
CC       Q14257:RCN2; NbExp=5; IntAct=EBI-720116, EBI-356710;
CC       Q9H6L5-1:RETREG1; NbExp=2; IntAct=EBI-720116, EBI-16159046;
CC       Q9H0K1:SIK2; NbExp=3; IntAct=EBI-720116, EBI-1181664;
CC       Q13501:SQSTM1; NbExp=18; IntAct=EBI-720116, EBI-307104;
CC       O95210:STBD1; NbExp=5; IntAct=EBI-720116, EBI-2947137;
CC       Q13188:STK3; NbExp=2; IntAct=EBI-720116, EBI-992580;
CC       Q13043:STK4; NbExp=2; IntAct=EBI-720116, EBI-367376;
CC       Q8TC07:TBC1D15; NbExp=2; IntAct=EBI-720116, EBI-1048247;
CC       Q9UPU7:TBC1D2B; NbExp=3; IntAct=EBI-720116, EBI-2947180;
CC       B9A6K1:TBC1D5; NbExp=3; IntAct=EBI-720116, EBI-10217641;
CC       Q92609:TBC1D5; NbExp=3; IntAct=EBI-720116, EBI-742381;
CC       Q66K14-2:TBC1D9B; NbExp=3; IntAct=EBI-720116, EBI-10217736;
CC       O15040:TECPR2; NbExp=2; IntAct=EBI-720116, EBI-2946991;
CC       Q15025:TNIP1; NbExp=5; IntAct=EBI-720116, EBI-357849;
CC       Q969E8:TSR2; NbExp=9; IntAct=EBI-720116, EBI-746981;
CC       Q9GZZ9:UBA5; NbExp=15; IntAct=EBI-720116, EBI-747805;
CC       O75385:ULK1; NbExp=3; IntAct=EBI-720116, EBI-908831;
CC       Q8IZQ1:WDFY3; NbExp=3; IntAct=EBI-720116, EBI-1569256;
CC   -!- SUBCELLULAR LOCATION: Golgi apparatus {ECO:0000250}. Cytoplasmic
CC       vesicle, autophagosome {ECO:0000269|PubMed:12507496,
CC       ECO:0000269|PubMed:15169837, ECO:0000269|PubMed:17580304,
CC       ECO:0000269|PubMed:19056683, ECO:0000269|PubMed:22311637}.
CC   -!- TISSUE SPECIFICITY: Ubiquitous. Expressed at high levels in the
CC       brain, heart, prostate, ovary, spleen and skeletal muscle.
CC       Expressed at very low levels in lung, thymus and small intestine.
CC       {ECO:0000269|PubMed:11146101, ECO:0000269|PubMed:11414770}.
CC   -!- PTM: The precursor molecule is cleaved by ATG4B to form the
CC       cytosolic form, GABARAPL2-I. This is activated by APG7L/ATG7,
CC       transferred to ATG3 and conjugated to phospholipid to form the
CC       membrane-bound form, GABARAPL2-II. ATG4B also mediates the
CC       delipidation required for GABARAPL1 recycling when autophagosomes
CC       fuse with lysosomes. {ECO:0000269|PubMed:15169837}.
CC   -!- PTM: The Legionella effector RavZ is a deconjugating enzyme that
CC       produces an ATG8 product that would be resistant to reconjugation
CC       by the host machinery due to the cleavage of the reactive C-
CC       terminal glycine. {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the ATG8 family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB030710; BAB21548.1; -; mRNA.
DR   EMBL; AF087848; AAK20400.1; -; mRNA.
DR   EMBL; AJ010569; CAA09249.1; -; mRNA.
DR   EMBL; AF077046; AAD27779.1; -; mRNA.
DR   EMBL; CR542217; CAG47013.1; -; mRNA.
DR   EMBL; AK289788; BAF82477.1; -; mRNA.
DR   EMBL; CH471114; EAW95630.1; -; Genomic_DNA.
DR   EMBL; BC005985; AAH05985.1; -; mRNA.
DR   EMBL; BC014594; AAH14594.1; -; mRNA.
DR   EMBL; BC029601; AAH29601.1; -; mRNA.
DR   CCDS; CCDS10921.1; -.
DR   RefSeq; NP_009216.1; NM_007285.6.
DR   UniGene; Hs.461379; -.
DR   PDB; 4CO7; X-ray; 2.00 A; A/B=1-117.
DR   PDBsum; 4CO7; -.
DR   ProteinModelPortal; P60520; -.
DR   SMR; P60520; -.
DR   BioGrid; 116473; 84.
DR   DIP; DIP-35051N; -.
DR   ELM; P60520; -.
DR   IntAct; P60520; 527.
DR   MINT; P60520; -.
DR   STRING; 9606.ENSP00000037243; -.
DR   iPTMnet; P60520; -.
DR   PhosphoSitePlus; P60520; -.
DR   BioMuta; GABARAPL2; -.
DR   DMDM; 44888808; -.
DR   UCD-2DPAGE; P60520; -.
DR   EPD; P60520; -.
DR   PaxDb; P60520; -.
DR   PeptideAtlas; P60520; -.
DR   PRIDE; P60520; -.
DR   DNASU; 11345; -.
DR   Ensembl; ENST00000037243; ENSP00000037243; ENSG00000034713.
DR   GeneID; 11345; -.
DR   KEGG; hsa:11345; -.
DR   UCSC; uc002fen.3; human.
DR   CTD; 11345; -.
DR   DisGeNET; 11345; -.
DR   EuPathDB; HostDB:ENSG00000034713.7; -.
DR   GeneCards; GABARAPL2; -.
DR   HGNC; HGNC:13291; GABARAPL2.
DR   HPA; HPA036726; -.
DR   MIM; 607452; gene.
DR   neXtProt; NX_P60520; -.
DR   OpenTargets; ENSG00000034713; -.
DR   PharmGKB; PA28482; -.
DR   eggNOG; KOG1654; Eukaryota.
DR   eggNOG; ENOG4111JAT; LUCA.
DR   GeneTree; ENSGT00390000012937; -.
DR   HOGENOM; HOG000232034; -.
DR   HOVERGEN; HBG051706; -.
DR   InParanoid; P60520; -.
DR   KO; K08341; -.
DR   OMA; AAAMKWM; -.
DR   OrthoDB; EOG091G10QX; -.
DR   PhylomeDB; P60520; -.
DR   TreeFam; TF312964; -.
DR   Reactome; R-HSA-1632852; Macroautophagy.
DR   Reactome; R-HSA-8854214; TBC/RABGAPs.
DR   SIGNOR; P60520; -.
DR   ChiTaRS; GABARAPL2; human.
DR   GeneWiki; GABARAPL2; -.
DR   GenomeRNAi; 11345; -.
DR   PMAP-CutDB; P60520; -.
DR   PRO; PR:P60520; -.
DR   Proteomes; UP000005640; Chromosome 16.
DR   Bgee; ENSG00000034713; -.
DR   CleanEx; HS_GABARAPL2; -.
DR   ExpressionAtlas; P60520; baseline and differential.
DR   Genevisible; P60520; HS.
DR   GO; GO:0005776; C:autophagosome; IDA:UniProtKB.
DR   GO; GO:0000421; C:autophagosome membrane; IDA:UniProtKB.
DR   GO; GO:0005737; C:cytoplasm; IDA:BHF-UCL.
DR   GO; GO:0031410; C:cytoplasmic vesicle; IEA:UniProtKB-KW.
DR   GO; GO:0005829; C:cytosol; ISS:UniProtKB.
DR   GO; GO:0005794; C:Golgi apparatus; ISS:UniProtKB.
DR   GO; GO:0000139; C:Golgi membrane; IDA:BHF-UCL.
DR   GO; GO:0005622; C:intracellular; IDA:LIFEdb.
DR   GO; GO:0051117; F:ATPase binding; ISS:UniProtKB.
DR   GO; GO:0048487; F:beta-tubulin binding; ISS:UniProtKB.
DR   GO; GO:0050811; F:GABA receptor binding; ISS:UniProtKB.
DR   GO; GO:0008017; F:microtubule binding; NAS:UniProtKB.
DR   GO; GO:0000149; F:SNARE binding; ISS:UniProtKB.
DR   GO; GO:0031625; F:ubiquitin protein ligase binding; IPI:UniProtKB.
DR   GO; GO:0000045; P:autophagosome assembly; IBA:GO_Central.
DR   GO; GO:0097352; P:autophagosome maturation; TAS:Reactome.
DR   GO; GO:0006914; P:autophagy; NAS:UniProtKB.
DR   GO; GO:0000422; P:autophagy of mitochondrion; IBA:GO_Central.
DR   GO; GO:0006995; P:cellular response to nitrogen starvation; IBA:GO_Central.
DR   GO; GO:0006891; P:intra-Golgi vesicle-mediated transport; ISS:UniProtKB.
DR   GO; GO:0016236; P:macroautophagy; TAS:Reactome.
DR   GO; GO:1901799; P:negative regulation of proteasomal protein catabolic process; IMP:BHF-UCL.
DR   GO; GO:0032781; P:positive regulation of ATPase activity; ISS:UniProtKB.
DR   GO; GO:0015031; P:protein transport; IEA:UniProtKB-KW.
DR   CDD; cd01611; GABARAP; 1.
DR   InterPro; IPR004241; Atg8-like.
DR   InterPro; IPR029071; Ubiquitin-like_domsf.
DR   PANTHER; PTHR10969; PTHR10969; 1.
DR   Pfam; PF02991; Atg8; 1.
DR   SUPFAM; SSF54236; SSF54236; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Autophagy; Complete proteome;
KW   Cytoplasmic vesicle; Golgi apparatus; Lipoprotein; Phosphoprotein;
KW   Polymorphism; Protein transport; Reference proteome; Transport.
FT   CHAIN         1    116       Gamma-aminobutyric acid receptor-
FT                                associated protein-like 2.
FT                                /FTId=PRO_0000212373.
FT   PROPEP      117    117       Removed in mature form.
FT                                /FTId=PRO_0000423070.
FT   REGION        1     22       Interaction with beta-tubulin.
FT                                {ECO:0000250}.
FT   REGION       36     68       Interaction with GABRG2. {ECO:0000255}.
FT   SITE        116    117       Cleavage; by ATG4.
FT   MOD_RES      24     24       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES      39     39       Phosphoserine.
FT                                {ECO:0000244|PubMed:17525332}.
FT   LIPID       116    116       Phosphatidylethanolamine amidated
FT                                glycine. {ECO:0000269|PubMed:12507496}.
FT   VARIANT      51     51       V -> A (in dbSNP:rs11556291).
FT                                /FTId=VAR_049756.
FT   MUTAGEN     116    116       G->A: Impairs localization at the
FT                                autophagosomal membrane.
FT                                {ECO:0000269|PubMed:15169837}.
FT   CONFLICT     29     29       V -> F (in Ref. 4; AAD27779).
FT                                {ECO:0000305}.
FT   HELIX         4      8       {ECO:0000244|PDB:4CO7}.
FT   HELIX        11     24       {ECO:0000244|PDB:4CO7}.
FT   STRAND       28     35       {ECO:0000244|PDB:4CO7}.
FT   STRAND       48     52       {ECO:0000244|PDB:4CO7}.
FT   HELIX        57     67       {ECO:0000244|PDB:4CO7}.
FT   STRAND       77     80       {ECO:0000244|PDB:4CO7}.
FT   HELIX        91     98       {ECO:0000244|PDB:4CO7}.
FT   STRAND      105    111       {ECO:0000244|PDB:4CO7}.
SQ   SEQUENCE   117 AA;  13667 MW;  17ACB540FD5B975B CRC64;
     MKWMFKEDHS LEHRCVESAK IRAKYPDRVP VIVEKVSGSQ IVDIDKRKYL VPSDITVAQF
     MWIIRKRIQL PSEKAIFLFV DKTVPQSSLT MGQLYEKEKD EDGFLYVAYS GENTFGF
//
ID   A0A0X9JFN5_HUMAN        Unreviewed;       242 AA.
AC   A0A0X9JFN5;
DT   13-APR-2016, integrated into UniProtKB/TrEMBL.
DT   13-APR-2016, sequence version 1.
DT   28-MAR-2018, entry version 10.
DE   SubName: Full=BCL-2-like protein 12 isoform 16 {ECO:0000313|EMBL:ALU57790.1};
GN   Name=BCL2L12 {ECO:0000313|EMBL:ALU57790.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:ALU57790.1};
RN   [1] {ECO:0000313|EMBL:ALU57790.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=26797417;
RA   Adamopoulos P.G., Kontos C.K., Tsiakanikas P., Scorilas A.;
RT   "Identification of novel alternative splice variants of the BCL2L12
RT   gene in human cancer cells using next-generation sequencing
RT   methodology.";
RL   Cancer Lett. 0:0-0(2016).
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; KR820282; ALU57790.1; -; mRNA.
DR   RefSeq; XP_016882834.1; XM_017027345.1.
DR   UniGene; Hs.289052; -.
DR   PeptideAtlas; A0A0X9JFN5; -.
DR   GeneID; 83596; -.
DR   CTD; 83596; -.
DR   ChiTaRS; BCL2L12; human.
PE   2: Evidence at transcript level;
SQ   SEQUENCE   242 AA;  26968 MW;  F818AC905E09EF2C CRC64;
     MGRPAGLFPP LCPFLGFRPE ACWERHMQIE RAPSVPPFLR WAGYRPGPVR RRGKVELIKF
     VRVQWRRPQV EWRRRRWGPG PGASMAGSEE LGLREDTLRV LAAFLRRGEA AGSPVPTPPS
     PAQEEPTDFL SRLRRCLPCS LGRGAAPSES PRPCSLPIRP CYGLEPGPAT PDFYALVAQR
     LEQLVQEQLK SPPSPELQGP PSTEKEAILR RLVALLEEEA EVINQKEGIL AVSPVDLNLP
     LD
//
ID   I6LJZ5_HUMAN            Unreviewed;       243 AA.
AC   I6LJZ5;
DT   03-OCT-2012, integrated into UniProtKB/TrEMBL.
DT   03-OCT-2012, sequence version 1.
DT   23-MAY-2018, entry version 29.
DE   SubName: Full=BCL2L12 protein isoform 4 {ECO:0000313|EMBL:ACZ28444.1};
GN   Name=BCL2L12 {ECO:0000313|EMBL:ACZ28444.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:ACZ28444.1};
RN   [1] {ECO:0000313|EMBL:ACZ28444.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=22664385; DOI=10.1016/j.gene.2012.04.084;
RA   Kontos C.K., Scorilas A.;
RT   "Molecular cloning of novel alternatively spliced variants of BCL2L12,
RT   a new member of the BCL2 gene family, and their expression analysis in
RT   cancer cells.";
RL   Gene 505:153-166(2012).
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; FJ868798; ACZ28444.1; -; mRNA.
DR   RefSeq; NP_001269445.1; NM_001282516.1.
DR   UniGene; Hs.289052; -.
DR   SMR; I6LJZ5; -.
DR   PeptideAtlas; I6LJZ5; -.
DR   GeneID; 83596; -.
DR   CTD; 83596; -.
DR   eggNOG; ENOG410IVDH; Eukaryota.
DR   eggNOG; ENOG410YTZU; LUCA.
DR   ChiTaRS; BCL2L12; human.
DR   GenomeRNAi; 83596; -.
PE   2: Evidence at transcript level;
SQ   SEQUENCE   243 AA;  27124 MW;  3FA60713C2F14D29 CRC64;
     MGRPAGLFPP LCPFLGFRPE ACWERHMQIE RAPSVPPFLR WAGYRPGPVR RRGKVELIKF
     VRVQWRRPQV EWRRRRWGPG PGASMAGSEE LGLREDTLRV LAAFLRRGEA AGSPVPTPPR
     SPAQEEPTDF LSRLRRCLPC SLGRGAAPSE SPRPCSLPIR PCYGLEPGPA TPDFYALVAQ
     RLEQLVQEQL KSPPSPELQG PPSTEKEAIL RRLVALLEEE AEVINQKEGI LAVSPVDLNL
     PLD
//
ID   I6LJZ6_HUMAN            Unreviewed;       176 AA.
AC   I6LJZ6;
DT   03-OCT-2012, integrated into UniProtKB/TrEMBL.
DT   03-OCT-2012, sequence version 1.
DT   23-MAY-2018, entry version 44.
DE   SubName: Full=BCL2-like 12 (Proline rich), isoform CRA_c {ECO:0000313|EMBL:EAW52516.1};
DE   SubName: Full=BCL2L12 protein isoform 2 {ECO:0000313|EMBL:ACZ28445.1};
GN   Name=BCL2L12 {ECO:0000313|EMBL:ACZ28445.1};
GN   ORFNames=hCG_21122 {ECO:0000313|EMBL:EAW52516.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:ACZ28445.1};
RN   [1] {ECO:0000313|EMBL:EAW52516.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAW52516.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3] {ECO:0000313|EMBL:ACZ28445.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=22664385; DOI=10.1016/j.gene.2012.04.084;
RA   Kontos C.K., Scorilas A.;
RT   "Molecular cloning of novel alternatively spliced variants of BCL2L12,
RT   a new member of the BCL2 gene family, and their expression analysis in
RT   cancer cells.";
RL   Gene 505:153-166(2012).
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; FJ868799; ACZ28445.1; -; mRNA.
DR   EMBL; CH471177; EAW52516.1; -; Genomic_DNA.
DR   RefSeq; NP_001269446.1; NM_001282517.1.
DR   RefSeq; XP_016882835.1; XM_017027346.1.
DR   UniGene; Hs.289052; -.
DR   SMR; I6LJZ6; -.
DR   GeneID; 83596; -.
DR   CTD; 83596; -.
DR   eggNOG; ENOG410IVDH; Eukaryota.
DR   eggNOG; ENOG410YTZU; LUCA.
DR   ChiTaRS; BCL2L12; human.
DR   GenomeRNAi; 83596; -.
PE   2: Evidence at transcript level;
SQ   SEQUENCE   176 AA;  19133 MW;  DC503A642100CAE4 CRC64;
     MGRPAGLFPP LCPFLGFRPE ACWERHMQIE RAPSVPPFLR WAGYRPGPVR RRGKVELIKF
     VRVQWRRPQV EWRRRRWGPG PGASMAGSEE LGLREDTLRV LAAFLRRGEA AGSPVPTPPR
     PSYSRLLCFG GPAAGTAGPR AAEISAQPRI TGSPIDREGS HTAEAGGPAG GGGRSH
//
ID   I6LJZ7_HUMAN            Unreviewed;       269 AA.
AC   I6LJZ7;
DT   03-OCT-2012, integrated into UniProtKB/TrEMBL.
DT   03-OCT-2012, sequence version 1.
DT   23-MAY-2018, entry version 39.
DE   SubName: Full=BCL2L12 protein isoform 5 {ECO:0000313|EMBL:ACZ28448.1};
DE   SubName: Full=Bcl-2-like protein 12 {ECO:0000313|Ensembl:ENSP00000483272};
GN   Name=BCL2L12 {ECO:0000313|EMBL:ACZ28448.1,
GN   ECO:0000313|Ensembl:ENSP00000483272};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:ACZ28448.1};
RN   [1] {ECO:0000313|Ensembl:ENSP00000483272, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057824; DOI=10.1038/nature02399;
RA   Grimwood J., Gordon L.A., Olsen A.S., Terry A., Schmutz J.,
RA   Lamerdin J.E., Hellsten U., Goodstein D., Couronne O., Tran-Gyamfi M.,
RA   Aerts A., Altherr M., Ashworth L., Bajorek E., Black S., Branscomb E.,
RA   Caenepeel S., Carrano A.V., Caoile C., Chan Y.M., Christensen M.,
RA   Cleland C.A., Copeland A., Dalin E., Dehal P., Denys M., Detter J.C.,
RA   Escobar J., Flowers D., Fotopulos D., Garcia C., Georgescu A.M.,
RA   Glavina T., Gomez M., Gonzales E., Groza M., Hammon N., Hawkins T.,
RA   Haydu L., Ho I., Huang W., Israni S., Jett J., Kadner K., Kimball H.,
RA   Kobayashi A., Larionov V., Leem S.-H., Lopez F., Lou Y., Lowry S.,
RA   Malfatti S., Martinez D., McCready P.M., Medina C., Morgan J.,
RA   Nelson K., Nolan M., Ovcharenko I., Pitluck S., Pollard M.,
RA   Popkie A.P., Predki P., Quan G., Ramirez L., Rash S., Retterer J.,
RA   Rodriguez A., Rogers S., Salamov A., Salazar A., She X., Smith D.,
RA   Slezak T., Solovyev V., Thayer N., Tice H., Tsai M., Ustaszewska A.,
RA   Vo N., Wagner M., Wheeler J., Wu K., Xie G., Yang J., Dubchak I.,
RA   Furey T.S., DeJong P., Dickson M., Gordon D., Eichler E.E.,
RA   Pennacchio L.A., Richardson P., Stubbs L., Rokhsar D.S., Myers R.M.,
RA   Rubin E.M., Lucas S.M.;
RT   "The DNA sequence and biology of human chromosome 19.";
RL   Nature 428:529-535(2004).
RN   [2] {ECO:0000213|PubMed:18669648}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [3] {ECO:0000313|EMBL:ACZ28448.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=22664385; DOI=10.1016/j.gene.2012.04.084;
RA   Kontos C.K., Scorilas A.;
RT   "Molecular cloning of novel alternatively spliced variants of BCL2L12,
RT   a new member of the BCL2 gene family, and their expression analysis in
RT   cancer cells.";
RL   Gene 505:153-166(2012).
RN   [4] {ECO:0000213|PubMed:22814378}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [5] {ECO:0000213|PubMed:23186163}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=23186163;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [6] {ECO:0000213|PubMed:24129315}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=24129315;
RA   Guo A., Gu H., Zhou J., Mulhern D., Wang Y., Lee K.A., Yang V.,
RA   Aguiar M., Kornhauser J., Jia X., Ren J., Beausoleil S.A., Silva J.C.,
RA   Vemulapalli V., Bedford M.T., Comb M.J.;
RT   "Immunoaffinity enrichment and mass spectrometry analysis of protein
RT   methylation.";
RL   Mol. Cell. Proteomics 13:372-387(2014).
RN   [7] {ECO:0000313|Ensembl:ENSP00000483272}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (SEP-2014) to UniProtKB.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AC011495; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; FJ868802; ACZ28448.1; -; mRNA.
DR   RefSeq; NP_001269448.1; NM_001282519.1.
DR   UniGene; Hs.289052; -.
DR   PeptideAtlas; I6LJZ7; -.
DR   Ensembl; ENST00000619007; ENSP00000483272; ENSG00000126453.
DR   GeneID; 83596; -.
DR   UCSC; uc031rlz.2; human.
DR   CTD; 83596; -.
DR   EuPathDB; HostDB:ENSG00000126453.9; -.
DR   HGNC; HGNC:13787; BCL2L12.
DR   OpenTargets; ENSG00000126453; -.
DR   eggNOG; ENOG410IVDH; Eukaryota.
DR   eggNOG; ENOG410YTZU; LUCA.
DR   GeneTree; ENSGT00390000001825; -.
DR   ChiTaRS; BCL2L12; human.
DR   GenomeRNAi; 83596; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   Bgee; ENSG00000126453; -.
DR   ExpressionAtlas; I6LJZ7; baseline and differential.
PE   1: Evidence at protein level;
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   Proteomics identification {ECO:0000213|EPD:I6LJZ7,
KW   ECO:0000213|MaxQB:I6LJZ7, ECO:0000213|PeptideAtlas:I6LJZ7};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640}.
SQ   SEQUENCE   269 AA;  29906 MW;  EA91BF1B1009E9DE CRC64;
     MGRPAGLFPP LCPFLGFRPE ACWERHMQIE RAPSVPPFLR WAGYRPGPVR RRGKVELIKF
     VRVQWRRPQV EWRRRRWGPG PGASMAGSEE LGLREDTLRV LAAFLRRGEA AGSPVPTPPR
     SPAQEEPTDF LSRLRRCLPC SLGRGAAPSE SPRPCSLPIR PCYGLEPGPA TPDFYALVAQ
     RLEQLVQEQL KSPPSPELQG PPSTEKEAIL RRLVALLEEE AEVINQKVMG ICPTPWQGQE
     LRNGGHPGCF TRGLELAIGL SSFSEAATR
//
ID   I6LJZ8_HUMAN            Unreviewed;       222 AA.
AC   I6LJZ8;
DT   03-OCT-2012, integrated into UniProtKB/TrEMBL.
DT   03-OCT-2012, sequence version 1.
DT   23-MAY-2018, entry version 26.
DE   SubName: Full=BCL2L12 protein isoform 6 {ECO:0000313|EMBL:ACZ28450.1};
GN   Name=BCL2L12 {ECO:0000313|EMBL:ACZ28450.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:ACZ28450.1};
RN   [1] {ECO:0000313|EMBL:ACZ28450.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=22664385; DOI=10.1016/j.gene.2012.04.084;
RA   Kontos C.K., Scorilas A.;
RT   "Molecular cloning of novel alternatively spliced variants of BCL2L12,
RT   a new member of the BCL2 gene family, and their expression analysis in
RT   cancer cells.";
RL   Gene 505:153-166(2012).
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; FJ911906; ACZ28450.1; -; mRNA.
DR   RefSeq; NP_001269449.1; NM_001282520.1.
DR   UniGene; Hs.289052; -.
DR   PeptideAtlas; I6LJZ8; -.
DR   GeneID; 83596; -.
DR   CTD; 83596; -.
DR   eggNOG; ENOG410IVDH; Eukaryota.
DR   eggNOG; ENOG410YTZU; LUCA.
DR   ChiTaRS; BCL2L12; human.
DR   GenomeRNAi; 83596; -.
PE   2: Evidence at transcript level;
SQ   SEQUENCE   222 AA;  24608 MW;  35F5D3B92C575850 CRC64;
     MGRPAGLFPP LCPFLGFRPE ACWERHMQIE RAPSVPPFLR WAGYRPGPVR RRGKVELIKF
     VRVQWRRPQV EWRRRRWGPG PGASMAGSEE LGLREDTLRV LAAFLRRGEA AGSPVPTPPR
     SPAQEEPTDF LSRLRRCLPC SLGRGAAPSE SPRPCSLPIR PCYGLEPGPA TPDFYALVAQ
     RLEQLVQEQL KSPPSPGGHP GCFTRGLELA IGLSSFSEAA TR
//
ID   I6LJZ9_HUMAN            Unreviewed;       193 AA.
AC   I6LJZ9;
DT   03-OCT-2012, integrated into UniProtKB/TrEMBL.
DT   03-OCT-2012, sequence version 1.
DT   23-MAY-2018, entry version 38.
DE   SubName: Full=BCL2L12 protein isoform 8 {ECO:0000313|EMBL:ACZ28451.1};
DE   SubName: Full=Bcl-2-like protein 12 {ECO:0000313|Ensembl:ENSP00000482154};
GN   Name=BCL2L12 {ECO:0000313|EMBL:ACZ28451.1,
GN   ECO:0000313|Ensembl:ENSP00000482154};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:ACZ28451.1};
RN   [1] {ECO:0000313|Ensembl:ENSP00000482154, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057824; DOI=10.1038/nature02399;
RA   Grimwood J., Gordon L.A., Olsen A.S., Terry A., Schmutz J.,
RA   Lamerdin J.E., Hellsten U., Goodstein D., Couronne O., Tran-Gyamfi M.,
RA   Aerts A., Altherr M., Ashworth L., Bajorek E., Black S., Branscomb E.,
RA   Caenepeel S., Carrano A.V., Caoile C., Chan Y.M., Christensen M.,
RA   Cleland C.A., Copeland A., Dalin E., Dehal P., Denys M., Detter J.C.,
RA   Escobar J., Flowers D., Fotopulos D., Garcia C., Georgescu A.M.,
RA   Glavina T., Gomez M., Gonzales E., Groza M., Hammon N., Hawkins T.,
RA   Haydu L., Ho I., Huang W., Israni S., Jett J., Kadner K., Kimball H.,
RA   Kobayashi A., Larionov V., Leem S.-H., Lopez F., Lou Y., Lowry S.,
RA   Malfatti S., Martinez D., McCready P.M., Medina C., Morgan J.,
RA   Nelson K., Nolan M., Ovcharenko I., Pitluck S., Pollard M.,
RA   Popkie A.P., Predki P., Quan G., Ramirez L., Rash S., Retterer J.,
RA   Rodriguez A., Rogers S., Salamov A., Salazar A., She X., Smith D.,
RA   Slezak T., Solovyev V., Thayer N., Tice H., Tsai M., Ustaszewska A.,
RA   Vo N., Wagner M., Wheeler J., Wu K., Xie G., Yang J., Dubchak I.,
RA   Furey T.S., DeJong P., Dickson M., Gordon D., Eichler E.E.,
RA   Pennacchio L.A., Richardson P., Stubbs L., Rokhsar D.S., Myers R.M.,
RA   Rubin E.M., Lucas S.M.;
RT   "The DNA sequence and biology of human chromosome 19.";
RL   Nature 428:529-535(2004).
RN   [2] {ECO:0000213|PubMed:18669648}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [3] {ECO:0000313|EMBL:ACZ28451.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=22664385; DOI=10.1016/j.gene.2012.04.084;
RA   Kontos C.K., Scorilas A.;
RT   "Molecular cloning of novel alternatively spliced variants of BCL2L12,
RT   a new member of the BCL2 gene family, and their expression analysis in
RT   cancer cells.";
RL   Gene 505:153-166(2012).
RN   [4] {ECO:0000213|PubMed:22814378}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [5] {ECO:0000213|PubMed:24129315}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=24129315;
RA   Guo A., Gu H., Zhou J., Mulhern D., Wang Y., Lee K.A., Yang V.,
RA   Aguiar M., Kornhauser J., Jia X., Ren J., Beausoleil S.A., Silva J.C.,
RA   Vemulapalli V., Bedford M.T., Comb M.J.;
RT   "Immunoaffinity enrichment and mass spectrometry analysis of protein
RT   methylation.";
RL   Mol. Cell. Proteomics 13:372-387(2014).
RN   [6] {ECO:0000313|Ensembl:ENSP00000482154}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (SEP-2014) to UniProtKB.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AC011495; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; FJ911907; ACZ28451.1; -; mRNA.
DR   RefSeq; NP_001269450.1; NM_001282521.1.
DR   UniGene; Hs.289052; -.
DR   PeptideAtlas; I6LJZ9; -.
DR   Ensembl; ENST00000614495; ENSP00000482154; ENSG00000126453.
DR   GeneID; 83596; -.
DR   UCSC; uc031rlv.2; human.
DR   CTD; 83596; -.
DR   EuPathDB; HostDB:ENSG00000126453.9; -.
DR   HGNC; HGNC:13787; BCL2L12.
DR   OpenTargets; ENSG00000126453; -.
DR   eggNOG; ENOG410IVDH; Eukaryota.
DR   eggNOG; ENOG410YTZU; LUCA.
DR   GeneTree; ENSGT00390000001825; -.
DR   ChiTaRS; BCL2L12; human.
DR   GenomeRNAi; 83596; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   Bgee; ENSG00000126453; -.
DR   ExpressionAtlas; I6LJZ9; baseline and differential.
PE   1: Evidence at protein level;
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   Proteomics identification {ECO:0000213|MaxQB:I6LJZ9,
KW   ECO:0000213|PeptideAtlas:I6LJZ9};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640}.
SQ   SEQUENCE   193 AA;  21446 MW;  85570CAEDBF99664 CRC64;
     MGRPAGLFPP LCPFLGFRPE ACWERHMQIE RAPSVPPFLR WAGYRPGPVR RRGKVELIKF
     VRVQWRRPQV EWRRRRWGPG PGASMAGSEE LGLREDTLRV LAAFLRRGEA AGSPVPTPPR
     SPAQEEPTDF LSRLRRCLPC SLGRGAAPSE SPRPCSLPIR PCYGLEPGGH PGCFTRGLEL
     AIGLSSFSEA ATR
//
ID   B2L12_HUMAN             Reviewed;         334 AA.
AC   Q9HB09; Q3SY11; Q3SY13; Q96I96; Q9HB08;
DT   19-SEP-2002, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2001, sequence version 1.
DT   28-MAR-2018, entry version 133.
DE   RecName: Full=Bcl-2-like protein 12;
DE            Short=Bcl2-L-12;
DE   AltName: Full=Bcl-2-related proline-rich protein;
GN   Name=BCL2L12; Synonyms=BPR;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORMS 1 AND 2).
RX   PubMed=11401436; DOI=10.1006/geno.2000.6455;
RA   Scorilas A., Kyriakopoulou L., Yousef G.M., Ashworth L.K., Kwamie A.,
RA   Diamandis E.P.;
RT   "Molecular cloning, physical mapping, and expression analysis of a
RT   novel gene, BCL2L12, encoding a proline-rich protein with a highly
RT   conserved BH2 domain of the Bcl-2 family.";
RL   Genomics 72:217-221(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057824; DOI=10.1038/nature02399;
RA   Grimwood J., Gordon L.A., Olsen A.S., Terry A., Schmutz J.,
RA   Lamerdin J.E., Hellsten U., Goodstein D., Couronne O., Tran-Gyamfi M.,
RA   Aerts A., Altherr M., Ashworth L., Bajorek E., Black S., Branscomb E.,
RA   Caenepeel S., Carrano A.V., Caoile C., Chan Y.M., Christensen M.,
RA   Cleland C.A., Copeland A., Dalin E., Dehal P., Denys M., Detter J.C.,
RA   Escobar J., Flowers D., Fotopulos D., Garcia C., Georgescu A.M.,
RA   Glavina T., Gomez M., Gonzales E., Groza M., Hammon N., Hawkins T.,
RA   Haydu L., Ho I., Huang W., Israni S., Jett J., Kadner K., Kimball H.,
RA   Kobayashi A., Larionov V., Leem S.-H., Lopez F., Lou Y., Lowry S.,
RA   Malfatti S., Martinez D., McCready P.M., Medina C., Morgan J.,
RA   Nelson K., Nolan M., Ovcharenko I., Pitluck S., Pollard M.,
RA   Popkie A.P., Predki P., Quan G., Ramirez L., Rash S., Retterer J.,
RA   Rodriguez A., Rogers S., Salamov A., Salazar A., She X., Smith D.,
RA   Slezak T., Solovyev V., Thayer N., Tice H., Tsai M., Ustaszewska A.,
RA   Vo N., Wagner M., Wheeler J., Wu K., Xie G., Yang J., Dubchak I.,
RA   Furey T.S., DeJong P., Dickson M., Gordon D., Eichler E.E.,
RA   Pennacchio L.A., Richardson P., Stubbs L., Rokhsar D.S., Myers R.M.,
RA   Rubin E.M., Lucas S.M.;
RT   "The DNA sequence and biology of human chromosome 19.";
RL   Nature 428:529-535(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 3).
RC   TISSUE=Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   SPLICE ISOFORM(S) THAT ARE POTENTIAL NMD TARGET(S).
RX   PubMed=14759258; DOI=10.1186/gb-2004-5-2-r8;
RA   Hillman R.T., Green R.E., Brenner S.E.;
RT   "An unappreciated role for RNA surveillance.";
RL   Genome Biol. 5:R8.1-R8.16(2004).
RN   [5]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-113; THR-117; SER-121
RP   AND SER-242, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [6]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-242, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-242 AND SER-243, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-195; SER-245 AND
RP   SER-273, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [11]
RP   METHYLATION [LARGE SCALE ANALYSIS] AT ARG-144, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Colon carcinoma;
RX   PubMed=24129315; DOI=10.1074/mcp.O113.027870;
RA   Guo A., Gu H., Zhou J., Mulhern D., Wang Y., Lee K.A., Yang V.,
RA   Aguiar M., Kornhauser J., Jia X., Ren J., Beausoleil S.A., Silva J.C.,
RA   Vemulapalli V., Bedford M.T., Comb M.J.;
RT   "Immunoaffinity enrichment and mass spectrometry analysis of protein
RT   methylation.";
RL   Mol. Cell. Proteomics 13:372-387(2014).
CC   -!- INTERACTION:
CC       P08107:HSPA1B; NbExp=2; IntAct=EBI-6969019, EBI-629985;
CC       P0CG48:UBC; NbExp=3; IntAct=EBI-6968951, EBI-3390054;
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q9HB09-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9HB09-2; Sequence=VSP_000522, VSP_000523;
CC         Note=May be produced at very low levels due to a premature stop
CC         codon in the mRNA, leading to nonsense-mediated mRNA decay.;
CC       Name=3;
CC         IsoId=Q9HB09-3; Sequence=VSP_043269;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Expressed mainly in breast, thymus, prostate,
CC       fetal liver, colon, placenta, pancreas, small intestine, spinal
CC       cord, kidney, and bone marrow and to a lesser extent in many other
CC       tissues. Isoform 2 is primarily expressed in skeletal muscle.
CC   -!- SIMILARITY: Belongs to the Bcl-2 family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/BCL2L12ID773ch19q13.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF289220; AAG29495.1; -; Genomic_DNA.
DR   EMBL; AF289220; AAG29496.1; -; Genomic_DNA.
DR   EMBL; AC011495; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC007724; AAH07724.2; -; mRNA.
DR   EMBL; BC104004; AAI04005.1; -; mRNA.
DR   EMBL; BC104005; AAI04006.1; -; mRNA.
DR   EMBL; BC104006; AAI04007.1; -; mRNA.
DR   CCDS; CCDS12776.1; -. [Q9HB09-1]
DR   CCDS; CCDS46144.1; -. [Q9HB09-3]
DR   RefSeq; NP_001035758.1; NM_001040668.1. [Q9HB09-3]
DR   RefSeq; NP_001269445.1; NM_001282516.1.
DR   RefSeq; NP_001269446.1; NM_001282517.1. [Q9HB09-2]
DR   RefSeq; NP_001269448.1; NM_001282519.1.
DR   RefSeq; NP_001269449.1; NM_001282520.1.
DR   RefSeq; NP_001269450.1; NM_001282521.1.
DR   RefSeq; NP_619580.1; NM_138639.1. [Q9HB09-1]
DR   RefSeq; XP_016882835.1; XM_017027346.1. [Q9HB09-2]
DR   UniGene; Hs.289052; -.
DR   ProteinModelPortal; Q9HB09; -.
DR   SMR; Q9HB09; -.
DR   BioGrid; 123692; 9.
DR   IntAct; Q9HB09; 3.
DR   STRING; 9606.ENSP00000246785; -.
DR   iPTMnet; Q9HB09; -.
DR   PhosphoSitePlus; Q9HB09; -.
DR   SwissPalm; Q9HB09; -.
DR   BioMuta; BCL2L12; -.
DR   DMDM; 23396468; -.
DR   EPD; Q9HB09; -.
DR   MaxQB; Q9HB09; -.
DR   PaxDb; Q9HB09; -.
DR   PeptideAtlas; Q9HB09; -.
DR   PRIDE; Q9HB09; -.
DR   DNASU; 83596; -.
DR   Ensembl; ENST00000246785; ENSP00000246785; ENSG00000126453. [Q9HB09-1]
DR   Ensembl; ENST00000441864; ENSP00000393803; ENSG00000126453. [Q9HB09-3]
DR   Ensembl; ENST00000616144; ENSP00000482218; ENSG00000126453. [Q9HB09-1]
DR   GeneID; 83596; -.
DR   KEGG; hsa:83596; -.
DR   UCSC; uc002ppa.4; human. [Q9HB09-1]
DR   CTD; 83596; -.
DR   DisGeNET; 83596; -.
DR   EuPathDB; HostDB:ENSG00000126453.9; -.
DR   GeneCards; BCL2L12; -.
DR   HGNC; HGNC:13787; BCL2L12.
DR   HPA; HPA020856; -.
DR   MIM; 610837; gene.
DR   neXtProt; NX_Q9HB09; -.
DR   OpenTargets; ENSG00000126453; -.
DR   PharmGKB; PA25306; -.
DR   eggNOG; ENOG410IVDH; Eukaryota.
DR   eggNOG; ENOG410YTZU; LUCA.
DR   GeneTree; ENSGT00390000001825; -.
DR   HOGENOM; HOG000294149; -.
DR   HOVERGEN; HBG050647; -.
DR   InParanoid; Q9HB09; -.
DR   OMA; RACWERH; -.
DR   OrthoDB; EOG091G0HI1; -.
DR   PhylomeDB; Q9HB09; -.
DR   TreeFam; TF338350; -.
DR   SIGNOR; Q9HB09; -.
DR   ChiTaRS; BCL2L12; human.
DR   GeneWiki; BCL2L12; -.
DR   GenomeRNAi; 83596; -.
DR   PRO; PR:Q9HB09; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   Bgee; ENSG00000126453; -.
DR   CleanEx; HS_BCL2L12; -.
DR   ExpressionAtlas; Q9HB09; baseline and differential.
DR   Genevisible; Q9HB09; HS.
DR   GO; GO:0016020; C:membrane; HDA:UniProtKB.
DR   GO; GO:0005634; C:nucleus; IDA:MGI.
DR   GO; GO:0002039; F:p53 binding; IEA:Ensembl.
DR   GO; GO:0006915; P:apoptotic process; IEA:UniProtKB-KW.
DR   GO; GO:1990001; P:inhibition of cysteine-type endopeptidase activity involved in apoptotic process; IDA:UniProtKB.
DR   GO; GO:2000773; P:negative regulation of cellular senescence; IEA:Ensembl.
DR   GO; GO:1902166; P:negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; IEA:Ensembl.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IDA:UniProtKB.
DR   InterPro; IPR036834; Blc2-like_sf.
DR   SUPFAM; SSF56854; SSF56854; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Apoptosis; Complete proteome; Methylation;
KW   Phosphoprotein; Polymorphism; Reference proteome.
FT   CHAIN         1    334       Bcl-2-like protein 12.
FT                                /FTId=PRO_0000143072.
FT   MOTIF       311    322       BH2.
FT   MOD_RES     113    113       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   MOD_RES     117    117       Phosphothreonine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   MOD_RES     121    121       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   MOD_RES     144    144       Omega-N-methylarginine.
FT                                {ECO:0000244|PubMed:24129315}.
FT   MOD_RES     195    195       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     242    242       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692}.
FT   MOD_RES     243    243       Phosphoserine.
FT                                {ECO:0000244|PubMed:21406692}.
FT   MOD_RES     245    245       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     273    273       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   VAR_SEQ     120    120       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_043269.
FT   VAR_SEQ     121    176       SPAQEEPTDFLSRLRRCLPCSLGRGAAPSESPRPCSLPIRP
FT                                CYGLEPGPATPDFYA -> PSYSRLLCFGGPAAGTAGPRAA
FT                                EISAQPRITGSPIDREGSHTAEAGGPAGGGGRSH (in
FT                                isoform 2). {ECO:0000305}.
FT                                /FTId=VSP_000522.
FT   VAR_SEQ     177    334       Missing (in isoform 2). {ECO:0000305}.
FT                                /FTId=VSP_000523.
FT   VARIANT      47     47       G -> V (in dbSNP:rs2060263).
FT                                /FTId=VAR_048419.
FT   CONFLICT    270    270       P -> S (in Ref. 3; AAH07724).
FT                                {ECO:0000305}.
SQ   SEQUENCE   334 AA;  36821 MW;  5398E54C83E7CAB7 CRC64;
     MGRPAGLFPP LCPFLGFRPE ACWERHMQIE RAPSVPPFLR WAGYRPGPVR RRGKVELIKF
     VRVQWRRPQV EWRRRRWGPG PGASMAGSEE LGLREDTLRV LAAFLRRGEA AGSPVPTPPR
     SPAQEEPTDF LSRLRRCLPC SLGRGAAPSE SPRPCSLPIR PCYGLEPGPA TPDFYALVAQ
     RLEQLVQEQL KSPPSPELQG PPSTEKEAIL RRLVALLEEE AEVINQKLAS DPALRSKLVR
     LSSDSFARLV ELFCSRDDSS RPSRACPGPP PPSPEPLARL ALAMELSRRV AGLGGTLAGL
     SVEHVHSFTP WIQAHGGWEG ILAVSPVDLN LPLD
//
ID   ADPPT_HUMAN             Reviewed;         309 AA.
AC   Q9NRN7; B2R6D1; B4DDW7; Q9C068; Q9P0Q3; Q9UG80; Q9Y389;
DT   08-NOV-2005, integrated into UniProtKB/Swiss-Prot.
DT   08-NOV-2005, sequence version 2.
DT   23-MAY-2018, entry version 136.
DE   RecName: Full=L-aminoadipate-semialdehyde dehydrogenase-phosphopantetheinyl transferase;
DE            EC=2.7.8.-;
DE   AltName: Full=4'-phosphopantetheinyl transferase;
DE   AltName: Full=Alpha-aminoadipic semialdehyde dehydrogenase-phosphopantetheinyl transferase;
DE            Short=AASD-PPT;
DE   AltName: Full=LYS5 ortholog;
GN   Name=AASDHPPT; ORFNames=CGI-80, HAH-P, HSPC223, x0005;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, AND TISSUE
RP   SPECIFICITY.
RX   PubMed=11286508; DOI=10.1006/mgme.2000.3138;
RA   Praphanphoj V., Sacksteder K.A., Gould S.J., Thomas G.H.,
RA   Geraghty M.T.;
RT   "Identification of the alpha-aminoadipic semialdehyde dehydrogenase-
RT   phosphopantetheinyl transferase gene, the human ortholog of the yeast
RT   LYS5 gene.";
RL   Mol. Genet. Metab. 72:336-342(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RX   PubMed=10810093; DOI=10.1101/gr.10.5.703;
RA   Lai C.-H., Chou C.-Y., Ch'ang L.-Y., Liu C.-S., Lin W.-C.;
RT   "Identification of novel human genes evolutionarily conserved in
RT   Caenorhabditis elegans by comparative proteomics.";
RL   Genome Res. 10:703-713(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Umbilical cord blood;
RX   PubMed=11042152; DOI=10.1101/gr.140200;
RA   Zhang Q.-H., Ye M., Wu X.-Y., Ren S.-X., Zhao M., Zhao C.-J., Fu G.,
RA   Shen Y., Fan H.-Y., Lu G., Zhong M., Xu X.-R., Han Z.-G., Zhang J.-W.,
RA   Tao J., Huang Q.-H., Zhou J., Hu G.-X., Gu J., Chen S.-J., Chen Z.;
RT   "Cloning and functional analysis of cDNAs with open reading frames for
RT   300 previously undefined genes expressed in CD34+ hematopoietic
RT   stem/progenitor cells.";
RL   Genome Res. 10:1546-1560(2000).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Adrenal gland;
RX   PubMed=10931946; DOI=10.1073/pnas.160270997;
RA   Hu R.-M., Han Z.-G., Song H.-D., Peng Y.-D., Huang Q.-H., Ren S.-X.,
RA   Gu Y.-J., Huang C.-H., Li Y.-B., Jiang C.-L., Fu G., Zhang Q.-H.,
RA   Gu B.-W., Dai M., Mao Y.-F., Gao G.-F., Rong R., Ye M., Zhou J.,
RA   Xu S.-H., Gu J., Shi J.-X., Jin W.-R., Zhang C.-K., Wu T.-M.,
RA   Huang G.-Y., Chen Z., Chen M.-D., Chen J.-L.;
RT   "Gene expression profiling in the human hypothalamus-pituitary-adrenal
RT   axis and full-length cDNA cloning.";
RL   Proc. Natl. Acad. Sci. U.S.A. 97:9543-9548(2000).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Dendritic cell;
RA   Li N., Peng Y., Li Y., Gu W., Han Z., Fu G., Chen Z.;
RT   "Novel genes expressed in human dendritic cell.";
RL   Submitted (NOV-1999) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Tongue, and Urinary bladder;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16554811; DOI=10.1038/nature04632;
RA   Taylor T.D., Noguchi H., Totoki Y., Toyoda A., Kuroki Y., Dewar K.,
RA   Lloyd C., Itoh T., Takeda T., Kim D.-W., She X., Barlow K.F.,
RA   Bloom T., Bruford E., Chang J.L., Cuomo C.A., Eichler E.,
RA   FitzGerald M.G., Jaffe D.B., LaButti K., Nicol R., Park H.-S.,
RA   Seaman C., Sougnez C., Yang X., Zimmer A.R., Zody M.C., Birren B.W.,
RA   Nusbaum C., Fujiyama A., Hattori M., Rogers J., Lander E.S.,
RA   Sakaki Y.;
RT   "Human chromosome 11 DNA sequence and analysis including novel gene
RT   identification.";
RL   Nature 440:497-500(2006).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Urinary bladder, and Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 99-309 (ISOFORM 1).
RC   TISSUE=Kidney;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [11]
RP   PROTEIN SEQUENCE OF 235-246, AND IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Brain, and Cajal-Retzius cell;
RA   Lubec G., Afjehi-Sadat L.;
RL   Submitted (MAR-2007) to UniProtKB.
RN   [12]
RP   FUNCTION, SUBUNIT, SUBCELLULAR LOCATION, COFACTOR, IDENTIFICATION BY
RP   MASS SPECTROMETRY, AND TISSUE SPECIFICITY.
RX   PubMed=12815048; DOI=10.1074/jbc.M305459200;
RA   Joshi A.K., Zhang L., Rangan V.S., Smith S.;
RT   "Cloning, expression, and characterization of a human 4'-
RT   phosphopantetheinyl transferase with broad substrate specificity.";
RL   J. Biol. Chem. 278:33142-33149(2003).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-258, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Embryonic kidney;
RX   PubMed=17525332; DOI=10.1126/science.1140321;
RA   Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,
RA   Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,
RA   Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.;
RT   "ATM and ATR substrate analysis reveals extensive protein networks
RT   responsive to DNA damage.";
RL   Science 316:1160-1166(2007).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-258, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-258, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [16]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-258, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [18]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [19]
RP   X-RAY CRYSTALLOGRAPHY (1.93 ANGSTROMS) OF 14-309 IN COMPLEXES WITH
RP   COENZYME A; MAGNESIUM IONS AND FASN, FUNCTION, BIOPHYSICOCHEMICAL
RP   PROPERTIES, COFACTOR, AND MUTAGENESIS OF ARG-47; ARG-86; HIS-111;
RP   GLN-112; ASP-129; GLU-181 AND LYS-185.
RX   PubMed=18022563; DOI=10.1016/j.chembiol.2007.10.013;
RA   Bunkoczi G., Pasta S., Joshi A., Wu X., Kavanagh K.L., Smith S.,
RA   Oppermann U.;
RT   "Mechanism and substrate recognition of human holo ACP synthase.";
RL   Chem. Biol. 14:1243-1253(2007).
CC   -!- FUNCTION: Catalyzes the post-translational modification of target
CC       proteins by phosphopantetheine. Can transfer the 4'-
CC       phosphopantetheine moiety from coenzyme A to a serine residue of a
CC       broad range of acceptors, such as the acyl carrier domain of FASN.
CC       {ECO:0000269|PubMed:11286508, ECO:0000269|PubMed:12815048,
CC       ECO:0000269|PubMed:18022563}.
CC   -!- CATALYTIC ACTIVITY: CoA-[4'-phosphopantetheine] + apo-[acyl-
CC       carrier-protein] = adenosine 3',5'-bisphosphate + holo-[acyl-
CC       carrier-protein].
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC         Evidence={ECO:0000269|PubMed:12815048,
CC         ECO:0000269|PubMed:18022563};
CC       Note=Binds 1 Mg(2+) ion. {ECO:0000269|PubMed:12815048,
CC       ECO:0000269|PubMed:18022563};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=0.44 mM for magnesium {ECO:0000269|PubMed:18022563};
CC         KM=0.025 mM for coenzyme A {ECO:0000269|PubMed:18022563};
CC   -!- SUBUNIT: Monomer. Interacts with FASN.
CC       {ECO:0000269|PubMed:12815048}.
CC   -!- INTERACTION:
CC       Q5JST6:EFHC2; NbExp=4; IntAct=EBI-740884, EBI-2349927;
CC       Q8IUQ4:SIAH1; NbExp=3; IntAct=EBI-740884, EBI-747107;
CC       Q12933:TRAF2; NbExp=6; IntAct=EBI-740884, EBI-355744;
CC       Q9UPT9:USP22; NbExp=6; IntAct=EBI-740884, EBI-723510;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:12815048}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9NRN7-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9NRN7-2; Sequence=VSP_055783, VSP_055784;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Detected in heart, skeletal muscle, placenta,
CC       testis, brain, pancreas, liver and kidney.
CC       {ECO:0000269|PubMed:11286508, ECO:0000269|PubMed:12815048}.
CC   -!- SIMILARITY: Belongs to the P-Pant transferase superfamily. AcpS
CC       family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAD34075.1; Type=Frameshift; Positions=34, 63; Evidence={ECO:0000305};
CC       Sequence=AAF86879.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF302110; AAG30872.1; -; mRNA.
DR   EMBL; AF151838; AAD34075.1; ALT_FRAME; mRNA.
DR   EMBL; AF151057; AAF36143.1; -; mRNA.
DR   EMBL; AF136978; AAG49439.1; -; mRNA.
DR   EMBL; AF201943; AAF86879.1; ALT_INIT; mRNA.
DR   EMBL; AK312529; BAG35428.1; -; mRNA.
DR   EMBL; AK293362; BAG56878.1; -; mRNA.
DR   EMBL; AP001001; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471065; EAW67078.1; -; Genomic_DNA.
DR   EMBL; BC015470; AAH15470.1; -; mRNA.
DR   EMBL; BC016728; AAH16728.1; -; mRNA.
DR   EMBL; AL050073; CAB43257.1; -; mRNA.
DR   CCDS; CCDS31664.1; -. [Q9NRN7-1]
DR   PIR; T08733; T08733.
DR   RefSeq; NP_056238.2; NM_015423.2. [Q9NRN7-1]
DR   UniGene; Hs.524009; -.
DR   PDB; 2BYD; X-ray; 2.00 A; A=14-309.
DR   PDB; 2C43; X-ray; 1.93 A; A=14-309.
DR   PDB; 2CG5; X-ray; 2.70 A; A=14-309.
DR   PDBsum; 2BYD; -.
DR   PDBsum; 2C43; -.
DR   PDBsum; 2CG5; -.
DR   ProteinModelPortal; Q9NRN7; -.
DR   SMR; Q9NRN7; -.
DR   BioGrid; 121927; 37.
DR   IntAct; Q9NRN7; 14.
DR   MINT; Q9NRN7; -.
DR   STRING; 9606.ENSP00000278618; -.
DR   ChEMBL; CHEMBL3137295; -.
DR   SwissLipids; SLP:000001260; -.
DR   iPTMnet; Q9NRN7; -.
DR   PhosphoSitePlus; Q9NRN7; -.
DR   SwissPalm; Q9NRN7; -.
DR   BioMuta; AASDHPPT; -.
DR   DMDM; 81170356; -.
DR   EPD; Q9NRN7; -.
DR   MaxQB; Q9NRN7; -.
DR   PaxDb; Q9NRN7; -.
DR   PeptideAtlas; Q9NRN7; -.
DR   PRIDE; Q9NRN7; -.
DR   DNASU; 60496; -.
DR   Ensembl; ENST00000278618; ENSP00000278618; ENSG00000149313. [Q9NRN7-1]
DR   Ensembl; ENST00000525660; ENSP00000437144; ENSG00000149313. [Q9NRN7-2]
DR   GeneID; 60496; -.
DR   KEGG; hsa:60496; -.
DR   UCSC; uc001pjc.2; human. [Q9NRN7-1]
DR   CTD; 60496; -.
DR   DisGeNET; 60496; -.
DR   EuPathDB; HostDB:ENSG00000149313.10; -.
DR   GeneCards; AASDHPPT; -.
DR   HGNC; HGNC:14235; AASDHPPT.
DR   HPA; HPA020253; -.
DR   HPA; HPA026687; -.
DR   MIM; 607756; gene.
DR   neXtProt; NX_Q9NRN7; -.
DR   OpenTargets; ENSG00000149313; -.
DR   PharmGKB; PA24368; -.
DR   eggNOG; KOG0945; Eukaryota.
DR   eggNOG; COG2091; LUCA.
DR   GeneTree; ENSGT00390000004663; -.
DR   HOGENOM; HOG000265195; -.
DR   HOVERGEN; HBG080822; -.
DR   InParanoid; Q9NRN7; -.
DR   KO; K06133; -.
DR   OMA; VRWAFRC; -.
DR   OrthoDB; EOG091G0CU8; -.
DR   PhylomeDB; Q9NRN7; -.
DR   TreeFam; TF313753; -.
DR   BioCyc; MetaCyc:HS14278-MONOMER; -.
DR   BRENDA; 2.7.8.7; 2681.
DR   Reactome; R-HSA-199220; Vitamin B5 (pantothenate) metabolism.
DR   SABIO-RK; Q9NRN7; -.
DR   ChiTaRS; AASDHPPT; human.
DR   EvolutionaryTrace; Q9NRN7; -.
DR   GeneWiki; AASDHPPT; -.
DR   GenomeRNAi; 60496; -.
DR   PRO; PR:Q9NRN7; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   Bgee; ENSG00000149313; -.
DR   CleanEx; HS_AASDHPPT; -.
DR   ExpressionAtlas; Q9NRN7; baseline and differential.
DR   Genevisible; Q9NRN7; HS.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0008897; F:holo-[acyl-carrier-protein] synthase activity; IDA:UniProtKB.
DR   GO; GO:0000287; F:magnesium ion binding; IDA:UniProtKB.
DR   GO; GO:0019878; P:lysine biosynthetic process via aminoadipic acid; IBA:GO_Central.
DR   GO; GO:0015939; P:pantothenate metabolic process; TAS:Reactome.
DR   Gene3D; 3.90.470.20; -; 3.
DR   InterPro; IPR008278; 4-PPantetheinyl_Trfase_dom.
DR   InterPro; IPR037143; 4-PPantetheinyl_Trfase_dom_sf.
DR   Pfam; PF01648; ACPS; 1.
DR   SUPFAM; SSF56214; SSF56214; 2.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Complete proteome; Cytoplasm;
KW   Direct protein sequencing; Magnesium; Metal-binding; Phosphoprotein;
KW   Reference proteome; Transferase.
FT   CHAIN         1    309       L-aminoadipate-semialdehyde
FT                                dehydrogenase-phosphopantetheinyl
FT                                transferase.
FT                                /FTId=PRO_0000175736.
FT   REGION       86     91       Coenzyme A binding.
FT   REGION      108    111       Coenzyme A binding.
FT   REGION      181    185       Coenzyme A binding.
FT   METAL       129    129       Magnesium.
FT   METAL       181    181       Magnesium.
FT   BINDING      47     47       Coenzyme A.
FT   MOD_RES     258    258       Phosphoserine.
FT                                {ECO:0000244|PubMed:17525332,
FT                                ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163}.
FT   VAR_SEQ     138    138       R -> T (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_055783.
FT   VAR_SEQ     139    309       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_055784.
FT   MUTAGEN      47     47       R->A: Reduces affinity for magnesium 7-
FT                                fold, and enzyme activity 2-fold.
FT                                {ECO:0000269|PubMed:18022563}.
FT   MUTAGEN      86     86       R->A: Reduces affinity for magnesium and
FT                                coenzyme A, and reduces enzyme activity
FT                                7-fold. {ECO:0000269|PubMed:18022563}.
FT   MUTAGEN     111    111       H->A: Reduces affinity for magnesium 75-
FT                                fold, and enzyme activity 150-fold.
FT                                {ECO:0000269|PubMed:18022563}.
FT   MUTAGEN     112    112       Q->E: Reduces affinity for magnesium 200-
FT                                fold and abolishes enzyme activity; when
FT                                associated with Q-181.
FT                                {ECO:0000269|PubMed:18022563}.
FT   MUTAGEN     129    129       D->A: Reduces affinity for magnesium 10-
FT                                fold, and enzyme activity 30000-fold.
FT                                {ECO:0000269|PubMed:18022563}.
FT   MUTAGEN     181    181       E->A: Reduces affinity for magnesium 40-
FT                                fold, and enzyme activity 32000-fold.
FT                                {ECO:0000269|PubMed:18022563}.
FT   MUTAGEN     181    181       E->Q: Reduces affinity for magnesium 20-
FT                                fold, and enzyme activity 6500-fold.
FT                                {ECO:0000269|PubMed:18022563}.
FT   MUTAGEN     185    185       K->A: Reduces enzyme activity 2000-fold,
FT                                with only minor change in the affinity
FT                                for magnesium and coenzyme A.
FT                                {ECO:0000269|PubMed:18022563}.
FT   CONFLICT    136    141       PGRGSI -> FQVVVQF (in Ref. 4; AAG49439).
FT                                {ECO:0000305}.
FT   CONFLICT    307    309       TKS -> YKVMMIP (in Ref. 4; AAG49439).
FT                                {ECO:0000305}.
FT   STRAND       17     21       {ECO:0000244|PDB:2C43}.
FT   HELIX        23     25       {ECO:0000244|PDB:2C43}.
FT   HELIX        30     38       {ECO:0000244|PDB:2C43}.
FT   HELIX        42     49       {ECO:0000244|PDB:2C43}.
FT   HELIX        54     74       {ECO:0000244|PDB:2C43}.
FT   HELIX        79     81       {ECO:0000244|PDB:2C43}.
FT   STRAND       84     86       {ECO:0000244|PDB:2C43}.
FT   STRAND       92     94       {ECO:0000244|PDB:2C43}.
FT   STRAND      102    104       {ECO:0000244|PDB:2C43}.
FT   STRAND      106    112       {ECO:0000244|PDB:2C43}.
FT   STRAND      115    132       {ECO:0000244|PDB:2C43}.
FT   STRAND      137    139       {ECO:0000244|PDB:2C43}.
FT   HELIX       141    147       {ECO:0000244|PDB:2C43}.
FT   HELIX       149    151       {ECO:0000244|PDB:2C43}.
FT   HELIX       154    160       {ECO:0000244|PDB:2C43}.
FT   STRAND      163    165       {ECO:0000244|PDB:2C43}.
FT   HELIX       166    187       {ECO:0000244|PDB:2C43}.
FT   HELIX       190    192       {ECO:0000244|PDB:2BYD}.
FT   HELIX       195    197       {ECO:0000244|PDB:2C43}.
FT   STRAND      198    201       {ECO:0000244|PDB:2C43}.
FT   STRAND      203    206       {ECO:0000244|PDB:2BYD}.
FT   STRAND      217    220       {ECO:0000244|PDB:2C43}.
FT   STRAND      228    236       {ECO:0000244|PDB:2C43}.
FT   STRAND      239    246       {ECO:0000244|PDB:2C43}.
FT   STRAND      270    272       {ECO:0000244|PDB:2C43}.
FT   HELIX       274    277       {ECO:0000244|PDB:2C43}.
FT   TURN        278    280       {ECO:0000244|PDB:2C43}.
FT   HELIX       289    291       {ECO:0000244|PDB:2C43}.
FT   HELIX       298    300       {ECO:0000244|PDB:2C43}.
FT   TURN        305    307       {ECO:0000244|PDB:2BYD}.
SQ   SEQUENCE   309 AA;  35776 MW;  6263E302600FDDED CRC64;
     MVFPAKRFCL VPSMEGVRWA FSCGTWLPSR AEWLLAVRSI QPEEKERIGQ FVFARDAKAA
     MAGRLMIRKL VAEKLNIPWN HIRLQRTAKG KPVLAKDSSN PYPNFNFNIS HQGDYAVLAA
     EPELQVGIDI MKTSFPGRGS IPEFFHIMKR KFTNKEWETI RSFKDEWTQL DMFYRNWALK
     ESFIKAIGVG LGFELQRLEF DLSPLNLDIG QVYKETRLFL DGEEEKEWAF EESKIDEHHF
     VAVALRKPDG SRHQDVPSQD DSKPTQRQFT ILNFNDLMSS AVPMTPEDPS FWDCFCFTEE
     IPIRNGTKS
//
ID   B3KNP8_HUMAN            Unreviewed;       397 AA.
AC   B3KNP8;
DT   02-SEP-2008, integrated into UniProtKB/TrEMBL.
DT   02-SEP-2008, sequence version 1.
DT   28-FEB-2018, entry version 57.
DE   SubName: Full=cDNA FLJ30111 fis, clone BNGH42000360, highly similar to 3-ketoacyl-CoA thiolase, mitochondrial (EC 2.3.1.16) {ECO:0000313|EMBL:BAG51410.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAG51410.1};
RN   [1] {ECO:0000313|EMBL:BAG51410.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
CC   -!- SIMILARITY: Belongs to the thiolase family.
CC       {ECO:0000256|RuleBase:RU003557}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK054673; BAG51410.1; -; mRNA.
DR   RefSeq; NP_006102.2; NM_006111.2.
DR   UniGene; Hs.200136; -.
DR   PeptideAtlas; B3KNP8; -.
DR   PRIDE; B3KNP8; -.
DR   DNASU; 10449; -.
DR   GeneID; 10449; -.
DR   KEGG; hsa:10449; -.
DR   CTD; 10449; -.
DR   PharmGKB; PA24420; -.
DR   eggNOG; KOG1391; Eukaryota.
DR   eggNOG; COG0183; LUCA.
DR   HOVERGEN; HBG003112; -.
DR   KO; K07508; -.
DR   GenomeRNAi; 10449; -.
DR   Genevisible; B3KNP8; HS.
DR   GO; GO:0016747; F:transferase activity, transferring acyl groups other than amino-acyl groups; IEA:InterPro.
DR   GO; GO:0008152; P:metabolic process; IEA:InterPro.
DR   CDD; cd00751; thiolase; 1.
DR   Gene3D; 3.40.47.10; -; 4.
DR   InterPro; IPR002155; Thiolase.
DR   InterPro; IPR016039; Thiolase-like.
DR   InterPro; IPR020615; Thiolase_acyl_enz_int_AS.
DR   InterPro; IPR020610; Thiolase_AS.
DR   InterPro; IPR020617; Thiolase_C.
DR   InterPro; IPR020613; Thiolase_CS.
DR   InterPro; IPR020616; Thiolase_N.
DR   Pfam; PF02803; Thiolase_C; 1.
DR   Pfam; PF00108; Thiolase_N; 1.
DR   PIRSF; PIRSF000429; Ac-CoA_Ac_transf; 1.
DR   SUPFAM; SSF53901; SSF53901; 2.
DR   TIGRFAMs; TIGR01930; AcCoA-C-Actrans; 1.
DR   PROSITE; PS00098; THIOLASE_1; 1.
DR   PROSITE; PS00737; THIOLASE_2; 1.
DR   PROSITE; PS00099; THIOLASE_3; 1.
PE   2: Evidence at transcript level;
KW   Acyltransferase {ECO:0000256|RuleBase:RU003557};
KW   Transferase {ECO:0000256|RuleBase:RU003557}.
FT   DOMAIN        7    266       Thiolase_N. {ECO:0000259|Pfam:PF00108}.
FT   DOMAIN      274    394       Thiolase_C. {ECO:0000259|Pfam:PF02803}.
FT   ACT_SITE     92     92       Acyl-thioester intermediate.
FT                                {ECO:0000256|PIRSR:PIRSR000429-1}.
FT   ACT_SITE    352    352       Proton acceptor.
FT                                {ECO:0000256|PIRSR:PIRSR000429-1}.
FT   ACT_SITE    382    382       Proton acceptor.
FT                                {ECO:0000256|PIRSR:PIRSR000429-1}.
SQ   SEQUENCE   397 AA;  41896 MW;  EF4467C17ACF7F98 CRC64;
     MALLRGVFVV AAKRTPFGAY GGLLKDFTAT DLSEFAAKAA LSAGKVSPET VDSVIMGNVL
     QSSSDAIYLA RHVGLRVGIP KETPALTINR LCGSGFQSIV NGCQEICVKE AEVVLCGGTE
     SMSQAPYCVR NVRFGTKLGS DIKLEDSLWV SLTDQHVQLP MAMTAENLAV KHKISREECD
     KYALQSQQRW KAANDAGYFN DEMAPIEVKT KKGKQTMQVD EHARPQTTLE QLQKLPPVFK
     KDGTVTAGNA SGVADGAGAV IIASEDAVKK HNFTPLARIV GYFVSGCDPS IMGIGPVPAI
     SGALKKAGLS LKDMDLVEAN EAFAPQYLAV ERSLDLDISK TNVNGGAIAL GHPLGGSGSR
     ITAHLVHELR RRGGKYAVGS ACIGGGQGIA VIIQSTA
//
ID   THIM_HUMAN              Reviewed;         397 AA.
AC   P42765; Q9BUT6;
DT   01-NOV-1995, integrated into UniProtKB/Swiss-Prot.
DT   04-JAN-2005, sequence version 2.
DT   23-MAY-2018, entry version 167.
DE   RecName: Full=3-ketoacyl-CoA thiolase, mitochondrial;
DE            EC=2.3.1.16;
DE   AltName: Full=Acetyl-CoA acyltransferase;
DE   AltName: Full=Beta-ketothiolase;
DE   AltName: Full=Mitochondrial 3-oxoacyl-CoA thiolase;
DE   AltName: Full=T1;
GN   Name=ACAA2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Liver;
RX   PubMed=8241273; DOI=10.1016/0167-4781(93)90160-F;
RA   Abe H., Ohtake A., Yamamoto S., Satoh Y., Takayanagi M., Amaya Y.,
RA   Takiguchi M., Sakuraba H., Suzuki Y., Mori M., Niimi H.;
RT   "Cloning and sequence analysis of a full length cDNA encoding human
RT   mitochondrial 3-oxoacyl-CoA thiolase.";
RL   Biochim. Biophys. Acta 1216:304-306(1993).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   PROTEIN SEQUENCE OF 15-25; 46-71 AND 341-360.
RC   TISSUE=Adipocyte;
RX   PubMed=15242332; DOI=10.1042/BJ20040647;
RA   Aboulaich N., Vainonen J.P., Stralfors P., Vener A.V.;
RT   "Vectorial proteomics reveal targeting, phosphorylation and specific
RT   fragmentation of polymerase I and transcript release factor (PTRF) at
RT   the surface of caveolae in human adipocytes.";
RL   Biochem. J. 383:237-248(2004).
RN   [4]
RP   FUNCTION, SUBCELLULAR LOCATION, AND INTERACTION WITH BNIP3.
RX   PubMed=18371312; DOI=10.1016/j.bbagen.2008.02.007;
RA   Cao W., Liu N., Tang S., Bao L., Shen L., Yuan H., Zhao X., Lu H.;
RT   "Acetyl-Coenzyme A acyltransferase 2 attenuates the apoptotic effects
RT   of BNIP3 in two human cell lines.";
RL   Biochim. Biophys. Acta 1780:873-880(2008).
RN   [5]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-119; SER-121 AND
RP   TYR-127, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [6]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-140 AND SER-333, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
CC   -!- FUNCTION: Abolishes BNIP3-mediated apoptosis and mitochondrial
CC       damage. {ECO:0000269|PubMed:18371312}.
CC   -!- CATALYTIC ACTIVITY: Acyl-CoA + acetyl-CoA = CoA + 3-oxoacyl-CoA.
CC   -!- PATHWAY: Lipid metabolism; fatty acid metabolism.
CC   -!- SUBUNIT: Homotetramer. Interacts with BNIP3.
CC       {ECO:0000269|PubMed:18371312}.
CC   -!- SUBCELLULAR LOCATION: Mitochondrion {ECO:0000269|PubMed:18371312}.
CC       Note=Colocalizes with BNIP3 in the mitochondria.
CC   -!- SIMILARITY: Belongs to the thiolase family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; D16294; BAA03800.1; -; mRNA.
DR   EMBL; BC001918; AAH01918.1; -; mRNA.
DR   CCDS; CCDS11939.1; -.
DR   PIR; S43440; S43440.
DR   RefSeq; NP_006102.2; NM_006111.2.
DR   UniGene; Hs.200136; -.
DR   PDB; 4C2J; X-ray; 2.00 A; A/B/C/D=1-397.
DR   PDB; 4C2K; X-ray; 2.00 A; A/B/C/D=1-397.
DR   PDBsum; 4C2J; -.
DR   PDBsum; 4C2K; -.
DR   ProteinModelPortal; P42765; -.
DR   SMR; P42765; -.
DR   BioGrid; 115713; 57.
DR   IntAct; P42765; 10.
DR   STRING; 9606.ENSP00000285093; -.
DR   SwissLipids; SLP:000001273; -.
DR   iPTMnet; P42765; -.
DR   PhosphoSitePlus; P42765; -.
DR   SwissPalm; P42765; -.
DR   BioMuta; ACAA2; -.
DR   DMDM; 57015371; -.
DR   REPRODUCTION-2DPAGE; IPI00001539; -.
DR   UCD-2DPAGE; P42765; -.
DR   EPD; P42765; -.
DR   MaxQB; P42765; -.
DR   PaxDb; P42765; -.
DR   PeptideAtlas; P42765; -.
DR   PRIDE; P42765; -.
DR   TopDownProteomics; P42765; -.
DR   DNASU; 10449; -.
DR   Ensembl; ENST00000285093; ENSP00000285093; ENSG00000167315.
DR   GeneID; 10449; -.
DR   KEGG; hsa:10449; -.
DR   UCSC; uc002ldw.5; human.
DR   CTD; 10449; -.
DR   DisGeNET; 10449; -.
DR   EuPathDB; HostDB:ENSG00000167315.17; -.
DR   GeneCards; ACAA2; -.
DR   H-InvDB; HIX0014445; -.
DR   HGNC; HGNC:83; ACAA2.
DR   HPA; HPA042303; -.
DR   MIM; 604770; gene.
DR   neXtProt; NX_P42765; -.
DR   OpenTargets; ENSG00000167315; -.
DR   PharmGKB; PA24420; -.
DR   eggNOG; KOG1391; Eukaryota.
DR   eggNOG; COG0183; LUCA.
DR   GeneTree; ENSGT00390000009412; -.
DR   HOGENOM; HOG000012238; -.
DR   HOVERGEN; HBG003112; -.
DR   InParanoid; P42765; -.
DR   KO; K07508; -.
DR   OMA; CGGTESM; -.
DR   OrthoDB; EOG091G09C6; -.
DR   PhylomeDB; P42765; -.
DR   TreeFam; TF105696; -.
DR   BioCyc; MetaCyc:HS09539-MONOMER; -.
DR   Reactome; R-HSA-77289; Mitochondrial Fatty Acid Beta-Oxidation.
DR   UniPathway; UPA00199; -.
DR   ChiTaRS; ACAA2; human.
DR   GeneWiki; ACAA2; -.
DR   GenomeRNAi; 10449; -.
DR   PRO; PR:P42765; -.
DR   Proteomes; UP000005640; Chromosome 18.
DR   Bgee; ENSG00000167315; -.
DR   ExpressionAtlas; P42765; baseline and differential.
DR   Genevisible; P42765; HS.
DR   GO; GO:0005759; C:mitochondrial matrix; TAS:Reactome.
DR   GO; GO:0005739; C:mitochondrion; IDA:UniProtKB.
DR   GO; GO:0003988; F:acetyl-CoA C-acyltransferase activity; IBA:GO_Central.
DR   GO; GO:0003723; F:RNA binding; HDA:UniProtKB.
DR   GO; GO:0071456; P:cellular response to hypoxia; IDA:BHF-UCL.
DR   GO; GO:0006695; P:cholesterol biosynthetic process; NAS:UniProtKB.
DR   GO; GO:0006635; P:fatty acid beta-oxidation; IBA:GO_Central.
DR   GO; GO:1902109; P:negative regulation of mitochondrial membrane permeability involved in apoptotic process; IDA:BHF-UCL.
DR   GO; GO:1901029; P:negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway; IDA:UniProtKB.
DR   CDD; cd00751; thiolase; 1.
DR   Gene3D; 3.40.47.10; -; 4.
DR   InterPro; IPR002155; Thiolase.
DR   InterPro; IPR016039; Thiolase-like.
DR   InterPro; IPR020615; Thiolase_acyl_enz_int_AS.
DR   InterPro; IPR020610; Thiolase_AS.
DR   InterPro; IPR020617; Thiolase_C.
DR   InterPro; IPR020613; Thiolase_CS.
DR   InterPro; IPR020616; Thiolase_N.
DR   Pfam; PF02803; Thiolase_C; 1.
DR   Pfam; PF00108; Thiolase_N; 1.
DR   PIRSF; PIRSF000429; Ac-CoA_Ac_transf; 1.
DR   SUPFAM; SSF53901; SSF53901; 2.
DR   TIGRFAMs; TIGR01930; AcCoA-C-Actrans; 1.
DR   PROSITE; PS00098; THIOLASE_1; 1.
DR   PROSITE; PS00737; THIOLASE_2; 1.
DR   PROSITE; PS00099; THIOLASE_3; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Acyltransferase; Complete proteome;
KW   Direct protein sequencing; Fatty acid metabolism; Lipid metabolism;
KW   Mitochondrion; Phosphoprotein; Polymorphism; Reference proteome;
KW   Transferase; Transit peptide.
FT   CHAIN         1    397       3-ketoacyl-CoA thiolase, mitochondrial.
FT                                /FTId=PRO_0000223299.
FT   TRANSIT       1     16       Mitochondrion; not cleaved.
FT   ACT_SITE     92     92       Acyl-thioester intermediate.
FT                                {ECO:0000250}.
FT   ACT_SITE    352    352       Proton acceptor. {ECO:0000255|PROSITE-
FT                                ProRule:PRU10020}.
FT   ACT_SITE    382    382       Proton acceptor. {ECO:0000255|PROSITE-
FT                                ProRule:PRU10020}.
FT   MOD_RES      25     25       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q8BWT1}.
FT   MOD_RES      25     25       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q8BWT1}.
FT   MOD_RES      45     45       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:Q8BWT1}.
FT   MOD_RES     119    119       Phosphothreonine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   MOD_RES     121    121       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   MOD_RES     127    127       Phosphotyrosine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   MOD_RES     136    136       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:Q8BWT1}.
FT   MOD_RES     137    137       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q8BWT1}.
FT   MOD_RES     137    137       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q8BWT1}.
FT   MOD_RES     140    140       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     143    143       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q8BWT1}.
FT   MOD_RES     143    143       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q8BWT1}.
FT   MOD_RES     171    171       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q8BWT1}.
FT   MOD_RES     171    171       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q8BWT1}.
FT   MOD_RES     191    191       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q8BWT1}.
FT   MOD_RES     191    191       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q8BWT1}.
FT   MOD_RES     209    209       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q8BWT1}.
FT   MOD_RES     209    209       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q8BWT1}.
FT   MOD_RES     211    211       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:Q8BWT1}.
FT   MOD_RES     212    212       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:Q8BWT1}.
FT   MOD_RES     214    214       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:Q8BWT1}.
FT   MOD_RES     234    234       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q8BWT1}.
FT   MOD_RES     234    234       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q8BWT1}.
FT   MOD_RES     240    240       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:Q8BWT1}.
FT   MOD_RES     241    241       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:Q8BWT1}.
FT   MOD_RES     269    269       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:Q8BWT1}.
FT   MOD_RES     270    270       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:Q8BWT1}.
FT   MOD_RES     305    305       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q8BWT1}.
FT   MOD_RES     305    305       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q8BWT1}.
FT   MOD_RES     310    310       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q8BWT1}.
FT   MOD_RES     312    312       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q8BWT1}.
FT   MOD_RES     312    312       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q8BWT1}.
FT   MOD_RES     333    333       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     340    340       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:Q8BWT1}.
FT   MOD_RES     375    375       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:Q8BWT1}.
FT   VARIANT     217    217       M -> V (in dbSNP:rs11549285).
FT                                /FTId=VAR_052577.
FT   CONFLICT      2      2       A -> R (in Ref. 1; BAA03800).
FT                                {ECO:0000305}.
FT   CONFLICT    169    169       A -> T (in Ref. 1; BAA03800).
FT                                {ECO:0000305}.
FT   STRAND        7     14       {ECO:0000244|PDB:4C2J}.
FT   TURN         23     26       {ECO:0000244|PDB:4C2J}.
FT   HELIX        29     43       {ECO:0000244|PDB:4C2J}.
FT   HELIX        48     50       {ECO:0000244|PDB:4C2J}.
FT   STRAND       53     57       {ECO:0000244|PDB:4C2J}.
FT   HELIX        66     68       {ECO:0000244|PDB:4C2J}.
FT   HELIX        69     76       {ECO:0000244|PDB:4C2J}.
FT   STRAND       85     89       {ECO:0000244|PDB:4C2J}.
FT   HELIX        91     93       {ECO:0000244|PDB:4C2J}.
FT   HELIX        94    107       {ECO:0000244|PDB:4C2J}.
FT   STRAND      112    122       {ECO:0000244|PDB:4C2J}.
FT   STRAND      127    129       {ECO:0000244|PDB:4C2J}.
FT   STRAND      142    146       {ECO:0000244|PDB:4C2J}.
FT   HELIX       147    151       {ECO:0000244|PDB:4C2J}.
FT   TURN        155    158       {ECO:0000244|PDB:4C2J}.
FT   HELIX       161    172       {ECO:0000244|PDB:4C2J}.
FT   HELIX       176    196       {ECO:0000244|PDB:4C2J}.
FT   TURN        197    202       {ECO:0000244|PDB:4C2J}.
FT   STRAND      206    208       {ECO:0000244|PDB:4C2J}.
FT   STRAND      215    217       {ECO:0000244|PDB:4C2J}.
FT   HELIX       229    234       {ECO:0000244|PDB:4C2J}.
FT   STRAND      238    240       {ECO:0000244|PDB:4C2J}.
FT   TURN        247    249       {ECO:0000244|PDB:4C2J}.
FT   STRAND      254    264       {ECO:0000244|PDB:4C2J}.
FT   HELIX       265    271       {ECO:0000244|PDB:4C2J}.
FT   STRAND      277    286       {ECO:0000244|PDB:4C2J}.
FT   HELIX       289    294       {ECO:0000244|PDB:4C2J}.
FT   HELIX       296    307       {ECO:0000244|PDB:4C2J}.
FT   HELIX       311    313       {ECO:0000244|PDB:4C2J}.
FT   STRAND      315    319       {ECO:0000244|PDB:4C2J}.
FT   HELIX       324    334       {ECO:0000244|PDB:4C2J}.
FT   STRAND      340    342       {ECO:0000244|PDB:4C2J}.
FT   HELIX       347    350       {ECO:0000244|PDB:4C2J}.
FT   TURN        354    356       {ECO:0000244|PDB:4C2J}.
FT   HELIX       357    372       {ECO:0000244|PDB:4C2J}.
FT   STRAND      375    383       {ECO:0000244|PDB:4C2J}.
FT   TURN        384    386       {ECO:0000244|PDB:4C2J}.
FT   STRAND      387    395       {ECO:0000244|PDB:4C2J}.
SQ   SEQUENCE   397 AA;  41924 MW;  380CC8262ACF6D01 CRC64;
     MALLRGVFVV AAKRTPFGAY GGLLKDFTAT DLSEFAAKAA LSAGKVSPET VDSVIMGNVL
     QSSSDAIYLA RHVGLRVGIP KETPALTINR LCGSGFQSIV NGCQEICVKE AEVVLCGGTE
     SMSQAPYCVR NVRFGTKLGS DIKLEDSLWV SLTDQHVQLP MAMTAENLAV KHKISREECD
     KYALQSQQRW KAANDAGYFN DEMAPIEVKT KKGKQTMQVD EHARPQTTLE QLQKLPPVFK
     KDGTVTAGNA SGVADGAGAV IIASEDAVKK HNFTPLARIV GYFVSGCDPS IMGIGPVPAI
     SGALKKAGLS LKDMDLVEVN EAFAPQYLAV ERSLDLDISK TNVNGGAIAL GHPLGGSGSR
     ITAHLVHELR RRGGKYAVGS ACIGGGQGIA VIIQSTA
//
ID   A0A024R0E5_HUMAN        Unreviewed;       286 AA.
AC   A0A024R0E5;
DT   09-JUL-2014, integrated into UniProtKB/TrEMBL.
DT   09-JUL-2014, sequence version 1.
DT   23-MAY-2018, entry version 38.
DE   SubName: Full=Capping protein (Actin filament) muscle Z-line, alpha 1, isoform CRA_a {ECO:0000313|EMBL:EAW56526.1};
GN   Name=CAPZA1 {ECO:0000313|EMBL:EAW56526.1};
GN   ORFNames=hCG_38464 {ECO:0000313|EMBL:EAW56526.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:EAW56526.1};
RN   [1] {ECO:0000313|EMBL:EAW56526.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAW56526.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
CC   -!- FUNCTION: F-actin-capping proteins bind in a Ca(2+)-independent
CC       manner to the fast growing ends of actin filaments (barbed end)
CC       thereby blocking the exchange of subunits at these ends. Unlike
CC       other capping proteins (such as gelsolin and severin), these
CC       proteins do not sever actin filaments.
CC       {ECO:0000256|SAAS:SAAS00943449}.
CC   -!- SUBUNIT: Heterodimer of an alpha and a beta subunit.
CC       {ECO:0000256|SAAS:SAAS00943440}.
CC   -!- SIMILARITY: Belongs to the F-actin-capping protein alpha subunit
CC       family. {ECO:0000256|SAAS:SAAS00943446}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; CH471122; EAW56525.1; -; Genomic_DNA.
DR   EMBL; CH471122; EAW56526.1; -; Genomic_DNA.
DR   RefSeq; NP_006126.1; NM_006135.2.
DR   UniGene; Hs.744974; -.
DR   SMR; A0A024R0E5; -.
DR   PRIDE; A0A024R0E5; -.
DR   GeneID; 829; -.
DR   KEGG; hsa:829; -.
DR   CTD; 829; -.
DR   EuPathDB; HostDB:ENSG00000116489.12; -.
DR   eggNOG; KOG0836; Eukaryota.
DR   eggNOG; ENOG410ZAWX; LUCA.
DR   KO; K10364; -.
DR   OMA; ACDSALR; -.
DR   OrthoDB; EOG091G0KST; -.
DR   ChiTaRS; CAPZA1; human.
DR   GenomeRNAi; 829; -.
DR   Bgee; ENSG00000116489; -.
DR   ExpressionAtlas; A0A024R0E5; baseline and differential.
DR   GO; GO:0008290; C:F-actin capping protein complex; IEA:InterPro.
DR   GO; GO:0003779; F:actin binding; IEA:UniProtKB-KW.
DR   GO; GO:0051016; P:barbed-end actin filament capping; IEA:InterPro.
DR   InterPro; IPR002189; CapZ_alpha.
DR   InterPro; IPR037282; CapZ_alpha/beta.
DR   InterPro; IPR017865; F-actin_cap_asu_CS.
DR   PANTHER; PTHR10653; PTHR10653; 1.
DR   Pfam; PF01267; F-actin_cap_A; 1.
DR   PRINTS; PR00191; FACTINCAPA.
DR   SUPFAM; SSF90096; SSF90096; 1.
DR   PROSITE; PS00748; F_ACTIN_CAPPING_A_1; 1.
DR   PROSITE; PS00749; F_ACTIN_CAPPING_A_2; 1.
PE   3: Inferred from homology;
KW   Actin capping {ECO:0000256|SAAS:SAAS00943444};
KW   Actin-binding {ECO:0000256|SAAS:SAAS00943447};
KW   Coiled coil {ECO:0000256|SAM:Coils}.
FT   COILED      218    245       {ECO:0000256|SAM:Coils}.
SQ   SEQUENCE   286 AA;  32923 MW;  0F47ADAB6A3689DD CRC64;
     MADFDDRVSD EEKVRIAAKF ITHAPPGEFN EVFNDVRLLL NNDNLLREGA AHAFAQYNMD
     QFTPVKIEGY EDQVLITEHG DLGNSRFLDP RNKISFKFDH LRKEASDPQP EEADGGLKSW
     RESCDSALRA YVKDHYSNGF CTVYAKTIDG QQTIIACIES HQFQPKNFWN GRWRSEWKFT
     ITPPTAQVVG VLKIQVHYYE DGNVQLVSHK DVQDSLTVSN EAQTAKEFIK IIENAENEYQ
     TAISENYQTM SDTTFKALRR QLPVTRTKID WNKILSYKIG KEMQNA
//
ID   CAZA1_HUMAN             Reviewed;         286 AA.
AC   P52907; Q53FQ6; Q6FHD5;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 3.
DT   23-MAY-2018, entry version 180.
DE   RecName: Full=F-actin-capping protein subunit alpha-1;
DE   AltName: Full=CapZ alpha-1;
GN   Name=CAPZA1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Placenta;
RX   PubMed=9331217;
RX   DOI=10.1002/(SICI)1097-0169(1997)38:2<120::AID-CM2>3.0.CO;2-B;
RA   Hart M.C., Korshunova Y.O., Cooper J.A.;
RT   "Vertebrates have conserved capping protein alpha isoforms with
RT   specific expression patterns.";
RL   Cell Motil. Cytoskeleton 38:120-132(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Halleck A., Ebert L., Mkoundinya M., Schick M., Eisenstein S.,
RA   Neubert P., Kstrang K., Schatten R., Shen B., Henze S., Mar W.,
RA   Korn B., Zuo D., Hu Y., LaBaer J.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (OCT-2004) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Gastric mucosa;
RA   Suzuki Y., Sugano S., Totoki Y., Toyoda A., Takeda T., Sakaki Y.,
RA   Tanaka A., Yokoyama S.;
RL   Submitted (APR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Cervix;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   PROTEIN SEQUENCE OF 2-12 AND 178-192, CLEAVAGE OF INITIATOR
RP   METHIONINE, ACETYLATION AT ALA-2, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RC   TISSUE=T-cell;
RA   Bienvenut W.V., Kanor S., Tissot J.-D., Quadroni M.;
RL   Submitted (MAY-2006) to UniProtKB.
RN   [8]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [9]
RP   IDENTIFICATION IN THE WASH COMPLEX.
RX   PubMed=19922875; DOI=10.1016/j.devcel.2009.09.010;
RA   Derivery E., Sousa C., Gautier J.J., Lombard B., Loew D., Gautreau A.;
RT   "The Arp2/3 activator WASH controls the fission of endosomes through a
RT   large multiprotein complex.";
RL   Dev. Cell 17:712-723(2009).
RN   [10]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-19 AND LYS-97, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [12]
RP   FUNCTION, AND INTERACTION WITH CD2AP AND SH3BP1.
RX   PubMed=22891260; DOI=10.1083/jcb.201202094;
RA   Elbediwy A., Zihni C., Terry S.J., Clark P., Matter K., Balda M.S.;
RT   "Epithelial junction formation requires confinement of Cdc42 activity
RT   by a novel SH3BP1 complex.";
RL   J. Cell Biol. 198:677-693(2012).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-9, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [15]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [16]
RP   VARIANT LEU-219.
RX   PubMed=24951542; DOI=10.1093/hmg/ddu318;
RA   Khan M.A., Rupp V.M., Orpinell M., Hussain M.S., Altmueller J.,
RA   Steinmetz M.O., Enzinger C., Thiele H., Hoehne W., Nuernberg G.,
RA   Baig S.M., Ansar M., Nuernberg P., Vincent J.B., Speicher M.R.,
RA   Goenczy P., Windpassinger C.;
RT   "A missense mutation in the PISA domain of HsSAS-6 causes autosomal
RT   recessive primary microcephaly in a large consanguineous Pakistani
RT   family.";
RL   Hum. Mol. Genet. 23:5940-5949(2014).
RN   [17]
RP   STRUCTURE BY NMR OF 265-276 IN COMPLEX WITH S100B AND CALCIUM.
RX   PubMed=12470955; DOI=10.1016/S0022-2836(02)01152-X;
RA   Inman K.G., Yang R., Rustandi R.R., Miller K.E., Baldisseri D.M.,
RA   Weber D.J.;
RT   "Solution NMR structure of S100B bound to the high-affinity target
RT   peptide TRTK-12.";
RL   J. Mol. Biol. 324:1003-1014(2002).
RN   [18]
RP   STRUCTURE BY NMR OF 265-276 IN COMPLEX WITH S100B AND CALCIUM.
RX   PubMed=12480931; DOI=10.1074/jbc.M210622200;
RA   McClintock K.A., Shaw G.S.;
RT   "A novel S100 target conformation is revealed by the solution
RT   structure of the Ca2+-S100B-TRTK-12 complex.";
RL   J. Biol. Chem. 278:6251-6257(2003).
CC   -!- FUNCTION: F-actin-capping proteins bind in a Ca(2+)-independent
CC       manner to the fast growing ends of actin filaments (barbed end)
CC       thereby blocking the exchange of subunits at these ends. Unlike
CC       other capping proteins (such as gelsolin and severin), these
CC       proteins do not sever actin filaments. May play a role in the
CC       formation of epithelial cell junctions.
CC       {ECO:0000269|PubMed:22891260}.
CC   -!- SUBUNIT: Heterodimer of an alpha and a beta subunit. Interacts
CC       with S100A (By similarity). Component of the WASH complex,
CC       composed of F-actin-capping protein subunit alpha (CAPZA1, CAPZA2
CC       or CAPZA3), F-actin-capping protein subunit beta (CAPZB), WASH
CC       (WASHC1, WASH2P, WASH3P, WASH4P, WASH5P or WASH6P), WASHC2
CC       (WASHC2A or WASHC2C), WASHC3, WASHC4 and WASHC5. Interacts with
CC       S100B. Interacts with SH3BP1; recruits CAPZA1 to forming cell
CC       junctions (PubMed:22891260). Interacts with CD2AP
CC       (PubMed:22891260). {ECO:0000250, ECO:0000269|PubMed:12470955,
CC       ECO:0000269|PubMed:12480931, ECO:0000269|PubMed:19922875,
CC       ECO:0000269|PubMed:22891260}.
CC   -!- INTERACTION:
CC       Q96B97:SH3KBP1; NbExp=2; IntAct=EBI-355586, EBI-346595;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the F-actin-capping protein alpha subunit
CC       family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U56637; AAC00533.1; -; mRNA.
DR   EMBL; CR407657; CAG28585.1; -; mRNA.
DR   EMBL; CR541819; CAG46618.1; -; mRNA.
DR   EMBL; BT019364; AAV38171.1; -; mRNA.
DR   EMBL; AK223226; BAD96946.1; -; mRNA.
DR   EMBL; AL603832; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL929470; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC000144; AAH00144.1; -; mRNA.
DR   CCDS; CCDS30805.1; -.
DR   PIR; G02639; G02639.
DR   RefSeq; NP_006126.1; NM_006135.2.
DR   UniGene; Hs.744974; -.
DR   PDB; 1MQ1; NMR; -; C/D=265-276.
DR   PDB; 1MWN; NMR; -; X/Y=265-276.
DR   PDBsum; 1MQ1; -.
DR   PDBsum; 1MWN; -.
DR   ProteinModelPortal; P52907; -.
DR   SMR; P52907; -.
DR   BioGrid; 107279; 113.
DR   CORUM; P52907; -.
DR   IntAct; P52907; 59.
DR   MINT; P52907; -.
DR   STRING; 9606.ENSP00000263168; -.
DR   iPTMnet; P52907; -.
DR   PhosphoSitePlus; P52907; -.
DR   SwissPalm; P52907; -.
DR   BioMuta; CAPZA1; -.
DR   OGP; P52907; -.
DR   REPRODUCTION-2DPAGE; IPI00005969; -.
DR   REPRODUCTION-2DPAGE; P52907; -.
DR   SWISS-2DPAGE; P52907; -.
DR   EPD; P52907; -.
DR   MaxQB; P52907; -.
DR   PaxDb; P52907; -.
DR   PeptideAtlas; P52907; -.
DR   PRIDE; P52907; -.
DR   TopDownProteomics; P52907; -.
DR   DNASU; 829; -.
DR   Ensembl; ENST00000263168; ENSP00000263168; ENSG00000116489.
DR   GeneID; 829; -.
DR   KEGG; hsa:829; -.
DR   UCSC; uc001ecj.2; human.
DR   CTD; 829; -.
DR   DisGeNET; 829; -.
DR   EuPathDB; HostDB:ENSG00000116489.12; -.
DR   GeneCards; CAPZA1; -.
DR   HGNC; HGNC:1488; CAPZA1.
DR   HPA; CAB045963; -.
DR   MIM; 601580; gene.
DR   neXtProt; NX_P52907; -.
DR   OpenTargets; ENSG00000116489; -.
DR   PharmGKB; PA26069; -.
DR   eggNOG; KOG0836; Eukaryota.
DR   eggNOG; ENOG410ZAWX; LUCA.
DR   GeneTree; ENSGT00390000006476; -.
DR   HOGENOM; HOG000036539; -.
DR   HOVERGEN; HBG050810; -.
DR   InParanoid; P52907; -.
DR   KO; K10364; -.
DR   OMA; ACDSALR; -.
DR   OrthoDB; EOG091G0KST; -.
DR   PhylomeDB; P52907; -.
DR   TreeFam; TF314822; -.
DR   Reactome; R-HSA-2132295; MHC class II antigen presentation.
DR   Reactome; R-HSA-3371497; HSP90 chaperone cycle for steroid hormone receptors (SHR).
DR   Reactome; R-HSA-6807878; COPI-mediated anterograde transport.
DR   Reactome; R-HSA-6811436; COPI-independent Golgi-to-ER retrograde traffic.
DR   Reactome; R-HSA-879415; Advanced glycosylation endproduct receptor signaling.
DR   Reactome; R-HSA-8950505; Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation.
DR   Reactome; R-HSA-983231; Factors involved in megakaryocyte development and platelet production.
DR   SIGNOR; P52907; -.
DR   ChiTaRS; CAPZA1; human.
DR   EvolutionaryTrace; P52907; -.
DR   GenomeRNAi; 829; -.
DR   PRO; PR:P52907; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000116489; -.
DR   CleanEx; HS_CAPZA1; -.
DR   ExpressionAtlas; P52907; baseline and differential.
DR   Genevisible; P52907; HS.
DR   GO; GO:0015629; C:actin cytoskeleton; TAS:ProtInc.
DR   GO; GO:0005856; C:cytoskeleton; TAS:UniProtKB.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0005576; C:extracellular region; TAS:Reactome.
DR   GO; GO:0008290; C:F-actin capping protein complex; TAS:ProtInc.
DR   GO; GO:0071203; C:WASH complex; IDA:UniProtKB.
DR   GO; GO:0003779; F:actin binding; TAS:ProtInc.
DR   GO; GO:0045296; F:cadherin binding; HDA:BHF-UCL.
DR   GO; GO:0019886; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; TAS:Reactome.
DR   GO; GO:0051016; P:barbed-end actin filament capping; IEA:InterPro.
DR   GO; GO:0007596; P:blood coagulation; TAS:Reactome.
DR   GO; GO:0034329; P:cell junction assembly; IMP:UniProtKB.
DR   GO; GO:0006888; P:ER to Golgi vesicle-mediated transport; TAS:Reactome.
DR   GO; GO:0045087; P:innate immune response; TAS:Reactome.
DR   GO; GO:0035722; P:interleukin-12-mediated signaling pathway; TAS:Reactome.
DR   GO; GO:0065003; P:protein-containing complex assembly; TAS:ProtInc.
DR   InterPro; IPR002189; CapZ_alpha.
DR   InterPro; IPR037282; CapZ_alpha/beta.
DR   InterPro; IPR017865; F-actin_cap_asu_CS.
DR   PANTHER; PTHR10653; PTHR10653; 1.
DR   Pfam; PF01267; F-actin_cap_A; 1.
DR   PRINTS; PR00191; FACTINCAPA.
DR   SUPFAM; SSF90096; SSF90096; 1.
DR   PROSITE; PS00748; F_ACTIN_CAPPING_A_1; 1.
DR   PROSITE; PS00749; F_ACTIN_CAPPING_A_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Actin capping; Actin-binding;
KW   Complete proteome; Cytoplasm; Cytoskeleton; Direct protein sequencing;
KW   Phosphoprotein; Polymorphism; Reference proteome.
FT   INIT_MET      1      1       Removed. {ECO:0000244|PubMed:19413330,
FT                                ECO:0000269|Ref.7}.
FT   CHAIN         2    286       F-actin-capping protein subunit alpha-1.
FT                                /FTId=PRO_0000208624.
FT   MOD_RES       2      2       N-acetylalanine.
FT                                {ECO:0000244|PubMed:19413330,
FT                                ECO:0000269|Ref.7}.
FT   MOD_RES       9      9       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES      19     19       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES      97     97       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   VARIANT     219    219       S -> L (in dbSNP:rs555597264).
FT                                {ECO:0000269|PubMed:24951542}.
FT                                /FTId=VAR_073834.
FT   CONFLICT    192    192       L -> P (in Ref. 4; BAD96946).
FT                                {ECO:0000305}.
FT   HELIX       271    275       {ECO:0000244|PDB:1MWN}.
SQ   SEQUENCE   286 AA;  32923 MW;  0F47ADAB6A3689DD CRC64;
     MADFDDRVSD EEKVRIAAKF ITHAPPGEFN EVFNDVRLLL NNDNLLREGA AHAFAQYNMD
     QFTPVKIEGY EDQVLITEHG DLGNSRFLDP RNKISFKFDH LRKEASDPQP EEADGGLKSW
     RESCDSALRA YVKDHYSNGF CTVYAKTIDG QQTIIACIES HQFQPKNFWN GRWRSEWKFT
     ITPPTAQVVG VLKIQVHYYE DGNVQLVSHK DVQDSLTVSN EAQTAKEFIK IIENAENEYQ
     TAISENYQTM SDTTFKALRR QLPVTRTKID WNKILSYKIG KEMQNA
//
ID   A4D0V4_HUMAN            Unreviewed;       286 AA.
AC   A4D0V4;
DT   03-APR-2007, integrated into UniProtKB/TrEMBL.
DT   03-APR-2007, sequence version 1.
DT   23-MAY-2018, entry version 102.
DE   SubName: Full=Capping protein (Actin filament) muscle Z-line, alpha 2 {ECO:0000313|EMBL:EAL24358.1};
DE   SubName: Full=Capping protein (Actin filament) muscle Z-line, alpha 2, isoform CRA_b {ECO:0000313|EMBL:EAW83513.1};
DE   SubName: Full=cDNA, FLJ95684, Homo sapiens capping protein (actin filament) muscle Z-line, alpha2 (CAPZA2), mRNA {ECO:0000313|EMBL:BAG37333.1};
GN   Name=CAPZA2 {ECO:0000313|EMBL:EAL24358.1};
GN   ORFNames=hCG_37884 {ECO:0000313|EMBL:EAW83513.1},
GN   tcag7.31 {ECO:0000313|EMBL:EAL24358.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:EAL24358.1};
RN   [1] {ECO:0000313|EMBL:EAW83513.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAL24358.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12690205; DOI=10.1126/science.1083423;
RA   Scherer S.W., Cheung J., MacDonald J.R., Osborne L.R., Nakabayashi K.,
RA   Herbrick J.A., Carson A.R., Parker-Katiraee L., Skaug J., Khaja R.,
RA   Zhang J., Hudek A.K., Li M., Haddad M., Duggan G.E., Fernandez B.A.,
RA   Kanematsu E., Gentles S., Christopoulos C.C., Choufani S.,
RA   Kwasnicka D., Zheng X.H., Lai Z., Nusskern D., Zhang Q., Gu Z., Lu F.,
RA   Zeesman S., Nowaczyk M.J., Teshima I., Chitayat D., Shuman C.,
RA   Weksberg R., Zackai E.H., Grebe T.A., Cox S.R., Kirkpatrick S.J.,
RA   Rahman N., Friedman J.M., Heng H.H., Pelicci P.G., Lo-Coco F.,
RA   Belloni E., Shaffer L.G., Pober B., Morton C.C., Gusella J.F.,
RA   Bruns G.A., Korf B.R., Quade B.J., Ligon A.H., Ferguson H.,
RA   Higgins A.W., Leach N.T., Herrick S.R., Lemyre E., Farra C.G.,
RA   Kim H.G., Summers A.M., Gripp K.W., Roberts W., Szatmari P.,
RA   Winsor E.J., Grzeschik K.H., Teebi A., Minassian B.A., Kere J.,
RA   Armengol L., Pujana M.A., Estivill X., Wilson M.D., Koop B.F.,
RA   Tosi S., Moore G.E., Boright A.P., Zlotorynski E., Kerem B.,
RA   Kroisel P.M., Petek E., Oscier D.G., Mould S.J., Dohner H., Dohner K.,
RA   Rommens J.M., Vincent J.B., Venter J.C., Li P.W., Mural R.J.,
RA   Adams M.D., Tsui L.C.;
RT   "Human chromosome 7: DNA sequence and biology.";
RL   Science 300:767-772(2003).
RN   [3] {ECO:0000313|EMBL:EAL24358.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Scherer S.W., Cheung J., MacDonald J.R., Osborne L.R., Nakabayashi K.,
RA   Herbrick J.-A., Carson A.R., Parker-Katiraee L., Skaug J., Khaja R.,
RA   Zhang J., Hudek A.K., Li M., Haddad M., Duggan G.E., Fernandez B.A.,
RA   Kanematsu E., Gentles S., Christopoulos C.C., Choufani S.,
RA   Kwasnicka D., Zheng X.H., Nusskern D., Zhang Q., Gu Z., Lu F.,
RA   Zeesman S., Teshima I., Chitayat D., Shuman C., Weksberg R.,
RA   Zackai E.H., Grebe T.A., Cox S.R., Kirkpatrick S.J., Rahman N.,
RA   Friedman J.M., Heng H.H.Q., Pelicci P., Lococo F., Belloni E.,
RA   Shaffer L.G., Morton C.C., Pober B., Gusella J., Bruns G., Korf B.R.,
RA   Quade B.J., Ligon A.H., Ferguson H., Higgins A.W., Leach N.T.,
RA   Herrick S.R., Lemyre E., Farra C.G., Kim H.-G., Summers A.M.,
RA   Gripp K.W., Roberts W., Szatmari P., Winsor E.J.T., Grzeschik K.-H.,
RA   Teebi A., Minassian B.A., Kere J., Armengol L., Pujana M.Angel.,
RA   Estivill X., Wilson M.D., Koop B.F., Tosi S., Moore G.E.,
RA   Boright A.P., Zlotorynski E., Kerem B., Kroisel P.M., Petek E.,
RA   Oscier D.G., Mould S.J., Doehner H., Doehner K., Rommens J.M.,
RA   Vincent J.B., Venter J.C., Li P.W., Mural R.J., Adams M.D.,
RA   Tsui L.-C.;
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [4] {ECO:0000313|EMBL:EAW83513.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5] {ECO:0000313|EMBL:BAG37333.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Wakamatsu A., Yamamoto J., Kimura K., Kaida T., Tsuchiya K., Iida Y.,
RA   Takayama Y., Murakawa K., Kanehori K., Andoh T., Kagawa N., Sato R.,
RA   Kawamura Y., Tanaka S., Kisu Y., Sugano S., Goshima N., Nomura N.,
RA   Isogai T.;
RT   "NEDO functional analysis of protein and research application
RT   project.";
RL   Submitted (JAN-2008) to the EMBL/GenBank/DDBJ databases.
CC   -!- FUNCTION: F-actin-capping proteins bind in a Ca(2+)-independent
CC       manner to the fast growing ends of actin filaments (barbed end)
CC       thereby blocking the exchange of subunits at these ends. Unlike
CC       other capping proteins (such as gelsolin and severin), these
CC       proteins do not sever actin filaments.
CC       {ECO:0000256|SAAS:SAAS00943449}.
CC   -!- SUBUNIT: Heterodimer of an alpha and a beta subunit.
CC       {ECO:0000256|SAAS:SAAS00943440}.
CC   -!- SIMILARITY: Belongs to the F-actin-capping protein alpha subunit
CC       family. {ECO:0000256|SAAS:SAAS00943446}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK314808; BAG37333.1; -; mRNA.
DR   EMBL; CH236947; EAL24358.1; -; Genomic_DNA.
DR   EMBL; CH471070; EAW83513.1; -; Genomic_DNA.
DR   EMBL; CH471070; EAW83515.1; -; Genomic_DNA.
DR   RefSeq; NP_006127.1; NM_006136.2.
DR   UniGene; Hs.446123; -.
DR   SMR; A4D0V4; -.
DR   PRIDE; A4D0V4; -.
DR   DNASU; 830; -.
DR   GeneID; 830; -.
DR   KEGG; hsa:830; -.
DR   CTD; 830; -.
DR   EuPathDB; HostDB:ENSG00000198898.12; -.
DR   PharmGKB; PA26071; -.
DR   eggNOG; KOG0836; Eukaryota.
DR   eggNOG; ENOG410ZAWX; LUCA.
DR   HOVERGEN; HBG050810; -.
DR   KO; K10364; -.
DR   OMA; WDKVLGY; -.
DR   OrthoDB; EOG091G0KST; -.
DR   ChiTaRS; CAPZA2; human.
DR   GenomeRNAi; 830; -.
DR   Bgee; ENSG00000198898; -.
DR   ExpressionAtlas; A4D0V4; baseline and differential.
DR   GO; GO:0005903; C:brush border; IEA:Ensembl.
DR   GO; GO:0030863; C:cortical cytoskeleton; IEA:Ensembl.
DR   GO; GO:0008290; C:F-actin capping protein complex; IEA:Ensembl.
DR   GO; GO:0016020; C:membrane; IEA:Ensembl.
DR   GO; GO:0003779; F:actin binding; IEA:UniProtKB-KW.
DR   GO; GO:0051016; P:barbed-end actin filament capping; IEA:InterPro.
DR   InterPro; IPR002189; CapZ_alpha.
DR   InterPro; IPR037282; CapZ_alpha/beta.
DR   InterPro; IPR017865; F-actin_cap_asu_CS.
DR   PANTHER; PTHR10653; PTHR10653; 1.
DR   Pfam; PF01267; F-actin_cap_A; 1.
DR   PRINTS; PR00191; FACTINCAPA.
DR   SUPFAM; SSF90096; SSF90096; 1.
DR   PROSITE; PS00748; F_ACTIN_CAPPING_A_1; 1.
DR   PROSITE; PS00749; F_ACTIN_CAPPING_A_2; 1.
PE   2: Evidence at transcript level;
KW   Actin capping {ECO:0000256|SAAS:SAAS00943444};
KW   Actin-binding {ECO:0000256|SAAS:SAAS00943447};
KW   Coiled coil {ECO:0000256|SAM:Coils}.
FT   COILED      225    245       {ECO:0000256|SAM:Coils}.
SQ   SEQUENCE   286 AA;  32949 MW;  B5E1B617A38E758B CRC64;
     MADLEEQLSD EEKVRIAAKF IIHAPPGEFN EVFNDVRLLL NNDNLLREGA AHAFAQYNLD
     QFTPVKIEGY EDQVLITEHG DLGNGKFLDP KNRICFKFDH LRKEATDPRP CEVENAVESW
     RTSVETALRA YVKEHYPNGV CTVYGKKIDG QQTIIACIES HQFQAKNFWN GRWRSEWKFT
     ITPSTTQVVG ILKIQVHYYE DGNVQLVSHK DIQDSLTVSN EVQTAKEFIK IVEAAENEYQ
     TAISENYQTM SDTTFKALRR QLPVTRTKID WNKILSYKIG KEMQNA
//
ID   CAZA2_HUMAN             Reviewed;         286 AA.
AC   P47755; B4DG50;
DT   01-FEB-1996, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 3.
DT   23-MAY-2018, entry version 166.
DE   RecName: Full=F-actin-capping protein subunit alpha-2;
DE   AltName: Full=CapZ alpha-2;
GN   Name=CAPZA2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Retina;
RX   PubMed=7665558; DOI=10.1074/jbc.270.37.21472;
RA   Barron-Casella E.A., Torres M.A., Scherer S.W., Heng H.H.Q.,
RA   Tsui L.-C., Casella J.F.;
RT   "Sequence analysis and chromosomal localization of human Cap Z.
RT   Conserved residues within the actin-binding domain may link Cap Z to
RT   gelsolin/severin and profilin protein families.";
RL   J. Biol. Chem. 270:21472-21479(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Amygdala;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12853948; DOI=10.1038/nature01782;
RA   Hillier L.W., Fulton R.S., Fulton L.A., Graves T.A., Pepin K.H.,
RA   Wagner-McPherson C., Layman D., Maas J., Jaeger S., Walker R.,
RA   Wylie K., Sekhon M., Becker M.C., O'Laughlin M.D., Schaller M.E.,
RA   Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Cordes M., Du H.,
RA   Sun H., Edwards J., Bradshaw-Cordum H., Ali J., Andrews S., Isak A.,
RA   Vanbrunt A., Nguyen C., Du F., Lamar B., Courtney L., Kalicki J.,
RA   Ozersky P., Bielicki L., Scott K., Holmes A., Harkins R., Harris A.,
RA   Strong C.M., Hou S., Tomlinson C., Dauphin-Kohlberg S.,
RA   Kozlowicz-Reilly A., Leonard S., Rohlfing T., Rock S.M.,
RA   Tin-Wollam A.-M., Abbott A., Minx P., Maupin R., Strowmatt C.,
RA   Latreille P., Miller N., Johnson D., Murray J., Woessner J.P.,
RA   Wendl M.C., Yang S.-P., Schultz B.R., Wallis J.W., Spieth J.,
RA   Bieri T.A., Nelson J.O., Berkowicz N., Wohldmann P.E., Cook L.L.,
RA   Hickenbotham M.T., Eldred J., Williams D., Bedell J.A., Mardis E.R.,
RA   Clifton S.W., Chissoe S.L., Marra M.A., Raymond C., Haugen E.,
RA   Gillett W., Zhou Y., James R., Phelps K., Iadanoto S., Bubb K.,
RA   Simms E., Levy R., Clendenning J., Kaul R., Kent W.J., Furey T.S.,
RA   Baertsch R.A., Brent M.R., Keibler E., Flicek P., Bork P., Suyama M.,
RA   Bailey J.A., Portnoy M.E., Torrents D., Chinwalla A.T., Gish W.R.,
RA   Eddy S.R., McPherson J.D., Olson M.V., Eichler E.E., Green E.D.,
RA   Waterston R.H., Wilson R.K.;
RT   "The DNA sequence of human chromosome 7.";
RL   Nature 424:157-164(2003).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Kidney;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 3-286 (ISOFORM 1).
RC   TISSUE=Pancreas;
RX   PubMed=9331217;
RX   DOI=10.1002/(SICI)1097-0169(1997)38:2<120::AID-CM2>3.0.CO;2-B;
RA   Hart M.C., Korshunova Y.O., Cooper J.A.;
RT   "Vertebrates have conserved capping protein alpha isoforms with
RT   specific expression patterns.";
RL   Cell Motil. Cytoskeleton 38:120-132(1997).
RN   [7]
RP   PROTEIN SEQUENCE OF 2-15.
RC   TISSUE=Platelet;
RX   PubMed=12665801; DOI=10.1038/nbt810;
RA   Gevaert K., Goethals M., Martens L., Van Damme J., Staes A.,
RA   Thomas G.R., Vandekerckhove J.;
RT   "Exploring proteomes and analyzing protein processing by mass
RT   spectrometric identification of sorted N-terminal peptides.";
RL   Nat. Biotechnol. 21:566-569(2003).
RN   [8]
RP   PROTEIN SEQUENCE OF 2-15; 20-66; 122-129 AND 179-210, CLEAVAGE OF
RP   INITIATOR METHIONINE, ACETYLATION AT ALA-2, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RC   TISSUE=Cervix carcinoma, and Mammary carcinoma;
RA   Bienvenut W.V., Calvo F., Matallanas D., Cooper W.N., Kolch W.;
RL   Submitted (MAR-2008) to UniProtKB.
RN   [9]
RP   PROTEIN SEQUENCE OF 20-86; 147-166 AND 179-226, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY.
RC   TISSUE=Brain, Cajal-Retzius cell, and Fetal brain cortex;
RA   Lubec G., Vishwanath V., Chen W.-Q., Sun Y.;
RL   Submitted (DEC-2008) to UniProtKB.
RN   [10]
RP   INTERACTION WITH RCSD1/CAPZIP, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RX   PubMed=15850461; DOI=10.1042/BJ20050387;
RA   Eyers C.E., McNeill H., Knebel A., Morrice N., Arthur S.J.C.,
RA   Cuenda A., Cohen P.;
RT   "The phosphorylation of CapZ-interacting protein (CapZIP) by stress-
RT   activated protein kinases triggers its dissociation from CapZ.";
RL   Biochem. J. 389:127-135(2005).
RN   [11]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [12]
RP   IDENTIFICATION IN THE WASH COMPLEX.
RX   PubMed=19922875; DOI=10.1016/j.devcel.2009.09.010;
RA   Derivery E., Sousa C., Gautier J.J., Lombard B., Loew D., Gautreau A.;
RT   "The Arp2/3 activator WASH controls the fission of endosomes through a
RT   large multiprotein complex.";
RL   Dev. Cell 17:712-723(2009).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [14]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22223895; DOI=10.1074/mcp.M111.015131;
RA   Bienvenut W.V., Sumpton D., Martinez A., Lilla S., Espagne C.,
RA   Meinnel T., Giglione C.;
RT   "Comparative large-scale characterisation of plant vs. mammal proteins
RT   reveals similar and idiosyncratic N-alpha acetylation features.";
RL   Mol. Cell. Proteomics 11:M111.015131-M111.015131(2012).
RN   [15]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-9, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [17]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [18]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
CC   -!- FUNCTION: F-actin-capping proteins bind in a Ca(2+)-independent
CC       manner to the fast growing ends of actin filaments (barbed end)
CC       thereby blocking the exchange of subunits at these ends. Unlike
CC       other capping proteins (such as gelsolin and severin), these
CC       proteins do not sever actin filaments.
CC   -!- SUBUNIT: Heterodimer of an alpha and a beta subunit. Component of
CC       the WASH complex, composed of F-actin-capping protein subunit
CC       alpha (CAPZA1, CAPZA2 or CAPZA3), F-actin-capping protein subunit
CC       beta (CAPZB), WASH (WASHC1, WASH2P, WASH3P, WASH4P, WASH5P or
CC       WASH6P), WASHC2 (WASHC2A or WASHC2C), WASHC3, WASHC4 and WASHC5.
CC       Interacts with RCSD1/CAPZIP. {ECO:0000269|PubMed:15850461,
CC       ECO:0000269|PubMed:19922875}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P47755-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P47755-2; Sequence=VSP_053871, VSP_053872;
CC         Note=No experimental confirmation available.;
CC   -!- SIMILARITY: Belongs to the F-actin-capping protein alpha subunit
CC       family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U03269; AAA88848.1; -; mRNA.
DR   EMBL; BT006735; AAP35381.1; -; mRNA.
DR   EMBL; AK294409; BAG57661.1; -; mRNA.
DR   EMBL; AC002543; AAC60382.1; -; Genomic_DNA.
DR   EMBL; BC005338; AAH05338.1; -; mRNA.
DR   EMBL; U03851; AAC00534.1; -; mRNA.
DR   CCDS; CCDS5768.1; -. [P47755-1]
DR   PIR; G01229; G01229.
DR   RefSeq; NP_006127.1; NM_006136.2. [P47755-1]
DR   UniGene; Hs.446123; -.
DR   ProteinModelPortal; P47755; -.
DR   SMR; P47755; -.
DR   BioGrid; 107280; 272.
DR   IntAct; P47755; 236.
DR   STRING; 9606.ENSP00000354947; -.
DR   iPTMnet; P47755; -.
DR   PhosphoSitePlus; P47755; -.
DR   BioMuta; CAPZA2; -.
DR   DMDM; 1345695; -.
DR   DOSAC-COBS-2DPAGE; P47755; -.
DR   OGP; P47755; -.
DR   REPRODUCTION-2DPAGE; P47755; -.
DR   EPD; P47755; -.
DR   MaxQB; P47755; -.
DR   PaxDb; P47755; -.
DR   PeptideAtlas; P47755; -.
DR   PRIDE; P47755; -.
DR   DNASU; 830; -.
DR   Ensembl; ENST00000361183; ENSP00000354947; ENSG00000198898. [P47755-1]
DR   GeneID; 830; -.
DR   KEGG; hsa:830; -.
DR   UCSC; uc003vil.4; human. [P47755-1]
DR   CTD; 830; -.
DR   EuPathDB; HostDB:ENSG00000198898.12; -.
DR   GeneCards; CAPZA2; -.
DR   HGNC; HGNC:1490; CAPZA2.
DR   HPA; HPA007470; -.
DR   HPA; HPA007643; -.
DR   MIM; 601571; gene.
DR   neXtProt; NX_P47755; -.
DR   OpenTargets; ENSG00000198898; -.
DR   PharmGKB; PA26071; -.
DR   eggNOG; KOG0836; Eukaryota.
DR   eggNOG; ENOG410ZAWX; LUCA.
DR   GeneTree; ENSGT00390000006476; -.
DR   HOGENOM; HOG000036539; -.
DR   HOVERGEN; HBG050810; -.
DR   InParanoid; P47755; -.
DR   KO; K10364; -.
DR   OMA; WDKVLGY; -.
DR   OrthoDB; EOG091G0KST; -.
DR   PhylomeDB; P47755; -.
DR   TreeFam; TF314822; -.
DR   Reactome; R-HSA-2132295; MHC class II antigen presentation.
DR   Reactome; R-HSA-3371497; HSP90 chaperone cycle for steroid hormone receptors (SHR).
DR   Reactome; R-HSA-6807878; COPI-mediated anterograde transport.
DR   Reactome; R-HSA-6811436; COPI-independent Golgi-to-ER retrograde traffic.
DR   Reactome; R-HSA-879415; Advanced glycosylation endproduct receptor signaling.
DR   Reactome; R-HSA-983231; Factors involved in megakaryocyte development and platelet production.
DR   ChiTaRS; CAPZA2; human.
DR   GeneWiki; CAPZA2; -.
DR   GenomeRNAi; 830; -.
DR   PRO; PR:P47755; -.
DR   Proteomes; UP000005640; Chromosome 7.
DR   Bgee; ENSG00000198898; -.
DR   CleanEx; HS_CAPZA2; -.
DR   ExpressionAtlas; P47755; baseline and differential.
DR   Genevisible; P47755; HS.
DR   GO; GO:0015629; C:actin cytoskeleton; TAS:ProtInc.
DR   GO; GO:0005903; C:brush border; IEA:Ensembl.
DR   GO; GO:0030863; C:cortical cytoskeleton; IEA:Ensembl.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0005576; C:extracellular region; TAS:Reactome.
DR   GO; GO:0008290; C:F-actin capping protein complex; TAS:ProtInc.
DR   GO; GO:0016020; C:membrane; IEA:Ensembl.
DR   GO; GO:0003779; F:actin binding; IEA:UniProtKB-KW.
DR   GO; GO:0019886; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; TAS:Reactome.
DR   GO; GO:0051016; P:barbed-end actin filament capping; IEA:InterPro.
DR   GO; GO:0007596; P:blood coagulation; TAS:Reactome.
DR   GO; GO:0006888; P:ER to Golgi vesicle-mediated transport; TAS:Reactome.
DR   GO; GO:0045087; P:innate immune response; TAS:Reactome.
DR   GO; GO:0065003; P:protein-containing complex assembly; TAS:ProtInc.
DR   InterPro; IPR002189; CapZ_alpha.
DR   InterPro; IPR037282; CapZ_alpha/beta.
DR   InterPro; IPR017865; F-actin_cap_asu_CS.
DR   PANTHER; PTHR10653; PTHR10653; 1.
DR   Pfam; PF01267; F-actin_cap_A; 1.
DR   PRINTS; PR00191; FACTINCAPA.
DR   SUPFAM; SSF90096; SSF90096; 1.
DR   PROSITE; PS00748; F_ACTIN_CAPPING_A_1; 1.
DR   PROSITE; PS00749; F_ACTIN_CAPPING_A_2; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Actin capping; Actin-binding; Alternative splicing;
KW   Complete proteome; Direct protein sequencing; Phosphoprotein;
KW   Reference proteome.
FT   INIT_MET      1      1       Removed. {ECO:0000244|PubMed:19413330,
FT                                ECO:0000244|PubMed:22223895,
FT                                ECO:0000244|PubMed:22814378,
FT                                ECO:0000269|PubMed:12665801,
FT                                ECO:0000269|Ref.8}.
FT   CHAIN         2    286       F-actin-capping protein subunit alpha-2.
FT                                /FTId=PRO_0000208627.
FT   MOD_RES       2      2       N-acetylalanine.
FT                                {ECO:0000244|PubMed:19413330,
FT                                ECO:0000244|PubMed:22223895,
FT                                ECO:0000244|PubMed:22814378,
FT                                ECO:0000269|Ref.8}.
FT   MOD_RES       9      9       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   VAR_SEQ     143    172       VYGKKIDGQQTIIACIESHQFQAKNFWNGR -> EWSLEVR
FT                                MEVYNHSFNHSSGWHLENSGSLL (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_053871.
FT   VAR_SEQ     173    286       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_053872.
SQ   SEQUENCE   286 AA;  32949 MW;  B5E1B617A38E758B CRC64;
     MADLEEQLSD EEKVRIAAKF IIHAPPGEFN EVFNDVRLLL NNDNLLREGA AHAFAQYNLD
     QFTPVKIEGY EDQVLITEHG DLGNGKFLDP KNRICFKFDH LRKEATDPRP CEVENAVESW
     RTSVETALRA YVKEHYPNGV CTVYGKKIDG QQTIIACIES HQFQAKNFWN GRWRSEWKFT
     ITPSTTQVVG ILKIQVHYYE DGNVQLVSHK DIQDSLTVSN EVQTAKEFIK IVEAAENEYQ
     TAISENYQTM SDTTFKALRR QLPVTRTKID WNKILSYKIG KEMQNA
//
ID   CTBP2_HUMAN             Reviewed;         445 AA.
AC   P56545; A8K2X5; D3DRF5; O43449; Q5SQP7; Q69YI3; Q86SV0; Q8IY44;
AC   Q9H2T8;
DT   15-JUL-1998, integrated into UniProtKB/Swiss-Prot.
DT   15-JUL-1998, sequence version 1.
DT   23-MAY-2018, entry version 182.
DE   RecName: Full=C-terminal-binding protein 2;
DE            Short=CtBP2;
GN   Name=CTBP2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=9479502; DOI=10.1006/geno.1997.5115;
RA   Katsanis N., Fisher E.M.C.;
RT   "A novel C-terminal binding protein (CTBP2) is closely related to
RT   CTBP1, an adenovirus E1A-binding protein, and maps to human chromosome
RT   21q21.3.";
RL   Genomics 47:294-299(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RX   PubMed=11163272; DOI=10.1016/S0896-6273(00)00159-8;
RA   Schmitz F., Koenigstorfer A., Suedhof T.C.;
RT   "RIBEYE, a component of synaptic ribbons: a protein's journey through
RT   evolution provides insight into synaptic ribbon function.";
RL   Neuron 28:857-872(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Umbilical cord blood;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Melanoma;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164054; DOI=10.1038/nature02462;
RA   Deloukas P., Earthrowl M.E., Grafham D.V., Rubenfield M., French L.,
RA   Steward C.A., Sims S.K., Jones M.C., Searle S., Scott C., Howe K.,
RA   Hunt S.E., Andrews T.D., Gilbert J.G.R., Swarbreck D., Ashurst J.L.,
RA   Taylor A., Battles J., Bird C.P., Ainscough R., Almeida J.P.,
RA   Ashwell R.I.S., Ambrose K.D., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Bates K., Beasley H., Bray-Allen S., Brown A.J.,
RA   Brown J.Y., Burford D.C., Burrill W., Burton J., Cahill P., Camire D.,
RA   Carter N.P., Chapman J.C., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Corby N., Coulson A., Dhami P., Dutta I., Dunn M., Faulkner L.,
RA   Frankish A., Frankland J.A., Garner P., Garnett J., Gribble S.,
RA   Griffiths C., Grocock R., Gustafson E., Hammond S., Harley J.L.,
RA   Hart E., Heath P.D., Ho T.P., Hopkins B., Horne J., Howden P.J.,
RA   Huckle E., Hynds C., Johnson C., Johnson D., Kana A., Kay M.,
RA   Kimberley A.M., Kershaw J.K., Kokkinaki M., Laird G.K., Lawlor S.,
RA   Lee H.M., Leongamornlert D.A., Laird G., Lloyd C., Lloyd D.M.,
RA   Loveland J., Lovell J., McLaren S., McLay K.E., McMurray A.,
RA   Mashreghi-Mohammadi M., Matthews L., Milne S., Nickerson T.,
RA   Nguyen M., Overton-Larty E., Palmer S.A., Pearce A.V., Peck A.I.,
RA   Pelan S., Phillimore B., Porter K., Rice C.M., Rogosin A., Ross M.T.,
RA   Sarafidou T., Sehra H.K., Shownkeen R., Skuce C.D., Smith M.,
RA   Standring L., Sycamore N., Tester J., Thorpe A., Torcasso W.,
RA   Tracey A., Tromans A., Tsolas J., Wall M., Walsh J., Wang H.,
RA   Weinstock K., West A.P., Willey D.L., Whitehead S.L., Wilming L.,
RA   Wray P.W., Young L., Chen Y., Lovering R.C., Moschonas N.K.,
RA   Siebert R., Fechtel K., Bentley D., Durbin R.M., Hubbard T.,
RA   Doucette-Stamm L., Beck S., Smith D.R., Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 10.";
RL   Nature 429:375-381(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (DEC-2006) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 3).
RC   TISSUE=Brain, Colon, Kidney, Pancreas, and Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [10]
RP   PROTEIN SEQUENCE OF 263-272, AND PHOSPHORYLATION.
RC   TISSUE=B-cell, and Cervix carcinoma;
RX   PubMed=7479821; DOI=10.1073/pnas.92.23.10467;
RA   Schaeper U., Boyd J.M., Verma S., Uhlmann E., Subramanian T.,
RA   Chinnadurai G.;
RT   "Molecular cloning and characterization of a cellular phosphoprotein
RT   that interacts with a conserved C-terminal domain of adenovirus E1A
RT   involved in negative modulation of oncogenic transformation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 92:10467-10471(1995).
RN   [11]
RP   INTERACTION WITH PNN.
RX   PubMed=15542832; DOI=10.1128/MCB.24.23.10223-10235.2004;
RA   Alpatov R., Munguba G.C., Caton P., Joo J.H., Shi Y., Shi Y.,
RA   Hunt M.E., Sugrue S.P.;
RT   "Nuclear speckle-associated protein Pnn/DRS binds to the
RT   transcriptional corepressor CtBP and relieves CtBP-mediated repression
RT   of the E-cadherin gene.";
RL   Mol. Cell. Biol. 24:10223-10235(2004).
RN   [12]
RP   INTERACTION WITH NRIP1.
RX   PubMed=15060175; DOI=10.1093/nar/gkh524;
RA   Castet A., Boulahtouf A., Versini G., Bonnet S., Augereau P.,
RA   Vignon F., Khochbin S., Jalaguier S., Cavailles V.;
RT   "Multiple domains of the receptor-interacting protein 140 contribute
RT   to transcription inhibition.";
RL   Nucleic Acids Res. 32:1957-1966(2004).
RN   [13]
RP   INTERACTION WITH WIZ.
RX   PubMed=16702210; DOI=10.1074/jbc.M603087200;
RA   Ueda J., Tachibana M., Ikura T., Shinkai Y.;
RT   "Zinc finger protein Wiz links G9a/GLP histone methyltransferases to
RT   the co-repressor molecule CtBP.";
RL   J. Biol. Chem. 281:20120-20128(2006).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [15]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [16]
RP   INTERACTION WITH HADV5 E1A.
RX   PubMed=23747199; DOI=10.1016/j.virol.2013.05.018;
RA   Subramanian T., Zhao L.J., Chinnadurai G.;
RT   "Interaction of CtBP with adenovirus E1A suppresses immortalization of
RT   primary epithelial cells and enhances virus replication during
RT   productive infection.";
RL   Virology 443:313-320(2013).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-428, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [18]
RP   METHYLATION [LARGE SCALE ANALYSIS] AT ARG-22, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Colon carcinoma;
RX   PubMed=24129315; DOI=10.1074/mcp.O113.027870;
RA   Guo A., Gu H., Zhou J., Mulhern D., Wang Y., Lee K.A., Yang V.,
RA   Aguiar M., Kornhauser J., Jia X., Ren J., Beausoleil S.A., Silva J.C.,
RA   Vemulapalli V., Bedford M.T., Comb M.J.;
RT   "Immunoaffinity enrichment and mass spectrometry analysis of protein
RT   methylation.";
RL   Mol. Cell. Proteomics 13:372-387(2014).
RN   [19]
RP   INTERACTION WITH MCRIP1.
RX   PubMed=25728771; DOI=10.1016/j.molcel.2015.01.023;
RA   Ichikawa K., Kubota Y., Nakamura T., Weng J.S., Tomida T., Saito H.,
RA   Takekawa M.;
RT   "MCRIP1, an ERK substrate, mediates ERK-induced gene silencing during
RT   epithelial-mesenchymal transition by regulating the co-repressor
RT   CtBP.";
RL   Mol. Cell 58:35-46(2015).
RN   [20]
RP   X-RAY CRYSTALLOGRAPHY (2.8 ANGSTROMS) OF 31-364 IN COMPLEX WITH NAD.
RG   Structural genomics consortium (SGC);
RT   "Crystal structure of human CTBP2 dehydrogenase complexed with
RT   NAD(H).";
RL   Submitted (FEB-2009) to the PDB data bank.
CC   -!- FUNCTION: Corepressor targeting diverse transcription regulators.
CC       Functions in brown adipose tissue (BAT) differentiation (By
CC       similarity). {ECO:0000250}.
CC   -!- FUNCTION: Isoform 2 probably acts as a scaffold for specialized
CC       synapses.
CC   -!- SUBUNIT: Interacts with the C-terminus of adenovirus E1A protein.
CC       Can form homodimers or heterodimers of CTBP1 and CTBP2. Interacts
CC       with HIPK2 and ZNF217. Interacts with PRDM16; represses white
CC       adipose tissue (WAT)-specific genes expression (By similarity).
CC       Interacts with PNN, NRIP1 and WIZ. Interacts with human adenovirus
CC       5 E1A protein; this interaction seems to potentiate viral
CC       replication (PubMed:23747199). Interacts with MCRIP1
CC       (PubMed:25728771). {ECO:0000250, ECO:0000269|PubMed:15060175,
CC       ECO:0000269|PubMed:15542832, ECO:0000269|PubMed:16702210,
CC       ECO:0000269|PubMed:23747199, ECO:0000269|PubMed:25728771,
CC       ECO:0000269|Ref.20}.
CC   -!- INTERACTION:
CC       Q9UIF8-2:BAZ2B; NbExp=3; IntAct=EBI-10171902, EBI-10321972;
CC       Q9H6U6:BCAS3; NbExp=3; IntAct=EBI-10171902, EBI-6083685;
CC       P20749:BCL3; NbExp=2; IntAct=EBI-741533, EBI-958997;
CC       P54284:CACNB3; NbExp=4; IntAct=EBI-10171902, EBI-1184651;
CC       P51946:CCNH; NbExp=5; IntAct=EBI-741533, EBI-741406;
CC       Q13363-2:CTBP1; NbExp=3; IntAct=EBI-10171902, EBI-10171858;
CC       A0A0S2Z5I3:DMRTB1; NbExp=3; IntAct=EBI-741533, EBI-16431245;
CC       I6L9A0:DMRTB1; NbExp=3; IntAct=EBI-10171902, EBI-10178554;
CC       Q01543:FLI1; NbExp=3; IntAct=EBI-10171902, EBI-2271018;
CC       O15409:FOXP2; NbExp=3; IntAct=EBI-741533, EBI-983612;
CC       Q8IVP5:FUNDC1; NbExp=3; IntAct=EBI-741533, EBI-3059266;
CC       Q9BZE0:GLIS2; NbExp=4; IntAct=EBI-10171902, EBI-7251368;
CC       Q14526:HIC1; NbExp=2; IntAct=EBI-741533, EBI-2507362;
CC       P09067:HOXB5; NbExp=5; IntAct=EBI-10171902, EBI-3893317;
CC       Q13422:IKZF1; NbExp=5; IntAct=EBI-741533, EBI-745305;
CC       Q9UKS7:IKZF2; NbExp=3; IntAct=EBI-10171902, EBI-3893057;
CC       Q96JN0:LCOR; NbExp=4; IntAct=EBI-741533, EBI-746045;
CC       O94818-2:NOL4; NbExp=3; IntAct=EBI-741533, EBI-10190763;
CC       Q96MY1:NOL4L; NbExp=3; IntAct=EBI-10171902, EBI-6660790;
CC       Q9NQ66:PLCB1; NbExp=3; IntAct=EBI-10171902, EBI-3396023;
CC       O75807:PPP1R15A; NbExp=2; IntAct=EBI-741533, EBI-714746;
CC       Q92786:PROX1; NbExp=2; IntAct=EBI-741533, EBI-3912635;
CC       Q9Y5P3:RAI2; NbExp=4; IntAct=EBI-741533, EBI-746228;
CC       Q9UFD9:RIMBP3; NbExp=3; IntAct=EBI-10171902, EBI-10182375;
CC       Q9UN79:SOX13; NbExp=2; IntAct=EBI-741533, EBI-3928516;
CC       Q15583:TGIF1; NbExp=5; IntAct=EBI-741533, EBI-714215;
CC       Q15583-2:TGIF1; NbExp=3; IntAct=EBI-741533, EBI-12691451;
CC       Q63HK5:TSHZ3; NbExp=5; IntAct=EBI-10171902, EBI-9053916;
CC       A2APF7:Zbp1 (xeno); NbExp=2; IntAct=EBI-741533, EBI-6115394;
CC       Q99592:ZBTB18; NbExp=5; IntAct=EBI-10171902, EBI-3232046;
CC       B2RXF5:ZBTB42; NbExp=4; IntAct=EBI-10171902, EBI-12287587;
CC       Q32MQ0:ZNF750; NbExp=3; IntAct=EBI-741533, EBI-10240029;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000305}. Cell junction,
CC       synapse {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=P56545-1; Sequence=Displayed;
CC       Name=2; Synonyms=Ribeye;
CC         IsoId=P56545-2; Sequence=VSP_027615;
CC         Note=Ref.2 (AAG45951) sequence is in conflict in position:
CC         455:Y->H. Ref.2 (AAG45951) sequence is in conflict in position:
CC         539:Q->E. {ECO:0000305};
CC       Name=3;
CC         IsoId=P56545-3; Sequence=VSP_058946;
CC   -!- TISSUE SPECIFICITY: Ubiquitous. Highest levels in heart, skeletal
CC       muscle, and pancreas.
CC   -!- SIMILARITY: Belongs to the D-isomer specific 2-hydroxyacid
CC       dehydrogenase family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF016507; AAC39603.1; -; mRNA.
DR   EMBL; AF222711; AAG45951.1; -; mRNA.
DR   EMBL; BT007012; AAP35658.1; -; mRNA.
DR   EMBL; AK290390; BAF83079.1; -; mRNA.
DR   EMBL; AL833398; CAH10590.1; -; mRNA.
DR   EMBL; AL596261; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL731571; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471066; EAW49247.1; -; Genomic_DNA.
DR   EMBL; CH471066; EAW49250.1; -; Genomic_DNA.
DR   EMBL; CH471066; EAW49249.1; -; Genomic_DNA.
DR   EMBL; BC002486; AAH02486.1; -; mRNA.
DR   EMBL; BC037900; AAH37900.1; -; mRNA.
DR   EMBL; BC047018; AAH47018.1; -; mRNA.
DR   EMBL; BC052276; AAH52276.1; -; mRNA.
DR   EMBL; BC072020; AAH72020.1; -; mRNA.
DR   CCDS; CCDS7643.1; -. [P56545-1]
DR   CCDS; CCDS7644.1; -. [P56545-2]
DR   RefSeq; NP_001077383.1; NM_001083914.2. [P56545-1]
DR   RefSeq; NP_001277143.1; NM_001290214.2. [P56545-1]
DR   RefSeq; NP_001277144.1; NM_001290215.2. [P56545-1]
DR   RefSeq; NP_001307941.1; NM_001321012.1. [P56545-1]
DR   RefSeq; NP_001307942.1; NM_001321013.1. [P56545-1]
DR   RefSeq; NP_001307943.1; NM_001321014.1. [P56545-1]
DR   RefSeq; NP_001320.1; NM_001329.3. [P56545-1]
DR   RefSeq; NP_073713.2; NM_022802.2. [P56545-2]
DR   RefSeq; XP_005269618.1; XM_005269561.2. [P56545-1]
DR   RefSeq; XP_005269621.1; XM_005269564.2. [P56545-1]
DR   RefSeq; XP_005269624.1; XM_005269567.2. [P56545-1]
DR   RefSeq; XP_005269625.1; XM_005269568.4. [P56545-1]
DR   RefSeq; XP_005269626.1; XM_005269569.2. [P56545-1]
DR   RefSeq; XP_005269628.1; XM_005269571.2. [P56545-1]
DR   RefSeq; XP_005269629.1; XM_005269572.3. [P56545-1]
DR   RefSeq; XP_006717705.1; XM_006717642.2. [P56545-1]
DR   RefSeq; XP_011537653.1; XM_011539351.1. [P56545-1]
DR   RefSeq; XP_011537655.1; XM_011539353.1. [P56545-1]
DR   RefSeq; XP_011537656.1; XM_011539354.1. [P56545-1]
DR   RefSeq; XP_011537657.1; XM_011539355.1. [P56545-1]
DR   RefSeq; XP_016871245.1; XM_017015756.1. [P56545-1]
DR   RefSeq; XP_016871246.1; XM_017015757.1. [P56545-1]
DR   UniGene; Hs.501345; -.
DR   PDB; 2OME; X-ray; 2.80 A; A/B/C/D/E/F/G/H=31-364.
DR   PDB; 4LCJ; X-ray; 2.86 A; A/B/C/D/E/F/G/H=31-362.
DR   PDBsum; 2OME; -.
DR   PDBsum; 4LCJ; -.
DR   ProteinModelPortal; P56545; -.
DR   SMR; P56545; -.
DR   BioGrid; 107870; 112.
DR   CORUM; P56545; -.
DR   DIP; DIP-42104N; -.
DR   IntAct; P56545; 106.
DR   MINT; P56545; -.
DR   STRING; 9606.ENSP00000311825; -.
DR   BindingDB; P56545; -.
DR   ChEMBL; CHEMBL3797016; -.
DR   iPTMnet; P56545; -.
DR   PhosphoSitePlus; P56545; -.
DR   BioMuta; CTBP2; -.
DR   DMDM; 3182976; -.
DR   EPD; P56545; -.
DR   MaxQB; P56545; -.
DR   PaxDb; P56545; -.
DR   PeptideAtlas; P56545; -.
DR   PRIDE; P56545; -.
DR   DNASU; 1488; -.
DR   Ensembl; ENST00000309035; ENSP00000311825; ENSG00000175029. [P56545-2]
DR   Ensembl; ENST00000334808; ENSP00000357816; ENSG00000175029. [P56545-3]
DR   Ensembl; ENST00000337195; ENSP00000338615; ENSG00000175029. [P56545-1]
DR   Ensembl; ENST00000411419; ENSP00000410474; ENSG00000175029. [P56545-1]
DR   Ensembl; ENST00000494626; ENSP00000436285; ENSG00000175029. [P56545-1]
DR   Ensembl; ENST00000531469; ENSP00000434630; ENSG00000175029. [P56545-1]
DR   GeneID; 1488; -.
DR   KEGG; hsa:1488; -.
DR   UCSC; uc001lie.5; human. [P56545-1]
DR   CTD; 1488; -.
DR   DisGeNET; 1488; -.
DR   EuPathDB; HostDB:ENSG00000175029.16; -.
DR   GeneCards; CTBP2; -.
DR   HGNC; HGNC:2495; CTBP2.
DR   HPA; CAB031916; -.
DR   HPA; HPA023559; -.
DR   HPA; HPA023564; -.
DR   HPA; HPA044971; -.
DR   MIM; 602619; gene.
DR   neXtProt; NX_P56545; -.
DR   OpenTargets; ENSG00000175029; -.
DR   PharmGKB; PA26996; -.
DR   eggNOG; KOG0067; Eukaryota.
DR   eggNOG; COG0111; LUCA.
DR   GeneTree; ENSGT00530000063021; -.
DR   HOVERGEN; HBG001898; -.
DR   InParanoid; P56545; -.
DR   KO; K04496; -.
DR   OMA; INGGYYA; -.
DR   OrthoDB; EOG091G08GS; -.
DR   PhylomeDB; P56545; -.
DR   TreeFam; TF313593; -.
DR   Reactome; R-HSA-4641265; Repression of WNT target genes.
DR   Reactome; R-HSA-5339700; TCF7L2 mutants don't bind CTBP.
DR   SignaLink; P56545; -.
DR   SIGNOR; P56545; -.
DR   ChiTaRS; CTBP2; human.
DR   EvolutionaryTrace; P56545; -.
DR   GeneWiki; CTBP2; -.
DR   GenomeRNAi; 1488; -.
DR   PRO; PR:P56545; -.
DR   Proteomes; UP000005640; Chromosome 10.
DR   Bgee; ENSG00000175029; -.
DR   CleanEx; HS_CTBP2; -.
DR   ExpressionAtlas; P56545; baseline and differential.
DR   Genevisible; P56545; HS.
DR   GO; GO:0030054; C:cell junction; IEA:UniProtKB-KW.
DR   GO; GO:0005829; C:cytosol; IBA:GO_Central.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0045202; C:synapse; IEA:UniProtKB-SubCell.
DR   GO; GO:0017053; C:transcriptional repressor complex; ISS:UniProtKB.
DR   GO; GO:0030267; F:glyoxylate reductase (NADP) activity; IBA:GO_Central.
DR   GO; GO:0016618; F:hydroxypyruvate reductase activity; IBA:GO_Central.
DR   GO; GO:0051287; F:NAD binding; IEA:InterPro.
DR   GO; GO:0042803; F:protein homodimerization activity; IBA:GO_Central.
DR   GO; GO:0019901; F:protein kinase binding; IPI:CAFA.
DR   GO; GO:0044877; F:protein-containing complex binding; IPI:CAFA.
DR   GO; GO:0003714; F:transcription corepressor activity; IBA:GO_Central.
DR   GO; GO:0008285; P:negative regulation of cell proliferation; TAS:ProtInc.
DR   GO; GO:0045892; P:negative regulation of transcription, DNA-templated; ISS:UniProtKB.
DR   GO; GO:0048386; P:positive regulation of retinoic acid receptor signaling pathway; IMP:MGI.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IMP:MGI.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   GO; GO:0019079; P:viral genome replication; TAS:ProtInc.
DR   GO; GO:0050872; P:white fat cell differentiation; ISS:UniProtKB.
DR   InterPro; IPR006139; D-isomer_2_OHA_DH_cat_dom.
DR   InterPro; IPR029753; D-isomer_DH_CS.
DR   InterPro; IPR006140; D-isomer_DH_NAD-bd.
DR   InterPro; IPR036291; NAD(P)-bd_dom_sf.
DR   Pfam; PF00389; 2-Hacid_dh; 1.
DR   Pfam; PF02826; 2-Hacid_dh_C; 1.
DR   SUPFAM; SSF51735; SSF51735; 1.
DR   PROSITE; PS00671; D_2_HYDROXYACID_DH_3; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Cell junction; Complete proteome;
KW   Differentiation; Direct protein sequencing; Host-virus interaction;
KW   Methylation; NAD; Nucleus; Oxidoreductase; Phosphoprotein;
KW   Reference proteome; Repressor; Synapse; Transcription;
KW   Transcription regulation.
FT   CHAIN         1    445       C-terminal-binding protein 2.
FT                                /FTId=PRO_0000076044.
FT   NP_BIND     186    191       NAD. {ECO:0000269|Ref.20}.
FT   NP_BIND     243    249       NAD. {ECO:0000269|Ref.20}.
FT   NP_BIND     270    272       NAD. {ECO:0000269|Ref.20}.
FT   NP_BIND     321    324       NAD. {ECO:0000269|Ref.20}.
FT   ACT_SITE    272    272       {ECO:0000250}.
FT   ACT_SITE    301    301       {ECO:0000250}.
FT   ACT_SITE    321    321       Proton donor. {ECO:0000250}.
FT   BINDING     106    106       NAD. {ECO:0000250}.
FT   BINDING     210    210       NAD. {ECO:0000269|Ref.20}.
FT   BINDING     296    296       NAD. {ECO:0000269|Ref.20}.
FT   MOD_RES      22     22       Asymmetric dimethylarginine.
FT                                {ECO:0000244|PubMed:24129315}.
FT   MOD_RES     428    428       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   VAR_SEQ       1     20       MALVDKHKVKRQRLDRICEG -> MPVPSRHINIGRSQSWD
FT                                AAGWYEGPWENAESLRPLGRRSSLTYGTAEGTWFEPNHRPQ
FT                                DAALPVAAEPYLYREAVYNSVAARKGSTPDFTFYDSRQAVM
FT                                SGRSPLLPREYYSDPSGAARVPKEPPLYRDPGVSRPVPSYG
FT                                VLGSRTSWDPMQGRSPALQDAGHLYRDPGGKMIPQGRQTQS
FT                                RAASPGRYGREQPDTRYGAEVPAYPLSQVFSDISERPIDPA
FT                                PARQVAPTCLVVDPSSAAAPEGSTGVAPGALNRGYGPARES
FT                                IPSKMAYETYEADLSTFQGPGGKRTVLPEFLAFLRAEGLAE
FT                                ATLGALLQQGFDSPAVLATLEDADIKSVAPNLGQARVLSRL
FT                                ANSCRTEMQLRRQDRGGPLPRARSSSFSHRSELLHGDLASL
FT                                GAAAPLQTASPRAGDPARRPSSAPSQHLLETAATYSAPGVG
FT                                THAPHFPSNSGYSSPTPCALTARLSPTYPLQAGVALTNPGP
FT                                SNPLHPGPRTAYSTAYTVPMELLKRERNVAASPLPSPHGSP
FT                                QVLRKPGAPLGPSTLPPASQSLHTPHSPYQKVARRTGAPII
FT                                VSTMLAPEPS (in isoform 2).
FT                                {ECO:0000303|PubMed:11163272}.
FT                                /FTId=VSP_027615.
FT   VAR_SEQ       1     19       MALVDKHKVKRQRLDRICE -> MRPGLPGPTGLCAQTSSR
FT                                GQKSVLKQKESCGIWQLYHFLSRKQEPRWEPCVSGSSSGDG
FT                                AVADLADELRGYPALCCTLPVHSYRSWA (in isoform
FT                                3).
FT                                /FTId=VSP_058946.
FT   CONFLICT     87     87       L -> F (in Ref. 2; AAG45951).
FT                                {ECO:0000305}.
FT   CONFLICT     88     88       T -> N (in Ref. 2; AAG45951).
FT                                {ECO:0000305}.
FT   CONFLICT    112    112       D -> N (in Ref. 2; AAG45951).
FT                                {ECO:0000305}.
FT   CONFLICT    292    292       G -> R (in Ref. 9; AAH37900).
FT                                {ECO:0000305}.
FT   CONFLICT    411    411       I -> T (in Ref. 9; AAH47018).
FT                                {ECO:0000305}.
FT   STRAND       35     38       {ECO:0000244|PDB:2OME}.
FT   HELIX        47     51       {ECO:0000244|PDB:2OME}.
FT   TURN         52     54       {ECO:0000244|PDB:2OME}.
FT   STRAND       56     59       {ECO:0000244|PDB:2OME}.
FT   HELIX        65     67       {ECO:0000244|PDB:2OME}.
FT   HELIX        70     75       {ECO:0000244|PDB:2OME}.
FT   STRAND       76     81       {ECO:0000244|PDB:2OME}.
FT   STRAND       83     85       {ECO:0000244|PDB:2OME}.
FT   HELIX        89     93       {ECO:0000244|PDB:2OME}.
FT   STRAND      100    106       {ECO:0000244|PDB:2OME}.
FT   HELIX       113    118       {ECO:0000244|PDB:2OME}.
FT   STRAND      122    124       {ECO:0000244|PDB:2OME}.
FT   STRAND      128    130       {ECO:0000244|PDB:2OME}.
FT   HELIX       131    147       {ECO:0000244|PDB:2OME}.
FT   HELIX       149    157       {ECO:0000244|PDB:2OME}.
FT   HELIX       165    171       {ECO:0000244|PDB:2OME}.
FT   TURN        172    174       {ECO:0000244|PDB:2OME}.
FT   STRAND      182    186       {ECO:0000244|PDB:2OME}.
FT   HELIX       190    199       {ECO:0000244|PDB:2OME}.
FT   HELIX       200    202       {ECO:0000244|PDB:2OME}.
FT   STRAND      205    209       {ECO:0000244|PDB:2OME}.
FT   HELIX       217    220       {ECO:0000244|PDB:2OME}.
FT   HELIX       229    235       {ECO:0000244|PDB:2OME}.
FT   STRAND      237    241       {ECO:0000244|PDB:2OME}.
FT   HELIX       255    258       {ECO:0000244|PDB:2OME}.
FT   STRAND      265    269       {ECO:0000244|PDB:2OME}.
FT   HELIX       273    275       {ECO:0000244|PDB:2OME}.
FT   HELIX       278    286       {ECO:0000244|PDB:2OME}.
FT   STRAND      289    296       {ECO:0000244|PDB:2OME}.
FT   STRAND      299    302       {ECO:0000244|PDB:2OME}.
FT   TURN        309    312       {ECO:0000244|PDB:2OME}.
FT   STRAND      314    318       {ECO:0000244|PDB:2OME}.
FT   HELIX       327    346       {ECO:0000244|PDB:2OME}.
FT   TURN        349    352       {ECO:0000244|PDB:2OME}.
FT   STRAND      354    356       {ECO:0000244|PDB:2OME}.
SQ   SEQUENCE   445 AA;  48945 MW;  0A8C21CEB36807FA CRC64;
     MALVDKHKVK RQRLDRICEG IRPQIMNGPL HPRPLVALLD GRDCTVEMPI LKDLATVAFC
     DAQSTQEIHE KVLNEAVGAM MYHTITLTRE DLEKFKALRV IVRIGSGYDN VDIKAAGELG
     IAVCNIPSAA VEETADSTIC HILNLYRRNT WLYQALREGT RVQSVEQIRE VASGAARIRG
     ETLGLIGFGR TGQAVAVRAK AFGFSVIFYD PYLQDGIERS LGVQRVYTLQ DLLYQSDCVS
     LHCNLNEHNH HLINDFTIKQ MRQGAFLVNA ARGGLVDEKA LAQALKEGRI RGAALDVHES
     EPFSFAQGPL KDAPNLICTP HTAWYSEQAS LEMREAAATE IRRAITGRIP ESLRNCVNKE
     FFVTSAPWSV IDQQAIHPEL NGATYRYPPG IVGVAPGGLP AAMEGIIPGG IPVTHNLPTV
     AHPSQAPSPN QPTKHGDNRE HPNEQ
//
ID   Q5SQP8_HUMAN            Unreviewed;       513 AA.
AC   Q5SQP8;
DT   21-DEC-2004, integrated into UniProtKB/TrEMBL.
DT   21-DEC-2004, sequence version 1.
DT   28-MAR-2018, entry version 114.
DE   SubName: Full=C-terminal-binding protein 2 {ECO:0000313|Ensembl:ENSP00000357816};
GN   Name=CTBP2 {ECO:0000313|Ensembl:ENSP00000357816};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000357816, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164054; DOI=10.1038/nature02462;
RA   Deloukas P., Earthrowl M.E., Grafham D.V., Rubenfield M., French L.,
RA   Steward C.A., Sims S.K., Jones M.C., Searle S., Scott C., Howe K.,
RA   Hunt S.E., Andrews T.D., Gilbert J.G.R., Swarbreck D., Ashurst J.L.,
RA   Taylor A., Battles J., Bird C.P., Ainscough R., Almeida J.P.,
RA   Ashwell R.I.S., Ambrose K.D., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Bates K., Beasley H., Bray-Allen S., Brown A.J.,
RA   Brown J.Y., Burford D.C., Burrill W., Burton J., Cahill P., Camire D.,
RA   Carter N.P., Chapman J.C., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Corby N., Coulson A., Dhami P., Dutta I., Dunn M., Faulkner L.,
RA   Frankish A., Frankland J.A., Garner P., Garnett J., Gribble S.,
RA   Griffiths C., Grocock R., Gustafson E., Hammond S., Harley J.L.,
RA   Hart E., Heath P.D., Ho T.P., Hopkins B., Horne J., Howden P.J.,
RA   Huckle E., Hynds C., Johnson C., Johnson D., Kana A., Kay M.,
RA   Kimberley A.M., Kershaw J.K., Kokkinaki M., Laird G.K., Lawlor S.,
RA   Lee H.M., Leongamornlert D.A., Laird G., Lloyd C., Lloyd D.M.,
RA   Loveland J., Lovell J., McLaren S., McLay K.E., McMurray A.,
RA   Mashreghi-Mohammadi M., Matthews L., Milne S., Nickerson T.,
RA   Nguyen M., Overton-Larty E., Palmer S.A., Pearce A.V., Peck A.I.,
RA   Pelan S., Phillimore B., Porter K., Rice C.M., Rogosin A., Ross M.T.,
RA   Sarafidou T., Sehra H.K., Shownkeen R., Skuce C.D., Smith M.,
RA   Standring L., Sycamore N., Tester J., Thorpe A., Torcasso W.,
RA   Tracey A., Tromans A., Tsolas J., Wall M., Walsh J., Wang H.,
RA   Weinstock K., West A.P., Willey D.L., Whitehead S.L., Wilming L.,
RA   Wray P.W., Young L., Chen Y., Lovering R.C., Moschonas N.K.,
RA   Siebert R., Fechtel K., Bentley D., Durbin R., Hubbard T.,
RA   Doucette-Stamm L., Beck S., Smith D.R., Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 10.";
RL   Nature 429:375-381(2004).
RN   [2] {ECO:0000313|Ensembl:ENSP00000357816}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [3] {ECO:0000213|PubMed:18669648}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [4] {ECO:0000213|PubMed:21269460}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Burckstummer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [5] {ECO:0000313|Ensembl:ENSP00000357816}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (JUL-2011) to UniProtKB.
RN   [6] {ECO:0000213|PubMed:24275569}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
CC   -!- INTERACTION:
CC       Q13643:FHL3; NbExp=4; IntAct=EBI-11742664, EBI-741101;
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AL157888; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL596261; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL731571; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   RefSeq; XP_011537651.1; XM_011539349.2.
DR   UniGene; Hs.501345; -.
DR   ProteinModelPortal; Q5SQP8; -.
DR   SMR; Q5SQP8; -.
DR   IntAct; Q5SQP8; 2.
DR   EPD; Q5SQP8; -.
DR   MaxQB; Q5SQP8; -.
DR   PRIDE; Q5SQP8; -.
DR   Ensembl; ENST00000334808; ENSP00000357816; ENSG00000175029.
DR   GeneID; 1488; -.
DR   UCSC; uc001lid.5; human.
DR   CTD; 1488; -.
DR   EuPathDB; HostDB:ENSG00000175029.16; -.
DR   HGNC; HGNC:2495; CTBP2.
DR   OpenTargets; ENSG00000175029; -.
DR   eggNOG; KOG0067; Eukaryota.
DR   eggNOG; COG0111; LUCA.
DR   GeneTree; ENSGT00530000063021; -.
DR   HOGENOM; HOG000136701; -.
DR   HOVERGEN; HBG001898; -.
DR   OMA; INGGYYA; -.
DR   ChiTaRS; CTBP2; human.
DR   GenomeRNAi; 1488; -.
DR   Proteomes; UP000005640; Chromosome 10.
DR   Bgee; ENSG00000175029; -.
DR   ExpressionAtlas; Q5SQP8; baseline and differential.
DR   GO; GO:0051287; F:NAD binding; IEA:InterPro.
DR   GO; GO:0016616; F:oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor; IEA:InterPro.
DR   InterPro; IPR006139; D-isomer_2_OHA_DH_cat_dom.
DR   InterPro; IPR029753; D-isomer_DH_CS.
DR   InterPro; IPR006140; D-isomer_DH_NAD-bd.
DR   InterPro; IPR036291; NAD(P)-bd_dom_sf.
DR   Pfam; PF00389; 2-Hacid_dh; 1.
DR   Pfam; PF02826; 2-Hacid_dh_C; 1.
DR   SUPFAM; SSF51735; SSF51735; 1.
DR   PROSITE; PS00671; D_2_HYDROXYACID_DH_3; 1.
PE   1: Evidence at protein level;
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   Proteomics identification {ECO:0000213|EPD:Q5SQP8,
KW   ECO:0000213|MaxQB:Q5SQP8, ECO:0000213|PeptideAtlas:Q5SQP8};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640}.
FT   DOMAIN      112    426       2-Hacid_dh. {ECO:0000259|Pfam:PF00389}.
FT   DOMAIN      208    391       2-Hacid_dh_C. {ECO:0000259|Pfam:PF02826}.
SQ   SEQUENCE   513 AA;  56102 MW;  A7A54EB7F0F34922 CRC64;
     MRPGLPGPTG LCAQTSSRGQ KSVLKQKESC GIWQLYHFLS RKQEPRWEPC VSGSSSGDGA
     VADLADELRG YPALCCTLPV HSYRSWAGIR PQIMNGPLHP RPLVALLDGR DCTVEMPILK
     DLATVAFCDA QSTQEIHEKV LNEAVGAMMY HTITLTREDL EKFKALRVIV RIGSGYDNVD
     IKAAGELGIA VCNIPSAAVE ETADSTICHI LNLYRRNTWL YQALREGTRV QSVEQIREVA
     SGAARIRGET LGLIGFGRTG QAVAVRAKAF GFSVIFYDPY LQDGIERSLG VQRVYTLQDL
     LYQSDCVSLH CNLNEHNHHL INDFTIKQMR QGAFLVNAAR GGLVDEKALA QALKEGRIRG
     AALDVHESEP FSFAQGPLKD APNLICTPHT AWYSEQASLE MREAAATEIR RAITGRIPES
     LRNCVNKEFF VTSAPWSVID QQAIHPELNG ATYRYPPGIV GVAPGGLPAA MEGIIPGGIP
     VTHNLPTVAH PSQAPSPNQP TKHGDNREHP NEQ
//
ID   Q5JPB8_HUMAN            Unreviewed;       737 AA.
AC   Q5JPB8;
DT   15-FEB-2005, integrated into UniProtKB/TrEMBL.
DT   15-FEB-2005, sequence version 1.
DT   28-FEB-2018, entry version 78.
DE   RecName: Full=Dipeptidyl peptidase 3 {ECO:0000256|PIRNR:PIRNR007828};
DE            EC=3.4.14.4 {ECO:0000256|PIRNR:PIRNR007828};
DE   AltName: Full=Dipeptidyl aminopeptidase III {ECO:0000256|PIRNR:PIRNR007828};
DE   AltName: Full=Dipeptidyl peptidase III {ECO:0000256|PIRNR:PIRNR007828};
GN   Name=DKFZp686O1117 {ECO:0000313|EMBL:CAI46122.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:CAI46122.1};
RN   [1] {ECO:0000313|EMBL:CAI46122.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Cervix {ECO:0000313|EMBL:CAI46122.1};
RG   The German cDNA Consortium;
RA   Bahr A., Lauber J., Mewes H.W., Weil B., Amid C., Osanger A., Fobo G.,
RA   Han M., Wiemann S.;
RL   Submitted (JAN-2005) to the EMBL/GenBank/DDBJ databases.
CC   -!- CATALYTIC ACTIVITY: Release of an N-terminal dipeptide from a
CC       peptide comprising four or more residues, with broad specificity.
CC       Also acts on dipeptidyl 2-naphthylamides.
CC       {ECO:0000256|PIRNR:PIRNR007828}.
CC   -!- COFACTOR:
CC       Name=Zn(2+); Xref=ChEBI:CHEBI:29105;
CC         Evidence={ECO:0000256|PIRNR:PIRNR007828,
CC         ECO:0000256|PIRSR:PIRSR007828-2};
CC       Note=Binds 1 zinc ion per subunit. {ECO:0000256|PIRNR:PIRNR007828,
CC       ECO:0000256|PIRSR:PIRSR007828-2};
CC   -!- SIMILARITY: Belongs to the peptidase M49 family.
CC       {ECO:0000256|PIRNR:PIRNR007828}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AL833475; CAI46122.1; -; mRNA.
DR   RefSeq; NP_569710.2; NM_130443.3.
DR   UniGene; Hs.502914; -.
DR   UniGene; Hs.740670; -.
DR   PeptideAtlas; Q5JPB8; -.
DR   PRIDE; Q5JPB8; -.
DR   DNASU; 10072; -.
DR   GeneID; 10072; -.
DR   CTD; 10072; -.
DR   PharmGKB; PA27466; -.
DR   eggNOG; KOG3675; Eukaryota.
DR   eggNOG; ENOG410XRK4; LUCA.
DR   HOVERGEN; HBG025680; -.
DR   GenomeRNAi; 10072; -.
DR   Genevisible; Q5JPB8; HS.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-KW.
DR   GO; GO:0008239; F:dipeptidyl-peptidase activity; IEA:UniProtKB-UniRule.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0008237; F:metallopeptidase activity; IEA:UniProtKB-UniRule.
DR   InterPro; IPR005317; Dipeptidyl-peptase3.
DR   PIRSF; PIRSF007828; Dipeptidyl-peptidase_III; 1.
PE   2: Evidence at transcript level;
KW   Aminopeptidase {ECO:0000256|PIRNR:PIRNR007828};
KW   Cytoplasm {ECO:0000256|PIRNR:PIRNR007828};
KW   Hydrolase {ECO:0000256|PIRNR:PIRNR007828};
KW   Metal-binding {ECO:0000256|PIRNR:PIRNR007828,
KW   ECO:0000256|PIRSR:PIRSR007828-2};
KW   Metalloprotease {ECO:0000256|PIRNR:PIRNR007828};
KW   Protease {ECO:0000256|PIRNR:PIRNR007828};
KW   Zinc {ECO:0000256|PIRNR:PIRNR007828, ECO:0000256|PIRSR:PIRSR007828-2}.
FT   ACT_SITE    451    451       {ECO:0000256|PIRSR:PIRSR007828-1}.
FT   METAL       450    450       Zinc; catalytic.
FT                                {ECO:0000256|PIRSR:PIRSR007828-2}.
FT   METAL       455    455       Zinc; catalytic.
FT                                {ECO:0000256|PIRSR:PIRSR007828-2}.
FT   METAL       508    508       Zinc; catalytic.
FT                                {ECO:0000256|PIRSR:PIRSR007828-2}.
SQ   SEQUENCE   737 AA;  82617 MW;  E5CFEA0639CAFDEC CRC64;
     MADTQYILPN DIGVSSLDCR EAFRLLSPTE RLYAYHLSRA AWYGGLAVLL QTSPEAPYIY
     ALLSRLFRAQ DPDQLRQHAL AEGLTEEEYQ AFLVYAAGVY SNMGNYKSFG DTKFVPNLPK
     EKLERVILGS EAAQQHPEEV RGLWQTCGEL MFSLEPRLRH LGLGKEGITT YFSGNCTMED
     AKLAQDFLDS QNLSAYNTRL FKEVDGEGRP YYEVRLASVL GSEPSLDSEV TSKLKSYEFR
     GSPFQVTRGD YAPILQKVVE QLEKAKAYAA NSHQGQMLAQ YIESFTQGSI EAHKRGSRFW
     IQDKGPIVES YIGFIESYRD PFGSRGEFEG FVAVVNKAMS AKFERLVASA EQLLKELPWP
     PTFEKDKFLT PDFTSLDVLT FAGSGIPAGI NIPNYDDLRQ TEGFKNVSLG NVLAVAYATQ
     REKLTFLEED DKDLYILWKG PSFDVQVGLH ELLGHGSGKL FVQDEKGAFN FDQETVINPE
     TGEQIQSWYR SGETWDSKFS TIASSYEECR AESVGLYLCL HPQVLEIFGF EGADAEDVIY
     VNWLNMVRAG LLALEFYTPE AFNWRQAHMQ ARFVILRVLL EAGEGLVTIT PTTGSDGRPD
     ARVRLDRSKI RSVGKPALER FLRRLQVLKS TGDVAGGRAL YEGYATVTDA PPECFLTLRD
     TVLLRKESRK LIVQPNTRLE GSDVQLLEYE ASAAGLIRSF SERFPEDGPE LEEILTQLAT
     ADARFWKGPS EAPSGQA
//
ID   DPP3_HUMAN              Reviewed;         737 AA.
AC   Q9NY33; B2RDB5; B4DLX4; F5H8L6; O95748; Q969H2; Q9BV67; Q9HAL6;
DT   27-APR-2001, integrated into UniProtKB/Swiss-Prot.
DT   10-MAY-2002, sequence version 2.
DT   28-FEB-2018, entry version 169.
DE   RecName: Full=Dipeptidyl peptidase 3;
DE            EC=3.4.14.4 {ECO:0000269|PubMed:11209758, ECO:0000269|PubMed:1515063, ECO:0000269|PubMed:3233187, ECO:0000269|PubMed:9425109};
DE   AltName: Full=Dipeptidyl aminopeptidase III;
DE   AltName: Full=Dipeptidyl arylamidase III;
DE   AltName: Full=Dipeptidyl peptidase III;
DE            Short=DPP III;
DE   AltName: Full=Enkephalinase B;
GN   Name=DPP3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANTS HIS-145 AND
RP   HIS-678.
RA   Chen J.M., Fortunato M., Barrett A.J.;
RT   "Cloning and sequencing of human dipeptidyl-peptidase III.";
RL   Submitted (JAN-2000) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1; 2 AND 4).
RC   TISSUE=Brain, and Embryo;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16554811; DOI=10.1038/nature04632;
RA   Taylor T.D., Noguchi H., Totoki Y., Toyoda A., Kuroki Y., Dewar K.,
RA   Lloyd C., Itoh T., Takeda T., Kim D.-W., She X., Barlow K.F.,
RA   Bloom T., Bruford E., Chang J.L., Cuomo C.A., Eichler E.,
RA   FitzGerald M.G., Jaffe D.B., LaButti K., Nicol R., Park H.-S.,
RA   Seaman C., Sougnez C., Yang X., Zimmer A.R., Zody M.C., Birren B.W.,
RA   Nusbaum C., Fujiyama A., Hattori M., Rogers J., Lander E.S.,
RA   Sakaki Y.;
RT   "Human chromosome 11 DNA sequence and analysis including novel gene
RT   identification.";
RL   Nature 440:497-500(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT
RP   HIS-76.
RC   TISSUE=Colon, Kidney, and Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 244-723 (ISOFORM 1), FUNCTION, CATALYTIC
RP   ACTIVITY, BIOPHYSICOCHEMICAL PROPERTIES, ENZYME REGULATION, AND
RP   VARIANT HIS-678.
RX   PubMed=9425109; DOI=10.1042/bj3290275;
RA   Fukasawa K., Fukusawa K.M., Kanai M., Fujii S., Hirose J., Harada M.;
RT   "Dipeptidyl peptidase III is a zinc metallo-exopeptidase. Molecular
RT   cloning and expression.";
RL   Biochem. J. 329:275-282(1998).
RN   [6]
RP   FUNCTION, CATALYTIC ACTIVITY, ENZYME REGULATION, BIOPHYSICOCHEMICAL
RP   PROPERTIES, SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=3233187; DOI=10.1016/0885-4505(88)90133-8;
RA   Shimamori Y., Watanabe Y., Fujimoto Y.;
RT   "Human placental dipeptidyl aminopeptidase III: hydrolysis of
RT   enkephalins and its stimulation by cobaltous ion.";
RL   Biochem. Med. Metab. Biol. 40:305-310(1988).
RN   [7]
RP   FUNCTION, CATALYTIC ACTIVITY, ENZYME REGULATION, SUBCELLULAR LOCATION,
RP   AND TISSUE SPECIFICITY.
RX   PubMed=1515063;
RA   Abramic M., Vitale L.;
RT   "Basic amino acids preferring broad specificity aminopeptidase from
RT   human erythrocytes.";
RL   Biol. Chem. Hoppe-Seyler 373:375-380(1992).
RN   [8]
RP   FUNCTION, CATALYTIC ACTIVITY, MASS SPECTROMETRY, PARTIAL PROTEIN
RP   SEQUENCE, BIOPHYSICOCHEMICAL PROPERTIES, AND ENZYME REGULATION.
RC   TISSUE=Erythrocyte;
RX   PubMed=11209758; DOI=10.1515/BC.2000.151;
RA   Abramic M., Schleuder D., Dolovcak L., Schroeder W., Strupat K.,
RA   Sagi D., Peter-Katalini J., Vitale L.;
RT   "Human and rat dipeptidyl peptidase III: biochemical and mass
RT   spectrometric arguments for similarities and differences.";
RL   Biol. Chem. 381:1233-1243(2000).
RN   [9]
RP   SPLICE ISOFORM(S) THAT ARE POTENTIAL NMD TARGET(S).
RX   PubMed=14759258; DOI=10.1186/gb-2004-5-2-r8;
RA   Hillman R.T., Green R.E., Brenner S.E.;
RT   "An unappreciated role for RNA surveillance.";
RL   Genome Biol. 5:R8.1-R8.16(2004).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [11]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22223895; DOI=10.1074/mcp.M111.015131;
RA   Bienvenut W.V., Sumpton D., Martinez A., Lilla S., Espagne C.,
RA   Meinnel T., Giglione C.;
RT   "Comparative large-scale characterisation of plant vs. mammal proteins
RT   reveals similar and idiosyncratic N-alpha acetylation features.";
RL   Mol. Cell. Proteomics 11:M111.015131-M111.015131(2012).
RN   [12]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [14]
RP   X-RAY CRYSTALLOGRAPHY (1.90 ANGSTROMS) OF 1-726 IN COMPLEX WITH ZINC
RP   AND OPIOID PEPTIDE, COFACTOR, AND ZINC-BINDING SITES.
RX   PubMed=22493238; DOI=10.1073/pnas.1118005109;
RA   Bezerra G.A., Dobrovetsky E., Viertlmayr R., Dong A., Binter A.,
RA   Abramic M., Macheroux P., Dhe-Paganon S., Gruber K.;
RT   "Entropy-driven binding of opioid peptides induces a large domain
RT   motion in human dipeptidyl peptidase III.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:6525-6530(2012).
CC   -!- FUNCTION: Cleaves and degrades bioactive peptides, including
CC       angiotensin, Leu-enkephalin and Met-enkephalin (PubMed:3233187,
CC       PubMed:1515063). Also cleaves Arg-Arg-beta-naphthylamide (in
CC       vitro) (PubMed:9425109, PubMed:3233187, PubMed:11209758).
CC       {ECO:0000269|PubMed:11209758, ECO:0000269|PubMed:1515063,
CC       ECO:0000269|PubMed:3233187, ECO:0000269|PubMed:9425109}.
CC   -!- CATALYTIC ACTIVITY: Release of an N-terminal dipeptide from a
CC       peptide comprising four or more residues, with broad specificity.
CC       Also acts on dipeptidyl 2-naphthylamides.
CC       {ECO:0000269|PubMed:11209758, ECO:0000269|PubMed:1515063,
CC       ECO:0000269|PubMed:3233187, ECO:0000269|PubMed:9425109}.
CC   -!- COFACTOR:
CC       Name=Zn(2+); Xref=ChEBI:CHEBI:29105;
CC         Evidence={ECO:0000269|PubMed:11209758,
CC         ECO:0000269|PubMed:22493238, ECO:0000269|PubMed:9425109};
CC       Note=Binds 1 zinc ion per subunit. {ECO:0000269|PubMed:22493238};
CC   -!- ENZYME REGULATION: Activated by Co(2+). Inhibited by EDTA and o-
CC       phenanthroline (in vitro). {ECO:0000269|PubMed:11209758,
CC       ECO:0000269|PubMed:1515063, ECO:0000269|PubMed:3233187,
CC       ECO:0000269|PubMed:9425109}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       pH dependence:
CC         Optimum pH is 8.8. {ECO:0000269|PubMed:11209758,
CC         ECO:0000269|PubMed:3233187, ECO:0000269|PubMed:9425109};
CC   -!- INTERACTION:
CC       Q14145:KEAP1; NbExp=7; IntAct=EBI-718333, EBI-751001;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytosol
CC       {ECO:0000269|PubMed:1515063, ECO:0000269|PubMed:3233187}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1;
CC         IsoId=Q9NY33-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9NY33-2; Sequence=VSP_005510;
CC         Note=May be produced at very low levels due to a premature stop
CC         codon in the mRNA, leading to nonsense-mediated mRNA decay. No
CC         experimental confirmation available.;
CC       Name=3; Synonyms=DPP3-BBS1;
CC         IsoId=Q8NFJ9-2; Sequence=External;
CC         Note=Based on a readthrough transcript which may produce a
CC         DPP3-BBS1 fusion protein. No experimental confirmation
CC         available.;
CC       Name=4;
CC         IsoId=Q9NY33-4; Sequence=VSP_044696;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Detected in placenta (at protein level)
CC       (PubMed:3233187). Detected in erythrocytes (at protein level)
CC       (PubMed:1515063). {ECO:0000269|PubMed:1515063,
CC       ECO:0000269|PubMed:3233187}.
CC   -!- MASS SPECTROMETRY: Mass=82500; Mass_error=60; Method=MALDI;
CC       Range=1-737 (Q9NY33-1); Evidence={ECO:0000269|PubMed:11209758};
CC   -!- SIMILARITY: Belongs to the peptidase M49 family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AJ271216; CAB72433.1; -; mRNA.
DR   EMBL; AK021449; BAB13828.1; -; mRNA.
DR   EMBL; AK297199; BAG59686.1; -; mRNA.
DR   EMBL; AK315478; BAG37862.1; -; mRNA.
DR   EMBL; AP002748; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC001446; AAH01446.1; -; mRNA.
DR   EMBL; BC007221; AAH07221.1; -; mRNA.
DR   EMBL; BC014038; AAH14038.1; -; mRNA.
DR   EMBL; BC024271; AAH24271.1; -; mRNA.
DR   EMBL; AB017970; BAA75785.1; -; mRNA.
DR   CCDS; CCDS58147.1; -. [Q9NY33-4]
DR   CCDS; CCDS8141.1; -. [Q9NY33-1]
DR   RefSeq; NP_001243599.1; NM_001256670.1. [Q9NY33-4]
DR   RefSeq; NP_005691.2; NM_005700.4. [Q9NY33-1]
DR   RefSeq; NP_569710.2; NM_130443.3. [Q9NY33-1]
DR   UniGene; Hs.502914; -.
DR   UniGene; Hs.740670; -.
DR   PDB; 3FVY; X-ray; 1.90 A; A=1-726.
DR   PDB; 3T6B; X-ray; 2.40 A; A/B=1-726.
DR   PDB; 3T6J; X-ray; 2.98 A; A=1-726.
DR   PDB; 5E2Q; X-ray; 2.40 A; A=1-726.
DR   PDB; 5E33; X-ray; 1.84 A; A=1-726.
DR   PDB; 5E3A; X-ray; 2.05 A; A=1-726.
DR   PDB; 5E3C; X-ray; 2.77 A; A=1-726.
DR   PDB; 5EGY; X-ray; 2.74 A; A=1-726.
DR   PDB; 5EHH; X-ray; 2.38 A; A=1-726.
DR   PDBsum; 3FVY; -.
DR   PDBsum; 3T6B; -.
DR   PDBsum; 3T6J; -.
DR   PDBsum; 5E2Q; -.
DR   PDBsum; 5E33; -.
DR   PDBsum; 5E3A; -.
DR   PDBsum; 5E3C; -.
DR   PDBsum; 5EGY; -.
DR   PDBsum; 5EHH; -.
DR   ProteinModelPortal; Q9NY33; -.
DR   SMR; Q9NY33; -.
DR   BioGrid; 115383; 24.
DR   DIP; DIP-53793N; -.
DR   IntAct; Q9NY33; 8.
DR   MINT; Q9NY33; -.
DR   STRING; 9606.ENSP00000353701; -.
DR   BindingDB; Q9NY33; -.
DR   ChEMBL; CHEMBL4520; -.
DR   MEROPS; M49.001; -.
DR   iPTMnet; Q9NY33; -.
DR   PhosphoSitePlus; Q9NY33; -.
DR   SwissPalm; Q9NY33; -.
DR   BioMuta; DPP3; -.
DR   DMDM; 20532389; -.
DR   EPD; Q9NY33; -.
DR   MaxQB; Q9NY33; -.
DR   PaxDb; Q9NY33; -.
DR   PeptideAtlas; Q9NY33; -.
DR   PRIDE; Q9NY33; -.
DR   DNASU; 10072; -.
DR   Ensembl; ENST00000530165; ENSP00000436941; ENSG00000254986. [Q9NY33-4]
DR   Ensembl; ENST00000541961; ENSP00000440502; ENSG00000254986. [Q9NY33-1]
DR   GeneID; 10072; -.
DR   KEGG; hsa:10072; -.
DR   UCSC; uc010rpe.3; human. [Q9NY33-1]
DR   CTD; 10072; -.
DR   DisGeNET; 10072; -.
DR   EuPathDB; HostDB:ENSG00000254986.7; -.
DR   GeneCards; DPP3; -.
DR   HGNC; HGNC:3008; DPP3.
DR   HPA; HPA035780; -.
DR   HPA; HPA035781; -.
DR   MIM; 606818; gene.
DR   neXtProt; NX_Q9NY33; -.
DR   OpenTargets; ENSG00000254986; -.
DR   PharmGKB; PA27466; -.
DR   eggNOG; KOG3675; Eukaryota.
DR   eggNOG; ENOG410XRK4; LUCA.
DR   GeneTree; ENSGT00390000007335; -.
DR   HOGENOM; HOG000187784; -.
DR   HOVERGEN; HBG025680; -.
DR   InParanoid; Q9NY33; -.
DR   KO; K01277; -.
DR   PhylomeDB; Q9NY33; -.
DR   TreeFam; TF300598; -.
DR   BRENDA; 3.4.14.4; 2681.
DR   ChiTaRS; DPP3; human.
DR   EvolutionaryTrace; Q9NY33; -.
DR   GeneWiki; DPP3; -.
DR   GenomeRNAi; 10072; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   Bgee; ENSG00000254986; -.
DR   CleanEx; HS_DPP3; -.
DR   ExpressionAtlas; Q9NY33; baseline and differential.
DR   Genevisible; Q9NY33; HS.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0016607; C:nuclear speck; IDA:HPA.
DR   GO; GO:0005886; C:plasma membrane; IDA:HPA.
DR   GO; GO:0008239; F:dipeptidyl-peptidase activity; IDA:UniProtKB.
DR   GO; GO:0008237; F:metallopeptidase activity; IEA:UniProtKB-KW.
DR   GO; GO:0008270; F:zinc ion binding; IDA:UniProtKB.
DR   GO; GO:0006508; P:proteolysis; IDA:UniProtKB.
DR   InterPro; IPR005317; Dipeptidyl-peptase3.
DR   PIRSF; PIRSF007828; Dipeptidyl-peptidase_III; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Aminopeptidase;
KW   Complete proteome; Cytoplasm; Direct protein sequencing; Hydrolase;
KW   Metal-binding; Metalloprotease; Polymorphism; Protease;
KW   Reference proteome; Zinc.
FT   INIT_MET      1      1       Removed. {ECO:0000244|PubMed:22223895,
FT                                ECO:0000244|PubMed:22814378}.
FT   CHAIN         2    737       Dipeptidyl peptidase 3.
FT                                /FTId=PRO_0000078238.
FT   ACT_SITE    451    451       {ECO:0000250|UniProtKB:O55096}.
FT   METAL       450    450       Zinc; catalytic. {ECO:0000244|PDB:3FVY,
FT                                ECO:0000269|PubMed:22493238}.
FT   METAL       455    455       Zinc; catalytic. {ECO:0000244|PDB:3FVY,
FT                                ECO:0000269|PubMed:22493238}.
FT   METAL       508    508       Zinc; catalytic. {ECO:0000244|PDB:3FVY,
FT                                ECO:0000269|PubMed:22493238}.
FT   MOD_RES       2      2       N-acetylalanine.
FT                                {ECO:0000244|PubMed:22223895,
FT                                ECO:0000244|PubMed:22814378}.
FT   VAR_SEQ      91    120       Missing (in isoform 4).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_044696.
FT   VAR_SEQ     182    601       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_005510.
FT   VARIANT      76     76       R -> H (in dbSNP:rs11826683).
FT                                {ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_033494.
FT   VARIANT     145    145       Q -> H (in dbSNP:rs11550299).
FT                                {ECO:0000269|Ref.1}.
FT                                /FTId=VAR_033495.
FT   VARIANT     678    678       R -> H (in dbSNP:rs2305535).
FT                                {ECO:0000269|PubMed:9425109,
FT                                ECO:0000269|Ref.1}.
FT                                /FTId=VAR_021850.
FT   VARIANT     690    690       E -> K (in dbSNP:rs12421620).
FT                                /FTId=VAR_051597.
FT   CONFLICT    224    224       P -> S (in Ref. 2; BAG59686).
FT                                {ECO:0000305}.
FT   CONFLICT    417    419       YAT -> TA (in Ref. 5; BAA75785).
FT                                {ECO:0000305}.
FT   CONFLICT    697    697       I -> Y (in Ref. 5; BAA75785).
FT                                {ECO:0000305}.
FT   HELIX         4      6       {ECO:0000244|PDB:3T6J}.
FT   STRAND       14     16       {ECO:0000244|PDB:5E33}.
FT   HELIX        20     25       {ECO:0000244|PDB:5E33}.
FT   HELIX        28     50       {ECO:0000244|PDB:5E33}.
FT   HELIX        56     69       {ECO:0000244|PDB:5E33}.
FT   HELIX        72     81       {ECO:0000244|PDB:5E33}.
FT   HELIX        86    102       {ECO:0000244|PDB:5E33}.
FT   STRAND      104    106       {ECO:0000244|PDB:5E33}.
FT   TURN        108    110       {ECO:0000244|PDB:5E33}.
FT   HELIX       120    128       {ECO:0000244|PDB:5E33}.
FT   HELIX       131    135       {ECO:0000244|PDB:5E33}.
FT   HELIX       137    152       {ECO:0000244|PDB:5E33}.
FT   HELIX       156    158       {ECO:0000244|PDB:5E33}.
FT   STRAND      159    161       {ECO:0000244|PDB:5E33}.
FT   HELIX       164    166       {ECO:0000244|PDB:3FVY}.
FT   STRAND      170    172       {ECO:0000244|PDB:5E33}.
FT   HELIX       178    190       {ECO:0000244|PDB:5E33}.
FT   STRAND      198    204       {ECO:0000244|PDB:5E33}.
FT   STRAND      206    208       {ECO:0000244|PDB:3T6J}.
FT   STRAND      210    217       {ECO:0000244|PDB:5E33}.
FT   STRAND      222    224       {ECO:0000244|PDB:3T6B}.
FT   HELIX       231    233       {ECO:0000244|PDB:5E33}.
FT   STRAND      235    239       {ECO:0000244|PDB:5E33}.
FT   STRAND      242    250       {ECO:0000244|PDB:5E33}.
FT   HELIX       252    266       {ECO:0000244|PDB:5E33}.
FT   HELIX       272    287       {ECO:0000244|PDB:5E33}.
FT   HELIX       290    302       {ECO:0000244|PDB:5E33}.
FT   STRAND      307    316       {ECO:0000244|PDB:5E33}.
FT   STRAND      318    323       {ECO:0000244|PDB:5E33}.
FT   STRAND      327    335       {ECO:0000244|PDB:5E33}.
FT   HELIX       337    346       {ECO:0000244|PDB:5E33}.
FT   HELIX       350    353       {ECO:0000244|PDB:5E33}.
FT   HELIX       354    356       {ECO:0000244|PDB:5E33}.
FT   STRAND      357    359       {ECO:0000244|PDB:5E33}.
FT   HELIX       361    363       {ECO:0000244|PDB:5E33}.
FT   STRAND      372    384       {ECO:0000244|PDB:5E33}.
FT   STRAND      388    392       {ECO:0000244|PDB:5E33}.
FT   HELIX       396    401       {ECO:0000244|PDB:5E33}.
FT   STRAND      405    409       {ECO:0000244|PDB:5E33}.
FT   HELIX       410    416       {ECO:0000244|PDB:5E33}.
FT   HELIX       421    423       {ECO:0000244|PDB:3FVY}.
FT   HELIX       429    452       {ECO:0000244|PDB:5E33}.
FT   TURN        453    456       {ECO:0000244|PDB:5E33}.
FT   STRAND      465    467       {ECO:0000244|PDB:5E33}.
FT   STRAND      469    471       {ECO:0000244|PDB:5E33}.
FT   TURN        473    475       {ECO:0000244|PDB:5E33}.
FT   TURN        479    481       {ECO:0000244|PDB:5E33}.
FT   STRAND      482    484       {ECO:0000244|PDB:5E33}.
FT   HELIX       495    499       {ECO:0000244|PDB:5E33}.
FT   HELIX       500    502       {ECO:0000244|PDB:5E33}.
FT   HELIX       503    518       {ECO:0000244|PDB:5E33}.
FT   HELIX       524    527       {ECO:0000244|PDB:5E33}.
FT   HELIX       533    552       {ECO:0000244|PDB:5E33}.
FT   HELIX       553    556       {ECO:0000244|PDB:5E33}.
FT   TURN        559    562       {ECO:0000244|PDB:5E33}.
FT   STRAND      563    565       {ECO:0000244|PDB:3FVY}.
FT   HELIX       567    581       {ECO:0000244|PDB:5E33}.
FT   STRAND      586    593       {ECO:0000244|PDB:5E33}.
FT   STRAND      597    605       {ECO:0000244|PDB:5E33}.
FT   HELIX       607    609       {ECO:0000244|PDB:5E33}.
FT   TURN        610    613       {ECO:0000244|PDB:5E33}.
FT   HELIX       614    630       {ECO:0000244|PDB:5E33}.
FT   HELIX       634    644       {ECO:0000244|PDB:5E33}.
FT   TURN        651    653       {ECO:0000244|PDB:5E33}.
FT   HELIX       655    664       {ECO:0000244|PDB:5E33}.
FT   STRAND      671    673       {ECO:0000244|PDB:5E33}.
FT   STRAND      676    680       {ECO:0000244|PDB:5E33}.
FT   STRAND      683    687       {ECO:0000244|PDB:5E33}.
FT   HELIX       693    701       {ECO:0000244|PDB:5E33}.
FT   TURN        705    707       {ECO:0000244|PDB:5E33}.
FT   HELIX       708    721       {ECO:0000244|PDB:5E33}.
FT   HELIX       722    725       {ECO:0000244|PDB:5E33}.
SQ   SEQUENCE   737 AA;  82589 MW;  E2BB1923C9CAFDEC CRC64;
     MADTQYILPN DIGVSSLDCR EAFRLLSPTE RLYAYHLSRA AWYGGLAVLL QTSPEAPYIY
     ALLSRLFRAQ DPDQLRQHAL AEGLTEEEYQ AFLVYAAGVY SNMGNYKSFG DTKFVPNLPK
     EKLERVILGS EAAQQHPEEV RGLWQTCGEL MFSLEPRLRH LGLGKEGITT YFSGNCTMED
     AKLAQDFLDS QNLSAYNTRL FKEVDGEGKP YYEVRLASVL GSEPSLDSEV TSKLKSYEFR
     GSPFQVTRGD YAPILQKVVE QLEKAKAYAA NSHQGQMLAQ YIESFTQGSI EAHKRGSRFW
     IQDKGPIVES YIGFIESYRD PFGSRGEFEG FVAVVNKAMS AKFERLVASA EQLLKELPWP
     PTFEKDKFLT PDFTSLDVLT FAGSGIPAGI NIPNYDDLRQ TEGFKNVSLG NVLAVAYATQ
     REKLTFLEED DKDLYILWKG PSFDVQVGLH ELLGHGSGKL FVQDEKGAFN FDQETVINPE
     TGEQIQSWYR SGETWDSKFS TIASSYEECR AESVGLYLCL HPQVLEIFGF EGADAEDVIY
     VNWLNMVRAG LLALEFYTPE AFNWRQAHMQ ARFVILRVLL EAGEGLVTIT PTTGSDGRPD
     ARVRLDRSKI RSVGKPALER FLRRLQVLKS TGDVAGGRAL YEGYATVTDA PPECFLTLRD
     TVLLRKESRK LIVQPNTRLE GSDVQLLEYE ASAAGLIRSF SERFPEDGPE LEEILTQLAT
     ADARFWKGPS EAPSGQA
//
ID   GGH_HUMAN               Reviewed;         318 AA.
AC   Q92820;
DT   15-JUL-1999, integrated into UniProtKB/Swiss-Prot.
DT   01-AUG-1998, sequence version 2.
DT   28-FEB-2018, entry version 160.
DE   RecName: Full=Gamma-glutamyl hydrolase;
DE            EC=3.4.19.9;
DE   AltName: Full=Conjugase;
DE   AltName: Full=GH;
DE   AltName: Full=Gamma-Glu-X carboxypeptidase;
DE   Flags: Precursor;
GN   Name=GGH;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=8816764; DOI=10.1073/pnas.93.19.10134;
RA   Yao R., Schneider E., Ryan T.J., Galivan J.;
RT   "Human gamma-glutamyl hydrolase: cloning and characterization of the
RT   enzyme expressed in vitro.";
RL   Proc. Natl. Acad. Sci. U.S.A. 93:10134-10138(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=10570974; DOI=10.1016/S0378-1119(99)00362-5;
RA   Yin D., Chave K.J., Macaluso C.R., Galivan J., Yao R.;
RT   "Structural organization of the human gamma-glutamyl hydrolase gene.";
RL   Gene 238:463-470(1999).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   MUTAGENESIS OF CYS-134.
RX   PubMed=10527932; DOI=10.1042/bj3430551;
RA   Chave K.J., Galivan J., Ryan T.J.;
RT   "Site-directed mutagenesis establishes cysteine-110 as essential for
RT   enzyme activity in human gamma-glutamyl hydrolase.";
RL   Biochem. J. 343:551-555(1999).
RN   [5]
RP   MUTAGENESIS OF CYS-134; HIS-244 AND GLU-246, AND 3D-STRUCTURE
RP   MODELING.
RX   PubMed=11005824; DOI=10.1074/jbc.M007908200;
RA   Chave K.J., Auger I.E., Galivan J., Ryan T.J.;
RT   "Molecular modeling and site-directed mutagenesis define the catalytic
RT   motif in human gamma -glutamyl hydrolase.";
RL   J. Biol. Chem. 275:40365-40370(2000).
RN   [6]
RP   SUBCELLULAR LOCATION [LARGE SCALE ANALYSIS].
RC   TISSUE=Melanoma;
RX   PubMed=12643545; DOI=10.1021/pr025562r;
RA   Basrur V., Yang F., Kushimoto T., Higashimoto Y., Yasumoto K.,
RA   Valencia J., Muller J., Vieira W.D., Watabe H., Shabanowitz J.,
RA   Hearing V.J., Hunt D.F., Appella E.;
RT   "Proteomic analysis of early melanosomes: identification of novel
RT   melanosomal proteins.";
RL   J. Proteome Res. 2:69-79(2003).
RN   [7]
RP   SUBUNIT.
RX   PubMed=16945597; DOI=10.1016/j.bbapap.2006.06.008;
RA   Eisele L.E., Chave K.J., Lehning A.C., Ryan T.J.;
RT   "Characterization of human gamma-glutamyl hydrolase in solution
RT   demonstrates that the enzyme is a non-dissociating homodimer.";
RL   Biochim. Biophys. Acta 1764:1479-1486(2006).
RN   [8]
RP   SUBCELLULAR LOCATION [LARGE SCALE ANALYSIS].
RC   TISSUE=Melanoma;
RX   PubMed=17081065; DOI=10.1021/pr060363j;
RA   Chi A., Valencia J.C., Hu Z.-Z., Watabe H., Yamaguchi H.,
RA   Mangini N.J., Huang H., Canfield V.A., Cheng K.C., Yang F., Abe R.,
RA   Yamagishi S., Shabanowitz J., Hearing V.J., Wu C., Appella E.,
RA   Hunt D.F.;
RT   "Proteomic and bioinformatic characterization of the biogenesis and
RT   function of melanosomes.";
RL   J. Proteome Res. 5:3135-3144(2006).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [11]
RP   X-RAY CRYSTALLOGRAPHY (1.60 ANGSTROMS) OF 25-318, IDENTIFICATION BY
RP   MASS SPECTROMETRY, GLYCOSYLATION AT ASN-163; ASN-203 AND ASN-307, AND
RP   SUBUNIT.
RX   PubMed=11953431; DOI=10.1074/jbc.M202020200;
RA   Li H., Ryan T.J., Chave K.J., Van Roey P.;
RT   "Three-dimensional structure of human gamma -glutamyl hydrolase. A
RT   class I glutamine amidotransferase adapted for a complex substate.";
RL   J. Biol. Chem. 277:24522-24529(2002).
CC   -!- FUNCTION: Hydrolyzes the polyglutamate sidechains of
CC       pteroylpolyglutamates. Progressively removes gamma-glutamyl
CC       residues from pteroylpoly-gamma-glutamate to yield pteroyl-alpha-
CC       glutamate (folic acid) and free glutamate. May play an important
CC       role in the bioavailability of dietary pteroylpolyglutamates and
CC       in the metabolism of pteroylpolyglutamates and antifolates.
CC   -!- CATALYTIC ACTIVITY: Hydrolysis of a gamma-glutamyl bond.
CC   -!- SUBUNIT: Homodimer. {ECO:0000269|PubMed:11953431,
CC       ECO:0000269|PubMed:16945597}.
CC   -!- SUBCELLULAR LOCATION: Secreted, extracellular space {ECO:0000305}.
CC       Lysosome {ECO:0000269|PubMed:12643545}. Melanosome
CC       {ECO:0000269|PubMed:12643545}. Note=While its intracellular
CC       location is primarily the lysosome, most of the enzyme activity is
CC       secreted. Identified by mass spectrometry in melanosome fractions
CC       from stage I to stage IV. {ECO:0000269|PubMed:12643545}.
CC   -!- SIMILARITY: Belongs to the peptidase C26 family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/GGHID44358ch8q12.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U55206; AAC05579.1; -; mRNA.
DR   EMBL; AF147083; AAF03360.1; -; Genomic_DNA.
DR   EMBL; AF147081; AAF03360.1; JOINED; Genomic_DNA.
DR   EMBL; AF147082; AAF03360.1; JOINED; Genomic_DNA.
DR   EMBL; BC025025; AAH25025.1; -; mRNA.
DR   CCDS; CCDS6177.1; -.
DR   PIR; JC6115; JC6115.
DR   RefSeq; NP_003869.1; NM_003878.2.
DR   UniGene; Hs.78619; -.
DR   PDB; 1L9X; X-ray; 1.60 A; A/B/C/D=25-318.
DR   PDBsum; 1L9X; -.
DR   ProteinModelPortal; Q92820; -.
DR   SMR; Q92820; -.
DR   BioGrid; 114363; 25.
DR   IntAct; Q92820; 5.
DR   STRING; 9606.ENSP00000260118; -.
DR   BindingDB; Q92820; -.
DR   ChEMBL; CHEMBL2223; -.
DR   DrugBank; DB00158; Folic Acid.
DR   DrugBank; DB00563; Methotrexate.
DR   MEROPS; C26.001; -.
DR   iPTMnet; Q92820; -.
DR   PhosphoSitePlus; Q92820; -.
DR   BioMuta; GGH; -.
DR   DMDM; 6016127; -.
DR   EPD; Q92820; -.
DR   MaxQB; Q92820; -.
DR   PaxDb; Q92820; -.
DR   PeptideAtlas; Q92820; -.
DR   PRIDE; Q92820; -.
DR   DNASU; 8836; -.
DR   Ensembl; ENST00000260118; ENSP00000260118; ENSG00000137563.
DR   GeneID; 8836; -.
DR   KEGG; hsa:8836; -.
DR   UCSC; uc003xuw.4; human.
DR   CTD; 8836; -.
DR   DisGeNET; 8836; -.
DR   EuPathDB; HostDB:ENSG00000137563.11; -.
DR   GeneCards; GGH; -.
DR   HGNC; HGNC:4248; GGH.
DR   HPA; CAB019296; -.
DR   HPA; HPA025226; -.
DR   MalaCards; GGH; -.
DR   MIM; 601509; gene.
DR   neXtProt; NX_Q92820; -.
DR   OpenTargets; ENSG00000137563; -.
DR   Orphanet; 306574; Methotrexate dose selection.
DR   PharmGKB; PA432; -.
DR   eggNOG; KOG1559; Eukaryota.
DR   eggNOG; ENOG410XQKI; LUCA.
DR   GeneTree; ENSGT00490000043388; -.
DR   HOGENOM; HOG000006721; -.
DR   HOVERGEN; HBG005833; -.
DR   InParanoid; Q92820; -.
DR   KO; K01307; -.
DR   OMA; GILMQKC; -.
DR   OrthoDB; EOG091G0E82; -.
DR   PhylomeDB; Q92820; -.
DR   TreeFam; TF323437; -.
DR   BRENDA; 3.4.19.9; 2681.
DR   Reactome; R-HSA-6798695; Neutrophil degranulation.
DR   ChiTaRS; GGH; human.
DR   EvolutionaryTrace; Q92820; -.
DR   GeneWiki; GGH_(gene); -.
DR   GenomeRNAi; 8836; -.
DR   PRO; PR:Q92820; -.
DR   Proteomes; UP000005640; Chromosome 8.
DR   Bgee; ENSG00000137563; -.
DR   CleanEx; HS_GGH; -.
DR   Genevisible; Q92820; HS.
DR   GO; GO:0035578; C:azurophil granule lumen; TAS:Reactome.
DR   GO; GO:0005829; C:cytosol; IEA:Ensembl.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0005576; C:extracellular region; TAS:Reactome.
DR   GO; GO:0005615; C:extracellular space; IDA:UniProtKB.
DR   GO; GO:0042470; C:melanosome; IEA:UniProtKB-SubCell.
DR   GO; GO:0005634; C:nucleus; HDA:UniProtKB.
DR   GO; GO:0035580; C:specific granule lumen; TAS:Reactome.
DR   GO; GO:1904724; C:tertiary granule lumen; TAS:Reactome.
DR   GO; GO:0005773; C:vacuole; IBA:GO_Central.
DR   GO; GO:0008238; F:exopeptidase activity; TAS:ProtInc.
DR   GO; GO:0034722; F:gamma-glutamyl-peptidase activity; IDA:UniProtKB.
DR   GO; GO:0008242; F:omega peptidase activity; TAS:ProtInc.
DR   GO; GO:0043312; P:neutrophil degranulation; TAS:Reactome.
DR   GO; GO:0045471; P:response to ethanol; IEA:Ensembl.
DR   GO; GO:0032868; P:response to insulin; IEA:Ensembl.
DR   GO; GO:0010043; P:response to zinc ion; IEA:Ensembl.
DR   GO; GO:0046900; P:tetrahydrofolylpolyglutamate metabolic process; IBA:GO_Central.
DR   Gene3D; 3.40.50.880; -; 1.
DR   InterPro; IPR029062; Class_I_gatase-like.
DR   InterPro; IPR015527; Pept_C26_g-glut_hydrolase.
DR   InterPro; IPR011697; Peptidase_C26.
DR   PANTHER; PTHR11315; PTHR11315; 1.
DR   Pfam; PF07722; Peptidase_C26; 1.
DR   SUPFAM; SSF52317; SSF52317; 1.
DR   PROSITE; PS51275; PEPTIDASE_C26_GGH; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Complete proteome; Glycoprotein; Hydrolase; Lysosome;
KW   Polymorphism; Reference proteome; Secreted; Signal.
FT   SIGNAL        1     24       {ECO:0000250}.
FT   CHAIN        25    318       Gamma-glutamyl hydrolase.
FT                                /FTId=PRO_0000026539.
FT   DOMAIN       25    318       Gamma-glutamyl hydrolase.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00607}.
FT   ACT_SITE    134    134       Nucleophile.
FT   ACT_SITE    244    244       Proton donor.
FT   CARBOHYD    116    116       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    163    163       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:11953431}.
FT   CARBOHYD    203    203       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:11953431}.
FT   CARBOHYD    307    307       N-linked (GlcNAc...) asparagine; partial.
FT                                {ECO:0000269|PubMed:11953431}.
FT   VARIANT       6      6       C -> R (in dbSNP:rs1800909).
FT                                /FTId=VAR_014697.
FT   VARIANT      31     31       A -> T (in dbSNP:rs11545077).
FT                                /FTId=VAR_029230.
FT   VARIANT     151    151       T -> I (in dbSNP:rs11545078).
FT                                /FTId=VAR_029231.
FT   MUTAGEN     134    134       C->A: Loss of activity.
FT                                {ECO:0000269|PubMed:10527932,
FT                                ECO:0000269|PubMed:11005824}.
FT   MUTAGEN     195    195       H->N: Reduces activity 250-fold.
FT   MUTAGEN     244    244       H->A: Loss of activity.
FT                                {ECO:0000269|PubMed:11005824}.
FT   MUTAGEN     246    246       E->A: Slightly reduced catalytic
FT                                activity. {ECO:0000269|PubMed:11005824}.
FT   STRAND       35     39       {ECO:0000244|PDB:1L9X}.
FT   HELIX        46     49       {ECO:0000244|PDB:1L9X}.
FT   STRAND       53     57       {ECO:0000244|PDB:1L9X}.
FT   HELIX        58     66       {ECO:0000244|PDB:1L9X}.
FT   STRAND       70     74       {ECO:0000244|PDB:1L9X}.
FT   HELIX        80     89       {ECO:0000244|PDB:1L9X}.
FT   STRAND       90     95       {ECO:0000244|PDB:1L9X}.
FT   TURN        102    104       {ECO:0000244|PDB:1L9X}.
FT   HELIX       106    123       {ECO:0000244|PDB:1L9X}.
FT   STRAND      130    133       {ECO:0000244|PDB:1L9X}.
FT   HELIX       135    145       {ECO:0000244|PDB:1L9X}.
FT   STRAND      151    160       {ECO:0000244|PDB:1L9X}.
FT   TURN        167    170       {ECO:0000244|PDB:1L9X}.
FT   TURN        173    176       {ECO:0000244|PDB:1L9X}.
FT   HELIX       179    187       {ECO:0000244|PDB:1L9X}.
FT   STRAND      191    198       {ECO:0000244|PDB:1L9X}.
FT   HELIX       201    205       {ECO:0000244|PDB:1L9X}.
FT   HELIX       208    213       {ECO:0000244|PDB:1L9X}.
FT   STRAND      214    224       {ECO:0000244|PDB:1L9X}.
FT   STRAND      226    236       {ECO:0000244|PDB:1L9X}.
FT   STRAND      238    243       {ECO:0000244|PDB:1L9X}.
FT   HELIX       247    250       {ECO:0000244|PDB:1L9X}.
FT   HELIX       262    279       {ECO:0000244|PDB:1L9X}.
FT   HELIX       289    295       {ECO:0000244|PDB:1L9X}.
FT   HELIX       297    299       {ECO:0000244|PDB:1L9X}.
FT   TURN        306    308       {ECO:0000244|PDB:1L9X}.
FT   STRAND      312    317       {ECO:0000244|PDB:1L9X}.
SQ   SEQUENCE   318 AA;  35964 MW;  C4069953573B9B24 CRC64;
     MASPGCLLCV LGLLLCGAAS LELSRPHGDT AKKPIIGILM QKCRNKVMKN YGRYYIAASY
     VKYLESAGAR VVPVRLDLTE KDYEILFKSI NGILFPGGSV DLRRSDYAKV AKIFYNLSIQ
     SFDDGDYFPV WGTCLGFEEL SLLISGECLL TATDTVDVAM PLNFTGGQLH SRMFQNFPTE
     LLLSLAVEPL TANFHKWSLS VKNFTMNEKL KKFFNVLTTN TDGKIEFIST MEGYKYPVYG
     VQWHPEKAPY EWKNLDGISH APNAVKTAFY LAEFFVNEAR KNNHHFKSES EEEKALIYQF
     SPIYTGNISS FQQCYIFD
//
ID   A0A024QZK7_HUMAN        Unreviewed;       921 AA.
AC   A0A024QZK7;
DT   09-JUL-2014, integrated into UniProtKB/TrEMBL.
DT   09-JUL-2014, sequence version 1.
DT   23-MAY-2018, entry version 43.
DE   SubName: Full=Hexokinase 1, isoform CRA_c {ECO:0000313|EMBL:EAW54322.1};
GN   Name=HK1 {ECO:0000313|EMBL:EAW54322.1};
GN   ORFNames=hCG_1812951 {ECO:0000313|EMBL:EAW54322.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:EAW54322.1};
RN   [1] {ECO:0000313|EMBL:EAW54322.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAW54322.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
CC   -!- SIMILARITY: Belongs to the hexokinase family.
CC       {ECO:0000256|SAAS:SAAS00672880}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; CH471083; EAW54321.1; -; Genomic_DNA.
DR   EMBL; CH471083; EAW54322.1; -; Genomic_DNA.
DR   RefSeq; NP_001309293.1; NM_001322364.1.
DR   RefSeq; NP_277032.1; NM_033497.2.
DR   RefSeq; NP_277033.1; NM_033498.2.
DR   UniGene; Hs.370365; -.
DR   SMR; A0A024QZK7; -.
DR   PRIDE; A0A024QZK7; -.
DR   GeneID; 3098; -.
DR   CTD; 3098; -.
DR   EuPathDB; HostDB:ENSG00000156515.21; -.
DR   eggNOG; KOG1369; Eukaryota.
DR   eggNOG; COG5026; LUCA.
DR   OMA; YDDQQCE; -.
DR   OrthoDB; EOG091G08MD; -.
DR   ChiTaRS; HK1; human.
DR   GenomeRNAi; 3098; -.
DR   Bgee; ENSG00000156515; -.
DR   ExpressionAtlas; A0A024QZK7; baseline and differential.
DR   GO; GO:0005829; C:cytosol; IEA:Ensembl.
DR   GO; GO:0045121; C:membrane raft; IEA:Ensembl.
DR   GO; GO:0005739; C:mitochondrion; IDA:HPA.
DR   GO; GO:0097228; C:sperm principal piece; IEA:Ensembl.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004340; F:glucokinase activity; IEA:Ensembl.
DR   GO; GO:0005536; F:glucose binding; IEA:InterPro.
DR   GO; GO:0042834; F:peptidoglycan binding; IEA:Ensembl.
DR   GO; GO:0001678; P:cellular glucose homeostasis; IEA:InterPro.
DR   GO; GO:0006096; P:glycolytic process; IEA:UniProtKB-KW.
DR   GO; GO:0002741; P:positive regulation of cytokine secretion involved in immune response; IEA:Ensembl.
DR   GO; GO:0050718; P:positive regulation of interleukin-1 beta secretion; IEA:Ensembl.
DR   InterPro; IPR001312; Hexokinase.
DR   InterPro; IPR019807; Hexokinase_BS.
DR   InterPro; IPR022673; Hexokinase_C.
DR   InterPro; IPR022672; Hexokinase_N.
DR   PANTHER; PTHR19443; PTHR19443; 4.
DR   Pfam; PF00349; Hexokinase_1; 2.
DR   Pfam; PF03727; Hexokinase_2; 2.
DR   PROSITE; PS00378; HEXOKINASE_1; 2.
DR   PROSITE; PS51748; HEXOKINASE_2; 2.
PE   3: Inferred from homology;
KW   ATP-binding {ECO:0000256|SAAS:SAAS00672869};
KW   Glycolysis {ECO:0000256|SAAS:SAAS00672870};
KW   Kinase {ECO:0000256|SAAS:SAAS00672871, ECO:0000313|EMBL:EAW54322.1};
KW   Nucleotide-binding {ECO:0000256|SAAS:SAAS00672869};
KW   Transferase {ECO:0000256|SAAS:SAAS00672871,
KW   ECO:0000313|EMBL:EAW54322.1}.
FT   DOMAIN       26    223       Hexokinase_1. {ECO:0000259|Pfam:PF00349}.
FT   DOMAIN      229    463       Hexokinase_2. {ECO:0000259|Pfam:PF03727}.
FT   DOMAIN      474    671       Hexokinase_1. {ECO:0000259|Pfam:PF00349}.
FT   DOMAIN      677    911       Hexokinase_2. {ECO:0000259|Pfam:PF03727}.
SQ   SEQUENCE   921 AA;  102738 MW;  329F41F87DF6E1D1 CRC64;
     MGQICQRESA TAAEKPKLHL LAESEIDKYL YAMRLSDETL IDIMTRFRKE MKNGLSRDFN
     PTATVKMLPT FVRSIPDGSE KGDFIALDLG GSSFRILRVQ VNHEKNQNVH MESEVYDTPE
     NIVHGSGSQL FDHVAECLGD FMEKRKIKDK KLPVGFTFSF PCQQSKIDEA ILITWTKRFK
     ASGVEGADVV KLLNKAIKKR GDYDANIVAV VNDTVGTMMT CGYDDQHCEV GLIIGTGTNA
     CYMEELRHID LVEGDEGRMC INTEWGAFGD DGSLEDIRTE FDREIDRGSL NPGKQLFEKM
     VSGMYLGELV RLILVKMAKE GLLFEGRITP ELLTRGKFNT SDVSAIEKNK EGLHNAKEIL
     TRLGVEPSDD DCVSVQHVCT IVSFRSANLV AATLGAILNR LRDNKGTPRL RTTVGVDGSL
     YKTHPQYSRR FHKTLRRLVP DSDVRFLLSE SGSGKGAAMV TAVAYRLAEQ HRQIEETLAH
     FHLTKDMLLE VKKRMRAEME LGLRKQTHNN AVVKMLPSFV RRTPDGTENG DFLALDLGGT
     NFRVLLVKIR SGKKRTVEMH NKIYAIPIEI MQGTGEELFD HIVSCISDFL DYMGIKGPRM
     PLGFTFSFPC QQTSLDAGIL ITWTKGFKAT DCVGHDVVTL LRDAIKRREE FDLDVVAVVN
     DTVGTMMTCA YEEPTCEVGL IVGTGSNACY MEEMKNVEMV EGDQGQMCIN MEWGAFGDNG
     CLDDIRTHYD RLVDEYSLNA GKQRYEKMIS GMYLGEIVRN ILIDFTKKGF LFRGQISETL
     KTRGIFETKF LSQIESDRLA LLQVRAILQQ LGLNSTCDDS ILVKTVCGVV SRRAAQLCGA
     GMAAVVDKIR ENRGLDRLNV TVGVDGTLYK LHPHFSRIMH QTVKELSPKC NVSFLLSEDG
     SGKGAALITA VGVRLRTEAS S
//
ID   A8K7J7_HUMAN            Unreviewed;       917 AA.
AC   A8K7J7;
DT   04-DEC-2007, integrated into UniProtKB/TrEMBL.
DT   04-DEC-2007, sequence version 1.
DT   31-JAN-2018, entry version 67.
DE   SubName: Full=cDNA FLJ78173, highly similar to Homo sapiens hexokinase 1 (HK1) mRNA {ECO:0000313|EMBL:BAF84701.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAF84701.1};
RN   [1] {ECO:0000313|EMBL:BAF84701.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Spleen {ECO:0000313|EMBL:BAF84701.1};
RA   Wakamatsu A., Yamamoto J., Kimura K., Ishii S., Watanabe K.,
RA   Sugiyama A., Murakawa K., Kaida T., Tsuchiya K., Fukuzumi Y.,
RA   Kumagai A., Oishi Y., Yamamoto S., Ono Y., Komori Y., Yamazaki M.,
RA   Kisu Y., Nishikawa T., Sugano S., Nomura N., Isogai T.;
RT   "NEDO human cDNA sequencing project.";
RL   Submitted (OCT-2007) to the EMBL/GenBank/DDBJ databases.
CC   -!- SIMILARITY: Belongs to the hexokinase family.
CC       {ECO:0000256|SAAS:SAAS00672880}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK292012; BAF84701.1; -; mRNA.
DR   RefSeq; NP_000179.2; NM_000188.2.
DR   UniGene; Hs.370365; -.
DR   ProteinModelPortal; A8K7J7; -.
DR   PeptideAtlas; A8K7J7; -.
DR   PRIDE; A8K7J7; -.
DR   DNASU; 3098; -.
DR   GeneID; 3098; -.
DR   KEGG; hsa:3098; -.
DR   CTD; 3098; -.
DR   PharmGKB; PA29300; -.
DR   eggNOG; KOG1369; Eukaryota.
DR   eggNOG; COG5026; LUCA.
DR   HOVERGEN; HBG005020; -.
DR   KO; K00844; -.
DR   GenomeRNAi; 3098; -.
DR   Genevisible; A8K7J7; HS.
DR   GO; GO:0005623; C:cell; IEA:GOC.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0005536; F:glucose binding; IEA:InterPro.
DR   GO; GO:0004396; F:hexokinase activity; IEA:InterPro.
DR   GO; GO:0001678; P:cellular glucose homeostasis; IEA:InterPro.
DR   GO; GO:0006096; P:glycolytic process; IEA:UniProtKB-KW.
DR   InterPro; IPR001312; Hexokinase.
DR   InterPro; IPR019807; Hexokinase_BS.
DR   InterPro; IPR022673; Hexokinase_C.
DR   InterPro; IPR022672; Hexokinase_N.
DR   PANTHER; PTHR19443; PTHR19443; 4.
DR   Pfam; PF00349; Hexokinase_1; 2.
DR   Pfam; PF03727; Hexokinase_2; 2.
DR   PROSITE; PS00378; HEXOKINASE_1; 2.
DR   PROSITE; PS51748; HEXOKINASE_2; 2.
PE   2: Evidence at transcript level;
KW   ATP-binding {ECO:0000256|SAAS:SAAS00672869};
KW   Glycolysis {ECO:0000256|SAAS:SAAS00672870};
KW   Kinase {ECO:0000256|SAAS:SAAS00672871, ECO:0000313|EMBL:BAF84701.1};
KW   Nucleotide-binding {ECO:0000256|SAAS:SAAS00672869};
KW   Transferase {ECO:0000256|SAAS:SAAS00672871,
KW   ECO:0000313|EMBL:BAF84701.1}.
FT   DOMAIN       22    219       Hexokinase_1. {ECO:0000259|Pfam:PF00349}.
FT   DOMAIN      225    459       Hexokinase_2. {ECO:0000259|Pfam:PF03727}.
FT   DOMAIN      470    667       Hexokinase_1. {ECO:0000259|Pfam:PF00349}.
FT   DOMAIN      673    907       Hexokinase_2. {ECO:0000259|Pfam:PF03727}.
SQ   SEQUENCE   917 AA;  102387 MW;  0795D838ECB91F3E CRC64;
     MIAAQLLAYY FTELKDDQVK KIDKYLYAMR LSDETLIDIM TRFRKEMKNG LSRDFNPTAT
     VKMLPTFVRS IPDGSEKGDF IALDLGGSSF RILRVQVNHE KNQNVHMESE VYDTPENIVH
     GSGSQLFDHV AECLGDFMEK RKIKDKKLPV GFTFSFPCQQ SKIDEAILIT WTKRFKASGV
     EGADVVKLLN KAIKKRGDYD ANIVAVVNDT VGTMMTCGYD DQHCEVGLII GTGTNACYME
     ELRHIDLVEG DEGRMCINTE WGAFGDDGSL EDIRTEFDRE IDRGSLNPGK QLFEKMVSGM
     YLGELVRLIL VKMAKEGLLF EGRITPELLT RGKFNTSDVS AIEKNKEGLH NAKEILTRLG
     VEPSDDDCVS VQHVCTIVSF RSANLVAATL GAILNRLRDN KGTPRLRTTV GVDGSLYKTH
     PQYSRRFHKT LRRLVPDSDV RFLLSESGSG KGAAMVTAVA YRLAEQHRQI EETLAHFHLT
     KDMLLEVKKR MRAEMELGLR KQTHNNAVVK MLPSFVRRTP DGTENGDFLA LDLGGTNFRV
     LLVKIRSGKK RTVEMHNKIY AIPIEIMQGT GEELFDHIVS CISDFLDYMG IKGPRMPLGF
     TFSFPCQQTS LDAGILITWT KGFKATDCVG HDVVTLLRDA IKRREEFDLD VVAVVNDTVG
     TMMTCAYEEP TCEVGLIVGT GSNACYMEEM KNVEMVEGDQ GQMCINMEWG AFGDNGCLDD
     IRTHYDRLVD EYSLNAGKQG YEKMISGMYL GEIVRNILID FTKKGFLFRG QISETLKTRG
     IFETKFLSQI ESDRLALLQV RAILQQLGLN STCDDSILVK TVCGVVSRRA AQLCGAGMAA
     VVDKIRENRG LDRLNVTVGV DGTLYKLHPH FSRIMHQTVK ELSPKCNVSF LLSEDGSGKG
     AALITAVGVR LRTEASS
//
ID   B3KXY9_HUMAN            Unreviewed;       952 AA.
AC   B3KXY9;
DT   02-SEP-2008, integrated into UniProtKB/TrEMBL.
DT   02-SEP-2008, sequence version 1.
DT   31-JAN-2018, entry version 64.
DE   SubName: Full=cDNA FLJ46359 fis, clone TESTI4049786, highly similar to Hexokinase-1 (EC 2.7.1.1) {ECO:0000313|EMBL:BAG54651.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAG54651.1};
RN   [1] {ECO:0000313|EMBL:BAG54651.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Testis {ECO:0000313|EMBL:BAG54651.1};
RA   Ninomiya K., Wagatsuma M., Kanda K., Kondo H., Yokoi T., Kodaira H.,
RA   Furuya T., Takahashi M., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Sugiyama T., Irie R.,
RA   Otsuki T., Sato H., Wakamatsu A., Ishii S., Yamamoto J., Isono Y.,
RA   Kawai-Hio Y., Saito K., Nishikawa T., Kimura K., Yamashita H.,
RA   Matsuo K., Nakamura Y., Sekine M., Kikuchi H., Murakawa K.,
RA   Kanehori K., Takahashi-Fujii A., Oshima A., Sugiyama A., Kawakami B.,
RA   Suzuki Y., Sugano S., Nagahari K., Masuho Y., Nagai K., Isogai T.;
RT   "NEDO human cDNA sequencing project.";
RL   Submitted (JUL-2003) to the EMBL/GenBank/DDBJ databases.
CC   -!- SIMILARITY: Belongs to the hexokinase family.
CC       {ECO:0000256|SAAS:SAAS00672880}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK128226; BAG54651.1; -; mRNA.
DR   RefSeq; NP_000179.2; NM_000188.2.
DR   RefSeq; NP_277031.1; NM_033496.2.
DR   RefSeq; NP_277032.1; NM_033497.2.
DR   RefSeq; NP_277033.1; NM_033498.2.
DR   RefSeq; NP_277035.2; NM_033500.2.
DR   UniGene; Hs.370365; -.
DR   MaxQB; B3KXY9; -.
DR   PeptideAtlas; B3KXY9; -.
DR   PRIDE; B3KXY9; -.
DR   DNASU; 3098; -.
DR   GeneID; 3098; -.
DR   KEGG; hsa:3098; -.
DR   CTD; 3098; -.
DR   PharmGKB; PA29300; -.
DR   eggNOG; KOG1369; Eukaryota.
DR   eggNOG; COG5026; LUCA.
DR   HOGENOM; HOG000162671; -.
DR   HOVERGEN; HBG005020; -.
DR   KO; K00844; -.
DR   GenomeRNAi; 3098; -.
DR   Genevisible; B3KXY9; HS.
DR   GO; GO:0005623; C:cell; IEA:GOC.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0005536; F:glucose binding; IEA:InterPro.
DR   GO; GO:0004396; F:hexokinase activity; IEA:InterPro.
DR   GO; GO:0001678; P:cellular glucose homeostasis; IEA:InterPro.
DR   GO; GO:0006096; P:glycolytic process; IEA:UniProtKB-KW.
DR   InterPro; IPR001312; Hexokinase.
DR   InterPro; IPR019807; Hexokinase_BS.
DR   InterPro; IPR022673; Hexokinase_C.
DR   InterPro; IPR022672; Hexokinase_N.
DR   PANTHER; PTHR19443; PTHR19443; 4.
DR   Pfam; PF00349; Hexokinase_1; 2.
DR   Pfam; PF03727; Hexokinase_2; 2.
DR   PROSITE; PS00378; HEXOKINASE_1; 2.
DR   PROSITE; PS51748; HEXOKINASE_2; 2.
PE   2: Evidence at transcript level;
KW   ATP-binding {ECO:0000256|SAAS:SAAS00672869};
KW   Glycolysis {ECO:0000256|SAAS:SAAS00672870};
KW   Kinase {ECO:0000256|SAAS:SAAS00672871, ECO:0000313|EMBL:BAG54651.1};
KW   Nucleotide-binding {ECO:0000256|SAAS:SAAS00672869};
KW   Transferase {ECO:0000256|SAAS:SAAS00672871,
KW   ECO:0000313|EMBL:BAG54651.1}.
FT   DOMAIN       57    254       Hexokinase_1. {ECO:0000259|Pfam:PF00349}.
FT   DOMAIN      260    494       Hexokinase_2. {ECO:0000259|Pfam:PF03727}.
FT   DOMAIN      505    702       Hexokinase_1. {ECO:0000259|Pfam:PF00349}.
FT   DOMAIN      708    942       Hexokinase_2. {ECO:0000259|Pfam:PF03727}.
SQ   SEQUENCE   952 AA;  106251 MW;  A94B1EA9F55547E7 CRC64;
     MGQICQRESR QGLAMLPRLF LNPWRQVILL PQPPKVLGLQ ATAAEKPKLH LLAESEIDKY
     LYAMRLSDET LIDIMTRFRK EMKNGLSRDF NPTATVKMLP TFVRPIPDGS EKGDFIALDL
     GGSSFRILRV QVNHEKNQNV HMESEVYDTP ENIVHGSGSQ LFDHVAECLG DFMEKRKIKD
     KKLPVGFTFS FPCQQSKIDE AILITWTKRF KASGVEGADV VKLLNKAIKK RGDYDANIVA
     VVNDTVGTMM TCGYDDQHCE VGLIIGTGTN ACYMEELRHI DLVEGDEGRM CINTEWGAFG
     DDGSLEDIRT EFDREIDRGS LNPGKQLFEK MVSGMYLGEL VRLILVKMAK EGLLFEGRIT
     PELLTRGKFN TSDVSAIEKN KEGLHNAKEI LTRLGVEPSD DDCVSVQHVC TIVSFRSANL
     VAATLGAILN RLRDNKGTPR LRTTVGVDGS LYKTHPQYSR RFHKTLRRLV PDSDVRFLLS
     ESGSGKGAAM VTAVAYRLAE QHRQIEETLA HFHLTKDMLL EVKKRMRAEM ELGLRKQTHN
     NAVVKMLPSF VRRTPDGTEN GDFLALDLGG TNFRVLLVKI RSGKKRTVEM HNKIYAIPIE
     IMQGTGEELF DHIVSCISDF LDYMGIKGPR MPLGFTFSFP CQQTSLDAGI LITWTKGFKA
     TDCVGHDVVT LLRDAIKRRE EFDLDVVAVV NDTVGTMMTC AYGEPTCEVG LIVGTGSNAC
     YMEEMKNVEM VEGDQGQMCI NMEWGAFGDN GCLDDIRTHY DRLVDEYSLN AGKQRYEKMI
     SGMYLGEIVR NILIDFTKKG FLFRGQISET LKTRGIFETK FLSQIESDRL ALLQVRAILQ
     QLGLNSTCDD SILVKTVCGV VSRRAAQLCG AGMAAVVDKI RENRGLDRLN VTVGVDGTLY
     KLHPHFSRIM HQTVKELSPK CNVSFLLSED GSGKGAALIT AVGVRLRTEA SS
//
ID   HXK1_HUMAN              Reviewed;         917 AA.
AC   P19367; E9PCK0; O43443; O43444; O75574; Q5VTC3; Q96HC8; Q9NNZ4;
AC   Q9NNZ5;
DT   01-NOV-1990, integrated into UniProtKB/Swiss-Prot.
DT   17-OCT-2006, sequence version 3.
DT   23-MAY-2018, entry version 215.
DE   RecName: Full=Hexokinase-1;
DE            EC=2.7.1.1;
DE   AltName: Full=Brain form hexokinase;
DE   AltName: Full=Hexokinase type I;
DE            Short=HK I;
GN   Name=HK1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANT MET-776.
RX   PubMed=3207429; DOI=10.1016/S0006-291X(88)80964-1;
RA   Nishi S., Seino S., Bell G.I.;
RT   "Human hexokinase: sequences of amino- and carboxyl-terminal halves
RT   are homologous.";
RL   Biochem. Biophys. Res. Commun. 157:937-943(1988).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND ALTERNATIVE SPLICING.
RX   PubMed=9531504; DOI=10.1042/bj3310607;
RA   Ruzzo A., Andreoni F., Magnani M.;
RT   "Structure of the human hexokinase type I gene and nucleotide sequence
RT   of the 5' flanking region.";
RL   Biochem. J. 331:607-613(1998).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164054; DOI=10.1038/nature02462;
RA   Deloukas P., Earthrowl M.E., Grafham D.V., Rubenfield M., French L.,
RA   Steward C.A., Sims S.K., Jones M.C., Searle S., Scott C., Howe K.,
RA   Hunt S.E., Andrews T.D., Gilbert J.G.R., Swarbreck D., Ashurst J.L.,
RA   Taylor A., Battles J., Bird C.P., Ainscough R., Almeida J.P.,
RA   Ashwell R.I.S., Ambrose K.D., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Bates K., Beasley H., Bray-Allen S., Brown A.J.,
RA   Brown J.Y., Burford D.C., Burrill W., Burton J., Cahill P., Camire D.,
RA   Carter N.P., Chapman J.C., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Corby N., Coulson A., Dhami P., Dutta I., Dunn M., Faulkner L.,
RA   Frankish A., Frankland J.A., Garner P., Garnett J., Gribble S.,
RA   Griffiths C., Grocock R., Gustafson E., Hammond S., Harley J.L.,
RA   Hart E., Heath P.D., Ho T.P., Hopkins B., Horne J., Howden P.J.,
RA   Huckle E., Hynds C., Johnson C., Johnson D., Kana A., Kay M.,
RA   Kimberley A.M., Kershaw J.K., Kokkinaki M., Laird G.K., Lawlor S.,
RA   Lee H.M., Leongamornlert D.A., Laird G., Lloyd C., Lloyd D.M.,
RA   Loveland J., Lovell J., McLaren S., McLay K.E., McMurray A.,
RA   Mashreghi-Mohammadi M., Matthews L., Milne S., Nickerson T.,
RA   Nguyen M., Overton-Larty E., Palmer S.A., Pearce A.V., Peck A.I.,
RA   Pelan S., Phillimore B., Porter K., Rice C.M., Rogosin A., Ross M.T.,
RA   Sarafidou T., Sehra H.K., Shownkeen R., Skuce C.D., Smith M.,
RA   Standring L., Sycamore N., Tester J., Thorpe A., Torcasso W.,
RA   Tracey A., Tromans A., Tsolas J., Wall M., Walsh J., Wang H.,
RA   Weinstock K., West A.P., Willey D.L., Whitehead S.L., Wilming L.,
RA   Wray P.W., Young L., Chen Y., Lovering R.C., Moschonas N.K.,
RA   Siebert R., Fechtel K., Bentley D., Durbin R.M., Hubbard T.,
RA   Doucette-Stamm L., Beck S., Smith D.R., Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 10.";
RL   Nature 429:375-381(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-126 (ISOFORM 4), AND ALTERNATIVE
RP   SPLICING.
RX   PubMed=10978502; DOI=10.1016/S0167-4781(00)00147-0;
RA   Andreoni F., Ruzzo A., Magnani M.;
RT   "Structure of the 5' region of the human hexokinase type I (HKI) gene
RT   and identification of an additional testis-specific HKI mRNA.";
RL   Biochim. Biophys. Acta 1493:19-26(2000).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-20 (ISOFORM 2).
RA   Murakami K., Piomelli S.;
RT   "The erythrocyte-specific hexokinase isozyme (HKR) and the common
RT   hexokinase isozyme (HKI) are produced from a single gene by alternate
RT   promoters.";
RL   Blood 90:272-272(1998).
RN   [7]
RP   PROTEIN SEQUENCE OF 1-20; 31-42; 382-396 AND 900-910, ACETYLATION AT
RP   MET-1, AND IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Embryonic kidney;
RA   Bienvenut W.V., Waridel P., Quadroni M.;
RL   Submitted (MAR-2009) to UniProtKB.
RN   [8]
RP   PROTEIN SEQUENCE OF 11-31 AND 103-120.
RC   TISSUE=Placenta;
RX   PubMed=1985912;
RA   Magnani M., Serafini G., Bianchi M., Casabianca A., Stocchi V.;
RT   "Human hexokinase type I microheterogeneity is due to different amino-
RT   terminal sequences.";
RL   J. Biol. Chem. 266:502-505(1991).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 287-917, AND VARIANT MET-776.
RC   TISSUE=Placenta;
RX   PubMed=1637300; DOI=10.1042/bj2850193;
RA   Magnani M., Bianchi M., Casabianca A., Stocchi V., Daniele A.,
RA   Altruda F., Ferrone M., Silengo L.;
RT   "A recombinant human 'mini'-hexokinase is catalytically active and
RT   regulated by hexose 6-phosphates.";
RL   Biochem. J. 285:193-199(1992).
RN   [10]
RP   ALTERNATIVE SPLICING.
RX   PubMed=9028305;
RA   Murakami K., Piomelli S.;
RT   "Identification of the cDNA for human red blood cell-specific
RT   hexokinase isozyme.";
RL   Blood 89:762-766(1997).
RN   [11]
RP   CRYSTALLIZATION.
RX   PubMed=8706938; DOI=10.1016/0014-5793(96)00688-6;
RA   Aleshin A.E., Zeng C., Fromm H.J., Honatko R.B.;
RT   "Crystallization and preliminary X-ray analysis of human brain
RT   hexokinase.";
RL   FEBS Lett. 391:9-10(1996).
RN   [12]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [13]
RP   INVOLVEMENT IN HMSNR.
RX   PubMed=19536174; DOI=10.1038/ejhg.2009.99;
RA   Hantke J., Chandler D., King R., Wanders R.J., Angelicheva D.,
RA   Tournev I., McNamara E., Kwa M., Guergueltcheva V., Kaneva R.,
RA   Baas F., Kalaydjieva L.;
RT   "A mutation in an alternative untranslated exon of hexokinase 1
RT   associated with hereditary motor and sensory neuropathy -- Russe
RT   (HMSNR).";
RL   Eur. J. Hum. Genet. 17:1606-1614(2009).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [15]
RP   INTERACTION WITH ATF2 AND VDAC1.
RX   PubMed=22304920; DOI=10.1016/j.cell.2012.01.016;
RA   Lau E., Kluger H., Varsano T., Lee K., Scheffler I., Rimm D.L.,
RA   Ideker T., Ronai Z.A.;
RT   "PKCepsilon promotes oncogenic functions of ATF2 in the nucleus while
RT   blocking its apoptotic function at mitochondria.";
RL   Cell 148:543-555(2012).
RN   [16]
RP   INVOLVEMENT IN RP79, AND VARIANT RP79 LYS-847.
RX   PubMed=25190649; DOI=10.1167/iovs.14-15419;
RA   Sullivan L.S., Koboldt D.C., Bowne S.J., Lang S., Blanton S.H.,
RA   Cadena E., Avery C.E., Lewis R.A., Webb-Jones K., Wheaton D.H.,
RA   Birch D.G., Coussa R., Ren H., Lopez I., Chakarova C., Koenekoop R.K.,
RA   Garcia C.A., Fulton R.S., Wilson R.K., Weinstock G.M., Daiger S.P.;
RT   "A dominant mutation in hexokinase 1 (HK1) causes retinitis
RT   pigmentosa.";
RL   Invest. Ophthalmol. Vis. Sci. 55:7147-7158(2014).
RN   [17]
RP   INVOLVEMENT IN RP79, VARIANT RP79 LYS-847, AND CHARACTERIZATION OF
RP   VARIANT RP79 LYS-847.
RX   PubMed=25316723; DOI=10.1167/iovs.14-15520;
RA   Wang F., Wang Y., Zhang B., Zhao L., Lyubasyuk V., Wang K., Xu M.,
RA   Li Y., Wu F., Wen C., Bernstein P.S., Lin D., Zhu S., Wang H.,
RA   Zhang K., Chen R.;
RT   "A missense mutation in HK1 leads to autosomal dominant retinitis
RT   pigmentosa.";
RL   Invest. Ophthalmol. Vis. Sci. 55:7159-7164(2014).
RN   [18]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [19]
RP   X-RAY CRYSTALLOGRAPHY (2.8 ANGSTROMS) OF 16-914 IN COMPLEX WITH
RP   GLUCOSE AND GLUCOSE-6-PHOSPHATE, AND SUBUNIT.
RX   PubMed=9493266; DOI=10.1016/S0969-2126(98)00006-9;
RA   Aleshin A.E., Zeng C., Bourenkov G.P., Bartunik H.D., Fromm H.J.,
RA   Honzatko R.B.;
RT   "The mechanism of regulation of hexokinase: new insights from the
RT   crystal structure of recombinant human brain hexokinase complexed with
RT   glucose and glucose-6-phosphate.";
RL   Structure 6:39-50(1998).
RN   [20]
RP   X-RAY CRYSTALLOGRAPHY (2.8 ANGSTROMS) OF 16-914.
RX   PubMed=9735292; DOI=10.1006/jmbi.1998.2017;
RA   Aleshin A.E., Zeng C., Bartunik H.D., Fromm H.J., Honzatko R.B.;
RT   "Regulation of hexokinase I: crystal structure of recombinant human
RT   brain hexokinase complexed with glucose and phosphate.";
RL   J. Mol. Biol. 282:345-357(1998).
RN   [21]
RP   X-RAY CRYSTALLOGRAPHY (2.25 ANGSTROMS) IN COMPLEX WITH AMP-PNP AND
RP   MAGNESIUM, AND SUBUNIT.
RX   PubMed=10574795; DOI=10.1016/S0969-2126(00)80032-5;
RA   Rosano C., Sabini E., Rizzi M., Deriu D., Murshudov G., Bianchi M.,
RA   Serafini G., Magnani M., Bolognesi M.;
RT   "Binding of non-catalytic ATP to human hexokinase I highlights the
RT   structural components for enzyme-membrane association control.";
RL   Structure 7:1427-1437(1999).
RN   [22]
RP   X-RAY CRYSTALLOGRAPHY (1.9 ANGSTROMS) IN COMPLEX WITH GLUCOSE;
RP   GLUCOSE-6-PHOSPHATE AND ADP.
RX   PubMed=10686099; DOI=10.1006/jmbi.1999.3494;
RA   Aleshin A.E., Kirby C., Liu X., Bourenkov G.P., Bartunik H.D.,
RA   Fromm H.J., Honzatko R.B.;
RT   "Crystal structures of mutant monomeric hexokinase I reveal multiple
RT   ADP binding sites and conformational changes relevant to allosteric
RT   regulation.";
RL   J. Mol. Biol. 296:1001-1015(2000).
RN   [23]
RP   VARIANT HK DEFICIENCY SER-529.
RX   PubMed=7655856; DOI=10.1006/bcmd.1995.0002;
RA   Bianchi M., Magnani M.;
RT   "Hexokinase mutations that produce nonspherocytic hemolytic anemia.";
RL   Blood Cells Mol. Dis. 21:2-8(1995).
RN   [24]
RP   VARIANT HK DEFICIENCY SER-680.
RX   PubMed=12393545; DOI=10.1182/blood-2002-06-1851;
RA   van Wijk R., Rijksen G., Huizinga E.G., Nieuwenhuis H.K.,
RA   van Solinge W.W.;
RT   "HK Utrecht: missense mutation in the active site of human hexokinase
RT   associated with hexokinase deficiency and severe nonspherocytic
RT   hemolytic anemia.";
RL   Blood 101:345-347(2003).
CC   -!- CATALYTIC ACTIVITY: ATP + D-hexose = ADP + D-hexose 6-phosphate.
CC   -!- ENZYME REGULATION: Hexokinase is an allosteric enzyme inhibited by
CC       its product Glc-6-P.
CC   -!- PATHWAY: Carbohydrate metabolism; hexose metabolism.
CC   -!- SUBUNIT: Monomer. Interacts with RABL2/RABL2A; binds
CC       preferentially to GTP-bound RABL2 (By similarity). Interacts with
CC       VDAC1. The HK1-VDAC1 complex interacts with ATF2. Interacts (via
CC       N-terminal spermatogenic cell-specific region) with PFKM (via C-
CC       terminus) (By similarity). {ECO:0000250,
CC       ECO:0000250|UniProtKB:P17710, ECO:0000269|PubMed:10574795,
CC       ECO:0000269|PubMed:10686099, ECO:0000269|PubMed:22304920,
CC       ECO:0000269|PubMed:9493266}.
CC   -!- INTERACTION:
CC       Self; NbExp=2; IntAct=EBI-713162, EBI-713162;
CC       P12931:SRC; NbExp=2; IntAct=EBI-713162, EBI-621482;
CC       P05480:Src (xeno); NbExp=8; IntAct=EBI-713162, EBI-298680;
CC   -!- SUBCELLULAR LOCATION: Mitochondrion outer membrane. Note=Its
CC       hydrophobic N-terminal sequence may be involved in membrane
CC       binding.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1; Synonyms=Common;
CC         IsoId=P19367-1; Sequence=Displayed;
CC       Name=2; Synonyms=Erythrocyte, R;
CC         IsoId=P19367-2; Sequence=VSP_002071;
CC       Name=3; Synonyms=TA, TB;
CC         IsoId=P19367-3; Sequence=VSP_002072;
CC       Name=4; Synonyms=TD;
CC         IsoId=P19367-4; Sequence=VSP_002073;
CC   -!- TISSUE SPECIFICITY: Isoform 2 is erythrocyte specific. Isoform 3
CC       and isoform 4 are testis-specific.
CC   -!- DOMAIN: The N- and C-terminal halves of this hexokinase show
CC       extensive sequence similarity to each other. The catalytic
CC       activity is associated with the C-terminus while regulatory
CC       function is associated with the N-terminus. Each domain can bind a
CC       single glucose and Gluc-6-P molecule.
CC   -!- DISEASE: Hexokinase deficiency (HK deficiency) [MIM:235700]: Rare
CC       autosomal recessive disease with nonspherocytic hemolytic anemia
CC       as the predominant clinical feature. {ECO:0000269|PubMed:12393545,
CC       ECO:0000269|PubMed:7655856}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Neuropathy, hereditary motor and sensory, Russe type
CC       (HMSNR) [MIM:605285]: An autosomal recessive progressive complex
CC       peripheral neuropathy characterized by onset in the first decade
CC       of distal lower limb weakness and muscle atrophy resulting in
CC       walking difficulties. Distal impairment of the upper limbs usually
CC       occurs later, as does proximal lower limb weakness. There is
CC       distal sensory impairment, with pes cavus and areflexia.
CC       Laboratory studies suggest that it is a myelinopathy resulting in
CC       reduced nerve conduction velocities in the demyelinating range as
CC       well as a length-dependent axonopathy.
CC       {ECO:0000269|PubMed:19536174}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Retinitis pigmentosa 79 (RP79) [MIM:617460]: A form of
CC       retinitis pigmentosa, a retinal dystrophy belonging to the group
CC       of pigmentary retinopathies. Retinitis pigmentosa is characterized
CC       by retinal pigment deposits visible on fundus examination and
CC       primary loss of rod photoreceptor cells followed by secondary loss
CC       of cone photoreceptors. Patients typically have night vision
CC       blindness and loss of midperipheral visual field. As their
CC       condition progresses, they lose their far peripheral visual field
CC       and eventually central vision as well. RP79 inheritance is
CC       autosomal dominant. {ECO:0000269|PubMed:25190649,
CC       ECO:0000269|PubMed:25316723}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- MISCELLANEOUS: In vertebrates there are four major glucose-
CC       phosphorylating isoenzymes, designated hexokinase I, II, III and
CC       IV (glucokinase).
CC   -!- SIMILARITY: Belongs to the hexokinase family.
CC       {ECO:0000255|PROSITE-ProRule:PRU01084, ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Wikipedia; Note=Hexokinase entry;
CC       URL="https://en.wikipedia.org/wiki/Hexokinase";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M75126; AAA52646.1; -; mRNA.
DR   EMBL; AF016365; AAC15862.1; -; Genomic_DNA.
DR   EMBL; AF016349; AAC15862.1; JOINED; Genomic_DNA.
DR   EMBL; AF016351; AAC15862.1; JOINED; Genomic_DNA.
DR   EMBL; AF016352; AAC15862.1; JOINED; Genomic_DNA.
DR   EMBL; AF016353; AAC15862.1; JOINED; Genomic_DNA.
DR   EMBL; AF016354; AAC15862.1; JOINED; Genomic_DNA.
DR   EMBL; AF016355; AAC15862.1; JOINED; Genomic_DNA.
DR   EMBL; AF016356; AAC15862.1; JOINED; Genomic_DNA.
DR   EMBL; AF016357; AAC15862.1; JOINED; Genomic_DNA.
DR   EMBL; AF016358; AAC15862.1; JOINED; Genomic_DNA.
DR   EMBL; AF016359; AAC15862.1; JOINED; Genomic_DNA.
DR   EMBL; AF016360; AAC15862.1; JOINED; Genomic_DNA.
DR   EMBL; AF016361; AAC15862.1; JOINED; Genomic_DNA.
DR   EMBL; AF016362; AAC15862.1; JOINED; Genomic_DNA.
DR   EMBL; AF016363; AAC15862.1; JOINED; Genomic_DNA.
DR   EMBL; AF016364; AAC15862.1; JOINED; Genomic_DNA.
DR   EMBL; AF016365; AAC15863.1; -; Genomic_DNA.
DR   EMBL; AF016349; AAC15863.1; JOINED; Genomic_DNA.
DR   EMBL; AF016351; AAC15863.1; JOINED; Genomic_DNA.
DR   EMBL; AF016352; AAC15863.1; JOINED; Genomic_DNA.
DR   EMBL; AF016353; AAC15863.1; JOINED; Genomic_DNA.
DR   EMBL; AF016354; AAC15863.1; JOINED; Genomic_DNA.
DR   EMBL; AF016355; AAC15863.1; JOINED; Genomic_DNA.
DR   EMBL; AF016356; AAC15863.1; JOINED; Genomic_DNA.
DR   EMBL; AF016357; AAC15863.1; JOINED; Genomic_DNA.
DR   EMBL; AF016358; AAC15863.1; JOINED; Genomic_DNA.
DR   EMBL; AF016359; AAC15863.1; JOINED; Genomic_DNA.
DR   EMBL; AF016360; AAC15863.1; JOINED; Genomic_DNA.
DR   EMBL; AF016361; AAC15863.1; JOINED; Genomic_DNA.
DR   EMBL; AF016362; AAC15863.1; JOINED; Genomic_DNA.
DR   EMBL; AF016363; AAC15863.1; JOINED; Genomic_DNA.
DR   EMBL; AF016364; AAC15863.1; JOINED; Genomic_DNA.
DR   EMBL; AF016365; AAF82319.1; -; Genomic_DNA.
DR   EMBL; AF163910; AAF82319.1; JOINED; Genomic_DNA.
DR   EMBL; AF163911; AAF82319.1; JOINED; Genomic_DNA.
DR   EMBL; AF016351; AAF82319.1; JOINED; Genomic_DNA.
DR   EMBL; AF016352; AAF82319.1; JOINED; Genomic_DNA.
DR   EMBL; AF016353; AAF82319.1; JOINED; Genomic_DNA.
DR   EMBL; AF016354; AAF82319.1; JOINED; Genomic_DNA.
DR   EMBL; AF016355; AAF82319.1; JOINED; Genomic_DNA.
DR   EMBL; AF016356; AAF82319.1; JOINED; Genomic_DNA.
DR   EMBL; AF016357; AAF82319.1; JOINED; Genomic_DNA.
DR   EMBL; AF016358; AAF82319.1; JOINED; Genomic_DNA.
DR   EMBL; AF016359; AAF82319.1; JOINED; Genomic_DNA.
DR   EMBL; AF016360; AAF82319.1; JOINED; Genomic_DNA.
DR   EMBL; AF016361; AAF82319.1; JOINED; Genomic_DNA.
DR   EMBL; AF016362; AAF82319.1; JOINED; Genomic_DNA.
DR   EMBL; AF016363; AAF82319.1; JOINED; Genomic_DNA.
DR   EMBL; AF016364; AAF82319.1; JOINED; Genomic_DNA.
DR   EMBL; AF016365; AAF82320.1; -; Genomic_DNA.
DR   EMBL; AF163912; AAF82320.1; JOINED; Genomic_DNA.
DR   EMBL; AF016351; AAF82320.1; JOINED; Genomic_DNA.
DR   EMBL; AF016352; AAF82320.1; JOINED; Genomic_DNA.
DR   EMBL; AF016353; AAF82320.1; JOINED; Genomic_DNA.
DR   EMBL; AF016354; AAF82320.1; JOINED; Genomic_DNA.
DR   EMBL; AF016355; AAF82320.1; JOINED; Genomic_DNA.
DR   EMBL; AF016356; AAF82320.1; JOINED; Genomic_DNA.
DR   EMBL; AF016357; AAF82320.1; JOINED; Genomic_DNA.
DR   EMBL; AF016358; AAF82320.1; JOINED; Genomic_DNA.
DR   EMBL; AF016359; AAF82320.1; JOINED; Genomic_DNA.
DR   EMBL; AF016360; AAF82320.1; JOINED; Genomic_DNA.
DR   EMBL; AF016361; AAF82320.1; JOINED; Genomic_DNA.
DR   EMBL; AF016362; AAF82320.1; JOINED; Genomic_DNA.
DR   EMBL; AF016363; AAF82320.1; JOINED; Genomic_DNA.
DR   EMBL; AF016364; AAF82320.1; JOINED; Genomic_DNA.
DR   EMBL; AC016821; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL596223; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL672126; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC008730; AAH08730.1; -; mRNA.
DR   EMBL; AF073786; AAC25424.1; -; mRNA.
DR   EMBL; AF029306; AAC00172.1; -; Genomic_DNA.
DR   EMBL; X66957; CAA47379.1; -; mRNA.
DR   CCDS; CCDS7289.1; -. [P19367-3]
DR   CCDS; CCDS7290.1; -. [P19367-4]
DR   CCDS; CCDS7291.1; -. [P19367-2]
DR   CCDS; CCDS7292.1; -. [P19367-1]
DR   PIR; A31869; A31869.
DR   RefSeq; NP_000179.2; NM_000188.2. [P19367-1]
DR   RefSeq; NP_001309293.1; NM_001322364.1. [P19367-3]
DR   RefSeq; NP_277031.1; NM_033496.2. [P19367-2]
DR   RefSeq; NP_277032.1; NM_033497.2. [P19367-3]
DR   RefSeq; NP_277033.1; NM_033498.2. [P19367-3]
DR   RefSeq; NP_277035.2; NM_033500.2. [P19367-4]
DR   RefSeq; XP_011538034.1; XM_011539732.1. [P19367-4]
DR   UniGene; Hs.370365; -.
DR   PDB; 1CZA; X-ray; 1.90 A; N=1-917.
DR   PDB; 1DGK; X-ray; 2.80 A; N=1-917.
DR   PDB; 1HKB; X-ray; 2.80 A; A/B=1-917.
DR   PDB; 1HKC; X-ray; 2.80 A; A=1-917.
DR   PDB; 1QHA; X-ray; 2.25 A; A/B=1-917.
DR   PDB; 4F9O; X-ray; 2.65 A; A/B=1-914.
DR   PDB; 4FOE; X-ray; 2.70 A; A/B=1-917.
DR   PDB; 4FOI; X-ray; 2.40 A; A/B=1-917.
DR   PDB; 4FPA; X-ray; 2.48 A; A/B=1-917.
DR   PDB; 4FPB; X-ray; 3.00 A; A/B=1-917.
DR   PDBsum; 1CZA; -.
DR   PDBsum; 1DGK; -.
DR   PDBsum; 1HKB; -.
DR   PDBsum; 1HKC; -.
DR   PDBsum; 1QHA; -.
DR   PDBsum; 4F9O; -.
DR   PDBsum; 4FOE; -.
DR   PDBsum; 4FOI; -.
DR   PDBsum; 4FPA; -.
DR   PDBsum; 4FPB; -.
DR   ProteinModelPortal; P19367; -.
DR   SMR; P19367; -.
DR   BioGrid; 109345; 51.
DR   DIP; DIP-56245N; -.
DR   IntAct; P19367; 43.
DR   MINT; P19367; -.
DR   STRING; 9606.ENSP00000384774; -.
DR   BindingDB; P19367; -.
DR   ChEMBL; CHEMBL2688; -.
DR   DrugBank; DB02007; alpha-D-glucose 6-phosphate.
DR   DrugBank; DB02379; Beta-D-Glucose.
DR   DrugBank; DB09502; Fludeoxyglucose F-18.
DR   DrugBank; DB04395; Phosphoaminophosphonic Acid-Adenylate Ester.
DR   CarbonylDB; P19367; -.
DR   iPTMnet; P19367; -.
DR   PhosphoSitePlus; P19367; -.
DR   SwissPalm; P19367; -.
DR   BioMuta; HK1; -.
DR   DMDM; 116242516; -.
DR   EPD; P19367; -.
DR   MaxQB; P19367; -.
DR   PaxDb; P19367; -.
DR   PeptideAtlas; P19367; -.
DR   PRIDE; P19367; -.
DR   DNASU; 3098; -.
DR   Ensembl; ENST00000298649; ENSP00000298649; ENSG00000156515. [P19367-2]
DR   Ensembl; ENST00000359426; ENSP00000352398; ENSG00000156515. [P19367-1]
DR   Ensembl; ENST00000360289; ENSP00000353433; ENSG00000156515. [P19367-4]
DR   Ensembl; ENST00000448642; ENSP00000402103; ENSG00000156515. [P19367-3]
DR   GeneID; 3098; -.
DR   KEGG; hsa:3098; -.
DR   UCSC; uc001jpg.5; human. [P19367-1]
DR   CTD; 3098; -.
DR   DisGeNET; 3098; -.
DR   EuPathDB; HostDB:ENSG00000156515.21; -.
DR   GeneCards; HK1; -.
DR   HGNC; HGNC:4922; HK1.
DR   HPA; CAB010052; -.
DR   HPA; HPA007043; -.
DR   HPA; HPA007044; -.
DR   MalaCards; HK1; -.
DR   MIM; 142600; gene.
DR   MIM; 235700; phenotype.
DR   MIM; 605285; phenotype.
DR   MIM; 617460; phenotype.
DR   neXtProt; NX_P19367; -.
DR   OpenTargets; ENSG00000156515; -.
DR   Orphanet; 99953; Charcot-Marie-Tooth disease type 4G.
DR   Orphanet; 90031; Non-spherocytic hemolytic anemia due to hexokinase deficiency.
DR   PharmGKB; PA29300; -.
DR   eggNOG; KOG1369; Eukaryota.
DR   eggNOG; COG5026; LUCA.
DR   GeneTree; ENSGT00390000017159; -.
DR   HOVERGEN; HBG005020; -.
DR   InParanoid; P19367; -.
DR   KO; K00844; -.
DR   OMA; YDDQQCE; -.
DR   PhylomeDB; P19367; -.
DR   TreeFam; TF314238; -.
DR   BioCyc; MetaCyc:HS08136-MONOMER; -.
DR   BRENDA; 2.7.1.1; 2681.
DR   Reactome; R-HSA-5619056; Defective HK1 causes hexokinase deficiency (HK deficiency).
DR   Reactome; R-HSA-70171; Glycolysis.
DR   SABIO-RK; P19367; -.
DR   SIGNOR; P19367; -.
DR   UniPathway; UPA00242; -.
DR   ChiTaRS; HK1; human.
DR   EvolutionaryTrace; P19367; -.
DR   GenomeRNAi; 3098; -.
DR   PRO; PR:P19367; -.
DR   Proteomes; UP000005640; Chromosome 10.
DR   Bgee; ENSG00000156515; -.
DR   CleanEx; HS_HK1; -.
DR   ExpressionAtlas; P19367; baseline and differential.
DR   Genevisible; P19367; HS.
DR   GO; GO:0005829; C:cytosol; IBA:GO_Central.
DR   GO; GO:0005741; C:mitochondrial outer membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005739; C:mitochondrion; IDA:HPA.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0008865; F:fructokinase activity; IBA:GO_Central.
DR   GO; GO:0004340; F:glucokinase activity; IBA:GO_Central.
DR   GO; GO:0005536; F:glucose binding; IEA:InterPro.
DR   GO; GO:0004396; F:hexokinase activity; IMP:CAFA.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0019158; F:mannokinase activity; IBA:GO_Central.
DR   GO; GO:0042834; F:peptidoglycan binding; IDA:CAFA.
DR   GO; GO:0061621; P:canonical glycolysis; TAS:Reactome.
DR   GO; GO:0046835; P:carbohydrate phosphorylation; IMP:CAFA.
DR   GO; GO:0001678; P:cellular glucose homeostasis; IBA:GO_Central.
DR   GO; GO:0072655; P:establishment of protein localization to mitochondrion; IMP:ParkinsonsUK-UCL.
DR   GO; GO:0006096; P:glycolytic process; TAS:ProtInc.
DR   GO; GO:0072656; P:maintenance of protein location in mitochondrion; IMP:ParkinsonsUK-UCL.
DR   InterPro; IPR001312; Hexokinase.
DR   InterPro; IPR019807; Hexokinase_BS.
DR   InterPro; IPR022673; Hexokinase_C.
DR   InterPro; IPR022672; Hexokinase_N.
DR   PANTHER; PTHR19443; PTHR19443; 4.
DR   Pfam; PF00349; Hexokinase_1; 2.
DR   Pfam; PF03727; Hexokinase_2; 2.
DR   PROSITE; PS00378; HEXOKINASE_1; 2.
DR   PROSITE; PS51748; HEXOKINASE_2; 2.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Allosteric enzyme; Alternative splicing;
KW   ATP-binding; Charcot-Marie-Tooth disease; Complete proteome;
KW   Direct protein sequencing; Disease mutation; Glycolysis; Kinase;
KW   Membrane; Mitochondrion; Mitochondrion outer membrane;
KW   Neurodegeneration; Neuropathy; Nucleotide-binding; Phosphoprotein;
KW   Polymorphism; Reference proteome; Repeat; Retinitis pigmentosa;
KW   Transferase.
FT   CHAIN         1    917       Hexokinase-1.
FT                                /FTId=PRO_0000197585.
FT   DOMAIN       16    458       Hexokinase 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU01084}.
FT   DOMAIN      464    906       Hexokinase 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU01084}.
FT   NP_BIND      84     89       ATP 1. {ECO:0000244|PDB:1DGK,
FT                                ECO:0000244|PDB:1HKC,
FT                                ECO:0000269|PubMed:10686099,
FT                                ECO:0000269|PubMed:9735292}.
FT   NP_BIND     425    426       ATP 1. {ECO:0000244|PDB:1CZA,
FT                                ECO:0000244|PDB:1DGK,
FT                                ECO:0000244|PDB:1QHA,
FT                                ECO:0000269|PubMed:10574795,
FT                                ECO:0000269|PubMed:10686099}.
FT   NP_BIND     532    537       ATP 2. {ECO:0000244|PDB:1DGK,
FT                                ECO:0000269|PubMed:10686099}.
FT   NP_BIND     747    748       ATP 2. {ECO:0000244|PDB:1DGK,
FT                                ECO:0000269|PubMed:10686099}.
FT   NP_BIND     784    788       ATP 2. {ECO:0000244|PDB:1DGK,
FT                                ECO:0000269|PubMed:10686099}.
FT   NP_BIND     863    867       ATP 2. {ECO:0000244|PDB:1DGK,
FT                                ECO:0000244|PDB:1HKC,
FT                                ECO:0000269|PubMed:10686099,
FT                                ECO:0000269|PubMed:9735292}.
FT   REGION        1     12       Hydrophobic.
FT   REGION       13    475       Regulatory.
FT   REGION       73    207       Hexokinase small subdomain 1.
FT                                {ECO:0000255|PROSITE-ProRule:PRU01084}.
FT   REGION       84     91       Glucose-6-phosphate 1 binding.
FT                                {ECO:0000244|PDB:1CZA,
FT                                ECO:0000244|PDB:1HKB,
FT                                ECO:0000244|PDB:1QHA,
FT                                ECO:0000244|PDB:4FOE,
FT                                ECO:0000244|PDB:4FOI,
FT                                ECO:0000244|PDB:4FPA,
FT                                ECO:0000269|PubMed:10574795,
FT                                ECO:0000269|PubMed:10686099,
FT                                ECO:0000269|PubMed:9493266}.
FT   REGION      172    173       Substrate 1 binding.
FT                                {ECO:0000244|PDB:1CZA,
FT                                ECO:0000244|PDB:1DGK,
FT                                ECO:0000244|PDB:1HKB,
FT                                ECO:0000244|PDB:1HKC,
FT                                ECO:0000244|PDB:1QHA,
FT                                ECO:0000244|PDB:4F9O,
FT                                ECO:0000244|PDB:4FOE,
FT                                ECO:0000244|PDB:4FOI,
FT                                ECO:0000244|PDB:4FPA,
FT                                ECO:0000244|PDB:4FPB,
FT                                ECO:0000269|PubMed:10574795,
FT                                ECO:0000269|PubMed:10686099,
FT                                ECO:0000269|PubMed:9493266,
FT                                ECO:0000269|PubMed:9735292}.
FT   REGION      208    447       Hexokinase large subdomain 1.
FT                                {ECO:0000255|PROSITE-ProRule:PRU01084}.
FT   REGION      208    209       Substrate 1 binding.
FT                                {ECO:0000244|PDB:1CZA,
FT                                ECO:0000244|PDB:1DGK,
FT                                ECO:0000244|PDB:1HKB,
FT                                ECO:0000244|PDB:1HKC,
FT                                ECO:0000244|PDB:1QHA,
FT                                ECO:0000244|PDB:4F9O,
FT                                ECO:0000244|PDB:4FOE,
FT                                ECO:0000244|PDB:4FOI,
FT                                ECO:0000244|PDB:4FPA,
FT                                ECO:0000244|PDB:4FPB,
FT                                ECO:0000269|PubMed:10574795,
FT                                ECO:0000269|PubMed:10686099,
FT                                ECO:0000269|PubMed:9493266,
FT                                ECO:0000269|PubMed:9735292}.
FT   REGION      291    294       Substrate 1 binding.
FT                                {ECO:0000244|PDB:1CZA,
FT                                ECO:0000244|PDB:1DGK,
FT                                ECO:0000244|PDB:1HKB,
FT                                ECO:0000244|PDB:1HKC,
FT                                ECO:0000244|PDB:1QHA,
FT                                ECO:0000244|PDB:4F9O,
FT                                ECO:0000244|PDB:4FOE,
FT                                ECO:0000244|PDB:4FOI,
FT                                ECO:0000244|PDB:4FPA,
FT                                ECO:0000244|PDB:4FPB,
FT                                ECO:0000269|PubMed:10574795,
FT                                ECO:0000269|PubMed:10686099,
FT                                ECO:0000269|PubMed:9493266,
FT                                ECO:0000269|PubMed:9735292}.
FT   REGION      413    415       Glucose-6-phosphate 1 binding.
FT                                {ECO:0000244|PDB:1CZA,
FT                                ECO:0000244|PDB:1HKB,
FT                                ECO:0000244|PDB:1QHA,
FT                                ECO:0000244|PDB:4F9O,
FT                                ECO:0000244|PDB:4FOE,
FT                                ECO:0000244|PDB:4FOI,
FT                                ECO:0000244|PDB:4FPA,
FT                                ECO:0000244|PDB:4FPB,
FT                                ECO:0000269|PubMed:10574795,
FT                                ECO:0000269|PubMed:10686099,
FT                                ECO:0000269|PubMed:9493266}.
FT   REGION      476    917       Catalytic.
FT   REGION      521    655       Hexokinase small subdomain 2.
FT                                {ECO:0000255|PROSITE-ProRule:PRU01084}.
FT   REGION      532    536       Glucose-6-phosphate 2 binding.
FT                                {ECO:0000244|PDB:1CZA,
FT                                ECO:0000244|PDB:1QHA,
FT                                ECO:0000244|PDB:4FOE,
FT                                ECO:0000244|PDB:4FOI,
FT                                ECO:0000244|PDB:4FPA,
FT                                ECO:0000269|PubMed:10574795,
FT                                ECO:0000269|PubMed:10686099}.
FT   REGION      603    604       Substrate 2 binding.
FT                                {ECO:0000244|PDB:1DGK,
FT                                ECO:0000244|PDB:1HKB,
FT                                ECO:0000244|PDB:4F9O,
FT                                ECO:0000244|PDB:4FOE,
FT                                ECO:0000244|PDB:4FOI,
FT                                ECO:0000244|PDB:4FPA,
FT                                ECO:0000244|PDB:4FPB,
FT                                ECO:0000269|PubMed:10686099,
FT                                ECO:0000269|PubMed:9493266}.
FT   REGION      620    621       Substrate 2 binding.
FT                                {ECO:0000244|PDB:1CZA,
FT                                ECO:0000244|PDB:1DGK,
FT                                ECO:0000244|PDB:1HKB,
FT                                ECO:0000244|PDB:1QHA,
FT                                ECO:0000244|PDB:4F9O,
FT                                ECO:0000244|PDB:4FOE,
FT                                ECO:0000244|PDB:4FOI,
FT                                ECO:0000244|PDB:4FPA,
FT                                ECO:0000244|PDB:4FPB,
FT                                ECO:0000269|PubMed:10574795,
FT                                ECO:0000269|PubMed:10686099,
FT                                ECO:0000269|PubMed:9493266}.
FT   REGION      656    895       Hexokinase large subdomain 2.
FT                                {ECO:0000255|PROSITE-ProRule:PRU01084}.
FT   REGION      656    657       Substrate 2 binding.
FT                                {ECO:0000244|PDB:1CZA,
FT                                ECO:0000244|PDB:1DGK,
FT                                ECO:0000244|PDB:1HKB,
FT                                ECO:0000244|PDB:1QHA,
FT                                ECO:0000244|PDB:4F9O,
FT                                ECO:0000244|PDB:4FOE,
FT                                ECO:0000244|PDB:4FOI,
FT                                ECO:0000244|PDB:4FPA,
FT                                ECO:0000244|PDB:4FPB,
FT                                ECO:0000269|PubMed:10574795,
FT                                ECO:0000269|PubMed:10686099,
FT                                ECO:0000269|PubMed:9493266}.
FT   REGION      682    683       Substrate 2 binding.
FT                                {ECO:0000244|PDB:1CZA,
FT                                ECO:0000244|PDB:1DGK,
FT                                ECO:0000244|PDB:1HKB,
FT                                ECO:0000244|PDB:1QHA,
FT                                ECO:0000244|PDB:4F9O,
FT                                ECO:0000244|PDB:4FOE,
FT                                ECO:0000244|PDB:4FOI,
FT                                ECO:0000244|PDB:4FPA,
FT                                ECO:0000244|PDB:4FPB,
FT                                ECO:0000269|PubMed:10574795,
FT                                ECO:0000269|PubMed:10686099,
FT                                ECO:0000269|PubMed:9493266}.
FT   REGION      861    863       Glucose-6-phosphate 2 binding.
FT                                {ECO:0000244|PDB:1CZA,
FT                                ECO:0000244|PDB:1HKB,
FT                                ECO:0000244|PDB:1QHA,
FT                                ECO:0000244|PDB:4F9O,
FT                                ECO:0000244|PDB:4FOE,
FT                                ECO:0000244|PDB:4FOI,
FT                                ECO:0000244|PDB:4FPA,
FT                                ECO:0000244|PDB:4FPB,
FT                                ECO:0000269|PubMed:10574795,
FT                                ECO:0000269|PubMed:10686099,
FT                                ECO:0000269|PubMed:9493266}.
FT   BINDING      30     30       ATP 1. {ECO:0000244|PDB:1CZA,
FT                                ECO:0000244|PDB:1DGK,
FT                                ECO:0000244|PDB:1QHA,
FT                                ECO:0000269|PubMed:10574795,
FT                                ECO:0000269|PubMed:10686099}.
FT   BINDING     155    155       Substrate 1. {ECO:0000244|PDB:1DGK,
FT                                ECO:0000244|PDB:1HKB,
FT                                ECO:0000244|PDB:1HKC,
FT                                ECO:0000244|PDB:4F9O,
FT                                ECO:0000244|PDB:4FOE,
FT                                ECO:0000244|PDB:4FOI,
FT                                ECO:0000244|PDB:4FPA,
FT                                ECO:0000269|PubMed:10686099,
FT                                ECO:0000269|PubMed:9493266,
FT                                ECO:0000269|PubMed:9735292}.
FT   BINDING     209    209       Glucose-6-phosphate 1.
FT                                {ECO:0000244|PDB:1CZA,
FT                                ECO:0000244|PDB:1HKB,
FT                                ECO:0000244|PDB:1QHA,
FT                                ECO:0000244|PDB:4FOE,
FT                                ECO:0000244|PDB:4FOI,
FT                                ECO:0000244|PDB:4FPA,
FT                                ECO:0000269|PubMed:10574795,
FT                                ECO:0000269|PubMed:10686099,
FT                                ECO:0000269|PubMed:9493266}.
FT   BINDING     232    232       Glucose-6-phosphate 1.
FT                                {ECO:0000244|PDB:1CZA,
FT                                ECO:0000244|PDB:1HKB,
FT                                ECO:0000244|PDB:1QHA,
FT                                ECO:0000244|PDB:4F9O,
FT                                ECO:0000244|PDB:4FOE,
FT                                ECO:0000244|PDB:4FOI,
FT                                ECO:0000244|PDB:4FPA,
FT                                ECO:0000244|PDB:4FPB,
FT                                ECO:0000269|PubMed:10574795,
FT                                ECO:0000269|PubMed:10686099,
FT                                ECO:0000269|PubMed:9493266}.
FT   BINDING     235    235       Substrate 1. {ECO:0000244|PDB:1CZA,
FT                                ECO:0000244|PDB:1DGK,
FT                                ECO:0000244|PDB:1HKB,
FT                                ECO:0000244|PDB:1HKC,
FT                                ECO:0000244|PDB:1QHA,
FT                                ECO:0000244|PDB:4F9O,
FT                                ECO:0000244|PDB:4FOE,
FT                                ECO:0000244|PDB:4FOI,
FT                                ECO:0000244|PDB:4FPA,
FT                                ECO:0000244|PDB:4FPB,
FT                                ECO:0000269|PubMed:10574795,
FT                                ECO:0000269|PubMed:10686099,
FT                                ECO:0000269|PubMed:9493266,
FT                                ECO:0000269|PubMed:9735292}.
FT   BINDING     260    260       Substrate 1. {ECO:0000244|PDB:1CZA,
FT                                ECO:0000244|PDB:1DGK,
FT                                ECO:0000244|PDB:1HKB,
FT                                ECO:0000244|PDB:1HKC,
FT                                ECO:0000244|PDB:1QHA,
FT                                ECO:0000244|PDB:4F9O,
FT                                ECO:0000244|PDB:4FOE,
FT                                ECO:0000244|PDB:4FOI,
FT                                ECO:0000244|PDB:4FPA,
FT                                ECO:0000244|PDB:4FPB,
FT                                ECO:0000269|PubMed:10574795,
FT                                ECO:0000269|PubMed:10686099,
FT                                ECO:0000269|PubMed:9493266,
FT                                ECO:0000269|PubMed:9735292}.
FT   BINDING     345    345       ATP 1. {ECO:0000244|PDB:1QHA,
FT                                ECO:0000269|PubMed:10574795}.
FT   BINDING     449    449       Glucose-6-phosphate 1.
FT                                {ECO:0000244|PDB:1CZA,
FT                                ECO:0000244|PDB:1HKB,
FT                                ECO:0000244|PDB:1QHA,
FT                                ECO:0000244|PDB:4F9O,
FT                                ECO:0000244|PDB:4FOE,
FT                                ECO:0000244|PDB:4FOI,
FT                                ECO:0000244|PDB:4FPA,
FT                                ECO:0000244|PDB:4FPB,
FT                                ECO:0000269|PubMed:10574795,
FT                                ECO:0000269|PubMed:10686099,
FT                                ECO:0000269|PubMed:9493266}.
FT   BINDING     657    657       Glucose-6-phosphate 2.
FT                                {ECO:0000244|PDB:1CZA,
FT                                ECO:0000244|PDB:1HKB,
FT                                ECO:0000244|PDB:1QHA,
FT                                ECO:0000244|PDB:4FOI,
FT                                ECO:0000244|PDB:4FPA,
FT                                ECO:0000269|PubMed:10574795,
FT                                ECO:0000269|PubMed:10686099,
FT                                ECO:0000269|PubMed:9493266}.
FT   BINDING     680    680       ATP 2. {ECO:0000244|PDB:1DGK,
FT                                ECO:0000244|PDB:1HKC,
FT                                ECO:0000269|PubMed:10686099,
FT                                ECO:0000269|PubMed:9735292}.
FT   BINDING     680    680       Glucose-6-phosphate 2.
FT                                {ECO:0000244|PDB:1CZA,
FT                                ECO:0000244|PDB:1HKB,
FT                                ECO:0000244|PDB:1QHA,
FT                                ECO:0000244|PDB:4F9O,
FT                                ECO:0000244|PDB:4FOE,
FT                                ECO:0000244|PDB:4FOI,
FT                                ECO:0000244|PDB:4FPA,
FT                                ECO:0000244|PDB:4FPB,
FT                                ECO:0000269|PubMed:10574795,
FT                                ECO:0000269|PubMed:10686099,
FT                                ECO:0000269|PubMed:9493266}.
FT   BINDING     708    708       Substrate 2. {ECO:0000244|PDB:1CZA,
FT                                ECO:0000244|PDB:1DGK,
FT                                ECO:0000244|PDB:1HKB,
FT                                ECO:0000244|PDB:1QHA,
FT                                ECO:0000244|PDB:4F9O,
FT                                ECO:0000244|PDB:4FOE,
FT                                ECO:0000244|PDB:4FOI,
FT                                ECO:0000244|PDB:4FPA,
FT                                ECO:0000244|PDB:4FPB,
FT                                ECO:0000269|PubMed:10574795,
FT                                ECO:0000269|PubMed:10686099,
FT                                ECO:0000269|PubMed:9493266}.
FT   BINDING     742    742       Substrate 2. {ECO:0000244|PDB:1CZA,
FT                                ECO:0000244|PDB:1DGK,
FT                                ECO:0000244|PDB:1HKB,
FT                                ECO:0000244|PDB:1QHA,
FT                                ECO:0000244|PDB:4F9O,
FT                                ECO:0000244|PDB:4FOE,
FT                                ECO:0000244|PDB:4FOI,
FT                                ECO:0000244|PDB:4FPA,
FT                                ECO:0000244|PDB:4FPB,
FT                                ECO:0000269|PubMed:10574795,
FT                                ECO:0000269|PubMed:10686099,
FT                                ECO:0000269|PubMed:9493266}.
FT   BINDING     897    897       Glucose-6-phosphate 2.
FT                                {ECO:0000244|PDB:1CZA,
FT                                ECO:0000244|PDB:1HKB,
FT                                ECO:0000244|PDB:1QHA,
FT                                ECO:0000244|PDB:4F9O,
FT                                ECO:0000244|PDB:4FOI,
FT                                ECO:0000244|PDB:4FPA,
FT                                ECO:0000244|PDB:4FPB,
FT                                ECO:0000269|PubMed:10574795,
FT                                ECO:0000269|PubMed:10686099,
FT                                ECO:0000269|PubMed:9493266}.
FT   MOD_RES       1      1       N-acetylmethionine.
FT                                {ECO:0000244|PubMed:19413330,
FT                                ECO:0000244|PubMed:25944712,
FT                                ECO:0000269|Ref.7}.
FT   MOD_RES     337    337       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P05708}.
FT   VAR_SEQ       1     21       MIAAQLLAYYFTELKDDQVKK -> MDCEHSLSLPCRGAEA
FT                                WEIG (in isoform 2). {ECO:0000305}.
FT                                /FTId=VSP_002071.
FT   VAR_SEQ       1     21       MIAAQLLAYYFTELKDDQVKK -> MGQICQRESATAAEKP
FT                                KLHLLAESE (in isoform 3). {ECO:0000305}.
FT                                /FTId=VSP_002072.
FT   VAR_SEQ       1     21       MIAAQLLAYYFTELKDDQVKK -> MAKRALHDF (in
FT                                isoform 4).
FT                                {ECO:0000303|PubMed:10978502}.
FT                                /FTId=VSP_002073.
FT   VARIANT     529    529       L -> S (in HK deficiency;
FT                                dbSNP:rs137853249).
FT                                {ECO:0000269|PubMed:7655856}.
FT                                /FTId=VAR_009878.
FT   VARIANT     680    680       T -> S (in HK deficiency; HK Utrecht;
FT                                dbSNP:rs398122379).
FT                                {ECO:0000269|PubMed:12393545}.
FT                                /FTId=VAR_023780.
FT   VARIANT     776    776       L -> M (in dbSNP:rs1054203).
FT                                {ECO:0000269|PubMed:1637300,
FT                                ECO:0000269|PubMed:3207429}.
FT                                /FTId=VAR_023781.
FT   VARIANT     847    847       E -> K (in RP79; unknown pathological
FT                                significance; no effect on hexokinase
FT                                activity; no effect on protein abundance;
FT                                dbSNP:rs777849213).
FT                                {ECO:0000269|PubMed:25190649,
FT                                ECO:0000269|PubMed:25316723}.
FT                                /FTId=VAR_078923.
FT   CONFLICT    730    730       D -> N (in Ref. 1; AAA52646 and 9;
FT                                CAA47379). {ECO:0000305}.
FT   HELIX        17     25       {ECO:0000244|PDB:1CZA}.
FT   HELIX        27     29       {ECO:0000244|PDB:1CZA}.
FT   HELIX        33     51       {ECO:0000244|PDB:1CZA}.
FT   TURN         53     55       {ECO:0000244|PDB:1CZA}.
FT   HELIX        56     58       {ECO:0000244|PDB:1CZA}.
FT   STRAND       78    100       {ECO:0000244|PDB:1CZA}.
FT   STRAND      103    112       {ECO:0000244|PDB:1CZA}.
FT   HELIX       116    119       {ECO:0000244|PDB:1CZA}.
FT   STRAND      120    122       {ECO:0000244|PDB:1CZA}.
FT   HELIX       123    141       {ECO:0000244|PDB:1CZA}.
FT   STRAND      144    146       {ECO:0000244|PDB:4FOI}.
FT   STRAND      150    154       {ECO:0000244|PDB:1CZA}.
FT   STRAND      161    164       {ECO:0000244|PDB:4FPB}.
FT   TURN        179    182       {ECO:0000244|PDB:4FPB}.
FT   HELIX       185    196       {ECO:0000244|PDB:1CZA}.
FT   STRAND      203    207       {ECO:0000244|PDB:1CZA}.
FT   HELIX       209    220       {ECO:0000244|PDB:1CZA}.
FT   STRAND      224    241       {ECO:0000244|PDB:1CZA}.
FT   HELIX       242    244       {ECO:0000244|PDB:1CZA}.
FT   STRAND      252    258       {ECO:0000244|PDB:1CZA}.
FT   HELIX       261    263       {ECO:0000244|PDB:1CZA}.
FT   TURN        264    273       {ECO:0000244|PDB:1CZA}.
FT   HELIX       276    283       {ECO:0000244|PDB:1CZA}.
FT   STRAND      285    287       {ECO:0000244|PDB:1CZA}.
FT   HELIX       294    297       {ECO:0000244|PDB:1CZA}.
FT   HELIX       299    315       {ECO:0000244|PDB:1CZA}.
FT   HELIX       320    322       {ECO:0000244|PDB:1CZA}.
FT   TURN        326    329       {ECO:0000244|PDB:1CZA}.
FT   HELIX       336    342       {ECO:0000244|PDB:1CZA}.
FT   TURN        345    347       {ECO:0000244|PDB:1CZA}.
FT   HELIX       348    358       {ECO:0000244|PDB:1CZA}.
FT   HELIX       365    401       {ECO:0000244|PDB:1CZA}.
FT   STRAND      404    413       {ECO:0000244|PDB:1CZA}.
FT   HELIX       415    419       {ECO:0000244|PDB:1CZA}.
FT   HELIX       423    434       {ECO:0000244|PDB:1CZA}.
FT   STRAND      438    444       {ECO:0000244|PDB:1CZA}.
FT   HELIX       449    475       {ECO:0000244|PDB:1CZA}.
FT   HELIX       481    499       {ECO:0000244|PDB:1CZA}.
FT   HELIX       501    504       {ECO:0000244|PDB:1CZA}.
FT   STRAND      526    546       {ECO:0000244|PDB:1CZA}.
FT   STRAND      548    550       {ECO:0000244|PDB:1QHA}.
FT   STRAND      552    560       {ECO:0000244|PDB:1CZA}.
FT   HELIX       564    567       {ECO:0000244|PDB:1CZA}.
FT   STRAND      568    570       {ECO:0000244|PDB:4F9O}.
FT   HELIX       571    589       {ECO:0000244|PDB:1CZA}.
FT   STRAND      597    602       {ECO:0000244|PDB:1CZA}.
FT   STRAND      606    610       {ECO:0000244|PDB:1CZA}.
FT   STRAND      613    616       {ECO:0000244|PDB:1CZA}.
FT   HELIX       633    644       {ECO:0000244|PDB:1CZA}.
FT   STRAND      650    655       {ECO:0000244|PDB:1CZA}.
FT   HELIX       657    666       {ECO:0000244|PDB:1CZA}.
FT   STRAND      672    689       {ECO:0000244|PDB:1CZA}.
FT   TURN        690    692       {ECO:0000244|PDB:1CZA}.
FT   STRAND      700    706       {ECO:0000244|PDB:1CZA}.
FT   HELIX       709    711       {ECO:0000244|PDB:1CZA}.
FT   TURN        712    715       {ECO:0000244|PDB:1CZA}.
FT   TURN        717    721       {ECO:0000244|PDB:1CZA}.
FT   HELIX       724    731       {ECO:0000244|PDB:1CZA}.
FT   TURN        734    737       {ECO:0000244|PDB:1CZA}.
FT   HELIX       742    744       {ECO:0000244|PDB:1CZA}.
FT   TURN        747    749       {ECO:0000244|PDB:1CZA}.
FT   HELIX       750    763       {ECO:0000244|PDB:1CZA}.
FT   HELIX       768    770       {ECO:0000244|PDB:1CZA}.
FT   TURN        774    777       {ECO:0000244|PDB:1CZA}.
FT   HELIX       784    790       {ECO:0000244|PDB:1CZA}.
FT   HELIX       797    807       {ECO:0000244|PDB:1CZA}.
FT   HELIX       813    848       {ECO:0000244|PDB:1CZA}.
FT   STRAND      852    861       {ECO:0000244|PDB:1CZA}.
FT   HELIX       863    867       {ECO:0000244|PDB:1CZA}.
FT   HELIX       871    882       {ECO:0000244|PDB:1CZA}.
FT   STRAND      886    892       {ECO:0000244|PDB:1CZA}.
FT   HELIX       898    912       {ECO:0000244|PDB:1CZA}.
SQ   SEQUENCE   917 AA;  102486 MW;  F29A6837531C0594 CRC64;
     MIAAQLLAYY FTELKDDQVK KIDKYLYAMR LSDETLIDIM TRFRKEMKNG LSRDFNPTAT
     VKMLPTFVRS IPDGSEKGDF IALDLGGSSF RILRVQVNHE KNQNVHMESE VYDTPENIVH
     GSGSQLFDHV AECLGDFMEK RKIKDKKLPV GFTFSFPCQQ SKIDEAILIT WTKRFKASGV
     EGADVVKLLN KAIKKRGDYD ANIVAVVNDT VGTMMTCGYD DQHCEVGLII GTGTNACYME
     ELRHIDLVEG DEGRMCINTE WGAFGDDGSL EDIRTEFDRE IDRGSLNPGK QLFEKMVSGM
     YLGELVRLIL VKMAKEGLLF EGRITPELLT RGKFNTSDVS AIEKNKEGLH NAKEILTRLG
     VEPSDDDCVS VQHVCTIVSF RSANLVAATL GAILNRLRDN KGTPRLRTTV GVDGSLYKTH
     PQYSRRFHKT LRRLVPDSDV RFLLSESGSG KGAAMVTAVA YRLAEQHRQI EETLAHFHLT
     KDMLLEVKKR MRAEMELGLR KQTHNNAVVK MLPSFVRRTP DGTENGDFLA LDLGGTNFRV
     LLVKIRSGKK RTVEMHNKIY AIPIEIMQGT GEELFDHIVS CISDFLDYMG IKGPRMPLGF
     TFSFPCQQTS LDAGILITWT KGFKATDCVG HDVVTLLRDA IKRREEFDLD VVAVVNDTVG
     TMMTCAYEEP TCEVGLIVGT GSNACYMEEM KNVEMVEGDQ GQMCINMEWG AFGDNGCLDD
     IRTHYDRLVD EYSLNAGKQR YEKMISGMYL GEIVRNILID FTKKGFLFRG QISETLKTRG
     IFETKFLSQI ESDRLALLQV RAILQQLGLN STCDDSILVK TVCGVVSRRA AQLCGAGMAA
     VVDKIRENRG LDRLNVTVGV DGTLYKLHPH FSRIMHQTVK ELSPKCNVSF LLSEDGSGKG
     AALITAVGVR LRTEASS
//
ID   P78542_HUMAN            Unreviewed;        30 AA.
AC   P78542;
DT   01-MAY-1997, integrated into UniProtKB/TrEMBL.
DT   01-MAY-1997, sequence version 1.
DT   23-MAY-2018, entry version 79.
DE   SubName: Full=Hexokinase 1 {ECO:0000313|EMBL:AAB40528.1};
DE            EC=2.7.1.1 {ECO:0000313|EMBL:AAB40528.1};
DE   Flags: Fragment;
GN   Name=HK1-tb {ECO:0000313|EMBL:AAB40528.1};
GN   Synonyms=HK1-ta {ECO:0000313|EMBL:AAB40527.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:AAB40528.1};
RN   [1] {ECO:0000313|EMBL:AAB40528.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Testis {ECO:0000313|EMBL:AAB40528.1};
RX   PubMed=8722688;
RX   DOI=10.1002/(SICI)1098-2795(199605)44:1<14::AID-MRD2>3.0.CO;2-W;
RA   Mori C., Nakamura N., Welch J.E., Shiota K., Eddy E.M.;
RT   "Testis-specific expression of mRNAs for a unique human type 1
RT   hexokinase lacking the porin-binding domain.";
RL   Mol. Reprod. Dev. 44:14-22(1996).
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U38226; AAB40527.1; -; mRNA.
DR   EMBL; U38227; AAB40528.1; -; mRNA.
DR   RefSeq; NP_277033.1; NM_033498.2.
DR   RefSeq; NP_277035.2; NM_033500.2.
DR   UniGene; Hs.370365; -.
DR   PeptideAtlas; P78542; -.
DR   PRIDE; P78542; -.
DR   DNASU; 3098; -.
DR   GeneID; 3098; -.
DR   CTD; 3098; -.
DR   PharmGKB; PA29300; -.
DR   eggNOG; KOG1369; Eukaryota.
DR   eggNOG; COG5026; LUCA.
DR   ChiTaRS; HK1; human.
DR   GenomeRNAi; 3098; -.
DR   GO; GO:0004396; F:hexokinase activity; IEA:UniProtKB-EC.
PE   2: Evidence at transcript level;
KW   Kinase {ECO:0000313|EMBL:AAB40528.1};
KW   Transferase {ECO:0000313|EMBL:AAB40528.1}.
FT   NON_TER      30     30       {ECO:0000313|EMBL:AAB40528.1}.
SQ   SEQUENCE   30 AA;  3374 MW;  E84D89B518AD02FC CRC64;
     MGQICQRESA TAAEKPKLHL LAESEIDKYL
//
ID   Q59FD4_HUMAN            Unreviewed;       949 AA.
AC   Q59FD4;
DT   26-APR-2005, integrated into UniProtKB/TrEMBL.
DT   26-APR-2005, sequence version 1.
DT   31-JAN-2018, entry version 85.
DE   SubName: Full=Hexokinase 1 isoform HKI variant {ECO:0000313|EMBL:BAD92763.1};
DE   Flags: Fragment;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAD92763.1};
RN   [1] {ECO:0000313|EMBL:BAD92763.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Brain {ECO:0000313|EMBL:BAD92763.1};
RA   Totoki Y., Toyoda A., Takeda T., Sakaki Y., Tanaka A., Yokoyama S.,
RA   Ohara O., Nagase T., Kikuno R.F.;
RT   "Homo sapiens protein coding cDNA.";
RL   Submitted (MAR-2005) to the EMBL/GenBank/DDBJ databases.
CC   -!- SIMILARITY: Belongs to the hexokinase family.
CC       {ECO:0000256|SAAS:SAAS00672880}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB209526; BAD92763.1; -; mRNA.
DR   RefSeq; NP_000179.2; NM_000188.2.
DR   UniGene; Hs.370365; -.
DR   ProteinModelPortal; Q59FD4; -.
DR   PRIDE; Q59FD4; -.
DR   DNASU; 3098; -.
DR   GeneID; 3098; -.
DR   KEGG; hsa:3098; -.
DR   CTD; 3098; -.
DR   PharmGKB; PA29300; -.
DR   eggNOG; KOG1369; Eukaryota.
DR   eggNOG; COG5026; LUCA.
DR   HOGENOM; HOG000162671; -.
DR   HOVERGEN; HBG005020; -.
DR   KO; K00844; -.
DR   GenomeRNAi; 3098; -.
DR   Genevisible; Q59FD4; HS.
DR   GO; GO:0005623; C:cell; IEA:GOC.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0005536; F:glucose binding; IEA:InterPro.
DR   GO; GO:0004396; F:hexokinase activity; IEA:InterPro.
DR   GO; GO:0001678; P:cellular glucose homeostasis; IEA:InterPro.
DR   GO; GO:0006096; P:glycolytic process; IEA:UniProtKB-KW.
DR   InterPro; IPR001312; Hexokinase.
DR   InterPro; IPR019807; Hexokinase_BS.
DR   InterPro; IPR022673; Hexokinase_C.
DR   InterPro; IPR022672; Hexokinase_N.
DR   PANTHER; PTHR19443; PTHR19443; 4.
DR   Pfam; PF00349; Hexokinase_1; 2.
DR   Pfam; PF03727; Hexokinase_2; 2.
DR   PROSITE; PS00378; HEXOKINASE_1; 2.
DR   PROSITE; PS51748; HEXOKINASE_2; 2.
PE   2: Evidence at transcript level;
KW   ATP-binding {ECO:0000256|SAAS:SAAS00672869};
KW   Glycolysis {ECO:0000256|SAAS:SAAS00672870};
KW   Kinase {ECO:0000256|SAAS:SAAS00672871, ECO:0000313|EMBL:BAD92763.1};
KW   Nucleotide-binding {ECO:0000256|SAAS:SAAS00672869};
KW   Transferase {ECO:0000256|SAAS:SAAS00672871,
KW   ECO:0000313|EMBL:BAD92763.1}.
FT   DOMAIN       54    251       Hexokinase_1. {ECO:0000259|Pfam:PF00349}.
FT   DOMAIN      257    491       Hexokinase_2. {ECO:0000259|Pfam:PF03727}.
FT   DOMAIN      502    699       Hexokinase_1. {ECO:0000259|Pfam:PF00349}.
FT   DOMAIN      705    939       Hexokinase_2. {ECO:0000259|Pfam:PF03727}.
FT   NON_TER       1      1       {ECO:0000313|EMBL:BAD92763.1}.
SQ   SEQUENCE   949 AA;  105804 MW;  54972BD394467EA3 CRC64;
     GAAEQPPEDH GSPGLRRTDR PHACRPATPT ASMIAAQLLA YYFTELKDDQ VKKIDKYLYA
     MRLSDETLID IMTRFRKEMK NGLSRDFNPT ATVKMLPTFV RSIPDGSEKG DFIALDLGGS
     SFRILRVQVN HEKNQNVHME SEVYDTPENI VHGSGSQLFD HVAECLGDFM EKRKIKDKKL
     PVGFTFSFPC QQSKIDEAIL ITWTKRFKAS GVEGADVVKL LNKAIKKRGD YDANIVAVVN
     DTVGTMMTCG YDDQHCEVGL IIGTGTNACY MEELRHIDLV EGDEGRMCIN TEWGAFGDDG
     SLEDIRTEFD REIDRGSLNP GKQLFEKMVS GMYLGELVRL ILVKMAKEGL LFEGRITPEL
     LTRGKFNTSD VSAIEKNKEG LHNAKEILTR LGVEPSDDDC VSVQHVCTIV SFRSANLVAA
     TLGAILNRLR DNKGTPRLRT TVGVDGSLYK THPQYSRRFH KTLRRLVPDS DVRFLLSESG
     SGKGAAMVTA VAYRLAEQHR QIEETLAHFH LTKDMLLEVK KRMRAEMELG LRKQTHNNAV
     VKMLPSFVRR TPDGTENGDF LALDLGGTNF RVLLVKIRSG KKRTVEMHNK IYAIPIEIMQ
     GTGEELFDHI VSCISDFLDY MGIKGPRMPL GFTFSFPCQQ TSLDAGILIT WTKGFKATDC
     VGHDVVTLLR DAIKRREEFD LDVVAVVNDT VGTMMTCAYE EPTCEVGLIV GTGSNACYME
     EMKNVEMVEG DQGQMCINME WGAFGDNGCL DDIRTHYDRL VDEYSLNAGK QRYEKMISGM
     YLGEIVRNIL IDFTKKGFLF RGQISETLKT RGIFETKFLS QIESDRLALL QVRAILQQLG
     LNSTCDDSIL VKTVCGVVSR RAAQLCGAGM AAVVDKIREN RGLDRLNVTV GVDGTLYKLH
     PHFSRIMHQT VKELSPKCNV SFLLSEDGSG KGAALITAVG VRLRTEASS
//
ID   A0A024R9C1_HUMAN        Unreviewed;       636 AA.
AC   A0A024R9C1;
DT   09-JUL-2014, integrated into UniProtKB/TrEMBL.
DT   09-JUL-2014, sequence version 1.
DT   23-MAY-2018, entry version 38.
DE   RecName: Full=Polyadenylate-binding protein {ECO:0000256|RuleBase:RU362004};
DE            Short=PABP {ECO:0000256|RuleBase:RU362004};
GN   Name=PABPC1 {ECO:0000313|EMBL:EAW91817.1};
GN   ORFNames=hCG_15683 {ECO:0000313|EMBL:EAW91817.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:EAW91817.1};
RN   [1] {ECO:0000313|EMBL:EAW91817.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAW91817.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
CC   -!- FUNCTION: Binds the poly(A) tail of mRNA.
CC       {ECO:0000256|RuleBase:RU362004}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000256|RuleBase:RU362004}.
CC   -!- SIMILARITY: Belongs to the polyadenylate-binding protein type-1
CC       family. {ECO:0000256|RuleBase:RU362004}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; CH471060; EAW91815.1; -; Genomic_DNA.
DR   EMBL; CH471060; EAW91817.1; -; Genomic_DNA.
DR   RefSeq; NP_002559.2; NM_002568.3.
DR   RefSeq; XP_005250918.1; XM_005250861.2.
DR   UniGene; Hs.387804; -.
DR   SMR; A0A024R9C1; -.
DR   PRIDE; A0A024R9C1; -.
DR   GeneID; 26986; -.
DR   KEGG; hsa:26986; -.
DR   CTD; 26986; -.
DR   EuPathDB; HostDB:ENSG00000070756.13; -.
DR   eggNOG; KOG0123; Eukaryota.
DR   eggNOG; ENOG410XR5X; LUCA.
DR   KO; K13126; -.
DR   OMA; RAAYYPA; -.
DR   OrthoDB; EOG091G03ZE; -.
DR   ChiTaRS; PABPC1; human.
DR   GenomeRNAi; 26986; -.
DR   Bgee; ENSG00000070756; -.
DR   ExpressionAtlas; A0A024R9C1; baseline and differential.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0003723; F:RNA binding; IEA:UniProtKB-UniRule.
DR   Gene3D; 3.30.70.330; -; 4.
DR   InterPro; IPR012677; Nucleotide-bd_a/b_plait_sf.
DR   InterPro; IPR036053; PABP-dom.
DR   InterPro; IPR006515; PABP_1234.
DR   InterPro; IPR002004; PABP_HYD.
DR   InterPro; IPR035979; RBD_domain_sf.
DR   InterPro; IPR000504; RRM_dom.
DR   InterPro; IPR003954; RRM_dom_euk.
DR   Pfam; PF00658; PABP; 1.
DR   Pfam; PF00076; RRM_1; 4.
DR   SMART; SM00517; PolyA; 1.
DR   SMART; SM00360; RRM; 4.
DR   SMART; SM00361; RRM_1; 3.
DR   SUPFAM; SSF54928; SSF54928; 2.
DR   SUPFAM; SSF63570; SSF63570; 1.
DR   TIGRFAMs; TIGR01628; PABP-1234; 1.
DR   PROSITE; PS51309; PABC; 1.
DR   PROSITE; PS50102; RRM; 4.
PE   3: Inferred from homology;
KW   Cytoplasm {ECO:0000256|RuleBase:RU362004};
KW   Repeat {ECO:0000256|SAAS:SAAS00454674};
KW   RNA-binding {ECO:0000256|PROSITE-ProRule:PRU00176,
KW   ECO:0000256|RuleBase:RU362004, ECO:0000256|SAAS:SAAS00572889}.
FT   DOMAIN       11     89       RRM. {ECO:0000259|PROSITE:PS50102}.
FT   DOMAIN       99    175       RRM. {ECO:0000259|PROSITE:PS50102}.
FT   DOMAIN      191    268       RRM. {ECO:0000259|PROSITE:PS50102}.
FT   DOMAIN      294    370       RRM. {ECO:0000259|PROSITE:PS50102}.
FT   DOMAIN      542    619       PABC. {ECO:0000259|PROSITE:PS51309}.
SQ   SEQUENCE   636 AA;  70671 MW;  2EB1B02A346132EE CRC64;
     MNPSAPSYPM ASLYVGDLHP DVTEAMLYEK FSPAGPILSI RVCRDMITRR SLGYAYVNFQ
     QPADAERALD TMNFDVIKGK PVRIMWSQRD PSLRKSGVGN IFIKNLDKSI DNKALYDTFS
     AFGNILSCKV VCDENGSKGY GFVHFETQEA AERAIEKMNG MLLNDRKVFV GRFKSRKERE
     AELGARAKEF TNVYIKNFGE DMDDERLKDL FGKFGPALSV KVMTDESGKS KGFGFVSFER
     HEDAQKAVDE MNGKELNGKQ IYVGRAQKKV ERQTELKRKF EQMKQDRITR YQGVNLYVKN
     LDDGIDDERL RKEFSPFGTI TSAKVMMEGG RSKGFGFVCF SSPEEATKAV TEMNGRIVAT
     KPLYVALAQR KEERQAHLTN QYMQRMASVR AVPNPVINPY QPAPPSGYFM AAIPQTQNRA
     AYYPPSQIAQ LRPSPRWTAQ GARPHPFQNM PGAIRPAAPR PPFSTMRPAS SQVPRVMSTQ
     RVANTSTQTM GPRPAAAAAA ATPAVRTVPQ YKYAAGVRNP QQHLNAQPQV TMQQPAVHVQ
     GQEPLTASML ASAPPQEQKQ MLGERLFPLI QAMHPTLAGK ITGMLLEIDN SELLHMLESP
     ESLRSKVDEA VAVLQAHQAK EAAQKAVNSA TGVPTV
//
ID   PABP1_HUMAN             Reviewed;         636 AA.
AC   P11940; Q15097; Q93004;
DT   01-OCT-1989, integrated into UniProtKB/Swiss-Prot.
DT   15-JUL-1998, sequence version 2.
DT   23-MAY-2018, entry version 224.
DE   RecName: Full=Polyadenylate-binding protein 1;
DE            Short=PABP-1;
DE            Short=Poly(A)-binding protein 1;
GN   Name=PABPC1; Synonyms=PAB1, PABP1, PABPC2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=2885805; DOI=10.1093/nar/15.12.4771;
RA   Grange T., de Sa C.M., Oddos J., Pictet R.;
RT   "Human mRNA polyadenylate binding protein: evolutionary conservation
RT   of a nucleic acid binding motif.";
RL   Nucleic Acids Res. 15:4771-4787(1987).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   TISSUE=Lung;
RA   Hornstein E., Abramzon-Talianker A., Wiesel I., Meyuhas O.;
RT   "The human poly(A)-binding protein (PABP) gene: structural and
RT   functional analysis.";
RL   Submitted (SEP-1996) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16421571; DOI=10.1038/nature04406;
RA   Nusbaum C., Mikkelsen T.S., Zody M.C., Asakawa S., Taudien S.,
RA   Garber M., Kodira C.D., Schueler M.G., Shimizu A., Whittaker C.A.,
RA   Chang J.L., Cuomo C.A., Dewar K., FitzGerald M.G., Yang X.,
RA   Allen N.R., Anderson S., Asakawa T., Blechschmidt K., Bloom T.,
RA   Borowsky M.L., Butler J., Cook A., Corum B., DeArellano K.,
RA   DeCaprio D., Dooley K.T., Dorris L. III, Engels R., Gloeckner G.,
RA   Hafez N., Hagopian D.S., Hall J.L., Ishikawa S.K., Jaffe D.B.,
RA   Kamat A., Kudoh J., Lehmann R., Lokitsang T., Macdonald P.,
RA   Major J.E., Matthews C.D., Mauceli E., Menzel U., Mihalev A.H.,
RA   Minoshima S., Murayama Y., Naylor J.W., Nicol R., Nguyen C.,
RA   O'Leary S.B., O'Neill K., Parker S.C.J., Polley A., Raymond C.K.,
RA   Reichwald K., Rodriguez J., Sasaki T., Schilhabel M., Siddiqui R.,
RA   Smith C.L., Sneddon T.P., Talamas J.A., Tenzin P., Topham K.,
RA   Venkataraman V., Wen G., Yamazaki S., Young S.K., Zeng Q.,
RA   Zimmer A.R., Rosenthal A., Birren B.W., Platzer M., Shimizu N.,
RA   Lander E.S.;
RT   "DNA sequence and analysis of human chromosome 8.";
RL   Nature 439:331-335(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Lung, and Muscle;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 26-636 (ISOFORM 2).
RA   Murphy E.P., McKenna N.J., Headon D.R.;
RT   "Nucleotide sequence of a partial cDNA encoding a novel human
RT   polyadenylate-binding protein.";
RL   Submitted (FEB-1995) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   PROTEIN SEQUENCE OF 31-41; 51-78; 84-89; 96-104; 158-166; 189-196;
RP   214-221; 232-240; 291-309; 312-324; 357-370; 375-385; 482-506; 566-580
RP   AND 605-620, METHYLATION AT ARG-493, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RC   TISSUE=Colon carcinoma, and Ovarian carcinoma;
RA   Bienvenut W.V., Zebisch A., Lilla S., von Kriegsheim A., Lempens A.,
RA   Kolch W.;
RL   Submitted (DEC-2008) to UniProtKB.
RN   [7]
RP   PROTEIN SEQUENCE OF 31-41; 51-78; 84-89; 96-104; 114-129; 139-153;
RP   158-166; 187-208; 214-221; 232-240; 291-324; 334-348; 357-370;
RP   375-385; 482-506; 519-559; 566-620 AND 626-636, METHYLATION AT LYS-299
RP   AND ARG-493, AND IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RA   Bienvenut W.V., Waridel P., Quadroni M.;
RL   Submitted (MAR-2009) to UniProtKB.
RN   [8]
RP   PARTIAL NUCLEOTIDE SEQUENCE [MRNA], AND SUBCELLULAR LOCATION.
RX   PubMed=7908267; DOI=10.1006/excr.1994.1104;
RA   Goerlach M., Burd C.G., Dreyfuss G.;
RT   "The mRNA poly(A)-binding protein: localization, abundance, and RNA-
RT   binding specificity.";
RL   Exp. Cell Res. 211:400-407(1994).
RN   [9]
RP   SUBCELLULAR LOCATION.
RX   PubMed=9582337; DOI=10.1074/jbc.273.21.13015;
RA   Afonina E., Stauber R., Pavlakis G.N.;
RT   "The human poly(A)-binding protein 1 shuttles between the nucleus and
RT   the cytoplasm.";
RL   J. Biol. Chem. 273:13015-13021(1998).
RN   [10]
RP   INTERACTION WITH PAIP1, AND DOMAIN.
RX   PubMed=9548260; DOI=10.1038/33198;
RA   Craig A.W.B., Haghighat A., Yu A.T.K., Sonenberg N.;
RT   "Interaction of polyadenylate-binding protein with the eIF4G homologue
RT   PAIP enhances translation.";
RL   Nature 392:520-523(1998).
RN   [11]
RP   FUNCTION IN TRANSLATIONALLY COUPLED MRNA TURNOVER, AND IDENTIFICATION
RP   IN A COMPLEX WITH HNRPD; SYNCRIP; PAIP1 AND CSDE1.
RX   PubMed=11051545; DOI=10.1016/S0092-8674(00)00102-1;
RA   Grosset C., Chen C.-Y.A., Xu N., Sonenberg N., Jacquemin-Sablon H.,
RA   Shyu A.-B.;
RT   "A mechanism for translationally coupled mRNA turnover: interaction
RT   between the poly(A) tail and a c-fos RNA coding determinant via a
RT   protein complex.";
RL   Cell 103:29-40(2000).
RN   [12]
RP   INTERACTION WITH PAIP2.
RX   PubMed=11172725; DOI=10.1016/S1097-2765(01)00168-X;
RA   Khaleghpour K., Svitkin Y.V., Craig A.W.B., DeMaria C.T., Deo R.C.,
RA   Burley S.K., Sonenberg N.;
RT   "Translational repression by a novel partner of human poly(A) binding
RT   protein, Paip2.";
RL   Mol. Cell 7:205-216(2001).
RN   [13]
RP   INTERACTION WITH PAIP2.
RX   PubMed=11438674; DOI=10.1128/MCB.21.15.5200-5213.2001;
RA   Khaleghpour K., Kahvejian A., De Crescenzo G., Roy G., Svitkin Y.V.,
RA   Imataka H., O'Connor-McCourt M., Sonenberg N.;
RT   "Dual interactions of the translational repressor Paip2 with poly(A)
RT   binding protein.";
RL   Mol. Cell. Biol. 21:5200-5213(2001).
RN   [14]
RP   METHYLATION AT ARG-455 AND ARG-460, AND MUTAGENESIS OF ARG-455 AND
RP   ARG-460.
RX   PubMed=11850402; DOI=10.1093/embo-reports/kvf052;
RA   Lee J., Bedford M.T.;
RT   "PABP1 identified as an arginine methyltransferase substrate using
RT   high-density protein arrays.";
RL   EMBO Rep. 3:268-273(2002).
RN   [15]
RP   INTERACTION WITH PAIP1.
RX   PubMed=11997512; DOI=10.1128/MCB.22.11.3769-3782.2002;
RA   Roy G., De Crescenzo G., Khaleghpour K., Kahvejian A.,
RA   O'Connor-McCourt M., Sonenberg N.;
RT   "Paip1 interacts with poly(A) binding protein through two independent
RT   binding motifs.";
RL   Mol. Cell. Biol. 22:3769-3782(2002).
RN   [16]
RP   IDENTIFICATION BY MASS SPECTROMETRY, AND IDENTIFICATION IN THE
RP   SPLICEOSOMAL C COMPLEX.
RX   PubMed=11991638; DOI=10.1017/S1355838202021088;
RA   Jurica M.S., Licklider L.J., Gygi S.P., Grigorieff N., Moore M.J.;
RT   "Purification and characterization of native spliceosomes suitable for
RT   three-dimensional structural analysis.";
RL   RNA 8:426-439(2002).
RN   [17]
RP   PHOSPHORYLATION BY MAPKAPK2.
RX   PubMed=12565831; DOI=10.1016/S0006-291X(03)00015-9;
RA   Bollig F., Winzen R., Gaestel M., Kostka S., Resch K., Holtmann H.;
RT   "Affinity purification of ARE-binding proteins identifies polyA-
RT   binding protein 1 as a potential substrate in MK2-induced mRNA
RT   stabilization.";
RL   Biochem. Biophys. Res. Commun. 301:665-670(2003).
RN   [18]
RP   INTERACTION WITH CSDE1.
RX   PubMed=15314026; DOI=10.1101/gad.1219104;
RA   Chang T.-C., Yamashita A., Chen C.-Y.A., Yamashita Y., Zhu W.,
RA   Durdan S., Kahvejian A., Sonenberg N., Shyu A.-B.;
RT   "UNR, a new partner of poly(A)-binding protein, plays a key role in
RT   translationally coupled mRNA turnover mediated by the c-fos major
RT   coding-region determinant.";
RL   Genes Dev. 18:2010-2023(2004).
RN   [19]
RP   IDENTIFICATION IN A MRNP COMPLEX WITH IGF2BP1 AND CSDE1.
RX   PubMed=16356927; DOI=10.1093/nar/gki1014;
RA   Patel G.P., Ma S., Bag J.;
RT   "The autoregulatory translational control element of poly(A)-binding
RT   protein mRNA forms a heteromeric ribonucleoprotein complex.";
RL   Nucleic Acids Res. 33:7074-7089(2005).
RN   [20]
RP   FUNCTION, HOMODIMERIZATION, INTERACTION WITH IGF2BP1, AND RNA-BINDING.
RX   PubMed=17212783; DOI=10.1111/j.1742-4658.2006.05556.x;
RA   Patel G.P., Bag J.;
RT   "IMP1 interacts with poly(A)-binding protein (PABP) and the
RT   autoregulatory translational control element of PABP-mRNA through the
RT   KH III-IV domain.";
RL   FEBS J. 273:5678-5690(2006).
RN   [21]
RP   INTERACTION WITH PAIP2B.
RX   PubMed=16804161; DOI=10.1261/rna.106506;
RA   Berlanga J.J., Baass A., Sonenberg N.;
RT   "Regulation of poly(A) binding protein function in translation:
RT   Characterization of the Paip2 homolog, Paip2B.";
RL   RNA 12:1556-1568(2006).
RN   [22]
RP   INTERACTION WITH AGO1 AND AGO2.
RX   PubMed=17932509; DOI=10.1038/sj.embor.7401088;
RA   Hoeck J., Weinmann L., Ender C., Ruedel S., Kremmer E., Raabe M.,
RA   Urlaub H., Meister G.;
RT   "Proteomic and functional analysis of Argonaute-containing mRNA-
RT   protein complexes in human cells.";
RL   EMBO Rep. 8:1052-1060(2007).
RN   [23]
RP   INTERACTION WITH NFX1.
RX   PubMed=17267499; DOI=10.1128/JVI.02007-06;
RA   Katzenellenbogen R.A., Egelkrout E.M., Vliet-Gregg P., Gewin L.C.,
RA   Gafken P.R., Galloway D.A.;
RT   "NFX1-123 and poly(A) binding proteins synergistically augment
RT   activation of telomerase in human papillomavirus type 16 E6-expressing
RT   cells.";
RL   J. Virol. 81:3786-3796(2007).
RN   [24]
RP   IDENTIFICATION IN A MRNP GRANULE COMPLEX, INTERACTION WITH IGF2BP1,
RP   AND SUBCELLULAR LOCATION.
RX   PubMed=17289661; DOI=10.1074/mcp.M600346-MCP200;
RA   Joeson L., Vikesaa J., Krogh A., Nielsen L.K., Hansen T., Borup R.,
RA   Johnsen A.H., Christiansen J., Nielsen F.C.;
RT   "Molecular composition of IMP1 ribonucleoprotein granules.";
RL   Mol. Cell. Proteomics 6:798-811(2007).
RN   [25]
RP   SUBCELLULAR LOCATION.
RX   PubMed=18799579; DOI=10.1128/JVI.00872-08;
RA   Harb M., Becker M.M., Vitour D., Baron C.H., Vende P., Brown S.C.,
RA   Bolte S., Arold S.T., Poncet D.;
RT   "Nuclear localization of cytoplasmic poly(A)-binding protein upon
RT   rotavirus infection involves the interaction of NSP3 with eIF4G and
RT   RoXaN.";
RL   J. Virol. 82:11283-11293(2008).
RN   [26]
RP   FUNCTION IN NONSENSE-MEDIATED MRNA DECAY, AND INTERACTION WITH GSPT2.
RX   PubMed=18447585; DOI=10.1371/journal.pbio.0060111;
RA   Singh G., Rebbapragada I., Lykke-Andersen J.;
RT   "A competition between stimulators and antagonists of Upf complex
RT   recruitment governs human nonsense-mediated mRNA decay.";
RL   PLoS Biol. 6:E111-E111(2008).
RN   [27]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-315, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [28]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [29]
RP   IDENTIFICATION IN A MRNP COMPLEX, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RX   PubMed=19029303; DOI=10.1261/rna.1175909;
RA   Weidensdorfer D., Stoehr N., Baude A., Lederer M., Koehn M.,
RA   Schierhorn A., Buchmeier S., Wahle E., Huettelmaiery S.;
RT   "Control of c-myc mRNA stability by IGF2BP1-associated cytoplasmic
RT   RNPs.";
RL   RNA 15:104-115(2009).
RN   [30]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-512, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [31]
RP   REVIEW.
RX   PubMed=20102337; DOI=10.1042/BJ20091571;
RA   Smith R.W., Gray N.K.;
RT   "Poly(A)-binding protein (PABP): a common viral target.";
RL   Biochem. J. 426:1-12(2010).
RN   [32]
RP   INTERACTION WITH LARP1.
RX   PubMed=20430826; DOI=10.1093/nar/gkq294;
RA   Burrows C., Abd Latip N., Lam S.J., Carpenter L., Sawicka K.,
RA   Tzolovsky G., Gabra H., Bushell M., Glover D.M., Willis A.E.,
RA   Blagden S.P.;
RT   "The RNA binding protein Larp1 regulates cell division, apoptosis and
RT   cell migration.";
RL   Nucleic Acids Res. 38:5542-5553(2010).
RN   [33]
RP   INTERACTION WITH HHV-5 PROTEIN UL69.
RX   PubMed=20133758; DOI=10.1073/pnas.0914856107;
RA   Aoyagi M., Gaspar M., Shenk T.E.;
RT   "Human cytomegalovirus UL69 protein facilitates translation by
RT   associating with the mRNA cap-binding complex and excluding 4EBP1.";
RL   Proc. Natl. Acad. Sci. U.S.A. 107:2640-2645(2010).
RN   [34]
RP   FUNCTION, SUBCELLULAR LOCATION, AND INTERACTION WITH PABPC1 AND RACK1.
RX   PubMed=20573744; DOI=10.1261/rna.2146910;
RA   Schaffler K., Schulz K., Hirmer A., Wiesner J., Grimm M., Sickmann A.,
RA   Fischer U.;
RT   "A stimulatory role for the La-related protein 4B in translation.";
RL   RNA 16:1488-1499(2010).
RN   [35]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-315, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [36]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [37]
RP   INTERACTION WITH SETX.
RX   PubMed=21700224; DOI=10.1016/j.molcel.2011.04.026;
RA   Skourti-Stathaki K., Proudfoot N.J., Gromak N.;
RT   "Human senataxin resolves RNA/DNA hybrids formed at transcriptional
RT   pause sites to promote Xrn2-dependent termination.";
RL   Mol. Cell 42:794-805(2011).
RN   [38]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-315 AND THR-319, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [39]
RP   INTERACTION WITH TRIM71.
RX   PubMed=23125361; DOI=10.1093/nar/gks1032;
RA   Loedige I., Gaidatzis D., Sack R., Meister G., Filipowicz W.;
RT   "The mammalian TRIM-NHL protein TRIM71/LIN-41 is a repressor of mRNA
RT   function.";
RL   Nucleic Acids Res. 41:518-532(2013).
RN   [40]
RP   FUNCTION.
RX   PubMed=25480299; DOI=10.1016/j.cell.2014.10.055;
RA   Lim J., Ha M., Chang H., Kwon S.C., Simanshu D.K., Patel D.J.,
RA   Kim V.N.;
RT   "Uridylation by TUT4 and TUT7 marks mRNA for degradation.";
RL   Cell 159:1365-1376(2014).
RN   [41]
RP   INTERACTION WITH LARP1.
RX   PubMed=24532714; DOI=10.1101/gad.231407.113;
RA   Tcherkezian J., Cargnello M., Romeo Y., Huttlin E.L., Lavoie G.,
RA   Gygi S.P., Roux P.P.;
RT   "Proteomic analysis of cap-dependent translation identifies LARP1 as a
RT   key regulator of 5'TOP mRNA translation.";
RL   Genes Dev. 28:357-371(2014).
RN   [42]
RP   METHYLATION [LARGE SCALE ANALYSIS] AT ARG-385; ARG-419; ARG-432;
RP   ARG-436; ARG-481; ARG-493; ARG-506 AND ARG-518, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Colon carcinoma;
RX   PubMed=24129315; DOI=10.1074/mcp.O113.027870;
RA   Guo A., Gu H., Zhou J., Mulhern D., Wang Y., Lee K.A., Yang V.,
RA   Aguiar M., Kornhauser J., Jia X., Ren J., Beausoleil S.A., Silva J.C.,
RA   Vemulapalli V., Bedford M.T., Comb M.J.;
RT   "Immunoaffinity enrichment and mass spectrometry analysis of protein
RT   methylation.";
RL   Mol. Cell. Proteomics 13:372-387(2014).
RN   [43]
RP   INTERACTION WITH LARP1.
RX   PubMed=25940091; DOI=10.1074/jbc.M114.621730;
RA   Fonseca B.D., Zakaria C., Jia J.J., Graber T.E., Svitkin Y.,
RA   Tahmasebi S., Healy D., Hoang H.D., Jensen J.M., Diao I.T.,
RA   Lussier A., Dajadian C., Padmanabhan N., Wang W., Matta-Camacho E.,
RA   Hearnden J., Smith E.M., Tsukumo Y., Yanagiya A., Morita M.,
RA   Petroulakis E., Gonzalez J.L., Hernandez G., Alain T., Damgaard C.K.;
RT   "La-related protein 1 (LARP1) represses terminal oligopyrimidine (TOP)
RT   mRNA translation downstream of mTOR complex 1 (mTORC1).";
RL   J. Biol. Chem. 290:15996-16020(2015).
RN   [44]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [45]
RP   INTERACTION WITH ZFC3H1.
RX   PubMed=27871484; DOI=10.1016/j.molcel.2016.09.025;
RA   Meola N., Domanski M., Karadoulama E., Chen Y., Gentil C., Pultz D.,
RA   Vitting-Seerup K., Lykke-Andersen S., Andersen J.S., Sandelin A.,
RA   Jensen T.H.;
RT   "Identification of a nuclear exosome decay pathway for processed
RT   transcripts.";
RL   Mol. Cell 64:520-533(2016).
RN   [46]
RP   IDENTIFICATION BY MASS SPECTROMETRY, FUNCTION, INTERACTION WITH RYDEN,
RP   AND IDENTIFICATION IN A COMPLEX WITH RYDEN AND LARP1.
RX   PubMed=26735137; DOI=10.1371/journal.ppat.1005357;
RA   Suzuki Y., Chin W.X., Han Q., Ichiyama K., Lee C.H., Eyo Z.W.,
RA   Ebina H., Takahashi H., Takahashi C., Tan B.H., Hishiki T., Ohba K.,
RA   Matsuyama T., Koyanagi Y., Tan Y.J., Sawasaki T., Chu J.J.,
RA   Vasudevan S.G., Sano K., Yamamoto N.;
RT   "Characterization of RyDEN (C19orf66) as an interferon-stimulated
RT   cellular inhibitor against dengue virus replication.";
RL   PLoS Pathog. 12:E1005357-E1005357(2016).
RN   [47]
RP   X-RAY CRYSTALLOGRAPHY (2.6 ANGSTROMS) OF 1-190.
RX   PubMed=10499800; DOI=10.1016/S0092-8674(00)81517-2;
RA   Deo R.C., Bonanno J.B., Sonenberg N., Burley S.K.;
RT   "Recognition of polyadenylate RNA by the poly(A)-binding protein.";
RL   Cell 98:835-845(1999).
RN   [48]
RP   STRUCTURE BY NMR OF 498-636, INTERACTION WITH GSPT1; PAIP1 AND PAIP2,
RP   AND DOMAIN.
RX   PubMed=11287632; DOI=10.1073/pnas.071024998;
RA   Kozlov G., Trempe J.F., Khaleghpour K., Kahvejian A., Ekiel I.,
RA   Gehring K.;
RT   "Structure and function of the C-terminal PABC domain of human
RT   poly(A)-binding protein.";
RL   Proc. Natl. Acad. Sci. U.S.A. 98:4409-4413(2001).
RN   [49]
RP   STRUCTURE BY NMR OF 541-623 IN COMPLEX WITH GSPT1.
RA   Osawa M., Nakanishi T., Hosoda N., Uchida S., Hoshino T., Katada I.,
RA   Shimada I.;
RT   "Eukaryotic translation termination factor Gspt/ERF3 recognizes Pabp
RT   with chemical exchange using two overlapping motifs.";
RL   Submitted (MAY-2009) to the PDB data bank.
RN   [50]
RP   X-RAY CRYSTALLOGRAPHY (1.4 ANGSTROMS) OF 544-626 IN COMPLEX WITH
RP   PAIP2, AND DOMAIN.
RX   PubMed=20096703; DOI=10.1016/j.jmb.2010.01.032;
RA   Kozlov G., Menade M., Rosenauer A., Nguyen L., Gehring K.;
RT   "Molecular determinants of PAM2 recognition by the MLLE domain of
RT   poly(A)-binding protein.";
RL   J. Mol. Biol. 397:397-407(2010).
RN   [51]
RP   X-RAY CRYSTALLOGRAPHY (1.70 ANGSTROMS) OF 543-621 IN COMPLEX WITH
RP   LARP4B.
RA   Grimm C., Pelz J.P.;
RT   "LARP4B binds to the PABC1 MLLE domain via a variant PAM2 motif.";
RL   Submitted (DEC-2010) to the PDB data bank.
RN   [52]
RP   X-RAY CRYSTALLOGRAPHY (1.80 ANGSTROMS) OF 544-626 IN COMPLEX WITH
RP   LARP4.
RX   PubMed=21098120; DOI=10.1128/MCB.01162-10;
RA   Yang R., Gaidamakov S.A., Xie J., Lee J., Martino L., Kozlov G.,
RA   Crawford A.K., Russo A.N., Conte M.R., Gehring K., Maraia R.J.;
RT   "La-related protein 4 binds poly(A), interacts with the poly(A)-
RT   binding protein MLLE domain via a variant PAM2w motif, and can promote
RT   mRNA stability.";
RL   Mol. Cell. Biol. 31:542-556(2011).
CC   -!- FUNCTION: Binds the poly(A) tail of mRNA, including that of its
CC       own transcript. May be involved in cytoplasmic regulatory
CC       processes of mRNA metabolism such as pre-mRNA splicing. Its
CC       function in translational initiation regulation can either be
CC       enhanced by PAIP1 or repressed by PAIP2. Can probably bind to
CC       cytoplasmic RNA sequences other than poly(A) in vivo. Involved in
CC       translationally coupled mRNA turnover. Implicated with other RNA-
CC       binding proteins in the cytoplasmic deadenylation/translational
CC       and decay interplay of the FOS mRNA mediated by the major coding-
CC       region determinant of instability (mCRD) domain. Involved in
CC       regulation of nonsense-mediated decay (NMD) of mRNAs containing
CC       premature stop codons; for the recognition of premature
CC       termination codons (PTC) and initiation of NMD a competitive
CC       interaction between UPF1 and PABPC1 with the ribosome-bound
CC       release factors is proposed. By binding to long poly(A) tails, may
CC       protect them from uridylation by ZCCHC6/ZCCHC11 and hence
CC       contribute to mRNA stability (PubMed:25480299). Positively
CC       regulates the replication of dengue virus (DENV)
CC       (PubMed:26735137). {ECO:0000269|PubMed:11051545,
CC       ECO:0000269|PubMed:17212783, ECO:0000269|PubMed:18447585,
CC       ECO:0000269|PubMed:20573744, ECO:0000269|PubMed:25480299,
CC       ECO:0000269|PubMed:26735137}.
CC   -!- SUBUNIT: May interact with SETX (PubMed:21700224). May form
CC       homodimers. Component of a multisubunit autoregulatory
CC       ribonucleoprotein complex (ARC), at least composed of IGF2BP1,
CC       PABPC1 and CSDE1 (PubMed:16356927). Directly interacts with
CC       IGF2BP1. Part of a complex associated with the FOS mCRD domain and
CC       consisting of HNRPD, SYNCRIP, PAIP1 and CSDE1/UNR
CC       (PubMed:11051545). Interacts with the PABPC1-interacting motif-1
CC       (PAM1) and -2 (PAM2) of PAIP1 and PAIP2 (PubMed:9548260,
CC       PubMed:11172725, PubMed:11438674, PubMed:11997512,
CC       PubMed:11287632, PubMed:20096703). Interacts with PAIP1 with a 1:1
CC       stoichiometry and with PAIP2 with a 1:2 stoichiometry. The
CC       interaction with CSDE1 is direct and RNA-independent. Found in a
CC       mRNP complex with YBX2 (By similarity). Interacts with PAPD4/GLD2
CC       (By similarity). Identified in the spliceosome C complex
CC       (PubMed:11991638). Identified in a mRNP complex, at least composed
CC       of DHX9, DDX3X, ELAVL1, HNRNPU, IGF2BP1, ILF3, PABPC1, PCBP2,
CC       PTBP2, STAU1, STAU2, SYNCRIP and YBX1. Identified in a IGF2BP1-
CC       dependent mRNP granule complex containing untranslated mRNAs.
CC       Interacts with NFX1 (PubMed:17267499). Interacts with PIWIL1 (By
CC       similarity). Interacts with AGO1, AGO2, GSPT1 and GSPT2
CC       (PubMed:17932509, PubMed:18447585, Ref.49). Interacts with human
CC       cytomegalovirus/HHV-5 protein UL69 (PubMed:20133758). Interacts
CC       with LARP4B (Ref.51). Interacts (via the second and third RRM
CC       domains and the C-terminus) with PAIP2B (via central acidic
CC       portion and C-terminus) (PubMed:16804161, PubMed:11287632).
CC       Interacts with LARP1 (PubMed:20430826, PubMed:24532714,
CC       PubMed:25940091). Interacts with RYDEN (PubMed:26735137). Found in
CC       a complex with RYDEN and LARP1 (PubMed:26735137). Interacts with
CC       LARP4 (PubMed:21098120). Interacts with ZFC3H1 in a RNase-
CC       sensitive manner (PubMed:27871484). Interacts with TRIM71 (via NHL
CC       repeats) in an RNA-dependent manner (PubMed:23125361).
CC       {ECO:0000250|UniProtKB:P29341, ECO:0000269|PubMed:11051545,
CC       ECO:0000269|PubMed:11172725, ECO:0000269|PubMed:11287632,
CC       ECO:0000269|PubMed:11438674, ECO:0000269|PubMed:11991638,
CC       ECO:0000269|PubMed:11997512, ECO:0000269|PubMed:15314026,
CC       ECO:0000269|PubMed:16356927, ECO:0000269|PubMed:16804161,
CC       ECO:0000269|PubMed:17212783, ECO:0000269|PubMed:17267499,
CC       ECO:0000269|PubMed:17289661, ECO:0000269|PubMed:17932509,
CC       ECO:0000269|PubMed:18447585, ECO:0000269|PubMed:19029303,
CC       ECO:0000269|PubMed:20096703, ECO:0000269|PubMed:20133758,
CC       ECO:0000269|PubMed:20430826, ECO:0000269|PubMed:20573744,
CC       ECO:0000269|PubMed:21098120, ECO:0000269|PubMed:21700224,
CC       ECO:0000269|PubMed:23125361, ECO:0000269|PubMed:24532714,
CC       ECO:0000269|PubMed:26735137, ECO:0000269|PubMed:27871484,
CC       ECO:0000269|PubMed:9548260, ECO:0000269|Ref.49}.
CC   -!- INTERACTION:
CC       Q99700:ATXN2; NbExp=6; IntAct=EBI-81531, EBI-697691;
CC       O00571:DDX3X; NbExp=10; IntAct=EBI-81531, EBI-353779;
CC       P06730:EIF4E; NbExp=5; IntAct=EBI-81531, EBI-73440;
CC       Q04637:EIF4G1; NbExp=4; IntAct=EBI-81531, EBI-73711;
CC       P15170-2:GSPT1; NbExp=2; IntAct=EBI-81531, EBI-9094806;
CC       Q8IYD1:GSPT2; NbExp=7; IntAct=EBI-81531, EBI-3869637;
CC       Q14103-4:HNRNPD; NbExp=2; IntAct=EBI-81531, EBI-432545;
CC       P35568:IRS1; NbExp=2; IntAct=EBI-81531, EBI-517592;
CC       Q09161:NCBP1; NbExp=4; IntAct=EBI-81531, EBI-464743;
CC       Q86U42:PABPN1; NbExp=2; IntAct=EBI-81531, EBI-1226435;
CC       Q9H074:PAIP1; NbExp=13; IntAct=EBI-81531, EBI-81519;
CC       Q9BPZ3:PAIP2; NbExp=5; IntAct=EBI-81531, EBI-2957445;
CC       Q58A45:PAN3; NbExp=4; IntAct=EBI-81531, EBI-2513054;
CC       Q96Q15:SMG1; NbExp=2; IntAct=EBI-81531, EBI-1049832;
CC       Q8NDV7:TNRC6A; NbExp=3; IntAct=EBI-81531, EBI-2269715;
CC       Q9UPQ9:TNRC6B; NbExp=3; IntAct=EBI-81531, EBI-947158;
CC       Q9HCJ0:TNRC6C; NbExp=22; IntAct=EBI-81531, EBI-6507625;
CC       P50616:TOB1; NbExp=4; IntAct=EBI-81531, EBI-723281;
CC       Q14106:TOB2; NbExp=4; IntAct=EBI-81531, EBI-2562000;
CC       Q9J0X9:UL54 (xeno); NbExp=3; IntAct=EBI-81531, EBI-7967856;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:20573744,
CC       ECO:0000269|PubMed:7908267, ECO:0000269|PubMed:9582337}. Nucleus
CC       {ECO:0000269|PubMed:18799579, ECO:0000269|PubMed:9582337}.
CC       Note=Localized in cytoplasmic mRNP granules containing
CC       untranslated mRNAs (PubMed:17289661). Shuttles between the
CC       cytoplasm and the nucleus (PubMed:9582337).
CC       {ECO:0000269|PubMed:17289661, ECO:0000269|PubMed:9582337}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P11940-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P11940-2; Sequence=VSP_009846;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Ubiquitous.
CC   -!- DOMAIN: The RNA-binding domains RRM1 and RRM2 and the C-terminus
CC       (last 138 amino acids) regions interact with the PABPC1-
CC       interacting motif-1 (PAM1) and -2 (PAM2) of PAIP1, respectively.
CC       {ECO:0000269|PubMed:11287632, ECO:0000269|PubMed:11997512}.
CC   -!- DOMAIN: The RNA-binding domains RRM2 and RRM3 and the C-terminus
CC       (last 138 amino acids) regions interact with the PABPC1-
CC       interacting motif-1 (PAM1) and -2 (PAM2) of PAIP2, respectively.
CC       {ECO:0000269|PubMed:11287632, ECO:0000269|PubMed:20096703}.
CC   -!- PTM: Phosphorylated by MAPKAPK2. {ECO:0000269|PubMed:12565831}.
CC   -!- PTM: Methylated by CARM1. Arg-493 is dimethylated, probably to
CC       asymmetric dimethylarginine. {ECO:0000269|PubMed:11850402,
CC       ECO:0000269|Ref.6, ECO:0000269|Ref.7}.
CC   -!- MISCELLANEOUS: Many viruses shutoff host mRNA translational
CC       machinery by inhibiting cellular PABPC1 activity using different
CC       mechanisms. Picornaviruses, caliciviruses or lentiviruses encode
CC       proteases that cleave PABPC1 at several defined sites in the
CC       proline-rich linker region between RRMs and the C-terminal domain.
CC       Rotaviruses, gammherpesviruses and bunyamwera virus relocalize
CC       PABPC1 from the cytoplasm to the nucleus thus altering its
CC       function. Many of these viruses translate their mRNA in a PABPC1-
CC       independent manner and are unaffected by host PABPC1 inhibition.
CC   -!- SIMILARITY: Belongs to the polyadenylate-binding protein type-1
CC       family. {ECO:0000305}.
CC   -!- CAUTION: Was termed (Ref.5) polyadenylate binding protein II.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; Y00345; CAA68428.1; -; mRNA.
DR   EMBL; U68104; AAD08718.1; -; Genomic_DNA.
DR   EMBL; U68093; AAD08718.1; JOINED; Genomic_DNA.
DR   EMBL; U68094; AAD08718.1; JOINED; Genomic_DNA.
DR   EMBL; U68095; AAD08718.1; JOINED; Genomic_DNA.
DR   EMBL; U68097; AAD08718.1; JOINED; Genomic_DNA.
DR   EMBL; U68098; AAD08718.1; JOINED; Genomic_DNA.
DR   EMBL; U68099; AAD08718.1; JOINED; Genomic_DNA.
DR   EMBL; U68100; AAD08718.1; JOINED; Genomic_DNA.
DR   EMBL; U68101; AAD08718.1; JOINED; Genomic_DNA.
DR   EMBL; U68102; AAD08718.1; JOINED; Genomic_DNA.
DR   EMBL; U68103; AAD08718.1; JOINED; Genomic_DNA.
DR   EMBL; AP001205; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC015958; AAH15958.1; -; mRNA.
DR   EMBL; BC023520; AAH23520.1; -; mRNA.
DR   EMBL; Z48501; CAA88401.1; -; mRNA.
DR   CCDS; CCDS6289.1; -. [P11940-1]
DR   PIR; A93668; DNHUPA.
DR   PIR; S52491; S52491.
DR   RefSeq; NP_002559.2; NM_002568.3. [P11940-1]
DR   RefSeq; XP_005250918.1; XM_005250861.2. [P11940-1]
DR   UniGene; Hs.387804; -.
DR   PDB; 1CVJ; X-ray; 2.60 A; A/B/C/D/E/F/G/H=1-190.
DR   PDB; 1G9L; NMR; -; A=498-636.
DR   PDB; 1JGN; NMR; -; A=544-636.
DR   PDB; 1JH4; NMR; -; A=544-636.
DR   PDB; 2K8G; NMR; -; A=90-182.
DR   PDB; 2RQG; NMR; -; B=541-623.
DR   PDB; 2RQH; NMR; -; B=541-623.
DR   PDB; 2X04; X-ray; 1.49 A; A/B=545-619.
DR   PDB; 3KTP; X-ray; 1.50 A; A=544-626.
DR   PDB; 3KTR; X-ray; 1.70 A; A=544-626.
DR   PDB; 3KUI; X-ray; 2.30 A; A=544-626.
DR   PDB; 3KUJ; X-ray; 1.40 A; A=544-626.
DR   PDB; 3KUR; X-ray; 2.50 A; A/B/C/D/E/F/G/H=544-617.
DR   PDB; 3KUS; X-ray; 1.40 A; A/B=544-626.
DR   PDB; 3KUT; X-ray; 1.50 A; A/B=544-626.
DR   PDB; 3PKN; X-ray; 1.80 A; A=544-626.
DR   PDB; 3PTH; X-ray; 1.70 A; A=543-621.
DR   PDB; 4F02; X-ray; 2.00 A; A/D=1-190.
DR   PDB; 4F25; X-ray; 1.90 A; A=99-199.
DR   PDB; 4F26; X-ray; 2.00 A; A=99-199.
DR   PDB; 5DX1; X-ray; 1.93 A; F/G/H/I=449-466.
DR   PDB; 5DX8; X-ray; 1.94 A; E/F/G/H=449-466.
DR   PDB; 5DXA; X-ray; 2.07 A; F/G/I=449-466.
DR   PDB; 5LGP; X-ray; 2.04 A; E/F/G/H=447-458.
DR   PDB; 5LGQ; X-ray; 2.11 A; E/F/G/H=456-466.
DR   PDB; 5LGR; X-ray; 2.00 A; E/F/G/H=447-458.
DR   PDB; 5LGS; X-ray; 2.10 A; E/F/G/H=456-464.
DR   PDBsum; 1CVJ; -.
DR   PDBsum; 1G9L; -.
DR   PDBsum; 1JGN; -.
DR   PDBsum; 1JH4; -.
DR   PDBsum; 2K8G; -.
DR   PDBsum; 2RQG; -.
DR   PDBsum; 2RQH; -.
DR   PDBsum; 2X04; -.
DR   PDBsum; 3KTP; -.
DR   PDBsum; 3KTR; -.
DR   PDBsum; 3KUI; -.
DR   PDBsum; 3KUJ; -.
DR   PDBsum; 3KUR; -.
DR   PDBsum; 3KUS; -.
DR   PDBsum; 3KUT; -.
DR   PDBsum; 3PKN; -.
DR   PDBsum; 3PTH; -.
DR   PDBsum; 4F02; -.
DR   PDBsum; 4F25; -.
DR   PDBsum; 4F26; -.
DR   PDBsum; 5DX1; -.
DR   PDBsum; 5DX8; -.
DR   PDBsum; 5DXA; -.
DR   PDBsum; 5LGP; -.
DR   PDBsum; 5LGQ; -.
DR   PDBsum; 5LGR; -.
DR   PDBsum; 5LGS; -.
DR   ProteinModelPortal; P11940; -.
DR   SMR; P11940; -.
DR   BioGrid; 117939; 252.
DR   CORUM; P11940; -.
DR   DIP; DIP-31613N; -.
DR   ELM; P11940; -.
DR   IntAct; P11940; 114.
DR   MINT; P11940; -.
DR   STRING; 9606.ENSP00000313007; -.
DR   BindingDB; P11940; -.
DR   ChEMBL; CHEMBL1293286; -.
DR   iPTMnet; P11940; -.
DR   PhosphoSitePlus; P11940; -.
DR   SwissPalm; P11940; -.
DR   BioMuta; PABPC1; -.
DR   DMDM; 3183544; -.
DR   EPD; P11940; -.
DR   MaxQB; P11940; -.
DR   PaxDb; P11940; -.
DR   PeptideAtlas; P11940; -.
DR   PRIDE; P11940; -.
DR   DNASU; 26986; -.
DR   Ensembl; ENST00000318607; ENSP00000313007; ENSG00000070756. [P11940-1]
DR   GeneID; 26986; -.
DR   KEGG; hsa:26986; -.
DR   UCSC; uc003yjs.2; human. [P11940-1]
DR   CTD; 26986; -.
DR   DisGeNET; 26986; -.
DR   EuPathDB; HostDB:ENSG00000070756.13; -.
DR   GeneCards; PABPC1; -.
DR   HGNC; HGNC:8554; PABPC1.
DR   HPA; CAB011536; -.
DR   HPA; HPA045423; -.
DR   HPA; HPA067156; -.
DR   MIM; 604679; gene.
DR   neXtProt; NX_P11940; -.
DR   OpenTargets; ENSG00000070756; -.
DR   PharmGKB; PA32880; -.
DR   eggNOG; KOG0123; Eukaryota.
DR   eggNOG; ENOG410XR5X; LUCA.
DR   GeneTree; ENSGT00760000118913; -.
DR   HOGENOM; HOG000217922; -.
DR   HOVERGEN; HBG002295; -.
DR   InParanoid; P11940; -.
DR   KO; K13126; -.
DR   OMA; RAAYYPA; -.
DR   OrthoDB; EOG091G03ZE; -.
DR   PhylomeDB; P11940; -.
DR   TreeFam; TF300458; -.
DR   Reactome; R-HSA-156827; L13a-mediated translational silencing of Ceruloplasmin expression.
DR   Reactome; R-HSA-429947; Deadenylation of mRNA.
DR   Reactome; R-HSA-450408; AUF1 (hnRNP D0) binds and destabilizes mRNA.
DR   Reactome; R-HSA-72649; Translation initiation complex formation.
DR   Reactome; R-HSA-9010553; Regulation of expression of SLITs and ROBOs.
DR   Reactome; R-HSA-975956; Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC).
DR   Reactome; R-HSA-975957; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC).
DR   SIGNOR; P11940; -.
DR   ChiTaRS; PABPC1; human.
DR   EvolutionaryTrace; P11940; -.
DR   GeneWiki; PABPC1; -.
DR   GenomeRNAi; 26986; -.
DR   PMAP-CutDB; P11940; -.
DR   PRO; PR:P11940; -.
DR   Proteomes; UP000005640; Chromosome 8.
DR   Bgee; ENSG00000070756; -.
DR   CleanEx; HS_PABPC1; -.
DR   ExpressionAtlas; P11940; baseline and differential.
DR   Genevisible; P11940; HS.
DR   GO; GO:0071013; C:catalytic step 2 spliceosome; IDA:UniProtKB.
DR   GO; GO:0005737; C:cytoplasm; TAS:UniProtKB.
DR   GO; GO:0036464; C:cytoplasmic ribonucleoprotein granule; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0010494; C:cytoplasmic stress granule; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0005925; C:focal adhesion; HDA:UniProtKB.
DR   GO; GO:0016020; C:membrane; HDA:UniProtKB.
DR   GO; GO:0005634; C:nucleus; IDA:MGI.
DR   GO; GO:1990904; C:ribonucleoprotein complex; IDA:UniProtKB.
DR   GO; GO:0003730; F:mRNA 3'-UTR binding; IDA:UniProtKB.
DR   GO; GO:0008143; F:poly(A) binding; IDA:MGI.
DR   GO; GO:0008266; F:poly(U) RNA binding; IDA:MGI.
DR   GO; GO:0008022; F:protein C-terminus binding; IPI:UniProtKB.
DR   GO; GO:0003723; F:RNA binding; IDA:CAFA.
DR   GO; GO:0008494; F:translation activator activity; TAS:UniProtKB.
DR   GO; GO:0031047; P:gene silencing by RNA; ISS:UniProtKB.
DR   GO; GO:0006378; P:mRNA polyadenylation; TAS:UniProtKB.
DR   GO; GO:0000398; P:mRNA splicing, via spliceosome; IC:UniProtKB.
DR   GO; GO:0048255; P:mRNA stabilization; TAS:UniProtKB.
DR   GO; GO:2000623; P:negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; IDA:UniProtKB.
DR   GO; GO:0000184; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; TAS:Reactome.
DR   GO; GO:1900153; P:positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; ISS:UniProtKB.
DR   GO; GO:0060213; P:positive regulation of nuclear-transcribed mRNA poly(A) tail shortening; ISS:UniProtKB.
DR   GO; GO:0045070; P:positive regulation of viral genome replication; IMP:UniProtKB.
DR   GO; GO:0043488; P:regulation of mRNA stability; TAS:Reactome.
DR   GO; GO:0006413; P:translational initiation; TAS:Reactome.
DR   Gene3D; 3.30.70.330; -; 4.
DR   InterPro; IPR012677; Nucleotide-bd_a/b_plait_sf.
DR   InterPro; IPR036053; PABP-dom.
DR   InterPro; IPR006515; PABP_1234.
DR   InterPro; IPR002004; PABP_HYD.
DR   InterPro; IPR035979; RBD_domain_sf.
DR   InterPro; IPR000504; RRM_dom.
DR   InterPro; IPR003954; RRM_dom_euk.
DR   Pfam; PF00658; PABP; 1.
DR   Pfam; PF00076; RRM_1; 4.
DR   SMART; SM00517; PolyA; 1.
DR   SMART; SM00360; RRM; 4.
DR   SMART; SM00361; RRM_1; 3.
DR   SUPFAM; SSF54928; SSF54928; 2.
DR   SUPFAM; SSF63570; SSF63570; 1.
DR   TIGRFAMs; TIGR01628; PABP-1234; 1.
DR   PROSITE; PS51309; PABC; 1.
DR   PROSITE; PS50102; RRM; 4.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Complete proteome;
KW   Cytoplasm; Direct protein sequencing; Methylation; mRNA processing;
KW   mRNA splicing; Nonsense-mediated mRNA decay; Nucleus; Phosphoprotein;
KW   Reference proteome; Repeat; RNA-binding; Spliceosome.
FT   CHAIN         1    636       Polyadenylate-binding protein 1.
FT                                /FTId=PRO_0000081698.
FT   DOMAIN       11     89       RRM 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00176}.
FT   DOMAIN       99    175       RRM 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00176}.
FT   DOMAIN      191    268       RRM 3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00176}.
FT   DOMAIN      294    370       RRM 4. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00176}.
FT   DOMAIN      542    619       PABC. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00641}.
FT   REGION      166    289       CSDE1-binding.
FT   COMPBIAS    495    501       Poly-Ala.
FT   MOD_RES       1      1       N-acetylmethionine.
FT                                {ECO:0000244|PubMed:19413330}.
FT   MOD_RES     299    299       N6-methyllysine. {ECO:0000269|Ref.7}.
FT   MOD_RES     315    315       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     319    319       Phosphothreonine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     385    385       Omega-N-methylarginine.
FT                                {ECO:0000244|PubMed:24129315}.
FT   MOD_RES     419    419       Omega-N-methylarginine.
FT                                {ECO:0000244|PubMed:24129315}.
FT   MOD_RES     432    432       Omega-N-methylarginine.
FT                                {ECO:0000244|PubMed:24129315}.
FT   MOD_RES     436    436       Omega-N-methylarginine.
FT                                {ECO:0000244|PubMed:24129315}.
FT   MOD_RES     455    455       Omega-N-methylated arginine; by CARM1;
FT                                partial. {ECO:0000305|PubMed:11850402}.
FT   MOD_RES     460    460       Omega-N-methylated arginine; by CARM1;
FT                                partial. {ECO:0000305|PubMed:11850402}.
FT   MOD_RES     475    475       Omega-N-methylarginine.
FT                                {ECO:0000250|UniProtKB:P29341}.
FT   MOD_RES     481    481       Omega-N-methylarginine.
FT                                {ECO:0000244|PubMed:24129315}.
FT   MOD_RES     493    493       Asymmetric dimethylarginine; alternate.
FT                                {ECO:0000244|PubMed:24129315}.
FT   MOD_RES     493    493       Dimethylated arginine; alternate.
FT                                {ECO:0000269|Ref.6, ECO:0000269|Ref.7}.
FT   MOD_RES     493    493       Omega-N-methylarginine; alternate.
FT                                {ECO:0000244|PubMed:24129315,
FT                                ECO:0000269|Ref.6, ECO:0000269|Ref.7}.
FT   MOD_RES     506    506       Omega-N-methylarginine.
FT                                {ECO:0000244|PubMed:24129315}.
FT   MOD_RES     512    512       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     518    518       Omega-N-methylarginine.
FT                                {ECO:0000244|PubMed:24129315}.
FT   VAR_SEQ     447    535       Missing (in isoform 2).
FT                                {ECO:0000303|Ref.5}.
FT                                /FTId=VSP_009846.
FT   MUTAGEN     455    455       R->A: Greatly reduces methylation by
FT                                CARM1 (in vitro); when associated with A-
FT                                460. {ECO:0000269|PubMed:11850402}.
FT   MUTAGEN     460    460       R->A: Greatly reduces methylation by
FT                                CARM1 (in vitro); when associated with A-
FT                                455. {ECO:0000269|PubMed:11850402}.
FT   CONFLICT    211    213       Missing (in Ref. 1; CAA68428).
FT                                {ECO:0000305}.
FT   CONFLICT    410    410       M -> I (in Ref. 5; CAA88401).
FT                                {ECO:0000305}.
FT   CONFLICT    428    428       I -> V (in Ref. 1; CAA68428).
FT                                {ECO:0000305}.
FT   STRAND       12     17       {ECO:0000244|PDB:4F02}.
FT   HELIX        24     31       {ECO:0000244|PDB:4F02}.
FT   HELIX        32     34       {ECO:0000244|PDB:4F02}.
FT   STRAND       37     44       {ECO:0000244|PDB:4F02}.
FT   TURN         46     48       {ECO:0000244|PDB:4F02}.
FT   STRAND       51     61       {ECO:0000244|PDB:4F02}.
FT   HELIX        62     72       {ECO:0000244|PDB:4F02}.
FT   STRAND       83     86       {ECO:0000244|PDB:4F02}.
FT   HELIX        92     96       {ECO:0000244|PDB:4F02}.
FT   STRAND      100    105       {ECO:0000244|PDB:4F25}.
FT   HELIX       112    119       {ECO:0000244|PDB:4F25}.
FT   HELIX       120    122       {ECO:0000244|PDB:4F25}.
FT   STRAND      125    133       {ECO:0000244|PDB:4F25}.
FT   STRAND      136    146       {ECO:0000244|PDB:4F25}.
FT   HELIX       148    158       {ECO:0000244|PDB:4F25}.
FT   STRAND      161    163       {ECO:0000244|PDB:2K8G}.
FT   STRAND      169    174       {ECO:0000244|PDB:4F25}.
FT   HELIX       176    183       {ECO:0000244|PDB:4F02}.
FT   HELIX       547    551       {ECO:0000244|PDB:3KUJ}.
FT   HELIX       555    557       {ECO:0000244|PDB:3KUJ}.
FT   HELIX       558    573       {ECO:0000244|PDB:3KUJ}.
FT   TURN        575    577       {ECO:0000244|PDB:3KUJ}.
FT   HELIX       578    585       {ECO:0000244|PDB:3KUJ}.
FT   HELIX       590    598       {ECO:0000244|PDB:3KUJ}.
FT   HELIX       600    619       {ECO:0000244|PDB:3KUJ}.
FT   TURN        623    625       {ECO:0000244|PDB:1JGN}.
FT   STRAND      628    630       {ECO:0000244|PDB:1G9L}.
SQ   SEQUENCE   636 AA;  70671 MW;  2EB1B02A346132EE CRC64;
     MNPSAPSYPM ASLYVGDLHP DVTEAMLYEK FSPAGPILSI RVCRDMITRR SLGYAYVNFQ
     QPADAERALD TMNFDVIKGK PVRIMWSQRD PSLRKSGVGN IFIKNLDKSI DNKALYDTFS
     AFGNILSCKV VCDENGSKGY GFVHFETQEA AERAIEKMNG MLLNDRKVFV GRFKSRKERE
     AELGARAKEF TNVYIKNFGE DMDDERLKDL FGKFGPALSV KVMTDESGKS KGFGFVSFER
     HEDAQKAVDE MNGKELNGKQ IYVGRAQKKV ERQTELKRKF EQMKQDRITR YQGVNLYVKN
     LDDGIDDERL RKEFSPFGTI TSAKVMMEGG RSKGFGFVCF SSPEEATKAV TEMNGRIVAT
     KPLYVALAQR KEERQAHLTN QYMQRMASVR AVPNPVINPY QPAPPSGYFM AAIPQTQNRA
     AYYPPSQIAQ LRPSPRWTAQ GARPHPFQNM PGAIRPAAPR PPFSTMRPAS SQVPRVMSTQ
     RVANTSTQTM GPRPAAAAAA ATPAVRTVPQ YKYAAGVRNP QQHLNAQPQV TMQQPAVHVQ
     GQEPLTASML ASAPPQEQKQ MLGERLFPLI QAMHPTLAGK ITGMLLEIDN SELLHMLESP
     ESLRSKVDEA VAVLQAHQAK EAAQKAVNSA TGVPTV
//
ID   PCNA_HUMAN              Reviewed;         261 AA.
AC   P12004; B2R897; D3DW02;
DT   01-OCT-1989, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-1989, sequence version 1.
DT   23-MAY-2018, entry version 212.
DE   RecName: Full=Proliferating cell nuclear antigen;
DE            Short=PCNA;
DE   AltName: Full=Cyclin;
GN   Name=PCNA;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=2882507; DOI=10.1073/pnas.84.6.1575;
RA   Almendral J.M., Huebsch D., Blundell P.A., Macdonald-Bravo H.,
RA   Bravo R.;
RT   "Cloning and sequence of the human nuclear protein cyclin: homology
RT   with DNA-binding proteins.";
RL   Proc. Natl. Acad. Sci. U.S.A. 84:1575-1579(1987).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=2565339;
RA   Travali S., Ku D.H., Rizzo M.G., Ottavio L., Baserga R.,
RA   Calabretta B.;
RT   "Structure of the human gene for the proliferating cell nuclear
RT   antigen.";
RL   J. Biol. Chem. 264:7466-7472(1989).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RG   NIEHS SNPs program;
RL   Submitted (JUL-2002) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Skeletal muscle;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11780052; DOI=10.1038/414865a;
RA   Deloukas P., Matthews L.H., Ashurst J.L., Burton J., Gilbert J.G.R.,
RA   Jones M., Stavrides G., Almeida J.P., Babbage A.K., Bagguley C.L.,
RA   Bailey J., Barlow K.F., Bates K.N., Beard L.M., Beare D.M.,
RA   Beasley O.P., Bird C.P., Blakey S.E., Bridgeman A.M., Brown A.J.,
RA   Buck D., Burrill W.D., Butler A.P., Carder C., Carter N.P.,
RA   Chapman J.C., Clamp M., Clark G., Clark L.N., Clark S.Y., Clee C.M.,
RA   Clegg S., Cobley V.E., Collier R.E., Connor R.E., Corby N.R.,
RA   Coulson A., Coville G.J., Deadman R., Dhami P.D., Dunn M.,
RA   Ellington A.G., Frankland J.A., Fraser A., French L., Garner P.,
RA   Grafham D.V., Griffiths C., Griffiths M.N.D., Gwilliam R., Hall R.E.,
RA   Hammond S., Harley J.L., Heath P.D., Ho S., Holden J.L., Howden P.J.,
RA   Huckle E., Hunt A.R., Hunt S.E., Jekosch K., Johnson C.M., Johnson D.,
RA   Kay M.P., Kimberley A.M., King A., Knights A., Laird G.K., Lawlor S.,
RA   Lehvaeslaiho M.H., Leversha M.A., Lloyd C., Lloyd D.M., Lovell J.D.,
RA   Marsh V.L., Martin S.L., McConnachie L.J., McLay K., McMurray A.A.,
RA   Milne S.A., Mistry D., Moore M.J.F., Mullikin J.C., Nickerson T.,
RA   Oliver K., Parker A., Patel R., Pearce T.A.V., Peck A.I.,
RA   Phillimore B.J.C.T., Prathalingam S.R., Plumb R.W., Ramsay H.,
RA   Rice C.M., Ross M.T., Scott C.E., Sehra H.K., Shownkeen R., Sims S.,
RA   Skuce C.D., Smith M.L., Soderlund C., Steward C.A., Sulston J.E.,
RA   Swann R.M., Sycamore N., Taylor R., Tee L., Thomas D.W., Thorpe A.,
RA   Tracey A., Tromans A.C., Vaudin M., Wall M., Wallis J.M.,
RA   Whitehead S.L., Whittaker P., Willey D.L., Williams L., Williams S.A.,
RA   Wilming L., Wray P.W., Hubbard T., Durbin R.M., Bentley D.R., Beck S.,
RA   Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 20.";
RL   Nature 414:865-871(2001).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Bone marrow, and Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   PROTEIN SEQUENCE OF 1-26.
RX   PubMed=2882422; DOI=10.1038/326471a0;
RA   Prelich G., Kostura M., Marshak D.R., Mathews M.B., Stillman B.;
RT   "The cell-cycle regulated proliferating cell nuclear antigen is
RT   required for SV40 DNA replication in vitro.";
RL   Nature 326:471-475(1987).
RN   [9]
RP   PROTEIN SEQUENCE OF 169-181, AND IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Fetal brain cortex;
RA   Lubec G., Chen W.-Q., Sun Y.;
RL   Submitted (DEC-2008) to UniProtKB.
RN   [10]
RP   INTERACTION WITH ERCC5/XPG.
RX   PubMed=9305916; DOI=10.1074/jbc.272.39.24522;
RA   Gary R., Ludwig D.L., Cornelius H.L., MacInnes M.A., Park M.S.;
RT   "The DNA repair endonuclease XPG binds to proliferating cell nuclear
RT   antigen (PCNA) and shares sequence elements with the PCNA-binding
RT   regions of FEN-1 and cyclin-dependent kinase inhibitor p21.";
RL   J. Biol. Chem. 272:24522-24529(1997).
RN   [11]
RP   INTERACTION WITH DNMT1.
RX   PubMed=9302295; DOI=10.1126/science.277.5334.1996;
RA   Chuang L.S.-H., Ian H.-I., Koh T.-W., Ng H.-H., Xu G., Li B.F.L.;
RT   "Human DNA-(cytosine-5) methyltransferase-PCNA complex as a target for
RT   p21WAF1.";
RL   Science 277:1996-2000(1997).
RN   [12]
RP   INTERACTION WITH CDC6.
RX   PubMed=9566895; DOI=10.1128/MCB.18.5.2758;
RA   Saha P., Chen J., Thome K.C., Lawlis S.J., Hou Z.H., Hendricks M.,
RA   Parvin J.D., Dutta A.;
RT   "Human CDC6/Cdc18 associates with Orc1 and cyclin-cdk and is
RT   selectively eliminated from the nucleus at the onset of S phase.";
RL   Mol. Cell. Biol. 18:2758-2767(1998).
RN   [13]
RP   INTERACTION WITH POLD3 AND CDKN1A, AND MUTAGENESIS OF 43-SER--VAL-45;
RP   125-GLN--ILE-128; 188-VAL--LYS-190 AND 251-LEU--LYS-254.
RX   PubMed=11595739; DOI=10.1074/jbc.M106990200;
RA   Ducoux M., Urbach S., Baldacci G., Huebscher U., Koundrioukoff S.,
RA   Christensen J., Hughes P.;
RT   "Mediation of proliferating cell nuclear antigen (PCNA)-dependent DNA
RT   replication through a conserved p21(Cip1)-like PCNA-binding motif
RT   present in the third subunit of human DNA polymerase delta.";
RL   J. Biol. Chem. 276:49258-49266(2001).
RN   [14]
RP   INTERACTION WITH APEX2.
RX   PubMed=11376153; DOI=10.1093/nar/29.11.2349;
RA   Tsuchimoto D., Sakai Y., Sakumi K., Nishioka K., Sasaki M.,
RA   Fujiwara T., Nakabeppu Y.;
RT   "Human APE2 protein is mostly localized in the nuclei and to some
RT   extent in the mitochondria, while nuclear APE2 is partly associated
RT   with proliferating cell nuclear antigen.";
RL   Nucleic Acids Res. 29:2349-2360(2001).
RN   [15]
RP   INTERACTION WITH POLK.
RX   PubMed=11784855; DOI=10.1128/MCB.22.3.784-791.2002;
RA   Haracska L., Unk I., Johnson R.E., Phillips B.B., Hurwitz J.,
RA   Prakash L., Prakash S.;
RT   "Stimulation of DNA synthesis activity of human DNA polymerase kappa
RT   by PCNA.";
RL   Mol. Cell. Biol. 22:784-791(2002).
RN   [16]
RP   INTERACTION WITH DNTTIP2.
RX   PubMed=12786946; DOI=10.1046/j.1365-2443.2003.00656.x;
RA   Fujita K., Shimazaki N., Ohta Y., Kubota T., Ibe S., Toji S.,
RA   Tamai K., Fujisaki S., Hayano T., Koiwai O.;
RT   "Terminal deoxynucleotidyltransferase forms a ternary complex with a
RT   novel chromatin remodeling protein with 82 kDa and core histone.";
RL   Genes Cells 8:559-571(2003).
RN   [17]
RP   INTERACTION WITH POLDIP2.
RC   TISSUE=Placenta;
RX   PubMed=12522211; DOI=10.1074/jbc.M208694200;
RA   Liu L., Rodriguez-Belmonte E.M., Mazloum N., Xie B., Lee M.Y.W.T.;
RT   "Identification of a novel protein, PDIP38, that interacts with the
RT   p50 subunit of DNA polymerase delta and proliferating cell nuclear
RT   antigen.";
RL   J. Biol. Chem. 278:10041-10047(2003).
RN   [18]
RP   INTERACTION WITH EXO1.
RX   PubMed=15225546; DOI=10.1016/j.molcel.2004.06.016;
RA   Dzantiev L., Constantin N., Genschel J., Iyer R.R., Burgers P.M.,
RA   Modrich P.;
RT   "A defined human system that supports bidirectional mismatch-provoked
RT   excision.";
RL   Mol. Cell 15:31-41(2004).
RN   [19]
RP   UBIQUITINATION, AND INTERACTION WITH POLH.
RX   PubMed=15149598; DOI=10.1016/S1097-2765(04)00259-X;
RA   Kannouche P.L., Wing J., Lehmann A.R.;
RT   "Interaction of human DNA polymerase eta with monoubiquitinated PCNA:
RT   a possible mechanism for the polymerase switch in response to DNA
RT   damage.";
RL   Mol. Cell 14:491-500(2004).
RN   [20]
RP   INTERACTION WITH BAZ1B.
RX   PubMed=15543136; DOI=10.1038/ncb1196;
RA   Poot R.A., Bozhenok L., van den Berg D.L.C., Steffensen S.,
RA   Ferreira F., Grimaldi M., Gilbert N., Ferreira J., Varga-Weisz P.D.;
RT   "The Williams syndrome transcription factor interacts with PCNA to
RT   target chromatin remodelling by ISWI to replication foci.";
RL   Nat. Cell Biol. 6:1236-1244(2004).
RN   [21]
RP   INTERACTION WITH POLD1; POLD3 AND POLD4.
RX   PubMed=16510448; DOI=10.1074/jbc.M600322200;
RA   Li H., Xie B., Zhou Y., Rahmeh A., Trusa S., Zhang S., Gao Y.,
RA   Lee E.Y., Lee M.Y.;
RT   "Functional roles of p12, the fourth subunit of human DNA polymerase
RT   delta.";
RL   J. Biol. Chem. 281:14748-14755(2006).
RN   [22]
RP   INTERACTION WITH SHPRH, UBIQUITINATION AT LYS-164, AND MUTAGENESIS OF
RP   LYS-164.
RX   PubMed=17130289; DOI=10.1083/jcb.200606145;
RA   Motegi A., Sood R., Moinova H., Markowitz S.D., Liu P.P., Myung K.;
RT   "Human SHPRH suppresses genomic instability through proliferating cell
RT   nuclear antigen polyubiquitination.";
RL   J. Cell Biol. 175:703-708(2006).
RN   [23]
RP   INTERACTION WITH CDT1.
RX   PubMed=16949367; DOI=10.1016/j.molcel.2006.08.010;
RA   Jin J., Arias E.E., Chen J., Harper J.W., Walter J.C.;
RT   "A family of diverse Cul4-Ddb1-interacting proteins includes Cdt2,
RT   which is required for S phase destruction of the replication factor
RT   Cdt1.";
RL   Mol. Cell 23:709-721(2006).
RN   [24]
RP   PHOSPHORYLATION AT TYR-211 BY EGFR, MUTAGENESIS OF TYR-211, AND
RP   INTERACTION WITH EGFR.
RX   PubMed=17115032; DOI=10.1038/ncb1501;
RA   Wang S.C., Nakajima Y., Yu Y.L., Xia W., Chen C.T., Yang C.C.,
RA   McIntush E.W., Li L.Y., Hawke D.H., Kobayashi R., Hung M.C.;
RT   "Tyrosine phosphorylation controls PCNA function through protein
RT   stability.";
RL   Nat. Cell Biol. 8:1359-1368(2006).
RN   [25]
RP   UBIQUITINATION AT LYS-164, AND MUTAGENESIS OF LYS-164.
RX   PubMed=17108083; DOI=10.1073/pnas.0608595103;
RA   Unk I., Hajdu I., Fatyol K., Szakal B., Blastyak A., Bermudez V.,
RA   Hurwitz J., Prakash L., Prakash S., Haracska L.;
RT   "Human SHPRH is a ubiquitin ligase for Mms2-Ubc13-dependent
RT   polyubiquitylation of proliferating cell nuclear antigen.";
RL   Proc. Natl. Acad. Sci. U.S.A. 103:18107-18112(2006).
RN   [26]
RP   UBIQUITINATION.
RX   PubMed=18948756; DOI=10.4161/cc.7.21.6949;
RA   Zhang S., Chea J., Meng X., Zhou Y., Lee E.Y.C., Lee M.Y.W.T.;
RT   "PCNA is ubiquitinated by RNF8.";
RL   Cell Cycle 7:3399-3404(2008).
RN   [27]
RP   INTERACTION WITH CDKN1A.
RX   PubMed=18794347; DOI=10.1101/gad.1676108;
RA   Abbas T., Sivaprasad U., Terai K., Amador V., Pagano M., Dutta A.;
RT   "PCNA-dependent regulation of p21 ubiquitylation and degradation via
RT   the CRL4Cdt2 ubiquitin ligase complex.";
RL   Genes Dev. 22:2496-2506(2008).
RN   [28]
RP   INTERACTION WITH DDX11.
RX   PubMed=18499658; DOI=10.1074/jbc.M802696200;
RA   Farina A., Shin J.H., Kim D.H., Bermudez V.P., Kelman Z., Seo Y.S.,
RA   Hurwitz J.;
RT   "Studies with the human cohesin establishment factor, ChlR1.
RT   Association of ChlR1 with Ctf18-RFC and Fen1.";
RL   J. Biol. Chem. 283:20925-20936(2008).
RN   [29]
RP   INTERACTION WITH CDKN1A.
RX   PubMed=18703516; DOI=10.1074/jbc.M806045200;
RA   Nishitani H., Shiomi Y., Iida H., Michishita M., Takami T.,
RA   Tsurimoto T.;
RT   "CDK inhibitor p21 is degraded by a proliferating cell nuclear
RT   antigen-coupled Cul4-DDB1Cdt2 pathway during S phase and after UV
RT   irradiation.";
RL   J. Biol. Chem. 283:29045-29052(2008).
RN   [30]
RP   FUNCTION, AND INTERACTION WITH APEX2.
RX   PubMed=19443450; DOI=10.1093/nar/gkp357;
RA   Burkovics P., Hajdu I., Szukacsov V., Unk I., Haracska L.;
RT   "Role of PCNA-dependent stimulation of 3'-phosphodiesterase and 3'-5'
RT   exonuclease activities of human Ape2 in repair of oxidative DNA
RT   damage.";
RL   Nucleic Acids Res. 37:4247-4255(2009).
RN   [31]
RP   UBIQUITINATION, AND INTERACTION WITH HLTF.
RX   PubMed=18316726; DOI=10.1073/pnas.0800563105;
RA   Unk I., Hajdu I., Fatyol K., Hurwitz J., Yoon J.-H., Prakash L.,
RA   Prakash S., Haracska L.;
RT   "Human HLTF functions as a ubiquitin ligase for proliferating cell
RT   nuclear antigen polyubiquitination.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:3768-3773(2008).
RN   [32]
RP   UBIQUITINATION, FUNCTION, INTERACTION WITH HLTF AND SHPRH, AND
RP   MUTAGENESIS OF LYS-164.
RX   PubMed=18719106; DOI=10.1073/pnas.0805685105;
RA   Motegi A., Liaw H.-J., Lee K.-Y., Roest H.P., Maas A., Wu X.,
RA   Moinova H., Markowitz S.D., Ding H., Hoeijmakers J.H.J., Myung K.;
RT   "Polyubiquitination of proliferating cell nuclear antigen by HLTF and
RT   SHPRH prevents genomic instability from stalled replication forks.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:12411-12416(2008).
RN   [33]
RP   INTERACTION WITH NUDT15, AND ACETYLATION AT LYS-14.
RX   PubMed=19419956; DOI=10.1074/jbc.M109.015289;
RA   Yu Y., Cai J.-P., Tu B., Wu L., Zhao Y., Liu X., Li L., McNutt M.A.,
RA   Feng J., He Q., Yang Y., Wang H., Sekiguchi M., Zhu W.-G.;
RT   "Proliferating cell nuclear antigen is protected from degradation by
RT   forming a complex with MutT Homolog2.";
RL   J. Biol. Chem. 284:19310-19320(2009).
RN   [34]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-77; LYS-80 AND LYS-248, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [35]
RP   UBIQUITINATION, AND MUTAGENESIS OF LYS-164.
RX   PubMed=20129063; DOI=10.1016/j.molcel.2009.12.018;
RA   Terai K., Abbas T., Jazaeri A.A., Dutta A.;
RT   "CRL4(Cdt2) E3 ubiquitin ligase monoubiquitinates PCNA to promote
RT   translesion DNA synthesis.";
RL   Mol. Cell 37:143-149(2010).
RN   [36]
RP   UBIQUITINATION IN RESPONSE TO UV IRRADIATION.
RX   PubMed=20227374; DOI=10.1016/j.molcel.2010.02.009;
RA   Ogi T., Limsirichaikul S., Overmeer R.M., Volker M., Takenaka K.,
RA   Cloney R., Nakazawa Y., Niimi A., Miki Y., Jaspers N.G.,
RA   Mullenders L.H., Yamashita S., Fousteri M.I., Lehmann A.R.;
RT   "Three DNA polymerases, recruited by different mechanisms, carry out
RT   NER repair synthesis in human cells.";
RL   Mol. Cell 37:714-727(2010).
RN   [37]
RP   INTERACTION WITH POLN.
RX   PubMed=19995904; DOI=10.1128/MCB.01124-09;
RA   Moldovan G.L., Madhavan M.V., Mirchandani K.D., McCaffrey R.M.,
RA   Vinciguerra P., D'Andrea A.D.;
RT   "DNA polymerase POLN participates in cross-link repair and homologous
RT   recombination.";
RL   Mol. Cell. Biol. 30:1088-1096(2010).
RN   [38]
RP   INTERACTION WITH SETMAR.
RX   PubMed=20457750; DOI=10.1093/nar/gkq339;
RA   De Haro L.P., Wray J., Williamson E.A., Durant S.T., Corwin L.,
RA   Gentry A.C., Osheroff N., Lee S.H., Hromas R., Nickoloff J.A.;
RT   "Metnase promotes restart and repair of stalled and collapsed
RT   replication forks.";
RL   Nucleic Acids Res. 38:5681-5691(2010).
RN   [39]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [40]
RP   INTERACTION WITH SMARCAD1.
RX   PubMed=21549307; DOI=10.1016/j.molcel.2011.02.036;
RA   Rowbotham S.P., Barki L., Neves-Costa A., Santos F., Dean W.,
RA   Hawkes N., Choudhary P., Will W.R., Webster J., Oxley D., Green C.M.,
RA   Varga-Weisz P., Mermoud J.E.;
RT   "Maintenance of silent chromatin through replication requires SWI/SNF-
RT   like chromatin remodeler SMARCAD1.";
RL   Mol. Cell 42:285-296(2011).
RN   [41]
RP   INTERACTION WITH PCLAF.
RX   PubMed=21628590; DOI=10.1073/pnas.1106136108;
RA   Emanuele M.J., Ciccia A., Elia A.E., Elledge S.J.;
RT   "Proliferating cell nuclear antigen (PCNA)-associated KIAA0101/PAF15
RT   protein is a cell cycle-regulated anaphase-promoting complex/cyclosome
RT   substrate.";
RL   Proc. Natl. Acad. Sci. U.S.A. 108:9845-9850(2011).
RN   [42]
RP   INTERACTION WITH POLD3.
RX   PubMed=22148433; DOI=10.1021/bi201638e;
RA   Rahmeh A.A., Zhou Y., Xie B., Li H., Lee E.Y., Lee M.Y.;
RT   "Phosphorylation of the p68 subunit of Pol delta acts as a molecular
RT   switch to regulate its interaction with PCNA.";
RL   Biochemistry 51:416-424(2012).
RN   [43]
RP   INTERACTION WITH PARPBP, AND SUMOYLATION.
RX   PubMed=22153967; DOI=10.1016/j.molcel.2011.11.010;
RA   Moldovan G.L., Dejsuphong D., Petalcorin M.I., Hofmann K., Takeda S.,
RA   Boulton S.J., D'Andrea A.D.;
RT   "Inhibition of homologous recombination by the PCNA-interacting
RT   protein PARI.";
RL   Mol. Cell 45:75-86(2012).
RN   [44]
RP   INTERACTION WITH SPRTN.
RX   PubMed=22681887; DOI=10.1016/j.molcel.2012.05.020;
RA   Centore R.C., Yazinski S.A., Tse A., Zou L.;
RT   "Spartan/C1orf124, a reader of PCNA ubiquitylation and a regulator of
RT   UV-induced DNA damage response.";
RL   Mol. Cell 46:625-635(2012).
RN   [45]
RP   INTERACTION WITH ZRANB3.
RX   PubMed=22759634; DOI=10.1101/gad.193516.112;
RA   Weston R., Peeters H., Ahel D.;
RT   "ZRANB3 is a structure-specific ATP-dependent endonuclease involved in
RT   replication stress response.";
RL   Genes Dev. 26:1558-1572(2012).
RN   [46]
RP   INTERACTION WITH ZRANB3.
RX   PubMed=22705370; DOI=10.1016/j.molcel.2012.05.025;
RA   Yuan J., Ghosal G., Chen J.;
RT   "The HARP-like domain-containing protein AH2/ZRANB3 binds to PCNA and
RT   participates in cellular response to replication stress.";
RL   Mol. Cell 47:410-421(2012).
RN   [47]
RP   INTERACTION WITH PCLAF.
RX   PubMed=23000965; DOI=10.1038/ncb2579;
RA   Povlsen L.K., Beli P., Wagner S.A., Poulsen S.L., Sylvestersen K.B.,
RA   Poulsen J.W., Nielsen M.L., Bekker-Jensen S., Mailand N.,
RA   Choudhary C.;
RT   "Systems-wide analysis of ubiquitylation dynamics reveals a key role
RT   for PAF15 ubiquitylation in DNA-damage bypass.";
RL   Nat. Cell Biol. 14:1089-1098(2012).
RN   [48]
RP   INTERACTION WITH ZRANB3.
RX   PubMed=22704558; DOI=10.1016/j.molcel.2012.05.024;
RA   Ciccia A., Nimonkar A.V., Hu Y., Hajdu I., Achar Y.J., Izhar L.,
RA   Petit S.A., Adamson B., Yoon J.C., Kowalczykowski S.C.,
RA   Livingston D.M., Haracska L., Elledge S.J.;
RT   "Polyubiquitinated PCNA recruits the ZRANB3 translocase to maintain
RT   genomic integrity after replication stress.";
RL   Mol. Cell 47:396-409(2012).
RN   [49]
RP   INTERACTION WITH CDKN1C.
RX   PubMed=22634751; DOI=10.1038/ng.2275;
RA   Arboleda V.A., Lee H., Parnaik R., Fleming A., Banerjee A.,
RA   Ferraz-de-Souza B., Delot E.C., Rodriguez-Fernandez I.A.,
RA   Braslavsky D., Bergada I., Dell'Angelica E.C., Nelson S.F.,
RA   Martinez-Agosto J.A., Achermann J.C., Vilain E.;
RT   "Mutations in the PCNA-binding domain of CDKN1C cause IMAGe
RT   syndrome.";
RL   Nat. Genet. 44:788-792(2012).
RN   [50]
RP   INTERACTION WITH ANKRD17.
RX   PubMed=23711367; DOI=10.1016/j.febslet.2013.05.037;
RA   Menning M., Kufer T.A.;
RT   "A role for the Ankyrin repeat containing protein Ankrd17 in Nod1- and
RT   Nod2-mediated inflammatory responses.";
RL   FEBS Lett. 587:2137-2142(2013).
RN   [51]
RP   INTERACTION WITH FBXO18.
RX   PubMed=23677613; DOI=10.1093/nar/gkt397;
RA   Bacquin A., Pouvelle C., Siaud N., Perderiset M., Salome-Desnoulez S.,
RA   Tellier-Lebegue C., Lopez B., Charbonnier J.B., Kannouche P.L.;
RT   "The helicase FBH1 is tightly regulated by PCNA via CRL4(Cdt2)-
RT   mediated proteolysis in human cells.";
RL   Nucleic Acids Res. 41:6501-6513(2013).
RN   [52]
RP   INTERACTION WITH RTEL1, AND SUBCELLULAR LOCATION.
RX   PubMed=24115439; DOI=10.1126/science.1241779;
RA   Vannier J.B., Sandhu S., Petalcorin M.I., Wu X., Nabi Z., Ding H.,
RA   Boulton S.J.;
RT   "RTEL1 is a replisome-associated helicase that promotes telomere and
RT   genome-wide replication.";
RL   Science 342:239-242(2013).
RN   [53]
RP   INVOLVEMENT IN ATLD2, INTERACTION WITH FEN1; LIG1 AND ERCC5, VARIANT
RP   ATLD2 ILE-228, AND CHARACTERIZATION OF VARIANT ATDL2 ILE-228.
RX   PubMed=24911150; DOI=10.1172/JCI74593;
RA   Baple E.L., Chambers H., Cross H.E., Fawcett H., Nakazawa Y.,
RA   Chioza B.A., Harlalka G.V., Mansour S., Sreekantan-Nair A.,
RA   Patton M.A., Muggenthaler M., Rich P., Wagner K., Coblentz R.,
RA   Stein C.K., Last J.I., Taylor A.M., Jackson A.P., Ogi T.,
RA   Lehmann A.R., Green C.M., Crosby A.H.;
RT   "Hypomorphic PCNA mutation underlies a human DNA repair disorder.";
RL   J. Clin. Invest. 124:3137-3146(2014).
RN   [54]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [55]
RP   INTERACTION WITH FAM111A.
RX   PubMed=24561620; DOI=10.1038/ncb2918;
RA   Alabert C., Bukowski-Wills J.C., Lee S.B., Kustatscher G.,
RA   Nakamura K., de Lima Alves F., Menard P., Mejlvang J., Rappsilber J.,
RA   Groth A.;
RT   "Nascent chromatin capture proteomics determines chromatin dynamics
RT   during DNA replication and identifies unknown fork components.";
RL   Nat. Cell Biol. 16:281-293(2014).
RN   [56]
RP   FUNCTION, TRIMERIZATION, INTERACTION WITH CREBBP; EP300 AND POLD1,
RP   ACETYLATION, UBIQUITINATION, ASSOCIATION WITH CHROMATIN, AND
RP   MUTAGENESIS OF LYS-13; LYS-14; LYS-20; LYS-77 AND LYS-80.
RX   PubMed=24939902; DOI=10.1093/nar/gku533;
RA   Cazzalini O., Sommatis S., Tillhon M., Dutto I., Bachi A., Rapp A.,
RA   Nardo T., Scovassi A.I., Necchi D., Cardoso M.C., Stivala L.A.,
RA   Prosperi E.;
RT   "CBP and p300 acetylate PCNA to link its degradation with nucleotide
RT   excision repair synthesis.";
RL   Nucleic Acids Res. 42:8433-8448(2014).
RN   [57]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-164, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25114211; DOI=10.1073/pnas.1413825111;
RA   Impens F., Radoshevich L., Cossart P., Ribet D.;
RT   "Mapping of SUMO sites and analysis of SUMOylation changes induced by
RT   external stimuli.";
RL   Proc. Natl. Acad. Sci. U.S.A. 111:12432-12437(2014).
RN   [58]
RP   METHYLATION.
RX   PubMed=25732820; DOI=10.1016/j.celrep.2015.01.054;
RA   Perry J.J., Ballard G.D., Albert A.E., Dobrolecki L.E., Malkas L.H.,
RA   Hoelz D.J.;
RT   "Human C6orf211 encodes Armt1, a protein carboxyl methyltransferase
RT   that targets PCNA and is linked to the DNA damage response.";
RL   Cell Rep. 10:1288-1296(2015).
RN   [59]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-164, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25772364; DOI=10.1016/j.celrep.2015.02.033;
RA   Hendriks I.A., Treffers L.W., Verlaan-de Vries M., Olsen J.V.,
RA   Vertegaal A.C.;
RT   "SUMO-2 orchestrates chromatin modifiers in response to DNA damage.";
RL   Cell Rep. 10:1778-1791(2015).
RN   [60]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-164, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25755297; DOI=10.1074/mcp.O114.044792;
RA   Xiao Z., Chang J.G., Hendriks I.A., Sigurdsson J.O., Olsen J.V.,
RA   Vertegaal A.C.;
RT   "System-wide analysis of SUMOylation dynamics in response to
RT   replication stress reveals novel small ubiquitin-like modified target
RT   proteins and acceptor lysines relevant for genome stability.";
RL   Mol. Cell. Proteomics 14:1419-1434(2015).
RN   [61]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [62]
RP   INTERACTION WITH SDE2.
RX   PubMed=27906959; DOI=10.1371/journal.pgen.1006465;
RA   Jo U., Cai W., Wang J., Kwon Y., D'Andrea A.D., Kim H.;
RT   "PCNA-dependent cleavage and degradation of SDE2 regulates response to
RT   replication stress.";
RL   PLoS Genet. 12:E1006465-E1006465(2016).
RN   [63]
RP   INTERACTION WITH DONSON.
RX   PubMed=28191891; DOI=10.1038/ng.3790;
RA   Reynolds J.J., Bicknell L.S., Carroll P., Higgs M.R., Shaheen R.,
RA   Murray J.E., Papadopoulos D.K., Leitch A., Murina O., Tarnauskaite Z.,
RA   Wessel S.R., Zlatanou A., Vernet A., von Kriegsheim A., Mottram R.M.,
RA   Logan C.V., Bye H., Li Y., Brean A., Maddirevula S., Challis R.C.,
RA   Skouloudaki K., Almoisheer A., Alsaif H.S., Amar A., Prescott N.J.,
RA   Bober M.B., Duker A., Faqeih E., Seidahmed M.Z., Al Tala S.,
RA   Alswaid A., Ahmed S., Al-Aama J.Y., Altmueller J., Al Balwi M.,
RA   Brady A.F., Chessa L., Cox H., Fischetto R., Heller R.,
RA   Henderson B.D., Hobson E., Nuernberg P., Percin E.F., Peron A.,
RA   Spaccini L., Quigley A.J., Thakur S., Wise C.A., Yoon G., Alnemer M.,
RA   Tomancak P., Yigit G., Taylor A.M., Reijns M.A., Simpson M.A.,
RA   Cortez D., Alkuraya F.S., Mathew C.G., Jackson A.P., Stewart G.S.;
RT   "Mutations in DONSON disrupt replication fork stability and cause
RT   microcephalic dwarfism.";
RL   Nat. Genet. 49:537-549(2017).
RN   [64]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-164 AND LYS-254, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-
RT   modification with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
RN   [65]
RP   X-RAY CRYSTALLOGRAPHY (2.6 ANGSTROMS).
RX   PubMed=8861913; DOI=10.1016/S0092-8674(00)81347-1;
RA   Gulbis J.M., Kelman Z., Hurwitz J., O'Donnell M., Kuriyan J.;
RT   "Structure of the C-terminal region of p21(WAF1/CIP1) complexed with
RT   human PCNA.";
RL   Cell 87:297-306(1996).
RN   [66]
RP   X-RAY CRYSTALLOGRAPHY (2.9 ANGSTROMS) IN COMPLEX WITH FEN1.
RX   PubMed=15616578; DOI=10.1038/sj.emboj.7600519;
RA   Sakurai S., Kitano K., Yamaguchi H., Hamada K., Okada K., Fukuda K.,
RA   Uchida M., Ohtsuka E., Morioka H., Hakoshima T.;
RT   "Structural basis for recruitment of human flap endonuclease 1 to
RT   PCNA.";
RL   EMBO J. 24:683-693(2005).
CC   -!- FUNCTION: Auxiliary protein of DNA polymerase delta and is
CC       involved in the control of eukaryotic DNA replication by
CC       increasing the polymerase's processibility during elongation of
CC       the leading strand. Induces a robust stimulatory effect on the 3'-
CC       5' exonuclease and 3'-phosphodiesterase, but not apurinic-
CC       apyrimidinic (AP) endonuclease, APEX2 activities. Has to be loaded
CC       onto DNA in order to be able to stimulate APEX2. Plays a key role
CC       in DNA damage response (DDR) by being conveniently positioned at
CC       the replication fork to coordinate DNA replication with DNA repair
CC       and DNA damage tolerance pathways (PubMed:24939902). Acts as a
CC       loading platform to recruit DDR proteins that allow completion of
CC       DNA replication after DNA damage and promote postreplication
CC       repair: Monoubiquitinated PCNA leads to recruitment of translesion
CC       (TLS) polymerases, while 'Lys-63'-linked polyubiquitination of
CC       PCNA is involved in error-free pathway and employs recombination
CC       mechanisms to synthesize across the lesion.
CC       {ECO:0000269|PubMed:18719106, ECO:0000269|PubMed:19443450,
CC       ECO:0000269|PubMed:24939902}.
CC   -!- SUBUNIT: Homotrimer (PubMed:24939902). Interacts with p300/EP300;
CC       the interaction occurs on chromatin in UV-irradiated damaged cells
CC       (PubMed:24939902). Interacts with CREBBP (via transactivation
CC       domain and C-terminus); the interaction occurs on chromatin in UV-
CC       irradiated damaged cells (PubMed:24939902). Directly interacts
CC       with POLD1, POLD3 and POLD4 subunits of the DNA polymerase delta
CC       complex, POLD3 being the major interacting partner; the
CC       interaction with POLD3 is inhibited by CDKN1A/p21(CIP1)
CC       (PubMed:11595739, PubMed:16510448, PubMed:22148433,
CC       PubMed:24939902). Forms a complex with activator 1 heteropentamer
CC       in the presence of ATP. Interacts with EXO1, POLH, POLK, DNMT1,
CC       ERCC5, FEN1, CDC6 and POLDIP2 (PubMed:9305916, PubMed:9302295,
CC       PubMed:9566895, PubMed:11784855, PubMed:12522211, PubMed:15225546,
CC       PubMed:15149598, PubMed:24911150, PubMed:15616578). Interacts with
CC       APEX2; this interaction is triggered by reactive oxygen species
CC       and increased by misincorporation of uracil in nuclear DNA
CC       (PubMed:11376153, PubMed:19443450). Forms a ternary complex with
CC       DNTTIP2 and core histone (PubMed:12786946). Interacts with KCTD10
CC       and PPP1R15A (By similarity). Directly interacts with BAZ1B
CC       (PubMed:15543136). Interacts with HLTF and SHPRH (PubMed:17130289,
CC       PubMed:18316726, PubMed:18719106). Interacts with NUDT15; this
CC       interaction is disrupted in response to UV irradiation and
CC       acetylation (PubMed:19419956). Interacts with CDKN1A/p21(CIP1) and
CC       CDT1; interacts via their PIP-box which also recruits the DCX(DTL)
CC       complex. The interaction with CDKN1A inhibits POLD3 binding
CC       (PubMed:11595739, PubMed:16949367, PubMed:18794347,
CC       PubMed:18703516). Interacts with DDX11 (PubMed:18499658).
CC       Interacts with EGFR; positively regulates PCNA (PubMed:17115032).
CC       Interacts with PARPBP (PubMed:22153967). Interacts (when
CC       ubiquitinated) with SPRTN; leading to enhance RAD18-mediated PCNA
CC       ubiquitination (PubMed:22681887). Interacts (when
CC       polyubiquitinated) with ZRANB3 (PubMed:22704558, PubMed:22705370,
CC       PubMed:22759634). Interacts with SMARCAD1 (PubMed:21549307).
CC       Interacts with CDKN1C (PubMed:22634751). Interacts with PCLAF (via
CC       PIP-box) (PubMed:21628590, PubMed:23000965). Interacts with RTEL1
CC       (via PIP-box); the interaction is direct and essential for the
CC       suppression of telomere fragility (PubMed:24115439). Interacts
CC       with FAM111A (via PIP-box); the interaction is direct and required
CC       for PCNA loading on chromatin binding (PubMed:24561620). Interacts
CC       with LIG1 (PubMed:24911150). Interacts with SETMAR
CC       (PubMed:20457750). Interacts with ANKRD17 (PubMed:23711367).
CC       Interacts with FBXO18/FBH1 (via PIP-box); the interaction recruits
CC       the DCX(DTL) complex and promotes ubiquitination and degradation
CC       of FBXO18/FBH1 (PubMed:23677613). Interacts with POLN
CC       (PubMed:19995904). Interacts with SDE2 (via PIP-box); the
CC       interaction is direct and prevents ultraviolet light induced
CC       monoubiquitination (PubMed:27906959). Component of the replisome
CC       complex composed of at least DONSON, MCM2, MCM7, PCNA and TICRR;
CC       interaction at least with PCNA occurs during DNA replication
CC       (PubMed:28191891). {ECO:0000250|UniProtKB:P04961,
CC       ECO:0000250|UniProtKB:P17918, ECO:0000269|PubMed:11376153,
CC       ECO:0000269|PubMed:11595739, ECO:0000269|PubMed:11784855,
CC       ECO:0000269|PubMed:12522211, ECO:0000269|PubMed:12786946,
CC       ECO:0000269|PubMed:15149598, ECO:0000269|PubMed:15225546,
CC       ECO:0000269|PubMed:15543136, ECO:0000269|PubMed:15616578,
CC       ECO:0000269|PubMed:16510448, ECO:0000269|PubMed:16949367,
CC       ECO:0000269|PubMed:17115032, ECO:0000269|PubMed:17130289,
CC       ECO:0000269|PubMed:18316726, ECO:0000269|PubMed:18499658,
CC       ECO:0000269|PubMed:18703516, ECO:0000269|PubMed:18719106,
CC       ECO:0000269|PubMed:18794347, ECO:0000269|PubMed:19419956,
CC       ECO:0000269|PubMed:19443450, ECO:0000269|PubMed:19995904,
CC       ECO:0000269|PubMed:20457750, ECO:0000269|PubMed:21549307,
CC       ECO:0000269|PubMed:21628590, ECO:0000269|PubMed:22148433,
CC       ECO:0000269|PubMed:22153967, ECO:0000269|PubMed:22634751,
CC       ECO:0000269|PubMed:22681887, ECO:0000269|PubMed:22704558,
CC       ECO:0000269|PubMed:22705370, ECO:0000269|PubMed:22759634,
CC       ECO:0000269|PubMed:23000965, ECO:0000269|PubMed:23677613,
CC       ECO:0000269|PubMed:23711367, ECO:0000269|PubMed:24115439,
CC       ECO:0000269|PubMed:24561620, ECO:0000269|PubMed:24911150,
CC       ECO:0000269|PubMed:24939902, ECO:0000269|PubMed:27906959,
CC       ECO:0000269|PubMed:28191891, ECO:0000269|PubMed:9302295,
CC       ECO:0000269|PubMed:9305916, ECO:0000269|PubMed:9566895}.
CC   -!- INTERACTION:
CC       Self; NbExp=7; IntAct=EBI-358311, EBI-358311;
CC       Q8TE30:-; NbExp=6; IntAct=EBI-358311, EBI-8874509;
CC       P04075:ALDOA; NbExp=3; IntAct=EBI-358311, EBI-709613;
CC       P03950:ANG; NbExp=4; IntAct=EBI-358311, EBI-525291;
CC       P61769:B2M; NbExp=2; IntAct=EBI-358311, EBI-714718;
CC       P38936:CDKN1A; NbExp=29; IntAct=EBI-358311, EBI-375077;
CC       P42771:CDKN2A; NbExp=8; IntAct=EBI-358311, EBI-375053;
CC       Q9H211:CDT1; NbExp=2; IntAct=EBI-358311, EBI-456953;
CC       Q13111:CHAF1A; NbExp=4; IntAct=EBI-358311, EBI-1020839;
CC       P06733:ENO1; NbExp=3; IntAct=EBI-358311, EBI-353877;
CC       P39748:FEN1; NbExp=9; IntAct=EBI-358311, EBI-707816;
CC       Q9Z111:Gadd45g (xeno); NbExp=9; IntAct=EBI-358311, EBI-1173616;
CC       P04406:GAPDH; NbExp=3; IntAct=EBI-358311, EBI-354056;
CC       Q14527:HLTF; NbExp=2; IntAct=EBI-358311, EBI-1045161;
CC       Q9H160:ING2; NbExp=3; IntAct=EBI-358311, EBI-389787;
CC       P20585:MSH3; NbExp=7; IntAct=EBI-358311, EBI-1164205;
CC       O95944:NCR2; NbExp=7; IntAct=EBI-358311, EBI-14058375;
CC       Q1K9H5:PB1 (xeno); NbExp=2; IntAct=EBI-358311, EBI-6050669;
CC       B4URF7:PB2 (xeno); NbExp=2; IntAct=EBI-358311, EBI-6050648;
CC       Q15004:PCLAF; NbExp=3; IntAct=EBI-358311, EBI-10971436;
CC       P18669:PGAM1; NbExp=2; IntAct=EBI-358311, EBI-717905;
CC       P28340:POLD1; NbExp=3; IntAct=EBI-358311, EBI-716569;
CC       P49005:POLD2; NbExp=2; IntAct=EBI-358311, EBI-372354;
CC       Q15054:POLD3; NbExp=7; IntAct=EBI-358311, EBI-864956;
CC       Q9HCU8:POLD4; NbExp=4; IntAct=EBI-358311, EBI-864968;
CC       A2RU14:TMEM218; NbExp=3; IntAct=EBI-358311, EBI-10173151;
CC       P60174:TPI1; NbExp=2; IntAct=EBI-358311, EBI-717475;
CC       Q5FWF4:ZRANB3; NbExp=8; IntAct=EBI-358311, EBI-13954615;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:24115439,
CC       ECO:0000269|PubMed:24939902}. Note=Colocalizes with CREBBP, EP300
CC       and POLD1 to sites of DNA damage (PubMed:24939902). Forms nuclear
CC       foci representing sites of ongoing DNA replication and vary in
CC       morphology and number during S phase. Together with APEX2, is
CC       redistributed in discrete nuclear foci in presence of oxidative
CC       DNA damaging agents. {ECO:0000269|PubMed:24939902}.
CC   -!- PTM: Phosphorylated. Phosphorylation at Tyr-211 by EGFR stabilizes
CC       chromatin-associated PCNA. {ECO:0000269|PubMed:17115032}.
CC   -!- PTM: Acetylated by CREBBP and p300/EP300; preferentially
CC       acetylated by CREBBP on Lys-80, Lys-13 and Lys-14 and on Lys-77 by
CC       p300/EP300 upon loading on chromatin in response to UV irradiation
CC       (PubMed:24939902, PubMed:19419956). Lysine acetylation disrupts
CC       association with chromatin, hence promoting PCNA ubiquitination
CC       and proteasomal degradation in response to UV damage in a
CC       CREBBP- and EP300-dependent manner (PubMed:24939902). Acetylation
CC       disrupts interaction with NUDT15 and promotes degradation
CC       (PubMed:19419956). {ECO:0000269|PubMed:24939902}.
CC   -!- PTM: Ubiquitinated (PubMed:24939902, PubMed:20227374). Following
CC       DNA damage, can be either monoubiquitinated to stimulate direct
CC       bypass of DNA lesions by specialized DNA polymerases or
CC       polyubiquitinated to promote recombination-dependent DNA synthesis
CC       across DNA lesions by template switching mechanisms. Following
CC       induction of replication stress, monoubiquitinated by the UBE2B-
CC       RAD18 complex on Lys-164, leading to recruit translesion (TLS)
CC       polymerases, which are able to synthesize across DNA lesions in a
CC       potentially error-prone manner. An error-free pathway also exists
CC       and requires non-canonical polyubiquitination on Lys-164 through
CC       'Lys-63' linkage of ubiquitin moieties by the E2 complex UBE2N-
CC       UBE2V2 and the E3 ligases, HLTF, RNF8 and SHPRH. This error-free
CC       pathway, also known as template switching, employs recombination
CC       mechanisms to synthesize across the lesion, using as a template
CC       the undamaged, newly synthesized strand of the sister chromatid.
CC       Monoubiquitination at Lys-164 also takes place in undamaged
CC       proliferating cells, and is mediated by the DCX(DTL) complex,
CC       leading to enhance PCNA-dependent translesion DNA synthesis.
CC       Sumoylated during S phase. {ECO:0000269|PubMed:15149598,
CC       ECO:0000269|PubMed:17108083, ECO:0000269|PubMed:17130289,
CC       ECO:0000269|PubMed:18316726, ECO:0000269|PubMed:18719106,
CC       ECO:0000269|PubMed:18948756, ECO:0000269|PubMed:20129063,
CC       ECO:0000269|PubMed:20227374, ECO:0000269|PubMed:22153967,
CC       ECO:0000269|PubMed:24939902}.
CC   -!- PTM: Methylated on glutamate residues by ARMT1/C6orf211.
CC       {ECO:0000269|PubMed:25732820}.
CC   -!- DISEASE: Ataxia-telangiectasia-like disorder 2 (ATLD2)
CC       [MIM:615919]: A neurodegenerative disorder due to defects in DNA
CC       excision repair. ATLD2 is characterized by developmental delay,
CC       ataxia, sensorineural hearing loss, short stature, cutaneous and
CC       ocular telangiectasia, and photosensitivity.
CC       {ECO:0000269|PubMed:24911150}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- MISCELLANEOUS: Antibodies against PCNA are present in sera from
CC       patients with systemic lupus erythematosus.
CC   -!- SIMILARITY: Belongs to the PCNA family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=NIEHS-SNPs;
CC       URL="http://egp.gs.washington.edu/data/pcna/";
CC   -!- WEB RESOURCE: Name=Wikipedia; Note=PCNA entry;
CC       URL="https://en.wikipedia.org/wiki/PCNA";
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/PCNAID41670ch20p12.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M15796; AAA35736.1; -; mRNA.
DR   EMBL; J04718; AAA60040.1; -; Genomic_DNA.
DR   EMBL; AF527838; AAM78556.1; -; Genomic_DNA.
DR   EMBL; AK313286; BAG36094.1; -; mRNA.
DR   EMBL; AL121924; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471133; EAX10428.1; -; Genomic_DNA.
DR   EMBL; CH471133; EAX10429.1; -; Genomic_DNA.
DR   EMBL; CH471133; EAX10430.1; -; Genomic_DNA.
DR   EMBL; BC000491; AAH00491.1; -; mRNA.
DR   EMBL; BC062439; AAH62439.1; -; mRNA.
DR   CCDS; CCDS13087.1; -.
DR   PIR; A27445; WMHUET.
DR   RefSeq; NP_002583.1; NM_002592.2.
DR   RefSeq; NP_872590.1; NM_182649.1.
DR   UniGene; Hs.147433; -.
DR   UniGene; Hs.744934; -.
DR   PDB; 1AXC; X-ray; 2.60 A; A/C/E=1-261.
DR   PDB; 1U76; X-ray; 2.60 A; A/C/E=1-261.
DR   PDB; 1U7B; X-ray; 1.88 A; A=1-261.
DR   PDB; 1UL1; X-ray; 2.90 A; A/B/C=1-261.
DR   PDB; 1VYJ; X-ray; 2.80 A; A/C/E/G/I/K=1-261.
DR   PDB; 1VYM; X-ray; 2.30 A; A/B/C=1-261.
DR   PDB; 1W60; X-ray; 3.15 A; A/B=1-261.
DR   PDB; 2ZVK; X-ray; 2.70 A; A/B/C=1-261.
DR   PDB; 2ZVL; X-ray; 2.50 A; A/B/C/D/E/F=1-261.
DR   PDB; 2ZVM; X-ray; 2.30 A; A/B/C=1-261.
DR   PDB; 3JA9; EM; 22.00 A; A/B/C=1-261.
DR   PDB; 3P87; X-ray; 2.99 A; A/B/C/D/E/F=1-261.
DR   PDB; 3TBL; X-ray; 2.90 A; A/B/C=1-261.
DR   PDB; 3VKX; X-ray; 2.10 A; A=1-261.
DR   PDB; 3WGW; X-ray; 2.80 A; A/B=1-261.
DR   PDB; 4D2G; X-ray; 2.65 A; A/B/C=1-261.
DR   PDB; 4RJF; X-ray; 2.01 A; A/C/E=1-261.
DR   PDB; 4ZTD; X-ray; 2.20 A; A/B/C=2-254.
DR   PDB; 5E0T; X-ray; 2.67 A; A/B/C=1-261.
DR   PDB; 5E0U; X-ray; 1.93 A; A/B/C=1-261.
DR   PDB; 5E0V; X-ray; 2.07 A; A/B=1-261.
DR   PDB; 5IY4; X-ray; 2.94 A; A/C/E=1-261.
DR   PDB; 5L7C; X-ray; 2.82 A; A/B/C=1-261.
DR   PDB; 5MAV; X-ray; 2.58 A; A/B/C/D/E/F=1-261.
DR   PDB; 5MLO; X-ray; 1.96 A; A/C/E=1-261.
DR   PDB; 5MLW; X-ray; 2.45 A; A/C/E=1-261.
DR   PDB; 5MOM; X-ray; 2.27 A; A/B/C=1-258.
DR   PDB; 5YCO; X-ray; 2.20 A; A/B/C/D=1-261.
DR   PDBsum; 1AXC; -.
DR   PDBsum; 1U76; -.
DR   PDBsum; 1U7B; -.
DR   PDBsum; 1UL1; -.
DR   PDBsum; 1VYJ; -.
DR   PDBsum; 1VYM; -.
DR   PDBsum; 1W60; -.
DR   PDBsum; 2ZVK; -.
DR   PDBsum; 2ZVL; -.
DR   PDBsum; 2ZVM; -.
DR   PDBsum; 3JA9; -.
DR   PDBsum; 3P87; -.
DR   PDBsum; 3TBL; -.
DR   PDBsum; 3VKX; -.
DR   PDBsum; 3WGW; -.
DR   PDBsum; 4D2G; -.
DR   PDBsum; 4RJF; -.
DR   PDBsum; 4ZTD; -.
DR   PDBsum; 5E0T; -.
DR   PDBsum; 5E0U; -.
DR   PDBsum; 5E0V; -.
DR   PDBsum; 5IY4; -.
DR   PDBsum; 5L7C; -.
DR   PDBsum; 5MAV; -.
DR   PDBsum; 5MLO; -.
DR   PDBsum; 5MLW; -.
DR   PDBsum; 5MOM; -.
DR   PDBsum; 5YCO; -.
DR   ProteinModelPortal; P12004; -.
DR   SMR; P12004; -.
DR   BioGrid; 111142; 298.
DR   CORUM; P12004; -.
DR   DIP; DIP-1098N; -.
DR   ELM; P12004; -.
DR   IntAct; P12004; 119.
DR   MINT; P12004; -.
DR   STRING; 9606.ENSP00000368438; -.
DR   BindingDB; P12004; -.
DR   ChEMBL; CHEMBL2346488; -.
DR   iPTMnet; P12004; -.
DR   PhosphoSitePlus; P12004; -.
DR   SwissPalm; P12004; -.
DR   BioMuta; PCNA; -.
DR   DMDM; 129694; -.
DR   SWISS-2DPAGE; P12004; -.
DR   EPD; P12004; -.
DR   MaxQB; P12004; -.
DR   PaxDb; P12004; -.
DR   PeptideAtlas; P12004; -.
DR   PRIDE; P12004; -.
DR   TopDownProteomics; P12004; -.
DR   DNASU; 5111; -.
DR   Ensembl; ENST00000379143; ENSP00000368438; ENSG00000132646.
DR   Ensembl; ENST00000379160; ENSP00000368458; ENSG00000132646.
DR   GeneID; 5111; -.
DR   KEGG; hsa:5111; -.
DR   UCSC; uc002wlp.4; human.
DR   CTD; 5111; -.
DR   DisGeNET; 5111; -.
DR   EuPathDB; HostDB:ENSG00000132646.10; -.
DR   GeneCards; PCNA; -.
DR   HGNC; HGNC:8729; PCNA.
DR   HPA; CAB000148; -.
DR   HPA; HPA030521; -.
DR   HPA; HPA030522; -.
DR   HPA; HPA030523; -.
DR   MalaCards; PCNA; -.
DR   MIM; 176740; gene.
DR   MIM; 615919; phenotype.
DR   neXtProt; NX_P12004; -.
DR   OpenTargets; ENSG00000132646; -.
DR   PharmGKB; PA263; -.
DR   eggNOG; KOG1636; Eukaryota.
DR   eggNOG; COG0592; LUCA.
DR   GeneTree; ENSGT00390000004965; -.
DR   HOGENOM; HOG000211098; -.
DR   HOVERGEN; HBG000947; -.
DR   InParanoid; P12004; -.
DR   KO; K04802; -.
DR   OMA; SDGFDKY; -.
DR   OrthoDB; EOG091G0GQ7; -.
DR   PhylomeDB; P12004; -.
DR   TreeFam; TF313441; -.
DR   Reactome; R-HSA-110312; Translesion synthesis by REV1.
DR   Reactome; R-HSA-110314; Recognition of DNA damage by PCNA-containing replication complex.
DR   Reactome; R-HSA-110320; Translesion Synthesis by POLH.
DR   Reactome; R-HSA-1362277; Transcription of E2F targets under negative control by DREAM complex.
DR   Reactome; R-HSA-174411; Polymerase switching on the C-strand of the telomere.
DR   Reactome; R-HSA-174414; Processive synthesis on the C-strand of the telomere.
DR   Reactome; R-HSA-174417; Telomere C-strand (Lagging Strand) Synthesis.
DR   Reactome; R-HSA-174437; Removal of the Flap Intermediate from the C-strand.
DR   Reactome; R-HSA-4615885; SUMOylation of DNA replication proteins.
DR   Reactome; R-HSA-5358565; Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha).
DR   Reactome; R-HSA-5358606; Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta).
DR   Reactome; R-HSA-539107; Activation of E2F1 target genes at G1/S.
DR   Reactome; R-HSA-5651801; PCNA-Dependent Long Patch Base Excision Repair.
DR   Reactome; R-HSA-5655862; Translesion synthesis by POLK.
DR   Reactome; R-HSA-5656121; Translesion synthesis by POLI.
DR   Reactome; R-HSA-5656169; Termination of translesion DNA synthesis.
DR   Reactome; R-HSA-5685942; HDR through Homologous Recombination (HRR).
DR   Reactome; R-HSA-5696397; Gap-filling DNA repair synthesis and ligation in GG-NER.
DR   Reactome; R-HSA-5696400; Dual Incision in GG-NER.
DR   Reactome; R-HSA-6782135; Dual incision in TC-NER.
DR   Reactome; R-HSA-6782210; Gap-filling DNA repair synthesis and ligation in TC-NER.
DR   Reactome; R-HSA-6804114; TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest.
DR   Reactome; R-HSA-69091; Polymerase switching.
DR   Reactome; R-HSA-69166; Removal of the Flap Intermediate.
DR   Reactome; R-HSA-69183; Processive synthesis on the lagging strand.
DR   Reactome; R-HSA-8866654; E3 ubiquitin ligases ubiquitinate target proteins.
DR   SignaLink; P12004; -.
DR   SIGNOR; P12004; -.
DR   ChiTaRS; PCNA; human.
DR   EvolutionaryTrace; P12004; -.
DR   GeneWiki; Proliferating_cell_nuclear_antigen; -.
DR   GenomeRNAi; 5111; -.
DR   PRO; PR:P12004; -.
DR   Proteomes; UP000005640; Chromosome 20.
DR   Bgee; ENSG00000132646; -.
DR   CleanEx; HS_PCNA; -.
DR   Genevisible; P12004; HS.
DR   GO; GO:0005813; C:centrosome; IDA:MGI.
DR   GO; GO:0005663; C:DNA replication factor C complex; TAS:UniProtKB.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0016604; C:nuclear body; IDA:HPA.
DR   GO; GO:0000784; C:nuclear chromosome, telomeric region; HDA:BHF-UCL.
DR   GO; GO:0043596; C:nuclear replication fork; IDA:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0043626; C:PCNA complex; IDA:UniProtKB.
DR   GO; GO:0070557; C:PCNA-p21 complex; IDA:UniProtKB.
DR   GO; GO:0005657; C:replication fork; IDA:MGI.
DR   GO; GO:0030894; C:replisome; TAS:BHF-UCL.
DR   GO; GO:0003682; F:chromatin binding; IDA:UniProtKB.
DR   GO; GO:0003684; F:damaged DNA binding; IDA:UniProtKB.
DR   GO; GO:0032139; F:dinucleotide insertion or deletion binding; IDA:BHF-UCL.
DR   GO; GO:0070182; F:DNA polymerase binding; IPI:UniProtKB.
DR   GO; GO:0030337; F:DNA polymerase processivity factor activity; IBA:GO_Central.
DR   GO; GO:0019899; F:enzyme binding; IPI:BHF-UCL.
DR   GO; GO:0035035; F:histone acetyltransferase binding; IPI:UniProtKB.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0032405; F:MutLalpha complex binding; IDA:HGNC.
DR   GO; GO:0000701; F:purine-specific mismatch base pair DNA N-glycosylase activity; IDA:BHF-UCL.
DR   GO; GO:0030971; F:receptor tyrosine kinase binding; IPI:UniProtKB.
DR   GO; GO:0008283; P:cell proliferation; TAS:ProtInc.
DR   GO; GO:0070301; P:cellular response to hydrogen peroxide; IEA:Ensembl.
DR   GO; GO:0034644; P:cellular response to UV; IDA:UniProtKB.
DR   GO; GO:0042769; P:DNA damage response, detection of DNA damage; TAS:Reactome.
DR   GO; GO:0006977; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; TAS:Reactome.
DR   GO; GO:0030855; P:epithelial cell differentiation; IEP:UniProtKB.
DR   GO; GO:0070987; P:error-free translesion synthesis; TAS:Reactome.
DR   GO; GO:0042276; P:error-prone translesion synthesis; TAS:Reactome.
DR   GO; GO:0044849; P:estrous cycle; IEA:Ensembl.
DR   GO; GO:0007507; P:heart development; IEA:Ensembl.
DR   GO; GO:0006272; P:leading strand elongation; IBA:GO_Central.
DR   GO; GO:0097421; P:liver regeneration; IEA:Ensembl.
DR   GO; GO:0006298; P:mismatch repair; IDA:BHF-UCL.
DR   GO; GO:1902990; P:mitotic telomere maintenance via semi-conservative replication; ISS:BHF-UCL.
DR   GO; GO:0006297; P:nucleotide-excision repair, DNA gap filling; TAS:Reactome.
DR   GO; GO:0033683; P:nucleotide-excision repair, DNA incision; TAS:Reactome.
DR   GO; GO:0006296; P:nucleotide-excision repair, DNA incision, 5'-to lesion; TAS:Reactome.
DR   GO; GO:0032077; P:positive regulation of deoxyribonuclease activity; IDA:UniProtKB.
DR   GO; GO:0045739; P:positive regulation of DNA repair; IMP:UniProtKB.
DR   GO; GO:0045740; P:positive regulation of DNA replication; IMP:UniProtKB.
DR   GO; GO:0016567; P:protein ubiquitination; TAS:Reactome.
DR   GO; GO:0000083; P:regulation of transcription involved in G1/S transition of mitotic cell cycle; TAS:Reactome.
DR   GO; GO:0031297; P:replication fork processing; ISS:BHF-UCL.
DR   GO; GO:0046686; P:response to cadmium ion; IEA:Ensembl.
DR   GO; GO:0071548; P:response to dexamethasone; IEA:Ensembl.
DR   GO; GO:0032355; P:response to estradiol; IEA:Ensembl.
DR   GO; GO:1902065; P:response to L-glutamate; IEA:Ensembl.
DR   GO; GO:0000723; P:telomere maintenance; TAS:Reactome.
DR   GO; GO:0032201; P:telomere maintenance via semi-conservative replication; TAS:Reactome.
DR   GO; GO:0006283; P:transcription-coupled nucleotide-excision repair; TAS:Reactome.
DR   GO; GO:0019985; P:translesion synthesis; IDA:UniProtKB.
DR   HAMAP; MF_00317; DNApol_clamp_arch; 1.
DR   InterPro; IPR000730; Pr_cel_nuc_antig.
DR   InterPro; IPR022649; Pr_cel_nuc_antig_C.
DR   InterPro; IPR022659; Pr_cel_nuc_antig_CS.
DR   InterPro; IPR022648; Pr_cel_nuc_antig_N.
DR   PANTHER; PTHR11352:SF0; PTHR11352:SF0; 1.
DR   Pfam; PF02747; PCNA_C; 1.
DR   Pfam; PF00705; PCNA_N; 1.
DR   PRINTS; PR00339; PCNACYCLIN.
DR   TIGRFAMs; TIGR00590; pcna; 1.
DR   PROSITE; PS01251; PCNA_1; 1.
DR   PROSITE; PS00293; PCNA_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Complete proteome; Deafness;
KW   Direct protein sequencing; Disease mutation; DNA damage; DNA repair;
KW   DNA replication; DNA-binding; Dwarfism; Isopeptide bond; Methylation;
KW   Neurodegeneration; Nucleus; Phosphoprotein; Reference proteome;
KW   Ubl conjugation.
FT   CHAIN         1    261       Proliferating cell nuclear antigen.
FT                                /FTId=PRO_0000149158.
FT   DNA_BIND     61     80       {ECO:0000255}.
FT   REGION        7    100       Interaction with NUDT15.
FT                                {ECO:0000269|PubMed:19419956}.
FT   MOD_RES      14     14       N6-acetyllysine.
FT                                {ECO:0000269|PubMed:19419956}.
FT   MOD_RES      77     77       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES      80     80       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     211    211       Phosphotyrosine; by EGFR.
FT                                {ECO:0000269|PubMed:17115032}.
FT   MOD_RES     248    248       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   CROSSLNK    164    164       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2);
FT                                alternate. {ECO:0000244|PubMed:25114211,
FT                                ECO:0000244|PubMed:25755297,
FT                                ECO:0000244|PubMed:25772364,
FT                                ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    164    164       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in ubiquitin);
FT                                alternate. {ECO:0000269|PubMed:17108083,
FT                                ECO:0000269|PubMed:17130289}.
FT   CROSSLNK    254    254       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   VARIANT     228    228       S -> I (in ATLD2; a hypomorphic mutation
FT                                affecting DNA repair in response to UV;
FT                                results in significantly decreased
FT                                interaction with FEN1, LIG1 and ERCC5;
FT                                dbSNP:rs369958038).
FT                                {ECO:0000269|PubMed:24911150}.
FT                                /FTId=VAR_071871.
FT   MUTAGEN      13     13       K->R: Inhibits acetylation, recruitment
FT                                to DNA damage sites, inducible
FT                                ubiquitination and protein degradation,
FT                                DNA replication and repair synthesis
FT                                efficiencies, but homotrimer formation,
FT                                nuclear recruitment to DNA damage sites,
FT                                interactions with CREBBP, EP300 and POLD1
FT                                are similar as the wild-type; in
FT                                association with R-14; R-20; R-77 and R-
FT                                80. {ECO:0000269|PubMed:24939902}.
FT   MUTAGEN      14     14       K->R: Inhibits acetylation, recruitment
FT                                to DNA damage sites, inducible
FT                                ubiquitination and protein degradation,
FT                                DNA replication and repair synthesis
FT                                efficiencies, but homotrimer formation,
FT                                nuclear recruitment to DNA damage sites,
FT                                interactions with CREBBP, EP300 and POLD1
FT                                are similar as the wild-type; in
FT                                association with R-13; R-20; R-77 and R-
FT                                80. {ECO:0000269|PubMed:24939902}.
FT   MUTAGEN      20     20       K->R: Inhibits acetylation, recruitment
FT                                to DNA damage sites, inducible
FT                                ubiquitination and protein degradation,
FT                                DNA replication and repair synthesis
FT                                efficiencies, but homotrimer formation,
FT                                nuclear recruitment to DNA damage sites,
FT                                interactions with CREBBP, EP300 and POLD1
FT                                are similar as the wild-type; in
FT                                association with R-13; R-14; R-77 and R-
FT                                80. {ECO:0000269|PubMed:24939902}.
FT   MUTAGEN      43     45       SHV->AAA: No effect on POLD3-binding.
FT                                {ECO:0000269|PubMed:11595739}.
FT   MUTAGEN      77     77       K->A: Inhibits recruitment to DNA damage
FT                                sites, but nuclear localization is
FT                                similar as the wild-type; in association
FT                                with A-80. {ECO:0000269|PubMed:24939902}.
FT   MUTAGEN      77     77       K->R: Inhibits acetylation, recruitment
FT                                to DNA damage sites, inducible
FT                                ubiquitination and protein degradation,
FT                                DNA replication and repair synthesis
FT                                efficiencies, but homotrimer formation,
FT                                nuclear recruitment to DNA damage sites,
FT                                interactions with CREBBP, EP300 and POLD1
FT                                are similar as the wild-type; in
FT                                association with R-13; R-14; R-20 and R-
FT                                80. {ECO:0000269|PubMed:24939902}.
FT   MUTAGEN      80     80       K->A: Inhibits recruitment to DNA damage
FT                                sites, but nuclear localization is
FT                                similar as the wild-type; in association
FT                                with A-77. {ECO:0000269|PubMed:24939902}.
FT   MUTAGEN      80     80       K->R: Inhibits acetylation, recruitment
FT                                to DNA damage sites, inducible
FT                                ubiquitination and protein degradation,
FT                                DNA replication and repair synthesis
FT                                efficiencies, but homotrimer formation,
FT                                nuclear recruitment to DNA damage sites,
FT                                interactions with CREBBP, EP300 and POLD1
FT                                are similar as the wild-type; in
FT                                association with R-13; R-14; R-20 and R-
FT                                77. {ECO:0000269|PubMed:24939902}.
FT   MUTAGEN     125    128       QLGI->AAAA: Strong decrease in POLD3-
FT                                binding. {ECO:0000269|PubMed:11595739}.
FT   MUTAGEN     164    164       K->R: Abolishes ubiquitination. No effect
FT                                on interaction with SHPRH.
FT                                {ECO:0000269|PubMed:17108083,
FT                                ECO:0000269|PubMed:17130289,
FT                                ECO:0000269|PubMed:18719106,
FT                                ECO:0000269|PubMed:20129063}.
FT   MUTAGEN     188    190       VDK->AAA: No effect on POLD3-binding.
FT                                {ECO:0000269|PubMed:11595739}.
FT   MUTAGEN     211    211       Y->F: Alters chromatin-associated PCNA
FT                                stability and its function in DNA
FT                                replication and repair.
FT                                {ECO:0000269|PubMed:17115032}.
FT   MUTAGEN     251    254       LAPK->AAAA: Decrease in POLD3-binding.
FT                                {ECO:0000269|PubMed:11595739}.
FT   STRAND        2      7       {ECO:0000244|PDB:1U7B}.
FT   HELIX        10     20       {ECO:0000244|PDB:1U7B}.
FT   STRAND       24     31       {ECO:0000244|PDB:1U7B}.
FT   STRAND       34     40       {ECO:0000244|PDB:1U7B}.
FT   STRAND       44     53       {ECO:0000244|PDB:1U7B}.
FT   HELIX        54     56       {ECO:0000244|PDB:1U7B}.
FT   STRAND       57     64       {ECO:0000244|PDB:1U7B}.
FT   STRAND       66     71       {ECO:0000244|PDB:1U7B}.
FT   HELIX        72     79       {ECO:0000244|PDB:1U7B}.
FT   STRAND       87     92       {ECO:0000244|PDB:1U7B}.
FT   STRAND       94     96       {ECO:0000244|PDB:1VYM}.
FT   STRAND       97    104       {ECO:0000244|PDB:1U7B}.
FT   STRAND      106    109       {ECO:0000244|PDB:4RJF}.
FT   STRAND      111    117       {ECO:0000244|PDB:1U7B}.
FT   STRAND      121    126       {ECO:0000244|PDB:5E0U}.
FT   STRAND      134    140       {ECO:0000244|PDB:1U7B}.
FT   HELIX       141    152       {ECO:0000244|PDB:1U7B}.
FT   STRAND      156    163       {ECO:0000244|PDB:1U7B}.
FT   STRAND      166    173       {ECO:0000244|PDB:1U7B}.
FT   STRAND      176    182       {ECO:0000244|PDB:1U7B}.
FT   HELIX       191    193       {ECO:0000244|PDB:5E0U}.
FT   STRAND      196    201       {ECO:0000244|PDB:1U7B}.
FT   STRAND      203    208       {ECO:0000244|PDB:1U7B}.
FT   HELIX       209    215       {ECO:0000244|PDB:1U7B}.
FT   HELIX       216    221       {ECO:0000244|PDB:1U7B}.
FT   STRAND      223    229       {ECO:0000244|PDB:1U7B}.
FT   STRAND      231    233       {ECO:0000244|PDB:1VYM}.
FT   STRAND      235    241       {ECO:0000244|PDB:1U7B}.
FT   TURN        242    244       {ECO:0000244|PDB:1U7B}.
FT   STRAND      245    251       {ECO:0000244|PDB:1U7B}.
SQ   SEQUENCE   261 AA;  28769 MW;  E6F08E7EDBC48B00 CRC64;
     MFEARLVQGS ILKKVLEALK DLINEACWDI SSSGVNLQSM DSSHVSLVQL TLRSEGFDTY
     RCDRNLAMGV NLTSMSKILK CAGNEDIITL RAEDNADTLA LVFEAPNQEK VSDYEMKLMD
     LDVEQLGIPE QEYSCVVKMP SGEFARICRD LSHIGDAVVI SCAKDGVKFS ASGELGNGNI
     KLSQTSNVDK EEEAVTIEMN EPVQLTFALR YLNFFTKATP LSSTVTLSMS ADVPLVVEYK
     IADMGHLKYY LAPKIEDEEG S
//
ID   C9J363_HUMAN            Unreviewed;       149 AA.
AC   C9J363;
DT   03-NOV-2009, integrated into UniProtKB/TrEMBL.
DT   03-NOV-2009, sequence version 1.
DT   23-MAY-2018, entry version 70.
DE   SubName: Full=Programmed cell death 10, isoform CRA_b {ECO:0000313|EMBL:EAW78579.1};
DE   SubName: Full=Programmed cell death protein 10 {ECO:0000313|Ensembl:ENSP00000417309};
GN   Name=PDCD10 {ECO:0000313|EMBL:EAW78579.1,
GN   ECO:0000313|Ensembl:ENSP00000417309};
GN   ORFNames=hCG_27561 {ECO:0000313|EMBL:EAW78579.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000417309, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|EMBL:EAW78579.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAW78579.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3] {ECO:0000313|Ensembl:ENSP00000417309, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16641997; DOI=10.1038/nature04728;
RA   Muzny D.M., Scherer S.E., Kaul R., Wang J., Yu J., Sudbrak R.,
RA   Buhay C.J., Chen R., Cree A., Ding Y., Dugan-Rocha S., Gill R.,
RA   Gunaratne P., Harris R.A., Hawes A.C., Hernandez J., Hodgson A.V.,
RA   Hume J., Jackson A., Khan Z.M., Kovar-Smith C., Lewis L.R.,
RA   Lozado R.J., Metzker M.L., Milosavljevic A., Miner G.R., Morgan M.B.,
RA   Nazareth L.V., Scott G., Sodergren E., Song X.Z., Steffen D., Wei S.,
RA   Wheeler D.A., Wright M.W., Worley K.C., Yuan Y., Zhang Z., Adams C.Q.,
RA   Ansari-Lari M.A., Ayele M., Brown M.J., Chen G., Chen Z.,
RA   Clendenning J., Clerc-Blankenburg K.P., Chen R., Chen Z., Davis C.,
RA   Delgado O., Dinh H.H., Dong W., Draper H., Ernst S., Fu G.,
RA   Gonzalez-Garay M.L., Garcia D.K., Gillett W., Gu J., Hao B.,
RA   Haugen E., Havlak P., He X., Hennig S., Hu S., Huang W., Jackson L.R.,
RA   Jacob L.S., Kelly S.H., Kube M., Levy R., Li Z., Liu B., Liu J.,
RA   Liu W., Lu J., Maheshwari M., Nguyen B.V., Okwuonu G.O., Palmeiri A.,
RA   Pasternak S., Perez L.M., Phelps K.A., Plopper F.J., Qiang B.,
RA   Raymond C., Rodriguez R., Saenphimmachak C., Santibanez J., Shen H.,
RA   Shen Y., Subramanian S., Tabor P.E., Verduzco D., Waldron L., Wang J.,
RA   Wang J., Wang Q., Williams G.A., Wong G.K., Yao Z., Zhang J.,
RA   Zhang X., Zhao G., Zhou J., Zhou Y., Nelson D., Lehrach H.,
RA   Reinhardt R., Naylor S.L., Yang H., Olson M., Weinstock G.,
RA   Gibbs R.A.;
RT   "The DNA sequence, annotation and analysis of human chromosome 3.";
RL   Nature 440:1194-1198(2006).
RN   [4] {ECO:0000213|PubMed:19608861}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [5] {ECO:0000213|PubMed:21269460}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Burckstummer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [6] {ECO:0000313|Ensembl:ENSP00000417309}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (JUL-2011) to UniProtKB.
RN   [7] {ECO:0000213|PubMed:25944712}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [8] {ECO:0000213|PubMed:28112733}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=28112733;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-
RT   modification with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AC079822; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471052; EAW78579.1; -; Genomic_DNA.
DR   RefSeq; XP_016861134.1; XM_017005645.1.
DR   UniGene; Hs.478150; -.
DR   Ensembl; ENST00000492396; ENSP00000417309; ENSG00000114209.
DR   GeneID; 11235; -.
DR   UCSC; uc062psn.1; human.
DR   CTD; 11235; -.
DR   EuPathDB; HostDB:ENSG00000114209.14; -.
DR   HGNC; HGNC:8761; PDCD10.
DR   OpenTargets; ENSG00000114209; -.
DR   eggNOG; KOG4025; Eukaryota.
DR   eggNOG; ENOG410XTA6; LUCA.
DR   GeneTree; ENSGT00390000017913; -.
DR   HOGENOM; HOG000007888; -.
DR   ChiTaRS; PDCD10; human.
DR   GenomeRNAi; 11235; -.
DR   Proteomes; UP000005640; Chromosome 3.
DR   Bgee; ENSG00000114209; -.
DR   InterPro; IPR009652; PDCD10.
DR   PANTHER; PTHR13250; PTHR13250; 1.
PE   1: Evidence at protein level;
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   Proteomics identification {ECO:0000213|EPD:C9J363,
KW   ECO:0000213|MaxQB:C9J363, ECO:0000213|PeptideAtlas:C9J363};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640}.
SQ   SEQUENCE   149 AA;  17534 MW;  20D6FC7686204480 CRC64;
     MKILEKKSVE VNFTESLLRM AADDVEEYMI ERPEPEFQDL NEKARALKQI LSKIPDEIND
     RVRFLQTIKD IASAIKELLD TVNNVFKKYQ YQNRRALEHQ KKEFVKYSKS FSDTLKTYFK
     DGKAINVFVS ANRLIHQTNL ILQTFKTVA
//
ID   PDC10_HUMAN             Reviewed;         212 AA.
AC   Q9BUL8; A8K515; D3DNN5; O14811;
DT   11-OCT-2005, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-2001, sequence version 1.
DT   23-MAY-2018, entry version 141.
DE   RecName: Full=Programmed cell death protein 10;
DE   AltName: Full=Cerebral cavernous malformations 3 protein;
DE   AltName: Full=TF-1 cell apoptosis-related protein 15;
GN   Name=PDCD10; Synonyms=CCM3, TFAR15;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT ALA-102.
RA   Wang Y.G., Liu H.T., Ma D.L., Zhang Y.M.;
RT   "cDNA cloning and expression of an apoptosis-related gene, human TFAR-
RT   15 gene.";
RL   Sci. China, Ser. C, Life Sci. 42:323-329(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16641997; DOI=10.1038/nature04728;
RA   Muzny D.M., Scherer S.E., Kaul R., Wang J., Yu J., Sudbrak R.,
RA   Buhay C.J., Chen R., Cree A., Ding Y., Dugan-Rocha S., Gill R.,
RA   Gunaratne P., Harris R.A., Hawes A.C., Hernandez J., Hodgson A.V.,
RA   Hume J., Jackson A., Khan Z.M., Kovar-Smith C., Lewis L.R.,
RA   Lozado R.J., Metzker M.L., Milosavljevic A., Miner G.R., Morgan M.B.,
RA   Nazareth L.V., Scott G., Sodergren E., Song X.-Z., Steffen D., Wei S.,
RA   Wheeler D.A., Wright M.W., Worley K.C., Yuan Y., Zhang Z., Adams C.Q.,
RA   Ansari-Lari M.A., Ayele M., Brown M.J., Chen G., Chen Z.,
RA   Clendenning J., Clerc-Blankenburg K.P., Chen R., Chen Z., Davis C.,
RA   Delgado O., Dinh H.H., Dong W., Draper H., Ernst S., Fu G.,
RA   Gonzalez-Garay M.L., Garcia D.K., Gillett W., Gu J., Hao B.,
RA   Haugen E., Havlak P., He X., Hennig S., Hu S., Huang W., Jackson L.R.,
RA   Jacob L.S., Kelly S.H., Kube M., Levy R., Li Z., Liu B., Liu J.,
RA   Liu W., Lu J., Maheshwari M., Nguyen B.-V., Okwuonu G.O., Palmeiri A.,
RA   Pasternak S., Perez L.M., Phelps K.A., Plopper F.J., Qiang B.,
RA   Raymond C., Rodriguez R., Saenphimmachak C., Santibanez J., Shen H.,
RA   Shen Y., Subramanian S., Tabor P.E., Verduzco D., Waldron L., Wang J.,
RA   Wang J., Wang Q., Williams G.A., Wong G.K.-S., Yao Z., Zhang J.,
RA   Zhang X., Zhao G., Zhou J., Zhou Y., Nelson D., Lehrach H.,
RA   Reinhardt R., Naylor S.L., Yang H., Olson M., Weinstock G.,
RA   Gibbs R.A.;
RT   "The DNA sequence, annotation and analysis of human chromosome 3.";
RL   Nature 440:1194-1198(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Skin, and Urinary bladder;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   PROTEIN SEQUENCE OF 36-45 AND 117-124, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RC   TISSUE=Platelet;
RA   Bienvenut W.V., Claeys D.;
RL   Submitted (NOV-2005) to UniProtKB.
RN   [8]
RP   FUNCTION, TISSUE SPECIFICITY, AND INVOLVEMENT IN CCM3.
RX   PubMed=15543491; DOI=10.1086/426952;
RA   Bergametti F., Denier C., Labauge P., Arnoult M., Boetto S.,
RA   Clanet M., Coubes P., Echenne B., Ibrahim R., Irthum B., Jacquet G.,
RA   Lonjon M., Moreau J.J., Neau J.P., Parker F., Tremoulet M.,
RA   Tournier-Lasserve E.;
RT   "Mutations within the programmed cell death 10 gene cause cerebral
RT   cavernous malformations.";
RL   Am. J. Hum. Genet. 76:42-51(2005).
RN   [9]
RP   INTERACTION WITH STK26, FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=17360971; DOI=10.1091/mbc.E06-07-0608;
RA   Ma X., Zhao H., Shan J., Long F., Chen Y., Chen Y., Zhang Y., Han X.,
RA   Ma D.;
RT   "PDCD10 interacts with Ste20-related kinase MST4 to promote cell
RT   growth and transformation via modulation of the ERK pathway.";
RL   Mol. Biol. Cell 18:1965-1978(2007).
RN   [10]
RP   INTERACTION WITH CCM2; STK25 AND STK26, AND IDENTIFICATION IN A
RP   COMPLEX WITH KRIT1 AND CCM2.
RX   PubMed=19370760; DOI=10.1002/humu.20996;
RA   Voss K., Stahl S., Hogan B.M., Reinders J., Schleider E.,
RA   Schulte-Merker S., Felbor U.;
RT   "Functional analyses of human and zebrafish 18-amino acid in-frame
RT   deletion pave the way for domain mapping of the cerebral cavernous
RT   malformation 3 protein.";
RL   Hum. Mutat. 30:1003-1011(2009).
RN   [11]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-179, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [12]
RP   FUNCTION, INTERACTION WITH GOLGA2; STK24; STK25 AND STK26, AND
RP   SUBCELLULAR LOCATION.
RX   PubMed=20332113; DOI=10.1242/jcs.061341;
RA   Fidalgo M., Fraile M., Pires A., Force T., Pombo C., Zalvide J.;
RT   "CCM3/PDCD10 stabilizes GCKIII proteins to promote Golgi assembly and
RT   cell orientation.";
RL   J. Cell Sci. 123:1274-1284(2010).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [15]
RP   FUNCTION, AND INTERACTION WITH RIPOR1; STK24 AND STK26.
RX   PubMed=27807006; DOI=10.1242/jcs.198614;
RA   Mardakheh F.K., Self A., Marshall C.J.;
RT   "RHO binding to FAM65A regulates Golgi reorientation during cell
RT   migration.";
RL   J. Cell Sci. 129:4466-4479(2016).
RN   [16]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-186, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-
RT   modification with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
RN   [17]
RP   X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS), SUBUNIT, INTERACTION WITH CCM2
RP   AND PXN, SUBCELLULAR LOCATION, AND MUTAGENESIS OF LYS-132; ALA-135;
RP   LYS-139; LYS-172; SER-175 AND LYS-179.
RX   PubMed=20489202; DOI=10.1074/jbc.M110.128470;
RA   Li X., Zhang R., Zhang H., He Y., Ji W., Min W., Boggon T.J.;
RT   "Crystal structure of CCM3, a cerebral cavernous malformation protein
RT   critical for vascular integrity.";
RL   J. Biol. Chem. 285:24099-24107(2010).
CC   -!- FUNCTION: Promotes cell proliferation. Modulates apoptotic
CC       pathways. Increases mitogen-activated protein kinase activity and
CC       STK26 activity (PubMed:27807006). Important for cell migration,
CC       and for normal structure and assembly of the Golgi complex
CC       (PubMed:27807006). Important for KDR/VEGFR2 signaling. Increases
CC       the stability of KDR/VEGFR2 and prevents its breakdown. Required
CC       for normal cardiovascular development. Required for normal
CC       angiogenesis, vasculogenesis and hematopoiesis during embryonic
CC       development (By similarity). {ECO:0000250|UniProtKB:Q8VE70,
CC       ECO:0000269|PubMed:15543491, ECO:0000269|PubMed:17360971,
CC       ECO:0000269|PubMed:20332113, ECO:0000269|PubMed:27807006}.
CC   -!- SUBUNIT: Homodimer (PubMed:20489202). Interacts (via C-terminus)
CC       with CCM2 (PubMed:17360971, PubMed:20489202). Interacts (via C-
CC       terminus) with PXN (PubMed:20489202). Interacts (via N-terminus)
CC       with STK25 (PubMed:17360971, PubMed:20332113). Interacts (via N-
CC       terminus) with STK26 (PubMed:17360971, PubMed:20332113,
CC       PubMed:27807006). Interacts (via N-terminus) with STK24
CC       (PubMed:20332113, PubMed:27807006). Interacts with GOLGA2
CC       (PubMed:20332113). Identified in a complex with KRIT1 and CCM2.
CC       Interacts with KDR/VEGFR2. Interaction with KDR/VEGFR2 is enhanced
CC       by stimulation with VEGFA (By similarity). Interacts with RIPOR1
CC       (via C-terminus); this interaction is required for the association
CC       of RIPOR1 with either STK24 and STK26 kinases and occurs in a Rho-
CC       independent manner (PubMed:27807006). {ECO:0000250,
CC       ECO:0000269|PubMed:17360971, ECO:0000269|PubMed:20332113,
CC       ECO:0000269|PubMed:20489202, ECO:0000269|PubMed:27807006}.
CC   -!- INTERACTION:
CC       Q96BA2:-; NbExp=5; IntAct=EBI-740195, EBI-10282278;
CC       Q8IY42:C4orf19; NbExp=5; IntAct=EBI-740195, EBI-10216552;
CC       Q9BSQ5:CCM2; NbExp=5; IntAct=EBI-740195, EBI-1573056;
CC       Q499L9:MST4; NbExp=5; IntAct=EBI-740195, EBI-6137569;
CC       Q12923:PTPN13; NbExp=3; IntAct=EBI-740195, EBI-355227;
CC       Q9Y6E0:STK24; NbExp=9; IntAct=EBI-740195, EBI-740175;
CC       Q9Y6E0-2:STK24; NbExp=5; IntAct=EBI-740195, EBI-10299018;
CC       O00506:STK25; NbExp=23; IntAct=EBI-740195, EBI-618295;
CC       Q9P289:STK26; NbExp=9; IntAct=EBI-740195, EBI-618239;
CC       Q9P289-1:STK26; NbExp=10; IntAct=EBI-740195, EBI-15996971;
CC       O43815:STRN; NbExp=4; IntAct=EBI-740195, EBI-1046642;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm. Golgi apparatus membrane;
CC       Peripheral membrane protein; Cytoplasmic side. Cell membrane;
CC       Peripheral membrane protein; Cytoplasmic side. Note=Partially co-
CC       localizes with endogenous PXN at the leading edges of migrating
CC       cells.
CC   -!- TISSUE SPECIFICITY: Ubiquitous. {ECO:0000269|PubMed:15543491}.
CC   -!- DISEASE: Cerebral cavernous malformations 3 (CCM3) [MIM:603285]: A
CC       congenital vascular anomaly of the central nervous system that can
CC       result in hemorrhagic stroke, seizures, recurrent headaches, and
CC       focal neurologic deficits. The lesions are characterized by
CC       grossly enlarged blood vessels consisting of a single layer of
CC       endothelium and without any intervening neural tissue, ranging in
CC       diameter from a few millimeters to several centimeters.
CC       {ECO:0000269|PubMed:15543491}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the PDCD10 family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF022385; AAB72225.1; -; mRNA.
DR   EMBL; CR457107; CAG33388.1; -; mRNA.
DR   EMBL; AK291130; BAF83819.1; -; mRNA.
DR   EMBL; AC079822; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471052; EAW78574.1; -; Genomic_DNA.
DR   EMBL; CH471052; EAW78575.1; -; Genomic_DNA.
DR   EMBL; CH471052; EAW78576.1; -; Genomic_DNA.
DR   EMBL; CH471052; EAW78577.1; -; Genomic_DNA.
DR   EMBL; CH471052; EAW78578.1; -; Genomic_DNA.
DR   EMBL; CH471052; EAW78580.1; -; Genomic_DNA.
DR   EMBL; CH471052; EAW78581.1; -; Genomic_DNA.
DR   EMBL; BC002506; AAH02506.1; -; mRNA.
DR   EMBL; BC016353; AAH16353.1; -; mRNA.
DR   CCDS; CCDS3202.1; -.
DR   RefSeq; NP_009148.2; NM_007217.3.
DR   RefSeq; NP_665858.1; NM_145859.1.
DR   RefSeq; NP_665859.1; NM_145860.1.
DR   RefSeq; XP_005247143.1; XM_005247086.4.
DR   RefSeq; XP_005247144.1; XM_005247087.4.
DR   RefSeq; XP_005247145.1; XM_005247088.3.
DR   RefSeq; XP_006713548.1; XM_006713485.3.
DR   RefSeq; XP_011510670.1; XM_011512368.2.
DR   RefSeq; XP_011510671.1; XM_011512369.2.
DR   RefSeq; XP_016861133.1; XM_017005644.1.
DR   UniGene; Hs.478150; -.
DR   PDB; 3AJM; X-ray; 2.30 A; A/B=8-212.
DR   PDB; 3L8I; X-ray; 2.50 A; A/B/C/D=1-212.
DR   PDB; 3L8J; X-ray; 3.05 A; A=14-212.
DR   PDB; 3RQE; X-ray; 2.80 A; A/B/C/D=1-212.
DR   PDB; 3RQF; X-ray; 2.70 A; A/B/C/D=1-212.
DR   PDB; 3RQG; X-ray; 2.50 A; A/B/C/D=1-212.
DR   PDB; 3W8H; X-ray; 2.43 A; A=8-212.
DR   PDB; 3W8I; X-ray; 2.40 A; A=8-212.
DR   PDB; 4GEH; X-ray; 1.95 A; A/C=9-212.
DR   PDB; 4TVQ; X-ray; 2.80 A; A/B/C/D=1-212.
DR   PDBsum; 3AJM; -.
DR   PDBsum; 3L8I; -.
DR   PDBsum; 3L8J; -.
DR   PDBsum; 3RQE; -.
DR   PDBsum; 3RQF; -.
DR   PDBsum; 3RQG; -.
DR   PDBsum; 3W8H; -.
DR   PDBsum; 3W8I; -.
DR   PDBsum; 4GEH; -.
DR   PDBsum; 4TVQ; -.
DR   ProteinModelPortal; Q9BUL8; -.
DR   SMR; Q9BUL8; -.
DR   BioGrid; 116400; 60.
DR   DIP; DIP-40607N; -.
DR   IntAct; Q9BUL8; 36.
DR   MINT; Q9BUL8; -.
DR   STRING; 9606.ENSP00000376506; -.
DR   iPTMnet; Q9BUL8; -.
DR   PhosphoSitePlus; Q9BUL8; -.
DR   BioMuta; PDCD10; -.
DR   DMDM; 74733232; -.
DR   OGP; Q9BUL8; -.
DR   EPD; Q9BUL8; -.
DR   MaxQB; Q9BUL8; -.
DR   PaxDb; Q9BUL8; -.
DR   PeptideAtlas; Q9BUL8; -.
DR   PRIDE; Q9BUL8; -.
DR   TopDownProteomics; Q9BUL8; -.
DR   DNASU; 11235; -.
DR   Ensembl; ENST00000392750; ENSP00000376506; ENSG00000114209.
DR   Ensembl; ENST00000461494; ENSP00000420021; ENSG00000114209.
DR   Ensembl; ENST00000470131; ENSP00000417202; ENSG00000114209.
DR   Ensembl; ENST00000473645; ENSP00000418317; ENSG00000114209.
DR   Ensembl; ENST00000497056; ENSP00000420553; ENSG00000114209.
DR   GeneID; 11235; -.
DR   KEGG; hsa:11235; -.
DR   UCSC; uc003fex.5; human.
DR   CTD; 11235; -.
DR   DisGeNET; 11235; -.
DR   EuPathDB; HostDB:ENSG00000114209.14; -.
DR   GeneCards; PDCD10; -.
DR   GeneReviews; PDCD10; -.
DR   HGNC; HGNC:8761; PDCD10.
DR   HPA; HPA027095; -.
DR   MalaCards; PDCD10; -.
DR   MIM; 603285; phenotype.
DR   MIM; 609118; gene.
DR   neXtProt; NX_Q9BUL8; -.
DR   OpenTargets; ENSG00000114209; -.
DR   Orphanet; 221061; Hereditary cerebral cavernous malformation.
DR   PharmGKB; PA33111; -.
DR   eggNOG; KOG4025; Eukaryota.
DR   eggNOG; ENOG410XTA6; LUCA.
DR   GeneTree; ENSGT00390000017913; -.
DR   HOGENOM; HOG000007888; -.
DR   HOVERGEN; HBG052811; -.
DR   InParanoid; Q9BUL8; -.
DR   KO; K18269; -.
DR   OMA; TMGDETP; -.
DR   OrthoDB; EOG091G0JQQ; -.
DR   PhylomeDB; Q9BUL8; -.
DR   TreeFam; TF105802; -.
DR   SIGNOR; Q9BUL8; -.
DR   ChiTaRS; PDCD10; human.
DR   EvolutionaryTrace; Q9BUL8; -.
DR   GeneWiki; PDCD10; -.
DR   GenomeRNAi; 11235; -.
DR   PRO; PR:Q9BUL8; -.
DR   Proteomes; UP000005640; Chromosome 3.
DR   Bgee; ENSG00000114209; -.
DR   CleanEx; HS_PDCD10; -.
DR   ExpressionAtlas; Q9BUL8; baseline and differential.
DR   Genevisible; Q9BUL8; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IDA:UniProtKB.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0005794; C:Golgi apparatus; IDA:UniProtKB.
DR   GO; GO:0000139; C:Golgi membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0042803; F:protein homodimerization activity; IPI:UniProtKB.
DR   GO; GO:0019901; F:protein kinase binding; IPI:UniProtKB.
DR   GO; GO:0047485; F:protein N-terminus binding; IPI:UniProtKB.
DR   GO; GO:0001525; P:angiogenesis; IEA:UniProtKB-KW.
DR   GO; GO:1990830; P:cellular response to leukemia inhibitory factor; IEA:Ensembl.
DR   GO; GO:0051683; P:establishment of Golgi localization; IMP:UniProtKB.
DR   GO; GO:0090168; P:Golgi reassembly; IMP:UniProtKB.
DR   GO; GO:0036481; P:intrinsic apoptotic signaling pathway in response to hydrogen peroxide; IGI:UniProtKB.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; IDA:UniProtKB.
DR   GO; GO:1903588; P:negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis; IMP:UniProtKB.
DR   GO; GO:0090051; P:negative regulation of cell migration involved in sprouting angiogenesis; IMP:UniProtKB.
DR   GO; GO:0010629; P:negative regulation of gene expression; IMP:UniProtKB.
DR   GO; GO:0030335; P:positive regulation of cell migration; IDA:UniProtKB.
DR   GO; GO:0008284; P:positive regulation of cell proliferation; IDA:UniProtKB.
DR   GO; GO:0010628; P:positive regulation of gene expression; IMP:UniProtKB.
DR   GO; GO:0090316; P:positive regulation of intracellular protein transport; IMP:UniProtKB.
DR   GO; GO:0043406; P:positive regulation of MAP kinase activity; IDA:UniProtKB.
DR   GO; GO:0045747; P:positive regulation of Notch signaling pathway; IMP:UniProtKB.
DR   GO; GO:0033138; P:positive regulation of peptidyl-serine phosphorylation; IMP:UniProtKB.
DR   GO; GO:0071902; P:positive regulation of protein serine/threonine kinase activity; IMP:UniProtKB.
DR   GO; GO:0032874; P:positive regulation of stress-activated MAPK cascade; IDA:UniProtKB.
DR   GO; GO:0050821; P:protein stabilization; IMP:UniProtKB.
DR   GO; GO:0042542; P:response to hydrogen peroxide; IDA:UniProtKB.
DR   GO; GO:0044319; P:wound healing, spreading of cells; IMP:UniProtKB.
DR   InterPro; IPR009652; PDCD10.
DR   PANTHER; PTHR13250; PTHR13250; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Angiogenesis; Apoptosis; Cell membrane;
KW   Complete proteome; Cytoplasm; Direct protein sequencing;
KW   Golgi apparatus; Isopeptide bond; Membrane; Polymorphism;
KW   Reference proteome; Ubl conjugation.
FT   CHAIN         1    212       Programmed cell death protein 10.
FT                                /FTId=PRO_0000187562.
FT   MOD_RES     179    179       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   CROSSLNK    186    186       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   VARIANT     102    102       D -> A (in dbSNP:rs1129087).
FT                                {ECO:0000269|Ref.1}.
FT                                /FTId=VAR_023578.
FT   MUTAGEN     132    132       K->D: Loss of interaction with CCM2 and
FT                                PXN; when associated with D-139; D-172
FT                                and D-179. {ECO:0000269|PubMed:20489202}.
FT   MUTAGEN     135    135       A->D: Loss of interaction with CCM2.
FT                                {ECO:0000269|PubMed:20489202}.
FT   MUTAGEN     139    139       K->D: Loss of interaction with CCM2 and
FT                                PXN; when associated with D-132; D-172
FT                                and D-179. {ECO:0000269|PubMed:20489202}.
FT   MUTAGEN     172    172       K->D: Loss of interaction with CCM2 and
FT                                PXN; when associated with D-132; D-139
FT                                and D-179. {ECO:0000269|PubMed:20489202}.
FT   MUTAGEN     175    175       S->D: Loss of interaction with CCM2.
FT                                {ECO:0000269|PubMed:20489202}.
FT   MUTAGEN     179    179       K->D: Loss of interaction with CCM2 and
FT                                PXN; when associated with D-132; D-139
FT                                and D-172. {ECO:0000269|PubMed:20489202}.
FT   HELIX         5      9       {ECO:0000244|PDB:3L8I}.
FT   HELIX        11     14       {ECO:0000244|PDB:3L8I}.
FT   HELIX        17     19       {ECO:0000244|PDB:4GEH}.
FT   HELIX        20     24       {ECO:0000244|PDB:4GEH}.
FT   HELIX        26     34       {ECO:0000244|PDB:4GEH}.
FT   HELIX        38     54       {ECO:0000244|PDB:4GEH}.
FT   HELIX        58     69       {ECO:0000244|PDB:4GEH}.
FT   HELIX        76     82       {ECO:0000244|PDB:4GEH}.
FT   TURN         83     85       {ECO:0000244|PDB:4GEH}.
FT   HELIX        88     91       {ECO:0000244|PDB:4GEH}.
FT   HELIX        98    115       {ECO:0000244|PDB:4GEH}.
FT   HELIX       117    120       {ECO:0000244|PDB:4GEH}.
FT   STRAND      121    123       {ECO:0000244|PDB:4TVQ}.
FT   HELIX       124    151       {ECO:0000244|PDB:4GEH}.
FT   TURN        152    156       {ECO:0000244|PDB:4GEH}.
FT   HELIX       157    184       {ECO:0000244|PDB:4GEH}.
FT   HELIX       187    208       {ECO:0000244|PDB:4GEH}.
SQ   SEQUENCE   212 AA;  24702 MW;  5AA613F71FAAEF56 CRC64;
     MRMTMEEMKN EAETTSMVSM PLYAVMYPVF NELERVNLSA AQTLRAAFIK AEKENPGLTQ
     DIIMKILEKK SVEVNFTESL LRMAADDVEE YMIERPEPEF QDLNEKARAL KQILSKIPDE
     INDRVRFLQT IKDIASAIKE LLDTVNNVFK KYQYQNRRAL EHQKKEFVKY SKSFSDTLKT
     YFKDGKAINV FVSANRLIHQ TNLILQTFKT VA
//
ID   A0A0S2Z3X8_HUMAN        Unreviewed;       447 AA.
AC   A0A0S2Z3X8;
DT   17-FEB-2016, integrated into UniProtKB/TrEMBL.
DT   17-FEB-2016, sequence version 1.
DT   23-MAY-2018, entry version 23.
DE   RecName: Full=Rab GDP dissociation inhibitor {ECO:0000256|RuleBase:RU363124};
DE   Flags: Fragment;
GN   Name=GDI1 {ECO:0000313|EMBL:ALQ33549.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:ALQ33549.1};
RN   [1] {ECO:0000313|EMBL:AEE61218.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Li J.Y.;
RT   "Human testis protein.";
RL   Submitted (MAR-2010) to the EMBL/GenBank/DDBJ databases.
RN   [2] {ECO:0000313|EMBL:ALQ33549.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=26871637; DOI=10.1016/j.cell.2016.01.029;
RA   Yang X., Coulombe-Huntington J., Kang S., Sheynkman G.M., Hao T.,
RA   Richardson A., Sun S., Yang F., Shen Y.A., Murray R., Spirohn K.,
RA   Begg B.E., Duran-Frigola M., MacWilliams A., Pevzner S.J., Zhong Q.,
RA   Trigg S.A., Tam S., Ghamsari L., Sahni N., Yi S., Rodriguez M.D.,
RA   Balcha D., Tan G., Costanzo M., Andrews B., Boone C., Zhou X.J.,
RA   Salehi-Ashtiani K., Charloteaux B., Chen A., Calderwood M.A., Aloy P.,
RA   Roth F.P., Hill D.E., Iakoucheva L.M., Xia Y., Vidal M.;
RT   "Widespread Expansion of Protein Interaction Capabilities by
RT   Alternative Splicing.";
RL   Cell 164:805-817(2016).
CC   -!- FUNCTION: Regulates the GDP/GTP exchange reaction of most RAB
CC       proteins by inhibiting the dissociation of GDP from them, and the
CC       subsequent binding of GTP. {ECO:0000256|RuleBase:RU363124}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000256|RuleBase:RU363124}.
CC   -!- SIMILARITY: Belongs to the Rab GDI family.
CC       {ECO:0000256|RuleBase:RU363124}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; HM005621; AEE61218.1; -; mRNA.
DR   EMBL; KU178091; ALQ33549.1; -; mRNA.
DR   RefSeq; NP_001484.1; NM_001493.2.
DR   UniGene; Hs.595950; -.
DR   UniGene; Hs.74576; -.
DR   SMR; A0A0S2Z3X8; -.
DR   PRIDE; A0A0S2Z3X8; -.
DR   GeneID; 2664; -.
DR   KEGG; hsa:2664; -.
DR   CTD; 2664; -.
DR   KO; K17255; -.
DR   OMA; EDPATHQ; -.
DR   ChiTaRS; GDI1; human.
DR   ExpressionAtlas; A0A0S2Z3X8; baseline and differential.
DR   GO; GO:0030424; C:axon; IEA:Ensembl.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0043209; C:myelin sheath; IEA:Ensembl.
DR   GO; GO:0043025; C:neuronal cell body; IEA:Ensembl.
DR   GO; GO:0032991; C:protein-containing complex; IEA:Ensembl.
DR   GO; GO:0005096; F:GTPase activator activity; IEA:UniProtKB-KW.
DR   GO; GO:0005093; F:Rab GDP-dissociation inhibitor activity; IEA:Ensembl.
DR   GO; GO:0017137; F:Rab GTPase binding; IEA:Ensembl.
DR   GO; GO:0050771; P:negative regulation of axonogenesis; IEA:Ensembl.
DR   GO; GO:0045773; P:positive regulation of axon extension; IEA:Ensembl.
DR   GO; GO:0015031; P:protein transport; IEA:InterPro.
DR   GO; GO:0051592; P:response to calcium ion; IEA:Ensembl.
DR   GO; GO:0007264; P:small GTPase mediated signal transduction; IEA:InterPro.
DR   Gene3D; 3.50.50.60; -; 3.
DR   InterPro; IPR036188; FAD/NAD-bd_sf.
DR   InterPro; IPR018203; GDP_dissociation_inhibitor.
DR   InterPro; IPR000806; RabGDI.
DR   PANTHER; PTHR11787; PTHR11787; 1.
DR   Pfam; PF00996; GDI; 1.
DR   PRINTS; PR00892; RABGDI.
DR   PRINTS; PR00891; RABGDIREP.
DR   SUPFAM; SSF51905; SSF51905; 2.
PE   2: Evidence at transcript level;
KW   Cytoplasm {ECO:0000256|RuleBase:RU363124};
KW   GTPase activation {ECO:0000256|RuleBase:RU363124}.
FT   NON_TER     447    447       {ECO:0000313|EMBL:ALQ33549.1}.
SQ   SEQUENCE   447 AA;  50583 MW;  BC283A445E50A652 CRC64;
     MDEEYDVIVL GTGLTECILS GIMSVNGKKV LHMDRNPYYG GESSSITPLE ELYKRFQLLE
     GPPESMGRGR DWNVDLIPKF LMANGQLVKM LLYTEVTRYL DFKVVEGSFV YKGGKIYKVP
     STETEALASN LMGMFEKRRF RKFLVFVANF DENDPKTFEG VDPQTTSMRD VYRKFDLGQD
     VIDFTGHALA LYRTDDYLDQ PCLETVNRIK LYSESLARYG KSPYLYPLYG LGELPQGFAR
     LSAIYGGTYM LNKPVDDIIM ENGKVVGVKS EGEVARCKQL ICDPSYIPDR VRKAGQVIRI
     ICILSHPIKN TNDANSCQII IPQNQVNRKS DIYVCMISYA HNVAAQGKYI AIASTTVETT
     DPEKEVEPAL ELLEPIDQKF VAISDLYEPI DDGCESQVFC SCSYDATTHF ETTCNDIKDI
     YKRMAGTAFD FENMKRKQND VFGEAEQ
//
ID   GDIA_HUMAN              Reviewed;         447 AA.
AC   P31150; P50394; Q6FG50; Q7Z2G6; Q7Z2G9; Q7Z2H5; Q7Z2I6;
DT   01-JUL-1993, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-1996, sequence version 2.
DT   23-MAY-2018, entry version 186.
DE   RecName: Full=Rab GDP dissociation inhibitor alpha;
DE            Short=Rab GDI alpha;
DE   AltName: Full=Guanosine diphosphate dissociation inhibitor 1;
DE            Short=GDI-1;
DE   AltName: Full=Oligophrenin-2;
DE   AltName: Full=Protein XAP-4;
GN   Name=GDI1; Synonyms=GDIL, OPHN2, RABGDIA, XAP4;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA].
RX   PubMed=7849400; DOI=10.1007/BF00411459;
RA   Sedlacek Z., Konecki D.S., Korn B., Klauck S.M., Poustka A.;
RT   "Evolutionary conservation and genomic organization of XAP-4, an Xq28
RT   located gene coding for a human rab GDP-dissociation inhibitor
RT   (GDI).";
RL   Mamm. Genome 5:633-639(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Retina;
RX   PubMed=7585614;
RA   Nishimura N., Goji J., Nakamura H., Orita S., Takai Y., Sano K.;
RT   "Cloning of a brain-type isoform of human Rab GDI and its expression
RT   in human neuroblastoma cell lines and tumor specimens.";
RL   Cancer Res. 55:5445-5450(1995).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA].
RX   PubMed=8733135; DOI=10.1093/hmg/5.5.659;
RA   Chen E.Y., Zollo M., Mazzarella R.A., Ciccodicola A., Chen C.-N.,
RA   Zuo L., Heiner C., Burough F.W., Ripetto M., Schlessinger D.,
RA   D'Urso M.;
RT   "Long-range sequence analysis in Xq28: thirteen known and six
RT   candidate genes in 219.4 kb of high GC DNA between the RCP/GCP and
RT   G6PD loci.";
RL   Hum. Mol. Genet. 5:659-668(1996).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RA   Feng Z., Zhang B., Zhou Y., Peng X., Yuan J., Qiang B.;
RL   Submitted (JUL-2001) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA].
RX   PubMed=12777533; DOI=10.1093/molbev/msg134;
RA   Kitano T., Schwarz C., Nickel B., Paeaebo S.;
RT   "Gene diversity patterns at 10 X-chromosomal loci in humans and
RT   chimpanzees.";
RL   Mol. Biol. Evol. 20:1281-1289(2003).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (OCT-2004) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15772651; DOI=10.1038/nature03440;
RA   Ross M.T., Grafham D.V., Coffey A.J., Scherer S., McLay K., Muzny D.,
RA   Platzer M., Howell G.R., Burrows C., Bird C.P., Frankish A.,
RA   Lovell F.L., Howe K.L., Ashurst J.L., Fulton R.S., Sudbrak R., Wen G.,
RA   Jones M.C., Hurles M.E., Andrews T.D., Scott C.E., Searle S.,
RA   Ramser J., Whittaker A., Deadman R., Carter N.P., Hunt S.E., Chen R.,
RA   Cree A., Gunaratne P., Havlak P., Hodgson A., Metzker M.L.,
RA   Richards S., Scott G., Steffen D., Sodergren E., Wheeler D.A.,
RA   Worley K.C., Ainscough R., Ambrose K.D., Ansari-Lari M.A., Aradhya S.,
RA   Ashwell R.I., Babbage A.K., Bagguley C.L., Ballabio A., Banerjee R.,
RA   Barker G.E., Barlow K.F., Barrett I.P., Bates K.N., Beare D.M.,
RA   Beasley H., Beasley O., Beck A., Bethel G., Blechschmidt K., Brady N.,
RA   Bray-Allen S., Bridgeman A.M., Brown A.J., Brown M.J., Bonnin D.,
RA   Bruford E.A., Buhay C., Burch P., Burford D., Burgess J., Burrill W.,
RA   Burton J., Bye J.M., Carder C., Carrel L., Chako J., Chapman J.C.,
RA   Chavez D., Chen E., Chen G., Chen Y., Chen Z., Chinault C.,
RA   Ciccodicola A., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Clerc-Blankenburg K., Clifford K., Cobley V., Cole C.G., Conquer J.S.,
RA   Corby N., Connor R.E., David R., Davies J., Davis C., Davis J.,
RA   Delgado O., Deshazo D., Dhami P., Ding Y., Dinh H., Dodsworth S.,
RA   Draper H., Dugan-Rocha S., Dunham A., Dunn M., Durbin K.J., Dutta I.,
RA   Eades T., Ellwood M., Emery-Cohen A., Errington H., Evans K.L.,
RA   Faulkner L., Francis F., Frankland J., Fraser A.E., Galgoczy P.,
RA   Gilbert J., Gill R., Gloeckner G., Gregory S.G., Gribble S.,
RA   Griffiths C., Grocock R., Gu Y., Gwilliam R., Hamilton C., Hart E.A.,
RA   Hawes A., Heath P.D., Heitmann K., Hennig S., Hernandez J.,
RA   Hinzmann B., Ho S., Hoffs M., Howden P.J., Huckle E.J., Hume J.,
RA   Hunt P.J., Hunt A.R., Isherwood J., Jacob L., Johnson D., Jones S.,
RA   de Jong P.J., Joseph S.S., Keenan S., Kelly S., Kershaw J.K., Khan Z.,
RA   Kioschis P., Klages S., Knights A.J., Kosiura A., Kovar-Smith C.,
RA   Laird G.K., Langford C., Lawlor S., Leversha M., Lewis L., Liu W.,
RA   Lloyd C., Lloyd D.M., Loulseged H., Loveland J.E., Lovell J.D.,
RA   Lozado R., Lu J., Lyne R., Ma J., Maheshwari M., Matthews L.H.,
RA   McDowall J., McLaren S., McMurray A., Meidl P., Meitinger T.,
RA   Milne S., Miner G., Mistry S.L., Morgan M., Morris S., Mueller I.,
RA   Mullikin J.C., Nguyen N., Nordsiek G., Nyakatura G., O'dell C.N.,
RA   Okwuonu G., Palmer S., Pandian R., Parker D., Parrish J.,
RA   Pasternak S., Patel D., Pearce A.V., Pearson D.M., Pelan S.E.,
RA   Perez L., Porter K.M., Ramsey Y., Reichwald K., Rhodes S.,
RA   Ridler K.A., Schlessinger D., Schueler M.G., Sehra H.K.,
RA   Shaw-Smith C., Shen H., Sheridan E.M., Shownkeen R., Skuce C.D.,
RA   Smith M.L., Sotheran E.C., Steingruber H.E., Steward C.A., Storey R.,
RA   Swann R.M., Swarbreck D., Tabor P.E., Taudien S., Taylor T.,
RA   Teague B., Thomas K., Thorpe A., Timms K., Tracey A., Trevanion S.,
RA   Tromans A.C., d'Urso M., Verduzco D., Villasana D., Waldron L.,
RA   Wall M., Wang Q., Warren J., Warry G.L., Wei X., West A.,
RA   Whitehead S.L., Whiteley M.N., Wilkinson J.E., Willey D.L.,
RA   Williams G., Williams L., Williamson A., Williamson H., Wilming L.,
RA   Woodmansey R.L., Wray P.W., Yen J., Zhang J., Zhou J., Zoghbi H.,
RA   Zorilla S., Buck D., Reinhardt R., Poustka A., Rosenthal A.,
RA   Lehrach H., Meindl A., Minx P.J., Hillier L.W., Willard H.F.,
RA   Wilson R.K., Waterston R.H., Rice C.M., Vaudin M., Coulson A.,
RA   Nelson D.L., Weinstock G., Sulston J.E., Durbin R.M., Hubbard T.,
RA   Gibbs R.A., Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence of the human X chromosome.";
RL   Nature 434:325-337(2005).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain, and Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [11]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 143-181.
RA   Hochgeschwender U.;
RT   "Rapid identification of gene sequences for transcriptional map
RT   assembly by direct cDNA screening of genomic reference libraries.";
RL   Submitted (SEP-1994) to the EMBL/GenBank/DDBJ databases.
RN   [12]
RP   PROTEIN SEQUENCE OF 143-156; 174-193 AND 222-240, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY.
RC   TISSUE=Brain, and Cajal-Retzius cell;
RA   Lubec G., Vishwanath V.;
RL   Submitted (MAR-2007) to UniProtKB.
RN   [13]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 328-436.
RA   Bhat K.S.;
RL   Submitted (NOV-1992) to the EMBL/GenBank/DDBJ databases.
RN   [14]
RP   PROTEIN SEQUENCE OF 349-361.
RC   TISSUE=Keratinocyte;
RX   PubMed=1286667; DOI=10.1002/elps.11501301199;
RA   Rasmussen H.H., van Damme J., Puype M., Gesser B., Celis J.E.,
RA   Vandekerckhove J.;
RT   "Microsequences of 145 proteins recorded in the two-dimensional gel
RT   protein database of normal human epidermal keratinocytes.";
RL   Electrophoresis 13:960-969(1992).
RN   [15]
RP   TISSUE SPECIFICITY.
RX   PubMed=7543319; DOI=10.1093/hmg/4.4.701;
RA   Bachner D., Sedlacek Z., Korn B., Hameister H., Poustka A.;
RT   "Expression patterns of two human genes coding for different rab GDP-
RT   dissociation inhibitors (GDIs), extremely conserved proteins involved
RT   in cellular transport.";
RL   Hum. Mol. Genet. 4:701-708(1995).
RN   [16]
RP   INTERACTION WITH RHOH.
RX   PubMed=11809807; DOI=10.1128/MCB.22.4.1158-1171.2002;
RA   Li X., Bu X., Lu B., Avraham H., Flavell R.A., Lim B.;
RT   "The hematopoiesis-specific GTP-binding protein RhoH is GTPase
RT   deficient and modulates activities of other Rho GTPases by an
RT   inhibitory function.";
RL   Mol. Cell. Biol. 22:1158-1171(2002).
RN   [17]
RP   INTERACTION WITH RAB10, AND SUBCELLULAR LOCATION.
RX   PubMed=19570034; DOI=10.1042/BJ20090624;
RA   Chen Y., Deng Y., Zhang J., Yang L., Xie X., Xu T.;
RT   "GDI-1 preferably interacts with Rab10 in insulin-stimulated GLUT4
RT   translocation.";
RL   Biochem. J. 422:229-235(2009).
RN   [18]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [19]
RP   INTERACTION WITH RAB1A AND RAB5A, AND FUNCTION.
RX   PubMed=23815289; DOI=10.3109/09687688.2013.818725;
RA   Kirsten M.L., Baron R.A., Seabra M.C., Ces O.;
RT   "Rab1a and Rab5a preferentially bind to binary lipid compositions with
RT   higher stored curvature elastic energy.";
RL   Mol. Membr. Biol. 30:303-314(2013).
RN   [20]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [21]
RP   VARIANT MRX41 PRO-92.
RX   PubMed=9620768; DOI=10.1038/487;
RA   D'Adamo P., Menegon A., Lo Nigro C., Grasso M., Gulisano M.,
RA   Tamanini F., Bienvenu T., Gedeon A.K., Oostra B., Wu S.-K., Tandon A.,
RA   Valtorta F., Balch W.E., Chelly J., Toniolo D.;
RT   "Mutations in GDI1 are responsible for X-linked non-specific mental
RT   retardation.";
RL   Nat. Genet. 19:134-139(1998).
RN   [22]
RP   VARIANT MRX41 PRO-423.
RX   PubMed=9668174; DOI=10.1093/hmg/7.8.1311;
RA   Bienvenu T., Des Portes V., Saint Martin A., McDonell N., Billuart P.,
RA   Carrie A., Vinet M.-C., Couvert P., Toniolo D., Ropers H.-H.,
RA   Moraine C., van Bokhoven H., Fryns J.-P., Kahn A., Beldjord C.,
RA   Chelly J.;
RT   "Non-specific X-linked semidominant mental retardation by mutations in
RT   a Rab GDP-dissociation inhibitor.";
RL   Hum. Mol. Genet. 7:1311-1315(1998).
CC   -!- FUNCTION: Regulates the GDP/GTP exchange reaction of most Rab
CC       proteins by inhibiting the dissociation of GDP from them, and the
CC       subsequent binding of GTP to them. Promotes the dissociation of
CC       GDP-bound Rab proteins from the membrane and inhibits their
CC       activation. Promotes the dissociation of RAB1A, RAB3A, RAB5A and
CC       RAB10 from membranes. {ECO:0000269|PubMed:23815289}.
CC   -!- SUBUNIT: Interacts with RHOH. Interacts with RAB1A, RAB3A, RAB5A
CC       and RAB10. {ECO:0000269|PubMed:11809807,
CC       ECO:0000269|PubMed:19570034, ECO:0000269|PubMed:23815289}.
CC   -!- INTERACTION:
CC       Q8TBB1:LNX1; NbExp=6; IntAct=EBI-946999, EBI-739832;
CC       P61027:Rab10 (xeno); NbExp=3; IntAct=EBI-946999, EBI-911581;
CC       P62820:RAB1A; NbExp=2; IntAct=EBI-946999, EBI-716845;
CC       P20338:RAB4A; NbExp=3; IntAct=EBI-946999, EBI-722284;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:19570034}.
CC       Golgi apparatus, trans-Golgi network
CC       {ECO:0000269|PubMed:19570034}.
CC   -!- TISSUE SPECIFICITY: Brain; predominant in neural and sensory
CC       tissues. {ECO:0000269|PubMed:7543319}.
CC   -!- DISEASE: Mental retardation, X-linked 41 (MRX41) [MIM:300849]: A
CC       disorder characterized by significantly below average general
CC       intellectual functioning associated with impairments in adaptive
CC       behavior and manifested during the developmental period.
CC       Intellectual deficiency is the only primary symptom of non-
CC       syndromic X-linked mental retardation, while syndromic mental
CC       retardation presents with associated physical, neurological and/or
CC       psychiatric manifestations. {ECO:0000269|PubMed:9620768,
CC       ECO:0000269|PubMed:9668174}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the Rab GDI family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X79353; CAA55908.1; -; mRNA.
DR   EMBL; X79354; CAA55909.1; -; Genomic_DNA.
DR   EMBL; X79355; CAA55909.1; JOINED; Genomic_DNA.
DR   EMBL; X79356; CAA55909.1; JOINED; Genomic_DNA.
DR   EMBL; X79357; CAA55909.1; JOINED; Genomic_DNA.
DR   EMBL; X79358; CAA55909.1; JOINED; Genomic_DNA.
DR   EMBL; X79359; CAA55909.1; JOINED; Genomic_DNA.
DR   EMBL; X79360; CAA55909.1; JOINED; Genomic_DNA.
DR   EMBL; X79364; CAA55909.1; JOINED; Genomic_DNA.
DR   EMBL; X79361; CAA55909.1; JOINED; Genomic_DNA.
DR   EMBL; X79362; CAA55909.1; JOINED; Genomic_DNA.
DR   EMBL; X79363; CAA55909.1; JOINED; Genomic_DNA.
DR   EMBL; D45021; BAA08078.1; -; mRNA.
DR   EMBL; L44140; AAA92648.1; -; Genomic_DNA.
DR   EMBL; AF400433; AAK92482.1; -; mRNA.
DR   EMBL; AB101741; BAC80330.1; -; Genomic_DNA.
DR   EMBL; AB101742; BAC80331.1; -; Genomic_DNA.
DR   EMBL; AB101743; BAC80332.1; -; Genomic_DNA.
DR   EMBL; AB101744; BAC80333.1; -; Genomic_DNA.
DR   EMBL; AB101745; BAC80334.1; -; Genomic_DNA.
DR   EMBL; AB101746; BAC80335.1; -; Genomic_DNA.
DR   EMBL; AB101747; BAC80336.1; -; Genomic_DNA.
DR   EMBL; AB101748; BAC80337.1; -; Genomic_DNA.
DR   EMBL; AB101749; BAC80338.1; -; Genomic_DNA.
DR   EMBL; AB101750; BAC80339.1; -; Genomic_DNA.
DR   EMBL; AB101751; BAC80340.1; -; Genomic_DNA.
DR   EMBL; AB101752; BAC80341.1; -; Genomic_DNA.
DR   EMBL; AB101753; BAC80342.1; -; Genomic_DNA.
DR   EMBL; AB101754; BAC80343.1; -; Genomic_DNA.
DR   EMBL; AB101755; BAC80344.1; -; Genomic_DNA.
DR   EMBL; AB101756; BAC80345.1; -; Genomic_DNA.
DR   EMBL; AB101757; BAC80346.1; -; Genomic_DNA.
DR   EMBL; AB101758; BAC80347.1; -; Genomic_DNA.
DR   EMBL; AB101759; BAC80348.1; -; Genomic_DNA.
DR   EMBL; AB101760; BAC80349.1; -; Genomic_DNA.
DR   EMBL; AB101771; BAC80360.1; -; Genomic_DNA.
DR   EMBL; AB101772; BAC80361.1; -; Genomic_DNA.
DR   EMBL; AB101773; BAC80362.1; -; Genomic_DNA.
DR   EMBL; AB101774; BAC80363.1; -; Genomic_DNA.
DR   EMBL; AB101775; BAC80364.1; -; Genomic_DNA.
DR   EMBL; AB101776; BAC80365.1; -; Genomic_DNA.
DR   EMBL; AB101777; BAC80366.1; -; Genomic_DNA.
DR   EMBL; AB101778; BAC80367.1; -; Genomic_DNA.
DR   EMBL; AB101779; BAC80368.1; -; Genomic_DNA.
DR   EMBL; AB101780; BAC80369.1; -; Genomic_DNA.
DR   EMBL; AB101781; BAC80370.1; -; Genomic_DNA.
DR   EMBL; AB101782; BAC80371.1; -; Genomic_DNA.
DR   EMBL; AB101783; BAC80372.1; -; Genomic_DNA.
DR   EMBL; AB101784; BAC80373.1; -; Genomic_DNA.
DR   EMBL; AB101785; BAC80374.1; -; Genomic_DNA.
DR   EMBL; AB101786; BAC80375.1; -; Genomic_DNA.
DR   EMBL; AB101787; BAC80376.1; -; Genomic_DNA.
DR   EMBL; AB101788; BAC80377.1; -; Genomic_DNA.
DR   EMBL; AB101789; BAC80378.1; -; Genomic_DNA.
DR   EMBL; AB101790; BAC80379.1; -; Genomic_DNA.
DR   EMBL; AB101801; BAC80390.1; -; Genomic_DNA.
DR   EMBL; AB101802; BAC80391.1; -; Genomic_DNA.
DR   EMBL; AB101803; BAC80392.1; -; Genomic_DNA.
DR   EMBL; AB101804; BAC80393.1; -; Genomic_DNA.
DR   EMBL; AB101805; BAC80394.1; -; Genomic_DNA.
DR   EMBL; AB101806; BAC80395.1; -; Genomic_DNA.
DR   EMBL; AB101807; BAC80396.1; -; Genomic_DNA.
DR   EMBL; AB101808; BAC80397.1; -; Genomic_DNA.
DR   EMBL; AB101809; BAC80398.1; -; Genomic_DNA.
DR   EMBL; AB101810; BAC80399.1; -; Genomic_DNA.
DR   EMBL; AB101811; BAC80400.1; -; Genomic_DNA.
DR   EMBL; AB101812; BAC80401.1; -; Genomic_DNA.
DR   EMBL; AB101813; BAC80402.1; -; Genomic_DNA.
DR   EMBL; AB101814; BAC80403.1; -; Genomic_DNA.
DR   EMBL; AB101815; BAC80404.1; -; Genomic_DNA.
DR   EMBL; AB101816; BAC80405.1; -; Genomic_DNA.
DR   EMBL; AB101817; BAC80406.1; -; Genomic_DNA.
DR   EMBL; AB101818; BAC80407.1; -; Genomic_DNA.
DR   EMBL; AB101819; BAC80408.1; -; Genomic_DNA.
DR   EMBL; AB101820; BAC80409.1; -; Genomic_DNA.
DR   EMBL; AB101831; BAC80420.1; -; Genomic_DNA.
DR   EMBL; AB101832; BAC80421.1; -; Genomic_DNA.
DR   EMBL; AB101833; BAC80422.1; -; Genomic_DNA.
DR   EMBL; AB101834; BAC80423.1; -; Genomic_DNA.
DR   EMBL; AB101835; BAC80424.1; -; Genomic_DNA.
DR   EMBL; AB101836; BAC80425.1; -; Genomic_DNA.
DR   EMBL; AB101837; BAC80426.1; -; Genomic_DNA.
DR   EMBL; AB101838; BAC80427.1; -; Genomic_DNA.
DR   EMBL; AB101839; BAC80428.1; -; Genomic_DNA.
DR   EMBL; AB101840; BAC80429.1; -; Genomic_DNA.
DR   EMBL; AB101841; BAC80430.1; -; Genomic_DNA.
DR   EMBL; AB101842; BAC80431.1; -; Genomic_DNA.
DR   EMBL; AB101843; BAC80432.1; -; Genomic_DNA.
DR   EMBL; AB101844; BAC80433.1; -; Genomic_DNA.
DR   EMBL; AB101845; BAC80434.1; -; Genomic_DNA.
DR   EMBL; AB101846; BAC80435.1; -; Genomic_DNA.
DR   EMBL; AB101847; BAC80436.1; -; Genomic_DNA.
DR   EMBL; AB101848; BAC80437.1; -; Genomic_DNA.
DR   EMBL; AB101849; BAC80438.1; -; Genomic_DNA.
DR   EMBL; AB101850; BAC80439.1; -; Genomic_DNA.
DR   EMBL; AB102647; BAC81116.1; -; mRNA.
DR   EMBL; CR542258; CAG47054.1; -; mRNA.
DR   EMBL; CR542276; CAG47072.1; -; mRNA.
DR   EMBL; BT019884; AAV38687.1; -; mRNA.
DR   EMBL; BX936385; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471172; EAW72710.1; -; Genomic_DNA.
DR   EMBL; BC000317; AAH00317.1; -; mRNA.
DR   EMBL; BC012201; AAH12201.1; -; mRNA.
DR   EMBL; U14623; AAA21558.1; -; Genomic_DNA.
DR   EMBL; L05086; AAC15851.1; -; mRNA.
DR   CCDS; CCDS35452.1; -.
DR   PIR; I37082; I37082.
DR   RefSeq; NP_001484.1; NM_001493.2.
DR   UniGene; Hs.595950; -.
DR   UniGene; Hs.74576; -.
DR   ProteinModelPortal; P31150; -.
DR   SMR; P31150; -.
DR   BioGrid; 108932; 85.
DR   IntAct; P31150; 37.
DR   MINT; P31150; -.
DR   STRING; 9606.ENSP00000394071; -.
DR   iPTMnet; P31150; -.
DR   PhosphoSitePlus; P31150; -.
DR   SwissPalm; P31150; -.
DR   BioMuta; GDI1; -.
DR   DMDM; 1707886; -.
DR   OGP; P31150; -.
DR   REPRODUCTION-2DPAGE; IPI00010154; -.
DR   UCD-2DPAGE; P31150; -.
DR   EPD; P31150; -.
DR   MaxQB; P31150; -.
DR   PaxDb; P31150; -.
DR   PeptideAtlas; P31150; -.
DR   PRIDE; P31150; -.
DR   DNASU; 2664; -.
DR   Ensembl; ENST00000447750; ENSP00000394071; ENSG00000203879.
DR   GeneID; 2664; -.
DR   KEGG; hsa:2664; -.
DR   UCSC; uc004fli.5; human.
DR   CTD; 2664; -.
DR   DisGeNET; 2664; -.
DR   EuPathDB; HostDB:ENSG00000203879.11; -.
DR   GeneCards; GDI1; -.
DR   H-InvDB; HIX0056464; -.
DR   HGNC; HGNC:4226; GDI1.
DR   HPA; CAB012979; -.
DR   HPA; HPA049290; -.
DR   HPA; HPA057668; -.
DR   MalaCards; GDI1; -.
DR   MIM; 300104; gene.
DR   MIM; 300849; phenotype.
DR   neXtProt; NX_P31150; -.
DR   OpenTargets; ENSG00000203879; -.
DR   Orphanet; 777; X-linked non-syndromic intellectual disability.
DR   PharmGKB; PA28641; -.
DR   eggNOG; KOG1439; Eukaryota.
DR   eggNOG; COG5044; LUCA.
DR   GeneTree; ENSGT00530000063044; -.
DR   HOVERGEN; HBG000839; -.
DR   InParanoid; P31150; -.
DR   KO; K17255; -.
DR   OMA; EDPATHQ; -.
DR   OrthoDB; EOG091G06PV; -.
DR   PhylomeDB; P31150; -.
DR   TreeFam; TF300449; -.
DR   Reactome; R-HSA-194840; Rho GTPase cycle.
DR   Reactome; R-HSA-8876198; RAB GEFs exchange GTP for GDP on RABs.
DR   ChiTaRS; GDI1; human.
DR   GeneWiki; GDI1; -.
DR   GenomeRNAi; 2664; -.
DR   PRO; PR:P31150; -.
DR   Proteomes; UP000005640; Chromosome X.
DR   Bgee; ENSG00000203879; -.
DR   CleanEx; HS_GDI1; -.
DR   ExpressionAtlas; P31150; baseline and differential.
DR   Genevisible; P31150; HS.
DR   GO; GO:0030424; C:axon; IEA:Ensembl.
DR   GO; GO:0005737; C:cytoplasm; IDA:LIFEdb.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0005794; C:Golgi apparatus; IEA:UniProtKB-SubCell.
DR   GO; GO:0030496; C:midbody; IDA:UniProtKB.
DR   GO; GO:0043209; C:myelin sheath; IEA:Ensembl.
DR   GO; GO:0043025; C:neuronal cell body; IEA:Ensembl.
DR   GO; GO:0032991; C:protein-containing complex; IEA:Ensembl.
DR   GO; GO:0005092; F:GDP-dissociation inhibitor activity; TAS:ProtInc.
DR   GO; GO:0005096; F:GTPase activator activity; IEA:UniProtKB-KW.
DR   GO; GO:0005093; F:Rab GDP-dissociation inhibitor activity; ISS:UniProtKB.
DR   GO; GO:0017137; F:Rab GTPase binding; IEA:Ensembl.
DR   GO; GO:0050771; P:negative regulation of axonogenesis; ISS:UniProtKB.
DR   GO; GO:0090315; P:negative regulation of protein targeting to membrane; IMP:UniProtKB.
DR   GO; GO:0045773; P:positive regulation of axon extension; IEA:Ensembl.
DR   GO; GO:0015031; P:protein transport; IEA:InterPro.
DR   GO; GO:0032482; P:Rab protein signal transduction; ISS:UniProtKB.
DR   GO; GO:0051056; P:regulation of small GTPase mediated signal transduction; TAS:Reactome.
DR   GO; GO:0051592; P:response to calcium ion; IEA:Ensembl.
DR   GO; GO:0007165; P:signal transduction; TAS:ProtInc.
DR   Gene3D; 3.50.50.60; -; 3.
DR   InterPro; IPR036188; FAD/NAD-bd_sf.
DR   InterPro; IPR018203; GDP_dissociation_inhibitor.
DR   InterPro; IPR000806; RabGDI.
DR   PANTHER; PTHR11787; PTHR11787; 1.
DR   Pfam; PF00996; GDI; 1.
DR   PRINTS; PR00892; RABGDI.
DR   PRINTS; PR00891; RABGDIREP.
DR   SUPFAM; SSF51905; SSF51905; 2.
PE   1: Evidence at protein level;
KW   Complete proteome; Cytoplasm; Direct protein sequencing;
KW   Disease mutation; Golgi apparatus; GTPase activation;
KW   Mental retardation; Reference proteome.
FT   CHAIN         1    447       Rab GDP dissociation inhibitor alpha.
FT                                /FTId=PRO_0000056671.
FT   VARIANT      92     92       L -> P (in MRX41; causes reduced binding
FT                                and recycling of RAB3A;
FT                                dbSNP:rs121434607).
FT                                {ECO:0000269|PubMed:9620768}.
FT                                /FTId=VAR_008130.
FT   VARIANT     423    423       R -> P (in MRX41; dbSNP:rs121434609).
FT                                {ECO:0000269|PubMed:9668174}.
FT                                /FTId=VAR_008131.
FT   CONFLICT     34     34       D -> G (in Ref. 2; BAA08078).
FT                                {ECO:0000305}.
FT   CONFLICT     36     36       N -> K (in Ref. 2; BAA08078).
FT                                {ECO:0000305}.
FT   CONFLICT    149    151       NFD -> GTY (in Ref. 2; BAA08078).
FT                                {ECO:0000305}.
FT   CONFLICT    347    347       G -> V (in Ref. 13; AAC15851).
FT                                {ECO:0000305}.
FT   CONFLICT    409    409       H -> Q (in Ref. 13; AAC15851).
FT                                {ECO:0000305}.
FT   CONFLICT    416    416       D -> G (in Ref. 13; AAC15851).
FT                                {ECO:0000305}.
FT   CONFLICT    442    442       F -> S (in Ref. 2; BAA08078).
FT                                {ECO:0000305}.
SQ   SEQUENCE   447 AA;  50583 MW;  BC283A445E50A652 CRC64;
     MDEEYDVIVL GTGLTECILS GIMSVNGKKV LHMDRNPYYG GESSSITPLE ELYKRFQLLE
     GPPESMGRGR DWNVDLIPKF LMANGQLVKM LLYTEVTRYL DFKVVEGSFV YKGGKIYKVP
     STETEALASN LMGMFEKRRF RKFLVFVANF DENDPKTFEG VDPQTTSMRD VYRKFDLGQD
     VIDFTGHALA LYRTDDYLDQ PCLETVNRIK LYSESLARYG KSPYLYPLYG LGELPQGFAR
     LSAIYGGTYM LNKPVDDIIM ENGKVVGVKS EGEVARCKQL ICDPSYIPDR VRKAGQVIRI
     ICILSHPIKN TNDANSCQII IPQNQVNRKS DIYVCMISYA HNVAAQGKYI AIASTTVETT
     DPEKEVEPAL ELLEPIDQKF VAISDLYEPI DDGCESQVFC SCSYDATTHF ETTCNDIKDI
     YKRMAGTAFD FENMKRKQND VFGEAEQ
//
ID   PCH2_HUMAN              Reviewed;         432 AA.
AC   Q15645; C9K0T3; D3DTC0; O15324;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   10-JAN-2006, sequence version 2.
DT   23-MAY-2018, entry version 158.
DE   RecName: Full=Pachytene checkpoint protein 2 homolog;
DE   AltName: Full=Human papillomavirus type 16 E1 protein-binding protein;
DE            Short=16E1-BP;
DE            Short=HPV16 E1 protein-binding protein;
DE   AltName: Full=Thyroid hormone receptor interactor 13;
DE   AltName: Full=Thyroid receptor-interacting protein 13;
DE            Short=TR-interacting protein 13;
DE            Short=TRIP-13;
GN   Name=TRIP13; Synonyms=PCH2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND INTERACTION WITH HPV16 E1.
RX   PubMed=9223484;
RA   Yasugi T., Vidal M., Sakai H., Howley P.M., Benson J.D.;
RT   "Two classes of human papillomavirus type 16 E1 mutants suggest
RT   pleiotropic conformational constraints affecting E1 multimerization,
RT   E2 interaction, and interaction with cellular proteins.";
RL   J. Virol. 71:5942-5951(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-417 (ISOFORM 2), AND INTERACTION WITH
RP   THRA.
RX   PubMed=7776974; DOI=10.1210/mend.9.2.7776974;
RA   Lee J.W., Choi H.-S., Gyuris J., Brent R., Moore D.D.;
RT   "Two classes of proteins dependent on either the presence or absence
RT   of thyroid hormone for interaction with the thyroid hormone
RT   receptor.";
RL   Mol. Endocrinol. 9:243-254(1995).
RN   [6]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=15592455; DOI=10.1038/nbt1046;
RA   Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H.,
RA   Zha X.-M., Polakiewicz R.D., Comb M.J.;
RT   "Immunoaffinity profiling of tyrosine phosphorylation in cancer
RT   cells.";
RL   Nat. Biotechnol. 23:94-101(2005).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [9]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [12]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22223895; DOI=10.1074/mcp.M111.015131;
RA   Bienvenut W.V., Sumpton D., Martinez A., Lilla S., Espagne C.,
RA   Meinnel T., Giglione C.;
RT   "Comparative large-scale characterisation of plant vs. mammal proteins
RT   reveals similar and idiosyncratic N-alpha acetylation features.";
RL   Mol. Cell. Proteomics 11:M111.015131-M111.015131(2012).
RN   [13]
RP   VARIANT MVA3 354-ARG--ILE-432 DEL, CHARACTERIZATION OF VARIANT MVA3
RP   354-ARG--ILE-432 DEL, AND FUNCTION.
RX   PubMed=28553959; DOI=10.1038/ng.3883;
RA   Yost S., de Wolf B., Hanks S., Zachariou A., Marcozzi C., Clarke M.,
RA   de Voer R., Etemad B., Uijttewaal E., Ramsay E., Wylie H., Elliott A.,
RA   Picton S., Smith A., Smithson S., Seal S., Ruark E., Houge G.,
RA   Pines J., Kops G.J.P.L., Rahman N.;
RT   "Biallelic TRIP13 mutations predispose to Wilms tumor and chromosome
RT   missegregation.";
RL   Nat. Genet. 49:1148-1151(2017).
CC   -!- FUNCTION: Plays a key role in chromosome recombination and
CC       chromosome structure development during meiosis. Required at early
CC       steps in meiotic recombination that leads to non-crossovers
CC       pathways. Also needed for efficient completion of homologous
CC       synapsis by influencing crossover distribution along the
CC       chromosomes affecting both crossovers and non-crossovers pathways.
CC       Also required for development of higher-order chromosome
CC       structures and is needed for synaptonemal-complex formation. In
CC       males, required for efficient synapsis of the sex chromosomes and
CC       for sex body formation. Promotes early steps of the DNA double-
CC       strand breaks (DSBs) repair process upstream of the assembly of
CC       RAD51 complexes. Required for depletion of HORMAD1 and HORMAD2
CC       from synapsed chromosomes (By similarity). Plays a role in mitotic
CC       spindle assembly checkpoint (SAC) activation (PubMed:28553959).
CC       {ECO:0000250|UniProtKB:Q3UA06, ECO:0000269|PubMed:28553959}.
CC   -!- SUBUNIT: Specifically interacts with the ligand binding domain of
CC       the thyroid receptor (TR). This interaction does not require the
CC       presence of thyroid hormone for its interaction. Interacts with
CC       HPV16 E1. {ECO:0000269|PubMed:7776974,
CC       ECO:0000269|PubMed:9223484}.
CC   -!- INTERACTION:
CC       Self; NbExp=5; IntAct=EBI-358993, EBI-358993;
CC       Q96EJ4:-; NbExp=3; IntAct=EBI-358993, EBI-750454;
CC       Q9Y303:AMDHD2; NbExp=3; IntAct=EBI-358993, EBI-2798672;
CC       Q969Q4:ARL11; NbExp=3; IntAct=EBI-358993, EBI-751892;
CC       P15289:ARSA; NbExp=12; IntAct=EBI-358993, EBI-2117357;
CC       Q9H0W9:C11orf54; NbExp=3; IntAct=EBI-358993, EBI-740204;
CC       Q8N1A6:C4orf33; NbExp=5; IntAct=EBI-358993, EBI-10264911;
CC       A0A0S2Z515:CFP; NbExp=3; IntAct=EBI-358993, EBI-16434710;
CC       P21964:COMT; NbExp=3; IntAct=EBI-358993, EBI-372265;
CC       P21964-2:COMT; NbExp=3; IntAct=EBI-358993, EBI-10200977;
CC       P53672:CRYBA2; NbExp=4; IntAct=EBI-358993, EBI-750444;
CC       Q6BCY4:CYB5R2; NbExp=4; IntAct=EBI-358993, EBI-744761;
CC       O95865:DDAH2; NbExp=5; IntAct=EBI-358993, EBI-749139;
CC       Q14689:DIP2A; NbExp=3; IntAct=EBI-358993, EBI-2564275;
CC       Q14689-6:DIP2A; NbExp=3; IntAct=EBI-358993, EBI-10233719;
CC       O14531:DPYSL4; NbExp=3; IntAct=EBI-358993, EBI-719542;
CC       Q96A09:FAM46B; NbExp=4; IntAct=EBI-358993, EBI-752030;
CC       Q9UBX5:FBLN5; NbExp=3; IntAct=EBI-358993, EBI-947897;
CC       A0A0S2Z576:FBXO8; NbExp=3; IntAct=EBI-358993, EBI-16434722;
CC       Q53EP0-3:FNDC3B; NbExp=7; IntAct=EBI-358993, EBI-10242151;
CC       A0A0S2Z4I0:GALT; NbExp=3; IntAct=EBI-358993, EBI-16434744;
CC       P07902:GALT; NbExp=4; IntAct=EBI-358993, EBI-750827;
CC       Q8IVS8:GLYCTK; NbExp=8; IntAct=EBI-358993, EBI-748515;
CC       Q9BSH5:HDHD3; NbExp=7; IntAct=EBI-358993, EBI-745201;
CC       P59990:KRTAP12-1; NbExp=5; IntAct=EBI-358993, EBI-10210845;
CC       P59991:KRTAP12-2; NbExp=3; IntAct=EBI-358993, EBI-10176379;
CC       Q6PEX3:KRTAP26-1; NbExp=3; IntAct=EBI-358993, EBI-3957672;
CC       Q16773:KYAT1; NbExp=3; IntAct=EBI-358993, EBI-10238309;
CC       Q14847:LASP1; NbExp=7; IntAct=EBI-358993, EBI-742828;
CC       Q8TBB1:LNX1; NbExp=6; IntAct=EBI-358993, EBI-739832;
CC       Q96JB6:LOXL4; NbExp=6; IntAct=EBI-358993, EBI-749562;
CC       Q96L50:LRR1; NbExp=3; IntAct=EBI-358993, EBI-2510106;
CC       Q8TC57:M1AP; NbExp=3; IntAct=EBI-358993, EBI-748182;
CC       Q15013:MAD2L1BP; NbExp=7; IntAct=EBI-358993, EBI-712181;
CC       A6NJ78-4:METTL15; NbExp=5; IntAct=EBI-358993, EBI-10174029;
CC       Q6PF18:MORN3; NbExp=3; IntAct=EBI-358993, EBI-9675802;
CC       Q15777:MPPED2; NbExp=7; IntAct=EBI-358993, EBI-2350461;
CC       Q9GZT8:NIF3L1; NbExp=3; IntAct=EBI-358993, EBI-740897;
CC       O00746:NME4; NbExp=3; IntAct=EBI-358993, EBI-744871;
CC       P55771:PAX9; NbExp=4; IntAct=EBI-358993, EBI-12111000;
CC       P30039:PBLD; NbExp=4; IntAct=EBI-358993, EBI-750589;
CC       Q6PIM4:PCMTD2; NbExp=3; IntAct=EBI-358993, EBI-10253759;
CC       Q96FA3:PELI1; NbExp=3; IntAct=EBI-358993, EBI-448369;
CC       Q9NRY6:PLSCR3; NbExp=6; IntAct=EBI-358993, EBI-750734;
CC       Q9NRQ2:PLSCR4; NbExp=3; IntAct=EBI-358993, EBI-769257;
CC       P67775:PPP2CA; NbExp=5; IntAct=EBI-358993, EBI-712311;
CC       O60260:PRKN; NbExp=3; IntAct=EBI-358993, EBI-716346;
CC       P47897:QARS; NbExp=5; IntAct=EBI-358993, EBI-347462;
CC       P47897-2:QARS; NbExp=3; IntAct=EBI-358993, EBI-10209725;
CC       Q9BQY4:RHOXF2; NbExp=7; IntAct=EBI-358993, EBI-372094;
CC       P22307:SCP2; NbExp=4; IntAct=EBI-358993, EBI-1050999;
CC       Q13228:SELENBP1; NbExp=3; IntAct=EBI-358993, EBI-711619;
CC       Q9NTN9:SEMA4G; NbExp=3; IntAct=EBI-358993, EBI-6447340;
CC       Q9NTN9-3:SEMA4G; NbExp=3; IntAct=EBI-358993, EBI-9089805;
CC       O15389:SIGLEC5; NbExp=4; IntAct=EBI-358993, EBI-750381;
CC       Q5W111:SPRYD7; NbExp=3; IntAct=EBI-358993, EBI-10248098;
CC       Q96LM6:TEX37; NbExp=6; IntAct=EBI-358993, EBI-743976;
CC       Q9GZM7:TINAGL1; NbExp=5; IntAct=EBI-358993, EBI-715869;
CC       Q9GZM7-3:TINAGL1; NbExp=3; IntAct=EBI-358993, EBI-10303636;
CC       Q6P9B6:TLDC1; NbExp=3; IntAct=EBI-358993, EBI-746504;
CC       Q8NDV7:TNRC6A; NbExp=3; IntAct=EBI-358993, EBI-2269715;
CC       P13693:TPT1; NbExp=3; IntAct=EBI-358993, EBI-1783169;
CC       P11473:VDR; NbExp=3; IntAct=EBI-358993, EBI-286357;
CC       Q96HA8:WDYHV1; NbExp=3; IntAct=EBI-358993, EBI-741158;
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q15645-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q15645-2; Sequence=VSP_016957;
CC         Note=No experimental confirmation available.;
CC   -!- DISEASE: Mosaic variegated aneuploidy syndrome 3 (MVA3)
CC       [MIM:617598]: A form of mosaic variegated aneuploidy syndrome, a
CC       severe disorder characterized by mosaic aneuploidies,
CC       predominantly trisomies and monosomies, involving multiple
CC       different chromosomes and tissues. Affected individuals typically
CC       present with severe intrauterine growth retardation and
CC       microcephaly. Eye anomalies, mild dysmorphism, variable
CC       developmental delay, and a broad spectrum of additional congenital
CC       abnormalities and medical conditions may also occur. The risk of
CC       malignancy is high, with rhabdomyosarcoma, Wilms tumor and
CC       leukemia reported in several cases. MVA3 inheritance is autosomal
CC       recessive. {ECO:0000269|PubMed:28553959}. Note=The disease is
CC       caused by mutations affecting the gene represented in this entry.
CC       MVA3 is caused by biallelic mutations in the TRIP13 gene.
CC   -!- SIMILARITY: Belongs to the AAA ATPase family. PCH2 subfamily.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAC41732.1; Type=Frameshift; Positions=1, 5; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U96131; AAB64095.1; -; mRNA.
DR   EMBL; CR456744; CAG33025.1; -; mRNA.
DR   EMBL; AC122719; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471102; EAX08185.1; -; Genomic_DNA.
DR   EMBL; CH471102; EAX08186.1; -; Genomic_DNA.
DR   EMBL; BC000404; AAH00404.1; -; mRNA.
DR   EMBL; BC019294; AAH19294.1; -; mRNA.
DR   EMBL; L40384; AAC41732.1; ALT_FRAME; mRNA.
DR   CCDS; CCDS3858.1; -. [Q15645-1]
DR   RefSeq; NP_004228.1; NM_004237.3. [Q15645-1]
DR   RefSeq; XP_011512465.1; XM_011514163.2. [Q15645-1]
DR   UniGene; Hs.436187; -.
DR   PDB; 5VQ9; X-ray; 3.02 A; D=1-432.
DR   PDB; 5VQA; X-ray; 2.54 A; A=1-432.
DR   PDBsum; 5VQ9; -.
DR   PDBsum; 5VQA; -.
DR   ProteinModelPortal; Q15645; -.
DR   SMR; Q15645; -.
DR   BioGrid; 114730; 127.
DR   DIP; DIP-34493N; -.
DR   IntAct; Q15645; 122.
DR   MINT; Q15645; -.
DR   STRING; 9606.ENSP00000166345; -.
DR   iPTMnet; Q15645; -.
DR   PhosphoSitePlus; Q15645; -.
DR   SwissPalm; Q15645; -.
DR   BioMuta; TRIP13; -.
DR   DMDM; 85541056; -.
DR   EPD; Q15645; -.
DR   MaxQB; Q15645; -.
DR   PaxDb; Q15645; -.
DR   PeptideAtlas; Q15645; -.
DR   PRIDE; Q15645; -.
DR   DNASU; 9319; -.
DR   Ensembl; ENST00000166345; ENSP00000166345; ENSG00000071539. [Q15645-1]
DR   GeneID; 9319; -.
DR   KEGG; hsa:9319; -.
DR   UCSC; uc003jbr.4; human. [Q15645-1]
DR   CTD; 9319; -.
DR   DisGeNET; 9319; -.
DR   EuPathDB; HostDB:ENSG00000071539.13; -.
DR   GeneCards; TRIP13; -.
DR   HGNC; HGNC:12307; TRIP13.
DR   HPA; HPA005727; -.
DR   HPA; HPA053093; -.
DR   MalaCards; TRIP13; -.
DR   MIM; 604507; gene.
DR   MIM; 617598; phenotype.
DR   neXtProt; NX_Q15645; -.
DR   OpenTargets; ENSG00000071539; -.
DR   PharmGKB; PA36986; -.
DR   eggNOG; KOG0744; Eukaryota.
DR   eggNOG; COG0464; LUCA.
DR   GeneTree; ENSGT00390000017432; -.
DR   HOGENOM; HOG000234557; -.
DR   HOVERGEN; HBG052830; -.
DR   InParanoid; Q15645; -.
DR   KO; K22399; -.
DR   OMA; HLNEEGP; -.
DR   OrthoDB; EOG091G0D83; -.
DR   PhylomeDB; Q15645; -.
DR   TreeFam; TF313507; -.
DR   GeneWiki; TRIP13; -.
DR   GenomeRNAi; 9319; -.
DR   PRO; PR:Q15645; -.
DR   Proteomes; UP000005640; Chromosome 5.
DR   Bgee; ENSG00000071539; -.
DR   CleanEx; HS_TRIP13; -.
DR   ExpressionAtlas; Q15645; baseline and differential.
DR   Genevisible; Q15645; HS.
DR   GO; GO:0001673; C:male germ cell nucleus; IEA:Ensembl.
DR   GO; GO:0005634; C:nucleus; TAS:ProtInc.
DR   GO; GO:0005524; F:ATP binding; NAS:UniProtKB.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0003712; F:transcription cofactor activity; TAS:ProtInc.
DR   GO; GO:0006302; P:double-strand break repair; ISS:UniProtKB.
DR   GO; GO:0007144; P:female meiosis I; IEA:Ensembl.
DR   GO; GO:0007141; P:male meiosis I; IEA:Ensembl.
DR   GO; GO:0007094; P:mitotic spindle assembly checkpoint; IMP:UniProtKB.
DR   GO; GO:0001556; P:oocyte maturation; IEA:Ensembl.
DR   GO; GO:0048477; P:oogenesis; ISS:UniProtKB.
DR   GO; GO:0007131; P:reciprocal meiotic recombination; ISS:UniProtKB.
DR   GO; GO:0007286; P:spermatid development; IEA:Ensembl.
DR   GO; GO:0007283; P:spermatogenesis; ISS:UniProtKB.
DR   GO; GO:0007130; P:synaptonemal complex assembly; ISS:UniProtKB.
DR   GO; GO:0006366; P:transcription by RNA polymerase II; TAS:ProtInc.
DR   InterPro; IPR003593; AAA+_ATPase.
DR   InterPro; IPR003959; ATPase_AAA_core.
DR   InterPro; IPR003960; ATPase_AAA_CS.
DR   InterPro; IPR001270; ClpA/B.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   Pfam; PF00004; AAA; 1.
DR   PRINTS; PR00300; CLPPROTEASEA.
DR   SMART; SM00382; AAA; 1.
DR   SUPFAM; SSF52540; SSF52540; 2.
DR   PROSITE; PS00674; AAA; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; ATP-binding;
KW   Complete proteome; Differentiation; Disease mutation; Meiosis;
KW   Nucleotide-binding; Oogenesis; Reference proteome; Spermatogenesis.
FT   CHAIN         1    432       Pachytene checkpoint protein 2 homolog.
FT                                /FTId=PRO_0000084782.
FT   NP_BIND     179    186       ATP. {ECO:0000255}.
FT   MOD_RES       1      1       N-acetylmethionine.
FT                                {ECO:0000244|PubMed:19413330,
FT                                ECO:0000244|PubMed:22223895}.
FT   VAR_SEQ     171    406       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:7776974}.
FT                                /FTId=VSP_016957.
FT   VARIANT     354    432       Missing (in MVA3; loss of protein
FT                                expression; impairment of spindle
FT                                assembly checkpoint).
FT                                {ECO:0000269|PubMed:28553959}.
FT                                /FTId=VAR_079275.
FT   STRAND       21     27       {ECO:0000244|PDB:5VQA}.
FT   HELIX        35     49       {ECO:0000244|PDB:5VQA}.
FT   STRAND       57     59       {ECO:0000244|PDB:5VQA}.
FT   HELIX        64     69       {ECO:0000244|PDB:5VQA}.
FT   STRAND       70     76       {ECO:0000244|PDB:5VQA}.
FT   STRAND       95    100       {ECO:0000244|PDB:5VQA}.
FT   STRAND      122    129       {ECO:0000244|PDB:5VQA}.
FT   HELIX       130    132       {ECO:0000244|PDB:5VQA}.
FT   HELIX       135    138       {ECO:0000244|PDB:5VQA}.
FT   HELIX       145    162       {ECO:0000244|PDB:5VQA}.
FT   TURN        166    168       {ECO:0000244|PDB:5VQA}.
FT   STRAND      173    178       {ECO:0000244|PDB:5VQA}.
FT   HELIX       185    199       {ECO:0000244|PDB:5VQA}.
FT   TURN        200    203       {ECO:0000244|PDB:5VQA}.
FT   STRAND      205    212       {ECO:0000244|PDB:5VQA}.
FT   HELIX       228    240       {ECO:0000244|PDB:5VQA}.
FT   STRAND      245    252       {ECO:0000244|PDB:5VQA}.
FT   HELIX       255    259       {ECO:0000244|PDB:5VQA}.
FT   HELIX       273    287       {ECO:0000244|PDB:5VQA}.
FT   STRAND      293    300       {ECO:0000244|PDB:5VQA}.
FT   STRAND      302    304       {ECO:0000244|PDB:5VQA}.
FT   TURN        307    312       {ECO:0000244|PDB:5VQA}.
FT   STRAND      314    318       {ECO:0000244|PDB:5VQA}.
FT   HELIX       324    340       {ECO:0000244|PDB:5VQA}.
FT   HELIX       353    358       {ECO:0000244|PDB:5VQA}.
FT   TURN        359    361       {ECO:0000244|PDB:5VQA}.
FT   TURN        365    367       {ECO:0000244|PDB:5VQA}.
FT   HELIX       368    379       {ECO:0000244|PDB:5VQA}.
FT   TURN        380    382       {ECO:0000244|PDB:5VQA}.
FT   HELIX       385    399       {ECO:0000244|PDB:5VQA}.
FT   HELIX       407    429       {ECO:0000244|PDB:5VQA}.
SQ   SEQUENCE   432 AA;  48551 MW;  DFB0B37462D1D581 CRC64;
     MDEAVGDLKQ ALPCVAESPT VHVEVHQRGS STAKKEDINL SVRKLLNRHN IVFGDYTWTE
     FDEPFLTRNV QSVSIIDTEL KVKDSQPIDL SACTVALHIF QLNEDGPSSE NLEEETENII
     AANHWVLPAA EFHGLWDSLV YDVEVKSHLL DYVMTTLLFS DKNVNSNLIT WNRVVLLHGP
     PGTGKTSLCK ALAQKLTIRL SSRYRYGQLI EINSHSLFSK WFSESGKLVT KMFQKIQDLI
     DDKDALVFVL IDEVESLTAA RNACRAGTEP SDAIRVVNAV LTQIDQIKRH SNVVILTTSN
     ITEKIDVAFV DRADIKQYIG PPSAAAIFKI YLSCLEELMK CQIIYPRQQL LTLRELEMIG
     FIENNVSKLS LLLNDISRKS EGLSGRVLRK LPFLAHALYV QAPTVTIEGF LQALSLAVDK
     QFEERKKLAA YI
//
ID   TRIP6_HUMAN             Reviewed;         476 AA.
AC   Q15654; A4D2E7; F2ZC07; F2ZC08; O15170; O15275; Q9BTB2; Q9BUE5;
AC   Q9BXP3; Q9UNT4;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   15-MAY-2002, sequence version 3.
DT   23-MAY-2018, entry version 173.
DE   RecName: Full=Thyroid receptor-interacting protein 6;
DE            Short=TR-interacting protein 6;
DE            Short=TRIP-6;
DE   AltName: Full=Opa-interacting protein 1;
DE            Short=OIP-1;
DE   AltName: Full=Zyxin-related protein 1;
DE            Short=ZRP-1;
GN   Name=TRIP6; Synonyms=OIP1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=9598321; DOI=10.1006/geno.1998.5248;
RA   Yi J., Beckerle M.C.;
RT   "The human TRIP6 gene encodes a LIM domain protein and maps to
RT   chromosome 7q22, a region associated with tumorigenesis.";
RL   Genomics 49:314-316(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORM 1), AND INTERACTION
RP   WITH PTPN13.
RX   PubMed=10400701; DOI=10.1074/jbc.274.29.20679;
RA   Murthy K.K., Clark K., Fortin Y., Shen S.-H., Banville D.;
RT   "ZRP-1, a zyxin-related protein, interacts with the second PDZ domain
RT   of the cytosolic protein tyrosine phosphatase hPTP1E.";
RL   J. Biol. Chem. 274:20679-20687(1999).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=11239002; DOI=10.1093/nar/29.6.1352;
RA   Wilson M.D., Riemer C., Martindale D.W., Schnupf P., Boright A.P.,
RA   Cheung T.L., Hardy D.M., Schwartz S., Scherer S.W., Tsui L.-C.,
RA   Miller W., Koop B.F.;
RT   "Comparative analysis of the gene-dense ACHE/TFR2 region on human
RT   chromosome 7q22 with the orthologous region on mouse chromosome 5.";
RL   Nucleic Acids Res. 29:1352-1365(2001).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RA   Kojima H., Masuhiro Y., Hanazawa S.;
RT   "Identification and characterization of novel isoforms of human
RT   TRIP6.";
RL   Submitted (MAY-2011) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12853948; DOI=10.1038/nature01782;
RA   Hillier L.W., Fulton R.S., Fulton L.A., Graves T.A., Pepin K.H.,
RA   Wagner-McPherson C., Layman D., Maas J., Jaeger S., Walker R.,
RA   Wylie K., Sekhon M., Becker M.C., O'Laughlin M.D., Schaller M.E.,
RA   Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Cordes M., Du H.,
RA   Sun H., Edwards J., Bradshaw-Cordum H., Ali J., Andrews S., Isak A.,
RA   Vanbrunt A., Nguyen C., Du F., Lamar B., Courtney L., Kalicki J.,
RA   Ozersky P., Bielicki L., Scott K., Holmes A., Harkins R., Harris A.,
RA   Strong C.M., Hou S., Tomlinson C., Dauphin-Kohlberg S.,
RA   Kozlowicz-Reilly A., Leonard S., Rohlfing T., Rock S.M.,
RA   Tin-Wollam A.-M., Abbott A., Minx P., Maupin R., Strowmatt C.,
RA   Latreille P., Miller N., Johnson D., Murray J., Woessner J.P.,
RA   Wendl M.C., Yang S.-P., Schultz B.R., Wallis J.W., Spieth J.,
RA   Bieri T.A., Nelson J.O., Berkowicz N., Wohldmann P.E., Cook L.L.,
RA   Hickenbotham M.T., Eldred J., Williams D., Bedell J.A., Mardis E.R.,
RA   Clifton S.W., Chissoe S.L., Marra M.A., Raymond C., Haugen E.,
RA   Gillett W., Zhou Y., James R., Phelps K., Iadanoto S., Bubb K.,
RA   Simms E., Levy R., Clendenning J., Kaul R., Kent W.J., Furey T.S.,
RA   Baertsch R.A., Brent M.R., Keibler E., Flicek P., Bork P., Suyama M.,
RA   Bailey J.A., Portnoy M.E., Torrents D., Chinwalla A.T., Gish W.R.,
RA   Eddy S.R., McPherson J.D., Olson M.V., Eichler E.E., Green E.D.,
RA   Waterston R.H., Wilson R.K.;
RT   "The DNA sequence of human chromosome 7.";
RL   Nature 424:157-164(2003).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12690205; DOI=10.1126/science.1083423;
RA   Scherer S.W., Cheung J., MacDonald J.R., Osborne L.R., Nakabayashi K.,
RA   Herbrick J.-A., Carson A.R., Parker-Katiraee L., Skaug J., Khaja R.,
RA   Zhang J., Hudek A.K., Li M., Haddad M., Duggan G.E., Fernandez B.A.,
RA   Kanematsu E., Gentles S., Christopoulos C.C., Choufani S.,
RA   Kwasnicka D., Zheng X.H., Lai Z., Nusskern D.R., Zhang Q., Gu Z.,
RA   Lu F., Zeesman S., Nowaczyk M.J., Teshima I., Chitayat D., Shuman C.,
RA   Weksberg R., Zackai E.H., Grebe T.A., Cox S.R., Kirkpatrick S.J.,
RA   Rahman N., Friedman J.M., Heng H.H.Q., Pelicci P.G., Lo-Coco F.,
RA   Belloni E., Shaffer L.G., Pober B., Morton C.C., Gusella J.F.,
RA   Bruns G.A.P., Korf B.R., Quade B.J., Ligon A.H., Ferguson H.,
RA   Higgins A.W., Leach N.T., Herrick S.R., Lemyre E., Farra C.G.,
RA   Kim H.-G., Summers A.M., Gripp K.W., Roberts W., Szatmari P.,
RA   Winsor E.J.T., Grzeschik K.-H., Teebi A., Minassian B.A., Kere J.,
RA   Armengol L., Pujana M.A., Estivill X., Wilson M.D., Koop B.F.,
RA   Tosi S., Moore G.E., Boright A.P., Zlotorynski E., Kerem B.,
RA   Kroisel P.M., Petek E., Oscier D.G., Mould S.J., Doehner H.,
RA   Doehner K., Rommens J.M., Vincent J.B., Venter J.C., Li P.W.,
RA   Mural R.J., Adams M.D., Tsui L.-C.;
RT   "Human chromosome 7: DNA sequence and biology.";
RL   Science 300:767-772(2003).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANTS
RP   GLN-111; ILE-230 AND PHE-296.
RC   TISSUE=Cervix, Kidney, and Pancreas;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 310-476 (ISOFORM 1).
RX   PubMed=7776974; DOI=10.1210/mend.9.2.7776974;
RA   Lee J.W., Choi H.-S., Gyuris J., Brent R., Moore D.D.;
RT   "Two classes of proteins dependent on either the presence or absence
RT   of thyroid hormone for interaction with the thyroid hormone
RT   receptor.";
RL   Mol. Endocrinol. 9:243-254(1995).
RN   [11]
RP   INTERACTION WITH PDLIM4 AND PTPN13, AND SUBCELLULAR LOCATION.
RX   PubMed=10826496; DOI=10.1078/S0171-9335(04)70031-X;
RA   Cuppen E., van Ham M., Wansink D.G., de Leeuw A., Wieringa B.,
RA   Hendriks W.;
RT   "The zyxin-related protein TRIP6 interacts with PDZ motifs in the
RT   adaptor protein RIL and the protein tyrosine phosphatase PTP-BL.";
RL   Eur. J. Cell Biol. 79:283-293(2000).
RN   [12]
RP   FUNCTION.
RX   PubMed=15489293; DOI=10.1101/gad.322404;
RA   Kassel O., Schneider S., Heilbock C., Litfin M., Goettlicher M.,
RA   Herrlich P.;
RT   "A nuclear isoform of the focal adhesion LIM-domain protein Trip6
RT   integrates activating and repressing signals at AP-1- and NF-kappaB-
RT   regulated promoters.";
RL   Genes Dev. 18:2518-2528(2004).
RN   [13]
RP   INTERACTION WITH LPAR2, AND FUNCTION.
RX   PubMed=14688263; DOI=10.1074/jbc.M311891200;
RA   Xu J., Lai Y.-J., Lin W.-C., Lin F.-T.;
RT   "TRIP6 enhances lysophosphatidic acid-induced cell migration by
RT   interacting with the lysophosphatidic acid 2 receptor.";
RL   J. Biol. Chem. 279:10459-10468(2004).
RN   [14]
RP   INTERACTION WITH SCRIB.
RX   PubMed=16137684; DOI=10.1016/j.febslet.2005.08.012;
RA   Petit M.M.R., Crombez K.R.M.O., Vervenne H.B.V.K., Weyns N.,
RA   Van de Ven W.J.M.;
RT   "The tumor suppressor Scrib selectively interacts with specific
RT   members of the zyxin family of proteins.";
RL   FEBS Lett. 579:5061-5068(2005).
RN   [15]
RP   PHOSPHORYLATION AT TYR-55.
RX   PubMed=15988003; DOI=10.1128/MCB.25.14.5859-5868.2005;
RA   Lai Y.-J., Chen C.-S., Lin W.-C., Lin F.-T.;
RT   "c-Src-mediated phosphorylation of TRIP6 regulates its function in
RT   lysophosphatidic acid-induced cell migration.";
RL   Mol. Cell. Biol. 25:5859-5868(2005).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-92, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [17]
RP   INTERACTION WITH PRKAA2, SUBCELLULAR LOCATION, MUTAGENESIS OF SER-101
RP   AND SER-102, AND FUNCTION.
RX   PubMed=16624523; DOI=10.1016/j.cellsig.2006.01.021;
RA   Solaz-Fuster M.C., Gimeno-Alcaniz J.V., Casado M., Sanz P.;
RT   "TRIP6 transcriptional co-activator is a novel substrate of AMP-
RT   activated protein kinase.";
RL   Cell. Signal. 18:1702-1712(2006).
RN   [18]
RP   INTERACTION WITH SVIL.
RX   PubMed=16880273; DOI=10.1083/jcb.200512051;
RA   Takizawa N., Smith T.C., Nebl T., Crowley J.L., Palmieri S.J.,
RA   Lifshitz L.M., Ehrhardt A.G., Hoffman L.M., Beckerle M.C., Luna E.J.;
RT   "Supervillin modulation of focal adhesions involving TRIP6/ZRP-1.";
RL   J. Cell Biol. 174:447-458(2006).
RN   [19]
RP   INTERACTION WITH SALMONELLA TYPHIMURIUM SSEI.
RX   PubMed=17095609; DOI=10.1073/pnas.0604054103;
RA   Worley M.J., Nieman G.S., Geddes K., Heffron F.;
RT   "Salmonella typhimurium disseminates within its host by manipulating
RT   the motility of infected cells.";
RL   Proc. Natl. Acad. Sci. U.S.A. 103:17915-17920(2006).
RN   [20]
RP   INTERACTION WITH PTPN13, AND PHOSPHORYLATION AT TYR-55.
RX   PubMed=17591779; DOI=10.1074/jbc.M701499200;
RA   Lai Y.-J., Lin W.-C., Lin F.-T.;
RT   "PTPL1/FAP-1 negatively regulates TRIP6 function in lysophosphatidic
RT   acid-induced cell migration.";
RL   J. Biol. Chem. 282:24381-24387(2007).
RN   [21]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-142, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [22]
RP   INTERACTION WITH MAGI1 AND PTPN13, MUTAGENESIS OF THR-474, TISSUE
RP   SPECIFICITY, AND FUNCTION.
RX   PubMed=19017743; DOI=10.1096/fj.08-106344;
RA   Chastre E., Abdessamad M., Kruglov A., Bruyneel E., Bracke M.,
RA   Di Gioia Y., Beckerle M.C., van Roy F., Kotelevets L.;
RT   "TRIP6, a novel molecular partner of the MAGI-1 scaffolding molecule,
RT   promotes invasiveness.";
RL   FASEB J. 23:916-928(2009).
RN   [23]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-92, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [24]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [25]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-142; SER-189 AND
RP   SER-249, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [26]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [27]
RP   METHYLATION [LARGE SCALE ANALYSIS] AT ARG-25; ARG-111; ARG-179;
RP   ARG-186; ARG-205; ARG-236 AND ARG-238, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Colon carcinoma;
RX   PubMed=24129315; DOI=10.1074/mcp.O113.027870;
RA   Guo A., Gu H., Zhou J., Mulhern D., Wang Y., Lee K.A., Yang V.,
RA   Aguiar M., Kornhauser J., Jia X., Ren J., Beausoleil S.A., Silva J.C.,
RA   Vemulapalli V., Bedford M.T., Comb M.J.;
RT   "Immunoaffinity enrichment and mass spectrometry analysis of protein
RT   methylation.";
RL   Mol. Cell. Proteomics 13:372-387(2014).
RN   [28]
RP   STRUCTURE BY NMR OF 279-396.
RG   RIKEN structural genomics initiative (RSGI);
RT   "Solution structure of the first and second LIM domain of thyroid
RT   receptor interacting protein 6 (TRIP6).";
RL   Submitted (OCT-2006) to the PDB data bank.
CC   -!- FUNCTION: Relays signals from the cell surface to the nucleus to
CC       weaken adherens junction and promote actin cytoskeleton
CC       reorganization and cell invasiveness. Involved in lysophosphatidic
CC       acid-induced cell adhesion and migration. Acts as a
CC       transcriptional coactivator for NF-kappa-B and JUN, and mediates
CC       the transrepression of these transcription factors induced by
CC       glucocorticoid receptor. {ECO:0000269|PubMed:14688263,
CC       ECO:0000269|PubMed:15489293, ECO:0000269|PubMed:16624523,
CC       ECO:0000269|PubMed:19017743}.
CC   -!- SUBUNIT: Specifically interacts with the ligand binding domain of
CC       the thyroid receptor (TR) in the presence of thyroid hormone
CC       (PubMed:14688263). Interacts (via the third LIM domain and C-
CC       terminus) with PTPN13 (via the second PDZ domain)
CC       (PubMed:10400701, PubMed:17591779, PubMed:19017743,
CC       PubMed:10826496). Interacts (via the second LIM domain or via the
CC       third LIM domain plus C-terminus) with PDLIM4 (via PDZ domain)
CC       (PubMed:10826496). Found in a complex with PTPN13 and PDLIM4 (By
CC       similarity). Interacts with SVIL isoform 2 (PubMed:16880273).
CC       Interacts with LPAR2 but not other LPA receptors
CC       (PubMed:14688263). Interacts with PRKAA2 (PubMed:16624523).
CC       Interacts with MAGI1 (PubMed:19017743). Interacts with SCRIB
CC       (PubMed:16137684). In case of infection, interacts with
CC       S.typhimurium protein sseI (PubMed:17095609).
CC       {ECO:0000250|UniProtKB:Q9Z1Y4, ECO:0000269|PubMed:10400701,
CC       ECO:0000269|PubMed:10826496, ECO:0000269|PubMed:14688263,
CC       ECO:0000269|PubMed:16137684, ECO:0000269|PubMed:16624523,
CC       ECO:0000269|PubMed:16880273, ECO:0000269|PubMed:17095609,
CC       ECO:0000269|PubMed:17591779, ECO:0000269|PubMed:19017743}.
CC   -!- INTERACTION:
CC       Q5W150:-; NbExp=3; IntAct=EBI-742327, EBI-10248148;
CC       Q95HA4:-; NbExp=3; IntAct=EBI-742327, EBI-10236795;
CC       Q9NYB9:ABI2; NbExp=3; IntAct=EBI-742327, EBI-743598;
CC       Q6UY14-3:ADAMTSL4; NbExp=3; IntAct=EBI-742327, EBI-10173507;
CC       P29972:AQP1; NbExp=6; IntAct=EBI-742327, EBI-745213;
CC       P54259:ATN1; NbExp=2; IntAct=EBI-742327, EBI-945980;
CC       P48047:ATP5O; NbExp=3; IntAct=EBI-742327, EBI-355815;
CC       A0A0S2Z4M1:AXIN1; NbExp=3; IntAct=EBI-742327, EBI-16429430;
CC       O15169:AXIN1; NbExp=6; IntAct=EBI-742327, EBI-710484;
CC       Q13895:BYSL; NbExp=6; IntAct=EBI-742327, EBI-358049;
CC       Q8NEC5:CATSPER1; NbExp=6; IntAct=EBI-742327, EBI-744545;
CC       Q8IYX8-2:CEP57L1; NbExp=3; IntAct=EBI-742327, EBI-10181988;
CC       P26441:CNTF; NbExp=3; IntAct=EBI-742327, EBI-1050897;
CC       Q02930-3:CREB5; NbExp=3; IntAct=EBI-742327, EBI-10192698;
CC       P53673:CRYBA4; NbExp=3; IntAct=EBI-742327, EBI-7519711;
CC       O75638:CTAG2; NbExp=3; IntAct=EBI-742327, EBI-10188927;
CC       Q9NQL9:DMRT3; NbExp=3; IntAct=EBI-742327, EBI-9679045;
CC       Q86UW9:DTX2; NbExp=3; IntAct=EBI-742327, EBI-740376;
CC       Q5JVL4:EFHC1; NbExp=3; IntAct=EBI-742327, EBI-743105;
CC       Q8N2X6:EXOC3-AS1; NbExp=6; IntAct=EBI-742327, EBI-749333;
CC       P48023:FASLG; NbExp=3; IntAct=EBI-742327, EBI-495538;
CC       O43559:FRS3; NbExp=5; IntAct=EBI-742327, EBI-725515;
CC       A0A0S2Z4D9:GAD1; NbExp=3; IntAct=EBI-742327, EBI-16430771;
CC       P15976-2:GATA1; NbExp=3; IntAct=EBI-742327, EBI-9090198;
CC       Q9HBR3:GDPD5; NbExp=3; IntAct=EBI-742327, EBI-10310206;
CC       P04899:GNAI2; NbExp=3; IntAct=EBI-742327, EBI-353997;
CC       Q9Y223-2:GNE; NbExp=4; IntAct=EBI-742327, EBI-11975289;
CC       Q13227:GPS2; NbExp=4; IntAct=EBI-742327, EBI-713355;
CC       Q14687:GSE1; NbExp=3; IntAct=EBI-742327, EBI-372619;
CC       V9HWD0:HEL-S-42; NbExp=3; IntAct=EBI-742327, EBI-10330219;
CC       P09022:Hoxa1 (xeno); NbExp=3; IntAct=EBI-742327, EBI-3957603;
CC       P31269:HOXA9; NbExp=4; IntAct=EBI-742327, EBI-742314;
CC       P17482:HOXB9; NbExp=3; IntAct=EBI-742327, EBI-745290;
CC       A0A0C4DGM4:HYKK; NbExp=3; IntAct=EBI-742327, EBI-10236738;
CC       Q0VD86:INCA1; NbExp=3; IntAct=EBI-742327, EBI-6509505;
CC       Q99706:KIR2DL4; NbExp=3; IntAct=EBI-742327, EBI-10294579;
CC       Q9H2R5:KLK15; NbExp=3; IntAct=EBI-742327, EBI-8645371;
CC       Q6PEX3:KRTAP26-1; NbExp=3; IntAct=EBI-742327, EBI-3957672;
CC       P25791:LMO2; NbExp=3; IntAct=EBI-742327, EBI-739696;
CC       O60336:MAPKBP1; NbExp=3; IntAct=EBI-742327, EBI-947402;
CC       Q9Y316:MEMO1; NbExp=3; IntAct=EBI-742327, EBI-1104564;
CC       Q9H7H0:METTL17; NbExp=4; IntAct=EBI-742327, EBI-749353;
CC       Q8IXL7:MSRB3; NbExp=3; IntAct=EBI-742327, EBI-8634060;
CC       O43639:NCK2; NbExp=6; IntAct=EBI-742327, EBI-713635;
CC       Q14511:NEDD9; NbExp=3; IntAct=EBI-742327, EBI-2108053;
CC       Q8WWR8-2:NEU4; NbExp=3; IntAct=EBI-742327, EBI-10277551;
CC       O43482:OIP5; NbExp=3; IntAct=EBI-742327, EBI-536879;
CC       Q9BWI9:OTUB2; NbExp=3; IntAct=EBI-742327, EBI-10300896;
CC       P09619:PDGFRB; NbExp=3; IntAct=EBI-742327, EBI-641237;
CC       Q13526:PIN1; NbExp=3; IntAct=EBI-742327, EBI-714158;
CC       Q3SYA9:POM121L1P; NbExp=3; IntAct=EBI-742327, EBI-10241319;
CC       Q96I34:PPP1R16A; NbExp=3; IntAct=EBI-742327, EBI-710402;
CC       Q13131:PRKAA1; NbExp=3; IntAct=EBI-742327, EBI-1181405;
CC       P54646:PRKAA2; NbExp=3; IntAct=EBI-742327, EBI-1383852;
CC       Q15678:PTPN14; NbExp=4; IntAct=EBI-742327, EBI-1237156;
CC       P54725:RAD23A; NbExp=3; IntAct=EBI-742327, EBI-746453;
CC       Q86VV4:RANBP3L; NbExp=4; IntAct=EBI-742327, EBI-12028066;
CC       P48380:RFX3; NbExp=3; IntAct=EBI-742327, EBI-742557;
CC       P61586:RHOA; NbExp=3; IntAct=EBI-742327, EBI-446668;
CC       Q63HN8-6:RNF213; NbExp=3; IntAct=EBI-742327, EBI-10248548;
CC       Q8IYX7:SAXO1; NbExp=3; IntAct=EBI-742327, EBI-3957636;
CC       Q9Y2K2-3:SIK3; NbExp=3; IntAct=EBI-742327, EBI-10326390;
CC       Q05CH4:SLC15A3; NbExp=3; IntAct=EBI-742327, EBI-10223741;
CC       P12236:SLC25A6; NbExp=3; IntAct=EBI-742327, EBI-356254;
CC       O75716:STK16; NbExp=3; IntAct=EBI-742327, EBI-749295;
CC       O46385:SVIL (xeno); NbExp=5; IntAct=EBI-742327, EBI-6995105;
CC       Q9Y4C2:TCAF1; NbExp=3; IntAct=EBI-742327, EBI-750484;
CC       Q8WW24:TEKT4; NbExp=3; IntAct=EBI-742327, EBI-750487;
CC       Q0P5Q0:TMSB4X; NbExp=3; IntAct=EBI-742327, EBI-10226570;
CC       Q5VU62:TPM3; NbExp=3; IntAct=EBI-742327, EBI-10184033;
CC       O43734:TRAF3IP2; NbExp=3; IntAct=EBI-742327, EBI-744798;
CC       Q9UL33:TRAPPC2L; NbExp=3; IntAct=EBI-742327, EBI-747601;
CC       Q14134:TRIM29; NbExp=3; IntAct=EBI-742327, EBI-702370;
CC       Q6ZVT0:TTLL10; NbExp=3; IntAct=EBI-742327, EBI-7844656;
CC       Q99757:TXN2; NbExp=3; IntAct=EBI-742327, EBI-2932492;
CC       Q86UY0:TXNDC5; NbExp=3; IntAct=EBI-742327, EBI-2825190;
CC       Q06250:WT1-AS; NbExp=3; IntAct=EBI-742327, EBI-10223946;
CC       Q8N4L5:XRCC6BP1; NbExp=3; IntAct=EBI-742327, EBI-10265517;
CC       A2RRL9:ZBP1; NbExp=3; IntAct=EBI-742327, EBI-10173066;
CC       Q9H0D2:ZNF541; NbExp=4; IntAct=EBI-742327, EBI-3957075;
CC       A0A0S2Z5X4:ZNF688; NbExp=6; IntAct=EBI-742327, EBI-16429014;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton
CC       {ECO:0000269|PubMed:16624523}. Cell junction, focal adhesion
CC       {ECO:0000269|PubMed:16624523}. Nucleus
CC       {ECO:0000269|PubMed:10826496, ECO:0000269|PubMed:16624523}.
CC       Cytoplasm {ECO:0000269|PubMed:16624523}. Note=Shuttles between
CC       nucleus and cytoplasm (PubMed:16624523). Colocalizes with actin
CC       (PubMed:10826496). {ECO:0000269|PubMed:10826496,
CC       ECO:0000269|PubMed:16624523}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q15654-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q15654-2; Sequence=VSP_047621, VSP_047624;
CC       Name=3;
CC         IsoId=Q15654-3; Sequence=VSP_047622, VSP_047623;
CC   -!- TISSUE SPECIFICITY: Abundantly expressed in kidney, liver and
CC       lung. Lower levels in heart, placenta and pancreas. Expressed in
CC       colonic epithelial cells. Up-regulated in colonic tumors.
CC       {ECO:0000269|PubMed:19017743}.
CC   -!- DOMAIN: The LIM zinc-binding domains mediate interaction with
CC       LPAR2 and with S.typhimurium protein sseI.
CC   -!- PTM: Phosphorylation at Tyr-55 by SRC is required for enhancement
CC       of lysophosphatidic acid-induced cell migration. Tyr-55 is
CC       dephosphorylated by PTPN13. {ECO:0000269|PubMed:15988003,
CC       ECO:0000269|PubMed:17591779}.
CC   -!- SIMILARITY: Belongs to the zyxin/ajuba family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAC41740.1; Type=Frameshift; Positions=461; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AJ001902; CAA05080.1; -; mRNA.
DR   EMBL; AF000974; AAB62222.1; -; mRNA.
DR   EMBL; AF093836; AAD03037.1; -; Genomic_DNA.
DR   EMBL; AF093834; AAD03037.1; JOINED; Genomic_DNA.
DR   EMBL; AF093835; AAD03037.1; JOINED; Genomic_DNA.
DR   EMBL; AF312032; AAK21007.1; -; Genomic_DNA.
DR   EMBL; AB628086; BAK20497.1; -; mRNA.
DR   EMBL; AB628087; BAK20498.1; -; mRNA.
DR   EMBL; AK291906; BAF84595.1; -; mRNA.
DR   EMBL; AC011895; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH236956; EAL23817.1; -; Genomic_DNA.
DR   EMBL; CH471091; EAW76472.1; -; Genomic_DNA.
DR   EMBL; BC002680; AAH02680.1; -; mRNA.
DR   EMBL; BC004249; AAH04249.1; -; mRNA.
DR   EMBL; BC004999; AAH04999.1; -; mRNA.
DR   EMBL; BC021540; AAH21540.1; -; mRNA.
DR   EMBL; BC028985; AAH28985.1; -; mRNA.
DR   EMBL; L40374; AAC41740.1; ALT_FRAME; mRNA.
DR   CCDS; CCDS5708.1; -. [Q15654-1]
DR   RefSeq; NP_003293.2; NM_003302.2. [Q15654-1]
DR   UniGene; Hs.534360; -.
DR   PDB; 1X61; NMR; -; A=279-337.
DR   PDB; 2DLO; NMR; -; A=329-396.
DR   PDBsum; 1X61; -.
DR   PDBsum; 2DLO; -.
DR   ProteinModelPortal; Q15654; -.
DR   SMR; Q15654; -.
DR   BioGrid; 113056; 200.
DR   CORUM; Q15654; -.
DR   DIP; DIP-34466N; -.
DR   IntAct; Q15654; 171.
DR   MINT; Q15654; -.
DR   STRING; 9606.ENSP00000200457; -.
DR   iPTMnet; Q15654; -.
DR   PhosphoSitePlus; Q15654; -.
DR   BioMuta; TRIP6; -.
DR   DMDM; 20981729; -.
DR   EPD; Q15654; -.
DR   MaxQB; Q15654; -.
DR   PaxDb; Q15654; -.
DR   PeptideAtlas; Q15654; -.
DR   PRIDE; Q15654; -.
DR   DNASU; 7205; -.
DR   Ensembl; ENST00000200457; ENSP00000200457; ENSG00000087077. [Q15654-1]
DR   Ensembl; ENST00000417475; ENSP00000413817; ENSG00000087077. [Q15654-2]
DR   Ensembl; ENST00000437505; ENSP00000410736; ENSG00000087077. [Q15654-3]
DR   Ensembl; ENST00000619988; ENSP00000479865; ENSG00000087077. [Q15654-3]
DR   GeneID; 7205; -.
DR   KEGG; hsa:7205; -.
DR   UCSC; uc003uww.4; human. [Q15654-1]
DR   CTD; 7205; -.
DR   DisGeNET; 7205; -.
DR   EuPathDB; HostDB:ENSG00000087077.11; -.
DR   GeneCards; TRIP6; -.
DR   H-InvDB; HIX0167828; -.
DR   HGNC; HGNC:12311; TRIP6.
DR   HPA; CAB046454; -.
DR   HPA; CAB046460; -.
DR   HPA; HPA052813; -.
DR   MIM; 602933; gene.
DR   neXtProt; NX_Q15654; -.
DR   OpenTargets; ENSG00000087077; -.
DR   PharmGKB; PA36989; -.
DR   eggNOG; KOG1701; Eukaryota.
DR   eggNOG; ENOG410Y3GP; LUCA.
DR   GeneTree; ENSGT00760000119039; -.
DR   HOVERGEN; HBG093602; -.
DR   InParanoid; Q15654; -.
DR   KO; K12792; -.
DR   OrthoDB; EOG091G085F; -.
DR   PhylomeDB; Q15654; -.
DR   TreeFam; TF320310; -.
DR   SignaLink; Q15654; -.
DR   SIGNOR; Q15654; -.
DR   ChiTaRS; TRIP6; human.
DR   EvolutionaryTrace; Q15654; -.
DR   GeneWiki; TRIP6; -.
DR   GenomeRNAi; 7205; -.
DR   PRO; PR:Q15654; -.
DR   Proteomes; UP000005640; Chromosome 7.
DR   Bgee; ENSG00000087077; -.
DR   CleanEx; HS_TRIP6; -.
DR   ExpressionAtlas; Q15654; baseline and differential.
DR   Genevisible; Q15654; HS.
DR   GO; GO:0005856; C:cytoskeleton; IEA:UniProtKB-SubCell.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005925; C:focal adhesion; IDA:UniProtKB.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0005886; C:plasma membrane; IDA:HPA.
DR   GO; GO:0005149; F:interleukin-1 receptor binding; IDA:UniProtKB.
DR   GO; GO:0019900; F:kinase binding; IPI:UniProtKB.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0003723; F:RNA binding; HDA:UniProtKB.
DR   GO; GO:0046966; F:thyroid hormone receptor binding; NAS:UniProtKB.
DR   GO; GO:0048041; P:focal adhesion assembly; NAS:UniProtKB.
DR   GO; GO:0030335; P:positive regulation of cell migration; IMP:UniProtKB.
DR   GO; GO:1901224; P:positive regulation of NIK/NF-kappaB signaling; IDA:UniProtKB.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   InterPro; IPR001781; Znf_LIM.
DR   Pfam; PF00412; LIM; 3.
DR   SMART; SM00132; LIM; 3.
DR   PROSITE; PS00478; LIM_DOMAIN_1; 2.
DR   PROSITE; PS50023; LIM_DOMAIN_2; 3.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Cell adhesion; Cell junction;
KW   Complete proteome; Cytoplasm; Cytoskeleton; LIM domain; Metal-binding;
KW   Methylation; Nucleus; Phosphoprotein; Polymorphism;
KW   Reference proteome; Repeat; Transcription; Transcription regulation;
KW   Zinc.
FT   CHAIN         1    476       Thyroid receptor-interacting protein 6.
FT                                /FTId=PRO_0000075908.
FT   DOMAIN      279    316       LIM zinc-binding 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00125}.
FT   DOMAIN      339    398       LIM zinc-binding 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00125}.
FT   DOMAIN      399    467       LIM zinc-binding 3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00125}.
FT   REGION      469    476       Interaction with MAGI1 and PTPN13.
FT                                {ECO:0000269|PubMed:19017743}.
FT   MOD_RES      25     25       Asymmetric dimethylarginine; alternate.
FT                                {ECO:0000250|UniProtKB:Q9Z1Y4}.
FT   MOD_RES      25     25       Omega-N-methylarginine; alternate.
FT                                {ECO:0000244|PubMed:24129315}.
FT   MOD_RES      55     55       Phosphotyrosine; by SRC.
FT                                {ECO:0000269|PubMed:15988003,
FT                                ECO:0000269|PubMed:17591779}.
FT   MOD_RES      92     92       Phosphoserine.
FT                                {ECO:0000244|PubMed:17081983,
FT                                ECO:0000244|PubMed:20068231}.
FT   MOD_RES     111    111       Omega-N-methylarginine.
FT                                {ECO:0000244|PubMed:24129315}.
FT   MOD_RES     142    142       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     179    179       Omega-N-methylarginine.
FT                                {ECO:0000244|PubMed:24129315}.
FT   MOD_RES     186    186       Omega-N-methylarginine.
FT                                {ECO:0000244|PubMed:24129315}.
FT   MOD_RES     189    189       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     205    205       Omega-N-methylarginine.
FT                                {ECO:0000244|PubMed:24129315}.
FT   MOD_RES     236    236       Omega-N-methylarginine.
FT                                {ECO:0000244|PubMed:24129315}.
FT   MOD_RES     238    238       Omega-N-methylarginine.
FT                                {ECO:0000244|PubMed:24129315}.
FT   MOD_RES     249    249       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   VAR_SEQ      37    106       ALQPHPRVNFCPLPSEQCYQAPGGPEDRGPAWVGSHGVLQH
FT                                TQGLPADRGGLRPGSLDAEIDLLSSTLAE -> VLPGPRGT
FT                                GGSGAGVGGVPWSTPAHAGAPCRQGGPSPWKPGRRDRLAEQ
FT                                HAGRAEWGSGSCVTATRPTGI (in isoform 2).
FT                                {ECO:0000303|Ref.4}.
FT                                /FTId=VSP_047621.
FT   VAR_SEQ      37     80       ALQPHPRVNFCPLPSEQCYQAPGGPEDRGPAWVGSHGVLQH
FT                                TQG -> GAPCRQGGPSPWKPGRRDRLAEQHAGRAEWGSGS
FT                                CVTATRPTGI (in isoform 3). {ECO:0000305}.
FT                                /FTId=VSP_047622.
FT   VAR_SEQ      81    476       Missing (in isoform 3). {ECO:0000305}.
FT                                /FTId=VSP_047623.
FT   VAR_SEQ     107    476       Missing (in isoform 2).
FT                                {ECO:0000303|Ref.4}.
FT                                /FTId=VSP_047624.
FT   VARIANT     111    111       R -> Q (in dbSNP:rs2437100).
FT                                {ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_062262.
FT   VARIANT     230    230       V -> I (in dbSNP:rs2075756).
FT                                {ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_050171.
FT   VARIANT     296    296       L -> F (in dbSNP:rs17855370).
FT                                {ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_013309.
FT   MUTAGEN     101    101       S->A: Exclusively located in nucleus.
FT                                {ECO:0000269|PubMed:16624523}.
FT   MUTAGEN     102    102       S->A: Exclusively located in nucleus.
FT                                {ECO:0000269|PubMed:16624523}.
FT   MUTAGEN     474    474       T->A: Reduces interaction with MAGI1.
FT                                {ECO:0000269|PubMed:19017743}.
FT   CONFLICT     39     40       Missing (in Ref. 9; AAH02680).
FT                                {ECO:0000305}.
FT   CONFLICT    102    102       S -> T (in Ref. 2; AAB62222).
FT                                {ECO:0000305}.
FT   CONFLICT    106    106       E -> K (in Ref. 2; AAB62222).
FT                                {ECO:0000305}.
FT   CONFLICT    135    135       S -> C (in Ref. 1; CAA05080).
FT                                {ECO:0000305}.
FT   CONFLICT    310    313       CRAQ -> MPGP (in Ref. 10; AAC41740).
FT                                {ECO:0000305}.
FT   STRAND      280    282       {ECO:0000244|PDB:1X61}.
FT   STRAND      288    290       {ECO:0000244|PDB:1X61}.
FT   STRAND      296    300       {ECO:0000244|PDB:1X61}.
FT   TURN        302    304       {ECO:0000244|PDB:1X61}.
FT   STRAND      308    310       {ECO:0000244|PDB:1X61}.
FT   STRAND      319    324       {ECO:0000244|PDB:1X61}.
FT   STRAND      326    328       {ECO:0000244|PDB:1X61}.
FT   HELIX       329    337       {ECO:0000244|PDB:1X61}.
FT   TURN        340    342       {ECO:0000244|PDB:2DLO}.
FT   STRAND      351    353       {ECO:0000244|PDB:2DLO}.
FT   STRAND      356    358       {ECO:0000244|PDB:2DLO}.
FT   TURN        360    362       {ECO:0000244|PDB:2DLO}.
FT   STRAND      366    368       {ECO:0000244|PDB:2DLO}.
FT   HELIX       388    394       {ECO:0000244|PDB:2DLO}.
SQ   SEQUENCE   476 AA;  50288 MW;  2BA7C747DF30A8FD CRC64;
     MSGPTWLPPK QPEPARAPQG RAIPRGTPGP PPAHGAALQP HPRVNFCPLP SEQCYQAPGG
     PEDRGPAWVG SHGVLQHTQG LPADRGGLRP GSLDAEIDLL SSTLAELNGG RGHASRRPDR
     QAYEPPPPPA YRTGSLKPNP ASPLPASPYG GPTPASYTTA STPAGPAFPV QVKVAQPVRG
     CGPPRRGASQ ASGPLPGPHF PLPGRGEVWG PGYRSQREPG PGAKEEAAGV SGPAGRGRGG
     EHGPQVPLSQ PPEDELDRLT KKLVHDMNHP PSGEYFGQCG GCGEDVVGDG AGVVALDRVF
     HVGCFVCSTC RAQLRGQHFY AVERRAYCEG CYVATLEKCA TCSQPILDRI LRAMGKAYHP
     GCFTCVVCHR GLDGIPFTVD ATSQIHCIED FHRKFAPRCS VCGGAIMPEP GQEETVRIVA
     LDRSFHIGCY KCEECGLLLS SEGECQGCYP LDGHILCKAC SAWRIQELSA TVTTDC
//
ID   1433B_HUMAN             Reviewed;         246 AA.
AC   P31946; A8K9K2; E1P616;
DT   01-JUL-1993, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 3.
DT   23-MAY-2018, entry version 208.
DE   RecName: Full=14-3-3 protein beta/alpha;
DE   AltName: Full=Protein 1054;
DE   AltName: Full=Protein kinase C inhibitor protein 1;
DE            Short=KCIP-1;
DE   Contains:
DE     RecName: Full=14-3-3 protein beta/alpha, N-terminally processed;
GN   Name=YWHAB;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Keratinocyte;
RX   PubMed=8515476; DOI=10.1006/jmbi.1993.1346;
RA   Leffers H., Madsen P., Rasmussen H.H., Honore B., Andersen A.H.,
RA   Walbum E., Vandekerckhove J., Celis J.E.;
RT   "Molecular cloning and expression of the transformation sensitive
RT   epithelial marker stratifin. A member of a protein family that has
RT   been involved in the protein kinase C signalling pathway.";
RL   J. Mol. Biol. 231:982-998(1993).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM LONG).
RC   TISSUE=Thymus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11780052; DOI=10.1038/414865a;
RA   Deloukas P., Matthews L.H., Ashurst J.L., Burton J., Gilbert J.G.R.,
RA   Jones M., Stavrides G., Almeida J.P., Babbage A.K., Bagguley C.L.,
RA   Bailey J., Barlow K.F., Bates K.N., Beard L.M., Beare D.M.,
RA   Beasley O.P., Bird C.P., Blakey S.E., Bridgeman A.M., Brown A.J.,
RA   Buck D., Burrill W.D., Butler A.P., Carder C., Carter N.P.,
RA   Chapman J.C., Clamp M., Clark G., Clark L.N., Clark S.Y., Clee C.M.,
RA   Clegg S., Cobley V.E., Collier R.E., Connor R.E., Corby N.R.,
RA   Coulson A., Coville G.J., Deadman R., Dhami P.D., Dunn M.,
RA   Ellington A.G., Frankland J.A., Fraser A., French L., Garner P.,
RA   Grafham D.V., Griffiths C., Griffiths M.N.D., Gwilliam R., Hall R.E.,
RA   Hammond S., Harley J.L., Heath P.D., Ho S., Holden J.L., Howden P.J.,
RA   Huckle E., Hunt A.R., Hunt S.E., Jekosch K., Johnson C.M., Johnson D.,
RA   Kay M.P., Kimberley A.M., King A., Knights A., Laird G.K., Lawlor S.,
RA   Lehvaeslaiho M.H., Leversha M.A., Lloyd C., Lloyd D.M., Lovell J.D.,
RA   Marsh V.L., Martin S.L., McConnachie L.J., McLay K., McMurray A.A.,
RA   Milne S.A., Mistry D., Moore M.J.F., Mullikin J.C., Nickerson T.,
RA   Oliver K., Parker A., Patel R., Pearce T.A.V., Peck A.I.,
RA   Phillimore B.J.C.T., Prathalingam S.R., Plumb R.W., Ramsay H.,
RA   Rice C.M., Ross M.T., Scott C.E., Sehra H.K., Shownkeen R., Sims S.,
RA   Skuce C.D., Smith M.L., Soderlund C., Steward C.A., Sulston J.E.,
RA   Swann R.M., Sycamore N., Taylor R., Tee L., Thomas D.W., Thorpe A.,
RA   Tracey A., Tromans A.C., Vaudin M., Wall M., Wallis J.M.,
RA   Whitehead S.L., Whittaker P., Willey D.L., Williams L., Williams S.A.,
RA   Wilming L., Wray P.W., Hubbard T., Durbin R.M., Bentley D.R., Beck S.,
RA   Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 20.";
RL   Nature 414:865-871(2001).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   PROTEIN SEQUENCE OF 1-11; 30-51; 63-73 AND 130-159, INTERACTION WITH
RP   PI4KB; TBC1D22A AND TBC1D22B, AND IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=23572552; DOI=10.1128/mBio.00098-13;
RA   Greninger A.L., Knudsen G.M., Betegon M., Burlingame A.L.,
RA   DeRisi J.L.;
RT   "ACBD3 interaction with TBC1 domain 22 protein is differentially
RT   affected by enteroviral and kobuviral 3A protein binding.";
RL   MBio 4:E00098-E00098(2013).
RN   [7]
RP   PROTEIN SEQUENCE OF 1-11; 14-57; 63-70; 106-117; 130-169 AND 215-246,
RP   CLEAVAGE OF INITIATOR METHIONINE, ACETYLATION AT MET-1 AND THR-2, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Colon carcinoma;
RA   Bienvenut W.V., Zebisch A., Kolch W.;
RL   Submitted (DEC-2008) to UniProtKB.
RN   [8]
RP   PROTEIN SEQUENCE OF 3-20.
RC   TISSUE=Platelet;
RX   PubMed=12665801; DOI=10.1038/nbt810;
RA   Gevaert K., Goethals M., Martens L., Van Damme J., Staes A.,
RA   Thomas G.R., Vandekerckhove J.;
RT   "Exploring proteomes and analyzing protein processing by mass
RT   spectrometric identification of sorted N-terminal peptides.";
RL   Nat. Biotechnol. 21:566-569(2003).
RN   [9]
RP   INTERACTION WITH AANAT.
RX   PubMed=11427721; DOI=10.1073/pnas.141118798;
RA   Ganguly S., Gastel J.A., Weller J.L., Schwartz C., Jaffe H.,
RA   Namboodiri M.A., Coon S.L., Hickman A.B., Rollag M., Obsil T.,
RA   Beauverger P., Ferry G., Boutin J.A., Klein D.C.;
RT   "Role of a pineal cAMP-operated arylalkylamine N-acetyltransferase/14-
RT   3-3-binding switch in melatonin synthesis.";
RL   Proc. Natl. Acad. Sci. U.S.A. 98:8083-8088(2001).
RN   [10]
RP   INTERACTION WITH CRTC2.
RX   PubMed=15454081; DOI=10.1016/j.cell.2004.09.015;
RA   Screaton R.A., Conkright M.D., Katoh Y., Best J.L., Canettieri G.,
RA   Jeffries S., Guzman E., Niessen S., Yates J.R. III, Takemori H.,
RA   Okamoto M., Montminy M.;
RT   "The CREB coactivator TORC2 functions as a calcium- and cAMP-sensitive
RT   coincidence detector.";
RL   Cell 119:61-74(2004).
RN   [11]
RP   INTERACTION WITH YWHAB.
RX   PubMed=15538381; DOI=10.1038/sj.emboj.7600477;
RA   Schmidlin M., Lu M., Leuenberger S.A., Stoecklin G., Mallaun M.,
RA   Gross B., Gherzi R., Hess D., Hemmings B.A., Moroni C.;
RT   "The ARE-dependent mRNA-destabilizing activity of BRF1 is regulated by
RT   protein kinase B.";
RL   EMBO J. 23:4760-4769(2004).
RN   [12]
RP   INTERACTION WITH SSH1.
RX   PubMed=15159416; DOI=10.1083/jcb.200401136;
RA   Nagata-Ohashi K., Ohta Y., Goto K., Chiba S., Mori R., Nishita M.,
RA   Ohashi K., Kousaka K., Iwamatsu A., Niwa R., Uemura T., Mizuno K.;
RT   "A pathway of neuregulin-induced activation of cofilin-phosphatase
RT   Slingshot and cofilin in lamellipodia.";
RL   J. Cell Biol. 165:465-471(2004).
RN   [13]
RP   INTERACTION WITH ABL1.
RX   PubMed=15696159; DOI=10.1038/ncb1228;
RA   Yoshida K., Yamaguchi T., Natsume T., Kufe D., Miki Y.;
RT   "JNK phosphorylation of 14-3-3 proteins regulates nuclear targeting of
RT   c-Abl in the apoptotic response to DNA damage.";
RL   Nat. Cell Biol. 7:278-285(2005).
RN   [14]
RP   SUBCELLULAR LOCATION [LARGE SCALE ANALYSIS].
RC   TISSUE=Melanoma;
RX   PubMed=17081065; DOI=10.1021/pr060363j;
RA   Chi A., Valencia J.C., Hu Z.-Z., Watabe H., Yamaguchi H.,
RA   Mangini N.J., Huang H., Canfield V.A., Cheng K.C., Yang F., Abe R.,
RA   Yamagishi S., Shabanowitz J., Hearing V.J., Wu C., Appella E.,
RA   Hunt D.F.;
RT   "Proteomic and bioinformatic characterization of the biogenesis and
RT   function of melanosomes.";
RL   J. Proteome Res. 5:3135-3144(2006).
RN   [15]
RP   INTERACTION WITH YAP1.
RX   PubMed=17974916; DOI=10.1101/gad.1602907;
RA   Zhao B., Wei X., Li W., Udan R.S., Yang Q., Kim J., Xie J.,
RA   Ikenoue T., Yu J., Li L., Zheng P., Ye K., Chinnaiyan A., Halder G.,
RA   Lai Z.C., Guan K.L.;
RT   "Inactivation of YAP oncoprotein by the Hippo pathway is involved in
RT   cell contact inhibition and tissue growth control.";
RL   Genes Dev. 21:2747-2761(2007).
RN   [16]
RP   INTERACTION WITH ROR2, FUNCTION, PHOSPHORYLATION, DIMERIZATION, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=17717073; DOI=10.1210/me.2007-0323;
RA   Liu Y., Ross J.F., Bodine P.V.N., Billiard J.;
RT   "Homodimerization of Ror2 tyrosine kinase receptor induces 14-3-
RT   3(beta) phosphorylation and promotes osteoblast differentiation and
RT   bone formation.";
RL   Mol. Endocrinol. 21:3050-3061(2007).
RN   [17]
RP   INTERACTION WITH SIRT2.
RX   PubMed=18249187; DOI=10.1016/j.bbrc.2008.01.114;
RA   Jin Y.H., Kim Y.J., Kim D.W., Baek K.H., Kang B.Y., Yeo C.Y.,
RA   Lee K.Y.;
RT   "Sirt2 interacts with 14-3-3 beta/gamma and down-regulates the
RT   activity of p53.";
RL   Biochem. Biophys. Res. Commun. 368:690-695(2008).
RN   [18]
RP   INTERACTION WITH GAB2.
RX   PubMed=19172738; DOI=10.1038/emboj.2008.159;
RA   Brummer T., Larance M., Herrera Abreu M.T., Lyons R.J., Timpson P.,
RA   Emmerich C.H., Fleuren E.D.G., Lehrbach G.M., Schramek D.,
RA   Guilhaus M., James D.E., Daly R.J.;
RT   "Phosphorylation-dependent binding of 14-3-3 terminates signalling by
RT   the Gab2 docking protein.";
RL   EMBO J. 27:2305-2316(2008).
RN   [19]
RP   INTERACTION WITH SLITRK1.
RX   PubMed=19640509; DOI=10.1016/j.biopsych.2009.05.033;
RA   Kajiwara Y., Buxbaum J.D., Grice D.E.;
RT   "SLITRK1 binds 14-3-3 and regulates neurite outgrowth in a
RT   phosphorylation-dependent manner.";
RL   Biol. Psychiatry 66:918-925(2009).
RN   [20]
RP   FUNCTION, AND INTERACTION WITH SRPK2.
RX   PubMed=19592491; DOI=10.1074/jbc.M109.026237;
RA   Jang S.W., Liu X., Fu H., Rees H., Yepes M., Levey A., Ye K.;
RT   "Interaction of Akt-phosphorylated SRPK2 with 14-3-3 mediates cell
RT   cycle and cell death in neurons.";
RL   J. Biol. Chem. 284:24512-24525(2009).
RN   [21]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [22]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-70 AND LYS-117, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [23]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [24]
RP   FUNCTION, AND INTERACTION WITH AKAP13.
RX   PubMed=21224381; DOI=10.1074/jbc.M110.185645;
RA   Cariolato L., Cavin S., Diviani D.;
RT   "A-kinase anchoring protein (AKAP)-Lbc anchors a PKN-based signaling
RT   complex involved in alpha1-adrenergic receptor-induced p38
RT   activation.";
RL   J. Biol. Chem. 286:7925-7937(2011).
RN   [25]
RP   INTERACTION WITH SOS1.
RX   PubMed=22827337; DOI=10.1042/BJ20120938;
RA   Saha M., Carriere A., Cheerathodi M., Zhang X., Lavoie G., Rush J.,
RA   Roux P.P., Ballif B.A.;
RT   "RSK phosphorylates SOS1 creating 14-3-3-docking sites and negatively
RT   regulating MAPK activation.";
RL   Biochem. J. 447:159-166(2012).
RN   [26]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1 AND THR-2, ACETYLATION
RP   [LARGE SCALE ANALYSIS] AT MET-1 (ISOFORM SHORT), CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [27]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-2, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [28]
RP   INTERACTION WITH HERPES SIMPLEX VIRUS 1 UL46 (MICROBIAL INFECTION).
RX   PubMed=23938468; DOI=10.1074/mcp.M113.030866;
RA   Lin A.E., Greco T.M., Dohner K., Sodeik B., Cristea I.M.;
RT   "A proteomic perspective of inbuilt viral protein regulation: pUL46
RT   tegument protein is targeted for degradation by ICP0 during herpes
RT   simplex virus type 1 infection.";
RL   Mol. Cell. Proteomics 12:3237-3252(2013).
RN   [29]
RP   INTERACTION WITH MYO1C.
RX   PubMed=24636949; DOI=10.1016/j.jmb.2014.03.004;
RA   Stefan Munnich M.H., Manstein D.J.;
RT   "Crystal structure of human myosin 1c - the motor in GLUT4 exocytosis:
RT   implications for Ca(2+)-regulation and 14-3-3 binding.";
RL   J. Mol. Biol. 426:2070-2081(2014).
RN   [30]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-232, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [31]
RP   INTERACTION WITH DAPK2.
RX   PubMed=26047703; DOI=10.1016/j.bbrc.2015.05.105;
RA   Yuasa K., Ota R., Matsuda S., Isshiki K., Inoue M., Tsuji A.;
RT   "Suppression of death-associated protein kinase 2 by interaction with
RT   14-3-3 proteins.";
RL   Biochem. Biophys. Res. Commun. 464:70-75(2015).
RN   [32]
RP   INTERACTION WITH RIPOR2.
RX   PubMed=25588844; DOI=10.1242/jcs.161497;
RA   Gao K., Tang W., Li Y., Zhang P., Wang D., Yu L., Wang C., Wu D.;
RT   "Front-signal-dependent accumulation of the RHOA inhibitor FAM65B at
RT   leading edges polarizes neutrophils.";
RL   J. Cell Sci. 128:992-1000(2015).
RN   [33]
RP   ACETYLATION AT THR-2, AND CLEAVAGE OF INITIATOR METHIONINE.
RX   PubMed=25489052; DOI=10.1093/hmg/ddu611;
RA   Myklebust L.M., Van Damme P., Stoeve S.I., Doerfel M.J., Abboud A.,
RA   Kalvik T.V., Grauffel C., Jonckheere V., Wu Y., Swensen J., Kaasa H.,
RA   Liszczak G., Marmorstein R., Reuter N., Lyon G.J., Gevaert K.,
RA   Arnesen T.;
RT   "Biochemical and cellular analysis of Ogden syndrome reveals
RT   downstream Nt-acetylation defects.";
RL   Hum. Mol. Genet. 24:1956-1976(2015).
RN   [34]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [35]
RP   X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS) OF 1-239, IDENTIFICATION BY MASS
RP   SPECTROMETRY, INTERACTION WITH PHOSPHOSERINE MOTIFS, AND SUBUNIT.
RX   PubMed=17085597; DOI=10.1073/pnas.0605779103;
RA   Yang X., Lee W.H., Sobott F., Papagrigoriou E., Robinson C.V.,
RA   Grossmann J.G., Sundstroem M., Doyle D.A., Elkins J.M.;
RT   "Structural basis for protein-protein interactions in the 14-3-3
RT   protein family.";
RL   Proc. Natl. Acad. Sci. U.S.A. 103:17237-17242(2006).
RN   [36]
RP   VARIANT ILE-99.
RX   PubMed=21248752; DOI=10.1038/nature09639;
RA   Varela I., Tarpey P., Raine K., Huang D., Ong C.K., Stephens P.,
RA   Davies H., Jones D., Lin M.L., Teague J., Bignell G., Butler A.,
RA   Cho J., Dalgliesh G.L., Galappaththige D., Greenman C., Hardy C.,
RA   Jia M., Latimer C., Lau K.W., Marshall J., McLaren S., Menzies A.,
RA   Mudie L., Stebbings L., Largaespada D.A., Wessels L.F.A., Richard S.,
RA   Kahnoski R.J., Anema J., Tuveson D.A., Perez-Mancera P.A.,
RA   Mustonen V., Fischer A., Adams D.J., Rust A., Chan-On W., Subimerb C.,
RA   Dykema K., Furge K., Campbell P.J., Teh B.T., Stratton M.R.,
RA   Futreal P.A.;
RT   "Exome sequencing identifies frequent mutation of the SWI/SNF complex
RT   gene PBRM1 in renal carcinoma.";
RL   Nature 469:539-542(2011).
CC   -!- FUNCTION: Adapter protein implicated in the regulation of a large
CC       spectrum of both general and specialized signaling pathways. Binds
CC       to a large number of partners, usually by recognition of a
CC       phosphoserine or phosphothreonine motif. Binding generally results
CC       in the modulation of the activity of the binding partner. Negative
CC       regulator of osteogenesis. Blocks the nuclear translocation of the
CC       phosphorylated form (by AKT1) of SRPK2 and antagonizes its
CC       stimulatory effect on cyclin D1 expression resulting in blockage
CC       of neuronal apoptosis elicited by SRPK2. Negative regulator of
CC       signaling cascades that mediate activation of MAP kinases via
CC       AKAP13. {ECO:0000269|PubMed:17717073, ECO:0000269|PubMed:19592491,
CC       ECO:0000269|PubMed:21224381}.
CC   -!- SUBUNIT: Homodimer (PubMed:17717073). Interacts with SAMSN1 and
CC       PRKCE (By similarity). Interacts with AKAP13 (PubMed:21224381).
CC       Interacts with SSH1 and TORC2/CRTC2 (PubMed:15454081,
CC       PubMed:15159416). Interacts with ABL1; the interaction results in
CC       cytoplasmic location of ABL1 and inhibition of cABL-mediated
CC       apoptosis (PubMed:15696159). Interacts with ROR2 (dimer); the
CC       interaction results in phosphorylation of YWHAB on tyrosine
CC       residues (PubMed:17717073). Interacts with GAB2 (PubMed:19172738).
CC       Interacts with YAP1 (phosphorylated form) (PubMed:17974916).
CC       Interacts with the phosphorylated (by AKT1) form of SRPK2
CC       (PubMed:19592491). Interacts with PKA-phosphorylated AANAT
CC       (PubMed:11427721). Interacts with MYO1C (PubMed:24636949).
CC       Interacts with SIRT2 (PubMed:18249187). Interacts with the 'Thr-
CC       369' phosphorylated form of DAPK2 (PubMed:26047703). Interacts
CC       with PI4KB, TBC1D22A and TBC1D22B (PubMed:23572552). Interacts
CC       with the 'Ser-1134' and 'Ser-1161' phosphorylated form of SOS1
CC       (PubMed:22827337). Interacts (via phosphorylated form) with YWHAB;
CC       this interaction occurs in a protein kinase AKT1-dependent manner
CC       (PubMed:15538381). Interacts with SLITRK1 (PubMed:19640509).
CC       Interacts with SYNPO2 (phosphorylated form); YWHAB competes with
CC       ACTN2 for interaction with SYNPO2 (By similarity). Interacts with
CC       RIPOR2 (via phosphorylated form) isoform 2; this interaction
CC       occurs in a chemokine-dependent manner and does not compete for
CC       binding of RIPOR2 with RHOA nor blocks inhibition of RIPOR2-
CC       mediated RHOA activity (PubMed:25588844).
CC       {ECO:0000250|UniProtKB:Q9CQV8, ECO:0000269|PubMed:11427721,
CC       ECO:0000269|PubMed:15159416, ECO:0000269|PubMed:15454081,
CC       ECO:0000269|PubMed:15538381, ECO:0000269|PubMed:15696159,
CC       ECO:0000269|PubMed:17085597, ECO:0000269|PubMed:17717073,
CC       ECO:0000269|PubMed:17974916, ECO:0000269|PubMed:18249187,
CC       ECO:0000269|PubMed:19172738, ECO:0000269|PubMed:19592491,
CC       ECO:0000269|PubMed:19640509, ECO:0000269|PubMed:21224381,
CC       ECO:0000269|PubMed:22827337, ECO:0000269|PubMed:23572552,
CC       ECO:0000269|PubMed:24636949, ECO:0000269|PubMed:25588844,
CC       ECO:0000269|PubMed:26047703}.
CC   -!- SUBUNIT: (Microbial infection) Interacts with herpes simplex virus
CC       1 protein UL46. {ECO:0000269|PubMed:23938468}.
CC   -!- INTERACTION:
CC       Self; NbExp=3; IntAct=EBI-359815, EBI-359815;
CC       Q76353:- (xeno); NbExp=3; IntAct=EBI-359815, EBI-6248077;
CC       Q9P0K1-3:ADAM22; NbExp=2; IntAct=EBI-359815, EBI-1567267;
CC       P15056:BRAF; NbExp=3; IntAct=EBI-359815, EBI-365980;
CC       P22681:CBL; NbExp=3; IntAct=EBI-359815, EBI-518228;
CC       O00257:CBX4; NbExp=2; IntAct=EBI-359815, EBI-722425;
CC       P30304:CDC25A; NbExp=10; IntAct=EBI-359815, EBI-747671;
CC       P30305:CDC25B; NbExp=5; IntAct=EBI-359815, EBI-1051746;
CC       P30307:CDC25C; NbExp=4; IntAct=EBI-359815, EBI-974439;
CC       O94921:CDK14; NbExp=5; IntAct=EBI-359815, EBI-1043945;
CC       P67828:CSNK1A1 (xeno); NbExp=3; IntAct=EBI-359815, EBI-7540603;
CC       Q9NYF0:DACT1; NbExp=4; IntAct=EBI-359815, EBI-3951744;
CC       Q13627-2:DYRK1A; NbExp=3; IntAct=EBI-359815, EBI-1053621;
CC       Q9UQC2:GAB2; NbExp=4; IntAct=EBI-359815, EBI-975200;
CC       P55040:GEM; NbExp=3; IntAct=EBI-359815, EBI-744104;
CC       P55041:Gem (xeno); NbExp=3; IntAct=EBI-359815, EBI-7082069;
CC       P56524:HDAC4; NbExp=3; IntAct=EBI-359815, EBI-308629;
CC       Q11184:let-756 (xeno); NbExp=2; IntAct=EBI-359815, EBI-3843983;
CC       Q5S007:LRRK2; NbExp=5; IntAct=EBI-359815, EBI-5323863;
CC       Q99759:MAP3K3; NbExp=2; IntAct=EBI-359815, EBI-307281;
CC       Q99683:MAP3K5; NbExp=3; IntAct=EBI-359815, EBI-476263;
CC       Q7KZI7:MARK2; NbExp=3; IntAct=EBI-359815, EBI-516560;
CC       P27448:MARK3; NbExp=4; IntAct=EBI-359815, EBI-707595;
CC       P26045:PTPN3; NbExp=4; IntAct=EBI-359815, EBI-1047946;
CC       P04049:RAF1; NbExp=18; IntAct=EBI-359815, EBI-365996;
CC       Q96TC7:RMDN3; NbExp=5; IntAct=EBI-359815, EBI-1056589;
CC       P61587:RND3; NbExp=2; IntAct=EBI-359815, EBI-1111534;
CC       P61588:Rnd3 (xeno); NbExp=5; IntAct=EBI-359815, EBI-6930266;
CC       P78362:SRPK2; NbExp=2; IntAct=EBI-359815, EBI-593303;
CC       Q8WYL5:SSH1; NbExp=3; IntAct=EBI-359815, EBI-1222387;
CC       Q91YE8:Synpo2 (xeno); NbExp=3; IntAct=EBI-359815, EBI-7623057;
CC       P49815:TSC2; NbExp=4; IntAct=EBI-359815, EBI-396587;
CC       P46937:YAP1; NbExp=6; IntAct=EBI-359815, EBI-1044059;
CC       P62258:YWHAE; NbExp=4; IntAct=EBI-359815, EBI-356498;
CC       P61981:YWHAG; NbExp=2; IntAct=EBI-359815, EBI-359832;
CC       P27348:YWHAQ; NbExp=2; IntAct=EBI-359815, EBI-359854;
CC       P22893:Zfp36 (xeno); NbExp=5; IntAct=EBI-359815, EBI-647803;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:17081065}.
CC       Melanosome {ECO:0000269|PubMed:17081065}. Note=Identified by mass
CC       spectrometry in melanosome fractions from stage I to stage IV.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative initiation; Named isoforms=2;
CC       Name=Long;
CC         IsoId=P31946-1; Sequence=Displayed;
CC       Name=Short;
CC         IsoId=P31946-2; Sequence=VSP_018632;
CC         Note=Contains a N-acetylmethionine at position 1.
CC         {ECO:0000244|PubMed:22814378};
CC   -!- PTM: The alpha, brain-specific form differs from the beta form in
CC       being phosphorylated. Phosphorylated on Ser-60 by protein kinase C
CC       delta type catalytic subunit in a sphingosine-dependent fashion.
CC       {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the 14-3-3 family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X57346; CAA40621.1; -; mRNA.
DR   EMBL; AK292717; BAF85406.1; -; mRNA.
DR   EMBL; AL008725; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471077; EAW75893.1; -; Genomic_DNA.
DR   EMBL; CH471077; EAW75894.1; -; Genomic_DNA.
DR   EMBL; CH471077; EAW75896.1; -; Genomic_DNA.
DR   EMBL; BC001359; AAH01359.1; -; mRNA.
DR   CCDS; CCDS13339.1; -. [P31946-1]
DR   PIR; S34755; S34755.
DR   RefSeq; NP_003395.1; NM_003404.4. [P31946-1]
DR   RefSeq; NP_647539.1; NM_139323.3. [P31946-1]
DR   RefSeq; XP_016883528.1; XM_017028039.1. [P31946-1]
DR   UniGene; Hs.643544; -.
DR   PDB; 2BQ0; X-ray; 2.50 A; A/B=2-239.
DR   PDB; 2C23; X-ray; 2.65 A; A=2-239.
DR   PDB; 4DNK; X-ray; 2.20 A; A/B=1-246.
DR   PDB; 5N10; X-ray; 1.60 A; A/B=1-246.
DR   PDBsum; 2BQ0; -.
DR   PDBsum; 2C23; -.
DR   PDBsum; 4DNK; -.
DR   PDBsum; 5N10; -.
DR   ProteinModelPortal; P31946; -.
DR   SMR; P31946; -.
DR   BioGrid; 113361; 366.
DR   CORUM; P31946; -.
DR   DIP; DIP-743N; -.
DR   ELM; P31946; -.
DR   IntAct; P31946; 270.
DR   MINT; P31946; -.
DR   STRING; 9606.ENSP00000300161; -.
DR   ChEMBL; CHEMBL3710403; -.
DR   iPTMnet; P31946; -.
DR   PhosphoSitePlus; P31946; -.
DR   SwissPalm; P31946; -.
DR   DMDM; 1345590; -.
DR   OGP; P31946; -.
DR   REPRODUCTION-2DPAGE; IPI00216318; -.
DR   EPD; P31946; -.
DR   PaxDb; P31946; -.
DR   PeptideAtlas; P31946; -.
DR   PRIDE; P31946; -.
DR   TopDownProteomics; P31946-1; -. [P31946-1]
DR   TopDownProteomics; P31946-2; -. [P31946-2]
DR   DNASU; 7529; -.
DR   Ensembl; ENST00000353703; ENSP00000300161; ENSG00000166913. [P31946-1]
DR   Ensembl; ENST00000372839; ENSP00000361930; ENSG00000166913. [P31946-1]
DR   GeneID; 7529; -.
DR   KEGG; hsa:7529; -.
DR   CTD; 7529; -.
DR   DisGeNET; 7529; -.
DR   EuPathDB; HostDB:ENSG00000166913.12; -.
DR   GeneCards; YWHAB; -.
DR   HGNC; HGNC:12849; YWHAB.
DR   HPA; CAB003759; -.
DR   HPA; HPA007925; -.
DR   HPA; HPA011212; -.
DR   MIM; 601289; gene.
DR   neXtProt; NX_P31946; -.
DR   OpenTargets; ENSG00000166913; -.
DR   PharmGKB; PA37438; -.
DR   eggNOG; KOG0841; Eukaryota.
DR   eggNOG; COG5040; LUCA.
DR   GeneTree; ENSGT00760000119116; -.
DR   HOGENOM; HOG000240379; -.
DR   HOVERGEN; HBG050423; -.
DR   InParanoid; P31946; -.
DR   KO; K16197; -.
DR   OMA; KKQQMGR; -.
DR   OrthoDB; EOG091G0VKY; -.
DR   PhylomeDB; P31946; -.
DR   TreeFam; TF102003; -.
DR   Reactome; R-HSA-111447; Activation of BAD and translocation to mitochondria.
DR   Reactome; R-HSA-1445148; Translocation of GLUT4 to the plasma membrane.
DR   Reactome; R-HSA-165159; mTOR signalling.
DR   Reactome; R-HSA-166208; mTORC1-mediated signalling.
DR   Reactome; R-HSA-170968; Frs2-mediated activation.
DR   Reactome; R-HSA-170984; ARMS-mediated activation.
DR   Reactome; R-HSA-2028269; Signaling by Hippo.
DR   Reactome; R-HSA-392517; Rap1 signalling.
DR   Reactome; R-HSA-450385; Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA.
DR   Reactome; R-HSA-450513; Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA.
DR   Reactome; R-HSA-5625740; RHO GTPases activate PKNs.
DR   Reactome; R-HSA-5628897; TP53 Regulates Metabolic Genes.
DR   Reactome; R-HSA-5673000; RAF activation.
DR   Reactome; R-HSA-5674135; MAP2K and MAPK activation.
DR   Reactome; R-HSA-5675221; Negative regulation of MAPK pathway.
DR   Reactome; R-HSA-6802946; Signaling by moderate kinase activity BRAF mutants.
DR   Reactome; R-HSA-6802948; Signaling by high-kinase activity BRAF mutants.
DR   Reactome; R-HSA-6802949; Signaling by RAS mutants.
DR   Reactome; R-HSA-6802952; Signaling by BRAF and RAF fusions.
DR   Reactome; R-HSA-6802955; Paradoxical activation of RAF signaling by kinase inactive BRAF.
DR   Reactome; R-HSA-75035; Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex.
DR   SignaLink; P31946; -.
DR   SIGNOR; P31946; -.
DR   ChiTaRS; YWHAB; human.
DR   EvolutionaryTrace; P31946; -.
DR   GeneWiki; YWHAB; -.
DR   GenomeRNAi; 7529; -.
DR   PRO; PR:P31946; -.
DR   Proteomes; UP000005640; Chromosome 20.
DR   Bgee; ENSG00000166913; -.
DR   CleanEx; HS_YWHAB; -.
DR   ExpressionAtlas; P31946; baseline and differential.
DR   Genevisible; P31946; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0005925; C:focal adhesion; HDA:UniProtKB.
DR   GO; GO:0042470; C:melanosome; IEA:UniProtKB-SubCell.
DR   GO; GO:0016020; C:membrane; HDA:UniProtKB.
DR   GO; GO:0005739; C:mitochondrion; IEA:GOC.
DR   GO; GO:0005634; C:nucleus; IEA:Ensembl.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IDA:UniProtKB.
DR   GO; GO:0017053; C:transcriptional repressor complex; IEA:Ensembl.
DR   GO; GO:0045296; F:cadherin binding; HDA:BHF-UCL.
DR   GO; GO:0019899; F:enzyme binding; IPI:BHF-UCL.
DR   GO; GO:0042826; F:histone deacetylase binding; IPI:BHF-UCL.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0051219; F:phosphoprotein binding; IPI:BHF-UCL.
DR   GO; GO:0050815; F:phosphoserine residue binding; IPI:BHF-UCL.
DR   GO; GO:0019904; F:protein domain specific binding; IPI:UniProtKB.
DR   GO; GO:0003714; F:transcription corepressor activity; IEA:Ensembl.
DR   GO; GO:0051220; P:cytoplasmic sequestering of protein; IDA:BHF-UCL.
DR   GO; GO:0035329; P:hippo signaling; TAS:Reactome.
DR   GO; GO:0000165; P:MAPK cascade; TAS:Reactome.
DR   GO; GO:0061024; P:membrane organization; TAS:Reactome.
DR   GO; GO:0045744; P:negative regulation of G-protein coupled receptor protein signaling pathway; IMP:UniProtKB.
DR   GO; GO:0035308; P:negative regulation of protein dephosphorylation; IDA:BHF-UCL.
DR   GO; GO:0045892; P:negative regulation of transcription, DNA-templated; IEA:Ensembl.
DR   GO; GO:0043085; P:positive regulation of catalytic activity; IDA:BHF-UCL.
DR   GO; GO:1900740; P:positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway; TAS:Reactome.
DR   GO; GO:0006605; P:protein targeting; IEA:Ensembl.
DR   GO; GO:0043488; P:regulation of mRNA stability; TAS:Reactome.
DR   GO; GO:0016032; P:viral process; IEA:UniProtKB-KW.
DR   Gene3D; 1.20.190.20; -; 1.
DR   InterPro; IPR000308; 14-3-3.
DR   InterPro; IPR023409; 14-3-3_CS.
DR   InterPro; IPR036815; 14-3-3_dom_sf.
DR   InterPro; IPR023410; 14-3-3_domain.
DR   PANTHER; PTHR18860; PTHR18860; 1.
DR   Pfam; PF00244; 14-3-3; 1.
DR   PIRSF; PIRSF000868; 14-3-3; 1.
DR   PRINTS; PR00305; 1433ZETA.
DR   SMART; SM00101; 14_3_3; 1.
DR   SUPFAM; SSF48445; SSF48445; 1.
DR   PROSITE; PS00796; 1433_1; 1.
DR   PROSITE; PS00797; 1433_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative initiation; Complete proteome;
KW   Cytoplasm; Direct protein sequencing; Host-virus interaction;
KW   Isopeptide bond; Nitration; Phosphoprotein; Polymorphism;
KW   Reference proteome; Ubl conjugation.
FT   CHAIN         1    246       14-3-3 protein beta/alpha.
FT                                /FTId=PRO_0000367900.
FT   INIT_MET      1      1       Removed; alternate.
FT                                {ECO:0000244|PubMed:22814378,
FT                                ECO:0000269|PubMed:25489052,
FT                                ECO:0000269|Ref.7}.
FT   CHAIN         2    246       14-3-3 protein beta/alpha, N-terminally
FT                                processed.
FT                                /FTId=PRO_0000000003.
FT   SITE         58     58       Interaction with phosphoserine on
FT                                interacting protein. {ECO:0000250}.
FT   SITE        129    129       Interaction with phosphoserine on
FT                                interacting protein. {ECO:0000250}.
FT   MOD_RES       1      1       N-acetylmethionine; in 14-3-3 protein
FT                                beta/alpha; alternate.
FT                                {ECO:0000244|PubMed:22814378,
FT                                ECO:0000269|Ref.7}.
FT   MOD_RES       2      2       N-acetylthreonine; in 14-3-3 protein
FT                                beta/alpha, N-terminally processed.
FT                                {ECO:0000244|PubMed:22814378,
FT                                ECO:0000269|PubMed:25489052,
FT                                ECO:0000269|Ref.7}.
FT   MOD_RES       2      2       Phosphothreonine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES       5      5       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:P27348}.
FT   MOD_RES      51     51       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P27348}.
FT   MOD_RES      60     60       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q9CQV8}.
FT   MOD_RES      70     70       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES      84     84       Nitrated tyrosine.
FT                                {ECO:0000250|UniProtKB:Q9CQV8}.
FT   MOD_RES     106    106       Nitrated tyrosine.
FT                                {ECO:0000250|UniProtKB:Q9CQV8}.
FT   MOD_RES     117    117       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     186    186       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P68251}.
FT   MOD_RES     232    232       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   CROSSLNK     51     51       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2);
FT                                alternate.
FT                                {ECO:0000250|UniProtKB:P27348}.
FT   VAR_SEQ       1      2       Missing (in isoform Short).
FT                                {ECO:0000305}.
FT                                /FTId=VSP_018632.
FT   VARIANT      99     99       V -> I (found in a renal cell carcinoma
FT                                sample; somatic mutation).
FT                                {ECO:0000269|PubMed:21248752}.
FT                                /FTId=VAR_064762.
FT   HELIX         5     17       {ECO:0000244|PDB:5N10}.
FT   HELIX        21     32       {ECO:0000244|PDB:5N10}.
FT   HELIX        40     70       {ECO:0000244|PDB:5N10}.
FT   TURN         73     75       {ECO:0000244|PDB:5N10}.
FT   HELIX        78    105       {ECO:0000244|PDB:5N10}.
FT   TURN        106    110       {ECO:0000244|PDB:5N10}.
FT   HELIX       114    134       {ECO:0000244|PDB:5N10}.
FT   HELIX       137    161       {ECO:0000244|PDB:5N10}.
FT   HELIX       167    182       {ECO:0000244|PDB:5N10}.
FT   HELIX       187    203       {ECO:0000244|PDB:5N10}.
FT   HELIX       204    207       {ECO:0000244|PDB:5N10}.
FT   TURN        210    212       {ECO:0000244|PDB:5N10}.
FT   HELIX       213    231       {ECO:0000244|PDB:5N10}.
SQ   SEQUENCE   246 AA;  28082 MW;  6BE1A9BF97468017 CRC64;
     MTMDKSELVQ KAKLAEQAER YDDMAAAMKA VTEQGHELSN EERNLLSVAY KNVVGARRSS
     WRVISSIEQK TERNEKKQQM GKEYREKIEA ELQDICNDVL ELLDKYLIPN ATQPESKVFY
     LKMKGDYFRY LSEVASGDNK QTTVSNSQQA YQEAFEISKK EMQPTHPIRL GLALNFSVFY
     YEILNSPEKA CSLAKTAFDE AIAELDTLNE ESYKDSTLIM QLLRDNLTLW TSENQGDEGD
     AGEGEN
//
ID   V9HWD6_HUMAN            Unreviewed;       246 AA.
AC   V9HWD6;
DT   19-MAR-2014, integrated into UniProtKB/TrEMBL.
DT   19-MAR-2014, sequence version 1.
DT   23-MAY-2018, entry version 32.
DE   SubName: Full=Epididymis secretory protein Li 1 {ECO:0000313|EMBL:ACJ13634.1};
GN   Name=HEL-S-1 {ECO:0000313|EMBL:ACJ13634.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:ACJ13634.1};
RN   [1] {ECO:0000313|EMBL:ACJ13634.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Li J.Y., Wang H.Y., Liu F.J., Liu J.;
RL   Submitted (JUN-2008) to the EMBL/GenBank/DDBJ databases.
CC   -!- SIMILARITY: Belongs to the 14-3-3 family.
CC       {ECO:0000256|RuleBase:RU003466, ECO:0000256|SAAS:SAAS00595241}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; EU794580; ACJ13634.1; -; mRNA.
DR   RefSeq; NP_003395.1; NM_003404.4.
DR   RefSeq; NP_647539.1; NM_139323.3.
DR   RefSeq; XP_016883528.1; XM_017028039.1.
DR   UniGene; Hs.643544; -.
DR   ProteinModelPortal; V9HWD6; -.
DR   SMR; V9HWD6; -.
DR   MaxQB; V9HWD6; -.
DR   PRIDE; V9HWD6; -.
DR   GeneID; 7529; -.
DR   KEGG; hsa:7529; -.
DR   UCSC; uc002xmt.5; human.
DR   CTD; 7529; -.
DR   EuPathDB; HostDB:ENSG00000166913.12; -.
DR   eggNOG; KOG0841; Eukaryota.
DR   eggNOG; COG5040; LUCA.
DR   KO; K16197; -.
DR   OMA; KKQQMGR; -.
DR   OrthoDB; EOG091G0VKY; -.
DR   PhylomeDB; V9HWD6; -.
DR   ChiTaRS; YWHAB; human.
DR   GenomeRNAi; 7529; -.
DR   Bgee; ENSG00000166913; -.
DR   ExpressionAtlas; V9HWD6; baseline and differential.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IEA:Ensembl.
DR   GO; GO:0017053; C:transcriptional repressor complex; IEA:Ensembl.
DR   GO; GO:0019904; F:protein domain specific binding; IEA:Ensembl.
DR   GO; GO:0003714; F:transcription corepressor activity; IEA:Ensembl.
DR   GO; GO:0045892; P:negative regulation of transcription, DNA-templated; IEA:Ensembl.
DR   GO; GO:0006605; P:protein targeting; IEA:Ensembl.
DR   Gene3D; 1.20.190.20; -; 1.
DR   InterPro; IPR000308; 14-3-3.
DR   InterPro; IPR023409; 14-3-3_CS.
DR   InterPro; IPR036815; 14-3-3_dom_sf.
DR   InterPro; IPR023410; 14-3-3_domain.
DR   PANTHER; PTHR18860; PTHR18860; 1.
DR   Pfam; PF00244; 14-3-3; 1.
DR   PIRSF; PIRSF000868; 14-3-3; 1.
DR   PRINTS; PR00305; 1433ZETA.
DR   SMART; SM00101; 14_3_3; 1.
DR   SUPFAM; SSF48445; SSF48445; 1.
DR   PROSITE; PS00796; 1433_1; 1.
DR   PROSITE; PS00797; 1433_2; 1.
PE   2: Evidence at transcript level;
KW   Coiled coil {ECO:0000256|SAM:Coils}.
FT   DOMAIN        5    244       14_3_3. {ECO:0000259|SMART:SM00101}.
FT   COILED       67    105       {ECO:0000256|SAM:Coils}.
SQ   SEQUENCE   246 AA;  28082 MW;  6BE1A9BF97468017 CRC64;
     MTMDKSELVQ KAKLAEQAER YDDMAAAMKA VTEQGHELSN EERNLLSVAY KNVVGARRSS
     WRVISSIEQK TERNEKKQQM GKEYREKIEA ELQDICNDVL ELLDKYLIPN ATQPESKVFY
     LKMKGDYFRY LSEVASGDNK QTTVSNSQQA YQEAFEISKK EMQPTHPIRL GLALNFSVFY
     YEILNSPEKA CSLAKTAFDE AIAELDTLNE ESYKDSTLIM QLLRDNLTLW TSENQGDEGD
     AGEGEN
//
ID   BAG2_HUMAN              Reviewed;         211 AA.
AC   O95816; B4DXE2; Q08AS9; Q6FID0;
DT   11-JAN-2001, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-1999, sequence version 1.
DT   23-MAY-2018, entry version 162.
DE   RecName: Full=BAG family molecular chaperone regulator 2;
DE            Short=BAG-2;
DE   AltName: Full=Bcl-2-associated athanogene 2;
GN   Name=BAG2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, AND INTERACTION WITH
RP   HSP70/HSC70 CHAPERONES.
RX   PubMed=9873016; DOI=10.1074/jbc.274.2.781;
RA   Takayama S., Xie Z., Reed J.C.;
RT   "An evolutionarily conserved family of Hsp70/Hsc70 molecular chaperone
RT   regulators.";
RL   J. Biol. Chem. 274:781-786(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Uterus;
RX   PubMed=11230166; DOI=10.1101/gr.GR1547R;
RA   Wiemann S., Weil B., Wellenreuther R., Gassenhuber J., Glassl S.,
RA   Ansorge W., Boecher M., Bloecker H., Bauersachs S., Blum H.,
RA   Lauber J., Duesterhoeft A., Beyer A., Koehrer K., Strack N.,
RA   Mewes H.-W., Ottenwaelder B., Obermaier B., Tampe J., Heubner D.,
RA   Wambutt R., Korn B., Klein M., Poustka A.;
RT   "Towards a catalog of human genes and proteins: sequencing and
RT   analysis of 500 novel complete protein coding human cDNAs.";
RL   Genome Res. 11:422-435(2001).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E.,
RA   Gilbert J.G.R., Clamp M.E., Bethel G., Milne S., Ainscough R.,
RA   Almeida J.P., Ambrose K.D., Andrews T.D., Ashwell R.I.S.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Banerjee R., Barker D.J.,
RA   Barlow K.F., Bates K., Beare D.M., Beasley H., Beasley O., Bird C.P.,
RA   Blakey S.E., Bray-Allen S., Brook J., Brown A.J., Brown J.Y.,
RA   Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E.,
RA   Ellington A.E., Evans K.A., Faulkner L., Francis M.D., Frankish A.,
RA   Frankland J., French L., Garner P., Garnett J., Ghori M.J.,
RA   Gilby L.M., Gillson C.J., Glithero R.J., Grafham D.V., Grant M.,
RA   Gribble S., Griffiths C., Griffiths M.N.D., Hall R., Halls K.S.,
RA   Hammond S., Harley J.L., Hart E.A., Heath P.D., Heathcott R.,
RA   Holmes S.J., Howden P.J., Howe K.L., Howell G.R., Huckle E.,
RA   Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M., Joy A.A.,
RA   Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R., Lloyd D.M.,
RA   Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K.,
RA   McMurray A., Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T.,
RA   Novik K.L., Oliver K., Overton-Larty E.K., Parker A., Patel R.,
RA   Pearce A.V., Peck A.I., Phillimore B.J.C.T., Phillips S., Plumb R.W.,
RA   Porter K.M., Ramsey Y., Ranby S.A., Rice C.M., Ross M.T., Searle S.M.,
RA   Sehra H.K., Sheridan E., Skuce C.D., Smith S., Smith M., Spraggon L.,
RA   Squares S.L., Steward C.A., Sycamore N., Tamlyn-Hall G., Tester J.,
RA   Theaker A.J., Thomas D.W., Thorpe A., Tracey A., Tromans A., Tubby B.,
RA   Wall M., Wallis J.M., West A.P., White S.S., Whitehead S.L.,
RA   Whittaker H., Wild A., Willey D.J., Wilmer T.E., Wood J.M., Wray P.W.,
RA   Wyatt J.C., Young L., Younger R.M., Bentley D.R., Coulson A.,
RA   Durbin R.M., Hubbard T., Sulston J.E., Dunham I., Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-73, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-20, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [10]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-31 AND SER-73, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [12]
RP   FUNCTION, AND INTERACTION WITH HSPA1A; HSPA1B AND HSPA8.
RX   PubMed=24318877; DOI=10.1074/jbc.M113.521997;
RA   Rauch J.N., Gestwicki J.E.;
RT   "Binding of human nucleotide exchange factors to heat shock protein 70
RT   (Hsp70) generates functionally distinct complexes in vitro.";
RL   J. Biol. Chem. 289:1402-1414(2014).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [14]
RP   INTERACTION WITH NWD1.
RX   PubMed=24681825;
RA   Correa R.G., Krajewska M., Ware C.F., Gerlic M., Reed J.C.;
RT   "The NLR-related protein NWD1 is associated with prostate cancer and
RT   modulates androgen receptor signaling.";
RL   Oncotarget 5:1666-1682(2014).
RN   [15]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
CC   -!- FUNCTION: Co-chaperone for HSP70 and HSC70 chaperone proteins.
CC       Acts as a nucleotide-exchange factor (NEF) promoting the release
CC       of ADP from the HSP70 and HSC70 proteins thereby triggering
CC       client/substrate protein release (PubMed:24318877,
CC       PubMed:9873016). {ECO:0000269|PubMed:24318877,
CC       ECO:0000269|PubMed:9873016}.
CC   -!- SUBUNIT: Binds to the ATPase domain of HSP/HSC70 chaperones
CC       (PubMed:9873016). May interact with NWD1 (PubMed:24681825).
CC       Interacts with HSPA1A (via NBD), HSPA1B (via NBD) and HSPA8
CC       (PubMed:24318877). {ECO:0000269|PubMed:24318877,
CC       ECO:0000269|PubMed:24681825, ECO:0000269|PubMed:9873016}.
CC   -!- INTERACTION:
CC       Self; NbExp=3; IntAct=EBI-355275, EBI-355275;
CC       A8K1F4:-; NbExp=2; IntAct=EBI-355275, EBI-9357094;
CC       Q96BE0:-; NbExp=2; IntAct=EBI-355275, EBI-9356686;
CC       Q99615:DNAJC7; NbExp=2; IntAct=EBI-355275, EBI-357552;
CC       Q8AZK7:EBNA-LP (xeno); NbExp=3; IntAct=EBI-355275, EBI-1185167;
CC       P11142:HSPA8; NbExp=7; IntAct=EBI-355275, EBI-351896;
CC       Q5S007:LRRK2; NbExp=2; IntAct=EBI-355275, EBI-5323863;
CC       O43765:SGTA; NbExp=2; IntAct=EBI-355275, EBI-347996;
CC       Q9UNE7:STUB1; NbExp=4; IntAct=EBI-355275, EBI-357085;
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=O95816-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=O95816-2; Sequence=VSP_056462;
CC         Note=No experimental confirmation available.;
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF095192; AAD16121.1; -; mRNA.
DR   EMBL; AL050287; CAB43388.1; -; mRNA.
DR   EMBL; AK301934; BAG63354.1; -; mRNA.
DR   EMBL; CR533496; CAG38527.1; -; mRNA.
DR   EMBL; AL031321; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL136311; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC125039; AAI25040.1; -; mRNA.
DR   CCDS; CCDS4961.1; -. [O95816-1]
DR   PIR; T08764; T08764.
DR   RefSeq; NP_004273.1; NM_004282.3. [O95816-1]
DR   RefSeq; XP_005249547.1; XM_005249490.3. [O95816-2]
DR   RefSeq; XP_011513300.1; XM_011514998.2. [O95816-2]
DR   RefSeq; XP_011513301.1; XM_011514999.2. [O95816-2]
DR   UniGene; Hs.745046; -.
DR   ProteinModelPortal; O95816; -.
DR   SMR; O95816; -.
DR   BioGrid; 114908; 116.
DR   IntAct; O95816; 154.
DR   MINT; O95816; -.
DR   STRING; 9606.ENSP00000359727; -.
DR   iPTMnet; O95816; -.
DR   PhosphoSitePlus; O95816; -.
DR   SwissPalm; O95816; -.
DR   BioMuta; BAG2; -.
DR   EPD; O95816; -.
DR   MaxQB; O95816; -.
DR   PaxDb; O95816; -.
DR   PeptideAtlas; O95816; -.
DR   PRIDE; O95816; -.
DR   TopDownProteomics; O95816-1; -. [O95816-1]
DR   DNASU; 9532; -.
DR   Ensembl; ENST00000370693; ENSP00000359727; ENSG00000112208. [O95816-1]
DR   GeneID; 9532; -.
DR   KEGG; hsa:9532; -.
DR   UCSC; uc003pdr.4; human. [O95816-1]
DR   CTD; 9532; -.
DR   DisGeNET; 9532; -.
DR   EuPathDB; HostDB:ENSG00000112208.11; -.
DR   GeneCards; BAG2; -.
DR   HGNC; HGNC:938; BAG2.
DR   HPA; HPA018862; -.
DR   HPA; HPA019918; -.
DR   MIM; 603882; gene.
DR   neXtProt; NX_O95816; -.
DR   OpenTargets; ENSG00000112208; -.
DR   PharmGKB; PA25238; -.
DR   eggNOG; KOG3633; Eukaryota.
DR   eggNOG; ENOG410XRW0; LUCA.
DR   GeneTree; ENSGT00390000017590; -.
DR   HOGENOM; HOG000073529; -.
DR   HOVERGEN; HBG004808; -.
DR   InParanoid; O95816; -.
DR   KO; K09556; -.
DR   OMA; QLEMRVE; -.
DR   OrthoDB; EOG091G0G1G; -.
DR   PhylomeDB; O95816; -.
DR   TreeFam; TF102012; -.
DR   Reactome; R-HSA-3371453; Regulation of HSF1-mediated heat shock response.
DR   SIGNOR; O95816; -.
DR   ChiTaRS; BAG2; human.
DR   GeneWiki; BAG2; -.
DR   GenomeRNAi; 9532; -.
DR   PRO; PR:O95816; -.
DR   Proteomes; UP000005640; Chromosome 6.
DR   Bgee; ENSG00000112208; -.
DR   CleanEx; HS_BAG2; -.
DR   Genevisible; O95816; HS.
DR   GO; GO:0030424; C:axon; ISS:ARUK-UCL.
DR   GO; GO:0101031; C:chaperone complex; IPI:ARUK-UCL.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0030425; C:dendrite; ISS:ARUK-UCL.
DR   GO; GO:1901588; C:dendritic microtubule; IEA:Ensembl.
DR   GO; GO:0000774; F:adenyl-nucleotide exchange factor activity; IDA:UniProtKB.
DR   GO; GO:0051087; F:chaperone binding; IPI:ARUK-UCL.
DR   GO; GO:0031072; F:heat shock protein binding; IEA:Ensembl.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0044325; F:ion channel binding; IPI:ARUK-UCL.
DR   GO; GO:0048156; F:tau protein binding; IEA:Ensembl.
DR   GO; GO:0031625; F:ubiquitin protein ligase binding; IEA:Ensembl.
DR   GO; GO:0032091; P:negative regulation of protein binding; IDA:ARUK-UCL.
DR   GO; GO:0031397; P:negative regulation of protein ubiquitination; IDA:ARUK-UCL.
DR   GO; GO:1904667; P:negative regulation of ubiquitin protein ligase activity; IDA:ARUK-UCL.
DR   GO; GO:1901800; P:positive regulation of proteasomal protein catabolic process; ISS:ARUK-UCL.
DR   GO; GO:0010954; P:positive regulation of protein processing; IMP:ARUK-UCL.
DR   GO; GO:0006457; P:protein folding; TAS:ProtInc.
DR   GO; GO:0019538; P:protein metabolic process; IDA:MGI.
DR   GO; GO:0050821; P:protein stabilization; IDA:ARUK-UCL.
DR   GO; GO:1900034; P:regulation of cellular response to heat; TAS:Reactome.
DR   InterPro; IPR037689; BAG2.
DR   InterPro; IPR003103; BAG_domain.
DR   PANTHER; PTHR12334; PTHR12334; 1.
DR   SMART; SM00264; BAG; 1.
DR   PROSITE; PS51035; BAG; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Alternative splicing; Chaperone; Coiled coil;
KW   Complete proteome; Phosphoprotein; Reference proteome.
FT   INIT_MET      1      1       Removed. {ECO:0000244|PubMed:22814378}.
FT   CHAIN         2    211       BAG family molecular chaperone regulator
FT                                2.
FT                                /FTId=PRO_0000088866.
FT   DOMAIN      109    189       BAG. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00369}.
FT   COILED       20     61       {ECO:0000255}.
FT   MOD_RES       2      2       N-acetylalanine.
FT                                {ECO:0000244|PubMed:22814378}.
FT   MOD_RES      20     20       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231}.
FT   MOD_RES      31     31       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES      73     73       Phosphoserine.
FT                                {ECO:0000244|PubMed:18691976,
FT                                ECO:0000244|PubMed:23186163}.
FT   VAR_SEQ       1     38       MAQAKINAKANEGRFCRSSSMADRSSRLLESLDQLELR ->
FT                                MPHMW (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_056462.
FT   CONFLICT    180    180       N -> D (in Ref. 4; CAG38527).
FT                                {ECO:0000305}.
SQ   SEQUENCE   211 AA;  23772 MW;  CAF631F4578FCCA3 CRC64;
     MAQAKINAKA NEGRFCRSSS MADRSSRLLE SLDQLELRVE ALREAATAVE QEKEILLEMI
     HSIQNSQDMR QISDGEREEL NLTANRLMGR TLTVEVSVET IRNPQQQESL KHATRIIDEV
     VNKFLDDLGN AKSHLMSLYS ACSSEVPHGP VDQKFQSIVI GCALEDQKKI KRRLETLLRN
     IENSDKAIKL LEHSKGAGSK TLQQNAESRF N
//
ID   GET4_HUMAN              Reviewed;         327 AA.
AC   Q7L5D6; A4D2Q1; B3KNC7; Q9UFC9; Q9Y309;
DT   21-MAR-2006, integrated into UniProtKB/Swiss-Prot.
DT   05-JUL-2004, sequence version 1.
DT   23-MAY-2018, entry version 121.
DE   RecName: Full=Golgi to ER traffic protein 4 homolog;
DE   AltName: Full=Conserved edge-expressed protein;
DE   AltName: Full=Transmembrane domain recognition complex 35 kDa subunit;
DE            Short=TRC35;
GN   Name=GET4; Synonyms=C7orf20, CEE, TRC35; ORFNames=CGI-20;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Ovary, Testis, and Thymus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Testis;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12690205; DOI=10.1126/science.1083423;
RA   Scherer S.W., Cheung J., MacDonald J.R., Osborne L.R., Nakabayashi K.,
RA   Herbrick J.-A., Carson A.R., Parker-Katiraee L., Skaug J., Khaja R.,
RA   Zhang J., Hudek A.K., Li M., Haddad M., Duggan G.E., Fernandez B.A.,
RA   Kanematsu E., Gentles S., Christopoulos C.C., Choufani S.,
RA   Kwasnicka D., Zheng X.H., Lai Z., Nusskern D.R., Zhang Q., Gu Z.,
RA   Lu F., Zeesman S., Nowaczyk M.J., Teshima I., Chitayat D., Shuman C.,
RA   Weksberg R., Zackai E.H., Grebe T.A., Cox S.R., Kirkpatrick S.J.,
RA   Rahman N., Friedman J.M., Heng H.H.Q., Pelicci P.G., Lo-Coco F.,
RA   Belloni E., Shaffer L.G., Pober B., Morton C.C., Gusella J.F.,
RA   Bruns G.A.P., Korf B.R., Quade B.J., Ligon A.H., Ferguson H.,
RA   Higgins A.W., Leach N.T., Herrick S.R., Lemyre E., Farra C.G.,
RA   Kim H.-G., Summers A.M., Gripp K.W., Roberts W., Szatmari P.,
RA   Winsor E.J.T., Grzeschik K.-H., Teebi A., Minassian B.A., Kere J.,
RA   Armengol L., Pujana M.A., Estivill X., Wilson M.D., Koop B.F.,
RA   Tosi S., Moore G.E., Boright A.P., Zlotorynski E., Kerem B.,
RA   Kroisel P.M., Petek E., Oscier D.G., Mould S.J., Doehner H.,
RA   Doehner K., Rommens J.M., Vincent J.B., Venter J.C., Li P.W.,
RA   Mural R.J., Adams M.D., Tsui L.-C.;
RT   "Human chromosome 7: DNA sequence and biology.";
RL   Science 300:767-772(2003).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   PROTEIN SEQUENCE OF 2-14 AND 111-122, CLEAVAGE OF INITIATOR
RP   METHIONINE, ACETYLATION AT ALA-2, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RC   TISSUE=Lung carcinoma;
RA   Bienvenut W.V., Vousden K.H., Lukashchuk N.;
RL   Submitted (MAR-2008) to UniProtKB.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 8-327 (ISOFORM 1).
RX   PubMed=10810093; DOI=10.1101/gr.10.5.703;
RA   Lai C.-H., Chou C.-Y., Ch'ang L.-Y., Liu C.-S., Lin W.-C.;
RT   "Identification of novel human genes evolutionarily conserved in
RT   Caenorhabditis elegans by comparative proteomics.";
RL   Genome Res. 10:703-713(2000).
RN   [7]
RP   IDENTIFICATION.
RX   PubMed=18249086; DOI=10.1016/j.ygeno.2007.10.017;
RA   Fernandes J.M.O., Macqueen D.J., Lee H.-T., Johnston I.A.;
RT   "Genomic, evolutionary, and expression analyses of cee, an ancient
RT   gene involved in normal growth and development.";
RL   Genomics 91:315-325(2008).
RN   [8]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [9]
RP   FUNCTION, SUBCELLULAR LOCATION, IDENTIFICATION BY MASS SPECTROMETRY,
RP   AND IDENTIFICATION IN THE BAG6/BAT3 COMPLEX.
RX   PubMed=20676083; DOI=10.1038/nature09296;
RA   Mariappan M., Li X., Stefanovic S., Sharma A., Mateja A., Keenan R.J.,
RA   Hegde R.S.;
RT   "A ribosome-associating factor chaperones tail-anchored membrane
RT   proteins.";
RL   Nature 466:1120-1124(2010).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [11]
RP   FUNCTION, INTERACTION WITH BAG6, AND SUBCELLULAR LOCATION.
RX   PubMed=21636303; DOI=10.1016/j.molcel.2011.05.010;
RA   Wang Q., Liu Y., Soetandyo N., Baek K., Hegde R., Ye Y.;
RT   "A ubiquitin ligase-associated chaperone holdase maintains
RT   polypeptides in soluble states for proteasome degradation.";
RL   Mol. Cell 42:758-770(2011).
RN   [12]
RP   FUNCTION.
RX   PubMed=21743475; DOI=10.1038/nature10181;
RA   Hessa T., Sharma A., Mariappan M., Eshleman H.D., Gutierrez E.,
RA   Hegde R.S.;
RT   "Protein targeting and degradation are coupled for elimination of
RT   mislocalized proteins.";
RL   Nature 475:394-397(2011).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [14]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22223895; DOI=10.1074/mcp.M111.015131;
RA   Bienvenut W.V., Sumpton D., Martinez A., Lilla S., Espagne C.,
RA   Meinnel T., Giglione C.;
RT   "Comparative large-scale characterisation of plant vs. mammal proteins
RT   reveals similar and idiosyncratic N-alpha acetylation features.";
RL   Mol. Cell. Proteomics 11:M111.015131-M111.015131(2012).
RN   [15]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-12, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [17]
RP   FUNCTION.
RX   PubMed=28104892; DOI=10.1126/science.aah6130;
RA   Shao S., Rodrigo-Brenni M.C., Kivlen M.H., Hegde R.S.;
RT   "Mechanistic basis for a molecular triage reaction.";
RL   Science 355:298-302(2017).
CC   -!- FUNCTION: As part of a cytosolic protein quality control complex,
CC       the BAG6/BAT3 complex, maintains misfolded and hydrophobic
CC       patches-containing proteins in a soluble state and participates to
CC       their proper delivery to the endoplasmic reticulum or
CC       alternatively can promote their sorting to the proteasome where
CC       they undergo degradation (PubMed:20676083, PubMed:21636303,
CC       PubMed:21743475, PubMed:28104892). The BAG6/BAT3 complex is
CC       involved in the post-translational delivery of tail-anchored/type
CC       II transmembrane proteins to the endoplasmic reticulum membrane.
CC       Recruited to ribosomes, it interacts with the transmembrane region
CC       of newly synthesized tail-anchored proteins and together with SGTA
CC       and ASNA1 mediates their delivery to the endoplasmic reticulum
CC       (PubMed:20676083, PubMed:28104892). Client proteins that cannot be
CC       properly delivered to the endoplasmic reticulum are ubiquitinated
CC       and sorted to the proteasome (PubMed:28104892). Similarly, the
CC       BAG6/BAT3 complex also functions as a sorting platform for
CC       proteins of the secretory pathway that are mislocalized to the
CC       cytosol either delivering them to the proteasome for degradation
CC       or to the endoplasmic reticulum (PubMed:21743475). The BAG6/BAT3
CC       complex also plays a role in the endoplasmic reticulum-associated
CC       degradation (ERAD), a quality control mechanism that eliminates
CC       unwanted proteins of the endoplasmic reticulum through their
CC       retrotranslocation to the cytosol and their targeting to the
CC       proteasome. It maintains these retrotranslocated proteins in an
CC       unfolded yet soluble state condition in the cytosol to ensure
CC       their proper delivery to the proteasome (PubMed:21636303).
CC       {ECO:0000269|PubMed:20676083, ECO:0000269|PubMed:21636303,
CC       ECO:0000269|PubMed:21743475, ECO:0000269|PubMed:28104892}.
CC   -!- SUBUNIT: Component of the BAG6/BAT3 complex, at least composed of
CC       BAG6, UBL4A and GET4/TRC35 (PubMed:20676083). Interacts with BAG6;
CC       the interaction is direct and localizes BAG6 to the cytosol
CC       (PubMed:21636303). {ECO:0000269|PubMed:20676083,
CC       ECO:0000269|PubMed:21636303}.
CC   -!- INTERACTION:
CC       O43681:ASNA1; NbExp=3; IntAct=EBI-711823, EBI-2515857;
CC       O43741:PRKAB2; NbExp=6; IntAct=EBI-711823, EBI-1053424;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytosol
CC       {ECO:0000269|PubMed:20676083, ECO:0000269|PubMed:21636303}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q7L5D6-1; Sequence=Displayed;
CC         Note=No experimental confirmation available.;
CC       Name=2;
CC         IsoId=Q7L5D6-2; Sequence=VSP_017652;
CC   -!- SIMILARITY: Belongs to the GET4 family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK024305; BAG51289.1; -; mRNA.
DR   EMBL; AK097899; BAG53546.1; -; mRNA.
DR   EMBL; AK125863; BAG54258.1; -; mRNA.
DR   EMBL; AL133014; CAB61355.1; -; mRNA.
DR   EMBL; CH236965; EAL23708.1; -; Genomic_DNA.
DR   EMBL; BC003550; AAH03550.2; -; mRNA.
DR   EMBL; AF132954; AAD27729.1; -; mRNA.
DR   CCDS; CCDS5317.1; -. [Q7L5D6-1]
DR   PIR; T42648; T42648.
DR   RefSeq; NP_057033.2; NM_015949.2. [Q7L5D6-1]
DR   UniGene; Hs.107387; -.
DR   UniGene; Hs.743756; -.
DR   PDB; 6AU8; X-ray; 1.80 A; A=23-305.
DR   PDBsum; 6AU8; -.
DR   ProteinModelPortal; Q7L5D6; -.
DR   SMR; Q7L5D6; -.
DR   BioGrid; 119636; 64.
DR   IntAct; Q7L5D6; 46.
DR   MINT; Q7L5D6; -.
DR   STRING; 9606.ENSP00000265857; -.
DR   iPTMnet; Q7L5D6; -.
DR   PhosphoSitePlus; Q7L5D6; -.
DR   BioMuta; GET4; -.
DR   DMDM; 74738593; -.
DR   EPD; Q7L5D6; -.
DR   MaxQB; Q7L5D6; -.
DR   PaxDb; Q7L5D6; -.
DR   PeptideAtlas; Q7L5D6; -.
DR   PRIDE; Q7L5D6; -.
DR   DNASU; 51608; -.
DR   Ensembl; ENST00000265857; ENSP00000265857; ENSG00000239857. [Q7L5D6-1]
DR   Ensembl; ENST00000407192; ENSP00000385646; ENSG00000239857. [Q7L5D6-2]
DR   GeneID; 51608; -.
DR   KEGG; hsa:51608; -.
DR   UCSC; uc003sjl.2; human. [Q7L5D6-1]
DR   CTD; 51608; -.
DR   EuPathDB; HostDB:ENSG00000239857.6; -.
DR   GeneCards; GET4; -.
DR   H-InvDB; HIX0033841; -.
DR   H-InvDB; HIX0201122; -.
DR   HGNC; HGNC:21690; GET4.
DR   HPA; HPA019765; -.
DR   MIM; 612056; gene.
DR   neXtProt; NX_Q7L5D6; -.
DR   OpenTargets; ENSG00000239857; -.
DR   PharmGKB; PA165618100; -.
DR   eggNOG; KOG3024; Eukaryota.
DR   eggNOG; ENOG410XRWE; LUCA.
DR   GeneTree; ENSGT00390000015750; -.
DR   HOGENOM; HOG000264232; -.
DR   HOVERGEN; HBG059877; -.
DR   InParanoid; Q7L5D6; -.
DR   OMA; QMYRTLF; -.
DR   OrthoDB; EOG091G0DTD; -.
DR   PhylomeDB; Q7L5D6; -.
DR   TreeFam; TF315163; -.
DR   GeneWiki; C7orf20; -.
DR   GenomeRNAi; 51608; -.
DR   PRO; PR:Q7L5D6; -.
DR   Proteomes; UP000005640; Chromosome 7.
DR   Bgee; ENSG00000239857; -.
DR   CleanEx; HS_C7orf20; -.
DR   ExpressionAtlas; Q7L5D6; baseline and differential.
DR   Genevisible; Q7L5D6; HS.
DR   GO; GO:0071818; C:BAT3 complex; IDA:UniProtKB.
DR   GO; GO:0005737; C:cytoplasm; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0005829; C:cytosol; IDA:UniProtKB.
DR   GO; GO:0005730; C:nucleolus; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0051087; F:chaperone binding; IPI:BHF-UCL.
DR   GO; GO:0051220; P:cytoplasmic sequestering of protein; IMP:ParkinsonsUK-UCL.
DR   GO; GO:1904378; P:maintenance of unfolded protein involved in ERAD pathway; IMP:ParkinsonsUK-UCL.
DR   GO; GO:0071816; P:tail-anchored membrane protein insertion into ER membrane; IMP:UniProtKB.
DR   Gene3D; 1.25.40.10; -; 1.
DR   InterPro; IPR011990; TPR-like_helical_dom_sf.
DR   InterPro; IPR007317; UPF0363.
DR   PANTHER; PTHR12875; PTHR12875; 1.
DR   Pfam; PF04190; DUF410; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Complete proteome;
KW   Cytoplasm; Direct protein sequencing; Phosphoprotein;
KW   Reference proteome; Transport.
FT   INIT_MET      1      1       Removed. {ECO:0000244|PubMed:19413330,
FT                                ECO:0000244|PubMed:22223895,
FT                                ECO:0000244|PubMed:22814378,
FT                                ECO:0000269|Ref.5}.
FT   CHAIN         2    327       Golgi to ER traffic protein 4 homolog.
FT                                /FTId=PRO_0000228104.
FT   MOD_RES       2      2       N-acetylalanine.
FT                                {ECO:0000244|PubMed:19413330,
FT                                ECO:0000244|PubMed:22223895,
FT                                ECO:0000244|PubMed:22814378,
FT                                ECO:0000269|Ref.5}.
FT   MOD_RES      12     12       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   VAR_SEQ       1     53       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:17974005}.
FT                                /FTId=VSP_017652.
FT   CONFLICT      9     22       EQESARNGGRNRGG -> DRRAPATALQPRA (in Ref.
FT                                6; AAD27729). {ECO:0000305}.
FT   CONFLICT    177    177       N -> D (in Ref. 6; AAD27729).
FT                                {ECO:0000305}.
FT   HELIX        26     35       {ECO:0000244|PDB:6AU8}.
FT   HELIX        39     55       {ECO:0000244|PDB:6AU8}.
FT   HELIX        59     75       {ECO:0000244|PDB:6AU8}.
FT   HELIX        79     95       {ECO:0000244|PDB:6AU8}.
FT   HELIX       102    114       {ECO:0000244|PDB:6AU8}.
FT   HELIX       120    133       {ECO:0000244|PDB:6AU8}.
FT   HELIX       143    155       {ECO:0000244|PDB:6AU8}.
FT   HELIX       159    167       {ECO:0000244|PDB:6AU8}.
FT   HELIX       172    186       {ECO:0000244|PDB:6AU8}.
FT   HELIX       189    191       {ECO:0000244|PDB:6AU8}.
FT   HELIX       192    205       {ECO:0000244|PDB:6AU8}.
FT   HELIX       209    222       {ECO:0000244|PDB:6AU8}.
FT   HELIX       235    248       {ECO:0000244|PDB:6AU8}.
FT   HELIX       252    261       {ECO:0000244|PDB:6AU8}.
FT   HELIX       263    266       {ECO:0000244|PDB:6AU8}.
FT   HELIX       272    284       {ECO:0000244|PDB:6AU8}.
FT   HELIX       294    298       {ECO:0000244|PDB:6AU8}.
FT   HELIX       301    303       {ECO:0000244|PDB:6AU8}.
SQ   SEQUENCE   327 AA;  36504 MW;  4D6C4233181B0512 CRC64;
     MAAAAAMAEQ ESARNGGRNR GGVQRVEGKL RASVEKGDYY EAHQMYRTLF FRYMSQSKHT
     EARELMYSGA LLFFSHGQQN SAADLSMLVL ESLEKAEVEV ADELLENLAK VFSLMDPNSP
     ERVTFVSRAL KWSSGGSGKL GHPRLHQLLA LTLWKEQNYC ESRYHFLHSA DGEGCANMLV
     EYSTSRGFRS EVDMFVAQAV LQFLCLKNKS SASVVFTTYT QKHPSIEDGP PFVEPLLNFI
     WFLLLAVDGG KLTVFTVLCE QYQPSLRRDP MYNEYLDRIG QLFFGVPPKQ TSSYGGLLGN
     LLTSLMGSSE QEDGEESPSD GSPIELD
//
ID   ASNA_HUMAN              Reviewed;         348 AA.
AC   O43681; A6NHP8; A8K740; Q53FC6; Q92849;
DT   30-MAY-2000, integrated into UniProtKB/Swiss-Prot.
DT   30-MAY-2000, sequence version 2.
DT   23-MAY-2018, entry version 169.
DE   RecName: Full=ATPase ASNA1 {ECO:0000255|HAMAP-Rule:MF_03112};
DE            EC=3.6.-.- {ECO:0000255|HAMAP-Rule:MF_03112};
DE   AltName: Full=Arsenical pump-driving ATPase {ECO:0000255|HAMAP-Rule:MF_03112};
DE   AltName: Full=Arsenite-stimulated ATPase {ECO:0000255|HAMAP-Rule:MF_03112};
DE   AltName: Full=Transmembrane domain recognition complex 40 kDa ATPase subunit;
DE   AltName: Full=hARSA-I;
DE   AltName: Full=hASNA-I;
GN   Name=ASNA1 {ECO:0000255|HAMAP-Rule:MF_03112}; Synonyms=ARSA, TRC40;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RA   Hu G.;
RT   "Human homolog of bacterial and mouse arsenite translocating ATPase
RT   gene, ArsA.";
RL   Submitted (FEB-1998) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Salivary gland;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Cerebellum;
RA   Totoki Y., Toyoda A., Takeda T., Sakaki Y., Tanaka A., Yokoyama S.;
RL   Submitted (APR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT SER-332.
RG   NIEHS SNPs program;
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057824; DOI=10.1038/nature02399;
RA   Grimwood J., Gordon L.A., Olsen A.S., Terry A., Schmutz J.,
RA   Lamerdin J.E., Hellsten U., Goodstein D., Couronne O., Tran-Gyamfi M.,
RA   Aerts A., Altherr M., Ashworth L., Bajorek E., Black S., Branscomb E.,
RA   Caenepeel S., Carrano A.V., Caoile C., Chan Y.M., Christensen M.,
RA   Cleland C.A., Copeland A., Dalin E., Dehal P., Denys M., Detter J.C.,
RA   Escobar J., Flowers D., Fotopulos D., Garcia C., Georgescu A.M.,
RA   Glavina T., Gomez M., Gonzales E., Groza M., Hammon N., Hawkins T.,
RA   Haydu L., Ho I., Huang W., Israni S., Jett J., Kadner K., Kimball H.,
RA   Kobayashi A., Larionov V., Leem S.-H., Lopez F., Lou Y., Lowry S.,
RA   Malfatti S., Martinez D., McCready P.M., Medina C., Morgan J.,
RA   Nelson K., Nolan M., Ovcharenko I., Pitluck S., Pollard M.,
RA   Popkie A.P., Predki P., Quan G., Ramirez L., Rash S., Retterer J.,
RA   Rodriguez A., Rogers S., Salamov A., Salazar A., She X., Smith D.,
RA   Slezak T., Solovyev V., Thayer N., Tice H., Tsai M., Ustaszewska A.,
RA   Vo N., Wagner M., Wheeler J., Wu K., Xie G., Yang J., Dubchak I.,
RA   Furey T.S., DeJong P., Dickson M., Gordon D., Eichler E.E.,
RA   Pennacchio L.A., Richardson P., Stubbs L., Rokhsar D.S., Myers R.M.,
RA   Rubin E.M., Lucas S.M.;
RT   "The DNA sequence and biology of human chromosome 19.";
RL   Nature 428:529-535(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 18-348.
RX   PubMed=8884272; DOI=10.1006/geno.1996.0494;
RA   Kurdi-Haidar B., Aebi S., Heath D., Enns R.E., Naredi P., Hom D.K.,
RA   Howell S.B.;
RT   "Isolation of the ATP-binding human homolog of the arsA component of
RT   the bacterial arsenite transporter.";
RL   Genomics 36:486-491(1996).
RN   [9]
RP   BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=9712828; DOI=10.1074/jbc.273.35.22173;
RA   Kurdi-Haidar B., Heath D., Aebi S., Howell S.B.;
RT   "Biochemical characterization of the human arsenite-stimulated ATPase
RT   (hASNA-I).";
RL   J. Biol. Chem. 273:22173-22176(1998).
RN   [10]
RP   SUBCELLULAR LOCATION.
RX   PubMed=9736449;
RX   DOI=10.1002/(SICI)1097-4644(19981001)71:1<1::AID-JCB1>3.3.CO;2-R;
RA   Kurdi-Haidar B., Hom D.K., Flittner D.E., Heath D., Fink L.,
RA   Naredi P., Howell S.B.;
RT   "Dual cytoplasmic and nuclear distribution of the novel arsenite-
RT   stimulated human ATPase (hASNA-I).";
RL   J. Cell. Biochem. 71:1-10(1998).
RN   [11]
RP   TISSUE SPECIFICITY.
RX   PubMed=9774623; DOI=10.1177/002215549804601104;
RA   Kurdi-Haidar B., Heath D., Naredi P., Varki N., Howell S.B.;
RT   "Immunohistochemical analysis of the distribution of the human ATPase
RT   (hASNA-I) in normal tissues and its overexpression in breast adenomas
RT   and carcinomas.";
RL   J. Histochem. Cytochem. 46:1243-1248(1998).
RN   [12]
RP   FUNCTION, IDENTIFICATION IN THE TRC COMPLEX, MUTAGENESIS OF GLY-46,
RP   SUBCELLULAR LOCATION, AND INTERACTION WITH SEC61B.
RX   PubMed=17382883; DOI=10.1016/j.cell.2007.01.036;
RA   Stefanovic S., Hegde R.S.;
RT   "Identification of a targeting factor for posttranslational membrane
RT   protein insertion into the ER.";
RL   Cell 128:1147-1159(2007).
RN   [13]
RP   FUNCTION, AND INTERACTION WITH SERP1 AND SEC61B.
RX   PubMed=18477612; DOI=10.1242/jcs.020321;
RA   Favaloro V., Spasic M., Schwappach B., Dobberstein B.;
RT   "Distinct targeting pathways for the membrane insertion of tail-
RT   anchored (TA) proteins.";
RL   J. Cell Sci. 121:1832-1840(2008).
RN   [14]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [15]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [16]
RP   INTERACTION WITH WRB, AND SUBCELLULAR LOCATION.
RX   PubMed=21444755; DOI=10.1242/jcs.084277;
RA   Vilardi F., Lorenz H., Dobberstein B.;
RT   "WRB is the receptor for TRC40/Asna1-mediated insertion of tail-
RT   anchored proteins into the ER membrane.";
RL   J. Cell Sci. 124:1301-1307(2011).
RN   [17]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
CC   -!- FUNCTION: ATPase required for the post-translational delivery of
CC       tail-anchored (TA) proteins to the endoplasmic reticulum.
CC       Recognizes and selectively binds the transmembrane domain of TA
CC       proteins in the cytosol. This complex then targets to the
CC       endoplasmic reticulum by membrane-bound receptors, where the tail-
CC       anchored protein is released for insertion. This process is
CC       regulated by ATP binding and hydrolysis. ATP binding drives the
CC       homodimer towards the closed dimer state, facilitating recognition
CC       of newly synthesized TA membrane proteins. ATP hydrolysis is
CC       required for insertion. Subsequently, the homodimer reverts
CC       towards the open dimer state, lowering its affinity for the
CC       membrane-bound receptor, and returning it to the cytosol to
CC       initiate a new round of targeting (By similarity). May be involved
CC       in insulin signaling. {ECO:0000255|HAMAP-Rule:MF_03112,
CC       ECO:0000269|PubMed:17382883, ECO:0000269|PubMed:18477612}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=0.22 mM for ATP {ECO:0000269|PubMed:9712828};
CC         Vmax=16.6 nmol/min/mg enzyme for ATP
CC         {ECO:0000269|PubMed:9712828};
CC   -!- SUBUNIT: Homodimer (By similarity). Component of a transmembrane
CC       domain recognition complex (TRC) (By similarity). Interacts with
CC       SERP1 and SEC61B (By similarity). Interacts with WRB.
CC       {ECO:0000255|HAMAP-Rule:MF_03112, ECO:0000269|PubMed:17382883,
CC       ECO:0000269|PubMed:18477612, ECO:0000269|PubMed:21444755}.
CC   -!- INTERACTION:
CC       Q12797:ASPH; NbExp=3; IntAct=EBI-2515857, EBI-2967294;
CC       Q12797-6:ASPH; NbExp=4; IntAct=EBI-2515857, EBI-12092171;
CC       Q7L5D6:GET4; NbExp=3; IntAct=EBI-2515857, EBI-711823;
CC       Q96SL4:GPX7; NbExp=5; IntAct=EBI-2515857, EBI-749411;
CC       Q9Y5L2:HILPDA; NbExp=3; IntAct=EBI-2515857, EBI-8803836;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm. Endoplasmic reticulum. Nucleus,
CC       nucleolus.
CC   -!- TISSUE SPECIFICITY: Expressed in the epithelial cells of the
CC       liver, kidney, and stomach wall, in the adrenal medulla, in the
CC       islet cells of the pancreas, in the red pulp of the spleen, and in
CC       cardiac and skeletal muscle. {ECO:0000269|PubMed:9774623}.
CC   -!- SIMILARITY: Belongs to the arsA ATPase family. {ECO:0000255|HAMAP-
CC       Rule:MF_03112}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAC50731.1; Type=Frameshift; Positions=19; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=NIEHS-SNPs;
CC       URL="http://egp.gs.washington.edu/data/asna1/";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF047469; AAC03551.1; -; mRNA.
DR   EMBL; AK291855; BAF84544.1; -; mRNA.
DR   EMBL; AK223363; BAD97083.1; -; mRNA.
DR   EMBL; AY304483; AAP45050.1; -; Genomic_DNA.
DR   EMBL; AC018761; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471106; EAW84303.1; -; Genomic_DNA.
DR   EMBL; BC002651; AAH02651.1; -; mRNA.
DR   EMBL; U60276; AAC50731.1; ALT_FRAME; mRNA.
DR   CCDS; CCDS32920.1; -.
DR   RefSeq; NP_004308.2; NM_004317.3.
DR   UniGene; Hs.465985; -.
DR   ProteinModelPortal; O43681; -.
DR   SMR; O43681; -.
DR   BioGrid; 106931; 48.
DR   IntAct; O43681; 19.
DR   MINT; O43681; -.
DR   STRING; 9606.ENSP00000349887; -.
DR   DrugBank; DB00171; Adenosine triphosphate.
DR   TCDB; 3.A.19.1.1; the tms recognition/insertion complex (trc) family.
DR   CarbonylDB; O43681; -.
DR   iPTMnet; O43681; -.
DR   PhosphoSitePlus; O43681; -.
DR   SwissPalm; O43681; -.
DR   BioMuta; ASNA1; -.
DR   OGP; O43681; -.
DR   EPD; O43681; -.
DR   MaxQB; O43681; -.
DR   PaxDb; O43681; -.
DR   PeptideAtlas; O43681; -.
DR   PRIDE; O43681; -.
DR   DNASU; 439; -.
DR   Ensembl; ENST00000357332; ENSP00000349887; ENSG00000198356.
DR   Ensembl; ENST00000591090; ENSP00000466379; ENSG00000198356.
DR   GeneID; 439; -.
DR   KEGG; hsa:439; -.
DR   UCSC; uc002muv.3; human.
DR   CTD; 439; -.
DR   DisGeNET; 439; -.
DR   EuPathDB; HostDB:ENSG00000198356.11; -.
DR   GeneCards; ASNA1; -.
DR   HGNC; HGNC:752; ASNA1.
DR   HPA; HPA045951; -.
DR   HPA; HPA048087; -.
DR   MIM; 601913; gene.
DR   neXtProt; NX_O43681; -.
DR   OpenTargets; ENSG00000198356; -.
DR   PharmGKB; PA25051; -.
DR   eggNOG; KOG2825; Eukaryota.
DR   eggNOG; COG0003; LUCA.
DR   GeneTree; ENSGT00390000003817; -.
DR   HOGENOM; HOG000197637; -.
DR   InParanoid; O43681; -.
DR   KO; K01551; -.
DR   OMA; DQIADLY; -.
DR   OrthoDB; EOG091G0CAR; -.
DR   PhylomeDB; O43681; -.
DR   BRENDA; 3.6.3.16; 2681.
DR   Reactome; R-HSA-381038; XBP1(S) activates chaperone genes.
DR   SABIO-RK; O43681; -.
DR   ChiTaRS; ASNA1; human.
DR   GeneWiki; ASNA1; -.
DR   GenomeRNAi; 439; -.
DR   PRO; PR:O43681; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   Bgee; ENSG00000198356; -.
DR   CleanEx; HS_ARSA; -.
DR   CleanEx; HS_ASNA1; -.
DR   ExpressionAtlas; O43681; baseline and differential.
DR   Genevisible; O43681; HS.
DR   GO; GO:0005737; C:cytoplasm; TAS:ProtInc.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0005730; C:nucleolus; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:HPA.
DR   GO; GO:0015105; F:arsenite transmembrane transporter activity; TAS:ProtInc.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0016887; F:ATPase activity; IEA:InterPro.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0005215; F:transporter activity; TAS:ProtInc.
DR   GO; GO:0036498; P:IRE1-mediated unfolded protein response; TAS:Reactome.
DR   CDD; cd02035; ArsA; 1.
DR   HAMAP; MF_03112; Asna1_Get3; 1.
DR   InterPro; IPR025723; Anion-transp_ATPase-like_dom.
DR   InterPro; IPR016300; ATPase_ArsA/GET3.
DR   InterPro; IPR027542; ATPase_ArsA/GET3_euk.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   PANTHER; PTHR10803; PTHR10803; 1.
DR   PANTHER; PTHR10803:SF3; PTHR10803:SF3; 1.
DR   Pfam; PF02374; ArsA_ATPase; 1.
DR   SUPFAM; SSF52540; SSF52540; 1.
DR   TIGRFAMs; TIGR00345; GET3_arsA_TRC40; 1.
PE   1: Evidence at protein level;
KW   Acetylation; ATP-binding; Complete proteome; Cytoplasm;
KW   Endoplasmic reticulum; Hydrolase; Metal-binding; Nucleotide-binding;
KW   Nucleus; Polymorphism; Reference proteome; Transport; Zinc.
FT   INIT_MET      1      1       Removed. {ECO:0000244|PubMed:19413330}.
FT   CHAIN         2    348       ATPase ASNA1.
FT                                /FTId=PRO_0000152253.
FT   NP_BIND      45     52       ATP. {ECO:0000255|HAMAP-Rule:MF_03112}.
FT   ACT_SITE     74     74       {ECO:0000255|HAMAP-Rule:MF_03112}.
FT   METAL       289    289       Zinc; shared with dimeric partner.
FT                                {ECO:0000255|HAMAP-Rule:MF_03112}.
FT   METAL       292    292       Zinc; shared with dimeric partner.
FT                                {ECO:0000255|HAMAP-Rule:MF_03112}.
FT   BINDING     251    251       ATP. {ECO:0000255|HAMAP-Rule:MF_03112}.
FT   BINDING     278    278       ATP. {ECO:0000255|HAMAP-Rule:MF_03112}.
FT   MOD_RES       2      2       N-acetylalanine.
FT                                {ECO:0000244|PubMed:19413330}.
FT   VARIANT     332    332       N -> S (in dbSNP:rs8177499).
FT                                {ECO:0000269|Ref.4}.
FT                                /FTId=VAR_018844.
FT   MUTAGEN      46     46       G->R: Abolishes ATPase activity,
FT                                dominantly inhibits the TA protein
FT                                insertion pathway.
FT                                {ECO:0000269|PubMed:17382883}.
FT   CONFLICT    113    114       EL -> DV (in Ref. 8; AAC50731).
FT                                {ECO:0000305}.
FT   CONFLICT    205    205       C -> F (in Ref. 1; AAC03551).
FT                                {ECO:0000305}.
FT   CONFLICT    303    303       L -> P (in Ref. 3; BAD97083).
FT                                {ECO:0000305}.
SQ   SEQUENCE   348 AA;  38793 MW;  DA52C4ACC35C7A36 CRC64;
     MAAGVAGWGV EAEEFEDAPD VEPLEPTLSN IIEQRSLKWI FVGGKGGVGK TTCSCSLAVQ
     LSKGRESVLI ISTDPAHNIS DAFDQKFSKV PTKVKGYDNL FAMEIDPSLG VAELPDEFFE
     EDNMLSMGKK MMQEAMSAFP GIDEAMSYAE VMRLVKGMNF SVVVFDTAPT GHTLRLLNFP
     TIVERGLGRL MQIKNQISPF ISQMCNMLGL GDMNADQLAS KLEETLPVIR SVSEQFKDPE
     QTTFICVCIA EFLSLYETER LIQELAKCKI DTHNIIVNQL VFPDPEKPCK MCEARHKIQA
     KYLDQMEDLY EDFHIVKLPL LPHEVRGADK VNTFSALLLE PYKPPSAQ
//
ID   J3KPS0_HUMAN            Unreviewed;       409 AA.
AC   J3KPS0;
DT   03-OCT-2012, integrated into UniProtKB/TrEMBL.
DT   03-OCT-2012, sequence version 1.
DT   23-MAY-2018, entry version 52.
DE   SubName: Full=DnaJ (Hsp40) homolog, subfamily B, member 12, isoform CRA_c {ECO:0000313|EMBL:EAW54456.1};
DE   SubName: Full=DnaJ homolog subfamily B member 12 {ECO:0000313|Ensembl:ENSP00000378363};
GN   Name=DNAJB12 {ECO:0000313|EMBL:EAW54456.1,
GN   ECO:0000313|Ensembl:ENSP00000378363};
GN   ORFNames=hCG_2024622 {ECO:0000313|EMBL:EAW54456.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000378363, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|EMBL:EAW54456.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|Ensembl:ENSP00000378363, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164054; DOI=10.1038/nature02462;
RA   Deloukas P., Earthrowl M.E., Grafham D.V., Rubenfield M., French L.,
RA   Steward C.A., Sims S.K., Jones M.C., Searle S., Scott C., Howe K.,
RA   Hunt S.E., Andrews T.D., Gilbert J.G.R., Swarbreck D., Ashurst J.L.,
RA   Taylor A., Battles J., Bird C.P., Ainscough R., Almeida J.P.,
RA   Ashwell R.I.S., Ambrose K.D., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Bates K., Beasley H., Bray-Allen S., Brown A.J.,
RA   Brown J.Y., Burford D.C., Burrill W., Burton J., Cahill P., Camire D.,
RA   Carter N.P., Chapman J.C., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Corby N., Coulson A., Dhami P., Dutta I., Dunn M., Faulkner L.,
RA   Frankish A., Frankland J.A., Garner P., Garnett J., Gribble S.,
RA   Griffiths C., Grocock R., Gustafson E., Hammond S., Harley J.L.,
RA   Hart E., Heath P.D., Ho T.P., Hopkins B., Horne J., Howden P.J.,
RA   Huckle E., Hynds C., Johnson C., Johnson D., Kana A., Kay M.,
RA   Kimberley A.M., Kershaw J.K., Kokkinaki M., Laird G.K., Lawlor S.,
RA   Lee H.M., Leongamornlert D.A., Laird G., Lloyd C., Lloyd D.M.,
RA   Loveland J., Lovell J., McLaren S., McLay K.E., McMurray A.,
RA   Mashreghi-Mohammadi M., Matthews L., Milne S., Nickerson T.,
RA   Nguyen M., Overton-Larty E., Palmer S.A., Pearce A.V., Peck A.I.,
RA   Pelan S., Phillimore B., Porter K., Rice C.M., Rogosin A., Ross M.T.,
RA   Sarafidou T., Sehra H.K., Shownkeen R., Skuce C.D., Smith M.,
RA   Standring L., Sycamore N., Tester J., Thorpe A., Torcasso W.,
RA   Tracey A., Tromans A., Tsolas J., Wall M., Walsh J., Wang H.,
RA   Weinstock K., West A.P., Willey D.L., Whitehead S.L., Wilming L.,
RA   Wray P.W., Young L., Chen Y., Lovering R.C., Moschonas N.K.,
RA   Siebert R., Fechtel K., Bentley D., Durbin R., Hubbard T.,
RA   Doucette-Stamm L., Beck S., Smith D.R., Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 10.";
RL   Nature 429:375-381(2004).
RN   [3] {ECO:0000313|EMBL:EAW54456.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4] {ECO:0000213|PubMed:21269460}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Burckstummer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [5] {ECO:0000213|PubMed:22814378}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [6] {ECO:0000313|Ensembl:ENSP00000378363}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (AUG-2012) to UniProtKB.
RN   [7] {ECO:0000213|PubMed:25944712}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AC091769; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471083; EAW54456.1; -; Genomic_DNA.
DR   RefSeq; NP_001002762.2; NM_001002762.2.
DR   RefSeq; NP_060096.3; NM_017626.4.
DR   RefSeq; XP_005269989.1; XM_005269932.3.
DR   UniGene; Hs.500013; -.
DR   MaxQB; J3KPS0; -.
DR   PeptideAtlas; J3KPS0; -.
DR   PRIDE; J3KPS0; -.
DR   Ensembl; ENST00000338820; ENSP00000345575; ENSG00000148719.
DR   Ensembl; ENST00000394903; ENSP00000378363; ENSG00000148719.
DR   GeneID; 54788; -.
DR   KEGG; hsa:54788; -.
DR   UCSC; uc001jsz.2; human.
DR   CTD; 54788; -.
DR   EuPathDB; HostDB:ENSG00000148719.14; -.
DR   HGNC; HGNC:14891; DNAJB12.
DR   OpenTargets; ENSG00000148719; -.
DR   eggNOG; KOG0714; Eukaryota.
DR   eggNOG; COG0484; LUCA.
DR   GeneTree; ENSGT00840000129767; -.
DR   KO; K09518; -.
DR   OMA; PSHKYSV; -.
DR   OrthoDB; EOG091G0CE9; -.
DR   TreeFam; TF105145; -.
DR   ChiTaRS; DNAJB12; human.
DR   GenomeRNAi; 54788; -.
DR   Proteomes; UP000005640; Chromosome 10.
DR   Bgee; ENSG00000148719; -.
DR   ExpressionAtlas; J3KPS0; baseline and differential.
DR   CDD; cd06257; DnaJ; 1.
DR   Gene3D; 1.10.287.110; -; 1.
DR   InterPro; IPR001623; DnaJ_domain.
DR   InterPro; IPR018253; DnaJ_domain_CS.
DR   InterPro; IPR015399; DUF1977_DnaJ-like.
DR   InterPro; IPR036869; J_dom_sf.
DR   Pfam; PF00226; DnaJ; 1.
DR   Pfam; PF09320; DUF1977; 1.
DR   PRINTS; PR00625; JDOMAIN.
DR   SMART; SM00271; DnaJ; 1.
DR   SUPFAM; SSF46565; SSF46565; 1.
DR   PROSITE; PS00636; DNAJ_1; 1.
DR   PROSITE; PS50076; DNAJ_2; 1.
PE   1: Evidence at protein level;
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   Proteomics identification {ECO:0000213|EPD:J3KPS0,
KW   ECO:0000213|MaxQB:J3KPS0, ECO:0000213|PeptideAtlas:J3KPS0};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640}.
FT   DOMAIN      144    208       J. {ECO:0000259|PROSITE:PS50076}.
SQ   SEQUENCE   409 AA;  45490 MW;  AE96AF740DE0C654 CRC64;
     MSSLRARLPA TRRRVAQPFA RPASPSLVPR SGSAMESNKD EAERCISIAL KAIQSNQPDR
     ALRFLEKAQR LYPTPRVRAL IESLNQKPQT AGDQPPPTDT THATHRKAGG TDAPSANGEA
     GGESTKGYTA EQVAAVKRVK QCKDYYEILG VSRGASDEDL KKAYRRLALK FHPDKNHAPG
     ATEAFKAIGT AYAVLSNPEK RKQYDQFGDD KSQAARHGHG HGDFHRGFEA DISPEDLFNM
     FFGGGFPSSN VHVYSNGRMR YTYQQRQDRR DNQGDGGLGV FVQLMPILIL ILVSALSQLM
     VSSPPYSLSP RPSVGHIHRR VTDHLGVVYY VGDTFSEEYT GSSLKTVERN VEDDYIANLR
     NNCWKEKQQK EGLLYRARYF GDTDMYHRAQ KMGTPSCSRL SEVQASLHG
//
ID   DJB12_HUMAN             Reviewed;         375 AA.
AC   Q9NXW2; B7Z7I3; Q9H6H0;
DT   18-OCT-2001, integrated into UniProtKB/Swiss-Prot.
DT   20-APR-2010, sequence version 4.
DT   25-APR-2018, entry version 154.
DE   RecName: Full=DnaJ homolog subfamily B member 12 {ECO:0000312|HGNC:HGNC:14891};
GN   Name=DNAJB12 {ECO:0000312|HGNC:HGNC:14891};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Adipose tissue, Kidney epithelium, and Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164054; DOI=10.1038/nature02462;
RA   Deloukas P., Earthrowl M.E., Grafham D.V., Rubenfield M., French L.,
RA   Steward C.A., Sims S.K., Jones M.C., Searle S., Scott C., Howe K.,
RA   Hunt S.E., Andrews T.D., Gilbert J.G.R., Swarbreck D., Ashurst J.L.,
RA   Taylor A., Battles J., Bird C.P., Ainscough R., Almeida J.P.,
RA   Ashwell R.I.S., Ambrose K.D., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Bates K., Beasley H., Bray-Allen S., Brown A.J.,
RA   Brown J.Y., Burford D.C., Burrill W., Burton J., Cahill P., Camire D.,
RA   Carter N.P., Chapman J.C., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Corby N., Coulson A., Dhami P., Dutta I., Dunn M., Faulkner L.,
RA   Frankish A., Frankland J.A., Garner P., Garnett J., Gribble S.,
RA   Griffiths C., Grocock R., Gustafson E., Hammond S., Harley J.L.,
RA   Hart E., Heath P.D., Ho T.P., Hopkins B., Horne J., Howden P.J.,
RA   Huckle E., Hynds C., Johnson C., Johnson D., Kana A., Kay M.,
RA   Kimberley A.M., Kershaw J.K., Kokkinaki M., Laird G.K., Lawlor S.,
RA   Lee H.M., Leongamornlert D.A., Laird G., Lloyd C., Lloyd D.M.,
RA   Loveland J., Lovell J., McLaren S., McLay K.E., McMurray A.,
RA   Mashreghi-Mohammadi M., Matthews L., Milne S., Nickerson T.,
RA   Nguyen M., Overton-Larty E., Palmer S.A., Pearce A.V., Peck A.I.,
RA   Pelan S., Phillimore B., Porter K., Rice C.M., Rogosin A., Ross M.T.,
RA   Sarafidou T., Sehra H.K., Shownkeen R., Skuce C.D., Smith M.,
RA   Standring L., Sycamore N., Tester J., Thorpe A., Torcasso W.,
RA   Tracey A., Tromans A., Tsolas J., Wall M., Walsh J., Wang H.,
RA   Weinstock K., West A.P., Willey D.L., Whitehead S.L., Wilming L.,
RA   Wray P.W., Young L., Chen Y., Lovering R.C., Moschonas N.K.,
RA   Siebert R., Fechtel K., Bentley D., Durbin R.M., Hubbard T.,
RA   Doucette-Stamm L., Beck S., Smith D.R., Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 10.";
RL   Nature 429:375-381(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Colon, and Pancreas;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   FUNCTION, SUBCELLULAR LOCATION, TOPOLOGY, INTERACTION WITH HSPA8, AND
RP   MUTAGENESIS OF HIS-138.
RX   PubMed=21150129; DOI=10.1247/csf.10023;
RA   Yamamoto Y.H., Kimura T., Momohara S., Takeuchi M., Tani T.,
RA   Kimata Y., Kadokura H., Kohno K.;
RT   "A novel ER J-protein DNAJB12 accelerates ER-associated degradation of
RT   membrane proteins including CFTR.";
RL   Cell Struct. Funct. 35:107-116(2010).
RN   [5]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [6]
RP   FUNCTION (MICROBIAL INFECTION).
RX   PubMed=21673190; DOI=10.1128/mBio.00101-11;
RA   Goodwin E.C., Lipovsky A., Inoue T., Magaldi T.G., Edwards A.P.,
RA   Van Goor K.E., Paton A.W., Paton J.C., Atwood W.J., Tsai B.,
RA   DiMaio D.;
RT   "BiP and multiple DNAJ molecular chaperones in the endoplasmic
RT   reticulum are required for efficient simian virus 40 infection.";
RL   MBio 2:E00101-E00111(2011).
RN   [7]
RP   FUNCTION, SUBCELLULAR LOCATION, TOPOLOGY, INTERACTION WITH HSPA8, AND
RP   MUTAGENESIS OF HIS-138.
RX   PubMed=21148293; DOI=10.1091/mbc.E10-09-0760;
RA   Grove D.E., Fan C.Y., Ren H.Y., Cyr D.M.;
RT   "The endoplasmic reticulum-associated Hsp40 DNAJB12 and Hsc70
RT   cooperate to facilitate RMA1 E3-dependent degradation of nascent
RT   CFTRDeltaF508.";
RL   Mol. Biol. Cell 22:301-314(2011).
RN   [8]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [9]
RP   FUNCTION, SUBCELLULAR LOCATION, INTERACTION WITH HSPA8, AND
RP   MUTAGENESIS OF HIS-138.
RX   PubMed=24732912; DOI=10.1371/journal.pone.0094322;
RA   Goodwin E.C., Motamedi N., Lipovsky A., Fernandez-Busnadiego R.,
RA   DiMaio D.;
RT   "Expression of DNAJB12 or DNAJB14 causes coordinate invasion of the
RT   nucleus by membranes associated with a novel nuclear pore structure.";
RL   PLoS ONE 9:E94322-E94322(2014).
RN   [10]
RP   FUNCTION (MICROBIAL INFECTION), AND IDENTIFICATION IN A COMPLEX WITH
RP   DNAJB14.
RX   PubMed=24675744; DOI=10.1371/journal.ppat.1004007;
RA   Walczak C.P., Ravindran M.S., Inoue T., Tsai B.;
RT   "A cytosolic chaperone complexes with dynamic membrane J-proteins and
RT   mobilizes a nonenveloped virus out of the endoplasmic reticulum.";
RL   PLoS Pathog. 10:E1004007-E1004007(2014).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [12]
RP   FUNCTION, SUBUNIT, SUBCELLULAR LOCATION, AND MUTAGENESIS OF
RP   184-GLY--PHE-212.
RX   PubMed=27916661; DOI=10.1016/j.molcel.2016.10.027;
RA   Li K., Jiang Q., Bai X., Yang Y.F., Ruan M.Y., Cai S.Q.;
RT   "Tetrameric assembly of K(+) channels requires ER-located chaperone
RT   proteins.";
RL   Mol. Cell 65:52-65(2017).
RN   [13]
RP   STRUCTURE BY NMR OF 110-174.
RG   RIKEN structural genomics initiative (RSGI);
RT   "Solution structure of J-domain from human DnaJ subfamily B member
RT   12.";
RL   Submitted (NOV-2005) to the PDB data bank.
CC   -!- FUNCTION: Acts as a co-chaperone with HSPA8/Hsc70; required to
CC       promote protein folding and trafficking, prevent aggregation of
CC       client proteins, and promote unfolded proteins to endoplasmic
CC       reticulum-associated degradation (ERAD) pathway (PubMed:21150129,
CC       PubMed:21148293). Acts by determining HSPA8/Hsc70's ATPase and
CC       polypeptide-binding activities. Can also act independently of
CC       HSPA8/Hsc70: together with DNAJB14, acts as a chaperone that
CC       promotes maturation of potassium channels KCND2 and KCNH2 by
CC       stabilizing nascent channel subunits and assembling them into
CC       tetramers (PubMed:27916661). While stabilization of nascent
CC       channel proteins is dependent on HSPA8/Hsc70, the process of
CC       oligomerization of channel subunits is independent of HSPA8/Hsc70
CC       (PubMed:27916661). When overexpressed, forms membranous structures
CC       together with DNAJB14 and HSPA8/Hsc70 within the nucleus; the role
CC       of these structures, named DJANGOs, is still unclear
CC       (PubMed:24732912). {ECO:0000269|PubMed:21148293,
CC       ECO:0000269|PubMed:21150129, ECO:0000269|PubMed:24732912,
CC       ECO:0000269|PubMed:27916661}.
CC   -!- FUNCTION: (Microbial infection) In case of infection by
CC       polyomavirus, involved in the virus endoplasmic reticulum membrane
CC       penetration and infection (PubMed:21673190, PubMed:24675744).
CC       {ECO:0000269|PubMed:21673190, ECO:0000269|PubMed:24675744}.
CC   -!- SUBUNIT: Homodimer and homotetramer (PubMed:27916661). Interacts
CC       (via J domain) with HSPA8/Hsc70 (PubMed:21150129, PubMed:21148293,
CC       PubMed:24732912, PubMed:27916661). Forms a multiprotein complex,
CC       at least composed of DNAJB12, DNAJB14, HSPA8/Hsc70 and SGTA;
CC       interaction with DNAJB14 and HSPA8/Hsc70 is direct
CC       (PubMed:24675744). {ECO:0000269|PubMed:21148293,
CC       ECO:0000269|PubMed:21150129, ECO:0000269|PubMed:24675744,
CC       ECO:0000269|PubMed:24732912, ECO:0000269|PubMed:27916661}.
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane
CC       {ECO:0000269|PubMed:21148293, ECO:0000269|PubMed:21150129,
CC       ECO:0000269|PubMed:24732912, ECO:0000269|PubMed:27916661}; Single-
CC       pass membrane protein {ECO:0000255}. Nucleus membrane
CC       {ECO:0000269|PubMed:24732912}; Single-pass membrane protein
CC       {ECO:0000305}. Note=Localizes to the endoplasmic reticulum
CC       membrane (PubMed:21150129, PubMed:21148293, PubMed:24732912,
CC       PubMed:27916661). When overexpressed, forms membranous structures
CC       in the nucleus (PubMed:24732912). {ECO:0000269|PubMed:21148293,
CC       ECO:0000269|PubMed:21150129, ECO:0000269|PubMed:24732912,
CC       ECO:0000269|PubMed:27916661}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9NXW2-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9NXW2-2; Sequence=VSP_039040;
CC   -!- SIMILARITY: Belongs to the DnaJ family. DNAJB12/DNAJB14 subfamily.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAB15289.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=BAH13619.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK000034; BAA90896.1; -; mRNA.
DR   EMBL; AK025942; BAB15289.1; ALT_INIT; mRNA.
DR   EMBL; AK302071; BAH13619.1; ALT_INIT; mRNA.
DR   EMBL; AC091769; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC011812; AAH11812.2; -; mRNA.
DR   EMBL; BC064920; AAH64920.1; -; mRNA.
DR   RefSeq; NP_001002762.2; NM_001002762.2.
DR   RefSeq; NP_060096.3; NM_017626.4.
DR   UniGene; Hs.500013; -.
DR   PDB; 2CTP; NMR; -; A=110-174.
DR   PDBsum; 2CTP; -.
DR   ProteinModelPortal; Q9NXW2; -.
DR   SMR; Q9NXW2; -.
DR   BioGrid; 120150; 12.
DR   IntAct; Q9NXW2; 15.
DR   MINT; Q9NXW2; -.
DR   STRING; 9606.ENSP00000345575; -.
DR   TCDB; 1.P.1.1.1; the polyoma virus sv40 er penitration channel (vpec) family.
DR   iPTMnet; Q9NXW2; -.
DR   PhosphoSitePlus; Q9NXW2; -.
DR   BioMuta; DNAJB12; -.
DR   DMDM; 294862531; -.
DR   EPD; Q9NXW2; -.
DR   MaxQB; Q9NXW2; -.
DR   PaxDb; Q9NXW2; -.
DR   PeptideAtlas; Q9NXW2; -.
DR   PRIDE; Q9NXW2; -.
DR   DNASU; 54788; -.
DR   Ensembl; ENST00000444643; ENSP00000403313; ENSG00000148719.
DR   GeneID; 54788; -.
DR   KEGG; hsa:54788; -.
DR   UCSC; uc057tyc.1; human. [Q9NXW2-1]
DR   CTD; 54788; -.
DR   DisGeNET; 54788; -.
DR   EuPathDB; HostDB:ENSG00000148719.14; -.
DR   GeneCards; DNAJB12; -.
DR   H-InvDB; HIX0127298; -.
DR   HGNC; HGNC:14891; DNAJB12.
DR   HPA; HPA010642; -.
DR   MIM; 608376; gene.
DR   neXtProt; NX_Q9NXW2; -.
DR   PharmGKB; PA27414; -.
DR   eggNOG; KOG0714; Eukaryota.
DR   eggNOG; COG0484; LUCA.
DR   HOGENOM; HOG000233608; -.
DR   HOVERGEN; HBG051373; -.
DR   InParanoid; Q9NXW2; -.
DR   KO; K09518; -.
DR   PhylomeDB; Q9NXW2; -.
DR   ChiTaRS; DNAJB12; human.
DR   EvolutionaryTrace; Q9NXW2; -.
DR   GenomeRNAi; 54788; -.
DR   PRO; PR:Q9NXW2; -.
DR   Proteomes; UP000005640; Chromosome 10.
DR   Bgee; ENSG00000148719; -.
DR   CleanEx; HS_DNAJB12; -.
DR   ExpressionAtlas; Q9NXW2; baseline and differential.
DR   Genevisible; Q9NXW2; HS.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:UniProtKB.
DR   GO; GO:0030176; C:integral component of endoplasmic reticulum membrane; IDA:UniProtKB.
DR   GO; GO:0016020; C:membrane; HDA:UniProtKB.
DR   GO; GO:0031965; C:nuclear membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0030544; F:Hsp70 protein binding; IPI:UniProtKB.
DR   GO; GO:0034622; P:cellular protein-containing complex assembly; IDA:UniProtKB.
DR   GO; GO:0071218; P:cellular response to misfolded protein; IDA:UniProtKB.
DR   GO; GO:0051085; P:chaperone cofactor-dependent protein refolding; IDA:UniProtKB.
DR   GO; GO:0036503; P:ERAD pathway; IDA:UniProtKB.
DR   CDD; cd06257; DnaJ; 1.
DR   Gene3D; 1.10.287.110; -; 1.
DR   InterPro; IPR001623; DnaJ_domain.
DR   InterPro; IPR018253; DnaJ_domain_CS.
DR   InterPro; IPR015399; DUF1977_DnaJ-like.
DR   InterPro; IPR036869; J_dom_sf.
DR   Pfam; PF00226; DnaJ; 1.
DR   Pfam; PF09320; DUF1977; 1.
DR   PRINTS; PR00625; JDOMAIN.
DR   SMART; SM00271; DnaJ; 1.
DR   SUPFAM; SSF46565; SSF46565; 1.
DR   PROSITE; PS00636; DNAJ_1; 1.
DR   PROSITE; PS50076; DNAJ_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Chaperone;
KW   Complete proteome; Endoplasmic reticulum; Membrane; Nucleus;
KW   Polymorphism; Reference proteome; Transmembrane; Transmembrane helix.
FT   CHAIN         1    375       DnaJ homolog subfamily B member 12.
FT                                /FTId=PRO_0000071037.
FT   TOPO_DOM      1    243       Cytoplasmic.
FT                                {ECO:0000305|PubMed:21148293,
FT                                ECO:0000305|PubMed:21150129}.
FT   TRANSMEM    244    264       Helical. {ECO:0000255}.
FT   TOPO_DOM    265    375       Lumenal. {ECO:0000305|PubMed:21148293,
FT                                ECO:0000305|PubMed:21150129}.
FT   DOMAIN      112    176       J. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00286}.
FT   MOD_RES       1      1       N-acetylmethionine.
FT                                {ECO:0000244|PubMed:22814378}.
FT   VAR_SEQ     369    375       VQASLHG -> TMKSLENFW (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_039040.
FT   VARIANT     304    304       E -> K (in dbSNP:rs3750784).
FT                                /FTId=VAR_017864.
FT   MUTAGEN     138    138       H->Q: Abolishes interaction with
FT                                HSPA8/Hsc70.
FT                                {ECO:0000269|PubMed:21148293,
FT                                ECO:0000269|PubMed:21150129,
FT                                ECO:0000269|PubMed:24732912}.
FT   MUTAGEN     184    212       Missing: In delta(G/F); impaired ability
FT                                to form tetramers and impaired ability to
FT                                promote potassium channel assembly into
FT                                tetramers. {ECO:0000269|PubMed:27916661}.
FT   CONFLICT     70     70       T -> S (in Ref. 1; BAA90896).
FT                                {ECO:0000305}.
FT   CONFLICT    212    212       F -> S (in Ref. 1; BAA90896).
FT                                {ECO:0000305}.
FT   CONFLICT    215    215       S -> G (in Ref. 1; BAH13619).
FT                                {ECO:0000305}.
FT   CONFLICT    336    336       S -> K (in Ref. 1; BAA90896/BAB15289/
FT                                BAH13619 and 2; AAH11812/AAH64920).
FT                                {ECO:0000305}.
FT   HELIX       111    115       {ECO:0000244|PDB:2CTP}.
FT   HELIX       123    134       {ECO:0000244|PDB:2CTP}.
FT   TURN        139    141       {ECO:0000244|PDB:2CTP}.
FT   HELIX       145    161       {ECO:0000244|PDB:2CTP}.
FT   HELIX       164    172       {ECO:0000244|PDB:2CTP}.
SQ   SEQUENCE   375 AA;  41819 MW;  27893FF3E22EF778 CRC64;
     MESNKDEAER CISIALKAIQ SNQPDRALRF LEKAQRLYPT PRVRALIESL NQKPQTAGDQ
     PPPTDTTHAT HRKAGGTDAP SANGEAGGES TKGYTAEQVA AVKRVKQCKD YYEILGVSRG
     ASDEDLKKAY RRLALKFHPD KNHAPGATEA FKAIGTAYAV LSNPEKRKQY DQFGDDKSQA
     ARHGHGHGDF HRGFEADISP EDLFNMFFGG GFPSSNVHVY SNGRMRYTYQ QRQDRRDNQG
     DGGLGVFVQL MPILILILVS ALSQLMVSSP PYSLSPRPSV GHIHRRVTDH LGVVYYVGDT
     FSEEYTGSSL KTVERNVEDD YIANLRNNCW KEKQQSEGLL YRARYFGDTD MYHRAQKMGT
     PSCSRLSEVQ ASLHG
//
ID   A0A140VKE7_HUMAN        Unreviewed;       839 AA.
AC   A0A140VKE7;
DT   08-JUN-2016, integrated into UniProtKB/TrEMBL.
DT   08-JUN-2016, sequence version 1.
DT   23-MAY-2018, entry version 12.
DE   SubName: Full=Testis tissue sperm-binding protein Li 64n {ECO:0000313|EMBL:AEE61284.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:AEE61284.1};
RN   [1] {ECO:0000313|EMBL:AEE61284.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Li J.Y.;
RT   "Human testis protein.";
RL   Submitted (MAR-2010) to the EMBL/GenBank/DDBJ databases.
CC   -!- SIMILARITY: Belongs to the heat shock protein 70 family.
CC       {ECO:0000256|RuleBase:RU003322}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; HM005687; AEE61284.1; -; mRNA.
DR   RefSeq; NP_055093.2; NM_014278.3.
DR   UniGene; Hs.135554; -.
DR   ProteinModelPortal; A0A140VKE7; -.
DR   SMR; A0A140VKE7; -.
DR   PRIDE; A0A140VKE7; -.
DR   GeneID; 22824; -.
DR   KEGG; hsa:22824; -.
DR   CTD; 22824; -.
DR   KO; K09485; -.
DR   OMA; LGFLNCY; -.
DR   PhylomeDB; A0A140VKE7; -.
DR   ExpressionAtlas; A0A140VKE7; baseline and differential.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   Gene3D; 1.20.1270.10; -; 1.
DR   Gene3D; 2.60.34.10; -; 1.
DR   InterPro; IPR018181; Heat_shock_70_CS.
DR   InterPro; IPR029048; HSP70_C_sf.
DR   InterPro; IPR029047; HSP70_peptide-bd_sf.
DR   InterPro; IPR013126; Hsp_70_fam.
DR   PANTHER; PTHR19375; PTHR19375; 1.
DR   Pfam; PF00012; HSP70; 2.
DR   PRINTS; PR00301; HEATSHOCK70.
DR   SUPFAM; SSF100920; SSF100920; 2.
DR   SUPFAM; SSF100934; SSF100934; 2.
DR   PROSITE; PS01036; HSP70_3; 1.
PE   2: Evidence at transcript level;
KW   ATP-binding {ECO:0000256|RuleBase:RU003322};
KW   Coiled coil {ECO:0000256|SAM:Coils};
KW   Nucleotide-binding {ECO:0000256|RuleBase:RU003322}.
FT   COILED      606    630       {ECO:0000256|SAM:Coils}.
SQ   SEQUENCE   839 AA;  94512 MW;  549933AECFF4369A CRC64;
     MSVVGIDLGF LNCYIAVARS GGIETIANEY SDRCTPACIS LGSRTRAIGN AAKSQIVTNV
     RNTIHGFKKL HGRSFDDPIV QTERIRLPYE LQKMPNGSAG VKVRYLEEER PFAIEQVTGM
     LLAKLKETSE NALKKPVADC VISIPSFFTD AERRSVMAAA QVAGLNCLRL MNETTAVALA
     YGIYKQDLPP LDEKPRNVVF IDMGHSAYQV LVCAFNKGKL KVLATTFDPY LGGRNFDEAL
     VDYFCDEFKT KYKINVKENS RALLRLYQEC EKLKKLMSAN ASDLPLNIEC FMNDLDVSSK
     MNRAQFEQLC ASLLARVEPP LKAVMEQANL QREDISSIEI VGGATRIPAV KEQITKFFLK
     DISTTLNADE AVARGCALQC AILSPAFKVR EFSITDLVPY SITLRWKTSF EDGSGECEVF
     CKNHPAPFSK VITFHKKEPF ELEAFYTNLH EVPYPDARIG SFTIQNVFPQ SDGDSSKVKV
     KVRVNIHGIF SVASASVIEK QNLEGDHSDA PMETETSFKN ENKDNMDKMQ VDQEEGHQKC
     HAEHTPEEEI DHTGAKTKSA VSDKQDRLNQ TLKKGKVKSI DLPIQSSLCR QLGQDLLNSY
     IENEGKMIMQ DKLEKERNDA KNAVEEYVYD FRDRLGTVYE KFITPEDLSK LSAVLEDTEN
     WLYEDGEDQP KQVYVDKLQE LKKYGQPIQM KYMEHEERPK ALNDLGKKIQ LVMKVIEAYR
     NKDERYDHLD PTEMEKVEKC ISDAMSWLNS KMNAQNKLSL TQDPVVKVSE IVAKSKELDN
     FCNPIIYKPK PKAEVPEDKP KANSEHNGPM DGQSGTETKS DSTKDSSQHT KSSGEMEVD
//
ID   B4DXT2_HUMAN            Unreviewed;       813 AA.
AC   B4DXT2;
DT   23-SEP-2008, integrated into UniProtKB/TrEMBL.
DT   23-SEP-2008, sequence version 1.
DT   28-FEB-2018, entry version 46.
DE   SubName: Full=cDNA FLJ59635, highly similar to Heat shock 70 kDa protein 4L {ECO:0000313|EMBL:BAG63494.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAG63494.1};
RN   [1] {ECO:0000313|EMBL:BAG63494.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Testis {ECO:0000313|EMBL:BAG63494.1};
RA   Wakamatsu A., Yamamoto J., Kimura K., Ishii S., Watanabe K.,
RA   Sugiyama A., Murakawa K., Kaida T., Tsuchiya K., Fukuzumi Y.,
RA   Kumagai A., Oishi Y., Yamamoto S., Ono Y., Komori Y., Yamazaki M.,
RA   Kisu Y., Nishikawa T., Sugano S., Nomura N., Isogai T.;
RT   "NEDO human cDNA sequencing project focused on splicing variants.";
RL   Submitted (OCT-2007) to the EMBL/GenBank/DDBJ databases.
CC   -!- SIMILARITY: Belongs to the heat shock protein 70 family.
CC       {ECO:0000256|RuleBase:RU003322}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK302115; BAG63494.1; -; mRNA.
DR   RefSeq; NP_001304311.1; NM_001317382.1.
DR   UniGene; Hs.135554; -.
DR   ProteinModelPortal; B4DXT2; -.
DR   PeptideAtlas; B4DXT2; -.
DR   PRIDE; B4DXT2; -.
DR   GeneID; 22824; -.
DR   CTD; 22824; -.
DR   eggNOG; KOG0103; Eukaryota.
DR   eggNOG; COG0443; LUCA.
DR   HOGENOM; HOG000228138; -.
DR   HOVERGEN; HBG047955; -.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   Gene3D; 1.20.1270.10; -; 1.
DR   Gene3D; 2.60.34.10; -; 1.
DR   InterPro; IPR018181; Heat_shock_70_CS.
DR   InterPro; IPR029048; HSP70_C_sf.
DR   InterPro; IPR029047; HSP70_peptide-bd_sf.
DR   InterPro; IPR013126; Hsp_70_fam.
DR   PANTHER; PTHR19375; PTHR19375; 1.
DR   Pfam; PF00012; HSP70; 2.
DR   PRINTS; PR00301; HEATSHOCK70.
DR   SUPFAM; SSF100920; SSF100920; 2.
DR   SUPFAM; SSF100934; SSF100934; 2.
DR   PROSITE; PS00329; HSP70_2; 1.
DR   PROSITE; PS01036; HSP70_3; 1.
PE   2: Evidence at transcript level;
KW   ATP-binding {ECO:0000256|RuleBase:RU003322};
KW   Coiled coil {ECO:0000256|SAM:Coils};
KW   Nucleotide-binding {ECO:0000256|RuleBase:RU003322};
KW   Stress response {ECO:0000313|EMBL:BAG63494.1}.
FT   COILED      580    604       {ECO:0000256|SAM:Coils}.
SQ   SEQUENCE   813 AA;  91940 MW;  1090F9C3E716EF03 CRC64;
     MKPILLFMER ACISLGSRTR AIGNAAKSQI VTNVRNTIHG FKKLHGRSFD DPIVQTERIR
     LPYELQKMPN GSAGVKVRYL EEERPFAIEQ VTGMLLAKLK ETSENALKKP VADCVISIPS
     FFTDAERRSV MAAAQVAGLN CLRLMNEITA VALAYGIYKQ DLPPLDEKPR NVVFIDMGHS
     AYQVSVCAFN KGKLKVLATT FDPYLGGRNF DEALVDYFCD EFKTKYKINV KENSRALLRL
     YQECEKLKKL MSANASDLPL NIECFMNDLD VSSKMNRAQF EQLCASLLAR VEPPLKAVME
     QANLQREDIS SIEIVGGATR IPAVKEQITK FFLKDISTTL NADEAVARGC ALQCAILSPA
     FKVREFSITD LVPYSITLRW KTSFEDGSGE CEVFCKNHPA PFSKVITFHK KEPFELEAFY
     TNLHEVPYPD ARIGSFTIQN VFPQSDGDSS KVKVKVRVNI HGIFSVASAS VIEKQNLEGD
     HSDAPMETET SFKNENKDNM DKMQVDQEEG HQKCHAEHTP EEEIDHTGAK TKSAVSDKQD
     RLNQTLKKGK VKSIDLPIQS SLCRQLGQDL LNSYIENEGK MIMQDKLEKE RNDAKNAVEE
     YVYDFRDRLG TVYEKFITPE DLSKLSAVLE DTENWLYEDG EDQPKQVYVD KLQELKKYGQ
     PIQMKYMEHE ERPKALNDLG KKIQLVMKVI EAYRNKDERY DHLDPTEMEK VEKCISDAMS
     WLNSKMNAQN KLSLTQDPVV KVSEIVAKSK ELDNFCNPII YKPKPKAEVP EDKPKANSEH
     NGPMDGQSGT ETKSDSTKDS SQHTKSSGEM EVD
//
ID   B4DZR0_HUMAN            Unreviewed;       868 AA.
AC   B4DZR0;
DT   23-SEP-2008, integrated into UniProtKB/TrEMBL.
DT   23-SEP-2008, sequence version 1.
DT   28-FEB-2018, entry version 47.
DE   SubName: Full=cDNA FLJ55529, highly similar to Heat shock 70 kDa protein 4L {ECO:0000313|EMBL:BAG64172.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAG64172.1};
RN   [1] {ECO:0000313|EMBL:BAG64172.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Testis {ECO:0000313|EMBL:BAG64172.1};
RA   Wakamatsu A., Yamamoto J., Kimura K., Ishii S., Watanabe K.,
RA   Sugiyama A., Murakawa K., Kaida T., Tsuchiya K., Fukuzumi Y.,
RA   Kumagai A., Oishi Y., Yamamoto S., Ono Y., Komori Y., Yamazaki M.,
RA   Kisu Y., Nishikawa T., Sugano S., Nomura N., Isogai T.;
RT   "NEDO human cDNA sequencing project focused on splicing variants.";
RL   Submitted (OCT-2007) to the EMBL/GenBank/DDBJ databases.
CC   -!- SIMILARITY: Belongs to the heat shock protein 70 family.
CC       {ECO:0000256|RuleBase:RU003322}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK303053; BAG64172.1; -; mRNA.
DR   RefSeq; NP_001304310.1; NM_001317381.1.
DR   UniGene; Hs.135554; -.
DR   ProteinModelPortal; B4DZR0; -.
DR   PeptideAtlas; B4DZR0; -.
DR   PRIDE; B4DZR0; -.
DR   GeneID; 22824; -.
DR   CTD; 22824; -.
DR   eggNOG; KOG0103; Eukaryota.
DR   eggNOG; COG0443; LUCA.
DR   HOGENOM; HOG000228138; -.
DR   HOVERGEN; HBG047955; -.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   Gene3D; 1.20.1270.10; -; 1.
DR   Gene3D; 2.60.34.10; -; 1.
DR   InterPro; IPR018181; Heat_shock_70_CS.
DR   InterPro; IPR029048; HSP70_C_sf.
DR   InterPro; IPR029047; HSP70_peptide-bd_sf.
DR   InterPro; IPR013126; Hsp_70_fam.
DR   PANTHER; PTHR19375; PTHR19375; 1.
DR   Pfam; PF00012; HSP70; 2.
DR   PRINTS; PR00301; HEATSHOCK70.
DR   SUPFAM; SSF100920; SSF100920; 2.
DR   SUPFAM; SSF100934; SSF100934; 2.
DR   PROSITE; PS00329; HSP70_2; 1.
DR   PROSITE; PS01036; HSP70_3; 1.
PE   2: Evidence at transcript level;
KW   ATP-binding {ECO:0000256|RuleBase:RU003322};
KW   Coiled coil {ECO:0000256|SAM:Coils};
KW   Nucleotide-binding {ECO:0000256|RuleBase:RU003322};
KW   Stress response {ECO:0000313|EMBL:BAG64172.1}.
FT   COILED      635    659       {ECO:0000256|SAM:Coils}.
SQ   SEQUENCE   868 AA;  97562 MW;  28B45335AEB9D4BD CRC64;
     MSRNPSSNSP EEDTVPVPKG SVPAARPSRG GMSVVGIDLG FLNCYIAVAR SGGIETIANE
     YSDRCTPACI SLGSRTRAIG NAAKSQIVTN VRNTIHGFKK LHGRSFDDPI VQTERIRLPY
     ELQKMPNGSA GVKVRYLEEE RPFAIEQVTG MLLAKLKETS ENALKKPVAD CVISIPSFFT
     DAERRSVMAA ALVAGLNCLR LMNETTAVAL AYGIYKQDLP PLDEKPRNVV FIDMGHSAYQ
     VSVCAFNKGK LKVLATTFDP YLGGRNFDEA LVDYFCDEFK TKYKINVKEN SRALLRLYQE
     CEKLKKLMSA NASDLPLNIE CFMNDLDVSS KMNRAQFEQL CASLLARVEP PLKAVMEQAN
     LQREDISSIE IVGGATRIPA VKEQITKFFL KDISTTLNAD EAVARGCALQ CAILSPAFKV
     REFSITDLVP YSITLRWKTS FEDGSGECEV FCKNHPAPFS KVITFHKKEP FELEAFYTNL
     HEVPYPDARI RSFTIQNVFP QSDGDSSKVR VKVRVNIHGI FSVASASVIE KQNLEGDHSD
     APMETETSFK NENKDNMDKM QVDQEEGHQK CHAEHTPEEE IDHTGAKTKS AVSDKQDRLN
     QTLKKVKSID LPIQSSLCRQ LGQDLLNSYI EDEGKMIMQD KLEKERNDAK NAVEEYVYDF
     RDRLGTVYEK FITPEDLSKL SAVLEDTENW LYEDGEDQPK QVYVDKLQEL KKYGQPIQMK
     YMEHEERPKA LNDLGKKIQL VMKVIEAYRN KDERYDHLDP TEMEKVEKCI SDAMSWLNSK
     MNAQNKLSLT QDPVVEVSEI VAKSKELDNF CNPIIYKPKP KAEVPEDKPK ANSEHNGPMD
     GQSGTETKSD STKDSSQHTK SSGEMEVD
//
ID   E9PDE8_HUMAN            Unreviewed;       813 AA.
AC   E9PDE8;
DT   05-APR-2011, integrated into UniProtKB/TrEMBL.
DT   05-APR-2011, sequence version 1.
DT   28-MAR-2018, entry version 55.
DE   SubName: Full=Heat shock 70 kDa protein 4L {ECO:0000313|Ensembl:ENSP00000425645};
GN   Name=HSPA4L {ECO:0000313|Ensembl:ENSP00000425645};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000425645, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Ensembl:ENSP00000425645, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [2] {ECO:0000213|PubMed:17525332}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=17525332; DOI=10.1126/science.1140321;
RA   Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R., Hurov K.E.,
RA   Luo J., Bakalarski C.E., Zhao Z., Solimini N., Lerenthal Y.,
RA   Shiloh Y., Gygi S.P., Elledge S.J.;
RT   "ATM and ATR substrate analysis reveals extensive protein networks
RT   responsive to DNA damage.";
RL   Science 316:1160-1166(2007).
RN   [3] {ECO:0000213|PubMed:18669648}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [4] {ECO:0000213|PubMed:21269460}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Burckstummer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [5] {ECO:0000313|Ensembl:ENSP00000425645}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (JUL-2011) to UniProtKB.
RN   [6] {ECO:0000213|PubMed:23186163}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=23186163;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
CC   -!- SIMILARITY: Belongs to the heat shock protein 70 family.
CC       {ECO:0000256|RuleBase:RU003322}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AC093591; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   RefSeq; NP_001304311.1; NM_001317382.1.
DR   UniGene; Hs.135554; -.
DR   ProteinModelPortal; E9PDE8; -.
DR   EPD; E9PDE8; -.
DR   MaxQB; E9PDE8; -.
DR   PeptideAtlas; E9PDE8; -.
DR   PRIDE; E9PDE8; -.
DR   Ensembl; ENST00000505726; ENSP00000425645; ENSG00000164070.
DR   GeneID; 22824; -.
DR   UCSC; uc062zlv.1; human.
DR   CTD; 22824; -.
DR   EuPathDB; HostDB:ENSG00000164070.11; -.
DR   HGNC; HGNC:17041; HSPA4L.
DR   OpenTargets; ENSG00000164070; -.
DR   eggNOG; KOG0103; Eukaryota.
DR   eggNOG; COG0443; LUCA.
DR   GeneTree; ENSGT00390000016919; -.
DR   ChiTaRS; HSPA4L; human.
DR   GenomeRNAi; 22824; -.
DR   Proteomes; UP000005640; Chromosome 4.
DR   Bgee; ENSG00000164070; -.
DR   ExpressionAtlas; E9PDE8; baseline and differential.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   Gene3D; 1.20.1270.10; -; 1.
DR   Gene3D; 2.60.34.10; -; 1.
DR   InterPro; IPR018181; Heat_shock_70_CS.
DR   InterPro; IPR029048; HSP70_C_sf.
DR   InterPro; IPR029047; HSP70_peptide-bd_sf.
DR   InterPro; IPR013126; Hsp_70_fam.
DR   PANTHER; PTHR19375; PTHR19375; 1.
DR   Pfam; PF00012; HSP70; 2.
DR   PRINTS; PR00301; HEATSHOCK70.
DR   SUPFAM; SSF100920; SSF100920; 2.
DR   SUPFAM; SSF100934; SSF100934; 2.
DR   PROSITE; PS01036; HSP70_3; 1.
PE   1: Evidence at protein level;
KW   ATP-binding {ECO:0000256|RuleBase:RU003322};
KW   Coiled coil {ECO:0000256|SAM:Coils};
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   Nucleotide-binding {ECO:0000256|RuleBase:RU003322};
KW   Proteomics identification {ECO:0000213|EPD:E9PDE8,
KW   ECO:0000213|MaxQB:E9PDE8, ECO:0000213|PeptideAtlas:E9PDE8};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640}.
FT   COILED      580    604       {ECO:0000256|SAM:Coils}.
SQ   SEQUENCE   813 AA;  91954 MW;  074485F95E01133F CRC64;
     MKPILLFMER ACISLGSRTR AIGNAAKSQI VTNVRNTIHG FKKLHGRSFD DPIVQTERIR
     LPYELQKMPN GSAGVKVRYL EEERPFAIEQ VTGMLLAKLK ETSENALKKP VADCVISIPS
     FFTDAERRSV MAAAQVAGLN CLRLMNETTA VALAYGIYKQ DLPPLDEKPR NVVFIDMGHS
     AYQVLVCAFN KGKLKVLATT FDPYLGGRNF DEALVDYFCD EFKTKYKINV KENSRALLRL
     YQECEKLKKL MSANASDLPL NIECFMNDLD VSSKMNRAQF EQLCASLLAR VEPPLKAVME
     QANLQREDIS SIEIVGGATR IPAVKEQITK FFLKDISTTL NADEAVARGC ALQCAILSPA
     FKVREFSITD LVPYSITLRW KTSFEDGSGE CEVFCKNHPA PFSKVITFHK KEPFELEAFY
     TNLHEVPYPD ARIGSFTIQN VFPQSDGDSS KVKVKVRVNI HGIFSVASAS VIEKQNLEGD
     HSDAPMETET SFKNENKDNM DKMQVDQEEG HQKCHAEHTP EEEIDHTGAK TKSAVSDKQD
     RLNQTLKKGK VKSIDLPIQS SLCRQLGQDL LNSYIENEGK MIMQDKLEKE RNDAKNAVEE
     YVYDFRDRLG TVYEKFITPE DLSKLSAVLE DTENWLYEDG EDQPKQVYVD KLQELKKYGQ
     PIQMKYMEHE ERPKALNDLG KKIQLVMKVI EAYRNKDERY DHLDPTEMEK VEKCISDAMS
     WLNSKMNAQN KLSLTQDPVV KVSEIVAKSK ELDNFCNPII YKPKPKAEVP EDKPKANSEH
     NGPMDGQSGT ETKSDSTKDS SQHTKSSGEM EVD
//
ID   HS74L_HUMAN             Reviewed;         839 AA.
AC   O95757; A2ICT2; Q4W5M5; Q8IWA2;
DT   30-MAY-2000, integrated into UniProtKB/Swiss-Prot.
DT   02-NOV-2010, sequence version 3.
DT   23-MAY-2018, entry version 158.
DE   RecName: Full=Heat shock 70 kDa protein 4L;
DE   AltName: Full=Heat shock 70-related protein APG-1;
DE   AltName: Full=Osmotic stress protein 94;
GN   Name=HSPA4L; Synonyms=APG1, OSP94;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT SER-211.
RC   TISSUE=Testis;
RX   PubMed=10524232; DOI=10.1016/S0378-1119(99)00325-X;
RA   Nonoguchi K., Itoh K., Xue J.H., Tokuchi H., Nishiyama H., Kaneko Y.,
RA   Tatsumi K., Okuno H., Tomiwa K., Fujita J.;
RT   "Cloning of human cDNAs for Apg-1 and Apg-2, members of the Hsp110
RT   family, and chromosomal assignment of their genes.";
RL   Gene 237:21-28(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND INDUCTION.
RC   TISSUE=Heart;
RX   PubMed=19169850; DOI=10.1007/s12033-009-9144-1;
RA   Mala J.G., Takeuchi S.;
RT   "Molecular cloning of OSP94: A significant biomarker protein of
RT   hypertensive human heart and a member of HSP110 family.";
RL   Mol. Biotechnol. 42:175-194(2009).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-761, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Embryonic kidney;
RX   PubMed=17525332; DOI=10.1126/science.1140321;
RA   Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,
RA   Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,
RA   Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.;
RT   "ATM and ATR substrate analysis reveals extensive protein networks
RT   responsive to DNA damage.";
RL   Science 316:1160-1166(2007).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-74; SER-508 AND SER-579,
RP   AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
CC   -!- FUNCTION: Possesses chaperone activity in vitro where it inhibits
CC       aggregation of citrate synthase. {ECO:0000250}.
CC   -!- SUBUNIT: Homodimer. {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}. Nucleus
CC       {ECO:0000250}. Note=May translocate to the nucleus after heat
CC       shock. {ECO:0000250}.
CC   -!- INDUCTION: By heat shock and osmotic imbalance.
CC       {ECO:0000269|PubMed:19169850}.
CC   -!- SIMILARITY: Belongs to the heat shock protein 70 family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB023421; BAA75063.1; -; mRNA.
DR   EMBL; EF197155; ABM69040.1; -; mRNA.
DR   EMBL; AC093591; AAY40975.1; -; Genomic_DNA.
DR   EMBL; CH471056; EAX05198.1; -; Genomic_DNA.
DR   EMBL; BC040560; AAH40560.1; -; mRNA.
DR   CCDS; CCDS3734.1; -.
DR   RefSeq; NP_001304310.1; NM_001317381.1.
DR   RefSeq; NP_001304311.1; NM_001317382.1.
DR   RefSeq; NP_001304312.1; NM_001317383.1.
DR   RefSeq; NP_055093.2; NM_014278.3.
DR   UniGene; Hs.135554; -.
DR   ProteinModelPortal; O95757; -.
DR   SMR; O95757; -.
DR   BioGrid; 116500; 64.
DR   IntAct; O95757; 22.
DR   MINT; O95757; -.
DR   STRING; 9606.ENSP00000296464; -.
DR   iPTMnet; O95757; -.
DR   PhosphoSitePlus; O95757; -.
DR   BioMuta; HSPA4L; -.
DR   REPRODUCTION-2DPAGE; IPI00295485; -.
DR   EPD; O95757; -.
DR   MaxQB; O95757; -.
DR   PaxDb; O95757; -.
DR   PeptideAtlas; O95757; -.
DR   PRIDE; O95757; -.
DR   Ensembl; ENST00000296464; ENSP00000296464; ENSG00000164070.
DR   Ensembl; ENST00000508776; ENSP00000422482; ENSG00000164070.
DR   GeneID; 22824; -.
DR   KEGG; hsa:22824; -.
DR   UCSC; uc003ifm.4; human.
DR   CTD; 22824; -.
DR   DisGeNET; 22824; -.
DR   EuPathDB; HostDB:ENSG00000164070.11; -.
DR   GeneCards; HSPA4L; -.
DR   HGNC; HGNC:17041; HSPA4L.
DR   HPA; CAB034450; -.
DR   HPA; HPA039149; -.
DR   HPA; HPA061446; -.
DR   neXtProt; NX_O95757; -.
DR   OpenTargets; ENSG00000164070; -.
DR   PharmGKB; PA134905749; -.
DR   eggNOG; KOG0103; Eukaryota.
DR   eggNOG; COG0443; LUCA.
DR   GeneTree; ENSGT00390000016919; -.
DR   HOGENOM; HOG000228138; -.
DR   HOVERGEN; HBG047955; -.
DR   InParanoid; O95757; -.
DR   KO; K09485; -.
DR   OMA; LGFLNCY; -.
DR   OrthoDB; EOG091G04Y6; -.
DR   PhylomeDB; O95757; -.
DR   TreeFam; TF105043; -.
DR   Reactome; R-HSA-3371453; Regulation of HSF1-mediated heat shock response.
DR   ChiTaRS; HSPA4L; human.
DR   GeneWiki; HSPA4L; -.
DR   GenomeRNAi; 22824; -.
DR   PRO; PR:O95757; -.
DR   Proteomes; UP000005640; Chromosome 4.
DR   Bgee; ENSG00000164070; -.
DR   CleanEx; HS_HSPA4L; -.
DR   ExpressionAtlas; O95757; baseline and differential.
DR   Genevisible; O95757; HS.
DR   GO; GO:0005737; C:cytoplasm; ISS:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IDA:UniProtKB.
DR   GO; GO:0005634; C:nucleus; ISS:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; ISS:UniProtKB.
DR   GO; GO:0006457; P:protein folding; ISS:UniProtKB.
DR   GO; GO:0006986; P:response to unfolded protein; ISS:UniProtKB.
DR   Gene3D; 1.20.1270.10; -; 1.
DR   Gene3D; 2.60.34.10; -; 1.
DR   InterPro; IPR018181; Heat_shock_70_CS.
DR   InterPro; IPR029048; HSP70_C_sf.
DR   InterPro; IPR029047; HSP70_peptide-bd_sf.
DR   InterPro; IPR013126; Hsp_70_fam.
DR   PANTHER; PTHR19375; PTHR19375; 1.
DR   Pfam; PF00012; HSP70; 2.
DR   PRINTS; PR00301; HEATSHOCK70.
DR   SUPFAM; SSF100920; SSF100920; 2.
DR   SUPFAM; SSF100934; SSF100934; 2.
DR   PROSITE; PS01036; HSP70_3; 1.
PE   1: Evidence at protein level;
KW   ATP-binding; Chaperone; Complete proteome; Cytoplasm;
KW   Nucleotide-binding; Nucleus; Phosphoprotein; Polymorphism;
KW   Reference proteome; Stress response.
FT   CHAIN         1    839       Heat shock 70 kDa protein 4L.
FT                                /FTId=PRO_0000078280.
FT   MOD_RES      74     74       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     508    508       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     545    545       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:P48722}.
FT   MOD_RES     579    579       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     761    761       Phosphothreonine.
FT                                {ECO:0000244|PubMed:17525332}.
FT   VARIANT     211    211       L -> S (in dbSNP:rs1380154).
FT                                {ECO:0000269|PubMed:10524232}.
FT                                /FTId=VAR_025405.
FT   VARIANT     216    216       N -> T (in dbSNP:rs12507229).
FT                                /FTId=VAR_031214.
FT   VARIANT     601    601       I -> T (in dbSNP:rs35518193).
FT                                /FTId=VAR_055966.
FT   CONFLICT    806    806       H -> R (in Ref. 1; BAA75063).
FT                                {ECO:0000305}.
SQ   SEQUENCE   839 AA;  94512 MW;  549933AECFF4369A CRC64;
     MSVVGIDLGF LNCYIAVARS GGIETIANEY SDRCTPACIS LGSRTRAIGN AAKSQIVTNV
     RNTIHGFKKL HGRSFDDPIV QTERIRLPYE LQKMPNGSAG VKVRYLEEER PFAIEQVTGM
     LLAKLKETSE NALKKPVADC VISIPSFFTD AERRSVMAAA QVAGLNCLRL MNETTAVALA
     YGIYKQDLPP LDEKPRNVVF IDMGHSAYQV LVCAFNKGKL KVLATTFDPY LGGRNFDEAL
     VDYFCDEFKT KYKINVKENS RALLRLYQEC EKLKKLMSAN ASDLPLNIEC FMNDLDVSSK
     MNRAQFEQLC ASLLARVEPP LKAVMEQANL QREDISSIEI VGGATRIPAV KEQITKFFLK
     DISTTLNADE AVARGCALQC AILSPAFKVR EFSITDLVPY SITLRWKTSF EDGSGECEVF
     CKNHPAPFSK VITFHKKEPF ELEAFYTNLH EVPYPDARIG SFTIQNVFPQ SDGDSSKVKV
     KVRVNIHGIF SVASASVIEK QNLEGDHSDA PMETETSFKN ENKDNMDKMQ VDQEEGHQKC
     HAEHTPEEEI DHTGAKTKSA VSDKQDRLNQ TLKKGKVKSI DLPIQSSLCR QLGQDLLNSY
     IENEGKMIMQ DKLEKERNDA KNAVEEYVYD FRDRLGTVYE KFITPEDLSK LSAVLEDTEN
     WLYEDGEDQP KQVYVDKLQE LKKYGQPIQM KYMEHEERPK ALNDLGKKIQ LVMKVIEAYR
     NKDERYDHLD PTEMEKVEKC ISDAMSWLNS KMNAQNKLSL TQDPVVKVSE IVAKSKELDN
     FCNPIIYKPK PKAEVPEDKP KANSEHNGPM DGQSGTETKS DSTKDSSQHT KSSGEMEVD
//
ID   SERP1_HUMAN             Reviewed;          66 AA.
AC   Q9Y6X1; D3DNI6;
DT   06-FEB-2007, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1999, sequence version 1.
DT   25-APR-2018, entry version 129.
DE   RecName: Full=Stress-associated endoplasmic reticulum protein 1;
DE   AltName: Full=Ribosome-attached membrane protein 4;
GN   Name=SERP1; Synonyms=RAMP4;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RA   Yamaguchi A., Hori O., Ogawa S.;
RT   "Human SERP1.";
RL   Submitted (JAN-1999) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Adrenal gland;
RX   PubMed=10931946; DOI=10.1073/pnas.160270997;
RA   Hu R.-M., Han Z.-G., Song H.-D., Peng Y.-D., Huang Q.-H., Ren S.-X.,
RA   Gu Y.-J., Huang C.-H., Li Y.-B., Jiang C.-L., Fu G., Zhang Q.-H.,
RA   Gu B.-W., Dai M., Mao Y.-F., Gao G.-F., Rong R., Ye M., Zhou J.,
RA   Xu S.-H., Gu J., Shi J.-X., Jin W.-R., Zhang C.-K., Wu T.-M.,
RA   Huang G.-Y., Chen Z., Chen M.-D., Chen J.-L.;
RT   "Gene expression profiling in the human hypothalamus-pituitary-adrenal
RT   axis and full-length cDNA cloning.";
RL   Proc. Natl. Acad. Sci. U.S.A. 97:9543-9548(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Testis;
RX   PubMed=11230166; DOI=10.1101/gr.GR1547R;
RA   Wiemann S., Weil B., Wellenreuther R., Gassenhuber J., Glassl S.,
RA   Ansorge W., Boecher M., Bloecker H., Bauersachs S., Blum H.,
RA   Lauber J., Duesterhoeft A., Beyer A., Koehrer K., Strack N.,
RA   Mewes H.-W., Ottenwaelder B., Obermaier B., Tampe J., Heubner D.,
RA   Wambutt R., Korn B., Klein M., Poustka A.;
RT   "Towards a catalog of human genes and proteins: sequencing and
RT   analysis of 500 novel complete protein coding human cDNAs.";
RL   Genome Res. 11:422-435(2001).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -!- FUNCTION: Interacts with target proteins during their
CC       translocation into the lumen of the endoplasmic reticulum.
CC       Protects unfolded target proteins against degradation during ER
CC       stress. May facilitate glycosylation of target proteins after
CC       termination of ER stress. May modulate the use of N-glycosylation
CC       sites on target proteins (By similarity). {ECO:0000250}.
CC   -!- SUBUNIT: Interacts with SEC61B, SEC61A1 and the SEC61 complex.
CC       Interacts with CANX (By similarity). {ECO:0000250}.
CC   -!- INTERACTION:
CC       Q16623:STX1A; NbExp=4; IntAct=EBI-10329948, EBI-712466;
CC       P32856-2:STX2; NbExp=4; IntAct=EBI-10329948, EBI-11956649;
CC       Q9BSE2:TMEM79; NbExp=3; IntAct=EBI-10329948, EBI-8649725;
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type IV membrane
CC       protein. Endoplasmic reticulum membrane {ECO:0000250}; Single-pass
CC       membrane protein {ECO:0000250}; Cytoplasmic side {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the RAMP4 family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB022427; BAA81895.1; -; mRNA.
DR   EMBL; AF136975; AAG49436.1; -; mRNA.
DR   EMBL; AL136807; CAB66741.1; -; mRNA.
DR   EMBL; CR533472; CAG38503.1; -; mRNA.
DR   EMBL; CH471052; EAW78834.1; -; Genomic_DNA.
DR   EMBL; CH471052; EAW78835.1; -; Genomic_DNA.
DR   EMBL; CH471052; EAW78836.1; -; Genomic_DNA.
DR   EMBL; BC108314; AAI08315.1; -; mRNA.
DR   EMBL; BC112364; AAI12365.1; -; mRNA.
DR   EMBL; BC112365; AAI12366.1; -; mRNA.
DR   CCDS; CCDS3150.1; -.
DR   RefSeq; NP_055260.1; NM_014445.3.
DR   RefSeq; XP_011511000.1; XM_011512698.2.
DR   UniGene; Hs.518326; -.
DR   UniGene; Hs.713956; -.
DR   ProteinModelPortal; Q9Y6X1; -.
DR   BioGrid; 118079; 14.
DR   IntAct; Q9Y6X1; 11.
DR   STRING; 9606.ENSP00000239944; -.
DR   iPTMnet; Q9Y6X1; -.
DR   PhosphoSitePlus; Q9Y6X1; -.
DR   BioMuta; SERP1; -.
DR   DMDM; 74721555; -.
DR   PaxDb; Q9Y6X1; -.
DR   PeptideAtlas; Q9Y6X1; -.
DR   PRIDE; Q9Y6X1; -.
DR   TopDownProteomics; Q9Y6X1; -.
DR   DNASU; 27230; -.
DR   Ensembl; ENST00000239944; ENSP00000239944; ENSG00000120742.
DR   Ensembl; ENST00000479209; ENSP00000420076; ENSG00000120742.
DR   GeneID; 27230; -.
DR   KEGG; hsa:27230; -.
DR   UCSC; uc003exy.4; human.
DR   CTD; 27230; -.
DR   DisGeNET; 27230; -.
DR   EuPathDB; HostDB:ENSG00000120742.10; -.
DR   GeneCards; SERP1; -.
DR   HGNC; HGNC:10759; SERP1.
DR   HPA; HPA038970; -.
DR   MIM; 617674; gene.
DR   neXtProt; NX_Q9Y6X1; -.
DR   OpenTargets; ENSG00000120742; -.
DR   PharmGKB; PA162402942; -.
DR   eggNOG; KOG3491; Eukaryota.
DR   eggNOG; ENOG411221U; LUCA.
DR   GeneTree; ENSGT00390000012245; -.
DR   HOVERGEN; HBG058555; -.
DR   InParanoid; Q9Y6X1; -.
DR   OMA; TSQWLIG; -.
DR   PhylomeDB; Q9Y6X1; -.
DR   TreeFam; TF313229; -.
DR   Reactome; R-HSA-381038; XBP1(S) activates chaperone genes.
DR   ChiTaRS; SERP1; human.
DR   GeneWiki; SERP1; -.
DR   GenomeRNAi; 27230; -.
DR   PRO; PR:Q9Y6X1; -.
DR   Proteomes; UP000005640; Chromosome 3.
DR   Bgee; ENSG00000120742; -.
DR   CleanEx; HS_SERP1; -.
DR   ExpressionAtlas; Q9Y6X1; baseline and differential.
DR   Genevisible; Q9Y6X1; HS.
DR   GO; GO:0005881; C:cytoplasmic microtubule; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0005783; C:endoplasmic reticulum; TAS:ProtInc.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005840; C:ribosome; TAS:ProtInc.
DR   GO; GO:0006464; P:cellular protein modification process; TAS:ProtInc.
DR   GO; GO:0030968; P:endoplasmic reticulum unfolded protein response; IBA:GO_Central.
DR   GO; GO:0006006; P:glucose metabolic process; IEA:Ensembl.
DR   GO; GO:0036498; P:IRE1-mediated unfolded protein response; TAS:Reactome.
DR   GO; GO:0010259; P:multicellular organism aging; IEA:Ensembl.
DR   GO; GO:0048644; P:muscle organ morphogenesis; IEA:Ensembl.
DR   GO; GO:0007009; P:plasma membrane organization; TAS:ProtInc.
DR   GO; GO:0060124; P:positive regulation of growth hormone secretion; IEA:Ensembl.
DR   GO; GO:0032024; P:positive regulation of insulin secretion; IEA:Ensembl.
DR   GO; GO:0046622; P:positive regulation of organ growth; IEA:Ensembl.
DR   GO; GO:0045727; P:positive regulation of translation; IEA:Ensembl.
DR   GO; GO:0009791; P:post-embryonic development; IEA:Ensembl.
DR   GO; GO:0006486; P:protein glycosylation; IBA:GO_Central.
DR   GO; GO:0015031; P:protein transport; IEA:UniProtKB-KW.
DR   GO; GO:0001501; P:skeletal system development; IEA:Ensembl.
DR   InterPro; IPR010580; ER_stress-assoc.
DR   PANTHER; PTHR15601; PTHR15601; 1.
DR   Pfam; PF06624; RAMP4; 1.
PE   1: Evidence at protein level;
KW   Complete proteome; Endoplasmic reticulum; Membrane; Protein transport;
KW   Reference proteome; Translocation; Transmembrane; Transmembrane helix;
KW   Transport.
FT   CHAIN         1     66       Stress-associated endoplasmic reticulum
FT                                protein 1.
FT                                /FTId=PRO_0000274794.
FT   TOPO_DOM      1     38       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     39     59       Helical; Anchor for type IV membrane
FT                                protein. {ECO:0000255}.
FT   TOPO_DOM     60     66       Extracellular. {ECO:0000255}.
SQ   SEQUENCE   66 AA;  7374 MW;  DC15C0143AAE0D91 CRC64;
     MVAKQRIRMA NEKHSKNITQ RGNVAKTSRN APEEKASVGP WLLALFIFVV CGSAIFQIIQ
     SIRMGM
//
ID   CD79B_HUMAN             Reviewed;         229 AA.
AC   P40259; Q53FS2; Q9BU06;
DT   01-FEB-1995, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-1995, sequence version 1.
DT   28-FEB-2018, entry version 171.
DE   RecName: Full=B-cell antigen receptor complex-associated protein beta chain;
DE   AltName: Full=B-cell-specific glycoprotein B29;
DE   AltName: Full=Ig-beta;
DE   AltName: Full=Immunoglobulin-associated B29 protein;
DE   AltName: CD_antigen=CD79b;
DE   Flags: Precursor;
GN   Name=CD79B; Synonyms=B29, IGB;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM LONG).
RX   PubMed=1534761; DOI=10.1002/eji.1830220641;
RA   Mueller B.S., Cooper L., Terhorst C.;
RT   "Cloning and sequencing of the cDNA encoding the human homologue of
RT   the murine immunoglobulin-associated protein B29.";
RL   Eur. J. Immunol. 22:1621-1625(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM LONG).
RX   PubMed=8486355; DOI=10.1006/geno.1993.1157;
RA   Wood W.J. Jr., Thompson A.A., Korenberg J., Chen X.-N., May W.,
RA   Wall R., Denny C.T.;
RT   "Isolation and chromosomal mapping of the human immunoglobulin-
RT   associated B29 gene (IGB).";
RL   Genomics 16:187-192(1993).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM LONG).
RX   PubMed=8419481;
RA   Hashimoto S., Gregersen P.K., Chiorazzi N.;
RT   "The human Ig-beta cDNA sequence, a homologue of murine B29, is
RT   identical in B cell and plasma cell lines producing all the human Ig
RT   isotypes.";
RL   J. Immunol. 150:491-498(1993).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM LONG).
RX   PubMed=7913081; DOI=10.1007/BF00188178;
RA   Hashimoto S., Chiorazzi N., Gregersen P.K.;
RT   "The complete sequence of the human CD79b (Ig beta/B29) gene:
RT   identification of a conserved exon/intron organization,
RT   immunoglobulin-like regulatory regions, and allelic polymorphism.";
RL   Immunogenetics 40:145-149(1994).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM SHORT).
RX   PubMed=7643857; DOI=10.1016/0161-5890(95)00023-8;
RA   Hashimoto S., Chiorazzi N., Gregersen P.K.;
RT   "Alternative splicing of CD79a (Ig-alpha/mb-1) and CD79b (Ig-beta/B29)
RT   RNA transcripts in human B cells.";
RL   Mol. Immunol. 32:651-659(1995).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM SHORT).
RA   Koyama M., Nakamura T.;
RL   Submitted (DEC-1994) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RC   TISSUE=Small intestine, and Spleen;
RA   Suzuki Y., Sugano S., Totoki Y., Toyoda A., Takeda T., Sakaki Y.,
RA   Tanaka A., Yokoyama S.;
RL   Submitted (APR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM LONG).
RC   TISSUE=Lymph;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   PROTEIN SEQUENCE OF 29-45.
RX   PubMed=7514267; DOI=10.1016/0161-5890(94)90061-2;
RA   Vasile S., Coligan J.E., Yoshida M., Seon B.K.;
RT   "Isolation and chemical characterization of the human B29 and mb-1
RT   proteins of the B cell antigen receptor complex.";
RL   Mol. Immunol. 31:419-427(1994).
RN   [10]
RP   FUNCTION.
RX   PubMed=8617796; DOI=10.1074/jbc.271.9.5158;
RA   Luisiri P., Lee Y.J., Eisfelder B.J., Clark M.R.;
RT   "Cooperativity and segregation of function within the Ig-alpha/beta
RT   heterodimer of the B cell antigen receptor complex.";
RL   J. Biol. Chem. 271:5158-5163(1996).
RN   [11]
RP   FUNCTION.
RX   PubMed=9057631;
RA   Tseng J., Eisfelder B.J., Clark M.R.;
RT   "B-cell antigen receptor-induced apoptosis requires both Ig alpha and
RT   Ig beta.";
RL   Blood 89:1513-1520(1997).
RN   [12]
RP   FUNCTION.
RX   PubMed=12097390; DOI=10.4049/jimmunol.169.2.865;
RA   Pelanda R., Braun U., Hobeika E., Nussenzweig M.C., Reth M.;
RT   "B cell progenitors are arrested in maturation but have intact VDJ
RT   recombination in the absence of Ig-alpha and Ig-beta.";
RL   J. Immunol. 169:865-872(2002).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [14]
RP   X-RAY CRYSTALLOGRAPHY (3.2 ANGSTROMS) OF 26-159, SUBUNIT, AND
RP   DISULFIDE BONDS.
RX   PubMed=20696394; DOI=10.1016/j.str.2010.04.019;
RA   Radaev S., Zou Z., Tolar P., Nguyen K., Nguyen A., Krueger P.D.,
RA   Stutzman N., Pierce S., Sun P.D.;
RT   "Structural and functional studies of Igalphabeta and its assembly
RT   with the B cell antigen receptor.";
RL   Structure 18:934-943(2010).
RN   [15]
RP   VARIANT AGM6 SER-137.
RX   PubMed=17675462; DOI=10.4049/jimmunol.179.4.2055;
RA   Dobbs A.K., Yang T., Farmer D., Kager L., Parolini O., Conley M.E.;
RT   "A hypomorphic mutation in Igbeta (CD79b) in a patient with
RT   immunodeficiency and a leaky defect in B cell development.";
RL   J. Immunol. 179:2055-2059(2007).
CC   -!- FUNCTION: Required in cooperation with CD79A for initiation of the
CC       signal transduction cascade activated by the B-cell antigen
CC       receptor complex (BCR) which leads to internalization of the
CC       complex, trafficking to late endosomes and antigen presentation.
CC       Enhances phosphorylation of CD79A, possibly by recruiting kinases
CC       which phosphorylate CD79A or by recruiting proteins which bind to
CC       CD79A and protect it from dephosphorylation.
CC       {ECO:0000269|PubMed:12097390, ECO:0000269|PubMed:8617796,
CC       ECO:0000269|PubMed:9057631}.
CC   -!- SUBUNIT: Heterodimer of alpha and beta chains; disulfide-linked.
CC       Part of the B-cell antigen receptor complex where the alpha/beta
CC       chain heterodimer is non-covalently associated with an antigen-
CC       specific membrane-bound surface immunoglobulin of two heavy chains
CC       and two light chains. Interacts with LYN (By similarity).
CC       {ECO:0000250}.
CC   -!- INTERACTION:
CC       O43765:SGTA; NbExp=6; IntAct=EBI-2873732, EBI-347996;
CC       Q96EQ0:SGTB; NbExp=4; IntAct=EBI-2873732, EBI-744081;
CC   -!- SUBCELLULAR LOCATION: Cell membrane; Single-pass type I membrane
CC       protein. Note=Following antigen binding, the BCR has been shown to
CC       translocate from detergent-soluble regions of the cell membrane to
CC       lipid rafts although signal transduction through the complex can
CC       also occur outside lipid rafts. {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=Long;
CC         IsoId=P40259-1; Sequence=Displayed;
CC       Name=Short;
CC         IsoId=P40259-2; Sequence=VSP_002477;
CC       Name=3;
CC         IsoId=P40259-3; Sequence=VSP_047222;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: B-cells.
CC   -!- PTM: Phosphorylated on tyrosine upon B-cell activation by SRC-type
CC       Tyr-kinases such as BLK, LYN and SYK.
CC   -!- DISEASE: Agammaglobulinemia 6, autosomal recessive (AGM6)
CC       [MIM:612692]: A primary immunodeficiency characterized by
CC       profoundly low or absent serum antibodies and low or absent
CC       circulating B-cells due to an early block of B-cell development.
CC       Affected individuals develop severe infections in the first years
CC       of life. {ECO:0000269|PubMed:17675462}. Note=The disease is caused
CC       by mutations affecting the gene represented in this entry.
CC   -!- WEB RESOURCE: Name=CD79Bbase; Note=CD79B mutation db;
CC       URL="http://structure.bmc.lu.se/idbase/CD79Bbase/";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M80461; AAA58387.1; -; mRNA.
DR   EMBL; M89957; AAA64459.1; -; mRNA.
DR   EMBL; S52229; AAB24822.2; -; mRNA.
DR   EMBL; L27587; AAA72424.1; -; Genomic_DNA.
DR   EMBL; S79249; AAC60654.1; -; mRNA.
DR   EMBL; X83539; CAA58522.1; -; mRNA.
DR   EMBL; AK222954; BAD96674.1; -; mRNA.
DR   EMBL; AK223210; BAD96930.1; -; mRNA.
DR   EMBL; BC002975; AAH02975.2; -; mRNA.
DR   EMBL; BC032651; AAH32651.1; -; mRNA.
DR   CCDS; CCDS11655.1; -. [P40259-1]
DR   CCDS; CCDS11656.1; -. [P40259-2]
DR   CCDS; CCDS42372.1; -. [P40259-3]
DR   PIR; I54534; A46527.
DR   RefSeq; NP_000617.1; NM_000626.3. [P40259-1]
DR   RefSeq; NP_001035022.1; NM_001039933.2. [P40259-3]
DR   RefSeq; NP_067613.1; NM_021602.3. [P40259-2]
DR   UniGene; Hs.89575; -.
DR   PDB; 3KG5; X-ray; 3.20 A; A/B=26-159.
DR   PDBsum; 3KG5; -.
DR   ProteinModelPortal; P40259; -.
DR   SMR; P40259; -.
DR   BioGrid; 107412; 110.
DR   DIP; DIP-59497N; -.
DR   ELM; P40259; -.
DR   IntAct; P40259; 3.
DR   STRING; 9606.ENSP00000376544; -.
DR   iPTMnet; P40259; -.
DR   PhosphoSitePlus; P40259; -.
DR   BioMuta; CD79B; -.
DR   DMDM; 728994; -.
DR   EPD; P40259; -.
DR   MaxQB; P40259; -.
DR   PaxDb; P40259; -.
DR   PeptideAtlas; P40259; -.
DR   PRIDE; P40259; -.
DR   TopDownProteomics; P40259-2; -. [P40259-2]
DR   Ensembl; ENST00000006750; ENSP00000006750; ENSG00000007312. [P40259-1]
DR   Ensembl; ENST00000349817; ENSP00000245862; ENSG00000007312. [P40259-2]
DR   Ensembl; ENST00000392795; ENSP00000376544; ENSG00000007312. [P40259-3]
DR   GeneID; 974; -.
DR   KEGG; hsa:974; -.
DR   UCSC; uc002jdp.2; human. [P40259-1]
DR   CTD; 974; -.
DR   DisGeNET; 974; -.
DR   EuPathDB; HostDB:ENSG00000007312.12; -.
DR   GeneCards; CD79B; -.
DR   HGNC; HGNC:1699; CD79B.
DR   HPA; CAB009751; -.
DR   HPA; HPA009178; -.
DR   MalaCards; CD79B; -.
DR   MIM; 147245; gene.
DR   MIM; 612692; phenotype.
DR   neXtProt; NX_P40259; -.
DR   OpenTargets; ENSG00000007312; -.
DR   Orphanet; 33110; Autosomal agammaglobulinemia.
DR   PharmGKB; PA26238; -.
DR   eggNOG; ENOG410J02H; Eukaryota.
DR   eggNOG; ENOG410Z4S5; LUCA.
DR   GeneTree; ENSGT00510000048811; -.
DR   HOGENOM; HOG000049137; -.
DR   HOVERGEN; HBG050855; -.
DR   InParanoid; P40259; -.
DR   KO; K06507; -.
DR   OMA; DQTATYE; -.
DR   OrthoDB; EOG091G0O8L; -.
DR   PhylomeDB; P40259; -.
DR   TreeFam; TF336032; -.
DR   Reactome; R-HSA-5690714; CD22 mediated BCR regulation.
DR   Reactome; R-HSA-983695; Antigen activates B Cell Receptor (BCR) leading to generation of second messengers.
DR   SignaLink; P40259; -.
DR   SIGNOR; P40259; -.
DR   ChiTaRS; CD79B; human.
DR   GeneWiki; CD79B; -.
DR   GenomeRNAi; 974; -.
DR   PRO; PR:P40259; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   Bgee; ENSG00000007312; -.
DR   CleanEx; HS_CD79B; -.
DR   Genevisible; P40259; HS.
DR   GO; GO:0019815; C:B cell receptor complex; IBA:GO_Central.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0009897; C:external side of plasma membrane; IBA:GO_Central.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0005794; C:Golgi apparatus; IDA:HPA.
DR   GO; GO:0005887; C:integral component of plasma membrane; TAS:ProtInc.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005886; C:plasma membrane; IDA:HPA.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0042803; F:protein homodimerization activity; IMP:CAFA.
DR   GO; GO:0004888; F:transmembrane signaling receptor activity; IEA:InterPro.
DR   GO; GO:0002250; P:adaptive immune response; IEA:UniProtKB-KW.
DR   GO; GO:0030183; P:B cell differentiation; IBA:GO_Central.
DR   GO; GO:0050853; P:B cell receptor signaling pathway; IBA:GO_Central.
DR   GO; GO:0006955; P:immune response; TAS:ProtInc.
DR   GO; GO:0051260; P:protein homooligomerization; IMP:CAFA.
DR   GO; GO:0007165; P:signal transduction; TAS:ProtInc.
DR   Gene3D; 2.60.40.10; -; 1.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR036179; Ig-like_dom_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR003599; Ig_sub.
DR   InterPro; IPR013106; Ig_V-set.
DR   InterPro; IPR003110; Phos_immunorcpt_sig_ITAM.
DR   Pfam; PF07686; V-set; 1.
DR   SMART; SM00409; IG; 1.
DR   SMART; SM00077; ITAM; 1.
DR   SUPFAM; SSF48726; SSF48726; 1.
DR   PROSITE; PS50835; IG_LIKE; 1.
DR   PROSITE; PS51055; ITAM_1; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Adaptive immunity; Alternative splicing; Cell membrane;
KW   Complete proteome; Direct protein sequencing; Disease mutation;
KW   Disulfide bond; Glycoprotein; Immunity; Immunoglobulin domain;
KW   Membrane; Phosphoprotein; Reference proteome; Signal; Transmembrane;
KW   Transmembrane helix.
FT   SIGNAL        1     28       {ECO:0000269|PubMed:7514267}.
FT   CHAIN        29    229       B-cell antigen receptor complex-
FT                                associated protein beta chain.
FT                                /FTId=PRO_0000014560.
FT   TOPO_DOM     29    159       Extracellular. {ECO:0000255}.
FT   TRANSMEM    160    180       Helical. {ECO:0000255}.
FT   TOPO_DOM    181    229       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN       38    138       Ig-like V-type.
FT   DOMAIN      185    213       ITAM. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00379}.
FT   MOD_RES     196    196       Phosphotyrosine; by SRC-type Tyr-kinases.
FT                                {ECO:0000250|UniProtKB:P15530,
FT                                ECO:0000255|PROSITE-ProRule:PRU00379}.
FT   MOD_RES     207    207       Phosphotyrosine; by SRC-type Tyr-kinases.
FT                                {ECO:0000250|UniProtKB:P15530,
FT                                ECO:0000255|PROSITE-ProRule:PRU00379}.
FT   CARBOHYD     73     73       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    101    101       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    127    127       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    128    128       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID     43    126       {ECO:0000255|PROSITE-ProRule:PRU00114,
FT                                ECO:0000269|PubMed:20696394}.
FT   DISULFID     65    122       {ECO:0000255|PROSITE-ProRule:PRU00114,
FT                                ECO:0000269|PubMed:20696394}.
FT   DISULFID    136    136       Interchain (with C-119 in alpha chain).
FT                                {ECO:0000255|PROSITE-ProRule:PRU00114,
FT                                ECO:0000269|PubMed:20696394}.
FT   VAR_SEQ      23     23       A -> AA (in isoform 3).
FT                                {ECO:0000303|Ref.7}.
FT                                /FTId=VSP_047222.
FT   VAR_SEQ      41    144       Missing (in isoform Short).
FT                                {ECO:0000303|PubMed:7643857,
FT                                ECO:0000303|Ref.6}.
FT                                /FTId=VSP_002477.
FT   VARIANT     137    137       G -> S (in AGM6; dbSNP:rs121912424).
FT                                {ECO:0000269|PubMed:17675462}.
FT                                /FTId=VAR_057833.
FT   CONFLICT     58     58       G -> A (in Ref. 3; AAB24822).
FT                                {ECO:0000305}.
FT   CONFLICT     58     58       G -> R (in Ref. 1; AAA58387).
FT                                {ECO:0000305}.
FT   CONFLICT     84     84       E -> A (in Ref. 3; AAB24822).
FT                                {ECO:0000305}.
FT   STRAND       47     49       {ECO:0000244|PDB:3KG5}.
FT   STRAND       51     56       {ECO:0000244|PDB:3KG5}.
FT   STRAND       61     66       {ECO:0000244|PDB:3KG5}.
FT   STRAND       75     84       {ECO:0000244|PDB:3KG5}.
FT   TURN         93     95       {ECO:0000244|PDB:3KG5}.
FT   STRAND       96    100       {ECO:0000244|PDB:3KG5}.
FT   STRAND      102    109       {ECO:0000244|PDB:3KG5}.
FT   TURN        114    116       {ECO:0000244|PDB:3KG5}.
FT   STRAND      118    125       {ECO:0000244|PDB:3KG5}.
FT   TURN        127    129       {ECO:0000244|PDB:3KG5}.
FT   STRAND      132    134       {ECO:0000244|PDB:3KG5}.
FT   STRAND      138    143       {ECO:0000244|PDB:3KG5}.
SQ   SEQUENCE   229 AA;  26048 MW;  C467175567D10883 CRC64;
     MARLALSPVP SHWMVALLLL LSAEPVPAAR SEDRYRNPKG SACSRIWQSP RFIARKRGFT
     VKMHCYMNSA SGNVSWLWKQ EMDENPQQLK LEKGRMEESQ NESLATLTIQ GIRFEDNGIY
     FCQQKCNNTS EVYQGCGTEL RVMGFSTLAQ LKQRNTLKDG IIMIQTLLII LFIIVPIFLL
     LDKDDSKAGM EEDHTYEGLD IDQTATYEDI VTLRTGEVKW SVGEHPGQE
//
ID   CAD15_HUMAN             Reviewed;         814 AA.
AC   P55291;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-1996, sequence version 1.
DT   28-FEB-2018, entry version 160.
DE   RecName: Full=Cadherin-15;
DE   AltName: Full=Cadherin-14;
DE   AltName: Full=Muscle cadherin;
DE            Short=M-cadherin;
DE   Flags: Precursor;
GN   Name=CDH15; Synonyms=CDH14, CDH3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Skeletal muscle;
RX   PubMed=9030594; DOI=10.1074/jbc.272.8.5236;
RA   Shibata T., Shimoyama Y., Gotoh M., Hirohashi S.;
RT   "Identification of human cadherin-14, a novel neurally specific type
RT   II cadherin, by protein interaction cloning.";
RL   J. Biol. Chem. 272:5236-5240(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Muscle;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   TISSUE SPECIFICITY, CHROMOSOMAL TRANSLOCATION WITH KIRREL3, VARIANTS
RP   MRD3 LEU-8; CYS-60; TRP-92 AND VAL-122, MUTAGENESIS OF LYS-103 AND
RP   MET-109, AND CHARACTERIZATION OF VARIANTS MRD3 CYS-60; TRP-92 AND
RP   VAL-122.
RX   PubMed=19012874; DOI=10.1016/j.ajhg.2008.10.020;
RA   Bhalla K., Luo Y., Buchan T., Beachem M.A., Guzauskas G.F., Ladd S.,
RA   Bratcher S.J., Schroer R.J., Balsamo J., DuPont B.R., Lilien J.,
RA   Srivastava A.K.;
RT   "Alterations in CDH15 and KIRREL3 in patients with mild to severe
RT   intellectual disability.";
RL   Am. J. Hum. Genet. 83:703-713(2008).
CC   -!- FUNCTION: Cadherins are calcium-dependent cell adhesion proteins.
CC       They preferentially interact with themselves in a homophilic
CC       manner in connecting cells; cadherins may thus contribute to the
CC       sorting of heterogeneous cell types. M-cadherin is part of the
CC       myogenic program and may provide a trigger for terminal muscle
CC       differentiation.
CC   -!- INTERACTION:
CC       O43765:SGTA; NbExp=5; IntAct=EBI-10215061, EBI-347996;
CC   -!- SUBCELLULAR LOCATION: Cell membrane; Single-pass type I membrane
CC       protein.
CC   -!- TISSUE SPECIFICITY: Expressed in the brain and cerebellum.
CC       {ECO:0000269|PubMed:19012874}.
CC   -!- DOMAIN: Three calcium ions are usually bound at the interface of
CC       each cadherin domain and rigidify the connections, imparting a
CC       strong curvature to the full-length ectodomain. {ECO:0000250}.
CC   -!- DISEASE: Note=A chromosomal aberration involving CDH15 and KIRREL3
CC       is found in a patient with severe mental retardation and
CC       dysmorphic facial features. Translocation t(11;16)(q24.2;q24).
CC   -!- DISEASE: Mental retardation, autosomal dominant 3 (MRD3)
CC       [MIM:612580]: A disorder characterized by significantly below
CC       average general intellectual functioning associated with
CC       impairments in adaptive behavior and manifested during the
CC       developmental period. {ECO:0000269|PubMed:19012874}. Note=The
CC       disease is caused by mutations affecting the gene represented in
CC       this entry.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; D83542; BAA12012.1; -; mRNA.
DR   EMBL; BC008951; AAH08951.1; -; mRNA.
DR   CCDS; CCDS10976.1; -.
DR   PIR; G02878; G02878.
DR   RefSeq; NP_004924.1; NM_004933.2.
DR   UniGene; Hs.148090; -.
DR   ProteinModelPortal; P55291; -.
DR   SMR; P55291; -.
DR   BioGrid; 107448; 6.
DR   IntAct; P55291; 3.
DR   STRING; 9606.ENSP00000289746; -.
DR   iPTMnet; P55291; -.
DR   PhosphoSitePlus; P55291; -.
DR   BioMuta; CDH15; -.
DR   DMDM; 1705553; -.
DR   EPD; P55291; -.
DR   PaxDb; P55291; -.
DR   PeptideAtlas; P55291; -.
DR   PRIDE; P55291; -.
DR   DNASU; 1013; -.
DR   Ensembl; ENST00000289746; ENSP00000289746; ENSG00000129910.
DR   GeneID; 1013; -.
DR   KEGG; hsa:1013; -.
DR   UCSC; uc002fmt.4; human.
DR   CTD; 1013; -.
DR   DisGeNET; 1013; -.
DR   EuPathDB; HostDB:ENSG00000129910.7; -.
DR   GeneCards; CDH15; -.
DR   HGNC; HGNC:1754; CDH15.
DR   HPA; HPA009139; -.
DR   HPA; HPA070961; -.
DR   MalaCards; CDH15; -.
DR   MIM; 114019; gene.
DR   MIM; 612580; phenotype.
DR   neXtProt; NX_P55291; -.
DR   OpenTargets; ENSG00000129910; -.
DR   Orphanet; 178469; Autosomal dominant non-syndromic intellectual disability.
DR   PharmGKB; PA26288; -.
DR   eggNOG; KOG3594; Eukaryota.
DR   eggNOG; ENOG410XQHI; LUCA.
DR   GeneTree; ENSGT00760000118906; -.
DR   HOGENOM; HOG000231254; -.
DR   HOVERGEN; HBG106438; -.
DR   InParanoid; P55291; -.
DR   KO; K06809; -.
DR   OMA; LKDGWYR; -.
DR   OrthoDB; EOG091G02MA; -.
DR   PhylomeDB; P55291; -.
DR   TreeFam; TF316817; -.
DR   Reactome; R-HSA-375170; CDO in myogenesis.
DR   Reactome; R-HSA-418990; Adherens junctions interactions.
DR   SIGNOR; P55291; -.
DR   GeneWiki; CDH15; -.
DR   GenomeRNAi; 1013; -.
DR   PRO; PR:P55291; -.
DR   Proteomes; UP000005640; Chromosome 16.
DR   Bgee; ENSG00000129910; -.
DR   CleanEx; HS_CDH15; -.
DR   CleanEx; HS_CDH3; -.
DR   Genevisible; P55291; HS.
DR   GO; GO:0005901; C:caveola; IEA:Ensembl.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0005794; C:Golgi apparatus; IDA:HPA.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0031594; C:neuromuscular junction; IEA:Ensembl.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   GO; GO:0034332; P:adherens junction organization; TAS:Reactome.
DR   GO; GO:0007155; P:cell adhesion; TAS:ProtInc.
DR   GO; GO:0007156; P:homophilic cell adhesion via plasma membrane adhesion molecules; IEA:InterPro.
DR   GO; GO:0051149; P:positive regulation of muscle cell differentiation; TAS:Reactome.
DR   Gene3D; 4.10.900.10; -; 1.
DR   InterPro; IPR002126; Cadherin.
DR   InterPro; IPR015919; Cadherin-like.
DR   InterPro; IPR020894; Cadherin_CS.
DR   InterPro; IPR000233; Cadherin_cytoplasmic-dom.
DR   InterPro; IPR027397; Catenin_binding_dom_sf.
DR   Pfam; PF00028; Cadherin; 4.
DR   Pfam; PF01049; Cadherin_C; 1.
DR   PRINTS; PR00205; CADHERIN.
DR   SMART; SM00112; CA; 4.
DR   SUPFAM; SSF49313; SSF49313; 5.
DR   PROSITE; PS00232; CADHERIN_1; 2.
DR   PROSITE; PS50268; CADHERIN_2; 5.
PE   1: Evidence at protein level;
KW   Calcium; Cell adhesion; Cell membrane; Chromosomal rearrangement;
KW   Cleavage on pair of basic residues; Complete proteome;
KW   Disease mutation; Glycoprotein; Membrane; Mental retardation;
KW   Metal-binding; Reference proteome; Repeat; Signal; Transmembrane;
KW   Transmembrane helix.
FT   SIGNAL        1     21       {ECO:0000255}.
FT   PROPEP       22     60       {ECO:0000255}.
FT                                /FTId=PRO_0000003805.
FT   CHAIN        61    814       Cadherin-15.
FT                                /FTId=PRO_0000003806.
FT   TOPO_DOM     61    606       Extracellular. {ECO:0000255}.
FT   TRANSMEM    607    626       Helical. {ECO:0000255}.
FT   TOPO_DOM    627    814       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN       61    152       Cadherin 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00043}.
FT   DOMAIN      153    260       Cadherin 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00043}.
FT   DOMAIN      261    375       Cadherin 3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00043}.
FT   DOMAIN      376    481       Cadherin 4. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00043}.
FT   DOMAIN      482    590       Cadherin 5. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00043}.
FT   CARBOHYD    227    227       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    531    531       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    538    538       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    576    576       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   VARIANT       8      8       V -> L (in MRD3; uncertain pathological
FT                                significance; dbSNP:rs567903921).
FT                                {ECO:0000269|PubMed:19012874}.
FT                                /FTId=VAR_054966.
FT   VARIANT      60     60       R -> C (in MRD3; affects cell-cell
FT                                adhesion but not surface expression of
FT                                the protein; dbSNP:rs121434539).
FT                                {ECO:0000269|PubMed:19012874}.
FT                                /FTId=VAR_054967.
FT   VARIANT      92     92       R -> W (in MRD3; affects cell-cell
FT                                adhesion but not surface expression of
FT                                the protein; dbSNP:rs121434540).
FT                                {ECO:0000269|PubMed:19012874}.
FT                                /FTId=VAR_054968.
FT   VARIANT     122    122       A -> V (in MRD3; affects cell-cell
FT                                adhesion but not surface expression of
FT                                the protein; dbSNP:rs121434541).
FT                                {ECO:0000269|PubMed:19012874}.
FT                                /FTId=VAR_054969.
FT   MUTAGEN     103    103       K->R: No effect on cell-cell adhesion.
FT                                {ECO:0000269|PubMed:19012874}.
FT   MUTAGEN     109    109       M->T: No effect on cell-cell adhesion.
FT                                {ECO:0000269|PubMed:19012874}.
SQ   SEQUENCE   814 AA;  88916 MW;  618A817DBF2B3343 CRC64;
     MDAAFLLVLG LLAQSLCLSL GVPGWRRPTT LYPWRRAPAL SRVRRAWVIP PISVSENHKR
     LPYPLVQIKS DKQQLGSVIY SIQGPGVDEE PRGVFSIDKF TGKVFLNAML DREKTDRFRL
     RAFALDLGGS TLEDPTDLEI VVVDQNDNRP AFLQEAFTGR VLEGAVPGTY VTRAEATDAD
     DPETDNAALR FSILQQGSPE LFSIDELTGE IRTVQVGLDR EVVAVYNLTL QVADMSGDGL
     TATASAIITL DDINDNAPEF TRDEFFMEAI EAVSGVDVGR LEVEDRDLPG SPNWVARFTI
     LEGDPDGQFT IRTDPKTNEG VLSIVKALDY ESCEHYELKV SVQNEAPLQA AALRAERGQA
     KVRVHVQDTN EPPVFQENPL RTSLAEGAPP GTLVATFSAR DPDTEQLQRL SYSKDYDPED
     WLQVDAATGR IQTQHVLSPA SPFLKGGWYR AIVLAQDDAS QPRTATGTLS IEILEVNDHA
     PVLAPPPPGS LCSEPHQGPG LLLGATDEDL PPHGAPFHFQ LSPRLPELGR NWSLSQVNVS
     HARLRPRHQV PEGLHRLSLL LRDSGQPPQQ REQPLNVTVC RCGKDGVCLP GAAALLAGGT
     GLSLGALVIV LASALLLLVL VLLVALRARF WKQSRGKGLL HGPQDDLRDN VLNYDEQGGG
     EEDQDAYDIS QLRHPTALSL PLGPPPLRRD APQGRLHPQP PRVLPTSPLD IADFINDGLE
     AADSDPSVPP YDTALIYDYE GDGSVAGTLS SILSSQGDED QDYDYLRDWG PRFARLADMY
     GHPCGLEYGA RWDHQAREGL SPGALLPRHR GRTA
//
ID   A0A0S2Z3H5_HUMAN        Unreviewed;      1366 AA.
AC   A0A0S2Z3H5;
DT   17-FEB-2016, integrated into UniProtKB/TrEMBL.
DT   17-FEB-2016, sequence version 1.
DT   23-MAY-2018, entry version 14.
DE   SubName: Full=Collagen type I alpha 2 isoform 1 {ECO:0000313|EMBL:ALQ33446.1};
DE   Flags: Fragment;
GN   Name=COL1A2 {ECO:0000313|EMBL:ALQ33446.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:ALQ33446.1};
RN   [1] {ECO:0000313|EMBL:ALQ33446.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=26871637; DOI=10.1016/j.cell.2016.01.029;
RA   Yang X., Coulombe-Huntington J., Kang S., Sheynkman G.M., Hao T.,
RA   Richardson A., Sun S., Yang F., Shen Y.A., Murray R., Spirohn K.,
RA   Begg B.E., Duran-Frigola M., MacWilliams A., Pevzner S.J., Zhong Q.,
RA   Trigg S.A., Tam S., Ghamsari L., Sahni N., Yi S., Rodriguez M.D.,
RA   Balcha D., Tan G., Costanzo M., Andrews B., Boone C., Zhou X.J.,
RA   Salehi-Ashtiani K., Charloteaux B., Chen A., Calderwood M.A., Aloy P.,
RA   Roth F.P., Hill D.E., Iakoucheva L.M., Xia Y., Vidal M.;
RT   "Widespread Expansion of Protein Interaction Capabilities by
RT   Alternative Splicing.";
RL   Cell 164:805-817(2016).
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; KU177988; ALQ33446.1; -; mRNA.
DR   RefSeq; NP_000080.2; NM_000089.3.
DR   UniGene; Hs.489142; -.
DR   ProteinModelPortal; A0A0S2Z3H5; -.
DR   SMR; A0A0S2Z3H5; -.
DR   PRIDE; A0A0S2Z3H5; -.
DR   GeneID; 1278; -.
DR   KEGG; hsa:1278; -.
DR   CTD; 1278; -.
DR   KO; K06236; -.
DR   OMA; PEWSSGY; -.
DR   PhylomeDB; A0A0S2Z3H5; -.
DR   ChiTaRS; COL1A2; human.
DR   ExpressionAtlas; A0A0S2Z3H5; baseline and differential.
DR   GO; GO:0005584; C:collagen type I trimer; IEA:Ensembl.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:HPA.
DR   GO; GO:0005615; C:extracellular space; IEA:Ensembl.
DR   GO; GO:0005201; F:extracellular matrix structural constituent; IEA:InterPro.
DR   GO; GO:0046332; F:SMAD binding; IEA:Ensembl.
DR   GO; GO:0071230; P:cellular response to amino acid stimulus; IEA:Ensembl.
DR   GO; GO:0070208; P:protein heterotrimerization; IEA:Ensembl.
DR   InterPro; IPR008160; Collagen.
DR   InterPro; IPR000885; Fib_collagen_C.
DR   Pfam; PF01410; COLFI; 1.
DR   Pfam; PF01391; Collagen; 6.
DR   ProDom; PD002078; Fib_collagen_C; 1.
DR   SMART; SM00038; COLFI; 1.
DR   PROSITE; PS51461; NC1_FIB; 1.
PE   2: Evidence at transcript level;
KW   Collagen {ECO:0000313|EMBL:ALQ33446.1};
KW   Signal {ECO:0000256|SAM:SignalP}.
FT   SIGNAL        1     20       {ECO:0000256|SAM:SignalP}.
FT   CHAIN        21   1366       {ECO:0000256|SAM:SignalP}.
FT                                /FTId=PRO_5006608209.
FT   DOMAIN     1133   1366       Fibrillar collagen NC1.
FT                                {ECO:0000259|PROSITE:PS51461}.
FT   NON_TER    1366   1366       {ECO:0000313|EMBL:ALQ33446.1}.
SQ   SEQUENCE   1366 AA;  129314 MW;  1E68A5970FB4210A CRC64;
     MLSFVDTRTL LLLAVTLCLA TCQSLQEETV RKGPAGDRGP RGERGPPGPP GRDGEDGPTG
     PPGPPGPPGP PGLGGNFAAQ YDGKGVGLGP GPMGLMGPRG PPGAAGAPGP QGFQGPAGEP
     GEPGQTGPAG ARGPAGPPGK AGEDGHPGKP GRPGERGVVG PQGARGFPGT PGLPGFKGIR
     GHNGLDGLKG QPGAPGVKGE PGAPGENGTP GQTGARGLPG ERGRVGAPGP AGARGSDGSV
     GPVGPAGPIG SAGPPGFPGA PGPKGEIGAV GNAGPAGPAG PRGEVGLPGL SGPVGPPGNP
     GANGLTGAKG AAGLPGVAGA PGLPGPRGIP GPVGAAGATG ARGLVGEPGP AGSKGESGNK
     GEPGSAGPQG PPGPSGEEGK RGPNGEAGSA GPPGPPGLRG SPGSRGLPGA DGRAGVMGPP
     GSRGASGPAG VRGPNGDAGR PGEPGLMGPR GLPGSPGNIG PAGKEGPVGL PGIDGRPGPI
     GPAGARGEPG NIGFPGPKGP TGDPGKNGDK GHAGLAGARG APGPDGNNGA QGPPGPQGVQ
     GGKGEQGPPG PPGFQGLPGP SGPAGEVGKP GERGLHGEFG LPGPAGPRGE RGPPGESGAA
     GPTGPIGSRG PSGPPGPDGN KGEPGVVGAV GTAGPSGPSG LPGERGAAGI PGGKGEKGEP
     GLRGEIGNPG RDGARGAPGA VGAPGPAGAT GDRGEAGAAG PAGPAGPRGS PGERGEVGPA
     GPNGFAGPAG AAGQPGAKGE RGAKGPKGEN GVVGPTGPVG AAGPAGPNGP PGPAGSRGDG
     GPPGMTGFPG AAGRTGPPGP SGISGPPGPP GPAGKEGLRG PRGDQGPVGR TGEVGAVGPP
     GFAGEKGPSG EAGTAGPPGT PGPQGLLGAP GILGLPGSRG ERGLPGVAGA VGEPGPLGIA
     GPPGARGPPG AVGSPGVNGA PGEAGRDGNP GNDGPPGRDG QPGHKGERGY PGNIGPVGAA
     GAPGPHGPVG PAGKHGNRGE TGPSGPVGPA GAVGPRGPSG PQGIRGDKGE PGEKGPRGLP
     GLKGHNGLQG LPGIAGHHGD QGAPGSVGPA GPRGPAGPSG PAGKDGRTGH PGTVGPAGIR
     GPQGHQGPAG PPGPPGPPGP PGVSGGGYDF GYDGDFYRAD QPRSAPSLRP KDYEVDATLK
     SLNNQIETLL TPEGSRKNPA RTCRDLRLSH PEWSSGYYWI DPNQGCTMDA IKVYCDFSTG
     ETCIRAQPEN IPAKNWYRSS KDKKHVWLGE TINAGSQFEY NVEGVTSKEM ATQLAFMRLL
     ANYASQNITY HCKNSIAYMD EETGNLKKAV ILQGSNDVEL VAEGNSRFTY TVLVDGCSKK
     TNEWGKTIIE YKTNKPSRLP FLDIAPLDIG GADQEFFVDI GPVCFK
//
ID   CO1A2_HUMAN             Reviewed;        1366 AA.
AC   P08123; P02464; Q13897; Q13997; Q13998; Q14038; Q14057; Q15177;
AC   Q15947; Q16480; Q16511; Q7Z5S6; Q9UEB6; Q9UEF9; Q9UM83; Q9UMI1;
AC   Q9UML5; Q9UMM6; Q9UPH0;
DT   01-AUG-1988, integrated into UniProtKB/Swiss-Prot.
DT   18-MAY-2010, sequence version 7.
DT   23-MAY-2018, entry version 210.
DE   RecName: Full=Collagen alpha-2(I) chain;
DE   AltName: Full=Alpha-2 type I collagen;
DE   Flags: Precursor;
GN   Name=COL1A2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANTS ASN-249; THR-276; VAL-483;
RP   ALA-549; HIS-678; GLY-743; PHE-1022; GLU-1189; PRO-1198 AND HIS-1354.
RX   PubMed=2824475;
RA   de Wet W.J., Bernard M.P., Benson-Chanda V., Chu M.-L., Dickson L.A.,
RA   Weil D., Ramirez F.;
RT   "Organization of the human pro-alpha 2(I) collagen gene.";
RL   J. Biol. Chem. 262:16032-16036(1987).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], REVIEW ON OI VARIANTS, AND VARIANTS
RP   ALA-549; HIS-678 AND HIS-1354.
RX   PubMed=9016532; DOI=10.1093/nar/25.1.181;
RA   Dalgleish R.;
RT   "The human type I collagen mutation database.";
RL   Nucleic Acids Res. 25:181-187(1997).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS ILE-270; VAL-483;
RP   HIS-678; GLY-743; PHE-1022; GLU-1189; PRO-1198 AND HIS-1354.
RX   PubMed=9443882; DOI=10.1086/301689;
RA   Korkko J.M., Ala-Kokko L., De Paepe A., Nuytinck L., Earley J.J.,
RA   Prockop D.J.;
RT   "Analysis of the COL1A1 and COL1A2 genes by PCR amplification and
RT   scanning by conformation-sensitive gel electrophoresis identifies only
RT   COL1A1 mutations in 15 patients with osteogenesis imperfecta type I:
RT   identification of common sequences of null-allele mutations.";
RL   Am. J. Hum. Genet. 62:98-110(1998).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT ALA-549.
RC   TISSUE=Skin, and Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-765, AND VARIANTS HIS-678 AND GLY-743.
RC   TISSUE=Placenta;
RX   PubMed=3421913; DOI=10.1042/bj2520633;
RA   Kuivaniemi H., Tromp G., Chu M.-L., Prockop D.J.;
RT   "Structure of a full-length cDNA clone for the prepro alpha 2(I) chain
RT   of human type I procollagen. Comparison with the chicken gene confirms
RT   unusual patterns of gene conservation.";
RL   Biochem. J. 252:633-640(1988).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-93, AND VARIANT PRO-59.
RX   PubMed=4011429; DOI=10.1093/nar/13.10.3427;
RA   Dickson L.A., de Wet W., Di Liberto M., Weil D., Ramirez F.;
RT   "Analysis of the promoter region and the N-propeptide domain of the
RT   human pro alpha 2(I) collagen gene.";
RL   Nucleic Acids Res. 13:3427-3438(1985).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-32.
RA   Akai J., Kimura A., Arai K., Uehara K., Hata R.;
RT   "Fine structural analysis of the unique 5' region of the human COL1A2
RT   gene containing two regions of dinucleotide repeats adjacent to the
RT   transcriptional start site.";
RL   Connect. Tissue Res. 30:1-6(1998).
RN   [8]
RP   PROTEIN SEQUENCE OF 32-111, HYDROXYLATION AT PRO-47; PRO-50; PRO-62;
RP   PRO-65; PRO-68; PRO-71; PRO-102 AND PRO-108, AND VARIANT EDS7B
RP   76-ASN--MET-93 DEL.
RX   PubMed=3680255;
RA   Wirtz M.K., Glanville R.W., Steinmann B., Rao V.H., Hollister D.W.;
RT   "Ehlers-Danlos syndrome type VIIB. Deletion of 18 amino acids
RT   comprising the N-telopeptide region of a pro-alpha 2(I) chain.";
RL   J. Biol. Chem. 262:16376-16385(1987).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 76-93, PROTEIN SEQUENCE OF 23-96,
RP   HYDROXYLATION AT PRO-47; PRO-50; PRO-62; PRO-65; PRO-68 AND PRO-71,
RP   PYROGLUTAMATE FORMATION AT GLN-23, AND VARIANT EDS7B 76-ASN--MET-93
RP   DEL.
RX   PubMed=2394758;
RA   Weil D., D'Alessio M., Ramirez F., Eyre D.R.;
RT   "Structural and functional characterization of a splicing mutation in
RT   the pro-alpha 2(I) collagen gene of an Ehlers-Danlos type VII
RT   patient.";
RL   J. Biol. Chem. 265:16007-16011(1990).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 76-93, AND VARIANT EDS7B
RP   76-ASN--MET-93 DEL.
RX   PubMed=1577745;
RA   Watson R.B., Wallis G.A., Holmes D.F., Viljoen D., Byers P.H.,
RA   Kadler K.E.;
RT   "Ehlers Danlos syndrome type VIIB. Incomplete cleavage of abnormal
RT   type I procollagen by N-proteinase in vitro results in the formation
RT   of copolymers of collagen and partially cleaved pNcollagen that are
RT   near circular in cross-section.";
RL   J. Biol. Chem. 267:9093-9100(1992).
RN   [11]
RP   PROTEIN SEQUENCE OF 80-96, ALLYSINE AT LYS-84, AND PYROGLUTAMATE
RP   FORMATION AT GLN-80.
RC   TISSUE=Skin;
RX   PubMed=5529814; DOI=10.1021/bi00826a012;
RA   Click E.M., Bornstein P.;
RT   "Isolation and characterization of the cyanogen bromide peptides from
RT   the alpha 1 and alpha 2 chains of human skin collagen.";
RL   Biochemistry 9:4699-4706(1970).
RN   [12]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 145-198.
RX   PubMed=3403536;
RA   Kuivaniemi H., Sabol C., Tromp G., Sippola-Thiele M., Prockop D.J.;
RT   "A 19-base pair deletion in the pro-alpha 2(I) gene of type I
RT   procollagen that causes in-frame RNA splicing from exon 10 to exon 12
RT   in a proband with atypical osteogenesis imperfecta and in his
RT   asymptomatic mother.";
RL   J. Biol. Chem. 263:11407-11413(1988).
RN   [13]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 163-213, AND VARIANT OI4
RP   181-GLY--LYS-198 DEL.
RX   PubMed=1642148; DOI=10.1002/jbmr.5650070709;
RA   Chipman S.D., Shapiro J.R., McKinstry M.B., Stover M.L., Branson P.,
RA   Rowe D.W.;
RT   "Expression of mutant alpha (I)-procollagen in osteoblast and
RT   fibroblast cultures from a proband with osteogenesis imperfecta type
RT   IV.";
RL   J. Bone Miner. Res. 7:793-805(1992).
RN   [14]
RP   PROTEIN SEQUENCE OF 175-180, HYDROXYLATION AT LYS-177, AND
RP   GLYCOSYLATION AT LYS-177.
RC   TISSUE=Skin;
RX   PubMed=4319110;
RA   Morgan P.H., Jacobs H.G., Segrest J.P., Cunningham L.W.;
RT   "A comparative study of glycopeptides derived from selected vertebrate
RT   collagens. A possible role of the carbohydrate in fibril formation.";
RL   J. Biol. Chem. 245:5042-5048(1970).
RN   [15]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 181-1366.
RA   Kalicki J., Wamsley P., Gibson A.;
RL   Submitted (SEP-1997) to the EMBL/GenBank/DDBJ databases.
RN   [16]
RP   PROTEIN SEQUENCE OF 417-447, AND HYDROXYLATION AT PRO-420; PRO-441 AND
RP   PRO-444.
RC   TISSUE=Skin;
RX   PubMed=4412529; DOI=10.1111/j.1432-1033.1974.tb03689.x;
RA   Fietzek P.P., Furthmayr H., Kuehn K.;
RT   "Comparative sequence studies on alpha2-CB2 from calf, human, rabbit
RT   and pig-skin collagen.";
RL   Eur. J. Biochem. 47:257-261(1974).
RN   [17]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 520-573, AND VARIANT ALA-549.
RX   PubMed=2839839; DOI=10.1073/pnas.85.14.5254;
RA   Tromp G., Prockop D.J.;
RT   "Single base mutation in the pro alpha 2(I) collagen gene that causes
RT   efficient splicing of RNA from exon 27 to exon 29 and synthesis of a
RT   shortened but in-frame pro alpha 2(I) chain.";
RL   Proc. Natl. Acad. Sci. U.S.A. 85:5254-5258(1988).
RN   [18]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 622-657.
RX   PubMed=6321602; DOI=10.1111/1523-1747.ep12260213;
RA   Tajima S., Ting J.P., Pinnell S.R., Kaufman R.E.;
RT   "Isolation and characterization of a human pro alpha 2(I) collagen
RT   gene segment.";
RL   J. Invest. Dermatol. 82:265-269(1984).
RN   [19]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 623-1366, AND VARIANTS HIS-678;
RP   PHE-1022; GLU-1189; PRO-1198 AND HIS-1354.
RX   PubMed=6687691; DOI=10.1021/bi00274a023;
RA   Bernard M.P., Myers J.C., Chu M.-L., Ramirez F., Eikenberry E.F.,
RA   Prockop D.J.;
RT   "Structure of a cDNA for the pro alpha 2 chain of human type I
RT   procollagen. Comparison with chick cDNA for pro alpha 2(I) identifies
RT   structurally conserved features of the protein and the gene.";
RL   Biochemistry 22:1139-1145(1983).
RN   [20]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 631-864, AND VARIANT OI2
RP   676-GLY--ALA-855 DEL.
RX   PubMed=1339453;
RA   Chessler S.D., Byers P.H.;
RT   "Defective folding and stable association with protein disulfide
RT   isomerase/prolyl hydroxylase of type I procollagen with a deletion in
RT   the pro alpha 2(I) chain that preserves the Gly-X-Y repeat pattern.";
RL   J. Biol. Chem. 267:7751-7757(1992).
RN   [21]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 663-746, AND VARIANT OI3 VAL-676.
RX   PubMed=7881420; DOI=10.1093/hmg/3.12.2201;
RA   Forlino A., Zolezzi F., Valli M., Pignatti P.F., Cetta G.,
RA   Brunelli P.C., Mottes M.;
RT   "Severe (type III) osteogenesis imperfecta due to glycine
RT   substitutions in the central domain of the collagen triple helix.";
RL   Hum. Mol. Genet. 3:2201-2206(1994).
RN   [22]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 960-1356, AND VARIANT HIS-1354.
RC   TISSUE=Skin;
RX   PubMed=2364107;
RA   Maekelae J.K., Vuorio T., Vuorio E.;
RT   "Growth-dependent modulation of type I collagen production and mRNA
RT   levels in cultured human skin fibroblasts.";
RL   Biochim. Biophys. Acta 1049:171-176(1990).
RN   [23]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 964-1019.
RX   PubMed=6267597; DOI=10.1073/pnas.78.6.3516;
RA   Myers J.C., Chu M.-L., Faro S.H., Clark W.J., Prockop D.J.,
RA   Ramirez F.;
RT   "Cloning a cDNA for the pro-alpha 2 chain of human type I collagen.";
RL   Proc. Natl. Acad. Sci. U.S.A. 78:3516-3520(1981).
RN   [24]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] OF 1090-1107, AND VARIANT OI4
RP   ARG-1102.
RX   PubMed=2897363;
RA   Wenstrup R.J., Cohn D.H., Cohen T., Byers P.H.;
RT   "Arginine for glycine substitution in the triple-helical domain of the
RT   products of one alpha 2(I) collagen allele (COL1A2) produces the
RT   osteogenesis imperfecta type IV phenotype.";
RL   J. Biol. Chem. 263:7734-7740(1988).
RN   [25]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1319-1366, AND VARIANT HIS-1354.
RX   PubMed=6309769;
RA   Myers J.C., Dickson L.A., de Wet W.J., Bernard M.P., Chu M.-L.,
RA   Di Liberto M., Pepe G., Sangiorgi F.O., Ramirez F.;
RT   "Analysis of the 3' end of the human pro-alpha 2(I) collagen gene.
RT   Utilization of multiple polyadenylation sites in cultured
RT   fibroblasts.";
RL   J. Biol. Chem. 258:10128-10135(1983).
RN   [26]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1319-1366, AND VARIANT HIS-1354.
RC   TISSUE=Skin;
RX   PubMed=6092353;
RA   Pihlajaniemi T., Dickson L.A., Pope F.M., Korhonen V.R., Nicholls A.,
RA   Prockop D.J., Myers J.C.;
RT   "Osteogenesis imperfecta: cloning of a pro-alpha 2(I) collagen gene
RT   with a frameshift mutation.";
RL   J. Biol. Chem. 259:12941-12944(1984).
RN   [27]
RP   REVIEW ON VARIANTS.
RX   PubMed=2010058;
RA   Kuivaniemi H., Tromp G., Prockop D.J.;
RT   "Mutations in collagen genes: causes of rare and some common diseases
RT   in humans.";
RL   FASEB J. 5:2052-2060(1991).
RN   [28]
RP   REVIEW ON VARIANTS.
RX   PubMed=9101290;
RX   DOI=10.1002/(SICI)1098-1004(1997)9:4<300::AID-HUMU2>3.0.CO;2-9;
RA   Kuivaniemi H., Tromp G., Prockop D.J.;
RT   "Mutations in fibrillar collagens (types I, II, III, and XI), fibril-
RT   associated collagen (type IX), and network-forming collagen (type X)
RT   cause a spectrum of diseases of bone, cartilage, and blood vessels.";
RL   Hum. Mutat. 9:300-315(1997).
RN   [29]
RP   REVIEW ON OI VARIANTS.
RX   PubMed=1895312; DOI=10.1136/jmg.28.7.433;
RA   Byers P.H., Wallis G.A., Willing M.C.;
RT   "Osteogenesis imperfecta: translation of mutation to phenotype.";
RL   J. Med. Genet. 28:433-442(1991).
RN   [30]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22905912; DOI=10.1021/pr300539b;
RA   Rosenow A., Noben J.P., Jocken J., Kallendrusch S.,
RA   Fischer-Posovszky P., Mariman E.C., Renes J.;
RT   "Resveratrol-induced changes of the human adipocyte secretion
RT   profile.";
RL   J. Proteome Res. 11:4733-4743(2012).
RN   [31]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [32]
RP   VARIANT OI2 ASP-997.
RX   PubMed=2914942;
RA   Baldwin C.T., Constantinou C., Dumars K.W., Prockop D.J.;
RT   "A single base mutation that converts glycine 907 of the alpha 2(I)
RT   chain of type I procollagen to aspartate in a lethal variant of
RT   osteogenesis imperfecta. The single amino acid substitution near the
RT   carboxyl terminus destabilizes the whole triple helix.";
RL   J. Biol. Chem. 264:3002-3006(1989).
RN   [33]
RP   VARIANT OI2 SER-955.
RX   PubMed=2777764;
RA   Lamande S.R., Dahl H.-H.M., Cole W.G., Bateman J.F.;
RT   "Characterization of point mutations in the collagen COL1A1 and COL1A2
RT   genes causing lethal perinatal osteogenesis imperfecta.";
RL   J. Biol. Chem. 264:15809-15812(1989).
RN   [34]
RP   VARIANT OI2 CYS-877.
RA   Fertala A., Westerhausen A., Morris G.M., Rooney J.E., Prockop D.J.;
RT   "Two cysteine substitutions in the type I procollagen genes (COL1A1
RT   and COL1A2) that cause lethal osteogenesis imperfecta. The location of
RT   glycine substitutions does not in any simple way predict their effects
RT   on protein function or phenotype.";
RL   Am. J. Hum. Genet. 47:A216-A216(1990).
RN   [35]
RP   VARIANT OI4 VAL-676.
RX   PubMed=2064612; DOI=10.1042/bj2760765;
RA   Bateman J.F., Hannagan M., Chan D., Cole W.G.;
RT   "Characterization of a type I collagen alpha 2(I) glycine-586 to
RT   valine substitution in osteogenesis imperfecta type IV. Detection of
RT   the mutation and prenatal diagnosis by a chemical cleavage method.";
RL   Biochem. J. 276:765-770(1991).
RN   [36]
RP   VARIANT OI3 CYS-349, AND VARIANT OI1 CYS-736.
RX   PubMed=1990009;
RA   Wenstrup R.J., Shrago-Howe A.W., Lever L.W., Phillips C.L.,
RA   Byers P.H., Cohn D.H.;
RT   "The effects of different cysteine for glycine substitutions within
RT   alpha 2(I) chains. Evidence of distinct structural domains within the
RT   type I collagen triple helix.";
RL   J. Biol. Chem. 266:2590-2594(1991).
RN   [37]
RP   VARIANT OI2 ARG-784.
RX   PubMed=1874719;
RA   Tsuneyoshi T., Westerhausen A., Constantinou C.D., Prockop D.J.;
RT   "Substitutions for glycine alpha 1-637 and glycine alpha 2-694 of type
RT   I procollagen in lethal osteogenesis imperfecta. The conformational
RT   strain on the triple helix introduced by a glycine substitution can be
RT   transmitted along the helix.";
RL   J. Biol. Chem. 266:15608-15613(1991).
RN   [38]
RP   VARIANT OI4 SER-751.
RX   PubMed=2052622; DOI=10.1073/pnas.88.12.5423;
RA   Spotila L.D., Constantinou C.D., Sereda L., Ganguly A., Riggs B.L.,
RA   Prockop D.J.;
RT   "Mutation in a gene for type I procollagen (COL1A2) in a woman with
RT   postmenopausal osteoporosis: evidence for phenotypic and genotypic
RT   overlap with mild osteogenesis imperfecta.";
RL   Proc. Natl. Acad. Sci. U.S.A. 88:5423-5427(1991).
RN   [39]
RP   VARIANT OI2 ARG-547.
RX   PubMed=1284475; DOI=10.1002/humu.1380010109;
RA   Bateman J.F., Moeller I., Hannagan M., Chan D., Cole W.G.;
RT   "Lethal perinatal osteogenesis imperfecta due to a type I collagen
RT   alpha 2(I) Gly to Arg substitution detected by chemical cleavage of an
RT   mRNA:cDNA sequence mismatch.";
RL   Hum. Mutat. 1:55-62(1992).
RN   [40]
RP   VARIANT OI2 ASP-670.
RX   PubMed=1385413;
RA   Niyibizi C., Bonadio J., Byers P.H., Eyre D.R.;
RT   "Incorporation of type I collagen molecules that contain a mutant
RT   alpha 2(I) chain (Gly580-->Asp) into bone matrix in a lethal case of
RT   osteogenesis imperfecta.";
RL   J. Biol. Chem. 267:23108-23112(1992).
RN   [41]
RP   VARIANT OI3 CYS-349, AND VARIANT OI1 CYS-736.
RX   PubMed=8456807; DOI=10.1002/ajmg.1320450215;
RA   Wenstrup R.J., Lever L.W., Phillips C.L., Quarles L.D.;
RT   "Mutations in the COL1A2 gene of type I collagen that result in
RT   nonlethal forms of osteogenesis imperfecta.";
RL   Am. J. Med. Genet. 45:228-232(1993).
RN   [42]
RP   VARIANT ALA-549.
RX   PubMed=8456808; DOI=10.1002/ajmg.1320450216;
RA   Bateman J.F., Lamande S.R., Hannagan M., Moeller I., Dahl H.-H.M.,
RA   Cole W.G.;
RT   "Chemical cleavage method for the detection of RNA base changes:
RT   experience in the application to collagen mutations in osteogenesis
RT   imperfecta.";
RL   Am. J. Med. Genet. 45:233-240(1993).
RN   [43]
RP   VARIANT OI3 VAL-345 DEL.
RX   PubMed=8444468; DOI=10.1007/BF00202479;
RA   Molyneux K., Starman B.J., Byers P.H., Dalgleish R.;
RT   "A single amino acid deletion in the alpha 2(I) chain of type I
RT   collagen produces osteogenesis imperfecta type III.";
RL   Hum. Genet. 90:621-628(1993).
RN   [44]
RP   VARIANT OI4 VAL-634.
RX   PubMed=8401517; DOI=10.1093/hmg/2.8.1319;
RA   Sztrolovics R., Glorieux F.H., van der Rest M., Roughley P.J.;
RT   "Identification of type I collagen gene (COL1A2) mutations in
RT   nonlethal osteogenesis imperfecta.";
RL   Hum. Mol. Genet. 2:1319-1321(1993).
RN   [45]
RP   VARIANT OI2 GLU-433.
RX   PubMed=7906591; DOI=10.1093/hmg/2.12.2175;
RA   Rose N.J., Mackay K., Byers P.H., Dalgleish R.;
RT   "A novel glycine to glutamic acid substitution at position 343 in the
RT   alpha 2 chain of type I collagen in an individual with lethal
RT   osteogenesis imperfecta.";
RL   Hum. Mol. Genet. 2:2175-2177(1993).
RN   [46]
RP   VARIANT OI4 SER-1012.
RX   PubMed=8094076;
RA   Marini J.C., Lewis M.B., Wang Q., Chen K.J., Orrison B.M.;
RT   "Serine for glycine substitutions in type I collagen in two cases of
RT   type IV osteogenesis imperfecta (OI). Additional evidence for a
RT   regional model of OI pathophysiology.";
RL   J. Biol. Chem. 268:2667-2673(1993).
RN   [47]
RP   VARIANT OI4 VAL-766, AND VARIANT OI2 SER-796.
RX   PubMed=7693712;
RA   Wang Q., Orrison B.M., Marini J.C.;
RT   "Two additional cases of osteogenesis imperfecta with substitutions
RT   for glycine in the alpha 2(I) collagen chain. A regional model
RT   relating mutation location with phenotype.";
RL   J. Biol. Chem. 268:25162-25167(1993).
RN   [48]
RP   VARIANT OI3 ARG-517.
RX   PubMed=7520724; DOI=10.1016/8756-3282(94)90295-X;
RA   Sztrolovics R., Glorieux F.H., Travers R., van der Rest M.,
RA   Roughley P.J.;
RT   "Osteogenesis imperfecta: comparison of molecular defects with bone
RT   histological changes.";
RL   Bone 15:321-328(1994).
RN   [49]
RP   VARIANT OI2 SER-592.
RX   PubMed=7959683; DOI=10.1007/BF00211014;
RA   Rose N.J., Mackay K., de Paepe A., Steinmann B., Punnett H.H.,
RA   Dalgleish R.;
RT   "Three unrelated individuals with perinatally lethal osteogenesis
RT   imperfecta resulting from identical Gly502Ser substitutions in the
RT   alpha 2-chain of type I collagen.";
RL   Hum. Genet. 94:497-503(1994).
RN   [50]
RP   VARIANT OI3 SER-949.
RX   PubMed=8081394; DOI=10.1002/humu.1380030411;
RA   Rose N.J., Mackay K., Byers P.H., Dalgleish R.;
RT   "A Gly859Ser substitution in the triple helical domain of the alpha 2
RT   chain of type I collagen resulting in osteogenesis imperfecta type III
RT   in two unrelated individuals.";
RL   Hum. Mutat. 3:391-394(1994).
RN   [51]
RP   VARIANT OI2 ASP-790.
RX   PubMed=8182080;
RA   Cohen-Solal L., Zylberberg L., Sangalli A., Gomez Lira M., Mottes M.;
RT   "Substitution of an aspartic acid for glycine 700 in the alpha 2(I)
RT   chain of type I collagen in a recurrent lethal type II osteogenesis
RT   imperfecta dramatically affects the mineralization of bone.";
RL   J. Biol. Chem. 269:14751-14758(1994).
RN   [52]
RP   VARIANT OI2 CYS-730.
RX   PubMed=7891382; DOI=10.1136/jmg.31.12.965;
RA   Gomez Lira M., Sangalli A., Pignatti P.F., Digilio M.C., Giannotti A.,
RA   Carnevale E., Mottes M.;
RT   "Determination of a new collagen type I alpha 2 gene point mutation
RT   which causes a Gly640 Cys substitution in osteogenesis imperfecta and
RT   prenatal diagnosis by DNA hybridisation.";
RL   J. Med. Genet. 31:965-968(1994).
RN   [53]
RP   VARIANT OI3 SER-778.
RX   PubMed=7720740; DOI=10.1007/BF01991915;
RA   Raghunath M., Mackay K., Dalgleish R., Steinmann B.;
RT   "Genetic counselling on brittle grounds: recurring osteogenesis
RT   imperfecta due to parental mosaicism for a dominant mutation.";
RL   Eur. J. Pediatr. 154:123-129(1995).
RN   [54]
RP   VARIANT OI3 SER-328.
RX   PubMed=7860070; DOI=10.1007/BF00209405;
RA   Rose N.J., Mackay K., Byers P.H., Dalgleish R.;
RT   "A Gly238Ser substitution in the alpha 2 chain of type I collagen
RT   results in osteogenesis imperfecta type III.";
RL   Hum. Genet. 95:215-218(1995).
RN   [55]
RP   VARIANT OI3 ALA-1096.
RX   PubMed=7749416; DOI=10.1002/humu.1380050212;
RA   Lu J., Costa T., Cole W.G.;
RT   "A novel G1006A substitution in the alpha 2(I) chain of type I
RT   collagen produces osteogenesis imperfecta type III.";
RL   Hum. Mutat. 5:175-178(1995).
RN   [56]
RP   VARIANT OI3 ASP-892, AND VARIANT OI4 ASP-892.
RX   PubMed=8800927;
RA   Lund A.M., Schwartz M., Raghunath M., Steinmann B., Skovby F.;
RT   "Gly802Asp substitution in the pro alpha 2(I) collagen chain in a
RT   family with recurrent osteogenesis imperfecta due to paternal
RT   mosaicism.";
RL   Eur. J. Hum. Genet. 4:39-45(1996).
RN   [57]
RP   VARIANTS OI1 ASP-211 AND SER-835, VARIANTS OI3 SER-337 AND SER-460,
RP   AND VARIANT HIS-822.
RX   PubMed=8829649;
RX   DOI=10.1002/(SICI)1098-1004(1996)7:2<89::AID-HUMU1>3.0.CO;2-K;
RA   Zhuang J., Tromp G., Kuivaniemi H., Castells S., Bugge M.,
RA   Prockop D.J.;
RT   "Direct sequencing of PCR products derived from cDNAs for the pro
RT   alpha 1 and pro alpha 2 chains of type I procollagen as a screening
RT   method to detect mutations in patients with osteogenesis imperfecta.";
RL   Hum. Mutat. 7:89-99(1996).
RN   [58]
RP   VARIANT OI3 PRO-1148.
RX   PubMed=8723681;
RX   DOI=10.1002/(SICI)1098-1004(1996)7:4<318::AID-HUMU5>3.0.CO;2-4;
RA   Oliver J.E., Thompson E.M., Pope F.M., Nicholls A.C.;
RT   "Mutation in the carboxy-terminal propeptide of the Pro alpha 1(I)
RT   chain of type I collagen in a child with severe osteogenesis
RT   imperfecta (OI type III): possible implications for protein folding.";
RL   Hum. Mutat. 7:318-326(1996).
RN   [59]
RP   VARIANTS OI2 VAL-409 AND CYS-787.
RX   PubMed=10627137;
RX   DOI=10.1002/(SICI)1098-1004(1998)12:1<71::AID-HUMU16>3.0.CO;2-4;
RA   Mottes M., Gomez Lira M., Zolezzi F., Valli M., Lisi V., Freising P.;
RT   "Four new cases of lethal osteogenesis imperfecta due to glycine
RT   substitutions in COL1A1 and genes.";
RL   Hum. Mutat. 12:71-72(1998).
RN   [60]
RP   VARIANTS OI3 ASP-331; CYS-337 AND VAL-973.
RX   PubMed=10408781;
RX   DOI=10.1002/(SICI)1098-1004(1999)13:6<503::AID-HUMU11>3.0.CO;2-L;
RA   Lund A.M., Astroem E., Soederhaell S., Schwartz M., Skovby F.;
RT   "Osteogenesis imperfecta: mosaicism and refinement of the genotype-
RT   phenotype map in OI type III.";
RL   Hum. Mutat. 13:503-503(1999).
RN   [61]
RP   CHROMOSOMAL REARRANGEMENT WITH PLAG1.
RX   PubMed=10987300;
RA   Hibbard M.K., Kozakewich H.P., Dal Cin P., Sciot R., Tan X., Xiao S.,
RA   Fletcher J.A.;
RT   "PLAG1 fusion oncogenes in lipoblastoma.";
RL   Cancer Res. 60:4869-4872(2000).
RN   [62]
RP   INVOLVEMENT IN CARDIAC VALVULAR EDS.
RX   PubMed=15077201; DOI=10.1086/420794;
RA   Schwarze U., Hata R., McKusick V.A., Shinkai H., Hoyme H.E.,
RA   Pyeritz R.E., Byers P.H.;
RT   "Rare autosomal recessive cardiac valvular form of Ehlers-Danlos
RT   syndrome results from mutations in the COL1A2 gene that activate the
RT   nonsense-mediated RNA decay pathway.";
RL   Am. J. Hum. Genet. 74:917-930(2004).
RN   [63]
RP   INVOLVEMENT IN EDSCV.
RX   PubMed=16816023; DOI=10.1136/jmg.2005.038224;
RA   Malfait F., Symoens S., Coucke P., Nunes L., De Almeida S.,
RA   De Paepe A.;
RT   "Total absence of the alpha2(I) chain of collagen type I causes a rare
RT   form of Ehlers-Danlos syndrome with hypermobility and propensity to
RT   cardiac valvular problems.";
RL   J. Med. Genet. 43:E36-E36(2006).
RN   [64]
RP   VARIANTS OI4 SER-193 AND CYS-754, VARIANT OI2 ASP-625, AND VARIANTS
RP   OI3 CYS-835 AND VAL-991.
RX   PubMed=16879195; DOI=10.1111/j.1399-0004.2006.00646.x;
RA   Venturi G., Tedeschi E., Mottes M., Valli M., Camilot M., Viglio S.,
RA   Antoniazzi F., Tato L.;
RT   "Osteogenesis imperfecta: clinical, biochemical and molecular
RT   findings.";
RL   Clin. Genet. 70:131-139(2006).
RN   [65]
RP   VARIANTS OI1/OI3/OI4 GLU-325; SER-328; SER-358; SER-601; ASP-676;
RP   SER-820; ARG-856; SER-1012; PRO-PRO-GLY-811 INS; VAL-GLY-PRO-989 INS
RP   AND 1094-PRO--GLY-1096 DEL.
RX   PubMed=16705691; DOI=10.1002/humu.9423;
RA   Lee K.S., Song H.R., Cho T.J., Kim H.J., Lee T.M., Jin H.S.,
RA   Park H.Y., Kang S., Jung S.C., Koo S.K.;
RT   "Mutational spectrum of type I collagen genes in Korean patients with
RT   osteogenesis imperfecta.";
RL   Hum. Mutat. 27:599-599(2006).
RN   [66]
RP   VARIANTS OI4 ARG-202 AND VAL-256, VARIANTS OI1 ARG-247; ARG-319;
RP   CYS-733 AND TYR-1195, VARIANTS OI2 ASP-253; ASP-982 AND ASP-1003, AND
RP   VARIANT OI3 ASP-1087.
RX   PubMed=16786509; DOI=10.1002/humu.9430;
RA   Pollitt R., McMahon R., Nunn J., Bamford R., Afifi A., Bishop N.,
RA   Dalton A.;
RT   "Mutation analysis of COL1A1 and COL1A2 in patients diagnosed with
RT   osteogenesis imperfecta type I-IV.";
RL   Hum. Mutat. 27:716-716(2006).
RN   [67]
RP   VARIANTS SER-528; ALA-549 AND THR-564.
RX   PubMed=18272325; DOI=10.1016/j.ygeno.2007.12.008;
RA   Chan T.F., Poon A., Basu A., Addleman N.R., Chen J., Phong A.,
RA   Byers P.H., Klein T.E., Kwok P.Y.;
RT   "Natural variation in four human collagen genes across an ethnically
RT   diverse population.";
RL   Genomics 91:307-314(2008).
RN   [68]
RP   VARIANTS OI2 CYS-234; ARG-283; GLU-397; CYS-454; LEU-457;
RP   461-PRO--GLY-466 DEL; GLU-526; VAL-562; 705-ALA--PRO-707 DEL; ARG-739;
RP   VAL-748; ASP-790; PRO-798 INS; 806-PRO--GLY-811 DEL; VAL-856; SER-949;
RP   ASP-955; GLU-1027 AND 1058-PRO--ALA-1062 DEL, AND VARIANT ALA-549.
RX   PubMed=18996919; DOI=10.1093/hmg/ddn374;
RA   Bodian D.L., Chan T.F., Poon A., Schwarze U., Yang K., Byers P.H.,
RA   Kwok P.Y., Klein T.E.;
RT   "Mutation and polymorphism spectrum in osteogenesis imperfecta type
RT   II: implications for genotype-phenotype relationships.";
RL   Hum. Mol. Genet. 18:463-471(2009).
RN   [69]
RP   VARIANT THR-1119, AND CHARACTERIZATION OF VARIANT THR-1119.
RX   PubMed=21344539; DOI=10.1002/humu.21475;
RA   Lindahl K., Barnes A.M., Fratzl-Zelman N., Whyte M.P., Hefferan T.E.,
RA   Makareeva E., Brusel M., Yaszemski M.J., Rubin C.J., Kindmark A.,
RA   Roschger P., Klaushofer K., McAlister W.H., Mumm S., Leikin S.,
RA   Kessler E., Boskey A.L., Ljunggren O., Marini J.C.;
RT   "COL1 C-propeptide cleavage site mutations cause high bone mass
RT   osteogenesis imperfecta.";
RL   Hum. Mutat. 32:598-609(2011).
RN   [70]
RP   VARIANT HIS-1067.
RX   PubMed=23656646; DOI=10.1056/NEJMoa1215458;
RA   Laine C.M., Joeng K.S., Campeau P.M., Kiviranta R., Tarkkonen K.,
RA   Grover M., Lu J.T., Pekkinen M., Wessman M., Heino T.J.,
RA   Nieminen-Pihala V., Aronen M., Laine T., Kroeger H., Cole W.G.,
RA   Lehesjoki A.E., Nevarez L., Krakow D., Curry C.J., Cohn D.H.,
RA   Gibbs R.A., Lee B.H., Maekitie O.;
RT   "WNT1 mutations in early-onset osteoporosis and osteogenesis
RT   imperfecta.";
RL   N. Engl. J. Med. 368:1809-1816(2013).
CC   -!- FUNCTION: Type I collagen is a member of group I collagen
CC       (fibrillar forming collagen).
CC   -!- SUBUNIT: Trimers of one alpha 2(I) and two alpha 1(I) chains.
CC   -!- INTERACTION:
CC       Q6PIL6:KCNIP4; NbExp=5; IntAct=EBI-983038, EBI-1051469;
CC       O43765:SGTA; NbExp=8; IntAct=EBI-983038, EBI-347996;
CC       Q96EQ0:SGTB; NbExp=3; IntAct=EBI-983038, EBI-744081;
CC       Q9UMX0:UBQLN1; NbExp=5; IntAct=EBI-983038, EBI-741480;
CC       Q9UMX0-2:UBQLN1; NbExp=6; IntAct=EBI-983038, EBI-10173939;
CC   -!- SUBCELLULAR LOCATION: Secreted, extracellular space, extracellular
CC       matrix {ECO:0000255|PROSITE-ProRule:PRU00793}.
CC   -!- TISSUE SPECIFICITY: Forms the fibrils of tendon, ligaments and
CC       bones. In bones the fibrils are mineralized with calcium
CC       hydroxyapatite.
CC   -!- DOMAIN: The C-terminal propeptide, also known as COLFI domain,
CC       have crucial roles in tissue growth and repair by controlling both
CC       the intracellular assembly of procollagen molecules and the
CC       extracellular assembly of collagen fibrils. It binds a calcium ion
CC       which is essential for its function. {ECO:0000250}.
CC   -!- PTM: Prolines at the third position of the tripeptide repeating
CC       unit (G-X-Y) are hydroxylated in some or all of the chains.
CC       {ECO:0000269|PubMed:4412529}.
CC   -!- DISEASE: Ehlers-Danlos syndrome 7B (EDS7B) [MIM:130060]: A
CC       connective tissue disorder characterized by hyperextensible skin,
CC       atrophic cutaneous scars due to tissue fragility and joint
CC       hyperlaxity. Marked by bilateral congenital hip dislocation,
CC       hyperlaxity of the joints, and recurrent partial dislocations.
CC       {ECO:0000269|PubMed:1577745, ECO:0000269|PubMed:2394758,
CC       ECO:0000269|PubMed:3680255}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Osteogenesis imperfecta 1 (OI1) [MIM:166200]: An
CC       autosomal dominant form of osteogenesis imperfecta, a connective
CC       tissue disorder characterized by low bone mass, bone fragility and
CC       susceptibility to fractures after minimal trauma. Disease severity
CC       ranges from very mild forms without fractures to intrauterine
CC       fractures and perinatal lethality. Extraskeletal manifestations,
CC       which affect a variable number of patients, are dentinogenesis
CC       imperfecta, hearing loss, and blue sclerae. OI1 is a non-deforming
CC       form with normal height or mild short stature, and no
CC       dentinogenesis imperfecta. {ECO:0000269|PubMed:16705691,
CC       ECO:0000269|PubMed:16786509, ECO:0000269|PubMed:1990009,
CC       ECO:0000269|PubMed:8456807, ECO:0000269|PubMed:8829649}. Note=The
CC       disease is caused by mutations affecting the gene represented in
CC       this entry.
CC   -!- DISEASE: Osteogenesis imperfecta 2 (OI2) [MIM:166210]: An
CC       autosomal dominant form of osteogenesis imperfecta, a connective
CC       tissue disorder characterized by low bone mass, bone fragility and
CC       susceptibility to fractures after minimal trauma. Disease severity
CC       ranges from very mild forms without fractures to intrauterine
CC       fractures and perinatal lethality. Extraskeletal manifestations,
CC       which affect a variable number of patients, are dentinogenesis
CC       imperfecta, hearing loss, and blue sclerae. OI2 is characterized
CC       by bone fragility, with many perinatal fractures, severe bowing of
CC       long bones, undermineralization, and death in the perinatal period
CC       due to respiratory insufficiency. {ECO:0000269|PubMed:10627137,
CC       ECO:0000269|PubMed:1284475, ECO:0000269|PubMed:1339453,
CC       ECO:0000269|PubMed:1385413, ECO:0000269|PubMed:16786509,
CC       ECO:0000269|PubMed:16879195, ECO:0000269|PubMed:1874719,
CC       ECO:0000269|PubMed:18996919, ECO:0000269|PubMed:2777764,
CC       ECO:0000269|PubMed:2914942, ECO:0000269|PubMed:7693712,
CC       ECO:0000269|PubMed:7891382, ECO:0000269|PubMed:7906591,
CC       ECO:0000269|PubMed:7959683, ECO:0000269|PubMed:8182080,
CC       ECO:0000269|Ref.34}. Note=The disease is caused by mutations
CC       affecting the gene represented in this entry.
CC   -!- DISEASE: Ehlers-Danlos syndrome, autosomal recessive, cardiac
CC       valvular form (EDSCV) [MIM:225320]: A connective tissue disorder
CC       characterized by hyperextensible skin, atrophic cutaneous scars
CC       due to tissue fragility and joint hyperlaxity. In addition to
CC       joint laxity, skin hyperextensibility and friability, and abnormal
CC       scar formation, patients have mitral valve prolapse and
CC       insufficiency, mitral regurgitation, and aortic insufficiency.
CC       {ECO:0000269|PubMed:16816023}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Osteogenesis imperfecta 3 (OI3) [MIM:259420]: An
CC       autosomal dominant form of osteogenesis imperfecta, a connective
CC       tissue disorder characterized by low bone mass, bone fragility and
CC       susceptibility to fractures after minimal trauma. Disease severity
CC       ranges from very mild forms without fractures to intrauterine
CC       fractures and perinatal lethality. Extraskeletal manifestations,
CC       which affect a variable number of patients, are dentinogenesis
CC       imperfecta, hearing loss, and blue sclerae. OI3 is characterized
CC       by progressively deforming bones, very short stature, a triangular
CC       face, severe scoliosis, grayish sclera and dentinogenesis
CC       imperfecta. {ECO:0000269|PubMed:10408781,
CC       ECO:0000269|PubMed:16786509, ECO:0000269|PubMed:16879195,
CC       ECO:0000269|PubMed:1990009, ECO:0000269|PubMed:7520724,
CC       ECO:0000269|PubMed:7720740, ECO:0000269|PubMed:7749416,
CC       ECO:0000269|PubMed:7860070, ECO:0000269|PubMed:7881420,
CC       ECO:0000269|PubMed:8081394, ECO:0000269|PubMed:8444468,
CC       ECO:0000269|PubMed:8456807, ECO:0000269|PubMed:8723681,
CC       ECO:0000269|PubMed:8800927, ECO:0000269|PubMed:8829649}. Note=The
CC       disease is caused by mutations affecting the gene represented in
CC       this entry.
CC   -!- DISEASE: Osteogenesis imperfecta 4 (OI4) [MIM:166220]: An
CC       autosomal dominant form of osteogenesis imperfecta, a connective
CC       tissue disorder characterized by low bone mass, bone fragility and
CC       susceptibility to fractures after minimal trauma. Disease severity
CC       ranges from very mild forms without fractures to intrauterine
CC       fractures and perinatal lethality. Extraskeletal manifestations,
CC       which affect a variable number of patients, are dentinogenesis
CC       imperfecta, hearing loss, and blue sclerae. OI4 is characterized
CC       by moderately short stature, mild to moderate scoliosis, grayish
CC       or white sclera and dentinogenesis imperfecta.
CC       {ECO:0000269|PubMed:1642148, ECO:0000269|PubMed:16786509,
CC       ECO:0000269|PubMed:16879195, ECO:0000269|PubMed:2052622,
CC       ECO:0000269|PubMed:2064612, ECO:0000269|PubMed:2897363,
CC       ECO:0000269|PubMed:7693712, ECO:0000269|PubMed:8094076,
CC       ECO:0000269|PubMed:8401517, ECO:0000269|PubMed:8800927}. Note=The
CC       disease is caused by mutations affecting the gene represented in
CC       this entry.
CC   -!- DISEASE: Note=A chromosomal aberration involving COL1A2 may be a
CC       cause of lipoblastomas, which are benign tumors resulting from
CC       transformation of adipocytes, usually diagnosed in children.
CC       Translocation t(7;8)(p22;q13) with PLAG1.
CC   -!- SIMILARITY: Belongs to the fibrillar collagen family.
CC       {ECO:0000255|PROSITE-ProRule:PRU00793}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/COL1A2ID411ch7q22.html";
CC   -!- WEB RESOURCE: Name=Osteogenesis imperfecta variant database;
CC       Note=Collagen type I alpha 2 (COL1A2);
CC       URL="http://oi.gene.le.ac.uk/home.php?select_db=COL1A2";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; J03464; AAB59374.1; -; mRNA.
DR   EMBL; Z74616; CAA98969.1; -; mRNA.
DR   EMBL; AF004877; AAB93981.1; -; Genomic_DNA.
DR   EMBL; BC042586; AAH42586.1; -; mRNA.
DR   EMBL; BC054498; AAH54498.1; -; mRNA.
DR   EMBL; Y00724; CAA68709.1; -; mRNA.
DR   EMBL; X02488; CAA26320.1; -; mRNA.
DR   EMBL; AB004317; BAA25383.1; -; Genomic_DNA.
DR   EMBL; M35391; AAA60041.1; -; Genomic_DNA.
DR   EMBL; S98904; AAB22126.1; -; Genomic_DNA.
DR   EMBL; M21671; AAA59994.1; -; Genomic_DNA.
DR   EMBL; S41099; AAB22761.1; -; mRNA.
DR   EMBL; AC002528; AAB69977.1; -; Genomic_DNA.
DR   EMBL; M21353; AAA52053.1; -; Genomic_DNA.
DR   EMBL; M28985; AAA60356.1; -; Genomic_DNA.
DR   EMBL; V00503; CAA23761.1; -; mRNA.
DR   EMBL; S96821; AAB22020.2; -; mRNA.
DR   EMBL; L47668; AAB59577.1; -; mRNA.
DR   EMBL; X55525; CAA39142.1; -; mRNA.
DR   EMBL; J00114; AAA51996.1; -; mRNA.
DR   EMBL; M22816; AAA51844.1; -; mRNA.
DR   EMBL; M22817; AAA51846.1; -; Genomic_DNA.
DR   EMBL; K01078; AAA51887.1; -; Genomic_DNA.
DR   EMBL; K02568; AAA51850.1; -; Genomic_DNA.
DR   CCDS; CCDS34682.1; -.
DR   PIR; A28500; CGHU2S.
DR   RefSeq; NP_000080.2; NM_000089.3.
DR   UniGene; Hs.489142; -.
DR   PDB; 5CTD; X-ray; 1.60 A; B=484-495.
DR   PDB; 5CTI; X-ray; 1.90 A; B=484-495.
DR   PDB; 5CVA; X-ray; 2.10 A; A/D=484-495.
DR   PDBsum; 5CTD; -.
DR   PDBsum; 5CTI; -.
DR   PDBsum; 5CVA; -.
DR   ProteinModelPortal; P08123; -.
DR   SMR; P08123; -.
DR   BioGrid; 107675; 22.
DR   DIP; DIP-36079N; -.
DR   IntAct; P08123; 20.
DR   MINT; P08123; -.
DR   STRING; 9606.ENSP00000297268; -.
DR   ChEMBL; CHEMBL2685; -.
DR   DrugBank; DB00048; Collagenase clostridium histolyticum.
DR   iPTMnet; P08123; -.
DR   PhosphoSitePlus; P08123; -.
DR   BioMuta; COL1A2; -.
DR   DMDM; 296439507; -.
DR   MaxQB; P08123; -.
DR   PaxDb; P08123; -.
DR   PeptideAtlas; P08123; -.
DR   PRIDE; P08123; -.
DR   Ensembl; ENST00000297268; ENSP00000297268; ENSG00000164692.
DR   GeneID; 1278; -.
DR   KEGG; hsa:1278; -.
DR   UCSC; uc003ung.1; human.
DR   CTD; 1278; -.
DR   DisGeNET; 1278; -.
DR   EuPathDB; HostDB:ENSG00000164692.17; -.
DR   GeneCards; COL1A2; -.
DR   GeneReviews; COL1A2; -.
DR   H-InvDB; HIX0006854; -.
DR   HGNC; HGNC:2198; COL1A2.
DR   HPA; CAB032650; -.
DR   HPA; HPA059738; -.
DR   MalaCards; COL1A2; -.
DR   MIM; 120160; gene.
DR   MIM; 130060; phenotype.
DR   MIM; 166200; phenotype.
DR   MIM; 166210; phenotype.
DR   MIM; 166220; phenotype.
DR   MIM; 225320; phenotype.
DR   MIM; 259420; phenotype.
DR   neXtProt; NX_P08123; -.
DR   OpenTargets; ENSG00000164692; -.
DR   Orphanet; 99876; Ehlers-Danlos syndrome type 7B.
DR   Orphanet; 230851; Ehlers-Danlos syndrome, cardiac valvular type.
DR   Orphanet; 230857; Ehlers-Danlos/osteogenesis imperfecta syndrome.
DR   Orphanet; 314029; High bone mass osteogenesis imperfecta.
DR   Orphanet; 216796; Osteogenesis imperfecta type 1.
DR   Orphanet; 216804; Osteogenesis imperfecta type 2.
DR   Orphanet; 216812; Osteogenesis imperfecta type 3.
DR   Orphanet; 216820; Osteogenesis imperfecta type 4.
DR   PharmGKB; PA35042; -.
DR   eggNOG; KOG3544; Eukaryota.
DR   eggNOG; ENOG410XNMM; LUCA.
DR   GeneTree; ENSGT00900000140789; -.
DR   HOVERGEN; HBG004933; -.
DR   InParanoid; P08123; -.
DR   KO; K06236; -.
DR   OMA; PEWSSGY; -.
DR   OrthoDB; EOG091G03LV; -.
DR   PhylomeDB; P08123; -.
DR   TreeFam; TF344135; -.
DR   Reactome; R-HSA-114604; GPVI-mediated activation cascade.
DR   Reactome; R-HSA-1442490; Collagen degradation.
DR   Reactome; R-HSA-1474244; Extracellular matrix organization.
DR   Reactome; R-HSA-1650814; Collagen biosynthesis and modifying enzymes.
DR   Reactome; R-HSA-198933; Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell.
DR   Reactome; R-HSA-2022090; Assembly of collagen fibrils and other multimeric structures.
DR   Reactome; R-HSA-202733; Cell surface interactions at the vascular wall.
DR   Reactome; R-HSA-216083; Integrin cell surface interactions.
DR   Reactome; R-HSA-2214320; Anchoring fibril formation.
DR   Reactome; R-HSA-2243919; Crosslinking of collagen fibrils.
DR   Reactome; R-HSA-3000170; Syndecan interactions.
DR   Reactome; R-HSA-3000171; Non-integrin membrane-ECM interactions.
DR   Reactome; R-HSA-3000178; ECM proteoglycans.
DR   Reactome; R-HSA-3000480; Scavenging by Class A Receptors.
DR   Reactome; R-HSA-430116; GP1b-IX-V activation signalling.
DR   Reactome; R-HSA-6785807; Interleukin-4 and 13 signaling.
DR   Reactome; R-HSA-75892; Platelet Adhesion to exposed collagen.
DR   Reactome; R-HSA-76009; Platelet Aggregation (Plug Formation).
DR   Reactome; R-HSA-8874081; MET activates PTK2 signaling.
DR   Reactome; R-HSA-8948216; Collagen chain trimerization.
DR   SIGNOR; P08123; -.
DR   ChiTaRS; COL1A2; human.
DR   GeneWiki; COL1A2; -.
DR   GenomeRNAi; 1278; -.
DR   PRO; PR:P08123; -.
DR   Proteomes; UP000005640; Chromosome 7.
DR   Bgee; ENSG00000164692; -.
DR   ExpressionAtlas; P08123; baseline and differential.
DR   Genevisible; P08123; HS.
DR   GO; GO:0005584; C:collagen type I trimer; IDA:UniProtKB.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:HPA.
DR   GO; GO:0005788; C:endoplasmic reticulum lumen; TAS:Reactome.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0031012; C:extracellular matrix; HDA:UniProtKB.
DR   GO; GO:0005576; C:extracellular region; HDA:BHF-UCL.
DR   GO; GO:0005615; C:extracellular space; IDA:UniProtKB.
DR   GO; GO:0005201; F:extracellular matrix structural constituent; NAS:UniProtKB.
DR   GO; GO:0042802; F:identical protein binding; IDA:UniProtKB.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0048407; F:platelet-derived growth factor binding; IDA:MGI.
DR   GO; GO:0002020; F:protease binding; IPI:CAFA.
DR   GO; GO:0030674; F:protein binding, bridging; IMP:UniProtKB.
DR   GO; GO:0046332; F:SMAD binding; IEA:Ensembl.
DR   GO; GO:0007596; P:blood coagulation; TAS:Reactome.
DR   GO; GO:0001568; P:blood vessel development; IMP:UniProtKB.
DR   GO; GO:0071230; P:cellular response to amino acid stimulus; IEA:Ensembl.
DR   GO; GO:0030199; P:collagen fibril organization; IMP:UniProtKB.
DR   GO; GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome.
DR   GO; GO:0030198; P:extracellular matrix organization; TAS:Reactome.
DR   GO; GO:0050900; P:leukocyte migration; TAS:Reactome.
DR   GO; GO:0042476; P:odontogenesis; NAS:UniProtKB.
DR   GO; GO:0030168; P:platelet activation; TAS:Reactome.
DR   GO; GO:0070208; P:protein heterotrimerization; IEA:Ensembl.
DR   GO; GO:0008217; P:regulation of blood pressure; IMP:UniProtKB.
DR   GO; GO:0050776; P:regulation of immune response; TAS:Reactome.
DR   GO; GO:0007266; P:Rho protein signal transduction; IDA:UniProtKB.
DR   GO; GO:0001501; P:skeletal system development; IMP:UniProtKB.
DR   GO; GO:0043589; P:skin morphogenesis; IMP:UniProtKB.
DR   GO; GO:0007179; P:transforming growth factor beta receptor signaling pathway; IDA:UniProtKB.
DR   InterPro; IPR008160; Collagen.
DR   InterPro; IPR000885; Fib_collagen_C.
DR   Pfam; PF01410; COLFI; 1.
DR   Pfam; PF01391; Collagen; 6.
DR   ProDom; PD002078; Fib_collagen_C; 1.
DR   SMART; SM00038; COLFI; 1.
DR   PROSITE; PS51461; NC1_FIB; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Calcium; Chromosomal rearrangement; Collagen;
KW   Complete proteome; Direct protein sequencing; Disease mutation;
KW   Disulfide bond; Dwarfism; Ehlers-Danlos syndrome;
KW   Extracellular matrix; Glycoprotein; Hydroxylation; Metal-binding;
KW   Osteogenesis imperfecta; Polymorphism; Pyrrolidone carboxylic acid;
KW   Reference proteome; Repeat; Secreted; Signal.
FT   SIGNAL        1     22       {ECO:0000250|UniProtKB:P02466}.
FT   PROPEP       23     79       N-terminal propeptide.
FT                                {ECO:0000269|PubMed:5529814}.
FT                                /FTId=PRO_0000005804.
FT   CHAIN        80   1119       Collagen alpha-2(I) chain.
FT                                /FTId=PRO_0000005805.
FT   PROPEP     1120   1366       C-terminal propeptide.
FT                                /FTId=PRO_0000005806.
FT   DOMAIN     1133   1366       Fibrillar collagen NC1.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00793}.
FT   METAL      1181   1181       Calcium. {ECO:0000250|UniProtKB:Q03692}.
FT   METAL      1183   1183       Calcium. {ECO:0000250|UniProtKB:Q03692}.
FT   METAL      1184   1184       Calcium; via carbonyl oxygen.
FT                                {ECO:0000250|UniProtKB:Q03692}.
FT   METAL      1186   1186       Calcium; via carbonyl oxygen.
FT                                {ECO:0000250|UniProtKB:Q03692}.
FT   METAL      1189   1189       Calcium. {ECO:0000250|UniProtKB:Q03692}.
FT   MOD_RES      23     23       Pyrrolidone carboxylic acid.
FT                                {ECO:0000269|PubMed:2394758}.
FT   MOD_RES      47     47       4-hydroxyproline.
FT                                {ECO:0000269|PubMed:2394758,
FT                                ECO:0000269|PubMed:3680255}.
FT   MOD_RES      50     50       4-hydroxyproline.
FT                                {ECO:0000269|PubMed:2394758,
FT                                ECO:0000269|PubMed:3680255}.
FT   MOD_RES      62     62       4-hydroxyproline.
FT                                {ECO:0000269|PubMed:2394758,
FT                                ECO:0000269|PubMed:3680255}.
FT   MOD_RES      65     65       4-hydroxyproline.
FT                                {ECO:0000269|PubMed:2394758,
FT                                ECO:0000269|PubMed:3680255}.
FT   MOD_RES      68     68       4-hydroxyproline.
FT                                {ECO:0000269|PubMed:2394758,
FT                                ECO:0000269|PubMed:3680255}.
FT   MOD_RES      71     71       4-hydroxyproline.
FT                                {ECO:0000269|PubMed:2394758,
FT                                ECO:0000269|PubMed:3680255}.
FT   MOD_RES      80     80       Pyrrolidone carboxylic acid.
FT                                {ECO:0000269|PubMed:5529814}.
FT   MOD_RES      84     84       Allysine. {ECO:0000269|PubMed:5529814}.
FT   MOD_RES     102    102       4-hydroxyproline.
FT                                {ECO:0000269|PubMed:3680255}.
FT   MOD_RES     108    108       4-hydroxyproline.
FT                                {ECO:0000269|PubMed:3680255}.
FT   MOD_RES     177    177       5-hydroxylysine; alternate.
FT                                {ECO:0000269|PubMed:4319110}.
FT   MOD_RES     420    420       4-hydroxyproline.
FT                                {ECO:0000269|PubMed:4412529}.
FT   MOD_RES     441    441       4-hydroxyproline.
FT                                {ECO:0000269|PubMed:4412529}.
FT   MOD_RES     444    444       4-hydroxyproline.
FT                                {ECO:0000269|PubMed:4412529}.
FT   CARBOHYD    177    177       O-linked (Gal...) hydroxylysine;
FT                                alternate. {ECO:0000269|PubMed:4319110}.
FT   CARBOHYD   1267   1267       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID   1163   1195       {ECO:0000255|PROSITE-ProRule:PRU00793}.
FT   DISULFID   1203   1364       {ECO:0000255|PROSITE-ProRule:PRU00793}.
FT   DISULFID   1272   1317       {ECO:0000255|PROSITE-ProRule:PRU00793}.
FT   VARIANT      59     59       T -> P (in dbSNP:rs1800221).
FT                                {ECO:0000269|PubMed:4011429}.
FT                                /FTId=VAR_030116.
FT   VARIANT      76     93       Missing (in EDS7B).
FT                                {ECO:0000269|PubMed:1577745,
FT                                ECO:0000269|PubMed:2394758,
FT                                ECO:0000269|PubMed:3680255}.
FT                                /FTId=VAR_001851.
FT   VARIANT     181    198       Missing (in OI4).
FT                                {ECO:0000269|PubMed:1642148}.
FT                                /FTId=VAR_030117.
FT   VARIANT     193    193       G -> S (in OI4; dbSNP:rs72656370).
FT                                {ECO:0000269|PubMed:16879195}.
FT                                /FTId=VAR_063343.
FT   VARIANT     202    202       G -> R (in OI4; dbSNP:rs72656376).
FT                                {ECO:0000269|PubMed:16786509}.
FT                                /FTId=VAR_063344.
FT   VARIANT     211    211       G -> D (in OI1; dbSNP:rs72656378).
FT                                {ECO:0000269|PubMed:8829649}.
FT                                /FTId=VAR_001852.
FT   VARIANT     234    234       R -> C (in OI2).
FT                                {ECO:0000269|PubMed:18996919}.
FT                                /FTId=VAR_063345.
FT   VARIANT     247    247       G -> R (in OI1).
FT                                {ECO:0000269|PubMed:16786509}.
FT                                /FTId=VAR_063346.
FT   VARIANT     249    249       I -> N (in dbSNP:rs1800228).
FT                                {ECO:0000269|PubMed:2824475}.
FT                                /FTId=VAR_001853.
FT   VARIANT     253    253       G -> D (in OI2; dbSNP:rs72656385).
FT                                {ECO:0000269|PubMed:16786509}.
FT                                /FTId=VAR_063347.
FT   VARIANT     256    256       G -> V (in OI4; dbSNP:rs67525025).
FT                                {ECO:0000269|PubMed:16786509}.
FT                                /FTId=VAR_063348.
FT   VARIANT     270    270       V -> I (in dbSNP:rs368468).
FT                                {ECO:0000269|PubMed:9443882}.
FT                                /FTId=VAR_030118.
FT   VARIANT     276    276       A -> T (in dbSNP:rs1800231).
FT                                {ECO:0000269|PubMed:2824475}.
FT                                /FTId=VAR_001854.
FT   VARIANT     283    283       G -> R (in OI2).
FT                                {ECO:0000269|PubMed:18996919}.
FT                                /FTId=VAR_063349.
FT   VARIANT     319    319       G -> R (in OI1; dbSNP:rs72656393).
FT                                {ECO:0000269|PubMed:16786509}.
FT                                /FTId=VAR_063350.
FT   VARIANT     325    325       G -> E (in OI4; dbSNP:rs72656395).
FT                                {ECO:0000269|PubMed:16705691}.
FT                                /FTId=VAR_063351.
FT   VARIANT     328    328       G -> S (in OI1, OI3 AND OI4;
FT                                dbSNP:rs66612022).
FT                                {ECO:0000269|PubMed:16705691,
FT                                ECO:0000269|PubMed:7860070}.
FT                                /FTId=VAR_001855.
FT   VARIANT     331    331       G -> D (in OI3; dbSNP:rs67729041).
FT                                {ECO:0000269|PubMed:10408781}.
FT                                /FTId=VAR_008119.
FT   VARIANT     334    334       G -> C (in OI2).
FT                                /FTId=VAR_001856.
FT   VARIANT     337    337       G -> C (in OI3; dbSNP:rs67865220).
FT                                {ECO:0000269|PubMed:10408781}.
FT                                /FTId=VAR_001857.
FT   VARIANT     337    337       G -> S (in OI3; dbSNP:rs67865220).
FT                                {ECO:0000269|PubMed:8829649}.
FT                                /FTId=VAR_001858.
FT   VARIANT     344    344       L -> V (in dbSNP:rs16868573).
FT                                /FTId=VAR_055677.
FT   VARIANT     345    345       Missing (in OI3).
FT                                {ECO:0000269|PubMed:8444468}.
FT                                /FTId=VAR_001859.
FT   VARIANT     349    349       G -> C (in OI3; dbSNP:rs66773001).
FT                                {ECO:0000269|PubMed:1990009,
FT                                ECO:0000269|PubMed:8456807}.
FT                                /FTId=VAR_001860.
FT   VARIANT     358    358       G -> S (in OI3; dbSNP:rs66619856).
FT                                {ECO:0000269|PubMed:16705691}.
FT                                /FTId=VAR_063352.
FT   VARIANT     397    397       G -> E (in OI2).
FT                                {ECO:0000269|PubMed:18996919}.
FT                                /FTId=VAR_063353.
FT   VARIANT     409    409       G -> V (in OI2; dbSNP:rs72658109).
FT                                {ECO:0000269|PubMed:10627137}.
FT                                /FTId=VAR_001861.
FT   VARIANT     433    433       G -> E (in OI2; dbSNP:rs72658114).
FT                                {ECO:0000269|PubMed:7906591}.
FT                                /FTId=VAR_001862.
FT   VARIANT     454    454       G -> C (in OI2; dbSNP:rs72658117).
FT                                {ECO:0000269|PubMed:18996919}.
FT                                /FTId=VAR_063354.
FT   VARIANT     457    457       G -> L (in OI2; requires 2 nucleotide
FT                                substitutions).
FT                                {ECO:0000269|PubMed:18996919}.
FT                                /FTId=VAR_063355.
FT   VARIANT     460    460       G -> S (in OI3; dbSNP:rs72658118).
FT                                {ECO:0000269|PubMed:8829649}.
FT                                /FTId=VAR_001863.
FT   VARIANT     461    466       Missing (in OI2).
FT                                {ECO:0000269|PubMed:18996919}.
FT                                /FTId=VAR_063356.
FT   VARIANT     483    483       A -> V (in dbSNP:rs414408).
FT                                {ECO:0000269|PubMed:2824475,
FT                                ECO:0000269|PubMed:9443882}.
FT                                /FTId=VAR_030119.
FT   VARIANT     511    511       G -> D (in OI2; dbSNP:rs66999265).
FT                                /FTId=VAR_001864.
FT   VARIANT     517    517       G -> R (in OI3; dbSNP:rs72658126).
FT                                {ECO:0000269|PubMed:7520724}.
FT                                /FTId=VAR_001865.
FT   VARIANT     526    526       G -> E (in OI2; dbSNP:rs72658130).
FT                                {ECO:0000269|PubMed:18996919}.
FT                                /FTId=VAR_063357.
FT   VARIANT     528    528       N -> S (in dbSNP:rs41317144).
FT                                {ECO:0000269|PubMed:18272325}.
FT                                /FTId=VAR_033040.
FT   VARIANT     547    547       G -> R (in OI2; dbSNP:rs72658136).
FT                                {ECO:0000269|PubMed:1284475}.
FT                                /FTId=VAR_001866.
FT   VARIANT     549    549       P -> A (in dbSNP:rs42524).
FT                                {ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|PubMed:18272325,
FT                                ECO:0000269|PubMed:18996919,
FT                                ECO:0000269|PubMed:2824475,
FT                                ECO:0000269|PubMed:2839839,
FT                                ECO:0000269|PubMed:8456808,
FT                                ECO:0000269|PubMed:9016532}.
FT                                /FTId=VAR_001867.
FT   VARIANT     562    562       G -> C (in OI2; dbSNP:rs72658138).
FT                                /FTId=VAR_001868.
FT   VARIANT     562    562       G -> V (in OI2).
FT                                {ECO:0000269|PubMed:18996919}.
FT                                /FTId=VAR_063358.
FT   VARIANT     564    564       A -> T (in dbSNP:rs41317153).
FT                                {ECO:0000269|PubMed:18272325}.
FT                                /FTId=VAR_033041.
FT   VARIANT     586    586       G -> R (in OI2; dbSNP:rs72658139).
FT                                /FTId=VAR_001869.
FT   VARIANT     592    592       G -> S (in OI2; dbSNP:rs72658141).
FT                                {ECO:0000269|PubMed:7959683}.
FT                                /FTId=VAR_001870.
FT   VARIANT     601    601       G -> S (in OI; dbSNP:rs72658143).
FT                                {ECO:0000269|PubMed:16705691}.
FT                                /FTId=VAR_063359.
FT   VARIANT     625    625       G -> D (in OI2; dbSNP:rs72658145).
FT                                {ECO:0000269|PubMed:16879195}.
FT                                /FTId=VAR_063360.
FT   VARIANT     634    634       G -> V (in OI4; dbSNP:rs72658147).
FT                                {ECO:0000269|PubMed:8401517}.
FT                                /FTId=VAR_001871.
FT   VARIANT     637    637       G -> D (in OI2; dbSNP:rs72658148).
FT                                /FTId=VAR_001872.
FT   VARIANT     640    640       G -> S (in OI2).
FT                                /FTId=VAR_001873.
FT   VARIANT     670    670       G -> D (in OI2; dbSNP:rs72658155).
FT                                {ECO:0000269|PubMed:1385413}.
FT                                /FTId=VAR_001874.
FT   VARIANT     676    855       Missing (in OI2).
FT                                {ECO:0000269|PubMed:1339453}.
FT                                /FTId=VAR_030120.
FT   VARIANT     676    676       G -> D (in OI3; dbSNP:rs66883877).
FT                                {ECO:0000269|PubMed:16705691}.
FT                                /FTId=VAR_063361.
FT   VARIANT     676    676       G -> V (in OI3 and OI4;
FT                                dbSNP:rs66883877).
FT                                {ECO:0000269|PubMed:2064612,
FT                                ECO:0000269|PubMed:7881420}.
FT                                /FTId=VAR_001875.
FT   VARIANT     678    678       P -> H (in dbSNP:rs409108).
FT                                {ECO:0000269|PubMed:2824475,
FT                                ECO:0000269|PubMed:3421913,
FT                                ECO:0000269|PubMed:6687691,
FT                                ECO:0000269|PubMed:9016532,
FT                                ECO:0000269|PubMed:9443882}.
FT                                /FTId=VAR_030121.
FT   VARIANT     705    707       Missing (in OI2).
FT                                {ECO:0000269|PubMed:18996919}.
FT                                /FTId=VAR_063362.
FT   VARIANT     708    708       R -> Q (in Marfan syndrome;
FT                                dbSNP:rs72658163).
FT                                /FTId=VAR_001876.
FT   VARIANT     715    715       G -> D (in OI2; dbSNP:rs72658167).
FT                                /FTId=VAR_001877.
FT   VARIANT     730    730       G -> C (in OI2; dbSNP:rs72658171).
FT                                {ECO:0000269|PubMed:7891382}.
FT                                /FTId=VAR_001878.
FT   VARIANT     733    733       G -> C (in OI1; dbSNP:rs72658172).
FT                                {ECO:0000269|PubMed:16786509}.
FT                                /FTId=VAR_063363.
FT   VARIANT     736    736       G -> C (in OI1; mild; dbSNP:rs72658173).
FT                                {ECO:0000269|PubMed:1990009,
FT                                ECO:0000269|PubMed:8456807}.
FT                                /FTId=VAR_001879.
FT   VARIANT     739    739       G -> R (in OI2; dbSNP:rs72658174).
FT                                {ECO:0000269|PubMed:18996919}.
FT                                /FTId=VAR_063364.
FT   VARIANT     743    743       A -> G (in dbSNP:rs408535).
FT                                {ECO:0000269|PubMed:2824475,
FT                                ECO:0000269|PubMed:3421913,
FT                                ECO:0000269|PubMed:9443882}.
FT                                /FTId=VAR_001880.
FT   VARIANT     748    748       G -> V (in OI2).
FT                                {ECO:0000269|PubMed:18996919}.
FT                                /FTId=VAR_063365.
FT   VARIANT     751    751       G -> S (in OI4; dbSNP:rs72658176).
FT                                {ECO:0000269|PubMed:2052622}.
FT                                /FTId=VAR_001881.
FT   VARIANT     754    754       G -> C (in OI4; dbSNP:rs72658177).
FT                                {ECO:0000269|PubMed:16879195}.
FT                                /FTId=VAR_063366.
FT   VARIANT     754    754       G -> R (in OI2).
FT                                /FTId=VAR_001882.
FT   VARIANT     766    766       G -> V (in OI4; dbSNP:rs72658183).
FT                                {ECO:0000269|PubMed:7693712}.
FT                                /FTId=VAR_001883.
FT   VARIANT     778    778       G -> S (in OI3; dbSNP:rs72658186).
FT                                {ECO:0000269|PubMed:7720740}.
FT                                /FTId=VAR_001884.
FT   VARIANT     784    784       G -> R (in OI2; dbSNP:rs66592844).
FT                                {ECO:0000269|PubMed:1874719}.
FT                                /FTId=VAR_001885.
FT   VARIANT     787    787       G -> C (in OI2; dbSNP:rs72658187).
FT                                {ECO:0000269|PubMed:10627137}.
FT                                /FTId=VAR_001886.
FT   VARIANT     790    790       G -> D (in OI2; dbSNP:rs72658188).
FT                                {ECO:0000269|PubMed:18996919,
FT                                ECO:0000269|PubMed:8182080}.
FT                                /FTId=VAR_001887.
FT   VARIANT     796    796       G -> S (in OI2; dbSNP:rs66716547).
FT                                {ECO:0000269|PubMed:7693712}.
FT                                /FTId=VAR_001888.
FT   VARIANT     798    798       P -> PP (in OI2).
FT                                {ECO:0000269|PubMed:18996919}.
FT                                /FTId=VAR_063367.
FT   VARIANT     806    811       Missing (in OI2).
FT                                {ECO:0000269|PubMed:18996919}.
FT                                /FTId=VAR_063368.
FT   VARIANT     811    811       G -> GPPG (in OI4).
FT                                /FTId=VAR_063369.
FT   VARIANT     820    820       G -> S (in OI3; dbSNP:rs72658191).
FT                                {ECO:0000269|PubMed:16705691}.
FT                                /FTId=VAR_063370.
FT   VARIANT     822    822       R -> H (in dbSNP:rs1800240).
FT                                {ECO:0000269|PubMed:8829649}.
FT                                /FTId=VAR_001889.
FT   VARIANT     835    835       G -> C (in OI3).
FT                                {ECO:0000269|PubMed:16879195}.
FT                                /FTId=VAR_063371.
FT   VARIANT     835    835       G -> S (in OI1; dbSNP:rs72658193).
FT                                {ECO:0000269|PubMed:8829649}.
FT                                /FTId=VAR_001890.
FT   VARIANT     856    856       G -> R (in OI3).
FT                                {ECO:0000269|PubMed:16705691}.
FT                                /FTId=VAR_063372.
FT   VARIANT     856    856       G -> V (in OI2).
FT                                {ECO:0000269|PubMed:18996919}.
FT                                /FTId=VAR_063373.
FT   VARIANT     877    877       G -> C (in OI2; dbSNP:rs72658201).
FT                                {ECO:0000269|Ref.34}.
FT                                /FTId=VAR_001891.
FT   VARIANT     892    892       G -> D (in OI3 and OI4;
FT                                dbSNP:rs72659304).
FT                                {ECO:0000269|PubMed:8800927}.
FT                                /FTId=VAR_001892.
FT   VARIANT     895    895       G -> D (in OI2; dbSNP:rs72659305).
FT                                /FTId=VAR_001893.
FT   VARIANT     949    949       G -> S (in OI3; moderate;
FT                                dbSNP:rs72659312).
FT                                {ECO:0000269|PubMed:18996919,
FT                                ECO:0000269|PubMed:8081394}.
FT                                /FTId=VAR_001894.
FT   VARIANT     955    955       G -> D (in OI2).
FT                                {ECO:0000269|PubMed:18996919}.
FT                                /FTId=VAR_063374.
FT   VARIANT     955    955       G -> S (in OI2; dbSNP:rs66507857).
FT                                {ECO:0000269|PubMed:2777764}.
FT                                /FTId=VAR_001895.
FT   VARIANT     973    973       G -> V (in OI3; dbSNP:rs67609234).
FT                                {ECO:0000269|PubMed:10408781}.
FT                                /FTId=VAR_008120.
FT   VARIANT     982    982       G -> D (in OI2; dbSNP:rs67422093).
FT                                {ECO:0000269|PubMed:16786509}.
FT                                /FTId=VAR_063375.
FT   VARIANT     989    989       P -> PVGP (in OI4).
FT                                /FTId=VAR_063376.
FT   VARIANT     991    991       G -> V (in OI3; dbSNP:rs72659316).
FT                                {ECO:0000269|PubMed:16879195}.
FT                                /FTId=VAR_063377.
FT   VARIANT     997    997       G -> D (in OI2; dbSNP:rs72659317).
FT                                {ECO:0000269|PubMed:2914942}.
FT                                /FTId=VAR_001896.
FT   VARIANT    1003   1003       G -> D (in OI2).
FT                                {ECO:0000269|PubMed:16786509}.
FT                                /FTId=VAR_063378.
FT   VARIANT    1012   1012       G -> S (in OI3 and OI4; moderate;
FT                                dbSNP:rs72659319).
FT                                {ECO:0000269|PubMed:16705691,
FT                                ECO:0000269|PubMed:8094076}.
FT                                /FTId=VAR_001897.
FT   VARIANT    1022   1022       L -> F (in dbSNP:rs392609).
FT                                {ECO:0000269|PubMed:2824475,
FT                                ECO:0000269|PubMed:6687691,
FT                                ECO:0000269|PubMed:9443882}.
FT                                /FTId=VAR_001898.
FT   VARIANT    1027   1027       G -> E (in OI2; dbSNP:rs72659323).
FT                                {ECO:0000269|PubMed:18996919}.
FT                                /FTId=VAR_063379.
FT   VARIANT    1058   1062       Missing (in OI2).
FT                                {ECO:0000269|PubMed:18996919}.
FT                                /FTId=VAR_063380.
FT   VARIANT    1066   1066       G -> D (in OI2; dbSNP:rs72659331).
FT                                /FTId=VAR_001899.
FT   VARIANT    1067   1067       R -> H (in dbSNP:rs530026906).
FT                                {ECO:0000269|PubMed:23656646}.
FT                                /FTId=VAR_069633.
FT   VARIANT    1078   1078       G -> C (in OI2).
FT                                /FTId=VAR_001900.
FT   VARIANT    1087   1087       G -> D (in OI3; dbSNP:rs72659335).
FT                                {ECO:0000269|PubMed:16786509}.
FT                                /FTId=VAR_063381.
FT   VARIANT    1094   1096       Missing (in OI4).
FT                                {ECO:0000269|PubMed:16705691}.
FT                                /FTId=VAR_063382.
FT   VARIANT    1096   1096       G -> A (in OI3; dbSNP:rs72659337).
FT                                {ECO:0000269|PubMed:7749416}.
FT                                /FTId=VAR_001901.
FT   VARIANT    1101   1101       P -> L.
FT                                /FTId=VAR_001903.
FT   VARIANT    1102   1102       G -> R (in OI4; dbSNP:rs67768540).
FT                                {ECO:0000269|PubMed:2897363}.
FT                                /FTId=VAR_001902.
FT   VARIANT    1119   1119       A -> T (found in a patient with mild
FT                                osteogenesis imperfecta associated with
FT                                increased bone mineral density; results
FT                                in defective type I procollagen
FT                                processing; incorporation of the immature
FT                                procollagen into the matrix leads to
FT                                increased bone matrix mineralization and
FT                                altered collagen fibril structure).
FT                                {ECO:0000269|PubMed:21344539}.
FT                                /FTId=VAR_066386.
FT   VARIANT    1148   1148       T -> P (in OI3; dbSNP:rs1800250).
FT                                {ECO:0000269|PubMed:8723681}.
FT                                /FTId=VAR_001904.
FT   VARIANT    1189   1189       D -> E (in dbSNP:rs422361).
FT                                {ECO:0000269|PubMed:2824475,
FT                                ECO:0000269|PubMed:6687691,
FT                                ECO:0000269|PubMed:9443882}.
FT                                /FTId=VAR_001905.
FT   VARIANT    1195   1195       C -> Y (in OI1; dbSNP:rs72659342).
FT                                {ECO:0000269|PubMed:16786509}.
FT                                /FTId=VAR_063383.
FT   VARIANT    1198   1198       S -> P (in dbSNP:rs384487).
FT                                {ECO:0000269|PubMed:2824475,
FT                                ECO:0000269|PubMed:6687691,
FT                                ECO:0000269|PubMed:9443882}.
FT                                /FTId=VAR_001906.
FT   VARIANT    1354   1354       Q -> H (in dbSNP:rs418570).
FT                                {ECO:0000269|PubMed:2364107,
FT                                ECO:0000269|PubMed:2824475,
FT                                ECO:0000269|PubMed:6092353,
FT                                ECO:0000269|PubMed:6309769,
FT                                ECO:0000269|PubMed:6687691,
FT                                ECO:0000269|PubMed:9016532,
FT                                ECO:0000269|PubMed:9443882}.
FT                                /FTId=VAR_030122.
FT   CONFLICT     55     55       E -> G (in Ref. 6; CAA26320).
FT                                {ECO:0000305}.
FT   CONFLICT    333    333       V -> P (in Ref. 1; AAB59374).
FT                                {ECO:0000305}.
FT   CONFLICT    338    338       A -> T (in Ref. 1; AAB59374).
FT                                {ECO:0000305}.
FT   CONFLICT    549    549       P -> D (in Ref. 5; CAA68709).
FT                                {ECO:0000305}.
FT   CONFLICT    828    828       V -> A (in Ref. 19; CAA23761).
FT                                {ECO:0000305}.
FT   CONFLICT    831    831       T -> P (in Ref. 19; CAA23761).
FT                                {ECO:0000305}.
FT   CONFLICT    837    837       V -> P (in Ref. 19; CAA23761).
FT                                {ECO:0000305}.
FT   CONFLICT    980    980       E -> V (in Ref. 23; AAA51996).
FT                                {ECO:0000305}.
FT   CONFLICT   1098   1098       P -> L (in Ref. 19; CAA23761).
FT                                {ECO:0000305}.
FT   CONFLICT   1122   1125       Missing (in Ref. 19; CAA23761).
FT                                {ECO:0000305}.
FT   CONFLICT   1338   1338       R -> A (in Ref. 25; AAA51887).
FT                                {ECO:0000305}.
SQ   SEQUENCE   1366 AA;  129314 MW;  1E68A5970FB4210A CRC64;
     MLSFVDTRTL LLLAVTLCLA TCQSLQEETV RKGPAGDRGP RGERGPPGPP GRDGEDGPTG
     PPGPPGPPGP PGLGGNFAAQ YDGKGVGLGP GPMGLMGPRG PPGAAGAPGP QGFQGPAGEP
     GEPGQTGPAG ARGPAGPPGK AGEDGHPGKP GRPGERGVVG PQGARGFPGT PGLPGFKGIR
     GHNGLDGLKG QPGAPGVKGE PGAPGENGTP GQTGARGLPG ERGRVGAPGP AGARGSDGSV
     GPVGPAGPIG SAGPPGFPGA PGPKGEIGAV GNAGPAGPAG PRGEVGLPGL SGPVGPPGNP
     GANGLTGAKG AAGLPGVAGA PGLPGPRGIP GPVGAAGATG ARGLVGEPGP AGSKGESGNK
     GEPGSAGPQG PPGPSGEEGK RGPNGEAGSA GPPGPPGLRG SPGSRGLPGA DGRAGVMGPP
     GSRGASGPAG VRGPNGDAGR PGEPGLMGPR GLPGSPGNIG PAGKEGPVGL PGIDGRPGPI
     GPAGARGEPG NIGFPGPKGP TGDPGKNGDK GHAGLAGARG APGPDGNNGA QGPPGPQGVQ
     GGKGEQGPPG PPGFQGLPGP SGPAGEVGKP GERGLHGEFG LPGPAGPRGE RGPPGESGAA
     GPTGPIGSRG PSGPPGPDGN KGEPGVVGAV GTAGPSGPSG LPGERGAAGI PGGKGEKGEP
     GLRGEIGNPG RDGARGAPGA VGAPGPAGAT GDRGEAGAAG PAGPAGPRGS PGERGEVGPA
     GPNGFAGPAG AAGQPGAKGE RGAKGPKGEN GVVGPTGPVG AAGPAGPNGP PGPAGSRGDG
     GPPGMTGFPG AAGRTGPPGP SGISGPPGPP GPAGKEGLRG PRGDQGPVGR TGEVGAVGPP
     GFAGEKGPSG EAGTAGPPGT PGPQGLLGAP GILGLPGSRG ERGLPGVAGA VGEPGPLGIA
     GPPGARGPPG AVGSPGVNGA PGEAGRDGNP GNDGPPGRDG QPGHKGERGY PGNIGPVGAA
     GAPGPHGPVG PAGKHGNRGE TGPSGPVGPA GAVGPRGPSG PQGIRGDKGE PGEKGPRGLP
     GLKGHNGLQG LPGIAGHHGD QGAPGSVGPA GPRGPAGPSG PAGKDGRTGH PGTVGPAGIR
     GPQGHQGPAG PPGPPGPPGP PGVSGGGYDF GYDGDFYRAD QPRSAPSLRP KDYEVDATLK
     SLNNQIETLL TPEGSRKNPA RTCRDLRLSH PEWSSGYYWI DPNQGCTMDA IKVYCDFSTG
     ETCIRAQPEN IPAKNWYRSS KDKKHVWLGE TINAGSQFEY NVEGVTSKEM ATQLAFMRLL
     ANYASQNITY HCKNSIAYMD EETGNLKKAV ILQGSNDVEL VAEGNSRFTY TVLVDGCSKK
     TNEWGKTIIE YKTNKPSRLP FLDIAPLDIG GADQEFFVDI GPVCFK
//
ID   E9PP49_HUMAN            Unreviewed;       638 AA.
AC   E9PP49;
DT   05-APR-2011, integrated into UniProtKB/TrEMBL.
DT   05-APR-2011, sequence version 1.
DT   23-MAY-2018, entry version 63.
DE   SubName: Full=Collagen alpha-2(VIII) chain {ECO:0000313|Ensembl:ENSP00000436433};
DE   SubName: Full=Collagen type VIII alpha 2 {ECO:0000313|EMBL:AGN55426.1};
GN   Name=COL8A2 {ECO:0000313|EMBL:AGN55426.1,
GN   ECO:0000313|Ensembl:ENSP00000436433};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000436433, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Ensembl:ENSP00000436433, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S., Hart E., Haugen E., Heath P.D., Holmes S.,
RA   Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G., Isherwood J.,
RA   James R., Johnson C., Johnson D., Joy A., Kay M., Kershaw J.K.,
RA   Kibukawa M., Kimberley A.M., King A., Knights A.J., Lad H., Laird G.,
RA   Lawlor S., Leongamornlert D.A., Lloyd D.M., Loveland J., Lovell J.,
RA   Lush M.J., Lyne R., Martin S., Mashreghi-Mohammadi M., Matthews L.,
RA   Matthews N.S., McLaren S., Milne S., Mistry S., Moore M.J.,
RA   Nickerson T., O'Dell C.N., Oliver K., Palmeiri A., Palmer S.A.,
RA   Parker A., Patel D., Pearce A.V., Peck A.I., Pelan S., Phelps K.,
RA   Phillimore B.J., Plumb R., Rajan J., Raymond C., Rouse G.,
RA   Saenphimmachak C., Sehra H.K., Sheridan E., Shownkeen R., Sims S.,
RA   Skuce C.D., Smith M., Steward C., Subramanian S., Sycamore N.,
RA   Tracey A., Tromans A., Van Helmond Z., Wall M., Wallis J.M., White S.,
RA   Whitehead S.L., Wilkinson J.E., Willey D.L., Williams H., Wilming L.,
RA   Wray P.W., Wu Z., Coulson A., Vaudin M., Sulston J.E., Durbin R.,
RA   Hubbard T., Wooster R., Dunham I., Carter N.P., McVean G., Ross M.T.,
RA   Harrow J., Olson M.V., Beck S., Rogers J., Bentley D.R., Banerjee R.,
RA   Bryant S.P., Burford D.C., Burrill W.D., Clegg S.M., Dhami P.,
RA   Dovey O., Faulkner L.M., Gribble S.M., Langford C.F., Pandian R.D.,
RA   Porter K.M., Prigmore E.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [2] {ECO:0000313|Ensembl:ENSP00000436433}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (JUL-2011) to UniProtKB.
RN   [3] {ECO:0000313|EMBL:AGN55426.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Tang H., Lei H., Dong H., Zhang W., Shou T., Yan X.-M.;
RL   Submitted (NOV-2012) to the EMBL/GenBank/DDBJ databases.
CC   -!- SUBCELLULAR LOCATION: Secreted {ECO:0000256|SAAS:SAAS00562217}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AL138787; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; KC130914; AGN55426.1; -; Genomic_DNA.
DR   EMBL; KC130915; AGN55427.1; -; Genomic_DNA.
DR   EMBL; KC130917; AGN55429.1; -; Genomic_DNA.
DR   RefSeq; NP_001281276.1; NM_001294347.1.
DR   UniGene; Hs.353001; -.
DR   Ensembl; ENST00000481785; ENSP00000436433; ENSG00000171812.
DR   GeneID; 1296; -.
DR   UCSC; uc001bzw.4; human.
DR   CTD; 1296; -.
DR   EuPathDB; HostDB:ENSG00000171812.11; -.
DR   HGNC; HGNC:2216; COL8A2.
DR   OpenTargets; ENSG00000171812; -.
DR   eggNOG; ENOG410IHF4; Eukaryota.
DR   eggNOG; ENOG410ZRFW; LUCA.
DR   GeneTree; ENSGT00760000118830; -.
DR   ChiTaRS; COL8A2; human.
DR   GenomeRNAi; 1296; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000171812; -.
DR   GO; GO:0005581; C:collagen trimer; IEA:UniProtKB-KW.
DR   GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR   Gene3D; 2.60.120.40; -; 1.
DR   InterPro; IPR001073; C1q_dom.
DR   InterPro; IPR008160; Collagen.
DR   InterPro; IPR008983; Tumour_necrosis_fac-like_dom.
DR   Pfam; PF00386; C1q; 1.
DR   Pfam; PF01391; Collagen; 3.
DR   PRINTS; PR00007; COMPLEMNTC1Q.
DR   SMART; SM00110; C1Q; 1.
DR   SUPFAM; SSF49842; SSF49842; 1.
DR   PROSITE; PS50871; C1Q; 1.
PE   1: Evidence at protein level;
KW   Collagen {ECO:0000256|SAAS:SAAS00562261, ECO:0000313|EMBL:AGN55426.1};
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   Proteomics identification {ECO:0000213|MaxQB:E9PP49,
KW   ECO:0000213|PeptideAtlas:E9PP49};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640};
KW   Secreted {ECO:0000256|SAAS:SAAS00562230}.
FT   DOMAIN      505    638       C1q. {ECO:0000259|PROSITE:PS50871}.
FT   NON_TER       1      1       {ECO:0000313|EMBL:AGN55426.1}.
SQ   SEQUENCE   638 AA;  60707 MW;  EA6328BCD8888E45 CRC64;
     MPLPLLPMDL KGEPGPPGKP GPRGPPGPPG FPGKPGMGKP GLHGQPGPAG PPGFSRMGKA
     GPPGLPGKVG PPGQPGLRGE PGIRGDQGLR GPPGPPGLPG PSGITIPGKP GAQGVPGPPG
     FQGEPGPQGE PGPPGDRGLK GDNGVGQPGL PGAPGQGGAP GPPGLPGPAG LGKPGLDGLP
     GAPGDKGESG PPGVPGPRGE PGAVGPKGPP GVDGVGVPGA AGLPGPQGPS GAKGEPGTRG
     PPGLIGPTGY GMPGLPGPKG DRGPAGVPGL LGDRGEPGED GEPGEQGPQG LGGPPGLPGS
     AGLPGRRGPP GPKGEAGPGG PPGVPGIRGD QGPSGLAGKP GVPGERGLPG AHGPPGPTGP
     KGEPGFTGRP GGPGVAGALG QKGDLGLPGQ PGLRGPSGIP GLQGPAGPIG PQGLPGLKGE
     PGLPGPPGEG RAGEPGTAGP TGPPGVPGSP GITGPPGPPG PPGPPGAPGA FDETGIAGLH
     LPNGGVEGAV LGKGGKPQFG LGELSAHATP AFTAVLTSPF PASGMPVKFD RTLYNGHSGY
     NPATGIFTCP VGGVYYFAYH VHVKGTNVWV ALYKNNVPAT YTYDEYKKGY LDQASGGAVL
     QLRPNDQVWV QMPSDQANGL YSTEYIHSSF SGFLLCPT
//
ID   CO8A2_HUMAN             Reviewed;         703 AA.
AC   P25067; Q5JV31; Q8TEJ5;
DT   01-MAY-1992, integrated into UniProtKB/Swiss-Prot.
DT   15-MAR-2004, sequence version 2.
DT   23-MAY-2018, entry version 168.
DE   RecName: Full=Collagen alpha-2(VIII) chain;
DE   AltName: Full=Endothelial collagen;
DE   Flags: Precursor;
GN   Name=COL8A2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Spleen;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 66-703.
RX   PubMed=2019595;
RA   Muragaki Y., Jacenko O., Apte S., Mattei M.-G., Ninomiya Y.,
RA   Olsen B.R.;
RT   "The alpha 2(VIII) collagen gene. A novel member of the short chain
RT   collagen family located on the human chromosome 1.";
RL   J. Biol. Chem. 266:7721-7727(1991).
RN   [5]
RP   PROTEOLYTIC PROCESSING.
RX   PubMed=1515454; DOI=10.1016/0925-4439(92)90103-T;
RA   Kittelberger R., Neale T.J., Francky K.T., Greenhill N.S.,
RA   Gibson G.J.;
RT   "Cleavage of type VIII collagen by human neutrophil elastase.";
RL   Biochim. Biophys. Acta 1139:295-299(1992).
RN   [6]
RP   TISSUE SPECIFICITY.
RX   PubMed=10686422; DOI=10.1016/S0945-053X(99)00053-0;
RA   Greenhill N.S., Ruger B.M., Hasan Q., Davis P.F.;
RT   "The alpha1(VIII) and alpha2(VIII) collagen chains form two distinct
RT   homotrimeric proteins in vivo.";
RL   Matrix Biol. 19:19-28(2000).
RN   [7]
RP   SUBUNIT.
RX   PubMed=14990571; DOI=10.1074/jbc.M305805200;
RA   Stephan S., Sherratt M.J., Hodson N., Shuttleworth C.A., Kielty C.M.;
RT   "Expression and supramolecular assembly of recombinant alpha1(viii)
RT   and alpha2(viii) collagen homotrimers.";
RL   J. Biol. Chem. 279:21469-21477(2004).
RN   [8]
RP   TISSUE SPECIFICITY, AND INDUCTION.
RX   PubMed=17888087; DOI=10.1111/j.1365-2362.2007.01864.x;
RA   Gerth J., Cohen C.D., Hopfer U., Lindenmeyer M.T., Sommer M.,
RA   Grone H.J., Wolf G.;
RT   "Collagen type VIII expression in human diabetic nephropathy.";
RL   Eur. J. Clin. Invest. 37:767-773(2007).
RN   [9]
RP   VARIANTS FECD1 GLN-155; GLN-304; ARG-357; HIS-434; LYS-455 AND
RP   LEU-575, VARIANT PPCD2 LYS-455, AND VARIANTS ARG-3 AND ILE-645.
RX   PubMed=11689488; DOI=10.1093/hmg/10.21.2415;
RA   Biswas S., Munier F.L., Yardley J., Hart-Holden N., Perveen R.,
RA   Cousin P., Sutphin J.E., Noble B., Batterbury M., Kielty C.,
RA   Hackett A., Bonshek R., Ridgway A., McLeod D., Sheffield V.C.,
RA   Stone E.M., Schorderet D.F., Black G.C.M.;
RT   "Missense mutations in COL8A2, the gene encoding the alpha-2 chain of
RT   type VIII collagen, cause two forms of corneal endothelial
RT   dystrophy.";
RL   Hum. Mol. Genet. 10:2415-2423(2001).
RN   [10]
RP   VARIANTS GLN-155 AND MET-502.
RX   PubMed=15175909; DOI=10.1007/s10384-003-0063-6;
RA   Kobayashi A., Fujiki K., Murakami A., Kato T., Chen L.-Z., Onoe H.,
RA   Nakayasu K., Sakurai M., Takahashi M., Sugiyama K., Kanai A.;
RT   "Analysis of COL8A2 gene mutation in Japanese patients with Fuchs'
RT   endothelial dystrophy and posterior polymorphous dystrophy.";
RL   Jpn. J. Ophthalmol. 48:195-198(2004).
CC   -!- FUNCTION: Macromolecular component of the subendothelium. Major
CC       component of the Descemet's membrane (basement membrane) of
CC       corneal endothelial cells. Also component of the endothelia of
CC       blood vessels. Necessary for migration and proliferation of
CC       vascular smooth muscle cells and thus, has a potential role in the
CC       maintenance of vessel wall integrity and structure, in particular
CC       in atherogenesis (By similarity). {ECO:0000250}.
CC   -!- SUBUNIT: Homotrimers, or heterotrimers in association with alpha
CC       2(VIII) type collagens. Four homotrimers can form a tetrahedron
CC       stabilized by central interacting C-terminal NC1 trimers.
CC       {ECO:0000269|PubMed:14990571}.
CC   -!- SUBCELLULAR LOCATION: Secreted, extracellular space, extracellular
CC       matrix, basement membrane.
CC   -!- TISSUE SPECIFICITY: Expressed primarily in the subendothelium of
CC       large blood vessels. Also expressed in arterioles and venules in
CC       muscle, heart, kidney, spleen, umbilical cord, liver and lung and
CC       is also found in connective tissue layers around hair follicles,
CC       around nerve bundles in muscle, in the dura of the optic nerve, in
CC       cornea and sclera, and in the perichondrium of cartilaginous
CC       tissues. In the kidney, expressed in mesangial cells, glomerular
CC       endothelial cells, and tubular epithelial cells. Also expressed in
CC       mast cells, and in astrocytes during the repair process. Expressed
CC       in Descemet's membrane. {ECO:0000269|PubMed:10686422,
CC       ECO:0000269|PubMed:17888087}.
CC   -!- INDUCTION: Some up-regulation in diabetic nephropathy.
CC       {ECO:0000269|PubMed:17888087}.
CC   -!- PTM: Proteolytically cleaved by neutrophil elastase, in vitro.
CC       {ECO:0000269|PubMed:1515454}.
CC   -!- PTM: Prolines at the third position of the tripeptide repeating
CC       unit (G-X-Y) are hydroxylated in some or all of the chains.
CC   -!- DISEASE: Corneal dystrophy, Fuchs endothelial, 1 (FECD1)
CC       [MIM:136800]: A corneal disease caused by loss of endothelium of
CC       the central cornea. It is characterized by focal wart-like guttata
CC       that arise from Descemet membrane and develop in the central
CC       cornea, epithelial blisters, reduced vision and pain. Descemet
CC       membrane is thickened by abnormal collagenous deposition.
CC       {ECO:0000269|PubMed:11689488}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Corneal dystrophy, posterior polymorphous, 2 (PPCD2)
CC       [MIM:609140]: A rare mild subtype of posterior corneal dystrophy
CC       characterized by alterations of Descemet membrane presenting as
CC       vesicles, opacities or band-like lesions on slit-lamp examination
CC       and specular microscopy. Affected patient typically are
CC       asymptomatic. {ECO:0000269|PubMed:11689488}. Note=The disease is
CC       caused by mutations affecting the gene represented in this entry.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAB84955.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK074129; BAB84955.1; ALT_INIT; mRNA.
DR   EMBL; AL138787; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471059; EAX07388.1; -; Genomic_DNA.
DR   EMBL; M60832; AAA62822.1; -; Genomic_DNA.
DR   CCDS; CCDS403.1; -.
DR   PIR; A57131; A57131.
DR   RefSeq; NP_001281276.1; NM_001294347.1.
DR   RefSeq; NP_005193.1; NM_005202.3.
DR   UniGene; Hs.353001; -.
DR   ProteinModelPortal; P25067; -.
DR   SMR; P25067; -.
DR   BioGrid; 107693; 18.
DR   STRING; 9606.ENSP00000305913; -.
DR   iPTMnet; P25067; -.
DR   PhosphoSitePlus; P25067; -.
DR   BioMuta; COL8A2; -.
DR   DMDM; 45644957; -.
DR   PaxDb; P25067; -.
DR   PeptideAtlas; P25067; -.
DR   PRIDE; P25067; -.
DR   Ensembl; ENST00000303143; ENSP00000305913; ENSG00000171812.
DR   Ensembl; ENST00000397799; ENSP00000380901; ENSG00000171812.
DR   GeneID; 1296; -.
DR   KEGG; hsa:1296; -.
DR   UCSC; uc001bzv.4; human.
DR   CTD; 1296; -.
DR   DisGeNET; 1296; -.
DR   EuPathDB; HostDB:ENSG00000171812.11; -.
DR   GeneCards; COL8A2; -.
DR   HGNC; HGNC:2216; COL8A2.
DR   HPA; HPA049788; -.
DR   MalaCards; COL8A2; -.
DR   MIM; 120252; gene.
DR   MIM; 136800; phenotype.
DR   MIM; 609140; phenotype.
DR   neXtProt; NX_P25067; -.
DR   OpenTargets; ENSG00000171812; -.
DR   Orphanet; 98974; Fuchs endothelial corneal dystrophy.
DR   Orphanet; 98973; Posterior polymorphous corneal dystrophy.
DR   PharmGKB; PA26732; -.
DR   eggNOG; ENOG410IHF4; Eukaryota.
DR   eggNOG; ENOG410ZRFW; LUCA.
DR   GeneTree; ENSGT00760000118830; -.
DR   HOGENOM; HOG000085653; -.
DR   HOVERGEN; HBG108220; -.
DR   InParanoid; P25067; -.
DR   OMA; KKGYMDQ; -.
DR   OrthoDB; EOG091G0L3Y; -.
DR   PhylomeDB; P25067; -.
DR   TreeFam; TF334029; -.
DR   Reactome; R-HSA-1442490; Collagen degradation.
DR   Reactome; R-HSA-1650814; Collagen biosynthesis and modifying enzymes.
DR   Reactome; R-HSA-2022090; Assembly of collagen fibrils and other multimeric structures.
DR   Reactome; R-HSA-216083; Integrin cell surface interactions.
DR   Reactome; R-HSA-8948216; Collagen chain trimerization.
DR   ChiTaRS; COL8A2; human.
DR   GeneWiki; COL8A2; -.
DR   GenomeRNAi; 1296; -.
DR   PRO; PR:P25067; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000171812; -.
DR   CleanEx; HS_COL8A2; -.
DR   ExpressionAtlas; P25067; baseline and differential.
DR   Genevisible; P25067; HS.
DR   GO; GO:0005604; C:basement membrane; NAS:UniProtKB.
DR   GO; GO:0005581; C:collagen trimer; IEA:UniProtKB-KW.
DR   GO; GO:0005788; C:endoplasmic reticulum lumen; TAS:Reactome.
DR   GO; GO:0005576; C:extracellular region; TAS:Reactome.
DR   GO; GO:0005578; C:proteinaceous extracellular matrix; NAS:UniProtKB.
DR   GO; GO:0005201; F:extracellular matrix structural constituent; NAS:UniProtKB.
DR   GO; GO:0030674; F:protein binding, bridging; NAS:UniProtKB.
DR   GO; GO:0001525; P:angiogenesis; IEA:UniProtKB-KW.
DR   GO; GO:0048593; P:camera-type eye morphogenesis; IEA:Ensembl.
DR   GO; GO:0098609; P:cell-cell adhesion; NAS:UniProtKB.
DR   GO; GO:0050673; P:epithelial cell proliferation; IEA:Ensembl.
DR   GO; GO:0030198; P:extracellular matrix organization; TAS:Reactome.
DR   Gene3D; 2.60.120.40; -; 1.
DR   InterPro; IPR001073; C1q_dom.
DR   InterPro; IPR008160; Collagen.
DR   InterPro; IPR008983; Tumour_necrosis_fac-like_dom.
DR   Pfam; PF00386; C1q; 1.
DR   Pfam; PF01391; Collagen; 1.
DR   PRINTS; PR00007; COMPLEMNTC1Q.
DR   SMART; SM00110; C1Q; 1.
DR   SUPFAM; SSF49842; SSF49842; 1.
DR   PROSITE; PS50871; C1Q; 1.
PE   1: Evidence at protein level;
KW   Angiogenesis; Basement membrane; Cell adhesion; Collagen;
KW   Complete proteome; Corneal dystrophy; Disease mutation;
KW   Extracellular matrix; Hydroxylation; Polymorphism; Reference proteome;
KW   Repeat; Secreted; Signal.
FT   SIGNAL        1     28       {ECO:0000255}.
FT   CHAIN        29    703       Collagen alpha-2(VIII) chain.
FT                                /FTId=PRO_0000005835.
FT   DOMAIN      570    703       C1q. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00368}.
FT   REGION       29     76       Nonhelical region (NC2).
FT   REGION       77    536       Triple-helical region.
FT   REGION      537    703       Nonhelical region (NC1).
FT   VARIANT       3      3       G -> R (in dbSNP:rs115156902).
FT                                {ECO:0000269|PubMed:11689488}.
FT                                /FTId=VAR_017893.
FT   VARIANT     155    155       R -> Q (in FECD1; identified as a
FT                                polymorphism in the Japanese population;
FT                                dbSNP:rs75864656).
FT                                {ECO:0000269|PubMed:11689488,
FT                                ECO:0000269|PubMed:15175909}.
FT                                /FTId=VAR_017894.
FT   VARIANT     304    304       R -> Q (in FECD1; dbSNP:rs369487110).
FT                                {ECO:0000269|PubMed:11689488}.
FT                                /FTId=VAR_017895.
FT   VARIANT     357    357       G -> R (in FECD1; unknown pathological
FT                                significance; dbSNP:rs199786966).
FT                                {ECO:0000269|PubMed:11689488}.
FT                                /FTId=VAR_017896.
FT   VARIANT     434    434       R -> H (in FECD1; dbSNP:rs201235688).
FT                                {ECO:0000269|PubMed:11689488}.
FT                                /FTId=VAR_017897.
FT   VARIANT     455    455       Q -> K (in FECD1 and PPCD2;
FT                                dbSNP:rs80358191).
FT                                {ECO:0000269|PubMed:11689488}.
FT                                /FTId=VAR_017898.
FT   VARIANT     502    502       T -> M (in dbSNP:rs117860804).
FT                                {ECO:0000269|PubMed:15175909}.
FT                                /FTId=VAR_021387.
FT   VARIANT     575    575       P -> L (in FECD1; unknown pathological
FT                                significance; dbSNP:rs145553904).
FT                                {ECO:0000269|PubMed:11689488}.
FT                                /FTId=VAR_017899.
FT   VARIANT     645    645       T -> I (in dbSNP:rs200767854).
FT                                {ECO:0000269|PubMed:11689488}.
FT                                /FTId=VAR_017900.
FT   CONFLICT     88     88       R -> W (in Ref. 4; AAA62822).
FT                                {ECO:0000305}.
FT   CONFLICT    102    102       M -> H (in Ref. 4; AAA62822).
FT                                {ECO:0000305}.
FT   CONFLICT    133    133       K -> N (in Ref. 4; AAA62822).
FT                                {ECO:0000305}.
FT   CONFLICT    347    347       E -> D (in Ref. 4; AAA62822).
FT                                {ECO:0000305}.
FT   CONFLICT    377    378       PK -> LR (in Ref. 4; AAA62822).
FT                                {ECO:0000305}.
FT   CONFLICT    506    506       T -> R (in Ref. 4; AAA62822).
FT                                {ECO:0000305}.
FT   CONFLICT    523    523       P -> L (in Ref. 4; AAA62822).
FT                                {ECO:0000305}.
FT   CONFLICT    529    531       Missing (in Ref. 4; AAA62822).
FT                                {ECO:0000305}.
FT   CONFLICT    585    585       F -> L (in Ref. 4; AAA62822).
FT                                {ECO:0000305}.
FT   CONFLICT    677    677       M -> I (in Ref. 4; AAA62822).
FT                                {ECO:0000305}.
SQ   SEQUENCE   703 AA;  67244 MW;  84BD7CBDBDECD466 CRC64;
     MLGTLTPLSS LLLLLLVLVL GCGPRASSGG GAGGAAGYAP VKYIQPMQKG PVGPPFREGK
     GQYLEMPLPL LPMDLKGEPG PPGKPGPRGP PGPPGFPGKP GMGKPGLHGQ PGPAGPPGFS
     RMGKAGPPGL PGKVGPPGQP GLRGEPGIRG DQGLRGPPGP PGLPGPSGIT IPGKPGAQGV
     PGPPGFQGEP GPQGEPGPPG DRGLKGDNGV GQPGLPGAPG QGGAPGPPGL PGPAGLGKPG
     LDGLPGAPGD KGESGPPGVP GPRGEPGAVG PKGPPGVDGV GVPGAAGLPG PQGPSGAKGE
     PGTRGPPGLI GPTGYGMPGL PGPKGDRGPA GVPGLLGDRG EPGEDGEPGE QGPQGLGGPP
     GLPGSAGLPG RRGPPGPKGE AGPGGPPGVP GIRGDQGPSG LAGKPGVPGE RGLPGAHGPP
     GPTGPKGEPG FTGRPGGPGV AGALGQKGDL GLPGQPGLRG PSGIPGLQGP AGPIGPQGLP
     GLKGEPGLPG PPGEGRAGEP GTAGPTGPPG VPGSPGITGP PGPPGPPGPP GAPGAFDETG
     IAGLHLPNGG VEGAVLGKGG KPQFGLGELS AHATPAFTAV LTSPFPASGM PVKFDRTLYN
     GHSGYNPATG IFTCPVGGVY YFAYHVHVKG TNVWVALYKN NVPATYTYDE YKKGYLDQAS
     GGAVLQLRPN DQVWVQMPSD QANGLYSTEY IHSSFSGFLL CPT
//
ID   A0A024R0A1_HUMAN        Unreviewed;       554 AA.
AC   A0A024R0A1;
DT   09-JUL-2014, integrated into UniProtKB/TrEMBL.
DT   09-JUL-2014, sequence version 1.
DT   23-MAY-2018, entry version 24.
DE   RecName: Full=Macrophage colony-stimulating factor 1 {ECO:0000256|PIRNR:PIRNR001948};
DE            Short=CSF-1 {ECO:0000256|PIRNR:PIRNR001948};
DE            Short=MCSF {ECO:0000256|PIRNR:PIRNR001948};
GN   Name=CSF1 {ECO:0000313|EMBL:EAW56420.1};
GN   ORFNames=hCG_40247 {ECO:0000313|EMBL:EAW56420.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:EAW56420.1};
RN   [1] {ECO:0000313|EMBL:EAW56420.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAW56420.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
CC   -!- FUNCTION: Cytokine that plays an essential role in the regulation
CC       of survival, proliferation and differentiation of hematopoietic
CC       precursor cells, especially mononuclear phagocytes, such as
CC       macrophages and monocytes. Promotes the release of proinflammatory
CC       chemokines, and thereby plays an important role in innate immunity
CC       and in inflammatory processes. Plays an important role in the
CC       regulation of osteoclast proliferation and differentiation, the
CC       regulation of bone resorption, and is required for normal bone
CC       development. Required for normal male and female fertility.
CC       Promotes reorganization of the actin cytoskeleton, regulates
CC       formation of membrane ruffles, cell adhesion and cell migration.
CC       Plays a role in lipoprotein clearance.
CC       {ECO:0000256|PIRNR:PIRNR001948}.
CC   -!- SUBUNIT: Homodimer or heterodimer; disulfide-linked. Interacts
CC       with CSF1R. {ECO:0000256|PIRNR:PIRNR001948}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; CH471122; EAW56420.1; -; Genomic_DNA.
DR   RefSeq; NP_000748.3; NM_000757.5.
DR   RefSeq; NP_757351.1; NM_172212.2.
DR   UniGene; Hs.173894; -.
DR   ProteinModelPortal; A0A024R0A1; -.
DR   SMR; A0A024R0A1; -.
DR   PeptideAtlas; A0A024R0A1; -.
DR   GeneID; 1435; -.
DR   KEGG; hsa:1435; -.
DR   CTD; 1435; -.
DR   eggNOG; ENOG410II8R; Eukaryota.
DR   eggNOG; ENOG410Z5Q9; LUCA.
DR   KO; K05453; -.
DR   ChiTaRS; CSF1; human.
DR   GenomeRNAi; 1435; -.
DR   GO; GO:0005615; C:extracellular space; IEA:UniProtKB-KW.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005125; F:cytokine activity; IEA:UniProtKB-KW.
DR   GO; GO:0008083; F:growth factor activity; IEA:UniProtKB-KW.
DR   GO; GO:0042803; F:protein homodimerization activity; IEA:UniProtKB-UniRule.
DR   GO; GO:0006954; P:inflammatory response; IEA:UniProtKB-UniRule.
DR   GO; GO:0045087; P:innate immune response; IEA:UniProtKB-UniRule.
DR   GO; GO:0030316; P:osteoclast differentiation; IEA:UniProtKB-UniRule.
DR   InterPro; IPR009079; 4_helix_cytokine-like_core.
DR   InterPro; IPR008001; MCSF-1.
DR   PANTHER; PTHR10058; PTHR10058; 1.
DR   Pfam; PF05337; CSF-1; 1.
DR   PIRSF; PIRSF001948; MCSF-1; 1.
DR   SUPFAM; SSF47266; SSF47266; 1.
PE   4: Predicted;
KW   Cytokine {ECO:0000256|PIRNR:PIRNR001948};
KW   Growth factor {ECO:0000256|PIRNR:PIRNR001948};
KW   Immunity {ECO:0000256|PIRNR:PIRNR001948};
KW   Inflammatory response {ECO:0000256|PIRNR:PIRNR001948};
KW   Innate immunity {ECO:0000256|PIRNR:PIRNR001948};
KW   Membrane {ECO:0000256|SAM:Phobius}; Signal {ECO:0000256|SAM:SignalP};
KW   Transmembrane {ECO:0000256|SAM:Phobius};
KW   Transmembrane helix {ECO:0000256|SAM:Phobius}.
FT   SIGNAL        1     32       {ECO:0000256|SAM:SignalP}.
FT   CHAIN        33    554       Macrophage colony-stimulating factor 1.
FT                                {ECO:0000256|SAM:SignalP}.
FT                                /FTId=PRO_5001533010.
FT   TRANSMEM    497    518       Helical. {ECO:0000256|SAM:Phobius}.
SQ   SEQUENCE   554 AA;  60119 MW;  657764E4E5492AED CRC64;
     MTAPGAAGRC PPTTWLGSLL LLVCLLASRS ITEEVSEYCS HMIGSGHLQS LQRLIDSQME
     TSCQITFEFV DQEQLKDPVC YLKKAFLLVQ DIMEDTMRFR DNTPNAIAIV QLQELSLRLK
     SCFTKDYEEH DKACVRTFYE TPLQLLEKVK NVFNETKNLL DKDWNIFSKN CNNSFAECSS
     QDVVTKPDCN CLYPKAIPSS DPASVSPHQP LAPSMAPVAG LTWEDSEGTE GSSLLPGEQP
     LHTVDPGSAK QRPPRSTCQS FEPPETPVVK DSTIGGSPQP RPSVGAFNPG MEDILDSAMG
     TNWVPEEASG EASEIPVPQG TELSPSRPGG GSMQTEPARP SNFLSASSPL PASAKGQQPA
     DVTGTALPRV GPVRPTGQDW NHTPQKTDHP SALLRDPPEP GSPRISSLRP QGLSNPSTLS
     AQPQLSRSHS SGSVLPLGEL EGRRSTRDRR SPAEPEGGPA SEGAARPLPR FNSVPLTDTG
     HERQSEGSSS PQLQESVFHL LVPSVILVLL AVGGLLFYRW RRRSHQEPQR ADSPLEQPEG
     SPLTQDDRQV ELPV
//
ID   CSF1_HUMAN              Reviewed;         554 AA.
AC   P09603; A8K6J5; Q13130; Q14086; Q14806; Q5VVF3; Q5VVF4; Q9UQR8;
DT   01-JUL-1989, integrated into UniProtKB/Swiss-Prot.
DT   02-NOV-2010, sequence version 2.
DT   23-MAY-2018, entry version 192.
DE   RecName: Full=Macrophage colony-stimulating factor 1;
DE            Short=CSF-1;
DE            Short=M-CSF;
DE            Short=MCSF;
DE   AltName: Full=Lanimostim;
DE   Contains:
DE     RecName: Full=Processed macrophage colony-stimulating factor 1;
DE   Flags: Precursor;
GN   Name=CSF1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], PROTEIN SEQUENCE OF 33-44 (ISOFORM
RP   3), AND VARIANT SER-489.
RC   TISSUE=Pancreatic carcinoma, and Urine;
RX   PubMed=2996129; DOI=10.1126/science.2996129;
RA   Kawasaki E.S., Ladner M.B., Wang A.M., van Arsdell J.N., Warren M.K.,
RA   Coyne M.Y., Schweickart V.L., Lee M.-T., Wilson K.J., Boosman A.,
RA   Stanley E.R., Ralph P., Mark D.F.;
RT   "Molecular cloning of a complementary DNA encoding human macrophage-
RT   specific colony-stimulating factor (CSF-1).";
RL   Science 230:291-296(1985).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), PARTIAL PROTEIN SEQUENCE, AND
RP   VARIANT SER-489.
RC   TISSUE=Trophoblast, and Urine;
RX   PubMed=3493529; DOI=10.1126/science.3493529;
RA   Wong G.G., Temple P.A., Leary A.C., Witek-Giannotti J.S., Yang Y.C.,
RA   Ciarletta A.B., Chung M., Murtha P., Kriz R., Kaufman R.J.,
RA   Ferenz C.R., Sibley B.S., Turner K.J., Hewick R.M., Clark S.C.,
RA   Yanai N., Yokota H., Yamada M., Saito M., Motoyoshi K., Takaku F.;
RT   "Human CSF-1: molecular cloning and expression of 4-kb cDNA encoding
RT   the human urinary protein.";
RL   Science 235:1504-1508(1987).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA], ALTERNATIVE SPLICING, MUTAGENESIS OF
RP   ISOFORM 3, AND VARIANT SER-489.
RC   TISSUE=Pancreatic carcinoma;
RX   PubMed=2460758; DOI=10.1016/0161-5890(88)90112-5;
RA   Cerretti D.P., Wignall J., Anderson D., Tushinski R.J., Gallis B.M.,
RA   Stya M., Gillis S., Urdal D.L., Cosman D.;
RT   "Human macrophage-colony stimulating factor: alternative RNA and
RT   protein processing from a single gene.";
RL   Mol. Immunol. 25:761-770(1988).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANTS PRO-408 AND
RP   SER-489.
RC   TISSUE=T lymphoblast;
RX   PubMed=2660794; DOI=10.1016/0006-291X(89)92683-1;
RA   Takahashi M., Hirato T., Takano M., Nishida T., Nagamura K.,
RA   Kamogashira T., Nakai S., Hirai Y.;
RT   "Amino-terminal region of human macrophage colony-stimulating factor
RT   (M-CSF) is sufficient for its in vitro biological activity: molecular
RT   cloning and expression of carboxyl-terminal deletion mutants of human
RT   M-CSF.";
RL   Biochem. Biophys. Res. Commun. 161:892-901(1989).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT
RP   SER-489.
RC   TISSUE=Placenta;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND VARIANT SER-489.
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT
RP   SER-489.
RC   TISSUE=Kidney;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] OF 1-13 AND 19-554 (ISOFORM
RP   1), AND VARIANT SER-489.
RC   TISSUE=Pancreatic carcinoma;
RX   PubMed=3500041;
RA   Ladner M.B., Martin G.A., Noble J.A., Nikoloff D.M., Tal R.,
RA   Kawasaki E.S., White T.J.;
RT   "Human CSF-1: gene structure and alternative splicing of mRNA
RT   precursors.";
RL   EMBO J. 6:2693-2698(1987).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 13-554 (ISOFORM 3), AND VARIANT SER-489.
RC   TISSUE=Endometrium;
RX   PubMed=1791839; DOI=10.1210/mend-5-12-1931;
RA   Pampfer S., Tabibzadeh S., Chuan F.-C., Pollard J.W.;
RT   "Expression of colony-stimulating factor-1 (CSF-1) messenger RNA in
RT   human endometrial glands during the menstrual cycle: molecular cloning
RT   of a novel transcript that predicts a cell surface form of CSF-1.";
RL   Mol. Endocrinol. 5:1931-1938(1991).
RN   [11]
RP   PROTEIN SEQUENCE OF 33-185 (ISOFORM 1).
RC   TISSUE=T lymphoblast;
RX   PubMed=8262907;
RA   Yamanishi K., Yasuda S., Masui Y., Nishida T., Shindo Y., Takano M.,
RA   Ohmoto Y., Takahashi M., Adachi M.;
RT   "The structure of recombinant human carboxy-terminal-truncated
RT   macrophage colony-stimulating factor derived from mammalian cells.";
RL   J. Biochem. 114:255-262(1993).
RN   [12]
RP   PROTEIN SEQUENCE OF 33-76.
RX   PubMed=3498652; DOI=10.1016/0014-5793(87)80398-8;
RA   Sakai N., Umeda T., Suzuki H., Ishimatsu Y., Shikita M.;
RT   "Macrophage colony-stimulating factor purified from normal human
RT   urine. Amino-terminal sequence and amino acid composition.";
RL   FEBS Lett. 222:341-344(1987).
RN   [13]
RP   PROTEIN SEQUENCE OF 35-61.
RX   PubMed=3259875; DOI=10.1016/S0006-291X(88)80441-8;
RA   Takahashi M., Hong Y.M., Yasuda S., Takano M., Kawai K., Nakai S.,
RA   Hirai Y.;
RT   "Macrophage colony-stimulating factor is produced by human T
RT   lymphoblastoid cell line, CEM-ON: identification by amino-terminal
RT   amino acid sequence analysis.";
RL   Biochem. Biophys. Res. Commun. 152:1401-1409(1988).
RN   [14]
RP   CHARACTERIZATION (ISOFORM 3).
RX   PubMed=3039346; DOI=10.1128/MCB.7.7.2378;
RA   Rettenmier C.W., Roussel M.F., Ashmun R.A., Ralph P., Price K.,
RA   Sherr C.J.;
RT   "Synthesis of membrane-bound colony-stimulating factor 1 (CSF-1) and
RT   downmodulation of CSF-1 receptors in NIH 3T3 cells transformed by
RT   cotransfection of the human CSF-1 and c-fms (CSF-1 receptor) genes.";
RL   Mol. Cell. Biol. 7:2378-2387(1987).
RN   [15]
RP   PROTEOLYTIC PROCESSING, SUBUNIT, GLYCOSYLATION, AND SUBCELLULAR
RP   LOCATION.
RX   PubMed=3264877; DOI=10.1128/MCB.8.11.5026;
RA   Rettenmier C.W., Roussel M.F.;
RT   "Differential processing of colony-stimulating factor 1 precursors
RT   encoded by two human cDNAs.";
RL   Mol. Cell. Biol. 8:5026-5034(1988).
RN   [16]
RP   PROTEOLYTIC PROCESSING, SUBUNIT, SUBCELLULAR LOCATION, AND STRUCTURE
RP   OF CARBOHYDRATES.
RX   PubMed=1531650;
RA   Suzu S., Ohtsuki T., Yanai N., Takatsu Z., Kawashima T., Takaku F.,
RA   Nagata N., Motoyoshi K.;
RT   "Identification of a high molecular weight macrophage colony-
RT   stimulating factor as a glycosaminoglycan-containing species.";
RL   J. Biol. Chem. 267:4345-4348(1992).
RN   [17]
RP   DISULFIDE BONDS.
RX   PubMed=8422357; DOI=10.1021/bi00053a012;
RA   Glocker M.O., Arbogast B., Schreurs J., Deinzer M.L.;
RT   "Assignment of the inter- and intramolecular disulfide linkages in
RT   recombinant human macrophage colony stimulating factor using fast atom
RT   bombardment mass spectrometry.";
RL   Biochemistry 32:482-488(1993).
RN   [18]
RP   REVIEW ON FUNCTION AND SIGNALING PATHWAYS.
RX   PubMed=15519852; DOI=10.1016/j.tcb.2004.09.016;
RA   Pixley F.J., Stanley E.R.;
RT   "CSF-1 regulation of the wandering macrophage: complexity in action.";
RL   Trends Cell Biol. 14:628-638(2004).
RN   [19]
RP   REVIEW ON FUNCTION IN IMMUNITY AND INFLAMMATION, AND ROLE IN DISEASE.
RX   PubMed=16337366; DOI=10.1016/j.coi.2005.11.006;
RA   Chitu V., Stanley E.R.;
RT   "Colony-stimulating factor-1 in immunity and inflammation.";
RL   Curr. Opin. Immunol. 18:39-48(2006).
RN   [20]
RP   REVIEW ON FUNCTION AND SIGNALING PATHWAYS.
RX   PubMed=18687298; DOI=10.1016/j.intimp.2008.04.016;
RA   Douglass T.G., Driggers L., Zhang J.G., Hoa N., Delgado C.,
RA   Williams C.C., Dan Q., Sanchez R., Jeffes E.W., Wepsic H.T.,
RA   Myers M.P., Koths K., Jadus M.R.;
RT   "Macrophage colony stimulating factor: not just for macrophages
RT   anymore! A gateway into complex biologies.";
RL   Int. Immunopharmacol. 8:1354-1376(2008).
RN   [21]
RP   ROLE IN DISEASE.
RX   PubMed=19934330; DOI=10.1158/0008-5472.CAN-09-1868;
RA   Patsialou A., Wyckoff J., Wang Y., Goswami S., Stanley E.R.,
RA   Condeelis J.S.;
RT   "Invasion of human breast cancer cells in vivo requires both paracrine
RT   and autocrine loops involving the colony-stimulating factor-1
RT   receptor.";
RL   Cancer Res. 69:9498-9506(2009).
RN   [22]
RP   FUNCTION IN RELEASE OF PROINFLAMMATORY CHEMOKINES.
RX   PubMed=20829061; DOI=10.1016/j.cyto.2010.08.005;
RA   Eda H., Zhang J., Keith R.H., Michener M., Beidler D.R., Monahan J.B.;
RT   "Macrophage-colony stimulating factor and interleukin-34 induce
RT   chemokines in human whole blood.";
RL   Cytokine 52:215-220(2010).
RN   [23]
RP   FUNCTION, AND INTERACTION WITH CSF1R.
RX   PubMed=20504948; DOI=10.1189/jlb.1209822;
RA   Wei S., Nandi S., Chitu V., Yeung Y.G., Yu W., Huang M.,
RA   Williams L.T., Lin H., Stanley E.R.;
RT   "Functional overlap but differential expression of CSF-1 and IL-34 in
RT   their CSF-1 receptor-mediated regulation of myeloid cells.";
RL   J. Leukoc. Biol. 88:495-505(2010).
RN   [24]
RP   GLYCOSYLATION AT THR-363 AND THR-365, STRUCTURE OF CARBOHYDRATES, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=22171320; DOI=10.1074/mcp.M111.013649;
RA   Halim A., Nilsson J., Ruetschi U., Hesse C., Larson G.;
RT   "Human urinary glycoproteomics; attachment site specific analysis of
RT   N-and O-linked glycosylations by CID and ECD.";
RL   Mol. Cell. Proteomics 11:1-17(2012).
RN   [25]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [26]
RP   GLYCOSYLATION, AND IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=23234360; DOI=10.1021/pr300963h;
RA   Halim A., Ruetschi U., Larson G., Nilsson J.;
RT   "LC-MS/MS characterization of O-glycosylation sites and glycan
RT   structures of human cerebrospinal fluid glycoproteins.";
RL   J. Proteome Res. 12:573-584(2013).
RN   [27]
RP   PHOSPHORYLATION AT THR-266.
RX   PubMed=26091039; DOI=10.1016/j.cell.2015.05.028;
RA   Tagliabracci V.S., Wiley S.E., Guo X., Kinch L.N., Durrant E., Wen J.,
RA   Xiao J., Cui J., Nguyen K.B., Engel J.L., Coon J.J., Grishin N.,
RA   Pinna L.A., Pagliarini D.J., Dixon J.E.;
RT   "A single kinase generates the majority of the secreted
RT   phosphoproteome.";
RL   Cell 161:1619-1632(2015).
RN   [28]
RP   X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS) OF 33-190.
RX   PubMed=1455231; DOI=10.1126/science.1455231;
RA   Pandit J., Bohm A., Jancarik J., Halenbeck R., Koths K., Kim S.H.;
RT   "Three-dimensional structure of dimeric human recombinant macrophage
RT   colony-stimulating factor.";
RL   Science 258:1358-1362(1992).
CC   -!- FUNCTION: Cytokine that plays an essential role in the regulation
CC       of survival, proliferation and differentiation of hematopoietic
CC       precursor cells, especially mononuclear phagocytes, such as
CC       macrophages and monocytes. Promotes the release of proinflammatory
CC       chemokines, and thereby plays an important role in innate immunity
CC       and in inflammatory processes. Plays an important role in the
CC       regulation of osteoclast proliferation and differentiation, the
CC       regulation of bone resorption, and is required for normal bone
CC       development. Required for normal male and female fertility.
CC       Promotes reorganization of the actin cytoskeleton, regulates
CC       formation of membrane ruffles, cell adhesion and cell migration.
CC       Plays a role in lipoprotein clearance.
CC       {ECO:0000269|PubMed:16337366, ECO:0000269|PubMed:19934330,
CC       ECO:0000269|PubMed:20504948, ECO:0000269|PubMed:20829061}.
CC   -!- SUBUNIT: Homodimer or heterodimer; disulfide-linked. Interacts
CC       with CSF1R. {ECO:0000269|PubMed:1531650,
CC       ECO:0000269|PubMed:20504948, ECO:0000269|PubMed:3264877,
CC       ECO:0000269|PubMed:8422357}.
CC   -!- INTERACTION:
CC       Self; NbExp=8; IntAct=EBI-2872294, EBI-2872294;
CC       P03228:BARF1 (xeno); NbExp=9; IntAct=EBI-2872294, EBI-16007073;
CC       P0CW72:BARF1 (xeno); NbExp=3; IntAct=EBI-2872294, EBI-2620133;
CC       P07333:CSF1R; NbExp=13; IntAct=EBI-2872294, EBI-2835440;
CC       P09581:Csf1r (xeno); NbExp=2; IntAct=EBI-2872294, EBI-6305373;
CC       Q13643:FHL3; NbExp=3; IntAct=EBI-2872294, EBI-741101;
CC       Q7Z3S9:NOTCH2NL; NbExp=3; IntAct=EBI-2872294, EBI-945833;
CC       O43765:SGTA; NbExp=5; IntAct=EBI-2872294, EBI-347996;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:1531650,
CC       ECO:0000269|PubMed:3264877}; Single-pass type I membrane protein
CC       {ECO:0000269|PubMed:1531650, ECO:0000269|PubMed:3264877}.
CC   -!- SUBCELLULAR LOCATION: Processed macrophage colony-stimulating
CC       factor 1: Secreted, extracellular space.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=P09603-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P09603-2; Sequence=VSP_001188;
CC       Name=3;
CC         IsoId=P09603-3; Sequence=VSP_001187;
CC   -!- PTM: N- and O-glycosylated. Glycosylation and proteolytic cleavage
CC       yield different soluble forms. One high molecular weight soluble
CC       form is a proteoglycan containing chondroitin sulfate. O-
CC       glycosylated with core 1 or possibly core 8 glycans. Isoform 1 is
CC       N- and O-glycosylated. Isoform 3 is only N-glycosylated.
CC       {ECO:0000269|PubMed:1531650, ECO:0000269|PubMed:22171320,
CC       ECO:0000269|PubMed:23234360, ECO:0000269|PubMed:3264877}.
CC   -!- DISEASE: Note=Aberrant expression of CSF1 or CSF1R can promote
CC       cancer cell proliferation, invasion and formation of metastases.
CC       Overexpression of CSF1 or CSF1R is observed in a significant
CC       percentage of breast, ovarian, prostate, and endometrial cancers.
CC   -!- DISEASE: Note=Aberrant expression of CSF1 or CSF1R may play a role
CC       in inflammatory diseases, such as rheumatoid arthritis,
CC       glomerulonephritis, atherosclerosis, and allograft rejection.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M11296; AAB59527.1; -; Genomic_DNA.
DR   EMBL; M11038; AAB59527.1; JOINED; Genomic_DNA.
DR   EMBL; M11295; AAB59527.1; JOINED; Genomic_DNA.
DR   EMBL; M37435; AAA52117.1; -; mRNA.
DR   EMBL; M64592; AAA59572.1; -; mRNA.
DR   EMBL; U22386; AAA64849.1; -; mRNA.
DR   EMBL; M27087; AAA59573.1; -; mRNA.
DR   EMBL; AK291660; BAF84349.1; -; mRNA.
DR   EMBL; AL450468; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471122; EAW56416.1; -; Genomic_DNA.
DR   EMBL; BC021117; AAH21117.1; -; mRNA.
DR   EMBL; X05825; CAA29265.1; -; mRNA.
DR   EMBL; X06106; CAA29479.1; -; Genomic_DNA.
DR   EMBL; M76453; AAA52120.2; -; mRNA.
DR   CCDS; CCDS30797.1; -. [P09603-3]
DR   CCDS; CCDS816.1; -. [P09603-1]
DR   CCDS; CCDS817.1; -. [P09603-2]
DR   PIR; A47583; FQHUMP.
DR   RefSeq; NP_000748.3; NM_000757.5.
DR   RefSeq; NP_757349.1; NM_172210.2.
DR   RefSeq; NP_757350.1; NM_172211.3.
DR   RefSeq; NP_757351.1; NM_172212.2.
DR   UniGene; Hs.173894; -.
DR   PDB; 1HMC; X-ray; 2.50 A; A/B=36-181.
DR   PDB; 3UEZ; X-ray; 3.41 A; E/F/G/H=33-181.
DR   PDB; 3UF2; X-ray; 2.75 A; A/B/C/D/E/F/G/H/I/J=33-181.
DR   PDB; 4ADF; X-ray; 4.40 A; G/H/I/J/K/L/S/T/U/V/W/X=33-181.
DR   PDB; 4FA8; X-ray; 2.20 A; E/F/G=36-180.
DR   PDB; 4WRL; X-ray; 2.80 A; B/D=33-181.
DR   PDB; 4WRM; X-ray; 6.85 A; B=33-181.
DR   PDB; 5LXF; X-ray; 2.00 A; A/B=33-181.
DR   PDBsum; 1HMC; -.
DR   PDBsum; 3UEZ; -.
DR   PDBsum; 3UF2; -.
DR   PDBsum; 4ADF; -.
DR   PDBsum; 4FA8; -.
DR   PDBsum; 4WRL; -.
DR   PDBsum; 4WRM; -.
DR   PDBsum; 5LXF; -.
DR   ProteinModelPortal; P09603; -.
DR   SMR; P09603; -.
DR   BioGrid; 107822; 8.
DR   DIP; DIP-41860N; -.
DR   IntAct; P09603; 14.
DR   STRING; 9606.ENSP00000327513; -.
DR   iPTMnet; P09603; -.
DR   PhosphoSitePlus; P09603; -.
DR   BioMuta; CSF1; -.
DR   DMDM; 311033367; -.
DR   MaxQB; P09603; -.
DR   PaxDb; P09603; -.
DR   PeptideAtlas; P09603; -.
DR   PRIDE; P09603; -.
DR   DNASU; 1435; -.
DR   Ensembl; ENST00000329608; ENSP00000327513; ENSG00000184371. [P09603-1]
DR   Ensembl; ENST00000369801; ENSP00000358816; ENSG00000184371. [P09603-2]
DR   Ensembl; ENST00000369802; ENSP00000358817; ENSG00000184371. [P09603-1]
DR   Ensembl; ENST00000420111; ENSP00000407317; ENSG00000184371. [P09603-3]
DR   GeneID; 1435; -.
DR   KEGG; hsa:1435; -.
DR   UCSC; uc001dyt.3; human. [P09603-1]
DR   CTD; 1435; -.
DR   DisGeNET; 1435; -.
DR   EuPathDB; HostDB:ENSG00000184371.13; -.
DR   GeneCards; CSF1; -.
DR   HGNC; HGNC:2432; CSF1.
DR   HPA; HPA076624; -.
DR   MIM; 120420; gene.
DR   neXtProt; NX_P09603; -.
DR   OpenTargets; ENSG00000184371; -.
DR   PharmGKB; PA26935; -.
DR   eggNOG; ENOG410II8R; Eukaryota.
DR   eggNOG; ENOG410Z5Q9; LUCA.
DR   GeneTree; ENSGT00390000015805; -.
DR   HOVERGEN; HBG005410; -.
DR   InParanoid; P09603; -.
DR   KO; K05453; -.
DR   OMA; DTGHERQ; -.
DR   OrthoDB; EOG091G0TMC; -.
DR   PhylomeDB; P09603; -.
DR   TreeFam; TF337718; -.
DR   Reactome; R-HSA-381426; Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs).
DR   Reactome; R-HSA-449836; Other interleukin signaling.
DR   Reactome; R-HSA-6783783; Interleukin-10 signaling.
DR   Reactome; R-HSA-8957275; Post-translational protein phosphorylation.
DR   SignaLink; P09603; -.
DR   SIGNOR; P09603; -.
DR   ChiTaRS; CSF1; human.
DR   EvolutionaryTrace; P09603; -.
DR   GeneWiki; Macrophage_colony-stimulating_factor; -.
DR   GenomeRNAi; 1435; -.
DR   PMAP-CutDB; P09603; -.
DR   PRO; PR:P09603; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000184371; -.
DR   CleanEx; HS_CSF1; -.
DR   ExpressionAtlas; P09603; baseline and differential.
DR   Genevisible; P09603; HS.
DR   GO; GO:1990682; C:CSF1-CSF1R complex; ISS:BHF-UCL.
DR   GO; GO:0005788; C:endoplasmic reticulum lumen; TAS:Reactome.
DR   GO; GO:0005576; C:extracellular region; TAS:Reactome.
DR   GO; GO:0005615; C:extracellular space; IDA:BHF-UCL.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0016020; C:membrane; NAS:UniProtKB.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IDA:BHF-UCL.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0005125; F:cytokine activity; IDA:BHF-UCL.
DR   GO; GO:0008083; F:growth factor activity; IDA:BHF-UCL.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0005157; F:macrophage colony-stimulating factor receptor binding; ISS:BHF-UCL.
DR   GO; GO:0042803; F:protein homodimerization activity; IDA:BHF-UCL.
DR   GO; GO:0060444; P:branching involved in mammary gland duct morphogenesis; IEA:Ensembl.
DR   GO; GO:0030154; P:cell differentiation; NAS:UniProtKB.
DR   GO; GO:0008283; P:cell proliferation; NAS:UniProtKB.
DR   GO; GO:0044267; P:cellular protein metabolic process; TAS:Reactome.
DR   GO; GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome.
DR   GO; GO:0003006; P:developmental process involved in reproduction; ISS:BHF-UCL.
DR   GO; GO:0030097; P:hemopoiesis; NAS:UniProtKB.
DR   GO; GO:0048873; P:homeostasis of number of cells within a tissue; IEA:Ensembl.
DR   GO; GO:0006954; P:inflammatory response; IEA:UniProtKB-KW.
DR   GO; GO:0045087; P:innate immune response; IEA:UniProtKB-KW.
DR   GO; GO:0038145; P:macrophage colony-stimulating factor signaling pathway; IEA:Ensembl.
DR   GO; GO:0030225; P:macrophage differentiation; TAS:UniProtKB.
DR   GO; GO:0060763; P:mammary duct terminal end bud growth; IEA:Ensembl.
DR   GO; GO:0060611; P:mammary gland fat development; IEA:Ensembl.
DR   GO; GO:0042117; P:monocyte activation; NAS:BHF-UCL.
DR   GO; GO:0030316; P:osteoclast differentiation; IDA:BHF-UCL.
DR   GO; GO:0002158; P:osteoclast proliferation; IEA:Ensembl.
DR   GO; GO:0030335; P:positive regulation of cell migration; ISS:BHF-UCL.
DR   GO; GO:0008284; P:positive regulation of cell proliferation; IDA:MGI.
DR   GO; GO:0001954; P:positive regulation of cell-matrix adhesion; ISS:BHF-UCL.
DR   GO; GO:0032270; P:positive regulation of cellular protein metabolic process; IDA:BHF-UCL.
DR   GO; GO:0010628; P:positive regulation of gene expression; IDA:BHF-UCL.
DR   GO; GO:0010759; P:positive regulation of macrophage chemotaxis; IDA:BHF-UCL.
DR   GO; GO:1902228; P:positive regulation of macrophage colony-stimulating factor signaling pathway; IDA:BHF-UCL.
DR   GO; GO:0010744; P:positive regulation of macrophage derived foam cell differentiation; IDA:BHF-UCL.
DR   GO; GO:0045651; P:positive regulation of macrophage differentiation; IDA:BHF-UCL.
DR   GO; GO:1904141; P:positive regulation of microglial cell migration; IDA:BHF-UCL.
DR   GO; GO:0045657; P:positive regulation of monocyte differentiation; ISS:BHF-UCL.
DR   GO; GO:0032946; P:positive regulation of mononuclear cell proliferation; IDA:BHF-UCL.
DR   GO; GO:0040018; P:positive regulation of multicellular organism growth; IEA:Ensembl.
DR   GO; GO:0042488; P:positive regulation of odontogenesis of dentin-containing tooth; IEA:Ensembl.
DR   GO; GO:0045672; P:positive regulation of osteoclast differentiation; IDA:BHF-UCL.
DR   GO; GO:0045860; P:positive regulation of protein kinase activity; ISS:BHF-UCL.
DR   GO; GO:0046579; P:positive regulation of Ras protein signal transduction; IEA:Ensembl.
DR   GO; GO:0043687; P:post-translational protein modification; TAS:Reactome.
DR   GO; GO:0010743; P:regulation of macrophage derived foam cell differentiation; NAS:BHF-UCL.
DR   GO; GO:0030278; P:regulation of ossification; IEA:Ensembl.
DR   GO; GO:0007169; P:transmembrane receptor protein tyrosine kinase signaling pathway; IDA:BHF-UCL.
DR   InterPro; IPR009079; 4_helix_cytokine-like_core.
DR   InterPro; IPR008001; MCSF-1.
DR   PANTHER; PTHR10058; PTHR10058; 1.
DR   Pfam; PF05337; CSF-1; 1.
DR   PIRSF; PIRSF001948; MCSF-1; 1.
DR   SUPFAM; SSF47266; SSF47266; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Cell membrane; Complete proteome;
KW   Cytokine; Direct protein sequencing; Disulfide bond; Glycoprotein;
KW   Growth factor; Immunity; Inflammatory response; Innate immunity;
KW   Membrane; Phosphoprotein; Polymorphism; Proteoglycan;
KW   Reference proteome; Secreted; Signal; Transmembrane;
KW   Transmembrane helix.
FT   SIGNAL        1     32       {ECO:0000269|PubMed:3498652}.
FT   CHAIN        33    554       Macrophage colony-stimulating factor 1.
FT                                /FTId=PRO_0000005857.
FT   CHAIN        33    450       Processed macrophage colony-stimulating
FT                                factor 1. {ECO:0000250|UniProtKB:Q8JZQ0}.
FT                                /FTId=PRO_0000296231.
FT   TOPO_DOM     33    496       Lumenal. {ECO:0000255}.
FT   TRANSMEM    497    517       Helical. {ECO:0000255}.
FT   TOPO_DOM    518    554       Cytoplasmic. {ECO:0000255}.
FT   REGION      406    426       O-glycosylated at one site.
FT   MOD_RES     266    266       Phosphothreonine; by FAM20C.
FT                                {ECO:0000269|PubMed:26091039}.
FT   CARBOHYD    154    154       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    172    172       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    363    363       O-linked (GalNAc...) threonine.
FT                                {ECO:0000269|PubMed:22171320}.
FT   CARBOHYD    365    365       O-linked (GalNAc...) threonine.
FT                                {ECO:0000269|PubMed:22171320}.
FT   DISULFID     39    122       {ECO:0000269|PubMed:8422357}.
FT   DISULFID     63     63       Interchain. {ECO:0000269|PubMed:8422357}.
FT   DISULFID     80    171       {ECO:0000269|PubMed:8422357}.
FT   DISULFID    134    178       {ECO:0000269|PubMed:8422357}.
FT   DISULFID    189    189       Interchain. {ECO:0000269|PubMed:8422357}.
FT   DISULFID    191    191       Interchain. {ECO:0000269|PubMed:8422357}.
FT   VAR_SEQ     182    479       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:1791839}.
FT                                /FTId=VSP_001187.
FT   VAR_SEQ     365    480       Missing (in isoform 2). {ECO:0000305}.
FT                                /FTId=VSP_001188.
FT   VARIANT     341    341       S -> N (in dbSNP:rs12565736).
FT                                /FTId=VAR_048810.
FT   VARIANT     408    408       L -> P (in dbSNP:rs1058885).
FT                                {ECO:0000269|PubMed:2660794}.
FT                                /FTId=VAR_020454.
FT   VARIANT     438    438       G -> R (in dbSNP:rs2229165).
FT                                /FTId=VAR_029320.
FT   VARIANT     489    489       F -> S (in dbSNP:rs333971).
FT                                {ECO:0000269|PubMed:14702039,
FT                                ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|PubMed:1791839,
FT                                ECO:0000269|PubMed:2460758,
FT                                ECO:0000269|PubMed:2660794,
FT                                ECO:0000269|PubMed:2996129,
FT                                ECO:0000269|PubMed:3493529,
FT                                ECO:0000269|PubMed:3500041,
FT                                ECO:0000269|Ref.7}.
FT                                /FTId=VAR_048811.
FT   VARIANT     496    496       S -> F (in dbSNP:rs12721516).
FT                                /FTId=VAR_020455.
FT   VARIANT     531    531       A -> V (in dbSNP:rs2229167).
FT                                /FTId=VAR_022146.
FT   MUTAGEN     489    554       Missing: Produces biologically active
FT                                protein which is secreted.
FT                                {ECO:0000269|PubMed:2460758}.
FT   CONFLICT     69     69       F -> S (in Ref. 12; AA sequence).
FT                                {ECO:0000305}.
FT   CONFLICT     91     91       D -> Y (in Ref. 1; AAB59527, 3; AAA59572/
FT                                AAA64849 and 10; AAA52120).
FT                                {ECO:0000305}.
FT   CONFLICT    104    106       PNA -> ANP (in Ref. 2; AAA52117).
FT                                {ECO:0000305}.
FT   CONFLICT    364    364       G -> A (in Ref. 2; AAA52117).
FT                                {ECO:0000305}.
FT   CONFLICT    374    374       R -> M (in Ref. 2; AAA52117).
FT                                {ECO:0000305}.
FT   CONFLICT    412    412       G -> A (in Ref. 2; AAA52117).
FT                                {ECO:0000305}.
FT   CONFLICT    450    450       R -> T (in Ref. 2; AAA52117).
FT                                {ECO:0000305}.
FT   CONFLICT    457    458       GG -> AA (in Ref. 2; AAA52117).
FT                                {ECO:0000305}.
FT   CONFLICT    480    480       Missing (in Ref. 4; AAA59573).
FT                                {ECO:0000305}.
FT   HELIX        37     41       {ECO:0000244|PDB:5LXF}.
FT   HELIX        45     56       {ECO:0000244|PDB:5LXF}.
FT   STRAND       65     70       {ECO:0000244|PDB:5LXF}.
FT   TURN         72     74       {ECO:0000244|PDB:5LXF}.
FT   HELIX        78     95       {ECO:0000244|PDB:5LXF}.
FT   HELIX       104    119       {ECO:0000244|PDB:5LXF}.
FT   HELIX       120    122       {ECO:0000244|PDB:5LXF}.
FT   HELIX       128    130       {ECO:0000244|PDB:5LXF}.
FT   STRAND      135    140       {ECO:0000244|PDB:5LXF}.
FT   HELIX       142    162       {ECO:0000244|PDB:5LXF}.
FT   HELIX       166    168       {ECO:0000244|PDB:5LXF}.
FT   HELIX       172    176       {ECO:0000244|PDB:5LXF}.
SQ   SEQUENCE   554 AA;  60179 MW;  656B0894F9255AED CRC64;
     MTAPGAAGRC PPTTWLGSLL LLVCLLASRS ITEEVSEYCS HMIGSGHLQS LQRLIDSQME
     TSCQITFEFV DQEQLKDPVC YLKKAFLLVQ DIMEDTMRFR DNTPNAIAIV QLQELSLRLK
     SCFTKDYEEH DKACVRTFYE TPLQLLEKVK NVFNETKNLL DKDWNIFSKN CNNSFAECSS
     QDVVTKPDCN CLYPKAIPSS DPASVSPHQP LAPSMAPVAG LTWEDSEGTE GSSLLPGEQP
     LHTVDPGSAK QRPPRSTCQS FEPPETPVVK DSTIGGSPQP RPSVGAFNPG MEDILDSAMG
     TNWVPEEASG EASEIPVPQG TELSPSRPGG GSMQTEPARP SNFLSASSPL PASAKGQQPA
     DVTGTALPRV GPVRPTGQDW NHTPQKTDHP SALLRDPPEP GSPRISSLRP QGLSNPSTLS
     AQPQLSRSHS SGSVLPLGEL EGRRSTRDRR SPAEPEGGPA SEGAARPLPR FNSVPLTDTG
     HERQSEGSFS PQLQESVFHL LVPSVILVLL AVGGLLFYRW RRRSHQEPQR ADSPLEQPEG
     SPLTQDDRQV ELPV
//
ID   CYTN_HUMAN              Reviewed;         141 AA.
AC   P01037; Q96LE6; Q9UCQ6;
DT   21-JUL-1986, integrated into UniProtKB/Swiss-Prot.
DT   02-NOV-2010, sequence version 3.
DT   23-MAY-2018, entry version 177.
DE   RecName: Full=Cystatin-SN;
DE   AltName: Full=Cystain-SA-I;
DE   AltName: Full=Cystatin-1;
DE   AltName: Full=Salivary cystatin-SA-1;
DE   Flags: Precursor;
GN   Name=CST1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT HIS-4.
RX   PubMed=3446578; DOI=10.1016/0378-1119(87)90196-X;
RA   Saitoh E., Kim H.-S., Smithies O., Maeda N.;
RT   "Human cysteine-proteinase inhibitors: nucleotide sequence analysis of
RT   three members of the cystatin gene family.";
RL   Gene 61:329-338(1987).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT HIS-4.
RX   PubMed=2837486;
RA   Al-Hashimi I., Dickinson D.P., Levine M.J.;
RT   "Purification, molecular cloning, and sequencing of salivary cystatin
RT   SA-1.";
RL   J. Biol. Chem. 263:9381-9387(1988).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11780052; DOI=10.1038/414865a;
RA   Deloukas P., Matthews L.H., Ashurst J.L., Burton J., Gilbert J.G.R.,
RA   Jones M., Stavrides G., Almeida J.P., Babbage A.K., Bagguley C.L.,
RA   Bailey J., Barlow K.F., Bates K.N., Beard L.M., Beare D.M.,
RA   Beasley O.P., Bird C.P., Blakey S.E., Bridgeman A.M., Brown A.J.,
RA   Buck D., Burrill W.D., Butler A.P., Carder C., Carter N.P.,
RA   Chapman J.C., Clamp M., Clark G., Clark L.N., Clark S.Y., Clee C.M.,
RA   Clegg S., Cobley V.E., Collier R.E., Connor R.E., Corby N.R.,
RA   Coulson A., Coville G.J., Deadman R., Dhami P.D., Dunn M.,
RA   Ellington A.G., Frankland J.A., Fraser A., French L., Garner P.,
RA   Grafham D.V., Griffiths C., Griffiths M.N.D., Gwilliam R., Hall R.E.,
RA   Hammond S., Harley J.L., Heath P.D., Ho S., Holden J.L., Howden P.J.,
RA   Huckle E., Hunt A.R., Hunt S.E., Jekosch K., Johnson C.M., Johnson D.,
RA   Kay M.P., Kimberley A.M., King A., Knights A., Laird G.K., Lawlor S.,
RA   Lehvaeslaiho M.H., Leversha M.A., Lloyd C., Lloyd D.M., Lovell J.D.,
RA   Marsh V.L., Martin S.L., McConnachie L.J., McLay K., McMurray A.A.,
RA   Milne S.A., Mistry D., Moore M.J.F., Mullikin J.C., Nickerson T.,
RA   Oliver K., Parker A., Patel R., Pearce T.A.V., Peck A.I.,
RA   Phillimore B.J.C.T., Prathalingam S.R., Plumb R.W., Ramsay H.,
RA   Rice C.M., Ross M.T., Scott C.E., Sehra H.K., Shownkeen R., Sims S.,
RA   Skuce C.D., Smith M.L., Soderlund C., Steward C.A., Sulston J.E.,
RA   Swann R.M., Sycamore N., Taylor R., Tee L., Thomas D.W., Thorpe A.,
RA   Tracey A., Tromans A.C., Vaudin M., Wall M., Wallis J.M.,
RA   Whitehead S.L., Whittaker P., Willey D.L., Williams L., Williams S.A.,
RA   Wilming L., Wray P.W., Hubbard T., Durbin R.M., Bentley D.R., Beck S.,
RA   Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 20.";
RL   Nature 414:865-871(2001).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 21-141.
RX   PubMed=3202964;
RA   Saitoh E., Isemura S., Sanada K., Kim H.-S., Smithies O., Maeda N.;
RT   "Cystatin superfamily. Evidence that family II cystatin genes are
RT   evolutionarily related to family III cystatin genes.";
RL   Biol. Chem. Hoppe-Seyler 369:191-197(1988).
RN   [6]
RP   PROTEIN SEQUENCE OF 21-40.
RC   TISSUE=Saliva;
RX   PubMed=1778989; DOI=10.1093/oxfordjournals.jbchem.a123634;
RA   Isemura S., Saitoh E., Sanada K., Minakata K.;
RT   "Identification of full-sized forms of salivary (S-type) cystatins
RT   (cystatin SN, cystatin SA, cystatin S, and two phosphorylated forms of
RT   cystatin S) in human whole saliva and determination of phosphorylation
RT   sites of cystatin S.";
RL   J. Biochem. 110:648-654(1991).
RN   [7]
RP   PROTEIN SEQUENCE OF 21-32.
RX   PubMed=11788998;
RX   DOI=10.1002/1615-9861(200201)2:1<112::AID-PROT112>3.0.CO;2-N;
RA   Ghafouri B., Stahlbom B., Tagesson C., Lindahl M.;
RT   "Newly identified proteins in human nasal lavage fluid from non-
RT   smokers and smokers using two-dimensional gel electrophoresis and
RT   peptide mass fingerprinting.";
RL   Proteomics 2:112-120(2002).
RN   [8]
RP   PROTEIN SEQUENCE OF 29-141.
RX   PubMed=3514272; DOI=10.1016/0014-5793(86)81201-7;
RA   Isemura S., Saitoh E., Sanada K.;
RT   "Characterization of a new cysteine proteinase inhibitor of human
RT   saliva, cystatin SN, which is immunologically related to cystatin S.";
RL   FEBS Lett. 198:145-149(1986).
RN   [9]
RP   PROTEIN SEQUENCE OF 21-35.
RX   PubMed=15340161; DOI=10.1110/ps.04682504;
RA   Zhang Z., Henzel W.J.;
RT   "Signal peptide prediction based on analysis of experimentally
RT   verified cleavage sites.";
RL   Protein Sci. 13:2819-2824(2004).
RN   [10]
RP   PROTEIN SEQUENCE OF 105-141, AND IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Tear;
RX   PubMed=25946035; DOI=10.1021/acs.jproteome.5b00179;
RA   Azkargorta M., Soria J., Ojeda C., Guzman F., Acera A., Iloro I.,
RA   Suarez T., Elortza F.;
RT   "Human basal tear peptidome characterization by CID, HCD, and ETD
RT   followed by in silico and in vitro analyses for antimicrobial peptide
RT   identification.";
RL   J. Proteome Res. 14:2649-2658(2015).
RN   [11]
RP   DISULFIDE BONDS, TISSUE SPECIFICITY, SUBCELLULAR LOCATION, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Saliva;
RX   PubMed=20189825; DOI=10.1016/j.jasms.2010.01.025;
RA   Ryan C.M., Souda P., Halgand F., Wong D.T., Loo J.A., Faull K.F.,
RA   Whitelegge J.P.;
RT   "Confident assignment of intact mass tags to human salivary cystatins
RT   using top-down Fourier-transform ion cyclotron resonance mass
RT   spectrometry.";
RL   J. Am. Soc. Mass Spectrom. 21:908-917(2010).
CC   -!- FUNCTION: Human saliva appears to contain several cysteine
CC       proteinase inhibitors that are immunologically related to cystatin
CC       S but that differ in their specificity due to amino acid sequence
CC       differences. Cystatin SN, with a pI of 7.5, is a much better
CC       inhibitor of papain and dipeptidyl peptidase I than is cystatin S,
CC       although both inhibit ficin equally well.
CC   -!- INTERACTION:
CC       Q9Y5U9:IER3IP1; NbExp=4; IntAct=EBI-1056240, EBI-725665;
CC       O43765:SGTA; NbExp=3; IntAct=EBI-1056240, EBI-347996;
CC   -!- SUBCELLULAR LOCATION: Secreted {ECO:0000269|PubMed:20189825}.
CC   -!- TISSUE SPECIFICITY: Expressed in submandibular and sublingual
CC       saliva but not in parotid saliva (at protein level). Expressed in
CC       saliva, tears, urine and seminal fluid.
CC       {ECO:0000269|PubMed:20189825}.
CC   -!- MASS SPECTROMETRY: Mass=14303.1553; Mass_error=0.0675;
CC       Method=Electrospray; Range=21-141;
CC       Evidence={ECO:0000269|PubMed:20189825};
CC   -!- MASS SPECTROMETRY: Mass=14319.171; Mass_error=0.0523;
CC       Method=Electrospray; Range=21-141; Note=Variant Leu-31.;
CC       Evidence={ECO:0000269|PubMed:20189825};
CC   -!- SIMILARITY: Belongs to the cystatin family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M19169; AAA36115.1; -; Genomic_DNA.
DR   EMBL; J03870; AAA60299.1; -; mRNA.
DR   EMBL; AL591074; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC021225; AAH21225.1; -; mRNA.
DR   CCDS; CCDS13160.1; -.
DR   PIR; A28110; UDHUP2.
DR   RefSeq; NP_001889.2; NM_001898.2.
DR   UniGene; Hs.123114; -.
DR   ProteinModelPortal; P01037; -.
DR   SMR; P01037; -.
DR   BioGrid; 107851; 38.
DR   IntAct; P01037; 3.
DR   STRING; 9606.ENSP00000305731; -.
DR   MEROPS; I25.010; -.
DR   BioMuta; CST1; -.
DR   DMDM; 311033460; -.
DR   EPD; P01037; -.
DR   MaxQB; P01037; -.
DR   PaxDb; P01037; -.
DR   PeptideAtlas; P01037; -.
DR   PRIDE; P01037; -.
DR   TopDownProteomics; P01037; -.
DR   Ensembl; ENST00000304749; ENSP00000305731; ENSG00000170373.
DR   Ensembl; ENST00000398402; ENSP00000381439; ENSG00000170373.
DR   GeneID; 1469; -.
DR   KEGG; hsa:1469; -.
DR   UCSC; uc002wtp.3; human.
DR   CTD; 1469; -.
DR   DisGeNET; 1469; -.
DR   EuPathDB; HostDB:ENSG00000170373.8; -.
DR   GeneCards; CST1; -.
DR   HGNC; HGNC:2473; CST1.
DR   HPA; CAB026769; -.
DR   HPA; HPA043706; -.
DR   HPA; HPA044763; -.
DR   MIM; 123855; gene.
DR   neXtProt; NX_P01037; -.
DR   OpenTargets; ENSG00000170373; -.
DR   PharmGKB; PA26972; -.
DR   eggNOG; ENOG410IZZH; Eukaryota.
DR   eggNOG; ENOG4112CFJ; LUCA.
DR   GeneTree; ENSGT00900000140934; -.
DR   HOGENOM; HOG000231754; -.
DR   HOVERGEN; HBG009556; -.
DR   InParanoid; P01037; -.
DR   KO; K13897; -.
DR   OMA; EYNKATK; -.
DR   OrthoDB; EOG091G0TP1; -.
DR   PhylomeDB; P01037; -.
DR   ChiTaRS; CST1; human.
DR   GeneWiki; CST1; -.
DR   GenomeRNAi; 1469; -.
DR   PRO; PR:P01037; -.
DR   Proteomes; UP000005640; Chromosome 20.
DR   Bgee; ENSG00000170373; -.
DR   CleanEx; HS_CST1; -.
DR   Genevisible; P01037; HS.
DR   GO; GO:0005615; C:extracellular space; IDA:UniProtKB.
DR   GO; GO:0004869; F:cysteine-type endopeptidase inhibitor activity; IBA:GO_Central.
DR   GO; GO:0002020; F:protease binding; IBA:GO_Central.
DR   GO; GO:0001580; P:detection of chemical stimulus involved in sensory perception of bitter taste; IDA:UniProtKB.
DR   GO; GO:2000117; P:negative regulation of cysteine-type endopeptidase activity; IBA:GO_Central.
DR   CDD; cd00042; CY; 1.
DR   InterPro; IPR027214; Cystatin.
DR   InterPro; IPR000010; Cystatin_dom.
DR   InterPro; IPR018073; Prot_inh_cystat_CS.
DR   PANTHER; PTHR11413; PTHR11413; 1.
DR   Pfam; PF00031; Cystatin; 1.
DR   SMART; SM00043; CY; 1.
DR   PROSITE; PS00287; CYSTATIN; 1.
PE   1: Evidence at protein level;
KW   Complete proteome; Direct protein sequencing; Disulfide bond;
KW   Polymorphism; Protease inhibitor; Reference proteome; Secreted;
KW   Signal; Thiol protease inhibitor.
FT   SIGNAL        1     20       {ECO:0000269|PubMed:11788998,
FT                                ECO:0000269|PubMed:15340161,
FT                                ECO:0000269|PubMed:1778989}.
FT   CHAIN        21    141       Cystatin-SN.
FT                                /FTId=PRO_0000006649.
FT   MOTIF        76     80       Secondary area of contact.
FT   SITE         32     32       Reactive site.
FT   DISULFID     94    104       {ECO:0000269|PubMed:20189825}.
FT   DISULFID    118    138       {ECO:0000269|PubMed:20189825}.
FT   VARIANT       4      4       Y -> H (in dbSNP:rs6076122).
FT                                {ECO:0000269|PubMed:2837486,
FT                                ECO:0000269|PubMed:3446578}.
FT                                /FTId=VAR_028932.
FT   VARIANT      31     31       P -> L (in dbSNP:rs2070856).
FT                                /FTId=VAR_028933.
FT   VARIANT     129    129       N -> D (in dbSNP:rs3188319).
FT                                /FTId=VAR_028934.
FT   VARIANT     131    131       R -> M (in dbSNP:rs3188320).
FT                                /FTId=VAR_028935.
FT   VARIANT     135    135       K -> N (in dbSNP:rs3188322).
FT                                /FTId=VAR_028936.
SQ   SEQUENCE   141 AA;  16388 MW;  9F9934704D6C077D CRC64;
     MAQYLSTLLL LLATLAVALA WSPKEEDRII PGGIYNADLN DEWVQRALHF AISEYNKATK
     DDYYRRPLRV LRARQQTVGG VNYFFDVEVG RTICTKSQPN LDTCAFHEQP ELQKKQLCSF
     EIYEVPWENR RSLVKSRCQE S
//
ID   A0A024R276_HUMAN        Unreviewed;       333 AA.
AC   A0A024R276;
DT   09-JUL-2014, integrated into UniProtKB/TrEMBL.
DT   09-JUL-2014, sequence version 1.
DT   23-MAY-2018, entry version 42.
DE   SubName: Full=Cathepsin L, isoform CRA_a {ECO:0000313|EMBL:EAW62733.1};
GN   Name=CTSL {ECO:0000313|EMBL:EAW62733.1};
GN   ORFNames=hCG_30369 {ECO:0000313|EMBL:EAW62733.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:EAW62733.1};
RN   [1] {ECO:0000313|EMBL:EAW62733.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAW62733.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
CC   -!- SIMILARITY: Belongs to the peptidase C1 family.
CC       {ECO:0000256|RuleBase:RU362133, ECO:0000256|SAAS:SAAS00689568}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; CH471089; EAW62731.1; -; Genomic_DNA.
DR   EMBL; CH471089; EAW62732.1; -; Genomic_DNA.
DR   EMBL; CH471089; EAW62733.1; -; Genomic_DNA.
DR   EMBL; CH471089; EAW62734.1; -; Genomic_DNA.
DR   EMBL; CH471089; EAW62736.1; -; Genomic_DNA.
DR   RefSeq; NP_001244900.1; NM_001257971.1.
DR   RefSeq; NP_001244901.1; NM_001257972.1.
DR   RefSeq; NP_001903.1; NM_001912.4.
DR   RefSeq; NP_666023.1; NM_145918.2.
DR   RefSeq; XP_005251773.1; XM_005251716.3.
DR   UniGene; Hs.731507; -.
DR   SMR; A0A024R276; -.
DR   PRIDE; A0A024R276; -.
DR   GeneID; 1514; -.
DR   KEGG; hsa:1514; -.
DR   CTD; 1514; -.
DR   EuPathDB; HostDB:ENSG00000135047.14; -.
DR   eggNOG; KOG1543; Eukaryota.
DR   eggNOG; COG4870; LUCA.
DR   KO; K01365; -.
DR   OMA; QHYRKSG; -.
DR   OrthoDB; EOG091G0AKT; -.
DR   ChiTaRS; CTSL; human.
DR   GenomeRNAi; 1514; -.
DR   Bgee; ENSG00000135047; -.
DR   ExpressionAtlas; A0A024R276; baseline and differential.
DR   GO; GO:0008234; F:cysteine-type peptidase activity; IEA:UniProtKB-KW.
DR   InterPro; IPR025661; Pept_asp_AS.
DR   InterPro; IPR000169; Pept_cys_AS.
DR   InterPro; IPR025660; Pept_his_AS.
DR   InterPro; IPR013128; Peptidase_C1A.
DR   InterPro; IPR000668; Peptidase_C1A_C.
DR   InterPro; IPR013201; Prot_inhib_I29.
DR   PANTHER; PTHR12411; PTHR12411; 1.
DR   Pfam; PF08246; Inhibitor_I29; 1.
DR   Pfam; PF00112; Peptidase_C1; 1.
DR   PRINTS; PR00705; PAPAIN.
DR   SMART; SM00848; Inhibitor_I29; 1.
DR   SMART; SM00645; Pept_C1; 1.
DR   PROSITE; PS00640; THIOL_PROTEASE_ASN; 1.
DR   PROSITE; PS00139; THIOL_PROTEASE_CYS; 1.
DR   PROSITE; PS00639; THIOL_PROTEASE_HIS; 1.
PE   3: Inferred from homology;
KW   Hydrolase {ECO:0000256|SAAS:SAAS00007616};
KW   Protease {ECO:0000256|SAAS:SAAS00007616};
KW   Signal {ECO:0000256|RuleBase:RU362133};
KW   Thiol protease {ECO:0000256|SAAS:SAAS00007616}.
FT   SIGNAL        1     17       {ECO:0000256|RuleBase:RU362133}.
FT   CHAIN        18    333       {ECO:0000256|RuleBase:RU362133}.
FT                                /FTId=PRO_5014202966.
FT   DOMAIN       29     88       Inhibitor_I29.
FT                                {ECO:0000259|SMART:SM00848}.
FT   DOMAIN      114    332       Pept_C1. {ECO:0000259|SMART:SM00645}.
SQ   SEQUENCE   333 AA;  37564 MW;  8CD17D00EF859D85 CRC64;
     MNPTLILAAF CLGIASATLT FDHSLEAQWT KWKAMHNRLY GMNEEGWRRA VWEKNMKMIE
     LHNQEYREGK HSFTMAMNAF GDMTSEEFRQ VMNGFQNRKP RKGKVFQEPL FYEAPRSVDW
     REKGYVTPVK NQGQCGSCWA FSATGALEGQ MFRKTGRLIS LSEQNLVDCS GPQGNEGCNG
     GLMDYAFQYV QDNGGLDSEE SYPYEATEES CKYNPKYSVA NDTGFVDIPK QEKALMKAVA
     TVGPISVAID AGHESFLFYK EGIYFEPDCS SEDMDHGVLV VGYGFESTES DNNKYWLVKN
     SWGEEWGMGG YVKMAKDRRN HCGIASAASY PTV
//
ID   CATL1_HUMAN             Reviewed;         333 AA.
AC   P07711; Q6IAV1; Q96QJ0;
DT   01-APR-1988, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-1989, sequence version 2.
DT   23-MAY-2018, entry version 203.
DE   RecName: Full=Cathepsin L1;
DE            EC=3.4.22.15;
DE   AltName: Full=Cathepsin L;
DE   AltName: Full=Major excreted protein;
DE            Short=MEP;
DE   Contains:
DE     RecName: Full=Cathepsin L1 heavy chain;
DE   Contains:
DE     RecName: Full=Cathepsin L1 light chain;
DE   Flags: Precursor;
GN   Name=CTSL; Synonyms=CTSL1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=3421948; DOI=10.1042/bj2530303;
RA   Gal S., Gottesman M.M.;
RT   "Isolation and sequence of a cDNA for human pro-(cathepsin L).";
RL   Biochem. J. 253:303-306(1988).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=2835398; DOI=10.1172/JCI113497;
RA   Joseph L.J., Chang L.C., Stamenkovich D., Sukhatme V.P.;
RT   "Complete nucleotide and deduced amino acid sequences of human and
RT   murine preprocathepsin L. An abundant transcript induced by
RT   transformation of fibroblasts.";
RL   J. Clin. Invest. 81:1621-1629(1988).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Colon endothelium;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164053; DOI=10.1038/nature02465;
RA   Humphray S.J., Oliver K., Hunt A.R., Plumb R.W., Loveland J.E.,
RA   Howe K.L., Andrews T.D., Searle S., Hunt S.E., Scott C.E., Jones M.C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Ashwell R.I.S.,
RA   Babbage A.K., Babbage S., Bagguley C.L., Bailey J., Banerjee R.,
RA   Barker D.J., Barlow K.F., Bates K., Beasley H., Beasley O., Bird C.P.,
RA   Bray-Allen S., Brown A.J., Brown J.Y., Burford D., Burrill W.,
RA   Burton J., Carder C., Carter N.P., Chapman J.C., Chen Y., Clarke G.,
RA   Clark S.Y., Clee C.M., Clegg S., Collier R.E., Corby N., Crosier M.,
RA   Cummings A.T., Davies J., Dhami P., Dunn M., Dutta I., Dyer L.W.,
RA   Earthrowl M.E., Faulkner L., Fleming C.J., Frankish A.,
RA   Frankland J.A., French L., Fricker D.G., Garner P., Garnett J.,
RA   Ghori J., Gilbert J.G.R., Glison C., Grafham D.V., Gribble S.,
RA   Griffiths C., Griffiths-Jones S., Grocock R., Guy J., Hall R.E.,
RA   Hammond S., Harley J.L., Harrison E.S.I., Hart E.A., Heath P.D.,
RA   Henderson C.D., Hopkins B.L., Howard P.J., Howden P.J., Huckle E.,
RA   Johnson C., Johnson D., Joy A.A., Kay M., Keenan S., Kershaw J.K.,
RA   Kimberley A.M., King A., Knights A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C., Lloyd D.M.,
RA   Lovell J., Martin S., Mashreghi-Mohammadi M., Matthews L., McLaren S.,
RA   McLay K.E., McMurray A., Milne S., Nickerson T., Nisbett J.,
RA   Nordsiek G., Pearce A.V., Peck A.I., Porter K.M., Pandian R.,
RA   Pelan S., Phillimore B., Povey S., Ramsey Y., Rand V., Scharfe M.,
RA   Sehra H.K., Shownkeen R., Sims S.K., Skuce C.D., Smith M.,
RA   Steward C.A., Swarbreck D., Sycamore N., Tester J., Thorpe A.,
RA   Tracey A., Tromans A., Thomas D.W., Wall M., Wallis J.M., West A.P.,
RA   Whitehead S.L., Willey D.L., Williams S.A., Wilming L., Wray P.W.,
RA   Young L., Ashurst J.L., Coulson A., Blocker H., Durbin R.M.,
RA   Sulston J.E., Hubbard T., Jackson M.J., Bentley D.R., Beck S.,
RA   Rogers J., Dunham I.;
RT   "DNA sequence and analysis of human chromosome 9.";
RL   Nature 429:369-374(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Prostate;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   PROTEIN SEQUENCE OF 114-288 AND 292-333.
RX   PubMed=3342889; DOI=10.1016/0014-5793(88)80028-0;
RA   Ritonja A., Popovic T., Kotnik M., Machleidt W., Turk V.;
RT   "Amino acid sequences of the human kidney cathepsins H and L.";
RL   FEBS Lett. 228:341-345(1988).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 113-154.
RX   PubMed=3550705; DOI=10.1093/nar/15.7.3186;
RA   Joseph L.J., Lapid S., Sukhatme V.P.;
RT   "The major ras induced protein in NIH3T3 cells is cathepsin L.";
RL   Nucleic Acids Res. 15:3186-3186(1987).
RN   [9]
RP   PROTEIN SEQUENCE OF 114-154 AND 292-333.
RX   PubMed=3545185; DOI=10.1042/bj2400373;
RA   Mason R.W., Walker J.E., Northrop F.D.;
RT   "The N-terminal amino acid sequences of the heavy and light chains of
RT   human cathepsin L. Relationship to a cDNA clone for a major cysteine
RT   proteinase from a mouse macrophage cell line.";
RL   Biochem. J. 240:373-377(1986).
RN   [10]
RP   GLYCOSYLATION AT ASN-221.
RX   PubMed=12754519; DOI=10.1038/nbt827;
RA   Zhang H., Li X.-J., Martin D.B., Aebersold R.;
RT   "Identification and quantification of N-linked glycoproteins using
RT   hydrazide chemistry, stable isotope labeling and mass spectrometry.";
RL   Nat. Biotechnol. 21:660-666(2003).
RN   [11]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-221.
RC   TISSUE=Plasma;
RX   PubMed=16335952; DOI=10.1021/pr0502065;
RA   Liu T., Qian W.-J., Gritsenko M.A., Camp D.G. II, Monroe M.E.,
RA   Moore R.J., Smith R.D.;
RT   "Human plasma N-glycoproteome analysis by immunoaffinity subtraction,
RT   hydrazide chemistry, and mass spectrometry.";
RL   J. Proteome Res. 4:2070-2080(2005).
RN   [12]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-221.
RC   TISSUE=Liver;
RX   PubMed=19159218; DOI=10.1021/pr8008012;
RA   Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.;
RT   "Glycoproteomics analysis of human liver tissue by combination of
RT   multiple enzyme digestion and hydrazide chemistry.";
RL   J. Proteome Res. 8:651-661(2009).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22905912; DOI=10.1021/pr300539b;
RA   Rosenow A., Noben J.P., Jocken J., Kallendrusch S.,
RA   Fischer-Posovszky P., Mariman E.C., Renes J.;
RT   "Resveratrol-induced changes of the human adipocyte secretion
RT   profile.";
RL   J. Proteome Res. 11:4733-4743(2012).
RN   [15]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [16]
RP   X-RAY CRYSTALLOGRAPHY (2.2 ANGSTROMS) OF 18-333.
RX   PubMed=8896443;
RA   Coulombe R., Grochulski P., Sivaraman J., Menard R., Mort J.S.,
RA   Cygler M.;
RT   "Structure of human procathepsin L reveals the molecular basis of
RT   inhibition by the prosegment.";
RL   EMBO J. 15:5492-5503(1996).
RN   [17]
RP   X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS) OF 114-333.
RX   PubMed=9141479; DOI=10.1016/S0014-5793(97)00216-0;
RA   Fujishima A., Imai Y., Nomura T., Fujisawa Y., Yamamoto Y.,
RA   Sugarawa T.;
RT   "The crystal structure of human cathepsin L complexed with E-64.";
RL   FEBS Lett. 407:47-50(1997).
RN   [18]
RP   X-RAY CRYSTALLOGRAPHY (1.8 ANGSTROMS) OF 18-333.
RA   Cygler M., Coulombe R.;
RL   Submitted (AUG-1999) to the PDB data bank.
CC   -!- FUNCTION: Important for the overall degradation of proteins in
CC       lysosomes.
CC   -!- CATALYTIC ACTIVITY: Specificity close to that of papain. As
CC       compared to cathepsin B, cathepsin L exhibits higher activity
CC       toward protein substrates, but has little activity on Z-Arg-Arg-
CC       NHMec, and no peptidyl-dipeptidase activity.
CC   -!- SUBUNIT: Dimer of a heavy and a light chain linked by disulfide
CC       bonds.
CC   -!- INTERACTION:
CC       O43765:SGTA; NbExp=3; IntAct=EBI-1220160, EBI-347996;
CC       G5EFH4:srp-6 (xeno); NbExp=2; IntAct=EBI-1220160, EBI-1549936;
CC   -!- SUBCELLULAR LOCATION: Lysosome.
CC   -!- SIMILARITY: Belongs to the peptidase C1 family.
CC       {ECO:0000255|PROSITE-ProRule:PRU10088, ECO:0000255|PROSITE-
CC       ProRule:PRU10089, ECO:0000255|PROSITE-ProRule:PRU10090}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/CTSL1ID40208ch9q21.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X12451; CAA30981.1; -; mRNA.
DR   EMBL; M20496; AAA66974.1; -; mRNA.
DR   EMBL; CR457053; CAG33334.1; -; mRNA.
DR   EMBL; BX537395; CAD97637.1; -; mRNA.
DR   EMBL; AL160279; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC012612; AAH12612.1; -; mRNA.
DR   EMBL; X05256; CAA28877.1; -; mRNA.
DR   CCDS; CCDS6675.1; -.
DR   PIR; S01002; KHHUL.
DR   RefSeq; NP_001244900.1; NM_001257971.1.
DR   RefSeq; NP_001244901.1; NM_001257972.1.
DR   RefSeq; NP_001903.1; NM_001912.4.
DR   RefSeq; NP_666023.1; NM_145918.2.
DR   RefSeq; XP_005251773.1; XM_005251716.3.
DR   UniGene; Hs.731507; -.
DR   PDB; 1CJL; X-ray; 2.20 A; A=22-333.
DR   PDB; 1CS8; X-ray; 1.80 A; A=19-333.
DR   PDB; 1ICF; X-ray; 2.00 A; A/C=114-288, B/D=292-333.
DR   PDB; 1MHW; X-ray; 1.90 A; A/B=114-288, C/D=292-333.
DR   PDB; 2NQD; X-ray; 1.75 A; B=113-333.
DR   PDB; 2VHS; X-ray; 1.50 A; A/B/C/D=114-333.
DR   PDB; 2XU1; X-ray; 1.45 A; A/B/C/D=114-333.
DR   PDB; 2XU3; X-ray; 0.90 A; A=114-333.
DR   PDB; 2XU4; X-ray; 1.12 A; A=114-333.
DR   PDB; 2XU5; X-ray; 1.60 A; A=114-333.
DR   PDB; 2YJ2; X-ray; 1.15 A; A=114-333.
DR   PDB; 2YJ8; X-ray; 1.30 A; A=114-333.
DR   PDB; 2YJ9; X-ray; 1.35 A; A=114-333.
DR   PDB; 2YJB; X-ray; 1.40 A; A=114-333.
DR   PDB; 2YJC; X-ray; 1.14 A; A=114-333.
DR   PDB; 3BC3; X-ray; 2.20 A; A/B=114-333.
DR   PDB; 3H89; X-ray; 2.50 A; A/B/C/D/E/F=114-333.
DR   PDB; 3H8B; X-ray; 1.80 A; A/B/C/D/E/F=114-333.
DR   PDB; 3H8C; X-ray; 2.50 A; A/B=114-333.
DR   PDB; 3HHA; X-ray; 1.27 A; A/B/C/D=114-333.
DR   PDB; 3HWN; X-ray; 2.33 A; A/B/C/D=76-333.
DR   PDB; 3IV2; X-ray; 2.20 A; A/B=114-333.
DR   PDB; 3K24; X-ray; 2.50 A; A/B=114-333.
DR   PDB; 3KSE; X-ray; 1.71 A; A/B/C=114-333.
DR   PDB; 3OF8; X-ray; 2.20 A; A=113-333.
DR   PDB; 3OF9; X-ray; 1.76 A; A=113-333.
DR   PDB; 4AXL; X-ray; 1.92 A; A=114-333.
DR   PDB; 4AXM; X-ray; 2.80 A; A/B/F/I/L/O=114-333.
DR   PDB; 5F02; X-ray; 1.43 A; A=114-333.
DR   PDB; 5I4H; X-ray; 1.42 A; A=113-218, B=222-333.
DR   PDB; 5MAE; X-ray; 1.00 A; A=114-333.
DR   PDB; 5MAJ; X-ray; 1.00 A; A=114-333.
DR   PDB; 5MQY; X-ray; 1.13 A; A=114-333.
DR   PDB; 6EZP; X-ray; 1.37 A; A=114-333.
DR   PDB; 6EZX; X-ray; 2.34 A; A/B=114-333.
DR   PDB; 6F06; X-ray; 2.02 A; A/B=114-333.
DR   PDBsum; 1CJL; -.
DR   PDBsum; 1CS8; -.
DR   PDBsum; 1ICF; -.
DR   PDBsum; 1MHW; -.
DR   PDBsum; 2NQD; -.
DR   PDBsum; 2VHS; -.
DR   PDBsum; 2XU1; -.
DR   PDBsum; 2XU3; -.
DR   PDBsum; 2XU4; -.
DR   PDBsum; 2XU5; -.
DR   PDBsum; 2YJ2; -.
DR   PDBsum; 2YJ8; -.
DR   PDBsum; 2YJ9; -.
DR   PDBsum; 2YJB; -.
DR   PDBsum; 2YJC; -.
DR   PDBsum; 3BC3; -.
DR   PDBsum; 3H89; -.
DR   PDBsum; 3H8B; -.
DR   PDBsum; 3H8C; -.
DR   PDBsum; 3HHA; -.
DR   PDBsum; 3HWN; -.
DR   PDBsum; 3IV2; -.
DR   PDBsum; 3K24; -.
DR   PDBsum; 3KSE; -.
DR   PDBsum; 3OF8; -.
DR   PDBsum; 3OF9; -.
DR   PDBsum; 4AXL; -.
DR   PDBsum; 4AXM; -.
DR   PDBsum; 5F02; -.
DR   PDBsum; 5I4H; -.
DR   PDBsum; 5MAE; -.
DR   PDBsum; 5MAJ; -.
DR   PDBsum; 5MQY; -.
DR   PDBsum; 6EZP; -.
DR   PDBsum; 6EZX; -.
DR   PDBsum; 6F06; -.
DR   ProteinModelPortal; P07711; -.
DR   SMR; P07711; -.
DR   BioGrid; 107894; 24.
DR   IntAct; P07711; 14.
DR   MINT; P07711; -.
DR   STRING; 9606.ENSP00000345344; -.
DR   BindingDB; P07711; -.
DR   ChEMBL; CHEMBL3837; -.
DR   DrugBank; DB07477; BIPHENYL-4-YL-ACETALDEHYDE.
DR   DrugBank; DB03661; Cysteinesulfonic Acid.
DR   GuidetoPHARMACOLOGY; 2351; -.
DR   MEROPS; I29.001; -.
DR   iPTMnet; P07711; -.
DR   PhosphoSitePlus; P07711; -.
DR   BioMuta; CTSL; -.
DR   DMDM; 115741; -.
DR   EPD; P07711; -.
DR   MaxQB; P07711; -.
DR   PaxDb; P07711; -.
DR   PeptideAtlas; P07711; -.
DR   PRIDE; P07711; -.
DR   TopDownProteomics; P07711; -.
DR   DNASU; 1514; -.
DR   Ensembl; ENST00000340342; ENSP00000365061; ENSG00000135047.
DR   Ensembl; ENST00000343150; ENSP00000345344; ENSG00000135047.
DR   GeneID; 1514; -.
DR   KEGG; hsa:1514; -.
DR   UCSC; uc004aph.4; human.
DR   CTD; 1514; -.
DR   DisGeNET; 1514; -.
DR   EuPathDB; HostDB:ENSG00000135047.14; -.
DR   GeneCards; CTSL; -.
DR   H-InvDB; HIX0058839; -.
DR   H-InvDB; HIX0170314; -.
DR   HGNC; HGNC:2537; CTSL.
DR   HPA; CAB000459; -.
DR   MIM; 116880; gene.
DR   neXtProt; NX_P07711; -.
DR   OpenTargets; ENSG00000135047; -.
DR   PharmGKB; PA162382890; -.
DR   eggNOG; KOG1543; Eukaryota.
DR   eggNOG; COG4870; LUCA.
DR   GeneTree; ENSGT00900000140823; -.
DR   HOGENOM; HOG000230774; -.
DR   HOVERGEN; HBG011513; -.
DR   InParanoid; P07711; -.
DR   KO; K01365; -.
DR   OMA; QHYRKSG; -.
DR   OrthoDB; EOG091G0AKT; -.
DR   PhylomeDB; P07711; -.
DR   TreeFam; TF313739; -.
DR   BRENDA; 3.4.22.15; 2681.
DR   Reactome; R-HSA-1236977; Endosomal/Vacuolar pathway.
DR   Reactome; R-HSA-1442490; Collagen degradation.
DR   Reactome; R-HSA-1474228; Degradation of the extracellular matrix.
DR   Reactome; R-HSA-1679131; Trafficking and processing of endosomal TLR.
DR   Reactome; R-HSA-2022090; Assembly of collagen fibrils and other multimeric structures.
DR   Reactome; R-HSA-2132295; MHC class II antigen presentation.
DR   Reactome; R-HSA-8939242; RUNX1 regulates transcription of genes involved in differentiation of keratinocytes.
DR   ChiTaRS; CTSL; human.
DR   EvolutionaryTrace; P07711; -.
DR   GeneWiki; Cathepsin_L1; -.
DR   GenomeRNAi; 1514; -.
DR   PMAP-CutDB; P07711; -.
DR   PRO; PR:P07711; -.
DR   Proteomes; UP000005640; Chromosome 9.
DR   Bgee; ENSG00000135047; -.
DR   CleanEx; HS_CTSL1; -.
DR   ExpressionAtlas; P07711; baseline and differential.
DR   Genevisible; P07711; HS.
DR   GO; GO:0036021; C:endolysosome lumen; TAS:Reactome.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0005576; C:extracellular region; TAS:Reactome.
DR   GO; GO:0005615; C:extracellular space; IDA:BHF-UCL.
DR   GO; GO:0043202; C:lysosomal lumen; TAS:Reactome.
DR   GO; GO:0005764; C:lysosome; IDA:UniProtKB.
DR   GO; GO:0005634; C:nucleus; TAS:BHF-UCL.
DR   GO; GO:0005518; F:collagen binding; IDA:BHF-UCL.
DR   GO; GO:0004197; F:cysteine-type endopeptidase activity; IDA:UniProtKB.
DR   GO; GO:0008234; F:cysteine-type peptidase activity; IDA:UniProtKB.
DR   GO; GO:0001968; F:fibronectin binding; IPI:BHF-UCL.
DR   GO; GO:0042393; F:histone binding; IDA:BHF-UCL.
DR   GO; GO:0043394; F:proteoglycan binding; IPI:BHF-UCL.
DR   GO; GO:0004252; F:serine-type endopeptidase activity; TAS:Reactome.
DR   GO; GO:0097655; F:serpin family protein binding; IPI:UniProtKB.
DR   GO; GO:0002250; P:adaptive immune response; IEP:UniProtKB.
DR   GO; GO:0019882; P:antigen processing and presentation; TAS:UniProtKB.
DR   GO; GO:0019886; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; TAS:Reactome.
DR   GO; GO:0097067; P:cellular response to thyroid hormone stimulus; IEP:UniProtKB.
DR   GO; GO:0030574; P:collagen catabolic process; IDA:BHF-UCL.
DR   GO; GO:0022617; P:extracellular matrix disassembly; TAS:Reactome.
DR   GO; GO:0071888; P:macrophage apoptotic process; NAS:BHF-UCL.
DR   GO; GO:0006508; P:proteolysis; IDA:UniProtKB.
DR   GO; GO:0051603; P:proteolysis involved in cellular protein catabolic process; IDA:BHF-UCL.
DR   GO; GO:0045616; P:regulation of keratinocyte differentiation; TAS:Reactome.
DR   InterPro; IPR025661; Pept_asp_AS.
DR   InterPro; IPR000169; Pept_cys_AS.
DR   InterPro; IPR025660; Pept_his_AS.
DR   InterPro; IPR013128; Peptidase_C1A.
DR   InterPro; IPR000668; Peptidase_C1A_C.
DR   InterPro; IPR013201; Prot_inhib_I29.
DR   PANTHER; PTHR12411; PTHR12411; 1.
DR   Pfam; PF08246; Inhibitor_I29; 1.
DR   Pfam; PF00112; Peptidase_C1; 1.
DR   PRINTS; PR00705; PAPAIN.
DR   SMART; SM00848; Inhibitor_I29; 1.
DR   SMART; SM00645; Pept_C1; 1.
DR   PROSITE; PS00640; THIOL_PROTEASE_ASN; 1.
DR   PROSITE; PS00139; THIOL_PROTEASE_CYS; 1.
DR   PROSITE; PS00639; THIOL_PROTEASE_HIS; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Complete proteome; Direct protein sequencing;
KW   Disulfide bond; Glycoprotein; Hydrolase; Lysosome; Protease;
KW   Reference proteome; Signal; Thiol protease; Zymogen.
FT   SIGNAL        1     17       {ECO:0000250|UniProtKB:P07154}.
FT   PROPEP       18    113       Activation peptide.
FT                                /FTId=PRO_0000026244.
FT   CHAIN       114    288       Cathepsin L1 heavy chain.
FT                                /FTId=PRO_0000026245.
FT   PROPEP      289    291
FT                                /FTId=PRO_0000026246.
FT   CHAIN       292    333       Cathepsin L1 light chain.
FT                                /FTId=PRO_0000026247.
FT   ACT_SITE    138    138
FT   ACT_SITE    276    276
FT   ACT_SITE    300    300
FT   CARBOHYD    221    221       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:12754519,
FT                                ECO:0000269|PubMed:16335952,
FT                                ECO:0000269|PubMed:19159218}.
FT   DISULFID    135    178
FT   DISULFID    169    211
FT   DISULFID    269    322       Interchain (between heavy and light
FT                                chains).
FT   CONFLICT     56     56       M -> V (in Ref. 6; AAH12612).
FT                                {ECO:0000305}.
FT   CONFLICT    268    268       D -> N (in Ref. 7; AA sequence).
FT                                {ECO:0000305}.
FT   HELIX        23     25       {ECO:0000244|PDB:1CS8}.
FT   HELIX        26     35       {ECO:0000244|PDB:1CS8}.
FT   HELIX        44     67       {ECO:0000244|PDB:1CS8}.
FT   STRAND       72     75       {ECO:0000244|PDB:1CS8}.
FT   TURN         79     82       {ECO:0000244|PDB:1CS8}.
FT   HELIX        85     92       {ECO:0000244|PDB:1CS8}.
FT   STRAND      103    105       {ECO:0000244|PDB:1CJL}.
FT   HELIX       120    123       {ECO:0000244|PDB:2XU3}.
FT   STRAND      134    136       {ECO:0000244|PDB:2XU3}.
FT   HELIX       138    155       {ECO:0000244|PDB:2XU3}.
FT   HELIX       163    169       {ECO:0000244|PDB:2XU3}.
FT   TURN        171    174       {ECO:0000244|PDB:2XU3}.
FT   HELIX       177    179       {ECO:0000244|PDB:2XU4}.
FT   HELIX       183    193       {ECO:0000244|PDB:2XU3}.
FT   STRAND      196    198       {ECO:0000244|PDB:2XU3}.
FT   TURN        199    201       {ECO:0000244|PDB:2XU3}.
FT   HELIX       215    217       {ECO:0000244|PDB:2XU3}.
FT   STRAND      218    220       {ECO:0000244|PDB:2XU3}.
FT   STRAND      223    227       {ECO:0000244|PDB:2XU3}.
FT   HELIX       232    241       {ECO:0000244|PDB:2XU3}.
FT   STRAND      245    249       {ECO:0000244|PDB:2XU3}.
FT   HELIX       254    257       {ECO:0000244|PDB:2XU3}.
FT   STRAND      261    264       {ECO:0000244|PDB:2XU3}.
FT   STRAND      271    273       {ECO:0000244|PDB:4AXL}.
FT   STRAND      276    285       {ECO:0000244|PDB:2XU3}.
FT   STRAND      289    291       {ECO:0000244|PDB:2XU3}.
FT   STRAND      294    299       {ECO:0000244|PDB:2XU3}.
FT   STRAND      304    306       {ECO:0000244|PDB:3KSE}.
FT   STRAND      311    315       {ECO:0000244|PDB:2XU3}.
FT   STRAND      317    320       {ECO:0000244|PDB:2XU3}.
FT   HELIX       321    323       {ECO:0000244|PDB:2XU3}.
FT   TURN        324    326       {ECO:0000244|PDB:2XU3}.
FT   STRAND      329    332       {ECO:0000244|PDB:2XU3}.
SQ   SEQUENCE   333 AA;  37564 MW;  8CD17D00EF859D85 CRC64;
     MNPTLILAAF CLGIASATLT FDHSLEAQWT KWKAMHNRLY GMNEEGWRRA VWEKNMKMIE
     LHNQEYREGK HSFTMAMNAF GDMTSEEFRQ VMNGFQNRKP RKGKVFQEPL FYEAPRSVDW
     REKGYVTPVK NQGQCGSCWA FSATGALEGQ MFRKTGRLIS LSEQNLVDCS GPQGNEGCNG
     GLMDYAFQYV QDNGGLDSEE SYPYEATEES CKYNPKYSVA NDTGFVDIPK QEKALMKAVA
     TVGPISVAID AGHESFLFYK EGIYFEPDCS SEDMDHGVLV VGYGFESTES DNNKYWLVKN
     SWGEEWGMGG YVKMAKDRRN HCGIASAASY PTV
//
ID   Q9HBQ7_HUMAN            Unreviewed;       151 AA.
AC   Q9HBQ7;
DT   01-MAR-2001, integrated into UniProtKB/TrEMBL.
DT   01-MAR-2001, sequence version 1.
DT   23-MAY-2018, entry version 100.
DE   SubName: Full=Cathepsin L, isoform CRA_b {ECO:0000313|EMBL:EAW62735.1};
GN   Name=CTSL {ECO:0000313|EMBL:EAW62735.1};
GN   ORFNames=hCG_30369 {ECO:0000313|EMBL:EAW62735.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:AAG17239.1};
RN   [1] {ECO:0000313|EMBL:AAG17239.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Gu J.R., Wan D.F., Zhao X.T., Zhou X.M., Jiang H.Q., Zhang P.P.,
RA   Qin W.X., Huang Y., Qiu X.K., Qian L.F., He L.P., Li H.N., Yu Y.,
RA   Yu J., Han L.H.;
RT   "Novel Human cDNA clones with function of inhibiting cancer cell
RT   growth.";
RL   Submitted (DEC-1999) to the EMBL/GenBank/DDBJ databases.
RN   [2] {ECO:0000313|EMBL:EAW62735.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [3] {ECO:0000313|EMBL:EAW62735.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
CC   -!- SIMILARITY: Belongs to the peptidase C1 family.
CC       {ECO:0000256|RuleBase:RU362133, ECO:0000256|SAAS:SAAS00689568}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF217997; AAG17239.1; -; mRNA.
DR   EMBL; CH471089; EAW62735.1; -; Genomic_DNA.
DR   RefSeq; NP_001244902.1; NM_001257973.1.
DR   UniGene; Hs.731507; -.
DR   PeptideAtlas; Q9HBQ7; -.
DR   PRIDE; Q9HBQ7; -.
DR   GeneID; 1514; -.
DR   CTD; 1514; -.
DR   eggNOG; KOG1543; Eukaryota.
DR   eggNOG; COG4870; LUCA.
DR   HOVERGEN; HBG011513; -.
DR   BRENDA; 3.4.22.15; 2681.
DR   ChiTaRS; CTSL; human.
DR   GenomeRNAi; 1514; -.
DR   GO; GO:0008234; F:cysteine-type peptidase activity; IEA:InterPro.
DR   InterPro; IPR025661; Pept_asp_AS.
DR   InterPro; IPR025660; Pept_his_AS.
DR   InterPro; IPR013128; Peptidase_C1A.
DR   InterPro; IPR000668; Peptidase_C1A_C.
DR   PANTHER; PTHR12411; PTHR12411; 1.
DR   Pfam; PF00112; Peptidase_C1; 1.
DR   SMART; SM00645; Pept_C1; 1.
DR   PROSITE; PS00640; THIOL_PROTEASE_ASN; 1.
DR   PROSITE; PS00639; THIOL_PROTEASE_HIS; 1.
PE   2: Evidence at transcript level;
FT   DOMAIN        1    150       Pept_C1. {ECO:0000259|SMART:SM00645}.
SQ   SEQUENCE   151 AA;  16839 MW;  539C686EE95C80B3 CRC64;
     MDYAFQYVQD NGGLDSEESY PYEATEESCK YNPKYSVAND TGFVDIPKQE KALMKAVATV
     GPISVAIDAG HESFLFYKEG IYFEPDCSSE DMDHGVLVVG YGFESTESDN NKYWLVKNSW
     GEEWGMGGYV KMAKDRRNHC GIASAASYPT V
//
ID   GIP_HUMAN               Reviewed;         153 AA.
AC   P09681; Q4VB42; Q6NTD3;
DT   01-JUL-1989, integrated into UniProtKB/Swiss-Prot.
DT   01-JUL-1989, sequence version 1.
DT   25-APR-2018, entry version 154.
DE   RecName: Full=Gastric inhibitory polypeptide;
DE            Short=GIP;
DE   AltName: Full=Glucose-dependent insulinotropic polypeptide;
DE   AltName: Full=Incretin hormone;
DE   Flags: Precursor;
GN   Name=GIP;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=2890159; DOI=10.1073/pnas.84.20.7005;
RA   Takeda J., Seino Y., Tanaka K., Fukumoto H., Kayano T., Takahashi H.,
RA   Mitani T., Kurono M., Suzuki T., Tobe T., Imura H.;
RT   "Sequence of an intestinal cDNA encoding human gastric inhibitory
RT   polypeptide precursor.";
RL   Proc. Natl. Acad. Sci. U.S.A. 84:7005-7008(1987).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=2739653; DOI=10.1210/mend-3-6-1014;
RA   Inagaki N., Seino Y., Takeda J., Yano H., Yamada Y., Bell G.I.,
RA   Eddy R.L. Jr., Fukushima Y., Byers M.G., Shows T.B., Imura H.;
RT   "Gastric inhibitory polypeptide: structure and chromosomal
RT   localization of the human gene.";
RL   Mol. Endocrinol. 3:1014-1021(1989).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT GLY-103.
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   PROTEIN SEQUENCE OF 52-93.
RX   PubMed=6745415; DOI=10.1016/0014-5793(84)81114-X;
RA   Moody A.J., Thim L., Valverde I.;
RT   "The isolation and sequencing of human gastric inhibitory peptide
RT   (GIP).";
RL   FEBS Lett. 172:142-148(1984).
RN   [5]
RP   STRUCTURE BY NMR OF 52-81.
RX   PubMed=15522230; DOI=10.1016/j.bbrc.2004.10.033;
RA   Alana I., Hewage C.M., Malthouse J.P., Parker J.C., Gault V.A.,
RA   O'Harte F.P.;
RT   "NMR structure of the glucose-dependent insulinotropic polypeptide
RT   fragment, GIP(1-30)amide.";
RL   Biochem. Biophys. Res. Commun. 325:281-286(2004).
CC   -!- FUNCTION: Potent stimulator of insulin secretion and relatively
CC       poor inhibitor of gastric acid secretion.
CC   -!- INTERACTION:
CC       Q6UY14-3:ADAMTSL4; NbExp=3; IntAct=EBI-8588553, EBI-10173507;
CC       P48546:GIPR; NbExp=3; IntAct=EBI-8588553, EBI-15653881;
CC       Q7Z3S9:NOTCH2NL; NbExp=3; IntAct=EBI-8588553, EBI-945833;
CC       O43765:SGTA; NbExp=7; IntAct=EBI-8588553, EBI-347996;
CC   -!- SUBCELLULAR LOCATION: Secreted.
CC   -!- SIMILARITY: Belongs to the glucagon family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M18185; AAA88043.1; -; mRNA.
DR   EMBL; M31679; AAA53192.1; -; Genomic_DNA.
DR   EMBL; M31675; AAA53192.1; JOINED; Genomic_DNA.
DR   EMBL; M31676; AAA53192.1; JOINED; Genomic_DNA.
DR   EMBL; M31677; AAA53192.1; JOINED; Genomic_DNA.
DR   EMBL; M31678; AAA53192.1; JOINED; Genomic_DNA.
DR   EMBL; BC069100; AAH69100.1; -; mRNA.
DR   EMBL; BC069663; AAH69663.1; -; mRNA.
DR   EMBL; BC069686; AAH69686.1; -; mRNA.
DR   EMBL; BC069746; AAH69746.1; -; mRNA.
DR   EMBL; BC096146; AAH96146.1; -; mRNA.
DR   EMBL; BC096147; AAH96147.1; -; mRNA.
DR   EMBL; BC096148; AAH96148.1; -; mRNA.
DR   EMBL; BC096149; AAH96149.1; -; mRNA.
DR   CCDS; CCDS11542.1; -.
DR   PIR; A28406; A28406.
DR   RefSeq; NP_004114.1; NM_004123.2.
DR   UniGene; Hs.1454; -.
DR   PDB; 1T5Q; NMR; -; A=52-81.
DR   PDB; 2B4N; NMR; -; A=52-93.
DR   PDB; 2L70; NMR; -; A=52-93.
DR   PDB; 2L71; NMR; -; A=52-93.
DR   PDB; 2OBU; NMR; -; A=52-93.
DR   PDB; 2QKH; X-ray; 1.90 A; B=52-93.
DR   PDBsum; 1T5Q; -.
DR   PDBsum; 2B4N; -.
DR   PDBsum; 2L70; -.
DR   PDBsum; 2L71; -.
DR   PDBsum; 2OBU; -.
DR   PDBsum; 2QKH; -.
DR   ProteinModelPortal; P09681; -.
DR   SMR; P09681; -.
DR   BioGrid; 108962; 12.
DR   DIP; DIP-46469N; -.
DR   IntAct; P09681; 7.
DR   MINT; P09681; -.
DR   STRING; 9606.ENSP00000350005; -.
DR   BindingDB; P09681; -.
DR   ChEMBL; CHEMBL5571; -.
DR   iPTMnet; P09681; -.
DR   PhosphoSitePlus; P09681; -.
DR   BioMuta; GIP; -.
DR   DMDM; 121194; -.
DR   PaxDb; P09681; -.
DR   PeptideAtlas; P09681; -.
DR   PRIDE; P09681; -.
DR   DNASU; 2695; -.
DR   Ensembl; ENST00000357424; ENSP00000350005; ENSG00000159224.
DR   GeneID; 2695; -.
DR   KEGG; hsa:2695; -.
DR   UCSC; uc002iol.2; human.
DR   CTD; 2695; -.
DR   DisGeNET; 2695; -.
DR   EuPathDB; HostDB:ENSG00000159224.4; -.
DR   GeneCards; GIP; -.
DR   HGNC; HGNC:4270; GIP.
DR   HPA; CAB016729; -.
DR   HPA; HPA021612; -.
DR   MIM; 137240; gene.
DR   neXtProt; NX_P09681; -.
DR   OpenTargets; ENSG00000159224; -.
DR   PharmGKB; PA28681; -.
DR   eggNOG; ENOG410JC1A; Eukaryota.
DR   eggNOG; ENOG4111BXQ; LUCA.
DR   GeneTree; ENSGT00390000005121; -.
DR   HOGENOM; HOG000112725; -.
DR   HOVERGEN; HBG005839; -.
DR   InParanoid; P09681; -.
DR   KO; K05258; -.
DR   OMA; LAWMVDQ; -.
DR   OrthoDB; EOG091G153X; -.
DR   PhylomeDB; P09681; -.
DR   TreeFam; TF332333; -.
DR   Reactome; R-HSA-400511; Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP).
DR   Reactome; R-HSA-418555; G alpha (s) signalling events.
DR   Reactome; R-HSA-420092; Glucagon-type ligand receptors.
DR   EvolutionaryTrace; P09681; -.
DR   GenomeRNAi; 2695; -.
DR   PRO; PR:P09681; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   Bgee; ENSG00000159224; -.
DR   CleanEx; HS_GIP; -.
DR   Genevisible; P09681; HS.
DR   GO; GO:0005788; C:endoplasmic reticulum lumen; TAS:Reactome.
DR   GO; GO:0005576; C:extracellular region; TAS:Reactome.
DR   GO; GO:0005615; C:extracellular space; IEA:Ensembl.
DR   GO; GO:0043025; C:neuronal cell body; IEA:Ensembl.
DR   GO; GO:0034774; C:secretory granule lumen; TAS:Reactome.
DR   GO; GO:0005179; F:hormone activity; TAS:ProtInc.
DR   GO; GO:0008344; P:adult locomotory behavior; IEA:Ensembl.
DR   GO; GO:0055123; P:digestive system development; IEA:Ensembl.
DR   GO; GO:0031018; P:endocrine pancreas development; IEA:Ensembl.
DR   GO; GO:0035640; P:exploration behavior; IEA:Ensembl.
DR   GO; GO:0007565; P:female pregnancy; IEA:Ensembl.
DR   GO; GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:Reactome.
DR   GO; GO:0060291; P:long-term synaptic potentiation; IEA:Ensembl.
DR   GO; GO:0007613; P:memory; IEA:Ensembl.
DR   GO; GO:0043950; P:positive regulation of cAMP-mediated signaling; IEA:Ensembl.
DR   GO; GO:0070094; P:positive regulation of glucagon secretion; IEA:Ensembl.
DR   GO; GO:0010828; P:positive regulation of glucose transmembrane transport; IEA:Ensembl.
DR   GO; GO:0032024; P:positive regulation of insulin secretion; IEA:Ensembl.
DR   GO; GO:0050796; P:regulation of insulin secretion; TAS:ParkinsonsUK-UCL.
DR   GO; GO:0010447; P:response to acidic pH; IEA:Ensembl.
DR   GO; GO:0043200; P:response to amino acid; IEA:Ensembl.
DR   GO; GO:0048678; P:response to axon injury; IEA:Ensembl.
DR   GO; GO:0042493; P:response to drug; IEA:Ensembl.
DR   GO; GO:0009749; P:response to glucose; IEA:Ensembl.
DR   GO; GO:0033993; P:response to lipid; IEA:Ensembl.
DR   GO; GO:0014070; P:response to organic cyclic compound; IEA:Ensembl.
DR   GO; GO:0043434; P:response to peptide hormone; IEA:Ensembl.
DR   GO; GO:0010269; P:response to selenium ion; IEA:Ensembl.
DR   GO; GO:0042594; P:response to starvation; IEA:Ensembl.
DR   GO; GO:0019233; P:sensory perception of pain; IEA:Ensembl.
DR   GO; GO:0007165; P:signal transduction; TAS:ProtInc.
DR   GO; GO:0070328; P:triglyceride homeostasis; IEA:Ensembl.
DR   InterPro; IPR000532; Glucagon_GIP_secretin_VIP.
DR   Pfam; PF00123; Hormone_2; 1.
DR   SMART; SM00070; GLUCA; 1.
DR   PROSITE; PS00260; GLUCAGON; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Cleavage on pair of basic residues; Complete proteome;
KW   Direct protein sequencing; Hormone; Polymorphism; Reference proteome;
KW   Secreted; Signal.
FT   SIGNAL        1     21       {ECO:0000255}.
FT   PROPEP       22     50
FT                                /FTId=PRO_0000011214.
FT   PEPTIDE      52     93       Gastric inhibitory polypeptide.
FT                                /FTId=PRO_0000011215.
FT   PROPEP       95    153
FT                                /FTId=PRO_0000011216.
FT   VARIANT     103    103       S -> G (in dbSNP:rs2291725).
FT                                {ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_021897.
FT   VARIANT     146    146       N -> S (in dbSNP:rs35703924).
FT                                /FTId=VAR_033973.
FT   HELIX        57     79       {ECO:0000244|PDB:2QKH}.
FT   TURN         80     82       {ECO:0000244|PDB:2QKH}.
FT   STRAND       86     88       {ECO:0000244|PDB:2L70}.
SQ   SEQUENCE   153 AA;  17108 MW;  51F5FC388A8897EC CRC64;
     MVATKTFALL LLSLFLAVGL GEKKEGHFSA LPSLPVGSHA KVSSPQPRGP RYAEGTFISD
     YSIAMDKIHQ QDFVNWLLAQ KGKKNDWKHN ITQREARALE LASQANRKEE EAVEPQSSPA
     KNPSDEDLLR DLLIQELLAC LLDQTNLCRL RSR
//
ID   GRN_HUMAN               Reviewed;         593 AA.
AC   P28799; D3DX55; P23781; P23782; P23783; P23784; Q53HQ8; Q53Y88;
AC   Q540U8; Q9BWE7; Q9H8S1; Q9UCH0;
DT   01-DEC-1992, integrated into UniProtKB/Swiss-Prot.
DT   11-OCT-2005, sequence version 2.
DT   23-MAY-2018, entry version 198.
DE   RecName: Full=Granulins;
DE   AltName: Full=Proepithelin;
DE            Short=PEPI;
DE   Contains:
DE     RecName: Full=Acrogranin;
DE     AltName: Full=Glycoprotein of 88 Kda;
DE              Short=GP88;
DE              Short=Glycoprotein 88;
DE     AltName: Full=Progranulin;
DE   Contains:
DE     RecName: Full=Paragranulin;
DE   Contains:
DE     RecName: Full=Granulin-1;
DE     AltName: Full=Granulin G;
DE   Contains:
DE     RecName: Full=Granulin-2;
DE     AltName: Full=Granulin F;
DE   Contains:
DE     RecName: Full=Granulin-3;
DE     AltName: Full=Granulin B;
DE   Contains:
DE     RecName: Full=Granulin-4;
DE     AltName: Full=Granulin A;
DE   Contains:
DE     RecName: Full=Granulin-5;
DE     AltName: Full=Granulin C;
DE   Contains:
DE     RecName: Full=Granulin-6;
DE     AltName: Full=Granulin D;
DE   Contains:
DE     RecName: Full=Granulin-7;
DE     AltName: Full=Granulin E;
DE   Flags: Precursor;
GN   Name=GRN;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND SEQUENCE REVISION.
RX   PubMed=1417868; DOI=10.1016/0006-291X(92)92349-3;
RA   Bhandari V., Bateman A.;
RT   "Structure and chromosomal location of the human granulin gene.";
RL   Biochem. Biophys. Res. Commun. 188:57-63(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Kidney;
RX   PubMed=1618805;
RA   Plowman G.D., Green J.M., Neubauer M.G., Buckley S.D., McDonald V.L.,
RA   Todaro G.J., Shoyab M.;
RT   "The epithelin precursor encodes two proteins with opposing activities
RT   on epithelial cell growth.";
RL   J. Biol. Chem. 267:13073-13078(1992).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND PARTIAL PROTEIN SEQUENCE.
RC   TISSUE=Bone marrow;
RX   PubMed=1542665; DOI=10.1073/pnas.89.5.1715;
RA   Bhandari V., Palfree R.G.E., Bateman A.;
RT   "Isolation and sequence of the granulin precursor cDNA from human bone
RT   marrow reveals tandem cysteine-rich granulin domains.";
RL   Proc. Natl. Acad. Sci. U.S.A. 89:1715-1719(1992).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RA   Lu R., Tian C., Serrero G.;
RT   "PCDGF sequence from lambda phage human Jurkat T cell cDNA library
RT   (Clontech).";
RL   Submitted (JUN-2002) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RA   Yu W., Gibbs R.A.;
RL   Submitted (MAR-1998) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RC   TISSUE=Ovary;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Adipose tissue;
RA   Suzuki Y., Sugano S., Totoki Y., Toyoda A., Takeda T., Sakaki Y.,
RA   Tanaka A., Yokoyama S.;
RL   Submitted (APR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Cervix, and Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [11]
RP   PROTEIN SEQUENCE OF 206-233; 281-336; 364-396 AND 442-447.
RC   TISSUE=Leukocyte;
RX   PubMed=2268320; DOI=10.1016/S0006-291X(05)80908-8;
RA   Bateman A., Belcourt D.R., Bennett H.P., Lazure C., Solomon S.;
RT   "Granulins, a novel class of peptide from leukocytes.";
RL   Biochem. Biophys. Res. Commun. 173:1161-1168(1990).
RN   [12]
RP   PROTEIN SEQUENCE OF 281-295.
RX   PubMed=8471426; DOI=10.1038/bjc.1993.127;
RA   Kardana A., Bagshawe K.D., Coles B., Read D., Taylor M.;
RT   "Characterisation of UGP and its relationship with beta-core
RT   fragment.";
RL   Br. J. Cancer 67:686-692(1993).
RN   [13]
RP   INVOLVEMENT IN UP-FTD.
RX   PubMed=16862116; DOI=10.1038/nature05016;
RA   Baker M., Mackenzie I.R., Pickering-Brown S.M., Gass J.,
RA   Rademakers R., Lindholm C., Snowden J., Adamson J., Sadovnick A.D.,
RA   Rollinson S., Cannon A., Dwosh E., Neary D., Melquist S.,
RA   Richardson A., Dickson D., Berger Z., Eriksen J., Robinson T.,
RA   Zehr C., Dickey C.A., Crook R., McGowan E., Mann D., Boeve B.,
RA   Feldman H., Hutton M.;
RT   "Mutations in progranulin cause tau-negative frontotemporal dementia
RT   linked to chromosome 17.";
RL   Nature 442:916-919(2006).
RN   [14]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-265.
RC   TISSUE=Liver;
RX   PubMed=19159218; DOI=10.1021/pr8008012;
RA   Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.;
RT   "Glycoproteomics analysis of human liver tissue by combination of
RT   multiple enzyme digestion and hydrazide chemistry.";
RL   J. Proteome Res. 8:651-661(2009).
RN   [15]
RP   GLYCOSYLATION AT ASN-118; ASN-265; ASN-368 AND ASN-530.
RX   PubMed=20188224; DOI=10.1016/j.jprot.2010.02.013;
RA   Songsrirote K., Li Z., Ashford D., Bateman A., Thomas-Oates J.;
RT   "Development and application of mass spectrometric methods for the
RT   analysis of progranulin N-glycosylation.";
RL   J. Proteomics 73:1479-1490(2010).
RN   [16]
RP   INVOLVEMENT IN CLN11.
RX   PubMed=22608501; DOI=10.1016/j.ajhg.2012.04.021;
RA   Smith K.R., Damiano J., Franceschetti S., Carpenter S., Canafoglia L.,
RA   Morbin M., Rossi G., Pareyson D., Mole S.E., Staropoli J.F.,
RA   Sims K.B., Lewis J., Lin W.L., Dickson D.W., Dahl H.H., Bahlo M.,
RA   Berkovic S.F.;
RT   "Strikingly different clinicopathological phenotypes determined by
RT   progranulin-mutation dosage.";
RL   Am. J. Hum. Genet. 90:1102-1107(2012).
RN   [17]
RP   SUBUNIT.
RX   PubMed=23364791; DOI=10.1074/jbc.M112.441949;
RA   Nguyen A.D., Nguyen T.A., Cenik B., Yu G., Herz J., Walther T.C.,
RA   Davidson W.S., Farese R.V. Jr.;
RT   "Secreted progranulin is a homodimer and is not a component of high
RT   density lipoproteins (HDL).";
RL   J. Biol. Chem. 288:8627-8635(2013).
RN   [18]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [19]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [20]
RP   STRUCTURE BY NMR OF 284-311.
RX   PubMed=10715107; DOI=10.1021/bi992130u;
RA   Tolkatchev D., Ng A., Vranken W., Ni F.;
RT   "Design and solution structure of a well-folded stack of two beta-
RT   hairpins based on the amino-terminal fragment of human granulin A.";
RL   Biochemistry 39:2878-2886(2000).
RN   [21]
RP   STRUCTURE BY NMR OF 123-179; 281-337 AND 364-417, AND DISULFIDE BONDS.
RX   PubMed=18359860; DOI=10.1110/ps.073295308;
RA   Tolkatchev D., Malik S., Vinogradova A., Wang P., Chen Z., Xu P.,
RA   Bennett H.P., Bateman A., Ni F.;
RT   "Structure dissection of human progranulin identifies well-folded
RT   granulin/epithelin modules with unique functional activities.";
RL   Protein Sci. 17:711-724(2008).
RN   [22]
RP   VARIANT UP-FTD ASP-9.
RX   PubMed=16983685; DOI=10.1002/ana.20963;
RA   Mukherjee O., Pastor P., Cairns N.J., Chakraverty S., Kauwe J.S.K.,
RA   Shears S., Behrens M.I., Budde J., Hinrichs A.L., Norton J.,
RA   Levitch D., Taylor-Reinwald L., Gitcho M., Tu P.-H.,
RA   Tenenholz Grinberg L., Liscic R.M., Armendariz J., Morris J.C.,
RA   Goate A.M.;
RT   "HDDD2 is a familial frontotemporal lobar degeneration with ubiquitin-
RT   positive, tau-negative inclusions caused by a missense mutation in the
RT   signal peptide of progranulin.";
RL   Ann. Neurol. 60:314-322(2006).
RN   [23]
RP   CHARACTERIZATION OF VARIANT UP-FTD ASP-9.
RX   PubMed=18183624; DOI=10.1002/humu.20681;
RA   Mukherjee O., Wang J., Gitcho M., Chakraverty S., Taylor-Reinwald L.,
RA   Shears S., Kauwe J.S.K., Norton J., Levitch D., Bigio E.H.,
RA   Hatanpaa K.J., White C.L., Morris J.C., Cairns N.J., Goate A.;
RT   "Molecular characterization of novel progranulin (GRN) mutations in
RT   frontotemporal dementia.";
RL   Hum. Mutat. 29:512-521(2008).
RN   [24]
RP   VARIANTS TRP-19; TRP-55; THR-69; ASN-119 DEL; TYR-120; MET-182;
RP   SER-221; LEU-275; ASN-376; LEU-398; GLN-433; ALA-515 AND HIS-564.
RX   PubMed=20020531; DOI=10.1002/humu.21152;
RA   Guerreiro R.J., Washecka N., Hardy J., Singleton A.;
RT   "A thorough assessment of benign genetic variability in GRN and
RT   MAPT.";
RL   Hum. Mutat. 31:E1126-E1140(2010).
CC   -!- FUNCTION: Granulins have possible cytokine-like activity. They may
CC       play a role in inflammation, wound repair, and tissue remodeling.
CC   -!- FUNCTION: Granulin-4 promotes proliferation of the epithelial cell
CC       line A431 in culture while granulin-3 acts as an antagonist to
CC       granulin-4, inhibiting the growth.
CC   -!- SUBUNIT: Acrogranin/Progranulin is secreted as a homodimer.
CC       {ECO:0000269|PubMed:23364791}.
CC   -!- INTERACTION:
CC       D3DTF8:APLN; NbExp=4; IntAct=EBI-747754, EBI-14157552;
CC       Q8N6T3:ARFGAP1; NbExp=3; IntAct=EBI-747754, EBI-716933;
CC       Q8N6T3-3:ARFGAP1; NbExp=3; IntAct=EBI-747754, EBI-10694449;
CC       O00555:CACNA1A; NbExp=2; IntAct=EBI-747754, EBI-766279;
CC       P42830:CXCL5; NbExp=4; IntAct=EBI-747754, EBI-12175919;
CC       Q16643:DBN1; NbExp=5; IntAct=EBI-747754, EBI-351394;
CC       Q07687:DLX2; NbExp=3; IntAct=EBI-747754, EBI-3908234;
CC       Q9NW38:FANCL; NbExp=3; IntAct=EBI-747754, EBI-2339898;
CC       O76003:GLRX3; NbExp=7; IntAct=EBI-747754, EBI-374781;
CC       P49639:HOXA1; NbExp=9; IntAct=EBI-747754, EBI-740785;
CC       P09022:Hoxa1 (xeno); NbExp=2; IntAct=EBI-747754, EBI-3957603;
CC       Q07627:KRTAP1-1; NbExp=4; IntAct=EBI-747754, EBI-11959885;
CC       P60409:KRTAP10-7; NbExp=3; IntAct=EBI-747754, EBI-10172290;
CC       Q6PEX3:KRTAP26-1; NbExp=6; IntAct=EBI-747754, EBI-3957672;
CC       Q96MT4:LINC01600; NbExp=4; IntAct=EBI-747754, EBI-12804988;
CC       Q9UBE8:NLK; NbExp=6; IntAct=EBI-747754, EBI-366978;
CC       Q7Z417:NUFIP2; NbExp=4; IntAct=EBI-747754, EBI-1210753;
CC       P32242:OTX1; NbExp=10; IntAct=EBI-747754, EBI-740446;
CC       O43765:SGTA; NbExp=6; IntAct=EBI-747754, EBI-347996;
CC       Q99523:SORT1; NbExp=3; IntAct=EBI-747754, EBI-1057058;
CC       O43597:SPRY2; NbExp=3; IntAct=EBI-747754, EBI-742487;
CC       P19438:TNFRSF1A; NbExp=4; IntAct=EBI-747754, EBI-299451;
CC       P20333:TNFRSF1B; NbExp=5; IntAct=EBI-747754, EBI-358983;
CC   -!- SUBCELLULAR LOCATION: Secreted.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=P28799-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P28799-2; Sequence=VSP_001837;
CC       Name=3;
CC         IsoId=P28799-3; Sequence=VSP_053472, VSP_053473;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: In myelogenous leukemic cell lines of
CC       promonocytic, promyelocytic, and proerythroid lineage, in
CC       fibroblasts, and very strongly in epithelial cell lines. Present
CC       in inflammatory cells and bone marrow. Highest levels in kidney.
CC   -!- PTM: Granulins are disulfide bridged.
CC   -!- DISEASE: Ubiquitin-positive frontotemporal dementia (UP-FTD)
CC       [MIM:607485]: Frontotemporal dementia (FTD) is the second most
CC       common cause of dementia in people under the age of 65 years. It
CC       is an autosomal dominant neurodegenerative disease.
CC       {ECO:0000269|PubMed:16862116, ECO:0000269|PubMed:16983685,
CC       ECO:0000269|PubMed:18183624}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Ceroid lipofuscinosis, neuronal, 11 (CLN11) [MIM:614706]:
CC       A form of neuronal ceroid lipofuscinosis characterized by rapidly
CC       progressive visual loss due to retinal dystrophy, seizures,
CC       cerebellar ataxia, and cerebellar atrophy. Cognitive decline may
CC       also occur. Neuronal ceroid lipofuscinoses are progressive
CC       neurodegenerative, lysosomal storage diseases characterized by
CC       intracellular accumulation of autofluorescent liposomal material.
CC       {ECO:0000269|PubMed:22608501}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the granulin family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/GRNID40757ch17q21.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X62320; CAA44196.1; -; mRNA.
DR   EMBL; AF055008; AAC09359.1; -; mRNA.
DR   EMBL; M75161; AAA58617.1; ALT_SEQ; mRNA.
DR   EMBL; AY124489; AAM94026.1; -; mRNA.
DR   EMBL; BT006844; AAP35490.1; -; mRNA.
DR   EMBL; AK023348; BAB14535.1; -; mRNA.
DR   EMBL; AK222522; BAD96242.1; -; mRNA.
DR   EMBL; CH471178; EAW51599.1; -; Genomic_DNA.
DR   EMBL; CH471178; EAW51600.1; -; Genomic_DNA.
DR   EMBL; BC000324; AAH00324.1; -; mRNA.
DR   EMBL; BC010577; AAH10577.1; -; mRNA.
DR   CCDS; CCDS11483.1; -. [P28799-1]
DR   PIR; JC1284; GYHU.
DR   RefSeq; NP_002078.1; NM_002087.3. [P28799-1]
DR   RefSeq; XP_005257310.1; XM_005257253.1. [P28799-1]
DR   UniGene; Hs.514220; -.
DR   PDB; 1G26; NMR; -; A=281-311.
DR   PDB; 2JYE; NMR; -; A=281-337.
DR   PDB; 2JYT; NMR; -; A=364-417.
DR   PDB; 2JYU; NMR; -; A=364-417.
DR   PDB; 2JYV; NMR; -; A=123-179.
DR   PDBsum; 1G26; -.
DR   PDBsum; 2JYE; -.
DR   PDBsum; 2JYT; -.
DR   PDBsum; 2JYU; -.
DR   PDBsum; 2JYV; -.
DR   ProteinModelPortal; P28799; -.
DR   SMR; P28799; -.
DR   BioGrid; 109153; 106.
DR   CORUM; P28799; -.
DR   DIP; DIP-41742N; -.
DR   IntAct; P28799; 90.
DR   MINT; P28799; -.
DR   STRING; 9606.ENSP00000053867; -.
DR   iPTMnet; P28799; -.
DR   PhosphoSitePlus; P28799; -.
DR   BioMuta; GRN; -.
DR   DMDM; 77416865; -.
DR   EPD; P28799; -.
DR   MaxQB; P28799; -.
DR   PaxDb; P28799; -.
DR   PeptideAtlas; P28799; -.
DR   PRIDE; P28799; -.
DR   TopDownProteomics; P28799-2; -. [P28799-2]
DR   TopDownProteomics; P28799-3; -. [P28799-3]
DR   DNASU; 2896; -.
DR   Ensembl; ENST00000053867; ENSP00000053867; ENSG00000030582. [P28799-1]
DR   Ensembl; ENST00000639447; ENSP00000492014; ENSG00000030582. [P28799-2]
DR   GeneID; 2896; -.
DR   KEGG; hsa:2896; -.
DR   UCSC; uc002igp.2; human. [P28799-1]
DR   CTD; 2896; -.
DR   DisGeNET; 2896; -.
DR   EuPathDB; HostDB:ENSG00000030582.16; -.
DR   GeneCards; GRN; -.
DR   GeneReviews; GRN; -.
DR   HGNC; HGNC:4601; GRN.
DR   HPA; CAB019394; -.
DR   HPA; HPA008763; -.
DR   HPA; HPA028747; -.
DR   MalaCards; GRN; -.
DR   MIM; 138945; gene.
DR   MIM; 607485; phenotype.
DR   MIM; 614706; phenotype.
DR   neXtProt; NX_P28799; -.
DR   OpenTargets; ENSG00000030582; -.
DR   Orphanet; 275864; Behavioral variant of frontotemporal dementia.
DR   Orphanet; 314629; CLN11 disease.
DR   Orphanet; 100070; Progressive non-fluent aphasia.
DR   Orphanet; 100069; Semantic dementia.
DR   PharmGKB; PA28998; -.
DR   eggNOG; KOG4296; Eukaryota.
DR   eggNOG; ENOG410XR6S; LUCA.
DR   GeneTree; ENSGT00470000042293; -.
DR   HOGENOM; HOG000067856; -.
DR   HOVERGEN; HBG000845; -.
DR   InParanoid; P28799; -.
DR   OMA; CCPLVKA; -.
DR   OrthoDB; EOG091G0H2Q; -.
DR   PhylomeDB; P28799; -.
DR   TreeFam; TF319678; -.
DR   Reactome; R-HSA-6798695; Neutrophil degranulation.
DR   SIGNOR; P28799; -.
DR   ChiTaRS; GRN; human.
DR   EvolutionaryTrace; P28799; -.
DR   GeneWiki; Granulin; -.
DR   GenomeRNAi; 2896; -.
DR   PMAP-CutDB; P28799; -.
DR   PRO; PR:P28799; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   Bgee; ENSG00000030582; -.
DR   CleanEx; HS_GRN; -.
DR   ExpressionAtlas; P28799; baseline and differential.
DR   Genevisible; P28799; HS.
DR   GO; GO:0035578; C:azurophil granule lumen; TAS:Reactome.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:HPA.
DR   GO; GO:0005768; C:endosome; IDA:HPA.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0005576; C:extracellular region; TAS:Reactome.
DR   GO; GO:0005764; C:lysosome; IDA:HPA.
DR   GO; GO:0005125; F:cytokine activity; IEA:UniProtKB-KW.
DR   GO; GO:0008083; F:growth factor activity; TAS:ProtInc.
DR   GO; GO:0003723; F:RNA binding; HDA:UniProtKB.
DR   GO; GO:0043312; P:neutrophil degranulation; TAS:Reactome.
DR   GO; GO:0007165; P:signal transduction; NAS:ProtInc.
DR   Gene3D; 3.10.20.500; -; 7.
DR   InterPro; IPR000118; Granulin.
DR   InterPro; IPR037277; Granulin_sf.
DR   Pfam; PF00396; Granulin; 7.
DR   SMART; SM00277; GRAN; 7.
DR   PROSITE; PS00799; GRANULINS; 7.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Complete proteome; Cytokine;
KW   Direct protein sequencing; Disulfide bond; Glycoprotein;
KW   Neurodegeneration; Neuronal ceroid lipofuscinosis; Polymorphism;
KW   Reference proteome; Repeat; Secreted; Signal.
FT   SIGNAL        1     17       {ECO:0000255}.
FT   CHAIN        18    593       Acrogranin.
FT                                /FTId=PRO_0000012693.
FT   PEPTIDE      18    ?47       Paragranulin.
FT                                /FTId=PRO_0000012694.
FT   PEPTIDE     ?58   ?113       Granulin-1.
FT                                /FTId=PRO_0000012695.
FT   PEPTIDE     123    179       Granulin-2.
FT                                /FTId=PRO_0000012696.
FT   PEPTIDE     206    261       Granulin-3.
FT                                /FTId=PRO_0000012697.
FT   PEPTIDE     281    336       Granulin-4.
FT                                /FTId=PRO_0000012698.
FT   PEPTIDE     364    417       Granulin-5.
FT                                /FTId=PRO_0000012699.
FT   PEPTIDE     442   ?496       Granulin-6.
FT                                /FTId=PRO_0000012700.
FT   PEPTIDE    ?518   ?573       Granulin-7.
FT                                /FTId=PRO_0000012701.
FT   CARBOHYD    118    118       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:20188224}.
FT   CARBOHYD    236    236       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    265    265       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:19159218,
FT                                ECO:0000269|PubMed:20188224}.
FT   CARBOHYD    368    368       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:20188224}.
FT   CARBOHYD    530    530       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:20188224}.
FT   DISULFID    126    139       {ECO:0000269|PubMed:18359860}.
FT   DISULFID    133    149       {ECO:0000269|PubMed:18359860}.
FT   DISULFID    284    296       {ECO:0000269|PubMed:18359860}.
FT   DISULFID    290    306       {ECO:0000269|PubMed:18359860}.
FT   DISULFID    297    314       {ECO:0000269|PubMed:18359860}.
FT   DISULFID    307    321       {ECO:0000269|PubMed:18359860}.
FT   DISULFID    315    328       {ECO:0000269|PubMed:18359860}.
FT   DISULFID    322    335       {ECO:0000269|PubMed:18359860}.
FT   DISULFID    366    378       {ECO:0000269|PubMed:18359860}.
FT   DISULFID    372    388       {ECO:0000269|PubMed:18359860}.
FT   DISULFID    397    410       {ECO:0000269|PubMed:18359860}.
FT   DISULFID    404    416       {ECO:0000269|PubMed:18359860}.
FT   VAR_SEQ       1     71       MWTLVSWVALTAGLVAGTRCPDGQFCPVACCLDPGGASYSC
FT                                CRPLLDKWPTTLSRHLGGPCQVDAHCSAGH -> MAITAAH
FT                                GASTAVQTGDPASKDQVTTPWVPSSALIVSSNARTSPRAVL
FT                                WSMAPGGAAPCPRLPAVKTGCTA (in isoform 3).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_053472.
FT   VAR_SEQ      72    251       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_053473.
FT   VAR_SEQ     377    531       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|Ref.6}.
FT                                /FTId=VSP_001837.
FT   VARIANT       9      9       A -> D (in UP-FTD; no significant
FT                                difference in the total mRNA between
FT                                cases and controls; although the mutant
FT                                protein is expressed it is not secreted
FT                                and appears to be trapped within an
FT                                intracellular compartment;
FT                                dbSNP:rs63751243).
FT                                {ECO:0000269|PubMed:16983685,
FT                                ECO:0000269|PubMed:18183624}.
FT                                /FTId=VAR_044451.
FT   VARIANT      19     19       R -> W (in dbSNP:rs63750723).
FT                                {ECO:0000269|PubMed:20020531}.
FT                                /FTId=VAR_064625.
FT   VARIANT      55     55       R -> W. {ECO:0000269|PubMed:20020531}.
FT                                /FTId=VAR_064626.
FT   VARIANT      69     69       A -> T (in dbSNP:rs199944486).
FT                                {ECO:0000269|PubMed:20020531}.
FT                                /FTId=VAR_064627.
FT   VARIANT     119    119       Missing. {ECO:0000269|PubMed:20020531}.
FT                                /FTId=VAR_064628.
FT   VARIANT     120    120       S -> Y (in dbSNP:rs63750043).
FT                                {ECO:0000269|PubMed:20020531}.
FT                                /FTId=VAR_064629.
FT   VARIANT     182    182       T -> M (in dbSNP:rs63750479).
FT                                {ECO:0000269|PubMed:20020531}.
FT                                /FTId=VAR_064630.
FT   VARIANT     221    221       C -> S (in dbSNP:rs758322775).
FT                                {ECO:0000269|PubMed:20020531}.
FT                                /FTId=VAR_064631.
FT   VARIANT     275    275       P -> L (in dbSNP:rs529849967).
FT                                {ECO:0000269|PubMed:20020531}.
FT                                /FTId=VAR_064632.
FT   VARIANT     376    376       D -> N (in dbSNP:rs143030899).
FT                                {ECO:0000269|PubMed:20020531}.
FT                                /FTId=VAR_064633.
FT   VARIANT     398    398       S -> L (in dbSNP:rs148213321).
FT                                {ECO:0000269|PubMed:20020531}.
FT                                /FTId=VAR_064634.
FT   VARIANT     433    433       R -> Q (in dbSNP:rs114248177).
FT                                {ECO:0000269|PubMed:20020531}.
FT                                /FTId=VAR_064635.
FT   VARIANT     515    515       G -> A (in dbSNP:rs25647).
FT                                {ECO:0000269|PubMed:20020531}.
FT                                /FTId=VAR_014830.
FT   VARIANT     564    564       R -> H (in dbSNP:rs971443926).
FT                                {ECO:0000269|PubMed:20020531}.
FT                                /FTId=VAR_064636.
FT   CONFLICT    219    219       S -> H (in Ref. 11; AA sequence).
FT                                {ECO:0000305}.
FT   CONFLICT    290    290       C -> S (in Ref. 12; AA sequence).
FT                                {ECO:0000305}.
FT   CONFLICT    386    386       W -> H (in Ref. 11; AA sequence).
FT                                {ECO:0000305}.
FT   CONFLICT    428    428       K -> E (in Ref. 8; BAD96242).
FT                                {ECO:0000305}.
FT   CONFLICT    454    454       Q -> G (in Ref. 3; AAA58617).
FT                                {ECO:0000305}.
FT   STRAND      137    141       {ECO:0000244|PDB:2JYV}.
FT   STRAND      143    145       {ECO:0000244|PDB:2JYV}.
FT   STRAND      147    151       {ECO:0000244|PDB:2JYV}.
FT   STRAND      282    285       {ECO:0000244|PDB:1G26}.
FT   STRAND      288    290       {ECO:0000244|PDB:1G26}.
FT   STRAND      294    298       {ECO:0000244|PDB:1G26}.
FT   STRAND      304    308       {ECO:0000244|PDB:1G26}.
FT   STRAND      315    319       {ECO:0000244|PDB:2JYE}.
FT   TURN        330    333       {ECO:0000244|PDB:2JYE}.
FT   TURN        367    369       {ECO:0000244|PDB:2JYU}.
FT   STRAND      377    380       {ECO:0000244|PDB:2JYT}.
FT   STRAND      382    384       {ECO:0000244|PDB:2JYT}.
FT   STRAND      386    389       {ECO:0000244|PDB:2JYT}.
FT   TURN        399    402       {ECO:0000244|PDB:2JYU}.
FT   STRAND      409    411       {ECO:0000244|PDB:2JYT}.
FT   TURN        412    414       {ECO:0000244|PDB:2JYT}.
FT   STRAND      415    417       {ECO:0000244|PDB:2JYT}.
SQ   SEQUENCE   593 AA;  63544 MW;  4E5947F1B4EDE619 CRC64;
     MWTLVSWVAL TAGLVAGTRC PDGQFCPVAC CLDPGGASYS CCRPLLDKWP TTLSRHLGGP
     CQVDAHCSAG HSCIFTVSGT SSCCPFPEAV ACGDGHHCCP RGFHCSADGR SCFQRSGNNS
     VGAIQCPDSQ FECPDFSTCC VMVDGSWGCC PMPQASCCED RVHCCPHGAF CDLVHTRCIT
     PTGTHPLAKK LPAQRTNRAV ALSSSVMCPD ARSRCPDGST CCELPSGKYG CCPMPNATCC
     SDHLHCCPQD TVCDLIQSKC LSKENATTDL LTKLPAHTVG DVKCDMEVSC PDGYTCCRLQ
     SGAWGCCPFT QAVCCEDHIH CCPAGFTCDT QKGTCEQGPH QVPWMEKAPA HLSLPDPQAL
     KRDVPCDNVS SCPSSDTCCQ LTSGEWGCCP IPEAVCCSDH QHCCPQGYTC VAEGQCQRGS
     EIVAGLEKMP ARRASLSHPR DIGCDQHTSC PVGQTCCPSL GGSWACCQLP HAVCCEDRQH
     CCPAGYTCNV KARSCEKEVV SAQPATFLAR SPHVGVKDVE CGEGHFCHDN QTCCRDNRQG
     WACCPYRQGV CCADRRHCCP AGFRCAARGT KCLRREAPRW DAPLRDPALR QLL
//
ID   A0A0C4DFT7_HUMAN        Unreviewed;       150 AA.
AC   A0A0C4DFT7;
DT   01-APR-2015, integrated into UniProtKB/TrEMBL.
DT   01-APR-2015, sequence version 1.
DT   23-MAY-2018, entry version 24.
DE   RecName: Full=Glycophorin {ECO:0000256|PIRNR:PIRNR002466};
GN   Name=GYPA {ECO:0000313|Ensembl:ENSP00000354003};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000354003, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Ensembl:ENSP00000354003, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [2] {ECO:0000213|PubMed:24275569}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [3] {ECO:0000313|Ensembl:ENSP00000354003}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (FEB-2015) to UniProtKB.
CC   -!- INTERACTION:
CC       O43889-2:CREB3; NbExp=3; IntAct=EBI-12044847, EBI-625022;
CC       Q14145:KEAP1; NbExp=3; IntAct=EBI-12044847, EBI-751001;
CC       O43765:SGTA; NbExp=3; IntAct=EBI-12044847, EBI-347996;
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AC098588; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC106871; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC107213; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC107223; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC109811; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC111001; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC112232; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC125337; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; KF510862; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   RefSeq; NP_002090.4; NM_002099.7.
DR   UniGene; Hs.434973; -.
DR   ProteinModelPortal; A0A0C4DFT7; -.
DR   SMR; A0A0C4DFT7; -.
DR   IntAct; A0A0C4DFT7; 3.
DR   Ensembl; ENST00000360771; ENSP00000354003; ENSG00000170180.
DR   GeneID; 2993; -.
DR   KEGG; hsa:2993; -.
DR   CTD; 2993; -.
DR   EuPathDB; HostDB:ENSG00000170180.19; -.
DR   HGNC; HGNC:4702; GYPA.
DR   OpenTargets; ENSG00000170180; -.
DR   eggNOG; ENOG410JM5B; Eukaryota.
DR   eggNOG; ENOG4111AH6; LUCA.
DR   GeneTree; ENSGT00550000075214; -.
DR   KO; K06575; -.
DR   OMA; THYPPEE; -.
DR   OrthoDB; EOG091G0PA5; -.
DR   PhylomeDB; A0A0C4DFT7; -.
DR   GenomeRNAi; 2993; -.
DR   Proteomes; UP000005640; Chromosome 4.
DR   Bgee; ENSG00000170180; -.
DR   ExpressionAtlas; A0A0C4DFT7; baseline and differential.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   InterPro; IPR001195; Glycophorin.
DR   InterPro; IPR018938; Glycophorin_CS.
DR   PANTHER; PTHR13813; PTHR13813; 1.
DR   PIRSF; PIRSF002466; Glycophorin; 1.
DR   PROSITE; PS00312; GLYCOPHORIN_A; 1.
PE   1: Evidence at protein level;
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   Glycoprotein {ECO:0000256|PIRNR:PIRNR002466};
KW   Membrane {ECO:0000256|SAM:Phobius};
KW   Proteomics identification {ECO:0000213|MaxQB:A0A0C4DFT7,
KW   ECO:0000213|PeptideAtlas:A0A0C4DFT7};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640};
KW   Sialic acid {ECO:0000256|PIRNR:PIRNR002466};
KW   Signal {ECO:0000256|SAM:SignalP};
KW   Transmembrane {ECO:0000256|SAM:Phobius};
KW   Transmembrane helix {ECO:0000256|SAM:Phobius}.
FT   SIGNAL        1     19       {ECO:0000256|SAM:SignalP}.
FT   CHAIN        20    150       Glycophorin. {ECO:0000256|SAM:SignalP}.
FT                                /FTId=PRO_5002181412.
FT   TRANSMEM     92    114       Helical. {ECO:0000256|SAM:Phobius}.
SQ   SEQUENCE   150 AA;  16430 MW;  53664F3D330A98A9 CRC64;
     MYGKIIFVLL LSEIVSISAL STTEVAMHTS TSSSVTKSYI SSQTNDTHKR DTYAATPRAH
     EVSEISVRTV YPPEEETGER VQLAHHFSEP EITLIIFGVM AGVIGTILLI SYGIRRLIKK
     SPSDVKPLPS PDTDVPLSSV EIENPETSDQ
//
ID   E9PD10_HUMAN            Unreviewed;       137 AA.
AC   E9PD10;
DT   05-APR-2011, integrated into UniProtKB/TrEMBL.
DT   05-APR-2011, sequence version 1.
DT   28-MAR-2018, entry version 48.
DE   RecName: Full=Glycophorin {ECO:0000256|PIRNR:PIRNR002466};
GN   Name=GYPA {ECO:0000313|Ensembl:ENSP00000426130};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000426130, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Ensembl:ENSP00000426130, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [2] {ECO:0000313|Ensembl:ENSP00000426130}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (JUL-2011) to UniProtKB.
RN   [3] {ECO:0000213|PubMed:24275569}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AC098588; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC106871; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC107213; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC107223; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC109811; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC111001; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC112232; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC125337; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; KF510862; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   RefSeq; NP_001295116.1; NM_001308187.1.
DR   UniGene; Hs.434973; -.
DR   ProteinModelPortal; E9PD10; -.
DR   PeptideAtlas; E9PD10; -.
DR   PRIDE; E9PD10; -.
DR   Ensembl; ENST00000512064; ENSP00000426130; ENSG00000170180.
DR   GeneID; 2993; -.
DR   UCSC; uc010ioq.4; human.
DR   CTD; 2993; -.
DR   EuPathDB; HostDB:ENSG00000170180.19; -.
DR   HGNC; HGNC:4702; GYPA.
DR   OpenTargets; ENSG00000170180; -.
DR   GeneTree; ENSGT00550000075214; -.
DR   GenomeRNAi; 2993; -.
DR   Proteomes; UP000005640; Chromosome 4.
DR   Bgee; ENSG00000170180; -.
DR   ExpressionAtlas; E9PD10; baseline and differential.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   InterPro; IPR001195; Glycophorin.
DR   InterPro; IPR018938; Glycophorin_CS.
DR   PANTHER; PTHR13813; PTHR13813; 1.
DR   PIRSF; PIRSF002466; Glycophorin; 1.
DR   PROSITE; PS00312; GLYCOPHORIN_A; 1.
PE   1: Evidence at protein level;
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   Glycoprotein {ECO:0000256|PIRNR:PIRNR002466};
KW   Membrane {ECO:0000256|SAM:Phobius};
KW   Proteomics identification {ECO:0000213|MaxQB:E9PD10,
KW   ECO:0000213|PeptideAtlas:E9PD10};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640};
KW   Sialic acid {ECO:0000256|PIRNR:PIRNR002466};
KW   Signal {ECO:0000256|SAM:SignalP};
KW   Transmembrane {ECO:0000256|SAM:Phobius};
KW   Transmembrane helix {ECO:0000256|SAM:Phobius}.
FT   SIGNAL        1     19       {ECO:0000256|SAM:SignalP}.
FT   CHAIN        20    137       Glycophorin. {ECO:0000256|SAM:SignalP}.
FT                                /FTId=PRO_5003242780.
FT   TRANSMEM     79    101       Helical. {ECO:0000256|SAM:Phobius}.
SQ   SEQUENCE   137 AA;  14941 MW;  388F5AE046C60A04 CRC64;
     MYGKIIFVLL LSEIVSISAL STTEVAMHTS TSSSVTKSYI SSQTNDTHKR DTYAATPRAH
     EVSEISVRTV YPPEEETEIT LIIFGVMAGV IGTILLISYG IRRLIKKSPS DVKPLPSPDT
     DVPLSSVEIE NPETSDQ
//
ID   GLPA_HUMAN              Reviewed;         150 AA.
AC   P02724; A8K3E6; B8Q182; B8Q185; Q9BS51;
DT   21-JUL-1986, integrated into UniProtKB/Swiss-Prot.
DT   22-SEP-2009, sequence version 2.
DT   23-MAY-2018, entry version 195.
DE   RecName: Full=Glycophorin-A;
DE   AltName: Full=MN sialoglycoprotein;
DE   AltName: Full=PAS-2;
DE   AltName: Full=Sialoglycoprotein alpha;
DE   AltName: CD_antigen=CD235a;
DE   Flags: Precursor;
GN   Name=GYPA; Synonyms=GPA;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANT ALA-13.
RX   PubMed=3456608; DOI=10.1073/pnas.83.6.1665;
RA   Siebert P.D., Fukuda M.;
RT   "Isolation and characterization of human glycophorin A cDNA clones by
RT   a synthetic oligonucleotide approach: nucleotide sequence and mRNA
RT   structure.";
RL   Proc. Natl. Acad. Sci. U.S.A. 83:1665-1669(1986).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANTS N LEU-20 AND
RP   GLU-24.
RX   PubMed=3196288; DOI=10.1042/bj2540743;
RA   Tate C.G., Tanner M.J.A.;
RT   "Isolation of cDNA clones for human erythrocyte membrane
RT   sialoglycoproteins alpha and delta.";
RL   Biochem. J. 254:743-750(1988).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT ALA-13.
RX   PubMed=2734312; DOI=10.1073/pnas.86.12.4619;
RA   Kudo S., Fukuda M.;
RT   "Structural organization of glycophorin A and B genes: glycophorin B
RT   gene evolved by homologous recombination at Alu repeat sequences.";
RL   Proc. Natl. Acad. Sci. U.S.A. 86:4619-4623(1989).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANT ALA-13.
RC   TISSUE=Blood;
RX   PubMed=2216775; DOI=10.1093/nar/18.19.5829;
RA   Jawad K., Burness T.H.;
RT   "The mechanism of production of multiple mRNAs for human glycophorin
RT   A.";
RL   Nucleic Acids Res. 18:5829-5836(1990).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANT ALA-13.
RC   TISSUE=Blood;
RX   PubMed=7798177;
RA   Kudo S., Onda M., Fukuda M.;
RT   "Characterization of glycophorin A transcripts: control by the common
RT   erythroid-specific promoter and alternative usage of different
RT   polyadenylation signals.";
RL   J. Biochem. 116:183-192(1994).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), AND ALTERNATIVE SPLICING.
RC   TISSUE=Blood;
RA   Hsu K., Huang S.-Y., Chi N., Lin M.;
RT   "Extensive alternative splicing of glycophorins in Southeast Asian
RT   populations.";
RL   Submitted (DEC-2009) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT
RP   ALA-13.
RC   TISSUE=Kidney;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND VARIANTS N LEU-20
RP   AND GLU-24.
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), VARIANT ALA-13,
RP   AND VARIANTS N LEU-20 AND GLU-24.
RC   TISSUE=Bone marrow, and Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-145 (ISOFORM 1), AND VARIANT ALA-13.
RX   PubMed=3809885; DOI=10.1016/S0338-4535(86)80019-8;
RA   Siebert P.D., Fukuda M.;
RT   "Molecular biological study of the structure and expression of human
RT   glycophorin A.";
RL   Rev. Fr. Transfus. Immunohematol. 29:251-266(1986).
RN   [11]
RP   PROTEIN SEQUENCE OF 20-150.
RX   PubMed=1059087; DOI=10.1073/pnas.72.8.2964;
RA   Tomita M., Marchesi V.T.;
RT   "Amino-acid sequence and oligosaccharide attachment sites of human
RT   erythrocyte glycophorin.";
RL   Proc. Natl. Acad. Sci. U.S.A. 72:2964-2968(1975).
RN   [12]
RP   SEQUENCE REVISION TO 81-120.
RA   Furthmayr H., Galardy R., Tomita M., Marchesi V.T.;
RL   Submitted (JUN-1977) to the PIR data bank.
RN   [13]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 23-150.
RX   PubMed=3345758; DOI=10.1111/j.1432-1033.1988.tb13866.x;
RA   Rahuel C., London J., D'Auriol L., Mattei M.-G., Tournamille C.,
RA   Skrzynia C., Lebouc Y., Galibert F., Cartron J.-P.;
RT   "Characterization of cDNA clones for human glycophorin A. Use for gene
RT   localization and for analysis of normal of glycophorin-A-deficient
RT   (Finnish type) genomic DNA.";
RL   Eur. J. Biochem. 172:147-153(1988).
RN   [14]
RP   PARTIAL PROTEIN SEQUENCE, AND VARIANT M(C) GLU-24.
RX   PubMed=6166001; DOI=10.1073/pnas.78.1.631;
RA   Furthmayr H., Metaxas M.N., Metaxas-Buhler M.;
RT   "Mg and Mc: mutations within the amino-terminal region of glycophorin
RT   A.";
RL   Proc. Natl. Acad. Sci. U.S.A. 78:631-635(1981).
RN   [15]
RP   PARTIAL PROTEIN SEQUENCE, AND VARIANT M(G) ASN-23.
RX   PubMed=6940143; DOI=10.1073/pnas.78.2.747;
RA   Blumenfeld O.O., Adamany A.M., Puglia K.V.;
RT   "Amino acid and carbohydrate structural variants of glycoprotein
RT   products (M-N glycoproteins) of the M-N allelic locus.";
RL   Proc. Natl. Acad. Sci. U.S.A. 78:747-751(1981).
RN   [16]
RP   GLYCOSYLATION.
RX   PubMed=5350948;
RA   Thomas D.B., Winzler R.J.;
RT   "Structural studies on human erythrocyte glycoproteins. Alkali-labile
RT   oligosaccharides.";
RL   J. Biol. Chem. 244:5943-5946(1969).
RN   [17]
RP   POLYMORPHISM, AND INVOLVEMENT IN RESISTANCE TO MALARIA.
RX   PubMed=7040988; DOI=10.1038/297064a0;
RA   Pasvol G., Wainscoat J.S., Weatherall D.J.;
RT   "Erythrocytes deficiency in glycophorin resist invasion by the
RT   malarial parasite Plasmodium falciparum.";
RL   Nature 297:64-66(1982).
RN   [18]
RP   GLYCOSYLATION.
RX   PubMed=3624241;
RA   Fukuda M., Lauffenburger M., Sasaki H., Rogers M.E., Dell A.;
RT   "Structures of novel sialylated O-linked oligosaccharides isolated
RT   from human erythrocyte glycophorins.";
RL   J. Biol. Chem. 262:11952-11957(1987).
RN   [19]
RP   SUBUNIT.
RX   PubMed=1463744; DOI=10.1021/bi00166a003;
RA   Treutlein H.R., Lemmon M.A., Engelman D.M., Brunger A.T.;
RT   "The glycophorin A transmembrane domain dimer: sequence-specific
RT   propensity for a right-handed supercoil of helices.";
RL   Biochemistry 31:12726-12732(1992).
RN   [20]
RP   GLYCOSYLATION AT SER-21; THR-22; THR-23; THR-29; SER-30; THR-31;
RP   SER-32; THR-36; SER-38; SER-41; THR-44; ASN-45; THR-52; THR-56;
RP   SER-63; SER-66 AND THR-69, AND PARTIAL PROTEIN SEQUENCE.
RX   PubMed=8286855; DOI=10.1093/glycob/3.5.429;
RA   Pisano A., Redmond J.W., Williams K.L., Gooley A.A.;
RT   "Glycosylation sites identified by solid-phase Edman degradation: O-
RT   linked glycosylation motifs on human glycophorin A.";
RL   Glycobiology 3:429-435(1993).
RN   [21]
RP   FUNCTION AS RECEPTOR FOR PLASMODIUM EBA-175.
RX   PubMed=8009226; DOI=10.1126/science.8009226;
RA   Sim B.K., Chitnis C.E., Wasniowska K., Hadley T.J., Miller L.H.;
RT   "Receptor and ligand domains for invasion of erythrocytes by
RT   Plasmodium falciparum.";
RL   Science 264:1941-1944(1994).
RN   [22]
RP   GLYCOSYLATION (AB BLOOD GROUP ANTIGENS).
RX   PubMed=10912628;
RA   Podbielska M., Krotkiewski H.;
RT   "Identification of blood group A and B antigens in human
RT   glycophorin.";
RL   Arch. Immunol. Ther. Exp. 48:211-221(2000).
RN   [23]
RP   FUNCTION, AND MUTAGENESIS OF LEU-94; ILE-95; GLY-98 AND GLY-102.
RX   PubMed=10926825; DOI=10.1042/bj3500053;
RA   Young M.T., Beckmann R., Toye A.M., Tanner M.J.;
RT   "Red-cell glycophorin A-band 3 interactions associated with the
RT   movement of band 3 to the cell surface.";
RL   Biochem. J. 350:53-60(2000).
RN   [24]
RP   SUBUNIT.
RX   PubMed=11313283; DOI=10.1182/blood.V97.9.2872;
RA   Auffray I., Marfatia S., de Jong K., Lee G., Huang C.H., Paszty C.,
RA   Tanner M.J., Mohandas N., Chasis J.A.;
RT   "Glycophorin A dimerization and band 3 interaction during erythroid
RT   membrane biogenesis: in vivo studies in human glycophorin A transgenic
RT   mice.";
RL   Blood 97:2872-2878(2001).
RN   [25]
RP   SUBCELLULAR LOCATION.
RX   PubMed=11402026; DOI=10.1074/jbc.M101889200;
RA   Gerber D., Shai Y.;
RT   "In vivo detection of hetero-association of glycophorin-A and its
RT   mutants within the membrane.";
RL   J. Biol. Chem. 276:31229-31232(2001).
RN   [26]
RP   FUNCTION, AND MUTAGENESIS OF PHE-87; SER-88; PRO-90 AND GLU-91.
RX   PubMed=12813056; DOI=10.1074/jbc.M302527200;
RA   Young M.T., Tanner M.J.;
RT   "Distinct regions of human glycophorin A enhance human red cell anion
RT   exchanger (band 3; AE1) transport function and surface trafficking.";
RL   J. Biol. Chem. 278:32954-32961(2003).
RN   [27]
RP   REVIEW, AND VARIANTS.
RA   Reid M.E., Christine Lomas-Francis C.;
RT   "The blood group system.";
RL   (In) Reid M.E., Christine Lomas-Francis C. (eds.);
RL   The blood group antigen factsbook, pp.29-104, Academic Press, Oxford
RL   (2004).
RN   [28]
RP   GLYCOSYLATION, AND IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=15313217; DOI=10.1016/j.abb.2004.06.018;
RA   Podbielska M., Fredriksson S.A., Nilsson B., Lisowska E.,
RA   Krotkiewski H.;
RT   "ABH blood group antigens in O-glycans of human glycophorin A.";
RL   Arch. Biochem. Biophys. 429:145-153(2004).
RN   [29]
RP   FUNCTION.
RX   PubMed=14604989; DOI=10.1074/jbc.M309826200;
RA   Bruce L.J., Pan R.J., Cope D.L., Uchikawa M., Gunn R.B., Cherry R.J.,
RA   Tanner M.J.;
RT   "Altered structure and anion transport properties of band 3 (AE1,
RT   SLC4A1) in human red cells lacking glycophorin A.";
RL   J. Biol. Chem. 279:2414-2420(2004).
RN   [30]
RP   FUNCTION AS RECEPTOR FOR FOR HEPATITIS A VIRUS.
RX   PubMed=15331714; DOI=10.1128/JVI.78.18.9807-9813.2004;
RA   Sanchez G., Aragones L., Costafreda M.I., Ribes E., Bosch A.,
RA   Pinto R.M.;
RT   "Capsid region involved in hepatitis A virus binding to glycophorin A
RT   of the erythrocyte membrane.";
RL   J. Virol. 78:9807-9813(2004).
RN   [31]
RP   INTERACTION WITH STREPTOCOCCUS GORDONII HSA PROTEIN.
RX   PubMed=18380804; DOI=10.1111/j.1348-0421.2008.00015.x;
RA   Yajima A., Urano-Tashiro Y., Shimazu K., Takashima E., Takahashi Y.,
RA   Konishi K.;
RT   "Hsa, an adhesin of Streptococcus gordonii DL1, binds to alpha2-3-
RT   linked sialic acid on glycophorin A of the erythrocyte membrane.";
RL   Microbiol. Immunol. 52:69-77(2008).
RN   [32]
RP   FUNCTION.
RX   PubMed=19438409; DOI=10.1042/BJ20090345;
RA   Pang A.J., Reithmeier R.A.;
RT   "Interaction of anion exchanger 1 and glycophorin A in human
RT   erythroleukaemic K562 cells.";
RL   Biochem. J. 421:345-356(2009).
RN   [33]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-133; SER-138 AND
RP   SER-148, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [34]
RP   STRUCTURE BY NMR.
RX   PubMed=2386609; DOI=10.1007/BF01025303;
RA   Dill K., Hu S.H., Berman E., Pavia A.A., Lacombe J.M.;
RT   "One- and two-dimensional NMR studies of the N-terminal portion of
RT   glycophorin A at 11.7 Tesla.";
RL   J. Protein Chem. 9:129-136(1990).
RN   [35]
RP   STRUCTURE BY NMR OF 81-120.
RX   PubMed=9082985; DOI=10.1126/science.276.5309.131;
RA   Mackenzie K.R., Prestegard J.H., Engelman D.M.;
RT   "A transmembrane helix dimer: structure and implications.";
RL   Science 276:131-133(1997).
RN   [36]
RP   3D-STRUCTURE MODELING OF 93-110.
RX   PubMed=8953647;
RX   DOI=10.1002/(SICI)1097-0134(199611)26:3<257::AID-PROT2>3.3.CO;2-O;
RA   Adams P.D., Engelman D.M., Bruenger A.T.;
RT   "Improved prediction for the structure of the dimeric transmembrane
RT   domain of glycophorin A obtained through global searching.";
RL   Proteins 26:257-261(1996).
RN   [37]
RP   VARIANT ENEH/VW MET-47.
RX   PubMed=1611092;
RA   Huang C.-H., Spruell P., Moulds J.J., Blumenfeld O.O.;
RT   "Molecular basis for the human erythrocyte glycophorin specifying the
RT   Miltenberger class I (MiI) phenotype.";
RL   Blood 80:257-263(1992).
RN   [38]
RP   VARIANT ENEH/HUT ANTIGEN LYS-47.
RX   PubMed=1421409;
RA   Huang C.H., Skov F., Daniels G., Tippett P., Blumenfeld O.O.;
RT   "Molecular analysis of human glycophorin MiIX gene shows a silent
RT   segment transfer and untemplated mutation resulting from gene
RT   conversion via sequence repeats.";
RL   Blood 80:2379-2387(1992).
RN   [39]
RP   VARIANT ERIK ARG-78.
RX   PubMed=8245024;
RA   Huang C.H., Reid M., Daniels G., Blumenfeld O.O.;
RT   "Alteration of splice site selection by an exon mutation in the human
RT   glycophorin A gene.";
RL   J. Biol. Chem. 268:25902-25908(1993).
RN   [40]
RP   VARIANT ENEP/HAG PRO-84.
RX   PubMed=10354388; DOI=10.1046/j.1365-3148.1999.00185.x;
RA   Poole J., Banks J., Bruce L.J., Ring S.M., Levene C., Stern H.,
RA   Overbeeke M.A., Tanner M.J.;
RT   "Glycophorin A mutation Ala65 --> Pro gives rise to a novel pair of
RT   MNS alleles ENEP (MNS39) and HAG (MNS41) and altered Wrb expression:
RT   direct evidence for GPA/band 3 interaction necessary for normal Wrb
RT   expression.";
RL   Transfus. Med. 9:167-174(1999).
RN   [41]
RP   VARIANTS NY(A) GLU-46 AND OS(A) SER-73.
RX   PubMed=10827258; DOI=10.1046/j.1537-2995.2000.40050555.x;
RA   Daniels G.L., Bruce L.J., Mawby W.J., Green C.A., Petty A., Okubo Y.,
RA   Kornstad L., Tanner M.J.;
RT   "The low-frequency MNS blood group antigens Ny(a) (MNS18) and Os(a)
RT   (MNS38) are associated with GPA amino acid substitutions.";
RL   Transfusion 40:555-559(2000).
RN   [42]
RP   VARIANTS VR TYR-66 AND MT(A) ILE-77.
RX   PubMed=10729812; DOI=10.1159/000031149;
RA   Storry J.R., Coghlan G., Poole J., Figueroa D., Reid M.E.;
RT   "The MNS blood group antigens, Vr (MNS12) and Mt(a) (MNS14), each
RT   arise from an amino acid substitution on glycophorin A.";
RL   Vox Sang. 78:52-56(2000).
CC   -!- FUNCTION: Glycophorin A is the major intrinsic membrane protein of
CC       the erythrocyte. The N-terminal glycosylated segment, which lies
CC       outside the erythrocyte membrane, has MN blood group receptors.
CC       Appears to be important for the function of SLC4A1 and is required
CC       for high activity of SLC4A1. May be involved in translocation of
CC       SLC4A1 to the plasma membrane. Is a receptor for influenza virus.
CC       Is a receptor for Plasmodium falciparum erythrocyte-binding
CC       antigen 175 (EBA-175); binding of EBA-175 is dependent on sialic
CC       acid residues of the O-linked glycans. Appears to be a receptor
CC       for Hepatitis A virus (HAV). {ECO:0000269|PubMed:10926825,
CC       ECO:0000269|PubMed:12813056, ECO:0000269|PubMed:14604989,
CC       ECO:0000269|PubMed:15331714, ECO:0000269|PubMed:19438409,
CC       ECO:0000269|PubMed:8009226}.
CC   -!- SUBUNIT: Homodimer. Interacts with Streptococcus gordonii hsa
CC       protein. {ECO:0000269|PubMed:11313283, ECO:0000269|PubMed:1463744,
CC       ECO:0000269|PubMed:18380804}.
CC   -!- INTERACTION:
CC       Self; NbExp=3; IntAct=EBI-702665, EBI-702665;
CC       P02730:SLC4A1; NbExp=4; IntAct=EBI-702665, EBI-7576138;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:11402026};
CC       Single-pass type I membrane protein {ECO:0000269|PubMed:11402026}.
CC       Note=Appears to be colocalized with SLC4A1.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=P02724-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P02724-2; Sequence=VSP_047822;
CC       Name=3;
CC         IsoId=P02724-3; Sequence=VSP_047823;
CC   -!- PTM: The major O-linked glycan are NeuAc-alpha-(2-3)-Gal-beta-(1-
CC       3)-[NeuAc-alpha-(2-6)]-GalNAcOH (about 78 %) and NeuAc-alpha-(2-
CC       3)-Gal-beta-(1-3)-GalNAcOH (17 %). Minor O-glycans (5 %) include
CC       NeuAc-alpha-(2-3)-Gal-beta-(1-3)-[NeuAc-alpha-(2-6)]-GalNAcOH
CC       NeuAc-alpha-(2-8)-NeuAc-alpha-(2-3)-Gal-beta-(1-3)-GalNAcOH. About
CC       1% of all O-linked glycans carry blood group A, B and H
CC       determinants. They derive from a type-2 precursor core structure,
CC       Gal-beta-(1,3)-GlcNAc-beta-1-R, and the antigens are synthesized
CC       by addition of fucose (H antigen-specific) and then N-
CC       acetylgalactosamine (A antigen-specific) or galactose (B antigen-
CC       specific). Specifically O-linked-glycans are NeuAc-alpha-(2-3)-
CC       Gal-beta-(1-3)-GalNAcOH-(6-1)-GlcNAc-beta-(4-1)-[Fuc-alpha-(1-2)]-
CC       Gal-beta-(3-1)-GalNAc-alpha (about 1%, B antigen-specific) and
CC       NeuAc-alpha-(2-3)-Gal-beta-(1-3)-GalNAcOH-(6-1)-GlcNAc-beta-(4-1)-
CC       [Fuc-alpha-(1-2)]-Gal-beta (1 %, O antigen-, A antigen- and B
CC       antigen-specific). {ECO:0000269|PubMed:10912628,
CC       ECO:0000269|PubMed:15313217, ECO:0000269|PubMed:3624241,
CC       ECO:0000269|PubMed:5350948, ECO:0000269|PubMed:8286855}.
CC   -!- POLYMORPHISM: Along with GYPB, GYPA is responsible for the MNS
CC       blood group system. The molecular basis of the GPA M/N bloodgroup
CC       antigen is a variation at positions 20 and 24. Ser-20 and Gly-24
CC       correspond to M (shown); 'Leu-20' and 'Glu-24' correspond to N.
CC   -!- POLYMORPHISM: GYPA polymorphisms are involved in resistance to
CC       malaria [MIM:611162].
CC   -!- MISCELLANEOUS: Involved in several unequal homologous
CC       recombinations or gene conversion events, predominantly with GYPB
CC       and more rarely with GYPE. The resulting fusion proteins are
CC       observed in different phenotypes and encode low incidence
CC       bloodgroup antigens.
CC   -!- SIMILARITY: Belongs to the glycophorin A family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAA52624.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=dbRBC/BGMUT; Note=Blood group antigen gene
CC       mutation database;
CC       URL="https://www.ncbi.nlm.nih.gov/gv/mhc/xslcgi.cgi?cmd=bgmut/systems_info&system=mns";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M12857; AAA88044.1; -; mRNA.
DR   EMBL; X08054; CAA30843.1; -; mRNA.
DR   EMBL; M24128; AAA52768.1; -; Genomic_DNA.
DR   EMBL; M24123; AAA52768.1; JOINED; Genomic_DNA.
DR   EMBL; M24134; AAA52768.1; JOINED; Genomic_DNA.
DR   EMBL; M24124; AAA52768.1; JOINED; Genomic_DNA.
DR   EMBL; M24126; AAA52768.1; JOINED; Genomic_DNA.
DR   EMBL; M24127; AAA52768.1; JOINED; Genomic_DNA.
DR   EMBL; X51798; CAA36095.1; -; mRNA.
DR   EMBL; L31860; AAA88051.1; -; mRNA.
DR   EMBL; EU338231; ACA96789.1; -; mRNA.
DR   EMBL; EU338233; ACA96791.1; -; mRNA.
DR   EMBL; EU338234; ACA96792.1; -; mRNA.
DR   EMBL; GU347002; ADU25340.1; -; mRNA.
DR   EMBL; GU347003; ADU25341.1; -; mRNA.
DR   EMBL; AK290561; BAF83250.1; -; mRNA.
DR   EMBL; AC107223; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC005319; AAH05319.1; -; mRNA.
DR   EMBL; BC013328; AAH13328.1; -; mRNA.
DR   EMBL; M36281; AAA52624.1; ALT_INIT; mRNA.
DR   CCDS; CCDS34069.1; -. [P02724-1]
DR   CCDS; CCDS82959.1; -. [P02724-3]
DR   PIR; A33931; A25131.
DR   RefSeq; NP_001295119.1; NM_001308190.1. [P02724-3]
DR   RefSeq; NP_002090.4; NM_002099.7.
DR   RefSeq; XP_016863624.1; XM_017008135.1. [P02724-2]
DR   UniGene; Hs.434973; -.
DR   PDB; 1AFO; NMR; -; A/B=81-120.
DR   PDB; 1MSR; Model; -; A/B=93-110.
DR   PDB; 2KPE; NMR; -; A/B=89-117.
DR   PDB; 2KPF; NMR; -; A/B=80-117.
DR   PDB; 5EH4; X-ray; 2.81 A; A/B/C/D=89-117.
DR   PDB; 5EH6; X-ray; 1.92 A; A=89-117.
DR   PDBsum; 1AFO; -.
DR   PDBsum; 1MSR; -.
DR   PDBsum; 2KPE; -.
DR   PDBsum; 2KPF; -.
DR   PDBsum; 5EH4; -.
DR   PDBsum; 5EH6; -.
DR   ProteinModelPortal; P02724; -.
DR   SMR; P02724; -.
DR   BioGrid; 109248; 13.
DR   IntAct; P02724; 8.
DR   STRING; 9606.ENSP00000354003; -.
DR   BindingDB; P02724; -.
DR   ChEMBL; CHEMBL5806; -.
DR   GlyConnect; 187; -.
DR   GlyConnect; 188; -.
DR   GlyConnect; 189; -.
DR   iPTMnet; P02724; -.
DR   PhosphoSitePlus; P02724; -.
DR   UniCarbKB; P02724; -.
DR   BioMuta; GYPA; -.
DR   DMDM; 259016238; -.
DR   PaxDb; P02724; -.
DR   PeptideAtlas; P02724; -.
DR   PRIDE; P02724; -.
DR   DNASU; 2993; -.
DR   Ensembl; ENST00000324022; ENSP00000324483; ENSG00000170180. [P02724-3]
DR   Ensembl; ENST00000641688; ENSP00000493142; ENSG00000170180. [P02724-2]
DR   GeneID; 2993; -.
DR   KEGG; hsa:2993; -.
DR   UCSC; uc003ijo.5; human. [P02724-1]
DR   CTD; 2993; -.
DR   DisGeNET; 2993; -.
DR   EuPathDB; HostDB:ENSG00000170180.19; -.
DR   GeneCards; GYPA; -.
DR   HGNC; HGNC:4702; GYPA.
DR   HPA; CAB002658; -.
DR   HPA; HPA014811; -.
DR   MalaCards; GYPA; -.
DR   MIM; 111300; gene+phenotype.
DR   MIM; 611162; phenotype.
DR   neXtProt; NX_P02724; -.
DR   OpenTargets; ENSG00000170180; -.
DR   PharmGKB; PA29080; -.
DR   eggNOG; ENOG410JM5B; Eukaryota.
DR   eggNOG; ENOG4111AH6; LUCA.
DR   GeneTree; ENSGT00550000075214; -.
DR   HOGENOM; HOG000089933; -.
DR   HOVERGEN; HBG005850; -.
DR   InParanoid; P02724; -.
DR   KO; K06575; -.
DR   PhylomeDB; P02724; -.
DR   TreeFam; TF338555; -.
DR   Reactome; R-HSA-202733; Cell surface interactions at the vascular wall.
DR   EvolutionaryTrace; P02724; -.
DR   GeneWiki; GYPA; -.
DR   GenomeRNAi; 2993; -.
DR   PRO; PR:P02724; -.
DR   Proteomes; UP000005640; Chromosome 4.
DR   Bgee; ENSG00000170180; -.
DR   CleanEx; HS_GYPA; -.
DR   ExpressionAtlas; P02724; baseline and differential.
DR   Genevisible; P02724; HS.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0016020; C:membrane; TAS:ProtInc.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0001618; F:virus receptor activity; IEA:UniProtKB-KW.
DR   GO; GO:0050900; P:leukocyte migration; TAS:Reactome.
DR   InterPro; IPR001195; Glycophorin.
DR   InterPro; IPR018938; Glycophorin_CS.
DR   PANTHER; PTHR13813; PTHR13813; 1.
DR   PIRSF; PIRSF002466; Glycophorin; 1.
DR   PROSITE; PS00312; GLYCOPHORIN_A; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Blood group antigen;
KW   Cell membrane; Complete proteome; Direct protein sequencing;
KW   Glycoprotein; Host cell receptor for virus entry;
KW   Host-virus interaction; Membrane; Phosphoprotein; Polymorphism;
KW   Receptor; Reference proteome; Sialic acid; Signal; Transmembrane;
KW   Transmembrane helix.
FT   SIGNAL        1     19       {ECO:0000269|PubMed:1059087}.
FT   CHAIN        20    150       Glycophorin-A.
FT                                /FTId=PRO_0000012134.
FT   TOPO_DOM     20     91       Extracellular.
FT   TRANSMEM     92    114       Helical.
FT   TOPO_DOM    115    150       Cytoplasmic.
FT   MOD_RES     133    133       Phosphothreonine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     138    138       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     148    148       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   CARBOHYD     21     21       O-linked (GalNAc...) serine.
FT                                {ECO:0000269|PubMed:1059087,
FT                                ECO:0000269|PubMed:8286855}.
FT   CARBOHYD     22     22       O-linked (GalNAc...) threonine.
FT                                {ECO:0000269|PubMed:1059087,
FT                                ECO:0000269|PubMed:8286855}.
FT   CARBOHYD     23     23       O-linked (GalNAc...) threonine.
FT                                {ECO:0000269|PubMed:1059087,
FT                                ECO:0000269|PubMed:8286855}.
FT   CARBOHYD     29     29       O-linked (GalNAc...) threonine.
FT                                {ECO:0000269|PubMed:1059087,
FT                                ECO:0000269|PubMed:8286855}.
FT   CARBOHYD     30     30       O-linked (GalNAc...) serine.
FT                                {ECO:0000269|PubMed:1059087,
FT                                ECO:0000269|PubMed:8286855}.
FT   CARBOHYD     31     31       O-linked (GalNAc...) threonine.
FT                                {ECO:0000269|PubMed:1059087,
FT                                ECO:0000269|PubMed:8286855}.
FT   CARBOHYD     32     32       O-linked (GalNAc...) serine.
FT                                {ECO:0000269|PubMed:1059087,
FT                                ECO:0000269|PubMed:8286855}.
FT   CARBOHYD     36     36       O-linked (GalNAc...) threonine.
FT                                {ECO:0000269|PubMed:8286855}.
FT   CARBOHYD     38     38       O-linked (GalNAc...) serine.
FT                                {ECO:0000269|PubMed:8286855}.
FT   CARBOHYD     41     41       O-linked (GalNAc...) serine.
FT                                {ECO:0000269|PubMed:1059087,
FT                                ECO:0000269|PubMed:8286855}.
FT   CARBOHYD     44     44       O-linked (GalNAc...) threonine.
FT                                {ECO:0000269|PubMed:1059087,
FT                                ECO:0000269|PubMed:8286855}.
FT   CARBOHYD     45     45       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:1059087,
FT                                ECO:0000269|PubMed:8286855}.
FT   CARBOHYD     52     52       O-linked (GalNAc...) threonine.
FT                                {ECO:0000269|PubMed:8286855}.
FT   CARBOHYD     56     56       O-linked (GalNAc...) threonine.
FT                                {ECO:0000269|PubMed:1059087,
FT                                ECO:0000269|PubMed:8286855}.
FT   CARBOHYD     63     63       O-linked (GalNAc...) serine.
FT                                {ECO:0000269|PubMed:1059087,
FT                                ECO:0000269|PubMed:8286855}.
FT   CARBOHYD     66     66       O-linked (GalNAc...) serine.
FT                                {ECO:0000269|PubMed:1059087,
FT                                ECO:0000269|PubMed:8286855}.
FT   CARBOHYD     69     69       O-linked (GalNAc...) threonine.
FT                                {ECO:0000269|PubMed:1059087,
FT                                ECO:0000269|PubMed:8286855}.
FT   VAR_SEQ       1     26       Missing (in isoform 2).
FT                                {ECO:0000303|Ref.6}.
FT                                /FTId=VSP_047822.
FT   VAR_SEQ      13     45       Missing (in isoform 3). {ECO:0000305}.
FT                                /FTId=VSP_047823.
FT   VARIANT      13     13       E -> A (in dbSNP:rs4449373).
FT                                {ECO:0000269|PubMed:14702039,
FT                                ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|PubMed:2216775,
FT                                ECO:0000269|PubMed:2734312,
FT                                ECO:0000269|PubMed:3456608,
FT                                ECO:0000269|PubMed:3809885,
FT                                ECO:0000269|PubMed:7798177}.
FT                                /FTId=VAR_058911.
FT   VARIANT      13     13       E -> G (in dbSNP:rs4449373).
FT                                /FTId=VAR_059977.
FT   VARIANT      20     20       S -> L (in N antigen and M(g) antigen;
FT                                dbSNP:rs7682260).
FT                                {ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|PubMed:15815621,
FT                                ECO:0000269|PubMed:3196288}.
FT                                /FTId=VAR_003190.
FT   VARIANT      23     23       T -> N (in M(g) antigen).
FT                                {ECO:0000269|PubMed:6940143}.
FT                                /FTId=VAR_058912.
FT   VARIANT      24     24       G -> D (in dbSNP:rs7658293).
FT                                /FTId=VAR_058913.
FT   VARIANT      24     24       G -> E (in N antigen, M(c) antigen and
FT                                M(g) antigen; dbSNP:rs7687256).
FT                                {ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|PubMed:15815621,
FT                                ECO:0000269|PubMed:3196288,
FT                                ECO:0000269|PubMed:6166001}.
FT                                /FTId=VAR_003191.
FT   VARIANT      46     46       D -> E (in Ny(a) antigen).
FT                                {ECO:0000269|PubMed:10827258}.
FT                                /FTId=VAR_058914.
FT   VARIANT      47     47       T -> K (in ENEH/Hut antigen).
FT                                {ECO:0000269|PubMed:1421409}.
FT                                /FTId=VAR_058915.
FT   VARIANT      47     47       T -> M (in ENEH/Vw antigen).
FT                                {ECO:0000269|PubMed:1611092}.
FT                                /FTId=VAR_058916.
FT   VARIANT      50     50       R -> W (in Or antigen).
FT                                /FTId=VAR_058917.
FT   VARIANT      66     66       S -> Y (in Vr antigen; dbSNP:rs56077914).
FT                                {ECO:0000269|PubMed:10729812}.
FT                                /FTId=VAR_058918.
FT   VARIANT      73     73       P -> S (in Os(a) antigen).
FT                                {ECO:0000269|PubMed:10827258}.
FT                                /FTId=VAR_058919.
FT   VARIANT      76     76       E -> K (in Ri(a) antigen).
FT                                /FTId=VAR_058920.
FT   VARIANT      77     77       T -> I (in Mt(a) antigen;
FT                                dbSNP:rs56172553).
FT                                {ECO:0000269|PubMed:10729812}.
FT                                /FTId=VAR_058921.
FT   VARIANT      78     78       G -> R (in ERIK antigen;
FT                                dbSNP:rs1800582).
FT                                {ECO:0000269|PubMed:8245024}.
FT                                /FTId=VAR_058922.
FT   VARIANT      82     82       Q -> K (in ENAV/MARS antigen).
FT                                /FTId=VAR_058923.
FT   VARIANT      84     84       A -> P (in ENEP/HAG antigen).
FT                                {ECO:0000269|PubMed:10354388}.
FT                                /FTId=VAR_058924.
FT   MUTAGEN      87     87       F->C: Diminishes dimerization.
FT                                {ECO:0000269|PubMed:12813056}.
FT   MUTAGEN      88     88       S->C: Diminishes dimerization.
FT                                {ECO:0000269|PubMed:12813056}.
FT   MUTAGEN      90     90       P->C: Diminishes dimerization.
FT                                {ECO:0000269|PubMed:12813056}.
FT   MUTAGEN      91     91       E->C: Diminishes dimerization.
FT                                {ECO:0000269|PubMed:12813056}.
FT   MUTAGEN      94     94       L->I: Diminishes dimerization.
FT                                {ECO:0000269|PubMed:10926825}.
FT   MUTAGEN      95     95       I->A: Diminishes dimerization.
FT                                {ECO:0000269|PubMed:10926825}.
FT   MUTAGEN      98     98       G->L: Diminishes dimerization.
FT                                {ECO:0000269|PubMed:10926825}.
FT   MUTAGEN     102    102       G->L: Abolishes dimerization.
FT                                {ECO:0000269|PubMed:10926825}.
FT   CONFLICT     30     30       S -> T (in Ref. 11; AA sequence).
FT                                {ECO:0000305}.
FT   CONFLICT     36     36       T -> S (in Ref. 11; AA sequence).
FT                                {ECO:0000305}.
FT   CONFLICT    133    133       T -> R (in Ref. 1; AAA88044).
FT                                {ECO:0000305}.
FT   STRAND       84     86       {ECO:0000244|PDB:2KPF}.
FT   HELIX        92    115       {ECO:0000244|PDB:5EH6}.
SQ   SEQUENCE   150 AA;  16331 MW;  48A5450E22FA99C9 CRC64;
     MYGKIIFVLL LSEIVSISAS STTGVAMHTS TSSSVTKSYI SSQTNDTHKR DTYAATPRAH
     EVSEISVRTV YPPEEETGER VQLAHHFSEP EITLIIFGVM AGVIGTILLI SYGIRRLIKK
     SPSDVKPLPS PDTDVPLSSV EIENPETSDQ
//
ID   Q14419_HUMAN            Unreviewed;       137 AA.
AC   Q14419;
DT   01-NOV-1996, integrated into UniProtKB/TrEMBL.
DT   01-NOV-1996, sequence version 1.
DT   23-MAY-2018, entry version 78.
DE   RecName: Full=Glycophorin {ECO:0000256|PIRNR:PIRNR002466};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:CAA40340.1};
RN   [1] {ECO:0000313|EMBL:CAA40340.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Liver {ECO:0000313|EMBL:CAA40340.1};
RA   Hoogenraad N.J.;
RL   Submitted (DEC-1990) to the EMBL/GenBank/DDBJ databases.
RN   [2] {ECO:0000313|EMBL:CAA40340.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Liver {ECO:0000313|EMBL:CAA40340.1};
RX   PubMed=1932122; DOI=10.1016/0167-4781(91)90115-3;
RA   Barton P., Collins A., Hoogenraad N.;
RT   "A variant of glycophorin A resulting from the deletion of exon 4.";
RL   Biochim. Biophys. Acta 1090:265-266(1991).
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X57023; CAA40340.1; -; mRNA.
DR   RefSeq; NP_001295116.1; NM_001308187.1.
DR   UniGene; Hs.434973; -.
DR   ProteinModelPortal; Q14419; -.
DR   PeptideAtlas; Q14419; -.
DR   GeneID; 2993; -.
DR   CTD; 2993; -.
DR   HOGENOM; HOG000089933; -.
DR   HOVERGEN; HBG005850; -.
DR   GenomeRNAi; 2993; -.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   InterPro; IPR001195; Glycophorin.
DR   InterPro; IPR018938; Glycophorin_CS.
DR   PANTHER; PTHR13813; PTHR13813; 1.
DR   PIRSF; PIRSF002466; Glycophorin; 1.
DR   PROSITE; PS00312; GLYCOPHORIN_A; 1.
PE   2: Evidence at transcript level;
KW   Glycoprotein {ECO:0000256|PIRNR:PIRNR002466};
KW   Membrane {ECO:0000256|SAM:Phobius};
KW   Sialic acid {ECO:0000256|PIRNR:PIRNR002466};
KW   Signal {ECO:0000256|SAM:SignalP};
KW   Transmembrane {ECO:0000256|SAM:Phobius};
KW   Transmembrane helix {ECO:0000256|SAM:Phobius}.
FT   SIGNAL        1     19       {ECO:0000256|SAM:SignalP}.
FT   CHAIN        20    137       Glycophorin. {ECO:0000256|SAM:SignalP}.
FT                                /FTId=PRO_5004183039.
FT   TRANSMEM     79    101       Helical. {ECO:0000256|SAM:Phobius}.
SQ   SEQUENCE   137 AA;  14785 MW;  B88ED20429B8C90C CRC64;
     MYGKIIFVLL LSAIVSISAS STTGVAMHTS TSSSVTKSYI SSQTNDTHKR DTYAATPRAH
     EVSEISVRTV YPPEEETEIT LIIFGVMAGV IGTILLISYG IRRLIKKSPS DVKPLPSPDT
     DVPLSSVEIE NPETSDQ
//
ID   A0A0S2Z428_HUMAN        Unreviewed;       564 AA.
AC   A0A0S2Z428;
DT   17-FEB-2016, integrated into UniProtKB/TrEMBL.
DT   17-FEB-2016, sequence version 1.
DT   23-MAY-2018, entry version 19.
DE   SubName: Full=HCG2039812, isoform CRA_b {ECO:0000313|EMBL:EAW96631.1};
DE   SubName: Full=Keratin 6A isoform 1 {ECO:0000313|EMBL:ALQ33615.1};
DE   Flags: Fragment;
GN   Name=KRT6A {ECO:0000313|EMBL:ALQ33615.1};
GN   ORFNames=hCG_2039812 {ECO:0000313|EMBL:EAW96631.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:ALQ33615.1};
RN   [1] {ECO:0000313|EMBL:EAW96631.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAW96631.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3] {ECO:0000313|EMBL:ALQ33615.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=26871637; DOI=10.1016/j.cell.2016.01.029;
RA   Yang X., Coulombe-Huntington J., Kang S., Sheynkman G.M., Hao T.,
RA   Richardson A., Sun S., Yang F., Shen Y.A., Murray R., Spirohn K.,
RA   Begg B.E., Duran-Frigola M., MacWilliams A., Pevzner S.J., Zhong Q.,
RA   Trigg S.A., Tam S., Ghamsari L., Sahni N., Yi S., Rodriguez M.D.,
RA   Balcha D., Tan G., Costanzo M., Andrews B., Boone C., Zhou X.J.,
RA   Salehi-Ashtiani K., Charloteaux B., Chen A., Calderwood M.A., Aloy P.,
RA   Roth F.P., Hill D.E., Iakoucheva L.M., Xia Y., Vidal M.;
RT   "Widespread Expansion of Protein Interaction Capabilities by
RT   Alternative Splicing.";
RL   Cell 164:805-817(2016).
CC   -!- SIMILARITY: Belongs to the intermediate filament family.
CC       {ECO:0000256|PROSITE-ProRule:PRU01188,
CC       ECO:0000256|RuleBase:RU000685, ECO:0000256|SAAS:SAAS01036505}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; KU178157; ALQ33615.1; -; mRNA.
DR   EMBL; CH471054; EAW96631.1; -; Genomic_DNA.
DR   RefSeq; NP_005545.1; NM_005554.3.
DR   UniGene; Hs.700779; -.
DR   SMR; A0A0S2Z428; -.
DR   PRIDE; A0A0S2Z428; -.
DR   GeneID; 3853; -.
DR   KEGG; hsa:3853; -.
DR   CTD; 3853; -.
DR   KO; K07605; -.
DR   OMA; MQDQVED; -.
DR   ChiTaRS; KRT6A; human.
DR   ExpressionAtlas; A0A0S2Z428; baseline and differential.
DR   GO; GO:0045095; C:keratin filament; IEA:InterPro.
DR   GO; GO:0005198; F:structural molecule activity; IEA:InterPro.
DR   InterPro; IPR001664; IF.
DR   InterPro; IPR018039; IF_conserved.
DR   InterPro; IPR039008; IF_rod_dom.
DR   InterPro; IPR032444; Keratin_2_head.
DR   InterPro; IPR003054; Keratin_II.
DR   PANTHER; PTHR23239; PTHR23239; 1.
DR   Pfam; PF00038; Filament; 1.
DR   Pfam; PF16208; Keratin_2_head; 1.
DR   PRINTS; PR01276; TYPE2KERATIN.
DR   SMART; SM01391; Filament; 1.
DR   PROSITE; PS00226; IF_ROD_1; 1.
DR   PROSITE; PS51842; IF_ROD_2; 1.
PE   2: Evidence at transcript level;
KW   Coiled coil {ECO:0000256|PROSITE-ProRule:PRU01188,
KW   ECO:0000256|SAAS:SAAS01036532, ECO:0000256|SAM:Coils};
KW   Intermediate filament {ECO:0000256|PROSITE-ProRule:PRU01188,
KW   ECO:0000256|RuleBase:RU000685, ECO:0000256|SAAS:SAAS01036494};
KW   Keratin {ECO:0000313|EMBL:ALQ33615.1}.
FT   DOMAIN      163    476       IF rod. {ECO:0000259|PROSITE:PS51842}.
FT   COILED      167    187       {ECO:0000256|SAM:Coils}.
FT   COILED      239    266       {ECO:0000256|SAM:Coils}.
FT   COILED      281    301       {ECO:0000256|SAM:Coils}.
FT   COILED      374    454       {ECO:0000256|SAM:Coils}.
FT   NON_TER     564    564       {ECO:0000313|EMBL:ALQ33615.1}.
SQ   SEQUENCE   564 AA;  60045 MW;  26708916C7DC923A CRC64;
     MASTSTTIRS HSSSRRGFSA NSARLPGVSR SGFSSVSVSR SRGSGGLGGA CGGAGFGSRS
     LYGLGGSKRI SIGGGSCAIS GGYGSRAGGS YGFGGAGSGF GFGGGAGIGF GLGGGAGLAG
     GFGGPGFPVC PPGGIQEVTV NQSLLTPLNL QIDPTIQRVR AEEREQIKTL NNKFASFIDK
     VRFLEQQNKV LETKWTLLQE QGTKTVRQNL EPLFEQYINN LRRQLDSIVG ERGRLDSELR
     GMQDLVEDFK NKYEDEINKR TAAENEFVTL KKDVDAAYMN KVELQAKADT LTDEINFLRA
     LYDAELSQMQ THISDTSVVL SMDNNRNLDL DSIIAEVKAQ YEEIAQRSRA EAESWYQTKY
     EELQVTAGRH GDDLRNTKQE IAEINRMIQR LRSEIDHVKK QCANLQAAIA DAEQRGEMAL
     KDAKNKLEGL EDALQKAKQD LARLLKEYQE LMNVKLALDV EIATYRKLLE GEECRLNGEG
     VGQVNISVVQ STVSSGYGGA SGVGSGLGLG GGSSYSYGSG LGVGGGFSSS SGRAIGGGLS
     SVGGGSSTIK YTTTSSSSRK SYKH
//
ID   K2C6A_HUMAN             Reviewed;         564 AA.
AC   P02538; A4QPC1; P48667; Q08AR4; Q6NT67; Q96CL4;
DT   21-JUL-1986, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 3.
DT   23-MAY-2018, entry version 186.
DE   RecName: Full=Keratin, type II cytoskeletal 6A;
DE   AltName: Full=Cytokeratin-6A;
DE            Short=CK-6A;
DE   AltName: Full=Cytokeratin-6D;
DE            Short=CK-6D;
DE   AltName: Full=Keratin-6A;
DE            Short=K6A;
DE   AltName: Full=Type-II keratin Kb6;
DE   AltName: Allergen=Hom s 5;
GN   Name=KRT6A; Synonyms=K6A, KRT6D;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   TISSUE=Skin;
RX   PubMed=7543104; DOI=10.1074/jbc.270.31.18581;
RA   Takahashi K., Paladini R.D., Coulombe P.A.;
RT   "Cloning and characterization of multiple human genes and cDNAs
RT   encoding highly related type II keratin 6 isoforms.";
RL   J. Biol. Chem. 270:18581-18592(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT SER-21.
RC   TISSUE=Brain, Ovary, and Pancreas;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   PROTEIN SEQUENCE OF 2-9; 31-40; 43-86; 169-204; 208-232; 241-347;
RP   350-369; 379-386; 425-436; 447-475 AND 534-550, CLEAVAGE OF INITIATOR
RP   METHIONINE, ACETYLATION AT ALA-2, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RC   TISSUE=Lung carcinoma;
RA   Bienvenut W.V., Vousden K.H., Lukashchuk N., Lilla S., Lange E.,
RA   Sumpton D.P.;
RL   Submitted (MAR-2008) to UniProtKB.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 208-564.
RX   PubMed=6191871; DOI=10.1016/0092-8674(83)90034-X;
RA   Hanukoglu I., Fuchs E.;
RT   "The cDNA sequence of a type II cytoskeletal keratin reveals constant
RT   and variable structural domains among keratins.";
RL   Cell 33:915-924(1983).
RN   [6]
RP   INTERACTION WITH TCHP.
RX   PubMed=15731013; DOI=10.1242/jcs.01667;
RA   Nishizawa M., Izawa I., Inoko A., Hayashi Y., Nagata K., Yokoyama T.,
RA   Usukura J., Inagaki M.;
RT   "Identification of trichoplein, a novel keratin filament-binding
RT   protein.";
RL   J. Cell Sci. 118:1081-1090(2005).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [8]
RP   INVOLVEMENT IN PC3.
RX   PubMed=22668561; DOI=10.1684/ejd.2012.1773;
RA   Du Z.F., Xu C.M., Zhao Y., Liu W.T., Chen X.L., Chen C.Y., Fang H.,
RA   Ke H.P., Zhang X.N.;
RT   "Two novel de novo mutations of KRT6A and KRT16 genes in two Chinese
RT   pachyonychia congenita pedigrees with fissured tongue or diffuse
RT   plantar keratoderma.";
RL   Eur. J. Dermatol. 22:476-480(2012).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [10]
RP   VARIANT PC3 ASN-171 DEL.
RX   PubMed=7545493; DOI=10.1038/ng0795-363;
RA   Bowden P.E., Haley J.L., Kansky A., Rothnagel J.A., Jones D.O.,
RA   Turner R.J.;
RT   "Mutation of a type II keratin gene (K6a) in pachyonychia congenita.";
RL   Nat. Genet. 10:363-365(1995).
RN   [11]
RP   VARIANTS PC3 LYS-171 AND SER-174.
RX   PubMed=10232400; DOI=10.1111/j.1600-0625.1999.tb00356.x;
RA   Smith F.J., McKenna K.E., Irvine A.D., Bingham E.A., Coleman C.M.,
RA   Uitto J., McLean W.H.;
RT   "A mutation detection strategy for the human keratin 6A gene and novel
RT   missense mutations in two cases of pachyonychia congenita type 1.";
RL   Exp. Dermatol. 8:109-114(1999).
RN   [12]
RP   VARIANTS PC3 VAL-174; ARG-469 AND LYS-472.
RX   PubMed=11886499; DOI=10.1046/j.0022-202x.2001.01565.x;
RA   Terrinoni A., Smith F.J.D., Didona B., Canzona F., Paradisi M.,
RA   Huber M., Hohl D., David A., Verloes A., Leigh I.M., Munro C.S.,
RA   Melino G., McLean W.H.I.;
RT   "Novel and recurrent mutations in the genes encoding keratins K6a, K16
RT   and K17 in 13 cases of pachyonychia congenita.";
RL   J. Invest. Dermatol. 117:1391-1396(2001).
RN   [13]
RP   VARIANT PC3 SER-462.
RX   PubMed=15387942;
RA   Kang X.J., Sun M., Yang W., Yu M., Ju Q., Lo W.H., Xia L.Q., Zhang X.;
RT   "[A de nono I462S mutation in the KRT6A gene is associated with
RT   pachyonychia congenita type I].";
RL   Zhonghua Yi Xue Za Zhi 84:1344-1347(2004).
RN   [14]
RP   VARIANT PC3 PRO-464.
RX   PubMed=15840119; DOI=10.1111/j.1365-2133.2005.06473.x;
RA   Garcia-Rio I., Penas P.F., Garcia-Diez A., McLean W.H., Smith F.J.;
RT   "A severe case of pachyonychia congenita type I due to a novel proline
RT   mutation in keratin 6a.";
RL   Br. J. Dermatol. 152:800-802(2005).
RN   [15]
RP   VARIANTS PC3 ASN-167; PHE-170; LYS-171; ASN-171 DEL; SER-171; SER-174;
RP   PRO-176; ASN-462; PRO-468 AND PRO-469.
RX   PubMed=16250206; DOI=10.1111/j.1087-0024.2005.10204.x;
RA   Smith F.J., Liao H., Cassidy A.J., Stewart A., Hamill K.J., Wood P.,
RA   Joval I., van Steensel M.A., Bjoerck E., Callif-Daley F., Pals G.,
RA   Collins P., Leachman S.A., Munro C.S., McLean W.H.;
RT   "The genetic basis of pachyonychia congenita.";
RL   J. Investig. Dermatol. Symp. Proc. 10:21-30(2005).
RN   [16]
RP   VARIANTS PC3 PRO-164; ASP-171; SER-171; TYR-171; ASN-172 DEL; CYS-174;
RP   ARG-469; PRO-469 AND LYS-472.
RX   PubMed=17719747; DOI=10.1016/j.jdermsci.2007.07.003;
RA   Liao H., Sayers J.M., Wilson N.J., Irvine A.D., Mellerio J.E.,
RA   Baselga E., Bayliss S.J., Uliana V., Fimiani M., Lane E.B.,
RA   McLean W.H., Leachman S.A., Smith F.J.;
RT   "A spectrum of mutations in keratins K6a, K16 and K17 causing
RT   pachyonychia congenita.";
RL   J. Dermatol. Sci. 48:199-205(2007).
RN   [17]
RP   VARIANT PC3 GLN-468.
RX   PubMed=17309457; DOI=10.1111/j.1468-3083.2006.01930.x;
RA   Zhou H.L., Yang S., Gao M., Zhao X.Y., Zhu Y.G., Li W., Ren Y.Q.,
RA   Liang Y.H., Du W.H., Zhang X.J.;
RT   "A novel missense mutation L468Q of keratin 6a in pachyonychia
RT   congenita type 1.";
RL   J. Eur. Acad. Dermatol. Venereol. 21:351-355(2007).
RN   [18]
RP   VARIANTS PC3 ASP-171 AND HIS-465.
RX   PubMed=18489596; DOI=10.1111/j.1365-2133.2008.08603.x;
RA   Bai Z.L., Feng Y.G., Tan S.S., Wang X.Y., Xiao S.X., Wang H.,
RA   Jia H.Q., Wu J.W., He D.L., Kang R.H.;
RT   "Mutations of KRT6A are more frequent than those of KRT16 in
RT   pachyonychia congenita type 1: report of a novel and a recently
RT   reported mutation in two unrelated Chinese families.";
RL   Br. J. Dermatol. 159:238-240(2008).
RN   [19]
RP   VARIANTS PC3 PRO-166; LYS-171; ASN-172 DEL; SER-174; ASN-178; PRO-463
RP   AND SER-465.
RX   PubMed=19416275; DOI=10.1111/j.1365-2133.2009.09062.x;
RA   Lv Y.M., Yang S., Zhang Z., Cui Y., Quan C., Zhou F.S., Fang Q.Y.,
RA   Du W.H., Zhang F.R., Chang J.M., Tao X.P., Zhang A.L., Kang R.H.,
RA   Du W.D., Zhang X.J.;
RT   "Novel and recurrent keratin 6A (KRT6A) mutations in Chinese patients
RT   with pachyonychia congenita type 1.";
RL   Br. J. Dermatol. 160:1327-1329(2009).
RN   [20]
RP   VARIANTS PC3 SER-171; LYS-171; ASN-172 DEL AND PRO-468.
RX   PubMed=21326300; DOI=10.1038/jid.2011.20;
RA   Wilson N.J., Leachman S.A., Hansen C.D., McMullan A.C., Milstone L.M.,
RA   Schwartz M.E., McLean W.H., Hull P.R., Smith F.J.;
RT   "A large mutational study in pachyonychia congenita.";
RL   J. Invest. Dermatol. 131:1018-1024(2011).
CC   -!- FUNCTION: Epidermis-specific type I keratin involved in wound
CC       healing. Involved in the activation of follicular keratinocytes
CC       after wounding, while it does not play a major role in
CC       keratinocyte proliferation or migration. Participates in the
CC       regulation of epithelial migration by inhibiting the activity of
CC       SRC during wound repair. {ECO:0000250|UniProtKB:P50446}.
CC   -!- SUBUNIT: Heterodimer of a type I and a type II keratin. KRT6
CC       isomers associate with KRT16 and/or KRT17 (By similarity).
CC       Interacts with TCHP (PubMed:15731013).
CC       {ECO:0000250|UniProtKB:P50446, ECO:0000269|PubMed:15731013}.
CC   -!- INTERACTION:
CC       Q15834:CCDC85B; NbExp=2; IntAct=EBI-702198, EBI-739674;
CC       Q08379:GOLGA2; NbExp=6; IntAct=EBI-702198, EBI-618309;
CC       O14964:HGS; NbExp=6; IntAct=EBI-702198, EBI-740220;
CC       F5H3M2:KIFC3; NbExp=4; IntAct=EBI-702198, EBI-11953930;
CC       Q9BVG8:KIFC3; NbExp=5; IntAct=EBI-702198, EBI-2125614;
CC       A1A4E9:KRT13; NbExp=5; IntAct=EBI-702198, EBI-10171552;
CC       P13646:KRT13; NbExp=5; IntAct=EBI-702198, EBI-1223876;
CC       P19012:KRT15; NbExp=13; IntAct=EBI-702198, EBI-739566;
CC       Q7Z3Y9:KRT26; NbExp=4; IntAct=EBI-702198, EBI-12084444;
CC       Q15323:KRT31; NbExp=11; IntAct=EBI-702198, EBI-948001;
CC       O76015:KRT38; NbExp=9; IntAct=EBI-702198, EBI-1047263;
CC       Q6A162:KRT40; NbExp=13; IntAct=EBI-702198, EBI-10171697;
CC       O43765:SGTA; NbExp=3; IntAct=EBI-702198, EBI-347996;
CC       Q9UBB9:TFIP11; NbExp=8; IntAct=EBI-702198, EBI-1105213;
CC       P36406:TRIM23; NbExp=8; IntAct=EBI-702198, EBI-740098;
CC       Q9BYV2:TRIM54; NbExp=9; IntAct=EBI-702198, EBI-2130429;
CC   -!- TISSUE SPECIFICITY: Constitutively expressed in distinct types of
CC       epithelia such as those in oral mucosa, esophagus, papillae of
CC       tongue and hair follicle outer root sheath.
CC   -!- DISEASE: Pachyonychia congenita 3 (PC3) [MIM:615726]: An autosomal
CC       dominant genodermatosis characterized by hypertrophic nail
CC       dystrophy, painful and highly debilitating plantar keratoderma,
CC       oral leukokeratosis, and a variety of epidermal cysts.
CC       {ECO:0000269|PubMed:10232400, ECO:0000269|PubMed:11886499,
CC       ECO:0000269|PubMed:15387942, ECO:0000269|PubMed:15840119,
CC       ECO:0000269|PubMed:16250206, ECO:0000269|PubMed:17309457,
CC       ECO:0000269|PubMed:17719747, ECO:0000269|PubMed:18489596,
CC       ECO:0000269|PubMed:19416275, ECO:0000269|PubMed:21326300,
CC       ECO:0000269|PubMed:22668561, ECO:0000269|PubMed:7545493}. Note=The
CC       disease is caused by mutations affecting the gene represented in
CC       this entry.
CC   -!- ALLERGEN: Causes an allergic reaction in human. Binds to IgE from
CC       atopic dermatitis (AD) patients. Identified as an IgE autoantigen
CC       in atopic dermatitis (AD) patients with severe skin
CC       manifestations.
CC   -!- MISCELLANEOUS: There are at least six isoforms of human type II
CC       keratin-6 (K6), K6A being the most abundant representing about 77%
CC       of all forms found in epithelia.
CC   -!- MISCELLANEOUS: There are two types of cytoskeletal and
CC       microfibrillar keratin, I (acidic) and II (neutral to basic) (40-
CC       55 and 56-70 kDa, respectively).
CC   -!- SIMILARITY: Belongs to the intermediate filament family.
CC       {ECO:0000255|PROSITE-ProRule:PRU01188}.
CC   -!- WEB RESOURCE: Name=Human Intermediate Filament Mutation Database;
CC       URL="http://www.interfil.org";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; L42583; AAC41767.1; -; Genomic_DNA.
DR   EMBL; L42575; AAC41767.1; JOINED; Genomic_DNA.
DR   EMBL; L42576; AAC41767.1; JOINED; Genomic_DNA.
DR   EMBL; L42577; AAC41767.1; JOINED; Genomic_DNA.
DR   EMBL; L42578; AAC41767.1; JOINED; Genomic_DNA.
DR   EMBL; L42579; AAC41767.1; JOINED; Genomic_DNA.
DR   EMBL; L42580; AAC41767.1; JOINED; Genomic_DNA.
DR   EMBL; L42581; AAC41767.1; JOINED; Genomic_DNA.
DR   EMBL; AH005420; AAB60696.1; -; Genomic_DNA.
DR   EMBL; BT006899; AAP35545.1; -; mRNA.
DR   EMBL; BC008807; AAH08807.1; -; mRNA.
DR   EMBL; BC014152; AAH14152.1; -; mRNA.
DR   EMBL; BC069269; AAH69269.1; -; mRNA.
DR   EMBL; BC125058; AAI25059.1; -; mRNA.
DR   EMBL; BC139753; AAI39754.1; -; mRNA.
DR   EMBL; V01516; CAA24760.1; -; Genomic_DNA.
DR   PIR; A57398; KRHUEA.
DR   PIR; I61769; I61769.
DR   RefSeq; NP_005545.1; NM_005554.3.
DR   UniGene; Hs.700779; -.
DR   PDB; 5KI0; NMR; -; A=533-551.
DR   PDBsum; 5KI0; -.
DR   ProteinModelPortal; P02538; -.
DR   SMR; P02538; -.
DR   BioGrid; 110051; 48.
DR   DIP; DIP-533N; -.
DR   IntAct; P02538; 51.
DR   MINT; P02538; -.
DR   STRING; 9606.ENSP00000369317; -.
DR   Allergome; 3326; Hom s 5.0101.
DR   Allergome; 415; Hom s 5.
DR   iPTMnet; P02538; -.
DR   PhosphoSitePlus; P02538; -.
DR   SwissPalm; P02538; -.
DR   BioMuta; KRT6A; -.
DR   DMDM; 1346344; -.
DR   PaxDb; P02538; -.
DR   PeptideAtlas; P02538; -.
DR   PRIDE; P02538; -.
DR   TopDownProteomics; P02538; -.
DR   DNASU; 3853; -.
DR   Ensembl; ENST00000330722; ENSP00000369317; ENSG00000205420.
DR   GeneID; 3853; -.
DR   KEGG; hsa:3853; -.
DR   UCSC; uc001sam.4; human.
DR   CTD; 3853; -.
DR   DisGeNET; 3853; -.
DR   EuPathDB; HostDB:ENSG00000205420.10; -.
DR   GeneCards; KRT6A; -.
DR   GeneReviews; KRT6A; -.
DR   HGNC; HGNC:6443; KRT6A.
DR   HPA; HPA045697; -.
DR   HPA; HPA061168; -.
DR   MalaCards; KRT6A; -.
DR   MIM; 148041; gene.
DR   MIM; 615726; phenotype.
DR   neXtProt; NX_P02538; -.
DR   OpenTargets; ENSG00000205420; -.
DR   Orphanet; 2309; Pachyonychia congenita.
DR   PharmGKB; PA30231; -.
DR   eggNOG; ENOG410IG4R; Eukaryota.
DR   eggNOG; ENOG410YY6B; LUCA.
DR   GeneTree; ENSGT00760000118796; -.
DR   HOGENOM; HOG000230976; -.
DR   HOVERGEN; HBG013015; -.
DR   InParanoid; P02538; -.
DR   KO; K07605; -.
DR   OMA; MQDQVED; -.
DR   OrthoDB; EOG091G09KR; -.
DR   PhylomeDB; P02538; -.
DR   TreeFam; TF317854; -.
DR   Reactome; R-HSA-6805567; Keratinization.
DR   Reactome; R-HSA-6809371; Formation of the cornified envelope.
DR   ChiTaRS; KRT6A; human.
DR   GeneWiki; Keratin_6A; -.
DR   GenomeRNAi; 3853; -.
DR   PRO; PR:P02538; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   Bgee; ENSG00000205420; -.
DR   CleanEx; HS_KRT6A; -.
DR   ExpressionAtlas; P02538; baseline and differential.
DR   Genevisible; P02538; HS.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0045095; C:keratin filament; IEA:InterPro.
DR   GO; GO:0016020; C:membrane; HDA:UniProtKB.
DR   GO; GO:0005634; C:nucleus; HDA:UniProtKB.
DR   GO; GO:0005200; F:structural constituent of cytoskeleton; NAS:UniProtKB.
DR   GO; GO:0061844; P:antimicrobial humoral immune response mediated by antimicrobial peptide; IDA:UniProtKB.
DR   GO; GO:0030154; P:cell differentiation; NAS:UniProtKB.
DR   GO; GO:0070268; P:cornification; TAS:Reactome.
DR   GO; GO:0051801; P:cytolysis in other organism involved in symbiotic interaction; IDA:UniProtKB.
DR   GO; GO:0050830; P:defense response to Gram-positive bacterium; IDA:UniProtKB.
DR   GO; GO:0031424; P:keratinization; TAS:Reactome.
DR   GO; GO:0002009; P:morphogenesis of an epithelium; ISS:UniProtKB.
DR   GO; GO:0001899; P:negative regulation of cytolysis by symbiont of host cells; IDA:UniProtKB.
DR   GO; GO:2000536; P:negative regulation of entry of bacterium into host cell; IDA:UniProtKB.
DR   GO; GO:0008284; P:positive regulation of cell proliferation; NAS:UniProtKB.
DR   GO; GO:0042060; P:wound healing; ISS:UniProtKB.
DR   InterPro; IPR001664; IF.
DR   InterPro; IPR018039; IF_conserved.
DR   InterPro; IPR039008; IF_rod_dom.
DR   InterPro; IPR032444; Keratin_2_head.
DR   InterPro; IPR003054; Keratin_II.
DR   PANTHER; PTHR23239; PTHR23239; 1.
DR   Pfam; PF00038; Filament; 1.
DR   Pfam; PF16208; Keratin_2_head; 1.
DR   PRINTS; PR01276; TYPE2KERATIN.
DR   SMART; SM01391; Filament; 1.
DR   PROSITE; PS00226; IF_ROD_1; 1.
DR   PROSITE; PS51842; IF_ROD_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Allergen; Coiled coil; Complete proteome;
KW   Direct protein sequencing; Disease mutation; Ectodermal dysplasia;
KW   Intermediate filament; Keratin; Palmoplantar keratoderma;
KW   Polymorphism; Reference proteome.
FT   INIT_MET      1      1       Removed. {ECO:0000269|Ref.4}.
FT   CHAIN         2    564       Keratin, type II cytoskeletal 6A.
FT                                /FTId=PRO_0000063731.
FT   DOMAIN      163    476       IF rod. {ECO:0000255|PROSITE-
FT                                ProRule:PRU01188}.
FT   REGION        2    162       Head.
FT   REGION      163    198       Coil 1A.
FT   REGION      199    217       Linker 1.
FT   REGION      218    309       Coil 1B.
FT   REGION      310    333       Linker 12.
FT   REGION      334    472       Coil 2.
FT   REGION      473    564       Tail.
FT   SITE        414    414       Stutter.
FT   MOD_RES       2      2       N-acetylalanine. {ECO:0000269|Ref.4}.
FT   VARIANT      21     21       N -> S (in dbSNP:rs17845411).
FT                                {ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_021264.
FT   VARIANT     111    111       G -> D (in dbSNP:rs681063).
FT                                /FTId=VAR_035030.
FT   VARIANT     164    164       R -> P (in PC3; dbSNP:rs62635293).
FT                                {ECO:0000269|PubMed:17719747}.
FT                                /FTId=VAR_072446.
FT   VARIANT     166    166       Q -> P (in PC3; dbSNP:rs267607460).
FT                                {ECO:0000269|PubMed:19416275}.
FT                                /FTId=VAR_072447.
FT   VARIANT     167    167       I -> N (in PC3; dbSNP:rs57126929).
FT                                {ECO:0000269|PubMed:16250206}.
FT                                /FTId=VAR_072448.
FT   VARIANT     170    170       L -> F (in PC3; dbSNP:rs57448541).
FT                                {ECO:0000269|PubMed:16250206}.
FT                                /FTId=VAR_072449.
FT   VARIANT     171    171       N -> D (in PC3; dbSNP:rs62635294).
FT                                {ECO:0000269|PubMed:17719747,
FT                                ECO:0000269|PubMed:18489596}.
FT                                /FTId=VAR_072450.
FT   VARIANT     171    171       N -> K (in PC3; dbSNP:rs59685571).
FT                                {ECO:0000269|PubMed:10232400,
FT                                ECO:0000269|PubMed:16250206,
FT                                ECO:0000269|PubMed:19416275,
FT                                ECO:0000269|PubMed:21326300}.
FT                                /FTId=VAR_072451.
FT   VARIANT     171    171       N -> S (in PC3; dbSNP:rs58556099).
FT                                {ECO:0000269|PubMed:16250206,
FT                                ECO:0000269|PubMed:17719747,
FT                                ECO:0000269|PubMed:21326300}.
FT                                /FTId=VAR_072452.
FT   VARIANT     171    171       N -> Y (in PC3; dbSNP:rs62635294).
FT                                {ECO:0000269|PubMed:17719747}.
FT                                /FTId=VAR_072453.
FT   VARIANT     171    171       Missing (in PC3).
FT                                {ECO:0000269|PubMed:16250206,
FT                                ECO:0000269|PubMed:7545493}.
FT                                /FTId=VAR_003878.
FT   VARIANT     172    172       Missing (in PC3).
FT                                {ECO:0000269|PubMed:17719747,
FT                                ECO:0000269|PubMed:19416275,
FT                                ECO:0000269|PubMed:21326300}.
FT                                /FTId=VAR_072454.
FT   VARIANT     174    174       F -> C (in PC3; dbSNP:rs61145796).
FT                                {ECO:0000269|PubMed:17719747}.
FT                                /FTId=VAR_072455.
FT   VARIANT     174    174       F -> S (in PC3; dbSNP:rs61145796).
FT                                {ECO:0000269|PubMed:10232400,
FT                                ECO:0000269|PubMed:16250206,
FT                                ECO:0000269|PubMed:19416275}.
FT                                /FTId=VAR_072456.
FT   VARIANT     174    174       F -> V (in PC3; dbSNP:rs28933087).
FT                                {ECO:0000269|PubMed:11886499}.
FT                                /FTId=VAR_017075.
FT   VARIANT     176    176       S -> P (in PC3; dbSNP:rs59642296).
FT                                {ECO:0000269|PubMed:16250206}.
FT                                /FTId=VAR_072457.
FT   VARIANT     178    178       I -> N (in PC3; dbSNP:rs267607461).
FT                                {ECO:0000269|PubMed:19416275}.
FT                                /FTId=VAR_072458.
FT   VARIANT     462    462       I -> N (in PC3; dbSNP:rs57629991).
FT                                {ECO:0000269|PubMed:16250206}.
FT                                /FTId=VAR_072459.
FT   VARIANT     462    462       I -> S (in PC3; dbSNP:rs57629991).
FT                                {ECO:0000269|PubMed:15387942}.
FT                                /FTId=VAR_072460.
FT   VARIANT     463    463       A -> P (in PC3; dbSNP:rs267607462).
FT                                {ECO:0000269|PubMed:19416275}.
FT                                /FTId=VAR_072461.
FT   VARIANT     464    464       T -> P (in PC3; dbSNP:rs61293647).
FT                                {ECO:0000269|PubMed:15840119}.
FT                                /FTId=VAR_072462.
FT   VARIANT     465    465       Y -> H (in PC3; dbSNP:rs267607463).
FT                                {ECO:0000269|PubMed:18489596}.
FT                                /FTId=VAR_072463.
FT   VARIANT     465    465       Y -> S (in PC3).
FT                                {ECO:0000269|PubMed:19416275}.
FT                                /FTId=VAR_072464.
FT   VARIANT     468    468       L -> P (in PC3; dbSNP:rs59018888).
FT                                {ECO:0000269|PubMed:16250206,
FT                                ECO:0000269|PubMed:21326300}.
FT                                /FTId=VAR_072465.
FT   VARIANT     468    468       L -> Q (in PC3; dbSNP:rs59018888).
FT                                {ECO:0000269|PubMed:17309457}.
FT                                /FTId=VAR_072466.
FT   VARIANT     469    469       L -> P (in PC3; dbSNP:rs57052654).
FT                                {ECO:0000269|PubMed:16250206,
FT                                ECO:0000269|PubMed:17719747}.
FT                                /FTId=VAR_072467.
FT   VARIANT     469    469       L -> R (in PC3; dbSNP:rs57052654).
FT                                {ECO:0000269|PubMed:11886499,
FT                                ECO:0000269|PubMed:17719747}.
FT                                /FTId=VAR_017076.
FT   VARIANT     472    472       E -> K (in PC3; dbSNP:rs60554162).
FT                                {ECO:0000269|PubMed:11886499,
FT                                ECO:0000269|PubMed:17719747}.
FT                                /FTId=VAR_017077.
FT   CONFLICT    192    192       E -> D (in Ref. 1; AAB60696).
FT                                {ECO:0000305}.
FT   CONFLICT    241    241       G -> N (in Ref. 1; AAB60696).
FT                                {ECO:0000305}.
FT   CONFLICT    249    249       F -> L (in Ref. 1; AAB60696).
FT                                {ECO:0000305}.
FT   CONFLICT    395    395       I -> S (in Ref. 5; CAA24760).
FT                                {ECO:0000305}.
FT   CONFLICT    404    404       N -> S (in Ref. 1; AAB60696).
FT                                {ECO:0000305}.
FT   CONFLICT    443    443       R -> W (in Ref. 3; AAH69269).
FT                                {ECO:0000305}.
FT   CONFLICT    486    486       I -> V (in Ref. 1; AAB60696).
FT                                {ECO:0000305}.
FT   HELIX       539    541       {ECO:0000244|PDB:5KI0}.
FT   HELIX       547    549       {ECO:0000244|PDB:5KI0}.
SQ   SEQUENCE   564 AA;  60045 MW;  26708916C7DC923A CRC64;
     MASTSTTIRS HSSSRRGFSA NSARLPGVSR SGFSSVSVSR SRGSGGLGGA CGGAGFGSRS
     LYGLGGSKRI SIGGGSCAIS GGYGSRAGGS YGFGGAGSGF GFGGGAGIGF GLGGGAGLAG
     GFGGPGFPVC PPGGIQEVTV NQSLLTPLNL QIDPTIQRVR AEEREQIKTL NNKFASFIDK
     VRFLEQQNKV LETKWTLLQE QGTKTVRQNL EPLFEQYINN LRRQLDSIVG ERGRLDSELR
     GMQDLVEDFK NKYEDEINKR TAAENEFVTL KKDVDAAYMN KVELQAKADT LTDEINFLRA
     LYDAELSQMQ THISDTSVVL SMDNNRNLDL DSIIAEVKAQ YEEIAQRSRA EAESWYQTKY
     EELQVTAGRH GDDLRNTKQE IAEINRMIQR LRSEIDHVKK QCANLQAAIA DAEQRGEMAL
     KDAKNKLEGL EDALQKAKQD LARLLKEYQE LMNVKLALDV EIATYRKLLE GEECRLNGEG
     VGQVNISVVQ STVSSGYGGA SGVGSGLGLG GGSSYSYGSG LGVGGGFSSS SGRAIGGGLS
     SVGGGSSTIK YTTTSSSSRK SYKH
//
ID   A0A024R663_HUMAN        Unreviewed;      1357 AA.
AC   A0A024R663;
DT   09-JUL-2014, integrated into UniProtKB/TrEMBL.
DT   09-JUL-2014, sequence version 1.
DT   23-MAY-2018, entry version 33.
DE   SubName: Full=Kinectin 1 (Kinesin receptor), isoform CRA_a {ECO:0000313|EMBL:EAW80681.1};
DE   SubName: Full=Kinectin 1 (Kinesin receptor), isoform CRA_b {ECO:0000313|EMBL:EAW80684.1};
GN   Name=KTN1 {ECO:0000313|EMBL:EAW80684.1};
GN   ORFNames=hCG_22120 {ECO:0000313|EMBL:EAW80684.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:EAW80684.1};
RN   [1] {ECO:0000313|EMBL:EAW80684.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAW80684.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; CH471061; EAW80681.1; -; Genomic_DNA.
DR   EMBL; CH471061; EAW80682.1; -; Genomic_DNA.
DR   EMBL; CH471061; EAW80684.1; -; Genomic_DNA.
DR   RefSeq; NP_001072989.1; NM_001079521.1.
DR   RefSeq; XP_006720201.1; XM_006720138.2.
DR   RefSeq; XP_011535053.1; XM_011536751.2.
DR   RefSeq; XP_016876767.1; XM_017021278.1.
DR   UniGene; Hs.509414; -.
DR   UniGene; Hs.687012; -.
DR   SMR; A0A024R663; -.
DR   PRIDE; A0A024R663; -.
DR   GeneID; 3895; -.
DR   KEGG; hsa:3895; -.
DR   CTD; 3895; -.
DR   EuPathDB; HostDB:ENSG00000126777.17; -.
DR   eggNOG; ENOG410IIAW; Eukaryota.
DR   eggNOG; ENOG410YAE3; LUCA.
DR   KO; K17975; -.
DR   OMA; KEHNVFQ; -.
DR   OrthoDB; EOG091G12OH; -.
DR   ChiTaRS; KTN1; human.
DR   GenomeRNAi; 3895; -.
DR   Bgee; ENSG00000126777; -.
DR   ExpressionAtlas; A0A024R663; baseline and differential.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:HPA.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0019894; F:kinesin binding; IEA:InterPro.
DR   GO; GO:0007018; P:microtubule-based movement; IEA:InterPro.
DR   InterPro; IPR024854; Kinectin.
DR   PANTHER; PTHR18864; PTHR18864; 1.
PE   4: Predicted;
KW   Coiled coil {ECO:0000256|SAM:Coils};
KW   Membrane {ECO:0000256|SAM:Phobius};
KW   Receptor {ECO:0000313|EMBL:EAW80684.1};
KW   Transmembrane {ECO:0000256|SAM:Phobius};
KW   Transmembrane helix {ECO:0000256|SAM:Phobius}.
FT   TRANSMEM      7     29       Helical. {ECO:0000256|SAM:Phobius}.
FT   COILED      341    368       {ECO:0000256|SAM:Coils}.
FT   COILED      405    432       {ECO:0000256|SAM:Coils}.
FT   COILED      441    496       {ECO:0000256|SAM:Coils}.
FT   COILED      564    591       {ECO:0000256|SAM:Coils}.
FT   COILED      602    643       {ECO:0000256|SAM:Coils}.
FT   COILED      651    674       {ECO:0000256|SAM:Coils}.
FT   COILED      686    720       {ECO:0000256|SAM:Coils}.
FT   COILED      730    753       {ECO:0000256|SAM:Coils}.
FT   COILED      758    785       {ECO:0000256|SAM:Coils}.
FT   COILED      796    851       {ECO:0000256|SAM:Coils}.
FT   COILED      862    920       {ECO:0000256|SAM:Coils}.
FT   COILED      928    955       {ECO:0000256|SAM:Coils}.
FT   COILED      963    983       {ECO:0000256|SAM:Coils}.
FT   COILED     1015   1035       {ECO:0000256|SAM:Coils}.
FT   COILED     1115   1163       {ECO:0000256|SAM:Coils}.
FT   COILED     1175   1275       {ECO:0000256|SAM:Coils}.
FT   COILED     1332   1357       {ECO:0000256|SAM:Coils}.
SQ   SEQUENCE   1357 AA;  156275 MW;  971FCDF8AA8FC88E CRC64;
     MEFYESAYFI VLIPSIVITV IFLFFWLFMK ETLYDEVLAK QKREQKLIPT KTDKKKAEKK
     KNKKKEIQNG NLHESDSESV PRDFKLSDAL AVEDDQVAPV PLNVVETSSS VRERKKKEKK
     QKPVLEEQVI KESDASKIPG KKVEPVPVTK QPTPPSEAAA SKKKPGQKKS KNGSDDQDKK
     VETLMVPSKR QEALPLHQET KQESGSGKKK ASSKKQKTEN VFVDEPLIHA TTYIPLMDNA
     DSSPVVDKRE VIDLLKPDQV EGIQKSGTKK LKTETDKENA EVKFKDFLLS LKTMMFSEDE
     ALCVVDLLKE KSGVIQDALK KSSKGELTTL IHQLQEKDKL LAAVKEDAAA TKDRCKQLTQ
     EMMTEKERSN VVITRMKDRI GTLEKEHNVF QNKIHVSYQE TQQMQMKFQQ VREQMEAEIA
     HLKQENGILR DAVSNTTNQL ESKQSAELNK LRQDYARLVN ELTEKTGKLQ QEEVQKKNAE
     QAATQLKVQL QEAERRWEEV QSYIRKRTAE HEAAQQDLQS KFVAKENEVQ SLHSKLTDTL
     VSKQQLEQRL MQLMESEQKR VNKEESLQMQ VQDILEQNEA LKAQIQQFHS QIAAQTSASV
     LAEELHKVIA EKDKQIKQTE DSLASERDRL TSKEEELKDI QNMNFLLKAE VQKLQALANE
     QAAAAHELEK MQQSVYVKDD KIRLLEEQLQ HEISNKMEEF KILNDQNKAL KSEVQKLQTL
     VSEQPNKDVV EQMEKCIQEK DEKLKTVEEL LETGLIQVAT KEEELNAIRT ENSSLTKEVQ
     DLKAKQNDQV SFASLVEELK KVIHEKDGKI KSVEELLEAE LLKVANKEKT VQDLKQEIKA
     LKEEIGNVQL EKAQQLSITS KVQELQNLLK GKEEQMNTMK AVLEEKEKDL ANTGKWLQDL
     QEENESLKAH VQEVAQHNLK EASSASQFEE LEIVLKEKEN ELKRLEAMLK ERESDLSSKT
     QLLQDVQDEN KLFKSQIEQL KQQNYQQASS FPPHEELLKV ISEREKEISG LWNELDSLKD
     AVEHQRKKNN DLREKNWEAM EALASTEKML QDKVNKTSKE RQQQVEAVEL EAKEVLKKLF
     PKVSVPSNLS YGEWLHGFEK KAKECMAGTS GSEEVKVLEH KLKEADEMHT LLQLECEKYK
     SVLAETEGIL QKLQRSVEQE ENKWKVKVDE SHKTIKQMQS SFTSSEQELE RLRSENKDIE
     NLRREREHLE MELEKAEMER STYVTEVREL KDLLTELQKK LDDSYSEAVR QNEELNLLKA
     QLNETLTKLR TEQNERQKVA GDLHKAQQSL ELIQSKIVKA AGDTTVIENS DVSPETESSE
     KETMSVSLNQ TVTQLQQLLQ AVNQQLTKEK EHYQVLE
//
ID   KTN1_HUMAN              Reviewed;        1357 AA.
AC   Q86UP2; B4DZ88; Q13999; Q14707; Q15387; Q17RZ5; Q5GGW3; Q86W57;
DT   15-AUG-2003, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-2003, sequence version 1.
DT   23-MAY-2018, entry version 151.
DE   RecName: Full=Kinectin;
DE   AltName: Full=CG-1 antigen;
DE   AltName: Full=Kinesin receptor;
GN   Name=KTN1; Synonyms=CG1, KIAA0004;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Lymphoid tissue;
RX   PubMed=7787243; DOI=10.1091/mbc.6.2.161;
RA   Fuetterer A., Kruppa G., Kraemer B., Lemke H., Kroenke M.;
RT   "Molecular cloning and characterization of human kinectin.";
RL   Mol. Biol. Cell 6:161-170(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RC   TISSUE=Peripheral blood lymphocyte;
RX   PubMed=8039706; DOI=10.1016/0378-1119(94)90381-6;
RA   Print C.G., Leung E., Harrison J.E.B., Watson J.D., Krissansen G.W.;
RT   "Cloning of a gene encoding a human leukocyte protein characterised by
RT   extensive heptad repeats.";
RL   Gene 144:221-228(1994).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RA   Wang H.-C., Chen W.-F., Su Y.-R.;
RT   "Identification of a variant of Homo sapiens kinectin mRNA.";
RL   Submitted (MAR-2003) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Bone marrow;
RX   PubMed=7584026; DOI=10.1093/dnares/1.1.27;
RA   Nomura N., Miyajima N., Sazuka T., Tanaka A., Kawarabayasi Y.,
RA   Sato S., Nagase T., Seki N., Ishikawa K., Tabata S.;
RT   "Prediction of the coding sequences of unidentified human genes. I.
RT   The coding sequences of 40 new genes (KIAA0001-KIAA0040) deduced by
RT   analysis of randomly sampled cDNA clones from human immature myeloid
RT   cell line KG-1.";
RL   DNA Res. 1:27-35(1994).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 4).
RC   TISSUE=Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12508121; DOI=10.1038/nature01348;
RA   Heilig R., Eckenberg R., Petit J.-L., Fonknechten N., Da Silva C.,
RA   Cattolico L., Levy M., Barbe V., De Berardinis V., Ureta-Vidal A.,
RA   Pelletier E., Vico V., Anthouard V., Rowen L., Madan A., Qin S.,
RA   Sun H., Du H., Pepin K., Artiguenave F., Robert C., Cruaud C.,
RA   Bruels T., Jaillon O., Friedlander L., Samson G., Brottier P.,
RA   Cure S., Segurens B., Aniere F., Samain S., Crespeau H., Abbasi N.,
RA   Aiach N., Boscus D., Dickhoff R., Dors M., Dubois I., Friedman C.,
RA   Gouyvenoux M., James R., Madan A., Mairey-Estrada B., Mangenot S.,
RA   Martins N., Menard M., Oztas S., Ratcliffe A., Shaffer T., Trask B.,
RA   Vacherie B., Bellemere C., Belser C., Besnard-Gonnet M.,
RA   Bartol-Mavel D., Boutard M., Briez-Silla S., Combette S.,
RA   Dufosse-Laurent V., Ferron C., Lechaplais C., Louesse C., Muselet D.,
RA   Magdelenat G., Pateau E., Petit E., Sirvain-Trukniewicz P., Trybou A.,
RA   Vega-Czarny N., Bataille E., Bluet E., Bordelais I., Dubois M.,
RA   Dumont C., Guerin T., Haffray S., Hammadi R., Muanga J., Pellouin V.,
RA   Robert D., Wunderle E., Gauguet G., Roy A., Sainte-Marthe L.,
RA   Verdier J., Verdier-Discala C., Hillier L.W., Fulton L., McPherson J.,
RA   Matsuda F., Wilson R., Scarpelli C., Gyapay G., Wincker P., Saurin W.,
RA   Quetier F., Waterston R., Hood L., Weissenbach J.;
RT   "The DNA sequence and analysis of human chromosome 14.";
RL   Nature 421:601-607(2003).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 3 AND 4), AND
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1-870 (ISOFORMS 1/2).
RC   TISSUE=Cerebellum, and Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   PROTEIN SEQUENCE OF 191-195; 395-405; 545-554; 747-761 AND 811-823.
RX   PubMed=11973345;
RA   Tran H., Pankov R., Tran S.D., Hampton B., Burgess W.H., Yamada K.M.;
RT   "Integrin clustering induces kinectin accumulation.";
RL   J. Cell Sci. 115:2031-2040(2002).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 538-1357.
RC   TISSUE=Embryonic rhabdomyosarcoma;
RA   Behrends U., Gotz C., Mautner J.;
RT   "SEREX-defined rhabdomyosarcoma antigens.";
RL   Submitted (JAN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [10]
RP   CHROMOSOMAL LOCATION.
RX   PubMed=8575822; DOI=10.1007/s002510050050;
RA   Print C.G., Morris C.M., Spurr N.K., Rooke L., Krissansen G.W.;
RT   "The CG-1 gene, a member of the kinectin and ES/130 family, maps to
RT   human chromosome band 14q22.";
RL   Immunogenetics 43:227-229(1996).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-153, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-75; THR-153 AND SER-156,
RP   AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-75 AND THR-153, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [15]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-75, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-75; SER-77; THR-153 AND
RP   SER-1313, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1084, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [19]
RP   PHOSPHORYLATION AT SER-75.
RX   PubMed=26091039; DOI=10.1016/j.cell.2015.05.028;
RA   Tagliabracci V.S., Wiley S.E., Guo X., Kinch L.N., Durrant E., Wen J.,
RA   Xiao J., Cui J., Nguyen K.B., Engel J.L., Coon J.J., Grishin N.,
RA   Pinna L.A., Pagliarini D.J., Dixon J.E.;
RT   "A single kinase generates the majority of the secreted
RT   phosphoproteome.";
RL   Cell 161:1619-1632(2015).
RN   [20]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [21]
RP   VARIANTS [LARGE SCALE ANALYSIS] ARG-226 AND PRO-1316.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S.,
RA   Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J.,
RA   Dawson D., Willson J.K.V., Gazdar A.F., Hartigan J., Wu L., Liu C.,
RA   Parmigiani G., Park B.H., Bachman K.E., Papadopoulos N.,
RA   Vogelstein B., Kinzler K.W., Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal
RT   cancers.";
RL   Science 314:268-274(2006).
RN   [22]
RP   VARIANT MET-1233.
RX   PubMed=27932480; DOI=10.1681/ASN.2016040387;
RG   NephroS;
RG   UK study of Nephrotic Syndrome;
RA   Bierzynska A., Soderquest K., Dean P., Colby E., Rollason R.,
RA   Jones C., Inward C.D., McCarthy H.J., Simpson M.A., Lord G.M.,
RA   Williams M., Welsh G.I., Koziell A.B., Saleem M.A.;
RT   "MAGI2 mutations cause congenital nephrotic syndrome.";
RL   J. Am. Soc. Nephrol. 28:1614-1621(2017).
CC   -!- FUNCTION: Receptor for kinesin thus involved in kinesin-driven
CC       vesicle motility. Accumulates in integrin-based adhesion complexes
CC       (IAC) upon integrin aggregation by fibronectin.
CC   -!- SUBUNIT: Parallel homodimers formed between the membrane-bound and
CC       the cytosolic form, and also between 2 cytosolic forms.
CC       {ECO:0000250}.
CC   -!- INTERACTION:
CC       Q12983:BNIP3; NbExp=3; IntAct=EBI-359761, EBI-749464;
CC       Q9BXN2:CLEC7A; NbExp=3; IntAct=EBI-359761, EBI-3939278;
CC       P50222:MEOX2; NbExp=3; IntAct=EBI-359761, EBI-748397;
CC       O43765:SGTA; NbExp=3; IntAct=EBI-359761, EBI-347996;
CC       Q8N205:SYNE4; NbExp=3; IntAct=EBI-359761, EBI-7131783;
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane; Single-pass
CC       type II membrane protein. Note=Vesicle membrane protein anchored
CC       to the endoplasmic reticulum.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC         Comment=Additional isoforms seem to exist.;
CC       Name=1;
CC         IsoId=Q86UP2-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q86UP2-2; Sequence=VSP_007981, VSP_007982;
CC       Name=3;
CC         IsoId=Q86UP2-3; Sequence=VSP_043207, VSP_007982;
CC       Name=4;
CC         IsoId=Q86UP2-4; Sequence=VSP_007982;
CC   -!- TISSUE SPECIFICITY: High levels in peripheral blood lymphocytes,
CC       testis and ovary, lower levels in spleen, thymus, prostate, small
CC       intestine and colon.
CC   -!- SIMILARITY: Belongs to the kinectin family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH50555.1; Type=Miscellaneous discrepancy; Note=Contaminating sequence. Potential poly-A sequence.; Evidence={ECO:0000305};
CC       Sequence=BAA02794.2; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; Z22551; CAA80271.1; -; mRNA.
DR   EMBL; L25616; AAB65853.1; -; mRNA.
DR   EMBL; AY264265; AAP20418.1; -; mRNA.
DR   EMBL; D13629; BAA02794.2; ALT_INIT; mRNA.
DR   EMBL; AK302797; BAG64000.1; -; mRNA.
DR   EMBL; AL138499; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL355773; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC050555; AAH50555.1; ALT_SEQ; mRNA.
DR   EMBL; BC112337; AAI12338.1; -; mRNA.
DR   EMBL; BC117132; AAI17133.1; -; mRNA.
DR   EMBL; BC143720; AAI43721.1; -; mRNA.
DR   EMBL; AY536375; AAT66048.1; -; mRNA.
DR   CCDS; CCDS41957.1; -. [Q86UP2-1]
DR   CCDS; CCDS41958.1; -. [Q86UP2-2]
DR   CCDS; CCDS41959.1; -. [Q86UP2-3]
DR   PIR; I53799; I53799.
DR   PIR; S32763; S32763.
DR   RefSeq; NP_001072989.1; NM_001079521.1. [Q86UP2-1]
DR   RefSeq; NP_001072990.1; NM_001079522.1. [Q86UP2-3]
DR   RefSeq; NP_001257943.1; NM_001271014.1. [Q86UP2-4]
DR   RefSeq; NP_004977.2; NM_004986.3. [Q86UP2-2]
DR   RefSeq; XP_006720201.1; XM_006720138.2. [Q86UP2-1]
DR   RefSeq; XP_006720202.1; XM_006720139.2. [Q86UP2-4]
DR   RefSeq; XP_011535053.1; XM_011536751.2. [Q86UP2-1]
DR   RefSeq; XP_011535055.1; XM_011536753.1. [Q86UP2-3]
DR   RefSeq; XP_016876767.1; XM_017021278.1. [Q86UP2-1]
DR   RefSeq; XP_016876771.1; XM_017021282.1. [Q86UP2-2]
DR   RefSeq; XP_016876772.1; XM_017021283.1. [Q86UP2-2]
DR   UniGene; Hs.509414; -.
DR   UniGene; Hs.687012; -.
DR   ProteinModelPortal; Q86UP2; -.
DR   SMR; Q86UP2; -.
DR   BioGrid; 110092; 62.
DR   CORUM; Q86UP2; -.
DR   DIP; DIP-27585N; -.
DR   IntAct; Q86UP2; 41.
DR   MINT; Q86UP2; -.
DR   STRING; 9606.ENSP00000378720; -.
DR   iPTMnet; Q86UP2; -.
DR   PhosphoSitePlus; Q86UP2; -.
DR   SwissPalm; Q86UP2; -.
DR   BioMuta; KTN1; -.
DR   DMDM; 34098465; -.
DR   EPD; Q86UP2; -.
DR   MaxQB; Q86UP2; -.
DR   PaxDb; Q86UP2; -.
DR   PeptideAtlas; Q86UP2; -.
DR   PRIDE; Q86UP2; -.
DR   DNASU; 3895; -.
DR   Ensembl; ENST00000395308; ENSP00000378719; ENSG00000126777. [Q86UP2-3]
DR   Ensembl; ENST00000395309; ENSP00000378720; ENSG00000126777. [Q86UP2-3]
DR   Ensembl; ENST00000395311; ENSP00000378722; ENSG00000126777. [Q86UP2-3]
DR   Ensembl; ENST00000395314; ENSP00000378725; ENSG00000126777. [Q86UP2-1]
DR   Ensembl; ENST00000413890; ENSP00000394992; ENSG00000126777. [Q86UP2-3]
DR   Ensembl; ENST00000438792; ENSP00000391964; ENSG00000126777. [Q86UP2-2]
DR   Ensembl; ENST00000459737; ENSP00000432149; ENSG00000126777. [Q86UP2-1]
DR   GeneID; 3895; -.
DR   KEGG; hsa:3895; -.
DR   UCSC; uc001xcb.4; human. [Q86UP2-1]
DR   CTD; 3895; -.
DR   DisGeNET; 3895; -.
DR   EuPathDB; HostDB:ENSG00000126777.17; -.
DR   GeneCards; KTN1; -.
DR   HGNC; HGNC:6467; KTN1.
DR   HPA; CAB015331; -.
DR   HPA; HPA003178; -.
DR   HPA; HPA017876; -.
DR   MIM; 600381; gene.
DR   neXtProt; NX_Q86UP2; -.
DR   OpenTargets; ENSG00000126777; -.
DR   PharmGKB; PA30256; -.
DR   eggNOG; ENOG410IIAW; Eukaryota.
DR   eggNOG; ENOG410YAE3; LUCA.
DR   GeneTree; ENSGT00530000063895; -.
DR   HOGENOM; HOG000113267; -.
DR   HOVERGEN; HBG007851; -.
DR   InParanoid; Q86UP2; -.
DR   KO; K17975; -.
DR   OMA; KEHNVFQ; -.
DR   OrthoDB; EOG091G12OH; -.
DR   PhylomeDB; Q86UP2; -.
DR   TreeFam; TF333579; -.
DR   Reactome; R-HSA-381426; Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs).
DR   Reactome; R-HSA-5625970; RHO GTPases activate KTN1.
DR   Reactome; R-HSA-8957275; Post-translational protein phosphorylation.
DR   SIGNOR; Q86UP2; -.
DR   ChiTaRS; KTN1; human.
DR   GeneWiki; KTN1; -.
DR   GenomeRNAi; 3895; -.
DR   PRO; PR:Q86UP2; -.
DR   Proteomes; UP000005640; Chromosome 14.
DR   Bgee; ENSG00000126777; -.
DR   CleanEx; HS_KTN1; -.
DR   ExpressionAtlas; Q86UP2; baseline and differential.
DR   Genevisible; Q86UP2; HS.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:HPA.
DR   GO; GO:0005788; C:endoplasmic reticulum lumen; TAS:Reactome.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0016021; C:integral component of membrane; TAS:ProtInc.
DR   GO; GO:0005887; C:integral component of plasma membrane; TAS:ProtInc.
DR   GO; GO:0016020; C:membrane; HDA:UniProtKB.
DR   GO; GO:0045296; F:cadherin binding; HDA:BHF-UCL.
DR   GO; GO:0019894; F:kinesin binding; IBA:GO_Central.
DR   GO; GO:0003723; F:RNA binding; HDA:UniProtKB.
DR   GO; GO:0044267; P:cellular protein metabolic process; TAS:Reactome.
DR   GO; GO:0007018; P:microtubule-based movement; NAS:ProtInc.
DR   GO; GO:0043687; P:post-translational protein modification; TAS:Reactome.
DR   InterPro; IPR024854; Kinectin.
DR   PANTHER; PTHR18864; PTHR18864; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Coiled coil; Complete proteome;
KW   Direct protein sequencing; Endoplasmic reticulum; Glycoprotein;
KW   Membrane; Phosphoprotein; Polymorphism; Reference proteome;
KW   Signal-anchor; Transmembrane; Transmembrane helix.
FT   CHAIN         1   1357       Kinectin.
FT                                /FTId=PRO_0000084337.
FT   TOPO_DOM      1      6       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM      7     29       Helical; Signal-anchor for type II
FT                                membrane protein. {ECO:0000255}.
FT   TOPO_DOM     30   1357       Lumenal. {ECO:0000255}.
FT   COILED      330   1356       {ECO:0000255}.
FT   MOD_RES      75     75       Phosphoserine; by FAM20C.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000269|PubMed:26091039}.
FT   MOD_RES      77     77       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     153    153       Phosphothreonine.
FT                                {ECO:0000244|PubMed:17081983,
FT                                ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     156    156       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   MOD_RES    1084   1084       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES    1313   1313       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   CARBOHYD    172    172       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    435    435       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    772    772       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    904    904       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1055   1055       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1088   1088       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1263   1263       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1329   1329       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   VAR_SEQ     832    854       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_043207.
FT   VAR_SEQ    1031   1059       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:7584026,
FT                                ECO:0000303|PubMed:8039706}.
FT                                /FTId=VSP_007981.
FT   VAR_SEQ    1232   1259       Missing (in isoform 2, isoform 3 and
FT                                isoform 4). {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:7584026,
FT                                ECO:0000303|PubMed:8039706}.
FT                                /FTId=VSP_007982.
FT   VARIANT     226    226       P -> R (in a breast cancer sample;
FT                                somatic mutation).
FT                                {ECO:0000269|PubMed:16959974}.
FT                                /FTId=VAR_035931.
FT   VARIANT     282    282       V -> M (in dbSNP:rs2274073).
FT                                /FTId=VAR_016206.
FT   VARIANT    1233   1233       L -> M (in dbSNP:rs372815686).
FT                                {ECO:0000269|PubMed:27932480}.
FT                                /FTId=VAR_079266.
FT   VARIANT    1316   1316       T -> P (in a breast cancer sample;
FT                                somatic mutation).
FT                                {ECO:0000269|PubMed:16959974}.
FT                                /FTId=VAR_035932.
FT   CONFLICT     15     15       S -> P (in Ref. 4; BAA02794).
FT                                {ECO:0000305}.
FT   CONFLICT    210    210       Missing (in Ref. 1; CAA80271).
FT                                {ECO:0000305}.
FT   CONFLICT    373    373       I -> M (in Ref. 1; CAA80271).
FT                                {ECO:0000305}.
FT   CONFLICT    939    939       E -> G (in Ref. 1; CAA80271).
FT                                {ECO:0000305}.
SQ   SEQUENCE   1357 AA;  156275 MW;  971FCDF8AA8FC88E CRC64;
     MEFYESAYFI VLIPSIVITV IFLFFWLFMK ETLYDEVLAK QKREQKLIPT KTDKKKAEKK
     KNKKKEIQNG NLHESDSESV PRDFKLSDAL AVEDDQVAPV PLNVVETSSS VRERKKKEKK
     QKPVLEEQVI KESDASKIPG KKVEPVPVTK QPTPPSEAAA SKKKPGQKKS KNGSDDQDKK
     VETLMVPSKR QEALPLHQET KQESGSGKKK ASSKKQKTEN VFVDEPLIHA TTYIPLMDNA
     DSSPVVDKRE VIDLLKPDQV EGIQKSGTKK LKTETDKENA EVKFKDFLLS LKTMMFSEDE
     ALCVVDLLKE KSGVIQDALK KSSKGELTTL IHQLQEKDKL LAAVKEDAAA TKDRCKQLTQ
     EMMTEKERSN VVITRMKDRI GTLEKEHNVF QNKIHVSYQE TQQMQMKFQQ VREQMEAEIA
     HLKQENGILR DAVSNTTNQL ESKQSAELNK LRQDYARLVN ELTEKTGKLQ QEEVQKKNAE
     QAATQLKVQL QEAERRWEEV QSYIRKRTAE HEAAQQDLQS KFVAKENEVQ SLHSKLTDTL
     VSKQQLEQRL MQLMESEQKR VNKEESLQMQ VQDILEQNEA LKAQIQQFHS QIAAQTSASV
     LAEELHKVIA EKDKQIKQTE DSLASERDRL TSKEEELKDI QNMNFLLKAE VQKLQALANE
     QAAAAHELEK MQQSVYVKDD KIRLLEEQLQ HEISNKMEEF KILNDQNKAL KSEVQKLQTL
     VSEQPNKDVV EQMEKCIQEK DEKLKTVEEL LETGLIQVAT KEEELNAIRT ENSSLTKEVQ
     DLKAKQNDQV SFASLVEELK KVIHEKDGKI KSVEELLEAE LLKVANKEKT VQDLKQEIKA
     LKEEIGNVQL EKAQQLSITS KVQELQNLLK GKEEQMNTMK AVLEEKEKDL ANTGKWLQDL
     QEENESLKAH VQEVAQHNLK EASSASQFEE LEIVLKEKEN ELKRLEAMLK ERESDLSSKT
     QLLQDVQDEN KLFKSQIEQL KQQNYQQASS FPPHEELLKV ISEREKEISG LWNELDSLKD
     AVEHQRKKNN DLREKNWEAM EALASTEKML QDKVNKTSKE RQQQVEAVEL EAKEVLKKLF
     PKVSVPSNLS YGEWLHGFEK KAKECMAGTS GSEEVKVLEH KLKEADEMHT LLQLECEKYK
     SVLAETEGIL QKLQRSVEQE ENKWKVKVDE SHKTIKQMQS SFTSSEQELE RLRSENKDIE
     NLRREREHLE MELEKAEMER STYVTEVREL KDLLTELQKK LDDSYSEAVR QNEELNLLKA
     QLNETLTKLR TEQNERQKVA GDLHKAQQSL ELIQSKIVKA AGDTTVIENS DVSPETESSE
     KETMSVSLNQ TVTQLQQLLQ AVNQQLTKEK EHYQVLE
//
ID   LAIR2_HUMAN             Reviewed;         152 AA.
AC   Q6ISS4; Q6PEZ4;
DT   03-OCT-2006, integrated into UniProtKB/Swiss-Prot.
DT   05-JUL-2004, sequence version 1.
DT   25-OCT-2017, entry version 112.
DE   RecName: Full=Leukocyte-associated immunoglobulin-like receptor 2;
DE            Short=LAIR-2;
DE   AltName: CD_antigen=CD306;
DE   Flags: Precursor;
GN   Name=LAIR2; Synonyms=CD306;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RX   PubMed=9285412; DOI=10.1016/S1074-7613(00)80530-0;
RA   Meyaard L., Adema G.J., Chang C., Woollatt E., Sutherland G.R.,
RA   Lanier L.L., Phillips J.H.;
RT   "LAIR-1, a novel inhibitory receptor expressed on human mononuclear
RT   leukocytes.";
RL   Immunity 7:283-290(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=10229813;
RA   Meyaard L., Hurenkamp J., Clevers H., Lanier L.L., Phillips J.H.;
RT   "Leukocyte-associated Ig-like receptor-1 functions as an inhibitory
RT   receptor on cytotoxic T cells.";
RL   J. Immunol. 162:5800-5804(1999).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -!- INTERACTION:
CC       Q9Y6C2:EMILIN1; NbExp=3; IntAct=EBI-10250491, EBI-744586;
CC       O43765:SGTA; NbExp=5; IntAct=EBI-10250491, EBI-347996;
CC       Q9UMX0:UBQLN1; NbExp=4; IntAct=EBI-10250491, EBI-741480;
CC   -!- SUBCELLULAR LOCATION: Secreted.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1; Synonyms=LAIR-2a;
CC         IsoId=Q6ISS4-1; Sequence=Displayed;
CC       Name=2; Synonyms=LAIR-2b;
CC         IsoId=Q6ISS4-2; Sequence=VSP_020720;
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF013250; AAB69325.1; -; mRNA.
DR   EMBL; AA133246; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; BC069366; AAH69366.1; -; mRNA.
DR   CCDS; CCDS12897.1; -. [Q6ISS4-1]
DR   CCDS; CCDS12898.1; -. [Q6ISS4-2]
DR   RefSeq; NP_002279.2; NM_002288.5. [Q6ISS4-1]
DR   RefSeq; NP_067154.1; NM_021270.4. [Q6ISS4-2]
DR   UniGene; Hs.43803; -.
DR   ProteinModelPortal; Q6ISS4; -.
DR   SMR; Q6ISS4; -.
DR   BioGrid; 110099; 34.
DR   IntAct; Q6ISS4; 5.
DR   STRING; 9606.ENSP00000301202; -.
DR   iPTMnet; Q6ISS4; -.
DR   PhosphoSitePlus; Q6ISS4; -.
DR   BioMuta; LAIR2; -.
DR   DMDM; 74736630; -.
DR   MaxQB; Q6ISS4; -.
DR   PaxDb; Q6ISS4; -.
DR   PeptideAtlas; Q6ISS4; -.
DR   PRIDE; Q6ISS4; -.
DR   DNASU; 3904; -.
DR   Ensembl; ENST00000301202; ENSP00000301202; ENSG00000167618. [Q6ISS4-1]
DR   Ensembl; ENST00000351841; ENSP00000301203; ENSG00000167618. [Q6ISS4-2]
DR   Ensembl; ENST00000612901; ENSP00000478193; ENSG00000274084. [Q6ISS4-1]
DR   Ensembl; ENST00000620256; ENSP00000477747; ENSG00000274084. [Q6ISS4-2]
DR   Ensembl; ENST00000621280; ENSP00000480904; ENSG00000277335. [Q6ISS4-2]
DR   Ensembl; ENST00000622556; ENSP00000477535; ENSG00000277335. [Q6ISS4-1]
DR   GeneID; 3904; -.
DR   KEGG; hsa:3904; -.
DR   UCSC; uc002qgc.4; human. [Q6ISS4-1]
DR   CTD; 3904; -.
DR   DisGeNET; 3904; -.
DR   EuPathDB; HostDB:ENSG00000167618.9; -.
DR   GeneCards; LAIR2; -.
DR   HGNC; HGNC:6478; LAIR2.
DR   MIM; 602993; gene.
DR   neXtProt; NX_Q6ISS4; -.
DR   OpenTargets; ENSG00000167618; -.
DR   PharmGKB; PA30267; -.
DR   eggNOG; ENOG410J37Q; Eukaryota.
DR   eggNOG; ENOG41119RI; LUCA.
DR   GeneTree; ENSGT00720000108843; -.
DR   HOGENOM; HOG000234395; -.
DR   InParanoid; Q6ISS4; -.
DR   KO; K06725; -.
DR   OMA; FRLGPSE; -.
DR   OrthoDB; EOG091G0RAQ; -.
DR   PhylomeDB; Q6ISS4; -.
DR   TreeFam; TF336644; -.
DR   Reactome; R-HSA-198933; Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell.
DR   GeneWiki; LAIR2; -.
DR   GenomeRNAi; 3904; -.
DR   PRO; PR:Q6ISS4; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   Bgee; ENSG00000167618; -.
DR   CleanEx; HS_LAIR2; -.
DR   ExpressionAtlas; Q6ISS4; baseline and differential.
DR   Genevisible; Q6ISS4; HS.
DR   GO; GO:0005576; C:extracellular region; TAS:Reactome.
DR   GO; GO:0050776; P:regulation of immune response; TAS:Reactome.
DR   Gene3D; 2.60.40.10; -; 1.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR036179; Ig-like_dom_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR003599; Ig_sub.
DR   Pfam; PF13895; Ig_2; 1.
DR   SMART; SM00409; IG; 1.
DR   SUPFAM; SSF48726; SSF48726; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Complete proteome; Disulfide bond;
KW   Immunoglobulin domain; Polymorphism; Receptor; Reference proteome;
KW   Secreted; Signal.
FT   SIGNAL        1     21       {ECO:0000255}.
FT   CHAIN        22    152       Leukocyte-associated immunoglobulin-like
FT                                receptor 2.
FT                                /FTId=PRO_0000250685.
FT   DOMAIN       29    117       Ig-like C2-type.
FT   DISULFID     49    101       {ECO:0000250}.
FT   VAR_SEQ     122    138       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:9285412}.
FT                                /FTId=VSP_020720.
FT   VARIANT      78     78       G -> S (in dbSNP:rs36121405).
FT                                /FTId=VAR_049882.
FT   VARIANT      87     87       H -> R (in dbSNP:rs34423078).
FT                                /FTId=VAR_049883.
FT   VARIANT     115    115       F -> Y (in dbSNP:rs34429135).
FT                                /FTId=VAR_049884.
SQ   SEQUENCE   152 AA;  16280 MW;  8097688A9DB42EC8 CRC64;
     MSPHLTALLG LVLCLAQTIH TQEGALPRPS ISAEPGTVIS PGSHVTFMCR GPVGVQTFRL
     EREDRAKYKD SYNVFRLGPS ESEARFHIDS VSEGNAGLYR CLYYKPPGWS EHSDFLELLV
     KESSGGPDSP DTEPGSSAGT VPGTEASGFD AP
//
ID   MSMB_HUMAN              Reviewed;         114 AA.
AC   P08118; B1API6; P11999; Q13125; Q6IAY9; Q9UC59;
DT   01-AUG-1988, integrated into UniProtKB/Swiss-Prot.
DT   01-AUG-1988, sequence version 1.
DT   22-NOV-2017, entry version 166.
DE   RecName: Full=Beta-microseminoprotein;
DE   AltName: Full=Immunoglobulin-binding factor;
DE            Short=IGBF;
DE   AltName: Full=PN44;
DE   AltName: Full=Prostate secreted seminal plasma protein;
DE   AltName: Full=Prostate secretory protein of 94 amino acids;
DE            Short=PSP-94;
DE            Short=PSP94;
DE   AltName: Full=Seminal plasma beta-inhibin;
DE   Flags: Precursor;
GN   Name=MSMB; Synonyms=PRSP;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM PSP94).
RX   PubMed=3829888; DOI=10.1089/dna.1987.6.23;
RA   Mbikay M., Nolet S., Fournier S., Benjannet S., Chapdelaine P.,
RA   Paradis G., Dube J.Y., Tremblay R., Lazure C., Seidah N.G.,
RA   Chretien M.;
RT   "Molecular cloning and sequence of the cDNA for a 94-amino-acid
RT   seminal plasma protein secreted by the human prostate.";
RL   DNA 6:23-29(1987).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM PSP94).
RX   PubMed=2590204; DOI=10.1016/0006-291X(89)91812-3;
RA   Ulvsbaeck M., Lindstroem C., Weiber H., Abrahamsson P.-A., Lilja H.,
RA   Lundwall A.;
RT   "Molecular cloning of a small prostate protein, known as beta-
RT   microseminoprotein, PSP94 or beta-inhibin, and demonstration of
RT   transcripts in non-genital tissues.";
RL   Biochem. Biophys. Res. Commun. 164:1310-1315(1989).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=2322265; DOI=10.1016/0006-291X(90)90648-7;
RA   Green C.B., Liu W.Y., Kwok S.C.M.;
RT   "Cloning and nucleotide sequence analysis of the human beta-
RT   microseminoprotein gene.";
RL   Biochem. Biophys. Res. Commun. 167:1184-1190(1990).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=2054385; DOI=10.1016/0167-4781(91)90016-F;
RA   Nolet S., Mbikay M., Chretien M.;
RT   "Prostatic secretory protein PSP94: gene organization and promoter
RT   sequence in rhesus monkey and human.";
RL   Biochim. Biophys. Acta 1089:247-249(1991).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM PSP94).
RC   TISSUE=Prostate;
RX   PubMed=7506990; DOI=10.1016/0304-3835(93)90049-F;
RA   Liu A.Y., Bradner R.C., Vessella R.L.;
RT   "Decreased expression of prostatic secretory protein PSP94 in prostate
RT   cancer.";
RL   Cancer Lett. 74:91-99(1993).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM PSP57), AND TISSUE SPECIFICITY.
RC   TISSUE=Prostate;
RX   PubMed=7566962;
RA   Xuan J.W., Chin J.L., Guo Y., Chambers A.F., Finkelman M.A.,
RA   Clarke M.W.;
RT   "Alternative splicing of PSP94 (prostatic secretory protein of 94
RT   amino acids) mRNA in prostate tissue.";
RL   Oncogene 11:1041-1047(1995).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM PSP94).
RA   Baijal-Gupta M., Clarke M.W.;
RT   "Prostate specific protein (PSP94) expression in a human endometrial
RT   cell line (KLE).";
RL   Submitted (DEC-1996) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM PSP94).
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM PSP94).
RA   Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164054; DOI=10.1038/nature02462;
RA   Deloukas P., Earthrowl M.E., Grafham D.V., Rubenfield M., French L.,
RA   Steward C.A., Sims S.K., Jones M.C., Searle S., Scott C., Howe K.,
RA   Hunt S.E., Andrews T.D., Gilbert J.G.R., Swarbreck D., Ashurst J.L.,
RA   Taylor A., Battles J., Bird C.P., Ainscough R., Almeida J.P.,
RA   Ashwell R.I.S., Ambrose K.D., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Bates K., Beasley H., Bray-Allen S., Brown A.J.,
RA   Brown J.Y., Burford D.C., Burrill W., Burton J., Cahill P., Camire D.,
RA   Carter N.P., Chapman J.C., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Corby N., Coulson A., Dhami P., Dutta I., Dunn M., Faulkner L.,
RA   Frankish A., Frankland J.A., Garner P., Garnett J., Gribble S.,
RA   Griffiths C., Grocock R., Gustafson E., Hammond S., Harley J.L.,
RA   Hart E., Heath P.D., Ho T.P., Hopkins B., Horne J., Howden P.J.,
RA   Huckle E., Hynds C., Johnson C., Johnson D., Kana A., Kay M.,
RA   Kimberley A.M., Kershaw J.K., Kokkinaki M., Laird G.K., Lawlor S.,
RA   Lee H.M., Leongamornlert D.A., Laird G., Lloyd C., Lloyd D.M.,
RA   Loveland J., Lovell J., McLaren S., McLay K.E., McMurray A.,
RA   Mashreghi-Mohammadi M., Matthews L., Milne S., Nickerson T.,
RA   Nguyen M., Overton-Larty E., Palmer S.A., Pearce A.V., Peck A.I.,
RA   Pelan S., Phillimore B., Porter K., Rice C.M., Rogosin A., Ross M.T.,
RA   Sarafidou T., Sehra H.K., Shownkeen R., Skuce C.D., Smith M.,
RA   Standring L., Sycamore N., Tester J., Thorpe A., Torcasso W.,
RA   Tracey A., Tromans A., Tsolas J., Wall M., Walsh J., Wang H.,
RA   Weinstock K., West A.P., Willey D.L., Whitehead S.L., Wilming L.,
RA   Wray P.W., Young L., Chen Y., Lovering R.C., Moschonas N.K.,
RA   Siebert R., Fechtel K., Bentley D., Durbin R.M., Hubbard T.,
RA   Doucette-Stamm L., Beck S., Smith D.R., Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 10.";
RL   Nature 429:375-381(2004).
RN   [11]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM PSP94).
RC   TISSUE=Prostate;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [12]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 2-72.
RX   PubMed=10491085; DOI=10.1046/j.1432-1327.1999.00614.x;
RA   Maekinen M., Valtonen-Andre C., Lundwall A.;
RT   "New world, but not old world, monkeys carry several genes encoding
RT   beta-microseminoprotein.";
RL   Eur. J. Biochem. 264:407-414(1999).
RN   [13]
RP   PROTEIN SEQUENCE OF 21-113.
RX   PubMed=3995056; DOI=10.1016/0167-4838(85)90200-6;
RA   Akiyama K., Yoshioka Y., Schmid K., Offner G.D., Troxler R.F.,
RA   Tsuda R., Hara M.;
RT   "The amino acid sequence of human beta-microseminoprotein.";
RL   Biochim. Biophys. Acta 829:288-294(1985).
RN   [14]
RP   PROTEIN SEQUENCE OF 21-114.
RX   PubMed=6434350; DOI=10.1016/0014-5793(84)80766-8;
RA   Seidah N.G., Arbatti N.J., Rochemont J., Sheth A.R., Chretien M.;
RT   "Complete amino acid sequence of human seminal plasma beta-inhibin.
RT   Prediction of post Gln-Arg cleavage as a maturation site.";
RL   FEBS Lett. 175:349-355(1984).
RN   [15]
RP   PROTEIN SEQUENCE OF 21-50 AND 113-114.
RX   PubMed=1930232; DOI=10.1016/S0006-291X(05)81300-2;
RA   Liang Z.G., Kamada M., Koide S.S.;
RT   "Structural identity of immunoglobulin binding factor and prostatic
RT   secretory protein of human seminal plasma.";
RL   Biochem. Biophys. Res. Commun. 180:356-359(1991).
RN   [16]
RP   PROTEIN SEQUENCE OF 21-41, AND TISSUE SPECIFICITY.
RC   TISSUE=Semen;
RX   PubMed=7671139; DOI=10.1016/1357-2725(95)00021-G;
RA   Ohkubo I., Tada T., Ochiai Y., Ueyama H., Eimoto T., Sasaki M.;
RT   "Human seminal plasma beta-microseminoprotein: its purification,
RT   characterization, and immunohistochemical localization.";
RL   Int. J. Biochem. Cell Biol. 27:603-611(1995).
RN   [17]
RP   PROTEIN SEQUENCE OF 21-32.
RX   PubMed=11788998;
RX   DOI=10.1002/1615-9861(200201)2:1<112::AID-PROT112>3.0.CO;2-N;
RA   Ghafouri B., Stahlbom B., Tagesson C., Lindahl M.;
RT   "Newly identified proteins in human nasal lavage fluid from non-
RT   smokers and smokers using two-dimensional gel electrophoresis and
RT   peptide mass fingerprinting.";
RL   Proteomics 2:112-120(2002).
RN   [18]
RP   INTERACTION WITH PI16.
RX   PubMed=15344909; DOI=10.1042/BJ20040290;
RA   Reeves J.R., Xuan J.W., Arfanis K., Morin C., Garde S.V., Ruiz M.T.,
RA   Wisniewski J., Panchal C., Tanner J.E.;
RT   "Identification, purification and characterization of a novel human
RT   blood protein with binding affinity for prostate secretory protein of
RT   94 amino acids.";
RL   Biochem. J. 385:105-114(2005).
RN   [19]
RP   INVOLVEMENT IN SUSCEPTIBILITY TO HEREDITARY PROSTATE CANCER.
RX   PubMed=18264096; DOI=10.1038/ng.91;
RA   Thomas G., Jacobs K.B., Yeager M., Kraft P., Wacholder S., Orr N.,
RA   Yu K., Chatterjee N., Welch R., Hutchinson A., Crenshaw A.,
RA   Cancel-Tassin G., Staats B.J., Wang Z., Gonzalez-Bosquet J., Fang J.,
RA   Deng X., Berndt S.I., Calle E.E., Feigelson H.S., Thun M.J.,
RA   Rodriguez C., Albanes D., Virtamo J., Weinstein S., Schumacher F.R.,
RA   Giovannucci E., Willett W.C., Cussenot O., Valeri A., Andriole G.L.,
RA   Crawford E.D., Tucker M., Gerhard D.S., Fraumeni J.F. Jr., Hoover R.,
RA   Hayes R.B., Hunter D.J., Chanock S.J.;
RT   "Multiple loci identified in a genome-wide association study of
RT   prostate cancer.";
RL   Nat. Genet. 40:310-315(2008).
RN   [20]
RP   INVOLVEMENT IN SUSCEPTIBILITY TO HEREDITARY PROSTATE CANCER.
RX   PubMed=22887727; DOI=10.1002/humu.22176;
RA   Fitzgerald L.M., Zhang X., Kolb S., Kwon E.M., Liew Y.C.,
RA   Hurtado-Coll A., Knudsen B.S., Ostrander E.A., Stanford J.L.;
RT   "Investigation of the relationship between prostate cancer and MSMB
RT   and NCOA4 genetic variants and protein expression.";
RL   Hum. Mutat. 34:149-156(2013).
RN   [21]
RP   STRUCTURE BY NMR OF 21-114, AND DISULFIDE BONDS.
RX   PubMed=16930619; DOI=10.1016/j.jmb.2006.07.029;
RA   Ghasriani H., Teilum K., Johnsson Y., Fernlund P., Drakenberg T.;
RT   "Solution structures of human and porcine beta-microseminoprotein.";
RL   J. Mol. Biol. 362:502-515(2006).
RN   [22]
RP   X-RAY CRYSTALLOGRAPHY (2.3 ANGSTROMS) OF 21-114, SUBUNIT, AND
RP   DISULFIDE BONDS.
RX   PubMed=20184897; DOI=10.1016/j.jmb.2010.02.035;
RA   Kumar A., Jagtap D.D., Mahale S.D., Kumar M.;
RT   "Crystal structure of prostate secretory protein PSP94 shows an edge-
RT   to-edge association of two monomers to form a homodimer.";
RL   J. Mol. Biol. 397:947-956(2010).
CC   -!- SUBUNIT: Homodimer; Interacts with PI16.
CC       {ECO:0000269|PubMed:15344909, ECO:0000269|PubMed:20184897}.
CC   -!- INTERACTION:
CC       O43765:SGTA; NbExp=3; IntAct=EBI-10195681, EBI-347996;
CC   -!- SUBCELLULAR LOCATION: Secreted. Note=Sperm surface.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=PSP94;
CC         IsoId=P08118-1; Sequence=Displayed;
CC       Name=PSP57;
CC         IsoId=P08118-2; Sequence=VSP_003275, VSP_003276;
CC   -!- TISSUE SPECIFICITY: Strongly expressed in prostate, liver, kidney,
CC       breast and penis. Also expressed in pancreas, esophagus, stomach,
CC       deodenum, colon, trachea, lung, salivary glands and fallopian
CC       tube. PSP94 is expressed in lung and breast, whereas PSP57 is
CC       found in kidney and bladder. {ECO:0000269|PubMed:7566962,
CC       ECO:0000269|PubMed:7671139}.
CC   -!- DISEASE: Prostate cancer, hereditary, 13 (HPC13) [MIM:611928]: A
CC       condition associated with familial predisposition to cancer of the
CC       prostate. Most prostate cancers are adenocarcinomas that develop
CC       in the acini of the prostatic ducts. Other rare histopathologic
CC       types of prostate cancer that occur in approximately 5% of
CC       patients include small cell carcinoma, mucinous carcinoma,
CC       prostatic ductal carcinoma, transitional cell carcinoma, squamous
CC       cell carcinoma, basal cell carcinoma, adenoid cystic carcinoma
CC       (basaloid), signet-ring cell carcinoma and neuroendocrine
CC       carcinoma. Note=Disease susceptibility is associated with
CC       variations affecting the gene represented in this entry.
CC   -!- MISCELLANEOUS: Specific receptors for this protein are found on
CC       spermatozoa and in the prostate.
CC   -!- SIMILARITY: Belongs to the beta-microseminoprotein family.
CC       {ECO:0000305}.
CC   -!- CAUTION: Was originally thought to inhibit the secretion of FSH by
CC       pituitary cells. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M15885; AAA36635.1; -; mRNA.
DR   EMBL; M34376; AAA59871.1; -; Genomic_DNA.
DR   EMBL; M34373; AAA59871.1; JOINED; Genomic_DNA.
DR   EMBL; M34374; AAA59871.1; JOINED; Genomic_DNA.
DR   EMBL; M34375; AAA59871.1; JOINED; Genomic_DNA.
DR   EMBL; X57928; CAA41002.1; -; Genomic_DNA.
DR   EMBL; X57929; CAA41002.1; JOINED; Genomic_DNA.
DR   EMBL; X57930; CAA41002.1; JOINED; Genomic_DNA.
DR   EMBL; X57931; CAA41002.1; JOINED; Genomic_DNA.
DR   EMBL; S67815; AAB29732.1; -; mRNA.
DR   EMBL; U22178; AAA83556.1; -; mRNA.
DR   EMBL; U78976; AAB37355.1; -; mRNA.
DR   EMBL; BT006816; AAP35462.1; -; mRNA.
DR   EMBL; CR457015; CAG33296.1; -; mRNA.
DR   EMBL; AL450342; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC005257; AAH05257.1; -; mRNA.
DR   EMBL; AJ133356; CAB39325.1; -; Genomic_DNA.
DR   CCDS; CCDS73095.1; -. [P08118-2]
DR   CCDS; CCDS73096.1; -. [P08118-1]
DR   PIR; A34567; A34567.
DR   PIR; G01730; G01730.
DR   RefSeq; NP_002434.1; NM_002443.3. [P08118-1]
DR   RefSeq; NP_619540.1; NM_138634.2. [P08118-2]
DR   UniGene; Hs.255462; -.
DR   PDB; 2IZ3; NMR; -; A=21-114.
DR   PDB; 3IX0; X-ray; 2.30 A; A/B/C/D=21-114.
DR   PDBsum; 2IZ3; -.
DR   PDBsum; 3IX0; -.
DR   ProteinModelPortal; P08118; -.
DR   SMR; P08118; -.
DR   BioGrid; 110583; 2.
DR   IntAct; P08118; 1.
DR   STRING; 9606.ENSP00000351363; -.
DR   iPTMnet; P08118; -.
DR   PhosphoSitePlus; P08118; -.
DR   BioMuta; MSMB; -.
DR   DMDM; 131436; -.
DR   PaxDb; P08118; -.
DR   PeptideAtlas; P08118; -.
DR   PRIDE; P08118; -.
DR   DNASU; 4477; -.
DR   Ensembl; ENST00000581478; ENSP00000462641; ENSG00000263639. [P08118-2]
DR   Ensembl; ENST00000582163; ENSP00000463092; ENSG00000263639. [P08118-1]
DR   GeneID; 4477; -.
DR   KEGG; hsa:4477; -.
DR   UCSC; uc001jiq.5; human. [P08118-1]
DR   CTD; 4477; -.
DR   DisGeNET; 4477; -.
DR   EuPathDB; HostDB:ENSG00000263639.5; -.
DR   GeneCards; MSMB; -.
DR   HGNC; HGNC:7372; MSMB.
DR   HPA; CAB026357; -.
DR   HPA; HPA051257; -.
DR   MalaCards; MSMB; -.
DR   MIM; 157145; gene.
DR   MIM; 611928; phenotype.
DR   neXtProt; NX_P08118; -.
DR   OpenTargets; ENSG00000263639; -.
DR   Orphanet; 1331; Familial prostate cancer.
DR   PharmGKB; PA31177; -.
DR   eggNOG; ENOG410J3M2; Eukaryota.
DR   eggNOG; ENOG410Y4MW; LUCA.
DR   GeneTree; ENSGT00390000010587; -.
DR   HOGENOM; HOG000113668; -.
DR   HOVERGEN; HBG031716; -.
DR   InParanoid; P08118; -.
DR   OMA; CKYIVVE; -.
DR   OrthoDB; EOG091G0YU5; -.
DR   PhylomeDB; P08118; -.
DR   TreeFam; TF338336; -.
DR   EvolutionaryTrace; P08118; -.
DR   GeneWiki; MSMB; -.
DR   GenomeRNAi; 4477; -.
DR   PRO; PR:P08118; -.
DR   Proteomes; UP000005640; Chromosome 10.
DR   Bgee; ENSG00000263639; -.
DR   CleanEx; HS_MSMB; -.
DR   Genevisible; P08118; HS.
DR   GO; GO:0005615; C:extracellular space; TAS:ProtInc.
DR   GO; GO:0005634; C:nucleus; TAS:ProtInc.
DR   InterPro; IPR008735; PSP94.
DR   PANTHER; PTHR10500; PTHR10500; 1.
DR   Pfam; PF05825; PSP94; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Complete proteome;
KW   Direct protein sequencing; Disulfide bond; Polymorphism;
KW   Reference proteome; Secreted; Signal.
FT   SIGNAL        1     20       {ECO:0000269|PubMed:11788998,
FT                                ECO:0000269|PubMed:1930232,
FT                                ECO:0000269|PubMed:3995056,
FT                                ECO:0000269|PubMed:6434350,
FT                                ECO:0000269|PubMed:7671139}.
FT   CHAIN        21    114       Beta-microseminoprotein.
FT                                /FTId=PRO_0000019268.
FT   DISULFID     22     70
FT   DISULFID     38     62
FT   DISULFID     57     93
FT   DISULFID     60     69
FT   DISULFID     84    107
FT   VAR_SEQ      37     77       KCMDLKGNKHPINSEWQTDNCETCTCYETEISCCTLVSTPV
FT                                -> MFLHLWVMTKTTAKESSRRRTASISWWRRRTQKRPVLS
FT                                VNG (in isoform PSP57).
FT                                {ECO:0000303|PubMed:7566962}.
FT                                /FTId=VSP_003275.
FT   VAR_SEQ      78    114       Missing (in isoform PSP57).
FT                                {ECO:0000303|PubMed:7566962}.
FT                                /FTId=VSP_003276.
FT   VARIANT      17     17       L -> S (in dbSNP:rs1804776).
FT                                /FTId=VAR_011935.
FT   VARIANT      25     25       I -> M (in dbSNP:rs1804778).
FT                                /FTId=VAR_011936.
FT   VARIANT      52     52       W -> R (in dbSNP:rs1804780).
FT                                /FTId=VAR_011937.
FT   VARIANT      53     53       Q -> R (in dbSNP:rs1804468).
FT                                /FTId=VAR_011938.
FT   VARIANT      80     80       D -> A (in dbSNP:rs1802774).
FT                                /FTId=VAR_011939.
FT   VARIANT      87     87       I -> T (in dbSNP:rs1802771).
FT                                /FTId=VAR_011940.
FT   VARIANT      91     91       E -> G (in dbSNP:rs1804469).
FT                                /FTId=VAR_011941.
FT   VARIANT      92     92       D -> G (in dbSNP:rs1804461).
FT                                /FTId=VAR_011942.
FT   VARIANT      98     98       V -> L (in dbSNP:rs1804464).
FT                                /FTId=VAR_011943.
FT   CONFLICT    113    113       I -> G (in Ref. 14; AA sequence).
FT                                {ECO:0000305}.
FT   STRAND       22     26       {ECO:0000244|PDB:3IX0}.
FT   STRAND       33     35       {ECO:0000244|PDB:3IX0}.
FT   STRAND       51     53       {ECO:0000244|PDB:3IX0}.
FT   STRAND       57     62       {ECO:0000244|PDB:3IX0}.
FT   STRAND       64     71       {ECO:0000244|PDB:3IX0}.
FT   STRAND       75     79       {ECO:0000244|PDB:3IX0}.
FT   TURN         81     83       {ECO:0000244|PDB:3IX0}.
FT   STRAND       84     89       {ECO:0000244|PDB:3IX0}.
FT   HELIX        90     92       {ECO:0000244|PDB:3IX0}.
FT   STRAND       94    101       {ECO:0000244|PDB:3IX0}.
FT   STRAND      110    113       {ECO:0000244|PDB:3IX0}.
SQ   SEQUENCE   114 AA;  12865 MW;  D0B13E436D70BB1D CRC64;
     MNVLLGSVVI FATFVTLCNA SCYFIPNEGV PGDSTRKCMD LKGNKHPINS EWQTDNCETC
     TCYETEISCC TLVSTPVGYD KDNCQRIFKK EDCKYIVVEK KDPKKTCSVS EWII
//
ID   A0A024QYT5_HUMAN        Unreviewed;       402 AA.
AC   A0A024QYT5;
DT   09-JUL-2014, integrated into UniProtKB/TrEMBL.
DT   09-JUL-2014, sequence version 1.
DT   23-MAY-2018, entry version 39.
DE   SubName: Full=Serpin peptidase inhibitor, clade E (Nexin, plasminogen activator inhibitor type 1), member 1, isoform CRA_b {ECO:0000313|EMBL:EAW50197.1};
GN   Name=SERPINE1 {ECO:0000313|EMBL:EAW50197.1};
GN   ORFNames=hCG_17353 {ECO:0000313|EMBL:EAW50197.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:EAW50197.1};
RN   [1] {ECO:0000313|EMBL:EAW50197.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAW50197.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
CC   -!- SIMILARITY: Belongs to the serpin family.
CC       {ECO:0000256|RuleBase:RU000411, ECO:0000256|SAAS:SAAS00596534}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; CH471197; EAW50196.1; -; Genomic_DNA.
DR   EMBL; CH471197; EAW50197.1; -; Genomic_DNA.
DR   RefSeq; NP_000593.1; NM_000602.4.
DR   UniGene; Hs.414795; -.
DR   UniGene; Hs.713079; -.
DR   UniGene; Hs.741440; -.
DR   SMR; A0A024QYT5; -.
DR   PRIDE; A0A024QYT5; -.
DR   GeneID; 5054; -.
DR   KEGG; hsa:5054; -.
DR   CTD; 5054; -.
DR   EuPathDB; HostDB:ENSG00000106366.8; -.
DR   eggNOG; KOG2392; Eukaryota.
DR   eggNOG; COG4826; LUCA.
DR   KO; K03982; -.
DR   OMA; PYEKEVP; -.
DR   OrthoDB; EOG091G0ION; -.
DR   ChiTaRS; SERPINE1; human.
DR   GenomeRNAi; 5054; -.
DR   Bgee; ENSG00000106366; -.
DR   ExpressionAtlas; A0A024QYT5; baseline and differential.
DR   GO; GO:0005615; C:extracellular space; IEA:InterPro.
DR   InterPro; IPR023795; Serpin_CS.
DR   InterPro; IPR023796; Serpin_dom.
DR   InterPro; IPR000215; Serpin_fam.
DR   InterPro; IPR036186; Serpin_sf.
DR   PANTHER; PTHR11461; PTHR11461; 1.
DR   Pfam; PF00079; Serpin; 1.
DR   SMART; SM00093; SERPIN; 1.
DR   SUPFAM; SSF56574; SSF56574; 1.
DR   PROSITE; PS00284; SERPIN; 1.
PE   3: Inferred from homology;
KW   Signal {ECO:0000256|SAM:SignalP}.
FT   SIGNAL        1     23       {ECO:0000256|SAM:SignalP}.
FT   CHAIN        24    402       {ECO:0000256|SAM:SignalP}.
FT                                /FTId=PRO_5014214164.
FT   DOMAIN       40    402       SERPIN. {ECO:0000259|SMART:SM00093}.
SQ   SEQUENCE   402 AA;  45060 MW;  A2E181ED28DD6082 CRC64;
     MQMSPALTCL VLGLALVFGE GSAVHHPPSY VAHLASDFGV RVFQQVAQAS KDRNVVFSPY
     GVASVLAMLQ LTTGGETQQQ IQAAMGFKID DKGMAPALRH LYKELMGPWN KDEISTTDAI
     FVQRDLKLVQ GFMPHFFRLF RSTVKQVDFS EVERARFIIN DWVKTHTKGM ISNLLGKGAV
     DQLTRLVLVN ALYFNGQWKT PFPDSSTHRR LFHKSDGSTV SVPMMAQTNK FNYTEFTTPD
     GHYYDILELP YHGDTLSMFI AAPYEKEVPL SALTNILSAQ LISHWKGNMT RLPRLLVLPK
     FSLETEVDLR KPLENLGMTD MFRQFQADFT SLSDQEPLHV AQALQKVKIE VNESGTVASS
     STAVIVSARM APEEIIMDRP FLFVVRHNPT GTVLFMGQVM EP
//
ID   PAI1_HUMAN              Reviewed;         402 AA.
AC   P05121; B7Z4S0; F8WD53;
DT   13-AUG-1987, integrated into UniProtKB/Swiss-Prot.
DT   13-AUG-1987, sequence version 1.
DT   23-MAY-2018, entry version 216.
DE   RecName: Full=Plasminogen activator inhibitor 1;
DE            Short=PAI;
DE            Short=PAI-1;
DE   AltName: Full=Endothelial plasminogen activator inhibitor;
DE   AltName: Full=Serpin E1;
DE   Flags: Precursor;
GN   Name=SERPINE1; Synonyms=PAI1, PLANH1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), TISSUE SPECIFICITY, AND
RP   SUBCELLULAR LOCATION.
RX   PubMed=2430793;
RA   Pannekoek H., Veerman H., Lambers H., Diergaarde P., Verweij C.L.,
RA   van Zonneveld A.-J., van Mourik J.A.;
RT   "Endothelial plasminogen activator inhibitor (PAI): a new member of
RT   the Serpin gene family.";
RL   EMBO J. 5:2539-2544(1986).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=2820474; DOI=10.1021/bi00387a004;
RA   Loskutoff D.J., Linders M., Keijer J., Veerman H.,
RA   van Heerikhuizen H., Pannekoek H.;
RT   "Structure of the human plasminogen activator inhibitor 1 gene:
RT   nonrandom distribution of introns.";
RL   Biochemistry 26:3763-3768(1987).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND TISSUE SPECIFICITY.
RX   PubMed=3097076; DOI=10.1172/JCI112761;
RA   Ginsburg D., Zeheb R., Yang A.Y., Rafferty U.M., Andreasen P.A.,
RA   Nielsen L., Dano K., Lebo R.V., Gelehrter T.D.;
RT   "cDNA cloning of human plasminogen activator-inhibitor from
RT   endothelial cells.";
RL   J. Clin. Invest. 78:1673-1680(1986).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=2612914; DOI=10.1016/0378-1119(89)90519-2;
RA   Follo M., Ginsburg D.;
RT   "Structure and expression of the human gene encoding plasminogen
RT   activator inhibitor, PAI-1.";
RL   Gene 84:447-453(1989).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=3262512; DOI=10.1111/j.1432-1033.1988.tb14320.x;
RA   Strandberg L., Lawrence D., Ny T.;
RT   "The organization of the human-plasminogen-activator-inhibitor-1 gene.
RT   Implications on the evolution of the serine-protease inhibitor
RT   family.";
RL   Eur. J. Biochem. 176:609-616(1988).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=3132455;
RA   Bosma P.J., van den Berg E.A., Kooistra T., Siemieniak D.R.,
RA   Slightom J.L.;
RT   "Human plasminogen activator inhibitor-1 gene. Promoter and structural
RT   gene nucleotide sequences.";
RL   J. Biol. Chem. 263:9129-9141(1988).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RA   Pannekoek H.;
RL   Submitted (FEB-1992) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS THR-15; ILE-17;
RP   PRO-25; HIS-209 AND ASN-255.
RG   SeattleSNPs variation discovery resource;
RL   Submitted (JUN-2001) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12853948; DOI=10.1038/nature01782;
RA   Hillier L.W., Fulton R.S., Fulton L.A., Graves T.A., Pepin K.H.,
RA   Wagner-McPherson C., Layman D., Maas J., Jaeger S., Walker R.,
RA   Wylie K., Sekhon M., Becker M.C., O'Laughlin M.D., Schaller M.E.,
RA   Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Cordes M., Du H.,
RA   Sun H., Edwards J., Bradshaw-Cordum H., Ali J., Andrews S., Isak A.,
RA   Vanbrunt A., Nguyen C., Du F., Lamar B., Courtney L., Kalicki J.,
RA   Ozersky P., Bielicki L., Scott K., Holmes A., Harkins R., Harris A.,
RA   Strong C.M., Hou S., Tomlinson C., Dauphin-Kohlberg S.,
RA   Kozlowicz-Reilly A., Leonard S., Rohlfing T., Rock S.M.,
RA   Tin-Wollam A.-M., Abbott A., Minx P., Maupin R., Strowmatt C.,
RA   Latreille P., Miller N., Johnson D., Murray J., Woessner J.P.,
RA   Wendl M.C., Yang S.-P., Schultz B.R., Wallis J.W., Spieth J.,
RA   Bieri T.A., Nelson J.O., Berkowicz N., Wohldmann P.E., Cook L.L.,
RA   Hickenbotham M.T., Eldred J., Williams D., Bedell J.A., Mardis E.R.,
RA   Clifton S.W., Chissoe S.L., Marra M.A., Raymond C., Haugen E.,
RA   Gillett W., Zhou Y., James R., Phelps K., Iadanoto S., Bubb K.,
RA   Simms E., Levy R., Clendenning J., Kaul R., Kent W.J., Furey T.S.,
RA   Baertsch R.A., Brent M.R., Keibler E., Flicek P., Bork P., Suyama M.,
RA   Bailey J.A., Portnoy M.E., Torrents D., Chinwalla A.T., Gish W.R.,
RA   Eddy S.R., McPherson J.D., Olson M.V., Eichler E.E., Green E.D.,
RA   Waterston R.H., Wilson R.K.;
RT   "The DNA sequence of human chromosome 7.";
RL   Nature 424:157-164(2003).
RN   [11]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [12]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 20-402 (ISOFORM 1).
RX   PubMed=3092219; DOI=10.1073/pnas.83.18.6776;
RA   Ny T., Sawdey M., Lawrence D., Millan J.L., Loskutoff D.J.;
RT   "Cloning and sequence of a cDNA coding for the human beta-migrating
RT   endothelial-cell-type plasminogen activator inhibitor.";
RL   Proc. Natl. Acad. Sci. U.S.A. 83:6776-6780(1986).
RN   [13]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-47 AND 364-402 (ISOFORM 1).
RX   PubMed=3025016; DOI=10.1016/0014-5793(86)81113-9;
RA   Andreasen P.A., Riccio A., Welinder K.G., Douglas R., Sartorio R.,
RA   Nielsen L.S., Oppenheimer C., Blasi F., Danoe K.;
RT   "Plasminogen activator inhibitor type-1: reactive center and amino-
RT   terminal heterogeneity determined by protein and cDNA sequencing.";
RL   FEBS Lett. 209:213-218(1986).
RN   [14]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 17-402 (ISOFORM 1), AND PARTIAL PROTEIN
RP   SEQUENCE.
RC   TISSUE=Placenta;
RX   PubMed=3026837; DOI=10.1016/0014-5793(87)81288-7;
RA   Wun T.C., Kretzmer K.K.;
RT   "cDNA cloning and expression in E. coli of a plasminogen activator
RT   inhibitor (PAI) related to a PAI produced by Hep G2 hepatoma cell.";
RL   FEBS Lett. 210:11-16(1987).
RN   [15]
RP   FUNCTION, AND INVOLVEMENT IN PAI-1D.
RX   PubMed=8481516;
RA   Lee M.H., Vosburgh E., Anderson K., McDonagh J.;
RT   "Deficiency of plasma plasminogen activator inhibitor 1 results in
RT   hyperfibrinolytic bleeding.";
RL   Blood 81:2357-2362(1993).
RN   [16]
RP   INTERACTION WITH VTN.
RX   PubMed=7522053; DOI=10.1016/0167-4838(94)90166-X;
RA   Sigurdardottir O., Wiman B.;
RT   "Identification of a PAI-1 binding site in vitronectin.";
RL   Biochim. Biophys. Acta 1208:104-110(1994).
RN   [17]
RP   FUNCTION, AND INVOLVEMENT IN PAI-1D.
RX   PubMed=9207454;
RA   Fay W.P., Parker A.C., Condrey L.R., Shapiro A.D.;
RT   "Human plasminogen activator inhibitor-1 (PAI-1) deficiency:
RT   characterization of a large kindred with a null mutation in the PAI-1
RT   gene.";
RL   Blood 90:204-208(1997).
RN   [18]
RP   FUNCTION.
RX   PubMed=9168821; DOI=10.1006/excr.1997.3540;
RA   Kjoeller L., Kanse S.M., Kirkegaard T., Rodenburg K.W., Roenne E.,
RA   Goodman S.L., Preissner K.T., Ossowski L., Andreasen P.A.;
RT   "Plasminogen activator inhibitor-1 represses integrin- and
RT   vitronectin-mediated cell migration independently of its function as
RT   an inhibitor of plasminogen activation.";
RL   Exp. Cell Res. 232:420-429(1997).
RN   [19]
RP   FUNCTION.
RX   PubMed=9175705;
RA   Planus E., Barlovatz-Meimon G., Rogers R.A., Bonavaud S., Ingber D.E.,
RA   Wang N.;
RT   "Binding of urokinase to plasminogen activator inhibitor type-1
RT   mediates cell adhesion and spreading.";
RL   J. Cell Sci. 110:1091-1098(1997).
RN   [20]
RP   INTERACTION WITH LRP1B.
RX   PubMed=11384978; DOI=10.1074/jbc.M102727200;
RA   Liu C.-X., Li Y., Obermoeller-McCormick L.M., Schwartz A.L., Bu G.;
RT   "The putative tumor suppressor LRP1B, a novel member of the low
RT   density lipoprotein (LDL) receptor family, exhibits both overlapping
RT   and distinct properties with the LDL receptor-related protein.";
RL   J. Biol. Chem. 276:28889-28896(2001).
RN   [21]
RP   FUNCTION.
RX   PubMed=15001579; DOI=10.1074/jbc.M313004200;
RA   Degryse B., Neels J.G., Czekay R.P., Aertgeerts K., Kamikubo Y.,
RA   Loskutoff D.J.;
RT   "The low density lipoprotein receptor-related protein is a motogenic
RT   receptor for plasminogen activator inhibitor-1.";
RL   J. Biol. Chem. 279:22595-22604(2004).
RN   [22]
RP   FUNCTION IN MEMBRANE-ANCHORED SERINE PROTEASE TMPRSS7 INHIBITION, AND
RP   HETERODIMER WITH TMPRSS7.
RX   PubMed=15853774; DOI=10.1042/BJ20050299;
RA   Szabo R., Netzel-Arnett S., Hobson J.P., Antalis T.M., Bugge T.H.;
RT   "Matriptase-3 is a novel phylogenetically preserved membrane-anchored
RT   serine protease with broad serpin reactivity.";
RL   Biochem. J. 390:231-242(2005).
RN   [23]
RP   FUNCTION.
RX   PubMed=16862142; DOI=10.1038/ncb1448;
RA   Kortlever R.M., Higgins P.J., Bernards R.;
RT   "Plasminogen activator inhibitor-1 is a critical downstream target of
RT   p53 in the induction of replicative senescence.";
RL   Nat. Cell Biol. 8:877-884(2006).
RN   [24]
RP   FUNCTION, AND MUTAGENESIS OF GLN-197 AND GLY-355.
RX   PubMed=17912461;
RA   Jankun J., Aleem A.M., Selman S.H., Skrzypczak-Jankun E.,
RA   Lysiak-Szydlowska W., Grafos N., Fryer H.J., Greenfield R.S.;
RT   "Highly stable plasminogen activator inhibitor type one (VLHL PAI-1)
RT   protects fibrin clots from tissue plasminogen activator-mediated
RT   fibrinolysis.";
RL   Int. J. Mol. Med. 20:683-687(2007).
RN   [25]
RP   FUNCTION.
RX   PubMed=18386027; DOI=10.1007/s00403-008-0845-2;
RA   Providence K.M., Higgins S.P., Mullen A., Battista A., Samarakoon R.,
RA   Higgins C.E., Wilkins-Port C.E., Higgins P.J.;
RT   "SERPINE1 (PAI-1) is deposited into keratinocyte migration 'trails'
RT   and required for optimal monolayer wound repair.";
RL   Arch. Dermatol. Res. 300:303-310(2008).
RN   [26]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22905912; DOI=10.1021/pr300539b;
RA   Rosenow A., Noben J.P., Jocken J., Kallendrusch S.,
RA   Fischer-Posovszky P., Mariman E.C., Renes J.;
RT   "Resveratrol-induced changes of the human adipocyte secretion
RT   profile.";
RL   J. Proteome Res. 11:4733-4743(2012).
RN   [27]
RP   FUNCTION.
RX   PubMed=25808697; DOI=10.1089/ten.TEA.2014.0399;
RA   Jin H., Choung H.W., Lim K.T., Jin B., Jin C., Chung J.H.,
RA   Choung P.H.;
RT   "Recombinant human plasminogen activator inhibitor-1 promotes
RT   cementogenic differentiation of human periodontal ligament stem
RT   cells.";
RL   Tissue Eng. Part A 21:2817-2828(2015).
RN   [28]
RP   FUNCTION.
RX   PubMed=27046084; DOI=10.1089/ten.tea.2015.0273;
RA   Jin B., Choung P.H.;
RT   "Recombinant human plasminogen activator inhibitor-1 accelerates
RT   odontoblastic differentiation of human stem cells from apical
RT   papilla.";
RL   Tissue Eng. Part A 22:721-732(2016).
RN   [29]
RP   INTERACTION WITH PPP1CB.
RX   PubMed=28296156; DOI=10.1111/jcmm.13127;
RA   Yao H., He G., Chen C., Yan S., Lu L., Song L., Vijayan K.V., Li Q.,
RA   Xiong L., Miao X., Deng X.;
RT   "PAI1: a novel PP1-interacting protein that mediates human plasma's
RT   anti-apoptotic effect in endothelial cells.";
RL   J. Cell. Mol. Med. 21:2068-2076(2017).
RN   [30]
RP   INVOLVEMENT IN PAI-1D.
RX   PubMed=29152572; DOI=10.1126/sciadv.aao1617;
RA   Khan S.S., Shah S.J., Klyachko E., Baldridge A.S., Eren M.,
RA   Place A.T., Aviv A., Puterman E., Lloyd-Jones D.M., Heiman M.,
RA   Miyata T., Gupta S., Shapiro A.D., Vaughan D.E.;
RT   "A null mutation in SERPINE1 protects against biological aging in
RT   humans.";
RL   Sci. Adv. 3:1-8(2017).
RN   [31]
RP   X-RAY CRYSTALLOGRAPHY (2.6 ANGSTROMS).
RX   PubMed=1731226; DOI=10.1038/355270a0;
RA   Mottonen J., Strand A., Symersky J., Sweet R.M., Danley D.E.,
RA   Geoghegan K.F., Gerard R.D., Goldsmith E.J.;
RT   "Structural basis of latency in plasminogen activator inhibitor-1.";
RL   Nature 355:270-273(1992).
RN   [32]
RP   X-RAY CRYSTALLOGRAPHY (2.7 ANGSTROMS).
RX   PubMed=7552714; DOI=10.1038/nsb1095-891;
RA   Aertgeerts K., de Bondt H.L., de Ranter C.J., Declerck P.J.;
RT   "Mechanisms contributing to the conformational and functional
RT   flexibility of plasminogen activator inhibitor-1.";
RL   Nat. Struct. Biol. 2:891-897(1995).
RN   [33]
RP   X-RAY CRYSTALLOGRAPHY (1.95 ANGSTROMS).
RX   PubMed=9634700; DOI=10.1016/S0969-2126(98)00064-1;
RA   Xue Y., Bjoerquist P., Inghardt T., Linschoten M., Musil D.,
RA   Sjoelin L., Deinum J.;
RT   "Interfering with the inhibitory mechanism of serpins: crystal
RT   structure of a complex formed between cleaved plasminogen activator
RT   inhibitor type 1 and a reactive-centre loop peptide.";
RL   Structure 6:627-636(1998).
RN   [34]
RP   X-RAY CRYSTALLOGRAPHY (2.99 ANGSTROMS).
RX   PubMed=10368279; DOI=10.1016/S0969-2126(99)80018-5;
RA   Sharp A.M., Stein P.E., Pannu N.S., Carrell R.W., Berkenpas M.B.,
RA   Ginsburg D., Lawrence D.A., Read R.J.;
RT   "The active conformation of plasminogen activator inhibitor 1, a
RT   target for drugs to control fibrinolysis and cell adhesion.";
RL   Structure 7:111-118(1999).
RN   [35]
RP   X-RAY CRYSTALLOGRAPHY (2.7 ANGSTROMS).
RX   PubMed=10731421; DOI=10.1006/jmbi.2000.3604;
RA   Nar H., Bauer M., Stassen J.M., Lang D., Gils A., Declerck P.J.;
RT   "Plasminogen activator inhibitor 1. Structure of the native serpin,
RT   comparison to its other conformers and implications for serpin
RT   inactivation.";
RL   J. Mol. Biol. 297:683-695(2000).
RN   [36]
RP   VARIANT THR-15.
RX   PubMed=9194591; DOI=10.1002/elps.1150180505;
RA   Turkmen B., Schmitt M., Schmalfeldt B., Trommler P., Hell W.,
RA   Creutzburg S., Graeff H., Magdolen V.;
RT   "Mutational analysis of the genes encoding urokinase-type plasminogen
RT   activator (uPA) and its inhibitor PAI-1 in advanced ovarian cancer.";
RL   Electrophoresis 18:686-689(1997).
RN   [37]
RP   VARIANTS THR-15 AND ILE-17.
RX   PubMed=10391209; DOI=10.1038/10290;
RA   Cargill M., Altshuler D., Ireland J., Sklar P., Ardlie K., Patil N.,
RA   Shaw N., Lane C.R., Lim E.P., Kalyanaraman N., Nemesh J., Ziaugra L.,
RA   Friedland L., Rolfe A., Warrington J., Lipshutz R., Daley G.Q.,
RA   Lander E.S.;
RT   "Characterization of single-nucleotide polymorphisms in coding regions
RT   of human genes.";
RL   Nat. Genet. 22:231-238(1999).
RN   [38]
RP   ERRATUM.
RA   Cargill M., Altshuler D., Ireland J., Sklar P., Ardlie K., Patil N.,
RA   Shaw N., Lane C.R., Lim E.P., Kalyanaraman N., Nemesh J., Ziaugra L.,
RA   Friedland L., Rolfe A., Warrington J., Lipshutz R., Daley G.Q.,
RA   Lander E.S.;
RL   Nat. Genet. 23:373-373(1999).
CC   -!- FUNCTION: Serine protease inhibitor. Inhibits TMPRSS7
CC       (PubMed:15853774). Is a primary inhibitor of tissue-type
CC       plasminogen activator (PLAT) and urokinase-type plasminogen
CC       activator (PLAU). As PLAT inhibitor, it is required for
CC       fibrinolysis down-regulation and is responsible for the controlled
CC       degradation of blood clots (PubMed:8481516, PubMed:9207454,
CC       PubMed:17912461). As PLAU inhibitor, it is involved in the
CC       regulation of cell adhesion and spreading (PubMed:9175705). Acts
CC       as a regulator of cell migration, independently of its role as
CC       protease inhibitor (PubMed:15001579, PubMed:9168821). It is
CC       required for stimulation of keratinocyte migration during
CC       cutaneous injury repair (PubMed:18386027). It is involved in
CC       cellular and replicative senescence (PubMed:16862142). Plays a
CC       role in alveolar type 2 cells senescence in the lung (By
CC       similarity). Is involved in the regulation of cementogenic
CC       differentiation of periodontal ligament stem cells, and regulates
CC       odontoblast differentiation and dentin formation during
CC       odontogenesis (PubMed:25808697, PubMed:27046084).
CC       {ECO:0000250|UniProtKB:P22777, ECO:0000269|PubMed:15001579,
CC       ECO:0000269|PubMed:15853774, ECO:0000269|PubMed:16862142,
CC       ECO:0000269|PubMed:17912461, ECO:0000269|PubMed:18386027,
CC       ECO:0000269|PubMed:25808697, ECO:0000269|PubMed:27046084,
CC       ECO:0000269|PubMed:8481516, ECO:0000269|PubMed:9168821,
CC       ECO:0000269|PubMed:9175705, ECO:0000269|PubMed:9207454}.
CC   -!- SUBUNIT: Forms a heterodimer with TMPRSS7 (PubMed:15853774).
CC       Interacts with VTN (PubMed:7522053). Binds LRP1B; binding is
CC       followed by internalization and degradation (PubMed:11384978).
CC       Interacts with PPP1CB (PubMed:28296156).
CC       {ECO:0000269|PubMed:11384978, ECO:0000269|PubMed:15853774,
CC       ECO:0000269|PubMed:28296156, ECO:0000269|PubMed:7522053}.
CC   -!- INTERACTION:
CC       P02763:ORM1; NbExp=4; IntAct=EBI-953978, EBI-976767;
CC       O43765:SGTA; NbExp=5; IntAct=EBI-953978, EBI-347996;
CC       Q96EQ0:SGTB; NbExp=5; IntAct=EBI-953978, EBI-744081;
CC       Q9UMX0:UBQLN1; NbExp=3; IntAct=EBI-953978, EBI-741480;
CC       Q9UMX0-2:UBQLN1; NbExp=3; IntAct=EBI-953978, EBI-10173939;
CC   -!- SUBCELLULAR LOCATION: Secreted {ECO:0000269|PubMed:2430793}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P05121-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P05121-2; Sequence=VSP_045493;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Expressed in endothelial cells
CC       (PubMed:2430793, PubMed:3097076). Found in plasma, platelets, and
CC       hepatoma and fibrosarcoma cells. {ECO:0000269|PubMed:2430793,
CC       ECO:0000269|PubMed:3097076}.
CC   -!- PTM: Inactivated by proteolytic attack of the urokinase-type (u-
CC       PA) and the tissue-type (TPA), cleaving the 369-Arg-|-Met-370
CC       bond.
CC   -!- DISEASE: Plasminogen activator inhibitor-1 deficiency (PAI-1D)
CC       [MIM:613329]: A hematologic disorder characterized by increased
CC       bleeding after trauma, injury, or surgery. Affected females have
CC       menorrhagia. The bleeding defect is due to increased fibrinolysis
CC       of fibrin blood clots due to deficiency of plasminogen activator
CC       inhibitor-1, which inhibits tissue and urinary activators of
CC       plasminogen. {ECO:0000269|PubMed:8481516,
CC       ECO:0000269|PubMed:9207454}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry. A rare
CC       PAI-1D mutation resulting in a frameshift and protein truncation
CC       has been found in an Old Order Amish community. Homozygous
CC       mutation carriers suffer from episodes of major hemorrhage, while
CC       heterozygous carriers do not manifest abnormal bleeding
CC       (PubMed:9207454). Heterozygosity for the mutation is associated
CC       with longer leukocyte telomere length, lower fasting insulin
CC       levels, lower prevalence of diabetes mellitus, and a longer life
CC       span (PubMed:29152572). {ECO:0000269|PubMed:29152572,
CC       ECO:0000269|PubMed:9207454}.
CC   -!- SIMILARITY: Belongs to the serpin family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Wikipedia; Note=Plasminogen activator
CC       inhibitor-1 entry;
CC       URL="https://en.wikipedia.org/wiki/Plasminogen_activator_inhibitor-1";
CC   -!- WEB RESOURCE: Name=SeattleSNPs;
CC       URL="http://pga.gs.washington.edu/data/serpine1/";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X04429; CAA28025.1; -; mRNA.
DR   EMBL; M14083; AAA60008.1; -; mRNA.
DR   EMBL; X04729; CAA28438.1; -; mRNA.
DR   EMBL; X04731; CAA28442.1; -; mRNA.
DR   EMBL; M16006; AAA60003.1; -; mRNA.
DR   EMBL; M22321; AAA60009.1; -; Genomic_DNA.
DR   EMBL; M22314; AAA60009.1; JOINED; Genomic_DNA.
DR   EMBL; M22315; AAA60009.1; JOINED; Genomic_DNA.
DR   EMBL; M22316; AAA60009.1; JOINED; Genomic_DNA.
DR   EMBL; M22317; AAA60009.1; JOINED; Genomic_DNA.
DR   EMBL; M22318; AAA60009.1; JOINED; Genomic_DNA.
DR   EMBL; M22319; AAA60009.1; JOINED; Genomic_DNA.
DR   EMBL; M22320; AAA60009.1; JOINED; Genomic_DNA.
DR   EMBL; X13323; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; X13338; CAA31722.1; -; Genomic_DNA.
DR   EMBL; X13339; CAB51639.1; -; Genomic_DNA.
DR   EMBL; X13340; CAB51737.1; -; Genomic_DNA.
DR   EMBL; X13341; CAB51606.1; -; Genomic_DNA.
DR   EMBL; X13342; CAB51607.1; -; Genomic_DNA.
DR   EMBL; X13343; CAB51738.1; -; Genomic_DNA.
DR   EMBL; X13344; CAB51739.1; -; Genomic_DNA.
DR   EMBL; X13345; CAA31729.1; -; Genomic_DNA.
DR   EMBL; J03764; AAA60007.1; -; Genomic_DNA.
DR   EMBL; X12701; CAA31208.1; -; mRNA.
DR   EMBL; AF386492; AAK60338.1; -; Genomic_DNA.
DR   EMBL; AK297728; BAH12656.1; -; mRNA.
DR   EMBL; AC004876; AAD45828.1; -; Genomic_DNA.
DR   EMBL; BC010860; AAH10860.1; -; mRNA.
DR   EMBL; X04744; CAA28444.1; -; mRNA.
DR   CCDS; CCDS5711.1; -. [P05121-1]
DR   PIR; A28107; ITHUP1.
DR   RefSeq; NP_000593.1; NM_000602.4. [P05121-1]
DR   UniGene; Hs.414795; -.
DR   UniGene; Hs.713079; -.
DR   UniGene; Hs.741440; -.
DR   PDB; 1A7C; X-ray; 1.95 A; A=24-402.
DR   PDB; 1B3K; X-ray; 2.99 A; A/B/C/D=24-402.
DR   PDB; 1C5G; X-ray; 2.60 A; A=1-402.
DR   PDB; 1DB2; X-ray; 2.70 A; A/B=26-402.
DR   PDB; 1DVM; X-ray; 2.40 A; A/B/C/D=24-402.
DR   PDB; 1DVN; X-ray; 2.10 A; A=24-402.
DR   PDB; 1LJ5; X-ray; 1.80 A; A=24-402.
DR   PDB; 1OC0; X-ray; 2.28 A; A=24-402.
DR   PDB; 3CVM; X-ray; 2.02 A; A/B=21-402.
DR   PDB; 3EOX; X-ray; 2.61 A; A=24-402.
DR   PDB; 3PB1; X-ray; 2.30 A; I=24-402.
DR   PDB; 3Q02; X-ray; 2.30 A; A/B=24-402.
DR   PDB; 3Q03; X-ray; 2.64 A; A/B=24-402.
DR   PDB; 3R4L; X-ray; 2.70 A; A=24-402.
DR   PDB; 3UT3; X-ray; 2.42 A; A/B/C/D=28-402.
DR   PDB; 4AQH; X-ray; 2.40 A; A/B/C=24-402.
DR   PDB; 4G8O; X-ray; 2.71 A; A/B/C/D=28-402.
DR   PDB; 4G8R; X-ray; 2.19 A; A/B=28-402.
DR   PDB; 4IC0; X-ray; 2.32 A; A/B/C/D=24-402.
DR   PDB; 5BRR; X-ray; 3.16 A; I=24-402.
DR   PDB; 9PAI; X-ray; 2.70 A; A=24-369, B=370-402.
DR   PDBsum; 1A7C; -.
DR   PDBsum; 1B3K; -.
DR   PDBsum; 1C5G; -.
DR   PDBsum; 1DB2; -.
DR   PDBsum; 1DVM; -.
DR   PDBsum; 1DVN; -.
DR   PDBsum; 1LJ5; -.
DR   PDBsum; 1OC0; -.
DR   PDBsum; 3CVM; -.
DR   PDBsum; 3EOX; -.
DR   PDBsum; 3PB1; -.
DR   PDBsum; 3Q02; -.
DR   PDBsum; 3Q03; -.
DR   PDBsum; 3R4L; -.
DR   PDBsum; 3UT3; -.
DR   PDBsum; 4AQH; -.
DR   PDBsum; 4G8O; -.
DR   PDBsum; 4G8R; -.
DR   PDBsum; 4IC0; -.
DR   PDBsum; 5BRR; -.
DR   PDBsum; 9PAI; -.
DR   DisProt; DP00320; -.
DR   ProteinModelPortal; P05121; -.
DR   SMR; P05121; -.
DR   BioGrid; 111091; 17.
DR   IntAct; P05121; 13.
DR   MINT; P05121; -.
DR   STRING; 9606.ENSP00000223095; -.
DR   BindingDB; P05121; -.
DR   ChEMBL; CHEMBL3475; -.
DR   DrugBank; DB00009; Alteplase.
DR   DrugBank; DB00029; Anistreplase.
DR   DrugBank; DB00055; Drotrecogin alfa.
DR   DrugBank; DB05254; Plasmin.
DR   DrugBank; DB00015; Reteplase.
DR   DrugBank; DB00031; Tenecteplase.
DR   DrugBank; DB00197; Troglitazone.
DR   DrugBank; DB00013; Urokinase.
DR   MEROPS; I04.020; -.
DR   GlyConnect; 639; -.
DR   iPTMnet; P05121; -.
DR   PhosphoSitePlus; P05121; -.
DR   UniCarbKB; P05121; -.
DR   BioMuta; SERPINE1; -.
DR   DMDM; 129576; -.
DR   OGP; P05121; -.
DR   SWISS-2DPAGE; P05121; -.
DR   EPD; P05121; -.
DR   MaxQB; P05121; -.
DR   PaxDb; P05121; -.
DR   PeptideAtlas; P05121; -.
DR   PRIDE; P05121; -.
DR   DNASU; 5054; -.
DR   Ensembl; ENST00000223095; ENSP00000223095; ENSG00000106366. [P05121-1]
DR   GeneID; 5054; -.
DR   KEGG; hsa:5054; -.
DR   UCSC; uc003uxt.4; human. [P05121-1]
DR   CTD; 5054; -.
DR   DisGeNET; 5054; -.
DR   EuPathDB; HostDB:ENSG00000106366.8; -.
DR   GeneCards; SERPINE1; -.
DR   HGNC; HGNC:8583; SERPINE1.
DR   HPA; HPA050039; -.
DR   MalaCards; SERPINE1; -.
DR   MIM; 173360; gene.
DR   MIM; 613329; phenotype.
DR   neXtProt; NX_P05121; -.
DR   OpenTargets; ENSG00000106366; -.
DR   Orphanet; 465; Congenital plasminogen activator inhibitor type 1 deficiency.
DR   PharmGKB; PA261; -.
DR   eggNOG; KOG2392; Eukaryota.
DR   eggNOG; COG4826; LUCA.
DR   GeneTree; ENSGT00900000140788; -.
DR   HOGENOM; HOG000238519; -.
DR   HOVERGEN; HBG106493; -.
DR   InParanoid; P05121; -.
DR   KO; K03982; -.
DR   OMA; PYEKEVP; -.
DR   OrthoDB; EOG091G0ION; -.
DR   PhylomeDB; P05121; -.
DR   TreeFam; TF352620; -.
DR   Reactome; R-HSA-114608; Platelet degranulation.
DR   Reactome; R-HSA-1368108; BMAL1:CLOCK,NPAS2 activates circadian gene expression.
DR   Reactome; R-HSA-2173796; SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription.
DR   Reactome; R-HSA-3000178; ECM proteoglycans.
DR   Reactome; R-HSA-75205; Dissolution of Fibrin Clot.
DR   SIGNOR; P05121; -.
DR   ChiTaRS; SERPINE1; human.
DR   EvolutionaryTrace; P05121; -.
DR   GeneWiki; Plasminogen_activator_inhibitor-1; -.
DR   GenomeRNAi; 5054; -.
DR   PMAP-CutDB; P05121; -.
DR   PRO; PR:P05121; -.
DR   Proteomes; UP000005640; Chromosome 7.
DR   Bgee; ENSG00000106366; -.
DR   CleanEx; HS_SERPINE1; -.
DR   ExpressionAtlas; P05121; baseline and differential.
DR   Genevisible; P05121; HS.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0031012; C:extracellular matrix; IDA:BHF-UCL.
DR   GO; GO:0005576; C:extracellular region; IDA:BHF-UCL.
DR   GO; GO:0005615; C:extracellular space; IDA:BHF-UCL.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0031093; C:platelet alpha granule lumen; TAS:Reactome.
DR   GO; GO:0002020; F:protease binding; IPI:UniProtKB.
DR   GO; GO:0004867; F:serine-type endopeptidase inhibitor activity; IDA:BHF-UCL.
DR   GO; GO:0005102; F:signaling receptor binding; IPI:BHF-UCL.
DR   GO; GO:0001525; P:angiogenesis; IEP:UniProtKB.
DR   GO; GO:0071277; P:cellular response to calcium ion; HEP:ARUK-UCL.
DR   GO; GO:0071222; P:cellular response to lipopolysaccharide; IMP:BHF-UCL.
DR   GO; GO:0001300; P:chronological cell aging; IEP:BHF-UCL.
DR   GO; GO:0007623; P:circadian rhythm; TAS:Reactome.
DR   GO; GO:0050829; P:defense response to Gram-negative bacterium; IGI:BHF-UCL.
DR   GO; GO:0097187; P:dentinogenesis; IDA:UniProtKB.
DR   GO; GO:0030198; P:extracellular matrix organization; TAS:Reactome.
DR   GO; GO:0042730; P:fibrinolysis; TAS:Reactome.
DR   GO; GO:0030195; P:negative regulation of blood coagulation; IC:BHF-UCL.
DR   GO; GO:0033629; P:negative regulation of cell adhesion mediated by integrin; IDA:BHF-UCL.
DR   GO; GO:0030336; P:negative regulation of cell migration; IDA:BHF-UCL.
DR   GO; GO:0010951; P:negative regulation of endopeptidase activity; IDA:BHF-UCL.
DR   GO; GO:2000352; P:negative regulation of endothelial cell apoptotic process; IMP:BHF-UCL.
DR   GO; GO:1902042; P:negative regulation of extrinsic apoptotic signaling pathway via death domain receptors; IMP:BHF-UCL.
DR   GO; GO:0051918; P:negative regulation of fibrinolysis; IDA:BHF-UCL.
DR   GO; GO:0010757; P:negative regulation of plasminogen activation; IDA:BHF-UCL.
DR   GO; GO:0014912; P:negative regulation of smooth muscle cell migration; IDA:BHF-UCL.
DR   GO; GO:2000098; P:negative regulation of smooth muscle cell-matrix adhesion; IDA:BHF-UCL.
DR   GO; GO:0061044; P:negative regulation of vascular wound healing; IGI:BHF-UCL.
DR   GO; GO:0061045; P:negative regulation of wound healing; IC:BHF-UCL.
DR   GO; GO:0002576; P:platelet degranulation; TAS:Reactome.
DR   GO; GO:0045766; P:positive regulation of angiogenesis; IMP:BHF-UCL.
DR   GO; GO:0030194; P:positive regulation of blood coagulation; IMP:BHF-UCL.
DR   GO; GO:0050729; P:positive regulation of inflammatory response; IGI:BHF-UCL.
DR   GO; GO:0032757; P:positive regulation of interleukin-8 production; IMP:BHF-UCL.
DR   GO; GO:0035491; P:positive regulation of leukotriene production involved in inflammatory response; IMP:BHF-UCL.
DR   GO; GO:0090026; P:positive regulation of monocyte chemotaxis; IMP:BHF-UCL.
DR   GO; GO:1901331; P:positive regulation of odontoblast differentiation; IDA:UniProtKB.
DR   GO; GO:0048260; P:positive regulation of receptor-mediated endocytosis; IDA:BHF-UCL.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; TAS:Reactome.
DR   GO; GO:0010469; P:regulation of signaling receptor activity; IDA:BHF-UCL.
DR   GO; GO:0090399; P:replicative senescence; IMP:UniProtKB.
DR   InterPro; IPR023795; Serpin_CS.
DR   InterPro; IPR023796; Serpin_dom.
DR   InterPro; IPR000215; Serpin_fam.
DR   InterPro; IPR036186; Serpin_sf.
DR   PANTHER; PTHR11461; PTHR11461; 1.
DR   Pfam; PF00079; Serpin; 1.
DR   SMART; SM00093; SERPIN; 1.
DR   SUPFAM; SSF56574; SSF56574; 1.
DR   PROSITE; PS00284; SERPIN; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Complete proteome;
KW   Direct protein sequencing; Glycoprotein; Polymorphism;
KW   Protease inhibitor; Reference proteome; Secreted;
KW   Serine protease inhibitor; Signal.
FT   SIGNAL        1     23
FT   CHAIN        24    402       Plasminogen activator inhibitor 1.
FT                                /FTId=PRO_0000032499.
FT   SITE        369    370       Reactive bond.
FT   CARBOHYD    232    232       N-linked (GlcNAc...) asparagine.
FT   CARBOHYD    288    288       N-linked (GlcNAc...) asparagine.
FT   CARBOHYD    352    352       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   VAR_SEQ      31     45       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_045493.
FT   VARIANT      15     15       A -> T (in dbSNP:rs6092).
FT                                {ECO:0000269|PubMed:10391209,
FT                                ECO:0000269|PubMed:9194591,
FT                                ECO:0000269|Ref.8}.
FT                                /FTId=VAR_007099.
FT   VARIANT      17     17       V -> I (in dbSNP:rs6090).
FT                                {ECO:0000269|PubMed:10391209,
FT                                ECO:0000269|Ref.8}.
FT                                /FTId=VAR_011750.
FT   VARIANT      25     25       H -> P (in dbSNP:rs2227647).
FT                                {ECO:0000269|Ref.8}.
FT                                /FTId=VAR_013086.
FT   VARIANT     209    209       R -> H (in dbSNP:rs2227669).
FT                                {ECO:0000269|Ref.8}.
FT                                /FTId=VAR_013087.
FT   VARIANT     255    255       T -> N (in dbSNP:rs2227685).
FT                                {ECO:0000269|Ref.8}.
FT                                /FTId=VAR_013088.
FT   MUTAGEN     197    197       Q->C: Increased half-life of the active
FT                                form when associated with C-355.
FT                                {ECO:0000269|PubMed:17912461}.
FT   MUTAGEN     355    355       G->C: Increased half-life of the active
FT                                form when associated with C-197.
FT                                {ECO:0000269|PubMed:17912461}.
FT   CONFLICT     53     53       R -> A (in Ref. 7; CAA31208).
FT                                {ECO:0000305}.
FT   CONFLICT     55     55       V -> L (in Ref. 2; AAA60009).
FT                                {ECO:0000305}.
FT   CONFLICT     75     75       G -> V (in Ref. 7; CAA31208).
FT                                {ECO:0000305}.
FT   CONFLICT    138    138       R -> K (in Ref. 7; CAA31208).
FT                                {ECO:0000305}.
FT   CONFLICT    226    226       A -> V (in Ref. 9; BAH12656).
FT                                {ECO:0000305}.
FT   CONFLICT    280    282       QLI -> HVM (in Ref. 7; CAA31208).
FT                                {ECO:0000305}.
FT   HELIX        27     49       {ECO:0000244|PDB:1LJ5}.
FT   STRAND       51     53       {ECO:0000244|PDB:4IC0}.
FT   STRAND       55     57       {ECO:0000244|PDB:1LJ5}.
FT   HELIX        59     72       {ECO:0000244|PDB:1LJ5}.
FT   HELIX        75     85       {ECO:0000244|PDB:1LJ5}.
FT   HELIX        94    106       {ECO:0000244|PDB:1LJ5}.
FT   HELIX       108    110       {ECO:0000244|PDB:1LJ5}.
FT   STRAND      111    123       {ECO:0000244|PDB:1LJ5}.
FT   HELIX       132    140       {ECO:0000244|PDB:1LJ5}.
FT   STRAND      145    147       {ECO:0000244|PDB:1LJ5}.
FT   HELIX       149    151       {ECO:0000244|PDB:3UT3}.
FT   HELIX       152    165       {ECO:0000244|PDB:1LJ5}.
FT   TURN        166    169       {ECO:0000244|PDB:1LJ5}.
FT   STRAND      170    172       {ECO:0000244|PDB:9PAI}.
FT   HELIX       176    179       {ECO:0000244|PDB:4G8R}.
FT   STRAND      186    200       {ECO:0000244|PDB:1LJ5}.
FT   HELIX       204    206       {ECO:0000244|PDB:3CVM}.
FT   STRAND      209    213       {ECO:0000244|PDB:1LJ5}.
FT   STRAND      216    218       {ECO:0000244|PDB:1C5G}.
FT   STRAND      219    237       {ECO:0000244|PDB:1LJ5}.
FT   TURN        239    241       {ECO:0000244|PDB:1C5G}.
FT   STRAND      243    251       {ECO:0000244|PDB:1LJ5}.
FT   STRAND      254    265       {ECO:0000244|PDB:1LJ5}.
FT   HELIX       271    274       {ECO:0000244|PDB:1LJ5}.
FT   HELIX       279    288       {ECO:0000244|PDB:1LJ5}.
FT   STRAND      290    299       {ECO:0000244|PDB:1LJ5}.
FT   STRAND      301    308       {ECO:0000244|PDB:1LJ5}.
FT   HELIX       310    315       {ECO:0000244|PDB:1LJ5}.
FT   HELIX       320    322       {ECO:0000244|PDB:1LJ5}.
FT   TURN        324    326       {ECO:0000244|PDB:1LJ5}.
FT   TURN        330    332       {ECO:0000244|PDB:1LJ5}.
FT   STRAND      334    336       {ECO:0000244|PDB:1LJ5}.
FT   STRAND      340    351       {ECO:0000244|PDB:1LJ5}.
FT   STRAND      353    368       {ECO:0000244|PDB:1LJ5}.
FT   STRAND      374    376       {ECO:0000244|PDB:3CVM}.
FT   STRAND      380    387       {ECO:0000244|PDB:1LJ5}.
FT   TURN        388    391       {ECO:0000244|PDB:1LJ5}.
FT   STRAND      392    400       {ECO:0000244|PDB:1LJ5}.
SQ   SEQUENCE   402 AA;  45060 MW;  A2E181ED28DD6082 CRC64;
     MQMSPALTCL VLGLALVFGE GSAVHHPPSY VAHLASDFGV RVFQQVAQAS KDRNVVFSPY
     GVASVLAMLQ LTTGGETQQQ IQAAMGFKID DKGMAPALRH LYKELMGPWN KDEISTTDAI
     FVQRDLKLVQ GFMPHFFRLF RSTVKQVDFS EVERARFIIN DWVKTHTKGM ISNLLGKGAV
     DQLTRLVLVN ALYFNGQWKT PFPDSSTHRR LFHKSDGSTV SVPMMAQTNK FNYTEFTTPD
     GHYYDILELP YHGDTLSMFI AAPYEKEVPL SALTNILSAQ LISHWKGNMT RLPRLLVLPK
     FSLETEVDLR KPLENLGMTD MFRQFQADFT SLSDQEPLHV AQALQKVKIE VNESGTVASS
     STAVIVSARM APEEIIMDRP FLFVVRHNPT GTVLFMGQVM EP
//
ID   PPIB_HUMAN              Reviewed;         216 AA.
AC   P23284; A8K534; Q6IBH5; Q9BVK5;
DT   01-NOV-1991, integrated into UniProtKB/Swiss-Prot.
DT   25-NOV-2008, sequence version 2.
DT   23-MAY-2018, entry version 193.
DE   RecName: Full=Peptidyl-prolyl cis-trans isomerase B;
DE            Short=PPIase B;
DE            EC=5.2.1.8;
DE   AltName: Full=CYP-S1;
DE   AltName: Full=Cyclophilin B;
DE   AltName: Full=Rotamase B;
DE   AltName: Full=S-cyclophilin;
DE            Short=SCYLP;
DE   Flags: Precursor;
GN   Name=PPIB; Synonyms=CYPB;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=2040592;
RA   Spik G., Haendler B., Delmas O., Mariller C., Chamoux M., Maes P.,
RA   Tartar A., Montreuil J., Stedman K., Kocher H.P., Keller R.,
RA   Hiestand P.C., Movva N.R.;
RT   "A novel secreted cyclophilin-like protein (SCYLP).";
RL   J. Biol. Chem. 266:10735-10738(1991).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RG   NIEHS SNPs program;
RL   Submitted (MAR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16572171; DOI=10.1038/nature04601;
RA   Zody M.C., Garber M., Sharpe T., Young S.K., Rowen L., O'Neill K.,
RA   Whittaker C.A., Kamal M., Chang J.L., Cuomo C.A., Dewar K.,
RA   FitzGerald M.G., Kodira C.D., Madan A., Qin S., Yang X., Abbasi N.,
RA   Abouelleil A., Arachchi H.M., Baradarani L., Birditt B., Bloom S.,
RA   Bloom T., Borowsky M.L., Burke J., Butler J., Cook A., DeArellano K.,
RA   DeCaprio D., Dorris L. III, Dors M., Eichler E.E., Engels R.,
RA   Fahey J., Fleetwood P., Friedman C., Gearin G., Hall J.L., Hensley G.,
RA   Johnson E., Jones C., Kamat A., Kaur A., Locke D.P., Madan A.,
RA   Munson G., Jaffe D.B., Lui A., Macdonald P., Mauceli E., Naylor J.W.,
RA   Nesbitt R., Nicol R., O'Leary S.B., Ratcliffe A., Rounsley S., She X.,
RA   Sneddon K.M.B., Stewart S., Sougnez C., Stone S.M., Topham K.,
RA   Vincent D., Wang S., Zimmer A.R., Birren B.W., Hood L., Lander E.S.,
RA   Nusbaum C.;
RT   "Analysis of the DNA sequence and duplication history of human
RT   chromosome 15.";
RL   Nature 440:671-675(2006).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain, Prostate, and Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 5-216, AND PROTEIN SEQUENCE OF 34-48.
RX   PubMed=2000394; DOI=10.1073/pnas.88.5.1903;
RA   Price E.R., Zydowsky L.D., Jin M., Hunter C.H., McKeon F.D.,
RA   Walsh C.T.;
RT   "Human cyclophilin B: a second cyclophilin gene encodes a peptidyl-
RT   prolyl isomerase with a signal sequence.";
RL   Proc. Natl. Acad. Sci. U.S.A. 88:1903-1907(1991).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 10-216.
RX   PubMed=1710767; DOI=10.1128/MCB.11.7.3484;
RA   Hasel K.W., Glass J.R., Godbout M., Sutcliffe J.G.;
RT   "An endoplasmic reticulum-specific cyclophilin.";
RL   Mol. Cell. Biol. 11:3484-3491(1991).
RN   [10]
RP   PROTEIN SEQUENCE OF 52-59; 64-76; 91-101; 138-150; 164-172 AND
RP   197-207, AND IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Fetal brain cortex;
RA   Lubec G., Chen W.-Q., Sun Y.;
RL   Submitted (DEC-2008) to UniProtKB.
RN   [11]
RP   PROTEIN SEQUENCE OF 72-84 AND 159-165.
RX   PubMed=1286667; DOI=10.1002/elps.11501301199;
RA   Rasmussen H.H., van Damme J., Puype M., Gesser B., Celis J.E.,
RA   Vandekerckhove J.;
RT   "Microsequences of 145 proteins recorded in the two-dimensional gel
RT   protein database of normal human epidermal keratinocytes.";
RL   Electrophoresis 13:960-969(1992).
RN   [12]
RP   SUBCELLULAR LOCATION.
RX   PubMed=1530944; DOI=10.1083/jcb.116.1.113;
RA   Arber S., Krause K.-H., Caroni P.;
RT   "S-cyclophilin is retained intracellularly via a unique COOH-terminal
RT   sequence and colocalizes with the calcium storage protein
RT   calreticulin.";
RL   J. Cell Biol. 116:113-125(1992).
RN   [13]
RP   SUBCELLULAR LOCATION [LARGE SCALE ANALYSIS].
RC   TISSUE=Melanoma;
RX   PubMed=17081065; DOI=10.1021/pr060363j;
RA   Chi A., Valencia J.C., Hu Z.-Z., Watabe H., Yamaguchi H.,
RA   Mangini N.J., Huang H., Canfield V.A., Cheng K.C., Yang F., Abe R.,
RA   Yamagishi S., Shabanowitz J., Hearing V.J., Wu C., Appella E.,
RA   Hunt D.F.;
RT   "Proteomic and bioinformatic characterization of the biogenesis and
RT   function of melanosomes.";
RL   J. Proteome Res. 5:3135-3144(2006).
RN   [14]
RP   INVOLVEMENT IN OI9.
RX   PubMed=19781681; DOI=10.1016/j.ajhg.2009.09.001;
RA   van Dijk F.S., Nesbitt I.M., Zwikstra E.H., Nikkels P.G.,
RA   Piersma S.R., Fratantoni S.A., Jimenez C.R., Huizer M., Morsman A.C.,
RA   Cobben J.M., van Roij M.H., Elting M.W., Verbeke J.I.,
RA   Wijnaendts L.C., Shaw N.J., Hogler W., McKeown C., Sistermans E.A.,
RA   Dalton A., Meijers-Heijboer H., Pals G.;
RT   "PPIB mutations cause severe osteogenesis imperfecta.";
RL   Am. J. Hum. Genet. 85:521-527(2009).
RN   [15]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [16]
RP   INTERACTION WITH DYM.
RX   PubMed=21280149; DOI=10.1002/humu.21413;
RA   Denais C., Dent C.L., Southgate L., Hoyle J., Dafou D., Trembath R.C.,
RA   Machado R.D.;
RT   "Dymeclin, the gene underlying Dyggve-Melchior-Clausen syndrome,
RT   encodes a protein integral to extracellular matrix and Golgi
RT   organization and is associated with protein secretion pathways
RT   critical in bone development.";
RL   Hum. Mutat. 32:231-239(2011).
RN   [17]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [18]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [19]
RP   X-RAY CRYSTALLOGRAPHY (1.85 ANGSTROMS) OF 39-216.
RX   PubMed=8197205; DOI=10.1073/pnas.91.11.5183;
RA   Mikol V., Kallen J., Walkinshaw M.D.;
RT   "X-ray structure of a cyclophilin B/cyclosporin complex: comparison
RT   with cyclophilin A and delineation of its calcineurin-binding
RT   domain.";
RL   Proc. Natl. Acad. Sci. U.S.A. 91:5183-5186(1994).
RN   [20]
RP   X-RAY CRYSTALLOGRAPHY (1.2 ANGSTROMS) OF 34-216 IN COMPLEX WITH CLGN,
RP   MUTAGENESIS OF LYS-129, AND INTERACTION WITH CALR; CANX AND CLGN.
RX   PubMed=20801878; DOI=10.1074/jbc.M110.160101;
RA   Kozlov G., Bastos-Aristizabal S., Maattanen P., Rosenauer A.,
RA   Zheng F., Killikelly A., Trempe J.F., Thomas D.Y., Gehring K.;
RT   "Structural basis of cyclophilin B binding by the
RT   calnexin/calreticulin P-domain.";
RL   J. Biol. Chem. 285:35551-35557(2010).
RN   [21]
RP   VARIANT OI9 ARG-9.
RX   PubMed=20089953; DOI=10.1056/NEJMoa0907705;
RA   Barnes A.M., Carter E.M., Cabral W.A., Weis M., Chang W.,
RA   Makareeva E., Leikin S., Rotimi C.N., Eyre D.R., Raggio C.L.,
RA   Marini J.C.;
RT   "Lack of cyclophilin B in osteogenesis imperfecta with normal collagen
RT   folding.";
RL   N. Engl. J. Med. 362:521-528(2010).
CC   -!- FUNCTION: PPIases accelerate the folding of proteins. It catalyzes
CC       the cis-trans isomerization of proline imidic peptide bonds in
CC       oligopeptides.
CC   -!- CATALYTIC ACTIVITY: Peptidylproline (omega=180) = peptidylproline
CC       (omega=0).
CC   -!- ENZYME REGULATION: Cyclosporin A (CsA) inhibits CYPB.
CC   -!- SUBUNIT: Interacts with DYM. Interacts with CALR, CLGN and CANX.
CC       {ECO:0000269|PubMed:20801878, ECO:0000269|PubMed:21280149}.
CC   -!- INTERACTION:
CC       Q9WMX2:- (xeno); NbExp=7; IntAct=EBI-359252, EBI-9005440;
CC       Q8N9N5:BANP; NbExp=3; IntAct=EBI-359252, EBI-744695;
CC       P13667:PDIA4; NbExp=3; IntAct=EBI-8771982, EBI-1054653;
CC       P40855:PEX19; NbExp=5; IntAct=EBI-359252, EBI-594747;
CC       O43765:SGTA; NbExp=5; IntAct=EBI-359252, EBI-347996;
CC       Q96EQ0:SGTB; NbExp=3; IntAct=EBI-359252, EBI-744081;
CC       Q9UMX0:UBQLN1; NbExp=3; IntAct=EBI-359252, EBI-741480;
CC       Q9UMX0-2:UBQLN1; NbExp=3; IntAct=EBI-359252, EBI-10173939;
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum lumen
CC       {ECO:0000269|PubMed:1530944}. Melanosome
CC       {ECO:0000269|PubMed:17081065}. Note=Identified by mass
CC       spectrometry in melanosome fractions from stage I to stage IV
CC       (PubMed:17081065). {ECO:0000269|PubMed:17081065}.
CC   -!- DISEASE: Osteogenesis imperfecta 9 (OI9) [MIM:259440]: A form of
CC       osteogenesis imperfecta, a connective tissue disorder
CC       characterized by low bone mass, bone fragility and susceptibility
CC       to fractures after minimal trauma. Disease severity ranges from
CC       very mild forms without fractures to intrauterine fractures and
CC       perinatal lethality. Extraskeletal manifestations, which affect a
CC       variable number of patients, are dentinogenesis imperfecta,
CC       hearing loss, and blue sclerae. OI9 is a severe autosomal
CC       recessive form of the disorder. {ECO:0000269|PubMed:19781681,
CC       ECO:0000269|PubMed:20089953}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the cyclophilin-type PPIase family. PPIase
CC       B subfamily. {ECO:0000305}.
CC   -!- CAUTION: It is uncertain whether Met-1 or Met-9 is the initiator.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAA52150.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=NIEHS-SNPs;
CC       URL="http://egp.gs.washington.edu/data/ppib/";
CC   -!- WEB RESOURCE: Name=Osteogenesis imperfecta variant database;
CC       Note=Peptidyl-prolyl cis-trans isomerase B (PPIB);
CC       URL="http://oi.gene.le.ac.uk/home.php?select_db=PPIB";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M63573; AAA36601.1; -; mRNA.
DR   EMBL; AK291149; BAF83838.1; -; mRNA.
DR   EMBL; CR456829; CAG33110.1; -; mRNA.
DR   EMBL; AY962310; AAX44050.1; -; Genomic_DNA.
DR   EMBL; AC100840; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471082; EAW77669.1; -; Genomic_DNA.
DR   EMBL; BC001125; AAH01125.1; -; mRNA.
DR   EMBL; BC008848; AAH08848.1; -; mRNA.
DR   EMBL; BC020800; AAH20800.1; -; mRNA.
DR   EMBL; BC032138; AAH32138.1; -; mRNA.
DR   EMBL; M60857; AAA52150.1; ALT_INIT; mRNA.
DR   EMBL; M60457; AAA35733.1; -; mRNA.
DR   CCDS; CCDS10191.1; -.
DR   PIR; A39118; CSHUB.
DR   RefSeq; NP_000933.1; NM_000942.4.
DR   UniGene; Hs.434937; -.
DR   PDB; 1CYN; X-ray; 1.85 A; A=39-216.
DR   PDB; 3ICH; X-ray; 1.20 A; A=34-216.
DR   PDB; 3ICI; X-ray; 1.70 A; A/B=34-216.
DR   PDBsum; 1CYN; -.
DR   PDBsum; 3ICH; -.
DR   PDBsum; 3ICI; -.
DR   ProteinModelPortal; P23284; -.
DR   SMR; P23284; -.
DR   BioGrid; 111475; 97.
DR   IntAct; P23284; 33.
DR   MINT; P23284; -.
DR   STRING; 9606.ENSP00000300026; -.
DR   BindingDB; P23284; -.
DR   ChEMBL; CHEMBL2075; -.
DR   DrugBank; DB00172; L-Proline.
DR   iPTMnet; P23284; -.
DR   PhosphoSitePlus; P23284; -.
DR   SwissPalm; P23284; -.
DR   BioMuta; PPIB; -.
DR   DMDM; 215273869; -.
DR   OGP; P23284; -.
DR   REPRODUCTION-2DPAGE; IPI00646304; -.
DR   SWISS-2DPAGE; P23284; -.
DR   EPD; P23284; -.
DR   MaxQB; P23284; -.
DR   PaxDb; P23284; -.
DR   PeptideAtlas; P23284; -.
DR   PRIDE; P23284; -.
DR   TopDownProteomics; P23284; -.
DR   DNASU; 5479; -.
DR   Ensembl; ENST00000300026; ENSP00000300026; ENSG00000166794.
DR   GeneID; 5479; -.
DR   KEGG; hsa:5479; -.
DR   UCSC; uc002and.4; human.
DR   CTD; 5479; -.
DR   DisGeNET; 5479; -.
DR   EuPathDB; HostDB:ENSG00000166794.4; -.
DR   GeneCards; PPIB; -.
DR   HGNC; HGNC:9255; PPIB.
DR   HPA; CAB011487; -.
DR   HPA; HPA012720; -.
DR   MalaCards; PPIB; -.
DR   MIM; 123841; gene.
DR   MIM; 259440; phenotype.
DR   neXtProt; NX_P23284; -.
DR   OpenTargets; ENSG00000166794; -.
DR   Orphanet; 216804; Osteogenesis imperfecta type 2.
DR   Orphanet; 216812; Osteogenesis imperfecta type 3.
DR   Orphanet; 216820; Osteogenesis imperfecta type 4.
DR   PharmGKB; PA33580; -.
DR   eggNOG; KOG0880; Eukaryota.
DR   eggNOG; ENOG410Z0G4; LUCA.
DR   GeneTree; ENSGT00760000119072; -.
DR   HOGENOM; HOG000065981; -.
DR   HOVERGEN; HBG001065; -.
DR   InParanoid; P23284; -.
DR   KO; K03768; -.
DR   OMA; EPFAVSK; -.
DR   OrthoDB; EOG091G0BGL; -.
DR   PhylomeDB; P23284; -.
DR   TreeFam; TF354259; -.
DR   BioCyc; MetaCyc:HS09452-MONOMER; -.
DR   BRENDA; 5.2.1.8; 2681.
DR   Reactome; R-HSA-1650814; Collagen biosynthesis and modifying enzymes.
DR   ChiTaRS; PPIB; human.
DR   EvolutionaryTrace; P23284; -.
DR   GeneWiki; PPIB; -.
DR   GenomeRNAi; 5479; -.
DR   PRO; PR:P23284; -.
DR   Proteomes; UP000005640; Chromosome 15.
DR   Bgee; ENSG00000166794; -.
DR   CleanEx; HS_PPIB; -.
DR   Genevisible; P23284; HS.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:UniProtKB.
DR   GO; GO:0034663; C:endoplasmic reticulum chaperone complex; IEA:Ensembl.
DR   GO; GO:0005788; C:endoplasmic reticulum lumen; TAS:Reactome.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0005925; C:focal adhesion; HDA:UniProtKB.
DR   GO; GO:0042470; C:melanosome; IEA:UniProtKB-SubCell.
DR   GO; GO:0016020; C:membrane; HDA:UniProtKB.
DR   GO; GO:0005634; C:nucleus; IDA:HPA.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IDA:AgBase.
DR   GO; GO:0032991; C:protein-containing complex; ISS:UniProtKB.
DR   GO; GO:0005790; C:smooth endoplasmic reticulum; IEA:Ensembl.
DR   GO; GO:0003755; F:peptidyl-prolyl cis-trans isomerase activity; ISS:UniProtKB.
DR   GO; GO:0044877; F:protein-containing complex binding; ISS:UniProtKB.
DR   GO; GO:0003723; F:RNA binding; HDA:UniProtKB.
DR   GO; GO:0070063; F:RNA polymerase binding; IPI:AgBase.
DR   GO; GO:0051082; F:unfolded protein binding; TAS:ProtInc.
DR   GO; GO:0060348; P:bone development; IMP:UniProtKB.
DR   GO; GO:0061077; P:chaperone-mediated protein folding; IDA:UniProtKB.
DR   GO; GO:0044829; P:positive regulation by host of viral genome replication; IMP:AgBase.
DR   GO; GO:0044794; P:positive regulation by host of viral process; IMP:AgBase.
DR   GO; GO:0040018; P:positive regulation of multicellular organism growth; IMP:UniProtKB.
DR   GO; GO:0000413; P:protein peptidyl-prolyl isomerization; ISS:UniProtKB.
DR   GO; GO:0050821; P:protein stabilization; IMP:UniProtKB.
DR   Gene3D; 2.40.100.10; -; 1.
DR   InterPro; IPR029000; Cyclophilin-like_dom_sf.
DR   InterPro; IPR024936; Cyclophilin-type_PPIase.
DR   InterPro; IPR020892; Cyclophilin-type_PPIase_CS.
DR   InterPro; IPR002130; Cyclophilin-type_PPIase_dom.
DR   PANTHER; PTHR11071; PTHR11071; 1.
DR   Pfam; PF00160; Pro_isomerase; 1.
DR   PIRSF; PIRSF001467; Peptidylpro_ismrse; 1.
DR   PRINTS; PR00153; CSAPPISMRASE.
DR   SUPFAM; SSF50891; SSF50891; 1.
DR   PROSITE; PS00170; CSA_PPIASE_1; 1.
DR   PROSITE; PS50072; CSA_PPIASE_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Complete proteome;
KW   Direct protein sequencing; Disease mutation; Dwarfism;
KW   Endoplasmic reticulum; Glycoprotein; Isomerase;
KW   Osteogenesis imperfecta; Polymorphism; Reference proteome; Rotamase;
KW   S-nitrosylation; Signal.
FT   SIGNAL        1     33       {ECO:0000269|PubMed:2000394}.
FT   CHAIN        34    216       Peptidyl-prolyl cis-trans isomerase B.
FT                                /FTId=PRO_0000025479.
FT   DOMAIN       47    204       PPIase cyclophilin-type.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00156}.
FT   MOTIF       213    216       Prevents secretion from ER.
FT   MOD_RES      84     84       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:Q99KR7}.
FT   MOD_RES     165    165       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:Q99KR7}.
FT   MOD_RES     202    202       S-nitrosocysteine.
FT                                {ECO:0000250|UniProtKB:Q99KR7}.
FT   MOD_RES     209    209       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P24369}.
FT   MOD_RES     209    209       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P24369}.
FT   CARBOHYD    148    148       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   VARIANT       9      9       M -> R (in OI9; patients have white
FT                                sclerae, normal dentition, no rhizomelia
FT                                or severe deformity of long bones;
FT                                dbSNP:rs137853864).
FT                                {ECO:0000269|PubMed:20089953}.
FT                                /FTId=VAR_063436.
FT   VARIANT      60     60       V -> L (in dbSNP:rs11558595).
FT                                /FTId=VAR_047711.
FT   MUTAGEN     129    129       K->A: Impairs interaction with CLGN and
FT                                CANX. {ECO:0000269|PubMed:20801878}.
FT   CONFLICT      5      5       S -> R (in Ref. 8; AAA52150).
FT                                {ECO:0000305}.
FT   CONFLICT    216    216       E -> D (in Ref. 3; CAG33110).
FT                                {ECO:0000305}.
FT   STRAND       41     52       {ECO:0000244|PDB:3ICH}.
FT   STRAND       55     64       {ECO:0000244|PDB:3ICH}.
FT   TURN         66     68       {ECO:0000244|PDB:3ICH}.
FT   HELIX        70     81       {ECO:0000244|PDB:3ICH}.
FT   TURN         82     84       {ECO:0000244|PDB:3ICH}.
FT   STRAND       95     97       {ECO:0000244|PDB:3ICH}.
FT   TURN         98    100       {ECO:0000244|PDB:3ICH}.
FT   STRAND      101    104       {ECO:0000244|PDB:3ICH}.
FT   TURN        107    109       {ECO:0000244|PDB:3ICH}.
FT   STRAND      110    113       {ECO:0000244|PDB:3ICH}.
FT   STRAND      137    140       {ECO:0000244|PDB:3ICH}.
FT   STRAND      142    144       {ECO:0000244|PDB:1CYN}.
FT   STRAND      152    157       {ECO:0000244|PDB:3ICH}.
FT   HELIX       160    162       {ECO:0000244|PDB:3ICH}.
FT   TURN        163    165       {ECO:0000244|PDB:3ICH}.
FT   STRAND      168    174       {ECO:0000244|PDB:3ICH}.
FT   HELIX       176    183       {ECO:0000244|PDB:3ICH}.
FT   STRAND      193    195       {ECO:0000244|PDB:3ICH}.
FT   STRAND      197    212       {ECO:0000244|PDB:3ICH}.
SQ   SEQUENCE   216 AA;  23743 MW;  2D0410A07AA9E420 CRC64;
     MLRLSERNMK VLLAAALIAG SVFFLLLPGP SAADEKKKGP KVTVKVYFDL RIGDEDVGRV
     IFGLFGKTVP KTVDNFVALA TGEKGFGYKN SKFHRVIKDF MIQGGDFTRG DGTGGKSIYG
     ERFPDENFKL KHYGPGWVSM ANAGKDTNGS QFFITTVKTA WLDGKHVVFG KVLEGMEVVR
     KVESTKTDSR DKPLKDVIIA DCGKIEVEKP FAIAKE
//
ID   PPIC_HUMAN              Reviewed;         212 AA.
AC   P45877; A4LBB5;
DT   01-NOV-1995, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1995, sequence version 1.
DT   28-FEB-2018, entry version 157.
DE   RecName: Full=Peptidyl-prolyl cis-trans isomerase C;
DE            Short=PPIase C;
DE            EC=5.2.1.8;
DE   AltName: Full=Cyclophilin C;
DE   AltName: Full=Rotamase C;
GN   Name=PPIC; Synonyms=CYPC;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=8031755; DOI=10.1021/bi00193a007;
RA   Schneider H., Charara N., Schmitz R., Wehrli S., Mikol V.,
RA   Zurini M.G., Quesniaux V.F., Movva N.R.;
RT   "Human cyclophilin C: primary structure, tissue distribution, and
RT   determination of binding specificity for cyclosporins.";
RL   Biochemistry 33:8218-8224(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS ARG-86; LEU-160 AND
RP   SER-190.
RG   NIEHS SNPs program;
RL   Submitted (MAR-2007) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -!- FUNCTION: PPIases accelerate the folding of proteins. It catalyzes
CC       the cis-trans isomerization of proline imidic peptide bonds in
CC       oligopeptides.
CC   -!- CATALYTIC ACTIVITY: Peptidylproline (omega=180) = peptidylproline
CC       (omega=0).
CC   -!- ENZYME REGULATION: Cyclosporin A (CsA) inhibits CYPC.
CC   -!- INTERACTION:
CC       Q8N9N5:BANP; NbExp=3; IntAct=EBI-953909, EBI-744695;
CC       O43765:SGTA; NbExp=5; IntAct=EBI-953909, EBI-347996;
CC       Q9NZ09:UBAP1; NbExp=3; IntAct=EBI-953909, EBI-9641159;
CC       Q9UMX0:UBQLN1; NbExp=3; IntAct=EBI-953909, EBI-741480;
CC       Q9UMX0-2:UBQLN1; NbExp=3; IntAct=EBI-953909, EBI-10173939;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm.
CC   -!- SIMILARITY: Belongs to the cyclophilin-type PPIase family.
CC       {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=NIEHS-SNPs;
CC       URL="http://egp.gs.washington.edu/data/ppic/";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; S71018; AAB31350.1; -; mRNA.
DR   EMBL; EF506885; ABO43038.1; -; Genomic_DNA.
DR   EMBL; CH471086; EAW48878.1; -; Genomic_DNA.
DR   EMBL; BC002678; AAH02678.1; -; mRNA.
DR   CCDS; CCDS4133.1; -.
DR   PIR; A54204; A54204.
DR   RefSeq; NP_000934.1; NM_000943.4.
DR   UniGene; Hs.110364; -.
DR   PDB; 2ESL; X-ray; 1.90 A; A/B/C/D/E/F=24-212.
DR   PDBsum; 2ESL; -.
DR   ProteinModelPortal; P45877; -.
DR   SMR; P45877; -.
DR   BioGrid; 111476; 9.
DR   IntAct; P45877; 8.
DR   STRING; 9606.ENSP00000303057; -.
DR   BindingDB; P45877; -.
DR   ChEMBL; CHEMBL2424505; -.
DR   DrugBank; DB00172; L-Proline.
DR   iPTMnet; P45877; -.
DR   PhosphoSitePlus; P45877; -.
DR   BioMuta; PPIC; -.
DR   DMDM; 1169178; -.
DR   EPD; P45877; -.
DR   MaxQB; P45877; -.
DR   PaxDb; P45877; -.
DR   PeptideAtlas; P45877; -.
DR   PRIDE; P45877; -.
DR   DNASU; 5480; -.
DR   Ensembl; ENST00000306442; ENSP00000303057; ENSG00000168938.
DR   GeneID; 5480; -.
DR   KEGG; hsa:5480; -.
DR   UCSC; uc003kth.4; human.
DR   CTD; 5480; -.
DR   DisGeNET; 5480; -.
DR   EuPathDB; HostDB:ENSG00000168938.5; -.
DR   GeneCards; PPIC; -.
DR   HGNC; HGNC:9256; PPIC.
DR   HPA; HPA039163; -.
DR   MIM; 123842; gene.
DR   neXtProt; NX_P45877; -.
DR   OpenTargets; ENSG00000168938; -.
DR   PharmGKB; PA33581; -.
DR   eggNOG; KOG0880; Eukaryota.
DR   eggNOG; ENOG410Z0G4; LUCA.
DR   GeneTree; ENSGT00760000119072; -.
DR   HOGENOM; HOG000065981; -.
DR   HOVERGEN; HBG001065; -.
DR   InParanoid; P45877; -.
DR   KO; K09563; -.
DR   OMA; DRPLTNC; -.
DR   OrthoDB; EOG091G0BGL; -.
DR   PhylomeDB; P45877; -.
DR   TreeFam; TF354259; -.
DR   BRENDA; 5.2.1.8; 2681.
DR   ChiTaRS; PPIC; human.
DR   EvolutionaryTrace; P45877; -.
DR   GeneWiki; PPIC; -.
DR   GenomeRNAi; 5480; -.
DR   PRO; PR:P45877; -.
DR   Proteomes; UP000005640; Chromosome 5.
DR   Bgee; ENSG00000168938; -.
DR   CleanEx; HS_PPIC; -.
DR   Genevisible; P45877; HS.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0016018; F:cyclosporin A binding; IDA:UniProtKB.
DR   GO; GO:0003755; F:peptidyl-prolyl cis-trans isomerase activity; IBA:GO_Central.
DR   GO; GO:0006457; P:protein folding; IEA:InterPro.
DR   Gene3D; 2.40.100.10; -; 1.
DR   InterPro; IPR029000; Cyclophilin-like_dom_sf.
DR   InterPro; IPR024936; Cyclophilin-type_PPIase.
DR   InterPro; IPR020892; Cyclophilin-type_PPIase_CS.
DR   InterPro; IPR002130; Cyclophilin-type_PPIase_dom.
DR   PANTHER; PTHR11071; PTHR11071; 1.
DR   Pfam; PF00160; Pro_isomerase; 1.
DR   PIRSF; PIRSF001467; Peptidylpro_ismrse; 1.
DR   PRINTS; PR00153; CSAPPISMRASE.
DR   SUPFAM; SSF50891; SSF50891; 1.
DR   PROSITE; PS00170; CSA_PPIASE_1; 1.
DR   PROSITE; PS50072; CSA_PPIASE_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Complete proteome; Cytoplasm; Isomerase;
KW   Polymorphism; Reference proteome; Rotamase.
FT   CHAIN         1    212       Peptidyl-prolyl cis-trans isomerase C.
FT                                /FTId=PRO_0000064147.
FT   DOMAIN       41    198       PPIase cyclophilin-type.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00156}.
FT   MOD_RES      78     78       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:Q99KR7}.
FT   MOD_RES     159    159       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:Q99KR7}.
FT   VARIANT      86     86       K -> R (in dbSNP:rs34341374).
FT                                {ECO:0000269|Ref.2}.
FT                                /FTId=VAR_051770.
FT   VARIANT     160    160       H -> L (in dbSNP:rs45560036).
FT                                {ECO:0000269|Ref.2}.
FT                                /FTId=VAR_060712.
FT   VARIANT     190    190       N -> S (in dbSNP:rs451195).
FT                                {ECO:0000269|Ref.2}.
FT                                /FTId=VAR_024319.
FT   STRAND       35     46       {ECO:0000244|PDB:2ESL}.
FT   STRAND       49     58       {ECO:0000244|PDB:2ESL}.
FT   TURN         60     62       {ECO:0000244|PDB:2ESL}.
FT   HELIX        64     75       {ECO:0000244|PDB:2ESL}.
FT   TURN         76     78       {ECO:0000244|PDB:2ESL}.
FT   STRAND       89     91       {ECO:0000244|PDB:2ESL}.
FT   TURN         92     94       {ECO:0000244|PDB:2ESL}.
FT   STRAND       95     98       {ECO:0000244|PDB:2ESL}.
FT   STRAND      102    107       {ECO:0000244|PDB:2ESL}.
FT   STRAND      131    134       {ECO:0000244|PDB:2ESL}.
FT   STRAND      136    138       {ECO:0000244|PDB:2ESL}.
FT   STRAND      146    151       {ECO:0000244|PDB:2ESL}.
FT   HELIX       154    156       {ECO:0000244|PDB:2ESL}.
FT   TURN        157    159       {ECO:0000244|PDB:2ESL}.
FT   STRAND      162    168       {ECO:0000244|PDB:2ESL}.
FT   HELIX       170    177       {ECO:0000244|PDB:2ESL}.
FT   STRAND      187    189       {ECO:0000244|PDB:2ESL}.
FT   STRAND      191    206       {ECO:0000244|PDB:2ESL}.
SQ   SEQUENCE   212 AA;  22763 MW;  6F3DB547A2AE581B CRC64;
     MGPGPRLLLP LVLCVGLGAL VFSSGAEGFR KRGPSVTAKV FFDVRIGDKD VGRIVIGLFG
     KVVPKTVENF VALATGEKGY GYKGSKFHRV IKDFMIQGGD ITTGDGTGGV SIYGETFPDE
     NFKLKHYGIG WVSMANAGPD TNGSQFFITL TKPTWLDGKH VVFGKVIDGM TVVHSIELQA
     TDGHDRPLTN CSIINSGKID VKTPFVVEIA DW
//
ID   HRSL4_HUMAN             Reviewed;         164 AA.
AC   Q9UL19; B2R599; B4DDW2; E7ENZ7; O95200;
DT   31-JAN-2002, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-2000, sequence version 1.
DT   23-MAY-2018, entry version 128.
DE   RecName: Full=Retinoic acid receptor responder protein 3;
DE            EC=3.1.1.-;
DE   AltName: Full=HRAS-like suppressor 4;
DE            Short=HRSL4;
DE   AltName: Full=RAR-responsive protein TIG3;
DE   AltName: Full=Retinoid-inducible gene 1 protein;
DE   AltName: Full=Tazarotene-induced gene 3 protein;
GN   Name=RARRES3; Synonyms=RIG1, TIG3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Keratinocyte;
RX   PubMed=9843971; DOI=10.1073/pnas.95.25.14811;
RA   DiSepio D., Ghosn C., Eckert R.L., Deucher A., Robinson N., Duvic M.,
RA   Chandraratna R.A.S., Nagpal S.;
RT   "Identification and characterization of a retinoid-induced class II
RT   tumor suppressor/growth regulatory gene.";
RL   Proc. Natl. Acad. Sci. U.S.A. 95:14811-14815(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), TISSUE SPECIFICITY, AND
RP   INDUCTION.
RC   TISSUE=Stomach cancer;
RX   PubMed=10687848; DOI=10.1016/S0303-7207(99)00207-5;
RA   Huang S.L., Shyu R.Y., Yeh M.Y., Jiang S.Y.;
RT   "Cloning and characterization of a novel retinoid-inducible gene
RT   1(RIG1) deriving from human gastric cancer cells.";
RL   Mol. Cell. Endocrinol. 159:15-24(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, TISSUE SPECIFICITY,
RP   AND BIOPHYSICOCHEMICAL PROPERTIES.
RC   TISSUE=Testis;
RX   PubMed=19615464; DOI=10.1016/j.bbalip.2009.07.001;
RA   Uyama T., Jin X.H., Tsuboi K., Tonai T., Ueda N.;
RT   "Characterization of the human tumor suppressors TIG3 and HRASLS2 as
RT   phospholipid-metabolizing enzymes.";
RL   Biochim. Biophys. Acta 1791:1114-1124(2009).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Gastric adenocarcinoma;
RA   Kato S.;
RL   Submitted (AUG-1999) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Spleen, and Urinary bladder;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16554811; DOI=10.1038/nature04632;
RA   Taylor T.D., Noguchi H., Totoki Y., Toyoda A., Kuroki Y., Dewar K.,
RA   Lloyd C., Itoh T., Takeda T., Kim D.-W., She X., Barlow K.F.,
RA   Bloom T., Bruford E., Chang J.L., Cuomo C.A., Eichler E.,
RA   FitzGerald M.G., Jaffe D.B., LaButti K., Nicol R., Park H.-S.,
RA   Seaman C., Sougnez C., Yang X., Zimmer A.R., Zody M.C., Birren B.W.,
RA   Nusbaum C., Fujiyama A., Hattori M., Rogers J., Lander E.S.,
RA   Sakaki Y.;
RT   "Human chromosome 11 DNA sequence and analysis including novel gene
RT   identification.";
RL   Nature 440:497-500(2006).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -!- FUNCTION: Exhibits PLA1/2 activity, catalyzing the calcium-
CC       independent hydrolysis of acyl groups in various
CC       phosphotidylcholines (PC) and phosphatidylethanolamine (PE). For
CC       most substrates, PLA1 activity is much higher than PLA2 activity.
CC       N- and O-acylation activity is hardly detectable.
CC       {ECO:0000269|PubMed:19615464}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=400 uM for dipalmitoyl-PC {ECO:0000269|PubMed:19615464};
CC         Vmax=530 nmol/min/mg enzyme with dipalmitoyl-PC as substrate
CC         {ECO:0000269|PubMed:19615464};
CC         Vmax=240 nmol/min/mg enzyme with dipalmitoyl-PE as substrate
CC         {ECO:0000269|PubMed:19615464};
CC       pH dependence:
CC         Optimum pH is 8. {ECO:0000269|PubMed:19615464};
CC   -!- INTERACTION:
CC       O43765:SGTA; NbExp=3; IntAct=EBI-10323452, EBI-347996;
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000250}; Single-pass membrane
CC       protein {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9UL19-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9UL19-2; Sequence=VSP_041496;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Widely expressed.
CC       {ECO:0000269|PubMed:10687848, ECO:0000269|PubMed:19615464}.
CC   -!- INDUCTION: By all-trans-retinoic acid and synthetic retinoids.
CC       {ECO:0000269|PubMed:10687848}.
CC   -!- SIMILARITY: Belongs to the H-rev107 family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/RARRES3ID42051ch11q12.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF060228; AAC84000.1; -; mRNA.
DR   EMBL; AF092922; AAF02294.1; -; mRNA.
DR   EMBL; AB453252; BAH22446.1; -; mRNA.
DR   EMBL; AB030815; BAB08109.1; -; mRNA.
DR   EMBL; AK293357; BAG56873.1; -; mRNA.
DR   EMBL; AK312110; BAG35046.1; -; mRNA.
DR   EMBL; AP001591; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471076; EAW74156.1; -; Genomic_DNA.
DR   EMBL; BC009678; AAH09678.1; -; mRNA.
DR   CCDS; CCDS41662.1; -. [Q9UL19-1]
DR   RefSeq; NP_004576.2; NM_004585.4. [Q9UL19-1]
DR   UniGene; Hs.17466; -.
DR   PDB; 2LKT; NMR; -; A=1-125.
DR   PDB; 2MY9; NMR; -; A=1-125.
DR   PDBsum; 2LKT; -.
DR   PDBsum; 2MY9; -.
DR   ProteinModelPortal; Q9UL19; -.
DR   SMR; Q9UL19; -.
DR   BioGrid; 111855; 13.
DR   IntAct; Q9UL19; 2.
DR   STRING; 9606.ENSP00000255688; -.
DR   SwissLipids; SLP:000001076; -.
DR   iPTMnet; Q9UL19; -.
DR   PhosphoSitePlus; Q9UL19; -.
DR   BioMuta; RARRES3; -.
DR   DMDM; 20140910; -.
DR   PaxDb; Q9UL19; -.
DR   PeptideAtlas; Q9UL19; -.
DR   PRIDE; Q9UL19; -.
DR   DNASU; 5920; -.
DR   Ensembl; ENST00000255688; ENSP00000255688; ENSG00000133321. [Q9UL19-1]
DR   Ensembl; ENST00000439013; ENSP00000402943; ENSG00000133321. [Q9UL19-2]
DR   GeneID; 5920; -.
DR   KEGG; hsa:5920; -.
DR   UCSC; uc001nxf.5; human. [Q9UL19-1]
DR   CTD; 5920; -.
DR   DisGeNET; 5920; -.
DR   EuPathDB; HostDB:ENSG00000133321.10; -.
DR   GeneCards; RARRES3; -.
DR   H-InvDB; HIX0128662; -.
DR   HGNC; HGNC:9869; RARRES3.
DR   MIM; 605092; gene.
DR   neXtProt; NX_Q9UL19; -.
DR   OpenTargets; ENSG00000133321; -.
DR   PharmGKB; PA34230; -.
DR   eggNOG; ENOG410J5BU; Eukaryota.
DR   eggNOG; ENOG410Y257; LUCA.
DR   GeneTree; ENSGT00390000013327; -.
DR   HOGENOM; HOG000293227; -.
DR   HOVERGEN; HBG028837; -.
DR   InParanoid; Q9UL19; -.
DR   OMA; RYGRSHC; -.
DR   PhylomeDB; Q9UL19; -.
DR   TreeFam; TF330836; -.
DR   Reactome; R-HSA-1482839; Acyl chain remodelling of PE.
DR   ChiTaRS; RARRES3; human.
DR   GeneWiki; RARRES3; -.
DR   GenomeRNAi; 5920; -.
DR   PRO; PR:Q9UL19; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   Bgee; ENSG00000133321; -.
DR   CleanEx; HS_RARRES3; -.
DR   ExpressionAtlas; Q9UL19; baseline and differential.
DR   Genevisible; Q9UL19; HS.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0004623; F:phospholipase A2 activity; IDA:UniProtKB.
DR   GO; GO:0016746; F:transferase activity, transferring acyl groups; TAS:Reactome.
DR   GO; GO:0016042; P:lipid catabolic process; IEA:UniProtKB-KW.
DR   GO; GO:0008285; P:negative regulation of cell proliferation; TAS:ProtInc.
DR   GO; GO:0036152; P:phosphatidylethanolamine acyl-chain remodeling; TAS:Reactome.
DR   GO; GO:0006644; P:phospholipid metabolic process; IDA:UniProtKB.
DR   InterPro; IPR007053; LRAT-like_dom.
DR   InterPro; IPR033210; RARRES3.
DR   PANTHER; PTHR13943:SF36; PTHR13943:SF36; 1.
DR   Pfam; PF04970; LRAT; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Complete proteome; Hydrolase;
KW   Lipid degradation; Lipid metabolism; Membrane; Polymorphism;
KW   Reference proteome; Transmembrane; Transmembrane helix.
FT   CHAIN         1    164       Retinoic acid receptor responder protein
FT                                3.
FT                                /FTId=PRO_0000152490.
FT   TOPO_DOM      1    133       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    134    155       Helical. {ECO:0000255}.
FT   TOPO_DOM    156    164       Lumenal. {ECO:0000255}.
FT   VAR_SEQ     131    164       EKAKVEVGVATALGILVVAGCSFAIRRYQKKATA -> RTS
FT                                LDNPSPSAWGWTHGAVQPGDHCE (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_041496.
FT   VARIANT      69     69       V -> L (in dbSNP:rs35502888).
FT                                /FTId=VAR_049480.
FT   VARIANT     162    162       A -> V (in dbSNP:rs35845275).
FT                                /FTId=VAR_049481.
FT   CONFLICT     44     44       G -> R (in Ref. 5; BAG56873).
FT                                {ECO:0000305}.
FT   CONFLICT     63     63       E -> G (in Ref. 1; AAC84000).
FT                                {ECO:0000305}.
FT   CONFLICT    118    118       T -> A (in Ref. 1; AAC84000).
FT                                {ECO:0000305}.
FT   STRAND        3      5       {ECO:0000244|PDB:2LKT}.
FT   STRAND       13     17       {ECO:0000244|PDB:2LKT}.
FT   STRAND       19     21       {ECO:0000244|PDB:2LKT}.
FT   STRAND       23     29       {ECO:0000244|PDB:2LKT}.
FT   STRAND       32     37       {ECO:0000244|PDB:2LKT}.
FT   HELIX        42     44       {ECO:0000244|PDB:2MY9}.
FT   STRAND       50     52       {ECO:0000244|PDB:2LKT}.
FT   STRAND       58     64       {ECO:0000244|PDB:2LKT}.
FT   HELIX        65     69       {ECO:0000244|PDB:2LKT}.
FT   STRAND       73     76       {ECO:0000244|PDB:2LKT}.
FT   HELIX        79     83       {ECO:0000244|PDB:2LKT}.
FT   HELIX        89     99       {ECO:0000244|PDB:2LKT}.
FT   HELIX       109    121       {ECO:0000244|PDB:2LKT}.
SQ   SEQUENCE   164 AA;  18179 MW;  95625B8FD375FD38 CRC64;
     MASPHQEPKP GDLIEIFRLG YEHWALYIGD GYVIHLAPPS EYPGAGSSSV FSVLSNSAEV
     KRERLEDVVG GCCYRVNNSL DHEYQPRPVE VIISSAKEMV GQKMKYSIVS RNCEHFVTQL
     RYGKSRCKQV EKAKVEVGVA TALGILVVAG CSFAIRRYQK KATA
//
ID   RPN1_HUMAN              Reviewed;         607 AA.
AC   P04843; B2R5Z0; D3DNB6; Q68DT1;
DT   13-AUG-1987, integrated into UniProtKB/Swiss-Prot.
DT   13-AUG-1987, sequence version 1.
DT   23-MAY-2018, entry version 178.
DE   RecName: Full=Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 1;
DE   AltName: Full=Dolichyl-diphosphooligosaccharide--protein glycosyltransferase 67 kDa subunit;
DE   AltName: Full=Ribophorin I;
DE            Short=RPN-I;
DE   AltName: Full=Ribophorin-1;
DE   Flags: Precursor;
GN   Name=RPN1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=3034581;
RA   Crimaudo C., Hortsch M., Gausepohl H., Meyer D.I.;
RT   "Human ribophorins I and II: the primary structure and membrane
RT   topology of two highly conserved rough endoplasmic reticulum-specific
RT   glycoproteins.";
RL   EMBO J. 6:75-82(1987).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Amygdala;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Uterine endothelium;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Cervix;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   SUBCELLULAR LOCATION [LARGE SCALE ANALYSIS].
RC   TISSUE=Melanoma;
RX   PubMed=12643545; DOI=10.1021/pr025562r;
RA   Basrur V., Yang F., Kushimoto T., Higashimoto Y., Yasumoto K.,
RA   Valencia J., Muller J., Vieira W.D., Watabe H., Shabanowitz J.,
RA   Hearing V.J., Hunt D.F., Appella E.;
RT   "Proteomic analysis of early melanosomes: identification of novel
RT   melanosomal proteins.";
RL   J. Proteome Res. 2:69-79(2003).
RN   [7]
RP   TISSUE SPECIFICITY.
RX   PubMed=12887896; DOI=10.1016/S1097-2765(03)00243-0;
RA   Kelleher D.J., Karaoglu D., Mandon E.C., Gilmore R.;
RT   "Oligosaccharyltransferase isoforms that contain different catalytic
RT   STT3 subunits have distinct enzymatic properties.";
RL   Mol. Cell 12:101-111(2003).
RN   [8]
RP   SUBCELLULAR LOCATION [LARGE SCALE ANALYSIS].
RC   TISSUE=Melanoma;
RX   PubMed=17081065; DOI=10.1021/pr060363j;
RA   Chi A., Valencia J.C., Hu Z.-Z., Watabe H., Yamaguchi H.,
RA   Mangini N.J., Huang H., Canfield V.A., Cheng K.C., Yang F., Abe R.,
RA   Yamagishi S., Shabanowitz J., Hearing V.J., Wu C., Appella E.,
RA   Hunt D.F.;
RT   "Proteomic and bioinformatic characterization of the biogenesis and
RT   function of melanosomes.";
RL   J. Proteome Res. 5:3135-3144(2006).
RN   [9]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-299.
RC   TISSUE=Liver;
RX   PubMed=19159218; DOI=10.1021/pr8008012;
RA   Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.;
RT   "Glycoproteomics analysis of human liver tissue by combination of
RT   multiple enzyme digestion and hydrazide chemistry.";
RL   J. Proteome Res. 8:651-661(2009).
RN   [10]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-187, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [12]
RP   IDENTIFICATION IN THE OLIGOSACCHARYLTRANSFERASE COMPLEX.
RX   PubMed=25135935; DOI=10.1083/jcb.201404083;
RA   Cherepanova N.A., Shrimal S., Gilmore R.;
RT   "Oxidoreductase activity is necessary for N-glycosylation of cysteine-
RT   proximal acceptor sites in glycoproteins.";
RL   J. Cell Biol. 206:525-539(2014).
RN   [13]
RP   IDENTIFICATION IN THE OLIGOSACCHARYLTRANSFERASE COMPLEX.
RX   PubMed=23606741; DOI=10.1242/jcs.115410;
RA   Dumax-Vorzet A., Roboti P., High S.;
RT   "OST4 is a subunit of the mammalian oligosaccharyltransferase required
RT   for efficient N-glycosylation.";
RL   J. Cell Sci. 126:2595-2606(2013).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [15]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-538, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25114211; DOI=10.1073/pnas.1413825111;
RA   Impens F., Radoshevich L., Cossart P., Ribet D.;
RT   "Mapping of SUMO sites and analysis of SUMOylation changes induced by
RT   external stimuli.";
RL   Proc. Natl. Acad. Sci. U.S.A. 111:12432-12437(2014).
RN   [16]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
CC   -!- FUNCTION: Essential subunit of the N-oligosaccharyl transferase
CC       (OST) complex which catalyzes the transfer of a high mannose
CC       oligosaccharide from a lipid-linked oligosaccharide donor to an
CC       asparagine residue within an Asn-X-Ser/Thr consensus motif in
CC       nascent polypeptide chains. {ECO:0000250|UniProtKB:E2RQ08,
CC       ECO:0000250|UniProtKB:Q9GMB0, ECO:0000305}.
CC   -!- PATHWAY: Protein modification; protein glycosylation.
CC   -!- SUBUNIT: Component of the oligosaccharyltransferase (OST) complex.
CC       OST exists in two different complex forms which contain common
CC       core subunits RPN1, RPN2, OST48, OST4, DAD1 and TMEM258, either
CC       STT3A or STT3B as catalytic subunits, and form-specific accessory
CC       subunits. OST can form stable complexes with the Sec61 complex or
CC       with both the Sec61 and TRAP complexes (By similarity).
CC       {ECO:0000250|UniProtKB:E2RQ08, ECO:0000269|PubMed:23606741,
CC       ECO:0000269|PubMed:25135935, ECO:0000305}.
CC   -!- INTERACTION:
CC       O43765:SGTA; NbExp=5; IntAct=EBI-355963, EBI-347996;
CC       Q9UMX0:UBQLN1; NbExp=3; IntAct=EBI-355963, EBI-741480;
CC       Q9UMX0-2:UBQLN1; NbExp=3; IntAct=EBI-355963, EBI-10173939;
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum
CC       {ECO:0000250|UniProtKB:E2RQ08, ECO:0000250|UniProtKB:Q9GMB0}.
CC       Endoplasmic reticulum membrane; Single-pass type I membrane
CC       protein {ECO:0000305}. Melanosome. Note=Identified by mass
CC       spectrometry in melanosome fractions from stage I to stage IV.
CC   -!- TISSUE SPECIFICITY: Expressed in all tissues tested.
CC       {ECO:0000269|PubMed:12887896}.
CC   -!- SIMILARITY: Belongs to the OST1 family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; Y00281; CAA68392.1; -; mRNA.
DR   EMBL; AK312369; BAG35287.1; -; mRNA.
DR   EMBL; CR749284; CAH18139.1; -; mRNA.
DR   EMBL; CH471052; EAW79306.1; -; Genomic_DNA.
DR   EMBL; CH471052; EAW79307.1; -; Genomic_DNA.
DR   EMBL; CH471052; EAW79308.1; -; Genomic_DNA.
DR   EMBL; BC010839; AAH10839.1; -; mRNA.
DR   CCDS; CCDS3051.1; -.
DR   PIR; A26168; A26168.
DR   RefSeq; NP_002941.1; NM_002950.3.
DR   UniGene; Hs.518244; -.
DR   UniGene; Hs.603636; -.
DR   ProteinModelPortal; P04843; -.
DR   SMR; P04843; -.
DR   BioGrid; 112099; 158.
DR   CORUM; P04843; -.
DR   DIP; DIP-38152N; -.
DR   IntAct; P04843; 49.
DR   MINT; P04843; -.
DR   STRING; 9606.ENSP00000296255; -.
DR   iPTMnet; P04843; -.
DR   PhosphoSitePlus; P04843; -.
DR   SwissPalm; P04843; -.
DR   BioMuta; RPN1; -.
DR   DMDM; 132559; -.
DR   EPD; P04843; -.
DR   MaxQB; P04843; -.
DR   PaxDb; P04843; -.
DR   PeptideAtlas; P04843; -.
DR   PRIDE; P04843; -.
DR   TopDownProteomics; P04843; -.
DR   DNASU; 6184; -.
DR   Ensembl; ENST00000296255; ENSP00000296255; ENSG00000163902.
DR   GeneID; 6184; -.
DR   KEGG; hsa:6184; -.
DR   UCSC; uc003ekr.2; human.
DR   CTD; 6184; -.
DR   DisGeNET; 6184; -.
DR   EuPathDB; HostDB:ENSG00000163902.11; -.
DR   GeneCards; RPN1; -.
DR   HGNC; HGNC:10381; RPN1.
DR   HPA; CAB009748; -.
DR   HPA; HPA026828; -.
DR   HPA; HPA051520; -.
DR   MalaCards; RPN1; -.
DR   MIM; 180470; gene.
DR   neXtProt; NX_P04843; -.
DR   OpenTargets; ENSG00000163902; -.
DR   Orphanet; 402020; 'Acute myeloid leukemia with inv3(p21;q26.2) or t(3;3)(p21;q26.2)'.
DR   PharmGKB; PA34777; -.
DR   eggNOG; KOG2291; Eukaryota.
DR   eggNOG; ENOG410XQVZ; LUCA.
DR   GeneTree; ENSGT00390000009630; -.
DR   HOGENOM; HOG000247000; -.
DR   HOVERGEN; HBG012864; -.
DR   InParanoid; P04843; -.
DR   KO; K12666; -.
DR   OMA; RYPIFGG; -.
DR   OrthoDB; EOG091G05K5; -.
DR   PhylomeDB; P04843; -.
DR   TreeFam; TF312988; -.
DR   Reactome; R-HSA-1799339; SRP-dependent cotranslational protein targeting to membrane.
DR   Reactome; R-HSA-446203; Asparagine N-linked glycosylation.
DR   SIGNOR; P04843; -.
DR   UniPathway; UPA00378; -.
DR   ChiTaRS; RPN1; human.
DR   GeneWiki; RPN1; -.
DR   GenomeRNAi; 6184; -.
DR   PRO; PR:P04843; -.
DR   Proteomes; UP000005640; Chromosome 3.
DR   Bgee; ENSG00000163902; -.
DR   CleanEx; HS_RPN1; -.
DR   ExpressionAtlas; P04843; baseline and differential.
DR   Genevisible; P04843; HS.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:HPA.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0042470; C:melanosome; IEA:UniProtKB-SubCell.
DR   GO; GO:0016020; C:membrane; HDA:UniProtKB.
DR   GO; GO:0008250; C:oligosaccharyltransferase complex; TAS:HGNC.
DR   GO; GO:0005791; C:rough endoplasmic reticulum; ISS:UniProtKB.
DR   GO; GO:0004579; F:dolichyl-diphosphooligosaccharide-protein glycotransferase activity; IEA:InterPro.
DR   GO; GO:0003723; F:RNA binding; HDA:UniProtKB.
DR   GO; GO:0006464; P:cellular protein modification process; TAS:ProtInc.
DR   GO; GO:0018279; P:protein N-linked glycosylation via asparagine; IMP:UniProtKB.
DR   InterPro; IPR007676; Ribophorin_I.
DR   PANTHER; PTHR21049; PTHR21049; 1.
DR   Pfam; PF04597; Ribophorin_I; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Complete proteome; Endoplasmic reticulum; Glycoprotein;
KW   Isopeptide bond; Membrane; Reference proteome; Signal; Transmembrane;
KW   Transmembrane helix; Ubl conjugation.
FT   SIGNAL        1     23
FT   CHAIN        24    607       Dolichyl-diphosphooligosaccharide--
FT                                protein glycosyltransferase subunit 1.
FT                                /FTId=PRO_0000022241.
FT   TOPO_DOM     24    438       Lumenal. {ECO:0000255}.
FT   TRANSMEM    439    457       Helical. {ECO:0000255}.
FT   TOPO_DOM    458    607       Cytoplasmic. {ECO:0000255}.
FT   MOD_RES     187    187       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     538    538       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q91YQ5}.
FT   CARBOHYD    299    299       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:19159218}.
FT   CROSSLNK    538    538       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2);
FT                                alternate. {ECO:0000244|PubMed:25114211}.
SQ   SEQUENCE   607 AA;  68569 MW;  A2351A9CFABAEB6C CRC64;
     MEAPAAGLFL LLLLGTWAPA PGSASSEAPP LINEDVKRTV DLSSHLAKVT AEVVLAHLGG
     GSTSRATSFL LALEPELEAR LAHLGVQVKG EDEEENNLEV RETKIKGKSG RFFTVKLPVA
     LDPGAKISVI VETVYTHVLH PYPTQITQSE KQFVVFEGNH YFYSPYPTKT QTMRVKLASR
     NVESYTKLGN PTRSEDLLDY GPFRDVPAYS QDTFKVHYEN NSPFLTITSM TRVIEVSHWG
     NIAVEENVDL KHTGAVLKGP FSRYDYQRQP DSGISSIRSF KTILPAAAQD VYYRDEIGNV
     STSHLLILDD SVEMEIRPRF PLFGGWKTHY IVGYNLPSYE YLYNLGDQYA LKMRFVDHVF
     DEQVIDSLTV KIILPEGAKN IEIDSPYEIS RAPDELHYTY LDTFGRPVIV AYKKNLVEQH
     IQDIVVHYTF NKVLMLQEPL LVVAAFYILF FTVIIYVRLD FSITKDPAAE ARMKVACITE
     QVLTLVNKRI GLYRHFDETV NRYKQSRDIS TLNSGKKSLE TEHKALTSEI ALLQSRLKTE
     GSDLCDRVSE MQKLDAQVKE LVLKSAVEAE RLVAGKLKKD TYIENEKLIS GKRQELVTKI
     DHILDAL
//
ID   B4E1S6_HUMAN            Unreviewed;       126 AA.
AC   B4E1S6;
DT   23-SEP-2008, integrated into UniProtKB/TrEMBL.
DT   23-SEP-2008, sequence version 1.
DT   23-MAY-2018, entry version 76.
DE   RecName: Full=Syndecan {ECO:0000256|RuleBase:RU000649};
GN   Name=SDC4 {ECO:0000313|EMBL:EAW75860.1};
GN   ORFNames=hCG_38363 {ECO:0000313|EMBL:EAW75860.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAG64888.1};
RN   [1] {ECO:0000313|EMBL:EAW75860.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAW75860.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3] {ECO:0000313|EMBL:BAG64888.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Trachea {ECO:0000313|EMBL:BAG64888.1};
RA   Wakamatsu A., Yamamoto J., Kimura K., Ishii S., Watanabe K.,
RA   Sugiyama A., Murakawa K., Kaida T., Tsuchiya K., Fukuzumi Y.,
RA   Kumagai A., Oishi Y., Yamamoto S., Ono Y., Komori Y., Yamazaki M.,
RA   Kisu Y., Nishikawa T., Sugano S., Nomura N., Isogai T.;
RT   "NEDO human cDNA sequencing project focused on splicing variants.";
RL   Submitted (OCT-2007) to the EMBL/GenBank/DDBJ databases.
CC   -!- FUNCTION: Cell surface proteoglycan.
CC       {ECO:0000256|RuleBase:RU000649}.
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000256|RuleBase:RU000649};
CC       Single-pass type I membrane protein
CC       {ECO:0000256|RuleBase:RU000649}.
CC   -!- SIMILARITY: Belongs to the syndecan proteoglycan family.
CC       {ECO:0000256|RuleBase:RU000649}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK303964; BAG64888.1; -; mRNA.
DR   EMBL; CH471077; EAW75860.1; -; Genomic_DNA.
DR   RefSeq; XP_011527279.1; XM_011528977.2.
DR   UniGene; Hs.632267; -.
DR   MaxQB; B4E1S6; -.
DR   PeptideAtlas; B4E1S6; -.
DR   PRIDE; B4E1S6; -.
DR   GeneID; 6385; -.
DR   CTD; 6385; -.
DR   eggNOG; ENOG410IXIG; Eukaryota.
DR   eggNOG; ENOG4111QSA; LUCA.
DR   HOVERGEN; HBG004501; -.
DR   ChiTaRS; SDC4; human.
DR   GenomeRNAi; 6385; -.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   InterPro; IPR003585; Neurexin-like.
DR   InterPro; IPR001050; Syndecan.
DR   InterPro; IPR027789; Syndecan/Neurexin_dom.
DR   InterPro; IPR030479; Syndecan_CS.
DR   PANTHER; PTHR10915; PTHR10915; 1.
DR   Pfam; PF01034; Syndecan; 1.
DR   SMART; SM00294; 4.1m; 1.
DR   PROSITE; PS00964; SYNDECAN; 1.
PE   2: Evidence at transcript level;
KW   Glycoprotein {ECO:0000256|RuleBase:RU000649};
KW   Heparan sulfate {ECO:0000256|RuleBase:RU000649};
KW   Membrane {ECO:0000256|SAAS:SAAS00416869, ECO:0000256|SAM:Phobius};
KW   Proteoglycan {ECO:0000256|RuleBase:RU000649};
KW   Transmembrane {ECO:0000256|SAAS:SAAS00416869,
KW   ECO:0000256|SAM:Phobius};
KW   Transmembrane helix {ECO:0000256|SAAS:SAAS00416869,
KW   ECO:0000256|SAM:Phobius}.
FT   TRANSMEM     74     98       Helical. {ECO:0000256|SAM:Phobius}.
FT   DOMAIN       97    115       4.1m. {ECO:0000259|SMART:SM00294}.
SQ   SEQUENCE   126 AA;  13910 MW;  FFFFA5D3D4B914A4 CRC64;
     MIGPEVVHPL VPLDNHIPER AGSGSQVPTE PKKLEENEVI PKRISPVEES EDVSNKVSMS
     STVQGSNIFE RTEVLAALIV GGIVGILFAV FLILLLMYRM KKKDEGSYDL GKKPIYKKAP
     TNEFYA
//
ID   SDC4_HUMAN              Reviewed;         198 AA.
AC   P31431; O00773; Q16833; Q53FN9; Q6FGN3;
DT   01-JUL-1993, integrated into UniProtKB/Swiss-Prot.
DT   15-JUL-1998, sequence version 2.
DT   23-MAY-2018, entry version 187.
DE   RecName: Full=Syndecan-4;
DE            Short=SYND4;
DE   AltName: Full=Amphiglycan;
DE   AltName: Full=Ryudocan core protein;
DE   Flags: Precursor;
GN   Name=SDC4;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), TISSUE SPECIFICITY, AND
RP   VARIANT LEU-12.
RC   TISSUE=Lung fibroblast;
RX   PubMed=1500433; DOI=10.1083/jcb.118.4.961;
RA   David G., van der Schueren B., Marynen P., Cassiman J.-J.,
RA   van den Berghe H.;
RT   "Molecular cloning of amphiglycan, a novel integral membrane heparan
RT   sulfate proteoglycan expressed by epithelial and fibroblastic cells.";
RL   J. Cell Biol. 118:961-969(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=7916598; DOI=10.1006/bbrc.1993.1122;
RA   Kojima T., Inazawa J., Takamatsu J., Rosenberg R.D., Saito H.;
RT   "Human ryudocan core protein: molecular cloning and characterization
RT   of the cDNA, and chromosomal localization of the gene.";
RL   Biochem. Biophys. Res. Commun. 190:814-822(1993).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   TISSUE=Placenta;
RX   PubMed=8797100; DOI=10.1093/oxfordjournals.jbchem.a021338;
RA   Takagi A., Kojima T., Tsuzuki S., Katsumi A., Yamazaki T., Sugiura I.,
RA   Hamaguchi M., Saito H.;
RT   "Structural organization and promoter activity of the human ryudocan
RT   gene.";
RL   J. Biochem. 119:979-984(1996).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Thalamus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT
RP   LEU-12.
RC   TISSUE=Stomach;
RA   Suzuki Y., Sugano S., Totoki Y., Toyoda A., Takeda T., Sakaki Y.,
RA   Tanaka A., Yokoyama S.;
RL   Submitted (APR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11780052; DOI=10.1038/414865a;
RA   Deloukas P., Matthews L.H., Ashurst J.L., Burton J., Gilbert J.G.R.,
RA   Jones M., Stavrides G., Almeida J.P., Babbage A.K., Bagguley C.L.,
RA   Bailey J., Barlow K.F., Bates K.N., Beard L.M., Beare D.M.,
RA   Beasley O.P., Bird C.P., Blakey S.E., Bridgeman A.M., Brown A.J.,
RA   Buck D., Burrill W.D., Butler A.P., Carder C., Carter N.P.,
RA   Chapman J.C., Clamp M., Clark G., Clark L.N., Clark S.Y., Clee C.M.,
RA   Clegg S., Cobley V.E., Collier R.E., Connor R.E., Corby N.R.,
RA   Coulson A., Coville G.J., Deadman R., Dhami P.D., Dunn M.,
RA   Ellington A.G., Frankland J.A., Fraser A., French L., Garner P.,
RA   Grafham D.V., Griffiths C., Griffiths M.N.D., Gwilliam R., Hall R.E.,
RA   Hammond S., Harley J.L., Heath P.D., Ho S., Holden J.L., Howden P.J.,
RA   Huckle E., Hunt A.R., Hunt S.E., Jekosch K., Johnson C.M., Johnson D.,
RA   Kay M.P., Kimberley A.M., King A., Knights A., Laird G.K., Lawlor S.,
RA   Lehvaeslaiho M.H., Leversha M.A., Lloyd C., Lloyd D.M., Lovell J.D.,
RA   Marsh V.L., Martin S.L., McConnachie L.J., McLay K., McMurray A.A.,
RA   Milne S.A., Mistry D., Moore M.J.F., Mullikin J.C., Nickerson T.,
RA   Oliver K., Parker A., Patel R., Pearce T.A.V., Peck A.I.,
RA   Phillimore B.J.C.T., Prathalingam S.R., Plumb R.W., Ramsay H.,
RA   Rice C.M., Ross M.T., Scott C.E., Sehra H.K., Shownkeen R., Sims S.,
RA   Skuce C.D., Smith M.L., Soderlund C., Steward C.A., Sulston J.E.,
RA   Swann R.M., Sycamore N., Taylor R., Tee L., Thomas D.W., Thorpe A.,
RA   Tracey A., Tromans A.C., Vaudin M., Wall M., Wallis J.M.,
RA   Whitehead S.L., Whittaker P., Willey D.L., Williams L., Williams S.A.,
RA   Wilming L., Wray P.W., Hubbard T., Durbin R.M., Bentley D.R., Beck S.,
RA   Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 20.";
RL   Nature 414:865-871(2001).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 75-153 (ISOFORM 2).
RA   Hillier L., Clark N., Dubuque T., Elliston K., Hawkins M., Holman M.,
RA   Hultman M., Kucaba T., Le M., Lennon G., Marra M., Parsons J.,
RA   Rifkin L., Rohlfing T., Soares M., Tan F., Trevaskis E., Waterston R.,
RA   Williamson A., Wohldmann P., Wilson R.;
RT   "The WashU-Merck EST project.";
RL   Submitted (MAR-2000) to the EMBL/GenBank/DDBJ databases.
RN   [11]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 125-153 (ISOFORM 2).
RC   TISSUE=Uterus;
RX   PubMed=8889549; DOI=10.1101/gr.6.9.807;
RA   Hillier L.D., Lennon G., Becker M., Bonaldo M.F., Chiapelli B.,
RA   Chissoe S., Dietrich N., DuBuque T., Favello A., Gish W., Hawkins M.,
RA   Hultman M., Kucaba T., Lacy M., Le M., Le N., Mardis E., Moore B.,
RA   Morris M., Parsons J., Prange C., Rifkin L., Rohlfing T.,
RA   Schellenberg K., Bento Soares M., Tan F., Thierry-Meg J.,
RA   Trevaskis E., Underwood K., Wohldman P., Waterston R., Wilson R.,
RA   Marra M.;
RT   "Generation and analysis of 280,000 human expressed sequence tags.";
RL   Genome Res. 6:807-828(1996).
RN   [12]
RP   SHEDDING, AND SUBCELLULAR LOCATION.
RX   PubMed=9169435; DOI=10.1074/jbc.272.23.14713;
RA   Subramanian S.V., Fitzgerald M.L., Bernfield M.;
RT   "Regulated shedding of syndecan-1 and -4 ectodomains by thrombin and
RT   growth factor receptor activation.";
RL   J. Biol. Chem. 272:14713-14720(1997).
RN   [13]
RP   ALTERNATIVE SPLICING (ISOFORM 2), AND SUBCELLULAR LOCATION.
RX   PubMed=14675776; DOI=10.1016/S0014-5793(03)01354-1;
RA   Xing Y., Xu Q., Lee C.;
RT   "Widespread production of novel soluble protein isoforms by
RT   alternative splicing removal of transmembrane anchoring domains.";
RL   FEBS Lett. 555:572-578(2003).
RN   [14]
RP   INTERACTION WITH CDCP1.
RX   PubMed=16007225; DOI=10.1038/sj.onc.1208582;
RA   Bhatt A.S., Erdjument-Bromage H., Tempst P., Craik C.S., Moasser M.M.;
RT   "Adhesion signaling by a novel mitotic substrate of src kinases.";
RL   Oncogene 24:5333-5343(2005).
RN   [15]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [16]
RP   FUNCTION.
RX   PubMed=22660413; DOI=10.1038/ncb2502;
RA   Baietti M.F., Zhang Z., Mortier E., Melchior A., Degeest G.,
RA   Geeraerts A., Ivarsson Y., Depoortere F., Coomans C., Vermeiren E.,
RA   Zimmermann P., David G.;
RT   "Syndecan-syntenin-ALIX regulates the biogenesis of exosomes.";
RL   Nat. Cell Biol. 14:677-685(2012).
RN   [17]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [18]
RP   STRUCTURE BY NMR OF 171-198.
RX   PubMed=11456484; DOI=10.1021/bi002750r;
RA   Shin J., Lee W., Lee D., Koo B.-K., Han I., Lim Y., Woods A.,
RA   Couchman J.R., Oh E.-S.;
RT   "Solution structure of the dimeric cytoplasmic domain of syndecan-4.";
RL   Biochemistry 40:8471-8478(2001).
RN   [19]
RP   X-RAY CRYSTALLOGRAPHY (1.85 ANGSTROMS) OF 193-198 IN COMPLEX WITH
RP   SDCBP.
RX   PubMed=12842047; DOI=10.1016/S0969-2126(03)00125-4;
RA   Kang B.S., Cooper D.R., Devedjiev Y., Derewenda U., Derewenda Z.S.;
RT   "Molecular roots of degenerate specificity in syntenin's PDZ2 domain:
RT   reassessment of the PDZ recognition paradigm.";
RL   Structure 11:845-853(2003).
RN   [20]
RP   X-RAY CRYSTALLOGRAPHY (2.3 ANGSTROMS) OF 182-198 IN COMPLEX WITH
RP   SDCBP.
RX   PubMed=16533050; DOI=10.1021/bi052225y;
RA   Grembecka J., Cierpicki T., Devedjiev Y., Derewenda U., Kang B.S.,
RA   Bushweller J.H., Derewenda Z.S.;
RT   "The binding of the PDZ tandem of syntenin to target proteins.";
RL   Biochemistry 45:3674-3683(2006).
CC   -!- FUNCTION: Cell surface proteoglycan that bears heparan sulfate.
CC       Regulates exosome biogenesis in concert with SDCBP and PDCD6IP
CC       (PubMed:22660413). {ECO:0000269|PubMed:22660413}.
CC   -!- SUBUNIT: Homodimer. Interacts (via its cytoplasmic domain) with
CC       GIPC (via its PDZ domain). Interacts (via its cytoplasmic domain)
CC       with NUDT16L1 (By similarity). Interacts with CDCP1 and SDCBP.
CC       {ECO:0000250|UniProtKB:O35988, ECO:0000269|PubMed:12842047,
CC       ECO:0000269|PubMed:16007225, ECO:0000269|PubMed:16533050}.
CC   -!- INTERACTION:
CC       Self; NbExp=3; IntAct=EBI-3913237, EBI-3913237;
CC       P17252:PRKCA; NbExp=2; IntAct=EBI-3913237, EBI-1383528;
CC       P34741:SDC2; NbExp=2; IntAct=EBI-3913237, EBI-1172957;
CC       O75056:SDC3; NbExp=2; IntAct=EBI-3913237, EBI-1642090;
CC       O43765:SGTA; NbExp=5; IntAct=EBI-3913237, EBI-347996;
CC   -!- SUBCELLULAR LOCATION: Isoform 1: Membrane {ECO:0000255}; Single-
CC       pass type I membrane protein {ECO:0000255}. Secreted
CC       {ECO:0000269|PubMed:9169435}. Note=Shedding of the ectodomain
CC       produces a soluble form. {ECO:0000269|PubMed:9169435}.
CC   -!- SUBCELLULAR LOCATION: Isoform 2: Secreted.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P31431-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P31431-2; Sequence=VSP_044449;
CC         Note=Soluble form, lacks the transmembrane domain.;
CC   -!- TISSUE SPECIFICITY: Expressed in epithelial and fibroblastic
CC       cells. {ECO:0000269|PubMed:1500433}.
CC   -!- PTM: Shedding is enhanced by a number of factors such as
CC       heparanase, thrombin or EGF. Also by stress and wound healing.
CC       PMA-mediated shedding is inhibited by TIMP3.
CC       {ECO:0000269|PubMed:9169435}.
CC   -!- SIMILARITY: Belongs to the syndecan proteoglycan family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X67016; CAA47406.1; -; mRNA.
DR   EMBL; D13292; BAA02550.1; -; mRNA.
DR   EMBL; D79206; BAA19613.1; -; Genomic_DNA.
DR   EMBL; AK312507; BAG35408.1; -; mRNA.
DR   EMBL; CR542045; CAG46842.1; -; mRNA.
DR   EMBL; CR542074; CAG46871.1; -; mRNA.
DR   EMBL; AK222695; BAD96415.1; -; mRNA.
DR   EMBL; AK223243; BAD96963.1; -; mRNA.
DR   EMBL; AL021578; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471077; EAW75861.1; -; Genomic_DNA.
DR   EMBL; CH471077; EAW75862.1; -; Genomic_DNA.
DR   EMBL; BC030805; AAH30805.1; -; mRNA.
DR   EMBL; AA151028; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; AA258502; -; NOT_ANNOTATED_CDS; mRNA.
DR   CCDS; CCDS13350.1; -. [P31431-1]
DR   PIR; JC1457; JC1457.
DR   RefSeq; NP_002990.2; NM_002999.3. [P31431-1]
DR   UniGene; Hs.632267; -.
DR   PDB; 1EJP; NMR; -; A/B=171-198.
DR   PDB; 1EJQ; NMR; -; A/B=171-198.
DR   PDB; 1OBY; X-ray; 1.85 A; P/Q=193-198.
DR   PDB; 1YBO; X-ray; 2.30 A; C/D=182-198.
DR   PDBsum; 1EJP; -.
DR   PDBsum; 1EJQ; -.
DR   PDBsum; 1OBY; -.
DR   PDBsum; 1YBO; -.
DR   ProteinModelPortal; P31431; -.
DR   SMR; P31431; -.
DR   BioGrid; 112286; 19.
DR   DIP; DIP-29945N; -.
DR   ELM; P31431; -.
DR   IntAct; P31431; 17.
DR   MINT; P31431; -.
DR   STRING; 9606.ENSP00000361818; -.
DR   TCDB; 9.A.35.1.1; the peptide translocating syndecan (syndecan) family.
DR   iPTMnet; P31431; -.
DR   PhosphoSitePlus; P31431; -.
DR   BioMuta; SDC4; -.
DR   DMDM; 2851418; -.
DR   EPD; P31431; -.
DR   PaxDb; P31431; -.
DR   PeptideAtlas; P31431; -.
DR   PRIDE; P31431; -.
DR   TopDownProteomics; P31431-1; -. [P31431-1]
DR   DNASU; 6385; -.
DR   Ensembl; ENST00000372733; ENSP00000361818; ENSG00000124145. [P31431-1]
DR   GeneID; 6385; -.
DR   KEGG; hsa:6385; -.
DR   UCSC; uc002xnu.4; human. [P31431-1]
DR   CTD; 6385; -.
DR   DisGeNET; 6385; -.
DR   EuPathDB; HostDB:ENSG00000124145.6; -.
DR   GeneCards; SDC4; -.
DR   HGNC; HGNC:10661; SDC4.
DR   HPA; CAB013240; -.
DR   HPA; HPA005716; -.
DR   MIM; 600017; gene.
DR   neXtProt; NX_P31431; -.
DR   OpenTargets; ENSG00000124145; -.
DR   PharmGKB; PA35591; -.
DR   eggNOG; ENOG410IXIG; Eukaryota.
DR   eggNOG; ENOG4111QSA; LUCA.
DR   GeneTree; ENSGT00530000063116; -.
DR   HOGENOM; HOG000263414; -.
DR   HOVERGEN; HBG004501; -.
DR   InParanoid; P31431; -.
DR   KO; K16338; -.
DR   OMA; QEPDDFE; -.
DR   OrthoDB; EOG091G0OOE; -.
DR   PhylomeDB; P31431; -.
DR   TreeFam; TF320463; -.
DR   Reactome; R-HSA-1971475; A tetrasaccharide linker sequence is required for GAG synthesis.
DR   Reactome; R-HSA-2022928; HS-GAG biosynthesis.
DR   Reactome; R-HSA-2024096; HS-GAG degradation.
DR   Reactome; R-HSA-202733; Cell surface interactions at the vascular wall.
DR   Reactome; R-HSA-3000170; Syndecan interactions.
DR   Reactome; R-HSA-3560783; Defective B4GALT7 causes EDS, progeroid type.
DR   Reactome; R-HSA-3560801; Defective B3GAT3 causes JDSSDHD.
DR   Reactome; R-HSA-3656237; Defective EXT2 causes exostoses 2.
DR   Reactome; R-HSA-3656253; Defective EXT1 causes exostoses 1, TRPS2 and CHDS.
DR   Reactome; R-HSA-4420332; Defective B3GALT6 causes EDSP2 and SEMDJL1.
DR   Reactome; R-HSA-975634; Retinoid metabolism and transport.
DR   SIGNOR; P31431; -.
DR   ChiTaRS; SDC4; human.
DR   EvolutionaryTrace; P31431; -.
DR   GeneWiki; SDC4; -.
DR   GenomeRNAi; 6385; -.
DR   PMAP-CutDB; P31431; -.
DR   PRO; PR:P31431; -.
DR   Proteomes; UP000005640; Chromosome 20.
DR   Bgee; ENSG00000124145; -.
DR   CleanEx; HS_SDC4; -.
DR   Genevisible; P31431; HS.
DR   GO; GO:0009986; C:cell surface; IBA:GO_Central.
DR   GO; GO:0043034; C:costamere; IEA:Ensembl.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0005925; C:focal adhesion; IEA:Ensembl.
DR   GO; GO:0005796; C:Golgi lumen; TAS:Reactome.
DR   GO; GO:0005887; C:integral component of plasma membrane; NAS:UniProtKB.
DR   GO; GO:0043202; C:lysosomal lumen; TAS:Reactome.
DR   GO; GO:0045121; C:membrane raft; IEA:Ensembl.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0001968; F:fibronectin binding; IEA:Ensembl.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0005080; F:protein kinase C binding; IEA:Ensembl.
DR   GO; GO:0070053; F:thrombospondin receptor activity; IMP:BHF-UCL.
DR   GO; GO:0016477; P:cell migration; IBA:GO_Central.
DR   GO; GO:0006024; P:glycosaminoglycan biosynthetic process; TAS:Reactome.
DR   GO; GO:0006027; P:glycosaminoglycan catabolic process; TAS:Reactome.
DR   GO; GO:0060122; P:inner ear receptor cell stereocilium organization; IEA:Ensembl.
DR   GO; GO:0050900; P:leukocyte migration; TAS:Reactome.
DR   GO; GO:0042130; P:negative regulation of T cell proliferation; IMP:ParkinsonsUK-UCL.
DR   GO; GO:0001843; P:neural tube closure; IEA:Ensembl.
DR   GO; GO:1903543; P:positive regulation of exosomal secretion; IMP:UniProtKB.
DR   GO; GO:1903553; P:positive regulation of extracellular exosome assembly; IMP:UniProtKB.
DR   GO; GO:0051894; P:positive regulation of focal adhesion assembly; IEA:Ensembl.
DR   GO; GO:0045860; P:positive regulation of protein kinase activity; IEA:Ensembl.
DR   GO; GO:0051496; P:positive regulation of stress fiber assembly; IEA:Ensembl.
DR   GO; GO:0010762; P:regulation of fibroblast migration; IEA:Ensembl.
DR   GO; GO:0001523; P:retinoid metabolic process; TAS:Reactome.
DR   GO; GO:0001657; P:ureteric bud development; IEA:Ensembl.
DR   GO; GO:0042060; P:wound healing; IEA:Ensembl.
DR   InterPro; IPR003585; Neurexin-like.
DR   InterPro; IPR001050; Syndecan.
DR   InterPro; IPR027789; Syndecan/Neurexin_dom.
DR   InterPro; IPR030479; Syndecan_CS.
DR   PANTHER; PTHR10915; PTHR10915; 1.
DR   Pfam; PF01034; Syndecan; 1.
DR   SMART; SM00294; 4.1m; 1.
DR   PROSITE; PS00964; SYNDECAN; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Complete proteome; Glycoprotein;
KW   Heparan sulfate; Membrane; Polymorphism; Proteoglycan;
KW   Reference proteome; Secreted; Signal; Transmembrane;
KW   Transmembrane helix.
FT   SIGNAL        1     18       {ECO:0000255}.
FT   CHAIN        19    198       Syndecan-4.
FT                                /FTId=PRO_0000033511.
FT   TOPO_DOM     19    145       Extracellular. {ECO:0000255}.
FT   TRANSMEM    146    170       Helical. {ECO:0000255}.
FT   TOPO_DOM    171    198       Cytoplasmic. {ECO:0000255}.
FT   CARBOHYD     39     39       O-linked (Xyl...) (heparan sulfate)
FT                                serine. {ECO:0000250}.
FT   CARBOHYD     61     61       O-linked (Xyl...) (heparan sulfate)
FT                                serine. {ECO:0000255}.
FT   CARBOHYD     63     63       O-linked (Xyl...) (heparan sulfate)
FT                                serine. {ECO:0000255}.
FT   VAR_SEQ     149    198       ALIVGGIVGILFAVFLILLLMYRMKKKDEGSYDLGKKPIYK
FT                                KAPTNEFYA -> GCPEH (in isoform 2).
FT                                {ECO:0000303|PubMed:8889549,
FT                                ECO:0000303|Ref.10}.
FT                                /FTId=VSP_044449.
FT   VARIANT      12     12       F -> L (in dbSNP:rs2228384).
FT                                {ECO:0000269|PubMed:1500433,
FT                                ECO:0000269|Ref.6}.
FT                                /FTId=VAR_021851.
FT   STRAND      192    194       {ECO:0000244|PDB:1EJQ}.
FT   STRAND      196    198       {ECO:0000244|PDB:1OBY}.
SQ   SEQUENCE   198 AA;  21642 MW;  8229AA2733F77A10 CRC64;
     MAPARLFALL LFFVGGVAES IRETEVIDPQ DLLEGRYFSG ALPDDEDVVG PGQESDDFEL
     SGSGDLDDLE DSMIGPEVVH PLVPLDNHIP ERAGSGSQVP TEPKKLEENE VIPKRISPVE
     ESEDVSNKVS MSSTVQGSNI FERTEVLAAL IVGGIVGILF AVFLILLLMY RMKKKDEGSY
     DLGKKPIYKK APTNEFYA
//
ID   A0A0S2Z4P8_HUMAN        Unreviewed;       263 AA.
AC   A0A0S2Z4P8;
DT   17-FEB-2016, integrated into UniProtKB/TrEMBL.
DT   17-FEB-2016, sequence version 1.
DT   23-MAY-2018, entry version 23.
DE   SubName: Full=Sarcoglycan alpha isoform 2 {ECO:0000313|EMBL:ALQ33790.1};
DE   SubName: Full=Sarcoglycan, alpha (50kDa dystrophin-associated glycoprotein), isoform CRA_a {ECO:0000313|EMBL:EAW94634.1};
DE   Flags: Fragment;
GN   Name=SGCA {ECO:0000313|EMBL:ALQ33790.1};
GN   ORFNames=hCG_29610 {ECO:0000313|EMBL:EAW94634.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:ALQ33790.1};
RN   [1] {ECO:0000313|EMBL:EAW94634.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAW94634.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3] {ECO:0000313|EMBL:ALQ33790.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=26871637; DOI=10.1016/j.cell.2016.01.029;
RA   Yang X., Coulombe-Huntington J., Kang S., Sheynkman G.M., Hao T.,
RA   Richardson A., Sun S., Yang F., Shen Y.A., Murray R., Spirohn K.,
RA   Begg B.E., Duran-Frigola M., MacWilliams A., Pevzner S.J., Zhong Q.,
RA   Trigg S.A., Tam S., Ghamsari L., Sahni N., Yi S., Rodriguez M.D.,
RA   Balcha D., Tan G., Costanzo M., Andrews B., Boone C., Zhou X.J.,
RA   Salehi-Ashtiani K., Charloteaux B., Chen A., Calderwood M.A., Aloy P.,
RA   Roth F.P., Hill D.E., Iakoucheva L.M., Xia Y., Vidal M.;
RT   "Widespread Expansion of Protein Interaction Capabilities by
RT   Alternative Splicing.";
RL   Cell 164:805-817(2016).
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; KU178332; ALQ33790.1; -; mRNA.
DR   EMBL; CH471109; EAW94634.1; -; Genomic_DNA.
DR   RefSeq; NP_001129169.1; NM_001135697.2.
DR   UniGene; Hs.463412; -.
DR   SMR; A0A0S2Z4P8; -.
DR   GeneID; 6442; -.
DR   CTD; 6442; -.
DR   ChiTaRS; SGCA; human.
DR   ExpressionAtlas; A0A0S2Z4P8; baseline and differential.
DR   GO; GO:0016012; C:sarcoglycan complex; IEA:InterPro.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   InterPro; IPR028658; Alpha-SG.
DR   InterPro; IPR006644; Cadg.
DR   InterPro; IPR015919; Cadherin-like.
DR   InterPro; IPR008908; Sarcoglycan_alpha/epsilon.
DR   PANTHER; PTHR10132; PTHR10132; 2.
DR   PANTHER; PTHR10132:SF16; PTHR10132:SF16; 2.
DR   Pfam; PF05510; Sarcoglycan_2; 1.
DR   SMART; SM00736; CADG; 1.
DR   SUPFAM; SSF49313; SSF49313; 1.
PE   2: Evidence at transcript level;
KW   Signal {ECO:0000256|SAM:SignalP}.
FT   SIGNAL        1     23       {ECO:0000256|SAM:SignalP}.
FT   CHAIN        24    263       {ECO:0000256|SAM:SignalP}.
FT                                /FTId=PRO_5014239286.
FT   DOMAIN       27    131       CADG. {ECO:0000259|SMART:SM00736}.
FT   NON_TER     263    263       {ECO:0000313|EMBL:ALQ33790.1}.
SQ   SEQUENCE   263 AA;  29354 MW;  A5437E496658776B CRC64;
     MAETLFWTPL LVVLLAGLGD TEAQQTTLHP LVGRVFVHTL DHETFLSLPE HVAVPPAVHI
     TYHAHLQGHP DLPRWLRYTQ RSPHHPGFLY GSATPEDRGL QVIEVTAYNR DSFDTTRQRL
     VLEIGDPEGP LLPYQAEFLV RSHDAEEVLP STPASRFLSA LGGLWEPGEL QLLNVTSALD
     RGGRVPLPIE GRKEGLKRDL ATSDIQMVHH CTIHGNTEEL RQMAASREVP RPLSTLPMFN
     VHTGERLPPR VDSAQVPLIL DQH
//
ID   A0A0S2Z4Q1_HUMAN        Unreviewed;       387 AA.
AC   A0A0S2Z4Q1;
DT   17-FEB-2016, integrated into UniProtKB/TrEMBL.
DT   17-FEB-2016, sequence version 1.
DT   28-MAR-2018, entry version 16.
DE   SubName: Full=Sarcoglycan alpha isoform 1 {ECO:0000313|EMBL:ALQ33789.1};
DE   Flags: Fragment;
GN   Name=SGCA {ECO:0000313|EMBL:ALQ33789.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:ALQ33789.1};
RN   [1] {ECO:0000313|EMBL:ALQ33789.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=26871637; DOI=10.1016/j.cell.2016.01.029;
RA   Yang X., Coulombe-Huntington J., Kang S., Sheynkman G.M., Hao T.,
RA   Richardson A., Sun S., Yang F., Shen Y.A., Murray R., Spirohn K.,
RA   Begg B.E., Duran-Frigola M., MacWilliams A., Pevzner S.J., Zhong Q.,
RA   Trigg S.A., Tam S., Ghamsari L., Sahni N., Yi S., Rodriguez M.D.,
RA   Balcha D., Tan G., Costanzo M., Andrews B., Boone C., Zhou X.J.,
RA   Salehi-Ashtiani K., Charloteaux B., Chen A., Calderwood M.A., Aloy P.,
RA   Roth F.P., Hill D.E., Iakoucheva L.M., Xia Y., Vidal M.;
RT   "Widespread Expansion of Protein Interaction Capabilities by
RT   Alternative Splicing.";
RL   Cell 164:805-817(2016).
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; KU178331; ALQ33789.1; -; mRNA.
DR   RefSeq; NP_000014.1; NM_000023.3.
DR   UniGene; Hs.463412; -.
DR   ProteinModelPortal; A0A0S2Z4Q1; -.
DR   SMR; A0A0S2Z4Q1; -.
DR   GeneID; 6442; -.
DR   KEGG; hsa:6442; -.
DR   CTD; 6442; -.
DR   KO; K12565; -.
DR   OMA; WCNVSLV; -.
DR   PhylomeDB; A0A0S2Z4Q1; -.
DR   ChiTaRS; SGCA; human.
DR   ExpressionAtlas; A0A0S2Z4Q1; baseline and differential.
DR   GO; GO:0005911; C:cell-cell junction; IEA:Ensembl.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0045121; C:membrane raft; IEA:Ensembl.
DR   GO; GO:0016012; C:sarcoglycan complex; IEA:InterPro.
DR   GO; GO:0042383; C:sarcolemma; IEA:Ensembl.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   GO; GO:0014894; P:response to denervation involved in regulation of muscle adaptation; IEA:Ensembl.
DR   GO; GO:0043403; P:skeletal muscle tissue regeneration; IEA:Ensembl.
DR   InterPro; IPR028658; Alpha-SG.
DR   InterPro; IPR006644; Cadg.
DR   InterPro; IPR015919; Cadherin-like.
DR   InterPro; IPR008908; Sarcoglycan_alpha/epsilon.
DR   PANTHER; PTHR10132; PTHR10132; 1.
DR   PANTHER; PTHR10132:SF16; PTHR10132:SF16; 1.
DR   Pfam; PF05510; Sarcoglycan_2; 1.
DR   SMART; SM00736; CADG; 1.
DR   SUPFAM; SSF49313; SSF49313; 1.
PE   2: Evidence at transcript level;
KW   Membrane {ECO:0000256|SAM:Phobius}; Signal {ECO:0000256|SAM:SignalP};
KW   Transmembrane {ECO:0000256|SAM:Phobius};
KW   Transmembrane helix {ECO:0000256|SAM:Phobius}.
FT   SIGNAL        1     23       {ECO:0000256|SAM:SignalP}.
FT   CHAIN        24    387       {ECO:0000256|SAM:SignalP}.
FT                                /FTId=PRO_5006608268.
FT   TRANSMEM    286    312       Helical. {ECO:0000256|SAM:Phobius}.
FT   DOMAIN       27    131       CADG. {ECO:0000259|SMART:SM00736}.
FT   NON_TER     387    387       {ECO:0000313|EMBL:ALQ33789.1}.
SQ   SEQUENCE   387 AA;  42875 MW;  9CD0270A00BE03E6 CRC64;
     MAETLFWTPL LVVLLAGLGD TEAQQTTLHP LVGRVFVHTL DHETFLSLPE HVAVPPAVHI
     TYHAHLQGHP DLPRWLRYTQ RSPHHPGFLY GSATPEDRGL QVIEVTAYNR DSFDTTRQRL
     VLEIGDPEGP LLPYQAEFLV RSHDAEEVLP STPASRFLSA LGGLWEPGEL QLLNVTSALD
     RGGRVPLPIE GRKEGVYIKV GSASPFSTCL KMVASPDSHA RCAQGQPPLL SCYDTLAPHF
     RVDWCNVTLV DKSVPEPADE VPTPGDGILE HDPFFCPPTE APDRDFLVDA LVTLLVPLLV
     ALLLTLLLAY VMCCRREGRL KRDLATSDIQ MVHHCTIHGN TEELRQMAAS REVPRPLSTL
     PMFNVHTGER LPPRVDSAQV PLILDQH
//
ID   SGCA_HUMAN              Reviewed;         387 AA.
AC   Q16586; A6NEB8; A8K3K7; Q13710; Q13712;
DT   27-APR-2001, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   28-MAR-2018, entry version 171.
DE   RecName: Full=Alpha-sarcoglycan;
DE            Short=Alpha-SG;
DE   AltName: Full=50 kDa dystrophin-associated glycoprotein;
DE            Short=50DAG;
DE   AltName: Full=Adhalin;
DE   AltName: Full=Dystroglycan-2;
DE   Flags: Precursor;
GN   Name=SGCA; Synonyms=ADL, DAG2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANTS LGMD2D HIS-98 AND ALA-175.
RC   TISSUE=Skeletal muscle;
RX   PubMed=8069911; DOI=10.1016/0092-8674(94)90527-4;
RA   Roberds S.L., Leturcq F., Allamand V., Piccolo F., Jeanpierre M.,
RA   Anderson R.D., Lim L.E., Lee J.C., Tome F.M.S., Romero N.B.,
RA   Fardeau M., Beckmann J.S., Kaplan J.-C., Campbell K.P.;
RT   "Missense mutations in the adhalin gene linked to autosomal recessive
RT   muscular dystrophy.";
RL   Cell 78:625-633(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND ALTERNATIVE SPLICING.
RC   TISSUE=Heart ventricle;
RX   PubMed=7937874; DOI=10.1073/pnas.91.21.9690;
RA   McNally E., Yoshida M., Mizuno Y., Ozawa E., Kunkel L.M.;
RT   "Human adhalin is alternatively spliced and the gene is on chromosome
RT   17q21.";
RL   Proc. Natl. Acad. Sci. U.S.A. 91:9690-9694(1994).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Heart;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16625196; DOI=10.1038/nature04689;
RA   Zody M.C., Garber M., Adams D.J., Sharpe T., Harrow J., Lupski J.R.,
RA   Nicholson C., Searle S.M., Wilming L., Young S.K., Abouelleil A.,
RA   Allen N.R., Bi W., Bloom T., Borowsky M.L., Bugalter B.E., Butler J.,
RA   Chang J.L., Chen C.-K., Cook A., Corum B., Cuomo C.A., de Jong P.J.,
RA   DeCaprio D., Dewar K., FitzGerald M., Gilbert J., Gibson R.,
RA   Gnerre S., Goldstein S., Grafham D.V., Grocock R., Hafez N.,
RA   Hagopian D.S., Hart E., Norman C.H., Humphray S., Jaffe D.B.,
RA   Jones M., Kamal M., Khodiyar V.K., LaButti K., Laird G., Lehoczky J.,
RA   Liu X., Lokyitsang T., Loveland J., Lui A., Macdonald P., Major J.E.,
RA   Matthews L., Mauceli E., McCarroll S.A., Mihalev A.H., Mudge J.,
RA   Nguyen C., Nicol R., O'Leary S.B., Osoegawa K., Schwartz D.C.,
RA   Shaw-Smith C., Stankiewicz P., Steward C., Swarbreck D.,
RA   Venkataraman V., Whittaker C.A., Yang X., Zimmer A.R., Bradley A.,
RA   Hubbard T., Birren B.W., Rogers J., Lander E.S., Nusbaum C.;
RT   "DNA sequence of human chromosome 17 and analysis of rearrangement in
RT   the human lineage.";
RL   Nature 440:1045-1049(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Pancreas, and Spleen;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-214, AND VARIANT LGMD2D CYS-77.
RX   PubMed=8528203; DOI=10.1093/hmg/4.7.1163;
RA   Bueno M.R.P., Moreira E.S., Vainzof M., Chamberlain J., Marie S.K.,
RA   Pereira L., Akiyama J., Roberds S.L., Campbell K.P., Zatz M.;
RT   "A common missense mutation in the adhalin gene in three unrelated
RT   Brazilian families with a relatively mild form of autosomal recessive
RT   limb-girdle muscular dystrophy.";
RL   Hum. Mol. Genet. 4:1163-1167(1995).
RN   [8]
RP   VARIANTS LGMD2D CYS-77; PRO-GLY-ALA-GLN-PRO-136 INS AND GLY-137.
RX   PubMed=7657792; DOI=10.1172/JCI118152;
RA   Kawai H., Akaike M., Endo T., Adachi K., Inui T., Mitsui T.,
RA   Kashiwagi S., Fujiwara T., Okuno S., Shin S., Miyoshi K.,
RA   Campbell K.P., Yamada H., Shimizu T., Matsumura K., Saito S.;
RT   "Adhalin gene mutations in patients with autosomal recessive childhood
RT   onset muscular dystrophy with adhalin deficiency.";
RL   J. Clin. Invest. 96:1202-1207(1995).
RN   [9]
RP   VARIANTS LGMD2D HIS-34; HIS-62; GLU-68; CYS-77 AND HIS-98.
RX   PubMed=7663524; DOI=10.1038/ng0695-243;
RA   Piccolo F., Roberds S.L., Jeanpierre M., Leturcq F., Azibi K.,
RA   Beldjord C., Carrie A., Recan D., Chaouch M., Reghis A., El Kerch F.,
RA   Sefiani A., Voit T., Merlini L., Collin H., Eymard B., Beckmann J.S.,
RA   Romero N.B., Tome F.M.S., Fardeau M., Campbell K.P., Kaplan J.-C.;
RT   "Primary adhalinopathy: a common cause of autosomal recessive muscular
RT   dystrophy of variable severity.";
RL   Nat. Genet. 10:243-245(1995).
RN   [10]
RP   ERRATUM.
RA   Piccolo F., Roberds S.L., Jeanpierre M., Leturcq F., Azibi K.,
RA   Beldjord C., Carrie A., Recan D., Chaouch M., Reghis A., El Kerch F.,
RA   Sefiani A., Voit T., Merlini L., Collin H., Eymard B., Beckmann J.S.,
RA   Romero N.B., Tome F.M.S., Fardeau M., Campbell K.P., Kaplan J.-C.;
RL   Nat. Genet. 11:104-104(1995).
RN   [11]
RP   VARIANTS LGMD2D LEU-30; CYS-34; CYS-77; ARG-91; THR-124; LYS-137;
RP   PRO-173 AND CYS-284.
RX   PubMed=9192266; DOI=10.1136/jmg.34.6.470;
RA   Carrie A., Piccolo F., Leturcq F., de Toma C., Azibi K., Beldjord C.,
RA   Vallat J.-M., Merlini L., Voit T., Sewry C., Urtizberea J.A.,
RA   Romero N.B., Tome F.M.S., Fardeau M., Sunada Y., Campbell K.P.,
RA   Kaplan J.-C., Jeanpierre M.;
RT   "Mutational diversity and hot spots in the alpha-sarcoglycan gene in
RT   autosomal recessive muscular dystrophy (LGMD2D).";
RL   J. Med. Genet. 34:470-475(1997).
RN   [12]
RP   VARIANTS LGMD2D CYS-77; VAL-93; GLY-97; THR-124; PHE-158; PRO-173;
RP   ILE-196 AND HIS-205.
RX   PubMed=9032047; DOI=10.1056/NEJM199702273360904;
RA   Duggan D.J., Gorospe J.R., Fanin M., Hoffman E.P., Angelini C.;
RT   "Mutations in the sarcoglycan genes in patients with myopathy.";
RL   N. Engl. J. Med. 336:618-624(1997).
RN   [13]
RP   VARIANT LGMD2D CYS-284.
RX   PubMed=9585331;
RX   DOI=10.1002/(SICI)1097-4598(199806)21:6<769::AID-MUS9>3.0.CO;2-5;
RA   Angelini C., Fanin M., Menegazzo E., Freda M.P., Duggan D.J.,
RA   Hoffman E.P.;
RT   "Homozygous alpha-sarcoglycan mutation in two siblings: one
RT   asymptomatic and one steroid-responsive mild limb-girdle muscular
RT   dystrophy patient.";
RL   Muscle Nerve 21:769-775(1998).
CC   -!- FUNCTION: Component of the sarcoglycan complex, a subcomplex of
CC       the dystrophin-glycoprotein complex which forms a link between the
CC       F-actin cytoskeleton and the extracellular matrix.
CC   -!- SUBUNIT: Interacts with the syntrophin SNTA1. Cross-link to form 2
CC       major subcomplexes: one consisting of SGCB, SGCD and SGCG and the
CC       other consisting of SGCB and SGCD. The association between SGCB
CC       and SGCG is particularly strong while SGCA is loosely associated
CC       with the other sarcoglycans (By similarity). {ECO:0000250}.
CC   -!- INTERACTION:
CC       O43765:SGTA; NbExp=12; IntAct=EBI-5663553, EBI-347996;
CC   -!- SUBCELLULAR LOCATION: Cell membrane, sarcolemma {ECO:0000250};
CC       Single-pass type I membrane protein {ECO:0000250}. Cytoplasm,
CC       cytoskeleton {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=SGCA-1;
CC         IsoId=Q16586-1; Sequence=Displayed;
CC       Name=SGCA-2;
CC         IsoId=Q16586-2; Sequence=VSP_006017;
CC   -!- TISSUE SPECIFICITY: Most strongly expressed in skeletal muscle.
CC       Also expressed in cardiac muscle and, at much lower levels, in
CC       lung. In the fetus, most abundant in cardiac muscle and, at lower
CC       levels, in lung. Also detected in liver and kidney. Not expressed
CC       in brain.
CC   -!- DISEASE: Limb-girdle muscular dystrophy 2D (LGMD2D) [MIM:608099]:
CC       An autosomal recessive degenerative myopathy characterized by
CC       progressive muscle wasting from early childhood with loss of
CC       independent ambulation by teenage years. Muscle biopsy shows
CC       necrosis, decreased immunostaining for alpha sarcoglycan, and
CC       adhalin deficiency. {ECO:0000269|PubMed:7657792,
CC       ECO:0000269|PubMed:7663524, ECO:0000269|PubMed:8069911,
CC       ECO:0000269|PubMed:8528203, ECO:0000269|PubMed:9032047,
CC       ECO:0000269|PubMed:9192266, ECO:0000269|PubMed:9585331}. Note=The
CC       disease is caused by mutations affecting the gene represented in
CC       this entry.
CC   -!- SIMILARITY: Belongs to the sarcoglycan alpha/epsilon family.
CC       {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Leiden Muscular Dystrophy pages; Note=SGCA
CC       mutations in LGMD2D;
CC       URL="http://www.dmd.nl/sgca_home.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U08895; AAA81637.1; -; mRNA.
DR   EMBL; L34355; AAA35510.1; -; mRNA.
DR   EMBL; L35853; AAA50461.1; -; mRNA.
DR   EMBL; AK290622; BAF83311.1; -; mRNA.
DR   EMBL; AC015909; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471109; EAW94635.1; -; Genomic_DNA.
DR   EMBL; BC025702; AAH25702.1; -; mRNA.
DR   EMBL; L46810; AAC37583.1; -; mRNA.
DR   CCDS; CCDS32679.1; -. [Q16586-1]
DR   CCDS; CCDS45729.1; -. [Q16586-2]
DR   PIR; A54746; A54746.
DR   RefSeq; NP_000014.1; NM_000023.3. [Q16586-1]
DR   RefSeq; NP_001129169.1; NM_001135697.2. [Q16586-2]
DR   UniGene; Hs.463412; -.
DR   ProteinModelPortal; Q16586; -.
DR   SMR; Q16586; -.
DR   BioGrid; 112340; 13.
DR   CORUM; Q16586; -.
DR   IntAct; Q16586; 6.
DR   MINT; Q16586; -.
DR   STRING; 9606.ENSP00000262018; -.
DR   PhosphoSitePlus; Q16586; -.
DR   BioMuta; SGCA; -.
DR   PaxDb; Q16586; -.
DR   PeptideAtlas; Q16586; -.
DR   PRIDE; Q16586; -.
DR   DNASU; 6442; -.
DR   Ensembl; ENST00000262018; ENSP00000262018; ENSG00000108823. [Q16586-1]
DR   Ensembl; ENST00000344627; ENSP00000345522; ENSG00000108823. [Q16586-2]
DR   GeneID; 6442; -.
DR   KEGG; hsa:6442; -.
DR   UCSC; uc002iqi.4; human. [Q16586-1]
DR   CTD; 6442; -.
DR   DisGeNET; 6442; -.
DR   EuPathDB; HostDB:ENSG00000108823.15; -.
DR   GeneCards; SGCA; -.
DR   GeneReviews; SGCA; -.
DR   HGNC; HGNC:10805; SGCA.
DR   HPA; HPA007537; -.
DR   MalaCards; SGCA; -.
DR   MIM; 600119; gene.
DR   MIM; 608099; phenotype.
DR   neXtProt; NX_Q16586; -.
DR   OpenTargets; ENSG00000108823; -.
DR   Orphanet; 62; Autosomal recessive limb-girdle muscular dystrophy type 2D.
DR   PharmGKB; PA35716; -.
DR   eggNOG; KOG4482; Eukaryota.
DR   eggNOG; ENOG4110FPC; LUCA.
DR   GeneTree; ENSGT00390000005672; -.
DR   HOGENOM; HOG000074154; -.
DR   HOVERGEN; HBG006891; -.
DR   InParanoid; Q16586; -.
DR   KO; K12565; -.
DR   OMA; WCNVSLV; -.
DR   OrthoDB; EOG091G07H7; -.
DR   PhylomeDB; Q16586; -.
DR   TreeFam; TF314655; -.
DR   ChiTaRS; SGCA; human.
DR   GeneWiki; SGCA; -.
DR   GenomeRNAi; 6442; -.
DR   PRO; PR:Q16586; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   Bgee; ENSG00000108823; -.
DR   CleanEx; HS_SGCA; -.
DR   ExpressionAtlas; Q16586; baseline and differential.
DR   Genevisible; Q16586; HS.
DR   GO; GO:0005911; C:cell-cell junction; IEA:Ensembl.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-KW.
DR   GO; GO:0005856; C:cytoskeleton; IEA:UniProtKB-SubCell.
DR   GO; GO:0016010; C:dystrophin-associated glycoprotein complex; TAS:ProtInc.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0045121; C:membrane raft; IEA:Ensembl.
DR   GO; GO:0016012; C:sarcoglycan complex; IEA:InterPro.
DR   GO; GO:0042383; C:sarcolemma; IEA:UniProtKB-SubCell.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   GO; GO:0061024; P:membrane organization; IBA:GO_Central.
DR   GO; GO:0006936; P:muscle contraction; TAS:ProtInc.
DR   GO; GO:0007517; P:muscle organ development; TAS:ProtInc.
DR   GO; GO:0014894; P:response to denervation involved in regulation of muscle adaptation; IEA:Ensembl.
DR   GO; GO:0043403; P:skeletal muscle tissue regeneration; IEA:Ensembl.
DR   InterPro; IPR028658; Alpha-SG.
DR   InterPro; IPR006644; Cadg.
DR   InterPro; IPR015919; Cadherin-like.
DR   InterPro; IPR008908; Sarcoglycan_alpha/epsilon.
DR   PANTHER; PTHR10132; PTHR10132; 1.
DR   PANTHER; PTHR10132:SF16; PTHR10132:SF16; 1.
DR   Pfam; PF05510; Sarcoglycan_2; 1.
DR   SMART; SM00736; CADG; 1.
DR   SUPFAM; SSF49313; SSF49313; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cell membrane; Complete proteome; Cytoplasm;
KW   Cytoskeleton; Disease mutation; Glycoprotein;
KW   Limb-girdle muscular dystrophy; Membrane; Phosphoprotein;
KW   Reference proteome; Signal; Transmembrane; Transmembrane helix.
FT   SIGNAL        1     23       {ECO:0000255}.
FT   CHAIN        24    387       Alpha-sarcoglycan.
FT                                /FTId=PRO_0000031673.
FT   TOPO_DOM     24    290       Extracellular. {ECO:0000255}.
FT   TRANSMEM    291    311       Helical. {ECO:0000255}.
FT   TOPO_DOM    312    387       Cytoplasmic. {ECO:0000255}.
FT   MOD_RES     377    377       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P82350}.
FT   CARBOHYD    174    174       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    246    246       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   VAR_SEQ     196    319       Missing (in isoform SGCA-2).
FT                                {ECO:0000305}.
FT                                /FTId=VSP_006017.
FT   VARIANT      30     30       P -> L (in LGMD2D; dbSNP:rs886043256).
FT                                {ECO:0000269|PubMed:9192266}.
FT                                /FTId=VAR_010402.
FT   VARIANT      31     31       L -> P (in LGMD2D; dbSNP:rs903823830).
FT                                /FTId=VAR_010403.
FT   VARIANT      34     34       R -> C (in LGMD2D; dbSNP:rs758647756).
FT                                {ECO:0000269|PubMed:9192266}.
FT                                /FTId=VAR_010404.
FT   VARIANT      34     34       R -> H (in LGMD2D; dbSNP:rs371675217).
FT                                {ECO:0000269|PubMed:7663524}.
FT                                /FTId=VAR_010405.
FT   VARIANT      62     62       Y -> H (in LGMD2D).
FT                                {ECO:0000269|PubMed:7663524}.
FT                                /FTId=VAR_010406.
FT   VARIANT      68     68       G -> E (in LGMD2D).
FT                                {ECO:0000269|PubMed:7663524}.
FT                                /FTId=VAR_010407.
FT   VARIANT      74     74       R -> W (in LGMD2D; dbSNP:rs757888349).
FT                                /FTId=VAR_010408.
FT   VARIANT      77     77       R -> C (in LGMD2D; dbSNP:rs28933693).
FT                                {ECO:0000269|PubMed:7657792,
FT                                ECO:0000269|PubMed:7663524,
FT                                ECO:0000269|PubMed:8528203,
FT                                ECO:0000269|PubMed:9032047,
FT                                ECO:0000269|PubMed:9192266}.
FT                                /FTId=VAR_010387.
FT   VARIANT      89     89       L -> P (in LGMD2D).
FT                                /FTId=VAR_010409.
FT   VARIANT      91     91       G -> R (in LGMD2D).
FT                                {ECO:0000269|PubMed:9192266}.
FT                                /FTId=VAR_010410.
FT   VARIANT      93     93       A -> V (in LGMD2D).
FT                                {ECO:0000269|PubMed:9032047}.
FT                                /FTId=VAR_010411.
FT   VARIANT      97     97       D -> G (in LGMD2D).
FT                                {ECO:0000269|PubMed:9032047}.
FT                                /FTId=VAR_010412.
FT   VARIANT      98     98       R -> C (in LGMD2D; dbSNP:rs138945081).
FT                                /FTId=VAR_010413.
FT   VARIANT      98     98       R -> H (in LGMD2D; dbSNP:rs137852621).
FT                                {ECO:0000269|PubMed:7663524,
FT                                ECO:0000269|PubMed:8069911}.
FT                                /FTId=VAR_010388.
FT   VARIANT     103    103       I -> T (in LGMD2D).
FT                                /FTId=VAR_010414.
FT   VARIANT     124    124       I -> T (in LGMD2D; dbSNP:rs768814872).
FT                                {ECO:0000269|PubMed:9032047,
FT                                ECO:0000269|PubMed:9192266}.
FT                                /FTId=VAR_010415.
FT   VARIANT     136    136       A -> APGAQP (in LGMD2D; associated with
FT                                G-137).
FT                                /FTId=VAR_037965.
FT   VARIANT     137    137       E -> G (in LGMD2D; associated with P-G-A-
FT                                Q-P-136 ins; dbSNP:rs397514451).
FT                                {ECO:0000269|PubMed:7657792}.
FT                                /FTId=VAR_037966.
FT   VARIANT     137    137       E -> K (in LGMD2D; dbSNP:rs372210292).
FT                                {ECO:0000269|PubMed:9192266}.
FT                                /FTId=VAR_010416.
FT   VARIANT     158    158       L -> F (in LGMD2D).
FT                                {ECO:0000269|PubMed:9032047}.
FT                                /FTId=VAR_010417.
FT   VARIANT     173    173       L -> P (in LGMD2D; dbSNP:rs143962150).
FT                                {ECO:0000269|PubMed:9032047,
FT                                ECO:0000269|PubMed:9192266}.
FT                                /FTId=VAR_010431.
FT   VARIANT     175    175       V -> A (in LGMD2D; dbSNP:rs137852622).
FT                                {ECO:0000269|PubMed:8069911}.
FT                                /FTId=VAR_010389.
FT   VARIANT     196    196       V -> I (in LGMD2D; dbSNP:rs752695991).
FT                                {ECO:0000269|PubMed:9032047}.
FT                                /FTId=VAR_010418.
FT   VARIANT     205    205       P -> H (in LGMD2D; dbSNP:rs757481230).
FT                                {ECO:0000269|PubMed:9032047}.
FT                                /FTId=VAR_010419.
FT   VARIANT     228    228       P -> Q (in LGMD2D).
FT                                /FTId=VAR_010432.
FT   VARIANT     242    242       V -> A (in LGMD2D).
FT                                /FTId=VAR_010420.
FT   VARIANT     247    247       V -> M (in LGMD2D; dbSNP:rs143570936).
FT                                /FTId=VAR_010433.
FT   VARIANT     284    284       R -> C (in LGMD2D; dbSNP:rs137852623).
FT                                {ECO:0000269|PubMed:9192266,
FT                                ECO:0000269|PubMed:9585331}.
FT                                /FTId=VAR_010390.
SQ   SEQUENCE   387 AA;  42875 MW;  9CD0270A00BE03E6 CRC64;
     MAETLFWTPL LVVLLAGLGD TEAQQTTLHP LVGRVFVHTL DHETFLSLPE HVAVPPAVHI
     TYHAHLQGHP DLPRWLRYTQ RSPHHPGFLY GSATPEDRGL QVIEVTAYNR DSFDTTRQRL
     VLEIGDPEGP LLPYQAEFLV RSHDAEEVLP STPASRFLSA LGGLWEPGEL QLLNVTSALD
     RGGRVPLPIE GRKEGVYIKV GSASPFSTCL KMVASPDSHA RCAQGQPPLL SCYDTLAPHF
     RVDWCNVTLV DKSVPEPADE VPTPGDGILE HDPFFCPPTE APDRDFLVDA LVTLLVPLLV
     ALLLTLLLAY VMCCRREGRL KRDLATSDIQ MVHHCTIHGN TEELRQMAAS REVPRPLSTL
     PMFNVHTGER LPPRVDSAQV PLILDQH
//
ID   SLPI_HUMAN              Reviewed;         132 AA.
AC   P03973; B2R5H8; P07757;
DT   23-OCT-1986, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-1989, sequence version 2.
DT   23-MAY-2018, entry version 185.
DE   RecName: Full=Antileukoproteinase;
DE            Short=ALP;
DE   AltName: Full=BLPI;
DE   AltName: Full=HUSI-1 {ECO:0000303|PubMed:3485543, ECO:0000303|PubMed:3533531};
DE   AltName: Full=Mucus proteinase inhibitor;
DE            Short=MPI;
DE   AltName: Full=Protease inhibitor WAP4;
DE   AltName: Full=Secretory leukocyte protease inhibitor {ECO:0000303|PubMed:3462719};
DE   AltName: Full=Seminal proteinase inhibitor;
DE   AltName: Full=WAP four-disulfide core domain protein 4;
DE   Flags: Precursor;
GN   Name=SLPI; Synonyms=WAP4, WFDC4;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, AND TISSUE SPECIFICITY.
RC   TISSUE=Cervix;
RX   PubMed=3533531; DOI=10.1111/j.1432-1033.1986.tb09940.x;
RA   Heinzel R., Appelhans H., Gassen G., Seemueller U., Machleidt W.,
RA   Fritz H., Steffens G.;
RT   "Molecular cloning and expression of cDNA for human antileukoprotease
RT   from cervix uterus.";
RL   Eur. J. Biochem. 160:61-67(1986).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA].
RC   TISSUE=Parotid gland;
RX   PubMed=3640338; DOI=10.1093/nar/14.20.7883;
RA   Stetler G., Brewer M.T., Thompson R.C.;
RT   "Isolation and sequence of a human gene encoding a potent inhibitor of
RT   leukocyte proteases.";
RL   Nucleic Acids Res. 14:7883-7896(1986).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Intestine;
RA   Si-Tahar M., Merlin D., Sitaraman S., Madara J.L.;
RT   "Cloning and characterization of SLPI from human intestinal
RT   epithelium.";
RL   Submitted (DEC-1998) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Tongue;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11780052; DOI=10.1038/414865a;
RA   Deloukas P., Matthews L.H., Ashurst J.L., Burton J., Gilbert J.G.R.,
RA   Jones M., Stavrides G., Almeida J.P., Babbage A.K., Bagguley C.L.,
RA   Bailey J., Barlow K.F., Bates K.N., Beard L.M., Beare D.M.,
RA   Beasley O.P., Bird C.P., Blakey S.E., Bridgeman A.M., Brown A.J.,
RA   Buck D., Burrill W.D., Butler A.P., Carder C., Carter N.P.,
RA   Chapman J.C., Clamp M., Clark G., Clark L.N., Clark S.Y., Clee C.M.,
RA   Clegg S., Cobley V.E., Collier R.E., Connor R.E., Corby N.R.,
RA   Coulson A., Coville G.J., Deadman R., Dhami P.D., Dunn M.,
RA   Ellington A.G., Frankland J.A., Fraser A., French L., Garner P.,
RA   Grafham D.V., Griffiths C., Griffiths M.N.D., Gwilliam R., Hall R.E.,
RA   Hammond S., Harley J.L., Heath P.D., Ho S., Holden J.L., Howden P.J.,
RA   Huckle E., Hunt A.R., Hunt S.E., Jekosch K., Johnson C.M., Johnson D.,
RA   Kay M.P., Kimberley A.M., King A., Knights A., Laird G.K., Lawlor S.,
RA   Lehvaeslaiho M.H., Leversha M.A., Lloyd C., Lloyd D.M., Lovell J.D.,
RA   Marsh V.L., Martin S.L., McConnachie L.J., McLay K., McMurray A.A.,
RA   Milne S.A., Mistry D., Moore M.J.F., Mullikin J.C., Nickerson T.,
RA   Oliver K., Parker A., Patel R., Pearce T.A.V., Peck A.I.,
RA   Phillimore B.J.C.T., Prathalingam S.R., Plumb R.W., Ramsay H.,
RA   Rice C.M., Ross M.T., Scott C.E., Sehra H.K., Shownkeen R., Sims S.,
RA   Skuce C.D., Smith M.L., Soderlund C., Steward C.A., Sulston J.E.,
RA   Swann R.M., Sycamore N., Taylor R., Tee L., Thomas D.W., Thorpe A.,
RA   Tracey A., Tromans A.C., Vaudin M., Wall M., Wallis J.M.,
RA   Whitehead S.L., Whittaker P., Willey D.L., Williams L., Williams S.A.,
RA   Wilming L., Wray P.W., Hubbard T., Durbin R.M., Bentley D.R., Beck S.,
RA   Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 20.";
RL   Nature 414:865-871(2001).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Liver;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   PROTEIN SEQUENCE OF 26-132, NUCLEOTIDE SEQUENCE [MRNA] OF 26-65,
RP   SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=3485543; DOI=10.1016/0014-5793(86)81220-0;
RA   Seemueller U., Arnhold M., Fritz H., Wiedenmann K., Machleidt W.,
RA   Heinzel R., Appelhans H., Gassen H.-G., Lottspeich F.;
RT   "The acid-stable proteinase inhibitor of human mucous secretions
RT   (HUSI-I, antileukoprotease). Complete amino acid sequence as revealed
RT   by protein and cDNA sequencing and structural homology to whey
RT   proteins and Red sea turtle proteinase inhibitor.";
RL   FEBS Lett. 199:43-48(1986).
RN   [9]
RP   PROTEIN SEQUENCE OF 26-132, FUNCTION, SUBCELLULAR LOCATION, AND TISSUE
RP   SPECIFICITY.
RX   PubMed=3462719; DOI=10.1073/pnas.83.18.6692;
RA   Thompson R.C., Ohlsson K.;
RT   "Isolation, properties, and complete amino acid sequence of human
RT   secretory leukocyte protease inhibitor, a potent inhibitor of
RT   leukocyte elastase.";
RL   Proc. Natl. Acad. Sci. U.S.A. 83:6692-6696(1986).
RN   [10]
RP   PROTEIN SEQUENCE OF 26-52, SUBCELLULAR LOCATION, TISSUE SPECIFICITY,
RP   AND FUNCTION.
RX   PubMed=2039600; DOI=10.1515/bchm3.1991.372.1.13;
RA   Sallenave J.-M., Ryle A.P.;
RT   "Purification and characterization of elastase-specific inhibitor.
RT   Sequence homology with mucus proteinase inhibitor.";
RL   Biol. Chem. Hoppe-Seyler 372:13-21(1991).
RN   [11]
RP   PROTEIN SEQUENCE OF 26-46 AND 94-132, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RC   TISSUE=Tear;
RX   PubMed=25946035; DOI=10.1021/acs.jproteome.5b00179;
RA   Azkargorta M., Soria J., Ojeda C., Guzman F., Acera A., Iloro I.,
RA   Suarez T., Elortza F.;
RT   "Human basal tear peptidome characterization by CID, HCD, and ETD
RT   followed by in silico and in vitro analyses for antimicrobial peptide
RT   identification.";
RL   J. Proteome Res. 14:2649-2658(2015).
RN   [12]
RP   FUNCTION, AND MUTAGENESIS OF ARG-45; LEU-97; MET-98 AND LEU-99.
RX   PubMed=2110563;
RA   Eisenberg S.P., Hale K.K., Heimdal P., Thompson R.C.;
RT   "Location of the protease-inhibitory region of secretory leukocyte
RT   protease inhibitor.";
RL   J. Biol. Chem. 265:7976-7981(1990).
RN   [13]
RP   FUNCTION, AND MUTAGENESIS OF ARG-45 AND LEU-97.
RX   PubMed=10702419; DOI=10.1016/S0002-9440(10)64971-1;
RA   Mulligan M.S., Lentsch A.B., Huber-Lang M., Guo R.F., Sarma V.,
RA   Wright C.D., Ulich T.R., Ward P.A.;
RT   "Anti-inflammatory effects of mutant forms of secretory leukocyte
RT   protease inhibitor.";
RL   Am. J. Pathol. 156:1033-1039(2000).
RN   [14]
RP   FUNCTION, SUBCELLULAR LOCATION, INDUCTION BY ELANE, AND TISSUE
RP   SPECIFICITY.
RX   PubMed=24352879; DOI=10.1182/blood-2013-06-508887;
RA   Klimenkova O., Ellerbeck W., Klimiankou M., Unalan M., Kandabarau S.,
RA   Gigina A., Hussein K., Zeidler C., Welte K., Skokowa J.;
RT   "A lack of secretory leukocyte protease inhibitor (SLPI) causes
RT   defects in granulocytic differentiation.";
RL   Blood 123:1239-1249(2014).
RN   [15]
RP   X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS) IN COMPLEX WITH CHYMOTRYPSIN,
RP   DISULFIDE BONDS, AND REACTIVE BOND.
RX   PubMed=3366116;
RA   Gruetter M.G., Fendrich G., Huber R., Bode W.;
RT   "The 2.5 A X-ray crystal structure of the acid-stable proteinase
RT   inhibitor from human mucous secretions analysed in its complex with
RT   bovine alpha-chymotrypsin.";
RL   EMBO J. 7:345-351(1988).
RN   [16]
RP   X-RAY CRYSTALLOGRAPHY (1.70 ANGSTROMS) OF 83-132 IN COMPLEX WITH
RP   ELANE, REACTIVE BOND, AND DISULFIDE BONDS.
RX   PubMed=18421166; DOI=10.1107/S0909049507060670;
RA   Koizumi M., Fujino A., Fukushima K., Kamimura T.,
RA   Takimoto-Kamimura M.;
RT   "Complex of human neutrophil elastase with 1/2SLPI.";
RL   J. Synchrotron Radiat. 15:308-311(2008).
RN   [17]
RP   X-RAY CRYSTALLOGRAPHY (2.00 ANGSTROMS) OF 85-131 IN COMPLEX WITH
RP   TRYPSIN, FUNCTION, REACTIVE BOND, AND DISULFIDE BONDS.
RX   PubMed=24121345; DOI=10.1107/S090904951302133X;
RA   Fukushima K., Kamimura T., Takimoto-Kamimura M.;
RT   "Structure basis 1/2SLPI and porcine pancreas trypsin interaction.";
RL   J. Synchrotron Radiat. 20:943-947(2013).
CC   -!- FUNCTION: Acid-stable proteinase inhibitor with strong affinities
CC       for trypsin, chymotrypsin, elastase, and cathepsin G
CC       (PubMed:3533531, PubMed:3462719, PubMed:2039600, PubMed:2110563,
CC       PubMed:10702419, PubMed:24121345). Modulates the inflammatory and
CC       immune responses after bacterial infection, and after infection by
CC       the intracellular parasite L.major. Down-regulates responses to
CC       bacterial lipopolysaccharide (LPS) (By similarity). Plays a role
CC       in regulating the activation of NF-kappa-B and inflammatory
CC       responses (PubMed:10702419, PubMed:24352879). Has antimicrobial
CC       activity against mycobacteria, but not against salmonella.
CC       Contributes to normal resistance against infection by
CC       M.tuberculosis. Required for normal resistance to infection by
CC       L.major. Required for normal wound healing, probably by preventing
CC       tissue damage by limiting protease activity (By similarity).
CC       Together with ELANE, required for normal differentiation and
CC       proliferation of bone marrow myeloid cells (PubMed:24352879).
CC       {ECO:0000250|UniProtKB:P97430, ECO:0000269|PubMed:10702419,
CC       ECO:0000269|PubMed:2039600, ECO:0000269|PubMed:2110563,
CC       ECO:0000269|PubMed:24121345, ECO:0000269|PubMed:24352879,
CC       ECO:0000269|PubMed:3462719, ECO:0000269|PubMed:3533531,
CC       ECO:0000305}.
CC   -!- INTERACTION:
CC       Q8IZU0:FAM9B; NbExp=3; IntAct=EBI-355293, EBI-10175124;
CC       O43765:SGTA; NbExp=3; IntAct=EBI-355293, EBI-347996;
CC   -!- SUBCELLULAR LOCATION: Secreted {ECO:0000269|PubMed:2039600,
CC       ECO:0000269|PubMed:24352879, ECO:0000269|PubMed:3462719,
CC       ECO:0000269|PubMed:3485543}.
CC   -!- TISSUE SPECIFICITY: Detected in blood plasma (PubMed:24352879).
CC       Detected in bone marrow myeloid cells (PubMed:24352879). Detected
CC       in airway sputum (PubMed:2039600). Detected in parotid gland
CC       secretions (PubMed:3462719). Detected in seminal plasma (at
CC       protein level) (PubMed:3485543). Detected in uterus cervix
CC       (PubMed:3533531). {ECO:0000269|PubMed:2039600,
CC       ECO:0000269|PubMed:24352879, ECO:0000269|PubMed:3462719,
CC       ECO:0000269|PubMed:3485543, ECO:0000269|PubMed:3533531}.
CC   -!- INDUCTION: Down-regulated in response to low ELANE activity. Up-
CC       regulated by ELANE treatment in bone marrow cells.
CC       {ECO:0000269|PubMed:24352879}.
CC   -!- MISCELLANEOUS: The pathologies of several chronic and acute
CC       diseases of the respiratory tract involve an imbalance between the
CC       proteases of cells involved in inflammatory responses and the
CC       inhibitors of these proteases. The inflammation-mediated release
CC       of neutrophil elastase in the lungs of patients whose levels of
CC       active alpha-1-antiprotease are compromised by genetic background,
CC       cigarette smoking, air pollutants, or a combination of all three
CC       can result in severe lung damage and a decreased lifespan. The
CC       relatively small size of this protein, its lack of glycosylation
CC       and its stability make this protein a candidate for use as a
CC       therapeutic agent in diseases mediated by leukocyte elastase-
CC       antielastase imbalances. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X04470; CAA28158.1; -; mRNA.
DR   EMBL; X04502; CAA28187.1; -; Genomic_DNA.
DR   EMBL; X04503; CAA28188.1; -; mRNA.
DR   EMBL; AF114471; AAD19661.1; -; mRNA.
DR   EMBL; AK312192; BAG35125.1; -; mRNA.
DR   EMBL; AL035660; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471077; EAW75869.1; -; Genomic_DNA.
DR   EMBL; BC020708; AAH20708.1; -; mRNA.
DR   CCDS; CCDS13347.1; -.
DR   PIR; A25541; TIHUSP.
DR   RefSeq; NP_003055.1; NM_003064.3.
DR   UniGene; Hs.517070; -.
DR   PDB; 2Z7F; X-ray; 1.70 A; I=83-132.
DR   PDB; 4DOQ; X-ray; 2.00 A; B/D=85-131.
DR   PDBsum; 2Z7F; -.
DR   PDBsum; 4DOQ; -.
DR   ProteinModelPortal; P03973; -.
DR   SMR; P03973; -.
DR   BioGrid; 112475; 6.
DR   IntAct; P03973; 7.
DR   MINT; P03973; -.
DR   STRING; 9606.ENSP00000342082; -.
DR   MEROPS; I17.001; -.
DR   iPTMnet; P03973; -.
DR   PhosphoSitePlus; P03973; -.
DR   DMDM; 113636; -.
DR   MaxQB; P03973; -.
DR   PaxDb; P03973; -.
DR   PeptideAtlas; P03973; -.
DR   PRIDE; P03973; -.
DR   DNASU; 6590; -.
DR   Ensembl; ENST00000338380; ENSP00000342082; ENSG00000124107.
DR   GeneID; 6590; -.
DR   KEGG; hsa:6590; -.
DR   UCSC; uc002xnm.2; human.
DR   CTD; 6590; -.
DR   DisGeNET; 6590; -.
DR   EuPathDB; HostDB:ENSG00000124107.5; -.
DR   GeneCards; SLPI; -.
DR   HGNC; HGNC:11092; SLPI.
DR   HPA; CAB002303; -.
DR   HPA; HPA027774; -.
DR   MIM; 107285; gene.
DR   neXtProt; NX_P03973; -.
DR   OpenTargets; ENSG00000124107; -.
DR   PharmGKB; PA35944; -.
DR   eggNOG; ENOG410J417; Eukaryota.
DR   eggNOG; ENOG41116TS; LUCA.
DR   GeneTree; ENSGT00730000111217; -.
DR   HOGENOM; HOG000115819; -.
DR   HOVERGEN; HBG018073; -.
DR   InParanoid; P03973; -.
DR   OMA; SDWQCPG; -.
DR   OrthoDB; EOG091G0S8U; -.
DR   PhylomeDB; P03973; -.
DR   TreeFam; TF338375; -.
DR   Reactome; R-HSA-6798695; Neutrophil degranulation.
DR   ChiTaRS; SLPI; human.
DR   EvolutionaryTrace; P03973; -.
DR   GeneWiki; SLPI; -.
DR   GenomeRNAi; 6590; -.
DR   PMAP-CutDB; P03973; -.
DR   PRO; PR:P03973; -.
DR   Proteomes; UP000005640; Chromosome 20.
DR   Bgee; ENSG00000124107; -.
DR   CleanEx; HS_SLPI; -.
DR   Genevisible; P03973; HS.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0005576; C:extracellular region; TAS:Reactome.
DR   GO; GO:0005615; C:extracellular space; IDA:UniProtKB.
DR   GO; GO:0035580; C:specific granule lumen; TAS:Reactome.
DR   GO; GO:0003677; F:DNA binding; IDA:UniProtKB.
DR   GO; GO:0004866; F:endopeptidase inhibitor activity; TAS:ProtInc.
DR   GO; GO:0019899; F:enzyme binding; IPI:UniProtKB.
DR   GO; GO:0003729; F:mRNA binding; IDA:UniProtKB.
DR   GO; GO:0004867; F:serine-type endopeptidase inhibitor activity; IDA:UniProtKB.
DR   GO; GO:0019731; P:antibacterial humoral response; IDA:UniProtKB.
DR   GO; GO:0006955; P:immune response; ISS:UniProtKB.
DR   GO; GO:0045087; P:innate immune response; ISS:UniProtKB.
DR   GO; GO:0035821; P:modification of morphology or physiology of other organism; IDA:UniProtKB.
DR   GO; GO:0032091; P:negative regulation of protein binding; IDA:UniProtKB.
DR   GO; GO:0045071; P:negative regulation of viral genome replication; IDA:UniProtKB.
DR   GO; GO:0043312; P:neutrophil degranulation; TAS:Reactome.
DR   GO; GO:0032496; P:response to lipopolysaccharide; ISS:UniProtKB.
DR   Gene3D; 4.10.75.10; -; 2.
DR   InterPro; IPR036645; Elafin-like_sf.
DR   InterPro; IPR008197; WAP_dom.
DR   Pfam; PF00095; WAP; 2.
DR   PRINTS; PR00003; 4DISULPHCORE.
DR   SMART; SM00217; WAP; 2.
DR   SUPFAM; SSF57256; SSF57256; 2.
DR   PROSITE; PS51390; WAP; 2.
PE   1: Evidence at protein level;
KW   3D-structure; Antibiotic; Antimicrobial; Complete proteome;
KW   Direct protein sequencing; Disulfide bond; Immunity; Innate immunity;
KW   Protease inhibitor; Reference proteome; Repeat; Secreted;
KW   Serine protease inhibitor; Signal.
FT   SIGNAL        1     25       {ECO:0000269|PubMed:2039600,
FT                                ECO:0000269|PubMed:25946035,
FT                                ECO:0000269|PubMed:3462719,
FT                                ECO:0000269|PubMed:3485543}.
FT   CHAIN        26    132       Antileukoproteinase.
FT                                /FTId=PRO_0000041355.
FT   DOMAIN       28     76       WAP 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00722}.
FT   DOMAIN       82    130       WAP 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00722}.
FT   REGION       84    132       Elastase inhibitory domain.
FT   SITE         97     98       Reactive bond for chymotrypsin, trypsin
FT                                and elastase.
FT                                {ECO:0000305|PubMed:18421166,
FT                                ECO:0000305|PubMed:24121345,
FT                                ECO:0000305|PubMed:3366116}.
FT   DISULFID     35     64       {ECO:0000269|PubMed:3366116}.
FT   DISULFID     43     68       {ECO:0000269|PubMed:3366116}.
FT   DISULFID     51     63       {ECO:0000269|PubMed:3366116}.
FT   DISULFID     57     72       {ECO:0000269|PubMed:3366116}.
FT   DISULFID     89    118       {ECO:0000244|PDB:2Z7F,
FT                                ECO:0000244|PDB:4DOQ,
FT                                ECO:0000269|PubMed:3366116}.
FT   DISULFID     96    122       {ECO:0000244|PDB:2Z7F,
FT                                ECO:0000244|PDB:4DOQ,
FT                                ECO:0000269|PubMed:3366116}.
FT   DISULFID    105    117       {ECO:0000244|PDB:2Z7F,
FT                                ECO:0000244|PDB:4DOQ,
FT                                ECO:0000269|PubMed:3366116}.
FT   DISULFID    111    126       {ECO:0000244|PDB:2Z7F,
FT                                ECO:0000244|PDB:4DOQ,
FT                                ECO:0000269|PubMed:3366116}.
FT   MUTAGEN      45     45       R->G: No significant effect on inhibition
FT                                of elastase, trypsin and chymotrypsin.
FT                                {ECO:0000269|PubMed:10702419,
FT                                ECO:0000269|PubMed:2110563}.
FT   MUTAGEN      45     45       R->M,V: No significant effect on
FT                                inhibition of elastase, trypsin and
FT                                chymotrypsin.
FT                                {ECO:0000269|PubMed:2110563}.
FT   MUTAGEN      97     97       L->F: Increases inhibition of
FT                                chymotrypsin.
FT                                {ECO:0000269|PubMed:10702419,
FT                                ECO:0000269|PubMed:2110563}.
FT   MUTAGEN      97     97       L->G: Reduced inhibition of elastase.
FT                                Strongly reduced inhibition of
FT                                chymotrypsin and trypsin.
FT                                {ECO:0000269|PubMed:10702419,
FT                                ECO:0000269|PubMed:2110563}.
FT   MUTAGEN      97     97       L->K,R: Strongly reduced inhibition of
FT                                elastase. Abolishes inhibition of
FT                                trypsin. {ECO:0000269|PubMed:10702419,
FT                                ECO:0000269|PubMed:2110563}.
FT   MUTAGEN      98     98       M->G: No significant effect on inhibition
FT                                of elastase, trypsin and chymotrypsin.
FT                                {ECO:0000269|PubMed:2110563}.
FT   MUTAGEN      99     99       L->G: No significant effect on inhibition
FT                                of elastase, trypsin and chymotrypsin.
FT                                {ECO:0000269|PubMed:2110563}.
FT   STRAND       86     88       {ECO:0000244|PDB:2Z7F}.
FT   STRAND       95     97       {ECO:0000244|PDB:2Z7F}.
FT   HELIX       108    110       {ECO:0000244|PDB:2Z7F}.
FT   STRAND      116    120       {ECO:0000244|PDB:2Z7F}.
FT   STRAND      123    127       {ECO:0000244|PDB:2Z7F}.
SQ   SEQUENCE   132 AA;  14326 MW;  B62F3221E0903D90 CRC64;
     MKSSGLFPFL VLLALGTLAP WAVEGSGKSF KAGVCPPKKS AQCLRYKKPE CQSDWQCPGK
     KRCCPDTCGI KCLDPVDTPN PTRRKPGKCP VTYGQCLMLN PPNFCEMDGQ CKRDLKCCMG
     MCGKSCVSPV KA
//
ID   A0A140VJU8_HUMAN        Unreviewed;       240 AA.
AC   A0A140VJU8;
DT   08-JUN-2016, integrated into UniProtKB/TrEMBL.
DT   08-JUN-2016, sequence version 1.
DT   23-MAY-2018, entry version 12.
DE   RecName: Full=Superoxide dismutase [Cu-Zn] {ECO:0000256|RuleBase:RU000393};
DE            EC=1.15.1.1 {ECO:0000256|RuleBase:RU000393};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:AEE61085.1};
RN   [1] {ECO:0000313|EMBL:AEE61085.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Li J.Y.;
RT   "Human testis protein.";
RL   Submitted (MAR-2010) to the EMBL/GenBank/DDBJ databases.
CC   -!- FUNCTION: Destroys radicals which are normally produced within the
CC       cells and which are toxic to biological systems.
CC       {ECO:0000256|RuleBase:RU000393}.
CC   -!- CATALYTIC ACTIVITY: 2 superoxide + 2 H(+) = O(2) + H(2)O(2).
CC       {ECO:0000256|RuleBase:RU000393}.
CC   -!- COFACTOR:
CC       Name=Cu cation; Xref=ChEBI:CHEBI:23378;
CC         Evidence={ECO:0000256|RuleBase:RU000393};
CC       Note=Binds 1 copper ion per subunit.
CC       {ECO:0000256|RuleBase:RU000393};
CC   -!- COFACTOR:
CC       Name=Zn(2+); Xref=ChEBI:CHEBI:29105;
CC         Evidence={ECO:0000256|RuleBase:RU000393};
CC       Note=Binds 1 zinc ion per subunit.
CC       {ECO:0000256|RuleBase:RU000393};
CC   -!- SIMILARITY: Belongs to the Cu-Zn superoxide dismutase family.
CC       {ECO:0000256|RuleBase:RU000393}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; HM005488; AEE61085.1; -; mRNA.
DR   RefSeq; NP_003093.2; NM_003102.2.
DR   UniGene; Hs.2420; -.
DR   ProteinModelPortal; A0A140VJU8; -.
DR   SMR; A0A140VJU8; -.
DR   PRIDE; A0A140VJU8; -.
DR   GeneID; 6649; -.
DR   KEGG; hsa:6649; -.
DR   CTD; 6649; -.
DR   KO; K16627; -.
DR   OMA; EQEDDMG; -.
DR   PhylomeDB; A0A140VJU8; -.
DR   ExpressionAtlas; A0A140VJU8; baseline and differential.
DR   GO; GO:0005737; C:cytoplasm; IEA:Ensembl.
DR   GO; GO:0031012; C:extracellular matrix; IEA:Ensembl.
DR   GO; GO:0005615; C:extracellular space; IEA:Ensembl.
DR   GO; GO:0005634; C:nucleus; IEA:Ensembl.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0004784; F:superoxide dismutase activity; IEA:UniProtKB-EC.
DR   GO; GO:0046688; P:response to copper ion; IEA:Ensembl.
DR   GO; GO:0001666; P:response to hypoxia; IEA:Ensembl.
DR   CDD; cd00305; Cu-Zn_Superoxide_Dismutase; 1.
DR   Gene3D; 2.60.40.200; -; 1.
DR   InterPro; IPR036423; SOD-like_Cu/Zn_dom_sf.
DR   InterPro; IPR024134; SOD_Cu/Zn_/chaperone.
DR   InterPro; IPR018152; SOD_Cu/Zn_BS.
DR   InterPro; IPR001424; SOD_Cu_Zn_dom.
DR   PANTHER; PTHR10003; PTHR10003; 1.
DR   Pfam; PF00080; Sod_Cu; 1.
DR   PRINTS; PR00068; CUZNDISMTASE.
DR   SUPFAM; SSF49329; SSF49329; 1.
DR   PROSITE; PS00087; SOD_CU_ZN_1; 1.
DR   PROSITE; PS00332; SOD_CU_ZN_2; 1.
PE   2: Evidence at transcript level;
KW   Copper {ECO:0000256|RuleBase:RU000393};
KW   Metal-binding {ECO:0000256|RuleBase:RU000393};
KW   Oxidoreductase {ECO:0000256|RuleBase:RU000393};
KW   Signal {ECO:0000256|SAM:SignalP};
KW   Zinc {ECO:0000256|RuleBase:RU000393}.
FT   SIGNAL        1     18       {ECO:0000256|SAM:SignalP}.
FT   CHAIN        19    240       Superoxide dismutase [Cu-Zn].
FT                                {ECO:0000256|SAM:SignalP}.
FT                                /FTId=PRO_5007491787.
FT   DOMAIN       75    210       Sod_Cu. {ECO:0000259|Pfam:PF00080}.
SQ   SEQUENCE   240 AA;  25851 MW;  585B8DEBFC506CF4 CRC64;
     MLALLCSCLL LAAGASDAWT GEDSAEPNSD SAEWIRDMYA KVTEIWQEVM QRRDDDGALH
     AACQVQPSAT LDAAQPRVTG VVLFRQLAPR AKLDAFFALE GFPTEPNSSS RAIHVHQFGD
     LSQGCESTGP HYNPLAVPHP QHPGDFGNFA VRDGSLWRYR AGLAASLAGP HSIVGRAVVV
     HAGEDDLGRG GNQASVENGN AGRRLACCVV GVCGPGLWER QAREHSERKK RRRESECKAA
//
ID   SODE_HUMAN              Reviewed;         240 AA.
AC   P08294; Q5U781; Q6FHA2;
DT   01-AUG-1988, integrated into UniProtKB/Swiss-Prot.
DT   30-MAY-2006, sequence version 2.
DT   23-MAY-2018, entry version 193.
DE   RecName: Full=Extracellular superoxide dismutase [Cu-Zn];
DE            Short=EC-SOD;
DE            EC=1.15.1.1;
DE   Flags: Precursor;
GN   Name=SOD3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], PARTIAL PROTEIN SEQUENCE, AND VARIANT
RP   THR-58.
RX   PubMed=3476950; DOI=10.1073/pnas.84.18.6340;
RA   Hjalmarsson K., Marklund S.L., Engstroem A., Edlund T.;
RT   "Isolation and sequence of complementary DNA encoding human
RT   extracellular superoxide dismutase.";
RL   Proc. Natl. Acad. Sci. U.S.A. 84:6340-6344(1987).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT THR-58.
RC   TISSUE=Blood;
RX   PubMed=7959763; DOI=10.1006/geno.1994.1357;
RA   Folz R.J., Crapo J.D.;
RT   "Extracellular superoxide dismutase (SOD3): tissue-specific
RT   expression, genomic characterization, and computer-assisted sequence
RT   analysis of the human EC SOD gene.";
RL   Genomics 22:162-171(1994).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT THR-58.
RA   Halleck A., Ebert L., Mkoundinya M., Schick M., Eisenstein S.,
RA   Neubert P., Kstrang K., Schatten R., Shen B., Henze S., Mar W.,
RA   Korn B., Zuo D., Hu Y., LaBaer J.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS THR-58; THR-91 AND
RP   GLY-231.
RG   NIEHS SNPs program;
RL   Submitted (OCT-2004) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT THR-58.
RC   TISSUE=Colon;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   GLYCATION AT LYS-229 AND LYS-230.
RX   PubMed=1505778; DOI=10.1016/0891-5849(92)90016-A;
RA   Adachi T., Ohta H., Hayashi K., Hirano K., Marklund S.L.;
RT   "The site of nonenzymic glycation of human extracellular-superoxide
RT   dismutase in vitro.";
RL   Free Radic. Biol. Med. 13:205-210(1992).
RN   [7]
RP   REVIEW.
RX   PubMed=16087389; DOI=10.1016/j.biocel.2005.06.012;
RA   Nozik-Grayck E., Suliman H.B., Piantadosi C.A.;
RT   "Extracellular superoxide dismutase.";
RL   Int. J. Biochem. Cell Biol. 37:2466-2471(2005).
RN   [8]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-107.
RC   TISSUE=Plasma;
RX   PubMed=16335952; DOI=10.1021/pr0502065;
RA   Liu T., Qian W.-J., Gritsenko M.A., Camp D.G. II, Monroe M.E.,
RA   Moore R.J., Smith R.D.;
RT   "Human plasma N-glycoproteome analysis by immunoaffinity subtraction,
RT   hydrazide chemistry, and mass spectrometry.";
RL   J. Proteome Res. 4:2070-2080(2005).
RN   [9]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-107.
RC   TISSUE=Liver;
RX   PubMed=19159218; DOI=10.1021/pr8008012;
RA   Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.;
RT   "Glycoproteomics analysis of human liver tissue by combination of
RT   multiple enzyme digestion and hydrazide chemistry.";
RL   J. Proteome Res. 8:651-661(2009).
RN   [10]
RP   X-RAY CRYSTALLOGRAPHY (1.7 ANGSTROMS) OF 19-240, SUBUNIT,
RP   METAL-BINDING SITES, AND DISULFIDE BONDS.
RX   PubMed=19289127; DOI=10.1016/j.jmb.2009.03.026;
RA   Antonyuk S.V., Strange R.W., Marklund S.L., Hasnain S.S.;
RT   "The structure of human extracellular copper-zinc superoxide dismutase
RT   at 1.7 A resolution: insights into heparin and collagen binding.";
RL   J. Mol. Biol. 388:310-326(2009).
RN   [11]
RP   VARIANT GLY-231.
RX   PubMed=8034674;
RA   Sandstrom J., Nilsson P., Karlsson K., Marklund S.L.;
RT   "10-fold increase in human plasma extracellular superoxide dismutase
RT   content caused by a mutation in heparin-binding domain.";
RL   J. Biol. Chem. 269:19163-19166(1994).
RN   [12]
RP   VARIANT GLY-231.
RX   PubMed=7662997; DOI=10.1007/BF01883574;
RA   Yamada H., Yamada Y., Adachi T., Goto H., Ogasawara N., Futenma A.,
RA   Kitano M., Hirano K., Kato K.;
RT   "Molecular analysis of extracellular-superoxide dismutase gene
RT   associated with high level in serum.";
RL   Jpn. J. Hum. Genet. 40:177-184(1995).
RN   [13]
RP   VARIANT GLY-231.
RX   PubMed=8546689; DOI=10.1042/bj3130235;
RA   Adachi T., Yamada H., Yamada Y., Morihara N., Yamazaki N.,
RA   Murakami T., Futenma A., Kato K., Hirano K.;
RT   "Substitution of glycine for arginine-213 in extracellular-superoxide
RT   dismutase impairs affinity for heparin and endothelial cell surface.";
RL   Biochem. J. 313:235-239(1996).
RN   [14]
RP   VARIANT GLY-231.
RX   PubMed=8864862; DOI=10.1093/oxfordjournals.jbchem.a021383;
RA   Adachi T., Morihara N., Yamazaki N., Yamada H., Futenma A., Kato K.,
RA   Hirano K.;
RT   "An arginine-213 to glycine mutation in human extracellular-superoxide
RT   dismutase reduces susceptibility to trypsin-like proteinases.";
RL   J. Biochem. 120:184-188(1996).
CC   -!- FUNCTION: Protect the extracellular space from toxic effect of
CC       reactive oxygen intermediates by converting superoxide radicals
CC       into hydrogen peroxide and oxygen.
CC   -!- CATALYTIC ACTIVITY: 2 superoxide + 2 H(+) = O(2) + H(2)O(2).
CC   -!- COFACTOR:
CC       Name=Cu cation; Xref=ChEBI:CHEBI:23378; Evidence={ECO:0000250};
CC       Note=Binds 1 copper ion per subunit. {ECO:0000250};
CC   -!- COFACTOR:
CC       Name=Zn(2+); Xref=ChEBI:CHEBI:29105; Evidence={ECO:0000250};
CC       Note=Binds 1 zinc ion per subunit. {ECO:0000250};
CC   -!- SUBUNIT: Homotetramer. {ECO:0000269|PubMed:19289127}.
CC   -!- INTERACTION:
CC       O43765:SGTA; NbExp=3; IntAct=EBI-10195782, EBI-347996;
CC   -!- SUBCELLULAR LOCATION: Secreted, extracellular space. Note=99% of
CC       EC-SOD is anchored to heparan sulfate proteoglycans in the tissue
CC       interstitium, and 1% is located in the vasculature in equilibrium
CC       between the plasma and the endothelium.
CC   -!- TISSUE SPECIFICITY: Expressed in blood vessels, heart, lung,
CC       kidney and placenta. Major SOD isoenzyme in extracellular fluids
CC       such as plasma, lymph and synovial fluid.
CC   -!- POLYMORPHISM: The variant Gly-231 which is found in about 2.2% of
CC       individual displays a 10-fold increased plasma EC-SOD content due
CC       to reduced heparin-binding affinity and thus the impairment of its
CC       binding ability to endothelial cell surface.
CC       {ECO:0000269|PubMed:7662997, ECO:0000269|PubMed:8034674,
CC       ECO:0000269|PubMed:8546689}.
CC   -!- SIMILARITY: Belongs to the Cu-Zn superoxide dismutase family.
CC       {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=NIEHS-SNPs;
CC       URL="http://egp.gs.washington.edu/data/sod3/";
CC   -!- WEB RESOURCE: Name=Wikipedia; Note=Superoxide dismutase entry;
CC       URL="https://en.wikipedia.org/wiki/Superoxide_dismutase";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; J02947; AAA66000.1; -; mRNA.
DR   EMBL; U10116; AAA62278.1; -; Genomic_DNA.
DR   EMBL; CR541853; CAG46651.1; -; mRNA.
DR   EMBL; AY787834; AAV40827.1; -; Genomic_DNA.
DR   EMBL; BC014418; AAH14418.1; -; mRNA.
DR   CCDS; CCDS3430.1; -.
DR   PIR; A28301; DSHUEC.
DR   RefSeq; NP_003093.2; NM_003102.2.
DR   UniGene; Hs.2420; -.
DR   PDB; 2JLP; X-ray; 1.70 A; A/B/C/D=19-240.
DR   PDBsum; 2JLP; -.
DR   ProteinModelPortal; P08294; -.
DR   SMR; P08294; -.
DR   BioGrid; 112532; 1.
DR   IntAct; P08294; 8.
DR   STRING; 9606.ENSP00000371554; -.
DR   BindingDB; P08294; -.
DR   ChEMBL; CHEMBL2069159; -.
DR   iPTMnet; P08294; -.
DR   PhosphoSitePlus; P08294; -.
DR   BioMuta; SOD3; -.
DR   DMDM; 108885292; -.
DR   EPD; P08294; -.
DR   MaxQB; P08294; -.
DR   PaxDb; P08294; -.
DR   PeptideAtlas; P08294; -.
DR   PRIDE; P08294; -.
DR   DNASU; 6649; -.
DR   Ensembl; ENST00000382120; ENSP00000371554; ENSG00000109610.
DR   GeneID; 6649; -.
DR   KEGG; hsa:6649; -.
DR   UCSC; uc003gqz.4; human.
DR   CTD; 6649; -.
DR   DisGeNET; 6649; -.
DR   EuPathDB; HostDB:ENSG00000109610.5; -.
DR   GeneCards; SOD3; -.
DR   HGNC; HGNC:11181; SOD3.
DR   HPA; HPA042110; -.
DR   MIM; 185490; gene.
DR   neXtProt; NX_P08294; -.
DR   OpenTargets; ENSG00000109610; -.
DR   PharmGKB; PA36018; -.
DR   eggNOG; KOG0441; Eukaryota.
DR   eggNOG; COG2032; LUCA.
DR   GeneTree; ENSGT00530000063226; -.
DR   HOGENOM; HOG000263447; -.
DR   HOVERGEN; HBG000062; -.
DR   InParanoid; P08294; -.
DR   KO; K16627; -.
DR   OMA; EQEDDMG; -.
DR   OrthoDB; EOG091G13ID; -.
DR   PhylomeDB; P08294; -.
DR   TreeFam; TF105133; -.
DR   BioCyc; MetaCyc:HS03242-MONOMER; -.
DR   Reactome; R-HSA-3299685; Detoxification of Reactive Oxygen Species.
DR   ChiTaRS; SOD3; human.
DR   EvolutionaryTrace; P08294; -.
DR   GeneWiki; SOD3; -.
DR   GenomeRNAi; 6649; -.
DR   PMAP-CutDB; P08294; -.
DR   PRO; PR:P08294; -.
DR   Proteomes; UP000005640; Chromosome 4.
DR   Bgee; ENSG00000109610; -.
DR   CleanEx; HS_SOD3; -.
DR   ExpressionAtlas; P08294; baseline and differential.
DR   Genevisible; P08294; HS.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0031012; C:extracellular matrix; HDA:BHF-UCL.
DR   GO; GO:0005576; C:extracellular region; HDA:BHF-UCL.
DR   GO; GO:0005615; C:extracellular space; HDA:BHF-UCL.
DR   GO; GO:0005796; C:Golgi lumen; TAS:Reactome.
DR   GO; GO:0005634; C:nucleus; IEA:Ensembl.
DR   GO; GO:0005507; F:copper ion binding; IBA:GO_Central.
DR   GO; GO:0008201; F:heparin binding; IEA:UniProtKB-KW.
DR   GO; GO:0004784; F:superoxide dismutase activity; IBA:GO_Central.
DR   GO; GO:0008270; F:zinc ion binding; IBA:GO_Central.
DR   GO; GO:0034599; P:cellular response to oxidative stress; TAS:Reactome.
DR   GO; GO:0046688; P:response to copper ion; IEA:Ensembl.
DR   GO; GO:0001666; P:response to hypoxia; IEA:Ensembl.
DR   CDD; cd00305; Cu-Zn_Superoxide_Dismutase; 1.
DR   Gene3D; 2.60.40.200; -; 1.
DR   InterPro; IPR036423; SOD-like_Cu/Zn_dom_sf.
DR   InterPro; IPR024134; SOD_Cu/Zn_/chaperone.
DR   InterPro; IPR018152; SOD_Cu/Zn_BS.
DR   InterPro; IPR001424; SOD_Cu_Zn_dom.
DR   PANTHER; PTHR10003; PTHR10003; 1.
DR   Pfam; PF00080; Sod_Cu; 1.
DR   PRINTS; PR00068; CUZNDISMTASE.
DR   SUPFAM; SSF49329; SSF49329; 1.
DR   PROSITE; PS00087; SOD_CU_ZN_1; 1.
DR   PROSITE; PS00332; SOD_CU_ZN_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Antioxidant; Complete proteome; Copper;
KW   Direct protein sequencing; Disulfide bond; Glycation; Glycoprotein;
KW   Heparin-binding; Metal-binding; Oxidoreductase; Polymorphism;
KW   Reference proteome; Secreted; Signal; Zinc.
FT   SIGNAL        1     18
FT   CHAIN        19    240       Extracellular superoxide dismutase [Cu-
FT                                Zn].
FT                                /FTId=PRO_0000032855.
FT   METAL       114    114       Copper; catalytic.
FT   METAL       116    116       Copper; catalytic.
FT   METAL       131    131       Copper; catalytic.
FT   METAL       131    131       Zinc; structural.
FT   METAL       139    139       Zinc; structural.
FT   METAL       142    142       Zinc; structural.
FT   METAL       145    145       Zinc; structural.
FT   METAL       181    181       Copper; catalytic.
FT   SITE         41     41       Not glycated.
FT   SITE         92     92       Not glycated.
FT   SITE        238    238       Not glycated.
FT   CARBOHYD    107    107       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:16335952,
FT                                ECO:0000269|PubMed:19159218}.
FT   CARBOHYD    229    229       N-linked (Glc) (glycation) lysine; in
FT                                vitro.
FT   CARBOHYD    230    230       N-linked (Glc) (glycation) lysine; in
FT                                vitro.
FT   DISULFID     63    208       {ECO:0000269|PubMed:19289127}.
FT   DISULFID    125    207       {ECO:0000269|PubMed:19289127}.
FT   VARIANT      58     58       A -> T (in dbSNP:rs2536512).
FT                                {ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|PubMed:3476950,
FT                                ECO:0000269|PubMed:7959763,
FT                                ECO:0000269|Ref.3, ECO:0000269|Ref.4}.
FT                                /FTId=VAR_020776.
FT   VARIANT      91     91       A -> T (in dbSNP:rs17879876).
FT                                {ECO:0000269|Ref.4}.
FT                                /FTId=VAR_020777.
FT   VARIANT     231    231       R -> G (in dbSNP:rs1799895).
FT                                {ECO:0000269|PubMed:7662997,
FT                                ECO:0000269|PubMed:8034674,
FT                                ECO:0000269|PubMed:8546689,
FT                                ECO:0000269|PubMed:8864862,
FT                                ECO:0000269|Ref.4}.
FT                                /FTId=VAR_014705.
FT   STRAND       59     67       {ECO:0000244|PDB:2JLP}.
FT   STRAND       79     88       {ECO:0000244|PDB:2JLP}.
FT   STRAND       93    100       {ECO:0000244|PDB:2JLP}.
FT   STRAND      104    117       {ECO:0000244|PDB:2JLP}.
FT   HELIX       124    128       {ECO:0000244|PDB:2JLP}.
FT   STRAND      145    152       {ECO:0000244|PDB:2JLP}.
FT   STRAND      155    164       {ECO:0000244|PDB:2JLP}.
FT   STRAND      166    169       {ECO:0000244|PDB:2JLP}.
FT   STRAND      176    183       {ECO:0000244|PDB:2JLP}.
FT   STRAND      190    192       {ECO:0000244|PDB:2JLP}.
FT   HELIX       195    198       {ECO:0000244|PDB:2JLP}.
FT   STRAND      204    209       {ECO:0000244|PDB:2JLP}.
FT   HELIX       216    222       {ECO:0000244|PDB:2JLP}.
SQ   SEQUENCE   240 AA;  25851 MW;  585B8DEBFC506CF4 CRC64;
     MLALLCSCLL LAAGASDAWT GEDSAEPNSD SAEWIRDMYA KVTEIWQEVM QRRDDDGALH
     AACQVQPSAT LDAAQPRVTG VVLFRQLAPR AKLDAFFALE GFPTEPNSSS RAIHVHQFGD
     LSQGCESTGP HYNPLAVPHP QHPGDFGNFA VRDGSLWRYR AGLAASLAGP HSIVGRAVVV
     HAGEDDLGRG GNQASVENGN AGRRLACCVV GVCGPGLWER QAREHSERKK RRRESECKAA
//
ID   A0A140VK72_HUMAN        Unreviewed;       471 AA.
AC   A0A140VK72;
DT   08-JUN-2016, integrated into UniProtKB/TrEMBL.
DT   08-JUN-2016, sequence version 1.
DT   23-MAY-2018, entry version 10.
DE   SubName: Full=Testis secretory sperm-binding protein Li 199a {ECO:0000313|EMBL:AEE61209.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:AEE61209.1};
RN   [1] {ECO:0000313|EMBL:AEE61209.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Li J.Y.;
RT   "Human testis protein.";
RL   Submitted (MAR-2010) to the EMBL/GenBank/DDBJ databases.
CC   -!- SIMILARITY: Belongs to the heat shock protein 70 family.
CC       {ECO:0000256|RuleBase:RU003322}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; HM005612; AEE61209.1; -; mRNA.
DR   RefSeq; NP_008879.3; NM_006948.4.
DR   UniGene; Hs.352341; -.
DR   ProteinModelPortal; A0A140VK72; -.
DR   SMR; A0A140VK72; -.
DR   PRIDE; A0A140VK72; -.
DR   GeneID; 6782; -.
DR   KEGG; hsa:6782; -.
DR   CTD; 6782; -.
DR   KO; K09491; -.
DR   OMA; TRAMSGN; -.
DR   PhylomeDB; A0A140VK72; -.
DR   ExpressionAtlas; A0A140VK72; baseline and differential.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   InterPro; IPR018181; Heat_shock_70_CS.
DR   InterPro; IPR013126; Hsp_70_fam.
DR   PANTHER; PTHR19375; PTHR19375; 1.
DR   Pfam; PF00012; HSP70; 2.
DR   PRINTS; PR00301; HEATSHOCK70.
DR   PROSITE; PS00297; HSP70_1; 1.
DR   PROSITE; PS00329; HSP70_2; 1.
DR   PROSITE; PS01036; HSP70_3; 1.
PE   2: Evidence at transcript level;
KW   ATP-binding {ECO:0000256|RuleBase:RU003322};
KW   Nucleotide-binding {ECO:0000256|RuleBase:RU003322};
KW   Signal {ECO:0000256|SAM:SignalP}.
FT   SIGNAL        1     22       {ECO:0000256|SAM:SignalP}.
FT   CHAIN        23    471       {ECO:0000256|SAM:SignalP}.
FT                                /FTId=PRO_5007491841.
SQ   SEQUENCE   471 AA;  51927 MW;  C78028E7CB0D03F3 CRC64;
     MAREMTILGS AVLTLLLAGY LAQQYLPLPT PKVIGIDLGT TYCSVGVFFP GTGKVKVIPD
     ENGHISIPSM VSFTDNDVYV GYESVELADS NPQNTIYDAK RFIGKIFTAE ELEAEIGRYP
     FKVLNKNGMV EFSVTSNETI TVSPEYVGSR LLLKLKEMAE AYLGMPVANA VISVPAEFDL
     KQRNSTIEAA NLAGLKILRV INEPTAAAMA YGLHKADVFH VLVIDLGGGT LDVSLLNKQG
     GMFLTRAMSG NNKLGGQDFN QRLLQYLYKQ IYQTYGFVPS RKEEIHRLRQ AVEMVKLNLT
     LHQSAQLSVL LTVEEQDRKE PHSSDTELPK DKLSSADDHR VNSGFGRGLS DKKSGESQVL
     FETEISRKLF DTLNEDLFQK ILVPIQQVLK EGHLEKTEID EVVLVGGSTR IPRIRQVIQE
     FFGKDPNTSV DPDLAVVTGV AIQAGIDGGS WPLQVSALEI PNKHLQKTNF N
//
ID   HSP13_HUMAN             Reviewed;         471 AA.
AC   P48723; B2R616; Q8NE40;
DT   01-FEB-1996, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-1996, sequence version 1.
DT   23-MAY-2018, entry version 157.
DE   RecName: Full=Heat shock 70 kDa protein 13;
DE   AltName: Full=Microsomal stress-70 protein ATPase core;
DE   AltName: Full=Stress-70 protein chaperone microsome-associated 60 kDa protein;
DE   Flags: Precursor;
GN   Name=HSPA13; Synonyms=STCH;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=8131751;
RA   Otterson G.A., Flynn G.C., Kratzke R.A., Coxon A., Johnston P.G.,
RA   Kaye F.J.;
RT   "Stch encodes the 'ATPase core' of a microsomal stress 70 protein.";
RL   EMBO J. 13:1216-1225(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RA   Blechschmidt K., Nordsiek G., Groet J., Nizetic D., Hildmann T.,
RA   Drescher B., Weber J., Menzel U., Schattevoy R., Yaspo M.-L.,
RA   Rosenthal A.;
RL   Submitted (FEB-1999) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Amygdala;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=10830953; DOI=10.1038/35012518;
RA   Hattori M., Fujiyama A., Taylor T.D., Watanabe H., Yada T.,
RA   Park H.-S., Toyoda A., Ishii K., Totoki Y., Choi D.-K., Groner Y.,
RA   Soeda E., Ohki M., Takagi T., Sakaki Y., Taudien S., Blechschmidt K.,
RA   Polley A., Menzel U., Delabar J., Kumpf K., Lehmann R., Patterson D.,
RA   Reichwald K., Rump A., Schillhabel M., Schudy A., Zimmermann W.,
RA   Rosenthal A., Kudoh J., Shibuya K., Kawasaki K., Asakawa S.,
RA   Shintani A., Sasaki T., Nagamine K., Mitsuyama S., Antonarakis S.E.,
RA   Minoshima S., Shimizu N., Nordsiek G., Hornischer K., Brandt P.,
RA   Scharfe M., Schoen O., Desario A., Reichelt J., Kauer G., Bloecker H.,
RA   Ramser J., Beck A., Klages S., Hennig S., Riesselmann L., Dagand E.,
RA   Wehrmeyer S., Borzym K., Gardiner K., Nizetic D., Francis F.,
RA   Lehrach H., Reinhardt R., Yaspo M.-L.;
RT   "The DNA sequence of human chromosome 21.";
RL   Nature 405:311-319(2000).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   INTERACTION WITH UBQLN2.
RX   PubMed=10675567; DOI=10.1016/S0014-5793(00)01135-2;
RA   Kaye F.J., Modi S., Ivanovska I., Koonin E.V., Thress K., Kubo A.,
RA   Kornbluth S., Rose M.D.;
RT   "A family of ubiquitin-like proteins binds the ATPase domain of Hsp70-
RT   like Stch.";
RL   FEBS Lett. 467:348-355(2000).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
CC   -!- FUNCTION: Has peptide-independent ATPase activity.
CC   -!- SUBUNIT: Binds UBQLN2.
CC   -!- INTERACTION:
CC       O43765:SGTA; NbExp=5; IntAct=EBI-750892, EBI-347996;
CC       Q9UMX0:UBQLN1; NbExp=7; IntAct=EBI-750892, EBI-741480;
CC       Q9UMX0-2:UBQLN1; NbExp=3; IntAct=EBI-750892, EBI-10173939;
CC       Q9UHD9:UBQLN2; NbExp=4; IntAct=EBI-750892, EBI-947187;
CC   -!- SUBCELLULAR LOCATION: Microsome. Endoplasmic reticulum.
CC   -!- TISSUE SPECIFICITY: Constitutively expressed in all tissues.
CC   -!- SIMILARITY: Belongs to the heat shock protein 70 family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U04735; AAA16954.1; -; mRNA.
DR   EMBL; AF130249; AAD21091.1; -; Genomic_DNA.
DR   EMBL; AK312396; BAG35313.1; -; mRNA.
DR   EMBL; AL163206; CAB90390.1; -; Genomic_DNA.
DR   EMBL; CH471079; EAX10056.1; -; Genomic_DNA.
DR   EMBL; BC036370; AAH36370.1; -; mRNA.
DR   CCDS; CCDS13567.1; -.
DR   PIR; S42631; S42631.
DR   RefSeq; NP_008879.3; NM_006948.4.
DR   UniGene; Hs.352341; -.
DR   ProteinModelPortal; P48723; -.
DR   SMR; P48723; -.
DR   BioGrid; 112659; 15.
DR   IntAct; P48723; 12.
DR   MINT; P48723; -.
DR   STRING; 9606.ENSP00000285667; -.
DR   iPTMnet; P48723; -.
DR   PhosphoSitePlus; P48723; -.
DR   BioMuta; HSPA13; -.
DR   DMDM; 1351125; -.
DR   REPRODUCTION-2DPAGE; IPI00299299; -.
DR   EPD; P48723; -.
DR   MaxQB; P48723; -.
DR   PaxDb; P48723; -.
DR   PeptideAtlas; P48723; -.
DR   PRIDE; P48723; -.
DR   TopDownProteomics; P48723; -.
DR   DNASU; 6782; -.
DR   Ensembl; ENST00000285667; ENSP00000285667; ENSG00000155304.
DR   GeneID; 6782; -.
DR   KEGG; hsa:6782; -.
DR   UCSC; uc002yjt.4; human.
DR   CTD; 6782; -.
DR   DisGeNET; 6782; -.
DR   EuPathDB; HostDB:ENSG00000155304.5; -.
DR   GeneCards; HSPA13; -.
DR   HGNC; HGNC:11375; HSPA13.
DR   HPA; HPA014797; -.
DR   MIM; 601100; gene.
DR   neXtProt; NX_P48723; -.
DR   OpenTargets; ENSG00000155304; -.
DR   PharmGKB; PA162391697; -.
DR   eggNOG; KOG0101; Eukaryota.
DR   eggNOG; COG0443; LUCA.
DR   GeneTree; ENSGT00890000139503; -.
DR   HOGENOM; HOG000228135; -.
DR   HOVERGEN; HBG098979; -.
DR   InParanoid; P48723; -.
DR   KO; K09491; -.
DR   OMA; TRAMSGN; -.
DR   OrthoDB; EOG091G06OD; -.
DR   PhylomeDB; P48723; -.
DR   TreeFam; TF105047; -.
DR   Reactome; R-HSA-3371453; Regulation of HSF1-mediated heat shock response.
DR   ChiTaRS; HSPA13; human.
DR   GeneWiki; STCH; -.
DR   GenomeRNAi; 6782; -.
DR   PRO; PR:P48723; -.
DR   Proteomes; UP000005640; Chromosome 21.
DR   Bgee; ENSG00000155304; -.
DR   CleanEx; HS_HSPA13; -.
DR   ExpressionAtlas; P48723; baseline and differential.
DR   Genevisible; P48723; HS.
DR   GO; GO:0005783; C:endoplasmic reticulum; IEA:UniProtKB-SubCell.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; TAS:ProtInc.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   InterPro; IPR018181; Heat_shock_70_CS.
DR   InterPro; IPR013126; Hsp_70_fam.
DR   PANTHER; PTHR19375; PTHR19375; 1.
DR   Pfam; PF00012; HSP70; 2.
DR   PRINTS; PR00301; HEATSHOCK70.
DR   PROSITE; PS00297; HSP70_1; 1.
DR   PROSITE; PS00329; HSP70_2; 1.
DR   PROSITE; PS01036; HSP70_3; 1.
PE   1: Evidence at protein level;
KW   ATP-binding; Complete proteome; Endoplasmic reticulum; Microsome;
KW   Nucleotide-binding; Reference proteome; Signal.
FT   SIGNAL        1     22       {ECO:0000255}.
FT   CHAIN        23    471       Heat shock 70 kDa protein 13.
FT                                /FTId=PRO_0000013558.
FT   CONFLICT    450    450       S -> F (in Ref. 6; AAH36370).
FT                                {ECO:0000305}.
SQ   SEQUENCE   471 AA;  51927 MW;  C78028E7CB0D03F3 CRC64;
     MAREMTILGS AVLTLLLAGY LAQQYLPLPT PKVIGIDLGT TYCSVGVFFP GTGKVKVIPD
     ENGHISIPSM VSFTDNDVYV GYESVELADS NPQNTIYDAK RFIGKIFTAE ELEAEIGRYP
     FKVLNKNGMV EFSVTSNETI TVSPEYVGSR LLLKLKEMAE AYLGMPVANA VISVPAEFDL
     KQRNSTIEAA NLAGLKILRV INEPTAAAMA YGLHKADVFH VLVIDLGGGT LDVSLLNKQG
     GMFLTRAMSG NNKLGGQDFN QRLLQYLYKQ IYQTYGFVPS RKEEIHRLRQ AVEMVKLNLT
     LHQSAQLSVL LTVEEQDRKE PHSSDTELPK DKLSSADDHR VNSGFGRGLS DKKSGESQVL
     FETEISRKLF DTLNEDLFQK ILVPIQQVLK EGHLEKTEID EVVLVGGSTR IPRIRQVIQE
     FFGKDPNTSV DPDLAVVTGV AIQAGIDGGS WPLQVSALEI PNKHLQKTNF N
//
ID   TFF3_HUMAN              Reviewed;          94 AA.
AC   Q07654; A0A0A6YYJ4; E9PBB5; Q96NX0; Q9UDA5;
DT   01-OCT-1994, integrated into UniProtKB/Swiss-Prot.
DT   28-MAR-2018, sequence version 2.
DT   23-MAY-2018, entry version 162.
DE   RecName: Full=Trefoil factor 3;
DE   AltName: Full=Intestinal trefoil factor;
DE            Short=hITF;
DE   AltName: Full=Polypeptide P1.B;
DE            Short=hP1.B;
DE   Flags: Precursor;
GN   Name=TFF3; Synonyms=ITF, TFI;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=9070946; DOI=10.1006/geno.1996.4511;
RA   Seib T., Blin N., Hilgert K., Seifert M., Theisinger B., Engel M.,
RA   Dooley S., Zang K.D., Welter C.;
RT   "The three human trefoil genes TFF1, TFF2, and TFF3 are located within
RT   a region of 55 kb on chromosome 21q22.3.";
RL   Genomics 40:200-202(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=10950923; DOI=10.1006/geno.2000.6253;
RA   Berry A., Scott H.S., Kudoh J., Talior I., Korostishevsky M.,
RA   Wattenhofer M., Guipponi M., Barras C., Rossier C., Shibuya K.,
RA   Wang J., Kawasaki K., Asakawa S., Minoshima S., Shimizu N.,
RA   Antonarakis S.E., Bonne-Tamir B.;
RT   "Refined localization of autosomal recessive nonsyndromic deafness
RT   DFNB10 locus using 34 novel microsatellite markers, genomic structure,
RT   and exclusion of six known genes in the region.";
RL   Genomics 68:22-29(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=10830953; DOI=10.1038/35012518;
RA   Hattori M., Fujiyama A., Taylor T.D., Watanabe H., Yada T.,
RA   Park H.-S., Toyoda A., Ishii K., Totoki Y., Choi D.-K., Groner Y.,
RA   Soeda E., Ohki M., Takagi T., Sakaki Y., Taudien S., Blechschmidt K.,
RA   Polley A., Menzel U., Delabar J., Kumpf K., Lehmann R., Patterson D.,
RA   Reichwald K., Rump A., Schillhabel M., Schudy A., Zimmermann W.,
RA   Rosenthal A., Kudoh J., Shibuya K., Kawasaki K., Asakawa S.,
RA   Shintani A., Sasaki T., Nagamine K., Mitsuyama S., Antonarakis S.E.,
RA   Minoshima S., Shimizu N., Nordsiek G., Hornischer K., Brandt P.,
RA   Scharfe M., Schoen O., Desario A., Reichelt J., Kauer G., Bloecker H.,
RA   Ramser J., Beck A., Klages S., Hennig S., Riesselmann L., Dagand E.,
RA   Wehrmeyer S., Borzym K., Gardiner K., Nizetic D., Francis F.,
RA   Lehrach H., Reinhardt R., Yaspo M.-L.;
RT   "The DNA sequence of human chromosome 21.";
RL   Nature 405:311-319(2000).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-65.
RC   TISSUE=Heart;
RX   PubMed=14637006; DOI=10.1016/S0378-1119(03)00835-7;
RA   Casadei R., Strippoli P., D'Addabbo P., Canaider S., Lenzi L.,
RA   Vitale L., Giannone S., Frabetti F., Facchin F., Carinci P.,
RA   Zannotti M.;
RT   "mRNA 5' region sequence incompleteness: a potential source of
RT   systematic errors in translation initiation codon assignment in human
RT   mRNAs.";
RL   Gene 321:185-193(2003).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 3-94, AND TISSUE SPECIFICITY.
RC   TISSUE=Small intestine;
RX   PubMed=8346203; DOI=10.1073/pnas.90.15.6961;
RA   Hauser F., Poulsom R., Chinery R., Rogers L.A., Hanby A.M.,
RA   Wright N.A., Hoffmann W.;
RT   "hP1.B, a human P-domain peptide homologous with rat intestinal
RT   trefoil factor, is expressed also in the ulcer-associated cell lineage
RT   and the uterus.";
RL   Proc. Natl. Acad. Sci. U.S.A. 90:6961-6965(1993).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 4-94.
RC   TISSUE=Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 22-94, SUBCELLULAR LOCATION, AND TISSUE
RP   SPECIFICITY.
RC   TISSUE=Colon;
RX   PubMed=8454642;
RA   Podolsky D.K., Lynch-Devaney K., Stow J.L., Oates P., Murgue B.,
RA   Debeaumont M., Sands B.E., Mahida Y.R.;
RT   "Identification of human intestinal trefoil factor. Goblet cell-
RT   specific expression of a peptide targeted for apical secretion.";
RL   J. Biol. Chem. 268:6694-6702(1993).
RN   [8]
RP   ERRATUM.
RA   Podolsky D.K., Lynch-Devaney K., Stow J.L., Oates P., Murgue B.,
RA   De-Beaumont M., Sands B.E., Mahida Y.R.;
RL   J. Biol. Chem. 268:12230-12230(1993).
RN   [9]
RP   PROTEIN SEQUENCE OF 36-50.
RX   PubMed=15340161; DOI=10.1110/ps.04682504;
RA   Zhang Z., Henzel W.J.;
RT   "Signal peptide prediction based on analysis of experimentally
RT   verified cleavage sites.";
RL   Protein Sci. 13:2819-2824(2004).
RN   [10]
RP   PROTEIN SEQUENCE OF 36-51, AND IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=19670903; DOI=10.1021/pr9004426;
RA   Casado-Vela J., Rodriguez-Suarez E., Iloro I., Ametzazurra A.,
RA   Alkorta N., Garcia-Velasco J.A., Matorras R., Prieto B., Gonzalez S.,
RA   Nagore D., Simon L., Elortza F.;
RT   "Comprehensive proteomic analysis of human endometrial fluid
RT   aspirate.";
RL   J. Proteome Res. 8:4622-4632(2009).
RN   [11]
RP   SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=10824705; DOI=10.1055/s-2007-978604;
RA   Griepentrog T., Bauer M., Hornstein C., Sauer H., Jirikowski G.F.;
RT   "Coexistence of intestinal trefoil factor (hITF) and oxytocin in
RT   magnocellular neurons in the human hypothalamus.";
RL   Horm. Metab. Res. 32:121-124(2000).
RN   [12]
RP   FUNCTION.
RX   PubMed=11694446; DOI=10.1165/ajrcmb.25.4.4429;
RA   Oertel M., Graness A., Thim L., Buhling F., Kalbacher H., Hoffmann W.;
RT   "Trefoil factor family-peptides promote migration of human bronchial
RT   epithelial cells: synergistic effect with epidermal growth factor.";
RL   Am. J. Respir. Cell Mol. Biol. 25:418-424(2001).
RN   [13]
RP   STRUCTURE BY NMR OF 36-94.
RX   PubMed=18209;
RA   De Luca S.;
RT   "Incorporation of mannose and glucose into prenylphosphate sugars in
RT   isolated human platelet membranes.";
RL   Biochim. Biophys. Acta 498:341-348(1977).
RN   [14]
RP   STRUCTURE BY NMR OF 36-94, AND SUBUNIT.
RX   PubMed=14690424; DOI=10.1021/bi030182k;
RA   Muskett F.W., May F.E., Westley B.R., Feeney J.;
RT   "Solution structure of the disulfide-linked dimer of human intestinal
RT   trefoil factor (TFF3): the intermolecular orientation and interactions
RT   are markedly different from those of other dimeric trefoil proteins.";
RL   Biochemistry 42:15139-15147(2003).
CC   -!- FUNCTION: Involved in the maintenance and repair of the intestinal
CC       mucosa. Promotes the mobility of epithelial cells in healing
CC       processes (motogen). {ECO:0000269|PubMed:11694446}.
CC   -!- SUBUNIT: Monomer. Homodimer; disulfide-linked.
CC       {ECO:0000269|PubMed:14690424}.
CC   -!- INTERACTION:
CC       P61457:PCBD1; NbExp=5; IntAct=EBI-10224676, EBI-740475;
CC       O43765:SGTA; NbExp=3; IntAct=EBI-10224676, EBI-347996;
CC   -!- SUBCELLULAR LOCATION: Secreted, extracellular space, extracellular
CC       matrix {ECO:0000269|PubMed:8454642}. Cytoplasm
CC       {ECO:0000269|PubMed:10824705, ECO:0000269|PubMed:8454642}.
CC   -!- TISSUE SPECIFICITY: Expressed in goblet cells of the intestines
CC       and colon (at protein level). Expressed by goblet cells of small
CC       and large intestinal epithelia and also by the uterus. Also
CC       expressed in the hypothalamus where it is detected in
CC       paraventricular, periventricular and supraoptic nuclei (at protein
CC       level). {ECO:0000269|PubMed:8346203, ECO:0000269|PubMed:8454642}.
CC   -!- CAUTION: It is uncertain whether Met-1 or Met-15 is the initiator.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAA59981.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=AAA83628.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=AAH17859.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=AAL28111.1; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC       Sequence=BAA95531.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=BAB13731.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/TFF3ID265.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U25657; AAA83628.1; ALT_INIT; Genomic_DNA.
DR   EMBL; U25654; AAA83628.1; JOINED; Genomic_DNA.
DR   EMBL; U25656; AAA83628.1; JOINED; Genomic_DNA.
DR   EMBL; AB038162; BAB13731.1; ALT_INIT; Genomic_DNA.
DR   EMBL; AP001746; BAA95531.1; ALT_INIT; Genomic_DNA.
DR   EMBL; AP001623; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AF432265; AAL28111.1; ALT_INIT; mRNA.
DR   EMBL; L15203; AAA59981.1; ALT_INIT; mRNA.
DR   EMBL; BC017859; AAH17859.1; ALT_INIT; mRNA.
DR   EMBL; L08044; AAA36766.1; -; mRNA.
DR   CCDS; CCDS33565.2; -.
DR   PIR; A48284; A48284.
DR   RefSeq; NP_003217.3; NM_003226.3.
DR   UniGene; Hs.82961; -.
DR   PDB; 1E9T; NMR; -; A=36-94.
DR   PDB; 1PE3; NMR; -; 1/2=36-94.
DR   PDBsum; 1E9T; -.
DR   PDBsum; 1PE3; -.
DR   ProteinModelPortal; Q07654; -.
DR   BioGrid; 112891; 5.
DR   IntAct; Q07654; 3.
DR   STRING; 9606.ENSP00000430690; -.
DR   DMDM; 585328; -.
DR   PaxDb; Q07654; -.
DR   PeptideAtlas; Q07654; -.
DR   PRIDE; Q07654; -.
DR   DNASU; 7033; -.
DR   Ensembl; ENST00000518498; ENSP00000430690; ENSG00000160180.
DR   GeneID; 7033; -.
DR   KEGG; hsa:7033; -.
DR   CTD; 7033; -.
DR   DisGeNET; 7033; -.
DR   EuPathDB; HostDB:ENSG00000160180.15; -.
DR   GeneCards; TFF3; -.
DR   H-InvDB; HIX0016137; -.
DR   HGNC; HGNC:11757; TFF3.
DR   HPA; HPA035464; -.
DR   MIM; 600633; gene.
DR   neXtProt; NX_Q07654; -.
DR   OpenTargets; ENSG00000160180; -.
DR   PharmGKB; PA36472; -.
DR   eggNOG; ENOG410J0FX; Eukaryota.
DR   eggNOG; ENOG41114KR; LUCA.
DR   GeneTree; ENSGT00840000129881; -.
DR   HOGENOM; HOG000121778; -.
DR   HOVERGEN; HBG004364; -.
DR   InParanoid; Q07654; -.
DR   KO; K22454; -.
DR   OMA; PLQETEC; -.
DR   PhylomeDB; Q07654; -.
DR   TreeFam; TF336092; -.
DR   Reactome; R-HSA-9018519; Estrogen-dependent gene expression.
DR   SIGNOR; Q07654; -.
DR   ChiTaRS; TFF3; human.
DR   EvolutionaryTrace; Q07654; -.
DR   GeneWiki; Trefoil_factor_3; -.
DR   GenomeRNAi; 7033; -.
DR   PRO; PR:Q07654; -.
DR   Proteomes; UP000005640; Chromosome 21.
DR   Bgee; ENSG00000160180; -.
DR   CleanEx; HS_TFF3; -.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0005576; C:extracellular region; IDA:GO_Central.
DR   GO; GO:0005615; C:extracellular space; IBA:GO_Central.
DR   GO; GO:0005578; C:proteinaceous extracellular matrix; IEA:UniProtKB-SubCell.
DR   GO; GO:0042060; P:wound healing; IBA:GO_Central.
DR   CDD; cd00111; Trefoil; 1.
DR   InterPro; IPR017994; P_trefoil_chordata.
DR   InterPro; IPR017957; P_trefoil_CS.
DR   InterPro; IPR000519; P_trefoil_dom.
DR   Pfam; PF00088; Trefoil; 1.
DR   PRINTS; PR00680; PTREFOIL.
DR   SMART; SM00018; PD; 1.
DR   PROSITE; PS00025; P_TREFOIL_1; 1.
DR   PROSITE; PS51448; P_TREFOIL_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Complete proteome; Cytoplasm; Direct protein sequencing;
KW   Disulfide bond; Extracellular matrix; Reference proteome; Secreted;
KW   Signal.
FT   SIGNAL        1     35       {ECO:0000269|PubMed:15340161,
FT                                ECO:0000269|PubMed:19670903}.
FT   CHAIN        36     94       Trefoil factor 3.
FT                                /FTId=PRO_0000023465.
FT   DOMAIN       44     87       P-type. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00779}.
FT   DISULFID     46     72       {ECO:0000255|PROSITE-ProRule:PRU00779}.
FT   DISULFID     56     71       {ECO:0000255|PROSITE-ProRule:PRU00779}.
FT   DISULFID     66     83       {ECO:0000255|PROSITE-ProRule:PRU00779}.
FT   DISULFID     92     92       Interchain.
FT   CONFLICT     88     90       QEA -> TRKT (in Ref. 7; AAA36766).
FT                                {ECO:0000305}.
FT   STRAND       42     44       {ECO:0000244|PDB:1E9T}.
FT   HELIX        45     47       {ECO:0000244|PDB:1PE3}.
FT   STRAND       50     53       {ECO:0000244|PDB:1PE3}.
FT   TURN         63     65       {ECO:0000244|PDB:1E9T}.
FT   HELIX        66     69       {ECO:0000244|PDB:1E9T}.
FT   STRAND       70     72       {ECO:0000244|PDB:1E9T}.
FT   STRAND       78     80       {ECO:0000244|PDB:1E9T}.
FT   STRAND       82     84       {ECO:0000244|PDB:1E9T}.
FT   HELIX        88     90       {ECO:0000244|PDB:1PE3}.
FT   TURN         91     93       {ECO:0000244|PDB:1PE3}.
SQ   SEQUENCE   94 AA;  10181 MW;  02276443AEE4CEA5 CRC64;
     MKRVLSCVPE PTVVMAARAL CMLGLVLALL SSSSAEEYVG LSANQCAVPA KDRVDCGYPH
     VTPKECNNRG CCFDSRIPGV PWCFKPLQEA ECTF
//
ID   A8K6Q8_HUMAN            Unreviewed;       760 AA.
AC   A8K6Q8;
DT   04-DEC-2007, integrated into UniProtKB/TrEMBL.
DT   04-DEC-2007, sequence version 1.
DT   31-JAN-2018, entry version 62.
DE   SubName: Full=cDNA FLJ75881, highly similar to Homo sapiens transferrin receptor (p90, CD71) (TFRC), mRNA {ECO:0000313|EMBL:BAF84412.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAF84412.1};
RN   [1] {ECO:0000313|EMBL:BAF84412.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Placenta {ECO:0000313|EMBL:BAF84412.1};
RA   Wakamatsu A., Yamamoto J., Kimura K., Ishii S., Watanabe K.,
RA   Sugiyama A., Murakawa K., Kaida T., Tsuchiya K., Fukuzumi Y.,
RA   Kumagai A., Oishi Y., Yamamoto S., Ono Y., Komori Y., Yamazaki M.,
RA   Kisu Y., Nishikawa T., Sugano S., Nomura N., Isogai T.;
RT   "NEDO human cDNA sequencing project.";
RL   Submitted (OCT-2007) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK291723; BAF84412.1; -; mRNA.
DR   RefSeq; NP_003225.2; NM_003234.3.
DR   UniGene; Hs.529618; -.
DR   PeptideAtlas; A8K6Q8; -.
DR   PRIDE; A8K6Q8; -.
DR   DNASU; 7037; -.
DR   GeneID; 7037; -.
DR   CTD; 7037; -.
DR   PharmGKB; PA36478; -.
DR   eggNOG; KOG2195; Eukaryota.
DR   eggNOG; COG2234; LUCA.
DR   HOVERGEN; HBG023177; -.
DR   Genevisible; A8K6Q8; HS.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005886; C:plasma membrane; IEA:InterPro.
DR   GO; GO:0004998; F:transferrin receptor activity; IEA:InterPro.
DR   GO; GO:0033570; F:transferrin transmembrane transporter activity; IEA:InterPro.
DR   GO; GO:0006879; P:cellular iron ion homeostasis; IEA:InterPro.
DR   CDD; cd02128; PA_TfR; 1.
DR   Gene3D; 1.20.930.40; -; 1.
DR   InterPro; IPR003137; PA_domain.
DR   InterPro; IPR007484; Peptidase_M28.
DR   InterPro; IPR029513; TfR.
DR   InterPro; IPR007365; TFR-like_dimer_dom.
DR   InterPro; IPR036757; TFR-like_dimer_dom_sf.
DR   InterPro; IPR037324; TfR1/2_PA.
DR   PANTHER; PTHR10404:SF26; PTHR10404:SF26; 1.
DR   Pfam; PF02225; PA; 1.
DR   Pfam; PF04389; Peptidase_M28; 1.
DR   Pfam; PF04253; TFR_dimer; 1.
DR   SUPFAM; SSF47672; SSF47672; 1.
PE   2: Evidence at transcript level;
KW   Membrane {ECO:0000256|SAM:Phobius};
KW   Receptor {ECO:0000313|EMBL:BAF84412.1};
KW   Transmembrane {ECO:0000256|SAM:Phobius};
KW   Transmembrane helix {ECO:0000256|SAM:Phobius}.
FT   TRANSMEM     66     88       Helical. {ECO:0000256|SAM:Phobius}.
FT   DOMAIN      229    345       PA. {ECO:0000259|Pfam:PF02225}.
FT   DOMAIN      388    576       Peptidase_M28.
FT                                {ECO:0000259|Pfam:PF04389}.
FT   DOMAIN      637    749       TFR_dimer. {ECO:0000259|Pfam:PF04253}.
SQ   SEQUENCE   760 AA;  84873 MW;  3DAEE97671E394D4 CRC64;
     MMDQARSAFS NLFGGEPLSY TRFSLARQVD GDNSHVEMKL AVDEEENADN NTKANVTKPK
     RCSGSICYGT IAVIVFFLIG FMIGYLGYCK GVEPKTECER LAGTESPVRE EPGEDFPAAR
     RLYWDDLKRK LSEKLDSTDF TSTIKLLNEN SYVPREAGSQ KDENLALYVE NQFREFKLSK
     VWRDQHFVKI QVKDSAQNSV IIVDKNGRLV YLVENPGGYV AYSKAATATG KLVHANFGTK
     KDFEDLYTPV NGSIVIVRAG KITFAEKVAN AESLNAIGVL IYMDQTKFPI VNAELSFFGH
     AHLGTGDPYT PGFPSFNHTQ FPPSRSSGLP NIPVQTISRA AAEKLFGNME GDCPSDWKTD
     STCRMVTSES KNVKLTVSNV LKEIKILNIF GVIKGFVEPD HYVVVGAQRD AWGPGAAKSG
     VGTALLLKLA QMFSDMVLKD GFQPSRSIIF ASWSAGDFGS VGATEWLEGY LSSLHLKAFT
     YINLDKAVLG TSNFKVSASP LLYTLIEKTM QNVKHPVTGQ FLYQDSNWAS KVEKLTLDNA
     AFPFLAYSGI PAVSFCFCED TDYPYLGTTM DTYKELIERI PELNKVARAA AEVAGQFVIK
     LTHDVELNLD YERYNSQLLS FVRDLNQYRA DIKEMGLSLQ WLYSARGDFF RATSRLTTDF
     GNAEKTDRFV MKKLNDRVMR VEYHFLSPYV SPKESPFRHV FWGSGSHTLP ALLENLKLRK
     QNNGAFNETL FRNQLALATW TIQGAANALS GDVWDIDNEF
//
ID   B7Z2I6_HUMAN            Unreviewed;       478 AA.
AC   B7Z2I6;
DT   03-MAR-2009, integrated into UniProtKB/TrEMBL.
DT   03-MAR-2009, sequence version 1.
DT   31-JAN-2018, entry version 42.
DE   SubName: Full=cDNA FLJ57106, highly similar to Transferrin receptor protein 1 {ECO:0000313|EMBL:BAH11872.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAH11872.1};
RN   [1] {ECO:0000313|EMBL:BAH11872.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Brain {ECO:0000313|EMBL:BAH11872.1};
RA   Wakamatsu A., Yamamoto J., Kimura K., Ishii S., Watanabe K.,
RA   Sugiyama A., Murakawa K., Kaida T., Tsuchiya K., Fukuzumi Y.,
RA   Kumagai A., Oishi Y., Yamamoto S., Ono Y., Komori Y., Yamazaki M.,
RA   Kisu Y., Nishikawa T., Sugano S., Nomura N., Isogai T.;
RT   "NEDO human cDNA sequencing project focused on splicing variants.";
RL   Submitted (OCT-2007) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK294758; BAH11872.1; -; mRNA.
DR   RefSeq; NP_001300895.1; NM_001313966.1.
DR   UniGene; Hs.529618; -.
DR   SMR; B7Z2I6; -.
DR   PeptideAtlas; B7Z2I6; -.
DR   GeneID; 7037; -.
DR   CTD; 7037; -.
DR   eggNOG; KOG2195; Eukaryota.
DR   eggNOG; COG2234; LUCA.
DR   HOGENOM; HOG000124067; -.
DR   HOVERGEN; HBG023177; -.
DR   GO; GO:0005886; C:plasma membrane; IEA:InterPro.
DR   GO; GO:0004998; F:transferrin receptor activity; IEA:InterPro.
DR   GO; GO:0006879; P:cellular iron ion homeostasis; IEA:InterPro.
DR   GO; GO:0033572; P:transferrin transport; IEA:InterPro.
DR   Gene3D; 1.20.930.40; -; 1.
DR   InterPro; IPR007484; Peptidase_M28.
DR   InterPro; IPR029513; TfR.
DR   InterPro; IPR007365; TFR-like_dimer_dom.
DR   InterPro; IPR036757; TFR-like_dimer_dom_sf.
DR   PANTHER; PTHR10404:SF26; PTHR10404:SF26; 1.
DR   Pfam; PF04389; Peptidase_M28; 1.
DR   Pfam; PF04253; TFR_dimer; 1.
DR   SUPFAM; SSF47672; SSF47672; 1.
PE   2: Evidence at transcript level;
KW   Receptor {ECO:0000313|EMBL:BAH11872.1}.
FT   DOMAIN      106    294       Peptidase_M28.
FT                                {ECO:0000259|Pfam:PF04389}.
FT   DOMAIN      355    467       TFR_dimer. {ECO:0000259|Pfam:PF04253}.
SQ   SEQUENCE   478 AA;  53484 MW;  D23C6217E3CC79EB CRC64;
     MDQTKFPIVN AELSFFGHAH LGTGDPYTPG FPSFNHTQFP PSRSSGLPNI PVQTISRAAA
     EKLFGNMEGD CPSDWKTDST CRMVTSESKN VKLTVSNVLK EIKILNIFGV IKGFVEPDHY
     VVVGAQRDAW GPGAAKSGVG TALLLKLAQM FSDMVLKDGF QPSRSIIFAS WSAGDFGSVG
     ATEWLEGYLS SLHLKAFTYI NLDKAVLGTS NFKVSASPLL YTLIEKTMQN VKHPFTGQFL
     YQDSNWASKV EKLTLDNAAF PFLAYSGIPA VSFCFCEDTD YPYLGTTMDT YKELIERIPE
     LNKVARAAAE VAGQFVIKLT HDVELNLDYE RYNSQLLSFV RDLNQYRADI KEMGLSLQWL
     YSARGDFFRA TSRLTTDFGN AEKTDRFVMK KLNDRVMRVE YHFLSPYVSP KESPFRHVFW
     GSGSHTLPAL LENLKLRKQN NGAFNETLFR NQLALATWTI QGAANALSGD VWDIDNEF
//
ID   G3V0E5_HUMAN            Unreviewed;       679 AA.
AC   G3V0E5;
DT   16-NOV-2011, integrated into UniProtKB/TrEMBL.
DT   16-NOV-2011, sequence version 1.
DT   23-MAY-2018, entry version 71.
DE   SubName: Full=Transferrin receptor (P90, CD71), isoform CRA_c {ECO:0000313|EMBL:EAW53672.1};
DE   SubName: Full=Transferrin receptor protein 1 {ECO:0000313|Ensembl:ENSP00000390133};
GN   Name=TFRC {ECO:0000313|EMBL:EAW53672.1,
GN   ECO:0000313|Ensembl:ENSP00000390133};
GN   ORFNames=hCG_22086 {ECO:0000313|EMBL:EAW53672.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000390133, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|EMBL:EAW53672.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAW53672.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3] {ECO:0000313|Ensembl:ENSP00000390133, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16641997; DOI=10.1038/nature04728;
RA   Muzny D.M., Scherer S.E., Kaul R., Wang J., Yu J., Sudbrak R.,
RA   Buhay C.J., Chen R., Cree A., Ding Y., Dugan-Rocha S., Gill R.,
RA   Gunaratne P., Harris R.A., Hawes A.C., Hernandez J., Hodgson A.V.,
RA   Hume J., Jackson A., Khan Z.M., Kovar-Smith C., Lewis L.R.,
RA   Lozado R.J., Metzker M.L., Milosavljevic A., Miner G.R., Morgan M.B.,
RA   Nazareth L.V., Scott G., Sodergren E., Song X.Z., Steffen D., Wei S.,
RA   Wheeler D.A., Wright M.W., Worley K.C., Yuan Y., Zhang Z., Adams C.Q.,
RA   Ansari-Lari M.A., Ayele M., Brown M.J., Chen G., Chen Z.,
RA   Clendenning J., Clerc-Blankenburg K.P., Chen R., Chen Z., Davis C.,
RA   Delgado O., Dinh H.H., Dong W., Draper H., Ernst S., Fu G.,
RA   Gonzalez-Garay M.L., Garcia D.K., Gillett W., Gu J., Hao B.,
RA   Haugen E., Havlak P., He X., Hennig S., Hu S., Huang W., Jackson L.R.,
RA   Jacob L.S., Kelly S.H., Kube M., Levy R., Li Z., Liu B., Liu J.,
RA   Liu W., Lu J., Maheshwari M., Nguyen B.V., Okwuonu G.O., Palmeiri A.,
RA   Pasternak S., Perez L.M., Phelps K.A., Plopper F.J., Qiang B.,
RA   Raymond C., Rodriguez R., Saenphimmachak C., Santibanez J., Shen H.,
RA   Shen Y., Subramanian S., Tabor P.E., Verduzco D., Waldron L., Wang J.,
RA   Wang J., Wang Q., Williams G.A., Wong G.K., Yao Z., Zhang J.,
RA   Zhang X., Zhao G., Zhou J., Zhou Y., Nelson D., Lehrach H.,
RA   Reinhardt R., Naylor S.L., Yang H., Olson M., Weinstock G.,
RA   Gibbs R.A.;
RT   "The DNA sequence, annotation and analysis of human chromosome 3.";
RL   Nature 440:1194-1198(2006).
RN   [4] {ECO:0000213|PubMed:21269460}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Burckstummer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [5] {ECO:0000313|Ensembl:ENSP00000390133}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (SEP-2011) to UniProtKB.
RN   [6] {ECO:0000213|PubMed:25944712}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AC024937; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471191; EAW53672.1; -; Genomic_DNA.
DR   RefSeq; NP_001300894.1; NM_001313965.1.
DR   UniGene; Hs.529618; -.
DR   Ensembl; ENST00000420415; ENSP00000390133; ENSG00000072274.
DR   GeneID; 7037; -.
DR   UCSC; uc010hzy.4; human.
DR   CTD; 7037; -.
DR   EuPathDB; HostDB:ENSG00000072274.12; -.
DR   HGNC; HGNC:11763; TFRC.
DR   OpenTargets; ENSG00000072274; -.
DR   eggNOG; KOG2195; Eukaryota.
DR   eggNOG; COG2234; LUCA.
DR   GeneTree; ENSGT00550000074421; -.
DR   ChiTaRS; TFRC; human.
DR   Proteomes; UP000005640; Chromosome 3.
DR   Bgee; ENSG00000072274; -.
DR   GO; GO:0005886; C:plasma membrane; IEA:InterPro.
DR   GO; GO:0004998; F:transferrin receptor activity; IEA:InterPro.
DR   GO; GO:0033570; F:transferrin transmembrane transporter activity; IEA:InterPro.
DR   GO; GO:0006879; P:cellular iron ion homeostasis; IEA:InterPro.
DR   CDD; cd02128; PA_TfR; 1.
DR   Gene3D; 1.20.930.40; -; 1.
DR   InterPro; IPR003137; PA_domain.
DR   InterPro; IPR007484; Peptidase_M28.
DR   InterPro; IPR029513; TfR.
DR   InterPro; IPR007365; TFR-like_dimer_dom.
DR   InterPro; IPR036757; TFR-like_dimer_dom_sf.
DR   InterPro; IPR037324; TfR1/2_PA.
DR   PANTHER; PTHR10404:SF26; PTHR10404:SF26; 1.
DR   Pfam; PF02225; PA; 1.
DR   Pfam; PF04389; Peptidase_M28; 1.
DR   Pfam; PF04253; TFR_dimer; 1.
DR   SUPFAM; SSF47672; SSF47672; 1.
PE   1: Evidence at protein level;
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   Proteomics identification {ECO:0000213|EPD:G3V0E5,
KW   ECO:0000213|MaxQB:G3V0E5, ECO:0000213|PeptideAtlas:G3V0E5};
KW   Receptor {ECO:0000313|EMBL:EAW53672.1};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640}.
FT   DOMAIN      147    264       PA. {ECO:0000259|Pfam:PF02225}.
FT   DOMAIN      307    495       Peptidase_M28.
FT                                {ECO:0000259|Pfam:PF04389}.
FT   DOMAIN      556    668       TFR_dimer. {ECO:0000259|Pfam:PF04253}.
SQ   SEQUENCE   679 AA;  75964 MW;  00830FDA9668C11B CRC64;
     MIGYLGYCKG VEPKTECERL AGTESPVREE PGEDFPAARR LYWDDLKRKL SEKLDSTDFT
     GTIKLLNENS YVPREAGSQK DENLALYVEN QFREFKLSKV WRDQHFVKIQ VKDSAQNSVI
     IVDKNGRLVY LVENPGGYVA YSKAATVTGK LVHANFGTKK DFEDLYTPVN GSIVIVRAGK
     ITFAEKVANA ESLNAIGVLI YMDQTKFPIV NAELSFFGHA HLGTGDPYTP GFPSFNHTQF
     PPSRSSGLPN IPVQTISRAA AEKLFGNMEG DCPSDWKTDS TCRMVTSESK NVKLTVSNVL
     KEIKILNIFG VIKGFVEPDH YVVVGAQRDA WGPGAAKSGV GTALLLKLAQ MFSDMVLKDG
     FQPSRSIIFA SWSAGDFGSV GATEWLEGYL SSLHLKAFTY INLDKAVLGT SNFKVSASPL
     LYTLIEKTMQ NVKHPVTGQF LYQDSNWASK VEKLTLDNAA FPFLAYSGIP AVSFCFCEDT
     DYPYLGTTMD TYKELIERIP ELNKVARAAA EVAGQFVIKL THDVELNLDY ERYNSQLLSF
     VRDLNQYRAD IKEMGLSLQW LYSARGDFFR ATSRLTTDFG NAEKTDRFVM KKLNDRVMRV
     EYHFLSPYVS PKESPFRHVF WGSGSHTLPA LLENLKLRKQ NNGAFNETLF RNQLALATWT
     IQGAANALSG DVWDIDNEF
//
ID   TFR1_HUMAN              Reviewed;         760 AA.
AC   P02786; D3DXB0; Q1HE24; Q59G55; Q9UCN0; Q9UCU5; Q9UDF9; Q9UK21;
DT   21-JUL-1986, integrated into UniProtKB/Swiss-Prot.
DT   30-MAY-2006, sequence version 2.
DT   23-MAY-2018, entry version 223.
DE   RecName: Full=Transferrin receptor protein 1;
DE            Short=TR;
DE            Short=TfR;
DE            Short=TfR1;
DE            Short=Trfr;
DE   AltName: Full=T9;
DE   AltName: Full=p90;
DE   AltName: CD_antigen=CD71;
DE   Contains:
DE     RecName: Full=Transferrin receptor protein 1, serum form;
DE              Short=sTfR;
GN   Name=TFRC;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT SER-142.
RX   PubMed=6090955; DOI=10.1038/311675b0;
RA   Schneider C., Owen M.J., Banville D., Williams J.G.;
RT   "Primary structure of human transferrin receptor deduced from the mRNA
RT   sequence.";
RL   Nature 311:675-678(1984).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT SER-142.
RX   PubMed=6094009; DOI=10.1016/0092-8674(84)90004-7;
RA   McClelland A., Kuhn L.C., Ruddle F.H.;
RT   "The human transferrin receptor gene: genomic organization, and the
RT   complete primary structure of the receptor deduced from a cDNA
RT   sequence.";
RL   Cell 39:267-274(1984).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   TISSUE=Placenta;
RX   PubMed=9358047; DOI=10.1016/S0378-1119(97)00356-9;
RA   Evans P., Kemp J.;
RT   "Exon/intron structure of the human transferrin receptor gene.";
RL   Gene 199:123-131(1997).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   TISSUE=Placenta;
RA   Wheeler D.L.;
RT   "Molecular and evolutionary studies of the transferrin receptor.";
RL   Thesis (1999), University of Iowa, United States.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RA   Totoki Y., Toyoda A., Takeda T., Sakaki Y., Tanaka A., Yokoyama S.,
RA   Ohara O., Nagase T., Kikuno R.F.;
RL   Submitted (MAR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RG   NIEHS SNPs program;
RL   Submitted (APR-2006) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Eye;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   PROTEIN SEQUENCE OF 101-119 (STFR).
RX   PubMed=2229063;
RA   Shih Y.J., Baynes R.D., Hudson B.G., Flowers C.H., Skikne B.S.,
RA   Cook J.D.;
RT   "Serum transferrin receptor is a truncated form of tissue receptor.";
RL   J. Biol. Chem. 265:19077-19081(1990).
RN   [10]
RP   PROTEIN SEQUENCE OF 101-123 (STFR), AND CHARACTERIZATION.
RC   TISSUE=Erythroleukemia;
RX   PubMed=1871153; DOI=10.3181/00379727-197-43276;
RA   Baynes R.D., Shih Y.J., Hudson B.G., Cook J.D.;
RT   "Characterization of transferrin receptor released by K562
RT   erythroleukemia cells.";
RL   Proc. Soc. Exp. Biol. Med. 197:416-423(1991).
RN   [11]
RP   PROTEIN SEQUENCE OF 288-302; 694-708 AND 721-730.
RC   TISSUE=Prostatic carcinoma;
RX   PubMed=7864799; DOI=10.1042/bj3060129;
RA   Coppolino M., Migliorini M., Argraves W.S., Dedhar S.;
RT   "Identification of a novel form of the alpha 3 integrin subunit:
RT   covalent association with transferrin receptor.";
RL   Biochem. J. 306:129-134(1995).
RN   [12]
RP   PROTEIN SEQUENCE OF 680-696.
RX   PubMed=1380674; DOI=10.1038/358764a0;
RA   Chicz R.M., Urban R.G., Lane W.S., Gorga J.C., Stern L.J.,
RA   Vignali D.A.A., Strominger J.L.;
RT   "Predominant naturally processed peptides bound to HLA-DR1 are derived
RT   from MHC-related molecules and are heterogeneous in size.";
RL   Nature 358:764-768(1992).
RN   [13]
RP   FUNCTION.
RX   PubMed=3568132; DOI=10.1016/0092-8674(87)90295-9;
RA   Rothenberger S., Iacopetta B.J., Kuhn L.C.;
RT   "Endocytosis of the transferrin receptor requires the cytoplasmic
RT   domain but not its phosphorylation site.";
RL   Cell 49:423-431(1987).
RN   [14]
RP   PALMITOYLATION AT CYS-62 AND CYS-67.
RX   PubMed=3582362;
RA   Jing S., Trowbridge I.S.;
RT   "Identification of the intermolecular disulfide bonds of the human
RT   transferrin receptor and its lipid-attachment site.";
RL   EMBO J. 6:327-331(1987).
RN   [15]
RP   MUTAGENESIS OF CYSTEINE RESIDUES INVOLVED IN INTERMOLECULAR BONDS.
RX   PubMed=2507316;
RA   Alvarez E., Girones N., Davis R.J.;
RT   "Intermolecular disulfide bonds are not required for the expression of
RT   the dimeric state and functional activity of the transferrin
RT   receptor.";
RL   EMBO J. 8:2231-2240(1989).
RN   [16]
RP   MUTAGENESIS OF TYR-20.
RX   PubMed=2327986; DOI=10.1042/bj2670031;
RA   Alvarez E., Girones N., Davis R.J.;
RT   "A point mutation in the cytoplasmic domain of the transferrin
RT   receptor inhibits endocytosis.";
RL   Biochem. J. 267:31-35(1990).
RN   [17]
RP   INTERNALIZATION SEQUENCE, AND MUTAGENESIS OF TYR-20.
RX   PubMed=2298808; DOI=10.1083/jcb.110.2.283;
RA   Jing S., Spencer T., Miller K., Hopkins C., Trowbridge I.S.;
RT   "Role of the human transferrin receptor cytoplasmic domain in
RT   endocytosis: localization of a specific signal sequence for
RT   internalization.";
RL   J. Cell Biol. 110:283-294(1990).
RN   [18]
RP   GLYCOSYLATION AT THR-104.
RX   PubMed=1421756; DOI=10.1093/glycob/2.4.345;
RA   Do S.-I., Cummings R.D.;
RT   "Presence of O-linked oligosaccharide on a threonine residue in the
RT   human transferrin receptor.";
RL   Glycobiology 2:345-353(1992).
RN   [19]
RP   GLYCOSYLATION AT THR-104.
RX   PubMed=1421757; DOI=10.1093/glycob/2.4.355;
RA   Hayes G.R., Enns C.A., Lucas J.J.;
RT   "Identification of the O-linked glycosylation site of the human
RT   transferrin receptor.";
RL   Glycobiology 2:355-359(1992).
RN   [20]
RP   MUTAGENESIS OF 20-TYR--PHE-23; TYR-20; THR-21 AND PHE-23.
RX   PubMed=8408022;
RA   Collawn J.F., Lai A., Domingo D.L., Fitch M., Hatton S.,
RA   Trowbridge I.S.;
RT   "YTRF is the conserved internalization signal of the transferrin
RT   receptor, and a second YTRF signal at position 31-34 enhances
RT   endocytosis.";
RL   J. Biol. Chem. 268:21686-21692(1993).
RN   [21]
RP   GLYCOSYLATION AT ASN-727, AND STRUCTURE OF CARBOHYDRATES ON ASN-727.
RX   PubMed=7780197; DOI=10.1093/glycob/5.2.227;
RA   Hayes G.R., Williams A., Costello C.E., Enns C.A., Lucas J.J.;
RT   "The critical glycosylation site of human transferrin receptor
RT   contains a high-mannose oligosaccharide.";
RL   Glycobiology 5:227-232(1995).
RN   [22]
RP   IDENTIFICATION OF LIGAND-BINDING DOMAIN.
RX   PubMed=8631371; DOI=10.1111/j.1432-1033.1996.0009u.x;
RA   Buchegger F., Trowbridge I.S., Liu L.F., White S., Collawn J.F.;
RT   "Functional analysis of human/chicken transferrin receptor chimeras
RT   indicates that the carboxy-terminal region is important for ligand
RT   binding.";
RL   Eur. J. Biochem. 235:9-17(1996).
RN   [23]
RP   MUTAGENESIS OF ARG-646; GLY-647 AND ASP-648.
RX   PubMed=10377239; DOI=10.1042/bj3410011;
RA   Dubljevic V., Sali A., Goding J.W.;
RT   "A conserved RGD (Arg-Gly-Asp) motif in the transferrin receptor is
RT   required for binding to transferrin.";
RL   Biochem. J. 341:11-14(1999).
RN   [24]
RP   MUTAGENESIS.
RX   PubMed=11800564; DOI=10.1006/jmbi.2001.5048;
RA   West A.P. Jr., Giannetti A.M., Herr A.B., Bennett M.J., Nangiana J.S.,
RA   Pierce J.R., Weiner L.P., Snow P.M., Bjorkman P.J.;
RT   "Mutational analysis of the transferrin receptor reveals overlapping
RT   HFE and transferrin binding sites.";
RL   J. Mol. Biol. 313:385-397(2001).
RN   [25]
RP   INTERACTION WITH SH3BP4.
RX   PubMed=16325581; DOI=10.1016/j.cell.2005.10.021;
RA   Tosoni D., Puri C., Confalonieri S., Salcini A.E., De Camilli P.,
RA   Tacchetti C., Di Fiore P.P.;
RT   "TTP specifically regulates the internalization of the transferrin
RT   receptor.";
RL   Cell 123:875-888(2005).
RN   [26]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-251.
RC   TISSUE=Plasma;
RX   PubMed=16335952; DOI=10.1021/pr0502065;
RA   Liu T., Qian W.-J., Gritsenko M.A., Camp D.G. II, Monroe M.E.,
RA   Moore R.J., Smith R.D.;
RT   "Human plasma N-glycoproteome analysis by immunoaffinity subtraction,
RT   hydrazide chemistry, and mass spectrometry.";
RL   J. Proteome Res. 4:2070-2080(2005).
RN   [27]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=15592455; DOI=10.1038/nbt1046;
RA   Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H.,
RA   Zha X.-M., Polakiewicz R.D., Comb M.J.;
RT   "Immunoaffinity profiling of tyrosine phosphorylation in cancer
RT   cells.";
RL   Nat. Biotechnol. 23:94-101(2005).
RN   [28]
RP   SUBCELLULAR LOCATION [LARGE SCALE ANALYSIS].
RC   TISSUE=Melanoma;
RX   PubMed=17081065; DOI=10.1021/pr060363j;
RA   Chi A., Valencia J.C., Hu Z.-Z., Watabe H., Yamaguchi H.,
RA   Mangini N.J., Huang H., Canfield V.A., Cheng K.C., Yang F., Abe R.,
RA   Yamagishi S., Shabanowitz J., Hearing V.J., Wu C., Appella E.,
RA   Hunt D.F.;
RT   "Proteomic and bioinformatic characterization of the biogenesis and
RT   function of melanosomes.";
RL   J. Proteome Res. 5:3135-3144(2006).
RN   [29]
RP   FUNCTION (MICROBIAL INFECTION), AND INTERACTION WITH MACHUPO VIRUS
RP   PROTEIN GLYCOPROTEIN COMPLEX.
RX   PubMed=17287727; DOI=10.1038/nature05539;
RA   Radoshitzky S.R., Abraham J., Spiropoulou C.F., Kuhn J.H., Nguyen D.,
RA   Li W., Nagel J., Schmidt P.J., Nunberg J.H., Andrews N.C., Farzan M.,
RA   Choe H.;
RT   "Transferrin receptor 1 is a cellular receptor for New World
RT   haemorrhagic fever arenaviruses.";
RL   Nature 446:92-96(2007).
RN   [30]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-21, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [31]
RP   FUNCTION (MICROBIAL INFECTION), INTERACTION WITH GUANARITO VIRUS
RP   GLYCOPROTEIN COMPLEX, INTERACTION WITH JUNIN VIRUS GLYCOPROTEIN
RP   COMPLEX, AND INTERACTION WITH MACHUPO VIRUS GLYCOPROTEIN COMPLEX.
RX   PubMed=18268337; DOI=10.1073/pnas.0709254105;
RA   Radoshitzky S.R., Kuhn J.H., Spiropoulou C.F., Albarino C.G.,
RA   Nguyen D.P., Salazar-Bravo J., Dorfman T., Lee A.S., Wang E.,
RA   Ross S.R., Choe H., Farzan M.;
RT   "Receptor determinants of zoonotic transmission of New World
RT   hemorrhagic fever arenaviruses.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:2664-2669(2008).
RN   [32]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-251 AND ASN-727.
RC   TISSUE=Liver;
RX   PubMed=19159218; DOI=10.1021/pr8008012;
RA   Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.;
RT   "Glycoproteomics analysis of human liver tissue by combination of
RT   multiple enzyme digestion and hydrazide chemistry.";
RL   J. Proteome Res. 8:651-661(2009).
RN   [33]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-251.
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19349973; DOI=10.1038/nbt.1532;
RA   Wollscheid B., Bausch-Fluck D., Henderson C., O'Brien R., Bibel M.,
RA   Schiess R., Aebersold R., Watts J.D.;
RT   "Mass-spectrometric identification and relative quantification of N-
RT   linked cell surface glycoproteins.";
RL   Nat. Biotechnol. 27:378-386(2009).
RN   [34]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [35]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-20, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [36]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [37]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-10, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [38]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [39]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [40]
RP   ELECTRON MICROSCOPY, AND PHOSPHORYLATION AT SER-24.
RX   PubMed=9782058; DOI=10.1016/S0969-2126(98)00124-5;
RA   Fuchs H., Luecken W., Tauber R., Engel A.;
RT   "Structural model of phospholipid-reconstituted human transferrin
RT   receptor derived by electron microscopy.";
RL   Structure 6:1235-1243(1998).
RN   [41]
RP   X-RAY CRYSTALLOGRAPHY (3.2 ANGSTROMS) OF 121-760, AND GLYCOSYLATION AT
RP   ASN-251; ASN-317 AND ASN-727.
RX   PubMed=10531064; DOI=10.1126/science.286.5440.779;
RA   Lawrence C.M., Ray S., Babyonyshev M., Galluser R., Borhani D.W.,
RA   Harrison S.C.;
RT   "Crystal structure of the ectodomain of human transferrin receptor.";
RL   Science 286:779-782(1999).
RN   [42]
RP   VARIANT SER-142.
RX   PubMed=11702220; DOI=10.1007/s004390100599;
RA   Douabin-Gicquel V., Soriano N., Ferran H., Wojcik F., Palierne E.,
RA   Tamim S., Jovelin T., McKie A.T., Le Gall J.-Y., David V., Mosser J.;
RT   "Identification of 96 single nucleotide polymorphisms in eight genes
RT   involved in iron metabolism: efficiency of bioinformatic extraction
RT   compared with a systematic sequencing approach.";
RL   Hum. Genet. 109:393-401(2001).
RN   [43]
RP   INVOLVEMENT IN IMD46, VARIANT IMD46 HIS-20, CHARACTERIZATION OF
RP   VARIANT IMD46 HIS-20, FUNCTION, AND INTERACTION WITH STEAP3.
RX   PubMed=26642240; DOI=10.1038/ng.3465;
RA   Jabara H.H., Boyden S.E., Chou J., Ramesh N., Massaad M.J., Benson H.,
RA   Bainter W., Fraulino D., Rahimov F., Sieff C., Liu Z.J.,
RA   Alshemmari S.H., Al-Ramadi B.K., Al-Dhekri H., Arnaout R.,
RA   Abu-Shukair M., Vatsayan A., Silver E., Ahuja S., Davies E.G.,
RA   Sola-Visner M., Ohsumi T.K., Andrews N.C., Notarangelo L.D.,
RA   Fleming M.D., Al-Herz W., Kunkel L.M., Geha R.S.;
RT   "A missense mutation in TFRC, encoding transferrin receptor 1, causes
RT   combined immunodeficiency.";
RL   Nat. Genet. 48:74-78(2016).
CC   -!- FUNCTION: Cellular uptake of iron occurs via receptor-mediated
CC       endocytosis of ligand-occupied transferrin receptor into
CC       specialized endosomes. Endosomal acidification leads to iron
CC       release. The apotransferrin-receptor complex is then recycled to
CC       the cell surface with a return to neutral pH and the concomitant
CC       loss of affinity of apotransferrin for its receptor. Transferrin
CC       receptor is necessary for development of erythrocytes and the
CC       nervous system (By similarity). A second ligand, the heditary
CC       hemochromatosis protein HFE, competes for binding with transferrin
CC       for an overlapping C-terminal binding site. Positively regulates T
CC       and B cell proliferation through iron uptake (PubMed:26642240).
CC       {ECO:0000250, ECO:0000269|PubMed:26642240,
CC       ECO:0000269|PubMed:3568132}.
CC   -!- FUNCTION: (Microbial infection) Acts as a receptor for new-world
CC       arenaviruses: Guanarito, Junin and Machupo virus.
CC       {ECO:0000269|PubMed:17287727, ECO:0000269|PubMed:18268337}.
CC   -!- SUBUNIT: Homodimer; disulfide-linked. Binds one transferrin or HFE
CC       molecule per subunit. Binds the HLA class II histocompatibility
CC       antigen, DR1. Interacts with SH3BP3. Interacts with STEAP3;
CC       facilitates TFRC endocytosis in erythroid precursor cells
CC       (PubMed:26642240). {ECO:0000269|PubMed:16325581,
CC       ECO:0000269|PubMed:26642240}.
CC   -!- SUBUNIT: (Microbial infection) Interacts with Guanarito, Junin and
CC       Machupo arenavirus glycoprotein complex (PubMed:17287727,
CC       PubMed:18268337). {ECO:0000269|PubMed:17287727,
CC       ECO:0000269|PubMed:18268337}.
CC   -!- INTERACTION:
CC       Self; NbExp=3; IntAct=EBI-355727, EBI-355727;
CC       P02768:ALB; NbExp=2; IntAct=EBI-355727, EBI-714423;
CC       Q96BA8:CREB3L1; NbExp=4; IntAct=EBI-355727, EBI-6942903;
CC       P02794:FTH1; NbExp=2; IntAct=EBI-355727, EBI-713259;
CC       Q30201:HFE; NbExp=3; IntAct=EBI-355727, EBI-1028850;
CC       Q30201-1:HFE; NbExp=3; IntAct=EBI-355727, EBI-15489346;
CC       O43765:SGTA; NbExp=5; IntAct=EBI-355727, EBI-347996;
CC       Q9P0V3:SH3BP4; NbExp=6; IntAct=EBI-355727, EBI-1049513;
CC       P02787:TF; NbExp=9; IntAct=EBI-355727, EBI-714319;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:17081065};
CC       Single-pass type II membrane protein
CC       {ECO:0000269|PubMed:17081065}. Melanosome
CC       {ECO:0000269|PubMed:17081065}. Note=Identified by mass
CC       spectrometry in melanosome fractions from stage I to stage IV.
CC       {ECO:0000269|PubMed:17081065}.
CC   -!- SUBCELLULAR LOCATION: Transferrin receptor protein 1, serum form:
CC       Secreted {ECO:0000269|PubMed:17081065}.
CC   -!- INDUCTION: Regulated by cellular iron levels through binding of
CC       the iron regulatory proteins, IRP1 and IRP2, to iron-responsive
CC       elements in the 3'-UTR. Up-regulated upon mitogenic stimulation.
CC   -!- PTM: N- and O-glycosylated, phosphorylated and palmitoylated. The
CC       serum form is only glycosylated. {ECO:0000269|PubMed:1421756,
CC       ECO:0000269|PubMed:1421757, ECO:0000269|PubMed:16335952,
CC       ECO:0000269|PubMed:19159218, ECO:0000269|PubMed:19349973,
CC       ECO:0000269|PubMed:3582362}.
CC   -!- PTM: Proteolytically cleaved on Arg-100 to produce the soluble
CC       serum form (sTfR).
CC   -!- PTM: Palmitoylated on both Cys-62 and Cys-67. Cys-62 seems to be
CC       the major site of palmitoylation. {ECO:0000269|PubMed:3582362}.
CC   -!- DISEASE: Immunodeficiency 46 (IMD46) [MIM:616740]: An autosomal
CC       recessive primary immunodeficiency disorder characterized by
CC       early-onset chronic diarrhea, recurrent infections, hypo- or
CC       agammaglobulinemia, normal lymphocyte counts, intermittent
CC       neutropenia, and intermittent thrombocytopenia.
CC       {ECO:0000269|PubMed:26642240}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- MISCELLANEOUS: Serum transferrin receptor (sTfR) is used as a
CC       means of detecting erythropoietin (EPO) misuse by athletes and as
CC       a diagnostic test for anemia resulting from a number of conditions
CC       including rheumatoid arthritis, pregnancy, irritable bowel
CC       syndrome and in HIV patients.
CC   -!- MISCELLANEOUS: Canine and feline parvoviruses bind human and
CC       feline transferrin receptors and use these receptors to enter and
CC       infect cells.
CC   -!- SIMILARITY: Belongs to the peptidase M28 family. M28B subfamily.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAD92491.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/TFRCID259ch3q29.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X01060; CAA25527.1; -; mRNA.
DR   EMBL; M11507; AAA61153.1; -; mRNA.
DR   EMBL; AF187320; AAF04564.1; -; Genomic_DNA.
DR   EMBL; AB209254; BAD92491.1; ALT_INIT; mRNA.
DR   EMBL; DQ496099; ABF47088.1; -; Genomic_DNA.
DR   EMBL; CH471191; EAW53670.1; -; Genomic_DNA.
DR   EMBL; CH471191; EAW53673.1; -; Genomic_DNA.
DR   EMBL; BC001188; AAH01188.1; -; mRNA.
DR   CCDS; CCDS3312.1; -.
DR   PIR; A93343; JXHU.
DR   RefSeq; NP_001121620.1; NM_001128148.2.
DR   RefSeq; NP_001300894.1; NM_001313965.1.
DR   RefSeq; NP_001300895.1; NM_001313966.1.
DR   RefSeq; NP_003225.2; NM_003234.3.
DR   UniGene; Hs.529618; -.
DR   PDB; 1CX8; X-ray; 3.20 A; A/B/C/D/E/F/G/H=122-760.
DR   PDB; 1DE4; X-ray; 2.80 A; C/F/I=121-760.
DR   PDB; 1SUV; EM; 7.50 A; A/B=122-760.
DR   PDB; 2NSU; EM; 27.00 A; A/B=122-760.
DR   PDB; 3KAS; X-ray; 2.40 A; A=121-760.
DR   PDB; 3S9L; X-ray; 3.22 A; A/B=120-760.
DR   PDB; 3S9M; X-ray; 3.32 A; A/B=120-760.
DR   PDB; 3S9N; X-ray; 3.25 A; A/B=120-760.
DR   PDBsum; 1CX8; -.
DR   PDBsum; 1DE4; -.
DR   PDBsum; 1SUV; -.
DR   PDBsum; 2NSU; -.
DR   PDBsum; 3KAS; -.
DR   PDBsum; 3S9L; -.
DR   PDBsum; 3S9M; -.
DR   PDBsum; 3S9N; -.
DR   ProteinModelPortal; P02786; -.
DR   SMR; P02786; -.
DR   BioGrid; 112895; 90.
DR   CORUM; P02786; -.
DR   DIP; DIP-2736N; -.
DR   ELM; P02786; -.
DR   IntAct; P02786; 76.
DR   MINT; P02786; -.
DR   STRING; 9606.ENSP00000353224; -.
DR   DrugBank; DB09412; Gallium citrate Ga-67.
DR   DrugBank; DB05260; Gallium nitrate.
DR   MEROPS; M28.972; -.
DR   TCDB; 9.B.229.1.1; the transferrin receptor, cd71, (tfr) family.
DR   GlyConnect; 607; -.
DR   iPTMnet; P02786; -.
DR   PhosphoSitePlus; P02786; -.
DR   SwissPalm; P02786; -.
DR   UniCarbKB; P02786; -.
DR   BioMuta; TFRC; -.
DR   DMDM; 108935939; -.
DR   EPD; P02786; -.
DR   MaxQB; P02786; -.
DR   PaxDb; P02786; -.
DR   PeptideAtlas; P02786; -.
DR   PRIDE; P02786; -.
DR   DNASU; 7037; -.
DR   Ensembl; ENST00000360110; ENSP00000353224; ENSG00000072274.
DR   Ensembl; ENST00000392396; ENSP00000376197; ENSG00000072274.
DR   GeneID; 7037; -.
DR   KEGG; hsa:7037; -.
DR   UCSC; uc003fvz.5; human.
DR   CTD; 7037; -.
DR   DisGeNET; 7037; -.
DR   EuPathDB; HostDB:ENSG00000072274.12; -.
DR   GeneCards; TFRC; -.
DR   HGNC; HGNC:11763; TFRC.
DR   HPA; CAB000153; -.
DR   HPA; HPA028598; -.
DR   MalaCards; TFRC; -.
DR   MIM; 190010; gene.
DR   MIM; 616740; phenotype.
DR   neXtProt; NX_P02786; -.
DR   OpenTargets; ENSG00000072274; -.
DR   PharmGKB; PA36478; -.
DR   eggNOG; KOG2195; Eukaryota.
DR   eggNOG; COG2234; LUCA.
DR   GeneTree; ENSGT00550000074421; -.
DR   HOVERGEN; HBG023177; -.
DR   InParanoid; P02786; -.
DR   KO; K06503; -.
DR   OMA; DNSHVEM; -.
DR   OrthoDB; EOG091G02ZM; -.
DR   PhylomeDB; P02786; -.
DR   TreeFam; TF312981; -.
DR   Reactome; R-HSA-432722; Golgi Associated Vesicle Biogenesis.
DR   Reactome; R-HSA-8856825; Cargo recognition for clathrin-mediated endocytosis.
DR   Reactome; R-HSA-8856828; Clathrin-mediated endocytosis.
DR   Reactome; R-HSA-917977; Transferrin endocytosis and recycling.
DR   SIGNOR; P02786; -.
DR   ChiTaRS; TFRC; human.
DR   EvolutionaryTrace; P02786; -.
DR   GeneWiki; TFRC; -.
DR   GenomeRNAi; 7037; -.
DR   PRO; PR:P02786; -.
DR   Proteomes; UP000005640; Chromosome 3.
DR   Bgee; ENSG00000072274; -.
DR   CleanEx; HS_TFRC; -.
DR   ExpressionAtlas; P02786; baseline and differential.
DR   Genevisible; P02786; HS.
DR   GO; GO:0016323; C:basolateral plasma membrane; IDA:BHF-UCL.
DR   GO; GO:0072562; C:blood microparticle; HDA:UniProtKB.
DR   GO; GO:0009986; C:cell surface; IDA:UniProtKB.
DR   GO; GO:0005905; C:clathrin-coated pit; IDA:UniProtKB.
DR   GO; GO:0030665; C:clathrin-coated vesicle membrane; TAS:Reactome.
DR   GO; GO:0031410; C:cytoplasmic vesicle; IDA:MGI.
DR   GO; GO:0005769; C:early endosome; IEA:Ensembl.
DR   GO; GO:0005768; C:endosome; IDA:MGI.
DR   GO; GO:0010008; C:endosome membrane; IDA:CAFA.
DR   GO; GO:0009897; C:external side of plasma membrane; IGI:BHF-UCL.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0005576; C:extracellular region; IDA:UniProtKB.
DR   GO; GO:0005615; C:extracellular space; HDA:UniProtKB.
DR   GO; GO:1903561; C:extracellular vesicle; HDA:UniProtKB.
DR   GO; GO:1990712; C:HFE-transferrin receptor complex; IDA:BHF-UCL.
DR   GO; GO:0005887; C:integral component of plasma membrane; IGI:BHF-UCL.
DR   GO; GO:0042470; C:melanosome; IEA:UniProtKB-SubCell.
DR   GO; GO:0016020; C:membrane; NAS:UniProtKB.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IDA:CAFA.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0055037; C:recycling endosome; IDA:UniProtKB.
DR   GO; GO:0003725; F:double-stranded RNA binding; IDA:MGI.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0042803; F:protein homodimerization activity; IPI:BHF-UCL.
DR   GO; GO:0003723; F:RNA binding; HDA:UniProtKB.
DR   GO; GO:0004998; F:transferrin receptor activity; IDA:UniProtKB.
DR   GO; GO:0033570; F:transferrin transmembrane transporter activity; IEA:InterPro.
DR   GO; GO:0001618; F:virus receptor activity; IEA:UniProtKB-KW.
DR   GO; GO:0006879; P:cellular iron ion homeostasis; TAS:ProtInc.
DR   GO; GO:0035690; P:cellular response to drug; IDA:MGI.
DR   GO; GO:1990830; P:cellular response to leukemia inhibitory factor; IEA:Ensembl.
DR   GO; GO:0097286; P:iron ion import; IDA:UniProtKB.
DR   GO; GO:0061024; P:membrane organization; TAS:Reactome.
DR   GO; GO:0030316; P:osteoclast differentiation; IEA:Ensembl.
DR   GO; GO:0030890; P:positive regulation of B cell proliferation; IDA:UniProtKB.
DR   GO; GO:0045780; P:positive regulation of bone resorption; IEA:Ensembl.
DR   GO; GO:0045830; P:positive regulation of isotype switching; IDA:UniProtKB.
DR   GO; GO:0042102; P:positive regulation of T cell proliferation; IDA:UniProtKB.
DR   GO; GO:0031623; P:receptor internalization; IDA:UniProtKB.
DR   GO; GO:0033572; P:transferrin transport; IDA:UniProtKB.
DR   CDD; cd02128; PA_TfR; 1.
DR   Gene3D; 1.20.930.40; -; 1.
DR   InterPro; IPR003137; PA_domain.
DR   InterPro; IPR007484; Peptidase_M28.
DR   InterPro; IPR029513; TfR.
DR   InterPro; IPR007365; TFR-like_dimer_dom.
DR   InterPro; IPR036757; TFR-like_dimer_dom_sf.
DR   InterPro; IPR037324; TfR1/2_PA.
DR   PANTHER; PTHR10404:SF26; PTHR10404:SF26; 1.
DR   Pfam; PF02225; PA; 1.
DR   Pfam; PF04389; Peptidase_M28; 1.
DR   Pfam; PF04253; TFR_dimer; 1.
DR   SUPFAM; SSF47672; SSF47672; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Cell membrane; Complete proteome;
KW   Direct protein sequencing; Disease mutation; Disulfide bond;
KW   Endocytosis; Glycoprotein; Host cell receptor for virus entry;
KW   Host-virus interaction; Lipoprotein; Membrane; Palmitate;
KW   Phosphoprotein; Polymorphism; Receptor; Reference proteome; Secreted;
KW   Signal-anchor; Transmembrane; Transmembrane helix.
FT   CHAIN         1    760       Transferrin receptor protein 1.
FT                                /FTId=PRO_0000174132.
FT   CHAIN       101    760       Transferrin receptor protein 1, serum
FT                                form.
FT                                /FTId=PRO_0000292265.
FT   TOPO_DOM      1     67       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     68     88       Helical; Signal-anchor for type II
FT                                membrane protein. {ECO:0000255}.
FT   TOPO_DOM     89    760       Extracellular. {ECO:0000255}.
FT   DOMAIN      223    313       PA.
FT   REGION        1     67       Mediates interaction with SH3BP4.
FT                                {ECO:0000269|PubMed:16325581}.
FT   REGION      569    760       Ligand-binding.
FT   MOTIF        20     23       Endocytosis signal.
FT   MOTIF        58     61       Stop-transfer sequence.
FT   MOTIF       646    648       Cell attachment site; required for
FT                                binding to transferrin.
FT   SITE        100    101       Cleavage; by trypsin; to produce soluble
FT                                form.
FT   MOD_RES      10     10       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES      19     19       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q62351}.
FT   MOD_RES      20     20       Phosphotyrosine.
FT                                {ECO:0000244|PubMed:20068231}.
FT   MOD_RES      21     21       Phosphothreonine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   MOD_RES      24     24       Phosphoserine.
FT                                {ECO:0000269|PubMed:9782058}.
FT   LIPID        62     62       S-palmitoyl cysteine.
FT                                {ECO:0000269|PubMed:3582362}.
FT   LIPID        67     67       S-palmitoyl cysteine.
FT                                {ECO:0000305|PubMed:3582362}.
FT   CARBOHYD    104    104       O-linked (GalNAc...) threonine.
FT                                {ECO:0000269|PubMed:1421756,
FT                                ECO:0000269|PubMed:1421757}.
FT                                /FTId=CAR_000072.
FT   CARBOHYD    251    251       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000244|PDB:1CX8,
FT                                ECO:0000269|PubMed:10531064,
FT                                ECO:0000269|PubMed:16335952,
FT                                ECO:0000269|PubMed:19159218,
FT                                ECO:0000269|PubMed:19349973}.
FT   CARBOHYD    317    317       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000244|PDB:1CX8,
FT                                ECO:0000269|PubMed:10531064}.
FT   CARBOHYD    727    727       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000244|PDB:1CX8,
FT                                ECO:0000269|PubMed:10531064,
FT                                ECO:0000269|PubMed:19159218,
FT                                ECO:0000269|PubMed:7780197}.
FT                                /FTId=CAR_000173.
FT   DISULFID     89     89       Interchain.
FT   DISULFID     98     98       Interchain.
FT   VARIANT      20     20       Y -> H (in IMD46; increases protein
FT                                expression; increases cell surface
FT                                expression on T and B cells; increases
FT                                soluble form level; impairs receptor
FT                                internalization; impairs transferrin
FT                                transport; impairs T and B cell
FT                                proliferation as well as B cell class-
FT                                switching; interacts with STEAP3; doesn't
FT                                affect receptor internalization in
FT                                erythroid precursor cells;
FT                                dbSNP:rs863225436).
FT                                {ECO:0000269|PubMed:26642240}.
FT                                /FTId=VAR_076365.
FT   VARIANT     142    142       G -> S (rare polymorphism;
FT                                dbSNP:rs3817672).
FT                                {ECO:0000269|PubMed:11702220,
FT                                ECO:0000269|PubMed:6090955,
FT                                ECO:0000269|PubMed:6094009}.
FT                                /FTId=VAR_012737.
FT   VARIANT     212    212       L -> V (in dbSNP:rs41301381).
FT                                /FTId=VAR_051806.
FT   VARIANT     420    420       G -> S (in dbSNP:rs41295879).
FT                                /FTId=VAR_051807.
FT   VARIANT     677    677       R -> H (in dbSNP:rs41298067).
FT                                /FTId=VAR_051808.
FT   MUTAGEN       9     12       FSNL->YTRF: Only 80% as active as wild-
FT                                type receptor.
FT   MUTAGEN      20     34       YTRFSLARQVDGDNS->PPGYSLARQVDYTRF: No
FT                                influence on endocytic uptake of the
FT                                receptor.
FT   MUTAGEN      20     23       YTRF->PPGY: Only 16% as active as wild-
FT                                type receptor.
FT                                {ECO:0000269|PubMed:8408022}.
FT   MUTAGEN      20     20       Y->C: Only 35% as active as wild-type
FT                                receptor. {ECO:0000269|PubMed:2298808,
FT                                ECO:0000269|PubMed:2327986,
FT                                ECO:0000269|PubMed:8408022}.
FT   MUTAGEN      20     20       Y->G: Only 20% as active as wild-type
FT                                receptor. {ECO:0000269|PubMed:2298808,
FT                                ECO:0000269|PubMed:2327986,
FT                                ECO:0000269|PubMed:8408022}.
FT   MUTAGEN      21     21       T->F: Only 88% as active as wild-type
FT                                receptor. {ECO:0000269|PubMed:8408022}.
FT   MUTAGEN      21     21       T->TA: Only 14% as active as wild-type
FT                                receptor. {ECO:0000269|PubMed:8408022}.
FT   MUTAGEN      21     21       T->TAA: Only 19% as active as wild-type
FT                                receptor. {ECO:0000269|PubMed:8408022}.
FT   MUTAGEN      23     23       F->Y: Only 48% as active as wild-type
FT                                receptor. {ECO:0000269|PubMed:8408022}.
FT   MUTAGEN      31     34       GDNS->YTRF: 2-fold increase of the
FT                                endocytic uptake of the receptor.
FT   MUTAGEN      47     50       NADN->YTRF: 1.27-fold increase of the
FT                                endocytic uptake of the receptor.
FT   MUTAGEN     619    619       L->A: 20-fold reduced affinity for
FT                                transferrin receptor. No binding to HFE.
FT   MUTAGEN     622    622       V->A: No significant effect on binding to
FT                                transferrin nor HFE.
FT   MUTAGEN     623    623       R->A: No significant effect on binding to
FT                                transferrin nor HFE.
FT   MUTAGEN     629    629       R->A: >5-fold reduced affinity for
FT                                transferrin. >10-fold reduced affinity
FT                                for HFE.
FT   MUTAGEN     640    640       Q->A: No effect on binding to
FT                                transferrin. >10-fold reduced affinity
FT                                for HFE.
FT   MUTAGEN     641    641       W->A: No significant effect on binding to
FT                                transferrin nor HFE.
FT   MUTAGEN     643    643       Y->A: 20-fold reduced affinity for
FT                                transferrin. No binding to HFE.
FT   MUTAGEN     644    644       S->A: No significant effect on binding to
FT                                transferrin nor HFE.
FT   MUTAGEN     646    646       R->A,H: No binding to transferrin.
FT                                {ECO:0000269|PubMed:10377239}.
FT   MUTAGEN     646    646       R->K: 5% binding to transferrin.
FT                                {ECO:0000269|PubMed:10377239}.
FT   MUTAGEN     647    647       G->A: Large effect on affinity for
FT                                transferrin. 4-fold reduced affinity for
FT                                HFE. {ECO:0000269|PubMed:10377239}.
FT   MUTAGEN     648    648       D->A: 16% binding to transferrin.
FT                                {ECO:0000269|PubMed:10377239}.
FT   MUTAGEN     648    648       D->E: 57% binding to transferrin.
FT                                {ECO:0000269|PubMed:10377239}.
FT   MUTAGEN     650    650       F->Q: >5-fold reduced affinity for
FT                                transferrin. >10-fold reduced affinity
FT                                for HFE.
FT   CONFLICT    104    104       T -> K (in Ref. 10; AA sequence).
FT                                {ECO:0000305}.
FT   CONFLICT    109    109       R -> V (in Ref. 10; AA sequence).
FT                                {ECO:0000305}.
FT   CONFLICT    123    123       Y -> T (in Ref. 10; AA sequence).
FT                                {ECO:0000305}.
FT   HELIX       124    136       {ECO:0000244|PDB:3KAS}.
FT   HELIX       140    146       {ECO:0000244|PDB:3KAS}.
FT   TURN        150    152       {ECO:0000244|PDB:3KAS}.
FT   HELIX       160    176       {ECO:0000244|PDB:3KAS}.
FT   STRAND      179    192       {ECO:0000244|PDB:3KAS}.
FT   STRAND      199    204       {ECO:0000244|PDB:3KAS}.
FT   TURN        205    208       {ECO:0000244|PDB:3KAS}.
FT   STRAND      209    214       {ECO:0000244|PDB:3KAS}.
FT   STRAND      220    222       {ECO:0000244|PDB:3S9L}.
FT   STRAND      226    230       {ECO:0000244|PDB:3KAS}.
FT   STRAND      232    234       {ECO:0000244|PDB:3KAS}.
FT   TURN        236    238       {ECO:0000244|PDB:1CX8}.
FT   HELIX       240    244       {ECO:0000244|PDB:3KAS}.
FT   STRAND      245    248       {ECO:0000244|PDB:1CX8}.
FT   STRAND      253    259       {ECO:0000244|PDB:3KAS}.
FT   HELIX       264    272       {ECO:0000244|PDB:3KAS}.
FT   TURN        273    275       {ECO:0000244|PDB:3KAS}.
FT   STRAND      277    282       {ECO:0000244|PDB:3KAS}.
FT   TURN        285    287       {ECO:0000244|PDB:3KAS}.
FT   STRAND      303    306       {ECO:0000244|PDB:3KAS}.
FT   STRAND      308    310       {ECO:0000244|PDB:3S9L}.
FT   STRAND      311    313       {ECO:0000244|PDB:1CX8}.
FT   HELIX       317    319       {ECO:0000244|PDB:1DE4}.
FT   STRAND      334    336       {ECO:0000244|PDB:3KAS}.
FT   HELIX       339    346       {ECO:0000244|PDB:3KAS}.
FT   STRAND      349    352       {ECO:0000244|PDB:3KAS}.
FT   HELIX       355    357       {ECO:0000244|PDB:3KAS}.
FT   STRAND      364    367       {ECO:0000244|PDB:3KAS}.
FT   STRAND      371    377       {ECO:0000244|PDB:3KAS}.
FT   STRAND      380    393       {ECO:0000244|PDB:3KAS}.
FT   STRAND      396    408       {ECO:0000244|PDB:3KAS}.
FT   STRAND      411    413       {ECO:0000244|PDB:3S9N}.
FT   TURN        416    419       {ECO:0000244|PDB:3KAS}.
FT   HELIX       420    438       {ECO:0000244|PDB:3KAS}.
FT   STRAND      445    455       {ECO:0000244|PDB:3KAS}.
FT   HELIX       456    458       {ECO:0000244|PDB:3KAS}.
FT   HELIX       461    469       {ECO:0000244|PDB:3KAS}.
FT   TURN        470    473       {ECO:0000244|PDB:3KAS}.
FT   HELIX       474    476       {ECO:0000244|PDB:3KAS}.
FT   STRAND      478    483       {ECO:0000244|PDB:3KAS}.
FT   STRAND      491    498       {ECO:0000244|PDB:3KAS}.
FT   HELIX       500    502       {ECO:0000244|PDB:3KAS}.
FT   HELIX       503    510       {ECO:0000244|PDB:3KAS}.
FT   TURN        516    518       {ECO:0000244|PDB:3KAS}.
FT   STRAND      520    522       {ECO:0000244|PDB:3KAS}.
FT   HELIX       528    531       {ECO:0000244|PDB:3KAS}.
FT   HELIX       541    546       {ECO:0000244|PDB:3KAS}.
FT   STRAND      552    558       {ECO:0000244|PDB:3KAS}.
FT   TURN        564    567       {ECO:0000244|PDB:3KAS}.
FT   HELIX       573    579       {ECO:0000244|PDB:3KAS}.
FT   HELIX       583    603       {ECO:0000244|PDB:3KAS}.
FT   STRAND      604    606       {ECO:0000244|PDB:3KAS}.
FT   HELIX       613    625       {ECO:0000244|PDB:3KAS}.
FT   HELIX       626    628       {ECO:0000244|PDB:3KAS}.
FT   TURN        629    636       {ECO:0000244|PDB:3KAS}.
FT   HELIX       640    662       {ECO:0000244|PDB:3KAS}.
FT   HELIX       668    680       {ECO:0000244|PDB:3KAS}.
FT   HELIX       682    685       {ECO:0000244|PDB:3KAS}.
FT   STRAND      688    690       {ECO:0000244|PDB:3S9L}.
FT   TURN        692    694       {ECO:0000244|PDB:3KAS}.
FT   TURN        700    702       {ECO:0000244|PDB:3KAS}.
FT   STRAND      705    708       {ECO:0000244|PDB:3S9M}.
FT   HELIX       709    717       {ECO:0000244|PDB:3KAS}.
FT   TURN        718    722       {ECO:0000244|PDB:3S9L}.
FT   HELIX       728    749       {ECO:0000244|PDB:3KAS}.
FT   HELIX       753    755       {ECO:0000244|PDB:1DE4}.
SQ   SEQUENCE   760 AA;  84871 MW;  C886F14000D90154 CRC64;
     MMDQARSAFS NLFGGEPLSY TRFSLARQVD GDNSHVEMKL AVDEEENADN NTKANVTKPK
     RCSGSICYGT IAVIVFFLIG FMIGYLGYCK GVEPKTECER LAGTESPVRE EPGEDFPAAR
     RLYWDDLKRK LSEKLDSTDF TGTIKLLNEN SYVPREAGSQ KDENLALYVE NQFREFKLSK
     VWRDQHFVKI QVKDSAQNSV IIVDKNGRLV YLVENPGGYV AYSKAATVTG KLVHANFGTK
     KDFEDLYTPV NGSIVIVRAG KITFAEKVAN AESLNAIGVL IYMDQTKFPI VNAELSFFGH
     AHLGTGDPYT PGFPSFNHTQ FPPSRSSGLP NIPVQTISRA AAEKLFGNME GDCPSDWKTD
     STCRMVTSES KNVKLTVSNV LKEIKILNIF GVIKGFVEPD HYVVVGAQRD AWGPGAAKSG
     VGTALLLKLA QMFSDMVLKD GFQPSRSIIF ASWSAGDFGS VGATEWLEGY LSSLHLKAFT
     YINLDKAVLG TSNFKVSASP LLYTLIEKTM QNVKHPVTGQ FLYQDSNWAS KVEKLTLDNA
     AFPFLAYSGI PAVSFCFCED TDYPYLGTTM DTYKELIERI PELNKVARAA AEVAGQFVIK
     LTHDVELNLD YERYNSQLLS FVRDLNQYRA DIKEMGLSLQ WLYSARGDFF RATSRLTTDF
     GNAEKTDRFV MKKLNDRVMR VEYHFLSPYV SPKESPFRHV FWGSGSHTLP ALLENLKLRK
     QNNGAFNETL FRNQLALATW TIQGAANALS GDVWDIDNEF
//
ID   Q7Z3E0_HUMAN            Unreviewed;        13 AA.
AC   Q7Z3E0;
DT   01-OCT-2003, integrated into UniProtKB/TrEMBL.
DT   01-OCT-2003, sequence version 1.
DT   28-FEB-2018, entry version 40.
DE   SubName: Full=Uncharacterized protein DKFZp686O0451 {ECO:0000313|EMBL:CAD97930.1};
GN   Name=DKFZp686O0451 {ECO:0000313|EMBL:CAD97930.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:CAD97930.1};
RN   [1] {ECO:0000313|EMBL:CAD97930.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Human endometrium carcinoma cell line
RC   {ECO:0000313|EMBL:CAD97930.1};
RA   Poustka A., Albert R., Moosmayer P., Schupp I., Wellenreuther R.,
RA   Mewes H.W., Weil B., Amid C., Osanger A., Fobo G., Han M., Wiemann S.;
RL   Submitted (JUN-2003) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; BX537966; CAD97930.1; -; mRNA.
DR   RefSeq; NP_001121620.1; NM_001128148.2.
DR   RefSeq; NP_001300894.1; NM_001313965.1.
DR   RefSeq; NP_003225.2; NM_003234.3.
DR   UniGene; Hs.529618; -.
DR   GeneID; 7037; -.
DR   KEGG; hsa:7037; -.
DR   CTD; 7037; -.
DR   KO; K06503; -.
PE   2: Evidence at transcript level;
SQ   SEQUENCE   13 AA;  1468 MW;  8FE0E6255E80CDC5 CRC64;
     MDQARSAFSN LDL
//
ID   E7EPT6_HUMAN            Unreviewed;       165 AA.
AC   E7EPT6;
DT   08-MAR-2011, integrated into UniProtKB/TrEMBL.
DT   08-MAR-2011, sequence version 1.
DT   28-MAR-2018, entry version 50.
DE   SubName: Full=Protransforming growth factor alpha {ECO:0000313|Ensembl:ENSP00000414127};
GN   Name=TGFA {ECO:0000313|Ensembl:ENSP00000414127};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000414127, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Ensembl:ENSP00000414127, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [2] {ECO:0000313|Ensembl:ENSP00000414127}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (JUL-2011) to UniProtKB.
CC   -!- CAUTION: Lacks conserved residue(s) required for the propagation
CC       of feature annotation. {ECO:0000256|PROSITE-ProRule:PRU00076}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AC005234; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC017084; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   RefSeq; NP_001295088.1; NM_001308159.1.
DR   UniGene; Hs.170009; -.
DR   UniGene; Hs.628298; -.
DR   ProteinModelPortal; E7EPT6; -.
DR   Ensembl; ENST00000450929; ENSP00000414127; ENSG00000163235.
DR   GeneID; 7039; -.
DR   UCSC; uc010fdr.4; human.
DR   CTD; 7039; -.
DR   EuPathDB; HostDB:ENSG00000163235.15; -.
DR   HGNC; HGNC:11765; TGFA.
DR   OpenTargets; ENSG00000163235; -.
DR   GeneTree; ENSGT00730000110951; -.
DR   ChiTaRS; TGFA; human.
DR   GenomeRNAi; 7039; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   Bgee; ENSG00000163235; -.
DR   ExpressionAtlas; E7EPT6; baseline and differential.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   InterPro; IPR013032; EGF-like_CS.
DR   InterPro; IPR000742; EGF-like_dom.
DR   InterPro; IPR015497; EGF_rcpt_ligand.
DR   PANTHER; PTHR10740; PTHR10740; 1.
DR   PROSITE; PS00022; EGF_1; 1.
DR   PROSITE; PS01186; EGF_2; 1.
DR   PROSITE; PS50026; EGF_3; 1.
PE   1: Evidence at protein level;
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   Disulfide bond {ECO:0000256|PROSITE-ProRule:PRU00076};
KW   EGF-like domain {ECO:0000256|PROSITE-ProRule:PRU00076};
KW   Membrane {ECO:0000256|SAM:Phobius};
KW   Proteomics identification {ECO:0000213|MaxQB:E7EPT6,
KW   ECO:0000213|PeptideAtlas:E7EPT6};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640};
KW   Signal {ECO:0000256|SAM:SignalP};
KW   Transmembrane {ECO:0000256|SAM:Phobius};
KW   Transmembrane helix {ECO:0000256|SAM:Phobius}.
FT   SIGNAL        1     24       {ECO:0000256|SAM:SignalP}.
FT   CHAIN        25    165       {ECO:0000256|SAM:SignalP}.
FT                                /FTId=PRO_5003217483.
FT   TRANSMEM    105    127       Helical. {ECO:0000256|SAM:Phobius}.
FT   DOMAIN       48     88       EGF-like. {ECO:0000259|PROSITE:PS50026}.
FT   DISULFID     78     87       {ECO:0000256|PROSITE-ProRule:PRU00076}.
SQ   SEQUENCE   165 AA;  17719 MW;  3494D4796413D984 CRC64;
     MFKIGRGALD LFSELLSFGG IVLAACQALE NSTSPLSDPP VAAAVVSHFN DCPDSHTQFC
     FHGTCRFLVQ EDKPACVCHS GYVGARCEHA DLLAVVAASQ KKQAITALVV VSIVALAVLI
     ITCVLIHCCQ VRKHCEWCRA LICRHEKPSA LLKGRTACCH SETVV
//
ID   F8VNR3_HUMAN            Unreviewed;       166 AA.
AC   F8VNR3;
DT   21-SEP-2011, integrated into UniProtKB/TrEMBL.
DT   21-SEP-2011, sequence version 1.
DT   28-MAR-2018, entry version 48.
DE   SubName: Full=Protransforming growth factor alpha {ECO:0000313|Ensembl:ENSP00000404131};
GN   Name=TGFA {ECO:0000313|Ensembl:ENSP00000404131};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000404131, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Ensembl:ENSP00000404131, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [2] {ECO:0000313|Ensembl:ENSP00000404131}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (JUL-2011) to UniProtKB.
CC   -!- CAUTION: Lacks conserved residue(s) required for the propagation
CC       of feature annotation. {ECO:0000256|PROSITE-ProRule:PRU00076}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AC005234; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC017084; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   RefSeq; NP_001295087.1; NM_001308158.1.
DR   UniGene; Hs.170009; -.
DR   UniGene; Hs.628298; -.
DR   ProteinModelPortal; F8VNR3; -.
DR   Ensembl; ENST00000444975; ENSP00000404131; ENSG00000163235.
DR   GeneID; 7039; -.
DR   UCSC; uc010fdq.4; human.
DR   CTD; 7039; -.
DR   EuPathDB; HostDB:ENSG00000163235.15; -.
DR   HGNC; HGNC:11765; TGFA.
DR   OpenTargets; ENSG00000163235; -.
DR   GeneTree; ENSGT00730000110951; -.
DR   OrthoDB; EOG091G0RK4; -.
DR   PhylomeDB; F8VNR3; -.
DR   ChiTaRS; TGFA; human.
DR   GenomeRNAi; 7039; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   Bgee; ENSG00000163235; -.
DR   ExpressionAtlas; F8VNR3; baseline and differential.
DR   GO; GO:0005615; C:extracellular space; IEA:Ensembl.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005634; C:nucleus; IEA:Ensembl.
DR   GO; GO:0005886; C:plasma membrane; IEA:Ensembl.
DR   GO; GO:0005154; F:epidermal growth factor receptor binding; IEA:Ensembl.
DR   GO; GO:0001525; P:angiogenesis; IEA:Ensembl.
DR   GO; GO:0007173; P:epidermal growth factor receptor signaling pathway; IEA:Ensembl.
DR   GO; GO:0072574; P:hepatocyte proliferation; IEA:Ensembl.
DR   GO; GO:0060749; P:mammary gland alveolus development; IEA:Ensembl.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; IEA:Ensembl.
DR   GO; GO:0008284; P:positive regulation of cell proliferation; IEA:Ensembl.
DR   GO; GO:0050731; P:positive regulation of peptidyl-tyrosine phosphorylation; IEA:Ensembl.
DR   GO; GO:0042493; P:response to drug; IEA:Ensembl.
DR   GO; GO:0042060; P:wound healing; IEA:Ensembl.
DR   InterPro; IPR013032; EGF-like_CS.
DR   InterPro; IPR000742; EGF-like_dom.
DR   InterPro; IPR015497; EGF_rcpt_ligand.
DR   PANTHER; PTHR10740; PTHR10740; 1.
DR   PROSITE; PS00022; EGF_1; 1.
DR   PROSITE; PS01186; EGF_2; 1.
DR   PROSITE; PS50026; EGF_3; 1.
PE   1: Evidence at protein level;
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   Disulfide bond {ECO:0000256|PROSITE-ProRule:PRU00076};
KW   EGF-like domain {ECO:0000256|PROSITE-ProRule:PRU00076};
KW   Membrane {ECO:0000256|SAM:Phobius};
KW   Proteomics identification {ECO:0000213|MaxQB:F8VNR3,
KW   ECO:0000213|PeptideAtlas:F8VNR3};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640};
KW   Signal {ECO:0000256|SAM:SignalP};
KW   Transmembrane {ECO:0000256|SAM:Phobius};
KW   Transmembrane helix {ECO:0000256|SAM:Phobius}.
FT   SIGNAL        1     24       {ECO:0000256|SAM:SignalP}.
FT   CHAIN        25    166       {ECO:0000256|SAM:SignalP}.
FT                                /FTId=PRO_5003379224.
FT   TRANSMEM    105    127       Helical. {ECO:0000256|SAM:Phobius}.
FT   DOMAIN       49     89       EGF-like. {ECO:0000259|PROSITE:PS50026}.
FT   DISULFID     79     88       {ECO:0000256|PROSITE-ProRule:PRU00076}.
SQ   SEQUENCE   166 AA;  17790 MW;  5557180147111D21 CRC64;
     MFKIGRGALD LFSELLSFGG IVLAACQALE NSTSPLSADP PVAAAVVSHF NDCPDSHTQF
     CFHGTCRFLV QEDKPACVCH SGYVGARCEH ADLLAVVAAS QKKQAITALV VVSIVALAVL
     IITCVLIHCC QVRKHCEWCR ALICRHEKPS ALLKGRTACC HSETVV
//
ID   TGFA_HUMAN              Reviewed;         160 AA.
AC   P01135; A8K286; Q15577; Q53SK7; Q9BS56; Q9UEI3; Q9UKM1; Q9UKM2;
AC   Q9UKM3;
DT   21-JUL-1986, integrated into UniProtKB/Swiss-Prot.
DT   21-JUL-1986, sequence version 1.
DT   23-MAY-2018, entry version 191.
DE   RecName: Full=Protransforming growth factor alpha;
DE   Contains:
DE     RecName: Full=Transforming growth factor alpha;
DE              Short=TGF-alpha;
DE     AltName: Full=EGF-like TGF;
DE              Short=ETGF;
DE     AltName: Full=TGF type 1;
DE   Flags: Precursor;
GN   Name=TGFA;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=6088071; DOI=10.1016/0092-8674(84)90550-6;
RA   Derynck R., Roberts A.B., Winkler M.E., Chen E.Y., Goeddel D.V.;
RT   "Human transforming growth factor-alpha: precursor structure and
RT   expression in E. coli.";
RL   Cell 38:287-297(1984).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=2464748; DOI=10.1210/mend-2-11-1056;
RA   Jakowlew S.B., Kondaiah P., Dillard P.J., Sporn M.B., Roberts A.B.;
RT   "A novel low molecular weight ribonucleic acid (RNA) related to
RT   transforming growth factor alpha messenger RNA.";
RL   Mol. Endocrinol. 2:1056-1063(1988).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Colon;
RX   PubMed=8224876; DOI=10.1016/0378-1119(93)90210-T;
RA   Qian J.F., Lazar-Wesley E., Breugnot C., May E.;
RT   "Human transforming growth factor alpha: sequence analysis of the 4.5-
RT   kb and 1.6-kb mRNA species.";
RL   Gene 132:291-296(1993).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=8100397;
RA   Qian J.F., Feingold J., Stoll C., May E.;
RT   "Transforming growth factor-alpha: characterization of the BamHI,
RT   RsaI, and TaqI polymorphic regions.";
RL   Am. J. Hum. Genet. 53:168-175(1993).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=10552925; DOI=10.1006/geno.1999.5962;
RA   Machida J., Yoshiura K., Funkhauser C.D., Natsume N., Kawai T.,
RA   Murray J.C.;
RT   "Transforming growth factor-alpha (TGFA): genomic structure, boundary
RT   sequences, and mutation analysis in nonsyndromic cleft lip/palate and
RT   cleft palate only.";
RL   Genomics 61:237-242(1999).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 3; 4 AND 5), AND TISSUE
RP   SPECIFICITY.
RX   PubMed=10523832; DOI=10.1038/sj.onc.1203091;
RA   Xu X., Liao J., Creek K.E., Pirisi L.;
RT   "Human keratinocytes and tumor-derived cell lines express
RT   alternatively spliced forms of transforming growth factor-alpha mRNA,
RT   encoding precursors lacking carboxyl-terminal valine residues.";
RL   Oncogene 18:5554-5562(1999).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) System Donor
RT   vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Thalamus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [11]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Kidney;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [12]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-58.
RX   PubMed=2907605; DOI=10.1128/MCB.8.12.5549;
RA   Jakobovits E.B., Schlokat U., Vannice J.L., Derynck R., Levinson A.D.;
RT   "The human transforming growth factor alpha promoter directs
RT   transcription initiation from a single site in the absence of a TATA
RT   sequence.";
RL   Mol. Cell. Biol. 8:5549-5554(1988).
RN   [13]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-31.
RX   PubMed=10066034; DOI=10.1034/j.1399-0004.1999.550111.x;
RA   Collin G.B., Marshall J.D., Naggert J.K., Nishina P.M.;
RT   "TGFA: exon-intron structure and evaluation as a candidate gene for
RT   Alstrom syndrome.";
RL   Clin. Genet. 55:61-62(1999).
RN   [14]
RP   DISULFIDE BONDS.
RX   PubMed=1632509; DOI=10.1016/0003-2697(92)90331-Z;
RA   Bean M.F., Carr S.A.;
RT   "Characterization of disulfide bond position in proteins and sequence
RT   analysis of cystine-bridged peptides by tandem mass spectrometry.";
RL   Anal. Biochem. 201:216-226(1992).
RN   [15]
RP   PALMITOYLATION AT CYS-153 AND CYS-154.
RX   PubMed=8910478; DOI=10.1074/jbc.271.45.28502;
RA   Shum L., Turck C.W., Derynck R.;
RT   "Cysteines 153 and 154 of transmembrane transforming growth factor-
RT   alpha are palmitoylated and mediate cytoplasmic protein association.";
RL   J. Biol. Chem. 271:28502-28508(1996).
RN   [16]
RP   INTERACTION WITH SNTA1 AND SDCBP.
RX   PubMed=10230395; DOI=10.1016/S1097-2765(00)80470-0;
RA   Fernandez-Larrea J., Merlos-Suarez A., Urena J.M., Baselga J.,
RA   Arribas J.;
RT   "A role for a PDZ protein in the early secretory pathway for the
RT   targeting of proTGF-alpha to the cell surface.";
RL   Mol. Cell 3:423-433(1999).
RN   [17]
RP   INTERACTION WITH CNIH AND GORASP2.
RX   PubMed=17607000; DOI=10.1242/jcs.004200;
RA   Perez Castro C., Piscopo D., Nakagawa T., Derynck R.;
RT   "Cornichon regulates transport and secretion of TGFalpha-related
RT   proteins in metazoan cells.";
RL   J. Cell Sci. 120:2454-2466(2007).
RN   [18]
RP   INTERACTION WITH NKD2.
RX   PubMed=18757723; DOI=10.1073/pnas.0806298105;
RA   Ding W., Li C., Hu T., Graves-Deal R., Fotia A.B., Weissman A.M.,
RA   Coffey R.J.;
RT   "EGF receptor-independent action of TGF-alpha protects Naked2 from
RT   AO7-mediated ubiquitylation and proteasomal degradation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:13433-13438(2008).
RN   [19]
RP   STRUCTURE BY NMR OF TGF-ALPHA.
RX   PubMed=2261437; DOI=10.1021/bi00486a005;
RA   Kline T.P., Brown F.K., Brown S.C., Jeffs P.W., Kopple K.D.,
RA   Mueller L.;
RT   "Solution structures of human transforming growth factor alpha derived
RT   from 1H NMR data.";
RL   Biochemistry 29:7805-7813(1990).
RN   [20]
RP   STRUCTURE BY NMR OF TGF-ALPHA.
RX   PubMed=2050136; DOI=10.1111/j.1432-1033.1991.tb16050.x;
RA   Harvey T.S., Wilkinson A.J., Tappin M.J., Cooke R.M., Campbell I.D.;
RT   "The solution structure of human transforming growth factor alpha.";
RL   Eur. J. Biochem. 198:555-562(1991).
RN   [21]
RP   STRUCTURE BY NMR OF TGF-ALPHA.
RX   PubMed=8338831; DOI=10.1021/bi00080a003;
RA   Moy F.J., Li Y.C., Rauenbuehler P., Winkler M.E., Scheraga H.A.,
RA   Montelione G.T.;
RT   "Solution structure of human type-alpha transforming growth factor
RT   determined by heteronuclear NMR spectroscopy and refined by energy
RT   minimization with restraints.";
RL   Biochemistry 32:7334-7353(1993).
CC   -!- FUNCTION: TGF alpha is a mitogenic polypeptide that is able to
CC       bind to the EGF receptor/EGFR and to act synergistically with TGF
CC       beta to promote anchorage-independent cell proliferation in soft
CC       agar.
CC   -!- SUBUNIT: Interacts with the PDZ domains of MAGI3, SDCBP and SNTA1.
CC       The interaction with SDCBP, is required for the targeting to the
CC       cell surface. In the endoplasmic reticulum, in its immature form
CC       (i.e. with a prosegment and lacking full N-glycosylation),
CC       interacts with CNIH. In the Golgi apparatus, may form a complex
CC       with CNIH and GORASP2. Interacts (via cytoplasmic C-terminal
CC       domain) with NKD2. {ECO:0000269|PubMed:10230395,
CC       ECO:0000269|PubMed:17607000, ECO:0000269|PubMed:18757723}.
CC   -!- INTERACTION:
CC       P00533:EGFR; NbExp=2; IntAct=EBI-1034374, EBI-297353;
CC       Q9EQJ9:Magi3 (xeno); NbExp=4; IntAct=EBI-1034374, EBI-7455245;
CC       Q969F2:NKD2; NbExp=3; IntAct=EBI-1034374, EBI-1538629;
CC       O43765:SGTA; NbExp=3; IntAct=EBI-1034374, EBI-347996;
CC   -!- SUBCELLULAR LOCATION: Transforming growth factor alpha: Secreted,
CC       extracellular space.
CC   -!- SUBCELLULAR LOCATION: Protransforming growth factor alpha: Cell
CC       membrane; Single-pass type I membrane protein.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=5;
CC       Name=1;
CC         IsoId=P01135-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P01135-2; Sequence=VSP_038369;
CC       Name=3; Synonyms=VaII;
CC         IsoId=P01135-3; Sequence=VSP_038369, VSP_038370;
CC       Name=4; Synonyms=VaI;
CC         IsoId=P01135-4; Sequence=VSP_038371;
CC       Name=5; Synonyms=VaIM;
CC         IsoId=P01135-5; Sequence=VSP_038369, VSP_038371;
CC   -!- TISSUE SPECIFICITY: Isoform 1, isoform 3 and isoform 4 are
CC       expressed in keratinocytes and tumor-derived cell lines.
CC       {ECO:0000269|PubMed:10523832}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; K03222; AAA61159.1; -; mRNA.
DR   EMBL; M31172; AAA61157.1; -; mRNA.
DR   EMBL; X70340; CAA49806.1; -; mRNA.
DR   EMBL; AF123243; AAF13491.1; -; Genomic_DNA.
DR   EMBL; AF123238; AAF13491.1; JOINED; Genomic_DNA.
DR   EMBL; AF123239; AAF13491.1; JOINED; Genomic_DNA.
DR   EMBL; AF123240; AAF13491.1; JOINED; Genomic_DNA.
DR   EMBL; AF123241; AAF13491.1; JOINED; Genomic_DNA.
DR   EMBL; AF123242; AAF13491.1; JOINED; Genomic_DNA.
DR   EMBL; AY325886; AAP97822.2; -; Genomic_DNA.
DR   EMBL; AY325885; AAP97822.2; JOINED; Genomic_DNA.
DR   EMBL; AY326405; AAP97822.2; JOINED; Genomic_DNA.
DR   EMBL; AY327131; AAP97822.2; JOINED; Genomic_DNA.
DR   EMBL; AY327132; AAP97822.2; JOINED; Genomic_DNA.
DR   EMBL; AY329368; AAP97822.2; JOINED; Genomic_DNA.
DR   EMBL; AF149096; AAF05089.1; -; mRNA.
DR   EMBL; AF149097; AAF05090.1; -; mRNA.
DR   EMBL; AF149098; AAF05091.1; -; mRNA.
DR   EMBL; BT006833; AAP35479.1; -; mRNA.
DR   EMBL; AK290151; BAF82840.1; -; mRNA.
DR   EMBL; AC005234; AAY14793.1; -; Genomic_DNA.
DR   EMBL; AC017084; AAY14705.1; -; Genomic_DNA.
DR   EMBL; CH471053; EAW99810.1; -; Genomic_DNA.
DR   EMBL; CH471053; EAW99812.1; -; Genomic_DNA.
DR   EMBL; BC005308; AAH05308.1; -; mRNA.
DR   EMBL; M22440; AAA52530.1; -; Genomic_DNA.
DR   EMBL; AF075584; AAD12238.1; -; Genomic_DNA.
DR   EMBL; AF075583; AAD12238.1; JOINED; Genomic_DNA.
DR   CCDS; CCDS1905.1; -. [P01135-1]
DR   CCDS; CCDS46316.1; -. [P01135-2]
DR   PIR; JN0876; WFHU1.
DR   RefSeq; NP_001093161.1; NM_001099691.2. [P01135-2]
DR   RefSeq; NP_001295087.1; NM_001308158.1.
DR   RefSeq; NP_001295088.1; NM_001308159.1.
DR   RefSeq; NP_003227.1; NM_003236.3. [P01135-1]
DR   UniGene; Hs.170009; -.
DR   UniGene; Hs.628298; -.
DR   PDB; 1GK5; NMR; -; A=83-89.
DR   PDB; 1MOX; X-ray; 2.50 A; C/D=40-89.
DR   PDB; 1YUF; NMR; -; A=40-89.
DR   PDB; 1YUG; NMR; -; A=40-89.
DR   PDB; 2TGF; NMR; -; A=40-89.
DR   PDB; 3E50; X-ray; 2.30 A; C/D=40-89.
DR   PDB; 3TGF; NMR; -; A=40-89.
DR   PDB; 4TGF; NMR; -; A=40-89.
DR   PDB; 5KN5; X-ray; 2.80 A; C/F=49-88.
DR   PDBsum; 1GK5; -.
DR   PDBsum; 1MOX; -.
DR   PDBsum; 1YUF; -.
DR   PDBsum; 1YUG; -.
DR   PDBsum; 2TGF; -.
DR   PDBsum; 3E50; -.
DR   PDBsum; 3TGF; -.
DR   PDBsum; 4TGF; -.
DR   PDBsum; 5KN5; -.
DR   ProteinModelPortal; P01135; -.
DR   SMR; P01135; -.
DR   BioGrid; 112897; 68.
DR   DIP; DIP-5765N; -.
DR   IntAct; P01135; 9.
DR   MINT; P01135; -.
DR   STRING; 9606.ENSP00000295400; -.
DR   SwissPalm; P01135; -.
DR   BioMuta; TGFA; -.
DR   DMDM; 135689; -.
DR   PaxDb; P01135; -.
DR   PeptideAtlas; P01135; -.
DR   PRIDE; P01135; -.
DR   DNASU; 7039; -.
DR   Ensembl; ENST00000295400; ENSP00000295400; ENSG00000163235. [P01135-1]
DR   Ensembl; ENST00000418333; ENSP00000404099; ENSG00000163235. [P01135-2]
DR   Ensembl; ENST00000445399; ENSP00000387493; ENSG00000163235. [P01135-3]
DR   GeneID; 7039; -.
DR   KEGG; hsa:7039; -.
DR   UCSC; uc002sgs.4; human. [P01135-1]
DR   CTD; 7039; -.
DR   DisGeNET; 7039; -.
DR   EuPathDB; HostDB:ENSG00000163235.15; -.
DR   GeneCards; TGFA; -.
DR   HGNC; HGNC:11765; TGFA.
DR   HPA; HPA042297; -.
DR   MalaCards; TGFA; -.
DR   MIM; 190170; gene.
DR   neXtProt; NX_P01135; -.
DR   OpenTargets; ENSG00000163235; -.
DR   Orphanet; 1991; Cleft lip with or without cleft palate.
DR   Orphanet; 2227; Hypodontia.
DR   Orphanet; 99798; Oligodontia.
DR   PharmGKB; PA36480; -.
DR   eggNOG; ENOG410IVW5; Eukaryota.
DR   eggNOG; ENOG4111Z4I; LUCA.
DR   GeneTree; ENSGT00730000110951; -.
DR   HOGENOM; HOG000013036; -.
DR   HOVERGEN; HBG000330; -.
DR   InParanoid; P01135; -.
DR   KO; K08774; -.
DR   OMA; LIHCCEV; -.
DR   PhylomeDB; P01135; -.
DR   TreeFam; TF332938; -.
DR   Reactome; R-HSA-204005; COPII-mediated vesicle transport.
DR   Reactome; R-HSA-5694530; Cargo concentration in the ER.
DR   Reactome; R-HSA-8866910; TFAP2 (AP-2) family regulates transcription of growth factors and their receptors.
DR   Reactome; R-HSA-9018519; Estrogen-dependent gene expression.
DR   SignaLink; P01135; -.
DR   SIGNOR; P01135; -.
DR   ChiTaRS; TGFA; human.
DR   EvolutionaryTrace; P01135; -.
DR   GeneWiki; TGF_alpha; -.
DR   GenomeRNAi; 7039; -.
DR   PMAP-CutDB; P01135; -.
DR   PRO; PR:P01135; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   Bgee; ENSG00000163235; -.
DR   CleanEx; HS_TGFA; -.
DR   ExpressionAtlas; P01135; baseline and differential.
DR   Genevisible; P01135; HS.
DR   GO; GO:0016323; C:basolateral plasma membrane; IDA:BHF-UCL.
DR   GO; GO:0009986; C:cell surface; IDA:BHF-UCL.
DR   GO; GO:0031410; C:cytoplasmic vesicle; IDA:BHF-UCL.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0033116; C:endoplasmic reticulum-Golgi intermediate compartment membrane; TAS:Reactome.
DR   GO; GO:0012507; C:ER to Golgi transport vesicle membrane; TAS:Reactome.
DR   GO; GO:0005615; C:extracellular space; IDA:BHF-UCL.
DR   GO; GO:0000139; C:Golgi membrane; IEA:GOC.
DR   GO; GO:0005887; C:integral component of plasma membrane; IBA:GO_Central.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IDA:BHF-UCL.
DR   GO; GO:0005886; C:plasma membrane; NAS:ProtInc.
DR   GO; GO:0005154; F:epidermal growth factor receptor binding; IDA:UniProtKB.
DR   GO; GO:0008083; F:growth factor activity; IDA:HGNC.
DR   GO; GO:0000187; P:activation of MAPK activity; IDA:HGNC.
DR   GO; GO:0008283; P:cell proliferation; TAS:ProtInc.
DR   GO; GO:0048208; P:COPII vesicle coating; TAS:Reactome.
DR   GO; GO:0006888; P:ER to Golgi vesicle-mediated transport; TAS:Reactome.
DR   GO; GO:0051781; P:positive regulation of cell division; IEA:UniProtKB-KW.
DR   GO; GO:0045741; P:positive regulation of epidermal growth factor-activated receptor activity; IDA:HGNC.
DR   GO; GO:0050679; P:positive regulation of epithelial cell proliferation; IDA:HGNC.
DR   GO; GO:0045840; P:positive regulation of mitotic nuclear division; IDA:HGNC.
DR   GO; GO:0006357; P:regulation of transcription by RNA polymerase II; TAS:Reactome.
DR   InterPro; IPR013032; EGF-like_CS.
DR   InterPro; IPR000742; EGF-like_dom.
DR   InterPro; IPR015497; EGF_rcpt_ligand.
DR   PANTHER; PTHR10740; PTHR10740; 1.
DR   PROSITE; PS00022; EGF_1; 1.
DR   PROSITE; PS01186; EGF_2; 1.
DR   PROSITE; PS50026; EGF_3; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Cell membrane; Complete proteome;
KW   Disulfide bond; EGF-like domain; Glycoprotein; Growth factor;
KW   Lipoprotein; Membrane; Mitogen; Palmitate; Polymorphism;
KW   Reference proteome; Secreted; Signal; Transmembrane;
KW   Transmembrane helix.
FT   SIGNAL        1     23       {ECO:0000255}.
FT   CHAIN        24    160       Protransforming growth factor alpha.
FT                                /FTId=PRO_0000302744.
FT   PROPEP       24     39       Removed in mature form.
FT                                /FTId=PRO_0000007752.
FT   CHAIN        40     89       Transforming growth factor alpha.
FT                                /FTId=PRO_0000007753.
FT   PROPEP       90    160       Removed in mature form.
FT                                /FTId=PRO_0000007754.
FT   TOPO_DOM     24     98       Extracellular. {ECO:0000255}.
FT   TRANSMEM     99    124       Helical. {ECO:0000255}.
FT   TOPO_DOM    125    160       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN       43     83       EGF-like. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   LIPID       153    153       S-palmitoyl cysteine.
FT                                {ECO:0000269|PubMed:8910478}.
FT   LIPID       154    154       S-palmitoyl cysteine.
FT                                {ECO:0000269|PubMed:8910478}.
FT   CARBOHYD     25     25       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID     47     60       {ECO:0000255|PROSITE-ProRule:PRU00076,
FT                                ECO:0000269|PubMed:1632509}.
FT   DISULFID     55     71       {ECO:0000255|PROSITE-ProRule:PRU00076,
FT                                ECO:0000269|PubMed:1632509}.
FT   DISULFID     73     82       {ECO:0000255|PROSITE-ProRule:PRU00076,
FT                                ECO:0000269|PubMed:1632509}.
FT   VAR_SEQ      32     32       Missing (in isoform 2, isoform 3 and
FT                                isoform 5). {ECO:0000303|PubMed:10523832,
FT                                ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|Ref.7}.
FT                                /FTId=VSP_038369.
FT   VAR_SEQ     159    160       VV -> ATLG (in isoform 3).
FT                                {ECO:0000303|PubMed:10523832}.
FT                                /FTId=VSP_038370.
FT   VAR_SEQ     159    160       VV -> GCRLY (in isoform 4 and isoform 5).
FT                                {ECO:0000303|PubMed:10523832}.
FT                                /FTId=VSP_038371.
FT   VARIANT     109    109       V -> M (in dbSNP:rs11466259).
FT                                /FTId=VAR_024271.
FT   CONFLICT     58     58       G -> A (in Ref. 2; AAA61157).
FT                                {ECO:0000305}.
FT   CONFLICT     65     65       Q -> H (in Ref. 2; AAA61157).
FT                                {ECO:0000305}.
FT   CONFLICT    159    159       V -> L (in Ref. 2; AAA61157).
FT                                {ECO:0000305}.
FT   STRAND       43     45       {ECO:0000244|PDB:1MOX}.
FT   HELIX        51     54       {ECO:0000244|PDB:1YUF}.
FT   STRAND       58     63       {ECO:0000244|PDB:1MOX}.
FT   TURN         64     67       {ECO:0000244|PDB:1MOX}.
FT   STRAND       68     73       {ECO:0000244|PDB:1MOX}.
FT   STRAND       77     79       {ECO:0000244|PDB:1MOX}.
FT   STRAND       84     86       {ECO:0000244|PDB:5KN5}.
SQ   SEQUENCE   160 AA;  17006 MW;  D692184F9353DE47 CRC64;
     MVPSAGQLAL FALGIVLAAC QALENSTSPL SADPPVAAAV VSHFNDCPDS HTQFCFHGTC
     RFLVQEDKPA CVCHSGYVGA RCEHADLLAV VAASQKKQAI TALVVVSIVA LAVLIITCVL
     IHCCQVRKHC EWCRALICRH EKPSALLKGR TACCHSETVV
//
ID   UPK3A_HUMAN             Reviewed;         287 AA.
AC   O75631; B0QY25; O60261; Q32N05; Q5TII6;
DT   30-MAY-2000, integrated into UniProtKB/Swiss-Prot.
DT   11-OCT-2004, sequence version 3.
DT   28-FEB-2018, entry version 136.
DE   RecName: Full=Uroplakin-3a;
DE            Short=UP3a;
DE   AltName: Full=Uroplakin III;
DE            Short=UPIII;
DE   Flags: Precursor;
GN   Name=UPK3A; Synonyms=UPK3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Ureter;
RA   Geall K., Hall G., Smith B., Southgate J.;
RL   Submitted (AUG-1998) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANT PRO-154.
RC   TISSUE=Urinary bladder urothelium;
RX   PubMed=9818021; DOI=10.1111/j.1349-7006.1998.tb00643.x;
RA   Yuasa T., Yoshiki T., Tanaka T., Kim C.J., Isono T., Okada Y.;
RT   "Expression of uroplakin Ib and uroplakin III genes in tissues and
RT   peripheral blood of patients with transitional cell carcinoma.";
RL   Jpn. J. Cancer Res. 89:879-882(1998).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RX   PubMed=15461802; DOI=10.1186/gb-2004-5-10-r84;
RA   Collins J.E., Wright C.L., Edwards C.A., Davis M.P., Grinham J.A.,
RA   Cole C.G., Goward M.E., Aguado B., Mallya M., Mokrab Y., Huckle E.J.,
RA   Beare D.M., Dunham I.;
RT   "A genome annotation-driven approach to cloning the human ORFeome.";
RL   Genome Biol. 5:R84.1-R84.11(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=10591208; DOI=10.1038/990031;
RA   Dunham I., Hunt A.R., Collins J.E., Bruskiewich R., Beare D.M.,
RA   Clamp M., Smink L.J., Ainscough R., Almeida J.P., Babbage A.K.,
RA   Bagguley C., Bailey J., Barlow K.F., Bates K.N., Beasley O.P.,
RA   Bird C.P., Blakey S.E., Bridgeman A.M., Buck D., Burgess J.,
RA   Burrill W.D., Burton J., Carder C., Carter N.P., Chen Y., Clark G.,
RA   Clegg S.M., Cobley V.E., Cole C.G., Collier R.E., Connor R.,
RA   Conroy D., Corby N.R., Coville G.J., Cox A.V., Davis J., Dawson E.,
RA   Dhami P.D., Dockree C., Dodsworth S.J., Durbin R.M., Ellington A.G.,
RA   Evans K.L., Fey J.M., Fleming K., French L., Garner A.A.,
RA   Gilbert J.G.R., Goward M.E., Grafham D.V., Griffiths M.N.D., Hall C.,
RA   Hall R.E., Hall-Tamlyn G., Heathcott R.W., Ho S., Holmes S.,
RA   Hunt S.E., Jones M.C., Kershaw J., Kimberley A.M., King A.,
RA   Laird G.K., Langford C.F., Leversha M.A., Lloyd C., Lloyd D.M.,
RA   Martyn I.D., Mashreghi-Mohammadi M., Matthews L.H., Mccann O.T.,
RA   Mcclay J., Mclaren S., McMurray A.A., Milne S.A., Mortimore B.J.,
RA   Odell C.N., Pavitt R., Pearce A.V., Pearson D., Phillimore B.J.C.T.,
RA   Phillips S.H., Plumb R.W., Ramsay H., Ramsey Y., Rogers L., Ross M.T.,
RA   Scott C.E., Sehra H.K., Skuce C.D., Smalley S., Smith M.L.,
RA   Soderlund C., Spragon L., Steward C.A., Sulston J.E., Swann R.M.,
RA   Vaudin M., Wall M., Wallis J.M., Whiteley M.N., Willey D.L.,
RA   Williams L., Williams S.A., Williamson H., Wilmer T.E., Wilming L.,
RA   Wright C.L., Hubbard T., Bentley D.R., Beck S., Rogers J., Shimizu N.,
RA   Minoshima S., Kawasaki K., Sasaki T., Asakawa S., Kudoh J.,
RA   Shintani A., Shibuya K., Yoshizaki Y., Aoki N., Mitsuyama S.,
RA   Roe B.A., Chen F., Chu L., Crabtree J., Deschamps S., Do A., Do T.,
RA   Dorman A., Fang F., Fu Y., Hu P., Hua A., Kenton S., Lai H., Lao H.I.,
RA   Lewis J., Lewis S., Lin S.-P., Loh P., Malaj E., Nguyen T., Pan H.,
RA   Phan S., Qi S., Qian Y., Ray L., Ren Q., Shaull S., Sloan D., Song L.,
RA   Wang Q., Wang Y., Wang Z., White J., Willingham D., Wu H., Yao Z.,
RA   Zhan M., Zhang G., Chissoe S., Murray J., Miller N., Minx P.,
RA   Fulton R., Johnson D., Bemis G., Bentley D., Bradshaw H., Bourne S.,
RA   Cordes M., Du Z., Fulton L., Goela D., Graves T., Hawkins J.,
RA   Hinds K., Kemp K., Latreille P., Layman D., Ozersky P., Rohlfing T.,
RA   Scheet P., Walker C., Wamsley A., Wohldmann P., Pepin K., Nelson J.,
RA   Korf I., Bedell J.A., Hillier L.W., Mardis E., Waterston R.,
RA   Wilson R., Emanuel B.S., Shaikh T., Kurahashi H., Saitta S.,
RA   Budarf M.L., McDermid H.E., Johnson A., Wong A.C.C., Morrow B.E.,
RA   Edelmann L., Kim U.J., Shizuya H., Simon M.I., Dumanski J.P.,
RA   Peyrard M., Kedra D., Seroussi E., Fransson I., Tapia I., Bruder C.E.,
RA   O'Brien K.P., Wilkinson P., Bodenteich A., Hartman K., Hu X.,
RA   Khan A.S., Lane L., Tilahun Y., Wright H.;
RT   "The DNA sequence of human chromosome 22.";
RL   Nature 402:489-495(1999).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   TISSUE SPECIFICITY.
RX   PubMed=9846985; DOI=10.1016/S0002-9440(10)65709-4;
RA   Lobban E.D., Smith B.A., Hall G.D., Harnden P., Roberts P.,
RA   Selby P.J., Trejdosiewicz L.K., Southgate J.;
RT   "Uroplakin gene expression by normal and neoplastic human
RT   urothelium.";
RL   Am. J. Pathol. 153:1957-1967(1998).
RN   [7]
RP   VARIANT LEU-273, POSSIBLE INVOLVEMENT IN KIDNEY AND URINARY TRACT
RP   ANOMALIES, AND CHARACTERIZATION OF VARIANT LEU-273.
RX   PubMed=15888565; DOI=10.1681/ASN.2004090776;
RA   Jenkins D., Bitner-Glindzicz M., Malcolm S., Hu C.-C.A., Allison J.,
RA   Winyard P.J.D., Gullett A.M., Thomas D.F.M., Belk R.A., Feather S.A.,
RA   Sun T.-T., Woolf A.S.;
RT   "De novo Uroplakin IIIa heterozygous mutations cause human renal
RT   adysplasia leading to severe kidney failure.";
RL   J. Am. Soc. Nephrol. 16:2141-2149(2005).
RN   [8]
RP   VARIANT ASP-202, AND POSSIBLE INVOLVEMENT IN KIDNEY AND URINARY TRACT
RP   ANOMALIES.
RX   PubMed=16731295; DOI=10.1053/j.ajkd.2006.02.177;
RA   Schoenfelder E.-M., Knueppel T., Tasic V., Miljkovic P., Konrad M.,
RA   Wuehl E., Antignac C., Bakkaloglu A., Schaefer F., Weber S.;
RT   "Mutations in Uroplakin IIIA are a rare cause of renal hypodysplasia
RT   in humans.";
RL   Am. J. Kidney Dis. 47:1004-1012(2006).
CC   -!- FUNCTION: Component of the asymmetric unit membrane (AUM); a
CC       highly specialized biomembrane elaborated by terminally
CC       differentiated urothelial cells. May play an important role in
CC       AUM-cytoskeleton interaction in terminally differentiated
CC       urothelial cells. It also contributes to the formation of
CC       urothelial glycocalyx which may play an important role in
CC       preventing bacterial adherence (By similarity). {ECO:0000250}.
CC   -!- SUBUNIT: Heterodimer with uroplakin-1B (UPK1B). {ECO:0000250}.
CC   -!- INTERACTION:
CC       O43765:SGTA; NbExp=3; IntAct=EBI-10188907, EBI-347996;
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane
CC       {ECO:0000250}; Single-pass type I membrane protein {ECO:0000250}.
CC       Note=Heterodimer formation with UPK1B is a prerequisite to exit
CC       out of the endoplasmic reticulum (ER). {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=O75631-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=O75631-2; Sequence=VSP_030004;
CC   -!- TISSUE SPECIFICITY: Expressed in ureter.
CC       {ECO:0000269|PubMed:9846985}.
CC   -!- DISEASE: Note=Mutations in UPK3A have been detected in patients
CC       with renal adyplasia suggesting a possible involvement of this
CC       gene in kidney and urinary tract anomalies.
CC   -!- SIMILARITY: Belongs to the uroplakin-3 family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF085808; AAC34888.1; -; mRNA.
DR   EMBL; AB010637; BAA31460.1; -; mRNA.
DR   EMBL; AB010116; BAA25678.1; -; mRNA.
DR   EMBL; CR456608; CAG30494.1; -; mRNA.
DR   EMBL; AL008718; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC069544; AAH69544.1; -; mRNA.
DR   EMBL; BC108900; AAI08901.1; -; mRNA.
DR   CCDS; CCDS14064.1; -. [O75631-1]
DR   CCDS; CCDS54539.1; -. [O75631-2]
DR   RefSeq; NP_001161046.1; NM_001167574.1. [O75631-2]
DR   RefSeq; NP_008884.1; NM_006953.3. [O75631-1]
DR   UniGene; Hs.632787; -.
DR   ProteinModelPortal; O75631; -.
DR   BioGrid; 113226; 2.
DR   IntAct; O75631; 2.
DR   STRING; 9606.ENSP00000216211; -.
DR   TCDB; 8.A.90.2.1; the uroplakin 2/3 (upk2/3) family.
DR   iPTMnet; O75631; -.
DR   PhosphoSitePlus; O75631; -.
DR   BioMuta; UPK3A; -.
DR   PaxDb; O75631; -.
DR   PeptideAtlas; O75631; -.
DR   PRIDE; O75631; -.
DR   DNASU; 7380; -.
DR   Ensembl; ENST00000216211; ENSP00000216211; ENSG00000100373. [O75631-1]
DR   Ensembl; ENST00000396082; ENSP00000379391; ENSG00000100373. [O75631-2]
DR   GeneID; 7380; -.
DR   KEGG; hsa:7380; -.
DR   UCSC; uc003bfy.4; human. [O75631-1]
DR   CTD; 7380; -.
DR   DisGeNET; 7380; -.
DR   EuPathDB; HostDB:ENSG00000100373.9; -.
DR   GeneCards; UPK3A; -.
DR   HGNC; HGNC:12580; UPK3A.
DR   HPA; HPA018407; -.
DR   HPA; HPA018415; -.
DR   MalaCards; UPK3A; -.
DR   MIM; 611559; gene.
DR   neXtProt; NX_O75631; -.
DR   OpenTargets; ENSG00000100373; -.
DR   Orphanet; 93100; Unilateral renal agenesis.
DR   PharmGKB; PA37212; -.
DR   eggNOG; ENOG410IE9T; Eukaryota.
DR   eggNOG; ENOG41123W4; LUCA.
DR   GeneTree; ENSGT00510000048620; -.
DR   HOGENOM; HOG000143412; -.
DR   HOVERGEN; HBG058769; -.
DR   InParanoid; O75631; -.
DR   KO; K19520; -.
DR   OMA; TEYRFKY; -.
DR   OrthoDB; EOG091G0F7J; -.
DR   PhylomeDB; O75631; -.
DR   TreeFam; TF336628; -.
DR   GeneWiki; UPK3A; -.
DR   GenomeRNAi; 7380; -.
DR   PRO; PR:O75631; -.
DR   Proteomes; UP000005640; Chromosome 22.
DR   Bgee; ENSG00000100373; -.
DR   CleanEx; HS_UPK3A; -.
DR   Genevisible; O75631; HS.
DR   GO; GO:0016324; C:apical plasma membrane; IEA:Ensembl.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0000902; P:cell morphogenesis; IEA:Ensembl.
DR   GO; GO:0030855; P:epithelial cell differentiation; IDA:UniProtKB.
DR   GO; GO:0001822; P:kidney development; IEA:Ensembl.
DR   GO; GO:0055075; P:potassium ion homeostasis; IEA:Ensembl.
DR   GO; GO:0055078; P:sodium ion homeostasis; IEA:Ensembl.
DR   GO; GO:0015840; P:urea transport; IEA:Ensembl.
DR   GO; GO:0060157; P:urinary bladder development; IEA:Ensembl.
DR   GO; GO:0006833; P:water transport; IEA:Ensembl.
DR   InterPro; IPR024831; Uroplakin-3.
DR   InterPro; IPR024825; Uroplakin-3a.
DR   PANTHER; PTHR15446; PTHR15446; 1.
DR   PANTHER; PTHR15446:SF17; PTHR15446:SF17; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Complete proteome; Disease mutation;
KW   Endoplasmic reticulum; Glycoprotein; Membrane; Polymorphism;
KW   Reference proteome; Signal; Transmembrane; Transmembrane helix.
FT   SIGNAL        1     18       {ECO:0000250}.
FT   CHAIN        19    287       Uroplakin-3a.
FT                                /FTId=PRO_0000022637.
FT   TOPO_DOM     19    207       Lumenal. {ECO:0000255}.
FT   TRANSMEM    208    235       Helical. {ECO:0000255}.
FT   TOPO_DOM    236    287       Cytoplasmic. {ECO:0000255}.
FT   CARBOHYD     74     74       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    139    139       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    170    170       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   VAR_SEQ      70    191       AISRNASVQDSTNTPLGSTFLQTEGGRTGPYKAVAFDLIPC
FT                                SDLPSLDAIGDVSKASQILNAYLVRVGANGTCLWDPNFQGL
FT                                CNAPLSAATEYRFKYVLVNMSTGLVEDQTLWSDPIRTNQL
FT                                -> V (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_030004.
FT   VARIANT      91     91       Q -> L (in dbSNP:rs6006979).
FT                                /FTId=VAR_044399.
FT   VARIANT     154    154       A -> P (in dbSNP:rs1057353).
FT                                {ECO:0000269|PubMed:9818021}.
FT                                /FTId=VAR_020158.
FT   VARIANT     202    202       G -> D (found in a patient with
FT                                unilateral multicystic kidney disease;
FT                                unknown pathological significance;
FT                                dbSNP:rs121918187).
FT                                {ECO:0000269|PubMed:16731295}.
FT                                /FTId=VAR_044400.
FT   VARIANT     273    273       P -> L (found in patients with renal
FT                                adysplasia; unknown pathological
FT                                significance; normal targeting to the
FT                                cell surface; dbSNP:rs121918186).
FT                                {ECO:0000269|PubMed:15888565}.
FT                                /FTId=VAR_044401.
FT   CONFLICT    236    236       D -> A (in Ref. 2; BAA31460/BAA25678).
FT                                {ECO:0000305}.
SQ   SEQUENCE   287 AA;  30670 MW;  2A14B21746FDBD25 CRC64;
     MPPLWALLAL GCLRFGSAVN LQPQLASVTF ATNNPTLTTV ALEKPLCMFD SKEALTGTHE
     VYLYVLVDSA ISRNASVQDS TNTPLGSTFL QTEGGRTGPY KAVAFDLIPC SDLPSLDAIG
     DVSKASQILN AYLVRVGANG TCLWDPNFQG LCNAPLSAAT EYRFKYVLVN MSTGLVEDQT
     LWSDPIRTNQ LTPYSTIDTW PGRRSGGMIV ITSILGSLPF FLLVGFAGAI ALSLVDMGSS
     DGETTHDSQI TQEAVPKSLG ASESSYTSVN RGPPLDRAEV YSSKLQD
//
ID   VIP_HUMAN               Reviewed;         170 AA.
AC   P01282; Q5TCY8; Q5TCY9; Q96QK3;
DT   21-JUL-1986, integrated into UniProtKB/Swiss-Prot.
DT   21-JUL-1986, sequence version 1.
DT   28-FEB-2018, entry version 182.
DE   RecName: Full=VIP peptides;
DE   Contains:
DE     RecName: Full=Intestinal peptide PHV-42;
DE     AltName: Full=Peptide histidine valine 42;
DE   Contains:
DE     RecName: Full=Intestinal peptide PHM-27;
DE     AltName: Full=Peptide histidine methioninamide 27;
DE   Contains:
DE     RecName: Full=Vasoactive intestinal peptide;
DE              Short=VIP;
DE     AltName: Full=Vasoactive intestinal polypeptide;
DE   Flags: Precursor;
GN   Name=VIP;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=6571696; DOI=10.1038/304547a0;
RA   Itoh N., Obata K., Yanaihara N., Okamoto H.;
RT   "Human preprovasoactive intestinal polypeptide contains a novel PHI-
RT   27-like peptide, PHM-27.";
RL   Nature 304:547-549(1983).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=3899557;
RA   Tsukada T., Horovitch S.J., Montminy M.R., Mandel G., Goodman R.H.;
RT   "Structure of the human vasoactive intestinal polypeptide gene.";
RL   DNA 4:293-300(1985).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=2995945; DOI=10.1016/0196-9781(85)90016-6;
RA   Delamarter J.F., Buell G.N., Kawashima E., Polak J.M., Bloom S.R.;
RT   "Vasoactive intestinal peptide: expression of the prohormone in
RT   bacterial cells.";
RL   Peptides 6 Suppl. 1:95-102(1985).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=3025882; DOI=10.1073/pnas.84.2.605;
RA   Linder S., Barkhem T., Norberg A., Persson H., Schalling M.,
RA   Hoekfelt T., Magnusson G.;
RT   "Structure and expression of the gene encoding the vasoactive
RT   intestinal peptide precursor.";
RL   Proc. Natl. Acad. Sci. U.S.A. 84:605-609(1987).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=2839091; DOI=10.1111/j.1749-6632.1988.tb26975.x;
RA   Yamagami T., Ohsawa K., Nishizawa M., Inoue C., Gotoh E.,
RA   Yanaihara N., Yamamoto H., Okamoto H.;
RT   "Complete nucleotide sequence of human vasoactive intestinal
RT   peptide/PHM-27 gene and its inducible promoter.";
RL   Ann. N. Y. Acad. Sci. 527:87-102(1988).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E.,
RA   Gilbert J.G.R., Clamp M.E., Bethel G., Milne S., Ainscough R.,
RA   Almeida J.P., Ambrose K.D., Andrews T.D., Ashwell R.I.S.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Banerjee R., Barker D.J.,
RA   Barlow K.F., Bates K., Beare D.M., Beasley H., Beasley O., Bird C.P.,
RA   Blakey S.E., Bray-Allen S., Brook J., Brown A.J., Brown J.Y.,
RA   Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E.,
RA   Ellington A.E., Evans K.A., Faulkner L., Francis M.D., Frankish A.,
RA   Frankland J., French L., Garner P., Garnett J., Ghori M.J.,
RA   Gilby L.M., Gillson C.J., Glithero R.J., Grafham D.V., Grant M.,
RA   Gribble S., Griffiths C., Griffiths M.N.D., Hall R., Halls K.S.,
RA   Hammond S., Harley J.L., Hart E.A., Heath P.D., Heathcott R.,
RA   Holmes S.J., Howden P.J., Howe K.L., Howell G.R., Huckle E.,
RA   Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M., Joy A.A.,
RA   Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R., Lloyd D.M.,
RA   Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K.,
RA   McMurray A., Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T.,
RA   Novik K.L., Oliver K., Overton-Larty E.K., Parker A., Patel R.,
RA   Pearce A.V., Peck A.I., Phillimore B.J.C.T., Phillips S., Plumb R.W.,
RA   Porter K.M., Ramsey Y., Ranby S.A., Rice C.M., Ross M.T., Searle S.M.,
RA   Sehra H.K., Sheridan E., Skuce C.D., Smith S., Smith M., Spraggon L.,
RA   Squares S.L., Steward C.A., Sycamore N., Tamlyn-Hall G., Tester J.,
RA   Theaker A.J., Thomas D.W., Thorpe A., Tracey A., Tromans A., Tubby B.,
RA   Wall M., Wallis J.M., West A.P., White S.S., Whitehead S.L.,
RA   Whittaker H., Wild A., Willey D.J., Wilmer T.E., Wood J.M., Wray P.W.,
RA   Wyatt J.C., Young L., Younger R.M., Bentley D.R., Coulson A.,
RA   Durbin R.M., Hubbard T., Sulston J.E., Dunham I., Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Prostate;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 8-170, AND AMIDATION AT MET-107
RP   AND ASN-152.
RX   PubMed=3748844; DOI=10.1016/0196-9781(86)90156-7;
RA   Gozes I., Bodener M., Shani Y., Fridkin M.;
RT   "Structure and expression of the vasoactive intestinal peptide (VIP)
RT   gene in a human tumor.";
RL   Peptides 7:1-6(1986).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 50-170 (ISOFORM 1).
RC   TISSUE=Pancreatic carcinoma;
RX   PubMed=6139527; DOI=10.1016/S0140-6736(83)91215-1;
RA   Bloom S.R., Delamarter J.F., Kawashima E., Christofides N.D.,
RA   Buell G., Polak J.M.;
RT   "Diarrhoea in vipoma patients associated with cosecretion of a second
RT   active peptide (peptide histidine isoleucine) explained by single
RT   coding gene.";
RL   Lancet 2:1163-1165(1983).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 78-155.
RX   PubMed=2434617; DOI=10.1111/j.1471-4159.1987.tb05638.x;
RA   Gozes I., Giladi E., Shani Y.;
RT   "Vasoactive intestinal peptide gene: putative mechanism of information
RT   storage at the RNA level.";
RL   J. Neurochem. 48:1136-1141(1987).
RN   [11]
RP   PROTEIN SEQUENCE OF 81-122.
RX   PubMed=3654650;
RA   Yiangou Y., di Marzo V., Spokes R.A., Panico M., Morris H.R.,
RA   Bloom S.R.;
RT   "Isolation, characterization, and pharmacological actions of peptide
RT   histidine valine 42, a novel prepro-vasoactive intestinal peptide-
RT   derived peptide.";
RL   J. Biol. Chem. 262:14010-14013(1987).
RN   [12]
RP   PROTEIN SEQUENCE OF 127-152.
RC   TISSUE=Pheochromocytoma;
RX   PubMed=1318039; DOI=10.1016/S0006-291X(05)80966-0;
RA   Kitamura K., Kangawa K., Kawamoto M., Ichiki Y., Matsuo H., Eto T.;
RT   "Isolation and characterization of peptides which act on rat
RT   platelets, from a pheochromocytoma.";
RL   Biochem. Biophys. Res. Commun. 185:134-141(1992).
RN   [13]
RP   FUNCTION (PHM-27).
RX   PubMed=15013843; DOI=10.1016/j.bcp.2003.11.008;
RA   Ma J.N., Currier E.A., Essex A., Feddock M., Spalding T.A., Nash N.R.,
RA   Brann M.R., Burstein E.S.;
RT   "Discovery of novel peptide/receptor interactions: identification of
RT   PHM-27 as a potent agonist of the human calcitonin receptor.";
RL   Biochem. Pharmacol. 67:1279-1284(2004).
RN   [14]
RP   STRUCTURE BY NMR OF VIP.
RX   PubMed=1863695; DOI=10.1002/bip.360310411;
RA   Theriault Y., Boulanger Y., St Pierre S.;
RT   "Structural determination of the vasoactive intestinal peptide by two-
RT   dimensional H-NMR spectroscopy.";
RL   Biopolymers 31:459-464(1991).
CC   -!- FUNCTION: VIP causes vasodilation, lowers arterial blood pressure,
CC       stimulates myocardial contractility, increases glycogenolysis and
CC       relaxes the smooth muscle of trachea, stomach and gall bladder.
CC       {ECO:0000269|PubMed:15013843}.
CC   -!- FUNCTION: PHM and PHV also cause vasodilation. PHM-27 is a potent
CC       agonist of the calcitonin receptor CALCR, with similar efficacy as
CC       calcitonin. {ECO:0000269|PubMed:15013843}.
CC   -!- INTERACTION:
CC       P27487:DPP4; NbExp=2; IntAct=EBI-751454, EBI-2871277;
CC       Q12884:FAP; NbExp=2; IntAct=EBI-751454, EBI-4319803;
CC       O43765:SGTA; NbExp=3; IntAct=EBI-751454, EBI-347996;
CC       P32241:VIPR1; NbExp=2; IntAct=EBI-6656819, EBI-3917984;
CC   -!- SUBCELLULAR LOCATION: Secreted.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P01282-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P01282-2; Sequence=VSP_023256;
CC   -!- SIMILARITY: Belongs to the glucagon family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Wikipedia; Note=Vasoactive intestinal peptide
CC       entry;
CC       URL="https://en.wikipedia.org/wiki/Vasoactive_intestinal_peptide";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; L00157; AAA61289.1; -; Genomic_DNA.
DR   EMBL; L00154; AAA61289.1; JOINED; Genomic_DNA.
DR   EMBL; L00155; AAA61289.1; JOINED; Genomic_DNA.
DR   EMBL; L00156; AAA61289.1; JOINED; Genomic_DNA.
DR   EMBL; M11553; AAA61284.1; -; Genomic_DNA.
DR   EMBL; M11549; AAA61284.1; JOINED; Genomic_DNA.
DR   EMBL; M11550; AAA61284.1; JOINED; Genomic_DNA.
DR   EMBL; M11551; AAA61284.1; JOINED; Genomic_DNA.
DR   EMBL; M11552; AAA61284.1; JOINED; Genomic_DNA.
DR   EMBL; M36634; AAA61287.1; -; mRNA.
DR   EMBL; M14623; AAA61288.1; -; Genomic_DNA.
DR   EMBL; M14619; AAA61288.1; JOINED; Genomic_DNA.
DR   EMBL; M14620; AAA61288.1; JOINED; Genomic_DNA.
DR   EMBL; M14621; AAA61288.1; JOINED; Genomic_DNA.
DR   EMBL; M14622; AAA61288.1; JOINED; Genomic_DNA.
DR   EMBL; M33027; AAA69515.1; -; Genomic_DNA.
DR   EMBL; AL133356; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC009794; AAH09794.1; -; mRNA.
DR   EMBL; M36610; AAA61286.1; -; Genomic_DNA.
DR   EMBL; M36606; AAA61286.1; JOINED; Genomic_DNA.
DR   EMBL; M36607; AAA61286.1; JOINED; Genomic_DNA.
DR   EMBL; M36608; AAA61286.1; JOINED; Genomic_DNA.
DR   EMBL; M36609; AAA61286.1; JOINED; Genomic_DNA.
DR   EMBL; M54930; AAA63268.1; -; mRNA.
DR   EMBL; M32162; AAA61285.1; -; Genomic_DNA.
DR   EMBL; M31645; AAA61285.1; JOINED; Genomic_DNA.
DR   CCDS; CCDS5240.1; -. [P01282-1]
DR   CCDS; CCDS5241.1; -. [P01282-2]
DR   PIR; A23296; VRHU.
DR   RefSeq; NP_003372.1; NM_003381.3. [P01282-1]
DR   RefSeq; NP_919416.1; NM_194435.2. [P01282-2]
DR   UniGene; Hs.53973; -.
DR   PDB; 2RRH; NMR; -; A=125-153.
DR   PDB; 2RRI; NMR; -; A=125-153.
DR   PDBsum; 2RRH; -.
DR   PDBsum; 2RRI; -.
DR   ProteinModelPortal; P01282; -.
DR   SMR; P01282; -.
DR   BioGrid; 113273; 9.
DR   IntAct; P01282; 9.
DR   MINT; P01282; -.
DR   STRING; 9606.ENSP00000356213; -.
DR   ChEMBL; CHEMBL5737; -.
DR   iPTMnet; P01282; -.
DR   PhosphoSitePlus; P01282; -.
DR   BioMuta; VIP; -.
DR   DMDM; 138574; -.
DR   PaxDb; P01282; -.
DR   PeptideAtlas; P01282; -.
DR   PRIDE; P01282; -.
DR   DNASU; 7432; -.
DR   Ensembl; ENST00000367243; ENSP00000356212; ENSG00000146469. [P01282-2]
DR   Ensembl; ENST00000367244; ENSP00000356213; ENSG00000146469. [P01282-1]
DR   GeneID; 7432; -.
DR   KEGG; hsa:7432; -.
DR   UCSC; uc003qpe.6; human. [P01282-1]
DR   CTD; 7432; -.
DR   DisGeNET; 7432; -.
DR   EuPathDB; HostDB:ENSG00000146469.12; -.
DR   GeneCards; VIP; -.
DR   HGNC; HGNC:12693; VIP.
DR   HPA; CAB018649; -.
DR   HPA; HPA017324; -.
DR   HPA; HPA072701; -.
DR   MIM; 192320; gene.
DR   neXtProt; NX_P01282; -.
DR   OpenTargets; ENSG00000146469; -.
DR   PharmGKB; PA37312; -.
DR   eggNOG; ENOG410IW68; Eukaryota.
DR   eggNOG; ENOG4111JKK; LUCA.
DR   GeneTree; ENSGT00530000063592; -.
DR   HOGENOM; HOG000253943; -.
DR   HOVERGEN; HBG018069; -.
DR   InParanoid; P01282; -.
DR   KO; K05264; -.
DR   OMA; FSHTLAW; -.
DR   OrthoDB; EOG091G0KH7; -.
DR   PhylomeDB; P01282; -.
DR   TreeFam; TF332804; -.
DR   Reactome; R-HSA-418555; G alpha (s) signalling events.
DR   Reactome; R-HSA-420092; Glucagon-type ligand receptors.
DR   SIGNOR; P01282; -.
DR   EvolutionaryTrace; P01282; -.
DR   GeneWiki; Vasoactive_intestinal_peptide; -.
DR   GenomeRNAi; 7432; -.
DR   PRO; PR:P01282; -.
DR   Proteomes; UP000005640; Chromosome 6.
DR   Bgee; ENSG00000146469; -.
DR   CleanEx; HS_VIP; -.
DR   ExpressionAtlas; P01282; baseline and differential.
DR   Genevisible; P01282; HS.
DR   GO; GO:0005576; C:extracellular region; TAS:Reactome.
DR   GO; GO:0005622; C:intracellular; IEA:GOC.
DR   GO; GO:0005179; F:hormone activity; IDA:BHF-UCL.
DR   GO; GO:0005184; F:neuropeptide hormone activity; TAS:ProtInc.
DR   GO; GO:0007189; P:adenylate cyclase-activating G-protein coupled receptor signaling pathway; IDA:BHF-UCL.
DR   GO; GO:0019731; P:antibacterial humoral response; IDA:UniProtKB.
DR   GO; GO:0019732; P:antifungal humoral response; IDA:UniProtKB.
DR   GO; GO:0061844; P:antimicrobial humoral immune response mediated by antimicrobial peptide; IDA:UniProtKB.
DR   GO; GO:0007589; P:body fluid secretion; TAS:ProtInc.
DR   GO; GO:0050829; P:defense response to Gram-negative bacterium; IDA:UniProtKB.
DR   GO; GO:0050830; P:defense response to Gram-positive bacterium; IDA:UniProtKB.
DR   GO; GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:Reactome.
DR   GO; GO:0045087; P:innate immune response; IDA:UniProtKB.
DR   GO; GO:0048255; P:mRNA stabilization; ISS:AgBase.
DR   GO; GO:0008284; P:positive regulation of cell proliferation; TAS:ProtInc.
DR   GO; GO:0045732; P:positive regulation of protein catabolic process; IDA:BHF-UCL.
DR   GO; GO:0070459; P:prolactin secretion; ISS:AgBase.
DR   GO; GO:0032880; P:regulation of protein localization; IDA:BHF-UCL.
DR   GO; GO:0001878; P:response to yeast; IDA:UniProtKB.
DR   InterPro; IPR000532; Glucagon_GIP_secretin_VIP.
DR   InterPro; IPR015523; VIP.
DR   PANTHER; PTHR11213:SF5; PTHR11213:SF5; 1.
DR   Pfam; PF00123; Hormone_2; 2.
DR   SMART; SM00070; GLUCA; 2.
DR   PROSITE; PS00260; GLUCAGON; 2.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Amidation;
KW   Cleavage on pair of basic residues; Complete proteome;
KW   Direct protein sequencing; Hormone; Phosphoprotein;
KW   Reference proteome; Secreted; Signal.
FT   SIGNAL        1     20       {ECO:0000255}.
FT   PROPEP       21     79
FT                                /FTId=PRO_0000011457.
FT   PEPTIDE      81    122       Intestinal peptide PHV-42.
FT                                /FTId=PRO_0000011458.
FT   PEPTIDE      81    107       Intestinal peptide PHM-27.
FT                                /FTId=PRO_0000011459.
FT   PEPTIDE     125    152       Vasoactive intestinal peptide.
FT                                /FTId=PRO_0000011460.
FT   PROPEP      156    170
FT                                /FTId=PRO_0000011461.
FT   MOD_RES      76     76       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P01283}.
FT   MOD_RES     107    107       Methionine amide.
FT                                {ECO:0000269|PubMed:3748844}.
FT   MOD_RES     152    152       Asparagine amide.
FT                                {ECO:0000269|PubMed:3748844}.
FT   VAR_SEQ     113    113       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_023256.
FT   CONFLICT     96     97       QL -> PP (in Ref. 8; AAA61286).
FT                                {ECO:0000305}.
FT   CONFLICT    116    116       S -> L (in Ref. 4; AAA61288).
FT                                {ECO:0000305}.
FT   CONFLICT    136    136       R -> G (in Ref. 4; AAA61288).
FT                                {ECO:0000305}.
FT   HELIX       128    152       {ECO:0000244|PDB:2RRH}.
SQ   SEQUENCE   170 AA;  19169 MW;  93EC0177F89508FD CRC64;
     MDTRNKAQLL VLLTLLSVLF SQTSAWPLYR APSALRLGDR IPFEGANEPD QVSLKEDIDM
     LQNALAENDT PYYDVSRNAR HADGVFTSDF SKLLGQLSAK KYLESLMGKR VSSNISEDPV
     PVKRHSDAVF TDNYTRLRKQ MAVKKYLNSI LNGKRSSEGE SPDFPEELEK
//
ID   A8K660_HUMAN            Unreviewed;       244 AA.
AC   A8K660;
DT   04-DEC-2007, integrated into UniProtKB/TrEMBL.
DT   04-DEC-2007, sequence version 1.
DT   23-MAY-2018, entry version 109.
DE   SubName: Full=Adiponectin {ECO:0000313|EMBL:ABZ10942.1};
DE   SubName: Full=Adiponectin, C1Q and collagen domain containing {ECO:0000313|EMBL:EAW78165.1};
DE   SubName: Full=cDNA FLJ78108, highly similar to Homo sapiens adiponectin, C1Q and collagen domain containing (ADIPOQ), mRNA {ECO:0000313|EMBL:BAF84214.1};
GN   Name=ADIPOQ {ECO:0000313|EMBL:EAW78165.1};
GN   ORFNames=hCG_1784052 {ECO:0000313|EMBL:EAW78165.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAF84214.1};
RN   [1] {ECO:0000313|EMBL:EAW78165.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAW78165.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3] {ECO:0000313|EMBL:BAF84214.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Pericardium {ECO:0000313|EMBL:BAF84214.1};
RA   Wakamatsu A., Yamamoto J., Kimura K., Ishii S., Watanabe K.,
RA   Sugiyama A., Murakawa K., Kaida T., Tsuchiya K., Fukuzumi Y.,
RA   Kumagai A., Oishi Y., Yamamoto S., Ono Y., Komori Y., Yamazaki M.,
RA   Kisu Y., Nishikawa T., Sugano S., Nomura N., Isogai T.;
RT   "NEDO human cDNA sequencing project.";
RL   Submitted (OCT-2007) to the EMBL/GenBank/DDBJ databases.
RN   [4] {ECO:0000313|EMBL:ABZ10942.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Liu F., Zheng J.G.;
RT   "Cloning and Expression of Adiponectin from Homo sapiens.";
RL   Submitted (JAN-2008) to the EMBL/GenBank/DDBJ databases.
CC   -!- INTERACTION:
CC       Q8N6L0:CCDC155; NbExp=3; IntAct=EBI-10174479, EBI-749265;
CC       O43765:SGTA; NbExp=3; IntAct=EBI-10174479, EBI-347996;
CC       Q8N205:SYNE4; NbExp=3; IntAct=EBI-10174479, EBI-7131783;
CC   -!- SUBCELLULAR LOCATION: Secreted {ECO:0000256|SAAS:SAAS00562217}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; EU420013; ABZ10942.1; -; mRNA.
DR   EMBL; AK291525; BAF84214.1; -; mRNA.
DR   EMBL; CH471052; EAW78165.1; -; Genomic_DNA.
DR   RefSeq; NP_001171271.1; NM_001177800.1.
DR   RefSeq; NP_004788.1; NM_004797.3.
DR   UniGene; Hs.80485; -.
DR   SMR; A8K660; -.
DR   IntAct; A8K660; 3.
DR   PRIDE; A8K660; -.
DR   GeneID; 9370; -.
DR   KEGG; hsa:9370; -.
DR   CTD; 9370; -.
DR   EuPathDB; HostDB:ENSG00000181092.9; -.
DR   PharmGKB; PA134933118; -.
DR   eggNOG; ENOG410IHSJ; Eukaryota.
DR   eggNOG; ENOG4111F5K; LUCA.
DR   HOVERGEN; HBG108220; -.
DR   KO; K07296; -.
DR   OMA; QQNHYDG; -.
DR   OrthoDB; EOG091G0L3Y; -.
DR   ChiTaRS; ADIPOQ; human.
DR   GenomeRNAi; 9370; -.
DR   Bgee; ENSG00000181092; -.
DR   ExpressionAtlas; A8K660; baseline and differential.
DR   GO; GO:0005581; C:collagen trimer; IEA:UniProtKB-KW.
DR   GO; GO:0005783; C:endoplasmic reticulum; IEA:Ensembl.
DR   GO; GO:0005615; C:extracellular space; IEA:Ensembl.
DR   GO; GO:0005179; F:hormone activity; IEA:Ensembl.
DR   GO; GO:0042802; F:identical protein binding; IEA:Ensembl.
DR   GO; GO:0033211; P:adiponectin-activated signaling pathway; IEA:Ensembl.
DR   GO; GO:0050873; P:brown fat cell differentiation; IEA:Ensembl.
DR   GO; GO:0071320; P:cellular response to cAMP; IEA:Ensembl.
DR   GO; GO:0035690; P:cellular response to drug; IEA:Ensembl.
DR   GO; GO:0071872; P:cellular response to epinephrine stimulus; IEA:Ensembl.
DR   GO; GO:0032869; P:cellular response to insulin stimulus; IEA:Ensembl.
DR   GO; GO:0007623; P:circadian rhythm; IEA:Ensembl.
DR   GO; GO:0070994; P:detection of oxidative stress; IEA:Ensembl.
DR   GO; GO:0006635; P:fatty acid beta-oxidation; IEA:Ensembl.
DR   GO; GO:0042593; P:glucose homeostasis; IEA:Ensembl.
DR   GO; GO:0006006; P:glucose metabolic process; IEA:Ensembl.
DR   GO; GO:0051899; P:membrane depolarization; IEA:Ensembl.
DR   GO; GO:0060081; P:membrane hyperpolarization; IEA:Ensembl.
DR   GO; GO:0045599; P:negative regulation of fat cell differentiation; IEA:Ensembl.
DR   GO; GO:0045721; P:negative regulation of gluconeogenesis; IEA:Ensembl.
DR   GO; GO:0046888; P:negative regulation of hormone secretion; IEA:Ensembl.
DR   GO; GO:0050728; P:negative regulation of inflammatory response; IEA:Ensembl.
DR   GO; GO:0043407; P:negative regulation of MAP kinase activity; IEA:Ensembl.
DR   GO; GO:2000590; P:negative regulation of metanephric mesenchymal cell migration; IEA:Ensembl.
DR   GO; GO:2000584; P:negative regulation of platelet-derived growth factor receptor-alpha signaling pathway; IEA:Ensembl.
DR   GO; GO:0045892; P:negative regulation of transcription, DNA-templated; IEA:Ensembl.
DR   GO; GO:0045777; P:positive regulation of blood pressure; IEA:Ensembl.
DR   GO; GO:2000481; P:positive regulation of cAMP-dependent protein kinase activity; IEA:Ensembl.
DR   GO; GO:0045923; P:positive regulation of fatty acid metabolic process; IEA:Ensembl.
DR   GO; GO:0046326; P:positive regulation of glucose import; IEA:Ensembl.
DR   GO; GO:2000467; P:positive regulation of glycogen (starch) synthase activity; IEA:Ensembl.
DR   GO; GO:0043123; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; IEA:Ensembl.
DR   GO; GO:2000478; P:positive regulation of metanephric glomerular visceral epithelial cell development; IEA:Ensembl.
DR   GO; GO:0050731; P:positive regulation of peptidyl-tyrosine phosphorylation; IEA:Ensembl.
DR   GO; GO:2000534; P:positive regulation of renal albumin absorption; IEA:Ensembl.
DR   GO; GO:0070208; P:protein heterotrimerization; IEA:Ensembl.
DR   GO; GO:0051260; P:protein homooligomerization; IEA:Ensembl.
DR   GO; GO:0014823; P:response to activity; IEA:Ensembl.
DR   GO; GO:0045471; P:response to ethanol; IEA:Ensembl.
DR   GO; GO:0051384; P:response to glucocorticoid; IEA:Ensembl.
DR   GO; GO:0009749; P:response to glucose; IEA:Ensembl.
DR   GO; GO:0001666; P:response to hypoxia; IEA:Ensembl.
DR   GO; GO:0070543; P:response to linoleic acid; IEA:Ensembl.
DR   GO; GO:0007584; P:response to nutrient; IEA:Ensembl.
DR   GO; GO:0009744; P:response to sucrose; IEA:Ensembl.
DR   Gene3D; 2.60.120.40; -; 1.
DR   InterPro; IPR001073; C1q_dom.
DR   InterPro; IPR008160; Collagen.
DR   InterPro; IPR008983; Tumour_necrosis_fac-like_dom.
DR   Pfam; PF00386; C1q; 1.
DR   Pfam; PF01391; Collagen; 1.
DR   PRINTS; PR00007; COMPLEMNTC1Q.
DR   SMART; SM00110; C1Q; 1.
DR   SUPFAM; SSF49842; SSF49842; 1.
DR   PROSITE; PS50871; C1Q; 1.
PE   1: Evidence at protein level;
KW   Collagen {ECO:0000256|SAAS:SAAS00562261, ECO:0000313|EMBL:BAF84214.1};
KW   Secreted {ECO:0000256|SAAS:SAAS00562230};
KW   Signal {ECO:0000256|SAM:SignalP}.
FT   SIGNAL        1     17       {ECO:0000256|SAM:SignalP}.
FT   CHAIN        18    244       {ECO:0000256|SAM:SignalP}.
FT                                /FTId=PRO_5014297568.
FT   DOMAIN      108    244       C1q. {ECO:0000259|PROSITE:PS50871}.
SQ   SEQUENCE   244 AA;  26414 MW;  64D8C6C1204B1018 CRC64;
     MLLLGAVLLL LALPGHDQET TTQGPGVLLP LPKGACTGWM AGIPGHPGHN GAPGRDGRDG
     TPGEKGEKGD PGLIGPKGDI GETGVPGAEG PRGFPGIQGR KGEPGEGAYV YRSAFSVGLE
     TYVTIPNMPI RFTKIFYNQQ NHYDGSTGKF HCNIPGLYYF AYHITVYMKD VKVSLFKKDK
     AMLFTYDQYQ ENNVDQASGS VLLHLEVGDQ VWLQVYGEGE RNGLYADNDN DSTFTGFLLY
     HDTN
//
ID   B2R773_HUMAN            Unreviewed;       244 AA.
AC   B2R773;
DT   01-JUL-2008, integrated into UniProtKB/TrEMBL.
DT   01-JUL-2008, sequence version 1.
DT   28-FEB-2018, entry version 64.
DE   SubName: Full=cDNA, FLJ93312, highly similar to Homo sapiens adipose most abundant gene transcript 1 (APM1), mRNA {ECO:0000313|EMBL:BAG35720.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAG35720.1};
RN   [1] {ECO:0000313|EMBL:BAG35720.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Trachea {ECO:0000313|EMBL:BAG35720.1};
RA   Wakamatsu A., Yamamoto J., Kimura K., Kaida T., Tsuchiya K., Iida Y.,
RA   Takayama Y., Murakawa K., Kanehori K., Andoh T., Kagawa N., Sato R.,
RA   Kawamura Y., Tanaka S., Kisu Y., Sugano S., Goshima N., Nomura N.,
RA   Isogai T.;
RT   "NEDO functional analysis of protein and research application
RT   project.";
RL   Submitted (JAN-2008) to the EMBL/GenBank/DDBJ databases.
CC   -!- SUBCELLULAR LOCATION: Secreted {ECO:0000256|SAAS:SAAS00562217}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK312868; BAG35720.1; -; mRNA.
DR   RefSeq; NP_001171271.1; NM_001177800.1.
DR   UniGene; Hs.80485; -.
DR   SMR; B2R773; -.
DR   PeptideAtlas; B2R773; -.
DR   PRIDE; B2R773; -.
DR   GeneID; 9370; -.
DR   KEGG; hsa:9370; -.
DR   CTD; 9370; -.
DR   PharmGKB; PA134933118; -.
DR   eggNOG; ENOG410IHSJ; Eukaryota.
DR   eggNOG; ENOG4111F5K; LUCA.
DR   HOVERGEN; HBG108220; -.
DR   KO; K07296; -.
DR   GenomeRNAi; 9370; -.
DR   Genevisible; B2R773; HS.
DR   GO; GO:0005581; C:collagen trimer; IEA:UniProtKB-KW.
DR   GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR   Gene3D; 2.60.120.40; -; 1.
DR   InterPro; IPR001073; C1q_dom.
DR   InterPro; IPR008160; Collagen.
DR   InterPro; IPR008983; Tumour_necrosis_fac-like_dom.
DR   Pfam; PF00386; C1q; 1.
DR   Pfam; PF01391; Collagen; 1.
DR   PRINTS; PR00007; COMPLEMNTC1Q.
DR   SMART; SM00110; C1Q; 1.
DR   SUPFAM; SSF49842; SSF49842; 1.
DR   PROSITE; PS50871; C1Q; 1.
PE   2: Evidence at transcript level;
KW   Collagen {ECO:0000256|SAAS:SAAS00562261};
KW   Secreted {ECO:0000256|SAAS:SAAS00562230};
KW   Signal {ECO:0000256|SAM:SignalP}.
FT   SIGNAL        1     17       {ECO:0000256|SAM:SignalP}.
FT   CHAIN        18    244       {ECO:0000256|SAM:SignalP}.
FT                                /FTId=PRO_5002781808.
FT   DOMAIN      108    244       C1q. {ECO:0000259|PROSITE:PS50871}.
SQ   SEQUENCE   244 AA;  26426 MW;  52AFAAD6076B577F CRC64;
     MLLLGAVLLL LALPGHDQET TTQGPGVLLP LPKGACTGWM AGIPGHPGHN GAPGRDGRDG
     TPGEKGEKGD PGLIGPKGDI GETGVPGAEG PRGFPGIQGR KGEPGEGAYV YRSAFSVGLE
     TYVTIPNMPI RFTKIFYNQQ NHYDGSTGKF HCNIPGLYYF AYHITVYMKD VKVSPFRKDK
     AMLFTYDQYQ ENNVDQASGS VLLHLEVGDQ VWLQVYGEGE RNGLYADNDN DSTFTGFLLY
     HDTN
//
ID   ADIPO_HUMAN             Reviewed;         244 AA.
AC   Q15848; Q58EX9;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   23-MAY-2018, entry version 184.
DE   RecName: Full=Adiponectin;
DE   AltName: Full=30 kDa adipocyte complement-related protein;
DE   AltName: Full=Adipocyte complement-related 30 kDa protein;
DE            Short=ACRP30;
DE   AltName: Full=Adipocyte, C1q and collagen domain-containing protein;
DE   AltName: Full=Adipose most abundant gene transcript 1 protein;
DE            Short=apM-1;
DE   AltName: Full=Gelatin-binding protein;
DE   Flags: Precursor;
GN   Name=ADIPOQ; Synonyms=ACDC, ACRP30, APM1, GBP28;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Adipose tissue;
RX   PubMed=8619847; DOI=10.1006/bbrc.1996.0587;
RA   Maeda K., Okubo K., Shimomura I., Funahashi T., Matsuzawa Y.,
RA   Matsubara K.;
RT   "cDNA cloning and expression of a novel adipose specific collagen-like
RT   factor, apM1 (AdiPose Most abundant Gene transcript 1).";
RL   Biochem. Biophys. Res. Commun. 221:286-289(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=10095105; DOI=10.1016/S0378-1119(99)00041-4;
RA   Saito K., Tobe T., Minoshima S., Asakawa S., Sumiya J., Yoda M.,
RA   Nakano Y., Shimizu N., Tomita M.;
RT   "Organization of the gene for gelatin-binding protein (GBP28).";
RL   Gene 229:67-73(1999).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=10403784; DOI=10.1006/bbrc.1999.0865;
RA   Schaeffler A., Orso E., Palitzsch K.D., Buechler C., Drobnik W.,
RA   Fuerst A., Schoelmerich J., Schmitz G.;
RT   "The human apM-1, an adipocyte-specific gene linked to the family of
RT   TNF's and to genes expressed in activated T cells, is mapped to
RT   chromosome 1q21.3-q23, a susceptibility locus identified for familial
RT   combined hyperlipidemia (FCH).";
RL   Biochem. Biophys. Res. Commun. 260:416-425(1999).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   PROTEIN SEQUENCE OF 19-33.
RX   PubMed=15340161; DOI=10.1110/ps.04682504;
RA   Zhang Z., Henzel W.J.;
RT   "Signal peptide prediction based on analysis of experimentally
RT   verified cleavage sites.";
RL   Protein Sci. 13:2819-2824(2004).
RN   [6]
RP   PROTEIN SEQUENCE OF N-TERMINUS, AND PARTIAL PROTEIN SEQUENCE.
RX   PubMed=8947845; DOI=10.1093/oxfordjournals.jbchem.a021483;
RA   Nakano Y., Tobe T., Choi-Miura N.H., Mazda T., Tomita M.;
RT   "Isolation and characterization of GBP28, a novel gelatin-binding
RT   protein purified from human plasma.";
RL   J. Biochem. 120:803-812(1996).
RN   [7]
RP   CHARACTERIZATION.
RX   PubMed=10961870;
RA   Yokota T., Oritani K., Takahashi I., Ishikawa J., Matsuyama A.,
RA   Ouchi N., Kihara S., Funahashi T., Tenner A.J., Tomiyama Y.,
RA   Matsuzawa Y.;
RT   "Adiponectin, a new member of the family of soluble defense collagens,
RT   negatively regulates the growth of myelomonocytic progenitors and the
RT   functions of macrophages.";
RL   Blood 96:1723-1732(2000).
RN   [8]
RP   CHARACTERIZATION.
RX   PubMed=10982546; DOI=10.1161/01.CIR.102.11.1296;
RA   Ouchi N., Kihara S., Arita Y., Okamoto Y., Maeda K., Kuriyama H.,
RA   Hotta K., Nishida M., Takahashi M., Muraguchi M., Ohmoto Y.,
RA   Nakamura T., Yamashita S., Funahashi T., Matsuzawa Y.;
RT   "Adiponectin, an adipocyte-derived plasma protein, inhibits
RT   endothelial NF-kappaB signaling through a cAMP-dependent pathway.";
RL   Circulation 102:1296-1301(2000).
RN   [9]
RP   FUNCTION.
RX   PubMed=11479627; DOI=10.1038/90984;
RA   Yamauchi T., Kamon J., Waki H., Terauchi Y., Kubota N., Hara K.,
RA   Mori Y., Ide T., Murakami K., Tsuboyama-Kasaoka N., Ezaki O.,
RA   Akanuma Y., Gavrilova O., Vinson C., Reitman M.L., Kagechika H.,
RA   Shudo K., Yoda M., Nakano Y., Tobe K., Nagai R., Kimura S., Tomita M.,
RA   Froguel P., Kadowaki T.;
RT   "The fat-derived hormone adiponectin reverses insulin resistance
RT   associated with both lipoatrophy and obesity.";
RL   Nat. Med. 7:941-946(2001).
RN   [10]
RP   SUBUNIT, DISULFIDE BOND, MUTAGENESIS OF CYS-36, AND CHARACTERIZATION
RP   OF VARIANTS ARG-84; SER-90; CYS-112 AND THR-164.
RX   PubMed=12878598; DOI=10.1074/jbc.M300365200;
RA   Waki H., Yamauchi T., Kamon J., Ito Y., Uchida S., Kita S., Hara K.,
RA   Hada Y., Vasseur F., Froguel P., Kimura S., Nagai R., Kadowaki T.;
RT   "Impaired multimerization of human adiponectin mutants associated with
RT   diabetes. Molecular structure and multimer formation of adiponectin.";
RL   J. Biol. Chem. 278:40352-40363(2003).
RN   [11]
RP   SUBUNIT, HYDROXYLATION AT PRO-44; PRO-47; PRO-53; LYS-65; LYS-68;
RP   PRO-71; PRO-76; LYS-77; PRO-91; PRO-95 AND LYS-101, GLYCOSYLATION AT
RP   LYS-65; LYS-68; LYS-77 AND LYS-101, DISULFIDE BOND, LACK OF
RP   HYDROXYLATION AT PRO-62; PRO-86 AND PRO-104, LACK OF GLYCOSYLATION AT
RP   ASN-230, MUTAGENESIS OF LYS-33; CYS-36; LYS-65; LYS-68; LYS-77 AND
RP   LYS-101, AND IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=16497731; DOI=10.1210/me.2005-0390;
RA   Richards A.A., Stephens T., Charlton H.K., Jones A., Macdonald G.A.,
RA   Prins J.B., Whitehead J.P.;
RT   "Adiponectin multimerization is dependent on conserved lysines in the
RT   collagenous domain: evidence for regulation of multimerization by
RT   alterations in posttranslational modifications.";
RL   Mol. Endocrinol. 20:1673-1687(2006).
RN   [12]
RP   GLYCOSYLATION AT THR-21 AND THR-22, SUBUNIT, IDENTIFICATION BY MASS
RP   SPECTROMETRY, AND MUTAGENESIS OF THR-20; THR-21 AND THR-22.
RX   PubMed=19855092; DOI=10.1210/me.2009-0133;
RA   Richards A.A., Colgrave M.L., Zhang J., Webster J., Simpson F.,
RA   Preston E., Wilks D., Hoehn K.L., Stephenson M., Macdonald G.A.,
RA   Prins J.B., Cooney G.J., Xu A., Whitehead J.P.;
RT   "Sialic acid modification of adiponectin is not required for
RT   multimerization or secretion but determines half-life in
RT   circulation.";
RL   Mol. Endocrinol. 24:229-239(2010).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22905912; DOI=10.1021/pr300539b;
RA   Rosenow A., Noben J.P., Jocken J., Kallendrusch S.,
RA   Fischer-Posovszky P., Mariman E.C., Renes J.;
RT   "Resveratrol-induced changes of the human adipocyte secretion
RT   profile.";
RL   J. Proteome Res. 11:4733-4743(2012).
RN   [14]
RP   X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) OF 104-244, AND SUBUNIT.
RX   PubMed=22449980; DOI=10.1016/j.febslet.2012.02.024;
RA   Min X., Lemon B., Tang J., Liu Q., Zhang R., Walker N., Li Y.,
RA   Wang Z.;
RT   "Crystal structure of a single-chain trimer of human adiponectin
RT   globular domain.";
RL   FEBS Lett. 586:912-917(2012).
RN   [15]
RP   VARIANT ADPND CYS-112.
RX   PubMed=10918532; DOI=10.1038/sj.ijo.0801244;
RA   Takahashi M., Arita Y., Yamagata K., Matsukawa Y., Okutomi K.,
RA   Horie M., Shimomura I., Hotta K., Kuriyama H., Kihara S., Nakamura T.,
RA   Yamashita S., Funahashi T., Matsuzawa Y.;
RT   "Genomic structure and mutations in adipose-specific gene,
RT   adiponectin.";
RL   Int. J. Obes. Relat. Metab. Disord. 24:861-868(2000).
RN   [16]
RP   VARIANTS ARG-84; MET-117; THR-164; SER-221 AND PRO-241.
RX   PubMed=11812766; DOI=10.2337/diabetes.51.2.536;
RA   Hara K., Boutin P., Mori Y., Tobe K., Dina C., Yasuda K., Yamauchi T.,
RA   Otabe S., Okada T., Eto K., Kadowaki H., Hagura R., Akanuma Y.,
RA   Yazaki Y., Nagai R., Taniyama M., Matsubara K., Yoda M., Nakano Y.,
RA   Kimura S., Tomita M., Kimura S., Ito C., Froguel P., Kadowaki T.;
RT   "Genetic variation in the gene encoding adiponectin is associated with
RT   an increased risk of type 2 diabetes in the Japanese population.";
RL   Diabetes 51:536-540(2002).
RN   [17]
RP   ERRATUM.
RA   Hara K., Boutin P., Mori Y., Tobe K., Dina C., Yasuda K., Yamauchi T.,
RA   Otabe S., Okada T., Eto K., Kadowaki H., Hagura R., Akanuma Y.,
RA   Yazaki Y., Nagai R., Taniyama M., Matsubara K., Yoda M., Nakano Y.,
RA   Kimura S., Tomita M., Kimura S., Ito C., Froguel P., Kadowaki T.;
RL   Diabetes 51:1294-1294(2002).
RN   [18]
RP   VARIANTS CYS-112; THR-164; SER-221 AND PRO-241, AND ASSOCIATION WITH
RP   LOW PLASMA ADIPONECTIN CONCENTRATION AND DIABETES MELLITUS TYPE 2.
RX   PubMed=12086969; DOI=10.2337/diabetes.51.7.2325;
RA   Kondo H., Shimomura I., Matsukawa Y., Kumada M., Takahashi M.,
RA   Matsuda M., Ouchi N., Kihara S., Kawamoto T., Sumitsuji S.,
RA   Funahashi T., Matsuzawa Y.;
RT   "Association of adiponectin mutation with type 2 diabetes: a candidate
RT   gene for the insulin resistance syndrome.";
RL   Diabetes 51:2325-2328(2002).
RN   [19]
RP   VARIANTS ARG-84; SER-90 AND HIS-111.
RX   PubMed=12354786; DOI=10.1093/hmg/11.21.2607;
RA   Vasseur F., Helbecque N., Dina C., Lobbens S., Delannoy V., Gaget S.,
RA   Boutin P., Vaxillaire M., Lepretre F., Dupont S., Hara K., Clement K.,
RA   Bihain B., Kadowaki T., Froguel P.;
RT   "Single-nucleotide polymorphism haplotypes in the both proximal
RT   promoter and exon 3 of the APM1 gene modulate adipocyte-secreted
RT   adiponectin hormone levels and contribute to the genetic risk for type
RT   2 diabetes in French Caucasians.";
RL   Hum. Mol. Genet. 11:2607-2614(2002).
CC   -!- FUNCTION: Important adipokine involved in the control of fat
CC       metabolism and insulin sensitivity, with direct anti-diabetic,
CC       anti-atherogenic and anti-inflammatory activities. Stimulates AMPK
CC       phosphorylation and activation in the liver and the skeletal
CC       muscle, enhancing glucose utilization and fatty-acid combustion.
CC       Antagonizes TNF-alpha by negatively regulating its expression in
CC       various tissues such as liver and macrophages, and also by
CC       counteracting its effects. Inhibits endothelial NF-kappa-B
CC       signaling through a cAMP-dependent pathway. May play a role in
CC       cell growth, angiogenesis and tissue remodeling by binding and
CC       sequestering various growth factors with distinct binding
CC       affinities, depending on the type of complex, LMW, MMW or HMW.
CC       {ECO:0000269|PubMed:11479627}.
CC   -!- SUBUNIT: Homomultimer. Forms trimers, hexamers and 12- to 18-mers.
CC       The trimers (low molecular weight complexes / LMW) are assembled
CC       via non-covalent interactions of the collagen-like domains in a
CC       triple helix and hydrophobic interactions within the globular C1q
CC       domain. Several trimers can associate to form disulfide-linked
CC       hexamers (middle molecular weight complexes / MMW) and larger
CC       complexes (higher molecular weight / HMW). The HMW-complex
CC       assembly may rely additionally on lysine hydroxylation and
CC       glycosylation. LMW, MMW and HMW complexes bind to HBEGF, MMW and
CC       HMW complexes bind to PDGFB, and HMW complex binds to FGF2.
CC       Interacts with CTRP9A via the C1q domain (heterotrimeric complex)
CC       (By similarity). {ECO:0000250}.
CC   -!- INTERACTION:
CC       O60238:BNIP3L; NbExp=3; IntAct=EBI-10827839, EBI-849893;
CC       Q8N6L0:CCDC155; NbExp=3; IntAct=EBI-10827839, EBI-749265;
CC       Q9UHP7-3:CLEC2D; NbExp=4; IntAct=EBI-10827839, EBI-11749983;
CC       O43765:SGTA; NbExp=5; IntAct=EBI-10827839, EBI-347996;
CC       Q8N205-2:SYNE4; NbExp=5; IntAct=EBI-10827839, EBI-12099160;
CC   -!- SUBCELLULAR LOCATION: Secreted.
CC   -!- TISSUE SPECIFICITY: Synthesized exclusively by adipocytes and
CC       secreted into plasma.
CC   -!- DOMAIN: The C1q domain is commonly called the globular domain.
CC   -!- PTM: Hydroxylated Lys-33 was not identified in PubMed:16497731,
CC       probably due to poor representation of the N-terminal peptide in
CC       mass fingerprinting. {ECO:0000269|PubMed:16497731}.
CC   -!- PTM: HMW complexes are more extensively glycosylated than smaller
CC       oligomers. Hydroxylation and glycosylation of the lysine residues
CC       within the collagene-like domain of adiponectin seem to be
CC       critically involved in regulating the formation and/or secretion
CC       of HMW complexes and consequently contribute to the insulin-
CC       sensitizing activity of adiponectin in hepatocytes (By
CC       similarity). {ECO:0000250}.
CC   -!- PTM: O-glycosylated. Not N-glycosylated. O-linked glycans on
CC       hydroxylysines consist of Glc-Gal disaccharides bound to the
CC       oxygen atom of post-translationally added hydroxyl groups.
CC       Sialylated to varying degrees depending on tissue. Thr-22 appears
CC       to be the major site of sialylation. Higher sialylation found in
CC       SGBS adipocytes than in HEK fibroblasts. Sialylation is not
CC       required neither for heterodimerization nor for secretion. Not
CC       sialylated on the glycosylated hydroxylysines. Desialylated forms
CC       are rapidly cleared from the circulation.
CC       {ECO:0000269|PubMed:16497731, ECO:0000269|PubMed:19855092}.
CC   -!- POLYMORPHISM: Genetic variations in ADIPOQ influence the variance
CC       in adiponectin serum levels and define the adiponectin serum
CC       levels quantitative trait locus 1 (ADIPQTL1) [MIM:612556].
CC   -!- DISEASE: Adiponectin deficiency (ADPND) [MIM:612556]: A condition
CC       that results in very low concentrations of plasma adiponectin.
CC       {ECO:0000269|PubMed:10918532}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Diabetes mellitus, non-insulin-dependent (NIDDM)
CC       [MIM:125853]: A multifactorial disorder of glucose homeostasis
CC       caused by a lack of sensitivity to the body's own insulin.
CC       Affected individuals usually have an obese body habitus and
CC       manifestations of a metabolic syndrome characterized by diabetes,
CC       insulin resistance, hypertension and hypertriglyceridemia. The
CC       disease results in long-term complications that affect the eyes,
CC       kidneys, nerves, and blood vessels. Note=Disease susceptibility is
CC       associated with variations affecting the gene represented in this
CC       entry.
CC   -!- PHARMACEUTICAL: Adiponectin might be used in the treatment of
CC       diabetes type 2 and insulin resistance.
CC   -!- MISCELLANEOUS: Variants Arg-84 and Ser-90 show impaired formation
CC       of HMW complexes whereas variants Cys-112 and Thr-164 show
CC       impaired secretion of adiponectin in any form.
CC   -!- MISCELLANEOUS: HMW-complex blood contents are higher in females
CC       than in males, are increased in males by castration and decreased
CC       again upon subsequent testosterone treatment, which blocks HMW-
CC       complex secretion (By similarity). In type 2 diabetic patients,
CC       both the ratios of HMW to total adiponectin and the degree of
CC       adiponectin glycosylation are significantly decreased as compared
CC       with healthy controls. {ECO:0000250}.
CC   -!- WEB RESOURCE: Name=Wikipedia; Note=Adiponectin entry;
CC       URL="https://en.wikipedia.org/wiki/Adiponectin";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; D45371; BAA08227.1; -; mRNA.
DR   EMBL; AB012165; BAA86716.1; -; Genomic_DNA.
DR   EMBL; AJ131460; CAB52413.1; -; Genomic_DNA.
DR   EMBL; AJ131461; CAB52413.1; JOINED; Genomic_DNA.
DR   EMBL; BC054496; AAH54496.1; -; mRNA.
DR   EMBL; BC096308; AAH96308.1; -; mRNA.
DR   EMBL; BC096309; AAH96309.1; -; mRNA.
DR   EMBL; BC096310; AAH96310.1; -; mRNA.
DR   EMBL; BC096311; AAH96311.1; -; mRNA.
DR   CCDS; CCDS3284.1; -.
DR   PIR; JC4708; JC4708.
DR   RefSeq; NP_001171271.1; NM_001177800.1.
DR   RefSeq; NP_004788.1; NM_004797.3.
DR   UniGene; Hs.80485; -.
DR   PDB; 4DOU; X-ray; 2.00 A; A=104-244.
DR   PDBsum; 4DOU; -.
DR   ProteinModelPortal; Q15848; -.
DR   SMR; Q15848; -.
DR   BioGrid; 114771; 21.
DR   IntAct; Q15848; 21.
DR   STRING; 9606.ENSP00000320709; -.
DR   TCDB; 8.A.94.1.1; the adiponectin (adiponectin) family.
DR   iPTMnet; Q15848; -.
DR   PhosphoSitePlus; Q15848; -.
DR   BioMuta; ADIPOQ; -.
DR   DMDM; 2493789; -.
DR   PaxDb; Q15848; -.
DR   PeptideAtlas; Q15848; -.
DR   PRIDE; Q15848; -.
DR   Ensembl; ENST00000320741; ENSP00000320709; ENSG00000181092.
DR   Ensembl; ENST00000444204; ENSP00000389814; ENSG00000181092.
DR   GeneID; 9370; -.
DR   KEGG; hsa:9370; -.
DR   UCSC; uc003fra.4; human.
DR   CTD; 9370; -.
DR   DisGeNET; 9370; -.
DR   EuPathDB; HostDB:ENSG00000181092.9; -.
DR   GeneCards; ADIPOQ; -.
DR   HGNC; HGNC:13633; ADIPOQ.
DR   HPA; CAB046467; -.
DR   HPA; HPA051767; -.
DR   MalaCards; ADIPOQ; -.
DR   MIM; 125853; phenotype.
DR   MIM; 605441; gene.
DR   MIM; 612556; phenotype.
DR   neXtProt; NX_Q15848; -.
DR   OpenTargets; ENSG00000181092; -.
DR   PharmGKB; PA134933118; -.
DR   eggNOG; ENOG410IHSJ; Eukaryota.
DR   eggNOG; ENOG4111F5K; LUCA.
DR   GeneTree; ENSGT00760000118830; -.
DR   HOGENOM; HOG000085653; -.
DR   HOVERGEN; HBG108220; -.
DR   InParanoid; Q15848; -.
DR   KO; K07296; -.
DR   OMA; QQNHYDG; -.
DR   OrthoDB; EOG091G0L3Y; -.
DR   PhylomeDB; Q15848; -.
DR   TreeFam; TF329591; -.
DR   Reactome; R-HSA-163680; AMPK inhibits chREBP transcriptional activation activity.
DR   Reactome; R-HSA-381340; Transcriptional regulation of white adipocyte differentiation.
DR   SIGNOR; Q15848; -.
DR   ChiTaRS; ADIPOQ; human.
DR   GeneWiki; Adiponectin; -.
DR   GenomeRNAi; 9370; -.
DR   PRO; PR:Q15848; -.
DR   Proteomes; UP000005640; Chromosome 3.
DR   Bgee; ENSG00000181092; -.
DR   CleanEx; HS_ADIPOQ; -.
DR   ExpressionAtlas; Q15848; baseline and differential.
DR   Genevisible; Q15848; HS.
DR   GO; GO:0009986; C:cell surface; IDA:BHF-UCL.
DR   GO; GO:0005581; C:collagen trimer; IEA:UniProtKB-KW.
DR   GO; GO:0005783; C:endoplasmic reticulum; ISS:UniProtKB.
DR   GO; GO:0005576; C:extracellular region; HDA:BHF-UCL.
DR   GO; GO:0005615; C:extracellular space; IDA:UniProtKB.
DR   GO; GO:0005125; F:cytokine activity; NAS:BHF-UCL.
DR   GO; GO:0005179; F:hormone activity; IDA:BHF-UCL.
DR   GO; GO:0042802; F:identical protein binding; TAS:BHF-UCL.
DR   GO; GO:0042803; F:protein homodimerization activity; IPI:BHF-UCL.
DR   GO; GO:0033691; F:sialic acid binding; IDA:UniProtKB.
DR   GO; GO:0005102; F:signaling receptor binding; ISS:UniProtKB.
DR   GO; GO:0033211; P:adiponectin-activated signaling pathway; IEA:Ensembl.
DR   GO; GO:0050873; P:brown fat cell differentiation; ISS:UniProtKB.
DR   GO; GO:0071320; P:cellular response to cAMP; IEA:Ensembl.
DR   GO; GO:0035690; P:cellular response to drug; ISS:UniProtKB.
DR   GO; GO:0071872; P:cellular response to epinephrine stimulus; IEA:Ensembl.
DR   GO; GO:0032869; P:cellular response to insulin stimulus; ISS:UniProtKB.
DR   GO; GO:0007623; P:circadian rhythm; IEA:Ensembl.
DR   GO; GO:0070994; P:detection of oxidative stress; ISS:UniProtKB.
DR   GO; GO:0006635; P:fatty acid beta-oxidation; ISS:UniProtKB.
DR   GO; GO:0019395; P:fatty acid oxidation; ISS:UniProtKB.
DR   GO; GO:0006091; P:generation of precursor metabolites and energy; TAS:ProtInc.
DR   GO; GO:0042593; P:glucose homeostasis; ISS:UniProtKB.
DR   GO; GO:0006006; P:glucose metabolic process; ISS:UniProtKB.
DR   GO; GO:0034383; P:low-density lipoprotein particle clearance; IDA:BHF-UCL.
DR   GO; GO:0051899; P:membrane depolarization; IEA:Ensembl.
DR   GO; GO:0060081; P:membrane hyperpolarization; IEA:Ensembl.
DR   GO; GO:0045776; P:negative regulation of blood pressure; IDA:UniProtKB.
DR   GO; GO:0030336; P:negative regulation of cell migration; ISS:UniProtKB.
DR   GO; GO:2000279; P:negative regulation of DNA biosynthetic process; IDA:UniProtKB.
DR   GO; GO:0070373; P:negative regulation of ERK1 and ERK2 cascade; IDA:UniProtKB.
DR   GO; GO:0045599; P:negative regulation of fat cell differentiation; IDA:BHF-UCL.
DR   GO; GO:0045721; P:negative regulation of gluconeogenesis; ISS:BHF-UCL.
DR   GO; GO:0030853; P:negative regulation of granulocyte differentiation; IDA:BHF-UCL.
DR   GO; GO:0034115; P:negative regulation of heterotypic cell-cell adhesion; IDA:BHF-UCL.
DR   GO; GO:0046888; P:negative regulation of hormone secretion; IEA:Ensembl.
DR   GO; GO:0043124; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; IDA:BHF-UCL.
DR   GO; GO:0050728; P:negative regulation of inflammatory response; ISS:UniProtKB.
DR   GO; GO:0090317; P:negative regulation of intracellular protein transport; IDA:UniProtKB.
DR   GO; GO:0045715; P:negative regulation of low-density lipoprotein particle receptor biosynthetic process; IDA:BHF-UCL.
DR   GO; GO:0010745; P:negative regulation of macrophage derived foam cell differentiation; IDA:BHF-UCL.
DR   GO; GO:0045650; P:negative regulation of macrophage differentiation; IDA:BHF-UCL.
DR   GO; GO:0043407; P:negative regulation of MAP kinase activity; ISS:UniProtKB.
DR   GO; GO:2000590; P:negative regulation of metanephric mesenchymal cell migration; ISS:UniProtKB.
DR   GO; GO:0050765; P:negative regulation of phagocytosis; IDA:BHF-UCL.
DR   GO; GO:0010642; P:negative regulation of platelet-derived growth factor receptor signaling pathway; IDA:UniProtKB.
DR   GO; GO:2000584; P:negative regulation of platelet-derived growth factor receptor-alpha signaling pathway; ISS:UniProtKB.
DR   GO; GO:0031953; P:negative regulation of protein autophosphorylation; IDA:UniProtKB.
DR   GO; GO:1900121; P:negative regulation of receptor binding; IDA:UniProtKB.
DR   GO; GO:0050805; P:negative regulation of synaptic transmission; IDA:UniProtKB.
DR   GO; GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB.
DR   GO; GO:0032720; P:negative regulation of tumor necrosis factor production; IDA:BHF-UCL.
DR   GO; GO:0010804; P:negative regulation of tumor necrosis factor-mediated signaling pathway; IDA:BHF-UCL.
DR   GO; GO:1904753; P:negative regulation of vascular associated smooth muscle cell migration; IDA:UniProtKB.
DR   GO; GO:1904706; P:negative regulation of vascular smooth muscle cell proliferation; IDA:UniProtKB.
DR   GO; GO:0045777; P:positive regulation of blood pressure; IEA:Ensembl.
DR   GO; GO:2000481; P:positive regulation of cAMP-dependent protein kinase activity; IDA:UniProtKB.
DR   GO; GO:0032270; P:positive regulation of cellular protein metabolic process; IDA:BHF-UCL.
DR   GO; GO:0010875; P:positive regulation of cholesterol efflux; IDA:BHF-UCL.
DR   GO; GO:0045923; P:positive regulation of fatty acid metabolic process; ISS:BHF-UCL.
DR   GO; GO:0046326; P:positive regulation of glucose import; ISS:BHF-UCL.
DR   GO; GO:2000467; P:positive regulation of glycogen (starch) synthase activity; ISS:UniProtKB.
DR   GO; GO:0043123; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; ISS:UniProtKB.
DR   GO; GO:0032757; P:positive regulation of interleukin-8 production; IDA:UniProtKB.
DR   GO; GO:2000478; P:positive regulation of metanephric glomerular visceral epithelial cell development; ISS:UniProtKB.
DR   GO; GO:0071639; P:positive regulation of monocyte chemotactic protein-1 production; IDA:UniProtKB.
DR   GO; GO:0033034; P:positive regulation of myeloid cell apoptotic process; IDA:BHF-UCL.
DR   GO; GO:0050731; P:positive regulation of peptidyl-tyrosine phosphorylation; IEA:Ensembl.
DR   GO; GO:0010739; P:positive regulation of protein kinase A signaling; IDA:BHF-UCL.
DR   GO; GO:0001934; P:positive regulation of protein phosphorylation; IDA:UniProtKB.
DR   GO; GO:2000534; P:positive regulation of renal albumin absorption; IDA:UniProtKB.
DR   GO; GO:0009967; P:positive regulation of signal transduction; ISS:BHF-UCL.
DR   GO; GO:0070208; P:protein heterotrimerization; IEA:Ensembl.
DR   GO; GO:0051260; P:protein homooligomerization; ISS:UniProtKB.
DR   GO; GO:0072659; P:protein localization to plasma membrane; IDA:UniProtKB.
DR   GO; GO:0042304; P:regulation of fatty acid biosynthetic process; TAS:Reactome.
DR   GO; GO:0010906; P:regulation of glucose metabolic process; IDA:UniProtKB.
DR   GO; GO:0014823; P:response to activity; IEA:Ensembl.
DR   GO; GO:0045471; P:response to ethanol; IEA:Ensembl.
DR   GO; GO:0051384; P:response to glucocorticoid; IEA:Ensembl.
DR   GO; GO:0009749; P:response to glucose; ISS:BHF-UCL.
DR   GO; GO:0001666; P:response to hypoxia; IEA:Ensembl.
DR   GO; GO:0070543; P:response to linoleic acid; IEA:Ensembl.
DR   GO; GO:0007584; P:response to nutrient; IEA:Ensembl.
DR   GO; GO:0009744; P:response to sucrose; IEA:Ensembl.
DR   GO; GO:0034612; P:response to tumor necrosis factor; IDA:BHF-UCL.
DR   Gene3D; 2.60.120.40; -; 1.
DR   InterPro; IPR001073; C1q_dom.
DR   InterPro; IPR008160; Collagen.
DR   InterPro; IPR008983; Tumour_necrosis_fac-like_dom.
DR   Pfam; PF00386; C1q; 1.
DR   Pfam; PF01391; Collagen; 1.
DR   PRINTS; PR00007; COMPLEMNTC1Q.
DR   SMART; SM00110; C1Q; 1.
DR   SUPFAM; SSF49842; SSF49842; 1.
DR   PROSITE; PS50871; C1Q; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Collagen; Complete proteome; Diabetes mellitus;
KW   Direct protein sequencing; Disease mutation; Disulfide bond;
KW   Glycoprotein; Hormone; Hydroxylation; Obesity; Pharmaceutical;
KW   Polymorphism; Reference proteome; Repeat; Secreted; Signal.
FT   SIGNAL        1     18       {ECO:0000269|PubMed:15340161,
FT                                ECO:0000269|PubMed:8947845}.
FT   CHAIN        19    244       Adiponectin.
FT                                /FTId=PRO_0000003543.
FT   DOMAIN       42    107       Collagen-like.
FT   DOMAIN      108    244       C1q. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00368}.
FT   SITE         62     62       Not hydroxylated.
FT                                {ECO:0000269|PubMed:16497731}.
FT   SITE         86     86       Not hydroxylated.
FT                                {ECO:0000269|PubMed:16497731}.
FT   SITE        104    104       Not hydroxylated.
FT                                {ECO:0000269|PubMed:16497731}.
FT   SITE        230    230       Not glycosylated.
FT                                {ECO:0000269|PubMed:16497731}.
FT   MOD_RES      33     33       5-hydroxylysine.
FT                                {ECO:0000250|UniProtKB:Q3Y5Z3}.
FT   MOD_RES      44     44       4-hydroxyproline.
FT                                {ECO:0000269|PubMed:16497731}.
FT   MOD_RES      47     47       4-hydroxyproline.
FT                                {ECO:0000269|PubMed:16497731}.
FT   MOD_RES      53     53       4-hydroxyproline.
FT                                {ECO:0000269|PubMed:16497731}.
FT   MOD_RES      65     65       5-hydroxylysine.
FT                                {ECO:0000269|PubMed:16497731}.
FT   MOD_RES      68     68       5-hydroxylysine.
FT                                {ECO:0000269|PubMed:16497731}.
FT   MOD_RES      71     71       4-hydroxyproline; partial.
FT                                {ECO:0000269|PubMed:16497731}.
FT   MOD_RES      76     76       4-hydroxyproline; partial.
FT                                {ECO:0000269|PubMed:16497731}.
FT   MOD_RES      77     77       5-hydroxylysine.
FT                                {ECO:0000269|PubMed:16497731}.
FT   MOD_RES      91     91       4-hydroxyproline.
FT                                {ECO:0000269|PubMed:16497731}.
FT   MOD_RES      95     95       4-hydroxyproline; partial.
FT                                {ECO:0000269|PubMed:16497731}.
FT   MOD_RES     101    101       5-hydroxylysine.
FT                                {ECO:0000269|PubMed:16497731}.
FT   CARBOHYD     21     21       O-linked (GalNAc...) threonine.
FT                                {ECO:0000269|PubMed:19855092}.
FT   CARBOHYD     22     22       O-linked (GalNAc...) threonine.
FT                                {ECO:0000269|PubMed:19855092}.
FT   CARBOHYD     65     65       O-linked (Gal...) hydroxylysine; partial.
FT                                {ECO:0000269|PubMed:16497731}.
FT   CARBOHYD     68     68       O-linked (Gal...) hydroxylysine; partial.
FT                                {ECO:0000269|PubMed:16497731}.
FT   CARBOHYD     77     77       O-linked (Gal...) hydroxylysine; partial.
FT                                {ECO:0000269|PubMed:16497731}.
FT   CARBOHYD    101    101       O-linked (Gal...) hydroxylysine; partial.
FT                                {ECO:0000269|PubMed:16497731}.
FT   DISULFID     36     36       Interchain; in form MMW and form HMW.
FT                                {ECO:0000269|PubMed:12878598,
FT                                ECO:0000269|PubMed:16497731}.
FT   VARIANT      84     84       G -> R (does not form high molecular
FT                                weight multimers; dbSNP:rs199646033).
FT                                {ECO:0000269|PubMed:11812766,
FT                                ECO:0000269|PubMed:12354786,
FT                                ECO:0000269|PubMed:12878598}.
FT                                /FTId=VAR_013273.
FT   VARIANT      90     90       G -> S (does not form high molecular
FT                                weight multimers; dbSNP:rs62625753).
FT                                {ECO:0000269|PubMed:12354786,
FT                                ECO:0000269|PubMed:12878598}.
FT                                /FTId=VAR_027395.
FT   VARIANT     111    111       Y -> H (in dbSNP:rs17366743).
FT                                {ECO:0000269|PubMed:12354786}.
FT                                /FTId=VAR_027396.
FT   VARIANT     112    112       R -> C (in ADPND; does not assemble into
FT                                trimers resulting in impaired secretion
FT                                from the cell; dbSNP:rs121917815).
FT                                {ECO:0000269|PubMed:10918532,
FT                                ECO:0000269|PubMed:12086969,
FT                                ECO:0000269|PubMed:12878598}.
FT                                /FTId=VAR_013274.
FT   VARIANT     117    117       V -> M (in dbSNP:rs747223144).
FT                                {ECO:0000269|PubMed:11812766}.
FT                                /FTId=VAR_013275.
FT   VARIANT     164    164       I -> T (associated with low plasma
FT                                adiponectin concentration and diabetes
FT                                mellitus type 2; does not assemble into
FT                                trimers resulting in impaired secretion
FT                                from the cell; dbSNP:rs185847354).
FT                                {ECO:0000269|PubMed:11812766,
FT                                ECO:0000269|PubMed:12086969,
FT                                ECO:0000269|PubMed:12878598}.
FT                                /FTId=VAR_013276.
FT   VARIANT     221    221       R -> S (in dbSNP:rs138773406).
FT                                {ECO:0000269|PubMed:11812766,
FT                                ECO:0000269|PubMed:12086969}.
FT                                /FTId=VAR_013277.
FT   VARIANT     241    241       H -> P (in dbSNP:rs141205818).
FT                                {ECO:0000269|PubMed:11812766,
FT                                ECO:0000269|PubMed:12086969}.
FT                                /FTId=VAR_013278.
FT   MUTAGEN      20     20       T->A: No change in sialylated isoforms.
FT                                {ECO:0000269|PubMed:19855092}.
FT   MUTAGEN      21     21       T->A: Some loss of sialylated isoforms.
FT                                {ECO:0000269|PubMed:19855092}.
FT   MUTAGEN      22     22       T->A: Abolishes sialylated isoforms.
FT                                {ECO:0000269|PubMed:19855092}.
FT   MUTAGEN      33     33       K->R: No effect on formation of HMW
FT                                multimers. {ECO:0000269|PubMed:16497731}.
FT   MUTAGEN      36     36       C->S: Impaired formation of MMW and HMW
FT                                multimers. {ECO:0000269|PubMed:12878598,
FT                                ECO:0000269|PubMed:16497731}.
FT   MUTAGEN      65     65       K->R: Impaired formation of HMW
FT                                multimers; when associated with R-68.
FT                                {ECO:0000269|PubMed:16497731}.
FT   MUTAGEN      68     68       K->R: Impaired formation of HMW
FT                                multimers; when associated with R-65.
FT                                {ECO:0000269|PubMed:16497731}.
FT   MUTAGEN      77     77       K->R: Impaired formation of HMW
FT                                multimers; when associated with R-101.
FT                                {ECO:0000269|PubMed:16497731}.
FT   MUTAGEN     101    101       K->R: Impaired formation of HMW
FT                                multimers; when associated with R-77.
FT                                {ECO:0000269|PubMed:16497731}.
FT   STRAND      114    118       {ECO:0000244|PDB:4DOU}.
FT   STRAND      134    137       {ECO:0000244|PDB:4DOU}.
FT   TURN        145    147       {ECO:0000244|PDB:4DOU}.
FT   STRAND      156    177       {ECO:0000244|PDB:4DOU}.
FT   STRAND      180    187       {ECO:0000244|PDB:4DOU}.
FT   STRAND      195    205       {ECO:0000244|PDB:4DOU}.
FT   STRAND      210    217       {ECO:0000244|PDB:4DOU}.
FT   STRAND      222    225       {ECO:0000244|PDB:4DOU}.
FT   STRAND      233    241       {ECO:0000244|PDB:4DOU}.
SQ   SEQUENCE   244 AA;  26414 MW;  64D8C6C1204B1018 CRC64;
     MLLLGAVLLL LALPGHDQET TTQGPGVLLP LPKGACTGWM AGIPGHPGHN GAPGRDGRDG
     TPGEKGEKGD PGLIGPKGDI GETGVPGAEG PRGFPGIQGR KGEPGEGAYV YRSAFSVGLE
     TYVTIPNMPI RFTKIFYNQQ NHYDGSTGKF HCNIPGLYYF AYHITVYMKD VKVSLFKKDK
     AMLFTYDQYQ ENNVDQASGS VLLHLEVGDQ VWLQVYGEGE RNGLYADNDN DSTFTGFLLY
     HDTN
//
ID   SYT11_HUMAN             Reviewed;         431 AA.
AC   Q9BT88; Q14998; Q5W0D4; Q68CT5; Q8IXU3; Q96SU2;
DT   18-OCT-2001, integrated into UniProtKB/Swiss-Prot.
DT   25-NOV-2008, sequence version 2.
DT   23-MAY-2018, entry version 159.
DE   RecName: Full=Synaptotagmin-11;
DE   AltName: Full=Synaptotagmin XI;
DE            Short=SytXI;
GN   Name=SYT11; Synonyms=KIAA0080;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT HIS-48.
RC   TISSUE=Bone marrow;
RX   PubMed=7584044; DOI=10.1093/dnares/1.5.223;
RA   Nomura N., Nagase T., Miyajima N., Sazuka T., Tanaka A., Sato S.,
RA   Seki N., Kawarabayasi Y., Ishikawa K., Tabata S.;
RT   "Prediction of the coding sequences of unidentified human genes. II.
RT   The coding sequences of 40 new genes (KIAA0041-KIAA0080) deduced by
RT   analysis of cDNA clones from human cell line KG-1.";
RL   DNA Res. 1:223-229(1994).
RN   [2]
RP   SEQUENCE REVISION.
RA   Ohara O., Nagase T., Kikuno R., Nomura N.;
RL   Submitted (JAN-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT HIS-48.
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT HIS-48.
RC   TISSUE=Amygdala;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANTS HIS-48 AND
RP   VAL-231.
RC   TISSUE=Brain, and Lymph;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   INTERACTION WITH PRKN, UBIQUITINATION, AND SUBCELLULAR LOCATION.
RX   PubMed=12925569; DOI=10.1093/hmg/ddg269;
RA   Huynh D.P., Scoles D.R., Nguyen D., Pulst S.M.;
RT   "The autosomal recessive juvenile Parkinson disease gene product,
RT   parkin, interacts with and ubiquitinates synaptotagmin XI.";
RL   Hum. Mol. Genet. 12:2587-2597(2003).
CC   -!- FUNCTION: May be involved in Ca(2+)-dependent exocytosis of
CC       secretory vesicles through Ca(2+) and phospholipid binding to the
CC       C2 domain or may serve as Ca(2+) sensors in the process of
CC       vesicular trafficking and exocytosis. {ECO:0000250}.
CC   -!- COFACTOR:
CC       Name=Ca(2+); Xref=ChEBI:CHEBI:29108; Evidence={ECO:0000250};
CC       Note=Binds 3 Ca(2+) ions per subunit. The ions are bound to the C2
CC       domains. {ECO:0000250};
CC   -!- SUBUNIT: Homodimer. Can also form heterodimers (By similarity).
CC       Interacts with PRKN. {ECO:0000250, ECO:0000269|PubMed:12925569}.
CC   -!- INTERACTION:
CC       Q92624:APPBP2; NbExp=3; IntAct=EBI-751770, EBI-743771;
CC       Q9NQ11:ATP13A2; NbExp=2; IntAct=EBI-751770, EBI-6308763;
CC       O43765:SGTA; NbExp=6; IntAct=EBI-751770, EBI-347996;
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000269|PubMed:12925569};
CC       Single-pass membrane protein {ECO:0000269|PubMed:12925569}. Cell
CC       junction, synapse {ECO:0000250}. Cytoplasmic vesicle, secretory
CC       vesicle, synaptic vesicle membrane {ECO:0000250}; Single-pass
CC       membrane protein {ECO:0000250}. Note=In substantia nigra, observed
CC       in neuronal cell bodies and neurites. Found in the core of the
CC       Lewy bodies in the brain of sporadic Parkinson disease patients.
CC   -!- PTM: Ubiquitinated and targeted to the proteasome complex for
CC       degradation. {ECO:0000269|PubMed:12925569}.
CC   -!- SIMILARITY: Belongs to the synaptotagmin family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAA07527.2; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; D38522; BAA07527.2; ALT_INIT; mRNA.
DR   EMBL; AK027540; BAB55186.1; -; mRNA.
DR   EMBL; AK074931; BAC11300.1; -; mRNA.
DR   EMBL; CR749792; CAH18653.1; -; mRNA.
DR   EMBL; AL139128; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC004291; AAH04291.1; -; mRNA.
DR   EMBL; BC013690; AAH13690.1; -; mRNA.
DR   EMBL; BC039205; AAH39205.1; -; mRNA.
DR   CCDS; CCDS1122.1; -.
DR   RefSeq; NP_689493.3; NM_152280.4.
DR   UniGene; Hs.32984; -.
DR   ProteinModelPortal; Q9BT88; -.
DR   SMR; Q9BT88; -.
DR   BioGrid; 116815; 10.
DR   ELM; Q9BT88; -.
DR   IntAct; Q9BT88; 5.
DR   MINT; Q9BT88; -.
DR   STRING; 9606.ENSP00000357307; -.
DR   iPTMnet; Q9BT88; -.
DR   PhosphoSitePlus; Q9BT88; -.
DR   BioMuta; SYT11; -.
DR   DMDM; 215273917; -.
DR   EPD; Q9BT88; -.
DR   MaxQB; Q9BT88; -.
DR   PaxDb; Q9BT88; -.
DR   PeptideAtlas; Q9BT88; -.
DR   PRIDE; Q9BT88; -.
DR   DNASU; 23208; -.
DR   Ensembl; ENST00000368324; ENSP00000357307; ENSG00000132718.
DR   GeneID; 23208; -.
DR   KEGG; hsa:23208; -.
DR   UCSC; uc001fmg.4; human.
DR   CTD; 23208; -.
DR   DisGeNET; 23208; -.
DR   EuPathDB; HostDB:ENSG00000132718.8; -.
DR   GeneCards; SYT11; -.
DR   H-InvDB; HIX0001138; -.
DR   HGNC; HGNC:19239; SYT11.
DR   HPA; HPA064091; -.
DR   MIM; 608741; gene.
DR   neXtProt; NX_Q9BT88; -.
DR   OpenTargets; ENSG00000132718; -.
DR   PharmGKB; PA134898675; -.
DR   eggNOG; KOG1028; Eukaryota.
DR   eggNOG; ENOG410XRME; LUCA.
DR   GeneTree; ENSGT00760000118973; -.
DR   HOGENOM; HOG000232126; -.
DR   HOVERGEN; HBG005010; -.
DR   InParanoid; Q9BT88; -.
DR   KO; K19911; -.
DR   OMA; IKVDYGD; -.
DR   OrthoDB; EOG091G09ZN; -.
DR   PhylomeDB; Q9BT88; -.
DR   TreeFam; TF315600; -.
DR   Reactome; R-HSA-8856825; Cargo recognition for clathrin-mediated endocytosis.
DR   Reactome; R-HSA-8856828; Clathrin-mediated endocytosis.
DR   ChiTaRS; SYT11; human.
DR   GeneWiki; SYT11; -.
DR   GenomeRNAi; 23208; -.
DR   PRO; PR:Q9BT88; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000132718; -.
DR   CleanEx; HS_SYT11; -.
DR   Genevisible; Q9BT88; HS.
DR   GO; GO:0030424; C:axon; ISS:ParkinsonsUK-UCL.
DR   GO; GO:0044297; C:cell body; IEA:Ensembl.
DR   GO; GO:0030054; C:cell junction; IEA:UniProtKB-KW.
DR   GO; GO:0043197; C:dendritic spine; ISS:ParkinsonsUK-UCL.
DR   GO; GO:0032009; C:early phagosome; ISS:ParkinsonsUK-UCL.
DR   GO; GO:0060076; C:excitatory synapse; ISS:ParkinsonsUK-UCL.
DR   GO; GO:0060077; C:inhibitory synapse; ISS:ParkinsonsUK-UCL.
DR   GO; GO:0005887; C:integral component of plasma membrane; IEA:Ensembl.
DR   GO; GO:0005764; C:lysosome; IEA:Ensembl.
DR   GO; GO:0043005; C:neuron projection; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IEA:Ensembl.
DR   GO; GO:0001891; C:phagocytic cup; IEA:Ensembl.
DR   GO; GO:0045335; C:phagocytic vesicle; ISS:ParkinsonsUK-UCL.
DR   GO; GO:0005886; C:plasma membrane; IBA:GO_Central.
DR   GO; GO:0014069; C:postsynaptic density; ISS:ParkinsonsUK-UCL.
DR   GO; GO:0098793; C:presynapse; ISS:ParkinsonsUK-UCL.
DR   GO; GO:0048787; C:presynaptic active zone membrane; ISS:ParkinsonsUK-UCL.
DR   GO; GO:0055037; C:recycling endosome; IEA:Ensembl.
DR   GO; GO:0008021; C:synaptic vesicle; ISS:ParkinsonsUK-UCL.
DR   GO; GO:0030672; C:synaptic vesicle membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0043195; C:terminal bouton; IEA:Ensembl.
DR   GO; GO:0048487; F:beta-tubulin binding; IEA:Ensembl.
DR   GO; GO:0030276; F:clathrin binding; IBA:GO_Central.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0042803; F:protein homodimerization activity; ISS:ParkinsonsUK-UCL.
DR   GO; GO:0019905; F:syntaxin binding; IBA:GO_Central.
DR   GO; GO:0031369; F:translation initiation factor binding; IEA:Ensembl.
DR   GO; GO:0031625; F:ubiquitin protein ligase binding; IPI:ParkinsonsUK-UCL.
DR   GO; GO:1990927; P:calcium ion regulated lysosome exocytosis; ISS:ParkinsonsUK-UCL.
DR   GO; GO:0048791; P:calcium ion-regulated exocytosis of neurotransmitter; IBA:GO_Central.
DR   GO; GO:1905469; P:negative regulation of clathrin-coated pit assembly; IEA:Ensembl.
DR   GO; GO:1900186; P:negative regulation of clathrin-dependent endocytosis; IEA:Ensembl.
DR   GO; GO:1900165; P:negative regulation of interleukin-6 secretion; ISS:ParkinsonsUK-UCL.
DR   GO; GO:1905154; P:negative regulation of membrane invagination; IEA:Ensembl.
DR   GO; GO:0046929; P:negative regulation of neurotransmitter secretion; TAS:ParkinsonsUK-UCL.
DR   GO; GO:0050765; P:negative regulation of phagocytosis; IEA:Ensembl.
DR   GO; GO:1900243; P:negative regulation of synaptic vesicle endocytosis; IEA:Ensembl.
DR   GO; GO:1904468; P:negative regulation of tumor necrosis factor secretion; ISS:ParkinsonsUK-UCL.
DR   GO; GO:0001778; P:plasma membrane repair; ISS:ParkinsonsUK-UCL.
DR   GO; GO:1905171; P:positive regulation of protein localization to phagocytic vesicle; ISS:ParkinsonsUK-UCL.
DR   GO; GO:0051289; P:protein homotetramerization; ISS:ParkinsonsUK-UCL.
DR   GO; GO:1900424; P:regulation of defense response to bacterium; IEA:Ensembl.
DR   GO; GO:1905162; P:regulation of phagosome maturation; IC:ParkinsonsUK-UCL.
DR   GO; GO:0006906; P:vesicle fusion; IBA:GO_Central.
DR   Gene3D; 2.60.40.150; -; 2.
DR   InterPro; IPR000008; C2_dom.
DR   InterPro; IPR035892; C2_domain_sf.
DR   InterPro; IPR001565; Synaptotagmin.
DR   InterPro; IPR028699; SYT11.
DR   PANTHER; PTHR10024:SF115; PTHR10024:SF115; 1.
DR   Pfam; PF00168; C2; 2.
DR   PRINTS; PR00399; SYNAPTOTAGMN.
DR   SMART; SM00239; C2; 2.
DR   PROSITE; PS50004; C2; 2.
PE   1: Evidence at protein level;
KW   Calcium; Cell junction; Complete proteome; Cytoplasmic vesicle;
KW   Membrane; Metal-binding; Phosphoprotein; Polymorphism;
KW   Reference proteome; Repeat; Synapse; Transmembrane;
KW   Transmembrane helix; Ubl conjugation.
FT   CHAIN         1    431       Synaptotagmin-11.
FT                                /FTId=PRO_0000183969.
FT   TOPO_DOM      1     15       Vesicular. {ECO:0000255}.
FT   TRANSMEM     16     36       Helical. {ECO:0000255}.
FT   TOPO_DOM     37    431       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN      174    262       C2 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00041}.
FT   DOMAIN      304    397       C2 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00041}.
FT   METAL       188    188       Calcium 1. {ECO:0000250}.
FT   METAL       188    188       Calcium 2. {ECO:0000250}.
FT   METAL       195    195       Calcium 1. {ECO:0000250}.
FT   METAL       249    249       Calcium 1; via carbonyl oxygen.
FT                                {ECO:0000250}.
FT   METAL       250    250       Calcium 1. {ECO:0000250}.
FT   METAL       250    250       Calcium 2. {ECO:0000250}.
FT   METAL       250    250       Calcium 3. {ECO:0000250}.
FT   METAL       253    253       Calcium 3. {ECO:0000250}.
FT   METAL       256    256       Calcium 2. {ECO:0000250}.
FT   METAL       256    256       Calcium 3. {ECO:0000250}.
FT   MOD_RES     134    134       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q9R0N3}.
FT   VARIANT      48     48       Q -> H (in dbSNP:rs822522).
FT                                {ECO:0000269|PubMed:14702039,
FT                                ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|PubMed:17974005,
FT                                ECO:0000269|PubMed:7584044}.
FT                                /FTId=VAR_047656.
FT   VARIANT     231    231       G -> V (in dbSNP:rs17853892).
FT                                {ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_047657.
FT   CONFLICT     50     50       N -> S (in Ref. 3; BAB55186).
FT                                {ECO:0000305}.
FT   CONFLICT    268    268       V -> A (in Ref. 3; BAB55186).
FT                                {ECO:0000305}.
FT   CONFLICT    359    359       F -> L (in Ref. 4; CAH18653).
FT                                {ECO:0000305}.
FT   CONFLICT    370    370       D -> G (in Ref. 4; CAH18653).
FT                                {ECO:0000305}.
SQ   SEQUENCE   431 AA;  48297 MW;  5C8667D2C23D758E CRC64;
     MAEITNIRPS FDVSPVVAGL IGASVLVVCV SVTVFVWSCC HQQAEKKQKN PPYKFIHMLK
     GISIYPETLS NKKKIIKVRR DKDGPGREGG RRNLLVDAAE AGLLSRDKDP RGPSSGSCID
     QLPIKMDYGE ELRSPITSLT PGESKTTSPS SPEEDVMLGS LTFSVDYNFP KKALVVTIQE
     AHGLPVMDDQ TQGSDPYIKM TILPDKRHRV KTRVLRKTLD PVFDETFTFY GIPYSQLQDL
     VLHFLVLSFD RFSRDDVIGE VMVPLAGVDP STGKVQLTRD IIKRNIQKCI SRGELQVSLS
     YQPVAQRMTV VVLKARHLPK MDITGLSGNP YVKVNVYYGR KRIAKKKTHV KKCTLNPIFN
     ESFIYDIPTD LLPDISIEFL VIDFDRTTKN EVVGRLILGA HSVTASGAEH WREVCESPRK
     PVAKWHSLSE Y
//
ID   TR13B_HUMAN             Reviewed;         293 AA.
AC   O14836; B2R8B0; B7Z6V8; Q32LX4; Q7Z6F5;
DT   27-MAY-2002, integrated into UniProtKB/Swiss-Prot.
DT   01-JAN-1998, sequence version 1.
DT   23-MAY-2018, entry version 156.
DE   RecName: Full=Tumor necrosis factor receptor superfamily member 13B;
DE   AltName: Full=Transmembrane activator and CAML interactor;
DE   AltName: CD_antigen=CD267;
GN   Name=TNFRSF13B; Synonyms=TACI;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=B-cell;
RX   PubMed=9311921; DOI=10.1126/science.278.5335.138;
RA   von Buelow G.-U., Bram R.J.;
RT   "NF-AT activation induced by a CAML-interacting member of the tumor
RT   necrosis factor receptor superfamily.";
RL   Science 278:138-141(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RA   Zhou G., Ke R., Li H., Zheng G., Shen C., Lin L., Yang S.;
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 3), AND VARIANT
RP   LEU-251.
RC   TISSUE=Spleen;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   FUNCTION.
RX   PubMed=10956646; DOI=10.1074/jbc.M005224200;
RA   Wu Y., Bressette D., Carrell J.A., Kaufman T., Feng P., Taylor K.,
RA   Gan Y., Cho Y.H., Garcia A.D., Gollatz E., Dimke D., LaFleur D.,
RA   Migone T.S., Nardelli B., Wei P., Ruben S.M., Ullrich S.J.,
RA   Olsen H.S., Kanakaraj P., Moore P.A., Baker K.P.;
RT   "Tumor necrosis factor (TNF) receptor superfamily member TACI is a
RT   high affinity receptor for TNF family members APRIL and BLyS.";
RL   J. Biol. Chem. 275:35478-35485(2000).
RN   [7]
RP   FUNCTION.
RX   PubMed=10973284; DOI=10.1038/79802;
RA   Yu G., Boone T., Delaney J., Hawkins N., Kelley M.J., Ramakrishnan M.,
RA   McCabe S., Qiu W.R., Kornuc M., Xia X.-Z., Guo J., Stolina M.,
RA   Boyle W.J., Sarosi I., Hsu H., Senaldi G., Theill L.E.;
RT   "APRIL and TALL-I and receptors BCMA and TACI: system for regulating
RT   humoral immunity.";
RL   Nat. Immunol. 1:252-256(2000).
RN   [8]
RP   INTERACTION WITH TRAF2 AND TRAF5.
RX   PubMed=10880535; DOI=10.1084/jem.192.1.137;
RA   Xia X.-Z., Treanor J., Senaldi G., Khare S.D., Boone T., Kelley M.,
RA   Theill L.E., Colombero A., Solovyev I., Lee F., McCabe S., Elliott R.,
RA   Miner K., Hawkins N., Guo J., Stolina M., Yu G., Wang J., Delaney J.,
RA   Meng S.-Y., Boyle W.J., Hsu H.;
RT   "TACI is a TRAF-interacting receptor for TALL-1, a tumor necrosis
RT   factor family member involved in B cell regulation.";
RL   J. Exp. Med. 192:137-143(2000).
RN   [9]
RP   X-RAY CRYSTALLOGRAPHY (1.9 ANGSTROMS) OF 68-109 IN COMPLEX WITH MOUSE
RP   TNFSF13, AND STRUCTURE BY NMR OF 68-109.
RX   PubMed=15542592; DOI=10.1074/jbc.M411714200;
RA   Hymowitz S.G., Patel D.R., Wallweber H.J., Runyon S., Yan M., Yin J.,
RA   Shriver S.K., Gordon N.C., Pan B., Skelton N.J., Kelley R.F.,
RA   Starovasnik M.A.;
RT   "Structures of APRIL-receptor complexes: like BCMA, TACI employs only
RT   a single cysteine-rich domain for high affinity ligand binding.";
RL   J. Biol. Chem. 280:7218-7227(2005).
RN   [10]
RP   VARIANT IGAD2 ARG-104, AND VARIANTS CVID2 ARG-104; GLY-181 AND
RP   HIS-202.
RX   PubMed=16007086; DOI=10.1038/ng1601;
RA   Castigli E., Wilson S.A., Garibyan L., Rachid R., Bonilla F.,
RA   Schneider L., Geha R.S.;
RT   "TACI is mutant in common variable immunodeficiency and IgA
RT   deficiency.";
RL   Nat. Genet. 37:829-834(2005).
RN   [11]
RP   VARIANT ASN-56.
RX   PubMed=21248752; DOI=10.1038/nature09639;
RA   Varela I., Tarpey P., Raine K., Huang D., Ong C.K., Stephens P.,
RA   Davies H., Jones D., Lin M.L., Teague J., Bignell G., Butler A.,
RA   Cho J., Dalgliesh G.L., Galappaththige D., Greenman C., Hardy C.,
RA   Jia M., Latimer C., Lau K.W., Marshall J., McLaren S., Menzies A.,
RA   Mudie L., Stebbings L., Largaespada D.A., Wessels L.F.A., Richard S.,
RA   Kahnoski R.J., Anema J., Tuveson D.A., Perez-Mancera P.A.,
RA   Mustonen V., Fischer A., Adams D.J., Rust A., Chan-On W., Subimerb C.,
RA   Dykema K., Furge K., Campbell P.J., Teh B.T., Stratton M.R.,
RA   Futreal P.A.;
RT   "Exome sequencing identifies frequent mutation of the SWI/SNF complex
RT   gene PBRM1 in renal carcinoma.";
RL   Nature 469:539-542(2011).
CC   -!- FUNCTION: Receptor for TNFSF13/APRIL and TNFSF13B/TALL1/BAFF/BLYS
CC       that binds both ligands with similar high affinity. Mediates
CC       calcineurin-dependent activation of NF-AT, as well as activation
CC       of NF-kappa-B and AP-1. Involved in the stimulation of B- and T-
CC       cell function and the regulation of humoral immunity.
CC       {ECO:0000269|PubMed:10956646, ECO:0000269|PubMed:10973284}.
CC   -!- SUBUNIT: Binds TRAF2, TRAF5 and TRAF6. Binds the NH2-terminal
CC       domain of CAMLG with its C-terminus.
CC       {ECO:0000269|PubMed:15542592}.
CC   -!- INTERACTION:
CC       Q99836:MYD88; NbExp=12; IntAct=EBI-519160, EBI-447677;
CC       O43765:SGTA; NbExp=5; IntAct=EBI-12023110, EBI-347996;
CC       Q9Y275:TNFSF13B; NbExp=7; IntAct=EBI-519160, EBI-519169;
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type III membrane
CC       protein.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=O14836-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=O14836-2; Sequence=VSP_013798;
CC       Name=3;
CC         IsoId=O14836-3; Sequence=VSP_054184, VSP_054185;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Highly expressed in spleen, thymus, small
CC       intestine and peripheral blood leukocytes. Expressed in resting B-
CC       cells and activated T-cells, but not in resting T-cells.
CC   -!- DISEASE: Immunodeficiency, common variable, 2 (CVID2)
CC       [MIM:240500]: A primary immunodeficiency characterized by antibody
CC       deficiency, hypogammaglobulinemia, recurrent bacterial infections
CC       and an inability to mount an antibody response to antigen. The
CC       defect results from a failure of B-cell differentiation and
CC       impaired secretion of immunoglobulins; the numbers of circulating
CC       B-cells is usually in the normal range, but can be low.
CC       {ECO:0000269|PubMed:16007086}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Immunoglobulin A deficiency 2 (IGAD2) [MIM:609529]:
CC       Selective deficiency of immunoglobulin A (IGAD) is the most common
CC       form of primary immunodeficiency, with an incidence of
CC       approximately 1 in 600 individuals in the western world.
CC       Individuals with symptomatic IGAD often have deficiency of IgG
CC       subclasses or decreased antibody response to carbohydrate antigens
CC       such as pneumococcal polysaccharide vaccine. Individuals with IGAD
CC       also suffer from recurrent sinopulmonary and gastrointestinal
CC       infections and have an increased incidence of autoimmune disorders
CC       and of lymphoid and non-lymphoid malignancies. In vitro studies
CC       have suggested that some individuals with IGAD have impaired
CC       isotype class switching to IgA and others may have a post-switch
CC       defect. IGAD and CVID have been known to coexist in families. Some
CC       individuals initially present with IGAD1 and then develop CVID.
CC       These observations suggest that some cases of IGAD and CVID may
CC       have a common etiology. {ECO:0000269|PubMed:16007086}. Note=The
CC       disease is caused by mutations affecting the gene represented in
CC       this entry.
CC   -!- WEB RESOURCE: Name=TNFRSF13Bbase; Note=TNFRSF13B mutation db;
CC       URL="http://structure.bmc.lu.se/idbase/TNFRSF13Bbase/";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF023614; AAC51790.1; -; mRNA.
DR   EMBL; AY302137; AAP57629.1; -; mRNA.
DR   EMBL; AK301032; BAH13394.1; -; mRNA.
DR   EMBL; AK313302; BAG36107.1; -; mRNA.
DR   EMBL; CH471196; EAW55729.1; -; Genomic_DNA.
DR   EMBL; BC109392; AAI09393.1; -; mRNA.
DR   CCDS; CCDS11181.1; -. [O14836-1]
DR   RefSeq; NP_036584.1; NM_012452.2. [O14836-1]
DR   UniGene; Hs.158341; -.
DR   PDB; 1XU1; X-ray; 1.90 A; R/S/T=68-109.
DR   PDB; 1XUT; NMR; -; A=68-109.
DR   PDBsum; 1XU1; -.
DR   PDBsum; 1XUT; -.
DR   ProteinModelPortal; O14836; -.
DR   SMR; O14836; -.
DR   BioGrid; 117046; 36.
DR   DIP; DIP-6224N; -.
DR   IntAct; O14836; 12.
DR   STRING; 9606.ENSP00000261652; -.
DR   iPTMnet; O14836; -.
DR   PhosphoSitePlus; O14836; -.
DR   SwissPalm; O14836; -.
DR   BioMuta; TNFRSF13B; -.
DR   PaxDb; O14836; -.
DR   PeptideAtlas; O14836; -.
DR   PRIDE; O14836; -.
DR   Ensembl; ENST00000261652; ENSP00000261652; ENSG00000240505. [O14836-1]
DR   Ensembl; ENST00000583789; ENSP00000462952; ENSG00000240505. [O14836-2]
DR   GeneID; 23495; -.
DR   KEGG; hsa:23495; -.
DR   UCSC; uc002gqt.2; human. [O14836-1]
DR   CTD; 23495; -.
DR   DisGeNET; 23495; -.
DR   EuPathDB; HostDB:ENSG00000240505.8; -.
DR   GeneCards; TNFRSF13B; -.
DR   GeneReviews; TNFRSF13B; -.
DR   H-InvDB; HIX0173687; -.
DR   HGNC; HGNC:18153; TNFRSF13B.
DR   HPA; HPA030453; -.
DR   MalaCards; TNFRSF13B; -.
DR   MIM; 240500; phenotype.
DR   MIM; 604907; gene.
DR   MIM; 609529; phenotype.
DR   neXtProt; NX_O14836; -.
DR   OpenTargets; ENSG00000240505; -.
DR   Orphanet; 1572; Common variable immunodeficiency.
DR   Orphanet; 69127; Immunoglobulin A deficiency.
DR   PharmGKB; PA38509; -.
DR   eggNOG; ENOG410IHJ8; Eukaryota.
DR   eggNOG; ENOG410Z545; LUCA.
DR   GeneTree; ENSGT00390000013910; -.
DR   HOGENOM; HOG000273905; -.
DR   HOVERGEN; HBG058015; -.
DR   InParanoid; O14836; -.
DR   KO; K05150; -.
DR   OMA; CHTRTTV; -.
DR   OrthoDB; EOG091G0ISO; -.
DR   PhylomeDB; O14836; -.
DR   TreeFam; TF337993; -.
DR   Reactome; R-HSA-5669034; TNFs bind their physiological receptors.
DR   SignaLink; O14836; -.
DR   SIGNOR; O14836; -.
DR   ChiTaRS; TNFRSF13B; human.
DR   EvolutionaryTrace; O14836; -.
DR   GeneWiki; TNFRSF13B; -.
DR   GenomeRNAi; 23495; -.
DR   PRO; PR:O14836; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   Bgee; ENSG00000240505; -.
DR   CleanEx; HS_TNFRSF13B; -.
DR   ExpressionAtlas; O14836; baseline and differential.
DR   Genevisible; O14836; HS.
DR   GO; GO:0005887; C:integral component of plasma membrane; TAS:ProtInc.
DR   GO; GO:0005886; C:plasma membrane; IBA:GO_Central.
DR   GO; GO:0038023; F:signaling receptor activity; TAS:ProtInc.
DR   GO; GO:0002250; P:adaptive immune response; IEA:UniProtKB-KW.
DR   GO; GO:0001782; P:B cell homeostasis; IBA:GO_Central.
DR   GO; GO:0007166; P:cell surface receptor signaling pathway; TAS:ProtInc.
DR   GO; GO:0002244; P:hematopoietic progenitor cell differentiation; IBA:GO_Central.
DR   GO; GO:0030889; P:negative regulation of B cell proliferation; IBA:GO_Central.
DR   GO; GO:0033209; P:tumor necrosis factor-mediated signaling pathway; TAS:Reactome.
DR   CDD; cd13415; TNFRSF13B; 1.
DR   InterPro; IPR015384; TACI_Cys-rich-dom.
DR   InterPro; IPR022317; TNFR_13B.
DR   PANTHER; PTHR15511; PTHR15511; 1.
DR   Pfam; PF09305; TACI-CRD2; 2.
DR   PRINTS; PR01963; TNFACTORR13B.
DR   PROSITE; PS00652; TNFR_NGFR_1; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Adaptive immunity; Alternative splicing;
KW   Complete proteome; Disease mutation; Disulfide bond; Glycoprotein;
KW   Immunity; Membrane; Polymorphism; Receptor; Reference proteome;
KW   Repeat; Signal-anchor; Transmembrane; Transmembrane helix.
FT   CHAIN         1    293       Tumor necrosis factor receptor
FT                                superfamily member 13B.
FT                                /FTId=PRO_0000058931.
FT   TOPO_DOM      1    165       Extracellular. {ECO:0000255}.
FT   TRANSMEM    166    186       Helical; Signal-anchor for type III
FT                                membrane protein. {ECO:0000255}.
FT   TOPO_DOM    187    293       Cytoplasmic. {ECO:0000255}.
FT   REPEAT       33     67       TNFR-Cys 1.
FT   REPEAT       70    104       TNFR-Cys 2.
FT   CARBOHYD    128    128       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID     34     47       {ECO:0000250}.
FT   DISULFID     50     62       {ECO:0000250}.
FT   DISULFID     54     66       {ECO:0000250}.
FT   DISULFID     71     86
FT   DISULFID     89    100
FT   DISULFID     93    104
FT   VAR_SEQ      21     67       FPQGLWTGVAMRSCPEEQYWDPLLGTCMSCKTICNHQSQRT
FT                                CAAFCR -> W (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|Ref.2}.
FT                                /FTId=VSP_013798.
FT   VAR_SEQ     150    176       LPGLKLSADQVALVYSTLGLCLCAVLC -> PRGCPAPGTR
FT                                KSFWDKENFQGEGFHLG (in isoform 3).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_054184.
FT   VAR_SEQ     177    293       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_054185.
FT   VARIANT      56     56       H -> N (found in a renal cell carcinoma
FT                                sample; somatic mutation).
FT                                {ECO:0000269|PubMed:21248752}.
FT                                /FTId=VAR_064758.
FT   VARIANT     104    104       C -> R (in CVID2 and IGAD2;
FT                                dbSNP:rs34557412).
FT                                {ECO:0000269|PubMed:16007086}.
FT                                /FTId=VAR_024027.
FT   VARIANT     181    181       A -> G (in CVID2).
FT                                {ECO:0000269|PubMed:16007086}.
FT                                /FTId=VAR_024028.
FT   VARIANT     202    202       R -> H (in CVID2; dbSNP:rs104894649).
FT                                {ECO:0000269|PubMed:16007086}.
FT                                /FTId=VAR_024029.
FT   VARIANT     251    251       P -> L (in dbSNP:rs34562254).
FT                                {ECO:0000269|PubMed:14702039}.
FT                                /FTId=VAR_052353.
FT   HELIX        73     75       {ECO:0000244|PDB:1XU1}.
FT   STRAND       77     80       {ECO:0000244|PDB:1XU1}.
FT   TURN         81     84       {ECO:0000244|PDB:1XU1}.
FT   STRAND       85     88       {ECO:0000244|PDB:1XU1}.
FT   HELIX        89     92       {ECO:0000244|PDB:1XU1}.
FT   HELIX        98    100       {ECO:0000244|PDB:1XU1}.
FT   HELIX       101    104       {ECO:0000244|PDB:1XU1}.
SQ   SEQUENCE   293 AA;  31816 MW;  411799F3DE17A5EB CRC64;
     MSGLGRSRRG GRSRVDQEER FPQGLWTGVA MRSCPEEQYW DPLLGTCMSC KTICNHQSQR
     TCAAFCRSLS CRKEQGKFYD HLLRDCISCA SICGQHPKQC AYFCENKLRS PVNLPPELRR
     QRSGEVENNS DNSGRYQGLE HRGSEASPAL PGLKLSADQV ALVYSTLGLC LCAVLCCFLV
     AVACFLKKRG DPCSCQPRSR PRQSPAKSSQ DHAMEAGSPV STSPEPVETC SFCFPECRAP
     TQESAVTPGT PDPTCAGRWG CHTRTTVLQP CPHIPDSGLG IVCVPAQEGG PGA
//
ID   Q4ACX1_HUMAN            Unreviewed;       293 AA.
AC   Q4ACX1;
DT   13-SEP-2005, integrated into UniProtKB/TrEMBL.
DT   13-SEP-2005, sequence version 1.
DT   23-MAY-2018, entry version 106.
DE   SubName: Full=TACI {ECO:0000313|EMBL:BAE16555.1};
DE   SubName: Full=Tumor necrosis factor receptor superfamily, member 13B {ECO:0000313|EMBL:ABK41894.1};
DE   SubName: Full=Tumor necrosis factor receptor superfamily, member 13B, isoform CRA_a {ECO:0000313|EMBL:EAW55728.1};
GN   Name=TACI {ECO:0000313|EMBL:BAE16555.1};
GN   Synonyms=TNFRSF13B {ECO:0000313|EMBL:ABK41894.1};
GN   ORFNames=hCG_28297 {ECO:0000313|EMBL:EAW55728.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAE16555.1};
RN   [1] {ECO:0000313|EMBL:EAW55728.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:BAE16555.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Kawasaki A., Tsuchiya N., Kusaoi M., Murakami Y., Fukazawa T.,
RA   Matsuta K., Hashimoto H., Tokunaga K.;
RT   "New polymorphisms of human BAFF-R gene.";
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3] {ECO:0000313|EMBL:BAE16555.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Kawasaki A., Tsuchiya N., Kusaoi M., Murakami T., Fukazawa T.,
RA   Matsuta H., Hashimoto H., Tokunaga K.;
RT   "New polymorphisms of human TACI gene.";
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4] {ECO:0000313|EMBL:EAW55728.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5] {ECO:0000313|EMBL:ABK41894.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Livingston R.J., Shaffer T., McFarland I., Nguyen C.P., Stanaway I.B.,
RA   Rajkumar N., Johnson E.J., da Ponte S.H., Willa H., Ahearn M.O.,
RA   Bertucci C., Acklestad J., Carroll A., Swanson J., Gildersleeve H.I.,
RA   Nickerson D.A.;
RL   Submitted (OCT-2006) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; EF064711; ABK41894.1; -; Genomic_DNA.
DR   EMBL; AB222991; BAE16555.1; -; Genomic_DNA.
DR   EMBL; CH471196; EAW55728.1; -; Genomic_DNA.
DR   RefSeq; NP_036584.1; NM_012452.2.
DR   UniGene; Hs.158341; -.
DR   SMR; Q4ACX1; -.
DR   MaxQB; Q4ACX1; -.
DR   GeneID; 23495; -.
DR   KEGG; hsa:23495; -.
DR   UCSC; uc002gqs.2; human.
DR   CTD; 23495; -.
DR   EuPathDB; HostDB:ENSG00000240505.8; -.
DR   PharmGKB; PA38509; -.
DR   eggNOG; ENOG410IHJ8; Eukaryota.
DR   eggNOG; ENOG410Z545; LUCA.
DR   HOVERGEN; HBG058015; -.
DR   KO; K05150; -.
DR   OMA; CHTRTTV; -.
DR   OrthoDB; EOG091G0ISO; -.
DR   ChiTaRS; TNFRSF13B; human.
DR   GenomeRNAi; 23495; -.
DR   Bgee; ENSG00000240505; -.
DR   ExpressionAtlas; Q4ACX1; baseline and differential.
DR   GO; GO:0005887; C:integral component of plasma membrane; IEA:InterPro.
DR   CDD; cd13415; TNFRSF13B; 1.
DR   InterPro; IPR015384; TACI_Cys-rich-dom.
DR   InterPro; IPR022317; TNFR_13B.
DR   PANTHER; PTHR15511; PTHR15511; 1.
DR   Pfam; PF09305; TACI-CRD2; 2.
DR   PRINTS; PR01963; TNFACTORR13B.
PE   4: Predicted;
KW   Membrane {ECO:0000256|SAM:Phobius};
KW   Receptor {ECO:0000313|EMBL:ABK41894.1};
KW   Transmembrane {ECO:0000256|SAM:Phobius};
KW   Transmembrane helix {ECO:0000256|SAM:Phobius}.
FT   TRANSMEM    161    186       Helical. {ECO:0000256|SAM:Phobius}.
FT   DOMAIN       37     67       TACI-CRD2. {ECO:0000259|Pfam:PF09305}.
FT   DOMAIN       69    107       TACI-CRD2. {ECO:0000259|Pfam:PF09305}.
SQ   SEQUENCE   293 AA;  31816 MW;  411799F3DE17A5EB CRC64;
     MSGLGRSRRG GRSRVDQEER FPQGLWTGVA MRSCPEEQYW DPLLGTCMSC KTICNHQSQR
     TCAAFCRSLS CRKEQGKFYD HLLRDCISCA SICGQHPKQC AYFCENKLRS PVNLPPELRR
     QRSGEVENNS DNSGRYQGLE HRGSEASPAL PGLKLSADQV ALVYSTLGLC LCAVLCCFLV
     AVACFLKKRG DPCSCQPRSR PRQSPAKSSQ DHAMEAGSPV STSPEPVETC SFCFPECRAP
     TQESAVTPGT PDPTCAGRWG CHTRTTVLQP CPHIPDSGLG IVCVPAQEGG PGA
//
ID   A0A024QZD6_HUMAN        Unreviewed;       262 AA.
AC   A0A024QZD6;
DT   09-JUL-2014, integrated into UniProtKB/TrEMBL.
DT   09-JUL-2014, sequence version 1.
DT   23-MAY-2018, entry version 30.
DE   SubName: Full=Linker for activation of T cells, isoform CRA_f {ECO:0000313|EMBL:EAW52030.1};
GN   Name=LAT {ECO:0000313|EMBL:EAW52030.1};
GN   ORFNames=hCG_2039637 {ECO:0000313|EMBL:EAW52030.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:EAW52030.1};
RN   [1] {ECO:0000313|EMBL:EAW52030.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAW52030.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; CH471267; EAW52029.1; -; Genomic_DNA.
DR   EMBL; CH471267; EAW52030.1; -; Genomic_DNA.
DR   RefSeq; NP_055202.1; NM_014387.3.
DR   UniGene; Hs.632179; -.
DR   GeneID; 27040; -.
DR   KEGG; hsa:27040; -.
DR   CTD; 27040; -.
DR   EuPathDB; HostDB:ENSG00000213658.10; -.
DR   KO; K07362; -.
DR   OMA; GSHRMPS; -.
DR   GenomeRNAi; 27040; -.
DR   Bgee; ENSG00000213658; -.
DR   ExpressionAtlas; A0A024QZD6; baseline and differential.
DR   GO; GO:0005794; C:Golgi apparatus; IDA:HPA.
DR   GO; GO:0005886; C:plasma membrane; IDA:HPA.
DR   GO; GO:0007165; P:signal transduction; IEA:InterPro.
DR   InterPro; IPR008359; Linker_for_activat_Tcells_prot.
DR   PANTHER; PTHR15586; PTHR15586; 1.
DR   Pfam; PF15234; LAT; 1.
DR   PRINTS; PR01781; LATPROTEIN.
PE   4: Predicted;
SQ   SEQUENCE   262 AA;  27930 MW;  BCD80AE7DCA64153 CRC64;
     MEEAILVPCV LGLLLLPILA MLMALCVHCH RLPGSYDSTS SDSLYPRGIQ FKRPHTVAPW
     PPAYPPVTSY PPLSQPDLLP IPRSPQPLGG SHRTPSSRRD SDGANSVASY ENEGASGIRG
     AQAGWGVWGP SWTRLTPVSL PPEPACEDAD EDEDDYHNPG YLVVLPDSTP ATSTAAPSAP
     ALSTPGIRDS AFSMESIDDY VNVPESGESA EASLDGSREY VNVSQELHPG AAKTEPAALS
     SQEAEEVEEE GAPDYENLQE LN
//
ID   LAT_HUMAN               Reviewed;         262 AA.
AC   O43561; B7WPI0; C7C5T6; G5E9K3; O43919;
DT   01-JUN-2001, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-1998, sequence version 1.
DT   23-MAY-2018, entry version 168.
DE   RecName: Full=Linker for activation of T-cells family member 1;
DE   AltName: Full=36 kDa phospho-tyrosine adapter protein;
DE            Short=pp36;
DE   AltName: Full=p36-38;
GN   Name=LAT;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2), PROTEIN SEQUENCE OF
RP   32-47 AND 219-233, PHOSPHORYLATION AT TYR-200, IDENTIFICATION BY MASS
RP   SPECTROMETRY, MUTAGENESIS OF TYR-200 AND TYR-220, TISSUE SPECIFICITY,
RP   SUBCELLULAR LOCATION, AND INTERACTION WITH PIK3R1; GRB2; GRAP AND
RP   PLCG1.
RC   TISSUE=Leukemia;
RX   PubMed=9489702; DOI=10.1016/S0092-8674(00)80901-0;
RA   Zhang W., Sloan-Lancaster J., Kitchen J., Trible R.P., Samelson L.E.;
RT   "LAT: the ZAP-70 tyrosine kinase substrate that links T cell receptor
RT   to cellular activation.";
RL   Cell 92:83-92(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RC   TISSUE=Thymus;
RX   PubMed=9529333; DOI=10.1084/jem.187.7.1157;
RA   Weber J.R., Orstavik S., Torgersen K.M., Danbolt N.C., Berg S.F.,
RA   Ryan J.C., Tasken K., Imboden J.B., Vaage J.T.;
RT   "Molecular cloning of the cDNA encoding pp36, a tyrosine-
RT   phosphorylated adaptor protein selectively expressed by T cells and
RT   natural killer cells.";
RL   J. Exp. Med. 187:1157-1161(1998).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 5).
RC   TISSUE=Bone marrow;
RA   Muschen M.;
RT   "Inactivation of pre-B cell receptor-mediated tumor suppression by
RT   aberrant splicing in Ph+ acute lymphoblastic leukemia.";
RL   Submitted (JUL-2009) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15616553; DOI=10.1038/nature03187;
RA   Martin J., Han C., Gordon L.A., Terry A., Prabhakar S., She X.,
RA   Xie G., Hellsten U., Chan Y.M., Altherr M., Couronne O., Aerts A.,
RA   Bajorek E., Black S., Blumer H., Branscomb E., Brown N.C., Bruno W.J.,
RA   Buckingham J.M., Callen D.F., Campbell C.S., Campbell M.L.,
RA   Campbell E.W., Caoile C., Challacombe J.F., Chasteen L.A.,
RA   Chertkov O., Chi H.C., Christensen M., Clark L.M., Cohn J.D.,
RA   Denys M., Detter J.C., Dickson M., Dimitrijevic-Bussod M., Escobar J.,
RA   Fawcett J.J., Flowers D., Fotopulos D., Glavina T., Gomez M.,
RA   Gonzales E., Goodstein D., Goodwin L.A., Grady D.L., Grigoriev I.,
RA   Groza M., Hammon N., Hawkins T., Haydu L., Hildebrand C.E., Huang W.,
RA   Israni S., Jett J., Jewett P.B., Kadner K., Kimball H., Kobayashi A.,
RA   Krawczyk M.-C., Leyba T., Longmire J.L., Lopez F., Lou Y., Lowry S.,
RA   Ludeman T., Manohar C.F., Mark G.A., McMurray K.L., Meincke L.J.,
RA   Morgan J., Moyzis R.K., Mundt M.O., Munk A.C., Nandkeshwar R.D.,
RA   Pitluck S., Pollard M., Predki P., Parson-Quintana B., Ramirez L.,
RA   Rash S., Retterer J., Ricke D.O., Robinson D.L., Rodriguez A.,
RA   Salamov A., Saunders E.H., Scott D., Shough T., Stallings R.L.,
RA   Stalvey M., Sutherland R.D., Tapia R., Tesmer J.G., Thayer N.,
RA   Thompson L.S., Tice H., Torney D.C., Tran-Gyamfi M., Tsai M.,
RA   Ulanovsky L.E., Ustaszewska A., Vo N., White P.S., Williams A.L.,
RA   Wills P.L., Wu J.-R., Wu K., Yang J., DeJong P., Bruce D.,
RA   Doggett N.A., Deaven L., Schmutz J., Grimwood J., Richardson P.,
RA   Rokhsar D.S., Eichler E.E., Gilna P., Lucas S.M., Myers R.M.,
RA   Rubin E.M., Pennacchio L.A.;
RT   "The sequence and analysis of duplication-rich human chromosome 16.";
RL   Nature 432:988-994(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Colon;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   SUBCELLULAR LOCATION, PALMITOYLATION AT CYS-26 AND CYS-29, AND
RP   MUTAGENESIS OF CYS-26 AND CYS-29.
RX   PubMed=9729044; DOI=10.1016/S1074-7613(00)80606-8;
RA   Zhang W., Trible R.P., Samelson L.E.;
RT   "LAT palmitoylation: its essential role in membrane microdomain
RT   targeting and tyrosine phosphorylation during T cell activation.";
RL   Immunity 9:239-246(1998).
RN   [8]
RP   INTERACTION WITH SHB.
RX   PubMed=10488157; DOI=10.1074/jbc.274.39.28050;
RA   Lindholm C.K., Gylfe E., Zhang W., Samelson L.E., Welsh M.;
RT   "Requirement of the Src homology 2 domain protein Shb for T cell
RT   receptor-dependent activation of the interleukin-2 gene nuclear factor
RT   for activation of T cells element in Jurkat T cells.";
RL   J. Biol. Chem. 274:28050-28057(1999).
RN   [9]
RP   FUNCTION IN NK CELLS, AND INTERACTION WITH PLCG1.
RX   PubMed=10072481;
RA   Jevremovic D., Billadeau D.D., Schoon R.A., Dick C.J., Irvin B.J.,
RA   Zhang W., Samelson L.E., Abraham R.T., Leibson P.J.;
RT   "A role for the adaptor protein LAT in human NK cell-mediated
RT   cytotoxicity.";
RL   J. Immunol. 162:2453-2456(1999).
RN   [10]
RP   INTERACTION WITH GRB2; GRAP2 AND PLCG1.
RX   PubMed=10811803; DOI=10.1074/jbc.M000404200;
RA   Zhang W., Trible R.P., Zhu M., Liu S.K., McGlade C.J., Samelson L.E.;
RT   "Association of Grb2, Gads, and phospholipase C-gamma 1 with
RT   phosphorylated LAT tyrosine residues. Effect of LAT tyrosine mutations
RT   on T cell antigen receptor-mediated signaling.";
RL   J. Biol. Chem. 275:23355-23361(2000).
RN   [11]
RP   INTERACTION WITH FCGR1A.
RX   PubMed=10781611; DOI=10.1074/jbc.M909462199;
RA   Tridandapani S., Lyden T.W., Smith J.L., Carter J.E., Coggeshall K.M.,
RA   Anderson C.L.;
RT   "The adapter protein LAT enhances fcgamma receptor-mediated signal
RT   transduction in myeloid cells.";
RL   J. Biol. Chem. 275:20480-20487(2000).
RN   [12]
RP   PHOSPHORYLATION, AND INTERACTION WITH LCP2; SKAP2; GRB2; PLCG2 AND
RP   CBL.
RX   PubMed=10942756; DOI=10.1074/jbc.M001439200;
RA   Asazuma N., Wilde J.I., Berlanga O., Leduc M., Leo A.,
RA   Schweighoffer E., Tybulewicz V., Bon C., Liu S.K., McGlade C.J.,
RA   Schraven B., Watson S.P.;
RT   "Interaction of linker for activation of T cells with multiple adapter
RT   proteins in platelets activated by the glycoprotein VI-selective
RT   ligand, convulxin.";
RL   J. Biol. Chem. 275:33427-33434(2000).
RN   [13]
RP   INTERACTION WITH PIK3R1 AND PLCG1, AND MUTAGENESIS OF TYR-161.
RX   PubMed=11368773; DOI=10.1042/0264-6021:3560461;
RA   Paz P.E., Wang S., Clarke H., Lu X., Stokoe D., Abo A.;
RT   "Mapping the Zap-70 phosphorylation sites on LAT (linker for
RT   activation of T cells) required for recruitment and activation of
RT   signalling proteins in T cells.";
RL   Biochem. J. 356:461-471(2001).
RN   [14]
RP   PROBABLE DEPHOSPHORYLATION BY PTPRJ.
RX   PubMed=11259588; DOI=10.1128/MCB.21.7.2393-2403.2001;
RA   Baker J.E., Majeti R., Tangye S.G., Weiss A.;
RT   "Protein tyrosine phosphatase CD148-mediated inhibition of T-cell
RT   receptor signal transduction is associated with reduced LAT and
RT   phospholipase Cgamma1 phosphorylation.";
RL   Mol. Cell. Biol. 21:2393-2403(2001).
RN   [15]
RP   PHOSPHORYLATION BY ITK.
RX   PubMed=12186560; DOI=10.1021/bi025554o;
RA   Perez-Villar J.J., Whitney G.S., Sitnick M.T., Dunn R.J.,
RA   Venkatesan S., O'Day K., Schieven G.L., Lin T.A., Kanner S.B.;
RT   "Phosphorylation of the linker for activation of T-cells by Itk
RT   promotes recruitment of Vav.";
RL   Biochemistry 41:10732-10740(2002).
RN   [16]
RP   PROBABLE DEPHOSPHORYLATION BY PTPRJ.
RX   PubMed=12913111; DOI=10.1083/jcb.200303040;
RA   Lin J., Weiss A.;
RT   "The tyrosine phosphatase CD148 is excluded from the immunologic
RT   synapse and down-regulates prolonged T cell signaling.";
RL   J. Cell Biol. 162:673-682(2003).
RN   [17]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=15144186; DOI=10.1021/ac035352d;
RA   Brill L.M., Salomon A.R., Ficarro S.B., Mukherji M., Stettler-Gill M.,
RA   Peters E.C.;
RT   "Robust phosphoproteomic profiling of tyrosine phosphorylation sites
RT   from human T cells using immobilized metal affinity chromatography and
RT   tandem mass spectrometry.";
RL   Anal. Chem. 76:2763-2772(2004).
RN   [18]
RP   REVIEW ON FUNCTION IN T-CELLS.
RX   PubMed=14696041; DOI=10.1002/bies.10384;
RA   Sommers C.L., Samelson L.E., Love P.E.;
RT   "LAT: a T lymphocyte adapter protein that couples the antigen receptor
RT   to downstream signaling pathways.";
RL   Bioessays 26:61-67(2004).
RN   [19]
RP   TISSUE SPECIFICITY.
RX   PubMed=16160011; DOI=10.1182/blood-2005-06-2273;
RA   Tedoldi S., Paterson J.C., Hansmann M.-L., Natkunam Y., Rudiger T.,
RA   Angelisova P., Du M.Q., Roberton H., Roncador G., Sanchez L.,
RA   Pozzobon M., Masir N., Barry R., Pileri S., Mason D.Y., Marafioti T.,
RA   Horejsi V.;
RT   "Transmembrane adaptor molecules: a new category of lymphoid-cell
RT   markers.";
RL   Blood 107:213-221(2006).
RN   [20]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-84; SER-101 AND SER-224,
RP   AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Platelet;
RX   PubMed=18088087; DOI=10.1021/pr0704130;
RA   Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J.,
RA   Schuetz C., Walter U., Gambaryan S., Sickmann A.;
RT   "Phosphoproteome of resting human platelets.";
RL   J. Proteome Res. 7:526-534(2008).
RN   [21]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-39; SER-40; SER-41;
RP   SER-43; SER-101; SER-106; SER-240; SER-241 AND TYR-255, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [22]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [23]
RP   INVOLVEMENT IN IMD52.
RX   PubMed=27242165; DOI=10.1084/jem.20151110;
RA   Keller B., Zaidman I., Yousefi O.S., Hershkovitz D., Stein J.,
RA   Unger S., Schachtrup K., Sigvardsson M., Kuperman A.A., Shaag A.,
RA   Schamel W.W., Elpeleg O., Warnatz K., Stepensky P.;
RT   "Early onset combined immunodeficiency and autoimmunity in patients
RT   with loss-of-function mutation in LAT.";
RL   J. Exp. Med. 213:1185-1199(2016).
RN   [24]
RP   INVOLVEMENT IN IMD52.
RX   PubMed=27522155; DOI=10.1016/j.jaci.2016.05.036;
RA   Bacchelli C., Moretti F.A., Carmo M., Adams S., Stanescu H.C.,
RA   Pearce K., Madkaikar M., Gilmour K.C., Nicholas A.K., Woods C.G.,
RA   Kleta R., Beales P.L., Qasim W., Gaspar H.B.;
RT   "Mutations in linker for activation of T cells (LAT) lead to a novel
RT   form of severe combined immunodeficiency.";
RL   J. Allergy Clin. Immunol. 139:634-642(2017).
CC   -!- FUNCTION: Required for TCR (T-cell antigen receptor)- and pre-TCR-
CC       mediated signaling, both in mature T-cells and during their
CC       development. Involved in FCGR3 (low affinity immunoglobulin gamma
CC       Fc region receptor III)-mediated signaling in natural killer cells
CC       and FCER1 (high affinity immunoglobulin epsilon receptor)-mediated
CC       signaling in mast cells. Couples activation of these receptors and
CC       their associated kinases with distal intracellular events such as
CC       mobilization of intracellular calcium stores, PKC activation, MAPK
CC       activation or cytoskeletal reorganization through the recruitment
CC       of PLCG1, GRB2, GRAP2, and other signaling molecules.
CC       {ECO:0000269|PubMed:10072481}.
CC   -!- SUBUNIT: When phosphorylated, interacts directly with the PIK3R1
CC       subunit of phosphoinositide 3-kinase and the SH2 domains of GRB2,
CC       GRAP, GRAP2, PLCG1 and PLCG2. Interacts indirectly with CBL, SOS,
CC       VAV, and LCP2. Interacts with SHB, SKAP2 and CLNK (By similarity).
CC       Interacts with FCGR1A. Interacts with GRB2, PLCG1 and THEMIS upon
CC       TCR activation in thymocytes (By similarity). {ECO:0000250}.
CC   -!- INTERACTION:
CC       P00533:EGFR; NbExp=2; IntAct=EBI-1222766, EBI-297353;
CC       P62993:GRB2; NbExp=7; IntAct=EBI-1222766, EBI-401755;
CC       P62993-1:GRB2; NbExp=3; IntAct=EBI-8070286, EBI-15787932;
CC       P06239:LCK; NbExp=2; IntAct=EBI-1222766, EBI-1348;
CC       P50222:MEOX2; NbExp=4; IntAct=EBI-8070286, EBI-748397;
CC       P27986:PIK3R1; NbExp=4; IntAct=EBI-1222766, EBI-79464;
CC       P08487:PLCG1 (xeno); NbExp=4; IntAct=EBI-8070286, EBI-8013886;
CC       P19174:PLCG1; NbExp=7; IntAct=EBI-1222766, EBI-79387;
CC       P18031:PTPN1; NbExp=3; IntAct=EBI-1222766, EBI-968788;
CC       O43765:SGTA; NbExp=3; IntAct=EBI-1222766, EBI-347996;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:9489702,
CC       ECO:0000269|PubMed:9729044}; Single-pass type III membrane protein
CC       {ECO:0000269|PubMed:9489702, ECO:0000269|PubMed:9729044}.
CC       Note=Present in lipid rafts.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=5;
CC       Name=1; Synonyms=Long;
CC         IsoId=O43561-1; Sequence=Displayed;
CC       Name=2; Synonyms=Short;
CC         IsoId=O43561-2; Sequence=VSP_004303;
CC       Name=3;
CC         IsoId=O43561-3; Sequence=VSP_054758, VSP_004303;
CC         Note=Gene prediction based on EST data.;
CC       Name=4;
CC         IsoId=O43561-4; Sequence=VSP_054759, VSP_004303;
CC       Name=5;
CC         IsoId=O43561-5; Sequence=VSP_054759;
CC   -!- TISSUE SPECIFICITY: Expressed in thymus, T-cells, NK cells, mast
CC       cells and, at lower levels, in spleen. Present in T-cells but not
CC       B-cells (at protein level). {ECO:0000269|PubMed:16160011,
CC       ECO:0000269|PubMed:9489702}.
CC   -!- PTM: Phosphorylated on tyrosines by ZAP70 upon TCR activation, or
CC       by SYK upon other immunoreceptor activation; which leads to the
CC       recruitment of multiple signaling molecules. Is one of the most
CC       prominently tyrosine-phosphorylated proteins detected following
CC       TCR engagement. May be dephosphorylated by PTPRJ. Phosphorylated
CC       by ITK leading to the recruitment of VAV1 to LAT-containing
CC       complexes.
CC   -!- PTM: Palmitoylation of Cys-26 and Cys-29 is required for raft
CC       targeting and efficient phosphorylation.
CC       {ECO:0000269|PubMed:9729044}.
CC   -!- DISEASE: Immunodeficiency 52 (IMD52) [MIM:617514]: An autosomal
CC       recessive primary immunodeficiency characterized by T-cell
CC       abnormalities, resulting in severe combined immunodeficiency,
CC       autoimmune disease, progressive lymphopenia and
CC       hypogammaglobulinemia, and lymphoproliferation with splenomegaly.
CC       Patients develop severe recurrent infections from infancy.
CC       {ECO:0000269|PubMed:27242165, ECO:0000269|PubMed:27522155}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- MISCELLANEOUS: Engagement of killer inhibitory receptors (KIR)
CC       disrupts the interaction of PLCG1 with LAT and blocks target cell-
CC       induced activation of PLC, maybe by inducing the dephosphorylation
CC       of LAT.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF036906; AAC39637.1; -; mRNA.
DR   EMBL; AF036905; AAC39636.1; -; mRNA.
DR   EMBL; AJ223280; CAA11218.1; -; mRNA.
DR   EMBL; FN432832; CBA11533.1; -; mRNA.
DR   EMBL; AC109460; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471267; EAW52027.1; -; Genomic_DNA.
DR   EMBL; CH471267; EAW52028.1; -; Genomic_DNA.
DR   EMBL; BC011563; AAH11563.1; -; mRNA.
DR   CCDS; CCDS10647.1; -. [O43561-1]
DR   CCDS; CCDS32425.1; -. [O43561-2]
DR   CCDS; CCDS45455.1; -. [O43561-4]
DR   CCDS; CCDS53999.1; -. [O43561-3]
DR   RefSeq; NP_001014987.1; NM_001014987.1. [O43561-2]
DR   RefSeq; NP_001014988.1; NM_001014988.1. [O43561-4]
DR   RefSeq; NP_001014989.2; NM_001014989.1. [O43561-3]
DR   RefSeq; NP_055202.1; NM_014387.3. [O43561-1]
DR   UniGene; Hs.632179; -.
DR   ProteinModelPortal; O43561; -.
DR   BioGrid; 117971; 40.
DR   CORUM; O43561; -.
DR   DIP; DIP-29231N; -.
DR   IntAct; O43561; 36.
DR   MINT; O43561; -.
DR   ChEMBL; CHEMBL5779; -.
DR   iPTMnet; O43561; -.
DR   PhosphoSitePlus; O43561; -.
DR   SwissPalm; O43561; -.
DR   BioMuta; LAT; -.
DR   MaxQB; O43561; -.
DR   PeptideAtlas; O43561; -.
DR   PRIDE; O43561; -.
DR   Ensembl; ENST00000360872; ENSP00000354119; ENSG00000213658. [O43561-1]
DR   Ensembl; ENST00000395456; ENSP00000378841; ENSG00000213658. [O43561-2]
DR   Ensembl; ENST00000395461; ENSP00000378845; ENSG00000213658. [O43561-3]
DR   Ensembl; ENST00000454369; ENSP00000398793; ENSG00000213658. [O43561-4]
DR   Ensembl; ENST00000564277; ENSP00000457036; ENSG00000213658. [O43561-4]
DR   Ensembl; ENST00000566177; ENSP00000456761; ENSG00000213658. [O43561-5]
DR   GeneID; 27040; -.
DR   KEGG; hsa:27040; -.
DR   UCSC; uc002dsb.4; human. [O43561-1]
DR   CTD; 27040; -.
DR   DisGeNET; 27040; -.
DR   EuPathDB; HostDB:ENSG00000213658.10; -.
DR   GeneCards; LAT; -.
DR   HGNC; HGNC:18874; LAT.
DR   HPA; CAB002223; -.
DR   HPA; CAB012978; -.
DR   HPA; HPA011157; -.
DR   MalaCards; LAT; -.
DR   MIM; 602354; gene.
DR   MIM; 617514; phenotype.
DR   neXtProt; NX_O43561; -.
DR   OpenTargets; ENSG00000213658; -.
DR   PharmGKB; PA38728; -.
DR   GeneTree; ENSGT00390000014223; -.
DR   HOGENOM; HOG000081810; -.
DR   HOVERGEN; HBG018198; -.
DR   InParanoid; O43561; -.
DR   KO; K07362; -.
DR   OMA; GSHRMPS; -.
DR   OrthoDB; EOG091G0QKO; -.
DR   PhylomeDB; O43561; -.
DR   Reactome; R-HSA-114604; GPVI-mediated activation cascade.
DR   Reactome; R-HSA-202433; Generation of second messenger molecules.
DR   Reactome; R-HSA-2424491; DAP12 signaling.
DR   Reactome; R-HSA-2454202; Fc epsilon receptor (FCERI) signaling.
DR   Reactome; R-HSA-2871796; FCERI mediated MAPK activation.
DR   Reactome; R-HSA-2871809; FCERI mediated Ca+2 mobilization.
DR   Reactome; R-HSA-5673001; RAF/MAP kinase cascade.
DR   SignaLink; O43561; -.
DR   SIGNOR; O43561; -.
DR   GeneWiki; Linker_of_activated_T_cells; -.
DR   GenomeRNAi; 27040; -.
DR   PRO; PR:O43561; -.
DR   Proteomes; UP000005640; Chromosome 16.
DR   Bgee; ENSG00000213658; -.
DR   CleanEx; HS_LAT; -.
DR   ExpressionAtlas; O43561; baseline and differential.
DR   Genevisible; O43561; HS.
DR   GO; GO:0005911; C:cell-cell junction; IEA:Ensembl.
DR   GO; GO:0008180; C:COP9 signalosome; ISS:UniProtKB.
DR   GO; GO:0005794; C:Golgi apparatus; IDA:HPA.
DR   GO; GO:0001772; C:immunological synapse; IDA:HGNC.
DR   GO; GO:0016021; C:integral component of membrane; IDA:HGNC.
DR   GO; GO:0042629; C:mast cell granule; IEA:GOC.
DR   GO; GO:0045121; C:membrane raft; TAS:HGNC.
DR   GO; GO:0005886; C:plasma membrane; IDA:HPA.
DR   GO; GO:0019901; F:protein kinase binding; IPI:UniProtKB.
DR   GO; GO:0005088; F:Ras guanyl-nucleotide exchange factor activity; TAS:Reactome.
DR   GO; GO:0005070; F:SH3/SH2 adaptor activity; IDA:HGNC.
DR   GO; GO:0002250; P:adaptive immune response; IEA:UniProtKB-KW.
DR   GO; GO:0019722; P:calcium-mediated signaling; IMP:HGNC.
DR   GO; GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome.
DR   GO; GO:0010467; P:gene expression; IEA:Ensembl.
DR   GO; GO:0006955; P:immune response; IDA:HGNC.
DR   GO; GO:0006954; P:inflammatory response; IEA:Ensembl.
DR   GO; GO:0007229; P:integrin-mediated signaling pathway; IDA:HGNC.
DR   GO; GO:0035556; P:intracellular signal transduction; IDA:HGNC.
DR   GO; GO:0002260; P:lymphocyte homeostasis; IEA:Ensembl.
DR   GO; GO:0000165; P:MAPK cascade; TAS:Reactome.
DR   GO; GO:0043303; P:mast cell degranulation; IEA:UniProtKB-KW.
DR   GO; GO:0045860; P:positive regulation of protein kinase activity; IEP:CACAO.
DR   GO; GO:0007265; P:Ras protein signal transduction; IMP:HGNC.
DR   GO; GO:0050863; P:regulation of T cell activation; IMP:HGNC.
DR   GO; GO:0042110; P:T cell activation; TAS:UniProtKB.
DR   GO; GO:0050852; P:T cell receptor signaling pathway; TAS:Reactome.
DR   InterPro; IPR008359; Linker_for_activat_Tcells_prot.
DR   PANTHER; PTHR15586; PTHR15586; 1.
DR   Pfam; PF15234; LAT; 1.
DR   PRINTS; PR01781; LATPROTEIN.
PE   1: Evidence at protein level;
KW   Adaptive immunity; Alternative splicing; Cell membrane;
KW   Complete proteome; Direct protein sequencing; Immunity; Lipoprotein;
KW   Mast cell degranulation; Membrane; Palmitate; Phosphoprotein;
KW   Reference proteome; Signal-anchor; Transmembrane; Transmembrane helix.
FT   CHAIN         1    262       Linker for activation of T-cells family
FT                                member 1.
FT                                /FTId=PRO_0000083325.
FT   TOPO_DOM      1      4       Extracellular. {ECO:0000255}.
FT   TRANSMEM      5     27       Helical; Signal-anchor for type III
FT                                membrane protein. {ECO:0000255}.
FT   TOPO_DOM     28    262       Cytoplasmic. {ECO:0000255}.
FT   REGION      161    164       Interaction with PLCG1.
FT   REGION      200    203       Interaction with GRB2, GRAP2 and PIK3R1.
FT                                {ECO:0000269|PubMed:10811803}.
FT   REGION      220    223       Interaction with GRB2, GRAP2 and PIK3R1.
FT                                {ECO:0000269|PubMed:10811803}.
FT   MOD_RES      39     39       Phosphothreonine.
FT                                {ECO:0000244|PubMed:19690332}.
FT   MOD_RES      40     40       Phosphoserine.
FT                                {ECO:0000244|PubMed:19690332}.
FT   MOD_RES      41     41       Phosphoserine.
FT                                {ECO:0000244|PubMed:19690332}.
FT   MOD_RES      43     43       Phosphoserine.
FT                                {ECO:0000244|PubMed:19690332}.
FT   MOD_RES      84     84       Phosphoserine.
FT                                {ECO:0000244|PubMed:18088087}.
FT   MOD_RES     101    101       Phosphoserine.
FT                                {ECO:0000244|PubMed:18088087,
FT                                ECO:0000244|PubMed:19690332}.
FT   MOD_RES     106    106       Phosphoserine.
FT                                {ECO:0000244|PubMed:19690332}.
FT   MOD_RES     109    109       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:O54957}.
FT   MOD_RES     110    110       Phosphotyrosine. {ECO:0000305}.
FT   MOD_RES     156    156       Phosphotyrosine. {ECO:0000305}.
FT   MOD_RES     161    161       Phosphotyrosine. {ECO:0000305}.
FT   MOD_RES     200    200       Phosphotyrosine.
FT                                {ECO:0000269|PubMed:9489702}.
FT   MOD_RES     220    220       Phosphotyrosine. {ECO:0000305}.
FT   MOD_RES     224    224       Phosphoserine.
FT                                {ECO:0000244|PubMed:18088087}.
FT   MOD_RES     240    240       Phosphoserine.
FT                                {ECO:0000244|PubMed:19690332}.
FT   MOD_RES     241    241       Phosphoserine.
FT                                {ECO:0000244|PubMed:19690332}.
FT   MOD_RES     255    255       Phosphotyrosine.
FT                                {ECO:0000244|PubMed:19690332}.
FT   LIPID        26     26       S-palmitoyl cysteine.
FT                                {ECO:0000269|PubMed:9729044}.
FT   LIPID        29     29       S-palmitoyl cysteine.
FT                                {ECO:0000269|PubMed:9729044}.
FT   VAR_SEQ       1      1       M -> MEATAASWQVAVPVLGGASRPLGPRGAASLLRAPLQ
FT                                M (in isoform 3). {ECO:0000305}.
FT                                /FTId=VSP_054758.
FT   VAR_SEQ      83     83       Missing (in isoform 4 and isoform 5).
FT                                {ECO:0000303|Ref.3}.
FT                                /FTId=VSP_054759.
FT   VAR_SEQ     114    142       Missing (in isoform 2, isoform 3 and
FT                                isoform 4). {ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:9489702,
FT                                ECO:0000303|PubMed:9529333}.
FT                                /FTId=VSP_004303.
FT   MUTAGEN      26     26       C->A: Reduces palmitoylation; abolishes
FT                                localization to lipid rafts.
FT                                {ECO:0000269|PubMed:9729044}.
FT   MUTAGEN      29     29       C->A: Reduces palmitoylation; impairs
FT                                localization to lipid rafts.
FT                                {ECO:0000269|PubMed:9729044}.
FT   MUTAGEN     161    161       Y->F: Abolishes interaction with PLCG1.
FT                                {ECO:0000269|PubMed:11368773}.
FT   MUTAGEN     200    200       Y->F: Abolishes interaction with GRB2 and
FT                                PIK3R1; when associated with F-220.
FT                                {ECO:0000269|PubMed:9489702}.
FT   MUTAGEN     220    220       Y->F: Abolishes interaction with GRB2 and
FT                                PIK3R1; when associated with F-200.
FT                                {ECO:0000269|PubMed:9489702}.
SQ   SEQUENCE   262 AA;  27930 MW;  BCD80AE7DCA64153 CRC64;
     MEEAILVPCV LGLLLLPILA MLMALCVHCH RLPGSYDSTS SDSLYPRGIQ FKRPHTVAPW
     PPAYPPVTSY PPLSQPDLLP IPRSPQPLGG SHRTPSSRRD SDGANSVASY ENEGASGIRG
     AQAGWGVWGP SWTRLTPVSL PPEPACEDAD EDEDDYHNPG YLVVLPDSTP ATSTAAPSAP
     ALSTPGIRDS AFSMESIDDY VNVPESGESA EASLDGSREY VNVSQELHPG AAKTEPAALS
     SQEAEEVEEE GAPDYENLQE LN
//
ID   TXD12_HUMAN             Reviewed;         172 AA.
AC   O95881; B3KQS0; Q5T1T4; Q96H50;
DT   11-APR-2003, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-1999, sequence version 1.
DT   28-MAR-2018, entry version 159.
DE   RecName: Full=Thioredoxin domain-containing protein 12;
DE            EC=1.8.4.2;
DE   AltName: Full=Endoplasmic reticulum resident protein 18;
DE            Short=ER protein 18;
DE            Short=ERp18;
DE   AltName: Full=Endoplasmic reticulum resident protein 19;
DE            Short=ER protein 19;
DE            Short=ERp19;
DE   AltName: Full=Thioredoxin-like protein p19;
DE   AltName: Full=hTLP19;
DE   Flags: Precursor;
GN   Name=TXNDC12; Synonyms=TLP19; ORFNames=UNQ713/PRO1376;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND TISSUE SPECIFICITY.
RX   PubMed=14557066; DOI=10.1016/S0378-1119(03)00732-7;
RA   Liu F., Rong Y.P., Zeng L.C., Zhang X., Han Z.G.;
RT   "Isolation and characterization of a novel human thioredoxin-like gene
RT   hTLP19 encoding a secretory protein.";
RL   Gene 315:71-78(2003).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RA   Mei G., Yu W., Gibbs R.A.;
RL   Submitted (FEB-1999) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=12975309; DOI=10.1101/gr.1293003;
RA   Clark H.F., Gurney A.L., Abaya E., Baker K., Baldwin D.T., Brush J.,
RA   Chen J., Chow B., Chui C., Crowley C., Currell B., Deuel B., Dowd P.,
RA   Eaton D., Foster J.S., Grimaldi C., Gu Q., Hass P.E., Heldens S.,
RA   Huang A., Kim H.S., Klimowski L., Jin Y., Johnson S., Lee J.,
RA   Lewis L., Liao D., Mark M.R., Robbie E., Sanchez C., Schoenfeld J.,
RA   Seshagiri S., Simmons L., Singh J., Smith V., Stinson J., Vagts A.,
RA   Vandlen R.L., Watanabe C., Wieand D., Woods K., Xie M.-H.,
RA   Yansura D.G., Yi S., Yu G., Yuan J., Zhang M., Zhang Z., Goddard A.D.,
RA   Wood W.I., Godowski P.J., Gray A.M.;
RT   "The secreted protein discovery initiative (SPDI), a large-scale
RT   effort to identify novel human secreted and transmembrane proteins: a
RT   bioinformatics assessment.";
RL   Genome Res. 13:2265-2270(2003).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=16303743; DOI=10.1093/dnares/12.2.117;
RA   Otsuki T., Ota T., Nishikawa T., Hayashi K., Suzuki Y., Yamamoto J.,
RA   Wakamatsu A., Kimura K., Sakamoto K., Hatano N., Kawai Y., Ishii S.,
RA   Saito K., Kojima S., Sugiyama T., Ono T., Okano K., Yoshikawa Y.,
RA   Aotsuka S., Sasaki N., Hattori A., Okumura K., Nagai K., Sugano S.,
RA   Isogai T.;
RT   "Signal sequence and keyword trap in silico for selection of full-
RT   length human cDNAs encoding secretion or membrane proteins from oligo-
RT   capped cDNA libraries.";
RL   DNA Res. 12:117-126(2005).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Colon, Kidney, and Ovary;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   PROTEIN SEQUENCE OF 27-41.
RX   PubMed=15340161; DOI=10.1110/ps.04682504;
RA   Zhang Z., Henzel W.J.;
RT   "Signal peptide prediction based on analysis of experimentally
RT   verified cleavage sites.";
RL   Protein Sci. 13:2819-2824(2004).
RN   [8]
RP   FUNCTION, SUBCELLULAR LOCATION, DISULFIDE BOND, AND MUTAGENESIS OF
RP   CYS-66 AND CYS-69.
RX   PubMed=12761212; DOI=10.1074/jbc.M304598200;
RA   Alanen H.I., Williamson R.A., Howard M.J., Lappi A.-K., Jaentti H.P.,
RA   Rautio S.M., Kellokumpu S., Ruddock L.W.;
RT   "Functional characterization of ERp18, a new endoplasmic reticulum-
RT   located thioredoxin superfamily member.";
RL   J. Biol. Chem. 278:28912-28920(2003).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [12]
RP   STRUCTURE BY NMR OF 24-172, AND DISULFIDE BOND.
RX   PubMed=19361226; DOI=10.1021/bi9003342;
RA   Rowe M.L., Ruddock L.W., Kelly G., Schmidt J.M., Williamson R.A.,
RA   Howard M.J.;
RT   "Solution structure and dynamics of ERp18, a small endoplasmic
RT   reticulum resident oxidoreductase.";
RL   Biochemistry 48:4596-4606(2009).
CC   -!- FUNCTION: Possesses significant protein thiol-disulfide oxidase
CC       activity. {ECO:0000269|PubMed:12761212}.
CC   -!- CATALYTIC ACTIVITY: 2 glutathione + protein-disulfide =
CC       glutathione disulfide + protein-dithiol.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=25 uM for Asn-Arg-Cys-Ser-Gln-Gly-Ser-Cys-Trp-Asn;
CC       pH dependence:
CC         Optimum pH is 6.5.;
CC   -!- INTERACTION:
CC       O95198:KLHL2; NbExp=3; IntAct=EBI-2564581, EBI-746999;
CC       O43765:SGTA; NbExp=3; IntAct=EBI-2564581, EBI-347996;
CC       Q96EQ0:SGTB; NbExp=5; IntAct=EBI-2564581, EBI-744081;
CC       Q9UMX0:UBQLN1; NbExp=3; IntAct=EBI-2564581, EBI-741480;
CC       Q9UMX0-2:UBQLN1; NbExp=3; IntAct=EBI-2564581, EBI-10173939;
CC       Q9UHD9:UBQLN2; NbExp=4; IntAct=EBI-2564581, EBI-947187;
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum lumen
CC       {ECO:0000269|PubMed:12761212}.
CC   -!- TISSUE SPECIFICITY: Widely expressed.
CC       {ECO:0000269|PubMed:14557066}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF543416; AAN34781.1; -; mRNA.
DR   EMBL; AF131758; AAD20035.1; -; mRNA.
DR   EMBL; AY358982; AAQ89341.1; -; mRNA.
DR   EMBL; AK075409; BAG52132.1; -; mRNA.
DR   EMBL; AL445685; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC001493; AAH01493.1; -; mRNA.
DR   EMBL; BC008953; AAH08953.1; -; mRNA.
DR   EMBL; BC008913; AAH08913.1; -; mRNA.
DR   CCDS; CCDS561.1; -.
DR   RefSeq; NP_056997.1; NM_015913.3.
DR   UniGene; Hs.476033; -.
DR   PDB; 1SEN; X-ray; 1.20 A; A=23-172.
DR   PDB; 2K8V; NMR; -; A=24-172.
DR   PDBsum; 1SEN; -.
DR   PDBsum; 2K8V; -.
DR   ProteinModelPortal; O95881; -.
DR   SMR; O95881; -.
DR   BioGrid; 119252; 24.
DR   IntAct; O95881; 8.
DR   STRING; 9606.ENSP00000360688; -.
DR   DrugBank; DB00143; Glutathione.
DR   iPTMnet; O95881; -.
DR   PhosphoSitePlus; O95881; -.
DR   BioMuta; TXNDC12; -.
DR   EPD; O95881; -.
DR   MaxQB; O95881; -.
DR   PaxDb; O95881; -.
DR   PeptideAtlas; O95881; -.
DR   PRIDE; O95881; -.
DR   TopDownProteomics; O95881; -.
DR   DNASU; 51060; -.
DR   Ensembl; ENST00000371626; ENSP00000360688; ENSG00000117862.
DR   GeneID; 51060; -.
DR   KEGG; hsa:51060; -.
DR   UCSC; uc001cti.5; human.
DR   CTD; 51060; -.
DR   DisGeNET; 51060; -.
DR   EuPathDB; HostDB:ENSG00000117862.11; -.
DR   GeneCards; TXNDC12; -.
DR   H-InvDB; HIX0116253; -.
DR   HGNC; HGNC:24626; TXNDC12.
DR   MIM; 609448; gene.
DR   neXtProt; NX_O95881; -.
DR   OpenTargets; ENSG00000117862; -.
DR   PharmGKB; PA142670665; -.
DR   eggNOG; ENOG410IWGE; Eukaryota.
DR   eggNOG; ENOG4111X7E; LUCA.
DR   GeneTree; ENSGT00530000063273; -.
DR   HOGENOM; HOG000231100; -.
DR   HOVERGEN; HBG107174; -.
DR   InParanoid; O95881; -.
DR   KO; K05360; -.
DR   OMA; GNPNYKY; -.
DR   OrthoDB; EOG091G0RHV; -.
DR   PhylomeDB; O95881; -.
DR   TreeFam; TF321449; -.
DR   ChiTaRS; TXNDC12; human.
DR   EvolutionaryTrace; O95881; -.
DR   GeneWiki; TXNDC12; -.
DR   GenomeRNAi; 51060; -.
DR   PRO; PR:O95881; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000117862; -.
DR   CleanEx; HS_TXNDC12; -.
DR   ExpressionAtlas; O95881; baseline and differential.
DR   Genevisible; O95881; HS.
DR   GO; GO:0005788; C:endoplasmic reticulum lumen; IDA:MGI.
DR   GO; GO:0015037; F:peptide disulfide oxidoreductase activity; IDA:MGI.
DR   GO; GO:0019153; F:protein-disulfide reductase (glutathione) activity; IEA:UniProtKB-EC.
DR   GO; GO:0030154; P:cell differentiation; IBA:GO_Central.
DR   GO; GO:0045454; P:cell redox homeostasis; IEA:InterPro.
DR   GO; GO:1902236; P:negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway; IDA:MGI.
DR   CDD; cd02959; ERp19; 1.
DR   InterPro; IPR037462; ERp19.
DR   InterPro; IPR036249; Thioredoxin-like_sf.
DR   InterPro; IPR017937; Thioredoxin_CS.
DR   InterPro; IPR013766; Thioredoxin_domain.
DR   SUPFAM; SSF52833; SSF52833; 1.
DR   PROSITE; PS00194; THIOREDOXIN_1; 1.
DR   PROSITE; PS51352; THIOREDOXIN_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Complete proteome; Direct protein sequencing;
KW   Disulfide bond; Endoplasmic reticulum; Oxidoreductase;
KW   Redox-active center; Reference proteome; Signal.
FT   SIGNAL        1     26       {ECO:0000269|PubMed:15340161}.
FT   CHAIN        27    172       Thioredoxin domain-containing protein 12.
FT                                /FTId=PRO_0000034189.
FT   DOMAIN       27    156       Thioredoxin. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00691}.
FT   MOTIF       169    172       Prevents secretion from ER.
FT                                {ECO:0000255}.
FT   DISULFID     66     69       Redox-active. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00691,
FT                                ECO:0000269|PubMed:12761212,
FT                                ECO:0000269|PubMed:19361226}.
FT   MUTAGEN      66     66       C->S: Loss of oxidase activity.
FT                                {ECO:0000269|PubMed:12761212}.
FT   MUTAGEN      69     69       C->S: Loss of oxidase activity.
FT                                {ECO:0000269|PubMed:12761212}.
FT   CONFLICT    102    102       D -> H (in Ref. 6; AAH08913).
FT                                {ECO:0000305}.
FT   STRAND       33     38       {ECO:0000244|PDB:2K8V}.
FT   HELIX        43     53       {ECO:0000244|PDB:1SEN}.
FT   STRAND       57     62       {ECO:0000244|PDB:1SEN}.
FT   HELIX        67     77       {ECO:0000244|PDB:1SEN}.
FT   HELIX        80     86       {ECO:0000244|PDB:1SEN}.
FT   STRAND       89     95       {ECO:0000244|PDB:1SEN}.
FT   HELIX        96     98       {ECO:0000244|PDB:1SEN}.
FT   HELIX       103    105       {ECO:0000244|PDB:1SEN}.
FT   STRAND      112    118       {ECO:0000244|PDB:1SEN}.
FT   TURN        120    122       {ECO:0000244|PDB:2K8V}.
FT   TURN        135    139       {ECO:0000244|PDB:2K8V}.
FT   HELIX       144    158       {ECO:0000244|PDB:1SEN}.
FT   HELIX       159    161       {ECO:0000244|PDB:1SEN}.
SQ   SEQUENCE   172 AA;  19206 MW;  3092E9515A7C4094 CRC64;
     METRPRLGAT CLLGFSFLLL VISSDGHNGL GKGFGDHIHW RTLEDGKKEA AASGLPLMVI
     IHKSWCGACK ALKPKFAEST EISELSHNFV MVNLEDEEEP KDEDFSPDGG YIPRILFLDP
     SGKVHPEIIN ENGNPSYKYF YVSAEQVVQG MKEAQERLTG DAFRKKHLED EL
//
ID   GALA_HUMAN              Reviewed;         123 AA.
AC   P22466; Q14413;
DT   01-AUG-1991, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1997, sequence version 3.
DT   28-MAR-2018, entry version 164.
DE   RecName: Full=Galanin peptides;
DE   Contains:
DE     RecName: Full=Galanin;
DE   Contains:
DE     RecName: Full=Galanin message-associated peptide;
DE              Short=GMAP;
DE   Flags: Precursor;
GN   Name=GAL; Synonyms=GAL1, GALN, GLNN;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-45.
RC   TISSUE=Blood;
RX   PubMed=7508413;
RA   Evans H., Baumgartner M., Shine J., Herzog H.;
RT   "Genomic organization and localization of the gene encoding human
RT   preprogalanin.";
RL   Genomics 18:473-477(1993).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 16-123, FUNCTION, AND SUBCELLULAR
RP   LOCATION.
RX   PubMed=1370155; DOI=10.2337/diab.41.1.82;
RA   McKnight G.L., Karlsen A.E., Kowalyk S., Mathewes S.L., Sheppard P.O.,
RA   O'Hara P.J., Taborsky G.L.;
RT   "Sequence of human galanin and its inhibition of glucose-stimulated
RT   insulin secretion from RIN cells.";
RL   Diabetes 41:82-87(1992).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Cervix;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   PROTEIN SEQUENCE OF 33-62.
RX   PubMed=1710578; DOI=10.1016/0014-5793(91)80585-Q;
RA   Bersani M., Johnsen A.H., Hoejrup P., Dunning B.E., Andreasen J.J.,
RA   Holst J.J.;
RT   "Human galanin: primary structure and identification of two molecular
RT   forms.";
RL   FEBS Lett. 283:189-194(1991).
RN   [5]
RP   PROTEIN SEQUENCE OF 33-62, SYNTHESIS, FUNCTION, AND SUBCELLULAR
RP   LOCATION.
RC   TISSUE=Pituitary;
RX   PubMed=1722333; DOI=10.1073/pnas.88.24.11435;
RA   Schmidt W.E., Kratzin H., Eckart K., Drevs D., Mundkowski G.,
RA   Clemens A., Katsoulis S., Schaefer H., Gallwitz B., Creutzfeldt W.;
RT   "Isolation and primary structure of pituitary human galanin, a 30-
RT   residue nonamidated neuropeptide.";
RL   Proc. Natl. Acad. Sci. U.S.A. 88:11435-11439(1991).
RN   [6]
RP   PHOSPHORYLATION AT SER-117.
RC   TISSUE=Pituitary;
RX   PubMed=14997482; DOI=10.1002/pmic.200300584;
RA   Giorgianni F., Beranova-Giorgianni S., Desiderio D.M.;
RT   "Identification and characterization of phosphorylated proteins in the
RT   human pituitary.";
RL   Proteomics 4:587-598(2004).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Pituitary;
RX   PubMed=16807684; DOI=10.1007/s11102-006-8916-x;
RA   Beranova-Giorgianni S., Zhao Y., Desiderio D.M., Giorgianni F.;
RT   "Phosphoproteomic analysis of the human pituitary.";
RL   Pituitary 9:109-120(2006).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-117, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-116, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [12]
RP   FUNCTION, INVOLVEMENT IN ETL8, VARIANT ETL8 GLU-39, AND
RP   CHARACTERIZATION OF VARIANT ETL8 GLU-39.
RX   PubMed=25691535; DOI=10.1093/hmg/ddv060;
RA   Guipponi M., Chentouf A., Webling K.E., Freimann K., Crespel A.,
RA   Nobile C., Lemke J.R., Hansen J., Dorn T., Lesca G., Ryvlin P.,
RA   Hirsch E., Rudolf G., Rosenberg D.S., Weber Y., Becker F., Helbig I.,
RA   Muhle H., Salzmann A., Chaouch M., Oubaiche M.L., Ziglio S.,
RA   Gehrig C., Santoni F., Pizzato M., Langel U., Antonarakis S.E.;
RT   "Galanin pathogenic mutations in temporal lobe epilepsy.";
RL   Hum. Mol. Genet. 24:3082-3091(2015).
CC   -!- FUNCTION: Endocrine hormone of the central and peripheral nervous
CC       systems that binds and activates the G protein-coupled receptors
CC       GALR1, GALR2, and GALR3. This small neuropeptide may regulate
CC       diverse physiologic functions including contraction of smooth
CC       muscle of the gastrointestinal and genitourinary tract, growth
CC       hormone and insulin release and adrenal secretion.
CC       {ECO:0000269|PubMed:1370155, ECO:0000269|PubMed:1722333,
CC       ECO:0000269|PubMed:25691535}.
CC   -!- INTERACTION:
CC       P47211:GALR1; NbExp=2; IntAct=EBI-6624800, EBI-6624741;
CC       O43603:GALR2; NbExp=2; IntAct=EBI-6624800, EBI-6624855;
CC       O43765:SGTA; NbExp=3; IntAct=EBI-6624768, EBI-347996;
CC   -!- SUBCELLULAR LOCATION: Secreted {ECO:0000269|PubMed:1370155,
CC       ECO:0000269|PubMed:1722333}.
CC   -!- DISEASE: Epilepsy, familial temporal lobe, 8 (ETL8) [MIM:616461]:
CC       A focal form of epilepsy characterized by recurrent seizures that
CC       arise from foci within the temporal lobe. Seizures are usually
CC       accompanied by sensory symptoms, most often auditory in nature.
CC       {ECO:0000269|PubMed:25691535}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the galanin family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; L11144; AAA18248.1; -; Genomic_DNA.
DR   EMBL; M77140; AAA60178.1; -; mRNA.
DR   EMBL; BC030241; AAH30241.1; -; mRNA.
DR   CCDS; CCDS8183.1; -.
DR   PIR; A49353; RHHUN.
DR   RefSeq; NP_057057.2; NM_015973.4.
DR   UniGene; Hs.278959; -.
DR   ProteinModelPortal; P22466; -.
DR   SMR; P22466; -.
DR   BioGrid; 119273; 12.
DR   IntAct; P22466; 6.
DR   MINT; P22466; -.
DR   STRING; 9606.ENSP00000265643; -.
DR   BindingDB; P22466; -.
DR   iPTMnet; P22466; -.
DR   PhosphoSitePlus; P22466; -.
DR   BioMuta; GAL; -.
DR   DMDM; 2506449; -.
DR   EPD; P22466; -.
DR   MaxQB; P22466; -.
DR   PaxDb; P22466; -.
DR   PeptideAtlas; P22466; -.
DR   PRIDE; P22466; -.
DR   DNASU; 51083; -.
DR   Ensembl; ENST00000265643; ENSP00000265643; ENSG00000069482.
DR   GeneID; 51083; -.
DR   KEGG; hsa:51083; -.
DR   UCSC; uc001oob.4; human.
DR   CTD; 51083; -.
DR   DisGeNET; 51083; -.
DR   EuPathDB; HostDB:ENSG00000069482.6; -.
DR   GeneCards; GAL; -.
DR   HGNC; HGNC:4114; GAL.
DR   HPA; HPA049864; -.
DR   MalaCards; GAL; -.
DR   MIM; 137035; gene.
DR   MIM; 616461; phenotype.
DR   neXtProt; NX_P22466; -.
DR   OpenTargets; ENSG00000069482; -.
DR   PharmGKB; PA28529; -.
DR   eggNOG; ENOG410IZPR; Eukaryota.
DR   eggNOG; ENOG410YNUP; LUCA.
DR   GeneTree; ENSGT00390000009663; -.
DR   HOGENOM; HOG000112690; -.
DR   HOVERGEN; HBG005799; -.
DR   InParanoid; P22466; -.
DR   KO; K05244; -.
DR   OMA; WSPAKEK; -.
DR   OrthoDB; EOG091G109K; -.
DR   PhylomeDB; P22466; -.
DR   TreeFam; TF335850; -.
DR   Reactome; R-HSA-375276; Peptide ligand-binding receptors.
DR   Reactome; R-HSA-418594; G alpha (i) signalling events.
DR   SIGNOR; P22466; -.
DR   ChiTaRS; GAL; human.
DR   GeneWiki; Galanin; -.
DR   GenomeRNAi; 51083; -.
DR   PRO; PR:P22466; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   Bgee; ENSG00000069482; -.
DR   CleanEx; HS_GAL; -.
DR   Genevisible; P22466; HS.
DR   GO; GO:0005576; C:extracellular region; TAS:Reactome.
DR   GO; GO:0005615; C:extracellular space; IDA:UniProtKB.
DR   GO; GO:0005794; C:Golgi apparatus; IEA:Ensembl.
DR   GO; GO:0043025; C:neuronal cell body; IDA:UniProtKB.
DR   GO; GO:0030141; C:secretory granule; IBA:GO_Central.
DR   GO; GO:0004966; F:galanin receptor activity; IMP:UniProtKB.
DR   GO; GO:0005184; F:neuropeptide hormone activity; IDA:UniProtKB.
DR   GO; GO:0031764; F:type 1 galanin receptor binding; IDA:UniProtKB.
DR   GO; GO:0031765; F:type 2 galanin receptor binding; IDA:UniProtKB.
DR   GO; GO:0031766; F:type 3 galanin receptor binding; IDA:UniProtKB.
DR   GO; GO:0019933; P:cAMP-mediated signaling; IDA:UniProtKB.
DR   GO; GO:0007631; P:feeding behavior; IEA:Ensembl.
DR   GO; GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:Reactome.
DR   GO; GO:0006954; P:inflammatory response; IEA:Ensembl.
DR   GO; GO:0030073; P:insulin secretion; NAS:UniProtKB.
DR   GO; GO:0050672; P:negative regulation of lymphocyte proliferation; IEA:Ensembl.
DR   GO; GO:1902891; P:negative regulation of root hair elongation; IDA:UniProtKB.
DR   GO; GO:0007399; P:nervous system development; IEA:Ensembl.
DR   GO; GO:0043065; P:positive regulation of apoptotic process; IEA:Ensembl.
DR   GO; GO:0051464; P:positive regulation of cortisol secretion; IDA:UniProtKB.
DR   GO; GO:1902608; P:positive regulation of large conductance calcium-activated potassium channel activity; IDA:UniProtKB.
DR   GO; GO:0051795; P:positive regulation of timing of catagen; IDA:UniProtKB.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IDA:UniProtKB.
DR   GO; GO:0010737; P:protein kinase A signaling; IDA:UniProtKB.
DR   GO; GO:0031943; P:regulation of glucocorticoid metabolic process; IEA:Ensembl.
DR   GO; GO:0042493; P:response to drug; IEA:Ensembl.
DR   GO; GO:0043627; P:response to estrogen; IEA:Ensembl.
DR   GO; GO:0035902; P:response to immobilization stress; IEA:Ensembl.
DR   GO; GO:0032868; P:response to insulin; IEA:Ensembl.
DR   InterPro; IPR008174; Galanin.
DR   InterPro; IPR008175; Galanin_pre.
DR   InterPro; IPR013068; GMAP.
DR   PANTHER; PTHR16839; PTHR16839; 1.
DR   Pfam; PF01296; Galanin; 1.
DR   Pfam; PF06540; GMAP; 1.
DR   PRINTS; PR00273; GALANIN.
DR   ProDom; PD005962; Galanin; 1.
DR   ProDom; PD012185; GMAP; 1.
DR   SMART; SM00071; Galanin; 1.
DR   PROSITE; PS00861; GALANIN; 1.
PE   1: Evidence at protein level;
KW   Cleavage on pair of basic residues; Complete proteome;
KW   Direct protein sequencing; Disease mutation; Epilepsy; Hormone;
KW   Neuropeptide; Phosphoprotein; Polymorphism; Reference proteome;
KW   Secreted; Signal.
FT   SIGNAL        1     19       {ECO:0000255}.
FT   PROPEP       20     30
FT                                /FTId=PRO_0000010448.
FT   PEPTIDE      33     62       Galanin.
FT                                /FTId=PRO_0000010449.
FT   PEPTIDE      65    123       Galanin message-associated peptide.
FT                                /FTId=PRO_0000010450.
FT   MOD_RES     116    116       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     117    117       Phosphoserine.
FT                                {ECO:0000244|PubMed:21406692,
FT                                ECO:0000269|PubMed:14997482}.
FT   VARIANT      16     16       A -> V (in dbSNP:rs34725707).
FT                                /FTId=VAR_049121.
FT   VARIANT      39     39       A -> E (in ETL8; decreased affinity for
FT                                GALR2; but no effect on affinity for
FT                                GALR1 and GALR3; decreased activity in
FT                                GALR2-mediated signaling; dominant-
FT                                negative that inhibits GALR1-mediated
FT                                signaling; dbSNP:rs1057517661).
FT                                {ECO:0000269|PubMed:25691535}.
FT                                /FTId=VAR_074671.
SQ   SEQUENCE   123 AA;  13302 MW;  48D2170AF1248E6D CRC64;
     MARGSALLLA SLLLAAALSA SAGLWSPAKE KRGWTLNSAG YLLGPHAVGN HRSFSDKNGL
     TSKRELRPED DMKPGSFDRS IPENNIMRTI IEFLSFLHLK EAGALDRLLD LPAAASSEDI
     ERS
//
ID   FKBP7_HUMAN             Reviewed;         222 AA.
AC   Q9Y680; Q4ZG70; Q6V3B2; Q86U65; Q96DA4; Q9Y6B0;
DT   19-SEP-2002, integrated into UniProtKB/Swiss-Prot.
DT   28-MAR-2018, sequence version 2.
DT   25-APR-2018, entry version 164.
DE   RecName: Full=Peptidyl-prolyl cis-trans isomerase FKBP7;
DE            Short=PPIase FKBP7;
DE            EC=5.2.1.8;
DE   AltName: Full=23 kDa FK506-binding protein;
DE            Short=23 kDa FKBP;
DE            Short=FKBP-23;
DE   AltName: Full=FK506-binding protein 7;
DE            Short=FKBP-7;
DE   AltName: Full=Rotamase;
DE   Flags: Precursor;
GN   Name=FKBP7; Synonyms=FKBP23; ORFNames=UNQ670/PRO1304;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Pituitary, and Pituitary tumor;
RX   PubMed=10931946; DOI=10.1073/pnas.160270997;
RA   Hu R.-M., Han Z.-G., Song H.-D., Peng Y.-D., Huang Q.-H., Ren S.-X.,
RA   Gu Y.-J., Huang C.-H., Li Y.-B., Jiang C.-L., Fu G., Zhang Q.-H.,
RA   Gu B.-W., Dai M., Mao Y.-F., Gao G.-F., Rong R., Ye M., Zhou J.,
RA   Xu S.-H., Gu J., Shi J.-X., Jin W.-R., Zhang C.-K., Wu T.-M.,
RA   Huang G.-Y., Chen Z., Chen M.-D., Chen J.-L.;
RT   "Gene expression profiling in the human hypothalamus-pituitary-adrenal
RT   axis and full-length cDNA cloning.";
RL   Proc. Natl. Acad. Sci. U.S.A. 97:9543-9548(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RX   PubMed=12975309; DOI=10.1101/gr.1293003;
RA   Clark H.F., Gurney A.L., Abaya E., Baker K., Baldwin D.T., Brush J.,
RA   Chen J., Chow B., Chui C., Crowley C., Currell B., Deuel B., Dowd P.,
RA   Eaton D., Foster J.S., Grimaldi C., Gu Q., Hass P.E., Heldens S.,
RA   Huang A., Kim H.S., Klimowski L., Jin Y., Johnson S., Lee J.,
RA   Lewis L., Liao D., Mark M.R., Robbie E., Sanchez C., Schoenfeld J.,
RA   Seshagiri S., Simmons L., Singh J., Smith V., Stinson J., Vagts A.,
RA   Vandlen R.L., Watanabe C., Wieand D., Woods K., Xie M.-H.,
RA   Yansura D.G., Yi S., Yu G., Yuan J., Zhang M., Zhang Z., Goddard A.D.,
RA   Wood W.I., Godowski P.J., Gray A.M.;
RT   "The secreted protein discovery initiative (SPDI), a large-scale
RT   effort to identify novel human secreted and transmembrane proteins: a
RT   bioinformatics assessment.";
RL   Genome Res. 13:2265-2270(2003).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Synovial cell;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RA   Li H., Zhong G., Yu R., Shen C., Zhou G., Li M., Xiao W., Lin L.,
RA   Yang S.;
RL   Submitted (JUL-2003) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
CC   -!- FUNCTION: PPIases accelerate the folding of proteins during
CC       protein synthesis.
CC   -!- CATALYTIC ACTIVITY: Peptidylproline (omega=180) = peptidylproline
CC       (omega=0).
CC   -!- INTERACTION:
CC       P40855:PEX19; NbExp=3; IntAct=EBI-3918971, EBI-594747;
CC       O43765:SGTA; NbExp=3; IntAct=EBI-3918971, EBI-347996;
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum lumen
CC       {ECO:0000255|PROSITE-ProRule:PRU10138}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=2;
CC         IsoId=Q9Y680-2; Sequence=Displayed;
CC       Name=3;
CC         IsoId=Q9Y680-3; Sequence=VSP_041018;
CC       Name=1;
CC         IsoId=Q9Y680-1; Sequence=VSP_059387, VSP_059388;
CC         Note=May be produced at very low levels due to a premature stop
CC         codon in the mRNA, leading to nonsense-mediated mRNA decay.
CC         {ECO:0000305};
CC   -!- PTM: Glycosylated. {ECO:0000250}.
CC   -!- MISCELLANEOUS: Binds calcium. {ECO:0000250}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAD43015.1; Type=Frameshift; Positions=Several; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF092137; AAD40379.1; -; mRNA.
DR   EMBL; AF100751; AAD43015.1; ALT_FRAME; mRNA.
DR   EMBL; AY359015; AAQ89374.1; -; mRNA.
DR   EMBL; AK292145; BAF84834.1; -; mRNA.
DR   EMBL; BT007122; AAP35786.1; -; mRNA.
DR   EMBL; AY353086; AAQ57208.1; -; mRNA.
DR   EMBL; AC009948; AAX88883.1; -; Genomic_DNA.
DR   EMBL; BC009711; AAH09711.1; -; mRNA.
DR   CCDS; CCDS2280.1; -. [Q9Y680-2]
DR   CCDS; CCDS46462.1; -. [Q9Y680-3]
DR   RefSeq; NP_001128684.1; NM_001135212.1. [Q9Y680-3]
DR   RefSeq; NP_851939.1; NM_181342.2. [Q9Y680-2]
DR   UniGene; Hs.410378; -.
DR   ProteinModelPortal; Q9Y680; -.
DR   SMR; Q9Y680; -.
DR   BioGrid; 119666; 33.
DR   IntAct; Q9Y680; 8.
DR   MINT; Q9Y680; -.
DR   iPTMnet; Q9Y680; -.
DR   PhosphoSitePlus; Q9Y680; -.
DR   BioMuta; FKBP7; -.
DR   DMDM; 23396602; -.
DR   EPD; Q9Y680; -.
DR   PeptideAtlas; Q9Y680; -.
DR   PRIDE; Q9Y680; -.
DR   DNASU; 51661; -.
DR   Ensembl; ENST00000233092; ENSP00000233092; ENSG00000079150. [Q9Y680-1]
DR   Ensembl; ENST00000424785; ENSP00000413152; ENSG00000079150. [Q9Y680-2]
DR   Ensembl; ENST00000434643; ENSP00000415486; ENSG00000079150. [Q9Y680-3]
DR   GeneID; 51661; -.
DR   KEGG; hsa:51661; -.
DR   UCSC; uc002umk.4; human. [Q9Y680-2]
DR   CTD; 51661; -.
DR   EuPathDB; HostDB:ENSG00000079150.17; -.
DR   GeneCards; FKBP7; -.
DR   H-InvDB; HIX0002629; -.
DR   HGNC; HGNC:3723; FKBP7.
DR   HPA; HPA008707; -.
DR   MIM; 607062; gene.
DR   neXtProt; NX_Q9Y680; -.
DR   OpenTargets; ENSG00000079150; -.
DR   PharmGKB; PA28164; -.
DR   GeneTree; ENSGT00530000062784; -.
DR   HOGENOM; HOG000154887; -.
DR   HOVERGEN; HBG051623; -.
DR   InParanoid; Q9Y680; -.
DR   KO; K09573; -.
DR   OMA; HRPENCS; -.
DR   OrthoDB; EOG091G02W1; -.
DR   PhylomeDB; Q9Y680; -.
DR   TreeFam; TF105296; -.
DR   ChiTaRS; FKBP7; human.
DR   GenomeRNAi; 51661; -.
DR   PRO; PR:Q9Y680; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   Bgee; ENSG00000079150; -.
DR   CleanEx; HS_FKBP7; -.
DR   ExpressionAtlas; Q9Y680; baseline and differential.
DR   Genevisible; Q9Y680; HS.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0005788; C:endoplasmic reticulum lumen; IEA:UniProtKB-SubCell.
DR   GO; GO:0005509; F:calcium ion binding; IEA:Ensembl.
DR   GO; GO:0005528; F:FK506 binding; IBA:GO_Central.
DR   GO; GO:0003755; F:peptidyl-prolyl cis-trans isomerase activity; IBA:GO_Central.
DR   GO; GO:0061077; P:chaperone-mediated protein folding; IBA:GO_Central.
DR   InterPro; IPR011992; EF-hand-dom_pair.
DR   InterPro; IPR018247; EF_Hand_1_Ca_BS.
DR   InterPro; IPR002048; EF_hand_dom.
DR   InterPro; IPR023566; PPIase_FKBP.
DR   InterPro; IPR001179; PPIase_FKBP_dom.
DR   PANTHER; PTHR10516; PTHR10516; 1.
DR   Pfam; PF13499; EF-hand_7; 1.
DR   Pfam; PF00254; FKBP_C; 1.
DR   SUPFAM; SSF47473; SSF47473; 1.
DR   PROSITE; PS00018; EF_HAND_1; 2.
DR   PROSITE; PS50222; EF_HAND_2; 2.
DR   PROSITE; PS00014; ER_TARGET; 1.
DR   PROSITE; PS50059; FKBP_PPIASE; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Calcium; Complete proteome;
KW   Endoplasmic reticulum; Glycoprotein; Isomerase; Metal-binding;
KW   Reference proteome; Repeat; Rotamase; Signal.
FT   SIGNAL        1     23       {ECO:0000255}.
FT   CHAIN        24    222       Peptidyl-prolyl cis-trans isomerase
FT                                FKBP7.
FT                                /FTId=PRO_0000025513.
FT   DOMAIN       53    145       PPIase FKBP-type. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00277}.
FT   DOMAIN      145    180       EF-hand 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00448}.
FT   DOMAIN      189    222       EF-hand 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00448}.
FT   CA_BIND     158    169       1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00448}.
FT   CA_BIND     202    213       2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00448}.
FT   MOTIF       219    222       Retention in the endoplasmic reticulum.
FT                                {ECO:0000255|PROSITE-ProRule:PRU10138}.
FT   CARBOHYD     45     45       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   VAR_SEQ     125    127       AEG -> GST (in isoform 1).
FT                                {ECO:0000303|PubMed:10931946}.
FT                                /FTId=VSP_059387.
FT   VAR_SEQ     125    125       Missing (in isoform 3).
FT                                {ECO:0000303|Ref.5}.
FT                                /FTId=VSP_041018.
FT   VAR_SEQ     128    222       Missing (in isoform 1).
FT                                {ECO:0000303|PubMed:10931946}.
FT                                /FTId=VSP_059388.
FT   CONFLICT    124    124       Y -> H (in Ref. 1; AAD40379).
FT                                {ECO:0000305}.
FT   CONFLICT    200    200       K -> M (in Ref. 5; AAQ57208).
FT                                {ECO:0000305}.
SQ   SEQUENCE   222 AA;  25794 MW;  362957BAD3C5C2A6 CRC64;
     MPKTMHFLFR FIVFFYLWGL FTAQRQKKEE STEEVKIEVL HRPENCSKTS KKGDLLNAHY
     DGYLAKDGSK FYCSRTQNEG HPKWFVLGVG QVIKGLDIAM TDMCPGEKRK VVIPPSFAYG
     KEGYAEGKIP PDATLIFEIE LYAVTKGPRS IETFKQIDMD NDRQLSKAEI NLYLQREFEK
     DEKPRDKSYQ DAVLEDIFKK NDHDGDGFIS PKEYNVYQHD EL
//
ID   FXYD7_HUMAN             Reviewed;          80 AA.
AC   P58549;
DT   23-JAN-2002, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2002, sequence version 1.
DT   23-MAY-2018, entry version 123.
DE   RecName: Full=FXYD domain-containing ion transport regulator 7;
GN   Name=FXYD7;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -!- INTERACTION:
CC       Q92624:APPBP2; NbExp=5; IntAct=EBI-10216171, EBI-743771;
CC       O43765:SGTA; NbExp=7; IntAct=EBI-10216171, EBI-347996;
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Single-pass membrane
CC       protein {ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the FXYD family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; BC018619; AAH18619.1; -; mRNA.
DR   CCDS; CCDS12446.1; -.
DR   RefSeq; NP_071289.1; NM_022006.1.
DR   UniGene; Hs.134729; -.
DR   ProteinModelPortal; P58549; -.
DR   SMR; P58549; -.
DR   BioGrid; 119795; 5.
DR   IntAct; P58549; 2.
DR   STRING; 9606.ENSP00000270310; -.
DR   iPTMnet; P58549; -.
DR   PhosphoSitePlus; P58549; -.
DR   BioMuta; FXYD7; -.
DR   DMDM; 20138168; -.
DR   PaxDb; P58549; -.
DR   PeptideAtlas; P58549; -.
DR   PRIDE; P58549; -.
DR   DNASU; 53822; -.
DR   Ensembl; ENST00000270310; ENSP00000270310; ENSG00000221946.
DR   GeneID; 53822; -.
DR   KEGG; hsa:53822; -.
DR   UCSC; uc002nye.2; human.
DR   CTD; 53822; -.
DR   EuPathDB; HostDB:ENSG00000221946.7; -.
DR   GeneCards; FXYD7; -.
DR   HGNC; HGNC:4034; FXYD7.
DR   HPA; HPA026916; -.
DR   MIM; 606684; gene.
DR   neXtProt; NX_P58549; -.
DR   OpenTargets; ENSG00000221946; -.
DR   PharmGKB; PA28450; -.
DR   eggNOG; ENOG410J7S9; Eukaryota.
DR   eggNOG; ENOG4111ECY; LUCA.
DR   GeneTree; ENSGT00530000064670; -.
DR   HOGENOM; HOG000112680; -.
DR   HOVERGEN; HBG051679; -.
DR   InParanoid; P58549; -.
DR   KO; K13364; -.
DR   PhylomeDB; P58549; -.
DR   TreeFam; TF333443; -.
DR   Reactome; R-HSA-5578775; Ion homeostasis.
DR   Reactome; R-HSA-936837; Ion transport by P-type ATPases.
DR   GenomeRNAi; 53822; -.
DR   PRO; PR:P58549; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   Bgee; ENSG00000221946; -.
DR   CleanEx; HS_FXYD7; -.
DR   ExpressionAtlas; P58549; baseline and differential.
DR   Genevisible; P58549; HS.
DR   GO; GO:0005887; C:integral component of plasma membrane; IBA:GO_Central.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0005216; F:ion channel activity; IEA:InterPro.
DR   GO; GO:0017080; F:sodium channel regulator activity; IBA:GO_Central.
DR   GO; GO:2000649; P:regulation of sodium ion transmembrane transporter activity; IBA:GO_Central.
DR   InterPro; IPR000272; Ion-transport_regulator_FXYD.
DR   Pfam; PF02038; ATP1G1_PLM_MAT8; 1.
DR   ProDom; PD005989; PD005989; 1.
DR   PROSITE; PS01310; FXYD; 1.
PE   1: Evidence at protein level;
KW   Complete proteome; Ion channel; Ion transport; Membrane;
KW   Phosphoprotein; Reference proteome; Transmembrane;
KW   Transmembrane helix; Transport.
FT   CHAIN         1     80       FXYD domain-containing ion transport
FT                                regulator 7.
FT                                /FTId=PRO_0000148190.
FT   TRANSMEM     24     46       Helical. {ECO:0000255}.
FT   MOD_RES      73     73       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P59649}.
SQ   SEQUENCE   80 AA;  8524 MW;  130DAC482EFF1939 CRC64;
     MATPTQTPTK APEEPDPFYY DYNTVQTVGM TLATILFLLG ILIVISKKVK CRKADSRSES
     PTCKSCKSEL PSSAPGGGGV
//
ID   WBP1L_HUMAN             Reviewed;         342 AA.
AC   Q9NX94; B3KPF4; B7Z6S7; D3DR90; Q1EG70; Q2HIY7; Q5F2G6;
DT   27-JUN-2006, integrated into UniProtKB/Swiss-Prot.
DT   27-JUN-2006, sequence version 2.
DT   28-FEB-2018, entry version 116.
DE   RecName: Full=WW domain binding protein 1-like;
DE   AltName: Full=Outcome predictor in acute leukemia 1;
GN   Name=WBP1L; Synonyms=C10orf26, OPA1L;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=B-cell lymphoma;
RA   Helman P., Veroff R.L., Shuster J., Kang H., Mosquera-Caro M.P.,
RA   Potter J.W., Harvey R.C., Martin S.B., Davidson G.S., Andries E.,
RA   Atlas S.W., Chen I.-M., Wilson C.S., Ar K., Xu Y., Murphy M.,
RA   Schultz F.A., Bedrick E., Carroll A.J., Camitta B., Willman C.L.;
RT   "Gene expression profiling reveals novel genes for improved risk
RT   classification and outcome prediction in pediatric acute lymphoblastic
RT   leukemia: identification, validation, and cloning of OPAL1.";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2), AND
RP   VARIANTS PRO-302 AND SER-320.
RC   TISSUE=Hepatoma;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Small intestine;
RA   Wakamatsu A., Yamamoto J., Kimura K., Ishii S., Watanabe K.,
RA   Sugiyama A., Murakawa K., Kaida T., Tsuchiya K., Fukuzumi Y.,
RA   Kumagai A., Oishi Y., Yamamoto S., Ono Y., Komori Y., Yamazaki M.,
RA   Kisu Y., Nishikawa T., Sugano S., Nomura N., Isogai T.;
RT   "NEDO human cDNA sequencing project focused on splicing variants.";
RL   Submitted (OCT-2007) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164054; DOI=10.1038/nature02462;
RA   Deloukas P., Earthrowl M.E., Grafham D.V., Rubenfield M., French L.,
RA   Steward C.A., Sims S.K., Jones M.C., Searle S., Scott C., Howe K.,
RA   Hunt S.E., Andrews T.D., Gilbert J.G.R., Swarbreck D., Ashurst J.L.,
RA   Taylor A., Battles J., Bird C.P., Ainscough R., Almeida J.P.,
RA   Ashwell R.I.S., Ambrose K.D., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Bates K., Beasley H., Bray-Allen S., Brown A.J.,
RA   Brown J.Y., Burford D.C., Burrill W., Burton J., Cahill P., Camire D.,
RA   Carter N.P., Chapman J.C., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Corby N., Coulson A., Dhami P., Dutta I., Dunn M., Faulkner L.,
RA   Frankish A., Frankland J.A., Garner P., Garnett J., Gribble S.,
RA   Griffiths C., Grocock R., Gustafson E., Hammond S., Harley J.L.,
RA   Hart E., Heath P.D., Ho T.P., Hopkins B., Horne J., Howden P.J.,
RA   Huckle E., Hynds C., Johnson C., Johnson D., Kana A., Kay M.,
RA   Kimberley A.M., Kershaw J.K., Kokkinaki M., Laird G.K., Lawlor S.,
RA   Lee H.M., Leongamornlert D.A., Laird G., Lloyd C., Lloyd D.M.,
RA   Loveland J., Lovell J., McLaren S., McLay K.E., McMurray A.,
RA   Mashreghi-Mohammadi M., Matthews L., Milne S., Nickerson T.,
RA   Nguyen M., Overton-Larty E., Palmer S.A., Pearce A.V., Peck A.I.,
RA   Pelan S., Phillimore B., Porter K., Rice C.M., Rogosin A., Ross M.T.,
RA   Sarafidou T., Sehra H.K., Shownkeen R., Skuce C.D., Smith M.,
RA   Standring L., Sycamore N., Tester J., Thorpe A., Torcasso W.,
RA   Tracey A., Tromans A., Tsolas J., Wall M., Walsh J., Wang H.,
RA   Weinstock K., West A.P., Willey D.L., Whitehead S.L., Wilming L.,
RA   Wray P.W., Young L., Chen Y., Lovering R.C., Moschonas N.K.,
RA   Siebert R., Fechtel K., Bentley D., Durbin R.M., Hubbard T.,
RA   Doucette-Stamm L., Beck S., Smith D.R., Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 10.";
RL   Nature 429:375-381(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-173, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
CC   -!- INTERACTION:
CC       O95208-2:EPN2; NbExp=4; IntAct=EBI-10316321, EBI-12135243;
CC       O43765:SGTA; NbExp=3; IntAct=EBI-10316321, EBI-347996;
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Single-pass membrane
CC       protein {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9NX94-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9NX94-2; Sequence=VSP_041670;
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAA91122.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AY656171; AAV68559.1; -; mRNA.
DR   EMBL; AK000374; BAA91122.1; ALT_INIT; mRNA.
DR   EMBL; AK316452; BAH14823.1; -; mRNA.
DR   EMBL; AK056285; BAG51666.1; -; mRNA.
DR   EMBL; AK300871; BAH13363.1; -; mRNA.
DR   EMBL; AL358790; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471066; EAW49673.1; -; Genomic_DNA.
DR   EMBL; CH471066; EAW49674.1; -; Genomic_DNA.
DR   EMBL; BC113857; AAI13858.1; -; mRNA.
DR   EMBL; BC114465; AAI14466.1; -; mRNA.
DR   CCDS; CCDS44473.1; -. [Q9NX94-2]
DR   CCDS; CCDS7540.1; -. [Q9NX94-1]
DR   RefSeq; NP_001077382.1; NM_001083913.1. [Q9NX94-2]
DR   RefSeq; NP_060257.4; NM_017787.4. [Q9NX94-1]
DR   UniGene; Hs.500897; -.
DR   UniGene; Hs.693257; -.
DR   UniGene; Hs.707763; -.
DR   ProteinModelPortal; Q9NX94; -.
DR   BioGrid; 120189; 2.
DR   IntAct; Q9NX94; 2.
DR   STRING; 9606.ENSP00000414721; -.
DR   iPTMnet; Q9NX94; -.
DR   PhosphoSitePlus; Q9NX94; -.
DR   BioMuta; WBP1L; -.
DR   DMDM; 109820639; -.
DR   PaxDb; Q9NX94; -.
DR   PeptideAtlas; Q9NX94; -.
DR   PRIDE; Q9NX94; -.
DR   Ensembl; ENST00000369889; ENSP00000358905; ENSG00000166272. [Q9NX94-1]
DR   Ensembl; ENST00000448841; ENSP00000414721; ENSG00000166272. [Q9NX94-2]
DR   GeneID; 54838; -.
DR   KEGG; hsa:54838; -.
DR   UCSC; uc001kwe.5; human. [Q9NX94-1]
DR   CTD; 54838; -.
DR   DisGeNET; 54838; -.
DR   EuPathDB; HostDB:ENSG00000166272.16; -.
DR   GeneCards; WBP1L; -.
DR   HGNC; HGNC:23510; WBP1L.
DR   HPA; HPA037635; -.
DR   HPA; HPA038371; -.
DR   MIM; 611129; gene.
DR   neXtProt; NX_Q9NX94; -.
DR   OpenTargets; ENSG00000166272; -.
DR   PharmGKB; PA128394674; -.
DR   eggNOG; ENOG410IHWG; Eukaryota.
DR   eggNOG; ENOG410Y9CC; LUCA.
DR   GeneTree; ENSGT00530000063663; -.
DR   HOVERGEN; HBG106189; -.
DR   InParanoid; Q9NX94; -.
DR   OMA; YSAFQLQ; -.
DR   OrthoDB; EOG091G0SD3; -.
DR   PhylomeDB; Q9NX94; -.
DR   TreeFam; TF330726; -.
DR   ChiTaRS; WBP1L; human.
DR   GeneWiki; C10orf26; -.
DR   GenomeRNAi; 54838; -.
DR   PRO; PR:Q9NX94; -.
DR   Proteomes; UP000005640; Chromosome 10.
DR   Bgee; ENSG00000166272; -.
DR   CleanEx; HS_C10orf26; -.
DR   Genevisible; Q9NX94; HS.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   InterPro; IPR021684; WBP1-like.
DR   Pfam; PF11669; WBP-1; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Complete proteome; Membrane; Phosphoprotein;
KW   Polymorphism; Reference proteome; Transmembrane; Transmembrane helix.
FT   CHAIN         1    342       WW domain binding protein 1-like.
FT                                /FTId=PRO_0000241450.
FT   TRANSMEM     42     62       Helical. {ECO:0000255}.
FT   COMPBIAS    101    183       Pro-rich.
FT   COMPBIAS    335    342       Poly-Ser.
FT   MOD_RES     173    173       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   VAR_SEQ       1      8       MPFLLGLR -> MERRRLLGGMALLLLQALPSPLSARAEPP
FT                                (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_041670.
FT   VARIANT     302    302       S -> P (in dbSNP:rs284860).
FT                                {ECO:0000269|PubMed:14702039}.
FT                                /FTId=VAR_026839.
FT   VARIANT     320    320       A -> S (in dbSNP:rs284859).
FT                                {ECO:0000269|PubMed:14702039}.
FT                                /FTId=VAR_026840.
FT   CONFLICT     90     90       Y -> H (in Ref. 6; AAI13858).
FT                                {ECO:0000305}.
SQ   SEQUENCE   342 AA;  37828 MW;  B8D73B065A2A222B CRC64;
     MPFLLGLRQD KEACVGTNNQ SYICDTGHCC GQSQCCNYYY ELWWFWLVWT IIIILSCCCV
     CHHRRAKHRL QAQQRQHEIN LIAYREAHNY SALPFYFRFL PNYLLPPYEE VVNRPPTPPP
     PYSAFQLQQQ QLLPPQCGPA GGSPPGIDPT RGSQGAQSSP LSEPSRSSTR PPSIADPDPS
     DLPVDRAATK APGMEPSGSV AGLGELDPGA FLDKDAECRE ELLKDDSSEH GAPDSKEKTP
     GRHRRFTGDS GIEVCVCNRG HHDDDLKEFN TLIDDALDGP LDFCDSCHVR PPGDEEEGLC
     QSSEEQAREP GHPHLPRPPA CLLLNTINEQ DSPNSQSSSS PS
//
ID   EVA1B_HUMAN             Reviewed;         165 AA.
AC   Q9NVM1; D3DPS7;
DT   09-JAN-2007, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2000, sequence version 1.
DT   28-FEB-2018, entry version 121.
DE   RecName: Full=Protein eva-1 homolog B;
DE   AltName: Full=Protein FAM176B;
GN   Name=EVA1B; Synonyms=C1orf78, FAM176B;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Bone, and Ovary;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=18318008; DOI=10.1002/pmic.200700884;
RA   Han G., Ye M., Zhou H., Jiang X., Feng S., Jiang X., Tian R., Wan D.,
RA   Zou H., Gu J.;
RT   "Large-scale phosphoproteome analysis of human liver tissue by
RT   enrichment and fractionation of phosphopeptides with strong anion
RT   exchange chromatography.";
RL   Proteomics 8:1346-1361(2008).
RN   [6]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
CC   -!- INTERACTION:
CC       O43765:SGTA; NbExp=5; IntAct=EBI-10314666, EBI-347996;
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Single-pass membrane
CC       protein {ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the EVA1 family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK001509; BAA91729.1; -; mRNA.
DR   EMBL; AL591845; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471059; EAX07377.1; -; Genomic_DNA.
DR   EMBL; CH471059; EAX07378.1; -; Genomic_DNA.
DR   EMBL; BC071697; AAH71697.1; -; mRNA.
DR   EMBL; BC006241; AAH06241.1; -; mRNA.
DR   CCDS; CCDS406.1; -.
DR   RefSeq; NP_001291691.1; NM_001304762.1.
DR   RefSeq; NP_060636.1; NM_018166.2.
DR   RefSeq; XP_016857116.1; XM_017001627.1.
DR   UniGene; Hs.87016; -.
DR   ProteinModelPortal; Q9NVM1; -.
DR   BioGrid; 120491; 49.
DR   IntAct; Q9NVM1; 3.
DR   MINT; Q9NVM1; -.
DR   iPTMnet; Q9NVM1; -.
DR   PhosphoSitePlus; Q9NVM1; -.
DR   BioMuta; EVA1B; -.
DR   DMDM; 74752997; -.
DR   EPD; Q9NVM1; -.
DR   MaxQB; Q9NVM1; -.
DR   PaxDb; Q9NVM1; -.
DR   PeptideAtlas; Q9NVM1; -.
DR   PRIDE; Q9NVM1; -.
DR   TopDownProteomics; Q9NVM1; -.
DR   Ensembl; ENST00000270824; ENSP00000270824; ENSG00000142694.
DR   GeneID; 55194; -.
DR   KEGG; hsa:55194; -.
DR   UCSC; uc001caj.1; human.
DR   CTD; 55194; -.
DR   EuPathDB; HostDB:ENSG00000142694.6; -.
DR   GeneCards; EVA1B; -.
DR   H-InvDB; HIX0000424; -.
DR   HGNC; HGNC:25558; EVA1B.
DR   HPA; HPA041928; -.
DR   HPA; HPA043537; -.
DR   neXtProt; NX_Q9NVM1; -.
DR   OpenTargets; ENSG00000142694; -.
DR   PharmGKB; PA162387367; -.
DR   eggNOG; ENOG410IYHF; Eukaryota.
DR   eggNOG; ENOG4111P45; LUCA.
DR   GeneTree; ENSGT00900000140931; -.
DR   HOGENOM; HOG000294093; -.
DR   HOVERGEN; HBG061487; -.
DR   InParanoid; Q9NVM1; -.
DR   OMA; IRISCKP; -.
DR   OrthoDB; EOG091G10V2; -.
DR   PhylomeDB; Q9NVM1; -.
DR   TreeFam; TF352986; -.
DR   GenomeRNAi; 55194; -.
DR   PRO; PR:Q9NVM1; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000142694; -.
DR   CleanEx; HS_FAM176B; -.
DR   Genevisible; Q9NVM1; HS.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
PE   1: Evidence at protein level;
KW   Complete proteome; Membrane; Phosphoprotein; Reference proteome;
KW   Transmembrane; Transmembrane helix.
FT   CHAIN         1    165       Protein eva-1 homolog B.
FT                                /FTId=PRO_0000271112.
FT   TRANSMEM     29     49       Helical. {ECO:0000255}.
FT   MOD_RES      85     85       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:Q8K2Y3}.
FT   MOD_RES     148    148       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:Q8K2Y3}.
FT   MOD_RES     158    158       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:Q8K2Y3}.
SQ   SEQUENCE   165 AA;  18374 MW;  872485ABDE8B2565 CRC64;
     MDAPRRDMEL LSNSLAAYAH IRANPESFGL YFVLGVCFGL LLTLCLLVIS ISWAPRPRPR
     GPAQRRDPRS STLEPEDDDE DEEDTVTRLG PDDTLPGPEL SAEPDGPLNV NVFTSAEELE
     RAQRLEERER ILREIWRTGQ PDLLGTGTLG PSPTATGTLG RMHYY
//
ID   A0A024RDX4_HUMAN        Unreviewed;       390 AA.
AC   A0A024RDX4;
DT   09-JUL-2014, integrated into UniProtKB/TrEMBL.
DT   09-JUL-2014, sequence version 1.
DT   23-MAY-2018, entry version 32.
DE   RecName: Full=ATP-dependent (S)-NAD(P)H-hydrate dehydratase {ECO:0000256|HAMAP-Rule:MF_03157};
DE            EC=4.2.1.93 {ECO:0000256|HAMAP-Rule:MF_03157};
DE   AltName: Full=ATP-dependent NAD(P)HX dehydratase {ECO:0000256|HAMAP-Rule:MF_03157};
DE   AltName: Full=Carbohydrate kinase domain-containing protein {ECO:0000256|HAMAP-Rule:MF_03157};
GN   Name=FLJ10769 {ECO:0000313|EMBL:EAX09123.1};
GN   Synonyms=CARKD {ECO:0000256|HAMAP-Rule:MF_03157};
GN   ORFNames=hCG_32552 {ECO:0000313|EMBL:EAX09123.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:EAX09123.1};
RN   [1] {ECO:0000313|EMBL:EAX09123.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAX09123.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
CC   -!- FUNCTION: Catalyzes the dehydration of the S-form of NAD(P)HX at
CC       the expense of ATP, which is converted to ADP. Together with
CC       NAD(P)HX epimerase, which catalyzes the epimerization of the
CC       S- and R-forms, the enzyme allows the repair of both epimers of
CC       NAD(P)HX, a damaged form of NAD(P)H that is a result of enzymatic
CC       or heat-dependent hydration. {ECO:0000256|HAMAP-Rule:MF_03157}.
CC   -!- CATALYTIC ACTIVITY: ATP + (6S)-6-beta-hydroxy-1,4,5,6-
CC       tetrahydronicotinamide-adenine dinucleotide = ADP + phosphate +
CC       NADH. {ECO:0000256|HAMAP-Rule:MF_03157}.
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC         Evidence={ECO:0000256|HAMAP-Rule:MF_03157};
CC   -!- SUBCELLULAR LOCATION: Mitochondrion {ECO:0000256|HAMAP-
CC       Rule:MF_03157}.
CC   -!- SIMILARITY: Belongs to the NnrD/CARKD family. {ECO:0000256|HAMAP-
CC       Rule:MF_03157}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; CH471085; EAX09123.1; -; Genomic_DNA.
DR   RefSeq; NP_060680.2; NM_018210.3.
DR   UniGene; Hs.408324; -.
DR   ProteinModelPortal; A0A024RDX4; -.
DR   SMR; A0A024RDX4; -.
DR   GeneID; 55739; -.
DR   CTD; 55739; -.
DR   EuPathDB; HostDB:ENSG00000213995.11; -.
DR   eggNOG; KOG3974; Eukaryota.
DR   eggNOG; COG0063; LUCA.
DR   OMA; FASWARH; -.
DR   OrthoDB; EOG091G0CC8; -.
DR   PhylomeDB; A0A024RDX4; -.
DR   ChiTaRS; NAXD; human.
DR   GenomeRNAi; 55739; -.
DR   Bgee; ENSG00000213995; -.
DR   ExpressionAtlas; A0A024RDX4; baseline and differential.
DR   GO; GO:0005739; C:mitochondrion; IEA:UniProtKB-SubCell.
DR   GO; GO:0052855; F:ADP-dependent NAD(P)H-hydrate dehydratase activity; IEA:InterPro.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0047453; F:ATP-dependent NAD(P)H-hydrate dehydratase activity; IEA:UniProtKB-UniRule.
DR   GO; GO:0046496; P:nicotinamide nucleotide metabolic process; IEA:UniProtKB-UniRule.
DR   CDD; cd01171; YXKO-related; 1.
DR   Gene3D; 3.40.1190.20; -; 1.
DR   HAMAP; MF_01965; NADHX_dehydratase; 1.
DR   InterPro; IPR000631; CARKD.
DR   InterPro; IPR029056; Ribokinase-like.
DR   Pfam; PF01256; Carb_kinase; 1.
DR   SUPFAM; SSF53613; SSF53613; 1.
DR   TIGRFAMs; TIGR00196; yjeF_cterm; 1.
DR   PROSITE; PS51383; YJEF_C_3; 1.
PE   3: Inferred from homology;
KW   ATP-binding {ECO:0000256|HAMAP-Rule:MF_03157};
KW   Lyase {ECO:0000256|HAMAP-Rule:MF_03157};
KW   Mitochondrion {ECO:0000256|HAMAP-Rule:MF_03157};
KW   NAD {ECO:0000256|HAMAP-Rule:MF_03157};
KW   Nucleotide-binding {ECO:0000256|HAMAP-Rule:MF_03157};
KW   Phosphoprotein {ECO:0000256|HAMAP-Rule:MF_03157}.
FT   NP_BIND     246    250       ATP. {ECO:0000256|HAMAP-Rule:MF_03157}.
FT   NP_BIND     265    274       ATP. {ECO:0000256|HAMAP-Rule:MF_03157}.
FT   REGION      206    212       NAD(P)HX. {ECO:0000256|HAMAP-
FT                                Rule:MF_03157}.
FT   BINDING     153    153       NAD(P)HX; via amide nitrogen.
FT                                {ECO:0000256|HAMAP-Rule:MF_03157}.
FT   BINDING     275    275       NAD(P)HX. {ECO:0000256|HAMAP-
FT                                Rule:MF_03157}.
SQ   SEQUENCE   390 AA;  41360 MW;  8A32124EA07160CE CRC64;
     MVTRAGAGTA VAGAVVVALL SAALALYGPP LDAVLERAFS LRKAHSIKDM ENTLQLVRNI
     IPPLSSTKHK GQDGRIGVVG GCQEYTGAPY FAAISALKVG ADLSHVFCAS AAAPVIKAYS
     PELIVHPVLD SPNAVHEVEK WLPRLHALVV GPGLGRDDAL LRNVQGILEV SKARDIPVVI
     DADGLWLVAQ QPALIHGYRK AVLTPNHVEF SRLYDAVLRG PMDSDDSHGS VLRLSQALGN
     VTVVQKGERD ILSNGQQVLV CSQEGSSRRC GGQGDLLSGS LGVLVHWALL AGPQKTNGGI
     SDLKLTIWGP EIETGVKTRA QGSCGPRTTT PTSPHLLLSP SPQVQPSPGG RVWRLLSHQA
     VQPPSLPEAR SLHHHLRHDR RGGGRLQQAL
//
ID   NNRD_HUMAN              Reviewed;         347 AA.
AC   Q8IW45; B4DXT4; Q5T9X3; Q9H7W1; Q9NVF5;
DT   20-MAY-2008, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2003, sequence version 1.
DT   28-MAR-2018, entry version 118.
DE   RecName: Full=ATP-dependent (S)-NAD(P)H-hydrate dehydratase {ECO:0000255|HAMAP-Rule:MF_03157};
DE            EC=4.2.1.93 {ECO:0000255|HAMAP-Rule:MF_03157};
DE   AltName: Full=ATP-dependent NAD(P)HX dehydratase {ECO:0000255|HAMAP-Rule:MF_03157};
DE   AltName: Full=Carbohydrate kinase domain-containing protein {ECO:0000255|HAMAP-Rule:MF_03157};
DE   AltName: Full=NAD(P)HX dehydratase {ECO:0000312|HGNC:HGNC:25576};
GN   Name=NAXD {ECO:0000312|HGNC:HGNC:25576};
GN   Synonyms=CARKD {ECO:0000255|HAMAP-Rule:MF_03157};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 2; 3 AND 4).
RC   TISSUE=Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057823; DOI=10.1038/nature02379;
RA   Dunham A., Matthews L.H., Burton J., Ashurst J.L., Howe K.L.,
RA   Ashcroft K.J., Beare D.M., Burford D.C., Hunt S.E.,
RA   Griffiths-Jones S., Jones M.C., Keenan S.J., Oliver K., Scott C.E.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Andrews D.T.,
RA   Ashwell R.I.S., Babbage A.K., Bagguley C.L., Bailey J., Bannerjee R.,
RA   Barlow K.F., Bates K., Beasley H., Bird C.P., Bray-Allen S.,
RA   Brown A.J., Brown J.Y., Burrill W., Carder C., Carter N.P.,
RA   Chapman J.C., Clamp M.E., Clark S.Y., Clarke G., Clee C.M.,
RA   Clegg S.C., Cobley V., Collins J.E., Corby N., Coville G.J.,
RA   Deloukas P., Dhami P., Dunham I., Dunn M., Earthrowl M.E.,
RA   Ellington A.G., Faulkner L., Frankish A.G., Frankland J., French L.,
RA   Garner P., Garnett J., Gilbert J.G.R., Gilson C.J., Ghori J.,
RA   Grafham D.V., Gribble S.M., Griffiths C., Hall R.E., Hammond S.,
RA   Harley J.L., Hart E.A., Heath P.D., Howden P.J., Huckle E.J.,
RA   Hunt P.J., Hunt A.R., Johnson C., Johnson D., Kay M., Kimberley A.M.,
RA   King A., Laird G.K., Langford C.J., Lawlor S., Leongamornlert D.A.,
RA   Lloyd D.M., Lloyd C., Loveland J.E., Lovell J., Martin S.,
RA   Mashreghi-Mohammadi M., McLaren S.J., McMurray A., Milne S.,
RA   Moore M.J.F., Nickerson T., Palmer S.A., Pearce A.V., Peck A.I.,
RA   Pelan S., Phillimore B., Porter K.M., Rice C.M., Searle S.,
RA   Sehra H.K., Shownkeen R., Skuce C.D., Smith M., Steward C.A.,
RA   Sycamore N., Tester J., Thomas D.W., Tracey A., Tromans A., Tubby B.,
RA   Wall M., Wallis J.M., West A.P., Whitehead S.L., Willey D.L.,
RA   Wilming L., Wray P.W., Wright M.W., Young L., Coulson A., Durbin R.M.,
RA   Hubbard T., Sulston J.E., Beck S., Bentley D.R., Rogers J., Ross M.T.;
RT   "The DNA sequence and analysis of human chromosome 13.";
RL   Nature 428:522-528(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-240.
RC   TISSUE=Liver;
RX   PubMed=19159218; DOI=10.1021/pr8008012;
RA   Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.;
RT   "Glycoproteomics analysis of human liver tissue by combination of
RT   multiple enzyme digestion and hydrazide chemistry.";
RL   J. Proteome Res. 8:651-661(2009).
RN   [6]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
CC   -!- FUNCTION: Catalyzes the dehydration of the S-form of NAD(P)HX at
CC       the expense of ATP, which is converted to ADP. Together with
CC       NAD(P)HX epimerase, which catalyzes the epimerization of the
CC       S- and R-forms, the enzyme allows the repair of both epimers of
CC       NAD(P)HX, a damaged form of NAD(P)H that is a result of enzymatic
CC       or heat-dependent hydration. {ECO:0000255|HAMAP-Rule:MF_03157}.
CC   -!- CATALYTIC ACTIVITY: ATP + (6S)-6-beta-hydroxy-1,4,5,6-
CC       tetrahydronicotinamide-adenine dinucleotide = ADP + phosphate +
CC       NADH. {ECO:0000255|HAMAP-Rule:MF_03157}.
CC   -!- CATALYTIC ACTIVITY: ATP + (6S)-6-beta-hydroxy-1,4,5,6-
CC       tetrahydronicotinamide-adenine dinucleotide phosphate = ADP +
CC       phosphate + NADPH.
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC         Evidence={ECO:0000255|HAMAP-Rule:MF_03157};
CC   -!- INTERACTION:
CC       Q15323:KRT31; NbExp=3; IntAct=EBI-8650724, EBI-948001;
CC       P60409:KRTAP10-7; NbExp=3; IntAct=EBI-8650724, EBI-10172290;
CC       P60410:KRTAP10-8; NbExp=5; IntAct=EBI-8650724, EBI-10171774;
CC       P60411:KRTAP10-9; NbExp=3; IntAct=EBI-8650724, EBI-10172052;
CC       P26371:KRTAP5-9; NbExp=3; IntAct=EBI-8650724, EBI-3958099;
CC       Q7Z3S9:NOTCH2NL; NbExp=3; IntAct=EBI-8650724, EBI-945833;
CC       O43765:SGTA; NbExp=6; IntAct=EBI-8650724, EBI-347996;
CC       Q9UMX0:UBQLN1; NbExp=3; IntAct=EBI-8650724, EBI-741480;
CC       Q9UMX0-2:UBQLN1; NbExp=3; IntAct=EBI-8650724, EBI-10173939;
CC   -!- SUBCELLULAR LOCATION: Mitochondrion {ECO:0000255|HAMAP-
CC       Rule:MF_03157}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1;
CC         IsoId=Q8IW45-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q8IW45-2; Sequence=VSP_033830;
CC       Name=3;
CC         IsoId=Q8IW45-3; Sequence=VSP_033829;
CC       Name=4;
CC         IsoId=Q8IW45-4; Sequence=VSP_042012;
CC         Note=No experimental confirmation available.;
CC   -!- MISCELLANEOUS: This protein may be expected to contain an N-
CC       terminal transit peptide but none has been predicted.
CC       {ECO:0000255|HAMAP-Rule:MF_03157}.
CC   -!- SIMILARITY: Belongs to the NnrD/CARKD family. {ECO:0000255|HAMAP-
CC       Rule:MF_03157}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK001631; BAA91797.1; -; mRNA.
DR   EMBL; AK024260; BAB14863.1; -; mRNA.
DR   EMBL; AK302117; BAG63496.1; -; mRNA.
DR   EMBL; AL139385; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471085; EAX09121.1; -; Genomic_DNA.
DR   EMBL; CH471085; EAX09125.1; -; Genomic_DNA.
DR   EMBL; BC041028; AAH41028.1; -; mRNA.
DR   CCDS; CCDS55903.1; -. [Q8IW45-4]
DR   CCDS; CCDS9513.1; -. [Q8IW45-2]
DR   RefSeq; NP_001229810.1; NM_001242881.1. [Q8IW45-1]
DR   RefSeq; NP_001229811.1; NM_001242882.1.
DR   RefSeq; NP_001229812.1; NM_001242883.1. [Q8IW45-4]
DR   RefSeq; NP_060680.2; NM_018210.3. [Q8IW45-2]
DR   UniGene; Hs.408324; -.
DR   ProteinModelPortal; Q8IW45; -.
DR   SMR; Q8IW45; -.
DR   BioGrid; 120857; 37.
DR   IntAct; Q8IW45; 16.
DR   MINT; Q8IW45; -.
DR   STRING; 9606.ENSP00000311984; -.
DR   iPTMnet; Q8IW45; -.
DR   PhosphoSitePlus; Q8IW45; -.
DR   BioMuta; CARKD; -.
DR   DMDM; 74728128; -.
DR   EPD; Q8IW45; -.
DR   MaxQB; Q8IW45; -.
DR   PaxDb; Q8IW45; -.
DR   PeptideAtlas; Q8IW45; -.
DR   PRIDE; Q8IW45; -.
DR   Ensembl; ENST00000309957; ENSP00000311984; ENSG00000213995. [Q8IW45-2]
DR   Ensembl; ENST00000424185; ENSP00000413191; ENSG00000213995. [Q8IW45-4]
DR   GeneID; 55739; -.
DR   KEGG; hsa:55739; -.
DR   UCSC; uc001vrc.4; human. [Q8IW45-1]
DR   CTD; 55739; -.
DR   DisGeNET; 55739; -.
DR   EuPathDB; HostDB:ENSG00000213995.11; -.
DR   GeneCards; NAXD; -.
DR   H-InvDB; HIX0011456; -.
DR   H-InvDB; HIX0011457; -.
DR   H-InvDB; HIX0171873; -.
DR   HGNC; HGNC:25576; NAXD.
DR   HPA; HPA010551; -.
DR   MIM; 615910; gene.
DR   neXtProt; NX_Q8IW45; -.
DR   OpenTargets; ENSG00000213995; -.
DR   PharmGKB; PA164717652; -.
DR   eggNOG; KOG3974; Eukaryota.
DR   eggNOG; COG0063; LUCA.
DR   GeneTree; ENSGT00390000000917; -.
DR   HOGENOM; HOG000163126; -.
DR   HOVERGEN; HBG103700; -.
DR   InParanoid; Q8IW45; -.
DR   KO; K17757; -.
DR   OMA; FASWARH; -.
DR   PhylomeDB; Q8IW45; -.
DR   TreeFam; TF300116; -.
DR   BioCyc; MetaCyc:ENSG00000153481-MONOMER; -.
DR   Reactome; R-HSA-197264; Nicotinamide salvaging.
DR   ChiTaRS; NAXD; human.
DR   GeneWiki; CARKD; -.
DR   GenomeRNAi; 55739; -.
DR   PRO; PR:Q8IW45; -.
DR   Proteomes; UP000005640; Chromosome 13.
DR   Bgee; ENSG00000213995; -.
DR   CleanEx; HS_CARKD; -.
DR   ExpressionAtlas; Q8IW45; baseline and differential.
DR   Genevisible; Q8IW45; HS.
DR   GO; GO:0005759; C:mitochondrial matrix; TAS:Reactome.
DR   GO; GO:0052855; F:ADP-dependent NAD(P)H-hydrate dehydratase activity; IEA:InterPro.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0047453; F:ATP-dependent NAD(P)H-hydrate dehydratase activity; TAS:Reactome.
DR   GO; GO:0034356; P:NAD biosynthesis via nicotinamide riboside salvage pathway; TAS:Reactome.
DR   CDD; cd01171; YXKO-related; 1.
DR   Gene3D; 3.40.1190.20; -; 1.
DR   HAMAP; MF_01965; NADHX_dehydratase; 1.
DR   InterPro; IPR000631; CARKD.
DR   InterPro; IPR029056; Ribokinase-like.
DR   Pfam; PF01256; Carb_kinase; 1.
DR   SUPFAM; SSF53613; SSF53613; 1.
DR   TIGRFAMs; TIGR00196; yjeF_cterm; 1.
DR   PROSITE; PS51383; YJEF_C_3; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; ATP-binding; Complete proteome; Glycoprotein;
KW   Lyase; Mitochondrion; NAD; NADP; Nucleotide-binding; Phosphoprotein;
KW   Polymorphism; Reference proteome.
FT   CHAIN         1    347       ATP-dependent (S)-NAD(P)H-hydrate
FT                                dehydratase.
FT                                /FTId=PRO_0000337021.
FT   DOMAIN       53    344       YjeF C-terminal. {ECO:0000255|HAMAP-
FT                                Rule:MF_03157}.
FT   NP_BIND     246    250       ATP. {ECO:0000255|HAMAP-Rule:MF_03157}.
FT   NP_BIND     265    274       ATP. {ECO:0000255|HAMAP-Rule:MF_03157}.
FT   REGION      206    212       NAD(P)HX. {ECO:0000255|HAMAP-
FT                                Rule:MF_03157}.
FT   BINDING     153    153       NAD(P)HX; via amide nitrogen.
FT                                {ECO:0000255|HAMAP-Rule:MF_03157}.
FT   BINDING     275    275       NAD(P)HX. {ECO:0000255|HAMAP-
FT                                Rule:MF_03157}.
FT   MOD_RES      85     85       Phosphotyrosine.
FT                                {ECO:0000250|UniProtKB:Q9CZ42}.
FT   CARBOHYD    240    240       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:19159218}.
FT   CARBOHYD    297    297       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   VAR_SEQ       1    221       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_033829.
FT   VAR_SEQ       1    129       MVTRAGAGTAVAGAVVVALLSAALALYGPPLDAVLERAFSL
FT                                RKAHSIKDMENTLQLVRNIIPPLSSTKHKGQDGRIGVVGGC
FT                                QEYTGAPYFAAISALKVGADLSHVFCASAAAPVIKAYSPEL
FT                                IVHPVL -> MLPDGPGSSLWGNPGLQTS (in isoform
FT                                4). {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_042012.
FT   VAR_SEQ     299    347       SSPLLVAAFGACSLTRQCNHQAFQKHGRSTTTSDMIAEVGA
FT                                AFSKLFET -> GISDLKLTIWGPEIETGVKTRAQGSCGPR
FT                                TTTPTSPHLLLSPSPQVQPSPGGRVWRLLSHQAVQPPSLPE
FT                                ARSLHHHLRHDRRGGGRLQQAL (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_033830.
FT   VARIANT     140    140       K -> E (in dbSNP:rs3742191).
FT                                /FTId=VAR_043564.
FT   VARIANT     149    149       V -> I (in dbSNP:rs3742192).
FT                                /FTId=VAR_043565.
FT   VARIANT     152    152       P -> T (in dbSNP:rs1044112).
FT                                /FTId=VAR_043566.
FT   CONFLICT    206    206       N -> D (in Ref. 1; BAA91797).
FT                                {ECO:0000305}.
FT   CONFLICT    253    253       S -> P (in Ref. 1; BAB14863).
FT                                {ECO:0000305}.
SQ   SEQUENCE   347 AA;  36576 MW;  70D42B97D6E8A41B CRC64;
     MVTRAGAGTA VAGAVVVALL SAALALYGPP LDAVLERAFS LRKAHSIKDM ENTLQLVRNI
     IPPLSSTKHK GQDGRIGVVG GCQEYTGAPY FAAISALKVG ADLSHVFCAS AAAPVIKAYS
     PELIVHPVLD SPNAVHEVEK WLPRLHALVV GPGLGRDDAL LRNVQGILEV SKARDIPVVI
     DADGLWLVAQ QPALIHGYRK AVLTPNHVEF SRLYDAVLRG PMDSDDSHGS VLRLSQALGN
     VTVVQKGERD ILSNGQQVLV CSQEGSSRRC GGQGDLLSGS LGVLVHWALL AGPQKTNGSS
     PLLVAAFGAC SLTRQCNHQA FQKHGRSTTT SDMIAEVGAA FSKLFET
//
ID   MYDGF_HUMAN             Reviewed;         173 AA.
AC   Q969H8; D6W628; O75256; O75272; Q9BTK7; Q9NP69;
DT   05-JUL-2004, integrated into UniProtKB/Swiss-Prot.
DT   01-DEC-2001, sequence version 1.
DT   23-MAY-2018, entry version 130.
DE   RecName: Full=Myeloid-derived growth factor {ECO:0000303|PubMed:25581518, ECO:0000312|HGNC:HGNC:16948};
DE            Short=MYDGF {ECO:0000303|PubMed:25581518};
DE   AltName: Full=Interleukin-25 {ECO:0000303|PubMed:11714798};
DE            Short=IL-25 {ECO:0000303|PubMed:11714798};
DE   AltName: Full=Stromal cell-derived growth factor SF20 {ECO:0000303|PubMed:11714798};
DE   Flags: Precursor;
GN   Name=MYDGF {ECO:0000312|HGNC:HGNC:16948};
GN   Synonyms=C19orf10 {ECO:0000312|HGNC:HGNC:16948},
GN   IL25 {ECO:0000303|PubMed:11714798};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Bone marrow;
RX   PubMed=11714798; DOI=10.4049/jimmunol.167.11.6338;
RA   Tulin E.E., Onoda N., Nakata Y., Maeda M., Hasegawa M., Nomura H.,
RA   Kitamura T.;
RT   "SF20/IL-25, a novel bone marrow stroma-derived growth factor that
RT   binds to mouse thymic shared antigen-1 and supports lymphoid cell
RT   proliferation.";
RL   J. Immunol. 167:6338-6347(2001).
RN   [2]
RP   ERRATUM, AND RETRACTION.
RX   PubMed=12538725; DOI=10.4049/jimmunol.170.3.1593;
RA   Tulin E.E., Onoda N., Nakata Y., Maeda M., Hasegawa M., Nomura H.,
RA   Kitamura T.;
RL   J. Immunol. 170:1593-1593(2003).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057824; DOI=10.1038/nature02399;
RA   Grimwood J., Gordon L.A., Olsen A.S., Terry A., Schmutz J.,
RA   Lamerdin J.E., Hellsten U., Goodstein D., Couronne O., Tran-Gyamfi M.,
RA   Aerts A., Altherr M., Ashworth L., Bajorek E., Black S., Branscomb E.,
RA   Caenepeel S., Carrano A.V., Caoile C., Chan Y.M., Christensen M.,
RA   Cleland C.A., Copeland A., Dalin E., Dehal P., Denys M., Detter J.C.,
RA   Escobar J., Flowers D., Fotopulos D., Garcia C., Georgescu A.M.,
RA   Glavina T., Gomez M., Gonzales E., Groza M., Hammon N., Hawkins T.,
RA   Haydu L., Ho I., Huang W., Israni S., Jett J., Kadner K., Kimball H.,
RA   Kobayashi A., Larionov V., Leem S.-H., Lopez F., Lou Y., Lowry S.,
RA   Malfatti S., Martinez D., McCready P.M., Medina C., Morgan J.,
RA   Nelson K., Nolan M., Ovcharenko I., Pitluck S., Pollard M.,
RA   Popkie A.P., Predki P., Quan G., Ramirez L., Rash S., Retterer J.,
RA   Rodriguez A., Rogers S., Salamov A., Salazar A., She X., Smith D.,
RA   Slezak T., Solovyev V., Thayer N., Tice H., Tsai M., Ustaszewska A.,
RA   Vo N., Wagner M., Wheeler J., Wu K., Xie G., Yang J., Dubchak I.,
RA   Furey T.S., DeJong P., Dickson M., Gordon D., Eichler E.E.,
RA   Pennacchio L.A., Richardson P., Stubbs L., Rokhsar D.S., Myers R.M.,
RA   Rubin E.M., Lucas S.M.;
RT   "The DNA sequence and biology of human chromosome 19.";
RL   Nature 428:529-535(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Kidney, and Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 4-173.
RG   The European IMAGE consortium;
RL   Submitted (JUL-2000) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   PROTEIN SEQUENCE [LARGE SCALE ANALYSIS] OF 32-44.
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19892738; DOI=10.1073/pnas.0908958106;
RA   Xu G., Shin S.B., Jaffrey S.R.;
RT   "Global profiling of protease cleavage sites by chemoselective
RT   labeling of protein N-termini.";
RL   Proc. Natl. Acad. Sci. U.S.A. 106:19310-19315(2009).
RN   [8]
RP   TISSUE SPECIFICITY, AND SUBCELLULAR LOCATION.
RX   PubMed=17362502; DOI=10.1186/ar2145;
RA   Weiler T., Du Q., Krokhin O., Ens W., Standing K., El-Gabalawy H.,
RA   Wilkins J.A.;
RT   "The identification and characterization of a novel protein, c19orf10,
RT   in the synovium.";
RL   Arthritis Res. Ther. 9:R30-R30(2007).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [10]
RP   FUNCTION, SUBCELLULAR LOCATION, TISSUE SPECIFICITY, AND INDUCTION.
RX   PubMed=25581518; DOI=10.1038/nm.3778;
RA   Korf-Klingebiel M., Reboll M.R., Klede S., Brod T., Pich A.,
RA   Polten F., Napp L.C., Bauersachs J., Ganser A., Brinkmann E.,
RA   Reimann I., Kempf T., Niessen H.W., Mizrahi J., Schoenfeld H.J.,
RA   Iglesias A., Bobadilla M., Wang Y., Wollert K.C.;
RT   "Myeloid-derived growth factor (C19orf10) mediates cardiac repair
RT   following myocardial infarction.";
RL   Nat. Med. 21:140-149(2015).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
CC   -!- FUNCTION: Bone marrow-derived monocyte and paracrine-acting
CC       protein that promotes cardiac myocyte survival and adaptive
CC       angiogenesis for cardiac protection and/or repair after myocardial
CC       infarction (MI). Stimulates endothelial cell proliferation through
CC       a MAPK1/3-, STAT3- and CCND1-mediated signaling pathway. Inhibits
CC       cardiac myocyte apoptosis in a PI3K/AKT-dependent signaling
CC       pathway (By similarity). Involved in endothelial cell
CC       proliferation and angiogenesis (PubMed:25581518).
CC       {ECO:0000250|UniProtKB:Q9CPT4, ECO:0000269|PubMed:25581518}.
CC   -!- INTERACTION:
CC       Q9NPJ3:ACOT13; NbExp=4; IntAct=EBI-718622, EBI-1045357;
CC       O43765:SGTA; NbExp=5; IntAct=EBI-718622, EBI-347996;
CC       Q9UHD9:UBQLN2; NbExp=4; IntAct=EBI-718622, EBI-947187;
CC   -!- SUBCELLULAR LOCATION: Secreted {ECO:0000269|PubMed:17362502,
CC       ECO:0000269|PubMed:25581518}. Endoplasmic reticulum-Golgi
CC       intermediate compartment {ECO:0000269|PubMed:17362502}.
CC       Note=Secreted into blood plasma. {ECO:0000269|PubMed:25581518}.
CC   -!- TISSUE SPECIFICITY: Expressed in bone marrow cells
CC       (PubMed:25581518). Expressed in synovial tissue. Found in synovial
CC       fluid of patients with arthropaties (PubMed:17362502).
CC       {ECO:0000269|PubMed:17362502, ECO:0000269|PubMed:25581518}.
CC   -!- INDUCTION: Up-regulated in response to myocardial infarction (MI).
CC       {ECO:0000269|PubMed:25581518}.
CC   -!- SIMILARITY: Belongs to the MYDGF family. {ECO:0000305}.
CC   -!- CAUTION: Was originally thought to signal lymphoid cells to
CC       proliferate via thymic shared antigen 1, but this work has been
CC       later retracted (PubMed:11714798, PubMed:12538725).
CC       {ECO:0000305|PubMed:11714798, ECO:0000305|PubMed:12538725}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAC27824.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC       Sequence=AAC33800.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AC005594; AAC33800.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; AC005339; AAC27824.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; CH471139; EAW69202.1; -; Genomic_DNA.
DR   EMBL; CH471139; EAW69203.1; -; Genomic_DNA.
DR   EMBL; BC003639; AAH03639.2; -; mRNA.
DR   EMBL; BC010129; AAH10129.1; -; mRNA.
DR   EMBL; BC014655; AAH14655.1; -; mRNA.
DR   EMBL; AL365373; CAB96947.1; -; mRNA.
DR   EMBL; AL365374; CAB96948.1; -; mRNA.
DR   CCDS; CCDS12133.1; -.
DR   RefSeq; NP_061980.1; NM_019107.3.
DR   UniGene; Hs.465645; -.
DR   ProteinModelPortal; Q969H8; -.
DR   BioGrid; 121028; 9.
DR   IntAct; Q969H8; 12.
DR   STRING; 9606.ENSP00000262947; -.
DR   iPTMnet; Q969H8; -.
DR   PhosphoSitePlus; Q969H8; -.
DR   SwissPalm; Q969H8; -.
DR   BioMuta; C19orf10; -.
DR   DMDM; 61221730; -.
DR   UCD-2DPAGE; Q969H8; -.
DR   EPD; Q969H8; -.
DR   MaxQB; Q969H8; -.
DR   PaxDb; Q969H8; -.
DR   PeptideAtlas; Q969H8; -.
DR   PRIDE; Q969H8; -.
DR   TopDownProteomics; Q969H8; -.
DR   Ensembl; ENST00000262947; ENSP00000262947; ENSG00000074842.
DR   GeneID; 56005; -.
DR   KEGG; hsa:56005; -.
DR   UCSC; uc002may.4; human.
DR   CTD; 56005; -.
DR   DisGeNET; 56005; -.
DR   EuPathDB; HostDB:ENSG00000074842.7; -.
DR   GeneCards; MYDGF; -.
DR   H-InvDB; HIX0014670; -.
DR   HGNC; HGNC:16948; MYDGF.
DR   HPA; HPA041872; -.
DR   HPA; HPA046744; -.
DR   MIM; 606746; gene.
DR   neXtProt; NX_Q969H8; -.
DR   OpenTargets; ENSG00000074842; -.
DR   PharmGKB; PA29827; -.
DR   eggNOG; ENOG410IKDN; Eukaryota.
DR   eggNOG; ENOG41126BF; LUCA.
DR   GeneTree; ENSGT00390000000777; -.
DR   HOGENOM; HOG000236299; -.
DR   HOVERGEN; HBG051127; -.
DR   InParanoid; Q969H8; -.
DR   OMA; GGTNEKW; -.
DR   PhylomeDB; Q969H8; -.
DR   TreeFam; TF332795; -.
DR   Reactome; R-HSA-381038; XBP1(S) activates chaperone genes.
DR   ChiTaRS; MYDGF; human.
DR   GenomeRNAi; 56005; -.
DR   PRO; PR:Q969H8; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   Bgee; ENSG00000074842; -.
DR   CleanEx; HS_C19orf10; -.
DR   CleanEx; HS_IL25; -.
DR   ExpressionAtlas; Q969H8; baseline and differential.
DR   Genevisible; Q969H8; HS.
DR   GO; GO:0005788; C:endoplasmic reticulum lumen; TAS:Reactome.
DR   GO; GO:0005793; C:endoplasmic reticulum-Golgi intermediate compartment; IEA:UniProtKB-SubCell.
DR   GO; GO:0005615; C:extracellular space; IDA:UniProtKB.
DR   GO; GO:0001525; P:angiogenesis; IEA:UniProtKB-KW.
DR   GO; GO:0006915; P:apoptotic process; IEA:UniProtKB-KW.
DR   GO; GO:0036498; P:IRE1-mediated unfolded protein response; TAS:Reactome.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; ISS:UniProtKB.
DR   GO; GO:0045766; P:positive regulation of angiogenesis; IDA:UniProtKB.
DR   GO; GO:0001938; P:positive regulation of endothelial cell proliferation; IDA:UniProtKB.
DR   GO; GO:0043410; P:positive regulation of MAPK cascade; ISS:UniProtKB.
DR   GO; GO:0014068; P:positive regulation of phosphatidylinositol 3-kinase signaling; ISS:UniProtKB.
DR   GO; GO:0051897; P:positive regulation of protein kinase B signaling; ISS:UniProtKB.
DR   GO; GO:0001934; P:positive regulation of protein phosphorylation; ISS:UniProtKB.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; ISS:UniProtKB.
DR   InterPro; IPR018887; MYDGF.
DR   PANTHER; PTHR31230; PTHR31230; 1.
DR   Pfam; PF10572; UPF0556; 1.
PE   1: Evidence at protein level;
KW   Angiogenesis; Apoptosis; Complete proteome; Direct protein sequencing;
KW   Polymorphism; Reference proteome; Secreted; Signal.
FT   SIGNAL        1     31       {ECO:0000269|PubMed:19892738}.
FT   CHAIN        32    173       Myeloid-derived growth factor.
FT                                /FTId=PRO_0000021008.
FT   VARIANT      12     12       G -> R (in dbSNP:rs2270090).
FT                                /FTId=VAR_060183.
SQ   SEQUENCE   173 AA;  18795 MW;  DD8910DEFEA5E3FC CRC64;
     MAAPSGGWNG VGASLWAALL LGAVALRPAE AVSEPTTVAF DVRPGGVVHS FSHNVGPGDK
     YTCMFTYASQ GGTNEQWQMS LGTSEDHQHF TCTIWRPQGK SYLYFTQFKA EVRGAEIEYA
     MAYSKAAFER ESDVPLKTEE FEVTKTAVAH RPGAFKAELS KLVIVAKASR TEL
//
ID   Q59H34_HUMAN            Unreviewed;       921 AA.
AC   Q59H34;
DT   26-APR-2005, integrated into UniProtKB/TrEMBL.
DT   26-APR-2005, sequence version 1.
DT   31-JAN-2018, entry version 81.
DE   SubName: Full=Protocadherin alpha 4 isoform 1 variant {ECO:0000313|EMBL:BAD92162.1};
DE   Flags: Fragment;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAD92162.1};
RN   [1] {ECO:0000313|EMBL:BAD92162.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Brain {ECO:0000313|EMBL:BAD92162.1};
RA   Totoki Y., Toyoda A., Takeda T., Sakaki Y., Tanaka A., Yokoyama S.,
RA   Ohara O., Nagase T., Kikuno R.F.;
RT   "Homo sapiens protein coding cDNA.";
RL   Submitted (MAR-2005) to the EMBL/GenBank/DDBJ databases.
CC   -!- SUBCELLULAR LOCATION: Cell membrane
CC       {ECO:0000256|SAAS:SAAS00533980}; Single-pass type I membrane
CC       protein {ECO:0000256|SAAS:SAAS00533980}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB208925; BAD92162.1; -; mRNA.
DR   RefSeq; NP_061730.1; NM_018907.3.
DR   RefSeq; NP_113688.1; NM_031500.2.
DR   UniGene; Hs.199343; -.
DR   ProteinModelPortal; Q59H34; -.
DR   PeptideAtlas; Q59H34; -.
DR   PRIDE; Q59H34; -.
DR   GeneID; 56144; -.
DR   KEGG; hsa:56144; -.
DR   CTD; 56144; -.
DR   eggNOG; KOG3594; Eukaryota.
DR   eggNOG; ENOG410XQHI; LUCA.
DR   HOVERGEN; HBG054878; -.
DR   KO; K16493; -.
DR   GenomeRNAi; 56144; -.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   GO; GO:0007156; P:homophilic cell adhesion via plasma membrane adhesion molecules; IEA:InterPro.
DR   InterPro; IPR002126; Cadherin.
DR   InterPro; IPR015919; Cadherin-like.
DR   InterPro; IPR031904; Cadherin_CBD.
DR   InterPro; IPR020894; Cadherin_CS.
DR   InterPro; IPR013164; Cadherin_N.
DR   Pfam; PF00028; Cadherin; 5.
DR   Pfam; PF08266; Cadherin_2; 1.
DR   Pfam; PF15974; Cadherin_tail; 1.
DR   PRINTS; PR00205; CADHERIN.
DR   SMART; SM00112; CA; 6.
DR   SUPFAM; SSF49313; SSF49313; 6.
DR   PROSITE; PS00232; CADHERIN_1; 3.
PE   2: Evidence at transcript level;
KW   Calcium {ECO:0000256|SAAS:SAAS00806088};
KW   Cell adhesion {ECO:0000256|SAAS:SAAS00049551};
KW   Cell membrane {ECO:0000256|SAAS:SAAS00441280};
KW   Membrane {ECO:0000256|SAAS:SAAS00049552,
KW   ECO:0000256|SAAS:SAAS00441280, ECO:0000256|SAM:Phobius};
KW   Repeat {ECO:0000256|SAAS:SAAS00806097};
KW   Transmembrane {ECO:0000256|SAAS:SAAS00049552,
KW   ECO:0000256|SAM:Phobius};
KW   Transmembrane helix {ECO:0000256|SAAS:SAAS00049552,
KW   ECO:0000256|SAM:Phobius}.
FT   TRANSMEM    718    738       Helical. {ECO:0000256|SAM:Phobius}.
FT   DOMAIN       65    151       CA. {ECO:0000259|SMART:SM00112}.
FT   DOMAIN      175    260       CA. {ECO:0000259|SMART:SM00112}.
FT   DOMAIN      284    368       CA. {ECO:0000259|SMART:SM00112}.
FT   DOMAIN      392    473       CA. {ECO:0000259|SMART:SM00112}.
FT   DOMAIN      497    583       CA. {ECO:0000259|SMART:SM00112}.
FT   DOMAIN      614    696       CA. {ECO:0000259|SMART:SM00112}.
FT   NON_TER       1      1       {ECO:0000313|EMBL:BAD92162.1}.
SQ   SEQUENCE   921 AA;  99712 MW;  534CAFC63ED8092B CRC64;
     KISLDFEKRY LIRTKYCALK MEFSWGSGQE SRRLLLLLLL LAAWEAGNGQ LHYSVSEEAK
     HGTFVGRIAQ DLGLELAELV PRLFRVASKG RGGLLEVNLQ NGILFVNSRI DREELCRRSA
     ECSIHLEVIV DRPLQVFHVD VEVRDINDNP PVFPATQKNL SIAESRPLDS RFPLEGASDA
     DIGENALLTY RLSPNEYFSL EKPPDDELVK GLGLILRKSL DREEAPEIFL VLTATDGGKP
     ELTGTVQLLI TVLDANDNAP AFDRTIYKVR LLENVPNGTL VIKLNASDLD EGLNGDIVYS
     FSNDISPNVK SKFHIDPITG QIIVKGYIDF EESKSYEIIV EGIDKGQLPL SGHCRVIVEV
     EDNNDNVPDL EFKSLSLPIR EDAPLGTVIA LISVSDKDMG VNGLVTCSLT SHVPFKLVST
     FKNYYSLVLD SALDRESVSA YELVVTARDG GSPSLWATAS VSVEVADVND NAPAFAQPEY
     TVFVKENNPP GCHIFTVSAW DADAQENALV SYSLVERRVG ERALSSYVSV HAESGKVYAL
     QPLDHEELEL LQFQVTARDA GVPPLGSNVT LQVFVLDEND NAPALLAPRA GGTGGAVSEL
     VPWSVGVGHV VAKVRAVDAD SGYNAWLSYE LQPGTGGARI PFRVGLYTGE ISTTRALDET
     DAPRHRLLVL VKDHGEPALT ATATVLVSLV ESGQAPKASS RALVGAVGPD AALVDVNVYL
     IIAICAVSSL LVLTLLLYTA LRCSALPTEG ACAPGKPTLV CSSAVGSWSY SQQRRPRVCS
     GEGPPKTDLM AFSPSLPDSR DREDQLQTTE ESFAKPRQPN PDWRYSASLR AGMHSSVHLE
     EAGILRAGPG GPDQQWPTVS SATPEPEAGE VSPPVGAGVN SNSWTFKYGP GNPKQSGPEP
     KKQTQVSFLL RRKGEASQPR Q
//
ID   PCDA4_HUMAN             Reviewed;         947 AA.
AC   Q9UN74; O75285; Q2M253;
DT   27-APR-2001, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-2000, sequence version 1.
DT   28-FEB-2018, entry version 153.
DE   RecName: Full=Protocadherin alpha-4 {ECO:0000305};
DE            Short=PCDH-alpha-4 {ECO:0000305};
DE   Flags: Precursor;
GN   Name=PCDHA4 {ECO:0000312|HGNC:HGNC:8670};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Brain;
RX   PubMed=10380929; DOI=10.1016/S0092-8674(00)80789-8;
RA   Wu Q., Maniatis T.;
RT   "A striking organization of a large family of human neural cadherin-
RT   like cell adhesion genes.";
RL   Cell 97:779-790(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15372022; DOI=10.1038/nature02919;
RA   Schmutz J., Martin J., Terry A., Couronne O., Grimwood J., Lowry S.,
RA   Gordon L.A., Scott D., Xie G., Huang W., Hellsten U., Tran-Gyamfi M.,
RA   She X., Prabhakar S., Aerts A., Altherr M., Bajorek E., Black S.,
RA   Branscomb E., Caoile C., Challacombe J.F., Chan Y.M., Denys M.,
RA   Detter J.C., Escobar J., Flowers D., Fotopulos D., Glavina T.,
RA   Gomez M., Gonzales E., Goodstein D., Grigoriev I., Groza M.,
RA   Hammon N., Hawkins T., Haydu L., Israni S., Jett J., Kadner K.,
RA   Kimball H., Kobayashi A., Lopez F., Lou Y., Martinez D., Medina C.,
RA   Morgan J., Nandkeshwar R., Noonan J.P., Pitluck S., Pollard M.,
RA   Predki P., Priest J., Ramirez L., Retterer J., Rodriguez A.,
RA   Rogers S., Salamov A., Salazar A., Thayer N., Tice H., Tsai M.,
RA   Ustaszewska A., Vo N., Wheeler J., Wu K., Yang J., Dickson M.,
RA   Cheng J.-F., Eichler E.E., Olsen A., Pennacchio L.A., Rokhsar D.S.,
RA   Richardson P., Lucas S.M., Myers R.M., Rubin E.M.;
RT   "The DNA sequence and comparative analysis of human chromosome 5.";
RL   Nature 431:268-274(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -!- FUNCTION: Calcium-dependent cell-adhesion protein involved in
CC       cells self-recognition and non-self discrimination. Thereby, it is
CC       involved in the establishment and maintenance of specific neuronal
CC       connections in the brain. {ECO:0000250|UniProtKB:O88689}.
CC   -!- SUBUNIT: Forms homodimers in trans (molecules expressed by two
CC       different cells). Forms promiscuous heterodimers in cis (at the
CC       plasma membrane of the same cell) with other protocadherins.
CC       Interacts with FYN. {ECO:0000250|UniProtKB:O88689}.
CC   -!- INTERACTION:
CC       O43765:SGTA; NbExp=3; IntAct=EBI-712273, EBI-347996;
CC   -!- SUBCELLULAR LOCATION: Cell membrane
CC       {ECO:0000250|UniProtKB:O88689}; Single-pass type I membrane
CC       protein {ECO:0000250|UniProtKB:O88689}. Note=Detected in dendrites
CC       and synapses. {ECO:0000250|UniProtKB:O88689}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9UN74-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9UN74-2; Sequence=VSP_000677, VSP_000678;
CC   -!- DOMAIN: Cadherin 1 to cadherin 4 domains mediate homophilic trans-
CC       interaction, the interaction with an identical protocadherin
CC       expressed by a neighboring cell. This is a head-to-tail
CC       interaction, the cadherin 1 domain interacting with the cadherin 4
CC       domain and the cadherin 2 domain interacting the cadherin 3 domain
CC       of the other protocadherin. The cadherin 6 domain mediates
CC       promiscuous interactions with protocadherins on the same cell
CC       membrane. Each cadherin domain binds three calcium ions.
CC       {ECO:0000250|UniProtKB:O88689}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF152312; AAD43706.1; -; mRNA.
DR   EMBL; AF152482; AAD43743.1; -; mRNA.
DR   EMBL; AC005609; AAC34322.1; -; Genomic_DNA.
DR   EMBL; BC112102; AAI12103.1; -; mRNA.
DR   EMBL; BC113609; AAI13610.1; -; mRNA.
DR   CCDS; CCDS54916.1; -. [Q9UN74-1]
DR   RefSeq; NP_061730.1; NM_018907.3. [Q9UN74-1]
DR   RefSeq; NP_113688.1; NM_031500.2. [Q9UN74-2]
DR   UniGene; Hs.199343; -.
DR   ProteinModelPortal; Q9UN74; -.
DR   SMR; Q9UN74; -.
DR   BioGrid; 121084; 41.
DR   IntAct; Q9UN74; 15.
DR   STRING; 9606.ENSP00000435300; -.
DR   iPTMnet; Q9UN74; -.
DR   PhosphoSitePlus; Q9UN74; -.
DR   BioMuta; PCDHA4; -.
DR   DMDM; 13878424; -.
DR   EPD; Q9UN74; -.
DR   PaxDb; Q9UN74; -.
DR   PeptideAtlas; Q9UN74; -.
DR   PRIDE; Q9UN74; -.
DR   TopDownProteomics; Q9UN74-2; -. [Q9UN74-2]
DR   DNASU; 56144; -.
DR   Ensembl; ENST00000530339; ENSP00000435300; ENSG00000204967. [Q9UN74-1]
DR   Ensembl; ENST00000618834; ENSP00000481220; ENSG00000204967. [Q9UN74-2]
DR   GeneID; 56144; -.
DR   KEGG; hsa:56144; -.
DR   UCSC; uc003lhi.4; human. [Q9UN74-1]
DR   CTD; 56144; -.
DR   EuPathDB; HostDB:ENSG00000204967.10; -.
DR   GeneCards; PCDHA4; -.
DR   HGNC; HGNC:8670; PCDHA4.
DR   HPA; HPA043180; -.
DR   HPA; HPA073478; -.
DR   MIM; 604966; gene.
DR   MIM; 606310; gene.
DR   neXtProt; NX_Q9UN74; -.
DR   OpenTargets; ENSG00000204967; -.
DR   PharmGKB; PA33016; -.
DR   eggNOG; KOG3594; Eukaryota.
DR   eggNOG; ENOG410XQHI; LUCA.
DR   GeneTree; ENSGT00910000144081; -.
DR   HOGENOM; HOG000220892; -.
DR   HOVERGEN; HBG054878; -.
DR   InParanoid; Q9UN74; -.
DR   KO; K16493; -.
DR   OMA; DNVPDLE; -.
DR   OrthoDB; EOG091G00KR; -.
DR   PhylomeDB; Q9UN74; -.
DR   TreeFam; TF332299; -.
DR   GeneWiki; PCDHA4; -.
DR   GenomeRNAi; 56144; -.
DR   PRO; PR:Q9UN74; -.
DR   Proteomes; UP000005640; Chromosome 5.
DR   Bgee; ENSG00000204967; -.
DR   ExpressionAtlas; Q9UN74; baseline and differential.
DR   Genevisible; Q9UN74; HS.
DR   GO; GO:0005783; C:endoplasmic reticulum; IEA:Ensembl.
DR   GO; GO:0005887; C:integral component of plasma membrane; TAS:ProtInc.
DR   GO; GO:0045202; C:synapse; IEA:Ensembl.
DR   GO; GO:0005509; F:calcium ion binding; ISS:UniProtKB.
DR   GO; GO:0042802; F:identical protein binding; ISS:UniProtKB.
DR   GO; GO:0007155; P:cell adhesion; TAS:ProtInc.
DR   GO; GO:0007267; P:cell-cell signaling; IBA:GO_Central.
DR   GO; GO:0007156; P:homophilic cell adhesion via plasma membrane adhesion molecules; IEA:InterPro.
DR   GO; GO:0007399; P:nervous system development; TAS:ProtInc.
DR   InterPro; IPR002126; Cadherin.
DR   InterPro; IPR015919; Cadherin-like.
DR   InterPro; IPR031904; Cadherin_CBD.
DR   InterPro; IPR020894; Cadherin_CS.
DR   InterPro; IPR013164; Cadherin_N.
DR   Pfam; PF00028; Cadherin; 5.
DR   Pfam; PF08266; Cadherin_2; 1.
DR   Pfam; PF15974; Cadherin_tail; 1.
DR   PRINTS; PR00205; CADHERIN.
DR   SMART; SM00112; CA; 6.
DR   SUPFAM; SSF49313; SSF49313; 6.
DR   PROSITE; PS00232; CADHERIN_1; 5.
DR   PROSITE; PS50268; CADHERIN_2; 6.
PE   1: Evidence at protein level;
KW   Alternative splicing; Calcium; Cell adhesion; Cell membrane;
KW   Complete proteome; Disulfide bond; Glycoprotein; Membrane;
KW   Metal-binding; Polymorphism; Reference proteome; Repeat; Signal;
KW   Transmembrane; Transmembrane helix.
FT   SIGNAL        1     29       {ECO:0000255}.
FT   CHAIN        30    947       Protocadherin alpha-4.
FT                                /FTId=PRO_0000003890.
FT   TOPO_DOM     30    697       Extracellular.
FT                                {ECO:0000250|UniProtKB:O88689}.
FT   TRANSMEM    698    718       Helical. {ECO:0000255}.
FT   TOPO_DOM    719    947       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:O88689}.
FT   DOMAIN       30    133       Cadherin 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00043}.
FT   DOMAIN      134    242       Cadherin 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00043}.
FT   DOMAIN      243    350       Cadherin 3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00043}.
FT   DOMAIN      351    455       Cadherin 4. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00043}.
FT   DOMAIN      456    565       Cadherin 5. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00043}.
FT   DOMAIN      588    678       Cadherin 6. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00043}.
FT   REPEAT      734    737       PXXP 1.
FT   REPEAT      774    777       PXXP 2.
FT   REPEAT      796    799       PXXP 3.
FT   REPEAT      829    832       PXXP 4.
FT   REPEAT      870    873       PXXP 5.
FT   REPEAT      888    891       PXXP 6.
FT   REGION      734    891       6 X 4 AA repeats of P-X-X-P.
FT   REGION      738    947       Required for interaction with FYN.
FT                                {ECO:0000250|UniProtKB:O88689}.
FT   COMPBIAS    920    927       Poly-Lys. {ECO:0000255}.
FT   CARBOHYD    139    139       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    257    257       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    265    265       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    548    548       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID     96    102       {ECO:0000250|UniProtKB:O88689}.
FT   VAR_SEQ     796    798       PRQ -> VSV (in isoform 2).
FT                                {ECO:0000303|PubMed:10380929,
FT                                ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_000677.
FT   VAR_SEQ     799    947       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:10380929,
FT                                ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_000678.
FT   VARIANT      55     55       E -> D (in dbSNP:rs11167605).
FT                                /FTId=VAR_059180.
FT   VARIANT     184    184       P -> S (in dbSNP:rs3822346).
FT                                /FTId=VAR_024390.
SQ   SEQUENCE   947 AA;  102293 MW;  2B06F20872D731D8 CRC64;
     MEFSWGSGQE SRRLLLLLLL LAAWEAGNGQ LHYSVSEEAK HGTFVGRIAQ DLGLELAELV
     PRLFRVASKG RGGLLEVNLQ NGILFVNSRI DREELCRRSA ECSIHLEVIV DRPLQVFHVD
     VEVRDINDNP PVFPATQKNL SIAESRPLDS RFPLEGASDA DIGENALLTY RLSPNEYFSL
     EKPPDDELVK GLGLILRKSL DREEAPEIFL VLTATDGGKP ELTGTVQLLI TVLDANDNAP
     AFDRTIYKVR LLENVPNGTL VIKLNASDLD EGLNGDIVYS FSNDISPNVK SKFHIDPITG
     QIIVKGYIDF EESKSYEIIV EGIDKGQLPL SGHCRVIVEV EDNNDNVPDL EFKSLSLPIR
     EDAPLGTVIA LISVSDKDMG VNGLVTCSLT SHVPFKLVST FKNYYSLVLD SALDRESVSA
     YELVVTARDG GSPSLWATAS VSVEVADVND NAPAFAQPEY TVFVKENNPP GCHIFTVSAW
     DADAQENALV SYSLVERRVG ERALSSYVSV HAESGKVYAL QPLDHEELEL LQFQVTARDA
     GVPPLGSNVT LQVFVLDEND NAPALLAPRA GGTGGAVSEL VPWSVGVGHV VAKVRAVDAD
     SGYNAWLSYE LQPGTGGARI PFRVGLYTGE ISTTRALDET DAPRHRLLVL VKDHGEPALT
     ATATVLVSLV ESGQAPKASS RALVGAVGPD AALVDVNVYL IIAICAVSSL LVLTLLLYTA
     LRCSALPTEG ACAPGKPTLV CSSAVGSWSY SQQRRPRVCS GEGPPKTDLM AFSPSLPDSR
     DREDQLQTTE ESFAKPRQPN PDWRYSASLR AGMHSSVHLE EAGILRAGPG GPDQQWPTVS
     SATPEPEAGE VSPPVGAGVN SNSWTFKYGP GNPKQSGPGE LPDKFIIPGS PAIISIRQEP
     TNSQIDKSDF ITFGKKEETK KKKKKKKGNK TQEKKEKGNS TTDNSDQ
//
ID   TWSG1_HUMAN             Reviewed;         223 AA.
AC   Q9GZX9; B2RE08; D3DUH9; Q8NBI7; Q96K46;
DT   06-MAR-2007, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2001, sequence version 1.
DT   23-MAY-2018, entry version 109.
DE   RecName: Full=Twisted gastrulation protein homolog 1;
DE   Flags: Precursor;
GN   Name=TWSG1; Synonyms=TSG; ORFNames=PSEC0250;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Aorta;
RX   PubMed=11260715; DOI=10.1038/35068572;
RA   Scott I.C., Blitz I.L., Pappano W.N., Maas S.A., Cho K.W.Y.,
RA   Greenspan D.S.;
RT   "Homologues of Twisted gastrulation are extracellular cofactors in
RT   antagonism of BMP signalling.";
RL   Nature 410:475-478(2001).
RN   [2]
RP   ERRATUM.
RA   Scott I.C., Blitz I.L., Pappano W.N., Maas S.A., Cho K.W.Y.,
RA   Greenspan D.S.;
RL   Nature 411:720-720(2001).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND DEVELOPMENTAL STAGE.
RX   PubMed=11420619; DOI=10.1007/s0033501-0005-x;
RA   Graf D., Timmons P.M., Hitchins M., Episkopou V., Moore G., Ito T.,
RA   Fujiyama A., Fisher A.G., Merkenschlager M.;
RT   "Evolutionary conservation, developmental expression, and genomic
RT   mapping of mammalian Twisted gastrulation.";
RL   Mamm. Genome 12:554-560(2001).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Testis;
RA   Li J.M., Sha J.H., Zhou Z.M.;
RT   "Human Twisted gastrulation protein: a new signal pathway for
RT   spermatogenesis.";
RL   Submitted (AUG-2000) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Teratocarcinoma, and Uterus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Teratocarcinoma;
RX   PubMed=16303743; DOI=10.1093/dnares/12.2.117;
RA   Otsuki T., Ota T., Nishikawa T., Hayashi K., Suzuki Y., Yamamoto J.,
RA   Wakamatsu A., Kimura K., Sakamoto K., Hatano N., Kawai Y., Ishii S.,
RA   Saito K., Kojima S., Sugiyama T., Ono T., Okano K., Yoshikawa Y.,
RA   Aotsuka S., Sasaki N., Hattori A., Okumura K., Nagai K., Sugano S.,
RA   Isogai T.;
RT   "Signal sequence and keyword trap in silico for selection of full-
RT   length human cDNAs encoding secretion or membrane proteins from oligo-
RT   capped cDNA libraries.";
RL   DNA Res. 12:117-126(2005).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16177791; DOI=10.1038/nature03983;
RA   Nusbaum C., Zody M.C., Borowsky M.L., Kamal M., Kodira C.D.,
RA   Taylor T.D., Whittaker C.A., Chang J.L., Cuomo C.A., Dewar K.,
RA   FitzGerald M.G., Yang X., Abouelleil A., Allen N.R., Anderson S.,
RA   Bloom T., Bugalter B., Butler J., Cook A., DeCaprio D., Engels R.,
RA   Garber M., Gnirke A., Hafez N., Hall J.L., Norman C.H., Itoh T.,
RA   Jaffe D.B., Kuroki Y., Lehoczky J., Lui A., Macdonald P., Mauceli E.,
RA   Mikkelsen T.S., Naylor J.W., Nicol R., Nguyen C., Noguchi H.,
RA   O'Leary S.B., Piqani B., Smith C.L., Talamas J.A., Topham K.,
RA   Totoki Y., Toyoda A., Wain H.M., Young S.K., Zeng Q., Zimmer A.R.,
RA   Fujiyama A., Hattori M., Birren B.W., Sakaki Y., Lander E.S.;
RT   "DNA sequence and analysis of human chromosome 18.";
RL   Nature 437:551-555(2005).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -!- FUNCTION: May be involved in dorsoventral axis formation. Seems to
CC       antagonize BMP signaling by forming ternary complexes with CHRD
CC       and BMPs, thereby preventing BMPs from binding to their receptors.
CC       In addition to the anti-BMP function, also has pro-BMP activity,
CC       partly mediated by cleavage and degradation of CHRD, which
CC       releases BMPs from ternary complexes. May be an important
CC       modulator of BMP-regulated cartilage development and chondrocyte
CC       differentiation. May play a role in thymocyte development (By
CC       similarity). {ECO:0000250}.
CC   -!- SUBUNIT: Interacts with CHRD and BMP4. This interaction enhances
CC       CHRD/BMP4 complex formation. Interacts with BMP7 (By similarity).
CC       {ECO:0000250}.
CC   -!- INTERACTION:
CC       O43765:SGTA; NbExp=3; IntAct=EBI-10304067, EBI-347996;
CC   -!- SUBCELLULAR LOCATION: Secreted {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9GZX9-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9GZX9-2; Sequence=VSP_042538, VSP_042539;
CC         Note=No experimental confirmation available. May be produced at
CC         very low levels due to a premature stop codon in the mRNA,
CC         leading to nonsense-mediated mRNA decay.;
CC   -!- DEVELOPMENTAL STAGE: Expressed in brain throughout development.
CC       {ECO:0000269|PubMed:11420619}.
CC   -!- DOMAIN: The N-terminal domain is sufficient to interact with BMP4.
CC       {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the twisted gastrulation protein family.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAB55246.1; Type=Erroneous translation; Note=Wrong choice of CDS.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF196834; AAG43468.1; -; mRNA.
DR   EMBL; AJ297391; CAC05581.1; -; mRNA.
DR   EMBL; AF294628; AAG10076.1; -; mRNA.
DR   EMBL; AK027629; BAB55246.1; ALT_SEQ; mRNA.
DR   EMBL; AK075550; BAC11693.1; -; mRNA.
DR   EMBL; AK315751; BAG38105.1; -; mRNA.
DR   EMBL; AP001033; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471113; EAX01606.1; -; Genomic_DNA.
DR   EMBL; CH471113; EAX01607.1; -; Genomic_DNA.
DR   EMBL; BC020490; AAH20490.1; -; mRNA.
DR   CCDS; CCDS11844.1; -. [Q9GZX9-1]
DR   RefSeq; NP_065699.1; NM_020648.5. [Q9GZX9-1]
DR   UniGene; Hs.514685; -.
DR   ProteinModelPortal; Q9GZX9; -.
DR   BioGrid; 121338; 6.
DR   CORUM; Q9GZX9; -.
DR   IntAct; Q9GZX9; 2.
DR   STRING; 9606.ENSP00000262120; -.
DR   iPTMnet; Q9GZX9; -.
DR   PhosphoSitePlus; Q9GZX9; -.
DR   BioMuta; TWSG1; -.
DR   DMDM; 74733506; -.
DR   EPD; Q9GZX9; -.
DR   MaxQB; Q9GZX9; -.
DR   PaxDb; Q9GZX9; -.
DR   PeptideAtlas; Q9GZX9; -.
DR   PRIDE; Q9GZX9; -.
DR   DNASU; 57045; -.
DR   Ensembl; ENST00000262120; ENSP00000262120; ENSG00000128791. [Q9GZX9-1]
DR   Ensembl; ENST00000583147; ENSP00000463331; ENSG00000128791. [Q9GZX9-2]
DR   GeneID; 57045; -.
DR   KEGG; hsa:57045; -.
DR   UCSC; uc002knz.3; human. [Q9GZX9-1]
DR   CTD; 57045; -.
DR   DisGeNET; 57045; -.
DR   EuPathDB; HostDB:ENSG00000128791.11; -.
DR   GeneCards; TWSG1; -.
DR   H-InvDB; HIX0014324; -.
DR   HGNC; HGNC:12429; TWSG1.
DR   HPA; HPA014898; -.
DR   MIM; 605049; gene.
DR   neXtProt; NX_Q9GZX9; -.
DR   OpenTargets; ENSG00000128791; -.
DR   PharmGKB; PA37089; -.
DR   eggNOG; ENOG410IF1M; Eukaryota.
DR   eggNOG; ENOG4110NGY; LUCA.
DR   GeneTree; ENSGT00390000007058; -.
DR   HOGENOM; HOG000044674; -.
DR   HOVERGEN; HBG055753; -.
DR   InParanoid; Q9GZX9; -.
DR   OMA; CTCCKEC; -.
DR   OrthoDB; EOG091G0J76; -.
DR   PhylomeDB; Q9GZX9; -.
DR   TreeFam; TF323922; -.
DR   GeneWiki; TWSG1; -.
DR   GenomeRNAi; 57045; -.
DR   PRO; PR:Q9GZX9; -.
DR   Proteomes; UP000005640; Chromosome 18.
DR   Bgee; ENSG00000128791; -.
DR   CleanEx; HS_TWSG1; -.
DR   ExpressionAtlas; Q9GZX9; baseline and differential.
DR   Genevisible; Q9GZX9; HS.
DR   GO; GO:0005615; C:extracellular space; IEA:Ensembl.
DR   GO; GO:0050431; F:transforming growth factor beta binding; IDA:BHF-UCL.
DR   GO; GO:0030509; P:BMP signaling pathway; IEA:Ensembl.
DR   GO; GO:0043010; P:camera-type eye development; IEA:Ensembl.
DR   GO; GO:0030154; P:cell differentiation; IEA:Ensembl.
DR   GO; GO:0030900; P:forebrain development; IEA:Ensembl.
DR   GO; GO:0030097; P:hemopoiesis; IEA:Ensembl.
DR   GO; GO:0001707; P:mesoderm formation; IEA:Ensembl.
DR   GO; GO:0030514; P:negative regulation of BMP signaling pathway; IEA:Ensembl.
DR   GO; GO:2000515; P:negative regulation of CD4-positive, alpha-beta T cell activation; IDA:BHF-UCL.
DR   GO; GO:2000562; P:negative regulation of CD4-positive, alpha-beta T cell proliferation; IDA:BHF-UCL.
DR   GO; GO:0001818; P:negative regulation of cytokine production; IDA:BHF-UCL.
DR   GO; GO:0045668; P:negative regulation of osteoblast differentiation; IEA:Ensembl.
DR   GO; GO:0001503; P:ossification; IEA:Ensembl.
DR   GO; GO:0030513; P:positive regulation of BMP signaling pathway; IEA:Ensembl.
DR   GO; GO:0010862; P:positive regulation of pathway-restricted SMAD protein phosphorylation; IDA:BHF-UCL.
DR   GO; GO:0007435; P:salivary gland morphogenesis; IEA:Ensembl.
DR   GO; GO:0007179; P:transforming growth factor beta receptor signaling pathway; IDA:BHF-UCL.
DR   InterPro; IPR006761; Tsg.
DR   PANTHER; PTHR12312; PTHR12312; 1.
DR   Pfam; PF04668; Tsg; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Complete proteome; Developmental protein;
KW   Glycoprotein; Reference proteome; Secreted; Signal.
FT   SIGNAL        1     25       {ECO:0000255}.
FT   CHAIN        26    223       Twisted gastrulation protein homolog 1.
FT                                /FTId=PRO_0000278808.
FT   COMPBIAS     26     77       Cys-rich.
FT   CARBOHYD     52     52       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD     81     81       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   VAR_SEQ      75     75       G -> D (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_042538.
FT   VAR_SEQ      76    223       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_042539.
FT   CONFLICT     35     35       V -> E (in Ref. 6; BAC11693).
FT                                {ECO:0000305}.
SQ   SEQUENCE   223 AA;  25017 MW;  34AEB1A836871772 CRC64;
     MKLHYVAVLT LAILMFLTWL PESLSCNKAL CASDVSKCLI QELCQCRPGE GNCSCCKECM
     LCLGALWDEC CDCVGMCNPR NYSDTPPTSK STVEELHEPI PSLFRALTEG DTQLNWNIVS
     FPVAEELSHH ENLVSFLETV NQPHHQNVSV PSNNVHAPYS SDKEHMCTVV YFDDCMSIHQ
     CKISCESMGA SKYRWFHNAC CECIGPECID YGSKTVKCMN CMF
//
ID   SMAGP_HUMAN             Reviewed;          97 AA.
AC   Q0VAQ4; A6NIL5;
DT   08-APR-2008, integrated into UniProtKB/Swiss-Prot.
DT   05-SEP-2006, sequence version 1.
DT   23-MAY-2018, entry version 94.
DE   RecName: Full=Small cell adhesion glycoprotein;
DE   AltName: Full=Small transmembrane and glycosylated protein;
GN   Name=SMAGP;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16541075; DOI=10.1038/nature04569;
RA   Scherer S.E., Muzny D.M., Buhay C.J., Chen R., Cree A., Ding Y.,
RA   Dugan-Rocha S., Gill R., Gunaratne P., Harris R.A., Hawes A.C.,
RA   Hernandez J., Hodgson A.V., Hume J., Jackson A., Khan Z.M.,
RA   Kovar-Smith C., Lewis L.R., Lozado R.J., Metzker M.L.,
RA   Milosavljevic A., Miner G.R., Montgomery K.T., Morgan M.B.,
RA   Nazareth L.V., Scott G., Sodergren E., Song X.-Z., Steffen D.,
RA   Lovering R.C., Wheeler D.A., Worley K.C., Yuan Y., Zhang Z.,
RA   Adams C.Q., Ansari-Lari M.A., Ayele M., Brown M.J., Chen G., Chen Z.,
RA   Clerc-Blankenburg K.P., Davis C., Delgado O., Dinh H.H., Draper H.,
RA   Gonzalez-Garay M.L., Havlak P., Jackson L.R., Jacob L.S., Kelly S.H.,
RA   Li L., Li Z., Liu J., Liu W., Lu J., Maheshwari M., Nguyen B.-V.,
RA   Okwuonu G.O., Pasternak S., Perez L.M., Plopper F.J.H., Santibanez J.,
RA   Shen H., Tabor P.E., Verduzco D., Waldron L., Wang Q., Williams G.A.,
RA   Zhang J., Zhou J., Allen C.C., Amin A.G., Anyalebechi V., Bailey M.,
RA   Barbaria J.A., Bimage K.E., Bryant N.P., Burch P.E., Burkett C.E.,
RA   Burrell K.L., Calderon E., Cardenas V., Carter K., Casias K.,
RA   Cavazos I., Cavazos S.R., Ceasar H., Chacko J., Chan S.N., Chavez D.,
RA   Christopoulos C., Chu J., Cockrell R., Cox C.D., Dang M.,
RA   Dathorne S.R., David R., Davis C.M., Davy-Carroll L., Deshazo D.R.,
RA   Donlin J.E., D'Souza L., Eaves K.A., Egan A., Emery-Cohen A.J.,
RA   Escotto M., Flagg N., Forbes L.D., Gabisi A.M., Garza M., Hamilton C.,
RA   Henderson N., Hernandez O., Hines S., Hogues M.E., Huang M.,
RA   Idlebird D.G., Johnson R., Jolivet A., Jones S., Kagan R., King L.M.,
RA   Leal B., Lebow H., Lee S., LeVan J.M., Lewis L.C., London P.,
RA   Lorensuhewa L.M., Loulseged H., Lovett D.A., Lucier A., Lucier R.L.,
RA   Ma J., Madu R.C., Mapua P., Martindale A.D., Martinez E., Massey E.,
RA   Mawhiney S., Meador M.G., Mendez S., Mercado C., Mercado I.C.,
RA   Merritt C.E., Miner Z.L., Minja E., Mitchell T., Mohabbat F.,
RA   Mohabbat K., Montgomery B., Moore N., Morris S., Munidasa M.,
RA   Ngo R.N., Nguyen N.B., Nickerson E., Nwaokelemeh O.O., Nwokenkwo S.,
RA   Obregon M., Oguh M., Oragunye N., Oviedo R.J., Parish B.J.,
RA   Parker D.N., Parrish J., Parks K.L., Paul H.A., Payton B.A., Perez A.,
RA   Perrin W., Pickens A., Primus E.L., Pu L.-L., Puazo M., Quiles M.M.,
RA   Quiroz J.B., Rabata D., Reeves K., Ruiz S.J., Shao H., Sisson I.,
RA   Sonaike T., Sorelle R.P., Sutton A.E., Svatek A.F., Svetz L.A.,
RA   Tamerisa K.S., Taylor T.R., Teague B., Thomas N., Thorn R.D.,
RA   Trejos Z.Y., Trevino B.K., Ukegbu O.N., Urban J.B., Vasquez L.I.,
RA   Vera V.A., Villasana D.M., Wang L., Ward-Moore S., Warren J.T.,
RA   Wei X., White F., Williamson A.L., Wleczyk R., Wooden H.S.,
RA   Wooden S.H., Yen J., Yoon L., Yoon V., Zorrilla S.E., Nelson D.,
RA   Kucherlapati R., Weinstock G., Gibbs R.A.;
RT   "The finished DNA sequence of human chromosome 12.";
RL   Nature 440:346-351(2006).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Colon;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   IDENTIFICATION, SUBCELLULAR LOCATION, TISSUE SPECIFICITY, AND
RP   GLYCOSYLATION.
RX   PubMed=15021913; DOI=10.1038/sj.onc.1207469;
RA   Tarbe N.G., Rio M.-C., Weidle U.H.;
RT   "SMAGP, a new small trans-membrane glycoprotein altered in cancer.";
RL   Oncogene 23:3395-3403(2004).
RN   [5]
RP   SUBCELLULAR LOCATION, AND FUNCTION.
RX   PubMed=15986429; DOI=10.1002/ijc.21275;
RA   Tarbe N.G., Rio M.-C., Hummel S., Weidle U.H., Zoeller M.;
RT   "Overexpression of the small transmembrane and glycosylated protein
RT   SMAGP supports metastasis formation of a rat pancreatic adenocarcinoma
RT   line.";
RL   Int. J. Cancer 117:913-922(2005).
CC   -!- FUNCTION: May play a role in epithelial cell-cell contacts. May
CC       play a role in tumor invasiveness and metastasis formation.
CC       {ECO:0000269|PubMed:15986429}.
CC   -!- INTERACTION:
CC       O43765:SGTA; NbExp=3; IntAct=EBI-10226799, EBI-347996;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:15021913};
CC       Single-pass type III membrane protein {ECO:0000255}. Cytoplasmic
CC       vesicle membrane {ECO:0000269|PubMed:15986429}; Single-pass type
CC       III membrane protein {ECO:0000255}. Note=Predominantly on lateral
CC       parts of the membrane, at cell-cell epithelial junctions
CC       (PubMed:15021913). Detected on cytoplasmic membranes in
CC       undifferentiated tumors (PubMed:15986429).
CC       {ECO:0000269|PubMed:15021913, ECO:0000269|PubMed:15986429}.
CC   -!- TISSUE SPECIFICITY: Detected in breast, endometrium, colon and
CC       biliary tract. Detected in polarized epithelial structures
CC       characterized by cell-cell adhesion (at protein level).
CC       {ECO:0000269|PubMed:15021913}.
CC   -!- PTM: O-glycosylated. The O-glycan is modified with sialic acid
CC       residues. {ECO:0000269|PubMed:15021913}.
CC   -!- SIMILARITY: Belongs to the SMAGP family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AC046135; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC139768; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471111; EAW58184.1; -; Genomic_DNA.
DR   EMBL; BC008712; AAH08712.2; -; mRNA.
DR   EMBL; BC120965; AAI20966.1; -; mRNA.
DR   EMBL; BC120966; AAI20967.1; -; mRNA.
DR   CCDS; CCDS44889.1; -.
DR   RefSeq; NP_001026798.1; NM_001031628.1.
DR   RefSeq; NP_001029045.1; NM_001033873.1.
DR   UniGene; Hs.652389; -.
DR   ProteinModelPortal; Q0VAQ4; -.
DR   SMR; Q0VAQ4; -.
DR   BioGrid; 121462; 3.
DR   IntAct; Q0VAQ4; 5.
DR   iPTMnet; Q0VAQ4; -.
DR   PhosphoSitePlus; Q0VAQ4; -.
DR   BioMuta; SMAGP; -.
DR   DMDM; 121940462; -.
DR   EPD; Q0VAQ4; -.
DR   MaxQB; Q0VAQ4; -.
DR   PaxDb; Q0VAQ4; -.
DR   PeptideAtlas; Q0VAQ4; -.
DR   PRIDE; Q0VAQ4; -.
DR   TopDownProteomics; Q0VAQ4; -.
DR   Ensembl; ENST00000398453; ENSP00000381471; ENSG00000170545.
DR   Ensembl; ENST00000603798; ENSP00000475068; ENSG00000170545.
DR   Ensembl; ENST00000603864; ENSP00000474892; ENSG00000170545.
DR   GeneID; 57228; -.
DR   KEGG; hsa:57228; -.
DR   UCSC; uc001ryd.2; human.
DR   CTD; 57228; -.
DR   DisGeNET; 57228; -.
DR   EuPathDB; HostDB:ENSG00000170545.16; -.
DR   GeneCards; SMAGP; -.
DR   HGNC; HGNC:26918; SMAGP.
DR   HPA; HPA039711; -.
DR   neXtProt; NX_Q0VAQ4; -.
DR   OpenTargets; ENSG00000170545; -.
DR   PharmGKB; PA165513352; -.
DR   eggNOG; ENOG410J3FG; Eukaryota.
DR   eggNOG; ENOG410ZCM8; LUCA.
DR   GeneTree; ENSGT00390000010077; -.
DR   HOGENOM; HOG000154341; -.
DR   HOVERGEN; HBG100579; -.
DR   InParanoid; Q0VAQ4; -.
DR   OMA; DREKEEY; -.
DR   OrthoDB; EOG091G16WO; -.
DR   PhylomeDB; Q0VAQ4; -.
DR   TreeFam; TF337016; -.
DR   ChiTaRS; SMAGP; human.
DR   GenomeRNAi; 57228; -.
DR   PRO; PR:Q0VAQ4; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   Bgee; ENSG00000170545; -.
DR   ExpressionAtlas; Q0VAQ4; baseline and differential.
DR   Genevisible; Q0VAQ4; HS.
DR   GO; GO:0030054; C:cell junction; IDA:HPA.
DR   GO; GO:0005913; C:cell-cell adherens junction; IBA:GO_Central.
DR   GO; GO:0030659; C:cytoplasmic vesicle membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005887; C:integral component of plasma membrane; IBA:GO_Central.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005886; C:plasma membrane; IDA:HPA.
DR   GO; GO:0050839; F:cell adhesion molecule binding; IBA:GO_Central.
DR   GO; GO:0042803; F:protein homodimerization activity; IBA:GO_Central.
DR   GO; GO:0005102; F:signaling receptor binding; IBA:GO_Central.
DR   GO; GO:0008037; P:cell recognition; IBA:GO_Central.
DR   GO; GO:0007157; P:heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules; IBA:GO_Central.
DR   GO; GO:0007156; P:homophilic cell adhesion via plasma membrane adhesion molecules; IBA:GO_Central.
PE   1: Evidence at protein level;
KW   Cell membrane; Complete proteome; Cytoplasmic vesicle; Glycoprotein;
KW   Membrane; Reference proteome; Sialic acid; Transmembrane;
KW   Transmembrane helix.
FT   CHAIN         1     97       Small cell adhesion glycoprotein.
FT                                /FTId=PRO_0000328795.
FT   TOPO_DOM      1     36       Extracellular. {ECO:0000255}.
FT   TRANSMEM     37     57       Helical; Signal-anchor for type III
FT                                membrane protein. {ECO:0000255}.
FT   TOPO_DOM     58     97       Cytoplasmic. {ECO:0000255}.
FT   CARBOHYD      2      2       O-linked (GalNAc...) threonine.
FT                                {ECO:0000255}.
FT   CARBOHYD      3      3       O-linked (GalNAc...) serine.
FT                                {ECO:0000255}.
FT   CARBOHYD      6      6       O-linked (GalNAc...) threonine.
FT                                {ECO:0000255}.
FT   CARBOHYD      7      7       O-linked (GalNAc...) threonine.
FT                                {ECO:0000255}.
FT   CARBOHYD      9      9       O-linked (GalNAc...) serine.
FT                                {ECO:0000255}.
FT   CARBOHYD     16     16       O-linked (GalNAc...) threonine.
FT                                {ECO:0000255}.
FT   CARBOHYD     17     17       O-linked (GalNAc...) threonine.
FT                                {ECO:0000255}.
FT   CARBOHYD     23     23       O-linked (GalNAc...) threonine.
FT                                {ECO:0000255}.
SQ   SEQUENCE   97 AA;  10679 MW;  90BC88F950B94904 CRC64;
     MTSLLTTPSP REELMTTPIL QPTEALSPED GASTALIAVV ITVVFLTLLS VVILIFFYLY
     KNKGSYVTYE PTEGEPSAIV QMESDLAKGS EKEEYFI
//
ID   B4E0K4_HUMAN            Unreviewed;       576 AA.
AC   B4E0K4;
DT   23-SEP-2008, integrated into UniProtKB/TrEMBL.
DT   23-SEP-2008, sequence version 1.
DT   31-JAN-2018, entry version 38.
DE   SubName: Full=cDNA FLJ58659, highly similar to Homo sapiens pre-B-cell leukemia transcription factor interacting protein 1 (PBXIP1), mRNA {ECO:0000313|EMBL:BAG64466.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAG64466.1};
RN   [1] {ECO:0000313|EMBL:BAG64466.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Thymus {ECO:0000313|EMBL:BAG64466.1};
RA   Wakamatsu A., Yamamoto J., Kimura K., Ishii S., Watanabe K.,
RA   Sugiyama A., Murakawa K., Kaida T., Tsuchiya K., Fukuzumi Y.,
RA   Kumagai A., Oishi Y., Yamamoto S., Ono Y., Komori Y., Yamazaki M.,
RA   Kisu Y., Nishikawa T., Sugano S., Nomura N., Isogai T.;
RT   "NEDO human cDNA sequencing project focused on splicing variants.";
RL   Submitted (OCT-2007) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK303413; BAG64466.1; -; mRNA.
DR   RefSeq; NP_001304664.1; NM_001317735.1.
DR   UniGene; Hs.505806; -.
DR   PeptideAtlas; B4E0K4; -.
DR   PRIDE; B4E0K4; -.
DR   GeneID; 57326; -.
DR   CTD; 57326; -.
DR   eggNOG; ENOG410II9I; Eukaryota.
DR   eggNOG; ENOG410YAJH; LUCA.
DR   HOGENOM; HOG000115464; -.
DR   HOVERGEN; HBG108234; -.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0003714; F:transcription corepressor activity; IEA:InterPro.
DR   GO; GO:0030154; P:cell differentiation; IEA:InterPro.
DR   GO; GO:0045892; P:negative regulation of transcription, DNA-templated; IEA:InterPro.
DR   InterPro; IPR033589; PBXIP1.
DR   PANTHER; PTHR28638:SF1; PTHR28638:SF1; 1.
PE   2: Evidence at transcript level;
KW   Coiled coil {ECO:0000256|SAM:Coils};
KW   Membrane {ECO:0000256|SAM:Phobius};
KW   Transmembrane {ECO:0000256|SAM:Phobius};
KW   Transmembrane helix {ECO:0000256|SAM:Phobius}.
FT   TRANSMEM     42     62       Helical. {ECO:0000256|SAM:Phobius}.
FT   COILED      117    147       {ECO:0000256|SAM:Coils}.
FT   COILED      162    189       {ECO:0000256|SAM:Coils}.
FT   COILED      222    256       {ECO:0000256|SAM:Coils}.
SQ   SEQUENCE   576 AA;  64618 MW;  83B830D245CB7370 CRC64;
     MEGLRRRRGR EAGPPQPMVP LAVENQAGGE GAGGELGISL NMCLLGALVL LGLGVLLFSG
     GLSESETGPM EEVERQVLPD PEVLEAVGDR QDGLREQLQA PVPPDSVPSL QNMGLLLDKL
     AKENQDIRLL QAQLQAQKEE LQSLMHQPKG LEEENAQLRG ALQQGEAFQR ALESELQQLR
     ARLQGLEADC VRGPDGVCLS GDRGPQGDKA IREQGPREQE PELSFLKQKE QLEAEAQALR
     QELERQRRLL GSVQQDLERS LQDASRGDPA HAGLAELGHR LAQKLQGLEN WGQDPGVSAN
     ASKAWHQKSH FQNSREWSGK EKWWDGQRDR KAEHWKHKKE ESGRERKKNW GGQEDREPAG
     RWKEGRPRVE ESGSKKEGKR QGPKEPPRKS GSFHSSGEKQ KQPRWREGTK DSHDPLPSWA
     ELLRPKYRAP QGCSGVDECA RQEGLTFFGT ELAPVRQQEL ASLLRTYLAR LPWAGQLTKE
     LPLSPAFFGE DGIFRHDRLR FRDFVDALED SLEEVAVQQT GDDDEVDDFE DFIFSHFFGD
     KALKKRSGKK DKHSQSPRAA GPREGHSHSH HHHHRG
//
ID   PBIP1_HUMAN             Reviewed;         731 AA.
AC   Q96AQ6; Q5T174; Q5T176; Q9H8X6; Q9HA02; Q9HD85;
DT   02-OCT-2007, integrated into UniProtKB/Swiss-Prot.
DT   01-DEC-2001, sequence version 1.
DT   23-MAY-2018, entry version 120.
DE   RecName: Full=Pre-B-cell leukemia transcription factor-interacting protein 1;
DE   AltName: Full=Hematopoietic PBX-interacting protein;
GN   Name=PBXIP1; Synonyms=HPIP;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, TISSUE SPECIFICITY,
RP   SUBCELLULAR LOCATION, INTERACTION WITH PBX1; PBX2 AND PBX3, AND
RP   VARIANT ASP-357.
RX   PubMed=10825160; DOI=10.1074/jbc.M001323200;
RA   Abramovich C., Shen W.-F., Pineault N., Imren S., Montpetit B.,
RA   Largman C., Humphries R.K.;
RT   "Functional cloning and characterization of a novel nonhomeodomain
RT   protein that inhibits the binding of PBX1-HOX complexes to DNA.";
RL   J. Biol. Chem. 275:26172-26177(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 2 AND 3), AND VARIANT
RP   ASP-357.
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Pancreas;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   FUNCTION, CHARACTERIZATION, AND SUBCELLULAR LOCATION.
RX   PubMed=12360403; DOI=10.1038/sj.onc.1205784;
RA   Abramovich C., Chavez E.A., Lansdorp P.M., Humphries R.K.;
RT   "Functional characterization of multiple domains involved in the
RT   subcellular localization of the hematopoietic Pbx interacting protein
RT   (HPIP).";
RL   Oncogene 21:6766-6771(2002).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-146; SER-147; SER-148
RP   AND THR-152, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [8]
RP   FUNCTION, SUBCELLULAR LOCATION, INTERACTION WITH ESR1, AND MUTAGENESIS
RP   OF 615-LEU--LEU-619.
RX   PubMed=17043237; DOI=10.1073/pnas.0607445103;
RA   Manavathi B., Acconcia F., Rayala S.K., Kumar R.;
RT   "An inherent role of microtubule network in the action of nuclear
RT   receptor.";
RL   Proc. Natl. Acad. Sci. U.S.A. 103:15981-15986(2006).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-146; SER-147 AND
RP   SER-148, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-43, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-43, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-43, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-43 AND SER-129, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
CC   -!- FUNCTION: Regulator of pre-B-cell leukemia transcription factors
CC       (BPXs) function. Inhibits the binding of PBX1-HOX complex to DNA
CC       and blocks the transcriptional activity of E2A-PBX1. Tethers
CC       estrogen receptor-alpha (ESR1) to microtubules and allows them to
CC       influence estrogen receptors-alpha signaling.
CC       {ECO:0000269|PubMed:10825160, ECO:0000269|PubMed:12360403,
CC       ECO:0000269|PubMed:17043237}.
CC   -!- SUBUNIT: Interacts with TEX11 (By similarity). Interacts with
CC       ESR1, PBX1, PBX2 and PBX3. {ECO:0000250,
CC       ECO:0000269|PubMed:10825160, ECO:0000269|PubMed:17043237}.
CC   -!- INTERACTION:
CC       P49069:CAMLG; NbExp=4; IntAct=EBI-740845, EBI-1748958;
CC       P24863:CCNC; NbExp=3; IntAct=EBI-740845, EBI-395261;
CC       Q9UER7:DAXX; NbExp=3; IntAct=EBI-740845, EBI-77321;
CC       Q9H4E7:DEF6; NbExp=3; IntAct=EBI-740845, EBI-745369;
CC       P03372:ESR1; NbExp=3; IntAct=EBI-15606280, EBI-78473;
CC       P03372-1:ESR1; NbExp=5; IntAct=EBI-15606280, EBI-15606245;
CC       Q53SE7:FLJ13057; NbExp=3; IntAct=EBI-740845, EBI-10172181;
CC       Q9UBU8:MORF4L1; NbExp=3; IntAct=EBI-740845, EBI-399246;
CC       Q9UBU8-2:MORF4L1; NbExp=3; IntAct=EBI-740845, EBI-10288852;
CC       O43765:SGTA; NbExp=3; IntAct=EBI-740845, EBI-347996;
CC       Q9UMX0-2:UBQLN1; NbExp=3; IntAct=EBI-740845, EBI-10173939;
CC       Q9Y3C0:WASHC3; NbExp=3; IntAct=EBI-740845, EBI-712969;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton
CC       {ECO:0000269|PubMed:12360403, ECO:0000269|PubMed:17043237}.
CC       Nucleus {ECO:0000269|PubMed:10825160,
CC       ECO:0000269|PubMed:12360403}. Note=Shuttles between the nucleus
CC       and the cytosol (PubMed:12360403). Mainly localized in the
CC       cytoplasm, associated with microtubules (PubMed:10825160,
CC       PubMed:12360403). Detected in small amounts in the nucleus
CC       (PubMed:10825160).
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q96AQ6-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q96AQ6-2; Sequence=VSP_028418;
CC       Name=3;
CC         IsoId=Q96AQ6-3; Sequence=VSP_028419;
CC   -!- TISSUE SPECIFICITY: Expressed in early hematopoietic precursors.
CC       {ECO:0000269|PubMed:10825160}.
CC   -!- DOMAIN: The C-terminal domain (AA 443-731) contains a nuclear
CC       export signal.
CC   -!- DOMAIN: Association to the cytoskeleton through a N-terminal
CC       leucine rich-domain (AA 190-218).
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF221521; AAG02026.1; -; mRNA.
DR   EMBL; AK022497; BAB14059.1; -; mRNA.
DR   EMBL; AK023219; BAB14471.1; -; mRNA.
DR   EMBL; AL451085; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471121; EAW53175.1; -; Genomic_DNA.
DR   EMBL; CH471121; EAW53176.1; -; Genomic_DNA.
DR   EMBL; BC016852; AAH16852.1; -; mRNA.
DR   CCDS; CCDS1074.1; -. [Q96AQ6-1]
DR   CCDS; CCDS81382.1; -. [Q96AQ6-2]
DR   RefSeq; NP_001304663.1; NM_001317734.1. [Q96AQ6-2]
DR   RefSeq; NP_001304664.1; NM_001317735.1.
DR   RefSeq; NP_065385.2; NM_020524.3. [Q96AQ6-1]
DR   UniGene; Hs.505806; -.
DR   ProteinModelPortal; Q96AQ6; -.
DR   SMR; Q96AQ6; -.
DR   BioGrid; 121486; 106.
DR   DIP; DIP-46922N; -.
DR   IntAct; Q96AQ6; 38.
DR   MINT; Q96AQ6; -.
DR   STRING; 9606.ENSP00000357448; -.
DR   iPTMnet; Q96AQ6; -.
DR   PhosphoSitePlus; Q96AQ6; -.
DR   SwissPalm; Q96AQ6; -.
DR   BioMuta; PBXIP1; -.
DR   DMDM; 74751749; -.
DR   EPD; Q96AQ6; -.
DR   MaxQB; Q96AQ6; -.
DR   PaxDb; Q96AQ6; -.
DR   PeptideAtlas; Q96AQ6; -.
DR   PRIDE; Q96AQ6; -.
DR   DNASU; 57326; -.
DR   Ensembl; ENST00000368463; ENSP00000357448; ENSG00000163346. [Q96AQ6-1]
DR   Ensembl; ENST00000368465; ENSP00000357450; ENSG00000163346. [Q96AQ6-2]
DR   GeneID; 57326; -.
DR   KEGG; hsa:57326; -.
DR   UCSC; uc001ffr.4; human. [Q96AQ6-1]
DR   CTD; 57326; -.
DR   DisGeNET; 57326; -.
DR   EuPathDB; HostDB:ENSG00000163346.16; -.
DR   GeneCards; PBXIP1; -.
DR   H-InvDB; HIX0001107; -.
DR   HGNC; HGNC:21199; PBXIP1.
DR   HPA; HPA006949; -.
DR   neXtProt; NX_Q96AQ6; -.
DR   OpenTargets; ENSG00000163346; -.
DR   PharmGKB; PA134956095; -.
DR   eggNOG; ENOG410II9I; Eukaryota.
DR   eggNOG; ENOG410YAJH; LUCA.
DR   GeneTree; ENSGT00530000063862; -.
DR   HOGENOM; HOG000115464; -.
DR   HOVERGEN; HBG108234; -.
DR   InParanoid; Q96AQ6; -.
DR   OMA; GISLNMC; -.
DR   OrthoDB; EOG091G0DI0; -.
DR   PhylomeDB; Q96AQ6; -.
DR   TreeFam; TF333202; -.
DR   ChiTaRS; PBXIP1; human.
DR   GenomeRNAi; 57326; -.
DR   PRO; PR:Q96AQ6; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000163346; -.
DR   CleanEx; HS_PBXIP1; -.
DR   ExpressionAtlas; Q96AQ6; baseline and differential.
DR   Genevisible; Q96AQ6; HS.
DR   GO; GO:0005829; C:cytosol; NAS:UniProtKB.
DR   GO; GO:0005874; C:microtubule; IEA:UniProtKB-KW.
DR   GO; GO:0005634; C:nucleus; NAS:UniProtKB.
DR   GO; GO:0003714; F:transcription corepressor activity; NAS:UniProtKB.
DR   GO; GO:0030154; P:cell differentiation; NAS:UniProtKB.
DR   GO; GO:0007275; P:multicellular organism development; NAS:UniProtKB.
DR   GO; GO:0045892; P:negative regulation of transcription, DNA-templated; NAS:UniProtKB.
DR   InterPro; IPR033589; PBXIP1.
DR   PANTHER; PTHR28638:SF1; PTHR28638:SF1; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Coiled coil; Complete proteome; Cytoplasm;
KW   Cytoskeleton; Microtubule; Nucleus; Phosphoprotein; Polymorphism;
KW   Reference proteome.
FT   CHAIN         1    731       Pre-B-cell leukemia transcription factor-
FT                                interacting protein 1.
FT                                /FTId=PRO_0000306115.
FT   COILED      270    348       {ECO:0000255}.
FT   COILED      377    417       {ECO:0000255}.
FT   MOTIF       485    505       Nuclear localization signal.
FT                                {ECO:0000255}.
FT   MOTIF       695    720       Nuclear localization signal.
FT                                {ECO:0000255}.
FT   COMPBIAS    160    165       Poly-Arg.
FT   COMPBIAS    721    729       His-rich.
FT   MOD_RES      43     43       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     129    129       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     146    146       Phosphoserine.
FT                                {ECO:0000244|PubMed:17081983,
FT                                ECO:0000244|PubMed:18669648}.
FT   MOD_RES     147    147       Phosphoserine.
FT                                {ECO:0000244|PubMed:17081983,
FT                                ECO:0000244|PubMed:18669648}.
FT   MOD_RES     148    148       Phosphoserine.
FT                                {ECO:0000244|PubMed:17081983,
FT                                ECO:0000244|PubMed:18669648}.
FT   MOD_RES     152    152       Phosphothreonine.
FT                                {ECO:0000244|PubMed:17081983}.
FT   MOD_RES     567    567       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:A2VD12}.
FT   VAR_SEQ       1     29       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_028418.
FT   VAR_SEQ     566    634       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_028419.
FT   VARIANT     356    356       G -> D (in dbSNP:rs2061690).
FT                                /FTId=VAR_051263.
FT   VARIANT     357    357       G -> D (in dbSNP:rs2061690).
FT                                {ECO:0000269|PubMed:10825160,
FT                                ECO:0000269|PubMed:14702039}.
FT                                /FTId=VAR_035265.
FT   MUTAGEN     615    619       LASLL->AASAA: Reduces interaction with
FT                                ESR1. {ECO:0000269|PubMed:17043237}.
FT   CONFLICT    139    139       I -> F (in Ref. 2; BAB14059).
FT                                {ECO:0000305}.
FT   CONFLICT    268    268       M -> I (in Ref. 1; AAG02026 and 2;
FT                                BAB14471). {ECO:0000305}.
FT   CONFLICT    381    381       L -> P (in Ref. 2; BAB14059).
FT                                {ECO:0000305}.
FT   CONFLICT    595    595       A -> P (in Ref. 1; AAG02026).
FT                                {ECO:0000305}.
SQ   SEQUENCE   731 AA;  80643 MW;  D9AB1F22A12E178D CRC64;
     MASCPDSDNS WVLAGSESLP VETLGPASRM DPESERALQA PHSPSKTDGK ELAGTMDGEG
     TLFQTESPQS GSILTEETEV KGTLEGDVCG VEPPGPGDTV VQGDLQETTV VTGLGPDTQD
     LEGQSPPQSL PSTPKAAWIR EEGRCSSSDD DTDVDMEGLR RRRGREAGPP QPMVPLAVEN
     QAGGEGAGGE LGISLNMCLL GALVLLGLGV LLFSGGLSES ETGPMEEVER QVLPDPEVLE
     AVGDRQDGLR EQLQAPVPPD SVPSLQNMGL LLDKLAKENQ DIRLLQAQLQ AQKEELQSLM
     HQPKGLEEEN AQLRGALQQG EAFQRALESE LQQLRARLQG LEADCVRGPD GVCLSGGRGP
     QGDKAIREQG PREQEPELSF LKQKEQLEAE AQALRQELER QRRLLGSVQQ DLERSLQDAS
     RGDPAHAGLA ELGHRLAQKL QGLENWGQDP GVSANASKAW HQKSHFQNSR EWSGKEKWWD
     GQRDRKAEHW KHKKEESGRE RKKNWGGQED REPAGRWKEG RPRVEESGSK KEGKRQGPKE
     PPRKSGSFHS SGEKQKQPRW REGTKDSHDP LPSWAELLRP KYRAPQGCSG VDECARQEGL
     TFFGTELAPV RQQELASLLR TYLARLPWAG QLTKELPLSP AFFGEDGIFR HDRLRFRDFV
     DALEDSLEEV AVQQTGDDDE VDDFEDFIFS HFFGDKALKK RSGKKDKHSQ SPRAAGPREG
     HSHSHHHHHR G
//
ID   B4DFQ1_HUMAN            Unreviewed;       264 AA.
AC   B4DFQ1;
DT   23-SEP-2008, integrated into UniProtKB/TrEMBL.
DT   23-SEP-2008, sequence version 1.
DT   23-MAY-2018, entry version 40.
DE   SubName: Full=cDNA FLJ60476, highly similar to Transmembrane and ubiquitin-like domain-containing protein 2 {ECO:0000313|EMBL:BAG57512.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAG57512.1};
RN   [1] {ECO:0000313|EMBL:BAG57512.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Amygdala {ECO:0000313|EMBL:BAG57512.1};
RA   Wakamatsu A., Yamamoto J., Kimura K., Ishii S., Watanabe K.,
RA   Sugiyama A., Murakawa K., Kaida T., Tsuchiya K., Fukuzumi Y.,
RA   Kumagai A., Oishi Y., Yamamoto S., Ono Y., Komori Y., Yamazaki M.,
RA   Kisu Y., Nishikawa T., Sugano S., Nomura N., Isogai T.;
RT   "NEDO human cDNA sequencing project focused on splicing variants.";
RL   Submitted (OCT-2007) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK294198; BAG57512.1; -; mRNA.
DR   RefSeq; NP_001317164.1; NM_001330235.1.
DR   UniGene; Hs.181391; -.
DR   MaxQB; B4DFQ1; -.
DR   PeptideAtlas; B4DFQ1; -.
DR   PRIDE; B4DFQ1; -.
DR   GeneID; 79089; -.
DR   CTD; 79089; -.
DR   HOGENOM; HOG000232067; -.
DR   HOVERGEN; HBG050920; -.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   InterPro; IPR029071; Ubiquitin-like_domsf.
DR   InterPro; IPR000626; Ubiquitin_dom.
DR   Pfam; PF00240; ubiquitin; 1.
DR   SMART; SM00213; UBQ; 1.
DR   SUPFAM; SSF54236; SSF54236; 1.
DR   PROSITE; PS50053; UBIQUITIN_2; 1.
PE   2: Evidence at transcript level;
KW   Membrane {ECO:0000256|SAM:Phobius};
KW   Transmembrane {ECO:0000256|SAM:Phobius};
KW   Transmembrane helix {ECO:0000256|SAM:Phobius}.
FT   TRANSMEM     16     39       Helical. {ECO:0000256|SAM:Phobius}.
FT   TRANSMEM    209    231       Helical. {ECO:0000256|SAM:Phobius}.
FT   TRANSMEM    243    262       Helical. {ECO:0000256|SAM:Phobius}.
FT   DOMAIN      117    190       Ubiquitin-like.
FT                                {ECO:0000259|PROSITE:PS50053}.
SQ   SEQUENCE   264 AA;  28002 MW;  1C311665A71BCA3F CRC64;
     MELSDVTLIE GVGNEVMVVA GVVVLILALV LAWLSTYVAD SGSNQLLGAI VSAGDTSVLH
     LGHVDHLVAG QGNPEPTELP HPSEGLPKRQ AGAGSSSPEA PLRSEDSTCL PPSPGLITVR
     LKFLNDTEEL AVARPEDTVG ALKSKYFPGQ ESQMKLIYQG RLLQDPARTL RSLNITDNCV
     IHCHRSPPGS AVPGPSASLA PSTTEPPSLG VNVGSLMVPV FVVLLGVVWY FRINYRQFFT
     APATVSLVGV TVFFSFLVFG MYGR
//
ID   E7ESS3_HUMAN            Unreviewed;       264 AA.
AC   E7ESS3;
DT   08-MAR-2011, integrated into UniProtKB/TrEMBL.
DT   08-MAR-2011, sequence version 1.
DT   28-MAR-2018, entry version 51.
DE   SubName: Full=Transmembrane and ubiquitin-like domain-containing protein 2 {ECO:0000313|Ensembl:ENSP00000413127};
GN   Name=TMUB2 {ECO:0000313|Ensembl:ENSP00000413127};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000413127, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Ensembl:ENSP00000413127, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16625196; DOI=10.1038/nature04689;
RA   Zody M.C., Garber M., Adams D.J., Sharpe T., Harrow J., Lupski J.R.,
RA   Nicholson C., Searle S.M., Wilming L., Young S.K., Abouelleil A.,
RA   Allen N.R., Bi W., Bloom T., Borowsky M.L., Bugalter B.E., Butler J.,
RA   Chang J.L., Chen C.K., Cook A., Corum B., Cuomo C.A., de Jong P.J.,
RA   DeCaprio D., Dewar K., FitzGerald M., Gilbert J., Gibson R.,
RA   Gnerre S., Goldstein S., Grafham D.V., Grocock R., Hafez N.,
RA   Hagopian D.S., Hart E., Norman C.H., Humphray S., Jaffe D.B.,
RA   Jones M., Kamal M., Khodiyar V.K., LaButti K., Laird G., Lehoczky J.,
RA   Liu X., Lokyitsang T., Loveland J., Lui A., Macdonald P., Major J.E.,
RA   Matthews L., Mauceli E., McCarroll S.A., Mihalev A.H., Mudge J.,
RA   Nguyen C., Nicol R., O'Leary S.B., Osoegawa K., Schwartz D.C.,
RA   Shaw-Smith C., Stankiewicz P., Steward C., Swarbreck D.,
RA   Venkataraman V., Whittaker C.A., Yang X., Zimmer A.R., Bradley A.,
RA   Hubbard T., Birren B.W., Rogers J., Lander E.S., Nusbaum C.;
RT   "DNA sequence of human chromosome 17 and analysis of rearrangement in
RT   the human lineage.";
RL   Nature 440:1045-1049(2006).
RN   [2] {ECO:0000313|Ensembl:ENSP00000413127}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (JUL-2011) to UniProtKB.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AC004596; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   RefSeq; NP_001317164.1; NM_001330235.1.
DR   RefSeq; XP_016880543.1; XM_017025054.1.
DR   RefSeq; XP_016880544.1; XM_017025055.1.
DR   UniGene; Hs.181391; -.
DR   ProteinModelPortal; E7ESS3; -.
DR   MaxQB; E7ESS3; -.
DR   PeptideAtlas; E7ESS3; -.
DR   PRIDE; E7ESS3; -.
DR   Ensembl; ENST00000446571; ENSP00000413127; ENSG00000168591.
DR   GeneID; 79089; -.
DR   UCSC; uc010wiu.3; human.
DR   CTD; 79089; -.
DR   EuPathDB; HostDB:ENSG00000168591.15; -.
DR   HGNC; HGNC:28459; TMUB2.
DR   OpenTargets; ENSG00000168591; -.
DR   GeneTree; ENSGT00390000014069; -.
DR   ChiTaRS; TMUB2; human.
DR   GenomeRNAi; 79089; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   Bgee; ENSG00000168591; -.
DR   ExpressionAtlas; E7ESS3; baseline and differential.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   InterPro; IPR029071; Ubiquitin-like_domsf.
DR   InterPro; IPR000626; Ubiquitin_dom.
DR   Pfam; PF00240; ubiquitin; 1.
DR   SMART; SM00213; UBQ; 1.
DR   SUPFAM; SSF54236; SSF54236; 1.
DR   PROSITE; PS50053; UBIQUITIN_2; 1.
PE   1: Evidence at protein level;
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   Membrane {ECO:0000256|SAM:Phobius};
KW   Proteomics identification {ECO:0000213|EPD:E7ESS3,
KW   ECO:0000213|MaxQB:E7ESS3, ECO:0000213|PeptideAtlas:E7ESS3};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640};
KW   Transmembrane {ECO:0000256|SAM:Phobius};
KW   Transmembrane helix {ECO:0000256|SAM:Phobius}.
FT   TRANSMEM     16     39       Helical. {ECO:0000256|SAM:Phobius}.
FT   TRANSMEM    209    231       Helical. {ECO:0000256|SAM:Phobius}.
FT   TRANSMEM    243    262       Helical. {ECO:0000256|SAM:Phobius}.
FT   DOMAIN      117    190       Ubiquitin-like.
FT                                {ECO:0000259|PROSITE:PS50053}.
SQ   SEQUENCE   264 AA;  27972 MW;  005D6665A70EDF3F CRC64;
     MELSDVTLIE GVGNEVMVVA GVVVLILALV LAWLSTYVAD SGSNQLLGAI VSAGDTSVLH
     LGHVDHLVAG QGNPEPTELP HPSEGLPKRQ AGAGSSSPEA PLRSEDSTCL PPSPGLITVR
     LKFLNDTEEL AVARPEDTVG ALKSKYFPGQ ESQMKLIYQG RLLQDPARTL RSLNITDNCV
     IHCHRSPPGS AVPGPSASLA PSATEPPSLG VNVGSLMVPV FVVLLGVVWY FRINYRQFFT
     APATVSLVGV TVFFSFLVFG MYGR
//
ID   TMUB2_HUMAN             Reviewed;         321 AA.
AC   Q71RG4; B3KU81; Q8NDI2; Q9BPZ5; Q9HAG3;
DT   11-JUL-2006, integrated into UniProtKB/Swiss-Prot.
DT   11-JUL-2006, sequence version 2.
DT   28-FEB-2018, entry version 110.
DE   RecName: Full=Transmembrane and ubiquitin-like domain-containing protein 2;
GN   Name=TMUB2; ORFNames=FP2653, UNQ1897/PRO4343;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RX   PubMed=15498874; DOI=10.1073/pnas.0404089101;
RA   Wan D., Gong Y., Qin W., Zhang P., Li J., Wei L., Zhou X., Li H.,
RA   Qiu X., Zhong F., He L., Yu J., Yao G., Jiang H., Qian L., Yu Y.,
RA   Shu H., Chen X., Xu H., Guo M., Pan Z., Chen Y., Ge C., Yang S.,
RA   Gu J.;
RT   "Large-scale cDNA transfection screening for genes related to cancer
RT   development and progression.";
RL   Proc. Natl. Acad. Sci. U.S.A. 101:15724-15729(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RX   PubMed=12975309; DOI=10.1101/gr.1293003;
RA   Clark H.F., Gurney A.L., Abaya E., Baker K., Baldwin D.T., Brush J.,
RA   Chen J., Chow B., Chui C., Crowley C., Currell B., Deuel B., Dowd P.,
RA   Eaton D., Foster J.S., Grimaldi C., Gu Q., Hass P.E., Heldens S.,
RA   Huang A., Kim H.S., Klimowski L., Jin Y., Johnson S., Lee J.,
RA   Lewis L., Liao D., Mark M.R., Robbie E., Sanchez C., Schoenfeld J.,
RA   Seshagiri S., Simmons L., Singh J., Smith V., Stinson J., Vagts A.,
RA   Vandlen R.L., Watanabe C., Wieand D., Woods K., Xie M.-H.,
RA   Yansura D.G., Yi S., Yu G., Yuan J., Zhang M., Zhang Z., Goddard A.D.,
RA   Wood W.I., Godowski P.J., Gray A.M.;
RT   "The secreted protein discovery initiative (SPDI), a large-scale
RT   effort to identify novel human secreted and transmembrane proteins: a
RT   bioinformatics assessment.";
RL   Genome Res. 13:2265-2270(2003).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RC   TISSUE=Brain, and Embryo;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Fetal brain;
RA   Li W.B., Gruber C., Jessee J., Polayes D.;
RT   "Full-length cDNA libraries and normalization.";
RL   Submitted (JUL-2004) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Fetal kidney;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 2 AND 4).
RC   TISSUE=Brain, Eye, and Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -!- INTERACTION:
CC       Q9BXK5:BCL2L13; NbExp=3; IntAct=EBI-2820477, EBI-747430;
CC       O43765:SGTA; NbExp=3; IntAct=EBI-2820477, EBI-347996;
CC       Q9UMX0-2:UBQLN1; NbExp=3; IntAct=EBI-2820477, EBI-10173939;
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Multi-pass membrane
CC       protein {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1;
CC         IsoId=Q71RG4-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q71RG4-2; Sequence=VSP_019700;
CC       Name=3;
CC         IsoId=Q71RG4-3; Sequence=VSP_019700, VSP_019703, VSP_019704;
CC         Note=No experimental confirmation available.;
CC       Name=4;
CC         IsoId=Q71RG4-4; Sequence=VSP_019700, VSP_019701, VSP_019702;
CC         Note=No experimental confirmation available.;
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF370373; AAQ15209.1; -; mRNA.
DR   EMBL; AY358780; AAQ89140.1; -; mRNA.
DR   EMBL; AK021759; BAB13886.1; -; mRNA.
DR   EMBL; AK096631; BAG53343.1; -; mRNA.
DR   EMBL; CR622157; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; AL833899; CAD38755.1; -; mRNA.
DR   EMBL; BC001792; AAH01792.1; -; mRNA.
DR   EMBL; BC004306; AAH04306.1; -; mRNA.
DR   EMBL; BC063489; AAH63489.1; -; mRNA.
DR   CCDS; CCDS11479.1; -. [Q71RG4-2]
DR   CCDS; CCDS54134.1; -. [Q71RG4-1]
DR   RefSeq; NP_001070142.1; NM_001076674.1. [Q71RG4-1]
DR   RefSeq; NP_001317164.1; NM_001330235.1.
DR   RefSeq; NP_077012.2; NM_024107.2. [Q71RG4-2]
DR   RefSeq; NP_803190.2; NM_177441.2. [Q71RG4-2]
DR   RefSeq; XP_011523500.1; XM_011525198.2.
DR   RefSeq; XP_011523503.1; XM_011525201.2. [Q71RG4-1]
DR   RefSeq; XP_011523507.1; XM_011525205.2. [Q71RG4-2]
DR   RefSeq; XP_011523508.1; XM_011525206.2.
DR   RefSeq; XP_011523509.1; XM_011525207.2.
DR   RefSeq; XP_011523510.1; XM_011525208.2.
DR   RefSeq; XP_011523511.1; XM_011525209.2.
DR   RefSeq; XP_016880537.1; XM_017025048.1.
DR   RefSeq; XP_016880538.1; XM_017025049.1.
DR   RefSeq; XP_016880539.1; XM_017025050.1.
DR   RefSeq; XP_016880540.1; XM_017025051.1.
DR   UniGene; Hs.181391; -.
DR   ProteinModelPortal; Q71RG4; -.
DR   SMR; Q71RG4; -.
DR   BioGrid; 122537; 12.
DR   DIP; DIP-60896N; -.
DR   IntAct; Q71RG4; 6.
DR   STRING; 9606.ENSP00000444565; -.
DR   iPTMnet; Q71RG4; -.
DR   PhosphoSitePlus; Q71RG4; -.
DR   BioMuta; TMUB2; -.
DR   DMDM; 110287995; -.
DR   EPD; Q71RG4; -.
DR   MaxQB; Q71RG4; -.
DR   PaxDb; Q71RG4; -.
DR   PeptideAtlas; Q71RG4; -.
DR   PRIDE; Q71RG4; -.
DR   DNASU; 79089; -.
DR   Ensembl; ENST00000319511; ENSP00000313214; ENSG00000168591. [Q71RG4-2]
DR   Ensembl; ENST00000357984; ENSP00000350672; ENSG00000168591. [Q71RG4-2]
DR   Ensembl; ENST00000538716; ENSP00000444565; ENSG00000168591. [Q71RG4-1]
DR   Ensembl; ENST00000587172; ENSP00000465153; ENSG00000168591. [Q71RG4-4]
DR   Ensembl; ENST00000587989; ENSP00000466971; ENSG00000168591. [Q71RG4-1]
DR   Ensembl; ENST00000589785; ENSP00000467364; ENSG00000168591. [Q71RG4-2]
DR   Ensembl; ENST00000589856; ENSP00000467960; ENSG00000168591. [Q71RG4-3]
DR   Ensembl; ENST00000590235; ENSP00000465015; ENSG00000168591. [Q71RG4-4]
DR   Ensembl; ENST00000592825; ENSP00000466189; ENSG00000168591. [Q71RG4-4]
DR   GeneID; 79089; -.
DR   KEGG; hsa:79089; -.
DR   UCSC; uc002ifo.4; human. [Q71RG4-1]
DR   CTD; 79089; -.
DR   EuPathDB; HostDB:ENSG00000168591.15; -.
DR   GeneCards; TMUB2; -.
DR   H-InvDB; HIX0013877; -.
DR   HGNC; HGNC:28459; TMUB2.
DR   HPA; HPA043137; -.
DR   neXtProt; NX_Q71RG4; -.
DR   OpenTargets; ENSG00000168591; -.
DR   PharmGKB; PA145147917; -.
DR   eggNOG; ENOG410IG1T; Eukaryota.
DR   eggNOG; ENOG4111WH7; LUCA.
DR   GeneTree; ENSGT00390000014069; -.
DR   HOGENOM; HOG000232067; -.
DR   HOVERGEN; HBG050920; -.
DR   InParanoid; Q71RG4; -.
DR   OMA; PVSSQAM; -.
DR   OrthoDB; EOG091G0NYR; -.
DR   PhylomeDB; Q71RG4; -.
DR   TreeFam; TF329265; -.
DR   ChiTaRS; TMUB2; human.
DR   GeneWiki; TMUB2; -.
DR   GenomeRNAi; 79089; -.
DR   PRO; PR:Q71RG4; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   Bgee; ENSG00000168591; -.
DR   CleanEx; HS_TMUB2; -.
DR   ExpressionAtlas; Q71RG4; baseline and differential.
DR   Genevisible; Q71RG4; HS.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   InterPro; IPR029071; Ubiquitin-like_domsf.
DR   InterPro; IPR000626; Ubiquitin_dom.
DR   Pfam; PF00240; ubiquitin; 1.
DR   SMART; SM00213; UBQ; 1.
DR   SUPFAM; SSF54236; SSF54236; 1.
DR   PROSITE; PS50053; UBIQUITIN_2; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Complete proteome; Membrane; Polymorphism;
KW   Reference proteome; Transmembrane; Transmembrane helix.
FT   CHAIN         1    321       Transmembrane and ubiquitin-like domain-
FT                                containing protein 2.
FT                                /FTId=PRO_0000245312.
FT   TRANSMEM     36     56       Helical. {ECO:0000255}.
FT   TRANSMEM    266    286       Helical. {ECO:0000255}.
FT   TRANSMEM    295    315       Helical. {ECO:0000255}.
FT   DOMAIN      174    247       Ubiquitin-like. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00214}.
FT   VAR_SEQ       1     20       Missing (in isoform 2, isoform 3 and
FT                                isoform 4). {ECO:0000303|PubMed:12975309,
FT                                ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:15498874,
FT                                ECO:0000303|PubMed:17974005}.
FT                                /FTId=VSP_019700.
FT   VAR_SEQ     105    114       GNDEKAEEAG -> ANTSLDKKAR (in isoform 4).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_019701.
FT   VAR_SEQ     115    321       Missing (in isoform 4).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_019702.
FT   VAR_SEQ     201    201       S -> R (in isoform 3).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_019703.
FT   VAR_SEQ     202    321       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_019704.
FT   VARIANT     228    228       R -> H (in dbSNP:rs9895154).
FT                                /FTId=VAR_052695.
FT   CONFLICT    265    265       S -> R (in Ref. 5; CAD38755).
FT                                {ECO:0000305}.
SQ   SEQUENCE   321 AA;  33788 MW;  C48656AD40A72454 CRC64;
     MISRHLQNNL MSVDPASSQA MELSDVTLIE GVGNEVMVVA GVVVLILALV LAWLSTYVAD
     SGSNQLLGAI VSAGDTSVLH LGHVDHLVAG QGNPEPTELP HPSEGNDEKA EEAGEGRGDS
     TGEAGAGGGV EPSLEHLLDI QGLPKRQAGA GSSSPEAPLR SEDSTCLPPS PGLITVRLKF
     LNDTEELAVA RPEDTVGALK SKYFPGQESQ MKLIYQGRLL QDPARTLRSL NITDNCVIHC
     HRSPPGSAVP GPSASLAPSA TEPPSLGVNV GSLMVPVFVV LLGVVWYFRI NYRQFFTAPA
     TVSLVGVTVF FSFLVFGMYG R
//
ID   TTMP_HUMAN              Reviewed;         217 AA.
AC   Q5BVD1; B4DNV2; B4E0Z2; Q96AJ4; Q9H5Q1;
DT   05-SEP-2006, integrated into UniProtKB/Swiss-Prot.
DT   11-JAN-2011, sequence version 2.
DT   25-APR-2018, entry version 103.
DE   RecName: Full=TPA-induced transmembrane protein;
GN   Name=TTMP; Synonyms=C3orf52;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), INDUCTION, AND VARIANT
RP   SER-144.
RC   TISSUE=Colon;
RX   PubMed=15737651; DOI=10.1016/j.bbrc.2005.02.037;
RA   Chan C.-Y., Salabat M.R., Ding X.-Z., Kelly D.L., Talamonti M.S.,
RA   Bell R.H. Jr., Adrian T.E.;
RT   "Identification and in silico characterization of a novel gene: TPA
RT   induced trans-membrane protein.";
RL   Biochem. Biophys. Res. Commun. 329:755-764(2005).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2), NUCLEOTIDE
RP   SEQUENCE [LARGE SCALE MRNA] OF 11-217 (ISOFORM 3), AND VARIANT
RP   SER-144.
RC   TISSUE=Lung, and Thymus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16641997; DOI=10.1038/nature04728;
RA   Muzny D.M., Scherer S.E., Kaul R., Wang J., Yu J., Sudbrak R.,
RA   Buhay C.J., Chen R., Cree A., Ding Y., Dugan-Rocha S., Gill R.,
RA   Gunaratne P., Harris R.A., Hawes A.C., Hernandez J., Hodgson A.V.,
RA   Hume J., Jackson A., Khan Z.M., Kovar-Smith C., Lewis L.R.,
RA   Lozado R.J., Metzker M.L., Milosavljevic A., Miner G.R., Morgan M.B.,
RA   Nazareth L.V., Scott G., Sodergren E., Song X.-Z., Steffen D., Wei S.,
RA   Wheeler D.A., Wright M.W., Worley K.C., Yuan Y., Zhang Z., Adams C.Q.,
RA   Ansari-Lari M.A., Ayele M., Brown M.J., Chen G., Chen Z.,
RA   Clendenning J., Clerc-Blankenburg K.P., Chen R., Chen Z., Davis C.,
RA   Delgado O., Dinh H.H., Dong W., Draper H., Ernst S., Fu G.,
RA   Gonzalez-Garay M.L., Garcia D.K., Gillett W., Gu J., Hao B.,
RA   Haugen E., Havlak P., He X., Hennig S., Hu S., Huang W., Jackson L.R.,
RA   Jacob L.S., Kelly S.H., Kube M., Levy R., Li Z., Liu B., Liu J.,
RA   Liu W., Lu J., Maheshwari M., Nguyen B.-V., Okwuonu G.O., Palmeiri A.,
RA   Pasternak S., Perez L.M., Phelps K.A., Plopper F.J., Qiang B.,
RA   Raymond C., Rodriguez R., Saenphimmachak C., Santibanez J., Shen H.,
RA   Shen Y., Subramanian S., Tabor P.E., Verduzco D., Waldron L., Wang J.,
RA   Wang J., Wang Q., Williams G.A., Wong G.K.-S., Yao Z., Zhang J.,
RA   Zhang X., Zhao G., Zhou J., Zhou Y., Nelson D., Lehrach H.,
RA   Reinhardt R., Naylor S.L., Yang H., Olson M., Weinstock G.,
RA   Gibbs R.A.;
RT   "The DNA sequence, annotation and analysis of human chromosome 3.";
RL   Nature 440:1194-1198(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT
RP   SER-144.
RC   TISSUE=Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -!- INTERACTION:
CC       O43765:SGTA; NbExp=5; IntAct=EBI-10243654, EBI-347996;
CC       Q8N205:SYNE4; NbExp=3; IntAct=EBI-10243654, EBI-7131783;
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane
CC       {ECO:0000305}; Single-pass type I membrane protein {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q5BVD1-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q5BVD1-2; Sequence=VSP_036120;
CC         Note=No experimental confirmation available.;
CC       Name=3;
CC         IsoId=Q5BVD1-3; Sequence=VSP_036121;
CC   -!- INDUCTION: Up-regulated following treatment with 12-O-
CC       tetradecanoylphorbol-13-acetate (TPA) in the pancreatic cancer
CC       cell line HPAF-II. The up-regulation by TPA is triggered at the
CC       promoter level. {ECO:0000269|PubMed:15737651}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH17064.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=BAB15569.1; Type=Frameshift; Positions=1; Evidence={ECO:0000305};
CC       Sequence=BAG60364.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AY830714; AAX21411.1; -; mRNA.
DR   EMBL; AK026839; BAB15569.1; ALT_FRAME; mRNA.
DR   EMBL; AK298076; BAG60364.1; ALT_INIT; mRNA.
DR   EMBL; AK303588; BAG64604.1; -; mRNA.
DR   EMBL; AC024887; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC017064; AAH17064.1; ALT_INIT; mRNA.
DR   CCDS; CCDS46887.1; -. [Q5BVD1-1]
DR   CCDS; CCDS54620.1; -. [Q5BVD1-3]
DR   RefSeq; NP_001165218.1; NM_001171747.1. [Q5BVD1-3]
DR   RefSeq; NP_078892.2; NM_024616.2.
DR   UniGene; Hs.434247; -.
DR   ProteinModelPortal; Q5BVD1; -.
DR   SMR; Q5BVD1; -.
DR   BioGrid; 122794; 12.
DR   IntAct; Q5BVD1; 23.
DR   iPTMnet; Q5BVD1; -.
DR   PhosphoSitePlus; Q5BVD1; -.
DR   BioMuta; TTMP; -.
DR   DMDM; 317373287; -.
DR   MaxQB; Q5BVD1; -.
DR   PaxDb; Q5BVD1; -.
DR   PeptideAtlas; Q5BVD1; -.
DR   PRIDE; Q5BVD1; -.
DR   DNASU; 79669; -.
DR   Ensembl; ENST00000264848; ENSP00000264848; ENSG00000114529. [Q5BVD1-1]
DR   Ensembl; ENST00000431717; ENSP00000399392; ENSG00000114529. [Q5BVD1-3]
DR   Ensembl; ENST00000480282; ENSP00000420539; ENSG00000114529. [Q5BVD1-2]
DR   GeneID; 79669; -.
DR   KEGG; hsa:79669; -.
DR   UCSC; uc003dyq.5; human. [Q5BVD1-1]
DR   CTD; 79669; -.
DR   EuPathDB; HostDB:ENSG00000114529.12; -.
DR   GeneCards; C3orf52; -.
DR   HGNC; HGNC:26255; C3orf52.
DR   HPA; HPA008119; -.
DR   HPA; HPA011968; -.
DR   MIM; 611956; gene.
DR   neXtProt; NX_Q5BVD1; -.
DR   OpenTargets; ENSG00000114529; -.
DR   PharmGKB; PA143485328; -.
DR   eggNOG; ENOG410IKBY; Eukaryota.
DR   eggNOG; ENOG410ZDDB; LUCA.
DR   GeneTree; ENSGT00390000014574; -.
DR   HOGENOM; HOG000168305; -.
DR   HOVERGEN; HBG094097; -.
DR   InParanoid; Q5BVD1; -.
DR   OMA; YFTSVEI; -.
DR   OrthoDB; EOG091G0LNF; -.
DR   PhylomeDB; Q5BVD1; -.
DR   TreeFam; TF330754; -.
DR   ChiTaRS; C3orf52; human.
DR   GenomeRNAi; 79669; -.
DR   PRO; PR:Q5BVD1; -.
DR   Proteomes; UP000005640; Chromosome 3.
DR   Bgee; ENSG00000114529; -.
DR   CleanEx; HS_C3orf52; -.
DR   ExpressionAtlas; Q5BVD1; baseline and differential.
DR   Genevisible; Q5BVD1; HS.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   InterPro; IPR033223; TTMP.
DR   PANTHER; PTHR14636; PTHR14636; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Complete proteome; Endoplasmic reticulum;
KW   Membrane; Polymorphism; Reference proteome; Transmembrane;
KW   Transmembrane helix.
FT   CHAIN         1    217       TPA-induced transmembrane protein.
FT                                /FTId=PRO_0000248024.
FT   TRANSMEM     66     86       Helical. {ECO:0000255}.
FT   VAR_SEQ     133    217       LTDVYSTSPSLGRYFTSVEIVDFSGENATVTYDLQFGVPSD
FT                                DENFMKYMMSEELVLGILLQDFRDQNIPGCESLGLDPTSLL
FT                                LYE -> EVGLKPNPEALVGFE (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_036120.
FT   VAR_SEQ     133    217       LTDVYSTSPSLGRYFTSVEIVDFSGENATVTYDLQFGVPSD
FT                                DENFMKYMMSEELVLGILLQDFRDQNIPGCESLGLDPTSLL
FT                                LYE -> NEVMEAGLCLKAVLYQVLEMKGIHSVLQKRFCGL
FT                                IQKHQQHQRGGDSFLSRFYSLALSPVKQLPSTASAGSSLDK
FT                                GRKPARVGAIGSAGMSHCWRSLVFCLFLFCFVLFFETGSRS
FT                                VA (in isoform 3).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_036121.
FT   VARIANT      66     66       L -> P (in dbSNP:rs16859172).
FT                                /FTId=VAR_059736.
FT   VARIANT     111    111       I -> V (in dbSNP:rs16859190).
FT                                /FTId=VAR_027203.
FT   VARIANT     144    144       G -> S (in dbSNP:rs340167).
FT                                {ECO:0000269|PubMed:14702039,
FT                                ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|PubMed:15737651}.
FT                                /FTId=VAR_027204.
FT   CONFLICT      1      1       M -> V (in Ref. 2; BAB15569).
FT                                {ECO:0000305}.
FT   CONFLICT    123    123       E -> K (in Ref. 2; BAB15569).
FT                                {ECO:0000305}.
SQ   SEQUENCE   217 AA;  24295 MW;  9240342865DBD743 CRC64;
     MDLAQPSQPV DELELSVLER QPEENTPLNG ADKVFPSLDE EVPPAEANKE SPWSSCNKNV
     VGRCKLWMII TSIFLGVITV IIIGLCLAAV TYVDEDENEI LELSSNKTFF IMLKIPEECV
     AEEELPHLLT ERLTDVYSTS PSLGRYFTSV EIVDFSGENA TVTYDLQFGV PSDDENFMKY
     MMSEELVLGI LLQDFRDQNI PGCESLGLDP TSLLLYE
//
ID   FIP1_HUMAN              Reviewed;         594 AA.
AC   Q6UN15; B4DIR3; G3XAD6; Q0VGE0; Q499Y4; Q49AU3; Q7Z608; Q8WVN3;
AC   Q96F80; Q9H077;
DT   20-DEC-2005, integrated into UniProtKB/Swiss-Prot.
DT   05-JUL-2004, sequence version 1.
DT   23-MAY-2018, entry version 133.
DE   RecName: Full=Pre-mRNA 3'-end-processing factor FIP1;
DE            Short=hFip1;
DE   AltName: Full=FIP1-like 1 protein;
DE   AltName: Full=Factor interacting with PAP;
DE   AltName: Full=Rearranged in hypereosinophilia;
GN   Name=FIP1L1; Synonyms=FIP1, RHE;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION IN PRE-MRNA 3'-END
RP   PROCESSING, IDENTIFICATION IN THE CPSF COMPLEX, IDENTIFICATION IN A
RP   COMPLEX WITH CPSF1 AND PAPOLA, INTERACTION WITH CPSF1; CPSF4; CSTF2;
RP   CSTF3 AND PAPOLA, RNA-BINDING, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RC   TISSUE=Testis;
RX   PubMed=14749727; DOI=10.1038/sj.emboj.7600070;
RA   Kaufmann I., Martin G., Friedlein A., Langen H., Keller W.;
RT   "Human Fip1 is a subunit of CPSF that binds to U-rich RNA elements and
RT   stimulates poly(A) polymerase.";
RL   EMBO J. 23:616-626(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RC   TISSUE=Uterus;
RX   PubMed=11230166; DOI=10.1101/gr.GR1547R;
RA   Wiemann S., Weil B., Wellenreuther R., Gassenhuber J., Glassl S.,
RA   Ansorge W., Boecher M., Bloecker H., Bauersachs S., Blum H.,
RA   Lauber J., Duesterhoeft A., Beyer A., Koehrer K., Strack N.,
RA   Mewes H.-W., Ottenwaelder B., Obermaier B., Tampe J., Heubner D.,
RA   Wambutt R., Korn B., Klein M., Poustka A.;
RT   "Towards a catalog of human genes and proteins: sequencing and
RT   analysis of 500 novel complete protein coding human cDNAs.";
RL   Genome Res. 11:422-435(2001).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 5).
RC   TISSUE=Hippocampus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 4).
RC   TISSUE=Brain, Eye, Placenta, and Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-339, DISEASE, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY OF THE FIP1L1-PDGFRA FUSION PROTEIN.
RC   TISSUE=Eosinophil;
RX   PubMed=12808148; DOI=10.1073/pnas.0932698100;
RA   Griffin J.H., Leung J., Bruner R.J., Caligiuri M.A., Briesewitz R.;
RT   "Discovery of a fusion kinase in EOL-1 cells and idiopathic
RT   hypereosinophilic syndrome.";
RL   Proc. Natl. Acad. Sci. U.S.A. 100:7830-7835(2003).
RN   [8]
RP   RNA-BINDING.
RX   PubMed=15767428; DOI=10.1128/JVI.79.7.4270-4288.2005;
RA   Zhao X., Oeberg D., Rush M., Fay J., Lambkin H., Schwartz S.;
RT   "A 57-nucleotide upstream early polyadenylation element in human
RT   papillomavirus type 16 interacts with hFip1, CstF-64, hnRNP C1/C2, and
RT   polypyrimidine tract binding protein.";
RL   J. Virol. 79:4270-4288(2005).
RN   [9]
RP   DISEASE.
RX   PubMed=12660384; DOI=10.1056/NEJMoa025217;
RA   Cools J., DeAngelo D.J., Gotlib J., Stover E.H., Legare R.D.,
RA   Cortes J., Kutok J., Clark J., Galinsky I., Griffin J.D., Cross N.C.,
RA   Tefferi A., Malone J., Alam R., Schrier S.L., Schmid J., Rose M.,
RA   Vandenberghe P., Verhoef G., Boogaerts M., Wlodarska I.,
RA   Kantarjian H., Marynen P., Coutre S.E., Stone R., Gilliland D.G.;
RT   "A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as
RT   a therapeutic target of imatinib in idiopathic hypereosinophilic
RT   syndrome.";
RL   N. Engl. J. Med. 348:1201-1214(2003).
RN   [10]
RP   INTERACTION WITH NUDT21/CPSF5.
RX   PubMed=15937220; DOI=10.1101/gad.1298605;
RA   Venkataraman K., Brown K.M., Gilmartin G.M.;
RT   "Analysis of a noncanonical poly(A) site reveals a tripartite
RT   mechanism for vertebrate poly(A) site recognition.";
RL   Genes Dev. 19:1315-1327(2005).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-426, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=15592455; DOI=10.1038/nbt1046;
RA   Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H.,
RA   Zha X.-M., Polakiewicz R.D., Comb M.J.;
RT   "Immunoaffinity profiling of tyrosine phosphorylation in cancer
RT   cells.";
RL   Nat. Biotechnol. 23:94-101(2005).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-500, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-492; SER-496 AND
RP   SER-500, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-554, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=18318008; DOI=10.1002/pmic.200700884;
RA   Han G., Ye M., Zhou H., Jiang X., Feng S., Jiang X., Tian R., Wan D.,
RA   Zou H., Gu J.;
RT   "Large-scale phosphoproteome analysis of human liver tissue by
RT   enrichment and fractionation of phosphopeptides with strong anion
RT   exchange chromatography.";
RL   Proteomics 8:1346-1361(2008).
RN   [16]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [17]
RP   INTERACTION WITH AHCYL1 AND PAPOLA.
RX   PubMed=19224921; DOI=10.1074/jbc.M807136200;
RA   Kiefer H., Mizutani A., Iemura S., Natsume T., Ando H., Kuroda Y.,
RA   Mikoshiba K.;
RT   "Inositol 1,4,5-triphosphate receptor-binding protein released with
RT   inositol 1,4,5-triphosphate (IRBIT) associates with components of the
RT   mRNA 3' processing machinery in a phosphorylation-dependent manner and
RT   inhibits polyadenylation.";
RL   J. Biol. Chem. 284:10694-10705(2009).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-492; THR-494; SER-496
RP   AND SER-500, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [19]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-492 AND SER-554, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [20]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-492 AND SER-496, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [21]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-492 AND SER-500, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [22]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-500 AND SER-554, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [23]
RP   INTERACTION WITH CPSF6 AND CPSF7, AND DOMAIN.
RX   PubMed=29276085; DOI=10.1016/j.molcel.2017.11.031;
RA   Zhu Y., Wang X., Forouzmand E., Jeong J., Qiao F., Sowd G.A.,
RA   Engelman A.N., Xie X., Hertel K.J., Shi Y.;
RT   "Molecular mechanisms for CFIm-mediated regulation of mRNA alternative
RT   polyadenylation.";
RL   Mol. Cell 69:62-74(2018).
CC   -!- FUNCTION: Component of the cleavage and polyadenylation
CC       specificity factor (CPSF) complex that plays a key role in pre-
CC       mRNA 3'-end formation, recognizing the AAUAAA signal sequence and
CC       interacting with poly(A) polymerase and other factors to bring
CC       about cleavage and poly(A) addition. FIP1L1 contributes to poly(A)
CC       site recognition and stimulates poly(A) addition. Binds to U-rich
CC       RNA sequence elements surrounding the poly(A) site. May act to
CC       tether poly(A) polymerase to the CPSF complex.
CC       {ECO:0000269|PubMed:14749727}.
CC   -!- SUBUNIT: Component of the cleavage and polyadenylation specificity
CC       factor (CPSF) complex, composed of CPSF1, CPSF2, CPSF3, CPSF4 and
CC       FIP1L1. Found in a complex with CPSF1, FIP1L1 and PAPOLA.
CC       Interacts with CPSF1, CPSF4, CSTF2 and CSTF3 (PubMed:14749727).
CC       Interacts with AHCYL1 (when phosphorylated); the interaction is
CC       direct and associates AHCYL1 with the CPSF complex and RNA
CC       (PubMed:19224921). Interacts with NUDT21/CPSF5; this interaction
CC       occurs in a RNA sequence-specific manner (PubMed:15937220).
CC       Interacts (preferentially via unphosphorylated form and
CC       Arg/Glu/Asp-rich domain) with CPSF6 (via Arg/Ser-rich domain);
CC       this interaction mediates, at least in part, the interaction
CC       between the CFIm and CPSF complexes and may be inhibited by CPSF6
CC       hyper-phosphorylation (PubMed:29276085). Interacts (preferentially
CC       via unphosphorylated form and Arg/Asp/Glu-rich domain) with CPSF7
CC       (via Arg/Ser-rich domain); this interaction mediates, at least in
CC       part, the interaction between the CFIm and CPSF complexes and may
CC       be inhibited by CPSF7 hyper-phosphorylation (PubMed:29276085).
CC       Interacts with PAPOLA; the interaction seems to be increased by
CC       the interaction with AHCYL1 (By similarity).
CC       {ECO:0000250|UniProtKB:Q9D824, ECO:0000269|PubMed:14749727,
CC       ECO:0000269|PubMed:15937220, ECO:0000269|PubMed:19224921,
CC       ECO:0000269|PubMed:29276085}.
CC   -!- INTERACTION:
CC       Q08379:GOLGA2; NbExp=3; IntAct=EBI-1021914, EBI-618309;
CC       P41227:NAA10; NbExp=3; IntAct=EBI-1021914, EBI-747693;
CC       Q96E35:ZMYND19; NbExp=3; IntAct=EBI-1021914, EBI-746595;
CC   -!- SUBCELLULAR LOCATION: Nucleus.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1;
CC         IsoId=Q6UN15-1; Sequence=Displayed;
CC       Name=3;
CC         IsoId=Q6UN15-3; Sequence=VSP_016728, VSP_016729, VSP_016730;
CC       Name=4;
CC         IsoId=Q6UN15-4; Sequence=VSP_016728, VSP_016731, VSP_016732;
CC       Name=5;
CC         IsoId=Q6UN15-5; Sequence=VSP_016728, VSP_046213;
CC         Note=No experimental confirmation available.;
CC   -!- DISEASE: Note=A chromosomal aberration involving FIP1L1 is found
CC       in some cases of hypereosinophilic syndrome. Interstitial
CC       chromosomal deletion del(4)(q12q12) causes the fusion of FIP1L1
CC       and PDGFRA (FIP1L1-PDGFRA). {ECO:0000269|PubMed:12660384,
CC       ECO:0000269|PubMed:12808148}.
CC   -!- SIMILARITY: Belongs to the FIP1 family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH24016.1; Type=Miscellaneous discrepancy; Note=Intron retention.; Evidence={ECO:0000305};
CC       Sequence=AAH52959.1; Type=Miscellaneous discrepancy; Note=Intron retention.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AY366510; AAQ88277.1; -; mRNA.
DR   EMBL; AL136910; CAB66844.1; -; mRNA.
DR   EMBL; AK295737; BAG58575.1; -; mRNA.
DR   EMBL; AC058822; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC095040; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC098587; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC098821; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC105384; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC110298; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC110792; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC124017; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC138607; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC138779; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471057; EAX05448.1; -; Genomic_DNA.
DR   EMBL; BC011543; AAH11543.1; -; mRNA.
DR   EMBL; BC017724; AAH17724.1; -; mRNA.
DR   EMBL; BC024016; AAH24016.1; ALT_SEQ; mRNA.
DR   EMBL; BC052959; AAH52959.1; ALT_SEQ; mRNA.
DR   EMBL; BC110383; AAI10384.1; -; mRNA.
DR   EMBL; AY229892; AAP69563.1; ALT_TERM; mRNA.
DR   CCDS; CCDS3491.1; -. [Q6UN15-1]
DR   CCDS; CCDS47055.1; -. [Q6UN15-5]
DR   CCDS; CCDS47056.1; -. [Q6UN15-3]
DR   RefSeq; NP_001128409.1; NM_001134937.1. [Q6UN15-5]
DR   RefSeq; NP_001128410.1; NM_001134938.1. [Q6UN15-3]
DR   RefSeq; NP_112179.2; NM_030917.3. [Q6UN15-1]
DR   UniGene; Hs.555109; -.
DR   UniGene; Hs.624245; -.
DR   ProteinModelPortal; Q6UN15; -.
DR   BioGrid; 123545; 63.
DR   CORUM; Q6UN15; -.
DR   DIP; DIP-42503N; -.
DR   IntAct; Q6UN15; 53.
DR   MINT; Q6UN15; -.
DR   STRING; 9606.ENSP00000336752; -.
DR   iPTMnet; Q6UN15; -.
DR   PhosphoSitePlus; Q6UN15; -.
DR   BioMuta; FIP1L1; -.
DR   DMDM; 74749365; -.
DR   EPD; Q6UN15; -.
DR   MaxQB; Q6UN15; -.
DR   PaxDb; Q6UN15; -.
DR   PeptideAtlas; Q6UN15; -.
DR   PRIDE; Q6UN15; -.
DR   DNASU; 81608; -.
DR   Ensembl; ENST00000306932; ENSP00000302993; ENSG00000145216. [Q6UN15-3]
DR   Ensembl; ENST00000337488; ENSP00000336752; ENSG00000145216. [Q6UN15-1]
DR   Ensembl; ENST00000358575; ENSP00000351383; ENSG00000145216. [Q6UN15-5]
DR   Ensembl; ENST00000507922; ENSP00000425456; ENSG00000145216. [Q6UN15-4]
DR   GeneID; 81608; -.
DR   KEGG; hsa:81608; -.
DR   UCSC; uc003gzx.5; human. [Q6UN15-1]
DR   CTD; 81608; -.
DR   DisGeNET; 81608; -.
DR   EuPathDB; HostDB:ENSG00000145216.15; -.
DR   GeneCards; FIP1L1; -.
DR   HGNC; HGNC:19124; FIP1L1.
DR   HPA; HPA037475; -.
DR   HPA; HPA058202; -.
DR   MalaCards; FIP1L1; -.
DR   MIM; 607685; phenotype.
DR   MIM; 607686; gene.
DR   neXtProt; NX_Q6UN15; -.
DR   OpenTargets; ENSG00000145216; -.
DR   Orphanet; 520; Acute promyelocytic leukemia.
DR   Orphanet; 314950; Primary hypereosinophilic syndrome.
DR   PharmGKB; PA134875694; -.
DR   eggNOG; KOG1049; Eukaryota.
DR   eggNOG; COG5213; LUCA.
DR   GeneTree; ENSGT00730000111028; -.
DR   HOGENOM; HOG000004854; -.
DR   HOVERGEN; HBG059889; -.
DR   KO; K14405; -.
DR   OMA; GNNIQVI; -.
DR   PhylomeDB; Q6UN15; -.
DR   TreeFam; TF318610; -.
DR   Reactome; R-HSA-109688; Cleavage of Growing Transcript in the Termination Region.
DR   Reactome; R-HSA-159231; Transport of Mature mRNA Derived from an Intronless Transcript.
DR   Reactome; R-HSA-72163; mRNA Splicing - Major Pathway.
DR   Reactome; R-HSA-72187; mRNA 3'-end processing.
DR   Reactome; R-HSA-77595; Processing of Intronless Pre-mRNAs.
DR   SIGNOR; Q6UN15; -.
DR   ChiTaRS; FIP1L1; human.
DR   GeneWiki; FIP1L1; -.
DR   GenomeRNAi; 81608; -.
DR   PMAP-CutDB; Q6UN15; -.
DR   PRO; PR:Q6UN15; -.
DR   Proteomes; UP000005640; Chromosome 4.
DR   Bgee; ENSG00000145216; -.
DR   CleanEx; HS_FIP1L1; -.
DR   ExpressionAtlas; Q6UN15; baseline and differential.
DR   Genevisible; Q6UN15; HS.
DR   GO; GO:0005847; C:mRNA cleavage and polyadenylation specificity factor complex; IBA:GO_Central.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0003723; F:RNA binding; HDA:UniProtKB.
DR   GO; GO:0031124; P:mRNA 3'-end processing; TAS:Reactome.
DR   GO; GO:0006406; P:mRNA export from nucleus; TAS:Reactome.
DR   GO; GO:0006378; P:mRNA polyadenylation; IBA:GO_Central.
DR   GO; GO:0000398; P:mRNA splicing, via spliceosome; TAS:Reactome.
DR   GO; GO:0098789; P:pre-mRNA cleavage required for polyadenylation; IBA:GO_Central.
DR   GO; GO:0006369; P:termination of RNA polymerase II transcription; TAS:Reactome.
DR   InterPro; IPR007854; Fip1.
DR   Pfam; PF05182; Fip1; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Complete proteome; mRNA processing; Nucleus;
KW   Phosphoprotein; Reference proteome; RNA-binding.
FT   CHAIN         1    594       Pre-mRNA 3'-end-processing factor FIP1.
FT                                /FTId=PRO_0000215037.
FT   REGION        1    356       Necessary for stimulating PAPOLA
FT                                activity.
FT   REGION        1    111       Sufficient for interaction with PAPOLA.
FT   REGION      137    243       Sufficient for interaction with CPSF4.
FT                                {ECO:0000269|PubMed:14749727}.
FT   REGION      443    594       Sufficient for interaction with CPSF1 and
FT                                CSTF3. {ECO:0000269|PubMed:14749727}.
FT   REGION      457    490       Arg/Asp/Glu-rich domain.
FT                                {ECO:0000269|PubMed:29276085}.
FT   COMPBIAS    356    406       Pro-rich.
FT   COMPBIAS    456    562       Arg-rich.
FT   COMPBIAS    478    594       Glu-rich.
FT   SITE        339    340       Breakpoint for interstitial deletion to
FT                                form the FIP1L1-PDGFRA fusion protein.
FT   MOD_RES      85     85       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q9D824}.
FT   MOD_RES      87     87       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q9D824}.
FT   MOD_RES      89     89       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q9D824}.
FT   MOD_RES     304    304       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q9D824}.
FT   MOD_RES     426    426       Phosphotyrosine.
FT                                {ECO:0000244|PubMed:15592455}.
FT   MOD_RES     492    492       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     494    494       Phosphothreonine.
FT                                {ECO:0000244|PubMed:19690332}.
FT   MOD_RES     496    496       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:21406692}.
FT   MOD_RES     500    500       Phosphoserine.
FT                                {ECO:0000244|PubMed:17081983,
FT                                ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     554    554       Phosphoserine.
FT                                {ECO:0000244|PubMed:18318008,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:24275569}.
FT   VAR_SEQ      29     43       Missing (in isoform 3, isoform 4 and
FT                                isoform 5). {ECO:0000303|PubMed:11230166,
FT                                ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_016728.
FT   VAR_SEQ     213    235       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:11230166}.
FT                                /FTId=VSP_016729.
FT   VAR_SEQ     272    307       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:11230166}.
FT                                /FTId=VSP_016730.
FT   VAR_SEQ     389    389       P -> PPPGIPITVP (in isoform 5).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_046213.
FT   VAR_SEQ     393    393       F -> K (in isoform 4).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_016731.
FT   VAR_SEQ     394    594       Missing (in isoform 4).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_016732.
FT   CONFLICT    118    118       V -> I (in Ref. 3; BAG58575).
FT                                {ECO:0000305}.
FT   CONFLICT    312    312       G -> R (in Ref. 6; AAH24016/AAH52959).
FT                                {ECO:0000305}.
FT   CONFLICT    524    524       K -> R (in Ref. 6; AAH52959).
FT                                {ECO:0000305}.
SQ   SEQUENCE   594 AA;  66526 MW;  B391D142419ED061 CRC64;
     MSAGEVERLV SELSGGTGGD EEEEWLYGGP WDVHVHSDLA KDLDENEVER PEEENASANP
     PSGIEDETAE NGVPKPKVTE TEDDSDSDSD DDEDDVHVTI GDIKTGAPQY GSYGTAPVNL
     NIKTGGRVYG TTGTKVKGVD LDAPGSINGV PLLEVDLDSF EDKPWRKPGA DLSDYFNYGF
     NEDTWKAYCE KQKRIRMGLE VIPVTSTTNK ITAEDCTMEV TPGAEIQDGR FNLFKVQQGR
     TGNSEKETAL PSTKAEFTSP PSLFKTGLPP SRNSTSSQSQ TSTASRKANS SVGKWQDRYG
     RAESPDLRRL PGAIDVIGQT ITISRVEGRR RANENSNIQV LSERSATEVD NNFSKPPPFF
     PPGAPPTHLP PPPFLPPPPT VSTAPPLIPP PGFPPPPGAP PPSLIPTIES GHSSGYDSRS
     ARAFPYGNVA FPHLPGSAPS WPSLVDTSKQ WDYYARREKD RDRERDRDRE RDRDRDRERE
     RTRERERERD HSPTPSVFNS DEERYRYREY AERGYERHRA SREKEERHRE RRHREKEETR
     HKSSRSNSRR RHESEEGDSH RRHKHKKSKR SKEGKEAGSE PAPEQESTEA TPAE
//
ID   A0A024R1J0_HUMAN        Unreviewed;       278 AA.
AC   A0A024R1J0;
DT   09-JUL-2014, integrated into UniProtKB/TrEMBL.
DT   09-JUL-2014, sequence version 1.
DT   23-MAY-2018, entry version 28.
DE   SubName: Full=C1q and tumor necrosis factor related protein 6, isoform CRA_a {ECO:0000313|EMBL:EAW60146.1};
GN   Name=C1QTNF6 {ECO:0000313|EMBL:EAW60146.1};
GN   ORFNames=hCG_2039683 {ECO:0000313|EMBL:EAW60146.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:EAW60146.1};
RN   [1] {ECO:0000313|EMBL:EAW60146.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAW60146.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
CC   -!- SUBCELLULAR LOCATION: Secreted {ECO:0000256|SAAS:SAAS00562217}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; CH471095; EAW60146.1; -; Genomic_DNA.
DR   RefSeq; NP_114116.3; NM_031910.3.
DR   RefSeq; NP_872292.1; NM_182486.1.
DR   UniGene; Hs.22011; -.
DR   ProteinModelPortal; A0A024R1J0; -.
DR   SMR; A0A024R1J0; -.
DR   GeneID; 114904; -.
DR   KEGG; hsa:114904; -.
DR   CTD; 114904; -.
DR   EuPathDB; HostDB:ENSG00000133466.13; -.
DR   eggNOG; ENOG410IKX5; Eukaryota.
DR   eggNOG; ENOG410XQIM; LUCA.
DR   KO; K19470; -.
DR   OMA; KETYVHV; -.
DR   OrthoDB; EOG091G0LRA; -.
DR   PhylomeDB; A0A024R1J0; -.
DR   ChiTaRS; C1QTNF6; human.
DR   GenomeRNAi; 114904; -.
DR   Bgee; ENSG00000133466; -.
DR   ExpressionAtlas; A0A024R1J0; baseline and differential.
DR   GO; GO:0005581; C:collagen trimer; IEA:UniProtKB-KW.
DR   GO; GO:0005615; C:extracellular space; IEA:Ensembl.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0042802; F:identical protein binding; IEA:Ensembl.
DR   GO; GO:0070208; P:protein heterotrimerization; IEA:Ensembl.
DR   Gene3D; 2.60.120.40; -; 1.
DR   InterPro; IPR001073; C1q_dom.
DR   InterPro; IPR008160; Collagen.
DR   InterPro; IPR008983; Tumour_necrosis_fac-like_dom.
DR   Pfam; PF00386; C1q; 1.
DR   Pfam; PF01391; Collagen; 1.
DR   PRINTS; PR00007; COMPLEMNTC1Q.
DR   SMART; SM00110; C1Q; 1.
DR   SUPFAM; SSF49842; SSF49842; 1.
DR   PROSITE; PS50871; C1Q; 1.
PE   4: Predicted;
KW   Collagen {ECO:0000256|SAAS:SAAS00562261};
KW   Membrane {ECO:0000256|SAM:Phobius};
KW   Secreted {ECO:0000256|SAAS:SAAS00562230};
KW   Transmembrane {ECO:0000256|SAM:Phobius};
KW   Transmembrane helix {ECO:0000256|SAM:Phobius}.
FT   TRANSMEM     20     39       Helical. {ECO:0000256|SAM:Phobius}.
FT   DOMAIN      139    278       C1q. {ECO:0000259|PROSITE:PS50871}.
SQ   SEQUENCE   278 AA;  30861 MW;  27A82CA863F23D47 CRC64;
     MQWLRVRESP GEATGHRVTM GTAALGPVWA ALLLFLLMCE IPMVELTFDR AVASGCQRCC
     DSEDPLDPAH VSSASSSGRP HALPEIRPYI NITILKGDKG DPGPMGLPGY MGREGPQGEP
     GPQGSKGDKG EMGSPGAPCQ KRFFAFSVGR KTALHSGEDF QTLLFERVFV NLDGCFDMAT
     GQFAAPLRGI YFFSLNVHSW NYKETYVHIM HNQKEAVILY AQPSERSIMQ SQSVMLDLAY
     GDRVWVRLFK RQRENAIYSN DFDTYITFSG HLIKAEDD
//
ID   C1QT6_HUMAN             Reviewed;         259 AA.
AC   Q9BXI9; Q5H9G8; Q6ZRM7;
DT   16-APR-2002, integrated into UniProtKB/Swiss-Prot.
DT   23-SEP-2008, sequence version 3.
DT   28-MAR-2018, entry version 150.
DE   RecName: Full=Complement C1q tumor necrosis factor-related protein 6;
DE   Flags: Precursor;
GN   Name=C1QTNF6; Synonyms=CTRP6; ORFNames=UNQ581/PRO1151;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RA   Piddington C.S., Sheppard P.O.;
RT   "Homo sapiens complement-c1q tumor necrosis factor-related protein.";
RL   Submitted (DEC-2000) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANTS VAL-2
RP   AND ARG-23.
RX   PubMed=12975309; DOI=10.1101/gr.1293003;
RA   Clark H.F., Gurney A.L., Abaya E., Baker K., Baldwin D.T., Brush J.,
RA   Chen J., Chow B., Chui C., Crowley C., Currell B., Deuel B., Dowd P.,
RA   Eaton D., Foster J.S., Grimaldi C., Gu Q., Hass P.E., Heldens S.,
RA   Huang A., Kim H.S., Klimowski L., Jin Y., Johnson S., Lee J.,
RA   Lewis L., Liao D., Mark M.R., Robbie E., Sanchez C., Schoenfeld J.,
RA   Seshagiri S., Simmons L., Singh J., Smith V., Stinson J., Vagts A.,
RA   Vandlen R.L., Watanabe C., Wieand D., Woods K., Xie M.-H.,
RA   Yansura D.G., Yi S., Yu G., Yuan J., Zhang M., Zhang Z., Goddard A.D.,
RA   Wood W.I., Godowski P.J., Gray A.M.;
RT   "The secreted protein discovery initiative (SPDI), a large-scale
RT   effort to identify novel human secreted and transmembrane proteins: a
RT   bioinformatics assessment.";
RL   Genome Res. 13:2265-2270(2003).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RC   TISSUE=Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=10591208; DOI=10.1038/990031;
RA   Dunham I., Hunt A.R., Collins J.E., Bruskiewich R., Beare D.M.,
RA   Clamp M., Smink L.J., Ainscough R., Almeida J.P., Babbage A.K.,
RA   Bagguley C., Bailey J., Barlow K.F., Bates K.N., Beasley O.P.,
RA   Bird C.P., Blakey S.E., Bridgeman A.M., Buck D., Burgess J.,
RA   Burrill W.D., Burton J., Carder C., Carter N.P., Chen Y., Clark G.,
RA   Clegg S.M., Cobley V.E., Cole C.G., Collier R.E., Connor R.,
RA   Conroy D., Corby N.R., Coville G.J., Cox A.V., Davis J., Dawson E.,
RA   Dhami P.D., Dockree C., Dodsworth S.J., Durbin R.M., Ellington A.G.,
RA   Evans K.L., Fey J.M., Fleming K., French L., Garner A.A.,
RA   Gilbert J.G.R., Goward M.E., Grafham D.V., Griffiths M.N.D., Hall C.,
RA   Hall R.E., Hall-Tamlyn G., Heathcott R.W., Ho S., Holmes S.,
RA   Hunt S.E., Jones M.C., Kershaw J., Kimberley A.M., King A.,
RA   Laird G.K., Langford C.F., Leversha M.A., Lloyd C., Lloyd D.M.,
RA   Martyn I.D., Mashreghi-Mohammadi M., Matthews L.H., Mccann O.T.,
RA   Mcclay J., Mclaren S., McMurray A.A., Milne S.A., Mortimore B.J.,
RA   Odell C.N., Pavitt R., Pearce A.V., Pearson D., Phillimore B.J.C.T.,
RA   Phillips S.H., Plumb R.W., Ramsay H., Ramsey Y., Rogers L., Ross M.T.,
RA   Scott C.E., Sehra H.K., Skuce C.D., Smalley S., Smith M.L.,
RA   Soderlund C., Spragon L., Steward C.A., Sulston J.E., Swann R.M.,
RA   Vaudin M., Wall M., Wallis J.M., Whiteley M.N., Willey D.L.,
RA   Williams L., Williams S.A., Williamson H., Wilmer T.E., Wilming L.,
RA   Wright C.L., Hubbard T., Bentley D.R., Beck S., Rogers J., Shimizu N.,
RA   Minoshima S., Kawasaki K., Sasaki T., Asakawa S., Kudoh J.,
RA   Shintani A., Shibuya K., Yoshizaki Y., Aoki N., Mitsuyama S.,
RA   Roe B.A., Chen F., Chu L., Crabtree J., Deschamps S., Do A., Do T.,
RA   Dorman A., Fang F., Fu Y., Hu P., Hua A., Kenton S., Lai H., Lao H.I.,
RA   Lewis J., Lewis S., Lin S.-P., Loh P., Malaj E., Nguyen T., Pan H.,
RA   Phan S., Qi S., Qian Y., Ray L., Ren Q., Shaull S., Sloan D., Song L.,
RA   Wang Q., Wang Y., Wang Z., White J., Willingham D., Wu H., Yao Z.,
RA   Zhan M., Zhang G., Chissoe S., Murray J., Miller N., Minx P.,
RA   Fulton R., Johnson D., Bemis G., Bentley D., Bradshaw H., Bourne S.,
RA   Cordes M., Du Z., Fulton L., Goela D., Graves T., Hawkins J.,
RA   Hinds K., Kemp K., Latreille P., Layman D., Ozersky P., Rohlfing T.,
RA   Scheet P., Walker C., Wamsley A., Wohldmann P., Pepin K., Nelson J.,
RA   Korf I., Bedell J.A., Hillier L.W., Mardis E., Waterston R.,
RA   Wilson R., Emanuel B.S., Shaikh T., Kurahashi H., Saitta S.,
RA   Budarf M.L., McDermid H.E., Johnson A., Wong A.C.C., Morrow B.E.,
RA   Edelmann L., Kim U.J., Shizuya H., Simon M.I., Dumanski J.P.,
RA   Peyrard M., Kedra D., Seroussi E., Fransson I., Tapia I., Bruder C.E.,
RA   O'Brien K.P., Wilkinson P., Bodenteich A., Hartman K., Hu X.,
RA   Khan A.S., Lane L., Tilahun Y., Wright H.;
RT   "The DNA sequence of human chromosome 22.";
RL   Nature 402:489-495(1999).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2), AND VARIANT VAL-2.
RC   TISSUE=Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   PROTEIN SEQUENCE OF 28-42.
RX   PubMed=15340161; DOI=10.1110/ps.04682504;
RA   Zhang Z., Henzel W.J.;
RT   "Signal peptide prediction based on analysis of experimentally
RT   verified cleavage sites.";
RL   Protein Sci. 13:2819-2824(2004).
CC   -!- INTERACTION:
CC       O43765:SGTA; NbExp=3; IntAct=EBI-10301084, EBI-347996;
CC   -!- SUBCELLULAR LOCATION: Secreted {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q9BXI9-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9BXI9-2; Sequence=VSP_035473;
CC       Name=3;
CC         IsoId=Q9BXI9-3; Sequence=VSP_035472, VSP_035474;
CC         Note=No experimental confirmation available.;
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF329842; AAK17966.1; -; mRNA.
DR   EMBL; AY358374; AAQ88740.1; -; mRNA.
DR   EMBL; AK128125; BAC87283.1; -; mRNA.
DR   EMBL; Z82188; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471095; EAW60145.1; -; Genomic_DNA.
DR   EMBL; BC020551; AAH20551.1; -; mRNA.
DR   CCDS; CCDS13943.1; -. [Q9BXI9-2]
DR   RefSeq; NP_114116.3; NM_031910.3. [Q9BXI9-2]
DR   RefSeq; NP_872292.1; NM_182486.1. [Q9BXI9-2]
DR   RefSeq; XP_011528159.1; XM_011529857.1. [Q9BXI9-1]
DR   RefSeq; XP_016884059.1; XM_017028570.1. [Q9BXI9-1]
DR   RefSeq; XP_016884060.1; XM_017028571.1. [Q9BXI9-1]
DR   RefSeq; XP_016884061.1; XM_017028572.1. [Q9BXI9-1]
DR   RefSeq; XP_016884062.1; XM_017028573.1. [Q9BXI9-1]
DR   RefSeq; XP_016884063.1; XM_017028574.1. [Q9BXI9-1]
DR   UniGene; Hs.22011; -.
DR   ProteinModelPortal; Q9BXI9; -.
DR   BioGrid; 125393; 9.
DR   IntAct; Q9BXI9; 10.
DR   STRING; 9606.ENSP00000338812; -.
DR   iPTMnet; Q9BXI9; -.
DR   PhosphoSitePlus; Q9BXI9; -.
DR   BioMuta; C1QTNF6; -.
DR   DMDM; 206729927; -.
DR   MaxQB; Q9BXI9; -.
DR   PaxDb; Q9BXI9; -.
DR   PeptideAtlas; Q9BXI9; -.
DR   PRIDE; Q9BXI9; -.
DR   DNASU; 114904; -.
DR   Ensembl; ENST00000337843; ENSP00000338812; ENSG00000133466. [Q9BXI9-2]
DR   Ensembl; ENST00000397110; ENSP00000380299; ENSG00000133466. [Q9BXI9-2]
DR   GeneID; 114904; -.
DR   KEGG; hsa:114904; -.
DR   UCSC; uc003aqx.2; human. [Q9BXI9-1]
DR   CTD; 114904; -.
DR   DisGeNET; 114904; -.
DR   EuPathDB; HostDB:ENSG00000133466.13; -.
DR   GeneCards; C1QTNF6; -.
DR   HGNC; HGNC:14343; C1QTNF6.
DR   HPA; HPA002042; -.
DR   MIM; 614910; gene.
DR   neXtProt; NX_Q9BXI9; -.
DR   OpenTargets; ENSG00000133466; -.
DR   PharmGKB; PA25633; -.
DR   eggNOG; ENOG410IKX5; Eukaryota.
DR   eggNOG; ENOG410XQIM; LUCA.
DR   GeneTree; ENSGT00900000140911; -.
DR   HOVERGEN; HBG108220; -.
DR   InParanoid; Q9BXI9; -.
DR   KO; K19470; -.
DR   OMA; KETYVHV; -.
DR   OrthoDB; EOG091G0LRA; -.
DR   PhylomeDB; Q9BXI9; -.
DR   TreeFam; TF329591; -.
DR   ChiTaRS; C1QTNF6; human.
DR   GenomeRNAi; 114904; -.
DR   PRO; PR:Q9BXI9; -.
DR   Proteomes; UP000005640; Chromosome 22.
DR   Bgee; ENSG00000133466; -.
DR   CleanEx; HS_C1QTNF6; -.
DR   ExpressionAtlas; Q9BXI9; baseline and differential.
DR   Genevisible; Q9BXI9; HS.
DR   GO; GO:0005581; C:collagen trimer; IEA:UniProtKB-KW.
DR   GO; GO:0005615; C:extracellular space; IEA:Ensembl.
DR   GO; GO:0042802; F:identical protein binding; IEA:Ensembl.
DR   GO; GO:0070208; P:protein heterotrimerization; IEA:Ensembl.
DR   Gene3D; 2.60.120.40; -; 1.
DR   InterPro; IPR001073; C1q_dom.
DR   InterPro; IPR008160; Collagen.
DR   InterPro; IPR008983; Tumour_necrosis_fac-like_dom.
DR   Pfam; PF00386; C1q; 1.
DR   Pfam; PF01391; Collagen; 1.
DR   PRINTS; PR00007; COMPLEMNTC1Q.
DR   SMART; SM00110; C1Q; 1.
DR   SUPFAM; SSF49842; SSF49842; 1.
DR   PROSITE; PS50871; C1Q; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Collagen; Complete proteome;
KW   Direct protein sequencing; Glycoprotein; Polymorphism;
KW   Reference proteome; Secreted; Signal.
FT   SIGNAL        1     27       {ECO:0000269|PubMed:15340161}.
FT   CHAIN        28    259       Complement C1q tumor necrosis factor-
FT                                related protein 6.
FT                                /FTId=PRO_0000003538.
FT   DOMAIN       78    119       Collagen-like.
FT   DOMAIN      120    259       C1q. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00368}.
FT   CARBOHYD     72     72       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   VAR_SEQ       1    101       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_035472.
FT   VAR_SEQ       1      1       M -> MQWLRVRESPGEATGHRVTM (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|Ref.1}.
FT                                /FTId=VSP_035473.
FT   VAR_SEQ     102    128       GPQGSKGDKGEMGSPGAPCQKRFFAFS -> MSVGTSLEQA
FT                                QMSTLTCPLFIPT (in isoform 3).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_035474.
FT   VARIANT       2      2       G -> V (in dbSNP:rs229527).
FT                                {ECO:0000269|PubMed:12975309,
FT                                ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_046624.
FT   VARIANT      23     23       P -> R (in dbSNP:rs229526).
FT                                {ECO:0000269|PubMed:12975309}.
FT                                /FTId=VAR_046625.
FT   VARIANT      36     36       G -> D (in dbSNP:rs7290488).
FT                                /FTId=VAR_046626.
FT   VARIANT     119    119       P -> L (in dbSNP:rs17812699).
FT                                /FTId=VAR_046627.
FT   VARIANT     207    207       R -> H (in dbSNP:rs17812681).
FT                                /FTId=VAR_046628.
SQ   SEQUENCE   259 AA;  28669 MW;  876DD0F84D217C9A CRC64;
     MGTAALGPVW AALLLFLLMC EIPMVELTFD RAVASGCQRC CDSEDPLDPA HVSSASSSGR
     PHALPEIRPY INITILKGDK GDPGPMGLPG YMGREGPQGE PGPQGSKGDK GEMGSPGAPC
     QKRFFAFSVG RKTALHSGED FQTLLFERVF VNLDGCFDMA TGQFAAPLRG IYFFSLNVHS
     WNYKETYVHI MHNQKEAVIL YAQPSERSIM QSQSVMLDLA YGDRVWVRLF KRQRENAIYS
     NDFDTYITFS GHLIKAEDD
//
ID   A6XND8_HUMAN            Unreviewed;       142 AA.
AC   A6XND8;
DT   21-AUG-2007, integrated into UniProtKB/TrEMBL.
DT   21-AUG-2007, sequence version 1.
DT   27-SEP-2017, entry version 51.
DE   SubName: Full=Proline-rich acidic protein 1 {ECO:0000313|EMBL:ABI63372.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:ABI63372.1};
RN   [1] {ECO:0000313|EMBL:ABI63372.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Yu Z., Zheng Z., Tang T., Fu Y.;
RT   "A computer system platform used to predict novel genes.";
RL   Submitted (JUL-2006) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; DQ884405; ABI63372.1; -; mRNA.
DR   RefSeq; NP_001138673.1; NM_001145201.1.
DR   UniGene; Hs.15951; -.
DR   ProteinModelPortal; A6XND8; -.
DR   DNASU; 118471; -.
DR   GeneID; 118471; -.
DR   UCSC; uc001lmr.3; human.
DR   CTD; 118471; -.
DR   EuPathDB; HostDB:ENSG00000165828.13; -.
DR   PharmGKB; PA134981678; -.
DR   HOVERGEN; HBG099538; -.
DR   GenomeRNAi; 118471; -.
DR   Bgee; ENSG00000165828; -.
DR   ExpressionAtlas; A6XND8; baseline and differential.
DR   Genevisible; A6XND8; HS.
DR   InterPro; IPR027922; PRAP.
DR   Pfam; PF15314; PRAP; 1.
PE   2: Evidence at transcript level;
KW   Signal {ECO:0000256|SAM:SignalP}.
FT   SIGNAL        1     20       {ECO:0000256|SAM:SignalP}.
FT   CHAIN        21    142       {ECO:0000256|SAM:SignalP}.
FT                                /FTId=PRO_5002704951.
SQ   SEQUENCE   142 AA;  16332 MW;  149282D65B6346E6 CRC64;
     MRRLLLVTSL VVVLLWEAGA VPAPKVPIKM QVKHWPSEQD PEKAWGARVV EPPEKDDQLV
     VLFPVQKPKL LTTEEKPRGT KAWMETEDTL GHVLSPEPDH DSLYHPPPEE DQGEERPRLW
     VMPNHQVLLG PEEDQDHIYH PQ
//
ID   PRAP1_HUMAN             Reviewed;         151 AA.
AC   Q96NZ9; B7ZL57; B7ZL58; E9KL31; Q5VWY4; Q7Z4X5; Q8IWR3; Q8NCS2;
DT   11-SEP-2007, integrated into UniProtKB/Swiss-Prot.
DT   11-JAN-2011, sequence version 2.
DT   23-MAY-2018, entry version 111.
DE   RecName: Full=Proline-rich acidic protein 1;
DE   AltName: Full=Epididymis tissue protein Li 178;
DE   AltName: Full=Uterine-specific proline-rich acidic protein;
DE   Flags: Precursor;
GN   Name=PRAP1; Synonyms=UPA; ORFNames=UNQ608/PRO1195;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1; 2 AND 4), FUNCTION, INDUCTION,
RP   SUBCELLULAR LOCATION, TISSUE SPECIFICITY, AND VARIANTS GLY-54; ARG-69
RP   AND ARG-101.
RX   PubMed=14583459;
RA   Zhang J., Wong H., Ramanan S., Cheong D., Leong A., Hooi S.C.;
RT   "The proline-rich acidic protein is epigenetically regulated and
RT   inhibits growth of cancer cell lines.";
RL   Cancer Res. 63:6658-6665(2003).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), VARIANT ARG-101, AND TISSUE
RP   SPECIFICITY.
RC   TISSUE=Epididymis;
RX   PubMed=20736409; DOI=10.1074/mcp.M110.001719;
RA   Li J., Liu F., Wang H., Liu X., Liu J., Li N., Wan F., Wang W.,
RA   Zhang C., Jin S., Liu J., Zhu P., Liu Y.;
RT   "Systematic mapping and functional analysis of a family of human
RT   epididymal secretory sperm-located proteins.";
RL   Mol. Cell. Proteomics 9:2517-2528(2010).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANT ARG-101.
RA   Zheng L.H., Yu L., Zhao S.Y.;
RT   "A novel human cDNA homologous to Mus musculus uterine-specific
RT   proline-rich acidic protein mRNA.";
RL   Submitted (JAN-1999) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT
RP   ARG-101.
RX   PubMed=12975309; DOI=10.1101/gr.1293003;
RA   Clark H.F., Gurney A.L., Abaya E., Baker K., Baldwin D.T., Brush J.,
RA   Chen J., Chow B., Chui C., Crowley C., Currell B., Deuel B., Dowd P.,
RA   Eaton D., Foster J.S., Grimaldi C., Gu Q., Hass P.E., Heldens S.,
RA   Huang A., Kim H.S., Klimowski L., Jin Y., Johnson S., Lee J.,
RA   Lewis L., Liao D., Mark M.R., Robbie E., Sanchez C., Schoenfeld J.,
RA   Seshagiri S., Simmons L., Singh J., Smith V., Stinson J., Vagts A.,
RA   Vandlen R.L., Watanabe C., Wieand D., Woods K., Xie M.-H.,
RA   Yansura D.G., Yi S., Yu G., Yuan J., Zhang M., Zhang Z., Goddard A.D.,
RA   Wood W.I., Godowski P.J., Gray A.M.;
RT   "The secreted protein discovery initiative (SPDI), a large-scale
RT   effort to identify novel human secreted and transmembrane proteins: a
RT   bioinformatics assessment.";
RL   Genome Res. 13:2265-2270(2003).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND VARIANT ARG-101.
RX   PubMed=15164054; DOI=10.1038/nature02462;
RA   Deloukas P., Earthrowl M.E., Grafham D.V., Rubenfield M., French L.,
RA   Steward C.A., Sims S.K., Jones M.C., Searle S., Scott C., Howe K.,
RA   Hunt S.E., Andrews T.D., Gilbert J.G.R., Swarbreck D., Ashurst J.L.,
RA   Taylor A., Battles J., Bird C.P., Ainscough R., Almeida J.P.,
RA   Ashwell R.I.S., Ambrose K.D., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Bates K., Beasley H., Bray-Allen S., Brown A.J.,
RA   Brown J.Y., Burford D.C., Burrill W., Burton J., Cahill P., Camire D.,
RA   Carter N.P., Chapman J.C., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Corby N., Coulson A., Dhami P., Dutta I., Dunn M., Faulkner L.,
RA   Frankish A., Frankland J.A., Garner P., Garnett J., Gribble S.,
RA   Griffiths C., Grocock R., Gustafson E., Hammond S., Harley J.L.,
RA   Hart E., Heath P.D., Ho T.P., Hopkins B., Horne J., Howden P.J.,
RA   Huckle E., Hynds C., Johnson C., Johnson D., Kana A., Kay M.,
RA   Kimberley A.M., Kershaw J.K., Kokkinaki M., Laird G.K., Lawlor S.,
RA   Lee H.M., Leongamornlert D.A., Laird G., Lloyd C., Lloyd D.M.,
RA   Loveland J., Lovell J., McLaren S., McLay K.E., McMurray A.,
RA   Mashreghi-Mohammadi M., Matthews L., Milne S., Nickerson T.,
RA   Nguyen M., Overton-Larty E., Palmer S.A., Pearce A.V., Peck A.I.,
RA   Pelan S., Phillimore B., Porter K., Rice C.M., Rogosin A., Ross M.T.,
RA   Sarafidou T., Sehra H.K., Shownkeen R., Skuce C.D., Smith M.,
RA   Standring L., Sycamore N., Tester J., Thorpe A., Torcasso W.,
RA   Tracey A., Tromans A., Tsolas J., Wall M., Walsh J., Wang H.,
RA   Weinstock K., West A.P., Willey D.L., Whitehead S.L., Wilming L.,
RA   Wray P.W., Young L., Chen Y., Lovering R.C., Moschonas N.K.,
RA   Siebert R., Fechtel K., Bentley D., Durbin R.M., Hubbard T.,
RA   Doucette-Stamm L., Beck S., Smith D.R., Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 10.";
RL   Nature 429:375-381(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 4), NUCLEOTIDE
RP   SEQUENCE [LARGE SCALE MRNA] OF 4-151 (ISOFORM 3), AND VARIANT ARG-101.
RC   TISSUE=Liver, and Pancreas;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -!- FUNCTION: May play an important role in maintaining normal growth
CC       homeostasis in epithelial cells. {ECO:0000269|PubMed:14583459}.
CC   -!- INTERACTION:
CC       O43765:SGTA; NbExp=5; IntAct=EBI-2116102, EBI-347996;
CC       Q9UMX0:UBQLN1; NbExp=5; IntAct=EBI-2116102, EBI-741480;
CC       Q9UMX0-2:UBQLN1; NbExp=3; IntAct=EBI-2116102, EBI-10173939;
CC       Q9UHD9:UBQLN2; NbExp=4; IntAct=EBI-2116102, EBI-947187;
CC   -!- SUBCELLULAR LOCATION: Secreted {ECO:0000269|PubMed:14583459}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1; Synonyms=PRAP;
CC         IsoId=Q96NZ9-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q96NZ9-2; Sequence=VSP_027661, VSP_027662;
CC       Name=3; Synonyms=PRAPV1;
CC         IsoId=Q96NZ9-3; Sequence=VSP_027660;
CC       Name=4; Synonyms=PRAPV2;
CC         IsoId=Q96NZ9-4; Sequence=VSP_027661;
CC   -!- TISSUE SPECIFICITY: Abundantly expressed in the epithelial cells
CC       of the liver, kidney, gastrointestinal tract and cervix.
CC       Significantly down-regulated in hepatocellular carcinoma and right
CC       colon adenocarcinoma compared with the respective adjacent normal
CC       tissues. Expressed in epididymis (at protein level).
CC       {ECO:0000269|PubMed:14583459, ECO:0000269|PubMed:20736409}.
CC   -!- INDUCTION: Up-regulated by butyrate, trichostatin A and 5'-aza-2'
CC       deoxycytidine. {ECO:0000269|PubMed:14583459}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAP97247.1; Type=Frameshift; Positions=81, 86; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF421885; AAL16670.1; -; mRNA.
DR   EMBL; AY158074; AAN87018.1; -; mRNA.
DR   EMBL; AF123768; AAP97247.1; ALT_FRAME; mRNA.
DR   EMBL; AY358908; AAQ89267.1; -; mRNA.
DR   EMBL; GU727628; ADU87630.1; -; mRNA.
DR   EMBL; AL360181; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471211; EAW61336.1; -; Genomic_DNA.
DR   EMBL; BC029447; AAH29447.2; -; mRNA.
DR   EMBL; BC061643; AAH61643.1; -; mRNA.
DR   EMBL; BC071872; AAH71872.1; -; mRNA.
DR   EMBL; BC093853; AAH93853.1; -; mRNA.
DR   EMBL; BC101743; AAI01744.1; -; mRNA.
DR   EMBL; BC143590; AAI43591.1; -; mRNA.
DR   EMBL; BC143592; AAI43593.1; -; mRNA.
DR   EMBL; BC143591; AAI43592.1; -; mRNA.
DR   CCDS; CCDS44498.1; -. [Q96NZ9-4]
DR   CCDS; CCDS7679.1; -. [Q96NZ9-1]
DR   RefSeq; NP_001138673.1; NM_001145201.1. [Q96NZ9-4]
DR   RefSeq; NP_660203.3; NM_145202.4. [Q96NZ9-1]
DR   UniGene; Hs.15951; -.
DR   ProteinModelPortal; Q96NZ9; -.
DR   BioGrid; 125610; 8.
DR   IntAct; Q96NZ9; 6.
DR   iPTMnet; Q96NZ9; -.
DR   PhosphoSitePlus; Q96NZ9; -.
DR   BioMuta; PRAP1; -.
DR   DMDM; 317373269; -.
DR   PaxDb; Q96NZ9; -.
DR   PeptideAtlas; Q96NZ9; -.
DR   PRIDE; Q96NZ9; -.
DR   DNASU; 118471; -.
DR   Ensembl; ENST00000433452; ENSP00000416126; ENSG00000165828. [Q96NZ9-1]
DR   Ensembl; ENST00000463201; ENSP00000486265; ENSG00000165828. [Q96NZ9-4]
DR   GeneID; 118471; -.
DR   KEGG; hsa:118471; -.
DR   UCSC; uc001lmp.3; human. [Q96NZ9-1]
DR   CTD; 118471; -.
DR   DisGeNET; 118471; -.
DR   EuPathDB; HostDB:ENSG00000165828.13; -.
DR   GeneCards; PRAP1; -.
DR   HGNC; HGNC:23304; PRAP1.
DR   HPA; HPA038713; -.
DR   HPA; HPA052451; -.
DR   MIM; 609776; gene.
DR   neXtProt; NX_Q96NZ9; -.
DR   OpenTargets; ENSG00000165828; -.
DR   PharmGKB; PA134981678; -.
DR   eggNOG; ENOG410J3WZ; Eukaryota.
DR   eggNOG; ENOG4111CMU; LUCA.
DR   GeneTree; ENSGT00390000012626; -.
DR   HOVERGEN; HBG099538; -.
DR   InParanoid; Q96NZ9; -.
DR   KO; K21250; -.
DR   PhylomeDB; Q96NZ9; -.
DR   TreeFam; TF337049; -.
DR   GenomeRNAi; 118471; -.
DR   PRO; PR:Q96NZ9; -.
DR   Proteomes; UP000005640; Chromosome 10.
DR   Bgee; ENSG00000165828; -.
DR   CleanEx; HS_PRAP1; -.
DR   ExpressionAtlas; Q96NZ9; baseline and differential.
DR   Genevisible; Q96NZ9; HS.
DR   GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR   GO; GO:0000981; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; ISA:NTNU_SB.
DR   InterPro; IPR027922; PRAP.
DR   Pfam; PF15314; PRAP; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Complete proteome; Polymorphism;
KW   Reference proteome; Secreted; Signal.
FT   SIGNAL        1     20       {ECO:0000255}.
FT   CHAIN        21    151       Proline-rich acidic protein 1.
FT                                /FTId=PRO_0000299416.
FT   VAR_SEQ      43     43       K -> NR (in isoform 3).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_027660.
FT   VAR_SEQ      79     87       Missing (in isoform 2 and isoform 4).
FT                                {ECO:0000303|PubMed:14583459,
FT                                ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_027661.
FT   VAR_SEQ      95    151       TEDTLGHVLSPEPDHDSLYHPPPEEDQGEERPRLWVMPNHQ
FT                                VLLGPEEDQDHIYHPQ -> SRARP (in isoform 2).
FT                                {ECO:0000303|PubMed:14583459}.
FT                                /FTId=VSP_027662.
FT   VARIANT      54     54       E -> G. {ECO:0000269|PubMed:14583459}.
FT                                /FTId=VAR_034815.
FT   VARIANT      69     69       K -> R. {ECO:0000269|PubMed:14583459}.
FT                                /FTId=VAR_034816.
FT   VARIANT      81     81       G -> S (in dbSNP:rs34780987).
FT                                /FTId=VAR_034817.
FT   VARIANT     101    101       H -> R (in dbSNP:rs4369319).
FT                                {ECO:0000269|PubMed:12975309,
FT                                ECO:0000269|PubMed:14583459,
FT                                ECO:0000269|PubMed:15164054,
FT                                ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|PubMed:20736409,
FT                                ECO:0000269|Ref.3}.
FT                                /FTId=VAR_034818.
SQ   SEQUENCE   151 AA;  17208 MW;  B751EDBFD24D08CA CRC64;
     MRRLLLVTSL VVVLLWEAGA VPAPKVPIKM QVKHWPSEQD PEKAWGARVV EPPEKDDQLV
     VLFPVQKPKL LTTEEKPRGQ GRGPILPGTK AWMETEDTLG HVLSPEPDHD SLYHPPPEED
     QGEERPRLWV MPNHQVLLGP EEDQDHIYHP Q
//
ID   F5GYS6_HUMAN            Unreviewed;       172 AA.
AC   F5GYS6;
DT   28-JUN-2011, integrated into UniProtKB/TrEMBL.
DT   28-JUN-2011, sequence version 1.
DT   23-MAY-2018, entry version 52.
DE   SubName: Full=Endoplasmic reticulum resident protein 27 {ECO:0000313|Ensembl:ENSP00000440573};
GN   Name=ERP27 {ECO:0000313|Ensembl:ENSP00000440573};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000440573, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Ensembl:ENSP00000440573, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16541075; DOI=10.1038/nature04569;
RG   Baylor College of Medicine Human Genome Sequencing Center Sequence Production Team;
RA   Scherer S.E., Muzny D.M., Buhay C.J., Chen R., Cree A., Ding Y.,
RA   Dugan-Rocha S., Gill R., Gunaratne P., Harris R.A., Hawes A.C.,
RA   Hernandez J., Hodgson A.V., Hume J., Jackson A., Khan Z.M.,
RA   Kovar-Smith C., Lewis L.R., Lozado R.J., Metzker M.L.,
RA   Milosavljevic A., Miner G.R., Montgomery K.T., Morgan M.B.,
RA   Nazareth L.V., Scott G., Sodergren E., Song X.Z., Steffen D.,
RA   Lovering R.C., Wheeler D.A., Worley K.C., Yuan Y., Zhang Z.,
RA   Adams C.Q., Ansari-Lari M.A., Ayele M., Brown M.J., Chen G., Chen Z.,
RA   Clerc-Blankenburg K.P., Davis C., Delgado O., Dinh H.H., Draper H.,
RA   Gonzalez-Garay M.L., Havlak P., Jackson L.R., Jacob L.S., Kelly S.H.,
RA   Li L., Li Z., Liu J., Liu W., Lu J., Maheshwari M., Nguyen B.V.,
RA   Okwuonu G.O., Pasternak S., Perez L.M., Plopper F.J., Santibanez J.,
RA   Shen H., Tabor P.E., Verduzco D., Waldron L., Wang Q., Williams G.A.,
RA   Zhang J., Zhou J., Allen C.C., Amin A.G., Anyalebechi V., Bailey M.,
RA   Barbaria J.A., Bimage K.E., Bryant N.P., Burch P.E., Burkett C.E.,
RA   Burrell K.L., Calderon E., Cardenas V., Carter K., Casias K.,
RA   Cavazos I., Cavazos S.R., Ceasar H., Chacko J., Chan S.N., Chavez D.,
RA   Christopoulos C., Chu J., Cockrell R., Cox C.D., Dang M.,
RA   Dathorne S.R., David R., Davis C.M., Davy-Carroll L., Deshazo D.R.,
RA   Donlin J.E., D'Souza L., Eaves K.A., Egan A., Emery-Cohen A.J.,
RA   Escotto M., Flagg N., Forbes L.D., Gabisi A.M., Garza M., Hamilton C.,
RA   Henderson N., Hernandez O., Hines S., Hogues M.E., Huang M.,
RA   Idlebird D.G., Johnson R., Jolivet A., Jones S., Kagan R., King L.M.,
RA   Leal B., Lebow H., Lee S., LeVan J.M., Lewis L.C., London P.,
RA   Lorensuhewa L.M., Loulseged H., Lovett D.A., Lucier A., Lucier R.L.,
RA   Ma J., Madu R.C., Mapua P., Martindale A.D., Martinez E., Massey E.,
RA   Mawhiney S., Meador M.G., Mendez S., Mercado C., Mercado I.C.,
RA   Merritt C.E., Miner Z.L., Minja E., Mitchell T., Mohabbat F.,
RA   Mohabbat K., Montgomery B., Moore N., Morris S., Munidasa M.,
RA   Ngo R.N., Nguyen N.B., Nickerson E., Nwaokelemeh O.O., Nwokenkwo S.,
RA   Obregon M., Oguh M., Oragunye N., Oviedo R.J., Parish B.J.,
RA   Parker D.N., Parrish J., Parks K.L., Paul H.A., Payton B.A., Perez A.,
RA   Perrin W., Pickens A., Primus E.L., Pu L.L., Puazo M., Quiles M.M.,
RA   Quiroz J.B., Rabata D., Reeves K., Ruiz S.J., Shao H., Sisson I.,
RA   Sonaike T., Sorelle R.P., Sutton A.E., Svatek A.F., Svetz L.A.,
RA   Tamerisa K.S., Taylor T.R., Teague B., Thomas N., Thorn R.D.,
RA   Trejos Z.Y., Trevino B.K., Ukegbu O.N., Urban J.B., Vasquez L.I.,
RA   Vera V.A., Villasana D.M., Wang L., Ward-Moore S., Warren J.T.,
RA   Wei X., White F., Williamson A.L., Wleczyk R., Wooden H.S.,
RA   Wooden S.H., Yen J., Yoon L., Yoon V., Zorrilla S.E., Nelson D.,
RA   Kucherlapati R., Weinstock G., Gibbs R.A., null.;
RT   "The finished DNA sequence of human chromosome 12.";
RL   Nature 440:346-351(2006).
RN   [2] {ECO:0000313|Ensembl:ENSP00000440573}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (JUL-2011) to UniProtKB.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AC007655; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   RefSeq; NP_001287713.1; NM_001300784.1.
DR   UniGene; Hs.162143; -.
DR   ProteinModelPortal; F5GYS6; -.
DR   SMR; F5GYS6; -.
DR   PeptideAtlas; F5GYS6; -.
DR   Ensembl; ENST00000540097; ENSP00000440573; ENSG00000139055.
DR   GeneID; 121506; -.
DR   UCSC; uc058lni.1; human.
DR   CTD; 121506; -.
DR   EuPathDB; HostDB:ENSG00000139055.6; -.
DR   HGNC; HGNC:26495; ERP27.
DR   OpenTargets; ENSG00000139055; -.
DR   eggNOG; KOG0191; Eukaryota.
DR   eggNOG; COG0526; LUCA.
DR   GeneTree; ENSGT00860000133691; -.
DR   ChiTaRS; ERP27; human.
DR   GenomeRNAi; 121506; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   Bgee; ENSG00000139055; -.
DR   ExpressionAtlas; F5GYS6; baseline and differential.
DR   InterPro; IPR036249; Thioredoxin-like_sf.
DR   SUPFAM; SSF52833; SSF52833; 1.
PE   1: Evidence at protein level;
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   Proteomics identification {ECO:0000213|PeptideAtlas:F5GYS6};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640}.
SQ   SEQUENCE   172 AA;  19708 MW;  9D958189AC597020 CRC64;
     MKETCQLEIQ VDNEQLNLED EDIESIDATK LSRFIEINSL HMVTEYNPVT VIGLFNSVIQ
     IHLLLIMNKA SPEYEENMHR YQKAAKLFQG KILFILVDSG MKENGKVISF FKLKESQLPA
     LAIYQTLDDE WDTLPTAEVS VEHVQNFCDG FLSGKLLKEN RESEGKTPKV EL
//
ID   ERP27_HUMAN             Reviewed;         273 AA.
AC   Q96DN0;
DT   20-MAR-2007, integrated into UniProtKB/Swiss-Prot.
DT   01-DEC-2001, sequence version 1.
DT   28-FEB-2018, entry version 125.
DE   RecName: Full=Endoplasmic reticulum resident protein 27;
DE            Short=ER protein 27;
DE            Short=ERp27;
DE   Flags: Precursor;
GN   Name=ERP27; Synonyms=C12orf46; ORFNames=UNQ781/PRO1575;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=12975309; DOI=10.1101/gr.1293003;
RA   Clark H.F., Gurney A.L., Abaya E., Baker K., Baldwin D.T., Brush J.,
RA   Chen J., Chow B., Chui C., Crowley C., Currell B., Deuel B., Dowd P.,
RA   Eaton D., Foster J.S., Grimaldi C., Gu Q., Hass P.E., Heldens S.,
RA   Huang A., Kim H.S., Klimowski L., Jin Y., Johnson S., Lee J.,
RA   Lewis L., Liao D., Mark M.R., Robbie E., Sanchez C., Schoenfeld J.,
RA   Seshagiri S., Simmons L., Singh J., Smith V., Stinson J., Vagts A.,
RA   Vandlen R.L., Watanabe C., Wieand D., Woods K., Xie M.-H.,
RA   Yansura D.G., Yi S., Yu G., Yuan J., Zhang M., Zhang Z., Goddard A.D.,
RA   Wood W.I., Godowski P.J., Gray A.M.;
RT   "The secreted protein discovery initiative (SPDI), a large-scale
RT   effort to identify novel human secreted and transmembrane proteins: a
RT   bioinformatics assessment.";
RL   Genome Res. 13:2265-2270(2003).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Pancreas;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   STRUCTURE BY NMR, SUBCELLULAR LOCATION, INTERACTION WITH PDIA3, AND
RP   MUTAGENESIS OF MET-168; ILE-196; GLU-231; TRP-232 AND ASP-233.
RX   PubMed=16940051; DOI=10.1074/jbc.M604314200;
RA   Alanen H.I., Williamson R.A., Howard M.J., Hatahet F.S., Salo K.E.H.,
RA   Kauppila A., Kellokumpu S., Ruddock L.W.;
RT   "ERp27, a new non-catalytic endoplasmic reticulum-located human
RT   protein disulfide isomerase family member, interacts with ERp57.";
RL   J. Biol. Chem. 281:33727-33738(2006).
CC   -!- SUBUNIT: Interacts with PDIA3. Binds somatostatin-14 via
CC       hydrophobic interactions. {ECO:0000269|PubMed:16940051}.
CC   -!- INTERACTION:
CC       P29692:EEF1D; NbExp=3; IntAct=EBI-953772, EBI-358607;
CC       O43765:SGTA; NbExp=5; IntAct=EBI-953772, EBI-347996;
CC       Q9UMX0:UBQLN1; NbExp=3; IntAct=EBI-953772, EBI-741480;
CC       Q9UMX0-2:UBQLN1; NbExp=3; IntAct=EBI-953772, EBI-10173939;
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum lumen
CC       {ECO:0000269|PubMed:16940051}.
CC   -!- MISCELLANEOUS: Does not contain a CXXC active site motif
CC       indicating that it is a catalytically redox-inactive member of the
CC       protein disulfide isomerase family.
CC   -!- SIMILARITY: Belongs to the protein disulfide isomerase family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AY358536; AAQ88900.1; -; mRNA.
DR   EMBL; AK056677; BAB71251.1; -; mRNA.
DR   EMBL; BC030218; AAH30218.1; -; mRNA.
DR   CCDS; CCDS8670.1; -.
DR   RefSeq; NP_001287713.1; NM_001300784.1.
DR   RefSeq; NP_689534.1; NM_152321.3.
DR   UniGene; Hs.162143; -.
DR   PDB; 2L4C; NMR; -; A=26-141.
DR   PDB; 4F9Z; X-ray; 2.20 A; A/B/C/D/E=30-256.
DR   PDBsum; 2L4C; -.
DR   PDBsum; 4F9Z; -.
DR   ProteinModelPortal; Q96DN0; -.
DR   SMR; Q96DN0; -.
DR   BioGrid; 125733; 12.
DR   IntAct; Q96DN0; 6.
DR   STRING; 9606.ENSP00000266397; -.
DR   BioMuta; ERP27; -.
DR   DMDM; 74731474; -.
DR   MaxQB; Q96DN0; -.
DR   PaxDb; Q96DN0; -.
DR   PeptideAtlas; Q96DN0; -.
DR   PRIDE; Q96DN0; -.
DR   DNASU; 121506; -.
DR   Ensembl; ENST00000266397; ENSP00000266397; ENSG00000139055.
DR   GeneID; 121506; -.
DR   KEGG; hsa:121506; -.
DR   UCSC; uc001rco.4; human.
DR   CTD; 121506; -.
DR   EuPathDB; HostDB:ENSG00000139055.6; -.
DR   GeneCards; ERP27; -.
DR   HGNC; HGNC:26495; ERP27.
DR   HPA; HPA039636; -.
DR   HPA; HPA052851; -.
DR   MIM; 610642; gene.
DR   neXtProt; NX_Q96DN0; -.
DR   OpenTargets; ENSG00000139055; -.
DR   PharmGKB; PA162385401; -.
DR   eggNOG; KOG0191; Eukaryota.
DR   eggNOG; COG0526; LUCA.
DR   GeneTree; ENSGT00860000133691; -.
DR   HOGENOM; HOG000112391; -.
DR   HOVERGEN; HBG081481; -.
DR   InParanoid; Q96DN0; -.
DR   KO; K20355; -.
DR   OMA; EHVQNFC; -.
DR   OrthoDB; EOG091G0CRI; -.
DR   PhylomeDB; Q96DN0; -.
DR   TreeFam; TF106381; -.
DR   BRENDA; 5.3.4.1; 2681.
DR   ChiTaRS; ERP27; human.
DR   GenomeRNAi; 121506; -.
DR   PRO; PR:Q96DN0; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   Bgee; ENSG00000139055; -.
DR   CleanEx; HS_ERP27; -.
DR   ExpressionAtlas; Q96DN0; baseline and differential.
DR   Genevisible; Q96DN0; HS.
DR   GO; GO:0005788; C:endoplasmic reticulum lumen; IEA:UniProtKB-SubCell.
DR   InterPro; IPR036249; Thioredoxin-like_sf.
DR   SUPFAM; SSF52833; SSF52833; 2.
PE   1: Evidence at protein level;
KW   3D-structure; Complete proteome; Endoplasmic reticulum; Polymorphism;
KW   Reference proteome; Signal.
FT   SIGNAL        1     25       {ECO:0000255}.
FT   CHAIN        26    273       Endoplasmic reticulum resident protein
FT                                27.
FT                                /FTId=PRO_0000281118.
FT   DOMAIN       39    152       Thioredoxin.
FT   REGION      230    233       PDIA3-binding site.
FT   MOTIF       270    273       Prevents secretion from ER.
FT   VARIANT      52     52       F -> L (in dbSNP:rs35030722).
FT                                /FTId=VAR_052582.
FT   MUTAGEN     168    168       M->W: Decreases somatostatin-14 binding.
FT                                {ECO:0000269|PubMed:16940051}.
FT   MUTAGEN     196    196       I->A,L,W: Decreases somatostatin-14
FT                                binding. {ECO:0000269|PubMed:16940051}.
FT   MUTAGEN     196    196       I->W: Conserved PDIA3 binding in vivo and
FT                                in vitro. {ECO:0000269|PubMed:16940051}.
FT   MUTAGEN     231    231       E->K,A: Greatly reduces PDIA3 binding in
FT                                vivo and in vitro.
FT                                {ECO:0000269|PubMed:16940051}.
FT   MUTAGEN     232    232       W->A: Greatly reduces PDIA3 binding in
FT                                vivo and in vitro.
FT                                {ECO:0000269|PubMed:16940051}.
FT   MUTAGEN     233    233       D->G: Greatly reduces PDIA3 binding in
FT                                vivo and in vitro.
FT                                {ECO:0000269|PubMed:16940051}.
FT   HELIX        46     54       {ECO:0000244|PDB:4F9Z}.
FT   STRAND       56     63       {ECO:0000244|PDB:4F9Z}.
FT   HELIX        71     78       {ECO:0000244|PDB:4F9Z}.
FT   TURN         79     81       {ECO:0000244|PDB:4F9Z}.
FT   STRAND       85     90       {ECO:0000244|PDB:4F9Z}.
FT   HELIX        93     98       {ECO:0000244|PDB:4F9Z}.
FT   STRAND      103    110       {ECO:0000244|PDB:4F9Z}.
FT   TURN        111    114       {ECO:0000244|PDB:4F9Z}.
FT   STRAND      115    119       {ECO:0000244|PDB:4F9Z}.
FT   HELIX       121    125       {ECO:0000244|PDB:4F9Z}.
FT   HELIX       129    139       {ECO:0000244|PDB:4F9Z}.
FT   STRAND      143    146       {ECO:0000244|PDB:4F9Z}.
FT   HELIX       149    157       {ECO:0000244|PDB:4F9Z}.
FT   STRAND      162    168       {ECO:0000244|PDB:4F9Z}.
FT   HELIX       175    188       {ECO:0000244|PDB:4F9Z}.
FT   TURN        189    192       {ECO:0000244|PDB:4F9Z}.
FT   STRAND      194    199       {ECO:0000244|PDB:4F9Z}.
FT   HELIX       203    205       {ECO:0000244|PDB:4F9Z}.
FT   HELIX       206    211       {ECO:0000244|PDB:4F9Z}.
FT   HELIX       216    218       {ECO:0000244|PDB:4F9Z}.
FT   STRAND      220    229       {ECO:0000244|PDB:4F9Z}.
FT   STRAND      232    235       {ECO:0000244|PDB:4F9Z}.
FT   HELIX       242    253       {ECO:0000244|PDB:4F9Z}.
SQ   SEQUENCE   273 AA;  30480 MW;  D47280F6F6FDE419 CRC64;
     MEAAPSRFMF LLFLLTCELA AEVAAEVEKS SDGPGAAQEP TWLTDVPAAM EFIAATEVAV
     IGFFQDLEIP AVPILHSMVQ KFPGVSFGIS TDSEVLTHYN ITGNTICLFR LVDNEQLNLE
     DEDIESIDAT KLSRFIEINS LHMVTEYNPV TVIGLFNSVI QIHLLLIMNK ASPEYEENMH
     RYQKAAKLFQ GKILFILVDS GMKENGKVIS FFKLKESQLP ALAIYQTLDD EWDTLPTAEV
     SVEHVQNFCD GFLSGKLLKE NRESEGKTPK VEL
//
ID   G8H6I3_HUMAN            Unreviewed;       208 AA.
AC   G8H6I3;
DT   25-JAN-2012, integrated into UniProtKB/TrEMBL.
DT   25-JAN-2012, sequence version 1.
DT   31-JAN-2018, entry version 36.
DE   SubName: Full=Endocrine and exocrine protein {ECO:0000313|EMBL:AET71202.1};
GN   Name=EECP {ECO:0000313|EMBL:AET71202.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:AET71202.1};
RN   [1] {ECO:0000313|EMBL:AET71202.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Zheng H., Li H.;
RT   "Gene EECP and diagnostic uses thereof (PCT/CN2007/002111).";
RL   Submitted (JUN-2011) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; JN411265; AET71202.1; -; mRNA.
DR   RefSeq; NP_660295.2; NM_145252.2.
DR   UniGene; Hs.105887; -.
DR   ProteinModelPortal; G8H6I3; -.
DR   SMR; G8H6I3; -.
DR   PRIDE; G8H6I3; -.
DR   GeneID; 124220; -.
DR   KEGG; hsa:124220; -.
DR   CTD; 124220; -.
DR   EuPathDB; HostDB:ENSG00000162078.11; -.
DR   eggNOG; ENOG410JCVC; Eukaryota.
DR   eggNOG; ENOG41115HP; LUCA.
DR   OMA; WNYPLEE; -.
DR   OrthoDB; EOG091G0Y3H; -.
DR   PhylomeDB; G8H6I3; -.
DR   GenomeRNAi; 124220; -.
DR   Bgee; ENSG00000162078; -.
DR   ExpressionAtlas; G8H6I3; baseline and differential.
DR   Genevisible; G8H6I3; HS.
DR   Gene3D; 2.100.10.30; -; 1.
DR   InterPro; IPR001229; Jacalin-like_lectin_dom.
DR   InterPro; IPR036404; Jacalin-like_lectin_dom_sf.
DR   Pfam; PF01419; Jacalin; 1.
DR   SMART; SM00915; Jacalin; 1.
DR   SUPFAM; SSF51101; SSF51101; 1.
DR   PROSITE; PS51752; JACALIN_LECTIN; 1.
PE   2: Evidence at transcript level;
FT   DOMAIN       50    185       Jacalin-type lectin.
FT                                {ECO:0000259|PROSITE:PS51752}.
SQ   SEQUENCE   208 AA;  22739 MW;  313B0ED64B24CDB2 CRC64;
     MGAQGAQESI KAMWRVPGTT RRPVTGESPG MHRPEAMLLL LTLALLGGPT WAGKMYGPGG
     GKYFSTTEDY DHEITGLRVS VGLLLVKSVQ VKLGDSWDVK LGALGGNTQE VTLQPGEYIT
     KVFVAFQAFL RGMVMYTSKD RYFYFGKLDG QISSAYPSQE GQVLVGIYGQ YQLLGIKSIG
     FEWNYPLEEP TTEPPVNLTY SANSPVGR
//
ID   ZG16B_HUMAN             Reviewed;         208 AA.
AC   Q96DA0; A6NIY1; B2R4F6; Q6UW28;
DT   05-SEP-2006, integrated into UniProtKB/Swiss-Prot.
DT   10-JUL-2007, sequence version 3.
DT   28-FEB-2018, entry version 113.
DE   RecName: Full=Zymogen granule protein 16 homolog B;
DE   Flags: Precursor;
GN   Name=ZG16B; ORFNames=UNQ773/PRO1567;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=12975309; DOI=10.1101/gr.1293003;
RA   Clark H.F., Gurney A.L., Abaya E., Baker K., Baldwin D.T., Brush J.,
RA   Chen J., Chow B., Chui C., Crowley C., Currell B., Deuel B., Dowd P.,
RA   Eaton D., Foster J.S., Grimaldi C., Gu Q., Hass P.E., Heldens S.,
RA   Huang A., Kim H.S., Klimowski L., Jin Y., Johnson S., Lee J.,
RA   Lewis L., Liao D., Mark M.R., Robbie E., Sanchez C., Schoenfeld J.,
RA   Seshagiri S., Simmons L., Singh J., Smith V., Stinson J., Vagts A.,
RA   Vandlen R.L., Watanabe C., Wieand D., Woods K., Xie M.-H.,
RA   Yansura D.G., Yi S., Yu G., Yuan J., Zhang M., Zhang Z., Goddard A.D.,
RA   Wood W.I., Godowski P.J., Gray A.M.;
RT   "The secreted protein discovery initiative (SPDI), a large-scale
RT   effort to identify novel human secreted and transmembrane proteins: a
RT   bioinformatics assessment.";
RL   Genome Res. 13:2265-2270(2003).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15616553; DOI=10.1038/nature03187;
RA   Martin J., Han C., Gordon L.A., Terry A., Prabhakar S., She X.,
RA   Xie G., Hellsten U., Chan Y.M., Altherr M., Couronne O., Aerts A.,
RA   Bajorek E., Black S., Blumer H., Branscomb E., Brown N.C., Bruno W.J.,
RA   Buckingham J.M., Callen D.F., Campbell C.S., Campbell M.L.,
RA   Campbell E.W., Caoile C., Challacombe J.F., Chasteen L.A.,
RA   Chertkov O., Chi H.C., Christensen M., Clark L.M., Cohn J.D.,
RA   Denys M., Detter J.C., Dickson M., Dimitrijevic-Bussod M., Escobar J.,
RA   Fawcett J.J., Flowers D., Fotopulos D., Glavina T., Gomez M.,
RA   Gonzales E., Goodstein D., Goodwin L.A., Grady D.L., Grigoriev I.,
RA   Groza M., Hammon N., Hawkins T., Haydu L., Hildebrand C.E., Huang W.,
RA   Israni S., Jett J., Jewett P.B., Kadner K., Kimball H., Kobayashi A.,
RA   Krawczyk M.-C., Leyba T., Longmire J.L., Lopez F., Lou Y., Lowry S.,
RA   Ludeman T., Manohar C.F., Mark G.A., McMurray K.L., Meincke L.J.,
RA   Morgan J., Moyzis R.K., Mundt M.O., Munk A.C., Nandkeshwar R.D.,
RA   Pitluck S., Pollard M., Predki P., Parson-Quintana B., Ramirez L.,
RA   Rash S., Retterer J., Ricke D.O., Robinson D.L., Rodriguez A.,
RA   Salamov A., Saunders E.H., Scott D., Shough T., Stallings R.L.,
RA   Stalvey M., Sutherland R.D., Tapia R., Tesmer J.G., Thayer N.,
RA   Thompson L.S., Tice H., Torney D.C., Tran-Gyamfi M., Tsai M.,
RA   Ulanovsky L.E., Ustaszewska A., Vo N., White P.S., Williams A.L.,
RA   Wills P.L., Wu J.-R., Wu K., Yang J., DeJong P., Bruce D.,
RA   Doggett N.A., Deaven L., Schmutz J., Grimwood J., Richardson P.,
RA   Rokhsar D.S., Eichler E.E., Gilna P., Lucas S.M., Myers R.M.,
RA   Rubin E.M., Pennacchio L.A.;
RT   "The sequence and analysis of duplication-rich human chromosome 16.";
RL   Nature 432:988-994(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Lung carcinoma;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 20-208.
RC   TISSUE=Trachea;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [6]
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=11678034;
RX   DOI=10.1002/1615-9861(200104)1:5<641::AID-PROT641>3.0.CO;2-R;
RA   Kuster B., Mortensen P., Andersen J.S., Mann M.;
RT   "Mass spectrometry allows direct identification of proteins in large
RT   genomes.";
RL   Proteomics 1:641-650(2001).
RN   [7]
RP   X-RAY CRYSTALLOGRAPHY (2.75 ANGSTROMS) OF 53-208.
RX   PubMed=21110947; DOI=10.1016/j.bbrc.2010.11.093;
RA   Kanagawa M., Satoh T., Ikeda A., Nakano Y., Yagi H., Kato K.,
RA   Kojima-Aikawa K., Yamaguchi Y.;
RT   "Crystal structures of human secretory proteins ZG16p and ZG16b reveal
RT   a Jacalin-related beta-prism fold.";
RL   Biochem. Biophys. Res. Commun. 404:201-205(2011).
CC   -!- INTERACTION:
CC       Q96EQ0:SGTB; NbExp=4; IntAct=EBI-953824, EBI-744081;
CC       Q9UHD9:UBQLN2; NbExp=4; IntAct=EBI-953824, EBI-947187;
CC   -!- SUBCELLULAR LOCATION: Secreted {ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the jacalin lectin family.
CC       {ECO:0000255|PROSITE-ProRule:PRU01088, ECO:0000305}.
CC   -!- CAUTION: It is uncertain whether Met-1, Met-13 or Met-31 is the
CC       initiator. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAQ89380.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC       Sequence=BAG34753.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AY359021; AAQ89380.1; ALT_INIT; mRNA.
DR   EMBL; AC005361; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471112; EAW85462.1; -; Genomic_DNA.
DR   EMBL; BC009722; AAH09722.2; -; mRNA.
DR   EMBL; AK311810; BAG34753.1; ALT_INIT; mRNA.
DR   CCDS; CCDS10479.2; -.
DR   RefSeq; NP_660295.2; NM_145252.2.
DR   UniGene; Hs.105887; -.
DR   PDB; 3AQG; X-ray; 2.75 A; A/B=53-208.
DR   PDBsum; 3AQG; -.
DR   ProteinModelPortal; Q96DA0; -.
DR   SMR; Q96DA0; -.
DR   BioGrid; 125855; 68.
DR   IntAct; Q96DA0; 7.
DR   STRING; 9606.ENSP00000371715; -.
DR   iPTMnet; Q96DA0; -.
DR   PhosphoSitePlus; Q96DA0; -.
DR   BioMuta; ZG16B; -.
DR   DMDM; 152031723; -.
DR   EPD; Q96DA0; -.
DR   MaxQB; Q96DA0; -.
DR   PaxDb; Q96DA0; -.
DR   PeptideAtlas; Q96DA0; -.
DR   PRIDE; Q96DA0; -.
DR   DNASU; 124220; -.
DR   Ensembl; ENST00000382280; ENSP00000371715; ENSG00000162078.
DR   Ensembl; ENST00000634500; ENSP00000489035; ENSG00000283056.
DR   GeneID; 124220; -.
DR   KEGG; hsa:124220; -.
DR   UCSC; uc002cru.4; human.
DR   CTD; 124220; -.
DR   DisGeNET; 124220; -.
DR   EuPathDB; HostDB:ENSG00000162078.11; -.
DR   GeneCards; ZG16B; -.
DR   HGNC; HGNC:30456; ZG16B.
DR   HPA; HPA041125; -.
DR   HPA; HPA053549; -.
DR   neXtProt; NX_Q96DA0; -.
DR   OpenTargets; ENSG00000162078; -.
DR   PharmGKB; PA164727732; -.
DR   eggNOG; ENOG410JCVC; Eukaryota.
DR   eggNOG; ENOG41115HP; LUCA.
DR   GeneTree; ENSGT00530000063886; -.
DR   HOGENOM; HOG000155786; -.
DR   InParanoid; Q96DA0; -.
DR   OMA; WNYPLEE; -.
DR   OrthoDB; EOG091G0Y3H; -.
DR   PhylomeDB; Q96DA0; -.
DR   TreeFam; TF333440; -.
DR   GeneWiki; LOC124220; -.
DR   GenomeRNAi; 124220; -.
DR   PRO; PR:Q96DA0; -.
DR   Proteomes; UP000005640; Chromosome 16.
DR   Bgee; ENSG00000162078; -.
DR   ExpressionAtlas; Q96DA0; baseline and differential.
DR   Genevisible; Q96DA0; HS.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0005615; C:extracellular space; HDA:UniProtKB.
DR   GO; GO:0030246; F:carbohydrate binding; IEA:UniProtKB-KW.
DR   GO; GO:0001895; P:retina homeostasis; HEP:UniProtKB.
DR   Gene3D; 2.100.10.30; -; 1.
DR   InterPro; IPR001229; Jacalin-like_lectin_dom.
DR   InterPro; IPR036404; Jacalin-like_lectin_dom_sf.
DR   Pfam; PF01419; Jacalin; 1.
DR   SMART; SM00915; Jacalin; 1.
DR   SUPFAM; SSF51101; SSF51101; 1.
DR   PROSITE; PS51752; JACALIN_LECTIN; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Complete proteome; Glycoprotein; Lectin; Polymorphism;
KW   Reference proteome; Secreted; Signal.
FT   SIGNAL        1     52       {ECO:0000255}.
FT   CHAIN        53    208       Zymogen granule protein 16 homolog B.
FT                                /FTId=PRO_0000248073.
FT   DOMAIN       53    185       Jacalin-type lectin.
FT                                {ECO:0000255|PROSITE-ProRule:PRU01088}.
FT   COMPBIAS     38     46       Poly-Leu.
FT   CARBOHYD    197    197       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   VARIANT     133    133       M -> V (in dbSNP:rs35533993).
FT                                /FTId=VAR_060067.
FT   STRAND       56     58       {ECO:0000244|PDB:3AQG}.
FT   STRAND       61     65       {ECO:0000244|PDB:3AQG}.
FT   STRAND       74     81       {ECO:0000244|PDB:3AQG}.
FT   STRAND       83     97       {ECO:0000244|PDB:3AQG}.
FT   STRAND      106    112       {ECO:0000244|PDB:3AQG}.
FT   STRAND      119    137       {ECO:0000244|PDB:3AQG}.
FT   STRAND      142    146       {ECO:0000244|PDB:3AQG}.
FT   STRAND      150    155       {ECO:0000244|PDB:3AQG}.
FT   STRAND      163    172       {ECO:0000244|PDB:3AQG}.
FT   STRAND      175    184       {ECO:0000244|PDB:3AQG}.
SQ   SEQUENCE   208 AA;  22739 MW;  313B0ED64B24CDB2 CRC64;
     MGAQGAQESI KAMWRVPGTT RRPVTGESPG MHRPEAMLLL LTLALLGGPT WAGKMYGPGG
     GKYFSTTEDY DHEITGLRVS VGLLLVKSVQ VKLGDSWDVK LGALGGNTQE VTLQPGEYIT
     KVFVAFQAFL RGMVMYTSKD RYFYFGKLDG QISSAYPSQE GQVLVGIYGQ YQLLGIKSIG
     FEWNYPLEEP TTEPPVNLTY SANSPVGR
//
ID   A0A024RAN0_HUMAN        Unreviewed;       243 AA.
AC   A0A024RAN0;
DT   09-JUL-2014, integrated into UniProtKB/TrEMBL.
DT   09-JUL-2014, sequence version 1.
DT   31-JAN-2018, entry version 19.
DE   SubName: Full=Uncharacterized protein {ECO:0000313|EMBL:EAW95720.1};
GN   Name=MGC13034 {ECO:0000313|EMBL:EAW95720.1};
GN   ORFNames=hCG_1644294 {ECO:0000313|EMBL:EAW95720.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:EAW95720.1};
RN   [1] {ECO:0000313|EMBL:EAW95720.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAW95720.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; CH471084; EAW95720.1; -; Genomic_DNA.
DR   RefSeq; NP_694949.1; NM_153217.2.
DR   UniGene; Hs.508588; -.
DR   ProteinModelPortal; A0A024RAN0; -.
DR   GeneID; 134288; -.
DR   KEGG; hsa:134288; -.
DR   CTD; 134288; -.
DR   EuPathDB; HostDB:ENSG00000164325.7; -.
DR   eggNOG; ENOG410IR9J; Eukaryota.
DR   eggNOG; ENOG410YMC9; LUCA.
DR   OMA; PPQYYTI; -.
DR   OrthoDB; EOG091G0I7E; -.
DR   PhylomeDB; A0A024RAN0; -.
DR   GenomeRNAi; 134288; -.
DR   Bgee; ENSG00000164325; -.
DR   ExpressionAtlas; A0A024RAN0; baseline and differential.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   InterPro; IPR027835; TMEM174.
DR   PANTHER; PTHR31020; PTHR31020; 1.
DR   Pfam; PF15029; TMEM174; 1.
PE   4: Predicted;
KW   Membrane {ECO:0000256|SAM:Phobius};
KW   Transmembrane {ECO:0000256|SAM:Phobius};
KW   Transmembrane helix {ECO:0000256|SAM:Phobius}.
FT   TRANSMEM     40     60       Helical. {ECO:0000256|SAM:Phobius}.
FT   TRANSMEM     72     90       Helical. {ECO:0000256|SAM:Phobius}.
SQ   SEQUENCE   243 AA;  26287 MW;  05A764F265B50258 CRC64;
     MEQGSGRLED FPVNVFSVTP YTPSTADIQV SDDDKAGATL LFSGIFLGLV GITFTVMGWI
     KYQGVSHFEW TQLLGPVLLS VGVTFILIAV CKFKMLSCQL CKESEERVPD SEQTPGGPSF
     VFTGINQPIT FHGATVVQYI PPPYGSPEPM GINTSYLQSV VSPCGLITSG GAAAAMSSPP
     QYYTIYPQDN SAFVVDEGCL SFTDGGNHRP NPDVDQLEET QLEEEACACF SPPPYEEIYS
     LPR
//
ID   TM174_HUMAN             Reviewed;         243 AA.
AC   Q8WUU8; B2RDA0; Q96N81;
DT   03-APR-2007, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2002, sequence version 1.
DT   27-SEP-2017, entry version 98.
DE   RecName: Full=Transmembrane protein 174;
GN   Name=TMEM174;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Kidney;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=20331980; DOI=10.1016/j.bbrc.2010.03.109;
RA   Wang P., Sun B., Hao D., Zhang X., Shi T., Ma D.;
RT   "Human TMEM174 that is highly expressed in kidney tissue activates AP-
RT   1 and promotes cell proliferation.";
RL   Biochem. Biophys. Res. Commun. 394:993-999(2010).
CC   -!- INTERACTION:
CC       O43765:SGTA; NbExp=5; IntAct=EBI-10276729, EBI-347996;
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane
CC       {ECO:0000269|PubMed:20331980}; Multi-pass membrane protein
CC       {ECO:0000269|PubMed:20331980}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q8WUU8-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q8WUU8-2; Sequence=VSP_024210;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Predominantly expressed in kidney.
CC       {ECO:0000269|PubMed:20331980}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK055830; BAB71025.1; -; mRNA.
DR   EMBL; AK315460; BAG37847.1; -; mRNA.
DR   EMBL; CH471084; EAW95719.1; -; Genomic_DNA.
DR   EMBL; BC019346; AAH19346.1; -; mRNA.
DR   CCDS; CCDS4018.1; -. [Q8WUU8-1]
DR   RefSeq; NP_694949.1; NM_153217.2. [Q8WUU8-1]
DR   UniGene; Hs.508588; -.
DR   ProteinModelPortal; Q8WUU8; -.
DR   BioGrid; 126393; 2.
DR   IntAct; Q8WUU8; 5.
DR   STRING; 9606.ENSP00000296776; -.
DR   PhosphoSitePlus; Q8WUU8; -.
DR   BioMuta; TMEM174; -.
DR   DMDM; 74730764; -.
DR   PaxDb; Q8WUU8; -.
DR   PeptideAtlas; Q8WUU8; -.
DR   PRIDE; Q8WUU8; -.
DR   DNASU; 134288; -.
DR   Ensembl; ENST00000296776; ENSP00000296776; ENSG00000164325. [Q8WUU8-1]
DR   GeneID; 134288; -.
DR   KEGG; hsa:134288; -.
DR   UCSC; uc010izc.4; human. [Q8WUU8-1]
DR   CTD; 134288; -.
DR   EuPathDB; HostDB:ENSG00000164325.7; -.
DR   GeneCards; TMEM174; -.
DR   HGNC; HGNC:28187; TMEM174.
DR   HPA; HPA037975; -.
DR   MIM; 614909; gene.
DR   neXtProt; NX_Q8WUU8; -.
DR   OpenTargets; ENSG00000164325; -.
DR   PharmGKB; PA162405935; -.
DR   eggNOG; ENOG410IR9J; Eukaryota.
DR   eggNOG; ENOG410YMC9; LUCA.
DR   GeneTree; ENSGT00390000004161; -.
DR   HOGENOM; HOG000059655; -.
DR   HOVERGEN; HBG095684; -.
DR   InParanoid; Q8WUU8; -.
DR   OMA; PPQYYTI; -.
DR   OrthoDB; EOG091G0I7E; -.
DR   PhylomeDB; Q8WUU8; -.
DR   TreeFam; TF335512; -.
DR   GenomeRNAi; 134288; -.
DR   PRO; PR:Q8WUU8; -.
DR   Proteomes; UP000005640; Chromosome 5.
DR   Bgee; ENSG00000164325; -.
DR   CleanEx; HS_TMEM174; -.
DR   ExpressionAtlas; Q8WUU8; baseline and differential.
DR   Genevisible; Q8WUU8; HS.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   InterPro; IPR027835; TMEM174.
DR   PANTHER; PTHR31020; PTHR31020; 1.
DR   Pfam; PF15029; TMEM174; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Complete proteome; Endoplasmic reticulum;
KW   Membrane; Reference proteome; Transmembrane; Transmembrane helix.
FT   CHAIN         1    243       Transmembrane protein 174.
FT                                /FTId=PRO_0000282577.
FT   TRANSMEM     40     60       Helical. {ECO:0000255}.
FT   TRANSMEM     73     93       Helical. {ECO:0000255}.
FT   VAR_SEQ     210    243       PNPDVDQLEETQLEEEACACFSPPPYEEIYSLPR -> YGP
FT                                ILMLTS (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_024210.
SQ   SEQUENCE   243 AA;  26287 MW;  05A764F265B50258 CRC64;
     MEQGSGRLED FPVNVFSVTP YTPSTADIQV SDDDKAGATL LFSGIFLGLV GITFTVMGWI
     KYQGVSHFEW TQLLGPVLLS VGVTFILIAV CKFKMLSCQL CKESEERVPD SEQTPGGPSF
     VFTGINQPIT FHGATVVQYI PPPYGSPEPM GINTSYLQSV VSPCGLITSG GAAAAMSSPP
     QYYTIYPQDN SAFVVDEGCL SFTDGGNHRP NPDVDQLEET QLEEEACACF SPPPYEEIYS
     LPR
//
ID   KASH5_HUMAN             Reviewed;         562 AA.
AC   Q8N6L0; Q96MC3;
DT   29-APR-2008, integrated into UniProtKB/Swiss-Prot.
DT   29-APR-2008, sequence version 2.
DT   23-MAY-2018, entry version 120.
DE   RecName: Full=Protein KASH5;
DE   AltName: Full=Coiled-coil domain-containing protein 155;
DE   AltName: Full=KASH domain-containing protein 5;
GN   Name=CCDC155; Synonyms=KASH5;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057824; DOI=10.1038/nature02399;
RA   Grimwood J., Gordon L.A., Olsen A.S., Terry A., Schmutz J.,
RA   Lamerdin J.E., Hellsten U., Goodstein D., Couronne O., Tran-Gyamfi M.,
RA   Aerts A., Altherr M., Ashworth L., Bajorek E., Black S., Branscomb E.,
RA   Caenepeel S., Carrano A.V., Caoile C., Chan Y.M., Christensen M.,
RA   Cleland C.A., Copeland A., Dalin E., Dehal P., Denys M., Detter J.C.,
RA   Escobar J., Flowers D., Fotopulos D., Garcia C., Georgescu A.M.,
RA   Glavina T., Gomez M., Gonzales E., Groza M., Hammon N., Hawkins T.,
RA   Haydu L., Ho I., Huang W., Israni S., Jett J., Kadner K., Kimball H.,
RA   Kobayashi A., Larionov V., Leem S.-H., Lopez F., Lou Y., Lowry S.,
RA   Malfatti S., Martinez D., McCready P.M., Medina C., Morgan J.,
RA   Nelson K., Nolan M., Ovcharenko I., Pitluck S., Pollard M.,
RA   Popkie A.P., Predki P., Quan G., Ramirez L., Rash S., Retterer J.,
RA   Rodriguez A., Rogers S., Salamov A., Salazar A., She X., Smith D.,
RA   Slezak T., Solovyev V., Thayer N., Tice H., Tsai M., Ustaszewska A.,
RA   Vo N., Wagner M., Wheeler J., Wu K., Xie G., Yang J., Dubchak I.,
RA   Furey T.S., DeJong P., Dickson M., Gordon D., Eichler E.E.,
RA   Pennacchio L.A., Richardson P., Stubbs L., Rokhsar D.S., Myers R.M.,
RA   Rubin E.M., Lucas S.M.;
RT   "The DNA sequence and biology of human chromosome 19.";
RL   Nature 428:529-535(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT GLN-129.
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -!- FUNCTION: As a component of the LINC (LInker of Nucleoskeleton and
CC       Cytoskeleton) complex, involved in the connection between the
CC       nuclear lamina and the cytoskeleton. The nucleocytoplasmic
CC       interactions established by the LINC complex play an important
CC       role in the transmission of mechanical forces across the nuclear
CC       envelope and in nuclear movement and positioning. Required for
CC       telomere attachment to nuclear envelope in the prophase of meiosis
CC       and for rapid telomere prophase movements implicating a
CC       SUN1/2:KASH5 LINC complex in which SUN1 and SUN2 seem to act at
CC       least partial redundantly. Required for homologue pairing during
CC       meiotic prophase in spermatocytes and probably oocytes. Essential
CC       for male and female gametogenesis. Recruits cytoplasmic dynein to
CC       telomere attachment sites at the nuclear envelope in
CC       spermatocytes. In oocytes is involved in meiotic resumption and
CC       spindle formation. {ECO:0000250|UniProtKB:Q80VJ8}.
CC   -!- SUBUNIT: Core component the LINC complex which is composed of
CC       inner nuclear membrane SUN domain-containing proteins coupled to
CC       outer nuclear membrane KASH domain-containing nesprins. SUN and
CC       KASH domain-containing proteins seem to bind each other
CC       promiscuously; however, differentially expression of LINC complex
CC       constituents is giving rise to specific assemblies. At least
CC       SUN1/2-containing core LINC complexes are proposed to be hexameric
CC       composed of three protomers of each KASH and SUN domain-containing
CC       protein. Interacts (via the last 22 AA) with SUN1; this
CC       interaction mediates its telomere localization by forming a
CC       SUN1:KASH5 LINC complex. Component of a probable SUN2:KASH5 LINC
CC       complex. Self-associates. Interacts with DYNC1H1, DCTN1, DYNC1I1/2
CC       and PAFAH1B1; suggesting the association with the dynein-dynactin
CC       motor complex. {ECO:0000250|UniProtKB:Q80VJ8}.
CC   -!- INTERACTION:
CC       B2R9H7:-; NbExp=3; IntAct=EBI-749265, EBI-10175711;
CC       Q96SE0:ABHD1; NbExp=3; IntAct=EBI-749265, EBI-10293349;
CC       A8K660:ADIPOQ; NbExp=3; IntAct=EBI-749265, EBI-10174479;
CC       Q15848:ADIPOQ; NbExp=3; IntAct=EBI-749265, EBI-10827839;
CC       P17544:ATF7; NbExp=3; IntAct=EBI-749265, EBI-765623;
CC       Q9UL15:BAG5; NbExp=5; IntAct=EBI-749265, EBI-356517;
CC       Q92843:BCL2L2; NbExp=7; IntAct=EBI-749265, EBI-707714;
CC       Q53XK0:BET1; NbExp=3; IntAct=EBI-749265, EBI-10242927;
CC       D3DR40:C10orf4; NbExp=3; IntAct=EBI-749265, EBI-10176576;
CC       Q9BQA9:C17orf62; NbExp=5; IntAct=EBI-749265, EBI-2680384;
CC       Q6P1J9:CDC73; NbExp=6; IntAct=EBI-749265, EBI-930143;
CC       Q8IVW4:CDKL3; NbExp=3; IntAct=EBI-749265, EBI-3919850;
CC       Q96Q77:CIB3; NbExp=3; IntAct=EBI-749265, EBI-10292696;
CC       P56748:CLDN8; NbExp=3; IntAct=EBI-749265, EBI-10215641;
CC       P29373:CRABP2; NbExp=5; IntAct=EBI-749265, EBI-10204806;
CC       Q07325:CXCL9; NbExp=3; IntAct=EBI-749265, EBI-3911467;
CC       P50402:EMD; NbExp=7; IntAct=EBI-749265, EBI-489887;
CC       Q3B820:FAM161A; NbExp=3; IntAct=EBI-749265, EBI-719941;
CC       Q9Y247:FAM50B; NbExp=4; IntAct=EBI-749265, EBI-742802;
CC       Q86YD7:FAM90A1; NbExp=3; IntAct=EBI-749265, EBI-6658203;
CC       Q969F0:FATE1; NbExp=5; IntAct=EBI-749265, EBI-743099;
CC       Q9Y3D6:FIS1; NbExp=3; IntAct=EBI-749265, EBI-3385283;
CC       O95954:FTCD; NbExp=3; IntAct=EBI-749265, EBI-10192648;
CC       P60520:GABARAPL2; NbExp=3; IntAct=EBI-749265, EBI-720116;
CC       Q10471:GALNT2; NbExp=5; IntAct=EBI-749265, EBI-10226985;
CC       Q96F15:GIMAP5; NbExp=4; IntAct=EBI-749265, EBI-6166686;
CC       O14653:GOSR2; NbExp=5; IntAct=EBI-749265, EBI-4401517;
CC       Q5T3I0:GPATCH4; NbExp=5; IntAct=EBI-749265, EBI-2372076;
CC       O00155:GPR25; NbExp=5; IntAct=EBI-749265, EBI-10178951;
CC       Q96DI8:HMOX1; NbExp=3; IntAct=EBI-749265, EBI-10284700;
CC       Q9Y287:ITM2B; NbExp=3; IntAct=EBI-749265, EBI-2866431;
CC       Q8N5M9:JAGN1; NbExp=5; IntAct=EBI-749265, EBI-10266796;
CC       Q6PKG0:LARP1; NbExp=3; IntAct=EBI-749265, EBI-1052114;
CC       Q96BZ8:LENG1; NbExp=3; IntAct=EBI-749265, EBI-726510;
CC       Q8TAF8:LHFPL5; NbExp=8; IntAct=EBI-749265, EBI-2820517;
CC       Q13021:MALL; NbExp=3; IntAct=EBI-749265, EBI-750078;
CC       Q9P0N8:MARCH2; NbExp=3; IntAct=EBI-749265, EBI-10317612;
CC       Q6N075:MFSD5; NbExp=3; IntAct=EBI-749265, EBI-3920969;
CC       P50281:MMP14; NbExp=3; IntAct=EBI-749265, EBI-992788;
CC       P11836:MS4A1; NbExp=3; IntAct=EBI-749265, EBI-2808234;
CC       O75431:MTX2; NbExp=5; IntAct=EBI-749265, EBI-7415268;
CC       Q9NQ35:NRIP3; NbExp=5; IntAct=EBI-749265, EBI-10311735;
CC       P42857:NSG1; NbExp=5; IntAct=EBI-749265, EBI-6380741;
CC       Q6UX06:OLFM4; NbExp=3; IntAct=EBI-749265, EBI-2804156;
CC       P16234:PDGFRA; NbExp=3; IntAct=EBI-749265, EBI-2861522;
CC       Q04941:PLP2; NbExp=3; IntAct=EBI-749265, EBI-608347;
CC       Q6NYC8:PPP1R18; NbExp=5; IntAct=EBI-749265, EBI-2557469;
CC       Q5TAB7:RIPPLY2; NbExp=9; IntAct=EBI-749265, EBI-10246897;
CC       Q9NTX7:RNF146; NbExp=3; IntAct=EBI-749265, EBI-722397;
CC       Q9NTX7-2:RNF146; NbExp=4; IntAct=EBI-749265, EBI-11750630;
CC       Q7L4I2-2:RSRC2; NbExp=3; IntAct=EBI-749265, EBI-10256202;
CC       Q5QGT7:RTP2; NbExp=3; IntAct=EBI-749265, EBI-10244780;
CC       Q9HC62:SENP2; NbExp=5; IntAct=EBI-749265, EBI-714881;
CC       Q8N6R1:SERP2; NbExp=5; IntAct=EBI-749265, EBI-749270;
CC       O43765:SGTA; NbExp=9; IntAct=EBI-749265, EBI-347996;
CC       Q9BRI3:SLC30A2; NbExp=8; IntAct=EBI-749265, EBI-8644112;
CC       Q96JW4:SLC41A2; NbExp=5; IntAct=EBI-749265, EBI-10290130;
CC       O00631:SLN; NbExp=3; IntAct=EBI-749265, EBI-10180786;
CC       Q9NRQ5:SMCO4; NbExp=3; IntAct=EBI-749265, EBI-8640191;
CC       O95210:STBD1; NbExp=3; IntAct=EBI-749265, EBI-2947137;
CC       Q13190:STX5; NbExp=5; IntAct=EBI-749265, EBI-714206;
CC       Q9BQ70:TCF25; NbExp=3; IntAct=EBI-749265, EBI-745182;
CC       P17152:TMEM11; NbExp=4; IntAct=EBI-749265, EBI-723946;
CC       Q9P0S9:TMEM14C; NbExp=3; IntAct=EBI-749265, EBI-2339195;
CC       Q8N511:TMEM199; NbExp=3; IntAct=EBI-749265, EBI-10265825;
CC       Q96HV5:TMEM41A; NbExp=3; IntAct=EBI-749265, EBI-10288884;
CC       Q9NRS4:TMPRSS4; NbExp=3; IntAct=EBI-749265, EBI-10313040;
CC       Q9NRS4-3:TMPRSS4; NbExp=3; IntAct=EBI-749265, EBI-10312990;
CC       Q9Y228:TRAF3IP3; NbExp=5; IntAct=EBI-749265, EBI-765817;
CC       Q63HK5:TSHZ3; NbExp=3; IntAct=EBI-749265, EBI-9053916;
CC       O00526:UPK2; NbExp=3; IntAct=EBI-749265, EBI-10179682;
CC       P23763:VAMP1; NbExp=3; IntAct=EBI-749265, EBI-10201335;
CC       O75379:VAMP4; NbExp=3; IntAct=EBI-749265, EBI-744953;
CC       O75379-2:VAMP4; NbExp=3; IntAct=EBI-749265, EBI-10187996;
CC       P15622-3:ZNF250; NbExp=3; IntAct=EBI-749265, EBI-10177272;
CC   -!- SUBCELLULAR LOCATION: Nucleus outer membrane
CC       {ECO:0000250|UniProtKB:Q80VJ8, ECO:0000305}; Single-pass type IV
CC       membrane protein {ECO:0000305}; Cytoplasmic side {ECO:0000305}.
CC       Nucleus {ECO:0000250|UniProtKB:Q80VJ8}. Chromosome, telomere
CC       {ECO:0000250|UniProtKB:Q80VJ8}. Note=Localized exclusively at
CC       telomeres from the leptotene to diplotene stages. Colocalizes with
CC       SUN2 at sites of telomere attachment in meiocytes. At oocyte MI
CC       stage localized around the spindle, at MII stage localized to the
CC       spindle poles. {ECO:0000250|UniProtKB:Q80VJ8}.
CC   -!- DOMAIN: The C-terminal 22 AA is required and sufficient for
CC       localization to telomeres at the nuclear envelope. {ECO:0000250}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK057220; BAB71384.1; -; mRNA.
DR   EMBL; AC010619; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC010643; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471177; EAW52478.1; -; Genomic_DNA.
DR   EMBL; BC029811; AAH29811.1; -; mRNA.
DR   CCDS; CCDS46140.1; -.
DR   RefSeq; NP_653289.3; NM_144688.4.
DR   UniGene; Hs.662085; -.
DR   UniGene; Hs.743867; -.
DR   ProteinModelPortal; Q8N6L0; -.
DR   SMR; Q8N6L0; -.
DR   BioGrid; 127094; 71.
DR   IntAct; Q8N6L0; 115.
DR   MINT; Q8N6L0; -.
DR   STRING; 9606.ENSP00000404220; -.
DR   BioMuta; CCDC155; -.
DR   DMDM; 187671940; -.
DR   PaxDb; Q8N6L0; -.
DR   PeptideAtlas; Q8N6L0; -.
DR   PRIDE; Q8N6L0; -.
DR   DNASU; 147872; -.
DR   Ensembl; ENST00000447857; ENSP00000404220; ENSG00000161609.
DR   GeneID; 147872; -.
DR   KEGG; hsa:147872; -.
DR   UCSC; uc002pnm.3; human.
DR   CTD; 147872; -.
DR   EuPathDB; HostDB:ENSG00000161609.9; -.
DR   GeneCards; CCDC155; -.
DR   HGNC; HGNC:26520; CCDC155.
DR   HPA; HPA019937; -.
DR   HPA; HPA019940; -.
DR   neXtProt; NX_Q8N6L0; -.
DR   OpenTargets; ENSG00000161609; -.
DR   PharmGKB; PA162381684; -.
DR   eggNOG; ENOG410IWIE; Eukaryota.
DR   eggNOG; ENOG4111U72; LUCA.
DR   GeneTree; ENSGT00420000029926; -.
DR   HOVERGEN; HBG064472; -.
DR   InParanoid; Q8N6L0; -.
DR   OMA; ACDPQRT; -.
DR   OrthoDB; EOG091G06B2; -.
DR   PhylomeDB; Q8N6L0; -.
DR   TreeFam; TF337560; -.
DR   ChiTaRS; CCDC155; human.
DR   GenomeRNAi; 147872; -.
DR   PRO; PR:Q8N6L0; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   Bgee; ENSG00000161609; -.
DR   CleanEx; HS_CCDC155; -.
DR   ExpressionAtlas; Q8N6L0; baseline and differential.
DR   Genevisible; Q8N6L0; HS.
DR   GO; GO:0000781; C:chromosome, telomeric region; ISS:UniProtKB.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0000800; C:lateral element; IEA:Ensembl.
DR   GO; GO:0034993; C:meiotic nuclear membrane microtubule tethering complex; IEA:Ensembl.
DR   GO; GO:0090619; C:meiotic spindle pole; IEA:Ensembl.
DR   GO; GO:0005640; C:nuclear outer membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0070840; F:dynein complex binding; IEA:Ensembl.
DR   GO; GO:0042802; F:identical protein binding; IEA:Ensembl.
DR   GO; GO:0007015; P:actin filament organization; IEA:Ensembl.
DR   GO; GO:0090220; P:chromosome localization to nuclear envelope involved in homologous chromosome segregation; IEA:Ensembl.
DR   GO; GO:0000724; P:double-strand break repair via homologous recombination; IEA:Ensembl.
DR   GO; GO:0090172; P:microtubule cytoskeleton organization involved in homologous chromosome segregation; IEA:Ensembl.
DR   GO; GO:0048477; P:oogenesis; IEA:Ensembl.
DR   GO; GO:0007283; P:spermatogenesis; IEA:Ensembl.
DR   GO; GO:0051225; P:spindle assembly; IEA:Ensembl.
DR   GO; GO:0051653; P:spindle localization; IEA:Ensembl.
DR   GO; GO:0007129; P:synapsis; IEA:Ensembl.
DR   GO; GO:0034397; P:telomere localization; IEA:Ensembl.
DR   InterPro; IPR024950; DUSP.
DR   InterPro; IPR011992; EF-hand-dom_pair.
DR   InterPro; IPR028170; KASH5.
DR   InterPro; IPR028168; KASH5_coiled-coil.
DR   PANTHER; PTHR10159; PTHR10159; 2.
DR   PANTHER; PTHR10159:SF376; PTHR10159:SF376; 2.
DR   Pfam; PF14662; KASH_CCD; 1.
DR   SUPFAM; SSF47473; SSF47473; 1.
PE   1: Evidence at protein level;
KW   Chromosome; Coiled coil; Complete proteome; Meiosis; Membrane;
KW   Nucleus; Polymorphism; Reference proteome; Telomere; Transmembrane;
KW   Transmembrane helix.
FT   CHAIN         1    562       Protein KASH5.
FT                                /FTId=PRO_0000331527.
FT   TOPO_DOM      1    521       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    522    542       Helical; Anchor for type IV membrane
FT                                protein. {ECO:0000255}.
FT   TOPO_DOM    543    562       Perinuclear space. {ECO:0000255}.
FT   COILED      164    349       {ECO:0000255}.
FT   COMPBIAS    448    451       Poly-Glu.
FT   COMPBIAS    528    536       Poly-Leu.
FT   VARIANT     116    116       L -> P (in dbSNP:rs8102582).
FT                                /FTId=VAR_059597.
FT   VARIANT     129    129       R -> Q (in dbSNP:rs10405154).
FT                                {ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_059598.
SQ   SEQUENCE   562 AA;  62783 MW;  39F47D3F236A9918 CRC64;
     MDLPEGPVGG PTAEMYLRER PEEARLGMPV SLEEQILNST FEACDPQRTG TVAVAQVLAY
     LEAVTGQGPQ DARLQTLANS LDPNGEGPKA TVDLDTFLVV MRDWIAACQL HGGLELEEET
     AFQGALTSRQ LPSGCPEAEE PANLESFGGE DPRPELQATA DLLSSLEDLE LSNRRLVGEN
     AKLQRSMETA EEGSARLGEE ILALRKQLHS TQQALQFAKA MDEELEDLKT LARSLEEQNR
     SLLAQARQAE KEQQHLVAEM ETLQEENGKL LAERDGVKKR SQELAMEKDT LKRQLFECEH
     LICQRDTILS ERTRDVESLA QTLEEYRVTT QELRLEISRL EEQLSQTYEG PDELPEGAQL
     RRVGWTELLP PSLGLEIEAI RQKQEVATAD LSNPLCGVWQ WEEVIHETSE ETEFPSEAPA
     GGQRNFQGEP AHPEEGRKEP SMWLTRREEE EDAESQVTAD LPVPLGAPRP GDIPENPPER
     PARRELQQAL VPVMKKLVPV RRRAWGQLCL PPQRLRVTRH PLIPAPVLGL LLLLLLSVLL
     LGPSPPPTWP HLQLCYLQPP PV
//
ID   IPIL1_HUMAN             Reviewed;         555 AA.
AC   Q6GPH6; F5H1L8; Q8NE61;
DT   26-FEB-2008, integrated into UniProtKB/Swiss-Prot.
DT   19-JUL-2004, sequence version 1.
DT   28-FEB-2018, entry version 107.
DE   RecName: Full=Inositol 1,4,5-trisphosphate receptor-interacting protein-like 1;
DE   Flags: Precursor;
GN   Name=ITPRIPL1; Synonyms=KIAA1754L;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2), AND VARIANT
RP   ARG-280.
RC   TISSUE=Pancreas, and Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -!- INTERACTION:
CC       O43765:SGTA; NbExp=3; IntAct=EBI-953819, EBI-347996;
CC       Q9UMX0:UBQLN1; NbExp=3; IntAct=EBI-953819, EBI-741480;
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Single-pass type I
CC       membrane protein {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q6GPH6-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q6GPH6-2; Sequence=VSP_031666;
CC       Name=3;
CC         IsoId=Q6GPH6-3; Sequence=VSP_054316;
CC         Note=No experimental confirmation available. Gene prediction
CC         based on EST data.;
CC   -!- SIMILARITY: Belongs to the ITPRIP family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AC021188; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC034503; AAH34503.2; -; mRNA.
DR   EMBL; BC073153; AAH73153.1; -; mRNA.
DR   CCDS; CCDS33250.1; -. [Q6GPH6-2]
DR   CCDS; CCDS46360.1; -. [Q6GPH6-1]
DR   CCDS; CCDS54378.1; -. [Q6GPH6-3]
DR   RefSeq; NP_001008949.1; NM_001008949.2. [Q6GPH6-1]
DR   RefSeq; NP_001156995.1; NM_001163523.1. [Q6GPH6-3]
DR   RefSeq; NP_001156996.1; NM_001163524.1. [Q6GPH6-3]
DR   RefSeq; NP_001311419.1; NM_001324490.1. [Q6GPH6-3]
DR   RefSeq; NP_848590.3; NM_178495.5. [Q6GPH6-2]
DR   RefSeq; XP_016858916.1; XM_017003427.1. [Q6GPH6-1]
DR   UniGene; Hs.65009; -.
DR   ProteinModelPortal; Q6GPH6; -.
DR   BioGrid; 127325; 13.
DR   IntAct; Q6GPH6; 6.
DR   STRING; 9606.ENSP00000355121; -.
DR   iPTMnet; Q6GPH6; -.
DR   PhosphoSitePlus; Q6GPH6; -.
DR   BioMuta; ITPRIPL1; -.
DR   DMDM; 74736480; -.
DR   EPD; Q6GPH6; -.
DR   PaxDb; Q6GPH6; -.
DR   PeptideAtlas; Q6GPH6; -.
DR   PRIDE; Q6GPH6; -.
DR   Ensembl; ENST00000361124; ENSP00000355121; ENSG00000198885. [Q6GPH6-2]
DR   Ensembl; ENST00000439118; ENSP00000389308; ENSG00000198885. [Q6GPH6-1]
DR   Ensembl; ENST00000536814; ENSP00000439566; ENSG00000198885. [Q6GPH6-3]
DR   GeneID; 150771; -.
DR   KEGG; hsa:150771; -.
DR   UCSC; uc002svx.4; human. [Q6GPH6-1]
DR   CTD; 150771; -.
DR   EuPathDB; HostDB:ENSG00000198885.9; -.
DR   GeneCards; ITPRIPL1; -.
DR   HGNC; HGNC:29371; ITPRIPL1.
DR   HPA; HPA017985; -.
DR   neXtProt; NX_Q6GPH6; -.
DR   OpenTargets; ENSG00000198885; -.
DR   PharmGKB; PA162392345; -.
DR   eggNOG; ENOG410IKQ2; Eukaryota.
DR   eggNOG; ENOG4111BJ6; LUCA.
DR   GeneTree; ENSGT00530000063794; -.
DR   HOGENOM; HOG000082468; -.
DR   HOVERGEN; HBG097589; -.
DR   InParanoid; Q6GPH6; -.
DR   PhylomeDB; Q6GPH6; -.
DR   TreeFam; TF332277; -.
DR   SIGNOR; Q6GPH6; -.
DR   ChiTaRS; ITPRIPL1; human.
DR   GenomeRNAi; 150771; -.
DR   PRO; PR:Q6GPH6; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   Bgee; ENSG00000198885; -.
DR   CleanEx; HS_ITPRIPL1; -.
DR   ExpressionAtlas; Q6GPH6; baseline and differential.
DR   Genevisible; Q6GPH6; HS.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0016020; C:membrane; HDA:UniProtKB.
DR   InterPro; IPR024808; IP3R-int-like_1.
DR   InterPro; IPR026250; ITPRIP_fam.
DR   InterPro; IPR024810; Mab-21_dom.
DR   PANTHER; PTHR10656:SF40; PTHR10656:SF40; 1.
DR   Pfam; PF03281; Mab-21; 1.
DR   PRINTS; PR02107; INOS145TPRIP.
DR   SMART; SM01265; Mab-21; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Coiled coil; Complete proteome; Membrane;
KW   Polymorphism; Reference proteome; Signal; Transmembrane;
KW   Transmembrane helix.
FT   SIGNAL        1     24       {ECO:0000255}.
FT   CHAIN        25    555       Inositol 1,4,5-trisphosphate receptor-
FT                                interacting protein-like 1.
FT                                /FTId=PRO_0000320566.
FT   TOPO_DOM     25    103       Extracellular. {ECO:0000255}.
FT   TRANSMEM    104    124       Helical. {ECO:0000255}.
FT   TOPO_DOM    125    555       Cytoplasmic. {ECO:0000255}.
FT   COILED       38     74       {ECO:0000255}.
FT   VAR_SEQ       1      8       Missing (in isoform 3). {ECO:0000305}.
FT                                /FTId=VSP_054316.
FT   VAR_SEQ       1      3       MNV -> MTTDSYSPTSP (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_031666.
FT   VARIANT     280    280       G -> R (in dbSNP:rs17853311).
FT                                {ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_039209.
FT   VARIANT     428    428       S -> C (in dbSNP:rs35855657).
FT                                /FTId=VAR_039210.
FT   VARIANT     463    463       T -> M (in dbSNP:rs2279105).
FT                                /FTId=VAR_039211.
SQ   SEQUENCE   555 AA;  63395 MW;  6B915F09A1ACEBFF CRC64;
     MNVDAEASMA VISLLFLAVM YVVHHPLMVS DRMDLDTLAR SRQLEKRMSE EMRLLEMEFE
     ERKRAAEQRQ KAENFWTGDT SSDQLVLGKK DMGWPFQADG QEGPLGWMLG NLWNTGLFCL
     FLVFELLRQN MQHEPAFDSS SEEEEEEVRV VPVTSYNWLT DFPSQEALDS FYKHYVQNAI
     RDLPCTCEFV ESFVDDLIEA CRVLSRQEAH PQLEDCLGIG AAFEKWGTLH ETQKFDILVP
     IVPPQGTMFV LEMRDPALGR RCGCVLVESE CVCKREKLLG DVLCLVHHHR DPSAVLGKCS
     SSIKAALCTG FHLDVCKTVQ WFRNMMGNAW ALVAHKYDFK LSLPPSTTSC KLRLDYRSGR
     FLSIHLVLGV QREDTLVYLV SQAPDQEQLT SVDWPESFVA CEHLFLKLVG RFAPENTCHL
     KCLQIILSLR QHQSLPHGAS RPILTSYHFK TALMHLLLRL PLTDWAHNML SQRLQDILWF
     LGRGLQQRSL HHFLIGNNFL PLTIPIPKTF RNAEPVNLFQ HLVLNPKAHS QAVEEFQNLL
     TQVKTLPHAP LAAAP
//
ID   AGR3_HUMAN              Reviewed;         166 AA.
AC   Q8TD06; A4D120;
DT   10-MAY-2005, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-2002, sequence version 1.
DT   28-FEB-2018, entry version 112.
DE   RecName: Full=Anterior gradient protein 3;
DE            Short=AG-3;
DE            Short=AG3;
DE            Short=hAG-3;
DE   AltName: Full=Anterior gradient 3 homolog {ECO:0000312|HGNC:HGNC:24167};
DE   AltName: Full=Breast cancer membrane protein 11 {ECO:0000312|HGNC:HGNC:24167};
DE   AltName: Full=Protein disulfide isomerase family A, member 18 {ECO:0000312|HGNC:HGNC:24167};
DE   Flags: Precursor;
GN   Name=AGR3; Synonyms=BCMP11, PDIA18; ORFNames=UNQ642/PRO1272;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=12477722; DOI=10.1074/jbc.M210184200;
RA   Adam P.J., Boyd R., Tyson K.L., Fletcher G.C., Stamps A., Hudson L.,
RA   Poyser H.R., Redpath N., Griffiths M., Steers G., Harris A.L.,
RA   Patel S., Berry J., Loader J.A., Townsend R.R., Daviet L., Legrain P.,
RA   Parekh R., Terrett J.A.;
RT   "Comprehensive proteomic analysis of breast cancer cell membranes
RT   reveals unique proteins with potential roles in clinical cancer.";
RL   J. Biol. Chem. 278:6482-6489(2003).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=12975309; DOI=10.1101/gr.1293003;
RA   Clark H.F., Gurney A.L., Abaya E., Baker K., Baldwin D.T., Brush J.,
RA   Chen J., Chow B., Chui C., Crowley C., Currell B., Deuel B., Dowd P.,
RA   Eaton D., Foster J.S., Grimaldi C., Gu Q., Hass P.E., Heldens S.,
RA   Huang A., Kim H.S., Klimowski L., Jin Y., Johnson S., Lee J.,
RA   Lewis L., Liao D., Mark M.R., Robbie E., Sanchez C., Schoenfeld J.,
RA   Seshagiri S., Simmons L., Singh J., Smith V., Stinson J., Vagts A.,
RA   Vandlen R.L., Watanabe C., Wieand D., Woods K., Xie M.-H.,
RA   Yansura D.G., Yi S., Yu G., Yuan J., Zhang M., Zhang Z., Goddard A.D.,
RA   Wood W.I., Godowski P.J., Gray A.M.;
RT   "The secreted protein discovery initiative (SPDI), a large-scale
RT   effort to identify novel human secreted and transmembrane proteins: a
RT   bioinformatics assessment.";
RL   Genome Res. 13:2265-2270(2003).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12690205; DOI=10.1126/science.1083423;
RA   Scherer S.W., Cheung J., MacDonald J.R., Osborne L.R., Nakabayashi K.,
RA   Herbrick J.-A., Carson A.R., Parker-Katiraee L., Skaug J., Khaja R.,
RA   Zhang J., Hudek A.K., Li M., Haddad M., Duggan G.E., Fernandez B.A.,
RA   Kanematsu E., Gentles S., Christopoulos C.C., Choufani S.,
RA   Kwasnicka D., Zheng X.H., Lai Z., Nusskern D.R., Zhang Q., Gu Z.,
RA   Lu F., Zeesman S., Nowaczyk M.J., Teshima I., Chitayat D., Shuman C.,
RA   Weksberg R., Zackai E.H., Grebe T.A., Cox S.R., Kirkpatrick S.J.,
RA   Rahman N., Friedman J.M., Heng H.H.Q., Pelicci P.G., Lo-Coco F.,
RA   Belloni E., Shaffer L.G., Pober B., Morton C.C., Gusella J.F.,
RA   Bruns G.A.P., Korf B.R., Quade B.J., Ligon A.H., Ferguson H.,
RA   Higgins A.W., Leach N.T., Herrick S.R., Lemyre E., Farra C.G.,
RA   Kim H.-G., Summers A.M., Gripp K.W., Roberts W., Szatmari P.,
RA   Winsor E.J.T., Grzeschik K.-H., Teebi A., Minassian B.A., Kere J.,
RA   Armengol L., Pujana M.A., Estivill X., Wilson M.D., Koop B.F.,
RA   Tosi S., Moore G.E., Boright A.P., Zlotorynski E., Kerem B.,
RA   Kroisel P.M., Petek E., Oscier D.G., Mould S.J., Doehner H.,
RA   Doehner K., Rommens J.M., Vincent J.B., Venter J.C., Li P.W.,
RA   Mural R.J., Adams M.D., Tsui L.-C.;
RT   "Human chromosome 7: DNA sequence and biology.";
RL   Science 300:767-772(2003).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   PROTEIN SEQUENCE OF 22-36.
RX   PubMed=15340161; DOI=10.1110/ps.04682504;
RA   Zhang Z., Henzel W.J.;
RT   "Signal peptide prediction based on analysis of experimentally
RT   verified cleavage sites.";
RL   Protein Sci. 13:2819-2824(2004).
RN   [7]
RP   INTERACTION WITH LYPD3 AND DAG1.
RX   PubMed=12592373; DOI=10.1038/sj.bjc.6600740;
RA   Fletcher G.C., Patel S., Tyson K., Adam P.J., Schenker M.,
RA   Loader J.A., Daviet L., Legrain P., Parekh R., Harris A.L.,
RA   Terrett J.A.;
RT   "hAG-2 and hAG-3, human homologues of genes involved in
RT   differentiation, are associated with oestrogen receptor-positive
RT   breast tumours and interact with metastasis gene C4.4a and
RT   dystroglycan.";
RL   Br. J. Cancer 88:579-585(2003).
RN   [8]
RP   SUBCELLULAR LOCATION, AND MUTAGENESIS OF 163-GLN--LEU-166.
RX   PubMed=18086916; DOI=10.1083/jcb.200705180;
RA   Raykhel I., Alanen H., Salo K., Jurvansuu J., Nguyen V.D.,
RA   Latva-Ranta M., Ruddock L.;
RT   "A molecular specificity code for the three mammalian KDEL
RT   receptors.";
RL   J. Cell Biol. 179:1193-1204(2007).
RN   [9]
RP   INDUCTION.
RX   PubMed=22361111; DOI=10.1016/j.jim.2012.01.013;
RA   Gray T.A., MacLaine N.J., Michie C.O., Bouchalova P., Murray E.,
RA   Howie J., Hrstka R., Maslon M.M., Nenutil R., Vojtesek B., Langdon S.,
RA   Hayward L., Gourley C., Hupp T.R.;
RT   "Anterior Gradient-3: a novel biomarker for ovarian cancer that
RT   mediates cisplatin resistance in xenograft models.";
RL   J. Immunol. Methods 378:20-32(2012).
RN   [10]
RP   INDUCTION.
RX   PubMed=23294566; DOI=10.1111/febs.12118;
RA   Bu H., Schweiger M.R., Manke T., Wunderlich A., Timmermann B.,
RA   Kerick M., Pasqualini L., Shehu E., Fuchsberger C., Cato A.C.,
RA   Klocker H.;
RT   "Anterior gradient 2 and 3--two prototype androgen-responsive genes
RT   transcriptionally upregulated by androgens and by oestrogens in
RT   prostate cancer cells.";
RL   FEBS J. 280:1249-1266(2013).
RN   [11]
RP   TISSUE SPECIFICITY, INDUCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=25751668; DOI=10.1165/rcmb.2014-0318OC;
RA   Bonser L.R., Schroeder B.W., Ostrin L.A., Baumlin N., Olson J.L.,
RA   Salathe M., Erle D.J.;
RT   "The ER resident protein AGR3 is required for regulation of ciliary
RT   beat frequency in the airway.";
RL   Am. J. Respir. Cell Mol. Biol. 53:536-543(2015).
RN   [12]
RP   TISSUE SPECIFICITY, AND SUBCELLULAR LOCATION.
RX   PubMed=26170690; DOI=10.2147/OTT.S82235;
RA   Obacz J., Brychtova V., Podhorec J., Fabian P., Dobes P., Vojtesek B.,
RA   Hrstka R.;
RT   "Anterior gradient protein 3 is associated with less aggressive tumors
RT   and better outcome of breast cancer patients.";
RL   Onco Targets Ther. 8:1523-1532(2015).
RN   [13] {ECO:0000244|PDB:3PH9}
RP   X-RAY CRYSTALLOGRAPHY (1.83 ANGSTROMS) OF 24-166.
RA   Nguyen V.D., Ruddock L.W., Salin M., Wierenga R.K.;
RT   "Crystal structure of the human anterior gradient protein 3.";
RL   Submitted (NOV-2010) to the PDB data bank.
CC   -!- FUNCTION: Required for calcium-mediated regulation of ciliary beat
CC       frequency and mucociliary clearance in the airway. Might be
CC       involved in the regulation of intracellular calcium in tracheal
CC       epithelial cells. {ECO:0000250|UniProtKB:Q8R3W7}.
CC   -!- SUBUNIT: Interacts with LYPD3 and DAG1 (alphaDAG1).
CC       {ECO:0000269|PubMed:12592373}.
CC   -!- INTERACTION:
CC       O75477:ERLIN1; NbExp=5; IntAct=EBI-3925742, EBI-359299;
CC       P37198:NUP62; NbExp=5; IntAct=EBI-3925742, EBI-347978;
CC       O43765:SGTA; NbExp=5; IntAct=EBI-3925742, EBI-347996;
CC       Q9UMX0:UBQLN1; NbExp=3; IntAct=EBI-3925742, EBI-741480;
CC       Q9UMX0-2:UBQLN1; NbExp=3; IntAct=EBI-3925742, EBI-10173939;
CC       Q9UHD9:UBQLN2; NbExp=4; IntAct=EBI-3925742, EBI-947187;
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum
CC       {ECO:0000269|PubMed:18086916, ECO:0000269|PubMed:25751668}.
CC       Note=Found in the cytoplasm, which could include the endoplasmic
CC       reticulum. {ECO:0000305|PubMed:26170690}.
CC   -!- TISSUE SPECIFICITY: Expressed in the lung, in the ciliated cells
CC       of the airway epithelium (PubMed:25751668). Expression increased
CC       with differentiation of airway epithelial cells (PubMed:25751668).
CC       Not detected in the mucous cells (PubMed:25751668). Expressed in
CC       ciliated cells in the oviduct (PubMed:26170690). Also detected in
CC       stomach, colon, prostate and liver (PubMed:25751668). Expressed in
CC       breast, ovary, prostate and liver cancer (PubMed:26170690).
CC       Expression is associated with the level of differentiation of
CC       breast cancer (at protein level) (PubMed:26170690).
CC       {ECO:0000269|PubMed:25751668, ECO:0000269|PubMed:26170690}.
CC   -!- INDUCTION: Not induced as part of the cellular response to
CC       endoplasmic reticulum stress (PubMed:25751668). Up-regulated by
CC       androgens and by estrogens in prostate cancer cells
CC       (PubMed:23294566) Up-regulated by a hormone (estrogen-receptor
CC       alpha) independent mechanism in ovarian cancer (PubMed:22361111).
CC       {ECO:0000269|PubMed:22361111, ECO:0000269|PubMed:23294566,
CC       ECO:0000269|PubMed:25751668}.
CC   -!- SIMILARITY: Belongs to the AGR family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AY069977; AAL55402.1; -; mRNA.
DR   EMBL; AY359065; AAQ89424.1; -; mRNA.
DR   EMBL; CH236948; EAL24282.1; -; Genomic_DNA.
DR   EMBL; CH471073; EAW93685.1; -; Genomic_DNA.
DR   EMBL; BC058284; AAH58284.1; -; mRNA.
DR   CCDS; CCDS5365.1; -.
DR   RefSeq; NP_789783.1; NM_176813.4.
DR   RefSeq; XP_005249684.1; XM_005249627.2.
DR   UniGene; Hs.100686; -.
DR   PDB; 3PH9; X-ray; 1.83 A; A/B=24-166.
DR   PDBsum; 3PH9; -.
DR   ProteinModelPortal; Q8TD06; -.
DR   SMR; Q8TD06; -.
DR   BioGrid; 127586; 17.
DR   IntAct; Q8TD06; 17.
DR   MINT; Q8TD06; -.
DR   STRING; 9606.ENSP00000308606; -.
DR   iPTMnet; Q8TD06; -.
DR   PhosphoSitePlus; Q8TD06; -.
DR   BioMuta; AGR3; -.
DR   DMDM; 66774045; -.
DR   MaxQB; Q8TD06; -.
DR   PaxDb; Q8TD06; -.
DR   PeptideAtlas; Q8TD06; -.
DR   PRIDE; Q8TD06; -.
DR   DNASU; 155465; -.
DR   Ensembl; ENST00000310398; ENSP00000308606; ENSG00000173467.
DR   GeneID; 155465; -.
DR   KEGG; hsa:155465; -.
DR   UCSC; uc003sts.4; human.
DR   CTD; 155465; -.
DR   DisGeNET; 155465; -.
DR   EuPathDB; HostDB:ENSG00000173467.8; -.
DR   GeneCards; AGR3; -.
DR   HGNC; HGNC:24167; AGR3.
DR   HPA; HPA053942; -.
DR   MIM; 609482; gene.
DR   neXtProt; NX_Q8TD06; -.
DR   OpenTargets; ENSG00000173467; -.
DR   PharmGKB; PA162375917; -.
DR   eggNOG; ENOG410IWAH; Eukaryota.
DR   eggNOG; ENOG4111K70; LUCA.
DR   GeneTree; ENSGT00530000063273; -.
DR   HOGENOM; HOG000231100; -.
DR   HOVERGEN; HBG006516; -.
DR   InParanoid; Q8TD06; -.
DR   KO; K20357; -.
DR   OMA; AQNNFIM; -.
DR   OrthoDB; EOG091G0RHV; -.
DR   PhylomeDB; Q8TD06; -.
DR   TreeFam; TF321449; -.
DR   GeneWiki; AGR3; -.
DR   GenomeRNAi; 155465; -.
DR   PRO; PR:Q8TD06; -.
DR   Proteomes; UP000005640; Chromosome 7.
DR   Bgee; ENSG00000173467; -.
DR   CleanEx; HS_AGR3; -.
DR   ExpressionAtlas; Q8TD06; baseline and differential.
DR   Genevisible; Q8TD06; HS.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:HPA.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; IDA:HPA.
DR   GO; GO:0002162; F:dystroglycan binding; IDA:UniProtKB.
DR   GO; GO:0030154; P:cell differentiation; IBA:GO_Central.
DR   GO; GO:0060548; P:negative regulation of cell death; IBA:GO_Central.
DR   InterPro; IPR036249; Thioredoxin-like_sf.
DR   SUPFAM; SSF52833; SSF52833; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Complete proteome; Direct protein sequencing;
KW   Endoplasmic reticulum; Reference proteome; Signal.
FT   SIGNAL        1     21       {ECO:0000269|PubMed:15340161}.
FT   CHAIN        22    166       Anterior gradient protein 3.
FT                                /FTId=PRO_0000001040.
FT   MOTIF       163    166       Prevents secretion from ER.
FT                                {ECO:0000269|PubMed:18086916}.
FT   MUTAGEN     163    166       Missing: Leads to Golgi localization;.
FT                                {ECO:0000269|PubMed:18086916}.
FT   STRAND       33     35       {ECO:0000244|PDB:3PH9}.
FT   HELIX        48     58       {ECO:0000244|PDB:3PH9}.
FT   STRAND       62     66       {ECO:0000244|PDB:3PH9}.
FT   HELIX        72     83       {ECO:0000244|PDB:3PH9}.
FT   HELIX        85     93       {ECO:0000244|PDB:3PH9}.
FT   STRAND       96    102       {ECO:0000244|PDB:3PH9}.
FT   HELIX       107    109       {ECO:0000244|PDB:3PH9}.
FT   STRAND      116    122       {ECO:0000244|PDB:3PH9}.
FT   HELIX       145    147       {ECO:0000244|PDB:3PH9}.
FT   HELIX       148    159       {ECO:0000244|PDB:3PH9}.
SQ   SEQUENCE   166 AA;  19171 MW;  B1A4804B47705D65 CRC64;
     MMLHSALGLC LLLVTVSSNL AIAIKKEKRP PQTLSRGWGD DITWVQTYEE GLFYAQKSKK
     PLMVIHHLED CQYSQALKKV FAQNEEIQEM AQNKFIMLNL MHETTDKNLS PDGQYVPRIM
     FVDPSLTVRA DIAGRYSNRL YTYEPRDLPL LIENMKKALR LIQSEL
//
ID   A0A140VK58_HUMAN        Unreviewed;       168 AA.
AC   A0A140VK58;
DT   08-JUN-2016, integrated into UniProtKB/TrEMBL.
DT   08-JUN-2016, sequence version 1.
DT   23-MAY-2018, entry version 16.
DE   SubName: Full=Testicular secretory protein Li 58 {ECO:0000313|EMBL:AEE61195.1};
DE   SubName: Full=Transmembrane protein 31 {ECO:0000313|EMBL:EAW54696.1};
GN   Name=TMEM31 {ECO:0000313|EMBL:EAW54696.1};
GN   ORFNames=hCG_1992124 {ECO:0000313|EMBL:EAW54696.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:AEE61195.1};
RN   [1] {ECO:0000313|EMBL:EAW54696.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAW54696.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3] {ECO:0000313|EMBL:AEE61195.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Li J.Y.;
RT   "Human testis protein.";
RL   Submitted (MAR-2010) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; HM005598; AEE61195.1; -; mRNA.
DR   EMBL; CH471190; EAW54696.1; -; Genomic_DNA.
DR   RefSeq; NP_872347.2; NM_182541.2.
DR   UniGene; Hs.98843; -.
DR   SMR; A0A140VK58; -.
DR   GeneID; 203562; -.
DR   KEGG; hsa:203562; -.
DR   CTD; 203562; -.
DR   OMA; YPEFILV; -.
DR   ExpressionAtlas; A0A140VK58; baseline and differential.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
PE   2: Evidence at transcript level;
KW   Membrane {ECO:0000256|SAM:Phobius};
KW   Transmembrane {ECO:0000256|SAM:Phobius};
KW   Transmembrane helix {ECO:0000256|SAM:Phobius}.
FT   TRANSMEM    119    136       Helical. {ECO:0000256|SAM:Phobius}.
FT   TRANSMEM    142    167       Helical. {ECO:0000256|SAM:Phobius}.
SQ   SEQUENCE   168 AA;  19813 MW;  7824918182ECAB48 CRC64;
     MRLTEKSEGE QQLKPNNSNA PNEDQEEEIQ QSEQHTPARQ RTQRADTQPS RCRLPSRRTP
     TTSSDRTINL LEVLPWPTEW IFNPYRLPAL FELYPEFLLV FKEAFHDISH CLKAQMEKIG
     LPIILHLFAL STLYFYKFFL PTILSLSFFI LLVLLLLLFI IVFILIFF
//
ID   TMM31_HUMAN             Reviewed;         168 AA.
AC   Q5JXX7; Q8NHR4;
DT   17-APR-2007, integrated into UniProtKB/Swiss-Prot.
DT   15-FEB-2005, sequence version 1.
DT   27-SEP-2017, entry version 86.
DE   RecName: Full=Transmembrane protein 31;
GN   Name=TMEM31;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15772651; DOI=10.1038/nature03440;
RA   Ross M.T., Grafham D.V., Coffey A.J., Scherer S., McLay K., Muzny D.,
RA   Platzer M., Howell G.R., Burrows C., Bird C.P., Frankish A.,
RA   Lovell F.L., Howe K.L., Ashurst J.L., Fulton R.S., Sudbrak R., Wen G.,
RA   Jones M.C., Hurles M.E., Andrews T.D., Scott C.E., Searle S.,
RA   Ramser J., Whittaker A., Deadman R., Carter N.P., Hunt S.E., Chen R.,
RA   Cree A., Gunaratne P., Havlak P., Hodgson A., Metzker M.L.,
RA   Richards S., Scott G., Steffen D., Sodergren E., Wheeler D.A.,
RA   Worley K.C., Ainscough R., Ambrose K.D., Ansari-Lari M.A., Aradhya S.,
RA   Ashwell R.I., Babbage A.K., Bagguley C.L., Ballabio A., Banerjee R.,
RA   Barker G.E., Barlow K.F., Barrett I.P., Bates K.N., Beare D.M.,
RA   Beasley H., Beasley O., Beck A., Bethel G., Blechschmidt K., Brady N.,
RA   Bray-Allen S., Bridgeman A.M., Brown A.J., Brown M.J., Bonnin D.,
RA   Bruford E.A., Buhay C., Burch P., Burford D., Burgess J., Burrill W.,
RA   Burton J., Bye J.M., Carder C., Carrel L., Chako J., Chapman J.C.,
RA   Chavez D., Chen E., Chen G., Chen Y., Chen Z., Chinault C.,
RA   Ciccodicola A., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Clerc-Blankenburg K., Clifford K., Cobley V., Cole C.G., Conquer J.S.,
RA   Corby N., Connor R.E., David R., Davies J., Davis C., Davis J.,
RA   Delgado O., Deshazo D., Dhami P., Ding Y., Dinh H., Dodsworth S.,
RA   Draper H., Dugan-Rocha S., Dunham A., Dunn M., Durbin K.J., Dutta I.,
RA   Eades T., Ellwood M., Emery-Cohen A., Errington H., Evans K.L.,
RA   Faulkner L., Francis F., Frankland J., Fraser A.E., Galgoczy P.,
RA   Gilbert J., Gill R., Gloeckner G., Gregory S.G., Gribble S.,
RA   Griffiths C., Grocock R., Gu Y., Gwilliam R., Hamilton C., Hart E.A.,
RA   Hawes A., Heath P.D., Heitmann K., Hennig S., Hernandez J.,
RA   Hinzmann B., Ho S., Hoffs M., Howden P.J., Huckle E.J., Hume J.,
RA   Hunt P.J., Hunt A.R., Isherwood J., Jacob L., Johnson D., Jones S.,
RA   de Jong P.J., Joseph S.S., Keenan S., Kelly S., Kershaw J.K., Khan Z.,
RA   Kioschis P., Klages S., Knights A.J., Kosiura A., Kovar-Smith C.,
RA   Laird G.K., Langford C., Lawlor S., Leversha M., Lewis L., Liu W.,
RA   Lloyd C., Lloyd D.M., Loulseged H., Loveland J.E., Lovell J.D.,
RA   Lozado R., Lu J., Lyne R., Ma J., Maheshwari M., Matthews L.H.,
RA   McDowall J., McLaren S., McMurray A., Meidl P., Meitinger T.,
RA   Milne S., Miner G., Mistry S.L., Morgan M., Morris S., Mueller I.,
RA   Mullikin J.C., Nguyen N., Nordsiek G., Nyakatura G., O'dell C.N.,
RA   Okwuonu G., Palmer S., Pandian R., Parker D., Parrish J.,
RA   Pasternak S., Patel D., Pearce A.V., Pearson D.M., Pelan S.E.,
RA   Perez L., Porter K.M., Ramsey Y., Reichwald K., Rhodes S.,
RA   Ridler K.A., Schlessinger D., Schueler M.G., Sehra H.K.,
RA   Shaw-Smith C., Shen H., Sheridan E.M., Shownkeen R., Skuce C.D.,
RA   Smith M.L., Sotheran E.C., Steingruber H.E., Steward C.A., Storey R.,
RA   Swann R.M., Swarbreck D., Tabor P.E., Taudien S., Taylor T.,
RA   Teague B., Thomas K., Thorpe A., Timms K., Tracey A., Trevanion S.,
RA   Tromans A.C., d'Urso M., Verduzco D., Villasana D., Waldron L.,
RA   Wall M., Wang Q., Warren J., Warry G.L., Wei X., West A.,
RA   Whitehead S.L., Whiteley M.N., Wilkinson J.E., Willey D.L.,
RA   Williams G., Williams L., Williamson A., Williamson H., Wilming L.,
RA   Woodmansey R.L., Wray P.W., Yen J., Zhang J., Zhou J., Zoghbi H.,
RA   Zorilla S., Buck D., Reinhardt R., Poustka A., Rosenthal A.,
RA   Lehrach H., Meindl A., Minx P.J., Hillier L.W., Willard H.F.,
RA   Wilson R.K., Waterston R.H., Rice C.M., Vaudin M., Coulson A.,
RA   Nelson D.L., Weinstock G., Sulston J.E., Durbin R.M., Hubbard T.,
RA   Gibbs R.A., Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence of the human X chromosome.";
RL   Nature 434:325-337(2005).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -!- INTERACTION:
CC       O43765:SGTA; NbExp=3; IntAct=EBI-10244617, EBI-347996;
CC       Q9UMX0:UBQLN1; NbExp=3; IntAct=EBI-10244617, EBI-741480;
CC       Q9UMX0-2:UBQLN1; NbExp=3; IntAct=EBI-10244617, EBI-10173939;
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Multi-pass membrane
CC       protein {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AL049610; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC029575; AAH29575.1; -; mRNA.
DR   CCDS; CCDS35359.1; -.
DR   RefSeq; NP_872347.2; NM_182541.2.
DR   UniGene; Hs.98843; -.
DR   ProteinModelPortal; Q5JXX7; -.
DR   SMR; Q5JXX7; -.
DR   BioGrid; 128478; 52.
DR   IntAct; Q5JXX7; 2.
DR   STRING; 9606.ENSP00000316940; -.
DR   iPTMnet; Q5JXX7; -.
DR   PhosphoSitePlus; Q5JXX7; -.
DR   BioMuta; TMEM31; -.
DR   PaxDb; Q5JXX7; -.
DR   PeptideAtlas; Q5JXX7; -.
DR   PRIDE; Q5JXX7; -.
DR   DNASU; 203562; -.
DR   Ensembl; ENST00000319560; ENSP00000316940; ENSG00000179363.
DR   GeneID; 203562; -.
DR   KEGG; hsa:203562; -.
DR   UCSC; uc004elh.4; human.
DR   CTD; 203562; -.
DR   EuPathDB; HostDB:ENSG00000179363.6; -.
DR   GeneCards; TMEM31; -.
DR   HGNC; HGNC:28601; TMEM31.
DR   HPA; HPA052760; -.
DR   neXtProt; NX_Q5JXX7; -.
DR   OpenTargets; ENSG00000179363; -.
DR   PharmGKB; PA134926659; -.
DR   eggNOG; ENOG410JCVU; Eukaryota.
DR   eggNOG; ENOG4111CGC; LUCA.
DR   GeneTree; ENSGT00390000001638; -.
DR   HOGENOM; HOG000154643; -.
DR   InParanoid; Q5JXX7; -.
DR   OMA; YPEFILV; -.
DR   OrthoDB; EOG091G0U0U; -.
DR   PhylomeDB; Q5JXX7; -.
DR   TreeFam; TF353626; -.
DR   GenomeRNAi; 203562; -.
DR   PRO; PR:Q5JXX7; -.
DR   Proteomes; UP000005640; Chromosome X.
DR   Bgee; ENSG00000179363; -.
DR   CleanEx; HS_TMEM31; -.
DR   ExpressionAtlas; Q5JXX7; baseline and differential.
DR   Genevisible; Q5JXX7; HS.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
PE   1: Evidence at protein level;
KW   Complete proteome; Membrane; Reference proteome; Transmembrane;
KW   Transmembrane helix.
FT   CHAIN         1    168       Transmembrane protein 31.
FT                                /FTId=PRO_0000284800.
FT   TRANSMEM    119    139       Helical. {ECO:0000255}.
FT   TRANSMEM    148    168       Helical. {ECO:0000255}.
FT   CONFLICT    154    155       Missing (in Ref. 2; AAH29575).
FT                                {ECO:0000305}.
SQ   SEQUENCE   168 AA;  19813 MW;  7824918182ECAB48 CRC64;
     MRLTEKSEGE QQLKPNNSNA PNEDQEEEIQ QSEQHTPARQ RTQRADTQPS RCRLPSRRTP
     TTSSDRTINL LEVLPWPTEW IFNPYRLPAL FELYPEFLLV FKEAFHDISH CLKAQMEKIG
     LPIILHLFAL STLYFYKFFL PTILSLSFFI LLVLLLLLFI IVFILIFF
//
ID   FER3L_HUMAN             Reviewed;         166 AA.
AC   Q96RJ6; Q495K0;
DT   08-APR-2008, integrated into UniProtKB/Swiss-Prot.
DT   01-DEC-2001, sequence version 1.
DT   23-MAY-2018, entry version 129.
DE   RecName: Full=Fer3-like protein;
DE   AltName: Full=Basic helix-loop-helix protein N-twist;
DE   AltName: Full=Class A basic helix-loop-helix protein 31;
DE            Short=bHLHa31;
DE   AltName: Full=Nephew of atonal 3;
DE   AltName: Full=Neuronal twist;
GN   Name=FERD3L; Synonyms=BHLHA31, NATO3, NTWIST;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=11472856; DOI=10.1016/S0925-4773(01)00437-3;
RA   Segev E., Halachmi N., Salzberg A., Ben-Arie N.;
RT   "Nato3 is an evolutionarily conserved bHLH transcription factor
RT   expressed in the CNS of Drosophila and mouse.";
RL   Mech. Dev. 106:197-202(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=12217327; DOI=10.1006/dbio.2002.0753;
RA   Verzi M.P., Anderson J.P., Dodou E., Kelly K.K., Greene S.B.,
RA   North B.J., Cripps R.M., Black B.L.;
RT   "N-twist, an evolutionarily conserved bHLH protein expressed in the
RT   developing CNS, functions as a transcriptional inhibitor.";
RL   Dev. Biol. 249:174-190(2002).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12690205; DOI=10.1126/science.1083423;
RA   Scherer S.W., Cheung J., MacDonald J.R., Osborne L.R., Nakabayashi K.,
RA   Herbrick J.-A., Carson A.R., Parker-Katiraee L., Skaug J., Khaja R.,
RA   Zhang J., Hudek A.K., Li M., Haddad M., Duggan G.E., Fernandez B.A.,
RA   Kanematsu E., Gentles S., Christopoulos C.C., Choufani S.,
RA   Kwasnicka D., Zheng X.H., Lai Z., Nusskern D.R., Zhang Q., Gu Z.,
RA   Lu F., Zeesman S., Nowaczyk M.J., Teshima I., Chitayat D., Shuman C.,
RA   Weksberg R., Zackai E.H., Grebe T.A., Cox S.R., Kirkpatrick S.J.,
RA   Rahman N., Friedman J.M., Heng H.H.Q., Pelicci P.G., Lo-Coco F.,
RA   Belloni E., Shaffer L.G., Pober B., Morton C.C., Gusella J.F.,
RA   Bruns G.A.P., Korf B.R., Quade B.J., Ligon A.H., Ferguson H.,
RA   Higgins A.W., Leach N.T., Herrick S.R., Lemyre E., Farra C.G.,
RA   Kim H.-G., Summers A.M., Gripp K.W., Roberts W., Szatmari P.,
RA   Winsor E.J.T., Grzeschik K.-H., Teebi A., Minassian B.A., Kere J.,
RA   Armengol L., Pujana M.A., Estivill X., Wilson M.D., Koop B.F.,
RA   Tosi S., Moore G.E., Boright A.P., Zlotorynski E., Kerem B.,
RA   Kroisel P.M., Petek E., Oscier D.G., Mould S.J., Doehner H.,
RA   Doehner K., Rommens J.M., Vincent J.B., Venter J.C., Li P.W.,
RA   Mural R.J., Adams M.D., Tsui L.-C.;
RT   "Human chromosome 7: DNA sequence and biology.";
RL   Science 300:767-772(2003).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   VARIANT [LARGE SCALE ANALYSIS] ARG-36.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S.,
RA   Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J.,
RA   Dawson D., Willson J.K.V., Gazdar A.F., Hartigan J., Wu L., Liu C.,
RA   Parmigiani G., Park B.H., Bachman K.E., Papadopoulos N.,
RA   Vogelstein B., Kinzler K.W., Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal
RT   cancers.";
RL   Science 314:268-274(2006).
CC   -!- FUNCTION: Transcription factor that binds to the E-box and
CC       functions as inhibitor of transcription. DNA binding requires
CC       dimerization with an E protein. Inhibits transcription activation
CC       by ASCL1/MASH1 by sequestering E proteins (By similarity).
CC       {ECO:0000250}.
CC   -!- SUBUNIT: Heterodimer with TCF3/E12. Interacts with the bHLH domain
CC       of TCF3/E12 (By similarity). {ECO:0000250}.
CC   -!- INTERACTION:
CC       Q8IZU0:FAM9B; NbExp=3; IntAct=EBI-10183007, EBI-10175124;
CC       O15481:MAGEB4; NbExp=3; IntAct=EBI-10183007, EBI-751857;
CC       O43765:SGTA; NbExp=3; IntAct=EBI-10183007, EBI-347996;
CC       P15884:TCF4; NbExp=3; IntAct=EBI-10183007, EBI-533224;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-
CC       ProRule:PRU00981}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF369897; AAK72956.1; -; Genomic_DNA.
DR   EMBL; AF517122; AAN04086.1; -; mRNA.
DR   EMBL; CH236948; EAL24278.1; -; Genomic_DNA.
DR   EMBL; CH471073; EAW93712.1; -; Genomic_DNA.
DR   EMBL; BC069147; AAH69147.1; -; mRNA.
DR   EMBL; BC101135; AAI01136.1; -; mRNA.
DR   EMBL; BC101136; AAI01137.1; -; mRNA.
DR   EMBL; BC101137; AAI01138.1; -; mRNA.
DR   EMBL; BC101138; AAI01139.1; -; mRNA.
DR   CCDS; CCDS5368.1; -.
DR   RefSeq; NP_690862.1; NM_152898.2.
DR   UniGene; Hs.592168; -.
DR   ProteinModelPortal; Q96RJ6; -.
DR   SMR; Q96RJ6; -.
DR   BioGrid; 128819; 11.
DR   IntAct; Q96RJ6; 4.
DR   PhosphoSitePlus; Q96RJ6; -.
DR   BioMuta; FERD3L; -.
DR   DMDM; 74752106; -.
DR   PaxDb; Q96RJ6; -.
DR   PeptideAtlas; Q96RJ6; -.
DR   PRIDE; Q96RJ6; -.
DR   Ensembl; ENST00000275461; ENSP00000275461; ENSG00000146618.
DR   GeneID; 222894; -.
DR   KEGG; hsa:222894; -.
DR   UCSC; uc003suo.1; human.
DR   CTD; 222894; -.
DR   EuPathDB; HostDB:ENSG00000146618.3; -.
DR   GeneCards; FERD3L; -.
DR   HGNC; HGNC:16660; FERD3L.
DR   HPA; HPA043494; -.
DR   MIM; 617578; gene.
DR   neXtProt; NX_Q96RJ6; -.
DR   OpenTargets; ENSG00000146618; -.
DR   PharmGKB; PA134973730; -.
DR   eggNOG; ENOG410ISUY; Eukaryota.
DR   eggNOG; ENOG4111V63; LUCA.
DR   GeneTree; ENSGT00730000110958; -.
DR   HOGENOM; HOG000046685; -.
DR   HOVERGEN; HBG094853; -.
DR   InParanoid; Q96RJ6; -.
DR   KO; K22400; -.
DR   OMA; RHPLLCD; -.
DR   OrthoDB; EOG091G0YNB; -.
DR   PhylomeDB; Q96RJ6; -.
DR   GenomeRNAi; 222894; -.
DR   PRO; PR:Q96RJ6; -.
DR   Proteomes; UP000005640; Chromosome 7.
DR   Bgee; ENSG00000146618; -.
DR   CleanEx; HS_FERD3L; -.
DR   Genevisible; Q96RJ6; HS.
DR   GO; GO:0005634; C:nucleus; ISS:UniProtKB.
DR   GO; GO:0046983; F:protein dimerization activity; IEA:InterPro.
DR   GO; GO:0000977; F:RNA polymerase II regulatory region sequence-specific DNA binding; IEA:Ensembl.
DR   GO; GO:0000981; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; ISA:NTNU_SB.
DR   GO; GO:0001227; F:transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific DNA binding; IEA:Ensembl.
DR   GO; GO:0048468; P:cell development; IEA:Ensembl.
DR   GO; GO:0033504; P:floor plate development; IEA:Ensembl.
DR   GO; GO:0045892; P:negative regulation of transcription, DNA-templated; ISS:UniProtKB.
DR   GO; GO:0050767; P:regulation of neurogenesis; IEA:Ensembl.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   CDD; cd00083; HLH; 1.
DR   Gene3D; 4.10.280.10; -; 1.
DR   InterPro; IPR011598; bHLH_dom.
DR   InterPro; IPR036638; HLH_DNA-bd_sf.
DR   Pfam; PF00010; HLH; 1.
DR   SMART; SM00353; HLH; 1.
DR   SUPFAM; SSF47459; SSF47459; 1.
DR   PROSITE; PS50888; BHLH; 1.
PE   1: Evidence at protein level;
KW   Complete proteome; DNA-binding; Nucleus; Polymorphism;
KW   Reference proteome; Repressor; Transcription;
KW   Transcription regulation.
FT   CHAIN         1    166       Fer3-like protein.
FT                                /FTId=PRO_0000328682.
FT   DOMAIN      101    153       bHLH. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00981}.
FT   COMPBIAS     63     68       Poly-Glu.
FT   COMPBIAS     75     81       Poly-Glu.
FT   VARIANT      36     36       G -> R (in a colorectal cancer sample;
FT                                somatic mutation; dbSNP:rs775679607).
FT                                {ECO:0000269|PubMed:16959974}.
FT                                /FTId=VAR_042439.
FT   CONFLICT     74     74       G -> GE (in Ref. 5; AAI01136/AAI01137).
FT                                {ECO:0000305}.
SQ   SEQUENCE   166 AA;  19017 MW;  206F6EDE1F54C79C CRC64;
     MAAYPESCVD TTVLDFVADL SLASPRRPLL CDFAPGVSLG DPALALREGR PRRMARFEEG
     DPEEEECEVD QGDGEEEEEE ERGRGVSLLG RPKRKRVITY AQRQAANIRE RKRMFNLNEA
     FDQLRRKVPT FAYEKRLSRI ETLRLAIVYI SFMTELLESC EKKESG
//
ID   ZG16_HUMAN              Reviewed;         167 AA.
AC   O60844; B2R4Z3; B9EK72;
DT   01-MAR-2005, integrated into UniProtKB/Swiss-Prot.
DT   16-APR-2014, sequence version 2.
DT   28-FEB-2018, entry version 125.
DE   RecName: Full=Zymogen granule membrane protein 16;
DE            Short=Zymogen granule protein 16;
DE            Short=hZG16;
DE   AltName: Full=Secretory lectin ZG16;
DE   Flags: Precursor;
GN   Name=ZG16;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT VAL-109.
RC   TISSUE=Colon adenocarcinoma;
RA   Hosokawa S., Kojima-Aikawa K.;
RT   "Carbohydrate-binding activity of ZG16p.";
RL   Submitted (OCT-2002) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT VAL-109.
RC   TISSUE=Colon, and Rectum;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15616553; DOI=10.1038/nature03187;
RA   Martin J., Han C., Gordon L.A., Terry A., Prabhakar S., She X.,
RA   Xie G., Hellsten U., Chan Y.M., Altherr M., Couronne O., Aerts A.,
RA   Bajorek E., Black S., Blumer H., Branscomb E., Brown N.C., Bruno W.J.,
RA   Buckingham J.M., Callen D.F., Campbell C.S., Campbell M.L.,
RA   Campbell E.W., Caoile C., Challacombe J.F., Chasteen L.A.,
RA   Chertkov O., Chi H.C., Christensen M., Clark L.M., Cohn J.D.,
RA   Denys M., Detter J.C., Dickson M., Dimitrijevic-Bussod M., Escobar J.,
RA   Fawcett J.J., Flowers D., Fotopulos D., Glavina T., Gomez M.,
RA   Gonzales E., Goodstein D., Goodwin L.A., Grady D.L., Grigoriev I.,
RA   Groza M., Hammon N., Hawkins T., Haydu L., Hildebrand C.E., Huang W.,
RA   Israni S., Jett J., Jewett P.B., Kadner K., Kimball H., Kobayashi A.,
RA   Krawczyk M.-C., Leyba T., Longmire J.L., Lopez F., Lou Y., Lowry S.,
RA   Ludeman T., Manohar C.F., Mark G.A., McMurray K.L., Meincke L.J.,
RA   Morgan J., Moyzis R.K., Mundt M.O., Munk A.C., Nandkeshwar R.D.,
RA   Pitluck S., Pollard M., Predki P., Parson-Quintana B., Ramirez L.,
RA   Rash S., Retterer J., Ricke D.O., Robinson D.L., Rodriguez A.,
RA   Salamov A., Saunders E.H., Scott D., Shough T., Stallings R.L.,
RA   Stalvey M., Sutherland R.D., Tapia R., Tesmer J.G., Thayer N.,
RA   Thompson L.S., Tice H., Torney D.C., Tran-Gyamfi M., Tsai M.,
RA   Ulanovsky L.E., Ustaszewska A., Vo N., White P.S., Williams A.L.,
RA   Wills P.L., Wu J.-R., Wu K., Yang J., DeJong P., Bruce D.,
RA   Doggett N.A., Deaven L., Schmutz J., Grimwood J., Richardson P.,
RA   Rokhsar D.S., Eichler E.E., Gilna P., Lucas S.M., Myers R.M.,
RA   Rubin E.M., Pennacchio L.A.;
RT   "The sequence and analysis of duplication-rich human chromosome 16.";
RL   Nature 432:988-994(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND VARIANT VAL-109.
RX   PubMed=10493829; DOI=10.1006/geno.1999.5927;
RA   Loftus B.J., Kim U.-J., Sneddon V.P., Kalush F., Brandon R.,
RA   Fuhrmann J., Mason T., Crosby M.L., Barnstead M., Cronin L.,
RA   Mays A.D., Cao Y., Xu R.X., Kang H.-L., Mitchell S., Eichler E.E.,
RA   Harris P.C., Venter J.C., Adams M.D.;
RT   "Genome duplications and other features in 12 Mb of DNA sequence from
RT   human chromosome 16p and 16q.";
RL   Genomics 60:295-308(1999).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND VARIANT VAL-109.
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANTS SER-32 AND
RP   VAL-109.
RC   TISSUE=Colon;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   PROTEIN SEQUENCE OF 17-31.
RX   PubMed=15340161; DOI=10.1110/ps.04682504;
RA   Zhang Z., Henzel W.J.;
RT   "Signal peptide prediction based on analysis of experimentally
RT   verified cleavage sites.";
RL   Protein Sci. 13:2819-2824(2004).
RN   [8]
RP   FUNCTION, SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=17307141; DOI=10.1016/j.bbrc.2007.02.020;
RA   Zhou Y.B., Cao J.B., Yang H.M., Zhu H., Xu Z.G., Wang K.S., Zhang X.,
RA   Wang Z.Q., Han Z.G.;
RT   "hZG16, a novel human secreted protein expressed in liver, was down-
RT   regulated in hepatocellular carcinoma.";
RL   Biochem. Biophys. Res. Commun. 355:679-686(2007).
RN   [9]
RP   X-RAY CRYSTALLOGRAPHY (1.65 ANGSTROMS) OF 21-159.
RX   PubMed=21110947; DOI=10.1016/j.bbrc.2010.11.093;
RA   Kanagawa M., Satoh T., Ikeda A., Nakano Y., Yagi H., Kato K.,
RA   Kojima-Aikawa K., Yamaguchi Y.;
RT   "Crystal structures of human secretory proteins ZG16p and ZG16b reveal
RT   a Jacalin-related beta-prism fold.";
RL   Biochem. Biophys. Res. Commun. 404:201-205(2011).
CC   -!- FUNCTION: May play a role in protein trafficking. May act as a
CC       linker molecule between the submembranous matrix on the luminal
CC       side of zymogen granule membrane (ZGM) and aggregated secretory
CC       proteins during granule formation in the TGN.
CC       {ECO:0000269|PubMed:17307141}.
CC   -!- INTERACTION:
CC       Q9UHX1:PUF60; NbExp=3; IntAct=EBI-746479, EBI-1053259;
CC       O43765:SGTA; NbExp=8; IntAct=EBI-746479, EBI-347996;
CC       Q96EQ0:SGTB; NbExp=4; IntAct=EBI-746479, EBI-744081;
CC       Q9UMX0:UBQLN1; NbExp=8; IntAct=EBI-746479, EBI-741480;
CC       Q9UMX0-2:UBQLN1; NbExp=3; IntAct=EBI-746479, EBI-10173939;
CC   -!- SUBCELLULAR LOCATION: Secreted, extracellular space, extracellular
CC       matrix {ECO:0000269|PubMed:17307141}. Cytoplasmic vesicle lumen
CC       {ECO:0000305|PubMed:17307141}. Golgi apparatus lumen
CC       {ECO:0000269|PubMed:17307141}. Note=Stored in zymogen granules.
CC       {ECO:0000250}.
CC   -!- TISSUE SPECIFICITY: Highly expressed in liver. Detected at lower
CC       levels in colon, ileum and jejunum. {ECO:0000269|PubMed:17307141}.
CC   -!- SIMILARITY: Belongs to the jacalin lectin family.
CC       {ECO:0000255|PROSITE-ProRule:PRU01088, ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB092813; BAC20361.1; -; mRNA.
DR   EMBL; AK312002; BAG34940.1; -; mRNA.
DR   EMBL; AK125559; BAG54214.1; -; mRNA.
DR   EMBL; AC009133; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC002301; AAC08708.1; -; Genomic_DNA.
DR   EMBL; CH471238; EAW80011.1; -; Genomic_DNA.
DR   EMBL; BC029149; AAH29149.1; -; mRNA.
DR   EMBL; BC150656; AAI50657.1; -; mRNA.
DR   CCDS; CCDS54000.1; -.
DR   RefSeq; NP_689551.2; NM_152338.3.
DR   UniGene; Hs.632195; -.
DR   PDB; 3APA; X-ray; 1.65 A; A=21-159.
DR   PDB; 3VY6; X-ray; 2.00 A; A=21-159.
DR   PDB; 3VY7; X-ray; 2.14 A; A=21-159.
DR   PDB; 3VZE; X-ray; 1.90 A; A=21-159.
DR   PDB; 3VZF; X-ray; 2.80 A; A=21-159.
DR   PDB; 3VZG; X-ray; 2.70 A; A=21-159.
DR   PDBsum; 3APA; -.
DR   PDBsum; 3VY6; -.
DR   PDBsum; 3VY7; -.
DR   PDBsum; 3VZE; -.
DR   PDBsum; 3VZF; -.
DR   PDBsum; 3VZG; -.
DR   ProteinModelPortal; O60844; -.
DR   SMR; O60844; -.
DR   BioGrid; 576089; 4.
DR   IntAct; O60844; 11.
DR   STRING; 9606.ENSP00000383563; -.
DR   iPTMnet; O60844; -.
DR   PhosphoSitePlus; O60844; -.
DR   BioMuta; ZG16; -.
DR   PaxDb; O60844; -.
DR   PeptideAtlas; O60844; -.
DR   PRIDE; O60844; -.
DR   Ensembl; ENST00000400752; ENSP00000383563; ENSG00000174992.
DR   GeneID; 653808; -.
DR   KEGG; hsa:653808; -.
DR   UCSC; uc002dtr.5; human.
DR   CTD; 653808; -.
DR   EuPathDB; HostDB:ENSG00000174992.7; -.
DR   GeneCards; ZG16; -.
DR   H-InvDB; HIX0012923; -.
DR   HGNC; HGNC:30961; ZG16.
DR   HPA; HPA052066; -.
DR   HPA; HPA052512; -.
DR   neXtProt; NX_O60844; -.
DR   PharmGKB; PA164727719; -.
DR   eggNOG; ENOG410IE5W; Eukaryota.
DR   eggNOG; ENOG41122DQ; LUCA.
DR   HOGENOM; HOG000015245; -.
DR   HOVERGEN; HBG079379; -.
DR   InParanoid; O60844; -.
DR   OrthoDB; EOG091G0Y3H; -.
DR   PhylomeDB; O60844; -.
DR   TreeFam; TF333440; -.
DR   EvolutionaryTrace; O60844; -.
DR   GeneWiki; ZG16; -.
DR   GenomeRNAi; 653808; -.
DR   PRO; PR:O60844; -.
DR   Proteomes; UP000005640; Chromosome 16.
DR   Bgee; ENSG00000174992; -.
DR   Genevisible; O60844; HS.
DR   GO; GO:0060205; C:cytoplasmic vesicle lumen; IEA:UniProtKB-SubCell.
DR   GO; GO:0031012; C:extracellular matrix; IDA:UniProtKB.
DR   GO; GO:0005796; C:Golgi lumen; IDA:UniProtKB.
DR   GO; GO:0005578; C:proteinaceous extracellular matrix; IEA:UniProtKB-SubCell.
DR   GO; GO:0042589; C:zymogen granule membrane; IEA:Ensembl.
DR   GO; GO:0030246; F:carbohydrate binding; IEA:UniProtKB-KW.
DR   GO; GO:0015031; P:protein transport; TAS:UniProtKB.
DR   Gene3D; 2.100.10.30; -; 1.
DR   InterPro; IPR001229; Jacalin-like_lectin_dom.
DR   InterPro; IPR036404; Jacalin-like_lectin_dom_sf.
DR   InterPro; IPR033563; ZG16.
DR   PANTHER; PTHR33589:SF4; PTHR33589:SF4; 1.
DR   Pfam; PF01419; Jacalin; 1.
DR   SMART; SM00915; Jacalin; 1.
DR   SUPFAM; SSF51101; SSF51101; 1.
DR   PROSITE; PS51752; JACALIN_LECTIN; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Complete proteome; Cytoplasmic vesicle;
KW   Direct protein sequencing; Extracellular matrix; Golgi apparatus;
KW   Lectin; Polymorphism; Protein transport; Reference proteome; Secreted;
KW   Signal; Transport.
FT   SIGNAL        1     16       {ECO:0000269|PubMed:15340161}.
FT   CHAIN        17    167       Zymogen granule membrane protein 16.
FT                                /FTId=PRO_0000017570.
FT   DOMAIN       24    159       Jacalin-type lectin.
FT                                {ECO:0000255|PROSITE-ProRule:PRU01088}.
FT   VARIANT      32     32       G -> S (in dbSNP:rs235636).
FT                                {ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_034587.
FT   VARIANT     109    109       L -> V. {ECO:0000269|PubMed:10493829,
FT                                ECO:0000269|PubMed:14702039,
FT                                ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|Ref.1, ECO:0000269|Ref.5}.
FT                                /FTId=VAR_070695.
FT   VARIANT     162    162       S -> T (in dbSNP:rs235638).
FT                                /FTId=VAR_034588.
FT   STRAND       25     31       {ECO:0000244|PDB:3APA}.
FT   STRAND       35     39       {ECO:0000244|PDB:3APA}.
FT   HELIX        41     46       {ECO:0000244|PDB:3APA}.
FT   STRAND       48     56       {ECO:0000244|PDB:3APA}.
FT   STRAND       58     68       {ECO:0000244|PDB:3APA}.
FT   STRAND       79     87       {ECO:0000244|PDB:3APA}.
FT   STRAND       94    112       {ECO:0000244|PDB:3APA}.
FT   STRAND      117    121       {ECO:0000244|PDB:3APA}.
FT   STRAND      125    130       {ECO:0000244|PDB:3APA}.
FT   STRAND      138    158       {ECO:0000244|PDB:3APA}.
SQ   SEQUENCE   167 AA;  18147 MW;  247AE2FB4FC180A3 CRC64;
     MLTVALLALL CASASGNAIQ ARSSSYSGEY GGGGGKRFSH SGNQLDGPIT ALRVRVNTYY
     IVGLQVRYGK VWSDYVGGRN GDLEEIFLHP GESVIQVSGK YKWYLKKLLF VTDKGRYLSF
     GKDSGTSFNA VPLHPNTVLR FISGRSGSLI DAIGLHWDVY PSSCSRC
//
ID   B7Z7I2_HUMAN            Unreviewed;       380 AA.
AC   B7Z7I2;
DT   03-MAR-2009, integrated into UniProtKB/TrEMBL.
DT   03-MAR-2009, sequence version 1.
DT   23-MAY-2018, entry version 89.
DE   SubName: Full=cDNA FLJ50281, highly similar to Glucocorticoid receptor {ECO:0000313|EMBL:BAH13618.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAH13618.1};
RN   [1] {ECO:0000313|EMBL:BAH13618.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Testis {ECO:0000313|EMBL:BAH13618.1};
RA   Wakamatsu A., Yamamoto J., Kimura K., Ishii S., Watanabe K.,
RA   Sugiyama A., Murakawa K., Kaida T., Tsuchiya K., Fukuzumi Y.,
RA   Kumagai A., Oishi Y., Yamamoto S., Ono Y., Komori Y., Yamazaki M.,
RA   Kisu Y., Nishikawa T., Sugano S., Nomura N., Isogai T.;
RT   "NEDO human cDNA sequencing project focused on splicing variants.";
RL   Submitted (OCT-2007) to the EMBL/GenBank/DDBJ databases.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000256|PROSITE-
CC       ProRule:PRU00407, ECO:0000256|RuleBase:RU004334,
CC       ECO:0000256|SAAS:SAAS01037405}.
CC   -!- SIMILARITY: Belongs to the nuclear hormone receptor family.
CC       {ECO:0000256|RuleBase:RU004334, ECO:0000256|SAAS:SAAS01037406}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK302050; BAH13618.1; -; mRNA.
DR   RefSeq; XP_011535939.1; XM_011537637.2.
DR   UniGene; Hs.122926; -.
DR   ProteinModelPortal; B7Z7I2; -.
DR   MaxQB; B7Z7I2; -.
DR   PeptideAtlas; B7Z7I2; -.
DR   PRIDE; B7Z7I2; -.
DR   GeneID; 2908; -.
DR   CTD; 2908; -.
DR   eggNOG; KOG3575; Eukaryota.
DR   eggNOG; ENOG410XRZC; LUCA.
DR   HOVERGEN; HBG007583; -.
DR   GenomeRNAi; 2908; -.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0003700; F:DNA binding transcription factor activity; IEA:InterPro.
DR   GO; GO:0043565; F:sequence-specific DNA binding; IEA:InterPro.
DR   GO; GO:0003707; F:steroid hormone receptor activity; IEA:InterPro.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-UniRule.
DR   Gene3D; 3.30.50.10; -; 1.
DR   InterPro; IPR035500; NHR_like_dom_sf.
DR   InterPro; IPR000536; Nucl_hrmn_rcpt_lig-bd.
DR   InterPro; IPR001723; Nuclear_hrmn_rcpt.
DR   InterPro; IPR001628; Znf_hrmn_rcpt.
DR   InterPro; IPR013088; Znf_NHR/GATA.
DR   Pfam; PF00104; Hormone_recep; 1.
DR   Pfam; PF00105; zf-C4; 1.
DR   PRINTS; PR00398; STRDHORMONER.
DR   PRINTS; PR00047; STROIDFINGER.
DR   SMART; SM00430; HOLI; 1.
DR   SMART; SM00399; ZnF_C4; 1.
DR   SUPFAM; SSF48508; SSF48508; 1.
DR   PROSITE; PS51843; NR_LBD; 1.
DR   PROSITE; PS00031; NUCLEAR_REC_DBD_1; 1.
DR   PROSITE; PS51030; NUCLEAR_REC_DBD_2; 1.
PE   2: Evidence at transcript level;
KW   DNA-binding {ECO:0000256|PROSITE-ProRule:PRU00407,
KW   ECO:0000256|RuleBase:RU004334, ECO:0000256|SAAS:SAAS00517091};
KW   Metal-binding {ECO:0000256|PROSITE-ProRule:PRU00407,
KW   ECO:0000256|RuleBase:RU004334, ECO:0000256|SAAS:SAAS00517125};
KW   Nucleus {ECO:0000256|PROSITE-ProRule:PRU00407,
KW   ECO:0000256|RuleBase:RU004334, ECO:0000256|SAAS:SAAS01037386};
KW   Receptor {ECO:0000256|RuleBase:RU004334,
KW   ECO:0000256|SAAS:SAAS01037471, ECO:0000313|EMBL:BAH13618.1};
KW   Transcription {ECO:0000256|PROSITE-ProRule:PRU00407,
KW   ECO:0000256|RuleBase:RU004334, ECO:0000256|SAAS:SAAS01037387};
KW   Transcription regulation {ECO:0000256|PROSITE-ProRule:PRU00407,
KW   ECO:0000256|RuleBase:RU004334, ECO:0000256|SAAS:SAAS01037387};
KW   Zinc {ECO:0000256|PROSITE-ProRule:PRU00407,
KW   ECO:0000256|RuleBase:RU004334, ECO:0000256|SAAS:SAAS00517125};
KW   Zinc-finger {ECO:0000256|PROSITE-ProRule:PRU00407,
KW   ECO:0000256|RuleBase:RU004334, ECO:0000256|SAAS:SAAS00517125}.
FT   DOMAIN       21     96       Nuclear receptor.
FT                                {ECO:0000259|PROSITE:PS51030}.
FT   DOMAIN      127    361       NR LBD. {ECO:0000259|PROSITE:PS51843}.
FT   DNA_BIND     21     96       Nuclear receptor. {ECO:0000256|PROSITE-
FT                                ProRule:PRU00407}.
SQ   SEQUENCE   380 AA;  43149 MW;  3D3F7C55D300C99F CRC64;
     MRPDVSSPPS SSSTATTGPP PKLCLVCSDE ASGCHYGVLT CGSCKVFFKR AVEGQHNYLC
     AGRNDCIIDK IRRKNCPACR YRKCLQAGMN LEARKTKKKI KGIQQATTGV SQETSENPGN
     KTIVPATLPQ LTPTLVSLLE VIEPEVLYAG YDSSVPDSTW RIMTTLNMLG GRQVIAAVKW
     AKAIPGFRNL HLDDQMTLLQ YSWMFLMAFA LGWRSYRQSS ANLLCFAPDL IINEQRMTLP
     CMYDQCKHML YVSSELHRLQ VSYEEYLCMK TLLLLSSVPK DGLKSQELFD EIRMTYIKEL
     GKAIVKREGN SSQNWQRFYQ LTKLLDSMHE VVENLLNYCF QTFLDKTMSI EFPEMLAEII
     TNQIPKYSNG NIKKLLFHQK
//
ID   E5KQF5_HUMAN            Unreviewed;       742 AA.
AC   E5KQF5;
DT   08-FEB-2011, integrated into UniProtKB/TrEMBL.
DT   08-FEB-2011, sequence version 1.
DT   23-MAY-2018, entry version 64.
DE   SubName: Full=Glucocorticoid receptor {ECO:0000313|EMBL:ADP91134.1};
DE   SubName: Full=Nuclear receptor subfamily 3, group C, member 1 (Glucocorticoid receptor), isoform CRA_b {ECO:0000313|EMBL:EAW61871.1};
GN   Name=NR3C1 {ECO:0000313|EMBL:EAW61871.1};
GN   ORFNames=hCG_37601 {ECO:0000313|EMBL:EAW61871.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:ADP91134.1};
RN   [1] {ECO:0000313|EMBL:EAW61871.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAW61871.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3] {ECO:0000313|EMBL:ADP91134.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=20843780; DOI=10.1093/nar/gkq750;
RA   Wang W., Shen P., Thiyagarajan S., Lin S., Palm C., Horvath R.,
RA   Klopstock T., Cutler D., Pique L., Schrijver I., Davis R.W.,
RA   Mindrinos M., Speed T.P., Scharfe C.;
RT   "Identification of rare DNA variants in mitochondrial disorders with
RT   improved array-based sequencing.";
RL   Nucleic Acids Res. 39:44-58(2011).
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000256|PROSITE-
CC       ProRule:PRU00407, ECO:0000256|RuleBase:RU004334,
CC       ECO:0000256|SAAS:SAAS01037405}.
CC   -!- SIMILARITY: Belongs to the nuclear hormone receptor family.
CC       {ECO:0000256|RuleBase:RU004334, ECO:0000256|SAAS:SAAS01037406}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; HQ205546; ADP91134.1; -; Genomic_DNA.
DR   EMBL; HQ205547; ADP91137.1; -; Genomic_DNA.
DR   EMBL; HQ205548; ADP91140.1; -; Genomic_DNA.
DR   EMBL; HQ205549; ADP91143.1; -; Genomic_DNA.
DR   EMBL; HQ205550; ADP91146.1; -; Genomic_DNA.
DR   EMBL; HQ205551; ADP91149.1; -; Genomic_DNA.
DR   EMBL; HQ205552; ADP91152.1; -; Genomic_DNA.
DR   EMBL; HQ205553; ADP91155.1; -; Genomic_DNA.
DR   EMBL; HQ205554; ADP91158.1; -; Genomic_DNA.
DR   EMBL; HQ205555; ADP91161.1; -; Genomic_DNA.
DR   EMBL; HQ205556; ADP91164.1; -; Genomic_DNA.
DR   EMBL; HQ205557; ADP91167.1; -; Genomic_DNA.
DR   EMBL; HQ205558; ADP91170.1; -; Genomic_DNA.
DR   EMBL; HQ205559; ADP91173.1; -; Genomic_DNA.
DR   EMBL; HQ205560; ADP91176.1; -; Genomic_DNA.
DR   EMBL; HQ205561; ADP91179.1; -; Genomic_DNA.
DR   EMBL; HQ205562; ADP91182.1; -; Genomic_DNA.
DR   EMBL; HQ205563; ADP91185.1; -; Genomic_DNA.
DR   EMBL; HQ205564; ADP91188.1; -; Genomic_DNA.
DR   EMBL; HQ205565; ADP91191.1; -; Genomic_DNA.
DR   EMBL; HQ205566; ADP91194.1; -; Genomic_DNA.
DR   EMBL; HQ205567; ADP91197.1; -; Genomic_DNA.
DR   EMBL; HQ205568; ADP91200.1; -; Genomic_DNA.
DR   EMBL; HQ205569; ADP91203.1; -; Genomic_DNA.
DR   EMBL; HQ205570; ADP91206.1; -; Genomic_DNA.
DR   EMBL; HQ205571; ADP91209.1; -; Genomic_DNA.
DR   EMBL; HQ205572; ADP91212.1; -; Genomic_DNA.
DR   EMBL; HQ205573; ADP91215.1; -; Genomic_DNA.
DR   EMBL; HQ205574; ADP91218.1; -; Genomic_DNA.
DR   EMBL; HQ205575; ADP91221.1; -; Genomic_DNA.
DR   EMBL; HQ205576; ADP91224.1; -; Genomic_DNA.
DR   EMBL; HQ205577; ADP91227.1; -; Genomic_DNA.
DR   EMBL; HQ205578; ADP91230.1; -; Genomic_DNA.
DR   EMBL; HQ205579; ADP91233.1; -; Genomic_DNA.
DR   EMBL; HQ205580; ADP91236.1; -; Genomic_DNA.
DR   EMBL; HQ205581; ADP91239.1; -; Genomic_DNA.
DR   EMBL; HQ205582; ADP91242.1; -; Genomic_DNA.
DR   EMBL; HQ205583; ADP91245.1; -; Genomic_DNA.
DR   EMBL; HQ205584; ADP91248.1; -; Genomic_DNA.
DR   EMBL; HQ205585; ADP91251.1; -; Genomic_DNA.
DR   EMBL; CH471062; EAW61871.1; -; Genomic_DNA.
DR   RefSeq; NP_001018661.1; NM_001020825.1.
DR   UniGene; Hs.122926; -.
DR   SMR; E5KQF5; -.
DR   PRIDE; E5KQF5; -.
DR   DNASU; 2908; -.
DR   GeneID; 2908; -.
DR   CTD; 2908; -.
DR   EuPathDB; HostDB:ENSG00000113580.14; -.
DR   eggNOG; KOG3575; Eukaryota.
DR   eggNOG; ENOG410XRZC; LUCA.
DR   ChiTaRS; NR3C1; human.
DR   GenomeRNAi; 2908; -.
DR   Bgee; ENSG00000113580; -.
DR   ExpressionAtlas; E5KQF5; baseline and differential.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0003700; F:DNA binding transcription factor activity; IEA:InterPro.
DR   GO; GO:0004883; F:glucocorticoid receptor activity; IEA:InterPro.
DR   GO; GO:0043565; F:sequence-specific DNA binding; IEA:InterPro.
DR   GO; GO:0005496; F:steroid binding; IEA:InterPro.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-UniRule.
DR   Gene3D; 3.30.50.10; -; 1.
DR   InterPro; IPR001409; Glcrtcd_rcpt.
DR   InterPro; IPR035500; NHR_like_dom_sf.
DR   InterPro; IPR000536; Nucl_hrmn_rcpt_lig-bd.
DR   InterPro; IPR001723; Nuclear_hrmn_rcpt.
DR   InterPro; IPR001628; Znf_hrmn_rcpt.
DR   InterPro; IPR013088; Znf_NHR/GATA.
DR   Pfam; PF02155; GCR; 1.
DR   Pfam; PF00104; Hormone_recep; 1.
DR   Pfam; PF00105; zf-C4; 1.
DR   PRINTS; PR00528; GLCORTICOIDR.
DR   PRINTS; PR00398; STRDHORMONER.
DR   PRINTS; PR00047; STROIDFINGER.
DR   SMART; SM00430; HOLI; 1.
DR   SMART; SM00399; ZnF_C4; 1.
DR   SUPFAM; SSF48508; SSF48508; 1.
DR   PROSITE; PS51843; NR_LBD; 1.
DR   PROSITE; PS00031; NUCLEAR_REC_DBD_1; 1.
DR   PROSITE; PS51030; NUCLEAR_REC_DBD_2; 1.
PE   3: Inferred from homology;
KW   Coiled coil {ECO:0000256|SAM:Coils};
KW   DNA-binding {ECO:0000256|PROSITE-ProRule:PRU00407,
KW   ECO:0000256|RuleBase:RU004334, ECO:0000256|SAAS:SAAS00517091};
KW   Metal-binding {ECO:0000256|PROSITE-ProRule:PRU00407,
KW   ECO:0000256|RuleBase:RU004334, ECO:0000256|SAAS:SAAS00517125};
KW   Nucleus {ECO:0000256|PROSITE-ProRule:PRU00407,
KW   ECO:0000256|RuleBase:RU004334, ECO:0000256|SAAS:SAAS01037386};
KW   Receptor {ECO:0000256|RuleBase:RU004334,
KW   ECO:0000256|SAAS:SAAS01037471, ECO:0000313|EMBL:ADP91134.1};
KW   Transcription {ECO:0000256|PROSITE-ProRule:PRU00407,
KW   ECO:0000256|RuleBase:RU004334, ECO:0000256|SAAS:SAAS01037387};
KW   Transcription regulation {ECO:0000256|PROSITE-ProRule:PRU00407,
KW   ECO:0000256|RuleBase:RU004334, ECO:0000256|SAAS:SAAS01037387};
KW   Zinc {ECO:0000256|PROSITE-ProRule:PRU00407,
KW   ECO:0000256|RuleBase:RU004334, ECO:0000256|SAAS:SAAS00517125};
KW   Zinc-finger {ECO:0000256|PROSITE-ProRule:PRU00407,
KW   ECO:0000256|RuleBase:RU004334, ECO:0000256|SAAS:SAAS00517125}.
FT   DOMAIN      418    493       Nuclear receptor.
FT                                {ECO:0000259|PROSITE:PS51030}.
FT   DOMAIN      524    742       NR LBD. {ECO:0000259|PROSITE:PS51843}.
FT   DNA_BIND    418    493       Nuclear receptor. {ECO:0000256|PROSITE-
FT                                ProRule:PRU00407}.
FT   COILED      112    132       {ECO:0000256|SAM:Coils}.
SQ   SEQUENCE   742 AA;  81509 MW;  E2D1F6EA0EE14704 CRC64;
     MDSKESLTPG REENPSSVLA QERGDVMDFY KTLRGGATVK VSASSPSLAV ASQSDSKQRR
     LLVDFPKGSV SNAQQPDLSK AVSLSMGLYM GETETKVMGN DLGFPQQGQI SLSSGETDLK
     LLEESIANLN RSTSVPENPK SSASTAVSAA PTEKEFPKTH SDVSSEQQHL KGQTGTNGGN
     VKLYTTDQST FDILQDLEFS SGSPGKETNE SPWRSDLLID ENCLLSPLAG EDDSFLLEGN
     SNEDCKPLIL PDTKPKIKDN GDLVLSSPSN VTLPQVKTEK EDFIELCTPG VIKQEKLGTV
     YCQASFPGAN IIGNKMSAIS VHGVSTSGGQ MYHYDMNTAS LSQQQDQKPI FNVIPPIPVG
     SENWNRCQGS GDDNLTSLGT LNFPGRTVFS NGYSSPSMRP DVSSPPSSSS TATTGPPPKL
     CLVCSDEASG CHYGVLTCGS CKVFFKRAVE GQHNYLCAGR NDCIIDKIRR KNCPACRYRK
     CLQAGMNLEA RKTKKKIKGI QQATTGVSQE TSENPGNKTI VPATLPQLTP TLVSLLEVIE
     PEVLYAGYDS SVPDSTWRIM TTLNMLGGRQ VIAAVKWAKA IPGFRNLHLD DQMTLLQYSW
     MFLMAFALGW RSYRQSSANL LCFAPDLIIN EQRMTLPCMY DQCKHMLYVS SELHRLQVSY
     EEYLCMKTLL LLSSVPKDGL KSQELFDEIR MTYIKELGKA IVKREGNSSQ NWQRFYQLTK
     LLDSMHENVM WLKPESTSHT LI
//
ID   E5KQF6_HUMAN            Unreviewed;       778 AA.
AC   E5KQF6;
DT   08-FEB-2011, integrated into UniProtKB/TrEMBL.
DT   08-FEB-2011, sequence version 1.
DT   23-MAY-2018, entry version 72.
DE   SubName: Full=Glucocorticoid receptor {ECO:0000313|EMBL:ADP91136.1};
DE   SubName: Full=Nuclear receptor subfamily 3, group C, member 1 (Glucocorticoid receptor), isoform CRA_a {ECO:0000313|EMBL:EAW61870.1};
GN   Name=NR3C1 {ECO:0000313|EMBL:EAW61870.1};
GN   ORFNames=hCG_37601 {ECO:0000313|EMBL:EAW61870.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:ADP91136.1};
RN   [1] {ECO:0000313|EMBL:EAW61870.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAW61870.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3] {ECO:0000313|EMBL:ADP91136.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=20843780; DOI=10.1093/nar/gkq750;
RA   Wang W., Shen P., Thiyagarajan S., Lin S., Palm C., Horvath R.,
RA   Klopstock T., Cutler D., Pique L., Schrijver I., Davis R.W.,
RA   Mindrinos M., Speed T.P., Scharfe C.;
RT   "Identification of rare DNA variants in mitochondrial disorders with
RT   improved array-based sequencing.";
RL   Nucleic Acids Res. 39:44-58(2011).
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000256|PROSITE-
CC       ProRule:PRU00407, ECO:0000256|RuleBase:RU004334,
CC       ECO:0000256|SAAS:SAAS01037405}.
CC   -!- SIMILARITY: Belongs to the nuclear hormone receptor family.
CC       {ECO:0000256|RuleBase:RU004334, ECO:0000256|SAAS:SAAS01037406}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; HQ205546; ADP91136.1; -; Genomic_DNA.
DR   EMBL; HQ205547; ADP91139.1; -; Genomic_DNA.
DR   EMBL; HQ205548; ADP91142.1; -; Genomic_DNA.
DR   EMBL; HQ205549; ADP91145.1; -; Genomic_DNA.
DR   EMBL; HQ205550; ADP91148.1; -; Genomic_DNA.
DR   EMBL; HQ205551; ADP91151.1; -; Genomic_DNA.
DR   EMBL; HQ205552; ADP91154.1; -; Genomic_DNA.
DR   EMBL; HQ205553; ADP91157.1; -; Genomic_DNA.
DR   EMBL; HQ205554; ADP91160.1; -; Genomic_DNA.
DR   EMBL; HQ205555; ADP91163.1; -; Genomic_DNA.
DR   EMBL; HQ205556; ADP91166.1; -; Genomic_DNA.
DR   EMBL; HQ205557; ADP91169.1; -; Genomic_DNA.
DR   EMBL; HQ205558; ADP91172.1; -; Genomic_DNA.
DR   EMBL; HQ205559; ADP91175.1; -; Genomic_DNA.
DR   EMBL; HQ205560; ADP91178.1; -; Genomic_DNA.
DR   EMBL; HQ205561; ADP91181.1; -; Genomic_DNA.
DR   EMBL; HQ205562; ADP91184.1; -; Genomic_DNA.
DR   EMBL; HQ205563; ADP91187.1; -; Genomic_DNA.
DR   EMBL; HQ205564; ADP91190.1; -; Genomic_DNA.
DR   EMBL; HQ205565; ADP91193.1; -; Genomic_DNA.
DR   EMBL; HQ205566; ADP91196.1; -; Genomic_DNA.
DR   EMBL; HQ205567; ADP91199.1; -; Genomic_DNA.
DR   EMBL; HQ205568; ADP91202.1; -; Genomic_DNA.
DR   EMBL; HQ205569; ADP91205.1; -; Genomic_DNA.
DR   EMBL; HQ205570; ADP91208.1; -; Genomic_DNA.
DR   EMBL; HQ205571; ADP91211.1; -; Genomic_DNA.
DR   EMBL; HQ205572; ADP91214.1; -; Genomic_DNA.
DR   EMBL; HQ205573; ADP91217.1; -; Genomic_DNA.
DR   EMBL; HQ205574; ADP91220.1; -; Genomic_DNA.
DR   EMBL; HQ205575; ADP91223.1; -; Genomic_DNA.
DR   EMBL; HQ205576; ADP91226.1; -; Genomic_DNA.
DR   EMBL; HQ205577; ADP91229.1; -; Genomic_DNA.
DR   EMBL; HQ205578; ADP91232.1; -; Genomic_DNA.
DR   EMBL; HQ205579; ADP91235.1; -; Genomic_DNA.
DR   EMBL; HQ205580; ADP91238.1; -; Genomic_DNA.
DR   EMBL; HQ205581; ADP91241.1; -; Genomic_DNA.
DR   EMBL; HQ205582; ADP91244.1; -; Genomic_DNA.
DR   EMBL; HQ205583; ADP91247.1; -; Genomic_DNA.
DR   EMBL; HQ205584; ADP91250.1; -; Genomic_DNA.
DR   EMBL; HQ205585; ADP91253.1; -; Genomic_DNA.
DR   EMBL; CH471062; EAW61870.1; -; Genomic_DNA.
DR   RefSeq; NP_001019265.1; NM_001024094.1.
DR   RefSeq; XP_005268476.1; XM_005268419.3.
DR   RefSeq; XP_005268477.1; XM_005268420.4.
DR   RefSeq; XP_005268479.1; XM_005268422.3.
DR   RefSeq; XP_005268480.1; XM_005268423.3.
DR   UniGene; Hs.122926; -.
DR   SMR; E5KQF6; -.
DR   PRIDE; E5KQF6; -.
DR   DNASU; 2908; -.
DR   GeneID; 2908; -.
DR   CTD; 2908; -.
DR   EuPathDB; HostDB:ENSG00000113580.14; -.
DR   eggNOG; KOG3575; Eukaryota.
DR   eggNOG; ENOG410XRZC; LUCA.
DR   OMA; QSTFDIL; -.
DR   OrthoDB; EOG091G02FB; -.
DR   ChiTaRS; NR3C1; human.
DR   GenomeRNAi; 2908; -.
DR   Bgee; ENSG00000113580; -.
DR   ExpressionAtlas; E5KQF6; baseline and differential.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0003700; F:DNA binding transcription factor activity; IEA:InterPro.
DR   GO; GO:0004883; F:glucocorticoid receptor activity; IEA:InterPro.
DR   GO; GO:0043565; F:sequence-specific DNA binding; IEA:InterPro.
DR   GO; GO:0005496; F:steroid binding; IEA:InterPro.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-UniRule.
DR   Gene3D; 3.30.50.10; -; 1.
DR   InterPro; IPR001409; Glcrtcd_rcpt.
DR   InterPro; IPR035500; NHR_like_dom_sf.
DR   InterPro; IPR000536; Nucl_hrmn_rcpt_lig-bd.
DR   InterPro; IPR001723; Nuclear_hrmn_rcpt.
DR   InterPro; IPR001628; Znf_hrmn_rcpt.
DR   InterPro; IPR013088; Znf_NHR/GATA.
DR   Pfam; PF02155; GCR; 1.
DR   Pfam; PF00104; Hormone_recep; 1.
DR   Pfam; PF00105; zf-C4; 1.
DR   PRINTS; PR00528; GLCORTICOIDR.
DR   PRINTS; PR00398; STRDHORMONER.
DR   PRINTS; PR00047; STROIDFINGER.
DR   SMART; SM00430; HOLI; 1.
DR   SMART; SM00399; ZnF_C4; 1.
DR   SUPFAM; SSF48508; SSF48508; 1.
DR   PROSITE; PS51843; NR_LBD; 1.
DR   PROSITE; PS00031; NUCLEAR_REC_DBD_1; 1.
DR   PROSITE; PS51030; NUCLEAR_REC_DBD_2; 1.
PE   3: Inferred from homology;
KW   Coiled coil {ECO:0000256|SAM:Coils};
KW   DNA-binding {ECO:0000256|PROSITE-ProRule:PRU00407,
KW   ECO:0000256|RuleBase:RU004334, ECO:0000256|SAAS:SAAS00517091};
KW   Metal-binding {ECO:0000256|PROSITE-ProRule:PRU00407,
KW   ECO:0000256|RuleBase:RU004334, ECO:0000256|SAAS:SAAS00517125};
KW   Nucleus {ECO:0000256|PROSITE-ProRule:PRU00407,
KW   ECO:0000256|RuleBase:RU004334, ECO:0000256|SAAS:SAAS01037386};
KW   Receptor {ECO:0000256|RuleBase:RU004334,
KW   ECO:0000256|SAAS:SAAS01037471, ECO:0000313|EMBL:ADP91136.1};
KW   Transcription {ECO:0000256|PROSITE-ProRule:PRU00407,
KW   ECO:0000256|RuleBase:RU004334, ECO:0000256|SAAS:SAAS01037387};
KW   Transcription regulation {ECO:0000256|PROSITE-ProRule:PRU00407,
KW   ECO:0000256|RuleBase:RU004334, ECO:0000256|SAAS:SAAS01037387};
KW   Zinc {ECO:0000256|PROSITE-ProRule:PRU00407,
KW   ECO:0000256|RuleBase:RU004334, ECO:0000256|SAAS:SAAS00517125};
KW   Zinc-finger {ECO:0000256|PROSITE-ProRule:PRU00407,
KW   ECO:0000256|RuleBase:RU004334, ECO:0000256|SAAS:SAAS00517125}.
FT   DOMAIN      418    494       Nuclear receptor.
FT                                {ECO:0000259|PROSITE:PS51030}.
FT   DOMAIN      525    759       NR LBD. {ECO:0000259|PROSITE:PS51843}.
FT   DNA_BIND    418    494       Nuclear receptor. {ECO:0000256|PROSITE-
FT                                ProRule:PRU00407}.
FT   COILED      112    132       {ECO:0000256|SAM:Coils}.
SQ   SEQUENCE   778 AA;  85815 MW;  23048D99B60B169C CRC64;
     MDSKESLTPG REENPSSVLA QERGDVMDFY KTLRGGATVK VSASSPSLAV ASQSDSKQRR
     LLVDFPKGSV SNAQQPDLSK AVSLSMGLYM GETETKVMGN DLGFPQQGQI SLSSGETDLK
     LLEESIANLN RSTSVPENPK SSASTAVSAA PTEKEFPKTH SDVSSEQQHL KGQTGTNGGN
     VKLYTTDQST FDILQDLEFS SGSPGKETNE SPWRSDLLID ENCLLSPLAG EDDSFLLEGN
     SNEDCKPLIL PDTKPKIKDN GDLVLSSPSN VTLPQVKTEK EDFIELCTPG VIKQEKLGTV
     YCQASFPGAN IIGNKMSAIS VHGVSTSGGQ MYHYDMNTAS LSQQQDQKPI FNVIPPIPVG
     SENWNRCQGS GDDNLTSLGT LNFPGRTVFS NGYSSPSMRP DVSSPPSSSS TATTGPPPKL
     CLVCSDEASG CHYGVLTCGS CKVFFKRAVE GRQHNYLCAG RNDCIIDKIR RKNCPACRYR
     KCLQAGMNLE ARKTKKKIKG IQQATTGVSQ ETSENPGNKT IVPATLPQLT PTLVSLLEVI
     EPEVLYAGYD SSVPDSTWRI MTTLNMLGGR QVIAAVKWAK AIPGFRNLHL DDQMTLLQYS
     WMFLMAFALG WRSYRQSSAN LLCFAPDLII NEQRMTLPCM YDQCKHMLYV SSELHRLQVS
     YEEYLCMKTL LLLSSVPKDG LKSQELFDEI RMTYIKELGK AIVKREGNSS QNWQRFYQLT
     KLLDSMHEVV ENLLNYCFQT FLDKTMSIEF PEMLAEIITN QIPKYSNGNI KKLLFHQK
//
ID   F1D8N4_HUMAN            Unreviewed;       777 AA.
AC   F1D8N4;
DT   03-MAY-2011, integrated into UniProtKB/TrEMBL.
DT   03-MAY-2011, sequence version 1.
DT   23-MAY-2018, entry version 62.
DE   SubName: Full=Glucocorticoid nuclear receptor variant 1 {ECO:0000313|EMBL:ADZ17333.1};
GN   Name=NR3C1 {ECO:0000313|EMBL:ADZ17333.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:ADZ17333.1};
RN   [1] {ECO:0000313|EMBL:ADZ17333.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Leukocyte {ECO:0000313|EMBL:ADZ17333.1};
RA   Kaighin V.A., Martin A.L., Aronstam R.S.;
RT   "Isolation of cDNA coding for multiple human nuclear receptor
RT   clones.";
RL   Submitted (DEC-2010) to the EMBL/GenBank/DDBJ databases.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000256|PROSITE-
CC       ProRule:PRU00407, ECO:0000256|RuleBase:RU004334,
CC       ECO:0000256|SAAS:SAAS01037405}.
CC   -!- SIMILARITY: Belongs to the nuclear hormone receptor family.
CC       {ECO:0000256|RuleBase:RU004334, ECO:0000256|SAAS:SAAS01037406}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; HQ692822; ADZ17333.1; -; mRNA.
DR   RefSeq; NP_000167.1; NM_000176.2.
DR   RefSeq; NP_001018084.1; NM_001018074.1.
DR   RefSeq; NP_001018085.1; NM_001018075.1.
DR   RefSeq; NP_001018086.1; NM_001018076.1.
DR   RefSeq; NP_001018087.1; NM_001018077.1.
DR   RefSeq; XP_016864886.1; XM_017009397.1.
DR   RefSeq; XP_016864887.1; XM_017009398.1.
DR   UniGene; Hs.122926; -.
DR   ProteinModelPortal; F1D8N4; -.
DR   SMR; F1D8N4; -.
DR   PRIDE; F1D8N4; -.
DR   DNASU; 2908; -.
DR   GeneID; 2908; -.
DR   KEGG; hsa:2908; -.
DR   CTD; 2908; -.
DR   EuPathDB; HostDB:ENSG00000113580.14; -.
DR   eggNOG; KOG3575; Eukaryota.
DR   eggNOG; ENOG410XRZC; LUCA.
DR   KO; K05771; -.
DR   PhylomeDB; F1D8N4; -.
DR   ChiTaRS; NR3C1; human.
DR   GenomeRNAi; 2908; -.
DR   Bgee; ENSG00000113580; -.
DR   ExpressionAtlas; F1D8N4; baseline and differential.
DR   Genevisible; F1D8N4; HS.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0003700; F:DNA binding transcription factor activity; IEA:InterPro.
DR   GO; GO:0004883; F:glucocorticoid receptor activity; IEA:InterPro.
DR   GO; GO:0043565; F:sequence-specific DNA binding; IEA:InterPro.
DR   GO; GO:0005496; F:steroid binding; IEA:InterPro.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-UniRule.
DR   Gene3D; 3.30.50.10; -; 1.
DR   InterPro; IPR001409; Glcrtcd_rcpt.
DR   InterPro; IPR035500; NHR_like_dom_sf.
DR   InterPro; IPR000536; Nucl_hrmn_rcpt_lig-bd.
DR   InterPro; IPR001723; Nuclear_hrmn_rcpt.
DR   InterPro; IPR001628; Znf_hrmn_rcpt.
DR   InterPro; IPR013088; Znf_NHR/GATA.
DR   Pfam; PF02155; GCR; 1.
DR   Pfam; PF00104; Hormone_recep; 1.
DR   Pfam; PF00105; zf-C4; 1.
DR   PRINTS; PR00528; GLCORTICOIDR.
DR   PRINTS; PR00398; STRDHORMONER.
DR   PRINTS; PR00047; STROIDFINGER.
DR   SMART; SM00430; HOLI; 1.
DR   SMART; SM00399; ZnF_C4; 1.
DR   SUPFAM; SSF48508; SSF48508; 1.
DR   PROSITE; PS51843; NR_LBD; 1.
DR   PROSITE; PS00031; NUCLEAR_REC_DBD_1; 1.
DR   PROSITE; PS51030; NUCLEAR_REC_DBD_2; 1.
PE   2: Evidence at transcript level;
KW   Coiled coil {ECO:0000256|SAM:Coils};
KW   DNA-binding {ECO:0000256|PROSITE-ProRule:PRU00407,
KW   ECO:0000256|RuleBase:RU004334, ECO:0000256|SAAS:SAAS00517091};
KW   Metal-binding {ECO:0000256|PROSITE-ProRule:PRU00407,
KW   ECO:0000256|RuleBase:RU004334, ECO:0000256|SAAS:SAAS00517125};
KW   Nucleus {ECO:0000256|PROSITE-ProRule:PRU00407,
KW   ECO:0000256|RuleBase:RU004334, ECO:0000256|SAAS:SAAS01037386};
KW   Receptor {ECO:0000256|RuleBase:RU004334,
KW   ECO:0000256|SAAS:SAAS01037471, ECO:0000313|EMBL:ADZ17333.1};
KW   Transcription {ECO:0000256|PROSITE-ProRule:PRU00407,
KW   ECO:0000256|RuleBase:RU004334, ECO:0000256|SAAS:SAAS01037387};
KW   Transcription regulation {ECO:0000256|PROSITE-ProRule:PRU00407,
KW   ECO:0000256|RuleBase:RU004334, ECO:0000256|SAAS:SAAS01037387};
KW   Zinc {ECO:0000256|PROSITE-ProRule:PRU00407,
KW   ECO:0000256|RuleBase:RU004334, ECO:0000256|SAAS:SAAS00517125};
KW   Zinc-finger {ECO:0000256|PROSITE-ProRule:PRU00407,
KW   ECO:0000256|RuleBase:RU004334, ECO:0000256|SAAS:SAAS00517125}.
FT   DOMAIN      418    493       Nuclear receptor.
FT                                {ECO:0000259|PROSITE:PS51030}.
FT   DOMAIN      524    758       NR LBD. {ECO:0000259|PROSITE:PS51843}.
FT   DNA_BIND    418    493       Nuclear receptor. {ECO:0000256|PROSITE-
FT                                ProRule:PRU00407}.
FT   COILED      112    132       {ECO:0000256|SAM:Coils}.
SQ   SEQUENCE   777 AA;  85659 MW;  C5C90C9A5DD16AAB CRC64;
     MDSKESLTPG REENPSSVLA QERGDVMDFY KTLRGGATVK VSASSPSLAV ASQSDSKQRR
     LLVDFPKGSV SNAQQPDLSK AVSLSMGLYM GETETKVMGN DLGFPQQGQI SLSSGETDLK
     LLEESIANLN RSTSVPENPK SSASTAVSAA PTEKEFPKTH SDVSSEQQHL KGQTGTNGGN
     VKLYTTDQST FDILQDLEFS SGSPGKETNE SPWRSDLLID ENCLLSPLAG EDDSFLLEGN
     SNEDCKPLIL PDTKPKIKDN GDLVLSSPSN VTLPQVKTEK EDFIELCTPG VIKQEKLGTV
     YCQASFPGAN IIGNKMSAIS VHGVSTSGGQ MYHYDMNTAS LSQQQDQKPI FNVIPPIPVG
     SENWNRCQGS GDDNLTSLGT LNFPGRTVFS NGYSSPSMRP DVSSPPSSSS TATTGPPPKL
     CLVCSDEASG CHYGVLTCGS CKVFFKRAVE GQHNYLCAGR NDCIIDKIRR KNCPACRYRK
     CLQAGMNLEA RKTKKKIKGI QQATTGVSQE TSENPGNKTI VPATLPQLTP TLVSLLEVIE
     PEVLYAGYDS SVPDSTWRIM TTLNMLGGRQ VIAAVKWAKA IPGFRNLHLD DQMTLLQYSW
     MFLMAFALGW RSYRQSSANL LCFAPDLIIN EQRMTLPCMY DQCKHMLYVS SELHRLQVSY
     EEYLCMKTLL LLSSVPKDGL KSQELFDEIR MTYIKELGKA IVKREGNSSQ NWQRFYQLTK
     LLDSMHEVVE NLLNYCFQTF LDKTMSIEFP EMLAEIITNQ IPKYSNGNIK KLLFHQK
//
ID   GCR_HUMAN               Reviewed;         777 AA.
AC   P04150; A0ZXF9; B0LPG8; D3DQF4; F5ATB7; P04151; Q53EP5; Q6N0A4;
DT   01-NOV-1986, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1986, sequence version 1.
DT   23-MAY-2018, entry version 249.
DE   RecName: Full=Glucocorticoid receptor;
DE            Short=GR;
DE   AltName: Full=Nuclear receptor subfamily 3 group C member 1;
GN   Name=NR3C1; Synonyms=GRL;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS ALPHA AND BETA).
RC   TISSUE=Fibroblast;
RX   PubMed=2867473; DOI=10.1038/318635a0;
RA   Hollenberg S.M., Weinberger C., Ong E.S., Cerelli G., Oro A., Lebo R.,
RA   Thompson E.B., Rosenfeld M.G., Evans R.M.;
RT   "Primary structure and expression of a functional human glucocorticoid
RT   receptor cDNA.";
RL   Nature 318:635-641(1985).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORMS ALPHA AND BETA).
RX   PubMed=1707881;
RA   Encio I.J., Detera-Wadleigh S.D.;
RT   "The genomic structure of the human glucocorticoid receptor.";
RL   J. Biol. Chem. 266:7182-7188(1991).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=20843780; DOI=10.1093/nar/gkq750;
RA   Wang W., Shen P., Thiyagarajan S., Lin S., Palm C., Horvath R.,
RA   Klopstock T., Cutler D., Pique L., Schrijver I., Davis R.W.,
RA   Mindrinos M., Speed T.P., Scharfe C.;
RT   "Identification of rare DNA variants in mitochondrial disorders with
RT   improved array-based sequencing.";
RL   Nucleic Acids Res. 39:44-58(2011).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 10).
RX   PubMed=17404046; DOI=10.1196/annals.1397.037;
RA   Turner J.D., Schote A.B., Keipes M., Muller C.P.;
RT   "A new transcript splice variant of the human glucocorticoid receptor:
RT   identification and tissue distribution of hGR Delta 313-338, an
RT   alternative exon 2 transactivation domain isoform.";
RL   Ann. N. Y. Acad. Sci. 1095:334-341(2007).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM ALPHA), VARIANTS ASP-72; ALA-321
RP   AND SER-766, AND CHARACTERIZATION OF VARIANTS ASP-72; ALA-321 AND
RP   SER-766.
RX   PubMed=21701417; DOI=10.1097/SHK.0b013e318228eca7;
RA   Tung K., Baker A.C., Amini A., Green T.L., Chew V.W., Lim D.,
RA   Nguyen S.T., Yee K.S., Cho K., Greenhalgh D.G.;
RT   "Novel hyperactive glucocorticoid receptor isoform identified within a
RT   human population.";
RL   Shock 36:339-344(2011).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM ALPHA-2).
RC   TISSUE=Osteosarcoma;
RA   Munroe D.G., Pang J., Taylor G.R., Lau C., Plante R.K., Zhou L.;
RT   "Alternative splicing within the DNA binding domain creates a novel
RT   isoform of the human glucocorticoid receptor.";
RL   Submitted (SEP-1993) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM ALPHA).
RC   TISSUE=Kidney;
RA   Totoki Y., Toyoda A., Takeda T., Sakaki Y., Tanaka A., Yokoyama S.;
RL   Submitted (APR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM ALPHA).
RC   TISSUE=Uterine endothelium;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS LYS-23 AND VAL-65.
RG   NIEHS SNPs program;
RL   Submitted (OCT-2003) to the EMBL/GenBank/DDBJ databases.
RN   [10]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RG   NHLBI resequencing and genotyping service (RS&G);
RL   Submitted (FEB-2007) to the EMBL/GenBank/DDBJ databases.
RN   [11]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15372022; DOI=10.1038/nature02919;
RA   Schmutz J., Martin J., Terry A., Couronne O., Grimwood J., Lowry S.,
RA   Gordon L.A., Scott D., Xie G., Huang W., Hellsten U., Tran-Gyamfi M.,
RA   She X., Prabhakar S., Aerts A., Altherr M., Bajorek E., Black S.,
RA   Branscomb E., Caoile C., Challacombe J.F., Chan Y.M., Denys M.,
RA   Detter J.C., Escobar J., Flowers D., Fotopulos D., Glavina T.,
RA   Gomez M., Gonzales E., Goodstein D., Grigoriev I., Groza M.,
RA   Hammon N., Hawkins T., Haydu L., Israni S., Jett J., Kadner K.,
RA   Kimball H., Kobayashi A., Lopez F., Lou Y., Martinez D., Medina C.,
RA   Morgan J., Nandkeshwar R., Noonan J.P., Pitluck S., Pollard M.,
RA   Predki P., Priest J., Ramirez L., Retterer J., Rodriguez A.,
RA   Rogers S., Salamov A., Salazar A., Thayer N., Tice H., Tsai M.,
RA   Ustaszewska A., Vo N., Wheeler J., Wu K., Yang J., Dickson M.,
RA   Cheng J.-F., Eichler E.E., Olsen A., Pennacchio L.A., Rokhsar D.S.,
RA   Richardson P., Lucas S.M., Myers R.M., Rubin E.M.;
RT   "The DNA sequence and comparative analysis of human chromosome 5.";
RL   Nature 431:268-274(2004).
RN   [12]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [13]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM ALPHA).
RC   TISSUE=Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [14]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-394.
RX   PubMed=2026589;
RA   Leclerc S., Xie B.X., Roy R., Govindan M.V.;
RT   "Purification of a human glucocorticoid receptor gene promoter-binding
RT   protein. Production of polyclonal antibodies against the purified
RT   factor.";
RL   J. Biol. Chem. 266:8711-8719(1991).
RN   [15]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-394.
RX   PubMed=1958537; DOI=10.1016/0960-0760(91)90197-D;
RA   Govindan M.V., Pothier F., Leclerc S., Palaniswami R., Xie B.;
RT   "Human glucocorticoid receptor gene promotor-homologous down
RT   regulation.";
RL   J. Steroid Biochem. Mol. Biol. 40:317-323(1991).
RN   [16]
RP   DOMAINS.
RX   PubMed=3841189; DOI=10.1038/318670a0;
RA   Weinberger C., Hollenberg S.M., Rosenfeld M.G., Evans R.M.;
RT   "Domain structure of human glucocorticoid receptor and its
RT   relationship to the v-erb-A oncogene product.";
RL   Nature 318:670-672(1985).
RN   [17]
RP   ALTERNATIVE SPLICING (ISOFORMS GR-P; GR-A ALPHA AND GR-A BETA).
RX   PubMed=8358712;
RA   Moalli P.A., Pillay S., Krett N.L., Rosen S.T.;
RT   "Alternatively spliced glucocorticoid receptor messenger RNAs in
RT   glucocorticoid-resistant human multiple myeloma cells.";
RL   Cancer Res. 53:3877-3879(1993).
RN   [18]
RP   FUNCTION (ISOFORM BETA), AND TISSUE SPECIFICITY (ISOFORM BETA).
RX   PubMed=7769088; DOI=10.1172/JCI117943;
RA   Bamberger C.M., Bamberger A.M., de Castro M., Chrousos G.P.;
RT   "Glucocorticoid receptor beta, a potential endogenous inhibitor of
RT   glucocorticoid action in humans.";
RL   J. Clin. Invest. 95:2435-2441(1995).
RN   [19]
RP   FUNCTION (ISOFORM BETA), SUBCELLULAR LOCATION (ISOFORMS ALPHA AND
RP   BETA), AND TISSUE SPECIFICITY (ISOFORM BETA).
RX   PubMed=8621628; DOI=10.1074/jbc.271.16.9550;
RA   Oakley R.H., Sar M., Cidlowski J.A.;
RT   "The human glucocorticoid receptor beta isoform. Expression,
RT   biochemical properties, and putative function.";
RL   J. Biol. Chem. 271:9550-9559(1996).
RN   [20]
RP   INTERACTION WITH HNRNPU.
RX   PubMed=9353307;
RA   Eggert M., Michel J., Schneider S., Bornfleth H., Baniahmad A.,
RA   Fackelmayer F.O., Schmidt S., Renkawitz R.;
RT   "The glucocorticoid receptor is associated with the RNA-binding
RT   nuclear matrix protein hnRNP U.";
RL   J. Biol. Chem. 272:28471-28478(1997).
RN   [21]
RP   INTERACTION WITH TADA2L AND THE ADA COMPLEX, AND MUTAGENESIS OF
RP   PHE-191; ILE-193; LEU-194; LEU-197; TRP-213; LEU-224; LEU-225; PHE-235
RP   AND LEU-236.
RX   PubMed=9154805; DOI=10.1128/MCB.17.6.3065;
RA   Henriksson A., Almloef T., Ford J., McEwan I.J., Gustafsson J.-A.,
RA   Wright A.P.H.;
RT   "Role of the Ada adaptor complex in gene activation by the
RT   glucocorticoid receptor.";
RL   Mol. Cell. Biol. 17:3065-3073(1997).
RN   [22]
RP   FUNCTION, AND INTERACTION WITH THE SMARCA4 COMPLEX; NCOA1; NCOA2 AND
RP   THE CREBBP/EP300 COMPLEX.
RX   PubMed=9590696; DOI=10.1038/30032;
RA   Fryer C.J., Archer T.K.;
RT   "Chromatin remodelling by the glucocorticoid receptor requires the
RT   BRG1 complex.";
RL   Nature 393:88-91(1998).
RN   [23]
RP   INTERACTION WITH BAG1.
RX   PubMed=10477749; DOI=10.1083/jcb.146.5.929;
RA   Schneikert J., Huebner S., Martin E., Cato A.B.C.;
RT   "A nuclear action of the eukaryotic cochaperone RAP46 in
RT   downregulation of glucocorticoid receptor activity.";
RL   J. Cell Biol. 146:929-940(1999).
RN   [24]
RP   ALTERNATIVE SPLICING (ISOFORMS ALPHA-2 AND BETA-2).
RX   PubMed=10566686; DOI=10.1210/jcem.84.11.6235;
RA   Rivers C., Levy A., Hancock J., Lightman S., Norman M.;
RT   "Insertion of an amino acid in the DNA-binding domain of the
RT   glucocorticoid receptor as a result of alternative splicing.";
RL   J. Clin. Endocrinol. Metab. 84:4283-4286(1999).
RN   [25]
RP   TISSUE SPECIFICITY.
RX   PubMed=10902803; DOI=10.1210/jcem.85.7.6663;
RA   Kayes-Wandover K.M., White P.C.;
RT   "Steroidogenic enzyme gene expression in the human heart.";
RL   J. Clin. Endocrinol. Metab. 85:2519-2525(2000).
RN   [26]
RP   INTERACTION WITH NCOA6.
RX   PubMed=10866662; DOI=10.1128/MCB.20.14.5048-5063.2000;
RA   Mahajan M.A., Samuels H.H.;
RT   "A new family of nuclear receptor coregulators that integrates nuclear
RT   receptor signaling through CBP.";
RL   Mol. Cell. Biol. 20:5048-5063(2000).
RN   [27]
RP   EFFECT ON EXPANDED POLYGLUTAMINE PROTEIN.
RX   PubMed=10639135; DOI=10.1073/pnas.97.2.657;
RA   Diamond M.I., Robinson M.R., Yamamoto K.R.;
RT   "Regulation of expanded polyglutamine protein aggregation and nuclear
RT   localization by the glucocorticoid receptor.";
RL   Proc. Natl. Acad. Sci. U.S.A. 97:657-661(2000).
RN   [28]
RP   FUNCTION (ISOFORM GR-P).
RX   PubMed=11358809;
RA   de Lange P., Segeren C.M., Koper J.W., Wiemer E., Sonneveld P.,
RA   Brinkmann A.O., White A., Brogan I.J., de Jong F.H., Lamberts S.W.;
RT   "Expression in hematological malignancies of a glucocorticoid receptor
RT   splice variant that augments glucocorticoid receptor-mediated effects
RT   in transfected cells.";
RL   Cancer Res. 61:3937-3941(2001).
RN   [29]
RP   GLUCOCORTICOID-MEDIATED DOWN-REGULATION.
RX   PubMed=11555652; DOI=10.1074/jbc.M106033200;
RA   Wallace A.D., Cidlowski J.A.;
RT   "Proteasome-mediated glucocorticoid receptor degradation restricts
RT   transcriptional signaling by glucocorticoids.";
RL   J. Biol. Chem. 276:42714-42721(2001).
RN   [30]
RP   REDUCTION OF CELL DEATH IN RESPONSE TO CORTICOSTEROIDS.
RX   PubMed=11238589; DOI=10.1084/jem.193.5.585;
RA   Strickland I., Kisich K., Hauk P.J., Vottero A., Chrousos G.P.,
RA   Klemm D.J., Leung D.Y.M.;
RT   "High constitutive glucocorticoid receptor beta in human neutrophils
RT   enables them to reduce their spontaneous rate of cell death in
RT   response to corticosteroids.";
RL   J. Exp. Med. 193:585-593(2001).
RN   [31]
RP   FUNCTION (ISOFORMS ALPHA AND ALPHA-B), ALTERNATIVE INITIATION, AND
RP   MUTAGENESIS OF MET-1 AND MET-27.
RX   PubMed=11435610; DOI=10.1210/mend.15.7.0667;
RA   Yudt M.R., Cidlowski J.A.;
RT   "Molecular identification and characterization of A and B forms of the
RT   glucocorticoid receptor.";
RL   Mol. Endocrinol. 15:1093-1103(2001).
RN   [32]
RP   INDUCTION (ISOFORMS ALPHA AND BETA).
RX   PubMed=11381138; DOI=10.1073/pnas.121455098;
RA   Webster J.C., Oakley R.H., Jewell C.M., Cidlowski J.A.;
RT   "Proinflammatory cytokines regulate human glucocorticoid receptor gene
RT   expression and lead to the accumulation of the dominant negative beta
RT   isoform: a mechanism for the generation of glucocorticoid
RT   resistance.";
RL   Proc. Natl. Acad. Sci. U.S.A. 98:6865-6870(2001).
RN   [33]
RP   SUMOYLATION, AND MUTAGENESIS OF LYS-277; LYS-293 AND LYS-703.
RX   PubMed=12144530; DOI=10.1042/BJ20021085;
RA   Tian S., Poukka H., Palvimo J.J., Jaenne O.A.;
RT   "Small ubiquitin-related modifier-1 (SUMO-1) modification of the
RT   glucocorticoid receptor.";
RL   Biochem. J. 367:907-911(2002).
RN   [34]
RP   PHOSPHORYLATION AT SER-203 AND SER-211.
RX   PubMed=12000743; DOI=10.1074/jbc.M110530200;
RA   Wang Z., Frederick J., Garabedian M.J.;
RT   "Deciphering the phosphorylation 'code' of the glucocorticoid receptor
RT   in vivo.";
RL   J. Biol. Chem. 277:26573-26580(2002).
RN   [35]
RP   INTERACTION WITH PELP1.
RX   PubMed=12415108; DOI=10.1073/pnas.192569699;
RA   Wong C.-W., McNally C., Nickbarg E., Komm B.S., Cheskis B.J.;
RT   "Estrogen receptor-interacting protein that modulates its nongenomic
RT   activity-crosstalk with Src/Erk phosphorylation cascade.";
RL   Proc. Natl. Acad. Sci. U.S.A. 99:14783-14788(2002).
RN   [36]
RP   REVIEW ON ALTERNATIVE SPLICING, AND ALTERNATIVE INITIATION.
RX   PubMed=15265776; DOI=10.1196/annals.1321.008;
RA   Lu N.Z., Cidlowski J.A.;
RT   "The origin and functions of multiple human glucocorticoid receptor
RT   isoforms.";
RL   Ann. N. Y. Acad. Sci. 1024:102-123(2004).
RN   [37]
RP   INTERACTION WITH TGFB1I1.
RX   PubMed=15211577; DOI=10.1002/jcb.20109;
RA   Guerrero-Santoro J., Yang L., Stallcup M.R., DeFranco D.B.;
RT   "Distinct LIM domains of Hic-5/ARA55 are required for nuclear matrix
RT   targeting and glucocorticoid receptor binding and coactivation.";
RL   J. Cell. Biochem. 92:810-819(2004).
RN   [38]
RP   FUNCTION (ISOFORMS ALPHA; ALPHA-B; ALPHA-C1; ALPHA-C2; ALPHA-C3;
RP   ALPHA-D1; ALPHA-D2 AND ALPHA-D3), SUBCELLULAR LOCATION (ISOFORM
RP   ALPHA-B), ALTERNATIVE INITIATION (ISOFORMS ALPHA; ALPHA-B; ALPHA-C1;
RP   ALPHA-C2; ALPHA-C3; ALPHA-D1; ALPHA-D2 AND ALPHA-D3), AND MUTAGENESIS
RP   OF MET-1; MET-27; MET-86; MET-90; MET-98; MET-316; MET-331 AND
RP   MET-336.
RX   PubMed=15866175; DOI=10.1016/j.molcel.2005.03.025;
RA   Lu N.Z., Cidlowski J.A.;
RT   "Translational regulatory mechanisms generate N-terminal
RT   glucocorticoid receptor isoforms with unique transcriptional target
RT   genes.";
RL   Mol. Cell 18:331-342(2005).
RN   [39]
RP   INTERACTION WITH NR4A3.
RX   PubMed=15591535; DOI=10.1210/me.2004-0333;
RA   Martens C., Bilodeau S., Maira M., Gauthier Y., Drouin J.;
RT   "Protein-protein interactions and transcriptional antagonism between
RT   the subfamily of NGFI-B/Nur77 orphan nuclear receptors and
RT   glucocorticoid receptor.";
RL   Mol. Endocrinol. 19:885-897(2005).
RN   [40]
RP   INTERACTION WITH HEXIM1.
RX   PubMed=15941832; DOI=10.1073/pnas.0409863102;
RA   Shimizu N., Ouchida R., Yoshikawa N., Hisada T., Watanabe H.,
RA   Okamoto K., Kusuhara M., Handa H., Morimoto C., Tanaka H.;
RT   "HEXIM1 forms a transcriptionally abortive complex with glucocorticoid
RT   receptor without involving 7SK RNA and positive transcription
RT   elongation factor b.";
RL   Proc. Natl. Acad. Sci. U.S.A. 102:8555-8560(2005).
RN   [41]
RP   INTERACTION WITH UNC45A.
RX   PubMed=16478993; DOI=10.1128/MCB.26.5.1722-1730.2006;
RA   Chadli A., Graham J.D., Abel M.G., Jackson T.A., Gordon D.F.,
RA   Wood W.M., Felts S.J., Horwitz K.B., Toft D.;
RT   "GCUNC-45 is a novel regulator for the progesterone receptor/hsp90
RT   chaperoning pathway.";
RL   Mol. Cell. Biol. 26:1722-1730(2006).
RN   [42]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=16964243; DOI=10.1038/nbt1240;
RA   Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
RT   "A probability-based approach for high-throughput protein
RT   phosphorylation analysis and site localization.";
RL   Nat. Biotechnol. 24:1285-1292(2006).
RN   [43]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [44]
RP   INTERACTION WITH GSK3B, SUBCELLULAR LOCATION (ISOFORM ALPHA),
RP   PHOSPHORYLATION AT SER-404, MUTAGENESIS OF SER-404, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY.
RX   PubMed=18838540; DOI=10.1128/MCB.00808-08;
RA   Galliher-Beckley A.J., Williams J.G., Collins J.B., Cidlowski J.A.;
RT   "Glycogen synthase kinase 3beta-mediated serine phosphorylation of the
RT   human glucocorticoid receptor redirects gene expression profiles.";
RL   Mol. Cell. Biol. 28:7309-7322(2008).
RN   [45]
RP   PHOSPHORYLATION AT SER-203; SER-211 AND SER-226, AND MUTAGENESIS OF
RP   SER-211 AND SER-226.
RX   PubMed=18483179; DOI=10.1210/me.2007-0219;
RA   Chen W., Dang T., Blind R.D., Wang Z., Cavasotto C.N., Hittelman A.B.,
RA   Rogatsky I., Logan S.K., Garabedian M.J.;
RT   "Glucocorticoid receptor phosphorylation differentially affects target
RT   gene expression.";
RL   Mol. Endocrinol. 22:1754-1766(2008).
RN   [46]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-134; SER-226 AND
RP   SER-267, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [47]
RP   FUNCTION (ISOFORMS ALPHA AND BETA), AND SUBCELLULAR LOCATION (ISOFORM
RP   BETA).
RX   PubMed=19248771; DOI=10.1016/j.bbrc.2009.02.110;
RA   Kino T., Manoli I., Kelkar S., Wang Y., Su Y.A., Chrousos G.P.;
RT   "Glucocorticoid receptor (GR) beta has intrinsic, GRalpha-independent
RT   transcriptional activity.";
RL   Biochem. Biophys. Res. Commun. 381:671-675(2009).
RN   [48]
RP   FUNCTION (ISOFORM ALPHA), ACETYLATION AT LYS-480; LYS-492; LYS-494 AND
RP   LYS-495, MUTAGENESIS OF LYS-480; LYS-492; LYS-494 AND LYS-495, AND
RP   INTERACTION WITH CLOCK.
RX   PubMed=19141540; DOI=10.1096/fj.08-117697;
RA   Nader N., Chrousos G.P., Kino T.;
RT   "Circadian rhythm transcription factor CLOCK regulates the
RT   transcriptional activity of the glucocorticoid receptor by acetylating
RT   its hinge region lysine cluster: potential physiological
RT   implications.";
RL   FASEB J. 23:1572-1583(2009).
RN   [49]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [50]
RP   FUNCTION (ISOFORMS ALPHA; BETA; ALPHA-2 AND 10).
RX   PubMed=20484466; DOI=10.1210/en.2009-1254;
RA   Taniguchi Y., Iwasaki Y., Tsugita M., Nishiyama M., Taguchi T.,
RA   Okazaki M., Nakayama S., Kambayashi M., Hashimoto K., Terada Y.;
RT   "Glucocorticoid receptor-beta and receptor-gamma exert dominant
RT   negative effect on gene repression but not on gene induction.";
RL   Endocrinology 151:3204-3213(2010).
RN   [51]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [52]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [53]
RP   FUNCTION (ISOFORM ALPHA), AND SUBCELLULAR LOCATION (ISOFORM ALPHA).
RX   PubMed=21664385; DOI=10.1016/j.bbamcr.2011.05.014;
RA   Psarra A.M., Sekeris C.E.;
RT   "Glucocorticoids induce mitochondrial gene transcription in HepG2
RT   cells: role of the mitochondrial glucocorticoid receptor.";
RL   Biochim. Biophys. Acta 1813:1814-1821(2011).
RN   [54]
RP   SUBUNIT.
RX   PubMed=21730050; DOI=10.1074/jbc.M111.256610;
RA   Gallo L.I., Lagadari M., Piwien-Pilipuk G., Galigniana M.D.;
RT   "The 90-kDa heat-shock protein (Hsp90)-binding immunophilin FKBP51 is
RT   a mitochondrial protein that translocates to the nucleus to protect
RT   cells against oxidative stress.";
RL   J. Biol. Chem. 286:30152-30160(2011).
RN   [55]
RP   INTERACTION WITH CRY1 AND CRY2.
RX   PubMed=22170608; DOI=10.1038/nature10700;
RA   Lamia K.A., Papp S.J., Yu R.T., Barish G.D., Uhlenhaut N.H.,
RA   Jonker J.W., Downes M., Evans R.M.;
RT   "Cryptochromes mediate rhythmic repression of the glucocorticoid
RT   receptor.";
RL   Nature 480:552-556(2011).
RN   [56]
RP   ACETYLATION, AND INTERACTION WITH CLOCK.
RX   PubMed=21980503; DOI=10.1371/journal.pone.0025612;
RA   Charmandari E., Chrousos G.P., Lambrou G.I., Pavlaki A., Koide H.,
RA   Ng S.S., Kino T.;
RT   "Peripheral CLOCK regulates target-tissue glucocorticoid receptor
RT   transcriptional activity in a circadian fashion in man.";
RL   PLoS ONE 6:E25612-E25612(2011).
RN   [57]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1 (ISOFORMS ALPHA-B AND
RP   BETA-B), AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [58]
RP   FUNCTION (ISOFORMS ALPHA; ALPHA-C3 AND ALPHA-D3).
RX   PubMed=23303127; DOI=10.1038/cddis.2012.193;
RA   Wu I., Shin S.C., Cao Y., Bender I.K., Jafari N., Feng G., Lin S.,
RA   Cidlowski J.A., Schleimer R.P., Lu N.Z.;
RT   "Selective glucocorticoid receptor translational isoforms reveal
RT   glucocorticoid-induced apoptotic transcriptomes.";
RL   Cell Death Dis. 4:E453-E453(2013).
RN   [59]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-8; SER-45 AND SER-267,
RP   AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [60]
RP   MUTAGENESIS OF LYS-703.
RX   PubMed=23508108; DOI=10.1128/MCB.01470-12;
RA   Druker J., Liberman A.C., Antunica-Noguerol M., Gerez J.,
RA   Paez-Pereda M., Rein T., Iniguez-Lluhi J.A., Holsboer F., Arzt E.;
RT   "RSUME enhances glucocorticoid receptor SUMOylation and
RT   transcriptional activity.";
RL   Mol. Cell. Biol. 33:2116-2127(2013).
RN   [61]
RP   FUNCTION (ISOFORMS ALPHA; ALPHA-C3 AND ALPHA-D3), AND MUTAGENESIS OF
RP   ASP-101; 106-GLN-GLN-107 AND 113-SER-SER-114.
RX   PubMed=23820903; DOI=10.1210/me.2013-1009;
RA   Bender I.K., Cao Y., Lu N.Z.;
RT   "Determinants of the heightened activity of glucocorticoid receptor
RT   translational isoforms.";
RL   Mol. Endocrinol. 27:1577-1587(2013).
RN   [62]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-203, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [63]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-293, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25114211; DOI=10.1073/pnas.1413825111;
RA   Impens F., Radoshevich L., Cossart P., Ribet D.;
RT   "Mapping of SUMO sites and analysis of SUMOylation changes induced by
RT   external stimuli.";
RL   Proc. Natl. Acad. Sci. U.S.A. 111:12432-12437(2014).
RN   [64]
RP   FUNCTION (ISOFORM BETA), AND SUBCELLULAR LOCATION (ISOFORM BETA).
RX   PubMed=26711253; DOI=10.1128/MCB.00908-15;
RA   He B., Cruz-Topete D., Oakley R.H., Xiao X., Cidlowski J.A.;
RT   "Human Glucocorticoid Receptor beta (hGRbeta) Regulates
RT   Gluconeogenesis and Inflammation in Mouse Liver.";
RL   Mol. Cell. Biol. 36:714-730(2015).
RN   [65]
RP   FUNCTION, AND INTERACTION WITH PNRC2.
RX   PubMed=25775514; DOI=10.1073/pnas.1409612112;
RA   Cho H., Park O.H., Park J., Ryu I., Kim J., Ko J., Kim Y.K.;
RT   "Glucocorticoid receptor interacts with PNRC2 in a ligand-dependent
RT   manner to recruit UPF1 for rapid mRNA degradation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 112:E1540-E1549(2015).
RN   [66]
RP   FUNCTION (ISOFORM ALPHA), SUBCELLULAR LOCATION (ISOFORM ALPHA), TISSUE
RP   SPECIFICITY, DOMAIN, AND PHOSPHORYLATION AT SER-203 AND SER-211.
RX   PubMed=25847991; DOI=10.1073/pnas.1411356112;
RA   Matthews L.C., Berry A.A., Morgan D.J., Poolman T.M., Bauer K.,
RA   Kramer F., Spiller D.G., Richardson R.V., Chapman K.E., Farrow S.N.,
RA   Norman M.R., Williamson A.J., Whetton A.D., Taylor S.S.,
RA   Tuckermann J.P., White M.R., Ray D.W.;
RT   "Glucocorticoid receptor regulates accurate chromosome segregation and
RT   is associated with malignancy.";
RL   Proc. Natl. Acad. Sci. U.S.A. 112:5479-5484(2015).
RN   [67]
RP   INTERACTION WITH FNIP1 AND FNIP2.
RX   PubMed=27353360; DOI=10.1038/ncomms12037;
RA   Woodford M.R., Dunn D.M., Blanden A.R., Capriotti D., Loiselle D.,
RA   Prodromou C., Panaretou B., Hughes P.F., Smith A., Ackerman W.,
RA   Haystead T.A., Loh S.N., Bourboulia D., Schmidt L.S.,
RA   Marston Linehan W., Bratslavsky G., Mollapour M.;
RT   "The FNIP co-chaperones decelerate the Hsp90 chaperone cycle and
RT   enhance drug binding.";
RL   Nat. Commun. 7:12037-12037(2016).
RN   [68]
RP   IDENTIFICATION IN A COMPLEX WITH HSP90; HSP70; CDC37; PPP5C; TSC1;
RP   TSC2; AKT; CDK4 AND RAF1.
RX   PubMed=29127155; DOI=10.15252/embj.201796700;
RA   Woodford M.R., Sager R.A., Marris E., Dunn D.M., Blanden A.R.,
RA   Murphy R.L., Rensing N., Shapiro O., Panaretou B., Prodromou C.,
RA   Loh S.N., Gutmann D.H., Bourboulia D., Bratslavsky G., Wong M.,
RA   Mollapour M.;
RT   "Tumor suppressor Tsc1 is a new Hsp90 co-chaperone that facilitates
RT   folding of kinase and non-kinase clients.";
RL   EMBO J. 36:3650-3665(2017).
RN   [69]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-258 AND LYS-277, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-
RT   modification with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
RN   [70]
RP   X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS) OF 521-777 OF MUTANT SER-602 IN
RP   COMPLEX WITH NCOA2; DEXAMETHASONE AND RU-486, AND MUTAGENESIS OF
RP   ARG-585; ASP-590; PHE-602; PRO-625 AND ILE-628.
RX   PubMed=12151000; DOI=10.1016/S0092-8674(02)00817-6;
RA   Bledsoe R.K., Montana V.G., Stanley T.B., Delves C.J., Apolito C.J.,
RA   McKee D.D., Consler T.G., Parks D.J., Stewart E.L., Willson T.M.,
RA   Lambert M.H., Moore J.T., Pearce K.H., Xu H.E.;
RT   "Crystal structure of the glucocorticoid receptor ligand binding
RT   domain reveals a novel mode of receptor dimerization and coactivator
RT   recognition.";
RL   Cell 110:93-105(2002).
RN   [71]
RP   X-RAY CRYSTALLOGRAPHY (2.3 ANGSTROMS) OF 500-777 OF MUTANT SER-602 IN
RP   COMPLEX WITH COACTIVATOR PEPTIDE; DEXAMETHASONE AND WITH RU-486.
RX   PubMed=12686538; DOI=10.1074/jbc.M212711200;
RA   Kauppi B., Jakob C., Faernegaardh M., Yang J., Ahola H., Alarcon M.,
RA   Calles K., Engstrom O., Harlan J., Muchmore S., Ramqvist A.-K.,
RA   Thorell S., Oehman L., Greer J., Gustafsson J.-A., Carlstedt-Duke J.,
RA   Carlquist M.;
RT   "The three-dimensional structures of antagonistic and agonistic forms
RT   of the glucocorticoid receptor ligand-binding domain: RU-486 induces a
RT   transconformation that leads to active antagonism.";
RL   J. Biol. Chem. 278:22748-22754(2003).
RN   [72]
RP   CHARACTERIZATION OF VARIANT GCCR VAL-641.
RX   PubMed=1704018; DOI=10.1172/JCI115046;
RA   Hurley D.M., Accili D., Stratakis C.A., Karl M., Vamvakopoulos N.,
RA   Rorer E., Constantine K., Taylor S.I., Chrousos G.P.;
RT   "Point mutation causing a single amino acid substitution in the
RT   hormone binding domain of the glucocorticoid receptor in familial
RT   glucocorticoid resistance.";
RL   J. Clin. Invest. 87:680-686(1991).
RN   [73]
RP   VARIANTS TYR-421 AND PHE-753.
RX   PubMed=8358735;
RA   Powers J.H., Hillmann A.G., Tang D.C., Harmon J.M.;
RT   "Cloning and expression of mutant glucocorticoid receptors from
RT   glucocorticoid-sensitive and -resistant human leukemic cells.";
RL   Cancer Res. 53:4059-4065(1993).
RN   [74]
RP   VARIANT SER-363.
RX   PubMed=8445027; DOI=10.1210/jcem.76.3.8445027;
RA   Karl M., Lamberts S.W.J., Detera-Wadleigh S.D., Encio I.J.,
RA   Stratakis C.A., Hurley D.M., Accili D., Chrousos G.P.;
RT   "Familial glucocorticoid resistance caused by a splice site deletion
RT   in the human glucocorticoid receptor gene.";
RL   J. Clin. Endocrinol. Metab. 76:683-689(1993).
RN   [75]
RP   VARIANT GCCR ILE-729.
RX   PubMed=7683692; DOI=10.1172/JCI116410;
RA   Malchoff D.M., Brufsky A., Reardon G., McDermott P., Javier E.C.,
RA   Bergh C.H., Rowe D., Malchoff C.D.;
RT   "A mutation of the glucocorticoid receptor in primary cortisol
RT   resistance.";
RL   J. Clin. Invest. 91:1918-1925(1993).
RN   [76]
RP   VARIANT PHE-753.
RX   PubMed=8316249; DOI=10.1210/mend.7.5.8316249;
RA   Ashraf J., Thompson E.B.;
RT   "Identification of the activation-labile gene: a single point mutation
RT   in the human glucocorticoid receptor presents as two distinct receptor
RT   phenotypes.";
RL   Mol. Endocrinol. 7:631-642(1993).
RN   [77]
RP   VARIANTS LYS-23 AND SER-363.
RX   PubMed=9150737; DOI=10.1007/s004390050425;
RA   Koper J.W., Stolk R.P., de Lange P., Huizenga N.A.T.M., Molijn G.-J.,
RA   Pols H.A.P., Grobbee D.E., Karl M., de Jong F.H., Brinkmann A.O.,
RA   Lamberts S.W.J.;
RT   "Lack of association between five polymorphisms in the human
RT   glucocorticoid receptor gene and glucocorticoid resistance.";
RL   Hum. Genet. 99:663-668(1997).
RN   [78]
RP   VARIANTS LYS-23; VAL-65 AND SER-363.
RX   PubMed=10391209; DOI=10.1038/10290;
RA   Cargill M., Altshuler D., Ireland J., Sklar P., Ardlie K., Patil N.,
RA   Shaw N., Lane C.R., Lim E.P., Kalyanaraman N., Nemesh J., Ziaugra L.,
RA   Friedland L., Rolfe A., Warrington J., Lipshutz R., Daley G.Q.,
RA   Lander E.S.;
RT   "Characterization of single-nucleotide polymorphisms in coding regions
RT   of human genes.";
RL   Nat. Genet. 22:231-238(1999).
RN   [79]
RP   ERRATUM.
RA   Cargill M., Altshuler D., Ireland J., Sklar P., Ardlie K., Patil N.,
RA   Shaw N., Lane C.R., Lim E.P., Kalyanaraman N., Nemesh J., Ziaugra L.,
RA   Friedland L., Rolfe A., Warrington J., Lipshutz R., Daley G.Q.,
RA   Lander E.S.;
RL   Nat. Genet. 23:373-373(1999).
RN   [80]
RP   VARIANTS LYS-23; LEU-29; PHE-112; ASN-233 AND SER-363.
RX   PubMed=10898924;
RX   DOI=10.1002/1096-8628(20000612)96:3<412::AID-AJMG33>3.0.CO;2-C;
RA   Feng J., Zheng J., Bennett W.P., Heston L.L., Jones I.R., Craddock N.,
RA   Sommer S.S.;
RT   "Five missense variants in the amino-terminal domain of the
RT   glucocorticoid receptor: no association with puerperal psychosis or
RT   schizophrenia.";
RL   Am. J. Med. Genet. 96:412-417(2000).
RN   [81]
RP   VARIANTS GCCR HIS-477 AND SER-679.
RX   PubMed=11589680; DOI=10.1046/j.1365-2265.2001.01323.x;
RA   Ruiz M., Lind U., Gaafvels M., Eggertsen G., Carlstedt-Duke J.,
RA   Nilsson L., Holtmann M., Stierna P., Wikstroem A.-C., Werner S.;
RT   "Characterization of two novel mutations in the glucocorticoid
RT   receptor gene in patients with primary cortisol resistance.";
RL   Clin. Endocrinol. (Oxf.) 55:363-371(2001).
RN   [82]
RP   VARIANT SER-363.
RX   PubMed=11344238; DOI=10.1210/jcem.86.5.7465;
RA   Dobson M.G., Redfern C.P.F., Unwin N., Weaver J.U.;
RT   "The N363S polymorphism of the glucocorticoid receptor: potential
RT   contribution to central obesity in men and lack of association with
RT   other risk factors for coronary heart disease and diabetes mellitus.";
RL   J. Clin. Endocrinol. Metab. 86:2270-2274(2001).
RN   [83]
RP   CHARACTERIZATION OF VARIANT GCCR ASN-559.
RX   PubMed=11701741; DOI=10.1210/jcem.86.11.8017;
RA   Kino T., Stauber R.H., Resau J.H., Pavlakis G.N., Chrousos G.P.;
RT   "Pathologic human GR mutant has a transdominant negative effect on the
RT   wild-type GR by inhibiting its translocation into the nucleus:
RT   importance of the ligand-binding domain for intracellular GR
RT   trafficking.";
RL   J. Clin. Endocrinol. Metab. 86:5600-5608(2001).
RN   [84]
RP   VARIANT LYS-23.
RX   PubMed=12351458; DOI=10.2337/diabetes.51.10.3128;
RA   van Rossum E.F.C., Koper J.W., Huizenga N.A.T.M., Uitterlinden A.G.,
RA   Janssen J.A.M.J.L., Brinkmann A.O., Grobbee D.E., de Jong F.H.,
RA   van Duyn C.M., Pols H.A.P., Lamberts S.W.J.;
RT   "A polymorphism in the glucocorticoid receptor gene, which decreases
RT   sensitivity to glucocorticoids in vivo, is associated with low insulin
RT   and cholesterol levels.";
RL   Diabetes 51:3128-3134(2002).
RN   [85]
RP   VARIANT PSEUDOHERMAPHRODITISM ALA-571.
RX   PubMed=11932321; DOI=10.1210/jcem.87.4.8379;
RA   Mendonca B.B., Leite M.V., de Castro M., Kino T., Elias L.L.K.,
RA   Bachega T.A.S., Arnhold I.J.P., Chrousos G.P., Latronico A.C.;
RT   "Female pseudohermaphroditism caused by a novel homozygous missense
RT   mutation of the GR gene.";
RL   J. Clin. Endocrinol. Metab. 87:1805-1809(2002).
RN   [86]
RP   VARIANT GCCR MET-747, AND ALTERED INTERACTION WITH THE COACTIVATOR
RP   NCOA2.
RX   PubMed=12050230; DOI=10.1210/jcem.87.6.8520;
RA   Vottero A., Kino T., Combe H., Lecomte P., Chrousos G.P.;
RT   "A novel, C-terminal dominant negative mutation of the GR causes
RT   familial glucocorticoid resistance through abnormal interactions with
RT   p160 steroid receptor coactivators.";
RL   J. Clin. Endocrinol. Metab. 87:2658-2667(2002).
RN   [87]
RP   VARIANT LYS-23.
RX   PubMed=15276593; DOI=10.1016/j.amjmed.2004.01.027;
RA   van Rossum E.F.C., Feelders R.A., van den Beld A.W.,
RA   Uitterlinden A.G., Janssen J.A.M.J.L., Ester W., Brinkmann A.O.,
RA   Grobbee D.E., de Jong F.H., Pols H.A.P., Koper J.W., Lamberts S.W.J.;
RT   "Association of the ER22/23EK polymorphism in the glucocorticoid
RT   receptor gene with survival and C-reactive protein levels in elderly
RT   men.";
RL   Am. J. Med. 117:158-162(2004).
RN   [88]
RP   VARIANT LYS-23.
RX   PubMed=15292341; DOI=10.1210/jc.2003-031422;
RA   van Rossum E.F.C., Voorhoeve P.G., te Velde S.J., Koper J.W.,
RA   Delemarre-van de Waal H.A., Kemper H.C.G., Lamberts S.W.J.;
RT   "The ER22/23EK polymorphism in the glucocorticoid receptor gene is
RT   associated with a beneficial body composition and muscle strength in
RT   young adults.";
RL   J. Clin. Endocrinol. Metab. 89:4004-4009(2004).
RN   [89]
RP   VARIANT GCCR PRO-773, CHARACTERIZATION OF VARIANT GCCR PRO-773,
RP   INVOLVEMENT IN GCCR, FUNCTION (ISOFORM ALPHA), INTERACTION WITH GRIP1,
RP   AND SUBCELLULAR LOCATION (ISOFORM ALPHA).
RX   PubMed=15769988; DOI=10.1210/jc.2004-1920;
RA   Charmandari E., Raji A., Kino T., Ichijo T., Tiulpakov A., Zachman K.,
RA   Chrousos G.P.;
RT   "A novel point mutation in the ligand-binding domain (LBD) of the
RT   human glucocorticoid receptor (hGR) causing generalized glucocorticoid
RT   resistance: the importance of the C terminus of hGR LBD in conferring
RT   transactivational activity.";
RL   J. Clin. Endocrinol. Metab. 90:3696-3705(2005).
RN   [90]
RP   VARIANTS LYS-23 AND SER-363, AND CHARACTERIZATION OF VARIANTS LYS-23
RP   AND SER-363.
RX   PubMed=16030164; DOI=10.1210/jc.2005-0646;
RA   Russcher H., Smit P., van den Akker E.L., van Rossum E.F.,
RA   Brinkmann A.O., de Jong F.H., Lamberts S.W., Koper J.W.;
RT   "Two polymorphisms in the glucocorticoid receptor gene directly affect
RT   glucocorticoid-regulated gene expression.";
RL   J. Clin. Endocrinol. Metab. 90:5804-5810(2005).
RN   [91]
RP   VARIANT GCCR LEU-737, CHARACTERIZATION OF VARIANT GCCR LEU-737,
RP   FUNCTION (ISOFORM ALPHA), INTERACTION WITH GRIP1, AND SUBCELLULAR
RP   LOCATION (ISOFORM ALPHA).
RX   PubMed=17635946; DOI=10.1210/jc.2006-2830;
RA   Charmandari E., Kino T., Ichijo T., Jubiz W., Mejia L., Zachman K.,
RA   Chrousos G.P.;
RT   "A novel point mutation in helix 11 of the ligand-binding domain of
RT   the human glucocorticoid receptor gene causing generalized
RT   glucocorticoid resistance.";
RL   J. Clin. Endocrinol. Metab. 92:3986-3990(2007).
RN   [92]
RP   VARIANT GCCR GLN-714, AND CHARACTERIZATION OF VARIANT GCCR GLN-714.
RX   PubMed=20335448; DOI=10.1210/jc.2009-2463;
RA   Nader N., Bachrach B.E., Hurt D.E., Gajula S., Pittman A., Lescher R.,
RA   Kino T.;
RT   "A novel point mutation in helix 10 of the human glucocorticoid
RT   receptor causes generalized glucocorticoid resistance by disrupting
RT   the structure of the ligand-binding domain.";
RL   J. Clin. Endocrinol. Metab. 95:2281-2285(2010).
RN   [93]
RP   VARIANT GCCR ILE-556.
RX   PubMed=21362280;
RA   Zhu H.J., Dai Y.F., Wang O., Li M., Lu L., Zhao W.G., Xing X.P.,
RA   Pan H., Li N.S., Gong F.Y.;
RT   "Generalized glucocorticoid resistance accompanied with an
RT   adrenocortical adenoma and caused by a novel point mutation of human
RT   glucocorticoid receptor gene.";
RL   Chin. Med. J. 124:551-555(2011).
RN   [94]
RP   CHARACTERIZATION OF VARIANT GCCR ALA-423.
RX   PubMed=23426617; DOI=10.1210/jc.2012-3549;
RA   Roberts M.L., Kino T., Nicolaides N.C., Hurt D.E., Katsantoni E.,
RA   Sertedaki A., Komianou F., Kassiou K., Chrousos G.P., Charmandari E.;
RT   "A novel point mutation in the DNA-binding domain (DBD) of the human
RT   glucocorticoid receptor causes primary generalized glucocorticoid
RT   resistance by disrupting the hydrophobic structure of its DBD.";
RL   J. Clin. Endocrinol. Metab. 98:E790-E795(2013).
RN   [95]
RP   VARIANT GCCR GLY-575, AND CHARACTERIZATION OF VARIANT GCCR GLY-575.
RX   PubMed=24483153; DOI=10.1210/jc.2013-3005;
RA   Nicolaides N.C., Roberts M.L., Kino T., Braatvedt G., Hurt D.E.,
RA   Katsantoni E., Sertedaki A., Chrousos G.P., Charmandari E.;
RT   "A novel point mutation of the human glucocorticoid receptor gene
RT   causes primary generalized glucocorticoid resistance through impaired
RT   interaction with the LXXLL motif of the p160 coactivators:
RT   dissociation of the transactivating and transreppressive activities.";
RL   J. Clin. Endocrinol. Metab. 99:E902-E907(2014).
RN   [96]
RP   VARIANT GCCR ARG-726, AND CHARACTERIZATION OF VARIANT GCCR ARG-726.
RX   PubMed=26031419; DOI=10.1111/eci.12470;
RA   Nicolaides N.C., Geer E.B., Vlachakis D., Roberts M.L., Psarra A.M.,
RA   Moutsatsou P., Sertedaki A., Kossida S., Charmandari E.;
RT   "A novel mutation of the hGR gene causing Chrousos syndrome.";
RL   Eur. J. Clin. Invest. 45:782-791(2015).
RN   [97]
RP   CHARACTERIZATION OF VARIANT GCCR ILE-556.
RX   PubMed=26541474; DOI=10.1111/eci.12563;
RA   Nicolaides N.C., Skyrla E., Vlachakis D., Psarra A.M., Moutsatsou P.,
RA   Sertedaki A., Kossida S., Charmandari E.;
RT   "Functional characterization of the hGRalphaT556I causing Chrousos
RT   syndrome.";
RL   Eur. J. Clin. Invest. 46:42-49(2016).
RN   [98]
RP   VARIANTS GCCR SER-477; CYS-478 AND PRO-672, CHARACTERIZATION OF
RP   VARIANTS GCCR SER-477; CYS-478 AND CYS-478, FUNCTION, AND SUBCELLULAR
RP   LOCATION.
RX   PubMed=27120390; DOI=10.1002/humu.23008;
RA   Vitellius G., Fagart J., Delemer B., Amazit L., Ramos N.,
RA   Bouligand J., Le Billan F., Castinetti F., Guiochon-Mantel A.,
RA   Trabado S., Lombes M.;
RT   "Three novel heterozygous point mutations of NR3C1 causing
RT   glucocorticoid resistance.";
RL   Hum. Mutat. 37:794-803(2016).
CC   -!- FUNCTION: Receptor for glucocorticoids (GC) (PubMed:27120390). Has
CC       a dual mode of action: as a transcription factor that binds to
CC       glucocorticoid response elements (GRE), both for nuclear and
CC       mitochondrial DNA, and as a modulator of other transcription
CC       factors. Affects inflammatory responses, cellular proliferation
CC       and differentiation in target tissues. Involved in chromatin
CC       remodeling (PubMed:9590696). Plays a role in rapid mRNA
CC       degradation by binding to the 5' UTR of target mRNAs and
CC       interacting with PNRC2 in a ligand-dependent manner which recruits
CC       the RNA helicase UPF1 and the mRNA-decapping enzyme DCP1A, leading
CC       to RNA decay (PubMed:25775514). Could act as a coactivator for
CC       STAT5-dependent transcription upon growth hormone (GH) stimulation
CC       and could reveal an essential role of hepatic GR in the control of
CC       body growth (By similarity). {ECO:0000250|UniProtKB:P06537,
CC       ECO:0000269|PubMed:25775514, ECO:0000269|PubMed:27120390,
CC       ECO:0000269|PubMed:9590696}.
CC   -!- FUNCTION: Isoform Alpha: Has transcriptional activation and
CC       repression activity (PubMed:15866175, PubMed:19248771,
CC       PubMed:20484466, PubMed:23820903, PubMed:11435610,
CC       PubMed:15769988, PubMed:17635946, PubMed:19141540,
CC       PubMed:21664385). Mediates glucocorticoid-induced apoptosis
CC       (PubMed:23303127). Promotes accurate chromosome segregation during
CC       mitosis (PubMed:25847991). May act as a tumor suppressor
CC       (PubMed:25847991). May play a negative role in adipogenesis
CC       through the regulation of lipolytic and antilipogenic gene
CC       expression (By similarity). {ECO:0000250|UniProtKB:P06537,
CC       ECO:0000269|PubMed:11435610, ECO:0000269|PubMed:15769988,
CC       ECO:0000269|PubMed:15866175, ECO:0000269|PubMed:17635946,
CC       ECO:0000269|PubMed:19141540, ECO:0000269|PubMed:19248771,
CC       ECO:0000269|PubMed:20484466, ECO:0000269|PubMed:21664385,
CC       ECO:0000269|PubMed:23303127, ECO:0000269|PubMed:23820903,
CC       ECO:0000269|PubMed:25847991}.
CC   -!- FUNCTION: Isoform Beta: Acts as a dominant negative inhibitor of
CC       isoform Alpha (PubMed:7769088, PubMed:8621628, PubMed:20484466).
CC       Has intrinsic transcriptional activity independent of isoform
CC       Alpha when both isoforms are coexpressed (PubMed:19248771,
CC       PubMed:26711253). Loses this transcription modulator function on
CC       its own (PubMed:20484466). Has no hormone-binding activity
CC       (PubMed:8621628). May play a role in controlling glucose
CC       metabolism by maintaining insulin sensitivity (By similarity).
CC       Reduces hepatic gluconeogenesis through down-regulation of PEPCK
CC       in an isoform Alpha-dependent manner (PubMed:26711253). Directly
CC       regulates STAT1 expression in isoform Alpha-independent manner
CC       (PubMed:26711253). {ECO:0000250|UniProtKB:P06537,
CC       ECO:0000269|PubMed:19248771, ECO:0000269|PubMed:20484466,
CC       ECO:0000269|PubMed:26711253, ECO:0000269|PubMed:7769088,
CC       ECO:0000269|PubMed:8621628}.
CC   -!- FUNCTION: Isoform Alpha-2: Has lower transcriptional activation
CC       activity than isoform Alpha. Exerts a dominant negative effect on
CC       isoform Alpha trans-repression mechanism (PubMed:20484466).
CC   -!- FUNCTION: Isoform GR-P: Increases activity of isoform Alpha.
CC       {ECO:0000269|PubMed:11358809}.
CC   -!- FUNCTION: Isoform Alpha-B: More effective than isoform Alpha in
CC       transcriptional activation, but not repression activity.
CC       {ECO:0000269|PubMed:11435610, ECO:0000269|PubMed:15866175}.
CC   -!- FUNCTION: Isoform 10: Has transcriptional activation activity.
CC       {ECO:0000269|PubMed:20484466}.
CC   -!- FUNCTION: Isoform Alpha-C1: Has transcriptional activation
CC       activity. {ECO:0000269|PubMed:15866175}.
CC   -!- FUNCTION: Isoform Alpha-C2: Has transcriptional activation
CC       activity. {ECO:0000269|PubMed:15866175}.
CC   -!- FUNCTION: Isoform Alpha-C3: Has highest transcriptional activation
CC       activity of all isoforms created by alternative initiation
CC       (PubMed:15866175, PubMed:23820903). Has transcriptional repression
CC       activity (PubMed:23303127). Mediates glucocorticoid-induced
CC       apoptosis (PubMed:23303127, PubMed:23820903).
CC       {ECO:0000269|PubMed:15866175, ECO:0000269|PubMed:23303127,
CC       ECO:0000269|PubMed:23820903}.
CC   -!- FUNCTION: Isoform Alpha-D1: Has transcriptional activation
CC       activity. {ECO:0000269|PubMed:15866175}.
CC   -!- FUNCTION: Isoform Alpha-D2: Has transcriptional activation
CC       activity. {ECO:0000269|PubMed:15866175}.
CC   -!- FUNCTION: Isoform Alpha-D3: Has lowest transcriptional activation
CC       activity of all isoforms created by alternative initiation
CC       (PubMed:15866175, PubMed:23820903). Has transcriptional repression
CC       activity (PubMed:23303127). {ECO:0000269|PubMed:15866175,
CC       ECO:0000269|PubMed:23303127, ECO:0000269|PubMed:23820903}.
CC   -!- SUBUNIT: Heteromultimeric cytoplasmic complex with HSP90AA1,
CC       HSPA1A/HSPA1B, and FKBP5 or another immunophilin such as PPID,
CC       STIP1, or the immunophilin homolog PPP5C (PubMed:21730050). Upon
CC       ligand binding FKBP5 dissociates from the complex and FKBP4 takes
CC       its place, thereby linking the complex to dynein and mediating
CC       transport to the nucleus, where the complex dissociates (By
CC       similarity). Probably forms a complex composed of chaperones HSP90
CC       and HSP70, co-chaperones CDC37, PPP5C, TSC1 and client protein
CC       TSC2, CDK4, AKT, RAF1 and NR3C1; this complex does not contain co-
CC       chaperones STIP1/HOP and PTGES3/p23 (PubMed:29127155). Directly
CC       interacts with UNC45A (PubMed:16478993). Binds to DNA as a
CC       homodimer, and as heterodimer with NR3C2 or the retinoid X
CC       receptor. Binds STAT5A and STAT5B homodimers and heterodimers (By
CC       similarity). Interacts with NRIP1, POU2F1, POU2F2 and TRIM28 (By
CC       similarity). Interacts with several coactivator complexes,
CC       including the SMARCA4 complex, CREBBP/EP300, TADA2L (Ada complex)
CC       and p160 coactivators such as NCOA2 and NCOA6 (PubMed:10866662,
CC       PubMed:12151000, PubMed:12686538, PubMed:9154805, PubMed:9590696).
CC       Interaction with BAG1 inhibits transactivation (PubMed:10477749).
CC       Interacts with HEXIM1, PELP1 and TGFB1I1 (PubMed:12415108,
CC       PubMed:15211577, PubMed:15941832). Interacts with NCOA1
CC       (PubMed:9590696). Interacts with NCOA3, SMARCA4, SMARCC1, SMARCD1,
CC       and SMARCE1 (By similarity). Interacts with CLOCK, CRY1 and CRY2
CC       in a ligand-dependent fashion (PubMed:19141540, PubMed:21980503,
CC       PubMed:22170608). Interacts with CIART (By similarity). Interacts
CC       with RWDD3 (By similarity). Interacts with UBE2I/UBC9 and this
CC       interaction is enhanced in the presence of RWDD3 (By similarity).
CC       Interacts with GRIP1 (PubMed:15769988, PubMed:17635946). Interacts
CC       with NR4A3 (via nuclear receptor DNA-binding domain), represses
CC       transcription activity of NR4A3 on the POMC promoter Nur response
CC       element (NurRE) (PubMed:15591535). Directly interacts with PNRC2
CC       to attract and form a complex with UPF1 and DCP1A; the interaction
CC       leads to rapid mRNA degradation (PubMed:25775514). Interacts with
CC       GSK3B (PubMed:18838540). Interacts with FNIP1 and FNIP2
CC       (PubMed:27353360). Interacts (via C-terminus) with HNRNPU (via C-
CC       terminus) (PubMed:9353307). {ECO:0000250|UniProtKB:P06536,
CC       ECO:0000250|UniProtKB:P06537, ECO:0000269|PubMed:10477749,
CC       ECO:0000269|PubMed:10866662, ECO:0000269|PubMed:12151000,
CC       ECO:0000269|PubMed:12415108, ECO:0000269|PubMed:12686538,
CC       ECO:0000269|PubMed:15211577, ECO:0000269|PubMed:15591535,
CC       ECO:0000269|PubMed:15769988, ECO:0000269|PubMed:15941832,
CC       ECO:0000269|PubMed:16478993, ECO:0000269|PubMed:17635946,
CC       ECO:0000269|PubMed:18838540, ECO:0000269|PubMed:19141540,
CC       ECO:0000269|PubMed:21730050, ECO:0000269|PubMed:21980503,
CC       ECO:0000269|PubMed:22170608, ECO:0000269|PubMed:25775514,
CC       ECO:0000269|PubMed:27353360, ECO:0000269|PubMed:29127155,
CC       ECO:0000269|PubMed:9154805, ECO:0000269|PubMed:9353307,
CC       ECO:0000269|PubMed:9590696}.
CC   -!- INTERACTION:
CC       P31749:AKT1; NbExp=5; IntAct=EBI-493507, EBI-296087;
CC       P59598:Asxl1 (xeno); NbExp=2; IntAct=EBI-493507, EBI-5743705;
CC       Q03135:CAV1; NbExp=2; IntAct=EBI-493507, EBI-603614;
CC       P01730:CD4; NbExp=2; IntAct=EBI-493507, EBI-353826;
CC       P00533:EGFR; NbExp=2; IntAct=EBI-493507, EBI-297353;
CC       P41235:HNF4A; NbExp=2; IntAct=EBI-493507, EBI-1049011;
CC       P07900:HSP90AA1; NbExp=7; IntAct=EBI-493507, EBI-296047;
CC       Q6ZU52:KIAA0408; NbExp=2; IntAct=EBI-493507, EBI-739493;
CC       P06239:LCK; NbExp=3; IntAct=EBI-493507, EBI-1348;
CC       Q62667:Mvp (xeno); NbExp=2; IntAct=EBI-493507, EBI-918333;
CC       P82094:TMF1; NbExp=3; IntAct=EBI-493507, EBI-949763;
CC   -!- SUBCELLULAR LOCATION: Isoform Alpha: Cytoplasm
CC       {ECO:0000269|PubMed:15769988, ECO:0000269|PubMed:17635946,
CC       ECO:0000269|PubMed:18838540, ECO:0000269|PubMed:27120390,
CC       ECO:0000269|PubMed:8621628}. Nucleus {ECO:0000269|PubMed:15769988,
CC       ECO:0000269|PubMed:17635946, ECO:0000269|PubMed:18838540,
CC       ECO:0000269|PubMed:27120390, ECO:0000269|PubMed:8621628}.
CC       Mitochondrion {ECO:0000269|PubMed:21664385}. Cytoplasm,
CC       cytoskeleton, spindle {ECO:0000269|PubMed:25847991}. Cytoplasm,
CC       cytoskeleton, microtubule organizing center, centrosome
CC       {ECO:0000269|PubMed:25847991}. Note=After ligand activation,
CC       translocates from the cytoplasm to the nucleus.
CC       {ECO:0000269|PubMed:18838540, ECO:0000269|PubMed:27120390,
CC       ECO:0000269|PubMed:8621628}.
CC   -!- SUBCELLULAR LOCATION: Isoform Beta: Nucleus
CC       {ECO:0000269|PubMed:19248771, ECO:0000269|PubMed:26711253,
CC       ECO:0000269|PubMed:8621628}. Cytoplasm
CC       {ECO:0000269|PubMed:19248771, ECO:0000269|PubMed:26711253}.
CC       Note=Expressed predominantly in the nucleus with some expression
CC       also detected in the cytoplasm. {ECO:0000269|PubMed:19248771,
CC       ECO:0000269|PubMed:26711253}.
CC   -!- SUBCELLULAR LOCATION: Isoform Alpha-B: Nucleus
CC       {ECO:0000269|PubMed:15866175}. Cytoplasm
CC       {ECO:0000269|PubMed:15866175}. Note=After ligand activation,
CC       translocates from the cytoplasm to the nucleus.
CC       {ECO:0000269|PubMed:15866175}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing, Alternative initiation; Named isoforms=16;
CC       Name=Alpha; Synonyms=Alpha-A, GR-alphaA;
CC         IsoId=P04150-1; Sequence=Displayed;
CC         Note=Predominant physiological form.
CC         {ECO:0000269|PubMed:15866175};
CC       Name=Beta; Synonyms=Beta-A;
CC         IsoId=P04150-2; Sequence=VSP_003703;
CC       Name=Alpha-2; Synonyms=Gamma;
CC         IsoId=P04150-3; Sequence=VSP_007363;
CC         Note=Due to a partial intron retention.;
CC       Name=Beta-2;
CC         IsoId=P04150-6; Sequence=VSP_007363, VSP_003703;
CC         Note=Due to a partial intron retention.;
CC       Name=GR-A alpha;
CC         IsoId=P04150-5; Sequence=VSP_013340;
CC         Note=Lacks exons 5, 6 and 7. Found in glucocorticoid-resistant
CC         myeloma patients. {ECO:0000269|PubMed:8358712};
CC       Name=GR-A beta;
CC         IsoId=P04150-7; Sequence=VSP_013340, VSP_003703;
CC         Note=Lacks exons 5, 6 and 7. {ECO:0000269|PubMed:8358712};
CC       Name=GR-P;
CC         IsoId=P04150-4; Sequence=Not described;
CC         Note=Encoded by exons 2-7 plus several basepairs from the
CC         subsequent intron region. Lacks the ligand binding domain.
CC         Accounts for up to 10-20% of mRNAs.
CC         {ECO:0000269|PubMed:8358712};
CC       Name=Alpha-B; Synonyms=GR-alphaB;
CC         IsoId=P04150-8; Sequence=VSP_018773;
CC         Note=Produced by alternative initiation at Met-27 of isoform
CC         Alpha. Contains a N-acetylmethionine at position 1.
CC         {ECO:0000244|PubMed:22814378};
CC       Name=Beta-B;
CC         IsoId=P04150-9; Sequence=VSP_018773, VSP_003703;
CC         Note=Produced by alternative initiation at Met-27 of isoform
CC         Beta. Contains a N-acetylmethionine at position 1.
CC         {ECO:0000244|PubMed:22814378, ECO:0000269|PubMed:15866175};
CC       Name=10; Synonyms=hGRDelta313-338;
CC         IsoId=P04150-10; Sequence=VSP_043908;
CC       Name=Alpha-C1; Synonyms=GR-alphaC1;
CC         IsoId=P04150-11; Sequence=VSP_058317;
CC         Note=Produced by alternative initiation at Met-86 of isoform
CC         Alpha. {ECO:0000269|PubMed:15866175};
CC       Name=Alpha-C2; Synonyms=GR-alphaC2;
CC         IsoId=P04150-12; Sequence=VSP_058316;
CC         Note=Produced by alternative initiation at Met-90 of isoform
CC         Alpha. {ECO:0000269|PubMed:15866175};
CC       Name=Alpha-C3; Synonyms=GR-alphaC3;
CC         IsoId=P04150-13; Sequence=VSP_058315;
CC         Note=Produced by alternative initiation at Met-98 of isoform
CC         Alpha. {ECO:0000269|PubMed:15866175};
CC       Name=Alpha-D1; Synonyms=GR-alphaD1;
CC         IsoId=P04150-14; Sequence=VSP_058314;
CC         Note=Produced by alternative initiation at Met-316 of isoform
CC         Alpha. {ECO:0000269|PubMed:15866175};
CC       Name=Alpha-D2; Synonyms=GR-alphaD2;
CC         IsoId=P04150-15; Sequence=VSP_058313;
CC         Note=Produced by alternative initiation at Met-331 of isoform
CC         Alpha. {ECO:0000269|PubMed:15866175};
CC       Name=Alpha-D3; Synonyms=GR-alphaD3;
CC         IsoId=P04150-16; Sequence=VSP_058312;
CC         Note=Produced by alternative initiation at Met-336 of isoform
CC         Alpha. {ECO:0000269|PubMed:15866175};
CC   -!- TISSUE SPECIFICITY: Widely expressed including bone, stomach,
CC       lung, liver, colon, breast, ovary, pancreas and kidney
CC       (PubMed:25847991). In the heart, detected in left and right atria,
CC       left and right ventricles, aorta, apex, intraventricular septum,
CC       and atrioventricular node as well as whole adult and fetal heart
CC       (PubMed:10902803). Isoform Beta: Widely expressed including brain,
CC       bone marrow, thymus, spleen, liver, kidney, pancreas, lung, fat,
CC       skeletal muscle, heart, placenta and blood leukocytes
CC       (PubMed:7769088, PubMed:8621628). Isoform Alpha-2: Expressed at
CC       low level. {ECO:0000269|PubMed:10902803,
CC       ECO:0000269|PubMed:25847991, ECO:0000269|PubMed:7769088,
CC       ECO:0000269|PubMed:8621628}.
CC   -!- INDUCTION: Isoform Alpha: Up-regulated by TNF (at protein level).
CC       Isoform Beta: Up-regulated by TNF and becomes the predominant
CC       isoform which may lead to glucocorticoid resistance (at protein
CC       level). {ECO:0000269|PubMed:11381138}.
CC   -!- DOMAIN: Composed of three domains: a modulating N-terminal domain,
CC       a DNA-binding domain and a C-terminal ligand-binding domain
CC       (PubMed:3841189). The ligand-binding domain is required for
CC       correct chromosome segregation during mitosis although ligand
CC       binding is not required (PubMed:25847991).
CC       {ECO:0000269|PubMed:25847991, ECO:0000269|PubMed:3841189}.
CC   -!- PTM: Acetylation by CLOCK reduces its binding to glucocorticoid
CC       response elements and its transcriptional activity.
CC       {ECO:0000269|PubMed:19141540, ECO:0000269|PubMed:21980503}.
CC   -!- PTM: Increased proteasome-mediated degradation in response to
CC       glucocorticoids (PubMed:11555652). Isoform Alpha-B appears to be
CC       more susceptible to proteolytic degradation than isoform Alpha
CC       (PubMed:11435610). {ECO:0000269|PubMed:11435610,
CC       ECO:0000269|PubMed:11555652}.
CC   -!- PTM: Phosphorylated in the absence of hormone; becomes
CC       hyperphosphorylated in the presence of glucocorticoid. The Ser-
CC       203, Ser-226 and Ser-404-phosphorylated forms are mainly
CC       cytoplasmic, and the Ser-211-phosphorylated form is nuclear
CC       (PubMed:12000743, PubMed:18838540). Phosphorylation at Ser-211
CC       increases transcriptional activity (PubMed:12000743,
CC       PubMed:18483179). Phosphorylation at Ser-203, Ser-226 and Ser-404
CC       decreases signaling capacity (PubMed:12000743, PubMed:18483179,
CC       PubMed:18838540). Phosphorylation at Ser-404 may protect from
CC       glucocorticoid-induced apoptosis (PubMed:18838540).
CC       Phosphorylation at Ser-203 and Ser-211 is not required in
CC       regulation of chromosome segregation (PubMed:25847991). May be
CC       dephosphorylated by PPP5C, attenuates NR3C1 action (By
CC       similarity). {ECO:0000250|UniProtKB:P06537,
CC       ECO:0000269|PubMed:12000743, ECO:0000269|PubMed:18483179,
CC       ECO:0000269|PubMed:18838540, ECO:0000269|PubMed:25847991}.
CC   -!- PTM: Sumoylation at Lys-277 and Lys-293 negatively regulates its
CC       transcriptional activity (PubMed:12144530). Sumoylation at Lys-703
CC       positively regulates its transcriptional activity in the presence
CC       of RWDD3 (By similarity). Sumoylation at Lys-277 and Lys-293 is
CC       dispensable whereas sumoylation at Lys-703 is critical for the
CC       stimulatory effect of RWDD3 on its transcriptional activity (By
CC       similarity). Heat shock increases sumoylation in a RWDD3-dependent
CC       manner (By similarity). {ECO:0000250|UniProtKB:P06536,
CC       ECO:0000269|PubMed:12144530}.
CC   -!- PTM: Ubiquitinated; restricts glucocorticoid-mediated
CC       transcriptional signaling. {ECO:0000250|UniProtKB:P06537}.
CC   -!- POLYMORPHISM: Carriers of the 22-Glu-Lys-23 allele are relatively
CC       more resistant to the effects of GCs with respect to the
CC       sensitivity of the adrenal feedback mechanism than non-carriers,
CC       resulting in a better metabolic health profile. Carriers have a
CC       better survival than non-carriers, as well as lower serum CRP
CC       levels. The 22-Glu-Lys-23 polymorphism is associated with a sex-
CC       specific, beneficial body composition at young-adult age, as well
CC       as greater muscle strength in males.
CC   -!- DISEASE: Glucocorticoid resistance, generalized (GCCR)
CC       [MIM:615962]: An autosomal dominant disease characterized by
CC       increased plasma cortisol concentration and high urinary free
CC       cortisol, resistance to adrenal suppression by dexamethasone, and
CC       the absence of Cushing syndrome typical signs. Clinical features
CC       include hypoglycemia, hypertension, metabolic alkalosis, chronic
CC       fatigue and profound anxiety. {ECO:0000269|PubMed:11589680,
CC       ECO:0000269|PubMed:11701741, ECO:0000269|PubMed:12050230,
CC       ECO:0000269|PubMed:15769988, ECO:0000269|PubMed:1704018,
CC       ECO:0000269|PubMed:17635946, ECO:0000269|PubMed:20335448,
CC       ECO:0000269|PubMed:21362280, ECO:0000269|PubMed:23426617,
CC       ECO:0000269|PubMed:24483153, ECO:0000269|PubMed:26031419,
CC       ECO:0000269|PubMed:26541474, ECO:0000269|PubMed:27120390,
CC       ECO:0000269|PubMed:7683692}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- MISCELLANEOUS: Isoform Beta: High constitutive expression by
CC       neutrophils may provide a mechanism by which these cells escape
CC       glucocorticoid-induced cell death and up-regulation by
CC       proinflammatory cytokines such as IL8 further enhances their
CC       survival in the presence of glucocorticoids during inflammation.
CC       {ECO:0000269|PubMed:11238589}.
CC   -!- MISCELLANEOUS: Can up- or down-modulate aggregation and nuclear
CC       localization of expanded polyglutamine polypeptides derived from
CC       AR and HD through specific regulation of gene expression.
CC       Aggregation and nuclear localization of expanded polyglutamine
CC       proteins are regulated cellular processes that can be modulated by
CC       this receptor, a well-characterized transcriptional regulator.
CC       {ECO:0000269|PubMed:10639135}.
CC   -!- SIMILARITY: Belongs to the nuclear hormone receptor family. NR3
CC       subfamily. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=NIEHS-SNPs;
CC       URL="http://egp.gs.washington.edu/data/nr3c1/";
CC   -!- WEB RESOURCE: Name=Wikipedia; Note=Glucocorticoid receptor entry;
CC       URL="https://en.wikipedia.org/wiki/Glucocorticoid_receptor";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X03225; CAA26976.1; -; mRNA.
DR   EMBL; X03348; CAA27054.1; -; mRNA.
DR   EMBL; AH005496; AAB64353.1; -; Genomic_DNA.
DR   EMBL; AH005496; AAB64354.1; -; Genomic_DNA.
DR   EMBL; HQ205546; ADP91135.1; -; Genomic_DNA.
DR   EMBL; HQ205547; ADP91138.1; -; Genomic_DNA.
DR   EMBL; HQ205548; ADP91141.1; -; Genomic_DNA.
DR   EMBL; HQ205549; ADP91144.1; -; Genomic_DNA.
DR   EMBL; HQ205550; ADP91147.1; -; Genomic_DNA.
DR   EMBL; HQ205551; ADP91150.1; -; Genomic_DNA.
DR   EMBL; HQ205552; ADP91153.1; -; Genomic_DNA.
DR   EMBL; HQ205553; ADP91156.1; -; Genomic_DNA.
DR   EMBL; HQ205554; ADP91159.1; -; Genomic_DNA.
DR   EMBL; HQ205555; ADP91162.1; -; Genomic_DNA.
DR   EMBL; HQ205556; ADP91165.1; -; Genomic_DNA.
DR   EMBL; HQ205557; ADP91168.1; -; Genomic_DNA.
DR   EMBL; HQ205558; ADP91171.1; -; Genomic_DNA.
DR   EMBL; HQ205559; ADP91174.1; -; Genomic_DNA.
DR   EMBL; HQ205560; ADP91177.1; -; Genomic_DNA.
DR   EMBL; HQ205561; ADP91180.1; -; Genomic_DNA.
DR   EMBL; HQ205562; ADP91183.1; -; Genomic_DNA.
DR   EMBL; HQ205563; ADP91186.1; -; Genomic_DNA.
DR   EMBL; HQ205564; ADP91189.1; -; Genomic_DNA.
DR   EMBL; HQ205565; ADP91192.1; -; Genomic_DNA.
DR   EMBL; HQ205566; ADP91195.1; -; Genomic_DNA.
DR   EMBL; HQ205567; ADP91198.1; -; Genomic_DNA.
DR   EMBL; HQ205568; ADP91201.1; -; Genomic_DNA.
DR   EMBL; HQ205569; ADP91204.1; -; Genomic_DNA.
DR   EMBL; HQ205570; ADP91207.1; -; Genomic_DNA.
DR   EMBL; HQ205571; ADP91210.1; -; Genomic_DNA.
DR   EMBL; HQ205572; ADP91213.1; -; Genomic_DNA.
DR   EMBL; HQ205573; ADP91216.1; -; Genomic_DNA.
DR   EMBL; HQ205574; ADP91219.1; -; Genomic_DNA.
DR   EMBL; HQ205575; ADP91222.1; -; Genomic_DNA.
DR   EMBL; HQ205576; ADP91225.1; -; Genomic_DNA.
DR   EMBL; HQ205577; ADP91228.1; -; Genomic_DNA.
DR   EMBL; HQ205578; ADP91231.1; -; Genomic_DNA.
DR   EMBL; HQ205579; ADP91234.1; -; Genomic_DNA.
DR   EMBL; HQ205580; ADP91237.1; -; Genomic_DNA.
DR   EMBL; HQ205581; ADP91240.1; -; Genomic_DNA.
DR   EMBL; HQ205582; ADP91243.1; -; Genomic_DNA.
DR   EMBL; HQ205583; ADP91246.1; -; Genomic_DNA.
DR   EMBL; HQ205584; ADP91249.1; -; Genomic_DNA.
DR   EMBL; HQ205585; ADP91252.1; -; Genomic_DNA.
DR   EMBL; AM183262; CAJ65924.1; -; mRNA.
DR   EMBL; HQ450643; AED99114.1; -; mRNA.
DR   EMBL; U01351; AAA16603.1; -; mRNA.
DR   EMBL; AK223594; BAD97314.1; -; mRNA.
DR   EMBL; BX640610; CAE45716.1; -; mRNA.
DR   EMBL; AY436590; AAQ97180.1; -; Genomic_DNA.
DR   EMBL; EU332858; ABY87547.1; -; Genomic_DNA.
DR   EMBL; AC005601; AAC34207.1; -; Genomic_DNA.
DR   EMBL; AC004782; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC091925; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471062; EAW61872.1; -; Genomic_DNA.
DR   EMBL; CH471062; EAW61873.1; -; Genomic_DNA.
DR   EMBL; BC015610; AAH15610.1; -; mRNA.
DR   EMBL; M69104; AAA88049.1; -; Genomic_DNA.
DR   EMBL; AH002750; AAA53151.1; -; Genomic_DNA.
DR   EMBL; S68378; AAB20466.1; -; Genomic_DNA.
DR   CCDS; CCDS34258.1; -. [P04150-3]
DR   CCDS; CCDS4278.1; -. [P04150-1]
DR   CCDS; CCDS47298.1; -. [P04150-2]
DR   PIR; A93370; QRHUGA.
DR   PIR; B93370; QRHUGB.
DR   RefSeq; NP_000167.1; NM_000176.2. [P04150-1]
DR   RefSeq; NP_001018084.1; NM_001018074.1. [P04150-1]
DR   RefSeq; NP_001018085.1; NM_001018075.1. [P04150-1]
DR   RefSeq; NP_001018086.1; NM_001018076.1. [P04150-1]
DR   RefSeq; NP_001018087.1; NM_001018077.1. [P04150-1]
DR   RefSeq; NP_001018661.1; NM_001020825.1. [P04150-2]
DR   RefSeq; NP_001019265.1; NM_001024094.1. [P04150-3]
DR   RefSeq; NP_001191187.1; NM_001204258.1. [P04150-8]
DR   RefSeq; NP_001191188.1; NM_001204259.1. [P04150-11]
DR   RefSeq; NP_001191189.1; NM_001204260.1. [P04150-12]
DR   RefSeq; NP_001191190.1; NM_001204261.1. [P04150-13]
DR   RefSeq; NP_001191191.1; NM_001204262.1. [P04150-14]
DR   RefSeq; NP_001191192.1; NM_001204263.1. [P04150-15]
DR   RefSeq; NP_001191193.1; NM_001204264.1. [P04150-16]
DR   RefSeq; XP_005268476.1; XM_005268419.3. [P04150-3]
DR   RefSeq; XP_005268477.1; XM_005268420.4. [P04150-3]
DR   RefSeq; XP_005268479.1; XM_005268422.3. [P04150-3]
DR   RefSeq; XP_005268480.1; XM_005268423.3. [P04150-3]
DR   RefSeq; XP_016864886.1; XM_017009397.1. [P04150-1]
DR   RefSeq; XP_016864887.1; XM_017009398.1. [P04150-1]
DR   UniGene; Hs.122926; -.
DR   PDB; 1M2Z; X-ray; 2.50 A; A/D=521-777.
DR   PDB; 1NHZ; X-ray; 2.30 A; A=500-777.
DR   PDB; 1P93; X-ray; 2.70 A; A/B/C/D=500-777.
DR   PDB; 3BQD; X-ray; 2.50 A; A=525-777.
DR   PDB; 3CLD; X-ray; 2.84 A; A/B=521-777.
DR   PDB; 3E7C; X-ray; 2.15 A; A/B=521-777.
DR   PDB; 3H52; X-ray; 2.80 A; A/B/C/D=528-777.
DR   PDB; 3K22; X-ray; 2.10 A; A/B=521-777.
DR   PDB; 3K23; X-ray; 3.00 A; A/B/C=521-777.
DR   PDB; 4CSJ; X-ray; 2.30 A; A=500-777.
DR   PDB; 4HN5; X-ray; 1.90 A; A/B=417-506.
DR   PDB; 4HN6; X-ray; 2.55 A; A/B=417-506.
DR   PDB; 4LSJ; X-ray; 2.35 A; A=522-777.
DR   PDB; 4MDD; X-ray; 2.40 A; A/B=522-777.
DR   PDB; 4P6W; X-ray; 1.95 A; A=526-777.
DR   PDB; 4P6X; X-ray; 2.50 A; A/C/E/G/I/K=523-777.
DR   PDB; 4UDC; X-ray; 2.50 A; A=500-777.
DR   PDB; 4UDD; X-ray; 1.80 A; A=500-777.
DR   PDB; 5CBX; X-ray; 2.00 A; A/B/E/F=415-495.
DR   PDB; 5CBY; X-ray; 2.00 A; A/B=415-495.
DR   PDB; 5CBZ; X-ray; 2.20 A; A/B/E/F=419-495.
DR   PDB; 5CC1; X-ray; 2.30 A; A/B/W/X=417-506.
DR   PDB; 5E69; X-ray; 1.85 A; A/B=417-506.
DR   PDB; 5E6A; X-ray; 2.20 A; A/B=417-506.
DR   PDB; 5E6B; X-ray; 2.25 A; A/B=417-506.
DR   PDB; 5E6C; X-ray; 2.20 A; A/B=417-506.
DR   PDB; 5E6D; X-ray; 2.40 A; A/B=417-506.
DR   PDB; 5EMC; X-ray; 2.30 A; A/B=411-500.
DR   PDB; 5EMP; X-ray; 2.30 A; A/B=411-500.
DR   PDB; 5EMQ; X-ray; 2.30 A; A/B=411-500.
DR   PDB; 5G3J; X-ray; 2.40 A; A=500-777.
DR   PDB; 5G5W; X-ray; 2.20 A; A=500-777.
DR   PDB; 5NFP; X-ray; 2.10 A; A=500-777.
DR   PDB; 5NFT; X-ray; 2.30 A; A=500-777.
DR   PDB; 5UC3; X-ray; 2.01 A; A/B=522-777.
DR   PDB; 5VA0; X-ray; 2.29 A; A/B=419-490.
DR   PDB; 5VA7; X-ray; 2.15 A; A/B=419-488.
DR   PDB; 6EL6; X-ray; 2.40 A; A=500-777.
DR   PDB; 6EL7; X-ray; 2.18 A; A=500-777.
DR   PDB; 6EL9; X-ray; 2.19 A; A=500-777.
DR   PDBsum; 1M2Z; -.
DR   PDBsum; 1NHZ; -.
DR   PDBsum; 1P93; -.
DR   PDBsum; 3BQD; -.
DR   PDBsum; 3CLD; -.
DR   PDBsum; 3E7C; -.
DR   PDBsum; 3H52; -.
DR   PDBsum; 3K22; -.
DR   PDBsum; 3K23; -.
DR   PDBsum; 4CSJ; -.
DR   PDBsum; 4HN5; -.
DR   PDBsum; 4HN6; -.
DR   PDBsum; 4LSJ; -.
DR   PDBsum; 4MDD; -.
DR   PDBsum; 4P6W; -.
DR   PDBsum; 4P6X; -.
DR   PDBsum; 4UDC; -.
DR   PDBsum; 4UDD; -.
DR   PDBsum; 5CBX; -.
DR   PDBsum; 5CBY; -.
DR   PDBsum; 5CBZ; -.
DR   PDBsum; 5CC1; -.
DR   PDBsum; 5E69; -.
DR   PDBsum; 5E6A; -.
DR   PDBsum; 5E6B; -.
DR   PDBsum; 5E6C; -.
DR   PDBsum; 5E6D; -.
DR   PDBsum; 5EMC; -.
DR   PDBsum; 5EMP; -.
DR   PDBsum; 5EMQ; -.
DR   PDBsum; 5G3J; -.
DR   PDBsum; 5G5W; -.
DR   PDBsum; 5NFP; -.
DR   PDBsum; 5NFT; -.
DR   PDBsum; 5UC3; -.
DR   PDBsum; 5VA0; -.
DR   PDBsum; 5VA7; -.
DR   PDBsum; 6EL6; -.
DR   PDBsum; 6EL7; -.
DR   PDBsum; 6EL9; -.
DR   DisProt; DP00030; -.
DR   ProteinModelPortal; P04150; -.
DR   SMR; P04150; -.
DR   BioGrid; 109165; 225.
DR   CORUM; P04150; -.
DR   DIP; DIP-576N; -.
DR   ELM; P04150; -.
DR   IntAct; P04150; 76.
DR   MINT; P04150; -.
DR   STRING; 9606.ENSP00000231509; -.
DR   BindingDB; P04150; -.
DR   ChEMBL; CHEMBL2034; -.
DR   DrugBank; DB00240; Alclometasone.
DR   DrugBank; DB00288; Amcinonide.
DR   DrugBank; DB00394; Beclomethasone dipropionate.
DR   DrugBank; DB00443; Betamethasone.
DR   DrugBank; DB01222; Budesonide.
DR   DrugBank; DB01410; Ciclesonide.
DR   DrugBank; DB01013; Clobetasol propionate.
DR   DrugBank; DB13158; Clobetasone.
DR   DrugBank; DB00838; Clocortolone.
DR   DrugBank; DB01380; Cortisone acetate.
DR   DrugBank; DB01260; Desonide.
DR   DrugBank; DB00547; Desoximetasone.
DR   DrugBank; DB01234; Dexamethasone.
DR   DrugBank; DB00223; Diflorasone.
DR   DrugBank; DB06781; Difluprednate.
DR   DrugBank; DB00687; Fludrocortisone.
DR   DrugBank; DB00663; Flumethasone.
DR   DrugBank; DB00180; Flunisolide.
DR   DrugBank; DB00591; Fluocinolone Acetonide.
DR   DrugBank; DB01047; Fluocinonide.
DR   DrugBank; DB00324; Fluorometholone.
DR   DrugBank; DB01185; Fluoxymesterone.
DR   DrugBank; DB00846; Flurandrenolide.
DR   DrugBank; DB08906; Fluticasone furoate.
DR   DrugBank; DB00588; Fluticasone Propionate.
DR   DrugBank; DB00769; Hydrocortamate.
DR   DrugBank; DB00741; Hydrocortisone.
DR   DrugBank; DB00873; Loteprednol.
DR   DrugBank; DB00253; Medrysone.
DR   DrugBank; DB00351; Megestrol acetate.
DR   DrugBank; DB00959; Methylprednisolone.
DR   DrugBank; DB00834; Mifepristone.
DR   DrugBank; DB00764; Mometasone.
DR   DrugBank; DB05423; ORG-34517.
DR   DrugBank; DB01384; Paramethasone.
DR   DrugBank; DB01130; Prednicarbate.
DR   DrugBank; DB00860; Prednisolone.
DR   DrugBank; DB00635; Prednisone.
DR   DrugBank; DB00896; Rimexolone.
DR   DrugBank; DB00421; Spironolactone.
DR   DrugBank; DB00620; Triamcinolone.
DR   DrugBank; DB08867; Ulipristal.
DR   DrugBank; DB00596; Ulobetasol.
DR   GuidetoPHARMACOLOGY; 625; -.
DR   iPTMnet; P04150; -.
DR   PhosphoSitePlus; P04150; -.
DR   BioMuta; NR3C1; -.
DR   DMDM; 121069; -.
DR   EPD; P04150; -.
DR   PaxDb; P04150; -.
DR   PeptideAtlas; P04150; -.
DR   PRIDE; P04150; -.
DR   DNASU; 2908; -.
DR   Ensembl; ENST00000231509; ENSP00000231509; ENSG00000113580. [P04150-3]
DR   Ensembl; ENST00000343796; ENSP00000343205; ENSG00000113580. [P04150-1]
DR   Ensembl; ENST00000394464; ENSP00000377977; ENSG00000113580. [P04150-1]
DR   Ensembl; ENST00000394466; ENSP00000377979; ENSG00000113580. [P04150-3]
DR   Ensembl; ENST00000415690; ENSP00000387672; ENSG00000113580. [P04150-2]
DR   Ensembl; ENST00000424646; ENSP00000405282; ENSG00000113580. [P04150-10]
DR   Ensembl; ENST00000503201; ENSP00000427672; ENSG00000113580. [P04150-1]
DR   Ensembl; ENST00000504572; ENSP00000422518; ENSG00000113580. [P04150-3]
DR   GeneID; 2908; -.
DR   KEGG; hsa:2908; -.
DR   UCSC; uc003lmy.4; human. [P04150-1]
DR   CTD; 2908; -.
DR   DisGeNET; 2908; -.
DR   EuPathDB; HostDB:ENSG00000113580.14; -.
DR   GeneCards; NR3C1; -.
DR   HGNC; HGNC:7978; NR3C1.
DR   HPA; CAB010435; -.
DR   HPA; HPA004248; -.
DR   MalaCards; NR3C1; -.
DR   MIM; 138040; gene.
DR   MIM; 615962; phenotype.
DR   neXtProt; NX_P04150; -.
DR   OpenTargets; ENSG00000113580; -.
DR   Orphanet; 786; Glucocorticoid resistance.
DR   PharmGKB; PA181; -.
DR   eggNOG; KOG3575; Eukaryota.
DR   eggNOG; ENOG410XRZC; LUCA.
DR   GeneTree; ENSGT00760000118887; -.
DR   HOGENOM; HOG000037950; -.
DR   HOVERGEN; HBG007583; -.
DR   InParanoid; P04150; -.
DR   KO; K05771; -.
DR   OMA; QSTFDIL; -.
DR   PhylomeDB; P04150; -.
DR   TreeFam; TF106510; -.
DR   Reactome; R-HSA-3371497; HSP90 chaperone cycle for steroid hormone receptors (SHR).
DR   Reactome; R-HSA-383280; Nuclear Receptor transcription pathway.
DR   Reactome; R-HSA-400253; Circadian Clock.
DR   Reactome; R-HSA-8849473; PTK6 Expression.
DR   Reactome; R-HSA-8939902; Regulation of RUNX2 expression and activity.
DR   SignaLink; P04150; -.
DR   SIGNOR; P04150; -.
DR   ChiTaRS; NR3C1; human.
DR   EvolutionaryTrace; P04150; -.
DR   GeneWiki; Glucocorticoid_receptor; -.
DR   GenomeRNAi; 2908; -.
DR   PRO; PR:P04150; -.
DR   Proteomes; UP000005640; Chromosome 5.
DR   Bgee; ENSG00000113580; -.
DR   CleanEx; HS_NR3C1; -.
DR   ExpressionAtlas; P04150; baseline and differential.
DR   Genevisible; P04150; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005815; C:microtubule organizing center; IEA:UniProtKB-SubCell.
DR   GO; GO:0005759; C:mitochondrial matrix; TAS:ProtInc.
DR   GO; GO:0016607; C:nuclear speck; IDA:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0032991; C:protein-containing complex; IDA:UniProtKB.
DR   GO; GO:0005819; C:spindle; IEA:UniProtKB-SubCell.
DR   GO; GO:0001047; F:core promoter binding; IDA:CAFA.
DR   GO; GO:0003700; F:DNA binding transcription factor activity; IDA:UniProtKB.
DR   GO; GO:0004883; F:glucocorticoid receptor activity; TAS:ProtInc.
DR   GO; GO:0038051; F:glucocorticoid-activated RNA polymerase II transcription factor binding transcription factor activity; IDA:UniProtKB.
DR   GO; GO:0051879; F:Hsp90 protein binding; IPI:UniProtKB.
DR   GO; GO:0019901; F:protein kinase binding; IPI:ARUK-UCL.
DR   GO; GO:0003723; F:RNA binding; IEA:UniProtKB-KW.
DR   GO; GO:0000978; F:RNA polymerase II proximal promoter sequence-specific DNA binding; IDA:NTNU_SB.
DR   GO; GO:0000981; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; ISA:NTNU_SB.
DR   GO; GO:0005496; F:steroid binding; IDA:UniProtKB.
DR   GO; GO:1990239; F:steroid hormone binding; IDA:UniProtKB.
DR   GO; GO:0032183; F:SUMO binding; IPI:CAFA.
DR   GO; GO:0001077; F:transcriptional activator activity, RNA polymerase II proximal promoter sequence-specific DNA binding; IDA:UniProtKB.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:0006915; P:apoptotic process; IEA:UniProtKB-KW.
DR   GO; GO:0007049; P:cell cycle; IEA:UniProtKB-KW.
DR   GO; GO:0051301; P:cell division; IEA:UniProtKB-KW.
DR   GO; GO:0071549; P:cellular response to dexamethasone stimulus; IMP:CAFA.
DR   GO; GO:0071385; P:cellular response to glucocorticoid stimulus; IDA:UniProtKB.
DR   GO; GO:0071383; P:cellular response to steroid hormone stimulus; IDA:UniProtKB.
DR   GO; GO:0071560; P:cellular response to transforming growth factor beta stimulus; IDA:CAFA.
DR   GO; GO:0006325; P:chromatin organization; IEA:UniProtKB-KW.
DR   GO; GO:0007059; P:chromosome segregation; IEA:UniProtKB-KW.
DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; IMP:CAFA.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IDA:UniProtKB.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; IDA:UniProtKB.
DR   GO; GO:0007165; P:signal transduction; TAS:ProtInc.
DR   GO; GO:0006366; P:transcription by RNA polymerase II; TAS:ProtInc.
DR   GO; GO:0006367; P:transcription initiation from RNA polymerase II promoter; TAS:Reactome.
DR   GO; GO:0006351; P:transcription, DNA-templated; IDA:CAFA.
DR   Gene3D; 3.30.50.10; -; 1.
DR   InterPro; IPR001409; Glcrtcd_rcpt.
DR   InterPro; IPR035500; NHR_like_dom_sf.
DR   InterPro; IPR000536; Nucl_hrmn_rcpt_lig-bd.
DR   InterPro; IPR001723; Nuclear_hrmn_rcpt.
DR   InterPro; IPR001628; Znf_hrmn_rcpt.
DR   InterPro; IPR013088; Znf_NHR/GATA.
DR   Pfam; PF02155; GCR; 1.
DR   Pfam; PF00104; Hormone_recep; 1.
DR   Pfam; PF00105; zf-C4; 1.
DR   PRINTS; PR00528; GLCORTICOIDR.
DR   PRINTS; PR00398; STRDHORMONER.
DR   PRINTS; PR00047; STROIDFINGER.
DR   SMART; SM00430; HOLI; 1.
DR   SMART; SM00399; ZnF_C4; 1.
DR   SUPFAM; SSF48508; SSF48508; 1.
DR   PROSITE; PS51843; NR_LBD; 1.
DR   PROSITE; PS00031; NUCLEAR_REC_DBD_1; 1.
DR   PROSITE; PS51030; NUCLEAR_REC_DBD_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative initiation;
KW   Alternative splicing; Apoptosis; Cell cycle; Cell division;
KW   Chromatin regulator; Chromosome partition; Complete proteome;
KW   Cytoplasm; Cytoskeleton; Disease mutation; DNA-binding;
KW   Isopeptide bond; Lipid-binding; Metal-binding; Methylation;
KW   Mitochondrion; Mitosis; Nucleus; Phosphoprotein; Polymorphism;
KW   Pseudohermaphroditism; Receptor; Reference proteome; RNA-binding;
KW   Steroid-binding; Transcription; Transcription regulation;
KW   Ubl conjugation; Zinc; Zinc-finger.
FT   CHAIN         1    777       Glucocorticoid receptor.
FT                                /FTId=PRO_0000019937.
FT   DOMAIN      524    758       NR LBD. {ECO:0000255|PROSITE-
FT                                ProRule:PRU01189}.
FT   DNA_BIND    418    493       Nuclear receptor. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00407}.
FT   ZN_FING     421    441       NR C4-type. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00407}.
FT   ZN_FING     457    476       NR C4-type. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00407}.
FT   REGION        1    420       Modulating.
FT   REGION       98    115       Required for high transcriptional
FT                                activity of isoform Alpha-C3.
FT                                {ECO:0000269|PubMed:23820903}.
FT   REGION      485    777       Interaction with CLOCK.
FT   REGION      487    523       Hinge.
FT   REGION      532    697       Interaction with CRY1.
FT                                {ECO:0000269|PubMed:22170608}.
FT   COMPBIAS    399    418       Glu/Pro/Ser/Thr-rich (PEST region).
FT   MOD_RES       8      8       Phosphothreonine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES      23     23       Omega-N-methylarginine.
FT                                {ECO:0000250|UniProtKB:P06537}.
FT   MOD_RES      45     45       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     113    113       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P06537}.
FT   MOD_RES     134    134       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   MOD_RES     141    141       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P06537}.
FT   MOD_RES     203    203       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569,
FT                                ECO:0000269|PubMed:12000743,
FT                                ECO:0000269|PubMed:18483179,
FT                                ECO:0000269|PubMed:25847991}.
FT   MOD_RES     211    211       Phosphoserine.
FT                                {ECO:0000269|PubMed:12000743,
FT                                ECO:0000269|PubMed:18483179,
FT                                ECO:0000269|PubMed:25847991}.
FT   MOD_RES     226    226       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000269|PubMed:18483179}.
FT   MOD_RES     267    267       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     404    404       Phosphoserine; by GSK3-beta.
FT                                {ECO:0000269|PubMed:18838540}.
FT   MOD_RES     480    480       N6-acetyllysine.
FT                                {ECO:0000269|PubMed:19141540}.
FT   MOD_RES     492    492       N6-acetyllysine.
FT                                {ECO:0000269|PubMed:19141540}.
FT   MOD_RES     494    494       N6-acetyllysine.
FT                                {ECO:0000269|PubMed:19141540}.
FT   MOD_RES     495    495       N6-acetyllysine.
FT                                {ECO:0000269|PubMed:19141540}.
FT   CROSSLNK    258    258       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    277    277       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO);
FT                                alternate. {ECO:0000269|PubMed:12144530}.
FT   CROSSLNK    277    277       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2);
FT                                alternate. {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    293    293       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO);
FT                                alternate. {ECO:0000269|PubMed:12144530}.
FT   CROSSLNK    293    293       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2);
FT                                alternate. {ECO:0000244|PubMed:25114211}.
FT   CROSSLNK    419    419       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in ubiquitin).
FT                                {ECO:0000250|UniProtKB:P06537}.
FT   CROSSLNK    703    703       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO).
FT                                {ECO:0000269|PubMed:12144530}.
FT   VAR_SEQ       1    335       Missing (in isoform Alpha-D3).
FT                                {ECO:0000269|PubMed:15866175}.
FT                                /FTId=VSP_058312.
FT   VAR_SEQ       1    330       Missing (in isoform Alpha-D2).
FT                                {ECO:0000269|PubMed:15866175}.
FT                                /FTId=VSP_058313.
FT   VAR_SEQ       1    315       Missing (in isoform Alpha-D1).
FT                                {ECO:0000269|PubMed:15866175}.
FT                                /FTId=VSP_058314.
FT   VAR_SEQ       1     97       Missing (in isoform Alpha-C3).
FT                                {ECO:0000269|PubMed:15866175}.
FT                                /FTId=VSP_058315.
FT   VAR_SEQ       1     89       Missing (in isoform Alpha-C2).
FT                                {ECO:0000269|PubMed:15866175}.
FT                                /FTId=VSP_058316.
FT   VAR_SEQ       1     85       Missing (in isoform Alpha-C1).
FT                                {ECO:0000269|PubMed:15866175}.
FT                                /FTId=VSP_058317.
FT   VAR_SEQ       1     26       Missing (in isoform Alpha-B and isoform
FT                                Beta-B). {ECO:0000305}.
FT                                /FTId=VSP_018773.
FT   VAR_SEQ     313    338       Missing (in isoform 10).
FT                                {ECO:0000303|PubMed:17404046}.
FT                                /FTId=VSP_043908.
FT   VAR_SEQ     451    451       G -> GR (in isoform Alpha-2 and isoform
FT                                Beta-2). {ECO:0000303|Ref.6}.
FT                                /FTId=VSP_007363.
FT   VAR_SEQ     491    674       Missing (in isoform GR-A alpha and
FT                                isoform GR-A beta). {ECO:0000305}.
FT                                /FTId=VSP_013340.
FT   VAR_SEQ     728    777       VVENLLNYCFQTFLDKTMSIEFPEMLAEIITNQIPKYSNGN
FT                                IKKLLFHQK -> NVMWLKPESTSHTLI (in isoform
FT                                Beta, isoform Beta-B, isoform Beta-2 and
FT                                isoform GR-A beta).
FT                                {ECO:0000303|PubMed:2867473}.
FT                                /FTId=VSP_003703.
FT   VARIANT      23     23       R -> K (polymorphism; reduces
FT                                transactivation activity; does not affect
FT                                transrepression activity; dbSNP:rs6190).
FT                                {ECO:0000269|PubMed:10391209,
FT                                ECO:0000269|PubMed:10898924,
FT                                ECO:0000269|PubMed:12351458,
FT                                ECO:0000269|PubMed:15276593,
FT                                ECO:0000269|PubMed:15292341,
FT                                ECO:0000269|PubMed:16030164,
FT                                ECO:0000269|PubMed:9150737,
FT                                ECO:0000269|Ref.9}.
FT                                /FTId=VAR_014140.
FT   VARIANT      29     29       F -> L (in dbSNP:rs148102613).
FT                                {ECO:0000269|PubMed:10898924}.
FT                                /FTId=VAR_015628.
FT   VARIANT      65     65       F -> V (in dbSNP:rs6192).
FT                                {ECO:0000269|PubMed:10391209,
FT                                ECO:0000269|Ref.9}.
FT                                /FTId=VAR_014622.
FT   VARIANT      72     72       N -> D (polymorphism; associated in cis
FT                                with A-321 and S-766 in one individual;
FT                                doubles transactivation potential).
FT                                {ECO:0000269|PubMed:21701417}.
FT                                /FTId=VAR_075797.
FT   VARIANT     112    112       L -> F (in dbSNP:rs542110718).
FT                                {ECO:0000269|PubMed:10898924}.
FT                                /FTId=VAR_015629.
FT   VARIANT     233    233       D -> N. {ECO:0000269|PubMed:10898924}.
FT                                /FTId=VAR_015630.
FT   VARIANT     321    321       V -> A (polymorphism; associated in cis
FT                                with D-72 and S-766 in one individual;
FT                                doubles transactivation potential).
FT                                {ECO:0000269|PubMed:21701417}.
FT                                /FTId=VAR_075798.
FT   VARIANT     363    363       N -> S (enhances transactivation
FT                                activity; does not affect transrepression
FT                                activity; may increase sensitivity to
FT                                exogenously administered glucocorticoids;
FT                                may contribute to central obesity in men
FT                                and show lack of association with other
FT                                risk factors for coronary heart disease
FT                                and diabetes mellitus; dbSNP:rs56149945).
FT                                {ECO:0000269|PubMed:10391209,
FT                                ECO:0000269|PubMed:10898924,
FT                                ECO:0000269|PubMed:11344238,
FT                                ECO:0000269|PubMed:16030164,
FT                                ECO:0000269|PubMed:8445027,
FT                                ECO:0000269|PubMed:9150737}.
FT                                /FTId=VAR_004675.
FT   VARIANT     421    421       C -> Y. {ECO:0000269|PubMed:8358735}.
FT                                /FTId=VAR_015631.
FT   VARIANT     423    423       V -> A (in GCCR; unknown pathological
FT                                significance; reduces transactivation
FT                                activity; delays nuclear translocation;
FT                                does not exert a dominant negative
FT                                effect; impairs DNA binding).
FT                                {ECO:0000269|PubMed:23426617}.
FT                                /FTId=VAR_075799.
FT   VARIANT     477    477       R -> H (in GCCR; dbSNP:rs104893913).
FT                                {ECO:0000269|PubMed:11589680}.
FT                                /FTId=VAR_013472.
FT   VARIANT     477    477       R -> S (in GCCR; loss of DNA-binding and
FT                                of transactivation activity; incomplete
FT                                dexamethasone-induced translocation to
FT                                the nucleus; no effect on dexamethasone-
FT                                binding affinity compared with wild-
FT                                type). {ECO:0000269|PubMed:27120390}.
FT                                /FTId=VAR_077143.
FT   VARIANT     478    478       Y -> C (in GCCR; decreased DNA-binding
FT                                and transactivation activity; incomplete
FT                                dexamethasone-induced translocation to
FT                                the nucleus; no effect on dexamethasone-
FT                                binding affinity compared with wild-
FT                                type). {ECO:0000269|PubMed:27120390}.
FT                                /FTId=VAR_077144.
FT   VARIANT     556    556       T -> I (in GCCR; reduces transactivation
FT                                activity; enhances transrepression
FT                                activity; reduces affinity for ligand;
FT                                delays nuclear translocation; does not
FT                                exert a dominant negative effect; does
FT                                not impair DNA binding).
FT                                {ECO:0000269|PubMed:21362280,
FT                                ECO:0000269|PubMed:26541474}.
FT                                /FTId=VAR_075800.
FT   VARIANT     559    559       I -> N (in GCCR; interferes with
FT                                translocation to the nucleus and thereby
FT                                strongly reduces transcription
FT                                activation; is equally impaired in
FT                                nuclear export; acts as dominant negative
FT                                mutant; dbSNP:rs104893909).
FT                                {ECO:0000269|PubMed:11701741}.
FT                                /FTId=VAR_015632.
FT   VARIANT     571    571       V -> A (in pseudohermaphroditism; female
FT                                with hypokalemia due to glucocorticoid
FT                                resistance; 6-fold reduction in binding
FT                                affinity compared with the wild-type
FT                                receptor; dbSNP:rs104893911).
FT                                {ECO:0000269|PubMed:11932321}.
FT                                /FTId=VAR_025014.
FT   VARIANT     575    575       V -> G (in GCCR; unknown pathological
FT                                significance; reduces transactivation
FT                                activity; enhances transrepression
FT                                activity; reduces affinity for ligand;
FT                                delays nuclear translocation; does not
FT                                exert a dominant negative effect; does
FT                                not impair DNA binding).
FT                                {ECO:0000269|PubMed:24483153}.
FT                                /FTId=VAR_075801.
FT   VARIANT     641    641       D -> V (in GCCR; dbSNP:rs104893908).
FT                                {ECO:0000269|PubMed:1704018}.
FT                                /FTId=VAR_004676.
FT   VARIANT     672    672       L -> P (in GCCR; loss of dexamethasone-
FT                                binding, dexamethasone-induced
FT                                translocation to the nucleus and of
FT                                transactivation activity).
FT                                {ECO:0000269|PubMed:27120390}.
FT                                /FTId=VAR_077145.
FT   VARIANT     679    679       G -> S (in GCCR; has 50% binding
FT                                affinity; dbSNP:rs104893914).
FT                                {ECO:0000269|PubMed:11589680}.
FT                                /FTId=VAR_013473.
FT   VARIANT     714    714       R -> Q (in GCCR; unknown pathological
FT                                significance; reduces transactivation;
FT                                reduces affinity for ligand; exerts a
FT                                dominant negative effect; does not impair
FT                                DNA binding).
FT                                {ECO:0000269|PubMed:20335448}.
FT                                /FTId=VAR_075802.
FT   VARIANT     726    726       H -> R (in GCCR; unknown pathological
FT                                significance; reduces transactivation and
FT                                transrepression activity; reduces
FT                                affinity for ligand; delays nuclear
FT                                translocation; does not impair DNA
FT                                binding). {ECO:0000269|PubMed:26031419}.
FT                                /FTId=VAR_075803.
FT   VARIANT     729    729       V -> I (in GCCR; dbSNP:rs1027058734).
FT                                {ECO:0000269|PubMed:7683692}.
FT                                /FTId=VAR_004677.
FT   VARIANT     737    737       F -> L (in GCCR; reduces transactivation
FT                                of the glucocorticoid-inducible tumor
FT                                virus promoter; reduces affinity for
FT                                ligand; delays its nuclear translocation;
FT                                acts as dominant negative mutant;
FT                                dbSNP:rs121909727).
FT                                {ECO:0000269|PubMed:17635946}.
FT                                /FTId=VAR_071935.
FT   VARIANT     747    747       I -> M (in GCCR; alters interaction with
FT                                NCOA2 and strongly reduces transcription
FT                                activation; acts as dominant negative
FT                                mutant; dbSNP:rs104893910).
FT                                {ECO:0000269|PubMed:12050230}.
FT                                /FTId=VAR_015633.
FT   VARIANT     753    753       L -> F (in dbSNP:rs121909726).
FT                                {ECO:0000269|PubMed:8316249,
FT                                ECO:0000269|PubMed:8358735}.
FT                                /FTId=VAR_004678.
FT   VARIANT     766    766       N -> S (polymorphism; associated in cis
FT                                with D-72 and A-321 in one individual;
FT                                doubles transactivation potential).
FT                                {ECO:0000269|PubMed:21701417}.
FT                                /FTId=VAR_075804.
FT   VARIANT     773    773       L -> P (in GCCR; reduces transactivation
FT                                of the glucocorticoid-inducible tumor
FT                                virus promoter; reduces affinity for
FT                                ligand; delays its nuclear translocation;
FT                                acts as dominant negative mutant;
FT                                dbSNP:rs104893912).
FT                                {ECO:0000269|PubMed:15769988}.
FT                                /FTId=VAR_071936.
FT   MUTAGEN       1      1       M->T: Abolishes expression of A-type
FT                                isoforms. {ECO:0000269|PubMed:11435610,
FT                                ECO:0000269|PubMed:15866175}.
FT   MUTAGEN      27     27       M->T: Abolishes expression of B-type
FT                                isoforms. {ECO:0000269|PubMed:11435610,
FT                                ECO:0000269|PubMed:15866175}.
FT   MUTAGEN      86     86       M->I: Abolishes expression of C-type
FT                                isoforms; when associated with I-90 and
FT                                I-98. {ECO:0000269|PubMed:15866175}.
FT   MUTAGEN      90     90       M->I: Abolishes expression of C-type
FT                                isoforms; when associated with I-86 and
FT                                I-98. {ECO:0000269|PubMed:15866175}.
FT   MUTAGEN      98     98       M->I: Abolishes expression of C-type
FT                                isoforms; when associated with I-86 and
FT                                I-90. {ECO:0000269|PubMed:15866175}.
FT   MUTAGEN     101    101       D->A: Reduces transcription activation
FT                                activity of isoform Alpha-C3 by half.
FT                                {ECO:0000269|PubMed:23820903}.
FT   MUTAGEN     101    101       D->K: Reduces transcription activation
FT                                activity of isoform Alpha-C3 by half.
FT                                Suppresses apoptosis-inducing activity of
FT                                isoform Alpha-C3. Impairs recruitment of
FT                                selected coregulators onto DNA binding
FT                                sites. {ECO:0000269|PubMed:23820903}.
FT   MUTAGEN     106    107       QQ->LL: Reduces activity of isoform
FT                                Alpha-C3 by half.
FT                                {ECO:0000269|PubMed:23820903}.
FT   MUTAGEN     113    114       SS->AA: Does not affect the activity of
FT                                isoform Alpha-C3.
FT                                {ECO:0000269|PubMed:23820903}.
FT   MUTAGEN     191    191       F->D: Reduces transactivation by the ADA
FT                                complex. {ECO:0000269|PubMed:9154805}.
FT   MUTAGEN     193    193       I->D: Reduces transactivation by the ADA
FT                                complex. {ECO:0000269|PubMed:9154805}.
FT   MUTAGEN     194    194       L->A: Strongly reduces transactivation by
FT                                the ADA complex; when associated with V-
FT                                224 and F-225.
FT                                {ECO:0000269|PubMed:9154805}.
FT   MUTAGEN     197    197       L->E: Reduces transactivation by the ADA
FT                                complex. {ECO:0000269|PubMed:9154805}.
FT   MUTAGEN     211    211       S->A: Reduces expression of target genes
FT                                IGFBP1 and IRF8.
FT                                {ECO:0000269|PubMed:18483179}.
FT   MUTAGEN     213    213       W->A: Strongly reduces transactivation by
FT                                the ADA complex.
FT                                {ECO:0000269|PubMed:9154805}.
FT   MUTAGEN     224    224       L->V: Strongly reduces transactivation by
FT                                the ADA complex; when associated with A-
FT                                194 and F-225.
FT                                {ECO:0000269|PubMed:9154805}.
FT   MUTAGEN     225    225       L->F: Strongly reduces transactivation by
FT                                the ADA complex; when associated with A-
FT                                194 and V-224.
FT                                {ECO:0000269|PubMed:9154805}.
FT   MUTAGEN     226    226       S->A: Abolishes phosphorylation and
FT                                enhances transcriptional activation.
FT                                {ECO:0000269|PubMed:18483179}.
FT   MUTAGEN     235    235       F->L: Strongly reduces transactivation by
FT                                the ADA complex; when associated with V-
FT                                236. {ECO:0000269|PubMed:9154805}.
FT   MUTAGEN     236    236       L->V: Strongly reduces transactivation by
FT                                the ADA complex; when associated with L-
FT                                235. {ECO:0000269|PubMed:9154805}.
FT   MUTAGEN     277    277       K->R: Strongly reduces sumoylation.
FT                                Almost complete loss of sumoylation; when
FT                                associated with R-293.
FT                                {ECO:0000269|PubMed:12144530}.
FT   MUTAGEN     293    293       K->R: Strongly reduces sumoylation.
FT                                Almost complete loss of sumoylation; when
FT                                associated with R-277.
FT                                {ECO:0000269|PubMed:12144530}.
FT   MUTAGEN     316    316       M->I: Abolishes expression of D-type
FT                                isoforms; when associated with I-331 and
FT                                I-336. {ECO:0000269|PubMed:15866175}.
FT   MUTAGEN     331    331       M->I: Abolishes expression of D-type
FT                                isoforms; when associated with I-316 and
FT                                I-336. {ECO:0000269|PubMed:15866175}.
FT   MUTAGEN     336    336       M->I: Abolishes expression of D-type
FT                                isoforms; when associated with I-316 and
FT                                I-331. {ECO:0000269|PubMed:15866175}.
FT   MUTAGEN     404    404       S->A: Abolishes phosphorylation. Does not
FT                                affect translocation to the nucleus
FT                                following ligand stimulation. Increases
FT                                protein half-life and transcriptional
FT                                repressor activity. Alters repertoire of
FT                                regulated genes. Increases cell death.
FT                                {ECO:0000269|PubMed:18838540}.
FT   MUTAGEN     404    404       S->D: Does not affect translocation to
FT                                the nucleus following ligand stimulation.
FT                                {ECO:0000269|PubMed:18838540}.
FT   MUTAGEN     480    480       K->A: Decrease in acetylation and in
FT                                repression of its transcriptional
FT                                activity by CLOCK-ARNTL/BMAL1
FT                                heterodimer. Complete loss in acetylation
FT                                and in repression of its transcriptional
FT                                activity by CLOCK-ARNTL/BMAL1
FT                                heterodimer; when associated with A-492;
FT                                A-494 and A-495.
FT                                {ECO:0000269|PubMed:19141540}.
FT   MUTAGEN     492    492       K->A: Decrease in acetylation and in
FT                                repression of its transcriptional
FT                                activity by CLOCK-ARNTL/BMAL1
FT                                heterodimer. Complete loss in acetylation
FT                                and in repression of its transcriptional
FT                                activity by CLOCK-ARNTL/BMAL1
FT                                heterodimer; when associated with A-480;
FT                                A-494 and A-495.
FT                                {ECO:0000269|PubMed:19141540}.
FT   MUTAGEN     494    494       K->A: Decrease in acetylation and in
FT                                repression of its transcriptional
FT                                activity by CLOCK-ARNTL/BMAL1
FT                                heterodimer; when associated with A-495.
FT                                Complete loss in acetylation and in
FT                                repression of its transcriptional
FT                                activity by CLOCK-ARNTL/BMAL1
FT                                heterodimer; when associated with A-480;
FT                                A-492 and A-495.
FT                                {ECO:0000269|PubMed:19141540}.
FT   MUTAGEN     495    495       K->A: Decrease in acetylation and in
FT                                repression of its transcriptional
FT                                activity by CLOCK-ARNTL/BMAL1
FT                                heterodimer; when associated with A-494.
FT                                Complete loss in acetylation and in
FT                                repression of its transcriptional
FT                                activity by CLOCK-ARNTL/BMAL1
FT                                heterodimer; when associated with A-480;
FT                                A-492 and A-494.
FT                                {ECO:0000269|PubMed:19141540}.
FT   MUTAGEN     585    585       R->A: Reduces activation mediated by
FT                                ligand binding domain; when associated
FT                                with A-590.
FT                                {ECO:0000269|PubMed:12151000}.
FT   MUTAGEN     590    590       D->A: Reduces activation mediated by
FT                                ligand binding domain; when associated
FT                                with A-585.
FT                                {ECO:0000269|PubMed:12151000}.
FT   MUTAGEN     602    602       F->S: Increases solubility. No effect on
FT                                transactivation by dexamethasone.
FT                                {ECO:0000269|PubMed:12151000}.
FT   MUTAGEN     625    625       P->A: Decreases transactivation by
FT                                dexamethasone by 95%.
FT                                {ECO:0000269|PubMed:12151000}.
FT   MUTAGEN     628    628       I->A: Decreases dimerization and
FT                                transactivation by dexamethasone; when
FT                                associated with S-602.
FT                                {ECO:0000269|PubMed:12151000}.
FT   MUTAGEN     703    703       K->R: Slightly reduces sumoylation.
FT                                Inhibits the stimulatory effect of RWDD3
FT                                on its transcriptional activity.
FT                                {ECO:0000269|PubMed:12144530,
FT                                ECO:0000269|PubMed:23508108}.
FT   CONFLICT    399    399       R -> G (in Ref. 7; BAD97314).
FT                                {ECO:0000305}.
FT   CONFLICT    754    754       A -> T (in Ref. 7; BAD97314).
FT                                {ECO:0000305}.
FT   TURN        422    424       {ECO:0000244|PDB:5E69}.
FT   STRAND      430    432       {ECO:0000244|PDB:5E69}.
FT   STRAND      435    437       {ECO:0000244|PDB:5E69}.
FT   HELIX       439    450       {ECO:0000244|PDB:5E69}.
FT   STRAND      458    461       {ECO:0000244|PDB:5E69}.
FT   TURN        467    472       {ECO:0000244|PDB:5E69}.
FT   HELIX       474    484       {ECO:0000244|PDB:5E69}.
FT   TURN        525    527       {ECO:0000244|PDB:1M2Z}.
FT   HELIX       532    538       {ECO:0000244|PDB:4UDD}.
FT   STRAND      550    552       {ECO:0000244|PDB:3K22}.
FT   HELIX       556    579       {ECO:0000244|PDB:4UDD}.
FT   HELIX       584    586       {ECO:0000244|PDB:4UDD}.
FT   HELIX       589    615       {ECO:0000244|PDB:4UDD}.
FT   STRAND      617    619       {ECO:0000244|PDB:4P6W}.
FT   STRAND      621    624       {ECO:0000244|PDB:4UDD}.
FT   STRAND      627    629       {ECO:0000244|PDB:4UDD}.
FT   HELIX       631    634       {ECO:0000244|PDB:4UDD}.
FT   HELIX       639    655       {ECO:0000244|PDB:4UDD}.
FT   HELIX       660    671       {ECO:0000244|PDB:4UDD}.
FT   STRAND      673    675       {ECO:0000244|PDB:4UDD}.
FT   HELIX       683    702       {ECO:0000244|PDB:4UDD}.
FT   STRAND      704    706       {ECO:0000244|PDB:4P6W}.
FT   HELIX       708    741       {ECO:0000244|PDB:4UDD}.
FT   HELIX       743    745       {ECO:0000244|PDB:4UDD}.
FT   HELIX       751    765       {ECO:0000244|PDB:4UDD}.
FT   STRAND      769    771       {ECO:0000244|PDB:5UC3}.
SQ   SEQUENCE   777 AA;  85659 MW;  C5C90C9A5DD16AAB CRC64;
     MDSKESLTPG REENPSSVLA QERGDVMDFY KTLRGGATVK VSASSPSLAV ASQSDSKQRR
     LLVDFPKGSV SNAQQPDLSK AVSLSMGLYM GETETKVMGN DLGFPQQGQI SLSSGETDLK
     LLEESIANLN RSTSVPENPK SSASTAVSAA PTEKEFPKTH SDVSSEQQHL KGQTGTNGGN
     VKLYTTDQST FDILQDLEFS SGSPGKETNE SPWRSDLLID ENCLLSPLAG EDDSFLLEGN
     SNEDCKPLIL PDTKPKIKDN GDLVLSSPSN VTLPQVKTEK EDFIELCTPG VIKQEKLGTV
     YCQASFPGAN IIGNKMSAIS VHGVSTSGGQ MYHYDMNTAS LSQQQDQKPI FNVIPPIPVG
     SENWNRCQGS GDDNLTSLGT LNFPGRTVFS NGYSSPSMRP DVSSPPSSSS TATTGPPPKL
     CLVCSDEASG CHYGVLTCGS CKVFFKRAVE GQHNYLCAGR NDCIIDKIRR KNCPACRYRK
     CLQAGMNLEA RKTKKKIKGI QQATTGVSQE TSENPGNKTI VPATLPQLTP TLVSLLEVIE
     PEVLYAGYDS SVPDSTWRIM TTLNMLGGRQ VIAAVKWAKA IPGFRNLHLD DQMTLLQYSW
     MFLMAFALGW RSYRQSSANL LCFAPDLIIN EQRMTLPCMY DQCKHMLYVS SELHRLQVSY
     EEYLCMKTLL LLSSVPKDGL KSQELFDEIR MTYIKELGKA IVKREGNSSQ NWQRFYQLTK
     LLDSMHEVVE NLLNYCFQTF LDKTMSIEFP EMLAEIITNQ IPKYSNGNIK KLLFHQK
//
ID   PRGR_HUMAN              Reviewed;         933 AA.
AC   P06401; A7LQ08; A7X8B0; B4E3T0; Q8TDS3; Q9UPF7;
DT   01-JAN-1988, integrated into UniProtKB/Swiss-Prot.
DT   21-MAR-2006, sequence version 4.
DT   23-MAY-2018, entry version 229.
DE   RecName: Full=Progesterone receptor;
DE            Short=PR;
DE   AltName: Full=Nuclear receptor subfamily 3 group C member 3;
GN   Name=PGR; Synonyms=NR3C3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], ALTERNATIVE PROMOTER USAGE, AND VARIANT
RP   THR-344.
RX   PubMed=2328727;
RA   Kastner P., Krust A., Turcotte B., Stropp U., Tora L., Gronemeyer H.,
RA   Chambon P.;
RT   "Two distinct estrogen-regulated promoters generate transcripts
RT   encoding the two functionally different human progesterone receptor
RT   forms A and B.";
RL   EMBO J. 9:1603-1614(1990).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT LEU-660.
RX   PubMed=3551956; DOI=10.1016/0006-291X(87)91416-1;
RA   Misrahi M., Atger M., D'Auriol L., Loosfelt H., Meriel C.,
RA   Fridlansky F., Guiochon-Mantel A., Galibert F., Milgrom E.;
RT   "Complete amino acid sequence of the human progesterone receptor
RT   deduced from cloned cDNA.";
RL   Biochem. Biophys. Res. Commun. 143:740-748(1987).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT LEU-660.
RA   Kieback D.G., Agoulnik I.U., Tong X.-W.;
RL   Submitted (JUL-1997) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 5).
RC   TISSUE=Mammary tumor;
RA   Hisatomi H., Wakita K., Kohno N., Nagao K., Hirata H., Hikiji K.;
RT   "Progesterone Receptor, alternative splicing variant, mRNA.";
RL   Submitted (APR-2002) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=18375150; DOI=10.1016/j.ympev.2007.12.026;
RA   Chen C., Opazo J.C., Erez O., Uddin M., Santolaya-Forgas J.,
RA   Goodman M., Grossman L.I., Romero R., Wildman D.E.;
RT   "The human progesterone receptor shows evidence of adaptive evolution
RT   associated with its ability to act as a transcription factor.";
RL   Mol. Phylogenet. Evol. 47:637-649(2008).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 4), ALTERNATIVE PROMOTER USAGE,
RP   AND VARIANT LEU-660.
RC   TISSUE=Adipose tissue, and Aorta;
RX   PubMed=12644308; DOI=10.1016/S0303-7207(02)00380-5;
RA   Saner K.J., Welter B.H., Zhang F., Hansen E., Dupont B., Wei Y.,
RA   Price T.M.;
RT   "Cloning and expression of a novel, truncated, progesterone
RT   receptor.";
RL   Mol. Cell. Endocrinol. 200:155-163(2003).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RC   TISSUE=Uterus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS THR-50; VAL-120;
RP   LEU-186; ARG-301; THR-344; SER-444; LEU-529; PRO-536; VAL-651 AND
RP   LEU-865.
RG   NIEHS SNPs program;
RL   Submitted (JAN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16554811; DOI=10.1038/nature04632;
RA   Taylor T.D., Noguchi H., Totoki Y., Toyoda A., Kuroki Y., Dewar K.,
RA   Lloyd C., Itoh T., Takeda T., Kim D.-W., She X., Barlow K.F.,
RA   Bloom T., Bruford E., Chang J.L., Cuomo C.A., Eichler E.,
RA   FitzGerald M.G., Jaffe D.B., LaButti K., Nicol R., Park H.-S.,
RA   Seaman C., Sougnez C., Yang X., Zimmer A.R., Zody M.C., Birren B.W.,
RA   Nusbaum C., Fujiyama A., Hattori M., Rogers J., Lander E.S.,
RA   Sakaki Y.;
RT   "Human chromosome 11 DNA sequence and analysis including novel gene
RT   identification.";
RL   Nature 440:497-500(2006).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [11]
RP   PROTEIN SEQUENCE OF 11-22 AND 673-679, PHOSPHORYLATION AT SER-20;
RP   SER-102; SER-130; SER-162; SER-190; SER-213; SER-345 AND SER-676, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=11110801; DOI=10.1074/jbc.M009805200;
RA   Knotts T.A., Orkiszewski R.S., Cook R.G., Edwards D.P., Weigel N.L.;
RT   "Identification of a phosphorylation site in the hinge region of the
RT   human progesterone receptor and additional amino-terminal
RT   phosphorylation sites.";
RL   J. Biol. Chem. 276:8475-8483(2001).
RN   [12]
RP   PROTEIN SEQUENCE OF 204-217, FUNCTION (ISOFORM 4), AND SUBCELLULAR
RP   LOCATION (ISOFORM 4).
RC   TISSUE=Heart;
RX   PubMed=23518922; DOI=10.1210/me.2012-1292;
RA   Dai Q., Shah A.A., Garde R.V., Yonish B.A., Zhang L., Medvitz N.A.,
RA   Miller S.E., Hansen E.L., Dunn C.N., Price T.M.;
RT   "A truncated progesterone receptor (PR-M) localizes to the
RT   mitochondrion and controls cellular respiration.";
RL   Mol. Endocrinol. 27:741-753(2013).
RN   [13]
RP   FUNCTION.
RX   PubMed=1587864;
RA   Meyer M.E., Quirin-Stricker C., Lerouge T., Bocquel M.T.,
RA   Gronemeyer H.;
RT   "A limiting factor mediates the differential activation of promoters
RT   by the human progesterone receptor isoforms.";
RL   J. Biol. Chem. 267:10882-10887(1992).
RN   [14]
RP   FUNCTION (ISOFORM A).
RX   PubMed=8264658; DOI=10.1210/mend.7.10.8264658;
RA   Vegeto E., Shahbaz M.M., Wen D.X., Goldman M.E., O'Malley B.W.,
RA   McDonnell D.P.;
RT   "Human progesterone receptor A form is a cell- and promoter-specific
RT   repressor of human progesterone receptor B function.";
RL   Mol. Endocrinol. 7:1244-1255(1993).
RN   [15]
RP   FUNCTION (ISOFORM A).
RX   PubMed=8180103; DOI=10.1016/0960-0760(94)90190-2;
RA   McDonnell D.P., Shahbaz M.M., Vegeto E., Goldman M.E.;
RT   "The human progesterone receptor A-form functions as a transcriptional
RT   modulator of mineralocorticoid receptor transcriptional activity.";
RL   J. Steroid Biochem. Mol. Biol. 48:425-432(1994).
RN   [16]
RP   FUNCTION.
RX   PubMed=7969170; DOI=10.1128/MCB.14.12.8356;
RA   Wen D.X., Xu Y.F., Mais D.E., Goldman M.E., McDonnell D.P.;
RT   "The A and B isoforms of the human progesterone receptor operate
RT   through distinct signaling pathways within target cells.";
RL   Mol. Cell. Biol. 14:8356-8364(1994).
RN   [17]
RP   PHOSPHORYLATION AT SER-81 AND SER-162.
RX   PubMed=7476977; DOI=10.1210/mend.9.8.7476977;
RA   Zhang Y., Beck C.A., Poletti A., Edwards D.P., Weigel N.L.;
RT   "Identification of a group of Ser-Pro motif hormone-inducible
RT   phosphorylation sites in the human progesterone receptor.";
RL   Mol. Endocrinol. 9:1029-1040(1995).
RN   [18]
RP   PHOSPHORYLATION AT SER-81; SER-102; SER-162; SER-294 AND SER-345.
RX   PubMed=8702648; DOI=10.1074/jbc.271.32.19546;
RA   Beck C.A., Zhang Y., Altmann M., Weigel N.L., Edwards D.P.;
RT   "Stoichiometry and site-specific phosphorylation of human progesterone
RT   receptor in native target cells and in the baculovirus expression
RT   system.";
RL   J. Biol. Chem. 271:19546-19555(1996).
RN   [19]
RP   FUNCTION.
RX   PubMed=9407067; DOI=10.1074/jbc.272.52.32889;
RA   Giangrande P.H., Pollio G., McDonnell D.P.;
RT   "Mapping and characterization of the functional domains responsible
RT   for the differential activity of the A and B isoforms of the human
RT   progesterone receptor.";
RL   J. Biol. Chem. 272:32889-32900(1997).
RN   [20]
RP   PHOSPHORYLATION AT SER-162; SER-190 AND SER-400.
RX   PubMed=9171245; DOI=10.1210/mend.11.6.0006;
RA   Zhang Y., Beck C.A., Poletti A., Clement J.P. IV, Prendergast P.,
RA   Yip T.-T., Hutchens T.W., Edwards D.P., Weigel N.L.;
RT   "Phosphorylation of human progesterone receptor by cyclin-dependent
RT   kinase 2 on three sites that are authentic basal phosphorylation sites
RT   in vivo.";
RL   Mol. Endocrinol. 11:823-832(1997).
RN   [21]
RP   TISSUE SPECIFICITY.
RX   PubMed=11041221; DOI=10.1093/humrep/15.suppl_3.48;
RA   Mote P.A., Balleine R.L., McGowan E.M., Clarke C.L.;
RT   "Heterogeneity of progesterone receptors A and B expression in human
RT   endometrial glands and stroma.";
RL   Hum. Reprod. 15:48-56(2000).
RN   [22]
RP   FUNCTION, AND INTERACTION WITH NCOR2; NCOA2 AND NCOA1.
RX   PubMed=10757795; DOI=10.1128/MCB.20.9.3102-3115.2000;
RA   Giangrande P.H., Kimbrel E.A., Edwards D.P., McDonnell D.P.;
RT   "The opposing transcriptional activities of the two isoforms of the
RT   human progesterone receptor are due to differential cofactor
RT   binding.";
RL   Mol. Cell. Biol. 20:3102-3115(2000).
RN   [23]
RP   PHOSPHORYLATION AT SER-190 AND SER-294.
RX   PubMed=10628747; DOI=10.1210/mend.14.1.0413;
RA   Clemm D.L., Sherman L., Boonyaratanakornkit V., Schrader W.T.,
RA   Weigel N.L., Edwards D.P.;
RT   "Differential hormone-dependent phosphorylation of progesterone
RT   receptor A and B forms revealed by a phosphoserine site-specific
RT   monoclonal antibody.";
RL   Mol. Endocrinol. 14:52-65(2000).
RN   [24]
RP   PHOSPHORYLATION AT SER-294, UBIQUITINATION, AND MUTAGENESIS OF
RP   SER-294; SER-344 AND SER-345.
RX   PubMed=10655479; DOI=10.1073/pnas.97.3.1032;
RA   Lange C.A., Shen T., Horwitz K.B.;
RT   "Phosphorylation of human progesterone receptors at serine-294 by
RT   mitogen-activated protein kinase signals their degradation by the 26S
RT   proteasome.";
RL   Proc. Natl. Acad. Sci. U.S.A. 97:1032-1037(2000).
RN   [25]
RP   FUNCTION, AND MUTAGENESIS OF LEU-55; LEU-58; LEU-59; LEU-115; LEU-118;
RP   LEU-119 AND TRP-140.
RX   PubMed=11546784; DOI=10.1074/jbc.M106843200;
RA   Tung L., Shen T., Abel M.G., Powell R.L., Takimoto G.S.,
RA   Sartorius C.A., Horwitz K.B.;
RT   "Mapping the unique activation function 3 in the progesterone B-
RT   receptor upstream segment. Two LXXLL motifs and a tryptophan residue
RT   are required for activity.";
RL   J. Biol. Chem. 276:39843-39851(2001).
RN   [26]
RP   INTERACTION WITH PRMT2.
RX   PubMed=12039952; DOI=10.1074/jbc.M201053200;
RA   Qi C., Chang J., Zhu Y., Yeldandi A.V., Rao S.M., Zhu Y.-J.;
RT   "Identification of protein arginine methyltransferase 2 as a
RT   coactivator for estrogen receptor alpha.";
RL   J. Biol. Chem. 277:28624-28630(2002).
RN   [27]
RP   INTERACTION WITH SMARD1.
RX   PubMed=12917342; DOI=10.1128/MCB.23.17.6210-6220.2003;
RA   Hsiao P.W., Fryer C.J., Trotter K.W., Wang W., Archer T.K.;
RT   "BAF60a mediates critical interactions between nuclear receptors and
RT   the BRG1 chromatin-remodeling complex for transactivation.";
RL   Mol. Cell. Biol. 23:6210-6220(2003).
RN   [28]
RP   PHOSPHORYLATION AT SER-400, FUNCTION, SUBCELLULAR LOCATION, AND
RP   MUTAGENESIS OF SER-400.
RX   PubMed=15572662; DOI=10.1128/MCB.24.24.10542-10557.2004;
RA   Pierson-Mullany L.K., Lange C.A.;
RT   "Phosphorylation of progesterone receptor serine 400 mediates ligand-
RT   independent transcriptional activity in response to activation of
RT   cyclin-dependent protein kinase 2.";
RL   Mol. Cell. Biol. 24:10542-10557(2004).
RN   [29]
RP   PHOSPHORYLATION AT SER-162; SER-190 AND SER-294, SUBCELLULAR LOCATION,
RP   AND FUNCTION.
RX   PubMed=15798179; DOI=10.1128/MCB.25.8.2885-2898.2005;
RA   Narayanan R., Edwards D.P., Weigel N.L.;
RT   "Human progesterone receptor displays cell cycle-dependent changes in
RT   transcriptional activity.";
RL   Mol. Cell. Biol. 25:2885-2898(2005).
RN   [30]
RP   INTERACTION WITH UNC45A.
RX   PubMed=16478993; DOI=10.1128/MCB.26.5.1722-1730.2006;
RA   Chadli A., Graham J.D., Abel M.G., Jackson T.A., Gordon D.F.,
RA   Wood W.M., Felts S.J., Horwitz K.B., Toft D.;
RT   "GCUNC-45 is a novel regulator for the progesterone receptor/hsp90
RT   chaperoning pathway.";
RL   Mol. Cell. Biol. 26:1722-1730(2006).
RN   [31]
RP   SUMOYLATION AT LYS-7; LYS-388 AND LYS-531, INTERACTION WITH PIAS3,
RP   FUNCTION, AND MUTAGENESIS OF LYS-7; LYS-388 AND LYS-531.
RX   PubMed=17020914; DOI=10.1093/nar/gkl691;
RA   Man J.-H., Li H.-Y., Zhang P.-J., Zhou T., He K., Pan X., Liang B.,
RA   Li A.-L., Zhao J., Gong W.-L., Jin B.-F., Xia Q., Yu M., Shen B.-F.,
RA   Zhang X.-M.;
RT   "PIAS3 induction of PRB sumoylation represses PRB transactivation by
RT   destabilizing its retention in the nucleus.";
RL   Nucleic Acids Res. 34:5552-5566(2006).
RN   [32]
RP   INTERACTION WITH CUEDC2, SUMOYLATION AT LYS-388, UBIQUITINATION AT
RP   LYS-388, FUNCTION, AND MUTAGENESIS OF LYS-388.
RX   PubMed=17347654; DOI=10.1038/sj.emboj.7601602;
RA   Zhang P.-J., Zhao J., Li H.-Y., Man J.-H., He K., Zhou T., Pan X.,
RA   Li A.-L., Gong W.-L., Jin B.-F., Xia Q., Yu M., Shen B.-F.,
RA   Zhang X.-M.;
RT   "CUE domain containing 2 regulates degradation of progesterone
RT   receptor by ubiquitin-proteasome.";
RL   EMBO J. 26:1831-1842(2007).
RN   [33]
RP   PHOSPHORYLATION AT SER-294, SUMOYLATION AT LYS-388, FUNCTION, AND
RP   MUTAGENESIS OF SER-294 AND LYS-388.
RX   PubMed=17717077; DOI=10.1210/me.2007-0248;
RA   Daniel A.R., Faivre E.J., Lange C.A.;
RT   "Phosphorylation-dependent antagonism of sumoylation derepresses
RT   progesterone receptor action in breast cancer cells.";
RL   Mol. Endocrinol. 21:2890-2906(2007).
RN   [34]
RP   PHOSPHORYLATION AT SER-294, FUNCTION, SUBCELLULAR LOCATION, AND
RP   MUTAGENESIS OF SER-294.
RX   PubMed=17173941; DOI=10.1016/j.steroids.2006.11.009;
RA   Daniel A.R., Qiu M., Faivre E.J., Ostrander J.H., Skildum A.,
RA   Lange C.A.;
RT   "Linkage of progestin and epidermal growth factor signaling:
RT   phosphorylation of progesterone receptors mediates transcriptional
RT   hypersensitivity and increased ligand-independent breast cancer cell
RT   growth.";
RL   Steroids 72:188-201(2007).
RN   [35]
RP   PHOSPHORYLATION AT SER-294; SER-345 AND SER-400, INTERACTION WITH SP1,
RP   FUNCTION, AND MUTAGENESIS OF SER-344; SER-345 AND SER-400.
RX   PubMed=18202149; DOI=10.1210/me.2007-0437;
RA   Faivre E.J., Daniel A.R., Hillard C.J., Lange C.A.;
RT   "Progesterone receptor rapid signaling mediates serine 345
RT   phosphorylation and tethering to specificity protein 1 transcription
RT   factors.";
RL   Mol. Endocrinol. 22:823-837(2008).
RN   [36]
RP   PALMITOYLATION.
RX   PubMed=22031296; DOI=10.1091/mbc.E11-07-0638;
RA   Pedram A., Razandi M., Deschenes R.J., Levin E.R.;
RT   "DHHC-7 and -21 are palmitoylacyltransferases for sex steroid
RT   receptors.";
RL   Mol. Biol. Cell 23:188-199(2012).
RN   [37]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-162, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [38]
RP   X-RAY CRYSTALLOGRAPHY (1.8 ANGSTROMS) OF 682-933.
RX   PubMed=9620806; DOI=10.1038/30775;
RA   Williams S.P., Sigler P.B.;
RT   "Atomic structure of progesterone complexed with its receptor.";
RL   Nature 393:392-396(1998).
RN   [39]
RP   X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) OF 676-933.
RX   PubMed=15937332; DOI=10.1074/jbc.M504144200;
RA   Zhang Z., Olland A.M., Zhu Y., Cohen J., Berrodin T., Chippari S.,
RA   Appavu C., Li S., Wilhem J., Chopra R., Fensome A., Zhang P.,
RA   Wrobel J., Unwalla R.J., Lyttle C.R., Winneker R.C.;
RT   "Molecular and pharmacological properties of a potent and selective
RT   novel nonsteroidal progesterone receptor agonist tanaproget.";
RL   J. Biol. Chem. 280:28468-28475(2005).
CC   -!- FUNCTION: The steroid hormones and their receptors are involved in
CC       the regulation of eukaryotic gene expression and affect cellular
CC       proliferation and differentiation in target tissues. Depending on
CC       the isoform, progesterone receptor functions as transcriptional
CC       activator or repressor. {ECO:0000269|PubMed:10757795,
CC       ECO:0000269|PubMed:1587864, ECO:0000269|PubMed:9407067,
CC       ECO:0000305}.
CC   -!- FUNCTION: Isoform A: Ligand-dependent transdominant repressor of
CC       steroid hormone receptor transcriptional activity including
CC       repression of its isoform B, MR and ER. Transrepressional activity
CC       may involve recruitment of corepressor NCOR2.
CC       {ECO:0000269|PubMed:7969170, ECO:0000269|PubMed:8180103,
CC       ECO:0000269|PubMed:8264658, ECO:0000305,
CC       ECO:0000305|PubMed:10757795}.
CC   -!- FUNCTION: Isoform B: Transcriptional activator of several
CC       progesteron-dependent promoters in a variety of cell types.
CC       Involved in activation of SRC-dependent MAPK signaling on hormone
CC       stimulation. {ECO:0000269|PubMed:7969170}.
CC   -!- FUNCTION: Isoform 4: Increases mitochondrial membrane potential
CC       and cellular respiration upon stimulation by progesterone.
CC   -!- SUBUNIT: Interacts with SMARD1 and UNC45A. Interacts with CUEDC2;
CC       the interaction promotes ubiquitination, decreases sumoylation,
CC       and represses transcriptional activity. Interacts with PIAS3; the
CC       interaction promotes sumoylation of PR in a hormone-dependent
CC       manner, inhibits DNA-binding, and alters nuclear export. Interacts
CC       with SP1; the interaction requires ligand-induced phosphorylation
CC       on Ser-345 by ERK1/2 MAPK. Interacts with PRMT2. Isoform A
CC       interacts with NCOR2. Isoform B (but not isoform A) interacts with
CC       NCOA2 and NCOA1. Isoform B (but not isoform A) interacts with
CC       KLF9. {ECO:0000250|UniProtKB:Q00175, ECO:0000269|PubMed:10757795,
CC       ECO:0000269|PubMed:12039952, ECO:0000269|PubMed:12917342,
CC       ECO:0000269|PubMed:16478993, ECO:0000269|PubMed:17020914,
CC       ECO:0000269|PubMed:17347654, ECO:0000269|PubMed:18202149}.
CC   -!- INTERACTION:
CC       Self; NbExp=2; IntAct=EBI-78539, EBI-78539;
CC       Q9H467:CUEDC2; NbExp=9; IntAct=EBI-78539, EBI-1248228;
CC       P03372:ESR1; NbExp=20; IntAct=EBI-78539, EBI-78473;
CC       P40763:STAT3; NbExp=3; IntAct=EBI-78539, EBI-518675;
CC   -!- SUBCELLULAR LOCATION: Nucleus. Cytoplasm. Note=Nucleoplasmic
CC       shuttling is both hormone- and cell cycle-dependent. On hormone
CC       stimulation, retained in the cytoplasm in the G(1) and G(2)/M
CC       phases.
CC   -!- SUBCELLULAR LOCATION: Isoform A: Nucleus. Cytoplasm. Note=Mainly
CC       nuclear.
CC   -!- SUBCELLULAR LOCATION: Isoform 4: Mitochondrion outer membrane
CC       {ECO:0000269|PubMed:23518922}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative promoter usage, Alternative splicing; Named isoforms=5;
CC       Name=B; Synonyms=PRB, PR-B;
CC         IsoId=P06401-1; Sequence=Displayed;
CC         Note=Produced by alternative promoter usage.;
CC       Name=A; Synonyms=PRA, PR-A;
CC         IsoId=P06401-2; Sequence=VSP_003706;
CC         Note=Produced by alternative promoter usage.;
CC       Name=3;
CC         IsoId=P06401-3; Sequence=VSP_046942;
CC         Note=Produced by alternative splicing of isoform B.;
CC       Name=4; Synonyms=PR-M;
CC         IsoId=P06401-4; Sequence=VSP_047454, VSP_047455;
CC         Note=Produced by alternative promoter usage.;
CC       Name=5; Synonyms=delta4;
CC         IsoId=P06401-5; Sequence=VSP_053543;
CC         Note=Produced by alternative splicing of isoform B.;
CC   -!- TISSUE SPECIFICITY: In reproductive tissues the expression of
CC       isoform A and isoform B varies as a consequence of developmental
CC       and hormonal status. Isoform A and isoform B are expressed in
CC       comparable levels in uterine glandular epithelium during the
CC       proliferative phase of the menstrual cycle. Expression of isoform
CC       B but not of isoform A persists in the glands during mid-secretory
CC       phase. In the stroma, isoform A is the predominant form throughout
CC       the cycle. Heterogeneous isoform expression between the glands of
CC       the endometrium basalis and functionalis is implying region-
CC       specific responses to hormonal stimuli.
CC       {ECO:0000269|PubMed:11041221}.
CC   -!- DOMAIN: Composed of three domains: a modulating N-terminal domain,
CC       a DNA-binding domain and a C-terminal ligand-binding domain.
CC   -!- PTM: Phosphorylated on multiple serine sites. Several of these
CC       sites are hormone-dependent. Phosphorylation on Ser-294 occurs
CC       preferentially on isoform B, is highly hormone-dependent and
CC       modulates ubiquitination and sumoylation on Lys-388.
CC       Phosphorylation on Ser-102 and Ser-345 also requires induction by
CC       hormone. Basal phosphorylation on Ser-81, Ser-162, Ser-190 and
CC       Ser-400 is increased in response to progesterone and can be
CC       phosphorylated in vitro by the CDK2-A1 complex. Increased levels
CC       of phosphorylation on Ser-400 also in the presence of EGF,
CC       heregulin, IGF, PMA and FBS. Phosphorylation at this site by CDK2
CC       is ligand-independent, and increases nuclear translocation and
CC       transcriptional activity. Phosphorylation at Ser-162 and Ser-294,
CC       but not at Ser-190, is impaired during the G(2)/M phase of the
CC       cell cycle. Phosphorylation on Ser-345 by ERK1/2 MAPK is required
CC       for interaction with SP1. {ECO:0000269|PubMed:10628747,
CC       ECO:0000269|PubMed:10655479, ECO:0000269|PubMed:11110801,
CC       ECO:0000269|PubMed:15572662, ECO:0000269|PubMed:15798179,
CC       ECO:0000269|PubMed:17020914, ECO:0000269|PubMed:17173941,
CC       ECO:0000269|PubMed:17347654, ECO:0000269|PubMed:17717077,
CC       ECO:0000269|PubMed:18202149, ECO:0000269|PubMed:7476977,
CC       ECO:0000269|PubMed:8702648, ECO:0000269|PubMed:9171245}.
CC   -!- PTM: Sumoylation is hormone-dependent and represses
CC       transcriptional activity. Sumoylation on all three sites is
CC       enhanced by PIAS3. Desumoylated by SENP1. Sumoylation on Lys-388,
CC       the main site of sumoylation, is repressed by ubiquitination on
CC       the same site, and modulated by phosphorylation at Ser-294.
CC       {ECO:0000269|PubMed:10628747, ECO:0000269|PubMed:10655479,
CC       ECO:0000269|PubMed:15798179, ECO:0000269|PubMed:17020914,
CC       ECO:0000269|PubMed:17173941, ECO:0000269|PubMed:17347654,
CC       ECO:0000269|PubMed:17717077, ECO:0000269|PubMed:18202149,
CC       ECO:0000269|PubMed:8702648}.
CC   -!- PTM: Ubiquitination is hormone-dependent and represses sumoylation
CC       on the same site. Promoted by MAPK-mediated phosphorylation on
CC       Ser-294. {ECO:0000269|PubMed:10628747,
CC       ECO:0000269|PubMed:10655479, ECO:0000269|PubMed:15798179,
CC       ECO:0000269|PubMed:17173941, ECO:0000269|PubMed:17717077,
CC       ECO:0000269|PubMed:18202149, ECO:0000269|PubMed:8702648}.
CC   -!- PTM: Palmitoylated by ZDHHC7 and ZDHHC21. Palmitoylation is
CC       required for plasma membrane targeting and for rapid intracellular
CC       signaling via ERK and AKT kinases and cAMP generation.
CC       {ECO:0000269|PubMed:22031296}.
CC   -!- SIMILARITY: Belongs to the nuclear hormone receptor family. NR3
CC       subfamily. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=NIEHS-SNPs;
CC       URL="http://egp.gs.washington.edu/data/pgr/";
CC   -!- WEB RESOURCE: Name=Wikipedia; Note=Progesterone receptor entry;
CC       URL="https://en.wikipedia.org/wiki/Progesterone_receptor";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X51730; CAA36018.1; -; mRNA.
DR   EMBL; M15716; AAA60081.1; -; mRNA.
DR   EMBL; AF016381; AAD01587.1; -; mRNA.
DR   EMBL; AB084248; BAB91074.1; -; mRNA.
DR   EMBL; DQ234979; ABB72139.1; -; Genomic_DNA.
DR   EMBL; AY212933; AAO61671.1; -; mRNA.
DR   EMBL; AK304853; BAG65592.1; -; mRNA.
DR   EMBL; AY525610; AAS00096.1; -; Genomic_DNA.
DR   EMBL; AP001533; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471065; EAW66999.1; -; Genomic_DNA.
DR   EMBL; CH471065; EAW67000.1; -; Genomic_DNA.
DR   CCDS; CCDS59229.1; -. [P06401-3]
DR   CCDS; CCDS8310.1; -. [P06401-1]
DR   PIR; S09971; QRHUP.
DR   RefSeq; NP_000917.3; NM_000926.4. [P06401-1]
DR   RefSeq; NP_001189403.1; NM_001202474.3. [P06401-2]
DR   RefSeq; NP_001258090.1; NM_001271161.2.
DR   RefSeq; NP_001258091.1; NM_001271162.1. [P06401-3]
DR   UniGene; Hs.32405; -.
DR   UniGene; Hs.742403; -.
DR   PDB; 1A28; X-ray; 1.80 A; A/B=678-933.
DR   PDB; 1E3K; X-ray; 2.80 A; A/B=676-933.
DR   PDB; 1SQN; X-ray; 1.45 A; A/B=673-933.
DR   PDB; 1SR7; X-ray; 1.46 A; A/B=676-933.
DR   PDB; 1ZUC; X-ray; 2.00 A; A/B=676-933.
DR   PDB; 2C7A; X-ray; 2.50 A; A/B=563-640.
DR   PDB; 2OVH; X-ray; 2.00 A; A=678-933.
DR   PDB; 2OVM; X-ray; 2.60 A; A=678-933.
DR   PDB; 2W8Y; X-ray; 1.80 A; A/B=678-933.
DR   PDB; 3D90; X-ray; 2.26 A; A/B=676-933.
DR   PDB; 3G8O; X-ray; 1.90 A; A/B=673-933.
DR   PDB; 3HQ5; X-ray; 2.10 A; A/B=678-933.
DR   PDB; 3KBA; X-ray; 2.00 A; A/B=681-933.
DR   PDB; 3ZR7; X-ray; 1.65 A; A/B=678-933.
DR   PDB; 3ZRA; X-ray; 1.90 A; A/B=678-933.
DR   PDB; 3ZRB; X-ray; 1.80 A; A/B=678-933.
DR   PDB; 4A2J; X-ray; 2.00 A; A/B=678-933.
DR   PDB; 4APU; X-ray; 1.90 A; A/B=678-933.
DR   PDB; 4OAR; X-ray; 2.41 A; A=678-933.
DR   PDB; 5CC0; X-ray; 2.40 A; A/B=561-641.
DR   PDBsum; 1A28; -.
DR   PDBsum; 1E3K; -.
DR   PDBsum; 1SQN; -.
DR   PDBsum; 1SR7; -.
DR   PDBsum; 1ZUC; -.
DR   PDBsum; 2C7A; -.
DR   PDBsum; 2OVH; -.
DR   PDBsum; 2OVM; -.
DR   PDBsum; 2W8Y; -.
DR   PDBsum; 3D90; -.
DR   PDBsum; 3G8O; -.
DR   PDBsum; 3HQ5; -.
DR   PDBsum; 3KBA; -.
DR   PDBsum; 3ZR7; -.
DR   PDBsum; 3ZRA; -.
DR   PDBsum; 3ZRB; -.
DR   PDBsum; 4A2J; -.
DR   PDBsum; 4APU; -.
DR   PDBsum; 4OAR; -.
DR   PDBsum; 5CC0; -.
DR   ProteinModelPortal; P06401; -.
DR   SMR; P06401; -.
DR   BioGrid; 111260; 68.
DR   DIP; DIP-5967N; -.
DR   ELM; P06401; -.
DR   IntAct; P06401; 14.
DR   MINT; P06401; -.
DR   STRING; 9606.ENSP00000325120; -.
DR   BindingDB; P06401; -.
DR   ChEMBL; CHEMBL208; -.
DR   DrugBank; DB01431; Allylestrenol.
DR   DrugBank; DB01406; Danazol.
DR   DrugBank; DB00304; Desogestrel.
DR   DrugBank; DB01395; Drospirenone.
DR   DrugBank; DB00378; Dydrogesterone.
DR   DrugBank; DB00823; Ethynodiol diacetate.
DR   DrugBank; DB00294; Etonogestrel.
DR   DrugBank; DB00588; Fluticasone Propionate.
DR   DrugBank; DB06789; Hydroxyprogesterone caproate.
DR   DrugBank; DB00367; Levonorgestrel.
DR   DrugBank; DB00603; Medroxyprogesterone acetate.
DR   DrugBank; DB00351; Megestrol acetate.
DR   DrugBank; DB02998; Methyltrienolone.
DR   DrugBank; DB00834; Mifepristone.
DR   DrugBank; DB06713; Norelgestromin.
DR   DrugBank; DB00717; Norethisterone.
DR   DrugBank; DB00957; Norgestimate.
DR   DrugBank; DB09389; Norgestrel.
DR   DrugBank; DB05253; Proellex.
DR   DrugBank; DB00396; Progesterone.
DR   DrugBank; DB00421; Spironolactone.
DR   DrugBank; DB04787; Tanaproget.
DR   DrugBank; DB08867; Ulipristal.
DR   GuidetoPHARMACOLOGY; 627; -.
DR   SwissLipids; SLP:000001574; -.
DR   iPTMnet; P06401; -.
DR   PhosphoSitePlus; P06401; -.
DR   SwissPalm; P06401; -.
DR   BioMuta; PGR; -.
DR   DMDM; 90110048; -.
DR   MaxQB; P06401; -.
DR   PaxDb; P06401; -.
DR   PeptideAtlas; P06401; -.
DR   PRIDE; P06401; -.
DR   DNASU; 5241; -.
DR   Ensembl; ENST00000263463; ENSP00000263463; ENSG00000082175. [P06401-5]
DR   Ensembl; ENST00000325455; ENSP00000325120; ENSG00000082175. [P06401-1]
DR   Ensembl; ENST00000534013; ENSP00000436561; ENSG00000082175. [P06401-3]
DR   GeneID; 5241; -.
DR   KEGG; hsa:5241; -.
DR   UCSC; uc001pgh.3; human. [P06401-1]
DR   CTD; 5241; -.
DR   DisGeNET; 5241; -.
DR   EuPathDB; HostDB:ENSG00000082175.14; -.
DR   GeneCards; PGR; -.
DR   HGNC; HGNC:8910; PGR.
DR   HPA; CAB000068; -.
DR   HPA; CAB055100; -.
DR   HPA; HPA004751; -.
DR   HPA; HPA008428; -.
DR   HPA; HPA017176; -.
DR   MalaCards; PGR; -.
DR   MIM; 607311; gene.
DR   neXtProt; NX_P06401; -.
DR   OpenTargets; ENSG00000082175; -.
DR   PharmGKB; PA266; -.
DR   eggNOG; KOG3575; Eukaryota.
DR   eggNOG; ENOG410XRZC; LUCA.
DR   GeneTree; ENSGT00760000118887; -.
DR   HOGENOM; HOG000290653; -.
DR   HOVERGEN; HBG007583; -.
DR   InParanoid; P06401; -.
DR   KO; K08556; -.
DR   OMA; CAYPPDA; -.
DR   OrthoDB; EOG091G04YC; -.
DR   PhylomeDB; P06401; -.
DR   TreeFam; TF106510; -.
DR   Reactome; R-HSA-1251985; Nuclear signaling by ERBB4.
DR   Reactome; R-HSA-3371497; HSP90 chaperone cycle for steroid hormone receptors (SHR).
DR   Reactome; R-HSA-383280; Nuclear Receptor transcription pathway.
DR   Reactome; R-HSA-9018519; Estrogen-dependent gene expression.
DR   SignaLink; P06401; -.
DR   SIGNOR; P06401; -.
DR   ChiTaRS; PGR; human.
DR   EvolutionaryTrace; P06401; -.
DR   GeneWiki; Progesterone_receptor; -.
DR   GenomeRNAi; 5241; -.
DR   PRO; PR:P06401; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   Bgee; ENSG00000082175; -.
DR   CleanEx; HS_PGR; -.
DR   ExpressionAtlas; P06401; baseline and differential.
DR   Genevisible; P06401; HS.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0005741; C:mitochondrial outer membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0051117; F:ATPase binding; IDA:MGI.
DR   GO; GO:0003677; F:DNA binding; TAS:ProtInc.
DR   GO; GO:0019899; F:enzyme binding; IPI:UniProtKB.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0004879; F:nuclear receptor activity; IEA:Ensembl.
DR   GO; GO:0000978; F:RNA polymerase II proximal promoter sequence-specific DNA binding; IDA:NTNU_SB.
DR   GO; GO:0000981; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; ISA:NTNU_SB.
DR   GO; GO:0005102; F:signaling receptor binding; IPI:UniProtKB.
DR   GO; GO:0005496; F:steroid binding; IEA:UniProtKB-KW.
DR   GO; GO:0003707; F:steroid hormone receptor activity; TAS:ProtInc.
DR   GO; GO:0001077; F:transcriptional activator activity, RNA polymerase II proximal promoter sequence-specific DNA binding; IDA:NTNU_SB.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:0007267; P:cell-cell signaling; TAS:ProtInc.
DR   GO; GO:0002070; P:epithelial cell maturation; IEA:Ensembl.
DR   GO; GO:0048286; P:lung alveolus development; IEA:Ensembl.
DR   GO; GO:0010629; P:negative regulation of gene expression; IEP:UniProtKB.
DR   GO; GO:0001542; P:ovulation from ovarian follicle; IEA:Ensembl.
DR   GO; GO:0038001; P:paracrine signaling; IEA:Ensembl.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IDA:NTNU_SB.
DR   GO; GO:0050847; P:progesterone receptor signaling pathway; IEA:Ensembl.
DR   GO; GO:0050678; P:regulation of epithelial cell proliferation; IEA:Ensembl.
DR   GO; GO:0007165; P:signal transduction; TAS:ProtInc.
DR   GO; GO:0060748; P:tertiary branching involved in mammary gland duct morphogenesis; IEA:Ensembl.
DR   GO; GO:0006367; P:transcription initiation from RNA polymerase II promoter; TAS:Reactome.
DR   Gene3D; 3.30.50.10; -; 1.
DR   InterPro; IPR035500; NHR_like_dom_sf.
DR   InterPro; IPR000536; Nucl_hrmn_rcpt_lig-bd.
DR   InterPro; IPR001723; Nuclear_hrmn_rcpt.
DR   InterPro; IPR000128; Progest_rcpt.
DR   InterPro; IPR001628; Znf_hrmn_rcpt.
DR   InterPro; IPR013088; Znf_NHR/GATA.
DR   Pfam; PF00104; Hormone_recep; 1.
DR   Pfam; PF02161; Prog_receptor; 1.
DR   Pfam; PF00105; zf-C4; 1.
DR   PRINTS; PR00544; PROGESTRONER.
DR   PRINTS; PR00398; STRDHORMONER.
DR   PRINTS; PR00047; STROIDFINGER.
DR   SMART; SM00430; HOLI; 1.
DR   SMART; SM00399; ZnF_C4; 1.
DR   SUPFAM; SSF48508; SSF48508; 2.
DR   PROSITE; PS51843; NR_LBD; 1.
DR   PROSITE; PS00031; NUCLEAR_REC_DBD_1; 1.
DR   PROSITE; PS51030; NUCLEAR_REC_DBD_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative promoter usage; Alternative splicing;
KW   Complete proteome; Cytoplasm; Direct protein sequencing; DNA-binding;
KW   Isopeptide bond; Lipid-binding; Lipoprotein; Membrane; Metal-binding;
KW   Mitochondrion; Mitochondrion outer membrane; Nucleus; Palmitate;
KW   Phosphoprotein; Polymorphism; Receptor; Reference proteome;
KW   Steroid-binding; Transcription; Transcription regulation;
KW   Ubl conjugation; Zinc; Zinc-finger.
FT   CHAIN         1    933       Progesterone receptor.
FT                                /FTId=PRO_0000053693.
FT   DOMAIN      679    913       NR LBD. {ECO:0000255|PROSITE-
FT                                ProRule:PRU01189}.
FT   DNA_BIND    567    639       Nuclear receptor. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00407}.
FT   ZN_FING     567    587       NR C4-type. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00407}.
FT   ZN_FING     603    627       NR C4-type. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00407}.
FT   REGION        1    566       Modulating, Pro-Rich.
FT   REGION        1    164       AF3; mediates transcriptional activation
FT                                (in isoform B).
FT                                {ECO:0000269|PubMed:11546784}.
FT   REGION      165    305       Mediates transcriptional transrepression
FT                                (in isoform A).
FT                                {ECO:0000269|PubMed:9407067}.
FT   REGION      456    546       AF1; mediates transcriptional activation.
FT                                {ECO:0000269|PubMed:1587864}.
FT   REGION      687    933       AF2; mediates transcriptional activation.
FT                                {ECO:0000269|PubMed:1587864}.
FT   MOTIF        55     59       LXXL motif 1.
FT                                {ECO:0000305|PubMed:11546784}.
FT   MOTIF       115    119       LXXL motif 2.
FT                                {ECO:0000305|PubMed:11546784}.
FT   MOTIF       183    187       Nuclear localization signal.
FT                                {ECO:0000255}.
FT   MOD_RES      20     20       Phosphoserine.
FT                                {ECO:0000269|PubMed:11110801}.
FT   MOD_RES      81     81       Phosphoserine.
FT                                {ECO:0000269|PubMed:7476977,
FT                                ECO:0000269|PubMed:8702648}.
FT   MOD_RES     102    102       Phosphoserine.
FT                                {ECO:0000269|PubMed:11110801,
FT                                ECO:0000269|PubMed:8702648}.
FT   MOD_RES     130    130       Phosphoserine.
FT                                {ECO:0000269|PubMed:11110801}.
FT   MOD_RES     162    162       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163,
FT                                ECO:0000269|PubMed:11110801,
FT                                ECO:0000269|PubMed:15798179,
FT                                ECO:0000269|PubMed:7476977,
FT                                ECO:0000269|PubMed:8702648,
FT                                ECO:0000269|PubMed:9171245}.
FT   MOD_RES     190    190       Phosphoserine.
FT                                {ECO:0000269|PubMed:10628747,
FT                                ECO:0000269|PubMed:11110801,
FT                                ECO:0000269|PubMed:15798179,
FT                                ECO:0000269|PubMed:9171245}.
FT   MOD_RES     213    213       Phosphoserine.
FT                                {ECO:0000269|PubMed:11110801}.
FT   MOD_RES     294    294       Phosphoserine; by MAPK1.
FT                                {ECO:0000269|PubMed:10628747,
FT                                ECO:0000269|PubMed:10655479,
FT                                ECO:0000269|PubMed:15798179,
FT                                ECO:0000269|PubMed:17173941,
FT                                ECO:0000269|PubMed:17717077,
FT                                ECO:0000269|PubMed:18202149,
FT                                ECO:0000269|PubMed:8702648}.
FT   MOD_RES     345    345       Phosphoserine; by MAPK.
FT                                {ECO:0000269|PubMed:11110801,
FT                                ECO:0000269|PubMed:18202149,
FT                                ECO:0000269|PubMed:8702648}.
FT   MOD_RES     400    400       Phosphoserine; by CDK2.
FT                                {ECO:0000269|PubMed:15572662,
FT                                ECO:0000269|PubMed:18202149,
FT                                ECO:0000269|PubMed:9171245}.
FT   MOD_RES     676    676       Phosphoserine.
FT                                {ECO:0000269|PubMed:11110801}.
FT   CROSSLNK      7      7       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO).
FT                                {ECO:0000269|PubMed:17020914}.
FT   CROSSLNK    388    388       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO);
FT                                alternate.
FT   CROSSLNK    388    388       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in ubiquitin);
FT                                alternate. {ECO:0000269|PubMed:17347654}.
FT   CROSSLNK    531    531       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO).
FT                                {ECO:0000269|PubMed:17020914}.
FT   VAR_SEQ       1    594       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_046942.
FT   VAR_SEQ       1    164       Missing (in isoform A). {ECO:0000305}.
FT                                /FTId=VSP_003706.
FT   VAR_SEQ       1     16       MTELKAKGPRAPHVAG -> MEFIYIYMNFFFFFSV (in
FT                                isoform 4).
FT                                {ECO:0000303|PubMed:12644308}.
FT                                /FTId=VSP_047454.
FT   VAR_SEQ      17    635       Missing (in isoform 4).
FT                                {ECO:0000303|PubMed:12644308}.
FT                                /FTId=VSP_047455.
FT   VAR_SEQ     636    737       Missing (in isoform 5).
FT                                {ECO:0000303|Ref.4}.
FT                                /FTId=VSP_053543.
FT   VARIANT      50     50       A -> T (in dbSNP:rs11571143).
FT                                {ECO:0000269|Ref.8}.
FT                                /FTId=VAR_019221.
FT   VARIANT     120    120       A -> V (in dbSNP:rs11571144).
FT                                {ECO:0000269|Ref.8}.
FT                                /FTId=VAR_019222.
FT   VARIANT     186    186       P -> L (in dbSNP:rs11571145).
FT                                {ECO:0000269|Ref.8}.
FT                                /FTId=VAR_019223.
FT   VARIANT     301    301       M -> R (in dbSNP:rs11571146).
FT                                {ECO:0000269|Ref.8}.
FT                                /FTId=VAR_019224.
FT   VARIANT     344    344       S -> T (in dbSNP:rs3740753).
FT                                {ECO:0000269|PubMed:2328727,
FT                                ECO:0000269|Ref.8}.
FT                                /FTId=VAR_016117.
FT   VARIANT     347    347       C -> S (in dbSNP:rs11571147).
FT                                /FTId=VAR_025555.
FT   VARIANT     444    444       A -> S (in dbSNP:rs11571150).
FT                                {ECO:0000269|Ref.8}.
FT                                /FTId=VAR_019225.
FT   VARIANT     529    529       V -> L (in dbSNP:rs11571151).
FT                                {ECO:0000269|Ref.8}.
FT                                /FTId=VAR_019226.
FT   VARIANT     536    536       Q -> P (in dbSNP:rs11571152).
FT                                {ECO:0000269|Ref.8}.
FT                                /FTId=VAR_019227.
FT   VARIANT     625    625       R -> I (in dbSNP:rs2020874).
FT                                /FTId=VAR_014627.
FT   VARIANT     651    651       L -> V (in dbSNP:rs11571222).
FT                                {ECO:0000269|Ref.8}.
FT                                /FTId=VAR_019228.
FT   VARIANT     660    660       V -> L (in dbSNP:rs1042838).
FT                                {ECO:0000269|PubMed:12644308,
FT                                ECO:0000269|PubMed:3551956,
FT                                ECO:0000269|Ref.3}.
FT                                /FTId=VAR_016118.
FT   VARIANT     865    865       S -> L (in dbSNP:rs2020880).
FT                                {ECO:0000269|Ref.8}.
FT                                /FTId=VAR_014628.
FT   MUTAGEN       7      7       K->R: Some loss of sumoylation; when
FT                                associated with R-531. Complete loss of
FT                                sumoylation; when associated with R-388
FT                                and R-531. {ECO:0000269|PubMed:17020914}.
FT   MUTAGEN      55     55       L->A: Reduces transcriptional activation;
FT                                when associated with A-58 and A-59.
FT                                {ECO:0000269|PubMed:11546784}.
FT   MUTAGEN      58     58       L->A: Reduces transcriptional activation;
FT                                when associated with A-55 and A-59.
FT                                {ECO:0000269|PubMed:11546784}.
FT   MUTAGEN      59     59       L->A: Reduces transcriptional activation;
FT                                when associated with A-55 and A-58.
FT                                {ECO:0000269|PubMed:11546784}.
FT   MUTAGEN     115    115       L->A: Reduces transcriptional activation;
FT                                when associated with A-118 and A-119.
FT                                {ECO:0000269|PubMed:11546784}.
FT   MUTAGEN     118    118       L->A: Reduces transcriptional activation;
FT                                when associated with A-115 and A-119.
FT                                {ECO:0000269|PubMed:11546784}.
FT   MUTAGEN     119    119       L->A: Reduces transcriptional activation;
FT                                when associated with A-115 and A-118.
FT                                {ECO:0000269|PubMed:11546784}.
FT   MUTAGEN     140    140       W->A,F,R: Reduces transcriptional
FT                                activation.
FT                                {ECO:0000269|PubMed:11546784}.
FT   MUTAGEN     294    294       S->A: No effect on interaction with
FT                                CUEDC2. Impaired progesterone-induced
FT                                transcriptional activity. No CUEDC2- nor
FT                                progestin-mediated protein degradation.
FT                                No change in sumoylation; when associated
FT                                with A-344 and A-345.
FT                                {ECO:0000269|PubMed:10655479,
FT                                ECO:0000269|PubMed:17173941,
FT                                ECO:0000269|PubMed:17717077}.
FT   MUTAGEN     294    294       S->D: Decreases protein stability and
FT                                increases progesterone-induced
FT                                transcriptional activity.
FT                                {ECO:0000269|PubMed:10655479,
FT                                ECO:0000269|PubMed:17173941,
FT                                ECO:0000269|PubMed:17717077}.
FT   MUTAGEN     344    344       S->A: No interaction with SP1. No change
FT                                in progestin-induced protein degradation;
FT                                when associated with A-345. No change in
FT                                sumoylation; when associated with A-294
FT                                and A-345. {ECO:0000269|PubMed:10655479,
FT                                ECO:0000269|PubMed:18202149}.
FT   MUTAGEN     345    345       S->A: No change in progestin-induced
FT                                protein degradation; when associated with
FT                                A-344. No change in sumoylation; when
FT                                associated with A-294 and A-344.
FT                                {ECO:0000269|PubMed:10655479,
FT                                ECO:0000269|PubMed:18202149}.
FT   MUTAGEN     388    388       K->R: Great loss of sumoylation; when
FT                                associated with R-7. Completely abolishes
FT                                sumoylation; when associated with R-7 and
FT                                R-531. Loss of CUEDC2-mediated protein
FT                                degradation. Increased ligand-dependent
FT                                transcriptional activity.
FT                                {ECO:0000269|PubMed:17020914,
FT                                ECO:0000269|PubMed:17347654,
FT                                ECO:0000269|PubMed:17717077}.
FT   MUTAGEN     400    400       S->A: Abolishes CDK2-induced activity in
FT                                the absence, but not in the presence, of
FT                                progestin. Delayed nuclear translocation
FT                                in presence of progestin.
FT                                {ECO:0000269|PubMed:15572662,
FT                                ECO:0000269|PubMed:18202149}.
FT   MUTAGEN     531    531       K->R: Some loss of sumoylation; when
FT                                associated with R-7. Completely abolishes
FT                                sumoylation; when associated with R-7 and
FT                                R-388. {ECO:0000269|PubMed:17020914}.
FT   CONFLICT    226    226       G -> S (in Ref. 1; CAA36018).
FT                                {ECO:0000305}.
FT   CONFLICT    256    256       V -> S (in Ref. 1; CAA36018).
FT                                {ECO:0000305}.
FT   TURN        568    570       {ECO:0000244|PDB:5CC0}.
FT   STRAND      576    578       {ECO:0000244|PDB:5CC0}.
FT   STRAND      581    583       {ECO:0000244|PDB:5CC0}.
FT   HELIX       585    596       {ECO:0000244|PDB:5CC0}.
FT   STRAND      604    607       {ECO:0000244|PDB:5CC0}.
FT   TURN        613    618       {ECO:0000244|PDB:5CC0}.
FT   HELIX       620    629       {ECO:0000244|PDB:5CC0}.
FT   HELIX       686    694       {ECO:0000244|PDB:1SQN}.
FT   HELIX       711    735       {ECO:0000244|PDB:1SQN}.
FT   HELIX       739    741       {ECO:0000244|PDB:1SQN}.
FT   HELIX       744    771       {ECO:0000244|PDB:1SQN}.
FT   STRAND      774    779       {ECO:0000244|PDB:1SQN}.
FT   STRAND      782    784       {ECO:0000244|PDB:1SQN}.
FT   HELIX       786    788       {ECO:0000244|PDB:1SQN}.
FT   HELIX       792    811       {ECO:0000244|PDB:1SQN}.
FT   HELIX       815    826       {ECO:0000244|PDB:1SQN}.
FT   STRAND      828    830       {ECO:0000244|PDB:1SQN}.
FT   HELIX       838    857       {ECO:0000244|PDB:1SQN}.
FT   HELIX       863    896       {ECO:0000244|PDB:1SQN}.
FT   HELIX       898    901       {ECO:0000244|PDB:1SQN}.
FT   HELIX       907    921       {ECO:0000244|PDB:1SQN}.
FT   STRAND      925    927       {ECO:0000244|PDB:1SQN}.
SQ   SEQUENCE   933 AA;  98981 MW;  80452E54FF3A0454 CRC64;
     MTELKAKGPR APHVAGGPPS PEVGSPLLCR PAAGPFPGSQ TSDTLPEVSA IPISLDGLLF
     PRPCQGQDPS DEKTQDQQSL SDVEGAYSRA EATRGAGGSS SSPPEKDSGL LDSVLDTLLA
     PSGPGQSQPS PPACEVTSSW CLFGPELPED PPAAPATQRV LSPLMSRSGC KVGDSSGTAA
     AHKVLPRGLS PARQLLLPAS ESPHWSGAPV KPSPQAAAVE VEEEDGSESE ESAGPLLKGK
     PRALGGAAAG GGAAAVPPGA AAGGVALVPK EDSRFSAPRV ALVEQDAPMA PGRSPLATTV
     MDFIHVPILP LNHALLAART RQLLEDESYD GGAGAASAFA PPRSSPCASS TPVAVGDFPD
     CAYPPDAEPK DDAYPLYSDF QPPALKIKEE EEGAEASARS PRSYLVAGAN PAAFPDFPLG
     PPPPLPPRAT PSRPGEAAVT AAPASASVSS ASSSGSTLEC ILYKAEGAPP QQGPFAPPPC
     KAPGASGCLL PRDGLPSTSA SAAAAGAAPA LYPALGLNGL PQLGYQAAVL KEGLPQVYPP
     YLNYLRPDSE ASQSPQYSFE SLPQKICLIC GDEASGCHYG VLTCGSCKVF FKRAMEGQHN
     YLCAGRNDCI VDKIRRKNCP ACRLRKCCQA GMVLGGRKFK KFNKVRVVRA LDAVALPQPV
     GVPNESQALS QRFTFSPGQD IQLIPPLINL LMSIEPDVIY AGHDNTKPDT SSSLLTSLNQ
     LGERQLLSVV KWSKSLPGFR NLHIDDQITL IQYSWMSLMV FGLGWRSYKH VSGQMLYFAP
     DLILNEQRMK ESSFYSLCLT MWQIPQEFVK LQVSQEEFLC MKVLLLLNTI PLEGLRSQTQ
     FEEMRSSYIR ELIKAIGLRQ KGVVSSSQRF YQLTKLLDNL HDLVKQLHLY CLNTFIQSRA
     LSVEFPEMMS EVIAAQLPKI LAGMVKPLLF HKK
//
ID   SC6B1_YEAST             Reviewed;          82 AA.
AC   P52870; D3DLZ4;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-1996, sequence version 1.
DT   23-MAY-2018, entry version 139.
DE   RecName: Full=Protein transport protein SBH1;
DE   AltName: Full=Sec61 complex subunit SBH1;
DE   AltName: Full=Sec61 complex subunit beta;
GN   Name=SBH1; Synonyms=SEB1; OrderedLocusNames=YER087C-B;
GN   ORFNames=YER087BC;
OS   Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast).
OC   Eukaryota; Fungi; Dikarya; Ascomycota; Saccharomycotina;
OC   Saccharomycetes; Saccharomycetales; Saccharomycetaceae; Saccharomyces.
OX   NCBI_TaxID=559292;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=8740416;
RX   DOI=10.1002/(SICI)1097-0061(199604)12:5<425::AID-YEA924>3.0.CO;2-B;
RA   Toikkanen J., Gatti E., Takei K., Saloheimo M., Olkkonen V.M.,
RA   Soederlund H., de Camilli P., Keraenen S.;
RT   "Yeast protein translocation complex: isolation of two genes SEB1 and
RT   SEB2 encoding proteins homologous to the Sec61 beta subunit.";
RL   Yeast 12:425-438(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 204508 / S288c;
RX   PubMed=9169868;
RA   Dietrich F.S., Mulligan J.T., Hennessy K.M., Yelton M.A., Allen E.,
RA   Araujo R., Aviles E., Berno A., Brennan T., Carpenter J., Chen E.,
RA   Cherry J.M., Chung E., Duncan M., Guzman E., Hartzell G.,
RA   Hunicke-Smith S., Hyman R.W., Kayser A., Komp C., Lashkari D., Lew H.,
RA   Lin D., Mosedale D., Nakahara K., Namath A., Norgren R., Oefner P.,
RA   Oh C., Petel F.X., Roberts D., Sehl P., Schramm S., Shogren T.,
RA   Smith V., Taylor P., Wei Y., Botstein D., Davis R.W.;
RT   "The nucleotide sequence of Saccharomyces cerevisiae chromosome V.";
RL   Nature 387:78-81(1997).
RN   [3]
RP   GENOME REANNOTATION.
RC   STRAIN=ATCC 204508 / S288c;
RX   PubMed=24374639; DOI=10.1534/g3.113.008995;
RA   Engel S.R., Dietrich F.S., Fisk D.G., Binkley G., Balakrishnan R.,
RA   Costanzo M.C., Dwight S.S., Hitz B.C., Karra K., Nash R.S., Weng S.,
RA   Wong E.D., Lloyd P., Skrzypek M.S., Miyasato S.R., Simison M.,
RA   Cherry J.M.;
RT   "The reference genome sequence of Saccharomyces cerevisiae: Then and
RT   now.";
RL   G3 (Bethesda) 4:389-398(2014).
RN   [4]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [5]
RP   ELECTRON MICROSCOPY OF THE SEC61 COMPLEX.
RX   PubMed=8929540; DOI=10.1016/S0092-8674(00)81391-4;
RA   Hanein D., Matlack K.E., Jungnickel B., Plath K., Kalies K.-U.,
RA   Miller K.R., Rapoport T.A., Akey C.W.;
RT   "Oligomeric rings of the Sec61p complex induced by ligands required
RT   for protein translocation.";
RL   Cell 87:721-732(1996).
RN   [6]
RP   TRANSLOCON COMPLEX PORE.
RX   PubMed=9160745; DOI=10.1016/S0092-8674(00)80235-4;
RA   Hamman B.D., Chen J.C., Johnson E.E., Johnson A.E.;
RT   "The aqueous pore through the translocon has a diameter of 40-60 A
RT   during cotranslational protein translocation at the ER membrane.";
RL   Cell 89:535-544(1997).
RN   [7]
RP   REVIEW ON THE TRANSLOCON COMPLEX.
RX   PubMed=10611978; DOI=10.1146/annurev.cellbio.15.1.799;
RA   Johnson A.E., van Waes M.A.;
RT   "The translocon: a dynamic gateway at the ER membrane.";
RL   Annu. Rev. Cell Dev. Biol. 15:799-842(1999).
RN   [8]
RP   ASSOCIATION OF THE SEC61 COMPLEX WITH RIBOSOMES.
RX   PubMed=10775273; DOI=10.1093/emboj/19.8.1900;
RA   Prinz A., Behrens C., Rapoport T.A., Hartmann E., Kalies K.-U.;
RT   "Evolutionarily conserved binding of ribosomes to the translocation
RT   channel via the large ribosomal RNA.";
RL   EMBO J. 19:1900-1906(2000).
RN   [9]
RP   INTERACTION WITH OST2; OST4 AND WBP1.
RX   PubMed=15831493; DOI=10.1074/jbc.M502858200;
RA   Chavan M., Yan A., Lennarz W.J.;
RT   "Subunits of the translocon interact with components of the
RT   oligosaccharyl transferase complex.";
RL   J. Biol. Chem. 280:22917-22924(2005).
CC   -!- FUNCTION: Part of the Sec61 complex, which is the major component
CC       of a channel-forming translocon complex that mediates protein
CC       translocation across the endoplasmic reticulum (ER). The
CC       functional states of the translocon complex include co- and post-
CC       translational ER import, cotranslational membrane protein
CC       integration and retrograde transport of misfolded proteins out of
CC       the ER. In the cotranslational pathway, ribosomes synthesizing
CC       presecretory proteins are targeted to the translocon by the
CC       cytosolic signal recognition particle (SRP) and its ER-localized
CC       receptor. The association of the Sec61 complex with the ribosome
CC       is mediated by the 28S rRNA of the large ribosomal subunit. SRP-
CC       independent post-translational translocation requires the
CC       association of additional factors, such as the Sec62/63 complex
CC       and KAR2.
CC   -!- SUBUNIT: Component of the heterotrimeric Sec61 complex, which is
CC       composed of SSH1, SBH1 and SSS1. Presumably three to four Sec61
CC       heterotrimers assemble into an oligomeric ring with a central
CC       aqueous pore. In cotranslational ER import, the pore diameter
CC       varies from 9-15 A in a ribosome-free resting state to 40-60 A in
CC       a functional state when associated with the ribosome. The Sec61
CC       complex is part of a channel-forming translocon complex whose
CC       composition seem to change dependent upon different functional
CC       states. During post-translational ER import the Sec61 complex
CC       associates with the Sec62/63 complex to form the Sec complex. SBH1
CC       interacts OST2, OST4 and WBP1 components of the OT complex.
CC       {ECO:0000269|PubMed:15831493}.
CC   -!- INTERACTION:
CC       P46964:OST2; NbExp=2; IntAct=EBI-16410, EBI-12673;
CC       Q99380:OST4; NbExp=2; IntAct=EBI-16410, EBI-12689;
CC       P33767:WBP1; NbExp=2; IntAct=EBI-16410, EBI-12658;
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane; Single-pass
CC       membrane protein.
CC   -!- SIMILARITY: Belongs to the SEC61-beta family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; Z47789; CAA87710.1; -; mRNA.
DR   EMBL; U18839; AAB64663.1; -; Genomic_DNA.
DR   EMBL; BK006939; DAA07748.1; -; Genomic_DNA.
DR   PIR; S68162; S68162.
DR   RefSeq; NP_011011.3; NM_001180032.3.
DR   ProteinModelPortal; P52870; -.
DR   SMR; P52870; -.
DR   BioGrid; 36832; 124.
DR   DIP; DIP-5681N; -.
DR   IntAct; P52870; 17.
DR   MINT; P52870; -.
DR   STRING; 4932.YER087C-B; -.
DR   TCDB; 3.A.5.8.1; the general secretory pathway (sec) family.
DR   iPTMnet; P52870; -.
DR   MaxQB; P52870; -.
DR   PaxDb; P52870; -.
DR   PRIDE; P52870; -.
DR   TopDownProteomics; P52870; -.
DR   EnsemblFungi; YER087C-B; YER087C-B; YER087C-B.
DR   GeneID; 856821; -.
DR   KEGG; sce:YER087C-B; -.
DR   EuPathDB; FungiDB:YER087C-B; -.
DR   SGD; S000002128; SBH1.
DR   HOGENOM; HOG000211109; -.
DR   InParanoid; P52870; -.
DR   KO; K09481; -.
DR   OrthoDB; EOG092C5YZH; -.
DR   BioCyc; YEAST:G3O-30349-MONOMER; -.
DR   PRO; PR:P52870; -.
DR   Proteomes; UP000002311; Chromosome V.
DR   GO; GO:0031205; C:endoplasmic reticulum Sec complex; IBA:GO_Central.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005784; C:Sec61 translocon complex; IDA:SGD.
DR   GO; GO:0005086; F:ARF guanyl-nucleotide exchange factor activity; IDA:SGD.
DR   GO; GO:0008565; F:protein transporter activity; IDA:SGD.
DR   GO; GO:0031204; P:posttranslational protein targeting to membrane, translocation; IDA:SGD.
DR   GO; GO:0006616; P:SRP-dependent cotranslational protein targeting to membrane, translocation; IMP:SGD.
DR   InterPro; IPR030671; Sec61-beta/Sbh.
DR   InterPro; IPR016482; SecG/Sec61-beta/Sbh.
DR   PANTHER; PTHR13509; PTHR13509; 1.
DR   Pfam; PF03911; Sec61_beta; 1.
DR   PIRSF; PIRSF006398; Sec61_beta_euk; 1.
PE   1: Evidence at protein level;
KW   Complete proteome; Endoplasmic reticulum; Membrane; Protein transport;
KW   Reference proteome; Translocation; Transmembrane; Transmembrane helix;
KW   Transport.
FT   CHAIN         1     82       Protein transport protein SBH1.
FT                                /FTId=PRO_0000157261.
FT   TOPO_DOM      1     53       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     54     74       Helical. {ECO:0000255}.
SQ   SEQUENCE   82 AA;  8711 MW;  23B0313EB37744FA CRC64;
     MSSPTPPGGQ RTLQKRKQGS SQKVAASAPK KNTNSNNSIL KIYSDEATGL RVDPLVVLFL
     AVGFIFSVVA LHVISKVAGK LF
//
ID   CGL_HUMAN               Reviewed;         405 AA.
AC   P32929; B4E1R2; E9PDV0; Q53FB3; Q53Y79; Q9H4W7; Q9H4W8;
DT   01-OCT-1993, integrated into UniProtKB/Swiss-Prot.
DT   10-JAN-2003, sequence version 3.
DT   28-FEB-2018, entry version 184.
DE   RecName: Full=Cystathionine gamma-lyase;
DE            EC=4.4.1.1;
DE   AltName: Full=Cysteine-protein sulfhydrase;
DE   AltName: Full=Gamma-cystathionase;
GN   Name=CTH;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2), AND VARIANT ILE-403.
RC   TISSUE=Liver;
RX   PubMed=1339280; DOI=10.1016/0006-291X(92)92265-Y;
RA   Lu Y., O'Dowd B.F., Orrego H., Israel Y.;
RT   "Cloning and nucleotide sequence of human liver cDNA encoding for
RT   cystathionine gamma-lyase.";
RL   Biochem. Biophys. Res. Commun. 189:749-758(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3), AND VARIANT
RP   ILE-403.
RC   TISSUE=Trachea;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT
RP   ILE-403.
RC   TISSUE=Kidney;
RA   Totoki Y., Toyoda A., Takeda T., Sakaki Y., Tanaka A., Yokoyama S.;
RL   Submitted (APR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   CATALYTIC ACTIVITY, SUBUNIT, COFACTOR, ENZYME REGULATION, AND
RP   BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=10212249; DOI=10.1074/jbc.274.18.12675;
RA   Steegborn C., Clausen T., Sondermann P., Jacob U., Worbs M.,
RA   Marinkovic S., Huber R., Wahl M.C.;
RT   "Kinetics and inhibition of recombinant human cystathionine gamma-
RT   lyase. Toward the rational control of transsulfuration.";
RL   J. Biol. Chem. 274:12675-12684(1999).
RN   [9]
RP   FUNCTION.
RX   PubMed=19261609; DOI=10.1074/jbc.M808026200;
RA   Chiku T., Padovani D., Zhu W., Singh S., Vitvitsky V., Banerjee R.;
RT   "H2S biogenesis by human cystathionine gamma-lyase leads to the novel
RT   sulfur metabolites lanthionine and homolanthionine and is responsive
RT   to the grade of hyperhomocysteinemia.";
RL   J. Biol. Chem. 284:11601-11612(2009).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [11]
RP   FUNCTION AS CYSTEINE-PROTEIN SULFHYDRASE.
RX   PubMed=22169477; DOI=10.1126/scisignal.2002329;
RA   Krishnan N., Fu C., Pappin D.J., Tonks N.K.;
RT   "H2s-induced sulfhydration of the phosphatase PTP1B and its role in
RT   the endoplasmic reticulum stress response.";
RL   Sci. Signal. 4:RA86-RA86(2011).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [13]
RP   X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) OF 1-402 IN COMPLEXES WITH
RP   PYRODOXAL PHOSPHATE; NITRATE AND PROPARGYLGLYCINE, FUNCTION, SUBUNIT,
RP   ENZYME REGULATION, CATALYTIC ACTIVITY, AND COFACTOR.
RX   PubMed=19019829; DOI=10.1074/jbc.M805459200;
RA   Sun Q., Collins R., Huang S., Holmberg-Schiavone L., Anand G.S.,
RA   Tan C.-H., van-den-Berg S., Deng L.-W., Moore P.K., Karlberg T.,
RA   Sivaraman J.;
RT   "Structural basis for the inhibition mechanism of human cystathionine
RT   gamma-lyase, an enzyme responsible for the production of H(2)S.";
RL   J. Biol. Chem. 284:3076-3085(2009).
RN   [14]
RP   VARIANTS CSTNU ILE-67 AND GLU-240, AND VARIANT ILE-403.
RX   PubMed=12574942; DOI=10.1007/s00439-003-0906-8;
RA   Wang J., Hegele R.A.;
RT   "Genomic basis of cystathioninuria (MIM 219500) revealed by multiple
RT   mutations in cystathionine gamma-lyase (CTH).";
RL   Hum. Genet. 112:404-408(2003).
RN   [15]
RP   CHARACTERIZATION OF VARIANTS CSTNU ILE-67 AND GLU-240, COFACTOR,
RP   BIOPHYSICOCHEMICAL PROPERTIES, AND SUBUNIT.
RX   PubMed=18476726; DOI=10.1021/bi800351a;
RA   Zhu W., Lin A., Banerjee R.;
RT   "Kinetic properties of polymorphic variants and pathogenic mutants in
RT   human cystathionine gamma-lyase.";
RL   Biochemistry 47:6226-6232(2008).
CC   -!- FUNCTION: Catalyzes the last step in the trans-sulfuration pathway
CC       from methionine to cysteine. Has broad substrate specificity.
CC       Converts cystathionine to cysteine, ammonia and 2-oxobutanoate.
CC       Converts two cysteine molecules to lanthionine and hydrogen
CC       sulfide. Can also accept homocysteine as substrate. Specificity
CC       depends on the levels of the endogenous substrates. Generates the
CC       endogenous signaling molecule hydrogen sulfide (H2S), and so
CC       contributes to the regulation of blood pressure. Acts as a
CC       cysteine-protein sulfhydrase by mediating sulfhydration of target
CC       proteins: sulfhydration consists of converting -SH groups into
CC       -SSH on specific cysteine residues of target proteins such as
CC       GAPDH, PTPN1 and NF-kappa-B subunit RELA, thereby regulating their
CC       function. {ECO:0000269|PubMed:19019829,
CC       ECO:0000269|PubMed:19261609, ECO:0000269|PubMed:22169477}.
CC   -!- CATALYTIC ACTIVITY: L-cystathionine + H(2)O = L-cysteine + NH(3) +
CC       2-oxobutanoate. {ECO:0000269|PubMed:10212249,
CC       ECO:0000269|PubMed:19019829}.
CC   -!- COFACTOR:
CC       Name=pyridoxal 5'-phosphate; Xref=ChEBI:CHEBI:597326;
CC         Evidence={ECO:0000269|PubMed:10212249,
CC         ECO:0000269|PubMed:18476726, ECO:0000269|PubMed:19019829};
CC   -!- ENZYME REGULATION: Inhibited by propargylglycine, trifluoroalanine
CC       and aminoethoxyvinylglycine. {ECO:0000269|PubMed:10212249,
CC       ECO:0000269|PubMed:19019829}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=0.5 mM for L-cystathionine {ECO:0000269|PubMed:10212249,
CC         ECO:0000269|PubMed:18476726};
CC         KM=5.4 mM for homocysteine {ECO:0000269|PubMed:10212249,
CC         ECO:0000269|PubMed:18476726};
CC         KM=3.5 mM for cysteine {ECO:0000269|PubMed:10212249,
CC         ECO:0000269|PubMed:18476726};
CC       pH dependence:
CC         Optimum pH is 8.2. {ECO:0000269|PubMed:10212249,
CC         ECO:0000269|PubMed:18476726};
CC   -!- PATHWAY: Amino-acid biosynthesis; L-cysteine biosynthesis; L-
CC       cysteine from L-homocysteine and L-serine: step 2/2.
CC   -!- SUBUNIT: Homotetramer. Interacts with CALM in a calcium-dependent
CC       manner (By similarity). {ECO:0000250}.
CC   -!- INTERACTION:
CC       Self; NbExp=4; IntAct=EBI-749763, EBI-749763;
CC       Q96NT3:GUCD1; NbExp=3; IntAct=EBI-749763, EBI-8293751;
CC       Q6P9E2:RECK; NbExp=5; IntAct=EBI-749763, EBI-10253121;
CC       Q96HA8:WDYHV1; NbExp=3; IntAct=EBI-749763, EBI-741158;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=P32929-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P32929-2; Sequence=VSP_006306;
CC       Name=3;
CC         IsoId=P32929-3; Sequence=VSP_047274;
CC   -!- DISEASE: Cystathioninuria (CSTNU) [MIM:219500]: Autosomal
CC       recessive phenotype characterized by abnormal accumulation of
CC       plasma cystathionine, leading to increased urinary excretion.
CC       {ECO:0000269|PubMed:12574942, ECO:0000269|PubMed:18476726}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- SIMILARITY: Belongs to the trans-sulfuration enzymes family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; S52784; AAB24700.1; -; mRNA.
DR   EMBL; S52028; AAB24699.1; -; mRNA.
DR   EMBL; BT006882; AAP35528.1; -; mRNA.
DR   EMBL; AK303946; BAG64874.1; -; mRNA.
DR   EMBL; AK223376; BAD97096.1; -; mRNA.
DR   EMBL; AL354872; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471059; EAX06450.1; -; Genomic_DNA.
DR   EMBL; BC015807; AAH15807.1; -; mRNA.
DR   CCDS; CCDS53333.1; -. [P32929-3]
DR   CCDS; CCDS650.1; -. [P32929-1]
DR   CCDS; CCDS651.1; -. [P32929-2]
DR   PIR; JC1362; JC1362.
DR   RefSeq; NP_001177392.1; NM_001190463.1. [P32929-3]
DR   RefSeq; NP_001893.2; NM_001902.5. [P32929-1]
DR   RefSeq; NP_714964.2; NM_153742.4. [P32929-2]
DR   UniGene; Hs.19904; -.
DR   PDB; 2NMP; X-ray; 2.60 A; A/B/C/D=1-402.
DR   PDB; 3COG; X-ray; 2.00 A; A/B/C/D=1-402.
DR   PDB; 3ELP; X-ray; 2.40 A; A/B/C/D=1-405.
DR   PDB; 5EIG; X-ray; 2.70 A; A/B/C/D/E/F/G/H=1-405.
DR   PDB; 5TSU; X-ray; 2.20 A; A/B/C/D/E/F/G/H=2-405.
DR   PDB; 5TT2; X-ray; 2.95 A; C/D=2-405.
DR   PDBsum; 2NMP; -.
DR   PDBsum; 3COG; -.
DR   PDBsum; 3ELP; -.
DR   PDBsum; 5EIG; -.
DR   PDBsum; 5TSU; -.
DR   PDBsum; 5TT2; -.
DR   ProteinModelPortal; P32929; -.
DR   SMR; P32929; -.
DR   BioGrid; 107873; 51.
DR   IntAct; P32929; 6.
DR   MINT; P32929; -.
DR   STRING; 9606.ENSP00000359976; -.
DR   BindingDB; P32929; -.
DR   DrugBank; DB02328; 2-[(3-Hydroxy-2-Methyl-5-Phosphonooxymethyl-Pyridin-4-Ylmethyl)-Imino]-5-Phosphono-Pent-3-Enoic Acid.
DR   DrugBank; DB04217; L-2-amino-3-butynoic acid.
DR   DrugBank; DB00151; L-Cysteine.
DR   DrugBank; DB00114; Pyridoxal Phosphate.
DR   GuidetoPHARMACOLOGY; 1444; -.
DR   iPTMnet; P32929; -.
DR   PhosphoSitePlus; P32929; -.
DR   BioMuta; CTH; -.
DR   DMDM; 27735163; -.
DR   EPD; P32929; -.
DR   MaxQB; P32929; -.
DR   PaxDb; P32929; -.
DR   PeptideAtlas; P32929; -.
DR   PRIDE; P32929; -.
DR   DNASU; 1491; -.
DR   Ensembl; ENST00000346806; ENSP00000311554; ENSG00000116761. [P32929-2]
DR   Ensembl; ENST00000370938; ENSP00000359976; ENSG00000116761. [P32929-1]
DR   Ensembl; ENST00000411986; ENSP00000413407; ENSG00000116761. [P32929-3]
DR   GeneID; 1491; -.
DR   KEGG; hsa:1491; -.
DR   UCSC; uc001dfd.4; human. [P32929-1]
DR   CTD; 1491; -.
DR   DisGeNET; 1491; -.
DR   EuPathDB; HostDB:ENSG00000116761.11; -.
DR   GeneCards; CTH; -.
DR   HGNC; HGNC:2501; CTH.
DR   HPA; HPA021591; -.
DR   HPA; HPA023300; -.
DR   MalaCards; CTH; -.
DR   MIM; 219500; phenotype.
DR   MIM; 607657; gene.
DR   neXtProt; NX_P32929; -.
DR   OpenTargets; ENSG00000116761; -.
DR   Orphanet; 212; Cystathioninuria.
DR   PharmGKB; PA27004; -.
DR   eggNOG; KOG0053; Eukaryota.
DR   eggNOG; COG0626; LUCA.
DR   GeneTree; ENSGT00390000000312; -.
DR   HOGENOM; HOG000246415; -.
DR   HOVERGEN; HBG005322; -.
DR   InParanoid; P32929; -.
DR   KO; K01758; -.
DR   OMA; HPGRMTH; -.
DR   OrthoDB; EOG091G0C7Z; -.
DR   PhylomeDB; P32929; -.
DR   TreeFam; TF300720; -.
DR   BioCyc; MetaCyc:HS04050-MONOMER; -.
DR   BRENDA; 4.4.1.1; 2681.
DR   Reactome; R-HSA-1614558; Degradation of cysteine and homocysteine.
DR   Reactome; R-HSA-1614603; Cysteine formation from homocysteine.
DR   Reactome; R-HSA-2408508; Metabolism of ingested SeMet, Sec, MeSec into H2Se.
DR   SABIO-RK; P32929; -.
DR   UniPathway; UPA00136; UER00202.
DR   ChiTaRS; CTH; human.
DR   EvolutionaryTrace; P32929; -.
DR   GenomeRNAi; 1491; -.
DR   PRO; PR:P32929; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000116761; -.
DR   CleanEx; HS_CTH; -.
DR   Genevisible; P32929; HS.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0005516; F:calmodulin binding; IEA:UniProtKB-KW.
DR   GO; GO:0016846; F:carbon-sulfur lyase activity; TAS:Reactome.
DR   GO; GO:0004123; F:cystathionine gamma-lyase activity; IDA:UniProtKB.
DR   GO; GO:0003962; F:cystathionine gamma-synthase activity; IBA:GO_Central.
DR   GO; GO:0047982; F:homocysteine desulfhydrase activity; TAS:Reactome.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0080146; F:L-cysteine desulfhydrase activity; TAS:Reactome.
DR   GO; GO:0044540; F:L-cystine L-cysteine-lyase (deaminating); IMP:UniProtKB.
DR   GO; GO:0030170; F:pyridoxal phosphate binding; IDA:UniProtKB.
DR   GO; GO:0071266; P:'de novo' L-methionine biosynthetic process; IBA:GO_Central.
DR   GO; GO:1990830; P:cellular response to leukemia inhibitory factor; IEA:Ensembl.
DR   GO; GO:0019344; P:cysteine biosynthetic process; IDA:UniProtKB.
DR   GO; GO:0019343; P:cysteine biosynthetic process via cystathionine; IDA:BHF-UCL.
DR   GO; GO:0006534; P:cysteine metabolic process; TAS:ProtInc.
DR   GO; GO:0030968; P:endoplasmic reticulum unfolded protein response; TAS:UniProtKB.
DR   GO; GO:0070814; P:hydrogen sulfide biosynthetic process; IDA:UniProtKB.
DR   GO; GO:2001234; P:negative regulation of apoptotic signaling pathway; IEA:Ensembl.
DR   GO; GO:1904831; P:positive regulation of aortic smooth muscle cell differentiation; IMP:BHF-UCL.
DR   GO; GO:0043123; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; IEA:Ensembl.
DR   GO; GO:0051092; P:positive regulation of NF-kappaB transcription factor activity; IEA:Ensembl.
DR   GO; GO:0051289; P:protein homotetramerization; IPI:UniProtKB.
DR   GO; GO:0044524; P:protein sulfhydration; IMP:UniProtKB.
DR   GO; GO:0018272; P:protein-pyridoxal-5-phosphate linkage via peptidyl-N6-pyridoxal phosphate-L-lysine; IDA:UniProtKB.
DR   GO; GO:0000098; P:sulfur amino acid catabolic process; TAS:Reactome.
DR   GO; GO:0019346; P:transsulfuration; IDA:BHF-UCL.
DR   CDD; cd00614; CGS_like; 1.
DR   Gene3D; 3.40.640.10; -; 1.
DR   Gene3D; 3.90.1150.10; -; 1.
DR   InterPro; IPR000277; Cys/Met-Metab_PyrdxlP-dep_enz.
DR   InterPro; IPR015424; PyrdxlP-dep_Trfase.
DR   InterPro; IPR015422; PyrdxlP-dep_Trfase_dom1.
DR   InterPro; IPR015421; PyrdxlP-dep_Trfase_major.
DR   PANTHER; PTHR11808; PTHR11808; 1.
DR   Pfam; PF01053; Cys_Met_Meta_PP; 1.
DR   PIRSF; PIRSF001434; CGS; 1.
DR   SUPFAM; SSF53383; SSF53383; 1.
DR   PROSITE; PS00868; CYS_MET_METAB_PP; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Amino-acid biosynthesis;
KW   Calmodulin-binding; Complete proteome; Cysteine biosynthesis;
KW   Cytoplasm; Disease mutation; Lyase; Polymorphism; Pyridoxal phosphate;
KW   Reference proteome.
FT   CHAIN         1    405       Cystathionine gamma-lyase.
FT                                /FTId=PRO_0000114749.
FT   BINDING      62     62       Substrate.
FT   BINDING     114    114       Substrate.
FT   BINDING     119    119       Substrate.
FT   BINDING     339    339       Substrate.
FT   MOD_RES     212    212       N6-(pyridoxal phosphate)lysine.
FT                                {ECO:0000250}.
FT   VAR_SEQ      85    116       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_047274.
FT   VAR_SEQ     153    196       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:1339280}.
FT                                /FTId=VSP_006306.
FT   VARIANT      67     67       T -> I (in CSTNU; reduces catalytic
FT                                activity and affinity for pyridoxal
FT                                phosphate; dbSNP:rs28941785).
FT                                {ECO:0000269|PubMed:12574942,
FT                                ECO:0000269|PubMed:18476726}.
FT                                /FTId=VAR_015450.
FT   VARIANT     240    240       Q -> E (in CSTNU; strongly reduces
FT                                catalytic activity and affinity for
FT                                pyridoxal phosphate; dbSNP:rs28941786).
FT                                {ECO:0000269|PubMed:12574942,
FT                                ECO:0000269|PubMed:18476726}.
FT                                /FTId=VAR_015451.
FT   VARIANT     403    403       S -> I (in dbSNP:rs1021737).
FT                                {ECO:0000269|PubMed:12574942,
FT                                ECO:0000269|PubMed:1339280,
FT                                ECO:0000269|PubMed:14702039,
FT                                ECO:0000269|Ref.4}.
FT                                /FTId=VAR_015452.
FT   HELIX        18     24       {ECO:0000244|PDB:3COG}.
FT   HELIX        29     31       {ECO:0000244|PDB:3COG}.
FT   STRAND       36     38       {ECO:0000244|PDB:3COG}.
FT   STRAND       45     47       {ECO:0000244|PDB:5TSU}.
FT   TURN         61     63       {ECO:0000244|PDB:3COG}.
FT   HELIX        66     79       {ECO:0000244|PDB:3COG}.
FT   STRAND       82     88       {ECO:0000244|PDB:3COG}.
FT   HELIX        90     98       {ECO:0000244|PDB:3COG}.
FT   STRAND      106    112       {ECO:0000244|PDB:3COG}.
FT   HELIX       115    123       {ECO:0000244|PDB:3COG}.
FT   HELIX       125    128       {ECO:0000244|PDB:3COG}.
FT   STRAND      131    135       {ECO:0000244|PDB:3COG}.
FT   HELIX       140    146       {ECO:0000244|PDB:3COG}.
FT   STRAND      151    159       {ECO:0000244|PDB:3COG}.
FT   TURN        161    163       {ECO:0000244|PDB:3COG}.
FT   HELIX       169    176       {ECO:0000244|PDB:3COG}.
FT   STRAND      178    180       {ECO:0000244|PDB:3COG}.
FT   STRAND      183    187       {ECO:0000244|PDB:3COG}.
FT   TURN        189    191       {ECO:0000244|PDB:3COG}.
FT   TURN        193    195       {ECO:0000244|PDB:3COG}.
FT   TURN        198    202       {ECO:0000244|PDB:3COG}.
FT   STRAND      204    209       {ECO:0000244|PDB:3COG}.
FT   TURN        210    215       {ECO:0000244|PDB:3COG}.
FT   STRAND      223    227       {ECO:0000244|PDB:3COG}.
FT   HELIX       230    243       {ECO:0000244|PDB:3COG}.
FT   HELIX       249    259       {ECO:0000244|PDB:3COG}.
FT   HELIX       262    281       {ECO:0000244|PDB:3COG}.
FT   STRAND      286    290       {ECO:0000244|PDB:3COG}.
FT   HELIX       300    306       {ECO:0000244|PDB:3COG}.
FT   STRAND      312    320       {ECO:0000244|PDB:3COG}.
FT   HELIX       322    331       {ECO:0000244|PDB:3COG}.
FT   STRAND      333    337       {ECO:0000244|PDB:3COG}.
FT   STRAND      342    345       {ECO:0000244|PDB:3COG}.
FT   STRAND      347    349       {ECO:0000244|PDB:3COG}.
FT   TURN        351    358       {ECO:0000244|PDB:3COG}.
FT   HELIX       361    367       {ECO:0000244|PDB:3COG}.
FT   STRAND      373    377       {ECO:0000244|PDB:3COG}.
FT   HELIX       383    397       {ECO:0000244|PDB:3COG}.
SQ   SEQUENCE   405 AA;  44508 MW;  003246D7C1D16723 CRC64;
     MQEKDASSQG FLPHFQHFAT QAIHVGQDPE QWTSRAVVPP ISLSTTFKQG APGQHSGFEY
     SRSGNPTRNC LEKAVAALDG AKYCLAFASG LAATVTITHL LKAGDQIICM DDVYGGTNRY
     FRQVASEFGL KISFVDCSKI KLLEAAITPE TKLVWIETPT NPTQKVIDIE GCAHIVHKHG
     DIILVVDNTF MSPYFQRPLA LGADISMYSA TKYMNGHSDV VMGLVSVNCE SLHNRLRFLQ
     NSLGAVPSPI DCYLCNRGLK TLHVRMEKHF KNGMAVAQFL ESNPWVEKVI YPGLPSHPQH
     ELVKRQCTGC TGMVTFYIKG TLQHAEIFLK NLKLFTLAES LGGFESLAEL PAIMTHASVL
     KNDRDVLGIS DTLIRLSVGL EDEEDLLEDL DQALKAAHPP SGSHS
//
ID   LSM7_HUMAN              Reviewed;         103 AA.
AC   Q9UK45;
DT   01-DEC-2000, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-2000, sequence version 1.
DT   28-MAR-2018, entry version 154.
DE   RecName: Full=U6 snRNA-associated Sm-like protein LSm7;
GN   Name=LSM7;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND PARTIAL PROTEIN SEQUENCE.
RX   PubMed=10523320; DOI=10.1093/emboj/18.20.5789;
RA   Achsel T., Brahms H., Kastner B., Bachi A., Wilm M., Luehrmann R.;
RT   "A doughnut-shaped heteromer of human Sm-like proteins binds to the
RT   3'-end of U6 snRNA, thereby facilitating U4/U6 duplex formation in
RT   vitro.";
RL   EMBO J. 18:5789-5802(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057824; DOI=10.1038/nature02399;
RA   Grimwood J., Gordon L.A., Olsen A.S., Terry A., Schmutz J.,
RA   Lamerdin J.E., Hellsten U., Goodstein D., Couronne O., Tran-Gyamfi M.,
RA   Aerts A., Altherr M., Ashworth L., Bajorek E., Black S., Branscomb E.,
RA   Caenepeel S., Carrano A.V., Caoile C., Chan Y.M., Christensen M.,
RA   Cleland C.A., Copeland A., Dalin E., Dehal P., Denys M., Detter J.C.,
RA   Escobar J., Flowers D., Fotopulos D., Garcia C., Georgescu A.M.,
RA   Glavina T., Gomez M., Gonzales E., Groza M., Hammon N., Hawkins T.,
RA   Haydu L., Ho I., Huang W., Israni S., Jett J., Kadner K., Kimball H.,
RA   Kobayashi A., Larionov V., Leem S.-H., Lopez F., Lou Y., Lowry S.,
RA   Malfatti S., Martinez D., McCready P.M., Medina C., Morgan J.,
RA   Nelson K., Nolan M., Ovcharenko I., Pitluck S., Pollard M.,
RA   Popkie A.P., Predki P., Quan G., Ramirez L., Rash S., Retterer J.,
RA   Rodriguez A., Rogers S., Salamov A., Salazar A., She X., Smith D.,
RA   Slezak T., Solovyev V., Thayer N., Tice H., Tsai M., Ustaszewska A.,
RA   Vo N., Wagner M., Wheeler J., Wu K., Xie G., Yang J., Dubchak I.,
RA   Furey T.S., DeJong P., Dickson M., Gordon D., Eichler E.E.,
RA   Pennacchio L.A., Richardson P., Stubbs L., Rokhsar D.S., Myers R.M.,
RA   Rubin E.M., Lucas S.M.;
RT   "The DNA sequence and biology of human chromosome 19.";
RL   Nature 428:529-535(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=B-cell;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   INTERACTION WITH TACC1.
RX   PubMed=12165861; DOI=10.1038/sj.onc.1205658;
RA   Conte N., Charafe-Jauffret E., Delaval B., Adelaide J., Ginestier C.,
RA   Geneix J., Isnardon D., Jacquemier J., Birnbaum D.;
RT   "Carcinogenesis and translational controls: TACC1 is down-regulated in
RT   human cancers and associates with mRNA regulators.";
RL   Oncogene 21:5619-5630(2002).
RN   [5]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [6]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
CC   -!- FUNCTION: Binds specifically to the 3'-terminal U-tract of U6
CC       snRNA and is probably a component of the spliceosome.
CC   -!- SUBUNIT: LSm subunits form a heteromer with a doughnut shape. Also
CC       interacts with TACC1. {ECO:0000269|PubMed:12165861}.
CC   -!- INTERACTION:
CC       Q96D03:DDIT4L; NbExp=7; IntAct=EBI-348372, EBI-742054;
CC       Q9Y333:LSM2; NbExp=9; IntAct=EBI-348372, EBI-347416;
CC       P62310:LSM3; NbExp=6; IntAct=EBI-348372, EBI-348239;
CC       Q9Y4Z0:LSM4; NbExp=8; IntAct=EBI-348372, EBI-372521;
CC       Q9Y4Y9:LSM5; NbExp=14; IntAct=EBI-348372, EBI-373007;
CC       P62312:LSM6; NbExp=4; IntAct=EBI-348372, EBI-373310;
CC       P62318:SNRPD3; NbExp=3; IntAct=EBI-348372, EBI-372789;
CC       P62306:SNRPF; NbExp=3; IntAct=EBI-348372, EBI-356900;
CC       O75410-1:TACC1; NbExp=4; IntAct=EBI-348372, EBI-624252;
CC       O75410-6:TACC1; NbExp=2; IntAct=EBI-348372, EBI-624278;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the snRNP Sm proteins family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF182293; AAD56231.1; -; mRNA.
DR   EMBL; AC005258; AAG45442.1; -; Genomic_DNA.
DR   EMBL; BC018621; AAH18621.1; -; mRNA.
DR   CCDS; CCDS45907.1; -.
DR   RefSeq; NP_057283.1; NM_016199.2.
DR   UniGene; Hs.512610; -.
DR   PDB; 3JCR; EM; 7.00 A; 7=1-103.
DR   PDB; 5O9Z; EM; 4.50 A; t=1-103.
DR   PDBsum; 3JCR; -.
DR   PDBsum; 5O9Z; -.
DR   ProteinModelPortal; Q9UK45; -.
DR   SMR; Q9UK45; -.
DR   BioGrid; 119678; 58.
DR   CORUM; Q9UK45; -.
DR   DIP; DIP-31129N; -.
DR   IntAct; Q9UK45; 25.
DR   MINT; Q9UK45; -.
DR   STRING; 9606.ENSP00000252622; -.
DR   iPTMnet; Q9UK45; -.
DR   PhosphoSitePlus; Q9UK45; -.
DR   BioMuta; LSM7; -.
DR   DMDM; 10720075; -.
DR   EPD; Q9UK45; -.
DR   MaxQB; Q9UK45; -.
DR   PaxDb; Q9UK45; -.
DR   PeptideAtlas; Q9UK45; -.
DR   PRIDE; Q9UK45; -.
DR   TopDownProteomics; Q9UK45; -.
DR   DNASU; 51690; -.
DR   Ensembl; ENST00000252622; ENSP00000252622; ENSG00000130332.
DR   GeneID; 51690; -.
DR   KEGG; hsa:51690; -.
DR   UCSC; uc002lvp.5; human.
DR   CTD; 51690; -.
DR   EuPathDB; HostDB:ENSG00000130332.14; -.
DR   GeneCards; LSM7; -.
DR   HGNC; HGNC:20470; LSM7.
DR   HPA; HPA041850; -.
DR   MIM; 607287; gene.
DR   neXtProt; NX_Q9UK45; -.
DR   OpenTargets; ENSG00000130332; -.
DR   PharmGKB; PA134888612; -.
DR   eggNOG; KOG1781; Eukaryota.
DR   eggNOG; ENOG4111VMJ; LUCA.
DR   GeneTree; ENSGT00510000047872; -.
DR   HOGENOM; HOG000223548; -.
DR   HOVERGEN; HBG000513; -.
DR   InParanoid; Q9UK45; -.
DR   KO; K12626; -.
DR   OMA; GPKREAI; -.
DR   OrthoDB; EOG091G14J2; -.
DR   PhylomeDB; Q9UK45; -.
DR   TreeFam; TF314385; -.
DR   Reactome; R-HSA-430039; mRNA decay by 5' to 3' exoribonuclease.
DR   Reactome; R-HSA-72163; mRNA Splicing - Major Pathway.
DR   GeneWiki; LSM7; -.
DR   GenomeRNAi; 51690; -.
DR   PRO; PR:Q9UK45; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   Bgee; ENSG00000130332; -.
DR   CleanEx; HS_LSM7; -.
DR   ExpressionAtlas; Q9UK45; baseline and differential.
DR   Genevisible; Q9UK45; HS.
DR   GO; GO:0071013; C:catalytic step 2 spliceosome; IBA:GO_Central.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:1990726; C:Lsm1-7-Pat1 complex; IBA:GO_Central.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0097526; C:spliceosomal tri-snRNP complex; IBA:GO_Central.
DR   GO; GO:0005689; C:U12-type spliceosomal complex; IBA:GO_Central.
DR   GO; GO:0071004; C:U2-type prespliceosome; IBA:GO_Central.
DR   GO; GO:0005688; C:U6 snRNP; IBA:GO_Central.
DR   GO; GO:0017070; F:U6 snRNA binding; NAS:UniProtKB.
DR   GO; GO:0043928; P:exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay; TAS:Reactome.
DR   GO; GO:0000398; P:mRNA splicing, via spliceosome; TAS:Reactome.
DR   GO; GO:0006396; P:RNA processing; IBA:GO_Central.
DR   CDD; cd01729; LSm7; 1.
DR   InterPro; IPR017132; Lsm7.
DR   InterPro; IPR001163; LSM_dom_euk/arc.
DR   InterPro; IPR010920; LSM_dom_sf.
DR   Pfam; PF01423; LSM; 1.
DR   SMART; SM00651; Sm; 1.
DR   SUPFAM; SSF50182; SSF50182; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Complete proteome;
KW   Direct protein sequencing; mRNA processing; mRNA splicing; Nucleus;
KW   Reference proteome; Ribonucleoprotein; RNA-binding; Spliceosome.
FT   INIT_MET      1      1       Removed. {ECO:0000244|PubMed:22814378}.
FT   CHAIN         2    103       U6 snRNA-associated Sm-like protein LSm7.
FT                                /FTId=PRO_0000125579.
FT   MOD_RES       2      2       N-acetylalanine.
FT                                {ECO:0000244|PubMed:22814378}.
SQ   SEQUENCE   103 AA;  11602 MW;  7429DC0FB365C9C8 CRC64;
     MADKEKKKKE SILDLSKYID KTIRVKFQGG REASGILKGF DPLLNLVLDG TIEYMRDPDD
     QYKLTEDTRQ LGLVVCRGTS VVLICPQDGM EAIPNPFIQQ QDA
//
ID   B4DF17_HUMAN            Unreviewed;       127 AA.
AC   B4DF17;
DT   23-SEP-2008, integrated into UniProtKB/TrEMBL.
DT   23-SEP-2008, sequence version 1.
DT   31-JAN-2018, entry version 51.
DE   SubName: Full=cDNA FLJ59187, highly similar to Multiple coagulation factor deficiency protein 2 homolog {ECO:0000313|EMBL:BAG57278.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAG57278.1};
RN   [1] {ECO:0000313|EMBL:BAG57278.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Cerebellum {ECO:0000313|EMBL:BAG57278.1};
RA   Wakamatsu A., Yamamoto J., Kimura K., Ishii S., Watanabe K.,
RA   Sugiyama A., Murakawa K., Kaida T., Tsuchiya K., Fukuzumi Y.,
RA   Kumagai A., Oishi Y., Yamamoto S., Ono Y., Komori Y., Yamazaki M.,
RA   Kisu Y., Nishikawa T., Sugano S., Nomura N., Isogai T.;
RT   "NEDO human cDNA sequencing project focused on splicing variants.";
RL   Submitted (OCT-2007) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK293889; BAG57278.1; -; mRNA.
DR   RefSeq; NP_001164982.1; NM_001171511.2.
DR   UniGene; Hs.662152; -.
DR   PeptideAtlas; B4DF17; -.
DR   PRIDE; B4DF17; -.
DR   DNASU; 90411; -.
DR   GeneID; 90411; -.
DR   CTD; 90411; -.
DR   eggNOG; KOG4065; Eukaryota.
DR   eggNOG; ENOG41124J6; LUCA.
DR   HOVERGEN; HBG060762; -.
DR   GenomeRNAi; 90411; -.
DR   Genevisible; B4DF17; HS.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   InterPro; IPR011992; EF-hand-dom_pair.
DR   InterPro; IPR018247; EF_Hand_1_Ca_BS.
DR   InterPro; IPR002048; EF_hand_dom.
DR   Pfam; PF13499; EF-hand_7; 1.
DR   SUPFAM; SSF47473; SSF47473; 1.
DR   PROSITE; PS00018; EF_HAND_1; 2.
DR   PROSITE; PS50222; EF_HAND_2; 2.
PE   2: Evidence at transcript level;
KW   Calcium {ECO:0000256|PROSITE-ProRule:PRU00448}.
FT   DOMAIN       49     84       EF-hand. {ECO:0000259|PROSITE:PS50222}.
FT   DOMAIN       97    127       EF-hand. {ECO:0000259|PROSITE:PS50222}.
FT   CA_BIND      62     73       {ECO:0000256|PROSITE-ProRule:PRU00448}.
FT   CA_BIND     110    121       {ECO:0000256|PROSITE-ProRule:PRU00448}.
SQ   SEQUENCE   127 AA;  14404 MW;  EF76E4228D31560E CRC64;
     MLSVCSCRTS SGMRSQWPSA RQRSSSLSTF RHIMEHLEGV INKPEAEMSP QELQLHYFKM
     HDYDGSNLLD GLELSTAITH VHKEEGSEQA PLMSEDELIN IIDGVLRDDD KNNDGYIDYA
     EFAKSLQ
//
ID   MCFD2_HUMAN             Reviewed;         146 AA.
AC   Q8NI22; A8K7W2; D6W5A9; E9PD95; Q53SS3; Q68D61; Q8N3M5;
DT   21-JUN-2004, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2002, sequence version 1.
DT   23-MAY-2018, entry version 140.
DE   RecName: Full=Multiple coagulation factor deficiency protein 2;
DE   AltName: Full=Neural stem cell-derived neuronal survival protein;
DE   Flags: Precursor;
GN   Name=MCFD2; Synonyms=SDNSF;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Heart;
RA   Toda H., Tashiro K., Takahashi J., Hashimoto N., Nakano I., Kobuke K.,
RA   Tsuji M., Honjo T.;
RT   "Isolation and characterization of SDNSF, a novel secretory molecule
RT   with neuronal survival effect, from adult rat hippocampal stem
RT   cells.";
RL   Submitted (JAN-2002) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), SUBCELLULAR LOCATION,
RP   INTERACTION WITH LMAN1, FUNCTION, AND VARIANTS F5F8D2 GLU-129 AND
RP   THR-136.
RX   PubMed=12717434; DOI=10.1038/ng1153;
RA   Zhang B., Cunningham M.A., Nichols W.C., Bernat J.A., Seligsohn U.,
RA   Pipe S.W., McVey J.H., Schulte-Overberg U., de Bosch N.B.,
RA   Ruiz-Saez A., White G.C., Tuddenham E.G., Kaufman R.J., Ginsburg D.;
RT   "Bleeding due to disruption of a cargo-specific ER-to-Golgi transport
RT   complex.";
RL   Nat. Genet. 34:220-225(2003).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Synovium;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Melanoma;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Brain, and Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [11]
RP   STRUCTURE BY NMR OF 27-146, DOMAIN, CHARACTERIZATION OF VARIANTS
RP   F5F8D2 GLU-129 AND THR-136, AND CALCIUM-BINDING.
RX   PubMed=18590741; DOI=10.1016/j.jmb.2008.06.042;
RA   Guy J.E., Wigren E., Svaerd M., Haerd T., Lindqvist Y.;
RT   "New insights into multiple coagulation factor deficiency from the
RT   solution structure of human MCFD2.";
RL   J. Mol. Biol. 381:941-955(2008).
RN   [12]
RP   X-RAY CRYSTALLOGRAPHY (2.45 ANGSTROMS) OF 58-146 IN COMPLEX WITH
RP   LMAN1, AND SUBUNIT.
RX   PubMed=20138881; DOI=10.1016/j.febslet.2010.02.009;
RA   Wigren E., Bourhis J.M., Kursula I., Guy J.E., Lindqvist Y.;
RT   "Crystal structure of the LMAN1-CRD/MCFD2 transport receptor complex
RT   provides insight into combined deficiency of factor V and factor
RT   VIII.";
RL   FEBS Lett. 584:878-882(2010).
RN   [13]
RP   X-RAY CRYSTALLOGRAPHY (1.84 ANGSTROMS) OF 27-146 IN COMPLEX WITH
RP   LMAN1, SUBUNIT, AND CALCIUM-BINDING SITES.
RX   PubMed=20142513; DOI=10.1073/pnas.0908526107;
RA   Nishio M., Kamiya Y., Mizushima T., Wakatsuki S., Sasakawa H.,
RA   Yamamoto K., Uchiyama S., Noda M., McKay A.R., Fukui K., Hauri H.P.,
RA   Kato K.;
RT   "Structural basis for the cooperative interplay between the two
RT   causative gene products of combined factor V and factor VIII
RT   deficiency.";
RL   Proc. Natl. Acad. Sci. U.S.A. 107:4034-4039(2010).
RN   [14]
RP   VARIANT F5F8D2 ASN-135.
RX   PubMed=18685427; DOI=10.1097/MBC.0b013e3283061103;
RA   Ivaskevicius V., Windyga J., Baran B., Bykowska K., Daugela L.,
RA   Watzka M., Seifried E., Oldenburg J.;
RT   "The first case of combined coagulation factor V and coagulation
RT   factor VIII deficiency in Poland due to a novel p.Tyr135Asn missense
RT   mutation in the MCFD2 gene.";
RL   Blood Coagul. Fibrinolysis 19:531-534(2008).
RN   [15]
RP   VARIANT F5F8D2 HIS-81.
RX   PubMed=20491958; DOI=10.1111/j.1365-2516.2010.02268.x;
RA   Abdallah H.E., Gouider E., Amor M.B., Jlizi A., Meddeb B.,
RA   Elgaaied A.;
RT   "Molecular analysis in two Tunisian families with combined factor V
RT   and factor VIII deficiency.";
RL   Haemophilia 16:801-804(2010).
CC   -!- FUNCTION: The MCFD2-LMAN1 complex forms a specific cargo receptor
CC       for the ER-to-Golgi transport of selected proteins. Plays a role
CC       in the secretion of coagulation factors.
CC       {ECO:0000269|PubMed:12717434}.
CC   -!- SUBUNIT: Interacts in a calcium-dependent manner with LMAN1.
CC       {ECO:0000269|PubMed:12717434, ECO:0000269|PubMed:20138881,
CC       ECO:0000269|PubMed:20142513}.
CC   -!- INTERACTION:
CC       P49257:LMAN1; NbExp=9; IntAct=EBI-2689785, EBI-1057738;
CC       Q15077:P2RY6; NbExp=4; IntAct=EBI-2689785, EBI-10235794;
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum-Golgi intermediate
CC       compartment {ECO:0000269|PubMed:12717434}. Endoplasmic reticulum
CC       {ECO:0000269|PubMed:12717434}. Golgi apparatus
CC       {ECO:0000269|PubMed:12717434}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q8NI22-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q8NI22-2; Sequence=VSP_043815;
CC       Name=3;
CC         IsoId=Q8NI22-3; Sequence=VSP_043814;
CC   -!- DOMAIN: Essentially unstructured in the absence of calcium ions.
CC       Requires calcium ions for folding. {ECO:0000269|PubMed:18590741}.
CC   -!- DISEASE: Factor V and factor VIII combined deficiency 2 (F5F8D2)
CC       [MIM:613625]: A blood coagulation disorder characterized by
CC       bleeding symptoms similar to those in hemophilia or
CC       parahemophilia, that are caused by single deficiency of FV or
CC       FVIII, respectively. The most common symptoms are epistaxis,
CC       menorrhagia, and excessive bleeding during or after trauma. Plasma
CC       levels of coagulation factors V and VIII are in the range of 5 to
CC       30% of normal. {ECO:0000269|PubMed:12717434,
CC       ECO:0000269|PubMed:18590741, ECO:0000269|PubMed:18685427,
CC       ECO:0000269|PubMed:20491958}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=CAD38756.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF475284; AAM28465.1; -; mRNA.
DR   EMBL; AF537214; AAP23162.1; -; mRNA.
DR   EMBL; AK292127; BAF84816.1; -; mRNA.
DR   EMBL; AL833900; CAD38756.1; ALT_INIT; mRNA.
DR   EMBL; CR749562; CAH18359.1; -; mRNA.
DR   EMBL; AC016722; AAY15013.1; -; Genomic_DNA.
DR   EMBL; AC093732; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471053; EAX00230.1; -; Genomic_DNA.
DR   EMBL; CH471053; EAX00231.1; -; Genomic_DNA.
DR   EMBL; CH471053; EAX00232.1; -; Genomic_DNA.
DR   EMBL; CH471053; EAX00233.1; -; Genomic_DNA.
DR   EMBL; BC037845; AAH37845.1; -; mRNA.
DR   EMBL; BC040357; AAH40357.1; -; mRNA.
DR   CCDS; CCDS33192.1; -. [Q8NI22-1]
DR   CCDS; CCDS54354.1; -. [Q8NI22-2]
DR   CCDS; CCDS54355.1; -. [Q8NI22-3]
DR   PIR; JS0027; JS0027.
DR   RefSeq; NP_001164977.1; NM_001171506.2. [Q8NI22-1]
DR   RefSeq; NP_001164978.1; NM_001171507.2. [Q8NI22-1]
DR   RefSeq; NP_001164979.1; NM_001171508.2. [Q8NI22-1]
DR   RefSeq; NP_001164980.1; NM_001171509.2. [Q8NI22-2]
DR   RefSeq; NP_001164981.1; NM_001171510.2. [Q8NI22-2]
DR   RefSeq; NP_001164982.1; NM_001171511.2. [Q8NI22-3]
DR   RefSeq; NP_644808.1; NM_139279.5. [Q8NI22-1]
DR   UniGene; Hs.662152; -.
DR   PDB; 2VRG; NMR; -; A=27-146.
DR   PDB; 3A4U; X-ray; 1.84 A; B=27-146.
DR   PDB; 3LCP; X-ray; 2.45 A; C/D=58-146.
DR   PDB; 3WHT; X-ray; 1.80 A; B=67-146.
DR   PDB; 3WHU; X-ray; 2.60 A; B=67-146.
DR   PDB; 3WNX; X-ray; 2.75 A; B=67-146.
DR   PDB; 4YGB; X-ray; 1.60 A; B/D=67-146.
DR   PDB; 4YGC; X-ray; 2.40 A; B/D/F/H=67-146.
DR   PDB; 4YGD; X-ray; 2.51 A; B/D/F/H=67-146.
DR   PDB; 4YGE; X-ray; 3.05 A; B/D/F=27-146.
DR   PDBsum; 2VRG; -.
DR   PDBsum; 3A4U; -.
DR   PDBsum; 3LCP; -.
DR   PDBsum; 3WHT; -.
DR   PDBsum; 3WHU; -.
DR   PDBsum; 3WNX; -.
DR   PDBsum; 4YGB; -.
DR   PDBsum; 4YGC; -.
DR   PDBsum; 4YGD; -.
DR   PDBsum; 4YGE; -.
DR   ProteinModelPortal; Q8NI22; -.
DR   SMR; Q8NI22; -.
DR   BioGrid; 124712; 42.
DR   DIP; DIP-56233N; -.
DR   IntAct; Q8NI22; 4.
DR   MINT; Q8NI22; -.
DR   STRING; 9606.ENSP00000317271; -.
DR   DrugBank; DB00025; Antihemophilic Factor (Recombinant).
DR   iPTMnet; Q8NI22; -.
DR   PhosphoSitePlus; Q8NI22; -.
DR   BioMuta; MCFD2; -.
DR   DMDM; 49036425; -.
DR   EPD; Q8NI22; -.
DR   MaxQB; Q8NI22; -.
DR   PaxDb; Q8NI22; -.
DR   PeptideAtlas; Q8NI22; -.
DR   PRIDE; Q8NI22; -.
DR   TopDownProteomics; Q8NI22-1; -. [Q8NI22-1]
DR   DNASU; 90411; -.
DR   Ensembl; ENST00000319466; ENSP00000317271; ENSG00000180398. [Q8NI22-1]
DR   Ensembl; ENST00000409105; ENSP00000386651; ENSG00000180398. [Q8NI22-1]
DR   Ensembl; ENST00000409147; ENSP00000387082; ENSG00000180398. [Q8NI22-2]
DR   Ensembl; ENST00000409207; ENSP00000386386; ENSG00000180398. [Q8NI22-1]
DR   Ensembl; ENST00000409218; ENSP00000386261; ENSG00000180398. [Q8NI22-1]
DR   Ensembl; ENST00000409800; ENSP00000387202; ENSG00000180398. [Q8NI22-2]
DR   Ensembl; ENST00000409913; ENSP00000386941; ENSG00000180398. [Q8NI22-2]
DR   Ensembl; ENST00000409973; ENSP00000386279; ENSG00000180398. [Q8NI22-1]
DR   Ensembl; ENST00000412438; ENSP00000402717; ENSG00000180398. [Q8NI22-1]
DR   Ensembl; ENST00000444761; ENSP00000394647; ENSG00000180398. [Q8NI22-3]
DR   GeneID; 90411; -.
DR   KEGG; hsa:90411; -.
DR   UCSC; uc002rvk.4; human. [Q8NI22-1]
DR   CTD; 90411; -.
DR   DisGeNET; 90411; -.
DR   EuPathDB; HostDB:ENSG00000180398.11; -.
DR   GeneCards; MCFD2; -.
DR   HGNC; HGNC:18451; MCFD2.
DR   HPA; CAB022410; -.
DR   HPA; HPA034593; -.
DR   MalaCards; MCFD2; -.
DR   MIM; 607788; gene.
DR   MIM; 613625; phenotype.
DR   neXtProt; NX_Q8NI22; -.
DR   OpenTargets; ENSG00000180398; -.
DR   Orphanet; 35909; Combined deficiency of factor V and factor VIII.
DR   PharmGKB; PA134925788; -.
DR   eggNOG; KOG4065; Eukaryota.
DR   eggNOG; ENOG41124J6; LUCA.
DR   GeneTree; ENSGT00390000003130; -.
DR   HOGENOM; HOG000113497; -.
DR   HOVERGEN; HBG060762; -.
DR   InParanoid; Q8NI22; -.
DR   KO; K20364; -.
DR   OMA; ISHVHKE; -.
DR   OrthoDB; EOG091G0ZJA; -.
DR   PhylomeDB; Q8NI22; -.
DR   TreeFam; TF315801; -.
DR   Reactome; R-HSA-204005; COPII-mediated vesicle transport.
DR   Reactome; R-HSA-5694530; Cargo concentration in the ER.
DR   Reactome; R-HSA-948021; Transport to the Golgi and subsequent modification.
DR   ChiTaRS; MCFD2; human.
DR   EvolutionaryTrace; Q8NI22; -.
DR   GeneWiki; MCFD2; -.
DR   GenomeRNAi; 90411; -.
DR   PRO; PR:Q8NI22; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   Bgee; ENSG00000180398; -.
DR   CleanEx; HS_MCFD2; -.
DR   ExpressionAtlas; Q8NI22; baseline and differential.
DR   Genevisible; Q8NI22; HS.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0033116; C:endoplasmic reticulum-Golgi intermediate compartment membrane; TAS:Reactome.
DR   GO; GO:0012507; C:ER to Golgi transport vesicle membrane; TAS:Reactome.
DR   GO; GO:0000139; C:Golgi membrane; IEA:GOC.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   GO; GO:0048208; P:COPII vesicle coating; TAS:Reactome.
DR   GO; GO:0006888; P:ER to Golgi vesicle-mediated transport; TAS:Reactome.
DR   GO; GO:0015031; P:protein transport; IEA:UniProtKB-KW.
DR   InterPro; IPR011992; EF-hand-dom_pair.
DR   InterPro; IPR018247; EF_Hand_1_Ca_BS.
DR   InterPro; IPR002048; EF_hand_dom.
DR   Pfam; PF13499; EF-hand_7; 1.
DR   SUPFAM; SSF47473; SSF47473; 1.
DR   PROSITE; PS00018; EF_HAND_1; 2.
DR   PROSITE; PS50222; EF_HAND_2; 2.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Calcium; Complete proteome;
KW   Disease mutation; Endoplasmic reticulum; ER-Golgi transport;
KW   Golgi apparatus; Metal-binding; Phosphoprotein; Protein transport;
KW   Reference proteome; Repeat; Signal; Transport.
FT   SIGNAL        1     26       {ECO:0000255}.
FT   CHAIN        27    146       Multiple coagulation factor deficiency
FT                                protein 2.
FT                                /FTId=PRO_0000004159.
FT   DOMAIN       68    103       EF-hand 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00448}.
FT   DOMAIN      116    146       EF-hand 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00448}.
FT   CA_BIND      81     92       1.
FT   CA_BIND     129    140       2.
FT   MOD_RES     106    106       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q8K5B3}.
FT   VAR_SEQ       1     52       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:17974005}.
FT                                /FTId=VSP_043815.
FT   VAR_SEQ       1     50       MTMRSLLRTPFLCGLLWAFCAPGARAEEPAASFSQPGSMGL
FT                                DKNTVHDQE -> MLSVCSCRTSSGMRSQWPSARQRSSSLS
FT                                TFR (in isoform 3). {ECO:0000305}.
FT                                /FTId=VSP_043814.
FT   VARIANT      81     81       D -> H (in F5F8D2; dbSNP:rs78289603).
FT                                {ECO:0000269|PubMed:20491958}.
FT                                /FTId=VAR_072245.
FT   VARIANT     129    129       D -> E (in F5F8D2; interferes with
FT                                protein folding; dbSNP:rs137852913).
FT                                {ECO:0000269|PubMed:12717434,
FT                                ECO:0000269|PubMed:18590741}.
FT                                /FTId=VAR_019076.
FT   VARIANT     135    135       Y -> N (in F5F8D2; dbSNP:rs748641905).
FT                                {ECO:0000269|PubMed:18685427}.
FT                                /FTId=VAR_072246.
FT   VARIANT     136    136       I -> T (in F5F8D2; interferes with
FT                                protein folding; dbSNP:rs137852914).
FT                                {ECO:0000269|PubMed:12717434,
FT                                ECO:0000269|PubMed:18590741}.
FT                                /FTId=VAR_019077.
FT   HELIX        70     78       {ECO:0000244|PDB:4YGB}.
FT   STRAND       85     89       {ECO:0000244|PDB:4YGB}.
FT   HELIX        90     97       {ECO:0000244|PDB:4YGB}.
FT   STRAND      106    108       {ECO:0000244|PDB:2VRG}.
FT   HELIX       114    128       {ECO:0000244|PDB:4YGB}.
FT   STRAND      133    137       {ECO:0000244|PDB:4YGB}.
FT   HELIX       138    142       {ECO:0000244|PDB:4YGB}.
SQ   SEQUENCE   146 AA;  16390 MW;  EF3F3B28E5C7A8A8 CRC64;
     MTMRSLLRTP FLCGLLWAFC APGARAEEPA ASFSQPGSMG LDKNTVHDQE HIMEHLEGVI
     NKPEAEMSPQ ELQLHYFKMH DYDGNNLLDG LELSTAITHV HKEEGSEQAP LMSEDELINI
     IDGVLRDDDK NNDGYIDYAE FAKSLQ
//
ID   A0A090N7U0_HUMAN        Unreviewed;       776 AA.
AC   A0A090N7U0;
DT   26-NOV-2014, integrated into UniProtKB/TrEMBL.
DT   26-NOV-2014, sequence version 1.
DT   23-MAY-2018, entry version 34.
DE   SubName: Full=Cullin 1 {ECO:0000313|EMBL:EAL24422.1};
DE   SubName: Full=Cullin 1, isoform CRA_b {ECO:0000313|EMBL:EAW80073.1};
GN   Name=CUL1 {ECO:0000313|EMBL:EAL24422.1};
GN   ORFNames=hCG_16546 {ECO:0000313|EMBL:EAW80073.1},
GN   tcag7.516 {ECO:0000313|EMBL:EAL24422.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:EAL24422.1};
RN   [1] {ECO:0000313|EMBL:EAW80073.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAL24422.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12690205; DOI=10.1126/science.1083423;
RA   Scherer S.W., Cheung J., MacDonald J.R., Osborne L.R., Nakabayashi K.,
RA   Herbrick J.A., Carson A.R., Parker-Katiraee L., Skaug J., Khaja R.,
RA   Zhang J., Hudek A.K., Li M., Haddad M., Duggan G.E., Fernandez B.A.,
RA   Kanematsu E., Gentles S., Christopoulos C.C., Choufani S.,
RA   Kwasnicka D., Zheng X.H., Lai Z., Nusskern D., Zhang Q., Gu Z., Lu F.,
RA   Zeesman S., Nowaczyk M.J., Teshima I., Chitayat D., Shuman C.,
RA   Weksberg R., Zackai E.H., Grebe T.A., Cox S.R., Kirkpatrick S.J.,
RA   Rahman N., Friedman J.M., Heng H.H., Pelicci P.G., Lo-Coco F.,
RA   Belloni E., Shaffer L.G., Pober B., Morton C.C., Gusella J.F.,
RA   Bruns G.A., Korf B.R., Quade B.J., Ligon A.H., Ferguson H.,
RA   Higgins A.W., Leach N.T., Herrick S.R., Lemyre E., Farra C.G.,
RA   Kim H.G., Summers A.M., Gripp K.W., Roberts W., Szatmari P.,
RA   Winsor E.J., Grzeschik K.H., Teebi A., Minassian B.A., Kere J.,
RA   Armengol L., Pujana M.A., Estivill X., Wilson M.D., Koop B.F.,
RA   Tosi S., Moore G.E., Boright A.P., Zlotorynski E., Kerem B.,
RA   Kroisel P.M., Petek E., Oscier D.G., Mould S.J., Dohner H., Dohner K.,
RA   Rommens J.M., Vincent J.B., Venter J.C., Li P.W., Mural R.J.,
RA   Adams M.D., Tsui L.C.;
RT   "Human chromosome 7: DNA sequence and biology.";
RL   Science 300:767-772(2003).
RN   [3] {ECO:0000313|EMBL:EAL24422.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Scherer S.W., Cheung J., MacDonald J.R., Osborne L.R., Nakabayashi K.,
RA   Herbrick J.-A., Carson A.R., Parker-Katiraee L., Skaug J., Khaja R.,
RA   Zhang J., Hudek A.K., Li M., Haddad M., Duggan G.E., Fernandez B.A.,
RA   Kanematsu E., Gentles S., Christopoulos C.C., Choufani S.,
RA   Kwasnicka D., Zheng X.H., Nusskern D., Zhang Q., Gu Z., Lu F.,
RA   Zeesman S., Teshima I., Chitayat D., Shuman C., Weksberg R.,
RA   Zackai E.H., Grebe T.A., Cox S.R., Kirkpatrick S.J., Rahman N.,
RA   Friedman J.M., Heng H.H.Q., Pelicci P., Lococo F., Belloni E.,
RA   Shaffer L.G., Morton C.C., Pober B., Gusella J., Bruns G., Korf B.R.,
RA   Quade B.J., Ligon A.H., Ferguson H., Higgins A.W., Leach N.T.,
RA   Herrick S.R., Lemyre E., Farra C.G., Kim H.-G., Summers A.M.,
RA   Gripp K.W., Roberts W., Szatmari P., Winsor E.J.T., Grzeschik K.-H.,
RA   Teebi A., Minassian B.A., Kere J., Armengol L., Pujana M.Angel.,
RA   Estivill X., Wilson M.D., Koop B.F., Tosi S., Moore G.E.,
RA   Boright A.P., Zlotorynski E., Kerem B., Kroisel P.M., Petek E.,
RA   Oscier D.G., Mould S.J., Doehner H., Doehner K., Rommens J.M.,
RA   Vincent J.B., Venter J.C., Li P.W., Mural R.J., Adams M.D.,
RA   Tsui L.-C.;
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [4] {ECO:0000313|EMBL:EAW80073.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
CC   -!- SIMILARITY: Belongs to the cullin family. {ECO:0000256|PROSITE-
CC       ProRule:PRU00330, ECO:0000256|RuleBase:RU003829,
CC       ECO:0000256|SAAS:SAAS00585788}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AACC02000041; EAL24422.1; -; Genomic_DNA.
DR   EMBL; CH471146; EAW80073.1; -; Genomic_DNA.
DR   RefSeq; NP_003583.2; NM_003592.2.
DR   RefSeq; XP_005250117.1; XM_005250060.4.
DR   RefSeq; XP_011514931.1; XM_011516629.2.
DR   RefSeq; XP_011514932.1; XM_011516630.2.
DR   RefSeq; XP_011514933.1; XM_011516631.2.
DR   RefSeq; XP_011514934.1; XM_011516632.2.
DR   UniGene; Hs.146806; -.
DR   SMR; A0A090N7U0; -.
DR   PRIDE; A0A090N7U0; -.
DR   GeneID; 8454; -.
DR   KEGG; hsa:8454; -.
DR   CTD; 8454; -.
DR   EuPathDB; HostDB:ENSG00000055130.15; -.
DR   eggNOG; KOG2166; Eukaryota.
DR   eggNOG; COG5647; LUCA.
DR   KO; K03347; -.
DR   OMA; TTHKHIE; -.
DR   OrthoDB; EOG091G02WR; -.
DR   ChiTaRS; CUL1; human.
DR   GenomeRNAi; 8454; -.
DR   Bgee; ENSG00000055130; -.
DR   ExpressionAtlas; A0A090N7U0; baseline and differential.
DR   GO; GO:0019005; C:SCF ubiquitin ligase complex; IEA:Ensembl.
DR   GO; GO:0031625; F:ubiquitin protein ligase binding; IEA:InterPro.
DR   GO; GO:0009887; P:animal organ morphogenesis; IEA:Ensembl.
DR   GO; GO:0006915; P:apoptotic process; IEA:Ensembl.
DR   GO; GO:0008283; P:cell proliferation; IEA:Ensembl.
DR   GO; GO:0006513; P:protein monoubiquitination; IEA:Ensembl.
DR   GO; GO:0031146; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; IEA:Ensembl.
DR   Gene3D; 1.10.10.10; -; 2.
DR   InterPro; IPR016157; Cullin_CS.
DR   InterPro; IPR016158; Cullin_homology.
DR   InterPro; IPR036317; Cullin_homology_sf.
DR   InterPro; IPR001373; Cullin_N.
DR   InterPro; IPR019559; Cullin_neddylation_domain.
DR   InterPro; IPR016159; Cullin_repeat-like_dom_sf.
DR   InterPro; IPR036388; WH-like_DNA-bd_sf.
DR   InterPro; IPR036390; WH_DNA-bd_sf.
DR   Pfam; PF00888; Cullin; 1.
DR   Pfam; PF10557; Cullin_Nedd8; 1.
DR   SMART; SM00182; CULLIN; 1.
DR   SMART; SM00884; Cullin_Nedd8; 1.
DR   SUPFAM; SSF46785; SSF46785; 1.
DR   SUPFAM; SSF74788; SSF74788; 1.
DR   SUPFAM; SSF75632; SSF75632; 1.
DR   PROSITE; PS01256; CULLIN_1; 1.
DR   PROSITE; PS50069; CULLIN_2; 1.
PE   3: Inferred from homology;
KW   Coiled coil {ECO:0000256|SAM:Coils}.
FT   DOMAIN      417    644       CULLIN_2. {ECO:0000259|PROSITE:PS50069}.
FT   COILED      261    281       {ECO:0000256|SAM:Coils}.
SQ   SEQUENCE   776 AA;  89679 MW;  6625A1FFA7799BBA CRC64;
     MSSTRSQNPH GLKQIGLDQI WDDLRAGIQQ VYTRQSMAKS RYMELYTHVY NYCTSVHQSN
     QARGAGVPPS KSKKGQTPGG AQFVGLELYK RLKEFLKNYL TNLLKDGEDL MDESVLKFYT
     QQWEDYRFSS KVLNGICAYL NRHWVRRECD EGRKGIYEIY SLALVTWRDC LFRPLNKQVT
     NAVLKLIEKE RNGETINTRL ISGVVQSYVE LGLNEDDAFA KGPTLTVYKE SFESQFLADT
     ERFYTRESTE FLQQNPVTEY MKKAEARLLE EQRRVQVYLH ESTQDELARK CEQVLIEKHL
     EIFHTEFQNL LDADKNEDLG RMYNLVSRIQ DGLGELKKLL ETHIHNQGLA AIEKCGEAAL
     NDPKMYVQTV LDVHKKYNAL VMSAFNNDAG FVAALDKACG RFINNNAVTK MAQSSSKSPE
     LLARYCDSLL KKSSKNPEEA ELEDTLNQVM VVFKYIEDKD VFQKFYAKML AKRLVHQNSA
     SDDAEASMIS KLKQACGFEY TSKLQRMFQD IGVSKDLNEQ FKKHLTNSEP LDLDFSIQVL
     SSGSWPFQQS CTFALPSELE RSYQRFTAFY ASRHSGRKLT WLYQLSKGEL VTNCFKNRYT
     LQASTFQMAI LLQYNTEDAY TVQQLTDSTQ IKMDILAQVL QILLKSKLLV LEDENANVDE
     VELKPDTLIK LYLGYKNKKL RVNINVPMKT EQKQEQETTH KNIEEDRKLL IQAAIVRIMK
     MRKVLKHQQL LGEVLTQLSS RFKPRVPVIK KCIDILIEKE YLERVDGEKD TYSYLA
//
ID   B3KTW0_HUMAN            Unreviewed;       607 AA.
AC   B3KTW0;
DT   02-SEP-2008, integrated into UniProtKB/TrEMBL.
DT   02-SEP-2008, sequence version 1.
DT   28-MAR-2018, entry version 73.
DE   SubName: Full=cDNA FLJ38844 fis, clone MESAN2003662, highly similar to Cullin-1 {ECO:0000313|EMBL:BAG53222.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAG53222.1};
RN   [1] {ECO:0000313|EMBL:BAG53222.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
CC   -!- SIMILARITY: Belongs to the cullin family. {ECO:0000256|PROSITE-
CC       ProRule:PRU00330, ECO:0000256|RuleBase:RU003829,
CC       ECO:0000256|SAAS:SAAS00585788}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK096163; BAG53222.1; -; mRNA.
DR   RefSeq; NP_003583.2; NM_003592.2.
DR   UniGene; Hs.146806; -.
DR   MaxQB; B3KTW0; -.
DR   PeptideAtlas; B3KTW0; -.
DR   DNASU; 8454; -.
DR   GeneID; 8454; -.
DR   KEGG; hsa:8454; -.
DR   CTD; 8454; -.
DR   PharmGKB; PA27047; -.
DR   eggNOG; KOG2166; Eukaryota.
DR   eggNOG; COG5647; LUCA.
DR   HOVERGEN; HBG106177; -.
DR   KO; K03347; -.
DR   GenomeRNAi; 8454; -.
DR   Genevisible; B3KTW0; HS.
DR   GO; GO:0031625; F:ubiquitin protein ligase binding; IEA:InterPro.
DR   GO; GO:0006511; P:ubiquitin-dependent protein catabolic process; IEA:InterPro.
DR   Gene3D; 1.10.10.10; -; 1.
DR   InterPro; IPR016158; Cullin_homology.
DR   InterPro; IPR036317; Cullin_homology_sf.
DR   InterPro; IPR001373; Cullin_N.
DR   InterPro; IPR016159; Cullin_repeat-like_dom_sf.
DR   InterPro; IPR036388; WH-like_DNA-bd_sf.
DR   Pfam; PF00888; Cullin; 1.
DR   SMART; SM00182; CULLIN; 1.
DR   SUPFAM; SSF74788; SSF74788; 1.
DR   SUPFAM; SSF75632; SSF75632; 1.
DR   PROSITE; PS50069; CULLIN_2; 1.
PE   2: Evidence at transcript level;
KW   Coiled coil {ECO:0000256|SAM:Coils}.
FT   DOMAIN      375    602       CULLIN_2. {ECO:0000259|PROSITE:PS50069}.
FT   COILED      219    239       {ECO:0000256|SAM:Coils}.
SQ   SEQUENCE   607 AA;  69886 MW;  B03AA71184726313 CRC64;
     MELYTHVYNY CTSVHQSNQA RGAGVPPSKS KKGQTPGGAQ FVGLELYKRL KEFLKNYLTN
     LLKDGEDLMD ESVLKFYTQQ WEDYRFSSKV LNGICAYLNR HWVRRECDEG RKGIYEIYSL
     ALVTWRDCLF RPLNKQVTNA VLKLIEKERN GETINTRLIS GVVQSYVELG LNEDDAFAKG
     PTLTVYKESF ESQFLADTER FYTRESTEFL QQNPVTEYMK KAEARLLEEQ RRVQVYLHES
     TQDELARKCE QVLIEKHLEI FHTEFQNLLD ADKNEDLGRM YNLVSRIQDG LGELKKLLET
     HIHNQGLAAI EKCGEAALND PKMYVQTVLD VHKKYNALVM SAFNNDAGFV AALDKACGRF
     INNNAVTKMA QSSSKSPELL ARYCDSLLKK SSKNPEEAEL EDTLNQVMVV FKYIEDKDVF
     QKFYAKMLAK RLVHQNSASD DAEASMISKL KQACGFEYTS KLQRMFQDIG VSKDLNEQFK
     KHLTNSEPLD LDFSIQVLSS GSWPFQQSCT FALPSELERS YQRFTAFYAS RHSGRKLTWL
     YQLSKGELVT NCFKNRYTLQ ASTFQMAILL QYNTEDAYTV QQLTDSTQIK MDILAQVLQI
     LLKSKLL
//
ID   CUL1_HUMAN              Reviewed;         776 AA.
AC   Q13616; D3DWG3; O60719; Q08AL6; Q8IYW1;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   14-AUG-2001, sequence version 2.
DT   23-MAY-2018, entry version 181.
DE   RecName: Full=Cullin-1;
DE            Short=CUL-1;
GN   Name=CUL1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=8681378; DOI=10.1016/S0092-8674(00)81267-2;
RA   Kipreos E.T., Lander L.E., Wing J.P., He W.W., Hedgecock E.M.;
RT   "cul-1 is required for cell cycle exit in C. elegans and identifies a
RT   novel gene family.";
RL   Cell 85:829-839(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, AND TISSUE SPECIFICITY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=9663463;
RA   Michel J.J., Xiong Y.;
RT   "Human CUL-1, but not other cullin family members, selectively
RT   interacts with SKP1 to form a complex with SKP2 and cyclin A.";
RL   Cell Growth Differ. 9:435-449(1998).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Endometrium;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12853948; DOI=10.1038/nature01782;
RA   Hillier L.W., Fulton R.S., Fulton L.A., Graves T.A., Pepin K.H.,
RA   Wagner-McPherson C., Layman D., Maas J., Jaeger S., Walker R.,
RA   Wylie K., Sekhon M., Becker M.C., O'Laughlin M.D., Schaller M.E.,
RA   Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Cordes M., Du H.,
RA   Sun H., Edwards J., Bradshaw-Cordum H., Ali J., Andrews S., Isak A.,
RA   Vanbrunt A., Nguyen C., Du F., Lamar B., Courtney L., Kalicki J.,
RA   Ozersky P., Bielicki L., Scott K., Holmes A., Harkins R., Harris A.,
RA   Strong C.M., Hou S., Tomlinson C., Dauphin-Kohlberg S.,
RA   Kozlowicz-Reilly A., Leonard S., Rohlfing T., Rock S.M.,
RA   Tin-Wollam A.-M., Abbott A., Minx P., Maupin R., Strowmatt C.,
RA   Latreille P., Miller N., Johnson D., Murray J., Woessner J.P.,
RA   Wendl M.C., Yang S.-P., Schultz B.R., Wallis J.W., Spieth J.,
RA   Bieri T.A., Nelson J.O., Berkowicz N., Wohldmann P.E., Cook L.L.,
RA   Hickenbotham M.T., Eldred J., Williams D., Bedell J.A., Mardis E.R.,
RA   Clifton S.W., Chissoe S.L., Marra M.A., Raymond C., Haugen E.,
RA   Gillett W., Zhou Y., James R., Phelps K., Iadanoto S., Bubb K.,
RA   Simms E., Levy R., Clendenning J., Kaul R., Kent W.J., Furey T.S.,
RA   Baertsch R.A., Brent M.R., Keibler E., Flicek P., Bork P., Suyama M.,
RA   Bailey J.A., Portnoy M.E., Torrents D., Chinwalla A.T., Gish W.R.,
RA   Eddy S.R., McPherson J.D., Olson M.V., Eichler E.E., Green E.D.,
RA   Waterston R.H., Wilson R.K.;
RT   "The DNA sequence of human chromosome 7.";
RL   Nature 424:157-164(2003).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   INTERACTION WITH RBX1, AND IDENTIFICATION IN SCF COMPLEX WITH RBX1;
RP   SKP1 AND SKP2.
RX   PubMed=10230406; DOI=10.1016/S1097-2765(00)80481-5;
RA   Tan P., Fuchs S.Y., Chen A., Wu K., Gomez C., Ronai Z., Pan Z.-Q.;
RT   "Recruitment of a ROC1-CUL1 ubiquitin ligase by Skp1 and HOS to
RT   catalyze the ubiquitination of I kappa B alpha.";
RL   Mol. Cell 3:527-533(1999).
RN   [8]
RP   INTERACTION WITH RBX1 AND RNF7.
RX   PubMed=10230407; DOI=10.1016/S1097-2765(00)80482-7;
RA   Ohta T., Michel J.J., Schottelius A.J., Xiong Y.;
RT   "ROC1, a homolog of APC11, represents a family of cullin partners with
RT   an associated ubiquitin ligase activity.";
RL   Mol. Cell 3:535-541(1999).
RN   [9]
RP   NEDDYLATION AT LYS-720.
RX   PubMed=10597293; DOI=10.1038/sj.onc.1203093;
RA   Hori T., Osaka F., Chiba T., Miyamoto C., Okabayashi K., Shimbara N.,
RA   Kato S., Tanaka K.;
RT   "Covalent modification of all members of human cullin family proteins
RT   by NEDD8.";
RL   Oncogene 18:6829-6834(1999).
RN   [10]
RP   NEDDYLATION.
RX   PubMed=10713156; DOI=10.1128/MCB.20.7.2326-2333.2000;
RA   Read M.A., Brownell J.E., Gladysheva T.B., Hottelet M., Parent L.A.,
RA   Coggins M.B., Pierce J.W., Podust V.N., Luo R.-S., Chau V.,
RA   Palombella V.J.;
RT   "Nedd8 modification of cul-1 activates SCF(beta(TrCP))-dependent
RT   ubiquitination of IkappaBalpha.";
RL   Mol. Cell. Biol. 20:2326-2333(2000).
RN   [11]
RP   INTERACTION WITH RNF7.
RX   PubMed=10851089; DOI=10.1038/sj.onc.1203635;
RA   Swaroop M., Wang Y., Miller P., Duan H., Jatkoe T., Madore S.J.,
RA   Sun Y.;
RT   "Yeast homolog of human SAG/ROC2/Rbx2/Hrt2 is essential for cell
RT   growth, but not for germination: chip profiling implicates its role in
RT   cell cycle regulation.";
RL   Oncogene 19:2855-2866(2000).
RN   [12]
RP   INTERACTION WITH COPS2.
RX   PubMed=11337588; DOI=10.1126/science.1059780;
RA   Lyapina S., Cope G., Shevchenko A., Serino G., Tsuge T., Zhou C.,
RA   Wolf D.A., Wei N., Shevchenko A., Deshaies R.J.;
RT   "Promotion of NEDD-CUL1 conjugate cleavage by COP9 signalosome.";
RL   Science 292:1382-1385(2001).
RN   [13]
RP   INTERACTION WITH TIP120A.
RX   PubMed=12504026; DOI=10.1016/S1097-2765(02)00784-0;
RA   Zheng J., Yang X., Harrell J.M., Ryzhikov S., Shim E.-H.,
RA   Lykke-Andersen K., Wei N., Sun H., Kobayashi R., Zhang H.;
RT   "CAND1 binds to unneddylated CUL1 and regulates the formation of SCF
RT   ubiquitin E3 ligase complex.";
RL   Mol. Cell 10:1519-1526(2002).
RN   [14]
RP   INTERACTION WITH TIP120A.
RX   PubMed=12609982; DOI=10.1074/jbc.M213070200;
RA   Min K.-W., Hwang J.-W., Lee J.-S., Park Y., Tamura T.-A., Yoon J.-B.;
RT   "TIP120A associates with cullins and modulates ubiquitin ligase
RT   activity.";
RL   J. Biol. Chem. 278:15905-15910(2003).
RN   [15]
RP   IDENTIFICATION IN THE SCF(FBXO7) COMPLEX.
RX   PubMed=15145941; DOI=10.1074/jbc.M404950200;
RA   Hsu J.-M., Lee Y.-C.G., Yu C.-T.R., Huang C.-Y.F.;
RT   "Fbx7 functions in the SCF complex regulating Cdk1-cyclin B-
RT   phosphorylated hepatoma up-regulated protein (HURP) proteolysis by a
RT   proline-rich region.";
RL   J. Biol. Chem. 279:32592-32602(2004).
RN   [16]
RP   RECONSTITUTION OF THE SCF(FBXO32) COMPLEX, AND FUNCTION IN
RP   UBIQUITINATION OF MYOD1.
RX   PubMed=15531760; DOI=10.1074/jbc.M411346200;
RA   Tintignac L.A., Lagirand J., Batonnet S., Sirri V., Leibovitch M.P.,
RA   Leibovitch S.A.;
RT   "Degradation of MyoD mediated by the SCF (MAFbx) ubiquitin ligase.";
RL   J. Biol. Chem. 280:2847-2856(2005).
RN   [17]
RP   INTERACTION WITH GCM1, AND FUNCTION IN UBIQUITINATION OF GCM1.
RX   PubMed=15640526; DOI=10.1074/jbc.M413986200;
RA   Yang C.S., Yu C., Chuang H.C., Chang C.W., Chang G.D., Yao T.P.,
RA   Chen H.;
RT   "FBW2 targets GCMa to the ubiquitin-proteasome degradation system.";
RL   J. Biol. Chem. 280:10083-10090(2005).
RN   [18]
RP   RECONSTITUTION OF THE SCF(FBXO25) COMPLEX.
RX   PubMed=16714087; DOI=10.1016/j.bbagen.2006.03.020;
RA   Maragno A.L., Baqui M.M., Gomes M.D.;
RT   "FBXO25, an F-box protein homologue of atrogin-1, is not induced in
RT   atrophying muscle.";
RL   Biochim. Biophys. Acta 1760:966-972(2006).
RN   [19]
RP   IDENTIFICATION IN THE SCF(FBXO33) COMPLEX WITH SKP1; RBX1 AND FBXO33.
RX   PubMed=16797541; DOI=10.1016/j.febslet.2006.06.023;
RA   Lutz M., Wempe F., Bahr I., Zopf D., von Melchner H.;
RT   "Proteasomal degradation of the multifunctional regulator YB-1 is
RT   mediated by an F-Box protein induced during programmed cell death.";
RL   FEBS Lett. 580:3921-3930(2006).
RN   [20]
RP   INTERACTION WITH THE SCF(SKP2)-LIKE COMPLEX, AND INTERACTION WITH
RP   TRIM21.
RX   PubMed=16880511; DOI=10.1128/MCB.01630-05;
RA   Sabile A., Meyer A.M., Wirbelauer C., Hess D., Kogel U., Scheffner M.,
RA   Krek W.;
RT   "Regulation of p27 degradation and S-phase progression by Ro52 RING
RT   finger protein.";
RL   Mol. Cell. Biol. 26:5994-6004(2006).
RN   [21]
RP   SELF-ASSOCIATION.
RX   PubMed=17254749; DOI=10.1016/j.cellsig.2006.12.002;
RA   Chew E.H., Poobalasingam T., Hawkey C.J., Hagen T.;
RT   "Characterization of cullin-based E3 ubiquitin ligases in intact
RT   mammalian cells -- evidence for cullin dimerization.";
RL   Cell. Signal. 19:1071-1080(2007).
RN   [22]
RP   IDENTIFICATION IN THE SCF(FBXO11) COMPLEX WITH SKP1; RBX1 AND FBXO11.
RX   PubMed=17098746; DOI=10.1074/jbc.M609001200;
RA   Abida W.M., Nikolaev A., Zhao W., Zhang W., Gu W.;
RT   "FBXO11 promotes the neddylation of p53 and inhibits its
RT   transcriptional activity.";
RL   J. Biol. Chem. 282:1797-1804(2007).
RN   [23]
RP   NEDDYLATION AT LYS-720.
RX   PubMed=18805092; DOI=10.1016/j.cell.2008.07.022;
RA   Duda D.M., Borg L.A., Scott D.C., Hunt H.W., Hammel M., Schulman B.A.;
RT   "Structural insights into NEDD8 activation of cullin-RING ligases:
RT   conformational control of conjugation.";
RL   Cell 134:995-1006(2008).
RN   [24]
RP   INTERACTION WITH FBXO44; FBXO17 AND FBXO27, AND IDENTIFICATION IN
RP   SCF-COMPLEX.
RX   PubMed=18203720; DOI=10.1074/jbc.M709508200;
RA   Glenn K.A., Nelson R.F., Wen H.M., Mallinger A.J., Paulson H.L.;
RT   "Diversity in tissue expression, substrate binding, and SCF complex
RT   formation for a lectin family of ubiquitin ligases.";
RL   J. Biol. Chem. 283:12717-12729(2008).
RN   [25]
RP   FUNCTION IN CHEK2 UBIQUITINATION, AND INTERACTION WITH CHEK2.
RX   PubMed=18644861; DOI=10.1128/MCB.00821-08;
RA   Lovly C.M., Yan L., Ryan C.E., Takada S., Piwnica-Worms H.;
RT   "Regulation of Chk2 ubiquitination and signaling through
RT   autophosphorylation of serine 379.";
RL   Mol. Cell. Biol. 28:5874-5885(2008).
RN   [26]
RP   FUNCTION, AND INTERACTION WITH HADV5 E1A (MICROBIAL INFECTION).
RX   PubMed=19679664; DOI=10.1074/jbc.M109.006809;
RA   Isobe T., Hattori T., Kitagawa K., Uchida C., Kotake Y., Kosugi I.,
RA   Oda T., Kitagawa M.;
RT   "Adenovirus E1A inhibits SCF(Fbw7) ubiquitin ligase.";
RL   J. Biol. Chem. 284:27766-27779(2009).
RN   [27]
RP   INTERACTION WITH EPSTEIN-BARR VIRUS BPLF1, AND DENEDDYLATION BY
RP   EPSTEIN-BARR VIRUS BPLF1 (MICROBIAL INFECTION).
RX   PubMed=20190741; DOI=10.1038/ncb2035;
RA   Gastaldello S., Hildebrand S., Faridani O., Callegari S.,
RA   Palmkvist M., Di Guglielmo C., Masucci M.G.;
RT   "A deneddylase encoded by Epstein-Barr virus promotes viral DNA
RT   replication by regulating the activity of cullin-RING ligases.";
RL   Nat. Cell Biol. 12:351-361(2010).
RN   [28]
RP   IDENTIFICATION IN THE SCF(CCNF) COMPLEX.
RX   PubMed=20596027; DOI=10.1038/nature09140;
RA   D'Angiolella V., Donato V., Vijayakumar S., Saraf A., Florens L.,
RA   Washburn M.P., Dynlacht B., Pagano M.;
RT   "SCF(Cyclin F) controls centrosome homeostasis and mitotic fidelity
RT   through CP110 degradation.";
RL   Nature 466:138-142(2010).
RN   [29]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [30]
RP   FUNCTION IN UBIQUITINATION OF BCL6, AND IDENTIFICATION IN THE
RP   SCF(FBXO11) COMPLEX.
RX   PubMed=22113614; DOI=10.1038/nature10688;
RA   Duan S., Cermak L., Pagan J.K., Rossi M., Martinengo C.,
RA   di Celle P.F., Chapuy B., Shipp M., Chiarle R., Pagano M.;
RT   "FBXO11 targets BCL6 for degradation and is inactivated in diffuse
RT   large B-cell lymphomas.";
RL   Nature 481:90-93(2012).
RN   [31]
RP   INTERACTION WITH ARIH1, AND NEDDYLATION.
RX   PubMed=24076655; DOI=10.1038/emboj.2013.209;
RA   Kelsall I.R., Duda D.M., Olszewski J.L., Hofmann K., Knebel A.,
RA   Langevin F., Wood N., Wightman M., Schulman B.A., Alpi A.F.;
RT   "TRIAD1 and HHARI bind to and are activated by distinct neddylated
RT   Cullin-RING ligase complexes.";
RL   EMBO J. 32:2848-2860(2013).
RN   [32]
RP   IDENTIFICATION IN THE SCF(FBXO9) COMPLEX, AND FUNCTION.
RX   PubMed=23263282; DOI=10.1038/ncb2651;
RA   Fernandez-Saiz V., Targosz B.S., Lemeer S., Eichner R., Langer C.,
RA   Bullinger L., Reiter C., Slotta-Huspenina J., Schroeder S.,
RA   Knorn A.M., Kurutz J., Peschel C., Pagano M., Kuster B.,
RA   Bassermann F.;
RT   "SCF(Fbxo9) and CK2 direct the cellular response to growth factor
RT   withdrawal via Tel2/Tti1 degradation and promote survival in multiple
RT   myeloma.";
RL   Nat. Cell Biol. 15:72-81(2013).
RN   [33]
RP   INTERACTION WITH COPS9.
RX   PubMed=23776465; DOI=10.1371/journal.pone.0065285;
RA   Ebina M., Tsuruta F., Katoh M.C., Kigoshi Y., Someya A., Chiba T.;
RT   "Myeloma overexpressed 2 (Myeov2) regulates L11 subnuclear
RT   localization through Nedd8 modification.";
RL   PLoS ONE 8:E65285-E65285(2013).
RN   [34]
RP   FUNCTION IN UBIQUITINATION OF BCL2, AND IDENTIFICATION IN THE
RP   SCF(FBXO10) COMPLEX.
RX   PubMed=23431138; DOI=10.1073/pnas.1217271110;
RA   Chiorazzi M., Rui L., Yang Y., Ceribelli M., Tishbi N., Maurer C.W.,
RA   Ranuncolo S.M., Zhao H., Xu W., Chan W.C., Jaffe E.S., Gascoyne R.D.,
RA   Campo E., Rosenwald A., Ott G., Delabie J., Rimsza L.M., Shaham S.,
RA   Staudt L.M.;
RT   "Related F-box proteins control cell death in Caenorhabditis elegans
RT   and human lymphoma.";
RL   Proc. Natl. Acad. Sci. U.S.A. 110:3943-3948(2013).
RN   [35]
RP   INTERACTION WITH DCUN1D3.
RX   PubMed=25349211; DOI=10.1074/jbc.M114.585505;
RA   Huang G., Stock C., Bommelje C.C., Weeda V.B., Shah K., Bains S.,
RA   Buss E., Shaha M., Rechler W., Ramanathan S.Y., Singh B.;
RT   "SCCRO3 (DCUN1D3) antagonizes the neddylation and oncogenic activity
RT   of SCCRO (DCUN1D1).";
RL   J. Biol. Chem. 289:34728-34742(2014).
RN   [36]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [37]
RP   METHYLATION [LARGE SCALE ANALYSIS] AT ARG-63, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Colon carcinoma;
RX   PubMed=24129315; DOI=10.1074/mcp.O113.027870;
RA   Guo A., Gu H., Zhou J., Mulhern D., Wang Y., Lee K.A., Yang V.,
RA   Aguiar M., Kornhauser J., Jia X., Ren J., Beausoleil S.A., Silva J.C.,
RA   Vemulapalli V., Bedford M.T., Comb M.J.;
RT   "Immunoaffinity enrichment and mass spectrometry analysis of protein
RT   methylation.";
RL   Mol. Cell. Proteomics 13:372-387(2014).
RN   [38]
RP   FUNCTION.
RX   PubMed=25704143; DOI=10.1016/j.ejcb.2015.01.004;
RA   Man X., Megraw T.L., Lim Y.P.;
RT   "Cep68 can be regulated by Nek2 and SCF complex.";
RL   Eur. J. Cell Biol. 94:162-172(2015).
RN   [39]
RP   FUNCTION, IDENTIFICATION IN SCF(FBXW11) COMPLEX, AND INTERACTION WITH
RP   CEP68.
RX   PubMed=25503564; DOI=10.1038/ncb3076;
RA   Pagan J.K., Marzio A., Jones M.J., Saraf A., Jallepalli P.V.,
RA   Florens L., Washburn M.P., Pagano M.;
RT   "Degradation of Cep68 and PCNT cleavage mediate Cep215 removal from
RT   the PCM to allow centriole separation, disengagement and licensing.";
RL   Nat. Cell Biol. 17:31-43(2015).
RN   [40]
RP   FUNCTION, INTERACTION WITH ARIH1, AND NEDDYLATION.
RX   PubMed=27565346; DOI=10.1016/j.cell.2016.07.027;
RA   Scott D.C., Rhee D.Y., Duda D.M., Kelsall I.R., Olszewski J.L.,
RA   Paulo J.A., de Jong A., Ovaa H., Alpi A.F., Harper J.W.,
RA   Schulman B.A.;
RT   "Two distinct types of E3 ligases work in unison to regulate substrate
RT   ubiquitylation.";
RL   Cell 166:1198-1214(2016).
RN   [41]
RP   INTERACTION WITH NOTCH2.
RX   PubMed=29149593; DOI=10.1016/j.molcel.2017.10.018;
RA   Fukushima H., Shimizu K., Watahiki A., Hoshikawa S., Kosho T., Oba D.,
RA   Sakano S., Arakaki M., Yamada A., Nagashima K., Okabe K., Fukumoto S.,
RA   Jimi E., Bigas A., Nakayama K.I., Nakayama K., Aoki Y., Wei W.,
RA   Inuzuka H.;
RT   "NOTCH2 Hajdu-Cheney mutations escape SCFFBW7-dependent proteolysis to
RT   promote osteoporosis.";
RL   Mol. Cell 68:645-658(2017).
RN   [42]
RP   INTERACTION WITH UBXN1.
RX   PubMed=28152074; DOI=10.1371/journal.ppat.1006187;
RA   Hu Y., O'Boyle K., Auer J., Raju S., You F., Wang P., Fikrig E.,
RA   Sutton R.E.;
RT   "Multiple UBXN family members inhibit retrovirus and lentivirus
RT   production and canonical NFkappaBeta signaling by stabilizing
RT   IkappaBalpha.";
RL   PLoS Pathog. 13:E1006187-E1006187(2017).
RN   [43]
RP   X-RAY CRYSTALLOGRAPHY (3.0 ANGSTROMS) OF 17-776 IN COMPLEX WITH 19-108
RP   OF RBX1, AND X-RAY CRYSTALLOGRAPHY (3.0 ANGSTROMS) IN SCF COMPLEX WITH
RP   RBX1; SKP1 AND SKP2.
RX   PubMed=11961546; DOI=10.1038/416703a;
RA   Zheng N., Schulman B.A., Song L., Miller J.J., Jeffrey P.D., Wang P.,
RA   Chu C., Koepp D.M., Elledge S.J., Pagano M., Conaway R.C.,
RA   Conaway J.W., Harper J.W., Pavletich N.P.;
RT   "Structure of the Cul1-Rbx1-Skp1-F box Skp2 SCF ubiquitin ligase
RT   complex.";
RL   Nature 416:703-709(2002).
RN   [44]
RP   X-RAY CRYSTALLOGRAPHY (3.1 ANGSTROMS) IN COMPLEX WITH CAND1 AND ROC1,
RP   NEDDYLATION AT LYS-720, AND SUBUNIT.
RX   PubMed=15537541; DOI=10.1016/j.cell.2004.10.019;
RA   Goldenberg S.J., Cascio T.C., Shumway S.D., Garbutt K.C., Liu J.,
RA   Xiong Y., Zheng N.;
RT   "Structure of the Cand1-Cul1-Roc1 complex reveals regulatory
RT   mechanisms for the assembly of the multisubunit cullin-dependent
RT   ubiquitin ligases.";
RL   Cell 119:517-528(2004).
RN   [45]
RP   X-RAY CRYSTALLOGRAPHY (1.5 ANGSTROMS) OF 702-776 IN COMPLEX WITH
RP   DCUN1D1 AND UBE2M.
RX   PubMed=21940857; DOI=10.1126/science.1209307;
RA   Scott D.C., Monda J.K., Bennett E.J., Harper J.W., Schulman B.A.;
RT   "N-terminal acetylation acts as an avidity enhancer within an
RT   interconnected multiprotein complex.";
RL   Science 334:674-678(2011).
RN   [46] {ECO:0000244|PDB:5V89}
RP   X-RAY CRYSTALLOGRAPHY (1.55 ANGSTROMS) OF 702-776 IN COMPLEX WITH
RP   DCUN1D4.
RX   PubMed=28581483; DOI=10.1038/nchembio.2386;
RA   Scott D.C., Hammill J.T., Min J., Rhee D.Y., Connelly M.,
RA   Sviderskiy V.O., Bhasin D., Chen Y., Ong S.S., Chai S.C., Goktug A.N.,
RA   Huang G., Monda J.K., Low J., Kim H.S., Paulo J.A., Cannon J.R.,
RA   Shelat A.A., Chen T., Kelsall I.R., Alpi A.F., Pagala V., Wang X.,
RA   Peng J., Singh B., Harper J.W., Schulman B.A., Guy R.K.;
RT   "Blocking an N-terminal acetylation-dependent protein interaction
RT   inhibits an E3 ligase.";
RL   Nat. Chem. Biol. 13:850-857(2017).
CC   -!- FUNCTION: Core component of multiple cullin-RING-based SCF (SKP1-
CC       CUL1-F-box protein) E3 ubiquitin-protein ligase complexes, which
CC       mediate the ubiquitination of proteins involved in cell cycle
CC       progression, signal transduction and transcription. SCF complexes
CC       and ARIH1 collaborate in tandem to mediate ubiquitination of
CC       target proteins (PubMed:27565346). In the SCF complex, serves as a
CC       rigid scaffold that organizes the SKP1-F-box protein and RBX1
CC       subunits. May contribute to catalysis through positioning of the
CC       substrate and the ubiquitin-conjugating enzyme. The E3 ubiquitin-
CC       protein ligase activity of the complex is dependent on the
CC       neddylation of the cullin subunit and exchange of the substrate
CC       recognition component is mediated by TIP120A/CAND1. The functional
CC       specificity of the SCF complex depends on the F-box protein as
CC       substrate recognition component. SCF(BTRC) and SCF(FBXW11) direct
CC       ubiquitination of CTNNB1 and participate in Wnt signaling.
CC       SCF(FBXW11) directs ubiquitination of phosphorylated NFKBIA.
CC       SCF(BTRC) directs ubiquitination of NFKBIB, NFKBIE, ATF4, SMAD3,
CC       SMAD4, CDC25A, FBXO5 and probably NFKB2. SCF(BTRC) and/or
CC       SCF(FBXW11) direct ubiquitination of CEP68 (PubMed:25704143,
CC       PubMed:25503564). SCF(SKP2) directs ubiquitination of
CC       phosphorylated CDKN1B/p27kip and is involved in regulation of G1/S
CC       transition. SCF(SKP2) directs ubiquitination of ORC1, CDT1, RBL2,
CC       ELF4, CDKN1A, RAG2, FOXO1A, and probably MYC and TAL1. SCF(FBXW7)
CC       directs ubiquitination of cyclin E, NOTCH1 released notch
CC       intracellular domain (NICD), and probably PSEN1. SCF(FBXW2)
CC       directs ubiquitination of GCM1. SCF(FBXO32) directs ubiquitination
CC       of MYOD1. SCF(FBXO7) directs ubiquitination of BIRC2 and DLGAP5.
CC       SCF(FBXO33) directs ubiquitination of YBX1. SCF(FBXO1) directs
CC       ubiquitination of BCL6 and DTL but does not seem to direct
CC       ubiquitination of TP53. SCF(BTRC) mediates the ubiquitination of
CC       NFKBIA at 'Lys-21' and 'Lys-22'; the degradation frees the
CC       associated NFKB1-RELA dimer to translocate into the nucleus and to
CC       activate transcription. SCF(CCNF) directs ubiquitination of
CC       CCP110. SCF(FBXL3) and SCF(FBXL21) direct ubiquitination of CRY1
CC       and CRY2. SCF(FBXO9) directs ubiquitination of TTI1 and TELO2.
CC       SCF(FBXO10) directs ubiquitination of BCL2.
CC       {ECO:0000269|PubMed:15531760, ECO:0000269|PubMed:15640526,
CC       ECO:0000269|PubMed:18644861, ECO:0000269|PubMed:19679664,
CC       ECO:0000269|PubMed:22113614, ECO:0000269|PubMed:23263282,
CC       ECO:0000269|PubMed:23431138, ECO:0000269|PubMed:25503564,
CC       ECO:0000269|PubMed:25704143, ECO:0000269|PubMed:27565346,
CC       ECO:0000269|PubMed:9663463}.
CC   -!- PATHWAY: Protein modification; protein ubiquitination.
CC   -!- SUBUNIT: Component of multiple SCF (SKP1-CUL1-F-box) E3 ubiquitin-
CC       protein ligase complexes formed of CUL1, SKP1, RBX1 and a variable
CC       F-box domain-containing protein as substrate-specific subunit.
CC       Component of the SCF(FBXW11) complex containing FBXW11. Component
CC       of the SCF(SKP2) complex containing SKP2, in which it interacts
CC       directly with SKP1, SKP2 and RBX1. Component of the SCF(FBXW2)
CC       complex containing FBXW2. Component of the SCF(FBXO32) complex
CC       containing FBXO32. Component of the probable SCF(FBXO7) complex
CC       containing FBXO7. Component of the SCF(FBXO10) complex containing
CC       FBXO10. Component of the SCF(FBXO11) complex containing FBXO11.
CC       Component of the SCF(FBXO25) complex containing FBXO25. Component
CC       of the SCF(FBXO33) complex containing FBXO33. Component of the
CC       probable SCF(FBXO4) complex containing FBXO4. Component of the
CC       SCF(FBXO44) complex, composed of SKP1, CUL1 and FBXO44. Component
CC       of the SCF(BTRC) complex, composed of SKP1, CUL1 and BTRC. This
CC       complex binds phosphorylated NFKBIA. Part of a SCF complex
CC       consisting of CUL1, RBX1, SKP1 and FBXO2. Component of a
CC       SCF(SKP2)-like complex containing CUL1, SKP1, TRIM21 and SKP2.
CC       Component of the SCF(FBXO17) complex, composed of SKP1, CUL1 and
CC       FBXO17. Component of the SCF(FBXO27) complex, composed of SKP1,
CC       CUL1 and FBXO27. Component of the SCF(CCNF) complex consisting of
CC       CUL1, RBX1, SKP1 and CCNF. Component of the SCF(FBXL3) complex
CC       composed of CUL1, SKP1, RBX1 and FBXL3. Component of the
CC       SCF(FBXL21) complex composed of CUL1, SKP1, RBX1 and FBXL21.
CC       Component of the SCF(FBXO9) composed of CUL1, SKP1, RBX1 and
CC       FBXO9. Component of the SCF(FBXW7) composed of CUL1, SKP1, RBX1
CC       and FBXW7. Interacts with CHEK2; mediates CHEK2 ubiquitination and
CC       regulates its function. Part of a complex with TIP120A/CAND1 and
CC       RBX1. The unneddylated form interacts with TIP120A/CAND1 and the
CC       interaction mediates the exchange of the F-box substrate-specific
CC       subunit. Can self-associate. Interacts with FBXW8. Interacts with
CC       RNF7. Interacts with CUL7; the interaction seems to be mediated by
CC       FBXW8. Interacts with TRIM21. Interacts with COPS2. Interacts with
CC       DCUN1D3. Interacts with CEP68 as part of the SCF(FBXW11) complex;
CC       the interaction is probably mediated by FBXW11 and the complex
CC       also contains CDK5RAP2 and PCNT (PubMed:25503564). Interacts (when
CC       neddylated) with ARIH1; leading to activate the E3 ligase activity
CC       of ARIH1 (PubMed:24076655, PubMed:27565346). Interacts with COPS9
CC       isoform 2 (PubMed:23776465). Interacts with UBXN1
CC       (PubMed:28152074). Interacts with KAT7, probably as part of an SCF
CC       complex; the interaction mediates KAT7 ubiquitination (By
CC       similarity). Interacts with NOTCH2 (PubMed:29149593).
CC       {ECO:0000250|UniProtKB:Q9WTX6, ECO:0000269|PubMed:10230406,
CC       ECO:0000269|PubMed:10230407, ECO:0000269|PubMed:10851089,
CC       ECO:0000269|PubMed:11337588, ECO:0000269|PubMed:11961546,
CC       ECO:0000269|PubMed:12504026, ECO:0000269|PubMed:12609982,
CC       ECO:0000269|PubMed:15145941, ECO:0000269|PubMed:15537541,
CC       ECO:0000269|PubMed:15640526, ECO:0000269|PubMed:16797541,
CC       ECO:0000269|PubMed:16880511, ECO:0000269|PubMed:17098746,
CC       ECO:0000269|PubMed:18203720, ECO:0000269|PubMed:18644861,
CC       ECO:0000269|PubMed:20190741, ECO:0000269|PubMed:20596027,
CC       ECO:0000269|PubMed:21940857, ECO:0000269|PubMed:22113614,
CC       ECO:0000269|PubMed:23263282, ECO:0000269|PubMed:23431138,
CC       ECO:0000269|PubMed:23776465, ECO:0000269|PubMed:24076655,
CC       ECO:0000269|PubMed:25349211, ECO:0000269|PubMed:25503564,
CC       ECO:0000269|PubMed:27565346, ECO:0000269|PubMed:28152074,
CC       ECO:0000269|PubMed:29149593}.
CC   -!- SUBUNIT: (Microbial infection) Interacts with Epstein-Barr virus
CC       BPLF1. {ECO:0000269|PubMed:20190741}.
CC   -!- SUBUNIT: (Microbial infection) Interacts with Human adenovirus
CC       early E1A protein; this interaction inhibits RBX1-CUL1-dependent
CC       elongation reaction of ubiquitin chains by the SCF(FBXW7) complex.
CC       {ECO:0000269|PubMed:19679664}.
CC   -!- INTERACTION:
CC       Q6TVW2:- (xeno); NbExp=5; IntAct=EBI-359390, EBI-15718527;
CC       Q9Y4X5:ARIH1; NbExp=6; IntAct=EBI-359390, EBI-2514233;
CC       Q9Y297:BTRC; NbExp=6; IntAct=EBI-359390, EBI-307461;
CC       Q86VP6:CAND1; NbExp=21; IntAct=EBI-359390, EBI-456077;
CC       O60826:CCDC22; NbExp=3; IntAct=EBI-359390, EBI-3943153;
CC       P41002:CCNF; NbExp=5; IntAct=EBI-359390, EBI-1207574;
CC       Q8ND76:CCNY; NbExp=3; IntAct=EBI-359390, EBI-1049189;
CC       P49427:CDC34; NbExp=3; IntAct=EBI-359390, EBI-975634;
CC       P46527:CDKN1B; NbExp=2; IntAct=EBI-359390, EBI-519280;
CC       Q8BFZ4:Fbxl21 (xeno); NbExp=3; IntAct=EBI-359390, EBI-6898235;
CC       Q8C4V4:Fbxl3 (xeno); NbExp=3; IntAct=EBI-359390, EBI-1266589;
CC       Q9UKT5:FBXO4; NbExp=2; IntAct=EBI-359390, EBI-960409;
CC       Q9UKB1:FBXW11; NbExp=4; IntAct=EBI-359390, EBI-355189;
CC       Q83730:m005R (xeno); NbExp=5; IntAct=EBI-359390, EBI-6859930;
CC       Q00987:MDM2; NbExp=3; IntAct=EBI-359390, EBI-389668;
CC       O75586:MED6; NbExp=2; IntAct=EBI-359390, EBI-394624;
CC       Q15843:NEDD8; NbExp=12; IntAct=EBI-359390, EBI-716247;
CC       P62877:RBX1; NbExp=24; IntAct=EBI-359390, EBI-398523;
CC       P63208:SKP1; NbExp=10; IntAct=EBI-359390, EBI-307486;
CC       Q13309:SKP2; NbExp=8; IntAct=EBI-359390, EBI-456291;
CC       P52491:UBC12 (xeno); NbExp=2; IntAct=EBI-359390, EBI-19772;
CC       P61081:UBE2M; NbExp=5; IntAct=EBI-359390, EBI-1041660;
CC       O94888:UBXN7; NbExp=8; IntAct=EBI-359390, EBI-1993627;
CC   -!- TISSUE SPECIFICITY: Expressed in lung fibroblasts.
CC       {ECO:0000269|PubMed:9663463}.
CC   -!- PTM: Neddylated; which enhances the ubiquitination activity of SCF
CC       and prevents binding of the inhibitor CAND1. Deneddylated via its
CC       interaction with the COP9 signalosome (CSN) complex
CC       (PubMed:10597293, PubMed:10713156, PubMed:15537541,
CC       PubMed:18805092). {ECO:0000269|PubMed:10597293,
CC       ECO:0000269|PubMed:10713156, ECO:0000269|PubMed:15537541,
CC       ECO:0000269|PubMed:18805092, ECO:0000269|PubMed:20190741,
CC       ECO:0000269|PubMed:24076655, ECO:0000269|PubMed:27565346}.
CC   -!- PTM: (Microbial infection) Deneddylated by Epstein-Barr virus
CC       BPLF1 leading to a S-phase-like environment that is required for
CC       efficient replication of the viral genome (PubMed:20190741).
CC       {ECO:0000269|PubMed:20190741}.
CC   -!- SIMILARITY: Belongs to the cullin family. {ECO:0000255|PROSITE-
CC       ProRule:PRU00330}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U58087; AAC50544.1; -; mRNA.
DR   EMBL; AF062536; AAC36681.1; -; mRNA.
DR   EMBL; BX537409; CAD97651.1; -; mRNA.
DR   EMBL; AC005229; AAM49153.1; -; Genomic_DNA.
DR   EMBL; CH471146; EAW80074.1; -; Genomic_DNA.
DR   EMBL; BC125119; AAI25120.1; -; mRNA.
DR   EMBL; BC125120; AAI25121.1; -; mRNA.
DR   CCDS; CCDS34772.1; -.
DR   RefSeq; NP_003583.2; NM_003592.2.
DR   RefSeq; XP_005250117.1; XM_005250060.4.
DR   RefSeq; XP_011514931.1; XM_011516629.2.
DR   RefSeq; XP_011514932.1; XM_011516630.2.
DR   RefSeq; XP_011514933.1; XM_011516631.2.
DR   RefSeq; XP_011514934.1; XM_011516632.2.
DR   UniGene; Hs.146806; -.
DR   PDB; 1LDJ; X-ray; 3.00 A; A=17-776.
DR   PDB; 1LDK; X-ray; 3.10 A; A=15-410, B=411-776.
DR   PDB; 1U6G; X-ray; 3.10 A; A=1-776.
DR   PDB; 3RTR; X-ray; 3.21 A; A/C/E/G=411-776.
DR   PDB; 3TDU; X-ray; 1.50 A; C/D=702-776.
DR   PDB; 3TDZ; X-ray; 2.00 A; C/D=702-776.
DR   PDB; 4F52; X-ray; 3.00 A; A/C=411-690.
DR   PDB; 4P5O; X-ray; 3.11 A; A/C=411-776.
DR   PDB; 5V89; X-ray; 1.55 A; C=702-776.
DR   PDBsum; 1LDJ; -.
DR   PDBsum; 1LDK; -.
DR   PDBsum; 1U6G; -.
DR   PDBsum; 3RTR; -.
DR   PDBsum; 3TDU; -.
DR   PDBsum; 3TDZ; -.
DR   PDBsum; 4F52; -.
DR   PDBsum; 4P5O; -.
DR   PDBsum; 5V89; -.
DR   ProteinModelPortal; Q13616; -.
DR   SMR; Q13616; -.
DR   BioGrid; 114032; 732.
DR   CORUM; Q13616; -.
DR   DIP; DIP-17013N; -.
DR   IntAct; Q13616; 98.
DR   MINT; Q13616; -.
DR   STRING; 9606.ENSP00000326804; -.
DR   iPTMnet; Q13616; -.
DR   PhosphoSitePlus; Q13616; -.
DR   BioMuta; CUL1; -.
DR   DMDM; 19863257; -.
DR   EPD; Q13616; -.
DR   MaxQB; Q13616; -.
DR   PaxDb; Q13616; -.
DR   PeptideAtlas; Q13616; -.
DR   PRIDE; Q13616; -.
DR   DNASU; 8454; -.
DR   Ensembl; ENST00000325222; ENSP00000326804; ENSG00000055130.
DR   Ensembl; ENST00000409469; ENSP00000387160; ENSG00000055130.
DR   Ensembl; ENST00000602748; ENSP00000473318; ENSG00000055130.
DR   GeneID; 8454; -.
DR   KEGG; hsa:8454; -.
DR   UCSC; uc003wey.4; human.
DR   CTD; 8454; -.
DR   DisGeNET; 8454; -.
DR   EuPathDB; HostDB:ENSG00000055130.15; -.
DR   GeneCards; CUL1; -.
DR   HGNC; HGNC:2551; CUL1.
DR   HPA; CAB002676; -.
DR   HPA; HPA064584; -.
DR   MIM; 603134; gene.
DR   neXtProt; NX_Q13616; -.
DR   OpenTargets; ENSG00000055130; -.
DR   PharmGKB; PA27047; -.
DR   eggNOG; KOG2166; Eukaryota.
DR   eggNOG; COG5647; LUCA.
DR   GeneTree; ENSGT00760000119212; -.
DR   HOGENOM; HOG000176713; -.
DR   HOVERGEN; HBG106177; -.
DR   InParanoid; Q13616; -.
DR   KO; K03347; -.
DR   OMA; TTHKHIE; -.
DR   OrthoDB; EOG091G02WR; -.
DR   PhylomeDB; Q13616; -.
DR   TreeFam; TF101151; -.
DR   BioCyc; MetaCyc:ENSG00000055130-MONOMER; -.
DR   Reactome; R-HSA-1169091; Activation of NF-kappaB in B cells.
DR   Reactome; R-HSA-1170546; Prolactin receptor signaling.
DR   Reactome; R-HSA-174113; SCF-beta-TrCP mediated degradation of Emi1.
DR   Reactome; R-HSA-187577; SCF(Skp2)-mediated degradation of p27/p21.
DR   Reactome; R-HSA-195253; Degradation of beta-catenin by the destruction complex.
DR   Reactome; R-HSA-202424; Downstream TCR signaling.
DR   Reactome; R-HSA-2122947; NOTCH1 Intracellular Domain Regulates Transcription.
DR   Reactome; R-HSA-2565942; Regulation of PLK1 Activity at G2/M Transition.
DR   Reactome; R-HSA-2644606; Constitutive Signaling by NOTCH1 PEST Domain Mutants.
DR   Reactome; R-HSA-2644607; Loss of Function of FBXW7 in Cancer and NOTCH1 Signaling.
DR   Reactome; R-HSA-2871837; FCERI mediated NF-kB activation.
DR   Reactome; R-HSA-2894862; Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants.
DR   Reactome; R-HSA-400253; Circadian Clock.
DR   Reactome; R-HSA-5607761; Dectin-1 mediated noncanonical NF-kB signaling.
DR   Reactome; R-HSA-5607764; CLEC7A (Dectin-1) signaling.
DR   Reactome; R-HSA-5610780; Degradation of GLI1 by the proteasome.
DR   Reactome; R-HSA-5610783; Degradation of GLI2 by the proteasome.
DR   Reactome; R-HSA-5610785; GLI3 is processed to GLI3R by the proteasome.
DR   Reactome; R-HSA-5676590; NIK-->noncanonical NF-kB signaling.
DR   Reactome; R-HSA-5684264; MAP3K8 (TPL2)-dependent MAPK1/3 activation.
DR   Reactome; R-HSA-68949; Orc1 removal from chromatin.
DR   Reactome; R-HSA-69231; Cyclin D associated events in G1.
DR   Reactome; R-HSA-8854050; FBXL7 down-regulates AURKA during mitotic entry and in early mitosis.
DR   Reactome; R-HSA-8939902; Regulation of RUNX2 expression and activity.
DR   Reactome; R-HSA-8951664; Neddylation.
DR   Reactome; R-HSA-9020702; Interleukin-1 signaling.
DR   Reactome; R-HSA-917937; Iron uptake and transport.
DR   Reactome; R-HSA-983168; Antigen processing: Ubiquitination & Proteasome degradation.
DR   SignaLink; Q13616; -.
DR   SIGNOR; Q13616; -.
DR   UniPathway; UPA00143; -.
DR   ChiTaRS; CUL1; human.
DR   EvolutionaryTrace; Q13616; -.
DR   GeneWiki; CUL1; -.
DR   GenomeRNAi; 8454; -.
DR   PRO; PR:Q13616; -.
DR   Proteomes; UP000005640; Chromosome 7.
DR   Bgee; ENSG00000055130; -.
DR   CleanEx; HS_CUL1; -.
DR   ExpressionAtlas; Q13616; baseline and differential.
DR   Genevisible; Q13616; HS.
DR   GO; GO:0031461; C:cullin-RING ubiquitin ligase complex; IDA:MGI.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:1990452; C:Parkin-FBXW7-Cul1 ubiquitin ligase complex; IPI:ParkinsonsUK-UCL.
DR   GO; GO:0019005; C:SCF ubiquitin ligase complex; IDA:UniProtKB.
DR   GO; GO:0031625; F:ubiquitin protein ligase binding; IBA:GO_Central.
DR   GO; GO:0004842; F:ubiquitin-protein transferase activity; EXP:Reactome.
DR   GO; GO:0009887; P:animal organ morphogenesis; IEA:Ensembl.
DR   GO; GO:0007050; P:cell cycle arrest; TAS:ProtInc.
DR   GO; GO:0008283; P:cell proliferation; IEA:Ensembl.
DR   GO; GO:0006879; P:cellular iron ion homeostasis; TAS:Reactome.
DR   GO; GO:0000082; P:G1/S transition of mitotic cell cycle; TAS:ProtInc.
DR   GO; GO:0000086; P:G2/M transition of mitotic cell cycle; TAS:Reactome.
DR   GO; GO:0070498; P:interleukin-1-mediated signaling pathway; TAS:Reactome.
DR   GO; GO:0097193; P:intrinsic apoptotic signaling pathway; TAS:ProtInc.
DR   GO; GO:0008285; P:negative regulation of cell proliferation; TAS:ProtInc.
DR   GO; GO:0010972; P:negative regulation of G2/M transition of mitotic cell cycle; TAS:Reactome.
DR   GO; GO:0038061; P:NIK/NF-kappaB signaling; TAS:Reactome.
DR   GO; GO:0043687; P:post-translational protein modification; TAS:Reactome.
DR   GO; GO:0006513; P:protein monoubiquitination; IEA:Ensembl.
DR   GO; GO:0000209; P:protein polyubiquitination; TAS:Reactome.
DR   GO; GO:0016567; P:protein ubiquitination; IDA:UniProtKB.
DR   GO; GO:0010265; P:SCF complex assembly; TAS:Reactome.
DR   GO; GO:0031146; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; IDA:UniProtKB.
DR   GO; GO:0051403; P:stress-activated MAPK cascade; TAS:Reactome.
DR   GO; GO:0016032; P:viral process; IEA:UniProtKB-KW.
DR   GO; GO:0016055; P:Wnt signaling pathway; TAS:Reactome.
DR   Gene3D; 1.10.10.10; -; 2.
DR   InterPro; IPR016157; Cullin_CS.
DR   InterPro; IPR016158; Cullin_homology.
DR   InterPro; IPR036317; Cullin_homology_sf.
DR   InterPro; IPR001373; Cullin_N.
DR   InterPro; IPR019559; Cullin_neddylation_domain.
DR   InterPro; IPR016159; Cullin_repeat-like_dom_sf.
DR   InterPro; IPR036388; WH-like_DNA-bd_sf.
DR   InterPro; IPR036390; WH_DNA-bd_sf.
DR   Pfam; PF00888; Cullin; 1.
DR   Pfam; PF10557; Cullin_Nedd8; 1.
DR   SMART; SM00182; CULLIN; 1.
DR   SMART; SM00884; Cullin_Nedd8; 1.
DR   SUPFAM; SSF46785; SSF46785; 1.
DR   SUPFAM; SSF74788; SSF74788; 1.
DR   SUPFAM; SSF75632; SSF75632; 1.
DR   PROSITE; PS01256; CULLIN_1; 1.
DR   PROSITE; PS50069; CULLIN_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Complete proteome; Host-virus interaction;
KW   Isopeptide bond; Methylation; Reference proteome; Ubl conjugation;
KW   Ubl conjugation pathway.
FT   CHAIN         1    776       Cullin-1.
FT                                /FTId=PRO_0000119787.
FT   MOD_RES      63     63       Omega-N-methylarginine.
FT                                {ECO:0000244|PubMed:24129315}.
FT   CROSSLNK    720    720       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in NEDD8).
FT                                {ECO:0000269|PubMed:10597293,
FT                                ECO:0000269|PubMed:15537541,
FT                                ECO:0000269|PubMed:18805092}.
FT   CONFLICT     59     82       Missing (in Ref. 1; AAC50544).
FT                                {ECO:0000305}.
FT   CONFLICT    726    726       K -> R (in Ref. 3; CAD97651).
FT                                {ECO:0000305}.
FT   HELIX        18     31       {ECO:0000244|PDB:1LDJ}.
FT   TURN         32     34       {ECO:0000244|PDB:1U6G}.
FT   HELIX        39     52       {ECO:0000244|PDB:1LDJ}.
FT   HELIX        87    105       {ECO:0000244|PDB:1LDJ}.
FT   TURN        106    109       {ECO:0000244|PDB:1U6G}.
FT   TURN        111    114       {ECO:0000244|PDB:1LDJ}.
FT   HELIX       115    136       {ECO:0000244|PDB:1LDJ}.
FT   HELIX       138    143       {ECO:0000244|PDB:1LDJ}.
FT   STRAND      144    146       {ECO:0000244|PDB:1LDJ}.
FT   HELIX       159    165       {ECO:0000244|PDB:1LDJ}.
FT   HELIX       168    171       {ECO:0000244|PDB:1LDJ}.
FT   TURN        172    177       {ECO:0000244|PDB:1LDJ}.
FT   HELIX       178    187       {ECO:0000244|PDB:1LDJ}.
FT   TURN        188    190       {ECO:0000244|PDB:1LDJ}.
FT   HELIX       199    210       {ECO:0000244|PDB:1LDJ}.
FT   TURN        211    213       {ECO:0000244|PDB:1LDK}.
FT   STRAND      215    219       {ECO:0000244|PDB:1LDJ}.
FT   HELIX       226    231       {ECO:0000244|PDB:1LDJ}.
FT   HELIX       233    254       {ECO:0000244|PDB:1LDJ}.
FT   HELIX       261    273       {ECO:0000244|PDB:1LDJ}.
FT   TURN        274    279       {ECO:0000244|PDB:1LDJ}.
FT   STRAND      281    284       {ECO:0000244|PDB:1LDJ}.
FT   HELIX       285    295       {ECO:0000244|PDB:1LDJ}.
FT   STRAND      296    300       {ECO:0000244|PDB:1LDJ}.
FT   HELIX       301    312       {ECO:0000244|PDB:1LDJ}.
FT   HELIX       318    328       {ECO:0000244|PDB:1LDJ}.
FT   HELIX       333    355       {ECO:0000244|PDB:1LDJ}.
FT   HELIX       359    361       {ECO:0000244|PDB:1LDJ}.
FT   HELIX       363    382       {ECO:0000244|PDB:1LDJ}.
FT   TURN        383    387       {ECO:0000244|PDB:1LDJ}.
FT   HELIX       389    404       {ECO:0000244|PDB:1LDJ}.
FT   HELIX       407    412       {ECO:0000244|PDB:1LDJ}.
FT   HELIX       417    430       {ECO:0000244|PDB:1LDJ}.
FT   HELIX       439    453       {ECO:0000244|PDB:1LDJ}.
FT   HELIX       459    475       {ECO:0000244|PDB:1LDJ}.
FT   HELIX       482    525       {ECO:0000244|PDB:1LDJ}.
FT   TURN        526    528       {ECO:0000244|PDB:1LDJ}.
FT   STRAND      532    541       {ECO:0000244|PDB:1LDJ}.
FT   TURN        542    544       {ECO:0000244|PDB:1LDJ}.
FT   HELIX       557    559       {ECO:0000244|PDB:1LDJ}.
FT   HELIX       560    569       {ECO:0000244|PDB:1LDJ}.
FT   TURN        570    573       {ECO:0000244|PDB:1LDJ}.
FT   STRAND      579    581       {ECO:0000244|PDB:1LDJ}.
FT   HELIX       583    585       {ECO:0000244|PDB:1LDJ}.
FT   STRAND      589    597       {ECO:0000244|PDB:1LDJ}.
FT   STRAND      600    602       {ECO:0000244|PDB:1LDJ}.
FT   HELIX       605    612       {ECO:0000244|PDB:1LDJ}.
FT   HELIX       613    615       {ECO:0000244|PDB:1LDJ}.
FT   STRAND      616    621       {ECO:0000244|PDB:1LDJ}.
FT   HELIX       622    628       {ECO:0000244|PDB:1LDJ}.
FT   HELIX       633    645       {ECO:0000244|PDB:1LDJ}.
FT   TURN        646    648       {ECO:0000244|PDB:1LDJ}.
FT   STRAND      652    654       {ECO:0000244|PDB:1LDK}.
FT   TURN        658    660       {ECO:0000244|PDB:1LDJ}.
FT   STRAND      668    671       {ECO:0000244|PDB:1LDJ}.
FT   STRAND      678    682       {ECO:0000244|PDB:1LDJ}.
FT   HELIX       691    700       {ECO:0000244|PDB:1LDK}.
FT   HELIX       703    722       {ECO:0000244|PDB:3TDU}.
FT   STRAND      723    726       {ECO:0000244|PDB:3TDU}.
FT   HELIX       727    738       {ECO:0000244|PDB:3TDU}.
FT   TURN        739    741       {ECO:0000244|PDB:3TDU}.
FT   HELIX       746    758       {ECO:0000244|PDB:3TDU}.
FT   STRAND      761    765       {ECO:0000244|PDB:3TDU}.
FT   STRAND      768    774       {ECO:0000244|PDB:3TDU}.
SQ   SEQUENCE   776 AA;  89679 MW;  6625A1FFA7799BBA CRC64;
     MSSTRSQNPH GLKQIGLDQI WDDLRAGIQQ VYTRQSMAKS RYMELYTHVY NYCTSVHQSN
     QARGAGVPPS KSKKGQTPGG AQFVGLELYK RLKEFLKNYL TNLLKDGEDL MDESVLKFYT
     QQWEDYRFSS KVLNGICAYL NRHWVRRECD EGRKGIYEIY SLALVTWRDC LFRPLNKQVT
     NAVLKLIEKE RNGETINTRL ISGVVQSYVE LGLNEDDAFA KGPTLTVYKE SFESQFLADT
     ERFYTRESTE FLQQNPVTEY MKKAEARLLE EQRRVQVYLH ESTQDELARK CEQVLIEKHL
     EIFHTEFQNL LDADKNEDLG RMYNLVSRIQ DGLGELKKLL ETHIHNQGLA AIEKCGEAAL
     NDPKMYVQTV LDVHKKYNAL VMSAFNNDAG FVAALDKACG RFINNNAVTK MAQSSSKSPE
     LLARYCDSLL KKSSKNPEEA ELEDTLNQVM VVFKYIEDKD VFQKFYAKML AKRLVHQNSA
     SDDAEASMIS KLKQACGFEY TSKLQRMFQD IGVSKDLNEQ FKKHLTNSEP LDLDFSIQVL
     SSGSWPFQQS CTFALPSELE RSYQRFTAFY ASRHSGRKLT WLYQLSKGEL VTNCFKNRYT
     LQASTFQMAI LLQYNTEDAY TVQQLTDSTQ IKMDILAQVL QILLKSKLLV LEDENANVDE
     VELKPDTLIK LYLGYKNKKL RVNINVPMKT EQKQEQETTH KNIEEDRKLL IQAAIVRIMK
     MRKVLKHQQL LGEVLTQLSS RFKPRVPVIK KCIDILIEKE YLERVDGEKD TYSYLA
//
ID   A0A0S2Z489_HUMAN        Unreviewed;       456 AA.
AC   A0A0S2Z489;
DT   17-FEB-2016, integrated into UniProtKB/TrEMBL.
DT   17-FEB-2016, sequence version 1.
DT   23-MAY-2018, entry version 22.
DE   SubName: Full=Proteasome (Prosome, macropain) 26S subunit, non-ATPase, 12, isoform CRA_a {ECO:0000313|EMBL:EAW89026.1};
DE   SubName: Full=Proteasome 26S subunit non-ATPase 12 isoform 1 {ECO:0000313|EMBL:ALQ33746.1};
DE   Flags: Fragment;
GN   Name=PSMD12 {ECO:0000313|EMBL:ALQ33746.1};
GN   ORFNames=hCG_1749256 {ECO:0000313|EMBL:EAW89026.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:ALQ33746.1};
RN   [1] {ECO:0000313|EMBL:EAW89026.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAW89026.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3] {ECO:0000313|EMBL:ALQ33746.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=26871637; DOI=10.1016/j.cell.2016.01.029;
RA   Yang X., Coulombe-Huntington J., Kang S., Sheynkman G.M., Hao T.,
RA   Richardson A., Sun S., Yang F., Shen Y.A., Murray R., Spirohn K.,
RA   Begg B.E., Duran-Frigola M., MacWilliams A., Pevzner S.J., Zhong Q.,
RA   Trigg S.A., Tam S., Ghamsari L., Sahni N., Yi S., Rodriguez M.D.,
RA   Balcha D., Tan G., Costanzo M., Andrews B., Boone C., Zhou X.J.,
RA   Salehi-Ashtiani K., Charloteaux B., Chen A., Calderwood M.A., Aloy P.,
RA   Roth F.P., Hill D.E., Iakoucheva L.M., Xia Y., Vidal M.;
RT   "Widespread Expansion of Protein Interaction Capabilities by
RT   Alternative Splicing.";
RL   Cell 164:805-817(2016).
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; KU178288; ALQ33746.1; -; mRNA.
DR   EMBL; CH471099; EAW89026.1; -; Genomic_DNA.
DR   RefSeq; NP_002807.1; NM_002816.4.
DR   UniGene; Hs.4295; -.
DR   UniGene; Hs.592689; -.
DR   SMR; A0A0S2Z489; -.
DR   PRIDE; A0A0S2Z489; -.
DR   GeneID; 5718; -.
DR   KEGG; hsa:5718; -.
DR   CTD; 5718; -.
DR   KO; K03035; -.
DR   OMA; KQAITKM; -.
DR   ChiTaRS; PSMD12; human.
DR   ExpressionAtlas; A0A0S2Z489; baseline and differential.
DR   GO; GO:0005838; C:proteasome regulatory particle; IEA:Ensembl.
DR   Gene3D; 1.10.10.10; -; 1.
DR   InterPro; IPR000717; PCI_dom.
DR   InterPro; IPR035297; PSMD12.
DR   InterPro; IPR036388; WH-like_DNA-bd_sf.
DR   InterPro; IPR036390; WH_DNA-bd_sf.
DR   PANTHER; PTHR10855:SF1; PTHR10855:SF1; 1.
DR   Pfam; PF01399; PCI; 1.
DR   SMART; SM00088; PINT; 1.
DR   SUPFAM; SSF46785; SSF46785; 1.
DR   PROSITE; PS50250; PCI; 1.
PE   2: Evidence at transcript level;
KW   Coiled coil {ECO:0000256|SAM:Coils};
KW   Proteasome {ECO:0000313|EMBL:ALQ33746.1}.
FT   DOMAIN      242    420       PCI. {ECO:0000259|PROSITE:PS50250}.
FT   COILED      152    172       {ECO:0000256|SAM:Coils}.
FT   NON_TER     456    456       {ECO:0000313|EMBL:ALQ33746.1}.
SQ   SEQUENCE   456 AA;  52904 MW;  97D0BDBDB0C96195 CRC64;
     MADGGSERAD GRIVKMEVDY SATVDQRLPE CAKLAKEGRL QEVIETLLSL EKQTRTASDM
     VSTSRILVAV VKMCYEAKEW DLLNENIMLL SKRRSQLKQA VAKMVQQCCT YVEEITDLPI
     KLRLIDTLRM VTEGKIYVEI ERARLTKTLA TIKEQNGDVK EAASILQELQ VETYGSMEKK
     ERVEFILEQM RLCLAVKDYI RTQIISKKIN TKFFQEENTE KLKLKYYNLM IQLDQHEGSY
     LSICKHYRAI YDTPCIQAES EKWQQALKSV VLYVILAPFD NEQSDLVHRI SGDKKLEEIP
     KYKDLLKLFT TMELMRWSTL VEDYGMELRK GSLESPATDV FGSTEEGEKR WKDLKNRVVE
     HNIRIMAKYY TRITMKRMAQ LLDLSVDESE AFLSNLVVNK TIFAKVDRLA GIINFQRPKD
     PNNLLNDWSQ KLNSLMSLVN KTTHLIAKEE MIHNLQ
//
ID   PSD12_HUMAN             Reviewed;         456 AA.
AC   O00232; A6NP15; Q53HA2; Q6P053;
DT   15-MAY-2002, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 3.
DT   23-MAY-2018, entry version 167.
DE   RecName: Full=26S proteasome non-ATPase regulatory subunit 12;
DE   AltName: Full=26S proteasome regulatory subunit RPN5;
DE   AltName: Full=26S proteasome regulatory subunit p55;
GN   Name=PSMD12;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=9426256; DOI=10.1016/S0378-1119(97)00524-6;
RA   Saito A., Watanabe T.K., Shimada Y., Fujiwara T., Slaughter C.A.,
RA   DeMartino G.N., Tanahashi N., Tanaka K.;
RT   "cDNA cloning and functional analysis of p44.5 and p55, two regulatory
RT   subunits of the 26S proteasome.";
RL   Gene 203:241-250(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Tongue;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RA   Suzuki Y., Sugano S., Totoki Y., Toyoda A., Takeda T., Sakaki Y.,
RA   Tanaka A., Yokoyama S.;
RL   Submitted (APR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16625196; DOI=10.1038/nature04689;
RA   Zody M.C., Garber M., Adams D.J., Sharpe T., Harrow J., Lupski J.R.,
RA   Nicholson C., Searle S.M., Wilming L., Young S.K., Abouelleil A.,
RA   Allen N.R., Bi W., Bloom T., Borowsky M.L., Bugalter B.E., Butler J.,
RA   Chang J.L., Chen C.-K., Cook A., Corum B., Cuomo C.A., de Jong P.J.,
RA   DeCaprio D., Dewar K., FitzGerald M., Gilbert J., Gibson R.,
RA   Gnerre S., Goldstein S., Grafham D.V., Grocock R., Hafez N.,
RA   Hagopian D.S., Hart E., Norman C.H., Humphray S., Jaffe D.B.,
RA   Jones M., Kamal M., Khodiyar V.K., LaButti K., Laird G., Lehoczky J.,
RA   Liu X., Lokyitsang T., Loveland J., Lui A., Macdonald P., Major J.E.,
RA   Matthews L., Mauceli E., McCarroll S.A., Mihalev A.H., Mudge J.,
RA   Nguyen C., Nicol R., O'Leary S.B., Osoegawa K., Schwartz D.C.,
RA   Shaw-Smith C., Stankiewicz P., Steward C., Swarbreck D.,
RA   Venkataraman V., Whittaker C.A., Yang X., Zimmer A.R., Bradley A.,
RA   Hubbard T., Birren B.W., Rogers J., Lander E.S., Nusbaum C.;
RT   "DNA sequence of human chromosome 17 and analysis of rearrangement in
RT   the human lineage.";
RL   Nature 440:1045-1049(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Muscle, and Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   PROTEIN SEQUENCE OF 2-12, AND ACETYLATION AT ALA-2.
RC   TISSUE=Platelet;
RX   PubMed=12665801; DOI=10.1038/nbt810;
RA   Gevaert K., Goethals M., Martens L., Van Damme J., Staes A.,
RA   Thomas G.R., Vandekerckhove J.;
RT   "Exploring proteomes and analyzing protein processing by mass
RT   spectrometric identification of sorted N-terminal peptides.";
RL   Nat. Biotechnol. 21:566-569(2003).
RN   [8]
RP   FUNCTION.
RX   PubMed=1317798; DOI=10.1111/j.1432-1033.1992.tb16961.x;
RA   Kanayama H.O., Tamura T., Ugai S., Kagawa S., Tanahashi N.,
RA   Yoshimura T., Tanaka K., Ichihara A.;
RT   "Demonstration that a human 26S proteolytic complex consists of a
RT   proteasome and multiple associated protein components and hydrolyzes
RT   ATP and ubiquitin-ligated proteins by closely linked mechanisms.";
RL   Eur. J. Biochem. 206:567-578(1992).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Embryonic kidney;
RX   PubMed=17323924; DOI=10.1021/bi061994u;
RA   Wang X., Chen C.-F., Baker P.R., Chen P.-L., Kaiser P., Huang L.;
RT   "Mass spectrometric characterization of the affinity-purified human
RT   26S proteasome complex.";
RL   Biochemistry 46:3553-3565(2007).
RN   [10]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [11]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-221 AND LYS-368, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [14]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-92, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25218447; DOI=10.1038/nsmb.2890;
RA   Hendriks I.A., D'Souza R.C., Yang B., Verlaan-de Vries M., Mann M.,
RA   Vertegaal A.C.;
RT   "Uncovering global SUMOylation signaling networks in a site-specific
RT   manner.";
RL   Nat. Struct. Mol. Biol. 21:927-936(2014).
RN   [15]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-92, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25114211; DOI=10.1073/pnas.1413825111;
RA   Impens F., Radoshevich L., Cossart P., Ribet D.;
RT   "Mapping of SUMO sites and analysis of SUMOylation changes induced by
RT   external stimuli.";
RL   Proc. Natl. Acad. Sci. U.S.A. 111:12432-12437(2014).
RN   [16]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-92, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25772364; DOI=10.1016/j.celrep.2015.02.033;
RA   Hendriks I.A., Treffers L.W., Verlaan-de Vries M., Olsen J.V.,
RA   Vertegaal A.C.;
RT   "SUMO-2 orchestrates chromatin modifiers in response to DNA damage.";
RL   Cell Rep. 10:1778-1791(2015).
RN   [17]
RP   INVOLVEMENT IN STISS.
RX   PubMed=28132691; DOI=10.1016/j.ajhg.2017.01.003;
RA   Kuery S., Besnard T., Ebstein F., Khan T.N., Gambin T., Douglas J.,
RA   Bacino C.A., Craigen W.J., Sanders S.J., Lehmann A., Latypova X.,
RA   Khan K., Pacault M., Sacharow S., Glaser K., Bieth E.,
RA   Perrin-Sabourin L., Jacquemont M.L., Cho M.T., Roeder E.,
RA   Denomme-Pichon A.S., Monaghan K.G., Yuan B., Xia F., Simon S.,
RA   Bonneau D., Parent P., Gilbert-Dussardier B., Odent S., Toutain A.,
RA   Pasquier L., Barbouth D., Shaw C.A., Patel A., Smith J.L., Bi W.,
RA   Schmitt S., Deb W., Nizon M., Mercier S., Vincent M., Rooryck C.,
RA   Malan V., Briceno I., Gomez A., Nugent K.M., Gibson J.B., Cogne B.,
RA   Lupski J.R., Stessman H.A.F., Eichler E.E., Retterer K., Yang Y.,
RA   Redon R., Katsanis N., Rosenfeld J.A., Kloetzel P.M., Golzio C.,
RA   Bezieau S., Stankiewicz P., Isidor B.;
RT   "De novo disruption of the proteasome regulatory subunit PSMD12 causes
RT   a syndromic neurodevelopmental disorder.";
RL   Am. J. Hum. Genet. 100:352-363(2017).
RN   [18]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-92, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-
RT   modification with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
RN   [19]
RP   STRUCTURE BY ELECTRON MICROSCOPY (3.50 ANGSTROMS), AND SUBUNIT.
RX   PubMed=27428775; DOI=10.1038/nsmb.3273;
RA   Huang X., Luan B., Wu J., Shi Y.;
RT   "An atomic structure of the human 26S proteasome.";
RL   Nat. Struct. Mol. Biol. 23:778-785(2016).
RN   [20]
RP   STRUCTURE BY ELECTRON MICROSCOPY (4.50 ANGSTROMS), AND SUBUNIT.
RX   PubMed=27342858; DOI=10.1073/pnas.1608050113;
RA   Schweitzer A., Aufderheide A., Rudack T., Beck F., Pfeifer G.,
RA   Plitzko J.M., Sakata E., Schulten K., Foerster F., Baumeister W.;
RT   "Structure of the human 26S proteasome at a resolution of 3.9 Aa.";
RL   Proc. Natl. Acad. Sci. U.S.A. 113:7816-7821(2016).
CC   -!- FUNCTION: Component of the 26S proteasome, a multiprotein complex
CC       involved in the ATP-dependent degradation of ubiquitinated
CC       proteins. This complex plays a key role in the maintenance of
CC       protein homeostasis by removing misfolded or damaged proteins,
CC       which could impair cellular functions, and by removing proteins
CC       whose functions are no longer required. Therefore, the proteasome
CC       participates in numerous cellular processes, including cell cycle
CC       progression, apoptosis, or DNA damage repair.
CC       {ECO:0000269|PubMed:1317798}.
CC   -!- SUBUNIT: Component of the 19S proteasome regulatory particle
CC       complex. The 26S proteasome consists of a 20S core particle (CP)
CC       and two 19S regulatory subunits (RP). The regulatory particle is
CC       made of a lid composed of 9 subunits including PSMD12, a base
CC       containing 6 ATPases and few additional components.
CC       {ECO:0000269|PubMed:27342858, ECO:0000269|PubMed:27428775}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=O00232-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=O00232-2; Sequence=VSP_042718;
CC         Note=No experimental confirmation available.;
CC   -!- DISEASE: Stankiewicz-Isidor syndrome (STISS) [MIM:617516]: A
CC       neurodevelopmental disorder characterized by delayed psychomotor
CC       development, intellectual disability, behavioral disorders, mild
CC       dysmorphism, ophthalmologic anomalies, feeding difficulties,
CC       deafness, and variable congenital malformations of the cardiac
CC       and/or urogenital systems. {ECO:0000269|PubMed:28132691}. Note=The
CC       disease is caused by mutations affecting the gene represented in
CC       this entry.
CC   -!- SIMILARITY: Belongs to the proteasome subunit p55 family.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH65826.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB003103; BAA19749.1; -; mRNA.
DR   EMBL; AK091198; BAG52303.1; -; mRNA.
DR   EMBL; AK222679; BAD96399.1; -; mRNA.
DR   EMBL; AC110921; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471099; EAW89028.1; -; Genomic_DNA.
DR   EMBL; BC019062; AAH19062.1; -; mRNA.
DR   EMBL; BC065826; AAH65826.1; ALT_INIT; mRNA.
DR   CCDS; CCDS11669.1; -. [O00232-1]
DR   CCDS; CCDS11670.1; -. [O00232-2]
DR   PIR; PC6501; JC6523.
DR   RefSeq; NP_001303270.1; NM_001316341.1.
DR   RefSeq; NP_002807.1; NM_002816.4. [O00232-1]
DR   RefSeq; NP_777360.1; NM_174871.3. [O00232-2]
DR   UniGene; Hs.4295; -.
DR   UniGene; Hs.592689; -.
DR   PDB; 5GJQ; EM; 4.50 A; P=1-456.
DR   PDB; 5GJR; EM; 3.50 A; 3/P=1-456.
DR   PDB; 5L4K; EM; 4.50 A; P=1-456.
DR   PDB; 5LN3; EM; 6.80 A; P=1-456.
DR   PDB; 5M32; EM; 3.80 A; k=1-456.
DR   PDB; 5T0C; EM; 3.80 A; AW/BW=1-456.
DR   PDB; 5T0G; EM; 4.40 A; W=1-456.
DR   PDB; 5T0H; EM; 6.80 A; W=1-456.
DR   PDB; 5T0I; EM; 8.00 A; W=1-456.
DR   PDB; 5T0J; EM; 8.00 A; W=1-456.
DR   PDB; 5VGZ; EM; 3.70 A; W=1-456.
DR   PDB; 5VHF; EM; 5.70 A; W=1-456.
DR   PDB; 5VHH; EM; 6.10 A; W=1-456.
DR   PDB; 5VHI; EM; 6.80 A; W=1-456.
DR   PDB; 5VHS; EM; 8.80 A; W=1-456.
DR   PDBsum; 5GJQ; -.
DR   PDBsum; 5GJR; -.
DR   PDBsum; 5L4K; -.
DR   PDBsum; 5LN3; -.
DR   PDBsum; 5M32; -.
DR   PDBsum; 5T0C; -.
DR   PDBsum; 5T0G; -.
DR   PDBsum; 5T0H; -.
DR   PDBsum; 5T0I; -.
DR   PDBsum; 5T0J; -.
DR   PDBsum; 5VGZ; -.
DR   PDBsum; 5VHF; -.
DR   PDBsum; 5VHH; -.
DR   PDBsum; 5VHI; -.
DR   PDBsum; 5VHS; -.
DR   ProteinModelPortal; O00232; -.
DR   SMR; O00232; -.
DR   BioGrid; 111690; 112.
DR   CORUM; O00232; -.
DR   DIP; DIP-27549N; -.
DR   IntAct; O00232; 30.
DR   MINT; O00232; -.
DR   STRING; 9606.ENSP00000348442; -.
DR   ChEMBL; CHEMBL2364701; -.
DR   iPTMnet; O00232; -.
DR   PhosphoSitePlus; O00232; -.
DR   SwissPalm; O00232; -.
DR   BioMuta; PSMD12; -.
DR   EPD; O00232; -.
DR   MaxQB; O00232; -.
DR   PaxDb; O00232; -.
DR   PeptideAtlas; O00232; -.
DR   PRIDE; O00232; -.
DR   DNASU; 5718; -.
DR   Ensembl; ENST00000356126; ENSP00000348442; ENSG00000197170. [O00232-1]
DR   Ensembl; ENST00000357146; ENSP00000349667; ENSG00000197170. [O00232-2]
DR   GeneID; 5718; -.
DR   KEGG; hsa:5718; -.
DR   UCSC; uc002jfy.4; human. [O00232-1]
DR   CTD; 5718; -.
DR   DisGeNET; 5718; -.
DR   EuPathDB; HostDB:ENSG00000197170.9; -.
DR   GeneCards; PSMD12; -.
DR   HGNC; HGNC:9557; PSMD12.
DR   HPA; HPA023119; -.
DR   MalaCards; PSMD12; -.
DR   MIM; 604450; gene.
DR   MIM; 617516; phenotype.
DR   neXtProt; NX_O00232; -.
DR   OpenTargets; ENSG00000197170; -.
DR   PharmGKB; PA33903; -.
DR   eggNOG; KOG1498; Eukaryota.
DR   eggNOG; COG5071; LUCA.
DR   GeneTree; ENSGT00730000111110; -.
DR   HOGENOM; HOG000194265; -.
DR   HOVERGEN; HBG053739; -.
DR   InParanoid; O00232; -.
DR   KO; K03035; -.
DR   OMA; KQAITKM; -.
DR   OrthoDB; EOG091G06CB; -.
DR   PhylomeDB; O00232; -.
DR   TreeFam; TF105721; -.
DR   Reactome; R-HSA-1169091; Activation of NF-kappaB in B cells.
DR   Reactome; R-HSA-1234176; Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha.
DR   Reactome; R-HSA-1236974; ER-Phagosome pathway.
DR   Reactome; R-HSA-1236978; Cross-presentation of soluble exogenous antigens (endosomes).
DR   Reactome; R-HSA-174084; Autodegradation of Cdh1 by Cdh1:APC/C.
DR   Reactome; R-HSA-174113; SCF-beta-TrCP mediated degradation of Emi1.
DR   Reactome; R-HSA-174154; APC/C:Cdc20 mediated degradation of Securin.
DR   Reactome; R-HSA-174178; APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1.
DR   Reactome; R-HSA-174184; Cdc20:Phospho-APC/C mediated degradation of Cyclin A.
DR   Reactome; R-HSA-180534; Vpu mediated degradation of CD4.
DR   Reactome; R-HSA-180585; Vif-mediated degradation of APOBEC3G.
DR   Reactome; R-HSA-187577; SCF(Skp2)-mediated degradation of p27/p21.
DR   Reactome; R-HSA-195253; Degradation of beta-catenin by the destruction complex.
DR   Reactome; R-HSA-202424; Downstream TCR signaling.
DR   Reactome; R-HSA-211733; Regulation of activated PAK-2p34 by proteasome mediated degradation.
DR   Reactome; R-HSA-2467813; Separation of Sister Chromatids.
DR   Reactome; R-HSA-2871837; FCERI mediated NF-kB activation.
DR   Reactome; R-HSA-349425; Autodegradation of the E3 ubiquitin ligase COP1.
DR   Reactome; R-HSA-350562; Regulation of ornithine decarboxylase (ODC).
DR   Reactome; R-HSA-382556; ABC-family proteins mediated transport.
DR   Reactome; R-HSA-450408; AUF1 (hnRNP D0) binds and destabilizes mRNA.
DR   Reactome; R-HSA-4608870; Asymmetric localization of PCP proteins.
DR   Reactome; R-HSA-4641257; Degradation of AXIN.
DR   Reactome; R-HSA-4641258; Degradation of DVL.
DR   Reactome; R-HSA-5358346; Hedgehog ligand biogenesis.
DR   Reactome; R-HSA-5362768; Hh mutants that don't undergo autocatalytic processing are degraded by ERAD.
DR   Reactome; R-HSA-5607761; Dectin-1 mediated noncanonical NF-kB signaling.
DR   Reactome; R-HSA-5607764; CLEC7A (Dectin-1) signaling.
DR   Reactome; R-HSA-5610780; Degradation of GLI1 by the proteasome.
DR   Reactome; R-HSA-5610783; Degradation of GLI2 by the proteasome.
DR   Reactome; R-HSA-5610785; GLI3 is processed to GLI3R by the proteasome.
DR   Reactome; R-HSA-5632684; Hedgehog 'on' state.
DR   Reactome; R-HSA-5658442; Regulation of RAS by GAPs.
DR   Reactome; R-HSA-5668541; TNFR2 non-canonical NF-kB pathway.
DR   Reactome; R-HSA-5676590; NIK-->noncanonical NF-kB signaling.
DR   Reactome; R-HSA-5678895; Defective CFTR causes cystic fibrosis.
DR   Reactome; R-HSA-5687128; MAPK6/MAPK4 signaling.
DR   Reactome; R-HSA-5689603; UCH proteinases.
DR   Reactome; R-HSA-5689880; Ub-specific processing proteases.
DR   Reactome; R-HSA-6798695; Neutrophil degranulation.
DR   Reactome; R-HSA-68827; CDT1 association with the CDC6:ORC:origin complex.
DR   Reactome; R-HSA-68949; Orc1 removal from chromatin.
DR   Reactome; R-HSA-69017; CDK-mediated phosphorylation and removal of Cdc6.
DR   Reactome; R-HSA-69229; Ubiquitin-dependent degradation of Cyclin D1.
DR   Reactome; R-HSA-69481; G2/M Checkpoints.
DR   Reactome; R-HSA-69601; Ubiquitin Mediated Degradation of Phosphorylated Cdc25A.
DR   Reactome; R-HSA-8852276; The role of GTSE1 in G2/M progression after G2 checkpoint.
DR   Reactome; R-HSA-8854050; FBXL7 down-regulates AURKA during mitotic entry and in early mitosis.
DR   Reactome; R-HSA-8939236; RUNX1 regulates transcription of genes involved in differentiation of HSCs.
DR   Reactome; R-HSA-8939902; Regulation of RUNX2 expression and activity.
DR   Reactome; R-HSA-8941858; Regulation of RUNX3 expression and activity.
DR   Reactome; R-HSA-8948751; Regulation of PTEN stability and activity.
DR   Reactome; R-HSA-8951664; Neddylation.
DR   Reactome; R-HSA-9010553; Regulation of expression of SLITs and ROBOs.
DR   Reactome; R-HSA-9020702; Interleukin-1 signaling.
DR   Reactome; R-HSA-983168; Antigen processing: Ubiquitination & Proteasome degradation.
DR   ChiTaRS; PSMD12; human.
DR   GeneWiki; PSMD12; -.
DR   GenomeRNAi; 5718; -.
DR   PRO; PR:O00232; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   Bgee; ENSG00000197170; -.
DR   CleanEx; HS_PSMD12; -.
DR   ExpressionAtlas; O00232; baseline and differential.
DR   Genevisible; O00232; HS.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0005576; C:extracellular region; TAS:Reactome.
DR   GO; GO:1904813; C:ficolin-1-rich granule lumen; TAS:Reactome.
DR   GO; GO:0016020; C:membrane; HDA:UniProtKB.
DR   GO; GO:0031595; C:nuclear proteasome complex; IBA:GO_Central.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0022624; C:proteasome accessory complex; ISS:UniProtKB.
DR   GO; GO:0000502; C:proteasome complex; IDA:UniProtKB.
DR   GO; GO:0005838; C:proteasome regulatory particle; TAS:ProtInc.
DR   GO; GO:0008541; C:proteasome regulatory particle, lid subcomplex; IBA:GO_Central.
DR   GO; GO:0034774; C:secretory granule lumen; TAS:Reactome.
DR   GO; GO:0043312; P:neutrophil degranulation; TAS:Reactome.
DR   GO; GO:0043687; P:post-translational protein modification; TAS:Reactome.
DR   GO; GO:0043161; P:proteasome-mediated ubiquitin-dependent protein catabolic process; IBA:GO_Central.
DR   GO; GO:0016579; P:protein deubiquitination; TAS:Reactome.
DR   Gene3D; 1.10.10.10; -; 1.
DR   InterPro; IPR000717; PCI_dom.
DR   InterPro; IPR035297; PSMD12.
DR   InterPro; IPR036388; WH-like_DNA-bd_sf.
DR   InterPro; IPR036390; WH_DNA-bd_sf.
DR   PANTHER; PTHR10855:SF1; PTHR10855:SF1; 1.
DR   Pfam; PF01399; PCI; 1.
DR   SMART; SM00088; PINT; 1.
DR   SUPFAM; SSF46785; SSF46785; 1.
DR   PROSITE; PS50250; PCI; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Complete proteome;
KW   Direct protein sequencing; Isopeptide bond; Mental retardation;
KW   Polymorphism; Proteasome; Reference proteome; Ubl conjugation.
FT   INIT_MET      1      1       Removed. {ECO:0000244|PubMed:19413330,
FT                                ECO:0000269|PubMed:12665801}.
FT   CHAIN         2    456       26S proteasome non-ATPase regulatory
FT                                subunit 12.
FT                                /FTId=PRO_0000173861.
FT   DOMAIN      242    420       PCI. {ECO:0000255|PROSITE-
FT                                ProRule:PRU01185}.
FT   MOD_RES       2      2       N-acetylalanine.
FT                                {ECO:0000244|PubMed:19413330,
FT                                ECO:0000269|PubMed:12665801}.
FT   MOD_RES     221    221       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     368    368       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   CROSSLNK     92     92       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO1);
FT                                alternate. {ECO:0000244|PubMed:25114211}.
FT   CROSSLNK     92     92       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2);
FT                                alternate. {ECO:0000244|PubMed:25114211,
FT                                ECO:0000244|PubMed:25218447,
FT                                ECO:0000244|PubMed:25772364,
FT                                ECO:0000244|PubMed:28112733}.
FT   VAR_SEQ      37     56       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_042718.
FT   VARIANT     358    358       V -> A (in dbSNP:rs2230680).
FT                                /FTId=VAR_051558.
FT   CONFLICT    300    300       P -> S (in Ref. 3; BAD96399).
FT                                {ECO:0000305}.
FT   CONFLICT    398    398       V -> D (in Ref. 3; BAD96399).
FT                                {ECO:0000305}.
SQ   SEQUENCE   456 AA;  52904 MW;  97D0BDBDB0C96195 CRC64;
     MADGGSERAD GRIVKMEVDY SATVDQRLPE CAKLAKEGRL QEVIETLLSL EKQTRTASDM
     VSTSRILVAV VKMCYEAKEW DLLNENIMLL SKRRSQLKQA VAKMVQQCCT YVEEITDLPI
     KLRLIDTLRM VTEGKIYVEI ERARLTKTLA TIKEQNGDVK EAASILQELQ VETYGSMEKK
     ERVEFILEQM RLCLAVKDYI RTQIISKKIN TKFFQEENTE KLKLKYYNLM IQLDQHEGSY
     LSICKHYRAI YDTPCIQAES EKWQQALKSV VLYVILAPFD NEQSDLVHRI SGDKKLEEIP
     KYKDLLKLFT TMELMRWSTL VEDYGMELRK GSLESPATDV FGSTEEGEKR WKDLKNRVVE
     HNIRIMAKYY TRITMKRMAQ LLDLSVDESE AFLSNLVVNK TIFAKVDRLA GIINFQRPKD
     PNNLLNDWSQ KLNSLMSLVN KTTHLIAKEE MIHNLQ
//
ID   A0A1S6GWG3_MOUSE        Unreviewed;       470 AA.
AC   A0A1S6GWG3;
DT   10-MAY-2017, integrated into UniProtKB/TrEMBL.
DT   10-MAY-2017, sequence version 1.
DT   28-MAR-2018, entry version 7.
DE   SubName: Full=Uncharacterized protein {ECO:0000313|EMBL:AQS27593.1};
GN   Name=Adrm1 {ECO:0000313|MGI:MGI:1929289};
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha;
OC   Muroidea; Muridae; Murinae; Mus; Mus.
OX   NCBI_TaxID=10090 {ECO:0000313|EMBL:AQS27593.1};
RN   [1] {ECO:0000313|EMBL:AQS27593.1}
RP   NUCLEOTIDE SEQUENCE.
RC   STRAIN=C57BL/6J {ECO:0000313|EMBL:AQS27593.1};
RX   PubMed=27899360; DOI=10.1182/blood-2016-09-741835;
RA   Alvarez-Dominguez J.R., Zhang X., Hu W.;
RT   "Widespread and dynamic translational control of red blood cell
RT   development.";
RL   Blood 129:619-629(2017).
RN   [2] {ECO:0000313|EMBL:AQS27593.1}
RP   NUCLEOTIDE SEQUENCE.
RC   STRAIN=C57BL/6J {ECO:0000313|EMBL:AQS27593.1};
RA   Mah S.A., Swanson W.J., Moy G.W., Vacquier V.D.;
RL   Submitted (JAN-2017) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; KY499672; AQS27593.1; -; mRNA.
DR   RefSeq; XP_006500743.1; XM_006500680.3.
DR   UniGene; Mm.316654; -.
DR   UniGene; Mm.379082; -.
DR   GeneID; 56436; -.
DR   CTD; 11047; -.
DR   MGI; MGI:1929289; Adrm1.
DR   GO; GO:0005737; C:cytoplasm; IEA:InterPro.
DR   GO; GO:0005634; C:nucleus; IEA:InterPro.
DR   Gene3D; 2.30.29.70; -; 1.
DR   Gene3D; 3.40.190.140; -; 1.
DR   InterPro; IPR006773; Rpn13/ADRM1.
DR   InterPro; IPR038633; Rpn13/ADRM1_sf.
DR   InterPro; IPR032368; RPN13_C.
DR   InterPro; IPR038108; RPN13_C_sf.
DR   PANTHER; PTHR12225; PTHR12225; 1.
DR   Pfam; PF04683; Proteasom_Rpn13; 1.
DR   Pfam; PF16550; RPN13_C; 1.
PE   2: Evidence at transcript level;
FT   DOMAIN      331    444       RPN13_C. {ECO:0000259|Pfam:PF16550}.
SQ   SEQUENCE   470 AA;  48531 MW;  DB8D3365825FDFAC CRC64;
     MRWTVTRANR DLVGAGRAAD GTQSAARAAA GRAKHGLPAR PGRRRGGRAS PDGAPRPSVS
     TARMTTSGAL FPSLVPGSRG SSTKYLVEFR AGKMSLKGTT VTPDKRKGLV YIQQTDDSLI
     HFCWKDRTSG TVEDDLIIFP DDCEFKRVPQ CPSGRVYVLK FKAGSKRLFF WMQEPKTDQD
     EEHCRKVNEC LNNPPMPGSL GASGSSGHEL SALGGEGGLQ SLLGNMSHSQ LMQLIGPAGL
     GGLGGLGALT GPGLASLLGS SGPPASSSSS SSRSQSAAVT PSSSTSSARA TPAPSAPAAA
     SATSPSPAPS SGNGTSTAAS PTQPIQLSDL QSILATMNVP AGPGGSQQVD LASVLTPEIM
     APILANADVQ ERLLPYLPSG ESLPQTADEI QNTLTSPQFQ QALGMFSAAL ASGQLGPLMC
     QFGLPAEAVE AANKGDVEAF AKAMQNNAKS DPKEGDTKDK KDEEEDMSLD
//
ID   ADRM1_MOUSE             Reviewed;         407 AA.
AC   Q9JKV1; Q3UKZ8; Q8BPH8; Q922A7;
DT   23-JAN-2002, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-2007, sequence version 2.
DT   28-MAR-2018, entry version 122.
DE   RecName: Full=Proteasomal ubiquitin receptor ADRM1;
DE   AltName: Full=110 kDa cell membrane glycoprotein;
DE            Short=Gp110;
DE   AltName: Full=Adhesion-regulating molecule 1;
DE            Short=ARM-1;
DE   AltName: Full=Rpn13 homolog;
GN   Name=Adrm1; Synonyms=Gp110;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha;
OC   Muroidea; Muridae; Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=10919708; DOI=10.1023/A:1006790912877;
RA   Simins A.B., Weighardt H., Weidner K.M., Weidle U.H., Holzmann B.;
RT   "Functional cloning of ARM-1, an adhesion-regulating molecule
RT   upregulated in metastatic tumor cells.";
RL   Clin. Exp. Metastasis 17:641-648(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=C57BL/6J; TISSUE=Embryo;
RX   PubMed=16141072; DOI=10.1126/science.1112014;
RA   Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,
RA   Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,
RA   Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M.,
RA   Davis M.J., Wilming L.G., Aidinis V., Allen J.E.,
RA   Ambesi-Impiombato A., Apweiler R., Aturaliya R.N., Bailey T.L.,
RA   Bansal M., Baxter L., Beisel K.W., Bersano T., Bono H., Chalk A.M.,
RA   Chiu K.P., Choudhary V., Christoffels A., Clutterbuck D.R.,
RA   Crowe M.L., Dalla E., Dalrymple B.P., de Bono B., Della Gatta G.,
RA   di Bernardo D., Down T., Engstrom P., Fagiolini M., Faulkner G.,
RA   Fletcher C.F., Fukushima T., Furuno M., Futaki S., Gariboldi M.,
RA   Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,
RA   Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N.,
RA   Hill D., Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T.,
RA   Jakt M., Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H.,
RA   Kitano H., Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K.,
RA   Kurochkin I.V., Lareau L.F., Lazarevic D., Lipovich L., Liu J.,
RA   Liuni S., McWilliam S., Madan Babu M., Madera M., Marchionni L.,
RA   Matsuda H., Matsuzawa S., Miki H., Mignone F., Miyake S., Morris K.,
RA   Mottagui-Tabar S., Mulder N., Nakano N., Nakauchi H., Ng P.,
RA   Nilsson R., Nishiguchi S., Nishikawa S., Nori F., Ohara O.,
RA   Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G., Pesole G.,
RA   Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z., Ringwald M.,
RA   Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,
RA   Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,
RA   Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B.,
RA   Sperling S., Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K.,
RA   Tammoja K., Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A.,
RA   Ueda H.R., van Nimwegen E., Verardo R., Wei C.L., Yagi K.,
RA   Yamanishi H., Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C.,
RA   Grimmond S.M., Teasdale R.D., Liu E.T., Brusic V., Quackenbush J.,
RA   Wahlestedt C., Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y.,
RA   Fukuda S., Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T.,
RA   Iida J., Imamura K., Itoh M., Kato T., Kawaji H., Kawagashira N.,
RA   Kawashima T., Kojima M., Kondo S., Konno H., Nakano K., Ninomiya N.,
RA   Nishio T., Okada M., Plessy C., Shibata K., Shiraki T., Suzuki S.,
RA   Tagami M., Waki K., Watahiki A., Okamura-Oho Y., Suzuki H., Kawai J.,
RA   Hayashizaki Y.;
RT   "The transcriptional landscape of the mammalian genome.";
RL   Science 309:1559-1563(2005).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=C57BL/6J;
RX   PubMed=19468303; DOI=10.1371/journal.pbio.1000112;
RA   Church D.M., Goodstadt L., Hillier L.W., Zody M.C., Goldstein S.,
RA   She X., Bult C.J., Agarwala R., Cherry J.L., DiCuccio M., Hlavina W.,
RA   Kapustin Y., Meric P., Maglott D., Birtle Z., Marques A.C., Graves T.,
RA   Zhou S., Teague B., Potamousis K., Churas C., Place M., Herschleb J.,
RA   Runnheim R., Forrest D., Amos-Landgraf J., Schwartz D.C., Cheng Z.,
RA   Lindblad-Toh K., Eichler E.E., Ponting C.P.;
RT   "Lineage-specific biology revealed by a finished genome assembly of
RT   the mouse.";
RL   PLoS Biol. 7:E1000112-E1000112(2009).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=Czech II; TISSUE=Mammary tumor;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   FUNCTION, SUBCELLULAR LOCATION, AND LACK OF GLYCOSYLATION.
RX   PubMed=15819879; DOI=10.1111/j.1742-4658.2005.04613.x;
RA   Lamerant N., Kieda C.;
RT   "Adhesion properties of adhesion-regulating molecule 1 protein on
RT   endothelial cells.";
RL   FEBS J. 272:1833-1844(2005).
RN   [6]
RP   TISSUE SPECIFICITY.
RX   PubMed=17139257; DOI=10.1038/sj.emboj.7601450;
RA   Qiu X.-B., Ouyang S.-Y., Li C.-J., Miao S., Wang L., Goldberg A.L.;
RT   "hRpn13/ADRM1/GP110 is a novel proteasome subunit that binds the
RT   deubiquitinating enzyme, UCH37.";
RL   EMBO J. 25:5742-5753(2006).
RN   [7]
RP   TISSUE SPECIFICITY.
RX   PubMed=16815440; DOI=10.1016/j.jmb.2006.06.011;
RA   Joergensen J.P., Lauridsen A.-M., Kristensen P., Dissing K.,
RA   Johnsen A.H., Hendil K.B., Hartmann-Petersen R.;
RT   "Adrm1, a putative cell adhesion regulating protein, is a novel
RT   proteasome-associated factor.";
RL   J. Mol. Biol. 360:1043-1052(2006).
RN   [8]
RP   STRUCTURE BY NMR OF 22-130, X-RAY CRYSTALLOGRAPHY (1.7 ANGSTROMS) OF
RP   1-150, FUNCTION, REGION, AND INTERACTION WITH UBIQUITIN; UCHL5 AND
RP   PSMD1.
RX   PubMed=18497827; DOI=10.1038/nature06924;
RA   Schreiner P., Chen X., Husnjak K., Randles L., Zhang N., Elsasser S.,
RA   Finley D., Dikic I., Walters K.J., Groll M.;
RT   "Ubiquitin docking at the proteasome through a novel pleckstrin-
RT   homology domain interaction.";
RL   Nature 453:548-552(2008).
CC   -!- FUNCTION: Component of the 26S proteasome, a multiprotein complex
CC       involved in the ATP-dependent degradation of ubiquitinated
CC       proteins. This complex plays a key role in the maintenance of
CC       protein homeostasis by removing misfolded or damaged proteins,
CC       which could impair cellular functions, and by removing proteins
CC       whose functions are no longer required. Therefore, the proteasome
CC       participates in numerous cellular processes, including cell cycle
CC       progression, apoptosis, or DNA damage repair. Within the complex,
CC       functions as a proteasomal ubiquitin receptor. Engages and thus
CC       activates 19S-associated deubiquitinases UCHL5 and PSMD14 during
CC       protein degradation. UCHL5 reversibly associate with the 19S
CC       regulatory particle whereas PSMD14 is an intrinsic subunit of the
CC       proteasome lid subcomplex. {ECO:0000269|PubMed:15819879,
CC       ECO:0000269|PubMed:18497827}.
CC   -!- SUBUNIT: Component of the 19S proteasome regulatory particle
CC       complex. The 26S proteasome consists of a 20S core particle (CP)
CC       and two 19S regulatory subunits (RP). Interacts with the
CC       proteasomal scaffolding protein PSMD1 (PubMed:18497827). Interacts
CC       with deubiquitinase UCHL5; this interaction activates the auto-
CC       inhibited UCHL5 by deoligomerizing it. Interacts with UBQLN2 and
CC       ubiquitin. {ECO:0000250|UniProtKB:Q16186,
CC       ECO:0000269|PubMed:18497827}.
CC   -!- INTERACTION:
CC       Q99460-1:PSMD1 (xeno); NbExp=2; IntAct=EBI-8762776, EBI-15703973;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:15819879}.
CC       Nucleus {ECO:0000250|UniProtKB:Q16186}.
CC   -!- TISSUE SPECIFICITY: Present in all tissues examined (at protein
CC       level). {ECO:0000269|PubMed:16815440,
CC       ECO:0000269|PubMed:17139257}.
CC   -!- DOMAIN: The Pru (pleckstrin-like receptor for ubiquitin) domain
CC       mediates interactions with PSMD1 and ubiquitin. Preferential
CC       binding to the proximal subunit of K48-linked diubiquitin allows
CC       UCHL5 access to the distal subunit. {ECO:0000269|PubMed:18497827}.
CC   -!- PTM: Not N-glycosylated.
CC   -!- PTM: Not O-glycosylated. {ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the ADRM1 family. {ECO:0000305}.
CC   -!- CAUTION: Although initially described as a cell membrane
CC       glycoprotein, ADRM1 is intracellular and non-glycosylated, and has
CC       probably no direct role in cell adhesion. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF225959; AAF33401.1; -; mRNA.
DR   EMBL; AK075674; BAC35889.1; -; mRNA.
DR   EMBL; AK145474; BAE26457.1; -; mRNA.
DR   EMBL; AK145792; BAE26653.1; -; mRNA.
DR   EMBL; AK166878; BAE39089.1; -; mRNA.
DR   EMBL; AL663027; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC008974; AAH08974.1; -; mRNA.
DR   EMBL; BC031517; AAH31517.1; -; mRNA.
DR   CCDS; CCDS17171.1; -.
DR   RefSeq; NP_062796.2; NM_019822.3.
DR   UniGene; Mm.316654; -.
DR   UniGene; Mm.379082; -.
DR   PDB; 2R2Y; X-ray; 1.70 A; A=2-150.
DR   PDB; 2Z59; NMR; -; A=22-130.
DR   PDBsum; 2R2Y; -.
DR   PDBsum; 2Z59; -.
DR   ProteinModelPortal; Q9JKV1; -.
DR   SMR; Q9JKV1; -.
DR   BioGrid; 207978; 10.
DR   DIP; DIP-60625N; -.
DR   IntAct; Q9JKV1; 19.
DR   STRING; 10090.ENSMUSP00000050076; -.
DR   iPTMnet; Q9JKV1; -.
DR   PhosphoSitePlus; Q9JKV1; -.
DR   EPD; Q9JKV1; -.
DR   MaxQB; Q9JKV1; -.
DR   PaxDb; Q9JKV1; -.
DR   PeptideAtlas; Q9JKV1; -.
DR   PRIDE; Q9JKV1; -.
DR   Ensembl; ENSMUST00000061437; ENSMUSP00000050076; ENSMUSG00000039041.
DR   GeneID; 56436; -.
DR   KEGG; mmu:56436; -.
DR   UCSC; uc008oin.1; mouse.
DR   CTD; 11047; -.
DR   MGI; MGI:1929289; Adrm1.
DR   eggNOG; KOG3037; Eukaryota.
DR   eggNOG; ENOG410XSJJ; LUCA.
DR   GeneTree; ENSGT00390000013839; -.
DR   HOGENOM; HOG000005947; -.
DR   HOVERGEN; HBG073518; -.
DR   InParanoid; Q9JKV1; -.
DR   KO; K06691; -.
DR   OMA; HCRRINE; -.
DR   OrthoDB; EOG091G0FEO; -.
DR   PhylomeDB; Q9JKV1; -.
DR   TreeFam; TF313410; -.
DR   Reactome; R-MMU-5689603; UCH proteinases.
DR   Reactome; R-MMU-5689880; Ub-specific processing proteases.
DR   EvolutionaryTrace; Q9JKV1; -.
DR   PRO; PR:Q9JKV1; -.
DR   Proteomes; UP000000589; Chromosome 2.
DR   Bgee; ENSMUSG00000039041; -.
DR   CleanEx; MM_ADRM1; -.
DR   Genevisible; Q9JKV1; MM.
DR   GO; GO:0005829; C:cytosol; ISO:MGI.
DR   GO; GO:0005654; C:nucleoplasm; ISO:MGI.
DR   GO; GO:0005886; C:plasma membrane; ISO:MGI.
DR   GO; GO:0000502; C:proteasome complex; ISO:MGI.
DR   GO; GO:0008541; C:proteasome regulatory particle, lid subcomplex; IBA:GO_Central.
DR   GO; GO:0061133; F:endopeptidase activator activity; ISO:MGI.
DR   GO; GO:0002020; F:protease binding; ISO:MGI.
DR   GO; GO:0070628; F:proteasome binding; ISO:MGI.
DR   GO; GO:0043130; F:ubiquitin binding; IBA:GO_Central.
DR   GO; GO:0060612; P:adipose tissue development; IMP:BHF-UCL.
DR   GO; GO:0042699; P:follicle-stimulating hormone signaling pathway; IMP:BHF-UCL.
DR   GO; GO:0048477; P:oogenesis; IMP:BHF-UCL.
DR   GO; GO:0001541; P:ovarian follicle development; IMP:BHF-UCL.
DR   GO; GO:0060399; P:positive regulation of growth hormone receptor signaling pathway; IMP:BHF-UCL.
DR   GO; GO:0043248; P:proteasome assembly; ISO:MGI.
DR   GO; GO:0033081; P:regulation of T cell differentiation in thymus; IMP:BHF-UCL.
DR   GO; GO:0072520; P:seminiferous tubule development; IMP:BHF-UCL.
DR   GO; GO:0060009; P:Sertoli cell development; IMP:BHF-UCL.
DR   GO; GO:0007286; P:spermatid development; IMP:BHF-UCL.
DR   GO; GO:0048538; P:thymus development; IMP:BHF-UCL.
DR   GO; GO:0006368; P:transcription elongation from RNA polymerase II promoter; ISO:MGI.
DR   GO; GO:0006511; P:ubiquitin-dependent protein catabolic process; IBA:GO_Central.
DR   Gene3D; 2.30.29.70; -; 1.
DR   Gene3D; 3.40.190.140; -; 1.
DR   InterPro; IPR006773; Rpn13/ADRM1.
DR   InterPro; IPR038633; Rpn13/ADRM1_sf.
DR   InterPro; IPR032368; RPN13_C.
DR   InterPro; IPR038108; RPN13_C_sf.
DR   PANTHER; PTHR12225; PTHR12225; 1.
DR   Pfam; PF04683; Proteasom_Rpn13; 1.
DR   Pfam; PF16550; RPN13_C; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Complete proteome; Cytoplasm;
KW   Isopeptide bond; Nucleus; Phosphoprotein; Proteasome;
KW   Reference proteome; Ubl conjugation.
FT   INIT_MET      1      1       Removed. {ECO:0000250|UniProtKB:Q16186}.
FT   CHAIN         2    407       Proteasomal ubiquitin receptor ADRM1.
FT                                /FTId=PRO_0000020632.
FT   REGION       22    130       Pru (pleckstrin-like receptor for
FT                                ubiquitin) domain.
FT                                {ECO:0000269|PubMed:18497827}.
FT   REGION      362    407       Interaction with UCHL5. {ECO:0000250}.
FT   COMPBIAS    135    202       Gly-rich.
FT   COMPBIAS    193    257       Ser-rich.
FT   COMPBIAS    203    213       Poly-Ser.
FT   MOD_RES       2      2       N-acetylthreonine.
FT                                {ECO:0000250|UniProtKB:Q16186}.
FT   MOD_RES      15     15       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q16186}.
FT   MOD_RES     140    140       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q16186}.
FT   MOD_RES     211    211       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q16186}.
FT   MOD_RES     217    217       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:Q16186}.
FT   MOD_RES     405    405       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q9JMB5}.
FT   CROSSLNK     34     34       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in ubiquitin).
FT                                {ECO:0000250|UniProtKB:Q16186}.
FT   CONFLICT    109    109       M -> I (in Ref. 2; BAC35889).
FT                                {ECO:0000305}.
FT   CONFLICT    171    171       L -> I (in Ref. 2; BAE26653).
FT                                {ECO:0000305}.
FT   CONFLICT    226    226       R -> S (in Ref. 2; BAC35889).
FT                                {ECO:0000305}.
FT   CONFLICT    359    359       F -> I (in Ref. 1; AAF33401).
FT                                {ECO:0000305}.
FT   STRAND       24     34       {ECO:0000244|PDB:2R2Y}.
FT   STRAND       37     40       {ECO:0000244|PDB:2R2Y}.
FT   STRAND       45     51       {ECO:0000244|PDB:2R2Y}.
FT   STRAND       57     63       {ECO:0000244|PDB:2R2Y}.
FT   TURN         64     66       {ECO:0000244|PDB:2R2Y}.
FT   STRAND       69     74       {ECO:0000244|PDB:2R2Y}.
FT   STRAND       79     84       {ECO:0000244|PDB:2R2Y}.
FT   STRAND       93     98       {ECO:0000244|PDB:2R2Y}.
FT   TURN         99    101       {ECO:0000244|PDB:2R2Y}.
FT   STRAND      104    109       {ECO:0000244|PDB:2R2Y}.
FT   STRAND      111    114       {ECO:0000244|PDB:2R2Y}.
FT   HELIX       117    129       {ECO:0000244|PDB:2R2Y}.
SQ   SEQUENCE   407 AA;  42060 MW;  210AFDF7379C962D CRC64;
     MTTSGALFPS LVPGSRGSST KYLVEFRAGK MSLKGTTVTP DKRKGLVYIQ QTDDSLIHFC
     WKDRTSGTVE DDLIIFPDDC EFKRVPQCPS GRVYVLKFKA GSKRLFFWMQ EPKTDQDEEH
     CRKVNECLNN PPMPGSLGAS GSSGHELSAL GGEGGLQSLL GNMSHSQLMQ LIGPAGLGGL
     GGLGALTGPG LASLLGSSGP PASSSSSSSR SQSAAVTPSS STSSARATPA PSAPAAASAT
     SPSPAPSSGN GTSTAASPTQ PIQLSDLQSI LATMNVPAGP GGSQQVDLAS VLTPEIMAPI
     LANADVQERL LPYLPSGESL PQTADEIQNT LTSPQFQQAL GMFSAALASG QLGPLMCQFG
     LPAEAVEAAN KGDVEAFAKA MQNNAKSDPK EGDTKDKKDE EEDMSLD
//
ID   A0A140VKF2_HUMAN        Unreviewed;       310 AA.
AC   A0A140VKF2;
DT   08-JUN-2016, integrated into UniProtKB/TrEMBL.
DT   08-JUN-2016, sequence version 1.
DT   23-MAY-2018, entry version 13.
DE   SubName: Full=Testis tissue sperm-binding protein Li 69n {ECO:0000313|EMBL:AEE61289.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:AEE61289.1};
RN   [1] {ECO:0000313|EMBL:AEE61289.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Li J.Y.;
RT   "Human testis protein.";
RL   Submitted (MAR-2010) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; HM005692; AEE61289.1; -; mRNA.
DR   RefSeq; NP_005796.1; NM_005805.5.
DR   UniGene; Hs.740477; -.
DR   ProteinModelPortal; A0A140VKF2; -.
DR   SMR; A0A140VKF2; -.
DR   PRIDE; A0A140VKF2; -.
DR   GeneID; 10213; -.
DR   KEGG; hsa:10213; -.
DR   CTD; 10213; -.
DR   KO; K03030; -.
DR   OMA; QTGRPET; -.
DR   PhylomeDB; A0A140VKF2; -.
DR   ExpressionAtlas; A0A140VKF2; baseline and differential.
DR   GO; GO:0031597; C:cytosolic proteasome complex; IEA:Ensembl.
DR   GO; GO:0022624; C:proteasome accessory complex; IEA:Ensembl.
DR   GO; GO:0061578; F:Lys63-specific deubiquitinase activity; IEA:InterPro.
DR   GO; GO:0045471; P:response to ethanol; IEA:Ensembl.
DR   InterPro; IPR000555; JAMM/MPN+_dom.
DR   InterPro; IPR037518; MPN.
DR   InterPro; IPR035299; PSMD14.
DR   InterPro; IPR024969; Rpn11/EIF3F_C.
DR   PANTHER; PTHR10410:SF13; PTHR10410:SF13; 1.
DR   Pfam; PF01398; JAB; 1.
DR   Pfam; PF13012; MitMem_reg; 1.
DR   SMART; SM00232; JAB_MPN; 1.
DR   PROSITE; PS50249; MPN; 1.
PE   2: Evidence at transcript level;
FT   DOMAIN       31    166       MPN. {ECO:0000259|PROSITE:PS50249}.
SQ   SEQUENCE   310 AA;  34577 MW;  18ACE876C7682039 CRC64;
     MDRLLRLGGG MPGLGQGPPT DAPAVDTAEQ VYISSLALLK MLKHGRAGVP MEVMGLMLGE
     FVDDYTVRVI DVFAMPQSGT GVSVEAVDPV FQAKMLDMLK QTGRPEMVVG WYHSHPGFGC
     WLSGVDINTQ QSFEALSERA VAVVVDPIQS VKGKVVIDAF RLINANMMVL GHEPRQTTSN
     LGHLNKPSIQ ALIHGLNRHY YSITINYRKN ELEQKMLLNL HKKSWMEGLT LQDYSEHCKH
     NESVVKEMLE LAKNYNKAVE EEDKMTPEQL AIKNVGKQDP KRHLEEHVDV LMTSNIVQCL
     AAMLDTVVFK
//
ID   PSDE_HUMAN              Reviewed;         310 AA.
AC   O00487; B3KNW2; O00176;
DT   31-AUG-2004, integrated into UniProtKB/Swiss-Prot.
DT   01-JUL-1997, sequence version 1.
DT   23-MAY-2018, entry version 168.
DE   RecName: Full=26S proteasome non-ATPase regulatory subunit 14;
DE            EC=3.4.19.-;
DE   AltName: Full=26S proteasome regulatory subunit RPN11;
DE   AltName: Full=26S proteasome-associated PAD1 homolog 1;
GN   Name=PSMD14; Synonyms=POH1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, AND TISSUE SPECIFICITY.
RC   TISSUE=Lung;
RX   PubMed=9374539; DOI=10.1074/jbc.272.48.30470;
RA   Spataro V., Toda T., Craig R., Seeger M., Dubiel W., Harris A.L.,
RA   Norbury C.;
RT   "Resistance to diverse drugs and ultraviolet light conferred by
RT   overexpression of a novel human 26 S proteasome subunit.";
RL   J. Biol. Chem. 272:30470-30475(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   PROTEIN SEQUENCE OF 199-208, AND IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Brain, and Cajal-Retzius cell;
RA   Lubec G., Afjehi-Sadat L.;
RL   Submitted (MAR-2007) to UniProtKB.
RN   [6]
RP   FUNCTION.
RX   PubMed=1317798; DOI=10.1111/j.1432-1033.1992.tb16961.x;
RA   Kanayama H.O., Tamura T., Ugai S., Kagawa S., Tanahashi N.,
RA   Yoshimura T., Tanaka K., Ichihara A.;
RT   "Demonstration that a human 26S proteolytic complex consists of a
RT   proteasome and multiple associated protein components and hydrolyzes
RT   ATP and ubiquitin-ligated proteins by closely linked mechanisms.";
RL   Eur. J. Biochem. 206:567-578(1992).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-224, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Embryonic kidney;
RX   PubMed=17323924; DOI=10.1021/bi061994u;
RA   Wang X., Chen C.-F., Baker P.R., Chen P.-L., Kaiser P., Huang L.;
RT   "Mass spectrometric characterization of the affinity-purified human
RT   26S proteasome complex.";
RL   Biochemistry 46:3553-3565(2007).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-150, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Embryonic kidney;
RX   PubMed=17693683; DOI=10.1074/mcp.M700120-MCP200;
RA   Tang L.-Y., Deng N., Wang L.-S., Dai J., Wang Z.-L., Jiang X.-S.,
RA   Li S.-J., Li L., Sheng Q.-H., Wu D.-Q., Li L., Zeng R.;
RT   "Quantitative phosphoproteome profiling of Wnt3a-mediated signaling
RT   network: indicating the involvement of ribonucleoside-diphosphate
RT   reductase M2 subunit phosphorylation at residue serine 20 in canonical
RT   Wnt signal transduction.";
RL   Mol. Cell. Proteomics 6:1952-1967(2007).
RN   [9]
RP   PROBABLE FUNCTION, AND IDENTIFICATION IN THE PROTEASOME.
RX   PubMed=19214193; DOI=10.1038/emboj.2009.27;
RA   Cooper E.M., Cutcliffe C., Kristiansen T.Z., Pandey A., Pickart C.M.,
RA   Cohen R.E.;
RT   "K63-specific deubiquitination by two JAMM/MPN+ complexes: BRISC-
RT   associated Brcc36 and proteasomal Poh1.";
RL   EMBO J. 28:621-631(2009).
RN   [10]
RP   INTERACTION WITH TXNL1.
RX   PubMed=19349277; DOI=10.1074/jbc.M900016200;
RA   Andersen K.M., Madsen L., Prag S., Johnsen A.H., Semple C.A.,
RA   Hendil K.B., Hartmann-Petersen R.;
RT   "Thioredoxin Txnl1/TRP32 is a redox-active cofactor of the 26 S
RT   proteasome.";
RL   J. Biol. Chem. 284:15246-15254(2009).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [13]
RP   FUNCTION, IDENTIFICATION IN THE PROTEASOME, AND MUTAGENESIS OF
RP   113-HIS--HIS-115.
RX   PubMed=22909820; DOI=10.1038/emboj.2012.232;
RA   Butler L.R., Densham R.M., Jia J., Garvin A.J., Stone H.R., Shah V.,
RA   Weekes D., Festy F., Beesley J., Morris J.R.;
RT   "The proteasomal de-ubiquitinating enzyme POH1 promotes the double-
RT   strand DNA break response.";
RL   EMBO J. 31:3918-3934(2012).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-266, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-150, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [16]
RP   STRUCTURE BY ELECTRON MICROSCOPY (3.50 ANGSTROMS), AND SUBUNIT.
RX   PubMed=27428775; DOI=10.1038/nsmb.3273;
RA   Huang X., Luan B., Wu J., Shi Y.;
RT   "An atomic structure of the human 26S proteasome.";
RL   Nat. Struct. Mol. Biol. 23:778-785(2016).
RN   [17]
RP   STRUCTURE BY ELECTRON MICROSCOPY (4.50 ANGSTROMS), AND SUBUNIT.
RX   PubMed=27342858; DOI=10.1073/pnas.1608050113;
RA   Schweitzer A., Aufderheide A., Rudack T., Beck F., Pfeifer G.,
RA   Plitzko J.M., Sakata E., Schulten K., Foerster F., Baumeister W.;
RT   "Structure of the human 26S proteasome at a resolution of 3.9 Aa.";
RL   Proc. Natl. Acad. Sci. U.S.A. 113:7816-7821(2016).
CC   -!- FUNCTION: Component of the 26S proteasome, a multiprotein complex
CC       involved in the ATP-dependent degradation of ubiquitinated
CC       proteins. This complex plays a key role in the maintenance of
CC       protein homeostasis by removing misfolded or damaged proteins,
CC       which could impair cellular functions, and by removing proteins
CC       whose functions are no longer required. Therefore, the proteasome
CC       participates in numerous cellular processes, including cell cycle
CC       progression, apoptosis, or DNA damage repair. The PSMD14 subunit
CC       is a metalloprotease that specifically cleaves 'Lys-63'-linked
CC       polyubiquitin chains within the complex. Plays a role in response
CC       to double-strand breaks (DSBs): acts as a regulator of non-
CC       homologous end joining (NHEJ) by cleaving 'Lys-63'-linked
CC       polyubiquitin, thereby promoting retention of JMJD2A/KDM4A on
CC       chromatin and restricting TP53BP1 accumulation. Also involved in
CC       homologous recombination repair by promoting RAD51 loading.
CC       {ECO:0000269|PubMed:1317798, ECO:0000269|PubMed:22909820,
CC       ECO:0000269|PubMed:9374539}.
CC   -!- SUBUNIT: Component of the 19S proteasome regulatory particle
CC       complex. The 26S proteasome consists of a 20S core particle (CP)
CC       and two 19S regulatory subunits (RP). The regulatory particle is
CC       made of a lid composed of 9 subunits including PSMD4, a base
CC       containing 6 ATPases and few additional components
CC       (PubMed:27428775, PubMed:27342858). Within the complex, PSMD4
CC       interacts with subunit PSMD7 through their respective MPN domain.
CC       Interacts with TXNL1 (PubMed:19349277).
CC       {ECO:0000269|PubMed:19214193, ECO:0000269|PubMed:19349277,
CC       ECO:0000269|PubMed:27342858, ECO:0000269|PubMed:27428775}.
CC   -!- INTERACTION:
CC       Q9C005:DPY30; NbExp=5; IntAct=EBI-722193, EBI-744973;
CC       Q8IZU0:FAM9B; NbExp=3; IntAct=EBI-722193, EBI-10175124;
CC       P50222:MEOX2; NbExp=3; IntAct=EBI-722193, EBI-748397;
CC       P51665:PSMD7; NbExp=8; IntAct=EBI-722193, EBI-357659;
CC   -!- TISSUE SPECIFICITY: Widely expressed. Highest levels in heart and
CC       skeletal muscle. {ECO:0000269|PubMed:9374539}.
CC   -!- SIMILARITY: Belongs to the peptidase M67A family. PSMD14
CC       subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U86782; AAC51866.1; -; mRNA.
DR   EMBL; AK055128; BAG51474.1; -; mRNA.
DR   EMBL; CH471058; EAX11370.1; -; Genomic_DNA.
DR   EMBL; BC066336; AAH66336.1; -; mRNA.
DR   CCDS; CCDS46437.1; -.
DR   RefSeq; NP_005796.1; NM_005805.5.
DR   UniGene; Hs.740477; -.
DR   PDB; 5GJQ; EM; 4.50 A; V=1-310.
DR   PDB; 5GJR; EM; 3.50 A; 9/V=1-310.
DR   PDB; 5L4K; EM; 4.50 A; V=1-310.
DR   PDB; 5LN3; EM; 6.80 A; V=1-310.
DR   PDB; 5M32; EM; 3.80 A; q=1-310.
DR   PDB; 5T0C; EM; 3.80 A; Ac/Bc=1-310.
DR   PDB; 5T0G; EM; 4.40 A; c=2-310.
DR   PDB; 5T0H; EM; 6.80 A; c=2-310.
DR   PDB; 5T0I; EM; 8.00 A; c=2-310.
DR   PDB; 5T0J; EM; 8.00 A; c=2-310.
DR   PDB; 5VGZ; EM; 3.70 A; c=24-310.
DR   PDB; 5VHF; EM; 5.70 A; c=24-310.
DR   PDB; 5VHH; EM; 6.10 A; c=24-310.
DR   PDB; 5VHI; EM; 6.80 A; c=24-310.
DR   PDB; 5VHS; EM; 8.80 A; c=24-310.
DR   PDBsum; 5GJQ; -.
DR   PDBsum; 5GJR; -.
DR   PDBsum; 5L4K; -.
DR   PDBsum; 5LN3; -.
DR   PDBsum; 5M32; -.
DR   PDBsum; 5T0C; -.
DR   PDBsum; 5T0G; -.
DR   PDBsum; 5T0H; -.
DR   PDBsum; 5T0I; -.
DR   PDBsum; 5T0J; -.
DR   PDBsum; 5VGZ; -.
DR   PDBsum; 5VHF; -.
DR   PDBsum; 5VHH; -.
DR   PDBsum; 5VHI; -.
DR   PDBsum; 5VHS; -.
DR   ProteinModelPortal; O00487; -.
DR   SMR; O00487; -.
DR   BioGrid; 115508; 116.
DR   CORUM; O00487; -.
DR   IntAct; O00487; 67.
DR   MINT; O00487; -.
DR   STRING; 9606.ENSP00000386541; -.
DR   BindingDB; O00487; -.
DR   ChEMBL; CHEMBL2007629; -.
DR   iPTMnet; O00487; -.
DR   PhosphoSitePlus; O00487; -.
DR   SwissPalm; O00487; -.
DR   BioMuta; PSMD14; -.
DR   OGP; O00487; -.
DR   REPRODUCTION-2DPAGE; IPI00024821; -.
DR   EPD; O00487; -.
DR   MaxQB; O00487; -.
DR   PaxDb; O00487; -.
DR   PeptideAtlas; O00487; -.
DR   PRIDE; O00487; -.
DR   TopDownProteomics; O00487; -.
DR   Ensembl; ENST00000409682; ENSP00000386541; ENSG00000115233.
DR   GeneID; 10213; -.
DR   KEGG; hsa:10213; -.
DR   UCSC; uc002ubu.4; human.
DR   CTD; 10213; -.
DR   DisGeNET; 10213; -.
DR   EuPathDB; HostDB:ENSG00000115233.11; -.
DR   GeneCards; PSMD14; -.
DR   HGNC; HGNC:16889; PSMD14.
DR   HPA; HPA002114; -.
DR   HPA; HPA003828; -.
DR   MIM; 607173; gene.
DR   neXtProt; NX_O00487; -.
DR   OpenTargets; ENSG00000115233; -.
DR   PharmGKB; PA134957776; -.
DR   eggNOG; KOG1555; Eukaryota.
DR   eggNOG; COG1310; LUCA.
DR   GeneTree; ENSGT00730000111116; -.
DR   HOGENOM; HOG000183690; -.
DR   HOVERGEN; HBG053742; -.
DR   InParanoid; O00487; -.
DR   KO; K03030; -.
DR   OMA; QTGRPET; -.
DR   OrthoDB; EOG091G0CMC; -.
DR   PhylomeDB; O00487; -.
DR   TreeFam; TF105748; -.
DR   Reactome; R-HSA-1169091; Activation of NF-kappaB in B cells.
DR   Reactome; R-HSA-1234176; Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha.
DR   Reactome; R-HSA-1236974; ER-Phagosome pathway.
DR   Reactome; R-HSA-1236978; Cross-presentation of soluble exogenous antigens (endosomes).
DR   Reactome; R-HSA-174084; Autodegradation of Cdh1 by Cdh1:APC/C.
DR   Reactome; R-HSA-174113; SCF-beta-TrCP mediated degradation of Emi1.
DR   Reactome; R-HSA-174154; APC/C:Cdc20 mediated degradation of Securin.
DR   Reactome; R-HSA-174178; APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1.
DR   Reactome; R-HSA-174184; Cdc20:Phospho-APC/C mediated degradation of Cyclin A.
DR   Reactome; R-HSA-180534; Vpu mediated degradation of CD4.
DR   Reactome; R-HSA-180585; Vif-mediated degradation of APOBEC3G.
DR   Reactome; R-HSA-187577; SCF(Skp2)-mediated degradation of p27/p21.
DR   Reactome; R-HSA-195253; Degradation of beta-catenin by the destruction complex.
DR   Reactome; R-HSA-202424; Downstream TCR signaling.
DR   Reactome; R-HSA-211733; Regulation of activated PAK-2p34 by proteasome mediated degradation.
DR   Reactome; R-HSA-2467813; Separation of Sister Chromatids.
DR   Reactome; R-HSA-2871837; FCERI mediated NF-kB activation.
DR   Reactome; R-HSA-349425; Autodegradation of the E3 ubiquitin ligase COP1.
DR   Reactome; R-HSA-350562; Regulation of ornithine decarboxylase (ODC).
DR   Reactome; R-HSA-382556; ABC-family proteins mediated transport.
DR   Reactome; R-HSA-450408; AUF1 (hnRNP D0) binds and destabilizes mRNA.
DR   Reactome; R-HSA-4608870; Asymmetric localization of PCP proteins.
DR   Reactome; R-HSA-4641257; Degradation of AXIN.
DR   Reactome; R-HSA-4641258; Degradation of DVL.
DR   Reactome; R-HSA-5358346; Hedgehog ligand biogenesis.
DR   Reactome; R-HSA-5362768; Hh mutants that don't undergo autocatalytic processing are degraded by ERAD.
DR   Reactome; R-HSA-5607761; Dectin-1 mediated noncanonical NF-kB signaling.
DR   Reactome; R-HSA-5607764; CLEC7A (Dectin-1) signaling.
DR   Reactome; R-HSA-5610780; Degradation of GLI1 by the proteasome.
DR   Reactome; R-HSA-5610783; Degradation of GLI2 by the proteasome.
DR   Reactome; R-HSA-5610785; GLI3 is processed to GLI3R by the proteasome.
DR   Reactome; R-HSA-5632684; Hedgehog 'on' state.
DR   Reactome; R-HSA-5658442; Regulation of RAS by GAPs.
DR   Reactome; R-HSA-5668541; TNFR2 non-canonical NF-kB pathway.
DR   Reactome; R-HSA-5676590; NIK-->noncanonical NF-kB signaling.
DR   Reactome; R-HSA-5678895; Defective CFTR causes cystic fibrosis.
DR   Reactome; R-HSA-5687128; MAPK6/MAPK4 signaling.
DR   Reactome; R-HSA-5689603; UCH proteinases.
DR   Reactome; R-HSA-5689880; Ub-specific processing proteases.
DR   Reactome; R-HSA-5689901; Metalloprotease DUBs.
DR   Reactome; R-HSA-6798695; Neutrophil degranulation.
DR   Reactome; R-HSA-68827; CDT1 association with the CDC6:ORC:origin complex.
DR   Reactome; R-HSA-68949; Orc1 removal from chromatin.
DR   Reactome; R-HSA-69017; CDK-mediated phosphorylation and removal of Cdc6.
DR   Reactome; R-HSA-69229; Ubiquitin-dependent degradation of Cyclin D1.
DR   Reactome; R-HSA-69481; G2/M Checkpoints.
DR   Reactome; R-HSA-69601; Ubiquitin Mediated Degradation of Phosphorylated Cdc25A.
DR   Reactome; R-HSA-8852276; The role of GTSE1 in G2/M progression after G2 checkpoint.
DR   Reactome; R-HSA-8854050; FBXL7 down-regulates AURKA during mitotic entry and in early mitosis.
DR   Reactome; R-HSA-8939236; RUNX1 regulates transcription of genes involved in differentiation of HSCs.
DR   Reactome; R-HSA-8939902; Regulation of RUNX2 expression and activity.
DR   Reactome; R-HSA-8941858; Regulation of RUNX3 expression and activity.
DR   Reactome; R-HSA-8948751; Regulation of PTEN stability and activity.
DR   Reactome; R-HSA-8951664; Neddylation.
DR   Reactome; R-HSA-9010553; Regulation of expression of SLITs and ROBOs.
DR   Reactome; R-HSA-9020702; Interleukin-1 signaling.
DR   Reactome; R-HSA-983168; Antigen processing: Ubiquitination & Proteasome degradation.
DR   ChiTaRS; PSMD14; human.
DR   GeneWiki; PSMD14; -.
DR   GenomeRNAi; 10213; -.
DR   PRO; PR:O00487; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   Bgee; ENSG00000115233; -.
DR   CleanEx; HS_PSMD14; -.
DR   ExpressionAtlas; O00487; baseline and differential.
DR   Genevisible; O00487; HS.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0031597; C:cytosolic proteasome complex; IEA:Ensembl.
DR   GO; GO:0005576; C:extracellular region; TAS:Reactome.
DR   GO; GO:1904813; C:ficolin-1-rich granule lumen; TAS:Reactome.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0005634; C:nucleus; HDA:UniProtKB.
DR   GO; GO:0022624; C:proteasome accessory complex; ISS:UniProtKB.
DR   GO; GO:0000502; C:proteasome complex; IDA:UniProtKB.
DR   GO; GO:0008541; C:proteasome regulatory particle, lid subcomplex; IMP:UniProtKB.
DR   GO; GO:0034774; C:secretory granule lumen; TAS:Reactome.
DR   GO; GO:0061133; F:endopeptidase activator activity; IMP:UniProtKB.
DR   GO; GO:0061578; F:Lys63-specific deubiquitinase activity; TAS:Reactome.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0008237; F:metallopeptidase activity; TAS:UniProtKB.
DR   GO; GO:0070628; F:proteasome binding; IDA:UniProtKB.
DR   GO; GO:0036459; F:thiol-dependent ubiquitinyl hydrolase activity; IMP:UniProtKB.
DR   GO; GO:0000724; P:double-strand break repair via homologous recombination; IMP:UniProtKB.
DR   GO; GO:0006303; P:double-strand break repair via nonhomologous end joining; IMP:UniProtKB.
DR   GO; GO:0043312; P:neutrophil degranulation; TAS:Reactome.
DR   GO; GO:0043687; P:post-translational protein modification; TAS:Reactome.
DR   GO; GO:0016579; P:protein deubiquitination; TAS:Reactome.
DR   GO; GO:0070536; P:protein K63-linked deubiquitination; IMP:UniProtKB.
DR   GO; GO:0061136; P:regulation of proteasomal protein catabolic process; IMP:UniProtKB.
DR   GO; GO:0045471; P:response to ethanol; IEA:Ensembl.
DR   GO; GO:0006511; P:ubiquitin-dependent protein catabolic process; TAS:UniProtKB.
DR   InterPro; IPR000555; JAMM/MPN+_dom.
DR   InterPro; IPR037518; MPN.
DR   InterPro; IPR035299; PSMD14.
DR   InterPro; IPR024969; Rpn11/EIF3F_C.
DR   PANTHER; PTHR10410:SF13; PTHR10410:SF13; 1.
DR   Pfam; PF01398; JAB; 1.
DR   Pfam; PF13012; MitMem_reg; 1.
DR   SMART; SM00232; JAB_MPN; 1.
DR   PROSITE; PS50249; MPN; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Complete proteome; Direct protein sequencing;
KW   DNA damage; DNA repair; Hydrolase; Metal-binding; Metalloprotease;
KW   Phosphoprotein; Protease; Proteasome; Reference proteome;
KW   Ubl conjugation pathway; Zinc.
FT   CHAIN         1    310       26S proteasome non-ATPase regulatory
FT                                subunit 14.
FT                                /FTId=PRO_0000213952.
FT   DOMAIN       31    166       MPN. {ECO:0000255|PROSITE-
FT                                ProRule:PRU01182}.
FT   MOTIF       113    126       JAMM motif. {ECO:0000255|PROSITE-
FT                                ProRule:PRU01182}.
FT   METAL       113    113       Zinc; catalytic. {ECO:0000255|PROSITE-
FT                                ProRule:PRU01182}.
FT   METAL       115    115       Zinc; catalytic. {ECO:0000255|PROSITE-
FT                                ProRule:PRU01182}.
FT   METAL       126    126       Zinc; catalytic. {ECO:0000255|PROSITE-
FT                                ProRule:PRU01182}.
FT   MOD_RES     150    150       Phosphoserine.
FT                                {ECO:0000244|PubMed:17693683,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     224    224       Phosphoserine.
FT                                {ECO:0000244|PubMed:17323924}.
FT   MOD_RES     266    266       Phosphothreonine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MUTAGEN     113    115       HSH->ASA: Abolishes ubiquitin
FT                                thioesterase activity, leading to prevent
FT                                maintenance of JMJD2A/KDM4A on chromatin.
FT                                {ECO:0000269|PubMed:22909820}.
SQ   SEQUENCE   310 AA;  34577 MW;  18ACE876C7682039 CRC64;
     MDRLLRLGGG MPGLGQGPPT DAPAVDTAEQ VYISSLALLK MLKHGRAGVP MEVMGLMLGE
     FVDDYTVRVI DVFAMPQSGT GVSVEAVDPV FQAKMLDMLK QTGRPEMVVG WYHSHPGFGC
     WLSGVDINTQ QSFEALSERA VAVVVDPIQS VKGKVVIDAF RLINANMMVL GHEPRQTTSN
     LGHLNKPSIQ ALIHGLNRHY YSITINYRKN ELEQKMLLNL HKKSWMEGLT LQDYSEHCKH
     NESVVKEMLE LAKNYNKAVE EEDKMTPEQL AIKNVGKQDP KRHLEEHVDV LMTSNIVQCL
     AAMLDTVVFK
//
ID   A0A087WX59_HUMAN        Unreviewed;       368 AA.
AC   A0A087WX59;
DT   29-OCT-2014, integrated into UniProtKB/TrEMBL.
DT   29-OCT-2014, sequence version 1.
DT   23-MAY-2018, entry version 33.
DE   SubName: Full=Proteasomal ubiquitin receptor ADRM1 {ECO:0000313|Ensembl:ENSP00000480756};
GN   Name=ADRM1 {ECO:0000313|Ensembl:ENSP00000480756};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000480756, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Ensembl:ENSP00000480756, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11780052; DOI=10.1038/414865a;
RA   Deloukas P., Matthews L.H., Ashurst J.L., Burton J., Gilbert J.G.R.,
RA   Jones M., Stavrides G., Almeida J.P., Babbage A.K., Bagguley C.L.,
RA   Bailey J., Barlow K.F., Bates K.N., Beard L.M., Beare D.M.,
RA   Beasley O.P., Bird C.P., Blakey S.E., Bridgeman A.M., Brown A.J.,
RA   Buck D., Burrill W.D., Butler A.P., Carder C., Carter N.P.,
RA   Chapman J.C., Clamp M., Clark G., Clark L.N., Clark S.Y., Clee C.M.,
RA   Clegg S., Cobley V.E., Collier R.E., Connor R.E., Corby N.R.,
RA   Coulson A., Coville G.J., Deadman R., Dhami P.D., Dunn M.,
RA   Ellington A.G., Frankland J.A., Fraser A., French L., Garner P.,
RA   Grafham D.V., Griffiths C., Griffiths M.N.D., Gwilliam R., Hall R.E.,
RA   Hammond S., Harley J.L., Heath P.D., Ho S., Holden J.L., Howden P.J.,
RA   Huckle E., Hunt A.R., Hunt S.E., Jekosch K., Johnson C.M., Johnson D.,
RA   Kay M.P., Kimberley A.M., King A., Knights A., Laird G.K., Lawlor S.,
RA   Lehvaeslaiho M.H., Leversha M.A., Lloyd C., Lloyd D.M., Lovell J.D.,
RA   Marsh V.L., Martin S.L., McConnachie L.J., McLay K., McMurray A.A.,
RA   Milne S.A., Mistry D., Moore M.J.F., Mullikin J.C., Nickerson T.,
RA   Oliver K., Parker A., Patel R., Pearce T.A.V., Peck A.I.,
RA   Phillimore B.J.C.T., Prathalingam S.R., Plumb R.W., Ramsay H.,
RA   Rice C.M., Ross M.T., Scott C.E., Sehra H.K., Shownkeen R., Sims S.,
RA   Skuce C.D., Smith M.L., Soderlund C., Steward C.A., Sulston J.E.,
RA   Swann R.M., Sycamore N., Taylor R., Tee L., Thomas D.W., Thorpe A.,
RA   Tracey A., Tromans A.C., Vaudin M., Wall M., Wallis J.M.,
RA   Whitehead S.L., Whittaker P., Willey D.L., Williams L., Williams S.A.,
RA   Wilming L., Wray P.W., Hubbard T., Durbin R.M., Bentley D.R., Beck S.,
RA   Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 20.";
RL   Nature 414:865-871(2001).
RN   [2] {ECO:0000213|PubMed:16964243}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=16964243; DOI=10.1038/nbt1240;
RA   Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
RT   "A probability-based approach for high-throughput protein
RT   phosphorylation analysis and site localization.";
RL   Nat. Biotechnol. 24:1285-1292(2006).
RN   [3] {ECO:0000213|PubMed:17323924}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=17323924; DOI=10.1021/bi061994u;
RA   Wang X., Chen C.F., Baker P.R., Chen P.L., Kaiser P., Huang L.;
RT   "Mass spectrometric characterization of the affinity-purified human
RT   26S proteasome complex.";
RL   Biochemistry 46:3553-3565(2007).
RN   [4] {ECO:0000213|PubMed:18669648}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [5] {ECO:0000213|PubMed:19413330}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [6] {ECO:0000213|PubMed:21269460}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Burckstummer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [7] {ECO:0000213|PubMed:22223895}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22223895; DOI=10.1074/mcp.M111.015131;
RA   Bienvenut W.V., Sumpton D., Martinez A., Lilla S., Espagne C.,
RA   Meinnel T., Giglione C.;
RT   "Comparative large scale characterization of plant versus mammal
RT   proteins reveals similar and idiosyncratic N-alpha-acetylation
RT   features.";
RL   Mol. Cell. Proteomics 11:M111.015131-M111.015131(2012).
RN   [8] {ECO:0000213|PubMed:22814378}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [9] {ECO:0000213|PubMed:23186163}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=23186163;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [10] {ECO:0000213|PubMed:24275569}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [11] {ECO:0000313|Ensembl:ENSP00000480756}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (SEP-2014) to UniProtKB.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AL354836; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   RefSeq; NP_001268366.1; NM_001281437.1.
DR   RefSeq; NP_001268367.1; NM_001281438.1.
DR   UniGene; Hs.90107; -.
DR   ProteinModelPortal; A0A087WX59; -.
DR   EPD; A0A087WX59; -.
DR   PeptideAtlas; A0A087WX59; -.
DR   Ensembl; ENST00000620230; ENSP00000480756; ENSG00000130706.
DR   GeneID; 11047; -.
DR   UCSC; uc032pos.2; human.
DR   CTD; 11047; -.
DR   EuPathDB; HostDB:ENSG00000130706.12; -.
DR   HGNC; HGNC:15759; ADRM1.
DR   OpenTargets; ENSG00000130706; -.
DR   GeneTree; ENSGT00390000013839; -.
DR   ChiTaRS; ADRM1; human.
DR   GenomeRNAi; 11047; -.
DR   Proteomes; UP000005640; Chromosome 20.
DR   Bgee; ENSG00000130706; -.
DR   ExpressionAtlas; A0A087WX59; baseline and differential.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005886; C:plasma membrane; IDA:HPA.
DR   Gene3D; 2.30.29.70; -; 1.
DR   Gene3D; 3.40.190.140; -; 1.
DR   InterPro; IPR006773; Rpn13/ADRM1.
DR   InterPro; IPR038633; Rpn13/ADRM1_sf.
DR   InterPro; IPR032368; RPN13_C.
DR   InterPro; IPR038108; RPN13_C_sf.
DR   PANTHER; PTHR12225; PTHR12225; 2.
DR   Pfam; PF04683; Proteasom_Rpn13; 1.
DR   Pfam; PF16550; RPN13_C; 1.
PE   1: Evidence at protein level;
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   Proteomics identification {ECO:0000213|EPD:A0A087WX59,
KW   ECO:0000213|MaxQB:A0A087WX59, ECO:0000213|PeptideAtlas:A0A087WX59};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640}.
FT   DOMAIN      229    342       RPN13_C. {ECO:0000259|Pfam:PF16550}.
SQ   SEQUENCE   368 AA;  37505 MW;  6D9C36FA320D7EE0 CRC64;
     MTTSGALFPS LVPGSRGASN KYLVEFRAGK MSLKGTTVTP DKRKGLVYIQ QTDDSLIHFC
     WKDRTSGNVE DEPKTDQDEE HCRKVNEYLN NPPMPGALGA SGSSGHELSA LGGEGGLQSL
     LGNMSHSQLM QLIGPAGLGG LGGLGALTGP GLASLLGSSG PPGSSSSSSS RSQSAAVTPS
     STTSSTRATP APSAPAAASA TSPSPAPSSG NGASTAASPT QPIQLSDLQS ILATMNVPAG
     PAGGQQVDLA SVLTPEIMAP ILANADVQER LLPYLPSGES LPQTADEIQN TLTSPQFQQA
     LGMFSAALAS GQLGPLMCQF GLPAEAVEAA NKGDVEAFAK AMQNNAKPEQ KEGDTKDKKD
     EEEDMSLD
//
ID   ADRM1_HUMAN             Reviewed;         407 AA.
AC   Q16186; A0PKB1; Q96FJ7; Q9H1P2;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2002, sequence version 2.
DT   23-MAY-2018, entry version 163.
DE   RecName: Full=Proteasomal ubiquitin receptor ADRM1;
DE   AltName: Full=110 kDa cell membrane glycoprotein;
DE            Short=Gp110;
DE   AltName: Full=Adhesion-regulating molecule 1;
DE            Short=ARM-1;
DE   AltName: Full=Proteasome regulatory particle non-ATPase 13;
DE            Short=hRpn13;
DE   AltName: Full=Rpn13 homolog;
GN   Name=ADRM1; Synonyms=GP110;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=8033103;
RA   Shimada S., Ogawa M., Takahashi M., Schlom J., Greiner J.W.;
RT   "Molecular cloning and characterization of the complementary DNA of an
RT   M(r) 110,000 antigen expressed by human gastric carcinoma cells and
RT   upregulated by gamma-interferon.";
RL   Cancer Res. 54:3831-3836(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, INTERACTION WITH PSMD1 AND
RP   UCHL5, SUBCELLULAR LOCATION, AND IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=16990800; DOI=10.1038/sj.emboj.7601338;
RA   Hamazaki J., Iemura S., Natsume T., Yashiroda H., Tanaka K.,
RA   Murata S.;
RT   "A novel proteasome-interacting protein recruits the deubiquitinating
RT   enzyme UCH37 to 26S proteasomes.";
RL   EMBO J. 25:4524-4536(2006).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11780052; DOI=10.1038/414865a;
RA   Deloukas P., Matthews L.H., Ashurst J.L., Burton J., Gilbert J.G.R.,
RA   Jones M., Stavrides G., Almeida J.P., Babbage A.K., Bagguley C.L.,
RA   Bailey J., Barlow K.F., Bates K.N., Beard L.M., Beare D.M.,
RA   Beasley O.P., Bird C.P., Blakey S.E., Bridgeman A.M., Brown A.J.,
RA   Buck D., Burrill W.D., Butler A.P., Carder C., Carter N.P.,
RA   Chapman J.C., Clamp M., Clark G., Clark L.N., Clark S.Y., Clee C.M.,
RA   Clegg S., Cobley V.E., Collier R.E., Connor R.E., Corby N.R.,
RA   Coulson A., Coville G.J., Deadman R., Dhami P.D., Dunn M.,
RA   Ellington A.G., Frankland J.A., Fraser A., French L., Garner P.,
RA   Grafham D.V., Griffiths C., Griffiths M.N.D., Gwilliam R., Hall R.E.,
RA   Hammond S., Harley J.L., Heath P.D., Ho S., Holden J.L., Howden P.J.,
RA   Huckle E., Hunt A.R., Hunt S.E., Jekosch K., Johnson C.M., Johnson D.,
RA   Kay M.P., Kimberley A.M., King A., Knights A., Laird G.K., Lawlor S.,
RA   Lehvaeslaiho M.H., Leversha M.A., Lloyd C., Lloyd D.M., Lovell J.D.,
RA   Marsh V.L., Martin S.L., McConnachie L.J., McLay K., McMurray A.A.,
RA   Milne S.A., Mistry D., Moore M.J.F., Mullikin J.C., Nickerson T.,
RA   Oliver K., Parker A., Patel R., Pearce T.A.V., Peck A.I.,
RA   Phillimore B.J.C.T., Prathalingam S.R., Plumb R.W., Ramsay H.,
RA   Rice C.M., Ross M.T., Scott C.E., Sehra H.K., Shownkeen R., Sims S.,
RA   Skuce C.D., Smith M.L., Soderlund C., Steward C.A., Sulston J.E.,
RA   Swann R.M., Sycamore N., Taylor R., Tee L., Thomas D.W., Thorpe A.,
RA   Tracey A., Tromans A.C., Vaudin M., Wall M., Wallis J.M.,
RA   Whitehead S.L., Whittaker P., Willey D.L., Williams L., Williams S.A.,
RA   Wilming L., Wray P.W., Hubbard T., Durbin R.M., Bentley D.R., Beck S.,
RA   Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 20.";
RL   Nature 414:865-871(2001).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain, and Pancreas;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   FUNCTION, INTERACTION WITH UCHL5, SUBCELLULAR LOCATION, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=17139257; DOI=10.1038/sj.emboj.7601450;
RA   Qiu X.-B., Ouyang S.-Y., Li C.-J., Miao S., Wang L., Goldberg A.L.;
RT   "hRpn13/ADRM1/GP110 is a novel proteasome subunit that binds the
RT   deubiquitinating enzyme, UCH37.";
RL   EMBO J. 25:5742-5753(2006).
RN   [6]
RP   FUNCTION, INTERACTION WITH 26S PROTEASOME, SUBCELLULAR LOCATION, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=16815440; DOI=10.1016/j.jmb.2006.06.011;
RA   Joergensen J.P., Lauridsen A.-M., Kristensen P., Dissing K.,
RA   Johnsen A.H., Hendil K.B., Hartmann-Petersen R.;
RT   "Adrm1, a putative cell adhesion regulating protein, is a novel
RT   proteasome-associated factor.";
RL   J. Mol. Biol. 360:1043-1052(2006).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-217, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=16964243; DOI=10.1038/nbt1240;
RA   Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
RT   "A probability-based approach for high-throughput protein
RT   phosphorylation analysis and site localization.";
RL   Nat. Biotechnol. 24:1285-1292(2006).
RN   [8]
RP   FUNCTION, INTERACTION WITH PSMD1 AND UCHL5, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RX   PubMed=16906146; DOI=10.1038/ncb1460;
RA   Yao T., Song L., Xu W., DeMartino G.N., Florens L., Swanson S.K.,
RA   Washburn M.P., Conaway R.C., Conaway J.W., Cohen R.E.;
RT   "Proteasome recruitment and activation of the Uch37 deubiquitinating
RT   enzyme by Adrm1.";
RL   Nat. Cell Biol. 8:994-1002(2006).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Embryonic kidney;
RX   PubMed=17323924; DOI=10.1021/bi061994u;
RA   Wang X., Chen C.-F., Baker P.R., Chen P.-L., Kaiser P., Huang L.;
RT   "Mass spectrometric characterization of the affinity-purified human
RT   26S proteasome complex.";
RL   Biochemistry 46:3553-3565(2007).
RN   [10]
RP   FUNCTION, INTERACTION WITH UBIQUITIN, AND REGION.
RX   PubMed=18497817; DOI=10.1038/nature06926;
RA   Husnjak K., Elsasser S., Zhang N., Chen X., Randles L., Shi Y.,
RA   Hofmann K., Walters K.J., Finley D., Dikic I.;
RT   "Proteasome subunit Rpn13 is a novel ubiquitin receptor.";
RL   Nature 453:481-488(2008).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-211 AND THR-217, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [12]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT THR-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [14]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT THR-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22223895; DOI=10.1074/mcp.M111.015131;
RA   Bienvenut W.V., Sumpton D., Martinez A., Lilla S., Espagne C.,
RA   Meinnel T., Giglione C.;
RT   "Comparative large-scale characterisation of plant vs. mammal proteins
RT   reveals similar and idiosyncratic N-alpha acetylation features.";
RL   Mol. Cell. Proteomics 11:M111.015131-M111.015131(2012).
RN   [15]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT THR-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-15 AND THR-217, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-127 AND SER-140, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [18]
RP   STRUCTURE BY NMR OF 1-407, INTERACTION WITH PSMD1, AND REGION.
RX   PubMed=20471946; DOI=10.1016/j.molcel.2010.04.019;
RA   Chen X., Lee B.H., Finley D., Walters K.J.;
RT   "Structure of proteasome ubiquitin receptor hRpn13 and its activation
RT   by the scaffolding protein hRpn2.";
RL   Mol. Cell 38:404-415(2010).
RN   [19]
RP   STRUCTURE BY NMR OF 270-407, INTERACTION WITH UCHL5, AND FUNCTION.
RX   PubMed=24752541; DOI=10.1007/s13238-014-0046-z;
RA   Jiao L., Ouyang S., Shaw N., Song G., Feng Y., Niu F., Qiu W., Zhu H.,
RA   Hung L.W., Zuo X., Eleonora Shtykova V., Zhu P., Dong Y.H., Xu R.,
RA   Liu Z.J.;
RT   "Mechanism of the Rpn13-induced activation of Uch37.";
RL   Protein Cell 5:616-630(2014).
RN   [20]
RP   X-RAY CRYSTALLOGRAPHY (2.30 ANGSTROMS) OF 266-388, INTERACTION WITH
RP   UCHL5, AND FUNCTION.
RX   PubMed=25702870; DOI=10.1016/j.molcel.2014.12.039;
RA   Sahtoe D.D., van Dijk W.J., El Oualid F., Ekkebus R., Ovaa H.,
RA   Sixma T.K.;
RT   "Mechanism of UCH-L5 activation and inhibition by DEUBAD domains in
RT   RPN13 and INO80G.";
RL   Mol. Cell 57:887-900(2015).
RN   [21]
RP   X-RAY CRYSTALLOGRAPHY (2.00 ANGSTROMS) OF 285-386, INTERACTION WITH
RP   UCHL5, AND FUNCTION.
RX   PubMed=25702872; DOI=10.1016/j.molcel.2015.01.016;
RA   VanderLinden R.T., Hemmis C.W., Schmitt B., Ndoja A., Whitby F.G.,
RA   Robinson H., Cohen R.E., Yao T., Hill C.P.;
RT   "Structural basis for the activation and inhibition of the UCH37
RT   deubiquitylase.";
RL   Mol. Cell 57:901-911(2015).
RN   [22]
RP   STRUCTURE BY NMR OF 1-150, AND INTERACTION WITH UBIQUITIN AND UBQLN2.
RX   PubMed=27396824; DOI=10.1016/j.str.2016.05.018;
RA   Chen X., Randles L., Shi K., Tarasov S.G., Aihara H., Walters K.J.;
RT   "Structures of Rpn1 T1:Rad23 and hRpn13:hPLIC2 reveal distinct binding
RT   mechanisms between substrate receptors and shuttle factors of the
RT   proteasome.";
RL   Structure 24:1257-1270(2016).
CC   -!- FUNCTION: Component of the 26S proteasome, a multiprotein complex
CC       involved in the ATP-dependent degradation of ubiquitinated
CC       proteins. This complex plays a key role in the maintenance of
CC       protein homeostasis by removing misfolded or damaged proteins,
CC       which could impair cellular functions, and by removing proteins
CC       whose functions are no longer required. Therefore, the proteasome
CC       participates in numerous cellular processes, including cell cycle
CC       progression, apoptosis, or DNA damage repair. Within the complex,
CC       functions as a proteasomal ubiquitin receptor. Engages and
CC       activates 19S-associated deubiquitinases UCHL5 and PSMD14 during
CC       protein degradation. UCHL5 reversibly associate with the 19S
CC       regulatory particle whereas PSMD14 is an intrinsic subunit of the
CC       proteasome lid subcomplex. {ECO:0000269|PubMed:16815440,
CC       ECO:0000269|PubMed:16906146, ECO:0000269|PubMed:16990800,
CC       ECO:0000269|PubMed:17139257, ECO:0000269|PubMed:18497817,
CC       ECO:0000269|PubMed:24752541, ECO:0000269|PubMed:25702870,
CC       ECO:0000269|PubMed:25702872}.
CC   -!- SUBUNIT: Component of the 19S proteasome regulatory particle
CC       complex. The 26S proteasome consists of a 20S core particle (CP)
CC       and two 19S regulatory subunits (RP) (PubMed:16990800). Interacts
CC       with the proteasomal scaffolding protein PSMD1
CC       (PubMed:16990800,PubMed:16815440, PubMed:16906146,
CC       PubMed:20471946). Interacts with deubiquitinase UCHL5; this
CC       interaction activates the auto-inhibited UCHL5 by deoligomerizing
CC       it (PubMed:17139257, PubMed:24752541, PubMed:25702870,
CC       PubMed:25702872). Interacts with UBQLN2 and ubiquitin
CC       (PubMed:27396824). {ECO:0000269|PubMed:16815440,
CC       ECO:0000269|PubMed:16906146, ECO:0000269|PubMed:16990800,
CC       ECO:0000269|PubMed:17139257, ECO:0000269|PubMed:18497817,
CC       ECO:0000269|PubMed:20471946, ECO:0000269|PubMed:24752541,
CC       ECO:0000269|PubMed:25702872, ECO:0000269|PubMed:27396824}.
CC   -!- INTERACTION:
CC       P48510:DSK2 (xeno); NbExp=4; IntAct=EBI-954387, EBI-6174;
CC       O35593:Psmd14 (xeno); NbExp=2; IntAct=EBI-954387, EBI-772796;
CC       P55036:PSMD4; NbExp=4; IntAct=EBI-954387, EBI-359318;
CC       P54727:RAD23B; NbExp=2; IntAct=EBI-954387, EBI-954531;
CC       P0CG48:UBC; NbExp=10; IntAct=EBI-954387, EBI-3390054;
CC       Q9UMX0:UBQLN1; NbExp=4; IntAct=EBI-954387, EBI-741480;
CC       Q9UHD9:UBQLN2; NbExp=5; IntAct=EBI-954387, EBI-947187;
CC       Q9Y5K5:UCHL5; NbExp=20; IntAct=EBI-954387, EBI-1051183;
CC       Q9Y5K5-3:UCHL5; NbExp=5; IntAct=EBI-954387, EBI-11749875;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:16990800}.
CC       Nucleus {ECO:0000269|PubMed:16990800}.
CC   -!- DOMAIN: The Pru (pleckstrin-like receptor for ubiquitin) domain
CC       mediates interactions with PSMD1 and ubiquitin. Preferential
CC       binding to the proximal subunit of K48-linked diubiquitin allows
CC       UCHL5 access to the distal subunit. {ECO:0000269|PubMed:18497817}.
CC   -!- SIMILARITY: Belongs to the ADRM1 family. {ECO:0000305}.
CC   -!- CAUTION: Although initially described as a cell membrane
CC       glycoprotein, ADRM1 is intracellular and non-glycosylated, and has
CC       probably no direct role in cell adhesion. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; D64154; BAA11023.1; -; mRNA.
DR   EMBL; AL354836; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BR000321; FAA00246.1; -; mRNA.
DR   EMBL; BC010733; AAH10733.1; -; mRNA.
DR   EMBL; BC017245; AAH17245.1; -; mRNA.
DR   CCDS; CCDS13496.1; -.
DR   PIR; I52703; I52703.
DR   RefSeq; NP_001268366.1; NM_001281437.1.
DR   RefSeq; NP_001268367.1; NM_001281438.1.
DR   RefSeq; NP_008933.2; NM_007002.3.
DR   RefSeq; NP_783163.1; NM_175573.2.
DR   RefSeq; XP_005260314.1; XM_005260257.1.
DR   UniGene; Hs.90107; -.
DR   PDB; 2KQZ; NMR; -; A=253-407.
DR   PDB; 2KR0; NMR; -; A=1-407.
DR   PDB; 2L5V; NMR; -; A=260-407.
DR   PDB; 2MKZ; NMR; -; A=270-407.
DR   PDB; 2NBV; NMR; -; A=1-150.
DR   PDB; 4UEL; X-ray; 2.30 A; C=266-388.
DR   PDB; 4UEM; X-ray; 2.82 A; B=266-388.
DR   PDB; 4WLQ; X-ray; 2.85 A; B=286-384.
DR   PDB; 4WLR; X-ray; 2.00 A; B=285-386.
DR   PDB; 5IRS; X-ray; 1.80 A; A=2-150.
DR   PDB; 5V1Y; X-ray; 1.42 A; A/B=19-132.
DR   PDB; 5V1Z; X-ray; 2.00 A; A/B=19-132.
DR   PDB; 6CO4; NMR; -; A=1-150.
DR   PDBsum; 2KQZ; -.
DR   PDBsum; 2KR0; -.
DR   PDBsum; 2L5V; -.
DR   PDBsum; 2MKZ; -.
DR   PDBsum; 2NBV; -.
DR   PDBsum; 4UEL; -.
DR   PDBsum; 4UEM; -.
DR   PDBsum; 4WLQ; -.
DR   PDBsum; 4WLR; -.
DR   PDBsum; 5IRS; -.
DR   PDBsum; 5V1Y; -.
DR   PDBsum; 5V1Z; -.
DR   PDBsum; 6CO4; -.
DR   DisProt; DP00839; -.
DR   ProteinModelPortal; Q16186; -.
DR   SMR; Q16186; -.
DR   BioGrid; 116235; 81.
DR   DIP; DIP-42668N; -.
DR   IntAct; Q16186; 58.
DR   MINT; Q16186; -.
DR   STRING; 9606.ENSP00000253003; -.
DR   ChEMBL; CHEMBL2364701; -.
DR   iPTMnet; Q16186; -.
DR   PhosphoSitePlus; Q16186; -.
DR   DMDM; 20141265; -.
DR   EPD; Q16186; -.
DR   MaxQB; Q16186; -.
DR   PaxDb; Q16186; -.
DR   PeptideAtlas; Q16186; -.
DR   PRIDE; Q16186; -.
DR   DNASU; 11047; -.
DR   Ensembl; ENST00000253003; ENSP00000253003; ENSG00000130706.
DR   Ensembl; ENST00000491935; ENSP00000478877; ENSG00000130706.
DR   GeneID; 11047; -.
DR   KEGG; hsa:11047; -.
DR   UCSC; uc002ycn.5; human.
DR   CTD; 11047; -.
DR   DisGeNET; 11047; -.
DR   EuPathDB; HostDB:ENSG00000130706.12; -.
DR   GeneCards; ADRM1; -.
DR   HGNC; HGNC:15759; ADRM1.
DR   HPA; HPA042266; -.
DR   MIM; 610650; gene.
DR   neXtProt; NX_Q16186; -.
DR   OpenTargets; ENSG00000130706; -.
DR   PharmGKB; PA24599; -.
DR   eggNOG; KOG3037; Eukaryota.
DR   eggNOG; ENOG410XSJJ; LUCA.
DR   GeneTree; ENSGT00390000013839; -.
DR   HOGENOM; HOG000005947; -.
DR   HOVERGEN; HBG073518; -.
DR   InParanoid; Q16186; -.
DR   KO; K06691; -.
DR   OMA; HCRRINE; -.
DR   OrthoDB; EOG091G0FEO; -.
DR   PhylomeDB; Q16186; -.
DR   TreeFam; TF313410; -.
DR   Reactome; R-HSA-5689603; UCH proteinases.
DR   Reactome; R-HSA-5689880; Ub-specific processing proteases.
DR   ChiTaRS; ADRM1; human.
DR   EvolutionaryTrace; Q16186; -.
DR   GeneWiki; ADRM1; -.
DR   GenomeRNAi; 11047; -.
DR   PRO; PR:Q16186; -.
DR   Proteomes; UP000005640; Chromosome 20.
DR   Bgee; ENSG00000130706; -.
DR   CleanEx; HS_ADRM1; -.
DR   ExpressionAtlas; Q16186; baseline and differential.
DR   Genevisible; Q16186; HS.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005887; C:integral component of plasma membrane; TAS:ProtInc.
DR   GO; GO:0016020; C:membrane; TAS:ProtInc.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005886; C:plasma membrane; IDA:HPA.
DR   GO; GO:0000502; C:proteasome complex; IDA:UniProtKB.
DR   GO; GO:0008541; C:proteasome regulatory particle, lid subcomplex; IBA:GO_Central.
DR   GO; GO:0061133; F:endopeptidase activator activity; IDA:UniProtKB.
DR   GO; GO:0002020; F:protease binding; IPI:UniProtKB.
DR   GO; GO:0070628; F:proteasome binding; IDA:UniProtKB.
DR   GO; GO:0043130; F:ubiquitin binding; IBA:GO_Central.
DR   GO; GO:0043248; P:proteasome assembly; IDA:UniProtKB.
DR   GO; GO:0016579; P:protein deubiquitination; TAS:Reactome.
DR   GO; GO:0006368; P:transcription elongation from RNA polymerase II promoter; IMP:UniProtKB.
DR   GO; GO:0006511; P:ubiquitin-dependent protein catabolic process; IBA:GO_Central.
DR   Gene3D; 2.30.29.70; -; 1.
DR   Gene3D; 3.40.190.140; -; 1.
DR   InterPro; IPR006773; Rpn13/ADRM1.
DR   InterPro; IPR038633; Rpn13/ADRM1_sf.
DR   InterPro; IPR032368; RPN13_C.
DR   InterPro; IPR038108; RPN13_C_sf.
DR   PANTHER; PTHR12225; PTHR12225; 1.
DR   Pfam; PF04683; Proteasom_Rpn13; 1.
DR   Pfam; PF16550; RPN13_C; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Complete proteome; Cytoplasm;
KW   Isopeptide bond; Nucleus; Phosphoprotein; Proteasome;
KW   Reference proteome; Ubl conjugation.
FT   INIT_MET      1      1       Removed. {ECO:0000244|PubMed:19413330,
FT                                ECO:0000244|PubMed:22223895,
FT                                ECO:0000244|PubMed:22814378}.
FT   CHAIN         2    407       Proteasomal ubiquitin receptor ADRM1.
FT                                /FTId=PRO_0000020631.
FT   REGION       22    130       Pru (pleckstrin-like receptor for
FT                                ubiquitin) domain.
FT                                {ECO:0000269|PubMed:18497817}.
FT   REGION      253    407       Interaction with UCHL5.
FT                                {ECO:0000269|PubMed:20471946}.
FT   COMPBIAS    135    202       Gly-rich.
FT   COMPBIAS    193    257       Ser-rich.
FT   COMPBIAS    203    213       Poly-Ser.
FT   MOD_RES       2      2       N-acetylthreonine.
FT                                {ECO:0000244|PubMed:19413330,
FT                                ECO:0000244|PubMed:22223895,
FT                                ECO:0000244|PubMed:22814378}.
FT   MOD_RES      15     15       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     127    127       Phosphotyrosine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     140    140       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     211    211       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   MOD_RES     217    217       Phosphothreonine.
FT                                {ECO:0000244|PubMed:16964243,
FT                                ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     405    405       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q9JMB5}.
FT   CROSSLNK     34     34       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in ubiquitin).
FT   CONFLICT    142    142       S -> T (in Ref. 1; BAA11023).
FT                                {ECO:0000305}.
FT   STRAND       23     34       {ECO:0000244|PDB:5V1Y}.
FT   STRAND       37     40       {ECO:0000244|PDB:5V1Y}.
FT   STRAND       45     51       {ECO:0000244|PDB:5V1Y}.
FT   STRAND       57     63       {ECO:0000244|PDB:5V1Y}.
FT   TURN         64     66       {ECO:0000244|PDB:5V1Y}.
FT   STRAND       69     75       {ECO:0000244|PDB:5V1Y}.
FT   STRAND       79     84       {ECO:0000244|PDB:5V1Y}.
FT   STRAND       89     91       {ECO:0000244|PDB:5V1Y}.
FT   STRAND       93     98       {ECO:0000244|PDB:5V1Y}.
FT   TURN         99    101       {ECO:0000244|PDB:2KR0}.
FT   STRAND      104    109       {ECO:0000244|PDB:5V1Y}.
FT   STRAND      111    114       {ECO:0000244|PDB:5V1Y}.
FT   HELIX       117    129       {ECO:0000244|PDB:5V1Y}.
FT   TURN        191    195       {ECO:0000244|PDB:2KR0}.
FT   STRAND      202    204       {ECO:0000244|PDB:2KR0}.
FT   STRAND      249    253       {ECO:0000244|PDB:2KR0}.
FT   TURN        254    256       {ECO:0000244|PDB:2KR0}.
FT   HELIX       266    273       {ECO:0000244|PDB:2KQZ}.
FT   STRAND      276    278       {ECO:0000244|PDB:2KR0}.
FT   STRAND      282    284       {ECO:0000244|PDB:2KQZ}.
FT   HELIX       288    291       {ECO:0000244|PDB:4WLR}.
FT   HELIX       294    297       {ECO:0000244|PDB:4WLR}.
FT   HELIX       300    302       {ECO:0000244|PDB:4WLR}.
FT   HELIX       304    310       {ECO:0000244|PDB:4WLR}.
FT   HELIX       311    313       {ECO:0000244|PDB:4WLR}.
FT   HELIX       324    326       {ECO:0000244|PDB:4WLR}.
FT   HELIX       327    332       {ECO:0000244|PDB:4WLR}.
FT   HELIX       334    348       {ECO:0000244|PDB:4WLR}.
FT   TURN        349    351       {ECO:0000244|PDB:4UEM}.
FT   HELIX       353    358       {ECO:0000244|PDB:4WLR}.
FT   HELIX       363    371       {ECO:0000244|PDB:4WLR}.
FT   HELIX       374    383       {ECO:0000244|PDB:4WLR}.
FT   STRAND      386    388       {ECO:0000244|PDB:2KR0}.
FT   STRAND      395    397       {ECO:0000244|PDB:2MKZ}.
SQ   SEQUENCE   407 AA;  42153 MW;  2D38811DCA231864 CRC64;
     MTTSGALFPS LVPGSRGASN KYLVEFRAGK MSLKGTTVTP DKRKGLVYIQ QTDDSLIHFC
     WKDRTSGNVE DDLIIFPDDC EFKRVPQCPS GRVYVLKFKA GSKRLFFWMQ EPKTDQDEEH
     CRKVNEYLNN PPMPGALGAS GSSGHELSAL GGEGGLQSLL GNMSHSQLMQ LIGPAGLGGL
     GGLGALTGPG LASLLGSSGP PGSSSSSSSR SQSAAVTPSS TTSSTRATPA PSAPAAASAT
     SPSPAPSSGN GASTAASPTQ PIQLSDLQSI LATMNVPAGP AGGQQVDLAS VLTPEIMAPI
     LANADVQERL LPYLPSGESL PQTADEIQNT LTSPQFQQAL GMFSAALASG QLGPLMCQFG
     LPAEAVEAAN KGDVEAFAKA MQNNAKPEQK EGDTKDKKDE EEDMSLD
//
ID   TRI25_HUMAN             Reviewed;         630 AA.
AC   Q14258;
DT   24-JAN-2001, integrated into UniProtKB/Swiss-Prot.
DT   30-NOV-2010, sequence version 2.
DT   23-MAY-2018, entry version 189.
DE   RecName: Full=E3 ubiquitin/ISG15 ligase TRIM25;
DE            EC=6.3.2.n3 {ECO:0000269|PubMed:16352599};
DE   AltName: Full=Estrogen-responsive finger protein;
DE   AltName: Full=RING finger protein 147;
DE   AltName: Full=RING-type E3 ubiquitin transferase;
DE            EC=2.3.2.27 {ECO:0000269|PubMed:17392790};
DE   AltName: Full=RING-type E3 ubiquitin transferase TRIM25 {ECO:0000305};
DE   AltName: Full=Tripartite motif-containing protein 25;
DE   AltName: Full=Ubiquitin/ISG15-conjugating enzyme TRIM25;
DE   AltName: Full=Zinc finger protein 147;
GN   Name=TRIM25; Synonyms=EFP, RNF147, ZNF147;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT LEU-358.
RC   TISSUE=Placenta;
RX   PubMed=8248217; DOI=10.1073/pnas.90.23.11117;
RA   Inoue S., Orimo A., Hosoi T., Kondo S., Toyoshima H., Kondo T.,
RA   Ikegami A., Ouchi Y., Orimo H., Muramatsu M.;
RT   "Genomic binding-site cloning reveals an estrogen-responsive gene that
RT   encodes a RING finger protein.";
RL   Proc. Natl. Acad. Sci. U.S.A. 90:11117-11121(1993).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16625196; DOI=10.1038/nature04689;
RA   Zody M.C., Garber M., Adams D.J., Sharpe T., Harrow J., Lupski J.R.,
RA   Nicholson C., Searle S.M., Wilming L., Young S.K., Abouelleil A.,
RA   Allen N.R., Bi W., Bloom T., Borowsky M.L., Bugalter B.E., Butler J.,
RA   Chang J.L., Chen C.-K., Cook A., Corum B., Cuomo C.A., de Jong P.J.,
RA   DeCaprio D., Dewar K., FitzGerald M., Gilbert J., Gibson R.,
RA   Gnerre S., Goldstein S., Grafham D.V., Grocock R., Hafez N.,
RA   Hagopian D.S., Hart E., Norman C.H., Humphray S., Jaffe D.B.,
RA   Jones M., Kamal M., Khodiyar V.K., LaButti K., Laird G., Lehoczky J.,
RA   Liu X., Lokyitsang T., Loveland J., Lui A., Macdonald P., Major J.E.,
RA   Matthews L., Mauceli E., McCarroll S.A., Mihalev A.H., Mudge J.,
RA   Nguyen C., Nicol R., O'Leary S.B., Osoegawa K., Schwartz D.C.,
RA   Shaw-Smith C., Stankiewicz P., Steward C., Swarbreck D.,
RA   Venkataraman V., Whittaker C.A., Yang X., Zimmer A.R., Bradley A.,
RA   Hubbard T., Birren B.W., Rogers J., Lander E.S., Nusbaum C.;
RT   "DNA sequence of human chromosome 17 and analysis of rearrangement in
RT   the human lineage.";
RL   Nature 440:1045-1049(2006).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT LEU-358.
RC   TISSUE=Lymph;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   TISSUE SPECIFICITY.
RX   PubMed=15130519; DOI=10.1016/j.mce.2003.12.008;
RA   Shimada N., Suzuki T., Inoue S., Kato K., Imatani A., Sekine H.,
RA   Ohara S., Shimosegawa T., Sasano H.;
RT   "Systemic distribution of estrogen-responsive finger protein (Efp) in
RT   human tissues.";
RL   Mol. Cell. Endocrinol. 218:147-153(2004).
RN   [5]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=15592455; DOI=10.1038/nbt1046;
RA   Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H.,
RA   Zha X.-M., Polakiewicz R.D., Comb M.J.;
RT   "Immunoaffinity profiling of tyrosine phosphorylation in cancer
RT   cells.";
RL   Nat. Biotechnol. 23:94-101(2005).
RN   [6]
RP   INDUCTION, AND FUNCTION.
RX   PubMed=17069755; DOI=10.1016/j.bbrc.2006.10.061;
RA   Nakasato N., Ikeda K., Urano T., Horie-Inoue K., Takeda S., Inoue S.;
RT   "A ubiquitin E3 ligase Efp is up-regulated by interferons and
RT   conjugated with ISG15.";
RL   Biochem. Biophys. Res. Commun. 351:540-546(2006).
RN   [7]
RP   FUNCTION AS A ISG15 E3 LIGASE, CATALYTIC ACTIVITY, AND INDUCTION.
RX   PubMed=16352599; DOI=10.1074/jbc.M510787200;
RA   Zou W., Zhang D.-E.;
RT   "The interferon-inducible ubiquitin-protein isopeptide ligase (E3) EFP
RT   also functions as an ISG15 E3 ligase.";
RL   J. Biol. Chem. 281:3989-3994(2006).
RN   [8]
RP   ISGYLATION AT LYS-117, MUTAGENESIS OF LYS-21; LYS-65; LYS-112 AND
RP   LYS-117, AND AUTOISGYLATION.
RX   PubMed=17222803; DOI=10.1016/j.bbrc.2006.12.210;
RA   Zou W., Wang J., Zhang D.-E.;
RT   "Negative regulation of ISG15 E3 ligase EFP through its
RT   autoISGylation.";
RL   Biochem. Biophys. Res. Commun. 354:321-327(2007).
RN   [9]
RP   FUNCTION AS AN UBIQUITIN LIGASE, CATALYTIC ACTIVITY, SUBCELLULAR
RP   LOCATION, AND INTERACTION WITH DDX58.
RX   PubMed=17392790; DOI=10.1038/nature05732;
RA   Gack M.U., Shin Y.C., Joo C.H., Urano T., Liang C., Sun L.,
RA   Takeuchi O., Akira S., Chen Z., Inoue S., Jung J.U.;
RT   "TRIM25 RING-finger E3 ubiquitin ligase is essential for RIG-I-
RT   mediated antiviral activity.";
RL   Nature 446:916-920(2007).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-100, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [11]
RP   INTERACTION WITH INFLUENZA VIRUS PROTEIN NS1.
RX   PubMed=19454348; DOI=10.1016/j.chom.2009.04.006;
RA   Gack M.U., Albrecht R.A., Urano T., Inn K.-S., Huang I.-C.,
RA   Carnero E., Farzan M., Inoue S., Jung J.U., Garcia-Sastre A.;
RT   "Influenza A virus NS1 targets the ubiquitin ligase TRIM25 to evade
RT   recognition by the host viral RNA sensor RIG-I.";
RL   Cell Host Microbe 5:439-449(2009).
RN   [12]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-273 AND LYS-567, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [15]
RP   FUNCTION, INTERACTION WITH ZFHX3, AND TISSUE SPECIFICITY.
RX   PubMed=22452784; DOI=10.1042/BJ20111890;
RA   Dong X.Y., Fu X., Fan S., Guo P., Su D., Dong J.T.;
RT   "Oestrogen causes ATBF1 protein degradation through the oestrogen-
RT   responsive E3 ubiquitin ligase EFP.";
RL   Biochem. J. 444:581-590(2012).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-91 AND SER-100, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-278, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [18]
RP   VARIANT [LARGE SCALE ANALYSIS] LEU-358, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
CC   -!- FUNCTION: Functions as a ubiquitin E3 ligase and as an ISG15 E3
CC       ligase. Involved in innate immune defense against viruses by
CC       mediating ubiquitination of DDX58. Mediates 'Lys-63'-linked
CC       polyubiquitination of the DDX58 N-terminal CARD-like region which
CC       is crucial for triggering the cytosolic signal transduction that
CC       leads to the production of interferons in response to viral
CC       infection. Promotes ISGylation of 14-3-3 sigma (SFN), an adapter
CC       protein implicated in the regulation of a large spectrum signaling
CC       pathway. Mediates estrogen action in various target organs.
CC       Mediates the ubiquitination and subsequent proteasomal degradation
CC       of ZFHX3 (PubMed:22452784). {ECO:0000269|PubMed:16352599,
CC       ECO:0000269|PubMed:17069755, ECO:0000269|PubMed:17392790,
CC       ECO:0000269|PubMed:22452784}.
CC   -!- CATALYTIC ACTIVITY: S-ubiquitinyl-[E2 ubiquitin-conjugating
CC       enzyme]-L-cysteine + [acceptor protein]-L-lysine = [E2 ubiquitin-
CC       conjugating enzyme]-L-cysteine + N(6)-ubiquitinyl-[acceptor
CC       protein]-L-lysine. {ECO:0000269|PubMed:17392790}.
CC   -!- CATALYTIC ACTIVITY: ATP + [ISG15] + [protein]-lysine = AMP +
CC       diphosphate + [protein]-N-ISGyllysine.
CC       {ECO:0000269|PubMed:16352599}.
CC   -!- PATHWAY: Protein modification; protein ubiquitination.
CC   -!- SUBUNIT: Interacts (via SPRY domain) with DDX58 (via CARD domain).
CC       Interacts (via coiled coil) with influenza A virus NS1 protein;
CC       this interaction specifically inhibits TRIM25 multimerization and
CC       TRIM25-mediated DDX58 CARD ubiquitination, thereby suppressing
CC       DDX58 signal transduction. Interacts with ZFHX3.
CC       {ECO:0000269|PubMed:17392790, ECO:0000269|PubMed:19454348,
CC       ECO:0000269|PubMed:22452784}.
CC   -!- INTERACTION:
CC       F1BA49:- (xeno); NbExp=5; IntAct=EBI-2341129, EBI-9687469;
CC       O95786:DDX58; NbExp=4; IntAct=EBI-2341129, EBI-995350;
CC       P03496:NS (xeno); NbExp=3; IntAct=EBI-2341129, EBI-2547442;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:17392790}.
CC       Note=Colocalized with DDX58 at cytoplasmic perinuclear bodies.
CC   -!- TISSUE SPECIFICITY: Expressed in breast tumors (at protein level).
CC       Ubiquitous. {ECO:0000269|PubMed:15130519,
CC       ECO:0000269|PubMed:22452784}.
CC   -!- INDUCTION: By interferons. {ECO:0000269|PubMed:16352599,
CC       ECO:0000269|PubMed:17069755}.
CC   -!- DOMAIN: The RING-type zinc finger is important for ISG15 E3 ligase
CC       activity and autoISGylation. AutoISGylation negatively regulates
CC       ISG15 E3 ligase activity.
CC   -!- DOMAIN: The C-terminal B30.2/SPRY domain interacts with the first
CC       N-terminal CARD domain of DDX58.
CC   -!- PTM: Auto-ISGylated. {ECO:0000269|PubMed:17222803}.
CC   -!- WEB RESOURCE: Name=Wikipedia; Note=TRIM25 entry;
CC       URL="https://en.wikipedia.org/wiki/TRIM25";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; D21205; BAA04747.1; -; mRNA.
DR   EMBL; AC015912; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC016924; AAH16924.1; -; mRNA.
DR   EMBL; BC042541; AAH42541.1; -; mRNA.
DR   CCDS; CCDS11591.1; -.
DR   PIR; A49656; A49656.
DR   RefSeq; NP_005073.2; NM_005082.4.
DR   UniGene; Hs.528952; -.
DR   PDB; 4CFG; X-ray; 2.80 A; A/B=1-630.
DR   PDB; 4LTB; X-ray; 2.59 A; A/B=189-379.
DR   PDB; 5EYA; X-ray; 2.40 A; F/G=1-83.
DR   PDB; 5FER; X-ray; 2.34 A; A/D=1-82.
DR   PDBsum; 4CFG; -.
DR   PDBsum; 4LTB; -.
DR   PDBsum; 5EYA; -.
DR   PDBsum; 5FER; -.
DR   ProteinModelPortal; Q14258; -.
DR   SMR; Q14258; -.
DR   BioGrid; 113500; 2371.
DR   CORUM; Q14258; -.
DR   IntAct; Q14258; 31.
DR   MINT; Q14258; -.
DR   STRING; 9606.ENSP00000323889; -.
DR   iPTMnet; Q14258; -.
DR   PhosphoSitePlus; Q14258; -.
DR   SwissPalm; Q14258; -.
DR   BioMuta; TRIM25; -.
DR   DMDM; 313104033; -.
DR   EPD; Q14258; -.
DR   MaxQB; Q14258; -.
DR   PaxDb; Q14258; -.
DR   PeptideAtlas; Q14258; -.
DR   PRIDE; Q14258; -.
DR   Ensembl; ENST00000316881; ENSP00000323889; ENSG00000121060.
DR   Ensembl; ENST00000537230; ENSP00000445961; ENSG00000121060.
DR   GeneID; 7706; -.
DR   KEGG; hsa:7706; -.
DR   UCSC; uc002iut.4; human.
DR   CTD; 7706; -.
DR   DisGeNET; 7706; -.
DR   EuPathDB; HostDB:ENSG00000121060.14; -.
DR   GeneCards; TRIM25; -.
DR   HGNC; HGNC:12932; TRIM25.
DR   HPA; HPA005909; -.
DR   MIM; 600453; gene.
DR   neXtProt; NX_Q14258; -.
DR   OpenTargets; ENSG00000121060; -.
DR   PharmGKB; PA37519; -.
DR   eggNOG; ENOG410ITFP; Eukaryota.
DR   eggNOG; ENOG410XQS1; LUCA.
DR   GeneTree; ENSGT00760000118995; -.
DR   HOVERGEN; HBG101063; -.
DR   InParanoid; Q14258; -.
DR   KO; K10652; -.
DR   OMA; SPAFQDH; -.
DR   OrthoDB; EOG091G05F6; -.
DR   PhylomeDB; Q14258; -.
DR   TreeFam; TF351086; -.
DR   BRENDA; 2.3.2.B10; 2681.
DR   Reactome; R-HSA-1169408; ISG15 antiviral mechanism.
DR   Reactome; R-HSA-168928; DDX58/IFIH1-mediated induction of interferon-alpha/beta.
DR   Reactome; R-HSA-5656169; Termination of translesion DNA synthesis.
DR   Reactome; R-HSA-5689896; Ovarian tumor domain proteases.
DR   Reactome; R-HSA-877300; Interferon gamma signaling.
DR   Reactome; R-HSA-918233; TRAF3-dependent IRF activation pathway.
DR   Reactome; R-HSA-933541; TRAF6 mediated IRF7 activation.
DR   Reactome; R-HSA-933542; TRAF6 mediated NF-kB activation.
DR   Reactome; R-HSA-933543; NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10.
DR   Reactome; R-HSA-936440; Negative regulators of DDX58/IFIH1 signaling.
DR   UniPathway; UPA00143; -.
DR   ChiTaRS; TRIM25; human.
DR   GeneWiki; TRIM25; -.
DR   GenomeRNAi; 7706; -.
DR   PRO; PR:Q14258; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   Bgee; ENSG00000121060; -.
DR   CleanEx; HS_TRIM25; -.
DR   ExpressionAtlas; Q14258; baseline and differential.
DR   Genevisible; Q14258; HS.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0016604; C:nuclear body; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0045296; F:cadherin binding; HDA:BHF-UCL.
DR   GO; GO:0003700; F:DNA binding transcription factor activity; TAS:ProtInc.
DR   GO; GO:0016874; F:ligase activity; IEA:UniProtKB-KW.
DR   GO; GO:0003723; F:RNA binding; HDA:UniProtKB.
DR   GO; GO:0061630; F:ubiquitin protein ligase activity; IMP:ParkinsonsUK-UCL.
DR   GO; GO:0004842; F:ubiquitin-protein transferase activity; EXP:Reactome.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:1990830; P:cellular response to leukemia inhibitory factor; IEA:Ensembl.
DR   GO; GO:0051607; P:defense response to virus; IEA:UniProtKB-KW.
DR   GO; GO:0045087; P:innate immune response; IDA:UniProtKB.
DR   GO; GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome.
DR   GO; GO:0032480; P:negative regulation of type I interferon production; TAS:Reactome.
DR   GO; GO:0046597; P:negative regulation of viral entry into host cell; IEA:Ensembl.
DR   GO; GO:1902187; P:negative regulation of viral release from host cell; IEA:Ensembl.
DR   GO; GO:0051091; P:positive regulation of DNA binding transcription factor activity; IMP:UniProtKB.
DR   GO; GO:0043123; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; IDA:UniProtKB.
DR   GO; GO:0051092; P:positive regulation of NF-kappaB transcription factor activity; IMP:UniProtKB.
DR   GO; GO:0006513; P:protein monoubiquitination; IMP:ParkinsonsUK-UCL.
DR   GO; GO:0046596; P:regulation of viral entry into host cell; IDA:UniProtKB.
DR   GO; GO:1902186; P:regulation of viral release from host cell; IMP:UniProtKB.
DR   GO; GO:0043627; P:response to estrogen; IDA:UniProtKB.
DR   GO; GO:0033280; P:response to vitamin D; IEA:Ensembl.
DR   GO; GO:0019985; P:translesion synthesis; TAS:Reactome.
DR   GO; GO:0030433; P:ubiquitin-dependent ERAD pathway; IMP:ParkinsonsUK-UCL.
DR   GO; GO:0006511; P:ubiquitin-dependent protein catabolic process; IMP:UniProtKB.
DR   GO; GO:0016032; P:viral process; IEA:UniProtKB-KW.
DR   CDD; cd00021; BBOX; 1.
DR   Gene3D; 3.30.40.10; -; 1.
DR   InterPro; IPR001870; B30.2/SPRY.
DR   InterPro; IPR003879; Butyrophylin_SPRY.
DR   InterPro; IPR013320; ConA-like_dom_sf.
DR   InterPro; IPR006574; PRY.
DR   InterPro; IPR003877; SPRY_dom.
DR   InterPro; IPR027370; Znf-RING_LisH.
DR   InterPro; IPR000315; Znf_B-box.
DR   InterPro; IPR001841; Znf_RING.
DR   InterPro; IPR013083; Znf_RING/FYVE/PHD.
DR   InterPro; IPR017907; Znf_RING_CS.
DR   Pfam; PF13765; PRY; 1.
DR   Pfam; PF00622; SPRY; 1.
DR   Pfam; PF13445; zf-RING_UBOX; 1.
DR   PRINTS; PR01407; BUTYPHLNCDUF.
DR   SMART; SM00589; PRY; 1.
DR   SMART; SM00184; RING; 1.
DR   SMART; SM00449; SPRY; 1.
DR   SUPFAM; SSF49899; SSF49899; 1.
DR   PROSITE; PS50188; B302_SPRY; 1.
DR   PROSITE; PS00518; ZF_RING_1; 1.
DR   PROSITE; PS50089; ZF_RING_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Antiviral defense; Coiled coil;
KW   Complete proteome; Cytoplasm; Host-virus interaction; Immunity;
KW   Innate immunity; Isopeptide bond; Ligase; Metal-binding;
KW   Phosphoprotein; Polymorphism; Reference proteome; Transferase;
KW   Ubl conjugation; Ubl conjugation pathway; Zinc; Zinc-finger.
FT   CHAIN         1    630       E3 ubiquitin/ISG15 ligase TRIM25.
FT                                /FTId=PRO_0000056233.
FT   DOMAIN      439    630       B30.2/SPRY. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00548}.
FT   ZN_FING      13     54       RING-type. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00175}.
FT   REGION      180    450       Interaction with influenza A virus NS1.
FT   COILED      217    307       {ECO:0000255}.
FT   MOD_RES      91     91       Phosphothreonine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     100    100       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     273    273       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     278    278       Phosphotyrosine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     567    567       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   CROSSLNK    117    117       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in ISG15).
FT                                {ECO:0000269|PubMed:17222803}.
FT   VARIANT      89     89       V -> G (in dbSNP:rs7212260).
FT                                /FTId=VAR_024614.
FT   VARIANT     358    358       P -> L (in dbSNP:rs205498).
FT                                {ECO:0000244|PubMed:21269460,
FT                                ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|PubMed:8248217}.
FT                                /FTId=VAR_024615.
FT   MUTAGEN      21     21       K->R: No effect on ISGylation.
FT                                {ECO:0000269|PubMed:17222803}.
FT   MUTAGEN      65     65       K->R: No effect on ISGylation.
FT                                {ECO:0000269|PubMed:17222803}.
FT   MUTAGEN     112    112       K->R: No effect on ISGylation.
FT                                {ECO:0000269|PubMed:17222803}.
FT   MUTAGEN     117    117       K->R: No ISGylation.
FT                                {ECO:0000269|PubMed:17222803}.
FT   HELIX         2      5       {ECO:0000244|PDB:5EYA}.
FT   HELIX         7     10       {ECO:0000244|PDB:5FER}.
FT   TURN         14     16       {ECO:0000244|PDB:5FER}.
FT   STRAND       17     19       {ECO:0000244|PDB:5FER}.
FT   STRAND       21     25       {ECO:0000244|PDB:5FER}.
FT   STRAND       31     33       {ECO:0000244|PDB:5FER}.
FT   HELIX        34     43       {ECO:0000244|PDB:5FER}.
FT   STRAND       46     49       {ECO:0000244|PDB:5FER}.
FT   TURN         51     53       {ECO:0000244|PDB:5FER}.
FT   STRAND       56     59       {ECO:0000244|PDB:5FER}.
FT   HELIX        67     78       {ECO:0000244|PDB:5FER}.
FT   HELIX       191    300       {ECO:0000244|PDB:4LTB}.
FT   HELIX       307    316       {ECO:0000244|PDB:4LTB}.
FT   HELIX       331    358       {ECO:0000244|PDB:4LTB}.
SQ   SEQUENCE   630 AA;  70973 MW;  EB0AB353F0AD4C80 CRC64;
     MAELCPLAEE LSCSICLEPF KEPVTTPCGH NFCGSCLNET WAVQGSPYLC PQCRAVYQAR
     PQLHKNTVLC NVVEQFLQAD LAREPPADVW TPPARASAPS PNAQVACDHC LKEAAVKTCL
     VCMASFCQEH LQPHFDSPAF QDHPLQPPVR DLLRRKCSQH NRLREFFCPE HSECICHICL
     VEHKTCSPAS LSQASADLEA TLRHKLTVMY SQINGASRAL DDVRNRQQDV RMTANRKVEQ
     LQQEYTEMKA LLDASETTST RKIKEEEKRV NSKFDTIYQI LLKKKSEIQT LKEEIEQSLT
     KRDEFEFLEK ASKLRGISTK PVYIPEVELN HKLIKGIHQS TIDLKNELKQ CIGRLQEPTP
     SSGDPGEHDP ASTHKSTRPV KKVSKEEKKS KKPPPVPALP SKLPTFGAPE QLVDLKQAGL
     EAAAKATSSH PNSTSLKAKV LETFLAKSRP ELLEYYIKVI LDYNTAHNKV ALSECYTVAS
     VAEMPQNYRP HPQRFTYCSQ VLGLHCYKKG IHYWEVELQK NNFCGVGICY GSMNRQGPES
     RLGRNSASWC VEWFNTKISA WHNNVEKTLP STKATRVGVL LNCDHGFVIF FAVADKVHLM
     YKFRVDFTEA LYPAFWVFSA GATLSICSPK
//
ID   CCND2_HUMAN             Reviewed;         289 AA.
AC   P30279; A8K531; Q13955; Q5U035;
DT   01-APR-1993, integrated into UniProtKB/Swiss-Prot.
DT   01-APR-1993, sequence version 1.
DT   23-MAY-2018, entry version 181.
DE   RecName: Full=G1/S-specific cyclin-D2;
GN   Name=CCND2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=1386336; DOI=10.1016/0888-7543(92)90127-E;
RA   Xiong Y., Menninger J., Beach D., Ward D.C.;
RT   "Molecular cloning and chromosomal mapping of CCND genes encoding
RT   human D-type cyclins.";
RL   Genomics 13:575-584(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=8455931;
RA   Palmero I., Holder A., Sinclair A.J., Dickson C., Peters G.;
RT   "Cyclins D1 and D2 are differentially expressed in human B-lymphoid
RT   cell lines.";
RL   Oncogene 8:1049-1054(1993).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Bone marrow;
RA   Miyajima N.;
RL   Submitted (MAR-1993) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (OCT-2004) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT ARG-268.
RG   NIEHS SNPs program;
RL   Submitted (JUN-2002) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16541075; DOI=10.1038/nature04569;
RA   Scherer S.E., Muzny D.M., Buhay C.J., Chen R., Cree A., Ding Y.,
RA   Dugan-Rocha S., Gill R., Gunaratne P., Harris R.A., Hawes A.C.,
RA   Hernandez J., Hodgson A.V., Hume J., Jackson A., Khan Z.M.,
RA   Kovar-Smith C., Lewis L.R., Lozado R.J., Metzker M.L.,
RA   Milosavljevic A., Miner G.R., Montgomery K.T., Morgan M.B.,
RA   Nazareth L.V., Scott G., Sodergren E., Song X.-Z., Steffen D.,
RA   Lovering R.C., Wheeler D.A., Worley K.C., Yuan Y., Zhang Z.,
RA   Adams C.Q., Ansari-Lari M.A., Ayele M., Brown M.J., Chen G., Chen Z.,
RA   Clerc-Blankenburg K.P., Davis C., Delgado O., Dinh H.H., Draper H.,
RA   Gonzalez-Garay M.L., Havlak P., Jackson L.R., Jacob L.S., Kelly S.H.,
RA   Li L., Li Z., Liu J., Liu W., Lu J., Maheshwari M., Nguyen B.-V.,
RA   Okwuonu G.O., Pasternak S., Perez L.M., Plopper F.J.H., Santibanez J.,
RA   Shen H., Tabor P.E., Verduzco D., Waldron L., Wang Q., Williams G.A.,
RA   Zhang J., Zhou J., Allen C.C., Amin A.G., Anyalebechi V., Bailey M.,
RA   Barbaria J.A., Bimage K.E., Bryant N.P., Burch P.E., Burkett C.E.,
RA   Burrell K.L., Calderon E., Cardenas V., Carter K., Casias K.,
RA   Cavazos I., Cavazos S.R., Ceasar H., Chacko J., Chan S.N., Chavez D.,
RA   Christopoulos C., Chu J., Cockrell R., Cox C.D., Dang M.,
RA   Dathorne S.R., David R., Davis C.M., Davy-Carroll L., Deshazo D.R.,
RA   Donlin J.E., D'Souza L., Eaves K.A., Egan A., Emery-Cohen A.J.,
RA   Escotto M., Flagg N., Forbes L.D., Gabisi A.M., Garza M., Hamilton C.,
RA   Henderson N., Hernandez O., Hines S., Hogues M.E., Huang M.,
RA   Idlebird D.G., Johnson R., Jolivet A., Jones S., Kagan R., King L.M.,
RA   Leal B., Lebow H., Lee S., LeVan J.M., Lewis L.C., London P.,
RA   Lorensuhewa L.M., Loulseged H., Lovett D.A., Lucier A., Lucier R.L.,
RA   Ma J., Madu R.C., Mapua P., Martindale A.D., Martinez E., Massey E.,
RA   Mawhiney S., Meador M.G., Mendez S., Mercado C., Mercado I.C.,
RA   Merritt C.E., Miner Z.L., Minja E., Mitchell T., Mohabbat F.,
RA   Mohabbat K., Montgomery B., Moore N., Morris S., Munidasa M.,
RA   Ngo R.N., Nguyen N.B., Nickerson E., Nwaokelemeh O.O., Nwokenkwo S.,
RA   Obregon M., Oguh M., Oragunye N., Oviedo R.J., Parish B.J.,
RA   Parker D.N., Parrish J., Parks K.L., Paul H.A., Payton B.A., Perez A.,
RA   Perrin W., Pickens A., Primus E.L., Pu L.-L., Puazo M., Quiles M.M.,
RA   Quiroz J.B., Rabata D., Reeves K., Ruiz S.J., Shao H., Sisson I.,
RA   Sonaike T., Sorelle R.P., Sutton A.E., Svatek A.F., Svetz L.A.,
RA   Tamerisa K.S., Taylor T.R., Teague B., Thomas N., Thorn R.D.,
RA   Trejos Z.Y., Trevino B.K., Ukegbu O.N., Urban J.B., Vasquez L.I.,
RA   Vera V.A., Villasana D.M., Wang L., Ward-Moore S., Warren J.T.,
RA   Wei X., White F., Williamson A.L., Wleczyk R., Wooden H.S.,
RA   Wooden S.H., Yen J., Yoon L., Yoon V., Zorrilla S.E., Nelson D.,
RA   Kucherlapati R., Weinstock G., Gibbs R.A.;
RT   "The finished DNA sequence of human chromosome 12.";
RL   Nature 440:346-351(2006).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Bone marrow, and Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-240.
RC   TISSUE=Placenta;
RX   PubMed=1386335; DOI=10.1016/0888-7543(92)90126-D;
RA   Inaba T., Matsushime H., Valentine M., Roussel M.F., Sherr C.J.,
RA   Look A.T.;
RT   "Genomic organization, chromosomal localization, and independent
RT   expression of human cyclin D genes.";
RL   Genomics 13:565-574(1992).
RN   [11]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 105-140 (ISOFORM 2).
RC   TISSUE=Glioblastoma;
RG   The Cancer Genome Anatomy Project (CGAP) at the National Cancer Institute;
RL   Submitted (SEP-1998) to the EMBL/GenBank/DDBJ databases.
RN   [12]
RP   INTERACTION WITH CDK4, AND SUBCELLULAR LOCATION.
RX   PubMed=18827403; DOI=10.1247/csf.08019;
RA   Wang Z., Xie Y., Zhang L., Zhang H., An X., Wang T., Meng A.;
RT   "Migratory localization of cyclin D2-Cdk4 complex suggests a spatial
RT   regulation of the G1-S transition.";
RL   Cell Struct. Funct. 33:171-183(2008).
RN   [13]
RP   SUBCELLULAR LOCATION (ISOFORM 2), AND ALTERNATIVE SPLICING.
RX   PubMed=17873913; DOI=10.1038/sj.onc.1210750;
RA   Denicourt C., Legault P., McNabb F.A., Rassart E.;
RT   "Human and mouse cyclin D2 splice variants: transforming activity and
RT   subcellular localization.";
RL   Oncogene 27:1253-1262(2008).
RN   [14]
RP   UBIQUITINATION BY SCF(FBXL2).
RX   PubMed=22323446; DOI=10.1182/blood-2011-06-358911;
RA   Chen B.B., Glasser J.R., Coon T.A., Zou C., Miller H.L., Fenton M.,
RA   McDyer J.F., Boyiadzis M., Mallampalli R.K.;
RT   "F-box protein FBXL2 targets cyclin D2 for ubiquitination and
RT   degradation to inhibit leukemic cell proliferation.";
RL   Blood 119:3132-3141(2012).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-271, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [16]
RP   INVOLVEMENT IN MPPH3, AND VARIANTS MPPH3 ASN-280; ALA-280; ARG-281;
RP   LEU-281 AND GLY-284.
RX   PubMed=24705253; DOI=10.1038/ng.2948;
RG   FORGE Canada Consortium;
RA   Mirzaa G.M., Parry D.A., Fry A.E., Giamanco K.A., Schwartzentruber J.,
RA   Vanstone M., Logan C.V., Roberts N., Johnson C.A., Singh S.,
RA   Kholmanskikh S.S., Adams C., Hodge R.D., Hevner R.F., Bonthron D.T.,
RA   Braun K.P., Faivre L., Riviere J.B., St-Onge J., Gripp K.W.,
RA   Mancini G.M., Pang K., Sweeney E., van Esch H., Verbeek N.,
RA   Wieczorek D., Steinraths M., Majewski J., Boycott K.M., Pilz D.T.,
RA   Ross M.E., Dobyns W.B., Sheridan E.G.;
RT   "De novo CCND2 mutations leading to stabilization of cyclin D2 cause
RT   megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome.";
RL   Nat. Genet. 46:510-515(2014).
CC   -!- FUNCTION: Regulatory component of the cyclin D2-CDK4 (DC) complex
CC       that phosphorylates and inhibits members of the retinoblastoma
CC       (RB) protein family including RB1 and regulates the cell-cycle
CC       during G(1)/S transition. Phosphorylation of RB1 allows
CC       dissociation of the transcription factor E2F from the RB/E2F
CC       complex and the subsequent transcription of E2F target genes which
CC       are responsible for the progression through the G(1) phase.
CC       Hypophosphorylates RB1 in early G(1) phase. Cyclin D-CDK4
CC       complexes are major integrators of various mitogenenic and
CC       antimitogenic signals. Also substrate for SMAD3, phosphorylating
CC       SMAD3 in a cell-cycle-dependent manner and repressing its
CC       transcriptional activity. Component of the ternary complex, cyclin
CC       D2/CDK4/CDKN1B, required for nuclear translocation and activity of
CC       the cyclin D-CDK4 complex (By similarity). {ECO:0000250}.
CC   -!- SUBUNIT: Interacts with either CDK4 or CDK6 protein kinase to form
CC       a serine/threonine kinase holoenzyme complex. The cyclin subunit
CC       imparts substrate specificity to the complex. Component of the
CC       ternary complex cyclin D/CDK4/CDKN1B required for nuclear
CC       translocation and modulation of CDK4-mediated kinase activity.
CC       {ECO:0000269|PubMed:18827403}.
CC   -!- INTERACTION:
CC       P11802:CDK4; NbExp=12; IntAct=EBI-748789, EBI-295644;
CC       Q00535:CDK5; NbExp=13; IntAct=EBI-748789, EBI-1041567;
CC       P38936:CDKN1A; NbExp=14; IntAct=EBI-748789, EBI-375077;
CC       P46527:CDKN1B; NbExp=5; IntAct=EBI-748789, EBI-519280;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:18827403}.
CC       Cytoplasm {ECO:0000269|PubMed:18827403}. Membrane
CC       {ECO:0000269|PubMed:18827403}. Note=Cyclin D-CDK4 complexes
CC       accumulate at the nuclear membrane and are then translocated into
CC       the nucleus through interaction with KIP/CIP family members.
CC       {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Isoform 2: Cytoplasm
CC       {ECO:0000269|PubMed:17873913}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P30279-1; Sequence=Displayed;
CC       Name=2; Synonyms=Truncated;
CC         IsoId=P30279-2; Sequence=VSP_057295, VSP_057296;
CC         Note=Acts as proto-oncogene. Retains ability to bind CDK4, but
CC         unable to catalyze efficiently RB phosphorylation and
CC         inactivation. {ECO:0000269|PubMed:17873913};
CC   -!- PTM: Polyubiquitinated by the SCF(FBXL2) complex, leading to
CC       proteasomal degradation. {ECO:0000269|PubMed:22323446}.
CC   -!- DISEASE: Megalencephaly-polymicrogyria-polydactyly-hydrocephalus
CC       syndrome 3 (MPPH3) [MIM:615938]: A syndrome characterized by
CC       megalencephaly, ventriculomegaly that may lead to hydrocephalus,
CC       and polymicrogyria; polydactyly may also be seen. There is
CC       considerable phenotypic similarity between this disorder and the
CC       megalencephaly-capillary malformation syndrome.
CC       {ECO:0000269|PubMed:24705253}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the cyclin family. Cyclin D subfamily.
CC       {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=NIEHS-SNPs;
CC       URL="http://egp.gs.washington.edu/data/ccnd2/";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M90813; AAA51926.1; -; mRNA.
DR   EMBL; X68452; CAA48493.1; -; mRNA.
DR   EMBL; D13639; BAA02802.1; -; mRNA.
DR   EMBL; BT019847; AAV38650.1; -; mRNA.
DR   EMBL; AF518005; AAM54041.1; -; Genomic_DNA.
DR   EMBL; AK291146; BAF83835.1; -; mRNA.
DR   EMBL; AC006122; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471116; EAW88851.1; -; Genomic_DNA.
DR   EMBL; BC010958; AAH10958.1; -; mRNA.
DR   EMBL; BC089384; AAH89384.1; -; mRNA.
DR   EMBL; M88083; AAA51928.1; -; Genomic_DNA.
DR   EMBL; M88080; AAA51928.1; JOINED; Genomic_DNA.
DR   EMBL; M88081; AAA51928.1; JOINED; Genomic_DNA.
DR   EMBL; M88082; AAA51928.1; JOINED; Genomic_DNA.
DR   EMBL; AI146555; -; NOT_ANNOTATED_CDS; mRNA.
DR   CCDS; CCDS8524.1; -. [P30279-1]
DR   PIR; A42822; A42822.
DR   RefSeq; NP_001750.1; NM_001759.3. [P30279-1]
DR   UniGene; Hs.376071; -.
DR   PDB; 6EI2; X-ray; 1.61 A; C=114-123.
DR   PDBsum; 6EI2; -.
DR   ProteinModelPortal; P30279; -.
DR   SMR; P30279; -.
DR   BioGrid; 107334; 90.
DR   CORUM; P30279; -.
DR   DIP; DIP-178N; -.
DR   IntAct; P30279; 8.
DR   MINT; P30279; -.
DR   STRING; 9606.ENSP00000261254; -.
DR   ChEMBL; CHEMBL3301386; -.
DR   iPTMnet; P30279; -.
DR   PhosphoSitePlus; P30279; -.
DR   BioMuta; CCND2; -.
DR   DMDM; 231741; -.
DR   EPD; P30279; -.
DR   MaxQB; P30279; -.
DR   PaxDb; P30279; -.
DR   PeptideAtlas; P30279; -.
DR   PRIDE; P30279; -.
DR   DNASU; 894; -.
DR   Ensembl; ENST00000261254; ENSP00000261254; ENSG00000118971. [P30279-1]
DR   GeneID; 894; -.
DR   KEGG; hsa:894; -.
DR   UCSC; uc001qmo.4; human. [P30279-1]
DR   CTD; 894; -.
DR   DisGeNET; 894; -.
DR   EuPathDB; HostDB:ENSG00000118971.7; -.
DR   GeneCards; CCND2; -.
DR   HGNC; HGNC:1583; CCND2.
DR   HPA; HPA049138; -.
DR   HPA; HPA054196; -.
DR   MalaCards; CCND2; -.
DR   MIM; 123833; gene.
DR   MIM; 615938; phenotype.
DR   neXtProt; NX_P30279; -.
DR   OpenTargets; ENSG00000118971; -.
DR   Orphanet; 83473; Megalencephaly - polymicrogyria - postaxial polydactyly - hydrocephalus.
DR   PharmGKB; PA26150; -.
DR   eggNOG; KOG0656; Eukaryota.
DR   eggNOG; ENOG410XRKC; LUCA.
DR   GeneTree; ENSGT00910000144111; -.
DR   HOGENOM; HOG000008182; -.
DR   HOVERGEN; HBG050837; -.
DR   InParanoid; P30279; -.
DR   KO; K10151; -.
DR   OMA; VVPTKKC; -.
DR   OrthoDB; EOG091G0URX; -.
DR   PhylomeDB; P30279; -.
DR   TreeFam; TF101004; -.
DR   Reactome; R-HSA-69231; Cyclin D associated events in G1.
DR   Reactome; R-HSA-8934593; Regulation of RUNX1 Expression and Activity.
DR   SignaLink; P30279; -.
DR   SIGNOR; P30279; -.
DR   ChiTaRS; CCND2; human.
DR   GeneWiki; Cyclin_D2; -.
DR   GenomeRNAi; 894; -.
DR   PRO; PR:P30279; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   Bgee; ENSG00000118971; -.
DR   CleanEx; HS_CCND2; -.
DR   ExpressionAtlas; P30279; baseline and differential.
DR   Genevisible; P30279; HS.
DR   GO; GO:0000785; C:chromatin; IDA:UniProtKB.
DR   GO; GO:0097129; C:cyclin D2-CDK4 complex; IEA:Ensembl.
DR   GO; GO:0000307; C:cyclin-dependent protein kinase holoenzyme complex; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IDA:UniProtKB.
DR   GO; GO:0031965; C:nuclear membrane; IDA:UniProtKB.
DR   GO; GO:0005730; C:nucleolus; IDA:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0019901; F:protein kinase binding; IPI:BHF-UCL.
DR   GO; GO:0008344; P:adult locomotory behavior; IEA:Ensembl.
DR   GO; GO:0007049; P:cell cycle; IEA:UniProtKB-KW.
DR   GO; GO:0051301; P:cell division; IEA:UniProtKB-KW.
DR   GO; GO:0071481; P:cellular response to X-ray; IEA:Ensembl.
DR   GO; GO:0007616; P:long-term memory; IEA:Ensembl.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; IMP:BHF-UCL.
DR   GO; GO:0008284; P:positive regulation of cell proliferation; IMP:BHF-UCL.
DR   GO; GO:0045737; P:positive regulation of cyclin-dependent protein serine/threonine kinase activity; IDA:BHF-UCL.
DR   GO; GO:1900087; P:positive regulation of G1/S transition of mitotic cell cycle; IMP:BHF-UCL.
DR   GO; GO:0001934; P:positive regulation of protein phosphorylation; IDA:BHF-UCL.
DR   CDD; cd00043; CYCLIN; 1.
DR   InterPro; IPR013763; Cyclin-like.
DR   InterPro; IPR036915; Cyclin-like_sf.
DR   InterPro; IPR004367; Cyclin_C-dom.
DR   InterPro; IPR015451; Cyclin_D.
DR   InterPro; IPR006671; Cyclin_N.
DR   PANTHER; PTHR10177:SF66; PTHR10177:SF66; 1.
DR   Pfam; PF02984; Cyclin_C; 1.
DR   Pfam; PF00134; Cyclin_N; 1.
DR   SMART; SM00385; CYCLIN; 1.
DR   SMART; SM01332; Cyclin_C; 1.
DR   SUPFAM; SSF47954; SSF47954; 2.
DR   PROSITE; PS00292; CYCLINS; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Cell cycle; Cell division;
KW   Complete proteome; Cyclin; Cytoplasm; Disease mutation; Membrane;
KW   Nucleus; Phosphoprotein; Polymorphism; Reference proteome;
KW   Ubl conjugation.
FT   CHAIN         1    289       G1/S-specific cyclin-D2.
FT                                /FTId=PRO_0000080437.
FT   DOMAIN       26    151       Cyclin N-terminal.
FT   MOD_RES     271    271       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     280    280       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:P30280}.
FT   VAR_SEQ     138    209       EWELVVLGKLKWNLAAVTPHDFIEHILRKLPQQREKLSLIR
FT                                KHAQTFIALCATDFKFAMYPPSMIATGSVGA -> VMTGPF
FT                                LPSFLRFPLSPGQQYAFYHHCQSKFLGSRMTPPIEFTHLWA
FT                                IAHLIGNHCLFFVCSYYVPRLRAQH (in isoform 2).
FT                                {ECO:0000303|Ref.11}.
FT                                /FTId=VSP_057295.
FT   VAR_SEQ     210    289       Missing (in isoform 2).
FT                                {ECO:0000303|Ref.11}.
FT                                /FTId=VSP_057296.
FT   VARIANT     268    268       G -> R (in dbSNP:rs3217921).
FT                                {ECO:0000269|Ref.5}.
FT                                /FTId=VAR_018820.
FT   VARIANT     280    280       T -> A (in MPPH3; dbSNP:rs587777618).
FT                                {ECO:0000269|PubMed:24705253}.
FT                                /FTId=VAR_072370.
FT   VARIANT     280    280       T -> N (in MPPH3; dbSNP:rs587777620).
FT                                {ECO:0000269|PubMed:24705253}.
FT                                /FTId=VAR_072371.
FT   VARIANT     281    281       P -> L (in MPPH3; dbSNP:rs587777622).
FT                                {ECO:0000269|PubMed:24705253}.
FT                                /FTId=VAR_072372.
FT   VARIANT     281    281       P -> R (in MPPH3; dbSNP:rs587777622).
FT                                {ECO:0000269|PubMed:24705253}.
FT                                /FTId=VAR_072373.
FT   VARIANT     284    284       V -> G (in MPPH3; dbSNP:rs777786993).
FT                                {ECO:0000269|PubMed:24705253}.
FT                                /FTId=VAR_072374.
FT   CONFLICT    166    167       KL -> NV (in Ref. 10; AAA51928).
FT                                {ECO:0000305}.
FT   CONFLICT    224    224       T -> H (in Ref. 10; AAA51928).
FT                                {ECO:0000305}.
SQ   SEQUENCE   289 AA;  33067 MW;  E4E5FEF476D76D90 CRC64;
     MELLCHEVDP VRRAVRDRNL LRDDRVLQNL LTIEERYLPQ CSYFKCVQKD IQPYMRRMVA
     TWMLEVCEEQ KCEEEVFPLA MNYLDRFLAG VPTPKSHLQL LGAVCMFLAS KLKETSPLTA
     EKLCIYTDNS IKPQELLEWE LVVLGKLKWN LAAVTPHDFI EHILRKLPQQ REKLSLIRKH
     AQTFIALCAT DFKFAMYPPS MIATGSVGAA ICGLQQDEEV SSLTCDALTE LLAKITNTDV
     DCLKACQEQI EAVLLNSLQQ YRQDQRDGSK SEDELDQAST PTDVRDIDL
//
ID   CYPD_YEAST              Reviewed;         225 AA.
AC   P35176; D6VST3;
DT   01-FEB-1994, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-1994, sequence version 1.
DT   23-MAY-2018, entry version 160.
DE   RecName: Full=Peptidyl-prolyl cis-trans isomerase D;
DE            Short=PPIase D;
DE            EC=5.2.1.8;
DE   AltName: Full=Cyclophilin D;
DE   AltName: Full=Rotamase D;
DE   Flags: Precursor;
GN   Name=CPR5; Synonyms=CYP5, CYPD; OrderedLocusNames=YDR304C;
GN   ORFNames=D9740.14;
OS   Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast).
OC   Eukaryota; Fungi; Dikarya; Ascomycota; Saccharomycotina;
OC   Saccharomycetes; Saccharomycetales; Saccharomycetaceae; Saccharomyces.
OX   NCBI_TaxID=559292;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=8377189; DOI=10.1006/jmbi.1993.1497;
RA   Frigerio G., Pelham H.R.B.;
RT   "A Saccharomyces cerevisiae cyclophilin resident in the endoplasmic
RT   reticulum.";
RL   J. Mol. Biol. 233:183-188(1993).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 204508 / S288c;
RX   PubMed=9169867;
RA   Jacq C., Alt-Moerbe J., Andre B., Arnold W., Bahr A., Ballesta J.P.G.,
RA   Bargues M., Baron L., Becker A., Biteau N., Bloecker H., Blugeon C.,
RA   Boskovic J., Brandt P., Brueckner M., Buitrago M.J., Coster F.,
RA   Delaveau T., del Rey F., Dujon B., Eide L.G., Garcia-Cantalejo J.M.,
RA   Goffeau A., Gomez-Peris A., Granotier C., Hanemann V., Hankeln T.,
RA   Hoheisel J.D., Jaeger W., Jimenez A., Jonniaux J.-L., Kraemer C.,
RA   Kuester H., Laamanen P., Legros Y., Louis E.J., Moeller-Rieker S.,
RA   Monnet A., Moro M., Mueller-Auer S., Nussbaumer B., Paricio N.,
RA   Paulin L., Perea J., Perez-Alonso M., Perez-Ortin J.E., Pohl T.M.,
RA   Prydz H., Purnelle B., Rasmussen S.W., Remacha M.A., Revuelta J.L.,
RA   Rieger M., Salom D., Saluz H.P., Saiz J.E., Saren A.-M., Schaefer M.,
RA   Scharfe M., Schmidt E.R., Schneider C., Scholler P., Schwarz S.,
RA   Soler-Mira A., Urrestarazu L.A., Verhasselt P., Vissers S., Voet M.,
RA   Volckaert G., Wagner G., Wambutt R., Wedler E., Wedler H., Woelfl S.,
RA   Harris D.E., Bowman S., Brown D., Churcher C.M., Connor R., Dedman K.,
RA   Gentles S., Hamlin N., Hunt S., Jones L., McDonald S., Murphy L.D.,
RA   Niblett D., Odell C., Oliver K., Rajandream M.A., Richards C.,
RA   Shore L., Walsh S.V., Barrell B.G., Dietrich F.S., Mulligan J.T.,
RA   Allen E., Araujo R., Aviles E., Berno A., Carpenter J., Chen E.,
RA   Cherry J.M., Chung E., Duncan M., Hunicke-Smith S., Hyman R.W.,
RA   Komp C., Lashkari D., Lew H., Lin D., Mosedale D., Nakahara K.,
RA   Namath A., Oefner P., Oh C., Petel F.X., Roberts D., Schramm S.,
RA   Schroeder M., Shogren T., Shroff N., Winant A., Yelton M.A.,
RA   Botstein D., Davis R.W., Johnston M., Andrews S., Brinkman R.,
RA   Cooper J., Ding H., Du Z., Favello A., Fulton L., Gattung S.,
RA   Greco T., Hallsworth K., Hawkins J., Hillier L.W., Jier M.,
RA   Johnson D., Johnston L., Kirsten J., Kucaba T., Langston Y.,
RA   Latreille P., Le T., Mardis E., Menezes S., Miller N., Nhan M.,
RA   Pauley A., Peluso D., Rifkin L., Riles L., Taich A., Trevaskis E.,
RA   Vignati D., Wilcox L., Wohldman P., Vaudin M., Wilson R.,
RA   Waterston R., Albermann K., Hani J., Heumann K., Kleine K.,
RA   Mewes H.-W., Zollner A., Zaccaria P.;
RT   "The nucleotide sequence of Saccharomyces cerevisiae chromosome IV.";
RL   Nature 387:75-78(1997).
RN   [3]
RP   GENOME REANNOTATION.
RC   STRAIN=ATCC 204508 / S288c;
RX   PubMed=24374639; DOI=10.1534/g3.113.008995;
RA   Engel S.R., Dietrich F.S., Fisk D.G., Binkley G., Balakrishnan R.,
RA   Costanzo M.C., Dwight S.S., Hitz B.C., Karra K., Nash R.S., Weng S.,
RA   Wong E.D., Lloyd P., Skrzypek M.S., Miyasato S.R., Simison M.,
RA   Cherry J.M.;
RT   "The reference genome sequence of Saccharomyces cerevisiae: Then and
RT   now.";
RL   G3 (Bethesda) 4:389-398(2014).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=ATCC 204508 / S288c;
RX   PubMed=17322287; DOI=10.1101/gr.6037607;
RA   Hu Y., Rolfs A., Bhullar B., Murthy T.V.S., Zhu C., Berger M.F.,
RA   Camargo A.A., Kelley F., McCarron S., Jepson D., Richardson A.,
RA   Raphael J., Moreira D., Taycher E., Zuo D., Mohr S., Kane M.F.,
RA   Williamson J., Simpson A.J.G., Bulyk M.L., Harlow E., Marsischky G.,
RA   Kolodner R.D., LaBaer J.;
RT   "Approaching a complete repository of sequence-verified protein-
RT   encoding clones for Saccharomyces cerevisiae.";
RL   Genome Res. 17:536-543(2007).
CC   -!- FUNCTION: PPIases accelerate the folding of proteins. It catalyzes
CC       the cis-trans isomerization of proline imidic peptide bonds in
CC       oligopeptides.
CC   -!- CATALYTIC ACTIVITY: Peptidylproline (omega=180) = peptidylproline
CC       (omega=0).
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum lumen.
CC   -!- SIMILARITY: Belongs to the cyclophilin-type PPIase family. PPIase
CC       B subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X73142; CAA51658.1; -; mRNA.
DR   EMBL; U28374; AAB64740.1; -; Genomic_DNA.
DR   EMBL; AY557734; AAS56060.1; -; Genomic_DNA.
DR   EMBL; BK006938; DAA12143.1; -; Genomic_DNA.
DR   PIR; S38324; S38324.
DR   RefSeq; NP_010590.3; NM_001180612.3.
DR   ProteinModelPortal; P35176; -.
DR   SMR; P35176; -.
DR   BioGrid; 32356; 87.
DR   DIP; DIP-5222N; -.
DR   IntAct; P35176; 1.
DR   MINT; P35176; -.
DR   STRING; 4932.YDR304C; -.
DR   iPTMnet; P35176; -.
DR   SWISS-2DPAGE; P35176; -.
DR   MaxQB; P35176; -.
DR   PaxDb; P35176; -.
DR   PRIDE; P35176; -.
DR   EnsemblFungi; YDR304C; YDR304C; YDR304C.
DR   GeneID; 851898; -.
DR   KEGG; sce:YDR304C; -.
DR   EuPathDB; FungiDB:YDR304C; -.
DR   SGD; S000002712; CPR5.
DR   GeneTree; ENSGT00760000119072; -.
DR   HOGENOM; HOG000065981; -.
DR   InParanoid; P35176; -.
DR   KO; K03770; -.
DR   OMA; VYFDIKH; -.
DR   OrthoDB; EOG092C5DG5; -.
DR   BioCyc; YEAST:YDR304C-MONOMER; -.
DR   PRO; PR:P35176; -.
DR   Proteomes; UP000002311; Chromosome IV.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:SGD.
DR   GO; GO:0005788; C:endoplasmic reticulum lumen; IEA:UniProtKB-SubCell.
DR   GO; GO:0003755; F:peptidyl-prolyl cis-trans isomerase activity; ISS:SGD.
DR   GO; GO:0006457; P:protein folding; IEA:InterPro.
DR   Gene3D; 2.40.100.10; -; 1.
DR   InterPro; IPR029000; Cyclophilin-like_dom_sf.
DR   InterPro; IPR024936; Cyclophilin-type_PPIase.
DR   InterPro; IPR020892; Cyclophilin-type_PPIase_CS.
DR   InterPro; IPR002130; Cyclophilin-type_PPIase_dom.
DR   PANTHER; PTHR11071; PTHR11071; 1.
DR   Pfam; PF00160; Pro_isomerase; 1.
DR   PIRSF; PIRSF001467; Peptidylpro_ismrse; 1.
DR   PRINTS; PR00153; CSAPPISMRASE.
DR   SUPFAM; SSF50891; SSF50891; 1.
DR   PROSITE; PS00170; CSA_PPIASE_1; 1.
DR   PROSITE; PS50072; CSA_PPIASE_2; 1.
DR   PROSITE; PS00014; ER_TARGET; 1.
PE   2: Evidence at transcript level;
KW   Complete proteome; Endoplasmic reticulum; Glycoprotein; Isomerase;
KW   Reference proteome; Rotamase; Signal.
FT   SIGNAL        1     22       {ECO:0000255}.
FT   CHAIN        23    225       Peptidyl-prolyl cis-trans isomerase D.
FT                                /FTId=PRO_0000025488.
FT   DOMAIN       37    195       PPIase cyclophilin-type.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00156}.
FT   MOTIF       222    225       Prevents secretion from ER.
FT   CARBOHYD    139    139       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
SQ   SEQUENCE   225 AA;  25327 MW;  F4861424C8443B58 CRC64;
     MKLQFFSFIT LFACLFTTAI FAKEDTAEDP EITHKVYFDI NHGDKQIGRI VMGLYGLTTP
     QTVENFYQLT ISRDPKMGYL NSIFHRVIPN FMIQGGDFTH RSGIGGKSIF GNTFKDENFD
     VKHDKPGRLS MANRGKNTNG SQFFITTVPC PWLDGKHVVF GEVLDGMDVV HYIENVKTDS
     RNMPVKEVII VESGELETVP LDNKDAAKLQ EEIKAEASEA AHDEL
//
ID   PTH2_YEAST              Reviewed;         208 AA.
AC   P34222; D6VPU3;
DT   01-FEB-1994, integrated into UniProtKB/Swiss-Prot.
DT   27-JUL-2011, sequence version 2.
DT   23-MAY-2018, entry version 147.
DE   RecName: Full=Peptidyl-tRNA hydrolase 2;
DE            Short=PTH 2;
DE            EC=3.1.1.29;
GN   Name=PTH2; OrderedLocusNames=YBL057C; ORFNames=YBL0510, YBL0514;
OS   Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast).
OC   Eukaryota; Fungi; Dikarya; Ascomycota; Saccharomycotina;
OC   Saccharomycetes; Saccharomycetales; Saccharomycetaceae; Saccharomyces.
OX   NCBI_TaxID=559292;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=ATCC 204508 / S288c;
RX   PubMed=8154187; DOI=10.1002/yea.320091210;
RA   Scherens B., el Bakkoury M., Vierendeels F., Dubois E., Messenguy F.;
RT   "Sequencing and functional analysis of a 32,560 bp segment on the left
RT   arm of yeast chromosome II. Identification of 26 open reading frames,
RT   including the KIP1 and SEC17 genes.";
RL   Yeast 9:1355-1371(1993).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 204508 / S288c;
RX   PubMed=7813418;
RA   Feldmann H., Aigle M., Aljinovic G., Andre B., Baclet M.C., Barthe C.,
RA   Baur A., Becam A.-M., Biteau N., Boles E., Brandt T., Brendel M.,
RA   Brueckner M., Bussereau F., Christiansen C., Contreras R., Crouzet M.,
RA   Cziepluch C., Demolis N., Delaveau T., Doignon F., Domdey H.,
RA   Duesterhus S., Dubois E., Dujon B., El Bakkoury M., Entian K.-D.,
RA   Feuermann M., Fiers W., Fobo G.M., Fritz C., Gassenhuber J.,
RA   Glansdorff N., Goffeau A., Grivell L.A., de Haan M., Hein C.,
RA   Herbert C.J., Hollenberg C.P., Holmstroem K., Jacq C., Jacquet M.,
RA   Jauniaux J.-C., Jonniaux J.-L., Kallesoee T., Kiesau P., Kirchrath L.,
RA   Koetter P., Korol S., Liebl S., Logghe M., Lohan A.J.E., Louis E.J.,
RA   Li Z.Y., Maat M.J., Mallet L., Mannhaupt G., Messenguy F., Miosga T.,
RA   Molemans F., Mueller S., Nasr F., Obermaier B., Perea J., Pierard A.,
RA   Piravandi E., Pohl F.M., Pohl T.M., Potier S., Proft M., Purnelle B.,
RA   Ramezani Rad M., Rieger M., Rose M., Schaaff-Gerstenschlaeger I.,
RA   Scherens B., Schwarzlose C., Skala J., Slonimski P.P., Smits P.H.M.,
RA   Souciet J.-L., Steensma H.Y., Stucka R., Urrestarazu L.A.,
RA   van der Aart Q.J.M., Van Dyck L., Vassarotti A., Vetter I.,
RA   Vierendeels F., Vissers S., Wagner G., de Wergifosse P., Wolfe K.H.,
RA   Zagulski M., Zimmermann F.K., Mewes H.-W., Kleine K.;
RT   "Complete DNA sequence of yeast chromosome II.";
RL   EMBO J. 13:5795-5809(1994).
RN   [3]
RP   GENOME REANNOTATION.
RC   STRAIN=ATCC 204508 / S288c;
RX   PubMed=24374639; DOI=10.1534/g3.113.008995;
RA   Engel S.R., Dietrich F.S., Fisk D.G., Binkley G., Balakrishnan R.,
RA   Costanzo M.C., Dwight S.S., Hitz B.C., Karra K., Nash R.S., Weng S.,
RA   Wong E.D., Lloyd P., Skrzypek M.S., Miyasato S.R., Simison M.,
RA   Cherry J.M.;
RT   "The reference genome sequence of Saccharomyces cerevisiae: Then and
RT   now.";
RL   G3 (Bethesda) 4:389-398(2014).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=ATCC 204508 / S288c;
RX   PubMed=17322287; DOI=10.1101/gr.6037607;
RA   Hu Y., Rolfs A., Bhullar B., Murthy T.V.S., Zhu C., Berger M.F.,
RA   Camargo A.A., Kelley F., McCarron S., Jepson D., Richardson A.,
RA   Raphael J., Moreira D., Taycher E., Zuo D., Mohr S., Kane M.F.,
RA   Williamson J., Simpson A.J.G., Bulyk M.L., Harlow E., Marsischky G.,
RA   Kolodner R.D., LaBaer J.;
RT   "Approaching a complete repository of sequence-verified protein-
RT   encoding clones for Saccharomyces cerevisiae.";
RL   Genome Res. 17:536-543(2007).
RN   [5]
RP   FUNCTION.
RX   PubMed=12475929; DOI=10.1073/pnas.222659199;
RA   Rosas-Sandoval G., Ambrogelly A., Rinehart J., Wei D., Cruz-Vera L.R.,
RA   Graham D.E., Stetter K.O., Guarneros G., Soell D.;
RT   "Orthologs of a novel archaeal and of the bacterial peptidyl-tRNA
RT   hydrolase are nonessential in yeast.";
RL   Proc. Natl. Acad. Sci. U.S.A. 99:16707-16712(2002).
RN   [6]
RP   LEVEL OF PROTEIN EXPRESSION [LARGE SCALE ANALYSIS].
RX   PubMed=14562106; DOI=10.1038/nature02046;
RA   Ghaemmaghami S., Huh W.-K., Bower K., Howson R.W., Belle A.,
RA   Dephoure N., O'Shea E.K., Weissman J.S.;
RT   "Global analysis of protein expression in yeast.";
RL   Nature 425:737-741(2003).
RN   [7]
RP   FUNCTION.
RX   PubMed=12799450; DOI=10.1093/nar/gkg428;
RA   Fromant M., Ferri-Fioni M.-L., Plateau P., Blanquet S.;
RT   "Peptidyl-tRNA hydrolase from Sulfolobus solfataricus.";
RL   Nucleic Acids Res. 31:3227-3235(2003).
RN   [8]
RP   UBIQUITINATION [LARGE SCALE ANALYSIS] AT LYS-152, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY.
RX   PubMed=14557538; DOI=10.1073/pnas.2135500100;
RA   Hitchcock A.L., Auld K., Gygi S.P., Silver P.A.;
RT   "A subset of membrane-associated proteins is ubiquitinated in response
RT   to mutations in the endoplasmic reticulum degradation machinery.";
RL   Proc. Natl. Acad. Sci. U.S.A. 100:12735-12740(2003).
RN   [9]
RP   UBIQUITINATION [LARGE SCALE ANALYSIS] AT LYS-152, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22106047; DOI=10.1002/pmic.201100166;
RA   Starita L.M., Lo R.S., Eng J.K., von Haller P.D., Fields S.;
RT   "Sites of ubiquitin attachment in Saccharomyces cerevisiae.";
RL   Proteomics 12:236-240(2012).
CC   -!- FUNCTION: The natural substrate for this enzyme may be peptidyl-
CC       tRNAs which drop off the ribosome during protein synthesis.
CC       {ECO:0000250, ECO:0000269|PubMed:12475929,
CC       ECO:0000269|PubMed:12799450}.
CC   -!- CATALYTIC ACTIVITY: N-substituted aminoacyl-tRNA + H(2)O = N-
CC       substituted amino acid + tRNA.
CC   -!- INTERACTION:
CC       P48510:DSK2; NbExp=11; IntAct=EBI-2345448, EBI-6174;
CC       P32628:RAD23; NbExp=5; IntAct=EBI-2345448, EBI-14668;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm.
CC   -!- MISCELLANEOUS: Present with 2190 molecules/cell in log phase SD
CC       medium. {ECO:0000269|PubMed:14562106}.
CC   -!- SIMILARITY: Belongs to the PTH2 family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAT92782.1; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC       Sequence=CAA80790.1; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC       Sequence=CAA84877.1; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; Z23261; CAA80790.1; ALT_INIT; Genomic_DNA.
DR   EMBL; Z35818; CAA84877.1; ALT_INIT; Genomic_DNA.
DR   EMBL; AY692763; AAT92782.1; ALT_INIT; Genomic_DNA.
DR   EMBL; BK006936; DAA07063.2; -; Genomic_DNA.
DR   PIR; S39831; S39831.
DR   RefSeq; NP_009496.2; NM_001178297.2.
DR   ProteinModelPortal; P34222; -.
DR   SMR; P34222; -.
DR   BioGrid; 32642; 69.
DR   IntAct; P34222; 3.
DR   MINT; P34222; -.
DR   STRING; 4932.YBL057C; -.
DR   iPTMnet; P34222; -.
DR   MaxQB; P34222; -.
DR   PaxDb; P34222; -.
DR   PRIDE; P34222; -.
DR   EnsemblFungi; YBL057C; YBL057C; YBL057C.
DR   GeneID; 852223; -.
DR   KEGG; sce:YBL057C; -.
DR   EuPathDB; FungiDB:YBL057C; -.
DR   SGD; S000000153; PTH2.
DR   GeneTree; ENSGT00390000015991; -.
DR   HOGENOM; HOG000227349; -.
DR   InParanoid; P34222; -.
DR   KO; K04794; -.
DR   OMA; KITLQVP; -.
DR   OrthoDB; EOG092C5K7L; -.
DR   BioCyc; YEAST:G3O-28955-MONOMER; -.
DR   PRO; PR:P34222; -.
DR   Proteomes; UP000002311; Chromosome II.
DR   GO; GO:0005737; C:cytoplasm; IC:SGD.
DR   GO; GO:0004045; F:aminoacyl-tRNA hydrolase activity; IDA:SGD.
DR   GO; GO:0032435; P:negative regulation of proteasomal ubiquitin-dependent protein catabolic process; IDA:SGD.
DR   CDD; cd02430; PTH2; 1.
DR   Gene3D; 3.40.1490.10; -; 1.
DR   InterPro; IPR023476; Pep_tRNA_hydro_II_dom_sf.
DR   InterPro; IPR002833; PTH2.
DR   Pfam; PF01981; PTH2; 1.
DR   SUPFAM; SSF102462; SSF102462; 1.
DR   TIGRFAMs; TIGR00283; arch_pth2; 1.
PE   1: Evidence at protein level;
KW   Complete proteome; Cytoplasm; Hydrolase; Isopeptide bond;
KW   Reference proteome; Ubl conjugation.
FT   CHAIN         1    208       Peptidyl-tRNA hydrolase 2.
FT                                /FTId=PRO_0000120284.
FT   CROSSLNK    152    152       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in ubiquitin).
FT                                {ECO:0000244|PubMed:22106047}.
SQ   SEQUENCE   208 AA;  22435 MW;  A77F3A5BAC578943 CRC64;
     MEKMTVSSNY TIALWATFTA ISFAVGYQLG TSNASSTKKS SATLLRSKEM KEGKLHNDTD
     EEESESEDES DEDEDIESTS LNDIPGEVRM ALVIRQDLGM TKGKIAAQCC HAALSCFRHI
     ATNPARASYN PIMTQRWLNA GQAKITLKCP DKFTMDELYA KAISLGVNAA VIHDAGRTQI
     AAGSATVLGL GPAPKAVLDQ ITGDLKLY
//
ID   INV2_YEAST              Reviewed;         532 AA.
AC   P00724; D6VVC4; Q12671;
DT   21-JUL-1986, integrated into UniProtKB/Swiss-Prot.
DT   21-JUL-1986, sequence version 1.
DT   23-MAY-2018, entry version 164.
DE   RecName: Full=Invertase 2;
DE            EC=3.2.1.26;
DE   AltName: Full=Beta-fructofuranosidase 2;
DE   AltName: Full=Saccharase;
DE   Flags: Precursor;
GN   Name=SUC2; OrderedLocusNames=YIL162W;
OS   Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast).
OC   Eukaryota; Fungi; Dikarya; Ascomycota; Saccharomycotina;
OC   Saccharomycetes; Saccharomycetales; Saccharomycetaceae; Saccharomyces.
OX   NCBI_TaxID=559292;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=6300785; DOI=10.1093/nar/11.6.1943;
RA   Taussig R., Carlson M.;
RT   "Nucleotide sequence of the yeast SUC2 gene for invertase.";
RL   Nucleic Acids Res. 11:1943-1954(1983).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 204508 / S288c;
RX   PubMed=9169870;
RA   Churcher C.M., Bowman S., Badcock K., Bankier A.T., Brown D.,
RA   Chillingworth T., Connor R., Devlin K., Gentles S., Hamlin N.,
RA   Harris D.E., Horsnell T., Hunt S., Jagels K., Jones M., Lye G.,
RA   Moule S., Odell C., Pearson D., Rajandream M.A., Rice P., Rowley N.,
RA   Skelton J., Smith V., Walsh S.V., Whitehead S., Barrell B.G.;
RT   "The nucleotide sequence of Saccharomyces cerevisiae chromosome IX.";
RL   Nature 387:84-87(1997).
RN   [3]
RP   GENOME REANNOTATION.
RC   STRAIN=ATCC 204508 / S288c;
RX   PubMed=24374639; DOI=10.1534/g3.113.008995;
RA   Engel S.R., Dietrich F.S., Fisk D.G., Binkley G., Balakrishnan R.,
RA   Costanzo M.C., Dwight S.S., Hitz B.C., Karra K., Nash R.S., Weng S.,
RA   Wong E.D., Lloyd P., Skrzypek M.S., Miyasato S.R., Simison M.,
RA   Cherry J.M.;
RT   "The reference genome sequence of Saccharomyces cerevisiae: Then and
RT   now.";
RL   G3 (Bethesda) 4:389-398(2014).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-67.
RC   STRAIN=33;
RX   PubMed=1888528;
RA   Xie K.W., Feng B., Li Y.Y.;
RT   "[The effects of upstream region of SUC2 gene on its expression].";
RL   Yi Chuan Xue Bao 18:175-184(1991).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-54.
RX   PubMed=6341817; DOI=10.1128/MCB.3.3.439;
RA   Carlson M., Taussig R., Kustu S., Botstein D.;
RT   "The secreted form of invertase in Saccharomyces cerevisiae is
RT   synthesized from mRNA encoding a signal sequence.";
RL   Mol. Cell. Biol. 3:439-447(1983).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-30.
RX   PubMed=6396505; DOI=10.1128/MCB.4.12.2750;
RA   Sarokin L., Carlson M.;
RT   "Upstream region required for regulated expression of the glucose-
RT   repressible SUC2 gene of Saccharomyces cerevisiae.";
RL   Mol. Cell. Biol. 4:2750-2757(1984).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-21.
RX   PubMed=3537718; DOI=10.1128/MCB.6.7.2382;
RA   Kaiser C.A., Botstein D.;
RT   "Secretion-defective mutations in the signal sequence for
RT   Saccharomyces cerevisiae invertase.";
RL   Mol. Cell. Biol. 6:2382-2391(1986).
RN   [8]
RP   PROTEIN SEQUENCE OF 20-27 AND 38-45, ACTIVE SITE, AND MUTAGENESIS OF
RP   ASP-42.
RX   PubMed=2113524;
RA   Reddy V.A., Maley F.;
RT   "Identification of an active-site residue in yeast invertase by
RT   affinity labeling and site-directed mutagenesis.";
RL   J. Biol. Chem. 265:10817-10820(1990).
RN   [9]
RP   PROTEIN SEQUENCE OF 21-532, AND GLYCOSYLATION AT ASN-23; ASN-64;
RP   ASN-97; ASN-111; ASN-118; ASN-165; ASN-266; ASN-275; ASN-356; ASN-369;
RP   ASN-384; ASN-398 AND ASN-512.
RX   PubMed=3284881;
RA   Reddy V.A., Johnson R.S., Biemann K., Williams R.S., Ziegler F.D.,
RA   Trimble R.B., Maley F.;
RT   "Characterization of the glycosylation sites in yeast external
RT   invertase. I. N-linked oligosaccharide content of the individual
RT   sequons.";
RL   J. Biol. Chem. 263:6978-6985(1988).
RN   [10]
RP   IDENTIFICATION OF ISOFORMS, AND SUBCELLULAR LOCATION.
RX   PubMed=7039847; DOI=10.1016/0092-8674(82)90384-1;
RA   Carlson M., Botstein D.;
RT   "Two differentially regulated mRNAs with different 5' ends encode
RT   secreted with intracellular forms of yeast invertase.";
RL   Cell 28:145-154(1982).
RN   [11]
RP   LEVEL OF PROTEIN EXPRESSION [LARGE SCALE ANALYSIS].
RX   PubMed=14562106; DOI=10.1038/nature02046;
RA   Ghaemmaghami S., Huh W.-K., Bower K., Howson R.W., Belle A.,
RA   Dephoure N., O'Shea E.K., Weissman J.S.;
RT   "Global analysis of protein expression in yeast.";
RL   Nature 425:737-741(2003).
CC   -!- CATALYTIC ACTIVITY: Hydrolysis of terminal non-reducing beta-D-
CC       fructofuranoside residues in beta-D-fructofuranosides.
CC       {ECO:0000255|PROSITE-ProRule:PRU10067}.
CC   -!- SUBCELLULAR LOCATION: Isoform Intracellular: Cytoplasm.
CC   -!- SUBCELLULAR LOCATION: Isoform Secreted: Secreted.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative initiation; Named isoforms=2;
CC       Name=Secreted;
CC         IsoId=P00724-1; Sequence=Displayed;
CC       Name=Intracellular;
CC         IsoId=P00724-2; Sequence=VSP_019611;
CC         Note=Produced by alternative initiation at Met-21 of isoform
CC         Secreted.;
CC   -!- PTM: Isoform Secreted is glycosylated. Isoform Intracellular is
CC       not glycosylated. {ECO:0000269|PubMed:3284881}.
CC   -!- MISCELLANEOUS: Present with 1780 molecules/cell in log phase SD
CC       medium. {ECO:0000269|PubMed:14562106}.
CC   -!- SIMILARITY: Belongs to the glycosyl hydrolase 32 family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; Z46921; CAA87030.1; -; Genomic_DNA.
DR   EMBL; U19781; AAA73474.1; -; Genomic_DNA.
DR   EMBL; V01311; CAA24618.1; -; Genomic_DNA.
DR   EMBL; K03294; AAA35127.1; -; Genomic_DNA.
DR   EMBL; M13627; AAA35129.1; -; Genomic_DNA.
DR   EMBL; BK006942; DAA08390.1; -; Genomic_DNA.
DR   PIR; A00899; IFBY.
DR   RefSeq; NP_012104.1; NM_001179510.1. [P00724-1]
DR   PDB; 4EQV; X-ray; 3.40 A; A/B/C/D/E/F/G/H=21-532.
DR   PDBsum; 4EQV; -.
DR   ProteinModelPortal; P00724; -.
DR   SMR; P00724; -.
DR   BioGrid; 34830; 86.
DR   DIP; DIP-5542N; -.
DR   IntAct; P00724; 2.
DR   MINT; P00724; -.
DR   STRING; 4932.YIL162W; -.
DR   CAZy; GH32; Glycoside Hydrolase Family 32.
DR   mycoCLAP; SUC32B_YEAST; -.
DR   GlyConnect; 303; -.
DR   iPTMnet; P00724; -.
DR   UniCarbKB; P00724; -.
DR   COMPLUYEAST-2DPAGE; P00724; -.
DR   PaxDb; P00724; -.
DR   PRIDE; P00724; -.
DR   EnsemblFungi; YIL162W; YIL162W; YIL162W. [P00724-1]
DR   GeneID; 854644; -.
DR   KEGG; sce:YIL162W; -.
DR   EuPathDB; FungiDB:YIL162W; -.
DR   SGD; S000001424; SUC2.
DR   HOGENOM; HOG000181424; -.
DR   InParanoid; P00724; -.
DR   KO; K01193; -.
DR   OMA; NDPNGLW; -.
DR   OrthoDB; EOG092C1VN1; -.
DR   BioCyc; YEAST:YIL162W-MONOMER; -.
DR   PRO; PR:P00724; -.
DR   Proteomes; UP000002311; Chromosome IX.
DR   GO; GO:0005737; C:cytoplasm; IDA:SGD.
DR   GO; GO:0005576; C:extracellular region; IDA:SGD.
DR   GO; GO:0004564; F:beta-fructofuranosidase activity; IDA:SGD.
DR   GO; GO:0051670; F:inulinase activity; IDA:SGD.
DR   GO; GO:0010147; P:fructan catabolic process; IMP:SGD.
DR   GO; GO:1902927; P:inulin catabolic process; IDA:SGD.
DR   GO; GO:0034484; P:raffinose catabolic process; IMP:SGD.
DR   GO; GO:0005987; P:sucrose catabolic process; IDA:SGD.
DR   Gene3D; 2.115.10.20; -; 1.
DR   InterPro; IPR013320; ConA-like_dom_sf.
DR   InterPro; IPR001362; Glyco_hydro_32.
DR   InterPro; IPR018053; Glyco_hydro_32_AS.
DR   InterPro; IPR013189; Glyco_hydro_32_C.
DR   InterPro; IPR013148; Glyco_hydro_32_N.
DR   InterPro; IPR023296; Glyco_hydro_beta-prop_sf.
DR   Pfam; PF08244; Glyco_hydro_32C; 1.
DR   Pfam; PF00251; Glyco_hydro_32N; 1.
DR   SMART; SM00640; Glyco_32; 1.
DR   SUPFAM; SSF49899; SSF49899; 1.
DR   SUPFAM; SSF75005; SSF75005; 1.
DR   PROSITE; PS00609; GLYCOSYL_HYDROL_F32; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative initiation; Complete proteome; Cytoplasm;
KW   Direct protein sequencing; Glycoprotein; Glycosidase; Hydrolase;
KW   Reference proteome; Secreted; Signal.
FT   SIGNAL        1     19       {ECO:0000269|PubMed:2113524}.
FT   CHAIN        20    532       Invertase 2.
FT                                /FTId=PRO_0000033399.
FT   REGION       39     42       Substrate binding. {ECO:0000250}.
FT   REGION      102    103       Substrate binding. {ECO:0000250}.
FT   REGION      170    171       Substrate binding. {ECO:0000250}.
FT   ACT_SITE     42     42       {ECO:0000255|PROSITE-ProRule:PRU10067,
FT                                ECO:0000269|PubMed:2113524}.
FT   BINDING      60     60       Substrate. {ECO:0000250}.
FT   BINDING     223    223       Substrate. {ECO:0000250}.
FT   BINDING     311    311       Substrate. {ECO:0000250}.
FT   CARBOHYD     23     23       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:3284881}.
FT   CARBOHYD     64     64       N-linked (GlcNAc...) asparagine; partial.
FT                                {ECO:0000269|PubMed:3284881}.
FT   CARBOHYD     97     97       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:3284881}.
FT   CARBOHYD    111    111       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:3284881}.
FT   CARBOHYD    118    118       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:3284881}.
FT   CARBOHYD    165    165       N-linked (GlcNAc...) asparagine; partial.
FT                                {ECO:0000269|PubMed:3284881}.
FT   CARBOHYD    266    266       N-linked (GlcNAc...) asparagine; partial.
FT                                {ECO:0000269|PubMed:3284881}.
FT   CARBOHYD    275    275       N-linked (GlcNAc...) asparagine; partial.
FT                                {ECO:0000269|PubMed:3284881}.
FT   CARBOHYD    356    356       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:3284881}.
FT   CARBOHYD    369    369       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:3284881}.
FT   CARBOHYD    384    384       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:3284881}.
FT   CARBOHYD    398    398       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:3284881}.
FT   CARBOHYD    512    512       N-linked (GlcNAc...) asparagine; partial.
FT                                {ECO:0000269|PubMed:3284881}.
FT   VAR_SEQ       1     20       Missing (in isoform Intracellular).
FT                                {ECO:0000305}.
FT                                /FTId=VSP_019611.
FT   MUTAGEN      42     42       D->N: Loss of activity.
FT                                {ECO:0000269|PubMed:2113524}.
FT   CONFLICT     51     51       K -> P (in Ref. 4; AAA73474).
FT                                {ECO:0000305}.
FT   CONFLICT    409    409       A -> P (in Ref. 9; AA sequence).
FT                                {ECO:0000305}.
FT   STRAND       30     32       {ECO:0000244|PDB:4EQV}.
FT   STRAND       36     49       {ECO:0000244|PDB:4EQV}.
FT   TURN         50     53       {ECO:0000244|PDB:4EQV}.
FT   STRAND       54     67       {ECO:0000244|PDB:4EQV}.
FT   STRAND       73     84       {ECO:0000244|PDB:4EQV}.
FT   STRAND       86     92       {ECO:0000244|PDB:4EQV}.
FT   STRAND      100    108       {ECO:0000244|PDB:4EQV}.
FT   HELIX       123    125       {ECO:0000244|PDB:4EQV}.
FT   STRAND      127    134       {ECO:0000244|PDB:4EQV}.
FT   STRAND      139    145       {ECO:0000244|PDB:4EQV}.
FT   STRAND      147    152       {ECO:0000244|PDB:4EQV}.
FT   STRAND      170    177       {ECO:0000244|PDB:4EQV}.
FT   TURN        178    181       {ECO:0000244|PDB:4EQV}.
FT   STRAND      182    189       {ECO:0000244|PDB:4EQV}.
FT   HELIX       190    192       {ECO:0000244|PDB:4EQV}.
FT   STRAND      194    205       {ECO:0000244|PDB:4EQV}.
FT   STRAND      207    212       {ECO:0000244|PDB:4EQV}.
FT   STRAND      223    234       {ECO:0000244|PDB:4EQV}.
FT   STRAND      239    247       {ECO:0000244|PDB:4EQV}.
FT   STRAND      257    265       {ECO:0000244|PDB:4EQV}.
FT   STRAND      270    275       {ECO:0000244|PDB:4EQV}.
FT   STRAND      278    280       {ECO:0000244|PDB:4EQV}.
FT   STRAND      283    285       {ECO:0000244|PDB:4EQV}.
FT   STRAND      287    291       {ECO:0000244|PDB:4EQV}.
FT   TURN        297    299       {ECO:0000244|PDB:4EQV}.
FT   STRAND      303    309       {ECO:0000244|PDB:4EQV}.
FT   TURN        311    315       {ECO:0000244|PDB:4EQV}.
FT   STRAND      316    318       {ECO:0000244|PDB:4EQV}.
FT   STRAND      320    323       {ECO:0000244|PDB:4EQV}.
FT   STRAND      329    343       {ECO:0000244|PDB:4EQV}.
FT   STRAND      345    354       {ECO:0000244|PDB:4EQV}.
FT   STRAND      374    382       {ECO:0000244|PDB:4EQV}.
FT   STRAND      387    397       {ECO:0000244|PDB:4EQV}.
FT   STRAND      410    416       {ECO:0000244|PDB:4EQV}.
FT   STRAND      418    423       {ECO:0000244|PDB:4EQV}.
FT   STRAND      425    430       {ECO:0000244|PDB:4EQV}.
FT   TURN        431    434       {ECO:0000244|PDB:4EQV}.
FT   STRAND      435    439       {ECO:0000244|PDB:4EQV}.
FT   HELIX       446    450       {ECO:0000244|PDB:4EQV}.
FT   STRAND      465    468       {ECO:0000244|PDB:4EQV}.
FT   STRAND      471    489       {ECO:0000244|PDB:4EQV}.
FT   TURN        490    493       {ECO:0000244|PDB:4EQV}.
FT   STRAND      494    499       {ECO:0000244|PDB:4EQV}.
FT   STRAND      503    505       {ECO:0000244|PDB:4EQV}.
FT   STRAND      510    517       {ECO:0000244|PDB:4EQV}.
FT   STRAND      521    530       {ECO:0000244|PDB:4EQV}.
SQ   SEQUENCE   532 AA;  60639 MW;  7D8AB33E6772B775 CRC64;
     MLLQAFLFLL AGFAAKISAS MTNETSDRPL VHFTPNKGWM NDPNGLWYDE KDAKWHLYFQ
     YNPNDTVWGT PLFWGHATSD DLTNWEDQPI AIAPKRNDSG AFSGSMVVDY NNTSGFFNDT
     IDPRQRCVAI WTYNTPESEE QYISYSLDGG YTFTEYQKNP VLAANSTQFR DPKVFWYEPS
     QKWIMTAAKS QDYKIEIYSS DDLKSWKLES AFANEGFLGY QYECPGLIEV PTEQDPSKSY
     WVMFISINPG APAGGSFNQY FVGSFNGTHF EAFDNQSRVV DFGKDYYALQ TFFNTDPTYG
     SALGIAWASN WEYSAFVPTN PWRSSMSLVR KFSLNTEYQA NPETELINLK AEPILNISNA
     GPWSRFATNT TLTKANSYNV DLSNSTGTLE FELVYAVNTT QTISKSVFAD LSLWFKGLED
     PEEYLRMGFE VSASSFFLDR GNSKVKFVKE NPYFTNRMSV NNQPFKSEND LSYYKVYGLL
     DQNILELYFN DGDVVSTNTY FMTTGNALGS VNMTTGVDNL FYIDKFQVRE VK
//
ID   TOM20_YEAST             Reviewed;         183 AA.
AC   P35180; D6VUL4;
DT   01-FEB-1994, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-1994, sequence version 1.
DT   23-MAY-2018, entry version 164.
DE   RecName: Full=Mitochondrial import receptor subunit TOM20;
DE   AltName: Full=Mitochondrial 20 kDa outer membrane protein;
DE   AltName: Full=Protein MAS20;
DE   AltName: Full=Translocase of outer membrane 20 kDa subunit;
GN   Name=TOM20; Synonyms=MAS20, MOM19; OrderedLocusNames=YGR082W;
OS   Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast).
OC   Eukaryota; Fungi; Dikarya; Ascomycota; Saccharomycotina;
OC   Saccharomycetes; Saccharomycetales; Saccharomycetaceae; Saccharomyces.
OX   NCBI_TaxID=559292;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=8223428;
RA   Ramage L., Junne T., Hahne K., Lithgow T., Schatz G.;
RT   "Functional cooperation of mitochondrial protein import receptors in
RT   yeast.";
RL   EMBO J. 12:4115-4123(1993).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=8132642;
RA   Moczko M., Ehmann B., Gaertner F., Hoenlinger A., Schaefer E.,
RA   Pfanner N.;
RT   "Deletion of the receptor MOM19 strongly impairs import of cleavable
RT   preproteins into Saccharomyces cerevisiae mitochondria.";
RL   J. Biol. Chem. 269:9045-9051(1994).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 204508 / S288c;
RX   PubMed=9169869;
RA   Tettelin H., Agostoni-Carbone M.L., Albermann K., Albers M.,
RA   Arroyo J., Backes U., Barreiros T., Bertani I., Bjourson A.J.,
RA   Brueckner M., Bruschi C.V., Carignani G., Castagnoli L., Cerdan E.,
RA   Clemente M.L., Coblenz A., Coglievina M., Coissac E., Defoor E.,
RA   Del Bino S., Delius H., Delneri D., de Wergifosse P., Dujon B.,
RA   Durand P., Entian K.-D., Eraso P., Escribano V., Fabiani L.,
RA   Fartmann B., Feroli F., Feuermann M., Frontali L., Garcia-Gonzalez M.,
RA   Garcia-Saez M.I., Goffeau A., Guerreiro P., Hani J., Hansen M.,
RA   Hebling U., Hernandez K., Heumann K., Hilger F., Hofmann B.,
RA   Indge K.J., James C.M., Klima R., Koetter P., Kramer B., Kramer W.,
RA   Lauquin G., Leuther H., Louis E.J., Maillier E., Marconi A.,
RA   Martegani E., Mazon M.J., Mazzoni C., McReynolds A.D.K.,
RA   Melchioretto P., Mewes H.-W., Minenkova O., Mueller-Auer S.,
RA   Nawrocki A., Netter P., Neu R., Nombela C., Oliver S.G., Panzeri L.,
RA   Paoluzi S., Plevani P., Portetelle D., Portillo F., Potier S.,
RA   Purnelle B., Rieger M., Riles L., Rinaldi T., Robben J.,
RA   Rodrigues-Pousada C., Rodriguez-Belmonte E., Rodriguez-Torres A.M.,
RA   Rose M., Ruzzi M., Saliola M., Sanchez-Perez M., Schaefer B.,
RA   Schaefer M., Scharfe M., Schmidheini T., Schreer A., Skala J.,
RA   Souciet J.-L., Steensma H.Y., Talla E., Thierry A., Vandenbol M.,
RA   van der Aart Q.J.M., Van Dyck L., Vanoni M., Verhasselt P., Voet M.,
RA   Volckaert G., Wambutt R., Watson M.D., Weber N., Wedler E., Wedler H.,
RA   Wipfli P., Wolf K., Wright L.F., Zaccaria P., Zimmermann M.,
RA   Zollner A., Kleine K.;
RT   "The nucleotide sequence of Saccharomyces cerevisiae chromosome VII.";
RL   Nature 387:81-84(1997).
RN   [4]
RP   GENOME REANNOTATION.
RC   STRAIN=ATCC 204508 / S288c;
RX   PubMed=24374639; DOI=10.1534/g3.113.008995;
RA   Engel S.R., Dietrich F.S., Fisk D.G., Binkley G., Balakrishnan R.,
RA   Costanzo M.C., Dwight S.S., Hitz B.C., Karra K., Nash R.S., Weng S.,
RA   Wong E.D., Lloyd P., Skrzypek M.S., Miyasato S.R., Simison M.,
RA   Cherry J.M.;
RT   "The reference genome sequence of Saccharomyces cerevisiae: Then and
RT   now.";
RL   G3 (Bethesda) 4:389-398(2014).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=ATCC 204508 / S288c;
RX   PubMed=17322287; DOI=10.1101/gr.6037607;
RA   Hu Y., Rolfs A., Bhullar B., Murthy T.V.S., Zhu C., Berger M.F.,
RA   Camargo A.A., Kelley F., McCarron S., Jepson D., Richardson A.,
RA   Raphael J., Moreira D., Taycher E., Zuo D., Mohr S., Kane M.F.,
RA   Williamson J., Simpson A.J.G., Bulyk M.L., Harlow E., Marsischky G.,
RA   Kolodner R.D., LaBaer J.;
RT   "Approaching a complete repository of sequence-verified protein-
RT   encoding clones for Saccharomyces cerevisiae.";
RL   Genome Res. 17:536-543(2007).
RN   [6]
RP   IDENTIFICATION IN THE TOM COMPLEX.
RX   PubMed=9774667; DOI=10.1128/MCB.18.11.6515;
RA   Dekker P.J.T., Ryan M.T., Brix J., Mueller H., Hoenlinger A.,
RA   Pfanner N.;
RT   "Preprotein translocase of the outer mitochondrial membrane: molecular
RT   dissection and assembly of the general import pore complex.";
RL   Mol. Cell. Biol. 18:6515-6524(1998).
RN   [7]
RP   INTERACTION WITH TOM22.
RX   PubMed=10519552; DOI=10.1038/46802;
RA   van Wilpe S., Ryan M.T., Hill K., Maarse A.C., Meisinger C., Brix J.,
RA   Dekker P.J.T., Moczko M., Wagner R., Meijer M., Guiard B.,
RA   Hoenlinger A., Pfanner N.;
RT   "Tom22 is a multifunctional organizer of the mitochondrial preprotein
RT   translocase.";
RL   Nature 401:485-489(1999).
RN   [8]
RP   LEVEL OF PROTEIN EXPRESSION [LARGE SCALE ANALYSIS].
RX   PubMed=14562106; DOI=10.1038/nature02046;
RA   Ghaemmaghami S., Huh W.-K., Bower K., Howson R.W., Belle A.,
RA   Dephoure N., O'Shea E.K., Weissman J.S.;
RT   "Global analysis of protein expression in yeast.";
RL   Nature 425:737-741(2003).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-172, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=18407956; DOI=10.1074/mcp.M700468-MCP200;
RA   Albuquerque C.P., Smolka M.B., Payne S.H., Bafna V., Eng J., Zhou H.;
RT   "A multidimensional chromatography technology for in-depth
RT   phosphoproteome analysis.";
RL   Mol. Cell. Proteomics 7:1389-1396(2008).
CC   -!- FUNCTION: Central component of the TOM (translocase of outer
CC       membrane) receptor complex responsible for the recognition and
CC       translocation of cytosolically synthesized mitochondrial
CC       preproteins. Together with TOM22 functions as the transit peptide
CC       receptor at the surface of the mitochondrion outer membrane and
CC       facilitates the movement of preproteins into the TOM40
CC       translocation pore.
CC   -!- SUBUNIT: Forms part of the preprotein translocase complex of the
CC       outer mitochondrial membrane (TOM complex) which consists of at
CC       least 7 different proteins (TOM5, TOM6, TOM7, TOM20, TOM22, TOM40
CC       and TOM70). In the complex, interacts with TOM22.
CC       {ECO:0000269|PubMed:10519552, ECO:0000269|PubMed:9774667}.
CC   -!- INTERACTION:
CC       P49334:TOM22; NbExp=4; IntAct=EBI-12522, EBI-12527;
CC       P23644:TOM40; NbExp=3; IntAct=EBI-12522, EBI-12539;
CC   -!- SUBCELLULAR LOCATION: Mitochondrion outer membrane {ECO:0000305};
CC       Single-pass membrane protein {ECO:0000305}.
CC   -!- MISCELLANEOUS: Present with 5680 molecules/cell in log phase SD
CC       medium. {ECO:0000269|PubMed:14562106}.
CC   -!- SIMILARITY: Belongs to the Tom20 family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X76139; CAA53742.1; -; Genomic_DNA.
DR   EMBL; X75319; CAA53068.1; -; mRNA.
DR   EMBL; Z72867; CAA97084.1; -; Genomic_DNA.
DR   EMBL; AY557775; AAS56101.1; -; Genomic_DNA.
DR   EMBL; BK006941; DAA08175.1; -; Genomic_DNA.
DR   PIR; S39568; S39568.
DR   RefSeq; NP_011596.1; NM_001181211.1.
DR   ProteinModelPortal; P35180; -.
DR   BioGrid; 33324; 90.
DR   DIP; DIP-2539N; -.
DR   IntAct; P35180; 14.
DR   MINT; P35180; -.
DR   STRING; 4932.YGR082W; -.
DR   TCDB; 3.A.8.1.1; the mitochondrial protein translocase (mpt) family.
DR   iPTMnet; P35180; -.
DR   MaxQB; P35180; -.
DR   PaxDb; P35180; -.
DR   PRIDE; P35180; -.
DR   EnsemblFungi; YGR082W; YGR082W; YGR082W.
DR   GeneID; 852973; -.
DR   KEGG; sce:YGR082W; -.
DR   EuPathDB; FungiDB:YGR082W; -.
DR   SGD; S000003314; TOM20.
DR   HOGENOM; HOG000216577; -.
DR   InParanoid; P35180; -.
DR   KO; K17770; -.
DR   OMA; FVGYCFY; -.
DR   OrthoDB; EOG092C52RN; -.
DR   BioCyc; YEAST:G3O-30794-MONOMER; -.
DR   PRO; PR:P35180; -.
DR   Proteomes; UP000002311; Chromosome VII.
DR   GO; GO:0031307; C:integral component of mitochondrial outer membrane; IDA:SGD.
DR   GO; GO:0005741; C:mitochondrial outer membrane; TAS:Reactome.
DR   GO; GO:0005742; C:mitochondrial outer membrane translocase complex; IDA:SGD.
DR   GO; GO:0030943; F:mitochondrion targeting sequence binding; IDA:SGD.
DR   GO; GO:0015450; F:P-P-bond-hydrolysis-driven protein transmembrane transporter activity; IBA:GO_Central.
DR   GO; GO:0070096; P:mitochondrial outer membrane translocase complex assembly; IMP:SGD.
DR   GO; GO:0030150; P:protein import into mitochondrial matrix; IMP:SGD.
DR   GO; GO:0016031; P:tRNA import into mitochondrion; IMP:SGD.
DR   Gene3D; 1.20.960.10; -; 1.
DR   InterPro; IPR002056; MAS20.
DR   InterPro; IPR023392; Tom20_dom_sf.
DR   PANTHER; PTHR12430; PTHR12430; 1.
DR   Pfam; PF02064; MAS20; 1.
DR   PIRSF; PIRSF037707; MAS20_rcpt; 1.
DR   PRINTS; PR00351; OM20RECEPTOR.
DR   SUPFAM; SSF47157; SSF47157; 1.
DR   TIGRFAMs; TIGR00985; 3a0801s04tom; 1.
PE   1: Evidence at protein level;
KW   Complete proteome; Membrane; Mitochondrion;
KW   Mitochondrion outer membrane; Phosphoprotein; Protein transport;
KW   Reference proteome; Transmembrane; Transmembrane helix; Transport.
FT   CHAIN         1    183       Mitochondrial import receptor subunit
FT                                TOM20.
FT                                /FTId=PRO_0000051550.
FT   TOPO_DOM      1      8       Mitochondrial intermembrane.
FT                                {ECO:0000255}.
FT   TRANSMEM      9     28       Helical. {ECO:0000255}.
FT   TOPO_DOM     29    183       Cytoplasmic. {ECO:0000255}.
FT   MOD_RES     172    172       Phosphoserine.
FT                                {ECO:0000244|PubMed:18407956}.
SQ   SEQUENCE   183 AA;  20317 MW;  9F76FE6010278410 CRC64;
     MSQSNPILRG LAITTAIAAL SATGYAIYFD YQRRNSPQFR KVLRQRAKEQ AKMEEQAKTH
     AKEVKLQKVT EFLSMELAKD PIPSDPSERE ATFTTNVENG ERLSMQQGKE LEAASKFYKA
     LTVYPQPADL LGIYQRSIPE AIYEYIILMI AILPPANVAS FVKGVVGSKA ESDAVAEAND
     IDD
//
ID   OST4_YEAST              Reviewed;          36 AA.
AC   Q99380; D6VRC4;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   23-MAY-2018, entry version 138.
DE   RecName: Full=Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit OST4;
DE            Short=Oligosaccharyl transferase subunit OST4;
DE            EC=2.4.99.18;
DE   AltName: Full=Oligosaccharyl transferase 4 kDa subunit;
DE            Short=OTase 4 kDa subunit;
GN   Name=OST4; OrderedLocusNames=YDL232W;
OS   Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast).
OC   Eukaryota; Fungi; Dikarya; Ascomycota; Saccharomycotina;
OC   Saccharomycetes; Saccharomycetales; Saccharomycetaceae; Saccharomyces.
OX   NCBI_TaxID=559292;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=NDY21;
RX   PubMed=8621712; DOI=10.1074/jbc.271.6.3132;
RA   Chi J.H., Roos J., Dean N.;
RT   "The OST4 gene of Saccharomyces cerevisiae encodes an unusually small
RT   protein required for normal levels of oligosaccharyltransferase
RT   activity.";
RL   J. Biol. Chem. 271:3132-3140(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 204508 / S288c;
RX   PubMed=9169867;
RA   Jacq C., Alt-Moerbe J., Andre B., Arnold W., Bahr A., Ballesta J.P.G.,
RA   Bargues M., Baron L., Becker A., Biteau N., Bloecker H., Blugeon C.,
RA   Boskovic J., Brandt P., Brueckner M., Buitrago M.J., Coster F.,
RA   Delaveau T., del Rey F., Dujon B., Eide L.G., Garcia-Cantalejo J.M.,
RA   Goffeau A., Gomez-Peris A., Granotier C., Hanemann V., Hankeln T.,
RA   Hoheisel J.D., Jaeger W., Jimenez A., Jonniaux J.-L., Kraemer C.,
RA   Kuester H., Laamanen P., Legros Y., Louis E.J., Moeller-Rieker S.,
RA   Monnet A., Moro M., Mueller-Auer S., Nussbaumer B., Paricio N.,
RA   Paulin L., Perea J., Perez-Alonso M., Perez-Ortin J.E., Pohl T.M.,
RA   Prydz H., Purnelle B., Rasmussen S.W., Remacha M.A., Revuelta J.L.,
RA   Rieger M., Salom D., Saluz H.P., Saiz J.E., Saren A.-M., Schaefer M.,
RA   Scharfe M., Schmidt E.R., Schneider C., Scholler P., Schwarz S.,
RA   Soler-Mira A., Urrestarazu L.A., Verhasselt P., Vissers S., Voet M.,
RA   Volckaert G., Wagner G., Wambutt R., Wedler E., Wedler H., Woelfl S.,
RA   Harris D.E., Bowman S., Brown D., Churcher C.M., Connor R., Dedman K.,
RA   Gentles S., Hamlin N., Hunt S., Jones L., McDonald S., Murphy L.D.,
RA   Niblett D., Odell C., Oliver K., Rajandream M.A., Richards C.,
RA   Shore L., Walsh S.V., Barrell B.G., Dietrich F.S., Mulligan J.T.,
RA   Allen E., Araujo R., Aviles E., Berno A., Carpenter J., Chen E.,
RA   Cherry J.M., Chung E., Duncan M., Hunicke-Smith S., Hyman R.W.,
RA   Komp C., Lashkari D., Lew H., Lin D., Mosedale D., Nakahara K.,
RA   Namath A., Oefner P., Oh C., Petel F.X., Roberts D., Schramm S.,
RA   Schroeder M., Shogren T., Shroff N., Winant A., Yelton M.A.,
RA   Botstein D., Davis R.W., Johnston M., Andrews S., Brinkman R.,
RA   Cooper J., Ding H., Du Z., Favello A., Fulton L., Gattung S.,
RA   Greco T., Hallsworth K., Hawkins J., Hillier L.W., Jier M.,
RA   Johnson D., Johnston L., Kirsten J., Kucaba T., Langston Y.,
RA   Latreille P., Le T., Mardis E., Menezes S., Miller N., Nhan M.,
RA   Pauley A., Peluso D., Rifkin L., Riles L., Taich A., Trevaskis E.,
RA   Vignati D., Wilcox L., Wohldman P., Vaudin M., Wilson R.,
RA   Waterston R., Albermann K., Hani J., Heumann K., Kleine K.,
RA   Mewes H.-W., Zollner A., Zaccaria P.;
RT   "The nucleotide sequence of Saccharomyces cerevisiae chromosome IV.";
RL   Nature 387:75-78(1997).
RN   [3]
RP   GENOME REANNOTATION.
RC   STRAIN=ATCC 204508 / S288c;
RX   PubMed=24374639; DOI=10.1534/g3.113.008995;
RA   Engel S.R., Dietrich F.S., Fisk D.G., Binkley G., Balakrishnan R.,
RA   Costanzo M.C., Dwight S.S., Hitz B.C., Karra K., Nash R.S., Weng S.,
RA   Wong E.D., Lloyd P., Skrzypek M.S., Miyasato S.R., Simison M.,
RA   Cherry J.M.;
RT   "The reference genome sequence of Saccharomyces cerevisiae: Then and
RT   now.";
RL   G3 (Bethesda) 4:389-398(2014).
RN   [4]
RP   IDENTIFICATION IN THE OLIGOSACCHARYL TRANSFERASE COMPLEX.
RX   PubMed=8175708;
RA   Kelleher D.J., Gilmore R.;
RT   "The Saccharomyces cerevisiae oligosaccharyltransferase is a protein
RT   complex composed of Wbp1p, Swp1p, and four additional polypeptides.";
RL   J. Biol. Chem. 269:12908-12917(1994).
RN   [5]
RP   IDENTIFICATION IN THE OLIGOSACCHARYL TRANSFERASE COMPLEX, AND
RP   INTERACTION WITH OST3 AND STT3.
RX   PubMed=9405463; DOI=10.1074/jbc.272.51.32513;
RA   Karaoglu D., Kelleher D.J., Gilmore R.;
RT   "The highly conserved Stt3 protein is a subunit of the yeast
RT   oligosaccharyltransferase and forms a subcomplex with Ost3p and
RT   Ost4p.";
RL   J. Biol. Chem. 272:32513-32520(1997).
RN   [6]
RP   REVIEW ON OLIGOSACCHARYL TRANSFERASE.
RX   PubMed=9878773; DOI=10.1016/S0304-4165(98)00128-7;
RA   Knauer R., Lehle L.;
RT   "The oligosaccharyltransferase complex from yeast.";
RL   Biochim. Biophys. Acta 1426:259-273(1999).
RN   [7]
RP   INTERACTION WITH OST3 AND STT3, AND MUTAGENESIS OF MET-18; MET-19;
RP   THR-20; LEU-21; VAL-23; ILE-24 AND TYR-25.
RX   PubMed=10677492; DOI=10.1073/pnas.040556797;
RA   Kim H., Park H., Montalvo L., Lennarz W.J.;
RT   "Studies on the role of the hydrophobic domain of Ost4p in
RT   interactions with other subunits of yeast oligosaccharyl
RT   transferase.";
RL   Proc. Natl. Acad. Sci. U.S.A. 97:1516-1520(2000).
RN   [8]
RP   LEVEL OF PROTEIN EXPRESSION [LARGE SCALE ANALYSIS].
RX   PubMed=14562106; DOI=10.1038/nature02046;
RA   Ghaemmaghami S., Huh W.-K., Bower K., Howson R.W., Belle A.,
RA   Dephoure N., O'Shea E.K., Weissman J.S.;
RT   "Global analysis of protein expression in yeast.";
RL   Nature 425:737-741(2003).
RN   [9]
RP   TOPOLOGY, AND MUTAGENESIS OF MET-18; MET-19; THR-20; LEU-21; VAL-23
RP   AND ILE-24.
RX   PubMed=12810948; DOI=10.1073/pnas.1332735100;
RA   Kim H., Yan Q., Von Heijne G., Caputo G.A., Lennarz W.J.;
RT   "Determination of the membrane topology of Ost4p and its subunit
RT   interactions in the oligosaccharyltransferase complex in Saccharomyces
RT   cerevisiae.";
RL   Proc. Natl. Acad. Sci. U.S.A. 100:7460-7464(2003).
RN   [10]
RP   COMPOSITION OF THE OLIGOSACCHARYL TRANSFERASE COMPLEXES.
RX   PubMed=16297388; DOI=10.1016/j.febslet.2005.10.063;
RA   Schwarz M., Knauer R., Lehle L.;
RT   "Yeast oligosaccharyltransferase consists of two functionally distinct
RT   sub-complexes, specified by either the Ost3p or Ost6p subunit.";
RL   FEBS Lett. 579:6564-6568(2005).
RN   [11]
RP   COMPOSITION OF THE OLIGOSACCHARYL TRANSFERASE COMPLEXES.
RX   PubMed=16096346; DOI=10.1093/glycob/cwj025;
RA   Spirig U., Bodmer D., Wacker M., Burda P., Aebi M.;
RT   "The 3.4-kDa Ost4 protein is required for the assembly of two distinct
RT   oligosaccharyltransferase complexes in yeast.";
RL   Glycobiology 15:1396-1406(2005).
RN   [12]
RP   COMPOSITION OF THE OLIGOSACCHARYL TRANSFERASE COMPLEXES.
RX   PubMed=16096345; DOI=10.1093/glycob/cwj026;
RA   Yan A., Lennarz W.J.;
RT   "Two oligosaccharyl transferase complexes exist in yeast and associate
RT   with two different translocons.";
RL   Glycobiology 15:1407-1415(2005).
RN   [13]
RP   INTERACTION WITH SEC61; SBH1 AND SSS1.
RX   PubMed=15831493; DOI=10.1074/jbc.M502858200;
RA   Chavan M., Yan A., Lennarz W.J.;
RT   "Subunits of the translocon interact with components of the
RT   oligosaccharyl transferase complex.";
RL   J. Biol. Chem. 280:22917-22924(2005).
RN   [14]
RP   INTERACTION WITH OST2; OST3; OST5; OST6; STT3; WBP1 AND SWP1.
RX   PubMed=15886282; DOI=10.1073/pnas.0502669102;
RA   Yan A., Wu E., Lennarz W.J.;
RT   "Studies of yeast oligosaccharyl transferase subunits using the split-
RT   ubiquitin system: topological features and in vivo interactions.";
RL   Proc. Natl. Acad. Sci. U.S.A. 102:7121-7126(2005).
RN   [15]
RP   STRUCTURE BY NMR, AND TRANSMEMBRANE DOMAIN.
RX   PubMed=15001703; DOI=10.1073/pnas.0400512101;
RA   Zubkov S., Lennarz W.J., Mohanty S.;
RT   "Structural basis for the function of a minimembrane protein subunit
RT   of yeast oligosaccharyltransferase.";
RL   Proc. Natl. Acad. Sci. U.S.A. 101:3821-3826(2004).
CC   -!- FUNCTION: Essential subunit of the N-oligosaccharyl transferase
CC       (OST) complex which catalyzes the transfer of a high mannose
CC       oligosaccharide from a lipid-linked oligosaccharide donor to an
CC       asparagine residue within an Asn-X-Ser/Thr consensus motif in
CC       nascent polypeptide chains. N-glycosylation occurs
CC       cotranslationally and the complex associates with the Sec61
CC       complex at the channel-forming translocon complex that mediates
CC       protein translocation across the endoplasmic reticulum (ER). All
CC       subunits are required for a maximal enzyme activity. OST4 is
CC       required for recruitment of OST3 or OST6 to the OST complex. It is
CC       essential for cell growth at 37 but not at 25 degrees Celsius.
CC   -!- CATALYTIC ACTIVITY: Dolichyl diphosphooligosaccharide + [protein]-
CC       L-asparagine = dolichyl diphosphate + a glycoprotein with the
CC       oligosaccharide chain attached by N-beta-D-glycosyl linkage to a
CC       protein L-asparagine.
CC   -!- PATHWAY: Protein modification; protein glycosylation.
CC   -!- SUBUNIT: Component of the oligosaccharyltransferase (OST) complex,
CC       which appears to exist in two assemblies comprising OST1, OST2,
CC       OST4, OST5, STT3, SWP1, WPB1, and either OST3 or OST6. OST3, OST4
CC       and STT3 probably form a subcomplex. May interact directly with
CC       OST2, OST3, OST5, OST6, STT3, WBP1 and SWP1. Interacts with SEC61,
CC       SBH1 and SSS1. {ECO:0000269|PubMed:10677492,
CC       ECO:0000269|PubMed:15831493, ECO:0000269|PubMed:15886282,
CC       ECO:0000269|PubMed:8175708, ECO:0000269|PubMed:9405463}.
CC   -!- INTERACTION:
CC       P48439:OST3; NbExp=2; IntAct=EBI-12689, EBI-12680;
CC       P52870:SBH1; NbExp=2; IntAct=EBI-12689, EBI-16410;
CC       P32915:SEC61; NbExp=2; IntAct=EBI-12689, EBI-16400;
CC       P35179:SSS1; NbExp=2; IntAct=EBI-12689, EBI-16406;
CC       P39007:STT3; NbExp=6; IntAct=EBI-12689, EBI-18447;
CC       Q02795:SWP1; NbExp=6; IntAct=EBI-12689, EBI-12666;
CC       P33767:WBP1; NbExp=6; IntAct=EBI-12689, EBI-12658;
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane; Single-pass
CC       type III membrane protein.
CC   -!- MISCELLANEOUS: Present with 2430 molecules/cell in log phase SD
CC       medium. {ECO:0000269|PubMed:14562106}.
CC   -!- SIMILARITY: Belongs to the OST4 family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; L42519; AAB06797.1; -; Genomic_DNA.
DR   EMBL; Z74280; CAA98811.1; -; Genomic_DNA.
DR   EMBL; BK006938; DAA11634.1; -; Genomic_DNA.
DR   PIR; S67795; S67795.
DR   RefSeq; NP_010049.1; NM_001180292.1.
DR   PDB; 1RKL; NMR; -; A=1-36.
DR   PDB; 6C26; EM; 3.50 A; 4=1-36.
DR   PDB; 6EZN; EM; 3.30 A; D=1-36.
DR   PDBsum; 1RKL; -.
DR   PDBsum; 6C26; -.
DR   PDBsum; 6EZN; -.
DR   ProteinModelPortal; Q99380; -.
DR   SMR; Q99380; -.
DR   BioGrid; 31879; 685.
DR   DIP; DIP-2457N; -.
DR   IntAct; Q99380; 13.
DR   MINT; Q99380; -.
DR   STRING; 4932.YDL232W; -.
DR   TCDB; 9.B.142.3.14; the integral membrane glycosyltransferase family 39 (gt39) family.
DR   PaxDb; Q99380; -.
DR   PRIDE; Q99380; -.
DR   EnsemblFungi; YDL232W; YDL232W; YDL232W.
DR   GeneID; 851366; -.
DR   KEGG; sce:YDL232W; -.
DR   EuPathDB; FungiDB:YDL232W; -.
DR   SGD; S000002391; OST4.
DR   InParanoid; Q99380; -.
DR   KO; K00730; -.
DR   OrthoDB; EOG092C5KCW; -.
DR   BioCyc; MetaCyc:YDL232W-MONOMER; -.
DR   BioCyc; YEAST:YDL232W-MONOMER; -.
DR   BRENDA; 2.4.99.18; 984.
DR   UniPathway; UPA00378; -.
DR   EvolutionaryTrace; Q99380; -.
DR   PRO; PR:Q99380; -.
DR   Proteomes; UP000002311; Chromosome IV.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IMP:SGD.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0008250; C:oligosaccharyltransferase complex; IDA:UniProtKB.
DR   GO; GO:0004579; F:dolichyl-diphosphooligosaccharide-protein glycotransferase activity; IMP:UniProtKB.
DR   GO; GO:0030674; F:protein binding, bridging; IDA:SGD.
DR   GO; GO:0006487; P:protein N-linked glycosylation; IMP:UniProtKB.
DR   InterPro; IPR018943; Oligosaccaryltransferase.
DR   InterPro; IPR036330; Ost4p_sf.
DR   Pfam; PF10215; Ost4; 1.
DR   SUPFAM; SSF103464; SSF103464; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Complete proteome; Endoplasmic reticulum;
KW   Glycosyltransferase; Membrane; Reference proteome; Signal-anchor;
KW   Transferase; Transmembrane; Transmembrane helix.
FT   CHAIN         1     36       Dolichyl-diphosphooligosaccharide--
FT                                protein glycosyltransferase subunit OST4.
FT                                /FTId=PRO_0000058093.
FT   TOPO_DOM      1      9       Lumenal. {ECO:0000269|PubMed:12810948}.
FT   TRANSMEM     10     28       Helical.
FT   TOPO_DOM     29     36       Cytoplasmic.
FT                                {ECO:0000269|PubMed:12810948}.
FT   MUTAGEN      18     18       M->K: Severe growth defect; abolishes
FT                                interaction with OST3 and STT3.
FT                                {ECO:0000269|PubMed:10677492,
FT                                ECO:0000269|PubMed:12810948}.
FT   MUTAGEN      18     18       M->L: No effect on interaction between
FT                                OST3 and STT3.
FT                                {ECO:0000269|PubMed:10677492,
FT                                ECO:0000269|PubMed:12810948}.
FT   MUTAGEN      19     19       M->K: Severe growth defect; abolishes
FT                                interaction with OST3.
FT                                {ECO:0000269|PubMed:10677492,
FT                                ECO:0000269|PubMed:12810948}.
FT   MUTAGEN      19     19       M->L: Disrupts interaction between OST3
FT                                and STT3. {ECO:0000269|PubMed:10677492,
FT                                ECO:0000269|PubMed:12810948}.
FT   MUTAGEN      20     20       T->D: Severe growth defect.
FT                                {ECO:0000269|PubMed:10677492,
FT                                ECO:0000269|PubMed:12810948}.
FT   MUTAGEN      20     20       T->K: Severe growth defect; abolishes
FT                                interaction with OST3; disrupts
FT                                interaction between OST3 and STT3.
FT                                {ECO:0000269|PubMed:10677492,
FT                                ECO:0000269|PubMed:12810948}.
FT   MUTAGEN      21     21       L->K: Abolishes interaction with OST3 and
FT                                STT3; disrupts interaction between OST3
FT                                and STT3. {ECO:0000269|PubMed:10677492,
FT                                ECO:0000269|PubMed:12810948}.
FT   MUTAGEN      23     23       V->D: Severe growth defect.
FT                                {ECO:0000269|PubMed:10677492,
FT                                ECO:0000269|PubMed:12810948}.
FT   MUTAGEN      23     23       V->K: Severe growth defect; abolishes
FT                                interaction with OST3; disrupts
FT                                interaction between OST3 and STT3.
FT                                {ECO:0000269|PubMed:10677492,
FT                                ECO:0000269|PubMed:12810948}.
FT   MUTAGEN      24     24       I->D: Severe growth defect.
FT                                {ECO:0000269|PubMed:10677492,
FT                                ECO:0000269|PubMed:12810948}.
FT   MUTAGEN      24     24       I->K: Disrupts interaction between OST3
FT                                and STT3. {ECO:0000269|PubMed:10677492,
FT                                ECO:0000269|PubMed:12810948}.
FT   MUTAGEN      25     25       Y->D: Severe growth defect.
FT                                {ECO:0000269|PubMed:10677492}.
FT   HELIX         4     31       {ECO:0000244|PDB:6EZN}.
SQ   SEQUENCE   36 AA;  3985 MW;  BA14A9C3B197F12A CRC64;
     MISDEQLNSL AITFGIVMMT LIVIYHAVDS TMSPKN
//
ID   OPY2_YEAST              Reviewed;         360 AA.
AC   Q06810; D6W479; Q6B149;
DT   12-DEC-2006, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   23-MAY-2018, entry version 118.
DE   RecName: Full=Protein OPY2;
DE   AltName: Full=Overproduction-induced pheromone-resistant protein 2;
GN   Name=OPY2; OrderedLocusNames=YPR075C;
OS   Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast).
OC   Eukaryota; Fungi; Dikarya; Ascomycota; Saccharomycotina;
OC   Saccharomycetes; Saccharomycetales; Saccharomycetaceae; Saccharomyces.
OX   NCBI_TaxID=559292;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=9383053;
RA   Edwards M.C., Liegeois N., Horecka J., DePinho R.A., Sprague G.F. Jr.,
RA   Tyers M., Elledge S.J.;
RT   "Human CPR (cell cycle progression restoration) genes impart a Far-
RT   phenotype on yeast cells.";
RL   Genetics 147:1063-1076(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 204508 / S288c;
RX   PubMed=9169875;
RA   Bussey H., Storms R.K., Ahmed A., Albermann K., Allen E., Ansorge W.,
RA   Araujo R., Aparicio A., Barrell B.G., Badcock K., Benes V.,
RA   Botstein D., Bowman S., Brueckner M., Carpenter J., Cherry J.M.,
RA   Chung E., Churcher C.M., Coster F., Davis K., Davis R.W.,
RA   Dietrich F.S., Delius H., DiPaolo T., Dubois E., Duesterhoeft A.,
RA   Duncan M., Floeth M., Fortin N., Friesen J.D., Fritz C., Goffeau A.,
RA   Hall J., Hebling U., Heumann K., Hilbert H., Hillier L.W.,
RA   Hunicke-Smith S., Hyman R.W., Johnston M., Kalman S., Kleine K.,
RA   Komp C., Kurdi O., Lashkari D., Lew H., Lin A., Lin D., Louis E.J.,
RA   Marathe R., Messenguy F., Mewes H.-W., Mirtipati S., Moestl D.,
RA   Mueller-Auer S., Namath A., Nentwich U., Oefner P., Pearson D.,
RA   Petel F.X., Pohl T.M., Purnelle B., Rajandream M.A., Rechmann S.,
RA   Rieger M., Riles L., Roberts D., Schaefer M., Scharfe M., Scherens B.,
RA   Schramm S., Schroeder M., Sdicu A.-M., Tettelin H., Urrestarazu L.A.,
RA   Ushinsky S., Vierendeels F., Vissers S., Voss H., Walsh S.V.,
RA   Wambutt R., Wang Y., Wedler E., Wedler H., Winnett E., Zhong W.-W.,
RA   Zollner A., Vo D.H., Hani J.;
RT   "The nucleotide sequence of Saccharomyces cerevisiae chromosome XVI.";
RL   Nature 387:103-105(1997).
RN   [3]
RP   GENOME REANNOTATION.
RC   STRAIN=ATCC 204508 / S288c;
RX   PubMed=24374639; DOI=10.1534/g3.113.008995;
RA   Engel S.R., Dietrich F.S., Fisk D.G., Binkley G., Balakrishnan R.,
RA   Costanzo M.C., Dwight S.S., Hitz B.C., Karra K., Nash R.S., Weng S.,
RA   Wong E.D., Lloyd P., Skrzypek M.S., Miyasato S.R., Simison M.,
RA   Cherry J.M.;
RT   "The reference genome sequence of Saccharomyces cerevisiae: Then and
RT   now.";
RL   G3 (Bethesda) 4:389-398(2014).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=ATCC 204508 / S288c;
RX   PubMed=17322287; DOI=10.1101/gr.6037607;
RA   Hu Y., Rolfs A., Bhullar B., Murthy T.V.S., Zhu C., Berger M.F.,
RA   Camargo A.A., Kelley F., McCarron S., Jepson D., Richardson A.,
RA   Raphael J., Moreira D., Taycher E., Zuo D., Mohr S., Kane M.F.,
RA   Williamson J., Simpson A.J.G., Bulyk M.L., Harlow E., Marsischky G.,
RA   Kolodner R.D., LaBaer J.;
RT   "Approaching a complete repository of sequence-verified protein-
RT   encoding clones for Saccharomyces cerevisiae.";
RL   Genome Res. 17:536-543(2007).
RN   [5]
RP   SUBCELLULAR LOCATION [LARGE SCALE ANALYSIS].
RX   PubMed=14562095; DOI=10.1038/nature02026;
RA   Huh W.-K., Falvo J.V., Gerke L.C., Carroll A.S., Howson R.W.,
RA   Weissman J.S., O'Shea E.K.;
RT   "Global analysis of protein localization in budding yeast.";
RL   Nature 425:686-691(2003).
RN   [6]
RP   LEVEL OF PROTEIN EXPRESSION [LARGE SCALE ANALYSIS].
RX   PubMed=14562106; DOI=10.1038/nature02046;
RA   Ghaemmaghami S., Huh W.-K., Bower K., Howson R.W., Belle A.,
RA   Dephoure N., O'Shea E.K., Weissman J.S.;
RT   "Global analysis of protein expression in yeast.";
RL   Nature 425:737-741(2003).
RN   [7]
RP   FUNCTION, SUBCELLULAR LOCATION, AND INTERACTION WITH STE50.
RX   PubMed=16543225; DOI=10.1101/gad.1375706;
RA   Wu C., Jansen G., Zhang J., Thomas D.Y., Whiteway M.;
RT   "Adaptor protein Ste50p links the Ste11p MEKK to the HOG pathway
RT   through plasma membrane association.";
RL   Genes Dev. 20:734-746(2006).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-348, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   STRAIN=ADR376;
RX   PubMed=17330950; DOI=10.1021/pr060559j;
RA   Li X., Gerber S.A., Rudner A.D., Beausoleil S.A., Haas W., Villen J.,
RA   Elias J.E., Gygi S.P.;
RT   "Large-scale phosphorylation analysis of alpha-factor-arrested
RT   Saccharomyces cerevisiae.";
RL   J. Proteome Res. 6:1190-1197(2007).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-285, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=18407956; DOI=10.1074/mcp.M700468-MCP200;
RA   Albuquerque C.P., Smolka M.B., Payne S.H., Bafna V., Eng J., Zhou H.;
RT   "A multidimensional chromatography technology for in-depth
RT   phosphoproteome analysis.";
RL   Mol. Cell. Proteomics 7:1389-1396(2008).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-285, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19779198; DOI=10.1126/science.1172867;
RA   Holt L.J., Tuch B.B., Villen J., Johnson A.D., Gygi S.P., Morgan D.O.;
RT   "Global analysis of Cdk1 substrate phosphorylation sites provides
RT   insights into evolution.";
RL   Science 325:1682-1686(2009).
CC   -!- FUNCTION: Component of the high-osmolarity glycerol (HOG) pathway
CC       involved in mating response and osmotolerance. May act as a
CC       membrane anchor for the STE50/STE11 complex.
CC       {ECO:0000269|PubMed:16543225}.
CC   -!- INTERACTION:
CC       P32334:MSB2; NbExp=3; IntAct=EBI-2068557, EBI-11328;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:16543225};
CC       Single-pass membrane protein {ECO:0000269|PubMed:16543225}.
CC       Vacuole membrane {ECO:0000269|PubMed:16543225}; Single-pass
CC       membrane protein {ECO:0000269|PubMed:16543225}.
CC   -!- MISCELLANEOUS: Present with 1160 molecules/cell in log phase SD
CC       medium. {ECO:0000269|PubMed:14562106}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF016263; AAB81506.1; -; mRNA.
DR   EMBL; U51033; AAB68126.1; -; Genomic_DNA.
DR   EMBL; AY693231; AAT93250.1; -; Genomic_DNA.
DR   EMBL; BK006949; DAA11495.1; -; Genomic_DNA.
DR   PIR; S69063; S69063.
DR   RefSeq; NP_015400.1; NM_001184172.1.
DR   ProteinModelPortal; Q06810; -.
DR   BioGrid; 36248; 149.
DR   IntAct; Q06810; 4.
DR   MINT; Q06810; -.
DR   STRING; 4932.YPR075C; -.
DR   iPTMnet; Q06810; -.
DR   MaxQB; Q06810; -.
DR   PaxDb; Q06810; -.
DR   PRIDE; Q06810; -.
DR   EnsemblFungi; YPR075C; YPR075C; YPR075C.
DR   GeneID; 856191; -.
DR   KEGG; sce:YPR075C; -.
DR   EuPathDB; FungiDB:YPR075C; -.
DR   SGD; S000006279; OPY2.
DR   HOGENOM; HOG000115274; -.
DR   InParanoid; Q06810; -.
DR   KO; K19850; -.
DR   OMA; YESFTRP; -.
DR   OrthoDB; EOG092C5U67; -.
DR   BioCyc; YEAST:G3O-34221-MONOMER; -.
DR   PRO; PR:Q06810; -.
DR   Proteomes; UP000002311; Chromosome XVI.
DR   GO; GO:0005887; C:integral component of plasma membrane; IDA:SGD.
DR   GO; GO:0005774; C:vacuolar membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0000751; P:mitotic cell cycle G1 arrest in response to pheromone; IGI:SGD.
DR   GO; GO:0007231; P:osmosensory signaling pathway; IGI:SGD.
DR   GO; GO:1900436; P:positive regulation of filamentous growth of a population of unicellular organisms in response to starvation; IMP:SGD.
DR   GO; GO:0072659; P:protein localization to plasma membrane; IGI:SGD.
DR   InterPro; IPR018571; Membrane_anchor_Opy2_N.
DR   Pfam; PF09463; Opy2; 1.
PE   1: Evidence at protein level;
KW   Cell membrane; Complete proteome; Glycoprotein; Membrane;
KW   Phosphoprotein; Reference proteome; Transmembrane;
KW   Transmembrane helix; Vacuole.
FT   CHAIN         1    360       Protein OPY2.
FT                                /FTId=PRO_0000268694.
FT   TRANSMEM     92    112       Helical. {ECO:0000255}.
FT   REGION      266    345       STE50-binding.
FT   COMPBIAS      2     86       Ser-rich.
FT   COMPBIAS    147    159       Asp-rich.
FT   MOD_RES     285    285       Phosphoserine.
FT                                {ECO:0000244|PubMed:18407956,
FT                                ECO:0000244|PubMed:19779198}.
FT   MOD_RES     348    348       Phosphoserine.
FT                                {ECO:0000244|PubMed:17330950}.
FT   CARBOHYD    172    172       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    185    185       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CONFLICT    234    234       I -> T (in Ref. 4; AAT93250).
FT                                {ECO:0000305}.
SQ   SEQUENCE   360 AA;  38901 MW;  6D444AFA25042FFB CRC64;
     MSSSSKASAS SSLSSTATSS TSATRGSDGC VVCDSTASCP VCASGEYCVM TSLTCDKCPS
     TYCAKQSDSQ LSSLSSSSSS SSSSNSNEKT SLIVGFTVGI VGGAMLIALV ALYFINKRYW
     KPKRQKNKAL KLEEASQSYG NEEEYFDDED DDDEDDEDDG GMRKDESHTL FNTSLVPPTL
     NVPGNRSSAS TTRTRASNIL PIAYIPGVTS GLSTDKLQSK LRSSSKRQNA AGDIRSHITL
     GSSILDGLDD EDDEHNQVLN KDADDNLITA IRAKPKLVQI AEEESDKEIQ DLDVIEEQTE
     ADDLSHMAKS EASHGNNDED DDEEGSFILD LEIPESIRES TQGSRTESPF EDKFEIHDER
//
ID   COA3_YEAST              Reviewed;          85 AA.
AC   Q3E7B2; D6VWB9;
DT   11-JUL-2006, integrated into UniProtKB/Swiss-Prot.
DT   08-NOV-2005, sequence version 1.
DT   23-MAY-2018, entry version 93.
DE   RecName: Full=Cytochrome c oxidase assembly factor 3, mitochondrial;
DE   AltName: Full=Cytochrome c oxidase protein 25;
DE   AltName: Full=Required for respiratory growth protein 10;
GN   Name=COA3; Synonyms=COX25, RRG10; OrderedLocusNames=YJL062W-A;
OS   Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast).
OC   Eukaryota; Fungi; Dikarya; Ascomycota; Saccharomycotina;
OC   Saccharomycetes; Saccharomycetales; Saccharomycetaceae; Saccharomyces.
OX   NCBI_TaxID=559292;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 204508 / S288c;
RX   PubMed=8641269;
RA   Galibert F., Alexandraki D., Baur A., Boles E., Chalwatzis N.,
RA   Chuat J.-C., Coster F., Cziepluch C., de Haan M., Domdey H.,
RA   Durand P., Entian K.-D., Gatius M., Goffeau A., Grivell L.A.,
RA   Hennemann A., Herbert C.J., Heumann K., Hilger F., Hollenberg C.P.,
RA   Huang M.-E., Jacq C., Jauniaux J.-C., Katsoulou C., Kirchrath L.,
RA   Kleine K., Kordes E., Koetter P., Liebl S., Louis E.J., Manus V.,
RA   Mewes H.-W., Miosga T., Obermaier B., Perea J., Pohl T.M.,
RA   Portetelle D., Pujol A., Purnelle B., Ramezani Rad M., Rasmussen S.W.,
RA   Rose M., Rossau R., Schaaff-Gerstenschlaeger I., Smits P.H.M.,
RA   Scarcez T., Soriano N., To Van D., Tzermia M., Van Broekhoven A.,
RA   Vandenbol M., Wedler H., von Wettstein D., Wambutt R., Zagulski M.,
RA   Zollner A., Karpfinger-Hartl L.;
RT   "Complete nucleotide sequence of Saccharomyces cerevisiae chromosome
RT   X.";
RL   EMBO J. 15:2031-2049(1996).
RN   [2]
RP   GENOME REANNOTATION.
RC   STRAIN=ATCC 204508 / S288c;
RX   PubMed=24374639; DOI=10.1534/g3.113.008995;
RA   Engel S.R., Dietrich F.S., Fisk D.G., Binkley G., Balakrishnan R.,
RA   Costanzo M.C., Dwight S.S., Hitz B.C., Karra K., Nash R.S., Weng S.,
RA   Wong E.D., Lloyd P., Skrzypek M.S., Miyasato S.R., Simison M.,
RA   Cherry J.M.;
RT   "The reference genome sequence of Saccharomyces cerevisiae: Then and
RT   now.";
RL   G3 (Bethesda) 4:389-398(2014).
RN   [3]
RP   GENOME REANNOTATION.
RX   PubMed=11152879; DOI=10.1016/S0014-5793(00)02275-4;
RA   Blandin G., Durrens P., Tekaia F., Aigle M., Bolotin-Fukuhara M.,
RA   Bon E., Casaregola S., de Montigny J., Gaillardin C., Lepingle A.,
RA   Llorente B., Malpertuy A., Neuveglise C., Ozier-Kalogeropoulos O.,
RA   Perrin A., Potier S., Souciet J.-L., Talla E., Toffano-Nioche C.,
RA   Wesolowski-Louvel M., Marck C., Dujon B.;
RT   "Genomic exploration of the hemiascomycetous yeasts: 4. The genome of
RT   Saccharomyces cerevisiae revisited.";
RL   FEBS Lett. 487:31-36(2000).
RN   [4]
RP   SUBCELLULAR LOCATION [LARGE SCALE ANALYSIS].
RX   PubMed=14562095; DOI=10.1038/nature02026;
RA   Huh W.-K., Falvo J.V., Gerke L.C., Carroll A.S., Howson R.W.,
RA   Weissman J.S., O'Shea E.K.;
RT   "Global analysis of protein localization in budding yeast.";
RL   Nature 425:686-691(2003).
RN   [5]
RP   LEVEL OF PROTEIN EXPRESSION [LARGE SCALE ANALYSIS].
RX   PubMed=14562106; DOI=10.1038/nature02046;
RA   Ghaemmaghami S., Huh W.-K., Bower K., Howson R.W., Belle A.,
RA   Dephoure N., O'Shea E.K., Weissman J.S.;
RT   "Global analysis of protein expression in yeast.";
RL   Nature 425:737-741(2003).
RN   [6]
RP   FUNCTION.
RX   PubMed=16510898; DOI=10.1101/gr.4355406;
RA   Kastenmayer J.P., Ni L., Chu A., Kitchen L.E., Au W.-C., Yang H.,
RA   Carter C.D., Wheeler D., Davis R.W., Boeke J.D., Snyder M.A.,
RA   Basrai M.A.;
RT   "Functional genomics of genes with small open reading frames (sORFs)
RT   in S. cerevisiae.";
RL   Genome Res. 16:365-373(2006).
RN   [7]
RP   SUBCELLULAR LOCATION [LARGE SCALE ANALYSIS].
RX   PubMed=16823961; DOI=10.1021/pr050477f;
RA   Reinders J., Zahedi R.P., Pfanner N., Meisinger C., Sickmann A.;
RT   "Toward the complete yeast mitochondrial proteome: multidimensional
RT   separation techniques for mitochondrial proteomics.";
RL   J. Proteome Res. 5:1543-1554(2006).
RN   [8]
RP   FUNCTION.
RX   PubMed=19751518; DOI=10.1186/gb-2009-10-9-r95;
RA   Merz S., Westermann B.;
RT   "Genome-wide deletion mutant analysis reveals genes required for
RT   respiratory growth, mitochondrial genome maintenance and mitochondrial
RT   protein synthesis in Saccharomyces cerevisiae.";
RL   Genome Biol. 10:R95.1-R95.18(2009).
RN   [9]
RP   IDENTIFICATION IN COA COMPLEXES, IDENTIFICATION BY MASS SPECTROMETRY,
RP   INTERACTION WITH SHY1; COX1 AND MSS51, SUBCELLULAR LOCATION, TOPOLOGY,
RP   AND FUNCTION.
RX   PubMed=20876281; DOI=10.1083/jcb.201007026;
RA   Mick D.U., Vukotic M., Piechura H., Meyer H.E., Warscheid B.,
RA   Deckers M., Rehling P.;
RT   "Coa3 and Cox14 are essential for negative feedback regulation of COX1
RT   translation in mitochondria.";
RL   J. Cell Biol. 191:141-154(2010).
RN   [10]
RP   IDENTIFICATION IN COA COMPLEXES, IDENTIFICATION BY MASS SPECTROMETRY,
RP   INTERACTION WITH COX1, SUBCELLULAR LOCATION, TOPOLOGY, AND FUNCTION.
RX   PubMed=21068384; DOI=10.1074/jbc.M110.188805;
RA   Fontanesi F., Clemente P., Barrientos A.;
RT   "Cox25 teams up with Mss51, Ssc1, and Cox14 to regulate mitochondrial
RT   cytochrome c oxidase subunit 1 expression and assembly in
RT   Saccharomyces cerevisiae.";
RL   J. Biol. Chem. 286:555-566(2011).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
CC   -!- FUNCTION: Required for assembly of cytochrome c oxidase (complex
CC       IV). With COX14, regulates negatively COX1 translation and is
CC       involved in MSS51 association with newly synthesized COX1.
CC       {ECO:0000269|PubMed:16510898, ECO:0000269|PubMed:19751518,
CC       ECO:0000269|PubMed:20876281, ECO:0000269|PubMed:21068384}.
CC   -!- SUBUNIT: Component of 250-400 kDa complexes called cytochrome
CC       oxidase assembly intermediates or COA complexes composed at least
CC       COA3, COX14, COX5A, SHY1 and SSC1. Interacts with COX1 and MSS51.
CC       {ECO:0000269|PubMed:20876281, ECO:0000269|PubMed:21068384}.
CC   -!- INTERACTION:
CC       P32335:MSS51; NbExp=4; IntAct=EBI-3680840, EBI-11318;
CC   -!- SUBCELLULAR LOCATION: Mitochondrion inner membrane
CC       {ECO:0000269|PubMed:14562095, ECO:0000269|PubMed:16823961,
CC       ECO:0000269|PubMed:20876281, ECO:0000269|PubMed:21068384}; Single-
CC       pass membrane protein {ECO:0000269|PubMed:14562095,
CC       ECO:0000269|PubMed:16823961, ECO:0000269|PubMed:20876281,
CC       ECO:0000269|PubMed:21068384}.
CC   -!- MISCELLANEOUS: Present with 2530 molecules/cell in log phase SD
CC       medium. {ECO:0000269|PubMed:14562106}.
CC   -!- SIMILARITY: Belongs to the COA3 family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; Z49338; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BK006943; DAA08735.1; -; Genomic_DNA.
DR   RefSeq; NP_076894.3; NM_001184477.3.
DR   ProteinModelPortal; Q3E7B2; -.
DR   BioGrid; 33691; 201.
DR   IntAct; Q3E7B2; 5.
DR   MINT; Q3E7B2; -.
DR   STRING; 4932.YJL062W-A; -.
DR   MaxQB; Q3E7B2; -.
DR   PaxDb; Q3E7B2; -.
DR   PRIDE; Q3E7B2; -.
DR   EnsemblFungi; YJL062W-A; YJL062W-A; YJL062W-A.
DR   GeneID; 853383; -.
DR   KEGG; sce:YJL062W-A; -.
DR   EuPathDB; FungiDB:YJL062W-A; -.
DR   SGD; S000007611; COA3.
DR   InParanoid; Q3E7B2; -.
DR   KO; K18176; -.
DR   OMA; MTPAMIR; -.
DR   OrthoDB; EOG092C5QUH; -.
DR   BioCyc; YEAST:G3O-31802-MONOMER; -.
DR   PRO; PR:Q3E7B2; -.
DR   Proteomes; UP000002311; Chromosome X.
DR   GO; GO:0031305; C:integral component of mitochondrial inner membrane; IDA:SGD.
DR   GO; GO:0005743; C:mitochondrial inner membrane; IDA:SGD.
DR   GO; GO:0033617; P:mitochondrial respiratory chain complex IV assembly; IMP:SGD.
DR   GO; GO:0070130; P:negative regulation of mitochondrial translation; IMP:SGD.
PE   1: Evidence at protein level;
KW   Complete proteome; Membrane; Mitochondrion;
KW   Mitochondrion inner membrane; Reference proteome; Transmembrane;
KW   Transmembrane helix.
FT   CHAIN         1     85       Cytochrome c oxidase assembly factor 3,
FT                                mitochondrial.
FT                                /FTId=PRO_0000245412.
FT   TOPO_DOM      1     26       Mitochondrial matrix.
FT   TRANSMEM     27     49       Helical. {ECO:0000255}.
FT   TOPO_DOM     50     85       Mitochondrial intermembrane.
SQ   SEQUENCE   85 AA;  9882 MW;  41403CD21F898C18 CRC64;
     MVLNPSKYQD TRTWKMTPAM IRARKPFFKG NMLGLTLLLG VTGSVYYYTY HFLHKDNDFA
     DVPIPPIDPQ ELEALKKEYE AKKKA
//
ID   SRPB_YEAST              Reviewed;         244 AA.
AC   P36057; D6VX44;
DT   01-JUN-1994, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-1994, sequence version 1.
DT   23-MAY-2018, entry version 163.
DE   RecName: Full=Signal recognition particle receptor subunit beta;
DE            Short=SR-beta;
GN   Name=SRP102; OrderedLocusNames=YKL154W; ORFNames=YKL609;
OS   Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast).
OC   Eukaryota; Fungi; Dikarya; Ascomycota; Saccharomycotina;
OC   Saccharomycetes; Saccharomycetales; Saccharomycetaceae; Saccharomyces.
OX   NCBI_TaxID=559292;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=ATCC 204508 / S288c;
RX   PubMed=8091859; DOI=10.1002/yea.320100005;
RA   Vandenbol M., Bolle P.-A., Dion C., Portetelle D., Hilger F.;
RT   "DNA sequencing of a 36.2 kb fragment located between the FAS1 and LAP
RT   loci of chromosome XI of Saccharomyces cerevisiae.";
RL   Yeast 10:S35-S40(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 204508 / S288c;
RX   PubMed=8196765; DOI=10.1038/369371a0;
RA   Dujon B., Alexandraki D., Andre B., Ansorge W., Baladron V.,
RA   Ballesta J.P.G., Banrevi A., Bolle P.-A., Bolotin-Fukuhara M.,
RA   Bossier P., Bou G., Boyer J., Buitrago M.J., Cheret G., Colleaux L.,
RA   Daignan-Fornier B., del Rey F., Dion C., Domdey H., Duesterhoeft A.,
RA   Duesterhus S., Entian K.-D., Erfle H., Esteban P.F., Feldmann H.,
RA   Fernandes L., Fobo G.M., Fritz C., Fukuhara H., Gabel C., Gaillon L.,
RA   Garcia-Cantalejo J.M., Garcia-Ramirez J.J., Gent M.E., Ghazvini M.,
RA   Goffeau A., Gonzalez A., Grothues D., Guerreiro P., Hegemann J.H.,
RA   Hewitt N., Hilger F., Hollenberg C.P., Horaitis O., Indge K.J.,
RA   Jacquier A., James C.M., Jauniaux J.-C., Jimenez A., Keuchel H.,
RA   Kirchrath L., Kleine K., Koetter P., Legrain P., Liebl S., Louis E.J.,
RA   Maia e Silva A., Marck C., Monnier A.-L., Moestl D., Mueller S.,
RA   Obermaier B., Oliver S.G., Pallier C., Pascolo S., Pfeiffer F.,
RA   Philippsen P., Planta R.J., Pohl F.M., Pohl T.M., Poehlmann R.,
RA   Portetelle D., Purnelle B., Puzos V., Ramezani Rad M., Rasmussen S.W.,
RA   Remacha M.A., Revuelta J.L., Richard G.-F., Rieger M.,
RA   Rodrigues-Pousada C., Rose M., Rupp T., Santos M.A., Schwager C.,
RA   Sensen C., Skala J., Soares H., Sor F., Stegemann J., Tettelin H.,
RA   Thierry A., Tzermia M., Urrestarazu L.A., van Dyck L.,
RA   van Vliet-Reedijk J.C., Valens M., Vandenbol M., Vilela C.,
RA   Vissers S., von Wettstein D., Voss H., Wiemann S., Xu G.,
RA   Zimmermann J., Haasemann M., Becker I., Mewes H.-W.;
RT   "Complete DNA sequence of yeast chromosome XI.";
RL   Nature 369:371-378(1994).
RN   [3]
RP   GENOME REANNOTATION.
RC   STRAIN=ATCC 204508 / S288c;
RX   PubMed=24374639; DOI=10.1534/g3.113.008995;
RA   Engel S.R., Dietrich F.S., Fisk D.G., Binkley G., Balakrishnan R.,
RA   Costanzo M.C., Dwight S.S., Hitz B.C., Karra K., Nash R.S., Weng S.,
RA   Wong E.D., Lloyd P., Skrzypek M.S., Miyasato S.R., Simison M.,
RA   Cherry J.M.;
RT   "The reference genome sequence of Saccharomyces cerevisiae: Then and
RT   now.";
RL   G3 (Bethesda) 4:389-398(2014).
RN   [4]
RP   LEVEL OF PROTEIN EXPRESSION [LARGE SCALE ANALYSIS].
RX   PubMed=14562106; DOI=10.1038/nature02046;
RA   Ghaemmaghami S., Huh W.-K., Bower K., Howson R.W., Belle A.,
RA   Dephoure N., O'Shea E.K., Weissman J.S.;
RT   "Global analysis of protein expression in yeast.";
RL   Nature 425:737-741(2003).
RN   [5]
RP   X-RAY CRYSTALLOGRAPHY (1.7 ANGSTROMS) OF 27-244 IN COMPLEX WITH GTP
RP   AND SRP101, AND SUBUNIT.
RX   PubMed=12654246; DOI=10.1016/S0092-8674(03)00161-2;
RA   Schwartz T., Blobel G.;
RT   "Structural basis for the function of the beta subunit of the
RT   eukaryotic signal recognition particle receptor.";
RL   Cell 112:793-803(2003).
CC   -!- FUNCTION: Component of the SRP (signal recognition particle)
CC       receptor. Ensures, in conjunction with the signal recognition
CC       particle, the correct targeting of the nascent secretory proteins
CC       to the endoplasmic reticulum membrane system. Has GTPase activity.
CC       May mediate the membrane association of SRPR.
CC   -!- SUBUNIT: Heterodimer of an alpha and a beta chain.
CC       {ECO:0000269|PubMed:12654246}.
CC   -!- INTERACTION:
CC       Self; NbExp=2; IntAct=EBI-18091, EBI-18091;
CC       P32916:SRP101; NbExp=5; IntAct=EBI-18091, EBI-18098;
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane
CC       {ECO:0000305}.
CC   -!- MISCELLANEOUS: Present with 8250 molecules/cell in log phase SD
CC       medium. {ECO:0000269|PubMed:14562106}.
CC   -!- SIMILARITY: Belongs to the SRP receptor beta subunit family.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=CAA81499.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; Z26877; CAA81499.1; ALT_INIT; Genomic_DNA.
DR   EMBL; Z28154; CAA81995.1; -; Genomic_DNA.
DR   EMBL; BK006944; DAA09010.1; -; Genomic_DNA.
DR   PIR; S37984; S37984.
DR   RefSeq; NP_012768.1; NM_001179720.1.
DR   PDB; 1NRJ; X-ray; 1.70 A; B=31-244.
DR   PDB; 2GED; X-ray; 2.20 A; A/B=36-183.
DR   PDBsum; 1NRJ; -.
DR   PDBsum; 2GED; -.
DR   ProteinModelPortal; P36057; -.
DR   SMR; P36057; -.
DR   BioGrid; 33983; 424.
DR   DIP; DIP-4753N; -.
DR   IntAct; P36057; 15.
DR   MINT; P36057; -.
DR   STRING; 4932.YKL154W; -.
DR   TCDB; 3.A.5.8.1; the general secretory pathway (sec) family.
DR   MaxQB; P36057; -.
DR   PaxDb; P36057; -.
DR   PRIDE; P36057; -.
DR   EnsemblFungi; YKL154W; YKL154W; YKL154W.
DR   GeneID; 853702; -.
DR   KEGG; sce:YKL154W; -.
DR   EuPathDB; FungiDB:YKL154W; -.
DR   SGD; S000001637; SRP102.
DR   GeneTree; ENSGT00510000048347; -.
DR   HOGENOM; HOG000248720; -.
DR   InParanoid; P36057; -.
DR   KO; K12272; -.
DR   OMA; NKQDQTT; -.
DR   OrthoDB; EOG092C5BU6; -.
DR   BioCyc; YEAST:G3O-31924-MONOMER; -.
DR   EvolutionaryTrace; P36057; -.
DR   PRO; PR:P36057; -.
DR   Proteomes; UP000002311; Chromosome XI.
DR   GO; GO:0030176; C:integral component of endoplasmic reticulum membrane; IDA:SGD.
DR   GO; GO:0005785; C:signal recognition particle receptor complex; IPI:SGD.
DR   GO; GO:0005525; F:GTP binding; IPI:SGD.
DR   GO; GO:0003924; F:GTPase activity; ISS:SGD.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0005047; F:signal recognition particle binding; IMP:SGD.
DR   GO; GO:0045047; P:protein targeting to ER; IMP:SGD.
DR   GO; GO:0006614; P:SRP-dependent cotranslational protein targeting to membrane; IC:SGD.
DR   CDD; cd04105; SR_beta; 1.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   InterPro; IPR019009; SRP_receptor_beta_su.
DR   PANTHER; PTHR11485:SF34; PTHR11485:SF34; 1.
DR   Pfam; PF09439; SRPRB; 1.
DR   SUPFAM; SSF52540; SSF52540; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Complete proteome; Endoplasmic reticulum; GTP-binding;
KW   Membrane; Nucleotide-binding; Receptor; Reference proteome;
KW   Transmembrane; Transmembrane helix.
FT   CHAIN         1    244       Signal recognition particle receptor
FT                                subunit beta.
FT                                /FTId=PRO_0000101230.
FT   TRANSMEM      7     23       Helical. {ECO:0000255}.
FT   NP_BIND      45     53       GTP. {ECO:0000269|PubMed:12654246}.
FT   NP_BIND      66     69       GTP. {ECO:0000269|PubMed:12654246}.
FT   NP_BIND     154    157       GTP. {ECO:0000269|PubMed:12654246}.
FT   BINDING      90     90       GTP; via amide nitrogen.
FT                                {ECO:0000269|PubMed:12654246}.
FT   STRAND       40     44       {ECO:0000244|PDB:1NRJ}.
FT   HELIX        51     60       {ECO:0000244|PDB:1NRJ}.
FT   STRAND       73     75       {ECO:0000244|PDB:1NRJ}.
FT   HELIX        78     80       {ECO:0000244|PDB:1NRJ}.
FT   STRAND       84     87       {ECO:0000244|PDB:1NRJ}.
FT   HELIX        92     95       {ECO:0000244|PDB:1NRJ}.
FT   HELIX        96    105       {ECO:0000244|PDB:1NRJ}.
FT   HELIX       106    108       {ECO:0000244|PDB:1NRJ}.
FT   STRAND      109    117       {ECO:0000244|PDB:1NRJ}.
FT   HELIX       126    142       {ECO:0000244|PDB:1NRJ}.
FT   STRAND      149    154       {ECO:0000244|PDB:1NRJ}.
FT   HELIX       164    187       {ECO:0000244|PDB:1NRJ}.
FT   HELIX       214    216       {ECO:0000244|PDB:1NRJ}.
FT   STRAND      217    219       {ECO:0000244|PDB:1NRJ}.
FT   STRAND      221    225       {ECO:0000244|PDB:1NRJ}.
FT   TURN        228    231       {ECO:0000244|PDB:1NRJ}.
FT   HELIX       234    243       {ECO:0000244|PDB:1NRJ}.
SQ   SEQUENCE   244 AA;  26974 MW;  EA4AE9126B2A04B5 CRC64;
     MLSNTLIIAC LLVIGTTIAL IAVQKASSKT GIKQKSYQPS IIIAGPQNSG KTSLLTLLTT
     DSVRPTVVSQ EPLSAADYDG SGVTLVDFPG HVKLRYKLSD YLKTRAKFVK GLIFMVDSTV
     DPKKLTTTAE FLVDILSITE SSCENGIDIL IACNKSELFT ARPPSKIKDA LESEIQKVIE
     RRKKSLNEVE RKINEEDYAE NTLDVLQSTD GFKFANLEAS VVAFEGSINK RKISQWREWI
     DEKL
//
ID   YL297_YEAST             Reviewed;         129 AA.
AC   Q05899; D6VYU1;
DT   25-JUL-2006, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   23-MAY-2018, entry version 102.
DE   RecName: Full=Uncharacterized vacuolar protein YLR297W;
GN   OrderedLocusNames=YLR297W;
OS   Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast).
OC   Eukaryota; Fungi; Dikarya; Ascomycota; Saccharomycotina;
OC   Saccharomycetes; Saccharomycetales; Saccharomycetaceae; Saccharomyces.
OX   NCBI_TaxID=559292;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 204508 / S288c;
RX   PubMed=9169871;
RA   Johnston M., Hillier L.W., Riles L., Albermann K., Andre B.,
RA   Ansorge W., Benes V., Brueckner M., Delius H., Dubois E.,
RA   Duesterhoeft A., Entian K.-D., Floeth M., Goffeau A., Hebling U.,
RA   Heumann K., Heuss-Neitzel D., Hilbert H., Hilger F., Kleine K.,
RA   Koetter P., Louis E.J., Messenguy F., Mewes H.-W., Miosga T.,
RA   Moestl D., Mueller-Auer S., Nentwich U., Obermaier B., Piravandi E.,
RA   Pohl T.M., Portetelle D., Purnelle B., Rechmann S., Rieger M.,
RA   Rinke M., Rose M., Scharfe M., Scherens B., Scholler P., Schwager C.,
RA   Schwarz S., Underwood A.P., Urrestarazu L.A., Vandenbol M.,
RA   Verhasselt P., Vierendeels F., Voet M., Volckaert G., Voss H.,
RA   Wambutt R., Wedler E., Wedler H., Zimmermann F.K., Zollner A.,
RA   Hani J., Hoheisel J.D.;
RT   "The nucleotide sequence of Saccharomyces cerevisiae chromosome XII.";
RL   Nature 387:87-90(1997).
RN   [2]
RP   GENOME REANNOTATION.
RC   STRAIN=ATCC 204508 / S288c;
RX   PubMed=24374639; DOI=10.1534/g3.113.008995;
RA   Engel S.R., Dietrich F.S., Fisk D.G., Binkley G., Balakrishnan R.,
RA   Costanzo M.C., Dwight S.S., Hitz B.C., Karra K., Nash R.S., Weng S.,
RA   Wong E.D., Lloyd P., Skrzypek M.S., Miyasato S.R., Simison M.,
RA   Cherry J.M.;
RT   "The reference genome sequence of Saccharomyces cerevisiae: Then and
RT   now.";
RL   G3 (Bethesda) 4:389-398(2014).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=ATCC 204508 / S288c;
RX   PubMed=17322287; DOI=10.1101/gr.6037607;
RA   Hu Y., Rolfs A., Bhullar B., Murthy T.V.S., Zhu C., Berger M.F.,
RA   Camargo A.A., Kelley F., McCarron S., Jepson D., Richardson A.,
RA   Raphael J., Moreira D., Taycher E., Zuo D., Mohr S., Kane M.F.,
RA   Williamson J., Simpson A.J.G., Bulyk M.L., Harlow E., Marsischky G.,
RA   Kolodner R.D., LaBaer J.;
RT   "Approaching a complete repository of sequence-verified protein-
RT   encoding clones for Saccharomyces cerevisiae.";
RL   Genome Res. 17:536-543(2007).
RN   [4]
RP   SUBCELLULAR LOCATION [LARGE SCALE ANALYSIS].
RX   PubMed=14562095; DOI=10.1038/nature02026;
RA   Huh W.-K., Falvo J.V., Gerke L.C., Carroll A.S., Howson R.W.,
RA   Weissman J.S., O'Shea E.K.;
RT   "Global analysis of protein localization in budding yeast.";
RL   Nature 425:686-691(2003).
RN   [5]
RP   LEVEL OF PROTEIN EXPRESSION [LARGE SCALE ANALYSIS].
RX   PubMed=14562106; DOI=10.1038/nature02046;
RA   Ghaemmaghami S., Huh W.-K., Bower K., Howson R.W., Belle A.,
RA   Dephoure N., O'Shea E.K., Weissman J.S.;
RT   "Global analysis of protein expression in yeast.";
RL   Nature 425:737-741(2003).
RN   [6]
RP   INDUCTION.
RX   PubMed=15878181; DOI=10.1016/j.mrfmmm.2005.02.005;
RA   Caba E., Dickinson D.A., Warnes G.R., Aubrecht J.;
RT   "Differentiating mechanisms of toxicity using global gene expression
RT   analysis in Saccharomyces cerevisiae.";
RL   Mutat. Res. 575:34-46(2005).
CC   -!- SUBCELLULAR LOCATION: Vacuole membrane {ECO:0000305}; Single-pass
CC       membrane protein {ECO:0000305}.
CC   -!- INDUCTION: By the genotoxic agents methyl methanesulfonate (MMS),
CC       bleomycin and cisplatin. {ECO:0000269|PubMed:15878181}.
CC   -!- MISCELLANEOUS: Present with 922 molecules/cell in log phase SD
CC       medium. {ECO:0000269|PubMed:14562106}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U17243; AAB67342.1; -; Genomic_DNA.
DR   EMBL; AY558216; AAS56542.1; -; Genomic_DNA.
DR   EMBL; BK006945; DAA09607.1; -; Genomic_DNA.
DR   PIR; S50381; S50381.
DR   RefSeq; NP_013400.1; NM_001182185.1.
DR   ProteinModelPortal; Q05899; -.
DR   SMR; Q05899; -.
DR   BioGrid; 31561; 58.
DR   DIP; DIP-4684N; -.
DR   IntAct; Q05899; 3.
DR   MINT; Q05899; -.
DR   STRING; 4932.YLR297W; -.
DR   PaxDb; Q05899; -.
DR   PRIDE; Q05899; -.
DR   EnsemblFungi; YLR297W; YLR297W; YLR297W.
DR   GeneID; 851004; -.
DR   KEGG; sce:YLR297W; -.
DR   EuPathDB; FungiDB:YLR297W; -.
DR   SGD; S000004288; YLR297W.
DR   OrthoDB; EOG092C5P1P; -.
DR   BioCyc; YEAST:G3O-32390-MONOMER; -.
DR   PRO; PR:Q05899; -.
DR   Proteomes; UP000002311; Chromosome XII.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005774; C:vacuolar membrane; IEA:UniProtKB-SubCell.
PE   1: Evidence at protein level;
KW   Complete proteome; Membrane; Reference proteome; Transmembrane;
KW   Transmembrane helix; Vacuole.
FT   CHAIN         1    129       Uncharacterized vacuolar protein YLR297W.
FT                                /FTId=PRO_0000247161.
FT   TRANSMEM     77     97       Helical. {ECO:0000255}.
SQ   SEQUENCE   129 AA;  13947 MW;  B5C03B420AD4C51A CRC64;
     MVEGDFVDEQ SNIALLSSKS MCGDHHSVKN SIGDEIFKLL TKILNSDEKA SGDVHTLVSG
     TPDLSNFNLD NEPLENILAV FIISFIIVVV GVLLLGLIGM IFISLRSGSS NDKKLQSNDE
     EKQALAEKA
//
ID   CUE4_YEAST              Reviewed;         117 AA.
AC   Q04201; D6W0I3;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1997, sequence version 1.
DT   23-MAY-2018, entry version 116.
DE   RecName: Full=CUE domain-containing protein CUE4;
DE   AltName: Full=Coupling of ubiquitin conjugation to ER degradation protein 4;
GN   Name=CUE4; OrderedLocusNames=YML101C;
OS   Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast).
OC   Eukaryota; Fungi; Dikarya; Ascomycota; Saccharomycotina;
OC   Saccharomycetes; Saccharomycetales; Saccharomycetaceae; Saccharomyces.
OX   NCBI_TaxID=559292;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 204508 / S288c;
RX   PubMed=9169872;
RA   Bowman S., Churcher C.M., Badcock K., Brown D., Chillingworth T.,
RA   Connor R., Dedman K., Devlin K., Gentles S., Hamlin N., Hunt S.,
RA   Jagels K., Lye G., Moule S., Odell C., Pearson D., Rajandream M.A.,
RA   Rice P., Skelton J., Walsh S.V., Whitehead S., Barrell B.G.;
RT   "The nucleotide sequence of Saccharomyces cerevisiae chromosome
RT   XIII.";
RL   Nature 387:90-93(1997).
RN   [2]
RP   GENOME REANNOTATION.
RC   STRAIN=ATCC 204508 / S288c;
RX   PubMed=24374639; DOI=10.1534/g3.113.008995;
RA   Engel S.R., Dietrich F.S., Fisk D.G., Binkley G., Balakrishnan R.,
RA   Costanzo M.C., Dwight S.S., Hitz B.C., Karra K., Nash R.S., Weng S.,
RA   Wong E.D., Lloyd P., Skrzypek M.S., Miyasato S.R., Simison M.,
RA   Cherry J.M.;
RT   "The reference genome sequence of Saccharomyces cerevisiae: Then and
RT   now.";
RL   G3 (Bethesda) 4:389-398(2014).
RN   [3]
RP   SUBCELLULAR LOCATION.
RX   PubMed=11914276; DOI=10.1101/gad.970902;
RA   Kumar A., Agarwal S., Heyman J.A., Matson S., Heidtman M.,
RA   Piccirillo S., Umansky L., Drawid A., Jansen R., Liu Y., Cheung K.-H.,
RA   Miller P., Gerstein M., Roeder G.S., Snyder M.;
RT   "Subcellular localization of the yeast proteome.";
RL   Genes Dev. 16:707-719(2002).
RN   [4]
RP   GENE NAME, CUE DOMAIN, AND UBIQUITINATION.
RX   PubMed=12628920; DOI=10.1093/emboj/cdg140;
RA   Shih S.C., Prag G., Francis S.A., Sutanto M.A., Hurley J.H., Hicke L.;
RT   "A ubiquitin-binding motif required for intramolecular
RT   monoubiquitylation, the CUE domain.";
RL   EMBO J. 22:1273-1281(2003).
RN   [5]
RP   SUBCELLULAR LOCATION [LARGE SCALE ANALYSIS].
RX   PubMed=14562095; DOI=10.1038/nature02026;
RA   Huh W.-K., Falvo J.V., Gerke L.C., Carroll A.S., Howson R.W.,
RA   Weissman J.S., O'Shea E.K.;
RT   "Global analysis of protein localization in budding yeast.";
RL   Nature 425:686-691(2003).
RN   [6]
RP   LEVEL OF PROTEIN EXPRESSION [LARGE SCALE ANALYSIS].
RX   PubMed=14562106; DOI=10.1038/nature02046;
RA   Ghaemmaghami S., Huh W.-K., Bower K., Howson R.W., Belle A.,
RA   Dephoure N., O'Shea E.K., Weissman J.S.;
RT   "Global analysis of protein expression in yeast.";
RL   Nature 425:737-741(2003).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-48, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=18407956; DOI=10.1074/mcp.M700468-MCP200;
RA   Albuquerque C.P., Smolka M.B., Payne S.H., Bafna V., Eng J., Zhou H.;
RT   "A multidimensional chromatography technology for in-depth
RT   phosphoproteome analysis.";
RL   Mol. Cell. Proteomics 7:1389-1396(2008).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-48, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19779198; DOI=10.1126/science.1172867;
RA   Holt L.J., Tuch B.B., Villen J., Johnson A.D., Gygi S.P., Morgan D.O.;
RT   "Global analysis of Cdk1 substrate phosphorylation sites provides
RT   insights into evolution.";
RL   Science 325:1682-1686(2009).
RN   [9]
RP   UBIQUITINATION [LARGE SCALE ANALYSIS] AT LYS-37, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22106047; DOI=10.1002/pmic.201100166;
RA   Starita L.M., Lo R.S., Eng J.K., von Haller P.D., Fields S.;
RT   "Sites of ubiquitin attachment in Saccharomyces cerevisiae.";
RL   Proteomics 12:236-240(2012).
CC   -!- INTERACTION:
CC       P47155:ILM1; NbExp=3; IntAct=EBI-27928, EBI-2051644;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:11914276}.
CC       Endoplasmic reticulum {ECO:0000269|PubMed:14562095}.
CC   -!- DOMAIN: The CUE domain binds ubiquitin, which may facilitate
CC       intramolecular monoubiquitination.
CC   -!- PTM: Ubiquitinated. {ECO:0000269|PubMed:12628920}.
CC   -!- MISCELLANEOUS: Present with 1850 molecules/cell in log phase SD
CC       medium. {ECO:0000269|PubMed:14562106}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X80835; CAA56796.1; -; Genomic_DNA.
DR   EMBL; BK006946; DAA09797.1; -; Genomic_DNA.
DR   PIR; S47448; S47448.
DR   RefSeq; NP_013607.1; NM_001182462.1.
DR   ProteinModelPortal; Q04201; -.
DR   SMR; Q04201; -.
DR   BioGrid; 35042; 63.
DR   DIP; DIP-4525N; -.
DR   IntAct; Q04201; 4.
DR   MINT; Q04201; -.
DR   STRING; 4932.YML101C; -.
DR   iPTMnet; Q04201; -.
DR   MaxQB; Q04201; -.
DR   PaxDb; Q04201; -.
DR   PRIDE; Q04201; -.
DR   EnsemblFungi; YML101C; YML101C; YML101C.
DR   GeneID; 854871; -.
DR   KEGG; sce:YML101C; -.
DR   EuPathDB; FungiDB:YML101C; -.
DR   SGD; S000004568; CUE4.
DR   InParanoid; Q04201; -.
DR   OrthoDB; EOG092C5I2D; -.
DR   BioCyc; YEAST:G3O-32685-MONOMER; -.
DR   PRO; PR:Q04201; -.
DR   Proteomes; UP000002311; Chromosome XIII.
DR   GO; GO:0000839; C:Hrd1p ubiquitin ligase ERAD-L complex; IBA:GO_Central.
DR   GO; GO:0030176; C:integral component of endoplasmic reticulum membrane; IBA:GO_Central.
DR   GO; GO:0043130; F:ubiquitin binding; IBA:GO_Central.
DR   GO; GO:0097027; F:ubiquitin-protein transferase activator activity; IBA:GO_Central.
DR   GO; GO:0030433; P:ubiquitin-dependent ERAD pathway; IBA:GO_Central.
DR   InterPro; IPR003892; CUE.
DR   Pfam; PF02845; CUE; 1.
DR   SMART; SM00546; CUE; 1.
DR   PROSITE; PS51140; CUE; 1.
PE   1: Evidence at protein level;
KW   Complete proteome; Cytoplasm; Endoplasmic reticulum; Isopeptide bond;
KW   Phosphoprotein; Reference proteome; Ubl conjugation.
FT   CHAIN         1    117       CUE domain-containing protein CUE4.
FT                                /FTId=PRO_0000203244.
FT   DOMAIN       74    116       CUE. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00468}.
FT   MOD_RES      48     48       Phosphoserine.
FT                                {ECO:0000244|PubMed:18407956,
FT                                ECO:0000244|PubMed:19779198}.
FT   CROSSLNK     37     37       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in ubiquitin).
FT                                {ECO:0000244|PubMed:22106047}.
SQ   SEQUENCE   117 AA;  12893 MW;  EC50D817C4B66947 CRC64;
     MDGSTIVFIL TMVCLFVYTV KHRGAKQVPS RTVQDAKPAP SVATNDPSPE PVPSAPEERV
     ARLNRHGSDR KRAVNSDMVE IVMTMAPHVP QEKVVQDLRN TGSIEHTMEN IFAGKLD
//
ID   GLRX2_YEAST             Reviewed;         143 AA.
AC   P17695; D6VTD4; Q6B234;
DT   01-AUG-1990, integrated into UniProtKB/Swiss-Prot.
DT   21-FEB-2006, sequence version 3.
DT   23-MAY-2018, entry version 169.
DE   RecName: Full=Glutaredoxin-2, mitochondrial;
DE   AltName: Full=Glutathione-dependent oxidoreductase 2;
DE   AltName: Full=Thioltransferase;
DE   Flags: Precursor;
GN   Name=GRX2; Synonyms=TTR, TTR1; OrderedLocusNames=YDR513W;
GN   ORFNames=D9719.17;
OS   Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast).
OC   Eukaryota; Fungi; Dikarya; Ascomycota; Saccharomycotina;
OC   Saccharomycetes; Saccharomycetales; Saccharomycetaceae; Saccharomyces.
OX   NCBI_TaxID=559292;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=DMY6;
RX   PubMed=1530649; DOI=10.1016/0006-291X(92)91289-3;
RA   Gan Z.-R.;
RT   "Cloning and sequencing of a gene encoding yeast thioltransferase.";
RL   Biochem. Biophys. Res. Commun. 187:949-955(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 204508 / S288c;
RX   PubMed=9169867;
RA   Jacq C., Alt-Moerbe J., Andre B., Arnold W., Bahr A., Ballesta J.P.G.,
RA   Bargues M., Baron L., Becker A., Biteau N., Bloecker H., Blugeon C.,
RA   Boskovic J., Brandt P., Brueckner M., Buitrago M.J., Coster F.,
RA   Delaveau T., del Rey F., Dujon B., Eide L.G., Garcia-Cantalejo J.M.,
RA   Goffeau A., Gomez-Peris A., Granotier C., Hanemann V., Hankeln T.,
RA   Hoheisel J.D., Jaeger W., Jimenez A., Jonniaux J.-L., Kraemer C.,
RA   Kuester H., Laamanen P., Legros Y., Louis E.J., Moeller-Rieker S.,
RA   Monnet A., Moro M., Mueller-Auer S., Nussbaumer B., Paricio N.,
RA   Paulin L., Perea J., Perez-Alonso M., Perez-Ortin J.E., Pohl T.M.,
RA   Prydz H., Purnelle B., Rasmussen S.W., Remacha M.A., Revuelta J.L.,
RA   Rieger M., Salom D., Saluz H.P., Saiz J.E., Saren A.-M., Schaefer M.,
RA   Scharfe M., Schmidt E.R., Schneider C., Scholler P., Schwarz S.,
RA   Soler-Mira A., Urrestarazu L.A., Verhasselt P., Vissers S., Voet M.,
RA   Volckaert G., Wagner G., Wambutt R., Wedler E., Wedler H., Woelfl S.,
RA   Harris D.E., Bowman S., Brown D., Churcher C.M., Connor R., Dedman K.,
RA   Gentles S., Hamlin N., Hunt S., Jones L., McDonald S., Murphy L.D.,
RA   Niblett D., Odell C., Oliver K., Rajandream M.A., Richards C.,
RA   Shore L., Walsh S.V., Barrell B.G., Dietrich F.S., Mulligan J.T.,
RA   Allen E., Araujo R., Aviles E., Berno A., Carpenter J., Chen E.,
RA   Cherry J.M., Chung E., Duncan M., Hunicke-Smith S., Hyman R.W.,
RA   Komp C., Lashkari D., Lew H., Lin D., Mosedale D., Nakahara K.,
RA   Namath A., Oefner P., Oh C., Petel F.X., Roberts D., Schramm S.,
RA   Schroeder M., Shogren T., Shroff N., Winant A., Yelton M.A.,
RA   Botstein D., Davis R.W., Johnston M., Andrews S., Brinkman R.,
RA   Cooper J., Ding H., Du Z., Favello A., Fulton L., Gattung S.,
RA   Greco T., Hallsworth K., Hawkins J., Hillier L.W., Jier M.,
RA   Johnson D., Johnston L., Kirsten J., Kucaba T., Langston Y.,
RA   Latreille P., Le T., Mardis E., Menezes S., Miller N., Nhan M.,
RA   Pauley A., Peluso D., Rifkin L., Riles L., Taich A., Trevaskis E.,
RA   Vignati D., Wilcox L., Wohldman P., Vaudin M., Wilson R.,
RA   Waterston R., Albermann K., Hani J., Heumann K., Kleine K.,
RA   Mewes H.-W., Zollner A., Zaccaria P.;
RT   "The nucleotide sequence of Saccharomyces cerevisiae chromosome IV.";
RL   Nature 387:75-78(1997).
RN   [3]
RP   GENOME REANNOTATION.
RC   STRAIN=ATCC 204508 / S288c;
RX   PubMed=24374639; DOI=10.1534/g3.113.008995;
RA   Engel S.R., Dietrich F.S., Fisk D.G., Binkley G., Balakrishnan R.,
RA   Costanzo M.C., Dwight S.S., Hitz B.C., Karra K., Nash R.S., Weng S.,
RA   Wong E.D., Lloyd P., Skrzypek M.S., Miyasato S.R., Simison M.,
RA   Cherry J.M.;
RT   "The reference genome sequence of Saccharomyces cerevisiae: Then and
RT   now.";
RL   G3 (Bethesda) 4:389-398(2014).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=ATCC 204508 / S288c;
RX   PubMed=17322287; DOI=10.1101/gr.6037607;
RA   Hu Y., Rolfs A., Bhullar B., Murthy T.V.S., Zhu C., Berger M.F.,
RA   Camargo A.A., Kelley F., McCarron S., Jepson D., Richardson A.,
RA   Raphael J., Moreira D., Taycher E., Zuo D., Mohr S., Kane M.F.,
RA   Williamson J., Simpson A.J.G., Bulyk M.L., Harlow E., Marsischky G.,
RA   Kolodner R.D., LaBaer J.;
RT   "Approaching a complete repository of sequence-verified protein-
RT   encoding clones for Saccharomyces cerevisiae.";
RL   Genome Res. 17:536-543(2007).
RN   [5]
RP   PROTEIN SEQUENCE OF 36-141.
RX   PubMed=2189409; DOI=10.1016/0006-291X(90)91120-H;
RA   Gan Z.-R., Polokoff M.A., Jacobs J.W., Sardana M.K.;
RT   "Complete amino acid sequence of yeast thioltransferase
RT   (glutaredoxin).";
RL   Biochem. Biophys. Res. Commun. 168:944-951(1990).
RN   [6]
RP   FUNCTION, AND INDUCTION.
RX   PubMed=9571241; DOI=10.1091/mbc.9.5.1081;
RA   Luikenhuis S., Perrone G., Dawes I.W., Grant C.M.;
RT   "The yeast Saccharomyces cerevisiae contains two glutaredoxin genes
RT   that are required for protection against reactive oxygen species.";
RL   Mol. Biol. Cell 9:1081-1091(1998).
RN   [7]
RP   INDUCTION.
RX   PubMed=10786615; DOI=10.1016/S0167-4781(99)00234-1;
RA   Grant C.M., Luikenhuis S., Beckhouse A., Soderbergh M., Dawes I.W.;
RT   "Differential regulation of glutaredoxin gene expression in response
RT   to stress conditions in the yeast Saccharomyces cerevisiae.";
RL   Biochim. Biophys. Acta 1490:33-42(2000).
RN   [8]
RP   SUBCELLULAR LOCATION.
RX   PubMed=11958675; DOI=10.1042/BJ20020570;
RA   Pedrajas J.R., Porras P., Martinez-Galisteo E., Padilla C.A.,
RA   Miranda-Vizuete A., Barcena J.A.;
RT   "Two isoforms of Saccharomyces cerevisiae glutaredoxin 2 are expressed
RT   in vivo and localize to different subcellular compartments.";
RL   Biochem. J. 364:617-623(2002).
RN   [9]
RP   FUNCTION, AND BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=11875065; DOI=10.1074/jbc.M111686200;
RA   Collinson E.J., Wheeler G.L., Garrido E.O., Avery A.M., Avery S.V.,
RA   Grant C.M.;
RT   "The yeast glutaredoxins are active as glutathione peroxidases.";
RL   J. Biol. Chem. 277:16712-16717(2002).
RN   [10]
RP   FUNCTION, AND BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=12684511; DOI=10.1074/jbc.M301387200;
RA   Collinson E.J., Grant C.M.;
RT   "Role of yeast glutaredoxins as glutathione S-transferases.";
RL   J. Biol. Chem. 278:22492-22497(2003).
RN   [11]
RP   LEVEL OF PROTEIN EXPRESSION [LARGE SCALE ANALYSIS].
RX   PubMed=14562106; DOI=10.1038/nature02046;
RA   Ghaemmaghami S., Huh W.-K., Bower K., Howson R.W., Belle A.,
RA   Dephoure N., O'Shea E.K., Weissman J.S.;
RT   "Global analysis of protein expression in yeast.";
RL   Nature 425:737-741(2003).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-37 AND SER-91, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=18407956; DOI=10.1074/mcp.M700468-MCP200;
RA   Albuquerque C.P., Smolka M.B., Payne S.H., Bafna V., Eng J., Zhou H.;
RT   "A multidimensional chromatography technology for in-depth
RT   phosphoproteome analysis.";
RL   Mol. Cell. Proteomics 7:1389-1396(2008).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-91, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19779198; DOI=10.1126/science.1172867;
RA   Holt L.J., Tuch B.B., Villen J., Johnson A.D., Gygi S.P., Morgan D.O.;
RT   "Global analysis of Cdk1 substrate phosphorylation sites provides
RT   insights into evolution.";
RL   Science 325:1682-1686(2009).
RN   [14]
RP   X-RAY CRYSTALLOGRAPHY (1.91 ANGSTROMS) OF 35-143 IN COMPLEX WITH
RP   GLUTATHIONE, FUNCTION, BIOPHYSICOCHEMICAL PROPERTIES,
RP   GLUTATHIONYLATION AT CYS-61, AND MUTAGENESIS OF CYS-64.
RX   PubMed=18992757; DOI=10.1016/j.jmb.2008.10.055;
RA   Discola K.F., de Oliveira M.A., Rosa Cussiol J.R., Monteiro G.,
RA   Barcena J.A., Porras P., Padilla C.A., Guimaraes B.G., Netto L.E.;
RT   "Structural aspects of the distinct biochemical properties of
RT   glutaredoxin 1 and glutaredoxin 2 from Saccharomyces cerevisiae.";
RL   J. Mol. Biol. 385:889-901(2009).
RN   [15]
RP   X-RAY CRYSTALLOGRAPHY (1.50 ANGSTROMS) OF 35-143 IN COMPLEX WITH
RP   GLUTATHIONE, DISULFIDE BOND, MUTAGENESIS OF SER-123, FUNCTION, AND
RP   BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=20417731; DOI=10.1016/j.bbapap.2010.04.010;
RA   Li W.F., Yu J., Ma X.X., Teng Y.B., Luo M., Tang Y.J., Zhou C.Z.;
RT   "Structural basis for the different activities of yeast Grx1 and
RT   Grx2.";
RL   Biochim. Biophys. Acta 1804:1542-1547(2010).
CC   -!- FUNCTION: Component of the glutathione system which performs
CC       several activities such as glutathione-dependent oxidoreductase,
CC       glutathione peroxidase and glutathione S-transferase (GST)
CC       activity. The disulfide bond functions as an electron carrier in
CC       the glutathione-dependent synthesis of deoxyribonucleotides by the
CC       enzyme ribonucleotide reductase. In addition, it is also involved
CC       in reducing cytosolic protein- and non-protein-disulfides in a
CC       coupled system with glutathione reductase. Required for resistance
CC       to reactive oxygen species (ROS) by directly reducing
CC       hydroperoxides and for the detoxification of ROS-mediated damage.
CC       GRX2 is more active as an oxidoreductase than GRX1.
CC       {ECO:0000269|PubMed:11875065, ECO:0000269|PubMed:12684511,
CC       ECO:0000269|PubMed:18992757, ECO:0000269|PubMed:20417731,
CC       ECO:0000269|PubMed:9571241}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=2.0 mM for H(2)O(2) {ECO:0000269|PubMed:11875065,
CC         ECO:0000269|PubMed:12684511};
CC         KM=2.2 mM for tert-butyl hydroperoxide
CC         {ECO:0000269|PubMed:11875065, ECO:0000269|PubMed:12684511};
CC         KM=0.87 mM for cumene hydroperoxide
CC         {ECO:0000269|PubMed:11875065, ECO:0000269|PubMed:12684511};
CC         KM=0.17 mM for 1-chloro-2,4-dinitrobenzene
CC         {ECO:0000269|PubMed:11875065, ECO:0000269|PubMed:12684511};
CC         KM=0.27 mM for 1,2-dichloro-4-nitrobenzene
CC         {ECO:0000269|PubMed:11875065, ECO:0000269|PubMed:12684511};
CC         KM=0.9 mM for reduced glutathione {ECO:0000269|PubMed:18992757};
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:11958675}.
CC       Mitochondrion {ECO:0000269|PubMed:11958675}. Note=Two forms, a
CC       long and a short one are found in the mitochondrion, but only the
CC       short one is detected in the cytoplasm.
CC   -!- INDUCTION: In response to exposure to reactive oxygen species
CC       (ROS) and upon entry into stationary phase.
CC       {ECO:0000269|PubMed:10786615, ECO:0000269|PubMed:9571241}.
CC   -!- MISCELLANEOUS: Present with 31400 molecules/cell in log phase SD
CC       medium. {ECO:0000269|PubMed:14562106}.
CC   -!- MISCELLANEOUS: It is unclear whether the long polypeptide observed
CC       in mitochondria represents the immature form of the protein before
CC       cleavage of the transit peptide and release of the short form into
CC       the cytoplasm or whether two mature isoforms exists.
CC   -!- SIMILARITY: Belongs to the glutaredoxin family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAB23389.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; S45268; AAB23389.1; ALT_INIT; Genomic_DNA.
DR   EMBL; U33057; AAB64953.1; -; Genomic_DNA.
DR   EMBL; AY692896; AAT92915.1; -; Genomic_DNA.
DR   EMBL; BK006938; DAA12344.1; -; Genomic_DNA.
DR   PIR; S69570; GDBY.
DR   RefSeq; NP_010801.1; NM_001180821.1.
DR   PDB; 3CTF; X-ray; 2.10 A; A=35-143.
DR   PDB; 3CTG; X-ray; 1.50 A; A=35-143.
DR   PDB; 3D4M; X-ray; 2.05 A; A=35-143.
DR   PDB; 3D5J; X-ray; 1.91 A; A/B=35-143.
DR   PDBsum; 3CTF; -.
DR   PDBsum; 3CTG; -.
DR   PDBsum; 3D4M; -.
DR   PDBsum; 3D5J; -.
DR   ProteinModelPortal; P17695; -.
DR   SMR; P17695; -.
DR   BioGrid; 32563; 89.
DR   DIP; DIP-5271N; -.
DR   IntAct; P17695; 1.
DR   STRING; 4932.YDR513W; -.
DR   iPTMnet; P17695; -.
DR   MaxQB; P17695; -.
DR   PaxDb; P17695; -.
DR   PRIDE; P17695; -.
DR   TopDownProteomics; P17695; -.
DR   EnsemblFungi; YDR513W; YDR513W; YDR513W.
DR   GeneID; 852124; -.
DR   KEGG; sce:YDR513W; -.
DR   EuPathDB; FungiDB:YDR513W; -.
DR   SGD; S000002921; GRX2.
DR   GeneTree; ENSGT00900000141123; -.
DR   HOGENOM; HOG000095204; -.
DR   InParanoid; P17695; -.
DR   OMA; DMLEYGS; -.
DR   OrthoDB; EOG092C3ZJC; -.
DR   BioCyc; YEAST:MONOMER3O-490; -.
DR   SABIO-RK; P17695; -.
DR   EvolutionaryTrace; P17695; -.
DR   PRO; PR:P17695; -.
DR   Proteomes; UP000002311; Chromosome IV.
DR   GO; GO:0005829; C:cytosol; IDA:SGD.
DR   GO; GO:0005739; C:mitochondrion; IDA:SGD.
DR   GO; GO:0015036; F:disulfide oxidoreductase activity; IMP:SGD.
DR   GO; GO:0009055; F:electron transfer activity; IEA:InterPro.
DR   GO; GO:0004602; F:glutathione peroxidase activity; IDA:SGD.
DR   GO; GO:0004364; F:glutathione transferase activity; IDA:SGD.
DR   GO; GO:0015035; F:protein disulfide oxidoreductase activity; IEA:InterPro.
DR   GO; GO:0045454; P:cell redox homeostasis; IEA:InterPro.
DR   GO; GO:0034599; P:cellular response to oxidative stress; IMP:SGD.
DR   GO; GO:0006749; P:glutathione metabolic process; IGI:SGD.
DR   InterPro; IPR011767; GLR_AS.
DR   InterPro; IPR002109; Glutaredoxin.
DR   InterPro; IPR011899; Glutaredoxin_euk/vir.
DR   InterPro; IPR014025; Glutaredoxin_subgr.
DR   InterPro; IPR036249; Thioredoxin-like_sf.
DR   Pfam; PF00462; Glutaredoxin; 1.
DR   PRINTS; PR00160; GLUTAREDOXIN.
DR   SUPFAM; SSF52833; SSF52833; 1.
DR   TIGRFAMs; TIGR02180; GRX_euk; 1.
DR   PROSITE; PS00195; GLUTAREDOXIN_1; 1.
DR   PROSITE; PS51354; GLUTAREDOXIN_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Complete proteome; Cytoplasm; Direct protein sequencing;
KW   Disulfide bond; Electron transport; Glutathionylation; Mitochondrion;
KW   Phosphoprotein; Redox-active center; Reference proteome;
KW   Transit peptide; Transport.
FT   TRANSIT       1     35       Mitochondrion.
FT                                {ECO:0000269|PubMed:2189409}.
FT   CHAIN        36    143       Glutaredoxin-2, mitochondrial.
FT                                /FTId=PRO_0000141612.
FT   DOMAIN       41    143       Glutaredoxin. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00686}.
FT   REGION       58     63       Glutathione binding.
FT                                {ECO:0000269|PubMed:18992757}.
FT   REGION      122    123       Glutathione binding.
FT                                {ECO:0000269|PubMed:18992757}.
FT   BINDING     109    109       Glutathione; via amide nitrogen and
FT                                carbonyl oxygen.
FT                                {ECO:0000269|PubMed:18992757}.
FT   MOD_RES      37     37       Phosphoserine.
FT                                {ECO:0000244|PubMed:18407956}.
FT   MOD_RES      61     61       S-glutathionyl cysteine; alternate.
FT                                {ECO:0000269|PubMed:18992757}.
FT   MOD_RES      91     91       Phosphoserine.
FT                                {ECO:0000244|PubMed:18407956,
FT                                ECO:0000244|PubMed:19779198}.
FT   DISULFID     61     64       Redox-active; alternate.
FT                                {ECO:0000269|PubMed:20417731}.
FT   MUTAGEN      64     64       C->S: Leads to 30 percent decreased
FT                                oxidoreductase activity.
FT                                {ECO:0000269|PubMed:18992757}.
FT   MUTAGEN     123    123       S->D: Leads to decreased oxidoreductase
FT                                activity. {ECO:0000269|PubMed:20417731}.
FT   HELIX        38     50       {ECO:0000244|PDB:3CTG}.
FT   STRAND       51     57       {ECO:0000244|PDB:3CTG}.
FT   HELIX        62     72       {ECO:0000244|PDB:3CTG}.
FT   HELIX        79     81       {ECO:0000244|PDB:3CTG}.
FT   STRAND       82     86       {ECO:0000244|PDB:3CTG}.
FT   HELIX        87     89       {ECO:0000244|PDB:3CTG}.
FT   HELIX        93    104       {ECO:0000244|PDB:3CTG}.
FT   STRAND      111    114       {ECO:0000244|PDB:3CTG}.
FT   STRAND      117    121       {ECO:0000244|PDB:3CTG}.
FT   HELIX       122    130       {ECO:0000244|PDB:3CTG}.
FT   HELIX       133    137       {ECO:0000244|PDB:3CTG}.
FT   TURN        138    141       {ECO:0000244|PDB:3CTG}.
SQ   SEQUENCE   143 AA;  15861 MW;  99A79B87695B2266 CRC64;
     METNFSFDSN LIVIIIITLF ATRIIAKRFL STPKMVSQET VAHVKDLIGQ KEVFVAAKTY
     CPYCKATLST LFQELNVPKS KALVLELDEM SNGSEIQDAL EEISGQKTVP NVYINGKHIG
     GNSDLETLKK NGKLAEILKP VFQ
//
ID   GBLP_YEAST              Reviewed;         319 AA.
AC   P38011; D6VZT9; Q6LAA5;
DT   01-OCT-1994, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 4.
DT   23-MAY-2018, entry version 176.
DE   RecName: Full=Guanine nucleotide-binding protein subunit beta-like protein;
DE   AltName: Full=Receptor for activated C kinase;
DE   AltName: Full=Receptor of activated protein kinase C 1;
DE            Short=RACK1;
DE   AltName: Full=Small ribosomal subunit protein RACK1 {ECO:0000303|PubMed:24524803};
GN   Name=ASC1; Synonyms=CPC2; OrderedLocusNames=YMR116C;
GN   ORFNames=YM9718.15C;
OS   Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast).
OC   Eukaryota; Fungi; Dikarya; Ascomycota; Saccharomycotina;
OC   Saccharomycetes; Saccharomycetales; Saccharomycetaceae; Saccharomyces.
OX   NCBI_TaxID=559292;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 204508 / S288c;
RX   PubMed=9169872;
RA   Bowman S., Churcher C.M., Badcock K., Brown D., Chillingworth T.,
RA   Connor R., Dedman K., Devlin K., Gentles S., Hamlin N., Hunt S.,
RA   Jagels K., Lye G., Moule S., Odell C., Pearson D., Rajandream M.A.,
RA   Rice P., Skelton J., Walsh S.V., Whitehead S., Barrell B.G.;
RT   "The nucleotide sequence of Saccharomyces cerevisiae chromosome
RT   XIII.";
RL   Nature 387:90-93(1997).
RN   [2]
RP   GENOME REANNOTATION.
RC   STRAIN=ATCC 204508 / S288c;
RX   PubMed=24374639; DOI=10.1534/g3.113.008995;
RA   Engel S.R., Dietrich F.S., Fisk D.G., Binkley G., Balakrishnan R.,
RA   Costanzo M.C., Dwight S.S., Hitz B.C., Karra K., Nash R.S., Weng S.,
RA   Wong E.D., Lloyd P., Skrzypek M.S., Miyasato S.R., Simison M.,
RA   Cherry J.M.;
RT   "The reference genome sequence of Saccharomyces cerevisiae: Then and
RT   now.";
RL   G3 (Bethesda) 4:389-398(2014).
RN   [3]
RP   PROTEIN SEQUENCE OF 2-10; 47-59; 91-102; 138-155; 217-228 AND 262-311,
RP   CLEAVAGE OF INITIATOR METHIONINE, ACETYLATION AT ALA-2, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RA   Bienvenut W.V., Peters C.;
RL   Submitted (MAY-2005) to UniProtKB.
RN   [4]
RP   PROTEIN SEQUENCE OF 54-62.
RC   STRAIN=ATCC 204508 / S288c;
RX   PubMed=7895733; DOI=10.1002/elps.11501501210;
RA   Garrels J.I., Futcher B., Kobayashi R., Latter G.I., Schwender B.,
RA   Volpe T., Warner J.R., McLaughlin C.S.;
RT   "Protein identifications for a Saccharomyces cerevisiae protein
RT   database.";
RL   Electrophoresis 15:1466-1486(1994).
RN   [5]
RP   PROTEIN SEQUENCE OF 63-70 AND 138-149.
RC   STRAIN=ATCC 44827 / SKQ2N;
RX   PubMed=9038161; DOI=10.1074/jbc.272.9.5544;
RA   Norbeck J., Blomberg A.;
RT   "Metabolic and regulatory changes associated with growth of
RT   Saccharomyces cerevisiae in 1.4 M NaCl. Evidence for osmotic induction
RT   of glycerol dissimilation via the dihydroxyacetone pathway.";
RL   J. Biol. Chem. 272:5544-5554(1997).
RN   [6]
RP   PROTEIN SEQUENCE OF 91-102; 162-176; 217-228 AND 250-261, INTERACTION
RP   WITH SCP160, AND SUBUNIT.
RX   PubMed=15012629; DOI=10.1042/BJ20031962;
RA   Baum S., Bittins M., Frey S., Seedorf M.;
RT   "Asc1p, a WD40-domain containing adaptor protein, is required for the
RT   interaction of the RNA-binding protein Scp160p with polysomes.";
RL   Biochem. J. 380:823-830(2004).
RN   [7]
RP   LEVEL OF PROTEIN EXPRESSION [LARGE SCALE ANALYSIS].
RX   PubMed=14562106; DOI=10.1038/nature02046;
RA   Ghaemmaghami S., Huh W.-K., Bower K., Howson R.W., Belle A.,
RA   Dephoure N., O'Shea E.K., Weissman J.S.;
RT   "Global analysis of protein expression in yeast.";
RL   Nature 425:737-741(2003).
RN   [8]
RP   FUNCTION, AND SUBUNIT.
RX   PubMed=15340087; DOI=10.1128/MCB.24.18.8276-8287.2004;
RA   Gerbasi V.R., Weaver C.M., Hill S., Friedman D.B., Link A.J.;
RT   "Yeast Asc1p and mammalian RACK1 are functionally orthologous core 40S
RT   ribosomal proteins that repress gene expression.";
RL   Mol. Cell. Biol. 24:8276-8287(2004).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-96, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=17287358; DOI=10.1073/pnas.0607084104;
RA   Chi A., Huttenhower C., Geer L.Y., Coon J.J., Syka J.E.P., Bai D.L.,
RA   Shabanowitz J., Burke D.J., Troyanskaya O.G., Hunt D.F.;
RT   "Analysis of phosphorylation sites on proteins from Saccharomyces
RT   cerevisiae by electron transfer dissociation (ETD) mass
RT   spectrometry.";
RL   Proc. Natl. Acad. Sci. U.S.A. 104:2193-2198(2007).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=18407956; DOI=10.1074/mcp.M700468-MCP200;
RA   Albuquerque C.P., Smolka M.B., Payne S.H., Bafna V., Eng J., Zhou H.;
RT   "A multidimensional chromatography technology for in-depth
RT   phosphoproteome analysis.";
RL   Mol. Cell. Proteomics 7:1389-1396(2008).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-168, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19779198; DOI=10.1126/science.1172867;
RA   Holt L.J., Tuch B.B., Villen J., Johnson A.D., Gygi S.P., Morgan D.O.;
RT   "Global analysis of Cdk1 substrate phosphorylation sites provides
RT   insights into evolution.";
RL   Science 325:1682-1686(2009).
RN   [12]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [13]
RP   UBIQUITINATION [LARGE SCALE ANALYSIS] AT LYS-46; LYS-53; LYS-107;
RP   LYS-137 AND LYS-161, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE
RP   SCALE ANALYSIS].
RX   PubMed=22106047; DOI=10.1002/pmic.201100166;
RA   Starita L.M., Lo R.S., Eng J.K., von Haller P.D., Fields S.;
RT   "Sites of ubiquitin attachment in Saccharomyces cerevisiae.";
RL   Proteomics 12:236-240(2012).
RN   [14]
RP   NOMENCLATURE.
RX   PubMed=24524803; DOI=10.1016/j.sbi.2014.01.002;
RA   Ban N., Beckmann R., Cate J.H.D., Dinman J.D., Dragon F., Ellis S.R.,
RA   Lafontaine D.L.J., Lindahl L., Liljas A., Lipton J.M., McAlear M.A.,
RA   Moore P.B., Noller H.F., Ortega J., Panse V.G., Ramakrishnan V.,
RA   Spahn C.M.T., Steitz T.A., Tchorzewski M., Tollervey D., Warren A.J.,
RA   Williamson J.R., Wilson D., Yonath A., Yusupov M.;
RT   "A new system for naming ribosomal proteins.";
RL   Curr. Opin. Struct. Biol. 24:165-169(2014).
RN   [15]
RP   3D-STRUCTURE MODELING OF 1-114, ELECTRON MICROSCOPY, AND SUBUNIT.
RX   PubMed=15334071; DOI=10.1038/nsmb822;
RA   Sengupta J., Nilsson J., Gursky R., Spahn C.M., Nissen P., Frank J.;
RT   "Identification of the versatile scaffold protein RACK1 on the
RT   eukaryotic ribosome by cryo-EM.";
RL   Nat. Struct. Mol. Biol. 11:957-962(2004).
RN   [16]
RP   X-RAY CRYSTALLOGRAPHY (4.00 ANGSTROMS) OF 80S RIBOSOME.
RX   PubMed=21109664; DOI=10.1126/science.1194294;
RA   Ben-Shem A., Jenner L., Yusupova G., Yusupov M.;
RT   "Crystal structure of the eukaryotic ribosome.";
RL   Science 330:1203-1209(2010).
RN   [17]
RP   X-RAY CRYSTALLOGRAPHY (2.90 ANGSTROMS), AND SUBUNIT.
RX   PubMed=21704636; DOI=10.1016/j.jmb.2011.06.017;
RA   Yatime L., Hein K.L., Nilsson J., Nissen P.;
RT   "Structure of the RACK1 dimer from Saccharomyces cerevisiae.";
RL   J. Mol. Biol. 411:486-498(2011).
RN   [18]
RP   X-RAY CRYSTALLOGRAPHY (3.00 ANGSTROMS) OF 80S RIBOSOME, SUBUNIT, AND
RP   SUBCELLULAR LOCATION.
RX   PubMed=22096102; DOI=10.1126/science.1212642;
RA   Ben-Shem A., Garreau de Loubresse N., Melnikov S., Jenner L.,
RA   Yusupova G., Yusupov M.;
RT   "The structure of the eukaryotic ribosome at 3.0 A resolution.";
RL   Science 334:1524-1529(2011).
CC   -!- FUNCTION: Component of the ribosome, a large ribonucleoprotein
CC       complex responsible for the synthesis of proteins in the cell. The
CC       small ribosomal subunit (SSU) binds messenger RNAs (mRNAs) and
CC       translates the encoded message by selecting cognate aminoacyl-
CC       transfer RNA (tRNA) molecules. The large subunit (LSU) contains
CC       the ribosomal catalytic site termed the peptidyl transferase
CC       center (PTC), which catalyzes the formation of peptide bonds,
CC       thereby polymerizing the amino acids delivered by tRNAs into a
CC       polypeptide chain. The nascent polypeptides leave the ribosome
CC       through a tunnel in the LSU and interact with protein factors that
CC       function in enzymatic processing, targeting, and the membrane
CC       insertion of nascent chains at the exit of the ribosomal tunnel
CC       (PubMed:22096102). Located at the head of the 40S ribosomal
CC       subunit in the vicinity of the mRNA exit channel, RACK1 serves as
CC       a scaffold protein that can recruit other proteins to the
CC       ribosome. Involved in the negative regulation of translation of a
CC       specific subset of proteins (PubMed:15340087).
CC       {ECO:0000269|PubMed:15340087, ECO:0000305|PubMed:22096102}.
CC   -!- SUBUNIT: Component of the small ribosomal subunit (SSU). Mature
CC       yeast ribosomes consist of a small (40S) and a large (60S)
CC       subunit. The 40S small subunit contains 1 molecule of ribosomal
CC       RNA (18S rRNA) and 33 different proteins (encoded by 57 genes).
CC       The large 60S subunit contains 3 rRNA molecules (25S, 5.8S and 5S
CC       rRNA) and 46 different proteins (encoded by 81 genes). RACK1 is
CC       located at the head of the SSU in the vicinity of the mRNA exit
CC       channel (PubMed:15340087, PubMed:15334071, PubMed:22096102). RACK1
CC       interacts with the mRNA-binding protein SCP16 (PubMed:15012629).
CC       RACK1 also exists simultaneously as a homodimer in a cytosolic
CC       non-ribosome-bound form (PubMed:21704636).
CC       {ECO:0000269|PubMed:15012629, ECO:0000269|PubMed:15334071,
CC       ECO:0000269|PubMed:15340087, ECO:0000269|PubMed:21704636,
CC       ECO:0000269|PubMed:22096102}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:22096102}.
CC   -!- MISCELLANEOUS: Present with 333112 molecules/cell in log phase SD
CC       medium. {ECO:0000269|PubMed:14562106}.
CC   -!- SIMILARITY: Belongs to the WD repeat G protein beta family.
CC       Ribosomal protein RACK1 subfamily. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=CAA89753.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; Z49702; CAA89753.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; Z49702; CAA89754.1; -; Genomic_DNA.
DR   EMBL; BK006946; DAA10013.1; -; Genomic_DNA.
DR   PIR; S54578; S54578.
DR   RefSeq; NP_013834.1; NM_001182616.1.
DR   PDB; 1TRJ; EM; 11.70 A; A=1-314.
DR   PDB; 3FRX; X-ray; 2.13 A; A/B/C/D=1-319.
DR   PDB; 3J6X; EM; 6.10 A; RA=1-319.
DR   PDB; 3J6Y; EM; 6.10 A; RA=1-319.
DR   PDB; 3J77; EM; 6.20 A; RC=1-319.
DR   PDB; 3J78; EM; 6.30 A; RC=1-319.
DR   PDB; 3RFG; X-ray; 3.90 A; A/B=2-319.
DR   PDB; 3RFH; X-ray; 2.90 A; A/B/C/D=2-319.
DR   PDB; 4U3M; X-ray; 3.00 A; SR/sR=2-319.
DR   PDB; 4U3N; X-ray; 3.20 A; SR/sR=2-319.
DR   PDB; 4U3U; X-ray; 2.90 A; SR/sR=2-319.
DR   PDB; 4U4N; X-ray; 3.10 A; SR/sR=2-319.
DR   PDB; 4U4O; X-ray; 3.60 A; SR/sR=2-319.
DR   PDB; 4U4Q; X-ray; 3.00 A; SR/sR=2-319.
DR   PDB; 4U4R; X-ray; 2.80 A; SR/sR=2-319.
DR   PDB; 4U4U; X-ray; 3.00 A; SR/sR=2-319.
DR   PDB; 4U4Y; X-ray; 3.20 A; SR/sR=2-319.
DR   PDB; 4U4Z; X-ray; 3.10 A; SR/sR=2-319.
DR   PDB; 4U50; X-ray; 3.20 A; SR/sR=2-319.
DR   PDB; 4U51; X-ray; 3.20 A; SR/sR=2-319.
DR   PDB; 4U52; X-ray; 3.00 A; SR/sR=2-319.
DR   PDB; 4U53; X-ray; 3.30 A; SR/sR=2-319.
DR   PDB; 4U55; X-ray; 3.20 A; SR/sR=2-319.
DR   PDB; 4U56; X-ray; 3.45 A; SR/sR=2-319.
DR   PDB; 4U6F; X-ray; 3.10 A; SR/sR=2-319.
DR   PDB; 4V6I; EM; 8.80 A; Aa=1-319.
DR   PDB; 4V7R; X-ray; 4.00 A; AT/CT=1-319.
DR   PDB; 4V88; X-ray; 3.00 A; Ag/Cg=1-319.
DR   PDB; 4V8Y; EM; 4.30 A; A6=1-319.
DR   PDB; 4V8Z; EM; 6.60 A; A6=1-319.
DR   PDB; 4V92; EM; 3.70 A; g=4-318.
DR   PDB; 5DAT; X-ray; 3.15 A; SR/sR=2-319.
DR   PDB; 5DC3; X-ray; 3.25 A; SR/sR=2-319.
DR   PDB; 5DGE; X-ray; 3.45 A; SR/sR=2-319.
DR   PDB; 5DGF; X-ray; 3.30 A; SR/sR=2-319.
DR   PDB; 5DGV; X-ray; 3.10 A; SR/sR=2-319.
DR   PDB; 5FCI; X-ray; 3.40 A; SR/sR=2-319.
DR   PDB; 5FCJ; X-ray; 3.10 A; SR/sR=2-319.
DR   PDB; 5I4L; X-ray; 3.10 A; SR/sR=2-319.
DR   PDB; 5JUO; EM; 4.00 A; WA=1-319.
DR   PDB; 5JUP; EM; 3.50 A; WA=1-319.
DR   PDB; 5JUS; EM; 4.20 A; WA=1-319.
DR   PDB; 5JUT; EM; 4.00 A; WA=1-319.
DR   PDB; 5JUU; EM; 4.00 A; WA=1-319.
DR   PDB; 5LYB; X-ray; 3.25 A; SR/sR=2-319.
DR   PDB; 5M1J; EM; 3.30 A; g2=2-319.
DR   PDB; 5MC6; EM; 3.80 A; O=1-319.
DR   PDB; 5MEI; X-ray; 3.50 A; h/sR=2-319.
DR   PDB; 5NDG; X-ray; 3.70 A; SR/sR=2-319.
DR   PDB; 5NDV; X-ray; 3.30 A; SR/sR=2-319.
DR   PDB; 5NDW; X-ray; 3.70 A; SR/sR=2-319.
DR   PDB; 5OBM; X-ray; 3.40 A; SR/sR=2-319.
DR   PDB; 5ON6; X-ray; 3.10 A; h/sR=2-319.
DR   PDB; 5TBW; X-ray; 3.00 A; Rb/h=2-319.
DR   PDB; 5TGA; X-ray; 3.30 A; SR/sR=2-319.
DR   PDB; 5TGM; X-ray; 3.50 A; SR/sR=2-319.
DR   PDB; 6FAI; EM; 3.40 A; g=1-319.
DR   PDBsum; 1TRJ; -.
DR   PDBsum; 3FRX; -.
DR   PDBsum; 3J6X; -.
DR   PDBsum; 3J6Y; -.
DR   PDBsum; 3J77; -.
DR   PDBsum; 3J78; -.
DR   PDBsum; 3RFG; -.
DR   PDBsum; 3RFH; -.
DR   PDBsum; 4U3M; -.
DR   PDBsum; 4U3N; -.
DR   PDBsum; 4U3U; -.
DR   PDBsum; 4U4N; -.
DR   PDBsum; 4U4O; -.
DR   PDBsum; 4U4Q; -.
DR   PDBsum; 4U4R; -.
DR   PDBsum; 4U4U; -.
DR   PDBsum; 4U4Y; -.
DR   PDBsum; 4U4Z; -.
DR   PDBsum; 4U50; -.
DR   PDBsum; 4U51; -.
DR   PDBsum; 4U52; -.
DR   PDBsum; 4U53; -.
DR   PDBsum; 4U55; -.
DR   PDBsum; 4U56; -.
DR   PDBsum; 4U6F; -.
DR   PDBsum; 4V6I; -.
DR   PDBsum; 4V7R; -.
DR   PDBsum; 4V88; -.
DR   PDBsum; 4V8Y; -.
DR   PDBsum; 4V8Z; -.
DR   PDBsum; 4V92; -.
DR   PDBsum; 5DAT; -.
DR   PDBsum; 5DC3; -.
DR   PDBsum; 5DGE; -.
DR   PDBsum; 5DGF; -.
DR   PDBsum; 5DGV; -.
DR   PDBsum; 5FCI; -.
DR   PDBsum; 5FCJ; -.
DR   PDBsum; 5I4L; -.
DR   PDBsum; 5JUO; -.
DR   PDBsum; 5JUP; -.
DR   PDBsum; 5JUS; -.
DR   PDBsum; 5JUT; -.
DR   PDBsum; 5JUU; -.
DR   PDBsum; 5LYB; -.
DR   PDBsum; 5M1J; -.
DR   PDBsum; 5MC6; -.
DR   PDBsum; 5MEI; -.
DR   PDBsum; 5NDG; -.
DR   PDBsum; 5NDV; -.
DR   PDBsum; 5NDW; -.
DR   PDBsum; 5OBM; -.
DR   PDBsum; 5ON6; -.
DR   PDBsum; 5TBW; -.
DR   PDBsum; 5TGA; -.
DR   PDBsum; 5TGM; -.
DR   PDBsum; 6FAI; -.
DR   ProteinModelPortal; P38011; -.
DR   SMR; P38011; -.
DR   BioGrid; 35292; 673.
DR   DIP; DIP-6465N; -.
DR   IntAct; P38011; 80.
DR   MINT; P38011; -.
DR   STRING; 4932.YMR116C; -.
DR   MoonProt; P38011; -.
DR   TCDB; 8.A.92.1.3; the g-protein AlphaBetaGama complex (gpc) family.
DR   iPTMnet; P38011; -.
DR   UCD-2DPAGE; P38011; -.
DR   MaxQB; P38011; -.
DR   PaxDb; P38011; -.
DR   PRIDE; P38011; -.
DR   TopDownProteomics; P38011; -.
DR   EnsemblFungi; YMR116C; YMR116C; YMR116C.
DR   GeneID; 855143; -.
DR   KEGG; sce:YMR116C; -.
DR   EuPathDB; FungiDB:YMR116C; -.
DR   SGD; S000004722; ASC1.
DR   GeneTree; ENSGT00910000144232; -.
DR   HOGENOM; HOG000091643; -.
DR   InParanoid; P38011; -.
DR   KO; K14753; -.
DR   OMA; QYGYPKR; -.
DR   OrthoDB; EOG092C10HM; -.
DR   BioCyc; YEAST:G3O-32811-MONOMER; -.
DR   EvolutionaryTrace; P38011; -.
DR   PRO; PR:P38011; -.
DR   Proteomes; UP000002311; Chromosome XIII.
DR   GO; GO:0022627; C:cytosolic small ribosomal subunit; IDA:SGD.
DR   GO; GO:0001965; F:G-protein alpha-subunit binding; IPI:SGD.
DR   GO; GO:0005092; F:GDP-dissociation inhibitor activity; IDA:SGD.
DR   GO; GO:0004871; F:signal transducer activity; IMP:SGD.
DR   GO; GO:0007186; P:G-protein coupled receptor signaling pathway; IMP:SGD.
DR   GO; GO:0001403; P:invasive growth in response to glucose limitation; IMP:SGD.
DR   GO; GO:1902660; P:negative regulation of glucose mediated signaling pathway; IMP:SGD.
DR   GO; GO:0017148; P:negative regulation of translation; IMP:SGD.
DR   GO; GO:2001125; P:negative regulation of translational frameshifting; IMP:SGD.
DR   Gene3D; 2.130.10.10; -; 1.
DR   InterPro; IPR020472; G-protein_beta_WD-40_rep.
DR   InterPro; IPR015943; WD40/YVTN_repeat-like_dom_sf.
DR   InterPro; IPR001680; WD40_repeat.
DR   InterPro; IPR019775; WD40_repeat_CS.
DR   InterPro; IPR017986; WD40_repeat_dom.
DR   InterPro; IPR036322; WD40_repeat_dom_sf.
DR   Pfam; PF00400; WD40; 6.
DR   PRINTS; PR00320; GPROTEINBRPT.
DR   SMART; SM00320; WD40; 7.
DR   SUPFAM; SSF50978; SSF50978; 1.
DR   PROSITE; PS00678; WD_REPEATS_1; 3.
DR   PROSITE; PS50082; WD_REPEATS_2; 6.
DR   PROSITE; PS50294; WD_REPEATS_REGION; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Complete proteome; Cytoplasm;
KW   Direct protein sequencing; Isopeptide bond; Phosphoprotein;
KW   Reference proteome; Repeat; Ribonucleoprotein; Ribosomal protein;
KW   Ubl conjugation; WD repeat.
FT   INIT_MET      1      1       Removed. {ECO:0000244|PubMed:22814378,
FT                                ECO:0000269|Ref.3}.
FT   CHAIN         2    319       Guanine nucleotide-binding protein
FT                                subunit beta-like protein.
FT                                /FTId=PRO_0000127758.
FT   REPEAT       15     55       WD 1.
FT   REPEAT       63    102       WD 2.
FT   REPEAT      105    145       WD 3.
FT   REPEAT      147    191       WD 4.
FT   REPEAT      194    233       WD 5.
FT   REPEAT      235    275       WD 6.
FT   REPEAT      284    319       WD 7.
FT   MOD_RES       2      2       N-acetylalanine.
FT                                {ECO:0000244|PubMed:22814378,
FT                                ECO:0000269|Ref.3}.
FT   MOD_RES      96     96       Phosphothreonine.
FT                                {ECO:0000244|PubMed:17287358}.
FT   MOD_RES     168    168       Phosphothreonine.
FT                                {ECO:0000244|PubMed:19779198}.
FT   CROSSLNK     46     46       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in ubiquitin).
FT                                {ECO:0000244|PubMed:22106047}.
FT   CROSSLNK     53     53       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in ubiquitin).
FT                                {ECO:0000244|PubMed:22106047}.
FT   CROSSLNK    107    107       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in ubiquitin).
FT                                {ECO:0000244|PubMed:22106047}.
FT   CROSSLNK    137    137       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in ubiquitin).
FT                                {ECO:0000244|PubMed:22106047}.
FT   CROSSLNK    161    161       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in ubiquitin).
FT                                {ECO:0000244|PubMed:22106047}.
FT   STRAND        5     13       {ECO:0000244|PDB:3FRX}.
FT   STRAND       20     25       {ECO:0000244|PDB:3FRX}.
FT   STRAND       32     37       {ECO:0000244|PDB:3FRX}.
FT   STRAND       40     50       {ECO:0000244|PDB:3FRX}.
FT   STRAND       53     62       {ECO:0000244|PDB:3FRX}.
FT   STRAND       68     73       {ECO:0000244|PDB:3FRX}.
FT   STRAND       77     84       {ECO:0000244|PDB:3FRX}.
FT   STRAND       87     93       {ECO:0000244|PDB:3FRX}.
FT   TURN         94     97       {ECO:0000244|PDB:3FRX}.
FT   STRAND       98    104       {ECO:0000244|PDB:3FRX}.
FT   STRAND      110    115       {ECO:0000244|PDB:3FRX}.
FT   STRAND      121    126       {ECO:0000244|PDB:3FRX}.
FT   STRAND      131    135       {ECO:0000244|PDB:3FRX}.
FT   STRAND      136    138       {ECO:0000244|PDB:6FAI}.
FT   STRAND      140    144       {ECO:0000244|PDB:3FRX}.
FT   STRAND      151    156       {ECO:0000244|PDB:3FRX}.
FT   STRAND      160    162       {ECO:0000244|PDB:6FAI}.
FT   STRAND      168    173       {ECO:0000244|PDB:3FRX}.
FT   STRAND      178    182       {ECO:0000244|PDB:3FRX}.
FT   TURN        183    186       {ECO:0000244|PDB:3FRX}.
FT   STRAND      187    192       {ECO:0000244|PDB:3FRX}.
FT   STRAND      199    204       {ECO:0000244|PDB:3FRX}.
FT   STRAND      208    215       {ECO:0000244|PDB:3FRX}.
FT   HELIX       216    218       {ECO:0000244|PDB:3RFH}.
FT   STRAND      219    224       {ECO:0000244|PDB:3FRX}.
FT   TURN        225    228       {ECO:0000244|PDB:3FRX}.
FT   STRAND      229    235       {ECO:0000244|PDB:3FRX}.
FT   STRAND      240    245       {ECO:0000244|PDB:3FRX}.
FT   STRAND      247    256       {ECO:0000244|PDB:3FRX}.
FT   STRAND      259    264       {ECO:0000244|PDB:3FRX}.
FT   TURN        265    268       {ECO:0000244|PDB:3FRX}.
FT   STRAND      269    274       {ECO:0000244|PDB:3FRX}.
FT   HELIX       283    285       {ECO:0000244|PDB:3FRX}.
FT   STRAND      289    294       {ECO:0000244|PDB:3FRX}.
FT   STRAND      298    305       {ECO:0000244|PDB:3FRX}.
FT   STRAND      310    317       {ECO:0000244|PDB:3FRX}.
SQ   SEQUENCE   319 AA;  34805 MW;  B9A5D4959A3C54FB CRC64;
     MASNEVLVLR GTLEGHNGWV TSLATSAGQP NLLLSASRDK TLISWKLTGD DQKFGVPVRS
     FKGHSHIVQD CTLTADGAYA LSASWDKTLR LWDVATGETY QRFVGHKSDV MSVDIDKKAS
     MIISGSRDKT IKVWTIKGQC LATLLGHNDW VSQVRVVPNE KADDDSVTII SAGNDKMVKA
     WNLNQFQIEA DFIGHNSNIN TLTASPDGTL IASAGKDGEI MLWNLAAKKA MYTLSAQDEV
     FSLAFSPNRY WLAAATATGI KVFSLDPQYL VDDLRPEFAG YSKAAEPHAV SLAWSADGQT
     LFAGYTDNVI RVWQVMTAN
//
ID   HNRPL_HUMAN             Reviewed;         589 AA.
AC   P14866; A6ND69; A6NIT8; Q9H3P3;
DT   01-APR-1990, integrated into UniProtKB/Swiss-Prot.
DT   25-NOV-2008, sequence version 2.
DT   23-MAY-2018, entry version 196.
DE   RecName: Full=Heterogeneous nuclear ribonucleoprotein L;
DE            Short=hnRNP L;
GN   Name=HNRNPL; Synonyms=HNRPL; ORFNames=P/OKcl.14;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Pancreatic cancer;
RX   PubMed=11280764;
RA   Ito M., Shichijo S., Tsuda N., Ochi M., Harashima N., Saito N.,
RA   Itoh K.;
RT   "Molecular basis of T cell-mediated recognition of pancreatic cancer
RT   cells.";
RL   Cancer Res. 61:2038-2046(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Synovium;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057824; DOI=10.1038/nature02399;
RA   Grimwood J., Gordon L.A., Olsen A.S., Terry A., Schmutz J.,
RA   Lamerdin J.E., Hellsten U., Goodstein D., Couronne O., Tran-Gyamfi M.,
RA   Aerts A., Altherr M., Ashworth L., Bajorek E., Black S., Branscomb E.,
RA   Caenepeel S., Carrano A.V., Caoile C., Chan Y.M., Christensen M.,
RA   Cleland C.A., Copeland A., Dalin E., Dehal P., Denys M., Detter J.C.,
RA   Escobar J., Flowers D., Fotopulos D., Garcia C., Georgescu A.M.,
RA   Glavina T., Gomez M., Gonzales E., Groza M., Hammon N., Hawkins T.,
RA   Haydu L., Ho I., Huang W., Israni S., Jett J., Kadner K., Kimball H.,
RA   Kobayashi A., Larionov V., Leem S.-H., Lopez F., Lou Y., Lowry S.,
RA   Malfatti S., Martinez D., McCready P.M., Medina C., Morgan J.,
RA   Nelson K., Nolan M., Ovcharenko I., Pitluck S., Pollard M.,
RA   Popkie A.P., Predki P., Quan G., Ramirez L., Rash S., Retterer J.,
RA   Rodriguez A., Rogers S., Salamov A., Salazar A., She X., Smith D.,
RA   Slezak T., Solovyev V., Thayer N., Tice H., Tsai M., Ustaszewska A.,
RA   Vo N., Wagner M., Wheeler J., Wu K., Xie G., Yang J., Dubchak I.,
RA   Furey T.S., DeJong P., Dickson M., Gordon D., Eichler E.E.,
RA   Pennacchio L.A., Richardson P., Stubbs L., Rokhsar D.S., Myers R.M.,
RA   Rubin E.M., Lucas S.M.;
RT   "The DNA sequence and biology of human chromosome 19.";
RL   Nature 428:529-535(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 23-589 (ISOFORM 1), FUNCTION, AND
RP   SUBCELLULAR LOCATION.
RX   PubMed=2687284; DOI=10.1083/jcb.109.6.2575;
RA   Pinol-Roma S., Swanson M.S., Gall J.G., Dreyfuss G.;
RT   "A novel heterogeneous nuclear RNP protein with a unique distribution
RT   on nascent transcripts.";
RL   J. Cell Biol. 109:2575-2587(1989).
RN   [6]
RP   PROTEIN SEQUENCE OF 67-76; 199-215; 218-233; 386-403; 425-448 AND
RP   549-558, AND IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Brain, Cajal-Retzius cell, and Fetal brain cortex;
RA   Lubec G., Vishwanath V., Chen W.-Q., Sun Y.;
RL   Submitted (DEC-2008) to UniProtKB.
RN   [7]
RP   PARTIAL PROTEIN SEQUENCE.
RC   TISSUE=Keratinocyte;
RX   PubMed=1286667; DOI=10.1002/elps.11501301199;
RA   Rasmussen H.H., van Damme J., Puype M., Gesser B., Celis J.E.,
RA   Vandekerckhove J.;
RT   "Microsequences of 145 proteins recorded in the two-dimensional gel
RT   protein database of normal human epidermal keratinocytes.";
RL   Electrophoresis 13:960-969(1992).
RN   [8]
RP   FUNCTION, AND INTERACTION WITH APEX1.
RX   PubMed=11809897; DOI=10.1093/nar/30.3.823;
RA   Kuninger D.T., Izumi T., Papaconstantinou J., Mitra S.;
RT   "Human AP-endonuclease 1 and hnRNP-L interact with a nCaRE-like
RT   repressor element in the AP-endonuclease 1 promoter.";
RL   Nucleic Acids Res. 30:823-829(2002).
RN   [9]
RP   IDENTIFICATION IN A MRNP GRANULE COMPLEX, IDENTIFICATION BY MASS
RP   SPECTROMETRY, AND SUBCELLULAR LOCATION.
RX   PubMed=17289661; DOI=10.1074/mcp.M600346-MCP200;
RA   Joeson L., Vikesaa J., Krogh A., Nielsen L.K., Hansen T., Borup R.,
RA   Johnsen A.H., Christiansen J., Nielsen F.C.;
RT   "Molecular composition of IMP1 ribonucleoprotein granules.";
RL   Mol. Cell. Proteomics 6:798-811(2007).
RN   [10]
RP   INTERACTION WITH ELAVL1.
RX   PubMed=18161049; DOI=10.1002/hep.22036;
RA   Matsui K., Nishizawa M., Ozaki T., Kimura T., Hashimoto I., Yamada M.,
RA   Kaibori M., Kamiyama Y., Ito S., Okumura T.;
RT   "Natural antisense transcript stabilizes inducible nitric oxide
RT   synthase messenger RNA in rat hepatocytes.";
RL   Hepatology 47:686-697(2008).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-52 AND SER-298, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [12]
RP   INTERACTION WITH HNRNPLL.
RX   PubMed=18669861; DOI=10.1126/science.1157610;
RA   Oberdoerffer S., Moita L.F., Neems D., Freitas R.P., Hacohen N.,
RA   Rao A.;
RT   "Regulation of CD45 alternative splicing by heterogeneous
RT   ribonucleoprotein, hnRNPLL.";
RL   Science 321:686-691(2008).
RN   [13]
RP   INTERACTION WITH SETD2.
RX   PubMed=19332550; DOI=10.1074/jbc.M808431200;
RA   Yuan W., Xie J., Long C., Erdjument-Bromage H., Ding X., Zheng Y.,
RA   Tempst P., Chen S., Zhu B., Reinberg D.;
RT   "Heterogeneous nuclear ribonucleoprotein L is a subunit of human
RT   KMT3a/Set2 complex required for H3 Lys-36 trimethylation activity in
RT   vivo.";
RL   J. Biol. Chem. 284:15701-15707(2009).
RN   [14]
RP   ALTERNATIVE SPLICING, AND MISCELLANEOUS.
RX   PubMed=19124611; DOI=10.1128/MCB.01689-08;
RA   Rossbach O., Hung L.H., Schreiner S., Grishina I., Heiner M., Hui J.,
RA   Bindereif A.;
RT   "Auto- and cross-regulation of the hnRNP L proteins by alternative
RT   splicing.";
RL   Mol. Cell. Biol. 29:1442-1451(2009).
RN   [15]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-269, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-52; SER-185 AND SER-298,
RP   AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [17]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-52; SER-101; SER-185;
RP   SER-291 AND SER-298, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE
RP   SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [19]
RP   PHOSPHORYLATION AT SER-544, AND FUNCTION.
RX   PubMed=22570490; DOI=10.1074/jbc.M112.357343;
RA   Liu G., Razanau A., Hai Y., Yu J., Sohail M., Lobo V.G., Chu J.,
RA   Kung S.K., Xie J.;
RT   "A conserved serine of heterogeneous nuclear ribonucleoprotein L
RT   (hnRNP L) mediates depolarization-regulated alternative splicing of
RT   potassium channels.";
RL   J. Biol. Chem. 287:22709-22716(2012).
RN   [20]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [21]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-52; SER-101; SER-185 AND
RP   SER-298, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [22]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [23]
RP   FUNCTION.
RX   PubMed=24164894; DOI=10.1128/MCB.00740-13;
RA   Shankarling G., Cole B.S., Mallory M.J., Lynch K.W.;
RT   "Transcriptome-wide RNA interaction profiling reveals physical and
RT   functional targets of hnRNP L in human T cells.";
RL   Mol. Cell. Biol. 34:71-83(2014).
RN   [24]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-62, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25218447; DOI=10.1038/nsmb.2890;
RA   Hendriks I.A., D'Souza R.C., Yang B., Verlaan-de Vries M., Mann M.,
RA   Vertegaal A.C.;
RT   "Uncovering global SUMOylation signaling networks in a site-specific
RT   manner.";
RL   Nat. Struct. Mol. Biol. 21:927-936(2014).
RN   [25]
RP   FUNCTION.
RX   PubMed=25623890; DOI=10.1016/j.bbagrm.2015.01.004;
RA   Loh T.J., Cho S., Moon H., Jang H.N., Williams D.R., Jung D.W.,
RA   Kim I.C., Ghigna C., Biamonti G., Zheng X., Shen H.;
RT   "hnRNP L inhibits CD44 V10 exon splicing through interacting with its
RT   upstream intron.";
RL   Biochim. Biophys. Acta 1849:743-750(2015).
RN   [26]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-136, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25772364; DOI=10.1016/j.celrep.2015.02.033;
RA   Hendriks I.A., Treffers L.W., Verlaan-de Vries M., Olsen J.V.,
RA   Vertegaal A.C.;
RT   "SUMO-2 orchestrates chromatin modifiers in response to DNA damage.";
RL   Cell Rep. 10:1778-1791(2015).
RN   [27]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=26051023; DOI=10.1016/j.jmb.2015.05.020;
RA   Blatter M., Dunin-Horkawicz S., Grishina I., Maris C., Thore S.,
RA   Maier T., Bindereif A., Bujnicki J.M., Allain F.H.;
RT   "The signature of the five-stranded vRRM fold defined by functional,
RT   structural and computational analysis of the hnRNP L protein.";
RL   J. Mol. Biol. 427:3001-3022(2015).
RN   [28]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-62, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25755297; DOI=10.1074/mcp.O114.044792;
RA   Xiao Z., Chang J.G., Hendriks I.A., Sigurdsson J.O., Olsen J.V.,
RA   Vertegaal A.C.;
RT   "System-wide analysis of SUMOylation dynamics in response to
RT   replication stress reveals novel small ubiquitin-like modified target
RT   proteins and acceptor lysines relevant for genome stability.";
RL   Mol. Cell. Proteomics 14:1419-1434(2015).
RN   [29]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [30]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-59; LYS-62; LYS-136; LYS-302
RP   AND LYS-568, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-
RT   modification with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
RN   [31]
RP   X-RAY CRYSTALLOGRAPHY (2.04 ANGSTROMS) OF 90-180, X-RAY
RP   CRYSTALLOGRAPHY (1.82 ANGSTROMS) OF 380-589, RNA-BINDING, RRM DOMAINS,
RP   AND MUTAGENESIS OF HIS-105; VAL-132; LEU-141; ASN-172; SER-174;
RP   HIS-504 AND PHE-506.
RX   PubMed=23782695; DOI=10.1074/jbc.M113.463901;
RA   Zhang W., Zeng F., Liu Y., Zhao Y., Lv H., Niu L., Teng M., Li X.;
RT   "Crystal structures and RNA-binding properties of the RNA recognition
RT   motifs of heterogeneous nuclear ribonucleoprotein L: insights into its
RT   roles in alternative splicing regulation.";
RL   J. Biol. Chem. 288:22636-22649(2013).
CC   -!- FUNCTION: Splicing factor binding to exonic or intronic sites and
CC       acting as either an activator or repressor of exon inclusion.
CC       Exhibits a binding preference for CA-rich elements
CC       (PubMed:11809897, PubMed:22570490, PubMed:24164894,
CC       PubMed:25623890, PubMed:26051023). Component of the heterogeneous
CC       nuclear ribonucleoprotein (hnRNP) complexes and associated with
CC       most nascent transcripts (PubMed:2687284). Associates, together
CC       with APEX1, to the negative calcium responsive element (nCaRE) B2
CC       of the APEX2 promoter (PubMed:11809897).
CC       {ECO:0000269|PubMed:11809897, ECO:0000269|PubMed:22570490,
CC       ECO:0000269|PubMed:25623890, ECO:0000269|PubMed:26051023,
CC       ECO:0000269|PubMed:2687284}.
CC   -!- SUBUNIT: Identified in a IGF2BP1-dependent mRNP granule complex
CC       containing untranslated mRNAs (PubMed:17289661). Interacts with
CC       HNRNPLL (PubMed:18669861). Interacts with APEX1; the interaction
CC       is DNA-dependent (PubMed:11809897). Component of a complex with
CC       SETD2 (PubMed:19332550). Interacts with ELAVL1 (PubMed:18161049).
CC       {ECO:0000269|PubMed:11809897, ECO:0000269|PubMed:17289661,
CC       ECO:0000269|PubMed:18161049, ECO:0000269|PubMed:18669861,
CC       ECO:0000269|PubMed:19332550}.
CC   -!- INTERACTION:
CC       P22626:HNRNPA2B1; NbExp=4; IntAct=EBI-16071645, EBI-299649;
CC       Q12906:ILF3; NbExp=2; IntAct=EBI-16071645, EBI-78756;
CC       P40337:VHL; NbExp=2; IntAct=EBI-719024, EBI-301246;
CC   -!- SUBCELLULAR LOCATION: Nucleus, nucleoplasm
CC       {ECO:0000269|PubMed:17289661, ECO:0000269|PubMed:2687284,
CC       ECO:0000305|PubMed:26051023}. Cytoplasm
CC       {ECO:0000269|PubMed:17289661}. Note=Localized in cytoplasmic mRNP
CC       granules containing untranslated mRNAs. These granules are not
CC       identical with P bodies or stress granules.
CC       {ECO:0000269|PubMed:17289661}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P14866-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P14866-2; Sequence=VSP_044301;
CC   -!- DOMAIN: RRM domain 2 has moderate RNA-binding affinity. RRM
CC       domains 3 and 4 may facilitate RNA looping when binding to two
CC       appropriately separated binding sites within the same target pre-
CC       mRNA (PubMed:23782695). {ECO:0000269|PubMed:23782695}.
CC   -!- PTM: Several isoelectric forms of the L protein are probably the
CC       results of post-translational modifications.
CC   -!- PTM: Phosphorylation at Ser-544 by CaMK4 enhances interaction with
CC       a CaMK4-responsive RNA element (CaRRE1), and prevents inclusion of
CC       the stress axis-regulated exon (STREX) of the KCNMA1 potassium
CC       channel transcripts upon membrane depolarization.
CC       {ECO:0000269|PubMed:22570490}.
CC   -!- MISCELLANEOUS: Excess hnRNP L activates NMD of its own mRNA by
CC       promoting the inclusion of a 'poison exon' containing a premature
CC       stop codon and leading to nonsense-mediated decay. It also cross-
CC       regulates inclusion of an analogous 'poison exon' in the hnRNP L-
CC       like pre-mRNA (PubMed:19124611). {ECO:0000305|PubMed:19124611}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=CAA34261.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB044547; BAB18649.1; -; mRNA.
DR   EMBL; AK292115; BAF84804.1; -; mRNA.
DR   EMBL; AC008982; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471126; EAW56828.1; -; Genomic_DNA.
DR   EMBL; X16135; CAA34261.1; ALT_INIT; mRNA.
DR   CCDS; CCDS33015.1; -. [P14866-1]
DR   CCDS; CCDS33016.1; -. [P14866-2]
DR   PIR; A33616; A33616.
DR   RefSeq; NP_001005335.1; NM_001005335.1. [P14866-2]
DR   RefSeq; NP_001524.2; NM_001533.2. [P14866-1]
DR   RefSeq; XP_011525191.1; XM_011526889.1. [P14866-2]
DR   UniGene; Hs.644906; -.
DR   PDB; 3R27; X-ray; 2.04 A; A/B=90-180.
DR   PDB; 3TO8; X-ray; 1.82 A; A=380-589.
DR   PDBsum; 3R27; -.
DR   PDBsum; 3TO8; -.
DR   ProteinModelPortal; P14866; -.
DR   SMR; P14866; -.
DR   BioGrid; 109432; 119.
DR   CORUM; P14866; -.
DR   DIP; DIP-36355N; -.
DR   IntAct; P14866; 45.
DR   MINT; P14866; -.
DR   STRING; 9606.ENSP00000221419; -.
DR   iPTMnet; P14866; -.
DR   PhosphoSitePlus; P14866; -.
DR   SwissPalm; P14866; -.
DR   BioMuta; HNRNPL; -.
DR   DMDM; 215274006; -.
DR   REPRODUCTION-2DPAGE; IPI00027834; -.
DR   SWISS-2DPAGE; P14866; -.
DR   EPD; P14866; -.
DR   MaxQB; P14866; -.
DR   PaxDb; P14866; -.
DR   PeptideAtlas; P14866; -.
DR   PRIDE; P14866; -.
DR   DNASU; 3191; -.
DR   Ensembl; ENST00000221419; ENSP00000221419; ENSG00000104824. [P14866-1]
DR   Ensembl; ENST00000600873; ENSP00000470231; ENSG00000104824. [P14866-2]
DR   Ensembl; ENST00000634237; ENSP00000489244; ENSG00000282947. [P14866-2]
DR   Ensembl; ENST00000634753; ENSP00000489021; ENSG00000282947. [P14866-1]
DR   GeneID; 3191; -.
DR   KEGG; hsa:3191; -.
DR   UCSC; uc060yfy.1; human. [P14866-1]
DR   CTD; 3191; -.
DR   DisGeNET; 3191; -.
DR   EuPathDB; HostDB:ENSG00000104824.16; -.
DR   GeneCards; HNRNPL; -.
DR   H-InvDB; HIX0174642; -.
DR   HGNC; HGNC:5045; HNRNPL.
DR   HPA; CAB016326; -.
DR   HPA; HPA051748; -.
DR   HPA; HPA052661; -.
DR   MIM; 164021; gene.
DR   MIM; 603083; gene.
DR   neXtProt; NX_P14866; -.
DR   OpenTargets; ENSG00000104824; -.
DR   PharmGKB; PA162391389; -.
DR   eggNOG; KOG1456; Eukaryota.
DR   eggNOG; ENOG410XQHN; LUCA.
DR   GeneTree; ENSGT00550000074508; -.
DR   HOGENOM; HOG000293298; -.
DR   HOVERGEN; HBG105786; -.
DR   InParanoid; P14866; -.
DR   KO; K13159; -.
DR   OMA; RAGAMVK; -.
DR   OrthoDB; EOG091G0PR3; -.
DR   PhylomeDB; P14866; -.
DR   TreeFam; TF354318; -.
DR   Reactome; R-HSA-72163; mRNA Splicing - Major Pathway.
DR   Reactome; R-HSA-72203; Processing of Capped Intron-Containing Pre-mRNA.
DR   SIGNOR; P14866; -.
DR   ChiTaRS; HNRNPL; human.
DR   GeneWiki; HNRNPL; -.
DR   GenomeRNAi; 3191; -.
DR   PRO; PR:P14866; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   Bgee; ENSG00000104824; -.
DR   CleanEx; HS_HNRNPL; -.
DR   ExpressionAtlas; P14866; baseline and differential.
DR   Genevisible; P14866; HS.
DR   GO; GO:0005829; C:cytosol; IEA:Ensembl.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0016020; C:membrane; HDA:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; IDA:UniProtKB.
DR   GO; GO:0005634; C:nucleus; IDA:MGI.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IEA:Ensembl.
DR   GO; GO:0045120; C:pronucleus; IEA:Ensembl.
DR   GO; GO:1990904; C:ribonucleoprotein complex; IDA:UniProtKB.
DR   GO; GO:0035770; C:ribonucleoprotein granule; IDA:UniProtKB.
DR   GO; GO:0003730; F:mRNA 3'-UTR binding; IEA:Ensembl.
DR   GO; GO:1990715; F:mRNA CDS binding; IEA:Ensembl.
DR   GO; GO:0097157; F:pre-mRNA intronic binding; IDA:UniProtKB.
DR   GO; GO:0003723; F:RNA binding; HDA:UniProtKB.
DR   GO; GO:0044212; F:transcription regulatory region DNA binding; IDA:UniProtKB.
DR   GO; GO:0034198; P:cellular response to amino acid starvation; IEA:Ensembl.
DR   GO; GO:0007623; P:circadian rhythm; IEA:Ensembl.
DR   GO; GO:0000398; P:mRNA splicing, via spliceosome; TAS:Reactome.
DR   GO; GO:0048025; P:negative regulation of mRNA splicing, via spliceosome; IEA:Ensembl.
DR   GO; GO:1902416; P:positive regulation of mRNA binding; IEA:Ensembl.
DR   GO; GO:0045727; P:positive regulation of translation; IEA:Ensembl.
DR   GO; GO:0000381; P:regulation of alternative mRNA splicing, via spliceosome; IMP:UniProtKB.
DR   GO; GO:1901652; P:response to peptide; IEA:Ensembl.
DR   GO; GO:0016070; P:RNA metabolic process; TAS:Reactome.
DR   GO; GO:0006396; P:RNA processing; TAS:ProtInc.
DR   CDD; cd12780; RRM1_hnRNPL; 1.
DR   CDD; cd12785; RRM2_hnRNPL; 1.
DR   CDD; cd12699; RRM3_hnRNPL; 1.
DR   CDD; cd12704; RRM4_hnRNPL; 1.
DR   Gene3D; 3.30.70.330; -; 4.
DR   InterPro; IPR006536; HnRNP-L/PTB.
DR   InterPro; IPR034816; hnRNP-L_RRM3.
DR   InterPro; IPR035005; hnRNPL_RRM1.
DR   InterPro; IPR035008; hnRNPL_RRM2.
DR   InterPro; IPR034817; hnRNPL_RRM4.
DR   InterPro; IPR012677; Nucleotide-bd_a/b_plait_sf.
DR   InterPro; IPR035979; RBD_domain_sf.
DR   InterPro; IPR000504; RRM_dom.
DR   Pfam; PF00076; RRM_1; 2.
DR   SMART; SM00360; RRM; 3.
DR   SUPFAM; SSF54928; SSF54928; 3.
DR   TIGRFAMs; TIGR01649; hnRNP-L_PTB; 1.
DR   PROSITE; PS50102; RRM; 3.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Complete proteome;
KW   Cytoplasm; Direct protein sequencing; Isopeptide bond; Methylation;
KW   Nucleus; Phosphoprotein; Reference proteome; Repeat;
KW   Ribonucleoprotein; RNA-binding; Ubl conjugation.
FT   CHAIN         1    589       Heterogeneous nuclear ribonucleoprotein
FT                                L.
FT                                /FTId=PRO_0000081862.
FT   DOMAIN      102    176       RRM 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00176}.
FT   DOMAIN      193    270       RRM 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00176}.
FT   DOMAIN      382    478       RRM 3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00176}.
FT   DOMAIN      495    583       RRM 4. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00176}.
FT   COMPBIAS     39     89       Gly-rich.
FT   COMPBIAS    335    382       Pro-rich.
FT   MOD_RES      52     52       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     101    101       Phosphoserine.
FT                                {ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     185    185       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     269    269       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     291    291       Phosphoserine.
FT                                {ECO:0000244|PubMed:21406692}.
FT   MOD_RES     298    298       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     354    354       Asymmetric dimethylarginine.
FT                                {ECO:0000250|UniProtKB:Q8R081}.
FT   MOD_RES     358    358       Asymmetric dimethylarginine.
FT                                {ECO:0000250|UniProtKB:Q8R081}.
FT   MOD_RES     381    381       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q8R081}.
FT   MOD_RES     544    544       Phosphoserine; by CaMK4.
FT                                {ECO:0000269|PubMed:22570490}.
FT   CROSSLNK     59     59       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK     62     62       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:25218447,
FT                                ECO:0000244|PubMed:25755297,
FT                                ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    136    136       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:25772364,
FT                                ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    302    302       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    568    568       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   VAR_SEQ       1    133       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_044301.
FT   MUTAGEN     105    105       H->A: 6-fold decrease in RNA-binding
FT                                affinity. {ECO:0000269|PubMed:23782695}.
FT   MUTAGEN     132    132       V->A: 4-fold increase in RNA-binding
FT                                affinity. {ECO:0000269|PubMed:23782695}.
FT   MUTAGEN     141    141       L->A: 15-fold decrease in RNA-binding
FT                                affinity; when associated with A-174.
FT                                {ECO:0000269|PubMed:23782695}.
FT   MUTAGEN     172    172       N->A: 1-fold increase in RNA-binding
FT                                affinity. {ECO:0000269|PubMed:23782695}.
FT   MUTAGEN     174    174       S->A: 15-fold decrease in RNA-binding
FT                                affinity; when associated with A-174.
FT                                {ECO:0000269|PubMed:23782695}.
FT   MUTAGEN     504    504       H->A: Significant decrease in RNA-binding
FT                                affinity. {ECO:0000269|PubMed:23782695}.
FT   MUTAGEN     506    506       F->A: Significant decrease in RNA-binding
FT                                affinity. {ECO:0000269|PubMed:23782695}.
FT   CONFLICT    396    396       C -> G (in Ref. 1; BAB18649 and 5;
FT                                CAA34261). {ECO:0000305}.
FT   STRAND      102    108       {ECO:0000244|PDB:3R27}.
FT   HELIX       115    122       {ECO:0000244|PDB:3R27}.
FT   HELIX       123    125       {ECO:0000244|PDB:3R27}.
FT   STRAND      128    134       {ECO:0000244|PDB:3R27}.
FT   TURN        135    138       {ECO:0000244|PDB:3R27}.
FT   STRAND      139    146       {ECO:0000244|PDB:3R27}.
FT   HELIX       147    159       {ECO:0000244|PDB:3R27}.
FT   STRAND      162    164       {ECO:0000244|PDB:3R27}.
FT   STRAND      167    173       {ECO:0000244|PDB:3R27}.
FT   STRAND      382    387       {ECO:0000244|PDB:3TO8}.
FT   TURN        391    393       {ECO:0000244|PDB:3TO8}.
FT   HELIX       396    403       {ECO:0000244|PDB:3TO8}.
FT   TURN        404    406       {ECO:0000244|PDB:3TO8}.
FT   STRAND      409    414       {ECO:0000244|PDB:3TO8}.
FT   STRAND      421    428       {ECO:0000244|PDB:3TO8}.
FT   HELIX       429    439       {ECO:0000244|PDB:3TO8}.
FT   STRAND      450    453       {ECO:0000244|PDB:3TO8}.
FT   STRAND      472    476       {ECO:0000244|PDB:3TO8}.
FT   HELIX       488    491       {ECO:0000244|PDB:3TO8}.
FT   STRAND      501    508       {ECO:0000244|PDB:3TO8}.
FT   HELIX       514    524       {ECO:0000244|PDB:3TO8}.
FT   STRAND      530    534       {ECO:0000244|PDB:3TO8}.
FT   STRAND      543    548       {ECO:0000244|PDB:3TO8}.
FT   HELIX       552    562       {ECO:0000244|PDB:3TO8}.
FT   STRAND      572    574       {ECO:0000244|PDB:3TO8}.
FT   STRAND      579    582       {ECO:0000244|PDB:3TO8}.
SQ   SEQUENCE   589 AA;  64133 MW;  31EEB51AF1C65F83 CRC64;
     MSRRLLPRAE KRRRRLEQRQ QPDEQRRRSG AMVKMAAAGG GGGGGRYYGG GSEGGRAPKR
     LKTDNAGDQH GGGGGGGGGA GAAGGGGGGE NYDDPHKTPA SPVVHIRGLI DGVVEADLVE
     ALQEFGPISY VVVMPKKRQA LVEFEDVLGA CNAVNYAADN QIYIAGHPAF VNYSTSQKIS
     RPGDSDDSRS VNSVLLFTIL NPIYSITTDV LYTICNPCGP VQRIVIFRKN GVQAMVEFDS
     VQSAQRAKAS LNGADIYSGC CTLKIEYAKP TRLNVFKNDQ DTWDYTNPNL SGQGDPGSNP
     NKRQRQPPLL GDHPAEYGGP HGGYHSHYHD EGYGPPPPHY EGRRMGPPVG GHRRGPSRYG
     PQYGHPPPPP PPPEYGPHAD SPVLMVYGLD QSKMNCDRVF NVFCLYGNVE KVKFMKSKPG
     AAMVEMADGY AVDRAITHLN NNFMFGQKLN VCVSKQPAIM PGQSYGLEDG SCSYKDFSES
     RNNRFSTPEQ AAKNRIQHPS NVLHFFNAPL EVTEENFFEI CDELGVKRPS SVKVFSGKSE
     RSSSGLLEWE SKSDALETLG FLNHYQMKNP NGPYPYTLKL CFSTAQHAS
//
ID   Q6NTA2_HUMAN            Unreviewed;       572 AA.
AC   Q6NTA2;
DT   05-JUL-2004, integrated into UniProtKB/TrEMBL.
DT   16-DEC-2008, sequence version 2.
DT   28-FEB-2018, entry version 111.
DE   SubName: Full=HNRNPL protein {ECO:0000313|EMBL:AAH69184.2};
DE   Flags: Fragment;
GN   Name=HNRNPL {ECO:0000313|EMBL:AAH69184.2};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:AAH69184.2};
RN   [1] {ECO:0000313|EMBL:AAH69184.2}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Uterus {ECO:0000313|EMBL:AAH69184.2};
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RA   Gerhard D.S., Wagner L., Feingold E.A., Shenmen C.M., Grouse L.H.,
RA   Schuler G., Klein S.L., Old S., Rasooly R., Good P., Guyer M.,
RA   Peck A.M., Derge J.G., Lipman D., Collins F.S., Jang W., Sherry S.,
RA   Feolo M., Misquitta L., Lee E., Rotmistrovsky K., Greenhut S.F.,
RA   Schaefer C.F., Buetow K., Bonner T.I., Haussler D., Kent J.,
RA   Kiekhaus M., Furey T., Brent M., Prange C., Schreiber K., Shapiro N.,
RA   Bhat N.K., Hopkins R.F., Hsie F., Driscoll T., Soares M.B.,
RA   Casavant T.L., Scheetz T.E., Brown-stein M.J., Usdin T.B.,
RA   Toshiyuki S., Carninci P., Piao Y., Dudekula D.B., Ko M.S.,
RA   Kawakami K., Suzuki Y., Sugano S., Gruber C.E., Smith M.R.,
RA   Simmons B., Moore T., Waterman R., Johnson S.L., Ruan Y., Wei C.L.,
RA   Mathavan S., Gunaratne P.H., Wu J., Garcia A.M., Hulyk S.W., Fuh E.,
RA   Yuan Y., Sneed A., Kowis C., Hodgson A., Muzny D.M., McPherson J.,
RA   Gibbs R.A., Fahey J., Helton E., Ketteman M., Madan A., Rodrigues S.,
RA   Sanchez A., Whiting M., Madari A., Young A.C., Wetherby K.D.,
RA   Granite S.J., Kwong P.N., Brinkley C.P., Pearson R.L., Bouffard G.G.,
RA   Blakesly R.W., Green E.D., Dickson M.C., Rodriguez A.C., Grimwood J.,
RA   Schmutz J., Myers R.M., Butterfield Y.S., Griffith M., Griffith O.L.,
RA   Krzywinski M.I., Liao N., Morin R., Morrin R., Palmquist D.,
RA   Petrescu A.S., Skalska U., Smailus D.E., Stott J.M., Schnerch A.,
RA   Schein J.E., Jones S.J., Holt R.A., Baross A., Marra M.A., Clifton S.,
RA   Makowski K.A., Bosak S., Malek J.;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; BC069184; AAH69184.2; -; mRNA.
DR   RefSeq; NP_001005335.1; NM_001005335.1.
DR   RefSeq; NP_001524.2; NM_001533.2.
DR   UniGene; Hs.644906; -.
DR   IntAct; Q6NTA2; 1.
DR   PeptideAtlas; Q6NTA2; -.
DR   PRIDE; Q6NTA2; -.
DR   DNASU; 3191; -.
DR   GeneID; 3191; -.
DR   KEGG; hsa:3191; -.
DR   CTD; 3191; -.
DR   PharmGKB; PA162391389; -.
DR   eggNOG; KOG1456; Eukaryota.
DR   eggNOG; ENOG410XQHN; LUCA.
DR   HOVERGEN; HBG105786; -.
DR   KO; K13159; -.
DR   ChiTaRS; HNRNPL; human.
DR   GenomeRNAi; 3191; -.
DR   Genevisible; Q6NTA2; HS.
DR   GO; GO:0005634; C:nucleus; IEA:InterPro.
DR   GO; GO:0003723; F:RNA binding; IEA:UniProtKB-UniRule.
DR   GO; GO:0006397; P:mRNA processing; IEA:InterPro.
DR   CDD; cd12780; RRM1_hnRNPL; 1.
DR   CDD; cd12785; RRM2_hnRNPL; 1.
DR   CDD; cd12699; RRM3_hnRNPL; 1.
DR   CDD; cd12704; RRM4_hnRNPL; 1.
DR   Gene3D; 3.30.70.330; -; 4.
DR   InterPro; IPR006536; HnRNP-L/PTB.
DR   InterPro; IPR034816; hnRNP-L_RRM3.
DR   InterPro; IPR035005; hnRNPL_RRM1.
DR   InterPro; IPR035008; hnRNPL_RRM2.
DR   InterPro; IPR034817; hnRNPL_RRM4.
DR   InterPro; IPR012677; Nucleotide-bd_a/b_plait_sf.
DR   InterPro; IPR035979; RBD_domain_sf.
DR   InterPro; IPR000504; RRM_dom.
DR   Pfam; PF00076; RRM_1; 2.
DR   SMART; SM00360; RRM; 3.
DR   SUPFAM; SSF54928; SSF54928; 3.
DR   TIGRFAMs; TIGR01649; hnRNP-L_PTB; 1.
DR   PROSITE; PS50102; RRM; 3.
PE   2: Evidence at transcript level;
KW   RNA-binding {ECO:0000256|PROSITE-ProRule:PRU00176}.
FT   DOMAIN       85    159       RRM. {ECO:0000259|PROSITE:PS50102}.
FT   DOMAIN      176    253       RRM. {ECO:0000259|PROSITE:PS50102}.
FT   DOMAIN      365    439       RRM. {ECO:0000259|PROSITE:PS50102}.
FT   NON_TER       1      1       {ECO:0000313|EMBL:AAH69184.2}.
SQ   SEQUENCE   572 AA;  61927 MW;  5E5EB8F6773DC522 CRC64;
     QRQQPDEQRR RSGAMVKMAA AGGGGGGGRY YGGGSEGGRA PKRLKTDNAG DQHGGGGGGG
     GGAGAAGGGG GGENYDDPHK TPASPVVHIR GLIDGVVEAD LVEALQEFGP ISYVVVMPKK
     RQALVEFEDV LGACNAVNYA ADNQIYIAGH PAFVNYSTSQ KISRPGDSDD SRSVNSVLLF
     TILNPIYSIT TDVLYTICNP CGPVQRIVIF RKNGVQAMVE FDSVQSAQRA KASLNGADIY
     SGCCTLKIEY AKPTRLNVFK NDQDTWDYTN PNLSGQGDPG SNPNKRQRQP PLLGDHPAEY
     GGPHGGYHSH YHDEGYGPPP PHYEGRRMGP PVGGHRRGPS RYGPQYGHPP PPPPPPEYGP
     HADSPVLMVY GLDQSKMNCD RVFNVFCLYG NVEKVKFMKS KPGAAMVEMA DGYAVDRAIT
     HLNNNFMFGQ KLNVCVSKQP AIMPGQSYGL EDGSCSYKDF SESRNNRFST PEQAAKNRIQ
     HPSNVLHFFN APLEVTEENF FEICDELGVK RPSSVKVFSG KSERSSSGLL EWESKSDALE
     TLGFLNHYQM KNPNGPYPYT LKLCFSTAQH AS
//
